FN Clarivate Analytics Web of Science
VR 1.0
PT J
AU Poteryaev, D
   Datta, S
   Ackema, K
   Zerial, M
   Spang, A
AF Poteryaev, Dmitry
   Datta, Sunando
   Ackema, Karin
   Zerial, Marino
   Spang, Anne
TI Identification of the Switch in Early-to-Late Endosome Transition
SO CELL
LA English
DT Article
ID CAENORHABDITIS-ELEGANS; YEAST; PROTEINS; COMPLEX; RABEX-5; SPECIFICITY;
   ENDOCYTOSIS; MATURATION; CASCADE; VPS21
AB Sequential transport from early to late endosomes requires the coordinated activities of the small GTPases Rab5 and Rab7. The transition between early and late endosomes could be mediated either through transport carriers or by Rab conversion, a process in which the loss of Rab5 from an endosome occurs concomitantly to the acquisition of Rab7. We demonstrate that Rab conversion is the mechanism by which proteins pass from early to late endosomes in Caenorhabditis elegans coelomocytes. Moreover, we identified SAND-1/Mon1 as the critical switch for Rab conversion in metazoa. SAND-1 serves a dual role in this process. First, it interrupts the positive feedback loop of RAB-5 activation by displacing RABX-5 from endosomal membranes; second, it times the recruitment of RAB-7, probably through interaction with the HOPS complex to the same membranes. SAND-1/Mon1 thus acts as a switch by controlling the localization of RAB-5 and RAB-7 GEFs.
C1 [Poteryaev, Dmitry; Ackema, Karin; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Datta, Sunando; Zerial, Marino] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203;
   Poteryaev, Dmitry/0000-0003-2695-8869
FU University Basel; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF); Max Planck SocietyMax Planck Society
FX We thank H. Fares, N. Andrews, and J. Hegemann for reagents and I.G.
   Macara and M. Labouesse for critical reading of the manuscript. L.
   Bermudo and I. G. Macara are acknowledged for fruitful discussions, and
   B. Grant is thanked for providing information about the RABX-5 ORF. This
   work was supported by the University Basel, the Swiss National Science
   Foundation (A.S.), and the Max Planck Society (M.Z.).
CR Allan RB, 1999, SCIENCE, V285, P63, DOI 10.1126/science.285.5424.63
   Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009
   BRENNER S, 1974, GENETICS, V77, P71
   Christoforidis S, 1999, NATURE, V397, P621
   De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744
   de Wit H, 2001, MOL BIOL CELL, V12, P3703, DOI 10.1091/mbc.12.11.3703
   Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45
   Delprato A, 2004, CELL, V118, P607, DOI 10.1016/j.cell.2004.08.009
   Gerrard SR, 2000, MOL BIOL CELL, V11, P613, DOI 10.1091/mbc.11.2.613
   Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577
   Golemis E A, 1997, Methods Mol Biol, V63, P197
   Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717
   Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737
   Mattera R, 2008, EMBO J, V27, P2484, DOI 10.1038/emboj.2008.177
   MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7
   Ortiz D, 2002, J CELL BIOL, V157, P1005, DOI 10.1083/jcb.200201003
   Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006
   Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199
   Poteryaev D, 2005, BIOCHEM SOC T, V33, P606, DOI 10.1042/BST0330606
   Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498
   Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043
   Sato M, 2005, NAT CELL BIOL, V7, P559, DOI 10.1038/ncb1261
   Seachrist JL, 2000, J BIOL CHEM, V275, P27221
   Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665
   Shin HW, 2005, J CELL BIOL, V170, P607, DOI 10.1083/jcb.200505128
   Spang A, 2009, BIOL CHEM, V390, P753, DOI 10.1515/BC.2009.056
   STENMARK H, 1994, EMBO J, V13, P575, DOI 10.1002/j.1460-2075.1994.tb06295.x
   Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233
   Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200
   Xiao QF, 2009, ELECTRON J LINEAR AL, V18, P21
   Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011
   Zhu HP, 2007, MOL BIOL CELL, V18, P4119, DOI 10.1091/mbc.E07-02-0100
NR 32
TC 364
Z9 381
U1 1
U2 34
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD APR 30
PY 2010
VL 141
IS 3
BP 497
EP 508
DI 10.1016/j.cell.2010.03.011
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 589UX
UT WOS:000277180800020
PM 20434987
DA 2021-01-25
ER

PT J
AU Meier, M
   Seelig, J
AF Meier, Matthias
   Seelig, Joachim
TI Lipid and Peptide Dynamics in Membranes upon Insertion of
   n-alkyl-beta-D-Glucopyranosides
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID CYTOCHROME-C-OXIDASE; FATTY ACYL CHAINS; SOLID-STATE NMR;
   NUCLEAR-MAGNETIC-RESONANCE; TRANSMEMBRANE HELIX DIMER; OCTYL GLUCOSIDE;
   GLYCOPHORIN-A; HEAD GROUP; PHOSPHOLIPID-MEMBRANES; NEUTRON-DIFFRACTION
AB The effect of nonionic detergents of the n-alkyl-beta-D-glucopyranoside class on the ordering of lipid bilayers and the dynamics of membrane-embedded peptides were investigated with H-2- and P-31-NMR. 1,2-dipalmitoyl-sn-glycero-3-phosphocholine was selectively deuterated at methylene segments C-2, C-7, and C-16 of the two fatty acyl chains. Two trans-membrane helices, WALP-19 and glycophorin A(71-98), were synthesized with Ala-d(3) in the central region of the alpha-helix. n-Alkyl-beta-D-glucopyranosides with alkyl chains with 6, 7, 8, and 10 carbon atoms were added at increasing concentrations to the lipid membrane. The bilayer structure is retained up to a detergent/lipid molar ratio of 1:1. The insertion of the detergents leads to a selective disordering of the lipids. The headgroup region remains largely unaffected; the fatty acyl chain segments parallel to the detergent alkyl chain are only modestly disordered (10-20%), whereas lipid segments beyond the methyl terminus of the detergent show a decrease of up to 50%. The change in the bilayer order profile corresponds to an increase in bilayer entropy. Insertion of detergents into the lipid bilayers is completely entropy-driven. The entropy change accompanying lipid disorder is equivalent in magnitude to the hydrophobic effect. Ala-d(3) deuterated WALP-19 and GlycA(71-97) were incorporated into bilayers of 1,2-dimyristoyl-sn-glycero-3-phosphocholine at a peptide/lipid molar ratio of 1:100 and measured above the 1,2-dimyristoyl-sn-glycero-3-phosphocholine gel/liquid-crystal phase transition. Well-resolved H-2-NMR quadrupole splittings were observed for the two trans-membrane helices, revealing a rapid rotation of the CD3 methyl rotor superimposed on an additional rotation of the whole peptide around the bilayer normal. The presence of detergent fluidizes the membrane and produces magnetic alignment of bilayer domains but does not produce essential changes in the peptide conformation or dynamics.
C1 [Seelig, Joachim] Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
   [Meier, Matthias] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Basel, Switzerland.
EM joachim.seelig@unibas.ch
RI Meier, Matthias/C-6917-2013
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100-107793]
FX This work was supported by the Swiss National Science Foundation (grant
   3100-107793).
CR Aagaard TH, 2006, BIOPHYS CHEM, V119, P61, DOI 10.1016/j.bpc.2005.09.003
   Aisenbrey C, 2007, EUR BIOPHYS J BIOPHY, V36, P451, DOI 10.1007/s00249-006-0122-2
   ALMOG S, 1990, BIOCHEMISTRY-US, V29, P4582, DOI 10.1021/bi00471a012
   BESCHIASCHVILI G, 1992, BIOCHEMISTRY-US, V31, P10044, DOI 10.1021/bi00156a026
   BLOOM M, 1991, Q REV BIOPHYS, V24, P293, DOI 10.1017/S0033583500003735
   BULDT G, 1978, NATURE, V271, P182, DOI 10.1038/271182a0
   BULDT G, 1979, J MOL BIOL, V134, P673, DOI 10.1016/0022-2836(79)90479-0
   Cantor RS, 1999, BIOPHYS J, V77, P2643, DOI 10.1016/S0006-3495(99)77098-0
   Capalbi A, 2004, COLLOID SURFACE A, V246, P99, DOI 10.1016/j.colsurfa.2004.04.076
   Fang C, 2006, P NATL ACAD SCI USA, V103, P16740, DOI 10.1073/pnas.0608243103
   Fisher LE, 2003, BIOPHYS J, V85, P3097, DOI 10.1016/S0006-3495(03)74728-6
   Greathouse DV, 2001, J PEPT RES, V57, P519, DOI 10.1034/j.1399-3011.2001.00849.x
   Grisshammer Reinhard, 2005, Journal of Structural and Functional Genomics, V6, P159, DOI 10.1007/s10969-005-1917-6
   Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7
   Heerklotz H, 2001, BIOPHYS J, V80, P271, DOI 10.1016/S0006-3495(01)76012-2
   Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5
   JACKSON ML, 1982, BIOCHEMISTRY-US, V21, P4576, DOI 10.1021/bi00262a010
   Kobayashi M, 2008, BIOPHYS J, V94, P4339, DOI 10.1529/biophysj.107.123745
   Kobayashi T, 1999, BIOTECHNOL LETT, V21, P105, DOI 10.1023/A:1005441126579
   LEMMON MA, 1992, J BIOL CHEM, V267, P7683
   LICHTENBERG D, 1983, BIOCHIM BIOPHYS ACTA, V737, P285, DOI 10.1016/0304-4157(83)90004-7
   LICHTENBERG D, 1985, BIOCHIM BIOPHYS ACTA, V821, P470, DOI 10.1016/0005-2736(85)90052-5
   Liu W, 2003, BIOPHYS J, V84, P1263, DOI 10.1016/S0006-3495(03)74941-8
   Ly HV, 2004, BIOPHYS J, V87, P1013, DOI 10.1529/biophysj.103.034280
   MacKenzie KR, 1997, SCIENCE, V276, P131, DOI 10.1126/science.276.5309.131
   Majhi PR, 2001, LANGMUIR, V17, P3844, DOI 10.1021/la001660k
   MCINTOSH TJ, 1980, BIOCHIM BIOPHYS ACTA, V597, P445, DOI 10.1016/0005-2736(80)90219-9
   OLLIVON M, 1988, BIOCHEMISTRY-US, V27, P1695, DOI 10.1021/bi00405a047
   Opatowski E, 2002, J COLLOID INTERF SCI, V246, P380, DOI 10.1006/jcis.2001.8050
   Opatowski E, 1997, BIOPHYS J, V73, P1458, DOI 10.1016/S0006-3495(97)78178-5
   OTTEN D, 1995, BIOPHYS J, V68, P584, DOI 10.1016/S0006-3495(95)80220-1
   Otten D, 2000, J PHYS CHEM B, V104, P12119, DOI 10.1021/jp001505e
   PHILLIPS MC, 1969, CHEM PHYS LIPIDS, V3, P234, DOI 10.1016/0009-3084(69)90015-2
   Prive GG, 2007, METHODS, V41, P388, DOI 10.1016/j.ymeth.2007.01.007
   SEELIG A, 1975, BIOCHIM BIOPHYS ACTA, V406, P1, DOI 10.1016/0005-2736(75)90037-1
   SEELIG A, 1978, H-S Z PHYSIOL CHEM, V359, P1747, DOI 10.1515/bchm2.1978.359.2.1747
   SEELIG A, 1974, BIOCHEMISTRY-US, V13, P4839, DOI 10.1021/bi00720a024
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   SEELIG A, 1985, BIOCHIM BIOPHYS ACTA, V815, P153, DOI 10.1016/0005-2736(85)90283-4
   Seelig J., 1981, Membranes and Intercellular Communication. Proceedings of Les Houches Summer School, Session XXXIII, P15
   SEELIG J, 1985, BIOCHIM BIOPHYS ACTA, V814, P195, DOI 10.1016/0005-2736(85)90437-7
   SHAN X, 1994, BBA-BIOMEMBRANES, V1193, P127, DOI 10.1016/0005-2736(94)90341-7
   Strandberg E, 2004, BIOPHYS J, V86, P3709, DOI 10.1529/biophysj.103.035402
   STUBBS GW, 1976, BIOCHIM BIOPHYS ACTA, V426, P46, DOI 10.1016/0005-2736(76)90428-4
   TAMM LK, 1983, BIOCHEMISTRY-US, V22, P1474, DOI 10.1021/bi00275a023
   THURMOND RL, 1994, J PHYS CHEM-US, V98, P972, DOI 10.1021/j100054a038
   UENO M, 1984, BIOCHEMISTRY-US, V23, P3070, DOI 10.1021/bi00308a034
   van der Wel PCA, 2002, BIOPHYS J, V83, P1479, DOI 10.1016/S0006-3495(02)73918-0
   Wenk MR, 1997, BIOPHYS J, V72, P1719, DOI 10.1016/S0006-3495(97)78818-0
   WESTERMAN PW, 1988, BIOCHIM BIOPHYS ACTA, V939, P64, DOI 10.1016/0005-2736(88)90048-X
   Wojtowicz P.J., 1974, INTRO LIQUID CRYSTAL, P31
   Yeliseev AA, 2005, PROTEIN SCI, V14, P2638, DOI 10.1110/ps.051550305
NR 52
TC 7
Z9 7
U1 0
U2 17
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD APR 21
PY 2010
VL 98
IS 8
BP 1529
EP 1538
DI 10.1016/j.bpj.2009.12.4286
PG 10
WC Biophysics
SC Biophysics
GA 586UT
UT WOS:000276939800019
PM 20409472
OA Green Published
DA 2021-01-25
ER

PT J
AU Chanut-Delalande, H
   Jung, AC
   Baer, MM
   Lin, L
   Payre, F
   Affolter, M
AF Chanut-Delalande, Helene
   Jung, Alain C.
   Baer, Magdalena M.
   Lin, Li
   Payre, Francois
   Affolter, Markus
TI The Hrs/Stam Complex Acts as a Positive and Negative Regulator of RTK
   Signaling during Drosophila Development
SO PLOS ONE
LA English
DT Article
ID RECEPTOR TYROSINE KINASES; GROWTH-FACTOR RECEPTOR; TRACHEAL
   CELL-MIGRATION; DOWN-REGULATION; BRANCHING MORPHOGENESIS; ENDOSOMAL
   TRAFFICKING; ESCRT MACHINERY; MOSAIC ANALYSIS; EGF-RECEPTOR; HRS
AB Background: Endocytosis is a key regulatory step of diverse signalling pathways, including receptor tyrosine kinase (RTK) signalling. Hrs and Stam constitute the ESCRT-0 complex that controls the initial selection of ubiquitinated proteins, which will subsequently be degraded in lysosomes. It has been well established ex vivo and during Drosophila embryogenesis that Hrs promotes EGFR down regulation. We have recently isolated the first mutations of stam in flies and shown that Stam is required for air sac morphogenesis, a larval respiratory structure whose formation critically depends on finely tuned levels of FGFR activity. This suggest that Stam, putatively within the ESCRT-0 complex, modulates FGF signalling, a possibility that has not been examined in Drosophila yet.
   Principal Findings: Here, we assessed the role of the Hrs/Stam complex in the regulation of signalling activity during Drosophila development. We show that stam and hrs are required for efficient FGFR signalling in the tracheal system, both during cell migration in the air sac primordium and during the formation of fine cytoplasmic extensions in terminal cells. We find that stam and hrs mutant cells display altered FGFR/Btl localisation, likely contributing to impaired signalling levels. Electron microscopy analyses indicate that endosome maturation is impaired at distinct steps by hrs and stam mutations. These somewhat unexpected results prompted us to further explore the function of stam and hrs in EGFR signalling. We show that while stam and hrs together downregulate EGFR signalling in the embryo, they are required for full activation of EGFR signalling during wing development.
   Conclusions/Significance: Our study shows that the ESCRT-0 complex differentially regulates RTK signalling, either positively or negatively depending on tissues and developmental stages, further highlighting the importance of endocytosis in modulating signalling pathways during development.
C1 [Chanut-Delalande, Helene; Jung, Alain C.; Baer, Magdalena M.; Lin, Li; Affolter, Markus] Univ Basel, Biozentrum, Abt Zellbiol, Basel, Switzerland.
   [Chanut-Delalande, Helene; Payre, Francois] Univ Toulouse 3, Ctr Biol Dev, UPS, Univ Toulouse, F-31062 Toulouse, France.
   [Chanut-Delalande, Helene; Payre, Francois] Ctr Dev Biol, CNRS, UMR5547, Toulouse, France.
RP Chanut-Delalande, H (corresponding author), Univ Basel, Biozentrum, Abt Zellbiol, Basel, Switzerland.
EM chanut@cict.fr; markus.affolter@unibas.ch
RI Jung, Alain/AAC-6598-2019; Jung, Alain/X-5384-2019
OI Jung, Alain/0000-0002-4049-4151; PAYRE, Francois/0000-0002-8144-6711;
   Affolter, Markus/0000-0002-5171-0016; Baer,
   Magdalena/0000-0003-3315-0921; CHANUT-DELALANDE,
   Helene/0000-0002-1720-2069
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Kantons Basel-Stadt and Basel-Land; European CommissionEuropean
   CommissionEuropean Commission Joint Research Centre; Association pour la
   Recherche contre le Cancer n [1111]; ANR Programme Blanc NetoshapeFrench
   National Research Agency (ANR)
FX Studies done in the laboratory of Markus Affolter are supported by
   research grants from the Swiss National Science Foundation, the Kantons
   Basel-Stadt and Basel-Land, and the European Commission via the FP6
   Network of Excellence "Cells into organs''. Experiments performed in
   Francois Payre laboratory are supported by Association pour la Recherche
   contre le Cancer n degrees 1111 and ANR Programme Blanc Netoshape. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0
   Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498
   Asao H, 1997, J BIOL CHEM, V272, P32785, DOI 10.1074/jbc.272.52.32785
   Bache KG, 2004, EMBO J, V23, P2707, DOI 10.1038/sj.emboj.7600292
   Bache KG, 2003, J CELL BIOL, V162, P435, DOI 10.1083/jcb.200302131
   Bache KG, 2003, J BIOL CHEM, V278, P12513, DOI 10.1074/jbc.M210843200
   Belleudi F, 2007, TRAFFIC, V8, P1854, DOI 10.1111/j.1600-0854.2007.00651.x
   Blair SS, 2007, ANNU REV CELL DEV BI, V23, P293, DOI 10.1146/annurev.cellbio.23.090506.123606
   Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008
   Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020
   Chanut-Delalande H, 2007, GENETICS, V176, P2177, DOI 10.1534/genetics.107.073890
   Dammai V, 2003, GENE DEV, V17, P2812, DOI 10.1101/gad.1096903
   Devergne O, 2007, J CELL SCI, V120, P3457, DOI 10.1242/jcs.005926
   Fischer JA, 2006, ANNU REV CELL DEV BI, V22, P181, DOI 10.1146/annurev.cellbio.22.010605.093205
   Gabay L, 1997, DEVELOPMENT, V124, P3535
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   Golembo M, 1996, DEVELOPMENT, V122, P223
   Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9
   Jekely G, 2005, DEV CELL, V9, P197, DOI 10.1016/j.devcel.2005.06.004
   Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019
   Kanazawa C, 2003, BIOCHEM BIOPH RES CO, V309, P848, DOI 10.1016/j.bbrc.2003.08.078
   Katzmann DJ, 2003, J CELL BIOL, V162, P413, DOI 10.1083/jcb.200302136
   Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973
   Kim MS, 2006, BIOCHEM BIOPH RES CO, V351, P612, DOI 10.1016/j.bbrc.2006.10.068
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   KOSAKA T, 1983, J CELL BIOL, V97, P499, DOI 10.1083/jcb.97.2.499
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6
   Lu Q, 2003, P NATL ACAD SCI USA, V100, P7626, DOI 10.1073/pnas.0932599100
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Marmor MD, 2004, ONCOGENE, V23, P2057, DOI 10.1038/sj.onc.1207390
   McCullough J, 2006, CURR BIOL, V16, P160, DOI 10.1016/j.cub.2005.11.073
   Miura GI, 2008, DEVELOPMENT, V135, P1913, DOI 10.1242/dev.017202
   Prag G, 2007, DEV CELL, V12, P973, DOI 10.1016/j.devcel.2007.04.013
   Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791
   Reich A, 2002, EMBO J, V21, P4287, DOI 10.1093/emboj/cdf439
   Row PE, 2005, BIOCHEM J, V389, P629, DOI 10.1042/BJ20050067
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2
   Sato M, 2008, DEV BIOL, V318, P247, DOI 10.1016/j.ydbio.2008.03.025
   Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/S0092-8674(00)00114-8
   Shilo BZ, 2003, EXP CELL RES, V284, P140, DOI 10.1016/S0014-4827(02)00094-0
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020
   Urbe S, 2003, J CELL SCI, V116, P4169, DOI 10.1242/jcs.00723
   Vecchione A, 2007, PROTEOMICS, V7, P4565, DOI 10.1002/pmic.200700615
   WEAVER M, 2008, SCIENCE
   Williams RL, 2007, NAT REV MOL CELL BIO, V8, P355, DOI 10.1038/nrm2162
   Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087
NR 49
TC 31
Z9 31
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 21
PY 2010
VL 5
IS 4
AR e10245
DI 10.1371/journal.pone.0010245
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 586YS
UT WOS:000276952500013
PM 20422006
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Tanaka, KF
   Ahmari, SE
   Leonardo, ED
   Richardson-Jones, JW
   Budreck, EC
   Scheiffele, P
   Sugio, S
   Inamura, N
   Ikenaka, K
   Hen, R
AF Tanaka, Kenji F.
   Ahmari, Susanne E.
   Leonardo, E. David
   Richardson-Jones, Jesse W.
   Budreck, Elaine C.
   Scheiffele, Peter
   Sugio, Shouta
   Inamura, Naoko
   Ikenaka, Kazuhiro
   Hen, Rene
TI Flexible Accelerated STOP Tetracycline Operator-Knockin (FAST): A
   Versatile and Efficient New Gene Modulating System
SO BIOLOGICAL PSYCHIATRY
LA English
DT Article
DE Animal model; conditional modulation of gene expression; developmental
   change; gene targeting; genetics; mouse
ID MICE; EXPRESSION; PROMOTERS; MUTATIONS; MOUSE
AB We created the Flexible Accelerated STOP Tetracycline Operator (tetO)-knockin (FAST) system, an efficient method for manipulating gene expression in vivo to rapidly screen animal models of disease. A single gene targeting event yields two distinct knockin mice STOP-tetO and tetO knockin that permit generation of multiple strains with variable expression patterns: 1) knockout, 2) Cre-mediated rescue, 3) tetracycline-controlled transcriptional activator (tTA)-mediated misexpression, 4) tetracycline-controlled transcriptional activator (tTA)mediated overexpression, and 5) tetracycline-controlled transcriptional silencer (tTS)-mediated conditional knockout/knockdown. Using the FAST system, multiple gain-of-function and loss-of-function strains can therefore be generated on a time scale not previously achievable. These strains can then be screened for clinically relevant abnormalities. We demonstrate the flexibility and broad applicability of the FAST system by targeting several genes encoding proteins implicated in neuropsychiatric disorders: Mid, neuroligin 3, the serotonin 1 A receptor, and the serotonin 1B receptor.
C1 [Tanaka, Kenji F.; Ahmari, Susanne E.; Leonardo, E. David; Richardson-Jones, Jesse W.; Hen, Rene] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.
   [Tanaka, Kenji F.; Ahmari, Susanne E.; Leonardo, E. David; Richardson-Jones, Jesse W.; Hen, Rene] Columbia Univ, Coll Phys & Surg, Dept Pharmacol & Psychiat, New York, NY 10032 USA.
   [Tanaka, Kenji F.; Inamura, Naoko; Ikenaka, Kazuhiro] Natl Inst Physiol Sci, Div Neurobiol & Bioinformat, Okazaki, Aichi 444, Japan.
   [Tanaka, Kenji F.; Sugio, Shouta; Ikenaka, Kazuhiro] Grad Univ Adv Studies SOKENDAI, Sch Life Sci, Dept Physiol Sci, Kanagawa, Japan.
   [Budreck, Elaine C.; Scheiffele, Peter] Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
RP Hen, R (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.
EM rh95@columbia.edu
RI Ahmari, Susanne E./J-5812-2013; Leonardo, Eduardo/AAH-1525-2020
OI Ahmari, Susanne E./0000-0003-4576-076X; Leonardo,
   Eduardo/0000-0001-7426-0217; Tanaka, Kenji/0000-0003-2511-0057
FU NARSAD (National Alliance Or Research on Schizophrenia and
   Depression)NARSAD [2008]; Monbukagakusho (MEXT)Ministry of Education,
   Culture, Sports, Science and Technology, Japan (MEXT); Ruth L.
   Kirschstein National Research ServiceUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [F30MH083473];
   National Institute of Mental HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Mental Health (NIMH) [T32]; NATIONAL INSTITUTE OF MENTAL
   HEALTHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R37MH068542, T32MH015144, K08MH076083, R37MH068542, T32MH015144,
   R37MH068542, R37MH068542, T32MH015144, T32MH015144, K08MH076083,
   T32MH015144, T32MH015144, T32MH015144, T32MH015144, R37MH068542,
   R37MH068542, T32MH015144, R37MH068542, T32MH015144, T32MH015144,
   R37MH068542, T32MH015144, F30MH083473, T32MH015144, T32MH015144,
   R37MH068542, T32MH015144, T32MH015144, T32MH015144, K08MH076083,
   T32MH015144, T32MH015144, K08MH076083, T32MH015144, T32MH015144,
   T32MH015144, T32MH015144, T32MH015144, T32MH015144, T32MH015144,
   T32MH015144, T32MH015144, K08MH076083, T32MH015144, T32MH015144,
   T32MH015144, T32MH015144, T32MH015144, F30MH083473, K08MH076083,
   T32MH015144, T32MH015144, R37MH068542, R37MH068542, F30MH083473] Funding
   Source: NIH RePORTER
FX KFT was supported by a NARSAD (National Alliance Or Research on
   Schizophrenia and Depression) 2008 Young Investigator Award and by
   Monbukagakusho (MEXT) Grant-in-Aid Or Young Scientists B. ECB was
   supported by Ruth L. Kirschstein National Research Service Award
   fellowship (F30MH083473). SEA was supported by a National Institute of
   Mental Health T32 research fellowship.
CR DEUSCHLE U, 1995, MOL CELL BIOL, V15, P1907
   Dietrich P, 2000, MAMM GENOME, V11, P196, DOI 10.1007/s003350010037
   Farley FW, 2000, GENESIS, V28, P106, DOI 10.1002/1526-968X(200011/12)28:3/4<106::AID-GENE30>3.0.CO;2-T
   GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547
   Gross C, 2002, NATURE, V416, P396, DOI 10.1038/416396a
   Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389
   Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059
   Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136
   LAKSO M, 1992, P NATL ACAD SCI USA, V89, P6232, DOI 10.1073/pnas.89.14.6232
   Leegwater PAJ, 2001, AM J HUM GENET, V68, P831, DOI 10.1086/319519
   Mallo M, 2003, GENOMICS, V81, P356, DOI 10.1016/S0888-7543(03)00032-6
   Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678
   Meyer J, 2001, MOL PSYCHIATR, V6, P302, DOI 10.1038/sj.mp.4000869
   Richardson-Jones JW, 2010, NEURON, V65, P40, DOI 10.1016/j.neuron.2009.12.003
   Weisstaub NV, 2006, SCIENCE, V313, P536, DOI 10.1126/science.1123432
NR 15
TC 62
Z9 65
U1 0
U2 3
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0006-3223
EI 1873-2402
J9 BIOL PSYCHIAT
JI Biol. Psychiatry
PD APR 15
PY 2010
VL 67
IS 8
BP 770
EP 773
DI 10.1016/j.biopsych.2009.12.020
PG 4
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 584EE
UT WOS:000276732600011
PM 20163789
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Schonichen, A
   Bigalke, JM
   Urbanke, C
   Grzesiek, S
   Dames, SA
   Geyer, M
AF Schoenichen, Andre
   Bigalke, Janna M.
   Urbanke, Claus
   Grzesiek, Stephan
   Dames, Sonja A.
   Geyer, Matthias
TI A Flexible Bipartite Coiled Coil Structure Is Required for the
   Interaction of Hexim1 with the P-TEFb Subunit Cyclin T1
SO BIOCHEMISTRY
LA English
DT Article
ID RNA-POLYMERASE-II; 7SK SNRNA; TRANSCRIPTION ELONGATION; BINDING DOMAIN;
   HIV-1 TAT; PROTEIN; COMPLEX; RIBONUCLEOPROTEIN; ALPHA; PHOSPHORYLATION
AB Transcription elongation is regulated by the cellular protein Hexim1, which inhibits phosphorylation of RNA polymerase II by interacting with the positive transcription elongation factor P-TEFb. Hexim1 binds directly to Cyclin T1 of P-TEFb with its coiled coil domain that is subdivided into a highly polar N-terminal segment containing nonconservative residues in the dimer interface and a C-terminal segment with an evolutionarily conserved sequence composition. Here we show that the noncanonical sequence composition of the first coiled coil segment is required for the interaction with Cyclin T1 while the second segment keeps the Cyclin T-binding domain dimeric upon binding. Both coiled coil segments exhibit distinct melting points as shown by heat denaturation experiments using circular dichroism spectroscopy. Deletion of the central stammer motif (Delta 316-318) leads to a single denaturation reaction, suggesting formation of a continuous coiled coil. Mutation of noncanonical coiled coil residues K284 and Y291 to valines in the dimer interface of the first segment only slightly increases its stability. Concomitantly, deletion of the stammer but not the double point mutation led to a reduced affinity for Cyclin T1 as shown by isothermal titration calorimetry. Moreover, Cyclin T1 bound Hexim1 with a 1:2 stoichiometry, whereas truncation of the C-terminal coiled coil led to formation of an equimolar complex. These observations suggest that binding to Cyclin T1 induces an asymmetry or sterical hindrance in the first coiled coil segment of dimeric Hexim1 that disallows formation of a 2:2 complex as further supported by analytical ultracentrifugation and cross-linking experiments.
C1 [Schoenichen, Andre; Bigalke, Janna M.; Geyer, Matthias] Max Planck Inst Mol Physiol, Phys Biochem Abt, D-44227 Dortmund, Germany.
   [Urbanke, Claus] Hannover Med Sch, D-30625 Hannover, Germany.
   [Grzesiek, Stephan; Dames, Sonja A.] Univ Basel, Dept Biol Struct, Biozentrum Basel, CH-4056 Basel, Switzerland.
RP Geyer, M (corresponding author), Max Planck Inst Mol Physiol, Phys Biochem Abt, Otto Hahn Str 11, D-44227 Dortmund, Germany.
EM maithias.geyer@mpi-dortmund.mpg.de
OI Dames, Sonja/0000-0001-7495-6943; Geyer, Matthias/0000-0002-7718-5002;
   Grzesiek, Stephan/0000-0003-1998-4225
FU Deutsche ForschungsaemeinschaftGerman Research Foundation (DFG)
   [GE-976/5]; Schweizer National-fonds [31-109712]; Treubel Fonds (Basel,
   Switzerland)
FX This work was supported by grants from the Deutsche
   Forschungsaemeinschaft to M.G. (GE-976/5) and from the Schweizer
   National-fonds to S.G. (SNF Grant 31-109712). S.A.D. was supported by a
   fellowship from the Treubel Fonds (Basel, Switzerland).
CR Anand K, 2008, NAT STRUCT MOL BIOL, V15, P1287, DOI 10.1038/nsmb.1513
   Anand K, 2007, J MOL BIOL, V370, P826, DOI 10.1016/j.jmb.2007.04.077
   Barboric M, 2009, P NATL ACAD SCI USA, V106, P7798, DOI 10.1073/pnas.0903188106
   Baumli S, 2008, EMBO J, V27, P1907, DOI 10.1038/emboj.2008.121
   Belanger F, 2009, J MOL BIOL, V386, P1094, DOI 10.1016/j.jmb.2009.01.015
   Bergbrede T, 2009, J BIOL CHEM, V284, P2628, DOI 10.1074/jbc.M806003200
   Bisgrovet DA, 2007, P NATL ACAD SCI USA, V104, P13690, DOI 10.1073/pnas.0705053104
   Breuer S, 2006, BIOCHEMISTRY-US, V45, P2339, DOI 10.1021/bi052052c
   Brown JH, 1996, PROTEINS, V26, P134
   Czudnochowski N, 2010, J MOL BIOL, V395, P28, DOI 10.1016/j.jmb.2009.10.055
   Dames SA, 2007, P NATL ACAD SCI USA, V104, P14312, DOI 10.1073/pnas.0701848104
   Dong G, 2007, MOL CELL, V25, P455, DOI 10.1016/j.molcel.2007.01.013
   Dulac C, 2005, J BIOL CHEM, V280, P30619, DOI 10.1074/jbc.M502471200
   Egloff S, 2006, MOL CELL BIOL, V26, P630, DOI 10.1128/MCB.26.2.630-642.2006
   Erickson HP, 2009, BIOL PROCED ONLINE, V11, P32, DOI 10.1007/s12575-009-9008-x
   He N, 2008, MOL CELL, V29, P588, DOI 10.1016/j.molcel.2008.01.003
   Hulko M, 2006, CELL, V126, P929, DOI 10.1016/j.cell.2006.06.058
   JANE M, 2005, MOL CELL, V19, P523
   Jeronimo C, 2007, MOL CELL, V27, P262, DOI 10.1016/j.molcel.2007.06.027
   Krueger BJ, 2008, NUCLEIC ACIDS RES, V36, P2219, DOI 10.1093/nar/gkn061
   Laue T. M., 1992, ANAL ULTRACENTRIFUGA, P90, DOI DOI 10.1007/S00249-009-0425-1
   Lebowitz J, 2002, PROTEIN SCI, V11, P2067, DOI 10.1110/ps.0207702
   Lee HH, 2008, SCIENCE, V322, P576, DOI 10.1126/science.1162042
   Li QT, 2007, NUCLEIC ACIDS RES, V35, P2503, DOI 10.1093/nar/gkm150
   Li QT, 2005, J BIOL CHEM, V280, P28819, DOI 10.1074/jbc.M502712200
   Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0
   Margaritis T, 2008, CELL, V133, P581, DOI 10.1016/j.cell.2008.04.027
   Markert A, 2008, EMBO REP, V9, P569, DOI 10.1038/embor.2008.72
   Mason JM, 2004, CHEMBIOCHEM, V5, P170, DOI 10.1002/cbic.200300781
   Michels AA, 2004, EMBO J, V23, P2608, DOI 10.1038/sj.emboj.7600275
   Michels AA, 2003, MOL CELL BIOL, V23, P4859, DOI 10.1128/MCB.23.14.4859-4869.2003
   Michels Annemieke A., 2008, Biotechnology Journal, V3, P1022, DOI 10.1002/biot.200800104
   Peterlin BM, 2006, MOL CELL, V23, P297, DOI 10.1016/j.molcel.2006.06.014
   Ping YH, 2001, J BIOL CHEM, V276, P12951, DOI 10.1074/jbc.M006130200
   Pylypenko O, 2008, J MOL BIOL, V377, P1334, DOI 10.1016/j.jmb.2008.01.099
   Qiang Z, 2006, MICROBIOL MOL BIOL R, V70, P646, DOI 10.1128/MMBR.00011-06
   Sato Y, 2007, P NATL ACAD SCI USA, V104, P8305, DOI 10.1073/pnas.0701550104
   Saunders A, 2006, NAT REV MOL CELL BIO, V7, P557, DOI 10.1038/nrm1981
   Schonichen A, 2006, J BIOL CHEM, V281, P5084, DOI 10.1074/jbc.M509226200
   Schulte A, 2005, J BIOL CHEM, V280, P24968, DOI 10.1074/jbc.M501431200
   Vollmuth F, 2009, J BIOL CHEM, V284, P36547, DOI 10.1074/jbc.M109.033712
   Wada T, 1998, EMBO J, V17, P7395, DOI 10.1093/emboj/17.24.7395
   Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2
   Xue YH, 2010, NUCLEIC ACIDS RES, V38, P360, DOI 10.1093/nar/gkp977
   Yang ZY, 2005, MOL CELL, V19, P535, DOI 10.1016/j.molcel.2005.06.029
   Yik JHN, 2003, MOL CELL, V12, P971, DOI 10.1016/S1097-2765(03)00388-5
NR 46
TC 11
Z9 11
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD APR 13
PY 2010
VL 49
IS 14
BP 3083
EP 3091
DI 10.1021/bi902072f
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 577YB
UT WOS:000276258800012
PM 20210365
DA 2021-01-25
ER

PT J
AU Bottova, I
   Sauder, U
   Olivieri, V
   Hehl, AB
   Sonda, S
AF Bottova, Iveta
   Sauder, Ursula
   Olivieri, Vesna
   Hehl, Adrian B.
   Sonda, Sabrina
TI The P-glycoprotein Inhibitor GF120918 Modulates Ca2+-Dependent Processes
   and Lipid Metabolism in Toxoplasma Gondii
SO PLOS ONE
LA English
DT Article
ID REGULATORY VOLUME DECREASE; MULTIDRUG-RESISTANCE; HOST-CELLS;
   APICOMPLEXAN PARASITES; NEOSPORA-CANINUM; IN-VITRO; INTRACELLULAR
   CALCIUM; SUBCELLULAR-LOCALIZATION; EXPRESSION ANALYSIS; GLIDING MOTILITY
AB Up-regulation of the membrane-bound efflux pump P-glycoprotein (P-gp) is associated with the phenomenon of multidrug-resistance in pathogenic organisms, including protozoan parasites. In addition, P-gp plays a role in normal physiological processes, however our understanding of these P-gp functions remains limited. In this study we investigated the effects of the P-gp inhibitor GF120918 in Toxoplasma gondii, a model apicomplexan parasite and an important human pathogen. We found that GF120918 treatment severely inhibited parasite invasion and replication. Further analyses of the molecular mechanisms involved revealed that the P-gp inhibitor modulated parasite motility, microneme secretion and egress from the host cell, all cellular processes known to depend on Ca2+ signaling in the parasite. In support of a potential role of P-gp in Ca2+-mediated processes, immunoelectron and fluorescence microscopy showed that T. gondii Pgp was localized in acidocalcisomes, the major Ca2+ storage in the parasite, at the plasma membrane, and in the intravacuolar tubular network. In addition, metabolic labeling of extracellular parasites revealed that inhibition or down-regulation of T. gondii P-gp resulted in aberrant lipid synthesis. These results suggest a crucial role of T. gondii P-gp in essential processes of the parasite biology and further validate the potential of P-gp activity as a target for drug development.
C1 [Bottova, Iveta; Hehl, Adrian B.; Sonda, Sabrina] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland.
   [Sauder, Ursula; Olivieri, Vesna] Univ Basel, Biozentrum, Basel, Switzerland.
RP Bottova, I (corresponding author), Univ Zurich, Inst Parasitol, Winterthurerstr 266A, CH-8057 Zurich, Switzerland.
EM sabrina.sonda@vetparas.uzh.ch
OI Hehl, Adrian/0000-0002-2110-4445
FU Marie Heim-Voegtlin Foundation; Fondation Pierre Mercier pour la
   Science; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF) [3100A0-112327]; SBF (Staatssekretariat fur Bildung
   und Forschung) [C03.0007]
FX This work was supported by grants of the Marie Heim-Voegtlin Foundation
   and Fondation Pierre Mercier pour la Science to SS and of the Swiss
   National Science Foundation (Grant nr. 3100A0-112327) and grant C03.0007
   (COST Action 857) from the SBF (Staatssekretariat fur Bildung und
   Forschung) to ABH. The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750
   Allikmets R, 1996, HUM MOL GENET, V5, P1649, DOI 10.1093/hmg/5.10.1649
   Austin C, 2000, CIRC RES, V86, P355, DOI 10.1161/01.RES.86.3.355
   Bardelmeijer HA, 2004, INVEST NEW DRUG, V22, P219, DOI 10.1023/B:DRUG.0000026248.45084.21
   Black MW, 2000, MOL CELL BIOL, V20, P9399, DOI 10.1128/MCB.20.24.9399-9408.2000
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Bottova I, 2009, J BIOL CHEM, V284, P17438, DOI 10.1074/jbc.M809420200
   Carey KL, 2004, P NATL ACAD SCI USA, V101, P7433, DOI 10.1073/pnas.0307769101
   Carruthers VB, 1999, CELL MICROBIOL, V1, P225, DOI 10.1046/j.1462-5822.1999.00023.x
   Carruthers VB, 2000, J BIOL CHEM, V275, P14346, DOI 10.1074/jbc.275.19.14346
   Charron AJ, 2002, J CELL SCI, V115, P3049
   Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056
   Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167
   Drozdowicz YM, 2003, J BIOL CHEM, V278, P1075, DOI 10.1074/jbc.M209436200
   ENDO T, 1982, EXP PARASITOL, V53, P179, DOI 10.1016/0014-4894(82)90059-5
   Ernest S, 1999, J AM SOC NEPHROL, V10, P2306
   Evers R, 2000, BRIT J CANCER, V83, P366, DOI 10.1054/bjoc.2000.1260
   Ford JM, 1996, EUR J CANCER, V32A, P991, DOI 10.1016/0959-8049(96)00047-0
   Fritz F, 1999, BIOCHEMISTRY-US, V38, P4214, DOI 10.1021/bi981929n
   Fuchs N, 1998, J PARASITOL, V84, P753, DOI 10.2307/3284583
   Hakansson S, 1999, MOL BIOL CELL, V10, P3539, DOI 10.1091/mbc.10.11.3539
   Hemphill A, 1996, INFECT IMMUN, V64, P4279, DOI 10.1128/IAI.64.10.4279-4287.1996
   Hemphill A, 1996, PARASITOLOGY, V112, P183, DOI 10.1017/S0031182000084754
   HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435
   HIGH KP, 1994, TRANSPLANTATION, V57, P1689, DOI 10.1097/00007890-199406270-00001
   Hoff EF, 2002, TRENDS PARASITOL, V18, P251, DOI 10.1016/S1471-4922(02)02240-7
   Hoffman MM, 1997, BIOCHEMISTRY-US, V36, P11153, DOI 10.1021/bi970530g
   HOMOLYA L, 1993, J BIOL CHEM, V268, P21493
   Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217
   HYAFIL F, 1993, CANCER RES, V53, P4595
   Jewett TJ, 2003, MOL CELL, V11, P885, DOI 10.1016/S1097-2765(03)00113-8
   Lavine MD, 2008, EUKARYOT CELL, V7, P131, DOI 10.1128/EC.00301-07
   Lefurgey A, 2005, J EUKARYOT MICROBIOL, V52, P277, DOI 10.1111/j.1550-7408.2005.00030.x
   Lovett JL, 2003, J CELL SCI, V116, P3009, DOI 10.1242/jcs.00596
   Luo SH, 2005, MOL MICROBIOL, V55, P1034, DOI 10.1111/j.1365-2958.2004.04464.x
   Maier P, 2006, RADIAT RES, V166, P463, DOI 10.1667/RR0550.1
   McAllister MM, 1996, J PARASITOL, V82, P354, DOI 10.2307/3284181
   MESTDAGH N, 1994, BIOCHEM PHARMACOL, V48, P709, DOI 10.1016/0006-2952(94)90048-5
   Miranda K, 2008, EXP PARASITOL, V118, P2, DOI 10.1016/j.exppara.2007.07.009
   Mondragon R, 1996, J EUKARYOT MICROBIOL, V43, P120, DOI 10.1111/j.1550-7408.1996.tb04491.x
   Moreno SNJ, 2003, CURR OPIN MICROBIOL, V6, P359, DOI 10.1016/S1369-5274(03)00091-2
   Moudy R, 2001, J BIOL CHEM, V276, P41492, DOI 10.1074/jbc.M106154200
   Nagamune Kisaburo, 2008, V47, P70
   Orlowski S, 2006, CELL MOL LIFE SCI, V63, P1038, DOI 10.1007/s00018-005-5554-9
   Persson EK, 2007, J IMMUNOL, V179, P8357, DOI 10.4049/jimmunol.179.12.8357
   Robert J, 1998, Expert Opin Investig Drugs, V7, P929, DOI 10.1517/13543784.7.6.929
   Rodrigues AC, 2009, EUR J PHARM SCI, V37, P486, DOI 10.1016/j.ejps.2009.04.006
   Sauvage V, 2004, MOL BIOCHEM PARASIT, V134, P89, DOI 10.1016/j.molbiopara.2003.08.015
   Sauvage V, 2006, MOL BIOCHEM PARASIT, V147, P177, DOI 10.1016/j.molbiopara.2006.02.008
   Sauvage V, 2009, MOL BIOCHEM PARASIT, V167, P81, DOI 10.1016/j.molbiopara.2009.05.005
   Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028
   Schmid A, 2009, MOL BIOCHEM PARASIT, V163, P54, DOI 10.1016/j.molbiopara.2008.09.010
   Seeber F, 1996, GENE, V169, P39, DOI 10.1016/0378-1119(95)00786-5
   Silverman JA, 1997, ANTIMICROB AGENTS CH, V41, P1859, DOI 10.1128/AAC.41.9.1859
   SOETE M, 1994, EXP PARASITOL, V78, P361, DOI 10.1006/expr.1994.1039
   Soldati D, 2004, CURR OPIN CELL BIOL, V16, P32, DOI 10.1016/j.ceb.2003.11.013
   Sonda S, 2001, J BIOL CHEM, V276, P34434, DOI 10.1074/jbc.M105025200
   Sulova Z, 2005, BIOCHEM BIOPH RES CO, V335, P777, DOI 10.1016/j.bbrc.2005.07.144
   Tamai I, 2000, J PHARM SCI-US, V89, P1371, DOI 10.1002/1520-6017(200011)89:11<1371::AID-JPS1>3.0.CO;2-D
   TSURUO T, 1984, CANCER RES, V44, P5095
   UEDA K, 1992, J BIOL CHEM, V267, P24248
   Valverde MA, 1996, EMBO J, V15, P4460, DOI 10.1002/j.1460-2075.1996.tb00823.x
   Velamakanni S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006137
   Wallstab A, 1999, BRIT J CANCER, V79, P1053, DOI 10.1038/sj.bjc.6690169
   Ward KW, 2004, J PHARMACOL EXP THER, V310, P703, DOI 10.1124/jpet.104.068288
   Wetzel DM, 2004, J CELL SCI, V117, P5739, DOI 10.1242/jcs.01495
   Wetzel DM, 2003, MOL BIOL CELL, V14, P396, DOI 10.1091/mbc.E02-08-0458
   Witherspoon SM, 1996, CLIN CANCER RES, V2, P7
   Zhang Y, 2003, ADV DRUG DELIVER REV, V55, P31, DOI 10.1016/S0169-409X(02)00170-9
NR 69
TC 11
Z9 12
U1 0
U2 0
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD APR 8
PY 2010
VL 5
IS 4
AR e10062
DI 10.1371/journal.pone.0010062
PG 15
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 580WT
UT WOS:000276482000008
PM 20386707
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Paoli, EE
   Kruse, DE
   Seo, JW
   Zhang, H
   Kheirolomoom, A
   Watson, KD
   Chiu, P
   Stahlberg, H
   Ferrara, KW
AF Paoli, E. E.
   Kruse, D. E.
   Seo, J. W.
   Zhang, H.
   Kheirolomoom, A.
   Watson, K. D.
   Chiu, P.
   Stahlberg, H.
   Ferrara, K. W.
TI An optical and microPET assessment of thermally-sensitive liposome
   biodistribution in the Met-1 tumor model: Importance of formulation
SO JOURNAL OF CONTROLLED RELEASE
LA English
DT Article
DE Temperature-sensitive liposomes; NIR imaging; Image-guided drug delivery
ID DRUG-RELEASE RATES; MOUSE MODEL; TRIGGERED RELEASE; XENOGRAFT MODEL;
   BREAST-CANCER; IN-VITRO; HYPERTHERMIA; DELIVERY; PHARMACOKINETICS; MRI
AB The design of delivery vehicles that are stable in circulation but can be activated by exogenous energy sources is challenging. Our goals are to validate new imaging methods for the assessment of particle stability, to engineer stable and activatable particles and to assess accumulation of a hydrophilic model drug in an orthotopic tumor. Here, liposomes were injected into the tail vein of FVB mice containing bilateral Met-1 tumors and imaged in vivo using microPET and optical imaging techniques. Cryo-electron microscopy was applied to assess particle shape prior to injection, ex vivo fluorescence images of dissected tissues were acquired, excised tissue was further processed with a cell-digest preparation and assayed for fluorescence. We find that for a stable particle, in vivo tumor images of a hydrophilic model drug were highly correlated with PET images of the particle shell and ex vivo fluorescence images of processed tissue, R-2 = 0.95 and R-2 = 0.99 respectively. We demonstrate that the accumulation of a hydrophilic model drug is increased by up to 177 fold by liposomal encapsulation, as compared to accumulation of the drug at 24 hours. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Paoli, E. E.; Kruse, D. E.; Seo, J. W.; Zhang, H.; Kheirolomoom, A.; Watson, K. D.; Ferrara, K. W.] Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
   [Chiu, P.; Stahlberg, H.] Univ Calif Davis, Dept Mol & Cellular Biol, Davis, CA 95616 USA.
   [Stahlberg, H.] Univ Basel, Biozentrum, C CINA, CH-4056 Basel, Switzerland.
RP Ferrara, KW (corresponding author), Univ Calif Davis, Dept Biomed Engn, Davis, CA 95616 USA.
EM kwferrar@ucdavis.edu
RI Chiu, Po-Lin/D-2762-2013; Stahlberg, Henning/H-1868-2011; Ferrara,
   Katherine/H-5503-2011; Seo, Jai Woong/B-7959-2008
OI Stahlberg, Henning/0000-0002-1185-4592; Seo, Jai
   Woong/0000-0002-2732-7498; Kheirolomoom, Azadeh/0000-0002-2173-4893;
   Ferrara, Katherine/0000-0002-4976-9107; Paoli, Eric/0000-0002-8585-9492;
   Chiu, Po-Lin/0000-0001-8608-7650
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [CA 103828, U54GM073929]; NATIONAL
   CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [R01CA103828, R01CA103828, R01CA103828, R01CA103828,
   R01CA103828, R01CA103828, R01CA103828, R01CA103828, R01CA103828,
   R01CA103828] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01GM073929, R01GM073929,
   R01GM073929, R01GM073929] Funding Source: NIH RePORTER
FX The support of NIH CA 103828 and NIH U54GM073929 is gratefully
   acknowledged.
CR Abu-Lila A, 2009, J CONTROL RELEASE, V134, P18, DOI 10.1016/j.jconrel.2008.10.018
   ALLEN TM, 1980, BIOCHIM BIOPHYS ACTA, V597, P418, DOI 10.1016/0005-2736(80)90118-2
   Bale R, 2007, MINIM INVASIV THER, V16, P196, DOI 10.1080/13645700701520578
   Charrois GJR, 2004, BBA-BIOMEMBRANES, V1663, P167, DOI 10.1016/j.bbamem.2004.03.006
   Chen X, 2008, IEEE T BIO-MED ENG, V55, P1004, DOI 10.1109/TBME.2008.915694
   Choi SH, 2006, BIOMACROMOLECULES, V7, P1864, DOI 10.1021/bm060182a
   Derfus AM, 2007, ADV MATER, V19, P3932, DOI 10.1002/adma.200700091
   Dewhirst MW, 2005, INT J HYPERTHER, V21, P779, DOI 10.1080/02656730500271668
   Dromi S, 2007, CLIN CANCER RES, V13, P2722, DOI 10.1158/1078-0432.CCR-06-2443
   Drummond DC, 2008, J PHARM SCI-US, V97, P4696, DOI 10.1002/jps.21358
   Drummond DC, 2006, CANCER RES, V66, P3271, DOI 10.1158/0008-5472.CAN-05-4007
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   GABER MH, 1995, PHARMACEUT RES, V12, P1407, DOI 10.1023/A:1016206631006
   Gannon Christopher J., 2008, Journal of Nanobiotechnology, V6, P2, DOI 10.1186/1477-3155-6-2
   GREGORIADIS G, 1984, LIPOSOME TECHNOLOGY
   GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954
   Han HD, 2006, J PHARM SCI-US, V95, P1909, DOI 10.1002/jps.20646
   Hauck ML, 2006, CLIN CANCER RES, V12, P4004, DOI 10.1158/1078-0432.CCR-06-0226
   Heyes J, 2006, J CONTROL RELEASE, V112, P280, DOI 10.1016/j.jconrel.2006.02.012
   HOPE MJ, 1985, BIOCHIM BIOPHYS ACTA, V812, P55, DOI 10.1016/0005-2736(85)90521-8
   Hossann M, 2007, BBA-BIOMEMBRANES, V1768, P2491, DOI 10.1016/j.bbamem.2007.05.021
   Kim IY, 2009, J CONTROL RELEASE, V140, P55, DOI 10.1016/j.jconrel.2009.07.005
   Kong G, 2000, CANCER RES, V60, P6950
   Lee RJ, 1997, J LIPOSOME RES, V7, P455, DOI 10.3109/08982109709035512
   Lencioni R, 2008, CRIT REV ONCOL HEMAT, V66, P200, DOI 10.1016/j.critrevonc.2008.01.003
   Mai JH, 2009, J CONTROL RELEASE, V139, P174, DOI 10.1016/j.jconrel.2009.06.024
   Marik J, 2007, NUCL MED BIOL, V34, P165, DOI 10.1016/j.nucmedbio.2006.12.004
   Matsumura S, 2009, MOL PHARMACEUT, V6, P441, DOI 10.1021/mp800141v
   Mills JK, 2005, BBA-BIOMEMBRANES, V1716, P77, DOI 10.1016/j.bbamem.2005.08.007
   Needham D, 2000, CANCER RES, V60, P1197
   OLSON F, 1982, EUR J CANCER CLIN ON, V18, P167, DOI 10.1016/0277-5379(82)90060-8
   Ponce AM, 2007, J NATL CANCER I, V99, P53, DOI 10.1093/jnci/djk005
   PRADHAN P, J CONTROLLE IN PRESS
   QIN S, MOL PHARM IN PRESS
   Safra T, 2000, ANN ONCOL, V11, P1029, DOI 10.1023/A:1008365716693
   Schmaljohann D, 2006, ADV DRUG DELIVER REV, V58, P1655, DOI 10.1016/j.addr.2006.09.020
   Schroeder A, 2009, J CONTROL RELEASE, V137, P63, DOI 10.1016/j.jconrel.2009.03.007
   Seo JW, 2008, BIOCONJUGATE CHEM, V19, P2577, DOI 10.1021/bc8002937
   Shim WS, 2007, INT J PHARM, V331, P11, DOI 10.1016/j.ijpharm.2006.09.027
   Terreno E, 2007, ANGEW CHEM INT EDIT, V46, P966, DOI 10.1002/anie.200604027
   Wang L, 2008, NUCL MED COMMUN, V29, P137, DOI 10.1097/MNM.0b013e3282f258c1
   Webb MS, 1998, BBA-BIOMEMBRANES, V1372, P272, DOI 10.1016/S0005-2736(98)00077-7
   Woo J, 2008, INT J PHARM, V349, P38, DOI 10.1016/j.ijpharm.2007.07.020
   Working PK, 1996, HUM EXP TOXICOL, V15, P751
   Yap JT, 2004, CANCER J, V10, P221, DOI 10.1097/00130404-200407000-00003
   YATVIN MB, 1978, SCIENCE, V202, P1290, DOI 10.1126/science.364652
   Yildirim Y, 2008, INT J GYNECOL CANCER, V18, P223, DOI 10.1111/j.1525-1438.2007.00992.x
   Yu C, 2004, ANAL CHEM, V76, P1761, DOI 10.1021/ac035077v
   Zhang H, 2008, BIOMATERIALS, V29, P1976, DOI 10.1016/j.biomaterials.2007.12.033
NR 49
TC 40
Z9 43
U1 0
U2 29
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-3659
EI 1873-4995
J9 J CONTROL RELEASE
JI J. Control. Release
PD APR 2
PY 2010
VL 143
IS 1
BP 13
EP 22
DI 10.1016/j.jconrel.2009.12.010
PG 10
WC Chemistry, Multidisciplinary; Pharmacology & Pharmacy
SC Chemistry; Pharmacology & Pharmacy
GA 584QF
UT WOS:000276766600003
PM 20006659
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Boehm, A
   Kaiser, M
   Li, H
   Spangler, C
   Kasper, CA
   Ackermann, M
   Kaever, V
   Sourjik, V
   Roth, V
   Jenal, U
AF Boehm, Alex
   Kaiser, Matthias
   Li, Hui
   Spangler, Christian
   Kasper, Christoph Alexander
   Ackermann, Martin
   Kaever, Volkhard
   Sourjik, Victor
   Roth, Volker
   Jenal, Urs
TI Second Messenger-Mediated Adjustment of Bacterial Swimming Velocity
SO CELL
LA English
DT Article
ID C-DI-GMP; FLAGELLAR ROTARY MOTOR; ESCHERICHIA-COLI; PILZ DOMAIN;
   IN-VIVO; MOTILITY; CHEMOTAXIS; PROTEINS; TORQUE; PATHWAY
AB Bacteria swim by means of rotating flagella that are powered by ion influx through membrane-spanning motor complexes. Escherichia coli and related species harness a chemosensory and signal transduction machinery that governs the direction of flagellar rotation and allows them to navigate in chemical gradients. Here, we show that Escherichia coli can also fine-tune its swimming speed with the help of a molecular brake (YcgR) that, upon binding of the nucleotide second messenger cyclic di-GMP, interacts with the motor protein MotA to curb flagellar motor output. Swimming velocity is controlled by the synergistic action of at least five signaling proteins that adjust the cellular concentration of cyclic di-GMP. Activation of this network and the resulting deceleration coincide with nutrient depletion and might represent an adaptation to starvation. These experiments demonstrate that bacteria can modulate flagellar motor output and thus swimming velocity in response to environmental cues.
C1 [Boehm, Alex; Kaiser, Matthias; Kasper, Christoph Alexander; Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Li, Hui; Sourjik, Victor] Univ Heidelberg, Zentrum Mol Biol, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany.
   [Spangler, Christian; Kaever, Volkhard] Hannover Med Sch, Inst Pharmacol, D-30625 Hannover, Germany.
   [Ackermann, Martin] ETH, Dept Environm Sci, CH-8092 Zurich, Switzerland.
   [Ackermann, Martin] EAWAG, Dept Environm Microbiol, CH-8092 Zurich, Switzerland.
   [Roth, Volker] Univ Basel, Dept Comp Sci, CH-4056 Basel, Switzerland.
RP Boehm, A (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM alexander.boehm@unibas.ch
RI Ackermann, Martin/V-4554-2017; Kaever, Volkhard/G-3280-2013; Roth,
   Volker/Q-4025-2017
OI Ackermann, Martin/0000-0003-0087-4819; Roth, Volker/0000-0003-0991-0273
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-108186]; Baden-Wurttemberg; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [SO 421/7-1]
FX We thank F. Hamburger for help with cloning, M. Durrenberger for
   microscopy support, M. Podvinec for IT service, A. Vaknin for pAV1, and
   S. Parkinson for FliC antibody and advice. This work was supported by
   Swiss National Science Foundation Fellowship 3100A0-108186 to U.J. H. L.
   was supported by the Bioquant Graduate Program of Baden-Wurttemberg, M.
   A. by a grant from the Swiss National Science Foundation, and V. S. by
   the grant SO 421/7-1 from the Deutsche Forschungsgemeinschaft.
CR Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739
   AMSLER CD, 1993, J BACTERIOL, V175, P6238, DOI 10.1128/JB.175.19.6238-6244.1993
   Berg HC, 2003, ANNU REV BIOCHEM, V72, P19, DOI 10.1146/annurev.biochem.72.121801.161737
   BLAIR DF, 1988, SCIENCE, V242, P1678, DOI 10.1126/science.2849208
   Blair KM, 2008, SCIENCE, V320, P1636, DOI 10.1126/science.1157877
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Darnton NC, 2007, J BACTERIOL, V189, P1756, DOI 10.1128/JB.01501-06
   Frye J, 2006, J BACTERIOL, V188, P2233, DOI 10.1128/JB.188.6.2233-2243.2006
   Gabel CV, 2003, P NATL ACAD SCI USA, V100, P8748, DOI 10.1073/pnas.1533395100
   Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35
   Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154
   Hazelbauer GL, 2008, TRENDS BIOCHEM SCI, V33, P9, DOI 10.1016/j.tibs.2007.09.014
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423
   Kentner D, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.77
   Ko M, 2000, J MOL BIOL, V303, P371, DOI 10.1006/jmbi.2000.4147
   Lemke JJ, 2009, MOL MICROBIOL, V74, P1368, DOI 10.1111/j.1365-2958.2009.06939.x
   MEISTER M, 1987, CELL, V49, P643, DOI 10.1016/0092-8674(87)90540-X
   Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808
   Pilizota T, 2009, P NATL ACAD SCI USA, V106, P11582, DOI 10.1073/pnas.0813164106
   Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c
   Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103
   Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203
   Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x
   SLOCUM MK, 1985, J BACTERIOL, V163, P586, DOI 10.1128/JB.163.2.586-594.1985
   Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199
   Sourjik V, 2007, METHOD ENZYMOL, V423, P365, DOI 10.1016/S0076-6879(07)23017-4
   Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691
   Stephens L, 2008, CURR BIOL, V18, pR485, DOI 10.1016/j.cub.2008.04.048
   van den Heuvel MGL, 2007, SCIENCE, V317, P333, DOI 10.1126/science.1139570
   Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x
   Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07
   Yuan JH, 2008, P NATL ACAD SCI USA, V105, P1182, DOI 10.1073/pnas.0711539105
   Zhou JD, 1998, P NATL ACAD SCI USA, V95, P6436, DOI 10.1073/pnas.95.11.6436
NR 35
TC 287
Z9 301
U1 9
U2 61
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
J9 CELL
JI Cell
PD APR 1
PY 2010
VL 141
IS 1
BP 107
EP 116
DI 10.1016/j.cell.2010.01.018
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 577GS
UT WOS:000276211100016
PM 20303158
DA 2021-01-25
ER

PT J
AU Hafner, M
   Landthaler, M
   Burger, L
   Khorshid, M
   Hausser, J
   Berninger, P
   Rothballer, A
   Ascano, M
   Jungkamp, AC
   Munschauer, M
   Ulrich, A
   Wardle, GS
   Dewell, S
   Zavolan, M
   Tuschl, T
AF Hafner, Markus
   Landthaler, Markus
   Burger, Lukas
   Khorshid, Mohsen
   Hausser, Jean
   Berninger, Philipp
   Rothballer, Andrea
   Ascano, Manuel, Jr.
   Jungkamp, Anna-Carina
   Munschauer, Mathias
   Ulrich, Alexander
   Wardle, Greg S.
   Dewell, Scott
   Zavolan, Mihaela
   Tuschl, Thomas
TI Transcriptome-wide Identification of RNA-Binding Protein and MicroRNA
   Target Sites by PAR-CLIP
SO CELL
LA English
DT Article
ID HETEROGENEOUS NUCLEAR-RNA; MAMMALIAN MESSENGER-RNAS; CROSS-LINKING;
   RIBONUCLEOPROTEIN COMPLEXES; ULTRAVIOLET-LIGHT; GENE-EXPRESSION; C.
   ELEGANS; CELLS; TRANSLATION; FAMILY
AB RNA transcripts are subject to posttranscriptional gene regulation involving hundreds of RNA-binding proteins (RBPs) and microRNA-containing ribonucleoprotein complexes (miRNPs) expressed in a cell-type dependent fashion. We developed a cell-based crosslinking approach to determine at high resolution and transcriptome-wide the binding sites of cellular RBPs and miRNPs. The crosslinked sites are revealed by thymidine to cytidine transitions in the cDNAs prepared from immunopurified RNPs of 4-thiouridine-treated cells. We determined the binding sites and regulatory consequences for several intensely studied RBPs and miRNPs, including PUM2, QKI, IGF2BP1-3, AGO/EIF2C1-4 and TNRC6A-C. Our study revealed that these factors bind thousands of sites containing defined sequence motifs and have distinct preferences for exonic versus intronic or coding versus untranslated transcript regions. The precise mapping of binding sites across the transcriptome will be critical to the interpretation of the rapidly emerging data on genetic variation between individuals and how these variations contribute to complex genetic diseases.
C1 [Burger, Lukas; Khorshid, Mohsen; Hausser, Jean; Berninger, Philipp; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Hafner, Markus; Landthaler, Markus; Rothballer, Andrea; Ascano, Manuel, Jr.; Jungkamp, Anna-Carina; Munschauer, Mathias; Ulrich, Alexander; Wardle, Greg S.; Tuschl, Thomas] Rockefeller Univ, Lab RNA Mol Biol, Howard Hughes Med Inst, New York, NY 10065 USA.
   [Burger, Lukas; Khorshid, Mohsen; Hausser, Jean; Berninger, Philipp; Zavolan, Mihaela] SIB, CH-4056 Basel, Switzerland.
   [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch; ttuschl@rockefeller.edu
RI Landthaler, Markus/A-1427-2010; Zavolan, Mihaela/S-3888-2016; Hafner,
   Markus/O-7100-2018; Ascano, Manuel/ABA-3586-2020; Munschauer,
   Mathias/AAK-2789-2020
OI Landthaler, Markus/0000-0002-1075-8734; Hafner,
   Markus/0000-0002-4336-6518; Ascano, Manuel/0000-0002-9370-5493;
   Munschauer, Mathias/0000-0001-6143-4548; Hausser,
   Jean/0000-0002-3321-7199; Ulrich, Alexander Konstantin
   Christian/0000-0003-4255-4856; Zavolan, Mihaela/0000-0002-8832-2041
FU Deutscher Akademischer Austauschdienst (DAAD)Deutscher Akademischer
   Austausch Dienst (DAAD); Swiss National FundSwiss National Science
   Foundation (SNSF) [3100A0-114001]; NIHUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [GM073047];
   Starr Foundation [MH08442]; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P01GM073047, P01GM073047, P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, P01GM073047, P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, P01GM073047, P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, P01GM073047, P01GM073047,
   P01GM073047, P01GM073047, P01GM073047] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Mental Health (NIMH) [R01MH080442, R01MH080442,
   R01MH080442, R01MH080442, R01MH080442, R01MH080442] Funding Source: NIH
   RePORTER
FX We thank V. Hovestadt for his help with the analysis of the crosslinking
   positions within miRNAs. We are grateful to W. Zhang and C. Zhao
   (Genomics Resource Center) for mRNA array analysis and Solexa
   sequencing. We thank Millipore for the antibodies. We thank members of
   the Tuschl laboratory for comments on the manuscript. M. H. is supported
   by the Deutscher Akademischer Austauschdienst (DAAD). This work was
   supported by the Swiss National Fund Grant # 3100A0-114001 to M. Z.; T.
   T. is an HHMI investigator, and work in his laboratory was supported by
   NIH grants GM073047 and MH08442 and the Starr Foundation.
CR Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002
   Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264
   Chenard CA, 2008, J NEUROSCI RES, V86, P233, DOI 10.1002/jnr.21485
   Chi SW, 2009, NATURE, V460, P479, DOI 10.1038/nature08170
   de Silanes IL, 2004, P NATL ACAD SCI USA, V101, P2987, DOI 10.1073/pnas.0306453101
   Dimitriadis E, 2007, INT J CANCER, V121, P486, DOI 10.1002/ijc.22716
   DREYFUSS G, 1984, MOL CELL BIOL, V4, P1104, DOI 10.1128/MCB.4.6.1104
   Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707
   FAVRE A, 1986, BIOCHEM BIOPH RES CO, V141, P847, DOI 10.1016/S0006-291X(86)80250-9
   Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Galarneau A, 2005, NAT STRUCT MOL BIOL, V12, P691, DOI 10.1038/nsmb963
   Galgano A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003164
   Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103
   Granneman S, 2009, P NATL ACAD SCI USA, V106, P9613, DOI 10.1073/pnas.0901997106
   GREENBERG JR, 1979, NUCLEIC ACIDS RES, V6, P715, DOI 10.1093/nar/6.2.715
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Gu S, 2009, NAT STRUCT MOL BIOL, V16, P144, DOI 10.1038/nsmb.1552
   Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250
   Hafner M, 2008, METHODS, V44, P3, DOI 10.1016/j.ymeth.2007.09.009
   Hausser J, 2009, GENOME RES, V19, P2009, DOI 10.1101/gr.091181.109
   Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111
   Kirino Y, 2008, RNA, V14, P2254, DOI 10.1261/rna.1133808
   Lall S, 2006, CURR BIOL, V16, P460, DOI 10.1016/j.cub.2006.01.050
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Lunde BM, 2007, NAT REV MOL CELL BIO, V8, P479, DOI 10.1038/nrm2178
   Lytle JR, 2007, P NATL ACAD SCI USA, V104, P9667, DOI 10.1073/pnas.0703820104
   Martin KC, 2009, CELL, V136, P719, DOI 10.1016/j.cell.2009.01.044
   MAYRAND S, 1981, J CELL BIOL, V90, P380, DOI 10.1083/jcb.90.2.380
   McKee AE, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-14
   Meisenheimer KM, 1997, CRIT REV BIOCHEM MOL, V32, P101, DOI 10.3109/10409239709108550
   Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001
   Orom UA, 2008, MOL CELL, V30, P460, DOI 10.1016/j.molcel.2008.05.001
   Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798
   Sanford JR, 2009, GENOME RES, V19, P381, DOI 10.1101/gr.082503.108
   Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281
   Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067
   Sonenberg N, 2009, CELL, V136, P731, DOI 10.1016/j.cell.2009.01.042
   Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023
   Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299
   Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085
   Ule J, 2003, SCIENCE, V302, P1212, DOI 10.1126/science.1090095
   Vella MC, 2004, GENE DEV, V18, P132, DOI 10.1101/gad.1165404
   WAGENMAKERS AJM, 1980, EUR J BIOCHEM, V112, P323, DOI 10.1111/j.1432-1033.1980.tb07207.x
   Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5
   Wang YL, 2009, NATURE, V461, P754, DOI 10.1038/nature08434
   Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666
   Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6
   Yeo GW, 2009, NAT STRUCT MOL BIOL, V16, P130, DOI 10.1038/nsmb.1545
   Yisraeli JK, 2005, BIOL CELL, V97, P87
   Zisoulis DG, 2010, NAT STRUCT MOL BIOL, V17, P173, DOI 10.1038/nsmb.1745
NR 59
TC 1749
Z9 1799
U1 8
U2 209
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD APR 1
PY 2010
VL 141
IS 1
BP 129
EP 141
DI 10.1016/j.cell.2010.03.009
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 577GS
UT WOS:000276211100018
PM 20371350
OA Green Accepted
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Hubner, NC
   Wang, LHC
   Kaulich, M
   Descombes, P
   Poser, I
   Nigg, EA
AF Huebner, Nadja C.
   Wang, Lily Hui-Ching
   Kaulich, Manuel
   Descombes, Patrick
   Poser, Ina
   Nigg, Erich A.
TI Re-examination of siRNA specificity questions role of PICH and Tao1 in
   the spindle checkpoint and identifies Mad2 as a sensitive target for
   small RNAs
SO CHROMOSOMA
LA English
DT Article
ID ANAPHASE; KINASE; PLK1; LOCALIZATION; CYTOKINESIS; INSTABILITY;
   CLEAVAGE; PROTEIN; POLO; BLM
AB The DNA-dependent adenosine triphosphatase (ATPase) Plk1-interacting checkpoint helicase (PICH) has recently been implicated in spindle checkpoint (SAC) signaling (Baumann et al., Cell 128(1):101-114, 2007). Depletion of PICH by siRNA abolished the SAC and resulted in an apparently selective loss of Mad2 from kinetochores, suggesting a role for PICH in the regulation of the Mad1-Mad2 interaction. An apparent rescue of SAC functionality by overexpression of PICH in PICH-depleted cells initially seemed to confirm a role for PICH in the SAC. However, we have subsequently discovered that all PICH-directed siRNA oligonucleotides that abolish the SAC also reduce Mad2 mRNA and protein expression. This reduction is functionally significant, as PICH siRNA does not abolish SAC activity in a cell line that harbors a bacterial artificial chromosome driving the expression of murine Mad2. Moreover, we identified several siRNA duplexes that effectively deplete PICH but do not significantly affect SAC functionality or Mad2 abundance or localization. Finally, we discovered that the ability of overexpressed PICH to restore SAC activity in PICH-depleted cells depends on sequestration of the mitotic kinase Plk1 rather than ATPase activity of PICH, pointing to an underlying mechanism of "bypass suppression." In support of this view, depletion or inhibition of Plk1 also rescued SAC activity in cells harboring low levels of Mad2. This observation suggests that a reduction of Plk1 activity partially compensates for reduced Mad2 levels and argues that Plk1 normally reduces the strength of SAC signaling. Collectively, our results question the role of PICH in the SAC and instead identify Mad2 as a sensitive off target for small RNA duplexes. In support of the latter conclusion, our evidence suggests that an off-target effect on Mad2 may also contribute to explain the apparent role of the Tao1 kinase in SAC signaling (Draviam et al., Nat Cell Biol 9(5):556-564, 2007).
C1 [Huebner, Nadja C.; Wang, Lily Hui-Ching; Kaulich, Manuel; Nigg, Erich A.] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Munich, Germany.
   [Descombes, Patrick] Univ Geneva, CMU, CH-1211 Geneva, Switzerland.
   [Poser, Ina] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany.
   [Wang, Lily Hui-Ching; Kaulich, Manuel; Nigg, Erich A.] Univ Basel, Biozentrum Basel, CH-4056 Basel, Switzerland.
RP Nigg, EA (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, Klopferspitz 18, D-82152 Munich, Germany.
EM erich.nigg@unibas.ch
RI Kaulich, Manuel/U-4523-2017; Wang, Lily Hui-Ching/D-1967-2011
OI Kaulich, Manuel/0000-0002-9528-8822; Wang, Lily
   Hui-Ching/0000-0003-0659-0139; nigg, erich/0000-0003-4835-5719
FU Max-Planck-SocietyMax Planck SocietyFoundation CELLEX; Taiwan Merit
   Scholarships program [NSC-095-SAF-I-564-627-TMS]; Boehringer Ingelheim
   FondsBoehringer Ingelheim
FX We thank Roger Tsien and Andreas Uldschmid for reagents, Christelle
   Barraclough for help with qRT-PCR, and Rainer Malik for help with
   bioinformatics. We also thank Christoph Baumann, Viji Draviam, Steve
   Elledge, and all members of the Nigg lab for helpful discussions. This
   work was supported by the Max-Planck-Society. L. H. W. acknowledges a
   fellowship from the Taiwan Merit Scholarships program
   (NSC-095-SAF-I-564-627-TMS). NCH gratefully acknowledges the Ph. D.
   fellowship from the Boehringer Ingelheim Fonds.
CR Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4
   Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041
   Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882
   Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777
   Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091
   Draviam VM, 2007, NAT CELL BIOL, V9, P556, DOI 10.1038/ncb1569
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Hauf S, 2001, SCIENCE, V293, P1320, DOI 10.1126/science.1061376
   Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820
   Johne C, 2008, MOL BIOL CELL, V19, P1391, DOI 10.1091/mbc.E07-07-0730
   Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133
   Leng M, 2008, CELL CYCLE, V7, P1480, DOI 10.4161/cc.7.10.5951
   Liu XQ, 2003, P NATL ACAD SCI USA, V100, P5789, DOI 10.1073/pnas.1031523100
   Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094
   Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883
   Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014
   Poser I, 2008, NAT METHODS, V5, P409, DOI 10.1038/NMETH.1199
   Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517
   Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070
   Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723
   Timm T, 2003, EMBO J, V22, P5090, DOI 10.1093/emboj/cdg447
   Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831
   Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034
   Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051
   Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7
NR 25
TC 45
Z9 46
U1 2
U2 5
PU SPRINGER
PI NEW YORK
PA ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES
SN 0009-5915
EI 1432-0886
J9 CHROMOSOMA
JI Chromosoma
PD APR
PY 2010
VL 119
IS 2
BP 149
EP 165
DI 10.1007/s00412-009-0244-2
PG 17
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 568QL
UT WOS:000275537400003
PM 19904549
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Hartmann, B
   Muller, M
   Hislop, NR
   Roth, B
   Tomljenovic, L
   Miller, DJ
   Reichert, H
AF Hartmann, Beate
   Mueller, Martin
   Hislop, Nikki R.
   Roth, Bettina
   Tomljenovic, Lucija
   Miller, David J.
   Reichert, Heinrich
TI Coral emx-Am can substitute for Drosophila empty spiracles function in
   head, but not brain development
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Brain development; Evolution; ems; Emx; Cephalic gap gene; Hexapeptide;
   Drosophila; Acropora
ID CNIDARIAN ACROPORA-MILLEPORA; CLASS-LEVEL RELATIONSHIPS; HOMEOBOX GENES;
   DORSAL TELENCEPHALON; HOMEODOMAIN PROTEINS; EARLY NEUROGENESIS; PHYLUM
   CNIDARIA; NERVOUS-SYSTEM; DNA-BINDING; EXPRESSION
AB The ems/Emx genes encode homeodomain transcription factors that have conserved actions in anterior embryonic patterning in bilaterian animals ranging from insects to mammals. Recently, genes of the ems/Emx family have been identified in cnidarians raising the possibility that some of their developmental functions might be conserved throughout the Eumetazoa. To determine to what extent functions of a cnidarian ems/Emx protein have been retained across phyla, we carried out cross-phylum rescue expression experiments in which the coral Acropora em-Am gene was misexpressed in Drosophila ems mutants. Our findings demonstrate that coral emx-Am can substitute for fly ems in embryonic head development and rescue the open head defect and the loss of segmental engrailed expression domains in Drosophila ems mutants. In contrast, the coral emx-Am gene can not substitute for fly ems in embryonic brain development. Even when a hexapeptide motif of the type present in the Drosophila ems gene is inserted into the coral emx-Am gene, rescue of the developmental brain defects in fly ems mutants fails. These findings have implications for understanding the evolutionary origins of head versus brain patterning mechanisms. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Hartmann, Beate; Mueller, Martin; Roth, Bettina; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Hislop, Nikki R.; Tomljenovic, Lucija; Miller, David J.] James Cook Univ, ARC Ctr Excellence Coral Reef Studies, Townsville, Qld 4811, Australia.
   [Hislop, Nikki R.; Tomljenovic, Lucija; Miller, David J.] James Cook Univ, Comparat Genom Ctr, Townsville, Qld 4811, Australia.
RP Reichert, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM heinrich.reichert@unibas.ch
FU Swiss NSF via the Centre of Excellence for Coral Reef Studies;
   Australian Research Council via the Centre of Excellence for Coral Reef
   StudiesAustralian Research Council; Australian Academy of Science
FX We thank Nathalie Dostatni (Curie Institute, Paris) for the
   nos-Gal4-3GCN4-Bcd3'UTR transgenic stock, Uwe Walldorf for the Ems
   antibody, Tanja Radimerski and Simon Sprecher for help at the initial
   stages of this work, Susanne Flister for technical assistance and Frank
   Hirth for helpful discussions. Supported by the Swiss NSF (to H.R.) and
   from the Australian Research Council (both directly and via the Centre
   of Excellence for Coral Reef Studies) and the Australian Academy of
   Science (to DJM).
CR Aspock G, 2003, DEVELOPMENT, V130, P3369, DOI 10.1242/dev.00551
   Bell E, 2001, DEV BIOL, V236, P76, DOI 10.1006/dbio.2001.0301
   Blanco J, 2009, DEV BIOL, V329, P104, DOI 10.1016/j.ydbio.2009.02.027
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   BRIDGE D, 1995, MOL BIOL EVOL, V12, P679
   BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750
   Bullok T. H., 1965, STRUCTURE FUNCTION N
   Burrows M, 1996, NEUROBIOLOGY INSECT
   Chan SK, 1996, EMBO J, V15, P2476, DOI 10.1002/j.1460-2075.1996.tb00605.x
   CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8
   CHANG CP, 1995, GENE DEV, V9, P663, DOI 10.1101/gad.9.6.663
   COHEN S, 1991, TRENDS GENET, V7, P267
   COHEN SM, 1990, NATURE, V346, P482, DOI 10.1038/346482a0
   DALTON D, 1989, GENE DEV, V3, P1940, DOI 10.1101/gad.3.12a.1940
   de Jong DM, 2006, DEV BIOL, V298, P632, DOI 10.1016/j.ydbio.2006.07.034
   Derobert Y, 2002, DEV BIOL, V247, P390, DOI 10.1006/dbio.2002.0700
   FINKELSTEIN R, 1990, NATURE, V346, P485, DOI 10.1038/346485a0
   GEHRING WJ, 1994, ANNU REV BIOCHEM, V63, P487, DOI 10.1146/annurev.bi.63.070194.002415
   Hartmann B, 2000, MECH DEVELOP, V90, P143, DOI 10.1016/S0925-4773(99)00237-3
   HIRTH F, 1995, NEURON, V15, P769, DOI 10.1016/0896-6273(95)90169-8
   Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063
   Holland LZ, 2000, CURR OPIN GENET DEV, V10, P434, DOI 10.1016/S0959-437X(00)00109-X
   Janody F, 2000, DEVELOPMENT, V127, P1573
   JOHNSON FB, 1995, P NATL ACAD SCI USA, V92, P739, DOI 10.1073/pnas.92.3.739
   JURGENS G, 1984, ROUX ARCH DEV BIOL, V193, P283, DOI 10.1007/BF00848157
   KLAES A, 1994, CELL, V78, P149, DOI 10.1016/0092-8674(94)90581-9
   Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/S0960-9822(03)00872-8
   Lichtneckert R, 2005, HEREDITY, V94, P465, DOI 10.1038/sj.hdy.6800664
   Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0
   Mackie GO, 2004, NEUROSIGNALS, V13, P5, DOI 10.1159/000076155
   Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3
   Martindale MQ, 2005, NAT REV GENET, V6, P917, DOI 10.1038/nrg1725
   Medina M, 2001, P NATL ACAD SCI USA, V98, P9707, DOI 10.1073/pnas.171316998
   Merabet S, 2003, DEV CELL, V4, P761, DOI 10.1016/S1534-5807(03)00126-6
   Mokady O, 1998, P NATL ACAD SCI USA, V95, P3673, DOI 10.1073/pnas.95.7.3673
   MORITA T, 1995, NEUROSCI LETT, V198, P131, DOI 10.1016/0304-3940(95)11988-9
   Myojin M, 2001, J EXP ZOOL, V291, P68, DOI 10.1002/jez.6
   NUSSLEINVOLHARD C, 1984, ROUX ARCH DEV BIOL, V193, P267, DOI 10.1007/BF00848156
   Pannese M, 1998, MECH DEVELOP, V73, P73, DOI 10.1016/S0925-4773(98)00034-3
   Patel N. H, 1994, DROSOPHILA MELANOGAS
   Pellegrini M, 1996, DEVELOPMENT, V122, P3893
   Qiu MS, 1996, DEV BIOL, V178, P174, DOI 10.1006/dbio.1996.0207
   ROBERTSON HM, 1988, GENETICS, V118, P461
   RUBIN GM, 1982, SCIENCE, V218, P348, DOI 10.1126/science.6289436
   SCHMIDTOTT U, 1992, DEVELOPMENT, V116, P111
   Schock F, 2000, NATURE, V405, P351
   SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x
   SIMEONE A, 1992, NATURE, V358, P687, DOI 10.1038/358687a0
   SLACK JMW, 1993, NATURE, V361, P490, DOI 10.1038/361490a0
   Sprecher SG, 2004, MECH DEVELOP, V121, P527, DOI 10.1016/j.mod.2004.04.009
   Strausfeld N. J., 1976, ATLAS INSECT BRAIN
   Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007
   THERIANOS S, 1995, DEVELOPMENT, V121, P3849
   Tour E, 2005, DEVELOPMENT, V132, P5271, DOI 10.1242/dev.02138
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   WALLDORF U, 1992, EMBO J, V11, P2247, DOI 10.1002/j.1460-2075.1992.tb05284.x
   Yoshida M, 1997, DEVELOPMENT, V124, P101
   YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7
   YounossiHartenstein A, 1997, DEV BIOL, V182, P270, DOI 10.1006/dbio.1996.8475
NR 59
TC 4
Z9 4
U1 0
U2 3
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
EI 1095-564X
J9 DEV BIOL
JI Dev. Biol.
PD APR 1
PY 2010
VL 340
IS 1
BP 125
EP 133
DI 10.1016/j.ydbio.2009.12.038
PG 9
WC Developmental Biology
SC Developmental Biology
GA 574FE
UT WOS:000275973300012
PM 20045685
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Breuker, C
   Moreau, A
   Lakhal, L
   Tamasi, V
   Parmentier, Y
   Meyer, U
   Maurel, P
   Lumbroso, S
   Vilarem, MJ
   Pascussi, JM
AF Breuker, Cyril
   Moreau, Amelie
   Lakhal, Laila
   Tamasi, Viola
   Parmentier, Yannick
   Meyer, Urs
   Maurel, Patrick
   Lumbroso, Serge
   Vilarem, Marie-Jose
   Pascussi, Jean-Marc
TI Hepatic Expression of Thyroid Hormone-Responsive Spot 14 Protein Is
   Regulated by Constitutive Androstane Receptor (NR1I3)
SO ENDOCRINOLOGY
LA English
DT Article
ID PREGNANE-X-RECEPTOR; GENE-EXPRESSION; SERUM TRIGLYCERIDE; LIPOGENIC
   PATHWAY; SIGNALING PATHWAY; NUCLEAR RECEPTORS; DRUG-METABOLISM;
   LIPID-SYNTHESIS; LIVER; CAR
AB The pregnane X receptors (PXRs) and the constitutive androstane receptor (CAR) were initially isolated as nuclear receptors regulating xenobiotic metabolism and elimination, alleviating chemical insults. However, recent works suggest that these xenoreceptors play an endobiotic role in modulating hepatic lipid metabolism. In this study, we show that CAR activators] phenobarbital and 6-(4-chlorophenyl)imidazo[2,1-b][ 1,3] thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime] induce the lipogenic gene thyroid hormone-responsivespot 14 protein( (THRSP) (orSpot14, S14) expression in human hepatocytes. In addition, we report that treatment of wild-type mice with mCAR activators (phenobarbital and 1,4-Bis[2-(3,5-dichloropyridyloxy)] benzene)efficiently increases thrsp expression, in contrast to CAR null mice. We demonstrate that CAR directly transactivates THRSP promoter through the direct repeat with 4-bp spacer thyroid hormone and PXR response element. Deletion or point mutations within this PXR response element led to a drastic inhibition of CAR-mediated THRSP transactivation. Gel-shift analysis revealed that the CAR/retinoid X receptor complex binds to this element. In conclusion, our results indicate that THRSP gene is a CAR and PXR target gene. Because THRSP expression correlates with lipogenesis and insulin sensitivity, our data suggest that CAR and/or PXR activating drugs and xenobiotics may promote aberrant hepatic de novo lipogenesis leading potentially to fatty liver diseases and insulin resistance. (Endocrinology 151: 1653-1661, 2010)
C1 [Breuker, Cyril; Moreau, Amelie; Maurel, Patrick; Vilarem, Marie-Jose; Pascussi, Jean-Marc] Univ Montpellier 1, INSERM, U632, F-34293 Montpellier, France.
   [Moreau, Amelie] Univ Rennes 1, EA Signalisat & Reponse Agents Infect & Chim 4427, INSERM, U620,Fac Pharm, F-35043 Rennes, France.
   [Lakhal, Laila] Inst Natl Rech Agron, Lab Pharmacol & Toxicol, Unite Rech 66, F-31027 Toulouse, France.
   [Tamasi, Viola; Meyer, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Parmentier, Yannick] Technol Servier, F-45000 Orleans, France.
   [Breuker, Cyril; Lumbroso, Serge; Pascussi, Jean-Marc] CNRS, UMR 5203, Inst Genom Fonct, F-34000 Montpellier, France.
   [Breuker, Cyril; Lumbroso, Serge; Pascussi, Jean-Marc] INSERM, U661, Montpellier, France.
   [Lumbroso, Serge] Ctr Hosp Univ Nimes, Biochim Lab, F-30029 Nimes 9, France.
RP Pascussi, JM (corresponding author), Univ Montpellier 1, INSERM, U632, 1919 Route Mende, F-34293 Montpellier, France.
EM jean-marc.pascussi@inserm.fr
RI pascussi, jean marc/F-9311-2013
OI pascussi, jean marc/0000-0002-5168-5383
FU Agence Nationale de la RechercheFrench National Research Agency (ANR)
   [JCJC-05-47810]; Technologie Servier Orleans
FX This work was supported by the Agence Nationale de la Recherche Grant
   JCJC-05-47810 (to J.- M. P. and C. T.), the Steroltalk European Project
   (to J.- M. P.), and Technologie Servier Orleans (to A. M.).
CR Anderson GW, 2009, MOL CELL ENDOCRINOL, V302, P99, DOI 10.1016/j.mce.2009.01.005
   BABANY G, 1989, J HEPATOL, V9, P252, DOI 10.1016/0168-8278(89)90059-7
   Bramlett KS, 2003, J PHARMACOL EXP THER, V307, P291, DOI 10.1124/jpet.103.052852
   Brown SB, 1997, J BIOL CHEM, V272, P2163, DOI 10.1074/jbc.272.4.2163
   Campbell MC, 2003, ENDOCRINOLOGY, V144, P5242, DOI 10.1210/en.2002-0008
   Cao ZP, 2007, POULTRY SCI, V86, P1873, DOI 10.1093/ps/86.9.1873
   Cunningham BA, 1998, THYROID, V8, P815, DOI 10.1089/thy.1998.8.815
   deLeval L, 1997, ACTA GASTRO-ENT BELG, V60, P180
   Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200
   Eveillard A, 2009, BIOCHEM PHARMACOL, V77, P1735, DOI 10.1016/j.bcp.2009.02.023
   Forman BM, 1998, NATURE, V395, P612, DOI 10.1038/26996
   Grieco A, 2005, Eur Rev Med Pharmacol Sci, V9, P261
   Grun F, 2007, REV ENDOCR METAB DIS, V8, P161, DOI 10.1007/s11154-007-9049-x
   Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101
   JUMP DB, 1984, J BIOL CHEM, V259, P2789
   KINLAW WB, 1995, J BIOL CHEM, V270, P16615, DOI 10.1074/jbc.270.28.16615
   Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9
   Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8
   Kretschmer XC, 2005, CHEM-BIOL INTERACT, V155, P111, DOI 10.1016/j.cbi.2005.06.003
   LaFave LT, 2006, ENDOCRINOLOGY, V147, P4044, DOI 10.1210/en.2006-0473
   LEWIS JH, 1982, HEPATOLOGY, V2, P870, DOI 10.1002/hep.1840020622
   LUOMA PV, 1979, ACTA MED SCAND, V206, P229
   Maglich JM, 2009, J LIPID RES, V50, P439, DOI 10.1194/jlr.M800226-JLR200
   Moreau A, 2009, HEPATOLOGY, V49, P2068, DOI 10.1002/hep.22907
   MORERE P, 1975, SEM HOP PARIS, V51, P2095
   Pascussi JM, 2007, HEPATOLOGY, V45, P1146, DOI 10.1002/hep.21592
   Pascussi JM, 2008, ANNU REV PHARMACOL, V48, P1, DOI 10.1146/annurev.pharmtox.47.120505.105349
   Pascussi JM, 2003, MOL ENDOCRINOL, V17, P42, DOI 10.1210/me.2002-0244
   Pawar A, 2003, J BIOL CHEM, V278, P40736, DOI 10.1074/jbc.M307973200
   PICHARD L, 1990, DRUG METAB DISPOS, V18, P595
   Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421
   Roth A, 2008, MOL PHARMACOL, V73, P1282, DOI 10.1124/mol.107.041012
   Sanchez-Rodriguez J, 2005, BIOCHEM J, V390, P57, DOI 10.1042/BJ20042080
   Stahlhut RW, 2007, ENVIRON HEALTH PERSP, V115, P876, DOI 10.1289/ehp.9882
   Tsatsos NG, 2008, ENDOCRINOLOGY, V149, P5155, DOI 10.1210/en.2008-0215
   Tzameli I, 2000, MOL CELL BIOL, V20, P2951, DOI 10.1128/MCB.20.9.2951-2958.2000
   Viollet B, 2006, J PHYSIOL-LONDON, V574, P41, DOI 10.1113/jphysiol.2006.108506
   Wang HB, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-193
   Wang XF, 2004, GENE, V332, P79, DOI 10.1016/j.gene.2004.02.021
   Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753
   Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200
   Zhu QH, 2005, ENDOCRINOLOGY, V146, P3343, DOI 10.1210/en.2005-0204
   Zhu QH, 2001, ENDOCRINOLOGY, V142, P4363, DOI 10.1210/en.142.10.4363
NR 43
TC 27
Z9 29
U1 0
U2 9
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0013-7227
EI 1945-7170
J9 ENDOCRINOLOGY
JI Endocrinology
PD APR
PY 2010
VL 151
IS 4
BP 1653
EP 1661
DI 10.1210/en.2009-1435
PG 9
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 572YL
UT WOS:000275874000030
PM 20185760
OA Bronze
DA 2021-01-25
ER

PT J
AU Kishore, S
   Khanna, A
   Zhang, ZY
   Hui, JY
   Balwierz, PJ
   Stefan, M
   Beach, C
   Nicholls, RD
   Zavolan, M
   Stamm, S
AF Kishore, Shivendra
   Khanna, Amit
   Zhang, Zhaiyi
   Hui, Jingyi
   Balwierz, Piotr J.
   Stefan, Mihaela
   Beach, Carol
   Nicholls, Robert D.
   Zavolan, Mihaela
   Stamm, Stefan
TI The snoRNA MBII-52 (SNORD 115) is processed into smaller RNAs and
   regulates alternative splicing
SO HUMAN MOLECULAR GENETICS
LA English
DT Article
ID NONCODING RNAS; MOUSE MODEL; NUCLEAR; DEFICIENCY; DEFECTS
AB The loss of HBII-52 and related C/D box small nucleolar RNA (snoRNA) expression units have been implicated as a cause for the Prader-Willi syndrome (PWS). We recently found that the C/D box snoRNA HBII-52 changes the alternative splicing of the serotonin receptor 2C pre-mRNA, which is different from the traditional C/D box snoRNA function in non-mRNA methylation. Using bioinformatic predictions and experimental verification, we identified five pre-mRNAs (DPM2, TAF1, RALGPS1, PBRM1 and CRHR1) containing alternative exons that are regulated by MBII-52, the mouse homolog of HBII-52. Analysis of a single member of the MBII-52 cluster of snoRNAs by RNase protection and northern blot analysis shows that the MBII-52 expressing unit generates shorter RNAs that originate from the full-length MBII-52 snoRNA through additional processing steps. These novel RNAs associate with hnRNPs and not with proteins associated with canonical C/D box snoRNAs. Our data indicate that not a traditional C/D box snoRNA MBII-52, but a processed version lacking the snoRNA stem is the predominant MBII-52 RNA missing in PWS. This processed snoRNA functions in alternative splice-site selection. Its substitution could be a therapeutic principle for PWS.
C1 [Stamm, Stefan] Univ Kentucky, Dept Mol & Cellular Biochem, BBSRB, Lexington, KY 40536 USA.
   [Kishore, Shivendra; Hui, Jingyi; Stamm, Stefan] Univ Erlangen Nurnberg, Inst Biochem, Erlangen, Germany.
   [Balwierz, Piotr J.; Zavolan, Mihaela] Univ Basel, Biozentrum, Swiss Inst Bioinformat, Basel, Switzerland.
   [Stefan, Mihaela; Nicholls, Robert D.] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA.
RP Stamm, S (corresponding author), Univ Kentucky, Dept Mol & Cellular Biochem, BBSRB, 741 S Limestone, Lexington, KY 40536 USA.
EM stefan@stamms-lab.net
RI Balwierz, Piotr J/AAG-4187-2020; Zavolan, Mihaela/S-3888-2016
OI Balwierz, Piotr J/0000-0002-1548-4605; Zavolan,
   Mihaela/0000-0002-8832-2041
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [GM083187]; DFGGerman Research
   Foundation (DFG) [Sta399/6-3]; Foundation for Prader-Willi Research;
   Prader-Willi Research Foundation; EURASNET; a CHP Scientific Program
   Innovation Award; NIH National Center for Research Resources
   (NCRR)United States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [P20 RR020171]; NATIONAL CENTER FOR RESEARCH
   RESOURCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Center for Research
   Resources (NCRR) [P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171, P20RR020171,
   P20RR020171, P20RR020171, P20RR020171, P20RR020171] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [R01GM083187, R01GM083187, R01GM083187, R01GM083187] Funding Source: NIH
   RePORTER
FX This work was supported by the NIH (GM083187 to S. S.), the DFG
   (Sta399/6-3), the Foundation for Prader-Willi Research, the Prader-Willi
   Research Foundation, EURASNET (S.S., M. Z.), and in part from a CHP
   Scientific Program Innovation Award (R. D. N.). The mass spectrometric
   analysis was performed at the University of Kentucky, Center for
   Structural Biology Protein Core Facility. This core facility is
   supported in part by funds from NIH National Center for Research
   Resources (NCRR) grant P20 RR020171.
CR Butler M.G., 2006, MANAGEMENT PRADER WI, P3
   Carrel A.L., 2006, MANAGEMENT PRADER WI, P201
   Cavaille J, 1998, NUCLEIC ACIDS RES, V26, P1576, DOI 10.1093/nar/26.7.1576
   Cavaille J, 2000, P NATL ACAD SCI USA, V97, P14311, DOI 10.1073/pnas.250426397
   Cummings DE, 2002, NAT MED, V8, P643, DOI 10.1038/nm0702-643
   Ding F, 2005, MAMM GENOME, V16, P424, DOI 10.1007/s00335-005-2460-2
   Doe CM, 2009, HUM MOL GENET, V18, P2140, DOI 10.1093/hmg/ddp137
   Eiholzer U, 1998, EUR J PEDIATR, V157, P368, DOI 10.1007/s004310050832
   Eiholzer U, 1998, EUR J PEDIATR, V157, P890, DOI 10.1007/s004310050961
   Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017
   Filipowicz W, 2002, CURR OPIN CELL BIOL, V14, P319, DOI 10.1016/S0955-0674(02)00334-4
   Hutzinger R, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000547
   Kanber D, 2009, EUR J HUM GENET, V17, P582, DOI 10.1038/ejhg.2008.232
   Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265
   Kishore S, 2006, COLD SPRING HARB SYM, V71, P329, DOI 10.1101/sqb.2006.71.024
   Kishore S, 2008, GENE, V427, P104, DOI 10.1016/j.gene.2008.09.021
   Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062
   LEE KAW, 1988, GENE ANAL TECH, V5, P22, DOI 10.1016/0735-0651(88)90023-4
   Licatalosi DD, 2008, NATURE, V456, P464, DOI 10.1038/nature07488
   Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124
   Nakatani J, 2009, CELL, V137, P1235, DOI 10.1016/j.cell.2009.04.024
   Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259
   Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604
   Runte M, 2001, HUM MOL GENET, V10, P2687, DOI 10.1093/hmg/10.23.2687
   Sahoo T, 2008, NAT GENET, V40, P719, DOI 10.1038/ng.158
   Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224
   Scott MS, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000507
   Stamm S, 2005, GENE, V344, P1, DOI 10.1016/j.gene.2004.10.022
   Stamm S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107
   Stefan M, 2005, ENDOCRINOLOGY, V146, P4377, DOI 10.1210/en.2005-0371
   STEITZ JA, 1995, SCIENCE, V270, P1626, DOI 10.1126/science.270.5242.1626
   Stoss O, 1999, BRAIN RES PROTOC, V4, P383, DOI 10.1016/S1385-299X(99)00043-4
   van Wijngaarden RFAD, 2008, J CLIN ENDOCR METAB, V93, P1649, DOI 10.1210/jc.2007-2294
   Vitali P, 2005, J CELL BIOL, V169, P745, DOI 10.1083/jcb.200411129
   Vitali P, 2010, J CELL SCI, V123, P70, DOI 10.1242/jcs.054957
   Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509
   Watkins NJ, 2000, CELL, V103, P457, DOI 10.1016/S0092-8674(00)00137-9
   Zhang Z, 2008, CELL, V133, P585, DOI 10.1016/j.cell.2008.03.031
NR 38
TC 166
Z9 174
U1 0
U2 19
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0964-6906
EI 1460-2083
J9 HUM MOL GENET
JI Hum. Mol. Genet.
PD APR
PY 2010
VL 19
IS 7
BP 1153
EP 1164
DI 10.1093/hmg/ddp585
PG 12
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 572HK
UT WOS:000275818500001
PM 20053671
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Tennant, DA
   Duran, RV
   Gottlieb, E
AF Tennant, Daniel A.
   Duran, Raul V.
   Gottlieb, Eyal
TI Targeting metabolic transformation for cancer therapy
SO NATURE REVIEWS CANCER
LA English
DT Review
ID FATTY-ACID SYNTHASE; TUMOR-CELL GROWTH; RECURRENT
   GLIOBLASTOMA-MULTIFORME; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA;
   CARBONIC-ANHYDRASE INHIBITORS; BREAST-CARCINOMA CELLS; PHASE-II TRIAL;
   PYRUVATE-KINASE; TEMSIROLIMUS CCI-779; KETOGENIC DIET
AB Cancer therapy has long relied on the rapid proliferation of tumour cells for effective treatment. However, the lack of specificity in this approach often leads to undesirable side effects. Many reports have described various 'metabolic transformation' events that enable cancer cells to survive, suggesting that metabolic pathways might be good targets. There are currently several drugs under development or in clinical trials that are based on specifically targeting the altered metabolic pathways of tumours. This Review highlights pathways against which there are already drugs in different stages of development and also discusses additional druggable targets.
C1 [Tennant, Daniel A.; Gottlieb, Eyal] Beatson Inst Canc Res, Canc Res UK, Glasgow G61 1BD, Lanark, Scotland.
   [Duran, Raul V.] Univ Basel, Growth & Dev Biozentrum, Basel, Switzerland.
RP Gottlieb, E (corresponding author), Beatson Inst Canc Res, Canc Res UK, Garscube Estate, Glasgow G61 1BD, Lanark, Scotland.
EM e.gottlieb@beatson.gla.ac.uk
RI Gottlieb, Eyal/G-6450-2010; Duran, Raul/E-4764-2011
OI Gottlieb, Eyal/0000-0002-9770-0956; Duran, Raul/0000-0002-2249-9215;
   Tennant, Daniel/0000-0003-0499-2732
CR Alo PL, 1996, CANCER, V77, P474, DOI 10.1002/(SICI)1097-0142(19960201)77:3<474::AID-CNCR8>3.0.CO;2-K
   Altomare DA, 2005, ONCOGENE, V24, P7455, DOI 10.1038/sj.onc.1209085
   Anisimov VN, 2005, EXP GERONTOL, V40, P685, DOI 10.1016/j.exger.2005.07.007
   Atsumi T, 2002, CANCER RES, V62, P5881
   Baumann F, 2009, NEURO-ONCOLOGY, V11, P368, DOI 10.1215/15228517-2008-106
   Baysal BE, 2000, SCIENCE, V287, P848, DOI 10.1126/science.287.5454.848
   Bhujwalla ZM, 1999, MAGN RESON MED, V41, P897
   Bonnet S, 2007, CANCER CELL, V11, P37, DOI 10.1016/j.ccr.2006.10.020
   Brachmann S, 2009, CURR OPIN CELL BIOL, V21, P194, DOI 10.1016/j.ceb.2008.12.011
   BRUSILOW SW, 1984, NEW ENGL J MED, V310, P1630, DOI 10.1056/NEJM198406213102503
   Bunpo P, 2009, J BIOL CHEM, V284, P32742, DOI 10.1074/jbc.M109.047910
   Cao XH, 2008, CLIN CANCER RES, V14, P1831, DOI 10.1158/1078-0432.CCR-07-1607
   Cao XH, 2007, CANCER CHEMOTH PHARM, V59, P495, DOI 10.1007/s00280-006-0291-9
   Chan S, 2005, J CLIN ONCOL, V23, P5314, DOI 10.1200/JCO.2005.66.130
   Chiche J, 2009, CANCER RES, V69, P358, DOI 10.1158/0008-5472.CAN-08-2470
   Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734
   Christofk HR, 2008, NATURE, V452, P181, DOI 10.1038/nature06667
   Chu-Shore CJ, 2010, BRAIN DEV-JPN, V32, P318, DOI 10.1016/j.braindev.2009.04.009
   Clem B, 2008, MOL CANCER THER, V7, P110, DOI 10.1158/1535-7163.MCT-07-0482
   Coy JF, 2005, CLIN LAB, V51, P257
   CUSHMAN SW, 1980, J BIOL CHEM, V255, P4758
   De Lena M, 2001, EUR J CANCER, V37, P364, DOI 10.1016/S0959-8049(00)00400-7
   DeBerardinis RJ, 2010, ONCOGENE, V29, P313, DOI 10.1038/onc.2009.358
   DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002
   DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104
   Deprez J, 1997, J BIOL CHEM, V272, P17269, DOI 10.1074/jbc.272.28.17269
   DEVI MA, 1993, CANCER LETT, V69, P191, DOI 10.1016/0304-3835(93)90174-8
   Di Cosimo S, 2003, DRUGS TODAY, V39, P157, DOI 10.1358/dot.2003.39.3.799451
   Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310
   Eigenbrodt E., 1992, Critical Reviews in Oncogenesis, V3, P91
   Ely J.O., 1954, J FRANKLIN I, V258, P157, DOI /10.1016/0016-0032(54) 90946-1.
   Engelman JA, 2009, NAT REV CANCER, V9, P550, DOI 10.1038/nrc2664
   Engelman JA, 2008, NAT MED, V14, P1351, DOI 10.1038/nm.1890
   Ewald B, 2008, ONCOGENE, V27, P6522, DOI 10.1038/onc.2008.316
   Fan QW, 2007, CANCER RES, V67, P7960, DOI 10.1158/0008-5472.CAN-07-2154
   Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023
   FARBER S, 1948, NEW ENGL J MED, V238, P787, DOI 10.1056/NEJM194806032382301
   Feun Lynn, 2006, Expert Opin Investig Drugs, V15, P815, DOI 10.1517/13543784.15.7.815
   FUNABASHI H, 1989, J BIOCHEM-TOKYO, V105, P751, DOI 10.1093/oxfordjournals.jbchem.a122739
   Galanis E, 2005, J CLIN ONCOL, V23, P5294, DOI 10.1200/JCO.2005.23.622
   Gambhir SS, 2002, NAT REV CANCER, V2, P683, DOI 10.1038/nrc882
   Gao P, 2009, NATURE, V458, P762, DOI 10.1038/nature07823
   Gatenby RA, 2006, CANCER RES, V66, P5216, DOI 10.1158/0008-5472.CAN-05-4193
   Gillies RJ, 2007, CANCER METAST REV, V26, P311, DOI 10.1007/s10555-007-9065-z
   Gottlieb E, 2005, NAT REV CANCER, V5, P857, DOI 10.1038/nrc1737
   Greco O, 2000, J RADIAT RES, V41, P201, DOI 10.1269/jrr.41.201
   Gualberto A, 2009, ONCOGENE, V28, P3009, DOI 10.1038/onc.2009.172
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   HASKELL CM, 1969, BIOCHEM PHARMACOL, V18, P2578, DOI 10.1016/0006-2952(69)90375-X
   HASKELL CM, 1969, NEW ENGL J MED, V281, P1028, DOI 10.1056/NEJM196911062811902
   Hatzivassiliou G, 2005, CANCER CELL, V8, P311, DOI 10.1016/j.ccr.2005.09.008
   Hudes G, 2007, NEW ENGL J MED, V356, P2271, DOI 10.1056/NEJMoa066838
   Izzo F, 2004, J CLIN ONCOL, V22, P1815, DOI 10.1200/JCO.2004.11.120
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jain RK, 2001, P NATL ACAD SCI USA, V98, P14748, DOI 10.1073/pnas.261606598
   Jiralerspong S, 2009, J CLIN ONCOL, V27, P3297, DOI 10.1200/JCO.2009.19.6410
   Jordan BF, 2005, NEOPLASIA, V7, P475, DOI 10.1593/neo.04628
   Jordan NF, 2005, NMR BIOMED, V18, P430, DOI 10.1002/nbm.977
   Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782
   Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002
   King A, 2009, CURR OPIN CELL BIOL, V21, P885, DOI 10.1016/j.ceb.2009.09.009
   Ko YH, 2004, BIOCHEM BIOPH RES CO, V324, P269, DOI 10.1016/j.bbrc.2004.09.047
   Kobori M, 1997, CANCER LETT, V119, P207, DOI 10.1016/S0304-3835(97)00271-1
   Koh MY, 2008, MOL CANCER THER, V7, P90, DOI 10.1158/1535-7163.MCT-07-0463
   Kridel SJ, 2004, CANCER RES, V64, P2070, DOI 10.1158/0008-5472.can-03-3645
   LANDAU BR, 1958, J NATL CANCER I, V21, P485
   Langbein S, 2006, BRIT J CANCER, V94, P578, DOI 10.1038/sj.bjc.6602962
   Lee K, 2009, P NATL ACAD SCI USA, V106, P17910, DOI 10.1073/pnas.0909353106
   Li JN, 2001, CANCER RES, V61, P1493
   Libby G, 2009, DIABETES CARE, V32, P1620, DOI 10.2337/dc08-2175
   Liu SC, 2002, GENE THER, V9, P291, DOI 10.1038/sj.gt.3301659
   Majewski N, 2004, MOL CELL, V16, P819, DOI 10.1016/j.molcel.2004.11.014
   Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161
   Marone R, 2009, MOL CANCER RES, V7, P601, DOI 10.1158/1541-7786.MCR-08-0366
   MartinezZaguilan R, 1996, CLIN EXP METASTAS, V14, P176, DOI 10.1007/BF00121214
   Maschek G, 2004, CANCER RES, V64, P31, DOI 10.1158/0008-5472.CAN-03-3294
   Masetti R, 2009, BIOL-TARGETS THER, V3, P359
   Mazurek S, 2005, SEMIN CANCER BIOL, V15, P300, DOI 10.1016/j.semcancer.2005.04.009
   McFate T, 2008, J BIOL CHEM, V283, P22700, DOI 10.1074/jbc.M801765200
   McKeown SR, 2007, CLIN ONCOL-UK, V19, P427, DOI 10.1016/j.clon.2007.03.006
   Mera P, 2009, BIOCHEM PHARMACOL, V77, P1084, DOI 10.1016/j.bcp.2008.11.020
   Moeller BJ, 2005, CANCER CELL, V8, P99, DOI 10.1016/j.ccr.2005.06.016
   Molckovsky A, 2008, J HEMATOL ONCOL, V1, DOI 10.1186/1756-8722-1-20
   Motzer RJ, 2008, LANCET, V372, P449, DOI 10.1016/S0140-6736(08)61039-9
   NEBELING LC, 1995, J AM COLL NUTR, V14, P202
   NELSON JAS, 1993, ANTICANCER RES, V13, P2287
   NEWSHOLME EA, 1985, ADV ENZYME REGUL, V31, P225
   Ni Y, 2008, CANCER LETT, V261, P1, DOI 10.1016/j.canlet.2007.11.038
   OLSON RE, 1951, CANCER RES, V11, P571
   Otto C, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-122
   Oudard S, 2003, J NEURO-ONCOL, V63, P81, DOI 10.1023/A:1023756707900
   Papaldo P, 2003, J CLIN ONCOL, V21, P3462, DOI 10.1200/JCO.2003.03.034
   Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012
   Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382
   Pearson H, 2007, NATURE, V446, P474, DOI 10.1038/446474a
   Pizer ES, 1998, CANCER-AM CANCER SOC, V83, P528, DOI 10.1002/(SICI)1097-0142(19980801)83:3<528::AID-CNCR22>3.0.CO;2-X
   Pizer ES, 2000, CANCER RES, V60, P213
   Pizer ES, 1998, CANCER RES, V58, P4611
   Rabbani ZN, 2009, FREE RADICAL BIO MED, V47, P992, DOI 10.1016/j.freeradbiomed.2009.07.001
   Rashid A, 1997, AM J PATHOL, V150, P201
   Rizell M, 2008, INT J CLIN ONCOL, V13, P66, DOI 10.1007/s10147-007-0733-3
   ROBERTS E, 1960, AMINO ACIDS PROTEINS, P127
   Robey IF, 2009, CANCER RES, V69, P2260, DOI 10.1158/0008-5472.CAN-07-5575
   ROSBE KW, 1989, CANCER CHEMOTH PHARM, V25, P32, DOI 10.1007/BF00694335
   ROSENFELD H, 1981, CANCER RES, V41, P1324
   SABERS CJ, 1995, J BIOL CHEM, V270, P815, DOI 10.1074/jbc.270.2.815
   Salway JG, 2004, METABOLISM GLANCE, P20
   SAMID D, 1992, BLOOD, V80, P1576
   SAMID D, 1994, CANCER RES, V54, P891
   SAMID D, 1993, J CLIN INVEST, V91, P2288, DOI 10.1172/JCI116457
   Semenza GL, 1996, J BIOL CHEM, V271, P32529, DOI 10.1074/jbc.271.51.32529
   Seyfried TN, 2008, EPILEPSIA, V49, P114, DOI 10.1111/j.1528-1167.2008.01853.x
   Seyfried Thomas N, 2005, Nutr Metab (Lond), V2, P30, DOI 10.1186/1743-7075-2-30
   Shackelford DB, 2009, NAT REV CANCER, V9, P563, DOI 10.1038/nrc2676
   Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658
   SIMELL O, 1986, PEDIATR RES, V20, P1117, DOI 10.1203/00006450-198611000-00011
   Singh DH, 2005, STRAHLENTHER ONKOL, V181, P507, DOI 10.1007/s00066-005-1320-z
   SOM P, 1980, J NUCL MED, V21, P670
   Sonveaux P, 2008, J CLIN INVEST, V118, P3930, DOI 10.1172/JCI36843
   Stuwe L, 2007, J PHYSIOL-LONDON, V585, P351, DOI 10.1113/jphysiol.2007.145185
   Sun RC, 2010, BREAST CANCER RES TR, V120, P253, DOI 10.1007/s10549-009-0435-9
   Supuran CT, 2008, NAT REV DRUG DISCOV, V7, P168, DOI 10.1038/nrd2467
   Supuran CT, 2003, EXPERT OPIN INV DRUG, V12, P283, DOI 10.1517/eoid.12.2.283.21409
   Supuran CT, 2001, BIOORGAN MED CHEM, V9, P703, DOI 10.1016/S0968-0896(00)00288-1
   SUZUKI K, 1980, P NATL ACAD SCI-BIOL, V77, P2542, DOI 10.1073/pnas.77.5.2542
   Szeliga M, 2009, NEUROCHEM INT, V55, P71, DOI 10.1016/j.neuint.2009.01.008
   Tennant DA, 2009, CARCINOGENESIS, V30, P1269, DOI 10.1093/carcin/bgp070
   THOMLINSON RH, 1955, BRIT J CANCER, V9, P539, DOI 10.1038/bjc.1955.55
   THORNTON SN, 2009, COMMUNICATION
   Tomlinson IPM, 2002, NAT GENET, V30, P406, DOI 10.1038/ng849
   Tong XM, 2009, CURR OPIN GENET DEV, V19, P32, DOI 10.1016/j.gde.2009.01.002
   Vazquez MJ, 2008, FEBS J, V275, P1556, DOI 10.1111/j.1742-4658.2008.06314.x
   Vazquez-Martin A, 2007, ONCOL REP, V18, P973
   Vazquez-Martin A, 2007, INT J ONCOL, V31, P769
   WANG GL, 1995, J BIOL CHEM, V270, P1230, DOI 10.1074/jbc.270.3.1230
   Warburg O, 1923, BIOCHEM Z, V142, P317
   WEBER G, 1983, ADV ENZYME REGUL, V21, P53, DOI 10.1016/0065-2571(83)90008-0
   WEINHOUSE S, 1972, CANCER RES, V32, P2007
   Welsh S, 2004, MOL CANCER THER, V3, P233
   Welsh SJ, 2002, EUR J CANCER, V38, pS90
   Wheatley DN, 2004, ANTI-CANCER DRUG, V15, P825, DOI 10.1097/00001813-200410000-00002
   Winum JY, 2007, BIOORG MED CHEM LETT, V17, P2685, DOI 10.1016/j.bmcl.2007.03.008
   Witzig TE, 2005, J CLIN ONCOL, V23, P5347, DOI 10.1200/JCO.2005.13.466
   Wong P, 2002, BRIT J CANCER, V87, P238, DOI 10.1038/sj.bjc.6600424
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Xu XJ, 2009, INT J CANCER, V124, P1330, DOI 10.1002/ijc.24078
   Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710
   ZAMECNIK PC, 1951, CANCER RES, V11, P592
   Zeidan A, 2009, EXPERT OPIN BIOL TH, V9, P111, DOI 10.1517/14712590802586058 
   Zhang S, 2007, CANCER LETT, V253, P108, DOI 10.1016/j.canlet.2007.01.010
   Zhou WH, 2007, NUTR METAB, V4, DOI 10.1186/1743-7075-4-5
NR 151
TC 733
Z9 754
U1 8
U2 247
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-175X
EI 1474-1768
J9 NAT REV CANCER
JI Nat. Rev. Cancer
PD APR
PY 2010
VL 10
IS 4
BP 267
EP 277
DI 10.1038/nrc2817
PG 11
WC Oncology
SC Oncology
GA 573RQ
UT WOS:000275932700010
PM 20300106
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Ninov, N
   Menezes-Cabral, S
   Prat-Rojo, C
   Manjon, C
   Weiss, A
   Pyrowolakis, G
   Affolter, M
   Martin-Blanco, E
AF Ninov, Nikolay
   Menezes-Cabral, Sofia
   Prat-Rojo, Carla
   Manjon, Cristina
   Weiss, Alexander
   Pyrowolakis, George
   Affolter, Markus
   Martin-Blanco, Enrique
TI Dpp Signaling Directs Cell Motility and Invasiveness during Epithelial
   Morphogenesis
SO CURRENT BIOLOGY
LA English
DT Article
ID ADULT ABDOMEN; DROSOPHILA; MIGRATION; MECHANISMS; INVASION; GROWTH;
   CANCER; METASTASIS; TRANSITION; EXTRUSION
AB Tissue remodeling in development and disease [1, 2] involves the coordinated invasion of neighboring territories and/or the replacement of entire cell populations. Cell guidance, cell matching, transitions from passive to migratory epithelia, cell growth and death, and extracellular matrix remodeling all impinge on epithelial spreading. Significantly, the extracellular signals that direct these activities and the specific cellular elements and mechanisms regulated by these signals remain in most cases to be identified. To address these issues, we performed an analysis of histoblasts (Drosophila abdominal epithelial founder cells [3, 4]) on their transition from a dormant state to active migration replacing obsolete larval epidermal cells (LECs). We found that during expansion, Decapentaplegic (Dpp) secreted from surrounding LECs leads to graded pathway activation in cells at the periphery of histoblast nests. Across nests, Dpp activity confers differential cellular behavior and motility by modulating cell-cell contacts, the organization and activity of the cytoskeleton, and histoblast attachment to the substrate. Furthermore, Dpp also prevents the premature death of LECs, allowing the coordination of histoblast expansion to LEC delamination. Dpp signaling activity directing histoblast spreading and invasiveness mimics transforming growth factor-beta and bone morphogenetic proteins' role in enhancing the motility and invasiveness of cancer cells, resulting in the promotion of metastasis [5, 6].
C1 [Ninov, Nikolay; Menezes-Cabral, Sofia; Prat-Rojo, Carla; Manjon, Cristina; Martin-Blanco, Enrique] CSIC, Inst Biol Mol Barcelona, E-08028 Barcelona, Spain.
   [Menezes-Cabral, Sofia] Univ Coimbra, Ctr Neurosci & Cell Biol, Programa Doutoral Biol Expt & Biomed, P-3004517 Coimbra, Portugal.
   [Weiss, Alexander; Pyrowolakis, George; Affolter, Markus] Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
   [Pyrowolakis, George] Univ Freiburg, Inst Biol 1, D-79104 Freiburg, Germany.
RP Martin-Blanco, E (corresponding author), CSIC, Inst Biol Mol Barcelona, Parc Cient Barcelona,Baldiri Reixac 10, E-08028 Barcelona, Spain.
EM embbmc@ibmb.csic.es
RI Martin-Blanco, Enrique/ABH-1280-2020
OI Martin-Blanco, Enrique/0000-0002-6926-910X; Ninov,
   Nikolay/0000-0003-3286-6100; Affolter, Markus/0000-0002-5171-0016
FU Harvard Medical School [NIH/NIGMS R01-GM084947]; Fundacao para a Ciencia
   e a Tecnologia (Portugal)Portuguese Foundation for Science and
   Technology; Spanish Ministry of ScienceSpanish Government; European
   UnionEuropean Union (EU); Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); Kanton Basel-Stadt; Kanton
   Basel-Landschaft; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of General Medical Sciences
   (NIGMS) [R01GM084947, R01GM084947, R01GM084947, R01GM084947,
   R01GM084947, R01GM084947, R01GM084947, R01GM084947, R01GM084947,
   R01GM084947, R01GM084947, R01GM084947] Funding Source: NIH RePORTER
FX We would like to thank all members of our laboratories for encouragement
   and criticism and C. Bakal, K. Basler, B. Belo, F. Bejarano, J.
   Colombelli, H. Herranz, and E. Rebollo for reagents and advice. We thank
   the Vienna Drosophila RNAi Center, the Bloomington Stock Center, and the
   Transgenic RNAi Resource Project at Harvard Medical School (NIH/NIGMS
   R01-GM084947) for providing fly stocks used in this study. N.N. held a
   Formacion de Profesorado Universitario PhD studentship, C.P.-R. held a
   "La Caixa" master fellowship, and S.M.-C. is supported by a PhD
   fellowship from the Fundacao para a Ciencia e a Tecnologia (Portugal).
   N.N. would like to thank U. Tepass for his assistance and support.
   Research in EM-B's laboratory is funded by grants from the Spanish
   Ministry of Science and the European Union. Research in MA's laboratory
   is supported by the Swiss National Science Foundation, Kanton
   Basel-Stadt, Kanton Basel-Landschaft, and the European Union.
CR Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166
   Bokel C, 2005, J CELL SCI, V118, P633, DOI 10.1242/jcs.01619
   Christiansen JJ, 2006, CANCER RES, V66, P8319, DOI 10.1158/0008-5472.CAN-06-0410
   Dominguez F, 2005, FASEB J, V19, P1056, DOI 10.1096/fj.05-3781hyp
   Farooqui R, 2005, J CELL SCI, V118, P51, DOI 10.1242/jcs.01577
   Fernandez BG, 2007, MECH DEVELOP, V124, P884, DOI 10.1016/j.mod.2007.09.002
   Friedl P, 2004, INT J DEV BIOL, V48, P441, DOI 10.1387/ijdb.041821pf
   Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075
   Gibson MC, 2005, SCIENCE, V307, P1785, DOI 10.1126/science.1104751
   Greenwood S, 1999, DEVELOPMENT, V126, P5795
   Gupta GP, 2006, CELL, V127, P679, DOI 10.1016/j.cell.2006.11.001
   Hegerfeldt Y, 2002, CANCER RES, V62, P2125
   Kato K, 2004, DEVELOPMENT, V131, P5253, DOI 10.1242/dev.01404
   Kopp A, 1999, DEVELOPMENT, V126, P3495
   Legan PK, 2000, NEURON, V28, P273, DOI 10.1016/S0896-6273(00)00102-1
   MADHAVAN MM, 1980, J EMBRYOL EXP MORPH, V60, P1
   Martin-Blanco E, 2000, P NATL ACAD SCI USA, V97, P7888, DOI 10.1073/pnas.97.14.7888
   Martin-Blanco E, 2001, CURR BIOL, V11, pR28, DOI 10.1016/S0960-9822(00)00039-7
   Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705
   McClure KD, 2005, DEVELOPMENT, V132, P5033, DOI 10.1242/dev.02092
   Morata G, 1999, DEVELOPMENT, V126, P2823
   Nabeshima K, 2000, CANCER RES, V60, P3364
   Ninov N, 2007, DEVELOPMENT, V134, P367, DOI 10.1242/dev.02728
   Ninov N, 2009, PLOS BIOL, V7, P892, DOI 10.1371/journal.pbio.1000079
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Shen J, 2005, SCIENCE, V307, P1789, DOI 10.1126/science.1104784
   Weiss A, 2010, NAT STRUCT MOL BIOL, V17, P69, DOI 10.1038/nsmb.1715
   Wolf K, 2007, NAT CELL BIOL, V9, P893, DOI 10.1038/ncb1616
   Yoshida S, 2005, DEVELOPMENT, V132, P4587, DOI 10.1242/dev.02040
   Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927
NR 31
TC 38
Z9 39
U1 0
U2 14
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD MAR 23
PY 2010
VL 20
IS 6
BP 513
EP 520
DI 10.1016/j.cub.2010.01.063
PG 8
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 574TT
UT WOS:000276017300025
PM 20226662
DA 2021-01-25
ER

PT J
AU Vajpai, N
   Gentner, M
   Huang, JR
   Blackledge, M
   Grzesiek, S
AF Vajpai, Navratna
   Gentner, Martin
   Huang, Jie-rong
   Blackledge, Martin
   Grzesiek, Stephan
TI Side-Chain chi(1) Conformations in Urea-Denatured Ubiquitin and Protein
   G from (3)J Coupling Constants and Residual Dipolar Couplings
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID NUCLEAR MAGNETIC RESONANCE; LIQUID-CRYSTALLINE PHASE; ALPHA-AMINO ACIDS;
   NMR DATA; POLYACRYLAMIDE GELS; INDUCED ALIGNMENT; CHEMICAL-SHIFTS;
   BINDING DOMAIN; STATE; SPECTROSCOPY
AB Current NMR information on side-chain conformations of unfolded protein states is sparse due to the poor dispersion particularly of side-chain proton resonances. We present here optimized schemes for the detection of (3)J(H alpha H beta), (3)J(NH beta), and (3)J(CH beta) scalar and D-1(C beta H beta) residual dipolar couplings (RDCs) in unfolded proteins. For urea-denatured ubiquitin and protein G, Up to Six (3)J-couplings to H-1(beta) are detected, which define the chi(1) angle at very high precision. Interpretation of the (3)J couplings by a model of mixed staggered chi(1) rotamers yields excellent agreement and also provides stereoassignments for H-1(beta) methylene protons. For all observed amino acids with the exception of leucine, the chemical shift of H-1(beta 3) protons was found downfield from H-1(beta 2). For most residues, the precision of individual chi(1) rotamer populations is better than 2%. The experimental rotamer populations are in the vicinity of averages obtained from coil regions in folded protein structures. However, individual variations from these averages of up to 40% are highly significant and indicate sequence- and residue-specific interactions. Particularly strong deviations from the coil average are found for serine and threonine residues, an effect that may be explained by a weakening of side-chain to backbone hydrogen bonds in the urea-denatured state. The measured D-1(C beta H beta) RDCs correlate well with predicted RDCs that were calculated from a sterically aligned coil model ensemble and the (3)J-derived chi(1) rotamer populations. This agreement supports the coil model as a good first approximation of the unfolded state. Deviations between measured and predicted values at certain sequence locations indicate that the description of the local backbone conformations can be improved by incorporation of the RDC information. The ease of detection of a large number of highly precise side-chain RDCs opens the possibility for a more rigorous characterization of both side-chain and backbone conformations in unfolded proteins.
C1 [Vajpai, Navratna; Gentner, Martin; Huang, Jie-rong; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Blackledge, Martin] CNRS, CEA, Inst Biol Struct Jean Pierre Ebel, UJF UMR 5075, F-38027 Grenoble, France.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch
RI Huang, Jie-rong/O-3661-2019; Huang, Jie-rong/B-4222-2009
OI Huang, Jie-rong/0000-0003-3674-2228; Grzesiek,
   Stephan/0000-0003-1998-4225
FU SNF [31-109712]
FX We thank C. Howald, K. Rathgeb-Szabo. and M. Rogowski for sample
   preparation, and we also thank H.-J. Sass and S. Kasprzak for helpful
   discussions. This work was supported by SNF Grant 31-109712.
CR ARCHER SJ, 1991, J MAGN RESON, V95, P636, DOI 10.1016/0022-2364(91)90182-S
   BAX A, 1994, METHOD ENZYMOL, V239, P79
   Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102
   Chou JJ, 2001, J BIOMOL NMR, V21, P377, DOI 10.1023/A:1013336502594
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DERRICK JP, 1994, J MOL BIOL, V243, P906, DOI 10.1006/jmbi.1994.1691
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002
   DZAKULA Z, 1992, J AM CHEM SOC, V114, P6195, DOI 10.1021/ja00041a043
   Fitzkee NC, 2005, PROTEINS, V58, P852, DOI 10.1002/prot.20394
   FRANK MK, 1995, PROTEIN SCI, V4, P2605, DOI 10.1002/pro.5560041218
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Gillespie JR, 1997, J MOL BIOL, V268, P170, DOI 10.1006/jmbi.1997.0953
   GRZESIEK S, 1992, J MAGN RESON, V96, P215, DOI 10.1016/0022-2364(92)90307-S
   GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P185
   Hennig M, 1999, J MOL BIOL, V288, P705, DOI 10.1006/jmbi.1999.2722
   Huang JR, 2010, J AM CHEM SOC, V132, P694, DOI 10.1021/ja907974m
   Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Lohr F, 1999, J AM CHEM SOC, V121, P11821, DOI 10.1021/ja991356h
   Mathieson S I, 1999, Pac Symp Biocomput, P542
   Meier S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2838167
   Meier S, 2007, J AM CHEM SOC, V129, P9799, DOI 10.1021/ja0724339
   Meier S, 2007, J AM CHEM SOC, V129, P754, DOI 10.1021/ja067522k
   Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009
   Moltke S, 1999, J BIOMOL NMR, V15, P77, DOI 10.1023/A:1008309630377
   Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159
   Nodet G, 2009, J AM CHEM SOC, V131, P17908, DOI 10.1021/ja9069024
   Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361
   PACHLER KGR, 1963, SPECTROCHIM ACTA, V19, P2085, DOI 10.1016/0371-1951(63)80228-3
   PACHLER KGR, 1964, SPECTROCHIM ACTA, V20, P581, DOI 10.1016/0371-1951(64)80055-2
   Perez C, 2001, J AM CHEM SOC, V123, P7081, DOI 10.1021/ja003724j
   Peti W, 2001, J BIOMOL NMR, V19, P153, DOI 10.1023/A:1008307323283
   PONDER JW, 1987, J MOL BIOL, V193, P775, DOI 10.1016/0022-2836(87)90358-5
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   SERRANO L, 1995, J MOL BIOL, V254, P322, DOI 10.1006/jmbi.1995.0619
   Shortle D, 1996, FASEB J, V10, P27
   Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438
   Smith LJ, 1996, J MOL BIOL, V255, P494, DOI 10.1006/jmbi.1996.0041
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   van Lune F, 2002, J BIOMOL NMR, V23, P169, DOI 10.1023/A:1019877830921
   West NJ, 1998, J MOL BIOL, V280, P867, DOI 10.1006/jmbi.1998.1911
   Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003
   Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908
NR 47
TC 30
Z9 31
U1 0
U2 21
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD MAR 10
PY 2010
VL 132
IS 9
BP 3196
EP 3203
DI 10.1021/ja910331t
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 570GO
UT WOS:000275660500059
PM 20155903
DA 2021-01-25
ER

PT J
AU Ravasi, T
   Suzuki, H
   Cannistraci, CV
   Katayama, S
   Bajic, VB
   Tan, K
   Akalin, A
   Schmeier, S
   Kanamori-Katayama, M
   Bertin, N
   Carninci, P
   Daub, CO
   Forrest, ARR
   Gough, J
   Grimmond, S
   Han, JH
   Hashimoto, T
   Hide, W
   Hofmann, O
   Kawaji, H
   Kubosaki, A
   Lassmann, T
   van Nimwegen, E
   Ogawa, C
   Teasdale, RD
   Tegner, J
   Lenhard, B
   Teichmann, SA
   Arakawa, T
   Ninomiya, N
   Murakami, K
   Tagami, M
   Fukuda, S
   Imamura, K
   Kai, C
   Ishihara, R
   Kitazume, Y
   Kawai, J
   Hume, DA
   Ideker, T
   Hayashizaki, Y
AF Ravasi, Timothy
   Suzuki, Harukazu
   Cannistraci, Carlo Vittorio
   Katayama, Shintaro
   Bajic, Vladimir B.
   Tan, Kai
   Akalin, Altuna
   Schmeier, Sebastian
   Kanamori-Katayama, Mutsumi
   Bertin, Nicolas
   Carninci, Piero
   Daub, Carsten O.
   Forrest, Alistair R. R.
   Gough, Julian
   Grimmond, Sean
   Han, Jung-Hoon
   Hashimoto, Takehiro
   Hide, Winston
   Hofmann, Oliver
   Kawaji, Hideya
   Kubosaki, Atsutaka
   Lassmann, Timo
   van Nimwegen, Erik
   Ogawa, Chihiro
   Teasdale, Rohan D.
   Tegner, Jesper
   Lenhard, Boris
   Teichmann, Sarah A.
   Arakawa, Takahiro
   Ninomiya, Noriko
   Murakami, Kayoko
   Tagami, Michihira
   Fukuda, Shiro
   Imamura, Kengo
   Kai, Chikatoshi
   Ishihara, Ryoko
   Kitazume, Yayoi
   Kawai, Jun
   Hume, David A.
   Ideker, Trey
   Hayashizaki, Yoshihide
TI An Atlas of Combinatorial Transcriptional Regulation in Mouse and Man
SO CELL
LA English
DT Article
ID EMBRYONIC STEM-CELLS; PROTEIN INTERACTIONS; GENE-EXPRESSION; NETWORKS;
   DNA; BINDING; FAMILY; YEAST; LIPOPOLYSACCHARIDE; DIFFERENTIATION
AB Combinatorial interactions among transcription factors are critical to directing tissue-specific gene expression. To build a global atlas of these combinations, we have screened for physical interactions among the majority of human and mouse DNA-binding transcription factors (TFs). The complete networks contain 762 human and 877 mouse interactions. Analysis of the networks reveals that highly connected TFs are broadly expressed across tissues, and that roughly half of the measured interactions are conserved between mouse and human. The data highlight the importance of TF combinations for determining cell fate, and they lead to the identification of a SMAD3/FLI1 complex expressed during development of immunity. The availability of large TF combinatorial networks in both human and mouse will provide many opportunities to study gene regulation, tissue differentiation, and mammalian evolution.
C1 [Ravasi, Timothy; Suzuki, Harukazu; Cannistraci, Carlo Vittorio; Katayama, Shintaro; Bajic, Vladimir B.; Tan, Kai; Akalin, Altuna; Schmeier, Sebastian; Kanamori-Katayama, Mutsumi; Bertin, Nicolas; Carninci, Piero; Daub, Carsten O.; Forrest, Alistair R. R.; Gough, Julian; Grimmond, Sean; Han, Jung-Hoon; Hashimoto, Takehiro; Hide, Winston; Hofmann, Oliver; Kawaji, Hideya; Kubosaki, Atsutaka; Lassmann, Timo; van Nimwegen, Erik; Ogawa, Chihiro; Teasdale, Rohan D.; Tegner, Jesper; Lenhard, Boris; Teichmann, Sarah A.; Arakawa, Takahiro; Ninomiya, Noriko; Murakami, Kayoko; Tagami, Michihira; Fukuda, Shiro; Imamura, Kengo; Kai, Chikatoshi; Ishihara, Ryoko; Kitazume, Yayoi; Kawai, Jun; Hume, David A.; Ideker, Trey; Hayashizaki, Yoshihide] Univ Calif San Diego, FANTOM Consortium, La Jolla, CA 92093 USA.
   [Suzuki, Harukazu; Katayama, Shintaro; Kanamori-Katayama, Mutsumi; Bertin, Nicolas; Carninci, Piero; Daub, Carsten O.; Forrest, Alistair R. R.; Hashimoto, Takehiro; Kawaji, Hideya; Kubosaki, Atsutaka; Lassmann, Timo; Ogawa, Chihiro; Arakawa, Takahiro; Ninomiya, Noriko; Murakami, Kayoko; Tagami, Michihira; Fukuda, Shiro; Imamura, Kengo; Kai, Chikatoshi; Ishihara, Ryoko; Kitazume, Yayoi; Kawai, Jun; Hayashizaki, Yoshihide] Univ Calif San Diego, RIKEN Om Sci Ctr, La Jolla, CA 92093 USA.
   [Ravasi, Timothy; Cannistraci, Carlo Vittorio; Tan, Kai; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Ravasi, Timothy; Cannistraci, Carlo Vittorio; Tan, Kai; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.
   [Ravasi, Timothy; Cannistraci, Carlo Vittorio; Bajic, Vladimir B.; Han, Jung-Hoon] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Div Chem & Life Sci & Engn, Red Sea Integrat Syst Biol Lab, Jeddah, Saudi Arabia.
   [Suzuki, Harukazu; Katayama, Shintaro; Kanamori-Katayama, Mutsumi; Bertin, Nicolas; Carninci, Piero; Daub, Carsten O.; Forrest, Alistair R. R.; Hashimoto, Takehiro; Kawaji, Hideya; Kubosaki, Atsutaka; Lassmann, Timo; Ogawa, Chihiro; Arakawa, Takahiro; Ninomiya, Noriko; Murakami, Kayoko; Tagami, Michihira; Fukuda, Shiro; Imamura, Kengo; Kai, Chikatoshi; Ishihara, Ryoko; Kitazume, Yayoi; Kawai, Jun; Hayashizaki, Yoshihide] RIKEN Yokohama Inst, RIKEN Om Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan.
   [Cannistraci, Carlo Vittorio] Politecn Torino, Dept Mech, I-10129 Turin, Italy.
   [Cannistraci, Carlo Vittorio] Ist Sci San Raffaele, I-20132 Milan, Italy.
   [Cannistraci, Carlo Vittorio] Politecn Torino, CMP Grp Microsoft Res, I-10129 Turin, Italy.
   [Bajic, Vladimir B.; Schmeier, Sebastian; Hide, Winston; Hofmann, Oliver] Univ Western Cape, S African Natl Bioinformat Inst, ZA-7535 Bellville, South Africa.
   [Akalin, Altuna; Lenhard, Boris] Bergen Ctr Computat Sci, N-5008 Bergen, Norway.
   [Forrest, Alistair R. R.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Griffith, Qld 4111, Australia.
   [Gough, Julian] Univ Bristol, Dept Comp Sci, Bristol BS8 1UB, Avon, England.
   [Grimmond, Sean; Teasdale, Rohan D.] Univ Queensland, Inst Mol Biosci, Australian Res Council, Special Res Ctr Funct & Appl Genom, St Lucia, Qld 4072, Australia.
   [Han, Jung-Hoon; Teichmann, Sarah A.] MRC Lab Mol Biol, Cambridge CB2 0QH, England.
   [Hide, Winston] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA.
   [van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [van Nimwegen, Erik] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Tegner, Jesper] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Atherosclerosis Res Unit,Ctr Mol Med,Computat Med, SE-17176 Stockholm, Sweden.
   [Tegner, Jesper] Linkoping Univ, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden.
   [Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland.
   [Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland.
   [Ideker, Trey] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA.
RP Ideker, T (corresponding author), Univ Calif San Diego, FANTOM Consortium, 9500 Gilman Dr, La Jolla, CA 92093 USA.
EM tideker@ucsd.edu; yosihide@gsc.riken.jp
RI Cannistraci, Carlo Vittorio/G-1710-2014; Califano, Andrea/F-7239-2012;
   Katayama, Shintaro/F-2958-2010; Hume, David A/C-7695-2013; Bertin,
   Nicolas/O-9602-2019; Hide, Winston A/V-2727-2017; Bertin,
   Nicolas/C-3025-2008; Tomic, Nevena/AAA-2135-2021; tegner, jesper
   N/R-5095-2017; Schmeier, Sebastian/D-4731-2011; Radovanovic,
   Aleksandar/D-1313-2012; Lassmann, Timo/A-8271-2008; Suzuki,
   Harukazu/N-9553-2015; Daub, Carsten O/A-7436-2010; Hofmann, Oliver
   M/F-1800-2013; Forrest, Alistair/A-6597-2008; Kaur, Mandeep/N-4550-2015;
   Teasdale, Rohan/AAD-6698-2019; Carninci, Piero/K-1568-2014; Radovanovic,
   Aleksandar/M-3687-2019; Grimmond, Sean M/J-5304-2016; Hide, Winston
   Hide/C-7217-2009; Bajic, Vladimir/D-2810-2009; Grimmond,
   Sean/K-3246-2019; AKALIN, ALTUNA/A-4424-2012; Hayashizaki,
   Yoshihide/N-6590-2015; Kawaji, Hideya/N-5116-2015; Teasdale, Rohan
   D/B-2538-2009; Kawai, Jun/A-6451-2016; Ravasi, Timothy/B-8777-2008;
   Hide, Winston/R-3815-2019
OI Cannistraci, Carlo Vittorio/0000-0003-0100-8410; Katayama,
   Shintaro/0000-0001-7581-5157; Bertin, Nicolas/0000-0002-9835-9606; Hide,
   Winston A/0000-0002-8621-3271; Bertin, Nicolas/0000-0002-9835-9606;
   tegner, jesper N/0000-0002-9568-5588; Schmeier,
   Sebastian/0000-0002-3947-8226; Radovanovic,
   Aleksandar/0000-0002-8749-7608; Lassmann, Timo/0000-0002-0138-2691;
   Suzuki, Harukazu/0000-0002-8087-0836; Daub, Carsten
   O/0000-0002-3295-8729; Hofmann, Oliver M/0000-0002-7738-1513; Forrest,
   Alistair/0000-0003-4543-1675; Kaur, Mandeep/0000-0002-9757-4048;
   Teasdale, Rohan/0000-0001-7455-5269; Carninci,
   Piero/0000-0001-7202-7243; Radovanovic, Aleksandar/0000-0002-8749-7608;
   Grimmond, Sean M/0000-0002-8102-7998; Hide, Winston
   Hide/0000-0002-8621-3271; Bajic, Vladimir/0000-0001-5435-4750; Grimmond,
   Sean/0000-0002-8102-7998; AKALIN, ALTUNA/0000-0002-0468-0117; Kawaji,
   Hideya/0000-0002-0575-0308; Teasdale, Rohan D/0000-0001-7455-5269; Hide,
   Winston/0000-0002-8621-3271; van Nimwegen, Erik/0000-0001-6338-1312;
   Lenhard, Boris/0000-0002-1114-1509; MacPherson,
   Cameron/0000-0002-8945-9736; Tan, Kai/0000-0002-9104-5567; Hume,
   David/0000-0002-2615-1478; Ravasi, Timothy/0000-0002-9950-465X;
   Teichmann, Sarah/0000-0002-6294-6366
FU Japanese Ministry of Education, Culture, Sports, Science and Technology
   (MEXT)Ministry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT); US National Institute of Mental HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [MH062261]; King
   Abdullah University of Science and TechnologyKing Abdullah University of
   Science & Technology; Max Planck Society for the Advancement of
   ScienceMax Planck Society; SA National Bioinformatics Network; Claude
   Leon Foundation; Australian NHMRCNational Health and Medical Research
   Council of Australia; Scuola Interpolitecnica di Dottorato;
   Biotechnology and Biological Sciences Research CouncilBiotechnology and
   Biological Sciences Research Council (BBSRC) [BB/G022771/1] Funding
   Source: researchfish; Medical Research CouncilMedical Research Council
   UK (MRC) [MC_U105161047, G9900991B] Funding Source: researchfish;
   NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Mental Health (NIMH) [P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261,
   P30MH062261, P30MH062261, P30MH062261, P30MH062261, P30MH062261] Funding
   Source: NIH RePORTER
FX The work for the RIKEN Omics Science Center was supported by grants from
   the Japanese Ministry of Education, Culture, Sports, Science and
   Technology (MEXT) through the Genome Network Project and for the RIKEN
   Omics Science Center (YH, Principal Investigator). Members of the FANTOM
   Consortium were supported by grant MH062261 from the US National
   Institute of Mental Health (TR, KT, TI), the King Abdullah University of
   Science and Technology (TR, VBB), the Max Planck Society for the
   Advancement of Science (AK), the SA National Bioinformatics Network (SS,
   AR, VBB, WAH), the Claude Leon Foundation (MK), a CJ Martin Fellowship
   from the Australian NHMRC (ARRF), and the Scuola Interpolitecnica di
   Dottorato (CVC). The authors gratefully acknowledge S. Choi for critical
   feedback on the manuscript.
CR Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006
   Ban J, 2008, CANCER RES, V68, P7100, DOI 10.1158/0008-5472.CAN-07-6145
   Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024
   Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408
   Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883
   Duverger O, 2008, J CELL PHYSIOL, V216, P337, DOI 10.1002/jcp.21491
   Fedorova E, 2008, BBA-MOL CELL RES, V1783, P2174, DOI 10.1016/j.bbamcr.2008.07.018
   Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885
   Jaenisch R, 2009, J THROMB HAEMOST, V7, P21, DOI 10.1111/j.1538-7836.2009.03418.x
   Jin GX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001207
   Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319
   Kalaev M, 2008, BIOINFORMATICS, V24, P594, DOI 10.1093/bioinformatics/btm630
   Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043
   Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453
   Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782
   Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478
   Mathur D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r126
   Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200
   Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213
   Naef F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni104
   O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107
   Park DU, 2005, BIOINFORMATICS, V21, P3234, DOI 10.1093/bioinformatics/bti512
   Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104
   Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609
   Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103
   Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192
   Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101
   Suzuki H, 2004, BIOTECHNIQUES, V37, P918, DOI 10.2144/04376BM06
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Tan K, 2008, P NATL ACAD SCI USA, V105, P2934, DOI 10.1073/pnas.0708670105
   Tan K, 2008, GENOMICS, V91, P219, DOI 10.1016/j.ygeno.2007.11.005
   Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522
   Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398
   Usui K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r98
   Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538
   Walhout AJM, 2006, GENOME RES, V16, P1445, DOI 10.1101/gr.5321506
   Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334
   Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684
   Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595
   Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16
   Zhou LQ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-54
NR 41
TC 465
Z9 475
U1 3
U2 46
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAR 5
PY 2010
VL 140
IS 5
BP 744
EP 752
DI 10.1016/j.cell.2010.01.044
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 564EZ
UT WOS:000275197400022
PM 20211142
OA Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Dames, SA
AF Dames, Sonja A.
TI Structural Basis for the Association of the Redox-sensitive Target of
   Rapamycin FATC Domain with Membrane-mimetic Micelles
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID MAMMALIAN TARGET; FKBP12-RAPAMYCIN-ASSOCIATED PROTEIN;
   SUBCELLULAR-LOCALIZATION; 3-DIMENSIONAL STRUCTURE; NMR-SPECTROSCOPY;
   MTOR PATHWAY; COMPLEX; KINASE; TOR; ACTIVATION
AB The target of rapamycin (TOR) is a conserved eukaryotic Ser/Thr kinase that regulates cellular growth in response to the nutrient and energy state. TOR signaling plays an important role in the development of diseases such as cancer, obesity, and diabetes and in different redox-sensitive processes (hypoxia, apoptosis, and aging). Because TOR has been detected at different cellular membranes and in the nucleus, its localization may influence the specific signaling readout. To better understand how TOR can associate with different membranes, the lipid-binding properties of the redox-sensitive yeast TOR1 FATC domain (y1fatc) have been characterized by solution NMR spectroscopy. Binding studies with different lipids indicate that y1fatc interacts specifically with a membrane-mimetic environment but appears not to recognize a specific lipid headgroup. In both, the structures of oxidized and reduced micelle-bound y1fatc, residues Ile-2456 to Trp-2470 of the lipid-binding motif form a hydrophobic bulb that has a rim of charged residues. The diffusion constants for both micelle-bound states are consistent with the rotational correlation times from the analysis of the N-15 relaxation data. Based on the K-d values, the oxidized form (K-d similar to 0.31 mM) binds dodecyl phosphocholine micelles slightly tighter than the reduced form (K-d similar to 1.86 mM). Binding studies with y1fatc in which one or both tryptophans (Trp-2466 and Trp-2470) were replaced by alanine suggest that these residues are important for the exact positioning in the membrane and that the other aromatic (His-2462, Tyr-2463, and Phe-2469) and aliphatic residues (Ile-2456, Leu-2459, Ile-2464, and Pro-2468) in the lipid-binding motif contribute significantly to the affinity.
C1 [Dames, Sonja A.] Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
RP Dames, SA (corresponding author), Tech Univ Munich, Dept Chem, Biomol NMR Spect, Lichtenbergstr 4, D-85747 Garching, Germany.
EM sonja.dames@tum.de
OI Dames, Sonja/0000-0001-7495-6943
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31-109712]; German Research Foundation (Deutsche
   Forschungsgemeinschaft)German Research Foundation (DFG) [1195/3-1]
FX This work was supported in part by the Swiss National Science Foundation
   through a grant (SNF Grant 31-109712) to Stephan Grzesiek and by the
   German Research Foundation (Deutsche Forschungsgemeinschaft Grant DA
   1195/3-1 to S.A.D.).
CR Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040
   Ahn HC, 2006, J AM CHEM SOC, V128, P4398, DOI 10.1021/ja057773d
   Almeida M, 2009, J BIOL CHEM, V284, P27438, DOI 10.1074/jbc.M109.023572
   Asnaghi L, 2004, PHARMACOL RES, V50, P545, DOI 10.1016/j.phrs.2004.03.007
   Begotka BA, 2006, MAGN RESON CHEM, V44, P586, DOI 10.1002/mrc.1793
   Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001
   Blagosklonny MV, 2008, CELL CYCLE, V7, P3344, DOI 10.4161/cc.7.21.6965
   Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2
   Buerger C, 2006, BIOCHEM BIOPH RES CO, V344, P869, DOI 10.1016/j.bbrc.2006.03.220
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200
   Dann SG, 2007, TRENDS MOL MED, V13, P252, DOI 10.1016/j.molmed.2007.04.002
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Desai BN, 2002, P NATL ACAD SCI USA, V99, P4319, DOI 10.1073/pnas.261702698
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Drenan RM, 2004, J BIOL CHEM, V279, P772, DOI 10.1074/jbc.M305912200
   Dunlop EA, 2009, CELL SIGNAL, V21, P827, DOI 10.1016/j.cellsig.2009.01.012
   Fang YM, 2001, SCIENCE, V294, P1942, DOI 10.1126/science.1066015
   Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556
   Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9
   Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613
   Ha SH, 2006, CELL SIGNAL, V18, P2283, DOI 10.1016/j.cellsig.2006.05.021
   Hall M N, 2008, Transplant Proc, V40, pS5, DOI 10.1016/j.transproceed.2008.10.009
   Hansen IA, 2005, J BIOL CHEM, V280, P20565, DOI 10.1074/jbc.M500712200
   Jaworski J, 2006, MOL NEUROBIOL, V34, P205, DOI 10.1385/MN:34:3:205
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   KORADI R, 1996, J MOL GRAPHICS, V14, P29
   Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200
   Kutateladze TG, 2004, J BIOL CHEM, V279, P3050, DOI 10.1074/jbc.M309007200
   Lane HA, 2009, CURR OPIN CELL BIOL, V21, P219, DOI 10.1016/j.ceb.2009.01.016
   Laskowski RA, 1996, J BIOMOL NMR, V8, P477, DOI 10.1007/BF00228148
   LAUTERWEIN J, 1979, BIOCHIM BIOPHYS ACTA, V556, P244, DOI 10.1016/0005-2736(79)90046-4
   Lazaridis T, 2005, J PHYS CHEM B, V109, P15098, DOI 10.1021/jp0516801
   Liu W, 2006, BIOCHEMISTRY-US, V45, P11713, DOI 10.1021/bi0608414
   Lucas LH, 2004, CONCEPT MAGN RESON A, V20A, P24, DOI 10.1002/cmr.a.10094
   Nanga RPR, 2009, J AM CHEM SOC, V131, P8252, DOI 10.1021/ja9010095
   Orfi L, 1998, ANAL CHEM, V70, P1339, DOI 10.1021/ac971011m
   Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010
   Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Seewald MJ, 2000, PROTEIN SCI, V9, P1177, DOI 10.1110/ps.9.6.1177
   Shao C, 2008, J BIOL CHEM, V283, P7230, DOI 10.1074/jbc.M705195200
   Sun H, 2008, J BIOL CHEM, V283, P22233, DOI 10.1074/jbc.M802074200
   Takahashi T, 2000, GENES CELLS, V5, P765, DOI 10.1046/j.1365-2443.2000.00365.x
   Thevenot C, 2005, COLLOID SURFACE A, V252, P105, DOI 10.1016/j.colsurfa.2004.10.062
   Tieleman DP, 2000, J PHYS CHEM B, V104, P6380, DOI 10.1021/jp001268f
   Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842
   Withers DJ, 1997, BIOCHEM BIOPH RES CO, V241, P704, DOI 10.1006/bbrc.1997.7878
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200
NR 58
TC 21
Z9 21
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAR 5
PY 2010
VL 285
IS 10
BP 7766
EP 7775
DI 10.1074/jbc.M109.058404
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 567AV
UT WOS:000275415600084
PM 20042596
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Nishio, M
   Kamiya, Y
   Mizushima, T
   Wakatsuki, S
   Sasakawa, H
   Yamamoto, K
   Uchiyama, S
   Noda, M
   McKay, AR
   Fukui, K
   Hauri, HP
   Kato, K
AF Nishio, Miho
   Kamiya, Yukiko
   Mizushima, Tsunehiro
   Wakatsuki, Soichi
   Sasakawa, Hiroaki
   Yamamoto, Kazuo
   Uchiyama, Susumu
   Noda, Masanori
   McKay, Adam R.
   Fukui, Kiichi
   Hauri, Hans-Peter
   Kato, Koichi
TI Structural basis for the cooperative interplay between the two causative
   gene products of combined factor V and factor VIII deficiency
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE MCFD2; ERGIC-53; calcium-binding protein; cargo receptor; intracellular
   lectin
ID L-TYPE LECTINS; TRANSPORT RECEPTOR; BINDING PROPERTIES; ERGIC-53;
   PROTEIN; RECOGNITION; VIPL; ULTRACENTRIFUGATION; GLYCOPROTEINS;
   COMPARTMENT
AB Combined deficiency of coagulation factors V and VIII (F5F8D), an autosomal recessive disorder characterized by coordinate reduction in the plasma levels of factor V (FV) and factor VIII (FVIII), is genetically linked to mutations in the transmembrane lectin ERGIC-53 and the soluble calcium-binding protein MCFD2. Growing evidence indicates that these two proteins form a complex recycling between the endoplasmic reticulum (ER) and the ER-Golgi intermediate compartment and thereby function as a cargo receptor in the early secretory pathway of FV and FVIII. For better understanding of the mechanisms underlying the functional coordination of ERGIC-53 and MCFD2, we herein characterize their interaction by x-ray crystallographic analysis in conjunction with NMR and ultracentrifugation analyses. Inspection of the combined data reveals that ERGIC-53-CRD binds MCFD2 through its molecular surface remote from the sugar-binding site, giving rise to a 1:1 complex in solution. The interaction is independent of sugar-binding of ERGIC-53 and involves most of the missense mutation sites of MCFD2 so far reported in F5F8D. Comparison with the previously reported uncomplexed structure of each protein indicates that MCFD2 but not ERGIC-53-CRD undergoes significant conformational alterations upon complex formation. Our findings provide a structural basis for the cooperative interplay between ERGIC-53 and MCFD2 in capturing FV and FVIII.
C1 [Nishio, Miho; Kamiya, Yukiko; Kato, Koichi] Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, Okazaki, Aichi 4448787, Japan.
   [Nishio, Miho; Kamiya, Yukiko; Sasakawa, Hiroaki; Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi 4448787, Japan.
   [Nishio, Miho; Kamiya, Yukiko; Mizushima, Tsunehiro; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Dept Struct Biol & Biomol Engn, Mizuho Ku, Nagoya, Aichi 4678603, Japan.
   [Wakatsuki, Soichi] High Energy Accelerator Res Org, KEK, Inst Mat Struct Sci, Struct Biol Res Ctr,Photon Factory, Tsukuba, Ibaraki 3050801, Japan.
   [Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Chiba 2778562, Japan.
   [Uchiyama, Susumu; Noda, Masanori; Fukui, Kiichi] Osaka Univ, Grad Sch Engn, Dept Biotechnol, Suita, Osaka 5650871, Japan.
   [McKay, Adam R.] UCL, Dept Chem, London WC1H 0AJ, England.
   [Hauri, Hans-Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kato, Koichi] Ochanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan.
   [Kato, Koichi] GLYENCE Co Ltd, Chikusa Ku, Nagoya, Aichi 4640858, Japan.
RP Kato, K (corresponding author), Natl Inst Nat Sci, Okazaki Inst Integrat Biosci, 5-1 Higashiyama, Okazaki, Aichi 4448787, Japan.
EM kkatonmr@ims.ac.jp
RI UCHIYAMA, Susumu/F-9590-2017
OI UCHIYAMA, Susumu/0000-0002-5181-179X; Kato, Koichi/0000-0001-7187-9612;
   Mizushima, Tsunehiro/0000-0002-6631-2889
FU Ministry of Education, Culture, Sports, Science, and TechnologyMinistry
   of Education, Culture, Sports, Science and Technology, Japan (MEXT)
   [20059030, 20107004, 21370050, 21870052]; Japan Science and Technology
   AgencyJapan Science & Technology Agency (JST); Grants-in-Aid for
   Scientific ResearchMinistry of Education, Culture, Sports, Science and
   Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [20107004]
   Funding Source: KAKEN
FX We thank Michiko Nakano (Institute for Molecular Science) for her help
   in NMR measurements. We thank Kiyomi Senda (Nagoy City University) and
   Yukiko Isono (Okazaki Institute for Integrative Bioscience) for their
   technical assistance in sample preparation. We thank Drs. Eiji Kurimoto
   (Meijo University), Norio Kudo (KEK), and Tatsuo Hikage (Nagoya
   University) for their supports in the data collection at the early stage
   of this study. This work was supported by Grant-in-Aid for Scientific
   Research on Priority Area 20059030, Grant-in-Aid for Scientific Research
   on Innovative Areas 20107004, Grant-in-Aid for Scientific Research (B)
   21370050, Grant-inAid for Young Scientists (Start-up) 21870052, and
   Nanotechnology Support Project from the Ministry of Education, Culture,
   Sports, Science, and Technology and by CREST project from the Japan
   Science and Technology Agency.
CR Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200
   Brookes E, 2010, EUR BIOPHYS J BIOPHY, V39, P423, DOI 10.1007/s00249-009-0418-0
   Collaborative Computational Project, ACTA CRYSTALLOGR D, V50, P760
   Demeler B, 2005, ANALYTICAL ULTRACENTRIFUGATION: TECHNIQUES AND METHODS, P210
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Fullekrug J, 1999, J CELL SCI, V112, P2813
   Gifford JL, 2007, BIOCHEM J, V405, P199, DOI 10.1042/BJ20070255
   Guy JE, 2008, J MOL BIOL, V381, P941, DOI 10.1016/j.jmb.2008.06.042
   Hauri HP, 2000, J CELL SCI, V113, P587
   Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566
   Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200
   Kamiya Y., 2009, GLYCOBIOLOGY RES TRE, P27
   Kamiya Y, 2008, J BIOL CHEM, V283, P1857, DOI 10.1074/jbc.M709384200
   Kato K, 2000, J MOL BIOL, V295, P213, DOI 10.1006/jmbi.1999.3351
   Kato K, 2007, GLYCOBIOLOGY, V17, P1031, DOI 10.1093/glycob/cwm046
   Kawasaki N, 2008, BLOOD, V111, P1972, DOI 10.1182/blood-2007-06-097022
   Lahtinen U, 1999, EUR J BIOCHEM, V260, P392, DOI 10.1046/j.1432-1327.1999.00158.x
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Leslie AGW, 1999, ACTA CRYSTALLOGR D, V55, P1696, DOI 10.1107/S090744499900846X
   Morris RJ, 2003, METHOD ENZYMOL, V374, P229, DOI 10.1016/S0076-6879(03)74011-7
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Neve EPA, 2003, EXP CELL RES, V288, P70, DOI 10.1016/S0014-4827(03)00161-7
   Nufer O, 2003, J BIOL CHEM, V278, P15886, DOI 10.1074/jbc.M211199200
   Nyfeler B, 2008, BLOOD, V111, P1299, DOI 10.1182/blood-2007-09-112854
   Nyfeler B, 2006, TRAFFIC, V7, P1473, DOI 10.1111/j.1600-0854.2006.00483.x
   Oda M, 2006, FEBS J, V273, P1476, DOI 10.1111/j.1742-4658.2006.05168.x
   OERI J, 1954, Bibl Paediatr, V58, P575
   Saff EB, 1997, MATH INTELL, V19, P5, DOI 10.1007/BF03024331
   Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200
   Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Sobott F, 2002, ANAL CHEM, V74, P1402, DOI 10.1021/ac0110552
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   Velloso LM, 2003, J MOL BIOL, V334, P845, DOI 10.1016/j.jmb.2003.10.031
   Velloso LM, 2002, J BIOL CHEM, V277, P15979, DOI 10.1074/jbc.M112098200
   Zhang B, 2006, BLOOD, V107, P1903, DOI 10.1182/blood-2005-09-3620
   Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200
   Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153
   Zhang B, 2008, BLOOD, V111, P5592, DOI 10.1182/blood-2007-10-113951
   Zhang B, 2009, BRIT J HAEMATOL, V145, P15, DOI 10.1111/j.1365-2141.2008.07559.x
NR 41
TC 32
Z9 34
U1 0
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 2
PY 2010
VL 107
IS 9
BP 4034
EP 4039
DI 10.1073/pnas.0908526107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 563KP
UT WOS:000275131100019
PM 20142513
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Papadopoulos, DK
   Vukojevic, V
   Adachi, Y
   Terenius, L
   Rigler, R
   Gehring, WJ
AF Papadopoulos, Dimitrios K.
   Vukojevic, Vladana
   Adachi, Yoshitsugu
   Terenius, Lars
   Rigler, Rudolf
   Gehring, Walter J.
TI Function and specificity of synthetic Hox transcription factors in vivo
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE synthetic genes; transcriptional specificity; Hox genes; Sex combs
   reduced; homeotic transformations
ID DROSOPHILA-MELANOGASTER; SALIVARY-GLAND; HOMEOBOX GENES; EYE
   DEVELOPMENT; DISTAL-ANTENNA; GROUND-STATE; DNA-BINDING; HOMEODOMAIN;
   PROTEIN; COMPLEX
AB Homeotic (Hox) genes encode transcription factors that confer segmental identity along the anteroposterior axis of the embryo. However the molecular mechanisms underlying Hox-mediated transcription and the differential requirements for specificity in the regulation of the vast number of Hox-target genes remain ill-defined. Here we show that synthetic Sex combs reduced (Scr) genes that encode the Scr C terminus containing the home domain (HD) and YPWM motif (Scr-HD) are functional in vivo. Synthetic Scr-HD peptides can induce ectopic salivary glands in the embryo and homeotic transformations in the adult fly, act as transcriptional activators and repressors during development, and participate in protein-protein interactions. Their transformation capacity was found to be enhanced over their full-length counterpart and mutations known to transform the full-length protein into constitutively active or inactive variants behaved accordingly in the synthetic peptides. Our results show that synthetic Scr-HD genes are sufficient for homeotic function in Drosophila and suggest that the N terminus of Scr has a role in transcriptional potency, rather than specificity. We also demonstrate that synthetic peptides behave largely in a predictable way, by exhibiting Scr-specific phenotypes throughout development, which makes them an important tool for synthetic biology.
C1 [Papadopoulos, Dimitrios K.; Gehring, Walter J.] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Vukojevic, Vladana; Terenius, Lars] Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden.
   [Adachi, Yoshitsugu] Kings Coll London, Inst Psychiat, Dept Neurosci, London SE5 8AF, England.
   [Rigler, Rudolf] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
   [Rigler, Rudolf] Swiss Fed Inst Technol, Lab Biomed Opt, CH-1015 Lausanne, Switzerland.
RP Gehring, WJ (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
EM walter.gehring@unibas.ch
OI Vukojevic, Vladana/0000-0003-0873-5653
FU Kantons of Basel-Stadt and Basel-Landschaft; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); European Network of
   Excellence; Swedish Brain Foundation; Swedish Research CouncilSwedish
   Research Council; Knut and Alice Wallenberg FoundationKnut & Alice
   Wallenberg Foundation; Ministry of Sciences and Technological
   Development of Serbia [142025, 142019]
FX This work was supported by the Kantons of Basel-Stadt and
   Basel-Landschaft, a grant from the Swiss National Science Foundation,
   the European Network of Excellence "Cells into Organs," the Swedish
   Brain Foundation, the Swedish Research Council, the Knut and Alice
   Wallenberg Foundation, and the Ministry of Sciences and Technological
   Development of Serbia ( Grants no. 142025 and 142019).
CR Abzhanov A, 2001, DEVELOPMENT, V128, P2803
   Affolter M, 1990, CURR OPIN CELL BIOL, V2, P485, DOI 10.1016/0955-0674(90)90132-X
   Andrew DJ, 2000, MECH DEVELOP, V92, P5, DOI 10.1016/S0925-4773(99)00321-4
   ANDREW DJ, 1994, EMBO J, V13, P1132, DOI 10.1002/j.1460-2075.1994.tb06362.x
   Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637
   Berry M, 2000, EMBO J, V19, P2946, DOI 10.1093/emboj/19.12.2946
   Brown S, 2000, DEVELOPMENT, V127, P4867
   Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252
   Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706
   Casares F, 2001, SCIENCE, V293, P1477, DOI 10.1126/science.1062542
   Curtiss J, 2007, DEV BIOL, V306, P685, DOI 10.1016/j.ydbio.2007.04.006
   Dong PDS, 2000, DEVELOPMENT, V127, P209
   EKKER SC, 1994, EMBO J, V13, P3551, DOI 10.1002/j.1460-2075.1994.tb06662.x
   Emerald BS, 2003, DEVELOPMENT, V130, P1171, DOI 10.1242/dev.00323
   Galant R, 2002, DEVELOPMENT, V129, P3115
   Gehring WJ, 2009, CURR TOP DEV BIOL, V88, P35, DOI 10.1016/S0070-2153(09)88002-2
   GEHRING WJ, 1987, SCIENCE, V236, P1245, DOI 10.1126/science.2884726
   GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5
   GIBSON G, 1990, CELL, V62, P1087, DOI 10.1016/0092-8674(90)90386-S
   Grieder NC, 2009, DEV BIOL, V329, P315, DOI 10.1016/j.ydbio.2009.03.006
   Haberman AS, 2003, DEV BIOL, V258, P443, DOI 10.1016/S0012-1606(03)00140-4
   JOHNSON FB, 1995, P NATL ACAD SCI USA, V92, P739, DOI 10.1073/pnas.92.3.739
   KAPPEN C, 1993, CURR OPIN GENET DEV, V3, P931, DOI 10.1016/0959-437X(93)90016-I
   KAZNESSIS YN, 2007, BMC SYST BIOL, V1
   Kerman BE, 2006, DIFFERENTIATION, V74, P326, DOI 10.1111/j.1432-0436.2006.00095.x
   Kmita-Cunisse M, 1998, P NATL ACAD SCI USA, V95, P3030, DOI 10.1073/pnas.95.6.3030
   LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0
   Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243
   Mayo AE, 2006, PLOS BIOL, V4, P555, DOI 10.1371/journal.pbio.0040045
   MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N
   Morata G, 1999, DEVELOPMENT, V126, P2823
   MULLER M, 1988, EMBO J, V7, P4299, DOI 10.1002/j.1460-2075.1988.tb03328.x
   ODENWALD WF, 1989, GENE DEV, V3, P158, DOI 10.1101/gad.3.2.158
   OTTING G, 1990, EMBO J, V9, P3085, DOI 10.1002/j.1460-2075.1990.tb07505.x
   PANZER S, 1992, DEVELOPMENT, V114, P49
   Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833
   Percival-Smith A, 1997, DEVELOPMENT, V124, P5049
   PHELAN ML, 1995, MOL CELL BIOL, V15, P3989
   Plaza S, 2001, EMBO J, V20, P802, DOI 10.1093/emboj/20.4.802
   Plaza S, 2008, P NATL ACAD SCI USA, V105, P13439, DOI 10.1073/pnas.0806106105
   Prince F, 2008, DEVELOPMENT, V135, P1669, DOI 10.1242/dev.018028
   QIAN YQ, 1992, P NATL ACAD SCI USA, V89, P10738, DOI 10.1073/pnas.89.22.10738
   Ryoo HD, 1999, GENE DEV, V13, P1704, DOI 10.1101/gad.13.13.1704
   SCOTT MP, 1989, BIOCHIM BIOPHYS ACTA, V989, P25, DOI 10.1016/0304-419X(89)90033-4
   Sivanantharajah L, 2009, GENETICS, V182, P191, DOI 10.1534/genetics.109.100438
   SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435
   Tour E, 2005, DEVELOPMENT, V132, P5271, DOI 10.1242/dev.02138
   VUKOJEVIC V, P NATL ACAD SCI US
   Vukojevic V, 2008, P NATL ACAD SCI USA, V105, P18176, DOI 10.1073/pnas.0809250105
   WAGNERBERNHOLZ JT, 1991, GENE DEV, V5, P2467, DOI 10.1101/gad.5.12b.2467
   WAKIMOTO BT, 1981, DEV BIOL, V81, P51, DOI 10.1016/0012-1606(81)90347-X
   Yao LC, 1999, DEV BIOL, V211, P268, DOI 10.1006/dbio.1999.9309
   ZHAO JJ, 1993, GENE DEV, V7, P343, DOI 10.1101/gad.7.3.343
   Zhao JJG, 1996, EMBO J, V15, P1313, DOI 10.1002/j.1460-2075.1996.tb00473.x
NR 54
TC 18
Z9 19
U1 0
U2 5
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 2
PY 2010
VL 107
IS 9
BP 4087
EP 4092
DI 10.1073/pnas.0914595107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 563KP
UT WOS:000275131100028
PM 20147626
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Vukojevic, V
   Papadopoulos, DK
   Terenius, L
   Gehring, WJ
   Rigler, R
AF Vukojevic, Vladana
   Papadopoulos, Dimitrios K.
   Terenius, Lars
   Gehring, Walter J.
   Rigler, Rudolf
TI Quantitative study of synthetic Hox transcription factor-DNA
   interactions in live cells
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE fluorescence correlation spectroscopy; single-molecule sensitivity;
   homeodomain; Sex combs reduced; synthetic peptides
ID FLUORESCENCE CORRELATION SPECTROSCOPY; GENE-EXPRESSION;
   DROSOPHILA-MELANOGASTER; NUCLEAR ARCHITECTURE; GENOME ORGANIZATION;
   FUNCTIONAL-ACTIVITY; DYNAMICS; MOLECULE; PROTEIN; FLUCTUATIONS
AB Transcription factor-DNA interactions are life sustaining and therefore the subject of intensive research. In spite of vast effort, quantitative in vivo studies of the molecular mechanisms underlying these fundamental interactions remain challenging. In the preceding paper, we designed synthetic Sex combs reduced (Scr) peptides and validated genetically their function as transcriptional regulators. Here we present a controllable system for quantitative studies of protein-DNA interactions in live cells that enables us to "titrate" the concentration of the synthetic Scr peptides in a single cell. Using methods with single-molecule sensitivity, advanced fluorescence imaging and fluorescence correlation spectroscopy (FCS), we were able to study the kinetics of Scr-DNA interactions in live salivary gland cells, where Scr is normally expressed during development. We discerned freely moving Scr molecules, characterized the specific and nonspecific Scr peptide-DNA interactions, and estimated their corresponding dissociation constants (K-d) in vivo. Our results suggest that the synthetic Scr transcription factors find their specific target sites primarily by multiple association/dissociation events, the rapidity of which is largely owed to electrostatic interactions. Based on these new findings, we formulate a model mechanism and emulate the kinetics of Scr homeodomain-DNA interactions in live cells using numerical simulations.
C1 [Rigler, Rudolf] Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
   [Vukojevic, Vladana; Terenius, Lars] Karolinska Inst, Dept Clin Neurosci, S-17176 Stockholm, Sweden.
   [Papadopoulos, Dimitrios K.; Gehring, Walter J.] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Rigler, Rudolf] Swiss Fed Inst Technol, Lab Biomed Opt, CH-1015 Lausanne, Switzerland.
RP Gehring, WJ (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, S-17177 Stockholm, Sweden.
EM walter.gehring@unibas.ch; rudolf.rigler@ki.se
OI Vukojevic, Vladana/0000-0003-0873-5653
FU Kantons of Basel-Stadt and Basel-Landschaft; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); European Network of
   Excellence; Swedish Brain Foundation; Swedish Research CouncilSwedish
   Research Council; Knut and Alice Wallenberg FoundationKnut & Alice
   Wallenberg Foundation; Ministry of Sciences and Technological
   Development of Serbia [142025, 142019]
FX This work was supported by the Kantons of Basel-Stadt and
   Basel-Landschaft, a grant from the Swiss National Science Foundation,
   the European Network of Excellence "Cells into Organs," the Swedish
   Brain Foundation, the Swedish Research Council, the Knut and Alice
   Wallenberg Foundation, and the Ministry of Sciences and Technological
   Development of Serbia ( Grants no. 142025 and 142019).
CR Bacia Kirsten, 2007, V398, P73, DOI 10.1007/978-1-59745-513-8_7
   Berry M, 2000, EMBO J, V19, P2946, DOI 10.1093/emboj/19.12.2946
   Biggin MD, 1997, DEVELOPMENT, V124, P4425
   Cornish PV, 2007, ACS CHEM BIOL, V2, P53, DOI 10.1021/cb600342a
   Cremer T, 2000, CRIT REV EUKAR GENE, V10, P179
   EHRENBER.M, 1974, CHEM PHYS, V4, P390, DOI 10.1016/0301-0104(74)85005-6
   Elf J, 2007, SCIENCE, V316, P1191, DOI 10.1126/science.1141967
   ELSON EL, 1974, BIOPOLYMERS, V13, P1, DOI 10.1002/bip.1974.360130102
   Elson EL, 2001, TRAFFIC, V2, P789, DOI 10.1034/j.1600-0854.2001.21107.x
   GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5
   Hager GL, 2009, MOL CELL, V35, P741, DOI 10.1016/j.molcel.2009.09.005
   Halford SE, 2004, NUCLEIC ACIDS RES, V32, P3040, DOI 10.1093/nar/gkh624
   Halford SE, 2009, BIOCHEM SOC T, V37, P343, DOI 10.1042/BST0370343
   HAYASHI S, 1990, CELL, V63, P883, DOI 10.1016/0092-8674(90)90492-W
   JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7
   Lewis M, 1996, SCIENCE, V271, P1247, DOI 10.1126/science.271.5253.1247
   MAGDE D, 1972, PHYS REV LETT, V29, P705, DOI 10.1103/PhysRevLett.29.705
   Mendes P, 1997, TRENDS BIOCHEM SCI, V22, P361, DOI 10.1016/S0968-0004(97)01103-1
   Metivier R, 2006, EMBO REP, V7, P161, DOI 10.1038/sj.embor.7400626
   Myong S, 2005, NATURE, V437, P1321, DOI 10.1038/nature04049
   PANZER S, 1992, DEVELOPMENT, V114, P49
   PAPADOPOULOS DK, P NATL ACAD SCI US
   RIGGS AD, 1970, J MOL BIOL, V53, P401, DOI 10.1016/0022-2836(70)90074-4
   Schneider R, 2007, GENE DEV, V21, P3027, DOI 10.1101/gad.1604607
   Schneider S, 1996, MOL CELL ENDOCRINOL, V116, P73, DOI 10.1016/0303-7207(95)03699-7
   Sorensen JG, 2005, CELL STRESS CHAPERON, V10, P312, DOI 10.1379/CSC-128R1.1
   Szczelkun M D, 2000, Essays Biochem, V35, P131
   Vukojevic V, 2005, CELL MOL LIFE SCI, V62, P535, DOI 10.1007/s00018-004-4305-7
   Vukojevic V, 1996, J PHYS CHEM-US, V100, P17175, DOI 10.1021/jp960785o
   Vukojevic V, 2008, P NATL ACAD SCI USA, V105, P18176, DOI 10.1073/pnas.0809250105
   Wachsmuth M, 2008, BBA-MOL CELL RES, V1783, P2061, DOI 10.1016/j.bbamcr.2008.07.022
   Wang XD, 2008, BIOCHEM SOC T, V36, P749, DOI 10.1042/BST0360749
   Xie XS, 2008, ANNU REV BIOPHYS, V37, P417, DOI 10.1146/annurev.biophys.37.092607.174640
   Yao J, 2008, METHODS, V45, P233, DOI 10.1016/j.ymeth.2008.06.004
   Yao J, 2007, MOL CELL, V28, P978, DOI 10.1016/j.molcel.2007.10.017
   Yao J, 2006, NATURE, V442, P1050, DOI 10.1038/nature05025
   Yu J, 2006, SCIENCE, V311, P1600, DOI 10.1126/science.1119623
NR 37
TC 39
Z9 42
U1 0
U2 12
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD MAR 2
PY 2010
VL 107
IS 9
BP 4093
EP 4098
DI 10.1073/pnas.0914612107
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 563KP
UT WOS:000275131100029
PM 20147625
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Nervi, P
   Li-Blatter, X
   Aanismaa, P
   Seelig, A
AF Nervi, Pierluigi
   Li-Blatter, Xiaochun
   Aanismaa, Paivi
   Seelig, Anna
TI P-glycoprotein substrate transport assessed by comparing cellular and
   vesicular ATPase activity
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article
DE ATPase activity; Extracellular acidification rate; Passive diffusion;
   Influx; P-glycoprotein substrate; Active efflux
ID BRAIN-BARRIER PERMEATION; MULTIDRUG TRANSPORTER; DRUG DISCOVERY;
   CATALYTIC CYCLE; MEMBRANE; HYDROLYSIS; BINDING; RESISTANCE; INHIBITORS;
   BLOOD
AB We compared the P-glycoprotein ATPase activity in inside-out plasma membrane vesicles and living NIH-MDR1-G185 cells with the aim to detect substrate transport. To this purpose we used six substrates which differ significantly in their passive influx through the plasma membrane. In cells, the cytosolic membrane leaflet harboring the substrate binding site of P-glycoprotein has to be approached by passive diffusion through the lipid membrane, whereas in inside-out plasma membrane vesicles, it is accessible directly from the aqueous phase. Compounds exhibiting fast passive influx compared to active efflux by P-glycoprotein induced similar ATPase activity profiles in cells and inside-out plasma membrane vesicles, because their concentrations in the cytosolic leaflets were similar. Compounds exhibiting similar influx as efflux induced in contrast different ATPase activity profiles in cells and inside-out vesicles. Their concentration was significantly lower in the cytosolic leaflet of cells than in the cytosolic leaflet of inside-out membrane vesicles, indicating that P-glycoprotein could cope with passive influx. P-glycoprotein thus transported all compounds at a rate proportional to ATP hydrolysis (i.e. all compounds were substrates). However, it prevented substrate entry into the cytosol only if passive influx of substrates across the lipid bilayer was in a similar range as active efflux. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Nervi, Pierluigi; Li-Blatter, Xiaochun; Aanismaa, Paivi; Seelig, Anna] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4003 Basel, Switzerland.
EM Anna.Seelig@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100-107793];  [NIH-MDR1-GI85]
FX We are indebted to Dr. M.M. Gottesman and Dr. S. Ambudkar for providing
   the NIH-MDR1-GI85 cells and the corresponding wild-type cells. P. Nervi
   is grateful for the opportunity to learn the handling of the cells in
   their laboratory. This work was supported by the Swiss National Science
   Foundation (Grant # 3100-107793).
CR Aanismaa P, 2008, BIOCHEMISTRY-US, V47, P10197, DOI 10.1021/bi800209h
   Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526
   Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200
   Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160
   BERRY JS, 1960, J ORG CHEM, V25, P1272, DOI 10.1021/jo01077a632
   CARDARELLI CO, 1995, CANCER RES, V55, P1086
   Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594
   Doan KMM, 2002, J PHARMACOL EXP THER, V303, P1029, DOI 10.1124/jpet.102.039255
   Eytan GD, 1996, J BIOL CHEM, V271, P12897, DOI 10.1074/jbc.271.22.12897
   Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434
   FISCHER H, 1998, PASSIVE DIFFUSION AC, P170
   Frezard F, 1998, BBA-LIPID LIPID MET, V1389, P13, DOI 10.1016/S0005-2760(97)00070-2
   Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+
   Gatlik-Landwojtowicz E, 2004, BIOCHEMISTRY-US, V43, P14840, DOI 10.1021/bi048761s
   Gerebtzoff G, 2004, CHEMBIOCHEM, V5, P676, DOI 10.1002/cbic.200400017
   Gerebtzoff G, 2006, J CHEM INF MODEL, V46, P2638, DOI 10.1021/ci0600814
   HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A
   Hochman JH, 2002, CURR DRUG METAB, V3, P257, DOI 10.2174/1389200023337559
   HORIO M, 1990, BIOCHIM BIOPHYS ACTA, V1027, P116, DOI 10.1016/0005-2736(90)90074-X
   Lantzsch G, 1996, BIOPHYS CHEM, V58, P289, DOI 10.1016/0301-4622(95)00108-5
   Li-Blatter X, 2009, BBA-BIOMEMBRANES, V1788, P2335, DOI 10.1016/j.bbamem.2009.07.010
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   MCCONNELL HM, 1992, SCIENCE, V257, P1906, DOI 10.1126/science.1329199
   Meier M, 2006, BIOPHYS J, V91, P2943, DOI 10.1529/biophysj.106.089581
   Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200
   Polli JW, 2001, J PHARMACOL EXP THER, V299, P620
   RAVIV Y, 1990, J BIOL CHEM, V265, P3975
   Reza MS, 2003, J PHARM PHARM SCI, V6, P282
   Sauna ZE, 2001, J BIOENERG BIOMEMBR, V33, P481, DOI 10.1023/A:1012875105006
   Sauna ZE, 2002, BIOCHEMISTRY-US, V41, P13989, DOI 10.1021/bi026626e
   Schwab D, 2003, J MED CHEM, V46, P1716, DOI 10.1021/jm021012t
   Seelig A, 2005, MINI-REV MED CHEM, V5, P135, DOI 10.2174/1389557053402693
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9
   SEELIG A, 2003, DRUG BIOAVAILABILITY, P461
   Seelig A, 2007, J MOL NEUROSCI, V33, P32, DOI 10.1007/s12031-007-0055-y
   Shapiro AB, 1998, EUR J BIOCHEM, V254, P189, DOI 10.1046/j.1432-1327.1998.2540189.x
   Shukla S, 2008, EXPERT OPIN DRUG MET, V4, P205, DOI 10.1517/17425255.4.2.205
   Stein WD, 1998, EXP PHYSIOL, V83, P221, DOI 10.1113/expphysiol.1998.sp004106
   Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984
   URBATSCH IL, 1995, ARCH BIOCHEM BIOPHYS, V316, P135, DOI 10.1006/abbi.1995.1020
   URBATSCH IL, 1995, J BIOL CHEM, V270, P26956, DOI 10.1074/jbc.270.45.26956
   WOLFENDEN R, 1988, J BIOL CHEM, V263, P8022
NR 43
TC 22
Z9 24
U1 1
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 0006-3002
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD MAR
PY 2010
VL 1798
IS 3
BP 515
EP 525
DI 10.1016/j.bbamem.2009.11.022
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 572OY
UT WOS:000275843700024
PM 20004641
DA 2021-01-25
ER

PT J
AU Lange, V
   Becker-Baldus, J
   Kunert, B
   van Rossum, BJ
   Casagrande, F
   Engel, A
   Roske, Y
   Scheffel, FM
   Schneider, E
   Oschkinat, H
AF Lange, Vivien
   Becker-Baldus, Johanna
   Kunert, Britta
   van Rossum, Barth-Jan
   Casagrande, Fabio
   Engel, Andreas
   Roske, Yvette
   Scheffel, Frank M.
   Schneider, Erwin
   Oschkinat, Hartmut
TI A MAS NMR Study of the Bacterial ABC Transporter ArtMP
SO CHEMBIOCHEM
LA English
DT Article
DE 2D and 3D crystals; ABC transporter; membrane proteins; selective
   isotope labeling; solid-state magic-angle spinning NMR spectroscopy
ID SOLID-STATE NMR; BINDING-CASSETTE TRANSPORTER; ECHO DOUBLE-RESONANCE;
   ANGLE-SPINNING NMR; ATP-BINDING; PROTEIN COMPLEX; DOMAIN; ASSIGNMENTS;
   HYDROLYSIS; MECHANISM
AB ATP-binding cassette (ABC) transport systems facilitate the translocation of substances, like amino acids, across cell membranes energised by ATP hydrolysis. This work describes first structural studies on the ABC transporter ArtMP from Geobacillus stearothermophilus in native lipid environment by magic-angle spinning NMR spectroscopy. The 2D crystals of ArtMP and 3D crystals of isolated ArtP were prepared in different nucleotide-bound or -unbound states. From selectively C-13,N-15-labelled ArtP, several sequence-specific assignments were obtained, most of which could be transferred to spectra of ArtMP. Residues Tyr133 and Pro134 protrude directly into the ATP-binding pocket at the interface of the ArtP subunits, and hence, are sensitive monitors for structural changes during nucleotide binding and hydrolysis. Distinct sets of NMR shifts were obtained for ArtP with different phosphorylation states of the ligand. Indications were found for an asymmetric or inhomogeneous state of the ArtP dimer bound with triphosphorylated nucleotides. With this investigation, a model system was established for screening all functional states occurring in one ABC transporter in native lipid environment.
C1 [Lange, Vivien; Becker-Baldus, Johanna; Kunert, Britta; van Rossum, Barth-Jan; Oschkinat, Hartmut] Leibniz Inst Mol Pharmakol FMP Berlin, NMR Supported Struct Biol, D-13125 Berlin, Germany.
   [Casagrande, Fabio; Engel, Andreas] Univ Basel, Biozentrum, ME Muller Inst, CH-4056 Basel, Switzerland.
   [Roske, Yvette] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany.
   [Scheffel, Frank M.; Schneider, Erwin] Humboldt Univ, Dept Biol Bacterial Physiol, D-10115 Berlin, Germany.
RP Oschkinat, H (corresponding author), Leibniz Inst Mol Pharmakol FMP Berlin, NMR Supported Struct Biol, R Rossle Str 10, D-13125 Berlin, Germany.
EM oschkinat@fmp-berlin.de
OI Becker-Baldus, Johanna/0000-0003-1995-7323; Oschkinat,
   Hartmut/0000-0002-4384-9544
FU Deutsche Forschungsgemeinschaft, Sonderforschungsbereich SFBGerman
   Research Foundation (DFG) [449]; European Drug Initiative on Channels
   and Transporters (EDICT)
FX We thank Dr. Ludwig Krabben for discussions and support during initial
   steps of this project and Dr. Gerd Krause for providing Figure 1C and D.
   This work was supported by the Deutsche Forschungsgemeinschaft,
   Sonderforschungsbereich SFB 449, and by the European Drug Initiative on
   Channels and Transporters (EDICT).
CR Ader C, 2008, NAT STRUCT MOL BIOL, V15, P605, DOI 10.1038/nsmb.1430
   Balayssac S, 2007, CHEMBIOCHEM, V8, P486, DOI 10.1002/cbic.200600408
   CARD GL, 1973, J BACTERIOL, V114, P1125, DOI 10.1128/JB.114.3.1125-1137.1973
   COLLINS FS, 1992, SCIENCE, V256, P774, DOI 10.1126/science.1375392
   Davidson AL, 2004, ANNU REV BIOCHEM, V73, P241, DOI 10.1146/annurev.biochem.73.011303.073626
   Davidson AL, 2008, MICROBIOL MOL BIOL R, V72, P317, DOI 10.1128/MMBR.00031-07
   Dawson RJP, 2007, MOL MICROBIOL, V65, P250, DOI 10.1111/j.1365-2958.2007.05792.x
   Dawson RJP, 2007, FEBS LETT, V581, P935, DOI 10.1016/j.febslet.2007.01.073
   Dawson RJP, 2006, NATURE, V443, P180, DOI 10.1038/nature05155
   Fetsch EE, 2002, P NATL ACAD SCI USA, V99, P9685, DOI 10.1073/pnas.152204499
   Fleischer R, 2005, MICROBIOL-SGM, V151, P835, DOI 10.1099/mic.0.27591-0
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Frericks HL, 2006, J BIOMOL NMR, V36, P55, DOI 10.1007/s10858-006-9070-5
   Gerber S, 2008, SCIENCE, V321, P246, DOI 10.1126/science.1156213
   Goetz BA, 2009, FEBS LETT, V583, P266, DOI 10.1016/j.febslet.2008.12.020
   Gottesman MM, 2001, J BIOENERG BIOMEMBR, V33, P453, DOI 10.1023/A:1012866803188
   GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1
   Hanekop N, 2006, FEBS LETT, V580, P1036, DOI 10.1016/j.febslet.2005.11.012
   Hellmich UA, 2009, BIOL CHEM, V390, P815, DOI 10.1515/BC.2009.084
   HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435
   Hiller M, 2005, CHEMBIOCHEM, V6, P1679, DOI 10.1002/cbic.200500132
   Holland IB, 1999, J MOL BIOL, V293, P381, DOI 10.1006/jmbi.1999.2993
   Hollenstein K, 2007, CURR OPIN STRUC BIOL, V17, P412, DOI 10.1016/j.sbi.2007.07.003
   Hollenstein K, 2007, NATURE, V446, P213, DOI 10.1038/nature05626
   Hvorup RN, 2007, SCIENCE, V317, P1387, DOI 10.1126/science.1145950
   Igumenova TI, 2004, J AM CHEM SOC, V126, P6720, DOI 10.1021/ja030547o
   Janas E, 2003, J BIOL CHEM, V278, P26862, DOI 10.1074/jbc.M301227200
   Jaroniec CP, 2000, J MAGN RESON, V146, P132, DOI 10.1006/jmre.2000.2128
   Jones PM, 2004, CELL MOL LIFE SCI, V61, P682, DOI 10.1007/s00018-003-3336-9
   JURADO AS, 1991, ARCH BIOCHEM BIOPHYS, V289, P167, DOI 10.1016/0003-9861(91)90457-T
   Kadaba NS, 2008, SCIENCE, V321, P250, DOI 10.1126/science.1157987
   Lange A, 2006, NATURE, V440, P959, DOI 10.1038/nature04649
   Li Y, 2007, CHEMBIOCHEM, V8, P434, DOI 10.1002/cbic.200600484
   Linton KJ, 2007, PHYSIOLOGY, V22, P122, DOI 10.1152/physiol.00046.2006
   Locher KP, 2002, SCIENCE, V296, P1091, DOI 10.1126/science.1071142
   Lorch M, 2005, CHEMBIOCHEM, V6, P1693, DOI 10.1002/cbic.200500054
   Mason AJ, 2004, FEBS LETT, V568, P117, DOI 10.1016/j.febslet.2004.05.016
   Moody JE, 2002, J BIOL CHEM, V277, P21111, DOI 10.1074/jbc.C200228200
   Nikaido K, 1997, J BIOL CHEM, V272, P27745, DOI 10.1074/jbc.272.44.27745
   Oldham ML, 2007, NATURE, V450, P515, DOI 10.1038/nature06264
   Oswald C, 2006, N-S ARCH PHARMACOL, V372, P385, DOI 10.1007/s00210-005-0031-4
   Pauli J, 2001, CHEMBIOCHEM, V2, P272, DOI 10.1002/1439-7633(20010401)2:4<272::AID-CBIC272>3.0.CO;2-2
   Pfleger N, 2009, BBA-BIOENERGETICS, V1787, P697, DOI 10.1016/j.bbabio.2009.02.022
   Pinkett HW, 2007, SCIENCE, V315, P373, DOI 10.1126/science.1133488
   Schaffer C, 2002, J BACTERIOL, V184, P6709, DOI 10.1128/JB.184.23.6709-6713.2002
   Schmees G, 1999, EUR J BIOCHEM, V266, P420, DOI 10.1046/j.1432-1327.1999.00871.x
   Smith PC, 2002, MOL CELL, V10, P139, DOI 10.1016/S1097-2765(02)00576-2
   SZEVERENYI NM, 1982, J MAGN RESON, V47, P462, DOI 10.1016/0022-2364(82)90213-X
   WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x
   Ward A, 2007, P NATL ACAD SCI USA, V104, P19005, DOI 10.1073/pnas.0709388104
   Zaitseva J, 2005, BIOCHEMISTRY-US, V44, P9680, DOI 10.1021/bi0506122
   Zaitseva J, 2005, EMBO J, V24, P1901, DOI 10.1038/sj.emboj.7600657
   Zaitseva J, 2006, EMBO J, V25, P3432, DOI 10.1038/sj.emboj.7601208
NR 53
TC 34
Z9 34
U1 0
U2 25
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1439-4227
EI 1439-7633
J9 CHEMBIOCHEM
JI ChemBioChem
PD MAR 1
PY 2010
VL 11
IS 4
BP 547
EP 555
DI 10.1002/cbic.200900472
PG 9
WC Biochemistry & Molecular Biology; Chemistry, Medicinal
SC Biochemistry & Molecular Biology; Pharmacology & Pharmacy
GA 568QJ
UT WOS:000275537200015
PM 20099290
DA 2021-01-25
ER

PT J
AU Barnes, SH
   Price, SR
   Wentzel, C
   Guthrie, SC
AF Barnes, Sarah H.
   Price, Stephen R.
   Wentzel, Corinna
   Guthrie, Sarah C.
TI Cadherin-7 and cadherin-6B differentially regulate the growth, branching
   and guidance of cranial motor axons
SO DEVELOPMENT
LA English
DT Article
DE Cadherins; Cad7; Cad6B; Cranial motoneuron; Hindbrain; Branching; Axon
   guidance; Chick
ID CELL-CELL ADHESION; CHICK-EMBRYO; KERATINOCYTE DIFFERENTIATION; CATENIN
   COMPLEX; BRAIN-STEM; N-CADHERIN; R-CADHERIN; IN-VIVO; EXPRESSION;
   HINDBRAIN
AB Cadherin-7 (Cad7) and cadherin-6B (Cad6B) are expressed in early and late phases of cranial motoneuron development, respectively. Cad7 is expressed by cranial motoneurons soon after they are generated, as well as in the environment through which their axons extend. By contrast, Cad6B is expressed by mature cranial motoneurons. We demonstrate in chick that these cadherins play distinct roles in cranial motor axon morphology, branching and projection. Using in vitro approaches, we show that Cad7 enhances motor axon outgrowth, suppresses the formation of multiple axons and restricts interstitial branching, thus promoting the development of a single unbranched axon characteristic of differentiating motoneurons. Conversely, Cad6B in vitro promotes motor axon branching, a characteristic of mature motoneurons. In vivo gain-and loss-of-function experiments for these cadherins yielded phenotypes consistent with this interpretation. In particular, a loss of cadherin-mediated interactions in vivo led to dysregulation of the cranial motoneuron normal branching programme and caused axon navigation defects. We also demonstrate that Cad6B functions via the phosphatidylinositol 3-kinase pathway. Together, these data show that Cad7 and Cad6B differentially regulate cranial motoneuron growth, branching and axon guidance.
C1 [Barnes, Sarah H.; Guthrie, Sarah C.] Kings Coll London, MRC Ctr Dev Neurobiol, London SE1 1UL, England.
   [Price, Stephen R.] UCL, Res Dept Cell & Dev Biol, London WC1E 6BT, England.
   [Wentzel, Corinna] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Guthrie, SC (corresponding author), Kings Coll London, MRC Ctr Dev Neurobiol, 4th Floor New Hunts House,Guys Campus, London SE1 1UL, England.
EM sarah.guthrie@kcl.ac.uk
OI Price, Stephen/0000-0001-7804-9849
FU Wellcome TrustWellcome Trust; Medical Research CouncilMedical Research
   Council UK (MRC); Biotechnology and Biological Sciences Research
   CouncilBiotechnology and Biological Sciences Research Council (BBSRC)
   [BBS/B/06512] Funding Source: researchfish; Medical Research
   CouncilMedical Research Council UK (MRC) [G0901899] Funding Source:
   researchfish
FX We are indebted to the Wellcome Trust (grants to S.C.G. and S.R.P.) and
   the Medical Research Council (PhD studentship to S. H. B.) for funding
   this work, and to Dr U. Drescher for helpful discussions on the
   manuscript. Deposited in PMC for release after 6 months.
CR Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666
   Andrews GL, 2003, J NEUROSCI, V23, P9873
   Boscher C, 2008, CELL SIGNAL, V20, P1061, DOI 10.1016/j.cellsig.2008.01.008
   Calautti E, 2005, J BIOL CHEM, V280, P32856, DOI 10.1074/jbc.M506119200
   Caton A, 2000, DEVELOPMENT, V127, P1751
   Das RM, 2006, DEV BIOL, V294, P554, DOI 10.1016/j.ydbio.2006.02.020
   FUJIMORI T, 1993, MOL BIOL CELL, V4, P37
   GUTHRIE S, 1992, DEVELOPMENT, V114, P663
   Guthrie S, 2007, NAT REV NEUROSCI, V8, P859, DOI 10.1038/nrn2254
   HAMBURGER V, 1992, DEV DYNAM, V195, P231, DOI 10.1002/dvdy.1001950404
   Hammond R, 2005, DEVELOPMENT, V132, P4483, DOI 10.1242/dev.02038
   Hirano S, 2003, FRONT BIOSCI-LANDMRK, V8, pD306, DOI 10.2741/972
   Iwai Y, 2002, MOL CELL NEUROSCI, V19, P375, DOI 10.1006/mcne.2001.1081
   Ju MJ, 2004, NEUROSCIENCE, V128, P785, DOI 10.1016/j.neuroscience.2004.06.063
   KINTNER C, 1992, CELL, V69, P225, DOI 10.1016/0092-8674(92)90404-Z
   Markus A, 2002, NEURON, V35, P65, DOI 10.1016/S0896-6273(02)00752-3
   Marthiens W, 2005, MOL CELL NEUROSCI, V28, P715, DOI 10.1016/j.mcn.2004.12.001
   MCCLEARN D, 1988, AM J ANAT, V183, P277, DOI 10.1002/aja.1001830402
   Momose T, 1999, DEV GROWTH DIFFER, V41, P335
   Naeem A, 2002, J NEUROBIOL, V51, P101, DOI 10.1002/neu.10048
   Nakagawa S, 1998, DEVELOPMENT, V125, P2963
   Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149
   Niederlander C, 1996, DEVELOPMENT, V122, P2367
   Patel SD, 2006, CELL, V124, P1255, DOI 10.1016/j.cell.2005.12.046
   Piper M, 2008, J NEUROSCI, V28, P100, DOI 10.1523/JNEUROSCI.4490-07.2008
   Prin F, 2005, DEV BIOL, V279, P402, DOI 10.1016/j.ydbio.2004.12.030
   REDIES C, 1992, J NEUROSCI, V12, P3525
   Redies C, 2000, PROG NEUROBIOL, V61, P611, DOI 10.1016/S0301-0082(99)00070-2
   Salinas PC, 2005, CURR OPIN NEUROBIOL, V15, P73, DOI 10.1016/j.conb.2005.01.001
   SIMON H, 1994, J NEUROBIOL, V25, P1129, DOI 10.1002/neu.480250908
   Takeichi M, 2007, NAT REV NEUROSCI, V8, P11, DOI 10.1038/nrn2043
   Togashi H, 2002, NEURON, V35, P77, DOI 10.1016/S0896-6273(02)00748-1
   Treubert-Zimmermann U, 2002, J NEUROSCI, V22, P7617
   Uemura M, 2007, NAT NEUROSCI, V10, P1151, DOI 10.1038/nn1960
   VarelaEchavarria A, 1997, NEURON, V18, P193, DOI 10.1016/S0896-6273(00)80261-5
   VarelaEchavarria A, 1996, MOL CELL NEUROSCI, V8, P242, DOI 10.1006/mcne.1996.0061
   VLAHOS CJ, 1994, J BIOL CHEM, V269, P5241
   Xie ZJ, 2007, J BIOL CHEM, V282, P8695, DOI 10.1074/jbc.M609135200
NR 38
TC 31
Z9 32
U1 0
U2 6
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD MAR 1
PY 2010
VL 137
IS 5
BP 805
EP 814
DI 10.1242/dev.042457
PG 10
WC Developmental Biology
SC Developmental Biology
GA 554GX
UT WOS:000274424600013
PM 20147381
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Poteryaev, D
   Datta, S
   Ackema, K
   Zerial, M
   Spang, A
AF Poteryaev, D.
   Datta, S.
   Ackema, K.
   Zerial, M.
   Spang, A.
TI Identification of the switch in early-to-late endosome transition
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
CT 33rd Annual Meeting of the German-Society-for-Cell-Biology/German
   Melanoma Research Network
CY MAR 10-13, 2010
CL Univ Regensburg, Regensburg, GERMANY
SP German Soc Cell Biol
HO Univ Regensburg
C1 [Poteryaev, D.; Ackema, K.; Spang, A.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Datta, S.; Zerial, M.] Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.
EM anne.spang@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD MAR
PY 2010
VL 89
SU 60
BP 28
EP 28
PG 1
WC Cell Biology
SC Cell Biology
GA 576QY
UT WOS:000276163000078
DA 2021-01-25
ER

PT J
AU Silvan, U
   Mannherz, HG
   Sutterlin, R
   Mittelholzer, C
   Burkhard, P
   Jockusch, BM
   Schoenenberger, CA
AF Silvan, U.
   Mannherz, H. G.
   Suetterlin, R.
   Mittelholzer, C.
   Burkhard, P.
   Jockusch, B. M.
   Schoenenberger, C. A.
TI Specific antibodies reveal the presence of an antiparallel actin dimer
   in cells
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
CT 33rd Annual Meeting of the German-Society-for-Cell-Biology/German
   Melanoma Research Network
CY MAR 10-13, 2010
CL Univ Regensburg, Regensburg, GERMANY
SP German Soc Cell Biol
HO Univ Regensburg
C1 [Silvan, U.; Suetterlin, R.; Mittelholzer, C.; Schoenenberger, C. A.] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
   [Mannherz, H. G.] Ruhr Univ Bochum, Bochum, Germany.
   [Burkhard, P.] Univ Connecticut, Storrs, CT USA.
   [Jockusch, B. M.] Tech Univ Carolo Wilhelmina Braunschweig, Braunschweig, Germany.
EM unai.silvan@gmail.com
RI Silvan, Unai/J-7376-2013
CR MILLONIG R, 1988, J CELL BIOL, V106, P785, DOI 10.1083/jcb.106.3.785
   Schroeder U, 2009, J MOL BIOL, V386, P1368, DOI 10.1016/j.jmb.2008.11.023
NR 2
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD MAR
PY 2010
VL 89
SU 60
BP 42
EP 42
PG 1
WC Cell Biology
SC Cell Biology
GA 576QY
UT WOS:000276163000119
DA 2021-01-25
ER

PT J
AU Wang, LHC
   Mayer, B
   Stemmann, O
   Nigg, EA
AF Wang, Lily Hui-Ching
   Mayer, Bernd
   Stemmann, Olaf
   Nigg, Erich A.
TI Centromere DNA decatenation depends on cohesin removal and is required
   for mammalian cell division
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE PICH; Topoisomerase-II alpha; Cohesin; Spindle-assembly checkpoint;
   NoCut
ID SPINDLE-ASSEMBLY CHECKPOINT; SISTER-CHROMATID SEPARATION; CHROMOSOME
   BI-ORIENTATION; TOPOISOMERASE-II-ALPHA; AURORA-B; MITOTIC CHROMOSOMES;
   MITOSIS; ANAPHASE; SEGREGATION; METAPHASE
AB Sister chromatid cohesion is mediated by DNA catenation and proteinaceous cohesin complexes. The recent visualization of PICH (Plk1-interacting checkpoint helicase)-coated DNA threads in anaphase cells raises new questions as to the role of DNA catenation and its regulation in time and space. In the present study we show that persistent DNA catenation induced by inhibition of Topoisomerase-II alpha can contribute to sister chromatid cohesion in the absence of cohesin complexes and that resolution of catenation is essential for abscission. Furthermore, we use an in vitro chromatid separation assay to investigate the temporal and functional relationship between cohesin removal and Topoisomerase-II alpha-mediated decatenation. Our data suggest that centromere decatenation can occur only after separase activation and cohesin removal, providing a plausible explanation for the persistence of centromere threads after anaphase onset.
C1 [Wang, Lily Hui-Ching; Nigg, Erich A.] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
   [Wang, Lily Hui-Ching; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Mayer, Bernd; Stemmann, Olaf] Max Planck Inst Biochem, Dept Mol Cell Biol, D-82152 Martinsried, Germany.
RP Wang, LHC (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
EM lily.wang@unibas.ch
RI ; Wang, Lily Hui-Ching/D-1967-2011
OI nigg, erich/0000-0003-4835-5719; Wang, Lily
   Hui-Ching/0000-0003-0659-0139; Stemmann, Olaf/0000-0003-3044-2515
FU Taiwan Merit Scholarships program [NSC-095-SAF-I-564-627-TMS];
   Max-Planck SocietyMax Planck Society; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB646];
   Deutsche KrebshilfeDeutsche Krebshilfe
FX We thank Sabine Elowe and Anna Santamaria for critical reading of the
   manuscript. L. H.-C. W. acknowledges a fellowship from the Taiwan Merit
   Scholarships program (NSC-095-SAF-I-564-627-TMS). This work was
   supported by Max-Planck Society (to E. A. N.), the Deutsche
   Forschungsgemeinschaft (SFB646 to E. A. N.), and a grant from Deutsche
   Krebshilfe (to O. S.).
CR Agostinho M, 2004, MOL BIOL CELL, V15, P2388, DOI 10.1091/mbc.E03-08-0558
   Bachrati CZ, 2008, CHROMOSOMA, V117, P219, DOI 10.1007/s00412-007-0142-4
   Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041
   Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882
   Chan KL, 2007, EMBO J, V26, P3397, DOI 10.1038/sj.emboj.7601777
   Dai J, 2006, DEV CELL, V11, P741, DOI 10.1016/j.devcel.2006.09.018
   Diaz-Martinez LA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000318
   DOWNES CS, 1991, P NATL ACAD SCI USA, V88, P8895, DOI 10.1073/pnas.88.20.8895
   Gandhi R, 2006, CURR BIOL, V16, P2406, DOI 10.1016/j.cub.2006.10.061
   GASSER SM, 1987, EXP CELL RES, V173, P85, DOI 10.1016/0014-4827(87)90334-X
   Gimenez-Abian JF, 2004, CURR BIOL, V14, P1187, DOI 10.1016/j.cub.2004.06.052
   Gimenez-Abian JF, 2002, EUR J CELL BIOL, V81, P9, DOI 10.1078/0171-9335-00226
   Gruber S, 2006, CELL, V127, P523, DOI 10.1016/j.cell.2006.08.048
   Haering CH, 2008, NATURE, V454, P297, DOI 10.1038/nature07098
   Harrison BD, 2009, CHROMOSOMA, V118, P633, DOI 10.1007/s00412-009-0224-6
   Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909
   Huang XX, 2005, MOL BIOL CELL, V16, P4725, DOI 10.1091/mbc.E05-03-0190
   HUEBNER NC, 2010, CHROMOSOMA IN PRESS
   Kelly AE, 2009, CURR OPIN CELL BIOL, V21, P51, DOI 10.1016/j.ceb.2009.01.004
   Kitajima TS, 2006, NATURE, V441, P46, DOI 10.1038/nature04663
   Kueng S, 2006, CELL, V127, P955, DOI 10.1016/j.cell.2006.09.040
   Leng M, 2008, CELL CYCLE, V7, P1480, DOI 10.4161/cc.7.10.5951
   Liu D, 2009, SCIENCE, V323, P1350, DOI 10.1126/science.1167000
   Losada A, 2002, GENE DEV, V16, P3004, DOI 10.1101/gad.249202
   Losada A, 2001, CURR BIOL, V11, P268, DOI 10.1016/S0960-9822(01)00066-5
   Losada A, 2007, CHROMOSOMA, V116, P321, DOI 10.1007/s00412-007-0104-x
   Maresca TJ, 2009, J CELL BIOL, V184, P373, DOI 10.1083/jcb.200808130
   McGuinness BE, 2005, PLOS BIOL, V3, P433, DOI 10.1371/journal.pbio.0030086
   Mendoza M, 2009, NAT CELL BIOL, V11, P477, DOI 10.1038/ncb1855
   MURRAY AW, 1991, METHOD CELL BIOL, V36, P581
   MURRAY AW, 1985, ANNU REV CELL BIOL, V1, P289, DOI 10.1146/annurev.cellbio.1.1.289
   Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163
   Naim V, 2009, NAT CELL BIOL, V11, P761, DOI 10.1038/ncb1883
   Nasmyth K, 2005, ANNU REV BIOCHEM, V74, P595, DOI 10.1146/annurev.biochem.74.082803.133219
   Norden C, 2006, CELL, V125, P85, DOI 10.1016/j.cell.2006.01.045
   O'Connell CB, 2008, J CELL BIOL, V183, P29, DOI 10.1083/jcb.200801038
   Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009
   Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005
   Porter ACG, 2004, CHROMOSOME RES, V12, P569, DOI 10.1023/B:CHRO.0000036608.91085.d1
   Rattner JB, 1996, J CELL BIOL, V134, P1097, DOI 10.1083/jcb.134.5.1097
   Salic A, 2004, CELL, V118, P567, DOI 10.1016/j.cell.2004.08.016
   Santamaria A, 2007, MOL BIOL CELL, V18, P4024, DOI 10.1091/mbc.E07-05-0517
   SHAMU CE, 1992, J CELL BIOL, V117, P921, DOI 10.1083/jcb.117.5.921
   Steigemann P, 2009, CELL, V136, P473, DOI 10.1016/j.cell.2008.12.020
   Stemmann O, 2001, CELL, V107, P715, DOI 10.1016/S0092-8674(01)00603-1
   Sumara I, 2002, MOL CELL, V9, P515, DOI 10.1016/S1097-2765(02)00473-2
   SUNDIN O, 1980, CELL, V21, P103, DOI 10.1016/0092-8674(80)90118-X
   Tanaka TU, 2002, CELL, V108, P317, DOI 10.1016/S0092-8674(02)00633-5
   Toyoda Y, 2006, MOL BIOL CELL, V17, P2287, DOI 10.1091/mbc.E05-11-1089
   Uchida KSK, 2009, J CELL BIOL, V184, P383, DOI 10.1083/jcb.200811028
   UEMURA T, 1987, CELL, V50, P917, DOI 10.1016/0092-8674(87)90518-6
   Uhlmann F, 1999, NATURE, V400, P37, DOI 10.1038/21831
   Vagnarelli P, 2004, EMBO REP, V5, P167, DOI 10.1038/sj.embor.7400077
   Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7
   Watanabe Y, 2005, CURR OPIN CELL BIOL, V17, P590, DOI 10.1016/j.ceb.2005.10.003
   Yanagida M, 2005, PHILOS T R SOC B, V360, P609, DOI 10.1098/rstb.2004.1615
NR 56
TC 67
Z9 66
U1 0
U2 5
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD MAR 1
PY 2010
VL 123
IS 5
BP 806
EP 813
DI 10.1242/jcs.058255
PG 8
WC Cell Biology
SC Cell Biology
GA 556MH
UT WOS:000274594700018
PM 20144989
OA Bronze
DA 2021-01-25
ER

PT J
AU Senthamarai, RRP
   Kuprov, I
   Pervushin, K
AF Senthamarai, Russell R. P.
   Kuprov, Ilya
   Pervushin, Konstantin
TI Benchmarking NMR experiments: A relational database of protein pulse
   sequences
SO JOURNAL OF MAGNETIC RESONANCE
LA English
DT Article
DE NMR; Relational database; Spin state space restriction; Spinach; Spin
   dynamics; Benchmarking of NMR experiments
ID KRYLOV SUBSPACE TECHNIQUES; SPIN DYNAMICS; SENSITIVITY IMPROVEMENT;
   CROSS-CORRELATIONS; COHERENCE TRANSFER; SPECTROSCOPY; RELAXATION;
   SIMULATION; PROGRAM; IMPLEMENTATION
AB Systematic benchmarking of multi-dimensional protein NMR experiments is a critical prerequisite for optimal allocation of NMR resources for structural analysis of challenging proteins, e g large proteins with limited Solubility or proteins prone to aggregation We propose a set of benchmarking parameters for essential protein NMR experiments organized into a lightweight (single XML file) relational database (RDB), which includes all the necessary auxiliaries (waveforms, decoupling sequences, calibration tables, setup algorithms and an RDB management system) The database is interfaced to the Spinach library (http//spindynamics org), which enables accurate simulation and benchmarking of NMR experiments oil large spin systems A key feature is the ability to use a single user-specified spin system to simulate the majority of deposited solution state NMR experiments, thus providing the (hitherto unavailable) unified framework for pulse sequence evaluation This development enables predicting relative sensitivity of deposited implementations of NMR experiments, thus providing a basis for comparison, optimization and. eventually, automation of NMR analysis. The benchmarking is demonstrated with two proteins, of 170 amino acids 1 domain of alpha X beta 2 Integrin and 440 amino acids NS3 helicase. (C) 2009 Elsevier Inc All rights reserved
C1 [Kuprov, Ilya] Univ Oxford, Oxford E Res Ctr, Oxford OX1 3QG, England.
   [Senthamarai, Russell R. P.; Pervushin, Konstantin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.
   [Pervushin, Konstantin] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Kuprov, I (corresponding author), Univ Oxford, Oxford E Res Ctr, 7 Keble Rd, Oxford OX1 3QG, England.
RI Pervushin, Konstantin/AAJ-6580-2020
OI Pervushin, Konstantin/0000-0002-6393-4340
FU Singapore Ministry of EducationMinistry of Education, Singapore; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF);
   EPSRCEngineering & Physical Sciences Research Council (EPSRC)
   [EP/F065205/1, EP/H003789/1]; Engineering and Physical Sciences Research
   CouncilEngineering & Physical Sciences Research Council (EPSRC)
   [EP/F065205/2, EP/F065205/1, EP/H003789/1] Funding Source: researchfish
FX The authors thank Singapore Ministry of Education as well as Swiss
   National Science Foundation for financial support (MOE Tier-2 grant and
   SNF grant to Konstantin Pervushin). The authors thank Peter Hore,
   Matthew Krzystyniak, Hannah Hogben and Gareth Charnock for helpful
   discussions, and Dr. Zhao Xiao and Leo Wong for making spectra of alpha
   X beta 2 Integrin and NS3Helicase available for us. This work was
   supported by EPSRC (EP/F065205/1, EP/H003789/1).
CR Allman T, 1996, J MAGN RESON SER A, V123, P26, DOI 10.1006/jmra.1996.0210
   Bai ZJ, 2002, APPL NUMER MATH, V43, P9, DOI 10.1016/S0168-9274(02)00116-2
   Bak M, 2000, J MAGN RESON, V147, P296, DOI 10.1006/jmre.2000.2179
   Blanton WB, 2003, J MAGN RESON, V162, P269, DOI 10.1016/S1090-7807(03)00035-1
   BODENHAUSEN G, 1980, CHEM PHYS LETT, V69, P185, DOI 10.1016/0009-2614(80)80041-8
   Bromek K, 2005, J AM CHEM SOC, V127, P405, DOI 10.1021/ja0462326
   BYSTROV VF, 1976, PROGR NMR SPECTROSCO, V10, P41
   Cavanagh, 1996, PROTEIN NMR SPECTROS
   CAVANAGH J, 1991, J MAGN RESON, V91, P429, DOI 10.1016/0022-2364(91)90209-C
   DEBOUREGAS FS, 1992, J MAGN RESON, V96, P280, DOI 10.1016/0022-2364(92)90081-H
   Ernst R.R., 1987, PRINCIPLES NUCL MAGN
   Ferentz AE, 2000, Q REV BIOPHYS, V33, P29, DOI 10.1017/S0033583500003589
   Freund R. W., 2003, Acta Numerica, V12, P267, DOI 10.1017/S0962492902000120
   Frueh DP, 2005, J BIOMOL NMR, V32, P23, DOI 10.1007/s10858-005-3592-0
   Glaser SJ, 1998, SCIENCE, V280, P421, DOI 10.1126/science.280.5362.421
   Goldman M, 2001, J MAGN RESON, V149, P160, DOI 10.1006/jmre.2000.2239
   GUNTERT P, 1993, J MAGN RESON SER A, V101, P103, DOI 10.1006/jmra.1993.1016
   Helgstrand M, 2004, J BIOMOL NMR, V30, P71, DOI 10.1023/B:JNMR.0000042962.00088.f4
   Jerschow A, 2005, J MAGN RESON, V176, P7, DOI 10.1016/j.jmr.2005.05.005
   KAY LE, 1992, J AM CHEM SOC, V114, P10663, DOI 10.1021/ja00052a088
   Khaneja N, 2003, P NATL ACAD SCI USA, V100, P13162, DOI 10.1073/pnas.2134111100
   Khaneja N, 2003, J MAGN RESON, V162, P311, DOI 10.1016/S1090-7807(03)00003-X
   Kohn W, 1999, REV MOD PHYS, V71, P1253, DOI 10.1103/RevModPhys.71.1253
   Krishnan VV, 1998, J BIOMOL NMR, V12, P177, DOI 10.1023/A:1008226330666
   Kumar A, 1996, CONCEPT MAGNETIC RES, V8, P139, DOI 10.1002/(SICI)1099-0534(1996)8:2<139::AID-CMR4>3.0.CO;2-#
   Kumar P, 1996, J MAGN RESON SER A, V119, P29, DOI 10.1006/jmra.1996.0048
   Kuprov I, 2008, J MAGN RESON, V195, P45, DOI 10.1016/j.jmr.2008.08.008
   Kuprov I, 2007, J MAGN RESON, V189, P241, DOI 10.1016/j.jmr.2007.09.014
   Kuprov I, 2007, J MAGN RESON, V184, P196, DOI 10.1016/j.jmr.2006.09.023
   Loth K, 2005, J AM CHEM SOC, V127, P6062, DOI 10.1021/ja042863o
   MULLER L, 1979, J AM CHEM SOC, V101, P4481
   Nicholas P, 2000, J MAGN RESON, V145, P262, DOI 10.1006/jmre.2000.2108
   Nietlispach D, 2005, J BIOMOL NMR, V31, P161, DOI 10.1007/s10858-004-8195-7
   PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S
   Pervushin K, 2005, J MAGN RESON, V172, P36, DOI 10.1016/j.jmr.2004.09.016
   Pervushin KV, 1998, J BIOMOL NMR, V12, P345, DOI 10.1023/A:1008268930690
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   REDFIELD AG, 1957, IBM J RES DEV, V1, P19, DOI 10.1147/rd.11.0019
   SHRIVER J, 1992, CONCEPT MAGNETIC RES, V4, P1
   Skinner TE, 2003, J MAGN RESON, V163, P8, DOI 10.1016/S1090-7807(03)00153-8
   SMITH SA, 1994, J MAGN RESON SER A, V106, P75, DOI 10.1006/jmra.1994.1008
   Sun HH, 2002, J AM CHEM SOC, V124, P5486, DOI 10.1021/ja011863a
   Tannor D. J., 2006, INTRO QUANTUM MECH T
   Veshtort M, 2006, J MAGN RESON, V178, P248, DOI 10.1016/j.jmr.2005.07.018
   Xu T, 2005, J VIROL, V79, P10278, DOI 10.1128/JVI.79.16.10278-10288.2005
   Yang DW, 1999, J BIOMOL NMR, V13, P3, DOI 10.1023/A:1008329230975
   Young K, 1999, J MAGN RESON, V140, P146, DOI 10.1006/jmre/1999.1809
NR 47
TC 7
Z9 7
U1 0
U2 20
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1090-7807
EI 1096-0856
J9 J MAGN RESON
JI J. Magn. Reson.
PD MAR
PY 2010
VL 203
IS 1
BP 129
EP 137
DI 10.1016/j.jmr.2009.12.008
PG 9
WC Biochemical Research Methods; Physics, Atomic, Molecular & Chemical;
   Spectroscopy
SC Biochemistry & Molecular Biology; Physics; Spectroscopy
GA 560RX
UT WOS:000274921000014
PM 20045660
DA 2021-01-25
ER

PT J
AU Das, A
   Reichert, H
   Rodrigues, V
AF Das, Abhijit
   Reichert, Heinrich
   Rodrigues, Veronica
TI Notch Regulates the Generation of Diverse Cell Types From the Lateral
   Lineage of Drosophila Antennal Lobe
SO JOURNAL OF NEUROGENETICS
LA English
DT Article
DE Fate specification; hemilineage; lateral neuroblast; local interneurons;
   projection neurons
ID CENTRAL-NERVOUS-SYSTEM; OLFACTORY SENSORY MAP; NEUROBLAST LINEAGE;
   NEURONAL DIVERSITY; TEMPORAL IDENTITY; BRAIN; SPECIFICATION;
   REPRESENTATIONS; INTERNEURONS; PROJECTION
AB Diverse neuronal cell types arise from the lateral neuroblast in the antennal lobe of Drosophila. The authors show that loss of Notch function from the entire lineage during development leads to an absence of local interneurons (LNs) with a concomitant increase in the number of projection neurons (PNs). The presence of the intracellular domain of Notch was observed within the nucleus of newly born neurons within the neuroblast lineage. This leads to the suggestion that Notch acts in a binary fate decision to determine formation of LNs and PNs, resulting in two distinct hemilineages from the single neuroblast. The observation of nuclear Notch in several neuroblast lineages leads us to speculate that this mechanism is widespread during the developing Drosophila brain.
C1 [Rodrigues, Veronica] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.
   [Das, Abhijit; Rodrigues, Veronica] Tata Inst Fundamental Res, Dept Biol Sci, Mumbai 400005, Maharashtra, India.
   [Reichert, Heinrich] Univ Basel, Biozentrum, Basel, Switzerland.
RP Rodrigues, V (corresponding author), Tata Inst Fundamental Res, Natl Ctr Biol Sci, GKVK Campus,Bellary Rd, Bangalore 560065, Karnataka, India.
EM Heinrich.Reichert@unibas.ch; veronica@ncbs.res.in
OI Das, Abhijit/0000-0001-5880-996X
FU TIFR; IndoSwiss Joint Research Program; Department of Science and
   Technology, Government of India-Centre for NanotechnologyDepartment of
   Science & Technology (India); Central Imaging and Flow Cytometry
   Facility;  [SR/S5/NM-36/2005]
FX We thank Kei Ito, Reinhard Stocker, Tzumin Lee, Liquin Luo, Gero
   Meisenbock, and the Bloomington Stock Centre for many of the fly stocks
   and Juan Botas and Developmental Studies Hybridoma Bank for antibodies.
   We acknowledge K. VijayRaghavan and Sonia Sen for discussions, and
   Tripti Gupta for technical help. This work was supported by grants from
   TIFR and the IndoSwiss Joint Research Program. We thank the Department
   of Science and Technology, Government of India-Centre for Nanotechnology
   (No. SR/S5/NM-36/2005), the Central Imaging and Flow Cytometry Facility,
   and the NCBS Olympus MicroImaging Centre, for imaging facilities.
CR AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154
   Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265
   Das A, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-33
   Dumstrei K, 2003, J COMP NEUROL, V455, P451, DOI 10.1002/cne.10484
   FEHON RG, 1990, CELL, V61, P523, DOI 10.1016/0092-8674(90)90534-L
   Jacob J, 2008, DEVELOPMENT, V135, P3481, DOI 10.1242/dev.016931
   Jefferis GSXE, 2006, SEMIN CELL DEV BIOL, V17, P50, DOI 10.1016/j.semcdb.2005.12.002
   Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574
   Karcavich R, 2005, J COMP NEUROL, V481, P240, DOI 10.1002/cne.20371
   Karcavich RE, 2005, DEV DYNAM, V232, P609, DOI 10.1002/dvdy.20273
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Kumar A, 2009, DEVELOPMENT, V136, P3433, DOI 10.1242/dev.037226
   Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lin SW, 2010, DEVELOPMENT, V137, P43, DOI 10.1242/dev.041699
   Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531
   Lundell MJ, 2003, DEVELOPMENT, V130, P4109, DOI 10.1242/dev.00593
   Mombaerts P, 1996, CELL, V87, P675, DOI 10.1016/S0092-8674(00)81387-2
   Novotny T, 2002, DEVELOPMENT, V129, P1027
   Okada R, 2009, J COMP NEUROL, V514, P74, DOI 10.1002/cne.21971
   Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010
   Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   Rodrigues V, 2008, ADV EXP MED BIOL, V628, P82, DOI 10.1007/978-0-387-78261-4_6
   Roegiers F, 2004, CURR OPIN CELL BIOL, V16, P195, DOI 10.1016/j.ceb.2004.02.010
   Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034
   Skeath JB, 1998, DEVELOPMENT, V125, P1857
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5
   Stopfer M, 2003, NEURON, V39, P991, DOI 10.1016/j.neuron.2003.08.011
   Truman JW, 2010, DEVELOPMENT, V137, P53, DOI 10.1242/dev.041749
   Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371
   Turner GC, 2008, J NEUROPHYSIOL, V99, P734, DOI 10.1152/jn.01283.2007
   Urbach R, 2003, ARTHROPOD STRUCT DEV, V32, P103, DOI 10.1016/S1467-8039(03)00042-2
   Vosshall LB, 2000, CELL, V102, P147, DOI 10.1016/S0092-8674(00)00021-0
   Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005
   Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782
   Yu HH, 2007, TRENDS NEUROSCI, V30, P520, DOI 10.1016/j.tins.2007.07.003
   Yu HH, 2009, NAT NEUROSCI, V12, P947, DOI 10.1038/nn.2345
NR 39
TC 6
Z9 6
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 0167-7063
EI 1563-5260
J9 J NEUROGENET
JI J. Neurogenet.
PD MAR
PY 2010
VL 24
IS 1
BP 42
EP U47
DI 10.3109/01677060903582202
PG 14
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 560CP
UT WOS:000274879800005
PM 20148759
DA 2021-01-25
ER

PT J
AU Iacovache, I
   Biasini, M
   Kowal, J
   Kukulski, W
   Chami, M
   van der Goot, FG
   Engel, A
   Remigy, HW
AF Iacovache, Ioan
   Biasini, Marco
   Kowal, Julia
   Kukulski, Wanda
   Chami, Mohamed
   van der Goot, F. Gisou
   Engel, Andreas
   Remigy, Herve-W.
TI The 2DX robot: A membrane protein 2D crystallization Swiss Army knife
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE 2D crystallization; Membrane protein; Cyclodextrin; High throughput;
   Electron microscopy
ID 2-DIMENSIONAL CRYSTALLIZATION; ANGSTROM STRUCTURE; BIO-BEADS;
   RECONSTITUTION; AEROLYSIN; CHANNEL; PHASE; SOLUBILIZATION; DETERGENTS;
   RESOLUTION
AB Among the state-of-the-art techniques that provide experimental information at atomic scale for membrane proteins, electron crystallography, atomic force microscopy and solid state NMR make use of two-dimensional crystals. We present a cyclodextrin-driven method for detergent removal implemented in a fully automated robot. The kinetics of the reconstitution processes is precisely controlled, because the detergent complexation by cyclodextrin is of stoichiometric nature. The method requires smaller volumes and lower protein concentrations than established 2D crystallization methods, making it possible to explore more conditions with the same amount of protein. The method yielded highly ordered 2D crystals diffracting to high resolution from the pore-forming toxin Aeromonas hydrophila aerolysin (2.9 angstrom), the plant aquaporin SoPIP2; 1 (3.1 angstrom) and the human aquaporin-8 (hAQP8; 3.3 angstrom). This new method outperforms traditional 2D crystallization approaches in terms of accuracy, flexibility, throughput, and allows the usage of detergents having low critical micelle concentration (CMC), which stabilize the structure of membrane proteins in solution. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Biasini, Marco; Kowal, Julia; Chami, Mohamed; Engel, Andreas; Remigy, Herve-W.] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
   [Iacovache, Ioan; van der Goot, F. Gisou] Ecole Polytech Fed Lausanne, Global Hlth Inst, Lausanne, Switzerland.
   [Kukulski, Wanda] European Mol Biol Lab, Heidelberg, Germany.
   [Engel, Andreas] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
RP Remigy, HW (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
EM Herve.Remigy@unibas.ch
RI Kukulski, Wanda/H-1766-2013; van der Goot, Gisou/B-2279-2012
OI van der Goot, Gisou/0000-0002-8522-274X; Kowal,
   Julia/0000-0003-4694-1896
CR Attrill H, 2009, PROTEIN EXPRES PURIF, V64, P32, DOI 10.1016/j.pep.2008.10.001
   Berg M, 2002, ACTA CRYSTALLOGR D, V58, P1643, DOI [10.1107/S0907444902012726, 10.1107/SO907444902012726]
   BERNHEIMER AW, 1975, INFECT IMMUN, V11, P1312, DOI 10.1128/IAI.11.6.1312-1319.1975
   BUCKLEY JT, 1990, BIOCHEM CELL BIOL, V68, P221, DOI 10.1139/o90-029
   CLADERA J, 2004, EUR J BIOCHEM, V243, P798
   Davis R.W., 1980, ADV BACTERIAL GENETI
   DeGrip WJ, 1998, BIOCHEM J, V330, P667
   Dolder M, 1996, FEBS LETT, V382, P203, DOI 10.1016/0014-5793(96)00180-9
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   ENGEL A, 1992, J STRUCT BIOL, V109, P219, DOI 10.1016/1047-8477(92)90035-9
   Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)80003-8
   GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7
   Grisshammer Reinhard, 2005, Journal of Structural and Functional Genomics, V6, P159, DOI 10.1007/s10969-005-1917-6
   GURCEL L, 2009, COMPREHENSIVE SOURCE
   Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796
   HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2
   Hirai T, 1999, J ELECTRON MICROSC, V48, P653, DOI 10.1093/oxfordjournals.jmicro.a023731
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6
   Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193
   Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001
   Lambert O, 1998, BIOPHYS J, V74, P918, DOI 10.1016/S0006-3495(98)74015-9
   LEVY D, 1990, BIOCHIM BIOPHYS ACTA, V1025, P179, DOI 10.1016/0005-2736(90)90096-7
   Levy D, 1999, J STRUCT BIOL, V127, P44, DOI 10.1006/jsbi.1999.4155
   Nakazato K, 1998, J APPL CRYSTALLOGR, V31, P644, DOI 10.1107/S0021889898002507
   Nyblom M, 2009, J MOL BIOL, V387, P653, DOI 10.1016/j.jmb.2009.01.065
   PATERNOSTRE MT, 1988, BIOCHEMISTRY-US, V27, P2668, DOI 10.1021/bi00408a006
   Remigy HW, 2003, FEBS LETT, V555, P160, DOI 10.1016/S0014-5793(03)01105-0
   Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848
   RIGAUD JL, 1995, BBA-BIOENERGETICS, V1231, P223, DOI 10.1016/0005-2728(95)00091-V
   Ringler P, 2000, PRACT APPROACH SER, P229
   Salom D, 2006, J STRUCT BIOL, V156, P497, DOI 10.1016/j.jsb.2006.05.003
   Saparov SM, 2007, J BIOL CHEM, V282, P5296, DOI 10.1074/jbc.M609343200
   Schenk AD, 2005, J MOL BIOL, V350, P278, DOI 10.1016/j.jmb.2005.04.030
   Scott EE, 2004, J BIOL CHEM, V279, P27294, DOI 10.1074/jbc.M403349200
   Sennoga C, 2003, ACTA CRYSTALLOGR D, V59, P239, DOI 10.1107/S0907444902020772
   Signorell GA, 2007, J STRUCT BIOL, V157, P321, DOI 10.1016/j.jsb.2006.07.011
   Tornroth-Horsefield S, 2006, NATURE, V439, P688, DOI 10.1038/nature04316
   VANDERGOOT FG, 1992, BIOCHEMISTRY-US, V31, P8566, DOI 10.1021/bi00151a026
   Vink M, 2007, J STRUCT BIOL, V160, P295, DOI 10.1016/j.jsb.2007.09.003
   WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x
   WILMSEN HU, 1992, EMBO J, V11, P2457, DOI 10.1002/j.1460-2075.1992.tb05310.x
NR 42
TC 26
Z9 27
U1 2
U2 14
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD MAR
PY 2010
VL 169
IS 3
BP 370
EP 378
DI 10.1016/j.jsb.2009.12.001
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 565MB
UT WOS:000275296100013
PM 19963066
DA 2021-01-25
ER

PT J
AU Lang, C
   Grava, S
   Finlayson, M
   Trimble, R
   Philippsen, P
   Jaspersen, SL
AF Lang, Claudia
   Grava, Sandrine
   Finlayson, Mark
   Trimble, Rhonda
   Philippsen, Peter
   Jaspersen, Sue L.
TI Structural Mutants of the Spindle Pole Body Cause Distinct Alteration of
   Cytoplasmic Microtubules and Nuclear Dynamics in Multinucleated Hyphae
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID GAMMA-TUBULIN COMPLEX; YEAST SPINDLE; SACCHAROMYCES-CEREVISIAE; MITOTIC
   SPINDLE; ASHBYA-GOSSYPII; BINDING PROTEIN; CELL-CYCLE; COMPONENT; STU2P;
   ORGANIZATION
AB In the multinucleate fungus Ashbya gossypii, cytoplasmic microtubules (cMTs) emerge from the spindle pole body outer plaque (OP) in perpendicular and tangential directions. To elucidate the role of cMTs in forward/backward movements (oscillations) and bypassing of nuclei, we constructed mutants potentially affecting cMT nucleation or stability. Hyphae lacking the OP components AgSpc72, AgNud1, AgCnm67, or the microtubule-stabilizing factor AgStu2 grew like wildtype but showed substantial alterations in the number, length, and/or nucleation sites of cMTs. These mutants differently influenced nuclear oscillation and bypassing. In Agspc72 Delta, only long cMTs were observed, which emanate tangentially from reduced OPs; nuclei mainly moved with the cytoplasmic stream but some performed rapid bypassing. Agnud1 Delta and Agcnm67 Delta lack OPs; short and long cMTs emerged from the spindle pole body bridge/half-bridge structures, explaining nuclear oscillation and bypassing in these mutants. In Agstu2 Delta only very short cMTs emanated from structurally intact OPs; all nuclei moved with the cytoplasmic stream. Therefore, long tangential cMTs promote nuclear bypassing and short cMTs are important for nuclear oscillation. Our electron microscopy ultrastructural analysis also indicated that assembly of the OP occurs in a stepwise manner, starting with AgCnm67, followed by AgNud1 and lastly AgSpc72.
C1 [Trimble, Rhonda; Jaspersen, Sue L.] Stowers Inst Med Res, Kansas City, MO 64110 USA.
   [Jaspersen, Sue L.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA.
   [Lang, Claudia; Grava, Sandrine; Finlayson, Mark; Philippsen, Peter] Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
RP Jaspersen, SL (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.
EM slj@stowers.org
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-112688]; March of Dimes Basil O'Connor AwardMarch of
   Dimes; Stowers Institute for Medical Research
FX We thank Geraldine Kasslin and Shanon Seger for help in strain
   construction and Dominic Hoepfner for guidance in the early stage of
   this project. We are grateful to Jenny Friederichs, Teri Johnson, and
   Fengli Guo for assistance with EM and to Katie Perko for help with
   AutoAligner. We acknowledge the advice and suggestions of Trisha Davis,
   Chad Pearson and the Philippsen and Jaspersen laboratories. This work
   was supported by Swiss National Science Foundation grant 3100A0-112688 (
   to P. P). S.L.J. is supported by a March of Dimes Basil O'Connor Award
   and the Stowers Institute for Medical Research.
CR Adams IR, 1999, J CELL BIOL, V145, P809, DOI 10.1083/jcb.145.4.809
   Al-Bassam J, 2006, J CELL BIOL, V172, P1009, DOI 10.1083/jcb.200511010
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Brachat A, 1998, MOL BIOL CELL, V9, P977, DOI 10.1091/mbc.9.5.977
   Brachat S, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-r45
   BYERS B, 1978, J CELL SCI, V30, P331
   BYERS B, 1975, J BACTERIOL, V124, P511, DOI 10.1128/JB.124.1.511-523.1975
   Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629
   Chen XYP, 1998, J CELL BIOL, V141, P1169, DOI 10.1083/jcb.141.5.1169
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Elliott S, 1999, P NATL ACAD SCI USA, V96, P6205, DOI 10.1073/pnas.96.11.6205
   Enke C, 2007, EUKARYOT CELL, V6, P555, DOI 10.1128/EC.00266-06
   Gard DL, 2004, INT REV CYTOL, V239, P179, DOI 10.1016/S0074-7696(04)39004-2
   Gattiker A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-9
   Geissler S, 1996, EMBO J, V15, P3899, DOI 10.1002/j.1460-2075.1996.tb00764.x
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Gruneberg U, 2000, EMBO J, V19, P6475, DOI 10.1093/emboj/19.23.6475
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   Hoepfner D, 2002, MOL BIOL CELL, V13, P1366, DOI 10.1091/mbc.01-07-0338
   Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197
   Hoyt MA, 2000, CELL, V102, P267, DOI 10.1016/S0092-8674(00)00031-3
   Kilmartin JV, 1996, EMBO J, V15, P4592, DOI 10.1002/j.1460-2075.1996.tb00837.x
   Knop M, 1998, EMBO J, V17, P3952, DOI 10.1093/emboj/17.14.3952
   Knop M, 1997, EMBO J, V16, P1550, DOI 10.1093/emboj/16.7.1550
   Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985
   Konzack S, 2005, MOL BIOL CELL, V16, P497, DOI 10.1091/mbc.E04-02-0083
   Kosco KA, 2001, MOL BIOL CELL, V12, P2870, DOI 10.1091/mbc.12.9.2870
   Lang C, 2010, MOL BIOL CELL, V21, P18, DOI 10.1091/mbc.E09-01-0063
   MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977
   McDonald K, 1999, METH MOL B, V117, P77
   Muller EGD, 2005, MOL BIOL CELL, V16, P3341, DOI 10.1091/mbc.E05-03-0214
   Nguyen T, 1998, MOL BIOL CELL, V9, P2201, DOI 10.1091/mbc.9.8.2201
   O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017
   Pearson CG, 2003, MOL BIOL CELL, V14, P4181, DOI 10.1091/mbc.E03-03-0180
   Pereira G, 1999, EMBO J, V18, P4180, DOI 10.1093/emboj/18.15.4180
   Pereira G, 1998, MOL BIOL CELL, V9, P775, DOI 10.1091/mbc.9.4.775
   Pereira G, 2001, CURR OPIN CELL BIOL, V13, P762, DOI 10.1016/S0955-0674(00)00281-7
   ROSE MD, 1987, CELL, V48, P1047, DOI 10.1016/0092-8674(87)90712-4
   ROUT MP, 1990, J CELL BIOL, V111, P1913, DOI 10.1083/jcb.111.5.1913
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schaerer F, 2001, MOL BIOL CELL, V12, P2519, DOI 10.1091/mbc.12.8.2519
   Severin F, 2001, J CELL BIOL, V153, P435, DOI 10.1083/jcb.153.2.435
   Shaw SL, 1997, J CELL BIOL, V139, P985, DOI 10.1083/jcb.139.4.985
   Soues S, 1998, J CELL SCI, V111, P2809
   Spang A, 1996, J CELL BIOL, V134, P429, DOI 10.1083/jcb.134.2.429
   Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051
   Usui T, 2003, EMBO J, V22, P4779, DOI 10.1093/emboj/cdg459
   van Breugel M, 2003, J CELL BIOL, V161, P359, DOI 10.1083/jcb.200211097
   Wang PJJ, 1997, J CELL BIOL, V139, P1271, DOI 10.1083/jcb.139.5.1271
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
NR 50
TC 15
Z9 15
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD MAR 1
PY 2010
VL 21
IS 5
BP 753
EP 766
DI 10.1091/mbc.E09-07-0555
PG 14
WC Cell Biology
SC Cell Biology
GA 561XD
UT WOS:000275012500007
PM 20053682
OA Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Spangler, C
   Bohm, A
   Jenal, U
   Seifert, R
   Kaever, V
AF Spangler, C.
   Boehm, A.
   Jenal, U.
   Seifert, R.
   Kaever, V.
TI Quantitation of in vitro di-guanylate cyclase activity and in vivo
   levels of cyclic diguanosine monophosphate by liquid
   chromatography-coupled tandem mass spectrometry
SO NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
LA English
DT Meeting Abstract
CT 51st Annual Meeting of the
   Deutsche-Gesellschaft-fur-Experimentelle-und-Klinische-Pharmakologie-und
   -Toxikologie
CY MAR 23-25, 2010
CL Mainz, GERMANY
SP Deutsch Gesell Expt & Klin Pharmakol & Toxikol
C1 [Spangler, C.; Seifert, R.; Kaever, V.] Hannover Med Sch, Inst Pharmacol, D-3000 Hannover, Germany.
   [Boehm, A.; Jenal, U.] Univ Basel, Biozentrum, Mol Microbiol Div, Basel, Switzerland.
RI Kaever, Volkhard/G-3280-2013
NR 0
TC 1
Z9 1
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0028-1298
J9 N-S ARCH PHARMACOL
JI Naunyn-Schmiedebergs Arch. Pharmacol.
PD MAR
PY 2010
VL 381
SU 1
BP 27
EP 27
PG 1
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 590XA
UT WOS:000277260500101
DA 2021-01-25
ER

PT J
AU Malone, JG
   Jaeger, T
   Spangler, C
   Ritz, D
   Spang, A
   Arrieumerlou, C
   Kaever, V
   Landmann, R
   Jenal, U
AF Malone, Jacob G.
   Jaeger, Tina
   Spangler, Christian
   Ritz, Daniel
   Spang, Anne
   Arrieumerlou, Cecile
   Kaever, Volkhard
   Landmann, Regine
   Jenal, Urs
TI YfiBNR Mediates Cyclic di-GMP Dependent Small Colony Variant Formation
   and Persistence in Pseudomonas aeruginosa
SO PLOS PATHOGENS
LA English
DT Article
ID REGULATES BIOFILM FORMATION; SWARMING MOTILITY; CELL-CYCLE; EXPERIMENTAL
   POPULATIONS; ANTIBIOTIC-RESISTANCE; ADAPTIVE DIVERGENCE; RESPONSE
   REGULATOR; TWITCHING MOTILITY; ALLOSTERIC CONTROL; GGDEF PROTEIN
AB During long-term cystic fibrosis lung infections, Pseudomonas aeruginosa undergoes genetic adaptation resulting in progressively increased persistence and the generation of adaptive colony morphotypes. This includes small colony variants (SCVs), auto-aggregative, hyper-adherent cells whose appearance correlates with poor lung function and persistence of infection. The SCV morphotype is strongly linked to elevated levels of cyclic-di-GMP, a ubiquitous bacterial second messenger that regulates the transition between motile and sessile, cooperative lifestyles. A genetic screen in PA01 for SCV-related loci identified the yfiBNR operon, encoding a tripartite signaling module that regulates c-di-GMP levels in P. aeruginosa. Subsequent analysis determined that YfiN is a membrane-integral diguanylate cyclase whose activity is tightly controlled by YfiR, a small periplasmic protein, and the OmpA/Pal-like outer-membrane lipoprotein YfiB. Exopolysaccharide synthesis was identified as the principal downstream target for YfiBNR, with increased production of Pel and Psl exopolysaccharides responsible for many characteristic SCV behaviors. An yfi-dependent SCV was isolated from the sputum of a CF patient. Consequently, the effect of the SCV morphology on persistence of infection was analyzed in vitro and in vivo using the YfiN-mediated SCV as a representative strain. The SCV strain exhibited strong, exopolysaccharide-dependent resistance to nematode scavenging and macrophage phagocytosis. Furthermore, the SCV strain effectively persisted over many weeks in mouse infection models, despite exhibiting a marked fitness disadvantage in vitro. Exposure to sub-inhibitory concentrations of antibiotics significantly decreased both the number of suppressors arising, and the relative fitness disadvantage of the SCV mutant in vitro, suggesting that the SCV persistence phenotype may play a more important role during antimicrobial chemotherapy. This study establishes YfiBNR as an important player in P. aeruginosa persistence, and implicates a central role for c-di-GMP, and by extension the SCV phenotype in chronic infections.
C1 [Malone, Jacob G.; Jaeger, Tina; Spang, Anne; Arrieumerlou, Cecile; Jenal, Urs] Univ Basel, Biozentrum, Basel, Switzerland.
   [Spangler, Christian; Kaever, Volkhard] Hannover Med Sch, Inst Pharmacol, D-3000 Hannover, Germany.
   [Ritz, Daniel] Actel Pharmaceut Ltd, Allschwil, Switzerland.
   [Landmann, Regine] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
RP Malone, JG (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM jacob.malone@unibas.ch; urs.jenal@unibas.ch
RI Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008; Malone,
   Jacob/G-8319-2011; Kaever, Volkhard/G-3280-2013
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203;
   Malone, Jacob/0000-0003-1959-6820; ARRIEUMERLOU,
   Cecile/0000-0002-6463-2897
FU Actelion Pharmaceuticals Ltd., Allschwil, Switzerland; Swiss National
   Science FoundationSwiss National Science Foundation (SNSF)
   [3100A0-108186]
FX This work was supported by a Research Grant from Actelion
   Pharmaceuticals Ltd., Allschwil, Switzerland (www.actelion.com) and a
   Swiss National Science Foundation Fellowship 3100A0-108186 to UJ. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   Alm RA, 1996, J BACTERIOL, V178, P46, DOI 10.1128/jb.178.1.46-53.1996
   Bantinaki E, 2007, GENETICS, V176, P441, DOI 10.1534/genetics.106.069906
   Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028
   Burrowes E, 2006, MICROBIOL-SGM, V152, P405, DOI 10.1099/mic.0.28324-0
   Caiazza NC, 2004, J BACTERIOL, V186, P4476, DOI 10.1128/JB.186.14.4476-4485.2004
   Caiazza NC, 2007, J BACTERIOL, V189, P3603, DOI 10.1128/JB.01685-06
   CANNON GJ, 1992, J CELL SCI, V101, P907
   Choi KH, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-30
   Choi KH, 2005, NAT METHODS, V2, P443, DOI 10.1038/NMETH765
   Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200
   Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200
   Conway BAD, 2004, J INFECT DIS, V190, P957, DOI 10.1086/423141
   D'Argenio DA, 2002, J BACTERIOL, V184, P6481, DOI 10.1128/JB.184.23.6481-6489.2002
   De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067
   Drenkard E, 2002, NATURE, V416, P740, DOI 10.1038/416740a
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409
   Friedman L, 2004, J BACTERIOL, V186, P4457, DOI 10.1128/JB.186.14.4457-4465.2004
   Gallagher LA, 2001, J BACTERIOL, V183, P6207, DOI 10.1128/JB.183.21.6207-6214.2001
   Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35
   Giddens SR, 2007, P NATL ACAD SCI USA, V104, P18247, DOI 10.1073/pnas.0706739104
   Gilbert P, 1997, Adv Dent Res, V11, P160
   GILBERT P, 1990, ANTIMICROB AGENTS CH, V34, P1865, DOI 10.1128/AAC.34.10.1865
   Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154
   Gjermansen M, 2005, ENVIRON MICROBIOL, V7, P894, DOI 10.1111/j.1462-2920.2005.00775.x
   Godlewska R, 2009, FEMS MICROBIOL LETT, V298, P1, DOI 10.1111/j.1574-6968.2009.01659.x
   GORDON CA, 1988, J ANTIMICROB CHEMOTH, V22, P667, DOI 10.1093/jac/22.5.667
   Gotoh H, 2008, RES MICROBIOL, V159, P294, DOI 10.1016/j.resmic.2008.02.002
   Govan JRW, 1996, MICROBIOL REV, V60, P539, DOI 10.1128/MMBR.60.3.539-574.1996
   Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x
   GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995
   Haussler S, 1999, CLIN INFECT DIS, V29, P621, DOI 10.1086/598644
   Haussler S, 2003, J MED MICROBIOL, V52, P295, DOI 10.1099/jmm.0.05069-0
   Haussler S, 2004, ENVIRON MICROBIOL, V6, P546, DOI 10.1111/j.1462-2920.2004.00618.x
   Haussler S, 2003, EUR J CLIN MICROBIOL, V22, P249, DOI 10.1007/s10096-003-0901-y
   Heeb S, 2000, MOL PLANT MICROBE IN, V13, P232, DOI 10.1094/MPMI.2000.13.2.232
   Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x
   Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912
   Huang BX, 2003, J BACTERIOL, V185, P7068, DOI 10.1128/JB.185.24.7068-7076.2003
   Jenal U, 2004, CURR OPIN MICROBIOL, V7, P185, DOI 10.1016/j.mib.2004.02.007
   Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752
   Karimova G, 2001, J MOL MICROB BIOTECH, V3, P73
   Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x
   Kirisits MJ, 2005, APPL ENVIRON MICROB, V71, P4809, DOI 10.1128/AEM.71.8.4809-4821.2005
   Klebensberger J, 2007, ENVIRON MICROBIOL, V9, P2247, DOI 10.1111/j.1462-2920.2007.01339.x
   KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1
   Kristian SA, 2008, J INFECT DIS, V197, P1028, DOI 10.1086/528992
   Kuchma SL, 2007, J BACTERIOL, V189, P8165, DOI 10.1128/JB.00586-07
   Kuchma SL, 2005, J BACTERIOL, V187, P1441, DOI 10.1128/JB.187.4.1441-1454.2005
   Kulasekara HD, 2005, MOL MICROBIOL, V55, P368, DOI 10.1111/j.1365-2958.2004.04402.x
   Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103
   Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x
   Leid JG, 2005, J IMMUNOL, V175, P7512, DOI 10.4049/jimmunol.175.11.7512
   Ma LM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000354
   Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x
   Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x
   Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07
   Merritt Judith H, 2005, Curr Protoc Microbiol, VChapter 1, DOI 10.1002/9780471729259.mc01b01s00
   MICHAELIS S, 1983, J BACTERIOL, V154, P366, DOI 10.1128/JB.154.1.366-374.1983
   Miller J., 1972, EXPT MOL GENETICS, P352
   MORGAN AF, 1979, J BACTERIOL, V139, P137, DOI 10.1128/JB.139.1.137-140.1979
   O'Toole GA, 1998, MOL MICROBIOL, V28, P449, DOI 10.1046/j.1365-2958.1998.00797.x
   Parsons LM, 2006, BIOCHEMISTRY-US, V45, P2122, DOI 10.1021/bi052227i
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200
   Rabinowitz JD, 2007, ANAL CHEM, V79, P6167, DOI 10.1021/ac070470c
   Reinhardt A, 2007, ANTIMICROB AGENTS CH, V51, P1341, DOI 10.1128/AAC.01278-06
   Roberts RC, 1996, CURR TOP DEV BIOL, V34, P207, DOI 10.1016/S0070-2153(08)60712-7
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005
   Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005
   Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857
   Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x
   Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   SPEERT DP, 1988, J CLIN INVEST, V82, P872, DOI 10.1172/JCI113692
   Spiers AJ, 2002, GENETICS, V161, P33
   Spiers AJ, 2003, MOL MICROBIOL, V50, P15, DOI 10.1046/j.1365-2958.2003.03670.x
   Spoering AL, 2001, J BACTERIOL, V183, P6746, DOI 10.1128/JB.183.23.6746-6751.2001
   Starkey M, 2009, J BACTERIOL, V191, P3492, DOI 10.1128/JB.00119-09
   Tischler AD, 2005, INFECT IMMUN, V73, P5873, DOI 10.1128/IAI.73.9.5873-5882.2005
   Tschowri N, 2009, GENE DEV, V23, P522, DOI 10.1101/gad.499409
   Ueda A, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000483
   Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198
   Vallet I, 2004, J BACTERIOL, V186, P2880, DOI 10.1128/JB.186.9.2880-2890.2004
   Ventre I, 2006, P NATL ACAD SCI USA, V103, P171, DOI 10.1073/pnas.0507407103
   Wagner T, 2005, CHEST, V128, P912, DOI 10.1378/chest.128.2.912
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Winson MK, 1998, FEMS MICROBIOL LETT, V163, P193, DOI 10.1111/j.1574-6968.1998.tb13045.x
   Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597
NR 92
TC 116
Z9 119
U1 1
U2 26
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD MAR
PY 2010
VL 6
IS 3
AR e1000804
DI 10.1371/journal.ppat.1000804
PG 17
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 596XY
UT WOS:000277720400014
PM 20300602
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Malik, R
   Dulla, K
   Nigg, EA
   Korner, R
AF Malik, Rainer
   Dulla, Kalyan
   Nigg, Erich A.
   Koerner, Roman
TI From proteome lists to biological impact- tools and strategies for the
   analysis of large MS data sets
SO PROTEOMICS
LA English
DT Review
DE Bioinformatics; Databases; Data mining; Interaction; Review
ID SCALE PHOSPHORYLATION ANALYSIS; PHOSPHOPROTEOME ANALYSIS; CELL-LINES;
   INFORMATION EXTRACTION; FUNCTIONAL ANNOTATION; INTEGRATED DATABASE;
   MASS-SPECTROMETRY; GENE ONTOLOGY; IN-VIVO; IDENTIFICATION
AB MS has become a method-of-choice for proteome analysis, generating large data sets, which reflect proteome-scale protein protein interaction and PTM networks. However, while a rapid growth in large-scale proteomics data can be observed, the sound biological interpretation of these results clearly lags behind. Therefore, combined efforts of bioinformaticians and biologists have been made to develop strategies and applications to help experimentalists perform this crucial task. This review presents an overview of currently available analytical strategies and tools to extract biologically relevant information from large protein lists. Moreover, we also present current research publications making use of these tools as examples of how the presented strategies may be incorporated into proteomic workflows. Emphasis is placed on the analysis of Gene Ontology terms, interaction networks, biological pathways and PTMs. In addition, topic's including domain analysis and text mining are reviewed in the context of computational analysis of proteomic results. We expect that these types of analyses will significantly contribute to a deeper understanding of the role of individual proteins, protein networks and pathways in complex systems.
C1 [Malik, Rainer; Dulla, Kalyan; Nigg, Erich A.; Koerner, Roman] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
   [Nigg, Erich A.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Korner, R (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, Klopferspitz 18A, D-82152 Martinsried, Germany.
EM rkoerner@biochem.mpg.de
RI Korner, Roman/G-8565-2011
OI Korner, Roman/0000-0001-9285-9290; nigg, erich/0000-0003-4835-5719
FU European CommissionEuropean CommissionEuropean Commission Joint Research
   Centre [LSHG-CT-2005-518254]
FX This work was supported by ENFIN, a Network of Excellence funded by the
   European Commission within its FP6 Programme, under the thematic area
   "Life sciences, genomics and biotechnology for health", contract number
   LSHG-CT-2005-518254.
CR Al-Shahrour F, 2006, NUCLEIC ACIDS RES, V34, pW472, DOI 10.1093/nar/gkl172
   Alfarano C, 2005, NUCLEIC ACIDS RES, V33, pD418, DOI 10.1093/nar/gki051
   Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166
   ANDERSSON L, 1986, ANAL BIOCHEM, V154, P250, DOI 10.1016/0003-2697(86)90523-3
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bader GD, 2006, NUCLEIC ACIDS RES, V34, pD504, DOI 10.1093/nar/gkj126
   Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664
   Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bodenmiller B, 2008, NAT BIOTECHNOL, V26, P1339, DOI 10.1038/nbt1208-1339
   Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003
   Bousette N, 2009, J PROTEOME RES, V8, P1887, DOI 10.1021/pr800845a
   Breitkreutz BJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-3-r22
   Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001
   Brown KR, 2005, BIOINFORMATICS, V21, P2076, DOI 10.1093/bioinformatics/bti273
   Bussey KJ, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-4-r27
   Carbon S, 2009, BIOINFORMATICS, V25, P288, DOI 10.1093/bioinformatics/btn615
   Cary MP, 2005, FEBS LETT, V579, P1815, DOI 10.1016/j.febslet.2005.02.005
   Chaurasia G, 2007, NUCLEIC ACIDS RES, V35, pD590, DOI 10.1093/nar/gkl817
   Chen H, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-147
   Cheng D, 2008, NUCLEIC ACIDS RES, V36, pW399, DOI 10.1093/nar/gkn296
   Cock PJA, 2009, BIOINFORMATICS, V25, P1422, DOI 10.1093/bioinformatics/btp163
   Cote RG, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-401
   Craig R, 2004, J PROTEOME RES, V3, P1234, DOI 10.1021/pr049882h
   Dai L, 2009, ELECTROPHORESIS, V30, P1119, DOI 10.1002/elps.200800505
   de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341
   Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60
   Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105
   Desiere F, 2005, GENOME BIOL, V6
   Deutsch EW, 2008, EMBO REP, V9, P429, DOI 10.1038/embor.2008.56
   Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772
   Ekins S, 2007, METH MOL B, V356, P319
   Ficenec David, 2003, Briefings in Bioinformatics, V4, P260, DOI 10.1093/bib/4.3.260
   Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960
   Futschik ME, 2007, BIOINFORMATICS, V23, P605, DOI 10.1093/bioinformatics/btl683
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Glatter T, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2008.75
   Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250
   Gough NR, 2002, ANN NY ACAD SCI, V971, P585, DOI 10.1111/j.1749-6632.2002.tb04532.x
   Grimes GR, 2006, BIOINFORMATICS, V22, P2055, DOI 10.1093/bioinformatics/btl342
   Guo A, 2008, P NATL ACAD SCI USA, V105, P692, DOI 10.1073/pnas.0707270105
   Hanke S, 2009, MOL CELL PROTEOMICS, V8, P519, DOI 10.1074/mcp.M800407-MCP200
   Hoffmann R, 2004, NAT GENET, V36, P664, DOI 10.1038/ng0704-664
   Holland RCG, 2008, BIOINFORMATICS, V24, P2096, DOI 10.1093/bioinformatics/btn397
   Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772
   Hosack DA, 2003, GENOME BIOL, V4, P4, DOI DOI 10.1186/GB-2003-4-6-P4
   Hsu PP, 2008, CELL, V134, P703, DOI 10.1016/j.cell.2008.08.021
   Hu ZJ, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-17
   Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828
   Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785
   Hur J, 2009, BIOINFORMATICS, V25, P838, DOI 10.1093/bioinformatics/btp049
   Jang CY, 2009, J CELL SCI, V122, P1334, DOI 10.1242/jcs.044321
   Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760
   Jones AME, 2009, J PROTEOMICS, V72, P439, DOI 10.1016/j.jprot.2009.02.004
   Jones P, 2008, NUCLEIC ACIDS RES, V36, pD878, DOI 10.1093/nar/gkm1021
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Kel A, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S2-S13
   Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958
   Kersey PJ, 2004, PROTEOMICS, V4, P1985, DOI 10.1002/pmic.200300721
   Khatri P, 2005, BIOINFORMATICS, V21, P3587, DOI 10.1093/bioinformatics/bti565
   Krallinger M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-S2-S8
   Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200
   Le Novere N, 2006, NUCLEIC ACIDS RES, V34, pD689, DOI 10.1093/nar/gkj092
   Lehne Benjamin, 2009, Human Genomics, V3, P291
   Letunic I, 2008, TRENDS BIOCHEM SCI, V33, P101, DOI 10.1016/j.tibs.2008.01.001
   Letunic I, 2009, NUCLEIC ACIDS RES, V37, pD229, DOI 10.1093/nar/gkn808
   Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j
   Linding R, 2007, CELL, V129, P1415, DOI 10.1016/j.cell.2007.05.052
   Lipscomb CE, 2000, B MED LIBR ASSOC, V88, P265
   Lucitt MB, 2008, MOL CELL PROTEOMICS, V7, P981, DOI 10.1074/mcp.M700382-MCP200
   Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551
   Mahrus S, 2008, CELL, V134, P866, DOI 10.1016/j.cell.2008.08.012
   Mathivanan S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-S5-S19
   Mawuenyega KG, 2003, J PROTEOME RES, V2, P23, DOI 10.1021/pr025551y
   McLaughlin T, 2006, NUCLEIC ACIDS RES, V34, pD649, DOI 10.1093/nar/gkj066
   Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433
   Minguez P, 2007, BIOINFORMATICS, V23, P3098, DOI 10.1093/bioinformatics/btm445
   Nagano K, 2009, PROTEOMICS, V9, P2861, DOI 10.1002/pmic.200800667
   Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026
   Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200
   Persico M, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-S4-S21
   Petronczki M, 2008, DEV CELL, V14, P646, DOI 10.1016/j.devcel.2008.04.014
   Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617
   Poulter GL, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-108
   Povey S, 2001, HUM GENET, V109, P678, DOI 10.1007/s00439-001-0615-0
   Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892
   Prieto C, 2006, NUCLEIC ACIDS RES, V34, pW298, DOI 10.1093/nar/gkl128
   Rebholz-Schuhmann D, 2007, BIOINFORMATICS, V23, pE237, DOI 10.1093/bioinformatics/btl302
   Salomonis N, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-217
   Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086
   Schaefer CF, 2009, NUCLEIC ACIDS RES, V37, pD674, DOI 10.1093/nar/gkn653
   Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146
   Schwartz D, 2009, MOL CELL PROTEOMICS, V8, P365, DOI 10.1074/mcp.M800332-MCP200
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Siepen JA, 2008, NUCLEIC ACIDS RES, V36, pW485, DOI 10.1093/nar/gkn196
   Stajich JE, 2002, GENOME RES, V12, P1611, DOI 10.1101/gr.361602
   Sugiyama N, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.32
   Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403
   Vailaya A, 2005, BIOINFORMATICS, V21, P430, DOI 10.1093/bioinformatics/bti187
   Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39
   Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104
   Waegele B, 2009, BIOINFORMATICS, V25, P141, DOI 10.1093/bioinformatics/btn590
   Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762
   Wilson-Grady JT, 2008, J PROTEOME RES, V7, P1088, DOI 10.1021/pr7006335
   Yeats C, 2008, NUCLEIC ACIDS RES, V36, pD414, DOI 10.1093/nar/gkm1019
   Yook SH, 2004, PROTEOMICS, V4, P928, DOI 10.1002/pmic.200300636
   Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858
   Zanivan S, 2008, J PROTEOME RES, V7, P5314, DOI 10.1021/pr800599n
   Zhai B, 2008, J PROTEOME RES, V7, P1675, DOI 10.1021/pr700696a
   Zhang LJ, 2007, J PROTEOME RES, V6, P34, DOI 10.1021/pr060069r
   Zlatkovic J, 2009, PROTEOMICS, V9, P1314, DOI 10.1002/pmic.200800718
   Zubarev RA, 2008, J PROTEOMICS, V71, P89, DOI 10.1016/j.jprot.2008.01.004
NR 112
TC 40
Z9 41
U1 1
U2 11
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD MAR
PY 2010
VL 10
IS 6
BP 1270
EP 1283
DI 10.1002/pmic.200900365
PG 14
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 579AG
UT WOS:000276337800019
PM 20077408
DA 2021-01-25
ER

PT J
AU Kapinos, LE
   Schumacher, J
   Mucke, N
   Machaidze, G
   Burkhard, P
   Aebi, U
   Strelkov, SV
   Herrmann, H
AF Kapinos, Larisa E.
   Schumacher, Jens
   Muecke, Norbert
   Machaidze, Gia
   Burkhard, Peter
   Aebi, Ueli
   Strelkov, Sergei V.
   Herrmann, Harald
TI Characterization of the Head-to-Tail Overlap Complexes Formed by Human
   Lamin A, B1 and B2 "Half-minflamin" Dimers
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE analytical ultracentrifugation; assembly; coiled coil; glycerol
   spraying/rotary metal shadowing electron microscopy; intermediate
   filaments
ID KERATIN INTERMEDIATE-FILAMENTS; NUCLEAR LAMIN; IN-VITRO;
   CAENORHABDITIS-ELEGANS; STRUCTURAL ELEMENTS; EXPRESSION PATTERN; CELL
   ARCHITECTURE; ATOMIC-STRUCTURE; BUILDING-BLOCKS; VIMENTIN
AB Half-minilamins, representing amino- and carboxy-terminal fragments of human lamins A, B1 and B2 with a truncated central rod domain, were investigated for their ability to form distinct head-to-tail-type dimer complexes. This mode of interaction represents an essential step in the longitudinal assembly reaction exhibited by full-length lamin dimers. As determined by analytical ultracentrifugation, the amino-terminal fragments were soluble under low ionic strength conditions sedimenting with distinct profiles and s-values (1.6-1.8 S) indicating the formation of coiled-coil dimers. The smaller carboxy-terminal fragments were, except for lamin B2, largely insoluble under these conditions. However, after equimolar amounts of homotypic amino- and carboxy-terminal lamin fragments had been mixed in 4 M urea, upon subsequent renaturation the carboxyterminal fragments were completely rescued from precipitation and distinct soluble complexes with higher s-values (2.3-2.7 S) were obtained. From this behavior, we conclude that the amino- and carboxy-terminal coiled-coil dimers interact to form distinct oligomers (i.e. tetramers). Furthermore, a corresponding interaction occurred also between heterotypic pairs of A- and B-type lamin fragments. Hence, A-type lamin dimers may interact with B-type lamin dimers head-to-tail to yield linear polymers. These findings indicate that a lamin dimer principally has the freedom for a "combinatorial" head-to-tail association with all types of lamins, a property that might be of significant importance for the assembly of the nuclear lamina. Furthermore, we suggest that the head-to-tail interaction of the rod end domains represents a principal step in the assembly of cytoplasmic intermediate filament proteins too. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Schumacher, Jens; Muecke, Norbert; Herrmann, Harald] German Canc Res Ctr, D-69120 Heidelberg, Germany.
   [Kapinos, Larisa E.; Machaidze, Gia; Aebi, Ueli] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Burkhard, Peter] Univ Connecticut, Inst Mat Sci, Storrs, CT 06269 USA.
   [Burkhard, Peter] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.
   [Strelkov, Sergei V.] Katholieke Univ Leuven, Dept Pharmaceut Sci, Leuven, Belgium.
RP Herrmann, H (corresponding author), German Canc Res Ctr, B065 Funct Architecture Cell, D-69120 Heidelberg, Germany.
EM h.herrmann@dkfz-heidelberg.de
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652
FU European CommissionEuropean CommissionEuropean Commission Joint Research
   Centre [LSHM-CT-2005-018690]; German-Israeli Foundation for Scientific
   Research and DevelopmentGerman-Israeli Foundation for Scientific
   Research and Development [915-111.13/2006]; K.U. LeuvenKU Leuven
   [/07/071]; M. E. Muller foundation; MHV-project [PMTDA-106174/1,
   2004-2005]
FX The authors gratefully acknowledge Ariel Lustig for help with the
   analytical ultracentrifugation and Tatjana Wedig for excellent technical
   assistance. U.A. and H.H. were supported by the ELTRO-Laminopathies
   research project of the European Commission (contract
   LSHM-CT-2005-018690). H.H. thanks the German-Israeli Foundation for
   Scientific Research and Development (GIF Grant No. 915-111.13/2006) for
   support. S.V.S. acknowledges the support of K.U. Leuven (OT grant
   /07/071). Moreover, U.A. received support from the M. E. Muller
   foundation and the MHV-project (Marie Heim-Vogtlin Program/SNF:
   PMTDA-106174/1, 2004-2005).
CR AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   Alsheimer M, 1996, EXP CELL RES, V228, P181, DOI 10.1006/excr.1996.0315
   Alsheimer M, 1998, J CELL SCI, V111, P2227
   Ben-Harush K, 2009, J MOL BIOL, V386, P1392, DOI 10.1016/j.jmb.2008.12.024
   Colakoglu G, 2009, J CELL BIOL, V185, P769, DOI 10.1083/jcb.200809166
   DESSEV G, 1991, J CELL BIOL, V112, P523, DOI 10.1083/jcb.112.4.523
   Erber A, 1999, J MOL EVOL, V49, P260, DOI 10.1007/PL00006548
   Foeger N, 2006, J STRUCT BIOL, V155, P340, DOI 10.1016/j.jsb.2006.03.026
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2
   GIEFFERS C, 1991, EUR J CELL BIOL, V55, P191
   Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485
   HEITLINGER E, 1992, J STRUCT BIOL, V108, P74, DOI 10.1016/1047-8477(92)90009-Y
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 2000, CURR OPIN CELL BIOL, V12, P79, DOI 10.1016/S0955-0674(99)00060-5
   Herrmann H, 2003, CELL MOL LIFE SCI, V60, P1607, DOI 10.1007/s00018-003-3004-0
   HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X
   Herrmann H, 1999, CELL MOL LIFE SCI, V55, P1416, DOI 10.1007/s000180050382
   Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   Herrmann H, 2009, J CLIN INVEST, V119, P1772, DOI 10.1172/JCI38214
   Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950
   Isobe K, 2007, BIOSCI BIOTECH BIOCH, V71, P1252, DOI 10.1271/bbb.60674
   Karabinos A, 2003, J MOL BIOL, V325, P241, DOI 10.1016/S0022-2836(02)01240-8
   Krohne G, 1998, Subcell Biochem, V31, P563
   Machaidze Gia, 2006, Journal of Biological Physics and Chemistry, V6, P91
   Margalit A, 2005, J CELL BIOCHEM, V95, P454, DOI 10.1002/jcb.20433
   McKeon F, 1991, CURR OPIN CELL BIOL, V3, P82, DOI 10.1016/0955-0674(91)90169-Y
   Meier M, 2009, J MOL BIOL, V390, P245, DOI 10.1016/j.jmb.2009.04.067
   Moir RD, 1995, INT REV CYTOL, V162B, P141
   Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   PETER M, 1991, EMBO J, V10, P1535, DOI 10.1002/j.1460-2075.1991.tb07673.x
   Philo JS, 2000, ANAL BIOCHEM, V279, P151, DOI 10.1006/abio.2000.4480
   Sasse B, 1997, EUR J BIOCHEM, V250, P30, DOI 10.1111/j.1432-1033.1997.t01-1-00030.x
   Sasse B, 1998, J STRUCT BIOL, V123, P56, DOI 10.1006/jsbi.1998.4006
   Schirmer EC, 2004, J BIOL CHEM, V279, P42811, DOI 10.1074/jbc.M407705200
   Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176
   Schirmer EC, 2001, J CELL BIOL, V153, P479, DOI 10.1083/jcb.153.3.479
   Shimi T, 2008, GENE DEV, V22, P3409, DOI 10.1101/gad.1735208
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2004, METHOD CELL BIOL, V78, P25
   Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   Stuurman N, 1996, J STRUCT BIOL, V117, P1, DOI 10.1006/jsbi.1996.0064
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   Vlcek S, 2001, CELL MOL LIFE SCI, V58, P1758, DOI 10.1007/PL00000815
   Wang H, 2000, J CELL BIOL, V151, P1459, DOI 10.1083/jcb.151.7.1459
   WEBER K, 1991, BIOCHEM SOC T, V19, P1021, DOI 10.1042/bst0191021
   Wiesel N, 2008, P NATL ACAD SCI USA, V105, P180, DOI 10.1073/pnas.0708974105
   Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679
NR 55
TC 51
Z9 51
U1 0
U2 6
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD FEB 26
PY 2010
VL 396
IS 3
BP 719
EP 731
DI 10.1016/j.jmb.2009.12.001
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 565XC
UT WOS:000275328500023
PM 20004208
DA 2021-01-25
ER

PT J
AU Podvinec, M
   Lim, SP
   Schmidt, T
   Scarsi, M
   Wen, DY
   Sonntag, LS
   Sanschagrin, P
   Shenkin, PS
   Schwede, T
AF Podvinec, Michael
   Lim, Siew Pheng
   Schmidt, Tobias
   Scarsi, Marco
   Wen, Daying
   Sonntag, Louis-Sebastian
   Sanschagrin, Paul
   Shenkin, Peter S.
   Schwede, Torsten
TI Novel Inhibitors of Dengue Virus Methyltransferase: Discovery by in
   Vitro-Driven Virtual Screening on a Desktop Computer Grid
SO JOURNAL OF MEDICINAL CHEMISTRY
LA English
DT Article
ID HIGH-THROUGHPUT; MESSENGER-RNA; HEMORRHAGIC-FEVER; STRUCTURAL BASIS;
   FORCE-FIELD; NS5; SINEFUNGIN; METHYLATION; DETERGENT; DOCKING
AB Dengue fever is a viral disease that affects 50-100 million people annually and is one of the most important emerging Infectious diseases ill many areas of the world. Currently, neither specific drugs nor vaccines are available. Here, we report oil the discovery of new inhibitors of the viral NS5 RNA methyltransferase, a promising flavivirus drug target. We have used a multistage molecular docking approach to screen a library of more than 5 million commercially available compounds against the two binding sites of this enzyme. In 263 compounds chosen for experimental verification, WC found 10 inhibitors with IC50 values of < 100 mu M, of which four exhibited IC50 values of < 10 mu M in in vitro assays. The initial lilt list also contained 25 nonspecific aggregators. We discuss why this likely occurred for this particular target. We also describe our attempts to use aggregation Prediction to further guide the study, following this finding.
C1 [Podvinec, Michael; Schmidt, Tobias; Scarsi, Marco; Schwede, Torsten] Univ Basel, Swiss Inst Bioinformat & Biozentrum, CH-4056 Basel, Switzerland.
   [Lim, Siew Pheng; Wen, Daying; Sonntag, Louis-Sebastian] Novartis Inst Trop Dis, Singapore 138670, Singapore.
   [Sanschagrin, Paul; Shenkin, Peter S.] Schrodinger LLC, New York, NY 10036 USA.
RP Schwede, T (corresponding author), Univ Basel, Swiss Inst Bioinformat & Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Lim, Siew Pheng/P-8528-2016; Schwede, Torsten/A-4650-2008; Sanschagrin,
   Paul/G-2179-2011
OI Schwede, Torsten/0000-0003-2715-335X; Sanschagrin,
   Paul/0000-0003-4074-4066; Lim, Siew Pheng/0000-0002-7377-5662
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Babaoglu K, 2008, J MED CHEM, V51, P2502, DOI 10.1021/jm701500e
   Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895
   Benarroch D, 2004, J BIOL CHEM, V279, P35638, DOI 10.1074/jbc.M400460200
   Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324
   Chang MW, 2007, J CHEM INF MODEL, V47, P1258, DOI 10.1021/ci700044s
   CLEAVES GR, 1979, VIROLOGY, V96, P159, DOI 10.1016/0042-6822(79)90181-8
   Copeland R.A., 2005, EVALUATION ENZYME IN
   Dong HP, 2008, ANTIVIR RES, V80, P1, DOI 10.1016/j.antiviral.2008.05.003
   Dunham EJ, 2007, J MOL EVOL, V64, P656, DOI 10.1007/s00239-006-0278-5
   Egloff MP, 2007, J MOL BIOL, V372, P723, DOI 10.1016/j.jmb.2007.07.005
   Egloff MP, 2002, EMBO J, V21, P2757, DOI 10.1093/emboj/21.11.2757
   Fauman EB, 1999, S ADENOSYLMETHIONINE, P1, DOI DOI 10.1142/9789812813077_0001
   Feng BY, 2006, NAT PROTOC, V1, P550, DOI 10.1038/nprot.2006.77
   Feng BY, 2007, J MED CHEM, V50, P2385, DOI 10.1021/jm061317y
   Feng BY, 2005, NAT CHEM BIOL, V1, P146, DOI 10.1038/nchembio718
   FINNEY DJ, 1976, BIOMETRICS, V32, P721, DOI 10.2307/2529258
   Furuichi Y, 2000, ADV VIRUS RES, V55, P135, DOI 10.1016/S0065-3527(00)55003-9
   Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X
   Guzman MG, 2003, J CLIN VIROL, V27, P1, DOI 10.1016/S1386-6532(03)00010-6
   Halgren TA, 1996, J COMPUT CHEM, V17, P490, DOI 10.1002/(SICI)1096-987X(199604)17:5/6<490::AID-JCC1>3.0.CO;2-P
   Hodel AE, 1998, MOL CELL, V1, P443, DOI 10.1016/S1097-2765(00)80044-1
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   Irwin JJ, 2005, J CHEM INF MODEL, V45, P177, DOI 10.1021/ci049714+
   Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760
   Kasam V, 2007, J CHEM INF MODEL, V47, P1818, DOI 10.1021/ci600451t
   Lim SP, 2008, ANTIVIR RES, V80, P360, DOI 10.1016/j.antiviral.2008.08.005
   Luzhkov VB, 2007, BIOORGAN MED CHEM, V15, P7795, DOI 10.1016/j.bmc.2007.08.049
   Milani M, 2009, ANTIVIR RES, V83, P28, DOI 10.1016/j.antiviral.2009.03.001
   Morens DM, 2008, JAMA-J AM MED ASSOC, V299, P214, DOI 10.1001/jama.2007.31-a
   Mukhopadhyay S, 2005, NAT REV MICROBIOL, V3, P13, DOI 10.1038/nrmicro1067
   Padmanabhan R, 2006, Novartis Found Symp, V277, P74, DOI 10.1002/0470058005.ch6
   Perera R, 2008, CURR OPIN MICROBIOL, V11, P369, DOI 10.1016/j.mib.2008.06.004
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   Podvinec M, 2008, COMPUTATIONAL STRUCT, P683
   Ray D, 2006, J VIROL, V80, P8362, DOI 10.1128/JVI.00814-06
   RODBARD D, 1974, S RIA RELATED PROCED, P165
   Ryan AJ, 2003, J MED CHEM, V46, P3448, DOI 10.1021/jm0340896
   Sanner MF, 1996, BIOPOLYMERS, V38, P305, DOI 10.1002/(SICI)1097-0282(199603)38:3<305::AID-BIP4>3.3.CO;2-8
   Seidler J, 2003, J MED CHEM, V46, P4477, DOI 10.1021/jm030191r
   Shoichet BK, 2006, J MED CHEM, V49, P7274, DOI 10.1021/jm061103g
   Shoichet BK, 2006, DRUG DISCOV TODAY, V11, P607, DOI 10.1016/j.drudis.2006.05.014
   Thomas O, 1902, P ZOOL SOC LOND, V1902, P2
   Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010
   VEDEL M, 1978, BIOCHEM BIOPH RES CO, V85, P371, DOI 10.1016/S0006-291X(78)80052-7
   Wang QY, 2009, ANTIMICROB AGENTS CH, V53, P1823, DOI 10.1128/AAC.01148-08
   Whitehead SS, 2007, NAT REV MICROBIOL, V5, P518, DOI 10.1038/nrmicro1690
   World Health Organization, 1997, DENG HAEM FEV DIAGN
   YEBRA MJ, 1991, J ANTIBIOT, V44, P1141, DOI 10.7164/antibiotics.44.1141
   ZHANG W, 2006, 5 INT C GRID COOP CO
   Zhou YS, 2007, J VIROL, V81, P3891, DOI 10.1128/JVI.02704-06
   ZWEYGARTH E, 1986, TROP MED PARASITOL, V37, P255
   DTP 2D 3D STRUCTURAL
   PDB ENTRIES 1L9K 2PI
   DENGUE DENGUE HEMORR
   DENGUE DENGUE HAEMOR
NR 56
TC 49
Z9 50
U1 0
U2 18
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0022-2623
EI 1520-4804
J9 J MED CHEM
JI J. Med. Chem.
PD FEB 25
PY 2010
VL 53
IS 4
BP 1483
EP 1495
DI 10.1021/jm900776m
PG 13
WC Chemistry, Medicinal
SC Pharmacology & Pharmacy
GA 556HN
UT WOS:000274581200007
PM 20108931
DA 2021-01-25
ER

PT J
AU Kolassa, IT
   Kolassa, S
   Ertl, V
   Papassotiropoulos, A
   De Quervain, DJF
AF Kolassa, Iris-Tatjana
   Kolassa, Stephan
   Ertl, Verena
   Papassotiropoulos, Andreas
   De Quervain, Dominique J. -F.
TI The Risk of Posttraumatic Stress Disorder After Trauma Depends on
   Traumatic Load and the Catechol-O-Methyltransferase Val(158)Met
   Polymorphism
SO BIOLOGICAL PSYCHIATRY
LA English
DT Article
DE COMT polymorphism; genetic polymorphisms; post-traumatic stress
   disorder; refugees; risk
ID FUNCTIONAL POLYMORPHISM; COMT VAL(158)MET; GENE; GENOTYPE; ANXIETY;
   AMYGDALA; PHARMACOGENETICS; RESPONSES; STIMULI; VARIANT
AB Background: The risk for posttraumatic stress disorder (PTSD) depends on the number of traumatic event types experienced in a dose-response relationship, but genetic factors are known to also influence the risk of PTSD. The catechol-O-methyltransferase (COMT) Val158Met polymorphism has been found to affect fear extinction and might play a role in the etiology of anxiety disorders.
   Methods: Traumatic load and lifetime and current diagnosis of PTSD and COMT genotype were assessed in a sample of 424 survivors of the Rwandan Genocide living in the Nakivale refugee camp in southwestern Uganda.
   Results: Higher numbers of different lifetime traumatic event types led to a higher prevalence of lifetime PTSD in a dose-response relationship. However, this effect was modulated by the COMT genotype: whereas Val allele carriers showed the typical dose-response relationship, Met/Met homozygotes exhibited a high risk for PTSD independently of the severity of traumatic load.
   Conclusions: The present findings indicate a gene-environment interaction between the human COMT Val158Met polymorphism and the number of traumatic event types experienced in the risk of developing PTSD.
C1 [Kolassa, Iris-Tatjana; Ertl, Verena] Univ Konstanz, D-78457 Constance, Germany.
   [Kolassa, Stephan] Simulat Anal & Forecasting AG, Res & Innovat, Tagerwilen, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Div Mol Psychol, Basel, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Life Sci Training Facil, Biozentrum, Basel, Switzerland.
   [De Quervain, Dominique J. -F.] Univ Basel, Div Cognit Neurosci, Basel, Switzerland.
   [De Quervain, Dominique J. -F.] Univ Basel, Psychiat Univ Clin, Basel, Switzerland.
RP Kolassa, IT (corresponding author), Univ Konstanz, Univ Str 10, D-78457 Constance, Germany.
EM Iris.Kolassa@uni-konstanz.de
RI Kolassa, Iris Tatjana/Y-3032-2018
OI Papassotiropoulos, Andreas/0000-0002-2210-9651; Kolassa,
   Stephan/0000-0001-9393-0765; de Quervain, Dominique/0000-0001-7131-2464
FU German Research Foundation (DFG)German Research Foundation (DFG); Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
   [PP00P3-123391, GRSIK0_122691, PP00P3-114813]; European Science
   FoundationEuropean Science Foundation (ESF); University of Konstanz
FX This study funded by the German Research Foundation (DFG), grants from
   the Swiss National Science Foundation to DQ and AP (PP00P3-123391;
   GRSIK0_122691; PP00P3-114813) and from the European Science Foundation
   (EUROStress), and a stipend of the Zukunftskolleg of the University of
   Konstanz awarded to ITK. The authors ITK and DQ designed the experiment.
   The author VE supervised data collection; AP and DQ performed the
   genetic analyses; ITK and SK performed the statistical analyses and
   wrote the manuscript. All authors commented on and approved the final
   manuscript. We would like to thank Cindy Eckart and Franka Glockner for
   support in data collection and Thomas Elbert for valuable support in all
   stages of this study.
CR American Psychiatric Association, 2000, DIAGN STAT MAN MENT
   Baekken PM, 2008, BMC PSYCHIATRY, V8, DOI 10.1186/1471-244X-8-48
   Barnett JH, 2008, BIOL PSYCHIAT, V64, P137, DOI 10.1016/j.biopsych.2008.01.005
   Bilder RM, 2004, NEUROPSYCHOPHARMACOL, V29, P1943, DOI 10.1038/sj.npp.1300542
   Broekman BFP, 2007, NEUROSCI BIOBEHAV R, V31, P348, DOI 10.1016/j.neubiorev.2006.10.001
   Caspi A, 2005, BIOL PSYCHIAT, V57, P1117, DOI 10.1016/j.biopsych.2005.01.026
   Caspi A, 2006, NAT REV NEUROSCI, V7, P583, DOI 10.1038/nrn1925
   Craddock N, 2006, MOL PSYCHIATR, V11, P446, DOI 10.1038/sj.mp.4001808
   de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945
   DEROGATIS LR, 1974, BEHAV SCI, V19, P1, DOI 10.1002/bs.3830190102
   Drabant EM, 2006, ARCH GEN PSYCHIAT, V63, P1396, DOI 10.1001/archpsyc.63.12.1396
   Enoch MA, 2003, PSYCHIAT GENET, V13, P33, DOI 10.1097/00041444-200303000-00006
   Foa EB, 1997, PSYCHOL ASSESSMENT, V9, P445, DOI 10.1037/1040-3590.9.4.445
   Good P., 2005, PERMUTATION PARAMETR
   Harrell F, 2001, REGRESSION MODELING
   Heinz A, 2006, REV NEUROSCIENCE, V17, P359
   Hosak L, 2007, EUR PSYCHIAT, V22, P276, DOI 10.1016/j.eurpsy.2007.02.002
   Kendler KS, 2005, AM J PSYCHIAT, V162, P1243, DOI 10.1176/appi.ajp.162.7.1243
   KOLASSA IT, J CLIN PSYC IN PRESS
   KOLASSA IT, PSYCH TRAUMA T UNPUB
   Lachman HM, 1996, PHARMACOGENETICS, V6, P243, DOI 10.1097/00008571-199606000-00007
   Lee HJ, 2005, DEPRESS ANXIETY, V21, P135, DOI 10.1002/da.20064
   Lonsdorf TB, 2009, PSYCHOL SCI, V20, P198, DOI 10.1111/j.1467-9280.2009.02280.x
   Lu BY, 2007, BIOL PSYCHIAT, V62, P822, DOI 10.1016/j.biopsych.2006.11.030
   Malhotra AK, 2002, AM J PSYCHIAT, V159, P652, DOI 10.1176/appi.ajp.159.4.652
   McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157
   Montag C, 2008, BEHAV NEUROSCI, V122, P901, DOI 10.1037/0735-7044.122.4.901
   Neuner F, 2008, J CONSULT CLIN PSYCH, V76, P686, DOI 10.1037/0022-006X.76.4.686
   Neuner F, 2004, BMC PSYCHIATRY, V4, DOI 10.1186/1471-244X-4-34
   Nugent NR, 2008, AM J MED GENET C, V148C, P127, DOI 10.1002/ajmg.c.30169
   Ohara K, 1998, NEUROREPORT, V9, P1305, DOI 10.1097/00001756-199805110-00009
   Olsson CA, 2007, GENES BRAIN BEHAV, V6, P647, DOI 10.1111/j.1601-183X.2007.00313.x
   Onur OA, 2009, SOC COGN AFFECT NEUR, V4, P119, DOI 10.1093/scan/nsn049
   ONYUT LP, 2004, INTERVENTION, V2, P90
   Palmatier MA, 1999, BIOL PSYCHIAT, V46, P557, DOI 10.1016/S0006-3223(99)00098-0
   Palmatier MA, 2004, MOL PSYCHIATR, V9, P859, DOI 10.1038/sj.mp.4001496
   R Core Team, 2017, R LANG ENV STAT COMP
   Segman RH, 2003, CNS SPECTRUMS, V8, P693, DOI 10.1017/S1092852900008889
   Smolka MN, 2005, J NEUROSCI, V25, P836, DOI 10.1523/JNEUROSCI.1792-04.2005
   Thapar A, 2005, ARCH GEN PSYCHIAT, V62, P1275, DOI 10.1001/archpsyc.62.11.1275
   TRUE WR, 1993, ARCH GEN PSYCHIAT, V50, P257, DOI 10.1001/archpsyc.1993.01820160019002
   Weinshilboum RM, 1999, ANNU REV PHARMACOL, V39, P19, DOI 10.1146/annurev.pharmtox.39.1.19
   Xu K, 2006, NEUROINFORMATICS, V4, P51, DOI 10.1385/NI:4:1:51
   Yehuda R, 2007, NEURON, V56, P19, DOI 10.1016/j.neuron.2007.09.006
   Zubieta JK, 2003, SCIENCE, V299, P1240, DOI 10.1126/science.1078546
NR 45
TC 172
Z9 178
U1 0
U2 27
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0006-3223
EI 1873-2402
J9 BIOL PSYCHIAT
JI Biol. Psychiatry
PD FEB 15
PY 2010
VL 67
IS 4
BP 304
EP 308
DI 10.1016/j.biopsych.2009.10.009
PG 5
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 554RC
UT WOS:000274451100003
PM 19944409
DA 2021-01-25
ER

PT J
AU Ma, J
   Flemr, M
   Stein, P
   Berninger, P
   Malik, R
   Zavolan, M
   Svoboda, P
   Schultz, RM
AF Ma, Jun
   Flemr, Matyas
   Stein, Paula
   Berninger, Philipp
   Malik, Radek
   Zavolan, Mihaela
   Svoboda, Petr
   Schultz, Richard M.
TI MicroRNA Activity Is Suppressed in Mouse Oocytes
SO CURRENT BIOLOGY
LA English
DT Article
ID EMBRYONIC STEM-CELLS; MEIOTIC MATURATION; GENE-EXPRESSION;
   MESSENGER-RNAS; TRANSCRIPTS; DEGRADATION; TARGETS; DICER
AB MicroRNAs (miRNAs) are small endogenous RNAs that typically imperfectly base pair with 3' untranslated regions (3'UTRs) and mediate translational repression and mRNA degradation. Dicer, which generates small RNAs in the miRNA and RNA interference (RNAi) pathways, is essential for meiotic maturation of mouse oocytes. We found that 3'UTRs of transcripts upregulated in Dicer1(-/-) oocytes are not enriched in miRNA binding sites, implicating a weak impact of miRNAs on the maternal transcriptome. Therefore, we tested the ability of endogenous miRNAs to mediate RNA-like cleavage or translational repression of reporter mRNAs. In contrast to somatic cells, endogenous miRNAs in oocytes poorly repressed translation of mRNA reporters, whereas their RNAi-like activity was much less affected. Reporter mRNA carrying let-7-binding sites failed to localize to P body-like structures in oocytes. Our data suggest that miRNA function is downregulated during oocyte development, an idea supported by normal melotic maturation of oocytes lacking Dgcr8, which is required for the miRNA but not the RNAi pathway (Suh et al. [1], this issue of Current Biology). Suppressing miRNA function during oocyte growth is likely an early event in reprogramming gene expression during the transition of a differentiated oocyte into pluripotent blastomeres of the embryo.
C1 [Flemr, Matyas; Malik, Radek; Svoboda, Petr] Acad Sci Czech Republic, Inst Mol Genet, CR-14220 Prague 4, Czech Republic.
   [Ma, Jun; Stein, Paula; Schultz, Richard M.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.
   [Berninger, Philipp; Zavolan, Mihaela] Univ Basel, Div Bioinformat, Biozentrum, CH-4056 Basel, Switzerland.
   [Berninger, Philipp; Zavolan, Mihaela] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Svoboda, P (corresponding author), Acad Sci Czech Republic, Inst Mol Genet, Videnska 1083, CR-14220 Prague 4, Czech Republic.
EM svobodap@img.cas.cz; rschultz@sas.upenn.edu
RI Zavolan, Mihaela/S-3888-2016; Svoboda, Petr/AAC-1501-2020; Svoboda,
   Petr/G-3890-2012; Malik, Radek/G-3578-2014; Stein, Paula/ABE-9388-2020
OI Svoboda, Petr/0000-0002-4370-3705; Malik, Radek/0000-0002-6783-1146;
   Stein, Paula/0000-0002-2040-4593; Zavolan, Mihaela/0000-0002-8832-2041
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [HD22681]; EMBO SDIG [1483]; GACRGrant
   Agency of the Czech Republic [P305/10/2215]; Kontakt [ME09039]; Purkinje
   Fellowship; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &
   HUMAN DEVELOPMENTUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy
   Shriver National Institute of Child Health & Human Development (NICHD)
   [R01HD022681, R01HD022681, R01HD022681, R01HD022681, R01HD022681,
   R01HD022681] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER
   NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENTUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH Eunice Kennedy Shriver National Institute of Child Health &
   Human Development (NICHD) [R01HD022681, R37HD022681, R37HD022681,
   R01HD022681, R37HD022681, R37HD022681, R01HD022681, R01HD022681,
   R01HD022681, R01HD022681, R01HD022681, R01HD022681, R01HD022681,
   R37HD022681, R37HD022681, R01HD022681, R01HD022681, R01HD022681,
   R01HD022681, R01HD022681, R01HD022681, R01HD022681, R37HD022681,
   R01HD022681, R37HD022681, R37HD022681, R01HD022681, R01HD022681,
   R01HD022681, R37HD022681, R01HD022681] Funding Source: NIH RePORTER
FX We thank G.J. Hannon for conditional Dicerl knockout mice and firefly
   luciferase let-7 reporters, W. Filipowicz for Renilla luciferase let-7
   reporters, and F. Duncan for help in preparing the RNA samples for
   microarray analysis. This research was supported by NIH grant HD22681 to
   R.M.S., EMBO SDIG project 1483, GACR P305/10/2215, Kontakt ME09039, and
   the Purkinje Fellowship to P.S.
CR Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104
   CHATOT CL, 1989, J REPROD FERTIL, V86, P679, DOI 10.1530/jrf.0.0860679
   Flemr M, 2010, BIOL REPROD, V82, P1008, DOI 10.1095/biolreprod.109.082057
   Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689
   Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112
   Gunaratne PH, 2009, CURR STEM CELL RES T, V4, P168, DOI 10.2174/157488809789057400
   Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706
   Kaneda M, 2009, EPIGENET CHROMATIN, V2, DOI 10.1186/1756-8935-2-9
   KURASAWA S, 1989, DEV BIOL, V133, P295, DOI 10.1016/0012-1606(89)90320-5
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Linsen SEV, 2009, NAT METHODS, V6, P474, DOI 10.1038/nmeth0709-474
   Liu JD, 2005, NAT CELL BIOL, V7, P719, DOI 10.1038/ncb1274
   Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020
   Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307
   Pan H, 2005, DEV BIOL, V286, P493, DOI 10.1016/j.ydbio.2005.08.023
   Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079
   Puschendorf M, 2006, BIOCHEM BIOPH RES CO, V347, P36, DOI 10.1016/j.bbrc.2006.06.106
   Salisbury J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007479
   Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646
   SCHULTZ RM, 1983, DEV BIOL, V97, P264, DOI 10.1016/0012-1606(83)90085-4
   Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391
   Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008
   Suh N, 2010, CURR BIOL, V20, P271, DOI 10.1016/j.cub.2009.12.044
   Svoboda P, 2001, BIOCHEM BIOPH RES CO, V287, P1099, DOI 10.1006/bbrc.2001.5707
   Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904
   Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707
   van Dongen S, 2008, NAT METHODS, V5, P1023, DOI 10.1038/nmeth.1267
   Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908
   Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018
NR 30
TC 159
Z9 163
U1 0
U2 20
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD FEB 9
PY 2010
VL 20
IS 3
BP 265
EP 270
DI 10.1016/j.cub.2009.12.042
PG 6
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 556FC
UT WOS:000274574100034
PM 20116252
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Groves, E
   Rittinger, K
   Amstutz, M
   Berry, S
   Holden, DW
   Cornelis, GR
   Caron, E
AF Groves, Eleanor
   Rittinger, Katrin
   Amstutz, Marlise
   Berry, Sara
   Holden, David W.
   Cornelis, Guy R.
   Caron, Emmanuelle
TI Sequestering of Rac by the Yersinia Effector YopO Blocks Fc gamma
   Receptor-mediated Phagocytosis
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID PROTEIN-KINASE-A; RHO-GTPASES; PLASMA-MEMBRANE; SER/THR KINASE;
   ACTIN-BINDING; INNER SURFACE; ACTIVATION; VIRULENCE; TARGET;
   IDENTIFICATION
AB Pathogenic Yersinia species neutralize innate immune mechanisms by injecting type three secretion effectors into immune cells, altering cell signaling. Our study elucidates how one of these effectors, YopO, blocks phagocytosis. We demonstrate using different phagocytic models that YopO specifically blocks Rac-dependent Fc gamma receptor internalization pathway but not complement receptor 3-dependent uptake, which is controlled by Rho activity. We show that YopO prevents Rac activation but does not affect Rac accumulation at the phagocytic cup. In addition, we show that plasma membrane localization and the guanine-nucleotide dissociation inhibitor (GDI)-like domain of YopO cooperate for maximal anti-phagocytosis. Although YopO has the same affinity for Rac1, Rac2, and RhoA in vitro, it selectively interacts with Rac isoforms in cells. This is due to the differential localization of the Rho family G proteins in resting cells; Rac isoforms partially exist as a GDI-free pool at the membrane of resting cells, whereas RhoA is trapped in the cytosol by RhoGDI alpha. We propose that YopO exploits this basic difference in localization and availability to selectively inhibit Rac-dependent phagocytosis.
C1 [Caron, Emmanuelle] Univ London Imperial Coll Sci Technol & Med, Ctr Mol Microbiol & Infect, London SW7 2AZ, England.
   [Rittinger, Katrin] Natl Inst Med Res, Div Mol Struct, London NW7 1AA, England.
   [Amstutz, Marlise; Cornelis, Guy R.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Groves, E (corresponding author), Univ London Imperial Coll Sci Technol & Med, CMMI2, Flowers Bldg, London SW15 3SH, England.
EM e.groves@imperial.ac.uk
RI Rittinger, Katrin/D-2586-2014; Rittinger, Katrin/N-3344-2019
OI Rittinger, Katrin/0000-0002-7698-4435; Rittinger,
   Katrin/0000-0002-7698-4435
FU Medical Research Council studentshipMedical Research Council UK (MRC);
   Medical Research Council and the Biotechnology and Biological Sciences
   Council; Medical Research CouncilMedical Research Council UK (MRC)
   [MC_U117565398, G0800148] Funding Source: researchfish
FX This work was supported by Medical Research Council studentship (to E.
   G.) and a core grant (to K. R.). Work in the Caron laboratory was funded
   by grants from the Medical Research Council and the Biotechnology and
   Biological Sciences Council.
CR ADAMSON P, 1992, J CELL BIOL, V119, P617, DOI 10.1083/jcb.119.3.617
   Alrutz MA, 2001, MOL MICROBIOL, V42, P689, DOI 10.1046/j.1365-2958.2001.02676.x
   Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031
   Barz C, 2000, FEBS LETT, V482, P139, DOI 10.1016/S0014-5793(00)02045-7
   Bijlmakers MJJE, 1997, J CELL BIOL, V137, P1029, DOI 10.1083/jcb.137.5.1029
   Booth JW, 2001, SEMIN IMMUNOL, V13, P357, DOI 10.1006/smim.2001.0332
   Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   Cougoule C, 2006, J BIOL CHEM, V281, P8756, DOI 10.1074/jbc.M513731200
   DerMardirossian C, 2005, TRENDS CELL BIOL, V15, P356, DOI 10.1016/j.tcb.2005.05.001
   Dukuzumuremyi JM, 2000, J BIOL CHEM, V275, P35281, DOI 10.1074/jbc.M003009200
   Finlay BB, 2005, CURR TOP MICROBIOL, V291, P1
   Gorvel JP, 1998, FEBS LETT, V422, P269, DOI 10.1016/S0014-5793(98)00020-9
   GRIFFIN FM, 1975, J EXP MED, V142, P1263, DOI 10.1084/jem.142.5.1263
   Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002
   Groves E, 2008, CELL MOL LIFE SCI, V65, P1957, DOI 10.1007/s00018-008-7578-4
   Hakansson S, 1996, MOL MICROBIOL, V20, P593, DOI 10.1046/j.1365-2958.1996.5251051.x
   Juris SJ, 2000, P NATL ACAD SCI USA, V97, P9431, DOI 10.1073/pnas.170281997
   Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202
   Marches O, 2008, CELL MICROBIOL, V10, P1104, DOI 10.1111/j.1462-5822.2007.01112.x
   Marketon MM, 2005, SCIENCE, V309, P1739, DOI 10.1126/science.1114580
   May RC, 2000, NAT CELL BIOL, V2, P246
   Michaelson D, 2001, J CELL BIOL, V152, P111, DOI 10.1083/jcb.152.1.111
   Navarro L, 2007, MOL CELL, V26, P465, DOI 10.1016/j.molcel.2007.04.025
   Nejedlik L, 2004, YEAST, V21, P759, DOI 10.1002/yea.1135
   Park H, 2007, J IMMUNOL, V178, P6426, DOI 10.4049/jimmunol.178.10.6426
   Patel JC, 2000, METHOD ENZYMOL, V325, P462
   Prehna G, 2006, CELL, V126, P869, DOI 10.1016/j.cell.2006.06.056
   Reid T, 1996, J BIOL CHEM, V271, P13556, DOI 10.1074/jbc.271.23.13556
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Swanson JA, 2008, NAT REV MOL CELL BIO, V9, P639, DOI 10.1038/nrm2447
   Thompson G, 1998, BIOCHEMISTRY-US, V37, P7885, DOI 10.1021/bi980140+
   Trasak C, 2007, J BIOL CHEM, V282, P2268, DOI 10.1074/jbc.M610071200
   Wheeler AP, 2006, J CELL SCI, V119, P2749, DOI 10.1242/jcs.03024
   Wiedemann AS, 2006, J CELL BIOL, V172, P1069, DOI 10.1083/jcb.200508075
   Wiley DJ, 2006, MICROB PATHOGENESIS, V40, P234, DOI 10.1016/j.micpath.2006.02.001
   Yamauchi A, 2004, J IMMUNOL, V173, P5971, DOI 10.4049/jimmunol.173.10.5971
   Yeung T, 2006, SCIENCE, V313, P347, DOI 10.1126/science.1129551
NR 38
TC 30
Z9 30
U1 0
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD FEB 5
PY 2010
VL 285
IS 6
BP 4087
EP 4098
DI 10.1074/jbc.M109.071035
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 564YF
UT WOS:000275254000061
PM 19926792
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Rauskolb, S
   Zagrebelsky, M
   Dreznjak, A
   Deogracias, R
   Matsumoto, T
   Wiese, S
   Erne, B
   Sendtner, M
   Schaeren-Wiemers, N
   Korte, M
   Barde, YA
AF Rauskolb, Stefanie
   Zagrebelsky, Marta
   Dreznjak, Anita
   Deogracias, Ruben
   Matsumoto, Tomoya
   Wiese, Stefan
   Erne, Beat
   Sendtner, Michael
   Schaeren-Wiemers, Nicole
   Korte, Martin
   Barde, Yves-Alain
TI Global Deprivation of Brain-Derived Neurotrophic Factor in the CNS
   Reveals an Area-Specific Requirement for Dendritic Growth
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID PRIMARY SENSORY NEURONS; LONG-TERM POTENTIATION; FACTOR MESSENGER-RNA;
   NERVE GROWTH; CONDITIONAL DELETION; DOPAMINERGIC-NEURONS;
   SUBSTANTIA-NIGRA; RAT HIPPOCAMPUS; IN-SITU; BDNF
AB Although brain-derived neurotrophic factor (BDNF) is linked with an increasing number of conditions causing brain dysfunction, its role in the postnatal CNS has remained difficult to assess. This is because the bdnf-null mutation causes the death of the animals before BDNF levels have reached adult levels. In addition, the anterograde axonal transport of BDNF complicates the interpretation of area-specific gene deletion. The present study describes the generation of a new conditional mouse mutant essentially lacking BDNF throughout the CNS. It shows that BDNF is not essential for prolonged postnatal survival, but that the behavior of such mutant animals is markedly altered. It also reveals that BDNF is not a major survival factor for most CNS neurons and for myelination of their axons. However, it is required for the postnatal growth of the striatum, and single-cell analyses revealed a marked decreased in dendritic complexity and spine density. In contrast, BDNF is dispensable for the growth of the hippocampus and only minimal changes were observed in the dendrites of CA1 pyramidal neurons in mutant animals. Spine density remained unchanged, whereas the proportion of the mushroom-type spine was moderately decreased. In line with these in vivo observations, we found that BDNF markedly promotes the growth of cultured striatal neurons and of their dendrites, but not of those of hippocampal neurons, suggesting that the differential responsiveness to BDNF is part of a neuron-intrinsic program.
C1 [Rauskolb, Stefanie; Deogracias, Ruben; Matsumoto, Tomoya; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Erne, Beat; Schaeren-Wiemers, Nicole] Univ Basel Hosp, Dept Biomed & Neurol, CH-4056 Basel, Switzerland.
   [Zagrebelsky, Marta; Dreznjak, Anita; Korte, Martin] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, D-38106 Braunschweig, Germany.
   [Wiese, Stefan; Sendtner, Michael] Univ Wurzburg, Inst Clin Neurobiol, D-97080 Wurzburg, Germany.
RP Barde, YA (corresponding author), Univ Basel, Biozentrum, 50-70 Klingelberg Str, CH-4056 Basel, Switzerland.
EM yves.barde@unibas.ch
RI Sendtner, Michael/J-1542-2012; Deogracias, Ruben/I-5751-2015; Barde,
   Yves/F-6019-2011; Sendtner, Michael/M-8137-2014
OI Sendtner, Michael/0000-0002-4737-2974; Deogracias,
   Ruben/0000-0002-9279-7867; Sendtner, Michael/0000-0002-4737-2974; Barde,
   Yves/0000-0002-7627-461X; Zagrebelsky, Marta/0000-0003-1083-7413
FU Max Planck SocietyMax Planck Society; Swiss National FoundationSwiss
   National Science Foundation (SNSF) [31003A_124902, 3100A0-112583];
   Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [FOR471]; SFBAustrian Science Fund (FWF) [581, B4]
FX This work was supported by a grant from the Max Planck Society (Hartmut
   Wekerle, Y.-A.B.), Swiss National Foundation Grants 31003A_124902
   (Y.-A.B.) and 3100A0-112583 (N.S.-W.), and Deutsche
   Forschungsgemeinschaft Grants FOR471 (M. K.) and SFB 581, B4 (M. S., S.
   W.). We thank Michaela Krug and Dr. Gurumoorthy Krishnamoorthy for help
   with quantitative RT-PCR experiments.
CR Altar CA, 1997, NATURE, V389, P856, DOI 10.1038/39885
   ALTAR CA, 1994, EUR J NEUROSCI, V6, P1389, DOI 10.1111/j.1460-9568.1994.tb01001.x
   Balkowiec A, 2000, J NEUROSCI, V20, P7417, DOI 10.1523/jneurosci.20-19-07417.2000
   Baquet ZC, 2005, J NEUROSCI, V25, P6251, DOI 10.1523/JNEUROSCI.4601-04.2005
   Baquet ZC, 2004, J NEUROSCI, V24, P4250, DOI 10.1523/JNEUROSCI.3920-03.2004
   Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105
   Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301
   CASTREN E, 1992, P NATL ACAD SCI USA, V89, P9444, DOI 10.1073/pnas.89.20.9444
   Cellerino A, 1997, MOL CELL NEUROSCI, V9, P397, DOI 10.1006/mcne.1997.0641
   Chan JP, 2006, NEUROSCIENCE, V142, P49, DOI 10.1016/j.neuroscience.2006.06.002
   Chan JP, 2008, MOL CELL NEUROSCI, V39, P372, DOI 10.1016/j.mcn.2008.07.017
   ERNFORS P, 1994, NATURE, V368, P147, DOI 10.1038/368147a0
   Franklin KBJ, 1997, MOUSE BRAIN STEREOTA
   Gascon S, 2008, J NEUROSCI METH, V168, P104, DOI 10.1016/j.jneumeth.2007.09.023
   Giacometti E, 2007, P NATL ACAD SCI USA, V104, P1931, DOI 10.1073/pnas.0610593104
   Gorski JA, 2003, J NEUROSCI, V23, P6856
   Graef IA, 2003, CELL, V113, P657, DOI 10.1016/S0092-8674(03)00390-8
   Guo H, 2005, EUR J NEUROSCI, V21, P2019, DOI 10.1111/j.1460-9568.2005.04016.x
   HARRIS KM, 1992, J NEUROSCI, V12, P2685
   He XP, 2004, NEURON, V43, P31, DOI 10.1016/j.neuron.2004.06.019
   HOFER M, 1990, EMBO J, V9, P2459, DOI 10.1002/j.1460-2075.1990.tb07423.x
   Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024
   HYMAN C, 1991, NATURE, V350, P230, DOI 10.1038/350230a0
   JONES KR, 1994, CELL, V76, P989, DOI 10.1016/0092-8674(94)90377-8
   Kermani P, 2005, J CLIN INVEST, V115, P653, DOI 10.1172/JCI200522655
   Kernie SG, 2000, EMBO J, V19, P1290, DOI 10.1093/emboj/19.6.1290
   Koh IYY, 2002, NEURAL COMPUT, V14, P1283, DOI 10.1162/089976602753712945
   Kohara K, 2007, J NEUROSCI, V27, P7234, DOI 10.1523/JNEUROSCI.1943-07.2007
   Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x
   Korets-Smith E, 2004, GENESIS, V40, P131, DOI 10.1002/gene.20074
   KORSCHING S, 1983, P NATL ACAD SCI-BIOL, V80, P3513, DOI 10.1073/pnas.80.11.3513
   KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856
   Krishnan V, 2007, CELL, V131, P391, DOI 10.1016/j.cell.2007.09.018
   LEVIMONTALCINI R, 1951, J EXP ZOOL, V116, P321, DOI 10.1002/jez.1401160206
   LEVIMONTALCINI R, 1960, ANN NY ACAD SCI, V85, P324
   Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023
   Luikart BW, 2005, J NEUROSCI, V25, P3774, DOI 10.1523/JNEUROSCI.0041-05.2005
   Lyons WE, 1999, P NATL ACAD SCI USA, V96, P15239, DOI 10.1073/pnas.96.26.15239
   MAISONPIERRE PC, 1990, NEURON, V5, P501, DOI 10.1016/0896-6273(90)90089-X
   Mamounas LA, 2000, J NEUROSCI, V20, P771, DOI 10.1523/JNEUROSCI.20-02-00771.2000
   Matsumoto T, 2008, NAT NEUROSCI, V11, P131, DOI 10.1038/nn2038
   Monteggia LM, 2007, BIOL PSYCHIAT, V61, P187, DOI 10.1016/j.biopsych.2006.03.021
   Patterson SL, 1996, NEURON, V16, P1137, DOI 10.1016/S0896-6273(00)80140-3
   Purves D., 1988, BODY BRAIN TROPHIC T
   Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748
   Strand AD, 2007, J NEUROSCI, V27, P11758, DOI 10.1523/JNEUROSCI.2461-07.2007
   SUDA K, 1978, P NATL ACAD SCI USA, V75, P4042, DOI 10.1073/pnas.75.8.4042
   Tucker KL, 2001, NAT NEUROSCI, V4, P29
   Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004
   Unger TJ, 2007, J NEUROSCI, V27, P14265, DOI 10.1523/JNEUROSCI.3308-07.2007
   Vicario-Abejon C, 1998, J NEUROSCI, V18, P7256
   Yang JM, 2009, NAT NEUROSCI, V12, P113, DOI 10.1038/nn.2244
   ZAFRA F, 1990, EMBO J, V9, P3545, DOI 10.1002/j.1460-2075.1990.tb07564.x
   Zhou XF, 1996, NEUROSCIENCE, V74, P945, DOI 10.1016/S0306-4522(96)00237-0
NR 54
TC 177
Z9 182
U1 0
U2 18
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD FEB 3
PY 2010
VL 30
IS 5
BP 1739
EP 1749
DI 10.1523/JNEUROSCI.5100-09.2010
PG 11
WC Neurosciences
SC Neurosciences & Neurology
GA 551XM
UT WOS:000274246700017
PM 20130183
OA Green Published, Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Braissant, O
   Wirz, D
   Gopfert, B
   Daniels, AU
AF Braissant, Olivier
   Wirz, Dieter
   Goepfert, Beat
   Daniels, Alma U.
TI Use of isothermal microcalorimetry to monitor microbial activities
SO FEMS MICROBIOLOGY LETTERS
LA English
DT Review
DE microcalorimetry; environmental microbiology; medical microbiology;
   microbial activity
ID MIC DETERMINATIONS; HEAT-PRODUCTION; CALORIMETRY; SOIL; GROWTH;
   CONSUMPTION; THERMOPILE; BIOSENSOR; BACTERIA; QUALITY
AB Isothermal calorimetry measures the heat flow of biological processes, which is proportional to the rate at which a given chemical or physical process takes place. Modern isothermal microcalorimeters make measurements of less than a microwatt of heat flow possible. As a result, as few as 10 000-100 000 active bacterial cells in culture are sufficient to produce a real-time signal dynamically related to the number of cells present and their activity. Specimens containing bacteria need little preparation, and isothermal microcalorimetry (IMC) is a nondestructive method. After IMC measurements, the undisturbed samples can be evaluated by any other means desired. In this review, we present a basic description of microcalorimetry and examples of microbiological applications of IMC for medical and environmental microbiology. In both fields, IMC has been used to quantify microbial activity over periods of hours or even days. Finally, the recent development of highly parallel instruments (up to 48 channels) and the constantly decreasing costs of equipment have made IMC increasingly attractive for microbiology. Miniaturization of isothermal calorimeters provides an even wider range of possibilities.
C1 [Braissant, Olivier; Wirz, Dieter; Goepfert, Beat; Daniels, Alma U.] Univ Basel, Biozentrum, Pharma Zentrum, Lab Biomech & Biocalorimetry, CH-4056 Basel, Switzerland.
RP Braissant, O (corresponding author), Univ Basel, Biozentrum, Pharma Zentrum, Lab Biomech & Biocalorimetry, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM olivier.braissant@unibas.ch
RI Braissant, Olivier/H-2284-2012; Braissant, Olivier/AAO-2371-2020
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
CR ANTOCE AO, 2001, ROUM BIOTECHNOL LETT, V6, P243
   Baldoni D, 2009, J CLIN MICROBIOL, V47, P774, DOI 10.1128/JCM.02374-08
   Barros N, 2003, THERMOCHIM ACTA, V406, P161, DOI 10.1016/S0040-6031(03)00255-7
   Barros N, 1999, THERMOCHIM ACTA, V328, P99, DOI 10.1016/S0040-6031(98)00629-7
   BATAILLARD P, 1993, BIOSENS BIOELECTRON, V8, P89, DOI 10.1016/0956-5663(93)80057-V
   BATAILLARD P, 1993, TRAC-TREND ANAL CHEM, V12, P387, DOI 10.1016/0165-9936(93)80002-2
   Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1
   Chardin B, 2002, J THERM ANAL CALORIM, V70, P475, DOI 10.1023/A:1021628608379
   Cooper MA, 2003, ANAL BIOANAL CHEM, V377, P834, DOI 10.1007/s00216-003-2111-y
   CRIDDLE RS, 1991, ANAL BIOCHEM, V194, P413, DOI 10.1016/0003-2697(91)90250-W
   Critter SAM, 2002, THERMOCHIM ACTA, V394, P133, DOI 10.1016/S0040-6031(02)00246-0
   Galindo FG, 2005, TRENDS FOOD SCI TECH, V16, P325, DOI 10.1016/j.tifs.2005.01.008
   Haglund AL, 2003, FEMS MICROBIOL ECOL, V46, P31, DOI 10.1016/S0168-6496(03)00190-9
   Hauser-Gerspach I, 2008, J BIOMED MATER RES B, V85B, P42, DOI 10.1002/jbm.b.30914
   Heng Z, 2005, J THERM ANAL CALORIM, V79, P45, DOI 10.1007/s10973-004-0560-y
   Higuera-Guisset J, 2005, THERMOCHIM ACTA, V427, P187, DOI 10.1016/j.tca.2004.09.010
   JESPERSEN ND, 1982, BIOCH CLIN APPL THER
   Johansson P, 1999, THERMOCHIM ACTA, V342, P19, DOI 10.1016/S0040-6031(99)00299-3
   Johnson MD, 2009, P NATL ACAD SCI USA, V106, P6696, DOI 10.1073/pnas.0902005106
   Laor Y, 2004, THERMOCHIM ACTA, V420, P119, DOI 10.1016/j.tca.2004.01.038
   LAVOISIER AL, 1780, MEMOIRE CHALEUR
   Lerchner J, 2006, THERMOCHIM ACTA, V445, P144, DOI 10.1016/j.tca.2005.07.011
   Lewis G, 2003, J BIOMED MATER RES B, V66B, P487, DOI 10.1002/jbm.b.10044
   Li X, 2002, THERMOCHIM ACTA, V387, P57
   LJUNGHOLM K, 1979, OIKOS, V33, P24, DOI 10.2307/3544507
   Maskow T, 2006, J BIOTECHNOL, V122, P431, DOI 10.1016/j.jbiotec.2005.10.008
   Maskow T, 2003, J BIOTECHNOL, V101, P267, DOI 10.1016/S0168-1656(02)00341-3
   Medina S, 2009, BIORESOURCE TECHNOL, V100, P4814, DOI 10.1016/j.biortech.2009.05.015
   MONOD J, 1949, ANNU REV MICROBIOL, V3, P371, DOI 10.1146/annurev.mi.03.100149.002103
   PAMATMAT MM, 1981, MAR ECOL PROG SER, V4, P135, DOI 10.3354/meps004135
   PAMATMAT MM, 1973, LIMNOL OCEANOGR, V18, P611, DOI 10.4319/lo.1973.18.4.0611
   Raubuch M, 1999, SOIL BIOL BIOCHEM, V31, P949, DOI 10.1016/S0038-0717(99)00003-6
   Recht MI, 2008, ANAL BIOCHEM, V377, P33, DOI 10.1016/j.ab.2008.03.007
   Rong XM, 2007, PEDOSPHERE, V17, P137, DOI 10.1016/S1002-0160(07)60019-8
   SPARLING GP, 1983, J SOIL SCI, V34, P381, DOI 10.1111/j.1365-2389.1983.tb01043.x
   Stumm W., 1996, AQUATIC CHEM
   Tan AM, 1999, J BIOCHEM BIOPH METH, V38, P225, DOI 10.1016/S0165-022X(98)00050-5
   Torres FE, 2004, P NATL ACAD SCI USA, V101, P9517, DOI 10.1073/pnas.0403573101
   Trampuz A, 2007, TRANSFUSION, V47, P1643, DOI 10.1111/j.1537-2995.2007.01336.x
   Van Hal M, 2000, FOOD REV INT, V16, P1, DOI 10.1081/FRI-100100280
   van Herwaarden AW, 2005, THERMOCHIM ACTA, V432, P192, DOI 10.1016/j.tca.2005.04.027
   von Ah U, 2008, J CLIN MICROBIOL, V46, P2083, DOI 10.1128/JCM.00611-08
   von Ah U, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-106
   von Rege H, 1998, J MICROBIOL METH, V33, P227, DOI 10.1016/S0167-7012(98)00055-4
   Vor T, 2002, BIOL FERT SOILS, V36, P66, DOI 10.1007/s00374-002-0510-4
   Wadso I, 2002, THERMOCHIM ACTA, V394, P305, DOI 10.1016/S0040-6031(02)00263-0
   Wadso I, 2001, PURE APPL CHEM, V73, P1625, DOI 10.1351/pac200173101625
   Wadso I, 2009, J THERM ANAL CALORIM, V95, P843, DOI 10.1007/s10973-008-9467-3
   Wadso I, 2001, J THERM ANAL CALORIM, V64, P75
   Wadso I, 1997, CHEM SOC REV, V26, P79, DOI 10.1039/cs9972600079
   Wadso L, 2004, THERMOCHIM ACTA, V422, P63, DOI 10.1016/j.tca.2004.05.034
   Wadso L, 2009, FOOD CONTROL, V20, P956, DOI 10.1016/j.foodcont.2008.11.008
   WEISS RF, 1970, DEEP-SEA RES, V17, P721, DOI 10.1016/0011-7471(70)90037-9
   Yang LN, 2008, J THERM ANAL CALORIM, V93, P417, DOI 10.1007/s10973-007-8680-9
   Yoon SI, 2008, J MICROELECTROMECH S, V17, P590, DOI 10.1109/JMEMS.2008.924846
   Zhang YY, 2004, BIOSENS BIOELECTRON, V19, P1733, DOI 10.1016/j.bios.2004.01.009
NR 56
TC 173
Z9 178
U1 1
U2 75
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0378-1097
EI 1574-6968
J9 FEMS MICROBIOL LETT
JI FEMS Microbiol. Lett.
PD FEB
PY 2010
VL 303
IS 1
BP 1
EP 8
DI 10.1111/j.1574-6968.2009.01819.x
PG 8
WC Microbiology
SC Microbiology
GA 541EI
UT WOS:000273396300001
PM 19895644
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Flueck, C
   Bartfai, R
   Niederwieser, I
   Witmer, K
   Alako, BTF
   Moes, S
   Bozdech, Z
   Jenoe, P
   Stunnenberg, HG
   Voss, TS
AF Flueck, Christian
   Bartfai, Richard
   Niederwieser, Igor
   Witmer, Kathrin
   Alako, Blaise T. F.
   Moes, Suzette
   Bozdech, Zbynek
   Jenoe, Paul
   Stunnenberg, Hendrik G.
   Voss, Till S.
TI A Major Role for the Plasmodium falciparum ApiAP2 Protein PfSIP2 in
   Chromosome End Biology
SO PLOS PATHOGENS
LA English
DT Article
ID CHROMATIN-REMODELING COMPLEX; MUTUALLY EXCLUSIVE EXPRESSION; ANTIGENIC
   VARIATION; DNA-BINDING; TELOMERE LENGTH; VIRULENCE GENES; TRANSCRIPTION
   FACTORS; COMPARATIVE GENOMICS; MALARIA; REPLICATION
AB The heterochromatic environment and physical clustering of chromosome ends at the nuclear periphery provide a functional and structural framework for antigenic variation and evolution of subtelomeric virulence gene families in the malaria parasite Plasmodium falciparum. While recent studies assigned important roles for reversible histone modifications, silent information regulator 2 and heterochromatin protein 1 (PfHP1) in epigenetic control of variegated expression, factors involved in the recruitment and organization of subtelomeric heterochromatin remain unknown. Here, we describe the purification and characterization of PfSIP2, a member of the ApiAP2 family of putative transcription factors, as the unknown nuclear factor interacting specifically with cis-acting SPE2 motif arrays in subtelomeric domains. Interestingly, SPE2 is not bound by the full-length protein but rather by a 60kDa N-terminal domain, PfSIP2-N, which is released during schizogony. Our experimental re-definition of the SPE2/PfSIP2-N interaction highlights the strict requirement of both adjacent AP2 domains and a conserved bipartite SPE2 consensus motif for high-affinity binding. Genome-wide in silico mapping identified 777 putative binding sites, 94% of which cluster in heterochromatic domains upstream of subtelomeric var genes and in telomere-associated repeat elements. Immunofluorescence and chromatin immunoprecipitation (ChIP) assays revealed co-localization of PfSIP2-N with PfHP1 at chromosome ends. Genome-wide ChIP demonstrated the exclusive binding of PfSIP2-N to subtelomeric SPE2 landmarks in vivo but not to single chromosome-internal sites. Consistent with this specialized distribution pattern, PfSIP2-N over-expression has no effect on global gene transcription. Hence, contrary to the previously proposed role for this factor in gene activation, our results provide strong evidence for the first time for the involvement of an ApiAP2 factor in heterochromatin formation and genome integrity. These findings are highly relevant for our understanding of chromosome end biology and variegated expression in P. falciparum and other eukaryotes, and for the future analysis of the role of ApiAP2-DNA interactions in parasite biology.
C1 [Flueck, Christian; Niederwieser, Igor; Witmer, Kathrin; Voss, Till S.] Univ Basel, Dept Med Parasitol & Infect Biol, Swiss Trop Inst, Basel, Switzerland.
   [Bartfai, Richard; Alako, Blaise T. F.; Stunnenberg, Hendrik G.] Radboud Univ Nijmegen, Dept Mol Biol, Nijmegen Ctr Mol Life Sci, NL-6525 ED Nijmegen, Netherlands.
   [Moes, Suzette; Jenoe, Paul] Univ Basel, Biozentrum, Basel, Switzerland.
   [Bozdech, Zbynek] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
RP Flueck, C (corresponding author), Univ Basel, Dept Med Parasitol & Infect Biol, Swiss Trop Inst, Basel, Switzerland.
EM till.voss@unibas.ch
RI Bartfai, Richard/E-2083-2012; Stunnenberg, Hendrik G./D-6875-2012;
   Bozdech, Zbynek/A-2205-2011
OI Bartfai, Richard/0000-0002-8460-6477; Stunnenberg, Hendrik
   G./0000-0002-0066-1576; Flueck, Christian/0000-0001-9145-9324; Alako,
   Blaise/0000-0001-6859-4421; Bozdech, Zbynek/0000-0002-9830-8446; Witmer,
   Kathrin/0000-0002-3159-7386
FU Netherlands Organization for Scientific ResearchNetherlands Organization
   for Scientific Research (NWO) [NWO-CW-TOP 700.53.311, 050-10-053];
   European CommissionEuropean CommissionEuropean Commission Joint Research
   Centre [LSHP-CT-2004-503578]; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF) [PP00A-110835]
FX Work in the Stunnenberg lab was supported by the Netherlands
   Organization for Scientific Research (NWO-CW-TOP 700.53.311 and
   NWO-Genomics 050-10-053; www.nwo.nl) and the European Commission
   (BioMalPar LSHP-CT-2004-503578; www.biomalpar.org). TSV is supported by
   the Swiss National Science Foundation (PP00A-110835; www.snf.ch). The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Aravind L, 2003, CELL, V115, P771, DOI 10.1016/S0092-8674(03)01023-7
   BAKER SS, 1994, PLANT MOL BIOL, V24, P701, DOI 10.1007/BF00029852
   Balaji S, 2005, NUCLEIC ACIDS RES, V33, P3994, DOI 10.1093/nar/gki709
   Barry JD, 2003, INT J PARASITOL, V33, P29, DOI 10.1016/S0020-7519(02)00247-3
   Baruch DI, 1996, P NATL ACAD SCI USA, V93, P3497, DOI 10.1073/pnas.93.8.3497
   BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3
   Beeson JG, 2005, CURR TOP MICROBIOL, V297, P187
   Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005
   Burgers PMJ, 1998, CHROMOSOMA, V107, P218, DOI 10.1007/s004120050300
   Chookajorn T, 2007, P NATL ACAD SCI USA, V104, P899, DOI 10.1073/pnas.0609084103
   Cinquin O, 2001, MOL BIOCHEM PARASIT, V117, P245, DOI 10.1016/S0166-6851(01)00354-1
   Clarke DJ, 2002, CELL CYCLE, V1, P231, DOI 10.4161/cc.1.4.129
   Collins N, 2002, NAT GENET, V32, P627, DOI 10.1038/ng1046
   Conaway RC, 2009, TRENDS BIOCHEM SCI, V34, P71, DOI 10.1016/j.tibs.2008.10.010
   CONRAD MN, 1990, CELL, V63, P739, DOI 10.1016/0092-8674(90)90140-A
   Cooper JP, 1997, NATURE, V385, P744, DOI 10.1038/385744a0
   Coulson RMR, 2004, GENOME RES, V14, P1548, DOI 10.1101/gr.2218604
   De Silva EK, 2008, P NATL ACAD SCI USA, V105, P8393, DOI 10.1073/pnas.0801993105
   DIFFLEY JFX, 1989, SCIENCE, V246, P1034, DOI 10.1126/science.2511628
   DIFFLEY JFX, 1988, P NATL ACAD SCI USA, V85, P2120, DOI 10.1073/pnas.85.7.2120
   Dror V, 2004, MOL CELL BIOL, V24, P8227, DOI 10.1128/MCB.24.18.8227-8235.2004
   Duraisingh MT, 2005, CELL, V121, P13, DOI 10.1016/j.cell.2005.01.036
   Ehrenhofer-Murray AE, 1999, GENETICS, V153, P1171
   Figueiredo LM, 2000, MOL BIOCHEM PARASIT, V106, P169, DOI 10.1016/S0166-6851(99)00199-1
   Figueiredo LM, 2002, EMBO J, V21, P815, DOI 10.1093/emboj/21.4.815
   Flueck C, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000569
   Franco AA, 2005, GENE DEV, V19, P1365, DOI 10.1101/gad.1305005
   Freitas-Junior LH, 2000, NATURE, V407, P1018, DOI 10.1038/35039531
   Freitas-Junior LH, 2005, CELL, V121, P25, DOI 10.1016/j.cell.2005.01.037
   Gardner JP, 1996, P NATL ACAD SCI USA, V93, P3503, DOI 10.1073/pnas.93.8.3503
   Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097
   Gasser SM, 2004, COLD SPRING HARB SYM, V69, P327, DOI 10.1101/sqb.2004.69.327
   Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n
   Gissot M, 2005, J MOL BIOL, V346, P29, DOI 10.1016/j.jmb.2004.11.045
   Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008
   Horrocks P, 2009, MOL BIOCHEM PARASIT, V164, P9, DOI 10.1016/j.molbiopara.2008.11.010
   Hu G, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-350
   Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018
   Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041
   Labib K, 2007, EMBO REP, V8, P346, DOI 10.1038/sj.embor.7400940
   LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287
   Lavazec C, 2007, MOL MICROBIOL, V64, P1621, DOI 10.1111/j.1365-2958.2007.05767.x
   Llinas M, 2006, NUCLEIC ACIDS RES, V34, P1166, DOI 10.1093/nar/gkj517
   Lopez-Rubio JJ, 2007, MOL MICROBIOL, V66, P1296, DOI 10.1111/j.1365-2958.2007.06009.x
   Lopez-Rubio JJ, 2009, CELL HOST MICROBE, V5, P179, DOI 10.1016/j.chom.2008.12.012
   Louis EJ, 2005, BIOESSAYS, V27, P685, DOI 10.1002/bies.20259
   MACPHERSON GG, 1985, AM J PATHOL, V119, P385
   Marty AJ, 2006, MOL MICROBIOL, V62, P72, DOI 10.1111/j.1365-2958.2006.05364.x
   Moazed D, 2001, MOL CELL, V8, P489, DOI 10.1016/S1097-2765(01)00340-9
   Mok BW, 2007, MOL BIOCHEM PARASIT, V151, P184, DOI 10.1016/j.molbiopara.2006.11.006
   Moon NS, 2001, MOL CELL BIOL, V21, P6332, DOI 10.1128/MCB.21.18.6332-6345.2001
   Moser BA, 2009, EMBO J, V28, P810, DOI 10.1038/emboj.2009.31
   Mossi R, 1998, EUR J BIOCHEM, V254, P209, DOI 10.1046/j.1432-1327.1998.254209.x
   Niang M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000307
   Nole-Wilson S, 2000, NUCLEIC ACIDS RES, V28, P4076, DOI 10.1093/nar/28.21.4076
   OHMETAKAGI M, 1995, PLANT CELL, V7, P173, DOI 10.1105/tpc.7.2.173
   Perez-Toledo K, 2009, NUCLEIC ACIDS RES, V37, P2596, DOI 10.1093/nar/gkp115
   PONGPONRATN E, 1991, AM J TROP MED HYG, V44, P168, DOI 10.4269/ajtmh.1991.44.168
   Pryde FE, 1997, CURR OPIN GENET DEV, V7, P822, DOI 10.1016/S0959-437X(97)80046-9
   Pryde FE, 1999, EMBO J, V18, P2538, DOI 10.1093/emboj/18.9.2538
   Ralph SA, 2005, P NATL ACAD SCI USA, V102, P5414, DOI 10.1073/pnas.0408883102
   Reed SH, 1999, GENE DEV, V13, P3052, DOI 10.1101/gad.13.23.3052
   Reeder JC, 1999, P NATL ACAD SCI USA, V96, P5198, DOI 10.1073/pnas.96.9.5198
   Rowe JA, 1997, NATURE, V388, P292, DOI 10.1038/40888
   Sadaie M, 2003, GENE DEV, V17, P2271, DOI 10.1101/gad.1112103
   Salcedo-Amaya AM, 2009, P NATL ACAD SCI USA, V106, P9655, DOI 10.1073/pnas.0902515106
   Scherf A, 1998, EMBO J, V17, P5418, DOI 10.1093/emboj/17.18.5418
   Scherf A, 2001, CURR OPIN MICROBIOL, V4, P409, DOI 10.1016/S1369-5274(00)00227-7
   Singh PB, 2002, J STRUCT BIOL, V140, P10, DOI 10.1016/S1047-8477(02)00536-1
   SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X
   Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342
   SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1
   Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705
   Tham WH, 2002, ONCOGENE, V21, P512, DOI 10.1038/sj.onc.1205078
   Tonkin CJ, 2009, PLOS BIOL, V7, P771, DOI 10.1371/journal.pbio.1000084
   TRAGER W, 1978, NATURE, V273, P621, DOI 10.1038/273621a0
   van Attikum H, 2005, CELL CYCLE, V4, P1011, DOI 10.4161/cc.4.8.1887
   vanSteensel B, 1997, NATURE, V385, P740, DOI 10.1038/385740a0
   VENDITTI P, 1994, BBA-GENE STRUCT EXPR, V1219, P677, DOI 10.1016/0167-4781(94)90227-5
   Voss TS, 2007, MOL MICROBIOL, V66, P139, DOI 10.1111/j.1365-2958.2007.05899.x
   Voss TS, 2006, NATURE, V439, P1004, DOI 10.1038/nature04407
   Voss TS, 2003, MOL MICROBIOL, V48, P1593, DOI 10.1046/j.1365-2958.2003.03528.x
   Young JA, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-70
   Yu SR, 2009, J BIOL CHEM, V284, P966, DOI 10.1074/jbc.M806830200
   Yuda M, 2009, MOL MICROBIOL, V71, P1402, DOI 10.1111/j.1365-2958.2009.06609.x
   Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141
NR 86
TC 102
Z9 104
U1 0
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD FEB
PY 2010
VL 6
IS 2
AR e1000784
DI 10.1371/journal.ppat.1000784
PG 15
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 565LZ
UT WOS:000275295900034
PM 20195509
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Zhang, JM
   Adrian, FJ
   Jahnke, W
   Cowan-Jacob, SW
   Li, AG
   Iacob, RE
   Sim, T
   Powers, J
   Dierks, C
   Sun, FX
   Guo, GR
   Ding, Q
   Okram, B
   Choi, Y
   Wojciechowski, A
   Deng, XM
   Liu, GX
   Fendrich, G
   Strauss, A
   Vajpai, N
   Grzesiek, S
   Tuntland, T
   Liu, Y
   Bursulaya, B
   Azam, M
   Manley, PW
   Engen, JR
   Daley, GQ
   Warmuth, M
   Gray, NS
AF Zhang, Jianming
   Adrian, Francisco J.
   Jahnke, Wolfgang
   Cowan-Jacob, Sandra W.
   Li, Allen G.
   Iacob, Roxana E.
   Sim, Taebo
   Powers, John
   Dierks, Christine
   Sun, Fangxian
   Guo, Gui-Rong
   Ding, Qiang
   Okram, Barun
   Choi, Yongmun
   Wojciechowski, Amy
   Deng, Xianming
   Liu, Guoxun
   Fendrich, Gabriele
   Strauss, Andre
   Vajpai, Navratna
   Grzesiek, Stephan
   Tuntland, Tove
   Liu, Yi
   Bursulaya, Badry
   Azam, Mohammad
   Manley, Paul W.
   Engen, John R.
   Daley, George Q.
   Warmuth, Markus
   Gray, Nathanael S.
TI Targeting Bcr-Abl by combining allosteric with ATP-binding-site
   inhibitors
SO NATURE
LA English
DT Article
ID CHRONIC MYELOID-LEUKEMIA; CELL LUNG-CANCER; KINASE-INHIBITOR; C-ABL;
   TYROSINE KINASE; LYMPHOBLASTIC-LEUKEMIA; IMATINIB RESISTANCE; SELECTIVE
   INHIBITOR; MUTATIONS; DYNAMICS
AB In an effort to find new pharmacological modalities to overcome resistance to ATP-binding-site inhibitors of Bcr-Abl, we recently reported the discovery of GNF-2, a selective allosteric Bcr-Abl inhibitor. Here, using solution NMR, X-ray crystallography, mutagenesis and hydrogen exchange mass spectrometry, we show that GNF-2 binds to the myristate-binding site of Abl, leading to changes in the structural dynamics of the ATP-binding site. GNF-5, an analogue of GNF-2 with improved pharmacokinetic properties, when used in combination with the ATP-competitive inhibitors imatinib or nilotinib, suppressed the emergence of resistance mutations in vitro, displayed additive inhibitory activity in biochemical and cellular assays against T315I mutant human Bcr-Abl and displayed in vivo efficacy against this recalcitrant mutant in a murine bone-marrow transplantation model. These results show that therapeutically relevant inhibition of Bcr-Abl activity can be achieved with inhibitors that bind to the myristate-binding site and that combining allosteric and ATP-competitive inhibitors can overcome resistance to either agent alone.
C1 [Adrian, Francisco J.; Li, Allen G.; Dierks, Christine; Sun, Fangxian; Guo, Gui-Rong; Ding, Qiang; Liu, Guoxun; Tuntland, Tove; Liu, Yi; Bursulaya, Badry] Novartis Res Fdn, Dept Chem, Genom Inst, San Diego, CA 92121 USA.
   [Zhang, Jianming; Sim, Taebo; Choi, Yongmun; Wojciechowski, Amy; Deng, Xianming; Gray, Nathanael S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA.
   [Zhang, Jianming; Sim, Taebo; Powers, John; Choi, Yongmun; Wojciechowski, Amy; Deng, Xianming; Azam, Mohammad; Daley, George Q.; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.
   [Jahnke, Wolfgang; Cowan-Jacob, Sandra W.; Fendrich, Gabriele; Strauss, Andre; Manley, Paul W.] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland.
   [Iacob, Roxana E.; Engen, John R.] Northwestern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA.
   [Iacob, Roxana E.; Engen, John R.] Northwestern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA.
   [Sim, Taebo] Korea Inst Sci & Technol, Life Sci Res Div, Seoul 136791, South Korea.
   [Powers, John; Azam, Mohammad; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA.
   [Powers, John; Azam, Mohammad; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA.
   [Powers, John; Azam, Mohammad; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA.
   [Okram, Barun] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA.
   [Okram, Barun] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA.
   [Vajpai, Navratna; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Warmuth, Markus] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA.
RP Adrian, FJ (corresponding author), Novartis Res Fdn, Dept Chem, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA.
EM fadrian@gnf.org; markus.warmuth@novartis.com;
   nathanael_gray@dfci.harvard.edu
RI Dierks, Christine/L-4358-2013; Powers, John/AAO-1018-2020
OI Engen, John/0000-0002-6918-9476; Deng, Xianming/0000-0002-9354-5864;
   Grzesiek, Stephan/0000-0003-1998-4225; Zhang,
   Jianming/0000-0001-6326-3906
FU NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [R01CA130876, R01CA130876, R01CA130876, R01CA130876,
   R01CA130876] Funding Source: NIH RePORTER; NCI NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [R01 CA130876, R01 CA130876-03]
   Funding Source: Medline
CR Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760
   Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9
   Azam M, 2006, P NATL ACAD SCI USA, V103, P9244, DOI 10.1073/pnas.0600001103
   Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140
   Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029
   Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580
   Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472
   BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0
   Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200
   Choi Y, 2009, J BIOL CHEM, V284, P29005, DOI 10.1074/jbc.M109.026633
   CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4
   Converso A, 2009, BIOORG MED CHEM LETT, V19, P1240, DOI 10.1016/j.bmcl.2008.12.076
   Cools J, 2004, CANCER RES, V64, P6385, DOI 10.1158/0008-5472.CAN-04-2148
   DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689
   Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538
   Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0
   Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106
   Jahnke W, 2004, CELL MOL LIFE SCI, V61, P580, DOI 10.1007/s00018-003-3382-3
   Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404
   Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238
   KORNBERG A, 1951, J BIOL CHEM, V189, P123
   Lee TS, 2008, CANCER-AM CANCER SOC, V112, P1744, DOI 10.1002/cncr.23355
   Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938
   Mishra S, 2006, CANCER RES, V66, P5387, DOI 10.1158/0008-5472.CAN-05-3058
   Nagar B, 2002, CANCER RES, V62, P4236
   Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6
   OPPI C, 1987, P NATL ACAD SCI USA, V84, P8200, DOI 10.1073/pnas.84.23.8200
   Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324
   Ray A, 2007, BLOOD, V109, P5011, DOI 10.1182/blood-2006-01-015347
   Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905
   Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X
   Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480
   Strauss A, 2005, J BIOMOL NMR, V31, P343, DOI 10.1007/s10858-005-2451-3
   TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315
   Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200
   VANETTEN RA, 1993, LEUKEMIA LYMPHOMA, V11, P239, DOI 10.3109/10428199309047893
   von Bubnoff N, 2005, BLOOD, V105, P1652, DOI 10.1182/blood-2004-06-2445
   Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064
   Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862
   Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025
   Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007
NR 41
TC 387
Z9 398
U1 7
U2 122
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JAN 28
PY 2010
VL 463
IS 7280
BP 501
EP U116
DI 10.1038/nature08675
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 548QK
UT WOS:000273981100042
PM 20072125
OA Green Accepted
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Mouro-Chanteloup, I
   Cochet, S
   Chami, M
   Genetet, S
   Zidi-Yahiaoui, N
   Engel, A
   Colin, Y
   Bertrand, O
   Ripoche, P
AF Mouro-Chanteloup, Isabelle
   Cochet, Sylvie
   Chami, Mohamed
   Genetet, Sandrine
   Zidi-Yahiaoui, Nedjma
   Engel, Andreas
   Colin, Yves
   Bertrand, Olivier
   Ripoche, Pierre
TI Functional Reconstitution into Liposomes of Purified Human RhCG Ammonia
   Channel
SO PLOS ONE
LA English
DT Article
ID RED-BLOOD-CELLS; NITROSOMONAS-EUROPAEA; TRANSPORT; PROTEINS;
   GLYCOPROTEIN; EXPRESSION; MEMBRANE; KIDNEY; WATER; RHBG
AB Background: Rh glycoproteins (RhAG, RhBG, RhCG) are members of the Amt/Mep/Rh family which facilitate movement of ammonium across plasma membranes. Changes in ammonium transport activity following expression of Rh glycoproteins have been described in different heterologous systems such as yeasts, oocytes and eukaryotic cell lines. However, in these complex systems, a potential contribution of endogenous proteins to this function cannot be excluded. To demonstrate that Rh glycoproteins by themselves transport NH(3), human RhCG was purified to homogeneity and reconstituted into liposomes, giving new insights into its channel functional properties.
   Methodology/Principal Findings: An HA-tag introduced in the second extracellular loop of RhCG was used to purify to homogeneity the HA-tagged RhCG glycoprotein from detergent-solubilized recombinant HEK293E cells. Electron microscopy analysis of negatively stained purified RhCG-HA revealed, after image processing, homogeneous particles of 9 nm diameter with a trimeric protein structure. Reconstitution was performed with sphingomyelin, phosphatidylcholine and phosphatidic acid lipids in the presence of the C(12)E(8) detergent which was subsequently removed by Biobeads. Control of protein incorporation was carried out by freeze-fracture electron microscopy. Particle density in liposomes was a function of the Lipid/Protein ratio. When compared to empty liposomes, ammonium permeability was increased two and three fold in RhCG-proteoliposomes, depending on the Lipid/Protein ratio (1/300 and 1/150, respectively). This strong NH(3) transport was reversibly inhibited by mercuric and copper salts and exhibited a low Arrhenius activation energy.
   Conclusions/Significance: This study allowed the determination of ammonia permeability per RhCG monomer, showing that the apparent Punit(NH3) (around 1 x 10(-3) mu m(3).s(-1)) is close to the permeability measured in HEK293E cells expressing a recombinant human RhCG (1.60 x 10(-3) mu m(3).s(-1)), and in human red blood cells endogenously expressing RhAG (2.18 x 10(-3) mu m(3).s(-1)). The major finding of this study is that RhCG protein is active as an NH(3) channel and that this function does not require any protein partner.
C1 [Mouro-Chanteloup, Isabelle; Cochet, Sylvie; Genetet, Sandrine; Zidi-Yahiaoui, Nedjma; Colin, Yves; Bertrand, Olivier; Ripoche, Pierre] INSERM, UMR S 665, Paris, France.
   [Mouro-Chanteloup, Isabelle; Cochet, Sylvie; Genetet, Sandrine; Zidi-Yahiaoui, Nedjma; Colin, Yves; Bertrand, Olivier; Ripoche, Pierre] Univ Paris Diderot Paris 7, Paris, France.
   [Mouro-Chanteloup, Isabelle; Cochet, Sylvie; Genetet, Sandrine; Zidi-Yahiaoui, Nedjma; Colin, Yves; Bertrand, Olivier; Ripoche, Pierre] Inst Natl Transfus Sanguine, F-75015 Paris, France.
   [Chami, Mohamed; Engel, Andreas] Univ Basel, Biozentrum, E Muller Inst Struct Biol, Ctr Imaging & Nanoanalyt,C CINA, Basel, Switzerland.
RP Mouro-Chanteloup, I (corresponding author), INSERM, UMR S 665, Paris, France.
EM isabelle.mouro-chanteloup@inserm.fr
RI colin, yves/O-1910-2017; Isabelle, Mouro-Chanteloup/M-9750-2018
OI colin, yves/0000-0001-5196-4254; Isabelle,
   Mouro-Chanteloup/0000-0002-6368-9904
FU Institut National de la Transfusion Sanguine, Paris; INSERM,
   ParisInstitut National de la Sante et de la Recherche Medicale (Inserm);
   Societe Francaise d'Hematologie; Societe Francaise de Nephrologie;
   Fondation pour la Recherche MedicaleFondation pour la Recherche Medicale
FX This work was supported by the Institut National de la Transfusion
   Sanguine, Paris and INSERM, Paris. N.Z.-Y. acknowledges the financial
   support of the Societe Francaise d'Hematologie, of the Societe Francaise
   de Nephrologie and of the Fondation pour la Recherche Medicale. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Bakouh N, 2004, J BIOL CHEM, V279, P15975, DOI 10.1074/jbc.M308528200
   Benjelloun F, 2005, PFLUG ARCH EUR J PHY, V450, P155, DOI 10.1007/s00424-005-1381-y
   Biver S, 2008, NATURE, V456, P339, DOI 10.1038/nature07518
   Bruce LJ, 2009, BLOOD, V113, P1350, DOI 10.1182/blood-2008-07-171140
   Bruce LJ, 2003, BLOOD, V101, P4180, DOI 10.1182/blood-2002-09-2824
   Butterworth RF, 2003, ALCOHOL RES HEALTH, V27, P143
   Callebaut I, 2006, TRANSFUS CLIN BIOL, V13, P70, DOI 10.1016/j.tracli.2006.02.001
   Cartron JP, 1999, BEST PRACT RES CL HA, V12, P655, DOI 10.1053/beha.1999.0047
   Eladari D, 2002, J AM SOC NEPHROL, V13, P1999, DOI 10.1097/01.ASN.0000025280.02386.9D
   Han KH, 2009, AM J PHYSIOL-LUNG C, V297, pL153, DOI 10.1152/ajplung.90524.2008
   HODAK M, 2009, P NATL ACAD SCI US
   Huang CH, 2005, P NATL ACAD SCI USA, V102, P15512, DOI 10.1073/pnas.0507886102
   Javelle A, 2007, J STRUCT BIOL, V158, P472, DOI 10.1016/j.jsb.2007.01.004
   Juge N, 2006, J BIOL CHEM, V281, P39499, DOI 10.1074/jbc.M607670200
   Kaufmann TC, 2006, BIOPHYS J, V90, P310, DOI 10.1529/biophysj.105.070193
   Khademi S, 2004, SCIENCE, V305, P1587, DOI 10.1126/science.1101952
   Lee SY, 2009, J MOL BIOL, V387, P1055, DOI 10.1016/j.jmb.2009.02.034
   Li X, 2007, P NATL ACAD SCI USA, V104, P19279, DOI 10.1073/pnas.0709710104
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Lupo D, 2007, P NATL ACAD SCI USA, V104, P19303, DOI 10.1073/pnas.0706563104
   Mak DOD, 2006, AM J PHYSIOL-RENAL, V290, pF297, DOI 10.1152/ajprenal.00147.2005
   Marini AM, 1997, TRENDS BIOCHEM SCI, V22, P460, DOI 10.1016/S0968-0004(97)01132-8
   Marini AM, 2000, NAT GENET, V26, P341
   Mayer M, 2006, J GEN PHYSIOL, V127, P133, DOI 10.1085/jgp.200509369
   Nakhoul NL, 2005, AM J PHYSIOL-RENAL, V288, pF170, DOI 10.1152/ajprenal.00419.2003
   Nicolas V, 2003, J BIOL CHEM, V278, P25526, DOI 10.1074/jbc.M302816200
   PORATH J, 1975, NATURE, V258, P598, DOI 10.1038/258598a0
   PRIVER NA, 1993, BIOCHEMISTRY-US, V32, P2459, DOI 10.1021/bi00061a002
   Quentin F, 2003, J AM SOC NEPHROL, V14, P545, DOI 10.1097/01.ASN.0000050413.43662.55
   Rigaud JL, 2003, METHOD ENZYMOL, V372, P65
   Ripoche P, 2004, P NATL ACAD SCI USA, V101, P17222, DOI 10.1073/pnas.0403704101
   Stewart GS, 2006, AM J PHYSIOL-RENAL, V290, pF1437, DOI 10.1152/ajprenal.00449.2005
   VANHEESWIJK MPE, 1986, J MEMBRANE BIOL, V92, P183, DOI 10.1007/BF01870707
   VERKMAN AS, 1989, AM J PHYSIOL, V257, pC837
   Verlander JW, 2003, AM J PHYSIOL-RENAL, V284, pF323, DOI 10.1152/ajprenal.00050.2002
   Weidinger K, 2007, FEMS MICROBIOL LETT, V273, P260, DOI 10.1111/j.1574-6968.2007.00805.x
   Weiner ID, 2007, ANNU REV PHYSIOL, V69, P317, DOI 10.1146/annurev.physiol.69.040705.142215
   Weiner ID, 2006, TRANSFUS CLIN BIOL, V13, P159, DOI 10.1016/j.tracli.2006.02.002
   Westhoff CM, 2002, J BIOL CHEM, V277, P12499, DOI 10.1074/jbc.C200060200
   ZEIDEL ML, 1992, BIOCHEMISTRY-US, V31, P7436, DOI 10.1021/bi00148a002
   Zheng L, 2004, P NATL ACAD SCI USA, V101, P17090, DOI 10.1073/pnas.0406475101
   Zidi-Yahiaoui N, 2005, BIOCHEM J, V391, P33, DOI 10.1042/BJ20050657
   ZIDIYAHIAOUI N, 2009, AM J PHYSL CELL PHYS
NR 43
TC 38
Z9 39
U1 0
U2 8
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JAN 28
PY 2010
VL 5
IS 1
AR e8921
DI 10.1371/journal.pone.0008921
PG 7
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 550OR
UT WOS:000274138000004
PM 20126667
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Biermann, B
   Ivankova-Susankova, K
   Bradaia, A
   Aziz, SA
   Besseyrias, V
   Kapfhammer, JP
   Missler, M
   Gassmann, M
   Bettler, B
AF Biermann, Barbara
   Ivankova-Susankova, Klara
   bradaia, Amyaouch
   Aziz, Said Abdel
   Besseyrias, Valerie
   Kapfhammer, Josef P.
   Missler, Markus
   Gassmann, Martin
   Bettler, Bernhard
TI The Sushi Domains of GABA(B) Receptors Function as Axonal Targeting
   Signals
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID METABOTROPIC GLUTAMATE-RECEPTOR; HIPPOCAMPAL-NEURONS;
   SUBCELLULAR-LOCALIZATION; PRESYNAPTIC INHIBITION; MEMBRANE-PROTEINS;
   PYRAMIDAL NEURONS; NERVE-TERMINALS; EXPRESSION; TRANSPORT; POLARITY
AB GABA(B) receptors are the G-protein-coupled receptors for GABA, the main inhibitory neurotransmitter in the brain. Two receptor subtypes, GABA(B(1a, 2)) and GABA(B(1b, 2)), are formed by the assembly of GABA(B1a) and GABA(B1b) subunits with GABA(B2) subunits. The GABA(B1b) subunit is a shorter isoform of the GABA(B1a) subunit lacking two N-terminal protein interaction motifs, the sushi domains. Selectively GABA(B1a) protein traffics into the axons of glutamatergic neurons, whereas both the GABA(B1a) and GABA(B1b) proteins traffic into the dendrites. The mechanism(s) and targeting signal(s) responsible for the selective trafficking of GABA(B1a) protein into axons are unknown. Here, we provide evidence that the sushi domains are axonal targeting signals that redirect GABA(B1a) protein from its default dendritic localization to axons. Specifically, we show that mutations in the sushi domains preventing protein interactions preclude axonal localization of GABA(B1a). When fused to CD8 alpha, the sushi domains polarize this uniformly distributed protein to axons. Likewise, when fused to mGluR1a the sushi domains redirect this somatodendritic protein to axons, showing that the sushi domains can override dendritic targeting information in a heterologous protein. Cell surface expression of the sushi domains is not required for axonal localization of GABA(B1a). Altogether, our findings are consistent with the sushi domains functioning as axonal targeting signals by interacting with axonally bound proteins along intracellular sorting pathways. Our data provide a mechanistic explanation for the selective trafficking of GABA(B(1a, 2)) receptors into axons while at the same time identifying a well defined axonal delivery module that can be used as an experimental tool.
C1 [Bettler, Bernhard] Univ Basel, Biozentrum, Pharmazentrum, Dept Biomed,Inst Physiol, CH-4056 Basel, Switzerland.
   [Biermann, Barbara; Missler, Markus] Univ Munster, Inst Anat & Mol Neurobiol, D-48149 Munster, Germany.
   [Kapfhammer, Josef P.] Univ Basel, Dept Biomed, Inst Anat, CH-4056 Basel, Switzerland.
RP Bettler, B (corresponding author), Univ Basel, Biozentrum, Pharmazentrum, Dept Biomed,Inst Physiol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM bernhard.bettler@unibas.ch
RI bettler, bernhard/AAO-8018-2020
OI Missler, Markus/0000-0001-8008-984X; Bettler,
   Bernhard/0000-0003-0842-8207; Gassmann, Martin/0000-0001-6201-3032
FU Swiss Science FoundationSwiss National Science Foundation (SNSF)
   [3100A0-117816]; European Community'sEuropean Community (EC)
   [FP7/2007-2013, 201714]; Deutsche ForschungsgemeinschaftGerman Research
   Foundation (DFG) [SFB629-TPB11]
FX This study was supported by grants from the Swiss Science Foundation
   (3100A0-117816 to B.B.), the European Community's Seventh Framework
   Programme (FP7/2007-2013) under Grant Agreement 201714 (to B.B.), and
   the Deutsche Forschungsgemeinschaft (SFB629-TPB11 to M. M.). We thank P.
   Philippsen and E. Raz for use of imaging equipment, J. Kinter and M.
   Akaaboune for critical reading of this manuscript, and S. Kaech for
   technical advice.
CR Ahmari SE, 2000, NAT NEUROSCI, V3, P445
   Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055
   Ango F, 1999, NEUROPHARMACOLOGY, V38, P793, DOI 10.1016/S0028-3908(99)00005-2
   Aoki S, 2002, J NEUROSCI, V22, P10751
   Aridor M, 2009, TRAFFIC, V10, P1669, DOI 10.1111/j.1600-0854.2009.00974.x
   BENSON DL, 1994, J NEUROCYTOL, V23, P279, DOI 10.1007/BF01188497
   Blein S, 2004, J BIOL CHEM, V279, P48292, DOI 10.1074/jbc.M406540200
   Boulos S, 2006, BRAIN RES, V1102, P27, DOI 10.1016/j.brainres.2006.04.089
   Bowery NG, 2002, PHARMACOL REV, V54, P247, DOI 10.1124/pr.54.2.247
   BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513
   CACERES A, 1984, J NEUROSCI, V4, P394
   Couve A, 2000, MOL CELL NEUROSCI, V16, P296, DOI 10.1006/mcne.2000.0908
   CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.ne.17.030194.001411
   Das SS, 2006, J NEUROSCI, V26, P8115, DOI 10.1523/JNEUROSCI.1015-06.2006
   Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005
   Francesconi A, 2002, J NEUROSCI, V22, P2196, DOI 10.1523/JNEUROSCI.22-06-02196.2002
   Gassmann M, 2004, J NEUROSCI, V24, P6086, DOI 10.1523/JNEUROSCI.5635-03.2004
   Goslin K, 1998, CULTURING NERVE CELL, P339
   Grace CRR, 2004, P NATL ACAD SCI USA, V101, P12836, DOI 10.1073/pnas.0404702101
   Gu C, 2003, SCIENCE, V301, P646, DOI 10.1126/science.1086998
   Guetg N, 2009, J NEUROSCI, V29, P1414, DOI 10.1523/JNEUROSCI.3697-08.2009
   Gunnersen JM, 2007, NEURON, V56, P621, DOI 10.1016/j.neuron.2007.09.018
   Hawrot E, 1998, FEBS LETT, V432, P103, DOI 10.1016/S0014-5793(98)00794-7
   Hirokawa N, 2005, NAT REV NEUROSCI, V6, P201, DOI 10.1038/nrn1624
   Horton AC, 2003, NEURON, V40, P277, DOI 10.1016/S0896-6273(03)00629-9
   Jareb M, 1998, NEURON, V20, P855, DOI 10.1016/S0896-6273(00)80468-7
   Kaupmann K, 1997, NATURE, V386, P239, DOI 10.1038/386239a0
   Kirkitadze MD, 2001, IMMUNOL REV, V180, P146, DOI 10.1034/j.1600-065X.2001.1800113.x
   Kraus DM, 2006, J IMMUNOL, V176, P4419, DOI 10.4049/jimmunol.176.7.4419
   Kugler S, 2001, MOL CELL NEUROSCI, V17, P78, DOI 10.1006/mcne.2000.0929
   Kulik A, 2003, J NEUROSCI, V23, P11026
   Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x
   Lehtinen MJ, 2004, J MOL BIOL, V344, P1385, DOI 10.1016/j.jmb.2004.10.017
   Margeta-Mitrovic M, 2000, NEURON, V27, P97, DOI 10.1016/S0896-6273(00)00012-X
   Marshall FH, 1999, TRENDS PHARMACOL SCI, V20, P396, DOI 10.1016/S0165-6147(99)01383-8
   MASU M, 1991, NATURE, V349, P760, DOI 10.1038/349760a0
   Merianda TT, 2009, MOL CELL NEUROSCI, V40, P128, DOI 10.1016/j.mcn.2008.09.008
   MORLEY BJ, 1984, EMBO J, V3, P153, DOI 10.1002/j.1460-2075.1984.tb01776.x
   Obermair GJ, 2003, EUR J NEUROSCI, V17, P721, DOI 10.1046/j.1460-9568.2003.02488.x
   Pagano A, 2001, J NEUROSCI, V21, P1189
   Parmentier ML, 2002, TRENDS PHARMACOL SCI, V23, P268, DOI 10.1016/S0165-6147(02)02016-3
   Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019
   Perrin MH, 2006, ANN NY ACAD SCI, V1070, P105, DOI 10.1196/annals.1317.065
   Poyatos I, 2000, MOL CELL NEUROSCI, V15, P99, DOI 10.1006/mcne.1999.0807
   Ramirez OA, 2009, J BIOL CHEM, V284, P13077, DOI 10.1074/jbc.M900575200
   Rivera JF, 2003, NAT NEUROSCI, V6, P243, DOI 10.1038/nn1020
   Roos J, 2000, NAT NEUROSCI, V3, P415, DOI 10.1038/74773
   Sampo B, 2003, NEURON, V37, P611, DOI 10.1016/S0896-6273(03)00058-8
   Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2
   Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732
   Soares DC, 2005, STRUCTURAL BIOLOGY OF THE COMPLEMENT SYSTEM, P19
   Steiger JL, 2004, J NEUROSCI, V24, P6115, DOI 10.1523/JNEUROSCI.1200-04.2004
   Tiao JY, 2008, J BIOL CHEM, V283, P31005, DOI 10.1074/jbc.M804464200
   Ulrich D, 2007, J NEUROPHYSIOL, V98, P3791, DOI 10.1152/jn.00756.2007
   Ulrich D, 2007, CURR OPIN NEUROBIOL, V17, P298, DOI 10.1016/j.conb.2007.04.001
   Vidal RL, 2007, MOL CELL NEUROSCI, V35, P501, DOI 10.1016/j.mcn.2007.04.008
   Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014
   Wei XQ, 2001, J IMMUNOL, V167, P277, DOI 10.4049/jimmunol.167.1.277
   West AE, 1997, J NEUROSCI, V17, P6038
   Winckler B, 1999, NEURON, V23, P637, DOI 10.1016/S0896-6273(01)80021-0
   Wisco D, 2003, J CELL BIOL, V162, P1317, DOI 10.1083/jcb.200307069
   Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4
NR 62
TC 61
Z9 64
U1 1
U2 14
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD JAN 27
PY 2010
VL 30
IS 4
BP 1385
EP 1394
DI 10.1523/JNEUROSCI.3172-09.2010
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 549LH
UT WOS:000274050000019
PM 20107064
OA Green Accepted, Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Frenkiel-Krispin, D
   Maco, B
   Aebi, U
   Medalia, O
AF Frenkiel-Krispin, Daphna
   Maco, Bohumil
   Aebi, Ueli
   Medalia, Ohad
TI Structural Analysis of a Metazoan Nuclear Pore Complex Reveals a Fused
   Concentric Ring Architecture
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein conformational disease; retinal degeneration; light damage;
   pharmacological chaperone; membrane protein misfolding
ID ATOMIC-FORCE MICROSCOPY; CRYOELECTRON TOMOGRAPHY; NUCLEOCYTOPLASMIC
   TRANSPORT; MOLECULAR ARCHITECTURE; ELECTRON-MICROSCOPY; P62 COMPLEX;
   CELL-CYCLE; NUCLEOPORINS; PROTEIN; LOCALIZATION
AB The sole gateway for molecular exchange between the cytoplasm and the nucleus is the nuclear pore complex (NPC). This large supramolecular assembly mediates transport of cargo into and out of the nucleus and fuse the inner and outer nuclear membranes to form an aqueous translocation channel. The NPC is composed of eight proteinaceous asymmetric units, forming a pseudo-8-fold symmetric passage. Due to its shear size, complexity, and plastic nature, dissecting the high-resolution three-dimensional structure of the NPC in its hydrated state is a formidable challenge. Toward this goal, we applied cryo-electron tomography to spread nuclear envelopes from Xenopus oocytes. To compensate for perturbations of the 8-fold symmetry of individual NPCs, we performed symmetry-independent asymmetric unit averaging of three-dimensional tomographic NPC volumes to eventually yield a refined model at 6.4 nm resolution. This approach revealed novel structural features, particularly in the spoke-ring complex and luminal domains. Fused concentric ring architecture of the spoke-ring complex was found along the translocation channel. Additionally, a comparison of the refined Xenopus model to that of its Dictyostelium homologue yielded similar pore diameters at the level of the three canonical rings, although the Xenopus NPC was found to be 30% taller than the Dictyostelium pore. This discrepancy is attributed primarily to the relatively low homology and different organization of some nucleoporins in the Dictyostelium genome as compared to that of vertebrates. Nevertheless, the experimental conditions impose a preferred axial orientation of the NPCs within spread Xenopus oocyte nuclear envelopes. This may at least in part explain the increased height of the reconstructed vertebrate NPCs compared to those obtained from tomographic reconstruction of intact Dictyostelium nuclei. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Medalia, Ohad] Ben Gurion Univ Negev, Dept Life Sci, IL-84120 Beer Sheva, Israel.
   [Medalia, Ohad] NIBN, IL-84120 Beer Sheva, Israel.
   [Maco, Bohumil] Univ Basel, Biozentrum, ME Mueller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Frenkiel-Krispin, Daphna] Max Planck Inst Biochem, D-82152 Martinsried, Germany.
RP Medalia, O (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84120 Beer Sheva, Israel.
EM omedalia@bgu.ac.il
OI Maco, Bohumil/0000-0001-8444-313X; Medalia, Ohad/0000-0003-0994-2937
FU European UnionEuropean Union (EU); Israel Science FoundationIsrael
   Science Foundation [794/06]; Maurice E. Mueller Foundation of
   Switzerland
FX This work was supported by the European Union "3D-EM" Network of
   Excellence within the 6th Framework Program (to U.A. and O.M.), by the
   Israel Science Foundation to O.M. (grant 794/06), and by the Maurice E.
   Mueller Foundation of Switzerland to U.A.
CR AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1
   AKEY CW, 1995, J MOL BIOL, V248, P273, DOI 10.1016/S0022-2836(95)80050-6
   Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405
   Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404
   Bapteste E, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-10-r85
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170
   Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022
   Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Elad N, 2009, CURR OPIN STRUC BIOL, V19, P226, DOI 10.1016/j.sbi.2009.02.009
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577
   Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102
   Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024
   GUAN TL, 1995, MOL BIOL CELL, V6, P1591
   Hegerl R, 1996, J STRUCT BIOL, V116, P30, DOI 10.1006/jsbi.1996.0006
   Hinshaw JE, 2003, J STRUCT BIOL, V141, P259, DOI 10.1016/S1047-8477(02)00626-3
   HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P
   Hsia KC, 2007, CELL, V131, P1313, DOI 10.1016/j.cell.2007.11.038
   JARNIK M, 1991, J STRUCT BIOL, V107, P291, DOI 10.1016/1047-8477(91)90054-Z
   JIMENEZ J, 1986, SCIENCE, V232, P1113, DOI 10.1126/science.3754654
   Kampmann M, 2009, NAT STRUCT MOL BIOL, V16, P782, DOI 10.1038/nsmb.1618
   Kiseleva E, 1998, J CELL SCI, V111, P223
   Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980
   Lutzmann M, 2002, EMBO J, V21, P387, DOI 10.1093/emboj/21.3.387
   Maco Bohumil, 2006, V322, P273
   Mans BJ, 2004, CELL CYCLE, V3, P1612
   Medalia O, 2002, SCIENCE, V298, P1209, DOI 10.1126/science.1076184
   Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730
   Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006
   Pante N, 1995, INT REV CYTOL, V162B, P225
   PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603
   Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044
   Rabut G, 2004, CURR OPIN CELL BIOL, V16, P314, DOI 10.1016/j.ceb.2004.04.001
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Schwarz-Herion K, 2007, J MOL BIOL, V370, P796, DOI 10.1016/j.jmb.2007.05.030
   Stoffler D, 1999, J MOL BIOL, V287, P741, DOI 10.1006/jmbi.1999.2637
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027
   Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5
   Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4
   YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0
NR 48
TC 74
Z9 74
U1 0
U2 13
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 22
PY 2010
VL 395
IS 3
BP 578
EP 586
DI 10.1016/j.jmb.2009.11.010
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 550ST
UT WOS:000274150700011
PM 19913035
DA 2021-01-25
ER

PT J
AU Huang, JR
   Grzesiek, S
AF Huang, Jie-rong
   Grzesiek, Stephan
TI Ensemble Calculations of Unstructured Proteins Constrained by RDC and
   PRE Data: A Case Study of Urea-Denatured Ubiquitin
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID RESIDUAL DIPOLAR COUPLINGS; PARAMAGNETIC RELAXATION ENHANCEMENT; ANGLE
   X-RAY; MOLECULAR-STRUCTURE DETERMINATION; LIQUID-CRYSTALLINE PHASE;
   LONG-RANGE STRUCTURE; STAPHYLOCOCCAL NUCLEASE; UNFOLDED STATE; BACKBONE
   DYNAMICS; ALPHA-SYNUCLEIN
AB The detailed, quantitative characterization of unfolded proteins is a largely unresolved task due to the enormous experimental and theoretical difficulties in describing the highly dimensional space of their conformational ensembles. Recently, residual dipolar coupling (RDC) and paramagnetic relaxation enhancement (PRE) data have provided large numbers of experimental parameters on unfolded states. To obtain a minimal model of the unfolded state according to such data we have developed new modules for the use of steric alignment RDCs and PRIES as constraints in ensemble structure calculations by the program XPLOR-NIH. As an example, ensemble calculations were carried out on urea-denatured ubiquitin using a total of 419 previously obtained RDCs and 253 newly determined PRIES from eight cysteine mutants coupled to MTSL. The results show that only a small number of about 10 conformers is necessary to fully reproduce the experimental RDCs, PRIES and average radius of gyration. C-alpha contacts determined on a large set (400) of 10-conformer ensembles show significant (10-20%) populations of conformations that are similar to ubiquitin's A-state, i.e. corresponding to an intact native first beta-hairpin and alpha-helix as well as non-native alpha-helical conformations in the C-terminal half. Thus, methanol/acid (A-state) and urea denaturation lead to similar low energy states of the protein ensemble, presumably due to the weakening of the hydrophobic core. Similar contacts are obtained in calculations using solely RDCs or PREs. The sampling statistics of the C-alpha contacts in the ensembles follow a simple binomial distribution. It follows that the present RDC, PRE, and computational methods allow the statistically significant detection of subconformations in the unfolded ensemble at population levels of a few percent.
C1 [Huang, Jie-rong; Grzesiek, Stephan] Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch
RI Huang, Jie-rong/B-4222-2009; Huang, Jie-rong/O-3661-2019
OI Huang, Jie-rong/0000-0003-3674-2228; Grzesiek,
   Stephan/0000-0003-1998-4225
FU SNF [31109712]
FX We thank K. Rathgeb-Szabo, R. Bobby, and M. Rogowski for protein
   preparation, Dr. D. Haussinger for help with MTSL-labeling, Dr. C.D.
   Schwieters for extensive help with XPLOR-NIH programming, Drs. H.-J.
   Sass and M. Blackledge for many helpful discussions, and the Basel
   Computational Biology Center as well as Prof. S. Berneche for providing
   access to their computer cluster. This work was supported by SNF Grant
   31109712.
CR Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102
   Bertoncini CW, 2007, J MOL BIOL, V372, P708, DOI 10.1016/j.jmb.2007.07.009
   Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102
   Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649
   Brutscher B, 1997, BIOCHEMISTRY-US, V36, P13043, DOI 10.1021/bi971538t
   Chen X, 2007, J AM CHEM SOC, V129, P15104, DOI 10.1021/ja075034m
   Choy WY, 2002, J MOL BIOL, V316, P101, DOI 10.1006/jmbi.2001.5328
   Cordier F, 2004, BIOCHEMISTRY-US, V43, P11295, DOI 10.1021/bi049314f
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   COX JPL, 1993, J MOL BIOL, V234, P483, DOI 10.1006/jmbi.1993.1600
   Dames SA, 2006, J AM CHEM SOC, V128, P13508, DOI 10.1021/ja063606h
   Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002
   Felitsky DJ, 2008, P NATL ACAD SCI USA, V105, P6278, DOI 10.1073/pnas.0710641105
   Fieber W, 2004, J MOL BIOL, V339, P1191, DOI 10.1016/j.jmb.2004.04.037
   Fitzkee NC, 2005, TRENDS BIOCHEM SCI, V30, P73, DOI 10.1016/j.tibs.2004.12.005
   Francis CJ, 2006, PROTEINS, V65, P145, DOI 10.1002/prot.21077
   Gabel F, 2009, J AM CHEM SOC, V131, P8769, DOI 10.1021/ja9013248
   Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954
   Gillespie JR, 1997, J MOL BIOL, V268, P170, DOI 10.1006/jmbi.1997.0953
   Hua L, 2008, P NATL ACAD SCI USA, V105, P16928, DOI 10.1073/pnas.0808427105
   Iwahara J, 2004, J AM CHEM SOC, V126, P5879, DOI 10.1021/ja031580d
   Iwahara J, 2007, J MAGN RESON, V184, P185, DOI 10.1016/j.jmr.2006.10.003
   Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102
   Jourdan M, 2000, BIOCHEMISTRY-US, V39, P12355, DOI 10.1021/bi000718r
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101
   Kristjansdottir S, 2005, J MOL BIOL, V347, P1053, DOI 10.1016/j.jmb.2005.01.009
   Levinthal C., 1969, MOSSBAUER SPECTROSCO, V67, P22
   Lietzow MA, 2002, J MOL BIOL, V322, P655, DOI 10.1016/S0022-2836(02)00847-1
   Lindorff-Larsen K, 2004, J AM CHEM SOC, V126, P3291, DOI 10.1021/ja039250g
   Marsh JA, 2007, J MOL BIOL, V367, P1494, DOI 10.1016/j.jmb.2007.01.038
   Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079
   Meier S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2838167
   Meier S, 2007, J AM CHEM SOC, V129, P9799, DOI 10.1021/ja0724339
   Meier S, 2007, J AM CHEM SOC, V129, P754, DOI 10.1021/ja067522k
   Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009
   Moltke S, 1999, J BIOMOL NMR, V15, P77, DOI 10.1023/A:1008309630377
   Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   Reif F., 1965, FUNDAMENTALS STAT TH
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   Schwieters CD, 2006, PROG NUCL MAG RES SP, V48, P47, DOI 10.1016/j.pnmrs.2005.10.001
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Schwieters CD, 2001, J MAGN RESON, V152, P288, DOI 10.1006/jmre.2001.2413
   SERRANO L, 1995, J MOL BIOL, V254, P322, DOI 10.1006/jmbi.1995.0619
   Shortle D, 1996, FASEB J, V10, P27
   Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438
   Smith LJ, 1996, J MOL BIOL, V255, P494, DOI 10.1006/jmbi.1996.0041
   SOLOMON I, 1956, J CHEM PHYS, V25, P261, DOI 10.1063/1.1742867
   Song J, 2008, P NATL ACAD SCI USA, V105, P1505, DOI 10.1073/pnas.0709558105
   Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008
   Svergun DI, 1998, P NATL ACAD SCI USA, V95, P2267, DOI 10.1073/pnas.95.5.2267
   Tang C, 2006, NATURE, V444, P383, DOI 10.1038/nature05201
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   van Lune F, 2002, J BIOMOL NMR, V23, P169, DOI 10.1023/A:1019877830921
   Went HM, 2005, PROTEIN ENG DES SEL, V18, P229, DOI 10.1093/protein/gzi025
   WILKINSON KD, 1986, ARCH BIOCHEM BIOPHYS, V250, P390, DOI 10.1016/0003-9861(86)90741-1
   WRIGHT PE, 2009, J CURR OPIN STRUCT B, V19, P31
   Yao LS, 2008, J AM CHEM SOC, V130, P16518, DOI 10.1021/ja805654f
   Zangi R, 2009, J AM CHEM SOC, V131, P1535, DOI 10.1021/ja807887g
   Zerella R, 1999, PROTEIN SCI, V8, P1320, DOI 10.1110/ps.8.6.1320
   ZWANZIG R, 1992, P NATL ACAD SCI USA, V89, P20, DOI 10.1073/pnas.89.1.20
   Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908
NR 67
TC 91
Z9 92
U1 0
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JAN 20
PY 2010
VL 132
IS 2
BP 694
EP 705
DI 10.1021/ja907974m
PG 12
WC Chemistry, Multidisciplinary
SC Chemistry
GA 562VY
UT WOS:000275084600048
PM 20000836
DA 2021-01-25
ER

PT J
AU Fernandes, I
   Chanut-Delalande, H
   Ferrer, P
   Latapie, Y
   Waltzer, L
   Affolter, M
   Payre, F
   Plaza, S
AF Fernandes, Isabelle
   Chanut-Delalande, Helene
   Ferrer, Pierre
   Latapie, Yvan
   Waltzer, Lucas
   Affolter, Markus
   Payre, Francois
   Plaza, Serge
TI Zona Pellucida Domain Proteins Remodel the Apical Compartment for
   Localized Cell Shape Changes
SO DEVELOPMENTAL CELL
LA English
DT Article
ID CAENORHABDITIS-ELEGANS; EPIDERMIS DIFFERENTIATION; DROSOPHILA
   EMBRYOGENESIS; ZP DOMAIN; MORPHOGENESIS; EVOLUTION; CUTICLE; EXPRESSION;
   SHAVENBABY; EPITHELIA
AB The zona pellucida domain (ZPD) defines a conserved family of membrane-anchored matrix proteins that are, as yet, poorly characterized with respect to their functions during development. Using genetic approaches in flies, we show here that a set of eight ZPD proteins is required for the localized reorganization of embryonic epidermal cells during morphogenesis. Despite varying degrees of sequence conservation, these ZPD proteins exert specific and nonredundant functions in the remodeling of epidermal cell shape. Each one accumulates in a restricted subregion of the apical compartment, where it organizes local interactions between the membrane and the extracellular matrix. In addition, ZPD proteins are required to sculpture the actin-rich cell extensions and maintain appropriate organization of the apical compartment. These results on ZPD proteins therefore reveal a functional subcompartmentalization of the apical membrane and its role in the polarized control of epithelial cell shape during development.
C1 [Fernandes, Isabelle; Chanut-Delalande, Helene; Ferrer, Pierre; Latapie, Yvan; Waltzer, Lucas; Payre, Francois; Plaza, Serge] Univ Toulouse, UPS, Ctr Dev Biol, F-31062 Toulouse, France.
   [Fernandes, Isabelle; Chanut-Delalande, Helene; Ferrer, Pierre; Latapie, Yvan; Waltzer, Lucas; Payre, Francois; Plaza, Serge] CNRS, UMR5547, Ctr Dev Biol, F-31062 Toulouse, France.
   [Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Ferrer, P (corresponding author), Univ Toulouse, UPS, Ctr Dev Biol, F-31062 Toulouse, France.
EM payre@cict.fr; plaza@cict.fr
RI plaza, serge/F-5290-2015
OI PAYRE, Francois/0000-0002-8144-6711; CHANUT-DELALANDE,
   Helene/0000-0002-1720-2069; Waltzer, Lucas/0000-0002-5361-727X;
   Affolter, Markus/0000-0002-5171-0016
FU Association pour la Recherche contre le CancerFondation ARC pour la
   Recherche sur le Cancer [3832, 1111]; Fondation pour la Recherche
   MedicaleFondation pour la Recherche Medicale
FX We are grateful to the Bloomington Drosophila Stock Center,
   Developmental Studies Hybridoma Bank, and the Drosophila Genomic
   Resource Center for providing us with flies, antibodies, and molecular
   clones. We are indebted to A. Leru, B. Ronsin, S. Balor, and N.
   Benmeradi (Toulouse RIO Imaging), M. Duggelin and U. Sauder (Zentrum
   Mikroskopie der Universitat Basel), I. Fourquaux and B. Payre (CMEAB),
   and S. Leblond (TEMSCAN) for their help with microscopy, and to P.
   Valenti for excellent technical assistance. We also thank J. Smith, P.
   Blader, and A. Vincent for critical reading of the manuscript. This work
   was supported by grants from the Association pour la Recherche contre le
   Cancer (no. 3832, no. 1111, and a fellowship to I.F.) and the Fondation
   pour la Recherche Medicale (programme equipe 2005). The authors declare
   no conflict of interest. I.F., H.C.D., F.P., and S.P. conceived and
   designed the experiments. I.F., H.C.D., Y.L., P.F., and S.P. performed
   the experiments and are listed according to their respective
   contributions. I.F., H.C.D., P.F., S.P., and F.P. wrote the paper. L..
   an M.A. contributed reagents and analytical tools.
CR Al-Awqati Q, 2008, J AM SOC NEPHROL, V19, P443, DOI 10.1681/ASN.2007111195
   Andrew DJ, 2008, DEV DYNAM, V237, P1198, DOI 10.1002/dvdy.21512
   Andrews J, 2000, DEVELOPMENT, V127, P881
   Bourbon HM, 2002, MECH DEVELOP, V110, P71, DOI 10.1016/S0925-4773(01)00566-4
   Chanut-Delalande H, 2006, PLOS BIOL, V4, P1549, DOI 10.1371/journal.pbio.0040290
   Delon I, 2004, TRENDS GENET, V20, P305, DOI 10.1016/j.tig.2004.05.003
   Delon I, 2003, MECH DEVELOP, V120, P747, DOI 10.1016/S0925-4773(03)00081-9
   Dubois L, 2001, CELL, V105, P613, DOI 10.1016/S0092-8674(01)00375-0
   Jazwinska A, 2004, GENE EXPR PATTERNS, V4, P413, DOI 10.1016/j.modgep.2004.01.003
   Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049
   Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039
   Jovine L, 2002, NAT CELL BIOL, V4, P457, DOI 10.1038/ncb802
   Jovine Luca, 2006, BMC Biochem, V7, P11, DOI 10.1186/1471-2091-7-11
   Kurotaki Y, 2007, SCIENCE, V316, P719, DOI 10.1126/science.1138591
   Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222
   LITSCHER ES, 2009, J INSECT PHYSL, V47, P495
   McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988
   Mellman I, 2008, NAT REV MOL CELL BIO, V9, P833, DOI 10.1038/nrm2525
   Monne M, 2008, NATURE, V456, P653, DOI 10.1038/nature07599
   MORGAN TH, 1916, SEX LINKED INHERITAN, P1
   Moussian B, 2007, MATRIX BIOL, V26, P337, DOI 10.1016/j.matbio.2007.02.001
   Moussian B, 2006, ARTHROPOD STRUCT DEV, V35, P137, DOI 10.1016/j.asd.2006.05.003
   Muller HAJ, 2003, MECH DEVELOP, V120, P1231, DOI 10.1016/j.mod.2003.06.001
   Muriel JM, 2003, DEV BIOL, V260, P339, DOI 10.1016/S0012-1606(03)00237-9
   Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312
   Payre F, 2004, INT J DEV BIOL, V48, P207, DOI 10.1387/ijdb.15272387
   Payre F, 1999, NATURE, V400, P271, DOI 10.1038/22330
   Roch F, 2003, J CELL SCI, V116, P1199, DOI 10.1242/jcs.00298
   Sapio MR, 2005, DEV BIOL, V282, P231, DOI 10.1016/j.ydbio.2005.03.011
   Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838
   SEBASTIANO M, 1991, DEV BIOL, V146, P519, DOI 10.1016/0012-1606(91)90253-Y
   Stark A, 2007, NATURE, V450, P219, DOI 10.1038/nature06340
   Sucena E, 2003, NATURE, V424, P935, DOI 10.1038/nature01768
   Takito J, 2004, J CELL BIOL, V166, P1093, DOI 10.1083/jcb.200405159
   Tian E, 2007, GLYCOBIOLOGY, V17, P820, DOI 10.1093/glycob/cwm056
   Tordai H, 1999, FEBS LETT, V461, P63, DOI 10.1016/S0014-5793(99)01416-7
   Verhoeven K, 1998, NAT GENET, V19, P60, DOI 10.1038/ng0598-60
   Wassarman PM, 2008, J BIOL CHEM, V283, P24285, DOI 10.1074/jbc.R800027200
   Wodarz A, 2007, NAT CELL BIOL, V9, P1016, DOI 10.1038/ncb433
NR 39
TC 63
Z9 63
U1 1
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD JAN 19
PY 2010
VL 18
IS 1
BP 64
EP 76
DI 10.1016/j.devcel.2009.11.009
PG 13
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 546RZ
UT WOS:000273829800009
PM 20152178
DA 2021-01-25
ER

PT J
AU Zimmer, C
   Lee, J
   Griveau, A
   Arber, S
   Pierani, A
   Garel, S
   Guillemot, F
AF Zimmer, Celine
   Lee, Jun
   Griveau, Amelie
   Arber, Silvia
   Pierani, Alessandra
   Garel, Sonia
   Guillemot, Francois
TI Role of Fgf8 signalling in the specification of rostral Cajal-Retzius
   cells
SO DEVELOPMENT
LA English
DT Article
DE Cajal-Retzius cells; Fgf8 signalling; Forebrain development; Neuronal
   specification; Mouse
ID DEVELOPING CEREBRAL-CORTEX; GROWTH-FACTOR RECEPTOR; DORSAL
   TELENCEPHALON; NEURONAL MIGRATION; MOUSE FOREBRAIN; OPTIC VESICLES;
   MARGINAL ZONE; MUTANT MICE; RADIAL GLIA; LAYER-I
AB Cajal-Retzius (CR) cells play a key role in the formation of the cerebral cortex. These pioneer neurons are distributed throughout the cortical marginal zone in distinct graded distributions. Fate mapping and cell lineage tracing studies have recently shown that CR cells arise from restricted domains of the pallial ventricular zone, which are associated with signalling centres involved in the early regionalisation of the telencephalic vesicles. In this study, we identified a subpopulation of CR cells in the rostral telencephalon that expresses Er81, a downstream target of Fgf8 signalling. We investigated the role of the rostral telencephalic patterning centre, which secretes FGF molecules, in the specification of these cells. Using pharmacological inhibitors and genetic inactivation of Fgf8, we showed that production of Fgf8 by the rostral telencephalic signalling centre is required for the specification of the Er81(+) CR cell population. Moreover, the analysis of Fgf8 gain-of-function in cultivated mouse embryos and of Emx2 and Gli3 mutant embryos revealed that ectopic Fgf8 signalling promotes the generation of CR cells with a rostral phenotype from the dorsal pallium. These data showed that Fgf8 signalling is both required and sufficient to induce rostral CR cells. Together, our results shed light on the mechanisms specifying rostral CR cells and further emphasise the crucial role of telencephalic signalling centres in the generation of distinct CR cell populations.
C1 [Zimmer, Celine; Guillemot, Francois] Natl Inst Med Res, MRC, Dept Mol Neurobiol, London NW7 1AA, England.
   [Lee, Jun; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Lee, Jun; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4056 Basel, Switzerland.
   [Griveau, Amelie; Pierani, Alessandra] CNRS, Inst Jacques Monod, Program Dev & Neurobiol, UMR 7592, F-75013 Paris, France.
   [Griveau, Amelie; Pierani, Alessandra] Univ Paris Diderot, F-75013 Paris, France.
   [Garel, Sonia] Ecole Normale Super, Dept Biol, INSERM, U784, F-75005 Paris, France.
RP Zimmer, C (corresponding author), Natl Inst Med Res, MRC, Dept Mol Neurobiol, London NW7 1AA, England.
EM zimmer@ibdml.univ-mrs.fr; fguille@nimr.mrc.ac.uk
RI garel, sonia/P-4538-2017; Pierani, Alessandra/O-6136-2017
OI garel, sonia/0000-0003-2984-3645; Pierani,
   Alessandra/0000-0002-4872-4791; Arber, Silvia/0000-0002-6261-250X
FU Medical Research CouncilMedical Research Council UK (MRC); Swiss
   National Science FoundationSwiss National Science Foundation (SNSF);
   NCCR Frontiers in GeneticsSwiss National Science Foundation (SNSF);
   Kanton Basel-Stadt; EUEuropean Union (EU); Novartis Research Foundation;
   French Ministry of Education; Association pour la Recherche sur le
   CancerFondation ARC pour la Recherche sur le CancerAustralian Research
   Council; CNRS (Centre National de la Recherche Scientifique)Centre
   National de la Recherche Scientifique (CNRS); Agence Nationale de la
   RechercheFrench National Research Agency (ANR) [ANR-05-NEUR-007-01 BIS];
   Avenir INSERMInstitut National de la Sante et de la Recherche Medicale
   (Inserm); Ville de Paris; EURYI awardEuropean Science Foundation (ESF);
   Medical Research CouncilMedical Research Council UK (MRC)
   [MC_U117570528] Funding Source: researchfish
FX We are particularly grateful to J. Falk for fruitful discussions during
   the course of this work and to K. Rizzoti and J. Falk for critically
   reading the manuscript. We thank J. L. L Rubenstein for the Fgf8TelKO
   embryos and J. Briscoe, C. Goridis, Y. Hashisaki, R. Hevner, E. Monuki,
   A. Joyner, G. Martin, J. Mason, J. Partanen and S. Price for sharing
   reagents. We particularly thank the animal husbandry service of the NIMR
   for their great contribution to this work. C. Z. was supported by a
   Medical Research Council career development fellowship. J. L. and S. A.
   were supported by grants from the Swiss National Science Foundation,
   NCCR Frontiers in Genetics, the Kanton Basel-Stadt, EU Framework Program
   7 and the Novartis Research Foundation. A. G. was the recipient of
   fellowships from the French Ministry of Education and the Association
   pour la Recherche sur le Cancer, A. P. is a CNRS (Centre National de la
   Recherche Scientifique) Investigator and their work was supported by a
   grant from the Agence Nationale de la Recherche (ANR-05-NEUR-007-01 BIS)
   to A. P. The work in S.G.'s lab was supported by Avenir INSERM, Ville de
   Paris and EURYI award. The work in F.G.'s lab was supported by
   institutional funds from the Medical Research Council. Deposited in PMC
   for release after 6 months.
CR Abraham H, 2003, HIPPOCAMPUS, V13, P715, DOI 10.1002/hipo.10125
   Alcantara S, 1998, J NEUROSCI, V18, P7779
   Bachler M, 2001, MECH DEVELOP, V100, P313, DOI 10.1016/S0925-4773(00)00518-9
   Bailey AP, 2006, DEV CELL, V11, P505, DOI 10.1016/j.devcel.2006.08.009
   Basson MA, 2008, DEVELOPMENT, V135, P889, DOI 10.1242/dev.011569
   Bielle F, 2005, NAT NEUROSCI, V8, P1002, DOI 10.1038/nn1511
   Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550
   Borello U, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-17
   Buscher D, 1998, MAMM GENOME, V9, P676, DOI 10.1007/s003359900845
   Carney RSE, 2009, CEREB CORTEX, V19, P745, DOI 10.1093/cercor/bhn123
   Chi CL, 2003, DEVELOPMENT, V130, P2633, DOI 10.1242/dev.00487
   Cholfin JA, 2008, J COMP NEUROL, V509, P144, DOI 10.1002/cne.21709
   Cholfin JA, 2007, P NATL ACAD SCI USA, V104, P7652, DOI 10.1073/pnas.0702225104
   Crossley PH, 2001, NEUROSCIENCE, V108, P183, DOI 10.1016/S0306-4522(01)00411-0
   CROSSLEY PH, 1995, DEVELOPMENT, V121, P439
   DARCANGELO G, 1995, NATURE, V374, P719, DOI 10.1038/374719a0
   DELRIO JA, 1995, CEREB CORTEX, V5, P13, DOI 10.1093/cercor/5.1.13
   DERER P, 1990, NEUROSCIENCE, V36, P839, DOI 10.1016/0306-4522(90)90027-2
   Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623
   Freeman KW, 2003, CANCER RES, V63, P6237
   Friedrichs M, 2008, DEV BIOL, V318, P203, DOI 10.1016/j.ydbio.2008.03.032
   Fukuchi-Shimogori T, 2003, NAT NEUROSCI, V6, P825, DOI 10.1038/nn1093
   Fukuchi-Shimogori T, 2001, SCIENCE, V294, P1071, DOI 10.1126/science.1064252
   Garcia-Moreno F, 2007, J COMP NEUROL, V500, P419, DOI 10.1002/cne.21128
   Garel S, 2003, DEVELOPMENT, V130, P1903, DOI 10.1242/dev.00416
   Gimeno L, 2007, DEV DYNAM, V236, P2285, DOI 10.1002/dvdy.21237
   Gutin G, 2006, DEVELOPMENT, V133, P2937, DOI 10.1242/dev.02465
   Hanashima C, 2007, J NEUROSCI, V27, P11103, DOI 10.1523/JNEUROSCI.1066-07.2007
   Hevner RF, 2003, DEV NEUROSCI-BASEL, V25, P139, DOI 10.1159/000072263
   Hevner RF, 2001, NEURON, V29, P353, DOI 10.1016/S0896-6273(01)00211-2
   Hirsch MR, 2007, DEV BIOL, V303, P687, DOI 10.1016/j.ydbio.2006.12.006
   Imayoshi I, 2008, DEVELOPMENT, V135, P2531, DOI 10.1242/dev.021535
   Kawauchi S, 2005, DEVELOPMENT, V132, P5211, DOI 10.1242/dev.02143
   Kimura J, 2005, J NEUROSCI, V25, P5097, DOI 10.1523/JNEUROSCI.0239-05.2005
   Kuschel S, 2003, DEV BIOL, V260, P484, DOI 10.1016/S0012-1606(03)00252-5
   Lee SMK, 2000, DEVELOPMENT, V127, P457
   Liu AM, 2003, DEVELOPMENT, V130, P6175, DOI 10.1242/dev.00845
   Mallamaci A, 2000, J NEUROSCI, V20, P1109, DOI 10.1523/JNEUROSCI.20-03-01109.2000
   Marin O, 2003, ANNU REV NEUROSCI, V26, P441, DOI 10.1146/annurev.neuro.26.041002.131058
   Marin-Padilla M, 1998, TRENDS NEUROSCI, V21, P64, DOI 10.1016/S0166-2236(97)01164-8
   MARINPADILLA M, 1990, J COMP NEUROL, V299, P89, DOI 10.1002/cne.902990107
   MARINPADILLA M, 1992, J COMP NEUROL, V321, P223, DOI 10.1002/cne.903210205
   Meyer G, 2004, J NEUROSCI, V24, P9878, DOI 10.1523/JNEUROSCI.3060-04.2004
   Meyer G, 2002, J NEUROSCI, V22, P4973, DOI 10.1523/JNEUROSCI.22-12-04973.2002
   Meyers EN, 1998, NAT GENET, V18, P136, DOI 10.1038/ng0298-136
   Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955
   Molyneaux BJ, 2007, NAT REV NEUROSCI, V8, P427, DOI 10.1038/nrn2151
   Monuki ES, 2001, NEURON, V32, P591, DOI 10.1016/S0896-6273(01)00504-9
   Nomura T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001454
   O'Leary DDM, 2007, NEURON, V56, P252, DOI 10.1016/j.neuron.2007.10.010
   OGAWA M, 1995, NEURON, V14, P899, DOI 10.1016/0896-6273(95)90329-1
   Ohkubo Y, 2002, NEUROSCIENCE, V111, P1, DOI 10.1016/S0306-4522(01)00616-9
   Okada T, 2008, DEV BIOL, V320, P92, DOI 10.1016/j.ydbio.2008.04.034
   Paek H, 2009, DEVELOPMENT, V136, P2457, DOI 10.1242/dev.032656
   Pellegrini M, 1996, DEVELOPMENT, V122, P3893
   RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116
   Rash BG, 2006, CURR OPIN NEUROBIOL, V16, P25, DOI 10.1016/j.conb.2006.01.004
   Rash BG, 2007, J NEUROSCI, V27, P11595, DOI 10.1523/JNEUROSCI.3204-07.2007
   Rice DS, 2001, ANNU REV NEUROSCI, V24, P1005, DOI 10.1146/annurev.neuro.24.1.1005
   Sato T, 2001, DEVELOPMENT, V128, P2461
   Shanmugalingam S, 2000, DEVELOPMENT, V127, P2549
   Shimamura K, 1997, DEVELOPMENT, V124, P2709
   Shimogori T, 2004, DEVELOPMENT, V131, P5639, DOI 10.1242/dev.01428
   Shinozaki K, 2002, DEVELOPMENT, V129, P3479
   Siegenthaler JA, 2008, DEV BIOL, V313, P35, DOI 10.1016/j.ydbio.2007.09.036
   Soriano E, 1997, NEURON, V18, P563, DOI 10.1016/S0896-6273(00)80298-6
   Storm EE, 2006, DEVELOPMENT, V133, P1831, DOI 10.1242/dev.02324
   Storm EE, 2003, P NATL ACAD SCI USA, V100, P1757, DOI 10.1073/pnas.0337736100
   Stoykova A, 2003, CEREB CORTEX, V13, P560, DOI 10.1093/cercor/13.6.560
   Stoykova A, 1996, DEVELOPMENT, V122, P3453
   Super H, 2000, CEREB CORTEX, V10, P602, DOI 10.1093/cercor/10.6.602
   Sur M, 2005, SCIENCE, V310, P805, DOI 10.1126/science.1112070
   Takiguchi-Hayashi K, 2004, J NEUROSCI, V24, P2286, DOI 10.1523/JNEUROSCI.4671-03.2004
   Theil T, 2005, DEV BIOL, V286, P559, DOI 10.1016/j.ydbio.2005.08.033
   Theil T, 1999, DEVELOPMENT, V126, P3561
   Tuoc TC, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-23
   Yoshida M, 1997, DEVELOPMENT, V124, P101
   Yoshida M, 2006, DEVELOPMENT, V133, P537, DOI 10.1242/dev.02209
   Yun K, 2001, DEVELOPMENT, V128, P193
   Zecevic N, 2001, J NEUROSCI, V21, P5607
   Zhao CJ, 2006, BRAIN RES, V1077, P48, DOI 10.1016/j.brainres.2006.01.042
NR 81
TC 33
Z9 33
U1 0
U2 3
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0950-1991
J9 DEVELOPMENT
JI Development
PD JAN 15
PY 2010
VL 137
IS 2
BP 293
EP 302
DI 10.1242/dev.041178
PG 10
WC Developmental Biology
SC Developmental Biology
GA 537CW
UT WOS:000273091500011
PM 20040495
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Olsen, JV
   Vermeulen, M
   Santamaria, A
   Kumar, C
   Miller, ML
   Jensen, LJ
   Gnad, F
   Cox, J
   Jensen, TS
   Nigg, EA
   Brunak, S
   Mann, M
AF Olsen, Jesper V.
   Vermeulen, Michiel
   Santamaria, Anna
   Kumar, Chanchal
   Miller, Martin L.
   Jensen, Lars J.
   Gnad, Florian
   Cox, Juergen
   Jensen, Thomas S.
   Nigg, Erich A.
   Brunak, Soren
   Mann, Matthias
TI Quantitative Phosphoproteomics Reveals Widespread Full Phosphorylation
   Site Occupancy During Mitosis
SO SCIENCE SIGNALING
LA English
DT Article
ID SELECTIVE ENRICHMENT; MITOTIC REGULATION; CELL-CULTURE; AMINO-ACIDS;
   IDENTIFICATION; PROTEINS; PROTEOMICS; RESOURCE; DATABASE; ACCURACY
AB Eukaryotic cells replicate by a complex series of evolutionarily conserved events that are tightly regulated at defined stages of the cell division cycle. Progression through this cycle involves a large number of dedicated protein complexes and signaling pathways, and deregulation of this process is implicated in tumorigenesis. We applied high-resolution mass spectrometry-based proteomics to investigate the proteome and phosphoproteome of the human cell cycle on a global scale and quantified 6027 proteins and 20,443 unique phosphorylation sites and their dynamics. Co-regulated proteins and phosphorylation sites were grouped according to their cell cycle kinetics and compared to publicly available messenger RNA microarray data. Most detected phosphorylation sites and more than 20% of all quantified proteins showed substantial regulation, mainly in mitotic cells. Kinase-motif analysis revealed global activation during S phase of the DNA damage response network, which was mediated by phosphorylation by ATM or ATR or DNA-dependent protein kinases. We determined site-specific stoichiometry of more than 5000 sites and found that most of the up-regulated sites phosphorylated by cyclin-dependent kinase 1 (CDK1) or CDK2 were almost fully phosphorylated in mitotic cells. In particular, nuclear proteins and proteins involved in regulating metabolic processes have high phosphorylation site occupancy in mitosis. This suggests that these proteins may be inactivated by phosphorylation in mitotic cells.
C1 [Olsen, Jesper V.; Vermeulen, Michiel; Kumar, Chanchal; Gnad, Florian; Cox, Juergen; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany.
   [Olsen, Jesper V.; Miller, Martin L.; Jensen, Lars J.; Brunak, Soren; Mann, Matthias] Univ Copenhagen, Novo Nordisk Fdn Ctr Prot Res, Fac Hlth Sci, DK-2200 Copenhagen, Denmark.
   [Vermeulen, Michiel] Univ Med Ctr Utrecht, Dept Physiol Chem, NL-3584 CG Utrecht, Netherlands.
   [Vermeulen, Michiel] Univ Med Ctr Utrecht, Canc Genom Ctr, NL-3584 CG Utrecht, Netherlands.
   [Santamaria, Anna; Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kumar, Chanchal] Lilly Singapore Ctr Drug Discovery, Singapore 138648, Singapore.
   [Miller, Martin L.] Mem Sloan Kettering Canc Ctr, Computat Biol Program, New York, NY 10065 USA.
   [Jensen, Thomas S.; Brunak, Soren] Tech Univ Denmark, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.
RP Mann, M (corresponding author), Max Planck Inst Biochem, Dept Prote & Signal Transduct, Klopferspitz 18, D-82152 Martinsried, Germany.
EM mmann@biochem.mpg.de
RI Cox, Jurgen/B-9481-2008; Vermeulen, Michiel/C-8883-2013; Kumar,
   Chanchal/C-2901-2008; Olsen, Jesper/ABH-4638-2020; Miller,
   Martin/D-4660-2009; Mann, Matthias/A-3454-2013; Brunak,
   Soren/O-6621-2016
OI Cox, Jurgen/0000-0001-8597-205X; Vermeulen, Michiel/0000-0003-0836-6894;
   Olsen, Jesper/0000-0002-4747-4938; Mann, Matthias/0000-0003-1292-4799;
   Jensen, Lars Juhl/0000-0001-7885-715X; nigg, erich/0000-0003-4835-5719;
   Gnad, Florian/0000-0002-2287-2251; Brunak, Soren/0000-0003-0316-5866;
   Miller, Martin L/0000-0003-3161-8690
CR Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2
   Blangy A, 1997, J BIOL CHEM, V272, P19418, DOI 10.1074/jbc.272.31.19418
   Bonaldi T, 2008, MOL CELL, V31, P762, DOI 10.1016/j.molcel.2008.07.018
   Branzei D, 2008, NAT REV MOL CELL BIO, V9, P297, DOI 10.1038/nrm2351
   Carson JP, 2004, CANCER RES, V64, P2096, DOI 10.1158/0008-5472.CAN-03-2029
   Charbonnier S, 2008, BIOTECHNOL ANN REV, V14, P1, DOI 10.1016/S1387-2656(08)00001-X
   Cho RJ, 2001, NAT GENET, V27, P48
   Cohen P, 1999, PHILOS T ROY SOC B, V354, P485, DOI 10.1098/rstb.1999.0399
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007
   de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341
   Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105
   Diella F, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-79
   DOMON B, 2006, ANAL SCI, V312, P212
   Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567
   Finn RD, 2007, BIOINFORMATICS, V23, P1568, DOI 10.1093/bioinformatics/btl650
   Flicek P, 2008, NUCLEIC ACIDS RES, V36, pD707, DOI 10.1093/nar/gkm988
   FOISNER R, 1993, CELL, V73, P1267, DOI 10.1016/0092-8674(93)90355-T
   Furukawa K, 1998, EUR J BIOCHEM, V251, P729, DOI 10.1046/j.1432-1327.1998.2510729.x
   Gnad F, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r250
   Gnad F, 2009, NUCLEIC ACIDS RES, V37, pD902, DOI 10.1093/nar/gkn773
   Graumann J, 2008, MOL CELL PROTEOMICS, V7, P672, DOI 10.1074/mcp.M700460-MCP200
   Harper JW, 2007, MOL CELL, V28, P739, DOI 10.1016/j.molcel.2007.11.015
   Hornbeck PV, 2004, PROTEOMICS, V4, P1551, DOI 10.1002/pmic.200300772
   Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760
   Jensen LJ, 2006, NATURE, V443, P594, DOI 10.1038/nature05186
   Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27
   Kastan MB, 2004, NATURE, V432, P316, DOI 10.1038/nature03097
   Kittler R, 2007, NAT CELL BIOL, V9, P1401, DOI 10.1038/ncb1659
   Kumar C, 2009, FEBS LETT, V583, P1703, DOI 10.1016/j.febslet.2009.03.035
   Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200
   Lienhard GE, 2008, TRENDS BIOCHEM SCI, V33, P351, DOI 10.1016/j.tibs.2008.05.004
   Linding R, 2008, NUCLEIC ACIDS RES, V36, pD695, DOI 10.1093/nar/gkm902
   Macek B, 2009, ANNU REV PHARMACOL, V49, P199, DOI 10.1146/annurev.pharmtox.011008.145606
   Mann M, 2008, P NATL ACAD SCI USA, V105, P18132, DOI 10.1073/pnas.0800788105
   Mardia K.V., 2000, DIRECTIONAL STAT
   Matsuoka S, 2007, SCIENCE, V316, P1160, DOI 10.1126/science.1140321
   Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433
   Morgan D. O., 2007, CELL CYCLE PRINCIPLE
   O'Donnell KA, 2005, NATURE, V435, P839, DOI 10.1038/nature03677
   O'Regan L, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-25
   O'Reilly PG, 2005, J BIOL CHEM, V280, P42383, DOI 10.1074/jbc.M510763200
   Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026
   Olsen JV, 2005, MOL CELL PROTEOMICS, V4, P2010, DOI 10.1074/mcp.T500030-MCP200
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200
   Pinkse MWH, 2004, ANAL CHEM, V76, P3935, DOI 10.1021/ac0498617
   R Core Team, 2017, R LANG ENV STAT COMP
   Schroeder MJ, 2004, ANAL CHEM, V76, P3590, DOI 10.1021/ac0497104
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Shah OJ, 2003, J BIOL CHEM, V278, P16433, DOI 10.1074/jbc.M300435200
   Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468
   Steen H, 2005, P NATL ACAD SCI USA, V102, P3948, DOI 10.1073/pnas.0409536102
   Steen JAJ, 2008, P NATL ACAD SCI USA, V105, P6069, DOI 10.1073/pnas.0709807104
   Sturn A, 2002, BIOINFORMATICS, V18, P207, DOI 10.1093/bioinformatics/18.1.207
   WHITFIELD ML, 1977, MOL BIOL CELL, V13, P2000
   Wisniewski JR, 2009, NAT METHODS, V6, P359, DOI [10.1038/NMETH.1322, 10.1038/nmeth.1322]
   Yamaguchi T, 2005, J CELL BIOL, V171, P431, DOI 10.1083/jcb.200504091
NR 59
TC 970
Z9 3724
U1 19
U2 292
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD JAN 12
PY 2010
VL 3
IS 104
AR ra3
DI 10.1126/scisignal.2000475
PG 15
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 570BR
UT WOS:000275647100003
PM 20068231
HC Y
HP N
DA 2021-01-25
ER

PT J
AU Li, KG
   Blum, Y
   Verma, A
   Liu, Z
   Pramanik, K
   Leigh, NR
   Chun, CZ
   Samant, GV
   Zhao, BF
   Garnaas, MK
   Horswill, MA
   Stanhope, SA
   North, PE
   Miao, RQ
   Wilkinson, GA
   Affolter, M
   Ramchandran, R
AF Li, Keguo
   Blum, Yannick
   Verma, Anjali
   Liu, Zhong
   Pramanik, Kallal
   Leigh, Noah R.
   Chun, Chang Z.
   Samant, Ganesh V.
   Zhao, Baofeng
   Garnaas, Maija K.
   Horswill, Mark A.
   Stanhope, Stephen A.
   North, Paula E.
   Miao, Robert Q.
   Wilkinson, George A.
   Affolter, Markus
   Ramchandran, Ramani
TI A noncoding antisense RNA in tie-1 locus regulates tie-1 function in
   vivo
SO BLOOD
LA English
DT Article
ID RECEPTOR TYROSINE KINASES; VASCULAR ENDOTHELIAL-CELLS; ZEBRAFISH;
   MALFORMATIONS; ANGIOGENESIS; EXPRESSION; DATABASE; GENE; TRANSCRIPTS;
   HEMANGIOMA
AB Recently, messenger RNAs in eukaryotes have shown to associate with antisense (AS) transcript partners that are often referred to as long noncoding RNAs (IncRNAs) whose function is largely unknown. Here, we have identified a natural AS transcript for tyrosine kinase containing immunoglobulin and epidermal growth factor homology domain-1 (tie-1), tie-1AS IncRNA in zebrafish, mouse, and humans. In embryonic zebrafish, tie-1AS IncRNA transcript is expressed temporally and spatially in vivo with its native target, the tie-1 coding transcript and in additional locations (ear and brain). The tie-1AS IncRNA selectively binds tie-1 mRNA in vivo and regulates tie-1 transcript levels, resulting in specific defects in endothelial cell contact junctions in vivo and in vitro. The ratio of tie-1 versus tie-1AS IncRNA is altered in human vascular anomaly samples. These results directly implicate noncoding RNA-mediated transcriptional regulation of gene expression as a fundamental control mechanism for physiologic processes, such as vascular development. (Blood. 2010;115:133-139)
C1 [Li, Keguo; Verma, Anjali; Pramanik, Kallal; Leigh, Noah R.; Chun, Chang Z.; Samant, Ganesh V.; Garnaas, Maija K.; Horswill, Mark A.; Wilkinson, George A.; Ramchandran, Ramani] Med Coll Wisconsin, Dept Pediat, Childrens Res Inst, Dev Vasc Biol Program, Milwaukee, WI 53226 USA.
   [Blum, Yannick; Affolter, Markus] Univ Basel, Biozentrum, Basel, Switzerland.
   [Liu, Zhong; Zhao, Baofeng; Miao, Robert Q.] Childrens Res Inst, Translat & Biomed Res Ctr, Milwaukee, WI USA.
   [Stanhope, Stephen A.] Univ Chicago, Div Biol Sci, Chicago, IL 60637 USA.
RP Ramchandran, R (corresponding author), Med Coll Wisconsin, Dept Pediat, Childrens Res Inst, Dev Vasc Biol Program, CRI C3420,8701 Watertown Plank Rd,POB 26509, Milwaukee, WI 53226 USA.
EM rramchan@mcw.edu
RI Miao, Qing/K-3186-2019
OI Miao, Qing/0000-0002-3125-1238; Affolter, Markus/0000-0002-5171-0016
FU Children's Research Institute at the Medical College of Wisconsin;
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [HL090712]; Advancing
   Healthier Wisconsin; State of Wisconsin Breast Cancer Research
   postdoctoral fellowship; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)
   [R01HL090712, R01HL090712, R01HL090712, R01HL102745, R01HL102745,
   R01HL090712, R01HL102745, R01HL102745, R01HL090712] Funding Source: NIH
   RePORTER
FX This work was supported in part by start-up funds from the Children's
   Research Institute at the Medical College of Wisconsin and the National
   Institutes of Health (HL090712 grant; R. R.). K. L. and C.Z.C. are
   supported partly by funds from Advancing Healthier Wisconsin Grant (R.
   R.). G. V. S. is a recipient of the State of Wisconsin Breast Cancer
   Research postdoctoral fellowship.
CR Bedell VM, 2005, P NATL ACAD SCI USA, V102, P6373, DOI 10.1073/pnas.0408318102
   Bhandarkar SS, 2009, J CLIN INVEST, V119, P2359, DOI 10.1172/JCI33877
   Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038
   Cheng J, 2005, SCIENCE, V308, P1149, DOI 10.1126/science.1108625
   Dellinger M, 2008, DEV BIOL, V319, P309, DOI 10.1016/j.ydbio.2008.04.024
   Dinger ME, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000176
   Faghihi MA, 2008, NAT MED, V14, P723, DOI 10.1038/nm1784
   FALLON MB, 1993, AM J PHYSIOL, V264, pC1439
   FOLKMAN J, 1971, NEW ENGL J MED, V285, P1182
   Garnaas MK, 2008, CIRC RES, V103, P710, DOI 10.1161/CIRCRESAHA.108.181388
   Gruber AR, 2008, NUCLEIC ACIDS RES, V36, pW70, DOI 10.1093/nar/gkn188
   Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672
   HOFACKER IL, 2004, CURR PROTOC BIOINFOR, P12
   Katayama S, 2005, SCIENCE, V309, P1564, DOI 10.1126/science.1112009
   Kim KE, 2007, ARTERIOSCL THROM VAS, V27, P564, DOI 10.1161/01.ATV.0000256458.82320.be
   Limaye N, 2009, NAT GENET, V41, P118, DOI 10.1038/ng.272
   Lyons MS, 1998, DEV DYNAM, V212, P133, DOI 10.1002/(SICI)1097-0177(199805)212:1<133::AID-AJA12>3.3.CO;2-3
   Mercer TR, 2009, NAT REV GENET, V10, P155, DOI 10.1038/nrg2521
   MULLIKEN JB, 1982, PLAST RECONSTR SURG, V69, P412, DOI 10.1097/00006534-198203000-00002
   Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951
   Navarro P, 1995, J BIOL CHEM, V270, P30965, DOI 10.1074/jbc.270.52.30965
   North PE, 2002, OPHTHALMOLOGY, V109, P223, DOI 10.1016/S0161-6420(01)00994-0
   Okada Y, 2007, CIRC RES, V100, P1712, DOI 10.1161/01.RES.0000269779.10644.dc
   Partanen J, 1996, DEVELOPMENT, V122, P3013
   Perry B, 2007, ARCH DERMATOL, V143, P504, DOI 10.1001/archderm.143.4.504
   Ponting CP, 2009, CELL, V136, P629, DOI 10.1016/j.cell.2009.02.006
   Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842
   Puri MC, 1999, DEVELOPMENT, V126, P4569
   PURI MC, 1995, EMBO J, V14, P5884, DOI 10.1002/j.1460-2075.1995.tb00276.x
   RIBATTI D, 2008, INT REV CELL MOL BIO, P2661
   SATO TN, 1993, P NATL ACAD SCI USA, V90, P9355, DOI 10.1073/pnas.90.20.9355
   SATO TN, 1995, NATURE, V376, P70, DOI 10.1038/376070a0
   Sprague J, 2008, NUCLEIC ACIDS RES, V36, pD768, DOI 10.1093/nar/gkm956
   Tsiamis AC, 2002, MICROVASC RES, V63, P149, DOI 10.1006/mvre.2001.2377
   Vikkula M, 1996, CELL, V87, P1181, DOI 10.1016/S0092-8674(00)81814-0
   Wang H, 2004, ONCOGENE, V23, P8700, DOI 10.1038/sj.onc.1208006
   Westerfield M, 1999, METHOD CELL BIOL, V60, P339
   Zhang Y, 2006, NUCLEIC ACIDS RES, V34, P3465, DOI 10.1093/nar/gkl473
NR 38
TC 108
Z9 128
U1 0
U2 16
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD JAN 7
PY 2010
VL 115
IS 1
BP 133
EP 139
DI 10.1182/blood-2009-09-242180
PG 7
WC Hematology
SC Hematology
GA 541CE
UT WOS:000273389600021
PM 19880500
OA Green Published
DA 2021-01-25
ER

PT J
AU Stahlberg, H
   Zeng, XY
   Masiel, DJ
   Browning, N
   Spence, J
   Mitsuoka, K
   Gipson, B
AF Stahlberg, Henning
   Zeng, Xiangyan
   Masiel, Daniel J.
   Browning, Nigel
   Spence, John
   Mitsuoka, Kaoru
   Gipson, Bryant
TI Filling the missing cone: Automatic recovery of data in tilt-limited
   microscopy
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE missing cone; electron crystallography; membrane protein structure
C1 [Stahlberg, Henning; Gipson, Bryant] Univ Basel, Biozentrum, C CINA, Basel, Switzerland.
   [Zeng, Xiangyan] Ft Valley State Univ, Dept Math & Comp Sci, Ft Valley, GA 31030 USA.
   [Masiel, Daniel J.; Browning, Nigel] Univ Calif Davis, Dept Chem Engn & Mat Sci, Davis, CA 95616 USA.
   [Spence, John] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA.
   [Mitsuoka, Kaoru] Natl Inst Adv Ind Sci & Technol, Biomed Informat Res Ctr, Tokyo, Japan.
EM Henning.Stahlberg@unibas.ch
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592
CR Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020
   Zeng X, 2007, J STRUCT BIOL, V160, P362, DOI 10.1016/j.jsb.2007.09.013
NR 2
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2010
VL 66
SU S
MA FA1-MS05-T
BP S17
EP S17
DI 10.1107/S0108767310099642
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI4CD
UT WOS:000483128900035
OA Bronze
DA 2021-01-25
ER

PT J
AU Ludolph, AC
   Bendotti, C
   Blaugrund, E
   Chio, A
   Greensmith, L
   Loeffler, JP
   Mead, R
   Niessen, HG
   Petri, S
   Pradat, PF
   Robberecht, W
   Ruegg, M
   Schwalenstocker, B
   Stiller, D
   van den Berg, L
   Vieira, F
   von Horsten, S
AF Ludolph, Albert C.
   Bendotti, Caterina
   Blaugrund, Eran
   Chio, Adriano
   Greensmith, Linda
   Loeffler, Jean-Philippe
   Mead, Richard
   Niessen, Heiko G.
   Petri, Susanne
   Pradat, Pierre-Francois
   Robberecht, Wim
   Ruegg, Markus
   Schwalenstoecker, Birgit
   Stiller, Detlev
   van den Berg, Leonard
   Vieira, Fernando
   von Horsten, Stephan
TI Guidelines for preclinical animal research in ALS/MND: A consensus
   meeting
SO AMYOTROPHIC LATERAL SCLEROSIS
LA English
DT Article
ID AMYOTROPHIC-LATERAL-SCLEROSIS; ALS; MUTATIONS; MICE; DEGENERATION;
   TDP-43; MOUSE; MODEL; PROGRESSION; TRIALS
AB The development of therapeutics for ALS/MND is largely based on work in experimental animals carrying human SOD mutations. However, translation of apparent therapeutic successes from in vivo to the human disease has proven difficult and a considerable amount of financial resources has been apparently wasted. Standard operating procedures (SOPs) for preclinical animal research in ALS/MND are urgently required. Such SOPs will help to establish SOPs for translational research for other neurological diseases within the next few years. To identify the challenges and to improve the research methodology, the European ALS/MND group held a meeting in 2006 and published guidelines in 2007 (1). A second international conference to improve the guidelines was held in 2009. These second and improved guidelines are dedicated to the memory of Sean F. Scott.</.
C1 [Ludolph, Albert C.; Schwalenstoecker, Birgit] Univ Ulm, Dept Neurol, D-89081 Ulm, Germany.
   [Bendotti, Caterina] Mario Negri Inst Pharmacol Res, Dept Neurosci, I-20157 Milan, Italy.
   [Blaugrund, Eran] Teva Pharmaceut, Netanya, Israel.
   [Chio, Adriano] Univ Turin, Dept Neurosci, Neurol Sect, I-10124 Turin, Italy.
   [Greensmith, Linda] UCL, Inst Neurol, London WC1E 6BT, England.
   [Loeffler, Jean-Philippe] Univ Strasbourg, Lab Signalizat Mol & Neurodegenescence, Strasbourg, France.
   [Mead, Richard] Univ Sheffield, Sch Med & Biomed Sci, Sect Neurosci, Acad Unit Neurol, Sheffield, S Yorkshire, England.
   [Niessen, Heiko G.; Stiller, Detlev] Boehringer Ingelheim Pharma GmbH & Co KG, In Vivo Imaging Unit, Biberach, Germany.
   [Petri, Susanne] Hannover Med Sch, Dept Neurol, D-30623 Hannover, Germany.
   [Pradat, Pierre-Francois] Grp Hosp Pitie Salpetriere, AP HP, F-75634 Paris, France.
   [Robberecht, Wim] Univ Leuven, Dept Neurol, Louvain, Belgium.
   [Ruegg, Markus] Univ Basel, Biozentrum, Basel, Switzerland.
   [van den Berg, Leonard] Univ Med Ctr, Rudolf Magnus Inst Neurosci, Utrecht, Netherlands.
   [Vieira, Fernando] ALS Therapy Dev Inst, Cambridge, MA USA.
   [von Horsten, Stephan] Univ Erlangen Nurnberg, Erlangen, Germany.
RP Ludolph, AC (corresponding author), Univ Ulm, Dept Neurol, Oberer Eselsberg 45, D-89081 Ulm, Germany.
EM albert.ludolph@rku.de
RI Chio, Adriano/K-3425-2016; LOEFFLER, Jean-Philippe/AAS-4401-2020; von
   Horsten, Stephan/G-9005-2015; Mead, Richard J/B-4779-2009; Vieira,
   Fernando/ABG-9082-2020; Bendotti, Caterina/AAB-2273-2020; Ruegg,
   Markus/X-7256-2019; Vieira, Fernando/L-6246-2013
OI Chio, Adriano/0000-0001-9579-5341; von Horsten,
   Stephan/0000-0001-6409-0664; Mead, Richard J/0000-0002-3207-0068;
   Vieira, Fernando/0000-0003-2996-6418; Ruegg, Markus/0000-0002-4974-9384;
   Vieira, Fernando/0000-0003-2996-6418; Bendotti,
   Caterina/0000-0003-1055-1271
FU Medical Research CouncilMedical Research Council UK (MRC) [G0601943]
   Funding Source: Medline; Medical Research CouncilMedical Research
   Council UK (MRC) [G0601943B] Funding Source: researchfish
CR Angelov DN, 2003, P NATL ACAD SCI USA, V100, P4790, DOI 10.1073/pnas.0530191100
   Benatar M, 2007, NEUROBIOL DIS, V26, P1, DOI 10.1016/j.nbd.2006.12.015
   Crow JP, 2005, ANN NEUROL, V58, P258, DOI 10.1002/ana.20552
   Fornai F, 2008, P NATL ACAD SCI USA, V105, P2052, DOI 10.1073/pnas.0708022105
   GURNEY ME, 1994, SCIENCE, V264, P1772, DOI 10.1126/science.8209258
   Kabashi E, 2008, NAT GENET, V40, P572, DOI 10.1038/ng.132
   Kwiatkowski TJ, 2009, SCIENCE, V323, P1205, DOI 10.1126/science.1166066
   Lacomblez L, 1996, LANCET, V347, P1425, DOI 10.1016/S0140-6736(96)91680-3
   Lagier-Tourenne C, 2009, CELL, V136, P1001, DOI 10.1016/j.cell.2009.03.006
   Laird FM, 2008, J NEUROSCI, V28, P1997, DOI 10.1523/JNEUROSCI.4231-07.2008
   Ludolph Albert C, 2007, Amyotroph Lateral Scler, V8, P217, DOI 10.1080/17482960701292837
   Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108
   Pizzasegola C, 2009, AMYOTROPH LATERAL SC, V10, P221, DOI 10.1080/17482960902803440
   Rothstein JD, 2003, ANN NEUROL, V53, P423, DOI 10.1002/ana.10561
   Schnabel J, 2008, NATURE, V454, P682, DOI 10.1038/454682a
   Scott S, 2008, AMYOTROPH LATERAL SC, V9, P4, DOI 10.1080/17482960701856300
   Sreedharan J, 2008, SCIENCE, V319, P1668, DOI 10.1126/science.1154584
   Vance C, 2009, SCIENCE, V323, P1208, DOI 10.1126/science.1165942
   WONG PC, 1995, NEURON, V14, P1105, DOI 10.1016/0896-6273(95)90259-7
NR 19
TC 207
Z9 208
U1 0
U2 9
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1748-2968
EI 1471-180X
J9 AMYOTROPH LATERAL SC
JI Amyotroph. Lateral. Scler.
PY 2010
VL 11
IS 1-2
BP 38
EP 45
DI 10.3109/17482960903545334
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA 562NV
UT WOS:000275059800004
PM 20184514
OA Bronze
DA 2021-01-25
ER

PT S
AU Shen, K
   Scheiffele, P
AF Shen, Kang
   Scheiffele, Peter
BE Hyman, SE
TI Genetics and Cell Biology of Building Specific Synaptic Connectivity
SO ANNUAL REVIEW OF NEUROSCIENCE, VOL 33
SE Annual Review of Neuroscience
LA English
DT Review; Book Chapter
DE recognition; trans-synaptic signaling; guidepost cell; synapse
   elimination
ID OCULAR DOMINANCE COLUMNS; CENTRAL-NERVOUS-SYSTEM; CAJAL-RETZIUS CELLS;
   N-TERMINAL DOMAIN; MOTOR-NEURON POOL; C-ELEGANS; NEUROMUSCULAR-JUNCTION;
   CAENORHABDITIS-ELEGANS; GAMMA-PROTOCADHERINS; GLUTAMATE-RECEPTOR
AB The assembly of specific synaptic connections during development of the nervous system represents a remarkable example of cellular recognition and differentiation. Neurons employ several different cellular signaling strategies to solve this puzzle, which successively limit unwanted interactions and reduce the number of direct recognition events that are required to result in a specific connectivity pattern. Specificity mechanisms include the action of contact-mediated and long-range signals that support or inhibit synapse formation, which can take place directly between synaptic partners or with transient partners and transient cell populations. The molecular signals that drive the synaptic differentiation process at individual synapses in the central nervous system are similarly diverse and act through multiple, parallel differentiation pathways. This molecular complexity balances the need for central circuits to be assembled with high accuracy during development while retaining plasticity for local and dynamic regulation.
C1 [Shen, Kang] Stanford Univ, Howard Hughes Med Inst, Dept Biol & Pathol, Stanford, CA 94305 USA.
   [Scheiffele, Peter] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Shen, K (corresponding author), Stanford Univ, Howard Hughes Med Inst, Dept Biol & Pathol, Stanford, CA 94305 USA.
EM kangshen@stanford.edu; peter.scheiffele@unibas.ch
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute Funding
   Source: Medline; NIDA NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Drug Abuse (NIDA) [R01 DA020844, DA20844] Funding Source: Medline;
   NINDS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01 NS048392, R01 NS048392-06A1, R37
   NS048392] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL
   DISORDERS AND STROKEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS) [R01NS048392, R01NS048392,
   R01NS048392, R01NS048392, R01NS048392, R01NS048392, R01NS048392,
   R01NS048392, R01NS048392, R01NS048392] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Drug Abuse (NIDA) [R01DA020844, R01DA020844, R01DA020844,
   R01DA020844, R01DA020844] Funding Source: NIH RePORTER
CR Aberle H, 2002, NEURON, V33, P545, DOI 10.1016/S0896-6273(02)00589-5
   Ahmad-Annuar A, 2006, J CELL BIOL, V174, P127, DOI 10.1083/jcb.200511054
   Altman J., 1997, RELATION ITS EVOLUTI
   AMBROS V, 1994, TRENDS GENET, V10, P123, DOI 10.1016/0168-9525(94)90213-5
   Ango F, 2004, CELL, V119, P257, DOI 10.1016/j.cell.2004.10.004
   Ango F, 2008, PLOS BIOL, V6, P739, DOI 10.1371/journal.pbio.0060103
   Ataman B, 2008, NEURON, V57, P705, DOI 10.1016/j.neuron.2008.01.026
   Barres BA, 2008, NEURON, V60, P430, DOI 10.1016/j.neuron.2008.10.013
   BARTLETT WP, 1984, J NEUROSCI, V4, P1954
   BATE CM, 1976, NATURE, V260, P54, DOI 10.1038/260054a0
   Biederer T, 2002, SCIENCE, V297, P1525, DOI 10.1126/science.1072356
   Biederer T, 2007, NAT PROTOC, V2, P670, DOI 10.1038/nprot.2007.92
   Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026
   Buffelli M, 2003, NATURE, V424, P430, DOI 10.1038/nature01844
   Busetto G, 2000, J NEUROSCI, V20, P685, DOI 10.1523/JNEUROSCI.20-02-00685.2000
   Cardozo T, 2004, NAT REV MOL CELL BIO, V5, P739, DOI 10.1038/nrm1471
   Chen BE, 2006, CELL, V125, P607, DOI 10.1016/j.cell.2006.03.034
   Chen F, 2007, NEURON, V55, P247, DOI 10.1016/j.neuron.2007.06.031
   Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470
   Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005
   Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020
   Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029
   Cohen S, 2008, ANNU REV CELL DEV BI, V24, P183, DOI 10.1146/annurev.cellbio.24.110707.175235
   Colman H, 1997, SCIENCE, V275, P356, DOI 10.1126/science.275.5298.356
   Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762
   CREPEL F, 1976, J NEUROBIOL, V7, P567, DOI 10.1002/neu.480070609
   Dahlhaus R, 2010, HIPPOCAMPUS, V20, P305, DOI 10.1002/hipo.20630
   Dalva MB, 2000, CELL, V103, P945, DOI 10.1016/S0092-8674(00)00197-5
   Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009
   Davis EK, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-32
   Davis GW, 2006, ANNU REV NEUROSCI, V29, P307, DOI 10.1146/annurev.neuro.28.061604.135751
   de Wit J, 2009, NEURON, V64, P799, DOI 10.1016/j.neuron.2009.12.019
   Dean C, 2003, NAT NEUROSCI, V6, P708, DOI 10.1038/nn1074
   DelRio JA, 1997, NATURE, V385, P70, DOI 10.1038/385070a0
   DESAI C, 1988, NATURE, V336, P638, DOI 10.1038/336638a0
   Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334
   Diaz E, 2002, NEURON, V36, P417, DOI 10.1016/S0896-6273(02)01016-4
   Ding M, 2007, SCIENCE, V317, P947, DOI 10.1126/science.1145727
   Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305
   Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025
   Esumi S, 2005, NAT GENET, V37, P171, DOI 10.1038/ng1500
   Fannon AM, 1996, NEURON, V17, P423, DOI 10.1016/S0896-6273(00)80175-0
   Fernandez-Monreal M, 2009, MOL CELL NEUROSCI, V40, P344, DOI 10.1016/j.mcn.2008.12.002
   Flavell SW, 2008, ANNU REV NEUROSCI, V31, P563, DOI 10.1146/annurev.neuro.31.060407.125631
   Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511
   Frotscher M, 1998, CURR OPIN NEUROBIOL, V8, P570, DOI 10.1016/S0959-4388(98)80082-2
   Fu ZY, 2003, J NEUROPHYSIOL, V90, P3950, DOI 10.1152/jn.00647.2003
   Fuentealba LC, 2007, CELL, V131, P980, DOI 10.1016/j.cell.2007.09.027
   Fuerst PG, 2008, NATURE, V451, P470, DOI 10.1038/nature06514
   Garrett AM, 2009, J NEUROSCI, V29, P11723, DOI 10.1523/JNEUROSCI.2818-09.2009
   GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0
   Gendrel M, 2009, NATURE, V461, P992, DOI 10.1038/nature08430
   Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015
   GHOSH A, 1992, SCIENCE, V255, P1441, DOI 10.1126/science.1542795
   Graf ER, 2004, CELL, V119, P1013, DOI 10.1016/j.cell.2004.11.035
   Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006
   Grunwald IC, 2001, NEURON, V32, P1027, DOI 10.1016/S0896-6273(01)00550-5
   Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4
   Hall AC, 2002, MOL CELL NEUROSCI, V20, P257, DOI 10.1006/mcne.2002.1117
   Hall AC, 2000, CELL, V100, P525, DOI 10.1016/S0092-8674(00)80689-3
   Hallam SJ, 1998, NATURE, V395, P78, DOI 10.1038/25757
   HAMOS JE, 1987, J COMP NEUROL, V259, P165, DOI 10.1002/cne.902590202
   Hasegawa S, 2008, MOL CELL NEUROSCI, V38, P66, DOI 10.1016/j.mcn.2008.01.016
   Henderson JT, 2001, NEURON, V32, P1041, DOI 10.1016/S0896-6273(01)00553-0
   Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033
   Herrera E, 2003, CELL, V114, P545, DOI 10.1016/S0092-8674(03)00684-6
   Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013
   Hines RM, 2008, J NEUROSCI, V28, P6055, DOI 10.1523/JNEUROSCI.0032-08.2008
   Hirai H, 2005, NAT NEUROSCI, V8, P1534, DOI 10.1038/nn1576
   HIRANO T, 1994, NEUROSCI LETT, V182, P172, DOI 10.1016/0304-3940(94)90790-0
   Hooks BM, 2006, NEURON, V52, P281, DOI 10.1016/j.neuron.2006.07.007
   Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218
   HUBEL DH, 1977, PHILOS T ROY SOC B, V278, P377, DOI 10.1098/rstb.1977.0050
   Hughes ME, 2007, NEURON, V54, P417, DOI 10.1016/j.neuron.2007.04.013
   ICHTCHENKO K, 1995, CELL, V81, P435, DOI 10.1016/0092-8674(95)90396-8
   Inaki M, 2007, CURR BIOL, V17, P1574, DOI 10.1016/j.cub.2007.08.013
   Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511
   Kakegawa W, 2008, J NEUROSCI, V28, P1460, DOI 10.1523/JNEUROSCI.2553-07.2008
   Kakegawa W, 2009, J NEUROSCI, V29, P5738, DOI 10.1523/JNEUROSCI.6013-08.2009
   Kalinovsky A, 2004, CURR OPIN NEUROBIOL, V14, P272, DOI 10.1016/j.conb.2004.05.011
   Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2
   Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7
   Kanold PO, 2003, SCIENCE, V301, P521, DOI 10.1126/science.1084152
   Katz LC, 1996, SCIENCE, V274, P1133, DOI 10.1126/science.274.5290.1133
   Kayser MS, 2008, NEURON, V59, P56, DOI 10.1016/j.neuron.2008.05.007
   Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026
   Kim S, 2006, NAT NEUROSCI, V9, P1294, DOI 10.1038/nn1763
   Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046
   Klein R, 2001, CURR OPIN CELL BIOL, V13, P196, DOI 10.1016/S0955-0674(00)00197-6
   Ko J, 2009, NEURON, V64, P791, DOI 10.1016/j.neuron.2009.12.012
   Kohmura N, 1998, NEURON, V20, P1137, DOI 10.1016/S0896-6273(00)80495-X
   Korkut C, 2009, NAT REV NEUROSCI, V10, P627, DOI 10.1038/nrn2681
   Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003
   Kurihara H, 1997, J NEUROSCI, V17, P9613
   Learte AR, 2007, ADV EXP MED BIOL, V621, P156, DOI 10.1007/978-0-387-76715-4_12
   Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855
   Lee KJ, 1999, ANNU REV NEUROSCI, V22, P261, DOI 10.1146/annurev.neuro.22.1.261
   Lefebvre JL, 2008, DEVELOPMENT, V135, P4141, DOI 10.1242/dev.027912
   Levinson JN, 2005, J BIOL CHEM, V280, P17312, DOI 10.1074/jbc.M413812200
   Li J, 2007, NEURON, V55, P741, DOI 10.1016/j.neuron.2007.08.002
   Lichtman JW, 2000, NEURON, V25, P269, DOI 10.1016/S0896-6273(00)80893-4
   Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5
   Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002
   Linhoff MW, 2009, NEURON, V61, P734, DOI 10.1016/j.neuron.2009.01.017
   Liu XB, 2005, J NEUROSCI, V25, P9124, DOI 10.1523/JNEUROSCI.2648-05.2005
   Low LK, 2008, P NATL ACAD SCI USA, V105, P8136, DOI 10.1073/pnas.0803849105
   Lu W, 2009, NEURON, V62, P254, DOI 10.1016/j.neuron.2009.02.027
   Luo LQ, 2005, ANNU REV NEUROSCI, V28, P127, DOI 10.1146/annurev.neuro.28.061604.135632
   Maloof JN, 1999, DEVELOPMENT, V126, P37
   Marques G, 2003, DEVELOPMENT, V130, P5457, DOI 10.1242/dev.00772
   Marques G, 2002, NEURON, V33, P529, DOI 10.1016/S0896-6273(02)00595-0
   Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035
   Mason CA, 1997, PERSPECT DEV NEUROBI, V5, P69
   Mathew D, 2005, SCIENCE, V310, P1344, DOI 10.1126/science.1117051
   Matthews BJ, 2007, CELL, V129, P593, DOI 10.1016/j.cell.2007.04.013
   Mauch DH, 2001, SCIENCE, V294, P1354, DOI 10.1126/science.294.5545.1354
   Maximov A, 2002, J NEUROSCI, V22, P6939
   McCabe BD, 2004, NEURON, V41, P891, DOI 10.1016/S0896-6273(04)00073-X
   McCabe BD, 2003, NEURON, V39, P241, DOI 10.1016/S0896-6273(03)00426-4
   Miles R, 1996, NEURON, V16, P815, DOI 10.1016/S0896-6273(00)80101-4
   Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102
   Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755
   Missler M, 1998, TRENDS GENET, V14, P20, DOI 10.1016/S0168-9525(97)01324-3
   Morey M, 2008, NATURE, V456, P795, DOI 10.1038/nature07419
   Morishita H, 2007, CURR OPIN CELL BIOL, V19, P584, DOI 10.1016/j.ceb.2007.09.006
   Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959
   Nam CI, 2005, P NATL ACAD SCI USA, V102, P6137, DOI 10.1073/pnas.0502038102
   Nelson SB, 2006, TRENDS NEUROSCI, V29, P339, DOI 10.1016/j.tins.2006.05.004
   Neves G, 2004, NAT GENET, V36, P240, DOI 10.1038/ng1299
   Nishimura-Akiyoshi S, 2007, P NATL ACAD SCI USA, V104, P14801, DOI 10.1073/pnas.0706919104
   NITKIN RM, 1987, J CELL BIOL, V105, P2471, DOI 10.1083/jcb.105.6.2471
   NOAKES PG, 1995, NATURE, V374, P258, DOI 10.1038/374258a0
   Nuriya M, 2006, J NEUROCHEM, V97, P652, DOI 10.1111/j.1471-4159.2006.03740.x
   O'Brien RJ, 1999, NEURON, V23, P309, DOI 10.1016/S0896-6273(00)80782-5
   O'Connor TP, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-18
   Packard M, 2002, CELL, V111, P319, DOI 10.1016/S0092-8674(02)01047-4
   Pan CL, 2006, DEV CELL, V10, P367, DOI 10.1016/j.devcel.2006.02.010
   Passafaro M, 2003, NATURE, V424, P677, DOI 10.1038/nature01781
   Patton BL, 1997, J CELL BIOL, V139, P1507, DOI 10.1083/jcb.139.6.1507
   Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000
   Phillips GR, 2003, J NEUROSCI, V23, P5096
   Polleux F, 2007, NAT REV NEUROSCI, V8, P331, DOI 10.1038/nrn2118
   Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291
   Pouille F, 2004, NATURE, V429, P717, DOI 10.1038/nature02615
   Poulopoulos A, 2009, NEURON, V63, P628, DOI 10.1016/j.neuron.2009.08.023
   Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357
   Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020
   Rawson JM, 2003, J NEUROBIOL, V55, P134, DOI 10.1002/neu.10189
   Rico B, 2002, NAT NEUROSCI, V5, P225, DOI 10.1038/nn808
   Roos J, 2000, NEURON, V26, P371, DOI 10.1016/S0896-6273(00)81170-8
   Ruiz-Canada C, 2006, INT REV NEUROBIOL, V75, P217, DOI 10.1016/S0074-7742(06)75010-3
   Saglietti L, 2007, NEURON, V54, P461, DOI 10.1016/j.neuron.2007.04.012
   Sanes JR, 1999, CURR OPIN NEUROBIOL, V9, P79, DOI 10.1016/S0959-4388(99)80010-5
   Sanes JR, 1999, ANNU REV NEUROSCI, V22, P389, DOI 10.1146/annurev.neuro.22.1.389
   Sawaya MR, 2008, CELL, V134, P1007, DOI 10.1016/j.cell.2008.07.042
   Scheiffele P, 2000, CELL, V101, P657, DOI 10.1016/S0092-8674(00)80877-6
   Schulz DJ, 2007, P NATL ACAD SCI USA, V104, P13187, DOI 10.1073/pnas.0705827104
   Schulz DJ, 2006, NAT NEUROSCI, V9, P356, DOI 10.1038/nn1639
   Shalizi A, 2006, SCIENCE, V311, P1012, DOI 10.1126/science.1122513
   Shapiro L, 2007, ANNU REV NEUROSCI, V30, P451, DOI 10.1146/annurev.neuro.29.051605.113034
   Shen K, 2003, CELL, V112, P619, DOI 10.1016/S0092-8674(03)00113-2
   Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X
   Shinza-Kameda M, 2006, NEURON, V49, P205, DOI 10.1016/j.neuron.2005.11.013
   Shirasaki R, 2006, NEURON, V50, P841, DOI 10.1016/j.neuron.2006.04.030
   Sia GM, 2007, NEURON, V55, P87, DOI 10.1016/j.neuron.2007.06.020
   Soba P, 2007, NEURON, V54, P403, DOI 10.1016/j.neuron.2007.03.029
   SORIANO E, 1994, J COMP NEUROL, V342, P571, DOI 10.1002/cne.903420406
   Steinberg MS, 2007, CURR OPIN GENET DEV, V17, P281, DOI 10.1016/j.gde.2007.05.002
   Stevens B, 2007, CELL, V131, P1164, DOI 10.1016/j.cell.2007.10.036
   Super H, 1998, J NEUROSCI, V18, P4616
   TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123
   Thompson CL, 2008, NEURON, V60, P1010, DOI 10.1016/j.neuron.2008.12.008
   Tietjen I, 2003, NEURON, V38, P161, DOI 10.1016/S0896-6273(03)00229-0
   Tran TS, 2009, NATURE, V462, P1065, DOI 10.1038/nature08628
   Tu SC, 2007, NEURON, V55, P69, DOI 10.1016/j.neuron.2007.06.021
   Uemura T, 2008, BIOCHEM BIOPH RES CO, V377, P1315, DOI 10.1016/j.bbrc.2008.10.170
   Ullian EM, 2001, SCIENCE, V291, P657, DOI 10.1126/science.291.5504.657
   Umemori H, 2004, CELL, V118, P257, DOI 10.1016/j.cell.2004.06.025
   USHKARYOV YA, 1992, SCIENCE, V257, P50, DOI 10.1126/science.1621094
   Varoqueaux F, 2004, EUR J CELL BIOL, V83, P449, DOI 10.1078/0171-9335-00410
   Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003
   Vicario-Abejon C, 2002, NAT REV NEUROSCI, V3, P965, DOI 10.1038/nrn988
   Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042
   Wadsworth WG, 1996, NEURON, V16, P35, DOI 10.1016/S0896-6273(00)80021-5
   Wang XZ, 2002, NEURON, V36, P843, DOI 10.1016/S0896-6273(02)01090-5
   Weiner JA, 2005, P NATL ACAD SCI USA, V102, P8, DOI 10.1073/pnas.0407931101
   WHITE JG, 1986, PHILOS T R SOC B, V314, P1, DOI 10.1098/rstb.1986.0056
   Wilson SI, 2008, NEURON, V59, P413, DOI 10.1016/j.neuron.2008.07.020
   Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3
   Wojtowicz WM, 2004, CELL, V118, P619, DOI 10.1016/j.cell.2004.08.021
   Wojtowicz WM, 2007, CELL, V130, P1134, DOI 10.1016/j.cell.2007.08.026
   Woo J, 2009, NAT NEUROSCI, V12, P428, DOI 10.1038/nn.2279
   Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8
   Xu JY, 2010, NAT NEUROSCI, V13, P22, DOI 10.1038/nn.2459
   Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8
   Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469
   Yaron A, 2005, NEURON, V45, P513, DOI 10.1016/j.neuron.2005.01.013
   Yuzaki M, 2008, CELL MOL LIFE SCI, V65, P1698, DOI 10.1007/s00018-008-7550-3
   Yuzaki M, 2003, NEUROSCI RES, V46, P11, DOI 10.1016/S0168-0102(03)00036-1
NR 199
TC 153
Z9 153
U1 0
U2 14
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0897 USA
SN 0147-006X
BN 978-0-8243-2433-9
J9 ANNU REV NEUROSCI
JI Annu. Rev. Neurosci.
PY 2010
VL 33
BP 473
EP 507
DI 10.1146/annurev.neuro.051508.135302
PG 35
WC Neurosciences
SC Neurosciences & Neurology
GA BRP46
UT WOS:000283330200020
PM 20367446
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Strobel, S
   Loparic, M
   Wendt, D
   Schenk, AD
   Candrian, C
   Lindberg, RLP
   Moldovan, F
   Barbero, A
   Martin, I
AF Stroebel, Simon
   Loparic, Marko
   Wendt, David
   Schenk, Andreas D.
   Candrian, Christian
   Lindberg, Raija L. P.
   Moldovan, Florina
   Barbero, Andrea
   Martin, Ivan
TI Anabolic and catabolic responses of human articular chondrocytes to
   varying oxygen percentages
SO ARTHRITIS RESEARCH & THERAPY
LA English
DT Article
ID TISSUE-ENGINEERED CARTILAGE; IN-VITRO; II COLLAGEN; OSTEOARTHRITIC
   CARTILAGE; HYDROSTATIC-PRESSURE; TENSION; REDIFFERENTIATION; BIOREACTOR;
   CULTURE; GROWTH
AB Introduction: Oxygen is a critical parameter proposed to modulate the functions of chondrocytes ex-vivo as well as in damaged joints. This article investigates the effect of low (more physiological) oxygen percentage on the biosynthetic and catabolic activity of human articular chondrocytes (HAC) at different phases of in vitro culture.
   Methods: HAC expanded in monolayer were cultured in pellets for two weeks (Phase I) or up to an additional two weeks (Phase II). In each Phase, cells were exposed to 19% or 5% oxygen. Resulting tissues and culture media were assessed to determine amounts of produced/released proteoglycans and collagens, metalloproteinases (MMPs), collagen degradation products and collagen fibril organization using biochemical, (immuno)-histochemical, gene expression and scanning electron microscopy analyses. In specific experiments, the hypoxia-inducible factor-1 alpha (HIF-1 alpha) inhibitor cadmium chloride was supplemented in the culture medium to assess the involvement of this pathway.
   Results: Independent from the oxygen percentage during expansion, HAC cultured at 5% O(2) (vs 19% O(2)) during Phase I accumulated higher amounts of glycosaminoglycans and type II collagen and expressed reduced levels of MMP-1 and MMP-13 mRNA and protein. Switching to 19% oxygen during Phase II resulted in reduced synthesis of proteoglycan and collagen, increased release of MMPs, accumulation of type II collagen fragments and higher branching of collagen fibrils. In contrast, reducing O(2) during Phase II resulted in increased proteoglycan and type II collagen synthesis and reduced expression and release of MMP-13 mRNA and protein. Supplementation of cadmium chloride during differentiation culture at 5% O(2) drastically reduced the up-regulation of type II collagen and the down-regulation of MMP-1 mRNA.
   Conclusions: The application of more physiologic oxygen percentage during specific phases of differentiation culture enhanced the biosynthetic activity and reduced the activity of catabolic enzymes implicated in cartilage breakdown. Modulation of the oxygen percentage during HAC culture may be used to study pathophysiological events occurring in osteoarthritis and to enhance properties of in vitro engineered cartilaginous tissues.
C1 [Stroebel, Simon; Loparic, Marko; Wendt, David; Candrian, Christian; Barbero, Andrea; Martin, Ivan] Univ Basel Hosp, Dept Surg, CH-4031 Basel, Switzerland.
   [Stroebel, Simon; Loparic, Marko; Wendt, David; Candrian, Christian; Lindberg, Raija L. P.; Barbero, Andrea; Martin, Ivan] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
   [Loparic, Marko; Schenk, Andreas D.] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Candrian, Christian] Osped Reg Lugano, Dept Orthopaed Surg & Traumatol, CH-6900 Lugano, Switzerland.
   [Lindberg, Raija L. P.] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland.
   [Moldovan, Florina] Univ Montreal, Fac Dent, Montreal, PQ H3T 1C5, Canada.
   [Moldovan, Florina] Univ Montreal, CHU St Justine, Montreal, PQ H3T 1C5, Canada.
RP Barbero, A (corresponding author), Univ Basel Hosp, Dept Surg, Hebelstr 20, CH-4031 Basel, Switzerland.
EM abarbero@uhbs.ch
RI Martin, Ivan/K-9286-2016
OI Martin, Ivan/0000-0001-6493-0432; Schenk, Andreas/0000-0001-9214-2505;
   Barbero, Andrea/0000-0001-5252-789X; Candrian,
   Christian/0000-0002-3543-981X
FU European UnionEuropean Union (EU) [NMP3-CT-2005-500465]; National
   Competence Center in Research (NCCR)Swiss National Science Foundation
   (SNSF); Swiss National Science FoundationSwiss National Science
   Foundation (SNSF)
FX We would like to acknowledge the European Union for financial support
   (STEPS; FP6-#NMP3-CT-2005-500465) and the National Competence Center in
   Research (NCCR) program Nanoscale Science, awarded by the Swiss National
   Science Foundation, for support to Mr. M. Loparic. We are grateful to
   Mrs F. Wolf and Mrs D. Thuillard for their assistance with
   immunohistochemical processing, to Dr. Riccardo Gottardi from Department
   for Biophysical Engineering (Genova, Italy) for his assistance with EM
   analysis and Dr. M. Duggelin and Ms. Melanie Burkhardt for the imaging
   analysis. We thank Dr. Christgau from Nordic Immunology (Tilburg, NL)
   for the generous supply of the antibodies against type II collagen
   fragments.
CR Barbero A, 2004, OSTEOARTHR CARTILAGE, V12, P476, DOI 10.1016/j.joca.2004.02.010
   BRIGHTON CT, 1974, ARTHRITIS RHEUM, V17, P245, DOI 10.1002/art.1780170307
   Burrage PS, 2006, FRONT BIOSCI-LANDMRK, V11, P529, DOI 10.2741/1817
   CANNY J, 1986, IEEE T PATTERN ANAL, V8, P679, DOI 10.1109/TPAMI.1986.4767851
   CLARK CC, 1991, J ORTHOPAED RES, V9, P477, DOI 10.1002/jor.1100090403
   Dahlberg L, 2000, ARTHRITIS RHEUM, V43, P673, DOI 10.1002/1529-0131(200003)43:3<673::AID-ANR25>3.0.CO;2-8
   Domm C, 2002, OSTEOARTHR CARTILAGE, V10, P13, DOI 10.1053/joca.2001.0477
   Duval E, 2009, ARTHRITIS RHEUM-US, V60, P3038, DOI 10.1002/art.24851
   Egli RJ, 2008, J ORTHOP RES, V26, P977, DOI 10.1002/jor.20603
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   Gonsalves M, 2000, BIOPHYS J, V78, P1578, DOI 10.1016/S0006-3495(00)76710-5
   Gonzalez RC, 2007, DIGITAL IMAGE PROCES
   Grimshaw MJ, 2000, OSTEOARTHR CARTILAGE, V8, P386, DOI 10.1053/joca.1999.0314
   Grogan SP, 2003, OSTEOARTHR CARTILAGE, V11, P403, DOI 10.1016/S1063-4584(03)00053-0
   HAGERMAN PJ, 1988, ANNU REV BIOPHYS BIO, V17, P265
   Hansen U, 2001, J BIOMECH, V34, P941, DOI 10.1016/S0021-9290(01)00050-1
   HOLLANDER AP, 1994, J CLIN INVEST, V93, P1722, DOI 10.1172/JCI117156
   Jakob M, 2001, J CELL BIOCHEM, V81, P368, DOI 10.1002/1097-4644(20010501)81:2<368::AID-JCB1051>3.0.CO;2-J
   Kurz B, 2004, TISSUE ENG, V10, P1277, DOI 10.1089/ten.2004.10.1277
   LANE JM, 1977, J RHEUMATOL, V4, P334
   Malda J, 2004, TISSUE ENG, V10, P987, DOI 10.1089/1076327041887637
   Malda J, 2004, OSTEOARTHR CARTILAGE, V12, P306, DOI 10.1016/j.joca.2003.12.001
   Malda J, 2003, CRIT REV BIOTECHNOL, V23, P175, DOI 10.1080/714037688
   MARCUS RE, 1973, ARTHRITIS RHEUM, V16, P646, DOI 10.1002/art.1780160509
   Martin J A, 2001, Iowa Orthop J, V21, P1
   Martin JA, 2004, BIORHEOLOGY, V41, P479
   Martinez I, 2008, CELL TRANSPLANT, V17, P987, DOI 10.3727/096368908786576499
   Murphy CL, 2001, TISSUE ENG, V7, P791, DOI 10.1089/107632701753337735
   Murphy CL, 2001, CONNECT TISSUE RES, V42, P87, DOI 10.3109/03008200109014251
   Murphy CL, 2004, J CELL PHYSIOL, V199, P451, DOI 10.1002/jcp.10481
   NEVO Z, 1988, MECH AGEING DEV, V45, P157, DOI 10.1016/0047-6374(88)90105-4
   NEVO Z, 1972, DEV BIOL, V28, P219, DOI 10.1016/0012-1606(72)90139-X
   Obradovic B, 1999, BIOTECHNOL BIOENG, V63, P197, DOI 10.1002/(SICI)1097-0290(19990420)63:2<197::AID-BIT8>3.0.CO;2-2
   Pfander D, 2003, J CELL SCI, V116, P1819, DOI 10.1242/jcs.00385
   Philippsen A, 2007, J STRUCT BIOL, V157, P28, DOI 10.1016/j.jsb.2006.06.009
   POOLE AR, 2001, CLIN ORTHOP S, V391, P26
   Raub CB, 2008, BIOPHYS J, V94, P2361, DOI 10.1529/biophysj.107.120006
   Reboul P, 1996, J CLIN INVEST, V97, P2011, DOI 10.1172/JCI118636
   Roy-Beaudry M, 2003, ARTHRITIS RHEUM, V48, P2855, DOI 10.1002/art.11247
   Saini S, 2004, TISSUE ENG, V10, P825, DOI 10.1089/1076327041348545
   Scherer K, 2004, BIORHEOLOGY, V41, P323
   SILVER IA, 1975, PHILOS T ROY SOC B, V271, P261, DOI 10.1098/rstb.1975.0050
   Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]
   Waldman SD, 2006, OSTEOARTHR CARTILAGE, V14, P323, DOI 10.1016/j.joca.2005.10.007
   Wendt D, 2006, BIORHEOLOGY, V43, P481
   Wu W, 2002, ARTHRITIS RHEUM, V46, P2087, DOI 10.1002/art.10428
   Ye Hong, 2005, J Huazhong Univ Sci Technolog Med Sci, V25, P382
   YSART GE, 1994, BBA-MOL CELL RES, V1221, P15, DOI 10.1016/0167-4889(94)90210-0
NR 48
TC 60
Z9 62
U1 0
U2 11
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1478-6354
J9 ARTHRITIS RES THER
JI Arthritis Res. Ther.
PY 2010
VL 12
IS 2
AR R34
DI 10.1186/ar2942
PG 15
WC Rheumatology
SC Rheumatology
GA 629VD
UT WOS:000280227200012
PM 20193091
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Nowak, C
   Knoll, W
   Walz, D
   Gennis, RB
   Naumann, RLC
AF Nowak, Christoph
   Knoll, Wolfgang
   Walz, Dieter
   Gennis, Robert B.
   Naumann, Renate L. C.
TI Conformational Transitions Associated with Electrochemically-Induced
   Redox Processes Through the Cytochrome C Oxidase Followed by
   Time-Resolved 2d-Surface-Enhanced Infrared Absorption Spectroscopy
   (tr-2d-Seiras)
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 [Nowak, Christoph; Naumann, Renate L. C.] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
   [Nowak, Christoph; Knoll, Wolfgang; Naumann, Renate L. C.] AIT, A-1220 Vienna, Austria.
   [Walz, Dieter] Univ Basel, Biozentrum, CH-4059 Basel, Switzerland.
   [Gennis, Robert B.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.
NR 0
TC 0
Z9 0
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2010
VL 98
IS 3
SU 1
BP 23A
EP 24A
DI 10.1016/j.bpj.2009.12.140
PG 2
WC Biophysics
SC Biophysics
GA V29QD
UT WOS:000208762000122
DA 2021-01-25
ER

PT J
AU Naumann, RL
   Nowak, C
   Walz, D
   Gennis, RB
AF Naumann, Renate L.
   Nowak, Christoph
   Walz, Dieter
   Gennis, Robert B.
TI How Electron Transfer Is Linked to Conformational Transitions of Peptide
   Groups of the Cytochrome C Oxidase, a Study By 2d-Ir
   Spectro-Electrochemistry
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 [Naumann, Renate L.; Nowak, Christoph] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
   [Naumann, Renate L.; Nowak, Christoph] AIT, A-1220 Vienna, Austria.
   [Walz, Dieter] Univ Basel, Biozentrum, CH-4059 Basel, Switzerland.
   [Gennis, Robert B.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2010
VL 98
IS 3
SU 1
BP 24A
EP 24A
DI 10.1016/j.bpj.2009.12.142
PG 1
WC Biophysics
SC Biophysics
GA V29QD
UT WOS:000208762000124
DA 2021-01-25
ER

PT J
AU Mouro-Chanteloup, I
   Cochet, S
   Chami, M
   Genetet, S
   Zidi-Yahiaoui, N
   Engel, A
   Colin, Y
   Bertrand, O
   Ripoche, P
AF Mouro-Chanteloup, Isabelle
   Cochet, Sylvie
   Chami, Mohamed
   Genetet, Sandrine
   Zidi-Yahiaoui, Nedjma
   Engel, Andreas
   Colin, Yves
   Bertrand, Olivier
   Ripoche, Pierre
TI Functional Reconstitution Into Liposomes of Purified Human RhCG Ammonia
   Channel
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 [Mouro-Chanteloup, Isabelle; Cochet, Sylvie; Genetet, Sandrine; Zidi-Yahiaoui, Nedjma; Colin, Yves; Bertrand, Olivier; Ripoche, Pierre] Univ Paris 07, INTS, INSERM UMR S 665, Paris, France.
   [Chami, Mohamed; Engel, Andreas] Univ Basel, Biozentrum, E Muller Inst Struct Biol, Ctr Imaging & Nanoanalyt,C CINA, Basel, Switzerland.
RI Isabelle, Mouro-Chanteloup/M-9750-2018
OI Isabelle, Mouro-Chanteloup/0000-0002-6368-9904
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2010
VL 98
IS 3
SU 1
BP 51A
EP 51A
DI 10.1016/j.bpj.2009.12.295
PG 1
WC Biophysics
SC Biophysics
GA V29QD
UT WOS:000208762000271
DA 2021-01-25
ER

PT J
AU Gubaev, A
   Hilbert, M
   Klostermeier, D
AF Gubaev, Airat
   Hilbert, Manuel
   Klostermeier, Dagmar
TI The DNA-Gate of Gyrase Is Predominantly in the Closed Conformation
   During DNA Supercoiling
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 [Gubaev, Airat; Hilbert, Manuel; Klostermeier, Dagmar] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2010
VL 98
IS 3
SU 1
BP 62A
EP 62A
DI 10.1016/j.bpj.2009.12.353
PG 1
WC Biophysics
SC Biophysics
GA V29QD
UT WOS:000208762000326
DA 2021-01-25
ER

PT J
AU Rudolph, MG
   Klostermeier, D
AF Rudolph, Markus G.
   Klostermeier, Dagmar
TI A Structural Model For RNA Remodeling By a Dimeric Dead Box Helicase
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 [Rudolph, Markus G.] Hoffmann La Roche AG, Basel, Switzerland.
   [Klostermeier, Dagmar] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN
PY 2010
VL 98
IS 3
SU 1
BP 71A
EP 72A
DI 10.1016/j.bpj.2009.12.406
PG 2
WC Biophysics
SC Biophysics
GA V29QD
UT WOS:000208762000377
DA 2021-01-25
ER

PT J
AU Plodinec, M
   Schoenenberger, CA
AF Plodinec, Marija
   Schoenenberger, Cora-Ann
TI Spatial organization acts on cell signaling: how physical force
   contributes to the development of cancer
SO BREAST CANCER RESEARCH
LA English
DT Article
ID MECHANICS; RESPONSES; EPHA2
AB Cells constantly encounter physical forces and respond to neighbors and circulating factors by triggering intracellular signaling cascades that in turn affect their behavior. The mechanisms by which cells transduce mechanical signals to downstream biochemical changes are not well understood. In their work, Salaita and coworkers show that the spatial organization of cell surface receptors is crucial for mechanotransduction. Consequently, force modulation that disrupts the mechanochemical coupling may represent a critical step in cancerogenesis.
C1 [Plodinec, Marija; Schoenenberger, Cora-Ann] Univ Basel, ME Muller Inst Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
RP Schoenenberger, CA (corresponding author), Univ Basel, ME Muller Inst Biol Struct, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Cora-ann.schoenenberger@unibas.ch
FU National Center of Competence in Research Nanoscale ScienceSwiss
   National Science Foundation (SNSF); Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); M.E. Muller
   Foundation
FX The authors are supported by the National Center of Competence in
   Research Nanoscale Science, the Swiss National Science Foundation, and
   the M.E. Muller Foundation.
CR Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995
   Hahn C, 2008, ARTERIOSCL THROM VAS, V28, P2101, DOI 10.1161/ATVBAHA.108.165951
   Janmey PA, 2007, ANNU REV BIOMED ENG, V9, P1, DOI 10.1146/annurev.bioeng.9.060906.151927
   Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002
   Kumar S, 2009, CANCER METAST REV, V28, P113, DOI 10.1007/s10555-008-9173-4
   Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020
   Millward-Sadler SJ, 2000, OSTEOARTHR CARTILAGE, V8, P272, DOI 10.1053/joca.1999.0301
   Murai KK, 2003, J CELL SCI, V116, P2823, DOI 10.1242/jcs.00625
   Paszek MJ, 2005, CANCER CELL, V8, P241, DOI 10.1016/j.ccr.2005.08.010
   Salaita K, 2010, SCIENCE, V327, P1380, DOI 10.1126/science.1181729
   Shen K, 2008, P NATL ACAD SCI USA, V105, P7791, DOI 10.1073/pnas.0710295105
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Zelinski DP, 2001, CANCER RES, V61, P2301
NR 13
TC 7
Z9 7
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-542X
EI 1465-5411
J9 BREAST CANCER RES
JI Breast Cancer Res.
PY 2010
VL 12
IS 4
AR 308
DI 10.1186/bcr2623
PG 3
WC Oncology
SC Oncology
GA 697HO
UT WOS:000285504100027
PM 20804566
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Hanisch, J
   Ehinger, J
   Ladwein, M
   Rohde, M
   Derivery, E
   Bosse, T
   Steffen, A
   Bumann, D
   Misselwitz, B
   Hardt, WD
   Gautreau, A
   Stradal, TEB
   Rottner, K
AF Haenisch, Jan
   Ehinger, Julia
   Ladwein, Markus
   Rohde, Manfred
   Derivery, Emmanuel
   Bosse, Tanja
   Steffen, Anika
   Bumann, Dirk
   Misselwitz, Benjamin
   Hardt, Wolf-Dietrich
   Gautreau, Alexis
   Stradal, Theresia E. B.
   Rottner, Klemens
TI Molecular dissection of Salmonella-induced membrane ruffling versus
   invasion
SO CELLULAR MICROBIOLOGY
LA English
DT Article
ID ENTEROPATHOGENIC ESCHERICHIA-COLI; ACTIN PEDESTAL FORMATION;
   HOST-CELL-INTERACTIONS; ARP2/3 COMPLEX; RHO-GTPASES; N-WASP;
   LISTERIA-MONOCYTOGENES; INTRACELLULAR MOTILITY; EPITHELIAL-CELLS;
   PROTEIN
AB Type III secretion system-mediated injection of a cocktail of bacterial proteins drives actin rearrangements, frequently adopting the shape of prominent protuberances of ruffling membrane, and culminating in host cell invasion of Gram-negative pathogens like Salmonella typhimurium. Different Salmonella effectors are able to bind actin and activate Rho-family GTPases, which have previously been implicated in mediating actin-dependent Salmonella entry by interacting with N-WASP or WAVE-complex, well-established activators of the actin nucleation machine Arp2/3-complex. Using genetic deletion and RNA interference studies, we show here that neither individual nor collective removal of these Arp2/3-complex activators affected host cell invasion as efficiently as Arp2/3-complex knock-down, although the latter was also not essential. However, interference with WAVE-complex function abrogated Salmonella-induced membrane ruffling without significantly affecting entry efficiency, actin or Arp2/3-complex accumulation. In addition, scanning electron microscopy images captured entry events in the absence of prominent membrane ruffles. Finally, localization and RNA interference studies indicated a relevant function in Salmonella entry for the novel Arp2/3-complex regulator WASH. These data establish for the first time that Salmonella invasion is separable from bacteria-induced membrane ruffling, and uncover an additional Arp2/3-complex activator as well as an Arp2/3-complex-independent actin assembly activity that contribute to Salmonella invasion.
C1 [Ehinger, Julia; Ladwein, Markus; Rottner, Klemens] Helmholtz Ctr Infect Res, Cytoskeleton Dynam Grp, D-38124 Braunschweig, Germany.
   [Haenisch, Jan; Stradal, Theresia E. B.] Helmholtz Ctr Infect Res, Signalling & Motil Grp, D-38124 Braunschweig, Germany.
   [Rohde, Manfred] Helmholtz Ctr Infect Res, Dept Microbial Pathogenesis, D-38124 Braunschweig, Germany.
   [Derivery, Emmanuel; Gautreau, Alexis] CNRS, Lab Enzymol & Biochim Struct, UPR3082, F-91198 Gif Sur Yvette, France.
   [Bosse, Tanja] Hannover Med Sch, Inst Virol, OE 5230, D-30625 Hannover, Germany.
   [Steffen, Anika] Univ Cologne, Fac Med, D-50931 Cologne, Germany.
   [Bumann, Dirk] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Misselwitz, Benjamin; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, CH-8093 Zurich, Switzerland.
RP Rottner, K (corresponding author), Helmholtz Ctr Infect Res, Cytoskeleton Dynam Grp, Inhoffen Str 7, D-38124 Braunschweig, Germany.
EM klemens.rottner@helmholtz-hzi.de
RI Gautreau, Alexis/AAT-2751-2020; Rottner, Klemens/AAE-5030-2020;
   Misselwitz, Benjamin/L-7193-2016
OI Gautreau, Alexis/0000-0002-2369-4362; Rottner,
   Klemens/0000-0003-4244-4198; Misselwitz, Benjamin/0000-0002-8719-5175;
   Steffen, Anika/0000-0002-2933-0543; Stradal,
   Theresia/0000-0002-0352-9474; Hardt, Wolf-Dietrich/0000-0002-9892-6420
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [SPP1150, SFB 621]; UBS AG; Bonizzi-Theler Foundation
FX This work was supported in part by grants from the Deutsche
   Forschungsgemeinschaft (SPP1150 to T. E. B. S. and K. R. and SFB 621 to
   K. R.). Work by B. M. and W.- D. H. was funded by UBS AG on behalf of a
   customer and by the Bonizzi-Theler Foundation. We thank Ken Campellone,
   MattWelch and Giorgio Scita for reagents, Brigitte Denker for excellent
   technical assistance and Jurgen Wehland for support and providing
   infrastructure.
CR Benesch S, 2005, J CELL SCI, V118, P3103, DOI 10.1242/jcs.02444
   Benesch S, 2002, J BIOL CHEM, V277, P37771, DOI 10.1074/jbc.M204145200
   Cain RJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000037
   Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032
   Chang JH, 2005, MOL MICROBIOL, V55, P1379, DOI 10.1111/j.1365-2958.2004.04480.x
   Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124
   Criss AK, 2003, INFECT IMMUN, V71, P2885, DOI 10.1128/IAI.71.5.2885-2891.2003
   Czuchra A, 2005, MOL BIOL CELL, V16, P4473, DOI 10.1091/mbc.E05-01-0061
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Di Nardo A, 2005, P NATL ACAD SCI USA, V102, P16263, DOI 10.1073/pnas.0508228102
   ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405
   Goley ED, 2006, NAT REV MOL CELL BIO, V7, P713, DOI 10.1038/nrm2026
   Hardt WD, 1998, CELL, V93, P815, DOI 10.1016/S0092-8674(00)81442-7
   Hayward RD, 1999, EMBO J, V18, P4926, DOI 10.1093/emboj/18.18.4926
   Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0
   Innocenti M, 2004, NAT CELL BIOL, V6, P319, DOI 10.1038/ncb1105
   Katoh H, 2003, NATURE, V424, P461, DOI 10.1038/nature01817
   Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237
   Lommel S, 2004, CELL MICROBIOL, V6, P243, DOI 10.1111/j.1462-5822.2004.00364.x
   Lommel S, 2001, EMBO REP, V2, P850, DOI 10.1093/embo-reports/kve197
   Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3
   May RC, 1999, CURR BIOL, V9, P759, DOI 10.1016/S0960-9822(99)80337-6
   McGhie EJ, 2004, MOL CELL, V13, P497, DOI 10.1016/S1097-2765(04)00053-X
   McGhie EJ, 2001, EMBO J, V20, P2131, DOI 10.1093/emboj/20.9.2131
   MUNTER S, 2006, SCI STKE, V335, pRE5
   Norris FA, 1998, P NATL ACAD SCI USA, V95, P14057, DOI 10.1073/pnas.95.24.14057
   Olazabal IM, 2002, CURR BIOL, V12, P1413, DOI 10.1016/S0960-9822(02)01069-2
   Patel JC, 2006, J CELL BIOL, V175, P453, DOI 10.1083/jcb.200605144
   Patel JC, 2009, CELL, V137, P283, DOI 10.1016/j.cell.2009.01.056
   Patel JC, 2005, CURR OPIN MICROBIOL, V8, P10, DOI 10.1016/j.mib.2004.09.001
   Perrett CA, 2009, CELL MICROBIOL, V11, P475, DOI 10.1111/j.1462-5822.2008.01268.x
   Pistor S, 2000, J CELL SCI, V113, P3277
   Rottner K, 2005, DEV CELL, V9, P3, DOI 10.1016/j.devcel.2005.06.002
   Schlumberger MC, 2006, CURR OPIN MICROBIOL, V9, P46, DOI 10.1016/j.mib.2005.12.006
   Shi J, 2005, J BIOL CHEM, V280, P29849, DOI 10.1074/jbc.M500617200
   Snapper SB, 2001, NAT CELL BIOL, V3, P897, DOI 10.1038/ncb1001-897
   Steffen A, 2004, EMBO J, V23, P749, DOI 10.1038/sj.emboj.7600084
   Steffen A, 2006, MOL BIOL CELL, V17, P2581, DOI 10.1091/mbc.E05-11-1088
   Stender S, 2000, MOL MICROBIOL, V36, P1206, DOI 10.1046/j.1365-2958.2000.01933.x
   Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320
   Stradal TEB, 2006, CURR OPIN CELL BIOL, V18, P4, DOI 10.1016/j.ceb.2005.12.003
   Takenawa T, 2007, NAT REV MOL CELL BIO, V8, P37, DOI 10.1038/nrm2069
   Unsworth KE, 2004, CELL MICROBIOL, V6, P1041, DOI 10.1111/j.1462-5822.2004.00417.x
   Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009
   Wennerberg K, 2002, J BIOL CHEM, V277, P47810, DOI 10.1074/jbc.M203816200
   Wheeler AP, 2006, CELL MOTIL CYTOSKEL, V63, P132, DOI 10.1002/cm.20111
   Zhou DG, 2001, MOL MICROBIOL, V39, P248, DOI 10.1046/j.1365-2958.2001.02230.x
   Zuchero JB, 2009, NAT CELL BIOL, V11, P451, DOI 10.1038/ncb1852
NR 49
TC 35
Z9 37
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD JAN
PY 2010
VL 12
IS 1
BP 84
EP 98
DI 10.1111/j.1462-5822.2009.01380.x
PG 15
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA 538CQ
UT WOS:000273162200008
PM 19732055
OA Bronze
DA 2021-01-25
ER

PT J
AU Zimbron, JM
   Sardo, A
   Heinisch, T
   Wohlschlager, T
   Gradinaru, J
   Massa, C
   Schirmer, T
   Creus, M
   Ward, TR
AF Zimbron, Jeremy M.
   Sardo, Alessia
   Heinisch, Tillmann
   Wohlschlager, Therese
   Gradinaru, Julieta
   Massa, Claudia
   Schirmer, Tilman
   Creus, Marc
   Ward, Thomas R.
TI Chemo-Genetic Optimization of DNA Recognition by Metallodrugs using a
   Presenter-Protein Strategy
SO CHEMISTRY-A EUROPEAN JOURNAL
LA English
DT Article
DE G-quadruplexes; metallodrug; proteins; ruthenium; supramolecular
   chemistry
ID ARENE ANTICANCER COMPLEX; BINDING; GLUTATHIONE; GUANINE; SELECTIVITY;
   RELEVANCE; LIGANDS
AB The mode of action of precious metal anticancer metallodrugs is generally believed to involve DNA as a target. However, the poor specificity of such drugs often requires high doses and leads to undesirable side-effects. With the aim of improving the specificity of a ruthenium piano-stool complex towards DNA, we employed a presenter protein strategy based on the biotinavidin technology. Guided by the X-ray structure of the assembly of streptavidin and a biotinylated piano-stool, we explored the formation of metallodrug-mediated ternary complexes with the presenter protein and DNA. The assemblies bound more strongly to telomere G-quadruplexes than to double-stranded DNA; chemo-genetic modifications (varying the complex or mutating the protein) modulated binding to these targets. We suggest that rational targeting of small molecules by presenter proteins could be exploited to bind metallodrugs to preferred macromolecular targets.
C1 [Heinisch, Tillmann; Massa, Claudia; Schirmer, Tilman] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Zimbron, Jeremy M.; Sardo, Alessia; Heinisch, Tillmann; Creus, Marc; Ward, Thomas R.] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   [Wohlschlager, Therese; Gradinaru, Julieta] Univ Neuchatel, Inst Chem, CH-2009 Neuchatel, Switzerland.
RP Schirmer, T (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch; marc.creus@unibas.ch; thomas.ward@unibas.ch
RI Ward, Thomas R/K-6419-2012; Wohlschlager, Therese/G-4622-2016; Creus,
   Marc/E-8397-2012
OI Ward, Thomas R/0000-0001-8602-5468; Wohlschlager,
   Therese/0000-0001-9359-6744; Di Spiezio Sardo,
   Attilio/0000-0001-6485-5735
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [200020-113348, 200020-126366]; COSTEuropean Cooperation in
   Science and Technology (COST) [D39]
FX This work was funded by the Swiss National Science Foundation (Grants
   FN: 200020-113348 and 200020-126366) as well as COST D39 and by generous
   support to M. C. from the Treubelfonds (Basel). The authors would like
   to acknowledge Dr. Andre Ziegler for help with interpretation of ITC
   data and both Maurus Schmid and Thibaud Rossel for assistance with the
   design of figures. We are also grateful to C. R. Cantor for the
   streptavidin expression plasmid and Umicore for a loan of ruthenium.
CR Allardyce CS, 2001, CHEM COMMUN, P1396, DOI 10.1039/b104021a
   Ang WH, 2007, CHEMMEDCHEM, V2, P1799, DOI 10.1002/cmdc.200700209
   [Anonymous], 2008, ANGEW CHEM, V120, P1422
   Balasubramanian S, 2009, CURR OPIN CHEM BIOL, V13, P345, DOI 10.1016/j.cbpa.2009.04.637
   Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y
   Barnes KR, 2004, CHEM BIOL, V11, P557, DOI 10.1016/j.chembiol.2004.03.024
   Briesewitz R, 1999, P NATL ACAD SCI USA, V96, P1953, DOI 10.1073/pnas.96.5.1953
   Bruijnincx PCA, 2008, CURR OPIN CHEM BIOL, V12, P197, DOI 10.1016/j.cbpa.2007.11.013
   Buczek P, 2006, J MOL BIOL, V359, P1217, DOI 10.1016/j.jmb.2006.02.082
   Casini A, 2009, J BIOL INORG CHEM, V14, P761, DOI 10.1007/s00775-009-0489-5
   Chen HM, 2002, J AM CHEM SOC, V124, P3064, DOI 10.1021/ja017482e
   Creus M, 2008, ANGEW CHEM INT EDIT, V47, P1400, DOI 10.1002/anie.200704865
   Draper DE, 1999, J MOL BIOL, V293, P255, DOI 10.1006/jmbi.1999.2991
   Gossens C, 2008, J AM CHEM SOC, V130, P10921, DOI 10.1021/ja800194a
   Han FXG, 1999, J AM CHEM SOC, V121, P3561, DOI 10.1021/ja984153m
   Hartinger CG, 2008, J INORG BIOCHEM, V102, P2136, DOI 10.1016/j.jinorgbio.2008.08.002
   Harvey I, 2002, P NATL ACAD SCI USA, V99, P1882, DOI 10.1073/pnas.042693399
   He Q, 2000, BIOCHEMISTRY-US, V39, P14426, DOI 10.1021/bi001700j
   Jaouen G, 2004, CURR MED CHEM, V11, P2505, DOI 10.2174/0929867043364487
   Kelland L, 2007, NAT REV CANCER, V7, P573, DOI 10.1038/nrc2167
   Kratz F, 2008, J CONTROL RELEASE, V132, P171, DOI 10.1016/j.jconrel.2008.05.010
   Liu H. K., 2006, ANGEW CHEM, V118, P8333
   Liu HK, 2006, ANGEW CHEM INT EDIT, V45, P8153, DOI 10.1002/anie.200602873
   McNae IW, 2004, CHEM COMMUN, P1786, DOI 10.1039/b408141b
   Morris RE, 2001, J MED CHEM, V44, P3616, DOI 10.1021/jm010051m
   Namba H, 2003, J CLIN ENDOCR METAB, V88, P4393, DOI 10.1210/jc.2003-030305
   Novakova O, 2009, BIOCHEM PHARMACOL, V77, P364, DOI 10.1016/j.bcp.2008.10.021
   Reedijk J, 2003, P NATL ACAD SCI USA, V100, P3611, DOI 10.1073/pnas.0737293100
   Reedijk J, 1999, CHEM REV, V99, P2499, DOI 10.1021/cr980422f
   Silverman AP, 2002, J BIOL CHEM, V277, P49743, DOI 10.1074/jbc.M206979200
   Tan JZ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000428
   Timerbaev AR, 2006, CHEM REV, V106, P2224, DOI 10.1021/cr040704h
   Wang D, 2005, NAT REV DRUG DISCOV, V4, P307, DOI 10.1038/nrd1691
   Wang FY, 2008, J AM SOC MASS SPECTR, V19, P544, DOI 10.1016/j.jasms.2007.12.002
   Wang FY, 2005, P NATL ACAD SCI USA, V102, P18269, DOI 10.1073/pnas.0505798102
   Wang FY, 2005, J AM CHEM SOC, V127, P17734, DOI 10.1021/ja053387k
   WEBER PC, 1989, SCIENCE, V243, P85, DOI 10.1126/science.2911722
   Wu B, 2008, NAT CHEM BIOL, V4, P110, DOI 10.1038/nchembio.2007.58
NR 38
TC 10
Z9 11
U1 0
U2 10
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 0947-6539
EI 1521-3765
J9 CHEM-EUR J
JI Chem.-Eur. J.
PY 2010
VL 16
IS 43
BP 12883
EP 12889
DI 10.1002/chem.201001573
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 678HE
UT WOS:000284063900017
PM 20878805
DA 2021-01-25
ER

PT S
AU Hanssen, E
   Goldie, KN
   Tilley, L
AF Hanssen, Eric
   Goldie, Kenneth N.
   Tilley, Leann
BE MullerReichert, T
TI Ultrastructure of the Asexual Blood Stages of Plasmodium falciparum
SO ELECTRON MICROSCOPY OF MODEL SYSTEMS
SE Methods in Cell Biology
LA English
DT Review; Book Chapter
ID MALARIA-INFECTED ERYTHROCYTES; MAURERS CLEFT ORGANELLES; VIRULENCE
   PROTEIN PFEMP1; PORE-FORMING PROTEINS; ELECTRON TOMOGRAPHY;
   3-DIMENSIONAL RECONSTRUCTION; SELECTIVE PERMEABILIZATION; CRYOELECTRON
   MICROSCOPY; APICOMPLEXAN PARASITES; BIOLOGICAL SPECIMENS
AB Plasmodium falciparum is the most deadly of the human malaria parasites. The particular virulence of this species derives from its ability to subvert the physiology of its host during the blood stages of its development. The parasite grows and divides within erythrocytes, feeding on the hemoglobin, and remodeling its host cells so they adhere to blood vessel walls. The advent of molecular transfection technology, coupled with optical microscopy of fluorescent protein reporters, has greatly improved our understanding of the ways in which the malaria parasite alters its host cell. However, a full interpretation of the information from these studies requires similar advances in our knowledge of the ultrastructure of the parasite. Here we give an overview of different electron microscopy techniques that have revealed the fine structure of the parasite at different stages of development. We present data on some of the unusual organelles of P. falciparum, in particular, the membrane structures that are elaborated in the erythrocyte cytoplasm and are thought to play an important role in trafficking of virulence proteins. We present and discuss some of the exciting whole cell imaging techniques that represent a new frontier in the studies of parasite ultrastructure.
C1 [Hanssen, Eric] Univ Melbourne, Electron Microscopy Unit, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.
   [Goldie, Kenneth N.] Univ Basel, C CINA, Struct Biol & Biophys Core Biozentrum, CH-4058 Basel, Switzerland.
   [Tilley, Leann] La Trobe Univ, Dept Biochem, Bundoora, Vic 3086, Australia.
   [Tilley, Leann] La Trobe Univ, Ctr Excellence Coherent Xray Sci, Bundoora, Vic 3086, Australia.
RP Hanssen, E (corresponding author), Univ Melbourne, Electron Microscopy Unit, Mol Sci & Biotechnol Inst Bio21, Parkville, Vic 3010, Australia.
RI Hanssen, Eric/A-7217-2013; Tilley, Leann/AAU-5281-2020
OI Hanssen, Eric/0000-0002-4064-1844; Tilley, Leann/0000-0001-9910-0199
CR AIKAWA M, 1985, J PROTOZOOL, V32, P424, DOI 10.1111/j.1550-7408.1985.tb04038.x
   AIKAWA M, 1988, BIOL CELL, V64, P173, DOI 10.1016/0248-4900(88)90077-9
   ALEY SB, 1986, PARASITOLOGY, V92, P511, DOI 10.1017/S0031182000065410
   Anderluh G, 1999, TOXICON, V37, P1391, DOI 10.1016/S0041-0101(99)00082-3
   Armer HEJ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007716
   ATKINSON CT, 1990, BLOOD CELLS, V16, P351
   ATKINSON CT, 1988, EUR J CELL BIOL, V45, P192
   Bakar N. A., 2010, Journal of Cell Science, V123, P441, DOI 10.1242/jcs.061499
   Bannister L H, 1993, Methods Mol Biol, V21, P415
   Bannister LH, 2009, PARASITOLOGY, V136, P1435, DOI 10.1017/S0031182009990734
   Bannister LH, 2000, PARASITOLOGY, V121, P273, DOI 10.1017/S0031182099006320
   Bannister LH, 2000, PARASITOL TODAY, V16, P427, DOI 10.1016/S0169-4758(00)01755-5
   BANNISTER LH, 1990, BLOOD CELLS, V16, P257
   Bannister LH, 2004, MICROSC MICROANAL, V10, P551, DOI 10.1017/S1431927604040917
   Baumeister S, 2001, MOL BIOCHEM PARASIT, V112, P133, DOI 10.1016/S0166-6851(00)00343-1
   Blackman MJ, 2001, MOL BIOCHEM PARASIT, V117, P11, DOI 10.1016/S0166-6851(01)00328-0
   DAY KP, 1993, P NATL ACAD SCI USA, V90, P8292, DOI 10.1073/pnas.90.17.8292
   Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329
   Dixon MWA, 2008, TRENDS PARASITOL, V24, P168, DOI 10.1016/j.pt.2008.01.004
   Drobne D, 2005, J MICROSC-OXFORD, V219, P29, DOI 10.1111/j.1365-2818.2005.01490.x
   DUBOCHET J, 1995, TRENDS CELL BIOL, V5, P366, DOI 10.1016/S0962-8924(00)89071-6
   Duffy PE, 2003, CURR OPIN MICROBIOL, V6, P371, DOI 10.1016/S1369-5274(03)00090-0
   Elford BC, 1997, TRENDS MICROBIOL, V5, P463, DOI 10.1016/S0966-842X(97)01169-4
   Elliott DA, 2008, P NATL ACAD SCI USA, V105, P2463, DOI 10.1073/pnas.0711067105
   Foth BJ, 2003, INT REV CYTOL, V224, P57, DOI 10.1016/S0074-7696(05)24003-2
   Frankland S, 2007, EUKARYOT CELL, V6, P1584, DOI 10.1128/EC.00063-07
   Frankland S, 2006, EUKARYOT CELL, V5, P849, DOI 10.1128/EC.5.5.849-860.2006
   Garcia CRS, 2008, INT REV CEL MOL BIO, V266, P85, DOI 10.1016/S1937-6448(07)66003-1
   GARNHAM P. C. C, 1961, TRANS ROY SOC TROP MED AND HYG, V55, P98, DOI 10.1016/0035-9203(61)90046-3
   Goldberg DE, 2005, CURR TOP MICROBIOL, V295, P275
   GRUENBERG J, 1983, J CELL BIOL, V97, P795, DOI 10.1083/jcb.97.3.795
   Grunewald K, 2003, BIOPHYS CHEM, V100, P577, DOI 10.1016/S0301-4622(02)00307-1
   Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d
   Hanssen E, 2008, MOL MICROBIOL, V69, P938, DOI 10.1111/j.1365-2958.2008.06329.x
   Hanssen E, 2008, MOL MICROBIOL, V67, P703, DOI 10.1111/j.1365-2958.2007.06063.x
   Hanssen E, 2010, INT J PARASITOL, V40, P123, DOI 10.1016/j.ijpara.2009.09.004
   Hawthorne PL, 2004, MOL BIOCHEM PARASIT, V136, P181, DOI 10.1016/j.molbiopara.2004.03.013
   Henrich Philipp, 2009, Biotechnology Journal, V4, P888, DOI 10.1002/biot.200900058
   Hodder AN, 2009, MOL MICROBIOL, V71, P48, DOI 10.1111/j.1365-2958.2008.06508.x
   Hohmann-Marriott MF, 2009, NAT METHODS, V6, P729, DOI [10.1038/NMETH.1367, 10.1038/nmeth.1367]
   Hopkins J, 1999, PROTIST, V150, P283, DOI 10.1016/S1434-4610(99)70030-1
   Horrocks P, 2005, J CELL SCI, V118, P2507, DOI 10.1242/jcs.02381
   HOWARD RJ, 1986, J CELL BIOL, V103, P1269, DOI 10.1083/jcb.103.4.1269
   Jackson KE, 2007, BIOCHEM J, V403, P167, DOI 10.1042/BJ20061725
   KILEJIAN A, 1979, P NATL ACAD SCI USA, V76, P4650, DOI 10.1073/pnas.76.9.4650
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Kriek N, 2003, MOL MICROBIOL, V50, P1215, DOI 10.1046/j.1365-2958.2003.03784.x
   LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287
   LANGRETH SG, 1978, J PROTOZOOL, V25, P443, DOI 10.1111/j.1550-7408.1978.tb04167.x
   Lanzer M, 2006, INT J PARASITOL, V36, P23, DOI 10.1016/j.ijpara.2005.10.001
   Lazarus MD, 2008, J CELL SCI, V121, P1937, DOI 10.1242/jcs.023150
   LEIGHTON SB, 1981, SCAN ELECT MICROSC, V233, P73
   Leser V, 2009, J MICROSC-OXFORD, V233, P309, DOI 10.1111/j.1365-2818.2009.03121.x
   Lew VL, 2003, BLOOD, V101, P4189, DOI 10.1182/blood-2002-08-2654
   Loria P, 1999, BIOCHEM J, V339, P363, DOI 10.1042/0264-6021:3390363
   Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112
   Macke JH, 2008, J NEUROSCI METH, V167, P349, DOI 10.1016/j.jneumeth.2007.07.021
   Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051
   Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110
   Marko M, 2006, J MICROSC-OXFORD, V222, P42, DOI 10.1111/j.1365-2818.2006.01567.x
   Marko M, 2007, NAT METHODS, V4, P215, DOI 10.1038/nmeth1014
   Marti M, 2005, J CELL BIOL, V171, P587, DOI 10.1083/jcb.200508051
   Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919
   Miller LH, 2002, NATURE, V415, P673, DOI 10.1038/415673a
   Noske AB, 2008, J STRUCT BIOL, V161, P298, DOI 10.1016/j.jsb.2007.09.015
   PASVOL G, 1978, ANN TROP MED PARASIT, V72, P87, DOI 10.1080/00034983.1978.11719283
   Proellocks NI, 2009, INT J PARASITOL, V39, P683, DOI 10.1016/j.ijpara.2008.11.002
   Rouquette J, 2009, CHROMOSOME RES, V17, P801, DOI 10.1007/s10577-009-9070-x
   Rug M, 2006, BLOOD, V108, P370, DOI 10.1182/blood-2005-11-4624
   Scherf A, 2008, ANNU REV MICROBIOL, V62, P445, DOI 10.1146/annurev.micro.61.080706.093134
   Schroeder-Reiter E, 2009, J STRUCT BIOL, V165, P97, DOI 10.1016/j.jsb.2008.10.002
   SLOMIANNY C, 1990, BLOOD CELLS, V16, P369
   SLOMIANNY C, 1986, J PARASITOL, V72, P595, DOI 10.2307/3281516
   Slot JW, 2007, NAT PROTOC, V2, P2480, DOI 10.1038/nprot.2007.365
   Spycher C, 2008, MOL MICROBIOL, V68, P1300, DOI 10.1111/j.1365-2958.2008.06235.x
   Spycher C, 2006, MOL CELL BIOL, V26, P4074, DOI 10.1128/MCB.00095-06
   Steven AC, 2003, TRENDS CELL BIOL, V13, P107, DOI 10.1016/S0962-8924(03)00023-0
   Struck NS, 2008, MOL MICROBIOL, V67, P1320, DOI 10.1111/j.1365-2958.2008.06125.x
   Tilley L, 2008, TRANSFUS CLIN BIOL, V15, P72, DOI 10.1016/j.tracli.2008.03.014
   Tilley L, 2008, TRAFFIC, V9, P187, DOI 10.1111/j.1600-0854.2007.00684.x
   TOKUYASU KT, 1980, HISTOCHEM J, V12, P381, DOI 10.1007/BF01011956
   Tonkin CJ, 2006, CURR OPIN MICROBIOL, V9, P381, DOI 10.1016/j.mib.2006.06.015
   TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840
   Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794
   West JB, 2010, RESP PHYSIOL NEUROBI, V170, P202, DOI 10.1016/j.resp.2009.12.010
   Wickert H, 2004, EUR J CELL BIOL, V83, P567, DOI 10.1078/0171-9335-00432
   Wickert H, 2003, EUR J CELL BIOL, V82, P271, DOI 10.1078/0171-9335-00319
   YAYON A, 1984, J PROTOZOOL, V31, P367, DOI 10.1111/j.1550-7408.1984.tb02981.x
   YONEHARA K, 1989, J ELECTRON MICR TECH, V12, P71, DOI 10.1002/jemt.1060120110
NR 89
TC 14
Z9 15
U1 0
U2 7
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0091-679X
BN 978-0-12-381007-6
J9 METHOD CELL BIOL
JI Methods Cell Biol.
PY 2010
VL 96
BP 93
EP 116
DI 10.1016/S0091-679X(10)96005-6
PG 24
WC Cell Biology
SC Cell Biology
GA BQP85
UT WOS:000281513200005
PM 20869520
DA 2021-01-25
ER

PT S
AU Zinzalla, V
   Sturgill, TW
   Hall, MN
AF Zinzalla, Vittoria
   Sturgill, Thomas W.
   Hall, Michael N.
BE Hall, MN
   Tamanoi, F
TI TOR Complexes: Composition, Structure, and Phosphorylation
SO ENZYMES, VOL 27: STRUCTURE, FUNCTION AND REGULATION OF TOR COMPLEXES
   FROM YEASTS TO MAMMALS, PT A
SE Enzymes
LA English
DT Article; Book Chapter
ID PLASMA-MEMBRANE LOCALIZATION; MAMMALIAN TARGET; RAPAMYCIN MTOR;
   CELL-GROWTH; PHOSPHATIDYLINOSITOL 3-KINASE; BINDING PARTNER;
   KINASE-ACTIVITY; DISTINCT ROLES; FISSION YEAST; HEAT REPEATS
AB The target of rapamycin (TOR) is the central node of a highly conserved signaling network that regulates cell growth in response to nutrients, growth factors, and cellular energy. TOR is found in two functionally distinct complexes, TOR complex 1 (TORC1) and TORC2. This chapter describes the composition of yeast and mammalian TOR complexes, with special focus on the roles of structural domains and phosphorylation in TOR complex function.
C1 [Zinzalla, Vittoria; Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Sturgill, Thomas W.] Univ Virginia, Hlth Sci Ctr, Dept Pharmacol, Charlottesville, VA 22908 USA.
RP Zinzalla, V (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
CR Acosta-Jaquez HA, 2009, MOL CELL BIOL, V29, P4308, DOI 10.1128/MCB.01665-08
   Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040
   Alarcon CM, 1999, MOL BIOL CELL, V10, P2531, DOI 10.1091/mbc.10.8.2531
   ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115
   Andrade MA, 2001, J MOL BIOL, V309, P1, DOI 10.1006/jmbi.2001.4624
   Aoki M, 2001, P NATL ACAD SCI USA, V98, P136, DOI 10.1073/pnas.011528498
   Aspuria PJ, 2007, CELL CYCLE, V6, P1692, DOI 10.4161/cc.6.14.4478
   Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y
   Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001
   Beugnet A, 2003, J BIOL CHEM, V278, P40717, DOI 10.1074/jbc.M308573200
   Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2
   CAFFERKEY R, 1993, MOL CELL BIOL, V13, P6012, DOI 10.1128/MCB.13.10.6012
   Carriere A, 2008, CURR BIOL, V18, P1269, DOI 10.1016/j.cub.2008.07.078
   Cheng SWY, 2004, J BIOL CHEM, V279, P15719, DOI 10.1074/jbc.C300534200
   Chiang GG, 2005, J BIOL CHEM, V280, P25485, DOI 10.1074/jbc.M501707200
   Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239
   Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014
   Cybulski N, 2009, TRENDS BIOCHEM SCI, V34, P620, DOI 10.1016/j.tibs.2009.09.004
   Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200
   Dibble CC, 2009, MOL CELL BIOL, V29, P5657, DOI 10.1128/MCB.00735-09
   Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738
   Foster KG, 2010, J BIOL CHEM, V285, P80, DOI 10.1074/jbc.M109.029637
   Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001
   Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x
   He YJ, 2009, CLIN CANCER RES, V15, P6956, DOI 10.1158/1078-0432.CCR-09-1165
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Helliwell SB, 1998, GENETICS, V148, P99
   HELLIWELL SB, 1994, MOL BIOL CELL, V5, P105
   HEMMINGS BA, 1990, BIOCHEMISTRY-US, V29, P3166, DOI 10.1021/bi00465a002
   Ho HL, 2005, CURR GENET, V47, P273, DOI 10.1007/s00294-005-0570-8
   Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200
   Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033
   Julien LA, 2010, MOL CELL BIOL, V30, P908, DOI 10.1128/MCB.00601-09
   KEITH CT, 1995, SCIENCE, V270, P50, DOI 10.1126/science.270.5233.50
   Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200
   Li H, 2010, EXP MOL PATHOL, V88, P150, DOI 10.1016/j.yexmp.2009.09.016
   Liu XY, 2007, MOL BIOL CELL, V18, P1073, DOI 10.1091/mbc.E06-05-0406
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053
   Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6
   Lorberg A, 2003, CURR TOP MICROBIOL, V279, P1
   Nojima H, 2003, J BIOL CHEM, V278, P15461, DOI 10.1074/jbc.C200665200
   Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200
   Oshiro N, 2004, GENES CELLS, V9, P359, DOI 10.1111/j.1356-9597.2004.00727.x
   Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200
   Panasyuk G, 2009, J BIOL CHEM, V284, P30807, DOI 10.1074/jbc.M109.056085
   Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540
   Perry J, 2003, CELL, V112, P151, DOI 10.1016/S0092-8674(03)00033-3
   Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416
   Platt FM, 2009, CLIN CANCER RES, V15, P6008, DOI 10.1158/1078-0432.CCR-09-0898
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200
   Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200
   Robaglia C, 2004, BIOCHEM SOC T, V32, P581, DOI 10.1042/BST0320581
   Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2005, J BIOL CHEM, V280, P39505, DOI 10.1074/jbc.M506096200
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4
   Schalm SS, 2002, CURR BIOL, V12, P632, DOI 10.1016/S0960-9822(02)00762-5
   Schroder W, 2004, GENE, V339, P17, DOI 10.1016/j.gene.2004.07.001
   Schroder WA, 2007, CELL SIGNAL, V19, P1279, DOI 10.1016/j.cellsig.2007.01.013
   Sehgal SN, 2003, TRANSPLANT P, V35, p7S, DOI 10.1016/S0041-1345(03)00211-2
   Soulard A, 2009, CURR OPIN CELL BIOL, V21, P825, DOI 10.1016/j.ceb.2009.08.007
   STAN R, 1994, J BIOL CHEM, V269, P32027
   Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08
   Sturgill TW, 2009, ACS CHEM BIOL, V4, P999, DOI 10.1021/cb900193e
   Takahara T, 2006, J BIOL CHEM, V281, P28605, DOI 10.1074/jbc.M606087200
   Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217
   Toschi A, 2009, MOL CELL BIOL, V29, P1411, DOI 10.1128/MCB.00782-08
   Treins C., 2009, ONCOGENE IN PRESS
   Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104
   Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547
   Veverka V, 2008, ONCOGENE, V27, P585, DOI 10.1038/sj.onc.1210693
   Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319
   Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200
   Wang LF, 2006, J BIOL CHEM, V281, P24293, DOI 10.1074/jbc.M603566200
   Wang L, 2009, J BIOL CHEM, V284, P14693, DOI 10.1074/jbc.C109.002907
   Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200
   Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200
   Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206
   Zhang Y, 2006, GENETICS, V172, P355, DOI 10.1534/genetics.105.051979
NR 94
TC 4
Z9 4
U1 0
U2 3
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1874-6047
BN 978-0-12-381540-8; 978-0-12-381539-2
J9 ENZYMES
JI Enzymes
PY 2010
VL 27
BP 1
EP 20
DI 10.1016/S1874-6047(10)27001-4
PG 20
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BCV58
UT WOS:000311574900002
DA 2021-01-25
ER

PT S
AU Tamanoi, F
   Hall, MN
AF Tamanoi, Fuyuhiko
   Hall, Michael N.
BE Tamanoi, F
   Hall, MN
TI The Enzymes VOLUME XXVIII STRUCTURE, FUNCTION AND REGULATION OF TOR
   COMPLEXES FROM YEASTS TO MAMMALS PART B Preface
SO ENZYMES, VOL 28: STRUCTURE, FUNCTION AND REGULATION OF TOR COMPLEXES
   FROM YEASTS TO MAMMALS, PT B
SE Enzymes
LA English
DT Editorial Material; Book Chapter
C1 [Tamanoi, Fuyuhiko] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Inst Mol Biol, Los Angeles, CA 90095 USA.
   [Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Tamanoi, F (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Inst Mol Biol, Los Angeles, CA 90095 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1874-6047
BN 978-0-12-381006-9
J9 ENZYMES
JI Enzymes
PY 2010
VL 28
BP XI
EP XI
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BCV59
UT WOS:000311575400001
DA 2021-01-25
ER

PT S
AU Cornu, M
   Hall, MN
AF Cornu, Marion
   Hall, Michael N.
BE Tamanoi, F
   Hall, MN
TI mTORC1 and mTORC2 in Energy Homeostasis
SO ENZYMES, VOL 28: STRUCTURE, FUNCTION AND REGULATION OF TOR COMPLEXES
   FROM YEASTS TO MAMMALS, PT B
SE Enzymes
LA English
DT Article; Book Chapter
ID ACTIVATED PROTEIN-KINASE; PANCREATIC BETA-CELLS; INSULIN-RECEPTOR
   SUBSTRATE-2; ELEMENT-BINDING PROTEIN-1; FATTY-ACID SYNTHESIS;
   DIET-INDUCED OBESITY; MAMMALIAN TARGET; ADIPOSE-TISSUE; FOOD-INTAKE;
   GLUCOSE-HOMEOSTASIS
AB Energy homeostasis is the regulation of energy uptake, storage, and expenditure such that an organism maintains a balanced metabolic state. It requires communication between the so-called metabolic organs, including the central nervous system (CNS), the pancreas, adipose tissue, skeletal muscle, and the liver. For example, nutrients stimulate the pancreas and adipose tissue to secrete hormones such as insulin and leptin, respectively. The hypothalamus in the CNS in turn integrates hormonal and nutrient signals to control energy uptake (appetite), storage, and expenditure. As a nutrient, hormone and energy sensor active in all metabolic organs, mTOR plays a central role in mediating energy homeostasis. Here, we review mTORC1 and mTORC2 in metabolic tissues and their role in the regulation of appetite, glucose homeostasis, and energy balance. The deregulation of mTOR signaling can lead to energy imbalance and metabolic disorders such as obesity and type 2 diabetes.
C1 [Cornu, Marion; Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Cornu, M (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
CR Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006
   Becard D, 2001, DIABETES, V50, P2425, DOI 10.2337/diabetes.50.11.2425
   Bell A, 2000, OBES RES, V8, P249, DOI 10.1038/oby.2000.29
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014
   Briaud I, 2005, J BIOL CHEM, V280, P2282, DOI 10.1074/jbc.M412179200
   Brown NF, 2007, METABOLISM, V56, P1500, DOI 10.1016/j.metabol.2007.06.016
   Bussiere CT, 2006, DIABETOLOGIA, V49, P2341, DOI 10.1007/s00125-006-0374-5
   Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200
   Cao R, J NEUROSCI, V30, P6302
   Cao RF, 2008, MOL CELL NEUROSCI, V38, P312, DOI 10.1016/j.mcn.2008.03.005
   Cho HJ, 2004, BIOCHEM BIOPH RES CO, V321, P942, DOI 10.1016/j.bbrc.2004.07.050
   Clegg DJ, 2002, DIABETES, V51, P3196, DOI 10.2337/diabetes.51.11.3196
   Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X
   Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106
   da Silva Xavier Gabriela, 2003, Biochem J, V371, P761, DOI 10.1042/BJ20021812
   Eberle D, 2004, BIOCHIMIE, V86, P839, DOI 10.1016/j.biochi.2004.09.018
   El-Chaar D, 2004, INT J OBESITY, V28, P191, DOI 10.1038/sj.ijo.0802554
   El-Hashemite N, 2003, LANCET, V361, P1348, DOI 10.1016/S0140-6736(03)13044-9
   Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881
   Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922
   Fu A, 2009, CELL METAB, V10, P285, DOI 10.1016/j.cmet.2009.08.008
   Gagnon A, 2001, J CELL PHYSIOL, V189, P14, DOI 10.1002/jcp.1132
   Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004
   Gao S, 2007, P NATL ACAD SCI USA, V104, P17358, DOI 10.1073/pnas.0708385104
   Gimeno RE, 2005, CURR OPIN PHARMACOL, V5, P122, DOI 10.1016/j.coph.2005.01.006
   Granot Z, 2009, CELL METAB, V10, P296, DOI 10.1016/j.cmet.2009.08.010
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Hamada S, 2009, DIABETES, V58, P1321, DOI 10.2337/db08-0519
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Hennige AM, 2003, J CLIN INVEST, V112, P1521, DOI 10.1172/JCI200318581
   Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961
   Horton JD, 2003, P NATL ACAD SCI USA, V100, P12027, DOI 10.1073/pnas.1534923100
   Hu ZY, 2005, J BIOL CHEM, V280, P39681, DOI 10.1074/jbc.C500398200
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003
   Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033
   Kefas BA, 2003, DIABETOLOGIA, V46, P250, DOI 10.1007/s00125-002-1030-3
   Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748
   Kloting N, 2008, DIABETES, V57, P2074, DOI 10.2337/db07-1538
   Kobayashi T, 1999, CANCER RES, V59, P1206
   Koketsu Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE719, DOI 10.1152/ajpendo.00253.2007
   Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07
   Kumar A, 2010, DIABETES, V59, P1397, DOI 10.2337/db09-1061
   Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525
   Lam TKT, 2005, NAT NEUROSCI, V8, P579, DOI 10.1038/nn1456
   Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528
   Leclerc I, 2004, AM J PHYSIOL-ENDOC M, V286, pE1023, DOI 10.1152/ajpendo.00532.2003
   Li S, P NATL ACAD SCI US, V107, P3441
   Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200
   Lingohr MK, 2002, DIABETES, V51, P966, DOI 10.2337/diabetes.51.4.966
   Loftus TM, 2000, SCIENCE, V288, P2379, DOI 10.1126/science.288.5475.2379
   Mauvoisin D, 2007, J CELL COMMUN SIGNAL, V1, P113, DOI 10.1007/s12079-007-0011-1
   Minokoshi Y, 2004, NATURE, V428, P569, DOI 10.1038/nature02440
   Mizuno TM, 1998, DIABETES, V47, P294, DOI 10.2337/diabetes.47.2.294
   Mori H, 2009, AM J PHYSIOL-ENDOC M, V297, pE1013, DOI 10.1152/ajpendo.00262.2009
   Mori H, 2009, CELL METAB, V9, P362, DOI 10.1016/j.cmet.2009.03.005
   Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004
   Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102
   Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231
   Onda H, 1999, J CLIN INVEST, V104, P687, DOI 10.1172/JCI7319
   Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599
   Pende M, 2000, NATURE, V408, P994
   Pocai A, 2006, J CLIN INVEST, V116, P1081, DOI 10.1172/JCI26640
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007
   Postic C, 2008, J CLIN INVEST, V118, P829, DOI 10.1172/JCI34275
   Proulx K, 2008, DIABETES, V57, P3231, DOI 10.2337/db07-1690
   Rachdi L, 2008, P NATL ACAD SCI USA, V105, P9250, DOI 10.1073/pnas.0803047105
   Riboulet-Chavey A, 2008, DIABETES, V57, P415, DOI 10.2337/db07-0993
   Richards SK, 2005, J ENDOCRINOL, V187, P225, DOI 10.1677/joe.1.06413
   Ropelle ER, 2008, DIABETES, V57, P594, DOI 10.2337/db07-0573
   Ruderman NB, 2003, ACTA PHYSIOL SCAND, V178, P435, DOI 10.1046/j.1365-201X.2003.01164.x
   Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781
   Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469
   Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07
   Shimano H, 1997, J CLIN INVEST, V99, P846, DOI 10.1172/JCI119248
   Shimomura I, 1997, J CLIN INVEST, V99, P838, DOI 10.1172/JCI119247
   Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013
   Shutter JR, 1997, GENE DEV, V11, P593, DOI 10.1101/gad.11.5.593
   Sun G, 2010, AM J PHYSIOL-ENDOC M, V298, pE1261, DOI 10.1152/ajpendo.00100.2010
   Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Withers DJ, 1999, NAT GENET, V23, P32
   Wortman MD, 2003, NAT MED, V9, P483, DOI 10.1038/nm0503-483
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yahagi N, 2002, J BIOL CHEM, V277, P19353, DOI 10.1074/jbc.M201584200
   Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206
   YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086
   Zang MW, 2004, J BIOL CHEM, V279, P47898, DOI 10.1074/jbc.M408149200
   Zhang HH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006189
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
NR 103
TC 3
Z9 3
U1 0
U2 4
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1874-6047
BN 978-0-12-381006-9; 978-0-12-381005-2
J9 ENZYMES
JI Enzymes
PY 2010
VL 28
BP 263
EP 278
DI 10.1016/S1874-6047(10)28013-7
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BCV59
UT WOS:000311575400014
DA 2021-01-25
ER

PT J
AU Obrdlik, A
   Louvet, E
   Kukalev, A
   Naschekin, D
   Kiseleva, E
   Fahrenkrog, B
   Percipalle, P
AF Obrdlik, Ales
   Louvet, Emilie
   Kukalev, Alexander
   Naschekin, Dmitri
   Kiseleva, Elena
   Fahrenkrog, Birthe
   Percipalle, Piergiorgio
TI Nuclear myosin 1 is in complex with mature rRNA transcripts and
   associates with the nuclear pore basket
SO FASEB JOURNAL
LA English
DT Article
DE preribosomal subunits; NPC; rRNA nuclear export
ID POLYMERASE-I TRANSCRIPTION; CHAIN-LIKE POLYPEPTIDE; GENE-EXPRESSION;
   EXPORT; SUBUNITS; ACTIN; NUP153; TRANSPORT; NUCLEOLUS; MESSENGER
AB In rRNA biogenesis, nuclear myosin 1 (NM1) and actin synergize to activate rRNA gene transcription. Evidence that actin is in preribosomal subunits and NM1 may control rRNA biogenesis post-transcriptionally prompted us to investigate whether NM1 associates with and accompanies rRNA to nuclear pores (NPC). Ultracentrifugation on HeLa nucleolar extracts showed RNA-dependent NM1 coelution with preribosomal subunits. In RNA immunoprecipitations (RIPs), NM1 coprecipitated with pre-rRNAs and 18S, 5.8S, and 28S rRNAs, but failed to precipitate 5S rRNA and 7SL RNA. In isolated nuclei and living HeLa cells, NM1 or actin inhibition and selective alterations in actin polymerization impaired 36S pre-rRNA processing. Immunoelectron microscopy (IEM) on sections of manually isolated Xenopus oocyte nuclei showed NM1 localization at the NPC basket. Field emission scanning IEM on isolated nuclear envelopes and intranuclear content confirmed basket localization and showed that NM1 decorates actin-rich pore-linked filaments. Finally, RIP and successive RIPs ( reRIPs) on cross-linked HeLa cells demonstrated that NM1, CRM1, and Nup153 precipitate same 18S and 28S rRNAs but not 5S rRNA. We conclude that NM1 facilitates maturation and accompanies export-competent preribosomal subunits to the NPC, thus modulating export.-Obrdlik, A., Louvet, E., Kukalev, A., Naschekin, D., Kiseleva, E., Fahrenkrog, B., Percipalle, P. Nuclear myosin 1 is in complex with mature rRNA transcripts and associates with the nuclear pore basket. FASEB J. 24, 146-157 ( 2010). www.fasebj.org
C1 [Obrdlik, Ales; Louvet, Emilie; Kukalev, Alexander; Naschekin, Dmitri; Percipalle, Piergiorgio] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden.
   [Kiseleva, Elena] Russian Acad Sci, Inst Cytol & Genet, Novosibirsk 630090, Russia.
   [Fahrenkrog, Birthe] Univ Basel, Biozentrum, Basel, Switzerland.
RP Percipalle, P (corresponding author), Karolinska Inst, Dept Cell & Mol Biol, Box 285, SE-17177 Stockholm, Sweden.
EM piergiorgio.percipalle@ki.se
RI Fahrenkrog, Birthe/D-5840-2011
OI Obrdlik, Ales/0000-0001-8499-3879; Nashchekin,
   Dmitry/0000-0001-7372-0752; Kiseleva, Elena/0000-0001-6949-182X;
   Fahrenkrog, Birthe/0000-0003-4080-9413
FU Swedish Research Council (Vetenskapsradet)Swedish Research Council;
   Fondation pour la Recherche MedicaleFondation pour la Recherche
   Medicale; Wenner-Gren Foundation; Wellcome TrustWellcome Trust; Russian
   Foundation for Basic ResearchRussian Foundation for Basic Research
   (RFBR); Russian Academy of Sciences Molecular and Cellular Biology (MCB
   RAS) programRussian Academy of Sciences
FX This work was supported by grants from the Swedish Research Council
   (Vetenskapsradet) to P. P. E. L. received postdoctoral fellowships from
   the Fondation pour la Recherche Medicale and the Wenner-Gren Foundation.
   E. K. was supported with grants from the Wellcome Trust, the Russian
   Foundation for Basic Research, and the Russian Academy of Sciences
   Molecular and Cellular Biology (MCB RAS) program.
CR Ball JR, 2004, RNA, V10, P19, DOI 10.1261/rna.5109104
   BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405
   BERRIOS M, 1986, J CELL BIOL, V103, P711, DOI 10.1083/jcb.103.3.711
   BERRIOS M, 1991, P NATL ACAD SCI USA, V88, P219, DOI 10.1073/pnas.88.1.219
   Cavellan E, 2006, J BIOL CHEM, V281, P16264, DOI 10.1074/jbc.M600233200
   Cisterna B, 2006, FASEB J, V20, P1901, DOI 10.1096/fj.05-5278fje
   Cisterna B, 2009, HISTOCHEM CELL BIOL, V131, P743, DOI 10.1007/s00418-009-0583-3
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fatica A, 2002, CURR OPIN CELL BIOL, V14, P313, DOI 10.1016/S0955-0674(02)00336-8
   Fomproix N, 2004, EXP CELL RES, V294, P140, DOI 10.1016/j.yexcr.2003.10.028
   Gadal O, 2001, MOL CELL BIOL, V21, P3405, DOI 10.1128/MCB.21.10.3405-3415.2001
   Granneman S, 2005, CURR OPIN CELL BIOL, V17, P281, DOI 10.1016/j.ceb.2005.04.001
   Grummt I, 2003, GENE DEV, V17, P1691, DOI 10.1101/gad.1098503R
   Hase ME, 2001, MOL BIOL CELL, V12, P2433, DOI 10.1091/mbc.12.8.2433
   Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152
   Hofmann WA, 2006, BIOCHEM CELL BIOL, V84, P418, DOI 10.1139/O06-069
   Hofmann WA, 2009, J CELL SCI, V122, P636, DOI 10.1242/jcs.030205
   Holaska JM, 2007, BIOCHEMISTRY-US, V46, P8897, DOI 10.1021/bi602636m
   Johnson AW, 2002, TRENDS BIOCHEM SCI, V27, P580, DOI 10.1016/S0968-0004(02)02208-9
   Kahle M, 2007, HISTOCHEM CELL BIOL, V127, P139, DOI 10.1007/s00418-006-0231-0
   Kiseleva E, 2004, J CELL SCI, V117, P2481, DOI 10.1242/jcs.01098
   Louvet E, 2009, INT REV CEL MOL BIO, V272, P107, DOI 10.1016/S1937-6448(08)01603-1
   Nissan TA, 2002, EMBO J, V21, P5539, DOI 10.1093/emboj/cdf547
   Obrdlik A, 2008, MOL CELL BIOL, V28, P6342, DOI 10.1128/MCB.00766-08
   OCHS RL, 1985, CHROMOSOMA, V92, P330, DOI 10.1007/BF00327463
   Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101
   Orru S, 2007, MOL CELL PROTEOMICS, V6, P382, DOI 10.1074/mcp.M600156-MCP200
   PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603
   Pante N, 2000, J STRUCT BIOL, V129, P306, DOI 10.1006/jsbi.2000.4232
   Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034
   Pederson T, 2000, J CELL BIOL, V148, P1091, DOI 10.1083/jcb.148.6.1091
   Percipalle P, 2006, EMBO REP, V7, P525, DOI 10.1038/sj.embor.7400657
   Percipalle P, 2009, CELL MOL LIFE SCI, V66, P2151, DOI 10.1007/s00018-009-0012-8
   Philimonenko VV, 2004, NAT CELL BIOL, V6, P1165, DOI 10.1038/ncb1190
   Politz JCR, 2003, MOL BIOL CELL, V14, P4805, DOI 10.1091/mbc.E03-06-0395
   Rouquette J, 2005, EMBO J, V24, P2862, DOI 10.1038/sj.emboj.7600752
   SCHINDLER M, 1986, J CELL BIOL, V102, P859, DOI 10.1083/jcb.102.3.859
   Smythe C, 2000, EMBO J, V19, P3918, DOI 10.1093/emboj/19.15.3918
   Soop T, 2005, MOL BIOL CELL, V16, P5610, DOI 10.1091/mbc.E05-08-0715
   Strezoska Z, 2000, MOL CELL BIOL, V20, P5516, DOI 10.1128/MCB.20.15.5516-5528.2000
   Thomas F, 2003, J CELL SCI, V116, P2409, DOI 10.1242/jcs.00464
   Trotta CR, 2003, EMBO J, V22, P2841, DOI 10.1093/emboj/cdg249
   Tschochner H, 2003, TRENDS CELL BIOL, V13, P255, DOI 10.1016/S0962-8924(03)00054-0
   Ullman KS, 1999, MOL BIOL CELL, V10, P649, DOI 10.1091/mbc.10.3.649
   Wilson DN, 2005, CRIT REV BIOCHEM MOL, V40, P243, DOI 10.1080/10409230500256523
   Yao W, 2007, MOL CELL, V26, P51, DOI 10.1016/j.molcel.2007.02.018
   Zemp I, 2007, FEBS LETT, V581, P2783, DOI 10.1016/j.febslet.2007.05.013
NR 47
TC 29
Z9 31
U1 0
U2 5
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD JAN
PY 2010
VL 24
IS 1
BP 146
EP 157
DI 10.1096/fj.09-135863
PG 12
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 539DL
UT WOS:000273233600017
PM 19729515
DA 2021-01-25
ER

PT J
AU Chen, K
   van Nimwegen, E
   Rajewsky, N
   Siegal, ML
AF Chen, Kevin
   van Nimwegen, Erik
   Rajewsky, Nikolaus
   Siegal, Mark L.
TI Correlating Gene Expression Variation with cis-Regulatory Polymorphism
   in Saccharomyces cerevisiae
SO GENOME BIOLOGY AND EVOLUTION
LA English
DT Article
DE Saccharomyces cerevisiae; transcription factors; transcription factor
   binding sites; population genetics; gene expression; SNP; eQTL
ID TRANSCRIPTION FACTOR-BINDING; YEAST; EVOLUTION; MOTIFS; SITES;
   DIVERGENCE; DROSOPHILA; ELEMENTS; COMPLEXITY; SELECTION
AB Identifying the nucleotides that cause gene expression variation is a critical step in dissecting the genetic basis of complex traits. Here, we focus on polymorphisms that are predicted to alter transcription factor binding sites (TFBSs) in the yeast, Saccharomyces cerevisiae. We assembled a confident set of transcription factor motifs using recent protein binding microarray and ChIP-chip data and used our collection of motifs to predict a comprehensive set of TFBSs across the S. cerevisiae genome. We used a population genomics analysis to show that our predictions are accurate and significantly improve on our previous annotation. Although predicting gene expression from sequence is thought to be difficult in general, we identified a subset of genes for which changes in predicted TFBSs correlate well with expression divergence between yeast strains. Our analysis thus demonstrates both the accuracy of our new TFBS predictions and the feasibility of using simple models of gene regulation to causally link differences in gene expression to variation at individual nucleotides.
C1 [Chen, Kevin; Siegal, Mark L.] NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.
   [Chen, Kevin; Rajewsky, Nikolaus] Max Delbruck Ctr Mol Med, Berlin, Germany.
   [Chen, Kevin] Rutgers State Univ, Dept Genet, Piscataway, NJ 08855 USA.
   [Chen, Kevin] Rutgers State Univ, BioMaPS Inst, Piscataway, NJ 08855 USA.
   [van Nimwegen, Erik] Univ Basel, Biozentrum, Swiss Inst Bioinformat, Basel, Switzerland.
RP Chen, K (corresponding author), NYU, Dept Biol, Ctr Genom & Syst Biol, New York, NY 10003 USA.
EM kcchen@biology.rutgers.edu; mark.siegal@nyu.edu
OI Rajewsky, Nikolaus/0000-0002-4785-4332; van Nimwegen,
   Erik/0000-0001-6338-1312; Siegal, Mark/0000-0001-6930-2988
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [F32HG 004590-01,
   K99HG004515-01, R00HG004515-02]; National Science FoundationNational
   Science Foundation (NSF) [IOS-0642999]; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [SNF: 3100A0-118318];
   NATIONAL HUMAN GENOME RESEARCH INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Human Genome Research Institute (NHGRI) [R00HG004515,
   R00HG004515, F32HG004590, K99HG004515, R00HG004515] Funding Source: NIH
   RePORTER
FX We thank Rachel Brem for sharing the eQTL data with us. We also thank
   Ian Ehrenreich, Sasha Levy, and Matt Rockman for comments on the
   manuscript as well as Nicholas Socci and the Siegal laboratory for
   helpful discussions. This work was partially supported by the National
   Institutes of Health (grant numbers F32HG 004590-01, K99HG004515-01,
   R00HG004515-02 to K. C.), National Science Foundation (grant number
   IOS-0642999 to M. L. S.), and Swiss National Science Foundation (grant
   number SNF: 3100A0-118318 to E.v.N.).
CR Altshuler D, 2008, SCIENCE, V322, P881, DOI 10.1126/science.1156409
   Andersen MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.0040005
   Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327
   Badis G, 2008, MOL CELL, V32, P878, DOI 10.1016/j.molcel.2008.11.020
   Berriz GF, 2009, BIOINFORMATICS, V25, P3043, DOI 10.1093/bioinformatics/btp498
   Bray N, 2004, GENOME RES, V14, P693, DOI 10.1101/gr.1960404
   Brem RB, 2005, P NATL ACAD SCI USA, V102, P1572, DOI 10.1073/pnas.0408709102
   Carroll SB, 2008, CELL, V134, P25, DOI 10.1016/j.cell.2008.06.030
   Castillo-Davis CI, 2004, GENOME RES, V14, P1530, DOI 10.1101/gr.2662504
   Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990
   Chen K, 2006, NAT GENET, V38, P1452, DOI 10.1038/ng1910
   Chen K, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005681
   Cliften PF, 2001, GENOME RES, V11, P1175, DOI 10.1101/gr.182901
   Cookson W, 2009, NAT REV GENET, V10, P184, DOI 10.1038/nrg2537
   David L, 2006, P NATL ACAD SCI USA, V103, P5320, DOI 10.1073/pnas.0601091103
   Dermitzakis ET, 2003, MOL BIOL EVOL, V20, P703, DOI 10.1093/molbev/msg077
   Doniger SW, 2007, PLOS COMPUT BIOL, V3, P932, DOI 10.1371/journal.pcbi.0030099
   Emberly E, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-57
   Emerson JJ, 2010, GENOME RES, V20, P826, DOI 10.1101/gr.101576.109
   ERB I, 2006, IEEE P 1 INT C COMP, P111
   Fairbrother WG, 2004, PLOS BIOL, V2, P1388, DOI 10.1371/journal.pbio.0020268
   Fay JC, 2002, NATURE, V415, P1024, DOI 10.1038/4151024a
   Fay JC, 2005, GENETICS, V170, P1575, DOI 10.1534/genetics.105.042283
   Gu X, 2005, P NATL ACAD SCI USA, V102, P707, DOI 10.1073/pnas.0409186102
   Harbison CT, 2004, NATURE, V431, P99, DOI 10.1038/nature02800
   Hindorff LA, 2009, P NATL ACAD SCI USA, V106, P9362, DOI 10.1073/pnas.0903103106
   Knight JC, 2005, J MOL MED, V83, P97, DOI 10.1007/s00109-004-0603-7
   Lapidot M, 2008, PLOS GENET, V4
   Leach LJ, 2007, MOL BIOL EVOL, V24, P2556, DOI 10.1093/molbev/msm188
   Li S, 1998, EMBO J, V17, P6952, DOI 10.1093/emboj/17.23.6952
   Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743
   MacIsaac KD, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-113
   Matys V, 2003, NUCLEIC ACIDS RES, V31, P374, DOI 10.1093/nar/gkg108
   Nogami S, 2007, PLOS GENET, V3, P305, DOI 10.1371/journal.pgen.0030031
   Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964
   Ronald J, 2005, PLOS GENET, V1, P213, DOI 10.1371/journal.pgen.0010025
   Ronald J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000678
   Rudra D, 2005, EMBO J, V24, P533, DOI 10.1038/sj.emboj.7600553
   Schadt EE, 2005, NAT GENET, V37, P710, DOI 10.1038/ng1589
   Schlecht U, 2008, MOL BIOL CELL, V19, P2193, DOI 10.1091/mbc.E07-12-1242
   Segal L, 2007, BIOINFORMATICS, V23, pI440, DOI 10.1093/bioinformatics/btm183
   Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067
   Siegal ML, 2007, GENETICA, V129, P83, DOI 10.1007/s10709-006-0035-0
   Sun W, 2007, BIOINFORMATICS, V23, P2290, DOI 10.1093/bioinformatics/btm327
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Swamy KBS, 2009, NUCLEIC ACIDS RES, V37, P6991, DOI 10.1093/nar/gkp743
   Tanay A, 2006, GENOME RES, V16, P962, DOI 10.1101/gr.5113606
   Tirosh I, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100198
   van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4
   Wang DY, 2007, GENOME RES, V17, P1161, DOI 10.1101/gr.6328907
   Wang YC, 2003, CELL, V112, P697, DOI 10.1016/S0092-8674(03)00121-1
   Westholm JO, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-601
   Wray GA, 2007, NAT REV GENET, V8, P206, DOI 10.1038/nrg2063
   Yang X, 2009, NAT GENET, V41, P415, DOI 10.1038/ng.325
   Ye C, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000311
   Yuan Y, 2007, PLOS COMPUT BIOL, V3, P2391, DOI 10.1371/journal.pcbi.0030243
   Yvert G, 2003, NAT GENET, V35, P57, DOI 10.1038/ng1222
   Zhang ZH, 2005, NUCLEIC ACIDS RES, V33, P2838, DOI 10.1093/nar/gki583
   Zhang ZQ, 2004, TRENDS GENET, V20, P403, DOI 10.1016/j.tig.2004.07.006
   Zheng W, 2010, NATURE, V464, P1187, DOI 10.1038/nature08934
   Zhou T, 2010, MOL BIOL EVOL, V27, P1912, DOI 10.1093/molbev/msq077
   Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108
   Zhu J, 1999, BIOINFORMATICS, V15, P607, DOI 10.1093/bioinformatics/15.7.607
NR 63
TC 25
Z9 25
U1 0
U2 9
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1759-6653
J9 GENOME BIOL EVOL
JI Genome Biol. Evol.
PY 2010
VL 2
BP 697
EP 707
DI 10.1093/gbe/evq054
PG 11
WC Evolutionary Biology; Genetics & Heredity
SC Evolutionary Biology; Genetics & Heredity
GA 775NT
UT WOS:000291467300013
PM 20829281
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT B
AU Muller, P
   Scherr, N
   Jayachandran, R
   Pieters, J
AF Mueller, Philipp
   Scherr, Nicole
   Jayachandran, Rajesh
   Pieters, Jean
BE Barton, AW
TI SUBVERSION OF HOST IMMUNE RESPONSES BY MYCOBACTERIUM TUBERCULOSIS
SO HOST-PATHOGEN INTERACTIONS: GENETICS, IMMUNOLOGY AND PHYSIOLOGY
SE Immunology and Immune System Disorders
LA English
DT Article; Book Chapter
ID PHAGOSOME MATURATION ARREST; PROTEIN-KINASE-G; PATHOGENIC MYCOBACTERIA;
   MEMBRANE TRAFFICKING; INNATE IMMUNITY; SURVIVAL; MACROPHAGES; SECRETION;
   VIRULENCE; CALCINEURIN
AB Tuberculosis, one of the world's oldest diseases has nowadays reached a pandemic prevalence. Despite its long history and intense research, efficient drugs against its causative agent, M. tuberculosis, are still limited. One reason for the pathogen's success lies within its capability to evade host immune defense mechanisms and to create a niche within host cells enabling the bacterium to persist for long periods. M. tuberculosis has evolved a diversified set of strategies to manipulate the immune response of the host. In this communication, we discuss some of the strategies employed by M. tuberculosis in order to survive within the hostile environment of the macrophage. A detailed analysis of the molecular basis of host-pathogen interactions will unravel novel mechanisms and might contribute to finding novel approaches to treat and combat tuberculosis.
C1 [Mueller, Philipp; Scherr, Nicole; Jayachandran, Rajesh; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
CR ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283
   Aramburu J, 2004, EMBO REP, V5, P343, DOI 10.1038/sj.embor.7400133
   Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0
   Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008
   Beresford NJ, 2009, J ANTIMICROB CHEMOTH, V63, P928, DOI 10.1093/jac/dkp031
   Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x
   Chua J, 2004, CURR OPIN MICROBIOL, V7, P71, DOI 10.1016/j.mib.2003.12.011
   CHUA J, 2004, J BIOL CHEM
   Cole ST, 1998, CURR OPIN MICROBIOL, V1, P567, DOI 10.1016/S1369-5274(98)80090-8
   Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159
   Cossart P, 2004, SCIENCE, V304, P242, DOI 10.1126/science.1090124
   de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7
   Downes CP, 2005, TRENDS CELL BIOL, V15, P259, DOI 10.1016/j.tcb.2005.03.008
   Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93
   Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102
   Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049
   Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x
   GATFIELD J, 2003, ADV IMMUNOL, V82
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Korbel DS, 2008, MICROBES INFECT, V10, P995, DOI 10.1016/j.micinf.2008.07.039
   Lemmon MA, 2008, NAT REV MOL CELL BIO, V9, P99, DOI 10.1038/nrm2328
   MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06
   MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063
   McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Mueller P, 2006, IMMUNOBIOLOGY, V211, P549, DOI 10.1016/j.imbio.2006.06.004
   Pieters J, 2002, TRENDS MICROBIOL, V10, P142, DOI 10.1016/S0966-842X(02)02305-3
   Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006
   Pieters Jean, 2008, V48, P116, DOI 10.1007/978-0-387-09595-0_11
   Rosenberger CM, 2003, NAT REV MOL CELL BIO, V4, P385, DOI 10.1038/nrm1104
   Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235
   Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104
   STEFAN S, 2009, MOL MICROBIOL, V71, P1341
   Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102
   Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527
   Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
NR 40
TC 0
Z9 0
U1 0
U2 4
PU NOVA SCIENCE PUBLISHERS, INC
PI HAUPPAUGE
PA 400 OSER AVE, STE 1600, HAUPPAUGE, NY 11788-3635 USA
BN 978-1-60876-286-6
J9 IMMUNOL IMMUNE SYST
PY 2010
BP 145
EP 151
PG 7
WC Immunology
SC Immunology
GA BPT70
UT WOS:000279878600006
DA 2021-01-25
ER

PT S
AU Reichert, H
   Bello, B
AF Reichert, Heinrich
   Bello, Bruno
BE Deutsch, JS
TI Hox Genes and Brain Development in Drosophila
SO HOX GENES: STUDIES FROM THE 20TH TO THE 21ST CENTURY
SE Advances in Experimental Medicine and Biology
LA English
DT Article; Book Chapter
ID CENTRAL-NERVOUS-SYSTEM; EMBRYONIC BRAIN; HOMEOTIC GENES; CELL IDENTITY;
   EXPRESSION; EXTRADENTICLE; NEUROGENESIS; HINDBRAIN; PROTEINS;
   PROLIFERATION
AB Hox genes are prominently expressed in the developing brain and ventral ganglia of Drosophila. In the embryonic brain, the Hox genes labial and Deformed are essential for the establishment of regionalized neuronal identity; in their absence cells are generated in the brain but fail to acquire appropriate neuronal features. Genetic analyses reveal that Hox proteins are largely equivalent in their action in embryonic brain development and that their expression is under the control of cross-regulatory interactions among Hox genes that are similar to those found in embryogenesis of trunk segments. Hox genes have a different role in postembryonic brain development. During the larval phase of CNS development, reactivation of specific Hox genes terminates neural proliferation by induction of apoptotic cell death in neural stem cell-like progenitors called neuroblasts. This reactivation process is tightly controlled by epigenetic mechanisms requiring the Polycomb group of genes. Many features of Hox gene action in Drosophila brain development are evolutionarily conserved and are manifest in brain development of vertebrates.
C1 [Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Reichert, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
CR Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   Bello B, 2007, DEVELOPMENT, V134, P1091, DOI 10.1242/dev.02793
   CARROLL SB, 1995, NATURE, V376, P479, DOI 10.1038/376479a0
   DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5
   DUBOULE D, 1995, CURR OPIN GENET DEV, V5, P525, DOI 10.1016/0959-437X(95)90058-O
   Gavalas A, 1998, DEVELOPMENT, V125, P1123
   Graba Y, 1997, BIOESSAYS, V19, P379, DOI 10.1002/bies.950190505
   Hirth F, 2001, DEVELOPMENT, V128, P4781
   Hirth F, 1998, DEVELOPMENT, V125, P1579
   HUNT P, 1991, CELL, V66, P1075, DOI 10.1016/0092-8674(91)90029-X
   Kaufman T C, 1990, Adv Genet, V27, P309
   Kourakis MJ, 1997, DEV BIOL, V190, P284, DOI 10.1006/dbio.1997.8689
   Lowe CJ, 2003, CELL, V113, P853, DOI 10.1016/S0092-8674(03)00469-0
   MANAK JR, 1994, DEVELOPMENT, P61
   Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5
   Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243
   Mann RS, 1997, BIOESSAYS, V19, P661, DOI 10.1002/bies.950190804
   Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3
   Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009
   MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N
   Miller RG, 2001, AMYOTROPH LATERAL SC, V2, P3, DOI 10.1080/146608201300079355
   Nagao T, 2000, DEV GENES EVOL, V210, P289, DOI 10.1007/s004270050316
   Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0
   Pinsonneault J, 1997, EMBO J, V16, P2032, DOI 10.1093/emboj/16.8.2032
   PROKOP A, 1991, DEVELOPMENT, V111, P79
   Reichert H, 1997, TRENDS NEUROSCI, V20, P258, DOI 10.1016/S0166-2236(96)01034-X
   Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723
   Ryoo HD, 1999, DEVELOPMENT, V126, P5137
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   Sprecher SG, 2004, MECH DEVELOP, V121, P527, DOI 10.1016/j.mod.2004.04.009
   Sprecher SG, 2007, GENE EXPR PATTERNS, V7, P584, DOI 10.1016/j.modgep.2007.01.004
   Sprecher SG, 2006, DEVELOPMENT, V133, P4331, DOI 10.1242/dev.02606
   Studer M, 1998, DEVELOPMENT, V125, P1025
   Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   Urbach R, 2003, DEVELOPMENT, V130, P3607, DOI 10.1242/dev.00532
   Urbach R, 2006, DEVELOPMENT, V133, P4315, DOI 10.1242/dev.02605
   WILKINSON DG, 1989, NATURE, V341, P405, DOI 10.1038/341405a0
   YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7
NR 40
TC 9
Z9 9
U1 0
U2 6
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0065-2598
BN 978-1-4419-6672-8
J9 ADV EXP MED BIOL
JI Adv.Exp.Med.Biol.
PY 2010
VL 689
BP 145
EP 153
D2 10.1007/978-1-4419-6673-5
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA BPO60
UT WOS:000279545800011
PM 20795329
DA 2021-01-25
ER

PT J
AU Gehring, W
   Seimiya, M
AF Gehring, Walter
   Seimiya, Makiko
TI Eye evolution and the origin of Darwin's eye prototype
SO ITALIAN JOURNAL OF ZOOLOGY
LA English
DT Review
DE Eye; evolution; prototypic eye; Pax6; MITF
ID TWIN-OF-EYELESS; DROSOPHILA-MELANOGASTER; ECTOPIC EYES; TRANSCRIPTION
   FACTORS; PIGMENTED EPITHELIUM; SINE-OCULIS; MOUSE MODEL; CELL-TYPES; PAX
   GENES; MITF
AB In The Origin of Species, Darwin proposed that the complex eyes of animals evolved from a simple prototype consisting of two cells only, a photoreceptor cell and a pigment cell shielding the light from one side and allowing for a directional vision. The discovery of Pax6 as a master control gene for eye development in bilateria lends considerable support to the hypothesis of a monophyletic origin of the metazoan eyes from a Darwinian prototype. Pax6 is found in all bilateria and it is capable of inducing ectopic eyes in both vertebrates and invertebrates. The Darwinian prototype eyes have been found in nature in certain planarians and in the trochophora larvae of Platynereis, an annelid worm, where they were found to express Pax6. The prototypic eye must have evolved from a single cell. Such a single-celled pigmented photoreceptor has been found in the larvae of Tripedalia, a jellyfish, whereas the adult has multicellular lens eyes. We propose that the evolution of the prototypic eye started with a first step of cellular differentiation from a single-celled pigmented photoreceptor, into two cell types: a photoreceptor cell specified by Pax6, and a pigment cell specified by the microphthalmia transcription factor (Mitf), which is also conserved from jellyfish to humans. From the prototypic eye more complex eyes can evolve by intercalating additional genes into the eye developmental pathway by gene duplication and subsequent divergence or by enhancer fusion.
C1 [Gehring, Walter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Seimiya, Makiko] Dept Biosyst Sci & Engn, Basel, Switzerland.
RP Gehring, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Walter.Gehring@unibas.ch
FU University of Basel; Kantons of Basel-Stadt; Basel-Landschaft; Swiss
   National FondsSwiss National Science Foundation (SNSF)
FX We acknowledge the research contributions of all the members of our
   team, and the financial support by the University of Basel, the Kantons
   of Basel-Stadt and Basel-Landschaft and the Swiss National Fonds.
   Special thanks go to Patrick Callaerts for carefully reviewing our
   manuscript.
CR Arendt D, 2003, INT J DEV BIOL, V47, P563
   Arendt D, 2002, DEVELOPMENT, V129, P1143
   Arendt D, 2001, PHILOS T R SOC B, V356, P1545, DOI 10.1098/rstb.2001.0971
   Arnheiter H, 1998, NATURE, V391, P632, DOI 10.1038/35487
   Baumer N, 2003, DEVELOPMENT, V130, P2903, DOI 10.1242/dev.00450
   Bharti K, 2006, PIGM CELL RES, V19, P380, DOI 10.1111/j.1600-0749.2006.00318.x
   Callaerts P, 1997, ANNU REV NEUROSCI, V20, P483, DOI 10.1146/annurev.neuro.20.1.483
   Callaerts P, 2001, J NEUROBIOL, V46, P73, DOI 10.1002/1097-4695(20010205)46:2<73::AID-NEU10>3.0.CO;2-N
   Chow RL, 1999, DEVELOPMENT, V126, P4213
   Clements J, 2008, P NATL ACAD SCI USA, V105, P16183, DOI 10.1073/pnas.0708330105
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   Darwin C. R., 1872, ORIGIN SPECIES MEANS
   Dominguez M, 2004, NAT GENET, V36, P31, DOI 10.1038/ng1281
   Eakin R.M., 1982, P91
   Erclik T, 2009, DEV BIOL, V332, P70, DOI 10.1016/j.ydbio.2009.05.565
   Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X
   GLASER T, 1990, SCIENCE, V250, P823, DOI 10.1126/science.2173141
   GOLDSMITH TH, 1990, Q REV BIOL, V65, P281, DOI 10.1086/416840
   GRINDLEY JC, 1995, DEVELOPMENT, V121, P1433
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   Hallsson JH, 2004, GENETICS, V167, P233, DOI 10.1534/genetics.167.1.233
   Hertwig P., 1942, ZEITSCHR INDUKT ABSTAMM U VERERBUNGSL, V80, P220, DOI 10.1007/BF01741984
   Hesse R., 1897, Z WISS ZOOL, V62, P527
   HODGKINSON CA, 1993, CELL, V74, P395, DOI 10.1016/0092-8674(93)90429-T
   HOGAN BLM, 1988, DEVELOPMENT, V103, P115
   HOGAN BLM, 1986, J EMBRYOL EXP MORPH, V97, P95
   Horsford DJ, 2005, DEVELOPMENT, V132, P177, DOI 10.1242/dev.01571
   HUGHES MJ, 1993, J BIOL CHEM, V268, P20687
   HUNT DM, 1970, GENET RES, V15, P29, DOI 10.1017/S0016672300001348
   Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522
   Janssens H, 1999, DEV BIOL, V207, P204, DOI 10.1006/dbio.1998.9170
   Jun S, 1998, P NATL ACAD SCI USA, V95, P13720, DOI 10.1073/pnas.95.23.13720
   Klassen HJ, 2004, INVEST OPHTH VIS SCI, V45, P4167, DOI 10.1167/iovs.04-0511
   Kozmik Z, 2003, DEV CELL, V5, P773, DOI 10.1016/S1534-5807(03)00325-3
   Kozmik Z, 2008, P NATL ACAD SCI USA, V105, P8989, DOI 10.1073/pnas.0800388105
   Kronhamn J, 2002, DEVELOPMENT, V129, P1015
   Lister JA, 2001, DEV BIOL, V237, P333, DOI 10.1006/dbio.2001.0379
   Lister JA, 1999, DEVELOPMENT, V126, P3757
   Malatesta P, 2000, DEVELOPMENT, V127, P5253
   Martinez-Morales JR, 2003, J BIOL CHEM, V278, P21721, DOI 10.1074/jbc.M301708200
   Martinez-Morales JR, 2001, DEVELOPMENT, V128, P2019
   MCREYNOLDS JS, 1970, J GEN PHYSIOL, V56, P376, DOI 10.1085/jgp.56.3.376
   Nakayama A, 1998, MECH DEVELOP, V70, P155, DOI 10.1016/S0925-4773(97)00188-3
   Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504
   Onuma Y, 2002, P NATL ACAD SCI USA, V99, P2020, DOI 10.1073/pnas.022626999
   PIATIGORSKY J, 1989, CELL, V57, P197, DOI 10.1016/0092-8674(89)90956-2
   Planque N, 1999, CELL GROWTH DIFFER, V10, P525
   Punzo C, 2002, DEVELOPMENT, V129, P625
   Rehli M, 1999, GENOMICS, V56, P111, DOI 10.1006/geno.1998.5588
   Rowan S, 2004, DEVELOPMENT, V131, P5139, DOI 10.1242/dev.01300
   SALVINIPLAWEN LV, 1977, EVOLUTION PHOTORECEP
   Seimiya M, 2000, DEVELOPMENT, V127, P1879
   SUGA H, PNAS UNPUB
   Suga H, 2008, CURR BIOL, V18, P51, DOI 10.1016/j.cub.2007.11.059
   TACHIBANA M, 1992, MOL CELL NEUROSCI, V3, P433, DOI 10.1016/1044-7431(92)90055-7
   Tachibana M, 1996, NAT GENET, V14, P50, DOI 10.1038/ng0996-50
   Takeda H, 2009, ZOOL SCI, V26, P805, DOI 10.2108/zsj.26.805
   Weasner B, 2007, DEV BIOL, V303, P756, DOI 10.1016/j.ydbio.2006.10.040
   Yajima I, 2003, MECH DEVELOP, V120, P1489, DOI 10.1016/j.mod.2003.08.009
NR 59
TC 15
Z9 15
U1 3
U2 93
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 1125-0003
EI 1748-5851
J9 ITAL J ZOOL
JI Ital. J. Zoolog.
PY 2010
VL 77
IS 2
BP 124
EP 136
DI 10.1080/11250001003795350
PG 13
WC Zoology
SC Zoology
GA 612AG
UT WOS:000278867400002
DA 2021-01-25
ER

PT J
AU Handschin, C
   Summermatter, S
   LeBrasseur, NK
   Lin, JD
   Spiegelman, BM
AF Handschin, Christoph
   Summermatter, Serge
   LeBrasseur, Nathan K.
   Lin, Jiandie
   Spiegelman, Bruce M.
TI FOR A PRAGMATIC APPROACH TO EXERCISE STUDIES
SO JOURNAL OF APPLIED PHYSIOLOGY
LA English
DT Letter
ID SKELETAL-MUSCLE
C1 [Handschin, Christoph] Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4003 Basel, Switzerland.
   [Lin, Jiandie] Univ Michigan, Ann Arbor, MI 48109 USA.
   [Spiegelman, Bruce M.] Harvard Univ, Sch Med, Cambridge, MA 02138 USA.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4003 Basel, Switzerland.
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097; LeBrasseur,
   Nathan/0000-0002-2002-0418
FU NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [R01DK054477, R01DK054477, R01DK054477,
   R01DK054477, R01DK054477, R01DK054477, R01DK054477, R01DK054477,
   R01DK054477, R01DK054477, R01DK054477, R01DK054477, R01DK054477,
   R01DK054477, R01DK054477, R01DK054477, R01DK054477, R01DK054477,
   R01DK054477] Funding Source: NIH RePORTER; NIDDK NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Diabetes & Digestive & Kidney Diseases
   (NIDDK) [R01 DK054477, R01 DK054477-11] Funding Source: Medline
CR BOOTH FW, J APPL PHYSL
   Delbono O, 2007, P NATL ACAD SCI USA, V104, P20108, DOI 10.1073/pnas.0707389104
   Keller P, 2007, BIOCHEM SOC T, V35, P1306, DOI 10.1042/BST0351306
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874
NR 5
TC 3
Z9 3
U1 0
U2 0
PU AMER PHYSIOLOGICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 8750-7587
J9 J APPL PHYSIOL
JI J. Appl. Physiol.
PD JAN
PY 2010
VL 108
IS 1
BP 223
EP 223
PG 1
WC Physiology; Sport Sciences
SC Physiology; Sport Sciences
GA 550VH
UT WOS:000274158200036
PM 20066760
DA 2021-01-25
ER

PT J
AU Kolla, V
   Jeno, P
   Moes, S
   Tercanli, S
   Lapaire, O
   Choolani, M
   Hahn, S
AF Kolla, Varaprasad
   Jenoe, Paul
   Moes, Suzette
   Tercanli, Sevgi
   Lapaire, Olav
   Choolani, Mahesh
   Hahn, Sinuhe
TI Quantitative Proteomics Analysis of Maternal Plasma in Down Syndrome
   Pregnancies Using Isobaric Tagging Reagent (iTRAQ)
SO JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY
LA English
DT Article
ID MASS-SPECTROMETRY; AMNIOTIC-FLUID; PROTEIN; CELLS; PROSPECTS; SEQUENCE;
   SERUM; TAGS
AB Currently no specific biomarkers exist for the screening of pregnancies at risk for down syndrome (DS). Since a quantitative proteomic approach with isobaric labelling (iTRAQ) has recently been suggested to be highly suitable for the discovery of novel plasma biomarkers, we have now used this method to examine for potential quantitative changes in the plasma proteome of the pregnancies bearing DS fetuses in comparison to normal healthy babies. In our study, we used plasma from six women with DS pregnancies and six with uncomplicated pregnancies care were taken to match cases and controls for gestational and maternal age, as these could be a confounder. In our quantitative proteomics analysis we were able to detect 178 proteins using iTRAQ labelling in conjunction with 4800 MALDI TOF/TOF. Amongst these we observed changes in beta HCG, a known screening marker for DS, indicating that our assay was functional. We found a number of elevated proteins Ig lambda chain C region, serum amyloid P-component, amyloid beta A4, and under expressed proteins like gamma-actin and titin in DS pregnancies. These proteins are also found in the sera of patients with Alzheimer disease, which share similar pathologies of DS. Our study therefore indicates that the iTRAQ labelling approach may be indeed useful for the detection of novel biomarkers.
C1 [Kolla, Varaprasad; Tercanli, Sevgi; Lapaire, Olav; Hahn, Sinuhe] Univ Womens Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
   [Jenoe, Paul; Moes, Suzette] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Choolani, Mahesh; Hahn, Sinuhe] Natl Univ Singapore, Dept Obstet & Gynecol, Biomarker Discovery Lab, Singapore 19077, Singapore.
RP Hahn, S (corresponding author), Univ Womens Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
EM shahn@uhbs.ch
FU PREGENESYS; Sixth Frame Work (FP6)European Union (EU)
FX The authors thank Vivian Kiefer for her technical assistance and
   Professor E. Palmer and Dr. D. Huang for the proofreading of the
   manuscript. This study was supported by PREGENESYS (ref. no. 37244),
   Sixth Frame Work (FP6) grant.
CR Anderson NL, 2002, MOL CELL PROTEOMICS, V1, P845, DOI 10.1074/mcp.R200007-MCP200
   Busch A, 2005, J HISTOCHEM CYTOCHEM, V53, P341, DOI 10.1369/jhc.4B6377.2005
   Du MR, 2007, HUM REPROD, V22, P2528, DOI 10.1093/humrep/dem222
   Eddleman KA, 2006, OBSTET GYNECOL, V108, P1067, DOI 10.1097/01.AOG.0000240135.13594.07
   Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019
   Gan CS, 2007, J PROTEOME RES, V6, P821, DOI 10.1021/pr060474i
   Glen A, 2008, J PROTEOME RES, V7, P897, DOI 10.1021/pr070378x
   Guetta E, 2004, STEM CELLS DEV, V13, P93, DOI 10.1089/154732804773099290
   Kolialexi A, 2008, MASS SPECTROM REV, V27, P624, DOI 10.1002/mas.20181
   Lange V, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.61
   Lo YMD, 2005, J HISTOCHEM CYTOCHEM, V53, P293, DOI 10.1369/jhc.4R6362.2005
   Mi HY, 2007, NUCLEIC ACIDS RES, V35, pD247, DOI 10.1093/nar/gkl869
   Nagalla SR, 2007, J PROTEOME RES, V6, P1245, DOI 10.1021/pr060539h
   Park SJ, 2006, PROTEOMICS, V6, P349, DOI 10.1002/pmic.200500084
   Ricco R, 2009, ANAL QUANT CYTOL, V31, P41
   Righetti PG, 2006, PROTEOMICS, V6, P3980, DOI 10.1002/pmic.200500904
   Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200
   Shilov IV, 2007, MOL CELL PROTEOMICS, V6, P1638, DOI 10.1074/mcp.T600050-MCP200
   Skornicka EL, 2004, CELL IMMUNOL, V232, P144, DOI 10.1016/j.cellimm.2005.03.007
   Song XM, 2008, J PROTEOME RES, V7, P2952, DOI 10.1021/pr800072x
   Spencer K, 2007, AM J MED GENET C, V145C, P18, DOI 10.1002/ajmg.c.30119
   Teller JK, 1996, NAT MED, V2, P93, DOI 10.1038/nm0196-93
   Timpl R, 1996, BIOESSAYS, V18, P123, DOI 10.1002/bies.950180208
   Tsangaris GT, 2006, IN VIVO, V20, P479
   Unwin RD, 2005, MOL CELL PROTEOMICS, V4, P924, DOI 10.1074/mcp.M400193-MCP200
   Vinggaard AM, 1997, CELL SIGNAL, V9, P189, DOI 10.1016/S0898-6568(96)00140-4
   Wilson RD, 2005, J OBSTET GYNAECOL CA, V27, P54, DOI 10.1016/S1701-2163(16)30173-6
   Wiseman FK, 2009, HUM MOL GENET, V18, pR75, DOI 10.1093/hmg/ddp010
NR 28
TC 67
Z9 68
U1 0
U2 15
PU HINDAWI PUBLISHING CORPORATION
PI NEW YORK
PA 410 PARK AVENUE, 15TH FLOOR, #287 PMB, NEW YORK, NY 10022 USA
SN 1110-7243
J9 J BIOMED BIOTECHNOL
JI J. Biomed. Biotechnol.
PY 2010
AR 952047
DI 10.1155/2010/952047
PG 10
WC Biotechnology & Applied Microbiology; Medicine, Research & Experimental
SC Biotechnology & Applied Microbiology; Research & Experimental Medicine
GA 519WA
UT WOS:000271798600001
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Elowe, S
   Dulla, K
   Uldschmid, A
   Li, XL
   Dou, Z
   Nigg, EA
AF Elowe, Sabine
   Dulla, Kalyan
   Uldschmid, Andreas
   Li, Xiuling
   Dou, Zhen
   Nigg, Erich A.
TI Uncoupling of the spindle-checkpoint and chromosome-congression
   functions of BubR1
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE BubR1; Chromosome congression; Kinetochore; Mitosis; Spindle checkpoint
ID MITOTIC CHECKPOINT; ASSEMBLY CHECKPOINT; PROTEIN BUBR1; PSEUDOSUBSTRATE
   INHIBITOR; UNATTACHED KINETOCHORES; ALIGNMENT; ANAPHASE; CDC20; MAD2;
   MITOSIS
AB The BubR1 checkpoint protein performs multiple functions in mitosis. We have carried out a functional analysis of conserved motifs of human BubR1 (also known as BUB1B) and demonstrate that spindle assembly checkpoint ( SAC) and chromosome attachment functions can be uncoupled from each other. Mutation of five proline-directed serine phosphorylation sites, identified in vivo by mass spectrometry, essentially abolishes attachment of chromosomes to the spindle but has no effect on SAC functionality. By contrast, mutation of the two conserved KEN boxes required for SAC function does not impact chromosome congression. Interestingly, the contribution of the two KEN-box motifs is not equal. Cdc20 associates with the N-terminal but not C-terminal KEN box, and mutation of the N-terminal KEN motif results in more severe acceleration of mitotic timing. Moreover, the two KEN motifs are not sufficient for maximal binding of Cdc20 and APC/C, which also requires sequences in the BubR1 C-terminus. Finally, mutation of the GLEBS motif causes loss of Bub3 interaction and mislocalization of BubR1 from the kinetochore; concomitantly, BubR1 phosphorylation as well as SAC activity and chromosome congression are impaired, indicating that the GLEBS motif is strictly required for both major functions of human BubR1.
C1 [Elowe, Sabine; Dulla, Kalyan; Uldschmid, Andreas; Dou, Zhen; Nigg, Erich A.] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
   [Li, Xiuling] Chinese Acad Sci, Dalian Inst Chem Phys, Grp 1803, Dalian 116023, Peoples R China.
   [Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Elowe, S (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
EM elowe@biochem.mpg.de
RI DOU, ZHEN/N-2022-2013
OI DOU, ZHEN/0000-0003-3303-9393; nigg, erich/0000-0003-4835-5719
FU Canadian Institute of Health Research (CIHR)Canadian Institutes of
   Health Research (CIHR); Max Planck SocietyMax Planck Society
FX The authors would like to thank Alessandro Tosi and Claudia Szalma for
   technical assistance, Roman Krner for assistance with mass spectrometry,
   and Lily Wang and Anna Santamaria for critical reading of the manuscript
   and insightful discussions. S. E. holds a post-doctoral fellowship from
   the Canadian Institute of Health Research (CIHR). This work was
   supported by the Max Planck Society.
CR Bentley AM, 2007, MOL BIOL CELL, V18, P4847, DOI 10.1091/mbc.E06-06-0539
   Blower MD, 2006, PLOS GENET, V2, P1025, DOI 10.1371/journal.pgen.0020110
   Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107
   Chen Q, 2008, CELL RES, V18, P268, DOI 10.1038/cr.2008.11
   Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018
   Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091
   Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007
   Fang GW, 2002, MOL BIOL CELL, V13, P755, DOI 10.1091/mbc.01-09-0437
   Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871
   Harris L, 2005, EXP CELL RES, V308, P85, DOI 10.1016/j.yexcr.2005.03.036
   Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053
   HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3
   Huang HM, 2008, J CELL BIOL, V183, P667, DOI 10.1083/jcb.200805163
   Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041
   King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342
   Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005
   Kulukian A, 2009, DEV CELL, V16, P105, DOI 10.1016/j.devcel.2008.11.005
   Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208
   Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004
   Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200
   Miller JJ, 2006, GENE DEV, V20, P2410, DOI 10.1101/gad.1454006
   Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163
   Nilsson J, 2008, NAT CELL BIOL, V10, P1411, DOI 10.1038/ncb1799
   Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200
   Tang ZY, 2001, DEV CELL, V1, P227, DOI 10.1016/S1534-5807(01)00019-3
   Yu HT, 2002, CURR OPIN CELL BIOL, V14, P706, DOI 10.1016/S0955-0674(02)00382-4
NR 26
TC 79
Z9 80
U1 0
U2 9
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD JAN 1
PY 2010
VL 123
IS 1
BP 84
EP 94
DI 10.1242/jcs.056507
PG 11
WC Cell Biology
SC Cell Biology
GA 533QR
UT WOS:000272839800010
PM 20016069
OA Bronze
DA 2021-01-25
ER

PT J
AU Baer, MM
   Bilstein, A
   Caussinus, E
   Csiszar, A
   Affolter, M
   Leptin, M
AF Baer, Magdalena M.
   Bilstein, Andreas
   Caussinus, Emmanuel
   Csiszar, Agnes
   Affolter, Markus
   Leptin, Maria
TI The role of apoptosis in shaping the tracheal system in the Drosophila
   embryo
SO MECHANISMS OF DEVELOPMENT
LA English
DT Article
DE Epithelial morphogenesis; Anoikis
ID PROGRAMMED CELL-DEATH; CENTRAL-NERVOUS-SYSTEM; BRANCHING MORPHOGENESIS;
   ROTATION; RECEPTOR
AB The tubular network of the tracheal system in the Drosophila embryo is created from a set of epithelial placodes by cell migration, rearrangements, fusions and shape changes. A designated number of cells is initially allocated to each branch of the system. We show here that the final cell number in the dorsal branches is not only determined by early patterning events and subsequent cell rearrangements but also by elimination of cells from the developing branch. Extruded cells die and are engulfed by macrophages. Our results suggest that the pattern of cell extrusion and death is not hard-wired, but is deter-mined by environmental cues. (C) 2009 Elsevier Ireland Ltd. All rights reserved.
C1 [Baer, Magdalena M.; Bilstein, Andreas; Csiszar, Agnes; Leptin, Maria] Univ Cologne, Inst Genet, D-50674 Cologne, Germany.
   [Baer, Magdalena M.; Caussinus, Emmanuel; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Leptin, M (corresponding author), Univ Cologne, Inst Genet, Zulpicher Str 47, D-50674 Cologne, Germany.
EM mleptin@uni-koeln.de
RI Csiszar, Agnes/I-2747-2019
OI Csiszar, Agnes/0000-0001-7911-3427; Affolter,
   Markus/0000-0002-5171-0016; Baer, Magdalena/0000-0003-3315-0921
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG); Kantons
   Basel-Stadt and Basel-Land; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); NRW Graduate School for Genetics and
   Functional Genomics, E.CEuropean CommissionEuropean Commission Joint
   Research CentreEuropean Community (EC); European communityEuropean
   Community (EC)
FX We thank Herve Agaisse for the crq-GAL4, UAS-eGFP line, Jean-Paul
   Vincent for the Apoliner line, the Bloomington Stock Collection for fly
   strains, Sofia J.Araujo for the trh antibody, Andreas Bergmann for
   discussions, Anne Uv and Francesca Peri for comments on the manuscript.
   The work was supported by grants from the Deutsche
   Forschungsgemeinschaft to M.L. and from the Kantons Basel-Stadt and
   Basel-Land and from the Swiss National Science Foundation to M.A. M.M.B.
   was supported by a fellowship from the NRW Graduate School for Genetics
   and Functional Genomics, E.C. by a FEBS fellowship, an EMBO long-term
   postdoctoral fellowship, and by a network of excellence grant "Cells
   into organs" from FP6 of the European community.
CR ABBOTT MK, 1991, GENETICS, V129, P783
   ABRAMS JM, 1993, DEVELOPMENT, V117, P29
   Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498
   Aoudjit F, 2001, J CELL BIOL, V152, P633, DOI 10.1083/jcb.152.3.633
   Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031
   Bardet PL, 2008, P NATL ACAD SCI USA, V105, P13901, DOI 10.1073/pnas.0806983105
   Buss Robert R., 2004, Anatomical Science International, V79, P191, DOI 10.1111/j.1447-073x.2004.00088.x
   Cheresh DA, 2008, ONCOGENE, V27, P6285, DOI 10.1038/onc.2008.304
   Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049
   Franc NC, 1996, IMMUNITY, V4, P431, DOI 10.1016/S1074-7613(00)80410-0
   Fraser AG, 1997, EMBO J, V16, P6192, DOI 10.1093/emboj/16.20.6192
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   HARTENSTEIN V, 1994, J COMP NEUROL, V350, P367, DOI 10.1002/cne.903500304
   HAY BA, 1994, DEVELOPMENT, V120, P2121
   Kaltschmidt JA, 2000, NAT CELL BIOL, V2, P7
   Katsumi A, 2004, J BIOL CHEM, V279, P12001, DOI 10.1074/jbc.R300038200
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Lohmann I, 2002, CELL, V110, P457, DOI 10.1016/S0092-8674(02)00871-1
   Nassif C, 1998, DEV BIOL, V197, P170, DOI 10.1006/dbio.1998.8875
   PERRIMON N, 1991, DEV GENET, V12, P238, DOI 10.1002/dvg.1020120309
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Rogulja-Ortmann A, 2007, DEVELOPMENT, V134, P105, DOI 10.1242/dev.02707
   Rusconi JC, 2000, CELL DEATH DIFFER, V7, P1063, DOI 10.1038/sj.cdd.4400767
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
NR 26
TC 10
Z9 10
U1 1
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4773
EI 1872-6356
J9 MECH DEVELOP
JI Mech. Dev.
PD JAN-FEB
PY 2010
VL 127
IS 1-2
BP 28
EP 35
DI 10.1016/j.mod.2009.11.003
PG 8
WC Developmental Biology
SC Developmental Biology
GA 558ED
UT WOS:000274722700003
PM 19995601
DA 2021-01-25
ER

PT B
AU Canepari, M
   Popovic, M
   Vogt, K
   Holthoff, K
   Konnerth, A
   Salzberg, BM
   Grinvald, A
   Antic, SD
   Zecevic, D
AF Canepari, Marco
   Popovic, Marko
   Vogt, Kaspar
   Holthoff, Knut
   Konnerth, Arthur
   Salzberg, Brian M.
   Grinvald, Amiram
   Antic, Srdjan D.
   Zecevic, Dejan
BE Canepari, M
   Zecevic, D
TI Imaging Submillisecond Membrane Potential Changes from Individual
   Regions of Single Axons, Dendrites and Spines
SO MEMBRANE POTENTIAL IMAGING IN THE NERVOUS SYSTEMS: METHODS AND
   APPLICATIONS
LA English
DT Article; Book Chapter
ID VOLTAGE-SENSITIVE DYES; 2ND-HARMONIC GENERATION MICROSCOPY; LAYER-5
   PYRAMIDAL NEURONS; RESONANCE ENERGY-TRANSFER; ELECTRICAL-ACTIVITY; BASAL
   DENDRITES; POTENTIOMETRIC PROBES; OPTICAL SIGNALS; IN-SITU; SYNAPTIC
   POTENTIALS
C1 [Canepari, Marco; Vogt, Kaspar] Univ Basel, Div Pharmacol & Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
   [Popovic, Marko; Zecevic, Dejan] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA.
   [Holthoff, Knut] Friedrich Schiller Univ Jena, Hans Berger Klin Neurol, Jena, Germany.
   [Konnerth, Arthur] Tech Univ Munich, Ctr tor Intergrated Prot Sci, Munich, Germany.
   [Konnerth, Arthur] Tech Univ Munich, Inst Neurosci, Munich, Germany.
   [Salzberg, Brian M.] Univ Penn, Sch Med, Dept Neurosci, Philadelphia, PA 19104 USA.
   [Salzberg, Brian M.] Univ Penn, Sch Med, Dept Physiol, Philadelphia, PA 19104 USA.
   [Grinvald, Amiram] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.
   [Antic, Srdjan D.] UConn Hlth Ctr, Dept Neurosci, Farmington, CT 06030 USA.
RP Canepari, M (corresponding author), Univ Basel, Div Pharmacol & Neurobiol, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
RI GRINVALD, AMIRAM/AAH-9919-2019; Canepari, Marco/H-6772-2012
OI Canepari, Marco/0000-0001-9759-2388
CR Acker CD, 2009, J NEUROPHYSIOL, V101, P1524, DOI 10.1152/jn.00651.2007
   Antic S, 2000, J PHYSIOL-LONDON, V527, P55, DOI 10.1111/j.1469-7793.2000.00055.x
   ANTIC S, 1995, J NEUROSCI, V15, P1392
   Antic S, 1999, J NEUROPHYSIOL, V82, P1615
   Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746
   Araya R, 2006, P NATL ACAD SCI USA, V103, P17961, DOI 10.1073/pnas.0608755103
   Araya R, 2006, P NATL ACAD SCI USA, V103, P18799, DOI 10.1073/pnas.0609225103
   Ataka K, 2002, BIOPHYS J, V82, P509, DOI 10.1016/S0006-3495(02)75415-5
   Bennett CB, 2009, ENDOCRINOLOGY, V150, P2829, DOI 10.1210/en.2008-1636
   Bischofberger J, 2006, NAT PROTOC, V1, P2075, DOI 10.1038/nprot.2006.312
   Bloodgood BL, 2005, SCIENCE, V310, P866, DOI 10.1126/science.1114816
   Bradley J, 2009, J NEUROSCI, V29, P9197, DOI 10.1523/JNEUROSCI.1240-09.2009
   Cacciatore TW, 1999, NEURON, V23, P449, DOI 10.1016/S0896-6273(00)80799-0
   Canepari M, 2007, J PHYSIOL-LONDON, V580, P463, DOI 10.1113/jphysiol.2006.125005
   Canepari M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004011
   Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y
   Caporale N, 2008, ANNU REV NEUROSCI, V31, P25, DOI 10.1146/annurev.neuro.31.060407.125639
   Chanda B, 2005, NAT NEUROSCI, V8, P1619, DOI 10.1038/nn1558
   Cohen L B, 1986, Soc Gen Physiol Ser, V40, P71
   COHEN LB, 1974, J MEMBRANE BIOL, V19, P1, DOI 10.1007/BF01869968
   Dainty J C, 1984, LASER SPECKLE RELATE
   DAVILA HV, 1974, J MEMBRANE BIOL, V15, P29, DOI 10.1007/BF01870080
   Dimitrov D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000440
   Djurisic M, 2004, J NEUROSCI, V24, P6703, DOI 10.1523/JNEUROSCI.0307-04.2004
   Djurisic M, 2008, J NEUROSCI, V28, P4057, DOI 10.1523/JNEUROSCI.5296-07.2008
   Dombeck DA, 2005, J NEUROPHYSIOL, V94, P3628, DOI 10.1152/jn.00416.2005
   Fisher JAN, 2008, J NEUROPHYSIOL, V99, P1545, DOI 10.1152/jn.00929.2007
   Gonzalez JE, 1997, CHEM BIOL, V4, P269, DOI 10.1016/S1074-5521(97)90070-3
   GONZALEZ JE, 1995, BIOPHYS J, V69, P1272, DOI 10.1016/S0006-3495(95)80029-9
   GRATTON E, 1989, HDB BIOL CONTOCA MIC
   GRINVALD A, 1981, P NATL ACAD SCI-BIOL, V78, P3245, DOI 10.1073/pnas.78.5.3245
   GRINVALD A, 1987, BIOPHYS J, V51, P643, DOI 10.1016/S0006-3495(87)83389-1
   GRINVALD A, 1982, BIOPHYS J, V39, P301, DOI 10.1016/S0006-3495(82)84520-7
   GRINVALD A, 1981, SCIENCE, V212, P1164, DOI 10.1126/science.7233210
   Holthoff H, 2010, J PHYSL, V588, P1085
   Iwasato T, 2000, NATURE, V406, P726, DOI 10.1038/35021059
   Jack JJ, 1975, ELECT CURRENT FLOW E
   Kampa BM, 2006, J NEUROSCI, V26, P7424, DOI 10.1523/JNEUROSCI.3062-05.2006
   Kerr JND, 2008, NAT REV NEUROSCI, V9, P195, DOI 10.1038/nrn2338
   Knopfel T, 2003, METHODS, V30, P42, DOI 10.1016/S1046-2023(03)00006-9
   KONNERTH A, 1987, J PHYSIOL-LONDON, V393, P681, DOI 10.1113/jphysiol.1987.sp016848
   Kuhn B, 2004, BIOPHYS J, V87, P631, DOI 10.1529/biophysj.104.040477
   Larkum ME, 2009, SCIENCE, V325, P756, DOI 10.1126/science.1171958
   LOEW LM, 1982, J BIOCHEM BIOPH METH, V6, P243, DOI 10.1016/0165-022X(82)90047-1
   Matsukawa H, 2003, J NEUROSCI, V23, P7677
   Milojkovic BA, 2007, J PHYSIOL-LONDON, V585, P447, DOI 10.1113/jphysiol.2007.142315
   Moreaux L, 2000, J OPT SOC AM B, V17, P1685, DOI 10.1364/JOSAB.17.001685
   Nevian T, 2007, NAT NEUROSCI, V10, P206, DOI 10.1038/nn1826
   Noguchi J, 2005, NEURON, V46, P609, DOI 10.1016/j.neuron.2005.03.015
   Nuriya M, 2006, P NATL ACAD SCI USA, V103, P786, DOI 10.1073/pnas.0510092103
   OBAID AL, 1982, BIOL BULL, V163, P388
   Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006
   Palmer LM, 2009, J NEUROSCI, V29, P6897, DOI 10.1523/JNEUROSCI.5847-08.2009
   PARSONS TD, 1991, J NEUROPHYSIOL, V66, P316
   PARSONS TD, 1989, BIOPHYS J, V56, P213, DOI 10.1016/S0006-3495(89)82666-9
   ROBERTS MJ, 2004, SIGNALS SYSTEMS ANAL
   ROHR S, 1994, BIOPHYS J, V67, P1301, DOI 10.1016/S0006-3495(94)80602-2
   ROSS WN, 1984, J NEUROSCI, V4, P659
   Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1
   Sakai R, 2001, EUR J NEUROSCI, V13, P2314, DOI 10.1046/j.0953-816x.2001.01617.x
   SALZBERG BM, 1978, BIOL BULL, V155, P463
   SEGEV I, 1988, J NEUROPHYSIOL, V60, P499
   Shoham D, 1999, NEURON, V24, P791, DOI 10.1016/S0896-6273(00)81027-2
   Shu YS, 2006, NATURE, V441, P761, DOI 10.1038/nature04720
   Siegel MS, 1997, NEURON, V19, P735, DOI 10.1016/S0896-6273(00)80955-1
   STUART GJ, 1994, NATURE, V367, P69, DOI 10.1038/367069a0
   STUART GJ, 1993, PFLUG ARCH EUR J PHY, V423, P511, DOI 10.1007/BF00374949
   Svoboda K, 1996, SCIENCE, V272, P716, DOI 10.1126/science.272.5262.716
   Vetter P, 2001, J NEUROPHYSIOL, V85, P926
   Waggoner A S, 1977, Ann N Y Acad Sci, V303, P217
   Wu J, 1999, FLUORESCENCE LUMINES
   Wuskell JP, 2006, J NEUROSCI METH, V151, P200, DOI 10.1016/j.jneumeth.2005.07.013
   YUSTE R, 1995, NATURE, V375, P682, DOI 10.1038/375682a0
   ZADOR A, 1994, J NEUROSCI, V14, P4705
   Zecevic D, 1996, NATURE, V381, P322, DOI 10.1038/381322a0
   Zhou WL, 2008, EUR J NEUROSCI, V27, P923, DOI 10.1111/j.1460-9568.2008.06075.x
   Zhou WL, 2007, J NEUROSCI METH, V164, P225, DOI 10.1016/j.jneumeth.2007.05.002
NR 77
TC 5
Z9 5
U1 0
U2 2
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 978-1-4419-6557-8
PY 2010
BP 25
EP 41
DI 10.1007/978-1-4419-6558-5_3
PG 17
WC Neurosciences
SC Neurosciences & Neurology
GA BSA52
UT WOS:000284031500003
DA 2021-01-25
ER

PT B
AU Canepari, M
   Saggau, P
   Zecevic, D
AF Canepari, Marco
   Saggau, Peter
   Zecevic, Dejan
BE Canepari, M
   Zecevic, D
TI Combined Voltage and Calcium Imaging and Signal Calibration
SO MEMBRANE POTENTIAL IMAGING IN THE NERVOUS SYSTEMS: METHODS AND
   APPLICATIONS
LA English
DT Article; Book Chapter
ID ACCESS FLUORESCENCE MICROSCOPY; CHARGE-SHIFT PROBES; SENSITIVE DYES;
   INTRACELLULAR CALCIUM; PURKINJE-CELLS; MITRAL CELLS; PATCH-CLAMP;
   HIGH-SPEED; MEMBRANE; INDICATORS
C1 [Canepari, Marco] Univ Basel, Div Pharmacol & Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
   [Saggau, Peter] Baylor Coll Med, Div Neurosci, Houston, TX 77030 USA.
   [Zecevic, Dejan] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA.
RP Canepari, M (corresponding author), Univ Basel, Div Pharmacol & Neurobiol, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
RI Canepari, Marco/H-6772-2012
OI Canepari, Marco/0000-0001-9759-2388
CR ANTIC S, 1995, J NEUROSCI, V15, P1392
   Beach JM, 1996, AM J PHYSIOL-HEART C, V270, pH2216
   BEDLACK RS, 1992, NEURON, V9, P393, DOI 10.1016/0896-6273(92)90178-G
   Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006
   Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x
   Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045
   Bullen A, 1997, BIOPHYS J, V73, P477, DOI 10.1016/S0006-3495(97)78086-X
   Bullen A, 1998, PFLUG ARCH EUR J PHY, V436, P788, DOI 10.1007/s004240050703
   Bullen A, 1999, BIOPHYS J, V76, P2272, DOI 10.1016/S0006-3495(99)77383-2
   Canepari M, 2007, J PHYSIOL-LONDON, V580, P463, DOI 10.1113/jphysiol.2006.125005
   Canepari M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004011
   Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y
   Chen WR, 1997, SCIENCE, V278, P463, DOI 10.1126/science.278.5337.463
   Djurisic M, 2008, J NEUROSCI, V28, P4057, DOI 10.1523/JNEUROSCI.5296-07.2008
   Eilers J, 2000, IMAGING NEURONS LAB
   Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713
   FLUHLER E, 1985, BIOCHEMISTRY-US, V24, P5749, DOI 10.1021/bi00342a010
   Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178
   GROSS E, 1994, BIOPHYS J, V67, P208, DOI 10.1016/S0006-3495(94)80471-0
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   GUPTA RK, 1981, J MEMBRANE BIOL, V58, P123, DOI 10.1007/BF01870975
   Hyrc KB, 2000, CELL CALCIUM, V27, P75, DOI 10.1054/ceca.1999.0092
   Kao WY, 2001, BIOPHYS J, V81, P1163, DOI 10.1016/S0006-3495(01)75773-6
   Knisley SB, 2000, AM J PHYSIOL-HEART C, V279, pH1421
   KREMER SG, 1992, AM J PHYSIOL, V263, pC1302
   LOEW LM, 1981, BIOPHYS J, V34, P353, DOI 10.1016/S0006-3495(81)84854-0
   MARTINE ZR, 1991, AM J PHYSIOL, V260, P297
   Milojkovic BA, 2007, J PHYSIOL-LONDON, V585, P447, DOI 10.1113/jphysiol.2007.142315
   MONTANA V, 1989, BIOCHEMISTRY-US, V28, P4536, DOI 10.1021/bi00437a003
   Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6
   Neher E, 2000, IMAGING NEURONS LAB
   Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x
   Sabatini BL, 1997, J NEUROSCI, V17, P3425
   Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1
   Sabatini BL, 1996, NATURE, V384, P170, DOI 10.1038/384170a0
   Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8
   Sinha SR, 1999, METHODS, V18, P204, DOI 10.1006/meth.1999.0773
   SINHA SR, 1995, J NEUROSCI METH, V60, P49, DOI 10.1016/0165-0270(94)00219-7
   Wu JY, 1993, BIOL TECHNIQUES FLUO
   YUSTE R, 2000, IMAGING NEURONS LAB
   Zhang J, 1998, BIOPHYS J, V74, P48, DOI 10.1016/S0006-3495(98)77765-3
   Zhou WL, 2007, J NEUROSCI METH, V164, P225, DOI 10.1016/j.jneumeth.2007.05.002
NR 42
TC 3
Z9 3
U1 0
U2 1
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
BN 978-1-4419-6557-8
PY 2010
BP 43
EP 52
DI 10.1007/978-1-4419-6558-5_4
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA BSA52
UT WOS:000284031500004
DA 2021-01-25
ER

PT S
AU Abeyrathne, PD
   Chami, M
   Pantelic, RS
   Goldie, KN
   Stahlberg, H
AF Abeyrathne, Priyanka D.
   Chami, Mohamed
   Pantelic, Radosav S.
   Goldie, Kenneth N.
   Stahlberg, Henning
BE Jensen, GJ
TI PREPARATION OF 2D CRYSTALS OF MEMBRANE PROTEINS FOR HIGH-RESOLUTION
   ELECTRON CRYSTALLOGRAPHY DATA COLLECTION
SO METHODS IN ENZYMOLOGY, VOL 481: CRYO-EM, PART A - SAMPLE PREPARATION AND
   DATA COLLECTION
SE Methods in Enzymology
LA English
DT Review; Book Chapter
ID GAP-JUNCTION CHANNEL; 2-DIMENSIONAL CRYSTALLIZATION; 3-DIMENSIONAL
   STRUCTURE; BIOLOGICAL SPECIMENS; RADIATION-DAMAGE; MICROSCOPY;
   CRYOMICROSCOPY; STRATEGY; COMPLEX; MODEL
AB Electron crystallography is a powerful technique for the structure determination of membrane proteins as well as soluble proteins. Sample preparation for 2D membrane protein crystals is a crucial step, as proteins have to be prepared for electron microscopy at close to native conditions. In this review, we discuss the factors of sample preparation that are key to elucidating the atomic structure of membrane proteins using electron crystallography.
C1 [Abeyrathne, Priyanka D.; Chami, Mohamed; Pantelic, Radosav S.; Goldie, Kenneth N.; Stahlberg, Henning] Univ Basel, Biozentrum, C CINA, Basel, Switzerland.
RP Abeyrathne, PD (corresponding author), Univ Basel, Biozentrum, C CINA, Basel, Switzerland.
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592
CR ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0
   Bammes BE, 2010, J STRUCT BIOL, V169, P331, DOI 10.1016/j.jsb.2009.11.001
   BOOY FP, 1993, ULTRAMICROSCOPY, V48, P273, DOI 10.1016/0304-3991(93)90101-3
   BOTTCHER B, 1992, BIOCHIM BIOPHYS ACTA, V1100, P125, DOI 10.1016/0167-4838(92)90544-N
   Braun T, 2000, EMBO REP, V1, P183, DOI 10.1093/embo-reports/kvd022
   Brink J, 1998, J MICROSC-OXFORD, V191, P67
   CESKA TA, 1990, J MOL BIOL, V213, P539, DOI 10.1016/S0022-2836(05)80214-1
   Comolli LR, 2005, J STRUCT BIOL, V152, P149, DOI 10.1016/j.jsb.2005.08.004
   CYRKLAFF M, 1994, ULTRAMICROSCOPY, V55, P141, DOI 10.1016/0304-3991(94)90165-1
   Dolder M, 1996, FEBS LETT, V382, P203, DOI 10.1016/0014-5793(96)00180-9
   DOWNING KH, 1991, SCIENCE, V251, P53, DOI 10.1126/science.1846047
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Ellis MJ, 2001, MICRON, V32, P541, DOI 10.1016/S0968-4328(00)00049-4
   Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)80003-8
   Ganser-Pornillos BK, 2007, CELL, V131, P70, DOI 10.1016/j.cell.2007.08.018
   Garavito RM, 2001, J BIOL CHEM, V276, P32403, DOI 10.1074/jbc.R100031200
   GLAESER RM, 1991, J MICROSC-OXFORD, V161, P21, DOI 10.1111/j.1365-2818.1991.tb03071.x
   Glaeser RM, 2007, ELECT CRYSTALLOGRAPH
   Glaeser RM, 2008, J STRUCT BIOL, V163, P271, DOI 10.1016/j.jsb.2008.06.001
   Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321
   Gyobu N, 2004, J STRUCT BIOL, V146, P325, DOI 10.1016/j.jsb.2004.01.012
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   Hirai T, 1999, J ELECTRON MICROSC, V48, P653, DOI 10.1093/oxfordjournals.jmicro.a023731
   Hite RK, 2010, EMBO J, V29, P1652, DOI 10.1038/emboj.2010.68
   Hu GB, 2008, J STRUCT BIOL, V161, P411, DOI 10.1016/j.jsb.2007.09.006
   Iacovache I, 2010, J STRUCT BIOL, V169, P370, DOI 10.1016/j.jsb.2009.12.001
   Iancu CV, 2006, J STRUCT BIOL, V153, P231, DOI 10.1016/j.jsb.2005.12.004
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323
   Koning RI, 2003, ULTRAMICROSCOPY, V94, P183, DOI 10.1016/S0304-3991(02)00263-2
   KUHLBRANDT W, 1992, Q REV BIOPHYS, V25, P1
   KUHLBRANDT W, 1989, J MOL BIOL, V207, P823, DOI 10.1016/0022-2836(89)90247-7
   Levy D, 2001, FEBS LETT, V504, P187, DOI 10.1016/S0014-5793(01)02748-X
   MANNELLA AC, 1986, MITOCHONDRIAL OUTER, V125, P595
   NEWMAN RH, 1991, FEBS LETT, V279, P21, DOI 10.1016/0014-5793(91)80240-4
   Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465
   NOGALES E, 1995, NATURE, V375, P424, DOI 10.1038/375424a0
   Oshima A, 2007, P NATL ACAD SCI USA, V104, P10034, DOI 10.1073/pnas.0703704104
   Remigy HW, 2003, FEBS LETT, V555, P160, DOI 10.1016/S0014-5793(03)01105-0
   Renault L, 2006, J COMPUT AID MOL DES, V20, P519, DOI 10.1007/s10822-006-9075-x
   Rhinow D, 2008, ULTRAMICROSCOPY, V108, P698, DOI 10.1016/j.ultramic.2007.11.005
   Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848
   SCHMIDT TGM, 1994, J CHROMATOGR A, V676, P337, DOI 10.1016/0021-9673(94)80434-6
   Signorell GA, 2007, J STRUCT BIOL, V157, P321, DOI 10.1016/j.jsb.2006.07.011
   TAYLOR KA, 1988, METHOD ENZYMOL, V157, P271
   Toei M, 2007, P NATL ACAD SCI USA, V104, P20256, DOI 10.1073/pnas.0706914105
   Unger VM, 1999, SCIENCE, V283, P1176, DOI 10.1126/science.283.5405.1176
   UNWIN PNT, 1975, J MOL BIOL, V94, P425, DOI 10.1016/0022-2836(75)90212-0
   Vink M, 2007, J STRUCT BIOL, V160, P295, DOI 10.1016/j.jsb.2007.09.003
   Vonck J, 2000, ULTRAMICROSCOPY, V85, P123, DOI 10.1016/S0304-3991(00)00052-8
   WALL JS, 1985, 35 EMSA M
   WALZ T, 1994, J BIOL CHEM, V269, P1583
   WANG DN, 1991, J MOL BIOL, V217, P691, DOI 10.1016/0022-2836(91)90526-C
   WANG H, 2010, MICRON IN PRESS
   Wright ER, 2006, J STRUCT BIOL, V153, P241, DOI 10.1016/j.jsb.2005.12.003
   YEAGER M, 1994, ACTA CRYSTALLOGR D, V50, P632, DOI 10.1107/S0907444993014313
NR 57
TC 20
Z9 20
U1 0
U2 12
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0076-6879
BN 978-0-12-374906-2
J9 METHOD ENZYMOL
JI Methods Enzymol.
PY 2010
VL 481
BP 25
EP 43
DI 10.1016/S0076-6879(10)81001-8
PG 19
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BRR95
UT WOS:000283516900002
PM 20887851
DA 2021-01-25
ER

PT S
AU Schenk, AD
   Castano-Diez, D
   Gipson, B
   Arheit, M
   Zeng, XY
   Stahlberg, H
AF Schenk, Andreas D.
   Castano-Diez, Daniel
   Gipson, Bryant
   Arheit, Marcel
   Zeng, Xiangyan
   Stahlberg, Henning
BE Jensen, GJ
TI 3D RECONSTRUCTION FROM 2D CRYSTAL IMAGE AND DIFFRACTION DATA
SO METHODS IN ENZYMOLOGY, VOL 482: CRYO-EM, PART B: 3-D RECONSTRUCTION
SE Methods in Enzymology
LA English
DT Review; Book Chapter
ID ELECTRON CRYSTALLOGRAPHY; PROCESSING LIBRARY; ANGSTROM STRUCTURE; PURPLE
   MEMBRANE; MODEL; BACTERIORHODOPSIN; CRYSTALLIZATION; MICROSCOPY; COMPLEX
AB Electron crystallography of 2D protein crystals can determine the structure of membrane embedded proteins at high resolution. Images or electron diffraction patterns are recorded with the electron microscope of the frozen hydrated samples, and the 3D structure of the proteins is then determined by computer data processing. Here we introduce the image-processing algorithms for crystallographic Fourier space based methods using the Medical Research Council (MRC) programs, and illustrate the usage of the software packages 2dx, XDP, and IPLT.
C1 [Schenk, Andreas D.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.
   [Castano-Diez, Daniel; Gipson, Bryant; Arheit, Marcel; Stahlberg, Henning] Univ Basel, Biozentrum, C CINA, Basel, Switzerland.
   [Castano-Diez, Daniel] Univ Basel, Dept Struct Biol & Biophys, Ctr Cellular Imaging & Nanoanalyt, Basel, Switzerland.
   [Zeng, Xiangyan] Ft Valley State Univ, Dept Math & Comp Sci, Ft Valley, GA USA.
   [Zeng, Xiangyan] EON Corp, San Jose, CA USA.
RP Schenk, AD (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.
RI Stahlberg, Henning/H-1868-2011
OI Stahlberg, Henning/0000-0002-1185-4592; Schenk,
   Andreas/0000-0001-9214-2505; Castano-Diez, daniel/0000-0002-0197-163X
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM084921] Funding Source: Medline
CR BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Chiu PL, 2007, STRUCTURE, V15, P1053, DOI 10.1016/j.str.2007.06.020
   Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003
   Downing KH, 1999, ULTRAMICROSCOPY, V75, P215, DOI 10.1016/S0304-3991(98)00065-5
   GIPSON B, 2010, AUTOMATIC RECO UNPUB
   Gipson B, 2007, J STRUCT BIOL, V160, P375, DOI 10.1016/j.jsb.2007.09.011
   Gipson B, 2007, J STRUCT BIOL, V157, P64, DOI 10.1016/j.jsb.2006.07.020
   Glaeser RM, 2007, ELECT CRYSTALLOGRAPH
   Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503
   Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321
   Grigorieff N, 1998, J MOL BIOL, V277, P1033, DOI 10.1006/jmbi.1998.1668
   Grigorieff N, 1996, J MOL BIOL, V259, P393, DOI 10.1006/jmbi.1996.0328
   HANSEN PC, 1987, BIT, V27, P534, DOI 10.1007/BF01937276
   Hardt S, 1996, J STRUCT BIOL, V116, P68, DOI 10.1006/jsbi.1996.0012
   HENDERSON R, 1990, J MOL BIOL, V213, P899, DOI 10.1016/S0022-2836(05)80271-2
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   HENDERSON R, 1986, ULTRAMICROSCOPY, V19, P147, DOI 10.1016/0304-3991(86)90203-2
   Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081
   HOVMOLLER S, 1992, ULTRAMICROSCOPY, V41, P121, DOI 10.1016/0304-3991(92)90102-P
   JAP BK, 1992, ULTRAMICROSCOPY, V46, P45, DOI 10.1016/0304-3991(92)90007-7
   KUHLBRANDT W, 1992, Q REV BIOPHYS, V25, P1
   KUHLBRANDT W, 1994, NATURE, V367, P614, DOI 10.1038/367614a0
   Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001
   KULIK V, 2004, STRUCTURE BOVINE LIV, P159
   Landsberg MJ, 2007, J STRUCT BIOL, V160, P332, DOI 10.1016/j.jsb.2007.07.002
   MARIANI V, 2009, TRANSFER TILTED SAMP
   Mitsuoka K, 1999, J MOL BIOL, V286, P861, DOI 10.1006/jmbi.1998.2529
   Morgan DG, 2009, J ELECTRON MICROSC, V58, P223, DOI 10.1093/jmicro/dfp007
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Philippsen A, 2003, J STRUCT BIOL, V144, P4, DOI 10.1016/j.jsb.2003.09.032
   Philippsen A, 2007, ULTRAMICROSCOPY, V107, P202, DOI 10.1016/j.ultramic.2006.07.010
   Philippsen A, 2007, J STRUCT BIOL, V157, P28, DOI 10.1016/j.jsb.2006.06.009
   Schenk AD, 2005, J MOL BIOL, V350, P278, DOI 10.1016/j.jmb.2005.04.030
   SCHMID MF, 1993, ULTRAMICROSCOPY, V48, P251, DOI 10.1016/0304-3991(93)90099-J
   Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006
   UNWIN PNT, 1975, J MOL BIOL, V94, P425, DOI 10.1016/0022-2836(75)90212-0
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   VALPUESTA JM, 1994, J MOL BIOL, V240, P281, DOI 10.1006/jmbi.1994.1445
   Vonck J, 2002, J MOL BIOL, V321, P307, DOI 10.1016/S0022-2836(02)00597-1
   Wilson AJC, 1942, NATURE, V150, P151, DOI 10.1038/150152a0
   Yeates TO, 1999, STRUCT FOLD DES, V7, pR25, DOI 10.1016/S0969-2126(99)80016-1
   Zeng X, 2007, J STRUCT BIOL, V160, P362, DOI 10.1016/j.jsb.2007.09.013
   Zeng X, 2007, J STRUCT BIOL, V160, P353, DOI 10.1016/j.jsb.2007.08.008
NR 43
TC 12
Z9 12
U1 0
U2 7
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0076-6879
BN 978-0-12-384991-5
J9 METHOD ENZYMOL
JI Methods Enzymol.
PY 2010
VL 482
BP 101
EP 129
DI 10.1016/S0076-6879(10)82004-X
PN B
PG 29
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BRR14
UT WOS:000283462200004
PM 20888959
DA 2021-01-25
ER

PT S
AU Amat, F
   Castano-Diez, D
   Lawrence, A
   Moussavi, F
   Winkler, H
   Horowitz, M
AF Amat, Fernando
   Castano-Diez, Daniel
   Lawrence, Albert
   Moussavi, Farshid
   Winkler, Hanspeter
   Horowitz, Mark
BE Jensen, GJ
TI ALIGNMENT OF CRYO-ELECTRON TOMOGRAPHY DATASETS
SO METHODS IN ENZYMOLOGY, VOL 482: CRYO-EM, PART B: 3-D RECONSTRUCTION
SE Methods in Enzymology
LA English
DT Review; Book Chapter
ID FIDUCIAL-LESS ALIGNMENT; TILT SERIES; ELECTRON TOMOGRAPHY; AUTOMATIC
   ALIGNMENT; IMAGE ALIGNMENT; RECONSTRUCTION
AB Data acquisition of cryo-electron tomography (CET) samples described in previous chapters involves relatively imprecise mechanical motions: the tilt series has shifts, rotations, and several other distortions between projections. Alignment is the procedure of correcting for these effects in each image and requires the estimation of a projection model that describes how points from the sample in three-dimensions are projected to generate two-dimensional images. This estimation is enabled by finding corresponding common features between images. This chapter reviews several software packages that perform alignment and reconstruction tasks completely automatically (or with minimal user intervention) in two main scenarios: using gold fiducial markers as high contrast features or using relevant biological structures present in the image (marker-free). In particular, we emphasize the key decision points in the process that users should focus on in order to obtain high-resolution reconstructions.
C1 [Amat, Fernando; Moussavi, Farshid; Horowitz, Mark] Stanford Univ, Dept Elect Engn, Stanford, CA 94305 USA.
   [Castano-Diez, Daniel] Univ Basel, Biozentrum, C CINA, Basel, Switzerland.
   [Castano-Diez, Daniel] Univ Basel, Dept Struct Biol & Biophys, Ctr Cellular Imaging & Nanoanalyt, Basel, Switzerland.
   [Lawrence, Albert] Univ Calif San Diego, Ctr Res Biol Struct, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA.
   [Winkler, Hanspeter] Florida State Univ, Inst Mol Biophys, Tallahassee, FL 32306 USA.
RP Amat, F (corresponding author), Howard Hughes Med Inst, Janelia Farm Res Campus, Ashburn, VA USA.
OI Castano-Diez, daniel/0000-0002-0197-163X
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM082948,
   R01GM082948, R01GM082948, R01GM082948, R01GM082948] Funding Source: NIH
   RePORTER; NIGMS NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01 GM082948] Funding Source:
   Medline
CR Amat F, 2008, J STRUCT BIOL, V161, P260, DOI 10.1016/j.jsb.2007.07.007
   Boyd S., 2004, CONVEX OPTIMIZATION
   Brandt S, 2001, J STRUCT BIOL, V136, P201, DOI 10.1006/jsbi.2001.4443
   Brandt S, 2001, J STRUCT BIOL, V133, P10, DOI 10.1006/jsbi.2001.4343
   Brandt SS, 2006, J MICROSC-OXFORD, V222, P1, DOI 10.1111/j.1365-2818.2006.01545.x
   Castano-Diez D, 2007, J STRUCT BIOL, V159, P413, DOI 10.1016/j.jsb.2007.04.014
   Castano-Diez D, 2010, J STRUCT BIOL, V170, P117, DOI 10.1016/j.jsb.2010.01.014
   DEFRISE M, 2002, NUCL SCI S, V3, P1465
   Diez DC, 2006, J STRUCT BIOL, V154, P195, DOI 10.1016/j.jsb.2005.12.009
   ELIDAN G, 2006, P 22 C UNC AI UAI
   Frank J., 2006, ELECT TOMOGRAPHY MET
   GUCKENBERGER R, 1982, ULTRAMICROSCOPY, V9, P167, DOI 10.1016/0304-3991(82)90239-X
   Hartley R., 2004, MULTIPLE VIEW GEOMET
   Herman GT, 2009, ADV PATTERN RECOGNIT, P1, DOI 10.1007/978-1-84628-723-7
   Heymann JB, 2008, J STRUCT BIOL, V161, P232, DOI 10.1016/j.jsb.2007.08.002
   Kak A.C., 2001, PRINCIPLES COMPUTERI
   Kang KB, 2001, EIGHTH IEEE INTERNATIONAL CONFERENCE ON COMPUTER VISION, VOL I, PROCEEDINGS, P198, DOI 10.1109/ICCV.2001.937518
   Kremer JR, 1996, J STRUCT BIOL, V116, P71, DOI 10.1006/jsbi.1996.0013
   Lanzavecchia S, 2005, J STRUCT BIOL, V149, P87, DOI 10.1016/j.jsb.2004.09.004
   Lawrence A, 2006, J STRUCT BIOL, V154, P144, DOI 10.1016/j.jsb.2005.12.012
   LAWRENCE A, 2009, 3D RECONSTRUCTION EL
   Liu J, 2006, J MOL BIOL, V362, P844, DOI 10.1016/j.jmb.2006.07.084
   Ma Y., 2003, INVITATION 3 D VISIO
   Mastronarde DN, 1997, J STRUCT BIOL, V120, P343, DOI 10.1006/jsbi.1997.3919
   Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006
   Patch SK, 2002, PHYS MED BIOL, V47, P2637, DOI 10.1088/0031-9155/47/15/306
   PENCZEK P, 1995, ULTRAMICROSCOPY, V60, P393, DOI 10.1016/0304-3991(95)00078-X
   PHAN S, 2009, WORLD C COMP SCI INF
   Sorzano COS, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-124
   Taylor KA, 1997, J STRUCT BIOL, V120, P372, DOI 10.1006/jsbi.1997.3932
   Torresani L, 2008, LECT NOTES COMPUT SC, V5303, P596, DOI 10.1007/978-3-540-88688-4_44
   Trucco E., 1998, INTRO TECHNIQUES 3 D
   Winkler H, 2006, ULTRAMICROSCOPY, V106, P240, DOI 10.1016/j.ultramic.2005.07.007
   Winkler H, 2007, J STRUCT BIOL, V157, P126, DOI 10.1016/j.jsb.2006.07.014
   Yedidia JS, 2005, IEEE T INFORM THEORY, V51, P2282, DOI 10.1109/TIT.2005.850085
   Zhu P, 2006, NATURE, V441, P847, DOI 10.1038/nature04817
NR 36
TC 21
Z9 21
U1 0
U2 7
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0076-6879
BN 978-0-12-384991-5
J9 METHOD ENZYMOL
JI Methods Enzymol.
PY 2010
VL 482
BP 343
EP 367
DI 10.1016/S0076-6879(10)82014-2
PN B
PG 25
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BRR14
UT WOS:000283462200013
PM 20888968
DA 2021-01-25
ER

PT J
AU Lang, C
   Grava, S
   van den Hoorn, T
   Trimble, R
   Philippsen, P
   Jaspersen, SL
AF Lang, Claudia
   Grava, Sandrine
   van den Hoorn, Tineke
   Trimble, Rhonda
   Philippsen, Peter
   Jaspersen, Sue L.
TI Mobility, Microtubule Nucleation and Structure of Microtubule-organizing
   Centers in Multinucleated Hyphae of Ashbya gossypii
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID SPINDLE-POLE-BODY; YEAST GAMMA-TUBULIN; SACCHAROMYCES-CEREVISIAE;
   ASPERGILLUS-NIDULANS; FISSION YEAST; POLARIZED GROWTH; MITOTIC SPINDLE;
   CELL-CYCLE; ORGANIZATION; MIGRATION
AB We investigated the migration of multiple nuclei in hyphae of the filamentous fungus Ashbya gossypii. Three types of cytoplasmic microtubule (cMT)-dependent nuclear movements were characterized using live cell imaging: short-range oscillations (up to 4.5 mu m/min), rotations (up to 180 degrees in 30 s), and long-range nuclear bypassing (up to 9 mu m/min). These movements were superimposed on a cMT-independent mode of nuclear migration, cotransport with the cytoplasmic stream. This latter mode is sufficient to support wild-type-like hyphal growth speeds. cMT-dependent nuclear movements were led by a nuclear-associated microtubule-organizing center, the spindle pole body (SPB), which is the sole site of microtubule nucleation in A. gossypii. Analysis of A. gossypii SPBs by electron microscopy revealed an overall laminar structure similar to the budding yeast SPB but with distinct differences at the cytoplasmic side. Up to six perpendicular and tangential cMTs emanated from a more spherical outer plaque. The perpendicular and tangential cMTs most likely correspond to short, often cortex-associated cMTs and to long, hyphal growth-axis-oriented cMTs, respectively, seen by in vivo imaging. Each SPB nucleates its own array of cMTs, and the lack of overlapping cMT arrays between neighboring nuclei explains the autonomous nuclear oscillations and bypassing observed in A. gossypii hyphae.
C1 [Trimble, Rhonda; Jaspersen, Sue L.] Stowers Inst Med Res, Kansas City, MO 64110 USA.
   [Lang, Claudia; Grava, Sandrine; van den Hoorn, Tineke; Philippsen, Peter] Univ Basel, Biozentrum, Dept Mol Microbiol, CH-4056 Basel, Switzerland.
   [Jaspersen, Sue L.] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA.
RP Jaspersen, SL (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.
EM slj@stowers.org
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-112688]; March of Dimes Basil O'Connor AwardMarch of
   Dimes; Stowers Institute for Medical Research
FX We are grateful to Dominic Hoepfner for guidance in the early stage of
   this project and to Mark Winey and Tom Giddings for advice and
   suggestions at later stages. We also thank Jenny Friederichs, Teri
   Johnson, and Fengli Guo for assistance with EM and Katie Perko for help
   with AutoAligner. This work was supported by a grant from the Swiss
   National Science Foundation grant 3100A0-112688 ( to P. P.). S. L. J. is
   supported by a March of Dimes Basil O'Connor Award and the Stowers
   Institute for Medical Research.
CR Adams IR, 1999, J CELL BIOL, V145, P809, DOI 10.1083/jcb.145.4.809
   Alberti-Segui C, 2001, J CELL SCI, V114, P975
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Bullitt E, 1997, CELL, V89, P1077, DOI 10.1016/S0092-8674(00)80295-0
   BYERS B, 1978, J CELL SCI, V30, P331
   BYERS B, 1975, J BACTERIOL, V124, P511, DOI 10.1128/JB.124.1.511-523.1975
   BYERS B, 1973, COLD SPRING HARB SYM, V38, P123
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Ding R, 1997, MOL BIOL CELL, V8, P1461
   Fischer R, 2008, MOL MICROBIOL, V68, P813, DOI 10.1111/j.1365-2958.2008.06193.x
   GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   Heitz MJ, 2001, J CELL SCI, V114, P4521
   HORIO T, 1991, J CELL SCI, V99, P693
   Inoue S, 1998, J CELL SCI, V111, P1555
   Jaspersen SL, 2004, ANNU REV CELL DEV BI, V20, P1, DOI 10.1146/annurev.cellbio.20.022003.114106
   Kaufmann A, 2009, MOL CELL BIOL, V29, P771, DOI 10.1128/MCB.01150-08
   Kaufmann A, 2009, FUNGAL GENET BIOL, V46, P595, DOI 10.1016/j.fgb.2009.05.002
   KNECHTLE P, 2002, THESIS BIOZENTRUM U
   Kohli M, 2008, J CELL SCI, V121, P1065, DOI [10.1242/jcs.015933, 10.1242/jcs.033852]
   Konzack S, 2005, MOL BIOL CELL, V16, P497, DOI 10.1091/mbc.E04-02-0083
   Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100
   MANDELKOW EM, 1991, J CELL BIOL, V114, P977, DOI 10.1083/jcb.114.5.977
   Marschall LG, 1996, J CELL BIOL, V134, P443, DOI 10.1083/jcb.134.2.443
   McDonald K, 1999, METH MOL B, V117, P77
   MEYER SLF, 1988, J CELL BIOL, V106, P773, DOI 10.1083/jcb.106.3.773
   Minke PF, 1999, FUNGAL GENET BIOL, V28, P55, DOI 10.1006/fgbi.1999.1160
   Minke PF, 1999, MOL MICROBIOL, V32, P1065, DOI 10.1046/j.1365-2958.1999.01421.x
   Morris NR, 2000, J CELL BIOL, V148, P1097, DOI 10.1083/jcb.148.6.1097
   Mourino-Perez RR, 2006, FUNGAL GENET BIOL, V43, P389, DOI 10.1016/j.fgb.2005.10.007
   O'Toole ET, 1999, MOL BIOL CELL, V10, P2017, DOI 10.1091/mbc.10.6.2017
   OAKLEY BR, 1980, CELL, V19, P255, DOI 10.1016/0092-8674(80)90407-9
   OAKLEY BR, 1983, J CELL BIOL, V96, P1155, DOI 10.1083/jcb.96.4.1155
   OAKLEY CE, 1989, NATURE, V338, P662, DOI 10.1038/338662a0
   Philippsen P, 2005, CURR OPIN MICROBIOL, V8, P370, DOI 10.1016/j.mib.2005.06.021
   Requena N, 2001, MOL MICROBIOL, V42, P121, DOI 10.1046/j.1365-2958.2001.02609.x
   ROUT MP, 1990, J CELL BIOL, V111, P1913, DOI 10.1083/jcb.111.5.1913
   Sambrook J., 2001, MOL CLONING LAB MANU
   Sawin KE, 2006, YEAST, V23, P1001, DOI 10.1002/yea.1404
   Schaerer F, 2001, MOL BIOL CELL, V12, P2519, DOI 10.1091/mbc.12.8.2519
   Schmitz HP, 2006, MOL BIOL CELL, V17, P130
   Sobel SG, 1995, J CELL BIOL, V131, P1775, DOI 10.1083/jcb.131.6.1775
   Spang A, 1996, J CELL BIOL, V134, P429, DOI 10.1083/jcb.134.2.429
   STEARNS T, 1991, CELL, V65, P825, DOI 10.1016/0092-8674(91)90390-K
   Straube A, 2003, MOL BIOL CELL, V14, P642, DOI 10.1091/mbc.E02-08-0513
   Suelmann R, 2000, RES MICROBIOL, V151, P247, DOI 10.1016/S0923-2508(00)00151-0
   Veith D, 2005, J CELL SCI, V118, P3705, DOI 10.1242/jcs.02501
   Vogel SK, 2009, PLOS BIOL, V7, P918, DOI 10.1371/journal.pbio.1000087
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Wendland J, 2005, NAT REV MICROBIOL, V3, P421, DOI 10.1038/nrmicro1148
   Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226
   WINEY M, 1995, J CELL BIOL, V129, P1601, DOI 10.1083/jcb.129.6.1601
   Xiang X, 2004, FUNGAL GENET BIOL, V41, P411, DOI 10.1016/j.fgb.2003.11.010
   Zekert N, 2009, MOL BIOL CELL, V20, P673, DOI 10.1091/mbc.E08-07-0685
NR 55
TC 27
Z9 27
U1 0
U2 1
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
EI 1939-4586
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD JAN 1
PY 2010
VL 21
IS 1
BP 18
EP 28
DI 10.1091/mbc.E09-01-0063
PG 11
WC Cell Biology
SC Cell Biology
GA 539MJ
UT WOS:000273258400007
PM 19910487
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Weiss, A
   Charbonnier, E
   Ellertsdottir, E
   Tsirigos, A
   Wolf, C
   Schuh, R
   Pyrowolakis, G
   Affolter, M
AF Weiss, Alexander
   Charbonnier, Enrica
   Ellertsdottir, Elin
   Tsirigos, Aristotelis
   Wolf, Christian
   Schuh, Reinhard
   Pyrowolakis, George
   Affolter, Markus
TI A conserved activation element in BMP signaling during Drosophila
   development
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID TRANSCRIPTIONAL REGULATION; DNA-BINDING; MORPHOGEN GRADIENT; SMAD7
   PROMOTER; TARGET GENES; DPP TARGETS; BRINKER; EXPRESSION; MAD;
   SPECIFICITY
AB The transforming growth factor beta (TGF-beta) family member Decapentaplegic (Dpp) is a key regulator of patterning and growth in Drosophila development. Previous studies have identified a short DNA motif called the silencer element (SE), which recruits a trimeric Smad complex and the repressor Schnurri to downregulate target enhancers upon Dpp signaling. We have now isolated the minimal enhancer of the dad gene and discovered a short motif we termed the activating element (AE). The AE is similar to the SE and recruits the Smad proteins via a conserved mechanism. However, the AE and SE differ at important nucleotide positions. As a consequence, the AE does not recruit Schnurri but rather integrates repressive input by the default repressor Brinker and activating input by the Smad signal transducers Mothers against Dpp (Mad) and Medea via competitive DNA binding. The AE allows the identification of hitherto unknown direct Dpp targets and is functionally conserved in vertebrates.
C1 [Charbonnier, Enrica; Pyrowolakis, George] Univ Freiburg, Inst Biol 1, D-7800 Freiburg, Germany.
   [Charbonnier, Enrica; Pyrowolakis, George] Univ Freiburg, Ctr Biol Signalling Studies Bioss, D-7800 Freiburg, Germany.
   [Weiss, Alexander; Ellertsdottir, Elin; Affolter, Markus] Univ Basel, Biozentrum, Basel, Switzerland.
   [Tsirigos, Aristotelis] IBM Corp, Thomas J Watson Res Ctr, Bioinformat & Pattern Discovery Grp, Yorktown Hts, NY 10598 USA.
   [Wolf, Christian; Schuh, Reinhard] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.
RP Pyrowolakis, G (corresponding author), Univ Freiburg, Inst Biol 1, Albertstr 21A, D-7800 Freiburg, Germany.
EM g.pyrowolakis@biologie.uni-freiburg.de; Markus.Affolter@unibas.ch
OI Affolter, Markus/0000-0002-5171-0016; Tsirigos,
   Aristotelis/0000-0002-7512-8477
FU German Research FoundationGerman Research Foundation (DFG) [SFB592];
   Excellence Initiative of the German Federal and State Governments
   [EXC294]
FX We are deeply thankful to B. Hartmann (University of Freiburg) for
   generously providing the flies transgenic for UAS-ShnVP16. Work in the
   lab of M. A. was supported by the Kantons Basel-Stadt and Basel-Land, by
   the Swiss National Science Foundation and by SystemsX.ch within the
   framework of the wingX RTD. Work in G.P.'s laboratory was supported by
   the German Research Foundation (SFB592) and the Excellence Initiative of
   the German Federal and State Governments (EXC294).
CR Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502
   Barrio R, 2004, P NATL ACAD SCI USA, V101, P6021, DOI 10.1073/pnas.0401590101
   Benchabane H, 2003, MOL CELL BIOL, V23, P6646, DOI 10.1128/MCB.23.18.6646-6661.2003
   Bischof J, 2007, P NATL ACAD SCI USA, V104, P3312, DOI 10.1073/pnas.0611511104
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Brodin G, 2000, J BIOL CHEM, V275, P29023, DOI 10.1074/jbc.M002815200
   Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5
   Chen CK, 1998, DEVELOPMENT, V125, P4959
   Chen DH, 2003, DEVELOPMENT, V130, P1159, DOI 10.1242/dev.00325
   Cordier F, 2006, J MOL BIOL, V361, P659, DOI 10.1016/j.jmb.2006.06.045
   Dai H, 2000, DEV BIOL, V227, P373, DOI 10.1006/dbio.2000.9901
   Denissova NG, 2000, P NATL ACAD SCI USA, V97, P6397, DOI 10.1073/pnas.090099297
   DERYNCK R, 2007, TGF BETA TGF BETA FA
   Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018
   Gao S, 2005, J BIOL CHEM, V280, P36158, DOI 10.1074/jbc.M506882200
   Gao S, 2007, BBA-GENE STRUCT EXPR, V1769, P484, DOI 10.1016/j.bbaexp.2007.05.006
   Grieder NC, 1997, EMBO J, V16, P7402, DOI 10.1093/emboj/16.24.7402
   Jazwinska A, 1999, DEVELOPMENT, V126, P3323
   Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1
   Karaulanov E, 2004, EMBO J, V23, P844, DOI 10.1038/sj.emboj.7600101
   Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102
   Kim J, 1997, NATURE, V388, P304, DOI 10.1038/40906
   Kirkpatrick H, 2001, J BIOL CHEM, V276, P18216, DOI 10.1074/jbc.M101365200
   Korchynskyi O, 2002, J BIOL CHEM, V277, P4883, DOI 10.1074/jbc.M111023200
   Kosman D, 2004, SCIENCE, V305, P846, DOI 10.1126/science.1099247
   Markstein M, 2002, P NATL ACAD SCI USA, V99, P763, DOI 10.1073/pnas.012591199
   Marty T, 2000, NAT CELL BIOL, V2, P745, DOI 10.1038/35036383
   Marty T, 2001, DEVELOPMENT, V128, P2833
   Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451
   Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1
   Nagarajan RP, 1999, J BIOL CHEM, V274, P33412, DOI 10.1074/jbc.274.47.33412
   Nellen D, 1996, CELL, V85, P357, DOI 10.1016/S0092-8674(00)81114-9
   Nikaido M, 1999, DEVELOPMENT, V126, P181
   Ohshiro T, 1997, DEVELOPMENT, V124, P3975
   PANKRATZ MJ, 1992, SCIENCE, V255, P986, DOI 10.1126/science.1546296
   Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008
   PYROWOLAKIS G, 2007, DROSOPHILA TGF BETA, P493
   Ross S, 2008, INT J BIOCHEM CELL B, V40, P383, DOI 10.1016/j.biocel.2007.09.006
   ROTHE M, 1989, EMBO J, V8, P3087, DOI 10.1002/j.1460-2075.1989.tb08460.x
   Rushlow C, 2001, GENE DEV, V15, P340, DOI 10.1101/gad.861401
   Saller E, 2001, EMBO REP, V2, P298, DOI 10.1093/embo-reports/kve068
   Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297
   SEGALAT L, 1994, MECH DEVELOP, V47, P241, DOI 10.1016/0925-4773(94)90042-6
   Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1
   Shi YG, 2003, CELL, V113, P685, DOI 10.1016/S0092-8674(03)00432-X
   Sivasankaran R, 2000, EMBO J, V19, P6162, DOI 10.1093/emboj/19.22.6162
   Torres-Vazquez J, 2001, DEVELOPMENT, V128, P1657
   Tsuneizumi K, 1997, NATURE, V389, P627, DOI 10.1038/39362
   von Gersdorff G, 2000, J BIOL CHEM, V275, P11320, DOI 10.1074/jbc.275.15.11320
   Xu M, 2005, DEVELOPMENT, V132, P1637, DOI 10.1242/dev.01722
   Yao LC, 2006, DEVELOPMENT, V133, P4025, DOI 10.1242/dev.02561
   Yui PB, 2008, NAT CHEM BIOL, V4, P33, DOI 10.1038/nchembio.2007.54
   Zawel L, 1998, MOL CELL, V1, P611, DOI 10.1016/S1097-2765(00)80061-1
   Zhang HL, 2001, GENE DEV, V15, P261, DOI 10.1101/gad.861201
NR 55
TC 66
Z9 66
U1 0
U2 15
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD JAN
PY 2010
VL 17
IS 1
BP 69
EP U91
DI 10.1038/nsmb.1715
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 541CL
UT WOS:000273390300013
PM 20010841
OA Green Published
DA 2021-01-25
ER

PT J
AU Iijima, T
   Wu, KR
   Witte, H
   Scheiffele, P
AF Iijima, Takatoshi
   Wu, Karen
   Witte, Harald
   Scheiffele, Peter
TI Depolarization-dependent regulation of alternative splicing: a mechanism
   underlying the dynamic regulation of the neurexin-neuroligin adhesion
   complex at central synapses
SO NEUROSCIENCE RESEARCH
LA English
DT Meeting Abstract
C1 [Iijima, Takatoshi; Witte, Harald; Scheiffele, Peter] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Wu, Karen; Scheiffele, Peter] Columbia Univ, Dept Physiol, New York, NY 10027 USA.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-0102
J9 NEUROSCI RES
JI Neurosci. Res.
PY 2010
VL 68
SU 1
BP E233
EP E234
DI 10.1016/j.neures.2010.07.1032
PG 2
WC Neurosciences
SC Neurosciences & Neurology
GA V24XS
UT WOS:000208443701418
DA 2021-01-25
ER

PT J
AU Scheiffele, P
AF Scheiffele, Peter
TI Molecular mechanisms of synaptic differentiation and selective synapse
   assembly
SO NEUROSCIENCE RESEARCH
LA English
DT Meeting Abstract
C1 [Scheiffele, Peter] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-0102
J9 NEUROSCI RES
JI Neurosci. Res.
PY 2010
VL 68
SU 1
BP E34
EP E35
DI 10.1016/j.neures.2010.07.395
PG 2
WC Neurosciences
SC Neurosciences & Neurology
GA V24XS
UT WOS:000208443700159
DA 2021-01-25
ER

PT J
AU Lussi, YC
   Shumaker, DK
   Shimi, T
   Fahrenkrog, B
AF Lussi, Yvonne C.
   Shumaker, Dale K.
   Shimi, Takeshi
   Fahrenkrog, Birthe
TI The nucleoporin Nup153 affects spindle checkpoint activity due to an
   association with Mad1
SO NUCLEUS-AUSTIN
LA English
DT Article
DE Nup153; nuclear pore complex; Mad1; spindle assembly checkpoint
AB The nucleoporin Nup153 is known to play pivotal roles in nuclear import and export in interphase cells and as the cell transitions into mitosis, Nup153 is involved in nuclear envelope breakdown. In this study, we demonstrate that the interaction of Nup153 with the spindle assembly checkpoint protein Mad1 is important in the regulation of the spindle checkpoint. Overexpression of human Nup153 in HeLa cells leads to the appearance of multinucleated cells and induces the formation of multipolar spindles. Importantly, it causes inactivation of the spindle checkpoint due to hypophosphorylation of Mad1. Depletion of Nup153 using RNA interference results in the decline of Mad1 at nuclear pores during interphase and more significantly causes a delayed dissociation of Mad1 from kinetochores in metaphase and an increase in the number of unresolved midbodies. In the absence of Nup153 the spindle checkpoint remains active. In vitro studies indicate direct binding of Mad1 to the N-terminal domain of Nup153. Importantly, Nup153 binding to Mad1 affects Mad1's phosphorylation status, but not its ability to interact with Mad2. Our data suggest that Nup153 levels regulate the localization of Mad1 during the metaphase/anaphase transition thereby affecting its phoshorylation status and in turn spindle checkpoint activity and mitotic exit.
C1 [Lussi, Yvonne C.; Fahrenkrog, Birthe] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
   [Shumaker, Dale K.] Northwestern Univ, Dept Urol, Feinberg Sch Med, Chicago, IL 60611 USA.
   [Shumaker, Dale K.; Shimi, Takeshi] Northwestern Univ, Dept Cell & Mol Biol, Feinberg Sch Med, Chicago, IL 60611 USA.
   Univ Libre Brussels, Inst Biol & Med Mol, Charleroi Gosselie, Belgium.
RP Fahrenkrog, B (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
EM bfahrenk@ulb.ac.be
OI Fahrenkrog, Birthe/0000-0003-4080-9413; Shimi,
   Takeshi/0000-0002-9864-1820; Lussi, Yvonne/0000-0002-5753-0235
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Kanton Basel Stadt; M.E. Muller Foundation of Switzerland
FX The authors wish to thank Katie Ullman and Brian Burke for providing us
   with antibodies against Nup153. Sara Paulillo is kindly acknowledged for
   initiating the RNA interference experiments and Markus Affolter for
   helpful suggestions. This work is supported by research grants from the
   Swiss National Science Foundation as well as the Kanton Basel Stadt and
   the M.E. Muller Foundation of Switzerland (to B.F.).
CR Ball JR, 2005, CHROMOSOMA, V114, P319, DOI 10.1007/s00412-005-0019-3
   BASCHONG W, 1990, J ELECTRON MICR TECH, V14, P313, DOI 10.1002/jemt.1060140405
   Bastos R, 1996, J CELL BIOL, V134, P1141, DOI 10.1083/jcb.134.5.1141
   BOGERD AM, 1994, J CELL BIOL, V127, P319, DOI 10.1083/jcb.127.2.319
   Brito DA, 2006, CURR BIOL, V16, P1194, DOI 10.1016/j.cub.2006.04.043
   Bruzzoni-Giovanelli H, 1999, ONCOGENE, V18, P7101, DOI 10.1038/sj.onc.1203187
   Campbell MS, 2001, J CELL SCI, V114, P953
   Chakraborty P, 2008, DEV CELL, V15, P657, DOI 10.1016/j.devcel.2008.08.020
   Chen RH, 1999, MOL BIOL CELL, V10, P2607, DOI 10.1091/mbc.10.8.2607
   Collin L, 2008, BIOL CELL, V100, P243, DOI 10.1042/BC20070123
   D'Angelo MA, 2008, TRENDS CELL BIOL, V18, P456, DOI 10.1016/j.tcb.2008.07.009
   Eggert US, 2006, ANNU REV BIOCHEM, V75, P543, DOI 10.1146/annurev.biochem.74.082803.133425
   Enarson P, 1998, CHROMOSOMA, V107, P228, DOI 10.1007/s004120050301
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Galy V, 2003, MOL BIOL CELL, V14, P5104, DOI 10.1091/mbc.E03-04-0237
   Harborth J, 2001, J CELL SCI, V114, P4557
   Harper NC, 2008, CURR GENET, V53, P95, DOI 10.1007/s00294-007-0168-4
   Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620
   Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.E04-10-0857
   Heidenblad M, 2008, BMC MED GENOMICS, V1, DOI 10.1186/1755-8794-1-3
   Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820
   Iouk T, 2002, J CELL BIOL, V159, P807, DOI 10.1083/jcb.200205068
   Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4
   Kastenmayer JP, 2005, GENETICS, V170, P509, DOI 10.1534/genetics.105.041426
   King RW, 2008, BBA-REV CANCER, V1786, P4, DOI 10.1016/j.bbcan.2008.07.007
   Lee SH, 2008, GENE DEV, V22, P2926, DOI 10.1101/gad.1677208
   Li R, 2007, CELL MOL LIFE SCI, V64, P3044, DOI 10.1007/s00018-007-7285-6
   Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x
   Lim RYH, 2006, CURR OPIN CELL BIOL, V18, P342, DOI 10.1016/j.ceb.2006.03.006
   Liu J, 2003, DEV CELL, V5, P487, DOI 10.1016/S1534-5807(03)00262-4
   Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878
   Mackay DR, 2009, MOL BIOL CELL, V20, P1652, DOI 10.1091/mbc.E08-08-0883
   Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007
   Michel LS, 2001, NATURE, V409, P355, DOI 10.1038/35053094
   Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163
   Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982
   Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682
   Orlic M, 2006, GENE CHROMOSOME CANC, V45, P72, DOI 10.1002/gcc.20263
   PANTE N, 1994, J CELL BIOL, V126, P603, DOI 10.1083/jcb.126.3.603
   Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034
   Plans V, 2008, ONCOGENE, V27, P1355, DOI 10.1038/sj.onc.1210782
   Prunuske AJ, 2006, MOL BIOL CELL, V17, P760, DOI 10.1091/mbc.E05-06-0485
   Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080
   Scott RJ, 2005, MOL BIOL CELL, V16, P4362, DOI 10.1091/mbc.E05-01-0011
   Shah S, 1998, J CELL BIOL, V141, P31, DOI 10.1083/jcb.141.1.31
   To-Ho KW, 2008, ONCOGENE, V27, P347, DOI 10.1038/sj.onc.1210633
   Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027
   Ullman KS, 1999, MOL BIOL CELL, V10, P649, DOI 10.1091/mbc.10.3.649
   Walter D, 2006, J CELL SCI, V119, P1843, DOI 10.1242/jcs.02902
   Walther TC, 2001, EMBO J, V20, P5703, DOI 10.1093/emboj/20.20.5703
   Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642
NR 51
TC 37
Z9 37
U1 0
U2 2
PU LANDES BIOSCIENCE
PI AUSTIN
PA 1806 RIO GRANDE ST, AUSTIN, TX 78702 USA
SN 1949-1034
J9 NUCLEUS-AUSTIN
JI Nucleus-Austin
PD JAN-FEB
PY 2010
VL 1
IS 1
BP 71
EP 84
DI 10.4161/nucl.1.1.10244
PG 14
WC Cell Biology
SC Cell Biology
GA V28GB
UT WOS:000208668200012
PM 21327106
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Burger, L
   van Nimwegen, E
AF Burger, Lukas
   van Nimwegen, Erik
TI Disentangling Direct from Indirect Co-Evolution of Residues in Protein
   Alignments
SO PLOS COMPUTATIONAL BIOLOGY
LA English
DT Article
ID MUTUAL INFORMATION; PREDICTION; CONSERVATION; IDENTIFICATION;
   COVARIANCE; MUTATIONS
AB Predicting protein structure from primary sequence is one of the ultimate challenges in computational biology. Given the large amount of available sequence data, the analysis of co-evolution, i.e., statistical dependency, between columns in multiple alignments of protein domain sequences remains one of the most promising avenues for predicting residues that are contacting in the structure. A key impediment to this approach is that strong statistical dependencies are also observed for many residue pairs that are distal in the structure. Using a comprehensive analysis of protein domains with available three-dimensional structures we show that co-evolving contacts very commonly form chains that percolate through the protein structure, inducing indirect statistical dependencies between many distal pairs of residues. We characterize the distributions of length and spatial distance traveled by these co-evolving contact chains and show that they explain a large fraction of observed statistical dependencies between structurally distal pairs. We adapt a recently developed Bayesian network model into a rigorous procedure for disentangling direct from indirect statistical dependencies, and we demonstrate that this method not only successfully accomplishes this task, but also allows contacts with weak statistical dependency to be detected. To illustrate how additional information can be incorporated into our method, we incorporate a phylogenetic correction, and we develop an informative prior that takes into account that the probability for a pair of residues to contact depends strongly on their primary-sequence distance and the amount of conservation that the corresponding columns in the multiple alignment exhibit. We show that our model including these extensions dramatically improves the accuracy of contact prediction from multiple sequence alignments.
C1 [Burger, Lukas] Univ Basel, Biozentrum, Basel, Switzerland.
   Swiss Inst Bioinformat, Basel, Switzerland.
RP Burger, L (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM erik.vannimwegen@unibas.ch
OI van Nimwegen, Erik/0000-0001-6338-1312
FU University of Basel; SNF [3100A0-118318]
FX The work in this study was funded by the University of Basel and
   partially by an SNF (http://www.snf.ch) grant (number 3100A0-118318) to
   EvN. The funders had no role in study design, data collection and
   analysis, decision to publish, or preparation of the manuscript.
CR Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI 10.1093/nar/gkh121
   Bollobas B., 1998, MODERN GRAPH THEORY
   Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203
   CERQUIDES J, 2003, P 20 INT C MACH LEAR
   Cheng JL, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-113
   CHIU DKY, 1991, COMPUT APPL BIOSCI, V7, P347
   CHOW CK, 1968, IEEE T INFORM THEORY, V14, P462, DOI 10.1109/TIT.1968.1054142
   Cover T. M., 1991, ELEMENTS INFORM THEO
   Dunn SD, 2008, BIOINFORMATICS, V24, P333, DOI 10.1093/bioinformatics/btm604
   Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755
   EDDY SR, 1994, NUCLEIC ACIDS RES, V22, P2079, DOI 10.1093/nar/22.11.2079
   Fares MA, 2006, GENETICS, V173, P9, DOI 10.1534/genetics.105.053249
   Finn RD, 2005, BIOINFORMATICS, V21, P410, DOI 10.1093/bioinformatics/bti011
   FITCH WM, 1970, BIOCHEM GENET, V4, P579, DOI 10.1007/BF00486096
   Fodor AA, 2004, PROTEINS, V56, P211, DOI 10.1002/prot.20098
   Fodor AA, 2004, J BIOL CHEM, V279, P19046, DOI 10.1074/jbc.M402560200
   Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e
   Gouveia-Oliveira R, 2007, ALGORITHM MOL BIOL, V2, DOI 10.1186/1748-7188-2-12
   Halabi N, 2009, CELL, V138, P774, DOI 10.1016/j.cell.2009.07.038
   HUNTER S, 2009, NUCLEIC ACIDS RES, V35, pD224
   Izarzugaza JMG, 2007, PROTEINS, V69, P152, DOI 10.1002/prot.21637
   Kortemme T, 2002, P NATL ACAD SCI USA, V99, P14116, DOI 10.1073/pnas.202485799
   Lindgreen S, 2006, BIOINFORMATICS, V22, P2988, DOI 10.1093/bioinformatics/btl514
   Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295
   Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019
   Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671
   Meila M, 2006, STAT COMPUT, V16, P77, DOI 10.1007/s11222-006-5535-3
   MILLER C, 2008, BIOINFORMATICS, V24
   Olmea O, 1999, J MOL BIOL, V293, P1221, DOI 10.1006/jmbi.1999.3208
   Pazos F, 2008, EMBO J, V27, P2648, DOI 10.1038/emboj.2008.189
   Pollock DD, 1999, J MOL BIOL, V287, P187, DOI 10.1006/jmbi.1998.2601
   ROST B, 1994, PROTEINS, V20, P216, DOI 10.1002/prot.340200303
   Shackelford G, 2007, PROTEINS, V69, P159, DOI 10.1002/prot.21791
   Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881
   Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072
   Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106
   Wollenberg KR, 2000, P NATL ACAD SCI USA, V97, P3288, DOI 10.1073/pnas.070154797
   YANOFSKY C, 1964, SCIENCE, V146, P1593, DOI 10.1126/science.146.3651.1593
   Yeang CH, 2007, PLOS COMPUT BIOL, V3, P2122, DOI 10.1371/journal.pcbi.0030211
NR 39
TC 127
Z9 127
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-734X
EI 1553-7358
J9 PLOS COMPUT BIOL
JI PLoS Comput. Biol.
PD JAN
PY 2010
VL 6
IS 1
AR e1000633
DI 10.1371/journal.pcbi.1000633
PG 18
WC Biochemical Research Methods; Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Mathematical & Computational Biology
GA 551SX
UT WOS:000274231500005
PM 20052271
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT S
AU Rodriguez, F
   Spang, A
AF Rodriguez, Fernanda
   Spang, Anne
BE Economou, A
TI Studying the ArfGAP-Dependent Conformational Changes in SNAREs
SO PROTEIN SECRETION: METHODS AND PROTOCOLS
SE Methods in Molecular Biology
LA English
DT Article; Book Chapter
DE SNAREs; Glo3p; Arf1p; conformational changes; SNARE binding assay;
   protease protection assays
ID GTPASE-ACTIVATING PROTEINS; VESICLE FORMATION; GOLGI; ARF1; COAT; GLO3
AB Vesicle SNAREs (v-SNAREs) arc included with high fidelity into each transport vesicle generated in the cell. These SNAREs determine the fate of vesicles, as they are the key factors deciding with which compartment a particular vesicle will fuse. The mechanism of high fidelity inclusion of SNAREs into transport vesicles is very difficult to study in vivo. Therefore, we use in vitro assays aiming to recapitulate SNARE uptake into vesicles. One of the key assays is a pull-down with SNARE tails fused to GST in the presence or absence of ArfGAPs and coat components such as the small GTPase Arf1 and coatomer. This in vitro assay allowed us to show that the ArfGAPs Glo3 and Gcs1 can induce a conformational change in SNAREs. Protease protection assays were used to confirm the conformational change and can also be used to address the question about the nature of the different conformations in SNARE proteins.
C1 [Rodriguez, Fernanda; Spang, Anne] Univ Basel, Biozentrum, Basel, Switzerland.
RP Rodriguez, F (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
RI Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
CR Albert S, 1999, J BIOL CHEM, V274, P33186, DOI 10.1074/jbc.274.47.33186
   KAHN RA, 1995, J BIOL CHEM, V270, P143, DOI 10.1074/jbc.270.1.143
   Kirchhausen T, 2002, CELL, V109, P413, DOI 10.1016/S0092-8674(02)00751-1
   Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008
   Lewis SM, 2004, MOL BIOL CELL, V15, P4064, DOI 10.1091/mbc.E04-04-0316
   Paris S, 1997, J BIOL CHEM, V272, P22221, DOI 10.1074/jbc.272.35.22221
   Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555
   Poon PP, 2001, METHOD ENZYMOL, V329, P317
   Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092
   Schindler C, 2007, MOL BIOL CELL, V18, P2852, DOI 10.1091/mbc.E06-08-0756
   Spang A, 2002, CURR OPIN CELL BIOL, V14, P423, DOI 10.1016/S0955-0674(02)00346-0
   Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698
NR 12
TC 1
Z9 1
U1 0
U2 0
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1064-3745
BN 978-1-60327-167-7
J9 METHODS MOL BIOL
JI Methods Mol. Biol.
PY 2010
VL 619
BP 377
EP 387
DI 10.1007/978-1-60327-412-8_22
D2 10.1007/978-1-60327-412-8
PG 11
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA BOU44
UT WOS:000277632300022
PM 20419422
DA 2021-01-25
ER

PT S
AU Engel, A
AF Engel, A.
BE Graslund, A
   Rigler, R
   Widengren, J
TI Assessing Biological Samples with Scanning Probes
SO SINGLE MOLECULE SPECTROSCOPY IN CHEMISTRY, PHYSICS AND BIOLOGY
SE Springer Series in Chemical Physics
LA English
DT Proceedings Paper
CT Nobel Symposium 138: Single Molecule Spectroscopy in Chemistry, Physics
   and Biosciences
CY JUN 01-06, 2008
CL Sanga-Saby, SWEDEN
ID ATOMIC-FORCE MICROSCOPE; TRANSMISSION ELECTRON-MICROSCOPY;
   PROTEIN-COUPLED RECEPTORS; SUPRAMOLECULAR ASSEMBLIES;
   MOLECULAR-INTERACTIONS; MEMBRANE-PROTEINS; NATIVE MEMBRANE;
   LIGAND-BINDING; CELL-CULTURE; RHODOPSIN
AB Scanning probe microscopes raster-scan an atomic scale sensor across an object. The scanning transmission electron microscope (STEM) uses an electron beam focused on a few angstrom spot, and measures the electron scattering power of the irradiated column of sample matter. Not only does the STEM create dark-filed images of superb clarity, but it also delivers the mass of single protein complexes within a range of 100 kDa to 100 MDa. The STEM appears to be the tool of choice to achieve high-throughput visual proteomics of single cells. In contrast, atomically sharp tips sample the object surface in the scanning tunneling microscope as well as the atomic force microscopes (AFM). Because the AFM can be operated on samples submerged in a physiological salt solution, biomacromolecules can be observed at work. Recent experiments provided new insights into the organization of different native biological membranes, and allowed molecular interaction forces, that determine protein folds and ligand binding, to be measured.
C1 Univ Basel, Maurice E Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Engel, A (corresponding author), Univ Basel, Maurice E Muller Inst Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch
CR Ardenne M. V., 1938, Z PHYS, V109, P553, DOI [DOI 10.1007/BF01341584, 10.1007/BF01341584]
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BINNIG G, 1982, HELV PHYS ACTA, V55, P726
   Bosshart PD, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384014
   BREMER A, 1994, J MOL BIOL, V242, P683, DOI 10.1006/jmbi.1994.1617
   Breslauer DN, 2006, MOL BIOSYST, V2, P97, DOI 10.1039/b515632g
   Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5
   COLE MD, 1977, J MOL BIOL, V117, P387, DOI 10.1016/0022-2836(77)90134-6
   CREWE AV, 1970, SCIENCE, V168, P1338, DOI 10.1126/science.168.3937.1338
   Di Carlo D, 2005, LAB CHIP, V5, P171, DOI 10.1039/b413139h
   Dietz H, 2006, P NATL ACAD SCI USA, V103, P12724, DOI 10.1073/pnas.0602995103
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   ENGEL A, 1995, SCIENCE, V269, P832, DOI 10.1126/science.7638600
   Engel A, 2008, ANNU REV BIOCHEM, V77, P127, DOI 10.1146/annurev.biochem.77.062706.154450
   EVANS E, 1999, J PHYS-CONDENS MAT, V11, P1
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Grandbois M, 2000, J HISTOCHEM CYTOCHEM, V48, P719, DOI 10.1177/002215540004800516
   Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102
   Hoogenboom BW, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384019
   Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073
   Hoogenboom BW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2202638
   Hung PJ, 2005, LAB CHIP, V5, P44, DOI 10.1039/b410743h
   Janovjak H, 2007, J AM CHEM SOC, V129, P246, DOI 10.1021/ja065684a
   Kedrov A, 2005, EMBO REP, V6, P668, DOI 10.1038/sj.embor.7400455
   Kedrov A, 2007, J STRUCT BIOL, V159, P290, DOI 10.1016/j.jsb.2007.02.010
   Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640
   Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   Moller C, 2003, J STRUCT BIOL, V142, P369, DOI 10.1016/S1047-8477(03)00066-2
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 2000, BBA-BIOENERGETICS, V1460, P27, DOI 10.1016/S0005-2728(00)00127-4
   Muller S, 1998, J MOL BIOL, V283, P383, DOI 10.1006/jmbi.1998.2078
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Nevill JT, 2007, LAB CHIP, V7, P1689, DOI 10.1039/b711874k
   Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Pamme N, 2007, LAB CHIP, V7, P1644, DOI 10.1039/b712784g
   Preiner J, 2007, BIOPHYS J, V93, P930, DOI 10.1529/biophysj.106.096982
   PUTMAN CAJ, 1994, APPL PHYS LETT, V64, P2454, DOI 10.1063/1.111597
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Sader JE, 1998, J APPL PHYS, V84, P64, DOI 10.1063/1.368002
   Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879
   Scheuring S, 2007, J STRUCT BIOL, V160, P385, DOI 10.1016/j.jsb.2007.07.009
   Scheuring S, 2007, J STRUCT BIOL, V159, P268, DOI 10.1016/j.jsb.2007.01.021
   Seitz M, 2003, CHEMPHYSCHEM, V4, P986, DOI 10.1002/cphc.200300760
   Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030
NR 51
TC 8
Z9 8
U1 0
U2 3
PU SPRINGER-VERLAG BERLIN
PI BERLIN
PA HEIDELBERGER PLATZ 3, D-14197 BERLIN, GERMANY
SN 0172-6218
BN 978-3-642-02596-9
J9 SPRINGER SERIES CHEM
PY 2010
VL 96
BP 417
EP 431
DI 10.1007/978-3-642-02597-6_21
PG 15
WC Chemistry, Analytical; Optics; Physics, Atomic, Molecular & Chemical
SC Chemistry; Optics; Physics
GA BST16
UT WOS:000285735900021
DA 2021-01-25
ER

PT J
AU Nowak, C
   Santonicola, MG
   Schach, D
   Zhu, JP
   Gennis, RB
   Ferguson-Miller, S
   Baurecht, D
   Walz, D
   Knoll, W
   Naumann, RLC
AF Nowak, Christoph
   Santonicola, Maria Gabriella
   Schach, Denise
   Zhu, Jiapeng
   Gennis, Robert B.
   Ferguson-Miller, Shelagh
   Baurecht, Dieter
   Walz, Dieter
   Knoll, Wolfgang
   Naumann, Renate L. C.
TI Conformational transitions and molecular hysteresis of cytochrome c
   oxidase: Varying the redox state by electronic wiring
SO SOFT MATTER
LA English
DT Article
ID P-M INTERMEDIATE; TRANSFORM INFRARED-SPECTROSCOPY;
   PARACOCCUS-DENITRIFICANS; VIBRATIONAL-MODES; ACTIVE-SITE; PROTON PUMP;
   ELECTROCHEMISTRY; REDUCTION; MEMBRANE; SURFACE
AB Even though the structures of cytochrome c oxidase (CcO) from different sources have been determined by X-ray crystallography in both the reduced and oxidized redox states, information about redox-induced structure-function relationships is still very limited. In the current work, redox-dependent structural changes are determined for CcO reconstituted in a protein-tethered bilayer lipid membrane by surface-enhanced infrared absorption spectroscopy in the ATR mode. Significantly, the redox changes in the enzyme are attained by direct wiring of CcO to a gold electrode, ensuring that sequential intra-protein electron transfer occurs by a directed pathway that is natural to the system. The characteristics of CcO were observed to be dramatically altered after the reconstituted enzyme was allowed to turn over in the presence of O-2. The data suggest that the enzyme is initially in an "inactive" state, but that direct electron transfer in the presence of O-2 converts the enzyme to an "activated" form which returns to the inactive conformation when the enzyme remains idle under anaerobic conditions. Potentiometric titrations are performed and reduced-minus-fully oxidized and oxidized-minus-fully reduced absorbance spectra are recorded at decreasing and increasing potentials, respectively, applied to the electrode in a regular succession. The two sets of difference spectra show mirror symmetry, however, they markedly differ from those measured in the presence of redox mediators. Plots of band area of individual bands obtained by Fourier self deconvolution vs. applied potential show a sigmoid dependence as expected for a redox process. However, the sigmoid curves do not coincide but are displaced depending on the direction of the potential change. In other words, these curves show hysteresis, which is an indication of cooperativity and non-equilibrium states for electron transfer and/or conformational changes of the protein. This is discussed in terms of known concepts of molecular hysteresis.
C1 [Nowak, Christoph; Santonicola, Maria Gabriella; Schach, Denise; Naumann, Renate L. C.] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
   [Zhu, Jiapeng; Gennis, Robert B.] Univ Illinois, Dept Biochem, Urbana, IL 61801 USA.
   [Ferguson-Miller, Shelagh] Michigan State Univ, E Lansing, MI 48824 USA.
   [Baurecht, Dieter] Univ Vienna, Inst Biophys Chem, A-1090 Vienna, Austria.
   [Walz, Dieter] Univ Basel, Biozentrum, CH-4059 Basel, Switzerland.
   [Nowak, Christoph; Schach, Denise; Knoll, Wolfgang; Naumann, Renate L. C.] Austrian Inst Technol GmbH AIT, A-1220 Vienna, Austria.
RP Naumann, RLC (corresponding author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.
EM nowakc@mpip-mainz.mpg.de; M.G.Santonicola@tnw.utwente.nl;
   schach@mpip-mainz.mpg.de; jzhu4@uiuc.edu; r-gennis@illinois.edu;
   fergus20@msu.edu; Dieter.Baurecht@univie.ac.at; dieter.walz@unibas.ch;
   wolfgang.knoll@ait.ac.at; naumannr@mpip-mainz.mpg.de
RI Santonicola, M.Gabriella/E-6355-2010
OI Santonicola, M.Gabriella/0000-0002-2736-8580; Baurecht,
   Dieter/0000-0002-3355-6772
FU ZIT, Center of Innovation and Technology of Vienna
FX Partial support for this work was provided by ZIT, Center of Innovation
   and Technology of Vienna.
CR ALBEN JO, 1984, BIOPHYS J, V45, pA369
   ANTONINI G, 1985, J INORG BIOCHEM, V23, P289, DOI 10.1016/0162-0134(85)85037-6
   Aoyama H, 2009, P NATL ACAD SCI USA, V106, P2165, DOI 10.1073/pnas.0806391106
   Ataka K, 1999, J ELECTROANAL CHEM, V473, P34, DOI 10.1016/S0022-0728(99)00119-9
   BRUNORI M, 1985, EMBO J, V4, P2365, DOI 10.1002/j.1460-2075.1985.tb03940.x
   BRUNORI M, 1985, J INORG BIOCHEM, V23, P373, DOI 10.1016/0162-0134(85)85048-0
   Friedrich MG, 2008, BIOPHYS J, V94, P3698, DOI 10.1529/biophysj.107.117846
   Friedrich MG, 2004, CHEM COMMUN, P2376, DOI 10.1039/b410998h
   Giess F, 2004, BIOPHYS J, V87, P3213, DOI 10.1529/biophysj.104.046169
   Gorbikova EA, 2006, BIOCHEMISTRY-US, V45, P5641, DOI 10.1021/bi060257v
   Harrenga A, 1999, J BIOL CHEM, V274, P33296, DOI 10.1074/jbc.274.47.33296
   Hellwig P, 1996, FEBS LETT, V385, P53, DOI 10.1016/0014-5793(96)00342-0
   Hellwig P, 1998, BBA-BIOENERGETICS, V1409, P107, DOI 10.1016/S0005-2728(98)00151-0
   Hellwig P, 1999, BIOCHEMISTRY-US, V38, P1685, DOI 10.1021/bi982282+
   Hellwig P, 2008, BBA-BIOENERGETICS, V1777, P220, DOI 10.1016/j.bbabio.2007.11.005
   Hesse M., 2005, SPEKTROSKOPISCHE MET
   Iwaki M, 2006, BBA-BIOENERGETICS, P180
   Iwaki M, 2002, BBA-BIOENERGETICS, V1555, P116, DOI 10.1016/S0005-2728(02)00265-7
   Iwaki M, 2006, BIOCHEMISTRY-US, V45, P10873, DOI 10.1021/bi061114b
   Jancura D, 2006, J BIOL CHEM, V281, P30319, DOI 10.1074/jbc.M605955200
   Katchalsky A, 1968, Q Rev Biophys, V1, P127
   KAUPPINEN JK, 1981, P SOC PHOTO-OPT INST, V289, P260
   Koepke J, 2009, BBA-BIOENERGETICS, V1787, P635, DOI 10.1016/j.bbabio.2009.04.003
   Merklin GT, 1997, LANGMUIR, V13, P6159, DOI 10.1021/la960828s
   MITCHELL DM, 1995, FEBS LETT, V368, P148, DOI 10.1016/0014-5793(95)00626-K
   NEUMANN E, 1972, P NATL ACAD SCI USA, V69, P993, DOI 10.1073/pnas.69.4.993
   NEUMANN E, 1973, ANGEW CHEM, V85, P430
   Nowak C, 2009, APPL SPECTROSC, V63, P1068, DOI 10.1366/000370209789379330
   Nowak C, 2009, J PHYS CHEM C, V113, P2256, DOI 10.1021/jp8071052
   Nowak C, 2011, J SOLID STATE ELECTR, V15, P105, DOI 10.1007/s10008-010-1032-x
   Osawa M., 2002, HDB VIBRATIONAL SPEC
   PERSSON BNJ, 1981, SURF SCI, V110, P356, DOI 10.1016/0039-6028(81)90644-0
   Qin L, 2009, BIOCHEMISTRY-US, V48, P5121, DOI 10.1021/bi9001387
   Schach D, 2010, J ELECTROANAL CHEM, V649, P268, DOI 10.1016/j.jelechem.2010.07.009
   SPODHEIM M, 1975, BIOPHYS CHEM, V3, P109, DOI 10.1016/0301-4622(75)80001-9
   TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554
   Udit AK, 2005, BIOCHEM BIOPH RES CO, V338, P470, DOI 10.1016/j.bbrc.2005.08.087
   Udit AK, 2006, LANGMUIR, V22, P10854, DOI 10.1021/la061162x
   Udit AK, 2006, J INORG BIOCHEM, V100, P519, DOI 10.1016/j.jinorgbio.2006.01.011
   Wikstrom M, 2004, BBA-BIOENERGETICS, V1655, P241, DOI 10.1016/j.bbabio.2003.07.013
   Zheng Z, 2009, PROTEINS, V75, P719, DOI 10.1002/prot.22282
NR 41
TC 19
Z9 19
U1 0
U2 17
PU ROYAL SOC CHEMISTRY
PI CAMBRIDGE
PA THOMAS GRAHAM HOUSE, SCIENCE PARK, MILTON RD, CAMBRIDGE CB4 0WF, CAMBS,
   ENGLAND
SN 1744-683X
EI 1744-6848
J9 SOFT MATTER
JI Soft Matter
PY 2010
VL 6
IS 21
BP 5523
EP 5532
DI 10.1039/c0sm00160k
PG 10
WC Chemistry, Physical; Materials Science, Multidisciplinary; Physics,
   Multidisciplinary; Polymer Science
SC Chemistry; Materials Science; Physics; Polymer Science
GA 666XF
UT WOS:000283155300037
DA 2021-01-25
ER

PT J
AU Koegler, E
   Bonnon, C
   Waldmeier, L
   Mitrovic, S
   Halbeisen, R
   Hauri, HP
AF Koegler, Eva
   Bonnon, Carine
   Waldmeier, Lorenz
   Mitrovic, Sandra
   Halbeisen, Regula
   Hauri, Hans-Peter
TI p28, A Novel ERGIC/cis Golgi Protein, Required for Golgi Ribbon
   Formation
SO TRAFFIC
LA English
DT Article
DE acetylated tubulin; ER-Golgi intermediate compartment (ERGIC); Golgi
   fragmentation; membrane traffic; organelle maintenance; p24 proteins
ID COATED TRANSPORT VESICLES; ENDOPLASMIC-RETICULUM; MEMBRANE-PROTEIN; P24
   FAMILY; TRANSMEMBRANE PROTEIN; RETROGRADE TRANSPORT; CYTOPLASMIC DOMAIN;
   CARGO RECEPTORS; EXIT SITES; BETA-COP
AB The mammalian Golgi apparatus consists of individual cisternae that are stacked in a polarized manner to form the compact zones of the Golgi. Several stacks are linked to form a ribbon via dynamic lateral bridges. The determinants required for maintaining the characteristic Golgi structure are incompletely understood. Here, we have characterized p28, a new gamma-subfamily member of p24 membrane proteins. p28 localized to endoplasmic reticulum-Golgi intermediate compartment (ERGIC) and cis Golgi and accumulated in the ERGIC upon Brefeldin A treatment, typical for a protein cycling in the early secretory pathway. p28 interacted with a subset of p24 proteins. Its depletion by small interfering RNA (siRNA) led to fragmentation of the Golgi without affecting the overall organization of microtubules but considerably reducing the amount of acetylated tubulin. The distribution of COPI and tethers, including GM130, was not affected. At the ultrastructural level, the Golgi fragments appeared as mini-stacks with apparently unchanged cis-trans topology. Golgi fragmentation did not impair anterograde or retrograde traffic. Fluorescence recovery after photobleaching (FRAP) experiments revealed that silencing p28 prevents protein exchange between Golgi stacks during reassembly after Brefeldin A-induced Golgi breakdown. These results show that the formation of a Golgi ribbon requires the structural membrane protein p28 in addition to previously identified SNAREs, coat proteins and tethers.
C1 [Koegler, Eva; Bonnon, Carine; Waldmeier, Lorenz; Mitrovic, Sandra; Halbeisen, Regula; Hauri, Hans-Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Hans-Peter.Hauri@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); University of Basel
FX We thank Ursula Sauder for electron microscopy analysis, Felix Wieland
   for antibodies to p23, p24 and p25, Ari Helenius for anti-VSV-G
   antibody, Kai Simons for ts045 VSV-G-GFP cDNA and Victor Hsu for
   VSV-G-KDELr cDNA. This work was supported by the Swiss National Science
   Foundation and the University of Basel.
CR Aguilera-Romero A, 2008, J CELL BIOL, V180, P713, DOI 10.1083/jcb.200710025
   Altan-Bonnet N, 2004, CURR OPIN CELL BIOL, V16, P364, DOI 10.1016/j.ceb.2004.06.011
   Anantharaman V, 2002, GENOME BIOL, V3
   Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019
   Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102
   BARROSO M, 1995, P NATL ACAD SCI USA, V92, P527, DOI 10.1073/pnas.92.2.527
   Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615
   Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7
   Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06
   Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1
   Breuza L, 2004, J BIOL CHEM, V279, P47242, DOI 10.1074/jbc.M406644200
   Ciufo LF, 2000, J BIOL CHEM, V275, P8382, DOI 10.1074/jbc.275.12.8382
   Cole NB, 1998, J CELL BIOL, V140, P1, DOI 10.1083/jcb.140.1.1
   Contreras FX, 2009, EUR J CELL BIOL, V88, P12
   COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252
   Denzel A, 2000, CURR BIOL, V10, P55, DOI 10.1016/S0960-9822(99)00266-3
   Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045
   Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751
   Emery G, 2000, J CELL SCI, V113, P2507
   Emery G, 2003, J CELL SCI, V116, P4821, DOI 10.1242/jcs.00802
   Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200
   Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396
   Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939
   Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5
   Gommel D, 1999, FEBS LETT, V447, P179, DOI 10.1016/S0014-5793(99)00246-X
   Gommel DU, 2001, EMBO J, V20, P6751, DOI 10.1093/emboj/20.23.6751
   Guo YS, 2008, MOL BIOL CELL, V19, P2830, DOI 10.1091/mbc.E07-12-1236
   Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010
   Harter C, 1998, P NATL ACAD SCI USA, V95, P11649, DOI 10.1073/pnas.95.20.11649
   JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x
   Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200
   Kasap M, 2004, TRAFFIC, V5, P595, DOI 10.1111/j.1398-9219.2004.00203.x
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Kodani A, 2008, MOL BIOL CELL, V19, P745, DOI 10.1091/mbc.E07-08-0847
   Ladinsky MS, 1999, J CELL BIOL, V144, P1135, DOI 10.1083/jcb.144.6.1135
   Lai CH, 2000, GENOME RES, V10, P703, DOI 10.1101/gr.10.5.703
   Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307
   Linstedt AD, 1997, MOL BIOL CELL, V8, P1073
   LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679
   LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W
   Luo WB, 2007, J BIOL CHEM, V282, P30246, DOI 10.1074/jbc.M703205200
   Marzioch M, 1999, MOL BIOL CELL, V10, P1923, DOI 10.1091/mbc.10.6.1923
   Meister P, 2007, EMBO J, V26, P1315, DOI 10.1038/sj.emboj.7601538
   Miller PM, 2009, NAT CELL BIOL, V11, P1069, DOI 10.1038/ncb1920
   MILLONIG G, 1961, J BIOPHYS BIOCHEM CY, V11, P736, DOI 10.1083/jcb.11.3.736
   Mitrovic S, 2008, MOL BIOL CELL, V19, P1976, DOI 10.1091/mbc.E07-10-0989
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715
   Nickel W, 1997, P NATL ACAD SCI USA, V94, P11393, DOI 10.1073/pnas.94.21.11393
   PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2
   Phillips R, 2009, NATURE, V459, P379, DOI 10.1038/nature08147
   Puri S, 2003, MOL BIOL CELL, V14, P5011, DOI 10.1091/mbc.E03-06-0437
   Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366
   Puthenveedu MA, 2004, P NATL ACAD SCI USA, V101, P1253, DOI 10.1073/pnas.0306373101
   Reinhard C, 1999, P NATL ACAD SCI USA, V96, P1224, DOI 10.1073/pnas.96.4.1224
   Rivero S, 2009, EMBO J, V28, P1016, DOI 10.1038/emboj.2009.47
   Rojo M, 2000, J CELL SCI, V113, P1043
   Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119
   SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Short B, 2001, J CELL BIOL, V155, P877, DOI 10.1083/jcb.200108079
   Shorter J, 1999, EMBO J, V18, P4949, DOI 10.1093/emboj/18.18.4949
   Shorter J, 1999, J CELL BIOL, V146, P57, DOI 10.1083/jcb.146.1.57
   Sohda M, 2005, BIOCHEM BIOPH RES CO, V338, P1268, DOI 10.1016/j.bbrc.2005.10.084
   Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239
   STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011
   Stauber T, 2006, CURR BIOL, V16, P2245, DOI 10.1016/j.cub.2006.09.060
   Strating JRPM, 2009, BIOL CELL, V101, P495, DOI 10.1042/BC20080233
   Styers ML, 2008, AM J PHYSIOL-CELL PH, V294, pC1485, DOI 10.1152/ajpcell.00010.2008
   Sutterlin C, 2005, MOL BIOL CELL, V16, P3211, DOI 10.1091/mbc.E04-12-1065
   Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27
   Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016
   Wang YZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001647
   Wang YZ, 2003, EMBO J, V22, P3279, DOI 10.1093/emboj/cdg317
   Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045
   Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x
   Wendeler MW, 2007, FASEB J, V21, P2352, DOI 10.1096/fj.07-8128com
   Yadav S, 2009, MOL BIOL CELL, V20, P1728, DOI 10.1091/mbc.E08-10-1077
   Zeuschner D, 2006, NAT CELL BIOL, V8, P377, DOI 10.1038/ncb1371
   Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595
NR 80
TC 17
Z9 19
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-9219
EI 1600-0854
J9 TRAFFIC
JI Traffic
PD JAN
PY 2010
VL 11
IS 1
BP 70
EP 89
DI 10.1111/j.1600-0854.2009.01009.x
PG 20
WC Cell Biology
SC Cell Biology
GA 551DA
UT WOS:000274184800008
PM 19948005
OA Bronze
DA 2021-01-25
ER

PT J
AU Braissant, O
   Wirz, D
   Gopfert, B
   Daniels, AU
AF Braissant, O.
   Wirz, D.
   Goepfert, B.
   Daniels, A. U.
TI "The heat is on": Rapid microcalorimetric detection of mycobacteria in
   culture
SO TUBERCULOSIS
LA English
DT Editorial Material
DE Mycobacterium tuberculosis; Mycobacteria; Microcalorimetry; Detection
ID STAPHYLOCOCCUS-AUREUS; THERMOPILE
AB Detection of mycobacterial infection can be achieved by different means; however, culture-based methods remain the gold standard. In this paper, we present a new culture-based method using real-time microcalorimetric detection of growth of Mycobacterium species including Mycobacterium tuberculosis. Microcalorimetric detection of heat production by 6 different growing species of Mycobacterium was achieved between 20 and 310 h depending on their type (fast vs. slow-growing mycobacteria) and initial concentration. This study demonstrates that microcalorimetric detection of mycobacterial growth is a potential advantageous alternative to methods using fluorescent or radiolabeled growth indicators. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Braissant, O.; Wirz, D.; Goepfert, B.; Daniels, A. U.] Univ Basel, Lab Biomech & Biocalorimetry LOB2, Fac Med, Biozentrum Pharmazentrum, CH-4056 Basel, Switzerland.
RP Braissant, O (corresponding author), Univ Basel, Lab Biomech & Biocalorimetry LOB2, Fac Med, Biozentrum Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Olivier.braissant@unibas.ch
RI Braissant, Olivier/H-2284-2012; Braissant, Olivier/AAO-2371-2020
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
CR Baldoni D, 2009, J CLIN MICROBIOL, V47, P774, DOI 10.1128/JCM.02374-08
   BATAILLARD P, 1993, BIOSENS BIOELECTRON, V8, P89, DOI 10.1016/0956-5663(93)80057-V
   BATAILLARD P, 1993, TRAC-TREND ANAL CHEM, V12, P387, DOI 10.1016/0165-9936(93)80002-2
   Braissant O, 2010, FEMS MICROBIOL LETT, V303, P1, DOI 10.1111/j.1574-6968.2009.01819.x
   DEBRUNNER M, 1992, CLIN INFEC DIS, V15, P30
   Higuera-Guisset J, 2005, THERMOCHIM ACTA, V427, P187, DOI 10.1016/j.tca.2004.09.010
   JAMES AM, 1987, THERMAL ENERGETIC ST
   Organization WH, 2008, WHO REP 2008 GLOB TU
   ORIOL E, 1987, Biotechnology Techniques, V1, P79, DOI 10.1007/BF00159326
   Reid MJA, 2009, LANCET INFECT DIS, V9, P173, DOI 10.1016/S1473-3099(09)70043-X
   Stop TB Partnership and World Health Organization, 2008, NEW LAB DIAGN TOOLS
   von Ah U, 2008, J CLIN MICROBIOL, V46, P2083, DOI 10.1128/JCM.00611-08
   VONAH U, 2009, J CLIN MICROBIOL, V9, P106
   Wadso L, 2004, THERMOCHIM ACTA, V422, P63, DOI 10.1016/j.tca.2004.05.034
   WAYNE LG, 1992, CLIN MICROBIOL REV, V5, P1
NR 15
TC 31
Z9 32
U1 0
U2 7
PU CHURCHILL LIVINGSTONE
PI EDINBURGH
PA JOURNAL PRODUCTION DEPT, ROBERT STEVENSON HOUSE, 1-3 BAXTERS PLACE,
   LEITH WALK, EDINBURGH EH1 3AF, MIDLOTHIAN, SCOTLAND
SN 1472-9792
J9 TUBERCULOSIS
JI Tuberculosis
PD JAN
PY 2010
VL 90
IS 1
BP 57
EP 59
DI 10.1016/j.tube.2009.11.001
PG 3
WC Immunology; Microbiology; Respiratory System
SC Immunology; Microbiology; Respiratory System
GA 549UZ
UT WOS:000274081100010
PM 19969505
DA 2021-01-25
ER

PT J
AU Hadziselimovic, NO
   de Geyter, C
   Demougin, P
   Oakeley, EJ
   Hadziselimovic, F
AF Hadziselimovic, N. O.
   de Geyter, Ch.
   Demougin, P.
   Oakeley, E. J.
   Hadziselimovic, F.
TI Decreased Expression of FGFR1, SOS1, RAF1 Genes in Cryptorchidism
SO UROLOGIA INTERNATIONALIS
LA English
DT Article
DE Cryptorchidism; FGFR1 gene; SOS1 gene; RAF1 gene; Microarray
ID GONADOTROPIN-RELEASING-HORMONE; MUTATIONS; MICE
AB Background: In recent years, several genes were found to be involved in the process of epididymo-testicular descent, the most frequently cited ones include INSL3, HOXA10, GNRHR, and KAL1. In this study, we analyzed the differences in gene expression profiles between cryptorchid and descended testes. In particular, we analyzed expression of all recently published genes known to be associated with undescended testis. Patients and Methods: Twenty-two testicular biopsies from 18 boys were analyzed. We analyzed gene expression in 16 cryptorchid and 6 descended testes using Affymetrix Human Genome U133 Plus 2.0 GeneChips, and validated the results with qPCR. Results: 3,688 transcripts were differentially expressed with an adjusted p value of <0.05 and a change of at least 1.5-fold. The list contained 1,866 downregulated and 1,822 upregulated transcripts in the cryptorchid testes. A novel observation in our study was that the fibroblast growth factor receptor 1 gene (FGFR1) and its mediators SOS1 and RAF1 were expressed less in undescended testes. Conclusion: Based on our results, it is possible that a subtle dysfunction (expression) of the FGFR1, SOS1 and RAF1 genes is involved in the development of the most common male reproductive tract disorder - unilateral or bilateral cryptorchidism. Copyright (C) 2010 S. Karger AG, Basel
C1 [Hadziselimovic, N. O.; Hadziselimovic, F.] Kindertagesklin Liestal, CH-4410 Liestal, Switzerland.
   [Hadziselimovic, N. O.; Hadziselimovic, F.] Inst Androl Liestal, Liestal, Switzerland.
   [Oakeley, E. J.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland.
   [Demougin, P.] Univ Basel, Biozentrum, Basel, Switzerland.
   [de Geyter, Ch.] Univ Basel Hosp, Dept Endocrinol & Reprod Med, CH-4031 Basel, Switzerland.
RP Hadziselimovic, F (corresponding author), Kindertagesklin Liestal, Oristalstr 87A, CH-4410 Liestal, Switzerland.
EM praxis@kindertagesklinik.ch
CR BASILICO C, 1992, ADV CANCER RES, V59, P115, DOI 10.1016/S0065-230X(08)60305-X
   Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104
   CHARLTON HM, 1983, ENDOCRINOLOGY, V113, P535, DOI 10.1210/endo-113-2-535
   Chen PY, 2009, BIOCHEM BIOPH RES CO, V382, P424, DOI 10.1016/j.bbrc.2009.03.040
   Crowley William F Jr, 2008, Trans Am Clin Climatol Assoc, V119, P29
   Deutsch EW, 2008, NAT BIOTECHNOL, V26, P305, DOI 10.1038/nbt1391
   Dode C, 2003, NAT GENET, V33, P463, DOI 10.1038/ng1122
   Feng S, 2009, ANN NY ACAD SCI, V1160, P197, DOI 10.1111/j.1749-6632.2009.03841.x
   Ferlin A, 2006, MOL HUM REPROD, V12, P401, DOI 10.1093/molehr/gal043
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   HADZISELIMOVIC F, 1976, J PEDIATR SURG, V11, P1, DOI 10.1016/0022-3468(76)90162-7
   Hadziselimovic Faruk, 2007, Int. braz j urol., V33, P407, DOI 10.1590/S1677-55382007000300015
   HUFF DS, 1991, J UROLOGY, V146, P630, DOI 10.1016/S0022-5347(17)37876-X
   Hughes IA, 2008, EUR J ENDOCRINOL, V159, pS75, DOI 10.1530/EJE-08-0458
   Nef S, 1999, NAT GENET, V22, P295, DOI 10.1038/10364
   Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995
   Pask AJ, 2005, MOL ENDOCRINOL, V19, P972, DOI 10.1210/me.2004-0192
   Pitteloud N, 2006, P NATL ACAD SCI USA, V103, P6281, DOI 10.1073/pnas.0600962103
   Sarkozy A, 2008, ORPHANET J RARE DIS, V3, DOI 10.1186/1750-1172-3-13
   Serrano-Martin M M, 2008, An Pediatr (Barc), V68, P365
   Seyed M, 2008, J MOL CELL CARDIOL, V44, P510, DOI 10.1016/j.yjmcc.2007.12.008
   Vogels A, 2008, J UROLOGY, V180, P1800, DOI 10.1016/j.juro.2008.03.113
   Watanabe M, 2007, HUM REPROD, V22, P1279, DOI 10.1093/humrep/del513
   Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449
   Yuan FP, 2006, HUM REPROD, V21, P936, DOI 10.1093/humrep/dei433
   Zhang FP, 2001, MOL ENDOCRINOL, V15, P172, DOI 10.1210/me.15.1.172
   Zimmermann S, 1999, MOL ENDOCRINOL, V13, P681, DOI 10.1210/me.13.5.681
NR 27
TC 20
Z9 22
U1 0
U2 1
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0042-1138
EI 1423-0399
J9 UROL INT
JI Urol.Int.
PY 2010
VL 84
IS 3
BP 353
EP 361
DI 10.1159/000288242
PG 9
WC Urology & Nephrology
SC Urology & Nephrology
GA 584NS
UT WOS:000276759900020
PM 20389169
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Beerli, RR
   Bauer, M
   Schmitz, N
   Buser, RB
   Gwerder, M
   Muntwiler, S
   Renner, WA
   Saudan, P
   Bachmann, MF
AF Beerli, Roger R.
   Bauer, Monika
   Schmitz, Nicole
   Buser, Regula B.
   Gwerder, Myriam
   Muntwiler, Simone
   Renner, Wolfgang A.
   Saudan, Philippe
   Bachmann, Martin F.
TI Prophylactic and therapeutic activity of fully human monoclonal
   antibodies directed against Influenza A M2 protein
SO VIROLOGY JOURNAL
LA English
DT Article
ID INTEGRAL MEMBRANE-PROTEIN; B-CELLS; EXTRACELLULAR DOMAIN; VIRUS
   HEMAGGLUTININ; CONJUGATE VACCINES; MICE; PROTECTION; IMMUNOGENICITY;
   NEUTRALIZATION; VACCINATION
AB Influenza virus infection is a prevalent disease in humans. Antibodies against hemagglutinin have been shown to prevent infection and hence hemagglutinin is the major constituent of current vaccines. Antibodies directed against the highly conserved extracellular domain of M2 have also been shown to mediate protection against Influenza A infection in various animal models. Active vaccination is generally considered the best approach to combat viral diseases. However, passive immunization is an attractive alternative, particularly in acutely exposed or immune compromized individuals, young children and the elderly. We recently described a novel method for the rapid isolation of natural human antibodies by mammalian cell display. Here we used this approach to isolate human monoclonal antibodies directed against the highly conserved extracellular domain of the Influenza A M2 protein. The identified antibodies bound M2 peptide with high affinities, recognized native cell-surface expressed M2 and protected mice from a lethal influenza virus challenge. Moreover, therapeutic treatment up to 2 days after infection was effective, suggesting that M2-specific monoclonals have a great potential as immunotherapeutic agents against Influenza infection.
C1 [Beerli, Roger R.; Bauer, Monika; Schmitz, Nicole; Buser, Regula B.; Gwerder, Myriam; Muntwiler, Simone; Renner, Wolfgang A.; Saudan, Philippe; Bachmann, Martin F.] Cytos Biotechnol AG, CH-8952 Schlieren, Switzerland.
   [Schmitz, Nicole] Actel Pharmaceut Ltd, CH-4123 Allschwil, Switzerland.
   [Gwerder, Myriam] GlycoVaxyn AG, CH-8952 Schlieren, Switzerland.
   [Muntwiler, Simone] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Beerli, RR (corresponding author), Cytos Biotechnol AG, Wagistr 25, CH-8952 Schlieren, Switzerland.
EM roger.beerli@cytos.com; monika.bauer@cytos.com;
   nicole.schmitz@actelion.com; regula.buser@cytos.com;
   myriam.gwerder@glycovaxyn.com; simone.muntwiler@vtxmail.ch;
   wolfgang.renner@cytos.com; philippe.saudan@cytos.com;
   martin.bachmann@cytos.com
CR Beerli RR, 2008, P NATL ACAD SCI USA, V105, P14336, DOI 10.1073/pnas.0805942105
   BIZEBARD T, 1995, NATURE, V376, P92, DOI 10.1038/376092a0
   CIAMPOR F, 1992, VIRUS RES, V22, P247, DOI 10.1016/0168-1702(92)90056-F
   De Filette M, 2008, J BIOL CHEM, V283, P11382, DOI 10.1074/jbc.M800650200
   De Filette M, 2006, VACCINE, V24, P6597, DOI 10.1016/j.vaccine.2006.05.082
   Edwards MJ, 2001, J GEN VIROL, V82, P1387, DOI 10.1099/0022-1317-82-6-1387
   Eliasson DG, 2008, VACCINE, V26, P1243, DOI 10.1016/j.vaccine.2007.12.027
   Fan JA, 2004, VACCINE, V22, P2993, DOI 10.1016/j.vaccine.2004.02.021
   Fiore AE, 2009, CURR TOP MICROBIOL, V333, P43, DOI 10.1007/978-3-540-92165-3_3
   Fischer WB, 2002, BBA-BIOMEMBRANES, V1561, P27, DOI 10.1016/S0304-4157(01)00009-0
   FRIGUET B, 1985, J IMMUNOL METHODS, V77, P305, DOI 10.1016/0022-1759(85)90044-4
   Fu TM, 2009, VACCINE, V27, P1440, DOI 10.1016/j.vaccine.2008.12.034
   Fu TM, 2009, VIROLOGY, V385, P218, DOI 10.1016/j.virol.2008.11.035
   HOLSINGER LJ, 1991, VIROLOGY, V183, P32, DOI 10.1016/0042-6822(91)90115-R
   Huleatt JW, 2008, VACCINE, V26, P201, DOI 10.1016/j.vaccine.2007.10.062
   ITO T, 1991, J VIROL, V65, P5491, DOI 10.1128/JVI.65.10.5491-5498.1991
   Jegerlehner A, 2004, J IMMUNOL, V172, P5598, DOI 10.4049/jimmunol.172.9.5598
   JOHANSSON BE, 1989, J VIROL, V63, P1239, DOI 10.1128/JVI.63.3.1239-1246.1989
   LAGERKVIST ACS, 1995, BIOTECHNIQUES, V18, P862
   LAMB RA, 1985, CELL, V40, P627, DOI 10.1016/0092-8674(85)90211-9
   LAMB RA, 1981, VIROLOGY, V112, P746, DOI 10.1016/0042-6822(81)90319-6
   LAMB RA, 1981, VIROLOGY, V112, P729, DOI 10.1016/0042-6822(81)90317-2
   Liu WL, 2004, IMMUNOL LETT, V93, P131, DOI 10.1016/j.imlet.2004.03.003
   Liu WL, 2003, FEMS IMMUNOL MED MIC, V35, P141, DOI 10.1016/S0928-8244(03)00009-9
   McCown MF, 2005, J VIROL, V79, P3595, DOI 10.1128/JVI.79.6.3595-3605.2005
   Mozdzanowska K, 2003, VACCINE, V21, P2616, DOI 10.1016/S0264-410X(03)00040-9
   Neirynck S, 1999, NAT MED, V5, P1157
   Sakaguchi T, 1996, J CELL BIOL, V133, P733, DOI 10.1083/jcb.133.4.733
   Schofield DJ, 1997, J GEN VIROL, V78, P2441, DOI 10.1099/0022-1317-78-10-2441
   SLEPUSHKIN VA, 1995, VACCINE, V13, P1399, DOI 10.1016/0264-410X(95)92777-Y
   Tompkins SM, 2007, EMERG INFECT DIS, V13, P426, DOI 10.3201/eid1303.061125
   Traggiai E, 2004, NAT MED, V10, P871, DOI 10.1038/nm1080
   TREANOR JJ, 1990, J VIROL, V64, P1375, DOI 10.1128/JVI.64.3.1375-1377.1990
   Wang RF, 2008, ANTIVIR RES, V80, P168, DOI 10.1016/j.antiviral.2008.06.002
   WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992
   Weitkamp JH, 2003, J IMMUNOL METHODS, V275, P223, DOI 10.1016/S0022-1759(03)00013-9
   *WHO, 211 WHO
   ZEBEDEE SL, 1988, J VIROL, V62, P2762, DOI 10.1128/JVI.62.8.2762-2772.1988
NR 38
TC 31
Z9 34
U1 0
U2 4
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1743-422X
J9 VIROL J
JI Virol. J.
PD DEC 21
PY 2009
VL 6
AR 224
DI 10.1186/1743-422X-6-224
PG 11
WC Virology
SC Virology
GA 541WW
UT WOS:000273453000001
PM 20025741
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Hilleringmann, M
   Ringler, P
   Muller, SA
   De Angelis, G
   Rappuoli, R
   Ferlenghi, I
   Engel, A
AF Hilleringmann, Markus
   Ringler, Philippe
   Mueller, Shirley A.
   De Angelis, Gabriella
   Rappuoli, Rino
   Ferlenghi, Ilaria
   Engel, Andreas
TI Molecular architecture of Streptococcus pneumoniae TIGR4 pili
SO EMBO JOURNAL
LA English
DT Article
DE Gram-positive bacteria; mass measurement; pilus; STEM; Streptococcus
   pneumoniae
ID GRAM-POSITIVE BACTERIA; CORYNEBACTERIUM-DIPHTHERIAE; ISOPEPTIDE BONDS;
   SORTASE; PROTEINS; ADHESION; SURFACE; GENOME; CELLS; BIOGENESIS
AB Although the pili of Gram-positive bacteria are putative virulence factors, little is known about their structure. Here we describe the molecular architecture of pilus-1 of Streptococcus pneumoniae, which is a major cause of morbidity and mortality worldwide. One major (RrgB) and two minor components (RrgA and RrgC) assemble into the pilus. Results from TEM and scanning transmission EM show that the native pili are approximately 6 nm wide, flexible filaments that can be over 1 mu m long. They are formed by a single string of RrgB monomers and have a polarity defined by nose-like protrusions. These protrusions correlate to the shape of monomeric RrgB-His, which like RrgA-His and RrgC-His has an elongated, multi-domain structure. RrgA and RrgC are only present at the opposite ends of the pilus shaft, compatible with their putative roles as adhesin and anchor to the cell wall surface, respectively. Our structural analyses provide the first direct experimental evidence that the native S. pneumoniae pilus shaft is composed exclusively of covalently linked monomeric RrgB subunits oriented head-to-tail. The EMBO Journal (2009) 28, 3921-3930. doi: 10.1038/emboj.2009.360; Published online 26 November 2009
C1 [Ringler, Philippe; Mueller, Shirley A.; Engel, Andreas] Univ Basel, Maurice E Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Ringler, Philippe; Mueller, Shirley A.; Engel, Andreas] Univ Basel, Biozentrum, C CINA, CH-4056 Basel, Switzerland.
   [Hilleringmann, Markus; De Angelis, Gabriella; Rappuoli, Rino; Ferlenghi, Ilaria] Novartis Vaccines & Diagnost Srl, Res Ctr, Siena, Italy.
RP Engel, A (corresponding author), Univ Basel, Maurice E Muller Inst Struct Biol, Biozentrum, WRO-1058-P-18,Mattenstr 26, CH-4056 Basel, Switzerland.
EM rino.rappuoli@novartis.com; andreas.engel@unibas.ch
OI Hilleringmann, Markus/0000-0001-7745-2038
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-108299]; Maurice E Muller Foundation of Switzerland;
   Novartis Vaccines and Diagnostics s.r.l.
FX We thank Vladislav Krzyzaneka and Rudolf Reichelt, University of
   Munster, for continuous help with improving the mass determination
   software used in this project; Francoise Erne-Brand for STEM mass
   measurements; Ruben Diaz-Avalos, Florida State University, for providing
   Tobacco Mosaic Virus samples; and Monica Moschioni and Angela H Nobbs
   for valuable discussions and for supplying material. Further we thank
   Silvana Savino and Vega Masignani for promoting the project. This work
   was supported by the Swiss National Science Foundation ( grant
   3100A0-108299 to AE), the Maurice E Muller Foundation of Switzerland and
   Novartis Vaccines and Diagnostics s.r.l.
CR Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x
   Bagnoli F, 2008, J BACTERIOL, V190, P5480, DOI 10.1128/JB.00384-08
   Barocchi MA, 2006, P NATL ACAD SCI USA, V103, P2857, DOI 10.1073/pnas.0511017103
   Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x
   Budzik JM, 2007, MOL MICROBIOL, V66, P495, DOI 10.1111/j.1365-2958.2007.05939.x
   Budzik JM, 2008, J BIOL CHEM, V283, P36676, DOI 10.1074/jbc.M806796200
   Dramsi S, 2006, MOL MICROBIOL, V60, P1401, DOI 10.1111/j.1365-2958.2006.05190.x
   Falker S, 2008, MOL MICROBIOL, V70, P595, DOI 10.1111/j.1365-2958.2008.06396.x
   Fronzes R, 2008, EMBO J, V27, P2271, DOI 10.1038/emboj.2008.155
   Hava D, 2002, MOL MICROBIOL, V45, P1389, DOI 10.1046/j.1365-2958.2002.03106.x
   Hilleringmann M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000026
   Hung TT, 2004, MOL MICROBIOL, V53, P251, DOI 10.1111/j.1365-2958.2004.04117.x
   Kang HJ, 2007, SCIENCE, V318, P1625, DOI 10.1126/science.1145806
   Kang HJ, 2009, J BIOL CHEM, V284, P20729, DOI 10.1074/jbc.M109.014514
   Krishnan V, 2007, STRUCTURE, V15, P893, DOI 10.1016/j.str.2007.06.015
   Krzyzanek V, 2009, J STRUCT BIOL, V165, P78, DOI 10.1016/j.jsb.2008.10.006
   Lauer P, 2005, SCIENCE, V309, P105, DOI 10.1126/science.1111563
   LeMieux J, 2006, INFECT IMMUN, V74, P2453, DOI 10.1128/IAI.74.4.2453-2456.2006
   LeMieux J, 2008, J BACTERIOL, V190, P6002, DOI 10.1128/JB.00379-08
   Lode HM, 2009, CLIN MICROBIOL INFEC, V15, P212, DOI 10.1111/j.1469-0691.2009.02738.x
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Maisey HC, 2007, J BACTERIOL, V189, P1464, DOI 10.1128/JB.01153-06
   Mandlik A, 2008, P NATL ACAD SCI USA, V105, P14147, DOI 10.1073/pnas.0806350105
   Mandlik A, 2008, TRENDS MICROBIOL, V16, P33, DOI 10.1016/j.tim.2007.10.010
   Manzano C, 2008, STRUCTURE, V16, P1838, DOI 10.1016/j.str.2008.10.007
   Marraffini LA, 2006, MICROBIOL MOL BIOL R, V70, P192, DOI 10.1128/MMBR.70.1.192-221.2006
   Mora M, 2005, P NATL ACAD SCI USA, V102, P15641, DOI 10.1073/pnas.0507808102
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Muller SA, 2006, CHIMIA, V60, pA749, DOI 10.2533/chimia.2006.749
   Muller SA, 2001, MICRON, V32, P21, DOI 10.1016/S0968-4328(00)00022-6
   Nallapareddy SR, 2006, J CLIN INVEST, V116, P2799, DOI 10.1172/JCI29021
   Neiers F, 2009, J MOL BIOL, V393, P704, DOI 10.1016/j.jmb.2009.08.058
   Nelson AL, 2007, MOL MICROBIOL, V66, P329, DOI 10.1111/j.1365-2958.2007.05908.x
   Nobbs AH, 2008, INFECT IMMUN, V76, P3550, DOI 10.1128/IAI.01613-07
   Osaki M, 2002, J BACTERIOL, V184, P971, DOI 10.1128/jb.184.4.971-982.2002
   Proft T, 2009, CELL MOL LIFE SCI, V66, P613, DOI 10.1007/s00018-008-8477-4
   Rosch JW, 2008, INFECT IMMUN, V76, P3187, DOI 10.1128/IAI.00054-08
   Swaminathan A, 2007, MOL MICROBIOL, V66, P961, DOI 10.1111/j.1365-2958.2007.05968.x
   Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443
   Tettelin H, 2001, SCIENCE, V293, P498, DOI 10.1126/science.1061217
   Ton-That H, 2003, MOL MICROBIOL, V50, P1429, DOI 10.1046/j.1365-2958.2003.03782.x
   Ton-That H, 2004, TRENDS MICROBIOL, V12, P228, DOI 10.1016/j.tim.2004.03.004
   Wu H, 2001, CRIT REV ORAL BIOL M, V12, P101
   Xu P, 2007, J BACTERIOL, V189, P3166, DOI 10.1128/JB.01808-06
NR 44
TC 88
Z9 88
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0261-4189
EI 1460-2075
J9 EMBO J
JI Embo J.
PD DEC 16
PY 2009
VL 28
IS 24
BP 3921
EP 3930
DI 10.1038/emboj.2009.360
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 533OM
UT WOS:000272833700014
PM 19942854
OA Green Published
DA 2021-01-25
ER

PT J
AU Risson, V
   Mazelin, L
   Roceri, M
   Sanchez, H
   Moncollin, V
   Corneloup, C
   Richard-Bulteau, H
   Vignaud, A
   Baas, D
   Defour, A
   Freyssenet, D
   Tanti, JF
   Le-Marchand-Brustel, Y
   Ferrier, B
   Conjard-Duplany, A
   Romanino, K
   Bauche, S
   Hantai, D
   Mueller, M
   Kozma, SC
   Thomas, G
   Ruegg, MA
   Ferry, A
   Pende, M
   Bigard, X
   Koulmann, N
   Schaeffer, L
   Gangloff, YG
AF Risson, Valerie
   Mazelin, Laetitia
   Roceri, Mila
   Sanchez, Herve
   Moncollin, Vincent
   Corneloup, Claudine
   Richard-Bulteau, Helene
   Vignaud, Alban
   Baas, Dominique
   Defour, Aurelia
   Freyssenet, Damien
   Tanti, Jean-Francois
   Le-Marchand-Brustel, Yannick
   Ferrier, Bernard
   Conjard-Duplany, Agnes
   Romanino, Klaas
   Bauche, Stephanie
   Hantai, Daniel
   Mueller, Matthias
   Kozma, Sara C.
   Thomas, George
   Rueegg, Markus A.
   Ferry, Arnaud
   Pende, Mario
   Bigard, Xavier
   Koulmann, Nathalie
   Schaeffer, Laurent
   Gangloff, Yann-Gael
TI Muscle inactivation of mTOR causes metabolic and dystrophin defects
   leading to severe myopathy
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID DEFICIENT SKELETAL-MUSCLE; MUSCULAR-DYSTROPHY; SIGNALING PATHWAYS;
   MAMMALIAN TARGET; MDX MICE; GLYCOPROTEIN COMPLEX; GLYCOGEN-SYNTHASE;
   ANIMAL-MODELS; RAPAMYCIN; CELLS
AB Mammalian target of rapamycin (mTOR) is a key regulator of cell growth that associates with raptor and rictor to form the mTOR complex 1 (mTORC1) and mTORC2, respectively. Raptor is required for oxidative muscle integrity, whereas rictor is dispensable. In this study, we show that muscle-specific inactivation of mTOR leads to severe myopathy, resulting in premature death. mTOR-deficient muscles display metabolic changes similar to those observed in muscles lacking raptor, including impaired oxidative metabolism, altered mitochondrial regulation, and glycogen accumulation associated with protein kinase B/Akt hyperactivation. In addition, mTOR-deficient muscles exhibit increased basal glucose uptake, whereas whole body glucose homeostasis is essentially maintained. Importantly, loss of mTOR exacerbates the myopathic features in both slow oxidative and fast glycolytic muscles. Moreover, mTOR but not raptor and rictor deficiency leads to reduced muscle dystrophin content. We provide evidence that mTOR controls dystrophin transcription in a cell-autonomous, rapamycin-resistant, and kinase-independent manner. Collectively, our results demonstrate that mTOR acts mainly via mTORC1, whereas regulation of dystrophin is raptor and rictor independent.
C1 [Risson, Valerie; Mazelin, Laetitia; Moncollin, Vincent; Corneloup, Claudine; Baas, Dominique; Schaeffer, Laurent; Gangloff, Yann-Gael] Univ Lyon, Ecole Normale Super, Equipe Differenciat Neuromusculaire, CNRS,UMR 5239,IFR1 28,Lab Biol Mol Cellule, F-69364 Lyon 07, France.
   [Roceri, Mila; Pende, Mario] Univ Paris 05, Fac Med Necker, INSERM, U845, F-75730 Paris 15, France.
   [Sanchez, Herve; Richard-Bulteau, Helene; Bigard, Xavier; Koulmann, Nathalie] Res Ctr Hlth Mil, Dept Human Factors, F-38702 La Tronche, France.
   [Vignaud, Alban; Ferry, Arnaud] Univ Paris 06, UMR 787, F-75013 Paris, France.
   [Defour, Aurelia; Freyssenet, Damien] Univ Lyon, Univ St Etienne, Equipe Accueil 4338, Exercise Physiol Lab, F-42023 St Etienne, France.
   [Tanti, Jean-Francois; Le-Marchand-Brustel, Yannick] Ctr Mediterraneen Med Mol, INSERM, U895, F-06204 Nice, France.
   [Tanti, Jean-Francois; Le-Marchand-Brustel, Yannick] Univ Nice Sophia Antipolis, Fac Med, F-06204 Nice, France.
   [Ferrier, Bernard; Conjard-Duplany, Agnes] Univ Lyon 1, Fac Med RTH Laennec, INSERM, U820, F-69372 Lyon 08, France.
   [Romanino, Klaas; Rueegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Bauche, Stephanie; Hantai, Daniel] Univ Paris 06, Hop La Pitie Salpetriere, INSERM, UMR 975, F-75651 Paris 13, France.
   [Mueller, Matthias] Novartis Pharma AG, Novartis Inst Biomed Res, Dept Dev & Mol Pathways, CH-4057 Basel, Switzerland.
   [Kozma, Sara C.; Thomas, George] Univ Cincinnati, Genome Res Inst, Dept Genome Sci, Cincinnati, OH 45237 USA.
RP Schaeffer, L (corresponding author), Univ Lyon, Ecole Normale Super, Equipe Differenciat Neuromusculaire, CNRS,UMR 5239,IFR1 28,Lab Biol Mol Cellule, F-69364 Lyon 07, France.
EM Laurent.Schaeffer@ens-lyon.fr; Yann-Gael.Gangloff@ens-lyon.fr
RI MONCOLLIN, Vincent/R-1941-2017; ferry, arnaud/D-2816-2019; GANGLOFF,
   Yann-Gael/I-2161-2014; Thomas, George/K-9235-2014; Ruegg,
   Markus/X-7256-2019; Mazelin, Laetitia/AAD-9319-2020
OI MONCOLLIN, Vincent/0000-0002-4163-0231; GANGLOFF,
   Yann-Gael/0000-0001-9031-1184; Thomas, George/0000-0003-3518-8149;
   Ruegg, Markus/0000-0002-4974-9384; Mazelin,
   Laetitia/0000-0002-4001-2132; Tanti, Jean-Francois/0000-0003-1782-1318;
   Risson, Valerie/0000-0002-6812-6297; Pende, Mario/0000-0002-7864-8937;
   Duplany, Agnes/0000-0002-3485-1597; defour, aurelia/0000-0002-9114-0054;
   Bauche, Stephanie/0000-0002-6926-339X; baas,
   dominique/0000-0001-7970-717X
FU EMBOEuropean Molecular Biology Organization (EMBO); Association
   Francaise contre les MyopathiesAssociation Francaise contre les
   Myopathies; Agence Nationale de la RechercheFrench National Research
   Agency (ANR); Association pour la Recherche contre le CancerFondation
   ARC pour la Recherche sur le Cancer; Ministere de la Recherche et de la
   Technologie
FX This work was supported by an EMBO fellowship (to Y.-G. Gangloff), the
   Association Francaise contre les Myopathies (to L. Mazelin, L.
   Schaeffer, and Y.-G. Gangloff), the Agence Nationale de la Recherche (to
   M. Pende and Y.-G. Gangloff), the Association pour la Recherche contre
   le Cancer (to Y.-G. Gangloff), and the Ministere de la Recherche et de
   la Technologie (ACI BDPI to L. Schaeffer).
CR Acharyya S, 2005, CANCER CELL, V8, P421, DOI 10.1016/j.ccr.2005.10.004
   Agbulut O, 2009, AM J PHYSIOL-CELL PH, V296, pC205, DOI 10.1152/ajpcell.00408.2008
   Barton-Davis ER, 1999, J CLIN INVEST, V104, P375, DOI 10.1172/JCI7866
   Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622
   Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Blaauw B, 2008, HUM MOL GENET, V17, P3686, DOI 10.1093/hmg/ddn264
   Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014
   Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99
   Cross DAE, 1997, FEBS LETT, V406, P211, DOI 10.1016/S0014-5793(97)00240-8
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dellorusso C, 2001, J MUSCLE RES CELL M, V22, P467, DOI 10.1023/A:1014587918367
   Dogra C, 2006, J CELL PHYSIOL, V208, P575, DOI 10.1002/jcp.20696
   Durbeej M, 2002, CURR OPIN GENET DEV, V12, P349, DOI 10.1016/S0959-437X(02)00309-X
   Edinger AL, 2003, CANCER RES, V63, P8451
   Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158
   Erbay E, 2001, J BIOL CHEM, V276, P36079, DOI 10.1074/jbc.C100406200
   Galvagni F, 1998, J BIOL CHEM, V273, P33708, DOI 10.1074/jbc.273.50.33708
   Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004
   Hardwick JS, 1999, P NATL ACAD SCI USA, V96, P14866, DOI 10.1073/pnas.96.26.14866
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07
   Kuznetsov AV, 2008, NAT PROTOC, V3, P965, DOI 10.1038/nprot.2008.61
   Kuznetsov AV, 1996, EUR J BIOCHEM, V241, P909, DOI 10.1111/j.1432-1033.1996.00909.x
   Leek BT, 2001, AM J PHYSIOL-REG I, V280, pR441
   Majumder PK, 2004, NAT MED, V10, P594, DOI 10.1038/nm1052
   Mejat A, 2005, NAT NEUROSCI, V8, P313, DOI 10.1038/nn1408
   Mouisel E, 2006, NEUROSCI RES, V55, P389, DOI 10.1016/j.neures.2006.05.002
   Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004
   Nicole S, 2003, J CELL BIOL, V161, P571, DOI 10.1083/jcb.200210117
   Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231
   OHLENDIECK K, 1991, J CELL BIOL, V115, P1685, DOI 10.1083/jcb.115.6.1685
   Passonneau J. V., 1993, ENZYMATIC ANAL PRACT
   Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08
   Peng T, 2002, MOL CELL BIOL, V22, P5575, DOI 10.1128/MCB.22.15.5575-5584.2002
   Peter AK, 2006, EXP CELL RES, V312, P2580, DOI 10.1016/j.yexcr.2006.04.024
   Peter AK, 2009, HUM MOL GENET, V18, P318, DOI 10.1093/hmg/ddn358
   Repetto S, 1999, BIOCHEM BIOPH RES CO, V261, P547, DOI 10.1006/bbrc.1999.1055
   Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schiaffino S, 2007, PHYSIOLOGY, V22, P269, DOI 10.1152/physiol.00009.2007
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4
   Straub V, 1997, J CELL BIOL, V139, P375, DOI 10.1083/jcb.139.2.375
   TALMADGE RJ, 1993, J APPL PHYSIOL, V75, P2337
   Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200
   Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033
   Um SH, 2006, CELL METAB, V3, P393, DOI 10.1016/j.cmet.2006.05.003
   Watchko JF, 2002, J APPL PHYSIOL, V93, P407, DOI 10.1152/japplphysiol.01242.2001
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 51
TC 221
Z9 228
U1 0
U2 26
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD DEC 14
PY 2009
VL 187
IS 6
BP 859
EP 874
DI 10.1083/jcb.200903131
PG 16
WC Cell Biology
SC Cell Biology
GA 531WJ
UT WOS:000272702500012
PM 20008564
OA Other Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Zhu, PX
   Narita, Y
   Bundschuh, ST
   Fajardo, O
   Scharer, YPZ
   Chattopadhyaya, B
   Bouldoires, EA
   Stepien, AE
   Deisseroth, K
   Arber, S
   Sprengel, R
   Rijli, FM
   Friedrich, RW
AF Zhu, Peixin
   Narita, Yuichi
   Bundschuh, Sebastian T.
   Fajardo, Otto
   Schaerer, Yan-Ping Zhang
   Chattopadhyaya, Bidisha
   Bouldoires, Estelle Am
   Stepien, Anna Ewa
   Deisseroth, Karl
   Arber, Silvia
   Sprengel, Rolf
   Rijli, Filippo M.
   Friedrich, Rainer W.
TI Optogenetic dissection of neuronal circuits in zebrafish using viral
   gene transfer and the Tet system
SO FRONTIERS IN NEURAL CIRCUITS
LA English
DT Article
DE zebrafish; Tet system; viral gene transfer; channelrhodopsin; olfactory
   bulb; optogenetics; multiphoton
AB The conditional expression of transgenes at high levels in sparse and specific populations of neurons is important for high-resolution optogenetic analyses of neuronal circuits. We explored two complementary methods, viral gene delivery and the iTet-Off system, to express transgenes in the brain of zebrafish. High-level gene expression in neurons was achieved by Sindbis and Rabies viruses. The Tet system produced strong and specific gene expression that could be modulated conveniently by doxycycline. Moreover, transgenic lines showed expression in distinct, sparse and stable populations of neurons that appeared to be subsets of the neurons targeted by the promoter driving the Tet-activator. The Tet system therefore provides the opportunity to generate libraries of diverse expression patterns similar to gene trap approaches or the thy-1 promoter in mice, but with the additional possibility to pre-select cell types of interest. In transgenic lines expressing channelrhodopsin-2, action potential firing could be precisely controlled by two-photon stimulation at low laser power, presumably because the expression levels of the Tet-controlled genes were high even in adults. In channelrhodopsin-2-expressing larvae, optical stimulation with a single blue LED evoked distinct swimming behaviors including backward swimming. These approaches provide new opportunities for the optogenetic dissection of neuronal circuit structure and function.
C1 [Zhu, Peixin; Narita, Yuichi; Bundschuh, Sebastian T.; Fajardo, Otto; Schaerer, Yan-Ping Zhang; Chattopadhyaya, Bidisha; Bouldoires, Estelle Am; Stepien, Anna Ewa; Arber, Silvia; Rijli, Filippo M.; Friedrich, Rainer W.] Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   [Stepien, Anna Ewa; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Deisseroth, Karl] Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.
   [Sprengel, Rolf] Max Planck Inst Med Res, Heidelberg, Germany.
RP Friedrich, RW (corresponding author), Novartis Res Fdn, Friedrich Miescher Inst Biomed Res, Maulbeerstr 66, CH-4058 Basel, Switzerland.
EM Rainer.Friedrich@fmi.ch
RI RIJLI, Filippo/AAP-2516-2020
OI RIJLI, Filippo/0000-0003-0515-0182; Arber, Silvia/0000-0002-6261-250X;
   Fajardo, Otto/0000-0002-3363-9287
FU Novartis Research Foundation; Deutsche ForschungsgemeinschaftGerman
   Research Foundation (DFG) [SFB 780]; Boehringer Ingelheim
   FondsBoehringer Ingelheim; Swiss National FondsSwiss National Science
   Foundation (SNSF); Max Planck SocietyMax Planck Society; VW
   foundationVolkswagen
FX We thank E. Callaway for AlstR:IRES:eGFP, K. Kawakami for Tol2
   transposon materials, R. Malinow for help with Sindbis virus and all
   Friedrich lab members for discussions. This work was supported by the
   Novartis Research Foundation, the Deutsche Forschungsgemeinschaft (SFB
   780), the Boehringer Ingelheim Fonds, the Swiss National Fonds, the Max
   Planck Society and the VW foundation.
CR Adamantidis AR, 2007, NATURE, V450, P420, DOI 10.1038/nature06310
   Arrenberg AB, 2009, P NATL ACAD SCI USA, V106, P17968, DOI 10.1073/pnas.0906252106
   Asakawa K, 2008, DEV GROWTH DIFFER, V50, P391, DOI [10.1111/j.1440-169x.2008.01044.x, 10.1111/j.1440-169X.2008.01044.x]
   Baier H, 2009, CURR OPIN NEUROBIOL, V19, P553, DOI 10.1016/j.conb.2009.08.001
   Baron U, 1997, NUCLEIC ACIDS RES, V25, P2723, DOI 10.1093/nar/25.14.2723
   Bochkov YA, 2006, BIOTECHNIQUES, V41, P283, DOI 10.2144/000112243
   Bockamp E, 2008, REGEN MED, V3, P217, DOI 10.2217/17460751.3.2.217
   Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Cambridge SB, 2009, NAT METHODS, V6, P527, DOI 10.1038/nmeth.1340
   Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5
   Distel M, 2009, P NATL ACAD SCI USA, V106, P13365, DOI 10.1073/pnas.0903060106
   Douglass AD, 2008, CURR BIOL, V18, P1133, DOI 10.1016/j.cub.2008.06.077
   Ehrengruber MU, 2002, MOL NEUROBIOL, V26, P183, DOI 10.1385/MN:26:2-3:183
   Emelyanov A, 2008, DEV BIOL, V320, P113, DOI 10.1016/j.ydbio.2008.04.042
   Esengil H, 2007, NAT CHEM BIOL, V3, P154, DOI 10.1038/nchembio858
   Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2
   FISCHER JA, 1988, NATURE, V332, P853, DOI 10.1038/332853a0
   Friedrich RW, 2001, SCIENCE, V291, P889, DOI 10.1126/science.291.5505.889
   Furuta T, 2001, J HISTOCHEM CYTOCHEM, V49, P1497, DOI 10.1177/002215540104901203
   Geisen MJ, 2008, PLOS BIOL, V6, P1178, DOI 10.1371/journal.pbio.0060142
   Gill RK, 1998, MOL ENDOCRINOL, V12, P57, DOI 10.1210/mend.12.1.0048
   GOSSEN M, 1992, P NATL ACAD SCI USA, V89, P5547, DOI 10.1073/pnas.89.12.5547
   Gradinaru V, 2009, SCIENCE, V324, P354, DOI 10.1126/science.1167093
   Higashijima S, 2003, J NEUROPHYSIOL, V90, P3986, DOI 10.1152/jn.00576.2003
   Huang CJ, 2005, DEV DYNAM, V233, P1294, DOI 10.1002/dvdy.20485
   Huber D, 2008, NATURE, V451, P61, DOI 10.1038/nature06445
   Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005
   Krestel HE, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e39
   Kwan KM, 2007, DEV DYNAM, V236, P3088, DOI 10.1002/dvdy.21343
   Li J, 2005, J NEUROSCI, V25, P5784, DOI 10.1523/JNEUROSCI.0922-05.2005
   Luo L, 2008, NEURON, V57, P634, DOI 10.1016/j.neuron.2008.01.002
   MATHIESON WB, 1988, J COMP PHYSIOL A, V163, P489, DOI 10.1007/BF00604903
   Mayford M, 1996, SCIENCE, V274, P1678, DOI 10.1126/science.274.5293.1678
   McLean DL, 2008, DEV NEUROBIOL, V68, P817, DOI 10.1002/dneu.20617
   Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100
   Orger MB, 2008, NAT NEUROSCI, V11, P327, DOI 10.1038/nn2048
   Park HC, 2000, DEV BIOL, V227, P279, DOI 10.1006/dbio.2000.9898
   Petreanu L, 2009, NATURE, V457, P1142, DOI 10.1038/nature07709
   Reboredo M, 2008, HUM GENE THER, V19, P1233, DOI 10.1089/hum.2008.057
   Rickgauer JP, 2009, P NATL ACAD SCI USA, V106, P15025, DOI 10.1073/pnas.0907084106
   Rink E, 2004, BRAIN RES, V1011, P206, DOI 10.1016/j.brainres.2004.03.027
   Scheer N, 1999, MECH DEVELOP, V80, P153, DOI 10.1016/S0925-4773(98)00209-3
   Schoenenberger P, 2008, BRAIN CELL BIOL, V36, P119, DOI 10.1007/s11068-008-9025-8
   Schonig Kai, 2003, Methods Mol Biol, V209, P69
   Scott EK, 2007, NAT METHODS, V4, P323, DOI 10.1038/NMETH1033
   Tabor R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001416
   Tan EM, 2006, NEURON, V51, P157, DOI 10.1016/j.neuron.2006.06.018
   Tang W, 2009, J NEUROSCI, V29, P8621, DOI 10.1523/JNEUROSCI.0359-09.2009
   Wagle M, 2004, J NEUROBIOL, V59, P57, DOI 10.1002/neu.10340
   Wickersham IR, 2007, NAT METHODS, V4, P47, DOI 10.1038/NMETH999
   Wullimann M. F., 1996, NEUROANATOMY ZEBRAFI, P1
   Wyart C, 2009, NATURE, V461, P407, DOI 10.1038/nature08323
   Yaksi E, 2006, NAT METHODS, V3, P377, DOI 10.1038/NMETH874
   Zerucha T, 2000, J NEUROSCI, V20, P709, DOI 10.1523/JNEUROSCI.20-02-00709.2000
   Zhang F, 2007, NAT REV NEUROSCI, V8, P577, DOI 10.1038/nrn2192
   Zhang YP, 2007, NAT METHODS, V4, P139, DOI 10.1038/nmeth988
   Zhu Z, 2002, SEMIN CELL DEV BIOL, V13, P121, DOI 10.1016/S1084-9521(02)00018-6
NR 58
TC 81
Z9 85
U1 0
U2 17
PU FRONTIERS RES FOUND
PI LAUSANNE
PA PO BOX 110, LAUSANNE, 1015, SWITZERLAND
SN 1662-5110
J9 FRONT NEURAL CIRCUIT
JI Front. Neural Circuits
PD DEC 11
PY 2009
VL 3
AR 21
DI 10.3389/neuro.04.021.2009
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA V16VF
UT WOS:000207896400001
PM 20126518
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Casagrande, F
   Harder, D
   Schenk, A
   Meury, M
   Ucurum, Z
   Engel, A
   Weitz, D
   Daniel, H
   Fotiadis, D
AF Casagrande, Fabio
   Harder, Daniel
   Schenk, Andreas
   Meury, Marcel
   Ucurum, Zohre
   Engel, Andreas
   Weitz, Dietmar
   Daniel, Hannelore
   Fotiadis, Dimitrios
TI Projection Structure of DtpD (YbgH), a Prokaryotic Member of the Peptide
   Transporter Family
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE membrane protein; peptide transport protein; structure; transmission
   electron microscopy; two-dimensional crystal
ID DIPEPTIDE-BINDING PROTEIN; IMAGE-PROCESSING LIBRARY; ESCHERICHIA-COLI;
   MEMBRANE-PROTEINS; OLIGOPEPTIDE TRANSPORTERS; SACCHAROMYCES-CEREVISIAE;
   SALMONELLA-TYPHIMURIUM; LACTOCOCCUS-LACTIS; ABC TRANSPORTERS; GENE
AB Cellular uptake of di- and tripeptides has been characterized in numerous organisms, and various transporters have been identified. In contrast, structural information on peptide transporters is very sparse. Here, we have cloned, overexpressed, purified, and biochemically characterized DtpD (YbgH) from Escherichia coli, a prokaryotic member of the peptide transporter family. Its homologues in mammals, PEPT1 (SLC15A1) and PEPT2 (SLC15A2), not only transport peptides but also are of relevance for uptake of drugs as they accept a large spectrum of peptidomimetics such as beta-lactam antibiotics, antivirals, peptidase inhibitors, and others as substrates. Uptake experiments indicated that DtpD functions as a canonical peptide transporter and is, therefore, a valid model for structural studies of this family of proteins. Blue native polyacrylamide gel electrophoresis, gel filtration, and transmission electron microscopy of single-DtpD particles suggest that the transporter exists in a monomeric form when solubilized in detergent. Two-dimensional crystallization of DtpD yielded first tubular crystals that allowed the determination of a projection structure at better than 19 angstrom resolution. This structure of DtpD represents the first structural view of a member of the peptide transporter family. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Harder, Daniel; Weitz, Dietmar; Daniel, Hannelore] Tech Univ Munich, Dept Food & Nutr, Mol Nutr Unit, D-85350 Freising Weihenstephan, Germany.
   [Casagrande, Fabio] Univ Calif San Diego, Dept Chem & Biochem, La Jolla, CA 92093 USA.
   [Schenk, Andreas; Engel, Andreas] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Meury, Marcel; Ucurum, Zohre; Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland.
   [Engel, Andreas] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
RP Daniel, H (corresponding author), Tech Univ Munich, Dept Food & Nutr, Mol Nutr Unit, Forum 5, D-85350 Freising Weihenstephan, Germany.
EM daniel@wzw.tum.de; dimitrios.fotiadis@mci.unibe.ch
RI Daniel, Hannelore/B-8982-2009
OI Harder, Daniel/0000-0003-4226-9748; Schenk, Andreas/0000-0001-9214-2505
FU Swiss National Foundation for Scientific ResearchSwiss National Science
   Foundation (SNSF) [31003A_125150/1]; ECEuropean CommissionEuropean
   Commission Joint Research CentreEuropean Community (EC) [502802]; Bern
   University Research Foundation; Novartis FoundationNovartis [08A10]
FX This work was supported by the Swiss National Foundation for Scientific
   Research (Grant 31003A_125150/1 to D.F.), the EC Project Grant 502802
   EUGINDAT (to D.F. and H.D.), the Bern University Research Foundation (to
   D.F. and Matthias Hediger), and the Novartis Foundation (Grant 08A10 to
   D.F.). We are very grateful to Manuel Palacin (University of Barcelona,
   Spain) for kindly providing the expression vectors of SteT and AdiC and
   to Heinz Gross and Peter Tittmann (ETH Zurich, Switzerland) for the
   unidirectional metal shadowing of tubular DtpD crystals.
CR ABOUHAMAD WN, 1991, MOL MICROBIOL, V5, P1035, DOI 10.1111/j.1365-2958.1991.tb01876.x
   Becker J. M., 1980, MICROORGANISMS NITRO, P257
   Biegel A, 2006, AMINO ACIDS, V31, P137, DOI 10.1007/s00726-006-0331-0
   Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200
   Covitz KMY, 1998, BIOCHEMISTRY-US, V37, P15214, DOI 10.1021/bi981128k
   Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005
   Daniel H, 2004, PFLUG ARCH EUR J PHY, V447, P610, DOI 10.1007/s00424-003-1101-4
   Detmers FJM, 2001, RES MICROBIOL, V152, P245, DOI 10.1016/S0923-2508(01)01196-2
   Doring F, 1998, J BIOL CHEM, V273, P23211, DOI 10.1074/jbc.273.36.23211
   Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200
   Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654
   Goh EB, 2004, J BACTERIOL, V186, P4019, DOI 10.1128/JB.186.12.4019-4024.2004
   Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321
   Hagting A, 1997, BIOCHEMISTRY-US, V36, P6777, DOI 10.1021/bi963068t
   HAGTING A, 1994, J BIOL CHEM, V269, P11391
   Harder D, 2008, FEBS J, V275, P3290, DOI 10.1111/j.1742-4658.2008.06477.x
   Hauser M, 2000, J BIOL CHEM, V275, P3037, DOI 10.1074/jbc.275.5.3037
   Hauser M, 2001, MOL MEMBR BIOL, V18, P105, DOI 10.1080/09687680117013
   HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435
   Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7
   HIGGINS CF, 1980, MICROORGANISMS NITRO, P609
   HILES ID, 1987, J MOL BIOL, V195, P125, DOI 10.1016/0022-2836(87)90332-9
   Hite RK, 2007, CURR OPIN STRUC BIOL, V17, P389, DOI 10.1016/j.sbi.2007.06.006
   KUHLBRANDT W, 1992, Q REV BIOPHYS, V25, P1
   Lubkowitz MA, 1998, MOL MICROBIOL, V28, P729, DOI 10.1046/j.1365-2958.1998.00827.x
   Lubkowitz MA, 1997, MICROBIOL-UK, V143, P387, DOI 10.1099/00221287-143-2-387
   Matthews D. M., 1987, CONTR INFUSION THER, V17, P6
   Meredith D, 2000, CELL MOL LIFE SCI, V57, P754, DOI 10.1007/s000180050040
   Nakajima H, 1997, APPL ENVIRON MICROB, V63, P2213, DOI 10.1128/AEM.63.6.2213-2217.1997
   Osawa H, 2006, BIOCHEM J, V393, P267, DOI 10.1042/BJ20050920
   PAULSEN IT, 1994, TRENDS BIOCHEM SCI, V19, P404, DOI 10.1016/0968-0004(94)90087-6
   PAYNE JW, 1994, ADV MICROB PHYSIOL, V36, P1, DOI 10.1016/S0065-2911(08)60176-9
   PERRY JR, 1994, MOL CELL BIOL, V14, P104, DOI 10.1128/MCB.14.1.104
   Philippsen A, 2003, J STRUCT BIOL, V144, P4, DOI 10.1016/j.jsb.2003.09.032
   Philippsen A, 2007, J STRUCT BIOL, V157, P28, DOI 10.1016/j.jsb.2006.06.009
   Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106
   Raunser S, 2006, BIOCHEMISTRY-US, V45, P12796, DOI 10.1021/bi061008+
   Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Smith MW, 1999, MICROBIOL-SGM, V145, P2891, DOI 10.1099/00221287-145-10-2891
   Stacey G, 2002, TRENDS PLANT SCI, V7, P257, DOI 10.1016/S1360-1385(02)02249-5
   Stahlberg H, 2001, FEBS LETT, V504, P166, DOI 10.1016/S0014-5793(01)02746-6
   STEINER HY, 1995, MOL MICROBIOL, V16, P825, DOI 10.1111/j.1365-2958.1995.tb02310.x
   Terada T, 2000, PFLUG ARCH EUR J PHY, V440, P679, DOI 10.1007/s004240000339
   Vinothkumar KR, 2006, J BIOL CHEM, V281, P4795, DOI 10.1074/jbc.M508993200
   Weitz D, 2007, J BIOL CHEM, V282, P2832, DOI 10.1074/jbc.M604866200
   Yen MR, 2001, MICROBIOL-SGM, V147, P2881, DOI 10.1099/00221287-147-11-2881
NR 47
TC 23
Z9 25
U1 1
U2 4
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD DEC 11
PY 2009
VL 394
IS 4
BP 708
EP 717
DI 10.1016/j.jmb.2009.09.048
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 530OT
UT WOS:000272602900012
PM 19782088
DA 2021-01-25
ER

PT J
AU Wirth, C
   Condemine, G
   Boiteux, C
   Berneche, S
   Schirmer, T
   Peneff, CM
AF Wirth, Christophe
   Condemine, Guy
   Boiteux, Celine
   Berneche, Simon
   Schirmer, Tilman
   Peneff, Caroline M.
TI NanC Crystal Structure, a Model for Outer-Membrane Channels of the
   Acidic Sugar-Specific KdgM Porin Family
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE KdgM family; outer-membrane channel; sialic acid; crystal structure
ID ESCHERICHIA-COLI; SIALIC-ACID; SALMONELLA-TYPHIMURIUM;
   MOLECULAR-DYNAMICS; EXPRESSION; MALTOPORIN; FIMB; TRANSLOCATION;
   SIMULATION; DIVERSITY
AB Sialic acids are acidic sugars present mostly on vertebrate cell surfaces, which can be metabolized by bacteria and act as an inflammation signal. N-Acetylneuraminic acid, the most abundant sialic acid, can enter into Escherichia coli K12 through NanC, an N-acetylneuraminic acid-inducible outer-membrane channel. With its 215 residues, NanC belongs to the family of small monomeric KdgM-related porins. KdgM homologues are found in gammaproteobacteria, including major plant and human pathogens, and together they define a large family of putative acidic sugar/oligosaccharide transporters, which are as yet poorly characterized. Here, we present the first high-resolution structure of a KdgM fan-Lily member. NanC folds into a 28-angstrom-high, 12-stranded beta-barrel, resembling the beta-domain of autotransporter NalP and defining an open pore with an average radius of 3.3 angstrom. The channel is lined by two strings of basic residues facing each other across the pore, a feature that appears largely conserved within the KdgM family and is likely to facilitate the diffusion of acidic oligosaccharides. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Wirth, Christophe; Schirmer, Tilman; Peneff, Caroline M.] Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
   [Condemine, Guy] Univ Lyon, F-69003 Lyon, France.
   [Condemine, Guy] Univ Lyon 1, F-69622 Villeurbanne, France.
   [Condemine, Guy] Inst Natl Sci Appl, F-69621 Villeurbanne, France.
   [Condemine, Guy] CNRS, UMR5240, F-75700 Paris, France.
   [Boiteux, Celine; Berneche, Simon] Univ Basel, Swiss Inst Bioinformat, Biozentrum, CH-4056 Basel, Switzerland.
RP Peneff, CM (corresponding author), Univ Basel, Dept Biol Struct, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM caroline.peneff@unibas.ch
RI Berneche, Simon/L-6389-2013
OI Berneche, Simon/0000-0002-6274-4094; Wirth,
   Christophe/0000-0001-8864-6508; Condemine, Guy/0000-0002-3256-3815
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100AO-105587, 118928]
FX We would like to thank Zora Markovic-Housley and Claudia Massa for
   critical reading of the manuscript, Arnaud Basle for his generous
   support and helpful discussion, and the Swiss Light Source (Villigen,
   Switzerland) for their excellent facilities. This work has been
   supported by a Swiss National Science Foundation grant number
   3100AO-105587 to T.S. and in part by a grant from the Swiss National
   Science Foundation to S. B. (SNF-Professorship #118928).
CR Abbott DW, 2008, MICROBIOL MOL BIOL R, V72, P301, DOI 10.1128/MMBR.00038-07
   Abrahams JP, 1996, ACTA CRYSTALLOGR D, V52, P30, DOI 10.1107/S0907444995008754
   Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Basle A, 2006, J MOL BIOL, V362, P933, DOI 10.1016/j.jmb.2006.08.002
   Biswas S, 2008, STRUCTURE, V16, P1027, DOI 10.1016/j.str.2008.04.009
   Biswas S, 2007, NAT STRUCT MOL BIOL, V14, P1108, DOI 10.1038/nsmb1304
   Blot N, 2002, J BIOL CHEM, V277, P7936, DOI 10.1074/jbc.M109193200
   Bricogne G, 2003, ACTA CRYSTALLOGR D, V59, P2023, DOI 10.1107/S0907444903017694
   Brooks BR, 2009, J COMPUT CHEM, V30, P1545, DOI 10.1002/jcc.21287
   Chang DE, 2004, P NATL ACAD SCI USA, V101, P7427, DOI 10.1073/pnas.0307888101
   Condemine G, 2005, J BACTERIOL, V187, P1959, DOI 10.1128/JB.187.6.1959-1965.2005
   Condemine G, 2007, J BACTERIOL, V189, P5955, DOI 10.1128/JB.00218-07
   COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0
   Cowtan K, 1994, JOINT CCP4 ESF EACBM, V31, P34
   Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216
   Delcour AH, 2003, FRONT BIOSCI-LANDMRK, V8, pD1055, DOI 10.2741/1132
   Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x
   Dutzler R, 1996, STRUCTURE, V4, P127, DOI 10.1016/S0969-2126(96)00016-0
   Dutzler R, 1999, STRUCT FOLD DES, V7, P425, DOI 10.1016/S0969-2126(99)80055-0
   El-Labany S, 2003, MOL MICROBIOL, V49, P1109, DOI 10.1046/j.1365-2958.2003.03624.x
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   EVENS PR, 2005, ACTA CRYSTALLOGR D, V62, P72
   Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215
   Forst D, 1998, NAT STRUCT BIOL, V5, P37, DOI 10.1038/nsb0198-37
   Hearn EM, 2008, P NATL ACAD SCI USA, V105, P8601, DOI 10.1073/pnas.0801264105
   Hirsch A, 1997, FEBS LETT, V404, P208, DOI 10.1016/S0014-5793(97)00131-2
   HUMPHREY W, 1999, BIOINFORMATICS, V15, P305
   Im W, 2003, BIOPHYS J, V85, P2900, DOI 10.1016/S0006-3495(03)74712-2
   Im WP, 2003, J COMPUT CHEM, V24, P1691, DOI 10.1002/jcc.10321
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   KREUSCH A, 1994, J MOL BIOL, V243, P891, DOI 10.1006/jmbi.1994.1690
   LESLIE AGW, 1992, JOINT CCP4 ESF EACBM, V4, P27
   Mackerell AD, 2004, J COMPUT CHEM, V25, P1400, DOI 10.1002/jcc.20065
   MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f
   MANZI AE, 1994, J BIOL CHEM, V269, P23617
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   Meyer JEW, 1997, J MOL BIOL, V266, P761, DOI 10.1006/jmbi.1996.0823
   Moraes TF, 2007, NAT STRUCT MOL BIOL, V14, P85, DOI 10.1038/nsmb1189
   NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407
   NIKAIDO H, 1981, J GEN PHYSIOL, V77, P121, DOI 10.1085/jgp.77.2.121
   NIKAIDO H, 1983, J BACTERIOL, V153, P241, DOI 10.1128/JB.153.1.241-252.1983
   Nikaido H, 2003, MICROBIOL MOL BIOL R, V67, P593, DOI 10.1128/MMBR.67.4.593-656.2003
   Oomen CJ, 2004, EMBO J, V23, P1257, DOI 10.1038/sj.emboj.7600148
   Pellinen T, 2003, BIOCHEM J, V372, P329, DOI 10.1042/BJ20030027
   Pratt LA, 1996, MOL MICROBIOL, V20, P911, DOI 10.1111/j.1365-2958.1996.tb02532.x
   Prilipov A, 1998, FEMS MICROBIOL LETT, V163, P65, DOI 10.1016/S0378-1097(98)00151-7
   Rodionov DA, 2004, MICROBIOL-SGM, V150, P3571, DOI 10.1099/mic.0.27041-0
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Schirmer T, 1999, J MOL BIOL, V294, P1159, DOI 10.1006/jmbi.1999.3326
   SCHIRMER T, 1995, SCIENCE, V267, P512, DOI 10.1126/science.7824948
   Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1
   Schulz GE, 1993, CURR OPIN CELL BIOL, V5, P701, DOI 10.1016/0955-0674(93)90143-E
   Severi E, 2008, J BIOL CHEM, V283, P4841, DOI 10.1074/jbc.M707822200
   Signorell GA, 2007, J STRUCT BIOL, V160, P395, DOI 10.1016/j.jsb.2007.08.007
   SMART OS, 1993, BIOPHYS J, V65, P2455, DOI 10.1016/S0006-3495(93)81293-1
   Sohanpal BK, 2007, MOL MICROBIOL, V63, P1223, DOI 10.1111/j.1365-2958.2006.05583.x
   Sohanpal BK, 2004, P NATL ACAD SCI USA, V101, P16322, DOI 10.1073/pnas.0405821101
   Subbarao GV, 2006, J MOL BIOL, V360, P750, DOI 10.1016/j.jmb.2006.05.045
   van den Berg B, 2004, SCIENCE, V304, P1506, DOI 10.1126/science.1097524
   Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004
   WEISS MS, 1991, SCIENCE, V254, P1627, DOI 10.1126/science.1721242
   Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736
   Ye JQ, 2004, EMBO J, V23, P3187, DOI 10.1038/sj.emboj.7600330
   Yildiz O, 2006, EMBO J, V25, P3702, DOI 10.1038/sj.emboj.7601237
   Zeth K, 2000, STRUCTURE, V8, P981, DOI 10.1016/S0969-2126(00)00189-1
NR 66
TC 26
Z9 27
U1 0
U2 14
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD DEC 11
PY 2009
VL 394
IS 4
BP 718
EP 731
DI 10.1016/j.jmb.2009.09.054
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 530OT
UT WOS:000272602900013
PM 19796645
DA 2021-01-25
ER

PT J
AU Izergina, N
   Balmer, J
   Bello, B
   Reichert, H
AF Izergina, Natalya
   Balmer, Jasmin
   Bello, Bruno
   Reichert, Heinrich
TI Postembryonic development of transit amplifying neuroblast lineages in
   the Drosophila brain
SO NEURAL DEVELOPMENT
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; ASYMMETRIC CELL-DIVISION; GANGLION MOTHER CELLS;
   LATE LARVAL STAGE; PROLIFERATION; NEUROGENESIS; MELANOGASTER;
   ARCHITECTURE; PATTERN; ORGANIZATION
AB Background: Specific dorsomedial (DM) neuroblast lineages of the Drosophila brain amplify their proliferation through generation of transit amplifying intermediate progenitor cells. Together, these DM neuroblast lineages comprise over 5,000 adult-specific neural cells and thus represent a substantial part of the brain. However, no information is currently available about the structure or function of any of the neural cells in these DM lineages. In this report we use MARCM-based clonal analysis together with immunocytochemical labeling techniques to investigate the type and fate of neural cells generated in the DM lineages.
   Results: Genetic cell lineage-tracing and immunocytochemical marker analysis reveal that DM neuroblasts are multipotent progenitors that produce a set of postembryonic brain glia as well as a large number of adult-specific protocerebral neurons. During larval development the adult-specific neurons of each DM lineage form several spatially separated axonal fascicles, some of which project along larval brain commissural structures that are primordia of midline neuropile. By taking advantage of a specific Gal4 reporter line, the DM-derived neuronal cells can be identified and followed into early pupal stages. During pupal development the neurons of the DM lineages arborize in many parts of the brain and contribute to neuropile substructures of the developing central complex, such as the fan-shaped body, noduli and protocerebral bridge.
   Conclusions: Our findings provide cellular and molecular evidence for the fact that DM neuroblasts are multipotent progenitors; thus, they represent the first identified progenitor cells in the fly brain that have neuroglioblast functions during postembryonic development. Moreover, our results demonstrate that the adult-specific neurons of the DM lineages arborize widely in the brain and also make a major contribution to the developing central complex. These findings suggest that the amplification of proliferation that characterizes DM lineages may be an important requirement for generating the large number of neurons required in highly complex neuropile structures such as the central complex in the Drosophila brain.
C1 [Izergina, Natalya; Balmer, Jasmin; Bello, Bruno; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Izergina, N (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM natalya.izergina@stud.unibas.ch; jasmin.balmer@stud.unibas.ch;
   bruno.bello@unibas.ch; heinrich.reichert@unibas.ch
FU Swiss NSFSwiss National Science Foundation (SNSF)
FX We thank A Brand, B Egger, V Rodrigues, the Bloomington Stock Center and
   the DSHB for strains and/or antibodies. We also thank all members of the
   Reichert lab for discussions and assistance. This work was supported by
   a grant from the Swiss NSF to HR.
CR Akiyama-Oda Y, 1999, DEVELOPMENT, V126, P1967
   [Anonymous], IMAGE PROCESSING ANA
   Awasaki T, 2008, J NEUROSCI, V28, P13742, DOI 10.1523/JNEUROSCI.4844-08.2008
   Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429
   Bello B, 2007, DEVELOPMENT, V134, P1091, DOI 10.1242/dev.02793
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004
   Boyan GS, 2008, ARTHROPOD STRUCT DEV, V37, P539, DOI 10.1016/j.asd.2008.07.005
   Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   Dumstrei K, 2003, J COMP NEUROL, V455, P451, DOI 10.1002/cne.10484
   Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011
   HANESCH U, 1989, CELL TISSUE RES, V257, P343, DOI 10.1007/BF00261838
   Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1
   Ito K, 2008, ADV EXP MED BIOL, V628, P137, DOI 10.1007/978-0-387-78261-4_9
   Karcavich RE, 2005, DEV DYNAM, V232, P609, DOI 10.1002/dvdy.20273
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Loesel R, 2002, ARTHROPOD STRUCT DEV, V31, P77, DOI 10.1016/S1467-8039(02)00017-8
   Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956
   Pereanu W, 2005, DEV BIOL, V283, P191, DOI 10.1016/j.ydbio.2005.04.024
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   PROKOP A, 1991, DEVELOPMENT, V111, P79
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   Strausfeld NJ, 2009, P ROY SOC B-BIOL SCI, V276, P1929, DOI 10.1098/rspb.2008.1471
   Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371
   Urbach R, 2004, BIOESSAYS, V26, P739, DOI 10.1002/bies.20062
   Zheng XY, 2006, EMBO J, V25, P615, DOI 10.1038/sj.emboj.7600962
   Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002
NR 31
TC 76
Z9 77
U1 0
U2 3
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1749-8104
J9 NEURAL DEV
JI Neural Dev.
PD DEC 11
PY 2009
VL 4
AR 44
DI 10.1186/1749-8104-4-44
PG 13
WC Developmental Biology; Neurosciences
SC Developmental Biology; Neurosciences & Neurology
GA 539UC
UT WOS:000273282900001
PM 20003348
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Sturgill, TW
   Hall, MN
AF Sturgill, Thomas W.
   Hall, Michael N.
TI Activating Mutations in TOR Are in Similar Structures As Oncogenic
   Mutations in PI3KC alpha
SO ACS CHEMICAL BIOLOGY
LA English
DT Article
ID MAMMALIAN TARGET; PHOSPHOINOSITIDE 3-KINASE; PROTEIN-KINASE; RAPAMYCIN
   MTOR; HUMAN CANCER; GROWTH; INHIBITOR; MUTANT; DOMAIN; YEAST
AB TOR (Target of Rapamycin) is a highly conserved Ser/Thr kinase and a central controller of cell growth. Using the crystal structure of the related lipid kinase PI3KC gamma, we built a model of the catalytic region of TOR, from the FAT domain to near the end of the FATC domain. The model reveals that activating mutations in TOR, identified in yeast in a genetic selection for Rheb-independence, correspond to hotspots for oncogenic mutations in PI3KC alpha. The activating mutations are in the catalytic domain (helices k alpha 3, k alpha 9, k alpha 11) and the helical domain of TOR. Docking studies with small molecule inhibitors (PP242, NVP-BEZ235, and Ku-0063794) show that drugs currently In development utilize a novel pharmacophore space to achieve specificity. Thus, our model provides insight on the regulation of TOR and may be useful in the design of new anticancer drugs.
C1 [Sturgill, Thomas W.] Univ Virginia, Dept Pharmacol, Hlth Sci Ctr, Charlottesville, VA 22908 USA.
   [Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Sturgill, TW (corresponding author), Univ Virginia, Dept Pharmacol, Hlth Sci Ctr, Charlottesville, VA 22908 USA.
EM tws7w@virginia.edu
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [DK052753]; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF);
   Swiss Cancer League; Canton of Basel; NATIONAL INSTITUTE OF DIABETES AND
   DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK067629,
   R01DK052753, R01DK052753, P30DK067629, P30DK067629, P30DK067629,
   R01DK052753, P30DK067629, P30DK067629, R01DK052753, R01DK052753,
   R01DK052753, P30DK067629, P30DK067629, R01DK052753, P30DK067629,
   R01DK052753, R01DK052753, P30DK067629, P30DK067629, P30DK067629,
   P30DK067629, P30DK067629, P30DK067629, P30DK067629, P30DK067629,
   P30DK067629, R01DK052753, P30DK067629, R01DK052753, R01DK052753,
   R01DK052753, P30DK067629, P30DK067629, P30DK067629, P30DK067629,
   R01DK052753, R01DK052753] Funding Source: NIH RePORTER
FX We especially thank Ruth Huey (Scripps), Nicolas Guex (Swiss
   Bioinformatics Institute), Jo-anne Pinson (Monash University), Sabita
   Sankar (CeliGene), and Ruth Brenk (University of Dundee) for their help
   with the model. We thank Tim Macdonald (University of Virginia) for
   helpful discussions. We acknowledge support from the National Institutes
   of Health (DK052753) (T.W.S.) and from the Swiss National Science
   Foundation, the Swiss Cancer League, and the Canton of Basel (M.N.H.).
CR Abraham RT, 2004, DNA REPAIR, V3, P883, DOI 10.1016/j.dnarep.2004.04.002
   Apsel B, 2008, NAT CHEM BIOL, V4, P691, DOI 10.1038/nchembio.117
   Blasina A, 1999, CURR BIOL, V9, P1135, DOI 10.1016/S0960-9822(99)80486-2
   Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197
   Brachmann S, 2009, CURR OPIN CELL BIOL, V21, P194, DOI 10.1016/j.ceb.2008.12.011
   Buzko OV, 2002, J COMPUT AID MOL DES, V16, P113, DOI 10.1023/A:1016366013656
   Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]
   Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014
   Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200
   Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216
   deHart AKA, 2003, MOL BIOL CELL, V14, P4676, DOI 10.1091/mbc.E03-05-0323
   DeLano W.L., 2009, PYMOL MOL GRAPHICS S
   Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738
   Fan QW, 2006, CANCER CELL, V9, P341, DOI 10.1016/j.ccr.2006.03.029
   Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038
   Garcia-Martinez JM, 2009, BIOCHEM J, V421, P29, DOI 10.1042/BJ20090489
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x
   Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809
   Holz MK, 2005, J BIOL CHEM, V280, P26089, DOI 10.1074/jbc.M504045200
   Huang CH, 2007, SCIENCE, V318, P1744, DOI 10.1126/science.1150799
   Johnson DA, 2001, CHEM REV, V101, P2243, DOI 10.1021/cr000226k
   Lempiainen H, 2009, EMBO J, V28, P3067, DOI 10.1038/emboj.2009.281
   Maira SM, 2008, MOL CANCER THER, V7, P1851, DOI 10.1158/1535-7163.MCT-08-0017
   Mandelker D, 2009, P NATL ACAD SCI USA, V106, P16996, DOI 10.1073/pnas.0908444106
   Marone R, 2008, BBA-PROTEINS PROTEOM, V1784, P159, DOI 10.1016/j.bbapap.2007.10.003
   Mordes DA, 2008, CELL CYCLE, V7, P2809, DOI 10.4161/cc.7.18.6689
   Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208
   Morris Garrett M, 2008, Curr Protoc Bioinformatics, VChapter 8, DOI 10.1002/0471250953.bi0814s24
   Morris GM, 2009, J COMPUT CHEM, V30, P2785, DOI 10.1002/jcc.21256
   Nowak P, 2009, J MED CHEM, V52, P7081, DOI 10.1021/jm9012642
   Ohne Y, 2008, J BIOL CHEM, V283, P31861, DOI 10.1074/jbc.M801546200
   Pacold ME, 2000, CELL, V103, P931, DOI 10.1016/S0092-8674(00)00196-3
   Peterson RT, 2000, J BIOL CHEM, V275, P7416, DOI 10.1074/jbc.275.10.7416
   Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200
   Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014
   Samuels Y, 2004, SCIENCE, V304, P554, DOI 10.1126/science.1096502
   Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679
   Sturgill TW, 2007, NAT CELL BIOL, V9, P1221, DOI 10.1038/ncb1107-1221
   Sun YL, 2007, MOL CELL BIOL, V27, P8502, DOI 10.1128/MCB.01382-07
   Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200
   Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104
   Walker EH, 2000, MOL CELL, V6, P909, DOI 10.1016/S1097-2765(05)00089-4
   Walker EH, 1999, NATURE, V402, P313, DOI 10.1038/46319
   Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 46
TC 29
Z9 29
U1 0
U2 2
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1554-8929
EI 1554-8937
J9 ACS CHEM BIOL
JI ACS Chem. Biol.
PD DEC
PY 2009
VL 4
IS 12
BP 999
EP 1015
DI 10.1021/cb900193e
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 533SS
UT WOS:000272845900005
PM 19902965
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Imer, R
   Akiyama, T
   de Rooij, NF
   Stolz, M
   Aebi, U
   Friederich, NF
   Staufer, U
AF Imer, Raphael
   Akiyama, Terunobu
   de Rooij, Nico F.
   Stolz, Martin
   Aebi, Ueli
   Friederich, Niklaus F.
   Staufer, Urs
TI The measurement of biomechanical properties of porcine articular
   cartilage using atomic force microscopy
SO ARCHIVES OF HISTOLOGY AND CYTOLOGY
LA English
DT Article
ID ELASTIC-MODULUS; OSTEOARTHRITIS; INDENTATION; MRI
AB We have recently demonstrated that indentation-type atomic force microscopy (IT-AFM) is capable of detecting early onset osteoarthritis (OA) (Stolz, 2009). This study was based on biopsies, using a desk-top commercial atomic force microscope (AFM). However, cartilage analysis in the knee joints needs to be non-destructive to avoid new seeding points for OA by the taking of biopsies. This requires bringing the probe tip in contact with the articular cartilage (AC) surface inside the joint. Here we present our recent progress towards a medical instrument for performing such IT-AFM measurements for in-vivo knee diagnostics. The scanning force arthroscope (SFA) integrates a miniaturized AFM into a standard arthroscopic sleeve, and is used for direct, quantitative, in situ inspection of AC (Imer et al., 2006). The stabilization and the positioning of the instrument relative to the surface under investigation were performed by means of eight inflatable balloons. An integrated three-dimensional, piezoelectric scanner allowed raster scanning and probing of a small area of cartilage around the point of insertion. An AFM probe with an integrated deflection sensor was mounted at the distal end of the instrument. Using this instrument, several measurements were performed on agarose gel and on porcine cartilage samples. The load-displacement curves obtained were analyzed and the dynamic elastic moduli vertical bar E*vertical bar were calculated. A good correlation between these values and those published in the scientific literature was found. Therefore, we concluded that the SFA can provide quantitative measurements to detect early pathological changes in OA.
C1 [Imer, Raphael] Centredoc, CH-2002 Neuchatel, Switzerland.
   [Imer, Raphael; Akiyama, Terunobu; de Rooij, Nico F.] Ecole Polytech Fed Lausanne, SAMLAB, Neuchatel, Switzerland.
   [Stolz, Martin] Univ Southampton, Sch Engn Sci, Bioengn Sci Res Grp, Southampton SO9 5NH, Hants, England.
   [Stolz, Martin; Aebi, Ueli] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
   [Friederich, Niklaus F.] Kantonsspital Bruderholz Basel, Dept Orthopaed Surg & Traumatol, Basel, Switzerland.
   [Staufer, Urs] Delft Univ Technol, Micro & Nano Engn Lab, Fac 3mE, Delft, Netherlands.
RP Imer, R (corresponding author), Centredoc, Jaquet Droz 1,Case Postale 526, CH-2002 Neuchatel, Switzerland.
EM rimer@centredoc.ch
RI Staufer, Urs/J-6866-2016
OI Staufer, Urs/0000-0002-3519-6467
FU NCCR Nanoscale Science of the Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); la Republique et Canton de Neuchatel
FX This work was financially supported by NCCR Nanoscale Science of the
   Swiss National Science Foundation and la Republique et Canton de
   Neuchatel.
CR Aigner T, 2009, NAT NANOTECHNOL, V4, P144, DOI 10.1038/nnano.2009.29
   Burstein D, 2006, OSTEOARTHR CARTILAGE, V14, P1087, DOI 10.1016/j.joca.2006.07.001
   Chen QS, 2004, J BIOMECH ENG-T ASME, V126, P666, DOI 10.1115/1.1797991
   GAUTSCH S, 2002, THESIS U NEUCHATEL
   Hattori K, 2004, CLIN BIOMECH, V19, P213, DOI 10.1016/j.clinbiomech.2003.11.005
   Hertz H., 1882, J REINE ANGEW MATH, V92, P156, DOI [DOI 10.1515/CRLL.1882.92.156, 10.1515/crll.1882.92.156]
   Hug TS, 2005, TRANSDUCERS '05, DIGEST OF TECHNICAL PAPERS, VOLS 1 AND 2, P1191
   Ikai A, 2008, WORLD OF NANO-BIOMECHANICS: MECHANICAL IMAGING AND MEASUREMENT BY ATOMIC FORCE MICROSCOPY, P1
   Imer R, 2006, JPN J APPL PHYS 1, V45, P2319, DOI 10.1143/JJAP.45.2319
   Kleemann RU, 2005, OSTEOARTHR CARTILAGE, V13, P958, DOI 10.1016/j.joca.2005.06.008
   LANGER R, 1993, SCIENCE, V260, P920, DOI 10.1126/science.8493529
   Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011
   Marsano A, 2006, BIOMATERIALS, V27, P5927, DOI 10.1016/j.biomaterials.2006.08.020
   OLIVER WC, 1992, J MATER RES, V7, P1564, DOI 10.1557/JMR.1992.1564
   PARRAT D, 2007, THESIS U NEUCHATEL
   Qazi AA, 2007, OSTEOARTHR CARTILAGE, V15, P1199, DOI 10.1016/j.joca.2007.03.016
   Saarakkala S, 2003, OSTEOARTHR CARTILAGE, V11, P697, DOI 10.1016/S1063-4584(03)00154-7
   Shepherd DET, 1997, P I MECH ENG H, V211, P155, DOI 10.1243/0954411971534278
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   Stolz M, 2009, NAT NANOTECHNOL, V4, P186, DOI [10.1038/nnano.2008.410, 10.1038/NNANO.2008.410]
   Thalhammer S, 1997, J STRUCT BIOL, V119, P232, DOI 10.1006/jsbi.1997.3869
   Vanlandingham MR, 1997, J MATER SCI LETT, V16, P117, DOI 10.1023/A:1018533708655
   Vlassak JJ, 2003, J MECH PHYS SOLIDS, V51, P1701, DOI 10.1016/S0022-5096(03)00066-8
NR 23
TC 12
Z9 12
U1 0
U2 14
PU INT SOC HISTOLOGY & CYTOLOGY
PI NIIGATA
PA C/O DIV MICROSCOPIC ANAT&BIO-IMAGING, NIIGATA UNIV GRAD SCH MED & DENTAL
   SCI, 1-757 ASAHIMACHI-DORI, NIIGATA, CHUO-KU 951-8510, JAPAN
SN 0914-9465
EI 1349-1717
J9 ARCH HISTOL CYTOL
JI Arch. Histol. Cytol.
PD DEC
PY 2009
VL 72
IS 4-5
SI SI
BP 251
EP 259
DI 10.1679/aohc.72.251
PG 9
WC Cell Biology
SC Cell Biology
GA V16PA
UT WOS:000207880300007
PM 21471660
OA Bronze
DA 2021-01-25
ER

PT J
AU Hilbert, M
   Karow, AR
   Klostermeier, D
AF Hilbert, Manuel
   Karow, Anne R.
   Klostermeier, Dagmar
TI The mechanism of ATP-dependent RNA unwinding by DEAD box proteins
SO BIOLOGICAL CHEMISTRY
LA English
DT Review
DE ATP hydrolysis; conformational changes; coupling; helicase; protein
   dynamics; RNA duplex destabilization
ID ESCHERICHIA-COLI DBPA; INITIATION-FACTOR 4A; C-TERMINAL DOMAIN; JUNCTION
   CORE COMPLEX; HELICASE-LIKE DOMAIN; 23S RIBOSOMAL-RNA;
   CRYSTAL-STRUCTURE; TRANSLATION-INITIATION; THERMUS-THERMOPHILUS;
   NUCLEOTIDE-BINDING
AB DEAD box proteins catalyze the ATP-dependent unwinding of double-stranded RNA (dsRNA). In addition, they facilitate protein displacement and remodeling of RNA or RNA/protein complexes. Their hallmark feature is local destabilization of RNA duplexes. Here, we summarize current data on the DEAD box protein mechanism and present a model for RNA unwinding that integrates recent data on the effect of ATP analogs and mutations on DEAD box protein activity. DEAD box proteins share a conserved helicase core with two flexibly linked RecA-like domains that contain all helicase signature motifs. Variable flanking regions contribute to substrate binding and modulate activity. In the presence of ATP and RNA, the helicase core adopts a compact, closed conformation with extensive interdomain contacts and high affinity for RNA. In the closed conformation, the RecA-like domains form a catalytic site for ATIP hydrolysis and a continuous RNA binding site. A kink in the backbone of the bound RNA locally destabilizes the duplex. Rearrangement of this initial complex generates a hydrolysis and unwinding-competent state. From this complex, the first RNA strand can dissociate. After ATIP hydrolysis and phosphate release, the DEAD box protein returns to a low-affinity state for RNA. Dissociation of the second RNA strand and reopening of the cleft in the helicase core allow for further catalytic cycles.
C1 [Hilbert, Manuel; Karow, Anne R.; Klostermeier, Dagmar] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@unibas.ch
FU VolkswagenstiftungVolkswagen; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); Verband der Chemischen Industrie;
   European Molecular Biology OrganizationEuropean Molecular Biology
   Organization (EMBO); Roche Research Foundation
FX Work on the DEAD box protein mechanism in the authors' laboratory was
   funded by the Volkswagenstiftung (D.K.), the Swiss National Science
   Foundation (D.K.), the Verband der Chemischen Industrie (M.H.), the
   European Molecular Biology Organization (M.H.), and the Roche Research
   Foundation (M.H.).
CR ABRAMSON RD, 1987, J BIOL CHEM, V262, P3826
   Ahmadian MR, 1997, NAT STRUCT BIOL, V4, P686, DOI 10.1038/nsb0997-686
   Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981
   Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895
   Ballut L, 2005, NAT STRUCT MOL BIOL, V12, P861, DOI 10.1038/nsmb990
   Banroques J, 2008, MOL CELL BIOL, V28, P3359, DOI 10.1128/MCB.01555-07
   Bellsolell L, 2006, STRUCTURE, V14, P913, DOI 10.1016/j.str.2006.03.012
   Bizebard T, 2004, BIOCHEMISTRY-US, V43, P7857, DOI 10.1021/bi049852s
   Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006
   Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080
   Chen YF, 2008, P NATL ACAD SCI USA, V105, P20203, DOI 10.1073/pnas.0811075106
   Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905
   Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200
   CONFALONIERI F, 1993, P NATL ACAD SCI USA, V90, P4753, DOI 10.1073/pnas.90.10.4753
   Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019
   Cordin O, 2004, EMBO J, V23, P2478, DOI 10.1038/sj.emboj.7600272
   Del Campo M, 2007, MOL CELL, V28, P159, DOI 10.1016/j.molcel.2007.07.028
   Del Campo M, 2009, MOL CELL, V35, P598, DOI 10.1016/j.molcel.2009.07.032
   Diges CM, 2005, BIOCHEMISTRY-US, V44, P7903, DOI 10.1021/bi050033x
   Diges CM, 2001, EMBO J, V20, P5503, DOI 10.1093/emboj/20.19.5503
   Du MX, 2002, BIOCHEM J, V363, P147, DOI 10.1042/0264-6021:3630147
   Duany YD, 2008, NUCLEIC ACIDS RES, V36, P5882, DOI 10.1093/nar/gkn587
   Elles LM, 2008, NUCLEIC ACIDS RES, V36, P41, DOI 10.1093/nar/gkm926
   Fairman ME, 2004, SCIENCE, V304, P730, DOI 10.1126/science.1095596
   Fan JS, 2009, J MOL BIOL, V388, P1, DOI 10.1016/j.jmb.2009.03.004
   Flaus A, 2001, CURR OPIN GENET DEV, V11, P148, DOI 10.1016/S0959-437X(00)00172-6
   Franca R, 2007, PROTEINS, V67, P1128, DOI 10.1002/prot.21433
   FULLERPACE FV, 1993, EMBO J, V12, P3619, DOI 10.1002/j.1460-2075.1993.tb06035.x
   Garcia I, 2008, BIOCHEMISTRY-US, V47, P12562, DOI 10.1021/bi8016119
   GORBALENYA AE, 1991, FEBS LETT, V291, P277, DOI 10.1016/0014-5793(91)81301-N
   GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2
   GOSS DJ, 1987, BIOCHEMISTRY-US, V26, P1551, DOI 10.1021/bi00380a009
   Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472
   Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083
   Henn A, 2002, J BIOL CHEM, V277, P46559, DOI 10.1074/jbc.M207438200
   Henn A, 2001, P NATL ACAD SCI USA, V98, P5007, DOI 10.1073/pnas.071372498
   Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046
   Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050
   Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101
   Iost I, 1999, J BIOL CHEM, V274, P17677, DOI 10.1074/jbc.274.25.17677
   Jankowsky E, 2000, NATURE, V403, P447, DOI 10.1038/35000239
   Karginov FV, 2005, J BIOL CHEM, V280, P35499, DOI 10.1074/jbc.M506815200
   Karow AR, 2007, FEBS J, V274, P463, DOI 10.1111/j.1742-4658.2006.05593.x
   Karow AR, 2009, NUCLEIC ACIDS RES, V37, P4464, DOI 10.1093/nar/gkp397
   Kaye NM, 2009, J BIOL CHEM, V284, P17742, DOI 10.1074/jbc.M109.009001
   Klostermeier D, 2009, NUCLEIC ACIDS RES, V37, P421, DOI 10.1093/nar/gkn947
   Korneeva NL, 2005, J BIOL CHEM, V280, P1872, DOI 10.1074/jbc.M406168200
   Kossen K, 2002, J MOL BIOL, V324, P625, DOI 10.1016/S0022-2836(02)01140-3
   Kossen K, 1999, NUCLEIC ACIDS RES, V27, P3811, DOI 10.1093/nar/27.19.3811
   Le Hir H, 2000, EMBO J, V19, P6860, DOI 10.1093/emboj/19.24.6860
   Leipe DD, 2003, J MOL BIOL, V333, P781, DOI 10.1016/j.jmb.2003.08.040
   Linden MH, 2008, NUCLEIC ACIDS RES, V36, P5800, DOI 10.1093/nar/gkn581
   LINDER P, 1989, NATURE, V337, P121, DOI 10.1038/337121a0
   Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468
   Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106
   Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g
   Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319
   Low WK, 2007, CHEM BIOL, V14, P715, DOI 10.1016/j.chembiol.2007.05.012
   Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005
   Marintchev A, 2009, CELL, V136, P447, DOI 10.1016/j.cell.2009.01.014
   Mohr G, 2008, J MOL BIOL, V375, P1344, DOI 10.1016/j.jmb.2007.11.041
   Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7
   Morlang S, 1999, J MOL BIOL, V294, P795, DOI 10.1006/jmbi.1999.3282
   Napetschnig J, 2009, P NATL ACAD SCI USA, V106, P3089, DOI 10.1073/pnas.0813267106
   NICOL SM, 1995, P NATL ACAD SCI USA, V92, P11681, DOI 10.1073/pnas.92.25.11681
   Nielsen KH, 2009, RNA, V15, P67, DOI 10.1261/rna.1283109
   Oberer M, 2005, GENE DEV, V19, P2212, DOI 10.1101/gad.1335305
   Ohnishi S, 2009, PROTEINS, V74, P133, DOI 10.1002/prot.22138
   PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789
   PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x
   Peck ML, 1999, RNA, V5, P1210, DOI 10.1017/S1355838299990817
   Peck ML, 2003, RNA, V9, P1180, DOI 10.1261/rna.2103703
   Polach KJ, 2002, BIOCHEMISTRY-US, V41, P3693, DOI 10.1021/bi012062n
   Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908
   Rajkowitsch L, 2007, RNA BIOL, V4, P118, DOI 10.4161/rna.4.3.5445
   Rodriguez AC, 2003, BIOCHEMISTRY-US, V42, P5993, DOI 10.1021/bi034188l
   Rodriguez AC, 2002, J BIOL CHEM, V277, P29865, DOI 10.1074/jbc.M202853200
   Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418
   Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236
   Rogers GW, 2002, PROG NUCLEIC ACID RE, V72, P307, DOI 10.1016/S0079-6603(02)72073-4
   Rogers GW, 2001, J BIOL CHEM, V276, P12598, DOI 10.1074/jbc.M007560200
   Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200
   ROZEN F, 1989, MOL CELL BIOL, V9, P4061, DOI 10.1128/MCB.9.9.4061
   Rozovsky N, 2008, RNA, V14, P2136, DOI 10.1261/rna.1049608
   Rudolph MG, 2006, J MOL BIOL, V361, P731, DOI 10.1016/j.jmb.2006.06.065
   Rudolph MG, 2009, RNA, V15, P1993, DOI 10.1261/rna.1820009
   Rudolph MG, 2009, ACTA CRYSTALLOGR F, V65, P248, DOI 10.1107/S1744309108043145
   SARASTE M, 1990, TRENDS BIOCHEM SCI, V15, P430, DOI 10.1016/0968-0004(90)90281-F
   SCHMID SR, 1992, MOL MICROBIOL, V6, P283, DOI 10.1111/j.1365-2958.1992.tb01470.x
   Schutz P, 2008, P NATL ACAD SCI USA, V105, P9564, DOI 10.1073/pnas.0800418105
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Singleton MR, 2007, ANNU REV BIOCHEM, V76, P23, DOI 10.1146/annurev.biochem.76.052305.115300
   Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465
   Szczelkun M D, 2000, Essays Biochem, V35, P131
   Talavera MA, 2006, J MOL BIOL, V355, P697, DOI 10.1016/j.jmb.2005.10.058
   Talavera MA, 2005, BIOCHEMISTRY-US, V44, P959, DOI 10.1021/bi048253i
   Tanner NK, 2003, CELL CYCLE, V2, P16, DOI 10.4161/cc.2.1.296
   Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   Tijerina P, 2006, P NATL ACAD SCI USA, V103, P16698, DOI 10.1073/pnas.0603127103
   Tsu CA, 1998, BIOCHEMISTRY-US, V37, P16989, DOI 10.1021/bi981837y
   Tsu CA, 2001, RNA, V7, P702, DOI 10.1017/S1355838201010135
   von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561
   WALKER JE, 1982, EMBO J, V1, P945, DOI 10.1002/j.1460-2075.1982.tb01276.x
   Wang S, 2008, BIOPHYS J, V94, pL1, DOI 10.1529/biophysj.107.120709
   Wang SY, 2006, RNA, V12, P959, DOI 10.1261/rna.5906
   Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946
   Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165
NR 108
TC 89
Z9 89
U1 0
U2 13
PU WALTER DE GRUYTER GMBH
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1431-6730
EI 1437-4315
J9 BIOL CHEM
JI Biol. Chem.
PD DEC
PY 2009
VL 390
IS 12
BP 1237
EP 1250
DI 10.1515/BC.2009.135
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 529BL
UT WOS:000272490600003
PM 19747077
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Handschin, C
AF Handschin, Christoph
TI Peroxisome proliferator-activated receptor-gamma coactivator-1 alpha in
   muscle links metabolism to inflammation
SO CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY
LA English
DT Review
DE exercise; inflammation; metabolism; muscle; peroxisome
   proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha)
ID NECROSIS-FACTOR-ALPHA; FATTY-ACID OXIDATION; SKELETAL-MUSCLE;
   INSULIN-RESISTANCE; MITOCHONDRIAL-FUNCTION; GENE-EXPRESSION;
   ADIPOSE-TISSUE; NEUROMUSCULAR-JUNCTION; PGC-1-ALPHA; EXERCISE
AB P>1. In higher eukaryotes, metabolism and immunity are tightly coupled. However, whereas in evolutionary terms a compromised immune response due to undernourishment has been the predominant problem, the inflammatory response to obesity and other lifestyle-associated diseases has increased in relevance in Western societies in the past 100 years.
   2. Traditionally, fat tissue has been considered as the major source of pro-inflammatory secreted factors in these pathologies. However, in recent years the contribution of other tissues to disease-causing chronic inflammation has been increasingly appreciated.
   3. Peroxisome proliferator-activated receptor-gamma coactivator-1 alpha (PGC-1 alpha) is one of the key regulatory factors in active skeletal muscle. Aberrant expression of PGC-1 alpha in inactive muscle fibres could be linked to a sedentary lifestyle, persistent systemic inflammation and a higher risk for many chronic diseases. Accordingly, modulation of PGC-1 alpha activity in skeletal muscle may have a broad range of therapeutic effects. Here, recent advances in the understanding of the role of muscle PGC-1 alpha in health and disease are reviewed.
C1 [Handschin, Christoph] Univ Basel, Focal Area Growth & Dev, Biozentrum, CH-4056 Basel, Switzerland.
   [Handschin, Christoph] Univ Zurich, Inst Physiol, Zurich, Switzerland.
   [Handschin, Christoph] Univ Zurich, Zurich Ctr Integrat Human Physiol, Zurich, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Focal Area Growth & Dev, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [SNF PP00A-110746]; Muscular Dystrophy Association USA
   (MDA)Muscular Dystrophy Association; SwissLife 'Jubilaumsstiftung fur
   Volksgesundheit und medizinische Forschung'; Swiss Society for Research
   on Muscle Diseases (SSEM); Swiss Diabetes Association; Roche Research
   Foundation; United Mitochondrial Disease Foundation (UMDF); Zurich
   Center for Integrative Human Physiology (ZIHP); Universities of Basel
   and Zurich
FX The author thanks his colleagues for discussions, ideas and suggestions
   during the writing of this manuscript and Christian Gasser (Institute of
   Physiology, University of Zurich, Zurich, Switzerland) for help with the
   artwork. Work in the author's laboratory related to this paper was
   supported by the Swiss National Science Foundation (SNF PP00A-110746),
   the Muscular Dystrophy Association USA (MDA), the SwissLife
   'Jubilaumsstiftung fur Volksgesundheit und medizinische Forschung', the
   Swiss Society for Research on Muscle Diseases (SSEM), the Swiss Diabetes
   Association, the Roche Research Foundation, the United Mitochondrial
   Disease Foundation (UMDF), the Zurich Center for Integrative Human
   Physiology (ZIHP) and the Universities of Basel and Zurich.
CR Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105
   Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200
   Berchtold MW, 2000, PHYSIOL REV, V80, P1215
   Booth FW, 2002, J APPL PHYSIOL, V93, P3, DOI 10.1152/japplphysiol.00073.2002
   Bouzakri K, 2005, CURR DIABETES REV, V1, P167, DOI 10.2174/1573399054022785
   Cai DS, 2004, CELL, V119, P285, DOI 10.1016/j.cell.2004.09.027
   Carey AL, 2004, DIABETOLOGIA, V47, P1135, DOI 10.1007/s00125-004-1447-y
   Chao LC, 2007, MOL ENDOCRINOL, V21, P2152, DOI 10.1210/me.2007-0169
   Coletti D, 2005, GENESIS, V43, P120, DOI 10.1002/gene.20160
   Czubryt MP, 2003, P NATL ACAD SCI USA, V100, P1711, DOI 10.1073/pnas.0337639100
   Febbraio MA, 2005, EXERC SPORT SCI REV, V33, P114, DOI 10.1097/00003677-200507000-00003
   Febbraio MA, 2007, J APPL PHYSIOL, V103, P376, DOI 10.1152/japplphysiol.00414.2007
   Fluck M, 2003, REV PHYSIOL BIOCH P, V146, P159, DOI 10.1007/s10254-002-0004-7
   Freyssenet D, 2007, J APPL PHYSIOL, V102, P529, DOI 10.1152/japplphysiol.01126.2005
   Gardiner P, 2006, J APPL PHYSIOL, V101, P1228, DOI 10.1152/japplphysiol.00482.2006
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004
   Gleeson M, 2007, J APPL PHYSIOL, V103, P693, DOI 10.1152/japplphysiol.00008.2007
   Haddad F, 2005, J APPL PHYSIOL, V98, P911, DOI 10.1152/japplphysiol.01026.2004
   Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Hossain P, 2007, NEW ENGL J MED, V356, P213, DOI 10.1056/NEJMp068177
   Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485
   Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449
   HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183
   Hu FB, 2004, NEW ENGL J MED, V351, P2694, DOI 10.1056/NEJMoa042135
   Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Kiens B, 2006, PHYSIOL REV, V86, P205, DOI 10.1152/physrev.00023.2004
   Knowler WC, 2002, NEW ENGL J MED, V346, P393, DOI 10.1056/NEJMoa012512
   Kristiansen OP, 2005, DIABETES, V54, pS114, DOI 10.2337/diabetes.54.suppl_2.S114
   Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Matsuzawa Y, 2006, FEBS LETT, V580, P2917, DOI 10.1016/j.febslet.2006.04.028
   Miura S, 2007, ENDOCRINOLOGY, V148, P3441, DOI 10.1210/en.2006-1646
   Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Narayan KMV, 2003, JAMA-J AM MED ASSOC, V290, P1884, DOI 10.1001/jama.290.14.1884
   Nisoli E, 2003, SCIENCE, V299, P896, DOI 10.1126/science.1079368
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Pearen MA, 2006, ENDOCRINOLOGY, V147, P5217, DOI 10.1210/en.2006-0447
   Pedersen BK, 2007, J APPL PHYSIOL, V103, P1093, DOI 10.1152/japplphysiol.00080.2007
   Pedersen BK, 2003, J MUSCLE RES CELL M, V24, P113, DOI 10.1023/A:1026070911202
   Pilegaard H, 2003, J PHYSIOL-LONDON, V546, P851, DOI 10.1113/jphysiol.2002.034850
   Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2
   Richter EA, 2009, BIOCHEM J, V418, P261, DOI 10.1042/BJ20082055
   Rodgers JT, 2008, FEBS LETT, V582, P46, DOI 10.1016/j.febslet.2007.11.034
   Romanyukha AA, 2006, J THEOR BIOL, V241, P1, DOI 10.1016/j.jtbi.2005.11.004
   Russell AP, 2003, DIABETES, V52, P2874, DOI 10.2337/diabetes.52.12.2874
   Saghizadeh M, 1996, J CLIN INVEST, V97, P1111, DOI 10.1172/JCI118504
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059
   St-Pierre J, 2003, J BIOL CHEM, V278, P26597, DOI 10.1074/jbc.M301850200
   Tilg H, 2006, NAT REV IMMUNOL, V6, P772, DOI 10.1038/nri1937
   Trujillo ME, 2006, ENDOCR REV, V27, P798, DOI 10.1210/er.2006-0033
   Vega RB, 2000, MOL CELL BIOL, V20, P1868, DOI 10.1128/MCB.20.5.1868-1876.2000
   Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387
   Waki H, 2007, ANNU REV PATHOL-MECH, V2, P31, DOI 10.1146/annurev.pathol.2.010506.091859
   Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102
   Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
NR 66
TC 29
Z9 31
U1 0
U2 6
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0305-1870
J9 CLIN EXP PHARMACOL P
JI Clin. Exp. Pharmacol. Physiol.
PD DEC
PY 2009
VL 36
IS 12
BP 1139
EP 1143
DI 10.1111/j.1440-1681.2009.05275.x
PG 5
WC Pharmacology & Pharmacy; Physiology
SC Pharmacology & Pharmacy; Physiology
GA 525CY
UT WOS:000272192300002
PM 19671064
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Soulard, A
   Cohen, A
   Hall, MN
AF Soulard, Alexandre
   Cohen, Adiel
   Hall, Michael N.
TI TOR signaling in invertebrates
SO CURRENT OPINION IN CELL BIOLOGY
LA English
DT Review
ID LIFE-SPAN EXTENSION; INHIBITS CELL-GROWTH; MTOR COMPLEX 2; FISSION
   YEAST; MOTIF PHOSPHORYLATION; INCREASED RESPIRATION;
   NUCLEAR-LOCALIZATION; RAPAMYCIN AY-22,989; DIETARY RESTRICTION; NITROGEN
   STARVATION
AB The Target of Rapamycin (TOR), a protein kinase, is the central node of a highly conserved signaling network that regulates cell growth in response to nutrients, hormones, and stresses. TOR is found in two functionally distinct complexes, TORC1 and TORC2. In this review we address the most recent advances in TOR signaling in invertebrate model organisms, including yeasts, plants, worms, and insects.
C1 [Soulard, Alexandre; Cohen, Adiel; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
OI Soulard, Alexandre/0000-0003-3556-1994
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Canton of Basel
FX We acknowledge support from the Swiss National Science Foundation and
   the Canton of Basel.
CR Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040
   Alvers AL, 2009, AGING CELL, V8, P353, DOI 10.1111/j.1474-9726.2009.00469.x
   Araki T, 2005, GENES GENET SYST, V80, P325, DOI 10.1266/ggs.80.325
   Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015
   Aronova S, 2007, MOL BIOL CELL, V18, P2779, DOI 10.1091/mbc.E07-03-0274
   Aspuria PJ, 2007, CELL CYCLE, V6, P1692, DOI 10.4161/cc.6.14.4478
   Balan V, 2008, J BIOL CHEM, V283, P27810, DOI 10.1074/jbc.M804681200
   Barchuk AR, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-70
   Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105
   Bastidas RJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000294
   Bateman JM, 2004, CELL, V119, P87, DOI 10.1016/j.cell.2004.08.028
   Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688
   Berchtold D, 2009, MOL BIOL CELL, V20, P1565, DOI 10.1091/mbc.E08-10-1001
   Berger AB, 2007, MOL CELL BIOL, V27, P8015, DOI 10.1128/MCB.01102-07
   Berkowitz O, 2008, PLANT CELL, V20, P3430, DOI 10.1105/tpc.108.061010
   Bielinski VA, 2007, EXP CELL RES, V313, P3117, DOI 10.1016/j.yexcr.2007.05.008
   Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188
   Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009
   Bultynck G, 2006, MOL CELL BIOL, V26, P4729, DOI 10.1128/MCB.01973-05
   Chang YY, 2009, MOL BIOL CELL, V20, P2004, DOI 10.1091/mbc.E08-12-1250
   Chiocchetti A, 2007, EXP GERONTOL, V42, P275, DOI 10.1016/j.exger.2006.11.002
   Claypool JA, 2004, MOL BIOL CELL, V15, P946, DOI 10.1091/mbc.E03-08-0594
   Cook M, 2007, CURR OPIN BIOTECH, V18, P341, DOI 10.1016/j.copbio.2007.07.006
   Curran SP, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030056
   Dabas N, 2007, EUKARYOT CELL, V6, P875, DOI 10.1128/EC.00307-06
   Dang CV, 2006, SEMIN CANCER BIOL, V16, P253, DOI 10.1016/j.semcancer.2006.07.014
   Daquinag A, 2007, MOL CELL BIOL, V27, P633, DOI 10.1128/MCB.00461-06
   Demontis F, 2009, DEVELOPMENT, V136, P983, DOI 10.1242/dev.027466
   Diaz-Troya S, 2008, AUTOPHAGY, V4, P851, DOI 10.4161/auto.6555
   Diaz-Troya S, 2008, EUKARYOT CELL, V7, P212, DOI 10.1128/EC.00361-07
   Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020
   Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120
   Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881
   Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668
   Grewal SS, 2007, J CELL BIOL, V179, P1105, DOI 10.1083/jcb.200709044
   Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017
   Hansen M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040024
   Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x
   Hartmuth S, 2009, J CELL SCI, V122, P1737, DOI 10.1242/jcs.049387
   Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307
   Ho HL, 2008, EUKARYOT CELL, V7, P1328, DOI 10.1128/EC.00065-08
   Hosiner D, 2009, MOL BIOL CELL, V20, P1048, DOI 10.1091/mbc.E08-04-0438
   Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528
   Hu J, 2008, GENE DEV, V22, P866, DOI 10.1101/gad.1624008
   Ikeda K, 2008, CELL CYCLE, V7, P358, DOI 10.4161/cc.7.3.5245
   Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518
   Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989
   Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060
   Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051
   Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707
   Kamada Y, 2000, J CELL BIOL, V150, P1507, DOI 10.1083/jcb.150.6.1507
   Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068
   Kanoh J, 2007, GENES CELLS, V12, P1301, DOI 10.1111/j.1365-2443.2007.01142.x
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Kim E, 2009, CELL CYCLE, V8, P1014, DOI 10.4161/cc.8.7.8124
   Kraft C, 2008, NAT CELL BIOL, V10, P602, DOI 10.1038/ncb1723
   Lavoie H, 2008, EUKARYOT CELL, V7, P1127, DOI 10.1128/EC.00330-07
   Layalle S, 2008, DEV CELL, V15, P568, DOI 10.1016/j.devcel.2008.08.003
   Lee G, 2007, BIOCHEM BIOPH RES CO, V357, P1154, DOI 10.1016/j.bbrc.2007.04.086
   Lee J, 2009, J BIOL CHEM, V284, P12604, DOI 10.1074/jbc.C900020200
   Lee SB, 2007, EMBO REP, V8, P360, DOI 10.1038/sj.embor.7400917
   Lempiainen H, 2009, MOL CELL, V33, P704, DOI 10.1016/j.molcel.2009.01.034
   Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020
   Liao WL, 2008, FUNGAL GENET BIOL, V45, P514, DOI 10.1016/j.fgb.2007.08.006
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931
   Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06
   Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504
   McNeill H, 2008, GENETICS, V179, P843, DOI 10.1534/genetics.107.083097
   Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261
   Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899
   Mulet JM, 2006, J BIOL CHEM, V281, P33000, DOI 10.1074/jbc.M604244200
   Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102
   Otsubo Y, 2008, CRIT REV BIOCHEM MOL, V43, P277, DOI [10.1080/10409230802254911, 10.1080/10409230802254911 ]
   Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x
   Panowski SH, 2007, NATURE, V447, P550, DOI 10.1038/nature05837
   Pascual-Ahuir A, 2007, EMBO J, V26, P3098, DOI 10.1038/sj.emboj.7601756
   Patel A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000509
   Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646
   Puria R, 2008, P NATL ACAD SCI USA, V105, P7194, DOI 10.1073/pnas.0801087105
   Read RD, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000374
   Rehmann H, 2008, FEBS LETT, V582, P3005, DOI 10.1016/j.febslet.2008.07.057
   Rohde JR, 2008, CURR OPIN MICROBIOL, V11, P153, DOI 10.1016/j.mib.2008.02.013
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Scott RC, 2007, CURR BIOL, V17, P1, DOI 10.1016/j.cub.2006.10.053
   SEHGAL SN, 1975, J ANTIBIOT, V28, P727, DOI 10.7164/antibiotics.28.727
   Sekiguchi T, 2008, BIOCHEM BIOPH RES CO, V368, P748, DOI 10.1016/j.bbrc.2008.01.133
   Sheaffer KL, 2008, CURR BIOL, V18, P1355, DOI 10.1016/j.cub.2008.07.097
   Silva RM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005212
   Simonsen A, 2008, AUTOPHAGY, V4, P176, DOI 10.4161/auto.5269
   Smets B, 2008, FEMS YEAST RES, V8, P1276, DOI 10.1111/j.1567-1364.2008.00432.x
   Sormani R, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-26
   Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409
   Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037
   Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08
   Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603
   Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05
   Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052
   Teleman AA, 2008, CELL METAB, V7, P21, DOI 10.1016/j.cmet.2007.11.010
   Agredano-Moreno LT, 2007, MOL BIOSYST, V3, P794, DOI 10.1039/b705803a
   Toth ML, 2008, AUTOPHAGY, V4, P330, DOI 10.4161/auto.5618
   Tsang CK, 2007, CELL CYCLE, V6, P25, DOI 10.4161/cc.6.1.3675
   Tsao CC, 2009, FUNGAL GENET BIOL, V46, P126, DOI 10.1016/j.fgb.2008.11.008
   Urano J, 2007, P NATL ACAD SCI USA, V104, P3514, DOI 10.1073/pnas.0608510104
   Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020
   Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x
   van der Horst A, 2007, MECH AGEING DEV, V128, P346, DOI 10.1016/j.mad.2007.01.004
   Vanrobays E, 2008, RNA, V14, P2061, DOI 10.1261/rna.1176708
   VEZINA C, 1975, J ANTIBIOT, V28, P721, DOI 10.7164/antibiotics.28.721
   Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200
   Wang YG, 2009, GENE, V437, P32, DOI 10.1016/j.gene.2009.01.018
   Wanke V, 2008, MOL MICROBIOL, V69, P277, DOI 10.1111/j.1365-2958.2008.06292.x
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013
   Weisman R, 2003, CURR TOP MICROBIOL, V279, P85
   Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485
   Yorimitsu T, 2009, AUTOPHAGY, V5, P616, DOI 10.4161/auto.5.5.8091
   Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200
   Zheng CL, 2007, FEMS YEAST RES, V7, P558, DOI 10.1111/j.1567-1364.2007.00210.x
   Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835
NR 127
TC 83
Z9 87
U1 0
U2 31
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0955-0674
EI 1879-0410
J9 CURR OPIN CELL BIOL
JI Curr. Opin. Cell Biol.
PD DEC
PY 2009
VL 21
IS 6
BP 825
EP 836
DI 10.1016/j.ceb.2009.08.007
PG 12
WC Cell Biology
SC Cell Biology
GA 534ZO
UT WOS:000272936500015
PM 19767189
OA Green Published
DA 2021-01-25
ER

PT J
AU de Buhr, MF
   Hedrich, HJ
   Westendorf, AM
   Obermeier, F
   Hofmann, C
   Zschemisch, NH
   Buer, J
   Bumann, D
   Goyert, SM
   Bleich, A
AF de Buhr, Maike F.
   Hedrich, Hans-J.
   Westendorf, Astrid M.
   Obermeier, Florian
   Hofmann, Claudia
   Zschemisch, Nils-H.
   Buer, Jan
   Bumann, Dirk
   Goyert, Sanna M.
   Bleich, Andre
TI Analysis of Cd14 as a Genetic Modifier of Experimental Inflammatory
   Bowel Disease (IBD) in Mice
SO INFLAMMATORY BOWEL DISEASES
LA English
DT Article
DE animal models of IBD; quantitative trait locus analysis; inflammation in
   IBD; Toll-like receptors; genetic susceptibility; innate immune system;
   pathology; cytokine-deficiency-induced colitis susceptibility
ID TOLL-LIKE RECEPTOR-4; SOLUBLE CD14; LIPOPOLYSACCHARIDE ACTIVATION;
   ULCERATIVE-COLITIS; EPITHELIAL-CELLS; CPG MOTIFS; POLYMORPHISM; TLR4;
   ASSOCIATION; BINDING
AB Background and Aim: By combining QTL and gene expression analyses, we have previously identified Cd14 as a potential candidate gene contributing to the differential IBD susceptibility of C3H/HeJBir (C3/J)-Il10-/- mice [carrying IBD-resistance alleles at this QTL (Cdcs6)] and C57BL/6J (B6)-Il10-/- mice, corroborating studies that showed an association of a CD/4-promoter polymorphism with Crohn's disease and ulcerative colitis. The aim of the present study was to analyze the molecular mechanisms leading to differential intestinal expression of Cd14 and its contribution to IBD development.
   Methods: Intestinal CD 14 expression was assessed by FACS, immunohistochemistry, and ELISA on supernatants of primary epithelial cell and tissue cultures. RAW264.7 cells were stimulated with LPS and PGN in the presence or absence of CD14. Cd14 alleles were sequenced and promoters cloned for luciferase assays in transfected RAW264.7 cells. The severity of typhlocolitis between Cd14(-/-) and wild-type mice was compared in 2 distinct mouse models of IBD (acute DSS and Il10-/-).
   Results: In the gut, CD14 was detected mainly in its soluble form (sCD14), with higher expression in C3/J-Il10(-/-) mice. Polymorphisms in C3/J mice caused higher activity of the Cd14 promoter (luciferase assays). Intestinal sCD14 concentrations influenced the LPS and PGN responses of RAW264.7 cells. In vivo, genetic deletion of Cd14 aggravated colitis in both mouse models of IBD.
   Conclusions: Our study shows that Cd14-promoter polymorphisms affect CD14 expression and confirms the protective effect of CD14 against experimental IBD, potentially mediated by TLR2- and TLR4-dependent effects on intestinal barrier function. These findings support the concept that human CD14-promoter polymorphisms contribute to disease development.
C1 [de Buhr, Maike F.; Hedrich, Hans-J.; Zschemisch, Nils-H.; Bleich, Andre] Hannover Med Sch, Inst Lab Anim Sci, D-30625 Hannover, Germany.
   [Westendorf, Astrid M.; Buer, Jan] Helmholtz Ctr Infect Res, Braunschweig, Germany.
   [Westendorf, Astrid M.; Buer, Jan] Univ Hosp Essen, Inst Med Microbiol, Essen, Germany.
   [Obermeier, Florian; Hofmann, Claudia] Univ Regensburg, Dept Internal Med 1, Regensburg, Germany.
   [Bumann, Dirk] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Goyert, Sanna M.] CUNY, Sch Med, Dept Microbiol & Immunol, Sophie Davis Sch Biomed Educ, New York, NY 10031 USA.
RP Bleich, A (corresponding author), Hannover Med Sch, Inst Lab Anim Sci, Carl Neuberg Str 1, D-30625 Hannover, Germany.
EM bleich.andre@mh-hannover.de
RI Westendorf, Astrid M./AAX-1937-2020; Goyert, Sanna/P-8351-2017
OI Buer, Jan/0000-0002-7602-1698; Goyert, Sanna/0000-0002-0994-7757
FU DFGGerman Research Foundation (DFG) [SFB621]; Hannover Medical School
FX Supported by grants from the DFG (SFB621, to H.H.) and Hannover Medical
   School (HILF, to A.B.).
CR Arnott IDR, 2004, GENES IMMUN, V5, P417, DOI 10.1038/sj.gene.6364111
   Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494
   Baumgart DC, 2007, DIGESTION, V76, P196, DOI 10.1159/000112646
   Berg DJ, 2002, GASTROENTEROLOGY, V123, P1527, DOI 10.1053/gast.2002.1231527
   Bleich A, 2005, PATHOBIOLOGY, V72, P293, DOI 10.1159/000091327
   Bleich A, 2004, MAMM GENOME, V15, P865, DOI 10.1007/s00335-004-2392-2
   BLEICH A, 2008, GASTROENTEROLOGY
   Bleich A, 2008, LAB ANIM-UK, V42, P369, DOI 10.1258/la.2007.06026e
   Bleich A, 2008, INT J EXP PATHOL, V89, P45, DOI 10.1111/j.1365-2613.2007.00560.x
   Bleich A, 2009, GASTROENTEROLOGY, V136, P278, DOI 10.1053/j.gastro.2008.09.022
   Branger J, 2004, INFECT IMMUN, V72, P788, DOI 10.1128/IAI.72.2.788-794.2004
   Canto E, 2006, CLIN IMMUNOL, V119, P156, DOI 10.1016/j.clim.2005.12.005
   Cario E, 2007, GASTROENTEROLOGY, V132, P1359, DOI 10.1053/j.gastro.2007.02.056
   Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473
   de Buhr MF, 2006, PHYSIOL GENOMICS, V25, P426, DOI 10.1152/physiolgenomics.00022.2005
   Dubuquoy L, 2003, GASTROENTEROLOGY, V124, P1265, DOI 10.1016/S0016-5085(03)00271-3
   Farmer MA, 2001, P NATL ACAD SCI USA, V98, P13820, DOI 10.1073/pnas.241258698
   Fine S, 2007, GASTROENTEROLOGY, V132, pA124
   Fukata M, 2005, AM J PHYSIOL-GASTR L, V288, pG1055, DOI 10.1152/ajpgi.00328.2004
   Fukata M, 2008, J IMMUNOL, V180, P1886, DOI 10.4049/jimmunol.180.3.1886
   Fukata M, 2006, GASTROENTEROLOGY, V131, P862, DOI 10.1053/j.gastro.2006.06.017
   Funda DP, 2001, INFECT IMMUN, V69, P3772, DOI 10.1128/IAI.69.6.3772-3781.2001
   Gazouli M, 2005, WORLD J GASTROENTERO, V11, P681, DOI 10.3748/wjg.v11.i5.681
   GREWELING MC, 2008, WIEN KLIN WOCHENS S1, V120, P360
   Griga T, 2005, HEPATO-GASTROENTEROL, V52, P808
   Gupta D, 1996, J BIOL CHEM, V271, P23310, DOI 10.1074/jbc.271.38.23310
   Hans W, 2000, EUR J GASTROEN HEPAT, V12, P267, DOI 10.1097/00042737-200012030-00002
   Jacque B, 2006, EUR J IMMUNOL, V36, P3007, DOI 10.1002/eji.200636038
   Kitajima S, 2001, EXP ANIM TOKYO, V50, P387, DOI 10.1538/expanim.50.387
   Kitchens RL, 2001, J CLIN INVEST, V108, P485, DOI 10.1172/JCI13139
   Klein W, 2002, SCAND J GASTROENTERO, V37, P189, DOI 10.1080/003655202753416867
   Klein W, 2003, SCAND J GASTROENTERO, V38, P834, DOI 10.1080/00365520310003147
   KUHN R, 1993, CELL, V75, P263, DOI 10.1016/0092-8674(93)80068-P
   Lee J, 2006, NAT CELL BIOL, V8, P1327, DOI 10.1038/ncb1500
   Lee JW, 2003, INFECT IMMUN, V71, P4034, DOI 10.1128/IAI.71.7.4034-4039.2003
   LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838
   Liedtke C, 2003, J BIOL CHEM, V278, P27593, DOI 10.1074/jbc.M304077200
   Liu GW, 2007, IMMUNOLOGY, V122, P149, DOI 10.1111/j.1365-2567.2007.02651.x
   Mahler M, 2002, GENOMICS, V80, P274, DOI 10.1006/geno.2002.6840
   Nenci A, 2007, NATURE, V446, P557, DOI 10.1038/nature05698
   Nicklas W, 2002, LAB ANIM-UK, V36, P20, DOI 10.1258/0023677021911740
   Obana N, 2002, SCAND J GASTROENTERO, V37, P699, DOI 10.1080/00365520212504
   Obermeier F, 2005, GUT, V54, P1428, DOI 10.1136/gut.2004.046946
   Obermeier F, 2005, GASTROENTEROLOGY, V129, P913, DOI 10.1053/j.gastro.2005.06.061
   OKAYASU I, 1990, GASTROENTEROLOGY, V98, P694, DOI 10.1016/0016-5085(90)90290-H
   Ortega-Cava CF, 2003, J IMMUNOL, V170, P3977, DOI 10.4049/jimmunol.170.8.3977
   Peters KE, 2005, SCAND J GASTROENTERO, V40, P194, DOI 10.1080/00365520510011506
   PUGIN J, 1993, P NATL ACAD SCI USA, V90, P2744, DOI 10.1073/pnas.90.7.2744
   Rakoff-Nahoum S, 2004, CELL, V118, P229, DOI 10.1016/j.cell.2004.07.002
   Rogler G, 1998, CLIN EXP IMMUNOL, V112, P205
   Rogler G, 1997, EUR J GASTROEN HEPAT, V9, P893, DOI 10.1097/00042737-199709000-00013
   Schreiber S, 2002, GUT, V51, P379, DOI 10.1136/gut.51.3.379
   Takeda N, 2003, J IMMUNOL, V171, P426, DOI 10.4049/jimmunol.171.1.426
   Torok HP, 2004, CLIN IMMUNOL, V112, P85, DOI 10.1016/j.clim.2004.03.002
   Wang FY, 2007, J GASTROEN HEPATOL, V22, P925, DOI 10.1111/j.1440-1746.2007.04909.x
   Wenneras C, 2001, J ENDOTOXIN RES, V7, P442, DOI 10.1179/096805101101533052
NR 56
TC 19
Z9 19
U1 1
U2 8
PU OXFORD UNIV PRESS INC
PI CARY
PA JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA
SN 1078-0998
EI 1536-4844
J9 INFLAMM BOWEL DIS
JI Inflamm. Bowel Dis.
PD DEC
PY 2009
VL 15
IS 12
BP 1824
EP 1836
DI 10.1002/ibd.21030
PG 13
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 530DH
UT WOS:000272568600010
PM 19637338
DA 2021-01-25
ER

PT J
AU Erb, M
   Meinen, S
   Barzaghi, P
   Sumanovski, LT
   Courdier-Fruh, I
   Ruegg, MA
   Meier, T
AF Erb, Michael
   Meinen, Sarina
   Barzaghi, Patrizia
   Sumanovski, Lazar T.
   Courdier-Frueh, Isabelle
   Rueegg, Markus A.
   Meier, Thomas
TI Omigapil Ameliorates the Pathology of Muscle Dystrophy Caused by
   Laminin-alpha 2 Deficiency
SO JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
LA English
DT Article
ID CONGENITAL MUSCULAR-DYSTROPHY; GLYCERALDEHYDE-3-PHOSPHATE DEHYDROGENASE;
   NUCLEAR TRANSLOCATION; PARKINSONS-DISEASE; APOPTOSIS; MODEL; GAPDH;
   INHIBITION; SURVIVAL; NEUROPROTECTION
AB Laminin alpha 2-deficient congenital muscular dystrophy, called MDC1A, is a rare, devastating genetic disease characterized by severe neonatal hypotonia ("floppy infant syndrome"), peripheral neuropathy, inability to stand or walk, respiratory distress, and premature death in early life. Transgenic overexpression of the apoptosis inhibitor protein BCL-2, or deletion of the proapoptotic Bax gene in a mouse model for MDC1A prolongs survival and mitigates pathology, indicating that apoptotic events are involved in the pathology. Here we demonstrate that the proapoptotic glyceraldehyde-3-phosphate dehydrogenase (GAPDH)-Siah1-CBP/p300-p53 pathway is activated in a mouse model for MDC1A. Moreover, we show that omigapil, which inhibits GAPDH-Siah1-mediated apoptosis, ameliorates several pathological hallmarks in the MDC1A mouse model. Specifically, we demonstrate that treatment with omigapil inhibits apoptosis in muscle, reduces body weight loss and skeletal deformation, increases locomotive activity, and protects from early mortality. These data qualify omigapil, which is in late phase of clinical development for human use, as a drug candidate for the treatment of MDC1A.
C1 [Meinen, Sarina; Rueegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Erb, Michael; Barzaghi, Patrizia; Sumanovski, Lazar T.; Courdier-Frueh, Isabelle; Meier, Thomas] Santhera Pharmaceut, Liestal, Switzerland.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU Muscular Dystrophy Association ( USA)Muscular Dystrophy Association
   [MDA4168]; Swiss Foundation for Research on Muscle Diseases
FX This work was supported by the Muscular Dystrophy Association ( USA) [
   Grant MDA4168] ( to M. A. R.); and the Swiss Foundation for Research on
   Muscle Diseases.
CR Andringa G, 2000, EUR J NEUROSCI, V12, P3033, DOI 10.1046/j.1460-9568.2000.00181.x
   Bentzinger CF, 2005, FASEB J, V19, P934, DOI 10.1096/fj.04-3376com
   Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008
   Carlile GW, 2000, MOL PHARMACOL, V57, P2
   Chakravarti IM, 1967, HDB METHODS APPL STA
   Chuang DM, 2005, ANNU REV PHARMACOL, V45, P269, DOI 10.1146/annurev.pharmtox.45.120403.095902
   Colognato H, 2000, DEV DYNAM, V218, P213, DOI 10.1002/(SICI)1097-0177(200006)218:2<213::AID-DVDY1>3.0.CO;2-R
   Dastoor Z, 2001, J CELL SCI, V114, P1643
   Dominov JA, 2005, HUM MOL GENET, V14, P1029, DOI 10.1093/hmg/ddi095
   Gawlik K, 2004, HUM MOL GENET, V13, P1775, DOI 10.1093/hmg/ddh190
   Girgenrath M, 2004, J CLIN INVEST, V114, P1635, DOI 10.1172/JCI200422928
   Girgenrath M, 2009, ANN NEUROL, V65, P47, DOI 10.1002/ana.21523
   Hara MR, 2006, P NATL ACAD SCI USA, V103, P3887, DOI 10.1073/pnas.0511321103
   Hara MR, 2005, NAT CELL BIOL, V7, P665, DOI 10.1038/ncb1268
   Hayashi YK, 2001, NEUROMUSCULAR DISORD, V11, P350, DOI 10.1016/S0960-8966(00)00203-0
   Kragten E, 1998, J BIOL CHEM, V273, P5821, DOI 10.1074/jbc.273.10.5821
   Kuang W, 1998, J CLIN INVEST, V102, P844, DOI 10.1172/JCI3705
   Kuang W, 1999, LAB INVEST, V79, P1601
   Langenbach KJ, 2002, MUSCLE NERVE, V26, P644, DOI 10.1002/mus.10258
   Laprise P, 2003, J CELL BIOCHEM, V89, P1115, DOI 10.1002/jcb.10581
   Meinen S, 2007, J CELL BIOL, V176, P979, DOI 10.1083/jcb.200611152
   Millay DP, 2008, NAT MED, V14, P442, DOI 10.1038/nm1736
   Miller R, 2007, NEUROLOGY, V69, P776, DOI 10.1212/01.wnl.0000269676.07319.09
   Miyagoe Y, 1997, FEBS LETT, V415, P33, DOI 10.1016/S0014-5793(97)01007-7
   Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054
   Muntoni F, 2004, NEUROMUSCULAR DISORD, V14, P635, DOI 10.1016/j.nmd.2004.06.009
   Olanow CW, 2006, LANCET NEUROL, V5, P1013, DOI 10.1016/S1474-4422(06)70602-0
   Palma E, 2009, HUM MOL GENET, V18, P2024, DOI 10.1093/hmg/ddp126
   Qiao CP, 2005, P NATL ACAD SCI USA, V102, P11999, DOI 10.1073/pnas.0502137102
   Sagot Y, 2000, BRIT J PHARMACOL, V131, P721, DOI 10.1038/sj.bjp.0703633
   Schessl Joachim, 2006, Semin Pediatr Neurol, V13, P80, DOI 10.1016/j.spen.2006.06.003
   Sen N, 2008, NAT CELL BIOL, V10, P866, DOI 10.1038/ncb1747
   Sen N, 2009, NEURON, V63, P81, DOI 10.1016/j.neuron.2009.05.024
   Tarze A, 2007, ONCOGENE, V26, P2606, DOI 10.1038/sj.onc.1210074
   Tatton W, 2003, J NEURAL TRANSM, V110, P509, DOI 10.1007/s00702-002-0827-z
   Waldmeier PC, 2000, ADV RES NEURODEGENER, V8, P197
   Waldmeier P, 2006, BIOCHEM PHARMACOL, V72, P1197, DOI 10.1016/j.bcp.2006.06.031
NR 37
TC 55
Z9 56
U1 0
U2 3
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0022-3565
EI 1521-0103
J9 J PHARMACOL EXP THER
JI J. Pharmacol. Exp. Ther.
PD DEC
PY 2009
VL 331
IS 3
BP 787
EP 795
DI 10.1124/jpet.109.160754
PG 9
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 523RY
UT WOS:000272093400003
PM 19759319
DA 2021-01-25
ER

PT J
AU Lu, BC
   Cebrian, C
   Chi, X
   Kuure, S
   Kuo, R
   Bates, CM
   Arber, S
   Hassell, J
   MacNeil, L
   Hoshi, M
   Jain, S
   Asai, N
   Takahashi, M
   Schmidt-Ott, KM
   Barasch, J
   D'Agati, V
   Costantini, F
AF Lu, Benson C.
   Cebrian, Cristina
   Chi, Xuan
   Kuure, Satu
   Kuo, Richard
   Bates, Carlton M.
   Arber, Silvia
   Hassell, John
   MacNeil, Lesley
   Hoshi, Masato
   Jain, Sanjay
   Asai, Naoya
   Takahashi, Masahide
   Schmidt-Ott, Kai M.
   Barasch, Jonathan
   D'Agati, Vivette
   Costantini, Frank
TI Etv4 and Etv5 are required downstream of GDNF and Ret for kidney
   branching morphogenesis
SO NATURE GENETICS
LA English
DT Article
ID ETS TRANSCRIPTION FACTORS; URETERAL BUD; GROWTH-FACTOR; MATRIX
   METALLOPROTEINASES; CELL-PROLIFERATION; NEPHRON NUMBER; EXPRESSION;
   RECEPTOR; MOUSE; GENE
AB Glial cell line-derived neurotrophic factor signaling through the Ret receptor tyrosine kinase is crucial for ureteric bud branching morphogenesis during kidney development, yet few of the downstream genes are known. Here we show that the ETS transcription factors Etv4 and Etv5 are positively regulated by Ret signaling in the ureteric bud tips. Mice lacking both Etv4 alleles and one Etv5 allele show either renal agenesis or severe hypodysplasia, whereas kidney development fails completely in double homozygotes. We identified several genes whose expression in the ureteric bud depends on Etv4 and Etv5, including Cxcr4, Myb, Met and Mmp14. Thus, Etv4 and Etv5 are key components of a gene network downstream of Ret that promotes and controls renal branching morphogenesis.
C1 [Lu, Benson C.; Cebrian, Cristina; Chi, Xuan; Kuure, Satu; Kuo, Richard; Costantini, Frank] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10027 USA.
   [Bates, Carlton M.] UPMC, Childrens Hosp Pittsburgh, Div Nephrol, Pittsburgh, PA USA.
   [Arber, Silvia] Univ Basel, Biozentrum, Basel, Switzerland.
   [Hassell, John; MacNeil, Lesley] McMaster Univ, Dept Biochem & Biomed Sci, Hamilton, ON, Canada.
   [Hoshi, Masato; Jain, Sanjay] Washington Univ, Sch Med, Div Renal, Dept Med, St Louis, MO 63110 USA.
   [Asai, Naoya; Takahashi, Masahide] Nagoya Univ, Grad Sch Med, Dept Pathol, Aichi, Japan.
   [Schmidt-Ott, Kai M.; Barasch, Jonathan] Columbia Univ, Dept Med, Med Ctr, New York, NY USA.
   [D'Agati, Vivette] Columbia Univ, Dept Pathol, Med Ctr, New York, NY USA.
RP Costantini, F (corresponding author), Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10027 USA.
EM fdc3@columbia.edu
RI , shkuure/AAE-2751-2019; TAKAHASHI, Masahide/I-7244-2014; ASAI,
   Naoya/I-7377-2014; Cebrian, Cristina/E-2185-2012; Takahashi,
   Masahide/AAN-4770-2020; Schmidt-Ott, Kai/F-4588-2011
OI , shkuure/0000-0002-9076-0622; Schmidt-Ott, Kai/0000-0002-7700-7142;
   jain, sanjay/0000-0003-2804-127X; Takahashi,
   Masahide/0000-0002-2803-2683; Cebrian, Cristina/0000-0002-1297-6591;
   Hoshi, Masato/0000-0003-2874-1807; Arber, Silvia/0000-0002-6261-250X
FU National Kidney Foundation [DK55388, DK075578]; American Heart
   AssociationAmerican Heart Association; Sigrid Juselius Foundation and
   Finnish Cultural Foundation; NATIONAL INSTITUTE OF DIABETES AND
   DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [P01DK055388,
   P01DK055388, P01DK055388, P01DK055388, R01DK075578, R01DK075578,
   P01DK055388, R01DK082531, P01DK055388, R01DK082531, P01DK055388,
   P01DK055388, P01DK055388, R01DK075578, R01DK075578, R01DK082531,
   P01DK055388, P01DK055388, R01DK082531, P01DK055388, P01DK055388,
   P01DK055388, P01DK055388, R01DK082531, R01DK075578, P01DK055388,
   P01DK055388, P01DK055388, P01DK055388, P01DK055388, P01DK055388,
   R01DK075578, P01DK055388, P01DK055388, P01DK055388, P01DK055388,
   R01DK082531, P01DK055388, P01DK055388, P01DK055388, R01DK082531,
   P01DK055388, P01DK055388, P01DK055388, P01DK055388, P01DK055388,
   P01DK055388, P01DK055388, P01DK055388, P01DK055388, R01DK075578,
   P01DK055388, P01DK055388, P01DK055388, P01DK055388, P01DK055388,
   R01DK075578, R01DK075578, P01DK055388, R01DK075578, P01DK055388,
   R01DK082531, P01DK055388, R01DK082531, R01DK075578, R01DK082531,
   P01DK055388, P01DK055388, P01DK055388, P01DK055388, P01DK055388,
   P01DK055388, P01DK055388, P01DK055388, P01DK055388, P01DK055388,
   R01DK075578] Funding Source: NIH RePORTER
FX We thank S. Simonet (Amgen) for Fgf10<SUP>-/-</SUP> mice, K. Murphy
   (Washington University) for Etv5<SUP>tm1Kmm</SUP> mice, L. Williams and
   Z. Wu for technical assistance and N. Kurpios and C. Mendelsohn for
   critical comments on the manuscript. This work was supported by grant
   DK55388 (to F. C. and J. B.) and grant DK075578 (to F. C.) and by
   fellowships from the National Kidney Foundation (to C. C.), the American
   Heart Association (to X. C.) and the Sigrid Juselius Foundation and
   Finnish Cultural Foundation (to S. K.).
CR Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X
   Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004
   Brent AE, 2004, DEVELOPMENT, V131, P3885, DOI 10.1242/dev.01275
   Buj-Bello A, 1999, HUM MUTAT, V14, P320, DOI 10.1002/(SICI)1098-1004(199910)14:4<320::AID-HUMU7>3.0.CO;2-O
   Castellone MD, 2004, ONCOGENE, V23, P5958, DOI 10.1038/sj.onc.1207790
   Chen C, 2005, NATURE, V436, P1030, DOI 10.1038/nature03894
   Chi LJ, 2004, DEVELOPMENT, V131, P3345, DOI 10.1242/dev.01200
   Chi X, 2009, DEV CELL, V17, P199, DOI 10.1016/j.devcel.2009.07.013
   Chi X, 2009, GENESIS, V47, P61, DOI 10.1002/dvg.20452
   Chotteau-Lelievre A, 2003, DEV BIOL, V259, P241, DOI 10.1016/S0012-1606(03)00182-9
   Colucci-D'Amato GL, 2000, J BIOL CHEM, V275, P19306, DOI 10.1074/jbc.275.25.19306
   Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357
   Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x
   de Graaff E, 2001, GENE DEV, V15, P2433, DOI 10.1101/gad.205001
   de Launoit Y, 2006, BBA-REV CANCER, V1766, P79, DOI 10.1016/j.bbcan.2006.02.002
   Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340
   Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001
   Firnberg N, 2002, DEV BIOL, V247, P237, DOI 10.1006/dbio.2002.0696
   Fisher CE, 2001, DEVELOPMENT, V128, P4329
   Gambarotta G, 1996, ONCOGENE, V13, P1911
   Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4
   Helmbacher F, 2003, NEURON, V39, P767, DOI 10.1016/S0896-6273(03)00493-8
   Hoy WE, 2008, CURR OPIN NEPHROL HY, V17, P258, DOI 10.1097/MNH.0b013e3282f9b1a5
   Ishibe S, 2009, DEVELOPMENT, V136, P337, DOI 10.1242/dev.024463
   Izumiyama Y, 2005, ONCOL REP, V13, P715
   Jain S, 2006, GENE DEV, V20, P321, DOI 10.1101/gad.1387206
   Jijiwa M, 2004, MOL CELL BIOL, V24, P8026, DOI 10.1128/MCB.24.18.8026-8036.2004
   Kanwar YS, 1999, AM J PHYSIOL-RENAL, V277, pF934
   Koshikawa N, 2003, FASEB J, V17, P364, DOI 10.1096/fj.03-0584fje
   Liu YR, 2003, DEV BIOL, V261, P10, DOI 10.1016/S0012-1606(03)00359-2
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520
   Maroni P, 2007, CARCINOGENESIS, V28, P267, DOI 10.1093/carcin/bgl129
   Meyer TN, 2004, DEV BIOL, V275, P44, DOI 10.1016/j.ydbio.2004.07.022
   Michael L, 2004, J ANAT, V204, P241, DOI 10.1111/j.0021-8782.2004.00285.x
   Michael L, 2007, J ANAT, V210, P89, DOI 10.1111/j.1469-7580.2006.00670.x
   Min HS, 1998, GENE DEV, V12, P3156, DOI 10.1101/gad.12.20.3156
   MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K
   Oblander SA, 2005, DEV BIOL, V277, P255, DOI 10.1016/j.ydbio.2004.09.033
   Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721
   Pepicelli CV, 1997, DEV BIOL, V192, P193, DOI 10.1006/dbio.1997.8745
   Pohl M, 2000, AM J PHYSIOL-RENAL, V279, pF891
   Qiao J, 2001, MECH DEVELOP, V109, P123, DOI 10.1016/S0925-4773(01)00592-5
   Qiao JZ, 1999, P NATL ACAD SCI USA, V96, P7330, DOI 10.1073/pnas.96.13.7330
   Ramsay RG, 2008, NAT REV CANCER, V8, P523, DOI 10.1038/nrc2439
   Ross J, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2001-2-2-reviews3004
   SANTOS OFP, 1994, DEV BIOL, V163, P525, DOI 10.1006/dbio.1994.1169
   Saxen L., 1987, ORGANOGENESIS KIDNEY
   SCHAERENWIEMERS N, 1993, HISTOCHEMISTRY, V100, P431, DOI 10.1007/BF00267823
   Schedl A, 2007, NAT REV GENET, V8, P791, DOI 10.1038/nrg2205
   Schier AF, 2003, CURR BIOL, V13, pR192, DOI 10.1016/S0960-9822(03)00122-2
   SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0
   Shakya R, 2005, DEV CELL, V8, P65, DOI 10.1016/j.devcel.2004.11.008
   Sharrocks AD, 2001, NAT REV MOL CELL BIO, V2, P827, DOI 10.1038/35099076
   Shi O, 2001, MOL CELL BIOL, V21, P811, DOI 10.1128/MCB.21.3.811-813.2001
   Skinner MA, 2008, AM J HUM GENET, V82, P344, DOI 10.1016/j.ajhg.2007.10.008
   Sullivan J, 1997, J BIOL CHEM, V272, P1943, DOI 10.1074/jbc.272.3.1943
   Takabatake Y, 2009, J AM SOC NEPHROL, V20, P1714, DOI 10.1681/ASN.2008060640
   Takahashi M, 2001, CYTOKINE GROWTH F R, V12, P361, DOI 10.1016/S1359-6101(01)00012-0
   Tang MJ, 2002, DEV BIOL, V243, P128, DOI 10.1006/dbio.2001.0557
   Toth M, 2002, J BIOL CHEM, V277, P26340, DOI 10.1074/jbc.M200655200
   Vu TH, 2000, GENE DEV, V14, P2123, DOI 10.1101/gad.815400
   WANG LG, 1994, CELL GROWTH DIFFER, V5, P1243
   Watanabe T, 2002, AM J PATHOL, V161, P249, DOI 10.1016/S0002-9440(10)64176-4
   Weaver M, 2000, DEVELOPMENT, V127, P2695
   WOOLF AS, 1995, J CELL BIOL, V128, P171, DOI 10.1083/jcb.128.1.171
   Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002
NR 67
TC 128
Z9 129
U1 2
U2 18
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1061-4036
EI 1546-1718
J9 NAT GENET
JI Nature Genet.
PD DEC
PY 2009
VL 41
IS 12
BP 1295
EP 1302
DI 10.1038/ng.476
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA 524LN
UT WOS:000272144900010
PM 19898483
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Affolter, M
   Zeller, R
   Caussinus, E
AF Affolter, Markus
   Zeller, Rolf
   Caussinus, Emmanuel
TI Tissue remodelling through branching morphogenesis
SO NATURE REVIEWS MOLECULAR CELL BIOLOGY
LA English
DT Review
ID ESTROGEN-RECEPTOR-ALPHA; MAMMARY-GLAND DEVELOPMENT; ENDOTHELIAL
   GROWTH-FACTOR; TRACHEAL CELL-MIGRATION; MOLECULAR-MECHANISMS;
   METANEPHRIC KIDNEY; FEEDBACK LOOP; KEY STAGES; END BUD; DROSOPHILA
AB Branched structures are evident at all levels of organization in living organisms. Many organs, such as the vascular system, lung, kidney and mammary gland, are heavily branched. In each of these cases, equally fascinating questions have been put forward, including those that address the cellular and molecular mechanisms that regulate the branching process itself, such as where the branches are initiated and how they extend and grow in the right direction. Recent experiments suggest that cell competition and cell rearrangements might be conserved key features in branch formation and might be controlled by local cell signalling.
C1 [Affolter, Markus; Caussinus, Emmanuel] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Zeller, Rolf] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
RI Zeller, Rolf/C-2610-2013
OI Zeller, Rolf/0000-0002-3186-7403; Affolter, Markus/0000-0002-5171-0016
CR Ackerman KG, 2007, AM J RESP CELL MOL, V36, P391, DOI 10.1165/rcmb.2006-0211RC
   Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498
   Al-Awqati Q, 1998, KIDNEY INT, V54, P1832, DOI 10.1046/j.1523-1755.1998.00196.x
   Basson MA, 2005, DEV CELL, V8, P229, DOI 10.1016/j.devcel.2004.12.004
   Bayer EM, 2009, GENE DEV, V23, P373, DOI 10.1101/gad.497009
   Bellusci S, 1996, DEVELOPMENT, V122, P1693
   Bellusci S, 1997, DEVELOPMENT, V124, P4867
   Benazet JD, 2009, CSH PERSPECT BIOL, V1, DOI 10.1101/cshperspect.a001339
   Benazet JD, 2009, SCIENCE, V323, P1050, DOI 10.1126/science.1168755
   Bocchinfuso WP, 2000, ENDOCRINOLOGY, V141, P2982, DOI 10.1210/en.141.8.2982
   Brisken C, 1998, P NATL ACAD SCI USA, V95, P5076, DOI 10.1073/pnas.95.9.5076
   Brodu V, 2006, GENE DEV, V20, P1817, DOI 10.1101/gad.375706
   Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523
   Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310
   Carmeliet P, 2005, NATURE, V436, P193, DOI 10.1038/nature03875
   Caussinus E, 2008, CURR BIOL, V18, P1727, DOI 10.1016/j.cub.2008.10.062
   Centanin L, 2008, DEV CELL, V14, P547, DOI 10.1016/j.devcel.2008.01.020
   Chi X, 2009, DEV CELL, V17, P199, DOI 10.1016/j.devcel.2009.07.013
   Chu EY, 2004, DEVELOPMENT, V131, P4819, DOI 10.1242/dev.01347
   Chuang PT, 2003, GENE DEV, V17, P342, DOI 10.1101/gad.1026303
   Chung S, 2008, J CELL SCI, V121, P3501, DOI 10.1242/jcs.037887
   Colombelli J, 2009, J CELL SCI, V122, P1665, DOI 10.1242/jcs.042986
   Costantini F, 2006, BIOESSAYS, V28, P117, DOI 10.1002/bies.20357
   Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x
   Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479
   Daniel CW, 1996, J MAMMARY GLAND BIOL, V1, P331, DOI 10.1007/BF02017389
   De Moerlooze L, 2000, DEVELOPMENT, V127, P483
   De Smet I, 2007, CURR OPIN GENET DEV, V17, P337, DOI 10.1016/j.gde.2007.04.012
   Desprat N, 2008, DEV CELL, V15, P470, DOI 10.1016/j.devcel.2008.07.009
   Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234
   Dressler GR, 2006, ANNU REV CELL DEV BI, V22, P509, DOI 10.1146/annurev.cellbio.22.010305.104340
   Dufraine J, 2008, ONCOGENE, V27, P5132, DOI 10.1038/onc.2008.227
   Eblaghie MC, 2006, DEV BIOL, V291, P67, DOI 10.1016/j.ydbio.2005.12.006
   Englund C, 2002, DEVELOPMENT, V129, P4941
   Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003
   Ewan KB, 2002, AM J PATHOL, V160, P2081, DOI 10.1016/S0002-9440(10)61158-3
   Farhadifar R, 2007, CURR BIOL, V17, P2095, DOI 10.1016/j.cub.2007.11.049
   Feng Y, 2007, P NATL ACAD SCI USA, V104, P14718, DOI 10.1073/pnas.0706933104
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Fraisl P, 2009, DEV CELL, V16, P167, DOI 10.1016/j.devcel.2009.01.003
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Gerhardt Holger, 2008, Organogenesis, V4, P241
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829
   Grieshammer U, 2004, DEV CELL, V6, P709, DOI 10.1016/S1534-5807(04)00108-X
   Hellstrom M, 2007, NATURE, V445, P776, DOI 10.1038/nature05571
   Hens JR, 2005, BREAST CANCER RES, V7, P220, DOI 10.1186/bcr1306
   Hens JR, 2007, DEVELOPMENT, V134, P1221, DOI 10.1242/dev.000182
   Hinck L, 2005, BREAST CANCER RES, V7, P245, DOI 10.1186/bcr1331
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818
   Hutson MS, 2003, SCIENCE, V300, P145, DOI 10.1126/science.1079552
   Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9
   Kato K, 2004, DEVELOPMENT, V131, P5253, DOI 10.1242/dev.01404
   Kiehart DP, 2000, J CELL BIOL, V149, P471, DOI 10.1083/jcb.149.2.471
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Kopan R, 2007, J AM SOC NEPHROL, V18, P2014, DOI 10.1681/ASN.2007040453
   Kuhlemeier C, 2007, TRENDS PLANT SCI, V12, P143, DOI 10.1016/j.tplants.2007.03.004
   Larrivee B, 2009, CIRC RES, V104, P428, DOI 10.1161/CIRCRESAHA.108.188144
   Lebeche D, 1999, MECH DEVELOP, V86, P125, DOI 10.1016/S0925-4773(99)00124-0
   Lecuit T, 2007, NATURE, V450, P189, DOI 10.1038/nature06304
   Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222
   Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244
   LEUNG DW, 1989, SCIENCE, V246, P1306, DOI 10.1126/science.2479986
   Liu Y, 2004, CURR BIOL, V14, P897, DOI 10.1016/j.cub.2004.05.020
   Liu ZJ, 2003, MOL CELL BIOL, V23, P14, DOI 10.1128/MCB.23.1.14-25.2003
   Llimargas M, 1999, DEV GENES EVOL, V209, P174, DOI 10.1007/s004270050241
   Lohela M, 2009, CURR OPIN CELL BIOL, V21, P154, DOI 10.1016/j.ceb.2008.12.012
   Lu PF, 2008, DEV BIOL, V321, P77, DOI 10.1016/j.ydbio.2008.06.005
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Mailleux AA, 2001, MECH DEVELOP, V102, P81, DOI 10.1016/S0925-4773(01)00286-6
   Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520
   Mallepell S, 2006, P NATL ACAD SCI USA, V103, P2196, DOI 10.1073/pnas.0510974103
   Metzger RJ, 2008, NATURE, V453, P745, DOI 10.1038/nature07005
   Michos O, 2004, DEVELOPMENT, V131, P3401, DOI 10.1242/dev.01251
   Michos O, 2007, DEVELOPMENT, V134, P2397, DOI 10.1242/dev.02861
   Miyazaki Y, 2000, J CLIN INVEST, V105, P863, DOI 10.1172/JCI8256
   Moraes RC, 2007, DEVELOPMENT, V134, P1231, DOI 10.1242/dev.02797
   Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200
   Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000
   Ohuchi H, 2000, BIOCHEM BIOPH RES CO, V277, P643, DOI 10.1006/bbrc.2000.3721
   Parsa S, 2008, DEV BIOL, V317, P121, DOI 10.1016/j.ydbio.2008.02.014
   Qiao JZ, 1999, DEVELOPMENT, V126, P547
   Quaggin SE, 2008, DEVELOPMENT, V135, P609, DOI 10.1242/dev.001081
   Rauzi M, 2008, NAT CELL BIOL, V10, P1401, DOI 10.1038/ncb1798
   Reinhardt D, 2003, NATURE, V426, P255, DOI 10.1038/nature02081
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207
   Ruhrberg C, 2003, BIOESSAYS, V25, P1052, DOI 10.1002/bies.10351
   Sagasti A, 2005, CURR BIOL, V15, P804, DOI 10.1016/j.cub.2005.03.048
   Scherz PJ, 2004, SCIENCE, V305, P396, DOI 10.1126/science.1096966
   Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096
   Shakya R, 2005, DEV BIOL, V283, P70, DOI 10.1016/j.ydbio.2005.04.008
   Shakya R, 2005, DEV CELL, V8, P65, DOI 10.1016/j.devcel.2004.11.008
   Shu WG, 2005, DEV BIOL, V283, P226, DOI 10.1016/j.ydbio.2005.04.014
   Shutter JR, 2000, GENE DEV, V14, P1313
   Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577
   Silberstein GB, 2001, MICROSC RES TECHNIQ, V52, P155, DOI 10.1002/1097-0029(20010115)52:2<155::AID-JEMT1001>3.0.CO;2-P
   Smith RS, 2006, P NATL ACAD SCI USA, V103, P1301, DOI 10.1073/pnas.0510457103
   Solon J, 2009, CELL, V137, P1331, DOI 10.1016/j.cell.2009.03.050
   Sternlicht MD, 2006, DIFFERENTIATION, V74, P365, DOI 10.1111/j.1432-0436.2006.00105.x
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   Tefft JD, 1999, CURR BIOL, V9, P219, DOI 10.1016/S0960-9822(99)80094-3
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Veltmaat JM, 2006, DEVELOPMENT, V133, P2325, DOI 10.1242/dev.02394
   Verheyden JM, 2008, NATURE, V454, P638, DOI 10.1038/nature07085
   Vincent S, 1997, DEVELOPMENT, V124, P2741
   Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n
   Watanabe T, 2004, DEV BIOL, V271, P98, DOI 10.1016/j.ydbio.2004.03.025
   Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439
   Williams CK, 2006, BLOOD, V107, P931, DOI 10.1182/blood-2005-03-1000
   Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002
NR 112
TC 124
Z9 126
U1 0
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-0072
EI 1471-0080
J9 NAT REV MOL CELL BIO
JI Nat. Rev. Mol. Cell Biol.
PD DEC
PY 2009
VL 10
IS 12
BP 831
EP 842
DI 10.1038/nrm2797
PG 12
WC Cell Biology
SC Cell Biology
GA 523FB
UT WOS:000272056400010
PM 19888266
DA 2021-01-25
ER

PT J
AU Ellena, JF
   Liang, BY
   Wiktor, M
   Stein, A
   Cafiso, DS
   Jahn, R
   Tamm, LK
AF Ellena, Jeffrey F.
   Liang, Binyong
   Wiktor, Maciej
   Stein, Alexander
   Cafiso, David S.
   Jahn, Reinhard
   Tamm, Lukas K.
TI Dynamic structure of lipid-bound synaptobrevin suggests a
   nucleation-propagation mechanism for trans-SNARE complex formation
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE structure; dynamics; membrane fusion; SNARE proteins; NMR
ID MEMBRANE-FUSION; NMR-SPECTROSCOPY; TRANSMEMBRANE DOMAIN; BACKBONE
   DYNAMICS; CRYSTAL-STRUCTURE; EXOCYTOSIS; PROTEINS; DETERMINANTS;
   VESICLES; SYNTAXIN
AB The synaptic vesicle protein synaptobrevin engages with syntaxin and SNAP-25 to form the SNARE complex, which drives membrane fusion in neuronal exocytosis. In the SNARE complex, the SNARE motif of synaptobrevin forms a 55-residue helix, but it has been assumed to be mostly unstructured in its prefusion form. NMR data for full-length synaptobrevin in dodecylphosphocholine micelles reveals two transient helical segments flanked by natively disordered regions and a third more stable helix. Transient helix I comprises the most N-terminal part of the SNARE motif, transient helix II extends the SNARE motif into the juxtamembrane region, and the more stable helix III is the transmembrane domain. These helices may have important consequences for SNARE complex folding and fusion: helix I likely forms a nucleation site, the C-terminal disordered SNARE motif may act as a folding arrest signal, and helix II likely couples SNARE complex folding and fusion.
C1 [Liang, Binyong; Wiktor, Maciej; Tamm, Lukas K.] Univ Virginia, Ctr Membrane Biol, Charlottesville, VA 22908 USA.
   [Liang, Binyong; Wiktor, Maciej; Tamm, Lukas K.] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.
   [Wiktor, Maciej] Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
   [Stein, Alexander; Jahn, Reinhard] Max Planck Inst Biophys Chem, Dept Neurobiol, D-37077 Gottingen, Germany.
   [Cafiso, David S.] Univ Virginia, Dept Chem, Charlottesville, VA 22904 USA.
RP Tamm, LK (corresponding author), Univ Virginia, Ctr Membrane Biol, POB 800886, Charlottesville, VA 22908 USA.
EM lkt2e@virginia.edu
RI Stein, Alexander/I-4950-2012
OI Stein, Alexander/0000-0002-2696-0611; Jahn, Reinhard/0000-0003-1542-3498
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [GM72694]; NATIONAL
   INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694, P01GM072694, P01GM072694,
   P01GM072694, P01GM072694, P01GM072694] Funding Source: NIH RePORTER
FX This work was supported by National Institutes of Health grant P01
   GM72694.
CR Altenbach C, 1996, BIOCHEMISTRY-US, V35, P12470, DOI 10.1021/bi960849l
   Antonin W, 2002, NAT STRUCT BIOL, V9, P107, DOI 10.1038/nsb746
   Arora A, 2001, NAT STRUCT BIOL, V8, P334, DOI 10.1038/86214
   Bowen M, 2006, P NATL ACAD SCI USA, V103, P8378, DOI 10.1073/pnas.0602644103
   Chen XC, 2002, NEURON, V33, P397, DOI 10.1016/S0896-6273(02)00583-4
   Columbus L, 2004, BIOCHEMISTRY-US, V43, P7273, DOI 10.1021/bi0497906
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   Deak F, 2006, J NEUROSCI, V26, P6668, DOI 10.1523/JNEUROSCI.5272-05.2006
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Domanska MK, 2009, J BIOL CHEM, V284, P32158, DOI 10.1074/jbc.M109.047381
   EISENBERG D, 1982, NATURE, V299, P371, DOI 10.1038/299371a0
   Fasshauer D, 2004, J BIOL CHEM, V279, P7613, DOI 10.1074/jbc.M312064200
   Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h
   Fasshauer D, 1997, J BIOL CHEM, V272, P28036, DOI 10.1074/jbc.272.44.28036
   Fiebig KM, 1999, NAT STRUCT BIOL, V6, P117
   Giraudo CG, 2009, SCIENCE, V323, P512, DOI 10.1126/science.1166500
   Goddard T., 2008, SPARKY NMR ASSIGNMEN
   Hazzard J, 1999, J BIOMOL NMR, V14, P203, DOI 10.1023/A:1008382027065
   Hong HD, 2007, J AM CHEM SOC, V129, P8320, DOI 10.1021/ja068849o
   Hwang TL, 1998, J BIOMOL NMR, V11, P221, DOI 10.1023/A:1008276004875
   JAHN R, 1994, ANNU REV NEUROSCI, V17, P219, DOI 10.1146/annurev.ne.17.030194.001251
   Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002
   Jarymowycz VA, 2006, CHEM REV, V106, P1624, DOI 10.1021/cr040421p
   KALLICK DA, 1995, J MAGN RESON SER B, V109, P60, DOI 10.1006/jmrb.1995.1146
   KAY LE, 1989, BIOCHEMISTRY-US, V28, P8972, DOI 10.1021/bi00449a003
   Kesavan J, 2007, CELL, V131, P351, DOI 10.1016/j.cell.2007.09.025
   Kweon DH, 2003, NAT STRUCT BIOL, V10, P440, DOI 10.1038/nsb928
   Lagow RD, 2007, PLOS BIOL, V5, P800, DOI 10.1371/journal.pbio.0050072
   Langosch D, 2001, J MOL BIOL, V311, P709, DOI 10.1006/jmbi.2001.4889
   Liang BY, 2007, P NATL ACAD SCI USA, V104, P16140, DOI 10.1073/pnas.0705466104
   Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306
   McNew JA, 1999, MOL CELL, V4, P415, DOI 10.1016/S1097-2765(00)80343-3
   Melia TJ, 2002, J CELL BIOL, V158, P929, DOI 10.1083/jcb.200112081
   Oxenoid K, 2005, P NATL ACAD SCI USA, V102, P10870, DOI 10.1073/pnas.0504920102
   Pobbati AV, 2006, SCIENCE, V313, P673, DOI 10.1126/science.1129486
   Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Siddiqui TJ, 2007, MOL BIOL CELL, V18, P2037, DOI 10.1091/mbc.E07-01-0049
   Sorensen JB, 2006, EMBO J, V25, P955, DOI 10.1038/sj.emboj.7601003
   Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156
   Steinmetz MO, 2007, P NATL ACAD SCI USA, V104, P7062, DOI 10.1073/pnas.0700321104
   Sutton RB, 1998, NATURE, V395, P347, DOI 10.1038/26412
   Van Horn WD, 2009, SCIENCE, V324, P1726, DOI 10.1126/science.1171716
   Wiederhold K, 2009, J BIOL CHEM, V284, P13143, DOI 10.1074/jbc.M900703200
   Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003
   Xue M, 2007, NAT STRUCT MOL BIOL, V14, P949, DOI 10.1038/nsmb1292
   Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028
NR 47
TC 76
Z9 77
U1 1
U2 21
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD DEC 1
PY 2009
VL 106
IS 48
BP 20306
EP 20311
DI 10.1073/pnas.0908317106
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 525YQ
UT WOS:000272254400033
PM 19918058
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Kobialka, S
   Beuret, N
   Ben-Tekaya, H
   Spiess, M
AF Kobialka, Szymon
   Beuret, Nicole
   Ben-Tekaya, Houchaima
   Spiess, Martin
TI Glycosaminoglycan Chains Affect Exocytic and Endocytic Protein Traffic
SO TRAFFIC
LA English
DT Article
DE endocytosis; exocytosis; glycosaminoglycan; recycling; sulfation
ID POLARIZED EPITHELIAL-CELLS; TRANS-GOLGI NETWORK; CANINE KIDNEY-CELLS;
   ASIALOGLYCOPROTEIN RECEPTOR; CHONDROITIN SULFATE; MDCK CELLS; TYROSINE
   SULFATION; SECRETORY VESICLES; APICAL SECRETION; SORTING SIGNALS
AB Protein glycosylation such as N- and O-linked glycans as well as glycosaminoglycans (GAGs) have been shown to contribute to polarized sorting in epithelial cells. Here, we analyzed the effect of GAGs more generally on protein traffic also in non-polarized cells. Using short sequence tags of 10-17 amino acids encoding known GAG attachment sites, we have converted the asialoglycoprotein receptor H1, which constitutively cycles between the plasma membrane and endosomes, into a proteoglycan. Expressed in HeLa cells, the receptor was almost completely modified with a chondroitin sulfate chain and could be efficiently labeled by [35S]sulfation. GAG attachment altered the steady-state distribution of the receptor by inhibiting endocytosis, while recycling was not affected. The reduced internalization is not the result of immobilization by interaction with the extracellular matrix, because fluorescence recovery after photobleaching did not detect an increased immobile fraction nor even a significant change in mobility. GAG chains furthermore accelerated Golgi-to-cell surface transport of H1. The same acceleration of export was also observed for a GAG-tagged version of the secretory protein alpha 1-protease inhibitor, suggesting that this effect acts generally on proteoglycans, possibly by directing them into distinct carriers. Our results show novel roles of GAGs in protein sorting also in non-polarized cells.
C1 [Kobialka, Szymon; Beuret, Nicole; Ben-Tekaya, Houchaima; Spiess, Martin] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM martin.spiess@unibas.ch
OI Spiess, Martin/0000-0001-7139-0550
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF)
FX This work was supported by the Swiss National Science Foundation. We
   thank David Hirschmann and Dr. Hans-Peter Hauri (Bozentrum) for their
   support.
CR Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165
   Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708
   Arneson LS, 2007, BIOCHEM J, V406, P97, DOI 10.1042/BJ20070446
   BAEUERLE PA, 1987, J CELL BIOL, V105, P2655, DOI 10.1083/jcb.105.6.2655
   BARTHEL A, 1995, ADV ENZYME REGUL, V35, P283, DOI 10.1016/0065-2571(94)00021-T
   Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615
   Bider MD, 1996, J BIOL CHEM, V271, P31996, DOI 10.1074/jbc.271.50.31996
   Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817
   Bonifacino JS, 2003, ANNU REV BIOCHEM, V72, P395, DOI 10.1146/annurev.biochem.72.121801.161800
   CAPLAN MJ, 1987, NATURE, V329, P632, DOI 10.1038/329632a0
   Esko JD, 1996, CURR OPIN STRUC BIOL, V6, P663, DOI 10.1016/S0959-440X(96)80034-0
   FUHRER C, 1991, J CELL BIOL, V114, P423, DOI 10.1083/jcb.114.3.423
   FUTTER CE, 1995, J BIOL CHEM, V270, P10999, DOI 10.1074/jbc.270.18.10999
   GEFFEN I, 1993, J BIOL CHEM, V268, P20772
   Ghosh P, 2003, NAT REV MOL CELL BIO, V4, P202, DOI 10.1038/nrm1050
   Gorsi B, 2007, TRENDS CELL BIOL, V17, P173, DOI 10.1016/j.tcb.2007.02.006
   Hirschberg K, 1998, J CELL BIOL, V143, P1485, DOI 10.1083/jcb.143.6.1485
   HUTTNER WB, 1988, ANNU REV PHYSIOL, V50, P363, DOI 10.1146/annurev.ph.50.030188.002051
   Jacob R, 2000, J BIOL CHEM, V275, P6566, DOI 10.1074/jbc.275.9.6566
   Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230
   Kolset SO, 1999, J CELL SCI, V112, P1797
   Laird V, 2000, EXP CELL RES, V260, P340, DOI 10.1006/excr.2000.5006
   LEITINGER B, 1994, J BIOL CHEM, V269, P8115
   LEITINGER B, 1995, P NATL ACAD SCI USA, V92, P10109, DOI 10.1073/pnas.92.22.10109
   LO ACY, 1995, J BIOL CHEM, V270, P12641, DOI 10.1074/jbc.270.21.12641
   Mertens G, 1996, J CELL BIOL, V132, P487, DOI 10.1083/jcb.132.3.487
   MONLAUZEUR L, 1995, J BIOL CHEM, V270, P12219, DOI 10.1074/jbc.270.20.12219
   NICKEL W, 1994, J CELL BIOL, V125, P721, DOI 10.1083/jcb.125.4.721
   Orzech E, 2000, J BIOL CHEM, V275, P15207, DOI 10.1074/jbc.275.20.15207
   Pagano A, 2004, MOL BIOL CELL, V15, P4990, DOI 10.1091/mbc.E04-04-0355
   Potter BA, 2006, AM J PHYSIOL-CELL PH, V290, pC1, DOI 10.1152/ajpcell.00333.2005
   Prydz K, 2000, J CELL SCI, V113, P193
   SCHEIFFELE P, 1995, NATURE, V378, P96, DOI 10.1038/378096a0
   SHIA MA, 1989, P NATL ACAD SCI USA, V86, P1158, DOI 10.1073/pnas.86.4.1158
   Silbert JE, 2002, IUBMB LIFE, V54, P177, DOI 10.1080/15216540214923
   Snapp Erik L, 2003, Curr Protoc Cell Biol, VChapter 21, DOI 10.1002/0471143030.cb2101s19
   Sugahara K, 2003, CURR OPIN STRUC BIOL, V13, P612, DOI 10.1016/j.sbi.2003.09.011
   Sugahara K, 2002, IUBMB LIFE, V54, P163, DOI 10.1080/15216540214928
   Sugimoto H, 2002, MOL BIOL CELL, V13, P2374, DOI 10.1091/mbc.E01-10-0096
   Traub LM, 2007, J CELL SCI, V120, P543, DOI 10.1242/jcs.03385
   URBAN J, 1987, J CELL BIOL, V105, P2735, DOI 10.1083/jcb.105.6.2735
   Yeaman C, 1997, J CELL BIOL, V139, P929, DOI 10.1083/jcb.139.4.929
   ZHANG LJ, 1994, J BIOL CHEM, V269, P19295
NR 43
TC 17
Z9 17
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-9219
EI 1600-0854
J9 TRAFFIC
JI Traffic
PD DEC
PY 2009
VL 10
IS 12
BP 1845
EP 1855
DI 10.1111/j.1600-0854.2009.00987.x
PG 11
WC Cell Biology
SC Cell Biology
GA 518ST
UT WOS:000271714300011
PM 19912578
OA Bronze
DA 2021-01-25
ER

PT J
AU Cybulski, N
   Hall, MN
AF Cybulski, Nadine
   Hall, Michael N.
TI TOR complex 2: a signaling pathway of its own
SO TRENDS IN BIOCHEMICAL SCIENCES
LA English
DT Review
ID EXCHANGE FACTOR ROM2; RICTOR-MTOR COMPLEX; FISSION YEAST; CELL-GROWTH;
   SACCHAROMYCES-CEREVISIAE; ACTIN CYTOSKELETON; SCHIZOSACCHAROMYCES-POMBE;
   CAENORHABDITIS-ELEGANS; MOTIF PHOSPHORYLATION; NITROGEN STARVATION
AB Research on TOR has grown exponentially during the last decade, generating a complex model of the TOR signaling network. Rapamycin treatment provides a simple and straightforward method to inhibit the TOR signaling pathway and to study the influence of TOR on multiple cellular processes. The discovery of two distinct TOR complexes, TORC1 and TORC2, showed that studies using rapamycin targeted only one TOR signaling branch. TORC1 is directly inhibited by rapamycin, whereas TORC2 is not. There is no known TORC2-specific inhibitor, so genetic manipulation is required to study its biological function(s). Many studies in genetically tractable model organisms have expanded our understanding of TORC2 signaling. Here we focus on the TORC2 signaling pathway as revealed by these (mostly recent) studies.
C1 [Cybulski, Nadine; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM M.Hall@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Louis-Jeantet Foundation
FX MNH acknowledges support from the Swiss National Science Foundation and
   the Louis-Jeantet Foundation.
CR Anderson GH, 2005, BMC BIOL, V3, DOI 10.1186/1741-7007-3-12
   Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015
   Barquilla A, 2008, P NATL ACAD SCI USA, V105, P14579, DOI 10.1073/pnas.0802668105
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Bickle M, 1998, EMBO J, V17, P2235, DOI 10.1093/emboj/17.8.2235
   Brunet A, 2001, MOL CELL BIOL, V21, P952, DOI 10.1128/MCB.21.3.952-965.2001
   Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432
   Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200
   Chen LF, 2003, MOL BIOL CELL, V14, P5028, DOI 10.1091/mbc.E03-05-0339
   Chen ML, 2006, GENE DEV, V20, P1569, DOI 10.1101/gad.1395006
   Copp J, 2009, CANCER RES, V69, P1821, DOI 10.1158/0008-5472.CAN-08-3014
   Cybulski N, 2009, P NATL ACAD SCI USA, V106, P9902, DOI 10.1073/pnas.0811321106
   Dada S, 2008, BIOCHEM BIOPH RES CO, V372, P875, DOI 10.1016/j.bbrc.2008.05.154
   Deprost D, 2007, EMBO REP, V8, P864, DOI 10.1038/sj.embor.7401043
   Diaz-Troya S, 2008, EUKARYOT CELL, V7, P212, DOI 10.1128/EC.00361-07
   Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120
   Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.E04-07-0564
   Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001
   Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668
   GRAHAM SW, 2006, MONOCOTS COMP BIOL E, V1, P3
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Guertin DA, 2009, CANCER CELL, V15, P148, DOI 10.1016/j.ccr.2008.12.017
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Hayashi T, 2007, GENES CELLS, V12, P1357, DOI 10.1111/j.1365-2443.2007.01141.x
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Helliwell SB, 1998, GENETICS, V148, P99
   Helliwell SB, 1998, CURR BIOL, V8, P1211, DOI 10.1016/S0960-9822(07)00511-8
   Hietakangas V, 2007, GENE DEV, V21, P632, DOI 10.1101/gad.416307
   Hoeller O, 2007, CURR BIOL, V17, P813, DOI 10.1016/j.cub.2007.04.004
   Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200
   Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08
   Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518
   Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033
   Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060
   Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005
   Kamimura Y, 2008, CURR BIOL, V18, P1034, DOI 10.1016/j.cub.2008.06.068
   Kawai M, 2001, CURR GENET, V39, P166
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07
   Lee G, 2007, BIOCHEM BIOPH RES CO, V357, P1154, DOI 10.1016/j.bbrc.2007.04.086
   Lee S, 2005, MOL BIOL CELL, V16, P4572, DOI 10.1091/mbc.E05-04-0342
   Liu L, 2006, ONCOGENE, V25, P7029, DOI 10.1038/sj.onc.1209691
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Luo GZ, 2008, J BIOL CHEM, V283, P10433, DOI 10.1074/jbc.M709972200
   Mahfouz MM, 2006, PLANT CELL, V18, P477, DOI 10.1105/tpc.105.035931
   Manning BD, 2003, TRENDS BIOCHEM SCI, V28, P573, DOI 10.1016/j.tibs.2003.09.003
   Masri J, 2007, CANCER RES, V67, P11712, DOI 10.1158/0008-5472.CAN-07-2223
   Matsuo T, 2003, EMBO J, V22, P3073, DOI 10.1093/emboj/cdg298
   Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06
   Mora A, 2004, SEMIN CELL DEV BIOL, V15, P161, DOI 10.1016/j.semcdb.2003.12.022
   Partovian C, 2008, MOL CELL, V32, P140, DOI 10.1016/j.molcel.2008.09.010
   Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540
   Peng XD, 2003, GENE DEV, V17, P1352, DOI 10.1101/gad.1089403
   Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schmidt A, 1996, P NATL ACAD SCI USA, V93, P13780, DOI 10.1073/pnas.93.24.13780
   Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0
   Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009
   Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013
   Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409
   Sturgill TW, 2008, EUKARYOT CELL, V7, P1819, DOI 10.1128/EC.00088-08
   Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217
   Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104
   Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020
   Weisman R, 2005, GENETICS, V169, P539, DOI 10.1534/genetics.104.034983
   Weisman R, 2001, J BIOL CHEM, V276, P24736, DOI 10.1074/jbc.M102090200
   Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200
   Weisman R, 1997, J BACTERIOL, V179, P6325, DOI 10.1128/jb.179.20.6325-6334.1997
   Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Wullschleger S, 2005, J BIOL CHEM, V280, P30697, DOI 10.1074/jbc.M505553200
   Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206
   Yang ZZ, 2005, MOL CELL BIOL, V25, P10407, DOI 10.1128/MCB.25.23.10407-10418.2005
   Yorimitsu T, 2007, MOL BIOL CELL, V18, P4180, DOI 10.1091/mbc.E07-05-0485
   Zhang HH, 2006, MOL CELL, V24, P185, DOI 10.1016/j.molcel.2006.09.019
NR 81
TC 189
Z9 197
U1 1
U2 21
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0968-0004
EI 1362-4326
J9 TRENDS BIOCHEM SCI
JI Trends Biochem.Sci.
PD DEC
PY 2009
VL 34
IS 12
BP 620
EP 627
DI 10.1016/j.tibs.2009.09.004
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 533EY
UT WOS:000272807700005
PM 19875293
DA 2021-01-25
ER

PT J
AU Aregger, R
   Klostermeier, D
AF Aregger, Regula
   Klostermeier, Dagmar
TI The DEAD Box Helicase YxiN Maintains a Closed Conformation during ATP
   Hydrolysis
SO BIOCHEMISTRY
LA English
DT Article
ID RNA HELICASE; RIBOSOMAL-RNA; BINDING; DOMAIN; CORE; INHIBITION;
   SUFFICIENT; COMPLEXES; MECHANISM; PHOSPHATE
AB DEAD box helicases unwind RNA duplexes at the expense of ATP hydrolysis. Recently, unwinding has been demonstrated in the absence of ATP hydrolysis. Herein, we show that ADP . BeFx supports RNA unwinding by YxiN, a DEAD box helicase that specifically recognizes a hairpin in 23S rRNA. ADP-AlFx and ADP.MgFx do not promote RNA unwinding, but all ATP analogues induce a closed conformation of the helicase core as required for RNA unwinding. Our results show that the interdomain cleft in the helicase core closes upon ATP binding at the beginning of the cycle. Reopening occurs after ATP hydrolysis, most likely coupled to phosphate release.
C1 [Aregger, Regula; Klostermeier, Dagmar] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@unibas.ch
FU VolkswagenStiftungVolkswagen; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF)
FX We thank Ines Hertel for excellent technical assistance and Anne Karow
   and Markus Rudolph for comments on the manuscript. This work was funded
   by the VolkswagenStiftung and the Swiss National Science Foundation.
CR Ahmad Z, 2006, FEBS LETT, V580, P517, DOI 10.1016/j.febslet.2005.12.057
   Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981
   ANTONNY B, 1990, FEBS LETT, V268, P277, DOI 10.1016/0014-5793(90)81027-L
   BIGAY J, 1987, EMBO J, V6, P2907, DOI 10.1002/j.1460-2075.1987.tb02594.x
   Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006
   CHABRE M, 1990, TRENDS BIOCHEM SCI, V15, P6, DOI 10.1016/0968-0004(90)90117-T
   Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200
   Del Campo M, 2009, MOL CELL, V35, P598, DOI 10.1016/j.molcel.2009.07.032
   FISHER AJ, 1995, BIOCHEMISTRY-US, V34, P8960, DOI 10.1021/bi00028a004
   Graham DL, 2002, CHEM BIOL, V9, P375, DOI 10.1016/S1074-5521(02)00112-6
   Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046
   Hilbert M, 2009, BIOL CHEM, V390, P1237, DOI 10.1515/BC.2009.135
   Karginov FV, 2005, J BIOL CHEM, V280, P35499, DOI 10.1074/jbc.M506815200
   Karow AR, 2007, FEBS J, V274, P463, DOI 10.1111/j.1742-4658.2006.05593.x
   Karow AR, 2009, NUCLEIC ACIDS RES, V37, P4464, DOI 10.1093/nar/gkp397
   Kossen K, 2002, J MOL BIOL, V324, P625, DOI 10.1016/S0022-2836(02)01140-3
   Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106
   Nielsen KH, 2009, RNA, V15, P67, DOI 10.1261/rna.1283109
   Park S, 1999, BBA-PROTEIN STRUCT M, V1430, P127, DOI 10.1016/S0167-4838(98)00262-3
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561
   Wang SY, 2006, RNA, V12, P959, DOI 10.1261/rna.5906
NR 23
TC 40
Z9 40
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD NOV 17
PY 2009
VL 48
IS 45
BP 10679
EP 10681
DI 10.1021/bi901278p
PG 3
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 515HH
UT WOS:000271459100001
PM 19839642
DA 2021-01-25
ER

PT J
AU Nigg, EA
   Raff, JW
AF Nigg, Erich A.
   Raff, Jordan W.
TI Centrioles, Centrosomes, and Cilia in Health and Disease
SO CELL
LA English
DT Review
ID NEURAL STEM-CELLS; DE-NOVO FORMATION; INTRAFLAGELLAR TRANSPORT PROTEINS;
   POLYCYSTIC KIDNEY-DISEASE; LEFT-RIGHT ASYMMETRY; C-ELEGANS;
   TUMOR-SUPPRESSOR; BASAL BODY; PERICENTRIOLAR MATERIAL;
   CAENORHABDITIS-ELEGANS
AB Centrioles are barrel-shaped structures that are essential for the formation of centrosomes, cilia, and flagella. Here we review recent advances in our understanding of the function and biogenesis of these organelles, and we emphasize their connection to human disease. Deregulation of centrosome numbers has long been proposed to contribute to genome instability and tumor formation, whereas mutations in centrosomal proteins have recently been genetically linked to microcephaly and dwarfism. Finally, structural or functional centriole aberrations contribute to ciliopathies, a variety of complex diseases that stem from the absence or dysfunction of cilia.
C1 [Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Raff, Jordan W.] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England.
RP Nigg, EA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erich.nigg@unibas.ch; jordan.raff@path.ox.ac.uk
OI nigg, erich/0000-0003-4835-5719
FU Cancer Research UKCancer Research UK [10530] Funding Source: Medline;
   The Francis Crick Institute [10530] Funding Source: researchfish
CR AFZELIUS B A, 1976, Science (Washington D C), V193, P317
   Ahn S, 2005, NATURE, V437, P894, DOI 10.1038/nature03994
   Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166
   ANDERSON CT, 2009, CURR BIOL, DOI DOI 10.1016/J.CUB.2006.07.34
   Azimzadeh J, 2009, J CELL BIOL, V185, P101, DOI 10.1083/jcb.200808082
   Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136
   Basto R, 2008, CELL, V133, P1032, DOI 10.1016/j.cell.2008.05.039
   Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025
   Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038
   Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042
   Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180
   Blacque OE, 2006, CELL MOL LIFE SCI, V63, P2145, DOI 10.1007/s00018-006-6180-x
   Bobinnec Y, 1998, J CELL BIOL, V143, P1575, DOI 10.1083/jcb.143.6.1575
   Bond J, 2006, CURR OPIN CELL BIOL, V18, P95, DOI 10.1016/j.ceb.2005.11.004
   Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539
   Bond J, 2002, NAT GENET, V32, P316, DOI 10.1038/ng995
   Boveri T, 1914, FRAGE ENTSTEHUNG MAL
   Brunk K, 2007, J CELL SCI, V120, P3578, DOI 10.1242/jcs.014290
   Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570
   CALLAINI G, 1990, J CELL SCI, V97, P539
   Castellanos E, 2008, CURR BIOL, V18, P1209, DOI 10.1016/j.cub.2008.07.029
   Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632
   Chang MY, 2008, NEPHRON PHYSIOL, V108, P1, DOI 10.1159/000112495
   Cheng J, 2008, NATURE, V456, P599, DOI 10.1038/nature07386
   Corbit KC, 2005, NATURE, V437, P1018, DOI 10.1038/nature04117
   Culver BP, 2009, MOL BIOL CELL, V20, P1865, DOI 10.1091/mbc.E08-08-0838
   D'Assoro AB, 2002, BREAST CANCER RES TR, V75, P25, DOI 10.1023/A:1016550619925
   Dammermann A, 2004, DEV CELL, V7, P815, DOI 10.1016/j.devcel.2004.10.015
   Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102
   Davenport JR, 2007, CURR BIOL, V17, P1586, DOI 10.1016/j.cub.2007.08.034
   Dawe HR, 2007, HUM MOL GENET, V16, P173, DOI 10.1093/hmg/ddl459
   Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146
   Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059
   Dix CI, 2007, CURR BIOL, V17, P1759, DOI 10.1016/j.cub.2007.08.065
   Dobbelaere J, 2008, PLOS BIOL, V6, P1975, DOI 10.1371/journal.pbio.0060224
   Dodson H, 2004, EMBO J, V23, P3864, DOI 10.1038/sj.emboj.7600393
   Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418
   Dutcher SK, 2003, TRAFFIC, V4, P443, DOI 10.1034/j.1600-0854.2003.00104.x
   Ewart-Toland A, 2005, CARCINOGENESIS, V26, P1368, DOI 10.1093/carcin/bgi085
   Feldman JL, 2007, PLOS BIOL, V5, P1284, DOI [10.1371/journal.pbio.0050149, 10.1371/journal.pbio.0050286]
   Fisk HA, 2003, P NATL ACAD SCI USA, V100, P14875, DOI 10.1073/pnas.2434156100
   Frew IJ, 2008, EMBO J, V27, P1747, DOI 10.1038/emboj.2008.96
   FRY AM, 2004, CENTROSOMES DEV DIS, P143
   Fukasawa K, 2007, NAT REV CANCER, V7, P911, DOI 10.1038/nrc2249
   Ganem NJ, 2009, NATURE, V460, P278, DOI 10.1038/nature08136
   Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023
   Giansanti MG, 2008, CURR BIOL, V18, P303, DOI 10.1016/j.cub.2008.01.058
   Gisselsson D, 2003, ADV CANCER RES, V87, P1
   Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388
   Gomez-Ferreria MA, 2008, CELL CYCLE, V7, P1507, DOI 10.4161/cc.7.11.5957
   Gonzalez C, 2007, NAT REV GENET, V8, P462, DOI 10.1038/nrg2103
   Gonzalez C, 2008, CURR OPIN CELL BIOL, V20, P694, DOI 10.1016/j.ceb.2008.10.003
   Griffith E, 2008, NAT GENET, V40, P232, DOI 10.1038/ng.2007.80
   Gundersen GG, 2002, NAT REV MOL CELL BIO, V3, P296, DOI 10.1038/nrm777
   Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320
   Hachet V, 2007, DEV CELL, V12, P531, DOI 10.1016/j.devcel.2007.02.015
   Han YG, 2009, NAT MED, V15, P1062, DOI 10.1038/nm.2020
   Harris H, 2008, J CELL SCI, V121, P3, DOI [10.1242/jcs.017483, 10.1242/jcs.025742]
   Hemerly AS, 2009, SCIENCE, V323, P789, DOI 10.1126/science.1166745
   Hergovich A, 2003, NAT CELL BIOL, V5, P64, DOI 10.1038/ncb899
   Hergovich A, 2007, MOL CELL, V25, P625, DOI 10.1016/j.molcel.2007.01.020
   Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001
   Huang KY, 2009, J CELL BIOL, V186, P601, DOI 10.1083/jcb.200903066
   Huangfu DW, 2003, NATURE, V426, P83, DOI 10.1038/nature02061
   Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000
   Hut HMJ, 2003, MOL BIOL CELL, V14, P1993, DOI 10.1091/mbc.E02-08-0510
   Huttner WB, 2005, CURR OPIN CELL BIOL, V17, P648, DOI 10.1016/j.ceb.2005.10.005
   Ishikawa H, 2005, NAT CELL BIOL, V7, P517, DOI 10.1038/ncb1251
   Jackman M, 2003, NAT CELL BIOL, V5, P143, DOI 10.1038/ncb918
   Jeffers LJ, 2008, ONCOGENE, V27, P139, DOI 10.1038/sj.onc.1210595
   Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010
   Jonassen JA, 2008, J CELL BIOL, V183, P377, DOI 10.1083/jcb.200808137
   Jurczyk A, 2004, J CELL BIOL, V166, P637, DOI 10.1083/jcb.200405023
   Kalab P, 2008, J CELL SCI, V121, P1577, DOI 10.1242/jcs.005959
   Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619
   Keller LC, 2005, CURR BIOL, V15, P1090, DOI 10.1016/j.cub.2005.05.024
   Kemp CA, 2004, DEV CELL, V6, P511, DOI 10.1016/S1534-5807(04)00066-8
   Khodjakov A, 2002, J CELL BIOL, V158, P1171, DOI 10.1083/jcb.200205102
   Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109
   Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   KLOTZ C, 1990, J CELL BIOL, V110, P405, DOI 10.1083/jcb.110.2.405
   Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018
   Kramer A, 2004, NAT CELL BIOL, V6, P884, DOI 10.1038/ncb1165
   Kumar A, 2009, AM J HUM GENET, V84, P286, DOI 10.1016/j.ajhg.2009.01.017
   Kuriyama R, 2009, CELL MOTIL CYTOSKEL, V66, P588, DOI 10.1002/cm.20368
   Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908
   La Terra S, 2005, J CELL BIOL, V168, P713, DOI 10.1083/jcb.200411126
   Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406
   Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220
   Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5
   Lingle WL, 2002, P NATL ACAD SCI USA, V99, P1978, DOI 10.1073/pnas.032479999
   Loncarek J, 2008, NAT CELL BIOL, V10, P322, DOI 10.1038/ncb1694
   Loncarek J, 2009, MOL CELLS, V27, P135, DOI 10.1007/s10059-009-0017-z
   Lucas EP, 2007, J CELL BIOL, V178, P725, DOI 10.1083/jcb.200704081
   Marshall WF, 2008, J CELL BIOL, V180, P17, DOI 10.1083/jcb.200710085
   Marshall WF, 2009, CURR OPIN CELL BIOL, V21, P14, DOI 10.1016/j.ceb.2009.01.008
   Marshall WF, 2001, CURR BIOL, V11, P308, DOI 10.1016/S0960-9822(01)00094-X
   Martinez-Campos M, 2004, J CELL BIOL, V165, P673, DOI 10.1083/jcb.200402130
   Matsumoto Y, 2004, SCIENCE, V306, P885, DOI 10.1126/science.1103544
   Matsuura K, 2004, J CELL BIOL, V165, P663, DOI 10.1083/jcb.200402022
   Meraldi P, 2004, CURR OPIN GENET DEV, V14, P29, DOI 10.1016/j.gde.2003.11.006
   Mikule K, 2007, NAT CELL BIOL, V9, P160, DOI 10.1038/ncb1529
   Mogensen M.M., 2004, CENTROSOMES DEV DIS
   Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038
   Nachury MV, 2007, CELL, V129, P1201, DOI 10.1016/j.cell.2007.03.053
   Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046
   Nauli SM, 2003, NAT GENET, V33, P129, DOI 10.1038/ng1076
   Nigg EA, 2002, NAT REV CANCER, V2, P815, DOI 10.1038/nrc924
   Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003
   Nonaka S, 2005, PLOS BIOL, V3, P1467, DOI 10.1371/journal.pbio.0030268
   Nonaka S, 1998, CELL, V95, P829, DOI 10.1016/S0092-8674(00)81705-5
   O'Connell KF, 2000, DEV BIOL, V222, P55, DOI 10.1006/dbio.2000.9714
   O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5
   Pan JM, 2004, DEV CELL, V6, P445, DOI 10.1016/S1534-5807(04)00064-4
   Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709
   Pedersen LB, 2008, CURR TOP DEV BIOL, V85, P23, DOI 10.1016/S0070-2153(08)00802-8
   Peel N, 2007, CURR BIOL, V17, P834, DOI 10.1016/j.cub.2007.04.036
   Pelletier L, 2004, CURR BIOL, V14, P863, DOI 10.1016/j.cub.2004.04.012
   Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318
   Piel M, 2000, J CELL BIOL, V149, P317, DOI 10.1083/jcb.149.2.317
   Pihan GA, 2003, CANCER RES, V63, P1398
   Pihan GA, 1998, CANCER RES, V58, P3974
   Portier N, 2007, DEV CELL, V12, P515, DOI 10.1016/j.devcel.2007.01.019
   Pugacheva EN, 2007, CELL, V129, P1351, DOI 10.1016/j.cell.2007.04.035
   Quinlan RJ, 2008, CURR TOP DEV BIOL, V84, P249, DOI 10.1016/S0070-2153(08)00605-4
   Quintyne NJ, 2005, SCIENCE, V307, P127, DOI 10.1126/science.1104905
   Rauch A, 2008, SCIENCE, V319, P816, DOI 10.1126/science.1151174
   Rebollo E, 2007, DEV CELL, V12, P467, DOI 10.1016/j.devcel.2007.01.021
   Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950
   Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140
   Satir P, 2007, ANNU REV PHYSIOL, V69, P377, DOI 10.1146/annurev.physiol.69.040705.141236
   Schermer B, 2006, J CELL BIOL, V175, P547, DOI 10.1083/jcb.200605092
   Schmidt TI, 2009, CURR BIOL, V19, P1005, DOI 10.1016/j.cub.2009.05.016
   Silkworth WT, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006564
   Singla V, 2006, SCIENCE, V313, P629, DOI 10.1126/science.1124534
   Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027
   Srsen V, 2006, J CELL BIOL, V174, P625, DOI 10.1083/jcb.200606051
   Stevens NR, 2007, CURR BIOL, V17, P1498, DOI 10.1016/j.cub.2007.07.060
   Stinchcombe JC, 2006, NATURE, V443, P462, DOI 10.1038/nature05071
   Storchova Z, 2004, NAT REV MOL CELL BIO, V5, P45, DOI 10.1038/nrm1276
   Strnad P, 2007, DEV CELL, V13, P203, DOI 10.1016/j.devcel.2007.07.004
   Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723
   Tachibana KEK, 2005, EMBO REP, V6, P1052, DOI 10.1038/sj.embor.7400527
   Takada S, 2003, CELL, V113, P87, DOI 10.1016/S0092-8674(03)00202-2
   Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889
   Tsai JW, 2007, NAT NEUROSCI, V10, P970, DOI 10.1038/nn1934
   Tsou MFB, 2006, NATURE, V442, P947, DOI 10.1038/nature04985
   Tsou MFB, 2009, DEV CELL, V17, P344, DOI 10.1016/j.devcel.2009.07.015
   Ueda M, 1997, P NATL ACAD SCI USA, V94, P9674, DOI 10.1073/pnas.94.18.9674
   Uetake Y, 2007, J CELL BIOL, V176, P173, DOI 10.1083/jcb.200607073
   Wadsworth P, 2004, TRENDS CELL BIOL, V14, P413, DOI 10.1016/j.tcb.2004.07.004
   Wakefield JG, 2000, CURR BIOL, V10, P1367, DOI 10.1016/S0960-9822(00)00776-4
   Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435
   Warnke S, 2004, CURR BIOL, V14, P1200, DOI 10.1016/j.cub.2004.06.059
   Wessely O, 2008, FRONT BIOSCI-LANDMRK, V13, P1866, DOI 10.2741/2806
   Wong C, 2003, NAT CELL BIOL, V5, P539, DOI 10.1038/ncb993
   Wong SY, 2009, NAT MED, V15, P1055, DOI 10.1038/nm.2011
   Woods CG, 2005, AM J HUM GENET, V76, P717, DOI 10.1086/429930
   Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795
   Yamashita YM, 2007, SCIENCE, V315, P518, DOI 10.1126/science.1134910
   Yang Z, 2008, NAT CELL BIOL, V10, P748, DOI 10.1038/ncb1738
   Yoshimura S, 2007, J CELL BIOL, V178, P363, DOI 10.1083/jcb.200703047
   Zhu F, 2008, CURR BIOL, V18, P136, DOI 10.1016/j.cub.2007.12.055
NR 164
TC 577
Z9 587
U1 2
U2 96
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD NOV 13
PY 2009
VL 139
IS 4
BP 663
EP 678
DI 10.1016/j.cell.2009.10.036
PG 16
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 519EG
UT WOS:000271747200012
PM 19914163
DA 2021-01-25
ER

PT J
AU Breidert, M
   Hofbauer, K
AF Breidert, M.
   Hofbauer, K.
TI Placebo: Misunderstandings and Prejudices
SO DEUTSCHES ARZTEBLATT INTERNATIONAL
LA English
DT Review
DE drug safety; drug research; treatment study; complementary medicine;
   medical prescriptions
ID TRIALS COMPARING PLACEBO; POWERLESS; ETHICS
AB Background: The role of placebos is often misunderstood, leading both to overvaluation and to inappropriate disdain. The effect of a placebo that contains no pharmacologically active substance is often confused with the effect of administration by a physician. The aim of this article is to review the current data on placebos, evaluate these data critically, and provide a well-founded and understandable explanation of the effects that placebos do and do not possess.
   Methods: Selective literature review.
   Results: Recent studies employing modern imaging techniques have provided objective correlates of the effect of placebo administration for certain indications. A recent paper even suggested a genetic basis for it. Two main mechanisms underlie the effect of placebo administration: conditioned reflexes, which are subconscious, and the patient's expectations, which are conscious. Further factors include the physician's personality and the setting in which the treatment takes place.
   Conclusions: The mechanisms of action of placebo administration, with which positive therapeutic effects can be achieved with little effort, should be consciously exploited by physicians when giving their patients pharmacologically active medications as well.
C1 [Breidert, M.] Kliniken Nat Pk Altmuhltal, Med Klin 1, Klin Kosching, D-85092 Kosching, Germany.
   [Hofbauer, K.] Univ Basel, Lehrstuhl Angew Pharmakol, Biozentrum, CH-4003 Basel, Switzerland.
RP Breidert, M (corresponding author), Kliniken Nat Pk Altmuhltal, Med Klin 1, Klin Kosching, Krankenhausstr 19, D-85092 Kosching, Germany.
RI anand, amit/A-7222-2009
CR Asmar R, 2001, AM J HYPERTENS, V14, P546, DOI 10.1016/S0895-7061(00)01286-3
   Barsky AJ, 2002, JAMA-J AM MED ASSOC, V287, P622, DOI 10.1001/jama.287.5.622
   BEECHER HK, 1955, JAMA-J AM MED ASSOC, V159, P1602, DOI 10.1001/jama.1955.02960340022006
   Benedetti F, 2007, NEUROSCIENCE, V147, P260, DOI 10.1016/j.neuroscience.2007.02.020
   Benedetti F, 2006, J NEUROSCI, V26, P12014, DOI 10.1523/JNEUROSCI.2947-06.2006
   BLAND JM, 1994, BRIT MED J, V308, P1499, DOI 10.1136/bmj.308.6942.1499
   deCraen AJM, 1996, BRIT MED J, V313, P1624, DOI 10.1136/bmj.313.7072.1624
   Di Blasi Z, 2001, LANCET, V357, P757, DOI 10.1016/S0140-6736(00)04169-6
   Edward SJL, 2005, WORLD J SURG, V29, P610, DOI 10.1007/s00268-005-7621-7
   Enck P, 2008, NEURON, V59, P195, DOI 10.1016/j.neuron.2008.06.030
   FEDELE L, 1989, PAIN, V36, P43, DOI 10.1016/0304-3959(89)90110-3
   Furmark T, 2008, J NEUROSCI, V28, P13066, DOI 10.1523/JNEUROSCI.2534-08.2008
   Geers AL, 2005, J PSYCHOSOM RES, V58, P121, DOI 10.1016/j.jpsychores.2004.08.011
   Graz B, 2005, SPINE, V30, P1448, DOI 10.1097/01.brs.0000166508.88846.b3
   Herr HW, 2005, UROL ONCOL-SEMIN ORI, V23, P346, DOI 10.1016/j.urolonc.2005.02.003
   Hrobjartsson A, 2001, NEW ENGL J MED, V344, P1594, DOI 10.1056/NEJM200105243442106
   Hrobjartsson A, 2004, J INTERN MED, V256, P91, DOI 10.1111/j.1365-2796.2004.01355.x
   Kaptchuk TJ, 2008, BMJ-BRIT MED J, V336, P999, DOI 10.1136/bmj.39524.439618.25
   KENNEDY W P, 1961, Med World, V95, P203
   Kienle GS, 1997, J CLIN EPIDEMIOL, V50, P1311, DOI 10.1016/S0895-4356(97)00203-5
   Koshi Edvin B, 2007, Pain Pract, V7, P4, DOI 10.1111/j.1533-2500.2007.00104.x
   Lichtenberg P, 2004, J MED ETHICS, V30, P551, DOI 10.1136/jme.2002.002832
   McQuay HJ, 2005, POSTGRAD MED J, V81, P155, DOI 10.1136/pgmj.2004.024737
   Oeltjenbruns J, 2008, ANAESTHESIST, V57, P447, DOI 10.1007/s00101-008-1370-6
   PARK LC, 1965, ARCH GEN PSYCHIAT, V12, P336
   Plassmann H, 2008, P NATL ACAD SCI USA, V105, P1050, DOI 10.1073/pnas.0706929105
   Quitkin FM, 1999, AM J PSYCHIAT, V156, P829, DOI 10.1176/ajp.156.6.829
   SCHONBACHLER G, 2007, SCHWEIZ MED FORUM, V7, P205
   Shang AJ, 2005, LANCET, V366, P726, DOI 10.1016/S0140-6736(05)67177-2
   Stockhorst U, 2005, CURR OPIN PSYCHIATR, V18, P181, DOI 10.1097/00001504-200503000-00012
   Tilburt JC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1938
   Waber RL, 2008, JAMA-J AM MED ASSOC, V299, P1016, DOI 10.1001/jama.299.9.1016
   Zernikow B, 2008, DTSCH ARZTEBL INT, V105, P511, DOI 10.3238/arztebl.2008.0511
   Zhang W, 2008, ANN RHEUM DIS, V67, P1716, DOI 10.1136/ard.2008.092015
   Zwingmann C, 2005, Rehabilitation (Stuttg), V44, P244
NR 35
TC 22
Z9 22
U1 0
U2 9
PU DEUTSCHER AERZTE-VERLAG GMBH
PI COLOGNE
PA DIESELSTRABE 2, POSTFACH 400265, D-50859 COLOGNE, GERMANY
SN 1866-0452
J9 DTSCH ARZTEBL INT
JI Dtsch. Arztebl. Int.
PD NOV 13
PY 2009
VL 106
IS 46
BP 751
EP U7
DI 10.3238/arztebl.2009.0751
PG 6
WC Medicine, General & Internal
SC General & Internal Medicine
GA 525UX
UT WOS:000272243000001
PM 20019863
OA Green Published
DA 2021-01-25
ER

PT J
AU Rasch, B
   Spalek, K
   Buholzer, S
   Luechinger, R
   Boesiger, P
   Papassotiropoulos, A
   de Quervain, DJF
AF Rasch, B.
   Spalek, K.
   Buholzer, S.
   Luechinger, R.
   Boesiger, P.
   Papassotiropoulos, A.
   de Quervain, D. J-F
TI A genetic variation of the noradrenergic system is related to
   differential amygdala activation during encoding of emotional memories
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE ADRA2B; fMRI; polymorphism; imaging genetics
ID POSTTRAUMATIC-STRESS-DISORDER; CONDITIONED TASTE-AVERSION; LONG-TERM
   POTENTIATION; INSULAR CORTEX; ADRENERGIC ACTIVATION; BASOLATERAL
   AMYGDALA; INHIBITORY AVOIDANCE; DECLARATIVE MEMORY; BRAIN SYSTEMS;
   BLOOD-FLOW
AB Emotionally arousing events are typically well remembered, but there is a large interindividual variability for this phenomenon. We have recently shown that a functional deletion variant of ADRA2B, the gene encoding the alpha 2b-adrenergic receptor, is related to enhanced emotional memory in healthy humans and enhanced traumatic memory in war victims. Here, we investigated the neural mechanisms of this effect in healthy participants by using fMRI. Carriers of the ADRA2B deletion variant exhibited increased activation of the amygdala during encoding of photographs with negative emotional valence compared with noncarriers of the deletion. Additionally, functional connectivity between amygdala and insula was significantly stronger in deletion carriers. The present findings indicate that the ADRA2B deletion variant is related to increased responsivity and connectivity of brain regions implicated in emotional memory.
C1 [Rasch, B.; de Quervain, D. J-F] Univ Basel, Div Cognit Neurosci, CH-4055 Basel, Switzerland.
   [Rasch, B.; Spalek, K.; Buholzer, S.; Papassotiropoulos, A.] Univ Basel, Div Mol Psychol, CH-4055 Basel, Switzerland.
   [Rasch, B.; Spalek, K.; Buholzer, S.; Papassotiropoulos, A.] Univ Basel, Biozentrum, Life Sci Training Facil, CH-4056 Basel, Switzerland.
   [Rasch, B.; de Quervain, D. J-F] Univ Basel, Psychiat Univ Clin, CH-4055 Basel, Switzerland.
   [Rasch, B.; de Quervain, D. J-F] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland.
   [Luechinger, R.; Boesiger, P.] Univ Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland.
   [Luechinger, R.; Boesiger, P.] ETH Inst, CH-8092 Zurich, Switzerland.
RP Rasch, B (corresponding author), Univ Basel, Div Cognit Neurosci, Birmannsgasse 8, CH-4055 Basel, Switzerland.
EM Bjoern.Rasch@unibas.ch; dominique.dequervain@unibas.ch
RI Luechinger, Roger/AAD-5192-2019; Rasch, Bjorn/A-3119-2015
OI Luechinger, Roger/0000-0002-7365-0421; Rasch, Bjorn/0000-0001-7607-3415;
   de Quervain, Dominique/0000-0001-7131-2464; Papassotiropoulos,
   Andreas/0000-0002-2210-9651
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PP00P3-123391, CRSIK0_122691]; European Science
   FoundationEuropean Science Foundation (ESF); Zurich Center for
   Integrative Human Physiology
FX This work was supported by Swiss National Science Foundation Grants
   PP00P3-123391 and CRSIK0_122691 (to D. J.-F. d. Q.) and PP00P3-114813
   and CRSIK0_122691 (to A. P.), the European Science Foundation
   (EUROStress) (D. J.-F. d. Q. and A. P.), and a grant from the Zurich
   Center for Integrative Human Physiology (to D. J.-F. d. Q.).
CR Adolphs R, 1997, LEARN MEMORY, V4, P291, DOI 10.1101/lm.4.3.291
   Bermudez-Rattoni F, 2004, CELL MOL NEUROBIOL, V24, P25, DOI 10.1023/B:CEMN.0000012722.45805.c8
   Britton JC, 2005, BIOL PSYCHIAT, V57, P832, DOI 10.1016/j.biopsych.2004.12.025
   Buchel C, 1999, J NEUROSCI, V19, P10869
   Buchel C, 1998, NEURON, V20, P947, DOI 10.1016/S0896-6273(00)80476-6
   CAHILL L, 1994, NATURE, V371, P702, DOI 10.1038/371702a0
   Cahill L, 1996, P W PHARMACOL SOC, V39, P81
   Cahill L, 1996, P NATL ACAD SCI USA, V93, P8016, DOI 10.1073/pnas.93.15.8016
   CAHILL L, 1995, NATURE, V377, P295, DOI 10.1038/377295a0
   de Quervain DJF, 2007, NAT NEUROSCI, V10, P1137, DOI 10.1038/nn1945
   Dolcos F, 2005, P NATL ACAD SCI USA, V102, P2626, DOI 10.1073/pnas.0409848102
   Dolcos F, 2004, NEUROIMAGE, V23, P64, DOI 10.1016/j.neuroimage.2004.05.015
   Escobar ML, 1998, BRAIN RES, V779, P314, DOI 10.1016/S0006-8993(97)01175-X
   Ferry B, 1999, J NEUROSCI, V19, P5119
   Ferry B, 1999, EUR J PHARMACOL, V372, P9, DOI 10.1016/S0014-2999(99)00169-7
   Friston KJ, 1997, NEUROIMAGE, V6, P218, DOI 10.1006/nimg.1997.0291
   Hamann SB, 1999, NAT NEUROSCI, V2, P289, DOI 10.1038/6404
   Hariri AR, 2003, BRIT MED BULL, V65, P259, DOI 10.1093/bmb/65.1.259
   Hurlemann R, 2005, J NEUROSCI, V25, P6343, DOI 10.1523/JNEUROSCI.0228-05.2005
   Jones MW, 1999, J NEUROSCI, V19, part. no.
   Kensinger EA, 2006, J NEUROSCI, V26, P2564, DOI 10.1523/JNEUROSCI.5241-05.2006
   LaBar KS, 2006, NAT REV NEUROSCI, V7, P54, DOI 10.1038/nrn1825
   Lancaster JL, 2000, HUM BRAIN MAPP, V10, P120, DOI 10.1002/1097-0193(200007)10:3<120::AID-HBM30>3.0.CO;2-8
   Lang PJ, 2008, INT AFFECTIVE PICTUR
   LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155
   LIANG KC, 1986, BRAIN RES, V368, P125, DOI 10.1016/0006-8993(86)91049-8
   Liberzon I, 2006, ANN NY ACAD SCI, V1071, P87, DOI 10.1196/annals.1364.009
   Maheu FS, 2004, BEHAV NEUROSCI, V118, P420, DOI 10.1037/0735-7044.118.2.420
   Maldjian JA, 2003, NEUROIMAGE, V19, P1233, DOI 10.1016/S1053-8119(03)00169-1
   MARKOWITSCH HJ, 1994, NEUROREPORT, V5, P1349, DOI 10.1097/00001756-199406000-00014
   Marschner A, 2008, J NEUROSCI, V28, P9030, DOI 10.1523/JNEUROSCI.1651-08.2008
   Mattay VS, 2004, CURR OPIN NEUROBIOL, V14, P239, DOI 10.1016/j.conb.2004.03.014
   McGaugh J.L., 2003, MEMORY EMOTION MAKIN
   McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9
   McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248
   McGaugh JL, 2004, ANNU REV NEUROSCI, V27, P1, DOI 10.1146/annurev.neuro.27.070203.144157
   McGaugh JL, 2002, NEUROBIOL LEARN MEM, V78, P539, DOI 10.1006/nlme.2002.4082
   McIntyre CK, 2002, EUR J NEUROSCI, V16, P1223, DOI 10.1046/j.1460-9568.2002.02188.x
   Miranda MI, 2004, LEARN MEMORY, V11, P312, DOI 10.1101/lm.72804
   Nagai M, 2007, EUR PSYCHIAT, V22, P387, DOI 10.1016/j.eurpsy.2007.02.006
   O'Carroll RE, 1999, PSYCHOL MED, V29, P1083, DOI 10.1017/S0033291799008703
   Osuch EA, 2001, BIOL PSYCHIAT, V50, P246, DOI 10.1016/S0006-3223(01)01107-6
   Phan KL, 2002, NEUROIMAGE, V16, P331, DOI 10.1006/nimg.2002.1087
   Phan KL, 2004, CNS SPECTRUMS, V9, P258, DOI 10.1017/S1092852900009196
   Phelps EA, 2004, CURR OPIN NEUROBIOL, V14, P198, DOI 10.1016/j.conb.2004.03.015
   Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025
   Pitman RK, 2002, BIOL PSYCHIAT, V51, P189, DOI 10.1016/S0006-3223(01)01279-3
   PITMAN RK, 1989, BIOL PSYCHIAT, V26, P221, DOI 10.1016/0006-3223(89)90033-4
   Pruessmann KP, 1999, MAGNET RESON MED, V42, P952, DOI 10.1002/(SICI)1522-2594(199911)42:5<952::AID-MRM16>3.0.CO;2-S
   Rasch B., 2006, QUANTITATIVE METHODS
   Rauch SL, 1996, ARCH GEN PSYCHIAT, V53, P380
   Reuter M, 2008, BIOL PSYCHOL, V79, P111, DOI 10.1016/j.biopsycho.2007.12.002
   Ritchey M, 2008, CEREB CORTEX, V18, P2494, DOI 10.1093/cercor/bhm262
   Sharot T, 2008, COGNITION, V106, P538, DOI 10.1016/j.cognition.2007.03.002
   Shin LM, 2006, ANN NY ACAD SCI, V1071, P67, DOI 10.1196/annals.1364.007
   Small KM, 2001, J BIOL CHEM, V276, P4917, DOI 10.1074/jbc.M008118200
   Sommer T, 2008, LEARN MEMORY, V15, P569, DOI 10.1101/lm.995108
   Southwick SM, 2002, AM J PSYCHIAT, V159, P1420, DOI 10.1176/appi.ajp.159.8.1420
   St Jacques PL, 2009, PSYCHOL SCI, V20, P74, DOI 10.1111/j.1467-9280.2008.02258.x
   Strange BA, 2004, P NATL ACAD SCI USA, V101, P11454, DOI 10.1073/pnas.0404282101
   Talmi D, 2008, LEARN MEMORY, V15, P172, DOI 10.1101/lm.722908
   Tan HY, 2007, J NEUROSCI, V27, P13393, DOI 10.1523/JNEUROSCI.4041-07.2007
   Welzl H, 2001, BEHAV BRAIN RES, V125, P205, DOI 10.1016/S0166-4328(01)00302-3
NR 63
TC 105
Z9 109
U1 1
U2 11
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD NOV 10
PY 2009
VL 106
IS 45
BP 19191
EP 19196
DI 10.1073/pnas.0907425106
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 517SJ
UT WOS:000271637500057
PM 19826083
OA Green Accepted, Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Peterle, T
   Ringler, P
   Mayor, M
AF Peterle, Torsten
   Ringler, Philippe
   Mayor, Marcel
TI Gold Nanoparticles Stabilized by Acetylene-Functionalized Multidentate
   Thioether Ligands: Building Blocks for Nanoparticle Superstructures
SO ADVANCED FUNCTIONAL MATERIALS
LA English
DT Article
ID SELF-ASSEMBLED MONOLAYERS; TERMINAL ALKYNES; MOLECULAR RECOGNITION; DNA;
   ORGANIZATION; SUPERLATTICE; DENDRIMERS; OLIGOMERS; NETWORKS; SULFIDES
AB Aiming at the formation of inorganic/organic hybrid gold nanoparticle superstructures, the design and synthesis of acetylene-monofunctionalized multidentate thioether ligands and their ability to stabilize gold nanoparticles are presented. Rather monodisperse gold particles with diameters of about 1 nm are obtained, which are coated by a small number of ligands, each comprising a silyl-protected acetylene. The acetylene is attached at the end of a rigid ethynylene-phenylene unit of variable length, leading to functionalized gold nanoparticles carrying acetylenes at different distances from the nanoparticle surface. These particles are interlinked by diacetylene formation and are investigated by transmission electron microscopy and UV/vis spectroscopy, revealing the formation of nanoparticle aggregates and small superstructures such as dimers or trimers while the nanoparticles themselves retain their integrity. The interparticle distance in small nanoparticle superstructures reflects the ethynylene-phenylene spacer length corroborating the wet chemical interlinking as the origin of these organic/inorganic hybrid structures.
C1 [Peterle, Torsten; Mayor, Marcel] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   [Mayor, Marcel] Forschungszentrum Karlsruhe, Inst Nanotechnol, D-76021 Karlsruhe, Germany.
   [Ringler, Philippe] Univ Basel, C CINA Biozentrum, CH-4002 Basel, Switzerland.
RP Peterle, T (corresponding author), Univ Basel, Dept Chem, St Johanns Ring 19, CH-4056 Basel, Switzerland.
EM marcel.mayor@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Gebert Rbf Foundation; EUEuropean Union (EU) [213382]; SNF
   [3100AO-108299]
FX This work was supported by the Swiss National Science Foundation, the
   Gebert Rbf Foundation and the EU through the project FUN MOL (number
   213382) ofthe call FP7-NMP-2007-SMALL-1. We thank Prof. Andreas Engel
   for his support of the TEM investigations (SNF grant 3100AO-108299).
   Supporting Information is available online from Wiley InterScience
   orfirom the authors.
CR Aldaye FA, 2006, ANGEW CHEM INT EDIT, V45, P2204, DOI 10.1002/anie.200502481
   Alivisatos AP, 1996, NATURE, V382, P609, DOI 10.1038/382609a0
   Alvarez MM, 1997, J PHYS CHEM B, V101, P3706, DOI 10.1021/jp962922n
   Andres RP, 1996, SCIENCE, V273, P1690, DOI 10.1126/science.273.5282.1690
   Bernard L, 2007, J PHYS CHEM C, V111, P18445, DOI 10.1021/jp077095c
   Beulen MWJ, 1998, LANGMUIR, V14, P7463, DOI 10.1021/la981031z
   Boal AK, 2000, NATURE, V404, P746
   BRUST M, 1994, J CHEM SOC CHEM COMM, P801, DOI 10.1039/c39940000801
   BRUST M, 1995, ADV MATER, V7, P795, DOI 10.1002/adma.19950070907
   Bunz UHF, 1999, CHEM SOC REV, V28, P107, DOI 10.1039/a708900g
   D'Aleo A, 2004, ADV FUNCT MATER, V14, P1167, DOI 10.1002/adfm.200400101
   Dadosh T, 2005, NATURE, V436, P677, DOI 10.1038/nature03898
   Deng ZX, 2005, ANGEW CHEM INT EDIT, V44, P3582, DOI 10.1002/anie.200463096
   DeVries GA, 2007, SCIENCE, V315, P358, DOI 10.1126/science.1133162
   Diederich F, 2001, CHEM COMMUN, P219, DOI 10.1039/b009180o
   EGLINTON G, 1956, CHEM IND-LONDON, P737
   Evans SD, 2000, J MATER CHEM, V10, P183, DOI 10.1039/a903951a
   Fairlamb IJS, 2003, CHEM COMMUN, P632, DOI 10.1039/b212430k
   Fischler M, 2008, CHEM COMMUN, P169, DOI 10.1039/b715602b
   Fullam S, 2002, CHEM MATER, V14, P3643, DOI 10.1021/cm011182e
   Glaser C., 1869, BER DTSCH CHEM GES, V2, P422, DOI DOI 10.1002/CBER.186900201183
   Glaser C., 1870, ANN CHEM PHARM, V154, P137, DOI DOI 10.1002/JLAC.18701540202
   Greene T. W., 2006, PROTECTIVE GROUPS OR
   Hainfeld JF, 2000, J HISTOCHEM CYTOCHEM, V48, P471, DOI 10.1177/002215540004800404
   HAY AS, 1962, J ORG CHEM, V27, P3320, DOI 10.1021/jo01056a511
   Hosokawa Y, 2005, B CHEM SOC JPN, V78, P1773, DOI 10.1246/bcsj.78.1773
   Huisgen R., 1963, ANGEW CHEM INT EDIT, V2, P633, DOI DOI 10.1002/ANIE.196306331
   Huisgen R., 1963, ANGEW CHEM INT EDIT, V2, P565, DOI DOI 10.1002/ANIE.196305651
   Huo FW, 2006, ADV MATER, V18, P2304, DOI 10.1002/adma.200601178
   Kanehara M, 2006, J AM CHEM SOC, V128, P13084, DOI 10.1021/ja064510q
   Katz E, 2004, ANGEW CHEM INT EDIT, V43, P6042, DOI 10.1002/anie.200400651
   KESSLER P, 1994, BIOCONJUGATE CHEM, V5, P199, DOI 10.1021/bc00027a004
   Klajn R, 2008, ADV FUNCT MATER, V18, P2763, DOI 10.1002/adfm.200800293
   Kolb HC, 2001, ANGEW CHEM INT EDIT, V40, P2004, DOI 10.1002/1521-3773(20010601)40:11<2004::AID-ANIE2004>3.3.CO;2-X
   Kruger C, 2008, J AM CHEM SOC, V130, P2710, DOI 10.1021/ja0763495
   Lavastre O, 1996, TETRAHEDRON, V52, P5495, DOI 10.1016/0040-4020(96)00240-2
   Lavrich DJ, 1998, J PHYS CHEM B, V102, P3456, DOI 10.1021/jp980047v
   Lee JH, 2007, ANGEW CHEM INT EDIT, V46, P9006, DOI 10.1002/anie.200702569
   Levy R, 2006, CHEMBIOCHEM, V7, P592, DOI 10.1002/cbic.200500457
   Li JH, 2005, J ORG CHEM, V70, P4393, DOI 10.1021/jo0503310
   Li XM, 2001, J MATER CHEM, V11, P1919, DOI 10.1039/b101686p
   Liao J, 2006, ADV MATER, V18, P2444, DOI 10.1002/adma.200601001
   Lin XM, 1999, CHEM MATER, V11, P198, DOI 10.1021/cm980665o
   Liu J, 1999, J AM CHEM SOC, V121, P4304, DOI 10.1021/ja990330n
   Maier SA, 2001, ADV MATER, V13, P1501, DOI 10.1002/1521-4095(200110)13:19<1501::AID-ADMA1501>3.0.CO;2-Z
   Maye MM, 2002, J AM CHEM SOC, V124, P4958, DOI 10.1021/ja025724k
   Mirkin CA, 1996, NATURE, V382, P607, DOI 10.1038/382607a0
   Naka K, 2003, LANGMUIR, V19, P5496, DOI 10.1021/la026898i
   Nakano Y, 2004, ORG LETT, V6, P2373, DOI 10.1021/ol049277k
   Niemeyer CM, 2003, ANGEW CHEM INT EDIT, V42, P5796, DOI 10.1002/anie.200301703
   Ozawa H, 2007, LANGMUIR, V23, P6365, DOI 10.1021/la0634544
   Park SY, 2008, NATURE, V451, P553, DOI 10.1038/nature06508
   Dmitrii F, 2007, ANGEW CHEM INT EDIT, V46, P6006, DOI 10.1002/anie.200701554
   Peterle T, 2008, CHEM COMMUN, P3438, DOI 10.1039/b802460j
   Reinhard BM, 2005, NANO LETT, V5, P2246, DOI 10.1021/nl051592s
   Riskin M, 2008, J AM CHEM SOC, V130, P9726, DOI 10.1021/ja711278c
   Rosi NL, 2005, CHEM REV, V105, P1547, DOI 10.1021/cr030067f
   Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4
   Schmid G, 2005, CHEM COMMUN, P697, DOI 10.1039/b411696h
   Schreiber F, 2000, PROG SURF SCI, V65, P151, DOI 10.1016/S0079-6816(00)00024-1
   Schultz DA, 2003, CURR OPIN BIOTECH, V14, P13, DOI 10.1016/S0958-1669(02)00015-0
   Seelig J, 2007, NANO LETT, V7, P685, DOI 10.1021/nl0627590
   Shelley EJ, 2002, LANGMUIR, V18, P1791, DOI 10.1021/la0109260
   Shenton W, 1999, ADV MATER, V11, P449, DOI 10.1002/(SICI)1521-4095(199904)11:6<449::AID-ADMA449>3.0.CO;2-A
   Shyr MHS, 2008, J AM CHEM SOC, V130, P8234, DOI 10.1021/ja711026r
   Siemsen P, 2000, ANGEW CHEM INT EDIT, V39, P2633
   Sommer WJ, 2007, LANGMUIR, V23, P11991, DOI 10.1021/la7018742
   Sonogashira K, 1998, METAL-CATALYZED CROSS-COUPLING REACTIONS, P203
   SONOGASHIRA K, 1975, TETRAHEDRON LETT, P4467, DOI 10.1016/s0040-4039(00)91094-3
   Sung KM, 2004, J AM CHEM SOC, V126, P5064, DOI 10.1021/ja049578p
   Takiguchi H, 2000, LANGMUIR, V16, P1703, DOI 10.1021/la981450w
   Taubert A, 2003, J MATER CHEM, V13, P1090, DOI 10.1039/b207895c
   Templeton AC, 1998, J AM CHEM SOC, V120, P1906, DOI 10.1021/ja973863+
   van den Brom CR, 2007, CHEM COMMUN, P4922, DOI 10.1039/b711435d
   Worden JG, 2004, CHEM COMMUN, P518, DOI 10.1039/b312819a
   Yamada M, 2006, CHEM COMMUN, P2569, DOI 10.1039/b604001b
   Yan J, 2007, SYNTHESIS-STUTTGART, P1301, DOI 10.1055/s-2007-966008
   Zanchet D, 2001, NANO LETT, V1, P32, DOI 10.1021/nl005508e
   Zeng FW, 1996, J AM CHEM SOC, V118, P5326, DOI 10.1021/ja960317s
   Zhang HL, 2002, NANOTECHNOLOGY, V13, P439, DOI 10.1088/0957-4484/13/3/339
   Zhang S, 2007, J AM CHEM SOC, V129, P4876, DOI 10.1021/ja0704380
   Zhou Y, 2008, ANGEW CHEM INT EDIT, V47, P7454, DOI 10.1002/anie.200802317
   Zotti G, 2008, CHEM MATER, V20, P397, DOI 10.1021/cm071701z
NR 83
TC 41
Z9 41
U1 3
U2 52
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1616-301X
EI 1616-3028
J9 ADV FUNCT MATER
JI Adv. Funct. Mater.
PD NOV 9
PY 2009
VL 19
IS 21
BP 3497
EP 3506
DI 10.1002/adfm.200901410
PG 10
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary; Physics, Applied;
   Physics, Condensed Matter
SC Chemistry; Science & Technology - Other Topics; Materials Science;
   Physics
GA 523YD
UT WOS:000272110100021
DA 2021-01-25
ER

PT J
AU Markovic-Housley, Z
   Basle, A
   Padavattan, S
   Maderegger, B
   Schirmer, T
   Hoffmann-Sommergruber, K
AF Markovic-Housley, Zora
   Basle, Arnaud
   Padavattan, Sivaraman
   Maderegger, Bernhard
   Schirmer, Tilman
   Hoffmann-Sommergruber, Karin
TI Structure of the major carrot allergen Dau c 1
SO ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY
LA English
DT Article
ID BET V 1; BIRCH POLLEN ALLERGENS; CRYSTAL-STRUCTURE; MOLECULAR
   CHARACTERIZATION; CROSS-REACTIVITIES; FOOD ALLERGY; IN-VITRO; PROTEIN;
   CELERY; BET-V-1
AB Dau c 1 is a major allergen of carrot ( Daucus carota) which displays IgE cross-reactivity with the homologous major birch-pollen allergen Bet v 1. The crystal structure of Dau c 1 has been determined to a resolution of 2.7 angstrom, revealing tight dimers. The structure of Dau c 1 is similar to those of the major allergens from celery, Api g 1, and birch pollen, Bet v 1. Electron density has been observed in the hydrophobic cavity of each monomer and has been modelled with polyethylene glycol oligomers of varying length. Comparison of the surface topology and physicochemical properties of Dau c 1 and Bet v 1 revealed that they may have some, but not all, epitopes in common. This is in agreement with the observation that the majority of carrot-allergic patients have Bet v 1 cross-reactive IgE antibodies, whereas others have Dau c 1-specific IgE antibodies which do not recognize Bet v 1.
C1 [Markovic-Housley, Zora; Basle, Arnaud; Padavattan, Sivaraman; Schirmer, Tilman] Univ Basel, Biozentrum, Core Program Struct Biol & Biophys, CH-4056 Basel, Switzerland.
   [Maderegger, Bernhard] Biomay AG, A-1090 Vienna, Austria.
   [Hoffmann-Sommergruber, Karin] Med Univ Vienna, Dept Pathophysiol, A-1090 Vienna, Austria.
RP Markovic-Housley, Z (corresponding author), Univ Basel, Biozentrum, Core Program Struct Biol & Biophys, CH-4056 Basel, Switzerland.
EM zora.housley@unibas.ch
OI Hoffmann-Sommergruber, Karin/0000-0002-8830-058X; Padavattan,
   Sivaraman/0000-0002-1732-5421
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31116804]
FX The authors would like to thank the staff at the synchrotron beamline PX
   at SLS in Villigen, Switzerland. This study was supported by Swiss
   National Science Foundation grant No. 31116804 to ZMH. This publication
   is dedicated to the memory of Dr Markus Susani, who unexpectedly passed
   away in August 2007.
CR BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Ballmer-Weber BK, 2005, CLIN EXP ALLERGY, V35, P970, DOI 10.1111/j.1365-2222.2005.02294.x
   Ballmer-Weber BK, 2001, J ALLERGY CLIN IMMUN, V108, P301, DOI 10.1067/mai.2001.116430
   Biesiadka J, 2002, J MOL BIOL, V319, P1223, DOI 10.1016/S0022-2836(02)00385-6
   Bohle B, 2003, EUR J IMMUNOL, V33, P3303, DOI 10.1002/eji.200324321
   Bohle B, 2006, J ALLERGY CLIN IMMUN, V118, P242, DOI 10.1016/j.jaci.2006.03.011
   Bolhaar STHP, 2004, CLIN EXP ALLERGY, V34, P761, DOI 10.1111/j.1365-2222.2004.1939.x
   BREITENEDER H, 1995, EUR J BIOCHEM, V233, P484, DOI 10.1111/j.1432-1033.1995.484_2.x
   Cowtan K, 1994, JOINT CCP4 ESF EACBM, V31, P34
   EBNER C, 1995, J ALLERGY CLIN IMMUN, V95, P962, DOI 10.1016/S0091-6749(95)70096-X
   Fernandes H, 2008, J MOL BIOL, V378, P1040, DOI 10.1016/j.jmb.2008.03.027
   Fernandes H, 2009, FEBS J, V276, P1596, DOI 10.1111/j.1742-4658.2009.06892.x
   Fernandez-Rivas M, 2004, ALLERGY, V59, P1239, DOI 10.1111/j.1398-9995.2004.00600.x
   Fritsch R, 1997, CLIN REV ALLERG IMMU, V15, P397, DOI 10.1007/BF02737735
   Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hoffmann-Sommergruber K, 1999, CLIN EXP ALLERGY, V29, P840, DOI 10.1046/j.1365-2222.1999.00529.x
   Hoffmann-Sommergruber K., 2004, PLANT FOOD ALLERGENS, P125
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Kinaciyan T, 2007, J ALLERGY CLIN IMMUN, V119, P937, DOI 10.1016/j.jaci.2006.11.010
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LESLIE AGW, 1992, JNT CCP4 ESF EACBM N, V26
   Markovic-Housley Z, 2003, J MOL BIOL, V325, P123, DOI 10.1016/S0022-2836(02)01197-X
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Moneo I, 1999, ANN ALLERG ASTHMA IM, V83, P71, DOI 10.1016/S1081-1206(10)63516-8
   Neudecker P, 2001, J BIOL CHEM, V276, P22756, DOI 10.1074/jbc.M101657200
   Niederberger V, 2007, J ALLERGY CLIN IMMUN, V119, P1013, DOI 10.1016/j.jaci.2006.12.661
   Pasternak O, 2005, ACTA CRYSTALLOGR D, V61, P99, DOI 10.1107/S0907444904028173
   Pasternak O, 2006, PLANT CELL, V18, P2622, DOI 10.1105/tpc.105.037119
   Ponstingl H, 2000, PROTEINS, V41, P47
   Radauer C, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-286
   Scheurer S, 1997, MOL IMMUNOL, V34, P619, DOI 10.1016/S0161-5890(97)00072-2
   Schirmer T, 2005, J MOL BIOL, V351, P1101, DOI 10.1016/j.jmb.2005.06.054
   Vagin A, 1997, J APPL CRYSTALLOGR, V30, P1022, DOI 10.1107/S0021889897006766
   Valenta R, 1996, J ALLERGY CLIN IMMUN, V97, P893, DOI 10.1016/S0091-6749(96)80062-5
   VIETHS S, 1994, ALLERGY, V49, P262, DOI 10.1111/j.1398-9995.1994.tb02659.x
   Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736
   WUTHRICH B, 1990, ALLERGY, V45, P566, DOI 10.1111/j.1398-9995.1990.tb00941.x
NR 38
TC 15
Z9 16
U1 2
U2 3
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2059-7983
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Struct. Biol.
PD NOV
PY 2009
VL 65
BP 1206
EP 1212
DI 10.1107/S0907444909034854
PN 11
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 509PO
UT WOS:000271030600007
PM 19923716
DA 2021-01-25
ER

PT J
AU Arber, W
AF Arber, Werner
TI The impact of science and technology on the civilization
SO BIOTECHNOLOGY ADVANCES
LA English
DT Article; Proceedings Paper
CT 13th International Biotechnology Symposium and Exhibition (IBS-2008)
CY OCT 12-17, 2008
CL Dalian, PEOPLES R CHINA
DE Research strategy; Scientific knowledge; Innovation; Cultural values;
   Technology assessment; Policy assessment; Molecular Darwinism; Genetic
   engineering; GM crops; Sustainability
ID EVOLUTION
AB The rapid increase of available scientific knowledge is largely clue to the introduction of novel research strategies. The application of these strategies, both in fundamental and in translational scientific research. leads to bursts of technological innovations. In order to fulfill the justified public request for sustainability of technological innovations that contribute to the shaping of the future, increasing attention should be given to science-based technology and policy assessment These requests are illustrated by benefit/risk evaluations of relevance for the use of genetic engineering as an efficient and effective research strategy Expected benefits of a responsibly planned introduction of GM crops are Outlined as a prospective example for the guiding theme "Biotechnology for sustainability of human society" (C) 2009 Elsevier Inc All rights reserved.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR Arber W, 2003, GENE, V317, P3, DOI 10.1016/S0378-1119(03)00654-1
   Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x
   Arber W, 2007, GENOMICS GENETICS, V1, P385
   ARBER W, 2002, MOL EVOLUTION COMP N, V103, P90
NR 4
TC 6
Z9 6
U1 0
U2 10
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0734-9750
J9 BIOTECHNOL ADV
JI Biotechnol. Adv.
PD NOV-DEC
PY 2009
VL 27
IS 6
BP 940
EP 944
DI 10.1016/j.biotechadv.2009.05.014
PG 5
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 516PH
UT WOS:000271554200023
PM 19463942
DA 2021-01-25
ER

PT J
AU Bar, H
   Sharma, S
   Kleiner, H
   Mucke, N
   Zentgraf, H
   Katus, HA
   Aebi, U
   Herrmann, H
AF Baer, Harald
   Sharma, Sarika
   Kleiner, Helga
   Muecke, Norbert
   Zentgraf, Hanswalter
   Katus, Hugo A.
   Aebi, Ueli
   Herrmann, Harald
TI Interference of Amino-Terminal Desmin Fragments With Desmin Filament
   Formation
SO CELL MOTILITY AND THE CYTOSKELETON
LA English
DT Article
DE analytical ultracentrifugation; assembly; desmin; intermediate
   filaments; monoclonal antibody; premature stop codon
ID INTERMEDIATE-FILAMENTS; IN-VITRO; MISSENSE MUTATIONS; MUSCLE DISEASE;
   HUMAN VIMENTIN; CELL-LINE; MYOPATHY; VIVO; CYTOSKELETAL; EXPRESSION
AB Short polypeptides from intermediate filament (IF) proteins containing one of the two IF-consensus motifs interfere severely with filament assembly in vitro. We now have systematically investigated a series of larger fragments of the muscle-specific IF protein desmin representing entire functional domains such as coil I or coil 2. "Half molecules" comprising the amino-terminal portion of desmin, such as Des Delta C240 and the "tagged" derivative Des(ESA)Delta C244, assembled into large, roundish aggregates already at low ionic strength, Des Delta C250 formed extended, relatively uniform filaments, whereas Des Delta C265 and Des Delta C300 were soluble under these conditions. Surprisingly, all mutant desmin fragments assembled very rapidly into long thick filaments or spacious aggregates when the ionic strength was raised to standard assembly conditions. In contrast, when these desmin mutants were assembled in the presence of wild-type (WT) desmin, their assembly properties were completely changed: The elongation of the two shorter desmin fragments was completely inhibited by WT desmin, whereas Des Delta C250, Des Delta C265 and Des Delta C300 coassembled with desmin into filaments, but these mixed filaments were distinctly disturbed and exhibited a very different phenotype for each mutant. After transfection into fibroblasts and cardiomyocytes, the truncated mutant Des(ESA)Delta C244 localized largely to the cytoplasm, as revealed by a tag-specific monoclonal antibody, and also partially colocalized there with the collapsed endogenous vimentin and desmin systems indicating its interference with IF-organizing processes. In contrast, in cells without an authentic cytoplasmic IF system such as line SW13, Des(ESA)Delta C242 entered the nucleus and was deposited in small dot-like structures in chromatin-free spaces without any noticeable effect on nuclear morphology. Cell Motil. Cytoskeleton 66: 986-999, 2009. (C) 2009 Wiley-Liss, Inc.
C1 [Baer, Harald] Univ Heidelberg, Med Univ Klin Heidelberg, Dept Cardiol, D-69120 Heidelberg, Germany.
   [Sharma, Sarika; Herrmann, Harald] German Canc Res Ctr, Dept Mol Genet, Heidelberg, Germany.
   [Muecke, Norbert] German Canc Res Ctr, Div Biophys Macromol, Heidelberg, Germany.
   [Zentgraf, Hanswalter] German Canc Res Ctr, Res Grp Electron Microscopy, Heidelberg, Germany.
   [Aebi, Ueli] Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, Basel, Switzerland.
RP Bar, H (corresponding author), Univ Heidelberg, Med Univ Klin Heidelberg, Dept Cardiol, Neuenheimer Feld 410, D-69120 Heidelberg, Germany.
EM h.baer@dkfz.de
FU German Research Foundation (DFG)German Research Foundation (DFG) [BA
   2186/2-1, BA 2186/3-1, HE 1853]; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF) [3100A0-100448]; Swiss Foundation for
   Research on Muscle Diseases; M.E. Mueller Foundation
FX German Research Foundation (DFG); Contract grant numbers: BA 2186/2-1,
   BA 2186/3-1, HE 1853; Contract grant sponsor: Swiss National Science
   Foundation; Contract grant number: 3100A0-100448; Contract grant
   sponsors: Swiss Foundation for Research on Muscle Diseases, M.E. Mueller
   Foundation.
CR Amrani N, 2006, NAT REV MOL CELL BIO, V7, P415, DOI 10.1038/nrm1942
   Arbustini E, 2006, EUR J HEART FAIL, V8, P477, DOI 10.1016/j.ejheart.2005.11.003
   BADER BL, 1991, J CELL BIOL, V115, P1293, DOI 10.1083/jcb.115.5.1293
   Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068
   Bar H, 2006, EXP CELL RES, V312, P1554, DOI 10.1016/j.yexcr.2006.01.021
   Bar H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136
   Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003
   Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102
   Bar H, 2007, HUM MUTAT, V28, P374, DOI 10.1002/humu.20459
   Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033
   Chen F, 2003, J BIOL CHEM, V278, P6848, DOI 10.1074/jbc.M212021200
   Claycomb WC, 1998, P NATL ACAD SCI USA, V95, P2979, DOI 10.1073/pnas.95.6.2979
   FRANKE WW, 1978, P NATL ACAD SCI USA, V75, P5034, DOI 10.1073/pnas.75.10.5034
   Fuchs E, 1998, SCIENCE, V279, P514, DOI 10.1126/science.279.5350.514
   Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300
   Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033
   GOLDMAN RD, 1979, ANNU REV PHYSIOL, V41, P703, DOI 10.1146/annurev.ph.41.030179.003415
   Haubold K, 2003, CELL MOTIL CYTOSKEL, V54, P105, DOI 10.1002/cm.10090
   HEDBERG KK, 1986, EXP CELL RES, V163, P509, DOI 10.1016/0014-4827(86)90081-9
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   HERRMANN H, 1993, J MOL BIOL, V234, P99, DOI 10.1006/jmbi.1993.1566
   Herrmann H, 1998, Subcell Biochem, V31, P319
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   Hess JF, 2006, BIOCHEMISTRY-US, V45, P11737, DOI 10.1021/bi060741y
   KOHLER G, 1975, NATURE, V256, P495, DOI 10.1038/256495a0
   LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312
   NIEHRS C, 1992, J BIOL CHEM, V267, P15938
   OHARA O, 1993, J CELL BIOL, V121, P387, DOI 10.1083/jcb.121.2.387
   Paulin D, 2004, J PATHOL, V204, P418, DOI 10.1002/path.1639
   SARRIA AJ, 1994, J CELL SCI, V107, P1593
   Schroder R, 2003, HUM MOL GENET, V12, P657, DOI 10.1093/hmg/ddg060
   SCHRODER R, 2007, HUM MOL GENET, V12, P1
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
NR 37
TC 4
Z9 5
U1 0
U2 6
PU WILEY-LISS
PI HOBOKEN
PA DIV JOHN WILEY & SONS INC, 111 RIVER ST, HOBOKEN, NJ 07030 USA
SN 0886-1544
J9 CELL MOTIL CYTOSKEL
JI Cell Motil. Cytoskeleton
PD NOV
PY 2009
VL 66
IS 11
BP 986
EP 999
DI 10.1002/cm.20396
PG 14
WC Cell Biology
SC Cell Biology
GA 514BW
UT WOS:000271369600009
PM 19530175
DA 2021-01-25
ER

PT J
AU Hausser, J
   Landthaler, M
   Jaskiewicz, L
   Gaidatzis, D
   Zavolan, M
AF Hausser, Jean
   Landthaler, Markus
   Jaskiewicz, Lukasz
   Gaidatzis, Dimos
   Zavolan, Mihaela
TI Relative contribution of sequence and structure features to the mRNA
   binding of Argonaute/EIF2C-miRNA complexes and the degradation of miRNA
   targets
SO GENOME RESEARCH
LA English
DT Article
ID SITE ACCESSIBILITY; MICRORNA TARGETS; LET-7; EXPRESSION; IMPACT;
   SPECIFICITY; PREDICTION; CLEAVAGE; GENES; DICER
AB How miRNAs recognize their target sites is a puzzle that many experimental and computational studies aimed to solve. Several features, such as perfect pairing of the miRNA seed, additional pairing in the 3' region of the miRNA, relative position in the 3' UTR, and the A/U content of the environment of the putative site, have been found to be relevant. Here we have used a large number of previously published data sets to assess the power that various sequence and structure features have in distinguishing between putative sites that do and those that do not appear to be functional. We found that although different data sets give widely different answers when it comes to ranking the relative importance of these features, the sites inferred from most transcriptomics experiments, as well as from comparative genomics, appear similar at this level. This suggests that miRNA target sites have been selected in evolution on their ability to trigger mRNA degradation. To understand at what step in the miRNA-induced response individual features play a role, we transfected human HEK293 cells with miRNAs and analyzed the association of Argonaute/EIF2C-miRNA complexes with target mRNAs and the degradation of these messages. We found that structural features of the target site are only important for Argonaute/EIF2C binding, while sequence features such as the A/U content of the 3' UTR are important for mRNA degradation.
C1 [Hausser, Jean; Jaskiewicz, Lukasz; Gaidatzis, Dimos; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Hausser, Jean; Jaskiewicz, Lukasz; Gaidatzis, Dimos; Zavolan, Mihaela] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Landthaler, Markus] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Biol, New York, NY 10021 USA.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016; Landthaler, Markus/A-1427-2010
OI Landthaler, Markus/0000-0002-1075-8734; Hausser,
   Jean/0000-0002-3321-7199; Zavolan, Mihaela/0000-0002-8832-2041
FU Swiss National FundSwiss National Science Foundation (SNSF)
   [3100A0114001]; Irma T. Hirschl Postdoctoral Fellowship; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [GM068476]; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM068476, R01GM068476, R01GM068476,
   R01GM068476, R01GM068476] Funding Source: NIH RePORTER
FX We thank Thomas Tuschl for support in performing the experiments, and
   for suggestions and discussions. We are grateful to Wenxiang Zhang and
   Connie Zhao (Rockefeller University Genomics Resource Center) for mRNA
   array analyses, to Erik van Nimwegen (Biozentrum, University of Basel)
   for suggesting the model to identify functional sites from multiple
   experiments, and to Ted Karginov for providing us the raw Agilent data
   of the miR-124 EIF2C-IP. J. H. was supported by the Swiss National Fund,
   grant no. 3100A0114001, to Mihaela Zavolan. M. L. was partially
   supported by an Irma T. Hirschl Postdoctoral Fellowship. In addition, M.
   L. was supported by NIH grant no. GM068476 to Thomas Tuschl. We also
   thank Lukas Burger, Erik van Nimwegen, and Walter Keller ( Biozentrum,
   University of Basel) for critical comments on the manuscript.
CR Ameres SL, 2007, CELL, V130, P101, DOI 10.1016/j.cell.2007.04.037
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031
   Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031
   Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085
   Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404
   Elkon R, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000189
   Enright AJ, 2004, GENOME BIOL, V5
   Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080
   Forman JJ, 2008, P NATL ACAD SCI USA, V105, P14879, DOI 10.1073/pnas.0803230105
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Hammell M, 2008, NAT METHODS, V5, P813, DOI 10.1038/NMETH.1247
   Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126
   Hofacker IL, 2003, NUCLEIC ACIDS RES, V31, P3429, DOI 10.1093/nar/gkg599
   Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038
   Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104
   Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   Khan AA, 2009, NAT BIOTECHNOL, V27, P549, DOI 10.1038/nbt.1543
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865
   Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06
   Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226
   Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152
   McCullagh P., 1989, GEN LINEAR MODELS
   Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007
   Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607
   Robins H, 2005, P NATL ACAD SCI USA, V102, P15557, DOI 10.1073/pnas.0507443102
   Robins H, 2005, P NATL ACAD SCI USA, V102, P4006, DOI 10.1073/pnas.0500775102
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Spackman Kent A, 1989, P 6 INT WORKSH MACH, P160, DOI [DOI 10.1016/B978-1-55860-036-2.50047-3, 10.1016/B978-1-55860-036-2.50047-3]
   Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023
   Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060
   Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404
   Tokumaru S, 2008, CARCINOGENESIS, V29, P2073, DOI 10.1093/carcin/bgn187
   WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4
   Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683
   Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403
   Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030
NR 45
TC 62
Z9 66
U1 0
U2 9
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD NOV
PY 2009
VL 19
IS 11
BP 2009
EP 2020
DI 10.1101/gr.091181.109
PG 12
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 514WK
UT WOS:000271426600009
PM 19767416
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Arber, W
AF Arber, Werner
TI Systemic aspects of biological evolution
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Review
DE Molecular Darwinism; Genetic variation; DNA acquisition; Evolution
   genes; Global gene pool; Biotechnological risks
ID ELEMENTS
AB In recent years molecular mechanisms and natural strategies have been explored that spontaneously generate genetic variations at low rates without seriously affecting genetic stability at the level of populations. Thereby acquired knowledge suggests systemic aspects of evolutionary interdependences both in the past and in future evolutionary developments. The natural strategy of DNA acquisition by horizontal gene transfer interconnects different branches of the tree of evolution at random times. This makes in principle the entire global gene pool of the biosphere available to any kinds of living beings for their further evolutionary development. The relevance of this knowledge for risk assessments of genetically engineered organisms is discussed. (C) 2009 Elsevier B.V. All rights reserved.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Werner.Arber@unibas.ch
CR Arber W, 2003, GENE, V317, P3, DOI 10.1016/S0378-1119(03)00654-1
   ARBER W, 1991, J MOL EVOL, V33, P4, DOI 10.1007/BF02100190
   Arber W, 2007, GENOMICS GENETICS, V1, P385
   ARBER W, P PLEN SESS IN PRESS
   Bernardi G, 2007, P NATL ACAD SCI USA, V104, P8385, DOI 10.1073/pnas.0701652104
   Weber M, 1996, BIOL PHILOS, V11, P67, DOI 10.1007/BF00127472
NR 6
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
J9 J BIOTECHNOL
JI J. Biotechnol.
PD NOV
PY 2009
VL 144
IS 3
BP 242
EP 244
DI 10.1016/j.jbiotec.2009.05.010
PG 3
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA 533YH
UT WOS:000272861600010
PM 19497339
DA 2021-01-25
ER

PT J
AU Belanger, KD
   Walter, D
   Henderson, TA
   Yelton, AL
   O'Brien, TG
   Belanger, KG
   Geier, SJ
   Fahrenkrog, B
AF Belanger, Kenneth D.
   Walter, David
   Henderson, Tracey A.
   Yelton, Allison L.
   O'Brien, Travis G.
   Belanger, Karyn G.
   Geier, Susan J.
   Fahrenkrog, Birthe
TI Nuclear localisation is crucial for the proapoptotic activity of the
   HtrA-like serine protease Nma111p
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Nma111p; HtrA; Serine protease; Yeast apoptosis; Nuclear-localisation
   signal
ID PROGRAMMED CELL-DEATH; SACCHAROMYCES-CEREVISIAE; REGULATES APOPTOSIS;
   MEDIATED APOPTOSIS; IN-SITU; YEAST; PATHWAY; IDENTIFICATION;
   MITOCHONDRIA; INHIBITOR
AB Programmed cell death is induced by the activation of a subset of intracellular proteins in response to specific extra- and intracellular signals. In the yeast Saccharomyces cerevisiae, Nma111p functions as a nuclear serine protease that is necessary for apoptosis under cellular stress conditions, such as elevated temperature or treatment of cells with hydrogen peroxide to induce cell death. We have examined the role of nuclear protein import in the function of Nma111p in apoptosis. Nma111p contains two small clusters of basic residues towards its N-terminus, both of which are necessary for efficient translocation into the nucleus. Nma111p does not shuttle between the nucleus and cytoplasm during either normal growth conditions or under environmental stresses that induce apoptosis. The N-terminal half of Nma111p is sufficient to provide the apoptosis-inducing activity of the protein, and the nuclear-localisation signal (NLS) sequences and catalytic serine 235 are both necessary for this function. We provide compelling evidence that intranuclear Nma111p activity is necessary for apoptosis in yeast.
C1 [Walter, David; Fahrenkrog, Birthe] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Belanger, Kenneth D.; Henderson, Tracey A.; Yelton, Allison L.; O'Brien, Travis G.; Belanger, Karyn G.; Geier, Susan J.] Colgate Univ, Dept Biol, Hamilton, NY 13346 USA.
RP Fahrenkrog, B (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM birthe.fahrenkrog@unibas.ch
RI Walter, David/A-8436-2008; Fahrenkrog, Birthe/D-5840-2011
OI Walter, David/0000-0003-4363-0339; Fahrenkrog,
   Birthe/0000-0003-4080-9413
FU Colgate University; NSF-FIBRNational Science Foundation (NSF)
   [EF-04245749]; Swiss National Science FoundationSwiss National Science
   Foundation (SNSF); Kanton Basel Stadt; M. E. Mueller Foundation
FX The authors would like to acknowledge Anita Hopper, Lucy Pemberton, Mark
   Rose, Pam Silver, Rodney Rothstein and Laura Davis for generously
   sharing plasmids and yeast strains. This research was supported by
   Colgate University and NSF-FIBR grant EF-04245749 to K. D. B., a Swiss
   National Science Foundation research grant to B. F., as well as by the
   Kanton Basel Stadt and the M. E. Mueller Foundation.
CR Ahn SH, 2005, CELL CYCLE, V4, P780, DOI 10.4161/cc.4.6.1745
   Almeida B, 2007, J CELL SCI, V120, P3279, DOI 10.1242/jcs.010926
   Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021
   Challa M, 2007, EMBO J, V26, P3144, DOI 10.1038/sj.emboj.7601745
   Clausen T, 2002, MOL CELL, V10, P443, DOI 10.1016/S1097-2765(02)00658-5
   Cokol M, 2000, EMBO REP, V1, P411, DOI 10.1093/embo-reports/kvd092
   CONDE J, 1976, P NATL ACAD SCI USA, V73, P3651, DOI 10.1073/pnas.73.10.3651
   DeLotto R, 2007, DEVELOPMENT, V134, P4233, DOI 10.1242/dev.010934
   Fabrizio P, 2008, BBA-MOL CELL RES, V1783, P1280, DOI 10.1016/j.bbamcr.2008.03.017
   Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848
   Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904
   Feng WQ, 2002, P NATL ACAD SCI USA, V99, P5412, DOI 10.1073/pnas.082682699
   GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493
   GORCZYCA W, 1993, CANCER RES, V53, P1945
   Gourlay CW, 2006, MOL CELL BIOL, V26, P6487, DOI 10.1128/MCB.00117-06
   Gourlay CW, 2005, J CELL SCI, V118, P2119, DOI 10.1242/jcs.02337
   Guthrie C., 1991, GUIDE YEAST GENETICS
   Hegde R, 2002, J BIOL CHEM, V277, P432, DOI 10.1074/jbc.M109721200
   Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014
   HOFFMAN CS, 1987, GENE, V57, P267, DOI 10.1016/0378-1119(87)90131-4
   Igaki T, 2007, BIOCHEM BIOPH RES CO, V356, P993, DOI 10.1016/j.bbrc.2007.03.079
   Kaffman A, 1998, NATURE, V396, P482
   Khan FS, 2008, CELL DEATH DIFFER, V15, P1073, DOI 10.1038/cdd.2008.19
   Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200
   Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x
   Ludovico P, 2001, MICROBIOL-SGM, V147, P3335, DOI 10.1099/00221287-147-12-3335
   Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161
   Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4
   Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729
   Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757
   Martins LM, 2002, J BIOL CHEM, V277, P439, DOI 10.1074/jbc.M109784200
   Mason DA, 2005, FEMS YEAST RES, V5, P1237, DOI 10.1016/j.femsyr.2005.07.008
   Mosammaparast N, 2002, J BIOL CHEM, V277, P862, DOI 10.1074/jbc.M106845200
   Mosammaparast N, 2001, J CELL BIOL, V153, P251, DOI 10.1083/jcb.153.2.251
   Nakai K, 1999, TRENDS BIOCHEM SCI, V24, P34, DOI 10.1016/S0968-0004(98)01336-X
   Padmanabhan N, 2009, MOL BIOL CELL, V20, P68, DOI 10.1091/mbc.E08-02-0178
   Pallen MJ, 1997, MOL MICROBIOL, V26, P209, DOI 10.1046/j.1365-2958.1997.5601928.x
   Plun-Favreau H, 2007, NAT CELL BIOL, V9, P1243, DOI 10.1038/ncb1644
   Ponting CP, 1997, PROTEIN SCI, V6, P464
   Poon IKH, 2005, TRAFFIC, V6, P173, DOI 10.1111/j.1600-0854.2005.00268.x
   Reiter J, 2005, J CELL BIOL, V168, P353, DOI 10.1083/jcb.200408071
   Rout MP, 1997, CELL, V89, P715, DOI 10.1016/S0092-8674(00)80254-8
   Selitrennik M, 2006, EUKARYOT CELL, V5, P2092, DOI 10.1128/EC.00288-06
   Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5
   Sharikabad MN, 2001, AM J PHYSIOL-HEART C, V280, pH344
   Silva RD, 2005, MOL MICROBIOL, V58, P824, DOI 10.1111/j.1365-2958.2005.04868.x
   Suzuki Y, 2004, CELL DEATH DIFFER, V11, P208, DOI 10.1038/sj.cdd.4401343
   Suzuki Y, 2001, MOL CELL, V8, P613, DOI 10.1016/S1097-2765(01)00341-0
   Tong FM, 2006, MOL GENET GENOMICS, V275, P330, DOI 10.1007/s00438-005-0089-1
   VALLEN EA, 1992, J CELL BIOL, V117, P1277, DOI 10.1083/jcb.117.6.1277
   Vande Walle L, 2008, CELL DEATH DIFFER, V15, P453, DOI 10.1038/sj.cdd.4402291
   Verhagen AM, 2002, J BIOL CHEM, V277, P445, DOI 10.1074/jbc.M109891200
   Walter D, 2006, J CELL SCI, V119, P1843, DOI 10.1242/jcs.02902
   Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138
   Woods R.A., 2001, METH MOL B, V177, P85
NR 55
TC 14
Z9 16
U1 0
U2 0
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD NOV 1
PY 2009
VL 122
IS 21
BP 3931
EP 3941
DI 10.1242/jcs.056887
PG 11
WC Cell Biology
SC Cell Biology
GA 515MK
UT WOS:000271475600013
PM 19808885
OA Bronze
DA 2021-01-25
ER

PT J
AU Birk, J
   Friberg, MA
   Prescianotto-Baschong, C
   Spiess, M
   Rutishauser, J
AF Birk, Julia
   Friberg, Michael A.
   Prescianotto-Baschong, Cristina
   Spiess, Martin
   Rutishauser, Jonas
TI Dominant pro-vasopressin mutants that cause diabetes insipidus form
   disulfide-linked fibrillar aggregates in the endoplasmic reticulum
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Aggregates; Diabetes insipidus; Fibrils; Neurophysin; Vasopressin
ID HYPOTHALAMIC NEURONS; PROTEIN AGGREGATION; CELLS; HEREDITARY; SIGNAL;
   NEURODEGENERATION; TRANSGENE; AUTOPHAGY; PRECURSOR; RATS
AB Autosomal dominant neurohypophyseal diabetes insipidus results from mutations in the precursor protein of the antidiuretic hormone arginine vasopressin. Mutant prohormone is retained in the endoplasmic reticulum of vasopressinergic neurons and causes their progressive degeneration by an unknown mechanism. Here, we show that several dominant pro-vasopressin mutants form disulfide-linked homo-oligomers and develop large aggregations visible by immunofluorescence and immunogold electron microscopy, both in a fibroblast and a neuronal cell line. Double-labeling showed the pro-vasopressin aggregates to colocalize with the chaperone calreticulin, indicating that they originated from the endoplasmic reticulum. The aggregates revealed a remarkable fibrillar substructure. Bacterially expressed and purified mutant pro-vasopressin spontaneously formed fibrils under oxidizing conditions. Mutagenesis experiments showed that the presence of cysteines, but no specific single cysteine, is essential for disulfide oligomerization and aggregation in vivo. Our findings assign autosomal dominant diabetes insipidus to the group of neurodegenerative diseases associated with the formation of fibrillar protein aggregates.
C1 [Birk, Julia; Friberg, Michael A.; Prescianotto-Baschong, Cristina; Spiess, Martin; Rutishauser, Jonas] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Rutishauser, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM j.rutishauser@unibas.ch
OI Spiess, Martin/0000-0001-7139-0550
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-113319, 3100A0-109424]; Novartis Biomedical Research
   Foundation [05A14]
FX We thank Jane Christensen, Hans-Peter Hauri and Beat Nyfeler for
   reagents, Christian Appenzeller-Herzog for valuable discussions, and
   Nicole Beuret for expert technical assistance and advice. This work was
   supported by grants 3100A0-113319 (to J. R.) and 3100A0-109424 (to M.
   S.) from the Swiss National Science Foundation, and grant 05A14 (to J.
   R.) from the Novartis Biomedical Research Foundation.
CR Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708
   BERGERON C, 1991, ACTA NEUROPATHOL, V81, P345, DOI 10.1007/BF00305879
   Beuret N, 2004, J BIOL CHEM, V279, P20242, DOI 10.1074/jbc.M310613200
   Beuret N, 1999, J BIOL CHEM, V274, P18965, DOI 10.1074/jbc.274.27.18965
   BRAVERMAN LE, 1965, ANN INTERN MED, V63, P503, DOI 10.7326/0003-4819-63-3-503
   Castino R, 2005, FASEB J, V19, P1021, DOI 10.1096/fj.04-3162fje
   Cescato R, 2000, J NEUROCHEM, V74, P1131
   CHEN LQ, 1991, P NATL ACAD SCI USA, V88, P4240, DOI 10.1073/pnas.88.10.4240
   Christensen JH, 2006, SEMIN NEPHROL, V26, P209, DOI 10.1016/j.semnephrol.2006.03.003
   Christensen JH, 2004, CLIN ENDOCRINOL, V60, P125, DOI 10.1111/j.1365-2265.2004.01953.x
   Chun W, 2002, FEBS LETT, V515, P61, DOI 10.1016/S0014-5793(02)02436-5
   Davies J, 2002, J NEUROENDOCRINOL, V14, P629, DOI 10.1046/j.1365-2826.2002.00822.x
   Friberg MA, 2004, J BIOL CHEM, V279, P19441, DOI 10.1074/jbc.M310249200
   GREEN JR, 1967, BRAIN, V90, P707, DOI 10.1093/brain/90.3.707
   ITO M, 1993, J CLIN INVEST, V91, P2565, DOI 10.1172/JCI116494
   Ito M, 1997, J CLIN INVEST, V99, P1897, DOI 10.1172/JCI119357
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Lansbury PT, 2006, NATURE, V443, P774, DOI 10.1038/nature05290
   Martinez-Vicente M, 2007, LANCET NEUROL, V6, P352, DOI 10.1016/S1474-4422(07)70076-5
   NAGAI I, 1984, ACTA ENDOCRINOL-COP, V105, P318, DOI 10.1530/acta.0.1050318
   Nijenhuis M, 1999, J BIOL CHEM, V274, P21200, DOI 10.1074/jbc.274.30.21200
   Olias G, 1996, DNA CELL BIOL, V15, P929, DOI 10.1089/dna.1996.15.929
   Ross CA, 2005, NAT REV MOL CELL BIO, V6, P891, DOI 10.1038/nrm1742
   Russell TA, 2003, J CLIN INVEST, V112, P1697, DOI 10.1172/JCI200318616
   SCHMALE H, 1984, NATURE, V308, P705, DOI 10.1038/308705a0
   Si-Hoe SL, 2000, FASEB J, V14, P1680
   Siggaard C, 1999, J CLIN ENDOCR METAB, V84, P2933, DOI 10.1210/jc.84.8.2933
   Willcutts MD, 1999, HUM MOL GENET, V8, P1303, DOI 10.1093/hmg/8.7.1303
NR 28
TC 50
Z9 50
U1 0
U2 3
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD NOV 1
PY 2009
VL 122
IS 21
BP 3994
EP 4002
DI 10.1242/jcs.051136
PG 9
WC Cell Biology
SC Cell Biology
GA 515MK
UT WOS:000271475600019
PM 19825939
OA Bronze
DA 2021-01-25
ER

PT J
AU Kumar, A
   Fung, S
   Lichtneckert, R
   Reichert, H
   Hartenstein, V
AF Kumar, Abhilasha
   Fung, S.
   Lichtneckert, Robert
   Reichert, Heinrich
   Hartenstein, Volker
TI Arborization Pattern of Engrailed-Positive Neural Lineages Reveal
   Neuromere Boundaries in the Drosophila Brain Neuropil
SO JOURNAL OF COMPARATIVE NEUROLOGY
LA English
DT Article
DE engrailed; neuropil; compartment; neuromere; arborization; lineage
ID CENTRAL-NERVOUS-SYSTEM; LOCUST SCHISTOCERCA-GREGARIA; ANTENNAL MOTOR
   SYSTEM; EMPTY-SPIRACLES; EXPRESSION PATTERNS; CENTRAL PROJECTIONS;
   DEVELOPMENTAL FATE; SEGMENTATION GENES; EARLY NEUROGENESIS; EMBRYONIC
   ORIGIN
AB The Drosophila brain is a highly complex structure composed of thousands of neurons that are interconnected in numerous exquisitely organized neuropil structures such as the mushroom bodies, central complex, antennal lobes, and other specialized neuropils. While the neurons of the insect brain are known to derive in a lineage-specific fashion from a stereotyped set of segmentally organized neuroblasts, the developmental origin and neuromeric organization of the neuropil formed by these neurons is still unclear. In this study we used genetic labeling techniques to characterize the neuropil innervation pattern of engrailed-expressing brain lineages of known neuromeric origin. We show that the neurons of these lineages project to and form most arborizations, in particular all of their proximal branches, in the same brain neuropil compartments in embryonic, larval and adult stages. Moreover, we show that engrailed-positive neurons of differing neuromeric origin respect boundaries between neuromere-specific compartments in the brain. This is confirmed by an analysis of the arborization pattern of empty spiracles-expressing lineages. These findings indicate that arborizations of lineages deriving from different brain neuromeres innervate a nonoverlapping set of neuropil compartments. This supports a model for neuromere-specific brain neuropil, in which a given lineage forms its proximal arborizations predominantly in the compartments that correspond to its neuromere of origin. J. Comp. Neurol. 517:87-104, 2009. (C) 2009 Wiley-Liss, Inc.
C1 [Fung, S.; Hartenstein, Volker] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.
   [Kumar, Abhilasha; Lichtneckert, Robert; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hartenstein, V (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.
EM volkerh@mcdb.ucla.edu
FU National Institutes of Health (NIH)United States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [R01 NS054814];
   Swiss NSFSwiss National Science Foundation (SNSF) [3100A0-112024];
   NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS054814, R01NS054814, R01NS054814, R01NS054814, R01NS054814,
   R01NS054814, R01NS054814, R01NS054814, R01NS054814, R01NS054814,
   R01NS054814, R01NS054814, R01NS054814] Funding Source: NIH RePORTER
FX Grant sponsor: National Institutes of Health (NIH); Grant number: R01
   NS054814 (to V.H.); Grant sponsor: Swiss NSF Grant 3100A0-112024 (to
   H.R.).
CR Baba Y, 2008, CELL TISSUE RES, V331, P751, DOI 10.1007/s00441-007-0545-9
   Beaster-Jones L, 2008, DEV GENES EVOL, V218, P599, DOI 10.1007/s00427-008-0257-5
   Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240
   Boyan G, 2002, ARTHROPOD STRUCT DEV, V30, P207, DOI 10.1016/S1467-8039(01)00034-2
   Bullock TH, 1965, STRUCTURE FUNCTION N
   Burrows M, 1996, NEUROBIOLOGY INSECT
   CamposOrtega J.A., 1997, EMBRYONIC DEV DROSOP
   Canestro C, 2005, DEV BIOL, V285, P298, DOI 10.1016/j.ydbio.2005.06.039
   Cardona A, 2009, J COMP NEUROL, V515, P427, DOI 10.1002/cne.22086
   Dahmann C, 2000, CELL, V100, P411, DOI 10.1016/S0092-8674(00)80677-7
   de Velasco B, 2006, DEV GENES EVOL, V216, P39, DOI 10.1007/s00427-005-0029-4
   DIEDERICH RJ, 1991, DEVELOPMENT, V113, P273
   Dumstrei K, 2003, J COMP NEUROL, V455, P451, DOI 10.1002/cne.10484
   Ehmer B, 1997, CELL TISSUE RES, V290, P153, DOI 10.1007/s004410050917
   GRENNINGLOH G, 1991, CELL, V67, P45, DOI 10.1016/0092-8674(91)90571-F
   HAMA C, 1990, GENE DEV, V4, P1079, DOI 10.1101/gad.4.7.1079
   Hanstrom B, 1928, VERGLEICHENDE ANATOM
   Hartenstein V, 2008, BIOSCIENCE, V58, P823, DOI 10.1641/B580910
   Hartenstein V, 2008, ADV EXP MED BIOL, V628, P1, DOI 10.1007/978-0-387-78261-4_1
   Hartmann B, 2000, MECH DEVELOP, V90, P143, DOI 10.1016/S0925-4773(99)00237-3
   Holland LZ, 1997, DEVELOPMENT, V124, P1723
   HOLMGREN B, 1928, VERGLEICHENDE ANATOM
   HOMBERG U, 1989, ANNU REV ENTOMOL, V34, P477, DOI 10.1146/annurev.en.34.010189.002401
   Homberg U, 2004, ACTA BIOL HUNG, V55, P81, DOI 10.1556/ABiol.55.2004.1-4.10
   HOMBERG U, 1994, J COMP PHYSIOL A, V175, P597, DOI 10.1007/BF00199481
   HORTSCH M, 1990, DEVELOPMENT, V110, P1327
   Iijima M, 2008, DEV GENES EVOL, V218, P237, DOI 10.1007/s00427-008-0217-0
   Imai Kaoru S., 2002, Gene Expression Patterns, V2, P319, DOI 10.1016/S0925-4773(02)00383-0
   Iwai Y, 1997, NEURON, V19, P77, DOI 10.1016/S0896-6273(00)80349-9
   Jacobs DK, 2000, EVOL DEV, V2, P340, DOI 10.1046/j.1525-142x.2000.00077.x
   Joly W, 2007, DEV BIOL, V301, P542, DOI 10.1016/j.ydbio.2006.10.019
   Joyner AL, 1996, TRENDS GENET, V12, P15, DOI 10.1016/0168-9525(96)81383-7
   Kloppenburg P, 1997, CELL TISSUE RES, V287, P425, DOI 10.1007/s004410050767
   Landgraf M, 2003, PLOS BIOL, V1, P221, DOI 10.1371/journal.pbio.0000041
   LARSEN C, 2009, DEV BIOL IN PRESS
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lichtneckert R, 2008, DEVELOPMENT, V135, P2415, DOI 10.1242/dev.022210
   Lichtneckert R, 2007, DEVELOPMENT, V134, P1291, DOI 10.1242/dev.02814
   Mathew D, 2003, J NEUROSCI, V23, P10710
   MERRITT DJ, 1995, J NEUROSCI, V15, P1755
   Moshel SM, 1998, DEV GENES EVOL, V208, P135, DOI 10.1007/s004270050164
   Nederbragt AJ, 2002, DEV BIOL, V246, P341, DOI 10.1006/dbio.2002.0653
   PATEL NH, 1989, CELL, V58, P955, DOI 10.1016/0092-8674(89)90947-1
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   Peterson MD, 1998, DEV GENES EVOL, V208, P547, DOI 10.1007/s004270050214
   Pfeiffer BD, 2008, P NATL ACAD SCI USA, V105, P9715, DOI 10.1073/pnas.0803697105
   PIOVANT M, 1988, DEVELOPMENT, V103, P145
   Prud'homme B, 2003, CURR BIOL, V13, P1876, DOI 10.1016/j.cub.2003.10.006
   RAJASHEKHAR KP, 1994, J COMP NEUROL, V349, P633, DOI 10.1002/cne.903490410
   Rodrigues V, 2008, ADV EXP MED BIOL, V628, P82, DOI 10.1007/978-0-387-78261-4_6
   Rogers BT, 1996, DEVELOPMENT, V122, P3419
   Rulifson EJ, 2002, SCIENCE, V296, P1118, DOI 10.1126/science.1070058
   Schmid A, 1999, DEVELOPMENT, V126, P4653
   SCHMIDTOTT U, 1992, DEVELOPMENT, V116, P111
   Schrader S, 2000, J COMP NEUROL, V425, P34
   Seaver EC, 2006, DEV BIOL, V289, P179, DOI 10.1016/j.ydbio.2005.10.025
   Seaver EC, 2001, DEV BIOL, V236, P195, DOI 10.1006/dbio.2001.0309
   Shain DH, 2000, DEVELOPMENT, V127, P735
   Simon HH, 2005, MOL CELL NEUROSCI, V28, P96, DOI 10.1016/j.mcn.2004.08.016
   Simon HH, 2004, CELL TISSUE RES, V318, P53, DOI 10.1007/s00441-004-0973-8
   Sintoni S, 2007, DEV GENES EVOL, V217, P791, DOI 10.1007/s00427-007-0189-5
   Sprecher SG, 2007, GENE EXPR PATTERNS, V7, P584, DOI 10.1016/j.modgep.2007.01.004
   Strausfeld N. J., 1976, ATLAS INSECT BRAIN
   STRAUSFELD NJ, 1990, J COMP NEUROL, V302, P954, DOI 10.1002/cne.903020419
   Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566
   TYRER NM, 1982, PHILOS T R SOC B, V297, P91, DOI 10.1098/rstb.1982.0035
   ULLMANN SL, 1964, PHILOS T R SOC LON B, V747, P245
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   Urbach R, 2003, DEVELOPMENT, V130, P3607, DOI 10.1242/dev.00532
   Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008
   WALLDORF U, 1992, EMBO J, V11, P2247, DOI 10.1002/j.1460-2075.1992.tb05284.x
   Wanninger A, 2001, EVOL DEV, V3, P312, DOI 10.1046/j.1525-142X.2001.01034.x
   WEDEEN CJ, 1991, DEVELOPMENT, V113, P805
   Younossi-Hartenstein A, 2003, J COMP NEUROL, V455, P435, DOI 10.1002/cne.10483
   Younossi-Hartenstein A, 2006, J COMP NEUROL, V497, P981, DOI 10.1002/cne.20884
   YOUNOSSIHARTENSTEIN A, 1993, ROUX ARCH DEV BIOL, V203, P60, DOI 10.1007/BF00539891
   YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7
   YounossiHartenstein A, 1997, DEV BIOL, V182, P270, DOI 10.1006/dbio.1996.8475
   ZARETSKY M, 1983, J COMP NEUROL, V216, P253, DOI 10.1002/cne.902160304
   Zlatic M, 2003, NEURON, V37, P41, DOI 10.1016/S0896-6273(02)01131-5
NR 81
TC 20
Z9 20
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0021-9967
EI 1096-9861
J9 J COMP NEUROL
JI J. Comp. Neurol.
PD NOV 1
PY 2009
VL 517
IS 1
BP 87
EP 104
DI 10.1002/cne.22112
PG 18
WC Neurosciences; Zoology
SC Neurosciences & Neurology; Zoology
GA 494VV
UT WOS:000269848300006
PM 19711412
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Gander, S
   Martin, D
   Hauri, S
   Moes, S
   Poletto, G
   Pagano, MA
   Marin, O
   Meggio, F
   Jenoe, P
AF Gander, Stefan
   Martin, Dietmar
   Hauri, Simon
   Moes, Suzette
   Poletto, Giorgia
   Pagano, Mario A.
   Marin, Oriano
   Meggio, Flavio
   Jenoe, Paul
TI A Modified KESTREL Search Reveals a Basophilic Substrate Consensus for
   the Saccharomyces cerevisiae Npr1 Protein Kinase
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE Nitrogen permease reactivator; Npr1; yeast; protein kinase; KESTREL;
   mass spectrometry; consensus sequence
ID AMINO-ACID PERMEASE; SODIUM DODECYL-SULFATE; SIGNALING PATHWAY;
   SECRETORY PATHWAY; MASS-SPECTROMETRY; PHOSPHORYLATION SITES;
   NUCLEOTIDE-SEQUENCE; UPTAKE SYSTEMS; GAP1 PERMEASE; YEAST
AB The Saccharomyces cerevisiae nitrogen permease reactivator Npr1 is a hyperphosphorylated protein that belongs to a family of Ser/Thr protein kinases dedicated to the regulation of plasma membrane transporters Its activity is regulated by the Tor (target of rapamycin) signaling pathway Inhibition of the Tor proteins by treating yeast cells with the immunosuppressant drug rapamycin promotes rapid dephosphorylation of Npr1. As an alternative to peptide arrays, the substrate requirement of Npr1 was probed with a peptide library that was generated by cleaving yeast cell extracts with CNBr, and after reverse-phase chromatography, the individual fractions were phosphorylated in vitro with recombinant Npr1. In this way, the ribosomal protein Rpl24a was found to be an excellent in vitro substrate for Npr1. Synthetic peptides tailored around the phosphorylation site of Rpl24a show that Npr1 is a Serf Thr protein kinase with an absolute requirement for a basic residue at the P-3 position and a strong preference for basic P + 1 residues, whereas proline at P + 1 is strongly disfavored. The results obtained with synthetic peptides suggest a (K/R)-X-X-S-(K/R) consensus sequence for Npr1 The availability of a consensus sequence allows a targeted search for physiologically relevant Npr1 substrates involved in the regulation of yeast amino acid permeases.
C1 [Gander, Stefan; Hauri, Simon; Moes, Suzette; Jenoe, Paul] Univ Basel, Biozentrum, Dept Biochem, CH-4056 Basel, Switzerland.
   [Martin, Dietmar] Univ Munich, Dept Chem & Biochem, Gene Ctr, D-81377 Munich, Germany.
   [Poletto, Giorgia; Pagano, Mario A.; Marin, Oriano; Meggio, Flavio] Univ Padua, Dept Biol Chem, I-35121 Padua, Italy.
RP Jenoe, P (corresponding author), Univ Basel, Biozentrum, Dept Biochem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
OI Pagano, Mario Angelo/0000-0003-4186-7658; Hauri,
   Simon/0000-0002-7249-2011
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF)
FX We would like to thank Alexandre Soulard for helpful suggestions The
   authors thank the Swiss National Science Foundation for funding.
CR Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200
   BARONASLOWELL DM, 1990, MOL CELL BIOL, V10, P5235, DOI 10.1128/MCB.10.10.5235
   Beausoleil SA, 2004, P NATL ACAD SCI USA, V101, P12130, DOI 10.1073/pnas.0404720101
   BECHERER KA, 1996, CELL, V7, P579
   Bonenfant D, 2003, P NATL ACAD SCI USA, V100, P880, DOI 10.1073/pnas.232735599
   Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104
   Cohen P, 2006, BIOCHEM J, V393, P1, DOI 10.1042/BJ20051545
   De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200
   Dresios J, 2000, BIOCHEMISTRY-US, V39, P7236, DOI 10.1021/bi9925266
   DUBOIS E, 1979, MOL GEN GENET, V175, P67, DOI 10.1007/BF00267857
   FIELDS GB, 1990, INT J PEPT PROT RES, V35, P161, DOI 10.1111/j.1399-3011.1990.tb00939.x
   Fukunaga Rikiro, 2004, Methods Mol Biol, V250, P211
   Gander S, 2008, RAPID COMMUN MASS SP, V22, P3743, DOI 10.1002/rcm.3790
   Gerrard SR, 2000, TRAFFIC, V1, P259, DOI 10.1034/j.1600-0854.2000.010308.x
   GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408
   GRENSON M, 1983, EUR J BIOCHEM, V133, P141, DOI 10.1111/j.1432-1033.1983.tb07439.x
   Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200
   Guo W, 2000, TRENDS CELL BIOL, V10, P251, DOI 10.1016/S0962-8924(00)01754-2
   Hattori S, 2008, EXPERT REV PROTEOMIC, V5, P497, DOI 10.1586/14789450.5.3.497
   Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649
   Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0
   JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x
   Knebel A, 2001, EMBO J, V20, P4360, DOI 10.1093/emboj/20.16.4360
   KONIGSBERG WH, 1983, METHOD ENZYMOL, V91, P254
   LASKO PF, 1981, J BACTERIOL, V148, P241, DOI 10.1128/JB.148.1.241-247.1981
   LJUNGDAHL PO, 1992, CELL, V71, P463, DOI 10.1016/0092-8674(92)90515-E
   Menzel N, 2007, ANAL BIOCHEM, V368, P178, DOI 10.1016/j.ab.2007.05.022
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Ptacek J, 2005, NATURE, V438, P679, DOI 10.1038/nature04187
   Radimerski T, 2000, BIOCHEMISTRY-US, V39, P5766, DOI 10.1021/bi9927484
   Righetti PG, 2006, PROTEOMICS, V6, P3980, DOI 10.1002/pmic.200500904
   Roberg KJ, 1997, GENETICS, V147, P1569
   Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SCHMIDT A, 1994, MOL CELL BIOL, V14, P6597, DOI 10.1128/MCB.14.10.6597
   Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924
   Shah Kavita, 2003, Methods Mol Biol, V233, P253
   Smirnova JB, 2005, MOL CELL BIOL, V25, P9340, DOI 10.1128/MCB.25.21.9340-9349.2005
   Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200
   Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253
   Springael JY, 1999, J CELL SCI, V112, P1375
   STANBROUGH M, 1995, J BACTERIOL, V177, P94, DOI 10.1128/jb.177.1.94-102.1995
   Sudol M, 2000, CELL, V103, P1001, DOI 10.1016/S0092-8674(00)00203-8
   Troiani S, 2005, J PROTEOME RES, V4, P1296, DOI 10.1021/pr050018e
   Van Belle D, 2001, CURR OPIN CELL BIOL, V13, P389, DOI 10.1016/S0955-0674(00)00226-X
   VANDENBOL M, 1990, MOL GEN GENET, V222, P393, DOI 10.1007/BF00633845
   VANDENBOL M, 1987, EUR J BIOCHEM, V164, P607, DOI 10.1111/j.1432-1033.1987.tb11170.x
   VANDENBOL M, 1989, GENE, V83, P153, DOI 10.1016/0378-1119(89)90413-7
   Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7
NR 49
TC 4
Z9 4
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD NOV
PY 2009
VL 8
IS 11
BP 5305
EP 5316
DI 10.1021/pr9005469
PG 12
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 586XV
UT WOS:000276949600038
PM 19780626
DA 2021-01-25
ER

PT J
AU Lundback, AK
   Muller, SA
   Engel, A
   Hebert, H
AF Lundbaeck, Anna-Karin
   Mueller, Shirley A.
   Engel, Andreas
   Hebert, Hans
TI Assembly of Kch, a putative potassium channel from Escherichia coli
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Kch; RCK; Potassium channel; Membrane protein; Single particle; Negative
   stain; Electron microscopy; Mass measurement; STEM
ID RCK DOMAIN; K+ CHANNEL; PROTEIN; HOMOLOG; RING
AB Attempts to explore the structure and function of Kch, a putative potassium channel of Escherichia coli have yielded varying results; potassium-associated functions have been found in vivo but not in vitro. Here the kch gene is shown to produce two proteins, full-length Kch and the large C-terminal cytosolic domain (the RCK domain). Further, these two proteins are associated at the initial stages of purification. Previous structural studies of full-length Kch claim that the isolated protein forms large aggregates that are not suitable for analysis. The results presented here show that the purified protein sample, although heterogeneous, has one major population with a mass of about 400 kDa, implying the presence of two Kch tetramers in a complex form. A three dimensional reconstruction at 25 angstrom based on electron microscopy data from negatively stained particles, revealed a 210 angstrom long and 95 angstrom wide complex in which the two tetrameric Kch units are linked by their RCK domains, giving rise to a large central ring of density. The formation of this dimer of tetramers on expression or during purification, may explain why attempts to reconstitute Kch into liposomes for activity measurements have failed. (C) 2009 Elsevier Inc. All fights reserved.
C1 [Lundbaeck, Anna-Karin; Hebert, Hans] Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden.
   [Lundbaeck, Anna-Karin; Hebert, Hans] Royal Inst Technol, Sch Technol & Hlth, Novum, S-14157 Huddinge, Sweden.
   [Mueller, Shirley A.; Engel, Andreas] Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Hebert, H (corresponding author), Karolinska Inst, Dept Biosci & Nutr, S-14157 Huddinge, Sweden.
EM hans.hebert@ki.se
FU Swedish Research CouncilSwedish Research Council; Swiss National
   FoundationSwiss National Science Foundation (SNSF) [3100A0-108299];
   Maurice E. Muller Foundation of Switzerland
FX This work was supported by the Swedish Research Council. The STEM was
   supported by Swiss National Foundation (SNF Grant 3100A0-108299 to A.E.)
   and the Maurice E. Muller Foundation of Switzerland. We thank Philippe
   Ringler for the STEM microscopy. The pET17b plasmid bearing the kch gene
   was a kind gift from Professor Gunnar von Heijne.
CR Albright RA, 2006, CELL, V126, P1147, DOI 10.1016/j.cell.2006.08.028
   Dong JB, 2005, J BIOL CHEM, V280, P41716, DOI 10.1074/jbc.M508144200
   Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69
   Everberg H, 2006, J CHROMATOGR A, V1122, P35, DOI 10.1016/j.chroma.2006.04.020
   JIANG Y, 2001, NEURON, V29, P3
   Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a
   Jiang YX, 2002, NATURE, V417, P523, DOI 10.1038/417523a
   Johansson M, 1996, J BIOL CHEM, V271, P25912, DOI 10.1074/jbc.271.42.25912
   Krzyzanek V, 2009, J STRUCT BIOL, V165, P78, DOI 10.1016/j.jsb.2008.10.006
   Kuo MMC, 2003, EMBO J, V22, P4049, DOI 10.1093/emboj/cdg409
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   MILKMAN R, 1994, P NATL ACAD SCI USA, V91, P3510, DOI 10.1073/pnas.91.9.3510
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Munsey TS, 2002, BIOCHEM BIOPH RES CO, V297, P10, DOI 10.1016/S0006-291X(02)02095-8
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Ptak CP, 2005, BIOCHEMISTRY-US, V44, P62, DOI 10.1021/bi048390f
   SCHLOSSER A, 1993, MOL MICROBIOL, V9, P533, DOI 10.1111/j.1365-2958.1993.tb01714.x
   Ungar D, 2001, EUR J BIOCHEM, V268, P5386, DOI 10.1046/j.0014-2956.2001.02477.x
   Voges D, 1998, FEBS LETT, V429, P104, DOI 10.1016/S0014-5793(98)00509-2
NR 19
TC 3
Z9 3
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD NOV
PY 2009
VL 168
IS 2
BP 288
EP 293
DI 10.1016/j.jsb.2009.07.018
PG 6
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 507OW
UT WOS:000270865000008
PM 19631752
DA 2021-01-25
ER

PT J
AU Eisenberg, T
   Knauer, H
   Schauer, A
   Buttner, S
   Ruckenstuhl, C
   Carmona-Gutierrez, D
   Ring, J
   Schroeder, S
   Magnes, C
   Antonacci, L
   Fussi, H
   Deszcz, L
   Hartl, R
   Schraml, E
   Criollo, A
   Megalou, E
   Weiskopf, D
   Laun, P
   Heeren, G
   Breitenbach, M
   Grubeck-Loebenstein, B
   Herker, E
   Fahrenkrog, B
   Frohlich, KU
   Sinner, F
   Tavernarakis, N
   Minois, N
   Kroemer, G
   Madeo, F
AF Eisenberg, Tobias
   Knauer, Heide
   Schauer, Alexandra
   Buettner, Sabrina
   Ruckenstuhl, Christoph
   Carmona-Gutierrez, Didac
   Ring, Julia
   Schroeder, Sabrina
   Magnes, Christoph
   Antonacci, Lucia
   Fussi, Heike
   Deszcz, Luiza
   Hartl, Regina
   Schraml, Elisabeth
   Criollo, Alfredo
   Megalou, Evgenia
   Weiskopf, Daniela
   Laun, Peter
   Heeren, Gino
   Breitenbach, Michael
   Grubeck-Loebenstein, Beatrix
   Herker, Eva
   Fahrenkrog, Birthe
   Froehlich, Kai-Uwe
   Sinner, Frank
   Tavernarakis, Nektarios
   Minois, Nadege
   Kroemer, Guido
   Madeo, Frank
TI Induction of autophagy by spermidine promotes longevity
SO NATURE CELL BIOLOGY
LA English
DT Article
ID LIFE-SPAN EXTENSION; NECROTIC CELL-DEATH; SACCHAROMYCES-CEREVISIAE;
   CAENORHABDITIS-ELEGANS; BUDDING YEAST; REGULATES APOPTOSIS; CALORIE
   RESTRICTION; OXIDATIVE STRESS; GENE-EXPRESSION; MURINE SKIN
AB Ageing results from complex genetically and epigenetically programmed processes that are elicited in part by noxious or stressful events that cause programmed cell death. Here, we report that administration of spermidine, a natural polyamine whose intracellular concentration declines during human ageing, markedly extended the lifespan of yeast, flies and worms, and human immune cells. In addition, spermidine administration potently inhibited oxidative stress in ageing mice. In ageing yeast, spermidine treatment triggered epigenetic deacetylation of histone H3 through inhibition of histone acetyltransferases (HAT), suppressing oxidative stress and necrosis. Conversely, depletion of endogenous polyamines led to hyperacetylation, generation of reactive oxygen species, early necrotic death and decreased lifespan. The altered acetylation status of the chromatin led to significant upregulation of various autophagy-related transcripts, triggering autophagy in yeast, flies, worms and human cells. Finally, we found that enhanced autophagy is crucial for polyamine-induced suppression of necrosis and enhanced longevity.
C1 [Eisenberg, Tobias; Knauer, Heide; Schauer, Alexandra; Buettner, Sabrina; Ruckenstuhl, Christoph; Carmona-Gutierrez, Didac; Ring, Julia; Schroeder, Sabrina; Antonacci, Lucia; Fussi, Heike; Froehlich, Kai-Uwe; Madeo, Frank] Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.
   [Magnes, Christoph; Sinner, Frank] Inst Med Technol & Hlth Management, Graz, Austria.
   [Deszcz, Luiza; Hartl, Regina; Minois, Nadege] Res Inst Mol Pathol, A-1030 Vienna, Austria.
   [Deszcz, Luiza; Hartl, Regina; Minois, Nadege] Austrian Acad Sci, Inst Mol Biotechnol IMBA, A-1010 Vienna, Austria.
   [Schraml, Elisabeth] Univ Nat Resources & Appl Life Sci, Inst Appl Microbiol, Vienna, Austria.
   [Criollo, Alfredo; Kroemer, Guido] INSERM, U848, Villejuif, France.
   [Criollo, Alfredo; Kroemer, Guido] Inst Gustave Roussy, F-94805 Villejuif, France.
   [Criollo, Alfredo; Kroemer, Guido] Univ Paris 11, F-94805 Villejuif, France.
   [Megalou, Evgenia; Tavernarakis, Nektarios] Inst Mol Biol & Biotechnol, Fdn Res & Technol Hellas, Iraklion 70013, Crete, Greece.
   [Weiskopf, Daniela; Grubeck-Loebenstein, Beatrix] Austrian Acad Sci, Inst Biomed Ageing Res, A-6020 Innsbruck, Austria.
   [Laun, Peter; Heeren, Gino; Breitenbach, Michael] Salzburg Univ, Dept Cell Biol, Div Genet, A-5020 Salzburg, Austria.
   [Herker, Eva] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.
   [Fahrenkrog, Birthe] Univ Basel, ME Mueller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Madeo, F (corresponding author), Graz Univ, Inst Mol Biosci, A-8010 Graz, Austria.
EM kroemer@orange.fr; frank.madeo@uni-graz.at
RI Tavernarakis, Nektarios/B-9684-2013; Herker, Eva/B-9699-2014;
   Fahrenkrog, Birthe/D-5840-2011; KROEMER, Guido/B-4263-2013
OI Tavernarakis, Nektarios/0000-0002-5253-1466; Herker,
   Eva/0000-0001-9644-2484; KROEMER, Guido/0000-0002-9334-4405; Buttner,
   Sabrina/0000-0002-2786-8542; Ring, Julia/0000-0003-4991-9328; Magnes,
   Christoph/0000-0002-5153-7444; Ruckenstuhl,
   Christoph/0000-0002-4338-4679; Carmona-Gutierrez,
   Didac/0000-0001-7548-7771; Schraml, Elisabeth/0000-0003-0738-9883;
   Criollo, Alfredo/0000-0002-2737-7751; Weiskopf,
   Daniela/0000-0003-2968-7371; Fahrenkrog, Birthe/0000-0003-4080-9413;
   Eisenberg, Tobias/0000-0003-3559-1130
FU Austrian Science Fund FWF (Austria)Austrian Science Fund (FWF)
   [S-9304-B05, S-9303-B05, S9302-B05, S-9301-B05]; European Commission
   (Brussels, Europe)European CommissionEuropean Commission Joint Research
   Centre [512020]; APOSYSEuropean CommissionEuropean Commission Joint
   Research Centre;  [FP6 036894]
FX We thank Ulrike Potocnik, Silvia Dichtinger, Arno Absenger and Elfgard
   Heintz for assistance. We are grateful to the Austrian Science Fund FWF
   (Austria) for grant S-9304-B05 (to F. M., S. B. and D. C.-G.), grant
   S-9303-B05 (to K.-U. F. and H. K.), grant LIPOTOX (to F. M. and S. B.),
   and grant S-9301-B05 (to B. G.-L.) and to the European Commission for
   project TransDeath (to K.-U. F. and C. R.), project APOSYS (to F. M., T.
   E. and G. K.) and project Lifespan (FP6 036894 to B. G.-L.). We are
   grateful to the Austrian Science Fund FWF (Vienna, Austria) for grants
   S9302-B05 (to M. B.) and to the European Commission (Brussels, Europe)
   for project MIMAGE (contract no. 512020; to M. B.).
CR Allen C, 2006, J CELL BIOL, V174, P89, DOI 10.1083/jcb.200604072
   Artal-Sanz M, 2006, J CELL BIOL, V173, P231, DOI 10.1083/jcb.200511103
   BALASUNDARAM D, 1991, P NATL ACAD SCI USA, V88, P5872, DOI 10.1073/pnas.88.13.5872
   Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009
   BRENNER S, 1974, GENETICS, V77, P71
   Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021
   BURHANS WC, 2009, CELL CYCLE, P8
   Burtner CR, 2009, CELL CYCLE, V8, P1256, DOI 10.4161/cc.8.8.8287
   Chattopadhyay MK, 2006, YEAST, V23, P751, DOI 10.1002/yea.1393
   Criollo A, 2007, CELL DEATH DIFFER, V14, P1029, DOI 10.1038/sj.cdd.4402099
   Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085
   Duncan EM, 2008, CELL, V135, P284, DOI 10.1016/j.cell.2008.09.055
   ELLMAN GL, 1959, ARCH BIOCHEM BIOPHYS, V82, P70, DOI 10.1016/0003-9861(59)90090-6
   Evans E, 2000, MOL CELL, V5, P789, DOI 10.1016/S1097-2765(00)80319-6
   Fabrizio P, 2005, CELL, V123, P655, DOI 10.1016/j.cell.2005.08.042
   Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002
   Fabrizio P, 2001, SCIENCE, V292, P288, DOI 10.1126/science.1059497
   Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848
   Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577
   Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016
   Galluzzi L, 2008, CURR MOL MED, V8, P78
   Gianotti V, 2008, J CHROMATOGR A, V1185, P296, DOI 10.1016/j.chroma.2008.02.038
   Golstein P, 2007, TRENDS BIOCHEM SCI, V32, P37, DOI 10.1016/j.tibs.2006.11.001
   Gueldener U, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.6.e23
   HARMAN D, 1956, J GERONTOL, V11, P298, DOI 10.1093/geronj/11.3.298
   Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221
   Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014
   Hobbs CA, 2003, EXP CELL RES, V290, P427, DOI 10.1016/S0014-4827(03)00352-5
   Hobbs CA, 2002, CANCER RES, V62, P67
   Howe L, 2001, GENE DEV, V15, P3144, DOI 10.1101/gad.931401
   Hoyer-Hansen M, 2008, AUTOPHAGY, V4, P574, DOI 10.4161/auto.5921
   Imai S, 2000, NATURE, V403, P795
   Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127
   Jia KL, 2007, AUTOPHAGY, V3, P597, DOI 10.4161/auto.4989
   Juhasz G, 2007, GENE DEV, V21, P3061, DOI 10.1101/gad.1600707
   Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084
   Kirisako T, 1999, J CELL BIOL, V147, P435, DOI 10.1083/jcb.147.2.435
   Lambert LA, 2008, CANCER RES, V68, P7966, DOI 10.1158/0008-5472.CAN-08-1333
   Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611
   Laun P, 2001, MOL MICROBIOL, V39, P1166, DOI 10.1046/j.1365-2958.2001.02317.x
   Lefranc F, 2007, ONCOLOGIST, V12, P1395, DOI 10.1634/theoncologist.12-12-1395
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Lin SJ, 2000, SCIENCE, V289, P2126, DOI 10.1126/science.289.5487.2126
   Liu BS, 2005, J BIOL CHEM, V280, P16659, DOI 10.1074/jbc.M414008200
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002
   Longo VD, 2003, SCIENCE, V299, P1342, DOI 10.1126/science.1077991
   Lotze MT, 2005, NAT REV IMMUNOL, V5, P331, DOI 10.1038/nri1594
   Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4
   Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729
   Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757
   Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   MINOCHA R, 1994, J PLANT GROWTH REGUL, V13, P187, DOI 10.1007/BF00226036
   NODA T, 1995, BIOCHEM BIOPH RES CO, V210, P126, DOI 10.1006/bbrc.1995.1636
   Orvedahl A, 2009, CELL DEATH DIFFER, V16, P57, DOI 10.1038/cdd.2008.130
   Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406
   Rainer J, 2006, NUCLEIC ACIDS RES, V34, pW498, DOI 10.1093/nar/gkl038
   Riener CK, 2002, ANAL BIOANAL CHEM, V373, P266, DOI 10.1007/s00216-002-1347-2
   Rozen S, 2000, Methods Mol Biol, V132, P365
   Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01
   Samara C, 2008, CELL DEATH DIFFER, V15, P105, DOI 10.1038/sj.cdd.4402231
   Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858
   SCALABRINO G, 1984, MECH AGEING DEV, V26, P149, DOI 10.1016/0047-6374(84)90090-3
   Schraml E, 2007, EXP GERONTOL, V42, P1072, DOI 10.1016/j.exger.2007.08.003
   Smith DL, 2007, AGING CELL, V6, P649, DOI 10.1111/j.1474-9726.2007.00326.x
   StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83
   Syntichaki P, 2005, CURR BIOL, V15, P1249, DOI 10.1016/j.cub.2005.05.057
   Tavernarakis N, 2008, AUTOPHAGY, V4, P870, DOI 10.4161/auto.6730
   VERMES I, 1995, J IMMUNOL METHODS, V184, P39, DOI 10.1016/0022-1759(95)00072-I
   Vicencio JM, 2008, GERONTOLOGY, V54, P92, DOI 10.1159/000129697
   Weinberger M, 2005, J CELL SCI, V118, P3543, DOI 10.1242/jcs.02477
   Weinberger M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000748
   Winkler GS, 2002, P NATL ACAD SCI USA, V99, P3517, DOI 10.1073/pnas.022042899
   Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138
   Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683
   Zong WX, 2006, GENE DEV, V20, P1, DOI 10.1101/gad.1376506
NR 76
TC 782
Z9 817
U1 5
U2 151
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-7392
EI 1476-4679
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD NOV
PY 2009
VL 11
IS 11
BP 1305
EP U102
DI 10.1038/ncb1975
PG 33
WC Cell Biology
SC Cell Biology
GA 514WC
UT WOS:000271425800010
PM 19801973
OA Green Published
DA 2021-01-25
ER

PT J
AU Crozier, SJ
   Ernst, SA
   Inoki, K
   Hall, MN
   Williams, JA
AF Crozier, S. J.
   Ernst, S. A.
   Inoki, K.
   Hall, M. N.
   Williams, J. A.
TI Inhibition of Pancreas Growth in Raptor-Deficient Mice
SO PANCREAS
LA English
DT Meeting Abstract
C1 [Crozier, S. J.; Williams, J. A.] Univ Michigan, Dept Mol & Integrat Physiol, Ann Arbor, MI 48109 USA.
   [Ernst, S. A.] Univ Michigan, Dept Cell & Dev Biol, Ann Arbor, MI 48109 USA.
   [Inoki, K.] Univ Michigan, Inst Life Sci, Ann Arbor, MI 48109 USA.
   [Hall, M. N.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0885-3177
J9 PANCREAS
JI Pancreas
PD NOV
PY 2009
VL 38
IS 8
BP 991
EP 991
PG 1
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 512DZ
UT WOS:000271225300074
DA 2021-01-25
ER

PT J
AU Jurges, G
   Kassemeyer, HH
   Durrenberger, M
   Duggelin, M
   Nick, P
AF Juerges, G.
   Kassemeyer, H. -H.
   Duerrenberger, M.
   Dueggelin, M.
   Nick, P.
TI The mode of interaction between Vitis and Plasmopara viticola Berk. &
   Curt. Ex de Bary depends on the host species
SO PLANT BIOLOGY
LA English
DT Article
DE Coevolution; guard cells; host-pathogen interaction; resistance
ID DOWNY MILDEW; INDUCED RESISTANCE; GRAPEVINE; VINIFERA; MICROSCOPY;
   INFECTION; RESPONSES; LIGHT
AB In order to obtain insight into host responses to grapevine downy mildew (Plasmopara viticola), we compared pathogen development on a panel of Vitis species from North America, Asia and Europe. Leaf discs from different host species were inoculated in parallel, and the colonisation of the mesophyll was visualised by aniline blue staining and quantified with respect to infection incidence and mycelial growth. In parallel, the morphology of guard cells was screened for the presence of an internal cuticular rim after staining with acridine orange and using low-temperature scanning electron microscopy. We observed three response patterns: (i) inhibition of pathogen development early after attachment of zoospores; (ii) successful colonisation of the mesophyll by the pathogen; and (iii) aberrant development, where the pathogen does not attach to guard cells, but produces hyphae on the leaf surface without formation of viable sporangiophores. Inhibition is observed in the North American and Siberian species, successful colonisation prevails in the European hosts, and surface hyphae are found on non-Siberian Asiatic species. We propose that the interaction between host and pathogen is under control of specific signals that have been subject to evolutionary diversification.
C1 [Juerges, G.; Nick, P.] Univ Karlsruhe, Inst Bot 1, D-76128 Karlsruhe, Germany.
   [Kassemeyer, H. -H.] State Inst Viticulture & Oenol, Freiburg, Germany.
   [Duerrenberger, M.; Dueggelin, M.] Univ Basel, Ctr Microscopy, Biozentrum, Pharmazentrum, Basel, Switzerland.
RP Nick, P (corresponding author), Univ Karlsruhe, Inst Bot 1, Kaiserstr 2, D-76128 Karlsruhe, Germany.
EM peter.nick@bio.uni-karlsruhe.de
FU USDA National Clonal Germplasm Repository; University of
   California-Davis (USA)University of California System
FX The competent and highly motivated support of Joachim Daumann (Botanical
   Garden, Karlsruhe University) in the cultivation and propagation of the
   different Vitis species is gratefully ackowledged. We also gratefully
   acknowledge the support of the USDA National Clonal Germplasm
   Repository, University of California-Davis (USA) who kindly provided
   some wild Vitis species.
CR Busam G, 1997, PLANT PHYSIOL, V115, P1039, DOI 10.1104/pp.115.3.1039
   CLARK JSC, 1993, NEW PHYTOL, V124, P107, DOI 10.1111/j.1469-8137.1993.tb03802.x
   DAI GH, 1995, PHYSIOL MOL PLANT P, V46, P177, DOI 10.1006/pmpp.1995.1014
   Dick MW, 2002, ADVANCES IN DOWNY MILDEW RESEARCH, P1, DOI 10.1007/0-306-47914-1_1
   Dick MW, 2001, MYCOTA, V7, P39
   Diez-Navajas AM, 2008, PHYTOPATHOLOGY, V98, P776, DOI 10.1094/PHYTO-98-7-0776
   ELGARIANI A, 2004, ADV DOWNY MILDEW RES, V2, P265
   Gindro K, 2003, PLANT PHYSIOL BIOCH, V41, P846, DOI 10.1016/S0981-9428(03)00124-4
   GRUNZEL H, 1959, ZENTRALBLATT BAKTE 2, V112, P454
   GUGGENHEIM R, 1991, J MICROSC-OXFORD, V161, P337, DOI 10.1111/j.1365-2818.1991.tb03094.x
   Hamiduzzaman MM, 2005, MOL PLANT MICROBE IN, V18, P819, DOI 10.1094/MPMI-18-0819
   Kiefer B, 2002, PLANTA, V215, P387, DOI 10.1007/s00425-002-0760-2
   Kortekamp A, 2005, MYCOL RES, V109, P640, DOI 10.1017/S0953756205002418
   Kortekamp A, 1997, VITIS, V36, P103
   LANGCAKE P, 1980, VITIS, V19, P321
   MULLER K., 1934, LANDW JAHRB, V79, P509
   MULLER T, 1991, J MICROSC-OXFORD, V161, P73
   Nishimura MT, 2003, SCIENCE, V301, P969, DOI 10.1126/science.1086716
   Riemann M, 2002, PROTOPLASMA, V219, P13, DOI 10.1007/s007090200001
   Unger S, 2007, PHYTOPATHOLOGY, V97, P780, DOI 10.1094/PHYTO-97-7-0780
   Vercesi A, 1999, MYCOL RES, V103, P193, DOI 10.1017/S095375629800700X
NR 21
TC 48
Z9 52
U1 0
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1435-8603
EI 1438-8677
J9 PLANT BIOLOGY
JI Plant Biol.
PD NOV
PY 2009
VL 11
IS 6
BP 886
EP 898
DI 10.1111/j.1438-8677.2008.00182.x
PG 13
WC Plant Sciences
SC Plant Sciences
GA 502BP
UT WOS:000270429300012
PM 19796366
DA 2021-01-25
ER

PT J
AU Jenal, U
AF Jenal, Urs
TI The role of proteolysis in the Caulobacter crescentus cell cycle and
   development
SO RESEARCH IN MICROBIOLOGY
LA English
DT Article
DE Caulobacter; ClpXP; CtrA; Cyclic di-GMP; Protein localization;
   Proteolysis
ID RESPONSE REGULATOR; DNA-REPLICATION; POLAR LOCALIZATION; DEPENDENT
   DEGRADATION; DYNAMIC LOCALIZATION; HISTIDINE KINASES; ESCHERICHIA-COLI;
   PROTEASE COMPLEX; DIVISION CYCLE; PROTEINS
AB Caulobacter crescentus cell cycle progression is implemented by oscillating global transcriptional regulators that establish temporal and spatial control of modular genetic subsystems during the cell cycle. The hierarchy of this regulatory circuit is established through a combination of gene expression control and regulated proteolysis. Recent results highlight the importance of spatial organization for controlled proteolysis in C. crescentus. (C) 2009 Elsevier Masson SAS. All rights reserved.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch
FU Swiss National Science Foundation FellowshipSwiss National Science
   Foundation (SNSF) [3100A0-108186]
FX I am grateful to Soren Abel, Alex Bohm, Tina Jaeger and Jake Malone for
   critical reading of the manuscript and for helpful comments and
   suggestions. Work in my lab is supported by Swiss National Science
   Foundation Fellowship 3100A0-108186.
CR Alba BM, 2004, MOL MICROBIOL, V52, P613, DOI 10.1111/j.1365-2958.2003.03982.x
   Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x
   Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   ALI AT, 1999, J BACTERIOL, V181, P6361
   Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321
   Bloom JD, 2007, GENETICS, V175, P255, DOI 10.1534/genetics.106.061754
   Bowers LM, 2008, CURR OPIN MICROBIOL, V11, P547, DOI 10.1016/j.mib.2008.09.019
   Brown PJB, 2009, ADV MICROB PHYSIOL, V54, P1, DOI 10.1016/S0065-2911(08)00001-5
   Chen JC, 2006, EMBO J, V25, P377, DOI 10.1038/sj.emboj.7600935
   Chen JC, 2005, MOL MICROBIOL, V55, P1085, DOI 10.1111/j.1365-2958.2004.04443.x
   Cheng L, 2009, J BACTERIOL, V191, P4268, DOI 10.1128/JB.00362-09
   Chien P, 2007, P NATL ACAD SCI USA, V104, P6590, DOI 10.1073/pnas.0701776104
   Collier J, 2006, EMBO J, V25, P346, DOI 10.1038/sj.emboj.7600927
   Collier J, 2007, P NATL ACAD SCI USA, V104, P17111, DOI 10.1073/pnas.0708112104
   Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648
   Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409
   Gorbatyuk B, 2005, MOL MICROBIOL, V55, P1233, DOI 10.1111/j.1365-2958.2004.04459.x
   Grunenfelder B, 2004, J BACTERIOL, V186, P4960, DOI 10.1128/JB.186.15.4960-4971.2004
   Grunenfelder B, 2001, P NATL ACAD SCI USA, V98, P4681, DOI 10.1073/pnas.071538098
   Holtzendorff J, 2004, SCIENCE, V304, P983, DOI 10.1126/science.1095191
   Hong SJ, 2007, P NATL ACAD SCI USA, V104, P17128, DOI 10.1073/pnas.0707671104
   Hottes AK, 2005, MOL MICROBIOL, V58, P1340, DOI 10.1111/j.1365-2958.2005.04912.x
   Iniesta AA, 2008, P NATL ACAD SCI USA, V105, P16602, DOI 10.1073/pnas.0808807105
   Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103
   Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998
   Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658
   Kain J, 2008, J BACTERIOL, V190, P6749, DOI 10.1128/JB.00589-08
   Keiler KC, 2003, J BACTERIOL, V185, P573, DOI 10.1128/JB.185.2.573-580.2003
   Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990
   Kirstein J, 2008, MOL MICROBIOL, V70, P682, DOI 10.1111/j.1365-2958.2008.06438.x
   LARRABEE KL, 1980, J BIOL CHEM, V255, P4125
   Laub MT, 2007, ANNU REV GENET, V41, P429, DOI 10.1146/annurev.genet.41.110306.130346
   Laub MT, 2000, SCIENCE, V290, P2144, DOI 10.1126/science.290.5499.2144
   Laub MT, 2002, P NATL ACAD SCI USA, V99, P4632, DOI 10.1073/pnas.062065699
   Lawler ML, 2006, MOL MICROBIOL, V59, P301, DOI 10.1111/j.1365-2958.2005.04935.x
   Lesley JA, 2008, J BACTERIOL, V190, P6867, DOI 10.1128/JB.00700-08
   Li S, 2008, PLOS COMPUT BIOL, V4, DOI [10.1371/journal.pcbi.0040009, 10.1371/journal.pcbi.0040009.eor]
   Makinoshima H, 2006, MICROBES INFECT, V8, P1882, DOI 10.1016/j.micinf.2006.02.021
   McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033
   Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045
   Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200
   PINE MJ, 1970, J BACTERIOL, V103, P207, DOI 10.1128/JB.103.1.207-215.1970
   Potocka I, 2002, J BACTERIOL, V184, P6635, DOI 10.1128/JB.184.23.6635-6642.2002
   Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120
   Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2
   Radhakrishnan SK, 2008, GENE DEV, V22, P212, DOI 10.1101/gad.1601808
   Reisenauer A, 1999, J BACTERIOL, V181, P2430, DOI 10.1128/JB.181.8.2430-2439.1999
   Reisenauer A, 2002, EMBO J, V21, P4969, DOI 10.1093/emboj/cdf490
   Ryan KR, 2004, P NATL ACAD SCI USA, V101, P7415, DOI 10.1073/pnas.0402153101
   Schirmer T, 2009, NAT REV MICROBIOL, V7, P724, DOI 10.1038/nrmicro2203
   Simmons LA, 2008, J BACTERIOL, V190, P6758, DOI 10.1128/JB.00590-08
   Slominska M, 2003, BIOCHEM J, V370, P867, DOI 10.1042/BJ20021161
   Stephens C, 1996, P NATL ACAD SCI USA, V93, P1210, DOI 10.1073/pnas.93.3.1210
   STEPHENS CM, 1995, J BACTERIOL, V177, P1662, DOI 10.1128/jb.177.7.1662-1669.1995
   Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016
   Tsai JW, 2001, J BACTERIOL, V183, P5001, DOI 10.1128/JB.183.17.5001-5007.2001
   Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2
   Wright R, 1996, GENE DEV, V10, P1532, DOI 10.1101/gad.10.12.1532
   Zeldovich KB, 2007, P NATL ACAD SCI USA, V104, P16152, DOI 10.1073/pnas.0705366104
   ZWEIGER G, 1994, J MOL BIOL, V235, P472, DOI 10.1006/jmbi.1994.1007
   ZWEIGER G, 1994, J BACTERIOL, V176, P401, DOI 10.1128/JB.176.2.401-408.1994
NR 66
TC 34
Z9 34
U1 0
U2 4
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0923-2508
EI 1769-7123
J9 RES MICROBIOL
JI Res. Microbiol.
PD NOV
PY 2009
VL 160
IS 9
SI SI
BP 687
EP 695
DI 10.1016/j.resmic.2009.09.006
PG 9
WC Microbiology
SC Microbiology
GA 528HY
UT WOS:000272435400011
PM 19781638
DA 2021-01-25
ER

PT J
AU Rudolph, MG
   Klostermeier, D
AF Rudolph, Markus G.
   Klostermeier, Dagmar
TI The Thermus thermophilus DEAD box helicase Hera contains a modified RNA
   recognition motif domain loosely connected to the helicase core
SO RNA
LA English
DT Article
DE RNA helicase; DEAD box protein; Hera; ATPase; RNA recognition motif
ID C-TERMINAL DOMAIN; ESCHERICHIA-COLI DBPA; 23S RIBOSOMAL-RNA;
   CRYSTAL-STRUCTURE; MOLECULAR GRAPHICS; BINDING DOMAIN; MESSENGER-RNA;
   GENERAL RNA; GROUP-I; PROTEIN
AB DEAD box family helicases consist of a helicase core that is formed by two flexibly linked RecA-like domains. The helicase activity can be regulated by N- or C-terminal extensions flanking the core. Thermus thermophilus heat resistant RNA-dependent ATPase (Hera) is the first DEAD box helicase that forms a dimer using a unique dimerization domain. In addition to the dimerization domain, Hera contains a C-terminal RNA binding domain (RBD) that shares sequence homology only to uncharacterized proteins of the Deinococcus/Thermus group. The crystal structure of Hera_RBD reveals the fold of an altered RNA recognition motif (RRM) with limited structural homology to the RBD of the DEAD box helicase YxiN from Bacillus subtilis. Comparison with RRM/RNA complexes shows that a RNA binding mode different than that suggested for YxiN, but similar to U1A, can be inferred for Hera. The orientation of the RBD relative to the helicase core was defined in a second crystal structure of a Hera fragment including the C-terminal RecA domain, the dimerization domain, and the RBD. The structures allow construction of a model for the entire Hera helicase dimer. A likely binding surface for large RNA substrates that spans both RecA-like domains and the RBD is identified.
C1 [Klostermeier, Dagmar] Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
   [Rudolph, Markus G.] Univ Gottingen, Dept Mol Struct Biol, D-37077 Gottingen, Germany.
RP Klostermeier, D (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@unibas.ch
OI Rudolph, Markus/0000-0003-0447-1101
FU DFGGerman Research Foundation (DFG); VolkswagenStiftungVolkswagen; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
FX We thank Ines Hertel for excellent technical assistance, and the
   colleagues at the Swiss Light Source for beamtime and guidance. This
   work was supported by grants from the DFG (to M. G. R.), the
   VolkswagenStiftung (to D. K.), and the Swiss National Science Foundation
   (to D. K.).
CR Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981
   Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006
   BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0
   Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080
   Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905
   Clery A, 2008, CURR OPIN STRUC BIOL, V18, P290, DOI 10.1016/j.sbi.2008.04.002
   Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200
   Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838
   Del Campo M, 2009, J MOL BIOL, V389, P674, DOI 10.1016/j.jmb.2009.04.043
   DELCAMPO M, 2009, MOL CELL IN PRESS
   Diges CM, 2005, BIOCHEMISTRY-US, V44, P7903, DOI 10.1021/bi050033x
   Diges CM, 2001, EMBO J, V20, P5503, DOI 10.1093/emboj/20.19.5503
   Dominguez C, 2006, NUCLEIC ACIDS RES, V34, P3634, DOI 10.1093/nar/gkl488
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1
   GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2
   Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305
   Grant GA, 2006, J BIOL CHEM, V281, P33825, DOI 10.1074/jbc.R600024200
   Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472
   Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083
   Hargous Y, 2006, EMBO J, V25, P5126, DOI 10.1038/sj.emboj.7601385
   HILBERT M, 2009, BIOL CHEM IN PRESS
   Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   Klostermeier D, 2009, NUCLEIC ACIDS RES, V37, P421, DOI 10.1093/nar/gkn947
   Kossen K, 2002, J MOL BIOL, V324, P625, DOI 10.1016/S0022-2836(02)01140-3
   Linden MH, 2008, NUCLEIC ACIDS RES, V36, P5800, DOI 10.1093/nar/gkn581
   Maris C, 2005, FEBS J, V272, P2118, DOI 10.1111/j.1742-4658.2005.04653.x
   Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206
   MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396
   Mohr G, 2008, J MOL BIOL, V375, P1344, DOI 10.1016/j.jmb.2007.11.041
   Mohr S, 2006, P NATL ACAD SCI USA, V103, P3569, DOI 10.1073/pnas.0600332103
   Myers JC, 2004, J MOL BIOL, V342, P743, DOI 10.1016/j.jmb.2004.07.029
   Netter C, 2009, RNA, V15, P1305, DOI 10.1261/rna.1359909
   OUBRIDGE C, 1994, NATURE, V372, P432, DOI 10.1038/372432a0
   Rao JN, 2006, BIOCHEM J, V400, P449, DOI 10.1042/BJ20060421
   Rudolph MG, 2006, J MOL BIOL, V361, P731, DOI 10.1016/j.jmb.2006.06.065
   Rudolph MG, 2009, ACTA CRYSTALLOGR F, V65, P248, DOI 10.1107/S1744309108043145
   Russell R, 2008, FRONT BIOSCI-LANDMRK, V13, P1, DOI 10.2741/2557
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   Tijerina P, 2006, P NATL ACAD SCI USA, V103, P16698, DOI 10.1073/pnas.0603127103
   von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561
   Wang SY, 2006, RNA, V12, P959, DOI 10.1261/rna.5906
   Warkentin Matthew, 2007, Journal of Structural and Functional Genomics, V8, P141, DOI 10.1007/s10969-007-9029-0
   Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28
NR 48
TC 20
Z9 20
U1 0
U2 4
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1355-8382
EI 1469-9001
J9 RNA
JI RNA
PD NOV
PY 2009
VL 15
IS 11
BP 1993
EP 2001
DI 10.1261/rna.1820009
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 507KC
UT WOS:000270851000007
PM 19710183
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Sabourin, JC
   Ackema, KB
   Ohayon, D
   Guichet, PO
   Perrin, FE
   Garces, A
   Ripoll, C
   Charite, J
   Simonneau, L
   Kettenmann, H
   Zine, A
   Privat, A
   Valmier, J
   Pattyn, A
   Hugnot, JP
AF Sabourin, Jean-Charles
   Ackema, Karin B.
   Ohayon, David
   Guichet, Pierre-Olivier
   Perrin, Florence E.
   Garces, Alain
   Ripoll, Chantal
   Charite, Jeroen
   Simonneau, Lionel
   Kettenmann, H.
   Zine, Azel
   Privat, Alain
   Valmier, Jean
   Pattyn, Alexandre
   Hugnot, Jean-Philippe
TI A Mesenchymal-Like ZEB1(+) Niche Harbors Dorsal Radial Glial Fibrillary
   Acidic Protein-Positive Stem Cells in the Spinal Cord
SO STEM CELLS
LA English
DT Article
DE Neural stem cells; Spinal cord; Niche; ZEB1
ID CENTRAL-NERVOUS-SYSTEM; NEURAL PROGENITOR CELLS; EPENDYMAL CELLS; ADULT
   BRAIN; PRECURSOR CELLS; VASCULAR NICHE; IN-VITRO; DIFFERENTIATION;
   NEUROGENESIS; ASTROCYTES
AB In humans and rodents the adult spinal cord harbors neural stem cells located around the central canal. Their identity, precise location, and specific signaling are still ill-defined and controversial. We report here on a detailed analysis of this niche. Using microdissection and glial fibrillary acidic protein (GFAP)-green fluorescent protein (GFP) transgenic mice, we demonstrate that neural stem cells are mostly dorsally located GFAP(+) cells lying ependymally and subependymally that extend radial processes toward the pial surface. The niche also harbors doublecortin protein (Dcx)(+) Nkx6.1(+) neurons sending processes into the lumen. Cervical and lumbar spinal cord neural stem cells maintain expression of specific rostro-caudal Hox gene combinations and the niche shows high levels of signaling proteins (CD15, Jagged1, Hes1, differential screening-selected gene aberrative in neuroblastoma [DAN]). More surprisingly, the niche displays mesenchymal traits such as expression of epithelial-mesenchymal-transition zinc finger E-box-binding protein 1 (ZEB1) transcription factor and smooth muscle actin. We found ZEB1 to be essential for neural stem cell survival in vitro. Proliferation within the niche progressively ceases around 13 weeks when the spinal cord reaches its final size, suggesting an active role in postnatal development. In addition to hippocampus and subventricular zone niches, adult spinal cord constitutes a third central nervous system stem cell niche with specific signaling, cellular, and structural characteristics that could possibly be manipulated to alleviate spinal cord traumatic and degenerative diseases. STEM CELLS 2009; 27: 2722-2733
C1 [Sabourin, Jean-Charles; Ohayon, David; Guichet, Pierre-Olivier; Perrin, Florence E.; Garces, Alain; Ripoll, Chantal; Zine, Azel; Privat, Alain; Valmier, Jean; Pattyn, Alexandre; Hugnot, Jean-Philippe] Hop St ELOI, INSERM, U583, Inst Neurosci Montpellier, Montpellier, France.
   [Ackema, Karin B.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Charite, Jeroen] Erasmus MC, Dept Cell Biol, Rotterdam, Netherlands.
   [Simonneau, Lionel] Univ Montpellier, Lab Interdisciplinaire Rech Didact & Format, F-34059 Montpellier, France.
   [Kettenmann, H.] Max Delbruck Centrum Mol Med, Berlin, Germany.
RP Hugnot, JP (corresponding author), Hop St ELOI, INSERM, U583, Inst Neurosci Montpellier, Montpellier, France.
EM hugnot@univ-montp2.fr
RI Alexandre, Pattyn/ABF-1346-2020
OI Pattyn, Alexandre/0000-0003-1215-1482; Guichet,
   Pierre-Olivier/0000-0003-0115-2199; OHAYON, David/0000-0003-3545-3774;
   Garces, Alain/0000-0001-6252-9995; Kettenmann,
   Helmut/0000-0001-8208-0291; PERRIN, Florence/0000-0002-7630-0515
FU European Union FP6 "Rescue" STREPEuropean Union (EU); "Association
   Francaise contre les Myopathies" (Evry, France)Association Francaise
   contre les Myopathies; Princess Grace of Monaco Fundation (Monaco);
   AFMAssociation Francaise contre les Myopathies
FX This work was supported by the European Union FP6 "Rescue" STREP, the
   "Association Francaise contre les Myopathies" (Evry, France), the
   Princess Grace of Monaco Fundation (Monaco). We are very grateful to Dr
   N. Heintz (New York), Dr P. Jay (Montpellier, France), Dr Darling
   (Louisville, KY), Dr Sudo (Toray, Japan), Dr Wegner (Erlangen, Germany),
   Dr A. Postigo (St. Louis), and Dr T. Walker (Brisbane, Australia) who
   generously provided us with BLBP, Sox9, ZEB1, Hes1, Sox10 antibodies,
   DB-ZEB construct, and Dcx-GFP mice, respectively. J.C.S. is a recipient
   of an AFM Ph.D. fellowship. We thank Dr C. Cazevielle (electron
   microscopy platform), Dr C. Duperray (cytometry platform), Dr H.
   Boukhaddaoui and C. Sar (cell imaging platform), I. Sassetti (histology
   platform), and Y. Gerber/G. Bonniface for high-quality technical
   assistance and experiment designs. We are grateful to Dr K. Langley for
   critical reading of the manuscript. A.P. and J.P.H. contributed equally
   to this work.
CR Alvarez-Buylla A, 2004, NEURON, V41, P683, DOI 10.1016/S0896-6273(04)00111-4
   Anthony TE, 2004, NEURON, V41, P881, DOI 10.1016/S0896-6273(04)00140-0
   Anthony TE, 2005, GENE DEV, V19, P1028, DOI 10.1101/gad.1302105
   Balemans W, 2002, DEV BIOL, V250, P231, DOI 10.1006/dbio.2002.0779
   Barnabe-Heider F, 2008, CELL STEM CELL, V3, P16, DOI 10.1016/j.stem.2008.06.011
   BRUNI JE, 1987, J ANAT, V152, P55
   Bruni JE, 1998, MICROSC RES TECHNIQ, V41, P2, DOI 10.1002/(SICI)1097-0029(19980401)41:1<2::AID-JEMT2>3.0.CO;2-Z
   CAJAL SRY, 1911, HISTOLOGIE SYSTEME N
   Capela A, 2006, DEV BIOL, V291, P300, DOI 10.1016/j.ydbio.2005.12.030
   Carlen M, 2009, NAT NEUROSCI, V12, P259, DOI 10.1038/nn.2268
   Carpenter EM, 2002, DEV NEUROSCI-BASEL, V24, P24, DOI 10.1159/000064943
   Chi LY, 2006, STEM CELLS, V24, P34, DOI 10.1634/stemcells.2005-0076
   Chojnacki AK, 2009, NAT REV NEUROSCI, V10, P153, DOI 10.1038/nrn2571
   Corti S, 2006, HUM MOL GENET, V15, P167, DOI 10.1093/hmg/ddi446
   Danilov AI, 2006, EUR J NEUROSCI, V23, P394, DOI 10.1111/j.1460-9568.2005.04563.x
   Deleyrolle L, 2006, STEM CELLS, V24, P748, DOI 10.1634/stemcells.2005-0138
   Doetsch F, 1999, P NATL ACAD SCI USA, V96, P11619, DOI 10.1073/pnas.96.20.11619
   Doetsch F, 2002, NEURON, V36, P1021, DOI 10.1016/S0896-6273(02)01133-9
   Dromard C, 2008, J NEUROSCI RES, V86, P1916, DOI 10.1002/jnr.21646
   Dromard C, 2007, STEM CELLS, V25, P340, DOI 10.1634/stemcells.2005-0556
   Fu H, 2003, J COMP NEUROL, V456, P237, DOI 10.1002/cne.10481
   Gurok U, 2004, J NEUROSCI, V24, P5982, DOI 10.1523/JNEUROSCI.0809-04.2004
   Johansson CB, 1999, CELL, V96, P25, DOI 10.1016/S0092-8674(00)80956-3
   Ke Y, 2006, STEM CELLS, V24, P1011, DOI 10.1634/stemcells.2005-0249
   Kehl LJ, 1997, SCIENCE, V276, P586, DOI 10.1126/science.276.5312.586
   Kulbatski I, 2009, J HISTOCHEM CYTOCHEM, V57, P405, DOI 10.1369/jhc.2008.951814
   Leatherman JL, 2008, CELL STEM CELL, V3, P44, DOI 10.1016/j.stem.2008.05.001
   Lledo PM, 2008, TRENDS NEUROSCI, V31, P392, DOI 10.1016/j.tins.2008.05.006
   Louis SA, 2008, STEM CELLS, V26, P988, DOI 10.1634/stemcells.2007-0867
   Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027
   Marichal N, 2009, J NEUROSCI, V29, P10010, DOI 10.1523/JNEUROSCI.6183-08.2009
   Martens DJ, 2002, EUR J NEUROSCI, V16, P1045, DOI 10.1046/j.1460-9568.2002.02181.x
   Meletis K, 2008, PLOS BIOL, V6, P1494, DOI 10.1371/journal.pbio.0060182
   Mirzadeh Z, 2008, CELL STEM CELL, V3, P265, DOI 10.1016/j.stem.2008.07.004
   Morel AP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002888
   Moreno-Manzano V, 2009, STEM CELLS, V27, P733, DOI 10.1002/stem.24
   Ninkovic J, 2007, CURR OPIN NEUROBIOL, V17, P338, DOI 10.1016/j.conb.2007.04.006
   Nishimura G, 2006, DEV CELL, V11, P93, DOI 10.1016/j.devcel.2006.05.011
   Nolte C, 2001, GLIA, V33, P72
   Peinado H, 2007, NAT REV CANCER, V7, P415, DOI 10.1038/nrc2131
   Postigo AA, 1997, EMBO J, V16, P3935, DOI 10.1093/emboj/16.13.3935
   RAFOLS JA, 1985, ANAT REC, V211, P75, DOI 10.1002/ar.1092110112
   Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243
   SEITZ R, 1981, CELL TISSUE RES, V220, P61
   Shechter R, 2007, STEM CELLS, V25, P2277, DOI 10.1634/stemcells.2006-0705
   Shen Q, 2008, CELL STEM CELL, V3, P289, DOI 10.1016/j.stem.2008.07.026
   Shihabuddin LS, 1997, EXP NEUROL, V148, P577, DOI 10.1006/exnr.1997.6697
   Tavazoie M, 2008, CELL STEM CELL, V3, P279, DOI 10.1016/j.stem.2008.07.025
   Thuret S, 2006, NAT REV NEUROSCI, V7, P628, DOI 10.1038/nrn1955
   Vigh B, 2004, HISTOL HISTOPATHOL, V19, P607, DOI 10.14670/HH-19.607
   Weiss S, 1996, J NEUROSCI, V16, P7599
NR 51
TC 51
Z9 52
U1 0
U2 6
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1066-5099
J9 STEM CELLS
JI Stem Cells
PD NOV
PY 2009
VL 27
IS 11
BP 2722
EP 2733
DI 10.1002/stem.226
PG 12
WC Cell & Tissue Engineering; Biotechnology & Applied Microbiology;
   Oncology; Cell Biology; Hematology
SC Cell Biology; Biotechnology & Applied Microbiology; Oncology; Hematology
GA 520GS
UT WOS:000271830700010
PM 19785035
DA 2021-01-25
ER

PT J
AU Pick, H
   Etter, S
   Baud, O
   Schmauder, R
   Bordoli, L
   Schwede, T
   Vogel, H
AF Pick, Horst
   Etter, Sylvain
   Baud, Olivia
   Schmauder, Ralf
   Bordoli, Lorenza
   Schwede, Torsten
   Vogel, Horst
TI Dual Activities of Odorants on Olfactory and Nuclear Hormone Receptors
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID HUMAN ESTROGEN-RECEPTOR; FUNCTIONAL EXPRESSION; MOLECULAR-BASIS;
   PROGESTERONE-RECEPTORS; CRYSTAL-STRUCTURE; BINDING AFFINITY; STRUCTURAL
   BASIS; ER-ALPHA; LIGAND; PREDICTION
AB We have screened an odorant compound library and discovered molecules acting as chemical signals that specifically activate both G-protein-coupled olfactory receptors (ORs) on the cell surface of olfactory sensory neurons and the human nuclear estrogen receptor alpha (ER) involved in transcriptional regulation of cellular differentiation and proliferation in a wide variety of tissues. Hence, these apparent dual active odorants induce distinct signal transduction pathways at different subcellular localizations, which affect both neuronal signaling, resulting in odor perception, and the ER-dependent transcriptional control of specific genes. We demonstrate these effects using fluorescence-based in vitro and cellular assays. Among these odorants, we have identified synthetic sandalwood compounds, an important class of molecules used in the fragrance industry. For one estrogenic odorant we have also identified the cognate OR. This prompted us to compare basic molecular recognition principles of odorants on the two structurally and apparent functionally non-related receptors using computational modeling in combination with functional assays. Faced with the increasing evidence that ORs may perform chemosensory functions in a number of tissues outside of the nasal olfactory epithelium, the unraveling of these molecular ligand-receptor interaction principles is of critical importance. In addition the evidence that certain olfactory sensory neurons naturally co-express ORs and ERs may provide a direct functional link between the olfactory and hormonal systems in humans. Our results are therefore useful for defining the structural and functional characteristics of ER-specific odorants and the role of odorant molecules in cellular processes other than olfaction.
C1 [Pick, Horst; Etter, Sylvain; Baud, Olivia; Schmauder, Ralf; Vogel, Horst] Ecole Polytech Fed Lausanne, Inst Sci & Ingenierie Chim, CH-1015 Lausanne, Switzerland.
   [Bordoli, Lorenza; Schwede, Torsten] Univ Basel, Swiss Inst Bioinformat, Biozentrum, CH-4056 Basel, Switzerland.
RP Vogel, H (corresponding author), Ecole Polytech Fed Lausanne, Inst Sci & Ingenierie Chim, CH-1015 Lausanne, Switzerland.
EM Horst.Vogel@epfl.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X; Schmauder,
   Ralf/0000-0002-8441-4264
FU SystemsX program of the Swiss National Science FoundationSwiss National
   Science Foundation (SNSF); Ecole Polytechnique Fe de rale de Lausaunne
FX This work was supported by the SystemsX program of the Swiss National
   Science Foundation and by internal grants of the Ecole Polytechnique Fe
   de rale de Lausaunne.
CR Abaffy T, 2007, J BIOL CHEM, V282, P1216, DOI 10.1074/jbc.M609355200
   Abdelrahim M, 2006, CANCER RES, V66, P2459, DOI 10.1158/0008-5472.CAN-05-3132
   Anstead GM, 1997, STEROIDS, V62, P268, DOI 10.1016/S0039-128X(96)00242-5
   Armougom F, 2006, NUCLEIC ACIDS RES, V34, pW604, DOI 10.1093/nar/gkl092
   Bain DL, 2007, ANNU REV PHYSIOL, V69, P201, DOI 10.1146/annurev.physiol.69.031905.160308
   Barni T, 1999, J CLIN ENDOCR METAB, V84, P4266, DOI 10.1210/jc.84.11.4266
   Bieri S, 2004, CHEM SENSES, V29, P483, DOI 10.1093/chemse/bjh050
   Bissantz C, 2004, J CHEM INF COMP SCI, V44, P1162, DOI 10.1021/ci034181a
   Blair RM, 2000, TOXICOL SCI, V54, P138, DOI 10.1093/toxsci/54.1.138
   Brown MB, 2006, DRUG DELIV, V13, P175, DOI 10.1080/10717540500455975
   Brzozowski AM, 1997, NATURE, V389, P753, DOI 10.1038/39645
   BUCK L, 1991, CELL, V65, P175, DOI 10.1016/0092-8674(91)90418-X
   Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203
   CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099
   Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577
   CRAMER CJ, 1992, J COMPUT AID MOL DES, V6, P629, DOI 10.1007/BF00126219
   Deroo BJ, 2006, J CLIN INVEST, V116, P561, DOI 10.1172/JCI27987
   Doszczak L, 2007, ANGEW CHEM INT EDIT, V46, P3367, DOI 10.1002/anie.200605002
   EVANS RM, 1988, SCIENCE, V240, P889, DOI 10.1126/science.3283939
   Fang H, 2000, ENVIRON HEALTH PERSP, V108, P723, DOI 10.1289/ehp.00108723
   Feige JN, 2005, J BIOL CHEM, V280, P17880, DOI 10.1074/jbc.M500786200
   Feldmesser E, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-121
   Floriano WB, 2004, CHEM SENSES, V29, P269, DOI 10.1093/chemse/bjh030
   Fukuda N, 2004, J CELL SCI, V117, P5835, DOI 10.1242/jcs.01507
   Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551
   Howes MJR, 2002, J PHARM PHARMACOL, V54, P1521, DOI 10.1211/002235702216
   Htun H, 1999, MOL BIOL CELL, V10, P471, DOI 10.1091/mbc.10.2.471
   Jacquier V, 2006, P NATL ACAD SCI USA, V103, P14325, DOI 10.1073/pnas.0603942103
   Jacquier V, 2006, J NEUROCHEM, V97, P537, DOI 10.1111/j.1471-4159.2006.03771.x
   Jankevics H, 2005, BIOCHEMISTRY-US, V44, P11676, DOI 10.1021/bi050744v
   Kaminski RM, 2006, J PHARMACOL EXP THER, V317, P694, DOI 10.1124/jpet.105.098319
   Katada S, 2005, J NEUROSCI, V25, P1806, DOI 10.1523/jneurosci.4723-04.2005
   Kraft P, 2000, ANGEW CHEM INT EDIT, V39, P2981
   Krautwurst D, 1998, CELL, V95, P917, DOI 10.1016/S0092-8674(00)81716-X
   Lacroix M, 2004, BREAST CANCER RES TR, V83, P249, DOI 10.1023/B:BREA.0000014042.54925.cc
   Likhite VS, 2006, MOL ENDOCRINOL, V20, P3120, DOI 10.1210/me.2006-0068
   Lill MA, 2006, CHEMMEDCHEM, V1, P73, DOI 10.1002/cmdc.200500024
   Man O, 2004, PROTEIN SCI, V13, P240, DOI 10.1110/ps.03296404
   Matsuda K, 2008, J CELL BIOCHEM, V103, P136, DOI 10.1002/jcb.21393
   Meegan MJ, 2007, J ENZYM INHIB MED CH, V22, P655, DOI 10.1080/14756360701503232
   MOHAMADI F, 1990, J COMPUT CHEM, V11, P440, DOI 10.1002/jcc.540110405
   Mombaerts P, 2004, NAT REV NEUROSCI, V5, P263, DOI 10.1038/nrn1365
   Mombaerts P, 1999, SCIENCE, V286, P707, DOI 10.1126/science.286.5440.707
   Mueller SO, 2004, ANAL BIOANAL CHEM, V378, P582, DOI 10.1007/s00216-003-2238-x
   Neuhaus EM, 2009, J BIOL CHEM, V284, P16218, DOI 10.1074/jbc.M109.012096
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Pick H, 2007, J MOL BIOL, V374, P1213, DOI 10.1016/j.jmb.2007.10.007
   Pluznick JL, 2009, P NATL ACAD SCI USA, V106, P2059, DOI 10.1073/pnas.0812859106
   Prossnitz ER, 2008, ANNU REV PHYSIOL, V70, P165, DOI 10.1146/annurev.physiol.70.113006.100518
   REESE JC, 1992, J BIOL CHEM, V267, P9868
   Rimkus GG, 1996, CHEMOSPHERE, V33, P2033, DOI 10.1016/0045-6535(96)00321-9
   Romanelli RG, 2004, J BIOL CHEM, V279, P117, DOI 10.1074/jbc.M307955200
   Saito H, 2004, CELL, V119, P679, DOI 10.1016/j.cell.2004.11.021
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schiniedeberg K, 2007, J STRUCT BIOL, V159, P400, DOI 10.1016/j.jsb.2007.04.013
   Schreurs RHMM, 2002, TOXICOL APPL PHARM, V183, P1, DOI 10.1006/taap.2002.9458
   Serrano-Vega MJ, 2008, P NATL ACAD SCI USA, V105, P877, DOI 10.1073/pnas.0711253105
   Shepherd GM, 2006, NATURE, V444, P316, DOI 10.1038/nature05405
   Sherman W, 2006, J MED CHEM, V49, P534, DOI 10.1021/jm050540c
   Shiau AK, 2002, NAT STRUCT BIOL, V9, P359, DOI 10.1038/nsb787
   Shiau AK, 1998, CELL, V95, P927, DOI 10.1016/S0092-8674(00)81717-1
   SOTO AM, 1995, ENVIRON HEALTH PERSP, V103, P113, DOI 10.2307/3432519
   Spehr M, 2003, SCIENCE, V299, P2054, DOI 10.1126/science.1080376
   Stenoien DL, 2001, MOL CELL BIOL, V21, P4404, DOI 10.1128/MCB.21.13.4404-4412.2001
   Tanenbaum DM, 1998, P NATL ACAD SCI USA, V95, P5998, DOI 10.1073/pnas.95.11.5998
   Terasaki M, 2009, ENVIRON TOXICOL CHEM, V28, P204, DOI 10.1897/08-225.1
   Touhara K, 2007, NEUROCHEM INT, V51, P132, DOI 10.1016/j.neuint.2007.05.020
   Touhara K, 2009, ANNU REV PHYSIOL, V71, P307, DOI 10.1146/annurev.physiol.010908.163209
   van Lipzig MMH, 2004, J MED CHEM, V47, P1018, DOI 10.1021/jm0309607
   Vedani A, 2005, J MED CHEM, V48, P3700, DOI 10.1021/jm050185q
   Wachsmuth M, 2000, J MOL BIOL, V298, P677, DOI 10.1006/jmbi.2000.3692
   WEINER SJ, 1984, J AM CHEM SOC, V106, P765, DOI 10.1021/ja00315a051
   Yamasaki K, 2003, TOXICOL LETT, V142, P119, DOI 10.1016/S0378-4274(03)00019-5
   Zozulya S, 2001, GENOME BIOL, V2
NR 74
TC 13
Z9 13
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD OCT 30
PY 2009
VL 284
IS 44
BP 30547
EP 30555
DI 10.1074/jbc.M109.040964
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 510LM
UT WOS:000271090000057
PM 19723634
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Hamaratoglu, F
   Basler, K
   Affolter, M
AF Hamaratoglu, Fisun
   Basler, Konrad
   Affolter, Markus
TI Confronting Morphogen Gradients: How Important Are They for Growth?
SO SCIENCE SIGNALING
LA English
DT Article
ID CELL-PROLIFERATION; WING GROWTH; DROSOPHILA; BRINKER; DPP
AB Morphogens are crucial for regulating the patterning and the growth of organs. In the developing fly wing, graded distributions of the morphogens Decapentaplegic and Wingless are essential for tissue patterning, but when it comes to growth, evidence suggests that it may not be so.
C1 [Hamaratoglu, Fisun; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Basler, Konrad] Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland.
RP Hamaratoglu, F (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM fisun.hamaratoglu@unibas.ch
OI Affolter, Markus/0000-0002-5171-0016; Basler,
   Konrad/0000-0003-3534-1529; Hamaratoglu, Fisun/0000-0002-1461-9248
CR Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166
   Baena-Lopez LA, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.2000360
   Burke R, 1996, DEVELOPMENT, V122, P2261
   Cadigan KM, 2002, SEMIN CELL DEV BIOL, V13, P83, DOI 10.1016/S1084-9521(02)00014-9
   Chen CM, 1999, DEVELOPMENT, V126, P5441
   Day SJ, 2000, DEVELOPMENT, V127, P2977
   Franch-Marro X, 2008, J CELL SCI, V121, P1587, DOI 10.1242/jcs.015958
   Johnston LA, 1998, NATURE, V394, P82, DOI 10.1038/27925
   Kicheva A, 2008, CURR OPIN CELL BIOL, V20, P137, DOI 10.1016/j.ceb.2008.01.008
   Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0
   Martin FA, 2004, DEVELOPMENT, V131, P4921, DOI 10.1242/dev.01385
   Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1
   Neumann CJ, 1996, DEVELOPMENT, V122, P1781
   NOORDERMEER J, 1994, NATURE, V367, P80, DOI 10.1038/367080a0
   OBROCHTA DA, 1985, NATURE, V313, P138, DOI 10.1038/313138a0
   Piddini E, 2009, CELL, V136, P296, DOI 10.1016/j.cell.2008.11.036
   Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008
   Rogulja D, 2005, CELL, V123, P449, DOI 10.1016/j.cell.2005.08.030
   Schwank G, 2008, DEVELOPMENT, V135, P4003, DOI 10.1242/dev.025635
   SIEGFRIED E, 1994, NATURE, V367, P76, DOI 10.1038/367076a0
   Tabata T, 2001, NAT REV GENET, V2, P620, DOI 10.1038/35084577
   Zecca M, 2007, DEVELOPMENT, V134, P3001, DOI 10.1242/dev.006411
   Zecca M, 2007, DEVELOPMENT, V134, P3011, DOI 10.1242/dev.006445
NR 23
TC 4
Z9 4
U1 0
U2 3
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 1945-0877
EI 1937-9145
J9 SCI SIGNAL
JI Sci. Signal.
PD OCT 27
PY 2009
VL 2
IS 94
AR pe67
DI 10.1126/scisignal.294pe67
PG 2
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 570AM
UT WOS:000275644000004
PM 19861687
DA 2021-01-25
ER

PT J
AU Haussinger, D
   Huang, JR
   Grzesiek, S
AF Haussinger, Daniel
   Huang, Jie-rong
   Grzesiek, Stephan
TI DOTA-M8: An Extremely Rigid, High-Affinity Lanthanide Chelating Tag for
   PCS NMR Spectroscopy
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID RESIDUAL DIPOLAR COUPLINGS; BINDING TAG; MAGNETIC-SUSCEPTIBILITY;
   CONFORMATIONAL MOBILITY; PSEUDOCONTACT SHIFTS; ALKYL SUBSTITUTION;
   PARAMAGNETIC NMR; AQUEOUS-SOLUTION; PROTEIN PROBE; COMPLEXES
AB A new lanthanide chelating tag (M8) for paramagnetic labeling of biomolecules is presented, which is based on an eight-fold, stereoselectively methyl-substituted DOTA that can be covalently linked to the host molecule by a single disulfide bond. The steric overcrowding of the DOTA scaffold leads to an extremely rigid, kinetically and chemically inert lanthanide chelator Its steric bulk restricts the motion of the tag relative to the host molecule. These properties result in very large pseudocontact shifts (>5 ppm) and residual dipolar couplings (>20 Hz) for Dy-M8 linked to ubiquitin, which are unprecedented for a small, single-point-attachment tag. Such large pseudocontact shifts should be well detectable even for larger proteins and distances beyond similar to 50 angstrom. Due to its exceptionally high stability and lanthanide affinity M8 can be used under extreme chemical or physical conditions, such as those applied for protein denaturation, or when it is undesirable that buffer or protein react with excess lanthanide ions.
C1 [Haussinger, Daniel] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   [Huang, Jie-rong; Grzesiek, Stephan] Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Haussinger, D (corresponding author), Univ Basel, Dept Chem, St Johanns Ring 19, CH-4056 Basel, Switzerland.
RI Haussinger, Daniel/C-6617-2016; Huang, Jie-rong/O-3661-2019; Huang,
   Jie-rong/B-4222-2009
OI Haussinger, Daniel/0000-0002-4798-0072; Huang,
   Jie-rong/0000-0003-3674-2228; Grzesiek, Stephan/0000-0003-1998-4225
FU SNF [31-109712]
FX We thank M. Rogowski for the expression of ubiquitin mutants and C
   Palivan for EPR measurements of [Dy(M8-SPy)] J. Desreux, I Bertum, and M
   Ubbink ire gratefully acknowledged for helpful discussions This work Was
   supported by SNF grant 31-109712 (S.G.)
CR Aime S, 1997, INORG CHEM, V36, P5104, DOI 10.1021/ic970240o
   Aime S, 1996, INORG CHIM ACTA, V246, P423, DOI 10.1016/0020-1693(96)05130-4
   Aime S, 1997, INORG CHEM, V36, P2059, DOI 10.1021/ic961364o
   Allegrozzi M, 2000, J AM CHEM SOC, V122, P4154, DOI 10.1021/ja993691b
   Banci L, 1998, J AM CHEM SOC, V120, P12903, DOI 10.1021/ja981791w
   Bertini I, 1999, CURR OPIN CHEM BIOL, V3, P145, DOI 10.1016/S1367-5931(99)80026-X
   Bertini I, 2001, J MAGN RESON, V152, P103, DOI 10.1006/jmre.2001.2378
   Bertini I, 2009, J AM CHEM SOC, V131, P5134, DOI 10.1021/ja8080764
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   Csajbok E, 2003, INORG CHEM, V42, P2342, DOI 10.1021/ic0261272
   Csajbok E, 2004, DALTON T, P2152, DOI 10.1039/b405116e
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Gaponenko V, 2004, J BIOMOL NMR, V28, P205, DOI 10.1023/B:JNMR.0000013706.09264.36
   Gaponenko V, 2002, J BIOMOL NMR, V24, P143, DOI 10.1023/A:1020948529076
   Gaponenko V, 2000, BIOCHEMISTRY-US, V39, P15217, DOI 10.1021/bi001381w
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Haussinger D, 2004, EMBO J, V23, P1699, DOI 10.1038/sj.emboj.7600192
   HAUSSINGER D, 2005, BOOK ABSTRACTS
   Ikegami T, 2004, J BIOMOL NMR, V29, P339, DOI 10.1023/B:JNMR.0000032611.72827.de
   Keizers PHJ, 2008, J AM CHEM SOC, V130, P14802, DOI 10.1021/ja8054832
   Keizers PHJ, 2007, J AM CHEM SOC, V129, P9292, DOI 10.1021/ja0725201
   Ma C, 2000, J MAGN RESON, V146, P381, DOI 10.1006/jmre.2000.2172
   Martin LJ, 2007, J AM CHEM SOC, V129, P7106, DOI 10.1021/ja070480v
   Meier S, 2007, J AM CHEM SOC, V129, P754, DOI 10.1021/ja067522k
   Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009
   Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361
   Otting G, 2008, J BIOMOL NMR, V42, P1, DOI 10.1007/s10858-008-9256-0
   Pintacuda G, 2007, ACCOUNTS CHEM RES, V40, P206, DOI 10.1021/ar050087z
   Prudencio M, 2004, CHEM-EUR J, V10, P3252, DOI 10.1002/chem.200306019
   Ranganathan RS, 2002, INORG CHEM, V41, P6846, DOI 10.1021/ic025657v
   Ranganathan RS, 2002, INORG CHEM, V41, P6856, DOI 10.1021/ic025695e
   ROCKLAGE SM, 1993, JMRI-J MAGN RESON IM, V3, P167, DOI 10.1002/jmri.1880030129
   Rodriguez-Castaneda F, 2006, MAGN RESON CHEM, V44, pS10, DOI 10.1002/mrc.1811
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   Su XC, 2008, J AM CHEM SOC, V130, P10486, DOI 10.1021/ja803741f
   Su XC, 2008, J AM CHEM SOC, V130, P1681, DOI 10.1021/ja076564l
   Su XC, 2006, CHEMBIOCHEM, V7, P1599, DOI 10.1002/cbic.200600142
   Vlasie MD, 2007, CHEM-EUR J, V13, P1715, DOI 10.1002/chem.200600916
   Wohnert J, 2003, J AM CHEM SOC, V125, P13338, DOI 10.1021/ja036022d
NR 39
TC 110
Z9 113
U1 0
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD OCT 21
PY 2009
VL 131
IS 41
BP 14761
EP 14767
DI 10.1021/ja903233w
PG 7
WC Chemistry, Multidisciplinary
SC Chemistry
GA 512SV
UT WOS:000271271800048
PM 19785413
DA 2021-01-25
ER

PT J
AU Kumar, A
   Bello, B
   Reichert, H
AF Kumar, Abhilasha
   Bello, Bruno
   Reichert, Heinrich
TI Lineage-specific cell death in postembryonic brain development of
   Drosophila
SO DEVELOPMENT
LA English
DT Article
DE Drosophila; Brain; engrailed; Cell death; Lineage; Neuroblast; Stem
   cell; Notch
ID CENTRAL-NERVOUS-SYSTEM; GANGLION MOTHER CELLS; LATE LARVAL STAGE;
   NEUROBLAST LINEAGES; IDENTIFIED NEUROBLASTS; MOLECULAR MARKERS; TEMPORAL
   PATTERNS; TOBACCO HORNWORM; SEGMENT POLARITY; NEURAL LINEAGES
AB The Drosophila central brain is composed of thousands of neurons that derive from approximately 100 neuroblasts per hemisphere. Functional circuits in the brain require precise neuronal wiring and tight control of neuronal numbers. How this accurate control of neuronal numbers is achieved during neural development is largely unclear. Specifically, the role of programmed cell death in control of cell numbers has not been studied in the central brain neuroblast lineages. Here, we focus on four postembryonic neuroblast lineages in the central brain identified on the basis that they express the homeobox gene engrailed (en). For each lineage, we determine the total number of adult-specific neurons generated as well as number and pattern of en-expressing cells. We then demonstrate that programmed cell death has a pronounced effect on the number of cells in the four lineages; approximately half of the immature adult-specific neurons in three of the four lineages are eliminated by cell death during postembryonic development. Moreover, we show that programmed cell death selectively affects en-positive versus en-negative cells in a lineage-specific manner and, thus, controls the relative number of en-expressing neurons in each lineage. Furthermore, we provide evidence that Notch signaling is involved in the regulation of en expression. Based on our findings, we conclude that lineage-specific programmed cell death plays a prominent role in the generation of neuronal number and lineage diversity in the Drosophila brain.
C1 [Kumar, Abhilasha; Bello, Bruno; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Reichert, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM heinrich.reichert@unibas.ch
FU Swiss NSFSwiss National Science Foundation (SNSF) [3100A0-112024]
FX We thank Dr Robert Lichtneckert for discussions and Susanne Flister for
   technical help. This study was funded by Swiss NSF Grant 3100A0-112024
   to H. R.
CR ABRAMS JM, 1993, DEVELOPMENT, V117, P29
   Alexandre C, 2003, DEVELOPMENT, V130, P729, DOI 10.1242/dev.00286
   Awad TA, 1997, DEV BIOL, V187, P283, DOI 10.1006/dbio.1997.8587
   Bello BC, 2003, NEURON, V37, P209, DOI 10.1016/S0896-6273(02)01181-9
   Bello B, 2007, DEVELOPMENT, V134, P1091, DOI 10.1242/dev.02793
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   Bhat KM, 1999, BIOESSAYS, V21, P472, DOI 10.1002/(SICI)1521-1878(199906)21:6<472::AID-BIES4>3.0.CO;2-W
   Bonini NM, 1999, BIOESSAYS, V21, P991, DOI 10.1002/(SICI)1521-1878(199912)22:1&lt;991::AID-BIES3&gt;3.0.CO;2-3
   BOOKER R, 1987, J COMP NEUROL, V255, P548, DOI 10.1002/cne.902550407
   Booker R, 1996, J NEUROBIOL, V29, P233, DOI 10.1002/(SICI)1097-4695(199602)29:2<233::AID-NEU8>3.3.CO;2-A
   Boone JQ, 2008, DEV NEUROBIOL, V68, P1185, DOI 10.1002/dneu.20648
   Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240
   Bowman SK, 2008, DEV CELL, V14, P535, DOI 10.1016/j.devcel.2008.03.004
   Broadus J, 1995, DEVELOPMENT, V121, P3989
   Buss RR, 2006, ANNU REV NEUROSCI, V29, P1, DOI 10.1146/annurev.neuro.29.051605.112800
   Cayouette M, 2002, NAT NEUROSCI, V5, P1265, DOI 10.1038/nn1202-1265
   Chanas G, 2005, MECH DEVELOP, V122, P975, DOI 10.1016/j.mod.2005.05.001
   Chen P, 1996, GENE DEV, V10, P1773, DOI 10.1101/gad.10.14.1773
   DOE CQ, 1992, DEVELOPMENT, V116, P855
   Dumstrei K, 2003, J COMP NEUROL, V455, P451, DOI 10.1002/cne.10484
   Egger B, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-1
   GRETHER ME, 1995, GENE DEV, V9, P1694, DOI 10.1101/gad.9.14.1694
   Hidalgo A, 2003, MECH DEVELOP, V120, P1311, DOI 10.1016/j.mod.2003.06.004
   Huang FD, 2004, NAT NEUROSCI, V7, P1070, DOI 10.1038/nn1313
   Joly W, 2007, DEV BIOL, V301, P542, DOI 10.1016/j.ydbio.2006.10.019
   Karcavich R, 2005, J COMP NEUROL, V481, P240, DOI 10.1002/cne.20371
   Karcavich RE, 2005, DEV DYNAM, V232, P609, DOI 10.1002/dvdy.20273
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Kobayashi M, 2003, DEVELOPMENT, V130, P741, DOI 10.1242/dev.00289
   Kumar A, 2009, J COMP NEUROL, V517, P87, DOI 10.1002/cne.22112
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Lu BW, 2000, ANNU REV NEUROSCI, V23, P531, DOI 10.1146/annurev.neuro.23.1.531
   Lundell MJ, 2003, DEVELOPMENT, V130, P4109, DOI 10.1242/dev.00593
   Miguel-Aliaga I, 2004, DEVELOPMENT, V131, P6093, DOI 10.1242/dev.01521
   Novotny T, 2002, DEVELOPMENT, V129, P1027
   Orgogozo V, 2002, DEVELOPMENT, V129, P4677
   Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   Peterson C, 2002, DEVELOPMENT, V129, P1467
   PROKOP A, 1991, DEVELOPMENT, V111, P79
   Rogulja-Ortmann A, 2008, DEVELOPMENT, V135, P3435, DOI 10.1242/dev.023986
   Rogulja-Ortmann A, 2007, DEVELOPMENT, V134, P105, DOI 10.1242/dev.02707
   Schmid A, 1999, DEVELOPMENT, V126, P4653
   Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660
   Skeath JB, 1998, DEVELOPMENT, V125, P1857
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   SONNENFELD MJ, 1995, DEVELOPMENT, V121, P569
   Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   TRUMAN JW, 1992, J NEUROBIOL, V23, P1295, DOI 10.1002/neu.480230917
   TRUMAN JW, 1983, J COMP NEUROL, V216, P445, DOI 10.1002/cne.902160410
   Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371
   Urbach R, 2003, DEVELOPMENT, V130, P3621, DOI 10.1242/dev.00533
   Urbach R, 2003, DEVELOPMENT, V130, P3607, DOI 10.1242/dev.00532
   Urbach R, 2003, ARTHROPOD STRUCT DEV, V32, P103, DOI 10.1016/S1467-8039(03)00042-2
   WEEKS JC, 1985, J NEUROSCI, V5, P2290
   Weeks JC, 2003, PROG NEUROBIOL, V70, P421, DOI 10.1016/S0301-0082(03)00102-3
   WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319
   YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7
   Zheng XY, 2006, EMBO J, V25, P615, DOI 10.1038/sj.emboj.7600962
NR 61
TC 32
Z9 32
U1 0
U2 0
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0950-1991
EI 1477-9129
J9 DEVELOPMENT
JI Development
PD OCT 15
PY 2009
VL 136
IS 20
BP 3433
EP 3442
DI 10.1242/dev.037226
PG 10
WC Developmental Biology
SC Developmental Biology
GA 499OA
UT WOS:000270230700007
PM 19762424
OA Bronze
DA 2021-01-25
ER

PT J
AU Farhan, H
   Hauri, HP
AF Farhan, Hesso
   Hauri, Hans-Peter
TI Membrane Biogenesis: Networking at the ER with Atlastin
SO CURRENT BIOLOGY
LA English
DT Editorial Material
ID HEREDITARY SPASTIC PARAPLEGIA; ENDOPLASMIC-RETICULUM; DYNAMIN;
   MICROTUBULES; FUSION; MORPHOGENESIS; GTPASES; GOLGI
AB The peripheral endoplasmic reticulum forms a dynamic network of interconnected membrane tubules. Although some determinants of this striking architecture are known, the mechanism underlying fusion of individual tubules has remained elusive. Two studies now identify atlastin proteins as key mediators of homotypic fusion of endoplasmic reticulum membranes.
C1 [Farhan, Hesso; Hauri, Hans-Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Farhan, H (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM hans-peter.hauri@unibas.ch
RI Farhan, Hesso/C-7997-2012
OI Farhan, Hesso/0000-0002-0889-8463
CR Beetz C, 2008, BRAIN, V131, P1078, DOI 10.1093/brain/awn026
   Dreier L, 2000, J CELL BIOL, V148, P883, DOI 10.1083/jcb.148.5.883
   English AR, 2009, CURR OPIN CELL BIOL, V21, P596, DOI 10.1016/j.ceb.2009.04.004
   Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005
   Hu JJ, 2009, CELL, V138, P549, DOI 10.1016/j.cell.2009.05.025
   Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168
   Kruchten AE, 2006, J CELL SCI, V119, P1683, DOI 10.1242/jcs.02963
   Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280
   Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313
   Puhka M, 2007, J CELL BIOL, V179, P895, DOI 10.1083/jcb.200705112
   Rismanchi N, 2008, HUM MOL GENET, V17, P1591, DOI 10.1093/hmg/ddn046
   Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019
   TERASAKI M, 1986, J CELL BIOL, V103, P1557, DOI 10.1083/jcb.103.4.1557
   Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016
   Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x
   Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047
   Zhao XP, 2001, NAT GENET, V29, P326, DOI 10.1038/ng758
   Zhu PP, 2003, J BIOL CHEM, V278, P49063, DOI 10.1074/jbc.M306702200
NR 18
TC 12
Z9 12
U1 0
U2 3
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD OCT 13
PY 2009
VL 19
IS 19
BP R906
EP R908
DI 10.1016/j.cub.2009.08.029
PG 3
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 510JU
UT WOS:000271085400017
PM 19825355
DA 2021-01-25
ER

PT J
AU Pasutto, F
   Matsumoto, T
   Mardin, CY
   Sticht, H
   Brandstatter, JH
   Michels-Rautenstrauss, K
   Weisschuh, N
   Gramer, E
   Ramdas, WD
   van Koolwijk, LME
   Klaver, CCW
   Vingerling, JR
   Weber, BHF
   Kruse, FE
   Rautenstrauss, B
   Barde, YA
   Reis, A
AF Pasutto, Francesca
   Matsumoto, Tomoya
   Mardin, Christian Y.
   Sticht, Heinrich
   Brandstaetter, Johann H.
   Michels-Rautenstrauss, Karin
   Weisschuh, Nicole
   Gramer, Eugen
   Ramdas, Wishal D.
   van Koolwijk, Leonieke M. E.
   Klaver, Caroline C. W.
   Vingerling, Johannes R.
   Weber, Bernhard H. F.
   Kruse, Friedrich E.
   Rautenstrauss, Bernd
   Barde, Yves-Alain
   Reis, Andre
TI Heterozygous NTF4 Mutations Impairing Neurotrophin-4 Signaling in
   Patients with Primary Open-Angle Glaucoma
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID RETINAL GANGLION-CELLS; IN-VIVO; CYP1B1 MUTATIONS; GERMAN PATIENTS;
   NEURONAL DEATH; GENE; EXPRESSION; SURVIVAL; TRKB; POPULATION
AB Glaucoma, a main cause of blindness in the developed world, is characterized by progressive degeneration of retinal ganglion cells (RGCs), resulting in irreversible loss of vision. Although members of the neurotrophin gene family in various species are known to support the survival of numerous neuronal populations, including RGCs, it is less clear whether they are also required for survival and maintenance of adult neurons in humans. Here, we report seven different heterozygous mutations in the Neurotrophin-4 (NTF4) gene accounting for about 1.7% of primary open-angle glaucoma patients of European origin. Molecular modeling predicted a decreased affinity of neurotrophin 4 protein (NIT-4) mutants with its specific tyrosine kinase receptor B (TrkB). Expression of recombinant NT-4 carrying the most frequent mutation was demonstrated to lead to decreased activation of TrkB. These findings suggest a pathway in the pathophysiology of glaucoma through loss of neurotrophic function and may eventually open the possibility of using ligands activating TrkB to prevent the progression of the disease.
C1 [Pasutto, Francesca; Michels-Rautenstrauss, Karin; Rautenstrauss, Bernd; Reis, Andre] Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany.
   [Mardin, Christian Y.; Kruse, Friedrich E.] Univ Erlangen Nurnberg, Dept Ophthalmol, D-91054 Erlangen, Germany.
   [Sticht, Heinrich] Univ Erlangen Nurnberg, Inst Biochem, D-91054 Erlangen, Germany.
   [Matsumoto, Tomoya; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Weisschuh, Nicole] Univ Eye Hosp, Mol Genet Lab, D-72076 Tubingen, Germany.
   [Gramer, Eugen] Univ Eye Hosp, D-97080 Wurzburg, Germany.
   [Ramdas, Wishal D.; van Koolwijk, Leonieke M. E.; Klaver, Caroline C. W.; Vingerling, Johannes R.] Erasmus Univ, Med Ctr, Dept Epidemiol, Rotterdam, Netherlands.
   [Ramdas, Wishal D.; Klaver, Caroline C. W.; Vingerling, Johannes R.] Erasmus Univ, Med Ctr, Dept Ophthalmol, Rotterdam, Netherlands.
   [Weber, Bernhard H. F.] Univ Regensburg, Inst Human Genet, D-93053 Regensburg, Germany.
RP Reis, A (corresponding author), Univ Erlangen Nurnberg, Inst Human Genet, D-91054 Erlangen, Germany.
EM reis@humgenet.uni-erlangen.de
RI Barde, Yves/F-6019-2011; Reis, Andre/D-2309-2009; Ramdas,
   Wishal/H-5062-2018; Klaver, Caroline C.W./A-2013-2016
OI Reis, Andre/0000-0002-6301-6363; Ramdas, Wishal/0000-0002-1780-5281;
   Rautenstrauss, Bernd/0000-0001-5099-7476; Klaver,
   Caroline/0000-0002-2355-5258; Weber, Bernhard H.F./0000-0002-8808-7723;
   Barde, Yves/0000-0002-7627-461X; Sticht, Heinrich/0000-0001-5644-045X
FU Deutsche Forschungsgerneinschaft (DFG)German Research Foundation (DFG); 
   [SFB539]
FX We thank all of the patients and control individuals for their
   participation, Claudia Preller and Freya Boggasch for technical
   assistance, and Juliane Niedzella for patient recruitment support. This
   work was supported by grants from the SFB539 to A.R., C.Y.M., B.R.,
   F.E.K., and J.H.B. and by an individual grant to B.H.F.W., both funded
   by the Deutsche Forschungsgerneinschaft (DFG).
CR Acharya M, 2006, MOL VIS, V12, P399
   Aulchenko YS, 2004, EUR J HUM GENET, V12, P527, DOI 10.1038/sj.ejhg.5201188
   Banfield MJ, 2001, STRUCTURE, V9, P1191, DOI 10.1016/S0969-2126(01)00681-5
   BERKEMEIER LR, 1991, NEURON, V7, P857, DOI 10.1016/0896-6273(91)90287-A
   Bibel M, 2000, GENE DEV, V14, P2919, DOI 10.1101/gad.841400
   Blesch A, 2006, BRAIN PATHOL, V16, P295, DOI 10.1111/j.1750-3639.2006.00036.x
   Chakrabarti S, 2007, INVEST OPHTH VIS SCI, V48, P5439, DOI 10.1167/iovs.07-0629
   Cheng L, 2002, J NEUROSCI, V22, P3977, DOI 10.1523/JNEUROSCI.22-10-03977.2002
   Clarke DB, 1998, VISION RES, V38, P1517, DOI 10.1016/S0042-6989(97)00341-6
   COHEN A, 1994, J NEUROBIOL, V25, P953, DOI 10.1002/neu.480250805
   Fan BJ, 2006, CLIN BIOCHEM, V39, P249, DOI 10.1016/j.clinbiochem.2005.11.001
   Ghazi-Nouri SMS, 2008, EXP EYE RES, V86, P819, DOI 10.1016/j.exer.2008.02.010
   Gong G, 2004, HUM MOL GENET, V13, pR91, DOI 10.1093/hmg/ddh074
   GOTZ R, 1994, COMP BIOCHEM PHYS C, V108, P1, DOI 10.1016/1367-8280(94)90082-5
   GREEN SH, 1986, J CELL BIOL, V102, P830, DOI 10.1083/jcb.102.3.830
   Harada C, 2005, INVEST OPHTH VIS SCI, V46, P669, DOI 10.1167/iovs.04-0826
   Hatsuzawa K, 1997, J BIOCHEM-TOKYO, V121, P270
   Hofman A, 2007, EUR J EPIDEMIOL, V22, P819, DOI 10.1007/s10654-007-9199-x
   IP NY, 1992, P NATL ACAD SCI USA, V89, P3060, DOI 10.1073/pnas.89.7.3060
   Iyengar Sudha K, 2007, Methods Mol Biol, V376, P71
   JOHNSON JE, 1986, J NEUROSCI, V6, P3031
   JONAS JB, 1988, GRAEF ARCH CLIN EXP, V226, P522, DOI 10.1007/BF02169199
   JONAS JB, 1995, OPHTHALMOLOGY, V102, P1102
   KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0
   LEYDHECKER W, 1960, GLAUKOM HDB
   Lutjen-Drecoll E, 2007, OPHTHALMOLOGE, V104, P167, DOI 10.1007/s00347-007-1481-5
   Medeiros FA, 2002, DRUGS TODAY, V38, P563, DOI 10.1358/dot.2002.38.8.704676
   Melki R, 2004, J MED GENET, V41, P647, DOI 10.1136/jmg.2004.020024
   Monemi S, 2005, HUM MOL GENET, V14, P725, DOI 10.1093/hmg/ddi068
   Murphy JA, 2006, MED HYPOTHESES, V67, P1208, DOI 10.1016/j.mehy.2006.04.049
   Nickells RW, 1996, J GLAUCOMA, V5, P345
   Pardo LM, 2005, ANN HUM GENET, V69, P288, DOI 10.1046/j.1529-8817.2005.00162.x
   PASUTTO F, 2009, INVEST OPHTHALMOL VI
   Pasutto F, 2008, INVEST OPHTH VIS SCI, V49, P270, DOI 10.1167/iovs.07-0500
   PeinadoRamon P, 1996, INVEST OPHTH VIS SCI, V37, P489
   Pritchard JK, 2001, AM J HUM GENET, V69, P124, DOI 10.1086/321272
   Quigley HA, 1999, PROG RETIN EYE RES, V18, P39, DOI 10.1016/S1350-9462(98)00014-7
   Rezaie T, 2002, SCIENCE, V295, P1077, DOI 10.1126/science.1066901
   Robinson RC, 1999, PROTEIN SCI, V8, P2589
   Rohrer B, 2001, EXP NEUROL, V172, P81, DOI 10.1006/exnr.2001.7795
   Rudzinski M, 2004, J NEUROBIOL, V58, P341, DOI 10.1002/neu.10293
   Sawai H, 1996, J NEUROSCI, V16, P3887
   Schlotzer-Schrehardt U, 2008, AM J PATHOL, V173, P1724, DOI 10.2353/ajpath.2008.080535
   Soto I, 2008, J NEUROSCI, V28, P548, DOI 10.1523/JNEUROSCI.3714-07.2008
   Stone EM, 1997, SCIENCE, V275, P668, DOI 10.1126/science.275.5300.668
   Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212
   Takahata K, 2003, INVEST OPHTH VIS SCI, V44, P1760, DOI 10.1167/iovs.02-0471
   Taylor S, 2003, MOL BRAIN RES, V111, P189, DOI 10.1016/S0169-328X(03)00030-5
   Tuck MW, 2003, OPHTHAL PHYSL OPT, V23, P175, DOI 10.1046/j.1475-1313.2003.00104.x
   WALLACE AC, 1995, PROTEIN ENG, V8, P127, DOI 10.1093/protein/8.2.127
   Weber YG, 2008, DEV MED CHILD NEUROL, V50, P648, DOI 10.1111/j.1469-8749.2008.03058.x
   Weisschuh N, 2007, MOL VIS, V13, P724
   Wiggs JL, 2007, ARCH OPHTHALMOL-CHIC, V125, P30, DOI 10.1001/archopht.125.1.30
   Wiggs JL, 2000, HUM MOL GENET, V9, P1109, DOI 10.1093/hmg/9.7.1109
   Wilkins MR, 1999, METH MOL B, V112, P531
   Wolfs RCW, 2000, INVEST OPHTH VIS SCI, V41, P3309
NR 56
TC 107
Z9 114
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD OCT 9
PY 2009
VL 85
IS 4
BP 447
EP 456
DI 10.1016/j.ajhg.2009.08.016
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA 507FA
UT WOS:000270836000002
PM 19765683
OA Green Published
DA 2021-01-25
ER

PT J
AU Lim, RYH
   Deng, J
AF Lim, Roderick Y. H.
   Deng, Jie
TI Interaction Forces and Reversible Collapse of a Polymer Brush-Gated
   Nanopore
SO ACS NANO
LA English
DT Article
DE polyethylene glycol; molecular gating; polymer brush; reversible
   collapse; steric repulsion; fouling; nanofabrication; force volume
   spectroscopy
ID NUCLEAR-PORE COMPLEX; MOLECULAR-DYNAMICS; POLYPEPTIDE BRUSH;
   NUCLEOPORINS; TRANSPORT; MEMBRANES; PERMEABILITY; MICROSCOPE; SYSTEM;
   MACROMOLECULES
AB Nanopores are ubiquitous in nature and technology, yet relatively little is known about how surface-grafted polymers can affect the interaction forces at the pore. By fabricating Au nanorings on Si substrates, we have constructed a unique experimental platform that allows for direct atomic force microscope (AFM) measurements to be made on polyethylene glycol (PEG) chains locally anchored onto a geometric pore surface. Force measurements show that the PEG gives rise to a steric repulsive barrier that envelops the entire nanoring, signifying polymer brush formation. This is confirmed by a direct imaging of the PEG brush, which reversibly collapses by switching between poor and good solvent conditions to "open" and "close" the pore, respectively. From the view of interaction forces, these results. highlight possible functionalities in which polymer brushes may play a role in minimizing fouling/clogging effects in synthetic nanopores and biological nuclear pore complexes (NPCs). By the mechanism of a reversible collapse, this work illustrates how polymer brush-gated nanopores may be used as nonfouling sieves for small molecules and/or solvent-controlled chemical valves that regulate solute traffic.
C1 [Lim, Roderick Y. H.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Lim, Roderick Y. H.] Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
   [Deng, Jie] ASTAR, Inst Mat Res & Engn, Singapore 117602, Singapore.
RP Lim, RYH (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM roderick.lim@unibas.ch
OI Lim, Roderick/0000-0001-5015-6087
FU National Center of Competence in Research "Nanoscale Science"
   (NCCR-Nano)Swiss National Science Foundation (SNSF); Swiss National
   Science FoundationSwiss National Science Foundation (SNSF); M.E. Muller
   Foundation of Switzerland; Canton Basel-Stadt
FX The authors' acknowledge the SERC Nano-Fabrication and Characterisation
   Facility (SNFC) at the Institute of Materials Research and Engineering
   for the usage of equipment and facilities. We would like to thank L.
   Kapinos for help with the dynamic light scattering measurements. This
   work is supported by the National Center of Competence in Research
   "Nanoscale Science" (NCCR-Nano), the Swiss National Science Foundation,
   the M.E. Muller Foundation of Switzerland, and the Canton Basel-Stadt.
CR Adiga SP, 2005, NANO LETT, V5, P2509, DOI 10.1021/nl051843x
   Adiga SP, 2002, NANO LETT, V2, P567, DOI 10.1021/nl025527j
   Al-Amoudi A, 2007, J MEMBRANE SCI, V303, P6, DOI 10.1016/j.memsci.2007.06.002
   ALEXANDER S, 1977, J PHYS-PARIS, V38, P983, DOI 10.1051/jphys:01977003808098300
   Asatekin A, 2007, J MEMBRANE SCI, V298, P136, DOI 10.1016/j.memsci.2007.04.011
   BAZILE D, 1995, J PHARM SCI, V84, P493, DOI 10.1002/jps.2600840420
   Butt HJ, 1999, LANGMUIR, V15, P2559, DOI 10.1021/la981503+
   Butt HJ, 2005, SURF SCI REP, V59, P1, DOI 10.1016/j.surfrep.2005.08.003
   Caspi Y, 2008, NANO LETT, V8, P3728, DOI 10.1021/nl801975q
   DEGENNES PG, 1980, MACROMOLECULES, V13, P1069, DOI 10.1021/ma60077a009
   DEGENNES PG, 1987, ADV COLLOID INTERFAC, V27, P189, DOI 10.1016/0001-8686(87)85003-0
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Ducker R, 2008, SOFT MATTER, V4, P1774, DOI 10.1039/b804861b
   Eijkel JCT, 2005, MICROFLUID NANOFLUID, V1, P249, DOI 10.1007/s10404-004-0012-9
   Elbert DL, 1996, ANNU REV MATER SCI, V26, P365, DOI 10.1146/annurev.ms.26.080196.002053
   Feldman K, 1999, J AM CHEM SOC, V121, P10134, DOI 10.1021/ja991049b
   Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024
   Granick S, 2003, J POLYM SCI POL PHYS, V41, P2755, DOI 10.1002/polb.10669
   HALPERIN A, 1992, ADV POLYM SCI, V100, P31
   Harris J. M., 1992, POLYETHYLENE GLYCOL
   Harris JM, 2003, NAT REV DRUG DISCOV, V2, P214, DOI 10.1038/nrd1033
   Heuberger M, 2005, BIOPHYS J, V88, P495, DOI 10.1529/biophysj.104.045443
   Hong SK, 1997, J MEMBRANE SCI, V132, P159, DOI 10.1016/S0376-7388(97)00060-4
   Israelachvili J. N., 1995, INTERMOLECULAR SURFA
   Ito Y, 1997, J AM CHEM SOC, V119, P1619, DOI 10.1021/ja963418z
   Ito Y, 2000, LANGMUIR, V16, P5376, DOI 10.1021/la991102+
   Iwata H, 1998, MACROMOLECULES, V31, P3671, DOI 10.1021/ma971243n
   Jaggi RD, 2003, BIOPHYS J, V84, P665
   Jonas AM, 2008, NANO LETT, V8, P3819, DOI 10.1021/nl802152q
   Jonas AM, 2008, MACROMOLECULES, V41, P6859, DOI 10.1021/ma801584k
   Jovanovic-Talisman T, 2009, NATURE, V457, P1023, DOI 10.1038/nature07600
   Koutsioubas AG, 2008, LANGMUIR, V24, P13717, DOI 10.1021/la802536v
   Koutsos V, 1997, MACROMOLECULES, V30, P4719, DOI 10.1021/ma961625d
   Langer R, 1998, NATURE, V392, P5
   Leckband D, 1999, J BIOMAT SCI-POLYM E, V10, P1125, DOI 10.1163/156856299X00720
   Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x
   Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
   Miao LL, 2009, STRUCTURE, V17, P449, DOI 10.1016/j.str.2008.12.021
   Mika AM, 1999, J MEMBRANE SCI, V153, P45, DOI 10.1016/S0376-7388(98)00246-4
   MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905
   Muller MT, 2005, MACROMOLECULES, V38, P5706, DOI 10.1021/ma0501545
   Oesterhelt F, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/006
   OSHEA SJ, 1993, LANGMUIR, V9, P1826, DOI 10.1021/la00031a034
   Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044
   Patra M, 2006, MACROMOLECULES, V39, P4540, DOI 10.1021/ma0606410
   Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664
   Schmelmer U, 2007, SMALL, V3, P459, DOI 10.1002/smll.200600528
   Shannon MA, 2008, NATURE, V452, P301, DOI 10.1038/nature06599
   Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003
   Steenackers M, 2007, SMALL, V3, P1764, DOI 10.1002/smll.200700187
   Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5
NR 52
TC 39
Z9 39
U1 2
U2 60
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1936-0851
J9 ACS NANO
JI ACS Nano
PD OCT
PY 2009
VL 3
IS 10
BP 2911
EP 2918
DI 10.1021/nn900152m
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Nanoscience &
   Nanotechnology; Materials Science, Multidisciplinary
SC Chemistry; Science & Technology - Other Topics; Materials Science
GA 510QR
UT WOS:000271106100008
PM 19728698
DA 2021-01-25
ER

PT J
AU Li-Blatter, X
   Nervi, P
   Seelig, A
AF Li-Blatter, Xiaochun
   Nervi, Pierluigi
   Seelig, Anna
TI Detergents as intrinsic P-glycoprotein substrates and inhibitors
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article
DE Un-competitive; Competitive inhibition; P-glycoprotein binding site;
   C12EO8 (C12E8); Triton X-100; Tween 80
ID BRAIN-BARRIER PERMEATION; DRUG-BINDING; MULTIDRUG-RESISTANCE; ATPASE
   ACTIVITY; PLASMA-MEMBRANE; CYTOPLASMIC LEAFLET; CATALYTIC CYCLE;
   LIPID-MEMBRANES; TRANSPORT; HYDROLYSIS
AB We assessed the interaction of three electrically neutral detergents (Triton X-100, C12EO8, and Tween 80) with P-glycoprotein (ABCB1, MDR1) and identified the molecular elements responsible for this interaction. To this purpose we titrated P-glycoprotein in inside-out plasma membrane vesicles of MDR1-transfected mouse embryo fibroblasts (NIH-MDR1-G185) with the detergents below their critical micelle concentration, CIVIC The P-glycoprotein ATPase measured as a function of the detergent concentration yielded bell-shaped activity curves which were evaluated with a two-site binding model. The lipid-water partition coefficient and the transporter-water binding constant of the detergents were measured independently. Knowledge of these two parameters allowed assessment of the free energy of detergent binding to P-glycoprotein in the lipid membrane, Delta G(tl)(0), that reflects the direct detergent-trans porter affinity. It increased as the number of ethoxyl groups increased, suggesting that these hydrogen bond acceptor groups are the key elements for the detergent-transporter interaction in the lipid membrane. The free energy of binding to P-glycoprotein per ethoxyl group (EO) was determined as approximately Delta G(EO)(0) = - 1.6 kJ/mol. The present findings moreover document that depending on the concentration applied, detergents are intrinsic substrates for, or inhibitors of P-glycoprotein. (C) 2009 Elsevier B.V. All rights reserved.
C1 [Li-Blatter, Xiaochun; Nervi, Pierluigi; Seelig, Anna] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Anna.Seelig@unibas.ch
CR Aanismaa P, 2008, BIOCHEMISTRY-US, V47, P10197, DOI 10.1021/bi800209h
   Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526
   Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200
   Aller SG, 2009, SCIENCE, V323, P1718, DOI 10.1126/science.1168750
   Alqawi O, 2003, BIOCHEM BIOPH RES CO, V303, P1135, DOI 10.1016/S0006-291X(03)00492-3
   Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160
   Arnulphi C, 2007, BIOPHYS J, V93, P3504, DOI 10.1529/biophysj.107.104463
   Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200
   Dey S, 1997, P NATL ACAD SCI USA, V94, P10594, DOI 10.1073/pnas.94.20.10594
   Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+
   Gerebtzoff G, 2006, J CHEM INF MODEL, V46, P2638, DOI 10.1021/ci0600814
   Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7
   HEGNER D, 1980, MECH AGEING DEV, V14, P101, DOI 10.1016/0047-6374(80)90109-8
   HIGGINS CF, 1992, TRENDS BIOCHEM SCI, V17, P18, DOI 10.1016/0968-0004(92)90419-A
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P169, DOI 10.1016/S0925-4439(97)00027-6
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   Lugo MR, 2005, BIOCHEMISTRY-US, V44, P643, DOI 10.1021/bi0485326
   Martin C, 2000, MOL PHARMACOL, V58, P624
   Meier M, 2006, BIOPHYS J, V91, P2943, DOI 10.1529/biophysj.106.089581
   NERVI P, BIOCH BIOPHYS UNPUB
   Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200
   Omote H, 2006, BIOPHYS J, V90, P4046, DOI 10.1529/biophysj.105.077743
   Orlowski S, 1998, Cancer Biochem Biophys, V16, P85
   RAVIV Y, 1990, J BIOL CHEM, V265, P3975
   Rege BD, 2002, EUR J PHARM SCI, V16, P237, DOI 10.1016/S0928-0987(02)00055-6
   Romsicki Y, 1999, BIOCHEMISTRY-US, V38, P6887, DOI 10.1021/bi990064q
   Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615
   Sauna ZE, 2004, BIOCHEMISTRY-US, V43, P2262, DOI 10.1021/bi035965k
   Scala S, 1997, MOL PHARMACOL, V51, P1024
   Seelig A, 2005, MINI-REV MED CHEM, V5, P135, DOI 10.2174/1389557053402693
   Seelig A, 1996, BIOCHEMISTRY-US, V35, P4365, DOI 10.1021/bi952434q
   Seelig A, 2000, INT J CLIN PHARM TH, V38, P111
   Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   Seelig A, 2000, EUR J PHARM SCI, V12, P31, DOI 10.1016/S0928-0987(00)00177-9
   Seelig A, 2007, J MOL NEUROSCI, V33, P32, DOI 10.1007/s12031-007-0055-y
   Seelig A, 2006, EXPERT OPIN DRUG MET, V2, P733, DOI 10.1517/17425255.2.5.733
   Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8
   Shapiro AB, 1998, EUR J BIOCHEM, V254, P181, DOI 10.1046/j.1432-1327.1998.2540181.x
   Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x
   SHAROM FJ, 1993, J BIOL CHEM, V268, P24197
   Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984
   Tanigawara Y, 2000, THER DRUG MONIT, V22, P137, DOI 10.1097/00007691-200002000-00029
   URBATSCH IL, 1995, ARCH BIOCHEM BIOPHYS, V316, P135, DOI 10.1006/abbi.1995.1020
   ZORDANNUDO T, 1993, CANCER RES, V53, P5994
NR 45
TC 46
Z9 47
U1 0
U2 12
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
EI 0006-3002
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD OCT
PY 2009
VL 1788
IS 10
BP 2335
EP 2344
DI 10.1016/j.bbamem.2009.07.010
PG 10
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 511FT
UT WOS:000271150000040
PM 19631191
OA Bronze
DA 2021-01-25
ER

PT J
AU Knechtle, B
   Wirth, A
   Knechtle, P
   Zimmermann, K
   Kohler, G
AF Knechtle, B.
   Wirth, A.
   Knechtle, P.
   Zimmermann, K.
   Kohler, G.
TI Personal best marathon performance is associated with performance in a
   24-h run and not anthropometry or training volume
SO BRITISH JOURNAL OF SPORTS MEDICINE
LA English
DT Article
ID DISTANCE RUNNING PERFORMANCE; SKINFOLD THICKNESSES; RUNNERS; MASS
AB Objective: In this study, the influence of anthropometric and training parameters on race performance in ultra-endurance runners in a 24-h run was investigated.
   Design: Descriptive field study.
   Setting: 24-h run in Basel 2007.
   Participants: 15 male Caucasian ultra-runners (mean (SD) 46.7 (5.8 years), 71.1 (6.8 kg), 1.76 (0.07 m), body mass index 23.1 (1.84 kg/m(2))).
   Interventions: None.
   Main outcome measures: Age, body mass, body height, length of lower limbs, skin-fold thicknesses, circumference of extremities, skeletal muscle mass, body mass, percentage of body fat, and training volume in 15 successful finishers were determined to correlate anthropometric and training parameters with race performance. Results: No significant association (p > 0.05) was found between the reached distance and the anthropometric properties. There was also no significant association between the reached distance with the weekly training hours, running years, the number of finished marathons and the number of finished 24-h runs. The reached distance was significantly (p, 0.05) positively correlated with the personal best marathon performance (r(2) = 0.40) and the personal best 24-h run distance (r(2) = 0.58). Furthermore, the personal best marathon performance was significantly and positively correlated (p < 0.01) with the best personal 24-h run distance (r(2) = 0.76).
   Conclusions: Anthropometry and training volume does not seem to have a major effect on race performance in a 24-h run. Instead, a fast personal best marathon time seems to be the only positive association with race performance in a 24-h run.
C1 [Knechtle, B.; Wirth, A.; Knechtle, P.] Gesundheitszentrum, CH-9001 St Gallen, Switzerland.
   [Knechtle, B.] Univ Zurich, Dept Gen Practice, Zurich, Switzerland.
   [Zimmermann, K.] Sri Chinmoy Marathon Team, Basel, Switzerland.
   [Kohler, G.] Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
RP Knechtle, B (corresponding author), Gesundheitszentrum, Vadianstr 26, CH-9001 St Gallen, Switzerland.
EM beat.knechtle@hispeed.ch
CR Arrese AL, 2005, J SPORT MED PHYS FIT, V45, P512
   Arrese AL, 2006, J SPORT SCI, V24, P69, DOI 10.1080/02640410500127751
   Bale P, 1986, Br J Sports Med, V20, P170
   Bale P, 1985, J SPORT SCI, V3, P115, DOI 10.1080/02640418508729741
   Ball SD, 2004, EUR J CLIN NUTR, V58, P1525, DOI 10.1038/sj.ejcn.1602003
   Billat V, 2003, MED SCI SPORT EXER, V35, P297, DOI 10.1249/01.MSS.0000053556.59992.A9
   Billat V, 2002, INT J SPORTS MED, V23, P336, DOI 10.1055/s-2002-33265
   Billat VL, 2001, MED SCI SPORT EXER, V33, P2089, DOI 10.1097/00005768-200112000-00018
   Christensen C L, 1983, Br J Sports Med, V17, P166
   COETZER P, 1993, J APPL PHYSIOL, V75, P1822
   DAVIES CTM, 1979, EUR J APPL PHYSIOL O, V41, P233, DOI 10.1007/BF00429740
   DOLGENER FA, 1994, RES Q EXERCISE SPORT, V65, P339, DOI 10.1080/02701367.1994.10607638
   Esteve-Lanao J, 2005, MED SCI SPORT EXER, V37, P496, DOI 10.1249/01.MSS.0000155393.78744.86
   Hagan R D, 1987, Br J Sports Med, V21, P3
   HAGAN RD, 1981, MED SCI SPORT EXER, V13, P185
   Kenney W L, 1985, Br J Sports Med, V19, P207
   KNECHTLE B, 2008, RES Q EXERC IN PRESS
   KNECHTLE B, BRIT J SPORT MED
   Lee RC, 2000, AM J CLIN NUTR, V72, P796
   Legaz A, 2005, BRIT J SPORT MED, V39, P851, DOI 10.1136/bjsm.2005.018960
   Maldonado S, 2002, INT J SPORTS MED, V23, P268, DOI 10.1055/s-2002-29083
   Noakes TD, 1990, J SPORT SCI, V8, P35, DOI 10.1080/02640419008732129
   R Development Core Team, 2007, R LANG ENV STAT COMP
   SAGNOL M, 1989, INT J SPORTS MED, V10, P202, DOI 10.1055/s-2007-1024901
   SCOTT BK, 1994, INT J SPORTS MED, V15, P504, DOI 10.1055/s-2007-1021095
   SCRIMGEOUR AG, 1986, EUR J APPL PHYSIOL O, V55, P202, DOI 10.1007/BF00715006
   SJODIN B, 1985, SPORTS MED, V2, P83
   TANAKA K, 1982, ANN HUM BIOL, V9, P473, DOI 10.1080/03014468200006001
   Wu HJ, 2004, WORLD J GASTROENTERO, V10, P2711, DOI 10.3748/wjg.v10.i18.2711
   Yeung SS, 2001, J SPORT MED PHYS FIT, V41, P170
NR 30
TC 55
Z9 55
U1 0
U2 2
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0306-3674
J9 BRIT J SPORT MED
JI Br. J. Sports Med.
PD OCT
PY 2009
VL 43
IS 11
BP 836
EP 839
DI 10.1136/bjsm.2007.045716
PG 4
WC Sport Sciences
SC Sport Sciences
GA 512NZ
UT WOS:000271258200008
PM 18385194
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Affolter, M
   Zeller, R
AF Affolter, Markus
   Zeller, Rolf
TI From cells to organs: new insight into organ morphogenesis Editorial
   overview
SO CURRENT OPINION IN GENETICS & DEVELOPMENT
LA English
DT Editorial Material
C1 [Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Zeller, Rolf] Univ Basel, Dept Biomed, CH-4058 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Markus.Affolter@unibas.ch; rolf.zeller@unibas.ch
RI Zeller, Rolf/C-2610-2013
OI Zeller, Rolf/0000-0002-3186-7403; Affolter, Markus/0000-0002-5171-0016
NR 0
TC 1
Z9 1
U1 0
U2 2
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-437X
J9 CURR OPIN GENET DEV
JI Curr. Opin. Genet. Dev.
PD OCT
PY 2009
VL 19
IS 5
BP 421
EP 423
DI 10.1016/j.gde.2009.09.005
PG 3
WC Cell Biology; Genetics & Heredity
SC Cell Biology; Genetics & Heredity
GA 527JR
UT WOS:000272363800001
PM 19836943
DA 2021-01-25
ER

PT J
AU Bumann, D
AF Bumann, Dirk
TI System-level analysis of Salmonella metabolism during infection
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review
ID ENTERICA SEROVAR TYPHIMURIUM; ESCHERICHIA-COLI K-12;
   LISTERIA-MONOCYTOGENES; GENE-EXPRESSION; MYCOBACTERIUM-TUBERCULOSIS;
   CARBON METABOLISM; HIGH-THROUGHPUT; ANIMAL-MODELS; VIRULENCE; HOST
AB Infectious diseases represent a major threat to human health. To develop urgently needed new control strategies, a transition from research focusing on individual factors to a more integrated system-level analysis might be needed. Such an approach faces great challenges and might require development of new concepts in large-scale data analysis. Here, I discuss for the well-characterized model pathogen Salmonella, how extensively studied metabolism can be used as a training field for infection biology at the systems level. Extensive experimental data can be analyzed in context using metabolic network visualization tools and in silico modeling based on genome-scale metabolic reconstructions. Suitable approaches to obtain still missing comprehensive quantitative data on Salmonella nutrition in infected host tissues are described. Such an integrated investigation of Salmonella metabolism during infection will enable an unprecedented large-scale understanding of pathogen in vivo activities, help to evaluate concepts and strategies for system-level analysis of host/pathogen interactions in general, and provide a basis for rational development of novel antimicrobials and efficacious live vaccines.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Bumann, D (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM dirk.bumann@unibas.ch
FU Deutsche Forschungsgemeinsuhaft; Schweizerischer NationalfondsSwiss
   National Science Foundation (SNSF)
FX I thank past and present members of my lab for stimulating discussions
   and Deutsche Forschungsgemeinsuhaft and Schweizerischer Nationalfonds
   for funding.
CR Alix E, 2008, MICROB PATHOGENESIS, V45, P236, DOI 10.1016/j.micpath.2008.06.001
   Arita M, 2004, P NATL ACAD SCI USA, V101, P1543, DOI 10.1073/pnas.0306458101
   BAUMLER AJ, 1994, INFECT IMMUN, V62, P1623
   Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   Bhan MK, 2005, LANCET, V366, P749, DOI 10.1016/S0140-6736(05)67181-4
   Black MT, 2005, ADV DRUG DELIVER REV, V57, P1528, DOI 10.1016/j.addr.2005.04.006
   Bowden SD, 2009, INFECT IMMUN, V77, P3117, DOI 10.1128/IAI.00093-09
   Brown KL, 2007, TRENDS IMMUNOL, V28, P260, DOI 10.1016/j.it.2007.04.005
   Bruggemann H, 2006, CELL MICROBIOL, V8, P1228, DOI 10.1111/j.1462-5822.2006.00703.x
   Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x
   Bumann D, 2000, FEMS IMMUNOL MED MIC, V27, P357, DOI 10.1016/S0928-8244(99)00214-X
   Bumann D, 2008, CURR OPIN MICROBIOL, V11, P387, DOI 10.1016/j.mib.2008.08.002
   Chang A, 2009, NUCLEIC ACIDS RES, V37, pD588, DOI 10.1093/nar/gkn820
   Chico-Calero I, 2002, P NATL ACAD SCI USA, V99, P431, DOI 10.1073/pnas.012363899
   COLLINS LV, 1991, INFECT IMMUN, V59, P1079, DOI 10.1128/IAI.59.3.1079-1085.1991
   Copley SD, 2003, CURR OPIN CHEM BIOL, V7, P265, DOI 10.1016/S1367-5931(03)00032-2
   Covert MW, 2004, NATURE, V429, P92, DOI 10.1038/nature02456
   Crouch MLV, 2008, MOL MICROBIOL, V67, P971, DOI 10.1111/j.1365-2958.2007.06089.x
   Csete M, 2004, TRENDS BIOTECHNOL, V22, P446, DOI 10.1016/j.tibtech.2004.07.007
   Drecktrah D, 2007, TRAFFIC, V8, P212, DOI 10.1111/j.1600-0854.2006.00529.x
   Eisenreich W, 2006, P NATL ACAD SCI USA, V103, P2040, DOI 10.1073/pnas.0507580103
   Epstein JE, 2007, CURR OPIN MOL THER, V9, P12
   Eriksson S, 2003, MOL MICROBIOL, V47, P103, DOI 10.1046/j.1365-2958.2003.03313.x
   Exley RM, 2005, J EXP MED, V201, P1637, DOI 10.1084/jem.20041548
   Feist AM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100155
   Forbes JR, 2001, TRENDS MICROBIOL, V9, P397, DOI 10.1016/S0966-842X(01)02098-4
   Forst CV, 2006, DRUG DISCOV TODAY, V11, P220, DOI 10.1016/S1359-6446(05)03735-9
   GERMANIER R, 1975, J INFECT DIS, V131, P553, DOI 10.1093/infdis/131.5.553
   GERMANIER R, 1971, INFECT IMMUN, V4, P663, DOI 10.1128/IAI.4.6.663-673.1971
   Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204
   Groisman EA, 1997, TRENDS MICROBIOL, V5, P343, DOI 10.1016/S0966-842X(97)01099-8
   Groisman EA, 2006, NAT REV MICROBIOL, V4, P705, DOI 10.1038/nrmicro1478
   GUNN JS, 1995, J BACTERIOL, V177, P5040, DOI 10.1128/jb.177.17.5040-5047.1995
   GUTNICK D, 1969, J BACTERIOL, V100, P215, DOI 10.1128/JB.100.1.215-219.1969
   Guzman CA, 2006, VACCINE, V24, P3804, DOI 10.1016/j.vaccine.2005.07.111
   Hamon M, 2006, NAT REV MICROBIOL, V4, P423, DOI 10.1038/nrmicro1413
   Hapfelmeier S, 2005, TRENDS MICROBIOL, V13, P497, DOI 10.1016/j.tim.2005.08.008
   Henry T, 2005, MOL MICROBIOL, V56, P252, DOI 10.1111/j.1365-2958.2005.04540.x
   HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105
   Hoffman LR, 2006, P NATL ACAD SCI USA, V103, P9377, DOI 10.1073/pnas.0603266103
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0
   ISBERG RR, 1985, NATURE, V317, P262, DOI 10.1038/317262a0
   Ishii N, 2007, SCIENCE, V316, P593, DOI 10.1126/science.1132067
   Jenner RG, 2005, NAT REV MICROBIOL, V3, P281, DOI 10.1038/nrmicro1126
   Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882
   Kaufmann SHE, 2007, NAT REV MICROBIOL, V5, P491, DOI 10.1038/nrmicro1688
   Keseler IM, 2009, NUCLEIC ACIDS RES, V37, pD464, DOI 10.1093/nar/gkn751
   Kuepfer L, 2005, GENOME RES, V15, P1421, DOI 10.1101/gr.3992505
   Kuznetsova E, 2005, FEMS MICROBIOL REV, V29, P263, DOI 10.1016/j.femsre.2004.12.006
   Lawley TD, 2006, PLOS PATHOG, V2, P87, DOI 10.1371/journal.ppat.0020011
   Lewis GK, 2007, EXPERT REV VACCINES, V6, P431, DOI 10.1586/14760584.6.3.431
   Li YH, 2009, P NATL ACAD SCI USA, V106, P593, DOI 10.1073/pnas.0811697106
   Liu MZ, 2005, J BIOL CHEM, V280, P15921, DOI 10.1074/jbc.M414050200
   Lloyd J B, 1996, Subcell Biochem, V27, P361
   Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200
   Macek B, 2007, MOL CELL PROTEOMICS, V6, P697, DOI 10.1074/mcp.M600464-MCP200
   MCFARLAND WC, 1987, MICROB PATHOGENESIS, V3, P129, DOI 10.1016/0882-4010(87)90071-4
   McKinney JD, 2000, NATURE, V406, P735, DOI 10.1038/35021074
   Milenbachs AA, 1997, MOL MICROBIOL, V23, P1075, DOI 10.1046/j.1365-2958.1997.2711634.x
   Morgan E, 2004, MOL MICROBIOL, V54, P994, DOI 10.1111/j.1365-2958.2004.04323.x
   Munoz-Elias EJ, 2006, CELL MICROBIOL, V8, P10, DOI 10.1111/j.1462-5822.2005.00648.x
   Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252
   Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1
   Papp B, 2004, NATURE, V429, P661, DOI 10.1038/nature02636
   Poltorak A, 1998, SCIENCE, V282, P2085, DOI 10.1126/science.282.5396.2085
   Raghunathan A, 2009, BMC SYST BIOL, V3, DOI 10.1186/1752-0509-3-38
   Santiviago CA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000477
   Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2
   Shi L, 2006, J BIOL CHEM, V281, P29131, DOI 10.1074/jbc.M604640200
   Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937
   Stevens JM, 2006, NAT REV MICROBIOL, V4, P91, DOI 10.1038/nrmicro1320
   Tacket CO, 2007, CLIN INFECT DIS, V45, pS20, DOI 10.1086/518135
   Tanaka R, 2005, IEE P SYST BIOL, V152, P179, DOI 10.1049/ip-syb:20050042
   Winchester B G, 2001, Eur J Paediatr Neurol, V5 Suppl A, P11, DOI 10.1053/ejpn.2000.0428
   Winzeler EA, 2006, NAT REV MICROBIOL, V4, P145, DOI 10.1038/nrmicro1327
   WRIGHT JA, 2009, MICROBIOLOGY, V18, P18
   Zinkernagel RM, 2004, SCAND J IMMUNOL, V60, P9, DOI 10.1111/j.0300-9475.2004.01460.x
NR 77
TC 39
Z9 39
U1 0
U2 13
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
EI 1879-0364
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD OCT
PY 2009
VL 12
IS 5
BP 559
EP 567
DI 10.1016/j.mib.2009.08.004
PG 9
WC Microbiology
SC Microbiology
GA 516SP
UT WOS:000271563200014
PM 19744878
DA 2021-01-25
ER

PT J
AU Grzesiek, S
   Sass, HJ
AF Grzesiek, Stephan
   Sass, Hans-Juergen
TI From biomolecular structure to functional understanding: new NMR
   developments narrow the gap
SO CURRENT OPINION IN STRUCTURAL BIOLOGY
LA English
DT Review
ID RESIDUAL DIPOLAR COUPLINGS; PARAMAGNETIC RELAXATION ENHANCEMENT;
   PROTEIN-STRUCTURE DETERMINATION; 8 M UREA; CHEMICAL-SHIFTS; DISPERSION
   NMR; PSEUDOCONTACT SHIFTS; SECONDARY STRUCTURE; DISORDERED PROTEIN;
   ATOMIC-RESOLUTION
AB Biomolecular structure provides the framework for dynamics and function. However, the information of more than 50000 protein and nucleic acid structures solved today has not yet yielded enough insight such that function could be predicted from structure or that structures and dynamics could be predicted to high resolution from sequence alone. Further experimental information is urgently needed to guide the process of relating sequence, structure, dynamics, and ultimately function. Recent progress in solution NMR methods encompasses better detection of dynamics and molecular interactions, a more detailed characterization of folding transitions, increases of the molecular weight limit and sensitivity, strongly enhanced computational approaches, and the in-cell detection of molecules. These developments are highly complementary and narrow the gap between structure and functional understanding. This article discusses recent advances and applications.
C1 [Grzesiek, Stephan; Sass, Hans-Juergen] Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
EM Stephan.Grzesiek@unibas.ch
OI Grzesiek, Stephan/0000-0003-1998-4225
FU SNF [31-109712]
FX This work was supported by SNF grant 31-109712.
CR Amero C, 2009, J AM CHEM SOC, V131, P3448, DOI 10.1021/ja809880p
   Baker KA, 2007, NAT STRUCT MOL BIOL, V14, P1089, DOI 10.1038/nsmb1311
   Bart J, 2009, J AM CHEM SOC, V131, P5014, DOI 10.1021/ja900389x
   Bax A, 2005, CURR OPIN STRUC BIOL, V15, P563, DOI 10.1016/j.sbi.2005.08.006
   Bayrhuber M, 2008, P NATL ACAD SCI USA, V105, P15370, DOI 10.1073/pnas.0808115105
   Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102
   Bertini I, 2005, CHEMBIOCHEM, V6, P1536, DOI 10.1002/cbic.200500124
   Bertoncini CW, 2007, J MOL BIOL, V372, P708, DOI 10.1016/j.jmb.2007.07.009
   Binolfi A, 2006, J AM CHEM SOC, V128, P9893, DOI 10.1021/ja0618649
   Boehr DD, 2006, SCIENCE, V313, P1638, DOI 10.1126/science.1130258
   Bouvignies G, 2005, P NATL ACAD SCI USA, V102, P13885, DOI 10.1073/pnas.0505129102
   Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801
   Buck J, 2007, P NATL ACAD SCI USA, V104, P15699, DOI 10.1073/pnas.0703182104
   Burz DS, 2006, NAT METHODS, V3, P91, DOI 10.1038/NMETH851
   Cady SD, 2009, J MOL BIOL, V385, P1127, DOI 10.1016/j.jmb.2008.11.022
   Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104
   Cierpicki T, 2006, J AM CHEM SOC, V128, P6947, DOI 10.1021/ja0608343
   Clore GM, 2007, CURR OPIN STRUC BIOL, V17, P603, DOI 10.1016/j.sbi.2007.08.013
   Cordier F, 2006, J MOL BIOL, V361, P659, DOI 10.1016/j.jmb.2006.06.045
   Dames SA, 2006, J AM CHEM SOC, V128, P13508, DOI 10.1021/ja063606h
   Doucleff M, 2008, P NATL ACAD SCI USA, V105, P13871, DOI 10.1073/pnas.0805050105
   Felitsky DJ, 2008, P NATL ACAD SCI USA, V105, P6278, DOI 10.1073/pnas.0710641105
   Fitzkee NC, 2005, TRENDS BIOCHEM SCI, V30, P73, DOI 10.1016/j.tibs.2004.12.005
   Gal M, 2007, J AM CHEM SOC, V129, P1372, DOI 10.1021/ja066915g
   Gaponenko V, 2004, J BIOMOL NMR, V28, P205, DOI 10.1023/B:JNMR.0000013706.09264.36
   Gautier A, 2008, ANGEW CHEM INT EDIT, V47, P7297, DOI 10.1002/anie.200802783
   Henzler-Wildman KA, 2007, NATURE, V450, P838, DOI 10.1038/nature06410
   Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407
   Hiller S, 2008, SCIENCE, V321, P1206, DOI 10.1126/science.1161302
   Horst R, 2005, P NATL ACAD SCI USA, V102, P12748, DOI 10.1073/pnas.0505642102
   Horst R, 2006, P NATL ACAD SCI USA, V103, P15445, DOI 10.1073/pnas.0607141103
   Hsu STD, 2007, P NATL ACAD SCI USA, V104, P16516, DOI 10.1073/pnas.0704664104
   Igumenova TI, 2007, J AM CHEM SOC, V129, P13396, DOI 10.1021/ja0761636
   Ikegami T, 2004, J BIOMOL NMR, V29, P339, DOI 10.1023/B:JNMR.0000032611.72827.de
   Inomata K, 2009, NATURE, V458, P106, DOI 10.1038/nature07839
   Iwahara J, 2006, NATURE, V440, P1227, DOI 10.1038/nature04673
   Iwahara J, 2006, P NATL ACAD SCI USA, V103, P15062, DOI 10.1073/pnas.0605868103
   Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102
   John M, 2007, CHEMPHYSCHEM, V8, P2309, DOI 10.1002/cphc.200700510
   Joo CG, 2009, J AM CHEM SOC, V131, P12, DOI 10.1021/ja805521y
   Kainosho M, 2006, NATURE, V440, P52, DOI 10.1038/nature04525
   Keizers PHJ, 2008, J AM CHEM SOC, V130, P14802, DOI 10.1021/ja8054832
   Klepeis JL, 2009, CURR OPIN STRUC BIOL, V19, P120, DOI 10.1016/j.sbi.2009.03.004
   Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655
   Korzhnev DM, 2008, ACCOUNTS CHEM RES, V41, P442, DOI 10.1021/ar700189y
   Kristjansdottir S, 2005, J MOL BIOL, V347, P1053, DOI 10.1016/j.jmb.2005.01.009
   Lange OF, 2008, SCIENCE, V320, P1471, DOI 10.1126/science.1157092
   Liang BY, 2007, P NATL ACAD SCI USA, V104, P16140, DOI 10.1073/pnas.0705466104
   Liang BY, 2006, J AM CHEM SOC, V128, P4389, DOI 10.1021/ja0574825
   Martin LJ, 2007, J AM CHEM SOC, V129, P7106, DOI 10.1021/ja070480v
   Meier S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2838167
   Meier S, 2007, J AM CHEM SOC, V129, P9799, DOI 10.1021/ja0724339
   Meier S, 2007, J AM CHEM SOC, V129, P754, DOI 10.1021/ja067522k
   Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009
   Mittermaier A, 2006, SCIENCE, V312, P224, DOI 10.1126/science.1124964
   Mok KH, 2007, NATURE, V447, P106, DOI 10.1038/nature05728
   Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159
   Neudecker P, 2007, P NATL ACAD SCI USA, V104, P15717, DOI 10.1073/pnas.0705097104
   Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t
   PARDI A, 1983, EUR J BIOCHEM, V137, P445, DOI 10.1111/j.1432-1033.1983.tb07848.x
   Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366
   Pervushin K, 2007, NAT STRUCT MOL BIOL, V14, P1202, DOI 10.1038/nsmb1325
   Pintacuda G, 2007, ACCOUNTS CHEM RES, V40, P206, DOI 10.1021/ar050087z
   Prandolini MJ, 2009, J AM CHEM SOC, V131, P6090, DOI 10.1021/ja901496g
   Sakai T, 2006, J BIOMOL NMR, V36, P179, DOI 10.1007/s10858-006-9079-9
   Sakakibara D, 2009, NATURE, V458, P102, DOI 10.1038/nature07814
   Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e
   Schanda P, 2008, J MOL BIOL, V380, P726, DOI 10.1016/j.jmb.2008.05.040
   Schanda P, 2007, P NATL ACAD SCI USA, V104, P11257, DOI 10.1073/pnas.0702069104
   Schanda P, 2006, J AM CHEM SOC, V128, P9042, DOI 10.1021/ja062025p
   Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531
   Selenko P, 2008, NAT STRUCT MOL BIOL, V15, P321, DOI 10.1038/nsmb.1395
   Selenko P, 2007, J STRUCT BIOL, V158, P244, DOI 10.1016/j.jsb.2007.04.001
   Selenko P, 2006, P NATL ACAD SCI USA, V103, P11904, DOI 10.1073/pnas.0604667103
   Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105
   Shen Y, 2007, J BIOMOL NMR, V38, P289, DOI 10.1007/s10858-007-9166-6
   Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438
   Sprangers R, 2008, BIOCHEMISTRY-US, V47, P6727, DOI 10.1021/bi8005913
   Sprangers R, 2007, NAT METHODS, V4, P697, DOI 10.1038/NMETH1080
   Sprangers R, 2007, NATURE, V445, P618, DOI 10.1038/nature05512
   Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528
   Su XC, 2008, J AM CHEM SOC, V130, P10486, DOI 10.1021/ja803741f
   Su XC, 2008, J AM CHEM SOC, V130, P1681, DOI 10.1021/ja076564l
   Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858
   Tang C, 2007, NATURE, V449, P1078, DOI 10.1038/nature06232
   Tugarinov V, 2005, CHEMBIOCHEM, V6, P1567, DOI 10.1002/cbic.200500110
   Uzawa T, 2008, P NATL ACAD SCI USA, V105, P13859, DOI 10.1073/pnas.0804033105
   Vallurupalli P, 2008, P NATL ACAD SCI USA, V105, P11766, DOI 10.1073/pnas.0804221105
   Vallurupalli P, 2008, J AM CHEM SOC, V130, P2734, DOI 10.1021/ja710817g
   Vallurupalli P, 2007, P NATL ACAD SCI USA, V104, P18473, DOI 10.1073/pnas.0708296104
   Velyvis A, 2007, P NATL ACAD SCI USA, V104, P8815, DOI 10.1073/pnas.0703347104
   Vlasie MD, 2008, J MOL BIOL, V375, P1405, DOI 10.1016/j.jmb.2007.11.056
   Volkov AN, 2006, P NATL ACAD SCI USA, V103, P18945, DOI 10.1073/pnas.0603551103
   Walton TA, 2009, P NATL ACAD SCI USA, V106, P1772, DOI 10.1073/pnas.0809275106
   WISHART DS, 1991, J MOL BIOL, V222, P311, DOI 10.1016/0022-2836(91)90214-Q
   Wright PE, 2009, CURR OPIN STRUC BIOL, V19, P31, DOI 10.1016/j.sbi.2008.12.003
   Xu XF, 2008, J AM CHEM SOC, V130, P6395, DOI 10.1021/ja7101357
   Zhang Q, 2007, NATURE, V450, P1263, DOI 10.1038/nature06389
   ZWANZIG R, 1992, P NATL ACAD SCI USA, V89, P20, DOI 10.1073/pnas.89.1.20
NR 99
TC 23
Z9 23
U1 0
U2 23
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-440X
J9 CURR OPIN STRUC BIOL
JI Curr. Opin. Struct. Biol.
PD OCT
PY 2009
VL 19
IS 5
BP 585
EP 595
DI 10.1016/j.sbi.2009.07.015
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 516PP
UT WOS:000271555000013
PM 19716691
DA 2021-01-25
ER

PT J
AU Malik, R
   Lenobel, R
   Santamaria, A
   Ries, A
   Nigg, EA
   Korner, R
AF Malik, Rainer
   Lenobel, Rene
   Santamaria, Anna
   Ries, Albert
   Nigg, Erich A.
   Koerner, Roman
TI Quantitative Analysis of the Human Spindle Phosphoproteome at Distinct
   Mitotic Stages
SO JOURNAL OF PROTEOME RESEARCH
LA English
DT Article
DE mitosis; spindle; phosphorylation; kinase consensus; signaling
ID METAL-OXIDE CHROMATOGRAPHY; TOPOISOMERASE II-ALPHA; PROTEIN-KINASE CK2;
   POLO-BOX DOMAIN; MASS-SPECTROMETRY; IN-VIVO; PHOSPHORYLATED PEPTIDES;
   CELL-DIVISION; SELECTIVE ENRICHMENT; PROTEOMIC ANALYSIS
AB During mitosis, phosphorylation of spindle associated proteins is a key regulatory mechanism for spindle formation, mitotic progression, and cytokinesis. In the recent past, mass spectrometry has been applied successfully to identify spindle proteomes and phosphoproteomes, but did not address their dynamics. Here, we present a quantitative comparison of spindle phosphoproteomes prepared from different mitotic stages. In total, we report the identification and SILAC based relative quantitation of 1940 unique phosphorylation sites and find that late mitosis (anaphase, telophase) is correlated with a drastic alteration in protein phosphorylation. Further statistical cluster analyses demonstrate a strong dependency of phosphorylation dynamics on kinase consensus patterns, thus, linking subgroups of identified phosphorylation sites to known key mitotic kinases. Surprisingly, we observed that during late mitosis strong dephosphorylation occurred on a significantly larger fraction of phospho-threonine than phospho-serine residues, suggesting a substrate preference of phosphatases for phospho-threonine at this stage. Taken together, our results constitute a large quantitative data resource of phosphorylation abundances at distinct mitotic stages and they provide insight into the systems properties of phosphorylation dynamics during mitosis.
C1 [Malik, Rainer; Lenobel, Rene; Santamaria, Anna; Ries, Albert; Nigg, Erich A.; Koerner, Roman] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
   [Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Korner, R (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.
EM rkoerner@biochem.mpg.de
RI LENOBEL, Rene/AAD-5606-2020; Korner, Roman/G-8565-2011
OI Korner, Roman/0000-0001-9285-9290; Lenobel, Rene/0000-0001-7387-0056;
   nigg, erich/0000-0003-4835-5719
FU Max-Planck SocietyMax Planck SocietyFoundation CELLEX
   [LSHG-CT-2005-518254]; European CommissionEuropean CommissionEuropean
   Commission Joint Research Centre; Czech Ministry of Education, Youth and
   SportsMinistry of Education, Youth & Sports - Czech Republic
   [MSM6198959216]; Spanish Education and Science MinistrySpanish
   Government
FX we thank Jurgen Cox and Matthias Mann for early access to the MaxQuant
   program. This work was supported by the Max-Planck Society as well as by
   ENFIN (contract number LSHG-CT-2005-518254), funded by the European
   Commission within its FP6 Program, under the thematic area 'Life
   sciences, genornics and biotechnology for health'. R.L. and A.S. were
   supported by grants from the Czech Ministry of Education, Youth and
   Sports (grant number MSM6198959216) and the Spanish Education and
   Science Ministry, respectively.
CR Amanchy R, 2005, J PROTEOME RES, V4, P1661, DOI 10.1021/pr050134h
   Andersen JS, 2006, EMBO REP, V7, P874, DOI 10.1038/sj.embor.7400780
   Andersen JS, 2003, NATURE, V426, P570, DOI 10.1038/nature02166
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Barr AR, 2007, J CELL SCI, V120, P2987, DOI 10.1242/jcs.013136
   Barr FA, 2004, NAT REV MOL CELL BIO, V5, P429, DOI 10.1038/nrm1401
   Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041
   Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6
   Bodenmiller B, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100182
   Bodenmiller B, 2007, NAT METHODS, V4, P231, DOI 10.1038/nmeth1005
   Bolshakova N, 2005, BIOINFORMATICS, V21, P451, DOI 10.1093/bioinformatics/bti190
   Bonaldi T, 2008, MOL CELL, V31, P762, DOI 10.1016/j.molcel.2008.07.018
   Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539
   Bose R, 2006, P NATL ACAD SCI USA, V103, P9773, DOI 10.1073/pnas.0603948103
   Collins MO, 2005, J BIOL CHEM, V280, P5972, DOI 10.1074/jbc.M411220200
   Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511
   Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007
   Daum JR, 1998, J BIOL CHEM, V273, P30622, DOI 10.1074/jbc.273.46.30622
   DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909
   Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105
   Diella F, 2008, NUCLEIC ACIDS RES, V36, pD240, DOI 10.1093/nar/gkm772
   DONELLADEANA A, 1991, BIOCHIM BIOPHYS ACTA, V1094, P130, DOI 10.1016/0167-4889(91)90034-U
   Dunn J. C., 1974, Journal of Cybernetics, V4, P95
   Elia AEH, 2003, CELL, V115, P83, DOI 10.1016/S0092-8674(03)00725-6
   Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007
   Faust M, 1999, FEBS LETT, V462, P51, DOI 10.1016/S0014-5793(99)01492-1
   Feng J, 2006, CHROMOSOMA, V115, P320, DOI 10.1007/s00412-006-0049-5
   Grisendi S, 2008, NAT CELL BIOL, V10, P512, DOI 10.1038/ncb0508-512
   Guarguaglini G, 2005, MOL BIOL CELL, V16, P1095, DOI 10.1091/mbc.E04-10-0939
   Guerra B, 1999, ELECTROPHORESIS, V20, P391, DOI 10.1002/(SICI)1522-2683(19990201)20:2<391::AID-ELPS391>3.0.CO;2-N
   Ishihama Y, 2002, J CHROMATOGR A, V979, P233, DOI 10.1016/S0021-9673(02)01402-4
   Jiang W, 1998, MOL CELL, V2, P877, DOI 10.1016/S1097-2765(00)80302-0
   Kolkman A, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100069
   Kraft C, 2003, EMBO J, V22, P6598, DOI 10.1093/emboj/cdg627
   Krogan NJ, 2002, MOL CELL BIOL, V22, P6979, DOI 10.1128/MCB.22.20.6979-6992.2002
   Kufer TA, 2002, J CELL BIOL, V158, P617, DOI 10.1083/jcb.200204155
   Kyono Y, 2008, J PROTEOME RES, V7, P4585, DOI 10.1021/pr800305y
   Larsen MR, 2005, MOL CELL PROTEOMICS, V4, P873, DOI 10.1074/mcp.T500007-MCP200
   Lee J, 2007, MOL CELL PROTEOMICS, V6, P669, DOI 10.1074/mcp.M600218-MCP200
   LEE JC, 1980, BIOCHEMISTRY-US, V19, P6209, DOI 10.1021/bi00567a041
   Lowery DM, 2007, EMBO J, V26, P2262, DOI 10.1038/sj.emboj.7601683
   Lu HJ, 2008, MOL CELL PROTEOMICS, V7, P2073, DOI 10.1074/mcp.M800064-MCP200
   Macek B, 2008, MOL CELL PROTEOMICS, V7, P299, DOI 10.1074/mcp.M700311-MCP200
   MACKAY DR, 2009, MOL BIOL CELL
   MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258
   Miller ML, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1159433
   Mohammed S, 2008, J PROTEOME RES, V7, P1565, DOI 10.1021/pr700635a
   Morgan DO, 2006, CELL CYCLE PRINCIPLE
   Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163
   Neef R, 2007, NAT CELL BIOL, V9, P436, DOI 10.1038/ncb1557
   Nigg EA, 2001, NAT REV MOL CELL BIO, V2, P21, DOI 10.1038/35048096
   Nishizuka S, 2003, P NATL ACAD SCI USA, V100, P14229, DOI 10.1073/pnas.2331323100
   Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103
   Ohsugi M, 2003, EMBO J, V22, P2091, DOI 10.1093/emboj/cdg208
   Ohsugi M, 2008, CELL, V132, P771, DOI 10.1016/j.cell.2008.01.029
   Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026
   Ong SE, 2003, METHODS, V29, P124, DOI 10.1016/S1046-2023(02)00303-1
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   PAI CY, 1995, J CELL SCI, V108, P1911
   Paramasivam M, 2007, CELL CYCLE, V6, P1605, DOI 10.4161/cc.6.13.4356
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i
   Ruchaud S, 2007, NAT REV MOL CELL BIO, V8, P798, DOI 10.1038/nrm2257
   Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200
   Saurin AT, 2008, NAT CELL BIOL, V10, P891, DOI 10.1038/ncb1749
   Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468
   Shiroguchi K, 2003, J BIOL CHEM, V278, P22460, DOI 10.1074/jbc.M212274200
   Sillje HHW, 2006, METHODS, V38, P25, DOI 10.1016/j.ymeth.2005.07.006
   St-Denis NA, 2009, MOL CELL BIOL, V29, P2068, DOI 10.1128/MCB.01563-08
   Stegmeier F, 2004, ANNU REV GENET, V38, P203, DOI 10.1146/annurev.genet.38.072902.093051
   Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200
   Sullivan M, 2007, NAT REV MOL CELL BIO, V8, P894, DOI 10.1038/nrm2276
   Takeda E, 2005, CELL STRUCT FUNCT, V30, P69, DOI 10.1247/csf.30.69
   Takemoto A, 2006, EMBO J, V25, P5339, DOI 10.1038/sj.emboj.7601394
   Tang J, 2008, ONCOGENE, V27, P6635, DOI 10.1038/onc.2008.262
   Tao WA, 2005, NAT METHODS, V2, P591, DOI 10.1038/NMETH776
   Thingholm TE, 2008, MOL CELL PROTEOMICS, V7, P661, DOI 10.1074/mcp.M700362-MCP200
   Trinkle-Mulcahy L, 2006, CURR OPIN CELL BIOL, V18, P623, DOI 10.1016/j.ceb.2006.09.001
   Vader G, 2006, J CELL BIOL, V173, P833, DOI 10.1083/jcb.200604032
   Vagnarelli P, 2006, NAT CELL BIOL, V8, P1133, DOI 10.1038/ncb1475
   Villen J, 2008, NAT PROTOC, V3, P1630, DOI 10.1038/nprot.2008.150
   WELLS NJ, 1994, J BIOL CHEM, V269, P29746
   Wepf A, 2009, NAT METHODS, V6, P203, DOI [10.1038/NMETH.1302, 10.1038/nmeth.1302]
   Wilson-Grady JT, 2008, J PROTEOME RES, V7, P1088, DOI 10.1021/pr7006335
   Yan Wei, 2008, V432, P389, DOI 10.1007/978-1-59745-028-7_26
   Ye KQ, 1998, P NATL ACAD SCI USA, V95, P1601, DOI 10.1073/pnas.95.4.1601
NR 88
TC 92
Z9 92
U1 0
U2 12
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1535-3893
EI 1535-3907
J9 J PROTEOME RES
JI J. Proteome Res.
PD OCT
PY 2009
VL 8
IS 10
BP 4553
EP 4563
DI 10.1021/pr9003773
PG 11
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 501BM
UT WOS:000270353900014
PM 19691289
DA 2021-01-25
ER

PT J
AU Schirmer, T
   Jenal, U
AF Schirmer, Tilman
   Jenal, Urs
TI Structural and mechanistic determinants of c-di-GMP signalling
SO NATURE REVIEWS MICROBIOLOGY
LA English
DT Review
ID CYCLIC DIMERIC GMP; PSEUDOMONAS-FLUORESCENS PF0-1; BACTERIAL RESPONSE
   REGULATORS; PILZ DOMAIN PROTEINS; HD-GYP DOMAIN; BIOFILM FORMATION;
   ESCHERICHIA-COLI; DIGUANYLATE CYCLASE; EAL DOMAIN; ACETOBACTER-XYLINUM
AB Bis-(3'-5')-cyclic dimeric GMP (c-di-GMP) is a ubiquitous second messenger that regulates cell surface-associated traits in bacteria. Components of this regulatory network include GGDEF and EAL domain-containing proteins that determine the cellular concentrations of c-di-GMP by mediating its synthesis and degradation, respectively. Crystal structure analyses in combination with functional studies have revealed the catalytic mechanisms and regulatory principles involved. Downstream, c-di-GMP is recognized by PilZ domain-containing receptors that can undergo large-scale domain rearrangements on ligand binding. Here, we review recent data on the structure and functional properties of the protein families that are involved in c-di-GMP signalling and discuss the mechanistic implications.
C1 [Schirmer, Tilman; Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Schirmer, T (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch; urs.jenal@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF)
FX We thank A. Bohm, J. Malone and C. Massa for critical reading and
   comments. Work carried out in the authors' laboratories and cited in
   this Review has been supported by the Swiss National Science Foundation.
CR ALONI Y, 1982, P NATL ACAD SCI-BIOL, V79, P6448, DOI 10.1073/pnas.79.21.6448
   Amikam D, 2006, BIOINFORMATICS, V22, P3, DOI 10.1093/bioinformatics/bti739
   Ausmees N, 2001, FEMS MICROBIOL LETT, V204, P163, DOI 10.1111/j.1574-6968.2001.tb10880.x
   Bachhawat P, 2007, J BACTERIOL, V189, P5987, DOI 10.1128/JB.00049-07
   Barends TRM, 2009, NATURE, V459, P1015, DOI 10.1038/nature07966
   Benach J, 2007, EMBO J, V26, P5153, DOI 10.1038/sj.emboj.7601918
   Beyhan S, 2008, J BACTERIOL, V190, P7392, DOI 10.1128/JB.00564-08
   BLOMMERS MJJ, 1988, BIOCHEMISTRY-US, V27, P8361, DOI 10.1021/bi00422a011
   Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036
   Boehm A, 2009, MOL MICROBIOL, V72, P1500, DOI 10.1111/j.1365-2958.2009.06739.x
   Boles BR, 2002, J BACTERIOL, V184, P5946, DOI 10.1128/JB.184.21.5946-5954.2002
   Brouillette E, 2005, ANTIMICROB AGENTS CH, V49, P3109, DOI 10.1128/AAC.49.8.3109-3113.2005
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Chang AL, 2001, BIOCHEMISTRY-US, V40, P3420, DOI 10.1021/bi0100236
   Chatterjee S, 2008, P NATL ACAD SCI USA, V105, P2670, DOI 10.1073/pnas.0712236105
   Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200
   Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200
   Christen M, 2007, P NATL ACAD SCI USA, V104, P4112, DOI 10.1073/pnas.0607738104
   Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006
   De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067
   Dow JM, 2006, MOL PLANT MICROBE IN, V19, P1378, DOI 10.1094/MPMI-19-1378
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409
   EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235
   Ferreira RBR, 2008, J BACTERIOL, V190, P851, DOI 10.1128/JB.01462-07
   Fineran PC, 2007, J BACTERIOL, V189, P7653, DOI 10.1128/JB.00671-07
   FREDERICK CA, 1988, BIOCHEMISTRY-US, V27, P8350, DOI 10.1021/bi00422a010
   Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05
   Galperin MY, 2005, BMC MICROBIOL, V5, DOI 10.1186/1471-2180-5-35
   Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002
   Garcia B, 2004, MOL MICROBIOL, V54, P264, DOI 10.1111/j.1365-2958.2004.04269.x
   Girgis HS, 2007, PLOS GENET, V3, P1644, DOI 10.1371/journal.pgen.0030154
   GUAN Y, 1993, J BIOMOL STRUCT DYN, V11, P253, DOI 10.1080/07391102.1993.10508725
   Guvener ZT, 2007, MOL MICROBIOL, V66, P1459, DOI 10.1111/j.1365-2958.2007.06008.x
   Hammer BK, 2009, J BACTERIOL, V191, P169, DOI 10.1128/JB.01307-08
   Hengge R, 2009, NAT REV MICROBIOL, V7, P263, DOI 10.1038/nrmicro2109
   Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x
   Hickman JW, 2005, P NATL ACAD SCI USA, V102, P14422, DOI 10.1073/pnas.0507170102
   Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0
   Holland LM, 2008, J BACTERIOL, V190, P5178, DOI 10.1128/JB.00375-08
   Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423
   Jung A, 2006, J MOL BIOL, V362, P717, DOI 10.1016/j.jmb.2006.07.024
   Karaolis DKR, 2007, J IMMUNOL, V178, P2171, DOI 10.4049/jimmunol.178.4.2171
   Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x
   Klebensberger J, 2007, ENVIRON MICROBIOL, V9, P2247, DOI 10.1111/j.1462-2920.2007.01339.x
   Kumar M, 2008, MICROBIOL-SGM, V154, P2942, DOI 10.1099/mic.0.2008/017806-0
   Lai TH, 2009, J BACTERIOL, V191, P693, DOI 10.1128/JB.01218-08
   Lee VT, 2007, MOL MICROBIOL, V65, P1474, DOI 10.1111/j.1365-2958.2007.05879.x
   Luscombe NM, 2001, NUCLEIC ACIDS RES, V29, P2860, DOI 10.1093/nar/29.13.2860
   Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0
   Mccarthy Y, 2008, MOL PLANT PATHOL, V9, P819, DOI [10.1111/j.1364-3703.2008.00495.x, 10.1111/J.1364-3703.2008.00495.X]
   Meissner A, 2007, ENVIRON MICROBIOL, V9, P2475, DOI 10.1111/j.1462-2920.2007.01366.x
   Merighi M, 2007, MOL MICROBIOL, V65, P876, DOI 10.1111/j.1365-2958.2007.05817.x
   Merritt JH, 2007, J BACTERIOL, V189, P8154, DOI 10.1128/JB.00585-07
   Minasov G, 2009, J BIOL CHEM, V284, P13174, DOI 10.1074/jbc.M808221200
   Monds RD, 2007, MOL MICROBIOL, V63, P656, DOI 10.1111/j.1365-2958.2006.05539.x
   Nakasone Y, 2007, J AM CHEM SOC, V129, P7028, DOI 10.1021/ja065682q
   Nakhamchik A, 2008, APPL ENVIRON MICROB, V74, P4199, DOI 10.1128/AEM.00176-08
   Newell PD, 2009, P NATL ACAD SCI USA, V106, P3461, DOI 10.1073/pnas.0808933106
   Ogunniyi AD, 2008, VACCINE, V26, P4676, DOI 10.1016/j.vaccine.2008.06.099
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045
   Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200
   Pesavento C, 2008, GENE DEV, V22, P2434, DOI 10.1101/gad.475808
   Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903
   Pratt JT, 2007, J BIOL CHEM, V282, P12860, DOI 10.1074/jbc.M611593200
   Rajagopal S, 2004, PHOTOCHEM PHOTOBIOL, V80, P542, DOI 10.1562/0031-8655(2004)080<0542:PAICOA>2.0.CO;2
   Ramelot TA, 2007, PROTEINS, V66, P266, DOI 10.1002/prot.21199
   Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08
   Rao F, 2009, J BACTERIOL, V191, P4722, DOI 10.1128/JB.00327-09
   Rauch A, 2008, P NATL ACAD SCI USA, V105, P15720, DOI 10.1073/pnas.0808473105
   Romling U, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.133pe39
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   Ryan RP, 2006, P NATL ACAD SCI USA, V103, P6712, DOI 10.1073/pnas.0600345103
   Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005
   Ryjenkov DA, 2006, J BIOL CHEM, V281, P30310, DOI 10.1074/jbc.C600179200
   Sabirova JS, 2008, FEMS MICROBIOL LETT, V285, P89, DOI 10.1111/j.1574-6968.2008.01222.x
   Sasakura Y, 2006, ACCOUNTS CHEM RES, V39, P37, DOI 10.1021/ar0501525
   Sasakura Y, 2002, J BIOL CHEM, V277, P23821, DOI 10.1074/jbc.M202738200
   Schmid FFF, 2007, J MOL BIOL, V374, P1270, DOI 10.1016/j.jmb.2007.09.068
   Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005
   Shenoy AR, 2006, FEBS LETT, V580, P3344, DOI 10.1016/j.febslet.2006.05.034
   Shenoy AR, 2006, TRENDS MICROBIOL, V14, P543, DOI 10.1016/j.tim.2006.10.005
   Simm R, 2009, ANAL BIOCHEM, V386, P53, DOI 10.1016/j.ab.2008.12.013
   Sinha SC, 2007, REV PHYSIOL BIOCH P, V157, P105, DOI 10.1007/112_0603
   Srivatsan A, 2008, CURR OPIN MICROBIOL, V11, P100, DOI 10.1016/j.mib.2008.02.001
   Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519
   Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606
   Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998
   Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200
   Tamayo R, 2008, INFECT IMMUN, V76, P1617, DOI 10.1128/IAI.01337-07
   Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426
   Tanaka A, 2007, J BIOL CHEM, V282, P21301, DOI 10.1074/jbc.M701920200
   Tarutina M, 2006, J BIOL CHEM, V281, P34751, DOI 10.1074/jbc.M604819200
   Tschowri N, 2009, GENE DEV, V23, P522, DOI 10.1101/gad.499409
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x
   Witte G, 2008, MOL CELL, V30, P167, DOI 10.1016/j.molcel.2008.02.020
   Wolfe AJ, 2008, J BACTERIOL, V190, P463, DOI 10.1128/JB.01418-07
   Yildiz FH, 2008, J BACTERIOL, V190, P781, DOI 10.1128/JB.01852-07
   Zhang ZY, 2006, J AM CHEM SOC, V128, P7015, DOI 10.1021/ja0613714
NR 100
TC 349
Z9 359
U1 1
U2 103
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1740-1526
J9 NAT REV MICROBIOL
JI Nat. Rev. Microbiol.
PD OCT
PY 2009
VL 7
IS 10
BP 724
EP 735
DI 10.1038/nrmicro2203
PG 12
WC Microbiology
SC Microbiology
GA 494QU
UT WOS:000269831000017
PM 19756011
DA 2021-01-25
ER

PT J
AU Perrot, M
   Moes, S
   Massoni, A
   Jenoe, P
   Boucherie, H
AF Perrot, Michel
   Moes, Suzette
   Massoni, Aurelie
   Jenoe, Paul
   Boucherie, Helian
TI Yeast proteome map (last update)
SO PROTEOMICS
LA English
DT Article
DE Microbiology; Saccharomyces cerevisiae; Yeast
ID RESOLUTION 2-DIMENSIONAL ELECTROPHORESIS; SACCHAROMYCES-CEREVISIAE;
   MASS-SPECTROMETRY; PROTEINS; IDENTIFICATION
AB The identification of proteins separated on 2-D gels is essential to exploit the full potential of 2-D gel electrophoresis for proteomic investigations. For this purpose we have undertaken the systematic identification of Saccharomyces cerevisiae proteins separated on 2-D gels. We report here the identification by mass spectrometry of 100 novel yeast protein spots that have so far not been tackled due to their scarcity on our standard 2-D gels. These identifications extend the number of protein spots identified on our yeast 2-D proteome map to 716. They correspond to 485 unique proteins. Among these, 154 were resolved into several isoforms. The present data set can now be expanded to report for the first time a map of 363 protein isoforms that significantly deepens our knowledge of the yeast proteome. The reference map and a list of all identified proteins can be accessed on the Yeast Protein Map server (www.ibgc.u-bordeaux2.fr/YPM).
C1 [Perrot, Michel; Massoni, Aurelie; Boucherie, Helian] CNRS, UMR 5095, IBGC, F-33077 Bordeaux, France.
   [Moes, Suzette; Jenoe, Paul] Univ Basel, Biozentrum, Dept Biochem, CH-4003 Basel, Switzerland.
RP Boucherie, H (corresponding author), CNRS, UMR 5095, IBGC, 1 Rue Camille St Saens, F-33077 Bordeaux, France.
EM H.Boucherie@ibgc.u-bordeaux2.fr
CR Arago Francois, 1839, CR HEBD ACAD SCI, V9, p[250, 260]
   BOUCHERIE H, 1995, YEAST, V11, P601, DOI 10.1002/yea.320110702
   Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301
   Garrels JI, 1997, ELECTROPHORESIS, V18, P1347, DOI 10.1002/elps.1150180810
   Gygi SP, 1999, MOL CELL BIOL, V19, P1720, DOI 10.1128/mcb.19.3.1720
   KLOSE J, 1975, HUMANGENETIK, V26, P231
   Kobi D, 2004, FEMS YEAST RES, V5, P213, DOI 10.1016/j.femsyr.2004.07.004
   Kolkman A, 2005, TRENDS BIOTECHNOL, V23, P598, DOI 10.1016/j.tibtech.2005.09.004
   LUDWIG JR, 1982, MOL CELL BIOL, V2, P117, DOI 10.1128/MCB.2.2.117
   Maillet I, 1996, J BIOL CHEM, V271, P10263, DOI 10.1074/jbc.271.17.10263
   MASSONI A, 2009, PROTEOMICS IN PRESS, V9, DOI DOI 10.1002/PMIC.200800965
   OFARRELL PH, 1975, J BIOL CHEM, V250, P4007
   OFARRELL PZ, 1977, CELL, V12, P1133, DOI 10.1016/0092-8674(77)90176-3
   Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200
   Peng JM, 2003, J PROTEOME RES, V2, P43, DOI 10.1021/pr025556v
   Perrot M, 2008, YEAST, V25, P513, DOI 10.1002/yea.1602
   Perrot M, 2007, PROTEOMICS, V7, P1117, DOI 10.1002/pmic.200600952
   Sarry JE, 2007, FEBS J, V274, P4287, DOI 10.1111/j.1742-4658.2007.05959.x
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Washburn MP, 2001, NAT BIOTECHNOL, V19, P242, DOI 10.1038/85686
   Wildgruber R, 2002, PROTEOMICS, V2, P727, DOI 10.1002/1615-9861(200206)2:6<727::AID-PROT727>3.0.CO;2-2
   Yin ZK, 2004, PROTEOMICS, V4, P2425, DOI 10.1002/pmic.200300760
NR 22
TC 10
Z9 10
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD OCT
PY 2009
VL 9
IS 20
BP 4669
EP 4673
DI 10.1002/pmic.200900273
PG 5
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 516PG
UT WOS:000271554100011
PM 19743426
DA 2021-01-25
ER

PT J
AU Massoni, A
   Moes, S
   Perrot, M
   Jenoe, P
   Boucherie, H
AF Massoni, Aurelie
   Moes, Suzette
   Perrot, Michel
   Jenoe, Paul
   Boucherie, Helian
TI Exploring the dynamics of the yeast proteome by means of 2-DE
SO PROTEOMICS
LA English
DT Article
DE Microbiology; Proteome; PTM; Saccharomyces cerevisiae; Turnover; Yeast
ID SACCHAROMYCES-CEREVISIAE; SEQUENCE REQUIREMENTS; TERMINAL ACETYLATION;
   MUTATIONAL ANALYSIS; MASS-SPECTROMETRY; PROTEINS; PHOSPHORYLATION; ACID;
   IDENTIFICATION; EXPRESSION
AB In this study we combined pulse chase experiments and 2-DE in order to investigate how newly synthesized proteins are processed or modified to yield a functional yeast proteome. This approach allowed us to follow the fate of 560 native yeast proteins from the time they were synthesized up to several hours later. Among these, 81 were observed to vary during the chase, either increasing or decreasing. In addition, 60 were found to be modified immediately after their synthesis. Taking advantage of protein identifications, we characterized a wide variety of post-translational events responsible for these changes, such as protein turnover, protein maturation and different types of PTMs. These events operate over very different time scales, ranging from the brief period required for co-translational modifications to one generation time or more. In light of these results, the functional proteome of exponentially growing cells appears to be the product of a permanent remodelling process that modifies native proteins far beyond the time they have been synthesized. This study also allowed us to obtain information on the half-lives of 260 abundant yeast proteins.
C1 [Massoni, Aurelie; Perrot, Michel; Boucherie, Helian] CNRS, IBGC, UMR 5095, F-33077 Bordeaux, France.
   [Moes, Suzette; Jenoe, Paul] Univ Basel, Biozentrum, Dept Biochem, CH-4003 Basel, Switzerland.
RP Boucherie, H (corresponding author), CNRS, IBGC, UMR 5095, 1 Rue Camille St Saens, F-33077 Bordeaux, France.
EM H.Boucherie@ibgc.u-bordeaux2.fr
CR Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103
   Beyer A, 2004, MOL CELL PROTEOMICS, V3, P1083, DOI 10.1074/mcp.M400099-MCP200
   Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075
   BOONCHIRD C, 1991, EUR J BIOCHEM, V199, P325, DOI 10.1111/j.1432-1033.1991.tb16128.x
   BOUCHERIE H, 2006, YEAST PROTOCOLS, P47
   Boucherie Helian, 2008, V424, P125, DOI 10.1007/978-1-60327-064-9_11
   Clarke S, 2003, AGEING RES REV, V2, P263, DOI 10.1016/S1568-1637(03)00011-4
   Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301
   Futcher B, 1999, MOL CELL BIOL, V19, P7357
   Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n
   Gey U, 2008, J BIOL CHEM, V283, P9759, DOI 10.1074/jbc.M708779200
   Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046
   Haurie V, 2004, PROTEOMICS, V4, P364, DOI 10.1002/pmic.200300564
   Kim S, 2007, FEBS LETT, V581, P1209, DOI 10.1016/j.febslet.2007.02.032
   Kimura Y, 2000, J BIOL CHEM, V275, P4635, DOI 10.1074/jbc.275.7.4635
   KLIER H, 1993, FEBS LETT, V334, P360, DOI 10.1016/0014-5793(93)80712-4
   KLIONSKY DJ, 1992, J CELL BIOL, V119, P287, DOI 10.1083/jcb.119.2.287
   Lee WC, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-440
   Lehmann A, 2002, J MOL BIOL, V317, P401, DOI 10.1006/jmbi.2002.5443
   Liu SH, 2004, MOL CELL BIOL, V24, P9487, DOI 10.1128/MCB.24.21.9487-9497.2004
   MORTIMER RK, 1986, GENETICS, V113, P35
   Perrot M, 2008, YEAST, V25, P513, DOI 10.1002/yea.1602
   Perrot M, 2007, PROTEOMICS, V7, P1117, DOI 10.1002/pmic.200600952
   Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X
   Pratt JM, 2002, MOL CELL PROTEOMICS, V1, P579, DOI 10.1074/mcp.M200046-MCP200
   Reinders J, 2007, MOL CELL PROTEOMICS, V6, P1896, DOI 10.1074/mcp.M700098-MCP200
   Ubersax JA, 2003, NATURE, V425, P859, DOI 10.1038/nature02062
   Wagner E, 2002, BIOCHEM J, V366, P777, DOI 10.1042/BJ20020525
   WERTMAN KF, 1992, GENETICS, V132, P337
   Zhou HL, 2001, NAT BIOTECHNOL, V19, P375, DOI 10.1038/86777
NR 30
TC 8
Z9 10
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD OCT
PY 2009
VL 9
IS 20
BP 4674
EP 4685
DI 10.1002/pmic.200800965
PG 12
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 516PG
UT WOS:000271554100012
PM 19795422
DA 2021-01-25
ER

PT J
AU Cailleau, G
   Verrecchia, EP
   Braissant, O
   Emmanuel, L
AF Cailleau, Guillaume
   Verrecchia, Eric P.
   Braissant, Olivier
   Emmanuel, Laurent
TI The biogenic origin of needle fibre calcite
SO SEDIMENTOLOGY
LA English
DT Article
DE Biomineralization; calcite; crystal growth; stable isotopes; vadose zone
ID BRITISH-WEST-INDIES; FUNGAL HYPHAE; IVORY-COAST; CAYMAN BRAC;
   MORPHOLOGY; CARBONATE; ACCUMULATIONS; ENVIRONMENT; DIAGENESIS; CRYSTALS
AB Needle fibre calcite is one of the most ubiquitous habits of calcite in vadose environments (caves deposits, soil pores, etc.). Its origin, either through inorganic, indirect or direct biological processes, has long been debated. In this study, investigations at 11 sites in Europe, Africa and Central America support arguments for its biogenic origin. The wide range of needle morphologies is the result of a gradual evolution of the simplest type, a rod. This rod is the elementary brick which, by aggregation and welding, builds more complex needles. The absence of cross-welded needles implies that they are welded in a mould, or under a longitudinal and unidirectional constraint, before being released inside the soil pores. The difference between the lengthening of the needles and the c axis can be explained by the existence of needles observed under a scanning electron microscope in organic sleeves, which can act as a mould during rod growth. Complex morphologies with epitaxial outgrowths on straight rods cannot have grown entirely inside organic microtubes; they must result from soil diagenesis after the release of straight rods in a soil-free medium. Whisker crystals are interpreted as the result of growth and coalescence of euhedral crystals on a rod. Rhomb chains are considered to be the consequence of successive epitaxial growth steps on a needle during variations in growth conditions. Isotopic signatures for needle fibre calcite vary from -16 center dot 63 parts per thousand to +1 center dot 10 parts per thousand and from -8 center dot 63 parts per thousand to -2 center dot 25 parts per thousand for delta 13C and delta 18O, respectively. The absence of high delta 18O values for needle fibre calcite precludes a purely physicochemical origin (evaporative) for this particular habit of calcite. As epitaxial growth cannot precipitate in the same conditions as initial needles, needle fibre calcite stable isotopic signatures should be used with caution as a proxy for palaeoenvironmental reconstructions. In addition, it is suggested that the term needle fibre calcite should be kept for the original biogenic form. The other habit should be referred to as epitaxial forms of needle fibre calcite.
C1 [Cailleau, Guillaume; Verrecchia, Eric P.] Univ Lausanne, Inst Geol & Paleontol, CH-1015 Lausanne, Switzerland.
   [Braissant, Olivier] Univ Basel, Biozentrum, Pharmazentrum, CH-4012 Basel, Switzerland.
   [Emmanuel, Laurent] Univ Paris 06, Lab Biomineralisat & Paleoenvironm, F-75252 Paris 05, France.
RP Cailleau, G (corresponding author), Univ Lausanne, Inst Geol & Paleontol, CH-1015 Lausanne, Switzerland.
EM eric.verrecchia@unil.ch
RI Cailleau, Guillaume/A-5229-2010; Braissant, Olivier/AAO-2371-2020;
   Braissant, Olivier/H-2284-2012; EMMANUEL, Laurent/E-6145-2013
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X; 
FU Swiss National FoundationSwiss National Science Foundation (SNSF)
   [2153-065174, 205320-101564]
FX The authors would like to thank Dr C. Durlet for Mexican samples, Prof.
   C. Dupraz for valuable discussions, Dr M. Dadras, M. Vlimant and M.
   Leboeuf for SEM and TEM support, and M. Lettingue for field work. Many
   thanks to two anonymous reviewers and Professor Peter Swart for their
   substantial help in improving this manuscript. This research has been
   funded by the Swiss National Foundation for scientific research, grants
   no. 2153-065174 and 205320-101564.
CR Bajnoczi B, 2006, CHEM ERDE-GEOCHEM, V66, P203, DOI 10.1016/j.chemer.2005.11.002
   BeczeDeak J, 1997, GEODERMA, V76, P221, DOI 10.1016/S0016-7061(96)00106-1
   Borsato A, 2000, J SEDIMENT RES, V70, P1171, DOI 10.1306/032300701171
   Braissant O, 2004, GEOBIOLOGY, V2, P59, DOI 10.1111/j.1472-4677.2004.00019.x
   Cailleau G, 2005, CATENA, V59, P1, DOI 10.1016/j.catena.2004.06.002
   Cailleau G, 2004, NATURWISSENSCHAFTEN, V91, P191, DOI 10.1007/s00114-004-0512-1
   CALLOT G, 1985, AGRONOMIE, V5, P209, DOI 10.1051/agro:19850303
   CALLOT G, 1985, AGRONOMIE, V5, P143, DOI 10.1051/agro:19850207
   CAROZZI AV, 1967, J SEDIMENT PETROL, V37, P597
   Cerling T. E., 1999, INT ASS SEDIMENTOLOG, V27, P43
   CERLING TE, 1984, EARTH PLANET SC LETT, V71, P229, DOI 10.1016/0012-821X(84)90089-X
   GESSNER K, 1555, LUCERNAE
   Harrison R. S., 1977, B CAN PETROL GEOL, V25, P123
   IWANOFF L. L., 1906, ANN GEOLOGIE MINERAL, V8, P23
   JAMES NP, 1972, J SEDIMENT PETROL, V42, P817
   JONES B, 1988, B CAN PETROL GEOL, V36, P191
   JONES B, 1988, J SEDIMENT PETROL, V58, P457
   JONES B, 1993, J SEDIMENT PETROL, V63, P1018
   LACROIX A, 1901, MINERALOGIE FRANCE S, V3
   Loisy C, 1999, SEDIMENT GEOL, V126, P193, DOI 10.1016/S0037-0738(99)00040-8
   LOISY C, 1997, THESIS U REIMS CHAMP
   MITTERER RM, 1985, SPEC PUBL SOC EC PAL, V36, P17, DOI DOI 10.2110/PEC.85.36.0017
   Mouchet POJ, 1998, ECLOGAE GEOL HELV, V91, P53
   MUGGE O., 1914, ZENTRALBLATT MINERAL, P673
   PHILLIPS SE, 1987, AUST J SOIL RES, V25, P429, DOI 10.1071/SR9870429
   Riche G., 1982, Cahiers ORSTOM Pedologie, V19, P257
   STOOPS GJ, 1976, AM MINERAL, V61, P172
   STRONG GE, 1992, SEDIMENTOLOGY, V39, P333, DOI 10.1111/j.1365-3091.1992.tb01042.x
   SUPKO P. R., 1971, STUDIES GEOLOGY, V19, P143
   VERGES V, 1982, B MINERAL, V105, P351
   VERRECCHIA EP, 1994, J SEDIMENT RES A, V64, P650
   Verrecchia EP, 2000, MICROBIAL SEDIMENTS, P68
NR 32
TC 62
Z9 67
U1 0
U2 20
PU WILEY-BLACKWELL
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0037-0746
EI 1365-3091
J9 SEDIMENTOLOGY
JI Sedimentology
PD OCT
PY 2009
VL 56
IS 6
BP 1858
EP 1875
DI 10.1111/j.1365-3091.2009.01060.x
PG 18
WC Geology
SC Geology
GA 495GG
UT WOS:000269878000014
DA 2021-01-25
ER

PT J
AU Boudko, SP
   Sasaki, T
   Engel, J
   Lerch, TF
   Nix, J
   Chapman, MS
   Bachinger, HP
AF Boudko, Sergei P.
   Sasaki, Takako
   Engel, Juergen
   Lerch, Thomas F.
   Nix, Jay
   Chapman, Michael S.
   Baechinger, Hans Peter
TI Crystal Structure of Human Collagen XVIII Trimerization Domain: A Novel
   Collagen Trimerization Fold
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE collagens XVIII and XV; crystal structure; trimerization domain;
   non-collagenous domain; endostatin
ID P22 TAILSPIKE PROTEIN; HELICAL COILED-COIL; OLIGOMERIZATION DOMAIN;
   TISSUE DISTRIBUTION; BINDING PROTEIN; NC1 DOMAIN; C-TERMINUS;
   ENDOSTATIN; STABILIZATION; CHAIN
AB Collagens contain a unique triple-helical structure with a repeating sequence -G-X-Y-, where proline and hydroxyproline are major constituents in X and Y positions, respectively. Folding of the collagen triple helix requires trimerization domains. Once trimerized, collagen chains are correctly aligned and the folding of the triple helix proceeds in a zipper-like fashion. Here we report the isolation, characterization, and crystal structure of the trimerization domain of human type XVIII collagen, a member of the multiplexin family. This domain differs from all other known trimerization domains in other collagens and exhibits a high trimerization potential at picomolar concentrations. Strong chain association and high specificity of binding are needed for multiplexins, which are present at very low levels. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Boudko, Sergei P.; Sasaki, Takako; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA.
   [Boudko, Sergei P.; Sasaki, Takako; Lerch, Thomas F.; Chapman, Michael S.; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.
   [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Nix, Jay] Univ Calif Berkeley, Lawrence Berkeley Lab, Mol Biol Consortium, Adv Light Source Beamline 422, Berkeley, CA 94720 USA.
RP Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
EM hpb@shcc.org
OI Chapman, Michael/0000-0001-8525-8585
FU Shriners Hospital for Children; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM066875, R01GM066875, R01GM066875,
   R01GM066875, R01GM066875, R01GM066875, R01GM066875, R01GM066875,
   R01GM066875, R01GM066875, R01GM066875, R01GM066875, R01GM066875] Funding
   Source: NIH RePORTER
FX This work was supported by a grant from Shriners Hospital for Children.
CR ABE N, 1993, BIOCHEM BIOPH RES CO, V196, P576, DOI 10.1006/bbrc.1993.2288
   Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   Areida SK, 2001, J BIOL CHEM, V276, P1594, DOI 10.1074/jbc.M008709200
   BACHINGER HP, 1981, J BIOL CHEM, V256, P3193
   Bachmann A, 2005, P NATL ACAD SCI USA, V102, P13897, DOI 10.1073/pnas.0505141102
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bogin O, 2002, STRUCTURE, V10, P165, DOI 10.1016/S0969-2126(02)00697-4
   Boudko SP, 2007, J MOL BIOL, V366, P1538, DOI 10.1016/j.jmb.2006.12.046
   Boudko SP, 2008, J BIOL CHEM, V283, P34345, DOI 10.1074/jbc.M806352200
   Boudko SP, 2004, J MOL BIOL, V339, P927, DOI 10.1016/j.jmb.2004.04.001
   Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054
   Boulegue C, 2008, ANTIOXID REDOX SIGN, V10, P113, DOI 10.1089/ars.2007.1868
   Brodsky B, 2008, BIOPOLYMERS, V89, P345, DOI 10.1002/bip.20958
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Cao Y, 2008, ADV CANCER RES, V100, P113, DOI 10.1016/S0065-230X(08)00004-3
   DEMELER B, ULTRASCAN VERSION 9
   Dhanabal M, 1999, CANCER RES, V59, P189
   Dhanabal M, 1999, J BIOL CHEM, V274, P11721, DOI 10.1074/jbc.274.17.11721
   DION AS, 1987, J MOL BIOL, V193, P127, DOI 10.1016/0022-2836(87)90632-2
   Dixelius J, 2000, BLOOD, V95, P3403, DOI 10.1182/blood.V95.11.3403.011k07_3403_3411
   DOEGE KJ, 1986, J BIOL CHEM, V261, P8924
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   FESSLER LI, 1974, J BIOL CHEM, V249, P7637
   Folkman J, 2006, EXP CELL RES, V312, P594, DOI 10.1016/j.yexcr.2005.11.015
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Gage MJ, 2003, PROTEIN SCI, V12, P2732, DOI 10.1110/ps.03150303
   GREENE RF, 1974, J BIOL CHEM, V249, P5388
   Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020
   Hakansson K, 1999, STRUCTURE, V7, P255, DOI 10.1016/S0969-2126(99)80036-7
   Halfter W, 1998, J BIOL CHEM, V273, P25404, DOI 10.1074/jbc.273.39.25404
   Hendrickson WA, 1997, METHOD ENZYMOL, V276, P494, DOI 10.1016/S0076-6879(97)76074-9
   Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507
   HOPPE HJ, 1994, FEBS LETT, V344, P191, DOI 10.1016/0014-5793(94)00383-1
   HYNES WL, 1995, INFECT IMMUN, V63, P3015, DOI 10.1128/IAI.63.8.3015-3020.1995
   Khoshnoodi J, 2006, J BIOL CHEM, V281, P38117, DOI 10.1074/jbc.R600025200
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Kuo CJ, 2001, J CELL BIOL, V152, P1233, DOI 10.1083/jcb.152.6.1233
   Kvansakul M, 2003, MATRIX BIOL, V22, P145, DOI 10.1016/S0945-053X(02)00119-1
   LEES JF, 1994, J BIOL CHEM, V269, P24354
   Li DQ, 2000, J BIOL CHEM, V275, P22339, DOI 10.1074/jbc.M000519200
   McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200
   Myers JC, 2007, BIOCHEM J, V404, P535, DOI 10.1042/BJ20070201
   MYERS JK, 1995, PROTEIN SCI, V4, P2138, DOI 10.1002/pro.5560041020
   OH SP, 1994, P NATL ACAD SCI USA, V91, P4229, DOI 10.1073/pnas.91.10.4229
   OReilly MS, 1997, CELL, V88, P277, DOI 10.1016/S0092-8674(00)81848-6
   Pace C N, 1986, Methods Enzymol, V131, P266
   Pakkanen O, 2003, J BIOL CHEM, V278, P32478, DOI 10.1074/jbc.M304405200
   Parry DAD, 2008, J STRUCT BIOL, V163, P258, DOI 10.1016/j.jsb.2008.01.016
   REHN M, 1994, J BIOL CHEM, V269, P13929
   REHN M, 1994, P NATL ACAD SCI USA, V91, P4234, DOI 10.1073/pnas.91.10.4234
   Saarela J, 1998, MATRIX BIOL, V16, P319, DOI 10.1016/S0945-053X(98)90003-8
   Lobo VJSA, 2006, INT J CANCER, V119, P455, DOI 10.1002/ijc.21851
   Sasaki T, 2000, J MOL BIOL, V301, P1179, DOI 10.1006/jmbi.2000.3996
   Sasaki T, 1998, EMBO J, V17, P4249, DOI 10.1093/emboj/17.15.4249
   SHERIFF S, 1994, NAT STRUCT BIOL, V1, P789, DOI 10.1038/nsb1194-789
   Snellman A, 2000, EMBO J, V19, P5051, DOI 10.1093/emboj/19.19.5051
   Standker L, 1997, FEBS LETT, V420, P129, DOI 10.1016/S0014-5793(97)01503-2
   STEINBACHER S, 1994, SCIENCE, V265, P383, DOI 10.1126/science.8023158
   Stetefeld J, 2003, STRUCTURE, V11, P339, DOI 10.1016/S0969-2126(03)00025-X
   Sundaramoorthy M, 2002, J BIOL CHEM, V277, P31142, DOI 10.1074/jbc.M201740200
   Than ME, 2002, P NATL ACAD SCI USA, V99, P6607, DOI 10.1073/pnas.062183499
   Walter M, 2008, J VIROL, V82, P2265, DOI 10.1128/JVI.01641-07
   Webber T, 2009, BIOCHEM J, V419, P595, DOI 10.1042/BJ20081449
   WEIS WI, 1994, STRUCTURE, V2, P1227, DOI 10.1016/S0969-2126(94)00124-3
   Yamaguchi N, 1999, EMBO J, V18, P4414, DOI 10.1093/emboj/18.16.4414
NR 65
TC 28
Z9 28
U1 3
U2 8
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD SEP 25
PY 2009
VL 392
IS 3
BP 787
EP 802
DI 10.1016/j.jmb.2009.07.057
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 500QE
UT WOS:000270317700019
PM 19631658
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Klein, UR
   Nigg, EA
AF Klein, Ulf R.
   Nigg, Erich A.
TI SUMO-dependent regulation of centrin-2
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Centrins; Centrin-2; XPC; SUMO; hPC2; Nucleocytoplasmic shuttling
ID NUCLEOTIDE EXCISION-REPAIR; GROUP-C PROTEIN; DAMAGE RECOGNITION; XPC
   PROTEIN; DNA-DAMAGE; CENTROSOME; COMPLEX; CELLS; SENP3; UBIQUITYLATION
AB Centrins are multifunctional Ca(2+)-binding proteins that are highly conserved from yeast to humans. Centrin-2 is a core component of the centrosome of higher eukaryotes. In addition, it is present within the nucleus, in which it is part of the xeroderma pigmentosum group C (XPC) complex, which controls nucleotide excision repair (NER). Regulation of the subcellular distribution of centrin-2 has so far remained elusive. Here we show that centrin-2 is a substrate of SUMOylation in vitro and in vivo, and that it is preferentially modified by SUMO2/3. Moreover, we identify the SUMO E3-like ligase human polycomb protein 2 (PC2; also known as hPC2) as essential for centrin-2 modification. Interference with the SUMOylation pathway leads to a striking defect in nuclear localization of centrin-2 and accumulation in the cytoplasm, whereas centrosomal recruitment of centrin-2 is unaffected. Depletion of the XPC protein mimics this situation and we provide evidence that SUMO conjugation of centrin-2 enhances its binding to the XPC protein. These data show that the nucleocytoplasmic shuttling of centrin-2 depends on the SUMO system and indicates that localization of centrin-2 within the nucleus depends on its ability to bind to the XPC protein.
C1 [Klein, Ulf R.; Nigg, Erich A.] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
   [Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Klein, UR (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.
EM uklein@biochem.mpg.de
OI nigg, erich/0000-0003-4835-5719
FU Max-Planck-SocietyMax Planck Society; Boehringer Ingelheim
   FondsBoehringer Ingelheim
FX We are grateful to Fumio Hanaoka for providing the anti-XPC antibody
   used for initial experiments, Michel Bornens for providing
   anti-centrin-3 antibody, Frauke Melchior for anti-RanGAP1 antibody, and
   the 'centrosome lab' for discussions, constructs and help. We
   specifically thank Julia Kleylein-Sohn and Stefan Muller for sharing
   unpublished data and Mikael LeClech for help. We also thank Stefan
   Muller for critical reading of the manuscript. This work was supported
   by the Max-Planck-Society and a fellowship from the Boehringer Ingelheim
   Fonds to U. R. K.
CR Anckar J, 2007, BIOCHEM SOC T, V35, P1409, DOI 10.1042/BST0351409
   Araki M, 2001, J BIOL CHEM, V276, P18665, DOI 10.1074/jbc.M100855200
   Batty DP, 2000, GENE, V241, P193, DOI 10.1016/S0378-1119(99)00489-8
   Blomster HA, 2009, MOL CELL PROTEOMICS, V8, P1382, DOI 10.1074/mcp.M800551-MCP200
   Bornens M, 2007, ADV EXP MED BIOL, V607, P119
   Charbonnier JB, 2007, J MOL BIOL, V373, P1032, DOI 10.1016/j.jmb.2007.08.046
   Cheng TS, 2006, LIFE SCI, V78, P1114, DOI 10.1016/j.lfs.2005.06.021
   de Laat WL, 1999, GENE DEV, V13, P768, DOI 10.1101/gad.13.7.768
   den Dulk B, 2008, DNA REPAIR, V7, P858, DOI 10.1016/j.dnarep.2008.02.004
   Despras E, 2007, CANCER RES, V67, P2526, DOI 10.1158/0008-5472.CAN-06-3371
   Fischer T, 2004, NAT CELL BIOL, V6, P840, DOI 10.1038/ncb1163
   Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293
   Gill G, 2004, GENE DEV, V18, P2046, DOI 10.1101/gad.1214604
   Haindl M, 2008, EMBO REP, V9, P273, DOI 10.1038/embor.2008.3
   Hay RT, 2007, TRENDS CELL BIOL, V17, P370, DOI 10.1016/j.tcb.2007.08.002
   Hay RT, 2005, MOL CELL, V18, P1, DOI 10.1016/j.molcel.2005.03.012
   Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118
   Kagey MH, 2005, EMBO J, V24, P108, DOI 10.1038/sj.emboj.7600506
   Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133
   Klein UR, 2009, MOL BIOL CELL, V20, P410, DOI 10.1091/mbc.E08-05-0511
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   Muller S, 2000, J BIOL CHEM, V275, P13321, DOI 10.1074/jbc.275.18.13321
   Muller S, 2004, ONCOGENE, V23, P1998, DOI 10.1038/sj.onc.1207415
   Nishi R, 2005, MOL CELL BIOL, V25, P5664, DOI 10.1128/MCB.25.13.5664-5674.2005
   Paoletti A, 1996, J CELL SCI, V109, P3089
   Pereira G, 2001, CURR OPIN CELL BIOL, V13, P762, DOI 10.1016/S0955-0674(00)00281-7
   Popescu A, 2003, J BIOL CHEM, V278, P40252, DOI 10.1074/jbc.M302546200
   Prosser SL, 2009, MOL CELL BIOL, V29, P1760, DOI 10.1128/MCB.01124-08
   Resendes KK, 2008, MOL CELL BIOL, V28, P1755, DOI 10.1128/MCB.01697-07
   Salisbury JL, 2007, J CELL PHYSIOL, V213, P420, DOI 10.1002/jcp.21226
   Salisbury JL, 2002, CURR BIOL, V12, P1287, DOI 10.1016/S0960-9822(02)01019-9
   Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035
   Sugasawa K, 1996, MOL CELL BIOL, V16, P4852
   Sugasawa K, 2007, NAT STRUCT MOL BIOL, V14, P887, DOI 10.1038/nsmb1007-887
   Thoma BS, 2003, MOL CARCINOGEN, V38, P1, DOI 10.1002/mc.10143
   Thompson JR, 2006, J BIOL CHEM, V281, P18746, DOI 10.1074/jbc.M513667200
   Vertegaal ACO, 2006, MOL CELL PROTEOMICS, V5, P2298, DOI 10.1074/mcp.M600212-MCP200
   Wang QE, 2005, NUCLEIC ACIDS RES, V33, P4023, DOI 10.1093/nar/gki684
   Wang QE, 2007, NUCLEIC ACIDS RES, V35, P5338, DOI 10.1093/nar/gkm550
   Watts FZ, 2007, CHROMOSOMA, V116, P15, DOI 10.1007/s00412-006-0079-z
   Wotton D, 2007, BIOCHEM SOC T, V35, P1401, DOI 10.1042/BST0351401
   Yang SH, 2005, EMBO J, V24, P2161, DOI 10.1038/sj.emboj.7600690
   Yun CW, 2008, J CELL BIOL, V183, P589, DOI 10.1083/jcb.200807185
NR 43
TC 38
Z9 40
U1 0
U2 8
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD SEP 15
PY 2009
VL 122
IS 18
BP 3312
EP 3321
DI 10.1242/jcs.050245
PG 10
WC Cell Biology
SC Cell Biology
GA 490RR
UT WOS:000269521900013
PM 19706679
OA Bronze
DA 2021-01-25
ER

PT J
AU Jensen, MR
   Markwick, PRL
   Meier, S
   Griesinger, C
   Zweckstetter, M
   Grzesiek, S
   Bernado, P
   Blackledge, M
AF Jensen, Malene Ringkjobing
   Markwick, Phineus R. L.
   Meier, Sebastian
   Griesinger, Christian
   Zweckstetter, Markus
   Grzesiek, Stephan
   Bernado, Pau
   Blackledge, Martin
TI Quantitative Determination of the Conformational Properties of Partially
   Folded and Intrinsically Disordered Proteins Using NMR Dipolar Couplings
SO STRUCTURE
LA English
DT Review
ID NATIVELY UNFOLDED PROTEINS; 8 M UREA; LONG-RANGE INTERACTIONS;
   CHEMICAL-SHIFT DATA; X-RAY-SCATTERING; ALPHA-SYNUCLEIN; SECONDARY
   STRUCTURE; DENATURED STATE; UNSTRUCTURED PROTEINS; MOLECULAR RECOGNITION
C1 [Jensen, Malene Ringkjobing; Markwick, Phineus R. L.; Bernado, Pau; Blackledge, Martin] CEA, CNRS, UJF, Inst Biol Struct,UMR 5075, F-38027 Grenoble, France.
   [Meier, Sebastian; Grzesiek, Stephan] Max Planck Inst Biophys Chem, Dept NMR Based Struct Biol, D-37077 Gottingen, Germany.
   [Griesinger, Christian; Zweckstetter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Blackledge, M (corresponding author), CEA, CNRS, UJF, Inst Biol Struct,UMR 5075, 41 Rue Jules Horowitz, F-38027 Grenoble, France.
EM martin.blackledge@ibs.fr
RI Bernado, Pau/F-9643-2013; Meier, Sebastian/A-4279-2015
OI Meier, Sebastian/0000-0003-3761-3217; Zweckstetter,
   Markus/0000-0002-2536-6581; Grzesiek, Stephan/0000-0003-1998-4225;
   Bernado, Pau/0000-0001-7395-5922; Jensen, Malene R./0000-0003-0419-2196
CR Alexandrescu AT, 2003, PROTEIN SCI, V12, P2132, DOI 10.1110/ps.03164403
   ALEXANDRESCU AT, 1994, BIOCHEMISTRY-US, V33, P1063, DOI 10.1021/bi00171a004
   Almond A, 2002, J AM CHEM SOC, V124, P9986, DOI 10.1021/ja026876i
   Aloy P, 2004, NAT BIOTECHNOL, V22, P1317, DOI 10.1038/nbt1018
   Andronesi OC, 2008, J AM CHEM SOC, V130, P5922, DOI 10.1021/ja7100517
   Bax A, 2003, PROTEIN SCI, V12, P1, DOI 10.1110/ps.0233303
   Bernado P, 2005, J AM CHEM SOC, V127, P17968, DOI 10.1021/ja055538p
   Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102
   Bernado P, 2004, J AM CHEM SOC, V126, P7760, DOI 10.1021/ja048785m
   Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n
   Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102
   Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200
   Blackledge M, 2005, PROG NUCL MAG RES SP, V46, P23, DOI 10.1016/j.pnmrs.2004.11.002
   Blanchard L, 2004, VIROLOGY, V319, P201, DOI 10.1016/j.virol.2003.10.029
   Bouvignies G, 2006, J AM CHEM SOC, V128, P15100, DOI 10.1021/ja066704b
   Briggman KB, 2003, J AM CHEM SOC, V125, P10164, DOI 10.1021/ja035904+
   Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104
   Cho MK, 2007, J AM CHEM SOC, V129, P3032, DOI 10.1021/ja067482k
   Clore GM, 2000, P NATL ACAD SCI USA, V97, P9021, DOI 10.1073/pnas.97.16.9021
   Clore GM, 2004, J AM CHEM SOC, V126, P2923, DOI 10.1021/ja0386804
   Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f
   Dames SA, 2006, J AM CHEM SOC, V128, P13508, DOI 10.1021/ja063606h
   Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j
   Denning DP, 2002, J BIOL CHEM, V277, P33447, DOI 10.1074/jbc.M203499200
   Ding KY, 2004, J MOL BIOL, V335, P1299, DOI 10.1016/j.jmb.2003.11.042
   Dunker AK, 2008, CURR OPIN STRUC BIOL, V18, P756, DOI 10.1016/j.sbi.2008.10.002
   Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s
   Dyson HJ, 2002, CURR OPIN STRUC BIOL, V12, P54, DOI 10.1016/S0959-440X(02)00289-0
   Emsley J. W., 1975, NMR SPECTROSCOPY USI
   Felitsky DJ, 2008, P NATL ACAD SCI USA, V105, P6278, DOI 10.1073/pnas.0710641105
   Fieber W, 2004, J MOL BIOL, V339, P1191, DOI 10.1016/j.jmb.2004.04.037
   Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002
   Fuxreiter M, 2004, J MOL BIOL, V338, P1015, DOI 10.1016/j.jmb.2004.03.017
   Gillespie JR, 1997, J MOL BIOL, V268, P158, DOI 10.1006/jmbi.1997.0954
   Graf J, 2007, J AM CHEM SOC, V129, P1179, DOI 10.1021/ja0660406
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   Houben K, 2007, J VIROL, V81, P6807, DOI 10.1128/JVI.00338-07
   Jeganathan S, 2006, BIOCHEMISTRY-US, V45, P2283, DOI 10.1021/bi0521543
   Jensen MR, 2008, J AM CHEM SOC, V130, P11266, DOI 10.1021/ja8039184
   Jensen MR, 2008, J AM CHEM SOC, V130, P8055, DOI 10.1021/ja801332d
   Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Lakomek NA, 2008, J BIOMOL NMR, V41, P139, DOI 10.1007/s10858-008-9244-4
   Louhivuori M, 2003, J AM CHEM SOC, V125, P15647, DOI 10.1021/ja035427v
   Louhivuori M, 2004, J BIOMOL NMR, V29, P517, DOI 10.1023/B:JNMR.0000034347.01925.ad
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Ortega-Roldan JL, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp211
   MACURA S, 1980, MOL PHYS, V41, P95, DOI 10.1080/00268978000102601
   Maiti NC, 2004, J AM CHEM SOC, V126, P2399, DOI 10.1021/ja0356176
   Markwick PRL, 2007, J AM CHEM SOC, V129, P4724, DOI 10.1021/ja0687668
   Marsh JA, 2008, J AM CHEM SOC, V130, P7804, DOI 10.1021/ja802220c
   Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306
   Meier S, 2003, J AM CHEM SOC, V125, P44, DOI 10.1021/ja028740q
   Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079
   Meier S, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2838167
   Meier S, 2007, J AM CHEM SOC, V129, P9799, DOI 10.1021/ja0724339
   Meier S, 2007, J AM CHEM SOC, V129, P754, DOI 10.1021/ja067522k
   Meiler J, 2001, J AM CHEM SOC, V123, P6098, DOI 10.1021/ja010002z
   Millet IS, 2002, ADV PROTEIN CHEM, V62, P241
   Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022
   Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159
   Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200
   Mukrasch MD, 2009, PLOS BIOL, V7, P399, DOI 10.1371/journal.pbio.1000034
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   Obolensky OI, 2007, J BIOMOL NMR, V39, P1, DOI 10.1007/s10858-007-9169-3
   Ohnishi S, 2004, BIOCHEMISTRY-US, V43, P4064, DOI 10.1021/bi049879b
   Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i
   Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h
   Salmon L, 2009, ANGEW CHEM INT EDIT, V48, P4154, DOI 10.1002/anie.200900476
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   Schuler B, 2008, CURR OPIN STRUC BIOL, V18, P16, DOI 10.1016/j.sbi.2007.12.003
   Schwalbe H, 1997, BIOCHEMISTRY-US, V36, P8977, DOI 10.1021/bi970049q
   Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i
   SERRANO L, 1995, J MOL BIOL, V254, P322, DOI 10.1006/jmbi.1995.0619
   Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105
   Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697
   Shortle D, 1996, FASEB J, V10, P27
   Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438
   Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o
   Sickmeier M, 2007, NUCLEIC ACIDS RES, V35, pD786, DOI 10.1093/nar/gkl893
   Skora L, 2006, ANGEW CHEM INT EDIT, V45, P7012, DOI 10.1002/anie.200602317
   Smith LJ, 1996, J MOL BIOL, V255, P494, DOI 10.1006/jmbi.1996.0041
   SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071
   Sugase K, 2007, NATURE, V447, P1021, DOI 10.1038/nature05858
   Sung YH, 2007, J MOL BIOL, V372, P689, DOI 10.1016/j.jmb.2007.07.008
   Syme CD, 2002, EUR J BIOCHEM, V269, P148, DOI 10.1046/j.0014-2956.2001.02633.x
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   Tjandra N, 1997, NAT STRUCT BIOL, V4, P732, DOI 10.1038/nsb0997-732
   Tolman JR, 2002, J AM CHEM SOC, V124, P12020, DOI 10.1021/ja0261123
   Tompa P, 2002, TRENDS BIOCHEM SCI, V27, P527, DOI 10.1016/S0968-0004(02)02169-2
   Tompa P, 2008, TRENDS BIOCHEM SCI, V33, P2, DOI 10.1016/j.tibs.2007.10.003
   TORBET J, 1979, J MOL BIOL, V134, P843, DOI 10.1016/0022-2836(79)90489-3
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684
   Uversky VN, 2002, PROTEIN SCI, V11, P739, DOI 10.1110/ps.4210102
   Vacic V, 2007, J PROTEOME RES, V6, P2351, DOI 10.1021/pr0701411
   Wang LY, 2005, J BIOMOL NMR, V32, P13, DOI 10.1007/s10858-005-1717-0
   Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102
   Wells M, 2008, P NATL ACAD SCI USA, V105, P5762, DOI 10.1073/pnas.0801353105
   WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471
   WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010
   Xie HB, 2007, J PROTEOME RES, V6, P1882, DOI 10.1021/pr060392u
   Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908
NR 103
TC 128
Z9 128
U1 1
U2 32
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD SEP 9
PY 2009
VL 17
IS 9
BP 1169
EP 1185
DI 10.1016/j.str.2009.08.001
PG 17
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 499DR
UT WOS:000270197700005
PM 19748338
OA Green Published
DA 2021-01-25
ER

PT J
AU Okuyama, K
   Bachinger, HP
   Mizuno, K
   Boudko, S
   Engel, J
   Berisio, R
   Vitagliano, L
AF Okuyama, Kenji
   Baechinger, Hans Peter
   Mizuno, Kazunori
   Boudko, Sergei
   Engel, Juergen
   Berisio, Rita
   Vitagliano, Luigi
TI Comment on Microfibrillar structure of type I collagen in situ by Orgel
   et al. (2006), Proc. Natl Acad. Sci. USA, 103, 9001-9005
SO ACTA CRYSTALLOGRAPHICA SECTION D-STRUCTURAL BIOLOGY
LA English
DT Letter
DE letters to the editor; type I collagen
ID CRYSTAL
AB A comment is published on the article Microfibrillar structure of type I collagen in situ by Orgel et al. [(2006), Proc. Natl Acad. Sci. USA, 103, 9001-9005].
C1 [Okuyama, Kenji] Osaka Univ, Grad Sch Sci, Dept Macromol Sci, Toyonaka, Osaka 5600043, Japan.
   [Baechinger, Hans Peter; Mizuno, Kazunori; Boudko, Sergei] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA.
   [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Berisio, Rita; Vitagliano, Luigi] CNR, Ist Biostruttre Bioimmagini, I-80134 Naples, Italy.
RP Okuyama, K (corresponding author), Osaka Univ, Grad Sch Sci, Dept Macromol Sci, Toyonaka, Osaka 5600043, Japan.
EM okuyamak@chem.sci.osaka-u.ac.jp
OI Mizuno, Kazunori/0000-0003-3354-6264; Berisio, Rita/0000-0001-5025-6483
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [19350059] Funding Source: KAKEN
CR ARNOTT S, 1966, J MOL BIOL, V21, P371, DOI 10.1016/0022-2836(66)90105-7
   Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451
   FRASER RDB, 1979, J MOL BIOL, V129, P463, DOI 10.1016/0022-2836(79)90507-2
   Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381
   OKUYAMA K, 1981, J MOL BIOL, V152, P427, DOI 10.1016/0022-2836(81)90252-7
   Orgel JPRO, 2006, P NATL ACAD SCI USA, V103, P9001, DOI 10.1073/pnas.0502718103
   Smith P. J. C., 1978, ACTA CRYSTALLOGR A, V34, P3
   Tsuruta H, 2008, CURR OPIN STRUC BIOL, V18, P601, DOI 10.1016/j.sbi.2008.08.002
   Vakonakis L, 2007, CURR OPIN CELL BIOL, V19, P578, DOI 10.1016/j.ceb.2007.09.005
NR 9
TC 12
Z9 12
U1 0
U2 65
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2059-7983
J9 ACTA CRYSTALLOGR D
JI Acta Crystallogr. Sect. D-Struct. Biol.
PD SEP
PY 2009
VL 65
BP 1007
EP 1008
DI 10.1107/S0907444909023051
PN 9
PG 2
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 488LA
UT WOS:000269350000016
PM 19690380
OA Bronze
DA 2021-01-25
ER

PT J
AU Hayley, M
   Perspicace, S
   Schulthess, T
   Seelig, J
AF Hayley, Michael
   Perspicace, Samantha
   Schulthess, Therese
   Seelig, Joachim
TI Calcium enhances the proteolytic activity of BACE1: An in vitro
   biophysical and biochemical characterization of the BACE1-calcium
   interaction
SO BIOCHIMICA ET BIOPHYSICA ACTA-BIOMEMBRANES
LA English
DT Article
DE BACE1; Calcium; Alzheimer's disease; Calcium dysregulation
ID AMYLOID PRECURSOR PROTEIN; BETA-SECRETASE; ALZHEIMERS-DISEASE; BRAIN;
   INHIBITOR; HYPOTHESIS; CLEAVAGE; DOMAIN
AB BACE1 is a novel type I transmembrane aspartyl protease that has been implicated in the pathogenesis of Alzheimer's disease. Cleavage of the amyloid precursor protein by the beta-secretase, BACE1, is the first step in the production of the A beta peptide and is a prime target for therapeutic intervention. Using circular dichroism, we reveal that the secondary structure of BACE1 in a membrane environment is significantly different from what was determined from the previously resolved crystal structure, and, we provide the first evidence that show differences in stability between the active (pH 4.8) and inactive (pH 7.4) forms of BACE1. In this study we have also examined Ca(2+) binding to BACE1, the effect of this binding on the secondary and tertiary structural characteristics of BACE1, and the influence of this binding on the specific activity of the purified protein. Circular dichroism and endogenous tryptophan fluorescence measurements demonstrated that the secondary and tertiary structures, respectively, are sensitive to increasing concentrations Of Ca(2+). Isothermal titration calorimetry was then used to characterize the Ca(2+)-BACE1 interaction in more detail. Our results suggest that there is a high affinity of binding (k(d) = 2.0 x mu M) between Ca(2+) and BACE1 and that the binding process was exothermic (Delta H = -3.5 kcal/mol). We also could demonstrate that low concentrations of Ca(2+) (mu M range) significantly increased the proteolytic activity of BACE1. Collectively. these results identify a direct interaction between BACE1 and Ca(2+) and suggest that under physiological conditions, the function(s) of BACE1 must also be influenced by Ca(2+). (c) 2009 Elsevier B.V. All rights reserved.
C1 [Hayley, Michael; Perspicace, Samantha; Schulthess, Therese; Seelig, Joachim] Univ Basel, Dept Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
RP Hayley, M (corresponding author), Univ Basel, Dept Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
EM michael.hayley@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100107793]
FX This work was supported by the Swiss National Science Foundation Grant
   3100107793.
CR Angeletti B, 2005, J BIOL CHEM, V280, P17930, DOI 10.1074/jbc.M412034200
   Bennett BD, 2000, J BIOL CHEM, V275, P20647, DOI 10.1074/jbc.M002688200
   Bennett BD, 2000, J BIOL CHEM, V275, P37712, DOI 10.1074/jbc.M005339200
   Bojarski L, 2008, NEUROCHEM INT, V52, P621, DOI 10.1016/j.neuint.2007.10.002
   DISTERHOFT JF, 1994, ANN NY ACAD SCI, V747, P382
   GIBSON GE, 1987, NEUROBIOL AGING, V8, P329, DOI 10.1016/0197-4580(87)90072-8
   Gruninger-Leitch F, 2002, J BIOL CHEM, V277, P4687, DOI 10.1074/jbc.M109266200
   Hong L, 2000, SCIENCE, V290, P150, DOI 10.1126/science.290.5489.150
   Hong L, 2002, BIOCHEMISTRY-US, V41, P10963, DOI 10.1021/bi026232n
   Hussain I, 1999, MOL CELL NEUROSCI, V14, P419, DOI 10.1006/mcne.1999.0811
   Khachaturian Z S, 1989, Aging (Milano), V1, P17
   KHACHATURIAN ZS, 1984, CLIN PHARMACY, V3, P522
   Kobayashi T, 2002, J BIOL CHEM, V277, P32157, DOI 10.1074/jbc.M202838200
   Landfield P. W, 1983, AGING BRAIN, P51
   LANDFIELD PW, 1987, NEUROBIOL AGING, V8, P346, DOI 10.1016/0197-4580(87)90074-1
   Pierrot N, 2004, J NEUROCHEM, V88, P1140, DOI 10.1046/j.1471-4159.2003.02227.x
   Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114
   Tanford C, 1968, Adv Protein Chem, V23, P121, DOI 10.1016/S0065-3233(08)60401-5
   Tanford C, 1970, Adv Protein Chem, V24, P1, DOI 10.1016/S0065-3233(08)60241-7
   Thibault O, 2007, AGING CELL, V6, P307, DOI 10.1111/j.1474-9726.2007.00295.x
   Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735
   Yan RQ, 1999, NATURE, V402, P533, DOI 10.1038/990107
   YANG JT, 1986, METHOD ENZYMOL, V130, P208
   Zatti G, 2006, CELL CALCIUM, V39, P539, DOI 10.1016/j.ceca.2006.03.002
NR 24
TC 30
Z9 30
U1 1
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0005-2736
J9 BBA-BIOMEMBRANES
JI Biochim. Biophys. Acta-Biomembr.
PD SEP
PY 2009
VL 1788
IS 9
BP 1933
EP 1938
DI 10.1016/j.bbamem.2009.05.015
PG 6
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 494ZS
UT WOS:000269859400027
PM 19486882
DA 2021-01-25
ER

PT J
AU Tamasi, V
   Juvan, P
   Beer, M
   Rozman, D
   Meyer, UA
AF Tamasi, Viola
   Juvan, Peter
   Beer, Markus
   Rozman, Damjana
   Meyer, Urs A.
TI Transcriptional Activation of PPAR alpha by Phenobarbital in the Absence
   of CAR and PXR
SO MOLECULAR PHARMACEUTICS
LA English
DT Article; Proceedings Paper
CT NanoMedicine Summit on Nanoparticles for Imaging, Diagnosis and
   Therapeutics
CY SEP 25-26, 2008-2009
CL Cleveland, OH
SP Case Western Reserve Univ, Cleveland Clinic
DE Phenobarbital; microarrays; CAR(-/-); PXR-/-; CAR/PXR-/-; PPAR alpha;
   HNF-4 alpha; AMPK
ID CONSTITUTIVE ANDROSTANE RECEPTOR; GENE-EXPRESSION; PROTEIN-KINASE;
   NUCLEAR TRANSLOCATION; INDUCTION; DRUG; MOUSE; METABOLISM; LIVER;
   HEPATOCYTES
AB The nuclear receptors CAR (constitutive androstane receptor) and PXR (pregnane X receptor) mediate the effects of phenobarbital on gene transcription. To investigate the relative contribution of these nuclear receptors to the expression of specific genes we studied the effect of phenobarbital in livers of wild type, CAR(-/-), PXR-/- and CAR/PXR-/- knockout mice. Spotted Steroltalk v1 cDNA arrays were applied containing probes for genes involved in drug metabolism, sterol biosynthesis, steroid synthesis/transport and heme synthesis. In the absence of CAR and PXR, phenobarbital unexpectedly induced mRNAs of several nuclear receptors, including PPAR alpha and its target genes Cyp4a10 and Cyp4a14. Interestingly, in primary cultures of hepatocytes isolated from CAR/PXR-/- knockout mice, phenobarbital increased HNF-4 alpha levels. In further experiments in these hepatocyte cultures we provide evidence that phenobarbital directly induces transcription of the PPAR alpha gene via its HNF-4 alpha response element, and indirectly by lack of inhibitory crosstalk of AMPK, CAR and PXR with HNF-4 alpha. Our results provide further insight into CAR and PXR-independent effects of phenobarbital and the crosstalk between different nuclear receptor signaling pathways.
C1 [Tamasi, Viola; Beer, Markus; Meyer, Urs A.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Juvan, Peter; Rozman, Damjana] Univ Ljubljana, Fac Med, Ctr Funct Genom & Biochips, Inst Biochem, Ljubljana, Slovenia.
RP Tamasi, V (corresponding author), Semmelweis Univ, Fac Med, Dept Genet Cell & Immunobiol, POB 370, H-1445 Budapest, Hungary.
EM vtamasi@mac.com
OI Rozman, Damjana/0000-0002-6501-2163; Juvan, Peter/0000-0003-2873-5247
CR Bell AW, 2006, HEPATOLOGY, V44, P186, DOI 10.1002/hep.21234
   BERRY MN, 1991, ISOLATED HEPATOCYTES, P34
   Bhalla S, 2004, J BIOL CHEM, V279, P45139, DOI 10.1074/jbc.M405423200
   Blattler SM, 2007, P NATL ACAD SCI USA, V104, P1045, DOI 10.1073/pnas.0610216104
   CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407
   Demsar J., 2004, ORANGE EXPT MACHINE
   Ferrini J B, 1998, Methods Mol Biol, V107, P341
   Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2
   Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001
   Holloway MG, 2008, MOL ENDOCRINOL, V22, P1274, DOI 10.1210/me.2007-0564
   Hong YH, 2003, J BIOL CHEM, V278, P27495, DOI 10.1074/jbc.M304112200
   Huang WD, 2003, P NATL ACAD SCI USA, V100, P4156, DOI 10.1073/pnas.0630614100
   Kawamoto T, 1999, MOL CELL BIOL, V19, P6318
   Konno Y, 2008, DRUG METAB PHARMACOK, V23, P8, DOI 10.2133/dmpk.23.8
   Kullak-Ublick GA, 2003, DRUG METAB REV, V35, P305, DOI 10.1081/DMR-120026398
   Maglich JM, 2009, J LIPID RES, V50, P439, DOI 10.1194/jlr.M800226-JLR200
   Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200
   Moreau A, 2008, MOL PHARM, V5, P35, DOI 10.1021/mp700103m
   PERAINO C, 1971, CANCER RES, V31, P1506
   Rencurel F, 2005, J BIOL CHEM, V280, P4367, DOI 10.1074/jbc.M412711200
   Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421
   Rezen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-76
   Rushmore TH, 2002, CURR DRUG METAB, V3, P481, DOI 10.2174/1389200023337171
   Shindo S, 2007, BIOCHEM J, V401, P735, DOI 10.1042/BJ20061238
   Shiraki T, 2003, J BIOL CHEM, V278, P11344, DOI 10.1074/jbc.M212859200
   Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   Torra IP, 2002, MOL ENDOCRINOL, V16, P1013
   Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1
   Wei P, 2000, NATURE, V407, P920, DOI 10.1038/35038112
   WHITE SJ, 1979, LANCET, V2, P458
   Yanai I, 2005, BIOINFORMATICS, V21, P650, DOI 10.1093/bioinformatics/bti042
   Zelko I, 2001, MOL CELL BIOL, V21, P2838, DOI 10.1128/MCB.21.8.2838-2846.2001
NR 33
TC 18
Z9 18
U1 0
U2 6
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1543-8384
J9 MOL PHARMACEUT
JI Mol. Pharm.
PD SEP-OCT
PY 2009
VL 6
IS 5
BP 1573
EP 1581
DI 10.1021/mp9001552
PG 9
WC Medicine, Research & Experimental; Pharmacology & Pharmacy
SC Research & Experimental Medicine; Pharmacology & Pharmacy
GA 501BR
UT WOS:000270354400033
PM 19708687
DA 2021-01-25
ER

PT J
AU Meinen, S
   Lin, S
   Ruegg, MA
AF Meinen, S.
   Lin, S.
   Rueegg, M. A.
TI Treatment approaches in laminin-alpha 2-deficient congenital muscular
   dystrophy (MDC1A)
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 14th International Congress of the World-Muscle-Society
CY SEP 09-12, 2009
CL Geneva, SWITZERLAND
SP World Muscle Soc
C1 [Meinen, S.; Lin, S.; Rueegg, M. A.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 2
Z9 2
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD SEP
PY 2009
VL 19
IS 8-9
BP 550
EP 550
DI 10.1016/j.nmd.2009.06.025
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 491OW
UT WOS:000269589600023
DA 2021-01-25
ER

PT J
AU Escher, CA
   Lochmuller, H
   Walter, MC
   Ehrat, M
   Reimann, J
   Ruegg, MA
   Gygax, D
AF Escher, C. A.
   Lochmueller, H.
   Walter, M. C.
   Ehrat, M.
   Reimann, J.
   Ruegg, M. A.
   Gygax, D.
TI Reverse protein arrays for efficient protein diagnosis of muscular
   dystrophies in less than 10 mg muscle tissue
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 14th International Congress of the World-Muscle-Society
CY SEP 09-12, 2009
CL Geneva, SWITZERLAND
SP World Muscle Soc
C1 [Escher, C. A.; Gygax, D.] Univ Appl Sci NW Switzerland, Sch Life Sci, D-5300 Muttenz, Switzerland.
   [Lochmueller, H.] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne, Tyne & Wear, England.
   [Walter, M. C.] Univ Munich, Friedrich Baur Inst, Munich, Germany.
   [Ehrat, M.] Zeptosens, Witterswil, Switzerland.
   [Reimann, J.] Univ Bonn, Dept Neurol, Bonn, Germany.
   [Ruegg, M. A.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD SEP
PY 2009
VL 19
IS 8-9
BP 606
EP 606
DI 10.1016/j.nmd.2009.06.197
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 491OW
UT WOS:000269589600194
DA 2021-01-25
ER

PT J
AU Haefeli, R
   Gemperli, A
   Guven, N
AF Haefeli, R.
   Gemperli, A.
   Gueven, N.
TI Effects of idebenone on mitochondrial function in cells from muscular
   dystrophy patients and healthy individuals
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 14th International Congress of the World-Muscle-Society
CY SEP 09-12, 2009
CL Geneva, SWITZERLAND
SP World Muscle Soc
C1 [Haefeli, R.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Gemperli, A.; Gueven, N.] Santhera Pharmaceut, Liestal, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD SEP
PY 2009
VL 19
IS 8-9
BP 613
EP 613
DI 10.1016/j.nmd.2009.06.216
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 491OW
UT WOS:000269589600213
DA 2021-01-25
ER

PT J
AU Porrello, E
   Domi, T
   Capotondo, A
   Triolo, D
   Sampaolesi, M
   Brunelli, S
   Comi, G
   Ruegg, MA
   Cossu, G
   Biffi, A
   Quattrini, A
   Previtali, SC
AF Porrello, E.
   Domi, T.
   Capotondo, A.
   Triolo, D.
   Sampaolesi, M.
   Brunelli, S.
   Comi, G.
   Ruegg, M. A.
   Cossu, G.
   Biffi, A.
   Quattrini, A.
   Previtali, S. C.
TI Restoring cell-basal lamina interaction to rescue tissue degeneration in
   congenital muscular dystrophy
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 14th International Congress of the World-Muscle-Society
CY SEP 09-12, 2009
CL Geneva, SWITZERLAND
SP World Muscle Soc
C1 [Porrello, E.; Domi, T.; Triolo, D.; Comi, G.; Quattrini, A.; Previtali, S. C.] Ist Sci San Raffaele, INSPE & Neurosci, I-20132 Milan, Italy.
   [Capotondo, A.; Brunelli, S.; Cossu, G.; Biffi, A.] Ist Sci San Raffaele, Div Regenerat Med, I-20132 Milan, Italy.
   [Sampaolesi, M.] Stem Cell Inst, Leuven, Belgium.
   [Ruegg, M. A.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Biffi, Alessandra/AAA-8890-2019; Ruegg, Markus/X-7256-2019; Previtali,
   Stefano/Z-1962-2019; domi, teuta/K-9646-2016; Sampaolesi,
   Maurilio/H-6509-2013; Brunelli, Silvia/J-3248-2014
OI Ruegg, Markus/0000-0002-4974-9384; Previtali,
   Stefano/0000-0003-2546-4357; domi, teuta/0000-0002-8377-5594;
   Sampaolesi, Maurilio/0000-0002-2422-3757; Brunelli,
   Silvia/0000-0003-1753-5346
NR 0
TC 0
Z9 0
U1 0
U2 2
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD SEP
PY 2009
VL 19
IS 8-9
BP 633
EP 633
DI 10.1016/j.nmd.2009.06.278
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 491OW
UT WOS:000269589600275
DA 2021-01-25
ER

PT J
AU Fernandez-Gonzalez, E
   de Paz, HD
   Dehio, C
   Sangari, FJ
   Llosa, M
AF Fernandez-Gonzalez, E.
   de Paz, H. D.
   Dehio, C.
   Sangari, F. J.
   Llosa, M.
TI Bacterial type IV secretion systems: a tool for DNA transfer into
   mammalian cells
SO NEW BIOTECHNOLOGY
LA English
DT Meeting Abstract
C1 [Fernandez-Gonzalez, E.; de Paz, H. D.; Sangari, F. J.; Llosa, M.] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain.
   [Fernandez-Gonzalez, E.; de Paz, H. D.; Sangari, F. J.; Llosa, M.] IBBTEC UC CSIC IDICAN, Santander, Spain.
   [Dehio, C.] Univ Basel, Biozentrum, Div Mol Microbiol, Basel, Switzerland.
RI Dehio, Christoph/AAD-5572-2019; , matxalen/ABG-5541-2020; Dehio,
   Christoph/R-8277-2016; Sangari, Felix J/K-9104-2014
OI Dehio, Christoph/0000-0001-7288-1052; , matxalen/0000-0002-4826-2240;
   Dehio, Christoph/0000-0001-7288-1052; Sangari, Felix
   J/0000-0002-3298-6076
NR 0
TC 0
Z9 0
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1871-6784
J9 NEW BIOTECHNOL
JI New Biotech.
PD SEP
PY 2009
VL 25
SU 1
BP S35
EP S35
DI 10.1016/j.nbt.2009.06.086
PG 1
WC Biochemical Research Methods; Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 649HU
UT WOS:000281760100079
DA 2021-01-25
ER

PT J
AU Mauss, A
   Tripodi, M
   Evers, JF
   Landgraf, M
AF Mauss, Alex
   Tripodi, Marco
   Evers, Jan Felix
   Landgraf, Matthias
TI Midline Signalling Systems Direct the Formation of a Neural Map by
   Dendritic Targeting in the Drosophila Motor System
SO PLOS BIOLOGY
LA English
DT Article
ID SPINAL-CORD; SYNAPTIC CONNECTIONS; ABDOMINAL MOTONEURONS;
   NETRIN-RECEPTOR; CENTRAL NEURONS; AXON GUIDANCE; ROBO; GROWTH; CNS;
   SPECIFICITY
AB A fundamental strategy for organising connections in the nervous system is the formation of neural maps. Map formation has been most intensively studied in sensory systems where the central arrangement of axon terminals reflects the distribution of sensory neuron cell bodies in the periphery or the sensory modality. This straightforward link between anatomy and function has facilitated tremendous progress in identifying cellular and molecular mechanisms that underpin map development. Much less is known about the way in which networks that underlie locomotion are organised. We recently showed that in the Drosophila embryo, dendrites of motorneurons form a neural map, being arranged topographically in the antero-posterior axis to represent the distribution of their target muscles in the periphery. However, the way in which a dendritic myotopic map forms has not been resolved and whether postsynaptic dendrites are involved in establishing sets of connections has been relatively little explored. In this study, we show that motorneurons also form a myotopic map in a second neuropile axis, with respect to the ventral midline, and they achieve this by targeting their dendrites to distinct medio-lateral territories. We demonstrate that this map is "hard-wired"; that is, it forms in the absence of excitatory synaptic inputs or when presynaptic terminals have been displaced. We show that the midline signalling systems Slit/Robo and Netrin/Frazzled are the main molecular mechanisms that underlie dendritic targeting with respect to the midline. Robo and Frazzled are required cell-autonomously in motorneurons and the balance of their opposite actions determines the dendritic target territory. A quantitative analysis shows that dendritic morphology emerges as guidance cue receptors determine the distribution of the available dendrites, whose total length and branching frequency are specified by other cell intrinsic programmes. Our results suggest that the formation of dendritic myotopic maps in response to midline guidance cues may be a conserved strategy for organising connections in motor systems. We further propose that sets of connections may be specified, at least to a degree, by global patterning systems that deliver pre- and postsynaptic partner terminals to common "meeting regions."
C1 [Mauss, Alex; Evers, Jan Felix; Landgraf, Matthias] Univ Cambridge, Dept Zool, Cambridge, England.
   [Tripodi, Marco] Univ Basel, Friedrich Miescher Inst, Basel, Switzerland.
   [Tripodi, Marco] Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
RP Mauss, A (corresponding author), Univ Cambridge, Dept Zool, Cambridge, England.
EM ml10006@cam.ac.uk
RI Evers, Jan Felix/P-7021-2019; Evers, Jan Felix/E-4753-2014
OI Evers, Jan Felix/0000-0001-6377-4570; Landgraf,
   Matthias/0000-0001-5142-1997; Mauss, Alex/0000-0002-8061-8024; Tripodi,
   Marco/0000-0002-6827-6690
FU Wellcome Trust ProgrammeWellcome Trust [075934]; Royal Society through a
   Royal Society University Research Fellowship
FX This work was supported by a Wellcome Trust Programme grant to Michael
   Bate and ML (Ref.: 075934) and by The Royal Society through a Royal
   Society University Research Fellowship to ML. AM was funded by a Medical
   Research Council studentship and a Gates Cambridge Scholarship. MT was
   supported by the Wellcome Trust by a studentship under the auspices of
   the 4-Year PhD Programme in Developmental Biology. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Andrews GL, 2008, DEVELOPMENT, V135, P3839, DOI 10.1242/dev.023739
   Baek M, 2009, J NEUROSCI, V29, P6904, DOI 10.1523/JNEUROSCI.1585-09.2009
   Baines RA, 2002, J NEUROSCI, V22, P6587
   Baines RA, 1998, J NEUROSCI, V18, P4673
   Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X
   Bate Michael, 1993, P1013
   Blagburn JM, 2004, ANNU REV NEUROSCI, V27, P29, DOI 10.1146/annurev.neuro.27.070203.144143
   BODNARENKO SR, 1993, NATURE, V364, P144, DOI 10.1038/364144a0
   Braisted JE, 2000, J NEUROSCI, V20, P5792
   Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625
   Brierley DJ, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000199
   Casso D, 2000, MECH DEVELOP, V91, P449
   Choi JC, 2004, J NEUROPHYSIOL, V91, P2353, DOI 10.1152/jn.01115.2003
   Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3
   Colon-Ramos DA, 2007, SCIENCE, V318, P103, DOI 10.1126/science.1143762
   Crisp S, 2008, DEVELOPMENT, V135, P3707, DOI 10.1242/dev.026773
   Crossley A.C., 1978, P499
   Cuntz H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000251
   Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165
   Dimitrova S, 2008, DEV BIOL, V324, P18, DOI 10.1016/j.ydbio.2008.08.028
   Evers JF, 2006, DEV BIOL, V297, P214, DOI 10.1016/j.ydbio.2006.05.012
   Evers JF, 2005, J NEUROPHYSIOL, V93, P2331, DOI 10.1152/jn.00761.2004
   Furrer MP, 2007, DEVELOPMENT, V134, P3795, DOI 10.1242/dev.02882
   Furrer MP, 2003, NAT NEUROSCI, V6, P223, DOI 10.1038/nn1017
   Gerrow K, 2006, NEURON, V49, P547, DOI 10.1016/j.neuron.2006.01.015
   Godenschwege TA, 2002, J NEUROSCI, V22, P3117, DOI 10.1523/JNEUROSCI.22-08-03117.2002
   GREENSPAN RJ, 1980, J COMP NEUROL, V189, P741, DOI 10.1002/cne.901890409
   HALPERN ME, 1991, J NEUROSCI, V11, P3227
   HARRIS RM, 1981, J COMP NEUROL, V196, P357, DOI 10.1002/cne.901960302
   HEDGECOCK EM, 1990, NEURON, V4, P61, DOI 10.1016/0896-6273(90)90444-K
   Hoang B, 2001, DEV BIOL, V229, P55, DOI 10.1006/dbio.2000.9983
   Huberman AD, 2008, ANNU REV NEUROSCI, V31, P479, DOI 10.1146/annurev.neuro.31.060407.125533
   Hummel T, 1999, DEVELOPMENT, V126, P771
   Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896
   Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574
   Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7
   Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0
   Kidd T, 1998, NEURON, V20, P25, DOI 10.1016/S0896-6273(00)80431-6
   Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0
   Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028
   Labrador JP, 2005, CURR BIOL, V15, P1413, DOI 10.1016/j.cub.2005.06.058
   Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026
   Landgraf M, 2003, DEV BIOL, V260, P207, DOI 10.1016/S0012-1606(03)00215-X
   Landgraf M, 2003, PLOS BIOL, V1, P221, DOI 10.1371/journal.pbio.0000041
   Landgraf M, 1997, J NEUROSCI, V17, P9642
   LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545
   Lattemann M, 2007, NEURON, V53, P169, DOI 10.1016/j.neuron.2006.12.024
   LEVINE RB, 1985, J NEUROSCI, V5, P2424
   Li WC, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-17
   Lohr R, 2002, J NEUROSCI, V22, P10357
   Luo LQ, 2007, NEURON, V56, P284, DOI 10.1016/j.neuron.2007.10.014
   Ly A, 2008, CELL, V133, P1241, DOI 10.1016/j.cell.2008.05.030
   MATTHES DJ, 1995, CELL, V81, P631, DOI 10.1016/0092-8674(95)90084-5
   Mumm JS, 2006, NEURON, V52, P609, DOI 10.1016/j.neuron.2006.10.004
   Nevin LM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-36
   OKADO N, 1990, ANAT EMBRYOL, V182, P113
   Ou YM, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-16
   Ozdinler PH, 2002, J NEUROSCI, V22, P4540, DOI 10.1523/JNEUROSCI.22-11-04540.2002
   Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907
   Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006
   Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000
   Petrovic M, 2008, NATURE, V456, P800, DOI 10.1038/nature07407
   Polleux F, 2000, NATURE, V404, P567
   Poon VY, 2008, NATURE, V455, P669, DOI 10.1038/nature07291
   Rasse TM, 2005, NAT NEUROSCI, V8, P898, DOI 10.1038/nn1484
   Romer A. S., 1970, VERTEBRATE BODY
   RUIGROK TJH, 1985, J COMP NEUROL, V238, P275, DOI 10.1002/cne.902380304
   Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4
   Sanchez-Soriano N, 2005, DEV BIOL, V288, P126, DOI 10.1016/j.ydbio.2005.09.026
   Schmitt S, 2004, NEUROIMAGE, V23, P1283, DOI 10.1016/j.neuroimage.2004.06.047
   Shishido E, 1998, SCIENCE, V280, P2118, DOI 10.1126/science.280.5372.2118
   SINK H, 1991, J NEUROBIOL, V22, P298, DOI 10.1002/neu.480220309
   Suli A, 2006, J NEUROSCI, V26, P13328, DOI 10.1523/JNEUROSCI.2858-06.2006
   Takizawa E, 2007, ZOOL SCI, V24, P504, DOI 10.2108/zsj.24.504
   Tian N, 2003, NEURON, V39, P85, DOI 10.1016/S0896-6273(03)00389-1
   Tripodi M, 2008, PLOS BIOL, V6, P2172, DOI 10.1371/journal.pbio.0060260
   Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042
   Wang LC, 1996, NEURON, V17, P849, DOI 10.1016/S0896-6273(00)80217-2
   Whitford KL, 2002, NEURON, V33, P47, DOI 10.1016/S0896-6273(01)00566-9
   Winberg ML, 1998, CELL, V93, P581, DOI 10.1016/S0092-8674(00)81187-3
   Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941
   Yamagata M, 2002, CELL, V110, P649, DOI 10.1016/S0092-8674(02)00910-8
   Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469
   Yang L, 2009, SCIENCE, V324, P944, DOI 10.1126/science.1171320
   Zhu HT, 2006, NAT NEUROSCI, V9, P349, DOI 10.1038/nn1652
   Zlatic M, 2003, NEURON, V37, P41, DOI 10.1016/S0896-6273(02)01131-5
   Zlatic M, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000135
NR 87
TC 56
Z9 56
U1 0
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1544-9173
EI 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD SEP
PY 2009
VL 7
IS 9
AR e1000200
DI 10.1371/journal.pbio.1000200
PG 18
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 507AF
UT WOS:000270820800013
PM 19771146
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Schindler, C
   Rodriguez, F
   Poon, PP
   Singer, RA
   Johnston, GC
   Spang, A
AF Schindler, Christina
   Rodriguez, Fernanda
   Poon, Pak P.
   Singer, Richard A.
   Johnston, Gerald C.
   Spang, Anne
TI The GAP Domain and the SNARE, Coatomer and Cargo Interaction Region of
   the ArfGAP2/3 Glo3 are Sufficient for Glo3 Function
SO TRAFFIC
LA English
DT Article
DE Arf1; ArfGAP; COPI; intracellular transport; small GTPases; vesicular
   transport; yeast
ID PROTEIN HOMOLOGY DETECTION; GTPASE-ACTIVATING PROTEIN;
   SACCHAROMYCES-CEREVISIAE; RETROGRADE TRANSPORT; COPI VESICLES; ARF GAPS;
   GOLGI; COMPLEX; BINDING; GCS1
AB The ArfGAP Glo3 is required for coat protein I vesicle generation in the Golgi-endoplasmic reticulum (ER) shuttle. The best-understood role of Glo3 is the stimulation of the GTPase activity of Arf1. In this study, we characterized functional domains of the ArfGAP Glo3 and identified an interaction interface for coatomer, SNAREs and cargo in the central region of Glo3 (BoCCS region). The GAP domain together with the BoCCS region is necessary and sufficient for all vital Glo3 functions. Expression of a truncated Glo3 lacking the GAP domain results in a dominant negative growth phenotype in glo3 delta cells at 37 degrees C. This phenotype was alleviated by mutating either the BoCCS region or the Glo3 regulatory motif (GRM), or by overexpression of ER-Golgi SNAREs or the ArfGAP Gcs1. The GRM is not essential for Glo3 function; it may act as an intrinsic sensor coupling GAP activity to SNARE binding to avoid dead-end complex formation at the Golgi membrane. Our data suggest that membrane-interaction modules and cargo-sensing regions have evolved independently in ArfGAP1s versus ArfGAP2/3s.
C1 [Schindler, Christina; Rodriguez, Fernanda; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Poon, Pak P.; Johnston, Gerald C.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada.
   [Poon, Pak P.; Singer, Richard A.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
FU Swiss National FundSwiss National Science Foundation (SNSF); Canadian
   Institutes of Health ResearchCanadian Institutes of Health Research
   (CIHR)
FX We thank H.-D. Schmitt for antibodies, A. Nakano for the Glo3 motif
   mutation plasmids and J. Benjamin for critical reading of the
   manuscript. We are grateful to B. Antonny and D. Cassel for discussions.
   This work was supported by the Swiss National Fund (A. S.) and the
   Canadian Institutes of Health Research (G. C. J. and R. A. S.).
CR Aguilera-Romero A, 2008, J CELL BIOL, V180, P713, DOI 10.1083/jcb.200710025
   Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61
   BARLOWE C, 1993, J BIOL CHEM, V268, P873
   Bennett-Lovsey RM, 2008, PROTEINS, V70, P611, DOI 10.1002/prot.21688
   Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714
   Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108
   Chartrand P, 2002, MOL CELL, V10, P1319, DOI 10.1016/S1097-2765(02)00694-9
   DeRegis CJ, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-3
   Frigerio G, 2007, TRAFFIC, V8, P1644, DOI 10.1111/j.1600-0854.2007.00631.x
   Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025
   Inoue H, 2007, TRAFFIC, V8, P1465, DOI 10.1111/j.1600-0854.2007.00624.x
   Karplus K, 1998, BIOINFORMATICS, V14, P846, DOI 10.1093/bioinformatics/14.10.846
   Karplus K, 2003, PROTEINS, V53, P491, DOI 10.1002/prot.10540
   Kliouchnikov L, 2009, MOL BIOL CELL, V20, P859, DOI 10.1091/mbc.E08-10-1010
   Knop M, 1997, EMBO J, V16, P6985, DOI 10.1093/emboj/16.23.6985
   Kuehn MJ, 1998, NATURE, V391, P187
   Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008
   LEWIS SM, 2004, MOL BIOL CELL, V14, P14
   Liu W, 2005, J CELL BIOL, V168, P1053, DOI 10.1083/jcb.200410142
   Matsuoka K, 1998, MOL CELL, V2, P703, DOI 10.1016/S1097-2765(00)80168-9
   Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555
   Poon PP, 2001, J CELL BIOL, V155, P1239, DOI 10.1083/jcb.200108075
   Poon PP, 1996, P NATL ACAD SCI USA, V93, P10074, DOI 10.1073/pnas.93.19.10074
   Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092
   Schindler C, 2007, MOL BIOL CELL, V18, P2852, DOI 10.1091/mbc.E06-08-0756
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125
   Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9
   Trautwein M, 2004, MOL BIOL CELL, V15, P5021, DOI 10.1091/mbc.E04-05-0411
   Yahara N, 2006, J CELL SCI, V119, P2604, DOI 10.1242/jcs.02997
   Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015
   Yeung T, 2008, SCIENCE, V319, P210, DOI 10.1126/science.1152066
   YOSHIHISA T, 1993, SCIENCE, V259, P1466, DOI 10.1126/science.8451644
   Zhang CJ, 2003, YEAST, V20, P315, DOI 10.1002/yea.966
NR 35
TC 22
Z9 24
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1398-9219
EI 1600-0854
J9 TRAFFIC
JI Traffic
PD SEP
PY 2009
VL 10
IS 9
BP 1362
EP 1375
DI 10.1111/j.1600-0854.2009.00952.x
PG 14
WC Cell Biology
SC Cell Biology
GA 481FZ
UT WOS:000268794100015
PM 19602196
OA Bronze
DA 2021-01-25
ER

PT J
AU Rezen, T
   Viola, T
   Lovgren-Sandblom, A
   Bjorkhem, I
   Meyer, UA
   Rozman, D
AF Rezen, Tadeja
   Viola Tamasi
   Lovgren-Sandblom, Anita
   Bjorkhem, Ingemar
   Meyer, Urs A.
   Rozman, Damjana
TI Effect of CAR activation on selected metabolic pathways in normal and
   hyperlipidemic mouse livers
SO BMC GENOMICS
LA English
DT Article
ID CONSTITUTIVE ANDROSTANE RECEPTOR; PREGNANE-X-RECEPTOR; NUCLEAR
   RECEPTORS; CROSS-TALK; DRUG-METABOLISM; BILE-ACID; CHOLESTEROL;
   ADIPONECTIN; HOMEOSTASIS; MICROARRAY
AB Background: Detoxification in the liver involves activation of nuclear receptors, such as the constitutive androstane receptor (CAR), which regulate downstream genes of xenobiotic metabolism. Frequently, the metabolism of endobiotics is also modulated, resulting in potentially harmful effects. We therefore used 1,4-Bis [2-(3,5-dichloropyridyloxy)] benzene (TCPOBOP) to study the effect of CAR activation on mouse hepatic transcriptome and lipid metabolome under conditions of diet-induced hyperlipidemia.
   Results: Using gene expression profiling with a dedicated microarray, we show that xenobiotic metabolism, PPAR alpha and adipocytokine signaling, and steroid synthesis are the pathways most affected by TCPOBOP in normal and hyperlipidemic mice. TCPOBOP-induced CAR activation prevented the increased hepatic and serum cholesterol caused by feeding mice a diet containing 1% cholesterol. We show that this is due to increased bile acid metabolism and up-regulated removal of LDL, even though TCPOBOP increased cholesterol synthesis under conditions of hyperlipidemia. Up-regulation of cholesterol synthesis was not accompanied by an increase in mature SREBP2 protein. As determined by studies in CAR -/- mice, up-regulation of cholesterol synthesis is however CAR-dependent; and no obvious CAR binding sites were detected in promoters of cholesterogenic genes. TCPOBOP also affected serum glucose and triglyceride levels and other metabolic processes in the liver, irrespective of the diet.
   Conclusion: Our data show that CAR activation modulates hepatic metabolism by lowering cholesterol and glucose levels, through effects on PPARa and adiponectin signaling pathways, and by compromising liver adaptations to hyperlipidemia.
C1 [Rezen, Tadeja; Rozman, Damjana] Univ Ljubljana, Ctr Funct Genom & Biochips, Inst Biochem, Fac Med, SI-1000 Ljubljana, Slovenia.
   [Viola Tamasi; Meyer, Urs A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Lovgren-Sandblom, Anita; Bjorkhem, Ingemar] Karolinska Univ Hosp Huddinge, Div Clin Chem, S-14186 Huddinge, Sweden.
RP Rozman, D (corresponding author), Univ Ljubljana, Ctr Funct Genom & Biochips, Inst Biochem, Fac Med, Zaloska 4, SI-1000 Ljubljana, Slovenia.
EM tadeja.rezen@mf.uni-lj.si; vtamasi@mac.com;
   anita.lovgren.sandblom@karolinska.se; ingemar.bjorkhem@karolinska.se;
   urs-A.Meyer@unibas.ch; damjana.rozman@mf.uni-lj.si
OI Bjorkhem, Ingemar/0000-0002-0575-9425; Bjorkhem,
   Ingemar/0000-0001-6087-9190; Rozman, Damjana/0000-0002-6501-2163
FU European CommunityEuropean Community (EC) [LSHG-CT-2005-512096];
   Slovenian Research AgencySlovenian Research Agency - Slovenia
FX This paper and work it concerns was generated in the context of the
   STEROLTALK project, funded by the European Community as contract No.
   LSHG-CT-2005-512096 under 6th Framework Programme for Research and
   Technological Development in the thematic area of Life sciences,
   genomics and biotechnology for health. This paper reflects only the
   author's views and the European Community is not liable for any use that
   may be made of the information contained therein. Tadeja Rezen was
   supported by a fellowship from the Slovenian Research Agency. We would
   like to acknowledge Martina Perse and Manica Eerne for help in the
   animal experiment; Helena Klavzar for technical support; and Klementina
   Fon Tacer for the help in the lab. We would also like to acknowledge
   Mateja Hafner for help with RT-PCR.
CR Acimovic J, 2008, BIOCHEM BIOPH RES CO, V376, P206, DOI 10.1016/j.bbrc.2008.08.126
   BJORKHEM I, 1987, J LIPID RES, V28, P1137
   Blanco-Bose WE, 2008, HEPATOLOGY, V48, P1302, DOI 10.1002/hep.22475
   CALANDRE EP, 1991, ACTA NEUROL SCAND, V83, P250, DOI 10.1111/j.1600-0404.1991.tb04691.x
   Carmona-Saez P, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r3
   Cave M, 2007, J NUTR BIOCHEM, V18, P184, DOI 10.1016/j.jnutbio.2006.12.006
   DURRINGTON PN, 1976, CLIN SCI MOL MED, V50, P349, DOI 10.1042/cs0500349
   FRANZONI E, 1992, EPILEPSIA, V33, P932, DOI 10.1111/j.1528-1157.1992.tb02203.x
   Guo GL, 2003, J BIOL CHEM, V278, P45062, DOI 10.1074/jbc.M307145200
   Hasmall SC, 1999, PHARMACOL THERAPEUT, V82, P63, DOI 10.1016/S0163-7258(98)00058-8
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Huang WD, 2005, MOL ENDOCRINOL, V19, P1646, DOI 10.1210/me.2004-0520
   Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101
   Kadowaki T, 2006, J CLIN INVEST, V116, P1784, DOI 10.1172/JCI29126
   Kakizaki S, 2008, CURR DRUG METAB, V9, P614, DOI 10.2174/138920008785821666
   Kaser S, 2005, GUT, V54, P117, DOI 10.1136/gut.2003.037010
   Kiyosawa N, 2004, ARCH TOXICOL, V78, P435, DOI 10.1007/s00204-004-0565-0
   Kodama S, 2004, MOL CELL BIOL, V24, P7931, DOI 10.1128/MCB.24.18.7931-7940.2004
   LAHTELA JT, 1985, DIABETES, V34, P911, DOI 10.2337/diabetes.34.9.911
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maglich JM, 2009, J LIPID RES, V50, P439, DOI 10.1194/jlr.M800226-JLR200
   Masson D, 2008, J LIPID RES, V49, P1682, DOI 10.1194/jlr.M700374-JLR200
   Miao J, 2006, J BIOL CHEM, V281, P14537, DOI 10.1074/jbc.M510713200
   Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269
   Qatanani M, 2005, CURR DRUG METAB, V6, P329, DOI 10.2174/1389200054633899
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   Rezen T, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-76
   Roth A, 2008, MOL PHARMACOL, V73, P1282, DOI 10.1124/mol.107.041012
   Stedman CAM, 2005, P NATL ACAD SCI USA, V102, P2063, DOI 10.1073/pnas.0409794102
   Tobin JF, 2006, TRENDS ENDOCRIN MET, V17, P284, DOI 10.1016/j.tem.2006.07.004
   Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1
   VENKATESAN N, 1994, METABOLISM, V43, P348, DOI 10.1016/0026-0495(94)90103-1
   Wagner M, 2005, HEPATOLOGY, V42, P420, DOI 10.1002/hep.20784
   Yamazaki Y, 2007, GUT, V56, P565, DOI 10.1136/gut.2006.093260
   Yun HJ, 2008, BIOL CHEM, V389, P1313, DOI 10.1515/BC.2008.149
NR 35
TC 37
Z9 40
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD AUG 19
PY 2009
VL 10
AR 384
DI 10.1186/1471-2164-10-384
PG 15
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 501PJ
UT WOS:000270393500002
PM 19691840
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Huze, C
   Bauche, S
   Richard, P
   Chevessier, F
   Goillot, E
   Gaudon, K
   Ben Ammar, A
   Chaboud, A
   Grosjean, I
   Lecuyer, HA
   Bernard, V
   Rouche, A
   Alexandri, N
   Kuntzer, T
   Fardeau, M
   Fournier, E
   Brancaccio, A
   Ruegg, MA
   Koenig, J
   Eymard, B
   Schaeffer, L
   Hantai, D
AF Huze, Caroline
   Bauche, Stephanie
   Richard, Pascale
   Chevessier, Frederic
   Goillot, Evelyne
   Gaudon, Karen
   Ben Ammar, Asma
   Chaboud, Annie
   Grosjean, Isabelle
   Lecuyer, Heba-Aude
   Bernard, Veronique
   Rouche, Andree
   Alexandri, Nektaria
   Kuntzer, Thierry
   Fardeau, Michel
   Fournier, Emmanuel
   Brancaccio, Andrea
   Rueegg, Markus A.
   Koenig, Jeanine
   Eymard, Bruno
   Schaeffer, Laurent
   Hantai, Daniel
TI Identification of an Agrin Mutation that Causes Congenital Myasthenia
   and Affects Synapse Function
SO AMERICAN JOURNAL OF HUMAN GENETICS
LA English
DT Article
ID SKELETAL-MUSCLE FIBERS; ACETYLCHOLINE-RECEPTOR; NEUROMUSCULAR-JUNCTION;
   MUSCULAR-DYSTROPHY; MUTANT MICE; DYSTROGLYCAN; BINDING; DIFFERENTIATION;
   DEFICIENT; PROTEIN
AB We report the case of a congenital myasthenic syndrome due to a mutation in AGRN, the gene encoding agrin, ail extracellular matrix molecule released by the nerve and critical for formation of the neuromuscular junction. Gene analysis identified a homozygous missense mutation, c.5125G>C, leading to the p.Gly1709Arg variant. The muscle-biopsy specimen showed a major disorganization of the neuromuscular junction, including changes in the nerve-terminal cytoskeleton and fragmentation of the synaptic gutters. Experiments performed in nonmuscle cells or in cultured C2C12 myotubes and using recombinant mini-agrin for the mutated and the wildtype forms showed that the mutated form did not impair the activation of MuSK or change the total number of induced acetylcholine receptor aggregates. A solid-phase assay using the dystrophin glycoprotein complex showed that the mutation did not affect the binding of agrin to a-dystroglycan. Injection of wild-type or mutated agrin into rat soleus muscle induced the formation of nonsynaptic acetylcholine receptor clusters, but the mutant protein specifically destabilized the endogenous neuromuscular junctions. Importantly, the changes observed in rat muscle injected with mutant agrin recapitulated the pre- and post-synaptic modifications observed in the patient. These results indicate that the mutation does not interfere with the ability of agrin to induce postsynaptic structures but that it dramatically perturbs the maintenance of the neuromuscular junction.
C1 [Bauche, Stephanie; Chevessier, Frederic; Ben Ammar, Asma; Rouche, Andree; Alexandri, Nektaria; Koenig, Jeanine; Eymard, Bruno; Hantai, Daniel] Hop La Pitie Salpetriere, Inst Cerveau & Moelle, Ctr Rech, INSERM,UMR S975, Paris, France.
   [Huze, Caroline; Goillot, Evelyne; Lecuyer, Heba-Aude; Schaeffer, Laurent] Univ Lyon, CNRS, Ecole Normale Super Lyon, UMR 5239,Equipe Differenciat Neuromusculaire, Lyon, France.
   [Bauche, Stephanie; Ben Ammar, Asma; Koenig, Jeanine; Eymard, Bruno; Hantai, Daniel] Univ Paris 06, Paris, France.
   [Bauche, Stephanie] Ecole Prat Hautes Etud, Paris, France.
   [Richard, Pascale; Gaudon, Karen] Hop La Pitie Salpetriere, AP HP, Unit fonct Cardiogenet & Myogenet, Paris, France.
   [Chevessier, Frederic] Max Planck Inst Med Res, D-69120 Heidelberg 1, Germany.
   [Ben Ammar, Asma] Univ Tunis El Manar, Inst Natl Neurol, Tunis, Tunisia.
   [Chaboud, Annie; Grosjean, Isabelle] Inst Federatif Rech, Lyon, France.
   [Bernard, Veronique] Univ Paris 05, INSERM, U686, Paris, France.
   [Kuntzer, Thierry] CHU Vaudois, Neurol Serv, Nerve Muscle Unit, CH-1011 Lausanne, Switzerland.
   [Kuntzer, Thierry] Univ Lausanne, Lausanne, Switzerland.
   [Fardeau, Michel; Eymard, Bruno; Hantai, Daniel] Hop La Pitie Salpetriere, AP HP, Ctr Natl Reference Maladies Neuromusculaires Pari, Inst Myol, Paris, France.
   [Fournier, Emmanuel] Hop La Pitie Salpetriere, AP HP, Serv Electrophysiol, Paris, France.
   [Brancaccio, Andrea] Univ Cattolica Sacro Cuore, Ist Chim Riconoscimento Mol, Rome, Italy.
   [Rueegg, Markus A.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Koenig, Jeanine] Univ Bordeaux 2, F-33076 Bordeaux, France.
RP Hantai, D (corresponding author), Hop La Pitie Salpetriere, Inst Cerveau & Moelle, Ctr Rech, INSERM,UMR S975, Paris, France.
EM d.hantai@institut-myologie.org
RI Kuntzer, Thierry/O-8589-2016; Ruegg, Markus/X-7256-2019; Bernard,
   Veronique/A-9691-2012; Brancaccio, Andrea/C-5876-2009
OI Kuntzer, Thierry/0000-0002-7788-1673; Ruegg, Markus/0000-0002-4974-9384;
   Bernard, Veronique/0000-0003-4748-5167; Brancaccio,
   Andrea/0000-0003-4690-8826; Bauche, Stephanie/0000-0002-6926-339X;
   Goillot, Evelyne/0000-0003-0026-4690; Richard,
   Pascale/0000-0002-2390-3005
FU Assistance Publique-Hopitaux de Paris [1036]; Reseaux Inserm;
   ANR-Maladies RaresFrench National Research Agency (ANR)
   [ANR-07-MRAR-001]; Association Francaise contre les
   MyopathiesAssociation Francaise contre les Myopathies; Comite Mixte
   Franco-Tunisien Pour la Cooperation Universitaire [05G0809]; Contrat
   d'Interface AP-HP InsermInstitut National de la Sante et de la Recherche
   Medicale (Inserm)
FX This work was supported by Assistance Publique-Hopitaux de Paris (PHRC
   AOM 1036), Reseaux Inserm, ANR-Maladies Rares (#ANR-07-MRAR-001),
   Association Francaise contre les Myopathies, Comite Mixte
   Franco-Tunisien Pour la Cooperation Universitaire (CMCU Project
   #05G0809), and a Contrat d'Interface AP-HP Inserm (to D.H.).
CR Adams ME, 2000, J CELL BIOL, V150, P1385, DOI 10.1083/jcb.150.6.1385
   Beeson D, 2006, SCIENCE, V313, P1975, DOI 10.1126/science.1130837
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Bezakova G, 2001, P NATL ACAD SCI USA, V98, P9924, DOI 10.1073/pnas.171539698
   Bezakova G, 2001, J CELL BIOL, V153, P1453, DOI 10.1083/jcb.153.7.1453
   Bezakova G, 2001, J CELL BIOL, V153, P1441, DOI 10.1083/jcb.153.7.1441
   BLAUSTEIN MP, 1993, AM J PHYSIOL, V264, pC1367
   Brockhausen J, 2008, DEV NEUROBIOL, V68, P1153, DOI 10.1002/dneu.20654
   BROOKE MH, 1969, J HISTOCHEM CYTOCHEM, V17, P431, DOI 10.1177/17.6.431
   Cairns NJ, 2004, J PATHOL, V204, P438, DOI 10.1002/path.1650
   Chevessier F, 2004, HUM MOL GENET, V13, P3229, DOI 10.1093/hmg/ddh333
   Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671
   Denzer AJ, 1997, CELL TISSUE RES, V290, P357, DOI 10.1007/s004410050941
   Engel AG, 2005, CURR OPIN PHARMACOL, V5, P308, DOI 10.1016/j.coph.2004.12.007
   Fuhrer C, 1997, EMBO J, V16, P4951, DOI 10.1093/emboj/16.16.4951
   Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2
   GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3
   Gesemann M, 1996, NEURON, V16, P755, DOI 10.1016/S0896-6273(00)80096-3
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   Grady RM, 2000, NEURON, V25, P279, DOI 10.1016/S0896-6273(00)80894-6
   Hantai D, 2004, CURR OPIN NEUROL, V17, P539, DOI 10.1097/00019052-200410000-00004
   Hashemolhosseini S, 2000, MOL CELL NEUROSCI, V16, P697, DOI 10.1006/mcne.2000.0911
   Hilgenberg LGW, 2006, CELL, V125, P359, DOI 10.1016/j.cell.2006.01.052
   Ishigaki K, 2003, NEUROMUSCULAR DISORD, V13, P236, DOI 10.1016/S0960-8966(02)00243-2
   Kim N, 2008, CELL, V135, P334, DOI 10.1016/j.cell.2008.10.002
   KOELLE GB, 1949, P SOC EXP BIOL MED, V70, P617
   Lin S, 2008, P NATL ACAD SCI USA, V105, P11406, DOI 10.1073/pnas.0801683105
   Maselli RA, 2009, J MED GENET, V46, P203, DOI 10.1136/jmg.2008.063693
   Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x
   Meinen S, 2007, J CELL BIOL, V176, P979, DOI 10.1083/jcb.200611152
   Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102
   Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054
   Mueller Juliane S., 2007, Expert Reviews in Molecular Medicine, V9, P1, DOI 10.1017/S1462399407000427
   Nishimune H, 2008, J CELL BIOL, V182, P1201, DOI 10.1083/jcb.200805095
   Pun S, 1997, J NEUROCHEM, V69, P2555
   RUPP F, 1992, J NEUROSCI, V12, P3535
   Scotton P, 2006, J BIOL CHEM, V281, P36835, DOI 10.1074/jbc.M607887200
   SOBEL A, 1978, P NATL ACAD SCI USA, V75, P510, DOI 10.1073/pnas.75.1.510
   TSIM KWK, 1992, NEURON, V8, P677, DOI 10.1016/0896-6273(92)90089-V
   Zahler R, 1996, CIRC RES, V78, P870, DOI 10.1161/01.RES.78.5.870
   Zhang B, 2008, NEURON, V60, P285, DOI 10.1016/j.neuron.2008.10.006
NR 41
TC 115
Z9 119
U1 1
U2 7
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0002-9297
EI 1537-6605
J9 AM J HUM GENET
JI Am. J. Hum. Genet.
PD AUG 14
PY 2009
VL 85
IS 2
BP 155
EP 167
DI 10.1016/j.ajhg.2009.06.015
PG 13
WC Genetics & Heredity
SC Genetics & Heredity
GA 488EV
UT WOS:000269332900005
PM 19631309
OA Green Published
DA 2021-01-25
ER

PT J
AU Gubaev, A
   Hilbert, M
   Klostermeier, D
AF Gubaev, Airat
   Hilbert, Manuel
   Klostermeier, Dagmar
TI The DNA-gate of Bacillus subtilis gyrase is predominantly in the closed
   conformation during the DNA supercoiling reaction
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE ATPase; negative supercoiling; topoisomerase; single molecule FRET
ID EUKARYOTIC TOPOISOMERASE-II; N-TERMINAL FRAGMENT; ATP-OPERATED CLAMP;
   NUCLEOTIDE-BINDING; 2-GATE MECHANISM; STRAND-PASSAGE; STRUCTURAL
   MECHANISM; CRYSTAL-STRUCTURE; NALIDIXIC-ACID; DOUBLE HELIX
AB Gyrase is the only type II topoisomerase that introduces negative supercoils into DNA. Supercoiling is catalyzed via a strand-passage mechanism, in which the gate DNA (gDNA) is transiently cleaved, and a second DNA segment, the transfer DNA (tDNA), is passed through the gap before the gDNA is religated. Strand passage requires an opening of the so-called DNA-gate by approximate to 2 nm. A single-molecule FRET study reported equal populations of open and closed DNA-gate in topoisomerase II. We present here single-molecule FRET experiments that monitor the conformation of DNA bound to the DNA-gate of Bacillus subtilis gyrase and the conformation of the DNA-gate itself. DNA bound to gyrase adopts two different conformations, one slightly, one severely distorted. DNA distortion requires cleavage, but neither ATP nor the presence of a tDNA. At the same time, the DNA-gate of gyrase is predominantly in the closed conformation. In agreement with the single molecule data and with the danger of dsDNA breaks for genome integrity, <5% of cleavage complexes are detected in equilibrium. Quinolone inhibitors favor DNA cleavage by B. subtilis gyrase, but disfavor DNA distortion, and the DNA-gate remains in the closed conformation. Our results demonstrate that DNA binding, distortion and cleavage, and gate-opening are mechanistically distinct events. During the relaxation and supercoiling reactions, gyrase with an open DNA-gate is not significantly populated, consistent with gate-opening as a very rare event that only occurs briefly to allow for strand passage.
C1 [Gubaev, Airat; Hilbert, Manuel; Klostermeier, Dagmar] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@unibas.ch
FU VolkswagenStiftungVolkswagen; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); Roche Research Foundation
FX We thank Alex Burgin (deCODE biostructures, WA) for generously providing
   the phosphoamidite for synthesis of the DNA substrates containing a
   3'-bridging phosphorothiolate; Andreas Schmidt, Ines Hertel, and Diana
   Blank for expert technical assistance; and Thomas Gottler for
   preliminary smFRET experiments with labeled gyrase. This work was funded
   by the VolkswagenStiftung and the Swiss National Science Foundation. M.
   H. is the recipient of a fellowship from the Roche Research Foundation.
CR ALI JA, 1995, BIOCHEMISTRY-US, V34, P9801, DOI 10.1021/bi00030a018
   BASHKIROV VI, 1991, GENETICA, V85, P3, DOI 10.1007/BF00056101
   Berger JM, 1996, NATURE, V379, P225, DOI 10.1038/379225a0
   Brino L, 2000, J BIOL CHEM, V275, P9468, DOI 10.1074/jbc.275.13.9468
   Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294
   Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369
   Collins TRL, 2009, NUCLEIC ACIDS RES, V37, P712, DOI 10.1093/nar/gkn1059
   Critchlow SE, 1996, BIOCHEMISTRY-US, V35, P7387, DOI 10.1021/bi9603175
   Deweese JE, 2008, BIOCHEMISTRY-US, V47, P4129, DOI 10.1021/bi702194x
   Dong KC, 2007, NATURE, V450, P1201, DOI 10.1038/nature06396
   Fass D, 1999, NAT STRUCT BIOL, V6, P322
   GELLERT M, 1976, P NATL ACAD SCI USA, V73, P3872, DOI 10.1073/pnas.73.11.3872
   GELLERT M, 1977, P NATL ACAD SCI USA, V74, P4772, DOI 10.1073/pnas.74.11.4772
   Gottler T, 2007, J MOL BIOL, V367, P1392, DOI 10.1016/j.jmb.2007.01.055
   HALLETT P, 1991, ANTIMICROB AGENTS CH, V35, P335, DOI 10.1128/AAC.35.2.335
   Heddle JG, 2004, J MOL BIOL, V337, P597, DOI 10.1016/j.jmb.2004.01.049
   HOROWITZ DS, 1987, J BIOL CHEM, V262, P5339
   JACKSON AP, 1993, P NATL ACAD SCI USA, V90, P11232, DOI 10.1073/pnas.90.23.11232
   Kampranis SC, 1999, P NATL ACAD SCI USA, V96, P8414, DOI 10.1073/pnas.96.15.8414
   Laponogov I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000301
   LIU LF, 1989, ANNU REV BIOCHEM, V58, P351, DOI 10.1146/annurev.bi.58.070189.002031
   LIU LF, 1978, CELL, V15, P979, DOI 10.1016/0092-8674(78)90281-7
   Maxwell A, 1997, TRENDS MICROBIOL, V5, P102, DOI 10.1016/S0966-842X(96)10085-8
   Mueller-Planitz F, 2008, J BIOL CHEM, V283, P17463, DOI 10.1074/jbc.M710014200
   Mueller-Planitz F, 2007, NUCLEIC ACIDS RES, V35, P3764, DOI 10.1093/nar/gkm335
   Mueller-Planitz F, 2006, J BIOL CHEM, V281, P23395, DOI 10.1074/jbc.M604119200
   ORPHANIDES G, 1994, NUCLEIC ACIDS RES, V22, P1567, DOI 10.1093/nar/22.9.1567
   Roca J, 1996, P NATL ACAD SCI USA, V93, P4057, DOI 10.1073/pnas.93.9.4057
   Roca J, 2004, J BIOL CHEM, V279, P25783, DOI 10.1074/jbc.M402555200
   ROCA J, 1994, CELL, V77, P609, DOI 10.1016/0092-8674(94)90222-4
   ROCA J, 1992, CELL, V71, P833, DOI 10.1016/0092-8674(92)90558-T
   Roca J, 2009, NUCLEIC ACIDS RES, V37, P721, DOI 10.1093/nar/gkn994
   Schoeffler AJ, 2005, BIOCHEM SOC T, V33, P1465, DOI 10.1042/BST0331465
   SHEN LL, 1985, P NATL ACAD SCI USA, V82, P307, DOI 10.1073/pnas.82.2.307
   SHEN LL, 1989, BIOCHEMISTRY-US, V28, P3879, DOI 10.1021/bi00435a038
   Smiley RD, 2007, P NATL ACAD SCI USA, V104, P4840, DOI 10.1073/pnas.0700342104
   TAMURA JK, 1992, J BIOL CHEM, V267, P9214
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   Tingey AP, 1996, NUCLEIC ACIDS RES, V24, P4868, DOI 10.1093/nar/24.24.4868
   Wang JC, 2007, P NATL ACAD SCI USA, V104, P4773, DOI 10.1073/pnas.0701070104
   Wang JC, 1998, Q REV BIOPHYS, V31, P107, DOI 10.1017/S0033583598003424
   WIGLEY DB, 1991, NATURE, V351, P624, DOI 10.1038/351624a0
   Williams NL, 2001, J MOL BIOL, V306, P969, DOI 10.1006/jmbi.2001.4468
   Williams NL, 1999, BIOCHEMISTRY-US, V38, P14157, DOI 10.1021/bi991478m
   Williams NL, 1999, BIOCHEMISTRY-US, V38, P13502, DOI 10.1021/bi9912488
   Wilstermann AM, 2003, CURR TOP MED CHEM, V3, P321, DOI 10.2174/1568026033452519
NR 46
TC 31
Z9 32
U1 0
U2 8
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 11
PY 2009
VL 106
IS 32
BP 13278
EP 13283
DI 10.1073/pnas.0902493106
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 482IA
UT WOS:000268877300026
PM 19666507
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Friese, A
   Kaltschmidt, JA
   Ladle, DR
   Sigrist, M
   Jessell, TM
   Arber, S
AF Friese, Andreas
   Kaltschmidt, Julia A.
   Ladle, David R.
   Sigrist, Markus
   Jessell, Thomas M.
   Arber, Silvia
TI Gamma and alpha motor neurons distinguished by expression of
   transcription factor Err3
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE motor neuron; spinal cord; transcription factors
ID LIM HOMEOBOX GENES; SPINAL-CORD; NEUROTROPHIC FACTOR; POOL IDENTITY;
   RAT; CONNECTIVITY; INNERVATION; NERVE; AXONS; PEA3
AB Spinal motor neurons are specified to innervate different muscle targets through combinatorial programs of transcription factor expression. Whether transcriptional programs also establish finer aspects of motor neuron subtype identity, notably the prominent functional distinction between alpha and gamma motor neurons, remains unclear. In this study, we identify DNA binding proteins with complementary expression profiles in alpha and gamma motor neurons, providing evidence for molecular distinctions in these two motor neuron subtypes. The transcription factor Err3 is expressed at high levels in gamma but not alpha motor neurons, whereas the neuronal DNA binding protein NeuN marks alpha but not gamma motor neurons. Signals from muscle spindles are needed to support the differentiation of Err3(on)/NeuN(off) presumptive gamma motor neurons, whereas direct proprioceptive sensory input to a motor neuron pool is apparently dispensable. Together, these findings provide evidence that transcriptional programs define functionally distinct motor neuron subpopulations, even within anatomically defined motor pools.
C1 [Kaltschmidt, Julia A.; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Neurosci, New York, NY 10027 USA.
   [Kaltschmidt, Julia A.; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, New York, NY 10027 USA.
   [Friese, Andreas; Ladle, David R.; Sigrist, Markus; Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, CH-4058 Basel, Switzerland.
   [Friese, Andreas; Ladle, David R.; Sigrist, Markus; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
RP Jessell, TM (corresponding author), Columbia Univ, Howard Hughes Med Inst, Dept Neurosci, 701 W 168th St, New York, NY 10032 USA.
EM tmj1@columbia.edu; silvia.arber@unibas.ch
OI Arber, Silvia/0000-0002-6261-250X
FU Howard Hughes Medical Institute (HHMI) Research AssociateHoward Hughes
   Medical Institute; Wellcome Trust Traveling Research FellowshipWellcome
   Trust [IPTRF 064871]; National Institute of Neurological Disorders and
   Stroke, EU FrameworkUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS)
FX We are grateful to Monika Mielich for help with the characterization of
   Err3 expression and to Michael Stadler and Ilir Agalliu for help with
   statistical analysis. A. F., D. R. L., M. S., and S. A. were supported
   by the Swiss National Science Foundation, National Centers of Competence
   in Research Frontiers in Genetics, the Kanton Basel- Stadt, European
   Union (EU) Framework Program 7, and the Novartis Research Foundation. J.
   A. K. was a Howard Hughes Medical Institute (HHMI) Research Associate
   and was supported by a Wellcome Trust Traveling Research Fellowship
   (IPTRF 064871). T. M. J. is an HHMI Investigator and is supported by
   National Institute of Neurological Disorders and Stroke, EU Framework
   Program 7, and Project ALS.
CR Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X
   Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   BURKE RE, 1977, J NEUROPHYSIOL, V40, P667
   Burke RE, 2004, SYNAPTIC ORG BRAIN, P79
   Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009
   di Sanguinetto SADT, 2008, CURR OPIN NEUROBIOL, V18, P36, DOI 10.1016/j.conb.2008.04.002
   ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794
   ECCLES JC, 1960, ACTA PHYSIOL SCAND, V50, P32, DOI 10.1111/j.1748-1716.1960.tb02070.x
   Garcia NVDM, 2008, NEURON, V57, P217, DOI 10.1016/j.neuron.2007.11.033
   Giguere V, 2002, TRENDS ENDOCRIN MET, V13, P220, DOI 10.1016/S1043-2760(02)00592-1
   Gould TW, 2008, J NEUROSCI, V28, P2131, DOI 10.1523/JNEUROSCI.5185-07.2008
   Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4
   Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159
   Hippenmeyer S, 2002, NEURON, V36, P1035, DOI 10.1016/S0896-6273(02)01101-7
   Hong H, 1999, J BIOL CHEM, V274, P22618, DOI 10.1074/jbc.274.32.22618
   HUNT CC, 1951, J PHYSIOL-LONDON, V113, P283, DOI 10.1113/jphysiol.1951.sp004572
   HUNT CC, 1951, J PHYSIOL-LONDON, V115, P456, DOI 10.1113/jphysiol.1951.sp004681
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2
   KUCERA J, 1989, AM J ANAT, V186, P144, DOI 10.1002/aja.1001860205
   KUCERA J, 1993, ANAT EMBRYOL, V187, P397
   KUFFLER SW, 1951, J NEUROPHYSIOL, V14, P29
   Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519
   Masland RH, 2004, CURR BIOL, V14, pR497, DOI 10.1016/j.cub.2004.06.035
   Milner LD, 1998, J NEUROSCI, V18, P3297
   MULLEN RJ, 1992, DEVELOPMENT, V116, P201
   Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249
   Pecho-Vrieseling E, 2009, NATURE, V459, P842, DOI 10.1038/nature08000
   Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5
   Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653
   Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1
   THOMPSON WJ, 1990, J NEUROBIOL, V21, P212, DOI 10.1002/neu.480210114
   Tourtellotte WG, 1998, NAT GENET, V20, P87
   TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2
   Tsujino H, 2000, MOL CELL NEUROSCI, V15, P170, DOI 10.1006/mcne.1999.0814
   Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042
   Wassle H, 2004, NAT REV NEUROSCI, V5, P747, DOI 10.1038/nrn1497
   Whitehead J, 2005, MECH DEVELOP, V122, P27, DOI 10.1016/j.mod.2004.09.003
   Wolf HK, 1996, J HISTOCHEM CYTOCHEM, V44, P1167, DOI 10.1177/44.10.8813082
   Yang X, 2001, NEURON, V30, P399, DOI 10.1016/S0896-6273(01)00287-2
NR 42
TC 114
Z9 114
U1 0
U2 8
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 11
PY 2009
VL 106
IS 32
BP 13588
EP 13593
DI 10.1073/pnas.0906809106
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 482IA
UT WOS:000268877300079
PM 19651609
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Spang, A
AF Spang, Anne
TI On the fate of early endosomes
SO BIOLOGICAL CHEMISTRY
LA English
DT Article; Proceedings Paper
CT International Symposium on Membrane Transport and Communication
CY NOV 21-22, 2008
CL GoetheUniv Frankfurt, Bioctr, Frankfurt, GERMANY
HO GoetheUniv Frankfurt, Bioctr
DE early-to-late endosome transition; endocytosis; endosomes; Rab GTPases;
   Rab conversion; sorting
ID RING FINGER PROTEIN; CAENORHABDITIS-ELEGANS; SACCHAROMYCES-CEREVISIAE;
   SORTING NEXIN-1; TRANS-GOLGI; PHOSPHATIDYLINOSITOL 3-KINASE; HOPS
   COMPLEX; SMALL GTPASE; LATE STEP; ENDOCYTOSIS
AB Proteins are endocytosed by various pathways into the cell. All these pathways converge at the level of the early endosome. The fate of the early endosome and how proteins are sorted into recycling and late endosomes/multi-vesicular body is a matter of debate and intense research. Obviously, the transition from early to late endosome poses an interesting logistic problem and would merit attention on an intellectual level. Numerous diseases are also caused by defects in turning off/over signaling molecules or mis-sorting of proteins at the level of the early endosome. This brief review aims to discuss different molecular mechanisms whereby early-to-late endosome transition could be achieved.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
CR Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055
   Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627
   Barbero P, 2002, J CELL BIOL, V156, P511, DOI 10.1083/jcb.200109030
   BONIFACINO JS, 2008, RETROMER CURR OPIN C, V20, P427
   BUCCI C, 1992, CELL, V70, P715, DOI 10.1016/0092-8674(92)90306-W
   Cabrera M, 2009, MOL BIOL CELL, V20, P1937, DOI 10.1091/mbc.E08-09-0943
   Cao C, 2007, TRAFFIC, V8, P1052, DOI 10.1111/j.1600-0854.2007.00586.x
   Caplan S, 2001, J CELL BIOL, V154, P109, DOI 10.1083/jcb.200102142
   Carlton J, 2004, CURR BIOL, V14, P1791, DOI 10.1016/j.cub.2004.09.077
   Christoforidis S, 1999, NATURE, V397, P621
   Dang H, 2004, MOL BIOL CELL, V15, P189, DOI 10.1091/mbc.E03-08-0605
   De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744
   de Wit H, 2001, MOL BIOL CELL, V12, P3703, DOI 10.1091/mbc.12.11.3703
   Del Conte-Zerial P, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.45
   Encalada SE, 2000, DEV BIOL, V228, P225, DOI 10.1006/dbio.2000.9965
   Enyenihi AH, 2003, GENETICS, V163, P47
   Fares H, 2001, GENETICS, V159, P133
   Fernandez AG, 2005, GENOME RES, V15, P250, DOI 10.1101/gr.3194805
   Flower TR, 2007, J CELL BIOL, V177, P1091, DOI 10.1083/jcb.200610071
   Frick M, 2007, CURR BIOL, V17, P1151, DOI 10.1016/j.cub.2007.05.078
   Ganley IG, 2008, J CELL BIOL, V180, P159, DOI 10.1083/jcb.200707136
   Gary JD, 1998, J CELL BIOL, V143, P65, DOI 10.1083/jcb.143.1.65
   Gaullier JM, 1998, NATURE, V394, P432, DOI 10.1038/28767
   Giaever G, 2002, NATURE, V418, P387, DOI 10.1038/nature00935
   Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577
   Gullapalli A, 2004, MOL BIOL CELL, V15, P2143, DOI 10.1091/mbc.E03-09-0711
   Guo HX, 2006, CELL PROLIFERAT, V39, P507, DOI 10.1111/j.1365-2184.2006.00408.x
   Hoffman-Sommer M, 2005, BIOCHEM BIOPH RES CO, V329, P197, DOI 10.1016/j.bbrc.2005.01.107
   Horazdovsky BF, 1996, J BIOL CHEM, V271, P33607, DOI 10.1074/jbc.271.52.33607
   Horazdovsky BF, 1997, MOL BIOL CELL, V8, P1529
   Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1
   Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519
   Lakadamyali M, 2006, CELL, V124, P997, DOI 10.1016/j.cell.2005.12.038
   Laporte J, 1998, HUM MOL GENET, V7, P1703, DOI 10.1093/hmg/7.11.1703
   LI GP, 1995, P NATL ACAD SCI USA, V92, P10207, DOI 10.1073/pnas.92.22.10207
   Liang CY, 2008, AUTOPHAGY, V4, P817, DOI 10.4161/auto.6496
   Liang CY, 2008, NAT CELL BIOL, V10, P776, DOI 10.1038/ncb1740
   Liang C, 2006, NAT CELL BIOL, V8, P688, DOI 10.1038/ncb1426
   Loria PM, 2004, J NEUROSCI, V24, P2191, DOI 10.1523/JNEUROSCI.5462-03.2004
   Marston AL, 2004, SCIENCE, V303, P1367, DOI 10.1126/science.1094220
   Mattera R, 2008, EMBO J, V27, P2484, DOI 10.1038/emboj.2008.177
   Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216
   MILLER TM, 1984, J CELL BIOL, V98, P685, DOI 10.1083/jcb.98.2.685
   Mills IG, 1999, MOL MEMBR BIOL, V16, P73, DOI 10.1080/096876899294788
   Montagnac G, 2008, CURR OPIN CELL BIOL, V20, P454, DOI 10.1016/j.ceb.2008.03.011
   Mosesson Y, 2008, NAT REV CANCER, V8, P835, DOI 10.1038/nrc2521
   Odorizzi G, 1998, CELL, V95, P847, DOI 10.1016/S0092-8674(00)81707-9
   Panaretou C, 1997, J BIOL CHEM, V272, P2477
   Peden AA, 2004, MOL BIOL CELL, V15, P3530, DOI 10.1091/mbc.E03-12-0918
   Peplowska K, 2007, DEV CELL, V12, P739, DOI 10.1016/j.devcel.2007.03.006
   Perelman B, 1997, GENOMICS, V41, P397, DOI 10.1006/geno.1997.4623
   Poteryaev D, 2005, BIOCHEM SOC T, V33, P606, DOI 10.1042/BST0330606
   Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498
   Richardson SCW, 2004, MOL BIOL CELL, V15, P1197, DOI 10.1091/mbc.E03-06-0358
   Rieder SE, 1997, MOL BIOL CELL, V8, P2307, DOI 10.1091/mbc.8.11.2307
   RIEDERER MA, 1994, J CELL BIOL, V125, P573, DOI 10.1083/jcb.125.3.573
   Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043
   Rojas R, 2008, J CELL BIOL, V183, P513, DOI 10.1083/jcb.200804048
   Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5
   Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929
   Schonthaler HB, 2008, DEVELOPMENT, V135, P387, DOI 10.1242/dev.006098
   Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665
   Seaman MNJ, 2004, J CELL BIOL, V165, P111, DOI 10.1083/jcb.200312034
   Sonnichsen B, 2005, NATURE, V434, P462, DOI 10.1038/nature03353
   STACK JH, 1995, J CELL BIOL, V129, P321, DOI 10.1083/jcb.129.2.321
   Stroupe C, 2006, EMBO J, V25, P1579, DOI 10.1038/sj.emboj.7601051
   Tizon B, 1999, YEAST, V15, P145, DOI 10.1002/(SICI)1097-0061(19990130)15:2<145::AID-YEA346>3.0.CO;2-J
   Tsujita K, 2004, J BIOL CHEM, V279, P13817, DOI 10.1074/jbc.M312294200
   Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233
   Wang CW, 2003, J CELL BIOL, V163, P973, DOI 10.1083/jcb.200308071
   Wang CW, 2002, J BIOL CHEM, V277, P47917, DOI 10.1074/jbc.M208191200
   Wang FD, 2007, NAT GENET, V39, P1025, DOI 10.1038/ng2059
   Xiao QF, 2009, ELECTRON J LINEAR AL, V18, P21
   Zerial M, 2001, NAT REV MOL CELL BIO, V2, P107, DOI 10.1038/35052055
   Zhang YH, 2001, MOL BIOL CELL, V12, P2011, DOI 10.1091/mbc.12.7.2011
NR 75
TC 44
Z9 44
U1 0
U2 13
PU WALTER DE GRUYTER & CO
PI BERLIN
PA GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY
SN 1431-6730
J9 BIOL CHEM
JI Biol. Chem.
PD AUG
PY 2009
VL 390
IS 8
BP 753
EP 759
DI 10.1515/BC.2009.056
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 480NH
UT WOS:000268741700012
PM 19361275
DA 2021-01-25
ER

PT J
AU Spang, A
AF Spang, Anne
TI On vesicle formation and tethering in the ER-Golgi shuttle
SO CURRENT OPINION IN CELL BIOLOGY
LA English
DT Article
ID RETICULUM EXIT SITES; GPI-ANCHORED PROTEINS; ENDOPLASMIC-RETICULUM;
   COPII COAT; TRANSPORT VESICLES; SACCHAROMYCES-CEREVISIAE; MEMBRANE
   CURVATURE; PLASMA-MEMBRANE; ESSENTIAL COMPONENT; STRUCTURAL BASIS
AB Transport in the ER-Golgi shuttle is performed by CORII in the anterograde and by COPI in the retrograde direction. How these transport steps are regulated and which mechanisms act to balance the vesicle flow between the ER and the Golgi apparatus are the issues currently under investigation. The elucidation of the structures of COPII components and tethers for COPI and COPII vesicles, together with detailed biochemical and cell biological analysis over the past few years greatly increased our knowledge on how vesicles are formed, not only at the ER and the Golgi but also at other organelles and the plasma membrane by analogy. Moreover, recent work provided more than just a glimpse on the function of tethering proteins at arrival sites on the ER and the Golgi. Most likely, organized exit and arrival sites exist at each vesicular transport step along the exocytic and endocytic routes.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); University of Basel
FX I apologize to all colleagues whose work was not cited because of space
   restraints and I wish to thank the members of the Spang lab for
   stimulating discussions. This work was funded by a grant of the Swiss
   National Science Foundation and the University of Basel.
CR Aguilera-Romero A, 2008, J CELL BIOL, V180, P713, DOI 10.1083/jcb.200710025
   Andag U, 2003, J BIOL CHEM, V278, P51722, DOI 10.1074/jbc.M308740200
   Antonny B, 2001, NAT CELL BIOL, V3, P531, DOI 10.1038/35078500
   BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4
   Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102
   Beck R, 2008, P NATL ACAD SCI USA, V105, P11731, DOI 10.1073/pnas.0805182105
   Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224
   Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006
   Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095
   Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876
   Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6
   Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527
   Cai YY, 2008, CELL, V133, P1202, DOI 10.1016/j.cell.2008.04.049
   Castillon GA, 2009, TRAFFIC, V10, P186, DOI 10.1111/j.1600-0854.2008.00857.x
   Connerly PL, 2005, CURR BIOL, V15, P1439, DOI 10.1016/j.cub.2005.06.065
   Dudognon P, 2004, FEBS LETT, V561, P44, DOI 10.1016/S0014-5793(04)00109-7
   Dukhovny A, 2008, J CELL SCI, V121, P865, DOI 10.1242/jcs.019463
   Fan JY, 2003, HISTOCHEM CELL BIOL, V120, P455, DOI 10.1007/s00418-003-0597-1
   Farhan H, 2008, EMBO J, V27, P2043, DOI 10.1038/emboj.2008.136
   Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036
   Feinstein TN, 2008, MOL BIOL CELL, V19, P2696, DOI 10.1091/mbc.E07-11-1200
   Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005
   Gillingham AK, 2004, J CELL BIOL, V167, P281, DOI 10.1083/jcb.200407088
   Gommel DU, 2001, EMBO J, V20, P6751, DOI 10.1093/emboj/20.23.6751
   Grieder NC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003241
   Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025
   Ivan V, 2008, MOL BIOL CELL, V19, P4352, DOI 10.1091/mbc.E08-03-0246
   Jones B, 2003, NAT GENET, V34, P29, DOI 10.1038/ng1145
   Jones S, 2000, MOL BIOL CELL, V11, P4403, DOI 10.1091/mbc.11.12.4403
   Kamena F, 2004, SCIENCE, V304, P286, DOI 10.1126/science.1095049
   Kamena F, 2008, J CELL SCI, V121, P1293, DOI 10.1242/jcs.016998
   Krauss M, 2008, J BIOL CHEM, V283, P27717, DOI 10.1074/jbc.M804528200
   Kuehn MJ, 1998, NATURE, V391, P187
   Kurihara T, 2000, MOL BIOL CELL, V11, P983, DOI 10.1091/mbc.11.3.983
   Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935
   Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025
   LEWIS MJ, 1992, CELL, V68, P353, DOI 10.1016/0092-8674(92)90476-S
   Lewis SM, 2004, MOL BIOL CELL, V15, P4064, DOI 10.1091/mbc.E04-04-0316
   Luedeke C, 2005, J CELL BIOL, V169, P897, DOI 10.1083/jcb.200412143
   Lundmark R, 2008, BIOCHEM J, V414, P189, DOI 10.1042/BJ20081237
   Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017
   Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9
   Michelsen K, 2007, J CELL BIOL, V179, P209, DOI 10.1083/jcb.200704142
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X
   Namekawa M, 2007, MOL CELL NEUROSCI, V35, P1, DOI 10.1016/j.mcn.2007.01.012
   Patterson GH, 2008, CELL, V133, P1055, DOI 10.1016/j.cell.2008.04.044
   Perez Castro C, 2007, J CELL SCI, V120, P2454, DOI 10.1242/jcs.004200
   Powers J, 2002, MOL BIOL CELL, V13, P880, DOI 10.1091/mbc.01-10-0499
   Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020
   Reilly BA, 2001, MOL BIOL CELL, V12, P3783, DOI 10.1091/mbc.12.12.3783
   Saito K, 2009, CELL, V136, P891, DOI 10.1016/j.cell.2008.12.025
   Salama NR, 1997, MOL BIOL CELL, V8, P205
   Sandmann T, 2003, MOL BIOL CELL, V14, P3097, DOI 10.1091/mbc.E02-11-0736
   Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973
   Sinka R, 2008, J CELL BIOL, V183, P607, DOI 10.1083/jcb.200808018
   Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199
   Stagg SM, 2008, CELL, V134, P474, DOI 10.1016/j.cell.2008.06.024
   Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339
   Stephens DJ, 2002, J CELL SCI, V115, P1149
   Supek F, 2002, J CELL BIOL, V158, P1029, DOI 10.1083/jcb.200207053
   Takida S, 2008, BIOCHEM J, V409, P555, DOI 10.1042/BJ20070234
   Tripathi A, 2009, NAT STRUCT MOL BIOL, V16, P114, DOI 10.1038/nsmb.1548
   Wang W, 2000, J CELL BIOL, V151, P289, DOI 10.1083/jcb.151.2.289
   Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x
   Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893
   Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774
   Zerangue N, 1999, NEURON, V22, P537, DOI 10.1016/S0896-6273(00)80708-4
NR 68
TC 44
Z9 45
U1 0
U2 4
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0955-0674
EI 1879-0410
J9 CURR OPIN CELL BIOL
JI Curr. Opin. Cell Biol.
PD AUG
PY 2009
VL 21
IS 4
BP 531
EP 536
DI 10.1016/j.ceb.2009.03.003
PG 6
WC Cell Biology
SC Cell Biology
GA 487AS
UT WOS:000269243300008
PM 19394211
DA 2021-01-25
ER

PT J
AU Kaufmann, A
AF Kaufmann, Andreas
TI A plasmid collection for PCR-based gene targeting in the filamentous
   ascomycete Ashbya gossypii
SO FUNGAL GENETICS AND BIOLOGY
LA English
DT Article
DE PCR-based gene targeting; Ashbya gossypii; Homologous recombination;
   Heterologous marker; Transformation; Filamentous fungus
ID GREEN FLUORESCENT PROTEIN; SACCHAROMYCES-CEREVISIAE;
   SCHIZOSACCHAROMYCES-POMBE; ESCHERICHIA-COLI; FISSION YEAST;
   TRANSFORMATION; EFFICIENT; VERSATILE; CASSETTES; MODULES
AB PCR-based gene targeting with heterologous markers is an efficient method to delete genes, generate gene fusions, and modulate gene expression. For the yeasts Saccharomyces cerevisiae and Schizosaccharomyces pombe, several plasmid collections are available covering a wide range of tags and markers. For several reasons, many of these cassettes cannot be used in the filamentous ascomycete Ashbya gossypii. This article describes the construction of 93 heterologous modules for C- and N-terminal tagging and promoter replacements in A. gossypii. The performance of 12 different fluorescent tags was evaluated by monitoring their brightness, detectability, and photostability when fused to the myosin light-chain protein Mlc2. Furthermore, the thiamine-repressible S. cerevisiae THI13 promoter was established to regulate gene expression in A. gossypii. This collection will help accelerate analysis of gene function in A. gossypii and in other ascomycetes where S. cerevisiae promoter elements are functional. (C) 2009 Elsevier Inc. All rights reserved.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Kaufmann, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM andreas.kaufmann@unibas.ch
FU University of Basel, Switzerland
FX This work was supported by funds of the University of Basel,
   Switzerland. I am indebted to Peter Philippsen for his continuing
   support, his advice, and critical reading of this manuscript. I also
   thank Dominic Hoepfner for providing pUC19NATPS, Hans-Peter Schmitz for
   pHPS144 and pHPS146, Anja Lorberg for pAN5, Mark Finlayson for pMF5, and
   Lars Molzahn for pLMz50b, and Raeka Aiyar for proofreading of this
   manuscript.
CR Alberti-Segui C, 2001, J CELL SCI, V114, P975
   AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y
   Baird GS, 2000, P NATL ACAD SCI USA, V97, P11984, DOI 10.1073/pnas.97.22.11984
   Burke D, 2000, METHODS YEAST GENETI
   Demay BS, 2009, MOL BIOL CELL, V20, P2311, DOI 10.1091/mbc.E08-12-1169
   DIETRICH FS, 2004, SCIENCE
   DUNKLER A, 2007, CURR GENET
   Entian KD, 1998, METHOD MICROBIOL, V26, P431
   FLEIG UN, 1986, GENE, V46, P237, DOI 10.1016/0378-1119(86)90408-7
   Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B
   Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100
   Hailey DW, 2002, METHOD ENZYMOL, V351, P34
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   HEIM R, 1995, NATURE, V373, P663, DOI 10.1038/373663b0
   Hein R, 1996, CURR BIOL, V6, P178, DOI 10.1016/S0960-9822(02)00450-5
   Helfer H, 2006, MOL BIOL CELL, V17, P4494, DOI 10.1091/mbc.E06-03-0215
   Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a
   Hoepfner D, 2000, MOL BIOL CELL, V11, P1197, DOI 10.1091/mbc.11.4.1197
   Huh WK, 2003, NATURE, V425, P686, DOI 10.1038/nature02026
   Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142
   Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024
   Kaufmann A, 2009, MOL CELL BIOL, V29, P771, DOI 10.1128/MCB.01150-08
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   Knechtle P, 2008, FUNGAL GENET BIOL, V45, P829, DOI 10.1016/j.fgb.2008.03.010
   Knop M, 1999, YEAST, V15, P963, DOI 10.1002/(SICI)1097-0061(199907)15:10B<963::AID-YEA399>3.0.CO;2-W
   Kohli M, 2008, J CELL SCI, V121, P1065, DOI [10.1242/jcs.015933, 10.1242/jcs.033852]
   LANGLEROUAULT F, 1995, NUCLEIC ACIDS RES, V23, P3079, DOI 10.1093/nar/23.15.3079
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   MAUNDRELL K, 1993, GENE, V123, P127, DOI 10.1016/0378-1119(93)90551-D
   MOHR C, 1997, GENETIC ENG FILAMENT
   Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87
   Ormo M, 1996, SCIENCE, V273, P1392
   Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schmitz HP, 2006, MOL BIOL CELL, V17, P130
   Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037
   Shaner NC, 2005, NAT METHODS, V2, P905, DOI 10.1038/NMETH819
   Sheff MA, 2004, YEAST, V21, P661, DOI 10.1002/yea.1130
   SIKORSKI RS, 1989, GENETICS, V122, P19
   STEINER S, 1995, GENETICS, V140, P973
   TOMMASINO M, 1991, CURR GENET, V20, P63, DOI 10.1007/BF00312766
   van Dijken JP, 2000, ENZYME MICROB TECH, V26, P706, DOI 10.1016/S0141-0229(00)00162-9
   Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.0.CO;2-K
   WACH A, 1994, YEAST, V10, P1793, DOI 10.1002/yea.320101310
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Winzeler EA, 1999, SCIENCE, V285, P901, DOI 10.1126/science.285.5429.901
   WRIGHT MC, 1991, GENE, V109, P99, DOI 10.1016/0378-1119(91)90593-Z
   Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1
   Zacharias DA, 2002, SCIENCE, V296, P913, DOI 10.1126/science.1068539
   Zhang YM, 1998, NAT GENET, V20, P123, DOI 10.1038/2417
NR 53
TC 21
Z9 21
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1087-1845
EI 1096-0937
J9 FUNGAL GENET BIOL
JI Fungal Genet. Biol.
PD AUG
PY 2009
VL 46
IS 8
BP 595
EP 603
DI 10.1016/j.fgb.2009.05.002
PG 9
WC Genetics & Heredity; Mycology
SC Genetics & Heredity; Mycology
GA 462KP
UT WOS:000267351700008
PM 19460453
DA 2021-01-25
ER

PT J
AU Wang, YY
   Hammes, F
   Boon, N
   Chami, M
   Egli, T
AF Wang, Yingying
   Hammes, Frederik
   Boon, Nico
   Chami, Mohamed
   Egli, Thomas
TI Isolation and characterization of low nucleic acid (LNA)-content
   bacteria
SO ISME JOURNAL
LA English
DT Article
DE AOC; cryo-TEM; DGGE; FACS; low nucleic acid (LNA) bacteria; extinction
   dilution
ID IN-SITU HYBRIDIZATION; DOMINANT BACTERIOPLANKTON GROUPS; FRESH-WATER
   BACTERIOPLANKTON; FLOW-CYTOMETRY; ESCHERICHIA-COLI; MARINE-BACTERIA;
   PLANKTONIC BACTERIA; ELECTRON-MICROSCOPY; DRINKING-WATER; CELL-SIZE
AB Most planktonic bacteria are 'uncultivable' with conventional methods. Flow cytometry (FCM) is one approach that has been taken to study these bacteria. In natural aquatic environments, bacteria with high nucleic acid (HNA) and low nucleic acid (LNA) content are commonly observed with FCM after staining with fluorescent dyes. Although several studies have focused on the relative abundance and in situ activities of these two groups, knowledge on the growth of particularly LNA bacteria is largely limited. In this study, typical LNA bacteria were enriched from three different freshwater sources using extinction dilution (ED) and fluorescence-activated cell sorting (FACS). We have shown for the first time that LNA bacteria can be isolated and cultivated by using sterile freshwater as a growth medium. During growth, the typical LNA characteristics (that is, low-fluorescence intensity and sideward scatter (SSC)) remained distinct from those of typical HNA bacteria. Three LNA pure cultures that are closely affiliated to the Polynucleobacter cluster according to 16S rRNA sequencing results were isolated. Owing to their small size, cells of the isolates remained intact during cryo-transmission electronic microscopy examination and showed a Gram-negative cell-wall structure. The extremely small cell volume (0.05 mu m(3)) observed for all three isolates indicates that they are among the smallest free-living heterotrophic organisms known in culture. Their isolation and cultivation allow further detailed investigation of this group of organisms under defined laboratory conditions. The ISME Journal (2009) 3, 889-902; doi: 10.1038/ismej.2009.46; published online 7 May 2009
C1 [Wang, Yingying; Hammes, Frederik; Egli, Thomas] Swiss Fed Inst Aquat Sci & Technol, Dept Environm Microbiol, EAWAG, CH-8600 Dubendorf, Switzerland.
   [Wang, Yingying; Egli, Thomas] ETH, Inst Biogeochem & Pollutant Dynam, Zurich, Switzerland.
   [Boon, Nico] Univ Ghent, Fac Biosci Engn, LabMET, B-9000 Ghent, Belgium.
   [Chami, Mohamed] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
RP Egli, T (corresponding author), Swiss Fed Inst Aquat Sci & Technol, Dept Environm Microbiol, EAWAG, Uberlandstr 133,POB 611, CH-8600 Dubendorf, Switzerland.
EM egli@eawag.ch
RI Boon, Nico/B-4083-2011; Hammes, Frederik/E-9328-2010
OI Boon, Nico/0000-0002-7734-3103; 
FU Eawag internal; EUEuropean Union (EU) [(018320]; Flemish Fund for
   Scientific ResearchFWO [GP.005.09N]
FX We are grateful to the financial support from Eawag internal funding
   (Wave21), the EU project TECHNEAU (018320), a research grant from the
   Flemish Fund for Scientific Research (FWO-Vlaanderen, GP. 005.09N) and
   electron microscope facility support from the Biozentrum of the
   University of Basel. We also thank Andreas Engel (Biozentrum, University
   of Basel) for his support and fruitful discussions, and Eva Siebel,
   Diederik Van Driessche and Oralea Buchi for their technical support.
CR Al-Amoudi A, 2004, J STRUCT BIOL, V148, P131, DOI 10.1016/j.jsb.2004.03.010
   Bernard L, 2000, MICROBIAL ECOL, V40, P148
   Berney M, 2008, WATER RES, V42, P4010, DOI 10.1016/j.watres.2008.07.017
   BILLEN G, 1990, NETH J SEA RES, V26, P265, DOI 10.1016/0077-7579(90)90093-V
   Boenigk J, 2004, APPL ENVIRON MICROB, V70, P5787, DOI 10.1128/AEM.70.10.5787-5793.2004
   Boon N, 2002, FEMS MICROBIOL ECOL, V39, P101, DOI 10.1111/j.1574-6941.2002.tb00911.x
   Bouvier T, 2007, ENVIRON MICROBIOL, V9, P2050, DOI 10.1111/j.1462-2920.2007.01321.x
   Bruns A, 2003, APPL ENVIRON MICROB, V69, P1980, DOI 10.1128/AEM.69.4.1980-1989.2003
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Eydal HSC, 2007, J MICROBIOL METH, V70, P363, DOI 10.1016/j.mimet.2007.05.012
   Felip M, 2007, APPL ENVIRON MICROB, V73, P4508, DOI 10.1128/AEM.00733-07
   Gasol JM, 1999, APPL ENVIRON MICROB, V65, P4475
   Gasol JM, 1999, AQUAT MICROB ECOL, V16, P251, DOI 10.3354/ame016251
   Glockner FO, 1999, APPL ENVIRON MICROB, V65, P3721
   GRAHAM LL, 1991, TRENDS BIOCHEM SCI, V16, P328, DOI 10.1016/0968-0004(91)90135-I
   Grossart HP, 2008, ENVIRON MICROBIOL, V10, P635, DOI 10.1111/j.1462-2920.2007.01487.x
   Hahn MW, 2005, APPL ENVIRON MICROB, V71, P4539, DOI 10.1128/AEM.71.8.4539-4547.2005
   Hahn MW, 2003, APPL ENVIRON MICROB, V69, P5248, DOI 10.1128/AEM.69.9.5248-5254.2003
   Hahn MW, 2003, APPL ENVIRON MICROB, V69, P1442, DOI 10.1128/AEM.69.3.1442-1451.2003
   Hammes FA, 2005, ENVIRON SCI TECHNOL, V39, P3289, DOI 10.1021/es048277c
   Hammes F, 2008, WATER RES, V42, P269, DOI 10.1016/j.watres.2007.07.009
   HECKMANN K, 1987, INT J SYST BACTERIOL, V37, P456, DOI 10.1099/00207713-37-4-456
   Jellett JF, 1996, MAR ECOL PROG SER, V136, P213, DOI 10.3354/meps136213
   Jochem FJ, 2004, MAR BIOL, V145, P1213, DOI 10.1007/s00227-004-1406-7
   Kajander EO, 1998, P NATL ACAD SCI USA, V95, P8274, DOI 10.1073/pnas.95.14.8274
   Koch AL, 1996, ANNU REV MICROBIOL, V50, P317, DOI 10.1146/annurev.micro.50.1.317
   Lebaron P, 2001, APPL ENVIRON MICROB, V67, P1775, DOI 10.1128/AEM.67.4.1775-1782.2001
   Lebaron P, 2002, AQUAT MICROB ECOL, V28, P131, DOI 10.3354/ame028131
   Li WKW, 1995, LIMNOL OCEANOGR, V40, P1485, DOI 10.4319/lo.1995.40.8.1485
   Longnecker K, 2005, APPL ENVIRON MICROB, V71, P7737, DOI 10.1128/AEM.71.12.7737-7749.2005
   Marie D, 1997, APPL ENVIRON MICROB, V63, P186, DOI 10.1128/AEM.63.1.186-193.1997
   Matias VRF, 2003, J BACTERIOL, V185, P6112, DOI 10.1128/JB.185.20.6112-6118.2003
   MORITA RY, 1997, BACTERIA OLIGOTROPHI, P193
   MUNSTER U, 1993, ANTON LEEUW INT J G, V63, P243, DOI 10.1007/BF00871222
   Nishimura Y, 2005, APPL ENVIRON MICROB, V71, P5828, DOI 10.1128/AEM.71.10.5828-5836.2005
   Oliver JD, 1993, STARVATION BACTERIA, P239
   Page KA, 2004, APPL ENVIRON MICROB, V70, P6542, DOI 10.1128/AEM.70.11.6542-6550.2004
   Pernthaler A, 2002, APPL ENVIRON MICROB, V68, P3094, DOI 10.1128/AEM.68.6.3094-3101.2002
   Pernthaler Annelie, 2007, Methods Mol Biol, V353, P153
   Rappe MS, 2002, NATURE, V418, P630, DOI 10.1038/nature00917
   Rappe MS, 2003, ANNU REV MICROBIOL, V57, P369, DOI 10.1146/annurev.micro.57.030502.090759
   Rosenberg E, 2002, ENVIRON MICROBIOL, V4, P318, DOI 10.1046/j.1462-2920.2002.00302.x
   SCHUT F, 1993, APPL ENVIRON MICROB, V59, P2150, DOI 10.1128/AEM.59.7.2150-2160.1993
   Schut F, 1997, AQUAT MICROB ECOL, V12, P177, DOI 10.3354/ame012177
   Sekar R, 2003, APPL ENVIRON MICROB, V69, P2928, DOI 10.1128/AEm.69.5.2928-2935.2003
   Servais P, 2003, AQUAT MICROB ECOL, V33, P41, DOI 10.3354/ame033041
   Tadonleke RD, 2005, MICROB ECOL, V49, P325, DOI 10.1007/s00248-004-0232-2
   Versalovic James, 1994, Methods in Molecular and Cellular Biology, V5, P25
   Vital M, 2008, ENVIRON MICROBIOL, V10, P2387, DOI 10.1111/j.1462-2920.2008.01664.x
   Vital M, 2007, MICROBIOL-SGM, V153, P1993, DOI 10.1099/mic.0.2006/005173-0
   Wang YY, 2008, ENVIRON SCI TECHNOL, V42, P6749, DOI 10.1021/es800720n
   Wang Y, 2007, ENVIRON SCI TECHNOL, V41, P7080, DOI 10.1021/es0707198
   WARD JH, 1963, J AM STAT ASSOC, V58, P236, DOI 10.2307/2282967
   Warnecke F, 2005, APPL ENVIRON MICROB, V71, P5551, DOI 10.1128/AEM.71.9.5551-5559.2005
   WHITE PA, 1991, MICROBIAL ECOL, V21, P99, DOI 10.1007/BF02539147
   Whitman WB, 1998, P NATL ACAD SCI USA, V95, P6578, DOI 10.1073/pnas.95.12.6578
   Wick LM, 2002, MICROBIOL-SGM, V148, P2889, DOI 10.1099/00221287-148-9-2889
   Zubkov MV, 2001, APPL ENVIRON MICROB, V67, P5210, DOI 10.1128/AEM.67.11.5210-5218.2001
   Zubkov MV, 2002, AQUAT MICROB ECOL, V29, P135, DOI 10.3354/ame029135
NR 59
TC 116
Z9 126
U1 0
U2 78
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1751-7362
EI 1751-7370
J9 ISME J
JI ISME J.
PD AUG
PY 2009
VL 3
IS 8
BP 889
EP 902
DI 10.1038/ismej.2009.46
PG 14
WC Ecology; Microbiology
SC Environmental Sciences & Ecology; Microbiology
GA 480NE
UT WOS:000268741300003
PM 19421234
OA Bronze
DA 2021-01-25
ER

PT J
AU Charbonnier, E
   Weiss, A
   Affolter, M
   Pyrowolakis, G
AF Charbonnier, Enrica
   Weiss, Alexander
   Affolter, Markus
   Pyrowolakis, George
TI Regulation of BMP signaling pathway in Drosophila melanogaster
SO MECHANISMS OF DEVELOPMENT
LA English
DT Meeting Abstract
CT 16th Annual Conference of the
   International-Society-of-Development-Biologists
CY SEP 06-10, 2009
CL Edinburgh, SCOTLAND
SP Int Soc Dev Biol
C1 [Charbonnier, Enrica; Pyrowolakis, George] Univ Freiburg, Inst Biol 1, Dept Dev Biol, D-7800 Freiburg, Germany.
   [Weiss, Alexander; Affolter, Markus] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4773
J9 MECH DEVELOP
JI Mech. Dev.
PD AUG
PY 2009
VL 126
BP S232
EP S232
DI 10.1016/j.mod.2009.06.596
PG 1
WC Developmental Biology
SC Developmental Biology
GA 497DM
UT WOS:000270034900678
DA 2021-01-25
ER

PT J
AU Hugnot, JP
   Sabourin, JC
   Ackema, K
   Ohayon, D
   Guichet, PO
   Garces, A
   Ripoll, C
   Charite, J
   Simonneau, L
   Kettenmann, H
   Zine, A
   Privat, A
   Valmier, J
   Pattyn, A
AF Hugnot, Jean-Philippe
   Sabourin, Jean-Charles
   Ackema, Karin
   Ohayon, David
   Guichet, Pierre Olivier
   Garces, Alain
   Ripoll, Chantal
   Charite, Jereon
   Simonneau, Lionel
   Kettenmann, Helmut
   Zine, Azel
   Privat, Alain
   Valmier, Jean
   Pattyn, Alex
TI A mesenchymal-like Zeb1+niche harbors dorsal radial GFAP plus stem cells
   in the spinal cord
SO MECHANISMS OF DEVELOPMENT
LA English
DT Meeting Abstract
CT 16th Annual Conference of the
   International-Society-of-Development-Biologists
CY SEP 06-10, 2009
CL Edinburgh, SCOTLAND
SP Int Soc Dev Biol
C1 [Hugnot, Jean-Philippe; Sabourin, Jean-Charles; Ohayon, David; Guichet, Pierre Olivier; Garces, Alain; Ripoll, Chantal; Simonneau, Lionel; Zine, Azel; Privat, Alain; Valmier, Jean; Pattyn, Alex] INSERM, U583, Inst Neurosci, Montpellier, France.
   [Charite, Jereon] Erasmus Univ, Dept Cell Biol, NL-3000 DR Rotterdam, Netherlands.
   [Ackema, Karin] Univ Basel, Biozentrum, Basel, Switzerland.
   [Kettenmann, Helmut] Max Delbruck Ctr Mol Med, Berlin, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 1
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4773
J9 MECH DEVELOP
JI Mech. Dev.
PD AUG
PY 2009
VL 126
BP S240
EP S240
DI 10.1016/j.mod.2009.06.623
PG 1
WC Developmental Biology
SC Developmental Biology
GA 497DM
UT WOS:000270034900701
DA 2021-01-25
ER

PT J
AU Ninov, N
   Manjon, C
   Cabral, S
   Weiss, A
   Pyrowolakis, G
   Affolter, M
   Martin-Blanco, E
   Prat, CR
AF Ninov, Nikolay
   Manjon, Cristina
   Cabral, Sofia
   Weiss, Alexander
   Pyrowolakis, George
   Affolter, Markus
   Martin-Blanco, Enrique
   Prat, Carla R.
TI Dpp signalling directs cell motility and invasiveness during epithelial
   morphogenesis
SO MECHANISMS OF DEVELOPMENT
LA English
DT Meeting Abstract
CT 16th Annual Conference of the
   International-Society-of-Development-Biologists
CY SEP 06-10, 2009
CL Edinburgh, SCOTLAND
SP Int Soc Dev Biol
C1 [Ninov, Nikolay; Manjon, Cristina; Cabral, Sofia; Martin-Blanco, Enrique; Prat, Carla R.] Inst Biol Mol Barcelona, Barcelona, Spain.
   [Weiss, Alexander; Pyrowolakis, George; Affolter, Markus] Univ Basel, Biozentrum, Basel, Switzerland.
   [Pyrowolakis, George] Univ Freiburg, Freiburg, Germany.
RI Martin-Blanco, Enrique/ABH-1280-2020
OI Martin-Blanco, Enrique/0000-0002-6926-910X
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0925-4773
J9 MECH DEVELOP
JI Mech. Dev.
PD AUG
PY 2009
VL 126
BP S313
EP S313
DI 10.1016/j.mod.2009.06.864
PG 1
WC Developmental Biology
SC Developmental Biology
GA 497DM
UT WOS:000270034900928
DA 2021-01-25
ER

PT J
AU Hutzinger, R
   Feederle, R
   Mrazek, J
   Schiefermeier, N
   Balwierz, PJ
   Zavolan, M
   Polacek, N
   Delecluse, HJ
   Huttenhofer, A
AF Hutzinger, Roland
   Feederle, Regina
   Mrazek, Jan
   Schiefermeier, Natalia
   Balwierz, Piotr J.
   Zavolan, Mihaela
   Polacek, Norbert
   Delecluse, Henri-Jacques
   Huettenhofer, Alexander
TI Expression and Processing of a Small Nucleolar RNA from the Epstein-Barr
   Virus Genome
SO PLOS PATHOGENS
LA English
DT Article
ID TRANSFORMED T-CELLS; NON-MESSENGER RNAS; NONCODING RNAS; SMALL NUCLEAR;
   RIBOSOMAL-RNA; SACCHAROMYCES-CEREVISIAE; MARMOSET LEUKOCYTES; ENCODED
   MICRORNAS; PRERIBOSOMAL RNA; DNA-REPLICATION
AB Small nucleolar RNAs (snoRNAs) are localized within the nucleolus, a sub-nuclear compartment, in which they guide ribosomal or spliceosomal RNA modifications, respectively. Up until now, snoRNAs have only been identified in eukaryal and archaeal genomes, but are notably absent in bacteria. By screening B lymphocytes for expression of non-coding RNAs (ncRNAs) induced by the Epstein-Barr virus (EBV), we here report, for the first time, the identification of a snoRNA gene within a viral genome, designated as v-snoRNA1. This genetic element displays all hallmark sequence motifs of a canonical C/D box snoRNA, namely C/C'-as well as D/D'-boxes. The nucleolar localization of v-snoRNA1 was verified by in situ hybridisation of EBV-infected cells. We also confirmed binding of the three canonical snoRNA proteins, fibrillarin, Nop56 and Nop58, to v-snoRNA1. The C-box motif of v-snoRNA1 was shown to be crucial for the stability of the viral snoRNA; its selective deletion in the viral genome led to a complete down-regulation of v-snoRNA1 expression levels within EBV-infected B cells. We further provide evidence that v-snoRNA1 might serve as a miRNA-like precursor, which is processed into 24 nt sized RNA species, designated as v-snoRNA1(24pp). A potential target site of v-snoRNA1(24pp) was identified within the 3'-UTR of BALF5 mRNA which encodes the viral DNA polymerase. V-snoRNA1 was found to be expressed in all investigated EBV-positive cell lines, including lymphoblastoid cell lines (LCL). Interestingly, induction of the lytic cycle markedly up-regulated expression levels of v-snoRNA1 up to 30-fold. By a computational approach, we identified a v-snoRNA1 homolog in the rhesus lymphocryptovirus genome. This evolutionary conservation suggests an important role of v-snoRNA1 during gamma-herpesvirus infection.
C1 [Hutzinger, Roland; Polacek, Norbert; Huettenhofer, Alexander] Innsbruck Med Univ, Innsbruck Bioctr, Div Genom & RNom, Innsbruck, Austria.
   [Feederle, Regina; Delecluse, Henri-Jacques] German Canc Res Ctr, Dept Virus Associated Tumours, D-6900 Heidelberg, Germany.
   [Mrazek, Jan] Univ Calif Los Angeles, Dept Biol Chem, David Geffen Sch Med, Los Angeles, CA 90024 USA.
   [Schiefermeier, Natalia] Innsbruck Med Univ, Innsbruck Bioctr, Div Cell Biol, Innsbruck, Austria.
   [Balwierz, Piotr J.; Zavolan, Mihaela] Univ Basel, Biozentrum, Swiss Inst Bioinformat, Basel, Switzerland.
RP Hutzinger, R (corresponding author), Innsbruck Med Univ, Innsbruck Bioctr, Div Genom & RNom, Innsbruck, Austria.
EM h.delecluse@dkfz-heidelberg.de; alexander.huettenhofer@i-med.ac.at
RI Polacek, Norbert/AAV-7346-2020; Balwierz, Piotr J/AAG-4187-2020;
   Zavolan, Mihaela/S-3888-2016
OI Balwierz, Piotr J/0000-0002-1548-4605; Zavolan,
   Mihaela/0000-0002-8832-2041; Schiefermeier-Mach,
   Natalia/0000-0001-6638-5298; Delecluse,
   Henri-Jacques/0000-0002-1744-6274; Polacek, Norbert/0000-0001-5317-3990
FU Austrian genome [D-110420-011-013, D-11420-011-015]; DKFZHelmholtz
   Association
FX This work was supported by two Austrian genome research grants (Gen-Au
   grant D-110420-011-013) to A. H. and N. P. and (D-11420-011-015) to A.
   H. and by DKFZ grant to H-J.D. The funders had no role in study design,
   data collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Amaral PP, 2008, SCIENCE, V319, P1787, DOI 10.1126/science.1155472
   Aspegren A, 2004, NUCLEIC ACIDS RES, V32, P4646, DOI 10.1093/nar/gkh804
   Bachellerie JP, 2002, BIOCHIMIE, V84, P775, DOI 10.1016/S0300-9084(02)01402-5
   Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080
   Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110
   Cai XZ, 2006, PLOS PATHOG, V2, P236, DOI 10.1371/journal.ppat.0020023
   Cavaille J, 1998, NUCLEIC ACIDS RES, V26, P1576, DOI 10.1093/nar/26.7.1576
   Chen HL, 2005, J VIROL, V79, P1724, DOI 10.1128/JVI.79.3.1724-1733.2005
   CHEREPANOV PP, 1995, GENE, V158, P9, DOI 10.1016/0378-1119(95)00193-A
   Choy EYW, 2008, J EXP MED, V205, P2551, DOI 10.1084/jem.20072581
   Cook HL, 2005, CURR BIOL, V15, P974, DOI 10.1016/j.cub.2005.04.034
   Cook HL, 2004, MOL CELL BIOL, V24, P4522, DOI 10.1128/MCB.24.10.4522-4533.2004
   Day L, 2007, J VIROL, V81, P6389, DOI 10.1128/JVI.02172-06
   Delecluse HJ, 1998, P NATL ACAD SCI USA, V95, P8245, DOI 10.1073/pnas.95.14.8245
   Dragon F, 2002, NATURE, V417, P967, DOI 10.1038/nature00769
   Edwards RH, 2008, J VIROL, V82, P9094, DOI 10.1128/JVI.00785-08
   Ender C, 2008, MOL CELL, V32, P519, DOI 10.1016/j.molcel.2008.10.017
   Falk KI, 1998, J VIROL, V72, P2969, DOI 10.1128/JVI.72.4.2969-2974.1998
   Feederle R, 2000, EMBO J, V19, P3080, DOI 10.1093/emboj/19.12.3080
   FEEDERLE R, 2009, J VIROL
   Fok V, 2006, J CELL BIOL, V173, P319, DOI 10.1083/jcb.200601026
   FRECH B, 1990, J VIROL, V64, P2759, DOI 10.1128/JVI.64.6.2759-2767.1990
   Ganot P, 1997, CELL, V89, P799, DOI 10.1016/S0092-8674(00)80263-9
   Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022
   GRIFFIN BE, 1981, J VIROL, V40, P11, DOI 10.1128/JVI.40.1.11-19.1981
   HAMMERSCHMIDT W, 1988, CELL, V55, P427, DOI 10.1016/0092-8674(88)90028-1
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Hislop AD, 2007, ANNU REV IMMUNOL, V25, P587, DOI 10.1146/annurev.immunol.25.022106.141553
   Holzerlandt R, 2002, GENOME RES, V12, P1739, DOI 10.1101/gr.334302
   HUANG GM, 1992, MOL CELL BIOL, V12, P4456, DOI 10.1128/MCB.12.10.4456
   Huttenhofer A, 2006, NAT REV GENET, V7, P475, DOI 10.1038/nrg1855
   Huttenhofer A, 2005, TRENDS GENET, V21, P289, DOI 10.1016/j.tig.2005.03.007
   Huttenhofer A, 2002, CURR OPIN CHEM BIOL, V6, P835, DOI 10.1016/S1367-5931(02)00397-6
   Huttenhofer A, 2001, EMBO J, V20, P2943, DOI 10.1093/emboj/20.11.2943
   Janz A, 2000, J VIROL, V74, P10142, DOI 10.1128/JVI.74.21.10142-10152.2000
   JARMOLOWSKI A, 1990, EMBO J, V9, P4503, DOI 10.1002/j.1460-2075.1990.tb07901.x
   Jochl C, 2008, NUCLEIC ACIDS RES, V36, P2677, DOI 10.1093/nar/gkn123
   Kelly G, 2002, NAT MED, V8, P1098, DOI 10.1038/nm758
   Kim DN, 2007, J VIROL, V81, P1033, DOI 10.1128/JVI.02271-06
   Kishore S, 2006, SCIENCE, V311, P230, DOI 10.1126/science.1118265
   Kiss AM, 2004, MOL CELL BIOL, V24, P5797, DOI 10.1128/MCB.24.13.5797-5807.2004
   Kiss T, 2002, CELL, V109, P145, DOI 10.1016/S0092-8674(02)00718-3
   Kiss T, 2001, EMBO J, V20, P3617, DOI 10.1093/emboj/20.14.3617
   KissLaszlo Z, 1996, CELL, V85, P1077, DOI 10.1016/S0092-8674(00)81308-2
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   LERNER MR, 1981, P NATL ACAD SCI-BIOL, V78, P805, DOI 10.1073/pnas.78.2.805
   Llave C, 2002, SCIENCE, V297, P2053, DOI 10.1126/science.1076311
   Lo AKF, 2007, P NATL ACAD SCI USA, V104, P16164, DOI 10.1073/pnas.0702896104
   MADEN BEH, 1995, BIOCHIMIE, V77, P22, DOI 10.1016/0300-9084(96)88100-4
   Mandin P, 2007, NUCLEIC ACIDS RES, V35, P962, DOI 10.1093/nar/gkl1096
   Maroney PA, 2007, RNA, V13, P930, DOI 10.1261/rna.518107
   Matera AG, 2007, NAT REV MOL CELL BIO, V8, P209, DOI 10.1038/nrm2124
   Mattick JS, 2004, NAT REV GENET, V5, P316, DOI 10.1038/nrg1321
   Michienzi A, 2000, P NATL ACAD SCI USA, V97, P8955, DOI 10.1073/pnas.97.16.8955
   MILLER G, 1973, P NATL ACAD SCI USA, V70, P190, DOI 10.1073/pnas.70.1.190
   MILLER G, 1972, P NATL ACAD SCI USA, V69, P383, DOI 10.1073/pnas.69.2.383
   Mrazek J, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm244
   Murray P G, 2001, Expert Rev Mol Med, V3, P1, DOI 10.1017/S1462399401003842
   Neuhierl Bernhard, 2005, Methods Mol Biol, V292, P353
   Omer AD, 2000, SCIENCE, V288, P517, DOI 10.1126/science.288.5465.517
   Pfeffer S, 2006, ONCOGENE, V25, P6211, DOI 10.1038/sj.onc.1209915
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   PRATT ZL, 2009, VIROLOGY
   RANGAN SRS, 1986, INT J CANCER, V38, P425, DOI 10.1002/ijc.2910380319
   Rickinson AB, 2007, EPSTEIN BARR VIRUS, P2655
   Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005
   Samarsky DA, 1998, EMBO J, V17, P3747, DOI 10.1093/emboj/17.13.3747
   Saraiya AA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000224
   Straathof KCM, 2003, ONCOLOGIST, V8, P83, DOI 10.1634/theoncologist.8-1-83
   Sullivan CS, 2008, NAT REV GENET, V9, P503, DOI 10.1038/nrg2349
   Xing L, 2007, J VIROL, V81, P9967, DOI 10.1128/JVI.02244-06
   Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434
   Zhu JY, 2009, J VIROL, V83, P3333, DOI 10.1128/JVI.01689-08
NR 73
TC 62
Z9 66
U1 0
U2 3
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD AUG
PY 2009
VL 5
IS 8
AR e1000547
DI 10.1371/journal.ppat.1000547
PG 13
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 506VK
UT WOS:000270804500019
PM 19680535
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Arber, W
AF Arber, Werner
TI Genetically encoded generators of genetic variants
SO JOURNAL OF PROTEOMICS
LA English
DT Review
DE Biological evolution; Spontaneous mutagenesis; Evolution genes; DNA
   recombination and repair; DNA acquisition; Activities of isomeric
   conformations
ID SEQUENCE
AB Several specific molecular mechanisms contribute to the generation of genetic variants at low rates. Some of these mechanisms involve the action of specific gene products as variation generators. We discuss here known as well as still hypothetical ways by which natural reality may succeed to keep the rates of genetic variation at low levels that insure a relatively high genetic stability of the individual organisms. (C) 2008 Elsevier B.V. All rights reserved.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Werner.Arber@unibas.ch
CR Arber W, 2005, PROTEOMICS, V5, DOI 10.1002/pmic.200401124
   Arber W, 2003, GENE, V317, P3, DOI 10.1016/S0378-1119(03)00654-1
   ARBER W, 1995, J MOL EVOL, V40, P7, DOI 10.1007/BF00166591
   Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x
   Arber W., 2002, V264/I, P1
   Arber W, 2007, GENOMICS GENETICS, V1, P385
   Arber W., 2008, PREDICTABILITY SCI A, V19, P126
   IIDA S, 1987, MOL GEN GENET, V208, P464, DOI 10.1007/BF00328140
   Saravanan M, 2008, P NATL ACAD SCI USA, V105, P10344, DOI 10.1073/pnas.0804974105
   SENGSTAG C, 1983, EMBO J, V2, P1777, DOI 10.1002/j.1460-2075.1983.tb01657.x
   Weber M, 1996, BIOL PHILOS, V11, P67, DOI 10.1007/BF00127472
NR 11
TC 1
Z9 1
U1 0
U2 0
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1874-3919
EI 1876-7737
J9 J PROTEOMICS
JI J. Proteomics
PD JUL 21
PY 2009
VL 72
IS 5
BP 836
EP 837
DI 10.1016/j.jprot.2008.11.002
PG 2
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 478RA
UT WOS:000268604400012
PM 19041737
DA 2021-01-25
ER

PT J
AU Scherr, N
   Muller, P
   Perisa, D
   Combaluzier, B
   Jeno, P
   Pieters, J
AF Scherr, Nicole
   Mueller, Philipp
   Perisa, Damir
   Combaluzier, Benoit
   Jenoe, Paul
   Pieters, Jean
TI Survival of Pathogenic Mycobacteria in Macrophages Is Mediated through
   Autophosphorylation of Protein Kinase G
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID SERINE/THREONINE KINASES; STRUCTURAL BASIS; FHA DOMAINS; SER/THR;
   TUBERCULOSIS; PHOSPHORYLATION; ACTIVATION; PKNF; ELECTROPHORESIS;
   PHOSPHATASE
AB Pathogenic mycobacteria survive within macrophages through the inhibition of phagosome-lysosome fusion. A crucial factor for avoiding lysosomal degradation is the mycobacterial serine/threonine protein kinase G (PknG). PknG is released into the macrophage cytosol upon mycobacterial infection, suggesting that PknG might exert its activity by interfering with host signaling cascades, but the mode of action of PknG remains unknown. Here, we show that PknG undergoes autophosphorylation on threonine residues located at the N terminus. In contrast to all other mycobacterial kinases investigated thus far, autophosphorylation of PknG was not involved in the regulation of its kinase activity. However, autophosphorylation was crucial for the capacity of PknG to promote mycobacterial survival within macrophages. These results will contribute to a better understanding of the virulence mechanisms of pathogenic mycobacteria and may help to design improved inhibitors of PknG to be developed as antimycobacterial compounds.
C1 [Scherr, Nicole; Mueller, Philipp; Perisa, Damir; Combaluzier, Benoit; Jenoe, Paul; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
RI Perisa, Damir/I-4217-2012
OI Pieters, Jean/0000-0002-5284-9757
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Lungenliga; Olga Mayenfisch Stiftung; Swiss Life Foundation;
   Kanton Basel Stadt
FX This work was supported by the Swiss National Science Foundation, the
   Lungenliga, the Olga Mayenfisch Stiftung, the Swiss Life Foundation, and
   the Kanton Basel Stadt.; We thank Suzette Moes, Martin Bratschi, and
   Rajesh Jayachandran for expert help and support.
CR Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0
   Boitel B, 2003, MOL MICROBIOL, V49, P1493, DOI 10.1046/j.1365-2958.2003.03657.x
   BURNETTE WN, 1981, ANAL BIOCHEM, V112, P195, DOI 10.1016/0003-2697(81)90281-5
   Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159
   Duran R, 2005, BIOCHEM BIOPH RES CO, V333, P858, DOI 10.1016/j.bbrc.2005.05.173
   Durocher D, 2002, FEBS LETT, V513, P58, DOI 10.1016/S0014-5793(01)03294-X
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645
   Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405
   Hasan Z, 1998, ELECTROPHORESIS, V19, P1179, DOI 10.1002/elps.1150190719
   Hasan Z, 1997, MOL MICROBIOL, V24, P545, DOI 10.1046/j.1365-2958.1997.3591731.x
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Johnson LN, 1996, CELL, V85, P149, DOI 10.1016/S0092-8674(00)81092-2
   Koul A, 2001, MICROBIOL-SGM, V147, P2307, DOI 10.1099/00221287-147-8-2307
   Molle V, 2004, FEMS MICROBIOL LETT, V234, P215, DOI 10.1016/j.femsle.2004.03.033
   Molle V, 2003, BIOCHEMISTRY-US, V42, P15300, DOI 10.1021/bi035150b
   Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005
   Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024
   O'Hare HM, 2008, MOL MICROBIOL, V70, P1408, DOI 10.1111/j.1365-2958.2008.06489.x
   Pallen M, 2002, TRENDS MICROBIOL, V10, P556, DOI 10.1016/S0966-842X(02)02476-9
   PIETERS, 2008, HDB TUBERCULOSIS MOL
   Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034
   Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049
   Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104
   Scherr Nicole, 2009, P171
   Sharma K, 2006, FEBS J, V273, P2711, DOI 10.1111/j.1742-4658.2006.05289.x
   SMITH JA, 1993, MOL CELL BIOCHEM, V128, P51, DOI 10.1007/BF01076757
   TULP A, 1993, ELECTROPHORESIS, V14, P1295, DOI 10.1002/elps.11501401198
   TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
NR 30
TC 45
Z9 48
U1 0
U2 8
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD JUL 15
PY 2009
VL 191
IS 14
BP 4546
EP 4554
DI 10.1128/JB.00245-09
PG 9
WC Microbiology
SC Microbiology
GA 462RH
UT WOS:000267372900007
PM 19447903
OA Bronze, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Hamaratoglu, F
   Gajewski, K
   Sansores-Garcia, L
   Morrison, C
   Tao, CY
   Halder, G
AF Hamaratoglu, Fisun
   Gajewski, Kathleen
   Sansores-Garcia, Leticia
   Morrison, Clayton
   Tao, Chunyao
   Halder, Georg
TI The Hippo tumor-suppressor pathway regulates apical-domain size in
   parallel to tissue growth
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Cell polarity; Drosophila; Growth control; Hippo
ID CELL-PROLIFERATION; SIGNALING PATHWAY; PROMOTES APOPTOSIS; ORGAN SIZE;
   PHOTORECEPTOR MORPHOGENESIS; EPITHELIAL POLARITY; DROSOPHILA HOMOLOG;
   TEAD/TEF FAMILY; GENETIC MOSAICS; BANTAM MICRORNA
AB The Hippo tumor-suppressor pathway controls tissue growth in Drosophila and mammals by regulating cell proliferation and apoptosis. The Hippo pathway includes the Fat cadherin, a transmembrane protein, which acts upstream of several other components that form a kinase cascade that culminates in the regulation of gene expression through the transcriptional coactivator Yorkie (Yki). Our previous work in Drosophila indicated that Merlin (Mer) and Expanded (Ex) are members of the Hippo pathway and act upstream of the Hippo kinase. In contrast to this model, it was suggested that Mer and Ex primarily regulate membrane dynamics and receptor trafficking, thereby affecting Hippo pathway activity only indirectly. Here, we examined the effects of Mer, Ex and the Hippo pathway on the size of the apical membrane and on apical-basal polarity complexes. We found that mer; ex double mutant imaginal disc cells have significantly increased levels of apical membrane determinants, such as Crb, aPKC and Patj. These phenotypes were shared with mutations in other Hippo pathway components and required Yki, indicating that Mer and Ex signal through the Hippo pathway. Interestingly, however, whereas Crb was required for the accumulation of other apical proteins and for the expansion of the apical domain observed in Hippo pathway mutants, its elimination did not significantly reverse the overgrowth phenotype of warts mutant cells. Therefore, Hippo signaling regulates cell polarity complexes in addition to and independently of its growth control function in imaginal disc cells.
C1 [Hamaratoglu, Fisun; Morrison, Clayton; Halder, Georg] Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.
   [Hamaratoglu, Fisun; Sansores-Garcia, Leticia; Morrison, Clayton; Tao, Chunyao; Halder, Georg] Univ Texas MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.
   [Hamaratoglu, Fisun] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Gajewski, Kathleen] Univ Texas MD Anderson Canc Ctr, Dept Syst Biol, Houston, TX 77030 USA.
   [Halder, Georg] Univ Texas MD Anderson Canc Ctr, Program Genes & Dev, Houston, TX 77030 USA.
RP Halder, G (corresponding author), Baylor Coll Med, Program Dev Biol, Houston, TX 77030 USA.
EM ghalder@mdanderson.org
RI Halder, Georg/F-2966-2015
OI Halder, Georg/0000-0001-7580-3236; Hamaratoglu,
   Fisun/0000-0002-1461-9248
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [CA 16672]; NATIONAL CANCER
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)
   [P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672,
   P30CA016672, P30CA016672, P30CA016672, P30CA016672, P30CA016672] Funding
   Source: NIH RePORTER
FX We thank Deborah Andrew, Hugo Bellen, David Bilder, Seth Blair, Peter
   Bryant, Kwang- Wook Choi, Richard G. Fehon, Bruce Hay, Allen Laughon,
   Graeme Mardon, Marek Mlodzik, Duojia Pan, Michael A. Simon, the
   Bloomington Drosophila Stock Center, and the Developmental Studies
   Hybridoma Bank (University of Iowa) for fly stocks and antibodies. We
   thank Kenn Dunner, Jr for help with EM imaging. Special thanks to Markus
   Affolter in whose laboratory part of this work was done. We thank
   Vincent Dion and Oguz Kanca for critical reading of the manuscript. This
   work was supported by an NIH grant to G. H., and non- overlapping Roche
   Research Foundation and MC- IEF postdoctoral fellowships to F. H. The M.
   D. Anderson EM Core Facility is supported by NIH grant CA 16672.
   Deposited in PMC for release after 12 months.
CR Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029
   Bennett FC, 2006, CURR BIOL, V16, P2101, DOI 10.1016/j.cub.2006.09.045
   Bilder D, 2003, NAT CELL BIOL, V5, P53, DOI 10.1038/ncb897
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Cho E, 2004, DEVELOPMENT, V131, P4489, DOI 10.1242/dev.01315
   Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887
   Datar SA, 2000, EMBO J, V19, P4543, DOI 10.1093/emboj/19.17.4543
   Dong JX, 2007, CELL, V130, P1120, DOI 10.1016/j.cell.2007.07.019
   Dutta S, 2008, CURR BIOL, V18, P1466, DOI 10.1016/j.cub.2008.08.052
   Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102
   Emoto K, 2006, NATURE, V443, P210, DOI 10.1038/nature05090
   Feng YQ, 2007, P NATL ACAD SCI USA, V104, P20362, DOI 10.1073/pnas.0706722105
   Goulev Y, 2008, CURR BIOL, V18, P435, DOI 10.1016/j.cub.2008.02.034
   Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339
   Harvey KF, 2003, CELL, V114, P457, DOI 10.1016/S0092-8674(03)00557-9
   Henrique D, 2003, CURR OPIN GENET DEV, V13, P341, DOI 10.1016/S0959-437X(03)00077-7
   Hipfner DR, 2002, GENETICS, V161, P1527
   Huang JB, 2005, CELL, V122, P421, DOI 10.1016/j.cell.2005.06.007
   Izaddoost S, 2002, NATURE, V416, P178, DOI 10.1038/nature720
   Jaiswal M, 2006, DEVELOPMENT, V133, P925, DOI 10.1242/dev.02243
   Jia JH, 2003, GENE DEV, V17, P2514, DOI 10.1101/gad.1134003
   Johnson K, 2003, NAT CELL BIOL, V5, P12, DOI 10.1038/ncb0103-12
   Johnston LA, 1999, CELL, V98, P779, DOI 10.1016/S0092-8674(00)81512-3
   JUSTICE RW, 1995, GENE DEV, V9, P534, DOI 10.1101/gad.9.5.534
   Kango-Singh M, 2002, DEVELOPMENT, V129, P5719, DOI 10.1242/dev.00168
   Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324
   Maitra S, 2006, CURR BIOL, V16, P702, DOI 10.1016/j.cub.2006.02.063
   Mao YP, 2006, DEVELOPMENT, V133, P2539, DOI 10.1242/dev.02427
   Meignin C, 2007, CURR BIOL, V17, P1871, DOI 10.1016/j.cub.2007.09.062
   Mikeladze-Dvali T, 2005, CELL, V122, P775, DOI 10.1016/j.cell.2005.07.026
   Nam SC, 2003, DEVELOPMENT, V130, P4363, DOI 10.1242/dev.00648
   Nolo R, 2006, CURR BIOL, V16, P1895, DOI 10.1016/j.cub.2006.08.057
   Oh H, 2008, DEVELOPMENT, V135, P1081, DOI 10.1242/dev.015255
   Pan DJ, 2007, GENE DEV, V21, P886, DOI 10.1101/gad.1536007
   Pantalacci S, 2003, NAT CELL BIOL, V5, P921, DOI 10.1038/ncb1051
   Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721
   Polesello C, 2007, CURR BIOL, V17, P1864, DOI 10.1016/j.cub.2007.09.049
   Reddy BVVG, 2008, DEVELOPMENT, V135, P2827, DOI 10.1242/dev.020974
   RICHARDSON H, 1995, DEVELOPMENT, V121, P3371
   Silva E, 2006, CURR BIOL, V16, P2081, DOI 10.1016/j.cub.2006.09.004
   Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031
   Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898
   Tanentzapf G, 2003, NAT CELL BIOL, V5, P46, DOI 10.1038/ncb896
   Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013
   Udan RS, 2003, NAT CELL BIOL, V5, P914, DOI 10.1038/ncb1050
   Willecke M, 2006, CURR BIOL, V16, P2090, DOI 10.1016/j.cub.2006.09.005
   Willecke M, 2008, P NATL ACAD SCI USA, V105, P14897, DOI 10.1073/pnas.0805201105
   WODARZ A, 1995, CELL, V82, P67, DOI 10.1016/0092-8674(95)90053-5
   Wu S, 2003, CELL, V114, P445, DOI 10.1016/S0092-8674(03)00549-X
   Wu S, 2008, DEV CELL, V14, P388, DOI 10.1016/j.devcel.2008.01.007
   XU T, 1993, DEVELOPMENT, V117, P1223
   XU TA, 1995, DEVELOPMENT, V121, P1053
   Yu JZ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001761
   Zhang L, 2008, DEV CELL, V14, P377, DOI 10.1016/j.devcel.2008.01.006
NR 54
TC 64
Z9 64
U1 0
U2 6
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD JUL 15
PY 2009
VL 122
IS 14
BP 2351
EP 2359
DI 10.1242/jcs.046482
PG 9
WC Cell Biology
SC Cell Biology
GA 474BQ
UT WOS:000268257600004
PM 19531584
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Longordo, F
   Kopp, C
   Mishina, M
   Lujan, R
   Luthi, A
AF Longordo, Fabio
   Kopp, Caroline
   Mishina, Masayoshi
   Lujan, Rafael
   Luethi, Anita
TI NR2A at CA1 Synapses Is Obligatory for the Susceptibility of Hippocampal
   Plasticity to Sleep Loss
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
ID LONG-TERM POTENTIATION; BIDIRECTIONAL SYNAPTIC PLASTICITY;
   NR2B-CONTAINING NMDA RECEPTORS; MICE LACKING; SUBTYPE SELECTIVITY;
   SUBUNIT COMPOSITION; DIFFERENTIAL ROLES; DEPRIVATION; LTP; GLUTAMATE
AB A loss in the necessary amount of sleep alters expression of genes and proteins implicated in brain plasticity, but key proteins that render neuronal circuits sensitive to sleep disturbance are unknown. We show that mild (4-6 h) sleep deprivation (SD) selectively augmented the number of NR2A subunits of NMDA receptors on postsynaptic densities of adult mouse CA1 synapses. The greater synaptic NR2A content facilitated induction of CA3-CA1 long-term depression in the theta frequency stimulation range and augmented the synaptic modification threshold. NR2A-knock-out mice maintained behavioral response to SD, including compensatory increase in post-deprivation resting time, but hippocampal synaptic plasticity was insensitive to sleep loss. After SD, the balance between synaptically activated and slowly recruited NMDA receptor pools during temporal summation was disrupted. Together, these results indicate that NR2A is obligatory for the consequences of sleep loss on hippocampal synaptic plasticity. These findings could advance pharmacological strategies aiming to sustain hippocampal function during sleep restriction.
C1 [Longordo, Fabio; Luethi, Anita] Univ Lausanne, Dept Cell Biol & Morphol, CH-1005 Lausanne, Switzerland.
   [Kopp, Caroline] Univ Basel, Biozentrum, CH-4009 Basel, Switzerland.
   [Mishina, Masayoshi] Univ Tokyo, Dept Mol Neurobiol & Pharmacol, Grad Sch Med, Tokyo 1130033, Japan.
   [Lujan, Rafael] Univ Castilla La Mancha, Dept Ciencias Med, Fac Med, Albacete 02006, Spain.
RP Luthi, A (corresponding author), Univ Lausanne, Dept Cell Biol & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.
EM anita.luthi@unil.ch
RI Lujan, Rafael/G-2555-2015
OI Luthi, Anita/0000-0002-4954-4143; Lujan Miras,
   Rafael/0000-0003-2001-9545
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-116006]; Consejerla de Educacion y Ciencia; Junta de
   Comunidades de Castilla-La ManchaJunta de Comunidades de Castilla-La
   Mancha [PAI08-0174-6967]; Grants-in-Aid for Scientific ResearchMinistry
   of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [21249012] Funding Source: KAKEN; NATIONAL INSTITUTE
   OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS) [U24NS050606,
   U24NS050606, U24NS050606, U24NS050606, U24NS050606, U24NS050606,
   U24NS050606, U24NS050606, U24NS050606, U24NS050606, U24NS050606,
   U24NS050606, U24NS050606, U24NS050606] Funding Source: NIH RePORTER
FX This work was supported by grants from the Swiss National Science
   Foundation to A. L. (No. 3100A0-116006) and from the Consejerla de
   Educacion y Ciencia, Junta de Comunidades de Castilla-La Mancha
   (PAI08-0174-6967) to R. L. A. L. was supported by the Prof. Dr.
   MaxCloetta Foundation. The monoclonal anti-NR2B glutamate receptor
   antibody (NeuroMab clone N59/20) was obtained from the University of
   California, Davis/National Institutes of Health (NIH) NeuroMab Facility,
   supported by NIH Grant U24NS050606 and maintained by the Department of
   Neurobiology, Physiology and Behavior, College of Biological Sciences,
   University of California, Davis (Davis, CA). We thank Dr. Delpire for
   making the NR2A-knock-out mice available to us. We are indebted to Prof.
   G. K. Popescu for providing us with the reaction rate models of NR2A-and
   NR2B-NMDA receptor subtypes. The constructive input of Profs. L. Acsady,
   M. Scanziani, and K. Vogt in the course of the experiments is greatly
   appreciated. We thank Prof. U. Gerber and Drs. S. Astori and A. Scimemi
   for critical reading of this manuscript. Dr. Y. Auberson (Novartis,
   Basel) kindly provided us with the NVP-AAM077. CP-101,606 was made
   available through Pfizer (Groton, CT). We thank C. Haeberli for
   excellent technical assistance.
CR Al-Hallaq RA, 2007, J NEUROSCI, V27, P8334, DOI 10.1523/JNEUROSCI.2155-07.2007
   Arnth-Jensen N, 2002, NAT NEUROSCI, V5, P325, DOI 10.1038/nn825
   Bannerman DM, 2008, J NEUROSCI, V28, P3623, DOI 10.1523/JNEUROSCI.3639-07.2008
   Barria A, 2005, NEURON, V48, P289, DOI 10.1016/j.neuron.2005.08.034
   Bartlett TE, 2007, NEUROPHARMACOLOGY, V52, P60, DOI 10.1016/j.neuropharm.2006.07.013
   BEACH ME, 1995, CELL, V81, P905, DOI 10.1016/0092-8674(95)90010-1
   Bellone C, 2007, NEURON, V55, P779, DOI 10.1016/j.neuron.2007.07.035
   Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005
   Campbell IG, 2002, J NEUROPHYSIOL, V88, P1073, DOI 10.1152/jn.2002.88.2.1073
   Chazot PL, 2002, NEUROPHARMACOLOGY, V42, P319, DOI 10.1016/S0028-3908(01)00191-5
   Chen C, 2006, BIOCHEM BIOPH RES CO, V340, P435, DOI 10.1016/j.bbrc.2005.12.021
   Chen WS, 2007, NEUROPHARMACOLOGY, V52, P200, DOI 10.1016/j.neuropharm.2006.07.003
   Cirelli C, 2006, SLEEP MED REV, V10, P307, DOI 10.1016/j.smrv.2006.04.001
   CLEMENTS JD, 1992, SCIENCE, V258, P1498, DOI 10.1126/science.1359647
   Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16
   Dang-Vu T T, 2006, Pediatr Rehabil, V9, P98, DOI 10.1080/13638490500138702
   Davis CJ, 2003, BRAIN RES, V973, P293, DOI 10.1016/S0006-8993(03)02508-3
   Diamond JS, 1997, J NEUROSCI, V17, P4672
   Diamond JS, 2001, J NEUROSCI, V21, P8328
   Erreger K, 2005, J PHYSIOL-LONDON, V563, P345, DOI 10.1113/jphysiol.2004.080028
   Fagiolini M, 2003, P NATL ACAD SCI USA, V100, P2854, DOI 10.1073/pnas.0536089100
   Finnerty GT, 1999, NATURE, V400, P367
   Frank MG, 2001, NEURON, V30, P275, DOI 10.1016/S0896-6273(01)00279-3
   Graves LA, 2003, LEARN MEMORY, V10, P168, DOI 10.1101/lm.48803
   Grivel J, 2005, J NEUROSCI, V25, P4127, DOI 10.1523/JNEUROSCI.0666-05.2005
   Harris AZ, 2008, J NEUROPHYSIOL, V99, P524, DOI 10.1152/jn.01169.2007
   Hennevin E, 2007, NEUROBIOL LEARN MEM, V87, P416, DOI 10.1016/j.nlm.2006.10.006
   Ito I, 1996, NEUROSCI LETT, V203, P69, DOI 10.1016/0304-3940(95)12258-3
   Kapfhamer D, 2002, NAT GENET, V32, P290, DOI 10.1038/ng991
   Kim MJ, 2005, NEURON, V46, P745, DOI 10.1016/j.neuron.2005.04.031
   Kirkwood A, 1996, NATURE, V381, P526, DOI 10.1038/381526a0
   Kiyama Y, 1998, J NEUROSCI, V18, P6704
   Kohr G, 2006, CELL TISSUE RES, V326, P439, DOI 10.1007/s00441-006-0273-6
   Kopp C, 2006, J NEUROSCI, V26, P12456, DOI 10.1523/JNEUROSCI.2702-06.2006
   KUTSUWADA T, 1992, NATURE, V358, P36, DOI 10.1038/358036a0
   Lin MT, 2008, NAT NEUROSCI, V11, P170, DOI 10.1038/nn2041
   Longordo F, 2009, EUR J NEUROSCI, V29, P1810, DOI 10.1111/j.1460-9568.2009.06719.x
   Lozovaya NA, 2004, J PHYSIOL-LONDON, V558, P451, DOI 10.1113/jphysiol.2004.063792
   Malenka RC, 2004, NEURON, V44, P5, DOI 10.1016/j.neuron.2004.09.012
   McDermott CM, 2006, J PHYSIOL-LONDON, V570, P553, DOI 10.1113/jphysiol.2005.093781
   McDermott CM, 2003, J NEUROSCI, V23, P9687
   Migaud M, 1998, NATURE, V396, P433
   Miyamoto H, 2003, NAT NEUROSCI, V6, P553, DOI 10.1038/nn1064
   Miyamoto Hiroyuki, 2003, Mol Interv, V3, P404, DOI 10.1124/mi.3.7.404
   Modirrousta M, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-15
   MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0
   Philpot BD, 2001, NEURON, V29, P157, DOI 10.1016/S0896-6273(01)00187-8
   Philpot BD, 2007, NEURON, V53, P495, DOI 10.1016/j.neuron.2007.01.027
   Popescu G, 2005, CELL MOL LIFE SCI, V62, P2100, DOI 10.1007/s00018-005-5227-8
   Popescu G, 2004, NATURE, V430, P790, DOI 10.1038/nature02775
   Quinlan EM, 2004, NEURON, V41, P185, DOI 10.1016/S0896-6273(03)00874-2
   Racca C, 2000, J NEUROSCI, V20, P2512
   Rumbaugh G, 1999, J NEUROSCI, V19, P10603
   SAKIMURA K, 1995, NATURE, V373, P151, DOI 10.1038/373151a0
   Scimemi A, 2004, J NEUROSCI, V24, P4767, DOI 10.1523/JNEUROSCI.0364-04.2004
   Sobczyk A, 2005, J NEUROSCI, V25, P6037, DOI 10.1523/JNEUROSCI.1221-05.2005
   Tang YP, 1999, NATURE, V401, P63
   Thomas MJ, 1996, NEURON, V17, P475, DOI 10.1016/S0896-6273(00)80179-8
   Vyazovskiy VV, 2008, NAT NEUROSCI, V11, P200, DOI 10.1038/nn2035
   Walker MP, 2004, NEURON, V44, P121, DOI 10.1016/j.neuron.2004.08.031
   Yashiro K, 2005, J NEUROSCI, V25, P11684, DOI 10.1523/JNEUROSCI.4362-05.2005
   Yashiro K, 2008, NEUROPHARMACOLOGY, V55, P1081, DOI 10.1016/j.neuropharm.2008.07.046
   Zeng HK, 2001, CELL, V107, P617, DOI 10.1016/S0092-8674(01)00585-2
NR 63
TC 27
Z9 27
U1 0
U2 6
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
EI 1529-2401
J9 J NEUROSCI
JI J. Neurosci.
PD JUL 15
PY 2009
VL 29
IS 28
BP 9026
EP 9041
DI 10.1523/JNEUROSCI.1215-09.2009
PG 16
WC Neurosciences
SC Neurosciences & Neurology
GA 470YI
UT WOS:000268018000017
PM 19605640
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Loimaranta, V
   Hytonen, J
   Pulliainen, AT
   Sharma, A
   Tenovuo, J
   Stromberg, N
   Finne, J
AF Loimaranta, Vuokko
   Hytonen, Jukka
   Pulliainen, Arto T.
   Sharma, Ashu
   Tenovuo, Jorma
   Stromberg, Nicklas
   Finne, Jukka
TI Leucine-rich Repeats of Bacterial Surface Proteins Serve as Common
   Pattern Recognition Motifs of Human Scavenger Receptor gp340
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID GROUP-A STREPTOCOCCUS; INNATE IMMUNE PROTEINS; ANTIGEN-I/II FAMILY;
   TOLL-LIKE RECEPTORS; SALIVARY AGGLUTININ; CELL-SURFACE; ANTIINFLUENZA
   ACTIVITIES; GEL-ELECTROPHORESIS; SEQUENCE-ANALYSIS; EPITHELIAL-CELLS
AB Scavenger receptors are innate immune molecules recognizing and inducing the clearance of non-host as well as modified host molecules. To recognize a wide pattern of invading microbes, many scavenger receptors bind to common pathogen-associated molecular patterns, such as lipopolysaccharides and lipoteichoic acids. Similarly, the gp340/DMBT1 protein, a member of the human scavenger receptor cysteine-rich protein family, displays a wide ligand repertoire. The peptide motif VEVLXXXXW derived from its scavenger receptor cysteine-rich domains is involved in some of these interactions, but most of the recognition mechanisms are unknown. In this study, we used mass spectrometry sequencing, gene inactivation, and recombinant proteins to identify Streptococcus pyogenes protein Spy0843 as a recognition receptor of gp340. Antibodies against Spy0843 are shown to protect against S. pyogenes infection, but no function or host receptor have been identified for the protein. Spy0843 belongs to the leucine-rich repeat (Lrr) family of eukaryotic and prokaryotic proteins. Experiments with truncated forms of the recombinant proteins confirmed that the Lrr region is needed in the binding of Spy0843 to gp340. The same motif of two other Lrr proteins, LrrG from the Gram-positive S. agalactiae and BspA from the Gram-negative Tannerella forsythia, also mediated binding to gp340. Moreover, inhibition of Spy0843 binding occurred with peptides containing the VEVLXXXXW motif, but also peptides devoid of the XXXXW motif inhibited binding of Lrr proteins. These results thus suggest that the conserved Lrr motif in bacterial proteins serves as a novel pattern recognition motif for unique core peptides of human scavenger receptor gp340.
C1 [Loimaranta, Vuokko; Hytonen, Jukka; Pulliainen, Arto T.; Finne, Jukka] Univ Turku, Dept Med Biochem & Genet, FI-20520 Turku, Finland.
   [Hytonen, Jukka] Univ Turku, Dept Med Microbiol & Immunol, FI-20520 Turku, Finland.
   [Tenovuo, Jorma] Univ Turku, Inst Dent, FI-20520 Turku, Finland.
   [Tenovuo, Jorma] Turku Univ Hosp, Dept Oral Dis, FI-20520 Turku, Finland.
   [Pulliainen, Arto T.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Sharma, Ashu] SUNY Buffalo, Sch Dent Med, Dept Oral Biol, Buffalo, NY 14214 USA.
   [Stromberg, Nicklas] Umea Univ, Dept Odontol, SE-90187 Umea, Sweden.
RP Loimaranta, V (corresponding author), Univ Turku, Dept Med Biochem & Genet, Kiinamyllynkatu 10, FI-20520 Turku, Finland.
EM vuokko.loimaranta@utu.fi
RI Abrams, William R/A-5782-2008; Finne, Jukka/B-6881-2008
OI Finne, Jukka/0000-0002-8076-3344; Pulliainen, Arto
   Tapio/0000-0002-9361-8963; Hytonen, Jukka/0000-0002-0585-9338
FU Academy of FinlandAcademy of Finland [114100]
FX This work was supported by Grant 114100 from the Academy of Finland.
CR AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877
   Bikker FJ, 2004, J BIOL CHEM, V279, P47699, DOI 10.1074/jbc.M406095200
   Bikker FJ, 2002, J BIOL CHEM, V277, P32109, DOI 10.1074/jbc.M203788200
   Brannstrom A, 2002, BIOCHEM BIOPH RES CO, V290, P1462, DOI 10.1006/bbrc.2002.6378
   Chaussee MS, 1999, INFECT IMMUN, V67, P1715
   CROWLEY PJ, 1993, INFECT IMMUN, V61, P1547, DOI 10.1128/IAI.61.4.1547-1552.1993
   Edwards AM, 2008, MOL MICROBIOL, V68, P1378, DOI 10.1111/j.1365-2958.2008.06220.x
   GAILLARD JL, 1991, CELL, V65, P1127, DOI 10.1016/0092-8674(91)90009-N
   Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7
   Hajishengallis G, 2002, CLIN DIAGN LAB IMMUN, V9, P403, DOI 10.1128/CDLI.9.2.403-411.2002
   Hartshorn KL, 2006, BIOCHEM J, V393, P545, DOI 10.1042/BJ20050695
   Hartshorn KL, 2003, AM J PHYSIOL-LUNG C, V285, pL1066, DOI 10.1152/ajplung.00057.2003
   Holmes AR, 1998, INFECT IMMUN, V66, P4633, DOI 10.1128/IAI.66.10.4633-4639.1998
   Holmskov U, 1997, J BIOL CHEM, V272, P13743, DOI 10.1074/jbc.272.21.13743
   Holmskov U, 1999, P NATL ACAD SCI USA, V96, P10794, DOI 10.1073/pnas.96.19.10794
   Hytonen J, 2003, INFECT IMMUN, V71, P784, DOI 10.1128/IAI.71.2.784-793.2003
   Jakubovics NS, 2005, INFECT IMMUN, V73, P6629, DOI 10.1128/IAI.73.10.6629-6638.2005
   Jenkinson HF, 1997, MOL MICROBIOL, V23, P183, DOI 10.1046/j.1365-2958.1997.2021577.x
   Jonasson A, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-57
   Kang W, 2002, CLIN EXP IMMUNOL, V130, P449, DOI 10.1046/j.1365-2249.2002.01992.x
   Kang WQ, 2003, FEBS LETT, V540, P21, DOI 10.1016/S0014-5793(03)00217-5
   Kobe B, 2001, CURR OPIN STRUC BIOL, V11, P725, DOI 10.1016/S0959-440X(01)00266-4
   Kussmann M, 1997, J MASS SPECTROM, V32, P483
   Ligtenberg TJM, 2001, BIOCHEM J, V359, P243, DOI 10.1042/0264-6021:3590243
   Loimaranta V, 2005, INFECT IMMUN, V73, P2245, DOI 10.1128/IAI.73.4.2245-2252.2005
   Matsushima N, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-124
   Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003143
   Mollenhauer J, 2000, CANCER RES, V60, P1704
   Mueller A, 2003, P NATL ACAD SCI USA, V100, P1292, DOI 10.1073/pnas.242741699
   Nyman TA, 2000, EUR J BIOCHEM, V267, P4011, DOI 10.1046/j.1432-1327.2000.01433.x
   Oho T, 1998, INFECT IMMUN, V66, P115, DOI 10.1128/IAI.66.1.115-121.1998
   Onishi S, 2008, INFECT IMMUN, V76, P198, DOI 10.1128/IAI.01139-07
   Prakobphol A, 2000, J BIOL CHEM, V275, P39860, DOI 10.1074/jbc.M006928200
   Pulliainen AT, 2003, J BIOL CHEM, V278, P7996, DOI 10.1074/jbc.M210174200
   Reid SD, 2003, INFECT IMMUN, V71, P7043, DOI 10.1128/IAI.71.12.7043-7052.2003
   Reid SD, 2002, J BACTERIOL, V184, P6316, DOI 10.1128/JB.184.22.6316-6324.2002
   Renner M, 2007, GASTROENTEROLOGY, V133, P1499, DOI 10.1053/j.gastro.2007.08.007
   ROSENFELD J, 1992, ANAL BIOCHEM, V203, P173, DOI 10.1016/0003-2697(92)90061-B
   Rosenstiel P, 2007, J IMMUNOL, V178, P8203, DOI 10.4049/jimmunol.178.12.8203
   Sarrias MR, 2004, CRIT REV IMMUNOL, V24, P1
   Schulz BL, 2002, BIOCHEM J, V366, P511, DOI 10.1042/BJ20011876
   Seepersaud R, 2005, INFECT IMMUN, V73, P1671, DOI 10.1128/IAI.73.3.1671-1683.2005
   Segers RPAM, 1998, FEMS MICROBIOL LETT, V167, P255, DOI 10.1111/j.1574-6968.1998.tb13236.x
   Sharma A, 1998, INFECT IMMUN, V66, P5703, DOI 10.1128/IAI.66.12.5703-5710.1998
   Shevchenko A, 1996, P NATL ACAD SCI USA, V93, P14440, DOI 10.1073/pnas.93.25.14440
   Takamatsu D, 2006, INFECT IMMUN, V74, P1933, DOI 10.1128/IAI.74.3.1933-1940.2006
   Virtaneva K, 2003, INFECT IMMUN, V71, P2199, DOI 10.1128/IAI.71.4.2199-2207.2003
   White MR, 2005, AM J PHYSIOL-LUNG C, V289, pL606, DOI 10.1152/ajplung.00130.2005
   White MR, 2005, AM J PHYSIOL-LUNG C, V288, pL831, DOI 10.1152/ajplung.00365.2004
   Wu ZW, 2003, AIDS RES HUM RETROV, V19, P201, DOI 10.1089/088922203763315704
NR 50
TC 32
Z9 33
U1 0
U2 9
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUL 10
PY 2009
VL 284
IS 28
BP 18614
EP 18623
DI 10.1074/jbc.M900581200
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 467BP
UT WOS:000267711500010
PM 19465482
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Meier, M
   Padilla, GP
   Herrmann, H
   Wedig, T
   Hergt, M
   Patel, TR
   Stetefeld, J
   Aebi, U
   Burkhard, P
AF Meier, Markus
   Padilla, G. Pauline
   Herrmann, Harald
   Wedig, Tatjana
   Hergt, Michaela
   Patel, Trushar R.
   Stetefeld, Joerg
   Aebi, Ueli
   Burkhard, Peter
TI Vimentin Coil 1A-A Molecular Switch Involved in the Initiation of
   Filament Elongation
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE biophysical analysis; coiled coil; intermediate filament; lamin;
   vimentin
ID AMINO-ACID SUBSTITUTIONS; GCN4 LEUCINE-ZIPPER; INTERMEDIATE-FILAMENTS;
   OLIGOMERIZATION STATE; CRYSTAL-STRUCTURE; HYDROPHOBIC CORE;
   ATOMIC-STRUCTURE; CONSENSUS MOTIF; ALPHA-HELICES; ROD DOMAIN
AB Interestingly, our previously published structure of the coil 1A fragment of the human intermediate filament protein vimentin turned out to be a monomeric alpha-helical coil instead of the expected dimeric coiled coil. However, the 39-amino-acid-long helix had an intrinsic curvature compatible with a coiled coil. We have now designed four mutants of vimentin coil 1A, modifying key a and d positions in the heptad repeat pattern, with the aim of investigating the molecular criteria that are needed to stabilize a dimeric coiled-coil structure. We have analysed the biophysical properties of the mutants by circular dichroism spectroscopy, analytical ultracentrifugation and X-ray crystallography. All four mutants exhibited an increased stability over the wild type as indicated by a rise in the melting temperature (T-m). At a concentration of 0.1 mg/ml, the T-m of the peptide with the single point mutation Y117L increased dramatically by 46 degrees C compared with the wild-type peptide. In general, the introduction of a single stabilizing point mutation at an a or a d position did induce the formation of a stable dimer as demonstrated by sedimentation equilibrium experiments. The dimeric oligomerisation state of the Y117L peptide was furthermore confirmed by Xray crystallography, which yielded a structure with a genuine coiled-coil geometry. Most notably, when this mutation was introduced into full-length vimentin, filament assembly was completely arrested at the unit-length filament (ULF) level, both in vitro and in cDNA-transfected cultured cells. Therefore, the low propensity of the wild-type coil 1A to form a stable two-stranded coiled coil is most likely a prerequisite for the end-to-end annealing of ULFs into filaments. Accordingly, the coil 1A domains might "switch" from a dimeric alpha-helical coiled coil into a more open structure, thus mediating, within the ULFs, the conformational rearrangements of the tetrameric subunits that are needed for the intermediate filament elongation reaction. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Meier, Markus; Patel, Trushar R.; Stetefeld, Joerg] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada.
   [Padilla, G. Pauline] Univ Connecticut, Dept Mol & Cell Biol, Storrs, CT 06269 USA.
   [Herrmann, Harald; Wedig, Tatjana; Hergt, Michaela] German Canc Res Ctr, Div Cell Biol, D-69120 Heidelberg, Germany.
   [Aebi, Ueli] Univ Basel, Maurice E Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Burkhard, Peter] Univ Connecticut, Inst Mat Sci, Storrs, CT 06269 USA.
RP Meier, M (corresponding author), Univ Manitoba, Dept Chem, 144 Dysart Rd, Winnipeg, MB R3T 2N2, Canada.
EM meier@cc.umanitoba.ca
RI Patel, Trushar R/F-2776-2011; Stetefeld, Joerg/H-7630-2017; Meier,
   Markus/F-2798-2011; Patel, Trushar R./AAB-6250-2020
OI Patel, Trushar R/0000-0003-0627-2923; Stetefeld,
   Joerg/0000-0003-1478-3248; Meier, Markus/0000-0003-1068-746X; Patel,
   Trushar R./0000-0003-0627-2923
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-100448, PBBSA-107303]; Swiss Foundation for Research on
   Muscle Diseases; M.E. Muller Foundation; German Research
   FoundationGerman Research Foundation (DFG) [DFG HE 1853/4-3]
FX U.A.'s work is supported by grants from the Swiss National Science
   Foundation (3100A0-100448), the Swiss Foundation for Research on Muscle
   Diseases and the M.E. Muller Foundation. H.H. is supported by a grant
   from the German Research Foundation (DFG HE 1853/4-3). M.M. received
   support by a Scholarship for Prospective Researchers of the Swiss
   National Science Foundation (PBBSA-107303). We thank Ariel Lustig
   (University of Basel) and Jeffrey W. Lary and James L. Cole (University
   of Connecticut) for running the AUC experiments; Arthur J. Rowe
   (University of Nottingham) for the algorithms for the AUC analysis and
   fruitful discussion; and George Orriss (University of Manitoba) for
   proofreading the manuscript.
CR BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003
   BRUNGER AT, 1993, ACTA CRYSTALLOGR D, V49, P24, DOI 10.1107/S0907444992007352
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Burkhard P, 2000, STRUCTURE, V8, P223, DOI 10.1016/S0969-2126(00)00100-3
   Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294
   COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3
   COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y
   CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964
   Delano W., 2008, PYMOL MOL GRAPHICS S
   ELZHOV TV, 2008, R INTERFACE LEVENBER
   Evans W, 1997, CHEM BRIT, V33, P22
   Faix J, 1996, CELL, V86, P631, DOI 10.1016/S0092-8674(00)80136-1
   FRENCH S, 1978, ACTA CRYSTALLOGR A, V34, P517, DOI 10.1107/S0567739478001114
   Fuchs E, 1996, ANNU REV GENET, V30, P197, DOI 10.1146/annurev.genet.30.1.197
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x
   Georgakopoulou S, 2009, J MOL BIOL, V386, P544, DOI 10.1016/j.jmb.2008.12.053
   Greenfield NJ, 2004, METHOD ENZYMOL, V383, P282
   HARBURY PB, 1993, SCIENCE, V262, P1401, DOI 10.1126/science.8248779
   Hearle JWS, 2008, INT J BIOL MACROMOL, V42, P420, DOI 10.1016/j.ijbiomac.2008.02.001
   HEINS S, 1994, CURR OPIN CELL BIOL, V6, P25, DOI 10.1016/0955-0674(94)90112-0
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 2003, INT REV CYTOL, V223, P83
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466
   HERRMANN H, 1993, J MOL BIOL, V234, P99, DOI 10.1006/jmbi.1993.1566
   Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   Hesse M, 2001, J CELL SCI, V114, P2569
   Hesse M, 2007, EXP CELL RES, V313, P3127, DOI 10.1016/j.yexcr.2007.05.019
   Hol W G, 1985, Adv Biophys, V19, P133, DOI 10.1016/0065-227X(85)90053-X
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107
   Kleywegt GJ, 1997, METHOD ENZYMOL, V277, P525, DOI 10.1016/S0076-6879(97)77029-0
   Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826
   LAMZIN VS, 1993, ACTA CRYSTALLOGR D, V49, P129, DOI 10.1107/S0907444992008886
   LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251
   Lee DL, 2003, PROTEIN SCI, V12, P1395, DOI 10.1110/ps.0241403
   Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.3.CO;2-U
   MARQUARDT DW, 1963, J SOC IND APPL MATH, V11, P431, DOI 10.1137/0111030
   McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617
   Meier M, 2006, J STRUCT BIOL, V155, P116, DOI 10.1016/j.jsb.2006.02.019
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Myronova N, 2006, BIOCHEMISTRY-US, V45, P11905, DOI 10.1021/bi061294p
   OSHEA EK, 1991, SCIENCE, V254, P539, DOI 10.1126/science.1948029
   Parry DAD, 2005, ADV PROTEIN CHEM, V70, P113, DOI 10.1016/S0065-3233(04)70005-4
   Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009
   PATEL TR, 2006, SOLUTION STRUCTURE I
   Potterton E, 2003, ACTA CRYSTALLOGR D, V59, P1131, DOI 10.1107/S0907444903008126
   Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159
   *QUANTUMSOFT, 2007, PRO FIT 6 1 US MAN
   QUAXJEUKEN YEFM, 1983, P NATL ACAD SCI-BIOL, V80, P3548, DOI 10.1073/pnas.80.12.3548
   R Development Core Team, 2009, R LANG ENV STAT COMP
   ROWE AJ, 2006, 15 INT S AN ULTR U C
   Schaffeld M, 2001, EUR J CELL BIOL, V80, P692, DOI 10.1078/0171-9335-00206
   Schietke R, 2006, EUR J CELL BIOL, V85, P1, DOI 10.1016/j.ejcb.2005.09.019
   SHOEMAKER KR, 1987, NATURE, V326, P563, DOI 10.1038/326563a0
   Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010
   Smith TA, 2002, J STRUCT BIOL, V137, P128, DOI 10.1006/jsbi.2002.4438
   STEINERT PM, 1985, ANNU REV CELL BIOL, V1, P41
   STEINERT PM, 1993, J MOL BIOL, V230, P436, DOI 10.1006/jmbi.1993.1161
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246
   Strelkov SV, 2002, J STRUCT BIOL, V137, P54, DOI 10.1006/jsbi.2002.4454
   Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   TAYLOR JW, 1987, METHOD ENZYMOL, V154, P473
   Tripet B, 2000, J MOL BIOL, V300, P377, DOI 10.1006/jmbi.2000.3866
   Wagschal K, 1999, J MOL BIOL, V285, P785, DOI 10.1006/jmbi.1998.2284
   Wagschal K, 1999, PROTEIN SCI, V8, P2312
   Walshaw J, 2001, J MOL BIOL, V307, P1427, DOI 10.1006/jmbi.2001.4545
   WORMAN HJ, 1988, J BIOL CHEM, V263, P12135
   Wu KC, 2000, MOL BIOL CELL, V11, P3539, DOI 10.1091/mbc.11.10.3539
   Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147
NR 77
TC 64
Z9 65
U1 0
U2 5
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JUL 10
PY 2009
VL 390
IS 2
BP 245
EP 261
DI 10.1016/j.jmb.2009.04.067
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 465XW
UT WOS:000267624600008
PM 19422834
DA 2021-01-25
ER

PT J
AU Scheidegger, F
   Ellner, Y
   Guye, P
   Rhomberg, TA
   Weber, H
   Augustin, HG
   Dehio, C
AF Scheidegger, F.
   Ellner, Y.
   Guye, P.
   Rhomberg, T. A.
   Weber, H.
   Augustin, H. G.
   Dehio, C.
TI Distinct activities of Bartonella henselae type IV secretion effector
   proteins modulate capillary-like sprout formation
SO CELLULAR MICROBIOLOGY
LA English
DT Article
ID ENDOTHELIAL-CELLS; BACILLARY ANGIOMATOSIS; EXTRACELLULAR MATRICES;
   PATHOGEN BARTONELLA; ANGIOGENESIS; INFECTION; MICE; PROLIFERATION;
   APOPTOSIS; STRATEGY
AB The zoonotic pathogen Bartonella henselae (Bh) can lead to vasoproliferative tumour lesions in the skin and inner organs known as bacillary angiomatosis and bacillary peliosis. The knowledge on the molecular and cellular mechanisms involved in this pathogen-triggered angiogenic process is confined by the lack of a suitable animal model and a physiologically relevant cell culture model of angiogenesis. Here we employed a three-dimensional in vitro angiogenesis assay of collagen gel-embedded endothelial cell (EC) spheroids to study the angiogenic properties of Bh. Spheroids generated from Bh-infected ECs displayed a high capacity to form sprouts, which represent capillary-like projections into the collagen gel. The VirB/VirD4 type IV secretion system and a subset of its translocated Bartonella effector proteins (Beps) were found to profoundly modulate this Bh-induced sprouting activity. BepA, known to protect ECs from apoptosis, strongly promoted sprout formation. In contrast, BepG, triggering cytoskeletal rearrangements, potently inhibited sprouting. Hence, the here established in vitro model of Bartonella- induced angiogenesis revealed distinct and opposing activities of type IV secretion system effector proteins, which together with a VirB/VirD4-independent effect may control the angiogenic activity of Bh during chronic infection of the vasculature.
C1 [Scheidegger, F.; Ellner, Y.; Guye, P.; Rhomberg, T. A.; Dehio, C.] Univ Basel, Focal Area Infect Biol Biozentrum, CH-4056 Basel, Switzerland.
   [Weber, H.; Augustin, H. G.] Univ Freiburg, Tumor Biol Ctr, D-79106 Freiburg, Germany.
   [Augustin, H. G.] Univ Heidelberg, Med Fac Mannheim, CBTM, Joint Res Div Vasc Biol, D-68167 Mannheim, Germany.
   [Augustin, H. G.] German Canc Res Ctr, DKFZ ZMBH Alliance, D-69120 Heidelberg, Germany.
RP Dehio, C (corresponding author), Univ Basel, Focal Area Infect Biol Biozentrum, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Augustin, Hellmut/AAA-5246-2020; Dehio,
   Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Augustin,
   Hellmut/0000-0002-7173-4242; Dehio, Christoph/0000-0001-7288-1052
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-109925/1]; Howard Hughes Medical InstituteHoward Hughes
   Medical Institute [55005501]; Misrock Foundation
FX We are grateful to Arto Pulliainen for critically reading of the
   manuscript. We thank C. Mistl and O. Siedentopf for technical
   assistance. The work was supported by Grant 3100A0-109925/1 from the
   Swiss National Science Foundation to C.D., Grant 55005501 from the
   Howard Hughes Medical Institute to C.D. and a PhD fellowship from the
   Misrock Foundation to F.S. We acknowledge the donation of human
   umbilical cords from the University Women's Hospital Basel.
CR Alajati A, 2008, NAT METHODS, V5, P439, DOI [10.1038/nmeth.1198, 10.1038/NMETH.1198]
   Arvand M, 2001, INFECT IMMUN, V69, P6427, DOI 10.1128/IAI.69.10.6427-6433.2001
   AUGUSTIN H, 2004, METHODS ENDOTHELIAL
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Chian CA, 2002, INT J DERMATOL, V41, P461, DOI 10.1046/j.1365-4362.2002.01489.x
   Davis GE, 2002, ANAT RECORD, V268, P252, DOI 10.1002/ar.10159
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2003, CURR OPIN MICROBIOL, V6, P61, DOI 10.1016/S1369-5274(03)00006-7
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Dehio M, 1998, GENE, V215, P223, DOI 10.1016/S0378-1119(98)00319-9
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   Goodwin AM, 2007, MICROVASC RES, V74, P172, DOI 10.1016/j.mvr.2007.05.006
   Kempf VAJ, 2002, TRENDS MICROBIOL, V10, P269, DOI 10.1016/S0966-842X(02)02372-7
   Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x
   Kirby JE, 2004, INFECT IMMUN, V72, P7315, DOI 10.1128/IAI.72.12.7315-7317.2004
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   KOEHLER JE, 1993, CLIN INFECT DIS, V17, P612, DOI 10.1093/clinids/17.4.612
   Koesling J, 2001, J IMMUNOL, V167, P11, DOI 10.4049/jimmunol.167.1.11
   Korff T, 1998, J CELL BIOL, V143, P1341, DOI 10.1083/jcb.143.5.1341
   Korff T, 1999, J CELL SCI, V112, P3249
   Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236
   Pulliainen AT, 2009, INT J BIOCHEM CELL B, V41, P507, DOI 10.1016/j.biocel.2008.10.018
   Resto-Ruiz S, 2003, DNA CELL BIOL, V22, P431, DOI 10.1089/104454903767650694
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   Rhomberg TA, 2009, CELL MICROBIOL, V11, P927, DOI 10.1111/j.1462-5822.2009.01302.x
   Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Scharpfenecker M, 2005, J CELL SCI, V118, P771, DOI 10.1242/jcs.01653
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   SELBACH M, 2009, CELL HOST MICROBE
   TAPPERO JW, 1993, JAMA-J AM MED ASSOC, V269, P770, DOI 10.1001/jama.269.6.770
   Velho PENF, 2002, ULTRASTRUCT PATHOL, V26, P161, DOI 10.1080/01913120290076829
   Weber H, 2008, TOXICOL IN VITRO, V22, P531, DOI 10.1016/j.tiv.2007.09.014
NR 40
TC 29
Z9 31
U1 0
U2 1
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD JUL
PY 2009
VL 11
IS 7
BP 1088
EP 1101
DI 10.1111/j.1462-5822.2009.01313.x
PG 14
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA 453TW
UT WOS:000266636800009
PM 19416269
OA Bronze
DA 2021-01-25
ER

PT J
AU Aebi, U
   Schoenenberger, CA
   Schroeder, U
   Silvan, U
   Mittelholzer, C
   Buchmeier, S
   Jockusch, B
   Stetefeld, J
   Burkhard, P
AF Aebi, U.
   Schoenenberger, C. A.
   Schroeder, U.
   Silvan, U.
   Mittelholzer, C.
   Buchmeier, S.
   Jockusch, B.
   Stetefeld, J.
   Burkhard, P.
TI Keeping track of multiple forms of actin in- and outside the nucleus
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT 34th Congress of the Federation-of-European-Biochemical-Societies
CY JUL 04-09, 2009
CL Prague, CZECH REPUBLIC
SP Federat European Biochem Soc
C1 [Aebi, U.; Schoenenberger, C. A.; Schroeder, U.; Silvan, U.; Mittelholzer, C.] Univ Basel, Biozentrum, ME Mueller Inst, Basel, Switzerland.
   [Buchmeier, S.; Jockusch, B.] Tech Univ Carolo Wilhelmina Braunschweig, Dept Cell Biol, Braunschweig, Germany.
   [Stetefeld, J.] Univ Manitoba, Dept Chem, Winnipeg, MB R3T 2N2, Canada.
   [Burkhard, P.] Univ Connecticut, Inst Mat Sci, Storrs, CT USA.
RI Silvan, Unai/J-7376-2013
NR 0
TC 0
Z9 0
U1 1
U2 1
PU WILEY-BLACKWELL PUBLISHING, INC
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUL
PY 2009
VL 276
BP 34
EP 34
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 458ZS
UT WOS:000267069900093
DA 2021-01-25
ER

PT J
AU Herrmann, H
   Strelkov, SV
   Burkhard, P
   Aebi, U
AF Herrmann, Harald
   Strelkov, Sergei V.
   Burkhard, Peter
   Aebi, Ueli
TI Intermediate filaments: primary determinants of cell architecture and
   plasticity
SO JOURNAL OF CLINICAL INVESTIGATION
LA English
DT Review
ID NEMATODE CAENORHABDITIS-ELEGANS; EPIDERMOLYSIS-BULLOSA SIMPLEX; DREIFUSS
   MUSCULAR-DYSTROPHY; JUVENILE ALEXANDER-DISEASE; DESMIN-RELATED MYOPATHY;
   MICE LACKING VIMENTIN; IN-VITRO; NUCLEAR-ENVELOPE; COILED-COIL; LAMIN
   A/C
AB Intermediate filaments (IFs) are major constituents of the cytoskeleton and nuclear boundary in animal cells. They are of prime importance for the functional organization of structural elements. Depending on the cell type, morphologically similar but biochemically distinct proteins form highly viscoelastic filament networks with multiple nanomechanical functions. Besides their primary role in cell plasticity and their established function as cellular stress absorbers, recently discovered gene defects have elucidated that structural alterations of IFs can affect their involvement both in signaling and in controlling gene regulatory networks. Here, we highlight the basic structural and functional properties of IFs and derive a concept of how mutations may affect cellular architecture and thereby tissue construction and physiology.
C1 [Herrmann, Harald] DKFZ, German Canc Res Ctr, Grp Funct Architecture Cell, D-69120 Heidelberg, Germany.
   [Strelkov, Sergei V.] Katholieke Univ Leuven, Dept Pharmaceut Sci, Louvain, Belgium.
   [Burkhard, Peter] Univ Connecticut, Inst Mat Sci, Storrs, CT USA.
   [Aebi, Ueli] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
RP Herrmann, H (corresponding author), DKFZ, German Canc Res Ctr, Grp Funct Architecture Cell, B065, D-69120 Heidelberg, Germany.
EM h.herrmann@dkfz-heidelberg.de
RI Strelkov, Sergei V/G-7425-2014
OI Strelkov, Sergei V/0000-0001-7189-4652
FU German Research FoundationGerman Research Foundation (DFG) [HE 1853];
   German-Israel FoundationGerman-Israeli Foundation for Scientific
   Research and Development; European CommissionEuropean CommissionEuropean
   Commission Joint Research Centre [LSHM-CT-2005-018690]; National Center
   of Competence in Research "Nanoscale Science,"Swiss National Science
   Foundation (SNSF); Swiss National Science FoundationSwiss National
   Science Foundation (SNSF); M.E. Muller Foundation; Swiss Society for
   Research on Muscular Diseases
FX We thank Rosmarie Sutterlin, Harald Bar, Monika Zwerger, and Norbert
   Mucke for their help with the figures and Gloria Conover for critical
   reading of the manuscript. Harald Herrmann acknowledges support from the
   German Research Foundation (DFG, grant HE 1853) and the German-Israel
   Foundation. Both Harald Herrmann and Ueli Aebi have been supported by
   the EURO-Laminopathies research project of the European Commission
   (contract LSHM-CT-2005-018690). This work was also supported by grants
   from the National Center of Competence in Research "Nanoscale Science,"
   the Swiss National Science Foundation, and the M.E. Muller Foundation,
   all awarded to Ueli Aebi. Sergei V. Strelkov and Ueli Aebi acknowledge
   support from the Swiss Society for Research on Muscular Diseases. Last
   but not least, Sergei V. Strelkov thanks the Research Council of the
   Katholieke Universiteit Leuven for support.
CR AEBI U, 1988, PROTOPLASMA, V145, P73, DOI 10.1007/BF01349341
   ALBERS K, 1987, J CELL BIOL, V105, P791, DOI 10.1083/jcb.105.2.791
   ALBERS K, 1989, J CELL BIOL, V108, P1477, DOI 10.1083/jcb.108.4.1477
   Ausmees N, 2003, CELL, V115, P705, DOI 10.1016/S0092-8674(03)00935-8
   Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068
   Bar H, 2006, EXP CELL RES, V312, P1554, DOI 10.1016/j.yexcr.2006.01.021
   Bagchi S, 2008, MOL MICROBIOL, V70, P1037, DOI 10.1111/j.1365-2958.2008.06473.x
   Bar H, 2004, J STRUCT BIOL, V148, P137, DOI 10.1016/j.jsb.2004.04.003
   Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102
   Ben-Harush K, 2009, J MOL BIOL, V386, P1392, DOI 10.1016/j.jmb.2008.12.024
   Bhosle RC, 2006, BIOCHEM BIOPH RES CO, V346, P768, DOI 10.1016/j.bbrc.2006.05.192
   BREMER A, 1992, Current Opinion in Cell Biology, V4, P20, DOI 10.1016/0955-0674(92)90054-G
   Burke B, 2002, NAT REV MOL CELL BIO, V3, P575, DOI 10.1038/nrm879
   Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732
   Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033
   CHAN YM, 1994, GENE DEV, V8, P2574, DOI 10.1101/gad.8.21.2574
   Chou YH, 2003, MOL BIOL CELL, V14, P1468, DOI 10.1091/mbc.E02-08-0545
   COLUCCIGUYON E, 1994, CELL, V79, P679, DOI 10.1016/0092-8674(94)90553-3
   Conover GM, 2009, MOL BIOL CELL, V20, P834, DOI 10.1091/mbc.E08-07-0753
   COOPER JA, 1987, J CELL BIOL, V105, P1473, DOI 10.1083/jcb.105.4.1473
   COULOMBE PA, 1991, CELL, V66, P1301, DOI 10.1016/0092-8674(91)90051-Y
   DAHLSTRAND J, 1992, J CELL SCI, V103, P589
   Dechat T, 2008, GENE DEV, V22, P832, DOI 10.1101/gad.1652708
   Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104
   Downing KH, 1998, CURR OPIN CELL BIOL, V10, P16, DOI 10.1016/S0955-0674(98)80082-3
   Eckes B, 1998, J CELL SCI, V111, P1897
   Eckes B, 2000, J CELL SCI, V113, P2455
   Foeger N, 2006, J STRUCT BIOL, V155, P340, DOI 10.1016/j.jsb.2006.03.026
   Fuchs E, 1996, ANNU REV GENET, V30, P197, DOI 10.1146/annurev.genet.30.1.197
   FUCHS E, 1994, ANNU REV BIOCHEM, V63, P345, DOI 10.1146/annurev.bi.63.070194.002021
   GEISLER N, 1982, EMBO J, V1, P1649, DOI 10.1002/j.1460-2075.1982.tb01368.x
   Geisler N, 1998, J MOL BIOL, V282, P601, DOI 10.1006/jmbi.1998.1995
   Georgakopoulou S, 2009, J MOL BIOL, V386, P544, DOI 10.1016/j.jmb.2008.12.053
   Goudeau B, 2006, HUM MUTAT, V27, P906, DOI 10.1002/humu.20351
   Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947
   Guzman C, 2006, J MOL BIOL, V360, P623, DOI 10.1016/j.jmb.2006.05.030
   Han XJ, 2008, NAT CELL BIOL, V10, P1333, DOI 10.1038/ncb1792
   HATZFELD M, 1990, J CELL BIOL, V110, P1199, DOI 10.1083/jcb.110.4.1199
   HEALD R, 1990, CELL, V61, P579, DOI 10.1016/0092-8674(90)90470-Y
   Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075
   HEINS S, 1994, CURR OPIN CELL BIOL, V6, P25, DOI 10.1016/0955-0674(94)90112-0
   HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 2003, INT REV CYTOL, V223, P83
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466
   Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   Hesse M, 2001, J CELL SCI, V114, P2569
   Hesse M, 2007, EXP CELL RES, V313, P3127, DOI 10.1016/j.yexcr.2007.05.019
   Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379
   Houseweart MK, 1998, CURR OPIN CELL BIOL, V10, P93, DOI 10.1016/S0955-0674(98)80091-4
   Hut PHL, 2000, J INVEST DERMATOL, V114, P616, DOI 10.1046/j.1523-1747.2000.00928.x
   INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0
   Ishigaki K, 2006, BRAIN DEV-JPN, V28, P663, DOI 10.1016/j.braindev.2006.05.001
   Ivaska J, 2007, EXP CELL RES, V313, P2050, DOI 10.1016/j.yexcr.2007.03.040
   JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155
   Jordan MA, 2007, CURR CANCER DRUG TAR, V7, P730, DOI 10.2174/156800907783220417
   Karabinos A, 2004, EUR J CELL BIOL, V83, P457, DOI 10.1078/0171-9335-00407
   Karabinos A, 2003, J MOL BIOL, V333, P307, DOI 10.1016/j.jmb.2003.08.041
   Karabinos A, 2003, J MOL BIOL, V325, P241, DOI 10.1016/S0022-2836(02)01240-8
   Karabinos A, 2001, P NATL ACAD SCI USA, V98, P7863, DOI 10.1073/pnas.121169998
   Kemp MW, 2009, J STRUCT BIOL, V165, P196, DOI 10.1016/j.jsb.2008.11.002
   Ketema M, 2007, J CELL SCI, V120, P3384, DOI 10.1242/jcs.014191
   Ki CS, 2002, J HUM GENET, V47, P225, DOI 10.1007/s100380200029
   Kim S, 2007, GENE DEV, V21, P1581, DOI 10.1101/gad.1552107
   Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200
   Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092
   Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826
   Lane EB, 2004, J PATHOL, V204, P355, DOI 10.1002/path.1643
   LAZARIDES E, 1982, ANNU REV BIOCHEM, V51, P219, DOI 10.1146/annurev.bi.51.070182.001251
   LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0
   Gonzalez JM, 2008, J CELL BIOL, V183, P653, DOI 10.1083/jcb.200805049
   Mei D, 2004, EXP CELL RES, V301, P84, DOI 10.1016/j.yexcr.2004.08.017
   MEIER M, 2009, J MOL BIOL IN PRESS
   MOLL R, 1982, CELL, V31, P11, DOI 10.1016/0092-8674(82)90400-7
   Muchir A, 2000, HUM MOL GENET, V9, P1453, DOI 10.1093/hmg/9.9.1453
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Muller FB, 2006, HUM MUTAT, V27, DOI 10.1002/humu.9437
   Mueller M, 2009, HUM MOL GENET, V18, P1052, DOI 10.1093/hmg/ddn440
   Munoz-Marmol AM, 1998, P NATL ACAD SCI USA, V95, P11312, DOI 10.1073/pnas.95.19.11312
   Nieminen M, 2006, NAT CELL BIOL, V8, P156, DOI 10.1038/ncb1355
   Oh SW, 2007, J DERMATOL SCI, V48, P229, DOI 10.1016/j.jdermsci.2007.07.014
   Olive M, 2004, J NEUROL SCI, V219, P125, DOI 10.1016/j.jns.2004.01.007
   Omary MB, 2006, TRENDS BIOCHEM SCI, V31, P383, DOI 10.1016/j.tibs.2006.05.008
   Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319
   Park KY, 2000, CLIN GENET, V57, P423, DOI 10.1034/j.1399-0004.2000.570604.x
   Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516
   Parry DAD, 2005, ADV PROTEIN CHEM, V70, P113, DOI 10.1016/S0065-3233(04)70005-4
   Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009
   PORTER S, 2009, LANGMUIR IN PRESS
   Prahlad V, 1998, J CELL BIOL, V143, P159, DOI 10.1083/jcb.143.1.159
   QUAX W, 1983, CELL, V35, P215, DOI 10.1016/0092-8674(83)90224-6
   QUAXJEUKEN YEFM, 1983, P NATL ACAD SCI-BIOL, V80, P3548, DOI 10.1073/pnas.80.12.3548
   Rankin J, 2006, CLIN GENET, V70, P261, DOI 10.1111/j.1399-0004.2006.00677.x
   Reichart B, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-12
   Riemer D, 1998, J CELL SCI, V111, P2967
   RIEMER D, 1993, EUR J CELL BIOL, V62, P214
   Sawaishi Y, 2002, NEUROLOGY, V58, P1541, DOI 10.1212/WNL.58.10.1541
   Schaffeld M, 2001, EUR J CELL BIOL, V80, P692, DOI 10.1078/0171-9335-00206
   Schietke R, 2006, EUR J CELL BIOL, V85, P1, DOI 10.1016/j.ejcb.2005.09.019
   Shah SB, 2004, BIOPHYS J, V86, P2993, DOI 10.1016/S0006-3495(04)74349-0
   Sihag RK, 2007, EXP CELL RES, V313, P2098, DOI 10.1016/j.yexcr.2007.04.010
   STARGER JM, 1978, J CELL BIOL, V78, P93, DOI 10.1083/jcb.78.1.93
   STEINERT PM, 1985, ANNU REV CELL BIOL, V1, P41
   STEINERT PM, 1990, J BIOL CHEM, V265, P8766
   Steinert PM, 1999, J BIOL CHEM, V274, P9881, DOI 10.1074/jbc.274.14.9881
   STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246
   Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093
   Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   Sun N, 2008, EXP CELL RES, V314, P1839, DOI 10.1016/j.yexcr.2008.01.034
   Sun N, 2008, BIOCHEM J, V409, P657, DOI 10.1042/BJ20071188
   Szeverenyi I, 2008, HUM MUTAT, V29, P351, DOI 10.1002/humu.20652
   Taylor MRG, 2007, CIRCULATION, V115, P1244, DOI 10.1161/CIRCULATIONAHA.106.646778
   Taylor MRG, 2003, J AM COLL CARDIOL, V41, P771, DOI 10.1016/S0735-1097(02)02954-6
   Titeux M, 2001, EUR J BIOCHEM, V268, P6435, DOI 10.1046/j.0014-2956.2001.02594.x
   Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771
   Vale C, 2008, FEBS J, V275, P6060, DOI 10.1111/j.1742-4658.2008.06711.x
   Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765
   VICEK S, 2007, CURR OPIN CELL BIOL, V19, P298
   Wagner OI, 2007, EXP CELL RES, V313, P2228, DOI 10.1016/j.yexcr.2007.04.025
   Wiesel N, 2008, P NATL ACAD SCI USA, V105, P180, DOI 10.1073/pnas.0708974105
   Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028
   Worman HJ, 2009, J CLIN INVEST, V119, P1825, DOI 10.1172/JCI37679
   Yoon M, 1998, J CELL BIOL, V143, P147, DOI 10.1083/jcb.143.1.147
   Zhang JL, 2008, AM J PHYSIOL-CELL PH, V294, pC1175, DOI 10.1152/ajpcell.00049.2008
   Zimek A, 2002, GENE, V288, P187, DOI 10.1016/S0378-1119(02)00484-5
NR 131
TC 194
Z9 200
U1 0
U2 27
PU AMER SOC CLINICAL INVESTIGATION INC
PI ANN ARBOR
PA 2015 MANCHESTER RD, ANN ARBOR, MI 48104 USA
SN 0021-9738
EI 1558-8238
J9 J CLIN INVEST
JI J. Clin. Invest.
PD JUL
PY 2009
VL 119
IS 7
BP 1772
EP 1783
DI 10.1172/JCI38214
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 466WI
UT WOS:000267694300005
PM 19587452
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Hausser, J
   Strimmer, K
AF Hausser, Jean
   Strimmer, Korbinian
TI Entropy Inference and the James-Stein Estimator, with Application to
   Nonlinear Gene Association Networks
SO JOURNAL OF MACHINE LEARNING RESEARCH
LA English
DT Article
DE entropy; shrinkage estimation; James-Stein estimator; "small n, large p"
   setting; mutual information; gene association network
ID EXPRESSION; GRAPHS
AB We present a procedure for effective estimation of entropy and mutual information from small-sample data, and apply it to the problem of inferring high-dimensional gene association networks. Specifically, we develop a James-Stein-type shrinkage estimator, resulting in a procedure that is highly efficient statistically as well as computationally. Despite its simplicity, we show that it outperforms eight other entropy estimation procedures across a diverse range of sampling scenarios and data-generating models, even in cases of severe undersampling. We illustrate the approach by analyzing E. coli gene expression data and computing an entropy-based gene-association network from gene expression data. A computer program is available that implements the proposed shrinkage estimator.
C1 [Hausser, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Strimmer, Korbinian] Univ Leipzig, Inst Med Informat Stat & Epidemiol, D-04107 Leipzig, Germany.
RP Hausser, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM JEAN.HAUSSER@UNIBAS.CH; STRIMMER@UNI-LEIPZIG.DE
RI Strimmer, Korbinian/C-1522-2009
OI Strimmer, Korbinian/0000-0001-7917-2056
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
FX This work was partially supported by a Emmy Noether grant of the
   Deutsche Forschungsgemeinschaft (to K. S.). We thank the anonymous
   referees and the editor for very helpful comments.
CR Agresti A., 2005, STAT METHODS APPL, V14, P297, DOI DOI 10.1007/S10260-005-0121-Y
   Butte AJ, 2000, P NATL ACAD SCI USA, V97, P12182, DOI 10.1073/pnas.220392197
   Chao A, 2003, ENVIRON ECOL STAT, V10, P429, DOI 10.1023/A:1026096204727
   Dobra A, 2004, J MULTIVARIATE ANAL, V90, P196, DOI 10.1016/j.jmva.2004.02.009
   EFRON B, 1973, J AM STAT ASSOC, V68, P117, DOI 10.2307/2284155
   FIENBERG SE, 1973, J AM STAT ASSOC, V68, P683, DOI 10.2307/2284799
   FREEDMAN D, 1981, Z WAHRSCHEINLICHKEIT, V57, P453, DOI 10.1007/BF01025868
   Friedman N, 2004, SCIENCE, V303, P799, DOI 10.1126/science.1094068
   GEISSER S, 1984, AM STAT, V38, P244, DOI 10.2307/2683393
   Gelman A, 2004, BAYESIAN DATA ANAL
   GOOD IJ, 1953, BIOMETRIKA, V40, P237, DOI 10.2307/2333344
   GOODMAN LA, 1953, ANN MATH STAT, V24, P114, DOI 10.1214/aoms/1177729089
   Gruber MHJ, 1998, IMPROVING EFFICIENCY
   Holste D, 1998, J PHYS A-MATH GEN, V31, P2551, DOI 10.1088/0305-4470/31/11/007
   HORVITZ DG, 1952, J AM STAT ASSOC, V47, P663, DOI 10.2307/2280784
   James W., 1961, P 4 BERK S MATH STAT, V1, P361, DOI DOI 10.1007/978-1-4612-0919-5
   JEFFREYS H, 1946, PROC R SOC LON SER-A, V186, P453, DOI 10.1098/rspa.1946.0056
   Kalisch M, 2007, J MACH LEARN RES, V8, P613
   KRICHEVSKY RE, 1981, IEEE T INFORM THEORY, V27, P199, DOI 10.1109/TIT.1981.1056331
   Lahdesmaki H, 2008, MACH LEARN, V71, P185, DOI 10.1007/s10994-008-5053-y
   Ledoit 0., 2003, J EMPIR FINANC, V10, P603, DOI DOI 10.1016/S0927-5398(03)00007-0
   MacKay D., 2003, INFORM THEORY INFERE
   Margolin LG, 2006, J TURBUL, V7, P1, DOI 10.1080/14685240500331595
   Meinshausen N, 2006, ANN STAT, V34, P1436, DOI 10.1214/009053606000000281
   Meyer PE, 2007, EURASIP J BIOINFORM, DOI 10.1155/2007/79879
   Miller G. A., 1955, INFORMATION THEORY B, V2, P95
   Nemenman I, 2002, ADV NEUR IN, V14, P471
   Opgen-Rhein R, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-37
   Opgen-Rhein R, 2007, STAT APPL GENET MOL, V6, DOI 10.2202/1544-6115.1252
   Orlitsky A, 2003, SCIENCE, V302, P427, DOI 10.1126/science.1088284
   Perks W, 1947, J I ACTUARIES, V73, P285, DOI 10.1017/s0020268100012270
   R Core Team, 2017, R LANG ENV STAT COMP
   Rangel C, 2004, BIOINFORMATICS, V20, P1361, DOI 10.1093/bioinformatics/bth093
   Schafer J, 2005, STAT APPL GENET MO B, V4, DOI 10.2202/1544-6115.1175
   Schafer J, 2005, BIOINFORMATICS, V21, P754, DOI 10.1093/bioinformatics/bti062
   SCHMIDTHECK W, 2004, P EUNITE S 10 12 JUN, P407
   Schurmann T, 1996, CHAOS, V6, P414, DOI 10.1063/1.166191
   Stigler SM, 1990, STAT SCI, V5, P147
   Stinson D.R., 2006, CRYPTOGRAPHY THEORY
   Strong SP, 1998, PHYS REV LETT, V80, P197, DOI 10.1103/PhysRevLett.80.197
   THOMPSON JR, 1968, J AM STAT ASSOC, V63, P113, DOI 10.2307/2283832
   TRYBULA S, 1958, ANN MATH STAT, V29, P245, DOI 10.1214/aoms/1177706722
   Tuyl F, 2008, AM STAT, V62, P40, DOI 10.1198/000313008X267839
   Vu VQ, 2007, STAT MED, V26, P4039, DOI 10.1002/sim.2942
   Yeo G, 2004, J COMPUT BIOL, V11, P377, DOI 10.1089/1066527041410418
NR 45
TC 149
Z9 150
U1 0
U2 9
PU MICROTOME PUBL
PI BROOKLINE
PA 31 GIBBS ST, BROOKLINE, MA 02446 USA
SN 1532-4435
J9 J MACH LEARN RES
JI J. Mach. Learn. Res.
PD JUL
PY 2009
VL 10
BP 1469
EP 1484
PG 16
WC Automation & Control Systems; Computer Science, Artificial Intelligence
SC Automation & Control Systems; Computer Science
GA 507BM
UT WOS:000270825000006
DA 2021-01-25
ER

PT J
AU Llosa, M
   Roy, C
   Dehio, C
AF Llosa, Matxalen
   Roy, Craig
   Dehio, Christoph
TI Bacterial type IV secretion systems in human disease
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID HORIZONTAL GENE-TRANSFER; LEGIONELLA-PNEUMOPHILA; AGROBACTERIUM VIRB10;
   HELICOBACTER-PYLORI; DNA TRANSPORT; PROTEIN; CELLS; MACROPHAGES;
   BARTONELLA; CONJUGATION
AB Type IV secretion (T4S) systems are versatile machines involved in many processes relevant to bacterial virulence, such as horizontal DNA transfer and effector translocation into human cells. A recent workshop organized by the International University of Andalousia in Baeza, Spain, covered most aspects of bacterial T4S relevant to human disease, ranging from the structural and mechanistic analysis of the T4S systems to the physiological roles of the translocated effector proteins in subverting cellular functions in infected humans. This review reports the highlights from this workshop, which include the first visualization of a T4S system core complex spanning both membranes of Gram-negative bacteria, the identification of the first host receptors for T4S systems, the identification and characterization of novel T4S effector proteins, the analysis of the molecular function of effector proteins in subverting human cellular functions and an analysis of the role of T4S systems in the evolution of pathogenic bacteria. Our increasing knowledge of the biology of T4S systems improves our ability to exploit them as biotechnological tools or to use them as novel targets for a new generation of antimicrobials.
C1 [Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
   [Llosa, Matxalen] Univ Cantabria, Dept Biol Mol, E-39005 Santander, Spain.
   [Llosa, Matxalen] Univ Cantabria, Inst Biomed & Biotecn, CSIC, IDICAN, E-39005 Santander, Spain.
   [Roy, Craig] Yale Univ, Sch Med, Boyer Ctr Mol Med, New Haven, CT USA.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019; ,
   matxalen/ABG-5541-2020
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; , matxalen/0000-0002-4826-2240; Roy,
   Craig/0000-0003-4490-440X
FU UNIA; Instituto de Salud Carlos III (Spanish Ministry of
   Health)Instituto de Salud Carlos IIISpanish Government; University of
   Cantabria (Spain); Spanish Ministry of Science of InnovationSpanish
   Government [BIO2008-00133]; Public Foundation Marques de Valdecilla [API
   07/01]; NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI041699, AI064559]; Swiss National
   Science FoundationSwiss National Science Foundation (SNSF)
   [3100A0-109925/2]; Howard Hughes Medical InstituteHoward Hughes Medical
   Institute [55005501]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS
   DISEASESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Allergy &
   Infectious Diseases (NIAID) [R01AI041699, R01AI041699, R29AI041699,
   R29AI041699, R01AI041699, R01AI041699, R01AI041699, R01AI041699,
   R01AI064559, R29AI041699, R29AI041699, R01AI064559, R01AI064559,
   R29AI041699, R01AI041699, R01AI064559, R01AI041699, R29AI041699,
   R01AI041699, R01AI064559, R01AI041699] Funding Source: NIH RePORTER
FX This workshop was organized by the UNIA (Spain) and supported by the
   UNIA, the Instituto de Salud Carlos III (Spanish Ministry of Health),
   and the University of Cantabria (Spain). We are very grateful to the
   UNIA staff and especially to Joaquin Torreblanca for his enthusiastic
   organization of the workshop. We thank many colleagues for allowing
   citation of their unpublished results. We are sorry that space
   limitation precluded us from mentioning the work of other contributors
   to the workshop. M. L. wishes to thank Hector de Paz for his help with
   Fig. 1. Research in our labs is funded by Grants BIO2008-00133 from the
   Spanish Ministry of Science of Innovation and API 07/01 from Public
   Foundation Marques de Valdecilla (to M. L.), NIH Grants AI041699 and
   AI064559 (to C. R.) and Grant 3100A0-109925/2 form the Swiss National
   Science Foundation and Grant 55005501 from the Howard Hughes Medical
   Institute (to C. D.).
CR Abajy MY, 2007, J BACTERIOL, V189, P2487, DOI 10.1128/JB.01491-06
   Atmakuri K, 2003, MOL MICROBIOL, V49, P1699, DOI 10.1046/j.1365-2958.2003.03669.x
   Babic A, 2008, SCIENCE, V319, P1533, DOI 10.1126/science.1153498
   Backert S, 2008, TRENDS MICROBIOL, V16, P409, DOI 10.1016/j.tim.2008.07.001
   Bao W, 2009, J BACTERIOL, V191, P278, DOI 10.1128/JB.01031-08
   Baron Christian, 2007, Infectious Disorders - Drug Targets, V7, P19, DOI 10.2174/187152607780090685
   Bayliss R, 2007, P NATL ACAD SCI USA, V104, P1673, DOI 10.1073/pnas.0609535104
   Cambronne ED, 2006, TRAFFIC, V7, P929, DOI 10.1111/j.1600-0854.2006.00446.x
   Cascales E, 2004, P NATL ACAD SCI USA, V101, P17228, DOI 10.1073/pnas.0405843101
   Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211
   Cheng ZH, 2008, J BACTERIOL, V190, P2096, DOI 10.1128/JB.01813-07
   COVACCI A, 1993, MOL MICROBIOL, V8, P429, DOI 10.1111/j.1365-2958.1993.tb01587.x
   de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x
   de Paz HD, 2005, MICROBIOL-SGM, V151, P3505, DOI 10.1099/mic.0.28410-0
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Draper O, 2005, P NATL ACAD SCI USA, V102, P16385, DOI 10.1073/pnas.0506081102
   Ensminger AW, 2009, CURR OPIN MICROBIOL, V12, P67, DOI 10.1016/j.mib.2008.12.004
   Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101
   Jakubowski SJ, 2009, MOL MICROBIOL, V71, P779, DOI 10.1111/j.1365-2958.2008.06565.x
   Juhas M, 2008, CELL MICROBIOL, V10, P2377, DOI 10.1111/j.1462-5822.2008.01187.x
   Juhas M, 2007, J BACTERIOL, V189, P761, DOI 10.1128/JB.01327-06
   Kubori T, 2008, MOL MICROBIOL, V67, P1307, DOI 10.1111/j.1365-2958.2008.06124.x
   Kutter S, 2008, J BACTERIOL, V190, P2161, DOI 10.1128/JB.01341-07
   Kwok T, 2007, NATURE, V449, P862, DOI 10.1038/nature06187
   Laguna RK, 2006, P NATL ACAD SCI USA, V103, P18745, DOI 10.1073/pnas.0609012103
   Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x
   Llosa M, 2002, MOL MICROBIOL, V45, P1, DOI 10.1046/j.1365-2958.2002.03014.x
   Llosa M, 2004, MOL MICROBIOL, V53, P1, DOI 10.1111/j.1365-2958.2004.04168.x
   Lopez JE, 2007, INFECT IMMUN, V75, P2333, DOI 10.1128/IAI.00061-07
   Luhrmann A, 2007, INFECT IMMUN, V75, P5282, DOI 10.1128/IAI.00863-07
   Ninio S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000278
   Nystedt B, 2008, MOL BIOL EVOL, V25, P287, DOI 10.1093/molbev/msm252
   Pan XX, 2008, SCIENCE, V320, P1651, DOI 10.1126/science.1158160
   Perez-Mendoza D, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-71
   Ragaz C, 2008, CELL MICROBIOL, V10, P2416, DOI 10.1111/j.1462-5822.2008.01219.x
   Rolan HG, 2008, INFECT IMMUN, V76, P3207, DOI 10.1128/IAI.00203-08
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Salcedo SP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040021
   Salgado-Pabon W, 2007, MOL MICROBIOL, V66, P930, DOI 10.1111/j.1365-2958.2007.05966.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Sexton JA, 2002, TRAFFIC, V3, P178, DOI 10.1034/j.1600-0854.2002.030303.x
   Terradot L, 2005, P NATL ACAD SCI USA, V102, P4596, DOI 10.1073/pnas.0408927102
   Vergunst AC, 2000, SCIENCE, V290, P979, DOI 10.1126/science.290.5493.979
   Voth DE, 2007, INFECT IMMUN, V75, P4263, DOI 10.1128/IAI.00594-07
   VOTH DE, 2009, J BACTERIOL IN PRESS
   Wang Wei-bin, 2009, Forest Research, V22, P29
   Weber SS, 2009, CELL MICROBIOL, V11, P442, DOI 10.1111/j.1462-5822.2008.01266.x
   WEISS AA, 1993, P NATL ACAD SCI USA, V90, P2970, DOI 10.1073/pnas.90.7.2970
   Zink SD, 2002, INFECT IMMUN, V70, P1657, DOI 10.1128/IAI.70.3.1657-1663.2002
NR 51
TC 53
Z9 54
U1 0
U2 9
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD JUL
PY 2009
VL 73
IS 2
BP 141
EP 151
DI 10.1111/j.1365-2958.2009.06751.x
PG 11
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 469GK
UT WOS:000267883900002
PM 19508287
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Karow, AR
   Klostermeier, D
AF Karow, Anne R.
   Klostermeier, Dagmar
TI A conformational change in the helicase core is necessary but not
   sufficient for RNA unwinding by the DEAD box helicase YxiN
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID INITIATION FACTOR-4A; COOPERATIVE BINDING; CRYSTAL-STRUCTURE;
   RIBOSOMAL-RNA; ATP-BINDING; COMPLEX
AB Cooperative binding of ATP and RNA to DEAD-box helicases induces the closed conformation of their helicase core, with extensive interactions across the domain interface. The bound RNA is bent, and its distortion may constitute the first step towards RNA unwinding. To dissect the role of the conformational change in the helicase core for RNA unwinding, we characterized the RNA-stimulated ATPase activity, RNA unwinding and the propensity to form the closed conformer for mutants of the DEAD box helicase YxiN. The ATPase-deficient K52Q mutant forms a closed conformer upon binding of ATP and RNA, but is deficient in RNA unwinding. A mutation in motif III slows down the catalytic cycle, but neither affects the propensity for the closed conformer nor its global conformation. Hence, the closure of the cleft in the helicase core is necessary but not sufficient for RNA unwinding. In contrast, the G303A mutation in motif V prevents a complete closure of the inter-domain cleft, affecting ATP binding and hydrolysis and is detrimental to unwinding. Possibly, the K52Q and motif III mutants still introduce a kink into the backbone of bound RNA, whereas G303A fails to kink the RNA substrate.
C1 [Karow, Anne R.; Klostermeier, Dagmar] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Dagmar.Klostermeier@unibas.ch
FU VolkswagenStiftung and the Swiss National Science Foundation
FX VolkswagenStiftung and the Swiss National Science Foundation. The Open
   Access publication charge for this paper has been waived by Oxford
   University Press.
CR Adam H., 1962, METHODEN ENZYMATISCH, P573
   Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981
   Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006
   Chen YF, 2008, P NATL ACAD SCI USA, V105, P20203, DOI 10.1073/pnas.0811075106
   Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905
   Collins R, 2009, J BIOL CHEM, V284, P10296, DOI 10.1074/jbc.C900018200
   Combet C, 2002, BIOINFORMATICS, V18, P213, DOI 10.1093/bioinformatics/18.1.213
   Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019
   Henn A, 2008, J MOL BIOL, V377, P193, DOI 10.1016/j.jmb.2007.12.046
   Karow AR, 2007, FEBS J, V274, P463, DOI 10.1111/j.1742-4658.2006.05593.x
   Kossen K, 2002, J MOL BIOL, V324, P625, DOI 10.1016/S0022-2836(02)01140-3
   Kossen K, 1999, NUCLEIC ACIDS RES, V27, P3811, DOI 10.1093/nar/27.19.3811
   Liu F, 2008, P NATL ACAD SCI USA, V105, P20209, DOI 10.1073/pnas.0811115106
   PAUSE A, 1993, MOL CELL BIOL, V13, P6789, DOI 10.1128/MCB.13.11.6789
   PAUSE A, 1992, EMBO J, V11, P2643, DOI 10.1002/j.1460-2075.1992.tb05330.x
   Polach KJ, 2002, BIOCHEMISTRY-US, V41, P3693, DOI 10.1021/bi012062n
   Rocak S, 2005, NUCLEIC ACIDS RES, V33, P999, DOI 10.1093/nar/gki244
   ROZEN F, 1989, MOL CELL BIOL, V9, P4061, DOI 10.1128/MCB.9.9.4061
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Tanner NK, 2003, MOL CELL, V11, P127, DOI 10.1016/S1097-2765(03)00006-6
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   von Moeller H, 2009, NAT STRUCT MOL BIOL, V16, P247, DOI 10.1038/nsmb.1561
   Wang S, 2008, BIOPHYS J, V94, pL1, DOI 10.1529/biophysj.107.120709
NR 23
TC 37
Z9 38
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUL
PY 2009
VL 37
IS 13
BP 4464
EP 4471
DI 10.1093/nar/gkp397
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 475BW
UT WOS:000268331800033
PM 19474341
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Benkert, P
   Kunzli, M
   Schwede, T
AF Benkert, Pascal
   Kuenzli, Michael
   Schwede, Torsten
TI QMEAN server for protein model quality estimation
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID STRUCTURE PREDICTION; FOLD RECOGNITION; MEAN FORCE; PCONS; STABILITY;
   WORKSPACE; ALIGNMENT; PROFILES; REGIONS; PROQ
AB Model quality estimation is an essential component of protein structure prediction, since ultimately the accuracy of a model determines its usefulness for specific applications. Usually, in the course of protein structure prediction a set of alternative models is produced, from which subsequently the most accurate model has to be selected. The QMEAN server provides access to two scoring functions successfully tested at the eighth round of the community-wide blind test experiment CASP. The user can choose between the composite scoring function QMEAN, which derives a quality estimate on the basis of the geometrical analysis of single models, and the clustering-based scoring function QMEANclust which calculates a global and local quality estimate based on a weighted all-against-all comparison of the models from the ensemble provided by the user. The web server performs a ranking of the input models and highlights potentially problematic regions for each model. The QMEAN server is available at http://swissmodel.expasy.org/qmean.
C1 [Benkert, Pascal; Kuenzli, Michael; Schwede, Torsten] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Benkert, Pascal; Kuenzli, Michael; Schwede, Torsten] SIB, Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008; Benkert, Pascal/C-3895-2009
OI Schwede, Torsten/0000-0003-2715-335X; 
FU Swiss Institute of Bioinformatics
FX Funding for open access charge: Swiss Institute of Bioinformatics.
CR Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   BENKERT P, 2009, PROTEINS S IN PRESS
   Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715
   Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197
   Chen H, 2008, PROTEINS, V71, P1255, DOI 10.1002/prot.21819
   Cheng J, 2005, NUCLEIC ACIDS RES, V33, pW72, DOI 10.1093/nar/gki396
   Cozzetto D, 2007, PROTEINS, V69, P175, DOI 10.1002/prot.21669
   Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750
   Kurowski MA, 2003, NUCLEIC ACIDS RES, V31, P3305, DOI 10.1093/nar/gkg557
   Lundstrom J, 2001, PROTEIN SCI, V10, P2354, DOI 10.1110/ps.08501
   LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0
   McGuffin LJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-345
   McGuffin LJ, 2008, BIOINFORMATICS, V24, P586, DOI 10.1093/bioinformatics/btn014
   Melo F, 1997, J MOL BIOL, V267, P207, DOI 10.1006/jmbi.1996.0868
   MELO F, 1997, P INT C INTELL SYST, V5, P187
   Moult J, 2007, PROTEINS, V69, P3, DOI 10.1002/prot.21767
   RAMACHANDRAN GN, 1963, J MOL BIOL, V7, P95, DOI 10.1016/S0022-2836(63)80023-6
   Rohl CA, 2004, METHOD ENZYMOL, V383, P66
   Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479
   SIPPL MJ, 1993, J COMPUT AID MOL DES, V7, P473, DOI 10.1007/BF02337562
   Tosatto SCE, 2005, J COMPUT BIOL, V12, P1316, DOI 10.1089/cmb.2005.12.1316
   Tress ML, 2003, J MOL BIOL, V330, P705, DOI 10.1016/S0022-2836(03)00622-3
   Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606
   Wallner B, 2003, PROTEINS, V53, P534, DOI 10.1002/prot.10536
   Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803
   Wallner B, 2007, PROTEINS, V69, P184, DOI 10.1002/prot.21774
   Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17
   Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571
   Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002
NR 32
TC 450
Z9 466
U1 0
U2 16
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUL 1
PY 2009
VL 37
SU S
BP W510
EP W514
DI 10.1093/nar/gkp322
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 469IG
UT WOS:000267889100089
PM 19429685
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Hausser, J
   Berninger, P
   Rodak, C
   Jantscher, Y
   Wirth, S
   Zavolan, M
AF Hausser, Jean
   Berninger, Philipp
   Rodak, Christoph
   Jantscher, Yvonne
   Wirth, Stefan
   Zavolan, Mihaela
TI MirZ: an integrated microRNA expression atlas and target prediction
   resource
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID SITE ACCESSIBILITY; SEQUENCE; DATABASE; DETERMINANTS; CONSERVATION;
   TRANSCRIPTS; SPECIFICITY; ZEBRAFISH; PROFILES; MOTIFS
AB MicroRNAs (miRNAs) are short RNAs that act as guides for the degradation and translational repression of protein-coding mRNAs. A large body of work showed that miRNAs are involved in the regulation of a broad range of biological functions, from development to cardiac and immune system function, to metabolism, to cancer. For most of the over 500 miRNAs that are encoded in the human genome the functions still remain to be uncovered. Identifying miRNAs whose expression changes between cell types or between normal and pathological conditions is an important step towards characterizing their function as is the prediction of mRNAs that could be targeted by these miRNAs. To provide the community the possibility of exploring interactively miRNA expression patterns and the candidate targets of miRNAs in an integrated environment, we developed the MirZ web server, which is accessible at www.mirz.unibas.ch. The server provides experimental and computational biologists with statistical analysis and data mining tools operating on up-to-date databases of sequencing-based miRNA expression profiles and of predicted miRNA target sites in species ranging from Caenorhabditis elegans to Homo sapiens.
C1 [Hausser, Jean; Berninger, Philipp; Rodak, Christoph; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Hausser, Jean; Berninger, Philipp; Rodak, Christoph; Zavolan, Mihaela] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Rodak, Christoph] Fachhsch Nordwestschweiz, CH-5201 Brugg, Switzerland.
   [Jantscher, Yvonne] Fachhsch Hagenberg, A-4232 Hagenberg, Austria.
   [Wirth, Stefan] Univ Leipzig, Inst Informat, D-04107 Leipzig, Germany.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041; Hausser, Jean/0000-0002-3321-7199
FU Swiss National FundSwiss National Science Foundation (SNSF)
   [3100A0-114001]; Swiss Institute of Bioinformatics
FX Swiss National Fund (grant #3100A0-114001 to M.Z.); Swiss Institute of
   Bioinformatics. Funding for open access charge: Swiss Institute of
   Bioinformatics.
CR Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4
   Bard J, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-2-r21
   Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433
   Berninger P, 2008, METHODS, V44, P13, DOI 10.1016/j.ymeth.2007.10.002
   Bieri T, 2007, NUCLEIC ACIDS RES, V35, pD506, DOI 10.1093/nar/gkl818
   Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085
   Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9
   Castillo-Davis CI, 2003, BIOINFORMATICS, V19, P891, DOI 10.1093/bioinformatics/btg114
   Chen PY, 2005, GENE DEV, V19, P1288, DOI 10.1101/gad.1310605
   Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341
   Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404
   Eglen R. M., 2006, Autonomic & Autacoid Pharmacology, V26, P219, DOI 10.1111/j.1474-8673.2006.00368.x
   Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588
   Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Gennarino VA, 2009, GENOME RES, V19, P481, DOI 10.1101/gr.084129.108
   Gibbs RA, 2004, NATURE, V428, P493, DOI 10.1038/nature02426
   Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689
   Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020
   Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Havlak P, 2004, GENOME RES, V14, P721, DOI 10.1101/gr.2264004
   He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552
   Huang JC, 2007, NAT METHODS, V4, P1045, DOI 10.1038/nmeth1130
   *INT CHICK GEN SEQ, 2004, NATURE, V423, P7018
   Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966
   Kasahara M, 2007, NATURE, V447, P714, DOI 10.1038/nature05846
   Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Landthaler M, 2008, RNA, V14, P2580, DOI 10.1261/rna.1351608
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Lindblad-Toh K, 2005, NATURE, V438, P803, DOI 10.1038/nature04338
   Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06
   Long D, 2007, NAT STRUCT MOL BIOL, V14, P287, DOI 10.1038/nsmb1226
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152
   Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207
   Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556
   Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076
   Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025
   Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003
   Rehmsmeier M, 2004, RNA, V10, P1507, DOI 10.1261/rna.5248604
   Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040
   Schomburg I, 2004, NUCLEIC ACIDS RES, V32, pD431, DOI 10.1093/nar/gkh081
   Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023
   Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101
   Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404
   Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262
   WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4
   Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021
   Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441
   Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1
   Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817
NR 59
TC 62
Z9 63
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUL 1
PY 2009
VL 37
SU S
BP W266
EP W272
DI 10.1093/nar/gkp412
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 469IG
UT WOS:000267889100047
PM 19468042
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Paolo, SS
   Vanacova, S
   Schenk, L
   Scherrer, T
   Blank, D
   Keller, W
   Gerber, AP
AF Paolo, Salvatore San
   Vanacova, Stepanka
   Schenk, Luca
   Scherrer, Tanja
   Blank, Diana
   Keller, Walter
   Gerber, Andre P.
TI Distinct Roles of Non-Canonical Poly(A) Polymerases in RNA Metabolism
SO PLOS GENETICS
LA English
DT Article
ID SISTER-CHROMATID COHESION; REPEAT-CONTAINING RNA;
   SACCHAROMYCES-CEREVISIAE; QUALITY-CONTROL; NUCLEAR EXOSOME;
   MESSENGER-RNA; TRANSCRIPTION TERMINATION; BIDIRECTIONAL PROMOTERS;
   DEBRANCHING ENZYME; II TRANSCRIPTION
AB Trf4p and Trf5p are non-canonical poly(A) polymerases and are part of the heteromeric protein complexes TRAMP4 and TRAMP5 that promote the degradation of aberrant and short-lived RNA substrates by interacting with the nuclear exosome. To assess the level of functional redundancy between the paralogous Trf4 and Trf5 proteins and to investigate the role of the Trf4-dependent polyadenylation in vivo, we used DNA microarrays to compare gene expression of the wild-type yeast strain of S. cerevisiae with either that of trf4 Delta or trf5 Delta mutant strains or the trf4 Delta mutant expressing the polyadenylation-defective Trf4(DADA) protein. We found little overlap between the sets of transcripts with altered expression in the trf4 Delta or the trf5 Delta mutants, suggesting that Trf4p and Trf5p target distinct groups of RNAs for degradation. Surprisingly, most RNAs the expression of which was altered by the trf4 deletion were restored to wild-type levels by overexpression of TRF4(DADA), showing that the polyadenylation activity of Trf4p is dispensable in vivo. Apart from previously reported Trf4p and Trf5p target RNAs, this analysis along with in vivo cross-linking and RNA immunopurification-chip experiments revealed that both the TRAMP4 and the TRAMP5 complexes stimulate the degradation of spliced-out introns via a mechanism that is independent of the polyadenylation activity of Trf4p. In addition, we show that disruption of trf4 causes severe shortening of telomeres suggesting that TRF4 functions in the maintenance of telomere length. Finally, our study demonstrates that TRF4, the exosome, and TRF5 participate in antisense RNA-mediated regulation of genes involved in phosphate metabolism. In conclusion, our results suggest that paralogous TRAMP complexes have distinct RNA selectivities with functional implications in RNA surveillance as well as other RNA-related processes. This indicates widespread and integrative functions of TRAMP complexes for the coordination of different gene expression regulatory processes.
C1 [Paolo, Salvatore San; Blank, Diana; Keller, Walter] Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
   [Vanacova, Stepanka] Masaryk Univ, Natl Ctr Biomol Res, Brno, Czech Republic.
   [Schenk, Luca; Scherrer, Tanja; Gerber, Andre P.] ETH, Dept Chem & Appl Biosci, Inst Pharmaceut Sci, Zurich, Switzerland.
RP Paolo, SS (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
EM walter.keller@unibas.ch; andre.gerber@pharma.ethz.ch
RI Vanacova, Stepanka/D-6858-2012
OI Vanacova, Stepanka/0000-0001-8807-0684
FU The Wellcome TrustWellcome Trust [084316/Z/07/Z]; EMBO Installation
   Grant [1642]; University of Basel; Swiss National Science FundSwiss
   National Science Foundation (SNSF); European Science FoundationEuropean
   Science Foundation (ESF); EC Sixth Framework ProgrammeEuropean
   CommissionEuropean Commission Joint Research CentreEuropean Union (EU)
   [ERAS-CT-2003-980409]; Human Frontier Science Program OrganizationHuman
   Frontier Science Program [CDA0048/2005]; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [3100A0-112235]
FX SV was supported by The Wellcome Trust Grant 084316/Z/07/Z and the EMBO
   Installation Grant, Project No. 1642. WK was supported by the University
   of Basel, the Swiss National Science Fund, and, as part of the European
   Science Foundation EUROCORES Programme EuroDYNA, from funds of the EC
   Sixth Framework Programme, under contract ERAS-CT-2003-980409. LS, TS,
   and APG were supported by a Career Development Award (CDA0048/2005) from
   the Human Frontier Science Program Organization and by a grant
   (3100A0-112235) from the Swiss National Science Foundation to APG. The
   funders had no role in study design, data collection and analysis,
   decision to publish, or preparation of the manuscript.
CR Askree SH, 2004, P NATL ACAD SCI USA, V101, P8658, DOI 10.1073/pnas.0401263101
   Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182
   Baldi P, 2001, BIOINFORMATICS, V17, P509, DOI 10.1093/bioinformatics/17.6.509
   Bernstein J, 2008, J BIOL CHEM, V283, P4930, DOI 10.1074/jbc.M706677200
   Berretta J, 2008, GENE DEV, V22, P615, DOI 10.1101/gad.458008
   Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481
   Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038
   Camblong J, 2007, CELL, V131, P706, DOI 10.1016/j.cell.2007.09.014
   Castano IB, 1996, NUCLEIC ACIDS RES, V24, P2404, DOI 10.1093/nar/24.12.2404
   Castano IB, 1996, GENE DEV, V10, P2564, DOI 10.1101/gad.10.20.2564
   CHAPMAN KB, 1991, CELL, V65, P483, DOI 10.1016/0092-8674(91)90466-C
   Danin-Kreiselman M, 2003, MOL CELL, V11, P1279, DOI 10.1016/S1097-2765(03)00137-0
   Davis CA, 2006, P NATL ACAD SCI USA, V103, P3262, DOI 10.1073/pnas.0507783103
   Dez C, 2006, EMBO J, V25, P1534, DOI 10.1038/sj.emboj.7601035
   Dichtl B, 2002, EMBO J, V21, P4125, DOI 10.1093/emboj/cdf390
   Dror V, 2004, MOL CELL BIOL, V24, P8227, DOI 10.1128/MCB.24.18.8227-8235.2004
   Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5
   Edwards S, 2003, MOL CELL BIOL, V23, P2733, DOI 10.1128/MCB.23.8.2733-2748.2003
   Egecioglu DE, 2006, RNA, V12, P26, DOI 10.1261/rna.2207206
   Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863
   Garas M, 2008, RNA, V14, P2671, DOI 10.1261/rna.1293008
   Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079
   Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103
   Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B
   Hilleren P, 2001, NATURE, V413, P538, DOI 10.1038/35097110
   Houalla R, 2006, YEAST, V23, P439, DOI 10.1002/yea.1369
   Houseley J, 2006, EMBO REP, V7, P205, DOI 10.1038/sj.embor.7400612
   Houseley J, 2008, BBA-GENE REGUL MECH, V1779, P239, DOI 10.1016/j.bbagrm.2007.12.008
   Houseley J, 2007, EMBO J, V26, P4996, DOI 10.1038/sj.emboj.7601921
   Houseley J, 2006, NAT REV MOL CELL BIO, V7, P529, DOI 10.1038/nrm1964
   Houseley J, 2009, CELL, V136, P763, DOI 10.1016/j.cell.2009.01.019
   Kadaba S, 2006, RNA, V12, P508, DOI 10.1261/rna.2305406
   Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804
   Khalid MF, 2005, NUCLEIC ACIDS RES, V33, P6349, DOI 10.1093/nar/gki934
   LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029
   Luke B, 2008, MOL CELL, V32, P465, DOI 10.1016/j.molcel.2008.10.019
   Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807
   Minvielle-Sebastia L, 1999, CURR OPIN CELL BIOL, V11, P352, DOI 10.1016/S0955-0674(99)80049-0
   Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7
   Neil H, 2009, NATURE, V457, P1038, DOI 10.1038/nature07747
   Pandit S, 2006, P NATL ACAD SCI USA, V103, P13700, DOI 10.1073/pnas.0603188103
   Peterson SE, 2001, NAT GENET, V27, P64
   Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45
   Rougemaille M, 2007, EMBO J, V26, P2317, DOI 10.1038/sj.emboj.7601669
   Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349
   Smogorzewska A, 2004, ANNU REV BIOCHEM, V73, P177, DOI 10.1146/annurev.biochem.73.071403.160049
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Uhler JP, 2007, P NATL ACAD SCI USA, V104, P8011, DOI 10.1073/pnas.0702431104
   Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189
   Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005
   Vasilieva L, 2008, MOL CELL, V29, P313, DOI 10.1016/j.molcel.2008.01.011
   Wang SW, 2008, MOL CELL BIOL, V28, P656, DOI 10.1128/MCB.01531-07
   Wang ZH, 2000, SCIENCE, V289, P774, DOI 10.1126/science.289.5480.774
   Wery M, 2009, RNA, V15, P406, DOI 10.1261/rna.1402709
   Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030
   Xu ZY, 2009, NATURE, V457, P1033, DOI 10.1038/nature07728
   Yamada M, 1998, J BIOL CHEM, V273, P33360, DOI 10.1074/jbc.273.50.33360
NR 57
TC 72
Z9 74
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1553-7390
J9 PLOS GENET
JI PLoS Genet.
PD JUL
PY 2009
VL 5
IS 7
AR e1000555
DI 10.1371/journal.pgen.1000555
PG 17
WC Genetics & Heredity
SC Genetics & Heredity
GA 486SZ
UT WOS:000269219500032
PM 19593367
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Pervushin, K
   Tan, E
   Parthasarathy, K
   Lin, X
   Jiang, FL
   Yu, DJ
   Vararattanavech, A
   Soong, TW
   Liu, DX
   Torres, J
AF Pervushin, Konstantin
   Tan, Edward
   Parthasarathy, Krupakar
   Lin, Xin
   Jiang, Feng Li
   Yu, Dejie
   Vararattanavech, Ardcharaporn
   Soong, Tuck Wah
   Liu, Ding Xiang
   Torres, Jaume
TI Structure and Inhibition of the SARS Coronavirus Envelope Protein Ion
   Channel
SO PLOS PATHOGENS
LA English
DT Article
ID ACUTE-RESPIRATORY-SYNDROME; INFECTIOUS-BRONCHITIS-VIRUS; INFLUENZA-A
   VIRUS; M2 PROTON CHANNEL; IN-VITRO; TRANSMEMBRANE DOMAIN;
   MOLECULAR-DYNAMICS; ACCURATE DOCKING; E-GENE; REPLICATION
AB The envelope (E) protein from coronaviruses is a small polypeptide that contains at least one alpha-helical transmembrane domain. Absence, or inactivation, of E protein results in attenuated viruses, due to alterations in either virion morphology or tropism. Apart from its morphogenetic properties, protein E has been reported to have membrane permeabilizing activity. Further, the drug hexamethylene amiloride (HMA), but not amiloride, inhibited in vitro ion channel activity of some synthetic coronavirus E proteins, and also viral replication. We have previously shown for the coronavirus species responsible for severe acute respiratory syndrome (SARS-CoV) that the transmembrane domain of E protein (ETM) forms pentameric alpha-helical bundles that are likely responsible for the observed channel activity. Herein, using solution NMR in dodecylphosphatidylcholine micelles and energy minimization, we have obtained a model of this channel which features regular alpha-helices that form a pentameric left-handed parallel bundle. The drug HMA was found to bind inside the lumen of the channel, at both the C-terminal and the N-terminal openings, and, in contrast to amiloride, induced additional chemical shifts in ETM. Full length SARS-CoV E displayed channel activity when transiently expressed in human embryonic kidney 293 (HEK-293) cells in a whole-cell patch clamp set-up. This activity was significantly reduced by hexamethylene amiloride (HMA), but not by amiloride. The channel structure presented herein provides a possible rationale for inhibition, and a platform for future structure-based drug design of this potential pharmacological target.
C1 [Pervushin, Konstantin; Tan, Edward; Parthasarathy, Krupakar; Lin, Xin; Vararattanavech, Ardcharaporn; Torres, Jaume] Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
   [Pervushin, Konstantin] Univ Basel, Biozentrum, Basel, Switzerland.
   [Jiang, Feng Li; Yu, Dejie; Soong, Tuck Wah] Natl Univ Singapore, Dept Physiol, Ctr Life Sci, Singapore 117548, Singapore.
   [Liu, Ding Xiang] Inst Mol Cell Biol, Singapore, Singapore.
RP Pervushin, K (corresponding author), Nanyang Technol Univ, Sch Biol Sci, Singapore, Singapore.
EM kpervushin@ntu.edu.sg; jtorres@ntu.edu.sg
RI Pervushin, Konstantin/AAJ-6580-2020; Torres, Jaume/AAJ-4510-2020;
   Torres, Jaume/A-2179-2011; Tan, Edward/W-8611-2019; Liu, Ding
   Xiang/A-2226-2011; parthasarathy, krupakar/F-3994-2017
OI Pervushin, Konstantin/0000-0002-6393-4340; Torres,
   Jaume/0000-0002-1282-9727; parthasarathy, krupakar/0000-0003-1846-800X
FU Biomedical Research Council (BMRC) of SingaporeAgency for Science
   Technology & Research (ASTAR) [04/1/22/19/361]
FX This work has been funded by the Biomedical Research Council (BMRC) of
   Singapore (grant 04/1/22/19/361). The funders had no role in study
   design, data collection and analysis, decision to publish, or
   preparation of the manuscript.
CR Amici C, 2006, ANTIVIR THER, V11, P1021
   Barnard DL, 2006, ANTIVIR RES, V71, P53, DOI 10.1016/j.antiviral.2006.03.001
   Baudoux P, 1998, J VIROL, V72, P8636, DOI 10.1128/JVI.72.11.8636-8643.1998
   Bos ECW, 1996, VIROLOGY, V218, P52, DOI 10.1006/viro.1996.0165
   Bouchard MJ, 2001, SCIENCE, V294, P2376, DOI 10.1126/science.294.5550.2376
   Briggs JAG, 2001, PROTEINS, V44, P370, DOI 10.1002/prot.1102
   Cady SD, 2008, P NATL ACAD SCI USA, V105, P1483, DOI 10.1073/pnas.0711500105
   Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055
   CAVANAGH J, 1991, J MAGN RESON, V91, P429, DOI 10.1016/0022-2364(91)90209-C
   Cavanagh J., 1996, PROTEIN NMR SPECTROS
   Chen F, 2004, J CLIN VIROL, V31, P69, DOI 10.1016/j.jcv.2004.03.003
   Cheng PW, 2006, CLIN EXP PHARMACOL P, V33, P612, DOI 10.1111/j.1440-1681.2006.04415.x
   Choma C, 2000, NAT STRUCT BIOL, V7, P161
   Corse E, 2000, J VIROL, V74, P4319, DOI 10.1128/JVI.74.9.4319-4326.2000
   Corse E, 2003, VIROLOGY, V312, P25, DOI 10.1016/S0042-6822(03)00175-2
   Curtis KM, 2002, J VIROL, V76, P1422, DOI 10.1128/JVI.76.3.1422-1434.2002
   DeDiego ML, 2008, VIROLOGY, V376, P379, DOI 10.1016/j.virol.2008.03.005
   DeDiego ML, 2007, J VIROL, V81, P1701, DOI 10.1128/JVI.01467-06
   Dosset P, 2001, J BIOMOL NMR, V20, P223, DOI 10.1023/A:1011206132740
   Enjuanes L., 2000, VIRUS TAXONOMY CLASS, P835
   Fischer F, 1998, J VIROL, V72, P7885, DOI 10.1128/JVI.72.10.7885-7894.1998
   Franco R, 2006, J MEMBRANE BIOL, V209, P43, DOI 10.1007/s00232-005-0837-5
   Friesner RA, 2004, J MED CHEM, V47, P1739, DOI 10.1021/jm0306430
   GEEN H, 1991, J MAGN RESON, V93, P93, DOI 10.1016/0022-2364(91)90034-Q
   Gonzaalez JM, 2003, ARCH VIROL, V148, P2207, DOI 10.1007/s00705-003-0162-1
   Gonzalez ME, 2003, FEBS LETT, V552, P28, DOI 10.1016/S0014-5793(03)00780-4
   Gorbalenya AE, 2004, J VIROL, V78, P7863, DOI 10.1128/JVI.78.15.7863-7866.2004
   Gratkowski H, 2001, P NATL ACAD SCI USA, V98, P880, DOI 10.1073/pnas.98.3.880
   Guntert Peter, 2004, Methods Mol Biol, V278, P353
   Halgren TA, 2004, J MED CHEM, V47, P1750, DOI 10.1021/jm030644s
   Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3
   Hon CC, 2008, J VIROL, V82, P1819, DOI 10.1128/JVI.01926-07
   Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5
   JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001
   Keyaerts E, 2004, BIOCHEM BIOPH RES CO, V323, P264, DOI 10.1016/j.bbrc.2004.08.085
   Kochendoerfer GG, 1999, BIOCHEMISTRY-US, V38, P11905, DOI 10.1021/bi990720m
   Li C, 2007, BBA-BIOMEMBRANES, V1768, P3162, DOI 10.1016/j.bbamem.2007.08.025
   Liao Y, 2006, VIROLOGY, V349, P264, DOI 10.1016/j.virol.2006.01.028
   Lin JT, 2007, ANTIVIR THER, V12, P1107
   Loutfy MR, 2003, JAMA-J AM MED ASSOC, V290, P3222, DOI 10.1001/jama.290.24.3222
   Madan V, 2005, FEBS LETT, V579, P3607, DOI 10.1016/j.febslet.2005.05.046
   Mortola E, 2004, FEBS LETT, V576, P174, DOI 10.1016/j.febslet.2004.09.009
   Ortego J, 2002, J VIROL, V76, P11518, DOI 10.1128/JVI.76.22.11518-11529.2002
   Parthasarathy K, 2008, BIOPHYS J, V95, pL39, DOI 10.1529/biophysj.108.133041
   Pervushin K, 2002, J AM CHEM SOC, V124, P12898, DOI 10.1021/ja027149q
   Pervushin K, 2007, NAT STRUCT MOL BIOL, V14, P1202, DOI 10.1038/nsmb1325
   Peterson BZ, 1999, NEURON, V22, P549, DOI 10.1016/S0896-6273(00)80709-6
   Pyrc K, 2006, ANTIMICROB AGENTS CH, V50, P2000, DOI 10.1128/AAC.01598-05
   Respondek M, 2007, J AM CHEM SOC, V129, P5228, DOI 10.1021/ja069004f
   Rota PA, 2003, SCIENCE, V300, P1394, DOI 10.1126/science.1085952
   Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531
   SIDDELL SG, 1995, CORONAVIRIDAE INTRO
   SKEHEL JJ, 1978, J GEN VIROL, V38, P97, DOI 10.1099/0022-1317-38-1-97
   Smart OS, 1996, J MOL GRAPH MODEL, V14, P354, DOI 10.1016/S0263-7855(97)00009-X
   Snijder EJ, 2003, J MOL BIOL, V331, P991, DOI 10.1016/S0022-2836(03)00865-9
   Stockman LJ, 2006, PLOS MED, V3, P1525, DOI 10.1371/journal.pmed.0030343
   Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528
   Tobler K, 1999, J VIROL, V73, P9695, DOI 10.1128/JVI.73.12.9695-9701.1999
   Torres J, 2005, BIOPHYS J, V88, P1283, DOI 10.1529/biophysj.104.051730
   Torres J, 2002, BIOPHYS J, V82, P3063, DOI 10.1016/S0006-3495(02)75647-6
   Torres J, 2007, PROTEIN SCI, V16, P2065, DOI 10.1110/ps.062730007
   Torres J, 2006, BIOPHYS J, V91, P938, DOI 10.1529/biophysj.105.080119
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   Vennema H, 1996, EMBO J, V15, P2020, DOI 10.1002/j.1460-2075.1996.tb00553.x
   Vijgen L, 2005, J VIROL, V79, P1595, DOI 10.1128/JVI.79.3.1595-1604.2005
   Weiss SR, 2005, MICROBIOL MOL BIOL R, V69, P635, DOI 10.1128/MMBR.69.4.635-664.2005
   Wellings DA, 1997, METHOD ENZYMOL, V289, P44
   Wilson L, 2004, VIROLOGY, V330, P322, DOI 10.1016/j.virol.2004.09.033
   Wilson L, 2006, VIROLOGY, V353, P294, DOI 10.1016/j.virol.2006.05.028
   Wu CJ, 2004, ANTIMICROB AGENTS CH, V48, P2693, DOI 10.1128/AAC.48.7.2693-2696.2004
   Wuthrich K., 1986, NMR PROTEINS NUCL AC
   Yang Y, 2005, BIOCHEM J, V392, P135, DOI 10.1042/BJ20050698
   Yuan Q, 2006, FEBS LETT, V580, P3192, DOI 10.1016/j.febslet.2006.04.076
   Zhou FX, 2001, P NATL ACAD SCI USA, V98, P2250, DOI 10.1073/pnas.041593698
NR 74
TC 87
Z9 88
U1 3
U2 33
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD JUL
PY 2009
VL 5
IS 7
AR e1000511
DI 10.1371/journal.ppat.1000511
PG 14
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 486UJ
UT WOS:000269224500027
PM 19593379
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Mustafi, D
   Engel, AH
   Palczewski, K
AF Mustafi, Debarshi
   Engel, Andreas H.
   Palczewski, Krzysztof
TI Structure of cone photoreceptors
SO PROGRESS IN RETINAL AND EYE RESEARCH
LA English
DT Review
DE Cone photoreceptors; Rod photoreceptors; Retinoids; Retinoid cycle;
   Chromophore; Opsins; Retina; Vision; Rhodopsin; Cone pigments; Enhanced
   S-cone syndrome; Retinitis pigmentosa; Age-related macular degeneration
ID NUCLEAR RECEPTOR NR2E3; OUTER SEGMENT MORPHOGENESIS; TRANSCRIPTION
   FACTOR NRL; INTRAFLAGELLAR TRANSPORT PROTEIN; DISK MEMBRANE
   MORPHOGENESIS; DEVELOPING MOUSE RETINA; VISUAL PIGMENTS; VERTEBRATE
   PHOTORECEPTORS; ROD PHOTORECEPTORS; GROUND-SQUIRREL
AB Although outnumbered more than 20:1 by rod photoreceptors, cone cells in the human retina mediate daylight vision and are critical for visual acuity and color discrimination. A variety of human diseases are characterized by a progressive loss of cone photoreceptors but the low abundance of cones and the absence of a macula in non-primate mammalian retinas have made it difficult to investigate cones directly. Conventional rodents (laboratory mice and rats) are nocturnal rod-dominated species with few cones in the retina, and studying other animals with cone-rich retinas presents various logistic and technical difficulties. Originating in the early 1900s, past research has begun to provide insights into cone ultrastructure but has yet to afford an overall perspective of cone cell organization. This review summarizes our past progress and focuses on the recent introduction of special mammalian models (transgenic mice and diurnal rats rich in cones) that together with new investigative techniques such as atomic force microscopy and cryo-electron tomography promise to reveal a more unified concept of cone photoreceptor organization and its role in retinal diseases. Published by Elsevier Ltd.
C1 [Palczewski, Krzysztof] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.
   [Engel, Andreas H.] Univ Basel, Biozentrum, ME Muller Inst, Ctr Cellular Imaging & Nanoanalyt, CH-4058 Basel, Switzerland.
RP Palczewski, K (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, 10900 Euclid Ave, Cleveland, OH 44106 USA.
EM kxp65@case.edu
OI Mustafi, Debarshi/0000-0002-9164-7488
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [EY09339, GM 079191, EY019478-01];
   Amgen Inc.Amgen; CWRU Medical Scientist Training Program (MSTP);
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [T32-GM007250,
   T32EY007157]; NATIONAL EYE INSTITUTEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [R01EY009339, R01EY009339, R01EY009339, T32EY007157,
   R01EY009339, R01EY009339, T32EY007157, R01EY009339, R01EY019478,
   R01EY009339, R01EY009339, R01EY009339, T32EY007157, R01EY009339,
   T32EY007157, R01EY019478, T32EY007157, R01EY019478, R01EY009339,
   R01EY009339, R01EY009339, R01EY009339, R01EY009339, T32EY007157,
   R01EY009339, T32EY007157, T32EY007157, R01EY009339, R01EY009339,
   T32EY007157, R01EY009339, R01EY009339, R01EY009339, R01EY009339,
   R01EY009339, T32EY007157, R01EY019478, R01EY009339, T32EY007157,
   R01EY009339, R01EY009339, T32EY007157, R01EY019478, T32EY007157,
   T32EY007157, R01EY009339, R01EY009339, R01EY009339, T32EY007157,
   T32EY007157, R01EY009339, R01EY009339, R01EY009339, T32EY007157,
   R01EY009339, T32EY007157, R01EY009339] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [T32GM007250,
   T32GM007250, T32GM007250, T32GM007250, T32GM007250, T32GM007250,
   T32GM007250, R01GM079191, T32GM007250, T32GM007250, T32GM007250,
   R01GM079191, T32GM007250, T32GM007250, T32GM007250, T32GM007250,
   T32GM007250, T32GM007250, T32GM007250, T32GM007250, T32GM007250,
   R01GM079191, T32GM007250, T32GM007250, T32GM007250, T32GM007250,
   T32GM007250, T32GM007250, T32GM007250, R01GM079191, T32GM007250,
   T32GM007250, T32GM007250, T32GM007250, T32GM007250, T32GM007250,
   T32GM007250, T32GM007250, T32GM007250, T32GM007250, T32GM007250,
   T32GM007250, R01GM079191, T32GM007250, T32GM007250, T32GM007250,
   T32GM007250] Funding Source: NIH RePORTER
FX Financial Support: This research was supported by NIH grants EY09339, GM
   079191, EY019478-01, and by an unrestricted grant from Amgen Inc. D.M.
   was supported in part by the CWRU Medical Scientist Training Program
   (MSTP) and National Institutes of Health grant T32-GM007250 and the
   Visual Sciences Training Grant from the National Institutes of Health
   (T32EY007157).
CR Akhmedov NB, 2000, P NATL ACAD SCI USA, V97, P5551, DOI 10.1073/pnas.97.10.5551
   Akimoto M, 2006, P NATL ACAD SCI USA, V103, P3890, DOI 10.1073/pnas.0508214103
   ANDERSON DH, 1976, J ULTRA MOL STRUCT R, V55, P119, DOI 10.1016/S0022-5320(76)80087-1
   ANDERSON DH, 1978, INVEST OPHTH VIS SCI, V17, P117
   ARDEN GB, 1979, NATURE, V279, P534, DOI 10.1038/279534a0
   Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955
   Arendt D, 2003, INT J DEV BIOL, V47, P563
   Arendt D, 2002, DEVELOPMENT, V129, P1143
   ARIKAWA K, 1992, J CELL BIOL, V116, P659, DOI 10.1083/jcb.116.3.659
   BARRONG SD, 1992, ARCH OPHTHALMOL-CHIC, V110, P706, DOI 10.1001/archopht.1992.01080170128040
   Battelle BA, 1998, J NEUROSCI, V18, P4548
   BAYLOR DA, 1984, J PHYSIOL-LONDON, V357, P575, DOI 10.1113/jphysiol.1984.sp015518
   BERNSTEIN SA, 1984, J CELL BIOL, V99, P379, DOI 10.1083/jcb.99.2.379
   BERSON EL, 1992, AM J OPHTHALMOL, V114, P748, DOI 10.1016/S0002-9394(14)74055-3
   BLAKESLEE B, 1988, J COMP PHYSIOL A, V162, P773, DOI 10.1007/BF00610966
   BLANKS JC, 1984, INVEST OPHTH VIS SCI, V25, P546
   Bobu C, 2008, VISION RES, V48, P424, DOI 10.1016/j.visres.2007.08.011
   Bobu C, 2006, INVEST OPHTH VIS SCI, V47, P3109, DOI 10.1167/iovs.05-1397
   BOK D, 1985, INVEST OPHTH VIS SCI, V26, P1659
   Bowmaker JK, 2006, CURR BIOL, V16, pR484, DOI 10.1016/j.cub.2006.06.016
   Braekevelt CR, 1998, TISSUE CELL, V30, P137, DOI 10.1016/S0040-8166(98)80062-1
   BRAEKEVELT CR, 1983, GRAEF ARCH CLIN EXP, V220, P273, DOI 10.1007/BF00231355
   BROWN PK, 1963, NECTURUS J CELL BIOL, V19, P79
   CARTERDAWSON LD, 1979, J COMP NEUROL, V188, P245, DOI 10.1002/cne.901880204
   Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005
   Chen SM, 1997, NEURON, V19, P1017, DOI 10.1016/S0896-6273(00)80394-3
   Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185
   Chuang JZ, 2007, CELL, V130, P535, DOI 10.1016/j.cell.2007.06.030
   Cideciyan AV, 1996, VISION RES, V36, P2609, DOI 10.1016/0042-6989(95)00327-4
   COHEN AI, 1968, J CELL BIOL, V37, P424, DOI 10.1083/jcb.37.2.424
   COHEN AI, 1965, ANAT REC, V152, P63, DOI 10.1002/ar.1091520108
   Collin SP, 1999, BRAIN BEHAV EVOLUT, V54, P96, DOI 10.1159/000006616
   Cook B, 2008, NAT GENET, V40, P1275, DOI 10.1038/ng1108-1275
   CORLESS JM, 1989, J COMP NEUROL, V287, P531, DOI 10.1002/cne.902870410
   Daniele LL, 2005, INVEST OPHTH VIS SCI, V46, P2156, DOI 10.1167/iovs.04-1427
   DITTO M, 1975, VISION RES, V15, P535, DOI 10.1016/0042-6989(75)90031-0
   DORN EM, 1995, INVEST OPHTH VIS SCI, V36, P2634
   Ebrey T, 2001, PROG RETIN EYE RES, V20, P49, DOI 10.1016/S1350-9462(00)00014-8
   Eckmiller M S, 1993, J Hirnforsch, V34, P179
   ECKMILLER MS, 1987, J CELL BIOL, V105, P2267, DOI 10.1083/jcb.105.5.2267
   ECKMILLER MS, 1990, CELL TISSUE RES, V260, P19, DOI 10.1007/BF00297486
   Eckmiller MS, 1997, PROG RETIN EYE RES, V16, P401, DOI 10.1016/S1350-9462(96)00026-2
   Eckmiller MS, 1996, CELL TISSUE RES, V285, P165, DOI 10.1007/s004410050632
   EDWARDS SC, 1987, J NEUROSCI, V7, P2811
   ESCHER P, 2008, HUM MUTAT, V3, P342
   Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036
   Farjo R, 2007, J COMP NEUROL, V504, P619, DOI 10.1002/cne.21476
   Farjo R, 2006, OPHTHALMIC GENET, V27, P117, DOI 10.1080/13816810600976806
   FETTER RD, 1987, INVEST OPHTH VIS SCI, V28, P646
   Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Freund CL, 1998, NAT GENET, V18, P311, DOI 10.1038/ng0498-311
   Freund CL, 1997, CELL, V91, P543, DOI 10.1016/S0092-8674(00)80440-7
   Friedman JS, 2004, J BIOL CHEM, V279, P47233, DOI 10.1074/jbc.M408298200
   FU Y, 2002, INVESTIGATIVE OPHTHA, V43
   Fu YB, 2007, PFLUG ARCH EUR J PHY, V454, P805, DOI 10.1007/s00424-006-0194-y
   Gaillard F, 2008, J COMP NEUROL, V510, P525, DOI 10.1002/cne.21798
   Gehring WJ, 2005, J HERED, V96, P171, DOI 10.1093/jhered/esi027
   Gehring WJ, 2002, INT J DEV BIOL, V46, P65
   Gomez MD, 2005, J NEUROSCI, V25, P2042, DOI 10.1523/JNEUROSCI.5129-04.2005
   GOVARDOVSKII VI, 1984, J COMP PHYSIOL, V154, P279, DOI 10.1007/BF00604994
   Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777
   Haider NB, 2006, VISUAL NEUROSCI, V23, P917, DOI 10.1017/S095252380623027X
   HALL MO, 1969, J MOL BIOL, V45, P397, DOI 10.1016/0022-2836(69)90114-4
   Hattar S, 2003, NATURE, V424, P76, DOI 10.1038/nature01761
   Hendrickson A, 2002, EXP EYE RES, V74, P435, DOI 10.1006/exer.2002.1181
   HOGAN JH, 1973, T PAC COAST OTOL OPH, V54, P11
   HOOD DC, 1995, VISION RES, V35, P2801, DOI 10.1016/0042-6989(95)00034-W
   HOOD DC, 1995, VISION RES, V35, P1473, DOI 10.1016/0042-6989(95)98727-Q
   Imai H, 2005, PHOTOCH PHOTOBIO SCI, V4, P667, DOI 10.1039/b416731g
   Insinna C, 2008, DEV DYNAM, V237, P1982, DOI 10.1002/dvdy.21554
   Jacobson SG, 2007, P NATL ACAD SCI USA, V104, P15123, DOI 10.1073/pnas.0706367104
   JACOBSON SG, 1991, AM J OPHTHALMOL, V111, P446, DOI 10.1016/S0002-9394(14)72379-7
   Johnson PT, 1999, J COMP NEUROL, V414, P1
   Katti C, 2009, EXP EYE RES, V89, P224, DOI 10.1016/j.exer.2009.03.011
   Kawamura S, 1997, VISION RES, V37, P1867, DOI 10.1016/S0042-6989(96)00309-4
   Kawamura S, 2008, COMP BIOCHEM PHYS A, V150, P369, DOI 10.1016/j.cbpa.2008.04.600
   Kefalov V, 2003, NATURE, V425, P526, DOI 10.1038/nature01992
   KINNEY MS, 1978, PROC R SOC SER B-BIO, V201, P149, DOI 10.1098/rspb.1978.0037
   Krock BL, 2008, J CELL SCI, V121, P1907, DOI 10.1242/jcs.029397
   Kryger Z, 1998, VISUAL NEUROSCI, V15, P685, DOI 10.1017/S0952523898154081
   Lamb T.D., 1990, Seminars in the Neurosciences, V2, P3
   Lamb TD, 2007, NAT REV NEUROSCI, V8, P960, DOI 10.1038/nrn2283
   Lamb Trevor D., 2008, Evolution Education and Outreach, V1, P415, DOI 10.1007/s12052-008-0091-2
   Liu XR, 1999, J NEUROSCI, V19, P6267
   LONG KO, 1983, J COMP NEUROL, V221, P329, DOI 10.1002/cne.902210308
   Luby-Phelps K, 2008, VISION RES, V48, P413, DOI 10.1016/j.visres.2007.08.022
   MAEDA T, 2009, HUMAN MOL GENETICS, V18
   MARC RE, 1977, SCIENCE, V196, P454, DOI 10.1126/science.403607
   Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774
   Milam AH, 2002, P NATL ACAD SCI USA, V99, P473, DOI 10.1073/pnas.022533099
   Mitton KP, 2003, HUM MOL GENET, V12, P365, DOI 10.1093/hmg/ddg035
   MOLDAY RS, 1987, INVEST OPHTH VIS SCI, V28, P50
   NATHANS J, 1987, ANNU REV NEUROSCI, V10, P163
   Ng L, 2001, NAT GENET, V27, P94
   Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010
   Nickle B, 2007, CELL MOL LIFE SCI, V64, P2917, DOI 10.1007/s00018-007-7253-1
   Nickle B, 2006, BIOCHEMISTRY-US, V45, P7307, DOI 10.1021/bi060234g
   Nikonov SS, 2005, J GEN PHYSIOL, V125, P287, DOI 10.1085/jgp.200409208
   Nishiguchi KM, 2004, P NATL ACAD SCI USA, V101, P17819, DOI 10.1073/pnas.0408183101
   Oh ECT, 2008, BRAIN RES, V1236, P16, DOI 10.1016/j.brainres.2008.01.028
   OKANO T, 1992, P NATL ACAD SCI USA, V89, P5932, DOI 10.1073/pnas.89.13.5932
   Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006
   Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743
   Parry JWL, 2003, VISION RES, V43, P31, DOI 10.1016/S0042-6989(02)00404-2
   Pazour GJ, 2002, J CELL BIOL, V157, P103, DOI 10.1083/jcb.200107108
   Peichl L, 2005, ANAT REC PART A, V287A, P1001, DOI 10.1002/ar.a.20262
   PEICHL L, 1994, VISUAL NEUROSCI, V11, P501, DOI 10.1017/S095252380000242X
   Polans A, 1996, TRENDS NEUROSCI, V19, P547, DOI 10.1016/S0166-2236(96)10059-X
   PORTIER MM, 1984, DEV NEUROSCI-BASEL, V6, P335, DOI 10.1159/000112360
   PU GA, 1981, J NEUROPHYSIOL, V46, P1018
   Pugh Jr EN, 2000, HDB BIOL PHYSICS, V3, P183, DOI DOI 10.1016/S1383-8121(00)80008-1
   Rattner A, 1999, ANNU REV GENET, V33, P89, DOI 10.1146/annurev.genet.33.1.89
   RAYMOND PA, 1985, J COMP NEUROL, V236, P90, DOI 10.1002/cne.902360108
   Rebrik TI, 1998, J GEN PHYSIOL, V112, P537, DOI 10.1085/jgp.112.5.537
   Rehemtulla A, 1996, P NATL ACAD SCI USA, V93, P191, DOI 10.1073/pnas.93.1.191
   REME CE, 1977, INVEST OPHTH VIS SCI, V16, P815
   Ridge KD, 2007, J BIOL CHEM, V282, P9297, DOI 10.1074/jbc.R600032200
   Roberts MR, 2006, P NATL ACAD SCI USA, V103, P6218, DOI 10.1073/pnas.0509981103
   Roberts MR, 2005, INVEST OPHTH VIS SCI, V46, P2897, DOI 10.1167/iovs.05-0093
   Rodieck R. W., 1998, 1 STEPS SEEING
   Rodieck RW, 1973, VERTEBRATE RETINA
   ROOF D, 1991, J COMP NEUROL, V305, P289, DOI 10.1002/cne.903050210
   Roorda A, 2001, VISION RES, V41, P1291, DOI 10.1016/S0042-6989(01)00043-8
   Samardzija M, 2009, HUM MOL GENET, V18, P1266, DOI 10.1093/hmg/ddp026
   SAMEJIMA M, 1989, CELL TISSUE RES, V258, P219
   Shelley EJ, 2009, ARCH OPHTHALMOL-CHIC, V127, P483, DOI 10.1001/archophthalmol.2008.622
   STEINBERG RH, 1980, J COMP NEUROL, V190, P501, DOI 10.1002/cne.901900307
   STEINBERG RH, 1977, PHILOS T ROY SOC B, V277, P459, DOI 10.1098/rstb.1977.0028
   Stenkamp RE, 2002, BBA-BIOMEMBRANES, V1565, P168, DOI 10.1016/S0005-2736(02)00567-9
   Strettoi E, 2004, J NEUROSCI, V24, P7576, DOI 10.1523/JNEUROSCI.2245-04.2004
   Swain PK, 1997, NEURON, V19, P1329, DOI 10.1016/S0896-6273(00)80423-7
   SWAROOP A, 1992, P NATL ACAD SCI USA, V89, P266, DOI 10.1073/pnas.89.1.266
   Szel A, 2000, J OPT SOC AM A, V17, P568, DOI 10.1364/JOSAA.17.000568
   TOWNESANDERSON E, 1995, INVEST OPHTH VIS SCI, V36, P1918
   Travis GH, 1998, AM J HUM GENET, V62, P503, DOI 10.1086/301772
   VAUGHAN DK, 1989, INVEST OPHTH VIS SCI, V30, P339
   WALLS GORDON L., 1934, ARCH OPHLHALMOL, V12, P914
   WILLIAMS DS, 1988, J COMP NEUROL, V272, P161, DOI 10.1002/cne.902720202
   Yoshida S, 2004, HUM MOL GENET, V13, P1487, DOI 10.1093/hmg/ddh160
   YOUNG RW, 1967, J CELL BIOL, V33, P61, DOI 10.1083/jcb.33.1.61
   YOUNG RW, 1976, INVEST OPHTH VISUAL, V15, P700
   YOUNG RW, 1969, INVEST OPHTH VISUAL, V8, P222
   YUODELIS C, 1986, VISION RES, V26, P847, DOI 10.1016/0042-6989(86)90143-4
   Zhang HB, 2008, J NEUROSCI, V28, P4008, DOI 10.1523/JNEUROSCI.0317-08.2008
   Znoiko SL, 2005, INVEST OPHTH VIS SCI, V46, P1473, DOI 10.1167/iovs.04-0653
NR 146
TC 104
Z9 107
U1 3
U2 29
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1350-9462
EI 1873-1635
J9 PROG RETIN EYE RES
JI Prog. Retin. Eye Res.
PD JUL
PY 2009
VL 28
IS 4
BP 289
EP 302
DI 10.1016/j.preteyeres.2009.05.003
PG 14
WC Ophthalmology
SC Ophthalmology
GA 487SS
UT WOS:000269296600004
PM 19501669
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Bottova, I
   Hehl, AB
   Stefanic, S
   Fabrias, G
   Casas, J
   Schraner, E
   Pieters, J
   Sonda, S
AF Bottova, Iveta
   Hehl, Adrian B.
   Stefanic, Sasa
   Fabrias, Gemma
   Casas, Josefina
   Schraner, Elisabeth
   Pieters, Jean
   Sonda, Sabrina
TI Host Cell P-glycoprotein Is Essential for Cholesterol Uptake and
   Replication of Toxoplasma gondii
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID MULTIDRUG-RESISTANCE; NEOSPORA-CANINUM; DENSITY-LIPOPROTEIN;
   ESTERIFICATION; MEMBRANE; ACCUMULATION; TRANSPORTERS; VACUOLE;
   SPHINGOMYELIN; SPHINGOLIPIDS
AB P-glycoprotein (P-gp) is a membrane-bound efflux pump that actively exports a wide range of compounds from the cell and is associated with the phenomenon of multidrug resistance. However, the role of P-gp in normal physiological processes remains elusive. Using P-gp-deficient fibroblasts, we showed that P-gp was critical for the replication of the intracellular parasite Toxoplasma gondii but was not involved in invasion of host cells by the parasite. Importantly, we found that the protein participated in the transport of host-derived cholesterol to the intracellular parasite. T. gondii replication in P-gp-deficient host cells not only resulted in reduced cholesterol content in the parasite but also altered its sphingolipid metabolism. In addition, we found that different levels of P-gp expression modified the cholesterol metabolism in uninfected fibroblasts. Collectively our findings reveal a key and previously undocumented role of P-gp in host-parasite interaction and suggest a physiological role for P-gp in cholesterol trafficking in mammalian cells.
C1 [Bottova, Iveta; Hehl, Adrian B.; Stefanic, Sasa; Sonda, Sabrina] Univ Zurich, Inst Parasitol, CH-8057 Zurich, Switzerland.
   [Schraner, Elisabeth] Univ Zurich, Inst Vet Anat, CH-8057 Zurich, Switzerland.
   [Fabrias, Gemma; Casas, Josefina] CSIC, Inst Quim Avancada Catalunya, ES-08034 Barcelona, Spain.
   [Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Sonda, S (corresponding author), Univ Zurich, Inst Parasitol, Winterthurerstr 266A, CH-8057 Zurich, Switzerland.
EM sabrina.sonda@vetparas.uzh.ch
RI Casas, Josefina/L-7934-2014; Stefanic, Sasa/AAF-3063-2020
OI Hehl, Adrian/0000-0002-2110-4445; Stefanic, Sasa/0000-0001-7367-1831;
   Pieters, Jean/0000-0002-5284-9757; Fabrias, Gemma/0000-0001-7162-3772
FU Marie Heim-Vogtlin Foundation; Fondation Pierre Mercier pour la Science;
   Roche and Novartis; Bundesamt fur Bildung and Wissenschaft [C03.0007];
   Swiss National FoundationSwiss National Science Foundation (SNSF)
FX This work was supported by grants from the Marie Heim-Vogtlin
   Foundation, Fondation Pierre Mercier pour la Science, Roche and Novartis
   (to S. S.), Bundesamt fur Bildung and Wissenschaft C03.0007 COST Action
   857 (to A. B. H.), and the Swiss National Foundation (to J. P.).
CR Aleman C, 2003, CANCER RES, V63, P3084
   Blackmore CG, 2001, MOL MEMBR BIOL, V18, P97, DOI 10.1080/09687680120426
   BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911
   Brown RE, 1998, J CELL SCI, V111, P1
   Coppens I, 2006, CELL, V125, P261, DOI 10.1016/j.cell.2006.01.056
   Coppens I, 2000, J CELL BIOL, V149, P167, DOI 10.1083/jcb.149.1.167
   CURRIER SJ, 1992, J BIOL CHEM, V267, P25153
   Debry P, 1997, J BIOL CHEM, V272, P1026, DOI 10.1074/jbc.272.2.1026
   Fu D, 2007, AM J PHYSIOL-CELL PH, V292, pC1543, DOI 10.1152/ajpcell.00068.2006
   Fuchs N, 1998, J PARASITOL, V84, P753, DOI 10.2307/3284583
   Garrigues A, 2002, P NATL ACAD SCI USA, V99, P10347, DOI 10.1073/pnas.162366399
   Gottesman MM, 1995, ANNU REV GENET, V29, P607, DOI 10.1146/annurev.ge.29.120195.003135
   Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329
   Hemphill A, 1996, INFECT IMMUN, V64, P4279, DOI 10.1128/IAI.64.10.4279-4287.1996
   Hemphill A, 1996, PARASITOLOGY, V112, P183, DOI 10.1017/S0031182000084754
   Kim H, 1997, AM J PHYSIOL-CELL PH, V273, pC687
   Lahiri S, 2007, CELL MOL LIFE SCI, V64, P2270, DOI 10.1007/s00018-007-7076-0
   Lencer WI, 2005, BBA-MOL CELL RES, V1746, P314, DOI 10.1016/j.bbamcr.2005.07.007
   Leppimaki P, 1998, BIOCHEM J, V335, P285, DOI 10.1042/bj3350285
   Lerch PG, 1996, VOX SANG, V71, P155, DOI 10.1046/j.1423-0410.1996.7130155.x
   Liscovitch M, 2000, TRENDS BIOCHEM SCI, V25, P530, DOI 10.1016/S0968-0004(00)01668-6
   London M, 2004, J BIOL CHEM, V279, P9997, DOI 10.1074/jbc.M309992200
   Loo TW, 1999, BIOCHEM CELL BIOL, V77, P11, DOI 10.1139/bcb-77-1-11
   Luker GD, 1999, J BIOL CHEM, V274, P6979, DOI 10.1074/jbc.274.11.6979
   Luker GD, 2001, J LIPID RES, V42, P1389
   Martin AM, 2007, J EUKARYOT MICROBIOL, V54, P25, DOI 10.1111/j.1550-7408.2006.00230.x
   Maubon D, 2008, TRENDS PARASITOL, V24, P299, DOI 10.1016/j.pt.2008.03.012
   Maxfield FR, 2005, NATURE, V438, P612, DOI 10.1038/nature04399
   McFadden DC, 1997, ANTIMICROB AGENTS CH, V41, P1849, DOI 10.1128/AAC.41.9.1849
   Monaghan P, 2003, J MICROSC-OXFORD, V212, P62, DOI 10.1046/j.1365-2818.2003.01245.x
   Mordue DG, 1999, EXP PARASITOL, V92, P87, DOI 10.1006/expr.1999.4412
   Munoz-Olaya JM, 2008, CHEMMEDCHEM, V3, P946, DOI 10.1002/cmdc.200700325
   Orlowski S, 2006, CELL MOL LIFE SCI, V63, P1038, DOI 10.1007/s00018-005-5554-9
   Ridgway ND, 2000, BBA-MOL CELL BIOL L, V1484, P129, DOI 10.1016/S1388-1981(00)00006-8
   Santini MT, 2001, BBA-MOL CELL BIOL L, V1531, P111, DOI 10.1016/S1388-1981(01)00093-2
   Schinkel AH, 1997, P NATL ACAD SCI USA, V94, P4028, DOI 10.1073/pnas.94.8.4028
   SCHINKEL AH, 1994, CELL, V77, P491, DOI 10.1016/0092-8674(94)90212-7
   Sehgal A, 2005, TRAFFIC, V6, P1125, DOI 10.1111/j.1600-0854.2005.00348.x
   Silverman JA, 1997, ANTIMICROB AGENTS CH, V41, P1859, DOI 10.1128/AAC.41.9.1859
   Sonda S, 2001, J BIOL CHEM, V276, P34434, DOI 10.1074/jbc.M105025200
   Underwood KW, 1996, J LIPID RES, V37, P1556
   van Veen HW, 1998, BBA-BIOENERGETICS, V1365, P31, DOI 10.1016/S0005-2728(98)00039-5
   WARNER GJ, 1995, J BIOL CHEM, V270, P5772, DOI 10.1074/jbc.270.11.5772
   Wijnholds J, 2000, J CLIN INVEST, V105, P279, DOI 10.1172/JCI8267
   Wild P, 2001, MICROSC RES TECHNIQ, V53, P313, DOI 10.1002/jemt.1098
   Zhang M, 2001, J BIOL CHEM, V276, P3417, DOI 10.1074/jbc.M005393200
NR 46
TC 13
Z9 13
U1 0
U2 1
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 26
PY 2009
VL 284
IS 26
BP 17438
EP 17448
DI 10.1074/jbc.M809420200
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 460QP
UT WOS:000267202500010
PM 19389707
OA Green Accepted, Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Stetak, A
   Horndli, F
   Maricq, AV
   van den Heuvel, S
   Hajnal, A
AF Stetak, Attila
   Hoerndli, Frederic
   Maricq, Andres V.
   van den Heuvel, Sander
   Hajnal, Alex
TI Neuron-Specific Regulation of Associative Learning and Memory by MAGI-1
   in C. elegans
SO PLOS ONE
LA English
DT Article
AB Background: Identifying the molecular mechanisms and neural circuits that control learning and memory are major challenges in neuroscience. Mammalian MAGI/S-SCAM is a multi-PDZ domain synaptic scaffolding protein that interacts with a number of postsynaptic signaling proteins and is thereby thought to regulate synaptic plasticity [1,2,3].
   Principal Findings: While investigating the behavioral defects of C. elegans nematodes carrying a mutation in the single MAGI ortholog magi-1, we have identified specific neurons that require MAGI-1 function for different aspects of associative learning and memory. Various sensory stimuli and a food deprivation signal are associated in RIA interneurons during learning, while additional expression of MAGI-1 in glutamatergic AVA, AVD and possibly AVE interneurons is required for efficient memory consolidation, i.e. the ability to retain the conditioned changes in behavior over time. During associative learning, MAGI-1 in RIA neurons controls in a cell non-autonomous fashion the dynamic remodeling of AVA, AVD and AVE synapses containing the ionotropic glutamate receptor (iGluR) GLR-1 [4]. During memory consolidation, however, MAGI-1 controls GLR-1 clustering in AVA and AVD interneurons cell-autonomously and depends on the ability to interact with the beta-catenin HMP-2.
   Significance: Together, these results indicate that different aspects of associative learning and memory in C. elegans are likely carried out by distinct subsets of interneurons. The synaptic scaffolding protein MAGI-1 plays a critical role in these processes in part by regulating the clustering of iGluRs at synapses.
RP Stetak, A (corresponding author), Univ Basel, Biozentrum Pharmazentrum, Basel, Switzerland.
EM a.stetak@unibas.ch
RI van den Heuvel, Sander J.L./B-8892-2011
OI van den Heuvel, Sander J.L./0000-0001-9015-7463; Hajnal,
   Alex/0000-0002-4098-3721
FU NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [P01CA095281, P01CA095281, P01CA095281, P01CA095281,
   P01CA095281, P01CA095281, P01CA095281, P01CA095281, P01CA095281,
   P01CA095281, P01CA095281] Funding Source: NIH RePORTER; NATIONAL
   INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS035812, R01NS035812, R01NS035812, R01NS035812, R01NS035812,
   R01NS035812, R01NS035812, R01NS035812, R01NS035812, R01NS035812,
   R01NS035812, R01NS035812, R01NS035812, R01NS035812, R01NS035812,
   R01NS035812, R01NS035812, R01NS035812, R01NS035812, R01NS035812,
   R01NS035812, R01NS035812, R01NS035812, R01NS035812, R01NS035812,
   R01NS035812] Funding Source: NIH RePORTER; NCI NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [P01 CA095281, CA095281]
   Funding Source: Medline; NINDS NIH HHSUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Neurological Disorders & Stroke (NINDS) [R01 NS035812]
   Funding Source: Medline
CR BARGMANN CI, 1993, CELL, V74, P515, DOI 10.1016/0092-8674(93)80053-H
   Blanpied TA, 2008, P NATL ACAD SCI USA, V105, P12587, DOI 10.1073/pnas.0711669105
   BRENNER S, 1974, GENETICS, V77, P71
   Brockie PJ, 2001, J NEUROSCI, V21, P1510
   Cassata G, 2000, GENESIS, V27, P141, DOI 10.1002/1526-968X(200008)27:4<141::AID-GENE20>3.0.CO;2-K
   Deng F, 2006, J NEUROSCI, V26, P7875, DOI 10.1523/JNEUROSCI.1851-06.2006
   Dobrosotskaya I, 1997, J BIOL CHEM, V272, P31589, DOI 10.1074/jbc.272.50.31589
   Dobrosotskaya IY, 2000, BIOCHEM BIOPH RES CO, V270, P903, DOI 10.1006/bbrc.2000.2471
   Emtage L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004613
   HART AC, 1995, NATURE, V378, P82, DOI 10.1038/378082a0
   Hirao K, 1998, J BIOL CHEM, V273, P21105, DOI 10.1074/jbc.273.33.21105
   Hobert O, 2002, BIOTECHNIQUES, V32, P728, DOI 10.2144/02324bm01
   Jansen G, 1997, NAT GENET, V17, P119, DOI 10.1038/ng0997-119
   Kano T, 2008, CURR BIOL, V18, P1010, DOI 10.1016/j.cub.2008.05.051
   KAPLAN JM, 1993, P NATL ACAD SCI USA, V90, P2227, DOI 10.1073/pnas.90.6.2227
   Kawajiri A, 2000, BIOCHEM BIOPH RES CO, V273, P712, DOI 10.1006/bbrc.2000.3002
   Kuhara A, 2006, J NEUROSCI, V26, P9355, DOI 10.1523/JNEUROSCI.0517-06.2006
   Lisman J, 2006, SCI STKE, V2006, pre11, DOI DOI 10.1126/STKE.3562006RE11
   Matus A, 2000, SCIENCE, V290, P754, DOI 10.1126/science.290.5492.754
   MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x
   Mohri A, 2005, GENETICS, V169, P1437, DOI 10.1534/genetics.104.036111
   Morrison GE, 2001, BEHAV NEUROSCI, V115, P640, DOI 10.1037//0735-7044.115.3.640
   Morrison GE, 1997, BEHAV NEUROSCI, V111, P564, DOI 10.1037/0735-7044.111.3.564
   Nuttley WM, 2002, P NATL ACAD SCI USA, V99, P12449, DOI 10.1073/pnas.192101699
   Okamoto KI, 2004, NAT NEUROSCI, V7, P1104, DOI 10.1038/nn1311
   Raghavachari S, 2004, J NEUROPHYSIOL, V92, P2456, DOI 10.1152/jn.00258.2004
   Rongo C, 1998, CELL, V94, P751, DOI 10.1016/S0092-8674(00)81734-1
   Rose JK, 2003, J NEUROSCI, V23, P9595
   Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X
   Shoji H, 2000, J BIOL CHEM, V275, P5485, DOI 10.1074/jbc.275.8.5485
   Tomioka M, 2006, NEURON, V51, P613, DOI 10.1016/j.neuron.2006.07.024
   Wicks SR, 2000, DEV BIOL, V221, P295, DOI 10.1006/dbio.2000.9686
NR 32
TC 37
Z9 40
U1 0
U2 12
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD JUN 24
PY 2009
VL 4
IS 6
AR e6019
DI 10.1371/journal.pone.0006019
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 462MF
UT WOS:000267356500007
PM 19551147
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Schmidt, TI
   Kleylein-Sohn, J
   Westendorf, J
   Le Clech, M
   Lavoie, SB
   Stierhof, YD
   Nigg, EA
AF Schmidt, Thorsten I.
   Kleylein-Sohn, Julia
   Westendorf, Jens
   Le Clech, Mikael
   Lavoie, Sebastien B.
   Stierhof, York-Dieter
   Nigg, Erich A.
TI Control of Centriole Length by CPAP and CP110
SO CURRENT BIOLOGY
LA English
DT Article
ID CENTROSOME DUPLICATION; C-ELEGANS; HUMAN-CELLS; PROTEIN; CILIA;
   BIOGENESIS; SAS-4; CYCLE; GENE; SUBSTRATE
AB Centrioles function as the major components of centrosomes, which organize microtubule (MT) arrays in proliferating cells, and as basal bodies for primary cilia formation in quiescent cells. Centrioles and basal bodies are structurally similar, barrel-shaped organelles composed of MTs. In proliferating cells, two new centrioles, termed procentrioles, form during the S phase of the cell cycle in close proximity to the proximal ends of the two preexisting parental centrioles, often at a near-orthogonal angle [1]. Considerable progress has been made toward understanding the biogenesis of centrioles, but the mechanisms that determine their lengths remain unknown. Here we show that overexpression of the centriolar protein CPAP in human cells enhances the accumulation of centriolar tubulin, leading to centrioles of strikingly increased length. Consistent with earlier work [2], we also find that elongated MT structures can be induced by depletion of the distal end-capping protein CP110 from centrioles. Importantly, though, these structures differ from genuine primary cilia. We thus propose that CPAP and CP110 play antagonistic roles in determining the extent of tubulin addition during centriole elongation, thereby controlling the length of newly formed centrioles.
C1 [Schmidt, Thorsten I.; Kleylein-Sohn, Julia; Westendorf, Jens; Le Clech, Mikael; Lavoie, Sebastien B.; Nigg, Erich A.] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
   [Stierhof, York-Dieter] Univ Tubingen, Ctr Plant Mol Biol, Electron Microscopy Unit, D-72076 Tubingen, Germany.
   [Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Nigg, EA (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.
EM erich.nigg@unibas.ch
OI nigg, erich/0000-0003-4835-5719
FU Max Planck SocietyMax Planck Society; International Max Planck Research
   School for Molecular and Cellular Life Sciences
FX This work was supported by the Max Planck Society and the International
   Max Planck Research School for Molecular and Cellular Life Sciences.
CR Azimzadeh J, 2007, J CELL SCI, V120, P2139, DOI 10.1242/jcs.005231
   Bettencourt-Dias M, 2005, CURR BIOL, V15, P2199, DOI 10.1016/j.cub.2005.11.042
   Bettencourt-Dias M, 2007, NAT REV MOL CELL BIO, V8, P451, DOI 10.1038/nrm2180
   Bond J, 2005, NAT GENET, V37, P353, DOI 10.1038/ng1539
   Chen ZH, 2002, DEV CELL, V3, P339, DOI 10.1016/S1534-5807(02)00258-7
   Cho JH, 2006, BIOCHEM BIOPH RES CO, V339, P742, DOI 10.1016/j.bbrc.2005.11.074
   Dammermann A, 2008, J CELL BIOL, V180, P771, DOI 10.1083/jcb.200709102
   Delattre M, 2004, NAT CELL BIOL, V6, P656, DOI 10.1038/ncb1146
   Delattre M, 2006, CURR BIOL, V16, P1844, DOI 10.1016/j.cub.2006.07.059
   Fry AM, 1998, J CELL BIOL, V141, P1563, DOI 10.1083/jcb.141.7.1563
   Graser S, 2007, J CELL BIOL, V179, P321, DOI 10.1083/jcb.200707181
   Gul A, 2006, J HUM GENET, V51, P760, DOI 10.1007/s10038-006-0017-1
   Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320
   Hsu WB, 2008, EXP CELL RES, V314, P2591, DOI 10.1016/j.yexcr.2008.05.012
   Hung LY, 2000, MOL CELL BIOL, V20, P7813, DOI 10.1128/MCB.20.20.7813-7825.2000
   Keller LC, 2009, MOL BIOL CELL, V20, P1150, DOI 10.1091/mbc.E08-06-0619
   Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109
   Kirkham M, 2003, CELL, V112, P575, DOI 10.1016/S0092-8674(03)00117-X
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   Kohlmaier G, 2009, CURR BIOL, V19, P1012, DOI 10.1016/j.cub.2009.05.018
   Leidel S, 2005, NAT CELL BIOL, V7, P115, DOI 10.1038/ncb1220
   Leidel S, 2003, DEV CELL, V4, P431, DOI 10.1016/S1534-5807(03)00062-5
   Mogensen MM, 2000, J CELL SCI, V113, P3013
   Nakazawa Y, 2007, CURR BIOL, V17, P2169, DOI 10.1016/j.cub.2007.11.046
   Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003
   O'Connell KF, 2001, CELL, V105, P547, DOI 10.1016/S0092-8674(01)00338-5
   Ohta T, 2002, J CELL BIOL, V156, P87, DOI 10.1083/jcb.200108088
   Pazour GJ, 2000, J CELL BIOL, V151, P709, DOI 10.1083/jcb.151.3.709
   Pearson CG, 2007, DEV CELL, V13, P319, DOI 10.1016/j.devcel.2007.08.007
   Pelletier L, 2006, NATURE, V444, P619, DOI 10.1038/nature05318
   Rodrigues-Martins A, 2007, SCIENCE, V316, P1046, DOI 10.1126/science.1142950
   Spektor A, 2007, CELL, V130, P678, DOI 10.1016/j.cell.2007.06.027
   Strnad P, 2008, TRENDS CELL BIOL, V18, P389, DOI 10.1016/j.tcb.2008.06.004
   TANG CC, 2009, NAT CELL BI IN PRESS
   Tsang WY, 2008, DEV CELL, V15, P187, DOI 10.1016/j.devcel.2008.07.004
NR 35
TC 202
Z9 206
U1 0
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD JUN 23
PY 2009
VL 19
IS 12
BP 1005
EP 1011
DI 10.1016/j.cub.2009.05.016
PG 7
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 462GH
UT WOS:000267338500022
PM 19481458
DA 2021-01-25
ER

PT J
AU Schlee, S
   Deuss, M
   Bruning, M
   Ivens, A
   Schwab, T
   Hellmann, N
   Mayans, O
   Sterner, R
AF Schlee, Sandra
   Deuss, Miriam
   Bruning, Marc
   Ivens, Andreas
   Schwab, Thomas
   Hellmann, Nadja
   Mayans, Olga
   Sterner, Reinhard
TI Activation of Anthranilate Phosphoribosyltransferase from Sulfolobus
   solfataricus by Removal of Magnesium Inhibition and Acceleration of
   Product Release
SO BIOCHEMISTRY
LA English
DT Article
ID HYPOXANTHINE-GUANINE PHOSPHORIBOSYLTRANSFERASE; NICOTINIC-ACID
   PHOSPHORIBOSYLTRANSFERASE; DIRECTED EVOLUTION; KINETIC MECHANISM;
   CRYSTAL-STRUCTURE; THERMUS-THERMOPHILUS; STRUCTURAL-ANALYSIS; PROTEIN
   STABILITY; COLD ADAPTATION; IN-VITRO
AB Anthranilate phosphoribosyltransferase from the hyperthermophilic archaeon Sulfolobus solfataricus (ssAnPRT) is encoded by the sstrpD gene and catalyzes the reaction of anthranilate (AA) with a complex of Mg2+ and 5'-phosphoribosyl-alpha 1-pyrophosphate (Mg center dot PRPP) to N-(5'-phosphoribosyl)-anthranilate (PRA) and pyrophosphate (PPi) within tryptophan biosynthesis. The ssAnPRT enzyme is highly thermostable (half-life at 85 degrees C = 35 min) but only marginally active at ambient temperatures (turnover number at 37 degrees C = 0.33 s(-1)). To understand the reason for the poor catalytic proficiency of ssAnPRT, we have isolated from an sstrpD library the activated ssAnPRT-D83G + F149S double mutant by metabolic complementation of an auxotrophic Escherichia coli strain. Whereas the activity of purified wildtype ssAnPRT is strongly reduced in the presence of high concentrations of Mg2+ ions, this inhibition is no longer observed in the double Mutant and the ssAnPRT-D83G single mutant. The comparison of the crystal Structures of activated and wild-type ssAnPRT shows that the D83G mutation alters the binding mode of the substrate Mg center dot PRPP. Analysis of PRPP and Mg2+-dependent enzymatic activity indicates that this leads to a decreased affinity for a second Mg2+ ion and thus reduces the concentration of enzymes with the inhibitory Mg-2 center dot PRPP complex bound to the active site. Moreover, the turnover number of the double mutant ssAnPRT-D83G + F149S is elevated 40-fold compared to the wild-type enzyme, which can be attributed to an accelerated release of the product PRA. This effect appears to be mainly caused by an increased conformational flexibility induced by the F149S Mutation, a hypothesis which is supported by the reduced thermal stability of the ssAnPRT-F149S single mutant.
C1 [Schlee, Sandra; Deuss, Miriam; Schwab, Thomas; Sterner, Reinhard] Univ Regensburg, Inst Biophys & Phys Biochem, D-93053 Regensburg, Germany.
   [Deuss, Miriam; Ivens, Andreas; Sterner, Reinhard] Univ Cologne, Inst Biochem, D-50674 Cologne, Germany.
   [Bruning, Marc] Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   [Hellmann, Nadja] Johannes Gutenberg Univ Mainz, Inst Mol Biophys, D-55128 Mainz, Germany.
   [Mayans, Olga] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England.
RP Sterner, R (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, Univ Str 31, D-93053 Regensburg, Germany.
EM Reinhard.Sterner@biologie.uni-regensburg.de
RI Sterner, Reinhard/ABI-6781-2020
OI Mayans, Olga/0000-0001-6876-8532; Sterner, Reinhard/0000-0001-8177-8460
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [SPP1170: STE 891/5-1, 5-2, 5-3]; Bayerische Eliteforderung
FX This work was Supported by grants of the Deutsche Forschungsgemeinschaft
   (SPP1170: STE 891/5-1, 5-2, 5-3) and a fellowship or the Bayerische
   Eliteforderung to S.S.
CR Arnold FH, 2001, TRENDS BIOCHEM SCI, V26, P100, DOI 10.1016/S0968-0004(00)01755-2
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BICKNELL R, 1985, BIOCHEM J, V231, P83, DOI 10.1042/bj2310083
   Cao H, 2002, BIOCHEMISTRY-US, V41, P3520, DOI 10.1021/bi012148g
   Chappie JS, 2005, STRUCTURE, V13, P1385, DOI 10.1016/j.str.2005.05.016
   Codreanu SG, 2002, BIOCHEMISTRY-US, V41, P15161, DOI 10.1021/bi026776p
   Craig SP, 2000, J BIOL CHEM, V275, P20231, DOI 10.1074/jbc.R000002200
   Eads JC, 1997, STRUCTURE, V5, P47, DOI 10.1016/S0969-2126(97)00165-2
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   FIERKE CA, 1995, METHOD ENZYMOL, V249, P3
   Giver L, 1998, P NATL ACAD SCI USA, V95, P12809, DOI 10.1073/pnas.95.22.12809
   GROGAN DW, 1989, J BACTERIOL, V171, P6710, DOI 10.1128/jb.171.12.6710-6719.1989
   Gross JW, 1998, BIOCHEMISTRY-US, V37, P4189, DOI 10.1021/bi972014w
   Henn-Sax M, 2002, BIOCHEMISTRY-US, V41, P12032, DOI 10.1021/bi026092h
   Hirano N, 2000, BIOCHEMISTRY-US, V39, P13285, DOI 10.1021/bi0015008
   HO SN, 1989, GENE, V77, P51, DOI 10.1016/0378-1119(89)90358-2
   HOMMEL U, 1989, EUR J BIOCHEM, V180, P33, DOI 10.1111/j.1432-1033.1989.tb14611.x
   HORTON RM, 1989, GENE, V77, P61, DOI 10.1016/0378-1119(89)90359-4
   HURWITZ C, 1967, J BIOL CHEM, V242, P3719
   Ivens A, 2001, EUR J BIOCHEM, V268, P2246, DOI 10.1046/j.1432-1327.2001.02102.x
   JAENICKE R, 1991, EUR J BIOCHEM, V202, P715, DOI 10.1111/j.1432-1033.1991.tb16426.x
   Jurgens C, 2000, P NATL ACAD SCI USA, V97, P9925, DOI 10.1073/pnas.160255397
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   Kim C, 2002, FEBS LETT, V523, P239, DOI 10.1016/S0014-5793(02)02905-8
   Kuzmic P, 1996, ANAL BIOCHEM, V237, P260, DOI 10.1006/abio.1996.0238
   Lee CE, 2006, J MOL BIOL, V355, P784, DOI 10.1016/j.jmb.2005.11.016
   Lonn A, 2002, EUR J BIOCHEM, V269, P157, DOI 10.1046/j.0014-2956.2002.02631.x
   Marino M, 2006, J BIOL CHEM, V281, P21410, DOI 10.1074/jbc.M601403200
   Mayans O, 2002, EMBO J, V21, P3245, DOI 10.1093/emboj/cdf298
   McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975
   Merz A, 2000, BIOCHEMISTRY-US, V39, P880, DOI 10.1021/bi992333i
   Miyazaki K, 2000, J MOL BIOL, V297, P1015, DOI 10.1006/jmbi.2000.3612
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Nagatani RA, 2007, BIOCHEMISTRY-US, V46, P6688, DOI 10.1021/bi700507d
   OZTURK DH, 1995, BIOCHEMISTRY-US, V34, P10755, DOI 10.1021/bi00034a007
   PACE CN, 1995, PROTEIN SCI, V4, P2411, DOI 10.1002/pro.5560041120
   SALERNO C, 1981, J BIOL CHEM, V256, P3671
   SCAPIN G, 1995, BIOCHEMISTRY-US, V34, P10744, DOI 10.1021/bi00034a006
   Schumacher MA, 2002, P NATL ACAD SCI USA, V99, P78, DOI 10.1073/pnas.012399599
   Schwab T, 2008, J MOL BIOL, V376, P506, DOI 10.1016/j.jmb.2007.11.078
   SHOICHET BK, 1995, P NATL ACAD SCI USA, V92, P452, DOI 10.1073/pnas.92.2.452
   Sinha SC, 2001, CURR OPIN STRUC BIOL, V11, P733, DOI 10.1016/S0959-440X(01)00274-3
   STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0
   STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747
   Sterner R, 1996, PROTEIN SCI, V5, P2000, DOI 10.1002/pro.5560051006
   Sterner R, 2001, CRIT REV BIOCHEM MOL, V36, P39, DOI 10.1080/20014091074174
   Stevenson BJ, 2008, BIOCHEMISTRY-US, V47, P3013, DOI 10.1021/bi701858u
   STOLL VS, 1990, METHOD ENZYMOL, V182, P24
   THOMPSON RE, 1978, BIOINORG CHEM, V9, P35, DOI 10.1016/S0006-3061(00)82004-9
   Tokuriki N, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000002
   Van den Burg B, 1998, P NATL ACAD SCI USA, V95, P2056, DOI 10.1073/pnas.95.5.2056
   VOGEL HJ, 1956, J BIOL CHEM, V218, P97
   Wang GP, 1999, BIOCHEMISTRY-US, V38, P275, DOI 10.1021/bi9820560
   Williams JC, 1999, PROTEIN ENG, V12, P243, DOI 10.1093/protein/12.3.243
   Wray JW, 1999, J MOL BIOL, V292, P1111, DOI 10.1006/jmbi.1999.3102
   Xu YM, 1997, BIOCHEMISTRY-US, V36, P3700, DOI 10.1021/bi9616007
   YANOFSKY C, 1981, J BACTERIOL, V145, P1334, DOI 10.1128/JB.145.3.1334-1341.1981
   Yasugi M, 2001, J BIOCHEM, V129, P477, DOI 10.1093/oxfordjournals.jbchem.a002880
NR 58
TC 10
Z9 11
U1 0
U2 4
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD JUN 16
PY 2009
VL 48
IS 23
BP 5199
EP 5209
DI 10.1021/bi802335s
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 456PX
UT WOS:000266860400018
PM 19385665
DA 2021-01-25
ER

PT J
AU Cybulski, N
   Polak, P
   Auwerx, J
   Ruegg, MA
   Hall, MN
AF Cybulski, Nadine
   Polak, Pazit
   Auwerx, Johan
   Rueegg, Markus A.
   Hall, Michael N.
TI mTOR complex 2 in adipose tissue negatively controls whole-body growth
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE genetics; mTORC2; signal transduction; rapamycin
ID MOTIF PHOSPHORYLATION; BINDING PARTNER; RICTOR; RAPTOR; TOR; KINASE;
   AKT; MICE; FAT; KNOCKOUT
AB Mammalian target of rapamycin (mTOR), a highly conserved protein kinase that controls cell growth and metabolism in response to nutrients and growth factors, is found in 2 structurally and functionally distinct multiprotein complexes termed mTOR complex 1 (mTORC1) and mTORC2. mTORC2, which consists of rictor, mSIN1, mLST8, and mTOR, is activated by insulin/IGF1 and phosphorylates Ser-473 in the hydrophobic motif of Akt/PKB. Though the role of mTOR in single cells is relatively well characterized, the role of mTOR signaling in specific tissues and how this may contribute to overall body growth is poorly understood. To examine the role of mTORC2 in an individual tissue, we generated adipose-specific rictor knockout mice (rictor(ad-/-)). Rictor(ad-/-) mice are increased in body size due to an increase in size of nonadipose organs, including heart, kidney, spleen, and bone. Furthermore, rictor(ad-/-) mice have a disproportionately enlarged pancreas and are hyperinsulinemic, but glucose tolerant, and display elevated levels of insulin-like growth factor 1 (IGF1) and IGF1 binding protein 3 (IGFBP3). These effects are observed in mice on either a high-fat or a normal diet, but are generally more pronounced in mice on a high-fat diet. Our findings suggest that adipose tissue, in particular mTORC2 in adipose tissue, plays an unexpectedly central role in controlling whole-body growth.
C1 [Cybulski, Nadine; Polak, Pazit; Rueegg, Markus A.; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Auwerx, Johan] Univ Strasbourg 1, INSERM, CNRS, Inst Genet & Biol Mol, F-67404 Illkirch Graffenstaden, France.
   [Auwerx, Johan] Univ Strasbourg 1, INSERM, CNRS, Inst Clin Souris, F-67404 Illkirch Graffenstaden, France.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU Roche Research Foundation; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); Canton of Basel
FX We thank A. Hein, K. Beier, I. Ginez, W. Dolci, and A. Loschmann for
   technical assistance, and T. Sorg, X. Warot, and M. F. Champy for
   support in generation and phenotyping of knockout mice. We acknowledge
   support from the Roche Research Foundation (P. P.), the Swiss National
   Science Foundation, and the Canton of Basel (M. A. R. and M.N.H.).
CR Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Butler AA, 2001, ANNU REV PHYSIOL, V63, P141, DOI 10.1146/annurev.physiol.63.1.141
   Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X
   Duan CM, 2005, GEN COMP ENDOCR, V142, P44, DOI 10.1016/j.ygcen.2004.12.022
   Dupont Joelle, 2003, Birth Defects Research, V69, P257, DOI 10.1002/bdrc.10022
   Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120
   Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Haugen F, 2007, P NUTR SOC, V66, P171, DOI 10.1017/S0029665107005423
   He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100
   Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200
   Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518
   Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033
   Jones KT, 2009, PLOS BIOL, V7, P604, DOI 10.1371/journal.pbio.1000060
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kloting N, 2008, DIABETES, V57, P2074, DOI 10.2337/db07-1538
   Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07
   Liao L, 2006, ENDOCRINOLOGY, V147, P3877, DOI 10.1210/en.2005-1537
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Polak P, 2009, CURR OPIN CELL BIOL, V21, P209, DOI 10.1016/j.ceb.2009.01.024
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469
   Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013
   Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yakar Shoshana, 2005, Pediatr Endocrinol Rev, V3, P11
   Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206
NR 35
TC 122
Z9 125
U1 0
U2 14
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUN 16
PY 2009
VL 106
IS 24
BP 9902
EP 9907
DI 10.1073/pnas.0811321106
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 458TD
UT WOS:000267045500064
PM 19497867
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Pecho-Vrieseling, E
   Sigrist, M
   Yoshida, Y
   Jessell, TM
   Arber, S
AF Pecho-Vrieseling, Eline
   Sigrist, Markus
   Yoshida, Yutaka
   Jessell, Thomas M.
   Arber, Silvia
TI Specificity of sensory-motor connections encoded by Sema3e-Plxnd1
   recognition
SO NATURE
LA English
DT Article
ID SYNAPTIC CONNECTIONS; SPINAL-CORD; MOTONEURONS; AFFERENTS; NEURONS;
   PROTEINS; AXONS; PEA3
AB Spinal reflexes are mediated by synaptic connections between sensory afferents and motor neurons(1-3). The organization of these circuits shows several levels of specificity. Only certain classes of proprioceptive sensory neurons make direct, monosynaptic connections with motor neurons(4). Those that do are bound by rules of motor pool specificity: they form strong connections with motor neurons supplying the same muscle, but avoid motor pools supplying antagonistic muscles(1,5-7). This pattern of connectivity is initially accurate and is maintained in the absence of activity(8), implying that wiring specificity relies on the matching of recognition molecules on the surface of sensory and motor neurons. However, determinants of fine synaptic specificity here, as in most regions of the central nervous system, have yet to be defined. To address the origins of synaptic specificity in these reflex circuits we have used molecular genetic methods to manipulate recognition proteins expressed by subsets of sensory and motor neurons. We show here that a recognition system involving expression of the class 3 semaphorin Sema3e by selected motor neuron pools, and its high-affinity receptor plexin D1 (Plxnd1) by proprioceptive sensory neurons, is a critical determinant of synaptic specificity in sensory-motor circuits in mice. Changing the profile of Sema3e-Plxnd1 signalling in sensory or motor neurons results in functional and anatomical rewiring of monosynaptic connections, but does not alter motor pool specificity. Our findings indicate that patterns of monosynaptic connectivity in this prototypic central nervous system circuit are constructed through a recognition program based on repellent signalling.
C1 [Pecho-Vrieseling, Eline; Sigrist, Markus; Arber, Silvia] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Pecho-Vrieseling, Eline; Sigrist, Markus; Arber, Silvia] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   [Yoshida, Yutaka; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Neurosci, Kavli Inst Brain Sci, New York, NY 10032 USA.
   [Yoshida, Yutaka; Jessell, Thomas M.] Columbia Univ, Howard Hughes Med Inst, Dept Biochem & Mol Biophys, Kavli Inst Brain Sci, New York, NY 10032 USA.
   [Yoshida, Yutaka] Cincinnati Childrens Hosp Med Ctr, Div Dev Biol, Cincinnati, OH 45229 USA.
RP Arber, S (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
EM tmj1@columbia.edu; silvia.arber@unibas.ch
RI Pecho-Vrieseling, Eline/AAP-7239-2020
OI Arber, Silvia/0000-0002-6261-250X
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); NCCR Frontiers in GeneticsSwiss National Science Foundation
   (SNSF); Kanton Basel-Stadt; EU Framework Program 7; Novartis Research
   Foundation; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [RO1NS065048];
   NINDSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS); Harold and Leila Mathers Foundation;
   Wellcome TrustWellcome Trust; NATIONAL INSTITUTE OF NEUROLOGICAL
   DISORDERS AND STROKEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Neurological Disorders & Stroke (NINDS) [R01NS065048, R01NS065048,
   R01NS065048, R01NS065048, R01NS065048] Funding Source: NIH RePORTER
FX We thank D. Ladle for help in analysis of electrophysiological data, J.
   Livet and C. Henderson for discussions, and P. Schwarb, A. Ponti and M.
   Stadler for help in image and statistical analysis. M. Mendelsohn, J.
   Kirkland and B. Han helped in the generation of Plxnd1<SUP>cond</SUP>
   mice and J. F. Spetz, P. Kopp and B. Kuchemann in the generation of
   Sema3e mutant and MN:: Sema3e mice. R. Axel, P. Caroni, E. Frank, A.
   Hantman, C. Henderson, D. Ladle and A. Luethi provided comments on the
   manuscript. E. P.-V., M. S. and S. A. are supported by the Swiss
   National Science Foundation, NCCR Frontiers in Genetics, the Kanton
   Basel-Stadt, EU Framework Program 7 and the Novartis Research
   Foundation. Y. Y. is supported by NIH grant RO1NS065048. T. M. J. is an
   HHMI Investigator, and is supported by grants from NINDS, EU Framework
   Program 7, Project ALS, The Harold and Leila Mathers Foundation, and The
   Wellcome Trust.
CR Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   Bagri A, 2003, CELL, V113, P285, DOI 10.1016/S0092-8674(03)00267-8
   BALDISSERA F, 1981, HDB PHYSL INTEGRATIO, V509
   BROWN AG, 1981, ORG SPINAL CORD
   Burke RE, 1996, J COMP NEUROL, V372, P465
   Chauvet S, 2007, NEURON, V56, P807, DOI 10.1016/j.neuron.2007.10.019
   Cohen S, 2005, EUR J NEUROSCI, V21, P1767, DOI 10.1111/j.1460-9568.2005.04021.x
   Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009
   ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794
   FRANK E, 1990, J NEUROSCI, V10, P2250
   Gu CH, 2005, SCIENCE, V307, P265, DOI 10.1126/science.1105416
   Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4
   Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159
   HOLSTEGE G, 1987, EXP BRAIN RES, V67, P179, DOI 10.1007/BF00269465
   Inaki M, 2007, CURR BIOL, V17, P1574, DOI 10.1016/j.cub.2007.08.013
   Klassen MP, 2007, CELL, V130, P704, DOI 10.1016/j.cell.2007.06.046
   Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   Low LK, 2008, P NATL ACAD SCI USA, V105, P8136, DOI 10.1073/pnas.0803849105
   Mears SC, 1997, J NEUROSCI, V17, P3128
   Oliveira ALR, 2003, SYNAPSE, V50, P117, DOI 10.1002/syn.10249
   Price SR, 2002, CELL, V109, P205, DOI 10.1016/S0092-8674(02)00695-5
   Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005
   Shen K, 2004, CELL, V116, P869, DOI 10.1016/S0092-8674(04)00251-X
   THERIAULT E, 1988, J NEUROPHYSIOL, V60, P463
   Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042
   Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010
   Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469
   Yoshida Y, 2006, NEURON, V52, P775, DOI 10.1016/j.neuron.2006.10.032
   Zhang Y, 2009, DEV BIOL, V325, P82, DOI 10.1016/j.ydbio.2008.09.031
NR 30
TC 118
Z9 122
U1 0
U2 12
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
EI 1476-4687
J9 NATURE
JI Nature
PD JUN 11
PY 2009
VL 459
IS 7248
BP 842
EP 846
DI 10.1038/nature08000
PG 5
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 459EV
UT WOS:000267084500039
PM 19421194
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Roy, A
   BoseDasgupta, S
   Ganguly, A
   Jaisankar, P
   Majumder, HK
AF Roy, Amit
   BoseDasgupta, Somdeb
   Ganguly, Agneyo
   Jaisankar, Parasuraman
   Majumder, Hemanta K.
TI Topoisomerase I Gene Mutations at F270 in the Large Subunit and N184 in
   the Small Subunit Contribute to the Resistance Mechanism of the
   Unicellular Parasite Leishmania donovani towards 3,3 '-Diindolylmethane
SO ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
LA English
DT Article
ID CAMPTOTHECIN RESISTANCE; DNA TOPOISOMERASE; LUNG-CANCER; CELL-LINE;
   INHIBITION; ENZYME; ANALOG
AB 3,3'-Diindolylmethane (DIM), a novel poison targeting Leishmania donovani topoisomerase I (LdTOP1LS), induces programmed cell death in Leishmania parasites. The development of resistant parasites by adaptation with increasing concentrations of DIM generates random mutations in LdTOP1LS. Single-nucleotide mutations result in the amino acid substitutions F270L and K430N in the large subunit and N184S in the small subunit of the enzyme. DIM failed to inhibit the catalytic activity of the recombinant mutant enzyme (LdTOP1DRLS). Transfection studies of the mutant genes showed that the mutated topoisomerase I confers DIM resistance on wild-type Leishmania parasites. Site-directed mutagenesis studies revealed that a substantial level of resistance is conferred by the F270L mutation alone; however, all three mutations (F270L, K430N, and N184S) together are required to reach a higher-resistance phenotype. DIM fails to stabilize the topoisomerase I-DNA covalent complexes in the F270 mutant. Moreover, DIM cannot interfere with the religation step in the catalytic cycle of the recombinant F270L mutant enzyme. Taken together, these findings identify novel mutations in topoisomerase I that hinder its interaction with DNA, thereby modulating enzyme catalysis and conferring resistance to DIM. These studies advance our understanding of the mechanism of cell poisoning by DIM and suggest a specific modification of the drug that may improve its efficacy.
C1 [Roy, Amit; BoseDasgupta, Somdeb; Majumder, Hemanta K.] Indian Inst Chem Biol, Mol Parasitol Lab, Kolkata 700032, India.
   [Jaisankar, Parasuraman] Indian Inst Chem Biol, Dept Med Chem, Kolkata 700032, India.
   [Ganguly, Agneyo] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Majumder, HK (corresponding author), Indian Inst Chem Biol, Mol Parasitol Lab, 4 Raja SC Mullick Rd, Kolkata 700032, India.
EM hkmajumder@iicb.res.in
RI Jaisankar, Parasuraman/C-1553-2009
OI Jaisankar, Parasuraman/0000-0003-0583-4920
FU Council of Scientific and Industrial Research (CSIR), Government of
   IndiaCouncil of Scientific & Industrial Research (CSIR) - India
   [NWP-38]; Department of Biotechnology; Government of IndiaDepartment of
   Biotechnology (DBT) India [BT/PR6399/BRB/10/434/2005]; CSIR, Government
   of IndiaCouncil of Scientific & Industrial Research (CSIR) - India
FX This work was supported by grants from Network Project NWP-38 of the
   Council of Scientific and Industrial Research (CSIR), Government of
   India, and the Department of Biotechnology; Government of India
   (BT/PR6399/BRB/10/434/2005), to H. K. M. A. R. was supported by a Senior
   Research Fellowship from the CSIR, Government of India.
CR BoseDasgupta S, 2008, MOL BIOCHEM PARASIT, V158, P176, DOI 10.1016/j.molbiopara.2007.12.007
   Champoux JJ, 2001, ANNU REV BIOCHEM, V70, P369, DOI 10.1146/annurev.biochem.70.1.369
   CHAMPOUX JJ, 1976, P NATL ACAD SCI USA, V73, P3488, DOI 10.1073/pnas.73.10.3488
   Chang JY, 2002, CANCER RES, V62, P3716
   Chrencik JE, 2004, J MOL BIOL, V339, P773, DOI 10.1016/j.jmb.2004.03.007
   Das BB, 2004, FEBS LETT, V565, P81, DOI 10.1016/j.febslet.2004.03.078
   Davies DR, 2006, J MOL BIOL, V357, P1202, DOI 10.1016/j.jmb.2006.01.022
   ENG WK, 1990, MOL PHARMACOL, V38, P471
   Fiorani P, 2003, J BIOL CHEM, V278, P43268, DOI 10.1074/jbc.M303899200
   Fiorani P, 2006, NUCLEIC ACIDS RES, V34, P5093, DOI 10.1093/nar/gkl670
   KANZAWA F, 1990, CANCER RES, V50, P5919
   KUBOTA N, 1992, BIOCHEM BIOPH RES CO, V188, P571, DOI 10.1016/0006-291X(92)91094-7
   Marquis JF, 2005, ANTIMICROB AGENTS CH, V49, P1441, DOI 10.1128/AAC.49.4.1441-1446.2005
   Pommier Y, 1999, DRUG RESIST UPDATE, V2, P307, DOI 10.1054/drup.1999.0102
   Robinson KA, 2003, MOL BIOCHEM PARASIT, V128, P217, DOI 10.1016/S0166-6851(03)00079-3
   Roy A, 2008, MOL PHARMACOL, V74, P1292, DOI 10.1124/mol.108.050161
   Roy A, 2008, BIOCHEM J, V409, P611, DOI 10.1042/BJ20071286
   Staker BL, 2002, P NATL ACAD SCI USA, V99, P15387, DOI 10.1073/pnas.242259599
   SUGIMOTO Y, 1990, CANCER RES, V50, P6925
   TAN KB, 1989, J NATL CANCER I, V81, P1732, DOI 10.1093/jnci/81.22.1732
   Wang JC, 2002, NAT REV MOL CELL BIO, V3, P430, DOI 10.1038/nrm831
NR 21
TC 10
Z9 10
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0066-4804
EI 1098-6596
J9 ANTIMICROB AGENTS CH
JI Antimicrob. Agents Chemother.
PD JUN
PY 2009
VL 53
IS 6
BP 2589
EP 2598
DI 10.1128/AAC.01648-08
PG 10
WC Microbiology; Pharmacology & Pharmacy
SC Microbiology; Pharmacology & Pharmacy
GA 448DY
UT WOS:000266244500049
PM 19332675
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Rhomberg, TA
   Truttmann, MC
   Guye, P
   Ellner, Y
   Dehio, C
AF Rhomberg, Thomas A.
   Truttmann, Matthias C.
   Guye, Patrick
   Ellner, Yvonne
   Dehio, Christoph
TI A translocated protein of Bartonella henselae interferes with endocytic
   uptake of individual bacteria and triggers uptake of large bacterial
   aggregates via the invasome
SO CELLULAR MICROBIOLOGY
LA English
DT Article
ID IV SECRETION SYSTEMS; ENDOTHELIAL-CELLS; RHO-GTPASES;
   YERSINIA-PSEUDOTUBERCULOSIS; INTERNALIZATION; CYTOSKELETON; INFECTION;
   IDENTIFICATION; MACROPHAGES; EXPRESSION
AB Bartonella henselae enters human endothelial cells (ECs) by two alternative routes: either by endocytosis, giving rise to Bartonella-containing vacuoles or by invasome-mediated internalization. Only the latter process depends on the type IV secretion system VirB/VirD4 and involves the formation of cell surface-associated bacterial aggregates, which get engulfed by EC membranes in an F-actin-dependent manner, eventually resulting in their complete internalization. Here, we report that among the VirB/VirD4-translocated effector proteins BepA-BepG only BepG is required for triggering invasome-mediated internalization. Expression of BepG in the Bep-deficient Delta bepA-G mutant restored invasome-mediated internalization. Likewise, ectopic expression of BepG in ECs also restored invasome-mediated internalization of the Delta bepA-G mutant, while no discernable cytoskeletal rearrangements were triggered in uninfected cells. Rather, BepG inhibited endocytic uptake of B. henselae into Bartonella-containing vacuoles and other endocytic processes, that is, invasin-mediated uptake of Yersinia enterocolitica and uptake of inert microspheres. BepG thus triggers invasome-mediated internalization primarily by inhibiting bacterial endocytosis. Bacteria accumulating on the cell surface then induce locally the F-actin rearrangements characteristic for the invasome. These cytoskeletal changes encompass both the rearrangement of pre-existing F-actin fibres and the de novo polymerization of cortical F-actin in the periphery of the invasome by Rac1/Scar1/WAVE- and Cdc42/WASP-dependent pathways that involve the recruitment of the Arp2/3 complex.
C1 [Rhomberg, Thomas A.; Truttmann, Matthias C.; Guye, Patrick; Ellner, Yvonne; Dehio, Christoph] Univ Basel, Focal Area Infect Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Focal Area Infect Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; truttmann, matthias/0000-0002-0536-7923
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100-061777]; Howard Hughes Medical InstituteHoward Hughes
   Medical Institute [55005501]
FX We would like to thank Arto Pulliainen for critical reading of the
   manuscript and Ilaria Carena and Nadege Devaux for excellent technical
   assistance. The Kantonspital Bruderholz and University Women's Hospital
   Basel are acknowledged for providing human umbilical cords. We are
   indebted to Anja Schmidt and Alan Hall (MRC Cell Biology, University
   College London, London, UK), Edith Gouin and Pascale Cossart (Unite des
   Interactions Bacteries x Cellules, Institut Pasteur, Paris, France),
   Francisco Garcia-del Portillo (Departamento de Biotecnologia Microbiana,
   Centro Nacional de Biotecnologia, Madrid, Spain) and Laura Machesky
   (Departement of Biochemistry, University of Birmingham, UK) for the kind
   gift of plasmids encoding different versions of small GTPases and their
   effectors Scar1 and WASP respectively. Furthermore, we would like to
   thank G. R. Cornelis for providing Y. enterocolitica strains. This work
   was supported by Grant 3100-061777 from the Swiss National Science
   Foundation and Grant 55005501 from the Howard Hughes Medical Institute.
CR Alrutz MA, 2001, MOL MICROBIOL, V42, P689, DOI 10.1046/j.1365-2958.2001.02676.x
   Alto NM, 2006, CELL, V124, P133, DOI 10.1016/j.cell.2005.10.031
   Dehio C, 1997, J BACTERIOL, V179, P538, DOI 10.1128/jb.179.2.538-540.1997
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Dehio M, 1998, GENE, V215, P223, DOI 10.1016/S0378-1119(98)00319-9
   del Pozo MA, 1999, EUR J IMMUNOL, V29, P3609
   Dersch P, 1999, EMBO J, V18, P1199, DOI 10.1093/emboj/18.5.1199
   Fallman M, 2005, INT REV CYTOL, V246, P135, DOI 10.1016/S0074-7696(05)46004-0
   Finlay BB, 2005, CURR TOP MICROBIOL, V291, P1
   Florin TA, 2008, PEDIATRICS, V121, pE1413, DOI 10.1542/peds.2007-1897
   Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721
   Kyme PA, 2005, CELL MICROBIOL, V7, P1019, DOI 10.1111/j.1462-5822.2005.00531.x
   Machesky LM, 1998, CURR BIOL, V8, P1347, DOI 10.1016/S0960-9822(98)00015-3
   OLSON MF, 1995, SCIENCE, V269, P1270, DOI 10.1126/science.7652575
   Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012
   Pulliainen AT, 2009, INT J BIOCHEM CELL B, V41, P507, DOI 10.1016/j.biocel.2008.10.018
   REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992
   RIDLEY AJ, 1992, CELL, V70, P389, DOI 10.1016/0092-8674(92)90163-7
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Scheidegger F, 2009, CELL MICROBIOL, V11, P1088, DOI 10.1111/j.1462-5822.2009.01313.x
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, TRANSLOCATED BACTERI
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Sory MP, 1995, P NATL ACAD SCI USA, V92, P11998, DOI 10.1073/pnas.92.26.11998
   Steele-Mortimer O, 2000, TRAFFIC, V1, P107, DOI 10.1034/j.1600-0854.2000.010203.x
   YAO L, 1995, INFECT IMMUN, V63, P1835, DOI 10.1128/IAI.63.5.1835-1839.1995
   YOUNG VB, 1992, J CELL BIOL, V116, P197, DOI 10.1083/jcb.116.1.197
NR 31
TC 42
Z9 44
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1462-5814
EI 1462-5822
J9 CELL MICROBIOL
JI Cell Microbiol.
PD JUN
PY 2009
VL 11
IS 6
BP 927
EP 945
DI 10.1111/j.1462-5822.2009.01302.x
PG 19
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA 443AV
UT WOS:000265883500007
PM 19302579
DA 2021-01-25
ER

PT J
AU Nigg, EA
AF Nigg, E. A.
TI Cell Cycle Control of Chromosome Integrity: Focus on the Centrosome
   Cycle and the Mitotic Spindle.
SO CHROMOSOME RESEARCH
LA English
DT Meeting Abstract
CT 7th European Cytogenetics Conference
CY JUL 04-07, 2009
CL Stockholm, SWEDEN
SP European Cytogeneticists Assoc
ID DUPLICATION; PROTEIN
C1 [Nigg, E. A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
CR GAITANOS, 2009, EMBO J IN PRESS
   Habedanck R, 2005, NAT CELL BIOL, V7, P1140, DOI 10.1038/ncb1320
   Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426
   Kleylein-Sohn J, 2007, DEV CELL, V13, P190, DOI 10.1016/j.devcel.2007.07.002
   Nigg EA, 2007, TRENDS CELL BIOL, V17, P215, DOI 10.1016/j.tcb.2007.03.003
   Nigg EA, 2006, INT J CANCER, V119, P2717, DOI 10.1002/ijc.22245
   Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103
   Santamaria A, 2008, CURR BIOL, V18, P723, DOI 10.1016/j.cub.2008.04.041
   Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070
NR 9
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0967-3849
J9 CHROMOSOME RES
JI Chromosome Res.
PD JUN
PY 2009
VL 17
SU 1
BP 19
EP 19
PG 1
WC Biochemistry & Molecular Biology; Genetics & Heredity
SC Biochemistry & Molecular Biology; Genetics & Heredity
GA 464DJ
UT WOS:000267485000022
DA 2021-01-25
ER

PT J
AU Guex, N
   Peitsch, MC
   Schwede, T
AF Guex, Nicolas
   Peitsch, Manuel C.
   Schwede, Torsten
TI Automated comparative protein structure modeling with SWISS-MODEL and
   Swiss-PdbViewer: A historical perspective
SO ELECTROPHORESIS
LA English
DT Article
DE Bioinformatics; Homology modeling; Protein structure; SWISS; MODEL;
   Swiss-PdbViewer
ID STRUCTURE PREDICTION; QUALITY ASSESSMENT; HIGH-THROUGHPUT; LARGE-SCALE;
   RESIDUE CONTACTS; DISULFIDE BOND; NEW-GENERATION; HIGH-ACCURACY; CD40
   LIGAND; SERVER
AB SWISS-MODEL pioneered the field of automated modeling as the first protein modeling service on the Internet. In combination with the visualization tool Swiss-PdbViewer, the Internet-based Workspace and the SWISS-MODEL Repository, it provides a fully integrated sequence to structure analysis and modeling platform. This computational environment is made freely available to the scientific community with the aim to hide the computational complexity of structural bioinformatics and encourage bench scientists to make use of the ever-increasing structural information available. Indeed, over the last decade, the availability of structural information has significantly increased for many organisms as a direct consequence of the complementary nature of comparative protein modeling and experimental structure determination. This has a very positive and enabling impact on many different applications in biomedical research as described in this paper.
C1 [Schwede, Torsten] Univ Basel, Biozentrum, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Guex, Nicolas; Peitsch, Manuel C.] Swiss Inst Bioinformat, Lausanne, Switzerland.
   [Peitsch, Manuel C.] Phillip Morris Int, Res & Dev, Neuchatel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Swiss Inst Bioinformat, Klingelberg Str 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008; Peitsch, Manuel/J-7416-2017
OI Schwede, Torsten/0000-0003-2715-335X; Peitsch,
   Manuel/0000-0001-5324-359X
CR Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   APPEL RD, 1994, TRENDS BIOCHEM SCI, V19, P258, DOI 10.1016/0968-0004(94)90153-8
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5
   Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070
   Bairoch A, 2009, NUCLEIC ACIDS RES, V37, pD169, DOI 10.1093/nar/gkn664
   Bartlett GJ, 2002, J MOL BIOL, V324, P105, DOI 10.1016/S0022-2836(02)01036-7
   Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761
   Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715
   Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971
   Berman HM, 2009, NUCLEIC ACIDS RES, V37, pD365, DOI 10.1093/nar/gkn790
   Bordoli L, 2009, NAT PROTOC, V4, P1, DOI 10.1038/nprot.2008.197
   Boutet Emmanuel, 2007, V406, P89
   Burger L, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb4100203
   Burley SK, 2000, NAT STRUCT BIOL, V7, P932, DOI 10.1038/80697
   Chivian D, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl480
   Cozzetto D, 2007, PROTEINS, V69, P175, DOI 10.1002/prot.21669
   Duret L, 1998, GENOME RES, V8, P348, DOI 10.1101/gr.8.4.348
   Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340
   Eramian D, 2008, PROTEIN SCI, V17, P1881, DOI 10.1110/ps.036061.108
   Fernandez-Fuentes N, 2007, NUCLEIC ACIDS RES, V35, pW363, DOI 10.1093/nar/gkm341
   Feyfant E, 2007, PROTEIN SCI, V16, P2030, DOI 10.1110/ps.072855507
   Fox JA, 2006, NUCLEIC ACIDS RES, V34, pW3, DOI 10.1093/nar/gkl379
   GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402
   Guex N, 1999, TRENDS BIOCHEM SCI, V24, P364, DOI 10.1016/S0968-0004(99)01427-9
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   GUEX N, 2001, CURR PROTOC PROTEIN, pCH2
   Guimaraes AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003449
   HAHNE M, 1995, INT IMMUNOL, V7, P1381, DOI 10.1093/intimm/7.9.1381
   Henrick K, 2008, NUCLEIC ACIDS RES, V36, pD426, DOI 10.1093/nar/gkm937
   Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Janin J, 2007, STRUCTURE, V15, P755, DOI 10.1016/j.str.2007.06.007
   Jenkinson AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S8-S3
   Joo K, 2007, PROTEINS, V69, P83, DOI 10.1002/prot.21628
   Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200
   KARPUSAS M, 1995, STRUCTURE, V3, P1031, DOI 10.1016/S0969-2126(01)00239-8
   Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750
   Kim SH, 2000, CURR OPIN STRUC BIOL, V10, P380, DOI 10.1016/S0959-440X(00)00100-7
   Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253
   Koh IYY, 2003, NUCLEIC ACIDS RES, V31, P3311, DOI 10.1093/nar/gkg619
   Kopp B, 2007, J BEHAV THER EXP PSY, V38, P56, DOI 10.1016/j.jbtep.2006.05.001
   Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008
   Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056
   Laskowski RA, 1996, J MOL BIOL, V259, P175, DOI 10.1006/jmbi.1996.0311
   Levitt M, 2007, P NATL ACAD SCI USA, V104, P3183, DOI 10.1073/pnas.0611678104
   Lovell SC, 2000, PROTEINS, V40, P389, DOI 10.1002/1097-0134(20000815)40:3<389::AID-PROT50>3.3.CO;2-U
   Marcatili P, 2008, BIOINFORMATICS, V24, P1953, DOI 10.1093/bioinformatics/btn341
   Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x
   Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665
   Notarangelo LD, 1996, IMMUNOL TODAY, V17, P511, DOI 10.1016/0167-5699(96)30059-5
   O'Hara FP, 2008, J INFECT DIS, V197, P187, DOI 10.1086/524684
   Pajerowska-Mukhtar KM, 2008, PLANTA, V228, P293, DOI 10.1007/s00425-008-0737-x
   Paluszewski M, 2009, PROTEINS, V75, P540, DOI 10.1002/prot.22262
   Peitsch M C, 2000, Pharmacogenomics, V1, P257, DOI 10.1517/14622416.1.3.257
   Peitsch MC, 1997, ELECTROPHORESIS, V18, P498, DOI 10.1002/elps.1150180326
   Peitsch MC, 1996, BIOCHEM SOC T, V24, P274, DOI 10.1042/bst0240274
   Peitsch MC, 2002, BIOINFORMATICS, V18, P934, DOI 10.1093/bioinformatics/18.7.934
   Peitsch MC, 1997, ISMB-97 - FIFTH INTERNATIONAL CONFERENCE ON INTELLIGENT SYSTEMS FOR MOLECULAR BIOLOGY, PROCEEDINGS, P234
   PEITSCH MC, 1993, INT IMMUNOL, V5, P233, DOI 10.1093/intimm/5.2.233
   PEITSCH MC, 1997, PROTEOME RES NEW FRO, P177
   Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249
   Raimondo D, 2007, PROTEINS, V66, P689, DOI 10.1002/prot.21225
   Redfern OC, 2008, CURR OPIN STRUC BIOL, V18, P394, DOI 10.1016/j.sbi.2008.05.007
   Rychlewski L, 2005, PROTEIN SCI, V14, P240, DOI 10.1110/ps.04888805
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Sanchez R, 1998, P NATL ACAD SCI USA, V95, P13597, DOI 10.1073/pnas.95.23.13597
   Sanders RW, 2008, MOL BIOL CELL, V19, P4707, DOI 10.1091/mbc.E08-07-0670
   Sayers EW, 2009, NUCLEIC ACIDS RES, V37, pD5, DOI 10.1093/nar/gkp967
   Scheib H, 2006, J MOL MODEL, V12, P813, DOI 10.1007/s00894-005-0066-y
   Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Schwede T, 2000, RES MICROBIOL, V151, P107, DOI 10.1016/S0923-2508(00)00121-2
   Schwede TF, 1999, PROTEIN ENG, V12, P151, DOI 10.1093/protein/12.2.151
   Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014
   Sivasubramanian A, 2009, PROTEINS, V74, P497, DOI 10.1002/prot.22309
   Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125
   STIRNIMANN C, 2008, COMPUTATIONAL STRUCT
   TRAMONTANO, 2008, COMPUTATIONAL STRUCT
   van Gunsteren W. F., 1996, BIOMOLECULAR SIMULAT
   Vangrevelinghe E, 2003, J MED CHEM, V46, P2656, DOI 10.1021/jm030827e
   Wallner B, 2007, PROTEINS, V69, P184, DOI 10.1002/prot.21774
   Wan Y, 2003, MOL ENDOCRINOL, V17, P2240, DOI 10.1210/me.2003-0162
   Wattenhofer M, 2002, J MOL MED-JMM, V80, P124, DOI 10.1007/s00109-001-0310-6
   Weigt M, 2009, P NATL ACAD SCI USA, V106, P67, DOI 10.1073/pnas.0805923106
   Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702
   Zhou HY, 2007, PROTEINS, V69, P90, DOI 10.1002/prot.21649
NR 88
TC 852
Z9 887
U1 9
U2 90
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0173-0835
EI 1522-2683
J9 ELECTROPHORESIS
JI Electrophoresis
PD JUN
PY 2009
VL 30
SU 1
BP S162
EP S173
DI 10.1002/elps.200900140
PG 12
WC Biochemical Research Methods; Chemistry, Analytical
SC Biochemistry & Molecular Biology; Chemistry
GA 581KU
UT WOS:000276522500017
PM 19517507
DA 2021-01-25
ER

PT J
AU Cailleau, G
   Braissant, O
   Verrecchia, EP
AF Cailleau, Guillaume
   Braissant, Olivier
   Verrecchia, Eric P.
TI Biomineralization of the iroko tree (Milicia excelsa): How does this
   carbon sink work?
SO GEOCHIMICA ET COSMOCHIMICA ACTA
LA English
DT Meeting Abstract
CT 19th Annual VM Goldschmidt Conference
CY JUN 21, 2009
CL Davos, SWITZERLAND
C1 [Cailleau, Guillaume; Verrecchia, Eric P.] Univ Lausanne, Inst Geol & Palaeontol, Biogeosci Lab, CH-1015 Lausanne, Switzerland.
   [Braissant, Olivier] Univ Basel, Biozentrum Pharmazentrum, CH-4012 Basel, Switzerland.
EM guillaume.cailleau@unil.ch
RI Cailleau, Guillaume/A-5229-2010; Braissant, Olivier/H-2284-2012;
   Braissant, Olivier/AAO-2371-2020
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
CR Braissant O, 2004, GEOBIOLOGY, V2, P59, DOI 10.1111/j.1472-4677.2004.00019.x
NR 1
TC 0
Z9 0
U1 0
U2 3
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0016-7037
J9 GEOCHIM COSMOCHIM AC
JI Geochim. Cosmochim. Acta
PD JUN
PY 2009
VL 73
IS 13
BP A184
EP A184
PG 1
WC Geochemistry & Geophysics
SC Geochemistry & Geophysics
GA 460YS
UT WOS:000267229900381
DA 2021-01-25
ER

PT J
AU Moreau, A
   Teruel, C
   Beylot, M
   Albalea, V
   Tamasi, V
   Umbdenstock, T
   Parmentier, Y
   Sa-Cunha, A
   Suc, B
   Fabre, JM
   Navarro, F
   Ramos, J
   Meyer, U
   Maurel, P
   Vilarem, MJ
   Pascussi, JM
AF Moreau, Amelie
   Teruel, Christelle
   Beylot, Michel
   Albalea, Valerie
   Tamasi, Viola
   Umbdenstock, Thierry
   Parmentier, Yannick
   Sa-Cunha, Antonio
   Suc, Bertrand
   Fabre, Jean-Michel
   Navarro, Francis
   Ramos, Jeanne
   Meyer, Urs
   Maurel, Patrick
   Vilarem, Marie-Jose
   Pascussi, Jean-Marc
TI A Novel Pregnane X Receptor and S14-Mediated Lipogenic Pathway in Human
   Hepatocyte
SO HEPATOLOGY
LA English
DT Article
ID CONSTITUTIVE ANDROSTANE RECEPTOR; HEPATIC GENE-EXPRESSION; RESPONSE
   ELEMENT; SPOT-14 PROTEIN; THYROID-HORMONE; GLUCOSE-METABOLISM; NUCLEAR
   RECEPTOR; DRUG-METABOLISM; LIPID-SYNTHESIS; HEPARG CELLS
AB The pregnane X receptor (PXR) initially isolated as a nuclear receptor regulating xenobiotic and drug metabolism and elimination, seems to play an endobiotic role by affecting lipid homeostasis. In mice, PXR affects lipid homeostasis and increases hepatic deposit of triglycerides. In this study, we show that, in human hepatocyte, PXR activation induces an increase of de novo lipogenesis through the up-regulation of S14. S14 was first identified as a thyroid-responsive gene and is known to transduce hormone-related and nutrient-related signals to genes involved in lipogenesis through a molecular mechanism not yet elucidated. We demonstrate that S14 is a novel transcriptional target of PXR. In addition, we report an increase of fatty acid synthase (FASN) and adenosine triphosphate citrate lyase genes expression after PXR activation in human hepatocyte, leading to an increase of fatty acids accumulation and de novo lipogenesis. RNA interference of the expression of S14 proportionally decreases the FASN induction, whereas S14 overexpression in human hepatic cells provokes an increase of fatty acids accumulation and lipogenesis. These results demonstrate for the first time that xenobiotic or drug-activated PXR promote aberrant hepatic de novo lipogenesis via activation of the nonclassical S14 pathway. In addition, these data suggest that the up-regulation of S14 by PXR may promote aberrant hepatic lipogenesis and hepatic steatosis in human hepatocytes. (HEPATOLOGY 2009;49:2068-2079.)
C1 [Moreau, Amelie; Teruel, Christelle; Fabre, Jean-Michel; Navarro, Francis; Maurel, Patrick; Vilarem, Marie-Jose; Pascussi, Jean-Marc] INSERM, U632, F-34293 Montpellier, France.
   [Moreau, Amelie; Teruel, Christelle; Fabre, Jean-Michel; Navarro, Francis; Maurel, Patrick; Vilarem, Marie-Jose; Pascussi, Jean-Marc] Univ Montpellier 1, UMR S632, F-34293 Montpellier, France.
   [Beylot, Michel] Ctr Leon Berard, INSERM, ERI22 EA 4173, Fac Med Rockefeller, F-69373 Lyon, France.
   [Albalea, Valerie] Sanofi Aventis, Montpellier, France.
   [Tamasi, Viola; Meyer, Urs] Univ Basel, Biozentrum, Basel, Switzerland.
   [Umbdenstock, Thierry; Parmentier, Yannick] Technol Servier, Orleans, France.
   [Sa-Cunha, Antonio] Hop Haut Leveque, Serv Chirurg Digest, Pessac, France.
   [Suc, Bertrand] CHU Rangueil, Serv Chirurg Digest, F-31054 Toulouse, France.
   [Fabre, Jean-Michel] CHU St Eloi, Serv Chirurg Digest 2, Montpellier, France.
   [Navarro, Francis] CHU St Eloi, Serv Med Chirurg Malad Appareil Digestife & Trans, Montpellier, France.
   [Ramos, Jeanne] CHU Gui de Chauliac, Serv Anat Pathol, Montpellier, France.
RP Pascussi, JM (corresponding author), INSERM, U632, 1919 Route Mende, F-34293 Montpellier, France.
EM pascussi@montp.inserm.fr
RI pascussi, jean marc/F-9311-2013; cunha, antonio sa/B-5781-2012
OI pascussi, jean marc/0000-0002-5168-5383; cunha, antonio
   sa/0000-0003-4015-5368
FU ANRFrench National Research Agency (ANR) [JCJC-05-47810]; Steroltalk
   European project; Technologie Servier Orlians
FX Supported by ANR JCJC-05-47810 (J.M. P & C T), the Steroltalk European
   project (I.M. P), and Technologie Servier Orlians (A.M.).
CR Aninat C, 2006, DRUG METAB DISPOS, V34, P75, DOI 10.1124/dmd.105.006759
   BABANY G, 1989, J HEPATOL, V9, P252, DOI 10.1016/0168-8278(89)90059-7
   Bhalla S, 2004, J BIOL CHEM, V279, P45139, DOI 10.1074/jbc.M405423200
   Bramlett KS, 2003, J PHARMACOL EXP THER, V307, P291, DOI 10.1124/jpet.103.052852
   Campbell MC, 2003, ENDOCRINOLOGY, V144, P5242, DOI 10.1210/en.2002-0008
   Chou WY, 2007, BIOCHEM BIOPH RES CO, V357, P133, DOI 10.1016/j.bbrc.2007.03.103
   Dentin R, 2004, J BIOL CHEM, V279, P20314, DOI 10.1074/jbc.M312475200
   Diraison F, 1997, J MASS SPECTROM, V32, P81, DOI 10.1002/(SICI)1096-9888(199701)32:1<81::AID-JMS454>3.0.CO;2-2
   Drocourt L, 2002, J BIOL CHEM, V277, P25125, DOI 10.1074/jbc.M201323200
   Drocourt L, 2001, DRUG METAB DISPOS, V29, P1325
   Feng X, 2000, MOL ENDOCRINOL, V14, P947, DOI 10.1210/me.14.7.947
   FOLCH J, 1957, J BIOL CHEM, V226, P497
   Grieco A, 2005, Eur Rev Med Pharmacol Sci, V9, P261
   Guillouzo A, 2007, CHEM-BIOL INTERACT, V168, P66, DOI 10.1016/j.cbi.2006.12.003
   Ishii S, 2004, P NATL ACAD SCI USA, V101, P15597, DOI 10.1073/pnas.0405238101
   Jiang W, 2004, J ENDOCRINOL, V182, P295, DOI 10.1677/joe.0.1820295
   Joseph SB, 2002, J BIOL CHEM, V277, P11019, DOI 10.1074/jbc.M111041200
   JUMP DB, 1984, J BIOL CHEM, V259, P2789
   KINLAW WB, 1995, J BIOL CHEM, V270, P16615, DOI 10.1074/jbc.270.28.16615
   Kliewer SA, 2002, ENDOCR REV, V23, P687, DOI 10.1210/er.2001-0038
   LaFave LT, 2006, ENDOCRINOLOGY, V147, P4044, DOI 10.1210/en.2006-0473
   Laffitte BA, 2003, P NATL ACAD SCI USA, V100, P5419, DOI 10.1073/pnas.0830671100
   Li TG, 2005, AM J PHYSIOL-GASTR L, V288, pG74, DOI 10.1152/ajpgi.00258.2004
   Louet JF, 2002, J BIOL CHEM, V277, P37991, DOI 10.1074/jbc.M205087200
   Luo G, 2002, DRUG METAB DISPOS, V30, P795, DOI 10.1124/dmd.30.7.795
   McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x
   Mitro N, 2007, FEBS LETT, V581, P1721, DOI 10.1016/j.febslet.2007.03.047
   MORERE P, 1975, SEM HOP PARIS, V51, P2095
   MORRISON WR, 1964, J LIPID RES, V5, P600
   Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200
   Oppenheimer J H, 1987, Horm Metab Res Suppl, V17, P1
   Pascussi JM, 2007, HEPATOLOGY, V45, P1146, DOI 10.1002/hep.21592
   Pascussi JM, 2003, MOL ENDOCRINOL, V17, P42, DOI 10.1210/me.2002-0244
   PASCUSSI JM, 2007, ANN REV PHARM TOXICO
   Pawar A, 2003, J BIOL CHEM, V278, P40736, DOI 10.1074/jbc.M307973200
   PICHARD L, 1990, DRUG METAB DISPOS, V18, P595
   Qin XF, 2003, P NATL ACAD SCI USA, V100, P183, DOI 10.1073/pnas.232688199
   Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900
   Repa JJ, 2002, NAT MED, V8, P1243, DOI 10.1038/nm1102-1243
   Roth A, 2008, MOL PHARMACOL, V73, P1282, DOI 10.1124/mol.107.041012
   Sanchez-Rodriguez J, 2005, BIOCHEM J, V390, P57, DOI 10.1042/BJ20042080
   SUGDEN MC, 1981, BIOSCIENCE REP, V1, P757, DOI 10.1007/BF01114797
   Willson TM, 2002, NAT REV DRUG DISCOV, V1, P259, DOI 10.1038/nrd753
   Zhou CC, 2007, MOL PHARMACOL, V71, P220, DOI 10.1124/mol.106.029264
   Zhou J, 2008, GASTROENTEROLOGY, V134, P556, DOI 10.1053/j.gastro.2007.11.037
   Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200
   Zhu QH, 2005, ENDOCRINOLOGY, V146, P3343, DOI 10.1210/en.2005-0204
NR 47
TC 58
Z9 61
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0270-9139
EI 1527-3350
J9 HEPATOLOGY
JI Hepatology
PD JUN
PY 2009
VL 49
IS 6
BP 2068
EP 2079
DI 10.1002/hep.22907
PG 12
WC Gastroenterology & Hepatology
SC Gastroenterology & Hepatology
GA 456KY
UT WOS:000266846400033
PM 19437491
OA Bronze
DA 2021-01-25
ER

PT J
AU Scherr, N
   Jayachandran, R
   Mueller, P
   Pieters, J
AF Scherr, Nicole
   Jayachandran, Rajesh
   Mueller, Philipp
   Pieters, Jean
TI Interference of Mycobacterium tuberculosis with macrophage responses
SO INDIAN JOURNAL OF EXPERIMENTAL BIOLOGY
LA English
DT Article; Proceedings Paper
CT 3rd International Tuberculosis Symposium
CY DEC, 2008
CL New Delhi, INDIA
DE Immune defence; Macrophage response; Mycobacterium tuberculosis
ID PROTEIN-KINASE-G; PHAGOSOME MATURATION ARREST; INTRACELLULAR SURVIVAL;
   VIRULENCE FACTOR; SECRETION; CORONIN-1; MEMBRANE; SUSCEPTIBILITY;
   PHAGOLYSOSOME; CYTOSKELETON
AB Tuberculosis, caused by Mycobacterium tuberculosis, has become an important health and economic burden, with more than four thousand people succumbing to the disease every day. Thus, there is an urgent need to understand the molecular basis of this pathogen's success in causing disease in humans, in order to develop new drugs superior to conventional drugs available at present. One reason why M. tuberculosis is such a dangerous microbe lies within its ability to survive within infected hosts, thereby efficiently circumventing host immune responses. Over the past few years, a number of mechanisms have been unravelled that are utilized by M. tuberculosis to survive within hosts and to avoid immune defence mechanisms. Several of these mechanisms have been described in this communication that may be useful for the development of novel compounds to treat tuberculosis.
C1 [Scherr, Nicole; Jayachandran, Rajesh; Mueller, Philipp; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Appleton BA, 2006, STRUCTURE, V14, P87, DOI 10.1016/j.str.2005.09.013
   ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713
   Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008
   Blower S, 2007, LANCET INFECT DIS, V7, P443, DOI 10.1016/S1473-3099(07)70143-3
   Brodin P, 2006, INFECT IMMUN, V74, P88, DOI 10.1128/IAI.74.1.88-98.2006
   CHAKRABORTY P, 1994, METHOD CELL BIOL, V45, P261
   Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x
   Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159
   Deghmane AE, 2007, J CELL SCI, V120, P2796, DOI 10.1242/jcs.006221
   Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Fortune SM, 2005, P NATL ACAD SCI USA, V102, P10676, DOI 10.1073/pnas.0504922102
   Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100
   Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   Grundner C, 2005, PROTEIN SCI, V14, P1918, DOI 10.1110/ps.051413405
   Hasan Z, 1997, MOL MICROBIOL, V24, P545, DOI 10.1046/j.1365-2958.1997.3591731.x
   Henry SC, 2007, J IMMUNOL, V179, P6963, DOI 10.4049/jimmunol.179.10.6963
   Houben ENG, 2009, MOL MICROBIOL, V72, P41, DOI 10.1111/j.1365-2958.2009.06612.x
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Kammerer RA, 2005, P NATL ACAD SCI USA, V102, P13891, DOI 10.1073/pnas.0502390102
   MacGurn JA, 2007, INFECT IMMUN, V75, P2668, DOI 10.1128/IAI.01872-06
   MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Narayan A, 2007, PHYSIOL GENOMICS, V29, P66, DOI 10.1152/physiolgenomics.00221.2006
   Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005
   Philips JA, 2008, CELL MICROBIOL, V10, P2408, DOI 10.1111/j.1462-5822.2008.01239.x
   Pieters J, 2008, CELL HOST MICROBE, V3, P399, DOI 10.1016/j.chom.2008.05.006
   Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x
   Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003
   Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235
   Saleh MT, 2000, J BACTERIOL, V182, P6850, DOI 10.1128/JB.182.23.6850-6853.2000
   SCHERR N, MYCOBACTERI IN PRESS
   Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104
   Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577
   Steinberg BE, 2008, J CLIN INVEST, V118, P2002, DOI 10.1172/JCI35433
   Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x
   van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059
   Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102
   Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527
   Vergne I, 2004, MOL BIOL CELL, V15, P751, DOI 10.1091/mbc.E03-05-0307
   Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5
NR 46
TC 8
Z9 10
U1 0
U2 1
PU NATL INST SCIENCE COMMUNICATION-NISCAIR
PI NEW DELHI
PA DR K S KRISHNAN MARG, PUSA CAMPUS, NEW DELHI 110 012, INDIA
SN 0019-5189
EI 0975-1009
J9 INDIAN J EXP BIOL
JI Indian J. Exp. Biol.
PD JUN
PY 2009
VL 47
IS 6
BP 401
EP 406
PG 6
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 454JB
UT WOS:000266677100004
PM 19634703
DA 2021-01-25
ER

PT J
AU Shin, H
   Mally, M
   Meyer, S
   Fiechter, C
   Paroz, C
   Zaehringer, U
   Cornelis, GR
AF Shin, Hwain
   Mally, Manuela
   Meyer, Salome
   Fiechter, Chantal
   Paroz, Cecile
   Zaehringer, Ulrich
   Cornelis, Guy R.
TI Resistance of Capnocytophaga canimorsus to Killing by Human Complement
   and Polymorphonuclear Leukocytes
SO INFECTION AND IMMUNITY
LA English
DT Article
ID YERSINIA-ENTEROCOLITICA; RIEMERELLA-ANATIPESTIFER;
   NEISSERIA-MENINGITIDIS; SALMONELLA-TYPHIMURIUM; HUMAN-SERUM; DOG-BITE;
   SP-NOV; INFECTION; SEPTICEMIA; BACTERIA
AB Capnocytophaga canimorsus is a bacterium of the canine oral flora known since 1976 to cause rare but severe septicemia and peripheral gangrene in patients that have been in contact with a dog. It was recently shown that these bacteria do not elicit an inflammatory response (H. Shin, M. Mally, M. Kuhn, C. Paroz, and G. R. Cornelis, J. Infect. Dis. 195: 375-386, 2007). Here, we analyze their sensitivity to the innate immune system. Bacteria from the archetype strain Cc5 were highly resistant to killing by complement. There was little membrane attack complex (MAC) deposition in spite of C3b deposition. Cc5 bacteria were as resistant to phagocytosis by human polymorphonuclear leukocytes (PMNs) as Yersinia enterocolitica MRS40, endowed with an antiphagocytic type III secretion system. We isolated Y1C12, a transposon mutant that is hypersensitive to killing by complement via the antibody-dependent classical pathway. The mutation inactivated a putative glycosyltransferase gene, suggesting that the Y1C12 mutant was affected at the level of a capsular polysaccharide or lipopolysaccharide (LPS) structure. Cc5 appeared to have several polysaccharidic structures, one being altered in Y1C12. The structure missing in Y1C12 could be purified by classical LPS purification procedures and labeled by tritiated palmitate, indicating that it is more likely to be an LPS structure than a capsule. Y1C12 bacteria were also more sensitive to phagocytosis by PMNs than wild-type bacteria. In conclusion, a polysaccharide structure, likely an LPS, protects C. canimorsus from deposition of the complement MAC and from efficient phagocytosis by PMNs.
C1 [Shin, Hwain; Mally, Manuela; Meyer, Salome; Fiechter, Chantal; Paroz, Cecile; Cornelis, Guy R.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Zaehringer, Ulrich] Forschungszentrum Borstel, Leibnitz Zentrum Med & Biowissensch, D-23845 Borstel, Germany.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [32-65393.01]
FX We thank Regine Landmann and Naja Jann for their help and advice
   concerning the isolation and handling of PMNs and Anna Blom for the gift
   of the anti-C4BP serum.; This work was supported by the Swiss National
   Science Foundation (grant 32-65393.01). We declare that no competing
   interests exist.
CR BAILIE WE, 1978, J CLIN MICROBIOL, V7, P223
   Blanche P, 1998, J INFECTION, V36, P134, DOI 10.1016/S0163-4453(98)93918-4
   BOBO RA, 1976, AM J CLIN PATHOL, V65, P564
   BRENNER DJ, 1989, J CLIN MICROBIOL, V27, P231, DOI 10.1128/JCM.27.2.231-235.1989
   CORNELIS G, 1987, MICROB PATHOGENESIS, V2, P367, DOI 10.1016/0882-4010(87)90078-7
   Coyne MJ, 2008, J BACTERIOL, V190, P736, DOI 10.1128/JB.01559-07
   Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313
   FINE DP, 1972, J IMMUNOL, V109, P807
   Frandsen EVG, 2008, INT J SYST EVOL MICR, V58, P324, DOI 10.1099/ijs.0.65373-0
   FRANK MM, 1987, REV INFECT DIS, V9, pS537
   GALANOS C, 1969, EUR J BIOCHEM, V9, P245, DOI 10.1111/j.1432-1033.1969.tb00601.x
   Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002
   HANSKI C, 1991, INFECT IMMUN, V59, P1106, DOI 10.1128/IAI.59.3.1106-1111.1991
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0
   Janda JM, 2006, EMERG INFECT DIS, V12, P340, DOI 10.3201/eid1202.050783
   JEPSEN LV, 1982, SCAND J CLIN LAB INV, V42, P235
   KADAM SK, 1985, J BACTERIOL, V161, P277, DOI 10.1128/JB.161.1.277-284.1985
   Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202
   Lion C, 1996, EUR J EPIDEMIOL, V12, P521, DOI 10.1007/BF00144007
   Mally M, 2008, APPL ENVIRON MICROB, V74, P6369, DOI 10.1128/AEM.01218-08
   Mally M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000164
   MARCUS S, 1954, SCIENCE, V119, P877, DOI 10.1126/science.119.3103.877
   Meyer S, 2008, IMMUNOBIOLOGY, V213, P805, DOI 10.1016/j.imbio.2008.07.019
   Meyers B, 2008, VET MICROBIOL, V127, P360, DOI 10.1016/j.vetmic.2007.09.004
   Parkhill J, 2000, NATURE, V404, P502, DOI 10.1038/35006655
   Pers C, 1996, CLIN INFECT DIS, V23, P71, DOI 10.1093/clinids/23.1.71
   Rautemaa R, 1999, MICROBES INFECT, V1, P785, DOI 10.1016/S1286-4579(99)80081-1
   Schagger H, 2006, NAT PROTOC, V1, P16, DOI 10.1038/nprot.2006.4
   Schuijffel DF, 2005, INFECT IMMUN, V73, P6812, DOI 10.1128/IAI.73.10.6812-6821.2005
   SEGERS P, 1993, INT J SYST BACTERIOL, V43, P768, DOI 10.1099/00207713-43-4-768
   Shin H, 2007, J INFECT DIS, V195, P375, DOI 10.1086/510243
   Slaney JM, 2006, INFECT IMMUN, V74, P5352, DOI 10.1128/IAI.00304-06
   Socransky SS, 2005, PERIODONTOL 2000, V38, P135, DOI 10.1111/j.1600-0757.2005.00107.x
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   Subramaniam S, 2000, CLIN DIAGN LAB IMMUN, V7, P168, DOI 10.1128/CDLI.7.2.168-174.2000
   Tierney DM, 2006, J CLIN MICROBIOL, V44, P649, DOI 10.1128/JCM.44.2.649-651.2006
   TSAI CM, 1982, ANAL BIOCHEM, V119, P115, DOI 10.1016/0003-2697(82)90673-X
   Tzeng YL, 2005, INFECT IMMUN, V73, P1491, DOI 10.1128/IAI.73.3.1491-1505.2005
   van Duijkeren E, 2006, VET MICROBIOL, V118, P148, DOI 10.1016/j.vetmic.2006.07.002
   WESTPHAL O, 1965, METHODS CARBOHYDR RE, V5, P91
   WESTWELL AJ, 1989, BRIT MED J, V298, P116, DOI 10.1136/bmj.298.6666.116-c
   WILSON ME, 1985, INFECT IMMUN, V50, P123, DOI 10.1128/IAI.50.1.123-129.1985
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
NR 43
TC 31
Z9 31
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0019-9567
EI 1098-5522
J9 INFECT IMMUN
JI Infect. Immun.
PD JUN
PY 2009
VL 77
IS 6
BP 2262
EP 2271
DI 10.1128/IAI.01324-08
PG 10
WC Immunology; Infectious Diseases
SC Immunology; Infectious Diseases
GA 447HO
UT WOS:000266182400003
PM 19307219
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Chan, YW
   Fava, LL
   Uldschmid, A
   Schmitz, MHA
   Gerlich, DW
   Nigg, EA
   Santamaria, A
AF Chan, Ying Wai
   Fava, Luca L.
   Uldschmid, Andreas
   Schmitz, Michael H. A.
   Gerlich, Daniel W.
   Nigg, Erich A.
   Santamaria, Anna
TI Mitotic control of kinetochore-associated dynein and spindle orientation
   by human Spindly
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID LIGHT INTERMEDIATE CHAIN; CYTOPLASMIC DYNEIN; CHROMOSOME ALIGNMENT;
   ASSEMBLY CHECKPOINT; MICROTUBULE ATTACHMENT; ROUGH DEAL; AURORA-B;
   DROSOPHILA ZW10; CENP-E; CELLS
AB Mitotic spindle formation and chromosome segregation depend critically on kinetochore-microtubule (KT-MT) interactions. A new protein, termed Spindly in Drosophila and SPDL-1 in C. elegans, was recently shown to regulate KT localization of dynein, but depletion phenotypes revealed striking differences, suggesting evolutionarily diverse roles of mitotic dynein. By characterizing the function of Spindly in human cells, we identify specific functions for KT dynein. We show that localization of human Spindly (hSpindly) to KTs is controlled by the Rod/Zw10/Zwilch (RZZ) complex and Aurora B. hSpindly depletion results in reduced inter-KT tension, unstable KT fibers, an extensive prometaphase delay, and severe chromosome misalignment. Moreover, depletion of hSpindly induces a striking spindle rotation, which can be rescued by co-depletion of dynein. However, in contrast to Drosophila, hSpindly depletion does not abolish the removal of MAD2 and ZW10 from KTs. Collectively, our data reveal hSpindly-mediated dynein functions and highlight a critical role of KT dynein in spindle orientation.
C1 [Chan, Ying Wai; Fava, Luca L.; Uldschmid, Andreas; Nigg, Erich A.; Santamaria, Anna] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
   [Nigg, Erich A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Schmitz, Michael H. A.; Gerlich, Daniel W.] ETH, Inst Biochem, CH-8093 Zurich, Switzerland.
RP Santamaria, A (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
EM santamaria@biochem.mpg.de
RI Gerlich, Daniel Wolfram W/A-6991-2016; Chan, Ying Wai/P-7347-2019; Fava,
   Luca/E-2876-2017
OI Gerlich, Daniel Wolfram W/0000-0003-1637-3365; Chan, Ying
   Wai/0000-0002-6196-7675; Fava, Luca/0000-0002-6741-1723; nigg,
   erich/0000-0003-4835-5719
CR Basto R, 2000, NAT CELL BIOL, V2, P939
   Basto R, 2004, CURR BIOL, V14, P56, DOI 10.1016/j.cub.2003.12.025
   Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052
   Busson S, 1998, CURR BIOL, V8, P541, DOI 10.1016/S0960-9822(98)70208-8
   Chan GKT, 2000, NAT CELL BIOL, V2, P944
   Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310
   Civril F, 2008, GENE DEV, V22, P2302, DOI 10.1101/gad.1719208
   Desai A, 2003, GENE DEV, V17, P2421, DOI 10.1101/gad.1126303
   Ditchfield C, 2003, J CELL BIOL, V161, P267, DOI 10.1083/jcb.200208091
   Echeverri CJ, 1996, J CELL BIOL, V132, P617, DOI 10.1083/jcb.132.4.617
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007
   Famulski JK, 2007, CURR BIOL, V17, P2143, DOI 10.1016/j.cub.2007.11.037
   Faulkner NE, 2000, NAT CELL BIOL, V2, P784, DOI 10.1038/35041020
   Feng YY, 2004, NEURON, V44, P279, DOI 10.1016/j.neuron.2004.09.023
   Feng YY, 2000, NEURON, V28, P665, DOI 10.1016/S0896-6273(00)00145-8
   Gaetz J, 2004, J CELL BIOL, V166, P465, DOI 10.1083/jcb.200404015
   Gaitanos TN, 2009, EMBO J, V28, P1442, DOI 10.1038/emboj.2009.96
   Gassmann R, 2008, GENE DEV, V22, P2385, DOI 10.1101/gad.1687508
   Goshima G, 2005, J CELL BIOL, V171, P229, DOI 10.1083/jcb.200505107
   Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062
   Hauf S, 2003, J CELL BIOL, V161, P281, DOI 10.1083/jcb.200208092
   Hirose H, 2004, EMBO J, V23, P1267, DOI 10.1038/sj.emboj.7600135
   Howell BJ, 2001, J CELL BIOL, V155, P1159, DOI 10.1083/jcb.200105093
   Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003
   King JM, 2000, J CELL BIOL, V151, P739, DOI 10.1083/jcb.151.4.739
   Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005
   Klein UR, 2006, MOL BIOL CELL, V17, P2547, DOI 10.1091/mbc.E05-12-1133
   Kops GJPL, 2005, J CELL BIOL, V169, P49, DOI 10.1083/jcb.200411118
   Li Y, 2007, CELL RES, V17, P701, DOI 10.1038/cr.2007.65
   Liang Y, 2004, J CELL BIOL, V164, P557, DOI 10.1083/jcb.200308058
   Liang Y, 2007, MOL BIOL CELL, V18, P2656, DOI 10.1091/mbc.E06-04-0345
   Lin YT, 2006, ONCOGENE, V25, P6901, DOI 10.1038/sj.onc.1209687
   Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596
   Mische S, 2008, MOL BIOL CELL, V19, P4918, DOI 10.1091/mbc.E08-05-0483
   Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163
   O'Connell CB, 2000, MOL BIOL CELL, V11, P1765, DOI 10.1091/mbc.11.5.1765
   O'Connell CB, 2007, J CELL SCI, V120, P1717, DOI 10.1242/jcs.03442
   RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368
   RIEDER CL, 1990, J CELL BIOL, V110, P81, DOI 10.1083/jcb.110.1.81
   Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200
   Savoian MS, 2000, NAT CELL BIOL, V2, P948
   Sharp DJ, 2000, MOL BIOL CELL, V11, P241, DOI 10.1091/mbc.11.1.241
   Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070
   Sivaram MVS, 2009, EMBO J, V28, P902, DOI 10.1038/emboj.2009.38
   Skoufias DA, 2001, P NATL ACAD SCI USA, V98, P4492, DOI 10.1073/pnas.081076898
   Starr DA, 1998, J CELL BIOL, V142, P763, DOI 10.1083/jcb.142.3.763
   Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112
   Tanaka TU, 2008, CHROMOSOMA, V117, P521, DOI 10.1007/s00412-008-0173-5
   Tanudji M, 2004, MOL BIOL CELL, V15, P3771, DOI 10.1091/mbc.E03-07-0482
   Thein KH, 2007, J CELL BIOL, V178, P345, DOI 10.1083/jcb.200701163
   Toyoshima F, 2007, DEV CELL, V13, P796, DOI 10.1016/j.devcel.2007.10.014
   Toyoshima F, 2007, EMBO J, V26, P1487, DOI 10.1038/sj.emboj.7601599
   VAISBERG EA, 1993, J CELL BIOL, V123, P849, DOI 10.1083/jcb.123.4.849
   Varma D, 2008, J CELL BIOL, V182, P1045, DOI 10.1083/jcb.200710106
   Vergnolle MAS, 2007, CURR BIOL, V17, P1173, DOI 10.1016/j.cub.2007.05.077
   Vorozhko VV, 2008, CHROMOSOMA, V117, P169, DOI 10.1007/s00412-007-0135-3
   Whyte J, 2008, J CELL BIOL, V183, P819, DOI 10.1083/jcb.200804114
   WILLIAMS BC, 1994, J CELL SCI, V107, P785
   Wojcik E, 2001, NAT CELL BIOL, V3, P1001, DOI 10.1038/ncb1101-1001
   Yamamoto TG, 2008, J CELL BIOL, V183, P187, DOI 10.1083/jcb.200805185
   Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056
   Yingling J, 2008, CELL, V132, P474, DOI 10.1016/j.cell.2008.01.026
NR 63
TC 98
Z9 100
U1 0
U2 22
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD JUN 1
PY 2009
VL 185
IS 5
BP 859
EP 874
DI 10.1083/jcb.200812167
PG 16
WC Cell Biology
SC Cell Biology
GA 457EU
UT WOS:000266912100011
PM 19468067
OA Green Published, Other Gold, Green Accepted
DA 2021-01-25
ER

PT J
AU Bruns, A
   Kunnecke, B
   Risterucci, C
   Moreau, JL
   von Kienlin, M
AF Bruns, Andreas
   Kunnecke, Basil
   Risterucci, Celine
   Moreau, Jean-Luc
   von Kienlin, Markus
TI Validation of Cerebral Blood Perfusion Imaging as a Modality for
   Quantitative Pharmacological MRI in Rats
SO MAGNETIC RESONANCE IN MEDICINE
LA English
DT Article
DE arterial spin labeling; pharmacological MRI; cerebral perfusion; animal
   models; psychostimulant
ID MAGNETIC-RESONANCE; ALPHA-CHLORALOSE; FUNCTIONAL MRI; BRAIN ACTIVITY;
   SOMATOSENSORY CORTEX; HEMODYNAMIC-RESPONSE; ANIMAL ANESTHESIA;
   NUCLEUS-ACCUMBENS; ANESTHETIZED RATS; CONSCIOUS RATS
AB The aim of this study was to validate continuous arterial spin labeling (CASL) as a quantitative imaging modality for pharmacological MRI (phMRI) based on local cerebral blood perfusion. Specifically, the capability of CASL to assess brain-activity signatures of pharmacological interventions in animal models was evaluated with respect to drug discovery in diseases of the central nervous system (CNS). Perfusion as a surrogate for neuronal activity was measured in various brain areas of the rat. The validation approach was threefold. First, perfusion was shown to reliably reflect differential effects of anesthesia on striatal activation. Different baseline levels and different temporal response profiles after amphetamine challenges under isoflurane, propofol, ketamine, and alpha-chloralose anesthesia were consistent with known properties of these anesthetic. Second, remarkable consistency of multi-area baseline perfusion patterns between independent groups of animals con firmed the notion that CASL is highly reproducible and thus particularly suitable for long-term longitudinal studies. Third administration of the well-characterized psychotomimetic compounds amphetamine and phencyclidine (PCP) elicited dose-dependent activation patterns that were related to the drugs' particular interactions with the dopaminergic and glutamatergic systems, respectively. In conclusion, perfusion-base phMRI is a robust, reliable and valid quantitative technique suitable for evaluating brain-activation patterns in animal mod els of IONS diseases. Magn Reson Med 61:1451-1458, 2009 (C) 2009 Wiley-Liss, Inc.
C1 [Bruns, Andreas; Kunnecke, Basil; Risterucci, Celine; Moreau, Jean-Luc; von Kienlin, Markus] F Hoffmann La Roche Pharmaceut Ltd, CH-4070 Basel, Switzerland.
   [Bruns, Andreas] Univ Basel, Biozentrum, Basel, Switzerland.
RP Kunnecke, B (corresponding author), F Hoffmann La Roche Pharmaceut Ltd, Grenzacherstr 124,PRDN A,Bldg 68-05A, CH-4070 Basel, Switzerland.
EM basil.kuennecke@roche.com
RI Bruns, Andreas/B-7330-2015
OI Bruns, Andreas/0000-0001-6965-641X; von Kienlin,
   Markus/0000-0002-7972-3003
CR Abo M, 2004, NEUROSIGNALS, V13, P144, DOI 10.1159/000076568
   Aguirre GK, 1998, NEUROIMAGE, V8, P302, DOI 10.1006/nimg.1998.0367
   Aguirre GK, 2002, NEUROIMAGE, V15, P488, DOI 10.1006/nimg.2001.0990
   Alkire MT, 2001, BRIT J ANAESTH, V86, P618, DOI 10.1093/bja/86.5.618
   Alsop DC, 1996, J CEREBR BLOOD F MET, V16, P1236, DOI 10.1097/00004647-199611000-00019
   Austin VC, 2005, NEUROIMAGE, V24, P92, DOI 10.1016/j.neuroimage.2004.08.011
   Baas D, 2004, BRAIN RES REV, V45, P96, DOI 10.1016/j.brainresrev.2004.02.004
   BALIS GU, 1964, PSYCHOPHARMACOLOGIA, V6, P1, DOI 10.1007/BF00710911
   BONVENTO G, 1994, BRAIN RES, V665, P213, DOI 10.1016/0006-8993(94)91340-4
   Borsook D, 2006, NAT REV DRUG DISCOV, V5, P411, DOI 10.1038/nrd2027
   Buxton RB, 2004, NEUROIMAGE, V23, pS220, DOI 10.1016/j.neuroimage.2004.07.013
   Deichmann R, 1999, MAGNET RESON MED, V42, P206, DOI 10.1002/(SICI)1522-2594(199907)42:1<206::AID-MRM28>3.0.CO;2-Q
   Febo M, 2004, J NEUROSCI METH, V139, P167, DOI 10.1016/j.jneumeth.2004.04.028
   Garrett KM, 1998, J PHARMACOL EXP THER, V285, P680
   Gavrilescu M, 2002, NEUROIMAGE, V17, P532, DOI 10.1006/nimg.2002.1226
   HAASE A, 1986, J MAGN RESON, V67, P258, DOI 10.1016/0022-2364(86)90433-6
   HANSEN TD, 1988, ANESTHESIOLOGY, V69, P332, DOI 10.1097/00000542-198809000-00008
   Hendrich KS, 2001, MAGNET RESON MED, V46, P202, DOI 10.1002/mrm.1178
   HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602
   Hertel P, 1996, BEHAV BRAIN RES, V72, P103, DOI 10.1016/0166-4328(96)00138-6
   Honey G, 2004, TRENDS PHARMACOL SCI, V25, P366, DOI 10.1016/j.tips.2004.05.009
   JENKINS BG, 2006, IN VIVO MR TECHNIQUE, P171
   Jentsch JD, 1999, NEUROPSYCHOPHARMACOL, V20, P201, DOI 10.1016/S0893-133X(98)00060-8
   King JA, 2005, J NEUROSCI METH, V148, P154, DOI 10.1016/j.jneumeth.2005.04.011
   Kiyatkin EA, 1997, BRAIN RES, V771, P14, DOI 10.1016/S0006-8993(97)00689-6
   Lahti KM, 1998, J NEUROSCI METH, V82, P75, DOI 10.1016/S0165-0270(98)00037-5
   Lahti KM, 1999, MAGNET RESON MED, V41, P412, DOI 10.1002/(SICI)1522-2594(199902)41:2<412::AID-MRM28>3.3.CO;2-V
   Leppanen JM, 2006, CURR OPIN PSYCHIATR, V19, P34, DOI 10.1097/01.yco.0000191500.46411.00
   LINDAUER U, 1993, AM J PHYSIOL, V264, pH1223
   Logothetis NK, 2004, ANNU REV PHYSIOL, V66, P735, DOI 10.1146/annurev.physiol.66.082602.092845
   Lukasik VM, 2003, NMR BIOMED, V16, P459, DOI 10.1002/nbm.836
   Marcus MM, 2001, NEUROPHARMACOLOGY, V40, P482, DOI 10.1016/S0028-3908(00)00199-4
   Masamoto K, 2007, CEREB CORTEX, V17, P942, DOI 10.1093/cercor/bhl005
   Matta BF, 1999, ANESTHESIOLOGY, V91, P677, DOI 10.1097/00000542-199909000-00019
   Millan MJ, 2005, PSYCHOPHARMACOLOGY, V179, P30, DOI 10.1007/s00213-005-2199-1
   Mueggler T, 2002, J NEUROSCI, V22, P7218
   Murphy FC, 2003, COGN AFFECT BEHAV NE, V3, P207, DOI 10.3758/CABN.3.3.207
   Nieoullon A, 2002, PROG NEUROBIOL, V67, P53, DOI 10.1016/S0301-0082(02)00011-4
   Orban GA, 2001, CURR OPIN NEUROL, V14, P47, DOI 10.1097/00019052-200102000-00008
   Orban GA, 2004, TRENDS COGN SCI, V8, P315, DOI 10.1016/j.tics.2004.05.009
   Parkes LM, 2004, MAGN RESON MED, V51, P736, DOI 10.1002/mrm.20023
   PAXINOS G, 1998, RAT BRAIN STEREOTAXI
   Peeters RR, 2001, MAGN RESON IMAGING, V19, P821, DOI 10.1016/S0730-725X(01)00391-5
   Rajah MN, 2005, BRAIN, V128, P1964, DOI 10.1093/brain/awh608
   Rausch M, 2005, NMR BIOMED, V18, P260, DOI 10.1002/nbm.956
   Risterucci C, 2005, PSYCHOPHARMACOLOGY, V180, P724, DOI 10.1007/s00213-005-2204-8
   Schwarz A, 2004, SYNAPSE, V54, P1, DOI 10.1002/syn.20055
   SHROUT PE, 1979, PSYCHOL BULL, V86, P420, DOI 10.1037/0033-2909.86.2.420
   Sicard K, 2003, J CEREBR BLOOD F MET, V23, P472, DOI 10.1097/01.WCB.0000054755.93668.20
   Silva AC, 2003, CONCEPTS MAGN RESO A, V16A, P16, DOI 10.1002/cmr.a.10050
   SILVERMAN J, 1993, LAB ANIM SCI, V43, P210
   Smith AM, 1999, NEUROIMAGE, V9, P526, DOI 10.1006/nimg.1999.0435
   Tootell RBH, 2003, J NEUROSCI, V23, P3981
   Trapani G, 2000, CURR MED CHEM, V7, P249, DOI 10.2174/0929867003375335
   UEKI M, 1992, ACTA ANAESTH SCAND, V36, P318, DOI 10.1111/j.1399-6576.1992.tb03474.x
   VILLRINGER A, 1995, CEREBROVAS BRAIN MET, V7, P240
   Wang JJ, 2003, MAGN RESON MED, V49, P796, DOI 10.1002/mrm.10437
   WANG ZR, 1992, SYNAPSE, V12, P312, DOI 10.1002/syn.890120408
   WERNER C, 1993, ANESTH ANALG, V76, P971
   WILLIAMS DS, 1992, P NATL ACAD SCI USA, V89, P212, DOI 10.1073/pnas.89.1.212
   Wise RG, 2006, J MAGN RESON IMAGING, V23, P862, DOI 10.1002/jmri.20584
NR 61
TC 42
Z9 42
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0740-3194
EI 1522-2594
J9 MAGN RESON MED
JI Magn. Reson. Med.
PD JUN
PY 2009
VL 61
IS 6
BP 1451
EP 1458
DI 10.1002/mrm.21779
PG 8
WC Radiology, Nuclear Medicine & Medical Imaging
SC Radiology, Nuclear Medicine & Medical Imaging
GA 450VS
UT WOS:000266429900020
PM 19358231
OA Bronze
DA 2021-01-25
ER

PT J
AU Boehm, A
   Steiner, S
   Zaehringer, F
   Casanova, A
   Hamburger, F
   Ritz, D
   Keck, W
   Ackermann, M
   Schirmer, T
   Jenal, U
AF Boehm, Alex
   Steiner, Samuel
   Zaehringer, Franziska
   Casanova, Alain
   Hamburger, Fabienne
   Ritz, Daniel
   Keck, Wolfgang
   Ackermann, Martin
   Schirmer, Tilman
   Jenal, Urs
TI Second messenger signalling governs Escherichia coli biofilm induction
   upon ribosomal stress
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID STRINGENT RESPONSE; SUBINHIBITORY CONCENTRATIONS; TRANSCRIPTIONAL
   MODULATION; POLYSACCHARIDE ADHESIN; CHROMOSOMAL GENES; RNA-SYNTHESIS;
   BACTERIAL; ANTIBIOTICS; PROTEIN; EXPRESSION
AB P>Biofilms are communities of surface-attached, matrix-embedded microbial cells that can resist antimicrobial chemotherapy and contribute to persistent infections. Using an Escherichia coli biofilm model we found that exposure of bacteria to subinhibitory concentrations of ribosome-targeting antibiotics leads to strong biofilm induction. We present evidence that this effect is elicited by the ribosome in response to translational stress. Biofilm induction involves upregulation of the polysaccharide adhesin poly-beta-1,6-N-acetyl-glucosamine (poly-GlcNAc) and two components of the poly-GlcNAc biosynthesis machinery, PgaA and PgaD. Poly-GlcNAc control depends on the bacterial signalling molecules guanosine-bis 3', 5'(diphosphate) (ppGpp) and bis-(3'-5')-cyclic di-GMP (c-di-GMP). Treatment with translation inhibitors causes a ppGpp hydrolase (SpoT)-mediated reduction of ppGpp levels, resulting in specific derepression of PgaA. Maximal induction of PgaD and poly-GlcNAc synthesis requires the production of c-di-GMP by the dedicated diguanylate cyclase YdeH. Our results identify a novel regulatory mechanism that relies on ppGpp signalling to relay information about ribosomal performance to the Pga machinery, thereby inducing adhesin production and biofilm formation. Based on the important synergistic roles of ppGpp and c-di-GMP in this process, we suggest that interference with bacterial second messenger signalling might represent an effective means for biofilm control during chronic infections.
C1 [Boehm, Alex; Steiner, Samuel; Zaehringer, Franziska; Casanova, Alain; Hamburger, Fabienne; Schirmer, Tilman; Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Ritz, Daniel; Keck, Wolfgang] Actel Pharmaceut Ltd, CH-4123 Allschwil, Switzerland.
   [Ackermann, Martin] ETH, Inst Biogeochem & Pollutant Dynam, CH-8092 Zurich, Switzerland.
   [Ackermann, Martin] EAWAG, Dept Environm Microbiol, CH-8092 Zurich, Switzerland.
RP Boehm, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM alexander.boehm@unibas.ch
RI Ackermann, Martin/V-4554-2017
OI Ackermann, Martin/0000-0003-0087-4819
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-108186]; Werner Siemens-Foundation
FX We gratefully acknowledge sharing of unpublished material by K. Datsenko
   and B. Wanner and thank M. Duggelin, D. Mathys and M. Durrenberger from
   the ZMB for excellent service, R. Landmann for the gift of
   anti-poly-GlcNAc antiserum, M. Folcher for assistance with HPLC and R.
   Hallez for strains and discussion. This work was supported by Swiss
   National Science Foundation Fellowship 3100A0-108186 to U.J. and a grant
   from the Werner Siemens-Foundation (Zug) to S.S.
CR Anderson GG, 2004, TRENDS MICROBIOL, V12, P424, DOI 10.1016/j.tim.2004.07.005
   Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050
   Babitzke P, 2007, CURR OPIN MICROBIOL, V10, P156, DOI 10.1016/j.mib.2007.03.007
   Balzer GJ, 2002, CAN J MICROBIOL, V48, P675, DOI 10.1139/W02-060
   BARACCHINI E, 1988, J BIOL CHEM, V263, P2597
   BILGIN N, 1992, J MOL BIOL, V224, P1011, DOI 10.1016/0022-2836(92)90466-W
   Bisognano C, 1997, ANTIMICROB AGENTS CH, V41, P906, DOI 10.1128/AAC.41.5.906
   Blickwede M, 2004, J ANTIMICROB CHEMOTH, V54, P286, DOI 10.1093/jac/dkh273
   Bobrov AG, 2008, ENVIRON MICROBIOL, V10, P1419, DOI 10.1111/j.1462-2920.2007.01554.x
   Bochner BR, 2001, GENOME RES, V11, P1246, DOI 10.1101/gr.186501
   Braeken K, 2006, TRENDS MICROBIOL, V14, P45, DOI 10.1016/j.tim.2005.11.006
   Branda SS, 2005, TRENDS MICROBIOL, V13, P20, DOI 10.1016/j.tim.2004.11.006
   Cashel M., 1996, ESCHERICHIA COLI SAL, P1458
   Cerca N, 2007, P NATL ACAD SCI USA, V104, P7528, DOI 10.1073/pnas.0700630104
   Clemett D, 2000, DRUGS, V59, P815, DOI 10.2165/00003495-200059040-00007
   Costerton JW, 1999, SCIENCE, V284, P1318, DOI 10.1126/science.284.5418.1318
   COSTERTON JW, 1995, ANNU REV MICROBIOL, V49, P711, DOI 10.1146/annurev.mi.49.100195.003431
   Cotter PA, 2007, CURR OPIN MICROBIOL, V10, P17, DOI 10.1016/j.mib.2006.12.006
   Craig WA, 1998, CLIN INFECT DIS, V26, P1, DOI 10.1086/516284
   Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730
   Dancer SJ, 2004, LANCET INFECT DIS, V4, P611, DOI 10.1016/S1473-3099(04)01145-4
   Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297
   Erickson DL, 2008, J BACTERIOL, V190, P8163, DOI 10.1128/JB.01181-08
   Fajardo A, 2008, CURR OPIN MICROBIOL, V11, P161, DOI 10.1016/j.mib.2008.02.006
   Furukawa S, 2006, J BACTERIOL, V188, P1211, DOI 10.1128/JB.188.4.1211-1217.2006
   Fux CA, 2005, TRENDS MICROBIOL, V13, P34, DOI 10.1016/j.tim.2004.11.010
   GALLANT J, 1972, J BIOL CHEM, V247, P6055
   GENTRY DR, 1995, J BACTERIOL, V177, P3890, DOI 10.1128/jb.177.13.3890-3893.1995
   Goh EB, 2002, P NATL ACAD SCI USA, V99, P17025, DOI 10.1073/pnas.252607699
   Goller C, 2006, J BACTERIOL, V188, P8022, DOI 10.1128/JB.01106-06
   Gotz F, 2002, MOL MICROBIOL, V43, P1367, DOI 10.1046/j.1365-2958.2002.02827.x
   GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995
   Harms JM, 2003, J CELL SCI, V116, P1391, DOI 10.1242/jcs.00365
   HERNANDEZ VJ, 1990, J BIOL CHEM, V265, P11605
   HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351
   Hoffman LR, 2005, NATURE, V436, P1171, DOI 10.1038/nature03912
   Hogg T, 2004, CELL, V117, P57, DOI 10.1016/S0092-8674(04)00260-0
   Itoh Y, 2008, J BACTERIOL, V190, P3670, DOI 10.1128/JB.01920-07
   Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423
   Jiang MX, 2007, J BACTERIOL, V189, P6140, DOI 10.1128/JB.00315-07
   Jonas K, 2008, MOL MICROBIOL, V70, P236, DOI 10.1111/j.1365-2958.2008.06411.x
   KUO MS, 1986, CARBOHYD RES, V156, P173, DOI 10.1016/S0008-6215(00)90109-5
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LANGE R, 1995, J BACTERIOL, V177, P4676, DOI 10.1128/jb.177.16.4676-4680.1995
   Letunic I, 2006, NUCLEIC ACIDS RES, V34, pD257, DOI 10.1093/nar/gkj079
   Lewis K, 2007, NAT REV MICROBIOL, V5, P48, DOI 10.1038/nrmicro1557
   Linares JF, 2006, P NATL ACAD SCI USA, V103, P19484, DOI 10.1073/pnas.0608949103
   LITTLE R, 1982, ANAL BIOCHEM, V126, P381, DOI 10.1016/0003-2697(82)90531-0
   Lucchetti-Miganeh C, 2008, MICROBIOL-SGM, V154, P16, DOI 10.1099/mic.0.2007/012286-0
   Mah TFC, 2001, TRENDS MICROBIOL, V9, P34, DOI 10.1016/S0966-842X(00)01913-2
   McLennan MK, 2008, J BACTERIOL, V190, P1097, DOI 10.1128/JB.00516-07
   Murray KD, 1996, J MOL BIOL, V259, P41
   MUTO A, 1975, MOL GEN GENET, V139, P321, DOI 10.1007/BF00267972
   Nakatogawa H, 2002, CELL, V108, P629, DOI 10.1016/S0092-8674(02)00649-9
   O'Toole GA, 1999, METHOD ENZYMOL, V310, P91
   OCHI K, 1986, J GEN MICROBIOL, V132, P2621, DOI 10.1099/00221287-132-9-2621
   OZAKI M, 1969, NATURE, V222, P333, DOI 10.1038/222333a0
   Parise G, 2007, J BACTERIOL, V189, P750, DOI 10.1128/JB.00953-06
   Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903
   Pratt LA, 1998, MOL MICROBIOL, V30, P285, DOI 10.1046/j.1365-2958.1998.01061.x
   Rachid S, 2000, ANTIMICROB AGENTS CH, V44, P3357, DOI 10.1128/AAC.44.12.3357-3363.2000
   RAMAGOPAL S, 1974, P NATL ACAD SCI USA, V71, P820, DOI 10.1073/pnas.71.3.820
   ROMEO T, 1993, J BACTERIOL, V175, P4744, DOI 10.1128/JB.175.15.4744-4755.1993
   Sabina J, 2003, J BACTERIOL, V185, P6158, DOI 10.1128/JB.185.20.6158-6170.2003
   Smith DL, 2002, P NATL ACAD SCI USA, V99, P6434, DOI 10.1073/pnas.082188899
   Suzuki K, 2006, GENE DEV, V20, P2605, DOI 10.1101/gad.1461606
   Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426
   Timmermans J, 2009, J BACTERIOL, V191, P1722, DOI 10.1128/JB.01573-08
   TIMMS AR, 1993, MOL MICROBIOL, V9, P335, DOI 10.1111/j.1365-2958.1993.tb01694.x
   Tomenius H, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-27
   Torres B, 2003, J BIOL CHEM, V278, P27575, DOI 10.1074/jbc.M303245200
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Traxler MF, 2008, MOL MICROBIOL, V68, P1128, DOI 10.1111/j.1365-2958.2008.06229.x
   Tsui WHW, 2004, CHEM BIOL, V11, P1307, DOI 10.1016/j.chembiol.2004.07.010
   Uzzau S, 2001, P NATL ACAD SCI USA, V98, P15264, DOI 10.1073/pnas.261348198
   VANBOGELEN RA, 1990, P NATL ACAD SCI USA, V87, P5589, DOI 10.1073/pnas.87.15.5589
   Vuong C, 2004, J BIOL CHEM, V279, P54881, DOI 10.1074/jbc.M411374200
   Walker CB, 1996, PERIODONTOL 2000, V10, P12, DOI 10.1111/j.1600-0757.1996.tb00066.x
   Wang X, 2004, J BACTERIOL, V186, P2724, DOI 10.1128/JB.186.9.2724-2734.2004
   Wang X, 2005, MOL MICROBIOL, V56, P1648, DOI 10.1111/j.1365-2958.2005.04648.x
   Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x
   Wout P, 2004, J BACTERIOL, V186, P5249, DOI 10.1128/JB.186.16.5249-5257.2004
   XIAO H, 1991, J BIOL CHEM, V266, P5980
   Yim G, 2007, PHILOS T R SOC B, V362, P1195, DOI 10.1098/rstb.2007.2044
   Yim G, 2006, J BACTERIOL, V188, P7988, DOI 10.1128/JB.00791-06
NR 85
TC 117
Z9 130
U1 2
U2 33
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD JUN
PY 2009
VL 72
IS 6
BP 1500
EP 1516
DI 10.1111/j.1365-2958.2009.06739.x
PG 17
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 456UB
UT WOS:000266875800016
PM 19460094
DA 2021-01-25
ER

PT J
AU Molina, N
   van Nimwegen, E
AF Molina, Nacho
   van Nimwegen, Erik
TI Scaling laws in functional genome content across prokaryotic clades and
   lifestyles
SO TRENDS IN GENETICS
LA English
DT Article
ID EVOLUTION; SIZE
AB For high-level functional categories that are represented in almost all prokaryotic genomes, the numbers of genes in these categories scale as power-laws in the total number of genes. We present a comprehensive analysis of the variation in these scaling laws across prokaryotic clades and lifestyles. For the large majority of functional categories, including transcription regulators, the inferred scaling laws are statistically indistinguishable across clades and lifestyles, supporting the simple hypothesis that these scaling laws are universally shared by all prokaryotes.
C1 [van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erik.vannimwegen@unibas.ch
RI Molina, Nacho/F-2244-2010; Hogeweg, paulien/D-1242-2011
OI Molina, Nacho/0000-0003-0233-3055; van Nimwegen,
   Erik/0000-0001-6338-1312
CR Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Babu MM, 2006, J MOL BIOL, V358, P614, DOI 10.1016/j.jmb.2006.02.019
   Cordero OX, 2007, TRENDS GENET, V23, P488, DOI 10.1016/j.tig.2007.07.006
   Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810
   Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755
   Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960
   Konstantinidis KT, 2004, P NATL ACAD SCI USA, V101, P3160, DOI 10.1073/pnas.0308653100
   Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668
   Molina N, 2008, GENOME RES, V18, P148, DOI 10.1101/gr.6759507
   Molina N, 2008, BIOL DIRECT, V3, DOI 10.1186/1745-6150-3-51
   Ranea JAG, 2004, J MOL BIOL, V336, P871, DOI 10.1016/j.jmb.2003.12.044
   Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631
   Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41
   Tringe SG, 2005, SCIENCE, V308, P554, DOI 10.1126/science.1107851
   van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8
   VANNIMWEGEN E, 2004, POWER LAWS SCALE FRE, P236
NR 16
TC 39
Z9 39
U1 0
U2 10
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0168-9525
EI 1362-4555
J9 TRENDS GENET
JI Trends Genet.
PD JUN
PY 2009
VL 25
IS 6
BP 243
EP 247
DI 10.1016/j.tig.2009.04.004
PG 5
WC Genetics & Heredity
SC Genetics & Heredity
GA 465LS
UT WOS:000267587000001
PM 19457568
DA 2021-01-25
ER

PT J
AU Handschin, C
AF Handschin, Christoph
TI The biology of PGC-1 alpha and its therapeutic potential
SO TRENDS IN PHARMACOLOGICAL SCIENCES
LA English
DT Review
ID TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; RECEPTOR-GAMMA
   COACTIVATOR-1-ALPHA; MUSCLE MITOCHONDRIAL-FUNCTION; ENERGY-METABOLISM;
   SKELETAL-MUSCLE; HEPATIC GLUCONEOGENESIS; HUNTINGTONS-DISEASE;
   INSULIN-RESISTANCE; PPAR-ALPHA; OXIDATIVE-PHOSPHORYLATION
AB In eukaryotes, cellular and. systemic metabolism is primarily controlled by mitochondrial activity. The peroxisome proliferator-activated receptor gamma coactivator let (PGC-1 alpha) is an important regulator of mitochondrial biogenesis and function. Furthermore, PGC-1 alpha controls many of the phenotypic adaptations of oxidative tissues to external and internal perturbations. By contrast, dysregulated metabolic plasticity is involved in the etiology of numerous diseases. Accordingly, modulation of PGC-1 alpha levels and activity has recently been proposed as a therapeutic option for several pathologies. However, pharmacological interventions aimed at PGC-1 alpha have to overcome inherent limitations of targeting a coactivator protein. Here, I focus on the recent breakthroughs in the identification of physiological and pathophysiological contexts involving PGC-1 alpha. In addition, perspectives regarding the therapeutic importance of PGC-1 alpha-controlled cellular and systemic metabolism are outlined.
C1 [Handschin, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Handschin, Christoph] Univ Zurich, Inst Physiol, CH-8057 Zurich, Switzerland.
   [Handschin, Christoph] Univ Zurich, Zurich Ctr Integrat Human Physiol, CH-8057 Zurich, Switzerland.
RP Handschin, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM christoph.handschin@unibas.ch
RI Handschin, Christoph/E-6886-2015
OI Handschin, Christoph/0000-0003-0603-1097
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [SNF PP00A110746]; Muscular Dystrophy Association USAMuscular
   Dystrophy Association; SwissLife 'Jubilaumsstiftung fur Volksgesundheit
   und medizinische Forschung'; Swiss Society for Research on Muscle
   Diseases; Swiss Diabetes Association; Roche Research Foundation; Zurich
   Center for Integrative Human Physiology; Universities of Basel and
   Zurich
FX I thank my colleagues for discussions, ideas and suggestions for writing
   this manuscript and Christian Gasser for help with the artwork. I
   apologize for the omission of several important contributions owing to
   space constraints. Work in my laboratory related to this manuscript has
   been supported by the Swiss National Science Foundation (SNF
   PP00A110746; www.snf.ch), the Muscular Dystrophy Association USA
   (www.mda.org), the SwissLife 'Jubilaumsstiftung fur Volksgesundheit und
   medizinische Forschung', the Swiss Society for Research on Muscle
   Diseases (SSEM; www.fsrmm.ch), the Swiss Diabetes Association
   (www.diabetesstiftung.org/sds.html), the Roche Research Foundation
   (www.research-foundation.org), the Zurich Center for Integrative Human
   Physiology (www.zihp.uzh.ch) and the Universities of Basel
   (www.unibas.ch) and Zurich (www.uzh.ch).
CR Andersson U, 2001, MOL CELL BIOL, V21, P3738, DOI 10.1128/MCB.21.11.3738-3749.2001
   Arany Z, 2005, CELL METAB, V1, P259, DOI 10.1016/j.cmet.2005.03.002
   Arany Z, 2008, P NATL ACAD SCI USA, V105, P4721, DOI 10.1073/pnas.0800979105
   Arany Z, 2006, P NATL ACAD SCI USA, V103, P10086, DOI 10.1073/pnas.0603615103
   Benton CR, 2008, J BIOL CHEM, V283, P4228, DOI 10.1074/jbc.M704332200
   Calvo JA, 2008, J APPL PHYSIOL, V104, P1304, DOI 10.1152/japplphysiol.01231.2007
   Chaturvedi RK, 2008, ANN NY ACAD SCI, V1147, P395, DOI 10.1196/annals.1427.027
   Choi CS, 2008, P NATL ACAD SCI USA, V105, P19926, DOI 10.1073/pnas.0810339105
   Coghlan MJ, 2003, MOL ENDOCRINOL, V17, P860, DOI 10.1210/me.2002-0355
   Cowell RM, 2007, J COMP NEUROL, V502, P1, DOI 10.1002/cne.21211
   Cui LB, 2006, CELL, V127, P59, DOI 10.1016/j.cell.2006.09.015
   Fan M, 2004, GENE DEV, V18, P278, DOI 10.1101/gad.1152204
   Finck BN, 2006, J CLIN INVEST, V116, P615, DOI 10.1172/JCI27794
   Finck BN, 2002, J CLIN INVEST, V109, P121, DOI 10.1172/JCI14080
   Ge K, 2002, NATURE, V417, P563, DOI 10.1038/417563a
   Gerhart-Hines Z, 2007, EMBO J, V26, P1913, DOI 10.1038/sj.emboj.7601633
   Ghorbani M, 1997, BIOCHEM PHARMACOL, V54, P121, DOI 10.1016/S0006-2952(97)00162-7
   Greenamyre JT, 2007, NEW ENGL J MED, V356, P518, DOI 10.1056/NEJMcibr067022
   Hanai JI, 2007, J CLIN INVEST, V117, P3940, DOI 10.1172/JCI32741
   Handschin C, 2005, CELL, V122, P505, DOI 10.1016/j.cell.2005.06.040
   Handschin C, 2003, P NATL ACAD SCI USA, V100, P7111, DOI 10.1073/pnas.1232352100
   Handschin C., 2005, DRUG DISCOV TODAY TH, V2, P151
   Handschin C, 2008, NATURE, V454, P463, DOI 10.1038/nature07206
   Handschin C, 2007, J CLIN INVEST, V117, P3463, DOI 10.1172/JCI31785
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Handschin C, 2007, GENE DEV, V21, P770, DOI 10.1101/gad.1525107
   Handschin C, 2006, ENDOCR REV, V27, P728, DOI 10.1210/er.2006-0037
   Herzig S, 2001, NATURE, V413, P179, DOI 10.1038/35093131
   Housley MP, 2009, J BIOL CHEM, V284, P5148, DOI 10.1074/jbc.M808890200
   Huss JM, 2005, J CLIN INVEST, V115, P547, DOI 10.1172/JCI200524405
   Huss JM, 2004, CIRC RES, V95, P568, DOI 10.1161/01.RES.0000141774.29937.e3
   Jager S, 2007, P NATL ACAD SCI USA, V104, P12017, DOI 10.1073/pnas.0705070104
   Kajimura S, 2008, GENE DEV, V22, P1397, DOI 10.1101/gad.1666108
   Kawakami Y, 2005, P NATL ACAD SCI USA, V102, P2414, DOI 10.1073/pnas.0407510102
   Knutti D, 2001, P NATL ACAD SCI USA, V98, P9713, DOI 10.1073/pnas.171184698
   Koo SH, 2004, NAT MED, V10, P530, DOI 10.1038/nm1044
   Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013
   Lee Y, 2002, P NATL ACAD SCI USA, V99, P11848, DOI 10.1073/pnas.182420899
   Lehman JJ, 2000, J CLIN INVEST, V106, P847, DOI 10.1172/JCI10268
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Li DS, 2005, CELL, V122, P487, DOI 10.1016/j.cell.2005.08.010
   Li SM, 2009, AM J PHYSIOL-ENDOC M, V296, pE543, DOI 10.1152/ajpendo.90719.2008
   Li S, 2008, CELL METAB, V8, P105, DOI 10.1016/j.cmet.2008.06.013
   Li XH, 2007, NATURE, V447, P1012, DOI 10.1038/nature05861
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Lin JD, 2004, CELL, V119, P121, DOI 10.1016/j.cell.2004.09.013
   Lin JD, 2005, CELL METAB, V1, P361, DOI 10.1016/j.cmet.2005.05.004
   Lin JD, 2003, J BIOL CHEM, V278, P30843, DOI 10.1074/jbc.M303643200
   Lin JD, 2002, J BIOL CHEM, V277, P1645, DOI 10.1074/jbc.C100631200
   Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292
   Ling C, 2008, DIABETOLOGIA, V51, P615, DOI 10.1007/s00125-007-0916-5
   Lonard DM, 2007, MOL CELL, V27, P691, DOI 10.1016/j.molcel.2007.08.012
   McGill JK, 2006, CELL, V127, P465, DOI 10.1016/j.cell.2006.10.023
   Miura S, 2006, AM J PATHOL, V169, P1129, DOI 10.2353/ajpath.2006.060034
   Mootha VK, 2004, P NATL ACAD SCI USA, V101, P6570, DOI 10.1073/pnas.0401401101
   Mootha VK, 2003, NAT GENET, V34, P267, DOI 10.1038/ng1180
   Nervina JM, 2006, BONE, V39, P1018, DOI 10.1016/j.bone.2006.04.023
   Patti ME, 2003, P NATL ACAD SCI USA, V100, P8466, DOI 10.1073/pnas.1032913100
   Phillips JD, 2005, NAT MED, V11, P1049, DOI 10.1038/nm1005-1049
   Puigserver P, 1999, SCIENCE, V286, P1368, DOI 10.1126/science.286.5443.1368
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Puigserver P, 2001, MOL CELL, V8, P971, DOI 10.1016/S1097-2765(01)00390-2
   Puigserver P, 2003, NATURE, V423, P550, DOI 10.1038/nature01667
   Rhee J, 2003, P NATL ACAD SCI USA, V100, P4012, DOI 10.1073/pnas.0730870100
   Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354
   Ross CA, 2006, NAT MED, V12, P1239, DOI 10.1038/nm1106-1239
   Sandri M, 2006, P NATL ACAD SCI USA, V103, P16260, DOI 10.1073/pnas.0607795103
   Sano M, 2007, J BIOL CHEM, V282, P25970, DOI 10.1074/jbc.M703634200
   Savkur RS, 2005, MOL PHARMACOL, V68, P511, DOI 10.1124/mol.105.012708.
   Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001
   Semple RK, 2004, INT J OBESITY, V28, P176, DOI 10.1038/sj.ijo.0802482
   Shlomai A, 2006, P NATL ACAD SCI USA, V103, P16003, DOI 10.1073/pnas.0607837103
   Spiegelman BM, 2004, CELL, V119, P157, DOI 10.1016/j.cell.2004.09.037
   St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024
   Taherzadeh-Fard E, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-10
   Teyssier C, 2005, GENE DEV, V19, P1466, DOI 10.1101/gad.1295005
   Tiraby C, 2003, J BIOL CHEM, V278, P33370, DOI 10.1074/jbc.M305235200
   Uldry M, 2006, CELL METAB, V3, P333, DOI 10.1016/j.cmet.2006.04.002
   Wagner BK, 2008, NAT BIOTECHNOL, V26, P343, DOI 10.1038/nbt1387
   Wenz T, 2008, CELL METAB, V8, P249, DOI 10.1016/j.cmet.2008.07.006
   Weydt P, 2006, CELL METAB, V4, P349, DOI 10.1016/j.cmet.2006.10.004
   Wilson-Fritch L, 2004, J CLIN INVEST, V114, P1281, DOI 10.1172/JCI200421752
   Wu ZD, 1999, CELL, V98, P115, DOI 10.1016/S0092-8674(00)80611-X
   Yang XL, 2003, OBES RES, V11, P1182, DOI 10.1038/oby.2003.163
   Yoon JC, 2003, DEV CELL, V5, P73, DOI 10.1016/S1534-5807(03)00170-9
   Yoon JC, 2001, NATURE, V413, P131, DOI 10.1038/35093050
   Zirngibl RA, 2008, J MOL ENDOCRINOL, V40, P61, DOI 10.1677/JME-07-0114
NR 87
TC 79
Z9 82
U1 1
U2 15
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0165-6147
J9 TRENDS PHARMACOL SCI
JI Trends Pharmacol. Sci.
PD JUN
PY 2009
VL 30
IS 6
BP 322
EP 329
DI 10.1016/j.tips.2009.03.006
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 463SD
UT WOS:000267451400007
PM 19446346
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Kayser, H
   Mann, K
   Machaidze, G
   Nimtz, M
   Ringler, P
   Muller, SA
   Aebi, U
AF Kayser, Hartmut
   Mann, Karlheinz
   Machaidze, Gia
   Nimtz, Manfred
   Ringler, Philippe
   Mueller, Shirley A.
   Aebi, Ueli
TI Isolation, Characterisation and Molecular Imaging of a
   High-Molecular-Weight Insect Biliprotein, a Member of the Hexameric
   Arylphorin Protein Family
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE hexamerin; arylphorin; biliprotein; 3D reconstruction; glycoprotein
ID AMINO-ACID-SEQUENCE; STEM-CELL PROLIFERATION; BILIN-BINDING-PROTEIN;
   JUVENILE-HORMONE; PIERIS-BRASSICAE; STORAGE PROTEINS; MANDUCA-SEXTA;
   MONOGLUCOSYLATED OLIGOSACCHARIDE; QUATERNARY STRUCTURE;
   RIPTORTUS-CLAVATUS
AB The abundant blue hemolymph protein of the last instar larvae of the moth Cerura vinula Was purified and characterized by protein-analytical, spectroscopic and electron microscopic methods. Amino acid sequences obtained from a large number of cleavage peptides revealed a high level of similarity of the blue protein with arylphorins from a number of other moth species. In particular, there is a high abundance of the aromatic amino acids tyrosine and phenylalanine amounting to about 19% of total an-Lino acids and a low content of methionine (0.8%) in the Cerura protein. The mass of the native protein complex was studied by size-exclusion chromatography, analytical Ultracentrifugation, dynamic light scattering and scanning transmission electron microscopy and found to be around 500 kDa. Denaturating gel electrophoresis and mass spectrometry Suggested the presence of two proteins with masses of about 85 kDa. The native Cerura protein is, therefore, a hexameric complex of two different subunits of similar size, as is known for arylphorins. The protein was further characterized as a weakly acidic (pI similar to 5.5) glycoprotein containing mannose, glucose and N-acetylglucosamine in an approximate ratio of 10:1:1. The structure proposed for the most abundant oligosaccharide of the Cerura arylphorin was the same as already identified in arylphorins from other moths. The intense blue colour of the Cerura protein is due to non-covalent association with a bilin of novel structure at an estimated protein subunit-to-ligand ratio of 3:1. Transmission electron microscopy of the biliprotein showed single particles of cylindrical shape measuring about 13 nm in diameter and 9 nm in height. A small fraction of particles of the same diameter but half the height was likely a trimeric arylphorin dissociation intermediate. Preliminary three-dimensional reconstruction based on averaged transmission electron microscopy projections of the individual particles revealed a double-trimeric structure for the hexameric Cerin-a biliprotein complex, suggesting it to be a dimer of trimers. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Kayser, Hartmut] Univ Ulm, Inst Allgemeine Zool & Endokrinol, D-89069 Ulm, Germany.
   [Mann, Karlheinz] Max Planck Inst Biochem, Abt Prot & Signaltransdukt, D-82152 Martinsried, Germany.
   [Machaidze, Gia; Ringler, Philippe; Mueller, Shirley A.; Aebi, Ueli] Univ Basel, Biozentrum, Maurice E Muller Inst Strukturbiol, CH-4056 Basel, Switzerland.
   [Nimtz, Manfred] Infek Forsch GmbH, Helmholtz Zentrum, D-38124 Braunschweig, Germany.
RP Kayser, H (corresponding author), Univ Ulm, Inst Allgemeine Zool & Endokrinol, Albert Einstein Allee 11, D-89069 Ulm, Germany.
EM hartmut.kayser@uni-ulm.de
RI Mann, Karlheinz/C-4254-2008
FU Maurice E. Muller Institute of Switzerland; Swiss National
   FoundationSwiss National Science Foundation (SNSF) [SNF 501 221]
FX We thank Ariel Lustig for studying CBP by analytical ultracentrifugation
   and Lars Prade for data from dynamic light scattering. STEM was
   supported by the Maurice E. Muller Institute of Switzerland and Swiss
   National Foundation grant number SNF 501 221 to Andreas Engel who we
   thank for aiding this project.
CR ANUMULA KR, 1992, ANAL BIOCHEM, V203, P101, DOI 10.1016/0003-2697(92)90048-C
   Ashfaq M, 2007, ARCH INSECT BIOCHEM, V64, P175, DOI 10.1002/arch.20168
   BEINTEMA JJ, 1994, MOL BIOL EVOL, V11, P493
   BENCZE WL, 1957, ANAL CHEM, V29, P1193, DOI 10.1021/ac60128a025
   Beresford PJ, 1997, DEV COMP IMMUNOL, V21, P253, DOI 10.1016/S0145-305X(97)00011-6
   Bitondi MMG, 2006, ARCH INSECT BIOCHEM, V63, P57, DOI 10.1002/arch.20142
   Blackburn MB, 2004, ARCH INSECT BIOCHEM, V55, P26, DOI 10.1002/arch.10119
   Braun RP, 1996, J BIOL CHEM, V271, P31756, DOI 10.1074/jbc.271.49.31756
   Burmester T, 1999, EUR J ENTOMOL, V96, P213
   Burmester T, 1998, J MOL EVOL, V47, P93, DOI 10.1007/PL00006366
   Burmester T, 2007, J INSECT PHYSIOL, V53, P285, DOI 10.1016/j.jinsphys.2006.12.006
   CHAPLIN MF, 1982, ANAL BIOCHEM, V123, P336, DOI 10.1016/0003-2697(82)90455-9
   CHINZEI Y, 1990, INSECT BIOCHEM, V20, P545, DOI 10.1016/0020-1790(90)90066-4
   DONOVAN JW, 1964, BIOCHEMISTRY-US, V3, P67, DOI 10.1021/bi00889a012
   EDSALL JT, 1953, PROTEINS, P549
   FUJII T, 1989, J BIOL CHEM, V264, P11020
   Goodwin T. W., 1946, BIOCHEM JOUR, V40, P628
   Hagner-Holler S, 2007, INSECT BIOCHEM MOLEC, V37, P1064, DOI 10.1016/j.ibmb.2007.06.001
   Hakim RS, 2007, ARCH INSECT BIOCHEM, V64, P63, DOI 10.1002/arch.20155
   HAUNERLAND NH, 1986, INSECT BIOCHEM, V16, P617, DOI 10.1016/0020-1790(86)90004-1
   HOLDEN HM, 1987, EMBO J, V6, P1565, DOI 10.1002/j.1460-2075.1987.tb02401.x
   HUBER R, 1987, J MOL BIOL, V198, P499, DOI 10.1016/0022-2836(87)90296-8
   Hughes AL, 1999, IMMUNOGENETICS, V49, P106, DOI 10.1007/s002510050469
   Jamroz RC, 1996, J INSECT PHYSIOL, V42, P115, DOI 10.1016/0022-1910(95)00093-3
   JONES G, 1990, J BIOL CHEM, V265, P8596
   Jung HI, 2005, BIOCHEM BIOPH RES CO, V331, P100, DOI 10.1016/j.bbrc.2005.02.192
   Kayser H., 1985, P367
   KAYSER H, 2005, COMPREHENSIVE MOL IN, V4, P267
   Kim S, 2003, GLYCOBIOLOGY, V13, P147, DOI 10.1093/glycob/cwg023
   KRAMER SJ, 1980, INSECT BIOCHEM, V10, P279, DOI 10.1016/0020-1790(80)90023-2
   Levenbook L., 1985, P307
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Machaidze Gia, 2006, Journal of Biological Physics and Chemistry, V6, P91
   MAGEE J, 1994, ARCH INSECT BIOCHEM, V25, P137, DOI 10.1002/arch.940250206
   MAGNUS KA, 1991, PROTEINS, V9, P240, DOI 10.1002/prot.340090403
   Mann K, 2004, BBA-PROTEINS PROTEOM, V1696, P41, DOI 10.1016/j.bbapap.2003.09.006
   MARKL J, 1992, J COMP PHYSIOL B, V162, P665, DOI 10.1007/BF00301616
   McDonagh AF, 1979, PORPHYRINS, P293
   Meissner U, 2003, J MOL BIOL, V325, P99, DOI 10.1016/S0022-2836(02)01173-7
   MEMMEL NA, 1992, INSECT BIOCHEM MOLEC, V22, P333, DOI 10.1016/0965-1748(92)90071-L
   Miura K, 1998, EUR J BIOCHEM, V258, P929, DOI 10.1046/j.1432-1327.1998.2580929.x
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   MUNN EA, 1971, BIOCHEM J, V124, P367, DOI 10.1042/bj1240367
   Nimtz M, 2004, BBA-GEN SUBJECTS, V1675, P71, DOI 10.1016/j.bbagen.2004.08.007
   PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444
   Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084
   RYAN RO, 1985, J BIOL CHEM, V260, P782
   RYAN RO, 1985, ARCH BIOCHEM BIOPHYS, V243, P115, DOI 10.1016/0003-9861(85)90779-9
   SCHEER H, 1988, Z NATURFORSCH C, V43, P84
   Schuck P, 2000, BIOPHYS J, V78, P1606, DOI 10.1016/S0006-3495(00)76713-0
   Smagghe G, 2005, ANN NY ACAD SCI, V1040, P472, DOI 10.1196/annals.1327.094
   SUTER F, 1988, BIOL CHEM H-S, V369, P497, DOI 10.1515/bchm3.1988.369.1.497
   TELFER WH, 1991, ANNU REV ENTOMOL, V36, P205, DOI 10.1146/annurev.en.36.010191.001225
   TELFER WH, 1983, INSECT BIOCHEM, V13, P601, DOI 10.1016/0020-1790(83)90034-3
   TOJO S, 1980, INSECT BIOCHEM, V10, P289, DOI 10.1016/0020-1790(80)90024-4
   Tomiya N, 2004, GLYCOCONJUGATE J, V21, P343, DOI 10.1023/B:GLYC.0000046275.28315.87
   VOLBEDA A, 1989, J MOL BIOL, V209, P249, DOI 10.1016/0022-2836(89)90276-3
   WICHERTJES T, 1989, EUR J BIOCHEM, V184, P287, DOI 10.1111/j.1432-1033.1989.tb15018.x
   Zheng YP, 2000, APPL ENTOMOL ZOOL, V35, P31, DOI 10.1303/aez.2000.31
   Zhou X, 2006, GENE, V376, P47, DOI 10.1016/j.gene.2006.02.002
   Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103
NR 61
TC 9
Z9 9
U1 0
U2 8
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAY 29
PY 2009
VL 389
IS 1
BP 74
EP 89
DI 10.1016/j.jmb.2009.03.075
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 457LR
UT WOS:000266930500007
PM 19361516
DA 2021-01-25
ER

PT J
AU Habazettl, J
   Reiner, A
   Kiefhaber, T
AF Habazettl, Judith
   Reiner, Andreas
   Kiefhaber, Thomas
TI NMR Structure of a Monomeric Intermediate on the Evolutionarily
   Optimized Assembly Pathway of a Small Trimerization Domain
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE protein folding; protein assembly; NMR structure; protein-protein
   interaction; fibritin
ID SEGMENTED COILED-COIL; BACTERIOPHAGE-T4 FIBRITIN; CHEMICAL-SHIFTS;
   PROTEIN STRUCTURES; SINGLE-DOMAIN; CONFORMATION; ASSOCIATION; STABILITY;
   DYNAMICS; KINETICS
AB Efficient formation of specific intermolecular interactions is essential for self-assembly of biological structures. Pie foldon domain is an evolutionarily optimized trimerization module required for assembly of the large, trimeric structural protein fibritin from phage T4. Monomers consisting of the 27 amino acids comprising a single foldon domain subunit spontaneously form a natively folded trimer. During assembly of the foldon domain, a monomeric intermediate is formed on the submillisecond time scale, which provides the basis for two consecutive very fast association reactions. Mutation of an intermolecular salt bridge leads to a monomeric protein that resembles the kinetic intermediate in its spectroscopic properties. NMR spectroscopy revealed essentially native topology of the monomeric intermediate with defined hydrogen bonds and side-chain interactions but largely reduced stability compared to the native trimer. This structural preorganization leads to an asymmetric charge distribution Oil the surface that can direct rapid Subunit recognition. The low stability of the intermediate allows a large free-energy gain upon trimerization, which serves as driving force for rapid assembly. These results indicate different free-energy landscapes for folding of small oligomeric proteins compared to monomeric proteins, which typically avoid the transient population of intermediates. (C) 2009 Elsevier Ltd. All rights reserved.
C1 [Reiner, Andreas; Kiefhaber, Thomas] Tech Univ Munich, Lehrstuhl Biophys Chem, D-85747 Garching, Germany.
   [Reiner, Andreas; Kiefhaber, Thomas] Tech Univ Munich, Munich Ctr Integrated Prot Sci, Dept Chem, D-85747 Garching, Germany.
   [Habazettl, Judith] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Tech Univ Munich, Lehrstuhl Biophys Chem, Lichtenbergstr 4, D-85747 Garching, Germany.
EM t.kiefhaber@tum.de
RI Reiner, Andreas/E-4897-2011; Kiefhaber, Thomas/A-3028-2010
OI Reiner, Andreas/0000-0003-0802-7278; 
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Munich Center for Integrated Protein Science
FX This work was supported by grants from the Swiss National Science
   Foundation and by the Munich Center for Integrated Protein Science.
CR Bachmann A, 2001, J MOL BIOL, V306, P375, DOI 10.1006/jmbi.2000.4399
   BAX A, 1985, J MAGN RESON, V61, P306, DOI 10.1016/0022-2364(85)90085-X
   Baxter NJ, 1997, J BIOMOL NMR, V9, P359, DOI 10.1023/A:1018334207887
   BEGLOV D, 1995, BIOPOLYMERS, V35, P171, DOI 10.1002/bip.360350205
   Bosshard HR, 2005, PROTEIN FOLDING HANDBOOK, P965, DOI 10.1002/9783527619498.ch27
   Boudko SP, 2002, EUR J BIOCHEM, V269, P833, DOI 10.1046/j.1432-1033.2002.02734.x
   BUNDI A, 1979, BIOPOLYMERS, V18, P285, DOI 10.1002/bip.1979.360180206
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   EVANS PA, 1991, PROTEINS, V9, P248, DOI 10.1002/prot.340090404
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   GILL SC, 1989, ANAL BIOCHEM, V182, P319, DOI 10.1016/0003-2697(89)90602-7
   Goddard T. D., SPARKY 3
   GOTO Y, 1991, J MOL BIOL, V222, P679, DOI 10.1016/0022-2836(91)90504-Y
   Grzesiek S, 1997, PROTEIN SCI, V6, P1248, DOI 10.1002/pro.5560060613
   GUNTERT P, 1991, J MOL BIOL, V217, P517, DOI 10.1016/0022-2836(91)90754-T
   Guthe S, 2004, J MOL BIOL, V337, P905, DOI 10.1016/j.jmb.2004.02.020
   HOLLAND DR, 1992, BIOCHEMISTRY-US, V31, P11310, DOI 10.1021/bi00161a008
   Ishima R, 1999, J BIOMOL NMR, V14, P369, DOI 10.1023/A:1008324025406
   Jackson SE, 1998, FOLD DES, V3, pR81, DOI 10.1016/S1359-0278(98)00033-9
   JORGENSEN WL, 1988, J AM CHEM SOC, V110, P1657, DOI 10.1021/ja00214a001
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Koradi R, 1996, J MOL GRAPHICS, V14, P51, DOI 10.1016/0263-7855(96)00009-4
   Letarov AV, 1999, BIOCHEMISTRY-MOSCOW+, V64, P817
   Linge JP, 2003, PROTEINS, V50, P496, DOI 10.1002/prot.10299
   Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079
   MILLA ME, 1994, BIOCHEMISTRY-US, V33, P1125, DOI 10.1021/bi00171a011
   Miroshnikov KA, 1998, PROTEIN ENG, V11, P329, DOI 10.1093/protein/11.4.329
   Papanikolopoulou K, 2004, J MOL BIOL, V342, P219, DOI 10.1016/j.jmb.2004.07.008
   PARDI A, 1983, EUR J BIOCHEM, V137, P445, DOI 10.1111/j.1432-1033.1983.tb07848.x
   PENG JW, 1992, BIOCHEMISTRY-US, V31, P8571, DOI 10.1021/bi00151a027
   PERKINS SJ, 1979, BIOCHIM BIOPHYS ACTA, V576, P409, DOI 10.1016/0005-2795(79)90416-1
   PIOTTO M, 1992, J BIOMOL NMR, V2, P661, DOI 10.1007/BF02192855
   RAIFORD DS, 1979, ANAL CHEM, V51, P2050, DOI 10.1021/ac50048a040
   Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5
   Schreiber G, 1996, NAT STRUCT BIOL, V3, P427, DOI 10.1038/nsb0596-427
   Schwarzinger S, 2001, J AM CHEM SOC, V123, P2970, DOI 10.1021/ja003760i
   Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9
   Tao YZ, 1997, STRUCTURE, V5, P789, DOI 10.1016/S0969-2126(97)00233-5
   Wagner C, 1999, P NATL ACAD SCI USA, V96, P6716, DOI 10.1073/pnas.96.12.6716
   WENDT H, 1995, BIOCHEMISTRY-US, V34, P4097, DOI 10.1021/bi00012a028
   WISHART DS, 1994, J BIOMOL NMR, V4, P171
   WUTHRICH K, 1983, J MOL BIOL, V169, P949, DOI 10.1016/S0022-2836(83)80144-2
   WUTHRICH K, 1984, J MOL BIOL, V180, P715, DOI 10.1016/0022-2836(84)90034-2
   Yang XZ, 2002, J VIROL, V76, P4634, DOI 10.1128/JVI.76.9.4634-4642.2002
NR 44
TC 16
Z9 17
U1 0
U2 11
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAY 29
PY 2009
VL 389
IS 1
BP 103
EP 114
DI 10.1016/j.jmb.2009.03.073
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 457LR
UT WOS:000266930500009
PM 19361528
DA 2021-01-25
ER

PT J
AU Benkert, P
   Schwede, T
   Tosatto, SCE
AF Benkert, Pascal
   Schwede, Torsten
   Tosatto, Silvio C. E.
TI QMEANclust: estimation of protein model quality by combining a composite
   scoring function with structural density information
SO BMC STRUCTURAL BIOLOGY
LA English
DT Article
ID STRUCTURE PREDICTION; STATISTICAL POTENTIALS; TERTIARY STRUCTURES;
   HOMOLOGY MODELS; MEAN FORCE; ALIGNMENT; RECOGNITION; SEQUENCE; TASSER;
   ENERGY
AB Background: The selection of the most accurate protein model from a set of alternatives is a crucial step in protein structure prediction both in template-based and ab initio approaches. Scoring functions have been developed which can either return a quality estimate for a single model or derive a score from the information contained in the ensemble of models for a given sequence. Local structural features occurring more frequently in the ensemble have a greater probability of being correct. Within the context of the CASP experiment, these so called consensus methods have been shown to perform considerably better in selecting good candidate models, but tend to fail if the best models are far from the dominant structural cluster. In this paper we show that model selection can be improved if both approaches are combined by pre-filtering the models used during the calculation of the structural consensus.
   Results: Our recently published QMEAN composite scoring function has been improved by including an all-atom interaction potential term. The preliminary model ranking based on the new QMEAN score is used to select a subset of reliable models against which the structural consensus score is calculated. This scoring function called QMEANclust achieves a correlation coefficient of predicted quality score and GDT_TS of 0.9 averaged over the 98 CASP7 targets and perform significantly better in selecting good models from the ensemble of server models than any other groups participating in the quality estimation category of CASP7. Both scoring functions are also benchmarked on the MOULDER test set consisting of 20 target proteins each with 300 alternatives models generated by MODELLER. QMEAN outperforms all other tested scoring functions operating on individual models, while the consensus method QMEANclust only works properly on decoy sets containing a certain fraction of near-native conformations. We also present a local version of QMEAN for the per-residue estimation of model quality (QMEANlocal) and compare it to a new local consensus-based approach.
   Conclusion: Improved model selection is obtained by using a composite scoring function operating on single models in order to enrich higher quality models which are subsequently used to calculate the structural consensus. The performance of consensus-based methods such as QMEANclust highly depends on the composition and quality of the model ensemble to be analysed. Therefore, performance estimates for consensus methods based on large meta-datasets (e. g. CASP) might overrate their applicability in more realistic modelling situations with smaller sets of models based on individual methods.
C1 [Benkert, Pascal; Schwede, Torsten] Univ Basel, Biozentrum, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Tosatto, Silvio C. E.] Univ Padua, Dept Biol, I-35121 Padua, Italy.
RP Benkert, P (corresponding author), Univ Basel, Biozentrum, Swiss Inst Bioinformat, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM pascal.benkert@unibas.ch; torsten.schwede@unibas.ch;
   silvio.tosatto@unipd.it
RI Tosatto, Silvio/B-2840-2009; Benkert, Pascal/C-3895-2009; Schwede,
   Torsten/A-4650-2008
OI Tosatto, Silvio/0000-0003-4525-7793; Schwede,
   Torsten/0000-0003-2715-335X
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF); Swiss Institute of Bioinformatics (SIB)
FX We thank James N. Battey for proofreading. We are grateful to Andrej
   Sali and Marc Marti-Renom for giving access to the MOULDER test set and
   Hongyi Zhou and Jeffrey Skolnick for providing the data of TASSER-QA. We
   would like to acknowledge financial support by the Swiss National
   Science Foundation (SNF) and by the Swiss Institute of Bioinformatics
   (SIB).
CR Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659
   Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761
   BENKERT P, 2009, NUCL ACIDS IN PRESS
   Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715
   Chen H, 2008, PROTEINS, V71, P1255, DOI 10.1002/prot.21819
   Cheng JL, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-18
   CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x
   Cozzetto D, 2007, PROTEINS, V69, P175, DOI 10.1002/prot.21669
   Cristobal S, 2001, BMC BIOINFORMATICS, V2, DOI 10.1186/1471-2105-2-5
   Dominy BN, 2002, J COMPUT CHEM, V23, P147, DOI 10.1002/jcc.10018
   Eramian D, 2008, PROTEIN SCI, V17, P1881, DOI 10.1110/ps.036061.108
   Eramian D, 2006, PROTEIN SCI, V15, P1653, DOI 10.1110/ps.062095806
   Fasnacht M, 2007, PROTEIN SCI, V16, P1557, DOI 10.1110/ps.072856307
   FERNANDEZFUENTE.N, 2007, NUCLEIC ACIDS RES, pW363
   Fischer D, 2006, CURR OPIN STRUC BIOL, V16, P178, DOI 10.1016/j.sbi.2006.03.004
   Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124
   Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI DOI 10.1080/10618600.1996.10474713
   John B, 2003, NUCLEIC ACIDS RES, V31, P3982, DOI 10.1093/nar/gkg460
   JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0
   Joo K, 2007, PROTEINS, V69, P83, DOI 10.1002/prot.21628
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lazaridis T, 1999, J MOL BIOL, V288, P477, DOI 10.1006/jmbi.1999.2685
   Lu H, 2001, PROTEINS, V44, P223, DOI 10.1002/prot.1087
   Lundstrom J, 2001, PROTEIN SCI, V10, P2354, DOI 10.1110/ps.08501
   LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0
   McGuffin LJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-345
   Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665
   Melo F, 2002, PROTEIN SCI, V11, P430, DOI 10.1002/pro.110430
   Moult J, 2007, PROTEINS, V69, P3, DOI 10.1002/prot.21767
   Petrey D, 2003, PROTEINS, V53, P430, DOI 10.1002/prot.10550
   Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249
   Qiu J, 2008, PROTEINS, V71, P1175, DOI 10.1002/prot.21809
   SALI A, 1995, MOL MED TODAY, V1, P270, DOI 10.1016/s1357-4310(95)91170-7
   Samudrala R, 1998, J MOL BIOL, V275, P895, DOI 10.1006/jmbi.1997.1479
   SAQI MAS, 1992, PROTEIN ENG, V5, P305, DOI 10.1093/protein/5.4.305
   Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606
   Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158
   Siew N, 2000, BIOINFORMATICS, V16, P776, DOI 10.1093/bioinformatics/16.9.776
   Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959
   Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623
   SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404
   SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4
   Sommer I, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-364
   Thorsteinsdottir HB, 2006, PROTEINS, V65, P407, DOI 10.1002/prot.21096
   Tosatto SCE, 2005, J COMPUT BIOL, V12, P1316, DOI 10.1089/cmb.2005.12.1316
   Tress ML, 2003, J MOL BIOL, V330, P705, DOI 10.1016/S0022-2836(03)00622-3
   Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606
   Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803
   Wallner B, 2007, PROTEINS, V69, P184, DOI 10.1002/prot.21774
   Wang Kai, 2004, BMC Structural Biology, V4
   Wu ST, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-17
   Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699
   Yang YD, 2008, PROTEINS, V73, P581, DOI 10.1002/prot.22082
   Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571
   Zhang Y, 2005, PROTEINS, V61, P91, DOI 10.1002/prot.20724
   Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264
   Zhou H, 2008, PROTEINS, V71, P1211, DOI 10.1002/prot.21813
   Zhou HY, 2007, PROTEINS, V69, P90, DOI 10.1002/prot.21649
   Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002
NR 63
TC 112
Z9 117
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
EI 1472-6807
J9 BMC STRUCT BIOL
JI BMC Struct. Biol.
PD MAY 20
PY 2009
VL 9
AR 35
DI 10.1186/1472-6807-9-35
PG 17
WC Biophysics
SC Biophysics
GA 472PN
UT WOS:000268144200001
PM 19457232
OA Green Published, Other Gold
DA 2021-01-25
ER

PT J
AU Gaitanos, TN
   Santamaria, A
   Jeyaprakash, AA
   Wang, B
   Conti, E
   Nigg, EA
AF Gaitanos, Thomas N.
   Santamaria, Anna
   Jeyaprakash, A. Arockia
   Wang, Bin
   Conti, Elena
   Nigg, Erich A.
TI Stable kinetochore-microtubule interactions depend on the Ska complex
   and its new component Ska3/C13Orf3
SO EMBO JOURNAL
LA English
DT Article
DE chromosome congression; kinetochore; microtubule-attachment; mitosis
ID SPINDLE-ASSEMBLY CHECKPOINT; HUMAN MITOTIC SPINDLE; RNA EXPORT FACTOR;
   TYROSINE PHOSPHORYLATION; PHOSPHOPROTEOME ANALYSIS; CHROMOSOME
   ALIGNMENT; OUTER KINETOCHORE; CELLS; PROTEIN; ATTACHMENT
AB Ska1 and Ska2 form a complex at the kinetochore-microtubule (KT-MT) interface and are required for timely progression from metaphase to anaphase. Here, we use mass spectrometry to search for additional components of the Ska complex. We identify C13Orf3 (now termed Ska3) as a novel member of this complex and map the interaction domains among the three known components. Ska3 displays similar characteristics as Ska1 and Ska2: it localizes to the spindle and KT throughout mitosis and its depletion markedly delays anaphase transition. Interestingly, a more complete removal of the Ska complex by concomitant depletion of Ska1 and Ska3 results in a chromosome congression failure followed by cell death. This severe phenotype reflects a destabilization of KT-MT interactions, as demonstrated by reduced cold stability of KT fibres. Yet, the depletion of the Ska complex only marginally impairs KT localization of the KMN network responsible for MT attachment. We propose that the Ska complex functionally complements the KMN, providing an additional layer of stability to KT-MT attachment and possibly signalling completion of attachment to the spindle checkpoint. The EMBO Journal (2009) 28, 1442-1452. doi:10.1038/emboj.2009.96; Published online 9 April 2009
C1 [Gaitanos, Thomas N.; Santamaria, Anna; Wang, Bin; Nigg, Erich A.] Max Planck Inst Biochem, Dept Cell Biol, D-82152 Martinsried, Germany.
   [Jeyaprakash, A. Arockia; Conti, Elena] Max Planck Inst Biochem, Dept Struct Cell Biol, D-82152 Martinsried, Germany.
   [Nigg, Erich A.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Nigg, EA (corresponding author), Max Planck Inst Biochem, Dept Cell Biol, Klopferspitz 18, D-82152 Martinsried, Germany.
EM erich.nigg@unibas.ch
RI Arulanandam, Arockia Jeyaprakash/Y-5885-2019
OI Arulanandam, Arockia Jeyaprakash/0000-0002-1889-8635; nigg,
   erich/0000-0003-4835-5719
FU Max Planck SocietyMax Planck SocietyFoundation CELLEX; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB 646];
   European CommissionEuropean CommissionEuropean Commission Joint Research
   Centre [LSHG-CT-2005-518254]; Spanish Education and Science
   MinistrySpanish Government; Chinese Academy of SciencesChinese Academy
   of Sciences
FX We thank Mitsuhiro Yanagida (Kyoto University) for the Blinkin antibody.
   We are thankful to Anja Wehner for excellent technical assistance, Luca
   Fava for help with gel filtration, Rainer Malik for bioinformatic
   support and Roman Korner for mass spectrometry guidance. We gratefully
   acknowledge Stefan Hummer, Lily Wang and Sabine Elowe for helpful
   discussions. This work was supported by the Max Planck Society, the
   Deutsche Forschungsgemeinschaft (SFB 646), and ENFIN, a Network of
   Excellence funded by the European Commission within its FP6 Programme
   (contract number LSHG-CT-2005-518254). AS is supported by a postdoctoral
   fellowship from the Spanish Education and Science Ministry. BW is
   partially supported by the Chinese Academy of Sciences.
CR Brill LM, 2004, ANAL CHEM, V76, P2763, DOI 10.1021/ac035352d
   Cheeseman IM, 2008, NAT REV MOL CELL BIO, V9, P33, DOI 10.1038/nrm2310
   Cheeseman IM, 2006, CELL, V127, P983, DOI 10.1016/j.cell.2006.09.039
   Cheeseman IM, 2004, GENE DEV, V18, P2255, DOI 10.1101/gad.1234104
   Cheeseman IM, 2001, J CELL BIOL, V152, P197, DOI 10.1083/jcb.152.1.197
   Ciferri C, 2008, CELL, V133, P427, DOI 10.1016/j.cell.2008.03.020
   Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6
   Cole C, 2008, NUCLEIC ACIDS RES, V36, pW197, DOI 10.1093/nar/gkn238
   Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007
   DeLuca JG, 2002, J CELL BIOL, V159, P549, DOI 10.1083/jcb.200208159
   DeLuca JG, 2005, MOL BIOL CELL, V16, P519, DOI 10.1091/mbc.E04-09-0852
   Dephoure N, 2008, P NATL ACAD SCI USA, V105, P10762, DOI 10.1073/pnas.0805139105
   Elbashir SM, 2001, NATURE, V411, P494, DOI 10.1038/35078107
   Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007
   Griffis ER, 2007, J CELL BIOL, V177, P1005, DOI 10.1083/jcb.200702062
   Hanisch A, 2006, EMBO J, V25, P5504, DOI 10.1038/sj.emboj.7601426
   Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031
   Karess R, 2005, TRENDS CELL BIOL, V15, P386, DOI 10.1016/j.tcb.2005.05.003
   Kiyomitsu T, 2007, DEV CELL, V13, P663, DOI 10.1016/j.devcel.2007.09.005
   Kline SL, 2006, J CELL BIOL, V173, P9, DOI 10.1083/jcb.200509158
   Lampson MA, 2005, NAT CELL BIOL, V7, P93, DOI 10.1038/ncb1208
   Larsen NA, 2007, P NATL ACAD SCI USA, V104, P1201, DOI 10.1073/pnas.0610358104
   Maiato H, 2004, J CELL SCI, V117, P5461, DOI 10.1242/jcs.01536
   Martin-Lluesma S, 2002, SCIENCE, V297, P2267, DOI 10.1126/science.1075596
   Matsumura S, 2007, J BIOL CHEM, V282, P15217, DOI 10.1074/jbc.M611053200
   McEwen BF, 1998, CHROMOSOMA, V107, P366, DOI 10.1007/s004120050320
   Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163
   Nousiainen M, 2006, P NATL ACAD SCI USA, V103, P5391, DOI 10.1073/pnas.0507066103
   Obuse C, 2004, NAT CELL BIOL, V6, P1135, DOI 10.1038/ncb1187
   Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005
   Pritchard CEJ, 1999, J CELL BIOL, V145, P237, DOI 10.1083/jcb.145.2.237
   Rappsilber J, 2003, ANAL CHEM, V75, P663, DOI 10.1021/ac026117i
   RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368
   Rines DR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r44
   Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046
   Sauer G, 2005, MOL CELL PROTEOMICS, V4, P35, DOI 10.1074/mcp.M400158-MCP200
   Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h
   Sillje HHW, 2006, CURR BIOL, V16, P731, DOI 10.1016/j.cub.2006.02.070
   Stehman SA, 2007, J CELL BIOL, V178, P583, DOI 10.1083/jcb.200610112
   Sui SH, 2008, PROTEOMICS, V8, P2024, DOI 10.1002/pmic.200700896
   Toso A, 2009, J CELL BIOL, V184, P365, DOI 10.1083/jcb.200809055
   Wang XS, 2001, J BIOL CHEM, V276, P26559, DOI 10.1074/jbc.M101083200
   Westermann S, 2007, ANNU REV BIOCHEM, V76, P563, DOI 10.1146/annurev.biochem.76.052705.160607
   Yamamoto TG, 2008, J CELL BIOL, V183, P187, DOI 10.1083/jcb.200805185
   Yang ZY, 2007, CURR BIOL, V17, P973, DOI 10.1016/j.cub.2007.04.056
NR 45
TC 140
Z9 145
U1 0
U2 4
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD MAY 20
PY 2009
VL 28
IS 10
BP 1442
EP 1452
DI 10.1038/emboj.2009.96
PG 11
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 448EV
UT WOS:000266246800008
PM 19360002
OA Green Published
DA 2021-01-25
ER

PT J
AU Grieder, NC
   Morata, G
   Affolter, M
   Gehring, WJ
AF Grieder, Nicole C.
   Morata, Gines
   Affolter, Markus
   Gehring, Walter J.
TI Spalt major controls the development of the notum and of wing hinge
   primordia of the Drosophila melanogaster wing imaginal disc
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Spalt major; Spalt related; Notum; Wing hinge; Imaginal disc patterning;
   Wing disc
ID GENE-FUNCTION; CELL FATE; DUAL ROLE; COMPLEX; BODY; EXPRESSION; DORSAL;
   SPECIFICATION; MECHANISMS; IDENTITY
AB The Drosophila wing and the dorsal thorax develop from primordia within the wing imaginal disc. Here we show that spalt major (salm) is expressed within the presumptive dorsal body wall primordium early in wing disc development to specify notum and wing hinge tissue. Upon ectopic salm expression, dorsally located second leg disc cells develop notum and wing hinge tissue instead of sternopleural tissue. Similarly, by salm over-expression within the wing disc, wing blade formation is suppressed and a mirror-image duplication of the notum and wing hinge is formed. in large dorsal clones, which lack saint and its neighboring paralogue spalt related (salr), the cells of the notum primordium do not grow; these dorsal cells are not specified as notum, hence no notum outgrowth develops. These results suggest that the zinc finger factors encoded by the salm/salr complex play important roles in defining cells of the early wing disc as dorsal body wall cells, which develop into a large dorsal body wall territory and form mesonotum and some wing hinge tissue, and in delimiting the wing primordium. We also find that salm activity is down-regulated by its own product and by that of the Pax gene eyegone. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Grieder, Nicole C.; Affolter, Markus; Gehring, Walter J.] Univ Basel, Biozentrum, Abt Zellbiol, CH-4056 Basel, Switzerland.
   [Morata, Gines] Univ Autonoma Madrid, Ctr Biol Mol, E-28049 Madrid, Spain.
RP Grieder, NC (corresponding author), NICHD, NIH, 18 Lib Dr,Bldg 32,Rm 103, Bethesda, MD 20892 USA.
EM griedern@gmail.nih.gov
OI Morata, Gines/0000-0003-3274-5173; Affolter, Markus/0000-0002-5171-0016
FU Kantons Basel-Stadt and Basel-Land; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); Treubel-Fonds, Basel
FX We thank Natalia Azpiazu and Reinhard Schuh for antibodies. The
   monoclonal antibody against Wg developed by S.M. Cohen was obtained from
   the Developmental Studies Hybridoma Bank developed under the auspices of
   the NICHD and maintained by The University of Iowa. We thank David del
   Alamo Rodriguez, Konrad Basler, Bruno Bello, Clemens Cabernard, Sean
   Carroll, Stephen Cohen, Susanne Flister, George Haider, Richard Mann,
   Juan Modolell, Mark Neumann, Pernille Rorth Ulrich Schafer, Reinhard
   Schuh, Y. Henry Sun and the Bloomington Stock Center for many fly lines
   or plasmids. We thank Paul Baumgartner for advice on construction of the
   phage library. We thank Veronique Charpignon and Salome Rock for
   comments on the manuscript. This work was supported by the Kantons
   Basel-Stadt and Basel-Land, the Swiss National Science Foundation and
   the Treubel-Fonds, Basel.
CR Aldaz S, 2003, DEVELOPMENT, V130, P4473, DOI 10.1242/dev.00643
   Azpiazu N, 2000, DEVELOPMENT, V127, P2685
   Barrio R, 1999, DEV BIOL, V215, P33, DOI 10.1006/dbio.1999.9434
   BRYANT PJ, 1970, DEV BIOL, V22, P389, DOI 10.1016/0012-1606(70)90160-0
   Calleja M, 2000, DEVELOPMENT, V127, P3971
   Calleja M, 2002, GENE, V292, P1, DOI 10.1016/S0378-1119(02)00628-5
   Calleja M, 1996, SCIENCE, V274, P252, DOI 10.1126/science.274.5285.252
   Casares F, 2000, DEVELOPMENT, V127, P1499
   COHEN B, 1993, MECH DEVELOP, V33, P229
   Cohen Stephen M., 1993, P747
   COUSO JP, 1993, SCIENCE, V259, P484, DOI 10.1126/science.8424170
   de Celis JF, 1999, DEVELOPMENT, V126, P2653
   de Celis JF, 2000, MECH DEVELOP, V91, P31, DOI 10.1016/S0925-4773(99)00261-0
   deCelis JF, 1996, NATURE, V381, P421, DOI 10.1038/381421a0
   DIAZBENJUMEA FJ, 1993, CELL, V75, P741, DOI 10.1016/0092-8674(93)90494-B
   Diez del Corral R, 1999, GENE DEV, V13, P1754, DOI 10.1101/gad.13.13.1754
   Emerald BS, 2004, DEV BIOL, V267, P462, DOI 10.1016/j.ydbio.2003.12.006
   Emerald BS, 2001, CURR BIOL, V11, pR1025, DOI 10.1016/S0960-9822(01)00616-9
   Franch-Marro X, 2002, DEV BIOL, V250, P374, DOI 10.1006/dbio.2002.0799
   Fuse N, 1996, DEVELOPMENT, V122, P1059
   Garaulet DL, 2008, DEVELOPMENT, V135, P3219, DOI 10.1242/dev.025809
   Garcia-Garcia MJ, 1999, DEVELOPMENT, V126, P3523
   GARCIABELLIDO A, 1976, DEV BIOL, V48, P132, DOI 10.1016/0012-1606(76)90052-X
   GARCIABELLIDO A, 1973, NATURE-NEW BIOL, V245, P251
   GEHRING W, 1966, J EMBRYOL EXP MORPH, V15, P77
   Gehring W, 2007, HOX GENE EXPRESSION, P1
   GomezSkarmeta JL, 1996, CELL, V85, P95, DOI 10.1016/S0092-8674(00)81085-5
   Grieder NC, 2007, GENETICS, V175, P1707, DOI 10.1534/genetics.106.064212
   Grimm S, 1996, SCIENCE, V271, P1601, DOI 10.1126/science.271.5255.1601
   Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522
   KASSIS JA, 1992, P NATL ACAD SCI USA, V89, P1919, DOI 10.1073/pnas.89.5.1919
   Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0
   Klein T, 2001, CURR OPIN GENET DEV, V11, P470, DOI 10.1016/S0959-437X(00)00219-7
   Kubota K, 2000, DEVELOPMENT, V127, P3769
   Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215
   KUHNLEIN RP, 1994, EMBO J, V13, P168, DOI 10.1002/j.1460-2075.1994.tb06246.x
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243
   Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1
   Montagne J, 1996, DEVELOPMENT, V122, P2589
   MORATA G, 1977, DEV BIOL, V56, P227, DOI 10.1016/0012-1606(77)90266-4
   Morata G, 1999, DEVELOPMENT, V126, P2823
   Netzer C, 2006, BBA-MOL BASIS DIS, V1762, P386, DOI 10.1016/j.bbadis.2005.12.005
   Neumann CJ, 1996, DEVELOPMENT, V122, P1781
   Ng M, 1996, NATURE, V381, P316, DOI 10.1038/381316a0
   Perez-Garijo A, 2005, P NATL ACAD SCI USA, V102, P17664, DOI 10.1073/pnas.0508966102
   Spradling AC, 1999, GENETICS, V153, P135
   STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585
   STEINER E, 1976, ROUX ARCH DEV BIOL, V180, P9, DOI 10.1007/BF00848882
   Sweetman D, 2006, DEV BIOL, V293, P285, DOI 10.1016/j.ydbio.2006.02.009
   WAGNERBERNHOLZ JT, 1991, GENE DEV, V5, P2467, DOI 10.1101/gad.5.12b.2467
   Wang SH, 2000, GENE DEV, V14, P2271, DOI 10.1101/gad.827000
   WIESCHAUS E, 1976, DEV BIOL, V50, P249, DOI 10.1016/0012-1606(76)90150-0
   Wu J, 2002, DEVELOPMENT, V129, P2411
   XU T, 1993, DEVELOPMENT, V117, P1223
   Yao JG, 2005, EMBO J, V24, P2602, DOI 10.1038/sj.emboj.7600725
   Zecca M, 2002, DEVELOPMENT, V129, P1357
   Zecca M, 2002, DEVELOPMENT, V129, P1369
NR 58
TC 13
Z9 14
U1 0
U2 11
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
EI 1095-564X
J9 DEV BIOL
JI Dev. Biol.
PD MAY 15
PY 2009
VL 329
IS 2
BP 315
EP 326
DI 10.1016/j.ydbio.2009.03.006
PG 12
WC Developmental Biology
SC Developmental Biology
GA 445JY
UT WOS:000266048300013
PM 19298807
DA 2021-01-25
ER

PT J
AU Colombelli, J
   Besser, A
   Kress, H
   Reynaud, EG
   Girard, P
   Caussinus, E
   Haselmann, U
   Small, JV
   Schwarz, US
   Stelzer, EHK
AF Colombelli, Julien
   Besser, Achim
   Kress, Holger
   Reynaud, Emmanuel G.
   Girard, Philippe
   Caussinus, Emmanuel
   Haselmann, Uta
   Small, John V.
   Schwarz, Ulrich S.
   Stelzer, Ernst H. K.
TI Mechanosensing in actin stress fibers revealed by a close correlation
   between force and protein localization
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Mechanosensing; Stress fibers; Zyxin; alpha-actinin; Actomyosin
   contractility; Laser nanosurgery; Correlative microscopy;
   Viscoelasticity
ID FOCAL ADHESIONS; CELL-ADHESION; IN-VIVO; ZYXIN; ABLATION; MECHANISMS;
   BINDING; KINASE; FAMILY
AB The mechanics of the actin cytoskeleton have a central role in the regulation of cells and tissues, but the details of how molecular sensors recognize deformations and forces are elusive. By performing cytoskeleton laser nanosurgery in cultured epithelial cells and fibroblasts, we show that the retraction of stress fibers (SFs) is restricted to the proximity of the cut and that new adhesions form at the retracting end. This suggests that SFs are attached to the substrate. A new computational model for SFs confirms this hypothesis and predicts the distribution and propagation of contractile forces along the SF. We then analyzed the dynamics of zyxin, a focal adhesion protein present in SFs. Fluorescent redistribution after laser nanosurgery and drug treatment shows a high correlation between the experimentally measured localization of zyxin and the computed localization of forces along SFs. Correlative electron microscopy reveals that zyxin is recruited very fast to intermediate substrate anchor points that are highly tensed upon SF release. A similar acute localization response is found if SFs are mechanically perturbed with the cantilever of an atomic force microscope. If actin bundles are cut by nanosurgery in living Drosophila egg chambers, we also find that zyxin redistribution dynamics correlate to force propagation and that zyxin relocates at tensed SF anchor points, demonstrating that these processes also occur in living organisms. In summary, our quantitative analysis shows that force and protein localization are closely correlated in stress fibers, suggesting a very direct force-sensing mechanism along actin bundles.
C1 [Colombelli, Julien; Kress, Holger; Reynaud, Emmanuel G.; Girard, Philippe; Haselmann, Uta; Stelzer, Ernst H. K.] European Mol Biol Lab, D-69117 Heidelberg, Germany.
   [Besser, Achim; Schwarz, Ulrich S.] Heidelberg Univ, D-69120 Heidelberg, Germany.
   [Kress, Holger] Yale Univ, Dept Mech Engn, New Haven, CT 06511 USA.
   [Caussinus, Emmanuel] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Small, John V.] Austrian Acad Sci IMBA, Inst Mol Biotechol, A-1030 Vienna, Austria.
RP Colombelli, J (corresponding author), European Mol Biol Lab, Meyerhofstr 1, D-69117 Heidelberg, Germany.
EM julien.colombelli@irbbarcelona.org
RI Ladoux, Benoit/A-9879-2013; Schwarz, Ulrich/ABB-5642-2020; Stelzer,
   Ernst H K/A-7648-2011; Reynaud, Emamnuel/H-2928-2019; Schwarz, Ulrich
   S/K-4111-2014
OI Schwarz, Ulrich/0000-0003-1483-640X; Stelzer, Ernst H
   K/0000-0003-1545-0736; Reynaud, Emamnuel/0000-0003-1502-661X; Schwarz,
   Ulrich S/0000-0003-1483-640X; Colombelli, Julien/0000-0002-2784-4276
CR Besser A, 2007, NEW J PHYS, V9, DOI 10.1088/1367-2630/9/11/425
   Brown CM, 2006, J CELL SCI, V119, P5204, DOI 10.1242/jcs.03321
   ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403
   Colombelli J, 2004, REV SCI INSTRUM, V75, P472, DOI 10.1063/1.1641163
   Colombelli J, 2005, TRAFFIC, V6, P1093, DOI 10.1111/j.1600-0854.2005.00334.x
   Colombelli J, 2007, METHOD CELL BIOL, V82, P267, DOI 10.1016/S0091-679X(06)82008-X
   Colombelli Julien, 2008, V457, P203, DOI 10.1007/978-1-59745-261-8_15
   CRAWFORD AW, 1992, J CELL BIOL, V116, P1381, DOI 10.1083/jcb.116.6.1381
   Djinovic-Carugo K, 2002, FEBS LETT, V513, P119, DOI 10.1016/S0014-5793(01)03304-X
   Ervasti JM, 2003, J BIOL CHEM, V278, P13591, DOI 10.1074/jbc.R200021200
   Fung Y. C., 1993, BIOMECHANICS MECH PR
   Gillespie PG, 2001, NATURE, V413, P194, DOI 10.1038/35093011
   Guo WH, 2007, MOL BIOL CELL, V18, P4519, DOI 10.1091/mbc.E07-06-0582
   Harborth J, 2001, J CELL SCI, V114, P4557
   HITARA H, 2008, J CELL SCI, V121, P2795
   Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115
   Horne-Badovinac S, 2005, DEV DYNAM, V232, P559, DOI 10.1002/dvdy.20286
   Hotulainen P, 2006, J CELL BIOL, V173, P383, DOI 10.1083/jcb.200511093
   Hu K, 2007, SCIENCE, V315, P111, DOI 10.1126/science.1135085
   Kim-Kaneyama J, 2005, J CELL SCI, V118, P937, DOI 10.1242/jcs.01683
   Kumar S, 2006, BIOPHYS J, V90, P3762, DOI 10.1529/biophysj.105.071506
   Lele TP, 2006, J CELL PHYSIOL, V207, P187, DOI 10.1002/jcp.20550
   Li B, 2001, J BIOL CHEM, V276, P33328, DOI 10.1074/jbc.M100789200
   Martinac B, 2004, J CELL SCI, V117, P2449, DOI 10.1242/jcs.01232
   Mirijanian DT, 2008, P NATL ACAD SCI USA, V105, P1204, DOI 10.1073/pnas.0707500105
   Mitra SK, 2005, NAT REV MOL CELL BIO, V6, P56, DOI 10.1038/nrm1549
   MORRIS CE, 1998, CELL PHYSL SOURCE BO, P668
   Nix DA, 1997, J CELL BIOL, V138, P1139, DOI 10.1083/jcb.138.5.1139
   Otey CA, 2004, CELL MOTIL CYTOSKEL, V58, P104, DOI 10.1002/cm.20007
   Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473
   Peterson LJ, 2004, MOL BIOL CELL, V15, P3497, DOI 10.1091/mbc.E03-09-0696
   Phair RD, 2004, METHOD ENZYMOL, V375, P393
   Reinhard M, 1999, J BIOL CHEM, V274, P13410, DOI 10.1074/jbc.274.19.13410
   Renfranz PJ, 2003, GENE, V305, P13, DOI 10.1016/S0378-1119(02)01173-3
   Riveline D, 2001, J CELL BIOL, V153, P1175, DOI 10.1083/jcb.153.6.1175
   Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945
   Rubin GM, 2000, SCIENCE, V287, P2222, DOI 10.1126/science.287.5461.2222
   Sakamoto T, 2005, BIOCHEMISTRY-US, V44, P584, DOI 10.1021/bi0483357
   Sawada Y, 2006, CELL, V127, P1015, DOI 10.1016/j.cell.2006.09.044
   Schmeichel KL, 1998, METHOD ENZYMOL, V298, P62, DOI 10.1016/S0076-6879(98)98009-0
   TRYBUS KM, 1987, J CELL BIOL, V105, P3007, DOI 10.1083/jcb.105.6.3007
   Vogel A, 2003, CHEM REV, V103, P577, DOI 10.1021/cr010379n
   Vogel V, 2006, NAT REV MOL CELL BIO, V7, P265, DOI 10.1038/nrm1890
   Wang Yu-li, 2007, Sci STKE, V2007, ppe10
   Wang YX, 2005, NATURE, V434, P1040, DOI 10.1038/nature03469
   Yoshigi M, 2005, J CELL BIOL, V171, P209, DOI 10.1083/jcb.200505018
   Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858
   Zaidel-Bar R, 2007, J CELL SCI, V120, P137, DOI 10.1242/jcs.03314
NR 48
TC 181
Z9 181
U1 0
U2 32
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD MAY 15
PY 2009
VL 122
IS 10
BP 1665
EP 1679
DI 10.1242/jcs.042986
PG 15
WC Cell Biology
SC Cell Biology
GA 442PC
UT WOS:000265852100021
PM 19401336
OA Other Gold
DA 2021-01-25
ER

PT J
AU Iinuma, T
   Aoki, T
   Arasaki, K
   Hirose, H
   Yamamoto, A
   Samata, R
   Hauri, HP
   Arimitsu, N
   Tagaya, M
   Tani, K
AF Iinuma, Takayuki
   Aoki, Takehiro
   Arasaki, Kohei
   Hirose, Hidenori
   Yamamoto, Akitsugu
   Samata, Rie
   Hauri, Hans-Peter
   Arimitsu, Nagisa
   Tagaya, Mitsuo
   Tani, Katsuko
TI Role of syntaxin 18 in the organization of endoplasmic reticulum
   subdomains
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Brefeldin A; COPII; Endoplasmic reticulum; Membrane fusion; Subdomain;
   Syntaxin 18
ID GOLGI INTERMEDIATE COMPARTMENT; ETHYLMALEIMIDE-SENSITIVE FACTOR;
   TRANSITIONAL ER ORGANIZATION; EXIT SITES; MEMBRANE-FUSION; RETROGRADE
   TRANSPORT; PROTEIN INTERACTIONS; VESICLE FORMATION; Q-SNARE; CELLS
AB The presence of subdomains in the endoplasmic reticulum ( ER) enables this organelle to perform a variety of functions, yet the mechanisms underlying their organization are poorly understood. In the present study, we show that syntaxin 18, a SNAP (soluble NSF attachment protein) receptor localized in the ER, is important for the organization of two ER subdomains, smooth/rough ER membranes and ER exit sites. Knockdown of syntaxin 18 caused a global change in ER membrane architecture, leading to the segregation of the smooth and rough ER. Furthermore, the organization of ER exit sites was markedly changed concomitantly with dispersion of the ER-olgi intermediate compartment and the Golgi complex. These morphological changes in the ER were substantially recovered by treatment of syntaxin-18-depleted cells with brefeldin A, a reagent that stimulates retrograde membrane flow to the ER. These results suggest that syntaxin 18 has an important role in ER subdomain organization by mediating the fusion of retrograde membrane carriers with the ER membrane.
C1 [Iinuma, Takayuki; Aoki, Takehiro; Arasaki, Kohei; Hirose, Hidenori; Arimitsu, Nagisa; Tagaya, Mitsuo; Tani, Katsuko] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo 1920392, Japan.
   [Yamamoto, Akitsugu; Samata, Rie] Nagahama Inst Biosci & Technol, Dept Biosci, Shiga 5260829, Japan.
   [Hauri, Hans-Peter] Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
RP Tani, K (corresponding author), Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo 1920392, Japan.
EM Tani@ls.toyaku.ac.jp
FU Ministry of Education, Science, Sports, and Culture of JapanMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)
   [18570186, 1837008]; Grants-in-Aid for Scientific ResearchMinistry of
   Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan
   Society for the Promotion of ScienceGrants-in-Aid for Scientific
   Research (KAKENHI) [20370050, 20570190, 20059032, 19036032] Funding
   Source: KAKEN
FX This work was supported in part by Grants-in-Aid for Scientific Research
   (# 18570186 and # 18370081) from the Ministry of Education, Science,
   Sports, and Culture of Japan. We thank M. Gerard Waters, D. Hans-Dieter
   Soling;, Jennifer Lippincott-Schwartz and Alberto Luini for gifts of
   reagents.
CR Annaert WG, 1997, J CELL BIOL, V139, P1397, DOI 10.1083/jcb.139.6.1397
   Aoki T, 2008, BIOCHEM J, V410, P93, DOI 10.1042/BJ20071304
   Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019
   Arasaki K, 2007, BIOCHEM BIOPH RES CO, V359, P811, DOI 10.1016/j.bbrc.2007.05.188
   Arasaki K, 2006, MOL BIOL CELL, V17, P2780, DOI 10.1091/mbc.E05-10-0973
   Aridor M, 1999, J BIOL CHEM, V274, P4389, DOI 10.1074/jbc.274.7.4389
   Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615
   BERGMANN JE, 1990, J CELL BIOL, V110, P625, DOI 10.1083/jcb.110.3.625
   Bhattacharyya D, 2007, MOL BIOL CELL, V18, P839, DOI 10.1091/mbc.E06-08-0707
   Borgese N, 2006, CURR OPIN CELL BIOL, V18, P358, DOI 10.1016/j.ceb.2006.06.008
   Cole NB, 1996, MOL BIOL CELL, V7, P631, DOI 10.1091/mbc.7.4.631
   Coleman R Edward, 1998, Clin Positron Imaging, V1, P15, DOI 10.1016/S1095-0397(97)00004-6
   Connerly PL, 2005, CURR BIOL, V15, P1439, DOI 10.1016/j.cub.2005.06.065
   DASCHER C, 1994, J BIOL CHEM, V269, P29363
   Forster R, 2006, CURR BIOL, V16, P173, DOI 10.1016/j.cub.2005.11.076
   Girod A, 1999, NAT CELL BIOL, V1, P423
   Guo YS, 2006, J CELL BIOL, V174, P53, DOI 10.1083/jcb.200604058
   Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025
   Hammond AT, 2000, MOL BIOL CELL, V11, P3013, DOI 10.1091/mbc.11.9.3013
   Hatsuzawa K, 2000, J BIOL CHEM, V275, P13713, DOI 10.1074/jbc.275.18.13713
   Hatsuzawa K, 2006, MOL BIOL CELL, V17, P3964, DOI 10.1091/mbc.E05-12-1174
   Heinzer S, 2008, J CELL SCI, V121, P55, DOI 10.1242/jcs.013383
   Hirose H, 2004, EMBO J, V23, P1267, DOI 10.1038/sj.emboj.7600135
   Hong WJ, 2005, BBA-MOL CELL RES, V1744, P120, DOI 10.1016/j.bbamcr.2005.03.014
   Iinuma T, 2007, J BIOL CHEM, V282, P17632, DOI 10.1074/jbc.M611237200
   Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002
   Kano F, 2005, GENES CELLS, V10, P989, DOI 10.1111/j.1365-2443.2005.00894.x
   Kano F, 2005, GENES CELLS, V10, P333, DOI 10.1111/j.1365-2443.2005.00837.x
   Klopfenstein DRC, 1998, EMBO J, V17, P6168, DOI 10.1093/emboj/17.21.6168
   Kok JW, 1998, J CELL BIOL, V142, P25, DOI 10.1083/jcb.142.1.25
   Kondylis V, 2003, J CELL BIOL, V162, P185, DOI 10.1083/jcb.200301136
   Kraynack BA, 2005, MOL BIOL CELL, V16, P3963, DOI 10.1091/mbc.E05-01-0056
   Levine T, 2005, CURR OPIN CELL BIOL, V17, P362, DOI 10.1016/j.ceb.2005.06.005
   Lewis MJ, 1996, CELL, V85, P205, DOI 10.1016/S0092-8674(00)81097-1
   Linstedt AD, 1997, MOL BIOL CELL, V8, P1073
   Lippincott-Schwartz Jennifer, 2006, Trends Cell Biol, V16, pe1, DOI 10.1016/j.tcb.2006.08.008
   LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W
   Mardones GA, 2006, MOL BIOL CELL, V17, P525, DOI 10.1091/mbc.E05-05-0447
   Mitrovic S, 2008, MOL BIOL CELL, V19, P1976, DOI 10.1091/mbc.E07-10-0989
   Nakajima K, 2004, EMBO J, V23, P3216, DOI 10.1038/sj.emboj.7600333
   NISHIKAWA S, 1994, MOL BIOL CELL, V5, P1129
   Nufer O, 2002, J CELL SCI, V115, P619
   Okumura AJ, 2006, J BIOL CHEM, V281, P4495, DOI 10.1074/jbc.M509715200
   Patel SK, 1998, CELL, V92, P611, DOI 10.1016/S0092-8674(00)81129-0
   Sannerud R, 2006, MOL BIOL CELL, V17, P1514, DOI 10.1091/mbc.E05-08-0792
   SARASTE J, 1991, J CELL SCI, V100, P415
   SCHWEIZER A, 1993, J CELL SCI, V104, P671
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Shibata Y, 2006, CELL, V126, P435, DOI 10.1016/j.cell.2006.07.019
   Shimoi W, 2005, J BIOL CHEM, V280, P10141, DOI 10.1074/jbc.M409673200
   Snapp EL, 2003, J CELL BIOL, V163, P257, DOI 10.1083/jcb.200306020
   Sprocati T, 2006, J CELL SCI, V119, P3249, DOI 10.1242/jcs.03058
   Steegmaier M, 1998, J BIOL CHEM, V273, P34171, DOI 10.1074/jbc.273.51.34171
   Steegmaier M, 2000, MOL BIOL CELL, V11, P2719, DOI 10.1091/mbc.11.8.2719
   Stephens DJ, 2003, EMBO REP, V4, P210, DOI 10.1038/sj.embor.embor736
   Storrie B, 1998, J CELL BIOL, V143, P1505, DOI 10.1083/jcb.143.6.1505
   Sun Y, 2007, MOL BIOL CELL, V18, P4129, DOI 10.1091/mbc.E07-01-0080
   Tagaya M, 1996, J BIOL CHEM, V271, P466, DOI 10.1074/jbc.271.1.466
   Tang BL, 2000, J BIOL CHEM, V275, P13597, DOI 10.1074/jbc.275.18.13597
   Tani K, 1999, J BIOL CHEM, V274, P20505, DOI 10.1074/jbc.274.29.20505
   Townley AK, 2008, J CELL SCI, V121, P3025, DOI 10.1242/jcs.031070
   Uchiyama K, 2002, J CELL BIOL, V159, P855, DOI 10.1083/jcb.200208112
   Uchiyama K, 2006, DEV CELL, V11, P803, DOI 10.1016/j.devcel.2006.10.016
   Uemura T, 2009, MOL CELL BIOL, V29, P1869, DOI 10.1128/MCB.01089-08
   Vedrenne C, 2006, TRAFFIC, V7, P639, DOI 10.1111/j.1600-0854.2006.00419.x
   Voeltz GK, 2006, CELL, V124, P573, DOI 10.1016/j.cell.2005.11.047
   Wakana Y, 2008, MOL BIOL CELL, V19, P1825, DOI 10.1091/mbc.E07-08-0781
   Ward TH, 2001, J CELL BIOL, V155, P557, DOI 10.1083/jcb.200107045
   WATERS MG, 1992, J CELL BIOL, V118, P1015, DOI 10.1083/jcb.118.5.1015
   Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x
   White J, 1999, J CELL BIOL, V147, P743, DOI 10.1083/jcb.147.4.743
   Xu Y, 1998, J BIOL CHEM, V273, P21783, DOI 10.1074/jbc.273.34.21783
   Yamaguchi T, 1997, J BIOL CHEM, V272, P25260, DOI 10.1074/jbc.272.40.25260
   Yang JS, 2008, NAT CELL BIOL, V10, P1146, DOI 10.1038/ncb1774
   Yang JS, 2005, EMBO J, V24, P4133, DOI 10.1038/sj.emboj.7600873
   Young J, 2005, MOL BIOL CELL, V16, P162, DOI 10.1091/mbc.E04-03-0260
   Zolov SN, 2005, J CELL BIOL, V168, P747, DOI 10.1083/jcb.200412003
NR 77
TC 35
Z9 35
U1 0
U2 4
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD MAY 15
PY 2009
VL 122
IS 10
BP 1680
EP 1690
DI 10.1242/jcs.036103
PG 11
WC Cell Biology
SC Cell Biology
GA 442PC
UT WOS:000265852100022
PM 19401338
OA Bronze
DA 2021-01-25
ER

PT J
AU Minasov, G
   Padavattan, S
   Shuvalova, L
   Brunzelle, JS
   Miller, DJ
   Basle, A
   Massa, C
   Collart, FR
   Schirmer, T
   Anderson, WF
AF Minasov, George
   Padavattan, Sivaraman
   Shuvalova, Ludmilla
   Brunzelle, Joseph S.
   Miller, Darcie J.
   Basle, Arnaud
   Massa, Claudia
   Collart, Frank R.
   Schirmer, Tilman
   Anderson, Wayne F.
TI Crystal Structures of YkuI and Its Complex with Second Messenger Cyclic
   Di-GMP Suggest Catalytic Mechanism of Phosphodiester Bond Cleavage by
   EAL Domains
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID ALLOSTERIC CONTROL; ACETOBACTER-XYLINUM; SIGNAL-TRANSDUCTION; RESPONSE
   REGULATOR; PROTEIN; DIGUANYLATE; FOLD; BLUF; CLASSIFICATION;
   DIMERIZATION
AB Cyclic di-GMP (c-di-GMP) is a ubiquitous bacterial second messenger that is involved in the regulation of cell surface-associated traits and the persistence of infections. Omnipresent GGDEF and EAL domains, which occur in various combinations with regulatory domains, catalyze c-di-GMP synthesis and degradation, respectively. Thecrystal structure of full-length YkuI from Bacillus subtilis, composed of an EAL domain and a C-terminal PAS-like domain, has been determined in its native form and in complex with c-di-GMP and Ca2+. The EAL domain exhibits a triose-phosphate isomerase-barrel fold with one antiparallel beta-strand. The complex with c-di-GMP-Ca2+ defines the active site of the putative phosphodiesterase located at the C-terminal end of the beta-barrel. The EAL motif is part of the active site with Glu-33 of the motif being involved in cation coordination. The structure of the complex allows the proposal of a phosphodiesterase mechanism, in which the divalent cation and the general base Glu-209 activate a catalytic water molecule for nucleophilic in-line attack on the phosphorus. The C-terminal domain closely resembles the PAS-fold. Its pocket-like structure could accommodate a yet unknown ligand. YkuI forms a tight dimer via EAL-EAL and trans EAL-PAS-like domain association. The possible regulatory significance of the EAL-EAL interface and a mechanism for signal transduction between sensory and catalytic domains of c-di-GMP-specific phosphodiesterases are discussed.
C1 [Minasov, George; Shuvalova, Ludmilla; Miller, Darcie J.; Anderson, Wayne F.] NW Feinberg Sch Med, Dept Mol Pharmacol & Biol Chem, Chicago, IL 60611 USA.
   [Minasov, George; Shuvalova, Ludmilla; Miller, Darcie J.; Anderson, Wayne F.] NW Feinberg Sch Med, Midwest Ctr Struct Genom, Chicago, IL 60611 USA.
   [Padavattan, Sivaraman; Massa, Claudia; Schirmer, Tilman] Univ Basel, Biozentrum, Core Program Struct Biol & Biophys, CH-4056 Basel, Switzerland.
   [Brunzelle, Joseph S.] Argonne Natl Lab, Adv Photon Source, LS CAT, Argonne, IL 60439 USA.
   [Miller, Darcie J.] St Jude Childrens Res Hosp, Dept Biol Struct, Memphis, TN 38105 USA.
   [Collart, Frank R.] Argonne Natl Lab, Midwest Ctr Struct Genom, Argonne, IL 60439 USA.
RP Schirmer, T (corresponding author), Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM tilman.schirmer@unibas.ch; wf-anderson@northwestern.edu
OI Minasov, George/0000-0001-5460-3462; Padavattan,
   Sivaraman/0000-0002-1732-5421; Collart, Frank/0000-0001-6942-4483
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [U54 GM074942]; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
   [3100A0-10587]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of General Medical Sciences
   (NIGMS) [U54GM074942, U54GM074942, U54GM074942, U54GM074942,
   U54GM074942, U54GM074942, U54GM074942, U54GM074942, U54GM074942,
   U54GM074942, U54GM074942, U54GM074942, U54GM074942, U54GM074942,
   U54GM074942, U54GM074942, U54GM074942, U54GM074942, U54GM074942,
   U54GM074942, U54GM074942, U54GM074942, U54GM074942, U54GM074942,
   U54GM074942, U54GM074942, U54GM074942, U54GM074942, U54GM074942,
   U54GM074942, U54GM074942, U54GM074942, U54GM074942, U54GM074942,
   U54GM074942, U54GM074942, U54GM074942, U54GM074942, U54GM074942,
   U54GM074942, U54GM074942, U54GM074942, U54GM074942, U54GM074942,
   U54GM074942, U54GM074942, U54GM074942, U54GM074942, U54GM074942,
   U54GM074942, U54GM074942, U54GM074942, U54GM074942] Funding Source: NIH
   RePORTER
FX This work was supported, in whole or in part, by National Institutes of
   Health Grant U54 GM074942 (Midwest Center for Structural Genomics). This
   work was also supported by Swiss National Science Foundation Grant
   3100A0-10587.
CR Amiot N, 2006, SYNTHESIS-STUTTGART, P4230, DOI 10.1055/s-2006-950361
   Anderson S, 2004, ACTA CRYSTALLOGR D, V60, P1008, DOI 10.1107/S090744490400616X
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BAYKOV AA, 1988, ANAL BIOCHEM, V171, P266, DOI 10.1016/0003-2697(88)90484-8
   Bobrov AG, 2005, FEMS MICROBIOL LETT, V247, P123, DOI 10.1016/j.femsle.2005.04.036
   BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200
   Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200
   De N, 2008, PLOS BIOL, V6, P601, DOI 10.1371/journal.pbio.0060067
   delaFortelle E, 1997, METHOD ENZYMOL, V276, P472, DOI 10.1016/S0076-6879(97)76073-7
   EGLI M, 1990, P NATL ACAD SCI USA, V87, P3235, DOI 10.1073/pnas.87.8.3235
   Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960
   Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05
   Galperin MY, 2001, FEMS MICROBIOL LETT, V203, P11, DOI 10.1111/j.1574-6968.2001.tb10814.x
   Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305
   Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959
   Hasegawa K, 2006, BIOCHEMISTRY-US, V45, P3785, DOI 10.1021/bi051820x
   Hefti MH, 2004, EUR J BIOCHEM, V271, P1198, DOI 10.1111/j.1432-1033.2004.04023.x
   Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423
   Jeon YH, 2005, CELL MOL LIFE SCI, V62, P1198, DOI 10.1007/s00018-005-4533-5
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   Kazmierczak BI, 2006, MOL MICROBIOL, V60, P1026, DOI 10.1111/j.1365-2958.2006.05156.x
   Korolev S, 2002, NAT STRUCT BIOL, V9, P27, DOI 10.1038/nsb737
   Krissinel E, 2004, ACTA CRYSTALLOGR D, V60, P2256, DOI 10.1107/S0907444904026460
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   LEBIODA L, 1989, J BIOL CHEM, V264, P3685
   LESLIE A, 1992, JOINT CCP4 ESF EACBM, V27
   LIAW YC, 1990, FEBS LETT, V264, P223, DOI 10.1016/0014-5793(90)80253-F
   Martinez SE, 2002, P NATL ACAD SCI USA, V99, P13260, DOI 10.1073/pnas.192374899
   Nagano N, 2002, J MOL BIOL, V321, P741, DOI 10.1016/S0022-2836(02)00649-6
   Nakasone Y, 2007, J AM CHEM SOC, V129, P7028, DOI 10.1021/ja065682q
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Rao F, 2008, J BACTERIOL, V190, P3622, DOI 10.1128/JB.00165-08
   Rau A, 2001, J BIOL CHEM, V276, P31994, DOI 10.1074/jbc.M102591200
   ROSS P, 1987, NATURE, V325, P279, DOI 10.1038/325279a0
   ROSSMANN MG, 1962, ACTA CRYSTALLOGR, V15, P24, DOI 10.1107/S0365110X62000067
   ROUSSEL A, 1989, SILICON GRAPHICS PAR
   Ryjenkov DA, 2005, J BACTERIOL, V187, P1792, DOI 10.1128/JB.187.5.1792-1798.2005
   Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005
   Schroeder C, 2008, CHEMBIOCHEM, V9, P2463, DOI 10.1002/cbic.200800280
   Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x
   Stols L, 2002, PROTEIN EXPRES PURIF, V25, P8, DOI 10.1006/prep.2001.1603
   Tal R, 1998, J BACTERIOL, V180, P4416, DOI 10.1128/JB.180.17.4416-4425.1998
   Tamayo R, 2005, J BIOL CHEM, V280, P33324, DOI 10.1074/jbc.M506500200
   Tamayo R, 2008, INFECT IMMUN, V76, P1617, DOI 10.1128/IAI.01337-07
   Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426
   Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6
   Tischler AD, 2004, MOL MICROBIOL, V53, P857, DOI 10.1111/j.1365-2958.2004.04155.x
   Ulrich LE, 2005, TRENDS MICROBIOL, V13, P52, DOI 10.1016/j.tim.2004.12.006
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x
   Winn MD, 2003, METHOD ENZYMOL, V374, P300, DOI 10.1016/S0076-6879(03)74014-2
NR 54
TC 66
Z9 67
U1 0
U2 14
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD MAY 8
PY 2009
VL 284
IS 19
BP 13174
EP 13184
DI 10.1074/jbc.M808221200
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 440GH
UT WOS:000265688300064
PM 19244251
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Blanco, J
   Seimiya, M
   Pauli, T
   Reichert, H
   Gehring, WJ
AF Blanco, Jorge
   Seimiya, Makiko
   Pauli, Tobias
   Reichert, Heinrich
   Gehring, Walter J.
TI Wingless and Hedgehog signaling pathways regulate orthodenticle and eyes
   absent during ocelli development in Drosophila
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE Ocelliless; Orthodenticle; Hedgehog; Wingless; Eyes absent; Cubitus
   interruptus; Ocelli development; Drosophila
ID TWIN-OF-EYELESS; SINE-OCULIS; MORPHOGENETIC FURROW; HEAD DEVELOPMENT;
   GENETIC-ANALYSIS; EGF RECEPTOR; ADULT HEAD; PROTEIN; SPECIFICATION;
   ENHANCER
AB The homeobox gene orthodenticle (old) controls the process of regional specification that takes place in the Drosophila eye-antennal disc during ocelli development. Mutations that reduce or abolish old expression in the ocelli primordium give rise to ocelliless flies. We have identified the cis-regulatory sequence (ocelliless enhancer) that controls old expression during ocelli development and studied its regulation at the molecular level. The ocelliless enhancer is initially activated by the combined action of Wingless (Wg) and Hedgehog (Hh) signaling pathways. Later, a positive autoregulatory feedback loop sets in to maintain otd expression. Moreover, we have analyzed the role of old during ocelli primordium development and determined its involvement in the expression of the retinal determination gene eyes absent (eya). old indirectly regulates eya in ocellar precursor cells through the inhibition of wg, an eya repressor, and the maintenance of hh expression in the ocelli primordium. Hh signaling is necessary for eya activation in ocellar precursor cells and this activation is mediated by the full-length activator form of the transcription factor Cubitus interruptus. (C) 2009 Elsevier Inc. All rights reserved.
C1 [Blanco, Jorge; Pauli, Tobias; Reichert, Heinrich; Gehring, Walter J.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Seimiya, Makiko] Dept Biosyst Sci & Engn, CH-4058 Basel, Switzerland.
RP Blanco, J (corresponding author), Inst Med Biol, 8A Biomed Grove, Singapore 138648, Singapore.
EM Jorge.Blanco@unibas.ch
FU Kantons of Basel-Stadt and Basel-Land; Swiss National FondsSwiss
   National Science Foundation (SNSF)
FX We acknowledge A. Baonza, K. Basler, B. Bello, C. Desplan, G. Mardon, G.
   Struhl, J. Taipale, U. Wallclorf, the Bloomington Stock Center and the
   Developmental Studies Hybridoma Bank for kindly providing fly strains
   and reagents. This work was supported by the Kantons of Basel-Stadt and
   Basel-Land and the Swiss National Fonds.
CR Amin A, 1999, DEVELOPMENT, V126, P2623
   Apitz H, 2002, DROS INF SERV, V85, P118
   Baonza A, 2002, DEVELOPMENT, V129, P5313, DOI 10.1242/dev.00096
   Bonini NM, 1997, DEVELOPMENT, V124, P4819
   Bui QT, 2000, DEV BIOL, V221, P355, DOI 10.1006/dbio.2000.9688
   Chen CM, 1999, DEVELOPMENT, V126, P5441
   Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X
   Chen R, 1999, DEVELOPMENT, V126, P935
   CHEYETTE BN, 1994, NEURON, V12, P996
   Cho KO, 2000, CELL, V103, P331, DOI 10.1016/S0092-8674(00)00124-0
   Curtiss J, 2000, DEVELOPMENT, V127, P1325
   Curtiss J, 2002, NAT CELL BIOL, V4, pE48, DOI 10.1038/ncb0302-e48
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   Dominguez M, 2005, DEV DYNAM, V232, P673, DOI 10.1002/dvdy.20311
   FINKELSTEIN R, 1990, GENE DEV, V4, P1516, DOI 10.1101/gad.4.9.1516
   Fu WM, 2003, DEVELOPMENT, V130, P5229, DOI 10.1242/dev.00764
   Greenwood S, 1999, DEVELOPMENT, V126, P5795
   Halder G, 1998, DEVELOPMENT, V125, P2181
   HAYNIE JL, 1986, J EXP ZOOL, V237, P293, DOI 10.1002/jez.1402370302
   Hazelett DJ, 1998, DEVELOPMENT, V125, P3741
   Hirth F, 2003, DEVELOPMENT, V130, P2365, DOI 10.1242/dev.00438
   Ingham PW, 2001, GENE DEV, V15, P3059, DOI 10.1101/gad.938601
   Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522
   Jemc J, 2007, DEV BIOL, V310, P416, DOI 10.1016/j.ydbio.2007.07.024
   Jun S, 1998, P NATL ACAD SCI USA, V95, P13720, DOI 10.1073/pnas.95.23.13720
   Kenyon KL, 2003, DEV CELL, V5, P403, DOI 10.1016/S1534-5807(03)00243-0
   KLINGENSMITH J, 1994, GENE DEV, V8, P118, DOI 10.1101/gad.8.1.118
   Kronhamn J, 2002, DEVELOPMENT, V129, P1015
   Kumar JP, 2001, CELL, V104, P687, DOI 10.1016/S0092-8674(02)08063-7
   Lee JD, 2001, DEVELOPMENT, V128, P1519
   LEE JJ, 1992, CELL, V71, P33, DOI 10.1016/0092-8674(92)90264-D
   Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1
   Li X, 2003, NATURE, V426, P247, DOI 10.1038/nature02083
   Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243
   Mann RS, 2002, CURR OPIN GENET DEV, V12, P592, DOI 10.1016/S0959-437X(02)00344-1
   Methot N, 1999, CELL, V96, P819, DOI 10.1016/S0092-8674(00)80592-9
   Niimi T, 1999, DEVELOPMENT, V126, P2253
   Pappu KS, 2003, DEVELOPMENT, V130, P3053, DOI 10.1242/dev.00534
   Pauli T, 2005, DEVELOPMENT, V132, P2771, DOI 10.1242/dev.01841
   Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8
   Punzo C, 2002, DEVELOPMENT, V129, P625
   QUIRING R, 1994, SCIENCE, V265, P785, DOI 10.1126/science.7914031
   Rogers EM, 2005, DEVELOPMENT, V132, P4833, DOI 10.1242/dev.02061
   ROYET J, 1995, DEVELOPMENT, V121, P3561
   Royet J, 1997, DEVELOPMENT, V124, P4793
   Royet J, 1996, DEVELOPMENT, V122, P1849
   Shen WP, 1997, DEVELOPMENT, V124, P45
   STAEHLINGHAMPTON K, 1994, DEV BIOL, V164, P502, DOI 10.1006/dbio.1994.1219
   Theisen H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000142
   Tootle TL, 2003, NATURE, V426, P299, DOI 10.1038/nature02097
   Wehrli M, 2000, NATURE, V407, P527, DOI 10.1038/35035110
   WIESCHAUS E, 1992, DEVELOPMENT, V115, P801
   Wilson DS, 1996, P NATL ACAD SCI USA, V93, P6886, DOI 10.1073/pnas.93.14.6886
   Yao JG, 2008, DEV BIOL, V315, P535, DOI 10.1016/j.ydbio.2007.12.037
   Zimmerman JE, 2000, GENETICS, V154, P237
NR 55
TC 30
Z9 30
U1 5
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
J9 DEV BIOL
JI Dev. Biol.
PD MAY 1
PY 2009
VL 329
IS 1
BP 104
EP 115
DI 10.1016/j.ydbio.2009.02.027
PG 12
WC Developmental Biology
SC Developmental Biology
GA 437XI
UT WOS:000265519800010
PM 19268449
DA 2021-01-25
ER

PT J
AU Nick, H
   Allegrini, PR
   Fozard, L
   Junker, U
   Rojkjaer, L
   Salie, R
   Niederkofler, V
   O'Reilly, T
AF Nick, Hanspeter
   Allegrini, Peter R.
   Fozard, Lucy
   Junker, Ursula
   Rojkjaer, Lisa
   Salie, Rishard
   Niederkofler, Vera
   O'Reilly, Terrence
TI Deferasirox Reduces Iron Overload in a Murine Model of Juvenile
   Hemochromatosis
SO EXPERIMENTAL BIOLOGY AND MEDICINE
LA English
DT Article
DE hemojuvelin; hemochromatosis; iron chelation; deferasirox; knock-out
   mouse
ID HEPCIDIN; EXPRESSION; FERROPORTIN; HOMEOSTASIS; HEMOJUVELIN;
   THALASSEMIA; PROTEIN-4; ICL670; GENE; MICE
AB Mutations in hemojuvelin (HJV) cause severe juvenile hemochromatosis, characterized by iron loading of the heart, liver, and pancreas. Knockout (KO) mice lacking HJV (Hjv(-/-)) spontaneously load with dietary iron and, therefore, present a model for hereditary hemochromatosis (NH). In HH, iron chelation may be considered in noncandidates for phlebotomy. We examined the effects of deferasirox, an oral chelator, in Hjv(-/-) mice. Hepatic, cardiac, splenic, and pancreatic iron were determined by measuring elemental iron and scoring histological sections. Heart and liver iron levels were also determined repeatedly by quantitative R-2* magnetic resonance imaging (MRI). The time course of iron loading without intervention was followed from Week 8 of age (study start) to Week 20, when once-daily (5xl week) deferasirox was administered, to Week 28. At 8 weeks, liver iron of KO mice was already markedly elevated versus wildtype mice (P < 0.001) and reached a plateau around Week 14. In contrast, Week 8 cardiac and pancreatic iron levels were similar in both KO and wild-type mice and, compared with the liver, showed a delayed but massive iron loading up to Week 20. Contrary to the liver, heart, and pancreas, the KO mice spleen had lower iron content versus wild-type mice. In Hjv(-/-) mice, liver and heart iron burden was effectively reduced with deferasirox 100 mg/kg (P < 0.05). Although deferasirox was less efficacious at this dose in the pancreas, over the observed time period, a clear trend toward reduced organ iron load was noted. There was no noticeable effect of deferasirox upon splenic iron in Hjv(-/-) mice. Quantitative R-2* MRI demonstrated the ability to assess iron concentrations in the liver and myocardial muscle accurately and repetitively. Hepatic (R = 0.86; P = 3.2*10(-12)) and delayed myocardial (R = 0.81; P = 2.9*10(-10)) iron accumulation could be followed noninvasively with high agreement to invasive methods. Exp Biol Med 234:492-503. 2009
C1 [Nick, Hanspeter] Novartis Pharma AG, Novartis Inst Biomed Res, CH-4002 Basel, Switzerland.
   [Salie, Rishard; Niederkofler, Vera] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Nick, H (corresponding author), Novartis Pharma AG, Novartis Inst Biomed Res, Lichtstr 35, CH-4002 Basel, Switzerland.
EM hanspeter.nick@novartis.com
CR Babitt JL, 2006, NAT GENET, V38, P531, DOI 10.1038/ng1777
   Bridle KR, 2003, LANCET, V361, P669, DOI 10.1016/S0140-6736(03)12602-5
   Brissot Pierre, 2006, Hematology Am Soc Hematol Educ Program, P36
   Cappellini MD, 2006, BLOOD, V107, P3455, DOI 10.1182/blood-2005-08-3430
   De Domenico I, 2007, MOL BIOL CELL, V18, P2569, DOI 10.1091/mbc.E07-01-0060
   Feder JN, 1996, NAT GENET, V13, P399, DOI 10.1038/ng0896-399
   Ganz T, 2006, BBA-MOL CELL RES, V1763, P690, DOI 10.1016/j.bbamcr.2006.03.014
   Ghugre NR, 2006, J MAGN RESON IMAGING, V23, P9, DOI 10.1002/jmri.20467
   Huang FW, 2005, J CLIN INVEST, V115, P2187, DOI 10.1172/JCI25049
   Nemeth E, 2004, SCIENCE, V306, P2090, DOI 10.1126/science.1104742
   Nicolas G, 2001, P NATL ACAD SCI USA, V98, P8780, DOI 10.1073/pnas.151179498
   Niederkofler V, 2005, J CLIN INVEST, V115, P2180, DOI 10.1172/JCI25683
   Pietrangelo A, 2007, BLOOD, V110, p788A
   Ramey G, 2007, FEBS LETT, V581, P1053, DOI 10.1016/j.febslet.2007.02.002
   Steinhauser S, 2004, EUR J INORG CHEM, P4177, DOI 10.1002/ejic.200400363
   Truksa J, 2006, P NATL ACAD SCI USA, V103, P10289, DOI 10.1073/pnas.0603124103
   Truksa J, 2007, BRIT J HAEMATOL, V139, P138, DOI 10.1111/j.1365-2141.2007.06728.x
   Waalen Jill, 2006, Curr Hematol Rep, V5, P34
   WOHLER F, 1964, INT S
   Wood JC, 2005, BLOOD, V106, P1460, DOI 10.1182/blood-2004-10-3982
   Wood JC, 2005, CIRCULATION, V112, P535, DOI 10.1161/CIRCULATIONAHA.104.504415
NR 21
TC 18
Z9 18
U1 0
U2 2
PU SAGE PUBLICATIONS LTD
PI LONDON
PA 1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND
SN 1535-3702
EI 1535-3699
J9 EXP BIOL MED
JI Exp. Biol. Med.
PD MAY
PY 2009
VL 234
IS 5
BP 492
EP 503
DI 10.3181/0811-RM-337
PG 12
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 439KU
UT WOS:000265626800003
PM 19234060
DA 2021-01-25
ER

PT J
AU Melchers, F
AF Melchers, F.
TI From stem cells to lymphocytes
SO ZEITSCHRIFT FUR RHEUMATOLOGIE
LA German
DT Article
DE Stem cells; Hematopoiesis; Innate and adaptive immune system; Autoimmune
   repertoires
ID RECEPTOR; MOUSE; PROGENITORS; REPERTOIRE; TOLERANCE; OPINION; CHAIN
AB Two types of pluripotent stem cells form the origins of the cells of the innate and the adaptive immune system, as well as of essential elements of cooperating environments of this system. Pluripotent hematopoietic stem cells and their subordinated, sub-specialized progenitor cells develop, throughout life, the red cells, platelets, myeloid and lymphoid cells of this continuously regenerating cell system. Pluripotent mesenchymal cells generate, among other types of differentiated cells, chondrocytes, epithelial cells, adipocytes and osteoblasts. These osteoblasts not only produce bone, the primary location for the hematopoietic cell development, but also directly interact with the hematopoietic stem and progenitor cells - and also with the mature, antigen-experienced memory types of lymphocytes which return after successful fights with antigens to the place of their origin. These interactions occur both by cell-cell contacts and cytokine-cytokine receptor recognitions in so-called"niches", and induce and guide the developments of the hematopoietic cells. These early phases of hematopoietic development are antigen-independent, because the cells of the adaptive system, the lymphocytes, have not yet made antigen-specific receptors. As soon as these cells express T-cell and B-cell receptors for antigen they are subjected to negative and positive selection pressures, first by auto-antigens in the primary lymphoid organs, then after maturation and migration to secondary lymphoid organs, also to external, foreign antigens. The repertoires of these lymphocytes expressing TcR and BcR adapt to the body's own, as well as external environmental, antigens. While cell-cell contacts with cooperating non-hematopoietic as well as hematopoietic cells, and cytokine-cytokine receptor interactions continue to induce the cellular responses resulting in proliferation, differentiation and/or programmed cell death (apoptosis) of the mature hematopoietic cells, such responses of lymphocytes are now dominated by the specific interactions of their antigen-specific receptors, TcRs or BrCs with antigens.
C1 [Melchers, F.] Charite Univ Med Berlin, Max Planck Inst Infekt Biol, Senior Res Grp Lymphozytenentwicklung, D-10117 Berlin, Germany.
   [Melchers, F.] Univ Basel, Biozentrum, Dept Cell Biol, CH-4003 Basel, Switzerland.
RP Melchers, F (corresponding author), Charite Univ Med Berlin, Max Planck Inst Infekt Biol, Senior Res Grp Lymphozytenentwicklung, Campus Mitte,Charitepl 1, D-10117 Berlin, Germany.
EM melchers@mpiib-berlin.mpg.de
CR Akashi K, 2000, NATURE, V404, P193, DOI 10.1038/35004599
   Allman D, 2008, CURR OPIN IMMUNOL, V20, P149, DOI 10.1016/j.coi.2008.03.014
   Banchereau J, 1998, NATURE, V392, P245, DOI 10.1038/32588
   Casellas R, 2001, SCIENCE, V291, P1541, DOI 10.1126/science.1056600
   Christensen JL, 2001, P NATL ACAD SCI USA, V98, P14541, DOI 10.1073/pnas.261562798
   Dorner T, 1998, J CLIN INVEST, V102, P688, DOI 10.1172/JCI3113
   GAY D, 1993, J EXP MED, V177, P999, DOI 10.1084/jem.177.4.999
   Ghia P, 1998, IMMUNOL TODAY, V19, P480, DOI 10.1016/S0167-5699(98)01330-9
   HARTLEY SB, 1993, CELL, V72, P325, DOI 10.1016/0092-8674(93)90111-3
   Hoffmann R, 2007, MOL BIOL EVOL, V24, P2610, DOI 10.1093/molbev/msm198
   Kondo M, 1997, CELL, V91, P661, DOI 10.1016/S0092-8674(00)80453-5
   Liston A, 2007, CURR OPIN IMMUNOL, V19, P176, DOI 10.1016/j.coi.2007.02.005
   Marrack P, 2008, CURR OPIN IMMUNOL, V20, P203, DOI 10.1016/j.coi.2008.03.008
   Melchers F, 2005, NAT REV IMMUNOL, V5, P578, DOI 10.1038/nri1649
   MELCHERS F, 2004, MOL BIOL B CELLS, P101
   NEMAZEE DA, 1989, NATURE, V337, P5626
   OETTINGER MA, 1990, SCIENCE, V248, P1517, DOI 10.1126/science.2360047
   Rolink AG, 2000, IMMUNOL REV, V175, P104, DOI 10.1111/j.1600-065X.2000.imr017512.x
   Schlissel MS, 2003, NAT REV IMMUNOL, V3, P890, DOI 10.1038/nri1225
   SPANGRUDE GJ, 1991, BLOOD, V78, P1395
   Stadanlick JE, 2008, CURR OPIN IMMUNOL, V20, P158, DOI 10.1016/j.coi.2008.03.015
   Tung JW, 2007, CURR OPIN IMMUNOL, V19, P150, DOI 10.1016/j.coi.2007.02.012
   von Boehmer H, 2005, NAT REV IMMUNOL, V5, P571, DOI 10.1038/nri1636
NR 23
TC 0
Z9 0
U1 0
U2 0
PU SPRINGER HEIDELBERG
PI HEIDELBERG
PA TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY
SN 0340-1855
J9 Z RHEUMATOL
JI Z. Rheumatol.
PD MAY
PY 2009
VL 68
IS 3
BP 196
EP +
DI 10.1007/s00393-008-0390-6
PG 8
WC Rheumatology
SC Rheumatology
GA 443AE
UT WOS:000265881800002
PM 19384553
DA 2021-01-25
ER

PT J
AU Sommer, JE
   Budreck, EC
AF Sommer, Julia E.
   Budreck, Elaine C.
TI Kalirin-7: Linking Spine Plasticity and Behavior
SO JOURNAL OF NEUROSCIENCE
LA English
DT Editorial Material
ID DENDRITIC SPINES; MORPHOGENESIS
C1 [Sommer, Julia E.; Budreck, Elaine C.] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Sommer, Julia E.] Columbia Univ, Coll Phys & Surg, Dept Physiol & Cellular Biophys, New York, NY 10032 USA.
   [Budreck, Elaine C.] Columbia Univ, Coll Phys & Surg, Dept Neurosci, New York, NY 10032 USA.
RP Sommer, JE (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Julia.Sommer@unibas.ch; Elaine.Budreck@unibas.ch
FU NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of Mental Health (NIMH) [F30MH083473, F30MH083473,
   F30MH083473] Funding Source: NIH RePORTER; NIMH NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Mental Health (NIMH) [F30MH083473, F30
   MH083473, F30 MH083473-01] Funding Source: Medline
CR Henkemeyer M, 2003, J CELL BIOL, V163, P1313, DOI 10.1083/jcb.200306033
   Kayser MS, 2006, J NEUROSCI, V26, P12152, DOI 10.1523/JNEUROSCI.3072-06.2006
   Ma XM, 2008, J NEUROSCI, V28, P12368, DOI 10.1523/JNEUROSCI.4269-08.2008
   Ma XM, 2003, J NEUROSCI, V23, P10593
   Nikolic M, 1998, NATURE, V395, P194
   Penzes P, 2001, NEURON, V29, P229, DOI 10.1016/S0896-6273(01)00193-3
   Penzes P, 2003, NEURON, V37, P263, DOI 10.1016/S0896-6273(02)01168-6
   Xie Z, 2008, J NEUROSCI, V28, P6079, DOI 10.1523/JNEUROSCI.1170-08.2008
   Xie Z, 2007, NEURON, V56, P640, DOI 10.1016/j.neuron.2007.10.005
NR 9
TC 8
Z9 9
U1 0
U2 1
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD APR 29
PY 2009
VL 29
IS 17
BP 5367
EP 5369
DI 10.1523/JNEUROSCI.0235-09.2009
PG 3
WC Neurosciences
SC Neurosciences & Neurology
GA 439QL
UT WOS:000265642000002
PM 19403804
OA Bronze, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Selbach, M
   Paul, FE
   Brandt, S
   Guye, P
   Daumke, O
   Backert, S
   Dehio, C
   Mann, M
AF Selbach, Matthias
   Paul, Florian Ernst
   Brandt, Sabine
   Guye, Patrick
   Daumke, Oliver
   Backert, Steffen
   Dehio, Christoph
   Mann, Matthias
TI Host Cell Interactome of Tyrosine-Phosphorylated Bacterial Proteins
SO CELL HOST & MICROBE
LA English
DT Article
ID HELICOBACTER-PYLORI CAGA; ESCHERICHIA-COLI TIR; ACTIN PEDESTAL
   FORMATION; MASS-SPECTROMETRY; KINASES; PROTEOMICS; SRC; NCK; SCATTERING;
   INDUCTION
AB Selective interactions between tyrosine-phosphorylated proteins and their cognate, SH2-domain containing ligands play key roles in mammalian signal transduction. Several bacterial pathogens use secretion systems to inject tyrosine kinase substrates into host cells. Upon phosphorylation, these effector proteins recruit cellular binding partners to manipulate host cell functions. So far, only a few interaction partners have been identified. Here we report the results of a proteomic screen to systematically identify binding partners of all known tyrosine-phosphorylated bacterial effectors by high-resolution mass spectrometry. We identified 39 host interactions, all mediated by SH2 domains, including four of the five already known interaction partners. Individual phosphorylation sites recruited a surprisingly high number of cellular interaction partners suggesting that individual phosphorylation sites can interfere with multiple cellular signaling pathways. Collectively, our results indicate that tyrosine-phosphorylation sites of bacterial effector proteins have evolved as versatile interaction modules that can recruit a rich repertoire of cellular SH2 domains.
C1 [Selbach, Matthias; Mann, Matthias] Max Planck Inst Biochem, Dept Prote & Signal Transduct, D-82152 Martinsried, Germany.
   [Selbach, Matthias; Paul, Florian Ernst; Daumke, Oliver] Max Delbruck Ctr Mol Med, D-13092 Berlin, Germany.
   [Brandt, Sabine] Otto von Guericke Univ, Inst Med Microbiol, D-39120 Magdeburg, Germany.
   [Guye, Patrick; Dehio, Christoph] Univ Basel, Focal Area Infect Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Backert, Steffen] Univ Coll Dublin, Sch Biomol & Biomed Sci, Dublin 4, Ireland.
RP Selbach, M (corresponding author), Max Planck Inst Biochem, Dept Prote & Signal Transduct, Klopferspitz 18, D-82152 Martinsried, Germany.
EM matthias.selbach@mdc-berlin.de; mmann@biochem.mpg.de
RI Mann, Matthias/A-3454-2013; Brandt, Sabine/ABE-9674-2020; Dehio,
   Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016; Selbach,
   Matthias/C-5988-2008
OI Mann, Matthias/0000-0003-1292-4799; Dehio,
   Christoph/0000-0001-7288-1052; Dehio, Christoph/0000-0001-7288-1052; 
FU European UnionEuropean Union (EU); Swiss National Science
   FoundationSwiss National Science Foundation (SNSF) [3100A0-109925/1];
   Howard Hughes Medical InstituteHoward Hughes Medical Institute; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [Ba1671/3-1,
   Ba1671/8-1]
FX We thank John Leong (University of Massachusetts) for providing us with
   HA-tagged Tir constructs and Luis Serrano (Centre de Regulacio Genomica,
   Barcelona, Spain) for the SH2-domain GST fusion proteins. We would also
   like to thank B. Blagoev, S. Hanke, B. Macek, J. Olsen, W. Schulze, and
   the other members of the department Department of Proteomics and Signal
   Transduction in Martinsried and the Center of Experimental
   Bioinformatics in Odense/Denmark for fruitful discussions and
   assistance. The work was supported by the Interaction Proteome project
   of the European Union (M.M.), the Swiss National Science Foundation
   (3100A0-109925/1) and the Howard Hughes Medical Institute (55005501)
   (C.D.), and the Deutsche Forschungsgemeinschaft (Ba1671/3-1 and
   Ba1671/8-1) (S.B.).
CR Backert S, 2005, TRENDS MICROBIOL, V13, P476, DOI 10.1016/j.tim.2005.08.002
   Backert S, 2001, MOL MICROBIOL, V42, P631, DOI 10.1046/j.1365-2958.2001.02649.x
   Bhavsar AP, 2007, NATURE, V449, P827, DOI 10.1038/nature06247
   Bommarius B, 2007, MOL MICROBIOL, V63, P1748, DOI 10.1111/j.1365-2958.2007.05626.x
   Brady MJ, 2007, CELL MICROBIOL, V9, P2242, DOI 10.1111/j.1462-5822.2007.00954.x
   Campellone KG, 2005, MOL MICROBIOL, V56, P416, DOI 10.1111/j.1365-2958.2005.04558.x
   Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753
   Clifton DR, 2004, P NATL ACAD SCI USA, V101, P10166, DOI 10.1073/pnas.0402829101
   Deng KP, 2008, INFECT IMMUN, V76, P4692, DOI 10.1128/IAI.00513-08
   Frank J., 1997, RETINOIDS, V13, P88
   Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272
   Gingras AC, 2007, NAT REV MOL CELL BIO, V8, P645, DOI 10.1038/nrm2208
   Gruenheid S, 2001, NAT CELL BIOL, V3, P856, DOI 10.1038/ncb0901-856
   Higashi H, 2002, SCIENCE, V295, P683, DOI 10.1126/science.1067147
   Kawabuchi M, 2000, NATURE, V404, P999
   Kenny B, 1997, CELL, V91, P511, DOI 10.1016/S0092-8674(00)80437-7
   Kocher T, 2007, NAT METHODS, V4, P807, DOI 10.1038/NMETH1093
   Lane BJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000014
   Lin MQ, 2007, CELL MICROBIOL, V9, P2644, DOI 10.1111/j.1462-5822.2007.00985.x
   Mann M, 2006, NAT REV MOL CELL BIO, V7, P952, DOI 10.1038/nrm2067
   Mimuro H, 2002, MOL CELL, V10, P745, DOI 10.1016/S1097-2765(02)00681-0
   Mimuro H, 2007, CELL HOST MICROBE, V2, P250, DOI 10.1016/j.chom.2007.09.005
   Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200
   Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736
   Phillips N, 2004, NAT CELL BIOL, V6, P618, DOI 10.1038/ncb1148
   Pizarro-Cerda J, 2006, CELL, V124, P715, DOI 10.1016/j.cell.2006.02.012
   Poppe M, 2007, ONCOGENE, V26, P3462, DOI 10.1038/sj.onc.1210139
   Schlessinger Joseph, 2003, Sci STKE, V2003, pRE12, DOI 10.1126/stke.2003.191.re12
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulze WX, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100012
   Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200
   Seet BT, 2006, NAT REV MOL CELL BIO, V7, P473, DOI 10.1038/nrm1960
   Segal ED, 1999, P NATL ACAD SCI USA, V96, P14559, DOI 10.1073/pnas.96.25.14559
   Selbach M, 2002, J BIOL CHEM, V277, P6775, DOI 10.1074/jbc.C100754200
   Selbach M, 2006, NAT METHODS, V3, P981, DOI 10.1038/nmeth972
   Stein M, 2002, MOL MICROBIOL, V43, P971, DOI 10.1046/j.1365-2958.2002.02781.x
   Stelzl U, 2006, CURR OPIN CHEM BIOL, V10, P551, DOI 10.1016/j.cbpa.2006.10.005
   Suzuki M, 2005, J EXP MED, V202, P1235, DOI 10.1084/jem.20051027
   Swimm A, 2004, MOL BIOL CELL, V15, P3520, DOI 10.1091/mbc.E04-02-0093
   Tammer I, 2007, GASTROENTEROLOGY, V132, P1309, DOI 10.1053/j.gastro.2007.01.050
   Tsutsumi R, 2003, J BIOL CHEM, V278, P3664, DOI 10.1074/jbc.M208155200
   ZHOU SY, 1993, CELL, V72, P767, DOI 10.1016/0092-8674(93)90404-E
NR 42
TC 125
Z9 127
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD APR 23
PY 2009
VL 5
IS 4
BP 397
EP 403
DI 10.1016/j.chom.2009.03.004
PG 7
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 438QX
UT WOS:000265571600012
PM 19380118
DA 2021-01-25
ER

PT J
AU Poy, MN
   Hausser, J
   Trajkovski, M
   Braun, M
   Collins, S
   Rorsman, P
   Zavolan, M
   Stoffel, M
AF Poy, Matthew N.
   Hausser, Jean
   Trajkovski, Mirko
   Braun, Matthias
   Collins, Stephan
   Rorsman, Patrik
   Zavolan, Mihaela
   Stoffel, Markus
TI miR-375 maintains normal pancreatic alpha- and beta-cell mass
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE diabetes; glucagon; microRNA; islet; proliferation
ID INSULIN-SECRETION; INDUCED APOPTOSIS; MICE; MICRORNAS; EXPRESSION;
   MECHANISM; ABSENCE; ARREST; GROWTH; ROLES
AB Altered growth and development of the endocrine pancreas is a frequent cause of the hyperglycemia associated with diabetes. Here we show that microRNA-375 (miR-375), which is highly expressed in pancreatic islets, is required for normal glucose homeostasis. Mice lacking miR-375 (375KO) are hyperglycemic, exhibit increased total pancreatic alpha-cell numbers, fasting and fed plasma glucagon levels, and increased gluconeogenesis and hepatic glucose output. Furthermore, pancreatic beta-cell mass is decreased in 375KO mice as a result of impaired proliferation. In contrast, pancreatic islets of obese mice (ob/ob), a model of increased beta-cell mass, exhibit increased expression of miR-375. Genetic deletion of miR-375 from these animals (375/ob) profoundly diminished the proliferative capacity of the endocrine pancreas and resulted in a severely diabetic state. Bioinformatic analysis of transcript data from 375KO islets revealed that miR-375 regulates a cluster of genes controlling cellular growth and proliferation. These data provide evidence that miR-375 is essential for normal glucose homeostasis, alpha- and beta-cell turnover, and adaptive beta-cell expansion in response to increasing insulin demand in insulin resistance.
C1 [Poy, Matthew N.; Trajkovski, Mirko; Stoffel, Markus] ETH, Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
   [Hausser, Jean; Zavolan, Mihaela] Univ Basel, Biozentrum, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Braun, Matthias; Collins, Stephan; Rorsman, Patrik] Univ Oxford, Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England.
RP Stoffel, M (corresponding author), ETH, Swiss Fed Inst Technol, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland.
EM stoffel@imsb.biol.ethz.ch
RI Rorsman, Patrik/A-4331-2016; Poy, Matthew/F-6914-2017; Zavolan,
   Mihaela/S-3888-2016; collins, stephan/P-4409-2016
OI Rorsman, Patrik/0000-0001-7578-0767; Poy, Matthew/0000-0002-4904-2426;
   collins, stephan/0000-0002-1533-3380; Trajkovski,
   Mirko/0000-0002-3152-9551; Hausser, Jean/0000-0002-3321-7199; Zavolan,
   Mihaela/0000-0002-8832-2041
FU Juvenile Diabetes Research FoundationJuvenile Diabetes Research
   Foundation; National Institutes of HealthUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA;
   Wellcome TrustWellcome Trust; Ruth L. Kirschstein FellowshipUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA; Schweizerische NationalfondsSwiss National Science
   Foundation (SNSF) [3100A0-114001]
FX We thank J. Krutzfeldt, M. Spranger, C. Wolfrum, F. von Meyenn, M.
   Gstaiger, A. von Eckhardstein, A. Schaefer, R. Yi, and V. Horsley for
   advice and technical assistance. This work was supported in part by the
   Juvenile Diabetes Research Foundation, the National Institutes of
   Health, and the Wellcome Trust. M.N.P. was supported by a Ruth L.
   Kirschstein Fellowship. J. H. is partially supported by Schweizerische
   Nationalfonds Grant 3100A0-114001 to M.Z. M. T. was supported by a
   Juvenile Diabetes Research Foundation Post-Doctoral Fellowship.
CR Akamatsu W, 2005, P NATL ACAD SCI USA, V102, P4625, DOI 10.1073/pnas.0407523102
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Bock T, 2003, DIABETES, V52, P1716, DOI 10.2337/diabetes.52.7.1716
   BONNERWEIR S, 1983, J CLIN INVEST, V71, P1544, DOI 10.1172/JCI110910
   Borelli Maria I, 2003, BMC Endocr Disord, V3, P2, DOI 10.1186/1472-6823-3-2
   Buckbinder L, 1997, P NATL ACAD SCI USA, V94, P7868, DOI 10.1073/pnas.94.15.7868
   Chen M, 2005, J CLIN INVEST, V115, P3217, DOI 10.1172/JCI24196
   Cheung ECC, 2006, EMBO J, V25, P4061, DOI 10.1038/sj.emboj.7601276
   Cohen AW, 2003, AM J PHYSIOL-CELL PH, V284, pC457, DOI 10.1152/ajpcell.00380.2002
   Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841
   Galbiati F, 2001, MOL BIOL CELL, V12, P2229, DOI 10.1091/mbc.12.8.2229
   Gromada J, 2007, ENDOCR REV, V28, P84, DOI 10.1210/er.2006-0007
   Joe MK, 2008, CELL SIGNAL, V20, P907, DOI 10.1016/j.cellsig.2008.01.005
   Johnson JD, 2003, J CLIN INVEST, V111, P1147, DOI 10.1172/JCI200316537
   Kamal A, 2006, APOPTOSIS, V11, P861, DOI 10.1007/s10495-006-5396-4
   Kee BL, 2005, J IMMUNOL, V175, P4518, DOI 10.4049/jimmunol.175.7.4518
   Kloosterman WP, 2007, PLOS BIOL, V5, P1738, DOI 10.1371/journal.pbio.0050203
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Kulkarni RN, 2002, NAT GENET, V31, P111, DOI 10.1038/ng872
   Kuramochi M, 2001, NAT GENET, V27, P427, DOI 10.1038/86934
   LEVEILLE GA, 1968, J NUTR, V96, P397
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175
   Park BJ, 2005, CELL, V120, P209, DOI 10.1016/j.cell.2004.11.054
   Parker JC, 2002, BIOCHEM BIOPH RES CO, V290, P839, DOI 10.1006/bbrc.2001.6265
   Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076
   Reyes JC, 1998, EMBO J, V17, P6979, DOI 10.1093/emboj/17.23.6979
   Shih DQ, 2002, P NATL ACAD SCI USA, V99, P3818, DOI 10.1073/pnas.062605899
   Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229
   Vaidyanathan G, 2004, ONCOGENE, V23, P5858, DOI 10.1038/sj.onc.1207774
   van Rooij E, 2007, SCIENCE, V316, P575, DOI 10.1126/science.1139089
   Wang SS, 2008, DEV CELL, V15, P261, DOI 10.1016/j.devcel.2008.07.002
   Yi R, 2006, NAT GENET, V38, P356, DOI 10.1038/ng1744
   Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030
NR 35
TC 512
Z9 539
U1 1
U2 29
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD APR 7
PY 2009
VL 106
IS 14
BP 5813
EP 5818
DI 10.1073/pnas.0810550106
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 430CX
UT WOS:000264967500065
PM 19289822
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Blagosklonny, MV
   Hall, MN
AF Blagosklonny, Mikhail V.
   Hall, Michael N.
TI Growth and aging: a common molecular mechanism
SO AGING-US
LA English
DT Review
DE aging; growth; rapamycin; TOR; mitochondria
ID LIFE-SPAN EXTENSION; CALORIE RESTRICTION; CELLULAR SENESCENCE;
   INSULIN-RECEPTOR; SACCHAROMYCES-CEREVISIAE; REDUCED INCIDENCE; MAMMALIAN
   TARGET; UP-REGULATION; TOR; YEAST
AB It is commonly assumed that growth and aging are somehow linked, but the nature of this link has been elusive. Here we review the aging process as a continuation of TOR-driven growth. TOR is absolutely essential for developmental growth, but upon completion of development it causes aging and age-related diseases. Thus, the nutrient-sensing and growth-promoting TOR signaling pathway may provide a molecular link between growth and aging that is universal from yeast to human.
C1 [Blagosklonny, Mikhail V.] Roswell Pk Canc Inst, Buffalo, NY 14263 USA.
   [Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Blagosklonny, MV (corresponding author), Roswell Pk Canc Inst, Elm & Carlton St, Buffalo, NY 14263 USA.
EM blagosklonny@oncotarget.com; m.hall@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Canton of Basel
FX M.N.H. acknowledges support from the Swiss National Science Foundation
   and the Canton of Basel.
CR An WL, 2003, AM J PATHOL, V163, P591, DOI 10.1016/S0002-9440(10)63687-5
   ANGELLO JC, 1987, J CELL PHYSIOL, V132, P125, DOI 10.1002/jcp.1041320117
   Austriaco NR, 1996, YEAST, V12, P623, DOI 10.1002/(SICI)1097-0061(19960615)12:7<623::AID-YEA968>3.0.CO;2-G
   Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882
   Bartke A, 2006, TRENDS ENDOCRIN MET, V17, P33, DOI 10.1016/j.tem.2006.01.002
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Berger Z, 2006, HUM MOL GENET, V15, P433, DOI 10.1093/hmg/ddi458
   Bilinski T, 2006, ACTA BIOCHIM POL, V53, P833
   Blagosklonny MV, 2006, CELL CYCLE, V5, P2087, DOI 10.4161/cc.5.18.3288
   Blagosklonny MV, 2009, AGING-US, V1, P281, DOI 10.18632/aging.100034
   Bluher M, 2003, SCIENCE, V299, P572, DOI 10.1126/science.1078223
   Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009
   Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616
   Campisi J, 1998, J Investig Dermatol Symp Proc, V3, P1
   Campistol JM, 2006, J AM SOC NEPHROL, V17, P581, DOI 10.1681/ASN.2005090993
   Colombani J, 2003, CELL, V114, P739, DOI 10.1016/S0092-8674(03)00713-X
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   DEMIDENKO ZN, 2009, AGING, V1
   DEMIDENKO ZN, 2009, CELL CYCLE, V8
   Demidenko ZN, 2008, CELL CYCLE, V7, P3355, DOI 10.4161/cc.7.21.6919
   Echave P, 2007, CELL CYCLE, V6, P218, DOI 10.4161/cc.6.2.3744
   Gu YP, 2004, FEBS LETT, V577, P357, DOI 10.1016/j.febslet.2004.10.040
   Guarente L, 2005, CELL, V120, P473, DOI 10.1016/j.cell.2005.01.029
   Guarente L, 2000, NATURE, V408, P255, DOI 10.1038/35041700
   Hansen M, 2007, AGING CELL, V6, P95, DOI 10.1111/j.1474-9726.2006.00267.x
   HAYFLICK L, 1965, EXP CELL RES, V37, P614, DOI 10.1016/0014-4827(65)90211-9
   Jia K, 2004, DEVELOPMENT, V131, P3897, DOI 10.1242/dev.01255
   Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535
   Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059
   Kauffman HM, 2005, TRANSPLANTATION, V80, P883, DOI 10.1097/01.TP.0000184006.43152.8D
   KENNEDY BK, 1994, J CELL BIOL, V127, P1985, DOI 10.1083/jcb.127.6.1985
   Kenyon C, 2005, CELL, V120, P449, DOI 10.1016/j.cell.2005.02.002
   Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042
   Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942
   KLIONSKY DJ, 2007, NAT REV MOL CELL BIO
   Krebs M, 2007, DIABETES, V56, P1600, DOI 10.2337/db06-1016
   Leelahavanichkul Asada, 2005, J Med Assoc Thai, V88 Suppl 4, pS157
   Leung LY, 2006, THER DRUG MONIT, V28, P51, DOI 10.1097/01.ftd.0000179838.33020.34
   Lin SJ, 2002, NATURE, V418, P344, DOI 10.1038/nature00829
   Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Medvedik O, 2007, PLOS BIOL, V5, P2330, DOI 10.1371/journal.pbio.0050261
   Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782
   Pan KZ, 2007, AGING CELL, V6, P111, DOI 10.1111/j.1474-9726.2006.00266.x
   Pan Y, 2009, AGING-US, V1, P131, DOI 10.18632/aging.100016
   PASCUAL J, 2006, NEPHROL DIAL TRANSPL, V3, P38
   Patil CK, 2005, MECH AGEING DEV, V126, P1040, DOI 10.1016/j.mad.2005.08.001
   PENDERGRASS W, 1989, EXP GERONTOL, V24, P383, DOI 10.1016/0531-5565(89)90046-6
   Pinkston JM, 2006, SCIENCE, V313, P971, DOI 10.1126/science.1121908
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406
   Powers T, 2007, CELL METAB, V6, P1, DOI 10.1016/j.cmet.2007.06.009
   Rovira J, 2008, TRANSPL INT, V21, P992, DOI 10.1111/j.1432-2277.2008.00710.x
   Rubin H, 2002, NAT BIOTECHNOL, V20, P675, DOI 10.1038/nbt0702-675
   Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291
   Schieke SM, 2007, CELL METAB, V5, P233, DOI 10.1016/j.cmet.2007.03.005
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   SHERWOOD SW, 1988, P NATL ACAD SCI USA, V85, P9086, DOI 10.1073/pnas.85.23.9086
   Sonntag WE, 2005, ENDOCRINOLOGY, V146, P2920, DOI 10.1210/en.2005-0058
   Stallone G, 2005, NEW ENGL J MED, V352, P1317, DOI 10.1056/NEJMoa042831
   Steffen KK, 2008, CELL, V133, P292, DOI 10.1016/j.cell.2008.02.037
   Syntichaki P, 2007, NATURE, V445, P922, DOI 10.1038/nature05603
   Tatar M, 2001, SCIENCE, V292, P107, DOI 10.1126/science.1057987
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a
   Wei M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040013
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yakupoglu YK, 2006, TRANSPL P, V38, P358, DOI 10.1016/j.transproceed.2006.01.019
   Zadrag R, 2006, ACTA BIOCHIM POL, V53, P747, DOI 10.18388/abp.2006_3302
   ZHANG H, 2000, GENES DEV, V14
NR 70
TC 164
Z9 173
U1 0
U2 14
PU IMPACT JOURNALS LLC
PI ORCHARD PARK
PA 6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA
SN 1945-4589
J9 AGING-US
JI Aging-US
PD APR
PY 2009
VL 1
IS 4
BP 357
EP 362
DI 10.18632/aging.100040
PG 6
WC Cell Biology; Geriatrics & Gerontology
SC Cell Biology; Geriatrics & Gerontology
GA 579UN
UT WOS:000276401100003
PM 20157523
OA Green Published
DA 2021-01-25
ER

PT J
AU Polak, P
   Hall, MN
AF Polak, Pazit
   Hall, Michael N.
TI mTOR and the control of whole body metabolism
SO CURRENT OPINION IN CELL BIOLOGY
LA English
DT Article
ID DIET-INDUCED OBESITY; P70 S6 KINASE; BETA-CELL MASS; MAMMALIAN TARGET;
   SKELETAL-MUSCLE; RAPAMYCIN COMPLEX-1; PROTEIN-KINASE; AMINO-ACIDS;
   DEPENDENT REGULATION; GLUCOSE-HOMEOSTASIS
AB Mammalian Target of Rapamycin (mTOR) is a highly conserved protein kinase that functions as part of two distinct multiprotein complexes to regulate growth and metabolism. This review describes the most important recent advances in the mTOR signaling field. In addition, we provide an overview on the functions of mTOR in different organs, with a special focus on the role of mTOR in whole body energy metabolism.
C1 [Polak, Pazit; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Canton of Basel
FX We apologize to colleagues whose work we could not describe owing to
   space limitations. MNH acknowledges support from the Swiss National
   Science Foundation and the Canton of Basel.
CR Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006
   Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008
   Azzariti A, 2008, BIOCHEM PHARMACOL, V75, P1035, DOI 10.1016/j.bcp.2007.11.018
   Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Blouet C, 2008, CELL METAB, V8, P459, DOI 10.1016/j.cmet.2008.10.004
   Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024
   Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028
   Bussiere CT, 2006, DIABETOLOGIA, V49, P2341, DOI 10.1007/s00125-006-0374-5
   Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200
   Carracedo A, 2008, J CLIN INVEST, V118, P3065, DOI [10.1172/jCI34739, 10.1172/JCI34739]
   Chen SH, 2007, MOL BIOL CELL, V18, P2525, DOI 10.1091/mbc.E07-02-0188
   Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008
   Cota D, 2006, SCIENCE, V312, P927, DOI 10.1126/science.1124147
   Cota D, 2008, J NEUROSCI, V28, P7202, DOI 10.1523/JNEUROSCI.1389-08.2008
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dan HC, 2008, GENE DEV, V22, P1490, DOI 10.1101/gad.1662308
   De Virgilio C, 2006, INT J BIOCHEM CELL B, V38, P1476, DOI 10.1016/j.biocel.2006.02.013
   Deldicque L, 2005, EUR J APPL PHYSIOL, V94, P1, DOI 10.1007/s00421-004-1255-6
   DeYoung MP, 2008, GENE DEV, V22, P239, DOI 10.1101/gad.1617608
   Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310
   Drummond MJ, 2008, CURR OPIN CLIN NUTR, V11, P222, DOI 10.1097/MCO.0b013e3282fa17fb
   DRUMMOND MJ, 2008, J APPL PHYSIOL, P90842
   Eskelinen EL, 2002, TRAFFIC, V3, P878, DOI 10.1034/j.1600-0854.2002.31204.x
   Facchinetti V, 2008, EMBO J, V27, P1932, DOI 10.1038/emboj.2008.120
   Feng ZH, 2005, P NATL ACAD SCI USA, V102, P8204, DOI 10.1073/pnas.0502857102
   Feng ZH, 2007, CANCER RES, V67, P3043, DOI 10.1158/0008-5472.CAN-06-4149
   Findlay GM, 2007, BIOCHEM J, V403, P13, DOI 10.1042/BJ20061881
   Fonseca BD, 2007, J BIOL CHEM, V282, P24514, DOI 10.1074/jbc.M704406200
   Fraenkel M, 2008, DIABETES, V57, P945, DOI 10.2337/db07-0922
   Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004
   Garcia-Martinez JM, 2008, BIOCHEM J, V416, P375, DOI 10.1042/BJ20081668
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Hong F, 2008, MOL CELL, V30, P701, DOI 10.1016/j.molcel.2008.04.027
   Hsu YC, 2007, NATURE, V445, P785, DOI 10.1038/nature05528
   Huang JX, 2008, MOL CELL BIOL, V28, P4104, DOI 10.1128/MCB.00289-08
   Ikenoue T, 2008, EMBO J, V27, P2270, DOI 10.1038/emboj.2008.146
   Inoki K, 2006, CELL, V126, P955, DOI 10.1016/j.cell.2006.06.055
   Jacinto E, 2008, BIOCHEM J, V410, P19, DOI 10.1042/BJ20071518
   Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033
   Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051
   Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Koketsu Y, 2008, AM J PHYSIOL-ENDOC M, V294, pE719, DOI 10.1152/ajpendo.00253.2007
   Kong M, 2004, SCIENCE, V306, P695, DOI 10.1126/science.1100537
   Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07
   Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528
   Lee CH, 2007, EMBO J, V26, P4812, DOI 10.1038/sj.emboj.7601900
   Lee DF, 2007, CELL, V130, P440, DOI 10.1016/j.cell.2007.05.058
   Ma DZ, 2008, J BIOL CHEM, V283, P25963, DOI 10.1074/jbc.M802356200
   MacKenzie MG, 2007, BIOCHEM SOC T, V35, P1314, DOI 10.1042/BST0351314
   Mak BC, 2003, J BIOL CHEM, V278, P5947, DOI 10.1074/jbc.C200473200
   Mao JH, 2008, SCIENCE, V321, P1499, DOI 10.1126/science.1162981
   Max X, 2008, CELL, V133, P303, DOI 10.1016/j.cell.2008.02.031
   Mordier S, 2007, BIOCHEM BIOPH RES CO, V362, P206, DOI 10.1016/j.bbrc.2007.08.004
   Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004
   Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102
   Oshiro N, 2007, J BIOL CHEM, V282, P20329, DOI 10.1074/jbc.M702636200
   Ozean U, 2008, MOL CELL, V29, P541, DOI [10.1016/j.moicel.2007.12.023, 10.1016/j.molcel.2007.12.023]
   Park KK, 2008, SCIENCE, V322, P963, DOI 10.1126/science.1161566
   Pearce LR, 2007, BIOCHEM J, V405, P513, DOI 10.1042/BJ20070540
   Pende M, 2000, NATURE, V408, P994
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Rachdi L, 2008, P NATL ACAD SCI USA, V105, P9250, DOI 10.1073/pnas.0803047105
   Rehmann H, 2008, FEBS LETT, V582, P3005, DOI 10.1016/j.febslet.2008.07.057
   Rovira J, 2008, TRANSPL INT, V21, P992, DOI 10.1111/j.1432-2277.2008.00710.x
   Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781
   Shen WH, 2008, J BIOL CHEM, V283, P13842, DOI 10.1074/jbc.M801510200
   Shigeyama Y, 2008, MOL CELL BIOL, V28, P2971, DOI 10.1128/MCB.01695-07
   Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013
   Takai H, 2007, CELL, V131, P1248, DOI 10.1016/j.cell.2007.10.052
   Tassa A, 2003, BIOCHEM J, V376, P577, DOI 10.1042/BJ20030826
   Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217
   Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547
   Wang CH, 2007, J BIOL CHEM, V282, P7991, DOI 10.1074/jbc.M700098200
   Wang LF, 2007, J BIOL CHEM, V282, P20036, DOI 10.1074/jbc.M702376200
   Wang XM, 2008, J BIOL CHEM, V283, P30482, DOI 10.1074/jbc.M803348200
   Woo SY, 2007, J BIOL CHEM, V282, P25604, DOI 10.1074/jbc.M704343200
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103
   Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64
   Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206
   Zahr E, 2008, TRANSPL P, V40, P436, DOI 10.1016/j.transproceed.2008.02.011
NR 94
TC 221
Z9 232
U1 2
U2 23
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0955-0674
EI 1879-0410
J9 CURR OPIN CELL BIOL
JI Curr. Opin. Cell Biol.
PD APR
PY 2009
VL 21
IS 2
BP 209
EP 218
DI 10.1016/j.ceb.2009.01.024
PG 10
WC Cell Biology
SC Cell Biology
GA 441MK
UT WOS:000265773000010
PM 19261457
DA 2021-01-25
ER

PT J
AU Jenal, U
   Dorman, CJ
AF Jenal, Urs
   Dorman, Charles J.
TI Small molecule signaling
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Editorial Material
ID BIOSYNTHESIS; MECHANISM; PROTEINS
C1 [Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Dorman, Charles J.] Trinity Coll Dublin, Moyne Inst Prevent Med, Sch Genet & Microbiol, Dept Microbiol, Dublin 2, Ireland.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch; cjdorman@tcd.ie
RI Dorman, Charles/N-9867-2015; Dorman, Charles/P-3481-2019
OI Dorman, Charles/0000-0002-6018-9170; Dorman, Charles/0000-0002-6018-9170
CR JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7
   MONOD J, 1963, J MOL BIOL, V6, P306, DOI 10.1016/S0022-2836(63)80091-1
   UMBARGER HE, 1956, SCIENCE, V123, P848, DOI 10.1126/science.123.3202.848
   YATES RA, 1956, J BIOL CHEM, V221, P757
NR 4
TC 7
Z9 7
U1 0
U2 4
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD APR
PY 2009
VL 12
IS 2
BP 125
EP 128
DI 10.1016/j.mib.2009.02.002
PG 4
WC Microbiology
SC Microbiology
GA 440NR
UT WOS:000265707500001
PM 19278897
DA 2021-01-25
ER

PT J
AU Jenal, U
   Galperin, MY
AF Jenal, Urs
   Galperin, Michael Y.
TI Single domain response regulators: molecular switches with emerging
   roles in cell organization and dynamics
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review
ID BACTERIAL SIGNAL-TRANSDUCTION; MYXOCOCCUS-XANTHUS;
   CAULOBACTER-CRESCENTUS; GLIDING MOTILITY; RHODOBACTER-SPHAEROIDES;
   DIGUANYLATE CYCLASE; ESCHERICHIA-COLI; STRUCTURAL BASIS; RECEIVER
   DOMAIN; PROTEASE COMPLEX
AB Single domain response regulators (SD-RRs) are signaling components of two-component phosphorylation pathways that harbor a phosphoryl receiver domain but lack a dedicated output domain. The Escherichia coli protein CheY, the paradigm member of this family, regulates chemotaxis by relaying information between chemoreceptors and the flagellar motor switch. New data provide a more complex picture of CheY-mediated motility control in several bacteria and suggest diverging mechanisms in control of cellular motors. Moreover, advances have been made in understanding cellular functions of SD-RRs beyond chemotaxis. We review recent reports indicating that SD-RRs constitute a family of versatile molecular switches that contribute to cellular organization and dynamics as spatial organizer and/or as allosteric regulators of histidine protein kinases.
C1 [Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Galperin, Michael Y.] Natl Inst Hlth, NCBI, Natl Lib Med, Bethesda, MD 20894 USA.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch; galperin@ncbi.nlm.nih.gov
RI Galperin, Michael Y./N-1457-2019; Galperin, Michael/B-5859-2013
OI Galperin, Michael Y./0000-0002-2265-5572; Galperin,
   Michael/0000-0002-2265-5572
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-108186]; National Library of Medicine at the National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Library of
   Medicine (NLM); NATIONAL LIBRARY OF MEDICINEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Library of Medicine (NLM) [ZIALM000073, ZIALM000073,
   ZIALM000073, ZIALM000073, ZIALM000073, ZIALM000073, ZIALM000073,
   ZIALM000073, ZIALM000073, ZIALM000073] Funding Source: NIH RePORTER
FX We would like to thank Tilman Schirmer for his help with Figure 2 and
   members of the Jenal lab for helpful comments. UJ is supported by Swiss
   National Science Foundation Fellowship 3100A0-108186. MYG is supported
   by the Intramural Research Program of the National Library of Medicine
   at the National Institutes of Health.
CR Bachhawat P, 2007, J BACTERIOL, V189, P5987, DOI 10.1128/JB.00049-07
   Baikalov I, 1996, BIOCHEMISTRY-US, V35, P11053, DOI 10.1021/bi960919o
   Batchelor JD, 2008, J MOL BIOL, V384, P1058, DOI 10.1016/j.jmb.2008.10.024
   Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321
   Bowers LM, 2008, CURR OPIN MICROBIOL, V11, P547, DOI 10.1016/j.mib.2008.09.019
   Bren A, 1998, J MOL BIOL, V278, P507, DOI 10.1006/jmbi.1998.1730
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Chien P, 2007, P NATL ACAD SCI USA, V104, P6590, DOI 10.1073/pnas.0701776104
   De Carlo S, 2006, GENE DEV, V20, P1485, DOI 10.1101/gad.1418306
   del Campo AM, 2007, J BACTERIOL, V189, P8397, DOI 10.1128/JB.00730-07
   Djordjevic S, 1998, P NATL ACAD SCI USA, V95, P1381, DOI 10.1073/pnas.95.4.1381
   Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4
   Duerig A, 2009, GENE DEV, V23, P93, DOI 10.1101/gad.502409
   Dyer CM, 2004, J MOL BIOL, V342, P1325, DOI 10.1016/j.jmb.2004.07.084
   Dyer CM, 2006, J BACTERIOL, V188, P7354, DOI 10.1128/JB.00637-06
   Galperin MY, 2006, J BACTERIOL, V188, P4169, DOI 10.1128/JB.01887-05
   Gao R, 2007, TRENDS BIOCHEM SCI, V32, P225, DOI 10.1016/j.tibs.2007.03.002
   Goldman BS, 2006, P NATL ACAD SCI USA, V103, P15200, DOI 10.1073/pnas.0607335103
   Goley ED, 2007, J CELL SCI, V120, P3501, DOI 10.1242/jcs.005967
   Hartzell PL, 1997, P NATL ACAD SCI USA, V94, P9881, DOI 10.1073/pnas.94.18.9881
   HECHT GB, 1995, J BACTERIOL, V177, P6223, DOI 10.1128/jb.177.21.6223-6229.1995
   HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x
   Hoch JA, 2001, J BACTERIOL, V183, P4941, DOI 10.1128/JB.183.17.4941-4949.2001
   HODGKIN J, 1979, MOL GEN GENET, V171, P177, DOI 10.1007/BF00270004
   Inclan YF, 2008, MOL MICROBIOL, V68, P1328, DOI 10.1111/j.1365-2958.2008.06238.x
   Inclan YF, 2007, MOL MICROBIOL, V65, P90, DOI 10.1111/j.1365-2958.2007.05774.x
   Iniesta AA, 2008, P NATL ACAD SCI USA, V105, P16602, DOI 10.1073/pnas.0808807105
   Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103
   Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998
   Jarrell KF, 2008, NAT REV MICROBIOL, V6, P466, DOI 10.1038/nrmicro1900
   Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658
   Kern D, 1999, NATURE, V402, P894, DOI 10.1038/47273
   KOSHLAND DE, 1977, SCIENCE, V196, P1055, DOI 10.1126/science.870969
   Lam H, 2003, DEV CELL, V5, P149, DOI 10.1016/S1534-5807(03)00191-6
   Lee SY, 2001, NAT STRUCT BIOL, V8, P52
   Leonardy S, 2007, EMBO J, V26, P4433, DOI 10.1038/sj.emboj.7601877
   Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019
   McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033
   Mignot T, 2005, SCIENCE, V310, P855, DOI 10.1126/science.1119052
   Mignot T, 2008, BIOESSAYS, V30, P733, DOI 10.1002/bies.20790
   Mignot T, 2007, SCIENCE, V315, P853, DOI 10.1126/science.1137223
   Nudleman E, 2006, MOL MICROBIOL, V60, P16, DOI 10.1111/j.1365-2958.2006.05095.x
   Park S, 2002, FASEB J, V16, P1964, DOI 10.1096/fj.02-0395fje
   Park SY, 2006, P NATL ACAD SCI USA, V103, P11886, DOI 10.1073/pnas.0602811103
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045
   Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200
   Porter SL, 2008, TRENDS MICROBIOL, V16, P251, DOI 10.1016/j.tim.2008.02.006
   Porter SL, 2006, J BIOL CHEM, V281, P32694, DOI 10.1074/jbc.M606016200
   Radhakrishnan SK, 2008, GENE DEV, V22, P212, DOI 10.1101/gad.1601808
   Ryan KR, 2004, P NATL ACAD SCI USA, V101, P7415, DOI 10.1073/pnas.0402153101
   Simonovic M, 2001, J BIOL CHEM, V276, P28637, DOI 10.1074/jbc.C100295200
   SOMMER JM, 1991, GENETICS, V129, P623
   Sourjik V, 1998, BIOCHEMISTRY-US, V37, P2327, DOI 10.1021/bi972330a
   Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199
   Spormann AM, 1999, J BACTERIOL, V181, P2593, DOI 10.1128/JB.181.8.2593-2601.1999
   Spormann AM, 1999, MICROBIOL MOL BIOL R, V63, P621, DOI 10.1128/MMBR.63.3.621-641.1999
   Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183
   Toker AS, 1997, J MOL BIOL, V273, P623, DOI 10.1006/jmbi.1997.1335
   Toro-Roman A, 2005, PROTEIN SCI, V14, P3077, DOI 10.1110/ps.051722805
   Toro-Roman A, 2005, J MOL BIOL, V349, P11, DOI 10.1016/j.jmb.2005.03.059
   Varughese KI, 2005, J BACTERIOL, V187, P8221, DOI 10.1128/JB.187.24.8221-8227.2005
   Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999
   Volkman BF, 2001, SCIENCE, V291, P2429, DOI 10.1126/science.291.5512.2429
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Zusman DR, 2007, NAT REV MICROBIOL, V5, P862, DOI 10.1038/nrmicro1770
NR 66
TC 69
Z9 72
U1 0
U2 10
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD APR
PY 2009
VL 12
IS 2
BP 152
EP 160
DI 10.1016/j.mib.2009.01.010
PG 9
WC Microbiology
SC Microbiology
GA 440NR
UT WOS:000265707500005
PM 19246239
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Elad, N
   Maimon, T
   Frenkiel-Krispin, D
   Lim, RYH
   Medalia, O
AF Elad, Nadav
   Maimon, Tal
   Frenkiel-Krispin, Daphna
   Lim, Roderick Y. H.
   Medalia, Ohad
TI Structural analysis of the nuclear pore complex by integrated approaches
SO CURRENT OPINION IN STRUCTURAL BIOLOGY
LA English
DT Article
ID PHENYLALANINE-GLYCINE NUCLEOPORINS; FG-REPEAT DOMAINS; NUCLEOCYTOPLASMIC
   TRANSPORT; CRYOELECTRON TOMOGRAPHY; MOLECULAR ARCHITECTURE;
   ELECTRON-MICROSCOPY; IMPORTIN-BETA; DYNAMICS; ENVELOPE; ASSEMBLIES
AB In eukaryotic cells, the nucleus is surrounded by a double membrane system, the nuclear envelope (NE), in which the outer membrane is continuous with the endoplasmic reticulum (ER). Nuclear pore complexes (NPCs) fuse the inner and outer nuclear membranes to form aqueous translocation channels that allow the free diffusion of small molecules and ions, as well as receptor-mediated transport of large macromolecules. Being the sole gateways for import and export to and from the nucleus, NPCs regulate the nucleocytoplasmic transport of macromolecules in a highly selective manner to maintain cellular functions. The large size and complexity of these multimolecular assemblies, which are composed of similar to 30 different proteins (termed nucleoporins), present a major challenge for structural biologists. Here, we discuss the latest structural findings related to the functional organization of the NPC.
C1 [Elad, Nadav; Maimon, Tal; Medalia, Ohad] Ben Gurion Univ Negev, Dept Life Sci, IL-84120 Beer Sheva, Israel.
   [Elad, Nadav; Maimon, Tal; Medalia, Ohad] NIBN, IL-84120 Beer Sheva, Israel.
   [Frenkiel-Krispin, Daphna] Max Planck Inst Biochem, D-82152 Martinsried, Germany.
   [Lim, Roderick Y. H.] Univ Basel, ME Mueller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Lim, Roderick Y. H.] Univ Basel, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
RP Medalia, O (corresponding author), Ben Gurion Univ Negev, Dept Life Sci, IL-84120 Beer Sheva, Israel.
EM omedalia@bgu.ac.il
OI Lim, Roderick/0000-0001-5015-6087; Medalia, Ohad/0000-0003-0994-2937;
   Elad, Nadav/0000-0001-6222-2280
CR ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0
   AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1
   AKEY CW, 1995, J MOL BIOL, V248, P273, DOI 10.1016/S0022-2836(95)80050-6
   Alber F, 2005, STRUCTURE, V13, P435, DOI 10.1016/j.str.2005.01.013
   Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405
   Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Beck M, 2008, HISTOL HISTOPATHOL, V23, P1025, DOI 10.14670/HH-23.1025
   Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170
   Boehmer T, 2008, MOL CELL, V30, P721, DOI 10.1016/j.molcel.2008.04.022
   Brohawn SG, 2008, SCIENCE, V322, P1369, DOI 10.1126/science.1165886
   CALLAN HG, 1950, PROC R SOC SER B-BIO, V137, P367, DOI 10.1098/rspb.1950.0047
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380
   Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Forster F, 2005, P NATL ACAD SCI USA, V102, P4729, DOI 10.1073/pnas.0409178102
   Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024
   Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516
   GERACE L, 1988, ANNU REV CELL BIOL, V4, P335, DOI 10.1146/annurev.cb.04.110188.002003
   GOLDBERG MW, 1993, J CELL SCI, V106, P261
   Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607
   Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007
   Isgro TA, 2007, STRUCTURE, V15, P977, DOI 10.1016/j.str.2007.06.011
   Isgro TA, 2007, J MOL BIOL, V366, P330, DOI 10.1016/j.jmb.2006.11.048
   JIMENEZ J, 1986, SCIENCE, V232, P1113, DOI 10.1126/science.3754654
   Kramer A, 2008, P NATL ACAD SCI USA, V105, P11236, DOI 10.1073/pnas.0801967105
   Krishnan VV, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000145
   Lim RYH, 2008, HISTOCHEM CELL BIOL, V129, P105, DOI 10.1007/s00418-007-0371-x
   Lim RYH, 2007, J STRUCT BIOL, V159, P277, DOI 10.1016/j.jsb.2007.01.018
   Lim RYH, 2007, SCIENCE, V318, P640, DOI 10.1126/science.1145980
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
   Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730
   Napetschnig J, 2007, P NATL ACAD SCI USA, V104, P1783, DOI 10.1073/pnas.0610828104
   Otsuka S, 2008, P NATL ACAD SCI USA, V105, P16101, DOI 10.1073/pnas.0802647105
   Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097
   Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X
   Terry LJ, 2007, SCIENCE, V318, P1412, DOI 10.1126/science.1142204
   Terry LJ, 2007, J CELL BIOL, V178, P1121, DOI 10.1083/jcb.200704174
   Winey M, 1997, MOL BIOL CELL, V8, P2119, DOI 10.1091/mbc.8.11.2119
   Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4
NR 46
TC 51
Z9 51
U1 0
U2 9
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-440X
EI 1879-033X
J9 CURR OPIN STRUC BIOL
JI Curr. Opin. Struct. Biol.
PD APR
PY 2009
VL 19
IS 2
BP 226
EP 232
DI 10.1016/j.sbi.2009.02.009
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 446HZ
UT WOS:000266114000016
PM 19327984
DA 2021-01-25
ER

PT J
AU Gabanyi, M
   Westbrook, J
   Tao, WD
   Shah, R
   Kouranov, A
   Schwede, T
   Arnold, K
   Kiefer, F
   Bordoli, L
   Podvinec, M
   Kopp, J
   Adams, P
   Carter, L
   Minor, W
   Nair, R
   La Baer, J
   Berman, HM
AF Gabanyi, Margaret
   Westbrook, John
   Tao, Wendy
   Shah, Raship
   Kouranov, Andrei
   Schwede, Torsten
   Arnold, Konstantin
   Kiefer, Florian
   Bordoli, Lorenza
   Podvinec, Michael
   Kopp, Jurgen
   Adams, Paul
   Carter, Lester
   Minor, Wladek
   Nair, Rajesh
   La Baer, Joshua
   Berman, Helen M.
TI The Protein Structure Initiative Structural Genomics Knowledgebase
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 [Gabanyi, Margaret; Westbrook, John; Tao, Wendy; Shah, Raship; Kouranov, Andrei; Berman, Helen M.] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ USA.
   [Schwede, Torsten; Arnold, Konstantin; Kiefer, Florian; Bordoli, Lorenza; Podvinec, Michael; Kopp, Jurgen] Univ Basel, Swiss Inst Bioinfomat, Basel, Switzerland.
   [Schwede, Torsten; Arnold, Konstantin; Kiefer, Florian; Bordoli, Lorenza; Podvinec, Michael; Kopp, Jurgen] Univ Basel, Biozentrum, Basel, Switzerland.
   [Kopp, Jurgen] Heidelberg Univ, Zentrum Biochem, Heidelberg, Germany.
   [Adams, Paul; Carter, Lester] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.
   [Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA USA.
   [Nair, Rajesh] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY USA.
   [La Baer, Joshua] Harvard Univ, Sch Med, Harvard Inst Prote, Boston, MA USA.
   [La Baer, Joshua] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.
RI Carter, Lester/G-6561-2014; Minor, Wladek/F-3096-2014; Adams, Paul
   D/A-1977-2013; Schwede, Torsten/A-4650-2008
OI Adams, Paul D/0000-0001-9333-8219; Schwede, Torsten/0000-0003-2715-335X
NR 0
TC 0
Z9 0
U1 0
U2 3
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2009
VL 23
MA 858.10
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA V27OC
UT WOS:000208621506361
DA 2021-01-25
ER

PT J
AU Taddei, A
   Van Houwe, G
   Nagai, S
   Erb, I
   van Nimwegen, E
   Gasser, SM
AF Taddei, Angela
   Van Houwe, Griet
   Nagai, Shigeki
   Erb, Ionas
   van Nimwegen, Erik
   Gasser, Susan M.
TI The functional importance of telomere clustering: Global changes in gene
   expression result from SIR factor dispersion
SO GENOME RESEARCH
LA English
DT Review
ID SACCHAROMYCES-CEREVISIAE TELOMERES; DOUBLE-STRAND BREAKS;
   RNA-POLYMERASE-II; NUCLEAR PERIPHERY; GENOME-WIDE; MEDIATED REPRESSION;
   SILENCED CHROMATIN; BINDING-PROTEIN; STRESS-RESPONSE; YEAST KU80
AB Budding yeast telomeres and cryptic mating-type loci are enriched at the nuclear envelope, forming foci that sequester silent information regulators (SIR factors), much as heterochromatic chromocenters in higher eukaryotes sequester HP1. Here we examine the impact of such subcompartments for regulating transcription genome-wide. We show that the efficiency of subtelomeric reporter gene repression depends not only on the strength of SIR factor recruitment by cis-acting elements, but also on the accumulation of SIRs in such perinuclear foci. To monitor the effects of disrupting this subnuclear compartment, we performed microarray analyses under conditions that eliminate telomere anchoring, while preserving SIR complex integrity. We found 60 genes reproducibly misregulated. Among those with increased expression, 22% were within 20 kb of a telomere, confirming that the nuclear envelope (NE) association of telomeres helps repress natural subtelomeric genes. In contrast, loci that were down-regulated were distributed over all chromosomes. Half of this ectopic repression was SIR complex dependent. We conclude that released SIR factors can promiscuously repress transcription at nontelomeric genes despite the presence of "anti-silencing'' mechanisms. Bioinformatic analysis revealed that promoters bearing the PAC (RNA Polymerase A and C promoters) or Abf1 binding consenses are consistently down-regulated by mislocalization of SIR factors. Thus, the normal telomeric sequestration of SIRs both favors subtelomeric repression and prevents promiscuous effects at a distinct subset of promoters. This demonstrates that patterns of gene expression can be regulated by changing the spatial distribution of repetitive DNA sequences that bind repressive factors.
C1 [Taddei, Angela; Nagai, Shigeki; Gasser, Susan M.] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   [Taddei, Angela; Nagai, Shigeki; Gasser, Susan M.] Natl Ctr Competence Res Frontiers Genet, CH-4058 Basel, Switzerland.
   [Taddei, Angela] Inst Curie, CNRS, Sect Rech, UMR 218, F-75231 Paris 05, France.
   [Van Houwe, Griet] Univ Geneva, Dept Mol Biol, CH-1211 Geneva 4, Switzerland.
   [Erb, Ionas; van Nimwegen, Erik] Univ Basel, Biozentrum, Div Bioinformat, CH-4056 Basel, Switzerland.
RP Gasser, SM (corresponding author), Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
EM Susan.gasser@fmi.ch
OI Erb, Ionas/0000-0002-2331-9714; van Nimwegen, Erik/0000-0001-6338-1312;
   Gasser, Susan/0000-0003-3610-9123; Taddei, Angela/0000-0002-3217-0739
CR Ai WD, 2002, MOL CELL, V10, P1295, DOI 10.1016/S1097-2765(02)00695-0
   Andrulis ED, 2002, MOL CELL BIOL, V22, P8292, DOI 10.1128/MCB.22.23.8292-8301.2002
   Andrulis ED, 2004, GENETICS, V166, P631, DOI 10.1534/genetics.166.1.631
   Andrulis ED, 1998, NATURE, V394, P592
   APARICIO OM, 1991, CELL, V66, P1279, DOI 10.1016/0092-8674(91)90049-5
   Bedalov A, 2001, P NATL ACAD SCI USA, V98, P15113, DOI 10.1073/pnas.261574398
   Bertuch AA, 2003, MOL CELL BIOL, V23, P8202, DOI 10.1128/MCB.23.22.8202-8215.2003
   Bi X, 2004, J MOL BIOL, V344, P893, DOI 10.1016/j.jmb.2004.10.002
   Bi X, 2002, GENETICS, V160, P1401
   Boscheron C, 1996, EMBO J, V15, P2184, DOI 10.1002/j.1460-2075.1996.tb00572.x
   Boy-Marcotte E, 1998, J BACTERIOL, V180, P1044, DOI 10.1128/JB.180.5.1044-1052.1998
   BRAND AH, 1985, CELL, V41, P41, DOI 10.1016/0092-8674(85)90059-5
   BUCK SW, 1995, GENE DEV, V9, P370, DOI 10.1101/gad.9.3.370
   Bupp JM, 2007, J CELL BIOL, V179, P845, DOI 10.1083/jcb.200706040
   CHIEN CT, 1993, CELL, V75, P531, DOI 10.1016/0092-8674(93)90387-6
   Cockell M, 1998, COLD SPRING HARB SYM, V63, P401, DOI 10.1101/sqb.1998.63.401
   Cockell MM, 2000, GENETICS, V154, P1069
   de Laat W, 2007, CURR OPIN GENET DEV, V17, P456, DOI 10.1016/j.gde.2007.07.009
   DEQUARDCHABLAT M, 1991, J BIOL CHEM, V266, P15300
   Dubacq C, 2004, MOL CELL BIOL, V24, P2560, DOI 10.1128/MCB.24.6.2560-2572.2004
   Fabre E, 2005, MOL BIOL EVOL, V22, P856, DOI 10.1093/molbev/msi070
   Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756
   Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039
   Fisher TS, 2005, DNA REPAIR, V4, P1215, DOI 10.1016/j.dnarep.2005.04.021
   Fourel G, 2002, BIOESSAYS, V24, P828, DOI 10.1002/bies.10139
   Fraser P, 2007, NATURE, V447, P413, DOI 10.1038/nature05916
   Galitski T, 1999, SCIENCE, V285, P251, DOI 10.1126/science.285.5425.251
   Gao L, 2008, MOL CELL BIOL, V28, P3979, DOI 10.1128/MCB.00019-08
   Gartenberg MR, 2004, CELL, V119, P955, DOI 10.1016/j.cell.2004.11.008
   Gasser SM, 2001, GENE, V279, P1, DOI 10.1016/S0378-1119(01)00741-7
   Ghaemmaghami S, 2003, NATURE, V425, P737, DOI 10.1038/nature02046
   Gotta M, 1998, MOL CELL BIOL, V18, P6110, DOI 10.1128/MCB.18.10.6110
   Gotta M, 1996, J CELL BIOL, V134, P1349, DOI 10.1083/jcb.134.6.1349
   GOTTSCHLING DE, 1990, CELL, V63, P751, DOI 10.1016/0092-8674(90)90141-Z
   Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947
   Halme A, 2004, CELL, V116, P405, DOI 10.1016/S0092-8674(04)00118-7
   HARDY CFJ, 1992, GENE DEV, V6, P801, DOI 10.1101/gad.6.5.801
   Hediger F, 2002, CURR BIOL, V12, P2076, DOI 10.1016/S0960-9822(02)01338-6
   Hediger F, 2002, J STRUCT BIOL, V140, P79, DOI 10.1016/S1047-8477(02)00533-6
   Huang Y, 2002, NUCLEIC ACIDS RES, V30, P1465, DOI 10.1093/nar/30.7.1465
   Hughes JD, 2000, J MOL BIOL, V296, P1205, DOI 10.1006/jmbi.2000.3519
   Kasten MM, 1997, MOL GEN GENET, V256, P376, DOI 10.1007/s004380050581
   Kimura A, 2002, NAT GENET, V32, P370, DOI 10.1038/ng993
   KORNBERG RD, 1988, NUCLEIC ACIDS RES, V16, P6677, DOI 10.1093/nar/16.14.6677
   Krogan NJ, 2003, MOL CELL BIOL, V23, P4207, DOI 10.1128/MCB.23.12.4207-4218.2003
   Kumaran RI, 2008, J CELL BIOL, V180, P51, DOI 10.1083/jcb.200706060
   Laroche T, 1998, CURR BIOL, V8, P653, DOI 10.1016/S0960-9822(98)70252-0
   Lee W, 2007, NAT GENET, V39, P1235, DOI 10.1038/ng2117
   Liko D, 2007, J BIOL CHEM, V282, DOI 10.1074/jbc.M704762200
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Lustig AJ, 1996, MOL CELL BIOL, V16, P2483
   Lutfiyya LL, 1998, GENETICS, V150, P1377
   Maillet L, 2001, EMBO REP, V2, P203, DOI 10.1093/embo-reports/kve044
   Maillet L, 1996, GENE DEV, V10, P1796, DOI 10.1101/gad.10.14.1796
   Marcand S, 1996, GENE DEV, V10, P1297, DOI 10.1101/gad.10.11.1297
   Martin SG, 1999, CELL, V97, P621, DOI 10.1016/S0092-8674(00)80773-4
   MartinezPastor MT, 1996, EMBO J, V15, P2227, DOI 10.1002/j.1460-2075.1996.tb00576.x
   Martino F, 2009, MOL CELL, V33, P323, DOI 10.1016/j.molcel.2009.01.009
   Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5
   Mercier G, 2005, NUCLEIC ACIDS RES, V33, P6635, DOI 10.1093/nar/gki959
   Mills KD, 1999, CELL, V97, P609, DOI 10.1016/S0092-8674(00)80772-2
   Mishra K, 1999, CURR BIOL, V9, P1123, DOI 10.1016/S0960-9822(99)80483-7
   Misteli T, 2007, CELL, V128, P787, DOI 10.1016/j.cell.2007.01.028
   Moazed Danesh, 2004, Novartis Found Symp, V259, P48
   Mondoux MA, 2007, GENETICS, V177, P2019, DOI 10.1534/genetics.107.079848
   MORETTI P, 1994, GENE DEV, V8, P2257, DOI 10.1101/gad.8.19.2257
   Ottaviani A, 2008, BIOCHIMIE, V90, P93, DOI 10.1016/j.biochi.2007.07.022
   Pachkov M, 2007, NUCLEIC ACIDS RES, V35, pD127, DOI 10.1093/nar/gkl857
   PALLADINO F, 1993, CELL, V75, P543, DOI 10.1016/0092-8674(93)90388-7
   Ray A, 2003, NAT GENET, V33, P522, DOI 10.1038/ng1132
   Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727
   Reifsnyder C, 1996, NAT GENET, V14, P42, DOI 10.1038/ng0996-42
   RENAULD H, 1993, GENE DEV, V7, P1133, DOI 10.1101/gad.7.7a.1133
   Robert F, 2004, MOL CELL, V16, P199, DOI 10.1016/j.molcel.2004.09.021
   Robyr D, 2002, CELL, V109, P437, DOI 10.1016/S0092-8674(02)00746-8
   Roy R, 2004, J BIOL CHEM, V279, P86, DOI 10.1074/jbc.M306841200
   Rusche LN, 2003, ANNU REV BIOCHEM, V72, P481, DOI 10.1146/annurev.biochem.72.121801.161547
   Rusche LN, 2002, MOL BIOL CELL, V13, P2207, DOI 10.1091/mbc.E02-03-0175
   Schmitt AP, 1996, P NATL ACAD SCI USA, V93, P5777, DOI 10.1073/pnas.93.12.5777
   Schober H, 2008, GENOME RES, V18, P261, DOI 10.1101/gr.6687808
   Shevchenko A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-11-r167
   Shia WJ, 2006, GENE DEV, V20, P2507, DOI 10.1101/gad.1439206
   Singer MS, 1998, GENETICS, V150, P613
   Smale ST, 2002, ANNU REV IMMUNOL, V20, P427, DOI 10.1146/annurev.immunol.20.100301.064739
   Smith CD, 2003, MOL BIOL CELL, V14, P556, DOI 10.1091/mbc.E02-08-0457
   Spector DL, 2003, ANNU REV BIOCHEM, V72, P573, DOI 10.1146/annurev.biochem.72.121801.161724
   STAVENHAGEN JB, 1994, GENE DEV, V8, P1411, DOI 10.1101/gad.8.12.1411
   Stone EM, 1996, J CELL BIOL, V135, P571, DOI 10.1083/jcb.135.3.571
   StrahlBolsinger S, 1997, GENE DEV, V11, P83, DOI 10.1101/gad.11.1.83
   Suka N, 2002, NAT GENET, V32, P378, DOI 10.1038/ng1017
   Taddei A, 2004, ANNU REV GENET, V38, P305, DOI 10.1146/annurev.genet.37.110801.142705
   Taddei A, 2004, EMBO J, V23, P1301, DOI 10.1038/sj.emboj.7600144
   Taddei A, 2007, CURR OPIN CELL BIOL, V19, P305, DOI 10.1016/j.ceb.2007.04.012
   Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845
   Therizols P, 2006, J CELL BIOL, V172, P189, DOI 10.1083/jcb.200505159
   THOMPSON JS, 1994, MOL CELL BIOL, V14, P446, DOI 10.1128/MCB.14.1.446
   Triolo T, 1996, NATURE, V381, P251, DOI 10.1038/381251a0
   Tsankov AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100106
   van Leeuwen F, 2002, CELL, V109, P745, DOI 10.1016/S0092-8674(02)00759-6
   Venkatasubrahmanyam S, 2007, P NATL ACAD SCI USA, V104, P16609, DOI 10.1073/pnas.0700914104
   Wotton D, 1997, GENE DEV, V11, P748, DOI 10.1101/gad.11.6.748
   Wyrick JJ, 1999, NATURE, V402, P418
   Yuan GC, 2005, SCIENCE, V309, P626, DOI 10.1126/science.1112178
   Zakian VA, 1996, ANNU REV GENET, V30, P141, DOI 10.1146/annurev.genet.30.1.141
   Zhu C, 2009, GENOME RES, V19, P556, DOI 10.1101/gr.090233.108
NR 105
TC 89
Z9 90
U1 0
U2 7
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
J9 GENOME RES
JI Genome Res.
PD APR
PY 2009
VL 19
IS 4
BP 611
EP 625
DI 10.1101/gr.083881.108
PG 15
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 427LX
UT WOS:000264781900010
PM 19179643
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Cailleau, G
   Dadras, M
   Abolhassani-Dadras, S
   Braissant, O
   Verrecchia, EP
AF Cailleau, Guillaume
   Dadras, Massoud
   Abolhassani-Dadras, Sousan
   Braissant, Olivier
   Verrecchia, Eric P.
TI Evidence for an organic origin of pedogenic calcitic nanofibres
SO JOURNAL OF CRYSTAL GROWTH
LA English
DT Article
DE Biomaterials; Biocrystallization; Nanostructures; Natural crystal
   growth; Minerals
ID HYPOGEAN ENVIRONMENTS; FIBER CALCITE; MORPHOLOGY; PRECIPITATION;
   MOONMILK; CRYSTALS; CAVES
AB Calcium carbonate nanofibres are found in numerous terrestrial environments, often associated with needle fibre calcite. This study attempts to mimic the natural system and generate comparable crystalline structures. A comparison of natural and synthesized nanofibre structures, using HRTEM as well as electron energy loss spectroscopy (EELS) and electron spectroscopic imaging (ESI), has demonstrated that this type of nanocrystal can result from precipitation on organic templates, most likely cellulose nanofibres. This study emphasizes the fundamental role of organic templates in the precipitation of calcium carbonate in vadose environments, even at the nanoscale. (c) 2009 Elsevier B.V. All rights reserved.
C1 [Cailleau, Guillaume; Verrecchia, Eric P.] Univ Lausanne, Inst Geol & Palaeontol, CH-1015 Lausanne, Switzerland.
   [Abolhassani-Dadras, Sousan] Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
   [Dadras, Massoud] Univ Neuchatel, Serv Microscopie & Nanoscopie, CH-2007 Neuchatel, Switzerland.
   [Braissant, Olivier] Univ Basel, Biozentrum, Pharmazentrum, CH-4012 Basel, Switzerland.
RP Verrecchia, EP (corresponding author), Univ Lausanne, Inst Geol & Palaeontol, CH-1015 Lausanne, Switzerland.
EM eric.verrecchia@unil.ch
RI Braissant, Olivier/AAO-2371-2020; Cailleau, Guillaume/A-5229-2010;
   Braissant, Olivier/H-2284-2012
OI Braissant, Olivier/0000-0003-0659-755X; Braissant,
   Olivier/0000-0003-0659-755X
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [2153-065174.01, 205320-101564]
FX The authors wish to thank the Centre of Electron Microscopy of the
   University of Lausanne for the use of their Zeiss CM902 microscope. The
   CSRS (Swiss Science Research Centre, Abidjan, Ivory Coast) provided
   field help. This study was supported by the Swiss National Science
   Foundation, Grant nos. 2153-065174.01 and 205320-101564.
CR Bajnoczi B, 2006, CHEM ERDE-GEOCHEM, V66, P203, DOI 10.1016/j.chemer.2005.11.002
   Ben Chekroun K, 2004, J SEDIMENT RES, V74, P868
   Borsato A, 2000, J SEDIMENT RES, V70, P1171, DOI 10.1306/032300701171
   BROOKS R, 1950, PHILOS T R SOC S-A, V243, P145, DOI 10.1098/rsta.1950.0016
   Cailleau G, 2005, CATENA, V59, P1, DOI 10.1016/j.catena.2004.06.002
   Canaveras JC, 2006, NATURWISSENSCHAFTEN, V93, P27, DOI 10.1007/s00114-005-0052-3
   Canaveras JC, 2001, GEOMICROBIOL J, V18, P223
   Groth I, 1999, GEOMICROBIOL J, V16, P1, DOI 10.1080/014904599270703
   JAMES NP, 1972, J SEDIMENT PETROL, V42, P817
   JONES B, 1993, J SEDIMENT PETROL, V63, P1018
   Loisy C, 1999, SEDIMENT GEOL, V126, P193, DOI 10.1016/S0037-0738(99)00040-8
   Muller M, 2000, J APPL CRYSTALLOGR, V33, P817, DOI 10.1107/S0021889800099751
   Northup DE, 2001, GEOMICROBIOL J, V18, P199, DOI 10.1080/01490450152467750
   Sanchez-Moral S, 2003, GEOMICROBIOL J, V20, P491, DOI 10.1080/713851131
   VERRECCHIA EP, 1994, J SEDIMENT RES A, V64, P650
NR 15
TC 12
Z9 12
U1 0
U2 10
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0022-0248
EI 1873-5002
J9 J CRYST GROWTH
JI J. Cryst. Growth
PD APR 1
PY 2009
VL 311
IS 8
BP 2490
EP 2495
DI 10.1016/j.jcrysgro.2009.02.029
PG 6
WC Crystallography; Materials Science, Multidisciplinary; Physics, Applied
SC Crystallography; Materials Science; Physics
GA 449SZ
UT WOS:000266351600045
DA 2021-01-25
ER

PT J
AU Mally, M
   Paroz, C
   Shin, H
   Meyer, S
   Soussoula, LV
   Schmiediger, U
   Saillen-Paroz, C
   Cornelis, GR
AF Mally, Manuela
   Paroz, Cecile
   Shin, Hwain
   Meyer, Salome
   Soussoula, Lavinia V.
   Schmiediger, Ueli
   Saillen-Paroz, Caroline
   Cornelis, Guy R.
TI Prevalence of Capnocytophaga canimorsus in dogs and occurrence of
   potential virulence factors
SO MICROBES AND INFECTION
LA English
DT Article
DE Pathogenesis; Inflammation; Macrophage
ID INFECTION; SEPTICEMIA; IDENTIFICATION; MACROPHAGES; BACTERIA; FLORA;
   DF-2
AB Capnocytophaga canimorsus is a Grain-negative commensal of dog's mouth causing severe human infections. A strain isolated from a human fatal infection was recently shown to have a sialidase, to inhibit the bactericidal activity of macrophages and to block the release of nitric oxide by LPS-stimulated macrophages. The present study aimed at determining the prevalence of C. canimorsus in dogs and the Occurrence of these hypothetical virulence factors. C. canimorsus Could be retrieved front the saliva of 61 dogs Out Of 106 sampled. Like in clinical isolates, all dog strains had a sialidase and 60% blocked the killing of phagocytosed Escherichia coli by macrophages. In contrast, only 6.5% of dog strains blocked the release of nitric oxide by LPS-challenged macrophages, Suggesting that this property might contribute to virulence. The comparative analysis of 69 16S rDNA sequences revealed the existence of C. canimorsus strains that could be misdiagnosed. (C) 2009 Elsevier Masson SAS. All rights reserved.
C1 [Mally, Manuela; Paroz, Cecile; Shin, Hwain; Meyer, Salome; Soussoula, Lavinia V.; Cornelis, Guy R.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [32-65393.01]
FX We would like to thank A. Junker and M. Kuhn for organizing sampling
   from 2 dogs and E. van Nimwegen for calculating probabilities. This work
   was supported by the Swiss National Science Foundation (grant
   32-65393.01).
CR BAILIE WE, 1978, J CLIN MICROBIOL, V7, P223
   Bernardet JF, 2002, INT J SYST EVOL MICR, V52, P1049, DOI [10.1099/ijs.0.02136-0, 10.1099/00207713-52-3-1049]
   Blanche P, 1998, J INFECTION, V36, P134, DOI 10.1016/S0163-4453(98)93918-4
   BOBO RA, 1976, AM J CLIN PATHOL, V65, P564
   BRENNER DJ, 1989, J CLIN MICROBIOL, V27, P231, DOI 10.1128/JCM.27.2.231-235.1989
   BUTLER T, 1977, ANN INTERN MED, V86, P1, DOI 10.7326/0003-4819-86-1-1
   Ciantar M, 2005, J CLIN MICROBIOL, V43, P1894, DOI 10.1128/JCM.43.4.1894-1901.2005
   COLE JR, 2008, RIBOSOMAL DATABASE P
   FISCHER LJ, 1995, INFECT IMMUN, V63, P3484, DOI 10.1128/IAI.63.9.3484-3490.1995
   Janda JM, 2006, EMERG INFECT DIS, V12, P340, DOI 10.3201/eid1202.050783
   Johnson John L., 1994, P683
   KRISTENSEN B, 1995, SCAND J INFECT DIS, V27, P153, DOI 10.3109/00365549509018997
   KRISTIANSEN JE, 1984, EUR J CLIN MICROBIOL, V3, P236, DOI 10.1007/BF02014892
   Lane D. J., 1991, NUCL ACID TECHNIQUES, P115, DOI DOI 10.1007/S00227-012-2133-0
   Lion C, 1996, EUR J EPIDEMIOL, V12, P521, DOI 10.1007/BF00144007
   Mally M, 2008, APPL ENVIRON MICROB, V74, P6369, DOI 10.1128/AEM.01218-08
   Mally M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000164
   Meyer S, 2008, IMMUNOBIOLOGY, V213, P805, DOI 10.1016/j.imbio.2008.07.019
   Pers C, 1996, CLIN INFECT DIS, V23, P71, DOI 10.1093/clinids/23.1.71
   SHIN H, INFECT IMMU IN PRESS
   Shin H, 2007, J INFECT DIS, V195, P375, DOI 10.1086/510243
   SPECK H, 1987, ZBL BAKT-INT J MED M, V266, P390
   Tierney DM, 2006, J CLIN MICROBIOL, V44, P649, DOI 10.1128/JCM.44.2.649-651.2006
   van Duijkeren E, 2006, VET MICROBIOL, V118, P148, DOI 10.1016/j.vetmic.2006.07.002
   WESTWELL AJ, 1989, BRIT MED J, V298, P116, DOI 10.1136/bmj.298.6666.116-c
NR 25
TC 29
Z9 31
U1 0
U2 3
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD APR
PY 2009
VL 11
IS 4
BP 509
EP 514
DI 10.1016/j.micinf.2009.02.005
PG 6
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 447LN
UT WOS:000266192700010
PM 19285152
DA 2021-01-25
ER

PT J
AU Houben, ENG
   Walburger, A
   Ferrari, G
   Nguyen, L
   Thompson, CJ
   Miess, C
   Vogel, G
   Mueller, B
   Pieters, J
AF Houben, Edith N. G.
   Walburger, Anne
   Ferrari, Giorgio
   Nguyen, Liem
   Thompson, Charles J.
   Miess, Christian
   Vogel, Guido
   Mueller, Bernd
   Pieters, Jean
TI Differential expression of a virulence factor in pathogenic and
   non-pathogenic mycobacteria
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID PROTEIN-KINASE-G; TUBERCULOSIS; MACROPHAGES; PHAGOSOMES; SURVIVAL;
   STRAINS; GROWTH; BCG
AB The pathogenicity of mycobacterial infections depends on virulence factors that mediate survival inside host macrophages. These virulence factors are generally believed to be specific for pathogenic species and absent or mutated in non-pathogenic strains. The serine/threonine protein kinase G (PknG) mediates survival of mycobacteria within macrophages by blocking lysosomal delivery. Here we describe a gene of the non-pathogenic species Mycobacterium smegmatis that is 78% identical with pknG of Mycobacterium tuberculosis and M. bovis bacillus Calmette-GuErin (BCG). When cloned into expression vectors, the M. smegmatis pknG orthologue produced an active kinase and performed the same function as its M. bovis BCG counterpart in intracellular survival. In addition, similar levels of pknG transcripts were found in M. bovis BCG and M. smegmatis. However, virtually no translation product of chromosomal pknG could be detected in M. smegmatis both after in vitro growth and after macrophage infection. This lack of efficient translation was shown to be caused by regulatory elements in the upstream region of the M. smegmatis gene. The data reveal dramatically increased translational efficiency of a virulence gene in a pathogenic mycobacterium compared with a non-pathogenic mycobacterium suggesting that changes in expression levels may underlie evolution of pknG and other pathogenicity genes in mycobacterium.
C1 [Houben, Edith N. G.; Walburger, Anne; Ferrari, Giorgio; Nguyen, Liem; Thompson, Charles J.; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Mueller, Bernd] Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland.
   [Vogel, Guido] Kantonales Lab Basel Stadt, CH-4012 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
RI Houben, Edith N.G./B-2110-2015
OI Houben, Edith N.G./0000-0002-8805-2002; Nguyen,
   Liem/0000-0002-1523-1472; Pieters, Jean/0000-0002-5284-9757
FU FEBS fellowships; World Health OrganizationWorld Health Organization;
   Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Swiss Life Jubileum Foundation; Olga Mayenfisch Foundation
FX We thank Roland Brosch (Institute Pasteur) for kindly providing M. bovis
   BCG Pasteur and Gerd Pluschke and Thomas Bodmer (Swiss Tropical
   instituite, Basel, Switzerland) for providing mycobacterial lysates.
   This work was supported by FEBS fellowships (to E.N.G.H. and A.W.) and
   grants from the World Health Organization, the Swiss National Science
   Foundation, the Swiss Life Jubileum Foundation and the Olga Mayenfisch
   Foundation (to J.P.).
CR ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713
   Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006
   Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033
   Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x
   de Miranda AB, 2000, J MOL EVOL, V50, P45, DOI 10.1007/s002399910006
   Denecker G, 2002, INFECT IMMUN, V70, P3510, DOI 10.1128/IAI.70.7.3510-3520.2002
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Granvogl B, 2006, PROTEOMICS, V6, P3681, DOI 10.1002/pmic.200500924
   Higashi H, 2002, P NATL ACAD SCI USA, V99, P14428, DOI 10.1073/pnas.222375399
   Houben ENG, 2006, CURR OPIN MICROBIOL, V9, P76, DOI 10.1016/j.mib.2005.12.014
   Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005
   Niebisch A, 2006, J BIOL CHEM, V281, P12300, DOI 10.1074/jbc.M512515200
   Parish T, 1998, METH MOL B, V101, P129, DOI 10.1385/0-89603-471-2:129
   Roche SM, 2005, APPL ENVIRON MICROB, V71, P6039, DOI 10.1128/AEM.71.10.6039-6048.2005
   Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034
   Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104
   SHINNICK TM, 1994, EUR J CLIN MICROBIOL, V13, P884, DOI 10.1007/BF02111489
   Springer B, 1996, J CLIN MICROBIOL, V34, P296, DOI 10.1128/JCM.34.2.296-303.1996
   STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0
   Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
NR 22
TC 31
Z9 32
U1 0
U2 6
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD APR
PY 2009
VL 72
IS 1
BP 41
EP 52
DI 10.1111/j.1365-2958.2009.06612.x
PG 12
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 421SY
UT WOS:000264379800005
PM 19210624
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Schatz, G
AF Schatz, Gottfried
TI Coming in from the cold: how answering a postcard can launch a
   scientific career
SO NATURE CELL BIOLOGY
LA English
DT Editorial Material
C1 [Schatz, Gottfried] Univ Basel, Biozentrum, CH-5056 Basel, Switzerland.
RP Schatz, G (corresponding author), Univ Basel, Biozentrum, Kingelbergstr 70, CH-5056 Basel, Switzerland.
EM gottfried.schatz@unibas.ch
NR 0
TC 1
Z9 1
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-7392
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD APR
PY 2009
VL 11
IS 4
BP 364
EP 364
DI 10.1038/ncb0409-364
PG 1
WC Cell Biology
SC Cell Biology
GA 434HD
UT WOS:000265264900003
PM 19337317
DA 2021-01-25
ER

PT J
AU Willmann, R
   Possekel, S
   Dubach-Powell, J
   Meier, T
   Ruegg, MA
AF Willmann, Raffaella
   Possekel, Stefanie
   Dubach-Powell, Judith
   Meier, Thomas
   Ruegg, Markus A.
TI Mammalian animal models for Duchenne muscular dystrophy
SO NEUROMUSCULAR DISORDERS
LA English
DT Review
DE Duchenne muscular dystrophy; Animal models; Mouse; Dog; Cat; GRMD; mdx
ID NECROSIS-FACTOR-ALPHA; 3 MOUSE MODELS; MDX MICE; SKELETAL-MUSCLE;
   DEFICIENT MICE; DYSTROPHIN/UTROPHIN-DEFICIENT; NATURAL-HISTORY; DOUBLE
   MUTANT; CANINE MODEL; LONG-TERM
AB Duchenne muscular dystrophy (DMD) is a fatal neuromuscular disease that affects boys and leads to early death. In the quest for new treatments that improve the quality Of life and in the search for a possible definitive cure, the rise of animal models Plays undoubtedly in important role. Therefore, a number of different mammalian models for DMD have been described. Much knowledge oil the molecular mechanisms Underlying the disease has arisen from studies in these animals, However, the rise of different models does nor often allow a direct comparison of results obtained in preclinical trials and therefore hinders a straightforward translational research. In the frame of "TREAT-NMD", a European Network of Excellence addressing the fragmentation in the assessment and treatment of neuromuscular diseases. we compare here the currently used mammalian animal models for DMD with the aim of selecting and recommending the most appropriate ones for preclinical efficacy testing of new therapeutic strategies. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Willmann, Raffaella; Ruegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Possekel, Stefanie; Dubach-Powell, Judith; Meier, Thomas] Santhera Pharmaceut, CH-4410 Liestal, Switzerland.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU European Network of Excellence [036825]
FX This manuscript was compiled within the frame of Activity 7 "Accelerate
   preclinical phase of new therapeutic treatment development" of the
   European Network of Excellence "TREAT-NMD" (Contract No. 036825). We
   thank our network partners as well as the collaborators of the Club of
   Interest. In particular, we are grateful for input and comments on the
   manuscripts to: Annemieke Aartsma-RLIs, Reginald Bittner, Stephan Blot,
   Serge Braun, Kay Davies, Annamaria De Luca, Patrice Denefle, Arnaud
   Ferry, Jean-Marie Gillis, Herve Laouenan, Hanns Lochmuller, Marie
   Montus, Jean-Marc Raymackers, Volker Straub, Christian Thirion, Jon
   Tinsley and Maaike van Putten.
CR AMBROSIO CE, 2008, NEUROMUSCUL DISORD
   ANDERSON JE, 1988, J MUSCLE RES CELL M, V9, P499, DOI 10.1007/BF01738755
   Araki E, 1997, BIOCHEM BIOPH RES CO, V238, P492, DOI 10.1006/bbrc.1997.7328
   Bia BL, 1999, J MOL CELL CARDIOL, V31, P1857, DOI 10.1006/jmcc.1999.1018
   Blake DJ, 2000, TRENDS NEUROSCI, V23, P92, DOI 10.1016/S0166-2236(99)01510-6
   Bogdanovich S, 2002, NATURE, V420, P418, DOI 10.1038/nature01154
   Briguet A, 2004, NEUROMUSCULAR DISORD, V14, P675, DOI 10.1016/j.nmd.2004.06.008
   BULFIELD G, 1984, P NATL ACAD SCI-BIOL, V81, P1189, DOI 10.1073/pnas.81.4.1189
   Burdi R, 2006, NEUROMUSCULAR DISORD, V16, P237, DOI 10.1016/j.nmd.2006.01.013
   Burkin DJ, 2001, J CELL BIOL, V152, P1207, DOI 10.1083/jcb.152.6.1207
   BUYSE GM, 2008, EUR HEART J
   CHAMBERLAIN JS, 2007, FASEB J
   CHAPMAN VM, 1989, P NATL ACAD SCI USA, V86, P1292, DOI 10.1073/pnas.86.4.1292
   Chetboul V, 2004, EUR HEART J, V25, P1934, DOI 10.1016/j.ehj.2004.09.007
   Cohn RD, 2007, NEUROMUSCULAR DISORD, V17, P290, DOI 10.1016/j.nmd.2007.01.011
   Connolly AM, 2001, NEUROMUSCULAR DISORD, V11, P703, DOI 10.1016/S0960-8966(01)00232-2
   COX GA, 1993, NAT GENET, V4, P87, DOI 10.1038/ng0593-87
   De Backer F, 2002, J PHYSIOL-LONDON, V542, P855, DOI 10.1113/jphysiol.2002.020487
   De Luca A, 2005, AM J PATHOL, V166, P477, DOI 10.1016/S0002-9440(10)62270-5
   Deconinck AE, 1997, CELL, V90, P717, DOI 10.1016/S0092-8674(00)80532-2
   Deconinck N, 1998, NEUROMUSCULAR DISORD, V8, P362, DOI 10.1016/S0960-8966(98)00048-0
   Ervasti JM, 2007, BBA-MOL BASIS DIS, V1772, P108, DOI 10.1016/j.bbadis.2006.05.010
   Fisher R, 2001, NEUROMUSCULAR DISORD, V11, P713, DOI 10.1016/S0960-8966(01)00220-6
   Fraysse B, 2004, NEUROBIOL DIS, V17, P144, DOI 10.1016/j.nbd.2004.06.002
   Gaedigk R, 2006, NEUROMUSCULAR DISORD, V16, P192, DOI 10.1016/j.nmd.2005.12.007
   Gailly P, 2002, BBA-PROTEINS PROTEOM, V1600, P38, DOI 10.1016/S1570-9639(02)00442-9
   GAILLY P, 1993, FEBS LETT, V326, P272, DOI 10.1016/0014-5793(93)81806-B
   GASCHEN FP, 1992, J NEUROL SCI, V110, P149, DOI 10.1016/0022-510X(92)90022-D
   Gaschen L, 1999, J VET INTERN MED, V13, P346, DOI 10.1892/0891-6640(1999)013&lt;0346:CIDDHF&gt;2.3.CO;2
   Gayraud J, 2007, J MUSCLE RES CELL M, V28, P29, DOI 10.1007/s10974-007-9101-1
   Gillis JM, 1996, ACTA PHYSIOL SCAND, V156, P397, DOI 10.1046/j.1365-201X.1996.201000.x
   GILLIS JM, 2007, PROTEIN MISFOLDING B, P409
   Gosselin LE, 2003, MUSCLE NERVE, V28, P336, DOI 10.1002/mus.10431
   Grady RM, 1997, CELL, V90, P729, DOI 10.1016/S0092-8674(00)80533-4
   Grady RM, 1999, NAT CELL BIOL, V1, P215, DOI 10.1038/12034
   Granchelli JA, 2000, NEUROMUSCULAR DISORD, V10, P235, DOI 10.1016/S0960-8966(99)00126-1
   Grounds MD, 2004, FASEB J, V18, P676, DOI 10.1096/fj.03-1024com
   Grounds MD, 2008, NEUROBIOL DIS, V31, P1, DOI 10.1016/j.nbd.2008.03.008
   Guo C, 2006, HUM MOL GENET, V15, P989, DOI 10.1093/hmg/ddl018
   Hodgetts S, 2006, NEUROMUSCULAR DISORD, V16, P591, DOI 10.1016/j.nmd.2006.06.011
   HOFFMAN EP, 1987, CELL, V51, P919, DOI 10.1016/0092-8674(87)90579-4
   Janssen PML, 2005, AM J PHYSIOL-HEART C, V289, pH2373, DOI 10.1152/ajpheart.00448.2005
   Keeling RM, 2007, MUSCLE NERVE, V35, P43, DOI 10.1002/mus.20646
   KOENIG M, 1989, AM J HUM GENET, V45, P498
   KORNEGAY JN, 1994, J NEUROL SCI, V123, P100, DOI 10.1016/0022-510X(94)90210-0
   Kornegay JN, 2003, NEUROMUSCULAR DISORD, V13, P493, DOI 10.1016/S0960-8966(03)00025-7
   Kornegay JN, 1999, J NEUROL SCI, V166, P115, DOI 10.1016/S0022-510X(99)00118-5
   Laws N, 2004, J APPL PHYSIOL, V97, P1970, DOI 10.1152/japplphysiol.01357.2003
   LEFAUCHEUR JP, 1995, ANAT REC, V242, P70, DOI 10.1002/ar.1092420109
   Liberona JL, 1998, MUSCLE NERVE, V21, P902, DOI 10.1002/(SICI)1097-4598(199807)21:7<902::AID-MUS8>3.0.CO;2-A
   Louis M, 2004, MUSCLE NERVE, V29, P687, DOI 10.1002/mus.20014
   Lynch GS, 2001, NEUROMUSCULAR DISORD, V11, P260, DOI 10.1016/S0960-8966(00)00192-9
   Mallouk N, 2000, P NATL ACAD SCI USA, V97, P4950, DOI 10.1073/pnas.97.9.4950
   Mayer U, 2003, J BIOL CHEM, V278, P14587, DOI 10.1074/jbc.R200022200
   MCGEACHIE JK, 1993, J NEUROL SCI, V119, P169, DOI 10.1016/0022-510X(93)90130-Q
   Megeney LA, 1996, GENE DEV, V10, P1173, DOI 10.1101/gad.10.10.1173
   Megeney LA, 1999, P NATL ACAD SCI USA, V96, P220, DOI 10.1073/pnas.96.1.220
   Messina S, 2006, EXP NEUROL, V198, P234, DOI 10.1016/j.expneurol.2005.11.021
   MOISE NS, 1991, J AM COLL CARDIOL, V17, P812, DOI 10.1016/S0735-1097(10)80202-5
   Morrison C, 2005, OPT PHOTONICS NEWS, V16, P10
   Nakamura A, 2002, FEBS LETT, V520, P18, DOI 10.1016/S0014-5793(02)02739-4
   Pierno S, 2007, NEUROPATH APPL NEURO, V33, P344, DOI 10.1111/j.1365-2990.2007.00798.x
   Quinlan JG, 2004, NEUROMUSCULAR DISORD, V14, P491, DOI 10.1016/j.nmd.2004.04.007
   Rafael JA, 1998, NAT GENET, V19, P79, DOI 10.1038/ng0598-79
   Raymackers JM, 2003, NEUROMUSCULAR DISORD, V13, P376, DOI 10.1016/S0960-8966(03)00031-2
   Robert V, 2001, J BIOL CHEM, V276, P4647, DOI 10.1074/jbc.M006337200
   Rolland JF, 2006, NEUROBIOL DIS, V24, P466, DOI 10.1016/j.nbd.2006.08.010
   SANO M, 1990, J NEUROL SCI, V97, P261, DOI 10.1016/0022-510X(90)90224-B
   SHARP NJH, 1992, GENOMICS, V13, P115, DOI 10.1016/0888-7543(92)90210-J
   Shimatsu Y, 2003, EXP ANIM TOKYO, V52, P93, DOI 10.1538/expanim.52.93
   Shimatsu Yoshiki, 2005, Acta Myol, V24, P145
   Spencer MJ, 1996, EXP CELL RES, V226, P264, DOI 10.1006/excr.1996.0227
   Spurney CF, 2008, NEUROMUSCULAR DISORD, V18, P371, DOI 10.1016/j.nmd.2008.03.008
   STEDMAN HH, 1991, NATURE, V352, P536, DOI 10.1038/352536a0
   Thibaud JL, 2007, NEUROMUSCULAR DISORD, V17, P575, DOI 10.1016/j.nmd.2007.03.013
   Tinsley J, 1998, NAT MED, V4, P1441, DOI 10.1038/4033
   VALENTINE BA, 1988, J NEUROL SCI, V88, P69, DOI 10.1016/0022-510X(88)90206-7
   VALENTINE BA, 1989, AM J PATHOL, V135, P671
   Van Erp C, 2006, MUSCLE NERVE, V34, P327, DOI 10.1002/mus.20590
   Vilquin JT, 1998, MUSCLE NERVE, V21, P567, DOI 10.1002/(SICI)1097-4598(199805)21:5<567::AID-MUS2>3.0.CO;2-6
   Vrbova G, 2002, NEUROMUSCULAR DISORD, V12, P608, DOI 10.1016/S0960-8966(02)00016-0
   Wakefield PM, 2000, GENE THER, V7, P201, DOI 10.1038/sj.gt.3301066
   Wang X, 2005, NAT CELL BIOL, V7, P525, DOI 10.1038/ncb1254
   Wehling-Henricks M, 2005, HUM MOL GENET, V14, P1921, DOI 10.1093/hmg/ddi197
   WINAND NJ, 1994, NEUROMUSCULAR DISORD, V4, P433, DOI 10.1016/0960-8966(94)90082-5
   WOO M, 1987, J NEUROL SCI, V82, P111, DOI 10.1016/0022-510X(87)90011-6
   Yue YP, 2006, MOL THER, V14, P79, DOI 10.1016/j.ymthe.2006.01.007
NR 87
TC 119
Z9 121
U1 1
U2 18
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
EI 1873-2364
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD APR
PY 2009
VL 19
IS 4
BP 241
EP 249
DI 10.1016/j.nmd.2008.11.015
PG 9
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 442VK
UT WOS:000265868500001
PM 19217290
DA 2021-01-25
ER

PT J
AU Peleg, O
   Kroger, M
   Rabin, Y
AF Peleg, Orit
   Kroeger, Martin
   Rabin, Yitzhak
TI Effect of network topology on phase separation in two-dimensional
   Lennard-Jones networks
SO PHYSICAL REVIEW E
LA English
DT Article
DE free energy; gels; Lennard-Jones potential; molecular dynamics method;
   nucleation; percolation; phase separation
ID DEFORMED SWOLLEN GELS; MICROPHASE SEPARATION; SCATTERING; MODEL
AB We generate two-dimensional Lennard-Jones networks with random topology by preparing a perfect four-functional network of identical harmonic springs and randomly cutting some of the springs. Using molecular-dynamics simulations we find that the fraction p of active springs affects both the temperature of phase separation and the type of structures observed below this temperature, from networklike high-density patterns at p>0.5 ("gel") to dropletlike structures at p < 0.5 ("sol"). In the gel domain, these patterns are determined by the interplay between free energy and network topology, with the former dominant as p -> 1 and the latter as p -> 0.5.
C1 [Peleg, Orit; Kroeger, Martin] Swiss Fed Inst Technol, Dept Mat, CH-8093 Zurich, Switzerland.
   [Rabin, Yitzhak] Bar Ilan Univ, Dept Phys, Inst Nanotechnol & Adv Mat, Nanomat Res Ctr, IL-52900 Ramat Gan, Israel.
RP Peleg, O (corresponding author), Univ Basel, Biozentrum, Swiss Nanosci Inst, CH-4056 Basel, Switzerland.
EM op@mat.ethz.ch
RI Kroger, Martin/C-1946-2008
OI Kroger, Martin/0000-0003-1402-6714; rabin, yitzhak/0000-0002-7708-8341
CR BARKER JA, 1981, PHYSICA A, V106, P226, DOI 10.1016/0378-4371(81)90222-3
   BASTIDE J, 1990, MACROMOLECULES, V23, P1821, DOI 10.1021/ma00208a044
   Bastide J., 1996, PHYS PROPERTIES POLY, P143
   Cohen J. P. Addad, 1996, PHYS PROPERTIES POLY
   Goren C, 2000, MACROMOLECULES, V33, P5757, DOI 10.1021/ma000605f
   Kroger M, 2008, SOFT MATTER, V4, P18, DOI 10.1039/b710147c
   Lay S, 2000, J CHEM PHYS, V113, P11355, DOI 10.1063/1.1326910
   Moussaid A, 1999, MACROMOLECULES, V32, P3774, DOI 10.1021/ma981159n
   Norisuye T, 2002, POLYMER, V43, P5289, DOI 10.1016/S0032-3861(02)00343-9
   ONUKI A, 1992, J PHYS II, V2, P45
   Onuki A, 1999, PHYS REV E, V59, pR1331, DOI 10.1103/PhysRevE.59.R1331
   Panyukov S, 1996, PHYS REP, V269, P1, DOI 10.1016/0370-1573(95)00068-2
   Peleg O, 2007, EPL-EUROPHYS LETT, V77, DOI 10.1209/0295-5075/77/58007
   Peleg O, 2008, MACROMOLECULES, V41, P3267, DOI 10.1021/ma702732t
   Sakai T, 2008, MACROMOLECULES, V41, P5379, DOI 10.1021/ma800476x
   SEKIMOTO K, 1989, PHYS REV A, V39, P4912, DOI 10.1103/PhysRevA.39.4912
   Shibayama M, 1997, J CHEM PHYS, V107, P5227, DOI 10.1063/1.474886
NR 17
TC 6
Z9 7
U1 0
U2 13
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 1539-3755
EI 1550-2376
J9 PHYS REV E
JI Phys. Rev. E
PD APR
PY 2009
VL 79
IS 4
AR 040401
DI 10.1103/PhysRevE.79.040401
PN 1
PG 4
WC Physics, Fluids & Plasmas; Physics, Mathematical
SC Physics
GA 443WK
UT WOS:000265941300008
PM 19518163
DA 2021-01-25
ER

PT J
AU Staple, DB
   Loparic, M
   Kreuzer, HJ
   Kreplak, L
AF Staple, Douglas B.
   Loparic, Marko
   Kreuzer, Hans Juergen
   Kreplak, Laurent
TI Stretching, Unfolding, and Deforming Protein Filaments Adsorbed at
   Solid-Liquid Interfaces Using the Tip of an Atomic-Force Microscope
SO PHYSICAL REVIEW LETTERS
LA English
DT Article
ID INTERMEDIATE-FILAMENTS; COLLAGEN; ELASTICITY; AFM; DNA
AB Cells move by actively remodeling a dense network of protein filaments. Here we analyze the force response of various filaments in a simplified experimental setup, where single filaments are moved with an atomic-force microscope (AFM) tip against surface friction, with the AFM operating in the torsional mode. Our experimental findings are well explained within a simple model based on Newtonian mechanics: we observe force plateaus, which are the signature of the sequential stretching of single repeat units, followed ultimately by deformation of the whole polymer shape.
C1 [Staple, Douglas B.; Kreuzer, Hans Juergen; Kreplak, Laurent] Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS B3H 3J5, Canada.
   [Loparic, Marko; Kreplak, Laurent] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Staple, DB (corresponding author), Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS B3H 3J5, Canada.
OI kreplak, laurent/0000-0001-9370-9809
FU NSERCNatural Sciences and Engineering Research Council of Canada; Office
   of Naval ResearchOffice of Naval Research
FX This work was supported by grants from NSERC and the Office of Naval
   Research. D. S. would like to acknowledge NSERC and the Killam Trusts.
   M. L. would like to acknowledge an NCCR" Nanoscale Science'' grant,
   awarded by the Swiss National Science Foundation to Ueli Aebi and Ivan
   Martin.
CR Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068
   BRISCOE BJ, 1982, P ROY SOC LOND A MAT, V380, P389, DOI 10.1098/rspa.1982.0048
   BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175
   Friedrichs J, 2007, J MOL BIOL, V372, P594, DOI 10.1016/j.jmb.2007.06.078
   Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3
   Fusco C, 2005, PHYS REV B, V71, DOI 10.1103/PhysRevB.71.045413
   GLOSLI JN, 1993, PHYS REV LETT, V70, P1960, DOI 10.1103/PhysRevLett.70.1960
   Hanke F, 2007, EUR PHYS J E, V22, P163, DOI 10.1140/epje/e2007-00027-8
   Kadler KE, 2008, CURR OPIN CELL BIOL, V20, P495, DOI 10.1016/j.ceb.2008.06.008
   Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092
   LANIR Y, 1978, BIOPHYS J, V24, P541, DOI 10.1016/S0006-3495(78)85400-9
   Liu W, 2006, SCIENCE, V313, P634, DOI 10.1126/science.1127317
   Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008
   Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776
   Serr A, 2006, EUROPHYS LETT, V73, P292, DOI 10.1209/epl/i2005-10379-4
   STOPAK D, 1985, P NATL ACAD SCI USA, V82, P2804, DOI 10.1073/pnas.82.9.2804
   Wolf K, 2003, J CELL BIOL, V160, P267, DOI 10.1083/jcb.200209006
NR 17
TC 13
Z9 13
U1 0
U2 13
PU AMER PHYSICAL SOC
PI COLLEGE PK
PA ONE PHYSICS ELLIPSE, COLLEGE PK, MD 20740-3844 USA
SN 0031-9007
J9 PHYS REV LETT
JI Phys. Rev. Lett.
PD MAR 27
PY 2009
VL 102
IS 12
AR 128302
DI 10.1103/PhysRevLett.102.128302
PG 4
WC Physics, Multidisciplinary
SC Physics
GA 425JF
UT WOS:000264632100074
PM 19392329
DA 2021-01-25
ER

PT J
AU Patursky-Polischuk, I
   Stolovich-Rain, M
   Hausner-Hanochi, M
   Kasir, J
   Cybulski, N
   Avruch, J
   Rueg, MA
   Hall, MN
   Meyuhas, O
AF Patursky-Polischuk, Ilona
   Stolovich-Rain, Miri
   Hausner-Hanochi, Mirito
   Kasir, Judith
   Cybulski, Nadine
   Avruch, Joseph
   Ruegg, Markus A.
   Hall, Michael N.
   Meyuhas, Oded
TI The TSC-mTOR Pathway Mediates Translational Activation of TOP mRNAs by
   Insulin Largely in a Raptor- or Rictor-Independent Manner (vol 29, pg
   640, 2009)
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Correction
C1 [Patursky-Polischuk, Ilona] Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Dept Biochem, Sch Med, IL-91120 Jerusalem, Israel.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Massachusetts Gen Hosp, Diabet Unit, Med Serv, Boston, MA 02114 USA.
   Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.
   Harvard Univ, Sch Med, Boston, MA 02114 USA.
RP Patursky-Polischuk, I (corresponding author), Hebrew Univ Jerusalem Hadassah Hosp & Med Sch, Dept Biochem, Sch Med, IL-91120 Jerusalem, Israel.
CR Patursky-Polischuk I, 2009, MOL CELL BIOL, V29, P640, DOI 10.1128/MCB.00980-08
NR 1
TC 0
Z9 0
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD MAR 15
PY 2009
VL 29
IS 6
BP 1670
EP 1670
DI 10.1128/MCB.00104-09
PG 1
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 412JB
UT WOS:000263720000025
OA Bronze, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Schroeder, U
   Graff, A
   Buchmeier, S
   Rigler, P
   Silvan, U
   Tropel, D
   Jockusch, BM
   Aebi, U
   Burkhard, P
   Schoenenberger, CA
AF Schroeder, Ulrich
   Graff, Alexandra
   Buchmeier, Sabine
   Rigler, Per
   Silvan, Unai
   Tropel, David
   Jockusch, Brigitte M.
   Aebi, Ueli
   Burkhard, Peter
   Schoenenberger, Cora-Ann
TI Peptide Nanoparticles Serve as a Powerful Platform for the Immunogenic
   Display of Poorly Antigenic Actin Determinants
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE actin conformations; actin antibodies; nanoparticles; antigenic display;
   fluorescence correlation spectroscopy
ID FLUORESCENCE CROSS-CORRELATION; TOBACCO-MOSAIC-VIRUS; CORRELATION
   SPECTROSCOPY; MONOCLONAL-ANTIBODY; DIRECT VISUALIZATION; MULTIPLE
   DISPLAY; F-ACTIN; PROTEIN; VACCINES; PARTICLES
AB The role of actin in transcription and RNA processing is now widely accepted but the form of nuclear actin remains enigmatic. Monomeric, oligomeric or polymeric forms of actin seem to be involved in nuclear functions. Moreover, uncommon forms of actin such as the "lower dimer" have been observed in vitro. Antibodies have been pivotal in revealing the presence and distribution of different forms of actin in different cellular locations. Because of its high degree of conservation, actin is a poor immunogen and only few specific actin antibodies are available. To unravel the mystery of less common forms of actin, in particular those in the nucleus, we chose to tailor monoclonal antibodies to recognize distinct forms of actin. To increase the immune response, we used a new approach based on peptide nanoparticles, which are designed to mimic an icosahedral virus capsid and allow the repetitive, ordered display of a specific epitope on their surface. Actin sequences representing the highly conserved "hydrophobic loop," which is buried in the filamentous actin filament, were grafted onto the surface of nanoparticles by genetic engineering. After immunization with "loop nanoparticles," a number of monoclonal antibodies were established that bind to the hydrophobic loop both in vitro and in situ. Immunofluorescence studies on cells revealed that filamentous actin filaments were only labeled once the epitope had been exposed. Our studies indicate that self-assembling peptide nanoparticles represent a versatile platform that can easily be customized to present antigenic determinants in repetitive, ordered arrays and elicit an immune response against poor antigens. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Schroeder, Ulrich; Graff, Alexandra; Silvan, Unai; Tropel, David; Aebi, Ueli; Schoenenberger, Cora-Ann] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Buchmeier, Sabine; Jockusch, Brigitte M.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, D-38092 Braunschweig, Germany.
   [Rigler, Per] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   [Burkhard, Peter] Univ Connecticut, Inst Mat Sci, Storrs, CT 06269 USA.
RP Schoenenberger, CA (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Cora-ann.schoenenberger@unibas.ch
RI Silvan, Unai/J-7376-2013
OI Silvan, Unai/0000-0003-0757-3621
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG);
   M.E. Muller Foundation
FX We gratefully acknowledge the help of Rosmarie Sutterlin (M. E. Muller
   Institute for Structural Biology, University of Basel) with
   immunofluorescence. This work was supported by a grant from the Swiss
   National Science Foundation (C.A.S.), the Deutsche
   Forschungsgemeinschaft (B.M.J.) and the M.E. Muller Foundation.
CR AEBI U, 1977, P NATL ACAD SCI USA, V74, P5514, DOI 10.1073/pnas.74.12.5514
   Bachmann MF, 2004, NAT REV DRUG DISCOV, V3, P81, DOI 10.1038/nrd1284
   Baschong W, 2003, J STRUCT BIOL, V143, P258, DOI 10.1016/j.jsb.2003.08.004
   Baschong W, 2001, J HISTOCHEM CYTOCHEM, V49, P1565, DOI 10.1177/002215540104901210
   Brandenberger R, 1996, J CELL BIOL, V135, P1583, DOI 10.1083/jcb.135.6.1583
   Burkhard P, 2000, PROTEIN SCI, V9, P2294, DOI 10.1110/ps.9.12.2294
   Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5
   Chackerian B, 2006, VACCINE, V24, P6321, DOI 10.1016/j.vaccine.2006.05.059
   Cho MW, 2003, CURR MOL MED, V3, P243, DOI 10.2174/1566524033479861
   Domingo GJ, 2001, J MOL BIOL, V305, P259, DOI 10.1006/jmbi.2000.4311
   GIMONA M, 1994, CELL MOTIL CYTOSKEL, V27, P108, DOI 10.1002/cm.970270203
   Gonsior SM, 1999, J CELL SCI, V112, P797
   Granito A, 2006, J CLIN PATHOL, V59, P280, DOI 10.1136/jcp.2005.027367
   GREENWOOD J, 1991, J MOL BIOL, V220, P821, DOI 10.1016/0022-2836(91)90354-9
   Grunwald D, 2005, CURR PHARM BIOTECHNO, V6, P381, DOI 10.2174/138920105774370616
   HOLMES KC, 1990, NATURE, V347, P44, DOI 10.1038/347044a0
   Jennings GT, 2008, BIOL CHEM, V389, P521, DOI 10.1515/BC.2008.064
   JOCKUSCH BM, 1978, HISTOCHEMISTRY, V55, P177, DOI 10.1007/BF00495757
   Jockusch BM, 2006, TRENDS CELL BIOL, V16, P391, DOI 10.1016/j.tcb.2006.06.006
   Kajava AV, 1996, PROTEINS, V24, P218, DOI 10.1002/(SICI)1097-0134(199602)24:2<218::AID-PROT8>3.3.CO;2-I
   Lagerkvist AC, 2001, PROTEIN SCI, V10, P1522, DOI 10.1110/ps.5701
   LAZARIDES E, 1974, P NATL ACAD SCI USA, V71, P2268, DOI 10.1073/pnas.71.6.2268
   LEAVITT J, 1985, NATURE, V316, P840, DOI 10.1038/316840a0
   Lee SY, 2003, TRENDS BIOTECHNOL, V21, P45, DOI 10.1016/S0167-7799(02)00006-9
   Lomonossoff GP, 1996, CURR OPIN STRUC BIOL, V6, P176, DOI 10.1016/S0959-440X(96)80072-8
   LORENZ M, 1993, J MOL BIOL, V234, P826, DOI 10.1006/jmbi.1993.1628
   Ludwig C, 2007, CURR OPIN BIOTECH, V18, P537, DOI 10.1016/j.copbio.2007.10.013
   Palmer KE, 2006, VACCINE, V24, P5516, DOI 10.1016/j.vaccine.2006.04.058
   Porta C, 1996, INTERVIROLOGY, V39, P79, DOI 10.1159/000150478
   Raman S, 2006, NANOMED-NANOTECHNOL, V2, P95, DOI 10.1016/j.nano.2006.04.007
   Reddy ST, 2007, NAT BIOTECHNOL, V25, P1159, DOI [10.1038/nbt1332, 10.1038/nbtl332]
   Ren ZJ, 1996, PROTEIN SCI, V5, P1833, DOI 10.1002/pro.5560050909
   Rigler R, 1998, J BIOTECHNOL, V63, P97, DOI 10.1016/S0168-1656(98)00079-0
   Roy P, 2008, HUM VACCINES, V4, P5, DOI 10.4161/hv.4.1.5559
   Ruan QQ, 2008, ANAL BIOCHEM, V374, P182, DOI 10.1016/j.ab.2007.11.007
   SANCHEZ J, 1989, P NATL ACAD SCI USA, V86, P481, DOI 10.1073/pnas.86.2.481
   Schoenenberger CA, 2005, J STRUCT BIOL, V152, P157, DOI 10.1016/j.jsb.2005.09.003
   Schwille P, 1997, BIOPHYS J, V72, P1878, DOI 10.1016/S0006-3495(97)78833-7
   Silvestrini RA, 2001, J CLIN PATHOL, V54, P677, DOI 10.1136/jcp.54.9.677
   SKALLI O, 1986, J CELL BIOL, V103, P2787, DOI 10.1083/jcb.103.6.2787
   SMALL JV, 1978, J CELL SCI, V31, P393
   Smith ML, 2006, VIROLOGY, V348, P475, DOI 10.1016/j.virol.2005.12.039
   SPUDICH JA, 1971, J BIOL CHEM, V246, P4866
   VANDEKERCKHOVE J, 1979, ARCH INT PHYSIOL BIO, V87, P210
   Zinkernagel RM, 2003, ANNU REV IMMUNOL, V21, P515, DOI 10.1146/annurev.immunol.21.120601.141045
NR 45
TC 43
Z9 43
U1 0
U2 17
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAR 13
PY 2009
VL 386
IS 5
BP 1368
EP 1381
DI 10.1016/j.jmb.2008.11.023
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 421UJ
UT WOS:000264383500016
PM 19063898
DA 2021-01-25
ER

PT J
AU Ben-Harush, K
   Wiesel, N
   Frenkiel-Krispin, D
   Moeller, D
   Soreq, E
   Aebi, U
   Herrmann, H
   Gruenbaum, Y
   Medalia, O
AF Ben-Harush, Kfir
   Wiesel, Naama
   Frenkiel-Krispin, Daphna
   Moeller, Dorothee
   Soreq, Eyal
   Aebi, Ueli
   Herrmann, Harald
   Gruenbaum, Yosef
   Medalia, Ohad
TI The Supramolecular Organization of the C. elegans Nuclear Lamin Filament
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE C. elegans; cryo-electron tomography; intermediate filaments; lamin
ID INTERMEDIATE-FILAMENTS; CAENORHABDITIS-ELEGANS; ELECTRON TOMOGRAPHY;
   ESCHERICHIA-COLI; TAIL; MICROSCOPY; DIMER; HEAD; LAMINOPATHIES;
   FLEXIBILITY
AB Nuclear lamins are involved in most nuclear activities and are essential for retaining the mechano-elastic properties of the nucleus. They are nuclear intermediate filament (IF) proteins forming a distinct meshwork-like layer adhering to the inner nuclear membrane, called the nuclear lamina. Here, we present for the first time, the three-dimensional supramolecular organization of lamin 10 nm filaments and paracrystalline fibres. We show that Caenorhabditis elegans nuclear lamin forms 10 nm IF-like filaments, which are distinct from their cytoplasmic counterparts. The IF-like lamin filaments are composed of three and four tetrameric protofilaments, each of which contains two partially staggered anti-parallel head-to-tail polymers. The beaded appearance of the lamin filaments stems from paired globular tail domains, which are spaced regularly, alternating between 21 nm and 27 rim. A mutation in an evolutionarily conserved residue that causes Hutchison-Gilford progeria syndrome in humans alters the supramolecular structure of the lamin filaments. On the basis of our structural analysis, we propose an assembly pathway that yields the observed 10 nm IF-like lamin filaments and paracrystalline fibres. These results serve also as a platform for understanding the effect of laminopathic mutations on lamin supramolecular organization. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Wiesel, Naama; Gruenbaum, Yosef] Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.
   [Ben-Harush, Kfir; Frenkiel-Krispin, Daphna; Medalia, Ohad] Ben Gurion Univ Negev, Dept Life Sci, IL-84120 Beer Sheva, Israel.
   [Ben-Harush, Kfir; Frenkiel-Krispin, Daphna; Medalia, Ohad] NIBN, IL-84120 Beer Sheva, Israel.
   [Moeller, Dorothee; Herrmann, Harald] German Canc Res Ctr, Dept Mol Genet, D-69120 Heidelberg, Germany.
   [Soreq, Eyal] Bezalel Acad Arts & Design, IL-91240 Jerusalem, Israel.
   [Aebi, Ueli] Univ Basel, Biozentrum, ME Mueller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Gruenbaum, Y (corresponding author), Hebrew Univ Jerusalem, Inst Life Sci, Dept Genet, IL-91904 Jerusalem, Israel.
EM gru@vms.huji.ac.il; omedalia@bgu.ac.il
OI Medalia, Ohad/0000-0003-0994-2937
FU German-Israel FoundationGerman-Israeli Foundation for Scientific
   Research and Development; European UnionEuropean Union (EU); Muscular
   Dystrophy AssociationMuscular Dystrophy Association [MDA4329]; Ministry
   of HealthMinistry of Health - Turkey; European CommissionEuropean
   CommissionEuropean Commission Joint Research Centre
   [LSHM-CT-2005-018690]
FX This work was supported by the German-Israel Foundation (to Y.G., H.H.
   and O.M.) and by the European Union "3D-EM." Network of Excellence
   within the 6th Framework Program (to U.A. and O. M.), by the Muscular
   Dystrophy Association (MDA4329) and by the Ministry of Health (to Y.G.),
   and by the EURO-Laminopathies research project of the European
   Commission (Contract LSHM-CT-2005-018690)(to Y.G., H.H. and U.A.).
CR AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Erber A, 1998, J MOL EVOL, V47, P751, DOI 10.1007/PL00006434
   Foeger N, 2006, J STRUCT BIOL, V155, P340, DOI 10.1016/j.jsb.2006.03.026
   Foisner Roland, 2003, ScientificWorldJournal, V3, P1
   Geisler N, 1998, J MOL BIOL, V282, P601, DOI 10.1006/jmbi.1998.1995
   Goldie KN, 2007, J STRUCT BIOL, V158, P378, DOI 10.1016/j.jsb.2006.12.007
   Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5
   Hegerl R, 1996, J STRUCT BIOL, V116, P30, DOI 10.1006/jsbi.1996.0006
   HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Holmes KC, 2003, NATURE, V425, P423, DOI 10.1038/nature02005
   Karabinos A, 2003, J MOL BIOL, V325, P241, DOI 10.1016/S0022-2836(02)01240-8
   Klapper M, 1997, J CELL SCI, V110, P2519
   Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826
   Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3
   Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937
   Lucic V, 2005, ANNU REV BIOCHEM, V74, P833, DOI 10.1146/annurev.biochem.73.011303.074112
   MOIR RD, 1991, J CELL SCI, V99, P363
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006
   Nogales E, 1998, NATURE, V391, P199, DOI 10.1038/34465
   ORLOVA A, 1993, J MOL BIOL, V232, P334, DOI 10.1006/jmbi.1993.1393
   OTT A, 1993, PHYS REV E, V48, pR1642, DOI 10.1103/PhysRevE.48.R1642
   Panorchan P, 2004, J BIOL CHEM, V279, P43462, DOI 10.1074/jbc.M402474200
   PETER M, 1991, EMBO J, V10, P1535, DOI 10.1002/j.1460-2075.1991.tb07673.x
   Rankin J, 2006, CLIN GENET, V70, P261, DOI 10.1111/j.1399-0004.2006.00677.x
   RIEMER D, 1993, EUR J CELL BIOL, V62, P214
   STEINERT PM, 1988, ANNU REV BIOCHEM, V57, P593, DOI 10.1146/annurev.bi.57.070188.003113
   Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   Tzur YB, 2006, NAT REV MOL CELL BIO, V7, P782, DOI 10.1038/nrm2003
   Wagner OI, 2007, EXP CELL RES, V313, P2228, DOI 10.1016/j.yexcr.2007.04.025
   Wiesel N, 2008, P NATL ACAD SCI USA, V105, P180, DOI 10.1073/pnas.0708974105
   Worman HJ, 2005, INT REV CYTOL, V246, P231, DOI 10.1016/S0074-7696(05)46006-4
   Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028
NR 38
TC 95
Z9 98
U1 0
U2 6
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAR 13
PY 2009
VL 386
IS 5
BP 1392
EP 1402
DI 10.1016/j.jmb.2008.12.024
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 421UJ
UT WOS:000264383500018
PM 19109977
DA 2021-01-25
ER

PT J
AU Barde, Y
AF Barde, Yves
TI Caution urged in trial of stem cells to treat spinal-cord injury
SO NATURE
LA English
DT Letter
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Barde, Y (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM yves.barde@unibas.ch
RI Barde, Yves/F-6019-2011
OI Barde, Yves/0000-0002-7627-461X
NR 0
TC 9
Z9 12
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD MAR 5
PY 2009
VL 458
IS 7234
BP 29
EP 29
DI 10.1038/458029a
PG 1
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 414AJ
UT WOS:000263836000012
PM 19262651
OA Bronze
DA 2021-01-25
ER

PT J
AU Rudolph, MG
   Wittmann, JG
   Klostermeier, D
AF Rudolph, Markus G.
   Wittmann, Julia G.
   Klostermeier, Dagmar
TI Crystallization and preliminary characterization of the Thermus
   thermophilus RNA helicase Hera C-terminal domain
SO ACTA CRYSTALLOGRAPHICA SECTION F-STRUCTURAL BIOLOGY COMMUNICATIONS
LA English
DT Article
ID DEAD-BOX PROTEIN; 23S RIBOSOMAL-RNA; CRYSTAL-STRUCTURE; DIFFRACTION
   DATA; GROUP-I; BINDING; MOTIF; ATP; MECHANISMS; REQUIRES
AB Heat-resistant RNA-dependent ATPase (Hera) from Thermus thermophilus is a DEAD-box RNA helicase. Two constructs encompassing the second RecA-like domain and the C-terminal domain of Hera were overproduced in Escherichia coli and purified to homogeneity. Single crystals of both Hera constructs were obtained in three crystal forms. A tetragonal crystal form belonged to space group P4(1)2(1)2, with unit-cell parameters a = 65.5, c = 153.0 angstrom, and contained one molecule per asymmetric unit. Two orthorhombic forms belonged to space group P2(1)2(1)2(1), with unit-cell parameters a = 62.8, b = 70.9, c = 102.3 angstrom (form I) and a = 41.6, b = 67.6, c = 183.5 angstrom (form II). Both orthorhombic forms contained two molecules per asymmetric unit. All crystals diffracted X-rays to beyond 3 angstrom resolution, but the tetragonal data sets displayed high Wilson B values and high mean vertical bar E-2 - 1 vertical bar values, indicating potential disorder and anisotropy. The tetragonal crystal was phased by MAD using a single selenium site.
C1 [Rudolph, Markus G.; Wittmann, Julia G.] Univ Gottingen, Inst Microbiol & Genet, Dept Mol Struct Biol, D-37077 Gottingen, Germany.
   [Klostermeier, Dagmar] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Rudolph, MG (corresponding author), Univ Gottingen, Inst Microbiol & Genet, Dept Mol Struct Biol, Justus von Liebig Weg 11, D-37077 Gottingen, Germany.
EM mrudolp2@gwdg.de
OI Rudolph, Markus/0000-0003-0447-1101
FU German Research FoundationGerman Research Foundation (DFG);
   VolkswagenStiftungVolkswagen; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF)
FX We thank Anke Henne for providing T. thermophilus HB27 genomic DNA, Ines
   Hertel, Kathrin Gasow and Andreas Schmidt for technical assistance and
   the staff at BESSY beamline BL-1 and SLS beamline X06SA for guidance
   during data collection. We would also like to thank Gerard Bricogne and
   Clemens Vonrhein for a prerelease of BUSTER-TNT and George Sheldrick for
   a conversion program from XDS to SADABS reflection-data format. This
   work was supported by the German Research Foundation (MGR), the
   VolkswagenStiftung (DK) and the Swiss National Science Foundation (DK).
CR Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981
   Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006
   Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080
   Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269
   Diges CM, 2001, EMBO J, V20, P5503, DOI 10.1093/emboj/20.19.5503
   Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556
   Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083
   Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   Kossen K, 2002, J MOL BIOL, V324, P625, DOI 10.1016/S0022-2836(02)01140-3
   Linden MH, 2008, NUCLEIC ACIDS RES, V36, P5800, DOI 10.1093/nar/gkn581
   Linder P, 2006, NUCLEIC ACIDS RES, V34, P4168, DOI 10.1093/nar/gkl468
   Mohr G, 2008, J MOL BIOL, V375, P1344, DOI 10.1016/j.jmb.2007.11.041
   Morlang S, 1999, J MOL BIOL, V294, P795, DOI 10.1006/jmbi.1999.3282
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908
   Roeser D, 2005, ACTA CRYSTALLOGR D, V61, P1057, DOI 10.1107/S0907444905013831
   Rudolph MG, 2006, J MOL BIOL, V361, P731, DOI 10.1016/j.jmb.2006.06.065
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930
   Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101
   Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839
   Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   Tsu CA, 2001, RNA, V7, P702, DOI 10.1017/S1355838201010135
   Wang SY, 2006, RNA, V12, P959, DOI 10.1261/rna.5906
   Warkentin M, 2006, J APPL CRYSTALLOGR, V39, P805, DOI 10.1107/S0021889806037484
NR 29
TC 6
Z9 6
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
EI 2053-230X
J9 ACTA CRYSTALLOGR F
JI Acta Crystallogr. F-Struct. Biol. Commun.
PD MAR
PY 2009
VL 65
BP 248
EP 252
DI 10.1107/S1744309108043145
PN 3
PG 5
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biophysics; Crystallography
SC Biochemistry & Molecular Biology; Biophysics; Crystallography
GA 413DN
UT WOS:000263773200013
PM 19255475
OA Green Published
DA 2021-01-25
ER

PT J
AU Peter, JC
   Bekel, A
   Lecourt, AC
   Zipfel, G
   Eftekhari, P
   Nesslinger, M
   Breidert, M
   Muller, S
   Kessler, L
   Hofbauer, KG
AF Peter, J. C.
   Bekel, A.
   Lecourt, A. C.
   Zipfel, G.
   Eftekhari, P.
   Nesslinger, M.
   Breidert, M.
   Muller, S.
   Kessler, L.
   Hofbauer, K. G.
TI Anti-Melanocortin-4 receptor autoantibodies and obesity
SO DIABETES & METABOLISM
LA French
DT Meeting Abstract
C1 [Peter, J. C.; Bekel, A.; Lecourt, A. C.; Zipfel, G.; Hofbauer, K. G.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Eftekhari, P.; Muller, S.] IBMC, Immunol & Chim Therapeut, Strasbourg, France.
   [Nesslinger, M.; Breidert, M.] Stadtklin, Med Klin, Baden, Allemagne, Switzerland.
   [Kessler, L.] Hop Univ Strasbourg, Malad Metab & Endocriniennes, Strasbourg, France.
RI Muller, Sylviane/J-5319-2014
NR 0
TC 0
Z9 0
U1 0
U2 1
PU MASSON EDITEUR
PI MOULINEAUX CEDEX 9
PA 21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE
SN 1262-3636
J9 DIABETES METAB
JI Diabetes Metab.
PD MAR
PY 2009
VL 35
BP A6
EP A6
DI 10.1016/S1262-3636(09)71714-8
PG 1
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 424RS
UT WOS:000264586100024
DA 2021-01-25
ER

PT J
AU Silvan, U
   Mittelholzer, C
   Burkhard, P
   Aebi, U
   Jockusch, BM
   Schoenenberger, CA
AF Silvan, U.
   Mittelholzer, C.
   Burkhard, P.
   Aebi, U.
   Jockusch, B. M.
   Schoenenberger, C. A.
TI Tailoring antibodies for the functional characterization of an
   antiparallel actin dimer
SO EUROPEAN JOURNAL OF CELL BIOLOGY
LA English
DT Meeting Abstract
CT 32nd Annual Meeting of the German-Society-for-Cell-Biology
CY MAR 24-27, 2009
CL Konstanz, GERMANY
SP German Soc Cell Biol
C1 [Silvan, U.; Mittelholzer, C.; Aebi, U.; Schoenenberger, C. A.] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
   [Burkhard, P.] Univ Connecticut, Inst Mat Sci, Storrs, CT USA.
   [Jockusch, B. M.] Tech Univ Carolo Wilhelmina Braunschweig, Inst Zool, D-3300 Braunschweig, Germany.
EM unai.silvan@unibas.ch
RI Silvan, Unai/J-7376-2013
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-9335
J9 EUR J CELL BIOL
JI Eur. J. Cell Biol.
PD MAR
PY 2009
VL 88
BP 28
EP 29
PG 2
WC Cell Biology
SC Cell Biology
GA 428RB
UT WOS:000264865700058
DA 2021-01-25
ER

PT J
AU Pulliainen, AT
   Dehio, C
AF Pulliainen, Arto Tapio
   Dehio, Christoph
TI Bartonella henselae: Subversion of vascular endothelial cell functions
   by translocated bacterial effector proteins
SO INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
LA English
DT Article
DE Bartonella; T4SS; Vasoproliferation; Tumor; Apoptosis
ID IV SECRETION SYSTEMS; CAT-SCRATCH DISEASE; IN-VITRO; INFECTION;
   PROLIFERATION; MACROPHAGES; INDUCTION; APOPTOSIS; INVASION; ANTIGEN
AB Bartonella henselae (Bit) is a worldwide distributed zoonotic pathogen. Depending on the immune status of the infected individual this bacterium can cause a wide spectrum of clinical manifestations, ranging from cat scratch disease (CSD) to bacillary angiomatosis (BA) and bacillary peliosis (BP). BA and BP are characterized by tumor-like lesions at the skin or in the inner organs, respectively. These structures display pathological sprouting of capillaries with enlarged and hyperproliferated vascular endothelial cells (ECs) that are frequently found in close association with bacteria. Here we review the cellular changes observed upon Bit infection of ECs in vitro and outline the role of the VirB type IV secretion system (T4SS) and its translocated effector proteins in the modulation of EC signalling cascades. The current model how this virulence system could contribute to the vasoproliferative activity of Bit is described. (C) 2008 Published by Elsevier Ltd.
C1 [Pulliainen, Arto Tapio; Dehio, Christoph] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Pulliainen, Arto
   Tapio/0000-0002-9361-8963
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-109925/1]; Howard Hughes Medical InstituteHoward Hughes
   Medical Institute; Academy of Finland and Emil Aaltonen
   FoundationAcademy of Finland
FX The authors apologize to those whose work could not be cited in this
   review because of space limitations. The research in our laboratory has
   been supported by grant 3100A0-109925/1 from the Swiss National Science
   Foundation, and grant 55005501 from the Howard Hughes Medical Institute
   (both to C.D.). A.T.R is indebted to the Academy of Finland and Emil
   Aaltonen Foundation for financial support.
CR ANDERSON B, 1995, J CLIN MICROBIOL, V33, P2358, DOI 10.1128/JCM.33.9.2358-2365.1995
   Backert S, 2005, TRENDS MICROBIOL, V13, P476, DOI 10.1016/j.tim.2005.08.002
   Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630
   CONLEY T, 1994, J LAB CLIN MED, V124, P521
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   ENGLISH CK, 1988, JAMA-J AM MED ASSOC, V259, P1347, DOI 10.1001/jama.259.9.1347
   Florin TA, 2008, PEDIATRICS, V121, pE1413, DOI 10.1542/peds.2007-1897
   Fuhrmann O, 2001, INFECT IMMUN, V69, P5088, DOI 10.1128/IAI.69.8.5088-5097.2001
   GARCIA FU, 1990, AM J PATHOL, V136, P1125
   Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   Kwon G, 2004, J BIOL CHEM, V279, P8938, DOI 10.1074/jbc.M310330200
   Kyme PA, 2005, CELL MICROBIOL, V7, P1019, DOI 10.1111/j.1462-5822.2005.00531.x
   Odenbreit S, 2000, SCIENCE, V287, P1497, DOI 10.1126/science.287.5457.1497
   Padmalayam I, 2000, DNA CELL BIOL, V19, P377, DOI 10.1089/10445490050043344
   REGNERY RL, 1992, J CLIN MICROBIOL, V30, P265, DOI 10.1128/JCM.30.2.265-274.1992
   Relman DA, 1999, J INFECT DIS, V180, P1386, DOI 10.1086/314975
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schmiederer M, 2001, INFECT IMMUN, V69, P6495, DOI 10.1128/IAI.69.10.6495-6502.2001
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Shamaei-Tousi A, 2004, J BACTERIOL, V186, P4796, DOI 10.1128/JB.186.14.4796-4801.2004
   UTSUMI R, 1982, J BACTERIOL, V151, P807, DOI 10.1128/JB.151.2.807-812.1982
NR 30
TC 25
Z9 26
U1 0
U2 4
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 1357-2725
EI 1878-5875
J9 INT J BIOCHEM CELL B
JI Int. J. Biochem. Cell Biol.
PD MAR
PY 2009
VL 41
IS 3
BP 507
EP 510
DI 10.1016/j.biocel.2008.10.018
PG 4
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 405AZ
UT WOS:000263195800014
PM 19010441
DA 2021-01-25
ER

PT J
AU Peter, JC
   Bekel, A
   Lecourt, AC
   Zipfel, G
   Eftekhari, P
   Nesslinger, M
   Breidert, M
   Muller, S
   Kessler, L
   Hofbauer, KG
AF Peter, Jean-Christophe
   Bekel, Akkiz
   Lecourt, Anne-Catherine
   Zipfel, Geraldine
   Eftekhari, Pierre
   Nesslinger, Maya
   Breidert, Matthias
   Muller, Sylviane
   Kessler, Laurence
   Hofbauer, Karl G.
TI Anti-Melanocortin-4 Receptor Autoantibodies in Obesity
SO JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; MELANOCORTIN-4 RECEPTOR;
   MONOCLONAL-ANTIBODY; ENERGY HOMEOSTASIS; MOLECULAR MIMICRY; MOUSE MODEL;
   DISEASE; IMMUNE; NEUROPEPTIDES
AB Background: The melanocortin-4 receptor (MC4R) is part of an important pathway regulating energy balance. Here we report the existence of autoantibodies (autoAbs) against the MC4R in sera of obese patients.
   Methods: The autoAbs were detected after screening of 216 patients' sera by using direct and inhibition ELISA with an N-terminal sequence of the MC4R. Binding to the native MC4R was evaluated by flow cytometry, and pharmacological effects were evaluated by measuring adenylyl cyclase activity.
   Results: Positive results in all tests were obtained in patients with overweight or obesity (prevalence, 3.6%) but not in normal weight patients. The selective binding properties of anti-MC4R autoAbs were confirmed by surface plasmon resonance and by immunoprecipitation with the native MC4R. Finally, it was demonstrated that these autoAbs increased food intake in rats after passive transfer via intracerebroventricular injection.
   Conclusion: These observations suggest that inhibitory anti-MC4R autoAbs might contribute to the development of obesity in a small subpopulation of patients. (J Clin Endocrinol Metab 94: 793-800, 2009)
C1 [Hofbauer, Karl G.] Univ Basel, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
   [Eftekhari, Pierre; Muller, Sylviane] CNRS, Inst Biol Mol & Cellulaire, Unite Propre Rech 9021, Lab Immunol & Chim Therapeut, F-67000 Strasbourg, France.
   [Eftekhari, Pierre] Forenap Therapeut Discovery, F-67000 Strasbourg, France.
   [Nesslinger, Maya; Breidert, Matthias] Stadtklin Baden Baden, Med Klin 1, D-76532 Baden Baden, Germany.
   [Kessler, Laurence] Hop Univ Strasbourg, F-67000 Strasbourg, France.
RP Hofbauer, KG (corresponding author), Univ Basel, Biozentrum, Pharmazentrum, 50-70 Klingelbergstr, CH-4056 Basel, Switzerland.
EM karl.hofbauer@unibas.ch
RI Muller, Sylviane/J-5319-2014
CR Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929
   Backhed F, 2005, SCIENCE, V307, P1915, DOI 10.1126/science.1104816
   Banks WA, 1996, PEPTIDES, V17, P305, DOI 10.1016/0196-9781(96)00025-3
   Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9
   Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682
   Cowley MA, 2003, EUR J PHARMACOL, V480, P3, DOI 10.1016/j.ejphar.2003.08.087
   Dragun D, 2005, NEW ENGL J MED, V352, P558, DOI 10.1056/NEJMoa035717
   Ellacott KLJ, 2004, RECENT PROG HORM RES, V59, P395, DOI 10.1210/rp.59.1.395
   Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050
   Fetissov SO, 2008, NUTRITION, V24, P348, DOI 10.1016/j.nut.2007.12.006
   Fetissov SO, 2005, P NATL ACAD SCI USA, V102, P14865, DOI 10.1073/pnas.0507204102
   Fetissov SO, 2002, P NATL ACAD SCI USA, V99, P17155, DOI 10.1073/pnas.222658699
   Freedman NJ, 2004, J CLIN INVEST, V113, P1379, DOI 10.1172/JCI200421748
   Giles I, 2008, LUPUS, V17, P895, DOI 10.1177/0961203308091541
   Guijarro A, 2006, PROG BRAIN RES, V153, P367, DOI 10.1016/S0079-6123(06)53022-5
   Hofbauer KG, 2008, NUTRITION, V24, P791, DOI 10.1016/j.nut.2008.06.001
   Irani S, 2008, AUTOIMMUNITY, V41, P55, DOI 10.1080/08916930701619490
   Kamel R, 2005, J AUTOIMMUN, V25, P72, DOI 10.1016/j.jaut.2005.04.005
   Kastin AJ, 2006, ENDOCRINOLOGY, V147, P2086, DOI 10.1210/en.2006-0208
   Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191
   Lebesgue D, 1998, EUR J PHARMACOL, V348, P123, DOI 10.1016/S0014-2999(98)00136-8
   NEIMARK J, 1993, PEPTIDE RES, V6, P219
   Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI12954
   Oldstone MBA, 2005, CURR TOP MICROBIOL, V296, P1
   Oldstone MBA, 1998, FASEB J, V12, P1255
   Peter JC, 2005, FASEB J, V19, P943, DOI 10.1096/fj.04-3042com
   Peter JC, 2007, AM J PHYSIOL-REG I, V292, pR2151, DOI 10.1152/ajpregu.00878.2006
   Scofield RH, 2004, LANCET, V363, P1544, DOI 10.1016/S0140-6736(04)16154-0
   Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927
   Steinman L, 2004, NAT IMMUNOL, V5, P575, DOI 10.1038/ni1078
   Tamura Y, 2005, NEUROBIOL DIS, V20, P541, DOI 10.1016/j.nbd.2005.04.007
   Tozzoli R, 2007, AUTOIMMUN REV, V6, P334, DOI 10.1016/j.autrev.2007.01.005
   Whitney KD, 1999, ANNU REV NEUROSCI, V22, P175, DOI 10.1146/annurev.neuro.22.1.175
NR 33
TC 9
Z9 9
U1 1
U2 2
PU ENDOCRINE SOC
PI WASHINGTON
PA 2055 L ST NW, SUITE 600, WASHINGTON, DC 20036 USA
SN 0021-972X
EI 1945-7197
J9 J CLIN ENDOCR METAB
JI J. Clin. Endocrinol. Metab.
PD MAR
PY 2009
VL 94
IS 3
BP 793
EP 800
DI 10.1210/jc.2008-1749
PG 8
WC Endocrinology & Metabolism
SC Endocrinology & Metabolism
GA 416QN
UT WOS:000264020700015
PM 19050052
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Combaluzier, B
   Pieters, J
AF Combaluzier, Benoit
   Pieters, Jean
TI Chemotaxis and Phagocytosis in Neutrophils Is Independent of Coronin 1
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID MICROTUBULE CYTOSKELETONS; CELL MOTILITY; ACTIN; PROTEIN; TRAFFICKING;
   ACTIVATION; SURVIVAL; MYCOBACTERIA; MOBILIZATION; CYTOKINESIS
AB The WD repeat protein family member coronin 1 is exclusively expressed in leukocytes, where it colocalizes with the cortical cytoskeleton. Although initially coronin 1 was believed to regulate F-actin dynamics such as leukocyte motility, phagocytosis, and membrane ruffling, recent work showed that in macrophages, T cells, and B cells, coronin I is dispensable for these F-actin dependent processes, instead being involved in the regulation of calcium dependent signaling reactions. In this study, we show that in mice lacking coronin 1 neutrophil populations developed normally, and that coronin 1-deficient neutrophils are fully functional with respect to adherence, membrane dynamics, migration, phagocytosis and the oxidative burst. Therefore, these data argue against a role for coronin 1 in the modulation of F-actin and suggest that coronin 1. is dispensable for neutrophil functioning. The Journal of Immunology, 2009, 182: 2745-2752.
C1 [Combaluzier, Benoit; Pieters, Jean] Univ Basel, Biozentrum, Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
CR Aggarwal S, 2003, J BIOL CHEM, V278, P1910, DOI 10.1074/jbc.M207577200
   Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530
   Cicchetti G, 2002, CRIT REV ORAL BIOL M, V13, P220, DOI 10.1177/154411130201300302
   Combaluzier B, 2009, J IMMUNOL, V182, P1954, DOI 10.4049/jimmunol.0801811
   DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x
   DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563
   Fukui Y, 1999, CELL MOTIL CYTOSKEL, V42, P204, DOI 10.1002/(SICI)1097-0169(1999)42:3<204::AID-CM4>3.0.CO;2-L
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83
   Grogan A, 1997, J CELL SCI, V110, P3071
   He R, 2004, J IMMUNOL, V173, P7462, DOI 10.4049/jimmunol.173.12.7462
   Heil-Chapdelaine RA, 1998, CURR BIOL, V8, P1281, DOI 10.1016/S0960-9822(07)00539-8
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Ley K, 2006, IMMUNOL RES, V34, P229, DOI 10.1385/IR:34:3:229
   MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4
   Mitchison TJ, 1996, CELL, V84, P371, DOI 10.1016/S0092-8674(00)81281-7
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Nathan C, 2006, NAT REV IMMUNOL, V6, P173, DOI 10.1038/nri1785
   Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235
   Smith E, 2007, J IMMUNOL, V179, P8274, DOI 10.4049/jimmunol.179.12.8274
   Stark MA, 2005, IMMUNITY, V22, P285, DOI 10.1016/j.immuni.2005.01.011
   Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989
   Yan M, 2007, J IMMUNOL, V178, P5769, DOI 10.4049/jimmunol.178.9.5769
NR 26
TC 24
Z9 24
U1 0
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD MAR 1
PY 2009
VL 182
IS 5
BP 2745
EP 2752
DI 10.4049/jimmunol.0801812
PG 8
WC Immunology
SC Immunology
GA 411MG
UT WOS:000263653100024
PM 19234169
OA Bronze
DA 2021-01-25
ER

PT J
AU Demeule, B
   Palais, C
   Machaidze, G
   Gurny, R
   Arvinte, T
AF Demeule, Barthelemy
   Palais, Caroline
   Machaidze, Gia
   Gurny, Robert
   Arvinte, Tudor
TI New methods allowing the detection of protein aggregates A case study on
   trastuzumab
SO MABS
LA English
DT Article
DE immunoglobulin; aggregation; stability; protein; trastuzumab; herceptin
   (R); methodology
ID MECHANISM; INHIBITION
AB Aggregation compromises the safety and efficacy of therapeutic proteins. According to the manufacturer, the therapeutic immunoglobulin trastuzumab (Herceptin(R)) should be diluted in 0.9% sodium chloride before administration. Dilution in 5% dextrose solutions is prohibited. The reason for the interdiction is not mentioned in the Food and Drug Administration (FDA) documentation, but the European Medicines Agency (EMEA) Summary of Product Characteristics states that dilution of trastuzumab in dextrose solutions results in protein aggregation. In this paper, asymmetrical flow field-flow fractionation (FFF), fluorescence spectroscopy, fluorescence microscopy and transmission electron microscopy (TEM) have been used to characterize trastuzumab samples diluted in 0.9% sodium chloride, a stable infusion solution, as well as in 5% dextrose (a solution prone to aggregation). When trastuzumab samples were injected in the FFF channel using a standard separation method, no difference could be seen between trastuzumab diluted in sodium chloride and trastuzumab diluted in dextrose. However, during FFF measurements made with appropriate protocols, aggregates were detected in 5% dextrose. The parameters enabling the detection of reversible trastuzumab aggregates are described. Aggregates could also be documented by fluorescence microscopy and TEM. Fluorescence spectroscopy data were indicative of conformational changes consistent with increased aggregation and adsorption to surfaces. The analytical methods presented in this study were able to detect and characterize trastuzumab aggregates.
C1 [Demeule, Barthelemy; Gurny, Robert; Arvinte, Tudor] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Dept Pharmaceut & Biopharmaceut, CH-1211 Geneva 4, Switzerland.
   [Palais, Caroline] Univ Geneva, Dept Pharmaceut & Biopharmaceut, Therapeomic Inc, CH-1211 Geneva 4, Switzerland.
   [Machaidze, Gia] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Basel, Switzerland.
RP Arvinte, T (corresponding author), Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Dept Pharmaceut & Biopharmaceut, 30 Quai Ernest Ansermet, CH-1211 Geneva 4, Switzerland.
EM tudor.arvinte@unige.ch
CR Arvinte T, 2005, BIOTECH PHARM ASPECT, P661
   Bajaj H, 2004, BIOPHYS J, V87, P4048, DOI 10.1529/biophysj.104.048686
   Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a
   Carpenter JF, 1999, METHOD ENZYMOL, V309, P236
   Chi EY, 2005, J PHARM SCI-US, V94, P256, DOI 10.1002/jps.20237
   Chi EY, 2003, PHARM RES-DORDR, V20, P1325, DOI 10.1023/A:1025771421906
   CUDD A, 1995, J PHARM SCI, V84, P717, DOI 10.1002/jps.2600840610
   Demeester J, 2005, BIOTECH PHARM ASPECT, P245
   Demeule B, 2007, INT J PHARMACEUT, V329, P37, DOI 10.1016/j.ijpharm.2006.08.024
   *EUR PUBL ASS, EUR PUBL ASS REP AUT
   Gabellieri E, 2006, BIOPHYS J, V90, P3239, DOI 10.1529/biophysj.105.074948
   Gabrielson JP, 2007, J PHARM SCI-US, V96, P268, DOI 10.1002/jps.20760
   Hawe A, 2008, PHARM RES-DORDR, V25, P1487, DOI 10.1007/s11095-007-9516-9
   Hermeling S, 2004, PHARM RES-DORDR, V21, P897, DOI 10.1023/B:PHAM.0000029275.41323.a6
   Ingle Jr JD, 1988, SPECTROCHEMICAL ANAL, P494
   Lakowicz J.R., 1999, PRINCIPLES FLUORESCE, P95
   Lawrence S, 2004, NAT BIOTECHNOL, V22, P1496, DOI 10.1038/nbt1204-1496
   Liu J, 2006, AAPS J, V8, pE580, DOI 10.1208/aapsj080367
   Tessier PM, 2003, CURR OPIN BIOTECH, V14, P512, DOI 10.1016/S0958-1669(03)00114-9
   Volkin D B, 1995, Methods Mol Biol, V40, P35
   Walsh G, 2005, TRENDS BIOTECHNOL, V23, P553, DOI 10.1016/j.tibtech.2005.07.005
   Wang W, 2005, INT J PHARMACEUT, V289, P1, DOI 10.1016/j.ijpharm.2004.11.014
   Wang W, 2000, INT J PHARMACEUT, V203, P1, DOI 10.1016/S0378-5173(00)00423-3
   Webb SD, 2002, J PHARM SCI, V91, P543, DOI 10.1002/jps.10033
   TRASTUZUMAB PRODUCT
NR 25
TC 53
Z9 53
U1 0
U2 15
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA
SN 1942-0862
EI 1942-0870
J9 MABS-AUSTIN
JI mAbs
PD MAR-APR
PY 2009
VL 1
IS 2
BP 142
EP 150
DI 10.4161/mabs.1.2.7632
PG 9
WC Medicine, Research & Experimental
SC Research & Experimental Medicine
GA 521CT
UT WOS:000271897900006
PM 20061815
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Stolz, M
   Gottardi, R
   Raiteri, R
   Miot, S
   Martin, I
   Imer, R
   Staufer, U
   Raducanu, A
   Duggelin, M
   Baschong, W
   Daniels, AU
   Friederich, NF
   Aszodi, A
   Aebi, U
AF Stolz, Martin
   Gottardi, Riccardo
   Raiteri, Roberto
   Miot, Sylvie
   Martin, Ivan
   Imer, Raphael
   Staufer, Urs
   Raducanu, Aurelia
   Dueggelin, Marcel
   Baschong, Werner
   Daniels, A. U.
   Friederich, Niklaus F.
   Aszodi, Attila
   Aebi, Ueli
TI Early detection of aging cartilage and osteoarthritis in mice and
   patient samples using atomic force microscopy
SO NATURE NANOTECHNOLOGY
LA English
DT Article
ID ARTICULAR-CARTILAGE; CHONDROMALACIA PATELLAE; IX COLLAGEN; MRI;
   PROTEOGLYCANS; AGE
AB The pathological changes in osteoarthritis-a degenerative joint disease prevalent among older people-start at the molecular scale and spread to the higher levels of the architecture of articular cartilage to cause progressive and irreversible structural and functional damage. At present, there are no treatments to cure or attenuate the degradation of cartilage. Early detection and the ability to monitor the progression of osteoarthritis are therefore important for developing effective therapies. Here, we show that indentation-type atomic force microscopy can monitor age-related morphological and biomechanical changes In the hips of normal and osteoarthritic mice. Early damage in the cartilage of osteoarthritic patients undergoing hip or knee replacements could similarly be detected using this method. Changes due to aging and osteoarthritis are clearly depicted at the nanometre scale well before morphological changes can be observed using current diagnostic methods. Indentation-type atomic force microscopy may potentially be developed into a minimally invasive arthroscopic tool to diagnose the early onset of osteoarthritis In situ.
C1 [Stolz, Martin; Baschong, Werner; Aebi, Ueli] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4003 Basel, Switzerland.
   [Gottardi, Riccardo; Raiteri, Roberto] Univ Genoa, Dept Biophys & Elect Engn, I-16126 Genoa, Italy.
   [Miot, Sylvie; Martin, Ivan] Univ Basel Hosp, Dept Surg, Basel, Switzerland.
   [Miot, Sylvie; Martin, Ivan] Univ Basel Hosp, Dept Biomed, Basel, Switzerland.
   [Imer, Raphael; Staufer, Urs] Univ Neuchatel, Inst Microtechnol, CH-2000 Neuchatel, Switzerland.
   [Staufer, Urs] Delft Univ Technol, Micro & Nano Engn Lab, Delft, Netherlands.
   [Raducanu, Aurelia; Aszodi, Attila] Max Planck Inst Biochem, D-82152 Martinsried, Germany.
   [Dueggelin, Marcel] Univ Basel, Ctr Microscopy, CH-4003 Basel, Switzerland.
   [Baschong, Werner] Univ Basel, Dept Oral Surg Oral Radiol & Oral Med, CH-4003 Basel, Switzerland.
   [Daniels, A. U.] Univ Basel, Fac Med, Orthopaed Biomech Lab, CH-4003 Basel, Switzerland.
   [Friederich, Niklaus F.] Kantonsspital Bruderholz Basel, Dept Traumat & Orthopaed Surg, Basel, Switzerland.
RP Stolz, M (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4003 Basel, Switzerland.
EM martin.stolz@unibas.ch
RI Martin, Ivan/K-9286-2016; Staufer, Urs/J-6866-2016; Gottardi,
   Riccardo/AAA-5047-2019
OI Staufer, Urs/0000-0002-3519-6467; Gottardi,
   Riccardo/0000-0001-8040-5531; Martin, Ivan/0000-0001-6493-0432; Stolz,
   Martin/0000-0002-0732-0811
FU NCCRSwiss National Science Foundation (SNSF); Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); M. E. Muller
   Foundation of Switzerland; Canton Basel-Stadt; Max Planck SocietyMax
   Planck Society; Hardy and Otto Frey-Zund Foundation; ProMotio Foundation
   for Biomechanical Research
FX This work was supported by an NCCR program grant on 'Nanoscale Science'
   awarded by the Swiss National Science Foundation, the M. E. Muller
   Foundation of Switzerland, the Canton Basel-Stadt, and the Max Planck
   Society. Part of the work has also been supported by the Hardy and Otto
   Frey-Zund Foundation, ProMotio Foundation for Biomechanical Research and
   other private promoters supporting the efforts of the University of
   Basel Laboratory for Orthopedic Biomechanics. Moreover, we thank
   Nanoworld AG (L. Aeschimann, M. Burri) for the silicon AFM probes and
   for the SEM image of the microspherical tip, and Z. Farkas for technical
   assistance. The authors thank F. Wolf for some of the
   glycosaminoglycan/DNA analysis. We thank T. Staehelin for critical
   review of the manuscript and discussion of the data, and Z. Housley for
   proofreading the manuscript.
CR Asamura K, 2005, NEUROSCIENCE, V132, P493, DOI 10.1016/j.neuroscience.2005.01.013
   Bayliss MT, 1999, J BIOL CHEM, V274, P15892, DOI 10.1074/jbc.274.22.15892
   BRUCKNER P, 1994, MICROSC RES TECHNIQ, V28, P378, DOI 10.1002/jemt.1070280504
   BUCKWALTER JA, 1985, J ORTHOP RES, V3, P251, DOI 10.1002/jor.1100030301
   Buckwalter Joseph A, 2005, Instr Course Lect, V54, P465
   Burstein D, 2006, OSTEOARTHR CARTILAGE, V14, P1087, DOI 10.1016/j.joca.2006.07.001
   CARNEY SL, 1988, PHYSIOL REV, V68, P858
   FARNDALE RW, 1986, BIOCHIM BIOPHYS ACTA, V883, P173, DOI 10.1016/0304-4165(86)90306-5
   FASSLER R, 1994, P NATL ACAD SCI USA, V91, P5070, DOI 10.1073/pnas.91.11.5070
   Glover P, 2002, REP PROG PHYS, V65, P1489, DOI 10.1088/0034-4885/65/10/203
   Hollander AP, 1995, J CLIN INVEST, V96, P2859, DOI 10.1172/JCI118357
   Hu K, 2006, ARTHRITIS RHEUM-US, V54, P2891, DOI 10.1002/art.22040
   Imer R, 2006, JPN J APPL PHYS 1, V45, P2319, DOI 10.1143/JJAP.45.2319
   Kleemann RU, 2005, OSTEOARTHR CARTILAGE, V13, P958, DOI 10.1016/j.joca.2005.06.008
   Lamers RJAN, 2005, OSTEOARTHR CARTILAGE, V13, P762, DOI 10.1016/j.joca.2005.04.005
   Li X, 2007, OSTEOARTHR CARTILAGE, V15, P789, DOI 10.1016/j.joca.2007.01.011
   MANKIN H, 1994, ORTHOPAEDIC BASIC SC, P443
   OUTERBRIDGE RE, 1975, CLIN ORTHOP RELAT R, P177
   OUTERBRIDGE RE, 1961, J BONE JOINT SURG BR, V43, P752
   Poole A. Robin, 1999, Frontiers in Bioscience, V4, pd662, DOI 10.2741/Poole
   Poole AR, 2003, RHEUM DIS CLIN N AM, V29, P803, DOI 10.1016/S0889-857X(03)00056-5
   Qazi AA, 2007, OSTEOARTHR CARTILAGE, V15, P1199, DOI 10.1016/j.joca.2007.03.016
   SEGAWA K, 1992, ANAT RECORD, V234, P493, DOI 10.1002/ar.1092340405
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   STOLZ M, 2003, BIOWORLD, V4, P2
   Xia Y, 2007, OSTEOARTHR CARTILAGE, V15, P363, DOI 10.1016/j.joca.2006.12.004
   Yang L, 2007, J BIOMED MATER RES A, V82A, P160, DOI 10.1002/jbm.a.31127
NR 27
TC 282
Z9 289
U1 1
U2 78
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1748-3387
J9 NAT NANOTECHNOL
JI Nat. Nanotechnol.
PD MAR
PY 2009
VL 4
IS 3
BP 186
EP 192
DI 10.1038/NNANO.2008.410
PG 7
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary
SC Science & Technology - Other Topics; Materials Science
GA 420VY
UT WOS:000264318500017
PM 19265849
DA 2021-01-25
ER

PT J
AU Cueni, L
   Canepari, M
   Adelman, JP
   Luthi, A
AF Cueni, Lucius
   Canepari, Marco
   Adelman, John P.
   Luethi, Anita
TI Ca2+ signaling by T-type Ca2+ channels in neurons
SO PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY
LA English
DT Review
DE Ca(v)3 channel; Low-threshold burst; Oscillation; Thalamus; SK channel;
   SERCA
ID THRESHOLD CALCIUM CURRENTS; THALAMIC RELAY CELLS; NEOCORTICAL PYRAMIDAL
   NEURONS; DEPENDENT SYNAPTIC PLASTICITY; RAT-CHROMAFFIN-CELLS;
   ACTION-POTENTIALS; IN-VITRO; THALAMOCORTICAL NEURONS; INTRACELLULAR
   CA2+; ABSENCE EPILEPSY
AB Among the major families of voltage-gated Ca2+ channels, the low-voltage-activated channels formed by the Ca(v)3 subunits, referred to as T-type Ca2+ channels, have recently gained increased interest in terms of the intracellular Ca2+ signals generated upon their activation. Here, we provide an overview of recent reports documenting that T-type Ca2+ channels act as an important Ca2+ source in a wide range of neuronal cell types. The work is focused on T-type Ca2+ channels in neurons, but refers to non-neuronal cells in cases where exemplary functions for Ca2+ entering through T-type Ca2+ channels have been described. Notably, Ca2+ influx through T-type Ca2+ channels is the predominant Ca2+ source in several neuronal cell types and carries out specific signaling roles. We also emphasize that Ca2+ signaling through T-type Ca2+ channels occurs often in select subcellular compartments, is mediated through strategically co-localized targets, and is exploited for unique physiological functions.
C1 [Luethi, Anita] Univ Lausanne, Fac Biol & Med, Dept Cell Biol & Morphol, CH-1005 Lausanne, Switzerland.
   [Adelman, John P.] OHSU, Vollum Inst, Portland, OR 97239 USA.
   [Cueni, Lucius; Canepari, Marco] Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
RP Luthi, A (corresponding author), Univ Lausanne, Fac Biol & Med, Dept Cell Biol & Morphol, Rue Bugnon 9, CH-1005 Lausanne, Switzerland.
EM anita.luthi@unil.ch
RI Canepari, Marco/H-6772-2012
OI Canepari, Marco/0000-0001-9759-2388; Luthi, Anita/0000-0002-4954-4143
CR Aizenman CD, 1998, NEURON, V21, P827, DOI 10.1016/S0896-6273(00)80598-X
   Autret L, 2005, J PHYSIOL-LONDON, V567, P67, DOI 10.1113/jphysiol.2005.089342
   AVANZINI G, 1989, J PHYSIOL-LONDON, V416, P111, DOI 10.1113/jphysiol.1989.sp017752
   Bal T, 1997, J NEUROPHYSIOL, V77, P3145
   Bal T, 1996, NEURON, V17, P297, DOI 10.1016/S0896-6273(00)80161-0
   BAL T, 1993, J PHYSIOL-LONDON, V468, P669, DOI 10.1113/jphysiol.1993.sp019794
   Bao JP, 1998, J NEUROSCI, V18, P8740
   Beck H, 2008, NAT REV NEUROSCI, V9, P357, DOI 10.1038/nrn2371
   Bender VA, 2006, J NEUROSCI, V26, P4166, DOI 10.1523/JNEUROSCI.0176-06.2006
   Beurrier C, 1999, J NEUROSCI, V19, P599, DOI 10.1523/jneurosci.19-02-00599.1999
   Bijlenga P, 2000, P NATL ACAD SCI USA, V97, P7627, DOI 10.1073/pnas.97.13.7627
   Birtoli B, 2004, J NEUROSCI, V24, P4935, DOI 10.1523/JNEUROSCI.0795-04.2004
   Blaustein MR, 2001, TRENDS NEUROSCI, V24, P602, DOI 10.1016/S0166-2236(00)01891-9
   Blethyn KL, 2006, J NEUROSCI, V26, P2474, DOI 10.1523/JNEUROSCI.3607-05.2006
   Broicher T, 2007, MOL CELL NEUROSCI, V36, P132, DOI 10.1016/j.mcn.2007.05.013
   Budde T, 2000, NEURON, V26, P483, DOI 10.1016/S0896-6273(00)81180-0
   Carabelli V, 2007, J PHYSIOL-LONDON, V584, P149, DOI 10.1113/jphysiol.2007.132274
   Carbone E, 2006, CELL CALCIUM, V40, P147, DOI 10.1016/j.ceca.2006.04.019
   Catterall WA, 2005, PHARMACOL REV, V57, P411, DOI 10.1124/pr.57.4.5
   Cavelier P, 2008, NEUROREPORT, V19, P299, DOI 10.1097/WNR.0b013e3282f4cb96
   Chambard JM, 1999, J PHYSIOL-LONDON, V518, P141, DOI 10.1111/j.1469-7793.1999.0141r.x
   Chang SY, 2004, J NEUROSCI, V24, P2172, DOI 10.1523/JNEUROSCI.4891-03.2004
   Chemin J, 2006, CELL CALCIUM, V40, P121, DOI 10.1016/j.ceca.2006.04.015
   Chen CC, 2003, SCIENCE, V302, P1416, DOI 10.1126/science.1089268
   Chevalier M, 2006, EUR J NEUROSCI, V23, P2321, DOI 10.1111/j.1460-9568.2006.04761.x
   CHRISTIE BR, 1995, J NEUROPHYSIOL, V73, P2553
   Crunelli V, 2005, J PHYSIOL-LONDON, V562, P121, DOI 10.1113/jphysiol.2004.076273
   Crunelli V, 2006, CELL CALCIUM, V40, P175, DOI 10.1016/j.ceca.2006.04.022
   Cueni L, 2008, NAT NEUROSCI, V11, P683, DOI 10.1038/nn.2124
   Cui GH, 2004, J NEUROSCI, V24, P11079, DOI 10.1523/JNEUROSCI.2713-04.2004
   Destexhe A, 1996, J NEUROSCI, V16, P169
   Destexhe A, 1998, J NEUROSCI, V18, P3574, DOI 10.1523/jneurosci.18-10-03574.1998
   Diana MA, 2007, J NEUROSCI, V27, P3823, DOI 10.1523/JNEUROSCI.4719-06.2007
   Egger V, 2005, J NEUROSCI, V25, P3521, DOI 10.1523/JNEUROSCI.4746-04.2005
   Egger V, 2003, J NEUROSCI, V23, P7551
   EILERS J, 1995, NATURE, V373, P155, DOI 10.1038/373155a0
   Feltz Anne, 2006, Critical Reviews in Neurobiology, V18, P169
   Fuentealba P, 2004, P NATL ACAD SCI USA, V101, P9816, DOI 10.1073/pnas.0402761101
   Gautam SH, 2007, NEUROSCIENCE, V144, P702, DOI 10.1016/j.neuroscience.2006.10.012
   Giancippoli A, 2006, BIOPHYS J, V90, P1830, DOI 10.1529/biophysj.105.071647
   Gillessen T, 1997, J NEUROPHYSIOL, V77, P1639
   Goaillard JM, 2002, J PHYSIOL-LONDON, V541, P453, DOI 10.1113/jphysiol.2001.013896
   GU X, 1993, J NEUROSCI, V13, P4936
   HAGIWARA N, 1988, J PHYSIOL-LONDON, V395, P233, DOI 10.1113/jphysiol.1988.sp016916
   Heppenstall PA, 2006, CELL CALCIUM, V40, P165, DOI 10.1016/j.ceca.2006.04.021
   Hughes SW, 2002, NEURON, V33, P947, DOI 10.1016/S0896-6273(02)00623-2
   Huguenard JR, 1996, ANNU REV PHYSIOL, V58, P329, DOI 10.1146/annurev.ph.58.030196.001553
   Huser J, 2000, J PHYSIOL-LONDON, V524, P415, DOI 10.1111/j.1469-7793.2000.00415.x
   Isope P, 2005, J PHYSIOL-LONDON, V562, P257, DOI 10.1113/jphysiol.2004.074211
   Ivanov AI, 2000, J NEUROSCI, V20, P4930
   Jevtovic-Todorovic V, 2006, CELL CALCIUM, V40, P197, DOI 10.1016/j.ceca.2006.04.024
   Joksovic PM, 2005, J PHYSIOL-LONDON, V566, P125, DOI 10.1113/jphysiol.2005.086579
   Jones SW, 2003, J BIOENERG BIOMEMBR, V35, P461, DOI 10.1023/B:JOBB.0000008020.86004.28
   Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032
   Kampa BM, 2006, J PHYSIOL-LONDON, V574, P283, DOI 10.1113/jphysiol.2006.111062
   KARST H, 1993, NEUROSCI LETT, V164, P154, DOI 10.1016/0304-3940(93)90880-T
   Kavalali ET, 1997, NEURON, V18, P651, DOI 10.1016/S0896-6273(00)80305-0
   Kawai F, 2001, J NEUROSCI, V21, DOI 10.1523/JNEUROSCI.21-10-j0002.2001
   Khosravani H, 2006, PHYSIOL REV, V86, P941, DOI 10.1152/physrev.00002.2006
   Kim Y, 2007, J NEUROPHYSIOL, V97, P1705, DOI 10.1152/jn.00536.2006
   Kiryushko D, 2006, MOL BIOL CELL, V17, P2278, DOI 10.1091/mbc.E05-10-0987
   Konig S, 2006, DEVELOPMENT, V133, P3107, DOI 10.1242/dev.02479
   Kozlov AS, 1999, EUR J NEUROSCI, V11, P4149, DOI 10.1046/j.1460-9568.1999.00841.x
   Krahe R, 2004, NAT REV NEUROSCI, V5, P13, DOI 10.1038/nrn1296
   Kuisle M, 2006, J PHYSIOL-LONDON, V575, P83, DOI 10.1113/jphysiol.2006.110486
   Lee JH, 1999, J NEUROSCI, V19, P1912
   Levic S, 2007, P NATL ACAD SCI USA, V104, P19108, DOI 10.1073/pnas.0705927104
   Lory P, 2006, CELL CALCIUM, V40, P135, DOI 10.1016/j.ceca.2006.04.017
   Luthi A, 1998, NEURON, V21, P9, DOI 10.1016/S0896-6273(00)80509-7
   Luthi A, 1998, NEURON, V20, P553, DOI 10.1016/S0896-6273(00)80994-0
   MAGEE JC, 1995, J PHYSIOL-LONDON, V487, P67, DOI 10.1113/jphysiol.1995.sp020862
   MAGEE JC, 1995, J NEUROPHYSIOL, V74, P1335
   Magee JC, 2000, NAT REV NEUROSCI, V1, P181, DOI 10.1038/35044552
   Mangoni ME, 2006, CIRC RES, V98, P1422, DOI 10.1161/01.RES.0000225862.14314.49
   MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207
   MARKRAM H, 1995, J PHYSIOL-LONDON, V485, P1
   MCCOBB DP, 1991, NEURON, V7, P119, DOI 10.1016/0896-6273(91)90080-J
   McKay BE, 2006, EUR J NEUROSCI, V24, P2581, DOI 10.1111/j.1460-9568.2006.05136.x
   Molineux ML, 2006, P NATL ACAD SCI USA, V103, P5555, DOI 10.1073/pnas.0601261103
   Mouginot D, 1997, J NEUROSCI, V17, P160
   Munsch T, 1997, NEUROREPORT, V8, P2411, DOI 10.1097/00001756-199707280-00001
   Murbartian J, 2004, J NEUROPHYSIOL, V92, P3399, DOI 10.1152/jn.00498.2004
   Nevian T, 2006, J NEUROSCI, V26, P11001, DOI 10.1523/JNEUROSCI.1749-06.2006
   Nilius B, 2006, CELL CALCIUM, V40, P81, DOI 10.1016/j.ceca.2006.04.011
   Oliet SHR, 1997, NEURON, V18, P969, DOI 10.1016/S0896-6273(00)80336-0
   Pan ZH, 2001, NEURON, V32, P89, DOI 10.1016/S0896-6273(01)00454-8
   Panner A, 2006, CELL CALCIUM, V40, P253, DOI 10.1016/j.ceca.2006.04.029
   Pape HC, 2004, PFLUG ARCH EUR J PHY, V448, P131, DOI 10.1007/s00424-003-1234-5
   Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002
   Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008
   Pugh JR, 2006, NEURON, V51, P113, DOI 10.1016/j.neuron.2006.05.021
   Randall AD, 1997, NEUROPHARMACOLOGY, V36, P879, DOI 10.1016/S0028-3908(97)00086-5
   Richter TA, 2005, J NEUROSCI, V25, P8267, DOI 10.1523/JNEUROSCI.1942-05.2005
   Richter TA, 2006, EUR J NEUROSCI, V24, P1316, DOI 10.1111/j.1460-9568.2006.05004.x
   Sherman SM, 2007, CURR OPIN NEUROBIOL, V17, P417, DOI 10.1016/j.conb.2007.07.003
   Shin HS, 2008, CURR OPIN PHARMACOL, V8, P33, DOI 10.1016/j.coph.2007.12.003
   Shin HS, 2006, CELL CALCIUM, V40, P191, DOI 10.1016/j.ceca.2006.04.023
   Sipido KR, 1998, J PHYSIOL-LONDON, V508, P439, DOI 10.1111/j.1469-7793.1998.439bq.x
   Sochivko D, 2002, J PHYSIOL-LONDON, V542, P699, DOI 10.1113/jphysiol.2002.020677
   Sotty F, 2003, J PHYSIOL-LONDON, V551, P927, DOI 10.1113/jphysiol.2003.046847
   Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516
   STUART GJ, 2000, SOC NEUR ABSTR, V30, P610
   Su H, 2002, J NEUROSCI, V22, P3645
   Swensen AM, 2003, J NEUROSCI, V23, P9650
   Talavera K, 2006, CELL CALCIUM, V40, P97, DOI 10.1016/j.ceca.2006.04.013
   Talley EM, 1999, J NEUROSCI, V19, P1895
   Thomas MJ, 1998, J NEUROSCI, V18, P7118, DOI 10.1523/jneurosci.18-18-07118.1998
   Tottene A, 2000, J NEUROSCI, V20, P171, DOI 10.1523/JNEUROSCI.20-01-00171.2000
   TSAKIRIDOU E, 1995, J NEUROSCI, V15, P3110, DOI 10.1523/jneurosci.15-04-03110.1995
   TURNER JP, 1994, J PHYSIOL-LONDON, V480, P281, DOI 10.1113/jphysiol.1994.sp020359
   Uebachs M, 2006, J PHYSIOL-LONDON, V571, P519, DOI 10.1113/jphysiol.2005.103614
   Vassort G, 2006, CELL CALCIUM, V40, P205, DOI 10.1016/j.ceca.2006.04.025
   Williams S, 1997, J NEUROSCI, V17, P7307
   Williams SR, 1997, J PHYSIOL-LONDON, V505, P689, DOI 10.1111/j.1469-7793.1997.689ba.x
   Williams SR, 2000, J NEUROSCI, V20, P1307
   Wolfart J, 2002, J NEUROSCI, V22, P3404
   Yaari Y, 2007, J PHYSIOL-LONDON, V580, P435, DOI 10.1113/jphysiol.2007.127670
   Zhou Q, 1997, J NEUROPHYSIOL, V77, P2816
NR 118
TC 51
Z9 54
U1 0
U2 10
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0031-6768
J9 PFLUG ARCH EUR J PHY
JI Pflugers Arch.
PD MAR
PY 2009
VL 457
IS 5
BP 1161
EP 1172
DI 10.1007/s00424-008-0582-6
PG 12
WC Physiology
SC Physiology
GA 404SQ
UT WOS:000263173700016
PM 18784939
DA 2021-01-25
ER

PT J
AU Chomel, BB
   Boulouis, HJ
   Breitschwerdt, EB
   Kasten, RW
   Vayssier-Taussat, M
   Birtles, RJ
   Koehler, JE
   Dehio, C
AF Chomel, Bruno B.
   Boulouis, Henri-Jean
   Breitschwerdt, Edward B.
   Kasten, Rickie W.
   Vayssier-Taussat, Muriel
   Birtles, Richard J.
   Koehler, Jane E.
   Dehio, Christoph
TI Ecological fitness and strategies of adaptation of Bartonella species to
   their hosts and vectors
SO VETERINARY RESEARCH
LA English
DT Review
DE Bartonella; vectors; ecological fitness; host adaptation; pathogenesis
ID CAT-SCRATCH DISEASE; IV SECRETION SYSTEMS; OUTER-MEMBRANE PROTEINS;
   HENSELAE TYPE-I; DOMESTIC CATS; EXPERIMENTAL-INFECTION;
   MOLECULAR-DETECTION; EXPERIMENTAL TRANSMISSION; ROCHALIMAEA-HENSELAE;
   BORRELIA-BURGDORFERI
AB Bartonella spp. are facultative intracellular bacteria that cause characteristic host-restricted hemotropic infections in mammals and are typically transmitted by blood-sucking arthropods. In the mammalian reservoir, these bacteria initially infect a yet unrecognized primary niche, which seeds organisms into the blood stream leading to the establishment of a long-lasting intra-erythrocytic bacteremia as the hall-mark of infection. Bacterial type IV secretion systems, which are supra-molecular transporters ancestrally related to bacterial conjugation systems, represent crucial pathogenicity factors that have contributed to a radial expansion of the Bartonella lineage in nature by facilitating adaptation to unique mammalian hosts. On the molecular level, the type IV secretion system VirB/VirD4 is known to translocate a cocktail of different effector proteins into host cells, which subvert multiple cellular functions to the benefit of the infecting pathogen. Furthermore, bacterial adhesins mediate a critical, early step in the pathogenesis of the bartonellae by binding to extracellular matrix components of host cells, which leads to firm bacterial adhesion to the cell surface as a prerequisite for the efficient translocation of type IV secretion effector proteins. The best-studied adhesins in bartonellae are the orthologous trimeric autotransporter adhesins, BadA in B. henselae and the Vomp family in B. quintana. Genetic diversity and strain variability also appear to enhance the ability of bartonellae to invade not only specific reservoir hosts, but also accidental hosts, as shown for B. henselae. Bartonellae have been identified in many different blood-sucking arthropods, in which they are typically found to cause extracellular infections of the mid-gut epithelium. Adaptation to specific vectors and reservoirs seems to be a common strategy of bartonellae for transmission and host diversity. However, knowledge regarding arthropod specificity/restriction, the mode of transmission, and the bacterial factors involved in arthropod infection and transmission is still limited.
C1 [Chomel, Bruno B.; Kasten, Rickie W.] Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.
   [Boulouis, Henri-Jean; Vayssier-Taussat, Muriel] Ecole Natl Vet Alfort, INRA, UMR, BIPAR,AFSSA,UPVM, F-94704 Maisons Alfort, France.
   [Breitschwerdt, Edward B.] N Carolina State Univ, Coll Vet Med, Ctr Comparat Med & Transit Res, Raleigh, NC 27606 USA.
   [Birtles, Richard J.] Univ Liverpool, Fac Vet Sci, Dept Vet Pathol, Leahurst CH64 7TE, England.
   [Koehler, Jane E.] Univ Calif San Francisco, Div Infect Dis, San Francisco, CA 94143 USA.
   [Dehio, Christoph] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
RP Chomel, BB (corresponding author), Univ Calif Davis, Sch Vet Med, Dept Populat Hlth & Reprod, Davis, CA 95616 USA.
EM bbchomel@ucdavis.edu
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Birtles, Richard/0000-0002-4216-5044;
   Breitschwerdt, Edward/0000-0002-3506-0279
CR Abbott RC, 1997, COMP IMMUNOL MICROB, V20, P41, DOI 10.1016/S0147-9571(96)00025-2
   Abdollahi-Roodsaz S, 2008, J CLIN INVEST, V118, P205, DOI 10.1172/JCI32639
   Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101
   Angelakis E, 2008, EMERG INFECT DIS, V14, P1951, DOI 10.3201/eid1412.080757
   Arvand M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001346
   Arvand M, 2008, EMERG INFECT DIS, V14, P152, DOI 10.3201/eid1401.070768
   Bai Y, 2008, MICROB ECOL, V56, P373, DOI 10.1007/s00248-007-9355-6
   Barbour AG, 2000, EMERG INFECT DIS, V6, P449, DOI 10.3201/eid0605.000502
   Bass JW, 1997, PEDIATR INFECT DIS J, V16, P2, DOI 10.1097/00006454-199701000-00003
   BATTISTTINI T., 1931, Rev. sud. -amer. Med. Chir., V2, P719
   Berghoff J, 2007, MICROBIOL-SGM, V153, P2045, DOI 10.1099/mic.0.2007/006379-0
   Bergmans AMC, 1996, J CLIN MICROBIOL, V34, P254, DOI 10.1128/JCM.34.2.254-260.1996
   Bergmans AMC, 1997, J CLIN MICROBIOL, V35, P2256, DOI 10.1128/JCM.35.9.2256-2261.1997
   Billeter SA, 2008, MED VET ENTOMOL, V22, P1, DOI 10.1111/j.1365-2915.2008.00713.x
   Birtles RJ, 2001, EPIDEMIOL INFECT, V126, P323, DOI 10.1017/S095026880100526X
   Boonjakuakul JK, 2007, INFECT IMMUN, V75, P2548, DOI 10.1128/IAI.01974-06
   BOUCHOUICHA R, 2009, EMERG INFEC IN PRESS
   Boulouis HJ, 2005, VET RES, V36, P383, DOI 10.1051/vetres:2005009
   Boulouis HJ, 2001, INFECT IMMUN, V69, P5313, DOI 10.1128/IAI.69.9.5313-5317.2001
   Bown KJ, 2004, EMERG INFECT DIS, V10, P684, DOI 10.3201/eid1004.030455
   Breitschwerdt EB, 2008, J CLIN MICROBIOL, V46, P2856, DOI 10.1128/JCM.00832-08
   Breitschwerdt EB, 2007, EMERG INFECT DIS, V13, P938, DOI 10.3201/eid1306.061337
   Breitschwerdt EB, 2007, J CLIN MICROBIOL, V45, P270, DOI 10.1128/JCM.01451-06
   Brouqui P, 1999, NEW ENGL J MED, V340, P184, DOI 10.1056/NEJM199901213400303
   Bruce D, 1921, J HYG-CAMBRIDGE, V20, P258, DOI 10.1017/S0022172400034008
   BYAM W, 1920, R SOC MED P, V13, P1
   Caceres Abraham G., 1997, Revista do Instituto de Medicina Tropical de Sao Paulo, V39, P51, DOI 10.1590/S0036-46651997000100011
   Caceres Abraham G., 1993, Revista do Instituto de Medicina Tropical de Sao Paulo, V35, P485, DOI 10.1590/S0036-46651993000600002
   Cadenas MB, 2008, J CLIN MICROBIOL, V46, P1858, DOI 10.1128/JCM.02456-07
   Carron MA, 2006, J GASTROINTEST SURG, V10, P712, DOI 10.1016/j.gassur.2005.10.019
   Chang CC, 2000, EMERG INFECT DIS, V6, P306, DOI 10.3201/eid0603.000313
   Chang CC, 2002, COMP IMMUNOL MICROB, V25, P229, DOI 10.1016/S0147-9571(02)00012-7
   Chang CC, 2001, J CLIN MICROBIOL, V39, P1221, DOI 10.1128/JCM.39.4.1221-1226.2001
   Chang CC, 2000, J CLIN MICROBIOL, V38, P4193, DOI 10.1128/JCM.38.11.4193-4200.2000
   Chomel BB, 2006, EMERG INFECT DIS, V12, P389, DOI 10.3201/eid1203.050931
   Chomel BB, 2004, JAVMA-J AM VET MED A, V224, P1270, DOI 10.2460/javma.2004.224.1270
   Chomel BB, 2003, ANN NY ACAD SCI, V990, P267, DOI 10.1111/j.1749-6632.2003.tb07376.x
   CHOMEL BB, 1995, J CLIN MICROBIOL, V33, P2445, DOI 10.1128/JCM.33.9.2445-2450.1995
   Chomel BB, 1996, J CLIN MICROBIOL, V34, P1952, DOI 10.1128/JCM.34.8.1952-1956.1996
   Chomel BB, 2006, ANN NY ACAD SCI, V1078, P410, DOI 10.1196/annals.1374.080
   Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630
   Chung CY, 2004, EMERG INFECT DIS, V10, P1311
   Colebrook E, 2004, VET PARASITOL, V120, P251, DOI 10.1016/j.vetpar.2004.01.012
   Coleman SA, 2003, MICROB PATHOGENESIS, V34, P179, DOI 10.1016/S0882-4010(03)00005-6
   Cotte V, 2008, EMERG INFECT DIS, V14, P1074, DOI 10.3201/eid1407.071110
   Dale C, 2006, CELL, V126, P453, DOI 10.1016/j.cell.2006.07.014
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2004, J CLIN MICROBIOL, V42, P5320, DOI 10.1128/JCM.42.11.5320-5323.2004
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 2001, TRENDS MICROBIOL, V9, P279, DOI 10.1016/S0966-842X(01)02047-9
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   DEMERS DM, 1995, J PEDIATR-US, V127, P23, DOI 10.1016/S0022-3476(95)70251-2
   Dillon B, 2002, J CLIN MICROBIOL, V40, P4691, DOI 10.1128/JCM.40.12.4691-4699.2002
   ENGEL P, GENOME DYNA IN PRESS, V6
   Eskow E, 2001, ARCH NEUROL-CHICAGO, V58, P1357, DOI 10.1001/archneur.58.9.1357
   Finkelstein JL, 2002, J MED ENTOMOL, V39, P915, DOI 10.1603/0022-2585-39.6.915
   Foil L, 1998, J MED ENTOMOL, V35, P625, DOI 10.1093/jmedent/35.5.625
   Fournier PE, 2002, EMERG INFECT DIS, V8, P1515, DOI 10.3201/eid0812.020111
   Fournier PE, 2001, INFECT IMMUN, V69, P1876, DOI 10.1128/IAI.69.3.1876-1879.2001
   Gilmore RD, 2005, INFECT IMMUN, V73, P3128, DOI 10.1128/IAI.73.5.3128-3136.2005
   Gurfield AN, 1997, J CLIN MICROBIOL, V35, P2120, DOI 10.1128/JCM.35.8.2120-2123.1997
   Halos L, 2004, APPL ENVIRON MICROB, V70, P6302, DOI 10.1128/AEM.70.10.6302-6305.2004
   Heller R, 1997, J CLIN MICROBIOL, V35, P1327, DOI 10.1128/JCM.35.6.1327-1331.1997
   Heller R, 1999, INT J SYST BACTERIOL, V49, P283, DOI 10.1099/00207713-49-1-283
   HERTIG M, 1942, AM J TROP MED HYG  S, V1, P2
   HERTIG M, 1942, AM J TROP MED HYG  S, V1, P11, DOI DOI 10.4269/AJTMH.1942.S1-22.11
   Higgins JA, 1996, J MED ENTOMOL, V33, P490, DOI 10.1093/jmedent/33.3.490
   Iredell J, 2003, J CLIN MICROBIOL, V41, P5071, DOI 10.1128/JCM.41.11.5071-5079.2003
   ITO S, 1965, J BACTERIOL, V89, P481, DOI 10.1002/path.1700890205
   Jendro MC, 1998, Z RHEUMATOL, V57, P159, DOI 10.1007/s003930050074
   Kabeya H, 2006, MICROBIOL IMMUNOL, V50, P171, DOI 10.1111/j.1348-0421.2006.tb03783.x
   Kabeya H, 2003, J VET MED SCI, V65, P479, DOI 10.1292/jvms.65.479
   Kabeya H, 2002, VET MICROBIOL, V89, P211, DOI 10.1016/S0378-1135(02)00175-X
   Kaiser PO, 2008, CELL MICROBIOL, V10, P2223, DOI 10.1111/j.1462-5822.2008.01201.x
   Kelly P, 2006, EMERG INFECT DIS, V12, P1869
   KOEHLER JE, 1994, JAMA-J AM MED ASSOC, V271, P531, DOI 10.1001/jama.271.7.531
   KOEHLER JE, 1992, NEW ENGL J MED, V327, P1625, DOI 10.1056/NEJM199212033272303
   Koesling J, 2001, J IMMUNOL, V167, P11, DOI 10.4049/jimmunol.167.1.11
   Kordick DL, 1998, EMERG INFECT DIS, V4, P325, DOI 10.3201/eid0402.980225
   KORDICK DL, 1995, J CLIN MICROBIOL, V33, P3245, DOI 10.1128/JCM.33.12.3245-3251.1995
   Kosoy MY, 1997, AM J TROP MED HYG, V57, P578, DOI 10.4269/ajtmh.1997.57.578
   KOSTRZEWSKI J, 1949, Bull Int Acad Pol Sci Let Cl Med, V7, P233
   Kruszewska D, 1996, Rocz Akad Med Bialymst, V41, P129
   Kyme P, 2003, MICROBIOL-SGM, V149, P621, DOI 10.1099/mic.0.26014-0
   La VD, 2005, EMERG INFECT DIS, V11, P1287, DOI 10.3201/eid1108.050101
   LEBOIT PE, 1989, AM J SURG PATHOL, V13, P909, DOI 10.1097/00000478-198911000-00001
   Li WJ, 2006, J CLIN MICROBIOL, V44, P2499, DOI 10.1128/JCM.00498-06
   Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005
   LJUNGH A, 1995, METHOD ENZYMOL, V253, P501
   LoGiudice K, 2003, P NATL ACAD SCI USA, V100, P567, DOI 10.1073/pnas.0233733100
   LUCEY D, 1992, CLIN INFECT DIS, V14, P683, DOI 10.1093/clinids/14.3.683
   MacKichan JK, 2008, INFECT IMMUN, V76, P788, DOI 10.1128/IAI.01174-07
   Maggi RG, 2006, MOL CELL PROBE, V20, P128, DOI 10.1016/j.mcp.2005.11.002
   Maillard R, 2006, J CLIN MICROBIOL, V44, P42, DOI 10.1128/JCM.44.1.42-46.2006
   Marie JL, 2006, AM J TROP MED HYG, V74, P436, DOI 10.4269/ajtmh.2006.74.436
   Matsumoto K, 2008, VECTOR-BORNE ZOONOT, V8, P549, DOI 10.1089/vbz.2007.0244
   Merrell DS, 2004, NATURE, V430, P250, DOI 10.1038/nature02760
   Monteil M, 2007, MICROBIOL-SGM, V153, P1141, DOI 10.1099/mic.0.2006/001164-0
   MOOSER H, 1953, P SOC EXP BIOL MED, V83, P699, DOI 10.3181/00379727-83-20464
   Noguchi H, 1929, J EXP MED, V49, P993, DOI 10.1084/jem.49.6.993
   Noguchi H, 1926, J EXP MED, V44, P729, DOI 10.1084/jem.44.5.729
   Nystedt B, 2008, MOL BIOL EVOL, V25, P287, DOI 10.1093/molbev/msm252
   O'Rourke LG, 2005, EMERG INFECT DIS, V11, P1931, DOI 10.3201/eid1112.030045
   Pappalardo BL, 2001, VET IMMUNOL IMMUNOP, V83, P125, DOI 10.1016/S0165-2427(01)00372-5
   Pappalardo BL, 2000, VET IMMUNOL IMMUNOP, V75, P43, DOI 10.1016/S0165-2427(00)00182-3
   Popa C, 2007, INFECT IMMUN, V75, P4831, DOI 10.1128/IAI.00237-07
   Raoult D, 2006, J CLIN MICROBIOL, V44, P278, DOI 10.1128/JCM.44.1.278-279.2006
   Raoult D, 1999, CLIN INFECT DIS, V29, P888, DOI 10.1086/520454
   Reeves WK, 2006, J WILDLIFE DIS, V42, P391, DOI 10.7589/0090-3558-42.2.391
   Riess T, 2004, J EXP MED, V200, P1267, DOI 10.1084/jem.20040500
   ROBERTSON BD, 1992, TRENDS GENET, V8, P422, DOI 10.1016/0168-9525(92)90325-X
   Rolain JM, 2003, ANN NY ACAD SCI, V990, P605, DOI 10.1111/j.1749-6632.2003.tb07434.x
   Rolain JM, 2003, ANN NY ACAD SCI, V990, P236, DOI 10.1111/j.1749-6632.2003.tb07370.x
   Rolain JM, 2003, EMERG INFECT DIS, V9, P338, DOI 10.3201/eid0903.020278
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schouls LM, 1999, J CLIN MICROBIOL, V37, P2215, DOI 10.1128/JCM.37.7.2215-2222.1999
   Schroder G, 2005, TRENDS MICROBIOL, V13, P336, DOI 10.1016/j.tim.2005.05.008
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Seki N, 2007, AM J TROP MED HYG, V77, P562, DOI 10.4269/ajtmh.2007.77.562
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Stevenson HL, 2003, J MED ENTOMOL, V40, P329, DOI 10.1603/0022-2585-40.3.329
   Telfer S, 2007, PARASITOLOGY, V134, P413, DOI 10.1017/S0031182006001624
   Telfer S, 2005, PARASITOLOGY, V130, P661, DOI 10.1017/S0031182005007250
   Telfer S, 2007, ECOLOGY, V88, P1841, DOI 10.1890/06-1004.1
   Townsend HHT, 1913, J AMER MED ASSOC, V61, P1717
   Tsao JI, 2009, VET RES, V40, DOI 10.1051/vetres/2009019
   Viezens J, 2008, MICROBIOL-SGM, V154, P2881, DOI 10.1099/mic.0.2008/018630-0
   VILLASECA P, 1999, REV MED EXP, V25, P28
   VINSON JW, 1969, AM J TROP MED HYG, V18, P713, DOI 10.4269/ajtmh.1969.18.713
   WEIGL R., 1924, Journal of Tropical Medicine and Hygiene, V27, P14
   WEYER F, 1960, ANNU REV ENTOMOL, V5, P405, DOI 10.1146/annurev.en.05.010160.002201
   Yamamoto K, 2003, VET MICROBIOL, V92, P73, DOI 10.1016/S0378-1135(02)00347-4
   Yamamoto K, 2002, VET RES, V33, P669, DOI 10.1051/vetres:2002048
   Zahringer U, 2004, J BIOL CHEM, V279, P21046, DOI 10.1074/jbc.M313370200
   ZANGWILL KM, 1993, NEW ENGL J MED, V329, P8, DOI 10.1056/NEJM199307013290102
   Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101
NR 141
TC 143
Z9 147
U1 0
U2 23
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0928-4249
EI 1297-9716
J9 VET RES
JI Vet. Res.
PD MAR-APR
PY 2009
VL 40
IS 2
AR 29
DI 10.1051/vetres/2009011
PG 28
WC Veterinary Sciences
SC Veterinary Sciences
GA 428VE
UT WOS:000264878700006
PM 19284965
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Gajendran, N
   Kapfhammer, JP
   Lain, E
   Canepari, M
   Vogt, K
   Wisden, W
   Brenner, HR
AF Gajendran, N.
   Kapfhammer, J. P.
   Lain, E.
   Canepari, M.
   Vogt, K.
   Wisden, W.
   Brenner, H. R.
TI Neuregulin Signaling Is Dispensable for NMDA- and GABA(A)-Receptor
   Expression in the Cerebellum In Vivo
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE synapse formation; development; neuregulin; cerebellum; granule cell;
   NMDA receptor
ID RECEPTOR SUBUNIT EXPRESSION; CLIMBING-FIBER; SYNAPSE ELIMINATION;
   RAT-BRAIN; POSTNATAL-DEVELOPMENT; DENDRITIC GROWTH; PURKINJE-CELLS;
   MESSENGER-RNAS; DIFFERENTIATION; MATURATION
AB Neuregulin-1s (NRG-1s) are a family of growth and differentiation factors with multiple roles in the development and function in different organs including the nervous system. Among the proposed functions of NRG-1s in the nervous system is the regulation of genes encoding certain neurotransmitter receptors during synapse formation as well as of other aspects of synaptic function. Here, we have examined, in granule cells of the cerebellum in vivo, the role of NRGs in the induction of NMDA receptor (NMDA-R) and GABA(A) receptor (GABA(A)-R), which are thought to be induced by NRG-1 secreted by the synaptic inputs. To this end, we used the Cre/loxP system to genetically ablate the NRG receptors ErbB2 and ErbB4 selectively in these cells, thus eliminating all NRG-mediated signaling to them. Unlike previous reports using cultured granule cells to address the same question, we found that the developmental expression patterns of the mRNAs encoding the NR2C subunit of the NMDA-R and the beta 2-subunit of the GABA(A)-R is normal in mice lacking the NRG receptors ErbB2 and ErbB4. Likewise, no alterations in cerebellar morphology nor in certain aspects of cerebellar wiring were resolved in these mutants. We conclude that NRG/ErbB signaling to the granule cells is dispensable for the normal development of their synaptic inputs.
C1 [Gajendran, N.; Brenner, H. R.] Univ Basel, Inst Physiol, Dept Biomed, CH-4056 Basel, Switzerland.
   [Kapfhammer, J. P.] Univ Basel, Inst Anat, Dept Biomed, CH-4056 Basel, Switzerland.
   [Canepari, M.; Vogt, K.] Univ Basel, Dept Pharmacol, Biozentrum, CH-4056 Basel, Switzerland.
   [Wisden, W.] Univ Aberdeen, Inst Med Sci, Aberdeen AB25 2ZD, Scotland.
RP Brenner, HR (corresponding author), Univ Basel, Inst Physiol, Dept Biomed, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM Hans-Rudolf.Brenner@unibas.ch
RI Wisden, William/A-4071-2011; Canepari, Marco/H-6772-2012
OI Wisden, William/0000-0003-4743-0334; Canepari,
   Marco/0000-0001-9759-2388; , Nadesan/0000-0002-7463-4220; Vogt,
   Kaspar/0000-0002-0859-876X
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Kanton Basel-Stadt
FX This work was supported by grants from the Swiss National Science
   Foundation and by the Kanton Basel-Stadt.
CR Adcock KH, 2004, EUR J NEUROSCI, V20, P1425, DOI 10.1111/j.1460-9568.2004.03573.x
   Agresti A, 1998, AM STAT, V52, P119, DOI 10.2307/2685469
   Aller MI, 2003, GENESIS, V36, P97, DOI 10.1002/gene.10204
   ALTMAN J, 1972, J COMP NEUROL, V145, P465, DOI 10.1002/cne.901450403
   Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y
   CORFAS G, 1995, NEURON, V14, P103, DOI 10.1016/0896-6273(95)90244-9
   Craig AM, 2006, TRENDS NEUROSCI, V29, P8, DOI 10.1016/j.tins.2005.11.002
   Cull-Candy Stuart G, 2004, Sci STKE, V2004, pre16, DOI 10.1126/stke.2552004re16
   Durand G, 2006, PFLUG ARCH EUR J PHY, V451, P716, DOI 10.1007/s00424-005-1514-3
   Ebralidze AK, 1996, J NEUROSCI, V16, P5014
   Escher P, 2005, SCIENCE, V308, P1920, DOI 10.1126/science.1108258
   Espinosa JS, 2008, J NEUROSCI, V28, P2301, DOI 10.1523/JNEUROSCI.5157-07.2008
   Falls DL, 2003, J NEUROCYTOL, V32, P619, DOI 10.1023/B:NEUR.0000020614.83883.be
   Feldmeyer D, 1996, J NEUROCYTOL, V25, P857, DOI 10.1007/BF02284847
   Hashimoto K, 2005, NEUROSCI RES, V53, P221, DOI 10.1016/j.neures.2005.07.007
   Hashimoto K, 2003, NEURON, V38, P785, DOI 10.1016/S0896-6273(03)00298-8
   Kakizawa S, 2000, J NEUROSCI, V20, P4954
   Kapfhammer JP, 2004, PROG HISTOCHEM CYTO, V39, P131, DOI 10.1016/j.proghi.2004.07.002
   Karavanova I, 2007, MOL CELL NEUROSCI, V34, P468, DOI 10.1016/j.mcn.2006.12.001
   KORBO L, 1993, BRAIN RES, V609, P262, DOI 10.1016/0006-8993(93)90881-M
   LAURIE DJ, 1992, J NEUROSCI, V12, P4151
   LAURIE DJ, 1992, J NEUROSCI, V12, P1063
   Li B, 2007, NEURON, V54, P583, DOI 10.1016/j.neuron.2007.03.028
   Mei L, 2008, NAT REV NEUROSCI, V9, P437, DOI 10.1038/nrn2392
   Mellor JR, 1998, J NEUROSCI, V18, P2822
   Momiyama A, 1996, J PHYSIOL-LONDON, V494, P479, DOI 10.1113/jphysiol.1996.sp021507
   MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0
   Nishiyama H, 2004, J NEUROSCI, V24, P3926, DOI 10.1523/JNEUROSCI.5610-03.2004
   Ozaki M, 1998, NEUROSCI RES, V30, P351, DOI 10.1016/S0168-0102(98)00013-3
   Ozaki M, 1997, NATURE, V390, P691
   Pitcher GM, 2008, NEUROREPORT, V19, P139, DOI 10.1097/WNR.0b013e3282f3da10
   Renzi M, 2007, J PHYSIOL-LONDON, V585, P91, DOI 10.1113/jphysiol.2007.141531
   Rieff HI, 2006, EUR J NEUROSCI, V23, P2225, DOI 10.1111/j.1460-9568.2006.04727.x
   Rieff HI, 1999, J NEUROSCI, V19, P10757
   SANDROCK AW, 1995, J NEUROSCI, V15, P6124
   Sirzen-Zelenskaya A, 2006, EUR J NEUROSCI, V24, P2978, DOI 10.1111/j.1460-9568.2006.05196.x
   Tsien JZ, 1996, CELL, V87, P1317, DOI 10.1016/S0092-8674(00)81826-7
   Vallano ML, 1996, J NEUROSCI, V16, P631
   Weiss FU, 1997, J CELL PHYSIOL, V173, P187, DOI 10.1002/(SICI)1097-4652(199711)173:2<187::AID-JCP19>3.3.CO;2-R
   Xie F, 2004, J NEUROCHEM, V90, P1521, DOI 10.1111/j.1471-4159.2004.02685.x
   Yang X, 1998, NEURON, V20, P255, DOI 10.1016/S0896-6273(00)80454-7
   ZHENG T, 1993, DEV BRAIN RES, V75, P91, DOI 10.1016/0165-3806(93)90068-L
NR 42
TC 18
Z9 19
U1 0
U2 1
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
EI 1529-2401
J9 J NEUROSCI
JI J. Neurosci.
PD FEB 25
PY 2009
VL 29
IS 8
BP 2404
EP 2413
DI 10.1523/JNEUROSCI.4303-08.2009
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 412IX
UT WOS:000263719600010
PM 19244516
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Reichert, H
AF Reichert, Heinrich
TI Evolutionary conservation of mechanisms for neural regionalization,
   proliferation and interconnection in brain development
SO BIOLOGY LETTERS
LA English
DT Article
DE brain development; pattern formation; proliferation; neural circuitry
ID NERVOUS-SYSTEM CENTRALIZATION; CELL-DIVISION; STEM-CELLS; VERTEBRATE
   BRAIN; DROSOPHILA; DIFFERENTIATION; SPECIFICATION; NEUROGENESIS;
   INSIGHTS; BIOLOGY
AB Comparative studies of brain development in vertebrate and invertebrate model systems demonstrate remarkable similarities in expression and action of developmental control genes during embryonic patterning, neural proliferation and circuit formation in the brain. Thus, comparable sets of developmental control genes are involved in specifying the early brain primordium as well as in regionalized patterning along its anteroposterior and dorsoventral axes. Furthermore, similar cellular and molecular mechanisms underlie the formation and proliferation of neural stem cell-like progenitors that generate the neurons in the central nervous systems. Finally, neural identity and some complex circuit interconnections in specific brain domains appear to be comparable in vertebrates and invertebrates and may depend on similar developmental control genes.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Reichert, H (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM heinrich.reichert@unibas.ch
CR Acampora D, 2005, BRAIN RES BULL, V66, P410, DOI 10.1016/j.brainresbull.2005.02.005
   ARENDT D, 1994, NATURE, V371, P26, DOI 10.1038/371026a0
   Arendt D, 2008, PHILOS T R SOC B, V363, P1523, DOI 10.1098/rstb.2007.2242
   Bello BC, 2008, NEURAL DEV, V3, DOI 10.1186/1749-8104-3-5
   Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550
   Bray S, 1998, SEMIN CELL DEV BIOL, V9, P591, DOI 10.1006/scdb.1998.0262
   Brusca R.C., 1990, INVERTEBRATES
   Cornell RA, 2000, CURR OPIN NEUROBIOL, V10, P63, DOI 10.1016/S0959-4388(99)00049-5
   Darwin C., 1859, ORIGIN SPECIES MEANS
   De Robertis EM, 2008, CELL, V132, P185, DOI 10.1016/j.cell.2008.01.003
   Denes AS, 2007, CELL, V129, P277, DOI 10.1016/j.cell.2007.02.040
   Doe CQ, 2008, DEVELOPMENT, V135, P1575, DOI 10.1242/dev.014977
   Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012
   Dumstrei K, 2003, J NEUROSCI, V23, P3325
   Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Guillemot F, 2007, DEVELOPMENT, V134, P3771, DOI 10.1242/dev.006379
   Kiecker C, 2005, NAT REV NEUROSCI, V6, P553, DOI 10.1038/nrn1702
   Knoblich JA, 2008, CELL, V132, P583, DOI 10.1016/j.cell.2008.02.007
   Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008
   Lichtneckert R, 2005, HEREDITY, V94, P465, DOI 10.1038/sj.hdy.6800664
   Lichtneckert R, 2008, DEVELOPMENT, V135, P2415, DOI 10.1242/dev.022210
   Mallamaci A, 1998, MECH DEVELOP, V77, P165, DOI 10.1016/S0925-4773(98)00141-5
   Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008
   Reichert H, 2001, PHILOS T R SOC B, V356, P1533, DOI 10.1098/rstb.2001.0972
   Schwann Th., 1839, MIKROSKOPISCHE UNTER
   Simeone A, 2002, CURR OPIN GENET DEV, V12, P409, DOI 10.1016/S0959-437X(02)00318-0
   Sprecher SG, 2006, DEVELOPMENT, V133, P4331, DOI 10.1242/dev.02606
   Tessmar-Raible K, 2007, CELL, V129, P1389, DOI 10.1016/j.cell.2007.04.041
   Thor S, 2002, CURR OPIN GENET DEV, V12, P558, DOI 10.1016/S0959-437X(02)00340-4
   Urbach R, 2003, DEVELOPMENT, V130, P3607, DOI 10.1242/dev.00532
   Zhong WM, 2008, CURR OPIN NEUROBIOL, V18, P4, DOI 10.1016/j.conb.2008.05.002
NR 32
TC 34
Z9 34
U1 0
U2 6
PU ROYAL SOC
PI LONDON
PA 6-9 CARLTON HOUSE TERRACE, LONDON SW1Y 5AG, ENGLAND
SN 1744-9561
EI 1744-957X
J9 BIOL LETTERS
JI Biol. Lett.
PD FEB 23
PY 2009
VL 5
IS 1
BP 112
EP 116
DI 10.1098/rsbl.2008.0337
PG 5
WC Biology; Ecology; Evolutionary Biology
SC Life Sciences & Biomedicine - Other Topics; Environmental Sciences &
   Ecology; Evolutionary Biology
GA 396MV
UT WOS:000262596700033
PM 18755655
OA Green Published
DA 2021-01-25
ER

PT J
AU Jayachandran, R
   Scherr, N
   Pieters, J
AF Jayachandran, Rajesh
   Scherr, Nicole
   Pieters, Jean
TI Analyzing the interaction of pathogens with the host immune system
SO IMMUNOLOGY LETTERS
LA English
DT Review
DE Mycobacterium tuberculosis; Coronin 1; Protein kinase G; Calcineurin;
   Calcium
ID PROTEIN-KINASE-G; MYCOBACTERIA; SURVIVAL
AB Infectious diseases continue to represent a great burden to human society, being responsible for approximately 14 to 16 million deaths annually. Today, Mycobacterium tuberculosis, the causative agent of tuberculosis, remains one of the most important infectious agents. Moreover, with the emergence of multi drug and extensive drug resistant strains of M. tuberculosis, there is a great need for a better understanding of the virulence strategies utilized by this pathogen. In this manuscript, we discuss some of the strategies that have been followed to unravel virulence mechanisms utilized by M. tuberculosis. Knowledge of these mechanisms is important to reveal potential targets that maybe useful for the development of compounds to treat tuberculosis. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Jayachandran, Rajesh; Scherr, Nicole; Pieters, Jean] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Jayachandran, R (corresponding author), Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
CR Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009
   Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
NR 7
TC 3
Z9 3
U1 0
U2 1
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0165-2478
EI 1879-0542
J9 IMMUNOL LETT
JI Immunol. Lett.
PD FEB 21
PY 2009
VL 122
IS 2
BP 112
EP 114
DI 10.1016/j.imlet.2008.11.016
PG 3
WC Immunology
SC Immunology
GA 432JM
UT WOS:000265129300004
PM 19135088
DA 2021-01-25
ER

PT J
AU Georgakopoulou, S
   Moller, D
   Sachs, N
   Herrmann, H
   Aebi, U
AF Georgakopoulou, Sofia
   Moeller, Dorothee
   Sachs, Nadine
   Herrmann, Harald
   Aebi, Ueli
TI Near-UV Circular Dichroism Reveals Structural Transitions of Vimentin
   Subunits during Intermediate Filament Assembly
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE intermediate filaments; circular dichroism; unit-length filaments;
   vimentin
ID MOLECULAR ARCHITECTURE; MICROTUBULE PROTEIN; PURPLE BACTERIA; BOVINE
   BRAIN; CONFORMATION; SPECTRA; TUBULIN; CD; COMPLEXES; DESMIN
AB In vitro assembly of vimentin intermediate filaments (IFs) proceeds from soluble, reconstituted tetrameric complexes to mature filaments in three distinct stages: (1) within the first seconds after initiation of assembly, tetramers laterally associate into unit-length filaments (ULFs), on average 17 nm wide; (2) for the next few minutes, ULFs grow by longitudinal annealing into short, immature filaments; (3) almost concomitant with elongation, these immature filaments begin to radially compact, yielding similar to 11-nm-wide IFs at around 15 min. The near-UV CD signal Of Soluble tetramers exhibits two main peaks at 285 and 278 nm, which do not change during ULF formation. In contrast, the CD signal of mature IFs exhibits two major changes: (1) the 278-nm band, denoting the transition of the tyrosines from the ground state to the first vibrational mode of the excited state, is lost; (2) a red-shifted band appears at 291 nm, indicating the emergence of a new electronic species. These changes take place independently and at different time scales. The 278-nm signal disappears within the first minute of assembly, compatible with increased rigidity of the tyrosines during elongation of the ULFs. The rise of the 291-nm band has a lifetime of similar to 13 min and denotes the generation of phenolates by deprotonation of the tyrosines' hydroxyl group after they relocalize into a negatively charged environment. The appearance of such tyrosine-binding "pockets" in the assembling filaments highlights an essential part of the molecular rearrangements characterizing the later stages of the assembly process, including the radial compaction. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Georgakopoulou, Sofia; Aebi, Ueli] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Moeller, Dorothee; Sachs, Nadine; Herrmann, Harald] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany.
RP Georgakopoulou, S (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM sofia.georgakopoulou@unibas.ch
RI Georgakopoulou, Sofia/H-3444-2016
OI Georgakopoulou, Sofia/0000-0003-1427-4531
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-100448]; Swiss Foundation for Research on Muscle
   Diseases; M. E. Mueller Foundation; German Research FoundationGerman
   Research Foundation (DFG) [DFG HE 1853/4-3]
FX We thank Dr. Sergei V. Strelkov for providing the Protein Data Bank file
   on which Fig. 1 was base and Norbert Mikke for preparing Fig. 3. U.A.'s
   work was supported by grants from the Swiss National Science Foundation
   (3100A0-100448), the Swiss Foundation for Research on Muscle Diseases,
   and the M. E. Mueller Foundation. H.H. is supported by a grant from the
   German Research Foundation (DFG HE 1853/4-3).
CR AEBI U, 1988, PROTOPLASMA, V145, P73, DOI 10.1007/BF01349341
   Birge RT, 1926, PHYS REV, V28, P1157, DOI 10.1103/PhysRev.28.1157
   BULLARD B, 1976, BIOCHIM BIOPHYS ACTA, V434, P90, DOI 10.1016/0005-2795(76)90038-6
   CLARK DC, 1981, BIOCHEMISTRY-US, V20, P1924, DOI 10.1021/bi00510a031
   CLARK DC, 1980, BIOCHEM BIOPH RES CO, V97, P628, DOI 10.1016/0006-291X(80)90310-1
   Condon E, 1926, PHYS REV, V28, P1182, DOI 10.1103/PhysRev.28.1182
   COOPER TM, 1990, BIOPOLYMERS, V30, P657, DOI 10.1002/bip.360300703
   CRICK FHC, 1953, ACTA CRYSTALLOGR, V6, P689, DOI 10.1107/S0365110X53001964
   Franck J, 1926, T FARADAY SOC, V21, P0536, DOI 10.1039/tf9262100536
   GEISLER N, 1982, CELL, V30, P277, DOI 10.1016/0092-8674(82)90033-2
   GEISLER N, 1983, FEBS LETT, V163, P22, DOI 10.1016/0014-5793(83)81153-3
   Georgakopoulou S, 2006, J PHYS CHEM B, V110, P3344, DOI 10.1021/jp051794c
   Georgakopoulou S, 2004, BIOPHYS J, V87, P3010, DOI 10.1529/biophysj.104.047498
   Georgakopoulou S, 2002, BIOPHYS J, V82, P2184, DOI 10.1016/S0006-3495(02)75565-3
   Georgakopoulou S, 2007, BIOCHEMISTRY-US, V46, P4745, DOI 10.1021/bi062031y
   Gigant B, 2000, CELL, V102, P809, DOI 10.1016/S0092-8674(00)00069-6
   GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2004, METHOD CELL BIOL, V78, P3
   Herrmann H, 1998, CURR OPIN STRUC BIOL, V8, P177, DOI 10.1016/S0959-440X(98)80035-3
   Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719
   Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200
   KOLLHAAS MHC, 1999, RELATION STRUCTURE S
   Kooijman M, 1997, J BIOL CHEM, V272, P22548, DOI 10.1074/jbc.272.36.22548
   Koolhaas MHC, 1997, J PHYS CHEM B, V101, P7262, DOI 10.1021/jp963368k
   KOUKLIS PD, 1993, J CELL SCI, V106, P919
   LAZARIDES E, 1980, NATURE, V283, P249, DOI 10.1038/283249a0
   MARTIN SR, 1982, BIOCHEM J, V203, P643, DOI 10.1042/bj2030643
   Mou TC, 2002, PROTEIN SCI, V11, P601, DOI 10.1110/ps.30002
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   NAGY B, 1977, BIOL CHEM, V252, P4557
   Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516
   Parry DAD, 1995, INTERMEDIATE FILAMEN
   Schaffeld M, 2001, EUR J CELL BIOL, V80, P692, DOI 10.1078/0171-9335-00206
   Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103
   Sreerama N, 1999, BIOCHEMISTRY-US, V38, P10814, DOI 10.1021/bi990516z
   STEINERT PM, 1985, ANNU REV CELL BIOL, V1, P41
   STEINERT PM, 1993, J BIOL CHEM, V268, P24916
   Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255
   STROMER MH, 1987, BIOCHEM J, V246, P75, DOI 10.1042/bj2460075
   WEBER K, 1984, CANCER CELL, V1, P153
   Woody AYM, 2003, BIOPOLYMERS, V72, P500, DOI 10.1002/bip.10488
   Woody RW, 1996, CIRCULAR DICHROISM C, P109
NR 45
TC 18
Z9 18
U1 0
U2 4
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD FEB 20
PY 2009
VL 386
IS 2
BP 544
EP 553
DI 10.1016/j.jmb.2008.12.053
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 413PA
UT WOS:000263803800022
PM 19136013
DA 2021-01-25
ER

PT J
AU Tiedt, R
   Coers, J
   Ziegler, S
   Wiestner, A
   Hao-Shen, H
   Bornmann, C
   Schenkel, J
   Karakhanova, S
   de Sauvage, FJ
   Jackson, CW
   Skoda, RC
AF Tiedt, Ralph
   Coers, Joern
   Ziegler, Sandra
   Wiestner, Adrian
   Hao-Shen, Hui
   Bornmann, Caroline
   Schenkel, Johannes
   Karakhanova, Svetlana
   de Sauvage, Frederic J.
   Jackson, Carl W.
   Skoda, Radek C.
TI Pronounced thrombocytosis in transgenic mice expressing reduced levels
   of Mp1 in platelets and terminally differentiated megakaryocytes
SO BLOOD
LA English
DT Article
ID C-MPL; THROMBOPOIETIN RECEPTOR; MYELOPROLIFERATIVE DISORDERS;
   POLYCYTHEMIA-VERA; MOLECULAR-CLONING; JAK2 V617F; MUTATIONS; MURINE;
   GROWTH; CELLS
AB We generated mice expressing a full-length Mpl transgene under the control of a 2-kb Mpl promoter in an Mpl(-/-) background, effectively obtaining mice that express full-length Mpl in the absence of other Mpl isoforms. These mice developed thrombocytosis with platelet levels approximately 5-fold higher than wildtype controls and markedly increased megakaryocyte numbers. The reintroduction of one wild-type Mpl allele restored normal platelet counts. We excluded the deletion of Mpl-tr, a dominant-negative isoform, as the underlying molecular cause for thrombocytosis. Instead, we found that transgene expression driven by the 2-kb Mpl promoter fragment was decreased during late megakaryocyte maturation, resulting in strongly diminished Mpl protein expression in platelets. Because platelets exert a negative feedback on thrombopoiesis by binding and consuming Tpo in the circulation through Mpl, we propose that the severe reduction of Mpl protein in platelets in Mpl-transgenic Mpl(-/-) mice shifts the equilibrium of this feedback loop, resulting in markedly elevated levels of megakaryocytes and platelets at steady state. Although the mechanism causing decreased expression of Mpl protein in platelets from patients with myeloproliferative disorders differs from this transgenic model, our results suggest that lowering Mpl protein in platelets could contribute to raising the platelet count. (Blood. 2009; 113: 1768-1777)
C1 [Tiedt, Ralph; Coers, Joern; Hao-Shen, Hui; Skoda, Radek C.] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
   [Coers, Joern; Schenkel, Johannes; Karakhanova, Svetlana; Skoda, Radek C.] German Canc Res Ctr, Clin Cooperat Unit, D-6900 Heidelberg, Germany.
   [Coers, Joern] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA.
   [Ziegler, Sandra; Wiestner, Adrian; Bornmann, Caroline; Skoda, Radek C.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Schenkel, Johannes] Heidelberg Univ, Inst Physiol & Pathophysiol, Heidelberg, Germany.
   [de Sauvage, Frederic J.] Genentech Inc, San Francisco, CA 94080 USA.
   [Jackson, Carl W.] St Jude Childrens Res Hosp, Memphis, TN 38105 USA.
RP Skoda, RC (corresponding author), Univ Basel Hosp, Dept Res, Hebelstr 20, CH-4031 Basel, Switzerland.
EM radek.skoda@unibas.ch
RI de Sauvage, Frederic/ABE-8400-2020
OI de Sauvage, Frederic/0000-0002-5275-2584; Coers,
   Jorn/0000-0001-8707-4608
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31-53677.98, 3100-066949.01, 310000-108006/1]; NATIONAL
   INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Allergy & Infectious Diseases (NIAID)
   [R01AI103197, R01AI103197, R01AI103197, R01AI103197, R01AI103197,
   R01AI103197] Funding Source: NIH RePORTER
FX We thank Verena Jaggin for FACS sorting, Dr Kenneth Kaushansky and Dr
   Norma Fox for providing serum and plasma from Tpo<SUP>-/-</SUP> mice,
   and Dr Francois Lanza and Dr Lucia Kubovcakova for helpful comments on
   the manuscript.; This work was supported in part by grants 31-53677.98,
   3100-066949.01, and 310000-108006/1 from the Swiss National Science
   Foundation to R. C. S.
CR Akimoto Y, 1992, Rinsho Ketsueki, V33, P520
   Alexander WS, 1996, BLOOD, V87, P2162, DOI 10.1182/blood.V87.6.2162.bloodjournal8762162
   Antonioli E, 2005, LEUKEMIA, V19, P1847, DOI 10.1038/sj.leu.2403902
   Arnold JT, 1997, BLOOD, V89, P823, DOI 10.1182/blood.V89.3.823
   Ballmaier M, 2001, BLOOD, V97, P139, DOI 10.1182/blood.V97.1.139
   Beer PA, 2008, BLOOD, V112, P141, DOI 10.1182/blood-2008-01-131664
   BURSTEIN SA, 1992, EXP HEMATOL, V20, P1170
   Choi ES, 1996, BRIT J HAEMATOL, V95, P227
   Coers J, 2004, J BIOL CHEM, V279, P36397, DOI 10.1074/jbc.M401386200
   deSauvage FJ, 1996, J EXP MED, V183, P651, DOI 10.1084/jem.183.2.651
   Ding F, 2004, BLOOD, V103, P4198, DOI 10.1182/blood-2003-10-3471
   Emmons RVB, 1996, BLOOD, V87, P4068, DOI 10.1182/blood.V87.10.4068.bloodjournal87104068
   Fielder PJ, 1996, BLOOD, V87, P2154, DOI 10.1182/blood.V87.6.2154.bloodjournal8762154
   Filippi MD, 2000, EXP HEMATOL, V28, P1363, DOI 10.1016/S0301-472X(00)00549-X
   Garrick D, 1998, NAT GENET, V18, P56, DOI 10.1038/ng0198-56
   GURNEY AL, 1994, SCIENCE, V265, P1445, DOI 10.1126/science.8073287
   Harrison CN, 1999, BRIT J HAEMATOL, V107, P139, DOI 10.1046/j.1365-2141.1999.01667.x
   Heaney ML, 1996, BLOOD, V87, P847, DOI 10.1182/blood.V87.3.847.bloodjournal873847
   Horikawa Y, 1997, BLOOD, V90, P4031, DOI 10.1182/blood.V90.10.4031
   Ihara K, 1999, P NATL ACAD SCI USA, V96, P3132, DOI 10.1073/pnas.96.6.3132
   JACKSON CW, 1973, BLOOD, V42, P413, DOI 10.1182/blood.V42.3.413.413
   Kaushansky K, 2005, J CLIN INVEST, V115, P3339, DOI 10.1172/JCI26674
   Kaushansky K, 1998, NEW ENGL J MED, V339, P746, DOI 10.1056/NEJM199809103391107
   Kimura S, 1998, P NATL ACAD SCI USA, V95, P1195, DOI 10.1073/pnas.95.3.1195
   Kitamura T, 1998, BLOOD, V92, P2596, DOI 10.1182/blood.V92.7.2596
   Kralovics R, 2003, BLOOD, V102, P1869, DOI 10.1182/blood-2003-03-0744
   Li JZ, 2000, CYTOKINE, V12, P835, DOI 10.1006/cyto.1999.0654
   Li JZ, 2000, BRIT J HAEMATOL, V111, P943
   LONG MW, 1981, BLOOD, V58, P1032
   Luoh SM, 2000, MOL CELL BIOL, V20, P507, DOI 10.1128/MCB.20.2.507-515.2000
   Mignotte V, 1996, Stem Cells, V14 Suppl 1, P232
   Mitsui T, 2003, BLOOD, V101, P2990, DOI 10.1182/blood.V101.8.2990
   Moliterno AR, 2006, BLOOD, V108, P3913, DOI 10.1182/blood-2006-03-008805
   Moliterno AR, 2004, P NATL ACAD SCI USA, V101, P11444, DOI 10.1073/pnas.0404241101
   Moliterno AR, 1999, BLOOD, V94, P2555, DOI 10.1182/blood.V94.8.2555.420k14_2555_2561
   Moliterno AR, 1998, NEW ENGL J MED, V338, P572, DOI 10.1056/NEJM199802263380903
   Nakamura Y, 1998, EXP HEMATOL, V26, P1105
   Pan D, 2007, BLOOD, V110, P3049, DOI 10.1182/blood-2007-02-074393
   Pardanani AD, 2006, BLOOD, V108, P3472, DOI 10.1182/blood-2006-04-018879
   Pikman Y, 2006, PLOS MED, V3, P1140, DOI 10.1371/journal.pmed.0030270
   Pillai MM, 2008, TRANSGENIC RES, V17, P749, DOI 10.1007/s11248-007-9161-4
   Shivdasani RA, 1997, BLOOD, V90, P1821, DOI 10.1182/blood.V90.5.1821
   SHIVDASANI RA, 1995, CELL, V81, P695, DOI 10.1016/0092-8674(95)90531-6
   SKODA RC, 1993, EMBO J, V12, P2645, DOI 10.1002/j.1460-2075.1993.tb05925.x
   Solar GP, 1998, BLOOD, V92, P4, DOI 10.1182/blood.V92.1.4.413k38_4_10
   SOUYRI M, 1990, CELL, V63, P1137, DOI 10.1016/0092-8674(90)90410-G
   Standen G, 2008, BRIT J HAEMATOL, V140, P714, DOI 10.1111/j.1365-2141.2008.06984.x
   Stoffel R, 1996, BLOOD, V87, P567, DOI 10.1182/blood.V87.2.567.bloodjournal872567
   Stoffel R, 1999, P NATL ACAD SCI USA, V96, P698, DOI 10.1073/pnas.96.2.698
   Tefferi A, 2000, BLOOD, V96, P771
   Teofili L, 2007, J CLIN ONCOL, V25, P1048, DOI 10.1200/JCO.2006.08.6884
   van den Oudenrijn S, 2000, BRIT J HAEMATOL, V110, P441, DOI 10.1046/j.1365-2141.2000.02175.x
   Vannucchi AM, 2008, BLOOD, V112, P844, DOI 10.1182/blood-2008-01-135897
   VIGON I, 1993, ONCOGENE, V8, P2607
   VIGON I, 1992, P NATL ACAD SCI USA, V89, P5640, DOI 10.1073/pnas.89.12.5640
   Wagner K, 2001, BLOOD, V98, P2689, DOI 10.1182/blood.V98.9.2689
   WHITE JG, 1969, BLOOD-J HEMATOL, V33, P598, DOI 10.1182/blood.V33.4.598.598
   White JG, 1998, SEMIN THROMB HEMOST, V24, P163, DOI 10.1055/s-2007-995836
   ZHANG JL, 1994, HISTOCHEM J, V26, P170, DOI 10.1007/BF00157966
   Ziegler S, 2002, BLOOD, V100, P1072, DOI 10.1182/blood-2002-01-0281
NR 60
TC 45
Z9 45
U1 1
U2 1
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 2021 L ST NW, SUITE 900, WASHINGTON, DC 20036 USA
SN 0006-4971
EI 1528-0020
J9 BLOOD
JI Blood
PD FEB 19
PY 2009
VL 113
IS 8
BP 1768
EP 1777
DI 10.1182/blood-2008-03-146084
PG 10
WC Hematology
SC Hematology
GA 410GS
UT WOS:000263566100020
PM 18845793
DA 2021-01-25
ER

PT J
AU Stettler, H
   Beuret, N
   Prescianotto-Baschong, C
   Fayard, B
   Taupenot, L
   Spiess, M
AF Stettler, Hansruedi
   Beuret, Nicole
   Prescianotto-Baschong, Cristina
   Fayard, Brengere
   Taupenot, Laurent
   Spiess, Martin
TI Determinants for chromogranin A sorting into the regulated secretory
   pathway are also sufficient to generate granule-like structures in
   non-endocrine cells
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE aggregation; chromogranin A (CgA); green fluorescent protein (GFP);
   regulated secretion; secretory granule; trans-Golgi network (TGN)
ID DISULFIDE-BONDED LOOP; CARBOXYPEPTIDASE-E; CONTENT PROTEINS; BIOGENESIS;
   EXPRESSION; IDENTIFICATION; TARGET
AB In endocrine cells, prohomlones and granins are segregated in the TGN (trans-Golgi network) from constitutively secreted proteins, stored in concentrated form in dense-core secretory granules, and released in a regulated manner on specific stimulation. The mechanism of granule formation is only partially understood. Expression of regulated secretory proteins, both peptide hormone precursors and granins, had been Found to be sufficient to generate structures that resemble secretory granules in the background of constitutively secreting, non-endocrine cells. To identify which segment of CgA (chromogranin A) is important to induce the formation of such granule-like structures, a series of deletion constructs fused to either GFP (green fluorescent protein) or a short epitope tag was expressed in COS-1 fibroblast cells and analysed by fluorescence and electron microscopy and pulse-chase labelling. Full-length CgA as well as deletion constructs containing the N-terminal 77 residues generated granule-like structures in the cell periphery that co-localized with co-expressed SgII (secretogranin II). These are essentially the same segments of the protein that were previously shown to be required for granule sorting in wild-type PC12 (pheochromocytoma cells) cells and for rescuing a regulated secretory pathway in A35C cells, a variant PC12 line deficient in granule formation. The results support the notion that self-aggregation is at the core of granule formation and sorting into the regulated pathway.
C1 [Stettler, Hansruedi; Beuret, Nicole; Prescianotto-Baschong, Cristina; Spiess, Martin] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Fayard, Brengere] Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   [Taupenot, Laurent] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM martin.spiess@unibas.ch
OI Taupenot, Laurent/0000-0003-2316-3825; Spiess,
   Martin/0000-0001-7139-0550
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31109424]; NIH (National Institutes of HealthUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USA [DK59628, HL58120]; Roche Research Foundation [216-20021];
   NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Heart Lung & Blood Institute (NHLBI) [P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120, P01HL058120, P01HL058120, P01HL058120, P01HL058120,
   P01HL058120] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [K01DK059628, K01DK059628, K01DK059628, K01DK059628, K01DK059628]
   Funding Source: NIH RePORTER
FX This work was supported by the Swiss National Science Foundation [grant
   number 31109424] to M. S. and the NIH (National Institutes of Health)
   [grant numbers DK59628 and HL58120] to L.T. H.S. was partially supported
   by the Roche Research Foundation [grant number 216-20021.
CR Arvan P, 1998, BIOCHEM J, V332, P593, DOI 10.1042/bj3320593
   Beuret N, 2004, J BIOL CHEM, V279, P20242, DOI 10.1074/jbc.M310613200
   Blazquez M, 2000, BIOCHEM J, V349, P843, DOI 10.1042/bj3490843
   COOL DR, 1994, BIOCHIMIE, V76, P265, DOI 10.1016/0300-9084(94)90156-2
   Courel M, 2006, J BIOL CHEM, V281, P38038, DOI 10.1074/jbc.M604037200
   Dikeakos JD, 2007, J CELL BIOL, V177, P191, DOI 10.1083/jcb.200701024
   Dikeakos JD, 2007, J BIOL CHEM, V282, P1136, DOI 10.1074/jbc.M605718200
   GEFFEN I, 1993, J BIOL CHEM, V268, P20772
   Glombik MM, 1999, EMBO J, V18, P1059, DOI 10.1093/emboj/18.4.1059
   GORR SU, 1991, J BIOL CHEM, V266, P5780
   Grundschober C, 2002, J BIOL CHEM, V277, P36715, DOI 10.1074/jbc.M203777200
   Huh YH, 2003, J BIOL CHEM, V278, P40581, DOI 10.1074/jbc.M304942200
   Kim T, 2006, PHYSIOLOGY, V21, P124, DOI 10.1152/physiol.00043.2005
   Kim T, 2006, MOL BIOL CELL, V17, P789, DOI 10.1091/mbc.E05-08-0755
   Kim T, 2005, J NEUROSCI, V25, P6958, DOI 10.1523/JNEUROSCI.1058-05.2005
   Kim T, 2001, CELL, V106, P499, DOI 10.1016/S0092-8674(01)00459-7
   KIZER JS, 1991, BIOCHEM BIOPH RES CO, V174, P586, DOI 10.1016/0006-291X(91)91457-N
   Kromer A, 1998, J CELL BIOL, V140, P1331, DOI 10.1083/jcb.140.6.1331
   Kuhn U, 2000, BIOCHEM BIOPH RES CO, V270, P631, DOI 10.1006/bbrc.2000.2469
   LEITINGER B, 1994, J BIOL CHEM, V269, P8115
   Mahapatra NR, 2005, J CLIN INVEST, V115, P1942, DOI 10.1172/JCI24354
   Malosio ML, 2004, J CELL SCI, V117, P743, DOI 10.1242/jcs.00934
   Rindler MJ, 1998, J BIOL CHEM, V273, P31180, DOI 10.1074/jbc.273.47.31180
   SIMPSON AM, 1995, GENE THER, V2, P223
   Sobota JA, 2006, MOL BIOL CELL, V17, P5038, DOI 10.1091/mbc.E06-07-0626
   STOLLER TJ, 1989, J CELL BIOL, V108, P1647, DOI 10.1083/jcb.108.5.1647
   Taupenot L, 2003, NEW ENGL J MED, V348, P1134, DOI 10.1056/NEJMra021405
   Taupenot L, 2002, J CELL SCI, V115, P4827, DOI 10.1242/jcs.00140
   Zhang CF, 2003, BIOCHEM J, V369, P453, DOI 10.1042/BJ20020827
NR 29
TC 23
Z9 23
U1 0
U2 2
PU PORTLAND PRESS LTD
PI LONDON
PA CHARLES DARWIN HOUSE, 12 ROGER STREET, LONDON WC1N 2JU, ENGLAND
SN 0264-6021
EI 1470-8728
J9 BIOCHEM J
JI Biochem. J.
PD FEB 15
PY 2009
VL 418
BP 81
EP 91
DI 10.1042/BJ20071382
PN 1
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 407BF
UT WOS:000263337900008
PM 18973469
DA 2021-01-25
ER

PT J
AU Combaluzier, B
   Mueller, P
   Massner, J
   Finke, D
   Pieters, J
AF Combaluzier, Benoit
   Mueller, Philipp
   Massner, Jan
   Finke, Daniela
   Pieters, Jean
TI Coronin 1 Is Essential for IgM-Mediated Ca2+ Mobilization in B Cells but
   Dispensable for the Generation of Immune Responses In Vivo
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID BCR CROSS-TALK; T-CELL; ALTERNATE PATHWAY; ANTIGEN RECEPTOR; INDEPENDENT
   ANTIGENS; CALCIUM MOBILIZATION; ACTIVATION; SURVIVAL; LYN; MYCOBACTERIA
AB Coronin 1 is a leukocyte specific regulator of Ca2+-dependent signaling and is essential for the survival of peripheral T lymphocytes, but its role in B cells is unknown. In this study, we show that coronin 1 is essential for intracellular Ca2+ mobilization and proliferation upon triggering of the BCR. However, the presence of costimulatory signals rendered coronin 1 dispensable for B cell signaling, consistent with the generation of normal immune responses against a variety of Ags in coronin 1-deficient mice. We conclude that coronin 1, while being essential for T cell function and survival, is dispensable for B cell function in vivo. The Journal of Immunology, 2009, 182: 1954-1961.
C1 [Combaluzier, Benoit; Mueller, Philipp; Massner, Jan; Pieters, Jean] Univ Basel, Biozentrum, Basel, Switzerland.
   [Finke, Daniela] Univ Basel, Dept Clin Biol Sci, Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Olga Mayenfisch Stiftung; Swiss Life Jubilaeumsstiftung; Canton
   of Basel-Stadt
FX This work was supported by grants from the Swiss National Science
   Foundation (to D.F. and J.P.) and the Olga Mayenfisch Stiftung, the
   Swiss Life Jubilaeumsstiftung, and the Canton of Basel-Stadt (to J.P.).
CR Acevedo-Suarez CA, 2006, J IMMUNOL, V177, P2234, DOI 10.4049/jimmunol.177.4.2234
   Albrecht I, 2006, INT IMMUNOL, V18, P755, DOI 10.1093/intimm/dxl013
   BANCHEREAU J, 1994, ANNU REV IMMUNOL, V12, P881, DOI 10.1146/annurev.immunol.12.1.881
   Brose N, 2004, CURR OPIN NEUROBIOL, V14, P328, DOI 10.1016/j.conb.2004.05.006
   Cahalan MD, 2007, CELL CALCIUM, V42, P133, DOI 10.1016/j.ceca.2007.03.002
   Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7
   COFFMAN RL, 1988, IMMUNOL REV, V102, P5, DOI 10.1111/j.1600-065X.1988.tb00739.x
   COMBALUZIER B, 2009, J IMMUNOL IN PRESS
   Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008
   de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Feske S, 2007, NAT REV IMMUNOL, V7, P690, DOI 10.1038/nri2152
   Fruman DA, 2000, IMMUNITY, V13, P1, DOI 10.1016/S1074-7613(00)00002-9
   Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   Guo BC, 2005, J IMMUNOL, V174, P5375, DOI 10.4049/jimmunol.174.9.5375
   Guo BC, 2007, J IMMUNOL, V178, P4726, DOI 10.4049/jimmunol.178.8.4726
   JANEWAY CJ, 1996, IMMUNOBIOLOGY
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Jun JE, 2003, NAT IMMUNOL, V4, P1057, DOI 10.1038/ni1001
   Kehry MR, 1996, J IMMUNOL, V156, P2345
   Kurosaki T, 2000, IMMUNOL REV, V176, P19
   Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497
   Mizuno T, 2005, J IMMUNOL, V174, P6062, DOI 10.4049/jimmunol.174.10.6062
   MOND JJ, 1995, ANNU REV IMMUNOL, V13, P655, DOI 10.1146/annurev.immunol.13.1.655
   MOND JJ, 1995, CURR OPIN IMMUNOL, V7, P349, DOI 10.1016/0952-7915(95)80109-X
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Oh-Hora M, 2008, CURR OPIN IMMUNOL, V20, P250, DOI 10.1016/j.coi.2008.04.004
   Parekh AB, 2006, PFLUG ARCH EUR J PHY, V453, P303, DOI 10.1007/s00424-006-0089-y
   PARKER DC, 1993, ANNU REV IMMUNOL, V11, P331, DOI 10.1146/annurev.immunol.11.1.331
   PAUL WE, 1987, ANNU REV IMMUNOL, V5, P429, DOI 10.1146/annurev.immunol.5.1.429
   Pieters Jean, 2008, V48, P116, DOI 10.1007/978-0-387-09595-0_11
   RABIN EM, 1985, P NATL ACAD SCI USA, V82, P2935, DOI 10.1073/pnas.82.9.2935
   Reth M, 1997, ANNU REV IMMUNOL, V15, P453, DOI 10.1146/annurev.immunol.15.1.453
   Rolink AG, 2004, IMMUNOL REV, V197, P41, DOI 10.1111/j.0105-2896.2004.0101.x
   Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q
   Schamel WWA, 2000, IMMUNITY, V13, P5, DOI 10.1016/S1074-7613(00)00003-0
   TAKATA M, 1994, EMBO J, V13, P1341, DOI 10.1002/j.1460-2075.1994.tb06387.x
   Yan M, 2007, J IMMUNOL, V178, P5769, DOI 10.4049/jimmunol.178.9.5769
NR 40
TC 29
Z9 29
U1 0
U2 1
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
J9 J IMMUNOL
JI J. Immunol.
PD FEB 15
PY 2009
VL 182
IS 4
BP 1954
EP 1961
DI 10.4049/jimmunol.0801811
PG 8
WC Immunology
SC Immunology
GA 404BS
UT WOS:000263126300023
PM 19201848
OA Bronze
DA 2021-01-25
ER

PT J
AU Schwede, T
   Sali, A
   Honig, B
   Levitt, M
   Berman, HM
   Jones, D
   Brenner, SE
   Burley, SK
   Das, R
   Dokholyan, NV
   Dunbrack, RL
   Fidelis, K
   Fiser, A
   Godzik, A
   Huang, YJ
   Humblet, C
   Jacobson, MP
   Joachimiak, A
   Krystek, SR
   Kortemme, T
   Kryshtafovych, A
   Montelione, GT
   Moult, J
   Murray, D
   Sanchez, R
   Sosnick, TR
   Standley, DM
   Stouch, T
   Vajda, S
   Vasquez, M
   Westbrook, JD
   Wilson, IA
AF Schwede, Torsten
   Sali, Andrej
   Honig, Barry
   Levitt, Michael
   Berman, Helen M.
   Jones, David
   Brenner, Steven E.
   Burley, Stephen K.
   Das, Rhiju
   Dokholyan, Nikolay V.
   Dunbrack, Roland L., Jr.
   Fidelis, Krzysztof
   Fiser, Andras
   Godzik, Adam
   Huang, Yuanpeng Janet
   Humblet, Christine
   Jacobson, Matthew P.
   Joachimiak, Andrzej
   Krystek, Stanley R., Jr.
   Kortemme, Tanja
   Kryshtafovych, Andriy
   Montelione, Gaetano T.
   Moult, John
   Murray, Diana
   Sanchez, Roberto
   Sosnick, Tobin R.
   Standley, Daron M.
   Stouch, Terry
   Vajda, Sandor
   Vasquez, Max
   Westbrook, John D.
   Wilson, Ian A.
TI Outcome of a Workshop on Applications of Protein Models in Biomedical
   Research
SO STRUCTURE
LA English
DT Editorial Material
ID MASS-SPECTROMETRY DATA; STRUCTURAL GENOMICS; STRUCTURE PREDICTION;
   COUPLED RECEPTOR; HOMOLOGY MODELS; HIGH-THROUGHPUT;
   BIOCHEMICAL-CHARACTERIZATION; MACROMOLECULAR ASSEMBLIES;
   SACCHAROMYCES-CEREVISIAE; 3-DIMENSIONAL STRUCTURE
AB We describe the proceedings and conclusions from the "Workshop on Applications of Protein Models in Biomedical Research" (the Workshop) that was held at the University of California, San Francisco on 11 and 12 July, 2008. Atthe Workshop, international scientists involved with structure modeling explored (i) how models are currently used in biomedical research, (ii) the requirements and challenges for different applications, and (iii) how the interaction between the computational and experimental research communities could be strengthened to advance the field.
C1 [Schwede, Torsten] Univ Basel, Biozentrum, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Sali, Andrej] Univ Calif San Francisco, Calif Inst Quantitat Biosci, Dept Pharmaceut Chem, Dept Biopharmaceut Sci, San Francisco, CA 94158 USA.
   [Honig, Barry] Columbia Univ, Howard Hughes Med Inst, Ctr Computat Biol & Bioinformat, Dept Biochem & Mol Biophys, New York, NY 10032 USA.
   [Levitt, Michael] Stanford Univ, Sch Med, Dept Biol Struct, Stanford, CA 94305 USA.
   [Berman, Helen M.; Westbrook, John D.] Rutgers State Univ, Prot Data Bank, Res Collaboratory Struct Bioinformat, Piscataway, NJ 08854 USA.
   [Jones, David] UCL, Dept Comp Sci, London WC1E 6BT, England.
   [Brenner, Steven E.] Univ Calif Berkeley, Dept Plant & Microbial Biol, Berkeley, CA 94720 USA.
   [Burley, Stephen K.] SGX Pharmaceut Inc, San Diego, CA 92121 USA.
   [Das, Rhiju] Univ Washington, Dept Biochem, Seattle, WA 98195 USA.
   [Dokholyan, Nikolay V.] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA.
   [Dunbrack, Roland L., Jr.] Fox Chase Canc Ctr, Inst Canc Res, Philadelphia, PA 19111 USA.
   [Fidelis, Krzysztof] Univ Calif Davis, Genome & Biomed Sci Facil, Davis, CA 95616 USA.
   [Fiser, Andras] Albert Einstein Coll Med, Bronx, NY 10461 USA.
   [Godzik, Adam] Burnham Inst Med Res, Bioinformat & Syst Biol Program, La Jolla, CA 92037 USA.
   [Huang, Yuanpeng Janet; Montelione, Gaetano T.] Rutgers State Univ, Ctr Adv Res Biotechnol, Dept Biochem & Mol Biol, Piscataway, NJ 08854 USA.
   [Humblet, Christine] Wyeth Ayerst Res, Compuatat Chem Cheminformat Chem & Screening Sci, Monmouth Jct, NJ 08852 USA.
   [Jacobson, Matthew P.] Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94158 USA.
   [Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Midwest Ctr Struct Genom, Argonne, IL 60439 USA.
   [Joachimiak, Andrzej] Argonne Natl Lab, Biosci Div, Struct Biol Ctr, Argonne, IL 60439 USA.
   [Krystek, Stanley R., Jr.] Bristol Myers Squibb Co, Res & Discovery, Princeton, NJ 08543 USA.
   [Kortemme, Tanja] Univ Calif San Francisco, Dept Biopharmaceut Sci, San Francisco, CA 94143 USA.
   [Kryshtafovych, Andriy] Univ Calif Davis, Prot Struct Predict Ctr, Davis, CA 95616 USA.
   [Moult, John] Univ Maryland, Maryland Biotechnol Inst, Ctr Adv Res Biotechnol, Rockville, MD 20850 USA.
   [Murray, Diana] Columbia Univ, Ctr Compuatat Biol & Bioinformat, New York, NY 10032 USA.
   [Sanchez, Roberto] Mt Sinai Sch Med, Dept Struct & Chem Biol, New York, NY 10029 USA.
   [Sosnick, Tobin R.] Univ Chicago, Chicago, IL 60637 USA.
   [Standley, Daron M.] Osaka Univ, Syst Immunol Lab, Immunol Frontier Res Ctr, Suita, Osaka 5650871, Japan.
   [Vajda, Sandor] Boston Univ, Biomed Engn Struct Bioinformat Lab, Boston, MA 02215 USA.
   [Westbrook, John D.] Bocarca, Palo Alto, CA 94306 USA.
   [Wilson, Ian A.] Scripps Res Inst, Joint Ctr Struct Genom, La Jolla, CA 92037 USA.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Swiss Inst Bioinformat, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch; sali@salilab.org
RI Godzik, Adam/A-7279-2009; Standley, Daron/D-2343-2009; Freed, Karl
   F/J-7764-2018; Godzik, Adam/AAW-1467-2020; Dunbrack,
   Roland/ABG-7141-2020; Dokholyan, Nikolay/B-2238-2009; Schwede,
   Torsten/A-4650-2008; Dokholyan, Nikolay/D-8081-2018; Jacobson, Matthew
   P/Y-5161-2018; Brenner, Steven E/A-8729-2008
OI Godzik, Adam/0000-0002-2425-852X; Freed, Karl F/0000-0001-6240-2599;
   Godzik, Adam/0000-0002-2425-852X; Dokholyan,
   Nikolay/0000-0002-8225-4025; Schwede, Torsten/0000-0003-2715-335X;
   Dokholyan, Nikolay/0000-0002-8225-4025; Jacobson, Matthew
   P/0000-0001-6262-655X; Brenner, Steven E/0000-0001-7559-6185; Westbrook,
   John/0000-0002-6686-5475; Burley, Stephen/0000-0002-2487-9713; Das,
   Rhiju/0000-0001-7497-0972; Moult, John/0000-0002-3012-2282; Berman,
   Helen/0000-0002-3337-0660; Dunbrack, Roland/0000-0001-7674-6667;
   Kortemme, Tanja/0000-0002-8494-680X
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM064700,
   R01GM061867, R01GM064700, U54GM074942, U54GM074942, U54GM074942,
   P20GM076222, U54GM074958, U54GM074942, R01GM063817, R01GM064700,
   R01GM061867, U54GM074958, U54GM074958, U54GM074942, U54GM074958,
   P20GM076222, R01GM063817, U54GM074958, U54GM074942, U54GM074958,
   U54GM074942, U54GM074958, U54GM074958, R01GM081642, R01GM063817,
   U54GM074942, U54GM074958, U54GM074942, R01GM081642, U54GM074942,
   U54GM074942, U54GM074942, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, R01GM063817, U54GM074958, R01GM061867, P20GM076222,
   R01GM063817, U54GM074958, R01GM064700, U54GM074958, U54GM074942,
   U54GM074958, P20GM076222, R01GM061867, R01GM063817, U54GM074942,
   R01GM064700, U54GM074942, R01GM064700, U54GM074958, U54GM074942,
   U54GM074942, U54GM074958, R01GM061867, U54GM074958, U54GM074958,
   U54GM074958, R01GM063817, U54GM074958, U54GM074958, U54GM074958,
   R01GM063817, U54GM074958, R01GM063817, U54GM074942, R01GM063817,
   U54GM074958, U54GM074958, U54GM074958, R01GM063817, P20GM076222,
   U54GM074958, U54GM074958, U54GM074942, R01GM061867, U54GM074958,
   U54GM074942, U54GM074942, U54GM074958, U54GM074942, U54GM074942,
   R01GM081642, U54GM074958, R01GM063817, R01GM064700, U54GM074942,
   R01GM064700, U54GM074942, U54GM074942, R01GM064700, U54GM074942,
   U54GM074958, U54GM074958, U54GM074942, U54GM074958, R01GM061867,
   U54GM074958, U54GM074958, U54GM074958, U54GM074942, U54GM074942,
   U54GM074958, U54GM074958, U54GM074942, R01GM064700, U54GM074958,
   R01GM061867, U54GM074958, U54GM074942, R01GM063817, R01GM063817,
   U54GM074958, R01GM064700, U54GM074958, U54GM074958, U54GM074942,
   U54GM074958, R01GM064700, U54GM074958, U54GM074958, U54GM074958,
   U54GM074942, U54GM074942, U54GM074958, U54GM074958, U54GM074942,
   U54GM074942, U54GM074942, U54GM074958, R01GM061867, U54GM074958,
   U54GM074942, U54GM074942, R01GM061867, U54GM074942, U54GM074958,
   U54GM074942, U54GM074942, U54GM074958, U54GM074942, U54GM074958,
   U54GM074942, R01GM061867, U54GM074942, R01GM063817, R01GM061867,
   U54GM074942, U54GM074942, R01GM064700, U54GM074942, U54GM074942,
   U54GM074958, U54GM074958, R01GM063817, R01GM061867, R01GM064700,
   U54GM074942, R01GM061867, U54GM074942, R01GM061867, R01GM061867,
   R01GM061867, U54GM074958, U54GM074942] Funding Source: NIH RePORTER;
   NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Library of
   Medicine (NLM) [P41LM007085, P41LM007085, P41LM007085, P41LM007085,
   P41LM007085, P41LM007085, P41LM007085, P41LM007085, P41LM007085,
   P41LM007085, P41LM007085, P41LM007085, P41LM007085, P41LM007085,
   P41LM007085, P41LM007085] Funding Source: NIH RePORTER; Grants-in-Aid
   for Scientific ResearchMinistry of Education, Culture, Sports, Science
   and Technology, Japan (MEXT)Japan Society for the Promotion of
   ScienceGrants-in-Aid for Scientific Research (KAKENHI) [21118513]
   Funding Source: KAKEN; NIGMS NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01 GM061867, P20
   GM076222-02S1, U54 GM074942, P20 GM076222, U54 GM074958-04S2, R01
   GM061867-09, R01 GM064700-08, R01 GM081642-01, R01 GM081642, R01
   GM081642-02, R01 GM063817, U54 GM074958, R01 GM064700, U54
   GM074942-04S2] Funding Source: Medline; NLM NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Library of Medicine (NLM) [P41 LM007085] Funding
   Source: Medline
CR Alber F, 2008, ANNU REV BIOCHEM, V77, P443, DOI 10.1146/annurev.biochem.77.060407.135530
   Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405
   Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404
   Alquati C, 2002, EUR J BIOCHEM, V269, P3321, DOI 10.1046/j.1432-1033.2002.03012.x
   Ananthanarayanan B, 2002, J BIOL CHEM, V277, P3568, DOI 10.1074/jbc.M109705200
   Arnold Konstantin, 2009, Journal of Structural and Functional Genomics, V10, P1, DOI 10.1007/s10969-008-9048-5
   Ash C, 2007, SCIENCE, V317, P1337, DOI 10.1126/science.317.5843.1337
   Babaoglu K, 2008, J MED CHEM, V51, P2502, DOI 10.1021/jm701500e
   Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715
   Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980
   Berman HM, 2006, STRUCTURE, V14, P1211, DOI 10.1016/j.str.2006.06.005
   Berman HM, 2009, NUCLEIC ACIDS RES, V37, pD365, DOI 10.1093/nar/gkn790
   Bhattacharya A, 2008, PROTEINS, V70, P105, DOI 10.1002/prot.21466
   Blatner NR, 2004, J BIOL CHEM, V279, P53818, DOI 10.1074/jbc.M408408200
   Bourdon A, 2007, NAT GENET, V39, P776, DOI 10.1038/ng2040
   BROWNE WJ, 1969, J MOL BIOL, V42, P65, DOI 10.1016/0022-2836(69)90487-2
   Bryson K, 2005, NUCLEIC ACIDS RES, V33, pW36, DOI 10.1093/nar/gki410
   Buckley GM, 2008, BIOORG MED CHEM LETT, V18, P3291, DOI 10.1016/j.bmcl.2008.04.039
   CARTER P, 1992, P NATL ACAD SCI USA, V89, P4285, DOI 10.1073/pnas.89.10.4285
   Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104
   Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018
   Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577
   Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371
   Cosconati S, 2007, J MED CHEM, V50, P1504, DOI 10.1021/jm061245a
   Dalton AK, 2005, J VIROL, V79, P6227, DOI 10.1128/JVI.79.10.6227-6238.2005
   Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838
   de Paulis T, 2007, CURR OPIN INVEST DR, V8, P78
   Di Bernardo MC, 2008, NAT GENET, V40, P1204, DOI 10.1038/ng.219
   Diller DJ, 2003, J MED CHEM, V46, P4638, DOI 10.1021/jm020503a
   Doman TN, 2002, J MED CHEM, V45, P2213, DOI 10.1021/jm010548w
   Engel S, 2008, J AM CHEM SOC, V130, P5115, DOI 10.1021/ja077620l
   Forrest LR, 2007, P NATL ACAD SCI USA, V104, P12761, DOI 10.1073/pnas.0705600104
   Geer LY, 2002, GENOME RES, V12, P1619, DOI 10.1101/gr.278202
   Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124
   Godzik Adam, 2003, Methods Biochem Anal, V44, P525
   Hamblin K, 2008, MOL MICROBIOL, V68, P1395, DOI 10.1111/j.1365-2958.2008.06228.x
   Hermann JC, 2007, NATURE, V448, P775, DOI 10.1038/nature05981
   Hermann JC, 2006, J AM CHEM SOC, V128, P15882, DOI 10.1021/ja065860f
   Hinton PR, 2004, J BIOL CHEM, V279, P6213, DOI 10.1074/jbc.C300470200
   Huang YPJ, 2008, MOL CELL PROTEOMICS, V7, P2048, DOI 10.1074/mcp.M700550-MCP200
   Huey R, 2007, J COMPUT CHEM, V28, P1145, DOI 10.1002/jcc.20634
   Hult K, 2003, CURR OPIN BIOTECH, V14, P395, DOI 10.1016/S0958-1669(03)00095-8
   Janin J, 2003, PROTEINS, V52, P2, DOI 10.1002/prot.10381
   Kalyanaraman C, 2005, BIOCHEMISTRY-US, V44, P2059, DOI 10.1021/bi0481186
   Kalyanaraman C, 2008, STRUCTURE, V16, P1668, DOI 10.1016/j.str.2008.08.015
   Kamal JKA, 2008, PROTEIN SCI, V17, P79, DOI 10.1110/ps.073071808
   Kamal JKA, 2007, P NATL ACAD SCI USA, V104, P7910, DOI 10.1073/pnas.0611283104
   Karchin R, 2007, PLOS COMPUT BIOL, V3, P268, DOI 10.1371/journal.pcbi.0030026
   Kiefer F, 2009, NUCLEIC ACIDS RES, V37, pD387, DOI 10.1093/nar/gkn750
   Kopp B, 2007, J BEHAV THER EXP PSY, V38, P56, DOI 10.1016/j.jbtep.2006.05.001
   Krasley E, 2006, GENETICS, V172, P1477, DOI 10.1534/genetics.105.052266
   Kryshtafovych A, 2007, PROTEINS, V69, P194, DOI 10.1002/prot.21769
   Lazar GA, 2006, P NATL ACAD SCI USA, V103, P4005, DOI 10.1073/pnas.0508123103
   Lensink MF, 2007, PROTEINS, V69, P704, DOI 10.1002/prot.21804
   Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336
   Liu JF, 2007, NAT BIOTECHNOL, V25, P850, DOI 10.1038/nbt0807-849
   Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x
   Murray PS, 2005, STRUCTURE, V13, P1521, DOI 10.1016/j.str.2005.07.010
   Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920
   Oshiro C, 2004, J MED CHEM, V47, P764, DOI 10.1021/jm0300781
   PAULING L, 1951, P NATL ACAD SCI USA, V37, P205, DOI 10.1073/pnas.37.4.205
   Petrey D, 2005, MOL CELL, V20, P811, DOI 10.1016/j.molcel.2005.12.005
   Pettitt CS, 2005, BIOINFORMATICS, V21, P3509, DOI 10.1093/bioinformatics/bti540
   Pieper U, 2009, NUCLEIC ACIDS RES, V37, pD347, DOI 10.1093/nar/gkn791
   Pietsch EC, 2008, J BIOL CHEM, V283, P21294, DOI 10.1074/jbc.M710539200
   Presta LG, 1997, CANCER RES, V57, P4593
   Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249
   QUEEN C, 1989, P NATL ACAD SCI USA, V86, P10029, DOI 10.1073/pnas.86.24.10029
   Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325
   Rester U, 2008, CURR OPIN DRUG DISC, V11, P559
   Robinson CV, 2007, NATURE, V450, P973, DOI 10.1038/nature06523
   Rockey WM, 2006, CURR PROTEIN PEPT SC, V7, P437, DOI 10.2174/138920306778559368
   Rossmann MG, 2005, STRUCTURE, V13, P355, DOI 10.1016/j.str.2005.01.005
   Rost Burkhard, 2003, Methods Biochem Anal, V44, P559
   Rumpel S, 2008, J BIOMOL NMR, V40, P1, DOI 10.1007/s10858-007-9204-4
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606
   Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105
   SIPPL MJ, 1993, PROTEINS, V17, P355, DOI 10.1002/prot.340170404
   Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427
   Sondermann H, 2005, P NATL ACAD SCI USA, V102, P16632, DOI 10.1073/pnas.0508315102
   Song L, 2007, NAT CHEM BIOL, V3, P486, DOI 10.1038/nchembio.2007.11
   Stacey SN, 2008, NAT GENET, V40, P703, DOI 10.1038/ng.131
   Stahelin RV, 2004, J BIOL CHEM, V279, P54918, DOI 10.1074/jbc.M407798200
   Tang Y, 2006, NAT STRUCT MOL BIOL, V13, P921, DOI 10.1038/nsmb1147
   Tarn C, 2005, CLIN CANCER RES, V11, P3668, DOI 10.1158/1078-0432.CCR-04-2515
   Topf M, 2008, STRUCTURE, V16, P295, DOI 10.1016/j.str.2007.11.016
   Tramontano A, 2006, FEBS LETT, V580, P2928, DOI 10.1016/j.febslet.2006.04.011
   VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0
   Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Webb ML, 1996, BIOCHEMISTRY-US, V35, P2548, DOI 10.1021/bi951836v
   WEBB ML, 1998, ENDOTHELIN RECEPTORS
   Westbrook John D, 2003, Methods Biochem Anal, V44, P161
   Winn MD, 2003, J SYNCHROTRON RADIAT, V10, P23, DOI 10.1107/S0909049502017235
   Yu JW, 2004, MOL CELL, V13, P677, DOI 10.1016/S1097-2765(04)00083-8
   Yue P, 2005, J MOL BIOL, V353, P459, DOI 10.1016/j.jmb.2005.08.020
   Zhang RG, 2005, DEV CELL, V8, P19, DOI 10.1016/j.devcel.2004.10.019
NR 98
TC 82
Z9 85
U1 0
U2 22
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0969-2126
EI 1878-4186
J9 STRUCTURE
JI Structure
PD FEB 13
PY 2009
VL 17
IS 2
BP 151
EP 159
DI 10.1016/j.str.2008.12.014
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 407SO
UT WOS:000263384800003
PM 19217386
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Cohen, A
   Hall, MN
AF Cohen, Adiel
   Hall, Michael N.
TI An Amino Acid Shuffle Activates mTORC1
SO CELL
LA English
DT Editorial Material
ID RAG GTPASES
AB The mammalian target of rapamycin complex 1 (mTORC1), which promotes cell growth, is regulated by specific nutrients such as the amino acid leucine. In this issue, Nicklin et al. (2009) describe a mechanism by which glutamine facilitates the uptake of leucine, leading to mTORC1 activation.
C1 [Cohen, Adiel; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
CR Avruch J, 2009, AM J PHYSIOL-ENDOC M, V296, pE592, DOI 10.1152/ajpendo.90645.2008
   Christie GR, 2002, J BIOL CHEM, V277, P9952, DOI 10.1074/jbc.M107694200
   DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104
   Edinger AL, 2002, MOL BIOL CELL, V13, P2276, DOI 10.1091/mbc.01-12-0584
   Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005
   Kim E, 2008, NAT CELL BIOL, V10, P935, DOI 10.1038/ncb1753
   Krause U, 2002, EUR J BIOCHEM, V269, P3742, DOI 10.1046/j.1432-1033.2002.03069.x
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 9
TC 37
Z9 40
U1 0
U2 11
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD FEB 6
PY 2009
VL 136
IS 3
BP 399
EP 401
DI 10.1016/j.cell.2009.01.021
PG 3
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 403ZN
UT WOS:000263120600010
PM 19203575
OA Bronze
DA 2021-01-25
ER

PT J
AU Guetg, N
   Seddik, R
   Vigot, R
   Turecek, R
   Gassmann, M
   Vogt, KE
   Brauner-Osborne, H
   Shigemoto, R
   Kretz, O
   Frotscher, M
   Kulik, A
   Bettler, B
AF Guetg, Nicole
   Seddik, Riad
   Vigot, Rejan
   Turecek, Rostislav
   Gassmann, Martin
   Vogt, Kaspar E.
   Braeuner-Osborne, Hans
   Shigemoto, Ryuichi
   Kretz, Oliver
   Frotscher, Michael
   Kulik, Akos
   Bettler, Bernhard
TI The GABA(B1a) Isoform Mediates Heterosynaptic Depression at Hippocampal
   Mossy Fiber Synapses
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE GABA(B); GABA-B; metabotropic; hippocampus; presynaptic inhibition;
   heteroreceptor
ID RECEPTOR SUBUNITS GABA(B1A/B); RECTIFYING K+ CHANNELS; PRESYNAPTIC
   INHIBITION; SYNAPTIC-TRANSMISSION; RAT HIPPOCAMPUS; PYRAMIDAL CELLS;
   ACTIVATION; NEURONS; GABA; PROTEIN
AB GABA(B) receptor subtypes are based on the subunit isoforms GABA(B1a) and GABA(B1b), which associate with GABA(B2) subunits to form pharmacologically indistinguishable GABAB(1a,2) and GABA(B(1b,2)) receptors. Studies with mice selectively expressing GABA(B1a) or GABA(B1b) subunits revealed that GABA(B(1a, 2)) receptors are more abundant than GABA(B(1b, 2)) receptors at glutamatergic terminals. Accordingly, it was found that GABA(B(1a, 2)) receptors are more efficient than GABA(B(1b, 2)) receptors in inhibiting glutamate release when maximally activated by exogenous application of the agonist baclofen. Here, we used a combination of genetic, ultrastructural and electrophysiological approaches to analyze to what extent GABA(B(1a, 2)) and GABA(B(1b, 2)) receptors inhibit glutamate release in response to physiological activation. We first show that at hippocampal mossy fiber (MF)-CA3 pyramidal neuron synapses more GABAB1a than GABAB1b protein is present at presynaptic sites, consistent with the findings at other glutamatergic synapses. In the presence of baclofen at concentrations >= 1 mu M, both GABA(B(1a, 2)) and GABA(B(1b, 2)) receptors contribute to presynaptic inhibition of glutamate release. However, at lower concentrations of baclofen, selectively GABA(B(1a, 2)) receptors contribute to presynaptic inhibition. Remarkably, exclusively GABA(B(1a, 2)) receptors inhibit glutamate release in response to synaptically released GABA. Specifically, we demonstrate that selectively GABA(B(1a, 2)) receptors mediate heterosynaptic depression of MF transmission, a physiological phenomenon involving transsynaptic inhibition of glutamate release via presynaptic GABA(B) receptors. Our data demonstrate that the difference in GABA(B1a) and GABA(B1b) protein levels at MF terminals is sufficient to produce a strictly GABA(B1a)-specific effect under physiological conditions. This consolidates that the differential subcellular localization of the GABA(B1a) and GABA(B1b) proteins is of regulatory relevance.
C1 [Guetg, Nicole; Seddik, Riad; Vigot, Rejan; Turecek, Rostislav; Gassmann, Martin; Braeuner-Osborne, Hans; Bettler, Bernhard] Univ Basel, Pharmazentrum, Inst Physiol, Dept Biomed, CH-4056 Basel, Switzerland.
   [Vogt, Kaspar E.] Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
   [Guetg, Nicole; Kretz, Oliver; Frotscher, Michael; Kulik, Akos] Univ Freiburg, Dept Neuroanat, Inst Anat & Cell Biol, D-79104 Freiburg, Germany.
   [Braeuner-Osborne, Hans] Univ Copenhagen, Fac Pharmaceut Sci, Dept Med Chem, DK-2100 Copenhagen, Denmark.
   [Shigemoto, Ryuichi] Grad Univ Adv Studies Sokendai, Natl Inst Physiol Sci, Div Cerebral Struct, Okazaki, Aichi 4448787, Japan.
   [Shigemoto, Ryuichi] Grad Univ Adv Studies Sokendai, Dept Physiol Sci, Okazaki, Aichi 4448787, Japan.
   [Shigemoto, Ryuichi] Japan Sci & Technol Corp, Solut Oriented Res Sci & Technol, Kawaguchi, Saitama 3320012, Japan.
RP Bettler, B (corresponding author), Univ Basel, Pharmazentrum, Inst Physiol, Dept Biomed, CH-4056 Basel, Switzerland.
EM akos.kulik@anat.uni-freiburg.de; bernhard.bettler@unibas.ch
RI Turecek, Rostislav/H-2706-2014; Turecek, Rostislav/AAL-3523-2020;
   Shigemoto, Ryuichi/E-3628-2013; Brauner-Osborne, Hans/D-7260-2011;
   bettler, bernhard/AAO-8018-2020
OI Turecek, Rostislav/0000-0003-4978-7556; Shigemoto,
   Ryuichi/0000-0001-8761-9444; Brauner-Osborne, Hans/0000-0001-9495-7388;
   Bettler, Bernhard/0000-0003-0842-8207; Vogt, Kaspar/0000-0002-0859-876X;
   Gassmann, Martin/0000-0001-6201-3032
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [20019031] Funding Source: KAKEN
CR Alle H, 2006, SCIENCE, V311, P1290, DOI 10.1126/science.1119055
   Bettler B, 2004, PHYSIOL REV, V84, P835, DOI 10.1152/physrev.00036.2003
   Calver AR, 2002, NEUROSIGNALS, V11, P299, DOI 10.1159/000068257
   Chandler KE, 2003, J NEUROSCI, V23, P11382
   Cunha RA, 2008, NEUROCHEM INT, V52, P65, DOI 10.1016/j.neuint.2007.06.026
   Dittert I, 2006, J NEUROSCI METH, V151, P178, DOI 10.1016/j.jneumeth.2005.07.005
   Fritschy JM, 1999, EUR J NEUROSCI, V11, P761, DOI 10.1046/j.1460-9568.1999.00481.x
   Hawrot E, 1998, FEBS LETT, V432, P103, DOI 10.1016/S0014-5793(98)00794-7
   Huang ZJ, 2006, NEURON, V50, P521, DOI 10.1016/j.neuron.2006.05.005
   ISAACSON JS, 1993, NEURON, V10, P165, DOI 10.1016/0896-6273(93)90308-E
   Jacobson LH, 2007, BEHAV BRAIN RES, V181, P158, DOI 10.1016/j.bbr.2007.03.033
   Jarolimek W, 1997, J NEUROSCI, V17, P1025
   Jensen K, 2003, J NEUROPHYSIOL, V90, P2690, DOI 10.1152/jn.00240.2003
   Jin WZ, 1999, BRAIN RES, V821, P286, DOI 10.1016/S0006-8993(99)01089-6
   Kamiya H, 1996, J PHYSIOL-LONDON, V493, P447, DOI 10.1113/jphysiol.1996.sp021395
   Karschin A, 1999, NEWS PHYSIOL SCI, V14, P215
   Kirschstein T, 2004, NEUROPHARMACOLOGY, V47, P157, DOI 10.1016/j.neuropharm.2004.04.004
   Kulik A, 2006, J NEUROSCI, V26, P4289, DOI 10.1523/JNEUROSCI.4178-05.2006
   Kulik A, 2003, J NEUROSCI, V23, P11026
   Kulik A, 2002, EUR J NEUROSCI, V15, P291, DOI 10.1046/j.0953-816x.2001.01855.x
   Lacey CJ, 2005, NEUROSCIENCE, V136, P1083, DOI 10.1016/j.neuroscience.2005.07.013
   Lei SB, 2003, J PHYSIOL-LONDON, V546, P439, DOI 10.1113/jphysiol.2002.034017
   Liu X, 2006, J NEUROENDOCRINOL, V18, P177, DOI 10.1111/j.1365-2826.2005.01402.x
   Lopez-Bendito G, 2004, HIPPOCAMPUS, V14, P836, DOI 10.1002/hipo.10221
   Luscher C, 1997, NEURON, V19, P687, DOI 10.1016/S0896-6273(00)80381-5
   Malitschek B, 1998, MOL CELL NEUROSCI, V12, P56, DOI 10.1006/mcne.1998.0698
   MANZONI OJ, 1994, SCIENCE, V265, P2098, DOI 10.1126/science.7916485
   MISGELD U, 1995, PROG NEUROBIOL, V46, P423, DOI 10.1016/0301-0082(95)00012-K
   Nicoll RA, 2005, NAT REV NEUROSCI, V6, P863, DOI 10.1038/nrn1786
   Perez-Garci E, 2006, NEURON, V50, P603, DOI 10.1016/j.neuron.2006.04.019
   Price CJ, 2005, J NEUROSCI, V25, P6775, DOI 10.1523/JNEUROSCI.1135-05.2005
   Sakaba T, 2003, NATURE, V424, P775, DOI 10.1038/nature01859
   SCANZIANI M, 1992, NEURON, V9, P919, DOI 10.1016/0896-6273(92)90244-8
   Scanziani M, 2000, NEURON, V25, P673, DOI 10.1016/S0896-6273(00)81069-7
   Schuler V, 2001, NEURON, V31, P47, DOI 10.1016/S0896-6273(01)00345-2
   Shaban H, 2006, NAT NEUROSCI, V9, P1028, DOI 10.1038/nn1732
   Steiger JL, 2004, J NEUROSCI, V24, P6115, DOI 10.1523/JNEUROSCI.1200-04.2004
   Tiao JY, 2008, J BIOL CHEM, V283, P31005, DOI 10.1074/jbc.M804464200
   Tosetti P, 2004, EUR J NEUROSCI, V19, P3227, DOI 10.1111/j.0953-816X.2004.03413.x
   Ulrich D, 2007, J NEUROPHYSIOL, V98, P3791, DOI 10.1152/jn.00756.2007
   Ulrich D, 2007, CURR OPIN NEUROBIOL, V17, P298, DOI 10.1016/j.conb.2007.04.001
   Vida I, 2000, P NATL ACAD SCI USA, V97, P1275, DOI 10.1073/pnas.97.3.1275
   Vigot R, 2006, NEURON, V50, P589, DOI 10.1016/j.neuron.2006.04.014
   Vogt KE, 1999, P NATL ACAD SCI USA, V96, P1118, DOI 10.1073/pnas.96.3.1118
   WEISSKOPF MG, 1993, NATURE, V365, P188, DOI 10.1038/365188a0
   Yamada J, 1999, NEUROPHARMACOLOGY, V38, P1743, DOI 10.1016/S0028-3908(99)00126-4
   Yeckel MF, 1999, NAT NEUROSCI, V2, P625
NR 47
TC 42
Z9 44
U1 0
U2 4
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD FEB 4
PY 2009
VL 29
IS 5
BP 1414
EP 1423
DI 10.1523/JNEUROSCI.3697-08.2009
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 403GZ
UT WOS:000263072400017
PM 19193888
OA Bronze, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Hayley, M
   Perspicace, S
   Schulthess, T
   Seelig, J
AF Hayley, Michael
   Perspicace, Samantha
   Schulthess, Therese
   Seelig, Joachim
TI Calcium Enhances The Proteolytic Activity Of BACE: An In Vitro
   Biophysical And Biochemical Characterization Of The BACE-Calcium
   Interaction
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 [Hayley, Michael; Perspicace, Samantha; Schulthess, Therese; Seelig, Joachim] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD FEB
PY 2009
VL 96
IS 3
SU 1
MA 3057-Pos
BP 593A
EP 594A
PG 2
WC Biophysics
SC Biophysics
GA VC0MS
UT WOS:000426362200147
DA 2021-01-25
ER

PT J
AU Boiteux, C
   Bernerche, S
AF Boiteux, Celine
   Bernerche, Simon
TI Stability And Conductance Assessment Of A Putative Low-k(+) Inactivated
   State Of The Kcsa Channel
SO BIOPHYSICAL JOURNAL
LA English
DT Meeting Abstract
C1 [Boiteux, Celine; Bernerche, Simon] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD FEB
PY 2009
VL 96
IS 3
SU 1
MA 3396-Pos
BP 657A
EP 658A
PG 2
WC Biophysics
SC Biophysics
GA VC0MS
UT WOS:000426362200484
DA 2021-01-25
ER

PT J
AU Jastrzebska, B
   Golczak, M
   Fotiadis, D
   Engel, A
   Palczewski, K
AF Jastrzebska, Beata
   Golczak, Marcin
   Fotiadis, Dimitrios
   Engel, Andreas
   Palczewski, Krzysztof
TI Isolation and functional characterization of a stable complex between
   photoactivated rhodopsin and the G protein, transducin
SO FASEB JOURNAL
LA English
DT Article
DE sucrose gradient; detergent; rhodopsin regeneration
ID ROD OUTER SEGMENTS; COUPLED RECEPTOR RHODOPSIN; G-ALPHA-SUBUNITS;
   CRYSTAL-STRUCTURE; METARHODOPSIN-II; OPSIN STABILITY; GAMMA-SUBUNIT;
   ACTIVATION; PHOTOTRANSDUCTION; MEMBRANES
AB Transitory binding between photoactivated rhodopsin (Rho* or Meta II) and the G protein transducin (Gt-GDP) is the first step in the visual signaling cascade. Light causes photoisomerization of the 11-cis-retinylidene chromophore in rhodopsin (Rho) to all-trans-retinylidene, which induces conformational changes that allow Gt-GDP to dock onto the Rho* surface. GDP then dissociates from Gt, leaving a transient nucleotide-empty Rho*-Gt(e) complex before GTP becomes bound, and Gt-GTP then dissociates from Rho*. Further biochemical advances are required before structural studies of the various Rho*-Gt complexes can be initiated. Here, we describe the isolation of n-dodecyl-beta-maltoside solubilized, stable, functionally active, Rho*-Gt(e), Rhoe*-Gt(e), and 9-cis-retinal/11-cis-retinal regenerated Rho-Gt(e) complexes by sucrose gradient centrifugation. In these complexes, Rho* spectrally remained in its Meta II state, and Gt(e) retained its ability to interact with GTP gamma S. Removal of all-trans-retinylidene from Rho*-Gt(e) had no effect on the stability of the Rho(e)*-Gt(e) complex. Moreover, opsin in the Rho(e)*-Gt(e) complex with an empty nucleotide-binding pocket in Gt and an empty retinoid-binding pocket in Rho was regenerated up to 75% without complex dissociation. These results indicate that once Rho* couples with Gt, the chromophore plays a minor role in stabilizing this complex. Moreover, in complexes regenerated with 9-cis-retinal/11-cis-retinal, Rho retains a conformation similar to Rho* that is stabilized by Gte apo-protein. - Jastrzebska, B., Golczak, M., Fotiadis, D., Engel, A., and Palczewski, K.. Isolation and functional characterization of a stable complex between photoactivated rhodopsin and the G protein, transducin. FASEB J. 23, 371-381 (2009)
C1 [Jastrzebska, Beata; Golczak, Marcin] Case Western Reserve Univ, Sch Med, Dept Pharmacol, Cleveland, OH 44106 USA.
   [Fotiadis, Dimitrios; Engel, Andreas] Univ Basel, Biozentrum, ME Muller Inst Microscopy, Basel, Switzerland.
   [Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, Bern, Switzerland.
RP Jastrzebska, B (corresponding author), Case Western Reserve Univ, Sch Med, Dept Pharmacol, Wood Bldg,10900 Euclid Ave, Cleveland, OH 44106 USA.
EM bxj27@case.edu
FU U. S. National Institutes of HealthUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USA [EY09339, GM
   079191, P30 EY11373]; Swiss National Foundation (SNF)Swiss National
   Science Foundation (SNSF) [3100A0 - 108299]; Amgen Inc.Amgen; NATIONAL
   EYE INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [P30EY011373, R01EY009339, P30EY011373, R01EY009339, P30EY011373,
   R01EY009339, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, R01EY009339,
   P30EY011373, R01EY009339, R01EY009339, P30EY011373, P30EY011373,
   P30EY011373, R01EY009339, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, R01EY009339, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   R01EY009339, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, R01EY009339, R01EY009339,
   P30EY011373, P30EY011373, R01EY009339, P30EY011373, P30EY011373,
   R01EY009339, R01EY009339, P30EY011373, P30EY011373, P30EY011373,
   R01EY009339, R01EY009339, R01EY009339, P30EY011373, R01EY009339,
   P30EY011373, P30EY011373, R01EY009339, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, R01EY009339, R01EY009339,
   P30EY011373, P30EY011373, P30EY011373, R01EY009339, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, R01EY009339,
   P30EY011373, R01EY009339, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, R01EY009339, R01EY009339,
   P30EY011373, P30EY011373, P30EY011373, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, R01EY009339, P30EY011373, P30EY011373,
   R01EY009339, P30EY011373, P30EY011373, R01EY009339, P30EY011373,
   P30EY011373, P30EY011373, P30EY011373, R01EY009339, P30EY011373,
   P30EY011373, R01EY009339, R01EY009339, P30EY011373, P30EY011373,
   P30EY011373, P30EY011373, R01EY009339, R01EY009339, P30EY011373,
   P30EY011373] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01GM079191, R01GM079191,
   R01GM079191, R01GM079191, R01GM079191] Funding Source: NIH RePORTER
FX We thank Drs. Leslie T. Webster Jr. and Thomas Angel (Case Western
   Reserve University) for valuable comments on the manuscript. This
   research was supported by U. S. National Institutes of Health grants
   EY09339, GM 079191, and P30 EY11373, the Swiss National Foundation (SNF
   grant 3100A0 - 108299 to A.E.), and by an unrestricted grant from Amgen
   Inc.
CR Angel TE, 2006, VISION RES, V46, P4547, DOI 10.1016/j.visres.2006.08.015
   Aris L, 2001, J BIOL CHEM, V276, P2333, DOI 10.1074/jbc.M002533200
   BORNANCIN F, 1989, EUR J BIOCHEM, V184, P687, DOI 10.1111/j.1432-1033.1989.tb15068.x
   Cherfils J, 2003, TRENDS BIOCHEM SCI, V28, P13, DOI 10.1016/S0968-0004(02)00006-3
   Filipek S, 2004, PHOTOCH PHOTOBIO SCI, V3, P628, DOI 10.1039/b315661c
   Fotiadis D, 2004, FEBS LETT, V564, P281, DOI 10.1016/S0014-5793(04)00194-2
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   GILMAN AG, 1987, ANNU REV BIOCHEM, V56, P615, DOI 10.1146/annurev.bi.56.070187.003151
   Granzin J, 1998, NATURE, V391, P918, DOI 10.1038/36147
   GROENENDIJK GWT, 1980, EUR J BIOCHEM, V106, P119
   Hamm HE, 1996, CURR OPIN CELL BIOL, V8, P189, DOI 10.1016/S0955-0674(96)80065-2
   Herrmann R, 2004, J BIOL CHEM, V279, P24283, DOI 10.1074/jbc.M311166200
   Jager S, 1996, BIOCHEMISTRY-US, V35, P2901, DOI 10.1021/bi9524068
   Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200
   Jastrzebska B, 2004, J BIOL CHEM, V279, P54663, DOI 10.1074/jbc.M408691200
   Kisselev OG, 2003, STRUCTURE, V11, P367, DOI 10.1016/S0969-2126(03)00045-5
   KISSELEV OG, 1994, J BIOL CHEM, V269, P21399
   KONIG B, 1989, P NATL ACAD SCI USA, V86, P6878, DOI 10.1073/pnas.86.18.6878
   KUHN H, 1980, NATURE, V283, P587, DOI 10.1038/283587a0
   Leskov IB, 2000, NEURON, V27, P525, DOI 10.1016/S0896-6273(00)00063-5
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   Loewen MC, 2001, P NATL ACAD SCI USA, V98, P4888, DOI 10.1073/pnas.051633098
   MATTHEWS RG, 1963, J GEN PHYSIOL, V47, P215, DOI 10.1085/jgp.47.2.215
   McKibbin C, 2007, J MOL BIOL, V374, P1319, DOI 10.1016/j.jmb.2007.10.018
   McKibbin C, 2007, J MOL BIOL, V374, P1309, DOI 10.1016/j.jmb.2007.10.013
   NAVON SE, 1984, J BIOL CHEM, V259, P6686
   Nickell S, 2007, J CELL BIOL, V177, P917, DOI 10.1083/jcb.200612010
   NOEL JP, 1993, NATURE, V366, P654, DOI 10.1038/366654a0
   Okada T, 2000, J STRUCT BIOL, V130, P73, DOI 10.1006/jsbi.1999.4209
   OPRIAN DD, 1987, P NATL ACAD SCI USA, V84, P8874, DOI 10.1073/pnas.84.24.8874
   PALCZEWSKI K, 1994, BIOCHEMISTRY-US, V33, P13741, DOI 10.1021/bi00250a027
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Palczewski K, 2006, ANNU REV BIOCHEM, V75, P743, DOI 10.1146/annurev.biochem.75.103004.142743
   PAPERMASTER DS, 1982, METHOD ENZYMOL, V81, P240
   Ridge KD, 2003, TRENDS BIOCHEM SCI, V28, P479, DOI 10.1016/S0968-0004(03)00172-5
   Salamon Z, 1996, BIOPHYS J, V71, P283, DOI 10.1016/S0006-3495(96)79224-X
   Salom D, 2006, P NATL ACAD SCI USA, V103, P16123, DOI 10.1073/pnas.0608022103
   Schadel SA, 2003, J BIOL CHEM, V278, P24896, DOI 10.1074/jbc.M302115200
   SCHLEICHER A, 1987, J MEMBRANE BIOL, V95, P271, DOI 10.1007/BF01869489
   Shichida Y, 1998, CELL MOL LIFE SCI, V54, P1299, DOI 10.1007/s000180050256
   Slep KC, 2001, NATURE, V409, P1071, DOI 10.1038/35059138
   Struthers M, 2000, BIOCHEMISTRY-US, V39, P7938, DOI 10.1021/bi000771f
   WALD G, 1953, J GEN PHYSIOL, V37, P189, DOI 10.1085/jgp.37.2.189
   Yan F, 2008, BIOCHEMISTRY-US, V47, P1567, DOI 10.1021/bi701476b
   ZHUKOVSKY EA, 1989, SCIENCE, V246, P928, DOI 10.1126/science.2573154
NR 45
TC 25
Z9 25
U1 0
U2 5
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
EI 1530-6860
J9 FASEB J
JI Faseb J.
PD FEB
PY 2009
VL 23
IS 2
BP 371
EP 381
DI 10.1096/fj.07-114835
PG 11
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 400TZ
UT WOS:000262892900009
PM 18827025
OA Green Published
DA 2021-01-25
ER

PT J
AU Hoffman, DR
   Padavattan, S
   Schmidt, M
   Markovic-Housley, Z
AF Hoffman, D. R.
   Padavattan, S.
   Schmidt, M.
   Markovic-Housley, Z.
TI The Crystal Structure of Sol i 3, a Major Fire Ant Venom Allergen
SO JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
LA English
DT Meeting Abstract
CT 65th Annual Meeting of the
   American-Academy-of-Allergy-Asthma-and-Immunology
CY MAR 13-17, 2009
CL Washington, DC
SP Amer Acad Allergy, Asthma & Immunol
C1 [Hoffman, D. R.] E Carolina Univ, Brody Sch Med, Greenville, NC USA.
   [Padavattan, S.; Markovic-Housley, Z.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU MOSBY-ELSEVIER
PI NEW YORK
PA 360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0091-6749
J9 J ALLERGY CLIN IMMUN
JI J. Allergy Clin. Immunol.
PD FEB
PY 2009
VL 123
IS 2
MA 940
BP S243
EP S243
DI 10.1016/j.jaci.2008.12.937
PG 1
WC Allergy; Immunology
SC Allergy; Immunology
GA 410RR
UT WOS:000263596301412
DA 2021-01-25
ER

PT J
AU Krzyzanek, V
   Muller, SA
   Engel, A
   Reichelt, R
AF Krzyzanek, Vladislav
   Mueller, Shirley A.
   Engel, Andreas
   Reichelt, Rudolf
TI MASDET-A fast and user-friendly multiplatform software for mass
   determination by dark-field electron microscopy
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Article
DE Mass determination; Molecular weight; Quantitative electron microscopy;
   Nanoanalytics; Single cell proteomics
ID CHEMICAL CROSS-LINKING; WEIGHT DETERMINATION; COMPLEXES; SPECTROMETRY;
   SCATTERING; FILAMENTS; DENSITY; DAMAGE
AB Electron microscopy has been used to measure the mass of biological nanoparticles since the early 60s, and is the only way to obtain the mass of large structures or parameters such as the mass-per-length of filaments. The ability of this method to sort heterogeneous samples both in terms of mass and shape promises to make it a key tool for proteomics down to the single cell level. A new multiplatform software package, MASDET, that can be run under MATLAB or as a standalone program is described. Based on a user-friendly graphical interface MASDET streamlines mass evaluation and greatly increases the speed of required optimisation procedures. Importantly, the immediate application of Monte-Carlo simulations to describe multiple scattering is possible, allowing the mass analysis of thicker samples and the generation of mass thickness maps. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Krzyzanek, Vladislav; Reichelt, Rudolf] Univ Munster, Univ Klinikum Munster, Inst Med Phys & Biophys, D-48149 Munster, Germany.
   [Mueller, Shirley A.; Engel, Andreas] Univ Basel, Maurice E Muller Inst Struct Biol, Biozentrum, CCINA, CH-4058 Basel, Switzerland.
RP Krzyzanek, V (corresponding author), Univ Munster, Univ Klinikum Munster, Inst Med Phys & Biophys, Robert Koch Str 31, D-48149 Munster, Germany.
EM krzyzane@uni-muenster.de
RI Krzyzanek, Vladislav/C-6275-2008
OI Krzyzanek, Vladislav/0000-0002-7996-2979
FU DFGGerman Research Foundation (DFG) [782/11-1]; NATO Science
   FellowshipsNATO (North Atlantic Treaty Organisation); State of North
   Rhine-Westphalia; Maurice E. Muller Foundation of Switzerland
FX We greatly appreciate the partial financial support by the DFG Grant RE
   782/11-1 (to R.R.), NATO Science Fellowships (to V.K.), and support of
   the State of North Rhine-Westphalia and the Maurice E. Muller Foundation
   of Switzerland.
CR Baxa U, 2003, J BIOL CHEM, V278, P43717, DOI 10.1074/jbc.M306004200
   Bevington P. R., 1992, DATA REDUCTION ERROR
   BOUVIER J, 1989, MOL BIOCHEM PARASIT, V37, P235, DOI 10.1016/0166-6851(89)90155-2
   Chen XB, 2005, P NATL ACAD SCI USA, V102, P11551, DOI 10.1073/pnas.0505359102
   CREWE AV, 1970, J MOL BIOL, V48, P375, DOI 10.1016/0022-2836(70)90052-5
   ENGEL A, 1982, P NATL ACAD SCI-BIOL, V79, P4050, DOI 10.1073/pnas.79.13.4050
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   ENGEL A, 1988, SCANNING MICROSCOPY, P285
   ENGEL A, 1981, ULTRAMICROSCOPY, V7, P45, DOI 10.1016/0304-3991(81)90022-X
   Feja B, 1997, J STRUCT BIOL, V119, P72, DOI 10.1006/jsbi.1997.3861
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   ISAACSON M, 1973, RADIAT RES, V55, P205, DOI 10.2307/3573678
   ISAACSON M, 1979, ULTRAMICROSCOPY, V4, P193, DOI 10.1016/S0304-3991(79)90193-1
   Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101
   Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x
   KRZYANEK V, 2004, 13 EUR MICR C BELG S, V1, P391
   Krzyzanek V., 2003, MICROSC MICROANAL S3, V9, P110
   KRZYZANEK V, 2005, MICR C MC DAV SWITZ, P49
   KRZYZANEK V, 2006, 16 INT MICR C SAPP J, V2, P959
   LAMVIK MK, 1978, J MOL BIOL, V122, P55, DOI 10.1016/0022-2836(78)90108-0
   Loo JA, 2005, J AM SOC MASS SPECTR, V16, P998, DOI 10.1016/j.jasms.2005.02.017
   Muller SA, 2006, CHIMIA, V60, pA749, DOI 10.2533/chimia.2006.749
   Muller SA, 1998, J STRUCT BIOL, V121, P219, DOI 10.1006/jsbi.1997.3953
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Muller SA, 2001, J MOL BIOL, V305, P1035, DOI 10.1006/jmbi.2000.4363
   Muller SA, 2001, MICRON, V32, P21, DOI 10.1016/S0968-4328(00)00022-6
   MULLER T, 1990, SCANNING MICROSCOPY, V4, P863
   Pimenova T, 2008, J MASS SPECTROM, V43, P185, DOI 10.1002/jms.1280
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   REICHELT R, 1984, ULTRAMICROSCOPY, V13, P279, DOI 10.1016/0304-3991(84)90206-7
   Riek U, 2008, J BIOL CHEM, V283, P18331, DOI 10.1074/jbc.M708379200
   Schenk AD, 2005, J MOL BIOL, V350, P278, DOI 10.1016/j.jmb.2005.04.030
   Sinz A, 2006, MASS SPECTROM REV, V25, P663, DOI 10.1002/mas.20082
   Sousa AA, 2007, J MICROSC-OXFORD, V228, P25, DOI 10.1111/j.1365-2818.2007.01819.x
   STEVEN AC, 1984, P NATL ACAD SCI-BIOL, V81, P6363, DOI 10.1073/pnas.81.20.6363
   STROUD AN, 1969, SCIENCE, V164, P830, DOI 10.1126/science.164.3881.830
   WALL J, 1974, OPTIK, V39, P359
   WALL J, 1974, P NATL ACAD SCI USA, V71, P1, DOI 10.1073/pnas.71.1.1
   WALL J, 1973, P C SCANN EL MICR SY, P136
   Wall JS, 2008, METHOD ENZYMOL, V436, P487, DOI 10.1016/S0076-6879(08)36027-3
   Wall JS, 2000, METH MOL B, V148, P589
   Wall JS, 1998, METHOD CELL BIOL, V53, P139
   WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355
   WALL JS, 1979, SCANNING ELECTRON MI, V2, P291
   WALZ T, 1994, J BIOL CHEM, V269, P1583
   Wenzel RJ, 2005, ANAL CHEM, V77, P4329, DOI 10.1021/ac0482054
   Yanes O, 2006, J PROTEOME RES, V5, P2711, DOI 10.1021/pr060202f
   ZEITLER E, 1962, J APPL PHYS, V33, P847, DOI 10.1063/1.1777179
NR 48
TC 22
Z9 22
U1 0
U2 7
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD FEB
PY 2009
VL 165
IS 2
BP 78
EP 87
DI 10.1016/j.jsb.2008.10.006
PG 10
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 404ZR
UT WOS:000263192100003
PM 19041401
DA 2021-01-25
ER

PT J
AU Patursky-Polischuk, I
   Stolovich-Rain, M
   Hausner-Hanochi, M
   Kasir, J
   Cybulski, N
   Avruch, J
   Ruegg, MA
   Hall, MN
   Meyuhas, O
AF Patursky-Polischuk, Ilona
   Stolovich-Rain, Miri
   Hausner-Hanochi, Mirit
   Kasir, Judith
   Cybulski, Nadine
   Avruch, Joseph
   Rueegg, Markus A.
   Hall, Michael N.
   Meyuhas, Oded
TI The TSC-mTOR Pathway Mediates Translational Activation of TOP mRNAs by
   Insulin Largely in a Raptor- or Rictor-Independent Manner
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID PROTEIN-SYNTHESIS; CELL-CYCLE; S6 KINASE; RAPAMYCIN; PHOSPHORYLATION;
   RHEB; STIMULATION; INITIATION; EXPRESSION; GROWTH
AB The stimulatory effect of insulin on protein synthesis is due to its ability to activate various translation factors. We now show that insulin can increase protein synthesis capacity also by translational activation of TOP mRNAs encoding various components of the translation machinery. This translational activation involves the tuberous sclerosis complex (TSC), as the knockout of TSC1 or TSC2 rescues TOP mRNAs from translational repression in mitotically arrested cells. Similar results were obtained upon overexpression of Rheb, an immediate TSC1-TSC2 target. The role of mTOR, a downstream effector of Rheb, in translational control of TOP mRNAs has been extensively studied, albeit with conflicting results. Even though rapamycin fully blocks mTOR complex 1 (mTORC1) kinase activity, the response of TOP mRNAs to this drug varies from complete resistance to high sensitivity. Here we show that mTOR knockdown blunts the translation efficiency of TOP mRNAs in insulin-treated cells, thus unequivocally establishing a role for mTOR in this mode of regulation. However, knockout of the raptor or rictor gene has only a slight effect on the translation efficiency of these mRNAs, implying that mTOR exerts its effect on TOP mRNAs through a novel pathway with a minor, if any, contribution of the canonical mTOR complexes mTORC1 and mTORC2. This conclusion is further supported by the observation that raptor knockout renders the translation of TOP mRNAs rapamycin hypersensitive.
C1 [Patursky-Polischuk, Ilona; Stolovich-Rain, Miri; Hausner-Hanochi, Mirit; Kasir, Judith; Meyuhas, Oded] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, IL-91120 Jerusalem, Israel.
   [Cybulski, Nadine; Rueegg, Markus A.; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Avruch, Joseph] Harvard Univ, Sch Med, Boston, MA 02114 USA.
   [Avruch, Joseph] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.
   [Avruch, Joseph] Massachusetts Gen Hosp, Med Serv, Diabet Unit, Boston, MA 02114 USA.
RP Meyuhas, O (corresponding author), Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem, POB 12272, IL-91120 Jerusalem, Israel.
EM meyuhas@cc.huji.ac.il
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU United States-Israel Binational Science FoundationUS-Israel Binational
   Science Foundation [BSF 2005034]; Israel Science FoundationIsrael
   Science Foundation [296/05]; German-Israeli FoundationGerman-Israeli
   Foundation for Scientific Research and Development [819/05f]; Otto
   Stieber Foundation; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF); Canton of Basel; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561, P30DK040561, P30DK040561, P30DK040561,
   P30DK040561, P30DK040561] Funding Source: NIH RePORTER
FX This work was supported by grants to O.M. from the United States-Israel
   Binational Science Foundation (BSF 2005034), the Israel Science
   Foundation (grant no. 296/05), the German-Israeli Foundation (grant no.
   819/05f), and the Otto Stieber Foundation. M.N.H. acknowledges support
   from the Swiss National Science Foundation and the Canton of Basel.; We
   thank Howard Green for the 3T3-L1 cells, Derek LeRoith for the NIH-IR
   cells, David Kwiatkowski for the TSC2<SUP>+/+</SUP>/p53<SUP>-/-</SUP>,
   TSC2<SUP>-/-</SUP>/p53<SUP>-/-</SUP>, TSC1<SUP>+/+</SUP>, and
   TSC1<SUP>-/-</SUP> MEF lines (26), John Blenis for the FLAG-Rheb
   plasmid, Kum-Liang Guan for the Myc-Rheb(5A) plasmid, Akira Kurisaki for
   the pcDNA3-6myc-hFKBP12 plasmid, and Michal Gropp for the Sin18 plasmid.
CR Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483
   ANTONETTI DA, 1993, J BIOL CHEM, V268, P25277
   Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379
   Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797
   Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x
   Bilanges B, 2007, MOL CELL BIOL, V27, P5746, DOI 10.1128/MCB.02136-06
   Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999
   Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x
   Cai SL, 2006, J CELL BIOL, V173, P279, DOI 10.1083/jcb.200507119
   CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947
   CHUNG S, 1989, MOL CELL BIOL, V9, P2075, DOI 10.1128/MCB.9.5.2075
   Dan HC, 2002, J BIOL CHEM, V277, P35364, DOI 10.1074/jbc.M205838200
   DEPHILIP RM, 1979, BIOCHEMISTRY-US, V18, P4812, DOI 10.1021/bi00589a008
   Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X
   Gingras AC, 2001, GENE DEV, V15, P807, DOI 10.1101/gad.887201
   Gingras AC, 1999, GENE DEV, V13, P1422, DOI 10.1101/gad.13.11.1422
   GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3
   Gropp M, 2003, MOL THER, V7, P281, DOI 10.1016/S1525-0016(02)00047-3
   Harris TE, 2006, EMBO J, V25, P1659, DOI 10.1038/sj.emboj.7601047
   Hornstein E, 1999, FEBS LETT, V457, P209, DOI 10.1016/S0014-5793(99)01039-X
   Hresko RC, 2005, J BIOL CHEM, V280, P40406, DOI 10.1074/jbc.M508361200
   Inoki K, 2005, NAT GENET, V37, P19, DOI 10.1038/ng1494
   Inoki K, 2002, NAT CELL BIOL, V4, P648, DOI 10.1038/ncb839
   Inoki K, 2003, GENE DEV, V17, P1829, DOI 10.1101/gad.1110003
   JEFFERIES HBJ, 1994, P NATL ACAD SCI USA, V91, P4441, DOI 10.1073/pnas.91.10.4441
   Kwiatkowski DJ, 2002, HUM MOL GENET, V11, P525, DOI 10.1093/hmg/11.5.525
   LALANNE JL, 1987, NUCLEIC ACIDS RES, V15, P4990, DOI 10.1093/nar/15.12.4990
   LEVENSON RM, 1989, J BIOL CHEM, V264, P11904
   LEVYTOLEDANO R, 1993, BIOCHIM BIOPHYS ACTA, V1220, P1, DOI 10.1016/0167-4889(93)90090-C
   Long X, 2005, CURR BIOL, V15, P702, DOI 10.1016/j.cub.2005.02.053
   Manning BD, 2007, CELL, V129, P1261, DOI 10.1016/j.cell.2007.06.009
   Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504
   Mendez R, 1996, MOL CELL BIOL, V16, P2857
   MEYUHAS O, 1980, GENE, V10, P113, DOI 10.1016/0378-1119(80)90129-8
   Meyuhas O, 2000, EUR J BIOCHEM, V267, P6321, DOI 10.1046/j.1432-1327.2000.01719.x
   MINTY AJ, 1981, J BIOL CHEM, V256, P1008
   Naldini L, 1996, P NATL ACAD SCI USA, V93, P11382, DOI 10.1073/pnas.93.21.11382
   Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231
   OLIVER MH, 1989, J CELL SCI, V92, P513
   Parrott LA, 1999, J BIOL CHEM, V274, P24731, DOI 10.1074/jbc.274.35.24731
   Pedersen S, 1997, EUR J BIOCHEM, V247, P449, DOI 10.1111/j.1432-1033.1997.00449.x
   Pende M, 2004, MOL CELL BIOL, V24, P3112, DOI 10.1128/MCB.24.8.3112-3124.2004
   Proud CG, 2006, BIOCHEM SOC T, V34, P213, DOI 10.1042/BST0340213
   Ruvinsky I, 2005, GENE DEV, V19, P2199, DOI 10.1101/gad.351605
   Ruvinsky I, 2006, TRENDS BIOCHEM SCI, V31, P342, DOI 10.1016/j.tibs.2006.04.003
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Stolovich M, 2005, J BIOL CHEM, V280, P5336, DOI 10.1074/jbc.M412434200
   Stolovich M, 2002, MOL CELL BIOL, V22, P8101, DOI 10.1128/MCB.22.23.8101-8113.2002
   Tang H, 2001, MOL CELL BIOL, V21, P8671, DOI 10.1128/MCB.21.24.8671-8683.2001
   Taniguchi CM, 2006, NAT REV MOL CELL BIO, V7, P85, DOI 10.1038/nrm1837
   Tee AR, 2003, CURR BIOL, V13, P1259, DOI 10.1016/S0960-9822(03)00506-2
   Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005
   TERADA N, 1994, P NATL ACAD SCI USA, V91, P11477, DOI 10.1073/pnas.91.24.11477
   TERADA N, 1995, J IMMUNOL, V155, P3418
   Thedieck K, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001217
   Wang LJ, 2000, AM J PHYSIOL-HEART C, V278, pH1056
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yang Q, 2007, CELL RES, V17, P666, DOI 10.1038/cr.2007.64
   Zhang HB, 2003, J CLIN INVEST, V112, P1223, DOI 10.1172/JCI200317222
   Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871
NR 61
TC 97
Z9 99
U1 0
U2 6
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD FEB 1
PY 2009
VL 29
IS 3
BP 640
EP 649
DI 10.1128/MCB.00980-08
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 396RP
UT WOS:000262609100003
PM 19047368
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Kaufmann, A
   Philippsen, P
AF Kaufmann, Andreas
   Philippsen, Peter
TI Of Bars and Rings: Hof1-Dependent Cytokinesis in Multiseptated Hyphae of
   Ashbya gossypii
SO MOLECULAR AND CELLULAR BIOLOGY
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; FISSION YEAST; ASPERGILLUS-NIDULANS;
   CONTRACTILE RING; ACTIN CYTOSKELETON; ACTOMYOSIN RING; BUDDING YEAST;
   CELL-DIVISION; SEPTIN RING; PROTEIN
AB We analyzed the development of multiple septa in elongated multinucleated cells ( hyphae) of the filamentous ascomycete Ashbya gossypii in which septation is apparently uncoupled from nuclear cycles. A key player for this compartmentalization is the PCH protein Hof1. Hyphae that are lacking this protein form neither actin rings nor septa but still elongate at wild-type speed. Using in vivo fluorescence microscopy, we present for the first time the coordination of cytokinesis and septation in multiseptated and multinucleated cells. Hof1, the type II myosin Myo1, the landmark protein Bud3, and the IQGAP Cyk1 form collars of cortical bars already adjacent to hyphal tips, thereby marking the sites of septation. While hyphae continue to elongate, these proteins gradually form cortical rings. This bar-to-ring transition depends on Hof1 and Cyk1 but not Myo1 and is required for actin ring assembly. The Fes/CIP4 homology (FCH) domain of Hof1 ensures efficient localization of Hof1, whereas ring integrity is conferred by the Src homology 3 (SH3) domain. Up to several hours after site selection, actin ring contraction leads to membrane invagination and subsequent cytokinesis. Simultaneously, a septum forms between the adjacent hyphal compartments, which do not separate. During evolution, A. gossypii lost the homologs of two enzymes essential for cell separation in Saccharomyces cerevisiae.
C1 [Kaufmann, Andreas; Philippsen, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, Klingelbergsrasse 50-70, CH-4056 Basel, Switzerland.
EM peter.philippsen@unibas.ch
FU European UnionEuropean Union (EU) [36076]
FX This work was supported by the University of Basel and was partly
   supported by the European Union Marie Curie Research Training Networks
   (RTN) PENELOPE project 36076.; We thank Hans-Peter Schmitz for his
   advice and suggestion to investigate the function of Hof1. We also thank
   Michal Kohli for critically reading the manuscript, Dominic Hoepfner for
   providing pUC19NATPS, Hans-Peter Helfer for sharing unpublished data on
   AgMyo1, AgCdc3, and AgCdc10; and Christian Bohmer for providing helpful
   discussions on the role of UmCdc15.
CR AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Bahler J, 1998, J CELL BIOL, V143, P1603, DOI 10.1083/jcb.143.6.1603
   Balasubramanian MK, 2004, CURR BIOL, V14, pR806, DOI 10.1016/j.cub.2004.09.022
   Bauer Y, 2004, MOL BIOL CELL, V15, P4622, DOI 10.1091/mbc.E04-02-0104
   Bi E, 1998, J CELL BIOL, V142, P1301, DOI 10.1083/jcb.142.5.1301
   Bi E, 2001, CELL STRUCT FUNCT, V26, P529, DOI 10.1247/csf.26.529
   Blondel M, 2005, EMBO J, V24, P1440, DOI 10.1038/sj.emboj.7600627
   Bohmer C, 2008, J CELL SCI, V121, P143, DOI 10.1242/jcs.014449
   Cappellaro C, 1998, J BACTERIOL, V180, P5030, DOI 10.1128/JB.180.19.5030-5037.1998
   Caviston JP, 2003, MOL BIOL CELL, V14, P4051, DOI 10.1091/mbc.E03-04-0247
   Chang F, 1996, J CELL SCI, V109, P131
   CHANT J, 1995, J CELL BIOL, V129, P751, DOI 10.1083/jcb.129.3.751
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Dobbelaere J, 2004, SCIENCE, V305, P393, DOI 10.1126/science.1099892
   FANKHAUSER C, 1995, CELL, V82, P435, DOI 10.1016/0092-8674(95)90432-8
   FUJIWARA K, 1976, J CELL BIOL, V71, P848, DOI 10.1083/jcb.71.3.848
   GIETZ RD, 1995, YEAST, V11, P355, DOI 10.1002/yea.320110408
   Gladfelter AS, 2005, J CELL SCI, V118, P1617, DOI 10.1242/jcs.02286
   Gladfelter AS, 2001, CURR OPIN MICROBIOL, V4, P681, DOI 10.1016/S1369-5274(01)00269-7
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Gladfelter AS, 2006, NAT REV MICROBIOL, V4, P223, DOI 10.1038/nrmicro1345
   Guertin DA, 2002, MICROBIOL MOL BIOL R, V66, P155, DOI 10.1128/MMBR.66.2.155-178.2002
   GULL K, 1978, DEV MYCOLOGY, P78
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   HARRIS SD, 1994, GENETICS, V136, P517
   HARTWELL LH, 1971, EXP CELL RES, V69, P265, DOI 10.1016/0014-4827(71)90223-0
   Helfer H, 2006, MOL BIOL CELL, V17, P4494, DOI 10.1091/mbc.E06-03-0215
   Hong EL, 2008, NUCLEIC ACIDS RES, V36, pD577, DOI 10.1093/nar/gkm909
   Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063
   Itoh T, 2005, DEV CELL, V9, P791, DOI 10.1016/j.devcel.2005.11.005
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   Kohli M, 2008, J CELL SCI, V121, P1065, DOI [10.1242/jcs.015933, 10.1242/jcs.033852]
   Korinek WS, 2000, CURR BIOL, V10, P947, DOI 10.1016/S0960-9822(00)00626-6
   Kovacech B, 1996, MOL CELL BIOL, V16, P3264
   KURANDA MJ, 1991, J BIOL CHEM, V266, P19758
   Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404
   Lippincott J, 2000, MICROSC RES TECHNIQ, V49, P168, DOI 10.1002/(SICI)1097-0029(20000415)49:2<168::AID-JEMT9>3.0.CO;2-T
   Lippincott J, 1998, J CELL BIOL, V143, P1947, DOI 10.1083/jcb.143.7.1947
   Lippincott J, 1998, J CELL BIOL, V140, P355, DOI 10.1083/jcb.140.2.355
   Longtine MS, 1996, CURR OPIN CELL BIOL, V8, P106, DOI 10.1016/S0955-0674(96)80054-8
   LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162
   Momany M, 2001, GENETICS, V157, P969
   Pelham RJ, 2002, NATURE, V419, P82, DOI 10.1038/nature00999
   Rasmussen CG, 2007, EUKARYOT CELL, V6, P1097, DOI 10.1128/EC.00050-07
   ROGERS S, 1986, SCIENCE, V234, P364, DOI 10.1126/science.2876518
   Sambrook J., 2001, MOL CLONING LAB MANU, V1
   Schmitz HP, 2006, MOL BIOL CELL, V17, P130
   Sohrmann M, 1996, GENE DEV, V10, P2707, DOI 10.1101/gad.10.21.2707
   STEINER S, 1995, GENETICS, V140, P973
   Sudbery PE, 2001, MOL MICROBIOL, V41, P19, DOI 10.1046/j.1365-2958.2001.02459.x
   Tsujita K, 2006, J CELL BIOL, V172, P269, DOI 10.1083/jcb.200508091
   Vallen EA, 2000, MOL BIOL CELL, V11, P593, DOI 10.1091/mbc.11.2.593
   Versele M, 2005, TRENDS CELL BIOL, V15, P414, DOI 10.1016/j.tcb.2005.06.007
   Versele M, 2004, MOL BIOL CELL, V15, P4568, DOI 10.1091/mbc.E04-04-0330
   Versele M, 2004, J CELL BIOL, V164, P701, DOI 10.1083/jcb.200312070
   Wachtler V, 2006, MOL BIOL CELL, V17, P3254, DOI 10.1091/mbc.E05-11-1086
   Walther A, 2004, J CELL SCI, V117, P4947, DOI 10.1242/jcs.01377
   Walther A, 2003, FUNGAL GENET BIOL, V40, P187, DOI 10.1016/j.fgb.2003.08.005
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Wendland J, 2003, EMBO REP, V4, P200, DOI 10.1038/sj.embor.embor727
   Wendland J, 2002, FUNGAL GENET BIOL, V37, P81, DOI 10.1016/S1087-1845(02)00034-8
   Wendland J, 2001, GENETICS, V157, P601
   Westfall PJ, 2002, MOL BIOL CELL, V13, P110, DOI 10.1091/mbc.01-06-0312
   WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107
   Wolkow TD, 1996, J CELL SCI, V109, P2179
   WRIGHT MC, 1991, GENE, V109, P99, DOI 10.1016/0378-1119(91)90593-Z
   Wu JQ, 2006, J CELL BIOL, V174, P391, DOI 10.1083/jcb.200602032
   Wu JQ, 2003, DEV CELL, V5, P723, DOI 10.1016/S1534-5807(03)00324-1
   Yang S, 1999, MOL BIOL CELL, V10, P2265, DOI 10.1091/mbc.10.7.2265
NR 70
TC 26
Z9 26
U1 0
U2 2
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0270-7306
EI 1098-5549
J9 MOL CELL BIOL
JI Mol. Cell. Biol.
PD FEB 1
PY 2009
VL 29
IS 3
BP 771
EP 783
DI 10.1128/MCB.01150-08
PG 13
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 396RP
UT WOS:000262609100014
PM 19029253
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Wagner, S
   Sorg, I
   Degiacomi, M
   Journet, L
   Dal Peraro, M
   Cornelis, GR
AF Wagner, Stefanie
   Sorg, Isabel
   Degiacomi, Matteo
   Journet, Laure
   Dal Peraro, Matteo
   Cornelis, Guy R.
TI The helical content of the YscP molecular ruler determines the length of
   the Yersinia injectisome
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID FLAGELLAR HOOK-LENGTH; ENTEROPATHOGENIC ESCHERICHIA-COLI; SECRETION
   SUBSTRATE-SPECIFICITY; III SECRETION; SALMONELLA-TYPHIMURIUM; NEEDLE
   COMPLEX; SECONDARY-STRUCTURE; PROTEIN SECRETION; STRUCTURAL INSIGHTS;
   EUKARYOTIC CELLS
AB The length of the Yersinia injectisome needle is determined by the protein YscP, which could act as a molecular ruler. The analysis of the correlation between the size of YscP and the needle length in seven wild-type strains of Yersinia enterocolitica reinforced this hypothesis but hinted that the secondary structure of YscP might influence needle length. Hence, 11 variants of YscP(515) were generated by multiple Pro or Gly substitutions. The needle length changed in inverse function of the helical content, indicating that not only the number of residues but also their structure controls length. Taking the secondary motifs into account, Pro/Gly-variants were subjected to in silico modelling to simulate the extension of YscP upon needle growth. The calculated lengths when the helical content is preserved correlated strikingly with the measured needle length, with a constant difference of similar to 29 nm, which corresponds approximately to the size of the basal body. These data support the ruler model and show that the functional ruler has a helical structure.
C1 [Wagner, Stefanie; Sorg, Isabel; Journet, Laure; Cornelis, Guy R.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Degiacomi, Matteo; Dal Peraro, Matteo] EPF Lausanne, Sch Life Sci, Inst Bioengn, Lab Biomol Modeling, Lausanne, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM cornelis@unibas.ch
RI Degiacomi, Matteo/M-4342-2017; Wagner, Stefanie/A-5756-2011
OI Degiacomi, Matteo/0000-0003-4672-471X; Journet,
   Laure/0000-0002-5847-2962; Wagner, Stefanie/0000-0002-3873-7011
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [310000-113333/1]
FX We thank Cecile Paroz for sequencing the wild-type yscP genes, Yaniv
   Cohen for generating the lcrV null mutant, Gianni Morson for assistance
   in electron microscopy and G. Wauters (Louvain) for the gift of the
   wild-type Y. enterocolitica strains. This work was supported by the
   Swiss National Science Foundation (Grant 310000-113333/1 to G. C.).
CR Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x
   Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x
   Chevance FFV, 2008, NAT REV MICROBIOL, V6, P455, DOI 10.1038/nrmicro1887
   Chou P Y, 1978, Adv Enzymol Relat Areas Mol Biol, V47, P45
   Cornelis GR, 2006, CURR OPIN MICROBIOL, V9, P201, DOI 10.1016/j.mib.2006.01.002
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   Crepin VF, 2005, J BACTERIOL, V187, P2881, DOI 10.1128/JB.187.8.2881-2889.2005
   Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x
   Ferris HU, 2006, TRENDS MICROBIOL, V14, P519, DOI 10.1016/j.tim.2006.10.006
   Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200
   Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272
   Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932
   HIRANO T, 1994, J BACTERIOL, V176, P5439, DOI 10.1128/JB.176.17.5439-5449.1994
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Izrailev S., 1998, LECT NOTES COMPUTATI, V4, P39
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   KATSURA I, 1987, NATURE, V327, P73, DOI 10.1038/327073a0
   KATSURA I, 1984, CELL, V39, P691, DOI 10.1016/0092-8674(84)90476-8
   Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997
   LEVIN JM, 1986, FEBS LETT, V205, P303, DOI 10.1016/0014-5793(86)80917-6
   Li CM, 2002, EMBO J, V21, P1909, DOI 10.1093/emboj/21.8.1909
   Lorenz C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000094
   MacKerell Jr AD, 1998, ENCY COMPUTATIONAL C, P271
   Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   Marshall WF, 2004, ANNU REV CELL DEV BI, V20, P677, DOI 10.1146/annurev.cellbio.20.012103.094437
   Minamino T, 1999, MOL MICROBIOL, V34, P295, DOI 10.1046/j.1365-2958.1999.01597.x
   Minamino T, 2004, J MOL BIOL, V341, P491, DOI 10.1016/j.jmb.2004.06.012
   Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200
   Moriya N, 2006, J MOL BIOL, V359, P466, DOI 10.1016/j.jmb.2006.03.025
   Mueller CA, 2008, MOL MICROBIOL, V68, P1085, DOI 10.1111/j.1365-2958.2008.06237.x
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Ogino T, 2006, J BACTERIOL, V188, P2801, DOI 10.1128/JB.188.8.2801-2811.2006
   Pedulla ML, 2003, CELL, V113, P171, DOI 10.1016/S0092-8674(03)00233-2
   Riordan KE, 2008, J BACTERIOL, V190, P6204, DOI 10.1128/JB.00467-08
   Riordan KE, 2008, MOL MICROBIOL, V68, P1485, DOI 10.1111/j.1365-2958.2008.06247.x
   Shibata S, 2007, MOL MICROBIOL, V64, P1404, DOI 10.1111/j.1365-2958.2007.05750.x
   Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731
   Sorg JA, 2006, P NATL ACAD SCI USA, V103, P16490, DOI 10.1073/pnas.0605974103
   Stainier I, 2000, MOL MICROBIOL, V37, P1005, DOI 10.1046/j.1365-2958.2000.02026.x
   Sukhan A, 2001, J BACTERIOL, V183, P1159, DOI 10.1128/JB.183.4.1159-1167.2001
   Tampakaki AP, 2004, CELL MICROBIOL, V6, P805, DOI 10.1111/j.1462-5822.2004.00432.x
   Van Gijsegem F, 2000, MOL MICROBIOL, V36, P249, DOI 10.1046/j.1365-2958.2000.01851.x
   Waters RC, 2007, PROTEIN SCI, V16, P769, DOI 10.1110/ps.072785407
   Williams AW, 1996, J BACTERIOL, V178, P2960, DOI 10.1128/jb.178.10.2960-2970.1996
   Yip CK, 2006, TRENDS BIOCHEM SCI, V31, P223, DOI 10.1016/j.tibs.2006.02.005
   Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832
NR 53
TC 32
Z9 32
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0950-382X
EI 1365-2958
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD FEB
PY 2009
VL 71
IS 3
BP 692
EP 701
DI 10.1111/j.1365-2958.2008.06556.x
PG 10
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 394VH
UT WOS:000262478800011
PM 19055526
OA Bronze
DA 2021-01-25
ER

PT J
AU Kleaveland, B
   Zheng, XJ
   Liu, JJ
   Blum, Y
   Tung, JJ
   Zou, ZY
   Chen, M
   Guo, LL
   Lu, MM
   Zhou, D
   Kitajewski, J
   Affolter, M
   Ginsberg, MH
   Kahn, ML
AF Kleaveland, Benjamin
   Zheng, Xiangjian
   Liu, Jian J.
   Blum, Yannick
   Tung, Jennifer J.
   Zou, Zhiying
   Chen, Mei
   Guo, Lili
   Lu, Min-min
   Zhou, Diane
   Kitajewski, Jan
   Affolter, Markus
   Ginsberg, Mark H.
   Kahn, Mark L.
TI Regulation of cardiovascular development and integrity by the heart of
   glass-cerebral cavernous malformation protein pathway
SO NATURE MEDICINE
LA English
DT Article
ID VASCULAR DEVELOPMENT; CONCENTRIC GROWTH; GENE; MUTATIONS; KRIT1; CCM1;
   MORPHOGENESIS; PATHOGENESIS
AB Cerebral cavernous malformations (CCMs) are human vascular malformations caused by mutations in three genes of unknown function: KRIT1, CCM2 and PDCD10. Here we show that the heart of glass (HEG1) receptor, which in zebrafish has been linked to ccm gene function, is selectively expressed in endothelial cells. Heg1(-/-) mice showed defective integrity of the heart, blood vessels and lymphatic vessels. Heg1(-/-); Ccm2(lacZ/+) and Ccm2(lacZ/lacZ) mice had more severe cardiovascular defects and died early in development owing to a failure of nascent endothelial cells to associate into patent vessels. This endothelial cell phenotype was shared by zebrafish embryos deficient in heg, krit1 or ccm2 and reproduced in CCM2-deficient human endothelial cells in vitro. Defects in the hearts of zebrafish lacking heg or ccm2, in the aortas of early mouse embryos lacking CCM2 and in the lymphatic vessels of neonatal mice lacking HEG1 were associated with abnormal endothelial cell junctions like those observed in human CCMs. Biochemical and cellular imaging analyses identified a cell-autonomous pathway in which the HEG1 receptor couples to KRIT1 at these cell junctions. This study identifies HEG1-CCM protein signaling as a crucial regulator of heart and vessel formation and integrity.
C1 [Kleaveland, Benjamin; Zheng, Xiangjian; Zou, Zhiying; Chen, Mei; Guo, Lili; Lu, Min-min; Zhou, Diane; Kahn, Mark L.] Univ Penn, Dept Med, Philadelphia, PA 19104 USA.
   [Kleaveland, Benjamin; Zheng, Xiangjian; Zou, Zhiying; Chen, Mei; Guo, Lili; Lu, Min-min; Zhou, Diane; Kahn, Mark L.] Univ Penn, Cardiovasc Inst, Philadelphia, PA 19104 USA.
   [Liu, Jian J.; Ginsberg, Mark H.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA.
   [Blum, Yannick; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kitajewski, Jan] Columbia Univ, Med Ctr, Inst Canc Genet & Herbert Irving, Dept Pathol, New York, NY 10032 USA.
   [Kitajewski, Jan] Columbia Univ, Med Ctr, Inst Canc Genet & Herbert Irving, Dept Obstet & Gynaecol, New York, NY 10032 USA.
RP Kahn, ML (corresponding author), Univ Penn, Dept Med, 421 Curie Blvd, Philadelphia, PA 19104 USA.
EM markkahn@mail.med.upenn.edu
RI Liu, Jay/D-4711-2011
OI Zheng, Xiangjian/0000-0001-6277-5168; Affolter,
   Markus/0000-0002-5171-0016
FU Swiss National Science Foundation,Swiss National Science Foundation
   (SNSF); European CommunityEuropean Community (EC); US National
   Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [T32 HL07439, T32
   HL07971, HL078784, AR27214, HL62454, HL075380, HL095326]; NATIONAL
   HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Heart Lung & Blood Institute (NHLBI) [T32HL007971, R01HL094326,
   P01HL078784, P01HL078784, R01HL062454, R01HL062454, P01HL078784,
   T32HL007971, T32HL007439, P01HL078784, P01HL078784, P01HL078784,
   R01HL094326, R01HL062454, T32HL007439, T32HL007439, P01HL078784,
   P01HL078784, P01HL078784, T32HL007439, R01HL094326, P01HL078784,
   P01HL078784, P01HL078784, T32HL007971, T32HL007439, T32HL007439,
   R01HL094326, T32HL007439, T32HL007439, P01HL078784, T32HL007971,
   P01HL078784, R01HL062454, T32HL007439, P01HL078784, P01HL078784,
   T32HL007971, P01HL078784, P01HL078784, P01HL078784, P01HL078784,
   T32HL007971, T32HL007439, T32HL007439, P01HL078784, P01HL078784,
   T32HL007439, T32HL007439, R01HL062454, P01HL078784, P01HL078784,
   T32HL007439, P01HL078784, T32HL007439, P01HL078784, T32HL007971,
   T32HL007439, P01HL078784, T32HL007439, T32HL007439, P01HL078784,
   P01HL078784, P01HL078784, T32HL007971, P01HL078784, T32HL007439,
   R01HL102138, R01HL102138, T32HL007439, T32HL007439, P01HL078784,
   P01HL078784, P01HL078784, T32HL007439, T32HL007439, T32HL007971,
   P01HL078784, P01HL078784, R01HL102138, T32HL007439, P01HL078784,
   R01HL102138, T32HL007439, P01HL078784, P01HL078784, T32HL007971,
   T32HL007971, P01HL078784, T32HL007971, R01HL062454, R01HL062454,
   P01HL078784, R01HL102138, P01HL078784, R01HL062454, P01HL078784,
   T32HL007971, P01HL078784, T32HL007971, P01HL078784, P01HL078784,
   T32HL007971, P01HL078784, P01HL078784, R01HL094326, T32HL007971,
   P01HL078784, P01HL078784, T32HL007439, P01HL078784, R01HL094326,
   R01HL094326, P01HL078784, P01HL078784, R01HL062454, R01HL094326,
   P01HL078784, T32HL007439, P01HL078784, P01HL078784, R01HL062454,
   P01HL078784, P01HL078784, P01HL078784, T32HL007439, P01HL078784,
   P01HL078784, P01HL078784, P01HL078784, T32HL007439, T32HL007971,
   T32HL007439, P01HL078784, T32HL007971, P01HL078784, T32HL007439,
   P01HL078784, T32HL007439, P01HL078784, R01HL062454, P01HL078784,
   T32HL007439, P01HL078784, P01HL078784, T32HL007439, P01HL078784,
   R01HL094326, T32HL007439, T32HL007439, P01HL078784, T32HL007971,
   P01HL078784] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Arthritis & Musculoskeletal & Skin Diseases
   (NIAMS) [R37AR027214, R01AR027214, R37AR027214, R01AR027214,
   R01AR027214, R01AR027214, R37AR027214, R37AR027214, R37AR027214,
   R01AR027214, R01AR027214, R01AR027214, R37AR027214, R37AR027214,
   R37AR027214, R01AR027214, R01AR027214, R37AR027214, R01AR027214,
   R01AR027214, R01AR027214, R01AR027214, R37AR027214, R01AR027214,
   R01AR027214, R01AR027214, R37AR027214] Funding Source: NIH RePORTER
FX We thank C. Bertozzi, C. Chen, A. Granger, J. Lee, D. Li, P. Mericko, A.
   Schmaier, E. Sebzda, N. Shanbhag, S. Sweeney and K. Whitehead for
   valuable insights; M. Pack and J. He for assistance with zebrafish
   studies; R. Meade for preparation of the electron microscopy samples;
   and T. Branson for animal husbandry. This work was supported by the
   Swiss National Science Foundation, a Network of Excellence grant from
   the European Community ( M. A.) and the US National Institutes of Health
   grants T32 HL07439 ( to B. K.), T32 HL07971 ( to X. Z.), HL078784 and
   AR27214 ( to M. G.), HL62454 ( to J. K.) and HL075380 and HL095326 ( to
   M. L. K.).
CR Amsterdam A, 2004, METHOD CELL BIOL, V77, P3
   Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970
   Bergametti F, 2005, AM J HUM GENET, V76, P42, DOI 10.1086/426952
   Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038
   Clatterbuck RE, 2001, J NEUROL NEUROSUR PS, V71, P188, DOI 10.1136/jnnp.71.2.188
   Denier C, 2004, AM J HUM GENET, V74, P326, DOI 10.1086/381718
   Eerola I, 2000, HUM MOL GENET, V9, P1351, DOI 10.1093/hmg/9.9.1351
   FOLKMAN J, 1980, NATURE, V288, P551, DOI 10.1038/288551a0
   Glading A, 2007, J CELL BIOL, V179, P247, DOI 10.1083/jcb.200705175
   Hogan BM, 2008, HUM MOL GENET, V17, P2424, DOI 10.1093/hmg/ddn142
   Jin SW, 2007, DEV BIOL, V307, P29, DOI 10.1016/j.ydbio.2007.03.526
   Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Lim CJ, 2007, NAT CELL BIOL, V9, P415, DOI 10.1038/ncb1561
   Liquori CL, 2003, AM J HUM GENET, V73, P1459, DOI 10.1086/380314
   Mably JD, 2003, CURR BIOL, V13, P2138, DOI 10.1016/S0960-9822(03)00911-4
   Mably JD, 2006, DEVELOPMENT, V133, P3139, DOI 10.1242/dev.02469
   Nakatsu MN, 2003, MICROVASC RES, V66, P102, DOI 10.1016/S0026-2862(03)00045-1
   Pfaff M, 1998, J BIOL CHEM, V273, P6104, DOI 10.1074/jbc.273.11.6104
   Plummer NW, 2006, MAMM GENOME, V17, P119, DOI 10.1007/s00335-005-0098-8
   Revencu N, 2006, J MED GENET, V43, P716, DOI 10.1136/jmg.2006.041079
   RIGAMONTI D, 1988, NEW ENGL J MED, V319, P343, DOI 10.1056/NEJM198808113190605
   Sahoo T, 1999, HUM MOL GENET, V8, P2325, DOI 10.1093/hmg/8.12.2325
   Sebzda E, 2006, DEV CELL, V11, P349, DOI 10.1016/j.devcel.2006.07.007
   Tu J, 2005, J NEUROSURG, V103, P903, DOI 10.3171/jns.2005.103.5.0903
   Voss K, 2007, NEUROGENETICS, V8, P249, DOI 10.1007/s10048-007-0098-9
   WEINSTEIN BM, 1995, NAT MED, V1, P1143, DOI 10.1038/nm1195-1143
   Whitehead KJ, 2004, DEVELOPMENT, V131, P1437, DOI 10.1242/dev.01036
   Wong JH, 2000, NEUROSURGERY, V46, P1454, DOI 10.1097/00006123-200006000-00027
   Zawistowski JS, 2005, HUM MOL GENET, V14, P2521, DOI 10.1093/hmg/ddi256
   Zhang J, 2007, NEUROSURGERY, V60, P353, DOI 10.1227/01.NEU.0000249268.11074.83
NR 31
TC 145
Z9 152
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1078-8956
EI 1546-170X
J9 NAT MED
JI Nat. Med.
PD FEB
PY 2009
VL 15
IS 2
BP 169
EP 176
DI 10.1038/nm.1918
PG 8
WC Biochemistry & Molecular Biology; Cell Biology; Medicine, Research &
   Experimental
SC Biochemistry & Molecular Biology; Cell Biology; Research & Experimental
   Medicine
GA 403ZB
UT WOS:000263119400019
PM 19151727
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Pena, JTG
   Sohn-Lee, C
   Rouhanifard, SH
   Ludwig, J
   Hafner, M
   Mihailovic, A
   Lim, C
   Holoch, D
   Berninger, P
   Zavolan, M
   Tuschl, T
AF Pena, John T. G.
   Sohn-Lee, Cherin
   Rouhanifard, Sara H.
   Ludwig, Janos
   Hafner, Markus
   Mihailovic, Aleksandra
   Lim, Cindy
   Holoch, Daniel
   Berninger, Philipp
   Zavolan, Mihaela
   Tuschl, Thomas
TI miRNA in situ hybridization in formaldehyde and EDC-fixed tissues
SO NATURE METHODS
LA English
DT Article
ID MICRORNA EXPRESSION; RNA; PROBES; THERMODYNAMICS; PRECURSOR; DISTINCT;
   SYSTEM; DNA
AB MicroRNAs are small regulatory RNAs with many biological functions and disease associations. We showed that in situ hybridization (ISH) using conventional formaldehyde fixation results in substantial microRNA loss from mouse tissue sections, which can be prevented by fixation with 1-ethyl-3-(3-dimethyl-aminopropyl) carbodiimide that irreversibly immobilizes the microRNA at its 5' phosphate. We determined optimal hybridization parameters for 130 locked nucleic acid probes by recording nucleic acid melting temperature during ISH.
C1 [Pena, John T. G.; Sohn-Lee, Cherin; Rouhanifard, Sara H.; Ludwig, Janos; Hafner, Markus; Mihailovic, Aleksandra; Lim, Cindy; Holoch, Daniel; Tuschl, Thomas] Rockefeller Univ, Lab RNA Mol Biol, Howard Hughes Med Inst, New York, NY 10065 USA.
   [Pena, John T. G.] Cornell Univ, Weill Med Coll, New York, NY 10021 USA.
   [Berninger, Philipp; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Berninger, Philipp; Zavolan, Mihaela] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Tuschl, T (corresponding author), Rockefeller Univ, Lab RNA Mol Biol, Howard Hughes Med Inst, 1230 York Ave,Box 186, New York, NY 10065 USA.
EM ttuschl@rockefeller.edu
RI Zavolan, Mihaela/S-3888-2016; Hafner, Markus/O-7100-2018; Ludwig,
   Janos/I-3544-2013
OI Hafner, Markus/0000-0002-4336-6518; Zavolan,
   Mihaela/0000-0002-8832-2041; Rouhanifard, Sara/0000-0002-6991-4877;
   Pena, John/0000-0001-9309-8198
FU Kirschstein-National Research Service AwardUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USA; US
   National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [GM073047,
   EY18082-01A2, MH080442]; NATIONAL CANCER INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [R01CA159227, R01CA159227,
   R01CA159227, R01CA159227, R01CA159227] Funding Source: NIH RePORTER;
   NATIONAL EYE INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Eye
   Institute (NEI) [F31EY018082, F31EY018082] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, T32GM007739, T32GM007739,
   T32GM007739, T32GM007739, P01GM073047, T32GM007739, P01GM073047,
   P01GM073047, T32GM007739, T32GM007739, T32GM007739, T32GM007739,
   T32GM007739, P01GM073047, T32GM007739, T32GM007739, P01GM073047,
   T32GM007739, T32GM007739, T32GM007739, T32GM007739, T32GM007739,
   T32GM007739, P01GM073047, T32GM007739, P01GM073047, T32GM007739,
   P01GM073047, T32GM007739, P01GM073047, T32GM007739, P01GM073047,
   T32GM007739, T32GM007739, T32GM007739, T32GM007739, T32GM007739,
   T32GM007739, T32GM007739, T32GM007739, T32GM007739, P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, T32GM007739, T32GM007739,
   T32GM007739, P01GM073047, P01GM073047, P01GM073047, T32GM007739,
   T32GM007739, T32GM007739, T32GM007739, T32GM007739] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Mental Health (NIMH) [R01MH080442, R01MH080442,
   R01MH080442, R01MH080442, R01MH080442, R01MH080442] Funding Source: NIH
   RePORTER
FX We thank members of the Memorial Sloan Kettering Sequencing Core for 454
   sequencing; S. Juranek, N. Renwick, J. McManus, H. Yamahachi and T.
   Farazi for comments on the manuscript; L. Fleming for the technical
   assistance; and C. D. Gilbert for his guidance. T. T. was supported by
   an Irma T. Hirschl Career Scientist Award, J. T. G. P. supported by a
   Kirschstein-National Research Service Award fellowship and the project
   was partly funded by US National Institutes of Health grants GM073047,
   EY18082-01A2 and MH080442.
CR Allawi HT, 1997, BIOCHEMISTRY-US, V36, P10581, DOI 10.1021/bi962590c
   Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108
   Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629
   Feldman M Y, 1973, Prog Nucleic Acid Res Mol Biol, V13, P1, DOI 10.1016/S0079-6603(08)60099-9
   Kaur H, 2008, BIOCHEMISTRY-US, V47, P1218, DOI 10.1021/bi700996z
   Kloosterman WP, 2006, NAT METHODS, V3, P27, DOI 10.1038/NMETH843
   Kosik KS, 2006, NAT REV NEUROSCI, V7, P911, DOI 10.1038/nrn2037
   Kye MJ, 2007, RNA, V13, P1224, DOI 10.1261/rna.480407
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Mansfield JH, 2004, NAT GENET, V36, P1079, DOI 10.1038/ng1421
   Masuda N, 1999, NUCLEIC ACIDS RES, V27, P4436, DOI 10.1093/nar/27.22.4436
   Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506
   Nuovo GJ, 2008, METHODS, V44, P39, DOI 10.1016/j.ymeth.2007.10.008
   Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112
   Ryan D, 2006, MOL VIS, V12, P1175
   Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823
   Sempere LF, 2007, CANCER RES, V67, P11612, DOI 10.1158/0008-5472.CAN-07-5019
   Silahtaroglu AN, 2007, NAT PROTOC, V2, P2520, DOI 10.1038/nprot.2007.313
   Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105
   Thompson RC, 2007, METHODS, V43, P153, DOI 10.1016/j.ymeth.2007.04.008
   Tymianski M, 1997, CELL CALCIUM, V21, P175, DOI 10.1016/S0143-4160(97)90042-7
   Wang WX, 2008, J NEUROSCI, V28, P1213, DOI 10.1523/JNEUROSCI.5065-07.2008
NR 22
TC 207
Z9 208
U1 2
U2 38
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1548-7091
EI 1548-7105
J9 NAT METHODS
JI Nat. Methods
PD FEB
PY 2009
VL 6
IS 2
BP 139
EP 141
DI 10.1038/NMETH.1294
PG 3
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 405CA
UT WOS:000263198500013
PM 19137005
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Klostermeier, D
   Rudolph, MG
AF Klostermeier, Dagmar
   Rudolph, Markus G.
TI A novel dimerization motif in the C-terminal domain of the Thermus
   thermophilus DEAD box helicase Hera confers substantial flexibility
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID RNASE-P PROTEIN; CRYSTAL-STRUCTURE; DIFFRACTION DATA; GENERAL RNA;
   GROUP-I; BINDING; ATP; YXIN; COMPLEX; RECOGNITION
AB DEAD box helicases are involved in nearly all aspects of RNA metabolism. They share a common helicase core, and may comprise additional domains that contribute to RNA binding. The Thermus thermophilus helicase Hera is the first dimeric DEAD box helicase. Crystal structures of Hera fragments reveal a bipartite C-terminal domain with a novel dimerization motif and an RNA-binding module. We provide a first glimpse on the additional RNA-binding module outside the Hera helicase core. The dimerization and RNA-binding domains are connected to the C-terminal RecA domain by a hinge region that confers exceptional flexibility onto the helicase, allowing for different juxtapositions of the RecA-domains in the dimer. Combination of the previously determined N-terminal Hera structure with the C-terminal Hera structures allows generation of a model for the entire Hera dimer, where two helicase cores can work in conjunction on large RNA substrates.
C1 [Klostermeier, Dagmar] Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
   [Rudolph, Markus G.] Univ Gottingen, Dept Mol Struct Biol, D-37077 Gottingen, Germany.
RP Klostermeier, D (corresponding author), Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@unibas.ch
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG);
   VolkswagenStiftungVolkswagen; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF)
FX Deutsche Forschungsgemeinschaft ( to M. G. R.); VolkswagenStiftung and
   the Swiss National Science Foundation ( to D. K.). Funding for open
   access charge: Swiss National Science Foundation.
CR Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Banroques J, 2008, MOL CELL BIOL, V28, P3359, DOI 10.1128/MCB.01555-07
   Blanc E, 2004, ACTA CRYSTALLOGR D, V60, P2210, DOI 10.1107/S0907444904016427
   Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006
   BRUNGER AT, 1992, NATURE, V355, P472, DOI 10.1038/355472a0
   Caruthers JM, 2000, P NATL ACAD SCI USA, V97, P13080, DOI 10.1073/pnas.97.24.13080
   Cheng ZH, 2005, RNA, V11, P1258, DOI 10.1261/rna.2920905
   Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019
   Diges CM, 2001, EMBO J, V20, P5503, DOI 10.1093/emboj/20.19.5503
   Dumont S, 2006, NATURE, V439, P105, DOI 10.1038/nature04331
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Esnouf RM, 1997, J MOL GRAPH MODEL, V15, P132, DOI 10.1016/S1093-3263(97)00021-1
   Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472
   Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083
   Hogbom M, 2007, J MOL BIOL, V372, P150, DOI 10.1016/j.jmb.2007.06.050
   Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101
   Jaenicke R, 1996, ADV PROTEIN CHEM, V48, P181
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   Karginov FV, 2005, J BIOL CHEM, V280, P35499, DOI 10.1074/jbc.M506815200
   Kazantsev AV, 2003, P NATL ACAD SCI USA, V100, P7497, DOI 10.1073/pnas.0932597100
   Kim JL, 1998, STRUCTURE, V6, P89, DOI 10.1016/S0969-2126(98)00010-0
   Koonin Eugene V., 1992, Protein Sequences and Data Analysis, V5, P43
   Kossen K, 2002, J MOL BIOL, V324, P625, DOI 10.1016/S0022-2836(02)01140-3
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648
   Linden MH, 2008, NUCLEIC ACIDS RES, V36, P5800, DOI 10.1093/nar/gkn581
   Locatelli GA, 2002, BIOCHEMISTRY-US, V41, P10332, DOI 10.1021/bi026082g
   McCoy AJ, 2007, ACTA CRYSTALLOGR D, V63, P32, DOI 10.1107/S0907444906045975
   MERRITT EA, 1994, ACTA CRYSTALLOGR D, V50, P869, DOI 10.1107/S0907444994006396
   Mohr G, 2008, J MOL BIOL, V375, P1344, DOI 10.1016/j.jmb.2007.11.041
   Mohr S, 2006, P NATL ACAD SCI USA, V103, P3569, DOI 10.1073/pnas.0600332103
   Morlang S, 1999, J MOL BIOL, V294, P795, DOI 10.1006/jmbi.1999.3282
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Rudolph MG, 2006, J MOL BIOL, V361, P731, DOI 10.1016/j.jmb.2006.06.065
   Rudolph MG, 2003, ACTA CRYSTALLOGR D, V59, P290, DOI 10.1107/S0907444902021704
   RUDOLPH MG, 2008, ACTA CRYS F IN PRESS
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Serebrov V, 2004, NATURE, V430, P476, DOI 10.1038/nature02704
   SHERIFF S, 1987, J MOL BIOL, V197, P273, DOI 10.1016/0022-2836(87)90124-0
   Shi H, 2004, P NATL ACAD SCI USA, V101, P17628, DOI 10.1073/pnas.0408172101
   STORY RM, 1992, NATURE, V355, P374, DOI 10.1038/355374a0
   Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465
   STORY RM, 1992, NATURE, V355, P318, DOI 10.1038/355318a0
   Talavera MA, 2006, J MOL BIOL, V355, P697, DOI 10.1016/j.jmb.2005.10.058
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   Tsai JY, 2006, PROTEINS, V62, P1138, DOI 10.1002/prot.20864
   Tsu CA, 2001, RNA, V7, P702, DOI 10.1017/S1355838201010135
   Wang S, 2008, BIOPHYS J, V94, pL1, DOI 10.1529/biophysj.107.120709
   Wang SY, 2006, RNA, V12, P959, DOI 10.1261/rna.5906
   Yao NH, 1997, NAT STRUCT BIOL, V4, P463, DOI 10.1038/nsb0697-463
   Zhao R, 2004, STRUCTURE, V12, P1373, DOI 10.1016/j.str.2004.06.006
   Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28
NR 53
TC 36
Z9 37
U1 0
U2 4
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD FEB
PY 2009
VL 37
IS 2
BP 421
EP 430
DI 10.1093/nar/gkn947
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 401SW
UT WOS:000262963400019
PM 19050012
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Xiao, SH
   Keiser, J
   Xue, J
   Tanner, M
   Morson, G
   Utzinger, J
AF Xiao, Shu-Hua
   Keiser, Jennifer
   Xue, Jian
   Tanner, Marcel
   Morson, Gianni
   Utzinger, Juerg
TI Effect of single-dose oral artemether and tribendimidine on the tegument
   of adult Clonorchis sinensis in rats
SO PARASITOLOGY RESEARCH
LA English
DT Article
ID SCHISTOSOMA-MANSONI; FASCIOLA-HEPATICA; IN-VIVO; PRAZIQUANTEL;
   ARTEMISININ; TREMATODIASIS; CHEMOTHERAPY; ARTESUNATE; INVITRO; AGENT
AB The tegument of trematodes plays a key role in nutrient absorption, exerts secretory functions, protects the parasite against the immune system of the host, and is a target for anti-trematocidal drugs. We performed a temporal examination of tegumental changes following artemether and tribendimidine administration on adult Clonorchis sinensis in rats using scanning electron microscopy. Rats infected with C. sinensis for 6 weeks were treated orally with a single dose of artemether (150 mg/kg) or tribendimidine (300 mg/kg). Worms were collected between 8 h and 7 days (artemether) and between 4 h and 2 days post-treatment (tribendimidine). Worms recovered from untreated rats served as controls. Eight hours after artemether administration, the tegument of C. sinensis was extensively disrupted, including severe swelling, fusion and vacuolization, and the suckers were damaged. Four hours after administration of tribendimidine, C. sinensis worms showed extensive tegumental alterations, characterized by massive sloughing, and the suckers were damaged. Interestingly, the severity of tegumental changes did not progress further with time. Our results show that both artemether and tribendimidine rapidly disrupt the tegument and damage the suckers of adult C. sinensis. The subtle differences in tegumental changes induced by artemether and tribendimidine might indicate different mechanisms of action of these drugs against C. sinensis.
C1 [Xiao, Shu-Hua; Xue, Jian] Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 200025, Peoples R China.
   [Keiser, Jennifer] Swiss Trop Inst, Dept Med Parasitol & Infect Biol, CH-4002 Basel, Switzerland.
   [Tanner, Marcel; Utzinger, Juerg] Swiss Trop Inst, Dept Epidemiol & Publ Hlth, CH-4002 Basel, Switzerland.
   [Morson, Gianni] Univ Basel, Biozentrum, Ctr Microscopy, CH-4056 Basel, Switzerland.
RP Xiao, SH (corresponding author), Chinese Ctr Dis Control & Prevent, Natl Inst Parasit Dis, Shanghai 200025, Peoples R China.
EM shxiao4@hotmail.com; jennifer.keiser@unibas.ch; xuejian74@yahoo.com.cn;
   marcel.tanner@unibas.ch; gianni.morson@unibas.ch;
   juerg.utzinger@unibas.ch
FU National Institute of Parasitic Diseases; Chinese Center for Disease
   Control and Prevention (Shanghai, China); Swiss Tropical Institute;
   Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PPOOA-114941, PPOOB-102883, PPOOB-119129]
FX This investigation received financial support from the National
   Institute of Parasitic Diseases, Chinese Center for Disease Control and
   Prevention (Shanghai, China) and Swiss Tropical Institute ( Basel,
   Switzerland). J. Keiser ( project no. PPOOA-114941) and J. Utzinger (
   project no. PPOOB-102883, PPOOB-119129) are grateful to the Swiss
   National Science Foundation for financial support.
CR BECKER B, 1980, Z PARASITENKD, V63, P113, DOI 10.1007/BF00927527
   CHEN RX, 1983, CHEM ABSTR 17251, V100
   COX FEG, 1979, NATURE, V278, P401, DOI 10.1038/278401a0
   Deng Lijun et al, 1990, Journal of China Medical University, V19, P272
   Fan Ping-Chin, 2005, Kaohsiung Journal of Medical Sciences, V21, P448
   Feng L X, 1983, Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V1, P110
   FUJINO T, 1979, J PARASITOL, V65, P579, DOI 10.2307/3280325
   Haynes RK, 2006, CURR TOP MED CHEM, V6, P509, DOI 10.2174/156802606776743129
   Keiser J, 2004, EXPERT OPIN PHARMACO, V5, P1711, DOI 10.1517/14656566.5.8.1711
   Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614
   KEISER J, 2008, PLOS NEGLECT TROP D, V2, pE201
   Keiser J, 2007, TRENDS PARASITOL, V23, P555, DOI 10.1016/j.pt.2007.07.012
   Keiser J, 2007, ANTIMICROB AGENTS CH, V51, P1096, DOI 10.1128/AAC.01366-06
   Keiser J, 2006, INT J ANTIMICROB AG, V28, P370, DOI 10.1016/j.ijantimicag.2006.08.004
   Keiser J, 2006, J PARASITOL, V92, P858, DOI 10.1645/GE-793R.1
   LI BZ, 1984, ACTA PHARM SIN, V19, P291
   Lun ZR, 2005, LANCET INFECT DIS, V5, P31, DOI 10.1016/S1473-3099(04)01252-6
   MEHLHORN H, 1981, ARZNEIMITTEL-FORSCH, V31-1, P544
   O'Neill PM, 2005, EXPERT OPIN INV DRUG, V14, P1117, DOI 10.1517/13543784.14.9.1117
   PAPPAS PW, 1975, EXP PARASITOL, V37, P469, DOI 10.1016/0014-4894(75)90016-8
   Quan M.X., 1988, ACTA CHONGQING MED U, V13, P6
   Steinmann P, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000322
   Tang Yonghuang, 1988, Chinese Journal of Parasitology and Parasitic Diseases, V6, P123
   Utzinger J, 2007, CURR OPIN INVEST DR, V8, P105
   White NJ, 2008, SCIENCE, V320, P330, DOI 10.1126/science.1155165
   WILSON RA, 1979, PARASITOLOGY, V78, P295, DOI 10.1017/S0031182000051167
   Xiao SH, 2000, J PARASITOL, V86, P1125, DOI 10.1645/0022-3395(2000)086[1125:TCIASM]2.0.CO;2
   Xiao SH, 2005, ACTA TROP, V94, P1, DOI 10.1016/j.actatropica.2005.01.013
   Xiao SH, 2002, ACTA TROP, V82, P175, DOI 10.1016/S0001-706X(02)00009-8
   Xiao SH, 2008, ACTA TROP, V106, P54, DOI 10.1016/j.actatropica.2008.01.003
   Xiao Shu-hua, 2007, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V25, P372
   Zhang Jian-Hui, 2008, Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi, V26, P6
NR 32
TC 13
Z9 17
U1 0
U2 3
PU SPRINGER
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0932-0113
J9 PARASITOL RES
JI Parasitol. Res.
PD FEB
PY 2009
VL 104
IS 3
BP 533
EP 541
DI 10.1007/s00436-008-1227-6
PG 9
WC Parasitology
SC Parasitology
GA 397ZQ
UT WOS:000262701400006
PM 18975004
DA 2021-01-25
ER

PT J
AU Fierz, B
   Reiner, A
   Kiefhaber, T
AF Fierz, Beat
   Reiner, Andreas
   Kiefhaber, Thomas
TI Local conformational dynamics in alpha-helices measured by fast triplet
   transfer
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE alpha-helix-coil transition; protein dynamics; protein folding;
   triplet-triplet energy transfer
ID UNFOLDED POLYPEPTIDE-CHAINS; COIL TRANSITION; HYDROGEN-EXCHANGE;
   RELAXATION MEASUREMENTS; LOOP FORMATION; KINETICS; PEPTIDE; ALANINE;
   MODEL; TEMPERATURE
AB Coupling fast triplet-triplet energy transfer (TTET) between xanthone and naphthylalanine to the helix-coil equilibrium in alanine-based peptides allowed the observation of local equilibrium fluctuations in alpha-helices on the nanoseconds to microseconds time scale. The experiments revealed faster helix unfolding in the terminal regions compared with the central parts of the helix with time constants varying from 250ns to 1.4 mu s at 5 degrees C. Local helix formation occurs with a time constant of approximate to 400 ns, independent of the position in the helix. Comparing the experimental data with simulations using a kinetic Ising model showed that the experimentally observed dynamics can be explained by a 1-dimensional boundary diffusion with position-independent elementary time constants of approximate to 50 ns for the addition and of approximate to 65 ns for the removal of an alpha-helical segment. The elementary time constant for helix growth agrees well with previously measured time constants for formation of short loops in unfolded polypeptide chains, suggesting that helix elongation is mainly limited by a conformational search.
C1 [Reiner, Andreas; Kiefhaber, Thomas] Tech Univ Munich, Dept Chem, D-85747 Garching, Germany.
   [Reiner, Andreas; Kiefhaber, Thomas] Tech Univ Munich, Munich Ctr Integrated Prot Sci, D-85747 Garching, Germany.
   [Fierz, Beat] Univ Basel, Biozentrum, Div Biophys Chem, CH-4056 Basel, Switzerland.
RP Kiefhaber, T (corresponding author), Tech Univ Munich, Dept Chem, Lichtenbergstr 4, D-85747 Garching, Germany.
EM t.kiefhaber@tum.de
RI Fierz, Beat/H-3143-2012; Reiner, Andreas/E-4897-2011; Kiefhaber,
   Thomas/A-3028-2010
OI Fierz, Beat/0000-0002-2991-3044; Reiner, Andreas/0000-0003-0802-7278; 
FU VolkswagenStiftungVolkswagen; Deutsche ForschungsgemeinschaftGerman
   Research Foundation (DFG) [SFB 749]; Munich Center for Integrated
   Protein Science
FX We thank JosefWey for the synthesis of 9-oxoxanthene2-carboxylic acid
   and Robert L. Baldwin, Annett Bachmann, and Rudolph A. Marcus for
   comments on the manuscript. This work was supported by grants from the
   VolkswagenStiftung and the Deutsche Forschungsgemeinschaft (SFB 749) and
   by the Munich Center for Integrated Protein Science.
CR Arrington CB, 1997, BIOCHEMISTRY-US, V36, P8686, DOI 10.1021/bi970872m
   Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597
   BRADLEY EK, 1990, J MOL BIOL, V215, P607, DOI 10.1016/S0022-2836(05)80172-X
   Bredenbeck J, 2005, P NATL ACAD SCI USA, V102, P2379, DOI 10.1073/pnas.0406948102
   CHAKRABARTTY A, 1991, NATURE, V351, P586, DOI 10.1038/351586a0
   Doshi UR, 2004, J PHYS CHEM B, V108, P8497, DOI 10.1021/jp049896a
   Fierz B, 2007, J AM CHEM SOC, V129, P672, DOI 10.1021/ja0666396
   FRAUENFELDER H, 1991, SCIENCE, V254, P1598, DOI 10.1126/science.1749933
   GRUENEWALD B, 1979, BIOPHYS CHEM, V9, P137, DOI 10.1016/0301-4622(79)87008-8
   Huang CY, 2002, P NATL ACAD SCI USA, V99, P2788, DOI 10.1073/pnas.052700099
   Huang CY, 2001, J AM CHEM SOC, V123, P9235, DOI 10.1021/ja0158814
   HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1
   Jaravine VA, 2001, PROTEIN SCI, V10, P943, DOI 10.1110/ps.48501
   KIEFHABER T, 1995, P NATL ACAD SCI USA, V92, P2657, DOI 10.1073/pnas.92.7.2657
   KIEFHABER T, 1992, J MOL BIOL, V224, P217, DOI 10.1016/0022-2836(92)90585-8
   Krieger F, 2003, J MOL BIOL, V332, P265, DOI 10.1016/S0022-2836(03)00892-1
   Krieger F, 2005, J AM CHEM SOC, V127, P3346, DOI 10.1021/ja042798i
   Lapidus LJ, 2002, J MOL BIOL, V319, P19, DOI 10.1016/S0022-2836(02)00193-6
   Lednev IK, 1999, J AM CHEM SOC, V121, P8074, DOI 10.1021/ja991382f
   LIFSON S, 1961, J CHEM PHYS, V34, P1963, DOI 10.1063/1.1731802
   LINDERSTROMLANG KU, 1955, CHEM SOC SPEC PUBL, V2, P1
   Luo PZ, 1997, BIOCHEMISTRY-US, V36, P8413, DOI 10.1021/bi9707133
   MIICK SM, 1991, BIOCHEMISTRY-US, V30, P9498, DOI 10.1021/bi00103a016
   Mikhonin AV, 2007, J PHYS CHEM B, V111, P3280, DOI 10.1021/jp0654009
   Moglich A, 2005, J MOL BIOL, V345, P153, DOI 10.1016/j.jmb.2004.10.036
   MUNOZ V, 1995, J MOL BIOL, V245, P297, DOI 10.1006/jmbi.1994.0024
   Munoz V, 1997, NATURE, V390, P196, DOI 10.1038/36626
   Pace C N, 1986, Methods Enzymol, V131, P266
   Palmer AG, 2004, CHEM REV, V104, P3623, DOI 10.1021/cr030413t
   Poland D, 1996, J CHEM PHYS, V105, P1242, DOI 10.1063/1.471965
   POLAND D, 1966, J CHEM PHYS, V45, P2071, DOI 10.1063/1.1727893
   Poland D., 1970, THEORY HELIX COIL TR
   QIAN H, 1992, J PHYS CHEM-US, V96, P3987, DOI 10.1021/j100189a015
   Ramajo AP, 2005, J AM CHEM SOC, V127, P13784, DOI 10.1021/ja054500+
   ROHL CA, 1994, BIOCHEMISTRY-US, V33, P7760, DOI 10.1021/bi00191a003
   Sanchez IE, 2003, J MOL BIOL, V327, P867, DOI 10.1016/S0022-2836(03)00171-2
   SANTORO MM, 1988, BIOCHEMISTRY-US, V27, P8063, DOI 10.1021/bi00421a014
   SCHELLMAN JA, 1959, J PHYS CHEM-US, V62, P1485
   SCHELLMAN JOHN A., 1955, COMPT REND TRAV LAB CARLSBERG SER CHIM, V29, P230
   SCHOLTZ JM, 1995, P NATL ACAD SCI USA, V92, P185, DOI 10.1073/pnas.92.1.185
   SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304
   SCHWARZ G, 1968, BIOPOLYMERS, V6, P1263, DOI 10.1002/bip.1968.360060904
   SCHWARZ G, 1965, J MOL BIOL, V11, P64, DOI 10.1016/S0022-2836(65)80171-1
   Thompson PA, 2000, J PHYS CHEM B, V104, P378, DOI 10.1021/jp990292u
   Thompson PA, 1997, BIOCHEMISTRY-US, V36, P9200, DOI 10.1021/bi9704764
   Werner JH, 2002, J PHYS CHEM B, V106, P487, DOI 10.1021/jp0125799
   Williams S, 1996, BIOCHEMISTRY-US, V35, P691, DOI 10.1021/bi952217p
   ZHOU HXX, 1994, J AM CHEM SOC, V116, P6482, DOI 10.1021/ja00093a078
   ZIMM BH, 1959, J CHEM PHYS, V31, P526, DOI 10.1063/1.1730390
NR 49
TC 52
Z9 52
U1 0
U2 37
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 27
PY 2009
VL 106
IS 4
BP 1057
EP 1062
DI 10.1073/pnas.0808581106
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 399XC
UT WOS:000262831600020
PM 19131517
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Wiesand, U
   Sorg, I
   Amstutz, M
   Wagner, S
   van den Heuvel, J
   Luhrs, T
   Cornelis, GR
   Heinz, DW
AF Wiesand, Ulrich
   Sorg, Isabel
   Amstutz, Marlise
   Wagner, Stefanie
   van den Heuvel, Joop
   Luehrs, Thorsten
   Cornelis, Guy R.
   Heinz, Dirk W.
TI Structure of the Type III Secretion Recognition Protein YscU from
   Yersinia enterocolitica
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE auto-proteolysis; crystal structure; type III secretion system; Yersinia
ID SUBSTRATE-SPECIFICITY; CRYSTAL-STRUCTURE; EXPORT; SALMONELLA; NEEDLE;
   LENGTH; SWITCH; FLHB; TRANSLOCATION; VALIDATION
AB The inner-membrane protein YscU has an important role during the assembly of the Yersinia enterocolitica type III secretion injectisome. Its cytoplasmic domain (YscU(C)) recognizes translocators as individual substrates in the export hierarchy. Activation of YscU entails autocleavage at a conserved NPTH motif. Modification of this motif markedly changes the properties of YscU, including translocator export cessation and production of longer injectisome needles. We determined the crystal structures of the uncleaved variants N263A and N263D of YscU(C) at 2.05 angstrom and 1.55 angstrom resolution, respectively. The globular domain is found to consist of a central, mixed beta-sheet surrounded by alpha-helices. The NPTH motif forms a type II beta-turn connecting two beta-strands. NMR analysis of cleaved and uncleaved YscU(C) indicates that the global structure of the protein is retained in cleaved YscU(C). The structure of YscU(C) variant N263D reveals that wild type YscU(C) is poised for cleavage due to an optimal reaction geometry for nucleophilic attack of the scissile bond by the side chain of Asn263. In vivo analysis of N263Q and H266A/R314A YscU variants showed a phenotype that combines the absence of translocator secretion with normal needle-length control. Comparing the structure of YscU to those of related proteins reveals that the linker domain between the N-terminal transmembrane domain and the autocleavage domain can switch from an extended to a largely a-helical conformation, allowing for optimal positioning of the autocleavage domain during injectisome assembly. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Wiesand, Ulrich; van den Heuvel, Joop; Luehrs, Thorsten; Heinz, Dirk W.] Helmholtz Ctr Infect Res HZI, Div Struct Biol, D-38124 Braunschweig, Germany.
   [Sorg, Isabel; Amstutz, Marlise; Wagner, Stefanie; Cornelis, Guy R.] Univ Basel, Biozentrum, Div Mol Microbial, CH-4056 Basel, Switzerland.
RP Heinz, DW (corresponding author), Helmholtz Ctr Infect Res HZI, Div Struct Biol, Inhoffenstr 7, D-38124 Braunschweig, Germany.
EM Dirk.Heinz@helmholtz-hzi.de
RI Wagner, Stefanie/A-5756-2011
OI Wagner, Stefanie/0000-0002-3873-7011
FU Fonds der Chemischen IndustrieFonds der Chemischen Industrie; Swiss
   National Science FoundationSwiss National Science Foundation (SNSF)
   [310000-113333/1]
FX We thank Hauke Pagel for his support during the initial stage of protein
   preparation. We are grateful to Dr Manfred Weiss (DESY/ EMBL, beamline
   X12), the team of ESRF-ID29, for helping during data collection and
   processing. We are grateful to Dr Victor Wray and Dr Wolf-Dieter
   Schubert for critical comments on the manuscript. D.W.H. acknowledges
   support by the Fonds der Chemischen Industrie. This work was supported
   by the Swiss National Science Foundation (grant 310000-113333/1 to GRC).
CR Agrain C, 2005, MOL MICROBIOL, V57, P1415, DOI 10.1111/j.1365-2958.2005.04758.x
   Agrain C, 2005, MOL MICROBIOL, V56, P54, DOI 10.1111/j.1365-2958.2005.04534.x
   ALLAOUI A, 1994, J BACTERIOL, V176, P4534, DOI 10.1128/JB.176.15.4534-4542.1994
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Blocker A, 2001, MOL MICROBIOL, V39, P652, DOI 10.1046/j.1365-2958.2001.02200.x
   BURGI HB, 1973, J AM CHEM SOC, V95, P5065, DOI 10.1021/ja00796a058
   BURGI HB, 1974, TETRAHEDRON, V30, P1563, DOI 10.1016/S0040-4020(01)90678-7
   CORNELIS G, 1987, MICROB PATHOGENESIS, V2, P367, DOI 10.1016/0882-4010(87)90078-7
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   Crepin VF, 2005, J BACTERIOL, V187, P2881, DOI 10.1128/JB.187.8.2881-2889.2005
   Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x
   Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216
   Deane JE, 2008, MOL MICROBIOL, V69, P267, DOI 10.1111/j.1365-2958.2008.06293.x
   Ding Y, 2003, J BIOL CHEM, V278, P39133, DOI 10.1074/jbc.M306197200
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Evans P, 2006, ACTA CRYSTALLOGR D, V62, P72, DOI 10.1107/S0907444905036693
   Ferris HU, 2005, J BIOL CHEM, V280, P41236, DOI 10.1074/jbc.M509438200
   Fraser GM, 2003, MOL MICROBIOL, V48, P1043, DOI 10.1046/j.1365-2958.2003.03487.x
   Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272
   Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932
   Guerrero SA, 2001, APPL MICROBIOL BIOT, V56, P718, DOI 10.1007/s002530100690
   Gunasekaran K, 1997, PROTEIN ENG, V10, P1131, DOI 10.1093/protein/10.10.1131
   GUNTERT P, 1992, J BIOMOL NMR, V2, P619, DOI 10.1007/BF02192850
   Hoiczyk E, 2001, P NATL ACAD SCI USA, V98, P4669, DOI 10.1073/pnas.071065798
   Journet L, 2003, SCIENCE, V302, P1757, DOI 10.1126/science.1091422
   Keller R, 2004, OPTIMIZING PROCESS N
   Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166
   Kubori T, 1998, SCIENCE, V280, P602, DOI 10.1126/science.280.5363.602
   Kubori T, 2002, J BACTERIOL, V184, P4699, DOI 10.1128/JB.184.17.4699-4708.2002
   Lavander M, 2002, J BACTERIOL, V184, P4500, DOI 10.1128/JB.184.16.4500-4509.2002
   Leslie AGW, 2006, ACTA CRYSTALLOGR D, V62, P48, DOI 10.1107/S0907444905039107
   Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832
   Makishima S, 2001, SCIENCE, V291, P2411, DOI 10.1126/science.1058366
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822
   McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617
   MICHIELS T, 1991, J BACTERIOL, V173, P1677, DOI 10.1128/jb.173.5.1677-1685.1991
   Minamino T, 2000, J BACTERIOL, V182, P4906, DOI 10.1128/JB.182.17.4906-4914.2000
   Morita-Ishihara T, 2006, J BIOL CHEM, V281, P599, DOI 10.1074/jbc.M509644200
   Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Panjikar S, 2005, ACTA CRYSTALLOGR D, V61, P449, DOI 10.1107/S0907444905001307
   Riordan KE, 2008, MOL MICROBIOL, V68, P1485, DOI 10.1111/j.1365-2958.2008.06247.x
   Sorg I, 2007, EMBO J, V26, P3015, DOI 10.1038/sj.emboj.7601731
   Van Gijsegem F, 2000, MOL MICROBIOL, V36, P249, DOI 10.1046/j.1365-2958.2000.01851.x
   Wood SE, 2008, J BACTERIOL, V190, P4252, DOI 10.1128/JB.00328-08
   Zarivach R, 2008, NATURE, V453, P124, DOI 10.1038/nature06832
NR 49
TC 35
Z9 35
U1 0
U2 3
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 23
PY 2009
VL 385
IS 3
BP 854
EP 866
DI 10.1016/j.jmb.2008.10.034
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 402HG
UT WOS:000263004200015
PM 18976663
OA Green Published
DA 2021-01-25
ER

PT J
AU Frederix, PLTM
   Bosshart, PD
   Engel, A
AF Frederix, Patrick L. T. M.
   Bosshart, Patrick D.
   Engel, Andreas
TI Atomic Force Microscopy of Biological Membranes
SO BIOPHYSICAL JOURNAL
LA English
DT Review
ID CONFORMATIONAL-CHANGES; HIGH-RESOLUTION; LIPID-BILAYERS; SURFACE-LAYER;
   AFM; PROTEINS; BINDING; SPECTROSCOPY; MOLECULES; PROBE
AB Atomic force microscopy (AFM) is an ideal method to study the surface topography of biological membranes. It allows membranes that are adsorbed to flat solid supports to be raster-scanned in physiological solutions with an atomically sharp tip. Therefore, AFM is capable of observing biological molecular machines at work. In addition, the tip can be tethered to the end of a single membrane protein, and forces acting on the tip upon its retraction indicate barriers that occur during the process of protein unfolding. Here we discuss the fundamental limitations of AFM determined by the properties of cantilevers, present aspects of sample preparation, and review results achieved on reconstituted and native biological membranes.
C1 [Frederix, Patrick L. T. M.; Bosshart, Patrick D.; Engel, Andreas] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
   [Engel, Andreas] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
EM andreas.engel@unibas.ch
FU Maurice E. Muller Foundation of Switzerland; Swiss National Center of
   Competence in Research on Nanoscale ScienceSwiss National Science
   Foundation (SNSF); European Commission ProjectEuropean
   CommissionEuropean Commission Joint Research Centre [29084 NANOMOT];
   Swiss University Conference; JPK Instruments AG, Berlin, Germany
FX This work was supported by the Maurice E. Muller Foundation of
   Switzerland, by the Swiss National Center of Competence in Research on
   Nanoscale Science, and by the European Commission Project 29084 NANOMOT.
   The AFM-facility used was built with contributions of the Swiss
   University Conference and JPK Instruments AG, Berlin, Germany.
CR Andersen C, 2002, J BIOL CHEM, V277, P41318, DOI 10.1074/jbc.M206804200
   Ando T, 2008, PFLUG ARCH EUR J PHY, V456, P211, DOI 10.1007/s00424-007-0406-0
   Ashby PD, 2007, APPL PHYS LETT, V91, DOI 10.1063/1.2824576
   Baumgartner W, 2000, P NATL ACAD SCI USA, V97, P4005, DOI 10.1073/pnas.070052697
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   BOSSHART P, 2008, NANOTECHNOLOGY, V19
   Burt DP, 2005, NANO LETT, V5, P639, DOI 10.1021/nl050018d
   Buzhynskyy N, 2007, EMBO REP, V8, P51, DOI 10.1038/sj.embor.7400858
   Cisneros DA, 2006, ANGEW CHEM INT EDIT, V45, P3252, DOI 10.1002/anie.200504506
   Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5
   Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Evans E, 2001, ANNU REV BIOPH BIOM, V30, P105, DOI 10.1146/annurev.biophys.30.1.105
   EVANS E, 1999, J PHYS-CONDENS MAT, V11, P1
   Fisher TE, 2000, NAT STRUCT BIOL, V7, P719
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Fotiadis D, 2004, J BIOL CHEM, V279, P2063, DOI 10.1074/jbc.M310382200
   FREDERIX PLT, 2008, NANOTECHNOLOGY, V19
   Frederix PLTM, 2005, NANOTECHNOLOGY, V16, P997, DOI 10.1088/0957-4484/16/8/001
   Fukuma T, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.1999856
   FUKUMA T, 2006, REV SCI INSTRUM, V77
   Fukuma T, 2007, BIOPHYS J, V92, P3603, DOI 10.1529/biophysj.106.100651
   Gamsjaeger R, 2005, BIOCHEM J, V389, P665, DOI 10.1042/BJ20050156
   Gardner CE, 2002, ANAL CHEM, V74, p576A, DOI 10.1021/ac0221482
   Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063
   Goncalves RP, 2006, NAT METHODS, V3, P1007, DOI 10.1038/nmeth965
   Grabiec P, 2002, MICROELECTRON ENG, V61-2, P981, DOI 10.1016/S0167-9317(02)00428-8
   Han WH, 1996, APPL PHYS LETT, V69, P4111, DOI 10.1063/1.117835
   HANSMA PK, 1989, SCIENCE, V243, P641, DOI 10.1126/science.2464851
   Hilge M, 2003, NAT STRUCT BIOL, V10, P468, DOI 10.1038/nsb924
   Hirata Y, 2004, BIOELECTROCHEMISTRY, V63, P217, DOI 10.1016/j.bioelechem.2004.01.001
   HOH JH, 1991, SCIENCE, V253, P1405, DOI 10.1126/science.1910206
   Hoogenboom BW, 2008, NANOTECHNOLOGY, V19, DOI 10.1088/0957-4484/19/38/384019
   Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073
   Hoogenboom BW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2202638
   Hoogenboom BW, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866229
   Kedrov A, 2005, EMBO REP, V6, P668, DOI 10.1038/sj.embor.7400455
   Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112
   Kessler M, 2006, STRUCTURE, V14, P521, DOI 10.1016/j.str.2005.11.023
   Kienberger F, 2004, EMBO REP, V5, P579, DOI 10.1038/sj.embor.7400149
   Kranz C, 2008, ANAL BIOANAL CHEM, V390, P239, DOI 10.1007/s00216-007-1670-8
   Kueng A, 2003, ANGEW CHEM INT EDIT, V42, P3238, DOI 10.1002/anie.200351111
   MANNELLA CA, 1984, SCIENCE, V224, P165, DOI 10.1126/science.6322311
   Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309
   Muller DJ, 2008, CURR OPIN COLLOID IN, V13, P338, DOI 10.1016/j.cocis.2007.09.002
   Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 2003, J MOL BIOL, V327, P925, DOI 10.1016/S0022-2836(03)00206-7
   Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365
   MULLER DJ, 1995, J MOL BIOL, V249, P239, DOI 10.1006/jmbi.1995.0292
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875
   Muller DJ, 1998, FEBS LETT, V430, P105, DOI 10.1016/S0014-5793(98)00623-1
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   Picco LM, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/4/044030
   Preiner J, 2007, BIOPHYS J, V93, P930, DOI 10.1529/biophysj.106.096982
   Puchner EM, 2008, BIOPHYS J, V95, P426, DOI 10.1529/biophysj.108.129999
   Sader JE, 1998, J APPL PHYS, V84, P64, DOI 10.1063/1.368002
   Sahin O, 2007, NAT NANOTECHNOL, V2, P507, DOI 10.1038/nnano.2007.226
   Sapra KT, 2006, J MOL BIOL, V355, P640, DOI 10.1016/j.jmb.2005.10.080
   Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879
   Scheuring S, 1999, J MICROSC-OXFORD, V193, P28, DOI 10.1046/j.1365-2818.1999.00434.x
   Scheuring S, 2002, MOL MICROBIOL, V44, P675, DOI 10.1046/j.1365-2958.2002.02864.x
   Scheuring S, 2002, EUR BIOPHYS J BIOPHY, V31, P172, DOI 10.1007/s00249-001-0197-8
   Scheuring S, 1999, EMBO J, V18, P4981, DOI 10.1093/emboj/18.18.4981
   Scheuring S, 2007, J STRUCT BIOL, V160, P385, DOI 10.1016/j.jsb.2007.07.009
   Scheuring S, 2006, CURR OPIN CHEM BIOL, V10, P387, DOI 10.1016/j.cbpa.2006.08.007
   Stark RW, 2004, NANOTECHNOLOGY, V15, P347, DOI 10.1088/0957-4484/15/3/020
   Stroh CM, 2004, BIOPHYS J, V87, P1981, DOI 10.1529/biophysj.104.043331
   Subramaniam S, 2000, NATURE, V406, P653, DOI 10.1038/35020614
   Tamayo J, 2001, BIOPHYS J, V81, P526, DOI 10.1016/S0006-3495(01)75719-0
   Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164
   Uchihashi T, 2004, APPL PHYS LETT, V85, P3575, DOI 10.1063/1.1803932
   Unwin N, 2002, J MOL BIOL, V319, P1165, DOI 10.1016/S0022-2836(02)00381-9
   Viani MB, 1999, REV SCI INSTRUM, V70, P4300, DOI 10.1063/1.1150069
   Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2
   Wielert-Badt S, 2002, BIOPHYS J, V82, P2767, DOI 10.1016/S0006-3495(02)75617-8
   Yasumura KY, 2000, J MICROELECTROMECH S, V9, P117, DOI 10.1109/84.825786
   Yokokawa M, 2006, EMBO J, V25, P4567, DOI 10.1038/sj.emboj.7601326
NR 80
TC 74
Z9 77
U1 1
U2 34
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD JAN 21
PY 2009
VL 96
IS 2
BP 329
EP 338
DI 10.1016/j.bpj.2008.09.046
PG 10
WC Biophysics
SC Biophysics
GA 450BY
UT WOS:000266377200007
PM 19167286
OA Green Published, Bronze
DA 2021-01-25
ER

PT S
AU Engel, A
AF Engel, Andreas
BA Hawkes, PW
BF Hawkes, PW
TI Scanning Transmission Electron Microscopy: Biological Applications
SO ADVANCES IN IMAGING AND ELECTRON PHYSICS, VOL 159: COLD FIELD EMISSION
   AND THE SCANNING TRANSMISSION ELECTRON MICROSCOPE
SE Advances in Imaging and Electron Physics
LA English
DT Review; Book Chapter
ID MASS ANALYSIS; MACROMOLECULAR COMPLEXES; SECRETIN PULD; CRYOELECTRON
   MICROSCOPY; MOLECULAR ARCHITECTURE; INELASTIC-SCATTERING;
   ESCHERICHIA-COLI; CHAPERONIN GROEL; ACTIN FILAMENT; F-ACTIN
C1 [Engel, Andreas] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Engel, Andreas] Case Western Reserve Univ, Dept Pharmacol, Cleveland, OH 44106 USA.
RP Engel, A (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR AEBI U, 1973, Journal of Supramolecular Structure, V1, P498, DOI 10.1002/jss.400010606
   AEBI U, 1988, PROTOPLASMA, V145, P73, DOI 10.1007/BF01349341
   Al-Amoudi A, 2004, EMBO J, V23, P3583, DOI 10.1038/sj.emboj.7600366
   ARMBRUSTER BL, 1982, J MICROSC-OXFORD, V126, P77, DOI 10.1111/j.1365-2818.1982.tb00358.x
   BASCHONG W, 1991, J STRUCT BIOL, V106, P93, DOI 10.1016/1047-8477(91)90078-B
   Baumeister W, 2005, FEBS LETT, V579, P933, DOI 10.1016/j.febslet.2004.10.102
   Baumeister W, 2005, PROTEIN SCI, V14, P257, DOI 10.1110/ps.041148605
   BRAIG K, 1993, P NATL ACAD SCI USA, V90, P3978, DOI 10.1073/pnas.90.9.3978
   BREMER A, 1992, ULTRAMICROSCOPY, V46, P85, DOI 10.1016/0304-3991(92)90008-8
   BREMER A, 1991, J CELL BIOL, V115, P689, DOI 10.1083/jcb.115.3.689
   BREMER A, 1994, J MOL BIOL, V242, P683, DOI 10.1006/jmbi.1994.1617
   Breslauer DN, 2006, MOL BIOSYST, V2, P97, DOI 10.1039/b515632g
   Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   CARLEMALM E, 1985, J MICROSC-OXFORD, V140, P55, DOI 10.1111/j.1365-2818.1985.tb02660.x
   CARLEMALM E, 1982, EMBO J, V1, P63, DOI 10.1002/j.1460-2075.1982.tb01125.x
   Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   CHEN S, 1994, NATURE, V371, P261, DOI 10.1038/371261a0
   Clare DK, 2009, NATURE, V457, P107, DOI 10.1038/nature07479
   COLE MD, 1977, J MOL BIOL, V117, P387, DOI 10.1016/0022-2836(77)90134-6
   COUDRAY N, 2008, MICROSCOPY TODAY, V16, P48
   CREWE AV, 1970, SCIENCE, V168, P1338, DOI 10.1126/science.168.3937.1338
   Di Carlo D, 2005, LAB CHIP, V5, P171, DOI 10.1039/b413139h
   DICAPUA E, 1982, J MOL BIOL, V157, P87, DOI 10.1016/0022-2836(82)90514-9
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Ducret A, 1998, J MOL BIOL, V278, P369, DOI 10.1006/jmbi.1998.1678
   EGERTON RF, 1982, ULTRAMICROSCOPY, V10, P297, DOI 10.1016/0304-3991(82)90051-1
   El-Ali J, 2006, NATURE, V442, P403, DOI 10.1038/nature05063
   ENGEL A, 1982, P NATL ACAD SCI-BIOL, V79, P4050, DOI 10.1073/pnas.79.13.4050
   ENGEL A, 1974, J APPL PHYS, V45, P2739, DOI 10.1063/1.1663659
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   ENGEL A, 1981, ULTRAMICROSCOPY, V7, P45, DOI 10.1016/0304-3991(81)90022-X
   ENGEL A, 1995, SCIENCE, V269, P832, DOI 10.1126/science.7638600
   ENGEL A, 1976, J ULTRA MOL STRUCT R, V57, P322, DOI 10.1016/S0022-5320(76)80120-7
   Frangakis AS, 2002, P NATL ACAD SCI USA, V99, P14153, DOI 10.1073/pnas.172520299
   Goldsbury C, 2000, J STRUCT BIOL, V130, P352, DOI 10.1006/jsbi.2000.4268
   Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029
   Goldsbury CS, 1997, J STRUCT BIOL, V119, P17, DOI 10.1006/jsbi.1997.3858
   HAASE J, 1970, Z NATURFORSCH PT A, VA 25, P1219
   Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7
   Herman GT, 2008, ULTRAMICROSCOPY, V108, P327, DOI 10.1016/j.ultramic.2007.05.005
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 2000, J MOL BIOL, V298, P817, DOI 10.1006/jmbi.2000.3719
   HOHN T, 1979, J MOL BIOL, V129, P359, DOI 10.1016/0022-2836(79)90501-1
   ISAACSON M, 1974, OPTIK, V41, P92
   JONES AV, 1978, NATURE, V271, P659, DOI 10.1038/271659a0
   Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101
   KELLENBERGER E, 1986, ANN NY ACAD SCI, V483, P202, DOI 10.1111/j.1749-6632.1986.tb34522.x
   KELLENBERGER E, 1987, J HISTOCHEM CYTOCHEM, V35, P959, DOI 10.1177/35.9.3302020
   Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x
   Krzyzanek V, 2009, J STRUCT BIOL, V165, P78, DOI 10.1016/j.jsb.2008.10.006
   LANGMORE JP, 1973, OPTIK, V38, P335
   MARTIN J, 1994, BIOL CHEM H-S, V375, P635
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Muller SA, 2006, CHIMIA, V60, pA749, DOI 10.2533/chimia.2006.749
   Muller S, 1998, J MOL BIOL, V283, P383, DOI 10.1006/jmbi.1998.2078
   Muller SA, 1998, J STRUCT BIOL, V121, P219, DOI 10.1006/jsbi.1997.3953
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Muller SA, 2001, MICRON, V32, P21, DOI 10.1016/S0968-4328(00)00022-6
   Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861
   Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229
   Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173
   Pamme N, 2007, LAB CHIP, V7, P1644, DOI 10.1039/b712784g
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   REICHELT R, 1986, ULTRAMICROSCOPY, V19, P43, DOI 10.1016/0304-3991(86)90006-9
   REICHELT R, 1984, ULTRAMICROSCOPY, V13, P279, DOI 10.1016/0304-3991(84)90206-7
   REIMER L, 1989, TRANSMISSION ELECT M
   Remigy HW, 1999, J MOL BIOL, V290, P851, DOI 10.1006/jmbi.1999.2925
   Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133
   Roman GT, 2007, J CHROMATOGR A, V1168, P170, DOI 10.1016/j.chroma.2007.06.010
   Schenk AD, 2005, J MOL BIOL, V350, P278, DOI 10.1016/j.jmb.2005.04.030
   SOSINSKY GE, 1992, P NATL ACAD SCI USA, V89, P4801, DOI 10.1073/pnas.89.11.4801
   Sousa AA, 2009, ULTRAMICROSCOPY, V109, P213, DOI 10.1016/j.ultramic.2008.10.005
   Steiner D, 2008, J MOL BIOL, V382, P1211, DOI 10.1016/j.jmb.2008.07.085
   Steinmetz MO, 1998, J MOL BIOL, V276, P1, DOI 10.1006/jmbi.1997.1529
   Steinmetz MO, 1997, J STRUCT BIOL, V119, P295, DOI 10.1006/jsbi.1997.3873
   STEVEN AC, 1984, P NATL ACAD SCI-BIOL, V81, P6363, DOI 10.1073/pnas.81.20.6363
   Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412
   Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030
   Telford JL, 2006, NAT REV MICROBIOL, V4, P509, DOI 10.1038/nrmicro1443
   THOMAS D, 1994, BIOL CELL, V80, P181, DOI 10.1016/0248-4900(94)90041-8
   UNWIN PNT, 1971, PHILOS T R SOC B, V261, P95, DOI 10.1098/rstb.1971.0039
   von Ardenne M, 1938, Z PHYS, V109, P553, DOI 10.1007/BF01341584
   WALL J, 1974, OPTIK, V39, P359
   WALL J, 1974, P NATL ACAD SCI USA, V71, P1, DOI 10.1073/pnas.71.1.1
   WALL JS, 1986, ANNU REV BIOPHYS BIO, V15, P355
   WALL JS, 1979, MASS MEASUREMENTS EL, V2
   WALZ T, 1994, EMBO J, V13, P2985, DOI 10.1002/j.1460-2075.1994.tb06597.x
   White HE, 2009, J MOL BIOL, V389, P48, DOI 10.1016/j.jmb.2009.03.066
NR 89
TC 20
Z9 20
U1 1
U2 23
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1076-5670
BN 978-0-12-374986-4
J9 ADV IMAG ELECT PHYS
JI Adv. Imag. Electron Phys.
PY 2009
VL 159
BP 357
EP 386
DI 10.1016/S1076-5670(09)59009-X
PG 30
WC Physics, Applied
SC Physics
GA BMF72
UT WOS:000272201800009
DA 2021-01-25
ER

PT J
AU Nguyen, L
   Pieters, J
AF Nguyen, Liem
   Pieters, Jean
TI Mycobacterial Subversion of Chemotherapeutic Reagents and Host Defense
   Tactics: Challenges in Tuberculosis Drug Development
SO ANNUAL REVIEW OF PHARMACOLOGY AND TOXICOLOGY
SE Annual Review of Pharmacology and Toxicology
LA English
DT Review; Book Chapter
DE mycobacteria; antibiotic resistance; macrophage; phagosome maturation;
   phagosome-lysosome fusion; tuberculosis
ID NITRIC-OXIDE SYNTHASE; INTRINSIC MACROLIDE RESISTANCE; PROTEIN-KINASE-G;
   PHAGOSOME MATURATION; INTRACELLULAR SURVIVAL; MULTIDRUG-RESISTANCE;
   ANTIBIOTIC-RESISTANCE; INTERFERON-GAMMA; SECRETION SYSTEM; VIRULENCE
   FACTOR
AB Recent worldwide emergence of multidrug-resistant and extensively drug-resistant tuberculosis is threatening to destabilize tuberculosis control programs and urging global attention to the development of alternative tuberculosis therapies. Major roadblocks limiting the development and effectiveness of new drugs to combat tuberculosis are the profound innate resistance of Mycobacterium tuberculosis to host defense mechanisms as well as its intrinsic tolerance to chemotherapeutic reagents. The triangle of interactions among the pathogen, the host responses, and the drugs used to cure the disease are critical for the outcome of tuberculosis. le must better understand this three-way interaction in order to develop drugs that are able to kill the bacillus in the most effective way and minimize the emergence of drug resistance. Here we review our recent understanding of the molecular basis underlying intrinsic antibiotic resistance and survival tactics of M. tuberculosis. This knowledge may help to reveal current targets for the development of novel antituberculosis drugs.
C1 [Nguyen, Liem] Case Western Reserve Univ, Dept Mol Biol & Microbiol, Sch Med, Cleveland, OH 44106 USA.
   [Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Nguyen, L (corresponding author), Case Western Reserve Univ, Dept Mol Biol & Microbiol, Sch Med, Cleveland, OH 44106 USA.
EM liem.nguyen@case.edu; jean.pieters@unibas.ch
OI Nguyen, Liem/0000-0002-1523-1472; Pieters, Jean/0000-0002-5284-9757
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Olga Mayenfisch Stiftung; World Health OrganizationWorld Health
   Organization; Case Western Reserve University School of Medicine; STERIS
   Infectious Diseases Research Grant; Case Center for AIDS Research
FX We thank Robert Bonomo, Kien Nguyen, Sebastien Gagneux, and Abram
   Stavitsky, as well as members of the laboratories, for critical reading
   of the manuscript. Work in the laboratory of J.P. is supported by the
   Swiss National Science Foundation, the Olga Mayenfisch Stiftung, and the
   World Health Organization. Current support in the laboratory of L.N. is
   provided by start-tip funds from Case Western Reserve University School
   of Medicine, a STERIS Infectious Diseases Research Grant, and a CFAR
   Developmental Award from the Case Center for AIDS Research.
CR Abdallah AM, 2006, MOL MICROBIOL, V62, P667, DOI 10.1111/j.1365-2958.2006.05409.x
   Ainsa JA, 1998, J BACTERIOL, V180, P5836
   Ainsa JA, 1996, ANTIMICROB AGENTS CH, V40, P2350, DOI 10.1128/AAC.40.10.2350
   Alexander DC, 2003, ANTIMICROB AGENTS CH, V47, P3208, DOI 10.1128/AAC.47.10.3208-3213.2003
   Alonso S, 2007, P NATL ACAD SCI USA, V104, P6031, DOI 10.1073/pnas.0700036104
   Andriole VT, 2005, CLIN INFECT DIS, V41, pS113, DOI 10.1086/428051
   ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713
   Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0
   Baumeister W, 1998, CELL, V92, P367, DOI 10.1016/S0092-8674(00)80929-0
   Belisle JT, 1997, SCIENCE, V276, P1420, DOI 10.1126/science.276.5317.1420
   Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158
   Boehm U, 1997, ANNU REV IMMUNOL, V15, P749, DOI 10.1146/annurev.immunol.15.1.749
   Botha T, 2002, IMMUNOLOGY, V107, P350, DOI 10.1046/j.1365-2567.2002.01511.x
   BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333
   Buchmeier NA, 2003, MOL MICROBIOL, V47, P1723, DOI 10.1046/j.1365-2958.2003.03416.x
   Buriankova K, 2004, ANTIMICROB AGENTS CH, V48, P143, DOI 10.1128/AAC.48.1.143-150.2004
   Cabral JHM, 1997, NATURE, V388, P903, DOI 10.1038/42294
   CHAMBERS HF, 1995, ANTIMICROB AGENTS CH, V39, P2620, DOI 10.1128/AAC.39.12.2620
   Chambers HF, 2005, ANTIMICROB AGENTS CH, V49, P2816, DOI 10.1128/AAC.49.7.2816-2821.2005
   Champion PAD, 2006, SCIENCE, V313, P1632, DOI 10.1126/science.1131167
   CHAN J, 1995, INFECT IMMUN, V63, P736, DOI 10.1128/IAI.63.2.736-740.1995
   Chen JM, 2008, NUCLEIC ACIDS RES, V36, P2123, DOI 10.1093/nar/gkm1162
   Chua J, 2004, CURR OPIN MICROBIOL, V7, P71, DOI 10.1016/j.mib.2003.12.011
   Colangeli R, 2005, MOL MICROBIOL, V55, P1829, DOI 10.1111/j.1365-2958.2005.04510.x
   Colangeli R, 2007, PLOS PATHOG, V3, P780, DOI 10.1371/journal.ppat.0030087
   COOPER RA, 1984, ANNU REV MICROBIOL, V38, P49, DOI 10.1146/annurev.mi.38.100184.000405
   Dabbs ER, 2000, FEMS MICROBIOL LETT, V182, P105
   Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176
   DAVIS NK, 1992, MOL GEN GENET, V232, P351, DOI 10.1007/BF00266237
   de Chastellier C, 2006, CELL MICROBIOL, V8, P242, DOI 10.1111/j.1462-5822.2005.00617.x
   de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7
   De Rossi E, 2006, FEMS MICROBIOL REV, V30, P36, DOI 10.1111/j.1574-6976.2005.00000.x
   De Souzaa MVN, 2006, CURR MED CHEM, V13, P455, DOI 10.2174/092986706775527965
   Deghmane AE, 2007, J CELL SCI, V120, P2796, DOI 10.1242/jcs.006221
   Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237
   Duncan K, 2004, CURR OPIN MICROBIOL, V7, P460, DOI 10.1016/j.mib.2004.08.011
   Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998
   Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163
   Ferber D, 2005, SCIENCE, V308, P1393
   Ferguson JS, 2004, INFECT IMMUN, V72, P2564, DOI 10.1128/IAI.72.5.2564-2573.2004
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Flores AR, 2005, MICROBIOL-SGM, V151, P521, DOI 10.1099/mic.0.27629-0
   FLYNN JL, 1993, J EXP MED, V178, P2249, DOI 10.1084/jem.178.6.2249
   Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100
   Frenkiel-Krispin D, 2001, EMBO J, V20, P1184, DOI 10.1093/emboj/20.5.1184
   Gandotra S, 2007, NAT MED, V13, P1515, DOI 10.1038/nm1683
   Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x
   Gao LY, 2003, MOL MICROBIOL, V49, P1547, DOI 10.1046/j.1365-2958.2003.03667.x
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Geiman DE, 2006, ANTIMICROB AGENTS CH, V50, P2836, DOI 10.1128/AAC.00295-06
   Gokhale RS, 2007, NAT PROD REP, V24, P267, DOI 10.1039/b616817p
   Gold B, 2001, MOL MICROBIOL, V42, P851, DOI 10.1046/j.1365-2958.2001.02684.x
   Goldberg AL, 2003, NATURE, V426, P895, DOI 10.1038/nature02263
   Goldman Robert C., 2007, Infectious Disorders - Drug Targets, V7, P73
   Gomez JE, 2000, P NATL ACAD SCI USA, V97, P8554, DOI 10.1073/pnas.140225297
   Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038
   Hegde SS, 2005, SCIENCE, V308, P1480, DOI 10.1126/science.1110699
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Jayakumar D, 2008, CELL MICROBIOL, V10, P365, DOI 10.1111/j.1462-5822.2007.01049.x
   Jouanguy E, 1997, J INTERF CYTOK RES, V17, P583, DOI 10.1089/jir.1997.17.583
   Kang YJ, 2007, J IMMUNOL, V179, P4598, DOI 10.4049/jimmunol.179.7.4598
   Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519
   Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345
   Lella RK, 2007, J BIOL CHEM, V282, P18671, DOI 10.1074/jbc.C600280200
   Leong ASY, 2008, J CLIN PATHOL, V61, P366, DOI 10.1136/jcp.2007.050690
   Levine B, 2004, DEV CELL, V6, P463, DOI 10.1016/S1534-5807(04)00099-1
   Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018
   Li SY, 2007, LIFE SCI, V80, P1051, DOI 10.1016/j.lfs.2006.11.035
   Liu J, 1999, P NATL ACAD SCI USA, V96, P4011, DOI 10.1073/pnas.96.7.4011
   Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933
   MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323
   MacMicking JD, 2005, CURR OPIN MICROBIOL, V8, P74, DOI 10.1016/j.mib.2004.12.012
   MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243
   MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063
   Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594
   MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763, DOI 10.1128/IAI.61.7.2763-2773.1993
   McKinney JD, 2000, NAT MED, V6, P1330, DOI 10.1038/82142
   Miller BH, 2004, INFECT IMMUN, V72, P2872, DOI 10.1128/IAI.72.5.2872-2878.2004
   MINNIKIN D, 1982, BIOL MYCOBACTERIA, P94
   Montero C, 2001, ANTIMICROB AGENTS CH, V45, P3387, DOI 10.1128/AAC.45.12.3387-3392.2001
   Morris RP, 2005, P NATL ACAD SCI USA, V102, P12200, DOI 10.1073/pnas.0505446102
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Mwandumba HC, 2004, J IMMUNOL, V172, P4592, DOI 10.4049/jimmunol.172.7.4592
   MYERS A, 1963, CHEST, V43, P327
   Nakagawa I, 2004, SCIENCE, V306, P1037, DOI 10.1126/science.1103966
   Nash KA, 2005, J ANTIMICROB CHEMOTH, V55, P170, DOI 10.1093/jac/dkh523
   Nash KA, 2003, ANTIMICROB AGENTS CH, V47, P3053, DOI 10.1128/AAC.47.10.3053-3060.2003
   NATHAN C, 1994, J BIOL CHEM, V269, P13725
   Nguyen L, 2005, J BACTERIOL, V187, P6603, DOI 10.1128/JB.187.19.6603-6611.2005
   Nguyen L, 2006, TRENDS MICROBIOL, V14, P304, DOI 10.1016/j.tim.2006.05.005
   Niederweis M, 2003, MOL MICROBIOL, V49, P1167, DOI 10.1046/j.1365-2958.2003.03662.x
   NIKAIDO H, 1994, SCIENCE, V264, P382, DOI 10.1126/science.8153625
   Ogawa M, 2005, SCIENCE, V307, P727, DOI 10.1126/science.1106036
   Pearce MJ, 2006, EMBO J, V25, P5423, DOI 10.1038/sj.emboj.7601405
   Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186
   Philalay JS, 2004, ANTIMICROB AGENTS CH, V48, P3412, DOI 10.1128/AAC.48.9.3412-3418.2004
   Pieters J, 2003, SCIENCE, V302, P1900, DOI 10.1126/science.1092873
   Pieters Jean, 2008, V48, P116, DOI 10.1007/978-0-387-09595-0_11
   Rachman H, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000029
   Ratledge C, 2004, TUBERCULOSIS, V84, P110, DOI 10.1016/j.tube.2003.08.012
   Rawat M, 2002, ANTIMICROB AGENTS CH, V46, P3348, DOI 10.1128/AAC.46.11.3348-3355.2002
   Rohde K, 2007, IMMUNOL REV, V219, P37, DOI 10.1111/j.1600-065X.2007.00547.x
   Samuel LP, 2007, MICROBIOL-SGM, V153, P529, DOI 10.1099/mic.0.2006/002642-0
   Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104
   Schoenborn JR, 2007, ADV IMMUNOL, V96, P41, DOI 10.1016/S0065-2776(07)96002-2
   Shiratsuchi A, 2004, J IMMUNOL, V172, P2039, DOI 10.4049/jimmunol.172.4.2039
   Siezen R. J., 2001, GENOME BIOL, V2
   Singh A, 2005, J BACTERIOL, V187, P4173, DOI 10.1128/JB.187.12.4173-4186.2005
   Singh A, 2003, FEMS MICROBIOL LETT, V227, P53, DOI 10.1016/S0378-1097(03)00648-7
   Singh A, 2007, P NATL ACAD SCI USA, V104, P11562, DOI 10.1073/pnas.0700490104
   St-Denis A, 1999, J IMMUNOL, V163, P5505
   Stamm LM, 2003, J EXP MED, V198, P1361, DOI 10.1084/jem.20031072
   Stephan J, 2004, ANTIMICROB AGENTS CH, V48, P4163, DOI 10.1128/AAC.48.11.4163-4170.2004
   Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399
   SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x
   Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   Tan T, 2006, CELL MICROBIOL, V8, P1417, DOI 10.1111/j.1462-5822.2006.00721.x
   Taylor GA, 2004, NAT REV IMMUNOL, V4, P100, DOI 10.1038/nri1270
   Teitelbaum R, 1999, P NATL ACAD SCI USA, V96, P15190, DOI 10.1073/pnas.96.26.15190
   van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059
   Vasanji A, 2004, DEV CELL, V6, P29, DOI 10.1016/S1534-5807(03)00397-6
   Velasco-Velazquez MA, 2003, MICROB PATHOGENESIS, V35, P125, DOI 10.1016/S0882-4010(03)00099-8
   Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102
   Vergne I, 2003, TRAFFIC, V4, P600, DOI 10.1034/j.1600-0854.2003.00120.x
   Vetting M, 2003, BIOCHEM SOC T, V31, P520, DOI 10.1042/BST0310520
   Viveiros M, 2003, INT J ANTIMICROB AG, V22, P274, DOI 10.1016/S0924-8579(03)00208-5
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   Wei J, 2000, J BACTERIOL, V182, P377, DOI 10.1128/JB.182.2.377-384.2000
   Wright GD, 2007, NAT REV MICROBIOL, V5, P175, DOI 10.1038/nrmicro1614
   Yang CS, 2007, CELL MICROBIOL, V9, P382, DOI 10.1111/j.1462-5822.2006.00797.x
   Zimmerli S, 1996, AM J RESP CELL MOL, V15, P760, DOI 10.1165/ajrcmb.15.6.8969271
NR 133
TC 49
Z9 51
U1 0
U2 10
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0362-1642
EI 1545-4304
J9 ANNU REV PHARMACOL
JI Annu. Rev. Pharmacol. Toxicol.
PY 2009
VL 49
BP 427
EP 453
DI 10.1146/annurev-pharmtox-061008-103123
PG 27
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 410GQ
UT WOS:000263565900019
PM 19281311
DA 2021-01-25
ER

PT J
AU Schatz, G
AF Schatz, Gottfried
TI Prelude at foot of East 16th street 1963-1965
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
LA English
DT Editorial Material
ID CATALYZING OXIDATIVE PHOSPHORYLATION; PARTIAL RESOLUTION; RESPIRATORY
   CHAIN; ENZYMES
C1 Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Schatz, G (corresponding author), Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
EM gottfried.schatz@unibas.ch
CR BUTOW RA, 1965, J GEN PHYSIOL, V49, P149, DOI 10.1085/jgp.49.1.149
   CHANCE B, 1955, J BIOL CHEM, V217, P383
   HINKLE PC, 1967, J BIOL CHEM, V242, P5169
   MITCHELL RA, 1964, BIOCHEM BIOPH RES CO, V16, P545, DOI 10.1016/0006-291X(64)90190-1
   PULLMAN ME, 1960, J BIOL CHEM, V235, P3322
   RACKER E, 1957, HARVEY LECT, P143
   TYLER DD, 1965, BIOCHEM BIOPH RES CO, V19, P551, DOI 10.1016/0006-291X(65)90161-0
NR 7
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-4889
J9 BBA-MOL CELL RES
JI Biochim. Biophys. Acta-Mol. Cell Res.
PD JAN
PY 2009
VL 1793
IS 1
BP 2
EP 4
DI 10.1016/j.bbamcr.2008.06.002
PG 3
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 398NH
UT WOS:000262738300002
DA 2021-01-25
ER

PT J
AU Vogler, C
   Spalek, K
   Aerni, A
   Demougin, P
   Muller, A
   Huynh, KD
   Papassotiropoulos, A
   de Quervain, DJF
AF Vogler, Christian
   Spalek, Klara
   Aerni, Amanda
   Demougin, Philippe
   Mueller, Ariane
   Huynh, Kim-Dung
   Papassotiropoulos, Andreas
   de Quervain, Dominique J. -F.
TI CPEB3 is associated with human episodic memory
SO FRONTIERS IN BEHAVIORAL NEUROSCIENCE
LA English
DT Article
DE CPEB3; emotional; episodic; memory; polymorphism
AB Cytoplasmic polyadenylation element-binding (CPEB) proteins are crucial for synaptic plasticity and memory in model organisms. A highly conserved, mammalian-specific short intronic sequence within CPEB3 has been identified as a ribozyme with self-cleavage properties. In humans, the ribozyme sequence is polymorphic and harbors a single nucleotide polymorphism that influences cleavage activity of the ribozyme. Here we show that this variation is related to performance in an episodic memory task and that the effect of the variation depends on the emotional valence of the presented material. Our data suggest a role for human CPEB3 in human episodic memory.
C1 [Aerni, Amanda; de Quervain, Dominique J. -F.] Univ Zurich, Div Psychiat Res, CH-8032 Zurich, Switzerland.
   [Vogler, Christian; Spalek, Klara; Demougin, Philippe; Mueller, Ariane; Huynh, Kim-Dung; Papassotiropoulos, Andreas] Univ Basel, Div Mol Psychol, Basel, Switzerland.
   [Vogler, Christian; Spalek, Klara; Demougin, Philippe; Mueller, Ariane; Huynh, Kim-Dung; Papassotiropoulos, Andreas] Univ Basel, Biozentrum, Life Sci Training Facil, Basel, Switzerland.
   [de Quervain, Dominique J. -F.] Univ Zurich, Ctr Integrat Human Physiol, Zurich, Switzerland.
RP de Quervain, DJF (corresponding author), Univ Zurich, Div Psychiat Res, Lenggstr 31, CH-8032 Zurich, Switzerland.
EM quervain@bli.uzh.ch
OI Papassotiropoulos, Andreas/0000-0002-2210-9651; de Quervain,
   Dominique/0000-0001-7131-2464; Spalek, Klara/0000-0002-4244-6495;
   Vogler, Christian/0000-0003-3922-109X
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [PP00B-106708, PP00B-68859, PP00B-114813]
FX This work was supported by grants from the Swiss National Science
   Foundation to D. Q. and A.P. (PP00B-106708, PP00B-68859, PP00B-114813).
CR Berger-Sweeney J, 2006, LEARN MEMORY, V13, P4, DOI 10.1101/lm.73706
   de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Hager W., 1994, HDB DEUTSCHSPRACHIGE
   Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322
   Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003
   Keleman K, 2007, NAT NEUROSCI, V10, P1587, DOI 10.1038/nn1996
   Klann E, 2004, NAT REV NEUROSCI, V5, P931, DOI 10.1038/nrn1557
   Mendez R, 2000, NATURE, V404, P302
   Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837
   Richter JD, 2007, TRENDS BIOCHEM SCI, V32, P279, DOI 10.1016/j.tibs.2007.04.004
   Salehi-Ashtiani K, 2006, SCIENCE, V313, P1788, DOI 10.1126/science.1129308
   Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1
   Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3
   Stuart G, 2000, J EXP PSYCHOL LEARN, V26, P796, DOI 10.1037/0278-7393.26.3.796
NR 15
TC 26
Z9 27
U1 0
U2 7
PU FRONTIERS MEDIA SA
PI LAUSANNE
PA AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND
SN 1662-5153
J9 FRONT BEHAV NEUROSCI
JI Front. Behav. Neurosci.
PY 2009
VL 3
AR 4
DI 10.3389/neuro.08.004.2009
PG 5
WC Behavioral Sciences; Neurosciences
SC Behavioral Sciences; Neurosciences & Neurology
GA V18VE
UT WOS:000208031500004
PM 19503753
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Duerig, A
   Abel, S
   Folcher, M
   Nicollier, M
   Schwede, T
   Amiot, N
   Giese, B
   Jenal, U
AF Duerig, Anna
   Abel, Soeren
   Folcher, Marc
   Nicollier, Micael
   Schwede, Torsten
   Amiot, Nicolas
   Giese, Bernd
   Jenal, Urs
TI Second messenger-mediated spatiotemporal control of protein degradation
   regulates bacterial cell cycle progression
SO GENES & DEVELOPMENT
LA English
DT Article
DE PopA; cyclic di-GMP; protein degradation; Caulobacter crescentus; cell
   cycle; second messenger
ID POLAR ORGANELLE DEVELOPMENT; RESPONSE REGULATOR; ALLOSTERIC CONTROL;
   LOCALIZATION FACTOR; CRYSTAL-STRUCTURE; PROTEOLYSIS; DIGUANYLATE;
   SIGNAL; GGDEF; PODJ
AB Second messengers control a wide range of important cellular functions in eukaryotes and prokaryotes. Here we show that cyclic di-GMP, a global bacterial second messenger, promotes cell cycle progression in Caulobacter crescentus by mediating the specific degradation of the replication initiation inhibitor CtrA. During the G1-to-S-phase transition, both CtrA and its cognate protease ClpXP dynamically localize to the old cell pole, where CtrA is rapidly degraded. Sequestration of CtrA to the cell pole depends on PopA, a newly identified cyclic di-GMP effector protein. PopA itself localizes to the cell pole and directs CtrA to this subcellular site via the direct interaction with a mediator protein, RcdA. We present evidence that c-di-GMP regulates CtrA degradation during the cell cycle by controlling the dynamic sequestration of the PopA recruitment factor to the cell pole. Furthermore, we show that cell cycle timing of CtrA degradation relies on converging pathways responsible for substrate and protease localization to the old cell pole. This is the first report that links cyclic di-GMP to protein dynamics and cell cycle control in bacteria.
C1 [Duerig, Anna; Abel, Soeren; Folcher, Marc; Nicollier, Micael; Schwede, Torsten; Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Amiot, Nicolas; Giese, Bernd] Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch
RI Ebbensgaard, Anna/AAH-2582-2019; Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X; Ebbensgaard, Anna
   Elisabeth/0000-0003-2557-4679; Abel, Soren/0000-0002-4041-6989
FU Swiss National Science Foundation FellowshipSwiss National Science
   Foundation (SNSF) [3100A0-108186]
FX We thank A. Iniesta and L. Shapiro for strains, F. Hamburger for
   construction of plasmids, and Victor Sourjik and Hui Li for their help
   with FRET analysis. This work was supported by Swiss National Science
   Foundation Fellowship 3100A0-108186 to U.J.
CR Alba BM, 2002, GENE DEV, V16, P2156, DOI 10.1101/gad.1008902
   Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321
   Chan C, 2004, P NATL ACAD SCI USA, V101, P17084, DOI 10.1073/pnas.0406134101
   Chen JC, 2006, EMBO J, V25, P377, DOI 10.1038/sj.emboj.7600935
   Chien P, 2007, P NATL ACAD SCI USA, V104, P6590, DOI 10.1073/pnas.0701776104
   Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200
   Christen M, 2005, J BIOL CHEM, V280, P30829, DOI 10.1074/jbc.M504429200
   Domian IJ, 1999, P NATL ACAD SCI USA, V96, P6648, DOI 10.1073/pnas.96.12.6648
   Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4
   ELY B, 1991, METHOD ENZYMOL, V204, P372
   Evans JH, 2007, P NATL ACAD SCI USA, V104, P16176, DOI 10.1073/pnas.0707719104
   Gonzalez M, 2000, EMBO J, V19, P5251, DOI 10.1093/emboj/19.19.5251
   Gottesman S, 2003, ANNU REV CELL DEV BI, V19, P565, DOI 10.1146/annurev.cellbio.19.110701.153228
   Grunenfelder B, 2001, P NATL ACAD SCI USA, V98, P4681, DOI 10.1073/pnas.071538098
   Hinz AJ, 2003, MOL MICROBIOL, V47, P929, DOI 10.1046/j.1365-2958.2003.03349.x
   Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103
   Insall R, 2007, CURR OPIN MICROBIOL, V10, P578, DOI 10.1016/j.mib.2007.10.004
   Janetopoulos C, 2005, DEV CELL, V8, P467, DOI 10.1016/j.devcel.2005.02.010
   Jenal U, 2003, CURR OPIN MICROBIOL, V6, P163, DOI 10.1016/S1369-5274(03)00029-8
   Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x
   Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658
   Jenal U, 2006, ANNU REV GENET, V40, P385, DOI 10.1146/annurev.genet.40.110405.090423
   Johansson J, 1999, P NATL ACAD SCI USA, V96, P10776, DOI 10.1073/pnas.96.19.10776
   Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x
   Kanehara K, 2002, GENE DEV, V16, P2147, DOI 10.1101/gad.1002302
   Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752
   Keiler KC, 1996, SCIENCE, V271, P990, DOI 10.1126/science.271.5251.990
   Kim DY, 2003, J BIOL CHEM, V278, P50664, DOI 10.1074/jbc.M305882200
   Kulesekara H, 2006, P NATL ACAD SCI USA, V103, P2839, DOI 10.1073/pnas.0511090103
   Lawler ML, 2006, MOL MICROBIOL, V59, P301, DOI 10.1111/j.1365-2958.2005.04935.x
   Levi A, 2006, J BACTERIOL, V188, P5315, DOI 10.1128/JB.01725-05
   Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x
   Malone JG, 2007, MICROBIOL-SGM, V153, P980, DOI 10.1099/mic.0.2006/002824-0
   McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033
   Miyawaki A, 2000, METHOD ENZYMOL, V327, P472, DOI 10.1016/S0076-6879(00)27297-2
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Paul R, 2008, CELL, V133, P452, DOI 10.1016/j.cell.2008.02.045
   Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200
   Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120
   Ryan KR, 2004, P NATL ACAD SCI USA, V101, P7415, DOI 10.1073/pnas.0402153101
   Ryan KR, 2002, J MOL BIOL, V324, P443, DOI 10.1016/S0022-2836(02)01042-2
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Selvin PR, 2000, NAT STRUCT BIOL, V7, P730, DOI 10.1038/78948
   Simm R, 2004, MOL MICROBIOL, V53, P1123, DOI 10.1111/j.1365-2958.2004.04206.x
   Sourjik V, 2002, P NATL ACAD SCI USA, V99, P123, DOI 10.1073/pnas.011589998
   Tamayo R, 2007, ANNU REV MICROBIOL, V61, P131, DOI 10.1146/annurev.micro.61.080706.093426
   Thanbichler M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm818
   Tsai JW, 2001, J BACTERIOL, V183, P5001, DOI 10.1128/JB.183.17.5001-5007.2001
   Turgay K, 1998, EMBO J, V17, P6730
   Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999
   Wang JM, 1998, J STRUCT BIOL, V124, P151, DOI 10.1006/jsbi.1998.4058
   WANG SP, 1993, P NATL ACAD SCI USA, V90, P630, DOI 10.1073/pnas.90.2.630
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x
   Wheeler DL, 2007, NUCLEIC ACIDS RES, V35, pD5, DOI 10.1093/nar/gkl1031
   Zhu J, 2001, P NATL ACAD SCI USA, V98, P1507, DOI 10.1073/pnas.98.4.1507
NR 59
TC 203
Z9 208
U1 0
U2 24
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 0890-9369
EI 1549-5477
J9 GENE DEV
JI Genes Dev.
PD JAN 1
PY 2009
VL 23
IS 1
BP 93
EP 104
DI 10.1101/gad.502409
PG 12
WC Cell Biology; Developmental Biology; Genetics & Heredity
SC Cell Biology; Developmental Biology; Genetics & Heredity
GA 393JN
UT WOS:000262369700009
PM 19136627
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Balwierz, PJ
   Carninci, P
   Daub, CO
   Kawai, J
   Hayashizaki, Y
   Van Belle, W
   Beisel, C
   van Nimwegen, E
AF Balwierz, Piotr J.
   Carninci, Piero
   Daub, Carsten O.
   Kawai, Jun
   Hayashizaki, Yoshihide
   Van Belle, Werner
   Beisel, Christian
   van Nimwegen, Erik
TI Methods for analyzing deep sequencing expression data: constructing the
   human and mouse promoterome with deepCAGE data
SO GENOME BIOLOGY
LA English
DT Article
ID GENOME-WIDE ANALYSIS; GENE-EXPRESSION; TRANSCRIPTIONAL LANDSCAPE; CAP
   ANALYSIS; RNA-SEQ; REPRODUCIBILITY; ARRAYS; CAGE
AB With the advent of ultra high-throughput sequencing technologies, increasingly researchers are turning to deep sequencing for gene expression studies. Here we present a set of rigorous methods for normalization, quantification of noise, and co-expression analysis of deep sequencing data. Using these methods on 122 cap analysis of gene expression (CAGE) samples of transcription start sites, we construct genome-wide 'promoteromes' in human and mouse consisting of a three-tiered hierarchy of transcription start sites, transcription start clusters, and transcription start regions.
C1 [Balwierz, Piotr J.; van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Balwierz, Piotr J.; van Nimwegen, Erik] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Carninci, Piero; Daub, Carsten O.; Kawai, Jun; Hayashizaki, Yoshihide] RIKEN Yokohama Inst, RIKEN Om Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan.
   [Van Belle, Werner; Beisel, Christian] Eidgenoss Tech Hsch Zurich, Dept Biosyst Sci & Engn, Lab Quantitat Genom, CH-4058 Basel, Switzerland.
RP van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erik.vannimwegen@unibas.ch
RI Carninci, Piero/K-1568-2014; Daub, Carsten O/A-7436-2010; Balwierz,
   Piotr J/AAG-4187-2020; Kawai, Jun/A-6451-2016
OI Carninci, Piero/0000-0001-7202-7243; Daub, Carsten
   O/0000-0002-3295-8729; Balwierz, Piotr J/0000-0002-1548-4605; van
   Nimwegen, Erik/0000-0001-6338-1312; Beisel,
   Christian/0000-0001-5360-2193
FU Ministry of Education, Culture, Sports, Science and Technology, Japan
   (MEXT)Ministry of Education, Culture, Sports, Science and Technology,
   Japan (MEXT); Swiss National Science FoundationSwiss National Science
   Foundation (SNSF) [SNF 3100A0-118318]; FP6 Alternative Splicing Network
   of Excellence (EURASNET) Young Investigator Award
FX The CAGE data used in this work were supported by grants for the Genome
   Network Project from the Ministry of Education, Culture, Sports, Science
   and Technology, Japan (MEXT) to YH, a Research Grant for the RIKEN
   Genome Exploration Research Project from MEXT to YH and a Cell
   Innovation Project from MEXT to YH. EvN and PB were supported by grant
   SNF 3100A0-118318 of the Swiss National Science Foundation. PB has been
   partially supported by the FP6 Alternative Splicing Network of
   Excellence (EURASNET) Young Investigator Award to Mihaela Zavolan. The
   authors thank the anonymous internal reviewers of the FANTOM4 project
   for many useful comments and suggestions.
CR Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185
   Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014
   Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789
   Carninci P, 2006, TRENDS GENET, V22, P501, DOI 10.1016/j.tig.2006.07.003
   Draghici S, 2006, TRENDS GENET, V22, P101, DOI 10.1016/j.tig.2005.12.005
   Faulkner GJ, 2008, GENOMICS, V91, P281, DOI 10.1016/j.ygeno.2007.11.003
   Frith MC, 2008, GENOME RES, V18, P1, DOI 10.1101/gr.6831208
   Jaynes E. T., 2003, PROBABILITY THEORY L
   Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966
   Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211
   Lassmann T, 2009, NUCLEIC ACIDS RES, V37, P858, DOI 10.1093/nar/gkn1006
   Lu T, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-37
   Maeda N, 2008, BIOTECHNIQUES, V45, P95, DOI 10.2144/000112814
   Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108
   Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226
   Nagalakshmi U, 2008, SCIENCE, V320, P1344, DOI 10.1126/science.1158441
   Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068
   Rosenkranz R, 2008, GENOMICS, V92, P187, DOI 10.1016/j.ygeno.2008.05.011
   Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103
   Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Ueda HR, 2004, P NATL ACAD SCI USA, V101, P3765, DOI 10.1073/pnas.0306244101
   Valen E, 2009, GENOME RES, V19, P255, DOI 10.1101/gr.084541.108
   Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002
   Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683
   Zhang ZD, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000158
NR 27
TC 91
Z9 91
U1 0
U2 12
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PY 2009
VL 10
IS 7
AR R79
DI 10.1186/gb-2009-10-7-r79
PG 21
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 487WV
UT WOS:000269309600014
PM 19624849
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Severin, J
   Waterhouse, AM
   Kawaji, H
   Lassmann, T
   van Nimwegen, E
   Balwierz, PJ
   de Hoon, MJL
   Hume, DA
   Carninci, P
   Hayashizaki, Y
   Suzuki, H
   Daub, CO
   Forrest, ARR
AF Severin, Jessica
   Waterhouse, Andrew M.
   Kawaji, Hideya
   Lassmann, Timo
   van Nimwegen, Erik
   Balwierz, Piotr J.
   de Hoon, Michiel J. L.
   Hume, David A.
   Carninci, Piero
   Hayashizaki, Yoshihide
   Suzuki, Harukazu
   Daub, Carsten O.
   Forrest, Alistair R. R.
TI FANTOM4 EdgeExpressDB: an integrated database of promoters, genes,
   microRNAs, expression dynamics and regulatory interactions
SO GENOME BIOLOGY
LA English
DT Article
ID FUNCTIONAL ANNOTATION; BINDING-SITES; INFORMATION; RESOURCE; REVEALS;
   DISCOVERY; NETWORKS; ACCESS; SYSTEM; CELLS
AB EdgeExpressDB is a novel database and set of interfaces for interpreting biological networks and comparing large high-throughput expression datasets that requires minimal development for new data types and search patterns. The FANTOM4 EdgeExpress database http://fantom.gsc.riken.jp/4/edgeexpress summarizes gene expression patterns in the context of alternative promoter structures and regulatory transcription factors and microRNAs using intuitive gene-centric and sub-network views. This is an important resource for gene regulation in acute myeloid leukemia, monocyte/macrophage differentiation and human transcriptional networks.
C1 [Severin, Jessica; Waterhouse, Andrew M.; Kawaji, Hideya; Lassmann, Timo; de Hoon, Michiel J. L.; Carninci, Piero; Hayashizaki, Yoshihide; Suzuki, Harukazu; Daub, Carsten O.; Forrest, Alistair R. R.] RIKEN Om Sci Ctr, RIKEN Yokohama Inst, Tsurumi Ku, Kanagawa 2300045, Japan.
   [van Nimwegen, Erik; Balwierz, Piotr J.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [van Nimwegen, Erik; Balwierz, Piotr J.] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland.
   [Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland.
   [Forrest, Alistair R. R.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Nathan, Qld 4111, Australia.
RP Severin, J (corresponding author), RIKEN Om Sci Ctr, RIKEN Yokohama Inst, Tsurumi Ku, 1-7-22 Suehiro Cho, Kanagawa 2300045, Japan.
EM severin@gsc.riken.jp; alistair.forrest@gmail.com
RI de Hoon, Michiel/A-6443-2013; Kawaji, Hideya/N-5116-2015; Suzuki,
   Harukazu/N-9553-2015; Balwierz, Piotr J/AAG-4187-2020; Forrest,
   Alistair/A-6597-2008; Lassmann, Timo/A-8271-2008; Hume, David
   A/C-7695-2013; Hayashizaki, Yoshihide/N-6590-2015; Daub, Carsten
   O/A-7436-2010; Severin, Jessica/AAQ-2723-2020; Carninci,
   Piero/K-1568-2014
OI Kawaji, Hideya/0000-0002-0575-0308; Suzuki,
   Harukazu/0000-0002-8087-0836; Balwierz, Piotr J/0000-0002-1548-4605;
   Forrest, Alistair/0000-0003-4543-1675; Lassmann,
   Timo/0000-0002-0138-2691; Daub, Carsten O/0000-0002-3295-8729; Severin,
   Jessica/0000-0003-1274-208X; Carninci, Piero/0000-0001-7202-7243; Hume,
   David/0000-0002-2615-1478; van Nimwegen, Erik/0000-0001-6338-1312
FU RIKEN Omics Science Center from MEXT; Ministry of Education, Culture,
   Sports, Science and Technology, JapanMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT); Australian NHMRCNational
   Health and Medical Research Council of Australia [ID 428261]; Medical
   Research CouncilMedical Research Council UK (MRC) [G9900991B] Funding
   Source: researchfish
FX This work was supported by a Research Grant for RIKEN Omics Science
   Center from MEXT to YH and a grant of the Genome Network Project [2]
   from the Ministry of Education, Culture, Sports, Science and Technology,
   Japan to YH. ARRF is supported by a CJ Martin Fellowship from the
   Australian NHMRC (ID 428261).
CR Addo-Quaye C, 2008, CURR BIOL, V18, P758, DOI 10.1016/j.cub.2008.04.042
   Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056
   Bar M, 2008, STEM CELLS, V26, P2496, DOI 10.1634/stemcells.2008-0356
   Barrasa MI, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-21
   Breitkreutz BJ, 2008, NUCLEIC ACIDS RES, V36, pD637, DOI 10.1093/nar/gkm1001
   Buske C, 2001, BLOOD, V97, P2286, DOI 10.1182/blood.V97.8.2286
   Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789
   Clamp M, 2003, NUCLEIC ACIDS RES, V31, P38, DOI 10.1093/nar/gkg083
   Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223
   Cooper SJ, 2007, GENOME RES, V17, P136, DOI 10.1101/gr.5875007
   Ellson J, 2002, LECT NOTES COMPUT SC, V2265, P483
   Faulkner GJ, 2008, GENOMICS, V91, P281, DOI 10.1016/j.ygeno.2007.11.003
   Finn RD, 2007, BIOINFORMATICS, V23, P1568, DOI 10.1093/bioinformatics/btl650
   Forrest ARR, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r5
   Freeman TC, 2007, PLOS COMPUT BIOL, V3, P2032, DOI 10.1371/journal.pcbi.0030206
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Giovinazzo WA, 2000, OBJECT ORIENTED DATA
   Griffith OL, 2008, NUCLEIC ACIDS RES, V36, pD107, DOI 10.1093/nar/gkm967
   Griffiths-Jones S, 2008, NUCLEIC ACIDS RES, V36, pD154, DOI 10.1093/nar/gkm952
   Hollenhorst PC, 2007, GENE DEV, V21, P1882, DOI 10.1101/gad.1561707
   Ikeo K, 2003, CR BIOL, V326, P1079, DOI 10.1016/j.crvi.2003.09.034
   Kasprzyk A, 2004, GENOME RES, V14, P160, DOI 10.1101/gr.1645104
   Kawai J, 2001, NATURE, V409, P685, DOI 10.1038/35055500
   Kawaji H, 2006, NUCLEIC ACIDS RES, V34, pD632, DOI 10.1093/nar/gkj034
   Kelly LM, 2000, EMBO J, V19, P1987, DOI 10.1093/emboj/19.9.1987
   Lin SM, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkm1075
   Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031
   MUCENSKI ML, 1991, CELL, V65, P677, DOI 10.1016/0092-8674(91)90099-K
   Odero MD, 2000, GENE CHROMOSOME CANC, V29, P333, DOI 10.1002/1098-2264(2000)9999:9999<::AID-GCC1040>3.0.CO;2-Z
   Okazaki Y, 2002, NATURE, V420, P563, DOI 10.1038/nature01266
   Peri S, 2004, NUCLEIC ACIDS RES, V32, pD497, DOI 10.1093/nar/gkh070
   Rebhan M, 1997, TRENDS GENET, V13, P163, DOI 10.1016/S0168-9525(97)01103-7
   Robertson G, 2007, NAT METHODS, V4, P651, DOI 10.1038/NMETH1068
   Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303
   Shiraki T, 2003, P NATL ACAD SCI USA, V100, P15776, DOI 10.1073/pnas.2136655100
   Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]
   Smyth Gordon K, 2003, Methods Mol Biol, V224, P111
   Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602
   Sun K, 2006, CLIN HEMORHEOL MICRO, V34, P103
   Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375
   Tateno Y, 2002, NUCLEIC ACIDS RES, V30, P27, DOI 10.1093/nar/30.1.27
   TSUCHIYA S, 1980, INT J CANCER, V26, P171, DOI 10.1002/ijc.2910260208
   Valouev A, 2008, GENOME RES, V18, P1051, DOI 10.1101/gr.076463.108
   von Mering C, 2007, NUCLEIC ACIDS RES, V35, pD358, DOI 10.1093/nar/gkl825
   Wakaguri H, 2008, NUCLEIC ACIDS RES, V36, pD97, DOI 10.1093/nar/gkm901
   Xenarios I, 2000, NUCLEIC ACIDS RES, V28, P289, DOI 10.1093/nar/28.1.289
   Xi HL, 2007, GENOME RES, V17, P798, DOI 10.1101/gr.5754707
   Xu XQ, 2007, GENOME RES, V17, P1550, DOI 10.1101/gr.6783507
   Zeller KI, 2006, P NATL ACAD SCI USA, V103, P17834, DOI 10.1073/pnas.0604129103
NR 49
TC 51
Z9 52
U1 0
U2 1
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1474-760X
J9 GENOME BIOL
JI Genome Biol.
PY 2009
VL 10
IS 4
AR R39
DI 10.1186/gb-2009-10-4-r39
PG 9
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 452MP
UT WOS:000266544600011
PM 19374773
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT S
AU Gehring, WJ
   Kloter, U
   Suga, H
AF Gehring, Walter J.
   Kloter, Urs
   Suga, Hiroshi
BE Pourquie, O
TI EVOLUTION OF THE HOX GENE COMPLEX FROM AN EVOLUTIONARY GROUND STATE
SO HOX GENES
SE Current Topics in Developmental Biology
LA English
DT Review; Book Chapter
ID HOMEOTIC GENES; DROSOPHILA-MELANOGASTER; BITHORAX COMPLEX; EMPTY
   SPIRACLES; HOMEOBOX GENES; DNA-SEQUENCE; EXPRESSION; ORGANIZATION; EYE;
   TRANSFORMATION
AB In this chapter, we consider the question of how the ordered clusters of Hox genes arose during evolution. Since ordered Hox clusters are found in all major superphyla, we have to assume that the Hox clusters arose before the Cambrian "explosion" giving rise to all of these taxa. Based on his studies of the bithorax complex (BX-C) in Drosophila Lewis considered the ground state to be the mesothoracic segment (T2) since the deletion of all of the genes of the BX-C leads to a transformation of all segments from T3 to A8/9 (the last abdominal segment) into T2 segments. We define the developmental ground state genetically, by assuming that loss-of-function mutants lead to transformations toward the ground state, whereas gain-of-function mutants lead to homeotic transformations away from the ground state. By this definition, T2 also represents the developmental ground state, if one includes the anterior genes, that is, those of the Antennapedia complex. We have reconstructed the evolution of the Hox cluster on the basis of known genetic mechanisms which involve unequal crossover and lead from an urhox gene, first to an anterior and a posterior gene and subsequently to intermediate genes which are progressively inserted, between the anterior and posterior genes. These intermediate genes are recombinant due to unequal crossover, whereas the anterior and posterior genes are not affected and therefore had the longest time to diverge from the urhox gene. The molecular phylogenetic analysis strongly supports this model. We consider the ground state to be both developmental and evolutionary and to represent the prototypic body segment. It corresponds to T2 and is specified by Antennapedia or Hox6, respectively. Experiments in the mouse also suggest that the ground state is a thoracic segment. Evolution leads from the prototypic segment to segmental divergence in both the anterior and posterior direction. The most anterior head and tail segments are specified by homeobox genes localized outside of the cluster.
C1 [Gehring, Walter J.; Kloter, Urs; Suga, Hiroshi] Univ Basel, Dept Cell Biol, Biozentrum, Basel, Switzerland.
RP Gehring, WJ (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, Klingelbergstr, Basel, Switzerland.
CR Aboobaker AA, 2003, CURR BIOL, V13, P37, DOI 10.1016/S0960-9822(02)01399-4
   Aplin AC, 1997, MECH DEVELOP, V62, P51, DOI 10.1016/S0925-4773(96)00649-1
   BATE M, 1991, DEVELOPMENT, V112, P755
   BENDER W, 2003, GENES DEV CANC LIFE
   Bender W, 2008, GENE DEV, V22, P14, DOI 10.1101/gad.1614208
   BONCINELLI E, 1989, GENOME, V31, P745, DOI 10.1139/g89-133
   Burglin Thomas R., 1994, P25
   BURGLIN TR, 1991, NATURE, V351, P703, DOI 10.1038/351703a0
   BURGLIN TR, 2005, ENCY MOL CELL BIOL M, P179
   BURGLIN TR, 1995, BIODIVERSITY EVOLUTI, P291
   BURKE AC, 1995, DEVELOPMENT, V121, P333
   Butts T, 2008, TRENDS GENET, V24, P259, DOI 10.1016/j.tig.2007.09.006
   Callaerts P, 2002, P NATL ACAD SCI USA, V99, P2088, DOI 10.1073/pnas.042683899
   Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705
   CARPENTER FM, 1992, TREATISE INVERTEBRAT, V3, P97
   CARRASCO AE, 1984, CELL, V37, P409, DOI 10.1016/0092-8674(84)90371-4
   Carroll SB, 2001, DNA DIVERSITY MOL GE
   CHAN LN, 1971, P NATL ACAD SCI USA, V68, P2217, DOI 10.1073/pnas.68.9.2217
   Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944
   Cook CE, 2004, EVOL DEV, V6, P154, DOI 10.1111/j.1525-142X.2004.04020.x
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   DALTON D, 1989, GENE DEV, V3, P1940, DOI 10.1101/gad.3.12a.1940
   DUBOULE D, 1994, TRENDS GENET, V10, P358, DOI 10.1016/0168-9525(94)90132-5
   DUBOULE D, 1989, EMBO J, V8, P1497, DOI 10.1002/j.1460-2075.1989.tb03534.x
   Duboule D., 1994, GUIDEBOOK HOMEOBOX G
   Duncan I., 1982, DEV ORDER ITS ORIGIN, P533
   Edvardsen RB, 2005, CURR BIOL, V15, pR12, DOI 10.1016/j.cub.2004.12.010
   Estrada B, 2001, DEVELOPMENT, V128, P331
   FINKELSTEIN R, 1990, GENE DEV, V4, P1516, DOI 10.1101/gad.4.9.1516
   Finnerty JR, 1999, EVOL DEV, V1, P16, DOI 10.1046/j.1525-142x.1999.99010.x
   Force A, 1999, GENETICS, V151, P1531
   GARCIAFERNANDEZ J, 1994, NATURE, V370, P563, DOI 10.1038/370563a0
   Gehring W.J., 1998, MASTER CONTROL GENES
   GOLDBERG ML, 1983, P NATL ACAD SCI-BIOL, V80, P5017, DOI 10.1073/pnas.80.16.5017
   GONZALEZREYES A, 1990, NATURE, V344, P78, DOI 10.1038/344078a0
   Gu X, 2005, P NATL ACAD SCI USA, V102, P707, DOI 10.1073/pnas.0409186102
   HAFEN E, 1984, NATURE, V307, P287, DOI 10.1038/307287a0
   Hildebrand M., 1995, ANAL VERTEBRATE STRU
   Holland PWH, 1996, DEV BIOL, V173, P382, DOI 10.1006/dbio.1996.0034
   Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030
   Ikuta T, 2005, DEV DYNAM, V233, P382, DOI 10.1002/dvdy.20374
   Ingham PW, 1998, INT J DEV BIOL, V42, P423
   KARCH F, 2003, GENES DEV CANC LIFE
   KAUFMAN TC, 1980, GENETICS, V94, P115
   Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753
   Kmita M, 2002, NATURE, V420, P145, DOI 10.1038/nature01189
   Kmita-Cunisse M, 1998, P NATL ACAD SCI USA, V95, P3030, DOI 10.1073/pnas.95.6.3030
   Kozmik Z, 2008, P NATL ACAD SCI USA, V105, P8989, DOI 10.1073/pnas.0800388105
   LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0
   Lewis EB, 2003, CURR BIOL, V13, pR587, DOI 10.1016/S0960-9822(03)00520-7
   LEWIS EB, 1992, JAMA-J AM MED ASSOC, V267, P1524, DOI 10.1001/jama.267.11.1524
   Lewis EB, 1995, GENES DEV CANC LIFE
   Li WH, 2005, TRENDS GENET, V21, P602, DOI 10.1016/j.tig.2005.08.006
   MALICKI J, 1990, CELL, V63, P961, DOI 10.1016/0092-8674(90)90499-5
   MCGINNIS W, 1984, NATURE, V308, P428, DOI 10.1038/308428a0
   MCGINNIS W, 1984, CELL, V38, P675, DOI 10.1016/0092-8674(84)90262-9
   MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2
   MLODZIK M, 1985, EMBO J, V4, P2961, DOI 10.1002/j.1460-2075.1985.tb04030.x
   Moreno E, 1999, NATURE, V400, P873
   Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504
   Ohno S., 1970, EVOLUTION GENE DUPLI
   Plaza S, 2001, EMBO J, V20, P802, DOI 10.1093/emboj/20.4.802
   Plaza S, 2008, P NATL ACAD SCI USA, V105, P13439, DOI 10.1073/pnas.0806106105
   Punzo C, 2004, DEVELOPMENT, V131, P3943, DOI 10.1242/dev.01278
   QUIQUAND M, 2009, DEV BIOL IN PRESS
   RiveraPomar R, 1996, NATURE, V379, P746, DOI 10.1038/379746a0
   Ronshaugen M, 2005, GENE DEV, V19, P2947, DOI 10.1101/gad.1372505
   ROSE LS, 1992, GENE DEV, V6, P1255, DOI 10.1101/gad.6.7.1255
   SANCHEZHERRERO E, 1985, NATURE, V313, P108, DOI 10.1038/313108a0
   SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115
   Seo HC, 2004, NATURE, V431, P67, DOI 10.1038/nature02709
   Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246
   Shimodaira H, 2002, SYST BIOL, V51, P492, DOI 10.1080/10635150290069913
   SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x
   SIMON J, 1990, EMBO J, V9, P3945, DOI 10.1002/j.1460-2075.1990.tb07615.x
   Steingrimsson E, 2004, ANNU REV GENET, V38, P365, DOI 10.1146/annurev.genet.38.072902.092717
   VonAllmen G, 1996, NATURE, V380, P116, DOI 10.1038/380116a0
   Wada H, 1999, DEV BIOL, V213, P131, DOI 10.1006/dbio.1999.9369
   Wada S, 2003, DEV GENES EVOL, V213, P222, DOI 10.1007/s00427-003-0321-0
   Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672
   Zhang JZ, 1996, GENETICS, V142, P295
NR 81
TC 65
Z9 68
U1 1
U2 28
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0070-2153
BN 978-0-12-374529-3
J9 CURR TOP DEV BIOL
JI Curr. Top. Dev. Biol.
PY 2009
VL 88
BP 35
EP 61
DI 10.1016/S0070-2153(09)88002-2
PG 27
WC Developmental Biology
SC Developmental Biology
GA BKM59
UT WOS:000268505300002
PM 19651301
DA 2021-01-25
ER

PT J
AU Maier, S
   Reiterer, V
   Ruggiero, AM
   Rothstein, JD
   Thomas, S
   Dahm, R
   Sitte, HH
   Farhan, H
AF Maier, S.
   Reiterer, V.
   Ruggiero, A. M.
   Rothstein, J. D.
   Thomas, S.
   Dahm, R.
   Sitte, H. H.
   Farhan, H.
TI GTRAP3-18 serves as a negative regulator of Rab1 in protein transport
   and neuronal differentiation
SO JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
LA English
DT Article
DE PRA1 family proteins; Rab GTPases; ER-Golgi trafficking; neuronal
   differentiation
ID TO-GOLGI TRANSPORT; ENDOPLASMIC-RETICULUM; EXPRESSION PROFILE; COPII;
   COMPLEX; BINDING; EXPORT; ER; VESICLES; FORM
AB Glutamate transporter associated protein 3-18 (GTRAP3-18) is an endoplasmic reticulum (ER)-localized protein belonging to the prenylated rab-acceptor-family interacting with small Rab GTPases, which regulate intracellular trafficking events. Its impact on secretory trafficking has not been investigated. We report here that GTRAP3-18 has an inhibitory effect on Rab1, which is involved in ER-to-Golgi trafficking. The effects on the early secretory pathway in HEK293 cells were: reduction of the rate of ER-to-Golgi transport of the vesicular stomatitis virus glycoprotein (VSVG), slowed accumulation of a Golgi marker plasmid in pre-Golgi structures after Brefeldin A treatment and inhibition of cargo concentration of the neuronal glutamate transporter excitatory amino-acid carrier 1 (EAAC1) into transport complexes in HEK293 cells, an effect that could be completely reversed in the presence of an excess of Rab1. In accordance with the known role of Rab1 in neurite formation, overexpression of GTRAP3-18 significantly inhibited the length of outgrowing neurites in differentiated CAD cells. The inhibitory effect of GTRAP3-18 on neurite growth was rescued by co-expression with Rab1, supporting the conclusion that GTRAP 3-18 acted by inhibiting Rab1 action. Finally, we hypothesized that expression of GTRAP3-18 in the brain should be lower at stages of active synaptogenesis compared to early developmental stages. This was the case as expression of GTRAP3-18 declined from E17 to P0 and adult rat brains. Thus, we propose a model where protein trafficking and neuronal differentiation are directly linked by the interaction of Rab1 and its regulator GTRAP3-18.
C1 [Maier, S.; Reiterer, V.; Sitte, H. H.; Farhan, H.] Med Univ Vienna, Ctr Biomol Med & Pharmacol, Inst Pharmacol, Vienna, Austria.
   [Reiterer, V.; Farhan, H.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Ruggiero, A. M.] Vanderbilt Univ, Dept Pharmacol, Nashville, TN USA.
   [Rothstein, J. D.] Johns Hopkins Univ, Dept Neurol, Baltimore, MD 21218 USA.
   [Thomas, S.; Dahm, R.] Med Univ Vienna, Div Neuronal Cell Biol, Ctr Brain Res, Vienna, Austria.
RP Sitte, HH (corresponding author), Waehringer Str 13A, A-1090 Vienna, Austria.
EM harald.sitte@meduniwien.ac.at
RI Sitte, Harald/N-2681-2013; rothstein, jeffrey d/C-9470-2013; Farhan,
   Hesso/C-7997-2012; Sitte, Harald/O-7025-2019
OI Sitte, Harald/0000-0002-1339-7444; Farhan, Hesso/0000-0002-0889-8463;
   Sitte, Harald/0000-0002-1339-7444; Dahm, Ralf/0000-0001-5203-8578
FU FWFAustrian Science Fund (FWF) [P17076, P18076, P18072]; Schram
   foundation; Austrian Science Fund (FWF)Austrian Science Fund (FWF) [F
   3506] Funding Source: researchfish
FX We gratefully acknowledge the skilled technical assistance of Marion
   Holy and the insightful discussions with Drs. Vladimir M. Korkhov,
   Michael Freissmuth and Michael Kiebler. This work was supported by the
   FWF (P17076, P18076 to H. H. S., SFB F35 to H. H. S. and Michael
   Freissmuth, and P18072 to H. F.) and the Schram foundation (to Michael
   Kiebler).
CR Abdul-Ghani M, 2001, J BIOL CHEM, V276, P6225, DOI 10.1074/jbc.M009073200
   Albertinazzi C, 2003, MOL BIOL CELL, V14, P1295, DOI 10.1091/mbc.E02-07-0406
   Alvarez C, 2003, MOL BIOL CELL, V14, P2116, DOI 10.1091/mbc.E02-09-0625
   ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875
   Aridor M, 1998, J CELL BIOL, V141, P61, DOI 10.1083/jcb.141.1.61
   Bannykh SI, 2005, TRAFFIC, V6, P803, DOI 10.1111/j.1600-0854.2005.00319.x
   Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1
   Butchbach MER, 2002, GENE, V292, P81, DOI 10.1016/S0378-1119(02)00669-8
   Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527
   Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200
   Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200
   Garcia-Mata R, 2003, MOL BIOL CELL, V14, P2250, DOI 10.1091/mbc.E02-11-0730
   Gommel D, 1999, FEBS LETT, V447, P179, DOI 10.1016/S0014-5793(99)00246-X
   Haas AK, 2007, J CELL SCI, V120, P2997, DOI 10.1242/jcs.014225
   Inoue K, 2005, NEUROSCI LETT, V386, P184, DOI 10.1016/j.neulet.2005.06.013
   Ledda F, 2007, NAT NEUROSCI, V10, P293, DOI 10.1038/nn1855
   Lin CLG, 2001, NATURE, V410, P84, DOI 10.1038/35065084
   LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5
   Liu Y, 2008, J BIOL CHEM, V283, P6561, DOI 10.1074/jbc.M708096200
   Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005
   NUOFFER C, 1994, J CELL BIOL, V125, P225, DOI 10.1083/jcb.125.2.225
   Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001
   Qi YP, 1997, J NEUROSCI, V17, P1217
   RUGGIERO AM, 2007, J BIOL CHEM, DOI DOI 10.1074/JBC.M706499200
   Sannerud R, 2006, MOL BIOL CELL, V17, P1514, DOI 10.1091/mbc.E05-08-0792
   SARASTE J, 1986, P NATL ACAD SCI USA, V83, P6425, DOI 10.1073/pnas.83.17.6425
   Schweneker M, 2005, FEBS LETT, V579, P1751, DOI 10.1016/j.febslet.2005.02.037
   Stephens DJ, 2002, J CELL SCI, V115, P1149
   Vega IE, 2001, J NEUROSCI, V21, P3839, DOI 10.1523/JNEUROSCI.21-11-03839.2001
   Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135
   Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044
   Zeitelhofer M, 2007, NAT PROTOC, V2, P1692, DOI 10.1038/nprot.2007.226
NR 32
TC 24
Z9 24
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1582-1838
EI 1582-4934
J9 J CELL MOL MED
JI J. Cell. Mol. Med.
PD JAN
PY 2009
VL 13
IS 1
BP 114
EP 124
DI 10.1111/j.1582-4934.2008.00303.x
PG 11
WC Cell Biology; Medicine, Research & Experimental
SC Cell Biology; Research & Experimental Medicine
GA 397EX
UT WOS:000262646300009
PM 18363836
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Mayoral, RJ
   Pipkin, ME
   Pachkov, M
   van Nimwegen, E
   Rao, A
   Monticelli, S
AF Mayoral, Ramon J.
   Pipkin, Matthew E.
   Pachkov, Mikhail
   van Nimwegen, Erik
   Rao, Anjana
   Monticelli, Silvia
TI MicroRNA-221-222 Regulate the Cell Cycle in Mast Cells
SO JOURNAL OF IMMUNOLOGY
LA English
DT Article
ID ACUTE PROMYELOCYTIC LEUKEMIA; TRANSCRIPTION FACTOR GATA-2; NF-KAPPA-B;
   IMMUNE-RESPONSES; MICE LACKING; GENOMIC DNA; DIFFERENTIATION;
   EXPRESSION; MICRORNAS; PROTEIN
AB MicroRNAs (miRNAs) constitute a large family of small noncoding RNAs that have emerged as key posttranscriptional regulators in a wide variety of organisms. Because any one miRNA can potentially regulate expression of a distinct set of genes, differential miRNA expression can shape the repertoire of proteins that are actually expressed during development and differentiation or disease. Here, we have used mast cells as a model to investigate the role of miRNAs in differentiated innate immune cells and found that miR-221-222 are significantly up-regulated upon mast cell activation. Using both bioinformatics and experimental approaches, we identified some signaling pathways, transcription factors, and potential cis-regulatory regions that control MiR-221-222 transcription. Overexpression of miR-221-222 in a model mast cell line perturbed cell morphology and cell cycle regulation without altering viability. While in stimulated cells miR-221-222 partially counteracted expression of the cell-cycle inhibitor p27(kip1), we found that in the mouse alternative splicing results in two p27(kip1) mRNA isoforms that differ in their 3' untranslated region, only one of which is subject to miR-221-222 regulation. Additionally, transgenic expression of miR-221-222 from bacterial artificial chromosome clones in embryonic stem cells dramatically reduced cell proliferation and severely impaired their accumulation. Our study provides further insights on miR-221-222 transcriptional regulation as well as evidences that miR-221-222 regulate cell cycle checkpoints in mast cells in response to acute activation stimuli. The Journal of Immunology, 2009, 182: 433-445.
C1 [Mayoral, Ramon J.; Monticelli, Silvia] Inst Res Biomed, CH-6500 Bellinzona, Switzerland.
   [Pipkin, Matthew E.; Rao, Anjana] Immune Dis Inst, Boston, MA 02115 USA.
   [Pipkin, Matthew E.; Rao, Anjana] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Pachkov, Mikhail; van Nimwegen, Erik] Univ Basel, Biozentrum, Basel, Switzerland.
RP Monticelli, S (corresponding author), Inst Res Biomed, Via Vincenzo Vela 6, CH-6500 Bellinzona, Switzerland.
EM silvia.monticelli@irb.unisi.ch
RI Monticelli, Silvia/ABE-7054-2020
OI Monticelli, Silvia/0000-0002-5909-8802; van Nimwegen,
   Erik/0000-0001-6338-1312; Pipkin, Matthew/0000-0002-9688-0190
FU Institute for Research in Biomedicine Foundation; National Institutes of
   HealthUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [AI44432, AI070788]; National Cancer
   InstituteUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [F32
   CA 126247-01]; Ceresio Foundation; San Raffaele "Vita e Salute"
   University; NATIONAL CANCER INSTITUTEUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Cancer Institute (NCI) [F32CA126247, F32CA126247, F32CA126247,
   F32CA126247] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY
   AND INFECTIOUS DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Allergy & Infectious Diseases (NIAID) [R01AI044432, R01AI044432,
   R01AI044432, R01AI044432, R01AI070788, R01AI070788, R01AI044432,
   R01AI044432, R01AI044432, R01AI044432, R01AI070788, R01AI070788,
   R01AI044432, R01AI044432, R01AI044432, R01AI044432, R01AI044432,
   R01AI070788, R01AI044432, R01AI044432] Funding Source: NIH RePORTER
FX This work was supported by a start-up grant from the Institute for
   Research in Biomedicine Foundation to S.M. and National Institutes of
   Health Grants AI44432 and AI070788 to A.R. M.E.P. is supported by a
   fellowship from the National Cancer Institute F32 CA 126247-01. R.J.M.
   was temporarily supported by a fellowship from the Ceresio Foundation
   and is now a recipient of a San Raffaele "Vita e Salute" University
   predoctoral fellowship.
CR Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1
   Ansel KM, 2004, NAT IMMUNOL, V5, P1251, DOI 10.1038/ni1135
   Avni O, 2002, NAT IMMUNOL, V3, P643, DOI 10.1038/ni808
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Cantor AB, 2008, J EXP MED, V205, P611, DOI 10.1084/jem.20070544
   Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30
   Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903
   David G, 1998, ONCOGENE, V16, P2549, DOI 10.1038/sj.onc.1202043
   Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023
   Felicetti F, 2008, CANCER RES, V68, P2745, DOI 10.1158/0008-5472.CAN-07-2538
   Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102
   Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290
   Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200
   Galli SJ, 2005, NAT IMMUNOL, V6, P135, DOI 10.1038/ni1158
   Galli SJ, 2008, NAT REV IMMUNOL, V8, P478, DOI 10.1038/nri2327
   Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112
   Hogan PG, 2003, GENE DEV, V17, P2205, DOI 10.1101/gad.1102703
   Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936
   Kanellopoulou C, 2008, SEMIN CANCER BIOL, V18, P79, DOI 10.1016/j.semcancer.2008.01.002
   Klemm S, 2006, IMMUNOBIOLOGY, V211, P815, DOI 10.1016/j.imbio.2006.07.001
   Labbaye C, 2002, ONCOGENE, V21, P6669, DOI 10.1038/sj.onc.1205884
   Labbaye C, 2008, NAT CELL BIOL, V10, P788, DOI 10.1038/ncb1741
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790
   Lee Y, 2004, EMBO J, V23, P4051, DOI 10.1038/sj.emboj.7600385
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Li QJ, 2007, CELL, V129, P147, DOI 10.1016/j.cell.2007.03.008
   Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702
   Melnick A, 1999, BLOOD, V93, P3167, DOI 10.1182/blood.V93.10.3167.410k44_3167_3215
   Miranda KC, 2006, CELL, V126, P1203, DOI 10.1016/j.cell.2006.07.031
   Monticelli S, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-8-r71
   Monticelli S, 2005, INT IMMUNOL, V17, P1513, DOI 10.1093/intimm/dxh329
   Monticelli S, 2004, J BIOL CHEM, V279, P36210, DOI 10.1074/jbc.M406354200
   Nardone J, 2004, NAT IMMUNOL, V5, P768, DOI 10.1038/ni0804-768
   Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907
   Okayama Y, 2006, IMMUNOL RES, V34, P97, DOI 10.1385/IR:34:2:97
   Rao A, 1997, ANNU REV IMMUNOL, V15, P707, DOI 10.1146/annurev.immunol.15.1.707
   Ricci-Vitiani L, 2004, J EXP MED, V200, P1257, DOI 10.1084/jem.20040921
   Rodriguez A, 2004, GENOME RES, V14, P1902, DOI 10.1101/gr.2722704
   Rosenbauer F, 2007, NAT REV IMMUNOL, V7, P105, DOI 10.1038/nri2024
   Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390
   Schwartz S, 2000, GENOME RES, V10, P577, DOI 10.1101/gr.10.4.577
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Shaknovich R, 1998, MOL CELL BIOL, V18, P5533, DOI 10.1128/MCB.18.9.5533
   Solymar DC, 2002, IMMUNITY, V17, P41, DOI 10.1016/S1074-7613(02)00334-5
   Taganov KD, 2006, P NATL ACAD SCI USA, V103, P12481, DOI 10.1073/pnas.0605298103
   Thai TH, 2007, SCIENCE, V316, P604, DOI 10.1126/science.1141229
   TSAI FY, 1994, NATURE, V371, P221, DOI 10.1038/371221a0
   Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643
   Valent P, 2005, LEUKEMIA LYMPHOMA, V46, P35, DOI 10.1080/10428190400010775
   van Nimwegen E, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S6-S4
   Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460
   Walsh JC, 2002, IMMUNITY, V17, P665, DOI 10.1016/S1074-7613(02)00452-1
   Xanthoudakis S, 1996, SCIENCE, V272, P892, DOI 10.1126/science.272.5263.892
   Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021
NR 55
TC 69
Z9 77
U1 0
U2 4
PU AMER ASSOC IMMUNOLOGISTS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA
SN 0022-1767
EI 1550-6606
J9 J IMMUNOL
JI J. Immunol.
PD JAN 1
PY 2009
VL 182
IS 1
BP 433
EP 445
DI 10.4049/jimmunol.182.1.433
PG 13
WC Immunology
SC Immunology
GA 388YU
UT WOS:000262057200052
PM 19109175
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Balmer, J
   Lichtneckert, R
   Bello, B
   Reichert, H
AF Balmer, Jasmin
   Lichtneckert, Robert
   Bello, Bruno
   Reichert, Heinrich
TI Amplifying brain neuroblasts contribute to central complex development
   in Drosophila melanogaster
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 [Balmer, Jasmin; Lichtneckert, Robert; Bello, Bruno; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PY 2009
VL 23
MA III.12
BP S23
EP S23
PG 1
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 410DC
UT WOS:000263555500068
DA 2021-01-25
ER

PT J
AU Izergina, N
   Bello, B
   Reichert, H
AF Izergina, Natalya
   Bello, Bruno
   Reichert, Heinrich
TI Postembryonic development of glial cells in dorsomedial brain neuroblast
   lineages.
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 [Izergina, Natalya; Bello, Bruno; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PY 2009
VL 23
MA III.24
BP S27
EP S27
PG 1
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 410DC
UT WOS:000263555500079
DA 2021-01-25
ER

PT J
AU Sen, S
   Das, A
   Lichtneckert, R
   Ito, K
   Rodrigues, V
   Reichert, H
AF Sen, Sonia
   Das, Abhijit
   Lichtneckert, Robert
   Ito, Kei
   Rodrigues, Veronica
   Reichert, Heinrich
TI Drosophila Olfactory Local Interneurons and Lateral Projection Neurons
   arise from a Single Lineage.
SO JOURNAL OF NEUROGENETICS
LA English
DT Meeting Abstract
C1 [Lichtneckert, Robert; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo 1138654, Japan.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND
SN 0167-7063
J9 J NEUROGENET
JI J. Neurogenet.
PY 2009
VL 23
MA II.26
BP S19
EP S20
PG 2
WC Genetics & Heredity; Neurosciences
SC Genetics & Heredity; Neurosciences & Neurology
GA 410DC
UT WOS:000263555500057
DA 2021-01-25
ER

PT J
AU Kulik, A
   Althof, D
   Gross, A
   Shigemoto, R
   Bettler, B
   Frotscher, M
   Vida, I
AF Kulik, Akos
   Althof, David
   Gross, Anna
   Shigemoto, Ryuichi
   Bettler, Bernhard
   Frotscher, Michael
   Vida, Imre
TI DUAL MODULATORY ROLE OF GABAB RECEPTORS IN HIPPOCAMPAL
   PARVALBUMIN-EXPRESSING CELLS
SO JOURNAL OF PHYSIOLOGICAL SCIENCES
LA English
DT Meeting Abstract
C1 [Shigemoto, Ryuichi] NIPS, Div Cerebral Struct, Okazaki, Aichi, Japan.
   [Bettler, Bernhard] Univ Basel, Biozentrum, Dept Biomed, Basel, Switzerland.
RI bettler, bernhard/AAO-8018-2020; Shigemoto, Ryuichi/E-3628-2013
OI Shigemoto, Ryuichi/0000-0001-8761-9444
NR 0
TC 0
Z9 0
U1 0
U2 1
PU SPRINGER TOKYO
PI TOKYO
PA 1-11-11 KUDAN-KITA, CHIYODA-KU, TOKYO, 102-0073, JAPAN
SN 1880-6546
J9 J PHYSIOL SCI
JI J. Physiol. Sci.
PY 2009
VL 59
SU 1
BP 234
EP 234
PG 1
WC Physiology
SC Physiology
GA 509MX
UT WOS:000271023101478
DA 2021-01-25
ER

PT J
AU Steiner, E
   Lyck, R
   Kroger, S
   Ruegg, M
   Engelhardt, B
AF Steiner, Esther
   Lyck, Ruth
   Kroeger, Stephan
   Rueegg, Markus
   Engelhardt, Britta
TI Impact of the extracellular matrix protein agrin on barrier properties
   of brain endothelial cells in vitro
SO JOURNAL OF VASCULAR RESEARCH
LA English
DT Meeting Abstract
CT Joint Meeting of the
   Society-for-Microcirculation-and-Vascular-Biology/Swiss-Society-for-Micr
   ocirculation
CY OCT 08-10, 2009
CL Bern, SWITZERLAND
SP Soc Microcirculat & Vasc Biol, Swiss Soc Microcirculat
C1 [Steiner, Esther; Lyck, Ruth; Engelhardt, Britta] Univ Bern, Theodor Kocher Inst, CH-3012 Bern, Switzerland.
   [Kroeger, Stephan] Univ Munich, Inst Physiol, D-80336 Munich, Germany.
   [Rueegg, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 0
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1018-1172
J9 J VASC RES
JI J. Vasc. Res.
PY 2009
VL 46
BP 35
EP 35
PG 1
WC Physiology; Peripheral Vascular Disease
SC Physiology; Cardiovascular System & Cardiology
GA 503RN
UT WOS:000270557100047
DA 2021-01-25
ER

PT S
AU Engel, P
   Dehio, C
AF Engel, P.
   Dehio, C.
BE DeReuse, H
   Bereswill, S
TI Genomics of Host-Restricted Pathogens of the Genus Bartonella
SO MICROBIAL PATHOGENOMICS
SE Genome Dynamics
LA English
DT Article; Book Chapter
ID IV SECRETION SYSTEMS; HENSELAE; VARIANTS; QUINTANA; BLOOD; CELLS
AB The alpha-proteobacterial genus Bartonella comprises numerous arthropod-borne pathogens that share a common host-restricted life-style, which is characterized by long-lasting intraerythrocytic infections in their specific mammalian reservoirs and transmission by blood-sucking arthropods. Infection of an incidental host (e.g. humans by a zoonotic species) may cause disease in the absence of intraerythrocytic infection. The genome sequences of four Bartonella species are known, i.e. those of the human-specific pathogens Bartonella bacilliformis and Bartonella quintana, the feline-specific Bartonella henselae also causing incidental human infections, and the rat-specific species Bartonella tribocorum. The circular chromosomes of these bartonellae range in size from 1.44 Mb (encoding 1,283 genes) to 2.62 Mb (encoding 2,136 genes). They share a mostly synthenic core genome of 959 genes that features characteristics of a host-integrated metabolism. The diverse accessory genomes highlight dynamic genome evolution at the species level, ranging from significant genome expansion in B. tribocorum due to gene duplication and lateral acquisition of prophages and genomic islands (such as type IV secretion systems that adopted prominent roles in host adaptation and specificity) to massive secondary genome reduction in B. quintana. Moreover, analysis of natural populations of B. henselae revealed genomic rearrangements, deletions and amplifications, evidencing marked genome dynamics at the strain level. Copyright (C) 2009 S. Karger AG, Basel
C1 [Engel, P.; Dehio, C.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/R-8277-2016; Dehio, Christoph/AAD-5572-2019; Engel,
   Philipp/N-1788-2015
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052; Engel, Philipp/0000-0002-4678-6200
CR Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101
   Berghoff J, 2007, MICROBIOL-SGM, V153, P2045, DOI 10.1099/mic.0.2007/006379-0
   Bown KJ, 2004, EMERG INFECT DIS, V10, P684, DOI 10.3201/eid1004.030455
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 2008, CELL MICROBIOL, V10, P1591, DOI 10.1111/j.1462-5822.2008.01171.x
   Engbaek K, 2004, APMIS, V112, P336, DOI 10.1111/j.1600-0463.2004.apm1120603.x
   Harms CA, 2008, VET RES, V39, DOI 10.1051/vetres:2008036
   Jones SL, 2008, J VET INTERN MED, V22, P495, DOI 10.1111/j.1939-1676.2008.0043.x
   Lindroos H, 2006, J BACTERIOL, V188, P7426, DOI 10.1128/JB.00472-06
   Lindroos HL, 2005, J BACTERIOL, V187, P6155, DOI 10.1128/JB.187.17.6155-6165.2005
   Maggi RG, 2005, EMERG INFECT DIS, V11, P1894
   Nystedt B, 2008, MOL BIOL EVOL, V25, P287, DOI 10.1093/molbev/msm252
   Pallen MJ, 2007, NATURE, V449, P835, DOI 10.1038/nature06248
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Zhang P, 2004, P NATL ACAD SCI USA, V101, P13630, DOI 10.1073/pnas.0405284101
NR 20
TC 17
Z9 19
U1 0
U2 1
PU KARGER
PI BASEL
PA POSTFACH, CH-4009 BASEL, SWITZERLAND
SN 1660-9263
BN 978-3-8055-9192-8
J9 GENOME DYNAM
JI Genome Dyn.
PY 2009
VL 6
BP 158
EP 169
PG 12
WC Genetics & Heredity; Microbiology
SC Genetics & Heredity; Microbiology
GA BLI31
UT WOS:000270230900011
PM 19696500
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Bordoli, L
   Kiefer, F
   Arnold, K
   Benkert, P
   Battey, J
   Schwede, T
AF Bordoli, Lorenza
   Kiefer, Florian
   Arnold, Konstantin
   Benkert, Pascal
   Battey, James
   Schwede, Torsten
TI Protein structure homology modeling using SWISS-MODEL workspace
SO NATURE PROTOCOLS
LA English
DT Article
ID STRUCTURE PREDICTION; KINASE-C; DNA GLYCOSYLASES; MEAN FORCE; SEQUENCE;
   POTENTIALS; DATABASE; FAMILIES; REGIONS; QUALITY
AB Homology modeling aims to build three-dimensional protein structure models using experimentally determined structures of related family members as templates. SWISS-MODEL workspace is an integrated Web-based modeling expert system. For a given target protein, a library of experimental protein structures is searched to identify suitable templates. On the basis of a sequence alignment between the target protein and the template structure, a three-dimensional model for the target protein is generated. Model quality assessment tools are used to estimate the reliability of the resulting models. Homology modeling is currently the most accurate computational method to generate reliable structural models and is routinely used in many biological applications. Typically, the computational effort for a modeling project is less than 2 h. However, this does not include the time required for visualization and interpretation of the model, which may vary depending on personal experience working with protein structures.
C1 [Schwede, Torsten] Univ Basel, Biozentrum, SIB, CH-4056 Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, SIB, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Benkert, Pascal/C-3895-2009; Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X
FU Swiss Institute of Bioinformatics (SIB)
FX We are grateful to Dr Michael Podvinec for his enthusiastic support and
   excellent coordination of the Scrum process for the SWISS-MODEL team. We
   are thankful for financial support of our group by the Swiss Institute
   of Bioinformatics (SIB).
CR Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404
   Aloy P, 2005, CURR OPIN STRUC BIOL, V15, P15, DOI 10.1016/j.sbi.2005.01.012
   Alseth I, 2006, MOL MICROBIOL, V59, P1602, DOI 10.1111/j.1365-2958.2006.05044.x
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Andreeva A, 2004, NUCLEIC ACIDS RES, V32, pD226, DOI 10.1093/nar/gkh039
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659
   Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI 10.1093/nar/gkh121
   Bates PA, 2001, PROTEINS, P39
   Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761
   Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715
   Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971
   Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503
   CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x
   CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0
   Dalhus B, 2007, NUCLEIC ACIDS RES, V35, P2451, DOI 10.1093/nar/gkm039
   Dunbrack RL, 2006, CURR OPIN STRUC BIOL, V16, P374, DOI 10.1016/j.sbi.2006.05.006
   Dyson HJ, 2005, NAT REV MOL CELL BIO, V6, P197, DOI 10.1038/nrm1589
   Eswar N, 2003, NUCLEIC ACIDS RES, V31, P3375, DOI 10.1093/nar/gkg543
   Fasnacht M, 2007, PROTEIN SCI, V16, P1557, DOI 10.1110/ps.072856307
   Ferns S, 2007, CHEM WORLD-UK, V4, P35
   Fink AL, 2005, CURR OPIN STRUC BIOL, V15, P35, DOI 10.1016/j.sbi.2005.01.002
   Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960
   Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753
   Fox JA, 2007, NUCLEIC ACIDS RES, V35, pW3, DOI 10.1093/nar/gkm459
   Greene LH, 2007, NUCLEIC ACIDS RES, V35, pD291, DOI 10.1093/nar/gkl959
   Groves MR, 1999, CURR OPIN STRUC BIOL, V9, P383, DOI 10.1016/S0959-440X(99)80052-9
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Henrick K, 1998, TRENDS BIOCHEM SCI, V23, P358, DOI 10.1016/S0968-0004(98)01253-5
   Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   Hulo N, 2006, NUCLEIC ACIDS RES, V34, pD227, DOI 10.1093/nar/gkj063
   Jauch R, 2007, PROTEINS, V69, P57, DOI 10.1002/prot.21771
   Jones DT, 2003, PROTEINS, V53, P573, DOI 10.1002/prot.10528
   JONES DT, 1994, BIOCHEMISTRY-US, V33, P3038, DOI 10.1021/bi00176a037
   Jones DT, 1999, J MOL BIOL, V292, P195, DOI 10.1006/jmbi.1999.3091
   Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200
   Koh IYY, 2003, NUCLEIC ACIDS RES, V31, P3311, DOI 10.1093/nar/gkg619
   Kopp B, 2007, J BEHAV THER EXP PSY, V38, P56, DOI 10.1016/j.jbtep.2006.05.001
   Kopp J, 2004, PHARMACOGENOMICS, V5, P405, DOI 10.1517/14622416.5.4.405
   Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008
   Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022
   Kryshtafovych A, 2007, PROTEINS, V69, P194, DOI 10.1002/prot.21769
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Martinez GL, 2000, J ELECTRON MATER, V29, P325, DOI 10.1007/s11664-000-0072-x
   Mellor H, 1998, BIOCHEM J, V332, P281, DOI 10.1042/bj3320281
   Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665
   Mulder NJ, 2007, NUCLEIC ACIDS RES, V35, pD224, DOI 10.1093/nar/gkl841
   Muller CW, 1996, STRUCTURE, V4, P147, DOI 10.1016/S0969-2126(96)00018-4
   NISHIZUKA Y, 1992, NEUROSCI RES, V15, P3, DOI 10.1016/0168-0102(92)90013-3
   PEITSCH MC, 1995, BIO-TECHNOL, V13, P658, DOI 10.1038/nbt0795-658
   Peitsch MC, 2002, BIOINFORMATICS, V18, P934, DOI 10.1093/bioinformatics/18.7.934
   Radivojac P, 2007, BIOPHYS J, V92, P1439, DOI 10.1529/biophysj.106.094045
   Rohl CA, 2004, PROTEINS, V55, P656, DOI 10.1002/prot.10629
   Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Schwede T, 2000, RES MICROBIOL, V151, P107, DOI 10.1016/S0923-2508(00)00121-2
   SEEBERG E, 1995, TRENDS BIOCHEM SCI, V20, P391, DOI 10.1016/S0968-0004(00)89086-6
   SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4
   Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408
   Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125
   Sommer I, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-364
   Soto CS, 2008, PROTEINS, V70, P834, DOI 10.1002/prot.21612
   Stivers JT, 2003, CHEM REV, V103, P2729, DOI 10.1021/cr010219b
   TOPHAM CM, 1990, BIOCHEM SOC SYMP, P1
   Tramontano A, 2003, PROTEINS, V53, P352, DOI 10.1002/prot.10543
   TRAMONTANO A, 2008, COMPUTATIONAL STRUCT
   Tress M, 2005, PROTEINS, V61, P27, DOI 10.1002/prot.20720
   Tress ML, 2003, J MOL BIOL, V330, P705, DOI 10.1016/S0022-2836(03)00622-3
   van Gunsteren W. F., 1996, BIOMOLECULAR SIMULAT
   Vingron M, 1996, CURR OPIN STRUC BIOL, V6, P346, DOI 10.1016/S0959-440X(96)80054-6
   Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606
   Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062
   Wu CH, 2006, NUCLEIC ACIDS RES, V34, pD187, DOI 10.1093/nar/gkj161
   Zdobnov EM, 2001, BIOINFORMATICS, V17, P847, DOI 10.1093/bioinformatics/17.9.847
   ZHANG GG, 1995, CELL, V81, P917, DOI 10.1016/0092-8674(95)90011-X
   Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002
NR 78
TC 809
Z9 838
U1 4
U2 130
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-2189
EI 1750-2799
J9 NAT PROTOC
JI Nat. Protoc.
PY 2009
VL 4
IS 1
BP 1
EP 13
DI 10.1038/nprot.2008.197
PG 13
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 441PS
UT WOS:000265781800001
PM 19131951
DA 2021-01-25
ER

PT J
AU Matsumoto, T
   Dieni, S
   Rauskolb, S
   Frotscher, M
   Barde, YA
AF Matsumoto, Tomoya
   Dieni, Sandra
   Rauskolb, Stefanie
   Frotscher, Michael
   Barde, Yves-Alain
TI Localization of BDNF in CNS neurons
SO NEUROSCIENCE RESEARCH
LA English
DT Meeting Abstract
C1 [Matsumoto, Tomoya] Hiroshima Univ, Dept Psychiat & Neurosci, Hiroshima, Japan.
   [Matsumoto, Tomoya; Rauskolb, Stefanie; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Dieni, Sandra; Frotscher, Michael] Univ Freiburg, Inst Anat & Cell Biol, D-7800 Freiburg, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-0102
J9 NEUROSCI RES
JI Neurosci. Res.
PY 2009
VL 65
SU 1
BP S161
EP S161
DI 10.1016/j.neures.2009.09.833
PG 1
WC Neurosciences
SC Neurosciences & Neurology
GA 528DK
UT WOS:000272421101197
DA 2021-01-25
ER

PT J
AU Berman, HM
   Westbrook, JD
   Gabanyi, MJ
   Tao, W
   Shah, R
   Kouranov, A
   Schwede, T
   Arnold, K
   Kiefer, F
   Bordoli, L
   Kopp, J
   Podvinec, M
   Adams, PD
   Carter, LG
   Minor, W
   Nair, R
   Baer, JL
AF Berman, Helen M.
   Westbrook, John D.
   Gabanyi, Margaret J.
   Tao, Wendy
   Shah, Raship
   Kouranov, Andrei
   Schwede, Torsten
   Arnold, Konstantin
   Kiefer, Florian
   Bordoli, Lorenza
   Kopp, Jrgen
   Podvinec, Michael
   Adams, Paul D.
   Carter, Lester G.
   Minor, Wladek
   Nair, Rajesh
   Baer, Joshua La
TI The protein structure initiative structural genomics knowledgebase
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID DATABASE; CLASSIFICATION; MODELS
AB The Protein Structure Initiative Structural Genomics Knowledgebase (PSI SGKB, http://kb.psi-structural genomics.org) has been created to turn the products of the PSI structural genomics effort into knowledge that can be used by the biological research community to understand living systems and disease. This resource provides central access to structures in the Protein Data Bank (PDB), along with functional annotations, associated homology models, worldwide protein target tracking information, available protocols and the potential to obtain DNA materials for many of the targets. It also offers the ability to search all of the structural and methodological publications and the innovative technologies that were catalyzed by the PSI's high-throughput research efforts. In collaboration with the Nature Publishing Group, the PSI SGKB provides a research library, editorials about new research advances, news and an events calendar to present a broader view of structural biology and structural genomics. By making these resources freely available, the PSI SGKB serves as a bridge to connect the structural biology and the greater biomedical communities.
C1 [Berman, Helen M.; Westbrook, John D.; Gabanyi, Margaret J.; Tao, Wendy; Shah, Raship; Kouranov, Andrei] Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.
   [Schwede, Torsten; Arnold, Konstantin; Kiefer, Florian; Bordoli, Lorenza; Kopp, Jrgen; Podvinec, Michael] Univ Basel, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Schwede, Torsten; Arnold, Konstantin; Kiefer, Florian; Bordoli, Lorenza; Kopp, Jrgen; Podvinec, Michael] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kopp, Jrgen] Heidelberg Univ, Biochem Zentrum, D-69120 Heidelberg, Germany.
   [Adams, Paul D.; Carter, Lester G.] Univ Calif Berkeley, Lawrence Berkeley Natl Lab, Phys Biosci Div, Berkeley, CA 94720 USA.
   [Minor, Wladek] Univ Virginia, Dept Mol Physiol & Biol Phys, Charlottesville, VA 22908 USA.
   [Nair, Rajesh] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10027 USA.
   [Baer, Joshua La] Harvard Univ, Sch Med, Harvard Inst Proteom, Boston, MA 02115 USA.
   [Baer, Joshua La] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA.
RP Berman, HM (corresponding author), Rutgers State Univ, Dept Chem & Chem Biol, Piscataway, NJ 08854 USA.
EM berman@rcsb.rutgers.edu
RI Adams, Paul/A-1977-2013; Schwede, Torsten/A-4650-2008
OI Adams, Paul/0000-0001-9333-8219; Kopp, Juergen/0000-0001-5633-7399;
   Gabanyi, Margaret/0000-0002-2869-7810; Berman,
   Helen/0000-0002-3337-0660; Minor, Wladek/0000-0001-7075-7090; Schwede,
   Torsten/0000-0003-2715-335X
FU National Institute of General Medical SciencesUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS); National
   Institutes of Health (NIH)United States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [3U54GM074958-04S1];
   NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958] Funding
   Source: NIH RePORTER
FX National Institute of General Medical Sciences. Funding for open access
   charge: The PSI SGKB is supported by the National Institutes of Health
   (NIH) as a sub-grant under Prime Agreement Award Number:
   3U54GM074958-04S1.
CR ARNOLD K, 2008, J STRUCT FU IN PRESS
   Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929
   Benson DA, 2000, NUCLEIC ACIDS RES, V28, P15, DOI 10.1093/nar/28.1.15
   Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980
   Berman HM, 2008, STRUCTURE, V16, P16, DOI 10.1016/j.str.2007.12.003
   Berman HM, 2006, STRUCTURE, V14, P1211, DOI 10.1016/j.str.2006.06.005
   Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235
   Chen L, 2004, BIOINFORMATICS, V20, P2860, DOI 10.1093/bioinformatics/bth300
   Corpet F, 1998, NUCLEIC ACIDS RES, V26, P323, DOI 10.1093/nar/26.1.323
   Haft DH, 2003, NUCLEIC ACIDS RES, V31, P371, DOI 10.1093/nar/gkg128
   Hulo N, 2008, NUCLEIC ACIDS RES, V36, pD245, DOI 10.1093/nar/gkm977
   Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056
   Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120
   Lo Conte L, 2000, NUCLEIC ACIDS RES, V28, P257, DOI 10.1093/nar/28.1.257
   Orengo CA, 1997, STRUCTURE, V5, P1093, DOI 10.1016/S0969-2126(97)00260-8
   PERKEL J, 2008, SCIENCE, V321, P707
   Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059
   Sonnhammer ELL, 1998, NUCLEIC ACIDS RES, V26, P320, DOI 10.1093/nar/26.1.320
   *UNIPROT C, 2000, NAT GENET, V25, P25
   Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000
   Wilson D, 2007, NUCLEIC ACIDS RES, V35, pD308, DOI 10.1093/nar/gkl910
   Wu CH, 2001, NUCLEIC ACIDS RES, V29, P52, DOI 10.1093/nar/29.1.52
NR 22
TC 64
Z9 74
U1 0
U2 7
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN
PY 2009
VL 37
SI SI
BP D365
EP D368
DI 10.1093/nar/gkn790
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 386TT
UT WOS:000261906200066
PM 19010965
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Kiefer, F
   Arnold, K
   Kunzli, M
   Bordoli, L
   Schwede, T
AF Kiefer, Florian
   Arnold, Konstantin
   Kuenzli, Michael
   Bordoli, Lorenza
   Schwede, Torsten
TI The SWISS-MODEL Repository and associated resources
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID PROTEIN-STRUCTURE MODELS; HOMOLOGY MODELS; STRUCTURAL GENOMICS; QUALITY
   ASSESSMENT; DRUG DESIGN; DATABASE; BINDING; CASP7; ENVIRONMENT;
   PREDICTION
AB SWISS-MODEL Repository (http://swissmodel.expasy.org/repository/) is a database of 3D protein structure models generated by the SWISS-MODEL homology-modelling pipeline. The aim of the SWISS-MODEL Repository is to provide access to an up-to-date collection of annotated 3D protein models generated by automated homology modelling for all sequences in Swiss-Prot and for relevant models organisms. Regular updates ensure that target coverage is complete, that models are built using the most recent sequence and template structure databases, and that improvements in the underlying modelling pipeline are fully utilised. As of September 2008, the database contains 3.4 million entries for 2.7 million different protein sequences from the UniProt database. SWISS-MODEL Repository allows the users to assess the quality of the models in the database, search for alternative template structures, and to build models interactively via SWISS-MODEL Workspace (http://swissmodel.expasy.org/workspace/). Annotation of models with functional information and cross-linking with other databases such as the Protein Model Portal (http://www.proteinmodelportal.org) of the PSI Structural Genomics Knowledge Base facilitates the navigation between protein sequence and structure resources.
C1 [Kiefer, Florian; Arnold, Konstantin; Kuenzli, Michael; Bordoli, Lorenza; Schwede, Torsten] Univ Basel, Biozentrum, Basel, Switzerland.
   [Kiefer, Florian; Arnold, Konstantin; Kuenzli, Michael; Bordoli, Lorenza; Schwede, Torsten] SIB Swiss Inst Bioinformat, Basel, Switzerland.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008
OI Schwede, Torsten/0000-0003-2715-335X
FU National Institutes of HealthUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [3 P20 GM076222-02S1];
   Prime Agreement Award Number [3U54GM074958-04S2]; Swiss Institute of
   Bioinformatics (SIB).; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, P20GM076222, U54GM074958,
   U54GM074958, P20GM076222, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   P20GM076222, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, P20GM076222, P20GM076222,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958, U54GM074958, U54GM074958,
   U54GM074958, U54GM074958, U54GM074958] Funding Source: NIH RePORTER
FX The PSI SGKB Protein Model Portal was supported by the National
   Institutes of Health as a sub-grant with Fox Chase Cancer Center (3 P20
   GM076222-02S1); as a sub-grant with Rutgers University, under Prime
   Agreement Award Number (3U54GM074958-04S2). SWISS-MODEL Workspace and
   Repository have been supported by the Swiss Institute of Bioinformatics
   (SIB). Funding for open access charges: Swiss Institute of
   Bioinformatics.
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770
   Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070
   Battey JND, 2007, PROTEINS, V69, P68, DOI 10.1002/prot.21761
   Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715
   Berman H, 2007, NUCLEIC ACIDS RES, V35, pD301, DOI 10.1093/nar/gkl971
   Berman HM, 2008, STRUCTURE, V16, P16, DOI 10.1016/j.str.2007.12.003
   BERMAN HM, 2008, NUCL ACIDS IN PRESS
   Boutet Emmanuel, 2007, V406, P89
   CHOTHIA C, 1992, NATURE, V357, P543, DOI 10.1038/357543a0
   Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hartshorn MJ, 2002, J COMPUT AID MOL DES, V16, P871, DOI 10.1023/A:1023813504011
   Hillisch A, 2004, DRUG DISCOV TODAY, V9, P659, DOI 10.1016/S1359-6446(04)03196-4
   Huang HZ, 2007, FRONT BIOSCI-LANDMRK, V12, P5071, DOI 10.2741/2449
   Jenkinson AM, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S8-S3
   Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200
   Koh IYY, 2003, NUCLEIC ACIDS RES, V31, P3311, DOI 10.1093/nar/gkg619
   Kopp B, 2007, J BEHAV THER EXP PSY, V38, P56, DOI 10.1016/j.jbtep.2006.05.001
   Kopp J, 2004, NUCLEIC ACIDS RES, V32, pD230, DOI 10.1093/nar/gkh008
   Kopp J, 2006, NUCLEIC ACIDS RES, V34, pD315, DOI 10.1093/nar/gkj056
   Kryshtafovych A, 2007, PROTEINS, V69, P194, DOI 10.1002/prot.21769
   Levitt M, 2007, P NATL ACAD SCI USA, V104, P3183, DOI 10.1073/pnas.0611678104
   Li YG, 2007, NAT BIOTECHNOL, V25, P1051, DOI 10.1038/nbt1333
   Lippow SM, 2007, NAT BIOTECHNOL, V25, P1171, DOI 10.1038/nbt1336
   Maniasetty BA, 2008, PROTEOMICS, V8, P612, DOI 10.1002/pmic.200700687
   McCleverty CJ, 2008, PROTEIN SCI, V17, P869, DOI 10.1110/ps.083432208
   Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665
   Mulder N. J., 2008, CURR PROTOC BIOINFOR, DOI DOI 10.1002/0471250953.BI0207S21
   Murray PS, 2005, STRUCTURE, V13, P1521, DOI 10.1016/j.str.2005.07.010
   Oshiro C, 2004, J MED CHEM, V47, P764, DOI 10.1021/jm0300781
   Peitsch MC, 2002, BIOINFORMATICS, V18, P934, DOI 10.1093/bioinformatics/18.7.934
   Pieper U, 2006, NUCLEIC ACIDS RES, V34, pD291, DOI 10.1093/nar/gkj059
   Sadowski MI, 2007, PROTEINS, V69, P476, DOI 10.1002/prot.21531
   Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520
   Slabinski L, 2007, PROTEIN SCI, V16, P2472, DOI 10.1110/ps.073037907
   Soding J, 2005, BIOINFORMATICS, V21, P951, DOI 10.1093/bioinformatics/bti125
   Tan ES, 2008, CHEM BIOL, V15, P343, DOI 10.1016/j.chembiol.2008.03.004
   Thorsteinsdottir HB, 2006, PROTEINS, V65, P407, DOI 10.1002/prot.21096
   TRAMONTANO A, 2008, COMPUTATIONAL STRUCT
   van Gunsteren W. F., 1996, BIOMOLECULAR SIMULAT
   Vangrevelinghe E, 2003, J MED CHEM, V46, P2656, DOI 10.1021/jm030827e
   Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606
   Xu QP, 2008, PROTEINS, V71, P1546, DOI 10.1002/prot.21992
   Yooseph S, 2007, PLOS BIOL, V5, P432, DOI 10.1371/journal.pbio.0050016
   Zhang Y, 2007, PROTEINS, V69, P108, DOI 10.1002/prot.21702
   Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002
NR 47
TC 1425
Z9 1499
U1 2
U2 106
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JAN
PY 2009
VL 37
SI SI
BP D387
EP D392
DI 10.1093/nar/gkn750
PG 6
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 386TT
UT WOS:000261906200070
PM 18931379
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT S
AU Jeno, P
   Horst, M
AF Jenoe, Paul
   Horst, Martin
BE Walker, JM
TI Electroelution of Proteins from Polyacrylamide Gels
SO PROTEIN PROTOCOLS HANDBOOK, THIRD EDITION
SE Springer Protocols Handbooks
LA English
DT Article; Book Chapter
ID SODIUM DODECYL-SULFATE; REMOVAL
C1 [Jenoe, Paul] Univ Basel, Biozentrum, Dept Biochem, Basel, Switzerland.
   [Horst, Martin] STRATEC Med, Oberdorf, Switzerland.
RP Jeno, P (corresponding author), Univ Basel, Biozentrum, Dept Biochem, Basel, Switzerland.
CR ALPERT AJ, 1990, J CHROMATOGR, V215, P292
   BOSSERHOFF A, 1989, J CHROMATOGR, V473, P71, DOI 10.1016/S0021-9673(00)91291-3
   HAGER DA, 1980, ANAL BIOCHEM, V109, P76, DOI 10.1016/0003-2697(80)90013-5
   HIGGINS RC, 1979, ANAL BIOCHEM, V93, P257, DOI 10.1016/S0003-2697(79)80077-9
   HORST M, 1993, EMBO J, V12, P3035, DOI 10.1002/j.1460-2075.1993.tb05972.x
   JACOBS E, 1986, ANAL BIOCHEM, V154, P583, DOI 10.1016/0003-2697(86)90033-3
   JENO P, 1993, ANAL BIOCHEM, V215, P292, DOI 10.1006/abio.1993.1589
   KONIGSBERG WH, 1983, METHOD ENZYMOL, V91, P254
   LAEMMLI UK, 1974, NATURE, V227, P680
   SIMPSON RJ, 1987, EUR J BIOCHEM, V165, P292
   STEARNE PA, 1985, J IMMUNOL, V134, P443
   WESSEL D, 1984, ANAL BIOCHEM, V138, P141, DOI 10.1016/0003-2697(84)90782-6
NR 12
TC 0
Z9 0
U1 0
U2 1
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1949-2448
BN 978-1-60327-474-6
J9 SPRINGER PROTOC HAND
PY 2009
BP 587
EP 594
DI 10.1007/978-1-59745-198-7_55
D2 10.1007/978-1-59745-198-7
PG 8
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA BLR02
UT WOS:000270829300055
DA 2021-01-25
ER

PT S
AU Gander, S
   Cremonesi, A
   Chicher, J
   Moes, S
   Jeno, P
AF Gander, Stefan
   Cremonesi, Alessio
   Chicher, Johana
   Moes, Suzette
   Jenoe, Paul
BE Walker, JM
TI Mass Spectrometric Analysis of Protein Phosphorylation
SO PROTEIN PROTOCOLS HANDBOOK, THIRD EDITION
SE Springer Protocols Handbooks
LA English
DT Article; Book Chapter
ID SITE-SPECIFIC PHOSPHORYLATION; SACCHAROMYCES-CEREVISIAE; PHOSPHOPROTEOME
   ANALYSIS; IDENTIFICATION; PHOSPHOPEPTIDE; QUANTITATION; DEGRADATION;
   PROTEOMICS; RECEPTOR; YEAST
C1 [Gander, Stefan; Cremonesi, Alessio; Chicher, Johana; Moes, Suzette; Jenoe, Paul] Univ Basel, Biozentrum, Dept Biochem, Basel, Switzerland.
RP Gander, S (corresponding author), Univ Basel, Biozentrum, Dept Biochem, Basel, Switzerland.
CR BANTSCHEFF M, 2007, NAT BIOTECHNOL
   Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227
   Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005
   Bonenfant D, 2003, P NATL ACAD SCI USA, V100, P880, DOI 10.1073/pnas.232735599
   BOYLE WJ, 1991, METHOD ENZYMOL, V201, P110
   Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104
   COHEN P, 1992, TRENDS BIOCHEM SCI, V17, P408, DOI 10.1016/0968-0004(92)90010-7
   Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301
   Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n
   Gerber SA, 2003, P NATL ACAD SCI USA, V100, P6940, DOI 10.1073/pnas.0832254100
   Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200
   HUBBARD MJ, 1993, TRENDS BIOCHEM SCI, V18, P172, DOI 10.1016/0968-0004(93)90109-Z
   HUNTER T, 1991, METHOD ENZYMOL, V200, P3
   Kalo MS, 1999, BIOCHEMISTRY-US, V38, P14396, DOI 10.1021/bi991628t
   KUIPER GGJM, 1995, BIOCHEMISTRY-US, V34, P1851, DOI 10.1021/bi00006a005
   Larsen MR, 2004, MOL CELL PROTEOMICS, V3, P456, DOI 10.1074/mcp.M300105-MCP200
   Larsen MR, 2001, PROTEOMICS, V1, P223
   Li X, 2007, J PROTEOME RES, V6, P1190, DOI 10.1021/pr060559j
   Lu BW, 2007, ANAL CHEM, V79, P1301, DOI 10.1021/ac061334v
   LUO KX, 1991, METHOD ENZYMOL, V201, P149
   Oda Y, 1999, P NATL ACAD SCI USA, V96, P6591, DOI 10.1073/pnas.96.12.6591
   PAYNE DM, 1991, EMBO J, V10, P885, DOI 10.1002/j.1460-2075.1991.tb08021.x
   Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2
   Radimerski T, 2000, BIOCHEMISTRY-US, V39, P5766, DOI 10.1021/bi9927484
   RESING KA, 1995, BIOCHEMISTRY-US, V34, P9477, DOI 10.1021/bi00029a024
   Schlosser A, 2001, ANAL CHEM, V73, P170, DOI 10.1021/ac000826j
   Tao WA, 2005, NAT METHODS, V2, P591, DOI 10.1038/NMETH776
   Tholey A, 1999, J MASS SPECTROM, V34, P117, DOI 10.1002/(SICI)1096-9888(199902)34:2<117::AID-JMS769>3.0.CO;2-V
   Verma R, 1997, SCIENCE, V278, P455, DOI 10.1126/science.278.5337.455
   WETTENHALL REH, 1991, METHOD ENZYMOL, V201, P186
   WINZ R, 1994, J BIOL CHEM, V269, P14438
   Zhang Y, 2005, MOL CELL PROTEOMICS, V4, P1240, DOI 10.1074/mcp.M500089-MCP200
NR 32
TC 0
Z9 0
U1 0
U2 1
PU HUMANA PRESS INC
PI TOTOWA
PA 999 RIVERVIEW DR, STE 208, TOTOWA, NJ 07512-1165 USA
SN 1949-2448
BN 978-1-60327-474-6
J9 SPRINGER PROTOC HAND
PY 2009
BP 1555
EP 1566
DI 10.1007/978-1-59745-198-7_161
D2 10.1007/978-1-59745-198-7
PG 12
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA BLR02
UT WOS:000270829300161
DA 2021-01-25
ER

PT J
AU Benkert, P
   Tosatto, SCE
   Schwede, T
AF Benkert, Pascal
   Tosatto, Silvio C. E.
   Schwede, Torsten
TI Global and local model quality estimation at CASP8 using the scoring
   functions QMEAN and QMEANclust
SO PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS
LA English
DT Article
DE CASP8; model quality assessment; QMEAN; scoring function; protein
   structure homology modeling; mean force potential
ID PROTEIN MODELS; MEAN FORCE; PREDICTION; POTENTIALS; ALIGNMENT; SEQUENCE;
   ENERGY; RECOGNITION; REGIONS; ERRORS
AB Identifying the best candidate model among an ensemble of alternatives is crucial in protein structure prediction. For this purpose, scoring functions have been developed which either calculate a quality estimate on the basis of a single model or derive a score from the information contained in the ensemble of models generated for a given sequence (i.e., consensus methods). At CASP7, consensus methods have performed considerably better than scoring functions operating on single models. However, consensus methods tend to fail if the best models are far from the center of the dominant structural cluster. At CASP8, we investigated whether our hybrid method QMEANclust may overcome this limitation by combining the QMEAN composite scoring function operating on single models with consensus information. We participated with four different scoring functions in the quality assessment category. The QMEANclust consensus scoring function turned out to be a successful method both for the ranking of entire models but especially for the estimation of the per-residue model quality. In this article, we briefly describe the two scoring functions QMEAN and QMEANclust and discuss their performance in the context of what went right and wrong at CASP8. Both scoring functions are publicly available athttp://swissmodel.expasy.org/qmean/.
C1 [Schwede, Torsten] Univ Basel, Biozentrum, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Benkert, Pascal; Schwede, Torsten] Swiss Inst Bioinformat, SIB, Basel, Switzerland.
   [Tosatto, Silvio C. E.] Univ Padua, Dept Biol, I-35121 Padua, Italy.
RP Schwede, T (corresponding author), Univ Basel, Biozentrum, Swiss Inst Bioinformat, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM torsten.schwede@unibas.ch
RI Schwede, Torsten/A-4650-2008; Tosatto, Silvio/B-2840-2009; Benkert,
   Pascal/C-3895-2009
OI Schwede, Torsten/0000-0003-2715-335X; Tosatto,
   Silvio/0000-0003-4525-7793; 
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Baker D, 2001, SCIENCE, V294, P93, DOI 10.1126/science.1065659
   Benkert P, 2008, PROTEINS, V71, P261, DOI 10.1002/prot.21715
   Benkert P, 2009, NUCLEIC ACIDS RES, V37, pW510, DOI 10.1093/nar/gkp322
   Benkert P, 2009, BMC STRUCT BIOL, V9, DOI 10.1186/1472-6807-9-35
   Chen H, 2008, PROTEINS, V71, P1255, DOI 10.1002/prot.21819
   CHOTHIA C, 1986, EMBO J, V5, P823, DOI 10.1002/j.1460-2075.1986.tb04288.x
   Cozzetto D, 2007, PROTEINS, V69, P175, DOI 10.1002/prot.21669
   Cozzetto D, 2009, PROTEINS, V77, P157, DOI 10.1002/prot.22534
   Dominy BN, 2002, J COMPUT CHEM, V23, P147, DOI 10.1002/jcc.10018
   Eramian D, 2006, PROTEIN SCI, V15, P1653, DOI 10.1110/ps.062095806
   Fasnacht M, 2007, PROTEIN SCI, V16, P1557, DOI 10.1110/ps.072856307
   Ginalski K, 2003, BIOINFORMATICS, V19, P1015, DOI 10.1093/bioinformatics/btg124
   Hooft RWW, 1996, NATURE, V381, P272, DOI 10.1038/381272a0
   JONES DT, 1992, NATURE, V358, P86, DOI 10.1038/358086a0
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Lazaridis T, 1999, J MOL BIOL, V288, P477, DOI 10.1006/jmbi.1999.2685
   Lu H, 2001, PROTEINS, V44, P223, DOI 10.1002/prot.1087
   Lundstrom J, 2001, PROTEIN SCI, V10, P2354, DOI 10.1110/ps.08501
   LUTHY R, 1992, NATURE, V356, P83, DOI 10.1038/356083a0
   McGuffin LJ, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-345
   Melo F, 1998, J MOL BIOL, V277, P1141, DOI 10.1006/jmbi.1998.1665
   Paluszewski M, 2009, PROTEINS, V75, P540, DOI 10.1002/prot.22262
   Pettitt CS, 2005, BIOINFORMATICS, V21, P3509, DOI 10.1093/bioinformatics/bti540
   Qiu J, 2008, PROTEINS, V71, P1175, DOI 10.1002/prot.21809
   Schwede T, 2009, STRUCTURE, V17, P151, DOI 10.1016/j.str.2008.12.014
   Shen MY, 2006, PROTEIN SCI, V15, P2507, DOI 10.1110/ps.062416606
   Shortle D, 1998, P NATL ACAD SCI USA, V95, P11158, DOI 10.1073/pnas.95.19.11158
   Shortle D, 2003, PROTEIN SCI, V12, P1298, DOI 10.1110/ps.0306903
   SIPPL MJ, 1990, J MOL BIOL, V213, P859, DOI 10.1016/S0022-2836(05)80269-4
   Tosatto SCE, 2005, J COMPUT BIOL, V12, P1316, DOI 10.1089/cmb.2005.12.1316
   Tosatto SCE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-155
   Tress ML, 2003, J MOL BIOL, V330, P705, DOI 10.1016/S0022-2836(03)00622-3
   Wallner B, 2006, PROTEIN SCI, V15, P900, DOI 10.1110/ps.051799606
   Wallner B, 2003, PROTEIN SCI, V12, P1073, DOI 10.1110/ps.0236803
   Wallner B, 2007, PROTEINS, V69, P184, DOI 10.1002/prot.21774
   Wang Kai, 2004, BMC Structural Biology, V4
   Xiang ZX, 2002, P NATL ACAD SCI USA, V99, P7432, DOI 10.1073/pnas.102179699
   Zhang Y, 2004, PROTEINS, V57, P702, DOI 10.1002/prot.20264
   Zhou H, 2008, PROTEINS, V71, P1211, DOI 10.1002/prot.21813
   Zhou HY, 2002, PROTEIN SCI, V11, P2714, DOI 10.1110/ps.0217002
NR 42
TC 41
Z9 42
U1 0
U2 4
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0887-3585
EI 1097-0134
J9 PROTEINS
JI Proteins
PY 2009
VL 77
SU 9
BP 173
EP 180
DI 10.1002/prot.22532
PG 8
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 525VL
UT WOS:000272244700020
PM 19705484
OA Bronze
DA 2021-01-25
ER

PT J
AU Knechtle, B
   Knechtle, P
   Andonie, JL
   Kohler, G
AF Knechtle, Beat
   Knechtle, Patrizia
   Luis Andonie, Jorge
   Kohler, Goetz
TI Body Composition, Energy, and Fluid Turnover in a Five-Day Multistage
   Ultratriathlon: A Case Study
SO RESEARCH IN SPORTS MEDICINE
LA English
DT Article
DE ultra-endurance; skin-fold thickness; anthropometry; percent body fat
ID SKELETAL-MUSCLE MASS; HEART-RATE; BIOELECTRICAL-IMPEDANCE; PREDICTION
   EQUATION; EXPENDITURE; EXERCISE; FAT; BALANCE; RACE; ALDOSTERONE
AB A multistage ultraendurance triathlon over five times the Ironman distance within five consecutive days leads in one ultraendurance triathlete to minimal changes in body mass (BM; -0.3 kg), fat mass (FM; -1.9 kg), skeletal muscle mass (SM; no change), and total body water (TBW; + 1.5 l). This might be explained by the continuously slower race times throughout the race every day and the positive energy balance (8,095 kcal), although he suffered an average energy deficit of -1,848 kcal per Ironman distance. The increase of TBW might be explained by the increase of plasma volume (PV) in the first 3 days. The increase of PV and TBW could be a result of an increase of sodium, which was increased after every stage. We presume that this could be the result of an increased activity of aldosterone.
C1 [Knechtle, Beat; Knechtle, Patrizia] Facharzt FMH Allgemeinmed, Gesundheitszentrum, CH-9001 St Gallen, Switzerland.
   [Knechtle, Beat] Univ Zurich, Inst Gen Practice, Zurich, Switzerland.
   [Knechtle, Beat] Univ Zurich, Hlth Serv Res, Zurich, Switzerland.
   [Luis Andonie, Jorge] Multisport Andonie, Monterrey, Mexico.
   [Kohler, Goetz] Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
   [Kohler, Goetz] Univ Basel Hosp, CH-4031 Basel, Switzerland.
RP Knechtle, B (corresponding author), Facharzt FMH Allgemeinmed, Gesundheitszentrum, Vadianstr 26, CH-9001 St Gallen, Switzerland.
EM beat.knechtle@hispeed.ch
RI Carmeli, Eli/I-2010-2019
OI Carmeli, Eli/0000-0002-1704-112X
CR Atwater W.O., 1909, P AM PHYSL SOC, V30, P14
   Ball SD, 2004, EUR J CLIN NUTR, V58, P1525, DOI 10.1038/sj.ejcn.1602003
   Bircher S, 2006, J SPORT SCI MED, V5, P154
   Bonora E, 1995, METABOLISM, V44, P1617, DOI 10.1016/0026-0495(95)90084-5
   Boschmann M, 2002, INT J SPORTS MED, V23, P537, DOI 10.1055/s-2002-35527
   Claessens M, 2000, Indian Heart J, V52, P307
   Davidson L, 1997, BRIT J NUTR, V78, P695, DOI 10.1079/BJN19970188
   Doupe MB, 1997, CAN J APPL PHYSIOL, V22, P598, DOI 10.1139/h97-039
   DRESSENDORFER RH, 1991, MED SCI SPORT EXER, V23, P954
   DURNIN JVG, 1967, BRIT J NUTR, V21, P681, DOI 10.1079/BJN19670070
   DURNIN JVGA, 1974, BRIT J NUTR, V32, P77, DOI 10.1079/BJN19740060
   FELLMANN N, 1992, SPORTS MED, V13, P37, DOI 10.2165/00007256-199213010-00004
   Fellmann N, 1999, EUR J APPL PHYSIOL, V80, P353, DOI 10.1007/s004210050603
   FELLMANN N, 1989, INT J SPORTS MED, V10, P406, DOI 10.1055/s-2007-1024934
   FRAYN KN, 1983, J APPL PHYSIOL, V55, P628
   FREUND BJ, 1987, J APPL PHYSIOL, V63, P669
   Frykman PN, 2003, WILD ENVIRON MED, V14, P240, DOI 10.1580/1080-6032(2003)14[240:EOAMEE]2.0.CO;2
   FULLER NJ, 1991, EUR J CLIN NUTR, V45, P43
   Gualdi-Russo Emanuela, 1997, Zeitschrift fuer Morphologie und Anthropologie, V81, P321
   Helge JW, 2003, J EXP BIOL, V206, P1075, DOI 10.1242/jeb.00218
   Hiilloskorpi HK, 2003, INT J SPORTS MED, V24, P332
   HOCHLI D, 1995, INT J SPORTS MED, V16, P343, DOI 10.1055/s-2007-973017
   HORTOBAGYI T, 1992, INT J SPORT NUTR, V2, P60, DOI 10.1123/ijsn.2.1.60
   Janssen I, 2000, J APPL PHYSIOL, V89, P465
   Kashiwazaki H, 1999, J NUTR SCI VITAMINOL, V45, P79, DOI 10.3177/jnsv.45.79
   Kavouras SA, 2002, CURR OPIN CLIN NUTR, V5, P519, DOI 10.1097/00075197-200209000-00010
   Keytel LR, 2005, J SPORT SCI, V23, P289, DOI 10.1080/02640410470001730089
   Kimber NE, 2002, INT J SPORT NUTR EXE, V12, P47, DOI 10.1123/ijsnem.12.1.47
   Kingsley M, 2005, INT J SPORTS MED, V26, P39, DOI 10.1055/s-2004-817878
   Kirchhoff E, 2002, J FOOD COMPOS ANAL, V15, P465, DOI 10.1006/jfca.2002.1091
   Knechtle B, 2008, INT J SPORTS MED, V29, P343, DOI 10.1055/s-2007-965354
   Knechtle B, 2008, BRIT J SPORT MED, V42, P121, DOI 10.1136/bjsm.2007.038034
   Knechtle B, 2005, Praxis (Bern 1994), V94, P371
   Knechtle B, 2005, INT J SPORTS MED, V26, P499, DOI 10.1055/s-2004-821136
   KNECHTLE B, 2003, SCHWEIZERISCHE Z SPO, V51, P180
   Knechtle B, 2007, J SPORT SCI MED, V6, P401
   Lean MEJ, 1996, AM J CLIN NUTR, V63, P4
   Lee RC, 2000, AM J CLIN NUTR, V72, P796
   LEHMANN M, 1995, INT J SPORTS MED, V16, P155, DOI 10.1055/s-2007-972984
   LI RW, 1993, AM J CLIN NUTR, V58, P602
   LIVINGSTONE MBE, 1990, AM J CLIN NUTR, V52, P59
   Macfarlane DJ, 2007, ASIA PAC J CLIN NUTR, V16, P66
   MELIN B, 1980, EUR J APPL PHYSIOL O, V44, P141, DOI 10.1007/BF00421092
   MILLEDGE JS, 1982, CLIN SCI, V62, P595, DOI 10.1042/cs0620595
   Mischler I, 2003, MED SCI SPORT EXER, V35, P75, DOI 10.1097/00005768-200301000-00013
   NAGEL D, 1989, EUR J APPL PHYSIOL O, V59, P16, DOI 10.1007/BF02396574
   Neumayr G, 2005, INT J SPORTS MED, V26, P2, DOI 10.1055/s-2004-815717
   POORTMANS JR, 1984, SPORTS MED, V1, P125, DOI 10.2165/00007256-198401020-00003
   RAMSAY DJ, 1989, BAILLIERE CLIN ENDOC, V3, P371, DOI 10.1016/S0950-351X(89)80008-4
   Raschka C, 1992, Schweiz Z Sportmed, V40, P13
   RASCHKA C, 1991, Z ERNAHRUNGSWISS, V30, P276, DOI 10.1007/BF01651957
   Reynolds RD, 1999, J NUTR, V129, P1307
   Rogers G, 1997, MED SCI SPORT EXER, V29, P1477, DOI 10.1097/00005768-199711000-00014
   Saunders MJ, 1998, MED SCI SPORT EXER, V30, P885, DOI 10.1097/00005768-199806000-00017
   Speedy DB, 2001, CLIN J SPORT MED, V11, P44, DOI 10.1097/00042752-200101000-00008
   Tucker LA, 1998, AM J HEALTH PROMOT, V12, P229, DOI 10.4278/0890-1171-12.4.229
   Uberoi H S, 1991, J Assoc Physicians India, V39, P677
   Vaananen II, 2005, J SPORT MED PHYS FIT, V45, P301
   van der Ploeg GE, 2003, EUR J CLIN NUTR, V57, P1009, DOI 10.1038/sj.ejcn.1601636
   VANBEAUMONT W, 1972, J APPL PHYSIOL, V32, P712
NR 60
TC 17
Z9 17
U1 0
U2 4
PU TAYLOR & FRANCIS LTD
PI ABINGDON
PA 2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND
SN 1543-8627
EI 1543-8635
J9 RES SPORTS MED
JI Res. Sports Med.
PY 2009
VL 17
IS 2
BP 104
EP 120
DI 10.1080/15438620902900260
PG 17
WC Sport Sciences
SC Sport Sciences
GA 451RX
UT WOS:000266488900004
PM 19479629
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Hadziselimovic, F
   Hadziselimovic, NO
   Demougin, P
   Krey, G
   Hoecht, B
   Oakeley, EJ
AF Hadziselimovic, F.
   Hadziselimovic, N. O.
   Demougin, P.
   Krey, G.
   Hoecht, B.
   Oakeley, E. J.
TI EGR4 Is a Master Gene Responsible for Fertility in Cryptorchidism
SO SEXUAL DEVELOPMENT
LA English
DT Article
DE Cryptorchidism; Infertility; Ad spermatogonia; EGR4; Microarray
ID FOLLICLE-STIMULATING-HORMONE; RNA HELICASE GRTH/DDX25; INFERTILITY;
   MATURATION; PITUITARY
AB The purpose of early medical or surgical treatment of boys with undescended testes is to prevent the development of infertility. However, early and successful surgery cannot prevent infertility in cryptorchid boys who lack type A dark (Ad) spermatogonia. The aim of this study was to compare the gene expression pattern of patients with completed transformation of gonocytes into Ad spermatogonia, associated with low infertility risk, with patients that had failed to undergo this process and had a high infertility risk. Genes expressed in the 16 cryptorchid testes were estimated using Affymetrix whole-genome microarray and compared to the expression profiles from four contralateral gonads of boys with unilateral testicular agenesis. Whole-genome expression profiling showed that boys in the high infertility risk group according to testicular histology, showed decreased or lack of expression of most of the genes essential for hypothalamo-pituitary-testicular axis function relative to low or intermediate risk group as well as controls. In particular, EGR4, which is involved in regulating the secretion of luteinizing hormone, was virtually not expressed. Thus, we found multiple differences in gene expression between the high and low infertility risk groups, confirming the importance of an intact hypothalamo-pituitary testicular axis and EGR4 in fertility development. Copyright (C) 2009 S. Karger AG, Basel
C1 [Hadziselimovic, F.] Childrens Day Care Clin Liestal, Liestal, Switzerland.
   [Hadziselimovic, F.; Hadziselimovic, N. O.; Krey, G.] Inst Androl, Liestal, Switzerland.
   [Demougin, P.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Oakeley, E. J.] Friedrich Miescher Inst Biomed Res, Basel, Switzerland.
   [Hoecht, B.] Univ Hosp Wurzburg, Dept Pediat Surg, Wurzburg, Germany.
RP Hadziselimovic, F (corresponding author), Kindertagesklin Liestal, Oristalstr 87A, CH-4410 Liestal, Switzerland.
EM praxis@kindertagesklinik.ch
CR Abel MH, 2000, ENDOCRINOLOGY, V141, P1795, DOI 10.1210/en.141.5.1795
   Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691
   Chalmel F, 2007, P NATL ACAD SCI USA, V104, P8346, DOI 10.1073/pnas.0701883104
   Deutsch EW, 2008, NAT BIOTECHNOL, V26, P305, DOI 10.1038/nbt1391
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gjerstorff MF, 2008, HUM REPROD, V23, P2194, DOI 10.1093/humrep/den262
   Hadziselimovic F, 2005, J UROLOGY, V174, P1536, DOI 10.1097/01.ju.0000181506.97839.b0
   Hadziselimovic F, 2001, LANCET, V358, P1156, DOI 10.1016/S0140-6736(01)06274-2
   HADZISELIMOVIC F, 1979, CRYPTORCHIDISM
   Hadziselimovic F., 2008, KLIN PADIATR, V219, P1
   Hadziselimovic F, 2008, INT BRAZ J UROL, V34, P319, DOI 10.1590/S1677-55382008000300009
   Hadziselimovic F, 2007, HORM RES, V68, P46, DOI 10.1159/000100874
   HUFF DS, 1991, J UROLOGY, V146, P630, DOI 10.1016/S0022-5347(17)37876-X
   Kim SS, 2008, J UROLOGY, V179, P144, DOI 10.1016/S0022-5347(08)60413-9
   Kumar TR, 1997, NAT GENET, V15, P201, DOI 10.1038/ng0297-201
   PANIAGUA R, 1984, J ANAT, V139, P535
   Parkinson H, 2007, NUCLEIC ACIDS RES, V35, pD747, DOI 10.1093/nar/gkl995
   Schulze W, 1999, HUM REPROD, V14, P82, DOI 10.1093/humrep/14.suppl_1.82
   SEGUCHI H, 1974, Verhandlungen der Anatomischen Gesellschaft, V68, P133
   Sheng Y, 2006, J BIOL CHEM, V281, P35048, DOI 10.1074/jbc.M605086200
   Topilko P, 1998, MOL ENDOCRINOL, V12, P107, DOI 10.1210/mend.12.1.0049
   Tourtellotte WG, 2000, MOL CELL BIOL, V20, P5261, DOI 10.1128/MCB.20.14.5261-5268.2000
   Tourtellotte WG, 1999, DEVELOPMENT, V126, P5061
   Trussell J C, 2004, Curr Urol Rep, V5, P142, DOI 10.1007/s11934-004-0028-4
   Tsai-Morris CH, 2004, P NATL ACAD SCI USA, V101, P6373, DOI 10.1073/pnas.0401855101
   Wettenhall JM, 2004, BIOINFORMATICS, V20, P3705, DOI 10.1093/bioinformatics/bth449
   Winters SJ, 2004, REPRODUCTION, V128, P13, DOI 10.1530/rep.1.00195
   ZIVKOVIC D, 2006, J PEDIATR UROL, V5, P468
NR 28
TC 33
Z9 34
U1 0
U2 2
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 1661-5425
EI 1661-5433
J9 SEX DEV
JI Sex. Dev.
PY 2009
VL 3
IS 5
BP 253
EP 263
DI 10.1159/000249147
PG 11
WC Developmental Biology
SC Developmental Biology
GA 530NZ
UT WOS:000272600900004
PM 19828938
OA Bronze
DA 2021-01-25
ER

PT S
AU Baer, MM
   Chanut-Delalande, H
   Affolter, M
AF Baer, Magdalena M.
   Chanut-Delalande, Helene
   Affolter, Markus
BE Lecuit, T
TI CELLULAR AND MOLECULAR MECHANISMS UNDERLYING THE FORMATION OF BIOLOGICAL
   TUBES
SO TISSUE REMODELING AND EPITHELIAL MORPHOGENESIS
SE Current Topics in Developmental Biology
LA English
DT Review; Book Chapter
ID CAENORHABDITIS-ELEGANS; GENETIC-CONTROL; TRACHEAL MORPHOGENESIS; LUMEN
   FORMATION; BRANCHING MORPHOGENESIS; DROSOPHILA TRACHEA; APICAL MEMBRANE;
   PLASMA-MEMBRANE; EXCRETORY CELL; SALIVARY-GLAND
AB Biological tubes are integral components of many organs. Based on their cellular organization, tubes can be divided into three types: multicellular, unicellular, and intracellular. The mechanisms by which these tubes form during development vary significantly, in many cases even for those sharing a similar final architecture. Here, we present recent advances in studying cellular and molecular aspects of tubulogenesis in different organisms.
C1 [Baer, Magdalena M.; Chanut-Delalande, Helene; Affolter, Markus] Univ Basel, Biozentrum, Basel, Switzerland.
   [Chanut-Delalande, Helene] CNRS, Ctr Dev Biol, UMR5547, Toulouse, France.
RP Baer, MM (corresponding author), Univ Basel, Biozentrum, Klingelbergstr, Basel, Switzerland.
OI CHANUT-DELALANDE, Helene/0000-0002-1720-2069; Affolter,
   Markus/0000-0002-5171-0016; Baer, Magdalena/0000-0003-3315-0921
CR Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   Affolter M, 2008, DEVELOPMENT, V135, P2055, DOI 10.1242/dev.014498
   Baer MM, 2007, GENETICS, V176, P2279, DOI 10.1534/genetics.107.074088
   Bagnat M, 2007, NAT CELL BIOL, V9, P954, DOI 10.1038/ncb1621
   Belting HG, 2007, NAT CELL BIOL, V9, P880, DOI 10.1038/ncb0807-880
   Berry KL, 2003, SCIENCE, V302, P2134, DOI 10.1126/science.1087667
   Brodu V, 2006, GENE DEV, V20, P1817, DOI 10.1101/gad.375706
   Bryant DM, 2008, NAT REV MOL CELL BIO, V9, P887, DOI 10.1038/nrm2523
   Buechner M, 1999, DEV BIOL, V214, P227, DOI 10.1006/dbio.1999.9398
   Buechner M, 2002, TRENDS CELL BIOL, V12, P479, DOI 10.1016/S0962-8924(02)02364-4
   Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Caussinus E, 2008, CURR BIOL, V18, P1727, DOI 10.1016/j.cub.2008.10.062
   Chung S, 2008, J CELL SCI, V121, P3501, DOI 10.1242/jcs.037887
   Ciruna B, 2006, NATURE, V439, P220, DOI 10.1038/nature04375
   Colas JF, 2001, DEV DYNAM, V221, P117, DOI 10.1002/dvdy.1144
   Ewald AJ, 2008, DEV CELL, V14, P570, DOI 10.1016/j.devcel.2008.03.003
   Fujita M, 2003, DEV BIOL, V256, P290, DOI 10.1016/S0012-1606(03)00040-X
   Gao JT, 2001, HUM MOL GENET, V10, P3049, DOI 10.1093/hmg/10.26.3049
   Gassama-Diagne A, 2006, NAT CELL BIOL, V8, P963, DOI 10.1038/ncb1461
   Geldmacher-Voss B, 2003, DEVELOPMENT, V130, P3767, DOI 10.1242/dev.00603
   Gobel V, 2004, DEV CELL, V6, P865, DOI 10.1016/j.devcel.2004.05.018
   Guillemin K, 1996, DEVELOPMENT, V122, P1353
   Haag TA, 1999, DEV BIOL, V208, P56, DOI 10.1006/dbio.1998.9188
   Haigo SL, 2003, CURR BIOL, V13, P2125, DOI 10.1016/j.cub.2003.11.054
   Hardin J, 2008, DEV CELL, V14, P465, DOI 10.1016/j.devcel.2008.03.014
   Helenius IT, 2008, J CELL BIOL, V182, P221, DOI 10.1083/jcb.200806186
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   Horne-Badovinac S, 2001, CURR BIOL, V11, P1492, DOI 10.1016/S0960-9822(01)00458-4
   Horowitz A, 2008, CIRC RES, V103, P784, DOI 10.1161/CIRCRESAHA.108.181818
   Huang DCS, 2000, CELL, V103, P839, DOI 10.1016/S0092-8674(00)00187-2
   Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964
   Jiang L, 2007, DEV BIOL, V311, P487, DOI 10.1016/j.ydbio.2007.08.049
   JONES SJM, 1995, MOL GEN GENET, V248, P719, DOI 10.1007/BF02191712
   Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012
   Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923
   Kerman BE, 2008, DEV BIOL, V320, P278, DOI 10.1016/j.ydbio.2008.05.541
   Kerman BE, 2006, DIFFERENTIATION, V74, P326, DOI 10.1111/j.1432-0436.2006.00095.x
   Lee M, 2003, DEVELOPMENT, V130, P5989, DOI 10.1242/dev.00806
   Lee S, 2002, DEVELOPMENT, V129, P1509
   Levi BP, 2006, DEVELOPMENT, V133, P2383, DOI 10.1242/dev.02404
   Liegeois S, 2007, GENETICS, V175, P709, DOI 10.1534/genetics.106.066035
   Liu KD, 2007, AM J PHYSIOL-RENAL, V293, pF1633, DOI 10.1152/ajprenal.00053.2007
   Lowery LA, 2005, DEVELOPMENT, V132, P2057, DOI 10.1242/dev.01791
   Lu PF, 2008, SCIENCE, V322, P1506, DOI 10.1126/science.1162783
   Lu PF, 2006, J MAMMARY GLAND BIOL, V11, P213, DOI 10.1007/s10911-006-9027-z
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Mailleux AA, 2007, DEV CELL, V12, P221, DOI 10.1016/j.devcel.2006.12.003
   Martin AC, 2009, NATURE, V457, P495, DOI 10.1038/nature07522
   Martin-Belmonte F, 2008, CURR BIOL, V18, P507, DOI 10.1016/j.cub.2008.02.076
   Martin-Belmonte F, 2007, CELL CYCLE, V6, P1957, DOI 10.4161/cc.6.16.4583
   Martin-Belmonte F, 2007, CELL, V128, P383, DOI 10.1016/j.cell.2006.11.051
   McKeown C, 1998, DEVELOPMENT, V125, P2087
   Medioni C, 2008, J CELL BIOL, V182, P249, DOI 10.1083/jcb.200801100
   MONTESANO R, 1991, CELL, V66, P697, DOI 10.1016/0092-8674(91)90115-F
   Munson C, 2008, DEV BIOL, V324, P41, DOI 10.1016/j.ydbio.2008.08.033
   Myat MM, 2002, CELL, V111, P879, DOI 10.1016/S0092-8674(02)01140-6
   NELSON FK, 1984, J EXP ZOOL, V231, P45, DOI 10.1002/jez.1402310107
   Nishimura M, 2007, DEVELOPMENT, V134, P4273, DOI 10.1242/dev.010397
   Nishimura T, 2008, DEVELOPMENT, V135, P1493, DOI 10.1242/dev.019646
   O'Brien LE, 2001, NAT CELL BIOL, V3, P831, DOI 10.1038/ncb0901-831
   Paul SM, 2007, DEVELOPMENT, V134, P147, DOI 10.1242/dev.02710
   Praitis V, 2005, DEV BIOL, V283, P157, DOI 10.1016/j.ydbio.2005.04.002
   Rasmussen JP, 2008, DEV CELL, V14, P559, DOI 10.1016/j.devcel.2008.01.019
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Riento K, 2003, NAT REV MOL CELL BIO, V4, P446, DOI 10.1038/nrm1128
   Samakovlis C, 1996, DEVELOPMENT, V122, P3531
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Santiago-Martinez E, 2008, J CELL BIOL, V182, P241, DOI 10.1083/jcb.200804120
   Shakya R, 2005, DEV CELL, V8, P65, DOI 10.1016/j.devcel.2004.11.008
   Stork T, 2008, J NEUROSCI, V28, P587, DOI 10.1523/JNEUROSCI.4367-07.2008
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   Suzuki N, 2001, EMBO REP, V2, P530, DOI 10.1093/embo-reports/kve110
   TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697
   Tawk M, 2007, NATURE, V446, P797, DOI 10.1038/nature05722
   Tong X, 2008, DEV BIOL, V317, P225, DOI 10.1016/j.ydbio.2008.02.040
   Tucker AS, 2007, SEMIN CELL DEV BIOL, V18, P237, DOI 10.1016/j.semcdb.2007.01.006
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED
   Yu W, 2005, MOL BIOL CELL, V16, P433, DOI 10.1091/mbc.e04-05-0435
NR 81
TC 31
Z9 32
U1 1
U2 15
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0070-2153
BN 978-0-12-374902-4
J9 CURR TOP DEV BIOL
JI Curr. Top. Dev. Biol.
PY 2009
VL 89
BP 137
EP 162
DI 10.1016/S0070-2153(09)89006-6
PG 26
WC Anatomy & Morphology; Developmental Biology
SC Anatomy & Morphology; Developmental Biology
GA BQB91
UT WOS:000280602300007
PM 19737645
DA 2021-01-25
ER

PT J
AU Laage, S
   Marchetti, A
   Sein, J
   Pierattelli, R
   Sass, HJ
   Grzesiek, S
   Lesage, A
   Pintacuda, G
   Emsley, L
AF Laage, Segolene
   Marchetti, Alessandro
   Sein, Julien
   Pierattelli, Roberta
   Sass, Hans Juergen
   Grzesiek, Stephan
   Lesage, Anne
   Pintacuda, Guido
   Emsley, Lyndon
TI Band-Selective H-1-C-13 Cross-Polarization in Fast Magic Angle Spinning
   Solid-State NMR Spectroscopy
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID THROUGH-BOND; PROTEINS; PROTON; ASSIGNMENTS; PULSES
AB A magic angle spinning (MAS) NMR technique to transfer polarization from protons to a specific set of the C-13 spins is introduced for the study of biomolecular samples in the solid-state. Ultrafast (>60 kHz) MAS and low irradiation rf fields are used to achieve band-selective Hartmann-Hahn cross-polarization (CP) between the whole proton bath and carbons whose resonances are close to the C-13-transmitter offset. When compared to conventional, broadband H-1-C-13 CP, the band-selective experiment can be established without any loss of sensitivity when polarizing the aliphatic signals of a protein sample, and with a significant gain when polarizing carbonyls, This scheme can be used as a building block in 2D C-13-C-13 homonuclear correlation experiments to obtain a faster and more sensitive characterization of biological solids.
C1 [Laage, Segolene; Marchetti, Alessandro; Sein, Julien; Lesage, Anne; Pintacuda, Guido; Emsley, Lyndon] Univ Lyon 1, CNRS, ENS Lyon, Ctr RMN Tres Hauts Champs, F-69100 Villeurbanne, France.
   [Pierattelli, Roberta] Univ Florence, Dept Chem, I-50019 Florence, Italy.
   [Pierattelli, Roberta] Univ Florence, Magnet Resonance Ctr, I-50019 Florence, Italy.
   [Sass, Hans Juergen; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pintacuda, G (corresponding author), Univ Lyon 1, CNRS, ENS Lyon, Ctr RMN Tres Hauts Champs, 5 Rue Doua, F-69100 Villeurbanne, France.
EM Guido.Pintacuda@ens-lyon.fr; Lyndon.Emsley@ens-lyon.fr
RI Emsley, Lyndon/AAS-6384-2020; Pierattelli, Roberta/F-9439-2012; Lesage,
   Anne/AAD-8352-2019; Emsley, Lyndon/C-6108-2008; Marchetti,
   Alessandro/M-8892-2017
OI Emsley, Lyndon/0000-0003-1360-2572; Pierattelli,
   Roberta/0000-0001-7755-0885; Emsley, Lyndon/0000-0003-1360-2572;
   Marchetti, Alessandro/0000-0002-6125-3920; Grzesiek,
   Stephan/0000-0003-1998-4225
FU ANRFrench National Research Agency (ANR) [ANR JC2005]; ECEuropean
   CommissionEuropean Commission Joint Research CentreEuropean Community
   (EC) [RII3-026145, EU-NMR]
FX We acknowledge support from the ANR (ANR JC2005) and from the Access to
   Research Infrastructures activity in the sixth FP of the EC
   (RII3-026145, EU-NMR).
CR Baldus M, 1998, MOL PHYS, V95, P1197, DOI 10.1080/002689798166215
   Baldus M, 1996, J MAGN RESON SER A, V121, P65, DOI 10.1006/jmra.1996.0137
   BALDUS M, 1994, CHEM PHYS LETT, V230, P329, DOI 10.1016/0009-2614(94)01209-1
   Castellani F, 2002, NATURE, V420, P98, DOI 10.1038/nature01070
   Chen LL, 2006, J AM CHEM SOC, V128, P9992, DOI 10.1021/ja062347t
   Chen L, 2007, J AM CHEM SOC, V129, P10650, DOI 10.1021/ja073498e
   Chiarparin E, 1998, MOL PHYS, V95, P759, DOI 10.1080/002689798166396
   Detken A, 2002, CHEM PHYS LETT, V356, P298, DOI 10.1016/S0009-2614(02)00335-4
   Elena B, 2005, J AM CHEM SOC, V127, P17296, DOI 10.1021/ja054411x
   Ernst M, 2001, CHEM PHYS LETT, V348, P293, DOI 10.1016/S0009-2614(01)01115-0
   Franks WT, 2005, J AM CHEM SOC, V127, P12291, DOI 10.1021/ja044497e
   Hardy EH, 2003, J MAGN RESON, V165, P208, DOI 10.1016/j.jmr.2003.08.003
   LAAGE S, 2008, J MAGN RESO IN PRESS
   LANGE A, 2006, ACCOUNTS CHEM RES, V440, P959
   Lesage A, 1997, J AM CHEM SOC, V119, P7867, DOI 10.1021/ja971089k
   Lesage A, 2001, J MAGN RESON, V148, P449, DOI 10.1006/jmre.2000.2249
   Loquet A, 2008, J AM CHEM SOC, V130, P10625, DOI 10.1021/ja801464g
   Luca S, 2003, ACCOUNTS CHEM RES, V36, P858, DOI 10.1021/ar020232y
   Marks D, 1996, J MAGN RESON SER A, V118, P157, DOI 10.1006/jmra.1996.0024
   McDermott AE, 2004, CURR OPIN STRUC BIOL, V14, P554, DOI 10.1016/j.sbi.2004.09.007
   MEIER BH, 1992, CHEM PHYS LETT, V188, P201, DOI 10.1016/0009-2614(92)90009-C
   Pintacuda G, 2007, ANGEW CHEM INT EDIT, V46, P1079, DOI 10.1002/anie.200603093
   STEJSKAL EO, 1977, J MAGN RESON, V28, P105, DOI 10.1016/0022-2364(77)90260-8
   Verel R, 1998, CHEM PHYS LETT, V287, P421, DOI 10.1016/S0009-2614(98)00172-9
   Wasmer C, 2008, SCIENCE, V319, P1523, DOI 10.1126/science.1151839
   Wickramasinghe NP, 2007, J MAGN RESON, V184, P350, DOI 10.1016/j.jmr.2006.10.012
   Zhou DHH, 2006, J BIOMOL NMR, V34, P245, DOI 10.1007/s10858-006-0026-6
NR 27
TC 66
Z9 68
U1 0
U2 36
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD DEC 24
PY 2008
VL 130
IS 51
BP 17216
EP +
DI 10.1021/ja805926d
PG 3
WC Chemistry, Multidisciplinary
SC Chemistry
GA 406UO
UT WOS:000263320600006
PM 19053413
DA 2021-01-25
ER

PT J
AU Canepari, M
   Vogt, KE
AF Canepari, Marco
   Vogt, Kaspar E.
TI Dendritic Spike Saturation of Endogenous Calcium Buffer and Induction of
   Postsynaptic Cerebellar LTP
SO PLOS ONE
LA English
DT Article
AB The architecture of parallel fiber axons contacting cerebellar Purkinje neurons retains spatial information over long distances. Parallel fiber synapses can trigger local dendritic calcium spikes, but whether and how this calcium signal leads to plastic changes that decode the parallel fiber input organization is unknown. By combining voltage and calcium imaging, we show that calcium signals, elicited by parallel fiber stimulation and mediated by voltage-gated calcium channels, increase non-linearly during high-frequency bursts of electrically constant calcium spikes, because they locally and transiently saturate the endogenous buffer. We demonstrate that these non-linear calcium signals, independently of NMDA or metabotropic glutamate receptor activation, can induce parallel fiber long-term potentiation. Two-photon imaging in coronal slices revealed that calcium signals inducing long-term potentiation can be observed by stimulating either the parallel fiber or the ascending fiber pathway. We propose that local dendritic calcium spikes, evoked by synaptic potentials, provide a unique mechanism to spatially decode parallel fiber signals into cerebellar circuitry changes.
C1 [Canepari, Marco; Vogt, Kaspar E.] Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Basel, Switzerland.
RP Canepari, M (corresponding author), Univ Basel, Biozentrum, Div Pharmacol & Neurobiol, Basel, Switzerland.
EM marco.canepari@unibas.ch
RI Canepari, Marco/H-6772-2012
OI Canepari, Marco/0000-0001-9759-2388; Vogt, Kaspar/0000-0002-0859-876X
FU University of Basel
FX This work was supported by the University of Basel. The funders had no
   role in study design, data collection and analysis, decision to publish,
   or preparation of the manuscript.
CR Blatow M, 2003, NEURON, V38, P79, DOI 10.1016/S0896-6273(03)00196-X
   Brenowitz SD, 2005, NEURON, V45, P419, DOI 10.1016/j.neuron.2004.12.045
   Canepari M, 2007, J PHYSIOL-LONDON, V580, P463, DOI 10.1113/jphysiol.2006.125005
   Canepari M, 2006, J PHYSIOL-LONDON, V573, P65, DOI 10.1113/jphysiol.2005.103770
   Canepari M, 2008, CELL MOL NEUROBIOL, V28, P1079, DOI 10.1007/s10571-008-9285-y
   CELIO MR, 1990, NEUROSCIENCE, V35, P375, DOI 10.1016/0306-4522(90)90091-H
   Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031
   Coutinho V, 2004, EUR J NEUROSCI, V20, P740, DOI 10.1111/j.1460-9568.2004.03533.x
   Dittman JS, 1998, J NEUROSCI, V18, P6147
   EBERHARD M, 1994, EUR J BIOCHEM, V222, P21, DOI 10.1111/j.1432-1033.1994.tb18836.x
   Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713
   Golding NL, 2002, NATURE, V418, P326, DOI 10.1038/nature00854
   Gundappa-Sulur G, 1999, J COMP NEUROL, V408, P580, DOI 10.1002/(SICI)1096-9861(19990614)408:4<580::AID-CNE11>3.0.CO;2-O
   Holthoff K, 2006, CELL TISSUE RES, V326, P369, DOI 10.1007/s00441-006-0263-8
   Jorntell H, 2006, NEURON, V52, P227, DOI 10.1016/j.neuron.2006.09.032
   Kuruma A, 2003, EUR J NEUROSCI, V18, P2677, DOI 10.1111/j.1460-9568.2003.02977.x
   Lee SH, 2000, J PHYSIOL-LONDON, V525, P419, DOI 10.1111/j.1469-7793.2000.t01-2-00419.x
   Lev-Ram V, 2002, P NATL ACAD SCI USA, V99, P8389, DOI 10.1073/pnas.122206399
   Maeda H, 1999, NEURON, V24, P989, DOI 10.1016/S0896-6273(00)81045-4
   Marcaggi P, 2005, NAT NEUROSCI, V8, P776, DOI 10.1038/nn1458
   Marcaggi P, 2007, J PHYSIOL-LONDON, V578, P545, DOI 10.1113/jphysiol.2006.115014
   MIYAKAWA H, 1992, J NEUROPHYSIOL, V68, P1178
   Nagerl UV, 2000, BIOPHYS J, V79, P3009
   Neher E, 1998, CELL CALCIUM, V24, P345, DOI 10.1016/S0143-4160(98)90058-6
   Rancz EA, 2006, J NEUROSCI, V26, P5428, DOI 10.1523/JNEUROSCI.5284-05.2006
   Renzi M, 2007, J PHYSIOL-LONDON, V585, P91, DOI 10.1113/jphysiol.2007.141531
   Safo PK, 2005, NEURON, V48, P647, DOI 10.1016/j.neuron.2005.09.020
   Sarkisov DV, 2008, J NEUROSCI, V28, P133, DOI 10.1523/JNEUROSCI.1729-07.2008
   Schmidt H, 2003, J PHYSIOL-LONDON, V551, P13, DOI 10.1113/jphysiol.2002.035824
   Schneggenburger R, 2000, NATURE, V406, P889, DOI 10.1038/35022702
   Silver RA, 1998, J PHYSIOL-LONDON, V510, P881, DOI 10.1111/j.1469-7793.1998.881bj.x
   Sims RE, 2005, J NEUROSCI, V25, P3246, DOI 10.1523/JNEUROSCI.0073-05.2005
   Sims RE, 2006, J NEUROSCI, V26, P5153, DOI 10.1523/JNEUROSCI.4121-05.2006
   STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X
   Tanaka K, 2007, NEURON, V54, P787, DOI 10.1016/j.neuron.2007.05.014
   Wang SSH, 2000, NAT NEUROSCI, V3, P1266
   Womack MD, 2004, J NEUROSCI, V24, P3511, DOI 10.1523/JNEUROSCI.0290-04.2004
   Womack MD, 2004, J NEUROSCI, V24, P8818, DOI 10.1523/JNEUROSCI.2915-04.2004
   Xu-Friedman MA, 1999, BIOPHYS J, V76, P2029, DOI 10.1016/S0006-3495(99)77360-1
NR 39
TC 32
Z9 32
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD DEC 23
PY 2008
VL 3
IS 12
AR e4011
DI 10.1371/journal.pone.0004011
PG 14
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 437CB
UT WOS:000265462400012
PM 19104665
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Molina, N
   van Nimwegen, E
AF Molina, Nacho
   van Nimwegen, Erik
TI The evolution of domain-content in bacterial genomes
SO BIOLOGY DIRECT
LA English
DT Article
ID HORIZONTAL GENE-TRANSFER; PROKARYOTES; INNOVATION; SIZES; DNA
AB Background: Across all sequenced bacterial genomes, the number of domains n(c) in different functional categories c scales as a power-law in the total number of domains n, i.e. n(c) proportional to n(alpha c), with exponents a c that vary across functional categories. Here we investigate the implications of these scaling laws for the evolution of domain-content in bacterial genomes and derive the simplest evolutionary model consistent with these scaling laws.
   Results: We show that, using only an assumption of time invariance, the scaling laws uniquely determine the relative rates of domain additions and deletions across all functional categories and evolutionary lineages. In particular, the model predicts that the rate of additions and deletions of domains of category c is proportional to the number of domains nc currently in the genome and we discuss the implications of this observation for the role of horizontal transfer in genome evolution. Second, in addition to being proportional to nc, the rate of additions and deletions of domains of category c is proportional to a category-dependent constant. c, which is the same for all evolutionary lineages. This 'evolutionary potential'. c represents the relative probability for additions/deletions of domains of category c to be fixed in the population by selection and is predicted to equal the scaling exponent a c. By comparing the domain content of 93 pairs of closely-related genomes from all over the phylogenetic tree of bacteria, we demonstrate that the model's predictions are supported by available genome-sequence data.
   Conclusion: Our results establish a direct quantitative connection between the scaling of domain numbers with genome size, and the rate of addition and deletions of domains during short evolutionary time intervals.
C1 [van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM j.molina@unibas.ch; erik.vannimwegen@unibas.ch
RI Molina, Nacho/F-2244-2010
OI Molina, Nacho/0000-0003-0233-3055; van Nimwegen,
   Erik/0000-0001-6338-1312
CR Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI 10.1093/nar/gkh121
   Beiko RG, 2005, P NATL ACAD SCI USA, V102, P14332, DOI 10.1073/pnas.0504068102
   Bentley SD, 2004, ANNU REV GENET, V38, P771, DOI 10.1146/annurev.genet.38.072902.094318
   Branden C., 1999, INTRO PROTEIN STRUCT
   Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061
   Dagan T, 2007, P NATL ACAD SCI USA, V104, P870, DOI 10.1073/pnas.0606318104
   Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755
   FARMER JD, 1999, COMPUTING SCI ENG
   FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359
   Gogarten JP, 2005, NAT REV MICROBIOL, V3, P679, DOI 10.1038/nrmicro1204
   HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0
   Huynen MA, 1998, MOL BIOL EVOL, V15, P583, DOI 10.1093/oxfordjournals.molbev.a025959
   KIMURA M, 1968, NATURE, V217, P624, DOI 10.1038/217624a0
   Kimura M, 1983, NEUTRAL THEORY MOL E
   Konstantinidis KT, 2005, P NATL ACAD SCI USA, V102, P2567, DOI 10.1073/pnas.0409727102
   Koonin EV, 2008, NUCLEIC ACIDS RES, V36, P6688, DOI 10.1093/nar/gkn668
   Koonin EV, 2002, NATURE, V420, P218, DOI 10.1038/nature01256
   Lerat E, 2005, PLOS BIOL, V3, P807, DOI 10.1371/journal.pbio.0030130
   Linz S, 2007, MOL BIOL EVOL, V24, P1312, DOI 10.1093/molbev/msm052
   Luscombe NM, 2002, GENOME BIOL, V3
   Mirkin BG, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-2
   Navarre WW, 2007, GENE DEV, V21, P1456, DOI 10.1101/gad.1543107
   NEI M, 1986, MOL BIOL EVOL, V3, P418
   Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500
   Pal C, 2005, NAT GENET, V37, P1372, DOI 10.1038/ng1686
   Snel B, 2000, TRENDS GENET, V16, P9, DOI 10.1016/S0168-9525(99)01924-1
   Snel B, 2002, GENOME RES, V12, P17, DOI 10.1101/gr.176501
   van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8
   VANNIMWEGEN E, 2004, POWER LAWS SCALE FRE, P236
   VANPASSEL MWJ, 2008, PLOS COMPUT BIOL, V4
   Zuckerkandl E., 1962, HORIZONS BIOCH, P189, DOI DOI 10.1038/NCHEMBIO.2477
NR 32
TC 18
Z9 18
U1 0
U2 5
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1745-6150
J9 BIOL DIRECT
JI Biol. Direct
PD DEC 11
PY 2008
VL 3
AR 51
DI 10.1186/1745-6150-3-51
PG 17
WC Biology
SC Life Sciences & Biomedicine - Other Topics
GA 396LW
UT WOS:000262594200001
PM 19077245
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Boudko, SP
   Engel, J
   Bachinger, HP
AF Boudko, Sergei P.
   Engel, Juergen
   Baechinger, Hans Peter
TI Trimerization and Triple Helix Stabilization of the Collagen XIX NC2
   Domain
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID COILED-COIL; PROTEIN; MODEL; CHAIN; SUPERFAMILY; TRANSITIONS;
   SUBDOMAINS; MEMBRANE; TRIMERS; REQUIRE
AB The mechanisms of chain selection and assembly of fibril-associated collagens with interrupted triple helices (FACITs) must differ from that of fibrillar collagens, since they lack the characteristic C-propeptide. We analyzed two carboxyl-terminal noncollagenous domains, NC2 and NC1, of collagen XIX as potential trimerization units and found that NC2 forms a stable trimer and substantially stabilizes a collagen triple helix attached to either end. In contrast, the NC1 domain requires formation of an adjacent collagen triple helix to form interchain disulfide bridges. The NC2 domain of collagen XIX and probably of other FACITs is responsible for chain selection and trimerization.
C1 [Boudko, Sergei P.; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA.
   [Boudko, Sergei P.; Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.
   [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Bachinger, HP (corresponding author), 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
EM hpb@shcc.org
FU Shriners Hospital for Children
FX This work was supported by a grant from Shriners Hospital for Children.
   The costs of publication of this article were defrayed in part by the
   payment of page charges. This article must therefore be hereby marked
   "advertisement" in accordance with 18 U. S. C. Section 1734 solely to
   indicate this fact.
CR Bachmann A, 2005, P NATL ACAD SCI USA, V102, P13897, DOI 10.1073/pnas.0505141102
   Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918
   Boudko SP, 2007, J MOL BIOL, V366, P1538, DOI 10.1016/j.jmb.2006.12.046
   Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054
   Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5
   Deng YQ, 2006, STRUCTURE, V14, P889, DOI 10.1016/j.str.2006.03.007
   Engel J, 2000, MATRIX BIOL, V19, P235, DOI 10.1016/S0945-053X(00)00071-8
   Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   INOGUCHI K, 1995, J BIOCHEM-TOKYO, V117, P137, DOI 10.1093/oxfordjournals.jbchem.a124700
   Jaalinoja J, 2008, BIOCHEM J, V409, P545, DOI 10.1042/BJ20070984
   Lesage A, 1996, BIOCHEMISTRY-US, V35, P9647, DOI 10.1021/bi952666p
   Liu J, 2006, P NATL ACAD SCI USA, V103, P15457, DOI 10.1073/pnas.0604871103
   Liu J, 2006, BIOCHEMISTRY-US, V45, P15224, DOI 10.1021/bi061914m
   Lupas A, 1996, TRENDS BIOCHEM SCI, V21, P375, DOI 10.1016/S0968-0004(96)10052-9
   MAZZORANA M, 1993, J BIOL CHEM, V268, P3029
   MAZZORANA M, 1995, MATRIX BIOL, V14, P583, DOI 10.1016/S0945-053X(05)80007-1
   Mazzorana M, 2001, J BIOL CHEM, V276, P27989, DOI 10.1074/jbc.M101633200
   McAlinden A, 2003, J BIOL CHEM, V278, P42200, DOI 10.1074/jbc.M302429200
   Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532
   Myers JC, 2003, J BIOL CHEM, V278, P32047, DOI 10.1074/jbc.M304629200
   MYERS JC, 1993, GENE, V123, P211, DOI 10.1016/0378-1119(93)90126-N
   MYERS JC, 1994, J BIOL CHEM, V269, P18549
   Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004
   Persikov AV, 2004, PROTEIN SCI, V13, P893, DOI 10.1110/ps.03501704
   Ricard-Blum S, 2005, PATHOL BIOL, V53, P430, DOI 10.1016/j.patbio.2004.12.024
   Sumiyoshi H, 2004, J CELL BIOL, V166, P591, DOI 10.1083/jcb.200402054
   YOSHIOKA H, 1992, GENOMICS, V13, P884, DOI 10.1016/0888-7543(92)90176-S
NR 28
TC 26
Z9 26
U1 0
U2 2
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD DEC 5
PY 2008
VL 283
IS 49
BP 34345
EP 34351
DI 10.1074/jbc.M806352200
PG 7
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 377UY
UT WOS:000261277700062
PM 18845531
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Das, A
   Sen, S
   Lichtneckert, R
   Okada, R
   Ito, K
   Rodrigues, V
   Reichert, H
AF Das, Abhijit
   Sen, Sonia
   Lichtneckert, Robert
   Okada, Ryuichi
   Ito, Kei
   Rodrigues, Veronica
   Reichert, Heinrich
TI Drosophila olfactory local interneurons and projection neurons derive
   from a common neuroblast lineage specified by the empty spiracles gene
SO NEURAL DEVELOPMENT
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; ANTENNAL LOBE; WIRING SPECIFICITY; TRANSCRIPTION
   FACTORS; BRAIN-DEVELOPMENT; HEAD DEVELOPMENT; MUSHROOM BODY;
   MELANOGASTER; MAP; REPRESENTATION
AB Background: Encoding of olfactory information in insects occurs in the antennal lobe where the olfactory receptor neurons interact with projection neurons and local interneurons in a complex sensory processing circuitry. While several studies have addressed the developmental mechanisms involved in specification and connectivity of olfactory receptor neurons and projection neurons in Drosophila, the local interneurons are far less well understood.
   Results: In this study, we use genetic marking techniques combined with antibody labelling and neuroblast ablation to analyse lineage specific aspects of local interneuron development. We find that a large set of local interneurons labelled by the GAL4-LNI (NP1227) and GAL4-LN2 (NP2426) lines arise from the lateral neuroblast, which has also been shown to generate uniglomerular projection neurons. Moreover, we find that a remarkable diversity of local interneuron cell types with different glomerular innervation patterns and neurotransmitter expression derives from this lineage. We analyse the birth order of these two distinct neuronal types by generating MARCM (mosaic analysis with a repressible cell marker) clones at different times during larval life. This analysis shows that local interneurons arise throughout the proliferative cycle of the lateral neuroblast beginning in the embryo, while uniglomerular projection neurons arise later during the second larval instar. The lateral neuroblast requires the function of the cephalic gap gene empty spiracles for the development of olfactory interneurons. In empty spiracles null mutant clones, most of the local interneurons and lateral projection neurons are lacking. These findings reveal similarities in the development of local interneurons and projection neurons in the olfactory system of Drosophila.
   Conclusion: We find that the lateral neuroblast of the deutocerebrum gives rise to a large and remarkably diverse set of local interneurons as well as to projection neurons in the antennal lobe. Moreover, we show that specific combinations of these two neuron types are produced in specific time windows in this neuroblast lineage. The development of both these cell types in this lineage requires the function of the empty spiracles gene.
C1 [Das, Abhijit; Rodrigues, Veronica] Tata Inst Fundamental Res, Dept Biol Sci, Bombay 400005, Maharashtra, India.
   [Sen, Sonia; Rodrigues, Veronica] Tata Inst Fundamental Res, Natl Ctr Biol Sci, Bangalore 560065, Karnataka, India.
   [Lichtneckert, Robert; Reichert, Heinrich] Univ Basel, Biozentrum, Basel, Switzerland.
   [Okada, Ryuichi; Ito, Kei] Univ Tokyo, Inst Mol & Cellular Biosci, Tokyo, Japan.
   [Okada, Ryuichi] Tokushima Bunri Univ, Kagawa Sch Pharmaceut Sci, Sanuki, Japan.
RP Rodrigues, V (corresponding author), Tata Inst Fundamental Res, Dept Biol Sci, Homi Bhabha Rd, Bombay 400005, Maharashtra, India.
EM abhi@tifr.res.in; sonia@ncbs.res.in; robert.lichtneckert@unibas.ch;
   ryuichi@iam.u-tokyo.ac.jp; itokei@iam.u-tokyo.ac.jp;
   veronica@ncbs.res.in; Heinrich.Reichert@unibas.ch
RI Sen, Sonia/H-6681-2019
OI Sen, Sonia/0000-0003-4693-3378; Das, Abhijit/0000-0001-5880-996X
FU TIFR; Indo Swiss Bilateral Research Initiative; Swiss NSFSwiss National
   Science Foundation (SNSF); Department of Science and Technology,
   Government of India - Centre for NanotechnologyDepartment of Science &
   Technology (India) [SR/S5/NM-36/2005]; Central Imaging and Flow
   Cytometry Facility; NCBS - Olympus MicroImaging Centre, Olympus Japan
FX This work was supported by grants from TIFR, the Indo Swiss Bilateral
   Research Initiative and the Swiss NSF. We thank the Department of
   Science and Technology, Government of India - Centre for Nanotechnology
   (No. SR/S5/NM-36/2005) and Central Imaging and Flow Cytometry Facility
   and NCBS - Olympus MicroImaging Centre, Olympus Japan for imaging
   facilities. We thank Tzumin Lee, Reinhard Stocker and Gero Meisenbock
   for generously providing many of the fly stocks and K VijayRaghavan for
   many useful discussions and comments on the manuscript.
CR AXEL R, 1995, SCI AM, V273, P154, DOI 10.1038/scientificamerican1095-154
   Bishop KM, 2003, J COMP NEUROL, V457, P345, DOI 10.1002/cne.10550
   Bossing T, 1996, DEV BIOL, V179, P41, DOI 10.1006/dbio.1996.0240
   COHEN SM, 1990, NATURE, V346, P482, DOI 10.1038/346482a0
   DALTON D, 1989, GENE DEV, V3, P1940, DOI 10.1101/gad.3.12a.1940
   Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2
   Goodman C, 1993, EMBRYONIC DEV DROSOP
   Hildebrand JG, 1997, ANNU REV NEUROSCI, V20, P595, DOI 10.1146/annurev.neuro.20.1.595
   Ito K, 1997, DEVELOPMENT, V124, P761
   ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q
   Jefferis GSXE, 2007, CELL, V128, P1187, DOI 10.1016/j.cell.2007.01.040
   JEFFERIS GS, 2005, CHEM SENSES S1, V30, P94
   Jefferis GSXE, 2006, SEMIN CELL DEV BIOL, V17, P50, DOI 10.1016/j.semcdb.2005.12.002
   Jefferis GSXE, 2005, CURR BIOL, V15, pR668, DOI 10.1016/j.cub.2005.08.033
   Jefferis GSXE, 2004, DEVELOPMENT, V131, P117, DOI 10.1242/dev.00896
   Jefferis GSXE, 2001, NATURE, V414, P204, DOI 10.1038/35102574
   Jhaveri D, 2000, DEV BIOL, V226, P73, DOI 10.1006/dbio.2000.9855
   Komiyama T, 2006, CURR OPIN NEUROBIOL, V16, P67, DOI 10.1016/j.conb.2005.12.002
   Komiyama T, 2003, CELL, V112, P157, DOI 10.1016/S0092-8674(03)00030-8
   Komiyama T, 2007, CELL, V128, P399, DOI 10.1016/j.cell.2006.12.028
   Komiyama T, 2007, CURR BIOL, V17, P278, DOI 10.1016/j.cub.2006.11.067
   Lai SL, 2008, DEVELOPMENT, V135, P2883, DOI 10.1242/dev.024380
   Lai SL, 2006, NAT NEUROSCI, V9, P703, DOI 10.1038/nn1681
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Lichtneckert R, 2005, HEREDITY, V94, P465, DOI 10.1038/sj.hdy.6800664
   Lichtneckert R, 2008, DEVELOPMENT, V135, P2415, DOI 10.1242/dev.022210
   Lichtneckert R, 2007, DEVELOPMENT, V134, P1291, DOI 10.1242/dev.02814
   Lin HH, 2007, CELL, V128, P1205, DOI 10.1016/j.cell.2007.03.006
   Marin EC, 2002, CELL, V109, P243, DOI 10.1016/S0092-8674(02)00700-6
   Maurange C, 2008, CELL, V133, P891, DOI 10.1016/j.cell.2008.03.034
   Nassif C, 1998, J COMP NEUROL, V402, P10
   Ng M, 2002, NEURON, V36, P463, DOI 10.1016/S0896-6273(02)00975-3
   OKADA R, J COMP NEUR IN PRESS
   Olsen SR, 2007, NEURON, V54, P89, DOI 10.1016/j.neuron.2007.03.010
   Rodrigues V, 2008, ADV EXP MED BIOL, V628, P82, DOI 10.1007/978-0-387-78261-4_6
   Schmidt H, 1997, DEV BIOL, V189, P186, DOI 10.1006/dbio.1997.8660
   Shang YH, 2007, CELL, V128, P601, DOI 10.1016/j.cell.2006.12.034
   Spletter ML, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-14
   Stocker RF, 1997, J NEUROBIOL, V32, P443, DOI 10.1002/(SICI)1097-4695(199705)32:5<443::AID-NEU1>3.0.CO;2-5
   Tanaka NK, 2004, CURR BIOL, V14, P449, DOI 10.1016/j.cub.2004.03.006
   Tissot M, 1997, J NEUROBIOL, V32, P281, DOI 10.1002/(SICI)1097-4695(199703)32:3<281::AID-NEU3>3.0.CO;2-3
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   TRUMAN JW, 1986, J NEUROBIOL, V17, P613, DOI 10.1002/neu.480170606
   Vosshall LB, 2000, CURR OPIN NEUROBIOL, V10, P498, DOI 10.1016/S0959-4388(00)00111-2
   Vosshall LB, 2007, ANNU REV NEUROSCI, V30, P505, DOI 10.1146/annurev.neuro.30.051606.094306
   WALLDORF U, 1992, EMBO J, V11, P2247, DOI 10.1002/j.1460-2075.1992.tb05284.x
   Wilson RI, 2005, J NEUROSCI, V25, P9069, DOI 10.1523/JNEUROSCI.2070-05.2005
   Wilson RI, 2004, SCIENCE, V303, P366, DOI 10.1126/science.1090782
   Wong AM, 2002, CELL, V109, P229, DOI 10.1016/S0092-8674(02)00707-9
   Wong K, 2002, CURR OPIN GENET DEV, V12, P583, DOI 10.1016/S0959-437X(02)00343-X
   Wu JS, 2006, NAT PROTOC, V1, P2110, DOI 10.1038/nprot.2006.336
   IMAGEJ
NR 52
TC 53
Z9 53
U1 0
U2 6
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1749-8104
J9 NEURAL DEV
JI Neural Dev.
PD DEC 3
PY 2008
VL 3
AR 33
DI 10.1186/1749-8104-3-33
PG 17
WC Developmental Biology; Neurosciences
SC Developmental Biology; Neurosciences & Neurology
GA 410RK
UT WOS:000263595600001
PM 19055770
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Canepari, M
   Vogt, K
   Zecevic, D
AF Canepari, Marco
   Vogt, Kaspar
   Zecevic, Dejan
TI Combining Voltage and Calcium Imaging from Neuronal Dendrites
SO CELLULAR AND MOLECULAR NEUROBIOLOGY
LA English
DT Article
DE Voltage-sensitive dyes; Calcium-sensitive dyes; Imaging; Neuronal
   dendrites
ID 2ND-HARMONIC GENERATION MICROSCOPY; HIGH SPATIOTEMPORAL RESOLUTION;
   PROPAGATING ACTION-POTENTIALS; CEREBELLAR PURKINJE-CELLS; CA1 PYRAMIDAL
   NEURONS; RAT PREFRONTAL CORTEX; INTRACELLULAR CALCIUM; SENSITIVE DYES;
   POSTSYNAPTIC ACTIVITY; HIPPOCAMPAL-NEURONS
AB The ability to monitor membrane potential (V-m) and calcium (Ca2+) transients at multiple locations on the same neuron can facilitate further progress in our understanding of neuronal function. Here we describe a method to combine V-m and Ca2+ imaging using styryl voltage sensitive dyes and Fura type UV-excitable Ca2+ indicators. In all cases V-m optical signals are linear with membrane potential changes, but the calibration of optical signals on an absolute scale is presently possible only in some neurons. The interpretation of Ca2+ optical signals depends on the indicator Ca2+ buffering capacity relative to the cell endogenous buffering capacity. In hippocampal CA1 pyramidal neurons, loaded with JPW-3028 and 300 mu M Bis-Fura-2, V-m optical signals cannot be calibrated and the physiological Ca2+ dynamics are compromised by the presence of the indicator. Nevertheless, at each individual site, relative changes in Vm and Ca2+ fluorescence signals under different conditions can provide meaningful new information on local dendritic integration. In cerebellar Purkinje neurons, loaded with JPW-1114 and 1 mM Fura-FF, V-m optical signals can be calibrated in terms of mV and Ca2+ optical signals quantitatively reveal the physiological changes in free Ca2+. Using these two examples, the method is explained in detail.
C1 [Canepari, Marco; Vogt, Kaspar] Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
   [Canepari, Marco; Zecevic, Dejan] Yale Univ, Sch Med, Dept Cellular & Mol Physiol, New Haven, CT 06520 USA.
RP Canepari, M (corresponding author), Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM marco.canepari@unibas.ch
RI Canepari, Marco/H-6772-2012; Olver, Ian/I-1518-2015
OI Canepari, Marco/0000-0001-9759-2388; Olver, Ian/0000-0001-5478-1576;
   Zecevic, Dejan/0000-0002-8917-5784; Vogt, Kaspar/0000-0002-0859-876X
FU University of Basel; NIHUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USA [RO1NS42739]; NATIONAL
   INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS068407, R01NS042739, R01NS068407, R01NS068407, R01NS068407,
   R01NS042739, R01NS042739, R01NS042739] Funding Source: NIH RePORTER
FX This work was supported by the University of Basel and the NIH Grant
   RO1NS42739. We are grateful to Leslie Loew and Joe Wuskel for kindly
   providing voltage-sensitive dyes, and to Helene Pierre for technical
   help.
CR Antic S, 2000, J PHYSIOL-LONDON, V527, P55, DOI 10.1111/j.1469-7793.2000.00055.x
   ANTIC S, 1995, J NEUROSCI, V15, P1392
   Antic S, 1999, J NEUROPHYSIOL, V82, P1615
   Antic SD, 2003, J PHYSIOL-LONDON, V550, P35, DOI 10.1113/jphysiol.2002.033746
   Berger T, 2007, J NEUROPHYSIOL, V97, P3751, DOI 10.1152/jn.01178.2006
   Bischofberger J, 1997, J PHYSIOL-LONDON, V504, P359, DOI 10.1111/j.1469-7793.1997.359be.x
   Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095
   Bullen A, 1998, PFLUG ARCH EUR J PHY, V436, P788, DOI 10.1007/s004240050703
   Canepari M, 2004, J NEUROSCI, V24, P3563, DOI 10.1523/JNEUROSCI.5374-03.2004
   Canepari M, 1999, J NEUROSCI METH, V87, P1, DOI 10.1016/S0165-0270(98)00127-7
   Canepari M, 2007, J PHYSIOL-LONDON, V580, P463, DOI 10.1113/jphysiol.2006.125005
   Coesmans M, 2004, NEURON, V44, P691, DOI 10.1016/j.neuron.2004.10.031
   COHEN LB, 1974, J MEMBRANE BIOL, V19, P1, DOI 10.1007/BF01869968
   Djurisic M, 2004, J NEUROSCI, V24, P6703, DOI 10.1523/JNEUROSCI.0307-04.2004
   Dombeck DA, 2005, J NEUROPHYSIOL, V94, P3628, DOI 10.1152/jn.00416.2005
   Fierro L, 1996, J PHYSIOL-LONDON, V496, P617, DOI 10.1113/jphysiol.1996.sp021713
   Fisher JAN, 2008, J NEUROPHYSIOL, V99, P1545, DOI 10.1152/jn.00929.2007
   Frick A, 2004, NAT NEUROSCI, V7, P126, DOI 10.1038/nn1178
   Gasparini S, 2007, J PHYSIOL-LONDON, V580, P787, DOI 10.1113/jphysiol.2006.121343
   GRINVALD A, 1987, BIOPHYS J, V51, P643, DOI 10.1016/S0006-3495(87)83389-1
   Helmchen F, 1996, BIOPHYS J, V70, P1069, DOI 10.1016/S0006-3495(96)79653-4
   Hyrc KB, 2000, CELL CALCIUM, V27, P75, DOI 10.1054/ceca.1999.0092
   Jackson MB, 2003, J NEUROSCI, V23, P1612
   JAFFE DB, 1992, NATURE, V357, P244, DOI 10.1038/357244a0
   Kaiser KMM, 2001, J PHYSIOL-LONDON, V535, P17, DOI 10.1111/j.1469-7793.2001.t01-1-00017.x
   Koester HJ, 1998, P NATL ACAD SCI USA, V95, P9596, DOI 10.1073/pnas.95.16.9596
   KREMER SG, 1992, AM J PHYSIOL, V263, pC1302
   Kuhn B, 2004, BIOPHYS J, V87, P631, DOI 10.1529/biophysj.104.040477
   Lips MB, 1998, J PHYSIOL-LONDON, V511, P105, DOI 10.1111/j.1469-7793.1998.105bi.x
   LLINAS R, 1980, J PHYSIOL-LONDON, V305, P197, DOI 10.1113/jphysiol.1980.sp013358
   LOEW LM, 1992, J MEMBRANE BIOL, V130, P1, DOI 10.1007/bf00233734
   LOEW LM, 1981, BIOPHYS J, V34, P353, DOI 10.1016/S0006-3495(81)84854-0
   Magee JC, 1997, SCIENCE, V275, P209, DOI 10.1126/science.275.5297.209
   MARTINEZZAGUILAN R, 1991, AM J PHYSIOL, V260, pC297
   Milojkovic BA, 2005, J NEUROSCI, V25, P3940, DOI 10.1523/JNEUROSCI.5314-04.2005
   Milojkovic BA, 2007, J PHYSIOL-LONDON, V585, P447, DOI 10.1113/jphysiol.2007.142315
   Naraghi M, 1997, CELL CALCIUM, V22, P255, DOI 10.1016/S0143-4160(97)90064-6
   NEHER E, 1995, NEUROPHARMACOLOGY, V34, P1423, DOI 10.1016/0028-3908(95)00144-U
   NOWYCKY MC, 1993, BIOPHYS J, V64, P77, DOI 10.1016/S0006-3495(93)81342-0
   Ogden D, 1997, J GEN PHYSIOL, V109, P741, DOI 10.1085/jgp.109.6.741
   Palecek J, 1999, J PHYSIOL-LONDON, V520, P485, DOI 10.1111/j.1469-7793.1999.00485.x
   Palmer LM, 2006, J NEUROSCI, V26, P1854, DOI 10.1523/JNEUROSCI.4812-05.2006
   Roth A, 2001, J PHYSIOL-LONDON, V535, P445, DOI 10.1111/j.1469-7793.2001.00445.x
   Sabatini BL, 2002, NEURON, V33, P439, DOI 10.1016/S0896-6273(02)00573-1
   Sacconi L, 2006, P NATL ACAD SCI USA, V103, P3124, DOI 10.1073/pnas.0511338103
   Schneggenburger R, 1999, NEURON, V23, P399, DOI 10.1016/S0896-6273(00)80789-8
   Sinha SR, 1999, METHODS, V18, P204, DOI 10.1006/meth.1999.0773
   SINHA SR, 1995, J NEUROSCI METH, V60, P49, DOI 10.1016/0165-0270(94)00219-7
   SPRUSTON N, 1995, SCIENCE, V268, P297, DOI 10.1126/science.7716524
   STUART G, 1994, NEURON, V13, P703, DOI 10.1016/0896-6273(94)90037-X
   Vanselow BK, 2000, J PHYSIOL-LONDON, V525, P433, DOI 10.1111/j.1469-7793.2000.t01-1-00433.x
   Wang J, 2004, J NEUROPHYSIOL, V91, P1596, DOI 10.1152/jn.01073.2003
   Zecevic D, 1996, NATURE, V381, P322, DOI 10.1038/381322a0
   Zhou WL, 2007, J NEUROSCI METH, V164, P225, DOI 10.1016/j.jneumeth.2007.05.002
NR 54
TC 40
Z9 40
U1 0
U2 5
PU SPRINGER/PLENUM PUBLISHERS
PI NEW YORK
PA 233 SPRING ST, NEW YORK, NY 10013 USA
SN 0272-4340
EI 1573-6830
J9 CELL MOL NEUROBIOL
JI Cell. Mol. Neurobiol.
PD DEC
PY 2008
VL 28
IS 8
BP 1079
EP 1093
DI 10.1007/s10571-008-9285-y
PG 15
WC Cell Biology; Neurosciences
SC Cell Biology; Neurosciences & Neurology
GA 378NV
UT WOS:000261329500006
PM 18500551
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Mizuno, K
   Peyton, DH
   Hayashi, T
   Engel, J
   Bachinger, HP
AF Mizuno, Kazunori
   Peyton, David H.
   Hayashi, Toshihiko
   Engel, Juergen
   Baechinger, Hans Peter
TI Effect of the -Gly-3(S)-hydroxyprolyl-4(R)-hydroxyprolyl- tripeptide
   unit on the stability of collagen model peptides
SO FEBS JOURNAL
LA English
DT Article
DE 3-hydroxylation; collagen; peptide; post-translational modification;
   thermal stability
ID GLOMERULAR BASEMENT-MEMBRANE; HYDROXYLATION-INDUCED STABILIZATION; CHICK
   BONE-COLLAGEN; TRIPLE-HELIX; XAA POSITION; OSTEOGENESIS IMPERFECTA;
   PROLYL 3-HYDROXYLASE; CHAIN; 3-HYDROXYPROLINE; MUTATIONS
AB In order to evaluate the role of 3(S)-hydroxyproline [3(S)-Hyp] in the triple-helical structure, we produced a series of model peptides with nine tripeptide units including 0-9 3(S)-hydroxyproline residues. The sequences are H-(Gly-Pro-4(R)Hyp)(l)-(Gly-3(S)Hyp-4(R)Hyp)(m)-(Gly-Pro-4(R)Hyp)(n)-OH, where (l, m, n) = (9, 0, 0), (4, 1, 4), (3, 2, 4), (3, 3, 3), (1, 7, 1) and (0, 9, 0). All peptides showed triple-helical CD spectra at room temperature and thermal transition curves. Sedimentation equilibrium analysis showed that peptide H-(Gly-3(S)Hyp-4(R)Hyp)(9)-OH is a trimer. Differential scanning calorimetry showed that replacement of Pro residues with 3(S)Hyp residues decreased the transition enthalpy, and the transition temperature increases by 4.5 degrees C from 52.0 degrees C for the peptide with no 3(S)Hyp residues to 56.5 degrees C for the peptide with nine 3(S)Hyp residues. The refolding kinetics of peptides H-(Gly-3(S)Hyp-4(R)Hyp)(9)-OH, H-(Gly-Pro-4(R)Hyp)(9)-OH and H-(Gly-4(R)Hyp-4(R)Hyp)(9)-OH were compared, and the apparent reaction orders of refolding at 10 degrees C were n = 1.5, 1.3 and 1.2, respectively. Replacement of Pro with 3(S)Hyp or 4(R)Hyp has little effect on the refolding kinetics. This result suggests that the refolding kinetics of collagen model peptides are influenced mainly by the residue in the Yaa position of the -Gly-Xaa-Yaa- repeated sequence. The experiments indicate that replacement of a Pro residue by a 3(S)Hyp residue in the Xaa position of the -Gly-Xaa-4(R)Hyp- repeat of collagen model peptides increases the stability, mainly due to entropic factors.
C1 [Mizuno, Kazunori; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA.
   [Peyton, David H.] Portland State Univ, Dept Chem, Portland, OR 97207 USA.
   [Hayashi, Toshihiko] Teikyo Heisei Univ, Fac Pharmaceut Sci, Chiba, Japan.
   [Engel, Juergen] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97201 USA.
RP Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, 3101 SW Sam Jackson Pk Rd, Portland, OR 97239 USA.
EM hpb@shcc.org
OI Mizuno, Kazunori/0000-0003-3354-6264; Peyton, David/0000-0001-5828-055X
FU Shriners Hospital for Children (Portland, OR, USA)
FX This work was supported by a grant from Shriners Hospital for Children
   (Portland, OR, USA). The authors thank Eric A. Steel and Jessica L.
   Hacker for expert technical assistance and Dr B. Kerry Maddox for amino
   acid analyses.
CR Bachinger HP, 2005, PROTEIN FOLDING HANDBOOK, P1059
   Balacco Giuseppe, 2000, Molecular Biology Today, V1, P23
   Bann JG, 2000, J BIOL CHEM, V275, P24466, DOI 10.1074/jbc.M003336200
   BELLON G, 1984, ANAL BIOCHEM, V137, P151, DOI 10.1016/0003-2697(84)90362-2
   Boudko S, 2002, J MOL BIOL, V317, P459, DOI 10.1006/jmbi.2002.5439
   Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968
   CLICK EM, 1970, BIOCHEMISTRY-US, V9, P4699
   ENGEL J, 1977, BIOPOLYMERS, V16, P601, DOI 10.1002/bip.1977.360160310
   Feng YB, 1996, J AM CHEM SOC, V118, P10351, DOI 10.1021/ja961260c
   FIETZEK PP, 1972, EUR J BIOCHEM, V30, P163, DOI 10.1111/j.1432-1033.1972.tb02083.x
   GAILL F, 1995, J MOL BIOL, V246, P284, DOI 10.1006/jmbi.1994.0084
   Hodges JA, 2005, J AM CHEM SOC, V127, P15923, DOI 10.1021/ja054674r
   Jenkins CL, 2003, J AM CHEM SOC, V125, P6422, DOI 10.1021/ja034015j
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Kawahara K, 2005, BIOCHEMISTRY-US, V44, P15812, DOI 10.1021/bi051619m
   Kielty CM, 2002, CONNECTIVE TISSUE IT, P159, DOI 10.1002/0471221929.ch2.
   KIMURA S, 1974, J BIOCHEM, V75, P1231, DOI 10.1093/oxfordjournals.jbchem.a130506
   KIMURA S, 1981, BIOCHIM BIOPHYS ACTA, V669, P251, DOI 10.1016/0005-2795(81)90248-8
   LANE JM, 1969, BIOCHEMISTRY-US, V8, P2134, DOI 10.1021/bi00833a053
   MARQUARDT H, 1973, BIOCHEMISTRY-US, V12, P3260, DOI 10.1021/bi00741a018
   MILLER EJ, 1967, J BIOL CHEM, V242, P5481
   MIURA S, 1985, J BIOL CHEM, V260, P5352
   Mizuno K, 2004, J BIOL CHEM, V279, P38072, DOI 10.1074/jbc.M402953200
   Mizuno K, 2004, J BIOL CHEM, V279, P282, DOI 10.1074/jbc.M308181200
   Mizuno K, 2003, J BIOL CHEM, V278, P32373, DOI 10.1074/jbc.M304741200
   Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039
   Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004
   OHagan D, 1997, CHEM COMMUN, P645, DOI 10.1039/a604140j
   OHNO M, 1975, J BIOL CHEM, V250, P7780
   Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381
   Okuyama K, 2006, BIOPOLYMERS, V84, P421, DOI 10.1002/bip.20499
   Raines RT, 2006, PROTEIN SCI, V15, P1219, DOI 10.1110/ps.062139406
   RISTELI J, 1978, ANAL BIOCHEM, V84, P423, DOI 10.1016/0003-2697(78)90060-X
   RISTELI J, 1977, EUR J BIOCHEM, V73, P485, DOI 10.1111/j.1432-1033.1977.tb11341.x
   SAKAKIBARA S, 1973, BIOCHIM BIOPHYS ACTA, V303, P198, DOI 10.1016/0005-2795(73)90164-5
   Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200
   TAKEMA Y, 1982, BIOCHIM BIOPHYS ACTA, V706, P123, DOI 10.1016/0167-4838(82)90382-X
   Terao K, 2008, MACROMOLECULES, V41, P7203, DOI 10.1021/ma800790w
   Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200
   WEST TW, 1980, J BIOL CHEM, V255, P451
   WOLFF JS, 1966, FED PROC, V25, P862
   WOLFF JS, 1966, J BIOL CHEM, V241, P1300
NR 42
TC 31
Z9 32
U1 1
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1742-464X
EI 1742-4658
J9 FEBS J
JI FEBS J.
PD DEC
PY 2008
VL 275
IS 23
BP 5830
EP 5840
DI 10.1111/j.1742-4658.2008.06704.x
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 371HP
UT WOS:000260822700009
PM 19021759
DA 2021-01-25
ER

PT J
AU Huang, JR
   Hsu, STD
   Christodoulou, J
   Jackson, SE
AF Huang, Jie-rong
   Hsu, Shang-Te Danny
   Christodoulou, John
   Jackson, Sophie E.
TI The extremely slow-exchanging core and acid-denatured state of green
   fluorescent protein
SO HFSP JOURNAL
LA English
DT Article
ID LONG-RANGE INTERACTIONS; GROUP HYDROGEN-EXCHANGE; AMIDE PROTON-EXCHANGE;
   UNFOLDED STATE; NMR-SPECTROSCOPY; ENERGY LANDSCAPE; HIV-1 PROTEASE;
   FOLDING INTERMEDIATE; GLOBULAR-PROTEINS; INTERNAL DYNAMICS
AB Green fluorescent protein (GFP) is a large protein with a complex eleven-stranded beta-barrel structure. Previous studies have shown that it has a complex energy landscape for folding on which there are several intermediate states and a denatured state with significant residual structure. Here, we use two different types of H/D exchange measurement and nuclear magnetic resonance (NMR) techniques to probe the energy landscape for folding of GFP in further detail. H/D exchange experiments were performed over a wide range of conditions including different concentrations of denaturant. Results show that the penetration model dominates the exchange mechanism, consistent with the known stability and slow unfolding kinetics of GFP. H/D exchange experiments at high pH establish that there is an extremely slow-exchanging superstable core of amide protons in GFP that are clustered and located in beta-strands 1, 2, 4, 5, and 6. These residues form part of a mini-beta-sheet which we propose constitutes a folding nucleus. Using a pulsed-labeling strategy, the acid-denatured state has been investigated and the residual structure observed in earlier studies shown to locate to beta-strands 1 and 3. There is some evidence that this residual structure is stabilized by a localized hydrophobic collapse of the polypeptide chain. [DOI: 10.2976/1.2976660]
C1 [Huang, Jie-rong; Hsu, Shang-Te Danny; Christodoulou, John; Jackson, Sophie E.] Univ Cambridge, Dept Chem, Cambridge CB2 1EW, England.
   [Huang, Jie-rong] Univ Basel, Div Struc Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Christodoulou, John] UCL, Inst Struct Mol Biol, Dept Biochem & Mol Biol, London WC1E 6BT, England.
   [Christodoulou, John] Univ London Birkbeck Coll, Sch Crystallog, London WC1E 7HX, England.
RP Jackson, SE (corresponding author), Univ Cambridge, Dept Chem, Lensfield Rd, Cambridge CB2 1EW, England.
EM sej13@cam.ac.uk
RI Huang, Jie-rong/B-4222-2009; Huang, Jie-rong/O-3661-2019; Hsu, Shang-Te
   Danny/B-2324-2009; Hsu, Shang-Te Danny/L-2826-2014
OI Huang, Jie-rong/0000-0003-3674-2228; Hsu, Shang-Te
   Danny/0000-0002-7231-0185; Hsu, Shang-Te Danny/0000-0002-7231-0185
FU Wellcome and Leverhulme Trusts
FX STDH is a recipient of a Netherlands Ramsay and a Human Frontier
   Long-term Fellowship (LT0798/2005). JC acknowledges funding from the
   Wellcome and Leverhulme Trusts. JC is a recipient of an HFSP Young
   Investigator's Award (RGY67/2007). We thank the staff and the use of the
   Biomolecular NMR Facility, Department of Chemistry, University of
   Cambridge.
CR Alkaabi KM, 2005, APPL BIOCHEM BIOTECH, V126, P149, DOI 10.1385/ABAB:126:2:149
   Andrews BT, 2007, J MOL BIOL, V373, P476, DOI 10.1016/j.jmb.2007.07.071
   BAI YW, 1993, PROTEINS, V17, P75, DOI 10.1002/prot.340170110
   BAI YW, 1994, PROTEINS, V20, P4, DOI 10.1002/prot.340200103
   BAI YW, 1995, SCIENCE, V269, P192, DOI 10.1126/science.7618079
   Bhavesh NS, 2004, PROTEIN SCI, V13, P3085, DOI 10.1110/ps.04805204
   Bhavesh NS, 2003, J BIOL CHEM, V278, P19980, DOI 10.1074/jbc.M301615200
   Bhavesh NS, 2001, FEBS LETT, V509, P218, DOI 10.1016/S0014-5793(01)03066-6
   Bhutani N, 2003, PROTEIN SCI, V12, P1719, DOI 10.1110/ps.0239503
   Bowler BE, 2007, MOL BIOSYST, V3, P88, DOI 10.1039/b611895j
   Chamberlain AK, 1996, NAT STRUCT BIOL, V3, P782, DOI 10.1038/nsb0996-782
   Chatterjee A, 2005, J BIOL CHEM, V280, P11369, DOI 10.1074/jbc.M412603200
   Clarke J, 1998, CURR OPIN STRUC BIOL, V8, P112, DOI 10.1016/S0959-440X(98)80018-3
   Clarke J, 1997, TRENDS BIOCHEM SCI, V22, P284, DOI 10.1016/S0968-0004(97)01087-6
   CONNELLY GP, 1993, PROTEINS, V17, P87, DOI 10.1002/prot.340170111
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dempsey CE, 2001, PROG NUCL MAG RES SP, V39, P135, DOI 10.1016/S0079-6565(01)00032-2
   Dietz H, 2004, P NATL ACAD SCI USA, V101, P16192, DOI 10.1073/pnas.0404549101
   Dyson HJ, 2004, CHEM REV, V104, P3607, DOI 10.1021/cr030403s
   Englander SW, 2007, Q REV BIOPHYS, V40, P287, DOI 10.1017/S0033583508004654
   Englander SW, 2000, ANNU REV BIOPH BIOM, V29, P213, DOI 10.1146/annurev.biophys.29.1.213
   ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217
   Enoki S, 2004, BIOCHEMISTRY-US, V43, P14238, DOI 10.1021/bi048733+
   Enoki S, 2006, J MOL BIOL, V361, P969, DOI 10.1016/j.jmb.2006.07.009
   *EPAPS, EHJFOA52001807 EPAPS
   Ferraro DM, 2004, BIOCHEMISTRY-US, V43, P587, DOI 10.1021/bi035943y
   Fukuda H, 2000, BIOCHEMISTRY-US, V39, P12025, DOI 10.1021/bi000543l
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P185
   Helms V, 1999, J PHYS CHEM B, V103, P3263, DOI 10.1021/jp983120q
   Huang JR, 2007, J MOL BIOL, V370, P356, DOI 10.1016/j.jmb.2007.04.039
   Huyghues-Despointes BMP, 1999, NAT STRUCT BIOL, V6, P910
   HVIDT AASE, 1966, ADVANCE PROTEIN CHEM, V21, P287, DOI 10.1016/S0065-3233(08)60129-1
   Iimura S, 2007, BIOCHEMISTRY-US, V46, P3664, DOI 10.1021/bi602456y
   Jackson SE, 2006, EXPERT REV PROTEOMIC, V3, P545, DOI 10.1586/14789450.3.5.545
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   KARPLUS M, 1981, CRC CR REV BIOCH MOL, V9, P293, DOI 10.3109/10409238109105437
   Khan F, 2006, J AM CHEM SOC, V128, P10729, DOI 10.1021/ja060618u
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Krishna MMG, 2004, METHODS, V34, P51, DOI 10.1016/j.ymeth.2004.03.005
   LinderstrOm-Lang K., 1958, S PROTEIN STRUCTURE, P23
   MAYO SL, 1993, SCIENCE, V262, P873, DOI 10.1126/science.8235609
   MILLER DW, 1995, PROTEIN SCI, V4, P1860, DOI 10.1002/pro.5560040921
   Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022
   NAKANISH.M, 1973, J MOL BIOL, V75, P673, DOI 10.1016/0022-2836(73)90300-8
   Oliveberg M, 1996, BIOCHEMISTRY-US, V35, P2738, DOI 10.1021/bi950967t
   Ormo M, 1996, SCIENCE, V273, P1392
   OTTING G, 1991, SCIENCE, V254, P974, DOI 10.1126/science.1948083
   PACE CN, 1992, BIOCHEMISTRY-US, V31, P2728, DOI 10.1021/bi00125a013
   PALMER AG, 1991, J MAGN RESON, V93, P151, DOI 10.1016/0022-2364(91)90036-S
   Reid BG, 1997, BIOCHEMISTRY-US, V36, P6786, DOI 10.1021/bi970281w
   Religa TL, 2005, NATURE, V437, P1053, DOI 10.1038/nature04054
   Robic S, 2003, P NATL ACAD SCI USA, V100, P11345, DOI 10.1073/pnas.1635051100
   Schanda P, 2005, J AM CHEM SOC, V127, P8014, DOI 10.1021/ja051306e
   SCHLEUCHER J, 1994, J BIOMOL NMR, V4, P301
   Seifert MHJ, 2003, BIOCHEMISTRY-US, V42, P2500, DOI 10.1021/bi026481b
   SHORTLE D, 1992, PROTEIN SCI, V1, P201
   Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438
   Takei J, 2002, BIOCHEMISTRY-US, V41, P12308, DOI 10.1021/bi026491c
   Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509
   WAGNER G, 1982, J MOL BIOL, V160, P343, DOI 10.1016/0022-2836(82)90180-2
   Wirmer J, 2004, ANGEW CHEM INT EDIT, V43, P5780, DOI 10.1002/anie.200460907
   WOODWARD C, 1982, MOL CELL BIOCHEM, V48, P135, DOI 10.1007/BF00421225
   Yan S, 2002, J MOL BIOL, V323, P363, DOI 10.1016/S0022-2836(02)00882-3
   Yang F, 1996, NAT BIOTECHNOL, V14, P1246, DOI 10.1038/nbt1096-1246
   Zhang XC, 2005, BIOCHEMISTRY-US, V44, P8117, DOI 10.1021/bi0501939
   ZHANG YZ, SPHERE SERVER PROGRA
   Zimmer M, 2002, CHEM REV, V102, P759, DOI 10.1021/cr010142r
NR 67
TC 16
Z9 16
U1 0
U2 6
PU HFSP PUBLISHING
PI STRASBOURG
PA 12 QUAI ST JEAN, STRASBOURG, 67000, FRANCE
SN 1955-2068
EI 1955-205X
J9 HFSP J
JI HFSP J.
PD DEC
PY 2008
VL 2
IS 6
BP 378
EP 387
DI 10.2976/1.2976660
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 384OU
UT WOS:000261754900011
PM 19436495
OA Green Published
DA 2021-01-25
ER

PT J
AU Peter, JC
   Zipfel, G
   Lecourt, AC
   Hofbauer, KG
AF Peter, J-C
   Zipfel, G.
   Lecourt, A-C
   Hofbauer, K. G.
TI Active immunization against the melanocortin-3 and-4 receptor results in
   different phenotypes in rats.
SO INTERNATIONAL JOURNAL OF OBESITY
LA English
DT Meeting Abstract
CT 4th Fribourg Obesity Research Conference
CY SEP 14, 2007
CL Fribourg, SWITZERLAND
C1 [Peter, J-C; Zipfel, G.; Lecourt, A-C; Hofbauer, K. G.] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0307-0565
J9 INT J OBESITY
JI Int. J. Obes.
PD DEC
PY 2008
VL 32
BP S79
EP S79
PG 1
WC Endocrinology & Metabolism; Nutrition & Dietetics
SC Endocrinology & Metabolism; Nutrition & Dietetics
GA 384AY
UT WOS:000261717100020
DA 2021-01-25
ER

PT J
AU Koehli, M
   Galati, V
   Boudier, K
   Roberson, RW
   Philippsen, P
AF Koehli, Michael
   Galati, Virginie
   Boudier, Kamila
   Roberson, Robert W.
   Philippsen, Peter
TI Growth-speed-correlated localization of exocyst and polarisome
   components in growth zones of Ashbya gossypii hyphal tips
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE Filamentous fungus; Spitzenkorper; Polar growth; Exocytosis; Cdc42;
   Bni1; Yeast
ID SACCHAROMYCES-CEREVISIAE; CELL POLARITY; ASPERGILLUS-NIDULANS; FUNGAL
   MORPHOGENESIS; ACTIN CYTOSKELETON; CANDIDA-ALBICANS; BUDDING YEAST;
   FUNCTIONAL-CHARACTERIZATION; NEUROSPORA-CRASSA; PROTEIN
AB We use the fungus Ashbya gossypii to investigate how its polar growth machinery is organized to achieve sustained hyphal growth. In slowly elongating hyphae exocyst, cell polarity and polarisome proteins permanently localize as cortical cap at hyphal tips, thus defining the zone of secretory vesicle fusion. In tenfold faster growing hyphae, this zone is only slightly enlarged demonstrating a capacity of hyphal growth zones to increase rates of vesicle processing to reach higher speeds. Concomitant with this increase, vesicles accumulate as spheroid associated with the tip cortex, indicating that a Spitzenkorper forms in fast hyphae. We also found spheroid-like accumulations for the exocyst components AgSec3, AgSec5, AgExo70 and the polarisome components AgSpa2, AgBni1 and AgPea2 (but not AgBud6 or cell polarity factors such as AgCdc42 or AgBem1). The localization of AgSpa2, AgPea2 and AgBni1 depend on each other but only marginally on AgBud6, as concluded from a set of deletions. Our data define three conditions to achieve fast growth at hyphal tips: permanent presence of the polarity machinery in a confined cortical area, organized accumulation of vesicles and a subset of polarity components close to this area, and spatial separation of the zones of exocytosis (tip front) and endocytosis (tip rim).
C1 [Koehli, Michael; Galati, Virginie; Boudier, Kamila; Philippsen, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Roberson, Robert W.] Arizona State Univ, Sch Life Sci, Tempe, AZ 85287 USA.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM peter.philippsen@unibas.ch
FU Swiss Federal Department of Home Affairs (ELTEM-Biotechnology);
   University of Basel
FX M. K. thanks R. W. R. for generous support during his 4 months electron
   microscopy training. We are very grateful to Daniele Cavicchioli and
   Philipp Knechtle for providing the AgBem1-GFP strain prior to
   publication, to Andreas Kaufmann for sharing new A. gossypii gene
   targeting cassettes, to Dominc Hoepfner for the NAT1 cassette, to Sylvia
   Voegeli for bioinformatics support and to David Drubin for yeast
   strains. We thank Sandrine Grava, Andreas Kaufmann, Hans-Peter Helfer
   and Katrin Hungerbuhler for helpful comments on the manuscript. We also
   acknowledge the help of Sandra Gass, Stephanie Hauselmann and Deborah
   Ley in strain constructions. The work was supported by a training grant
   form the Swiss Federal Department of Home Affairs (ELTEM-Biotechnology)
   and by research grants from the University of Basel.
CR Adamo JE, 1999, MOL BIOL CELL, V10, P4121, DOI 10.1091/mbc.10.12.4121
   AKASHI T, 1994, MICROBIOL-SGM, V140, P271, DOI 10.1099/13500872-140-2-271
   AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911
   Ashby SF, 1926, ANN BOT-LONDON, V40, P69, DOI 10.1093/oxfordjournals.aob.a090018
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Ayscough KR, 1997, J CELL BIOL, V137, P399, DOI 10.1083/jcb.137.2.399
   BARTNICKIGARCIA S, 1989, PROTOPLASMA, V153, P46, DOI 10.1007/BF01322464
   BARTNICKIGARCIA S, 1969, SCIENCE, V165, P302, DOI 10.1126/science.165.3890.302
   BOURETT TM, 1991, PROTOPLASMA, V163, P199, DOI 10.1007/BF01323344
   Boyd C, 2004, J CELL BIOL, V167, P889, DOI 10.1083/jcb.200408124
   Braun M, 2004, PLANTA, V219, P379, DOI 10.1007/s00425-004-1235-4
   Braun M, 1999, ADV SPACE RES, V24, P707, DOI 10.1016/S0273-1177(99)00402-0
   Buttery SM, 2007, MOL BIOL CELL, V18, P1826, DOI 10.1091/mbc.E06-09-0820
   COLLINGE AJ, 1974, ARCH MICROBIOL, V99, P353, DOI 10.1007/BF00696249
   Crampin H, 2005, J CELL SCI, V118, P2935, DOI 10.1242/jcs.02414
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Evangelista M, 1997, SCIENCE, V276, P118, DOI 10.1126/science.276.5309.118
   Finger FP, 1998, CELL, V92, P559, DOI 10.1016/S0092-8674(00)80948-4
   Fischer-Parton S, 2000, J MICROSC-OXFORD, V198, P246, DOI 10.1046/j.1365-2818.2000.00708.x
   France YE, 2006, J CELL SCI, V119, P876, DOI 10.1242/jcs.02849
   Fuchs U, 2005, MOL BIOL CELL, V16, P2746, DOI 10.1091/mbc.E05-03-0176
   Fujiwara T, 1998, MOL BIOL CELL, V9, P1221, DOI 10.1091/mbc.9.5.1221
   Gierz G, 2001, J THEOR BIOL, V208, P151, DOI 10.1006/jtbi.2000.2209
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   GROVE SN, 1970, J BACTERIOL, V104, P989, DOI 10.1128/JB.104.2.989-1009.1970
   Guo W, 1999, EMBO J, V18, P1071, DOI 10.1093/emboj/18.4.1071
   Guo W, 2001, NAT CELL BIOL, V3, P353, DOI 10.1038/35070029
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   Harris SD, 2005, EUKARYOT CELL, V4, P225, DOI 10.1128/EC.4.2.225-229.2005
   Holly SP, 1999, J CELL BIOL, V147, P845, DOI 10.1083/jcb.147.4.845
   Horio T, 2005, MOL BIOL CELL, V16, P918, DOI 10.1091/mbc.E04-09-0798
   Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173
   Jin H, 2000, MOL BIOL CELL, V11, P647, DOI 10.1091/mbc.11.2.647
   Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3
   Karpova TS, 2000, MOL BIOL CELL, V11, P1727, DOI 10.1091/mbc.11.5.1727
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   Knechtle P, 2006, EUKARYOT CELL, V5, P1635, DOI 10.1128/EC.00210-06
   Kohli M, 2008, J CELL SCI, V121, P1065, DOI [10.1242/jcs.015933, 10.1242/jcs.033852]
   Li CR, 2007, J CELL SCI, V120, P1898, DOI 10.1242/jcs.002931
   LopezFranco R, 1996, PROTOPLASMA, V195, P90, DOI 10.1007/BF01279189
   McDaniel DP, 2000, FUNGAL GENET BIOL, V31, P233, DOI 10.1006/fgbi.2000.1249
   Moseley JB, 2005, J BIOL CHEM, V280, P28023, DOI 10.1074/jbc.M503094200
   Moseley JB, 2004, MOL BIOL CELL, V15, P896, DOI 10.1091/mbc.E03-08-0621
   Moskow JJ, 2000, MOL CELL BIOL, V20, P7559, DOI 10.1128/MCB.20.20.7559-7571.2000
   Ozaki-Kuroda K, 2001, MOL CELL BIOL, V21, P827, DOI 10.1128/MCB.21.3.827-839.2001
   Park HO, 2007, MICROBIOL MOL BIOL R, V71, P48, DOI 10.1128/MMBR.00028-06
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   Riquelme M, 2007, EUKARYOT CELL, V6, P1853, DOI 10.1128/EC.00088-07
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schmitz HP, 2006, MOL BIOL CELL, V17, P130
   Sharpless KE, 2002, MOL BIOL CELL, V13, P469, DOI 10.1091/mbc.01-07-0356
   Sheu YJ, 1998, MOL CELL BIOL, V18, P4053, DOI 10.1128/MCB.18.7.4053
   Shih JL, 2005, MOL BIOL CELL, V16, P4595, DOI 10.1091/mbc.E05-02-0108
   SNYDER M, 1989, J CELL BIOL, V108, P1419, DOI 10.1083/jcb.108.4.1419
   SRIJAYANTHI S, 1996, MYCOLOGIA, V88, P57
   Steinberg G, 2007, EUKARYOT CELL, V6, P351, DOI 10.1128/EC.00381-06
   Taheri-Talesh N, 2008, MOL BIOL CELL, V19, P1439, DOI 10.1091/mbc.E07-05-0464
   TerBush DR, 1996, EMBO J, V15, P6483, DOI 10.1002/j.1460-2075.1996.tb01039.x
   Torralba S, 1998, MICROBIOL-SGM, V144, P45, DOI 10.1099/00221287-144-1-45
   Valtz N, 1996, J CELL BIOL, V135, P725, DOI 10.1083/jcb.135.3.725
   Virag A, 2006, EUKARYOT CELL, V5, P881, DOI 10.1128/EC.00036-06
   Wedlich-Soldner R, 2003, SCIENCE, V299, P1231, DOI 10.1126/science.1080944
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Wendland J, 2001, GENETICS, V157, P601
   WRIGHT MC, 1991, GENE, V109, P99, DOI 10.1016/0378-1119(91)90593-Z
   Zajac A, 2005, MOL BIOL CELL, V16, P1500, DOI 10.1091/mbc.E04-10-0896
   Zhang XY, 2001, J BIOL CHEM, V276, P46745, DOI 10.1074/jbc.M107464200
NR 68
TC 41
Z9 41
U1 0
U2 3
PU COMPANY BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING, STATION RD, HISTON, CAMBRIDGE CB24 9LF, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD DEC 1
PY 2008
VL 121
IS 23
BP 3878
EP 3889
DI 10.1242/jcs.033852
PG 12
WC Cell Biology
SC Cell Biology
GA 374IY
UT WOS:000261038200004
PM 18984630
OA Bronze
DA 2021-01-25
ER

PT J
AU Freed, NE
   Silander, OK
   Stecher, B
   Bohm, A
   Hardt, WD
   Ackermann, M
AF Freed, Nikki E.
   Silander, Olin K.
   Stecher, Baerbel
   Boehm, Alex
   Hardt, Wolf-Dietrich
   Ackermann, Martin
TI A Simple Screen to Identify Promoters Conferring High Levels of
   Phenotypic Noise
SO PLOS GENETICS
LA English
DT Article
ID ENTERICA SEROVAR TYPHIMURIUM; TOLL-LIKE RECEPTOR-5; GENE-EXPRESSION;
   SALMONELLA-ENTERICA; SINGLE-CELL; PHASE VARIATION; FLAGELLIN; MICE;
   MACROPHAGES; DIVERSITY
AB Genetically identical populations of unicellular organisms often show marked variation in some phenotypic traits. To investigate the molecular causes and possible biological functions of this phenotypic noise, it would be useful to have a method to identify genes whose expression varies stochastically on a certain time scale. Here, we developed such a method and used it for identifying genes with high levels of phenotypic noise in Salmonella enterica ssp. I serovar Typhimurium (S. Typhimurium). We created a genomic plasmid library fused to a green fluorescent protein (GFP) reporter and subjected replicate populations harboring this library to fluctuating selection for GFP expression using fluorescent-activated cell sorting (FACS). After seven rounds of fluctuating selection, the populations were strongly enriched for promoters that showed a high amount of noise in gene expression. Our results indicate that the activity of some promoters of S. Typhimurium varies on such a short time scale that these promoters can absorb rapid fluctuations in the direction of selection, as imposed during our experiment. The genomic fragments that conferred the highest levels of phenotypic variation were promoters controlling the synthesis of flagella, which are associated with virulence and host-pathogen interactions. This confirms earlier reports that phenotypic noise may play a role in pathogenesis and indicates that these promoters have among the highest levels of noise in the S. Typhimurium genome. This approach can be applied to many other bacterial and eukaryotic systems as a simple method for identifying genes with noisy expression.
C1 [Freed, Nikki E.] ETH, Dept Environm Microbiol, EAWAG, Inst Integrat Biol, Zurich, Switzerland.
   [Stecher, Baerbel; Hardt, Wolf-Dietrich] ETH, Inst Microbiol, Zurich, Switzerland.
   [Boehm, Alex] Univ Basel, Biozentrum, Basel, Switzerland.
RP Freed, NE (corresponding author), ETH, Dept Environm Microbiol, EAWAG, Inst Integrat Biol, Zurich, Switzerland.
EM martin.ackermann@env.ethz.ch
RI Ackermann, Martin/V-4554-2017; Stecher, Barbel/A-2911-2015; Stecher,
   Barbel/B-9940-2019
OI Ackermann, Martin/0000-0003-0087-4819; Stecher,
   Barbel/0000-0002-7445-5193; Hardt, Wolf-Dietrich/0000-0002-9892-6420;
   Silander, Olin/0000-0003-4105-8316
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Roche Research Foundation; Novartis Stiftung; ETH research
   foundation [TH-1006-1]; UBS foundation
FX NEF, OKS, and MA were supported by a grant from the Swiss National
   Science Foundation. MA and OKS were also supported by grants from the
   Roche Research Foundation and the Novartis Stiftung. WDH was supported
   by ETH research foundation (TH-1006-1). BS was supported by the UBS
   foundation.
CR Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524
   Ackermann M, 2008, NATURE, V454, P987, DOI 10.1038/nature07067
   Blake WJ, 2003, NATURE, V422, P633, DOI 10.1038/nature01546
   Bonifield HR, 2003, J BACTERIOL, V185, P3567, DOI 10.1128/JB.185.12.3567-3574.2003
   Booth IR, 2002, INT J FOOD MICROBIOL, V78, P19, DOI 10.1016/S0168-1605(02)00239-8
   Cookson BT, 1997, J IMMUNOL, V158, P4310
   Cummings LA, 2006, MOL MICROBIOL, V61, P795, DOI 10.1111/j.1365-2958.2006.05271.x
   Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919
   GILLEN KL, 1991, J BACTERIOL, V173, P2301, DOI 10.1128/JB.173.7.2301-2310.1991
   HACKETT J, 1988, J INFECT DIS, V157, P78, DOI 10.1093/infdis/157.1.78
   Hapfelmeier S, 2005, J IMMUNOL, V174, P1675, DOI 10.4049/jimmunol.174.3.1675
   Hautefort I, 2003, APPL ENVIRON MICROB, V69, P7480, DOI 10.1128/AEM.69.12.7480-7491.2003
   Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106
   Henderson IR, 1999, MOL MICROBIOL, V33, P919, DOI 10.1046/j.1365-2958.1999.01555.x
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0
   Kussell E, 2005, SCIENCE, V309, P2075, DOI 10.1126/science.1114383
   Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818
   Newman JRS, 2006, NATURE, V441, P840, DOI 10.1038/nature04785
   Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869
   Raser JM, 2005, SCIENCE, V309, P2010, DOI 10.1126/science.1105891
   Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914
   Salazar-Gonzalez RM, 2005, IMMUNOL LETT, V101, P117, DOI 10.1016/j.imlet.2005.05.004
   Schmitt CK, 2001, INFECT IMMUN, V69, P5619, DOI 10.1128/IAI.69.9.5619-5625.2001
   Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011
   Stecher B, 2004, INFECT IMMUN, V72, P4138, DOI 10.1128/IAI.72.7.4138-4150.2004
   Stecher B, 2008, CELL MICROBIOL, V10, P1166, DOI 10.1111/j.1462-5822.2008.01118.x
   STOCKER BAD, 1949, J HYG-CAMBRIDGE, V47, P398, DOI 10.1017/S002217240001473X
   ZIEG J, 1980, P NATL ACAD SCI-BIOL, V77, P4196, DOI 10.1073/pnas.77.7.4196
NR 28
TC 56
Z9 56
U1 2
U2 11
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA
SN 1553-7390
J9 PLOS GENET
JI PLoS Genet.
PD DEC
PY 2008
VL 4
IS 12
AR e1000307
DI 10.1371/journal.pgen.1000307
PG 6
WC Genetics & Heredity
SC Genetics & Heredity
GA 411RO
UT WOS:000263667900022
PM 19096504
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Gander, S
   Bonenfant, D
   Altermatt, P
   Martin, DE
   Hauri, S
   Moes, S
   Hall, MN
   Jenoe, P
AF Gander, Stefan
   Bonenfant, Debora
   Altermatt, Patrick
   Martin, Dietmar E.
   Hauri, Simon
   Moes, Suzette
   Hall, Michael N.
   Jenoe, Paul
TI Identification of the rapamycin-sensitive phosphorylation sites within
   the Ser/Thr-rich domain of the yeast Npr1 protein kinase
SO RAPID COMMUNICATIONS IN MASS SPECTROMETRY
LA English
DT Article
ID AMINO-ACID PERMEASES; FACTOR 4E-BINDING PROTEIN-1; ENHANCES SPERMINE
   UPTAKE; SACCHAROMYCES-CEREVISIAE; GENE; TRANSPORT; GAP1; SPECIFICITY;
   UBIQUITIN; ENCODES
AB The Saccharomyces cerevisae nitrogen permease reactivator Npr1 is a hyperphosphorylated protein that belongs to a fungus-specific family of Ser/Thr protein kinases dedicated to the regulation of plasma membrane transporters. Its activity is regulated by the TOR (target of rapamycin) signalling pathway. Inhibition of the TOR proteins by treating yeast cells with the immunosuppressant drug rapamycin promotes rapid dephosphorylation of Npr1. To identify the rapamycin-sensitive phosphorylation sites in yeast Npr1, glutathione-S-transferase (GST)-tagged Npr1 was isolated from untreated or rapamycin-treated cells, and analyzed by mass spectrometry. Here, we report for the first time 22 phosphorylation sites that are clustered in two regions of the N-terminal serine-rich domain. All phosphorylation sites, except two, were found to be rapamycin-sensitive. Some phosphorylation sites are contained in motifs that closely resemble those in mammalian S6K (serines followed by a tyrosine or a phenylalanine) and 4E-BP1 (serines followed by a proline). Other sites, such as serines followed by Ala, Asn, Gln, His, Ile, Leu, or Val, appear to define new motifs. Thus, TOR controls an unusually broad array of phosphorylation sites in Npr1. In addition to phosphorylation by upstream kinases, Npr1 undergoes autophosphorylation that was mapped to three distinct serines in the N-terminal domain of which Ser257 appears to be the main autophosphorylation site. Site-directed mutagenesis confirmed the mass spectral assignments of the autophosphorylation sites and shows that Ser257 is specifically involved in forming an in vitro substrate-binding site. Copyright (C) 2008 John Wiley & Sons, Ltd.
C1 [Gander, Stefan; Hauri, Simon; Moes, Suzette; Hall, Michael N.; Jenoe, Paul] Univ Basel, Dept Biochem, Biozentrum, CH-4056 Basel, Switzerland.
   [Bonenfant, Debora] Novartis Inst Biomed Res, Dept Dev & Mol Pathways, CH-4002 Basel, Switzerland.
   [Altermatt, Patrick] Vifor Int AG, Preclin Res, CH-9001 St Gallen, Switzerland.
   [Martin, Dietmar E.] Univ Munich, Dept Chem & Biochem, Gene Ctr, D-81377 Munich, Germany.
RP Jenoe, P (corresponding author), Univ Basel, Dept Biochem, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM paul.jenoe@unibas.ch
OI Hauri, Simon/0000-0002-7249-2011
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A0-105]
FX We would like to thank Alexandre Soulard for helpful Suggestions. The
   authors thank the Swiss National Science Foundation for funding (Grant
   No. 3100A0-105).
CR Andre B, 1995, YEAST, V11, P1575, DOI 10.1002/yea.320111605
   Beck T, 1999, J CELL BIOL, V146, P1227, DOI 10.1083/jcb.146.6.1227
   Bonenfant D, 2003, P NATL ACAD SCI USA, V100, P880, DOI 10.1073/pnas.232735599
   Burchett SA, 2001, J BIOL CHEM, V276, P26472, DOI 10.1074/jbc.M103436200
   BUSS JE, 1983, METHOD ENZYMOL, V99, P7
   Chi A, 2007, P NATL ACAD SCI USA, V104, P2193, DOI 10.1073/pnas.0607084104
   Clark K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001876
   COURCHESNE WE, 1983, MOL CELL BIOL, V3, P672, DOI 10.1128/MCB.3.4.672
   De Craene JO, 2001, J BIOL CHEM, V276, P43939, DOI 10.1074/jbc.M102944200
   DiComo CJ, 1996, GENE DEV, V10, P1904, DOI 10.1101/gad.10.15.1904
   Fadden P, 1997, J BIOL CHEM, V272, P10240
   Ferrari S, 2005, BIOCHEM J, V390, P293, DOI 10.1042/BJ20050343
   Gingras AC, 2001, GENE DEV, V15, P2852
   Goossens A, 2000, MOL CELL BIOL, V20, P7654, DOI 10.1128/MCB.20.20.7654-7661.2000
   GRENSON M, 1983, EUR J BIOCHEM, V133, P141, DOI 10.1111/j.1432-1033.1983.tb07439.x
   Heesom KJ, 1998, BIOCHEM J, V336, P39, DOI 10.1042/bj3360039
   Helliwell SB, 2001, J CELL BIOL, V153, P649, DOI 10.1083/jcb.153.4.649
   HOFFMANN W, 1985, J BIOL CHEM, V260, P1831
   Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2
   Jacinto E, 2001, MOL CELL, V8, P1017, DOI 10.1016/S1097-2765(01)00386-0
   JAUNIAUX JC, 1990, EUR J BIOCHEM, V190, P39, DOI 10.1111/j.1432-1033.1990.tb15542.x
   KAKINUMA Y, 1995, BIOCHEM BIOPH RES CO, V216, P985, DOI 10.1006/bbrc.1995.2717
   Kaouass M, 1997, MOL CELL BIOL, V17, P2994, DOI 10.1128/MCB.17.6.2994
   LASKO PF, 1981, J BACTERIOL, V148, P241, DOI 10.1128/JB.148.1.241-247.1981
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Magasanik B, 2002, GENE, V290, P1, DOI 10.1016/S0378-1119(02)00558-9
   Mann M, 2002, TRENDS BIOTECHNOL, V20, P261, DOI 10.1016/S0167-7799(02)01944-3
   Mulet JM, 1999, MOL CELL BIOL, V19, P3328
   Nelissen B, 1997, FEMS MICROBIOL REV, V21, P113, DOI 10.1111/j.1574-6976.1997.tb00347.x
   Nozaki T, 1996, BIOCHEM BIOPH RES CO, V228, P452, DOI 10.1006/bbrc.1996.1681
   PEARSON RB, 1995, EMBO J, V14, P5279, DOI 10.1002/j.1460-2075.1995.tb00212.x
   Regenberg B, 1999, CURR GENET, V36, P317, DOI 10.1007/s002940050506
   Roberg KJ, 1997, J CELL BIOL, V137, P1469, DOI 10.1083/jcb.137.7.1469
   SCHAGGER H, 1987, ANAL BIOCHEM, V166, P368, DOI 10.1016/0003-2697(87)90587-2
   SCHMIDT A, 1994, MOL CELL BIOL, V14, P6597, DOI 10.1128/MCB.14.10.6597
   Schmidt A, 1998, EMBO J, V17, P6924, DOI 10.1093/emboj/17.23.6924
   Soetens O, 2001, J BIOL CHEM, V276, P43949, DOI 10.1074/jbc.M102945200
   Springael JY, 1998, MOL BIOL CELL, V9, P1253, DOI 10.1091/mbc.9.6.1253
   Sugiyama N, 2007, MOL CELL PROTEOMICS, V6, P1103, DOI 10.1074/mcp.T600060-MCP200
   TANAKA J, 1985, GENE, V38, P205, DOI 10.1016/0378-1119(85)90219-7
   VACQUIER VD, 1991, METHOD ENZYMOL B, V201, P261
   VANDENBOL M, 1990, MOL GEN GENET, V222, P393, DOI 10.1007/BF00633845
   VANDENBOL M, 1987, EUR J BIOCHEM, V164, P607, DOI 10.1111/j.1432-1033.1987.tb11170.x
   Wang XM, 2003, MOL CELL BIOL, V23, P1546, DOI 10.1128/MCB.23.5.1546-1557.2003
   WIAME JM, 1985, ADV MICROB PHYSIOL, V26, P1, DOI 10.1016/S0065-2911(08)60394-X
NR 45
TC 24
Z9 25
U1 0
U2 5
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0951-4198
EI 1097-0231
J9 RAPID COMMUN MASS SP
JI Rapid Commun. Mass Spectrom.
PD DEC
PY 2008
VL 22
IS 23
BP 3743
EP 3753
DI 10.1002/rcm.3790
PG 11
WC Biochemical Research Methods; Chemistry, Analytical; Spectroscopy
SC Biochemistry & Molecular Biology; Chemistry; Spectroscopy
GA 381AI
UT WOS:000261506800007
PM 18980262
DA 2021-01-25
ER

PT J
AU Landthaler, M
   Gaidatzis, D
   Rothballer, A
   Chen, PY
   Soll, SJ
   Dinic, L
   Ojo, T
   Hafner, M
   Zavolan, M
   Tuschl, T
AF Landthaler, Markus
   Gaidatzis, Dimos
   Rothballer, Andrea
   Chen, Po Yu
   Soll, Steven Joseph
   Dinic, Lana
   Ojo, Tolulope
   Hafner, Markus
   Zavolan, Mihaela
   Tuschl, Thomas
TI Molecular characterization of human Argonaute-containing
   ribonucleoprotein complexes and their bound target mRNAs
SO RNA
LA English
DT Review
DE microRNA; Argonaute; GW182/TNRC6; microRNA targets; immunoprecipitation
ID MEDIATED TRANSLATIONAL REPRESSION; MICRORNA TARGETS; SYSTEMATIC
   IDENTIFICATION; CAENORHABDITIS-ELEGANS; PROTEIN-SYNTHESIS;
   CRYSTAL-STRUCTURE; STRUCTURAL BASIS; LET-7 MICRORNA; NUCLEAR EXPORT;
   MIRNA TARGETS
AB microRNAs (miRNAs) regulate the expression of mRNAs in animals and plants through miRNA-containing ribonucleoprotein particles (RNPs). At the core of these miRNA silencing effector complexes are the Argonaute (AGO) proteins that bind miRNAs and mediate target mRNA recognition. We generated HEK293 cell lines stably expressing epitope-tagged human AGO proteins and other RNA silencing-related proteins and used these cells to purify miRNA-containing RNPs. Mass spectrometric analyses of the proteins associated with different AGO proteins revealed a common set of helicases and mRNA-binding proteins, among them the three trinucleotide repeat containing proteins 6 (TNRC6A,-B,-C). mRNA microarray analyses of these miRNAassociated RNPs revealed that AGO and TNRC6 proteins bind highly similar sets of transcripts enriched in binding sites for highly expressed endogenous miRNAs, indicating that the TNRC6 proteins are a component of the mRNA-targeting miRNA silencing complex. Together with the very similar proteomic composition of each AGO complex, this result suggests substantial functional redundancy within families of human AGO and TNRC6 proteins. Our results further demonstrate that we have developed an effective biochemical approach to identify physiologically relevant human miRNA targets.
C1 [Gaidatzis, Dimos; Zavolan, Mihaela] Univ Basel, Biozentrum, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
   [Landthaler, Markus; Rothballer, Andrea; Chen, Po Yu; Soll, Steven Joseph; Dinic, Lana; Ojo, Tolulope; Hafner, Markus; Tuschl, Thomas] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10065 USA.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
EM Mihaela.Zavolan@unibas.ch; ttuschl@rockefeller.edu
RI Landthaler, Markus/A-1427-2010; Zavolan, Mihaela/S-3888-2016; Hafner,
   Markus/O-7100-2018
OI Landthaler, Markus/0000-0002-1075-8734; Hafner,
   Markus/0000-0002-4336-6518; Zavolan, Mihaela/0000-0002-8832-2041
FU Swiss National FundSwiss National Science Foundation (SNSF)
   [3100A0-114001]; Irma T. Hirschl Postdoctoral Fellowship; NIHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USA [GM073047, GM068476]; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [P01GM073047, P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, R01GM068476, P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, P01GM073047, P01GM073047,
   P01GM073047, R01GM068476, P01GM073047, P01GM073047, P01GM073047,
   R01GM068476, P01GM073047, R01GM068476, P01GM073047, P01GM073047,
   P01GM073047, P01GM073047, P01GM073047, R01GM068476] Funding Source: NIH
   RePORTER
FX We are grateful to Haiteng Deng and Joseph Fernandenz (Rockefeller
   University Proteomics Resource Facility) for the MS analysis, Wenxiang
   Zhang and Connie Zhao (Genomics Resource Center) for mRNA array
   analysis, and the Memorial Sloan Kettering Sequencing Core for 454
   sequencing. We thank Jean Hausser for sharing some of his programs and
   Manuel Ascano, Thalia Farazi, Stefan Juranek, and other members of the
   laboratory for comments on the manuscript. We also thank Millipore for
   antibodies. D.G. was supported by Swiss National Fund grant
   #3100A0-114001 to M.Z. M.L. was supported by an Irma T. Hirschl
   Postdoctoral Fellowship. T.T. is an HHMI investigator, and work in his
   laboratory was supported by NIH grants GM073047 and GM068476.
CR Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242
   Bagga S, 2005, CELL, V122, P553, DOI 10.1016/j.cell.2005.07.031
   Balzer E, 2007, RNA BIOL, V4, P16, DOI 10.4161/rna.4.1.4364
   Barth S, 2008, NUCLEIC ACIDS RES, V36, P666, DOI 10.1093/nar/gkm1080
   Behm-Ansmant I, 2006, GENE DEV, V20, P1885, DOI 10.1101/gad.1424106
   Beitzinger M, 2007, RNA BIOL, V4, P76, DOI 10.4161/rna.4.2.4640
   Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110
   Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031
   Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406
   Chapman EJ, 2007, NAT REV GENET, V8, P884, DOI 10.1038/nrg2179
   Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868
   Chu CY, 2006, PLOS BIOL, V4, P1122, DOI 10.1371/journal.pbio.0040210
   Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049
   Didiano D, 2006, NAT STRUCT MOL BIOL, V13, P849, DOI 10.1038/nsmb1138
   Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404
   Easow G, 2007, RNA, V13, P1198, DOI 10.1261/rna.563707
   Eulalio A, 2008, NAT STRUCT MOL BIOL, V15, P346, DOI 10.1038/nsmb.1405
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689
   Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7
   Grun D, 2005, PLOS COMPUT BIOL, V1, P51, DOI 10.1371/journal.pcbi.0010013
   Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509
   Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023
   Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043
   Han JJ, 2004, GENE DEV, V18, P3016, DOI 10.1101/gad.1262504
   Hendrickson DG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002126
   Hock J, 2007, EMBO REP, V8, P1052, DOI 10.1038/sj.embor.7401088
   Humphreys DT, 2005, P NATL ACAD SCI USA, V102, P16961, DOI 10.1073/pnas.0506482102
   Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961
   Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827
   Jakymiw A, 2005, NAT CELL BIOL, V7, P1267, DOI 10.1038/ncb1334
   Jing Q, 2005, CELL, V120, P623, DOI 10.1016/j.cell.2004.12.038
   John B, 2005, PLOS BIOL, V3, P1328, DOI 10.1371/journal.pbio.0030264
   Jones-Rhoades MW, 2006, ANNU REV PLANT BIOL, V57, P19, DOI 10.1146/annurev.arplant.57.032905.105218
   Karginov FV, 2007, P NATL ACAD SCI USA, V104, P19291, DOI 10.1073/pnas.0709971104
   Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034
   Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801
   Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8
   Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100
   Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001
   Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942
   Lee Y, 2006, COLD SPRING HARB SYM, V71, P51, DOI 10.1101/sqb.2006.71.041
   Leung AKL, 2007, CELL, V130, P581, DOI 10.1016/j.cell.2007.08.010
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777
   Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06
   Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513
   Liu JD, 2005, NAT CELL BIOL, V7, P1261, DOI 10.1038/ncb1333
   Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599
   Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514
   Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519
   MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105
   Maroney PA, 2006, NAT STRUCT MOL BIOL, V13, P1102, DOI 10.1038/nsmb1174
   Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X
   Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048
   Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007
   Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873
   Mourelatos Z, 2002, GENE DEV, V16, P720, DOI 10.1101/gad.974702
   Nelson PT, 2004, RNA, V10, P387, DOI 10.1261/rna.5181104
   Nottrott S, 2006, NAT STRUCT MOL BIOL, V13, P1108, DOI 10.1038/nsmb1173
   Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523
   Orom UA, 2007, METHODS, V43, P162, DOI 10.1016/j.ymeth.2007.04.007
   Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462
   Patel DJ, 2006, COLD SPRING HARB SYM, V71, P81, DOI 10.1101/sqb.2006.71.053
   Pellino JL, 2005, RNA, V11, P1719, DOI 10.1261/rna.2102805
   Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001
   Petersen CP, 2006, MOL CELL, V21, P533, DOI 10.1016/j.molcel.2006.01.031
   Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2
   Pillai RS, 2005, SCIENCE, V309, P1573, DOI 10.1126/science.1115079
   Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798
   Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006
   Rehwinkel J, 2005, RNA, V11, P1640, DOI 10.1261/rna.2191905
   Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016
   Rodriguez A, 2007, SCIENCE, V316, P608, DOI 10.1126/science.1139253
   Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646
   Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1
   Seggerson K, 2002, DEV BIOL, V243, P215, DOI 10.1006/dbio.2001.0563
   Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228
   Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514
   Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016
   Thermann R, 2007, NATURE, V447, P875, DOI 10.1038/nature05878
   Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848
   Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460
   Vasudevan S, 2007, CELL, V128, P1105, DOI 10.1016/j.cell.2007.01.038
   Vinther J, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl590
   Wakiyama M, 2007, GENE DEV, V21, P1857, DOI 10.1101/gad.1566707
   WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4
   Wu LG, 2006, P NATL ACAD SCI USA, V103, P4034, DOI 10.1073/pnas.0510928103
   Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683
   Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129
   Yekta S, 2004, SCIENCE, V304, P594, DOI 10.1126/science.1097434
   Yi R, 2003, GENE DEV, V17, P3011, DOI 10.1101/gad.1158803
   Yisraeli JK, 2005, BIOL CELL, V97, P87
   Zeng Y, 2002, MOL CELL, V9, P1327, DOI 10.1016/S1097-2765(02)00541-5
   Zhang L, 2007, MOL CELL, V28, P598, DOI 10.1016/j.molcel.2007.09.014
   Zhao Y, 2007, CELL, V129, P303, DOI 10.1016/j.cell.2007.03.030
NR 104
TC 257
Z9 260
U1 0
U2 13
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1355-8382
EI 1469-9001
J9 RNA
JI RNA
PD DEC
PY 2008
VL 14
IS 12
BP 2580
EP 2596
DI 10.1261/rna.1351608
PG 17
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 379LT
UT WOS:000261398400015
PM 18978028
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Garas, M
   Dichtl, B
   Keller, W
AF Garas, Monika
   Dichtl, Bernhard
   Keller, Walter
TI The role of the putative 3 ' end processing endonuclease Ysh1p in mRNA
   and snoRNA synthesis
SO RNA
LA English
DT Article
DE 3' end formation; 3' endonuclease; RNA polymerase II transcription
   termination; snoRNA; Nrd1 autoregulation
ID POLYMERASE-II TRANSCRIPTION; POLYADENYLATION SPECIFICITY FACTOR; SMALL
   NUCLEOLAR RNAS; BETA-LACTAMASE FOLD; SACCHAROMYCES-CEREVISIAE; 3'-END
   FORMATION; LYSINE-4 METHYLATION; FUNCTIONAL-ANALYSIS; MAMMALIAN
   CLEAVAGE; ELONGATION COMPLEX
AB Pre-mRNA 39 end formation is tightly linked to upstream and downstream events of eukaryotic mRNA synthesis. The two-step reaction involves endonucleolytic cleavage of the primary transcript followed by poly(A) addition to the upstream cleavage product. To further characterize the putative 39 end processing endonuclease Ysh1p/Brr5p, we isolated and analyzed a number of new temperature-and cold-sensitive mutant alleles. We show that Ysh1p plays a crucial role in 39 end formation and in RNA polymerase II (RNAP II) transcription termination on mRNA genes. In addition, we observed a range of additional functional deficiencies in ysh1 mutant strains, which were partially allele-specific. Interestingly, snoRNA 39 end formation and RNAP II termination were defective on specific snoRNAs in the cold-sensitive ysh1-12 strain. Moreover, we observed the accumulation of several mRNAs including the NRD1 transcript in this mutant. We provide evidence that NRD1 autoregulation is associated with endonucleolytic cleavage and that this process may involve Ysh1p. In addition, the ysh1-12 strain displayed defects in RNA splicing indicating that a functional link may exist between intron removal and 39 end formation in yeast. These observations suggest that Ysh1p has multiple roles in RNA synthesis and processing.
C1 [Garas, Monika; Keller, Walter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Dichtl, Bernhard] Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland.
RP Keller, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM walter.keller@unibas.ch
OI Dichtl, Bernhard/0000-0001-5514-4982
FU University of Basel; Swiss National Science FundSwiss National Science
   Foundation (SNSF) [PP00A-102941]; EC Sixth Framework ProgrammeEuropean
   CommissionEuropean Commission Joint Research CentreEuropean Union (EU)
   [ERAS-CT-2003- 980409]; European Science FoundationEuropean Science
   Foundation (ESF)
FX We thank Drs. Claire Moore and Jeffry Corden for generous gifts of yeast
   strains, Drs. David Brow and Eric Steinmetz for anti-Nrd1p antibody, and
   Dr. Bertrand Paguet for purified CPF. We also thank the reviewers for
   constructive suggestions. We are grateful to Drs. Stepanka Vanacova and
   Bertrand Paguet for comments and discussions on the project and for
   improving the manuscript. W. K. was supported by the University of
   Basel, the Swiss National Science Fund, and, as part of the European
   Science Foundation EUROCORES Programme EuroDYNA, from funds of the EC
   Sixth Framework Programme, under contract ERAS-CT-2003- 980409. B.D. was
   supported by the Swiss National Science Fund (Grant no. PP00A-102941).
CR Allmang C, 1999, EMBO J, V18, P5399, DOI 10.1093/emboj/18.19.5399
   Aravind L, 1999, In Silico Biol, V1, P69
   Arigo JT, 2006, MOL CELL, V21, P641, DOI 10.1016/j.molcel.2006.02.005
   BELTRAME M, 1992, EMBO J, V11, P1531, DOI 10.1002/j.1460-2075.1992.tb05198.x
   Bentley DL, 2005, CURR OPIN CELL BIOL, V17, P251, DOI 10.1016/j.ceb.2005.04.006
   Birse CE, 1998, SCIENCE, V280, P298, DOI 10.1126/science.280.5361.298
   Buratowski S, 2005, CURR OPIN CELL BIOL, V17, P257, DOI 10.1016/j.ceb.2005.04.003
   Butler JS, 2002, TRENDS CELL BIOL, V12, P90, DOI 10.1016/S0962-8924(01)02225-5
   Callebaut I, 2002, NUCLEIC ACIDS RES, V30, P3592, DOI 10.1093/nar/gkf470
   Chanfreau G, 1996, SCIENCE, V274, P1511, DOI 10.1126/science.274.5292.1511
   Chanfreau G, 1998, J MOL BIOL, V284, P975, DOI 10.1006/jmbi.1998.2237
   Chen EJ, 1998, MOL CELL BIOL, V18, P7139, DOI 10.1128/MCB.18.12.7139
   Cheng HL, 2004, MOL CELL BIOL, V24, P2932, DOI 10.1128/MCB.24.7.2932-2943.2004
   CONNELLY S, 1988, GENE DEV, V2, P440, DOI 10.1101/gad.2.4.440
   Conrad NK, 2000, GENETICS, V154, P557
   Daiyasu H, 2001, FEBS LETT, V503, P1, DOI 10.1016/S0014-5793(01)02686-2
   Dheur S, 2003, EMBO J, V22, P2831, DOI 10.1093/emboj/cdg253
   Dichtl B, 2002, EMBO J, V21, P4125, DOI 10.1093/emboj/cdf390
   Dichtl B, 2002, MOL CELL, V10, P1139, DOI 10.1016/S1097-2765(02)00707-4
   Dichtl E, 2004, RNA, V10, P965, DOI 10.1261/rna.7090104
   Fatica A, 2000, EMBO J, V19, P6218, DOI 10.1093/emboj/19.22.6218
   Ganem C, 2003, EMBO J, V22, P1588, DOI 10.1093/emboj/cdg141
   Gilmour DS, 2008, J BIOL CHEM, V283, P661, DOI 10.1074/jbc.R700032200
   HENRY Y, 1994, EMBO J, V13, P2452, DOI 10.1002/j.1460-2075.1994.tb06530.x
   Jenny A, 1996, SCIENCE, V274, P1514, DOI 10.1126/science.274.5292.1514
   Kaneko S, 2007, GENE DEV, V21, P1779, DOI 10.1101/gad.1565207
   Kim M, 2004, NATURE, V432, P517, DOI 10.1038/nature03041
   Kim M, 2006, MOL CELL, V24, P723, DOI 10.1016/j.molcel.2006.11.011
   Kuehner JN, 2008, MOL CELL, V31, P201, DOI 10.1016/j.molcel.2008.05.018
   Kyburz A, 2003, NUCLEIC ACIDS RES, V31, P3936, DOI 10.1093/nar/gkg478
   Kyburz A, 2006, MOL CELL, V23, P195, DOI 10.1016/j.molcel.2006.05.037
   LOGAN J, 1987, P NATL ACAD SCI USA, V84, P8306, DOI 10.1073/pnas.84.23.8306
   Luo WF, 2006, GENE DEV, V20, P954, DOI 10.1101/gad.1409106
   Luo WF, 2004, CELL, V119, P911, DOI 10.1016/j.cell.2004.11.041
   MANDART E, 1995, MOL CELL BIOL, V15, P6979
   Mandel CR, 2006, NATURE, V444, P953, DOI 10.1038/nature05363
   Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331
   Minvielle-Sebastia L, 1998, EMBO J, V17, P7454, DOI 10.1093/emboj/17.24.7454
   MINVIELLESEBASTIA L, 1994, SCIENCE, V266, P1702, DOI 10.1126/science.7992054
   MOIR D, 1982, GENETICS, V100, P547
   Morlando M, 2002, MOL CELL BIOL, V22, P1379, DOI 10.1128/MCB.22.5.1379-1389.2002
   Nedea E, 2003, J BIOL CHEM, V278, P33000, DOI 10.1074/jbc.M304454200
   Nedea E, 2008, MOL CELL, V29, P577, DOI 10.1016/j.molcel.2007.12.031
   Noble SM, 1996, GENETICS, V143, P67
   Ohnacker M, 2000, EMBO J, V19, P37, DOI 10.1093/emboj/19.1.37
   Orozco IJ, 2002, J BIOL CHEM, V277, P42899, DOI 10.1074/jbc.M207415200
   Preker PJ, 1997, EMBO J, V16, P4727, DOI 10.1093/emboj/16.15.4727
   PREKER PJ, 1995, CELL, V81, P379, DOI 10.1016/0092-8674(95)90391-7
   Proudfoot N, 2004, CURR OPIN CELL BIOL, V16, P272, DOI 10.1016/j.ceb.2004.03.007
   Proudfoot NJ, 2002, CELL, V108, P501, DOI 10.1016/S0092-8674(02)00617-7
   Rosonina E, 2006, GENE DEV, V20, P1050, DOI 10.1101/gad.1431606
   Roth KM, 2005, MOL CELL BIOL, V25, P1577, DOI 10.1128/MCB.25.5.1577-1585.2005
   Ryan K, 2004, RNA, V10, P565, DOI 10.1261/rna.5214404
   Sadowski M, 2003, EMBO J, V22, P2167, DOI 10.1093/emboj/cdg200
   Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026
   Steinmetz EJ, 2003, MOL CELL BIOL, V23, P6339, DOI 10.1128/MCB.23.18.6339-6349.2003
   Steinmetz EJ, 2006, MOL CELL BIOL, V26, P2688, DOI 10.1128/MCB.26.7.2688-2696.2006
   Steinmetz EJ, 1998, P NATL ACAD SCI USA, V95, P6699, DOI 10.1073/pnas.95.12.6699
   Steinmetz EJ, 2001, NATURE, V413, P327, DOI 10.1038/35095090
   Steinmetz EJ, 2006, MOL CELL, V24, P735, DOI 10.1016/j.molcel.2006.10.023
   THOMAS BJ, 1989, CELL, V56, P619, DOI 10.1016/0092-8674(89)90584-9
   Ursic D, 1997, NUCLEIC ACIDS RES, V25, P4778, DOI 10.1093/nar/25.23.4778
   Van Hoof A, 2000, MOL CELL BIOL, V20, P441, DOI 10.1128/MCB.20.2.441-452.2000
   West S, 2008, MOL CELL, V29, P600, DOI 10.1016/j.molcel.2007.12.019
   Weston RJ, 2004, Z NATURFORSCH C, V59, P39
   Wickens M, 2004, SCIENCE, V306, P1299, DOI 10.1126/science.1100137
   WINSTON F, 1995, YEAST, V11, P53, DOI 10.1002/yea.320110107
   Zhang ZQ, 2006, MOL CELL, V21, P65, DOI 10.1016/j.molcel.2005.11.002
   Zhang ZQ, 2005, GENE DEV, V19, P1572, DOI 10.1101/gad.1296305
   Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999
   Zhelkovsky A, 2006, RNA, V12, P435, DOI 10.1261/rna.2267606
NR 71
TC 21
Z9 21
U1 0
U2 0
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1355-8382
EI 1469-9001
J9 RNA
JI RNA
PD DEC
PY 2008
VL 14
IS 12
BP 2671
EP 2684
DI 10.1261/rna.1293008
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 379LT
UT WOS:000261398400022
PM 18971324
OA Bronze, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Casagrande, F
   Ratera, M
   Schenk, AD
   Chami, M
   Valencia, E
   Lopez, JM
   Torrents, D
   Engel, A
   Palacin, M
   Fotiadis, D
AF Casagrande, Fabio
   Ratera, Merce
   Schenk, Andreas D.
   Chami, Mohamed
   Valencia, Eva
   Maria Lopez, Jesus
   Torrents, David
   Engel, Andreas
   Palacin, Manuel
   Fotiadis, Dimitrios
TI Projection Structure of a Member of the Amino
   Acid/Polyamine/Organocation Transporter Superfamily
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID LYSINURIC PROTEIN INTOLERANCE; IMAGE-PROCESSING LIBRARY; EXTREME ACID
   RESISTANCE; ESCHERICHIA-COLI; PYROCOCCUS-HORIKOSHII; AGMATINE
   ANTIPORTER; MEMBRANE TOPOLOGY; APC SUPERFAMILY; ARGININE; PERMEASE
AB The L-arginine/agmatine antiporter AdiC is a key component of the arginine-dependent extreme acid resistance system of Escherichia coli. Phylogenetic analysis indicated that AdiC belongs to the amino acid/polyamine/organocation (APC) transporter superfamily having sequence identities of 15-17% to eukaryotic and human APC transporters. For functional and structural characterization, we cloned, overexpressed, and purified wild-type AdiC and the point mutant AdiC-W293L, which is unable to bind and consequently transport L-arginine. Purified detergent-solubilized AdiC particles were dimeric. Reconstitution experiments yielded two-dimensional crystals of AdiC-W293L diffracting beyond 6 angstrom resolution from which we determined the projection structure at 6.5 angstrom resolution. The projection map showed 10-12 density peaks per monomer and suggested mainly tilted helices with the exception of one distinct perpendicular membrane spanning alpha-helix. Comparison of AdiC-W293L with the projection map of the oxalate/formate antiporter from Oxalobacter formigenes, a member from the major facilitator superfamily, indicated different structures. Thus, two-dimensional crystals of AdiC-W293L yielded the first detailed view of a transport protein from the APC superfamily at sub-nanometer resolution.
C1 [Casagrande, Fabio; Schenk, Andreas D.; Chami, Mohamed; Engel, Andreas; Fotiadis, Dimitrios] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Ratera, Merce; Valencia, Eva; Palacin, Manuel] Ctr Invest Biomed Red Enfermedades Raras, E-08028 Barcelona, Spain.
   [Maria Lopez, Jesus; Torrents, David] Barcelona Supercomp Ctr, Life Sci Program, E-08034 Barcelona, Spain.
   [Maria Lopez, Jesus] Natl Inst Bioinformat, E-08034 Barcelona, Spain.
   [Torrents, David] Inst Catalana Recerca & Estudis Avancats, E-08034 Barcelona, Spain.
   [Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland.
   [Ratera, Merce; Valencia, Eva; Palacin, Manuel] Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Inst Biomed Res, E-08028 Barcelona, Spain.
RP Palacin, M (corresponding author), Univ Barcelona, Fac Biol, Dept Biochem & Mol Biol, Inst Biomed Res, Barcelona Sci Pk,Josep Samitier 1-5, E-08028 Barcelona, Spain.
EM manuel.palacin@irbbarcelona.org; dimitrios.fotiadis@mci.unibe.ch
RI ; Torrents, David/G-5785-2015
OI Schenk, Andreas/0000-0001-9214-2505; Lopez Marti, Jesus
   Maria/0000-0002-3006-1360; Torrents, David/0000-0002-6086-9037
FU European Community ProjectEuropean Community (EC) [502802]; Berne
   University Research Foundation; Spanish Ministry of Science and
   EducationSpanish Government [BFU2006-14600]; Swiss National Center of
   Competence in Research for Structural BiologySwiss National Science
   Foundation (SNSF); Maurice E. Muller Foundation of Switzerland; Fondo
   Social EuropeoEuropean Social Fund (ESF); ICREAICREA Funding Source:
   Custom
FX This work was supported by the European Community Project Grant 502802
   EUGINDAT (to D. F. and M. P.), by the Berne University Research
   Foundation (to D. F. and Matthias Hediger), by the Spanish Ministry of
   Science and Education Grant BFU2006-14600 (to M. P.), by the Swiss
   National Center of Competence in Research for Structural Biology (to A.
   E.), and by the Maurice E. Muller Foundation of Switzerland (to A. E.).
   The costs of publication of this article were defrayed in part by the
   payment of page charges. This article must therefore be hereby marked
   "advertisement" in accordance with 18 U. S. C. Section 1734 solely to
   indicate this fact.; Recipient of a pre-doctoral fellowship from the
   Spanish Ministry of Science and Education.; Recipient of a Juan de La
   Cierva contract from the Spanish Ministry of Science and Education with
   support from the Fondo Social Europeo.
CR Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196
   Borsani G, 1999, NAT GENET, V21, P297, DOI 10.1038/6815
   CALONGE MT, 1994, NAT GENET, V6, P420, DOI 10.1038/ng0494-420
   Cosgriff AJ, 1997, J BACTERIOL, V179, P3317, DOI 10.1128/jb.179.10.3317-3323.1997
   Donnenberg MS, 2000, NATURE, V406, P768, DOI 10.1038/35021212
   ELLIS J, 1995, MICROBIOL-UK, V141, P1927, DOI 10.1099/13500872-141-8-1927
   Engel A, 2000, EMBO J, V19, P800, DOI 10.1093/emboj/19.5.800
   Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200
   Feliubadalo L, 1999, NAT GENET, V23, P52
   Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021
   Fuchs BC, 2005, SEMIN CANCER BIOL, V15, P254, DOI 10.1016/j.semcancer.2005.04.005
   Gasol E, 2004, J BIOL CHEM, V279, P31228, DOI 10.1074/jbc.M402428200
   Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003
   Heymann JAW, 2001, EMBO J, V20, P4408, DOI 10.1093/emboj/20.16.4408
   Hirai T, 1999, J ELECTRON MICROSC, V48, P653, DOI 10.1093/oxfordjournals.jmicro.a023731
   Hu LA, 1998, BIOCHEM J, V336, P69, DOI 10.1042/bj3360069
   Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754
   Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003
   Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797
   Jimenez-Vidal M, 2004, J BIOL CHEM, V279, P11214, DOI 10.1074/jbc.M309866200
   Kaleeba JAR, 2006, SCIENCE, V311, P1921, DOI 10.1126/science.1120878
   Karlsson M, 2003, FEBS LETT, V537, P68, DOI 10.1016/S0014-5793(03)00082-6
   Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200
   Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001
   Letunic I, 2007, BIOINFORMATICS, V23, P127, DOI 10.1093/bioinformatics/btl529
   Nicholson B, 2001, J BIOL CHEM, V276, P15881, DOI 10.1074/jbc.M010030200
   Philippsen A, 2003, J STRUCT BIOL, V144, P4, DOI 10.1016/j.jsb.2003.09.032
   Philippsen A, 2007, J STRUCT BIOL, V157, P28, DOI 10.1016/j.jsb.2006.06.009
   Raunser S, 2006, BIOCHEMISTRY-US, V45, P12796, DOI 10.1021/bi061008+
   Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200
   Saier M H Jr, 1999, J Mol Microbiol Biotechnol, V1, P257
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Stahlberg H, 2001, FEBS LETT, V504, P166, DOI 10.1016/S0014-5793(01)02746-6
   Subramaniam S, 2002, PHILOS T ROY SOC A, V360, P859, DOI 10.1098/rsta.2001.0971
   Suda K, 2004, MOL MEMBR BIOL, V21, P435, DOI 10.1080/09687860400020291
   Torrents D, 1999, NAT GENET, V21, P293
   VALPUESTA JM, 1994, J MOL BIOL, V240, P281, DOI 10.1006/jmbi.1994.1445
   Xie H, 2004, MOL MEMBR BIOL, V21, P323, DOI 10.1080/09687860400003941
   Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978
   Yeramian A, 2006, J IMMUNOL, V176, P5918, DOI 10.4049/jimmunol.176.10.5918
   Yeramian A, 2006, EUR J IMMUNOL, V36, P1516, DOI 10.1002/eji.200535694
   Yernool D, 2004, NATURE, V431, P811, DOI 10.1038/nature03018
NR 42
TC 31
Z9 31
U1 0
U2 8
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 28
PY 2008
VL 283
IS 48
BP 33240
EP 33248
DI 10.1074/jbc.M806917200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 376KY
UT WOS:000261183700027
PM 18819925
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Krehenbrink, M
   Chami, M
   Guilvout, I
   Alzari, PM
   Pecorari, F
   Pugsley, AP
AF Krehenbrink, Martin
   Chami, Mohamed
   Guilvout, Ingrid
   Alzari, Pedro M.
   Pecorari, Frederic
   Pugsley, Anthony P.
TI Artificial Binding Proteins (Affitins) as Probes for Conformational
   Changes in Secretin PulD
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE Sac7d; outer membrane protein; secretin; Type II protein secretion;
   protein folding
ID CIRCULAR-DICHROISM SPECTROSCOPY; SECONDARY STRUCTURE ANALYSES;
   OUTER-MEMBRANE PROTEIN; II SECRETION; PULLULANASE SECRETION;
   ERWINIA-CHRYSANTHEMI; DNA-BINDING; PATHWAY; THERMODYNAMICS; REQUIREMENT
AB The DNA-binding protein Sac7d was previously modified to bind with high affinity to the N domain of the outer membrane secretin PulD from the bacterium Klebsiella oxytoca. Here, we show that binding of the Sac7d derivatives (affitins) to PulD is sensitive to conformational changes caused by denaturant and by the zwitterionic detergent Zwittergent 3-14 routinely used to extract secretins from outer membranes. This sensitivity to the conformational state of PulD allowed us to use the affitins as probes for the native structure of PulD and to devise protocols for examining in vitro synthesized protein in nonionic detergent and for the affinity purification of native PulD using affitins as ligands. When fused to periplasmic PhoA, three affitins inhibited PulD multimerization in vivo and caused loss of function. In two cases, this was likely to be due to dimerization of the affitin by the bound PhoA, as the effect was absent when the affitins were fused to monomeric MalE. In the third case, the MalE and PhoA moieties probably interfered sterically with PulD protomer interactions and, thereby, inhibited multimerization. None of the affitins tested interacted with PulD at sites of protomer interaction or blocked the secretin channel through which exoproteins cross the Outer membrane in the Type II secretion pathway of which PulD is a key component. (c) 2008 Elsevier Ltd. All rights reserved.
C1 [Krehenbrink, Martin; Guilvout, Ingrid; Pugsley, Anthony P.] Inst Pasteur, Unite Genet Mol, CNRS, URA2172, F-75724 Paris 15, France.
   [Alzari, Pedro M.; Pecorari, Frederic] Inst Pasteur, Unite Biochim Struct, CNRS, URA2185, F-75724 Paris 15, France.
   [Pecorari, Frederic] Univ Nantes, CNRS, UMR6204, F-44322 Nantes 3, France.
   [Chami, Mohamed] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Pugsley, AP (corresponding author), Inst Pasteur, Unite Genet Mol, CNRS, URA2172, 25 Rue Dr Roux, F-75724 Paris 15, France.
EM max@pasteur.fr
RI Pecorari, Frederic/L-2942-2015
OI Pecorari, Frederic/0000-0002-7854-0643; Alzari,
   Pedro/0000-0002-4233-1903
FU French National Research AgencyFrench National Research Agency (ANR)
   [ANR-05-0307-01]; Swiss National Science FoundationSwiss National
   Science Foundation (SNSF) [3100A-108299]; Muller Foundation of
   Switzerland
FX We are grateful to our colleagues in the Structural Biology and
   Molecular Genetics Units of the Institut Pasteur for their help and
   interest and to Patrick England and Andreas Engel for discussions
   concerning conformational changes in PulD. We thank Masayuki Takahashi
   and Fabrice Fleury (Universite de Nantes, UMR6204) for their help and
   for the use of the CD instrument. The work was financed in part by a
   grant from the French National Research Agency (ANR-05-0307-01), by
   Swiss National Science Foundation grant 3100A-108299, and by the M.E.
   Muller Foundation of Switzerland.
CR Arcus V, 2002, CURR OPIN STRUC BIOL, V12, P794, DOI 10.1016/S0959-440X(02)00392-5
   Bouley J, 2001, J MOL BIOL, V308, P205, DOI 10.1006/jmbi.2001.4594
   Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   Collins RF, 2005, J BIOL CHEM, V280, P18923, DOI 10.1074/jbc.M411603200
   Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200
   COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1
   Gao YG, 1998, NAT STRUCT BIOL, V5, P782, DOI 10.1038/1822
   Guilvout I, 2008, J MOL BIOL, V382, P13, DOI 10.1016/j.jmb.2008.06.055
   Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402
   Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x
   Johnson TL, 2006, FEMS MICROBIOL LETT, V255, P175, DOI 10.1111/j.1574-6968.2006.00102.x
   KORNACKER MG, 1989, MOL MICROBIOL, V4, P73
   Koster M, 1997, MOL MICROBIOL, V26, P789, DOI 10.1046/j.1365-2958.1997.6141981.x
   Lees JG, 2006, BIOINFORMATICS, V22, P1955, DOI 10.1093/bioinformatics/btl327
   Letellier L, 1997, J BIOL CHEM, V272, P11109
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   McCrary BS, 1996, J MOL BIOL, V264, P784, DOI 10.1006/jmbi.1996.0677
   Mouratou B, 2007, P NATL ACAD SCI USA, V104, P17983, DOI 10.1073/pnas.0702963104
   Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9
   Peters WB, 2004, J MOL BIOL, V343, P339, DOI 10.1016/j.jmb.2004.08.042
   Possot OM, 1997, MOL MICROBIOL, V24, P457, DOI 10.1046/j.1365-2958.1997.3451726.x
   Possot OM, 2000, J BACTERIOL, V182, P2142, DOI 10.1128/JB.182.8.2142-2152.2000
   Pugsley AP, 2001, J BACTERIOL, V183, P1312, DOI 10.1128/JB.183.4.1312-1319.2001
   Sandkvist M, 2001, INFECT IMMUN, V69, P3523, DOI 10.1128/IAI.69.6.3523-3535.2001
   Sandkvist M, 2001, MOL MICROBIOL, V40, P271, DOI 10.1046/j.1365-2958.2001.02403.x
   Shevchik VE, 1997, EMBO J, V16, P3007, DOI 10.1093/emboj/16.11.3007
   Su SY, 2000, J MOL BIOL, V303, P395, DOI 10.1006/jmbi.2000.4112
   Whitmore L, 2004, NUCLEIC ACIDS RES, V32, pW668, DOI 10.1093/nar/gkh371
   Whitmore L, 2008, BIOPOLYMERS, V89, P392, DOI 10.1002/bip.20853
   Wolfgang M, 2000, EMBO J, V19, P6408, DOI 10.1093/emboj/19.23.6408
NR 30
TC 37
Z9 37
U1 0
U2 10
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD NOV 28
PY 2008
VL 383
IS 5
BP 1058
EP 1068
DI 10.1016/j.jmb.2008.09.016
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 374HD
UT WOS:000261033500011
PM 18822295
DA 2021-01-25
ER

PT J
AU Caussinus, E
   Colombelli, J
   Affolter, M
AF Caussinus, Emmanuel
   Colombelli, Julien
   Affolter, Markus
TI Tip-Cell Migration Controls Stalk-Cell Intercalation during Drosophila
   Tracheal Tube Elongation
SO CURRENT BIOLOGY
LA English
DT Article
ID XENOPUS-LAEVIS EMBRYOS; BRANCHING MORPHOGENESIS; TISSUE MORPHOGENESIS;
   GENETIC-CONTROL; FUSION PROTEIN; DUAL FUNCTION; SYSTEM; REARRANGEMENT;
   DYNAMICS; FGF
AB Background: Branching morphogenesis remodels epithelial tissues into tubular networks. This process is crucial to many organs, from the insect trachea to the vertebrate vasculature. Although Drosophila tracheal development has been well characterized morphologically and genetically, very little is known about the forces involved during morphogenesis. The repertoire of cell behaviors underlying tracheal primary branch remodeling is limited to cell migration, cell-shape changes, and stalk-cell intercalation (SCI), a process in which cells insert in between cells previously in contact with each other.
   Results: Here, we identify the major forces that contribute to tracheal primary branch remodeling by using genetic and microsurgery experiments. As the tip cells migrate, they elongate the branches and create a tensile stress. This tensile stress triggers SCI, which, in turn, allows the branches to further elongate.
   Conclusions: The mechanism that we describe contrasts with "convergent extension by cell intercalation" acting during Drosophila germ band extension (GBE), where cell intercalation is the cause of epithelium elongation. Surprisingly, in tracheal branches, one or two leading cells produce enough mechanical power to intercalate many lagging cells. This may apply to other tubular networks.
C1 [Caussinus, Emmanuel; Affolter, Markus] Univ Basel, Growth & Dev Biozentrum, CH-4056 Basel, Switzerland.
   [Colombelli, Julien] EMBIL Heidelberg, Cell Biol & Biophys, D-69117 Heidelberg, Germany.
RP Affolter, M (corresponding author), Univ Basel, Growth & Dev Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch
OI Affolter, Markus/0000-0002-5171-0016; Colombelli,
   Julien/0000-0002-2784-4276
CR Araujo SJ, 2007, DEVELOPMENT, V134, P3665, DOI 10.1242/dev.007328
   Beitel GJ, 2000, DEVELOPMENT, V127, P3271
   Beloussov LV, 2000, DEV GENES EVOL, V210, P92, DOI 10.1007/s004270050015
   Bertet C, 2004, NATURE, V429, P667, DOI 10.1038/nature02590
   Blankenship JT, 2006, DEV CELL, V11, P459, DOI 10.1016/j.devcel.2006.09.007
   Casanova J, 2007, EMBO REP, V8, P335, DOI 10.1038/sj.embor.7400942
   Chihara T, 2003, DEVELOPMENT, V130, P1419, DOI 10.1242/dev.00361
   Colombelli J, 2004, REV SCI INSTRUM, V75, P472, DOI 10.1063/1.1641163
   Elul T, 1997, DEV BIOL, V191, P243, DOI 10.1006/dbio.1997.8711
   Elul T, 2000, DEV BIOL, V224, P3, DOI 10.1006/dbio.2000.9746
   Franch-Marro X, 2000, DEV BIOL, V227, P80, DOI 10.1006/dbio.2000.9890
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829
   IRVINE KD, 1994, DEVELOPMENT, V120, P827
   Iwaki DD, 2001, DEV BIOL, V240, P611, DOI 10.1006/dbio.2001.0483
   Jacinto A, 2002, DEV CELL, V3, P9, DOI 10.1016/S1534-5807(02)00208-3
   Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049
   Jung AC, 2006, CURR BIOL, V16, P1224, DOI 10.1016/j.cub.2006.04.048
   Kato K, 2004, DEVELOPMENT, V131, P5253, DOI 10.1242/dev.01404
   Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215
   Lecuit T, 2005, TRENDS CELL BIOL, V15, P34, DOI 10.1016/j.tcb.2004.11.007
   Leung B, 1999, DEV BIOL, V216, P114, DOI 10.1006/dbio.1999.9471
   Neumann M, 2006, EMBO REP, V7, P36, DOI 10.1038/sj.embor.7400597
   Oshima K, 2006, CURR BIOL, V16, P1531, DOI 10.1016/j.cub.2006.06.032
   Pandey R, 2005, J CELL SCI, V118, P733, DOI 10.1242/jcs.01663
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Royou A, 2004, MOL BIOL CELL, V15, P838, DOI 10.1091/mbc.E03-06-0440
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Shaye DD, 2008, NAT CELL BIOL, V10, P964, DOI 10.1038/ncb1756
   Shiga Y, 1996, DEV GROWTH DIFFER, V38, P99
   Shindo M, 2008, DEVELOPMENT, V135, P1355, DOI 10.1242/dev.015982
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Verkhusha VV, 1999, FEBS LETT, V445, P395, DOI 10.1016/S0014-5793(99)00124-6
   Zallen JA, 2004, DEV CELL, V6, P343, DOI 10.1016/S1534-5807(04)00060-7
NR 38
TC 100
Z9 100
U1 2
U2 8
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD NOV 25
PY 2008
VL 18
IS 22
BP 1727
EP 1734
DI 10.1016/j.cub.2008.10.062
PG 8
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 377IL
UT WOS:000261244800021
PM 19026547
DA 2021-01-25
ER

PT J
AU Poon, PP
   Spang, A
AF Poon, Pak P.
   Spang, Anne
TI Vesicular Transport: EnSNAREd by GAPs
SO CURRENT BIOLOGY
LA English
DT Editorial Material
ID CLATHRIN-COATED VESICLES; ENDOPLASMIC-RETICULUM; V-SNARES; GOLGI;
   LOCALIZATION; ENDOSOME; PROTEIN; FUSION; YEAST
AB How are SNARE proteins included into transport vesicles? One way is through the interaction with ArfGAP proteins. A recent study reports that the ArfGAP Hrb can wrap around the SNARE VAMP7, causing its endocytosis by clathrin-coated vesicles.
C1 [Poon, Pak P.] Dalhousie Univ, Dept Biochem & Mol Biol, Halifax, NS B3H 1X5, Canada.
   [Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Poon, Pak P.] Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada.
RP Poon, PP (corresponding author), Dalhousie Univ, Dept Microbiol & Immunol, Halifax, NS B3H 1X5, Canada.
EM anne.spang@unibas.ch
RI Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008; Zdilla, Michael
   J/B-4145-2011; Wunder, Stephanie L/B-5066-2012
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203; 
CR Chidambaram S, 2008, J CELL SCI, V121, P329, DOI 10.1242/jcs.012708
   Hamilton RS, 2007, SEMIN CELL DEV BIOL, V18, P178, DOI 10.1016/j.semcdb.2007.02.001
   Kama R, 2007, MOL CELL BIOL, V27, P605, DOI 10.1128/MCB.00699-06
   Lewis SM, 2004, MOL BIOL CELL, V15, P4064, DOI 10.1091/mbc.E04-04-0316
   Liu YT, 2004, J BIOL CHEM, V279, P27225, DOI 10.1074/jbc.M312122200
   Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017
   Martinez-Arca S, 2003, P NATL ACAD SCI USA, V100, P9011, DOI 10.1073/pnas.1431910100
   Miller SE, 2007, NATURE, V450, P570, DOI 10.1038/nature06353
   Mossessova E, 2003, CELL, V114, P483, DOI 10.1016/S0092-8674(03)00608-1
   Pryor PR, 2008, CELL, V134, P817, DOI 10.1016/j.cell.2008.07.023
   Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092
   Robinson M, 2006, MOL BIOL CELL, V17, P1845, DOI 10.1091/mbc.E05-09-0832
   Schindler C, 2007, MOL BIOL CELL, V18, P2852, DOI 10.1091/mbc.E06-08-0756
   SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2
   SOLLNER T, 1993, NATURE, V362, P318, DOI 10.1038/362318a0
   Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698
   Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9
NR 17
TC 1
Z9 1
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0960-9822
J9 CURR BIOL
JI Curr. Biol.
PD NOV 25
PY 2008
VL 18
IS 22
BP R1053
EP R1054
DI 10.1016/j.cub.2008.10.002
PG 2
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 377IL
UT WOS:000261244800012
PM 19036332
DA 2021-01-25
ER

PT J
AU Boudko, SP
   Engel, J
   Okuyama, K
   Mizuno, K
   Bachinger, HP
   Schumacher, MA
AF Boudko, Sergei P.
   Engel, Juergen
   Okuyama, Kenji
   Mizuno, Kazunori
   Baechinger, Hans Peter
   Schumacher, Maria A.
TI Crystal Structure of Human Type III Collagen Gly(991)-Gly(1032) Cystine
   Knot-containing Peptide Shows Both 7/2 and 10/3 Triple Helical
   Symmetries
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID MACROPHAGE SCAVENGER RECEPTORS; AMINO-ACID SEQUENCE;
   MOLECULAR-STRUCTURE; ANGSTROM RESOLUTION; POLYPEPTIDE (PRO-PRO-GLY)10;
   ELECTROSTATIC INTERACTIONS; REPEATING SEQUENCE; MODEL PEPTIDES; PROLINE
   RING; XAA POSITION
AB Type III collagen is a critical collagen that comprises extensible connective tissue such as skin, lung, and the vascular system. Mutations in the type III collagen gene, COL3A1, are associated with the most severe forms of Ehlers-Danlos syndrome. A characteristic feature of type III collagen is the presence of a stabilizing C-terminal cystine knot. Crystal structures of collagen triple helices reported so far contain artificial sequences like (Gly-Pro-Pro)(n) or (Gly-Pro-Hyp)(n). To gain insight into the structural properties exhibited by the natural type III collagen triple helix, we synthesized, crystallized, and determined the structure of a 12-triplet repeating peptide containing the natural type III collagen sequence from residues 991 to 1032 including the C-terminal cystine knot region, to 2.3 angstrom resolution. This represents the longest collagen triple helical structure determined to date with a native sequence. Strikingly, the Gly(991)-Gly(1032) structure reveals that the central non-imino acid-containing region adopts 10/3 superhelical properties, whereas the imino acid rich N- and C-terminal regions adhere to a 7/2 superhelical conformation. The structure is consistent with two models for the cystine knot; however, the poor density for the majority of this region suggests that multiple conformations may be adopted. The structure shows that the multiple non-imino acids make several types of direct intrahelical as well as interhelical contacts. The looser superhelical structure of the non-imino acid region of collagen triple helices combined with the extra contacts afforded by ionic and polar residues likely play a role in fibrillar assembly and interactions with other extracellular components.
C1 [Boudko, Sergei P.; Mizuno, Kazunori; Baechinger, Hans Peter] Shriners Hosp Children, Res Dept, Portland, OR 97239 USA.
   [Engel, Juergen] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Okuyama, Kenji] Osaka Univ, Grad Sch Sci, Dept Macromol Sci, Osaka 5600043, Japan.
   [Schumacher, Maria A.] Univ Texas Houston, MD Anderson Canc Ctr, Dept Biochem & Mol Biol, Houston, TX 77030 USA.
RP Bachinger, HP (corresponding author), Shriners Hosp Children, Res Dept, Portland, OR 97239 USA.
EM hbp@shcc.org; maschuma@mdanderson.org
OI Mizuno, Kazunori/0000-0003-3354-6264
FU Shriners Hospital; Burroughs Wellcome Career Development AwardBurroughs
   Wellcome Fund [992863]; United States Department of EnergyUnited States
   Department of Energy (DOE) [DE-AC03-78SF00098]
FX This work was supported by a grant from the Shriners Hospital for
   Children, in part by Burroughs Wellcome Career Development Award 992863
   ( to M. A. S.), and in part by United States Department of Energy
   Contract DE-AC03-78SF00098. The costs of publication of this article
   were defrayed in part by the payment of page charges. This article must
   therefore be hereby marked "advertisement" in accordance with 18 U. S.
   C. Section 1734 solely to indicate this fact.
CR ACTON S, 1993, J BIOL CHEM, V268, P3530
   ALAKOKKO L, 1989, BIOCHEM J, V260, P509, DOI 10.1042/bj2600509
   ALLMANN H, 1979, H-S Z PHYSIOL CHEM, V360, P861
   Bachmann A, 2005, P NATL ACAD SCI USA, V102, P13897, DOI 10.1073/pnas.0505141102
   Barth D, 2003, CHEM-EUR J, V9, P3703, DOI 10.1002/chem.200304918
   BELLA J, 1994, SCIENCE, V266, P75, DOI 10.1126/science.7695699
   Berisio R, 2002, PROTEIN SCI, V11, P262, DOI 10.1110/ps.32602
   Boudko SP, 2004, J MOL BIOL, V335, P1289, DOI 10.1016/j.jmb.2003.11.054
   Boulegue C, 2008, ANTIOXID REDOX SIGN, V10, P113, DOI 10.1089/ars.2007.1868
   Brodsky B, 2005, ADV PROTEIN CHEM, V70, P301, DOI 10.1016/S0065-3233(05)70009-7
   BRUCKNER P, 1978, EUR J BIOCHEM, V90, P595, DOI 10.1111/j.1432-1033.1978.tb12640.x
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   BRUNS RR, 1973, BIOCHEMISTRY-US, V12, P808, DOI 10.1021/bi00729a004
   Bulleid NJ, 1996, BIOCHEM J, V317, P195, DOI 10.1042/bj3170195
   Burjanadze TV, 2000, BIOPOLYMERS, V53, P523, DOI 10.1002/(SICI)1097-0282(200005)53:6<523::AID-BIP8>3.0.CO;2-7
   COHEN H, 1953, Br J Phys Med, V16, P169
   COWAN PM, 1955, NATURE, V176, P1062, DOI 10.1038/1761062a0
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   DOI T, 1993, J BIOL CHEM, V268, P2126
   DOYLE BB, 1974, PROC R SOC SER B-BIO, V187, P37, DOI 10.1098/rspb.1974.0059
   Frank S, 2003, J BIOL CHEM, V278, P7747, DOI 10.1074/jbc.C200698200
   Frank S, 2001, J MOL BIOL, V308, P1081, DOI 10.1006/jmbi.2001.4644
   Frankfurter D, 2003, J EARLY CHRISTIAN ST, V11, P339, DOI 10.1353/earl.2003.0043
   HAUKIPURO K, 1987, ANN SURG, V206, P752, DOI 10.1097/00000658-198712000-00011
   HOFMANN H, 1978, J MOL BIOL, V125, P137, DOI 10.1016/0022-2836(78)90342-X
   Hongo C, 2001, POLYM J, V33, P812
   HOPPE HJ, 1994, PROTEIN SCI, V3, P1143, DOI 10.1002/pro.5560030801
   HULMES DJS, 1973, J MOL BIOL, V79, P137, DOI 10.1016/0022-2836(73)90275-1
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Kawahara K, 2005, BIOCHEMISTRY-US, V44, P15812, DOI 10.1021/bi051619m
   KIELTY ME, 1993, CONNECTIVE TISSUE IT
   Kramer RZ, 2000, J MOL BIOL, V301, P1191, DOI 10.1006/jmbi.2000.4017
   Kramer RZ, 1999, NAT STRUCT BIOL, V6, P454
   Kramer RZ, 1998, J MOL BIOL, V280, P623, DOI 10.1006/jmbi.1998.1881
   Kramer RZ, 2001, J MOL BIOL, V311, P131, DOI 10.1006/jmbi.2001.4849
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LI ST, 1975, J MOL BIOL, V98, P835, DOI 10.1016/S0022-2836(75)80015-5
   Liu X, 1997, P NATL ACAD SCI USA, V94, P1852, DOI 10.1073/pnas.94.5.1852
   Mechling DE, 2000, J BIOL CHEM, V275, P14532, DOI 10.1074/jbc.275.19.14532
   Myllyharju J, 2003, MATRIX BIOL, V22, P15, DOI 10.1016/S0945-053X(03)00006-4
   Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004
   Nagarajan V, 1998, J BIOCHEM-TOKYO, V124, P1117, DOI 10.1093/oxfordjournals.jbchem.a022229
   Nagarajan V, 1999, J BIOCHEM-TOKYO, V125, P310, DOI 10.1093/oxfordjournals.jbchem.a022288
   Okuyama K, 2006, BIOPOLYMERS, V84, P181, DOI 10.1002/bip.20381
   Okuyama K, 2004, BIOPOLYMERS, V76, P367, DOI 10.1002/bip.20107
   OKUYAMA K, 1981, J MOL BIOL, V152, P427, DOI 10.1016/0022-2836(81)90252-7
   OKUYAMA K, 1972, J MOL BIOL, V72, P571, DOI 10.1016/0022-2836(72)90175-1
   Okuyama K, 2006, BIOPOLYMERS, V84, P421, DOI 10.1002/bip.20499
   PROCKOP DJ, 1979, NEW ENGL J MED, V301, P13, DOI 10.1056/NEJM197907053010104
   RAMACHANDRAN GN, 1954, NATURE, V174, P269, DOI 10.1038/174269c0
   RICH A, 1955, NATURE, V176, P915, DOI 10.1038/176915a0
   Schumacher M, 2005, J BIOL CHEM, V280, P20397, DOI 10.1074/jbc.M501453200
   Schumacher MA, 2006, J BIOL CHEM, V281, P27566, DOI 10.1074/jbc.M602797200
   Smith LT, 1997, J INVEST DERMATOL, V108, P241, DOI 10.1111/1523-1747.ep12286441
   SUGETA H, 1967, BIOPOLYMERS, V5, P673, DOI 10.1002/bip.1967.360050708
   Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839
   TORCHIA DA, 1976, J MOL BIOL, V104, P315, DOI 10.1016/0022-2836(76)90018-8
   TRUS BL, 1976, J MOL BIOL, V108, P705, DOI 10.1016/S0022-2836(76)80113-1
   VENUGOPAL MG, 1994, BIOCHEMISTRY-US, V33, P7948, DOI 10.1021/bi00191a023
NR 59
TC 59
Z9 62
U1 0
U2 7
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 21
PY 2008
VL 283
IS 47
BP 32580
EP 32589
DI 10.1074/jbc.M805394200
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 372HW
UT WOS:000260893700047
PM 18805790
OA Other Gold
DA 2021-01-25
ER

PT J
AU Musante, V
   Longordo, F
   Neri, E
   Pedrazzi, M
   Kalfas, F
   Severi, P
   Raiteri, M
   Pittaluga, A
AF Musante, Veronica
   Longordo, Fabio
   Neri, Elisa
   Pedrazzi, Marco
   Kalfas, Fotios
   Severi, Paolo
   Raiteri, Maurizio
   Pittaluga, Anna
TI RANTES Modulates the Release of Glutamate in Human Neocortex
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE human RANTES; human neocortex; basal glutamate release; evoked glutamate
   release; chemokine receptors; cytokine
ID CEREBROCORTICAL NERVE-TERMINALS; MULTIPLE-SCLEROSIS PATIENTS;
   EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CHEMOKINE-RECEPTOR
   EXPRESSION; VIRUS TYPE-1 INFECTION; CHEMOTACTIC MIGRATION;
   CEREBROSPINAL-FLUID; BETA-CHEMOKINES; HUMAN BRAIN; IN-VITRO
AB The effects of the recombinant chemokine human RANTES (hRANTES) on the release of glutamate from human neocortex glutamatergic nerve endings were investigated. hRANTES facilitated the spontaneous release of d [H-3]D-aspartate ([H-3]D-ASP) by binding Pertussis toxin-sensitive G-protein-coupled receptors (GPCRs), whose activation caused Ca2+ mobilization from inositol trisphosphate-sensitive stores and cytosolic tyrosine kinase-mediated phosphorylations. Facilitation of release switched to inhibition when the effects of hRANTES on the 12mM K+-evoked [H-3]D-ASP exocytosis were studied. Inhibition of exocytosis relied on activation of Pertussis toxin-sensitive GPCRs negatively coupled to adenylyl cyclase. Both hRANTES effects were prevented by met-RANTES, an antagonist at the chemokine receptors (CCRs) of the CCR1, CCR3, and CCR5 subtypes. Interestingly, human neocortex glutamatergic nerve endings seem to possess all three receptor subtypes. Blockade of CCR1 and CCR5 by antibodies against the extracellular domain of CCRs prevented both the hRANTES effect on [H-3]D-ASP release, whereas blockade of CCR3 prevented inhibition, but not facilitation, of release. The effects of RANTES on the spontaneous and the evoked release of [H-3]D-ASP were also observed in experiments with mouse cortical synaptosomes, which may therefore represent an appropriate animal model to study RANTES-induced effects on neurotransmission. It is concluded that glutamate transmission can be modulated in opposite directions by RANTES acting at distinct CCR receptor subtypes coupled to different transduction pathways, consistent with the multiple and sometimes contrasting effects of the chemokine.
C1 [Musante, Veronica; Neri, Elisa; Raiteri, Maurizio; Pittaluga, Anna] Univ Genoa, Sect Pharmacol & Toxicol, Dept Expt Med, I-16148 Genoa, Italy.
   [Pedrazzi, Marco] Univ Genoa, Sect Biochem, Dept Expt Med, I-16148 Genoa, Italy.
   [Longordo, Fabio] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kalfas, Fotios; Severi, Paolo] Galliera Hosp, Div Neurosurg, I-16128 Genoa, Italy.
   [Raiteri, Maurizio; Pittaluga, Anna] Univ Genoa, Ctr Excellence Biomed Res, I-16132 Genoa, Italy.
RP Pittaluga, A (corresponding author), Univ Genoa, Sect Pharmacol & Toxicol, Dept Expt Med, Viale Cembrano, I-16148 Genoa, Italy.
EM pittalug@pharmatox.unige.it
RI Pittaluga, Anna/C-5960-2008
FU Istituto Superiore di Sanita; Fondazione Italiana Sclerosi
   MultiplaFondazione Italiana Sclerosi Multipla (FISM) [2005/R/17];
   Ministero dell'Istruzione, dell'Universita e della Ricerca Scientifica
   ProjectMinistry of Education, Universities and Research (MIUR)
   [2004052809_004, 2003053993]; Department of Immunology and Oncology
FX This work was supported by grants from Istituto Superiore di Sanita
   (Quinto Programma Nazionale di Ricerca sull'AIDS: Progetto "Patologia,
   Clinica e Terapia dell'AIDS"), from Fondazione Italiana Sclerosi
   Multipla (cod. 2005/R/17), and from Ministero dell'Istruzione,
   dell'Universita e della Ricerca Scientifica Project numbers
   2004052809_004 (A. P.) and 2003053993 (M. R.). We thank the Department
   of Immunology and Oncology, the National Institute for Biological
   Standards and Control (NIBSC) Centralised Facility for AIDS reagents
   (European Union Programme EVA, contract QLKZ-CT-1999-00609), and the
   United Kingdom Medical Research Council (Hertfordshire, UK) for kindly
   supplying us with anti-CCR5 antibody and with human recombinant RANTES
   (NIBSC 92/520). We thank Maura Agate and Silvia E. Smith for careful
   editorial assistance.
CR Amella CA, 2005, J VIROL, V79, P5625, DOI 10.1128/JVI.79.9.5625-5631.2005
   BAGGIOLINI M, 1994, ADV IMMUNOL, V55, P97
   Bajetto A, 2002, J NEUROCHEM, V82, P1311, DOI 10.1046/j.1471-4159.2002.01091.x
   Besong G, 2002, J NEUROSCI, V22, P5403
   Blanpain C, 2002, MOL BIOL CELL, V13, P723, DOI 10.1091/mbc.01-03-0129
   Bolin LM, 1998, J NEUROIMMUNOL, V81, P49, DOI 10.1016/S0165-5728(97)00158-6
   Boutet A, 2001, NEUROSCI LETT, V311, P105, DOI 10.1016/S0304-3940(01)02149-8
   BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3
   Cartier L, 2005, BRAIN RES REV, V48, P16, DOI 10.1016/j.brainresrev.2004.07.021
   Cho C, 2002, J NEUROVIROL, V8, P573, DOI 10.1080/13550280290101003
   DUNKLEY PR, 1986, BRAIN RES, V372, P115, DOI 10.1016/0006-8993(86)91464-2
   El-Asmar L, 2005, MOL PHARMACOL, V67, P460, DOI 10.1124/mol.104.003624
   Elsner J, 1999, INT ARCH ALLERGY IMM, V118, P462, DOI 10.1159/000024164
   Gafni J, 1997, NEURON, V19, P723, DOI 10.1016/S0896-6273(00)80384-0
   Ganor Y, 2003, J IMMUNOL, V170, P4362, DOI 10.4049/jimmunol.170.8.4362
   Gillard SE, 2002, J NEUROIMMUNOL, V124, P16, DOI 10.1016/S0165-5728(02)00005-X
   Grilli M, 2004, NEUROPHARMACOLOGY, V46, P388, DOI 10.1016/j.neuropharm.2003.09.012
   Heath H, 1997, J CLIN INVEST, V99, P178, DOI 10.1172/JCI119145
   Hegg CC, 2000, NEUROSCIENCE, V98, P191, DOI 10.1016/S0306-4522(00)00101-9
   Iarlori C, 2000, J NEUROIMMUNOL, V107, P100, DOI 10.1016/S0165-5728(00)00261-7
   Ignatov A, 2006, BRIT J PHARMACOL, V149, P490, DOI 10.1038/sj.bjp.0706909
   Karpus WJ, 1998, J IMMUNOL, V161, P2667
   Kaul M, 2007, CELL DEATH DIFFER, V14, P296, DOI 10.1038/sj.cdd.4402006
   Kaul M, 1999, P NATL ACAD SCI USA, V96, P8212, DOI 10.1073/pnas.96.14.8212
   Kelder W, 1998, ANN NEUROL, V44, P831, DOI 10.1002/ana.410440521
   Klein RS, 1999, J IMMUNOL, V163, P1636
   Kolb SA, 1999, J NEUROIMMUNOL, V93, P172, DOI 10.1016/S0165-5728(98)00223-9
   LEVI G, 1993, TRENDS NEUROSCI, V16, P415, DOI 10.1016/0166-2236(93)90010-J
   Longordo F, 2006, J PHARMACOL EXP THER, V317, P1097, DOI 10.1124/jpet.105.099630
   Losada SA, 2002, NEUROBIOL DIS, V11, P469, DOI 10.1006/nbdi.2002.0566
   McManus CM, 2000, AM J PATHOL, V156, P1441, DOI 10.1016/S0002-9440(10)65013-4
   Mellado M, 2001, EMBO J, V20, P2497, DOI 10.1093/emboj/20.10.2497
   Meucci O, 1998, P NATL ACAD SCI USA, V95, P14500, DOI 10.1073/pnas.95.24.14500
   Millan C, 2003, J NEUROCHEM, V87, P1101, DOI 10.1046/j.1471-4159.2003.02065.x
   Mueller A, 2002, BRIT J PHARMACOL, V135, P1033, DOI 10.1038/sj.bjp.0704540
   MYERS SJ, 1995, J BIOL CHEM, V270, P5786, DOI 10.1074/jbc.270.11.5786
   Oh SB, 2002, J NEUROIMMUNOL, V123, P66, DOI 10.1016/S0165-5728(01)00485-4
   Oh SB, 2001, J NEUROSCI, V21, P5027, DOI 10.1523/JNEUROSCI.21-14-05027.2001
   Proudfoot AEI, 1999, J BIOL CHEM, V274, P32478, DOI 10.1074/jbc.274.45.32478
   Raiteri L, 2000, NEUROCHEM RES, V25, P1265, DOI 10.1023/A:1007648229795
   Raiteri M, 2000, J NEUROCHEM, V74, P423, DOI 10.1046/j.1471-4159.2000.0740423.x
   Raiteri M, 2006, PHARMACOL REV, V58, P162, DOI 10.1124/pr.58.2.5
   RANSOHOFF RM, 1993, FASEB J, V7, P592
   Rousseau SJ, 2005, NEUROPHARMACOLOGY, V49, P59, DOI 10.1016/j.neuropharm.2005.01.030
   Sarchielli P, 2007, J NEUROIMMUNOL, V188, P146, DOI 10.1016/j.jneuroim.2007.05.021
   Sorensen TL, 1999, J CLIN INVEST, V103, P807, DOI 10.1172/JCI5150
   Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005
   Thellung S, 2007, ANN NY ACAD SCI, V1096, P258, DOI 10.1196/annals.1397.092
   Ubogu EE, 2006, TRENDS PHARMACOL SCI, V27, P48, DOI 10.1016/j.tips.2005.11.002
   van der Meer P, 2000, EXP MOL PATHOL, V69, P192, DOI 10.1006/exmp.2000.2336
   Wang SJ, 2003, NEUROPHARMACOLOGY, V44, P686, DOI 10.1016/S0028-3908(03)00045-5
   Wang SJ, 2006, J NEUROSCI RES, V84, P1528, DOI 10.1002/jnr.21060
   Watson C, 2005, MOL PHARMACOL, V67, P1268, DOI 10.1124/mol.104.008565
   Wells TNC, 2006, TRENDS PHARMACOL SCI, V27, P41, DOI 10.1016/j.tips.2005.11.001
   Zhao J, 1998, J CELL BIOCHEM, V71, P36, DOI 10.1002/(SICI)1097-4644(19981001)71:1<36::AID-JCB4>3.0.CO;2-2
NR 55
TC 41
Z9 41
U1 0
U2 2
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
J9 J NEUROSCI
JI J. Neurosci.
PD NOV 19
PY 2008
VL 28
IS 47
BP 12231
EP 12240
DI 10.1523/JNEUROSCI.3212-08.2008
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 376NT
UT WOS:000261191000010
PM 19020017
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Reiterer, V
   Maier, S
   Sitte, HH
   Kriz, A
   Ruegg, MA
   Hauri, HP
   Freissmuth, M
   Farhan, H
AF Reiterer, Veronika
   Maier, Susanne
   Sitte, Harald H.
   Kriz, Alexander
   Rueegg, Markus A.
   Hauri, Hans-Peter
   Freissmuth, Michael
   Farhan, Hesso
TI Sec24-and ARFGAP1-Dependent Trafficking of GABA Transporter-1 Is a
   Prerequisite for Correct Axonal Targeting
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE GABA transporter-1; axonal targeting; ARFGAP1; COPII; Sec24; endoplasmic
   reticulum export
ID GOLGI INTERMEDIATE COMPARTMENT; ENDOPLASMIC-RETICULUM; PRE-GOLGI;
   TRANSLOCATION MACHINERY; MEMBRANE-PROTEINS; CELL-LINE; COMPLEX; CARGO;
   ER; BINDING
AB The GABA transporter-1 (GAT1) is a prototypical protein of the synaptic specialization. Export of GAT1 from the endoplasmic reticulum (ER) is contingent on its interaction with the COPII (coatomer protein-II) coat subunit Sec24D. Here we show that silencing all four Sec24 isoforms strongly inhibits transport of GAT1 to the cell surface. In contrast, transport of GAT1-RL/AS, a mutant that is deficient in Sec24D recruitment, was not inhibited, suggesting a nonconventional, COPII-independent pathway. However, ARFGAP1 bound directly to the C terminus of both GAT1-RL/AS and wild-type GAT1. Surface expression of GAT1-RL/AS involved ARFGAP1. GAT1-RL/AS appeared to bypass the ER-Golgi-intermediate compartment, but its pathway to the plasma membrane still involved passage through the Golgi. Thus, the GAT1-RL/AS mutant allowed to test whether COPII-dependent ER-export is required for correct sorting of GAT1 to the axon terminal in neuronal cells. In contrast to wild-type GAT1, GAT1-RL/AS failed to be specifically enriched at the tip of neurite extensions of CAD. a cells (a neuroblastoma cell line that can be differentiated into a neuron-like phenotype) and in the axon terminals of hippocampal neurons. These findings indicate that correct sorting to the axon is contingent on ER export via the COPII machinery and passage through the ER-Golgi-intermediate compartment.
C1 [Reiterer, Veronika; Maier, Susanne; Sitte, Harald H.; Freissmuth, Michael; Farhan, Hesso] Med Univ Vienna, Inst Pharmacol, A-1090 Vienna, Austria.
   [Kriz, Alexander; Rueegg, Markus A.; Hauri, Hans-Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Freissmuth, M (corresponding author), Med Univ Vienna, Inst Pharmacol, Waehringer Str 13, A-1090 Vienna, Austria.
EM michael.freissmuth@meduniwien.ac.at
RI Farhan, Hesso/C-7997-2012; Ruegg, Markus/X-7256-2019; Sitte,
   Harald/O-7025-2019; Sitte, Harald/N-2681-2013
OI Farhan, Hesso/0000-0002-0889-8463; Ruegg, Markus/0000-0002-4974-9384;
   Sitte, Harald/0000-0002-1339-7444; Sitte, Harald/0000-0002-1339-7444;
   Freissmuth, Michael/0000-0001-9398-1765
FU Austrian National Bank [10507]; Austrian Science FundAustrian Science
   Fund (FWF) [P18072]; FWFAustrian Science Fund (FWF) [SFB-35, J2680]
FX This work was supported by grants from the Austrian National Bank
   (10507) and from the Austrian Science Fund (FWF) P18072 and the FWF-
   sponsored SFB-35. H. F. is a recipient of a Schrodinger Fellowship from
   the FWF (J2680). We thank Julie Donaldson and Jennifer
   Lippincott-Schwartz for generous gifts of plasmids. We thank Dan Cassel
   for ARFGAP1 expression vectors, for anti-ARFGAP1 antibody, and for his
   comments on this manuscript.
CR Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019
   Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615
   Chiu CS, 2002, J NEUROSCI, V22, P10251
   CUKIERMAN E, 1995, SCIENCE, V270, P1999, DOI 10.1126/science.270.5244.1999
   Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200
   Farhan H, 2006, HANDB EXP PHARM, V175, P233
   Farhan H, 2008, J CELL SCI, V121, P753, DOI 10.1242/jcs.017681
   Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200
   Gomez M, 2000, J BIOL CHEM, V275, P29162, DOI 10.1074/jbc.M003630200
   GRIFFITHS G, 1985, J CELL BIOL, V101, P949, DOI 10.1083/jcb.101.3.949
   GUO Q, 1994, J CELL BIOL, V125, P1213, DOI 10.1083/jcb.125.6.1213
   Guo W, 2004, TRENDS CELL BIOL, V14, P61, DOI 10.1016/j.tcb.2003.12.008
   Hauri HP, 2000, J CELL SCI, V113, P587
   Horton AC, 2005, NEURON, V48, P757, DOI 10.1016/j.neuron.2005.11.005
   Huber I, 1998, J BIOL CHEM, V273, P24786, DOI 10.1074/jbc.273.38.24786
   KRIJNSELOCKER J, 1995, MOL BIOL CELL, V6, P1315
   Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307
   Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008
   Li YL, 2007, J NEUROSCI RES, V85, P2601, DOI 10.1002/jnr.21216
   Lipschutz JH, 2003, J BIOL CHEM, V278, P20954, DOI 10.1074/jbc.M213210200
   Manzano J, 2007, ENDOCRINOLOGY, V148, P5746, DOI 10.1210/en.2007-0567
   McHugh EM, 2004, MOL CELL NEUROSCI, V26, P406, DOI 10.1016/j.mcn.2004.03.006
   Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X
   Nickel W, 1998, J CELL SCI, V111, P3081
   Pepperkok R, 2000, J CELL SCI, V113, P135
   PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2
   Pierce JP, 2000, NAT NEUROSCI, V3, P311
   Qi YP, 1997, J NEUROSCI, V17, P1217
   Quick MW, 1997, J NEUROSCI, V17, P2967
   Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092
   Sannerud R, 2006, MOL BIOL CELL, V17, P1514, DOI 10.1091/mbc.E05-08-0792
   Sans N, 2005, NAT CELL BIOL, V7, P1179, DOI 10.1038/ncb1325
   SARASTE J, 1984, CELL, V38, P535, DOI 10.1016/0092-8674(84)90508-7
   Scheffzek K, 1997, SCIENCE, V277, P333, DOI 10.1126/science.277.5324.333
   Schmid JA, 2001, J BIOL CHEM, V276, P3805, DOI 10.1074/jbc.M007357200
   Scholze P, 2002, J BIOL CHEM, V277, P43682, DOI 10.1074/jbc.M205602200
   SCHWEIZER A, 1990, EUR J CELL BIOL, V53, P185
   Shima DT, 1999, CURR BIOL, V9, P821, DOI 10.1016/S0960-9822(99)80365-0
   Shin DM, 2000, J CELL BIOL, V150, P1101, DOI 10.1083/jcb.150.5.1101
   Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893
   Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135
   Ye B, 2007, CELL, V130, P717, DOI 10.1016/j.cell.2007.06.032
   Yu S, 2002, MOL BIOL CELL, V13, P2559, DOI 10.1091/mbc.E02-04-0189
NR 43
TC 26
Z9 26
U1 0
U2 0
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
EI 1529-2401
J9 J NEUROSCI
JI J. Neurosci.
PD NOV 19
PY 2008
VL 28
IS 47
BP 12453
EP 12464
DI 10.1523/JNEUROSCI.3451-08.2008
PG 12
WC Neurosciences
SC Neurosciences & Neurology
GA 376NT
UT WOS:000261191000031
PM 19020038
OA Green Accepted, Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Polak, P
   Cybulski, N
   Feige, JN
   Auwerx, J
   Ruegg, MA
   Hall, MN
AF Polak, Pazit
   Cybulski, Nadine
   Feige, Jerome N.
   Auwerx, Johan
   Rueegg, Markus A.
   Hall, Michael N.
TI Adipose-Specific Knockout of raptor Results in Lean Mice with Enhanced
   Mitochondrial Respiration
SO CELL METABOLISM
LA English
DT Article
ID CHRONOLOGICAL LIFE-SPAN; DIET-INDUCED OBESITY; P70 S6 KINASE; HIGH-FAT
   DIET; MAMMALIAN TARGET; INSULIN-RESISTANCE; ADIPOCYTE DIFFERENTIATION;
   PREADIPOCYTE DIFFERENTIATION; BINDING PARTNER; ENDOCRINE ORGAN
AB raptor is a specific and essential component of mammalian TOR complex 1 (mTORC1), a key regulator of cell growth and metabolism. To investigate a role of adipose mTORC1 in regulation of adipose and whole-body metabolism, we generated mice with an adipose-specific knockout of raptor (raptor(ad-/-)). Compared to control littermates, raptor(ad-1-) mice had substantially less adipose tissue, were protected against diet-induced obesity and hypercholesterolemia, and exhibited improved insulin sensitivity. Leanness was in spite of reduced physical activity and unaffected caloric intake, lipolysis, and absorption of lipids from the food. White adipose tissue of raptor(ad-/-) mice displayed enhanced expression of genes encoding mitochondrial uncoupling proteins characteristic of brown fat. Leanness of the raptorad-1- mice was attributed to elevated energy expenditure due to mitochondrial uncoupling. These results suggest that adipose mTORC1 is a regulator of adipose metabolism and, thereby, controls wholebody energy homeostasis.
C1 [Polak, Pazit; Cybulski, Nadine; Rueegg, Markus A.; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Feige, Jerome N.; Auwerx, Johan] Univ Strasbourg 1, INSERM, CNRS, Inst Clin Souris,Inst Genet & Biol Mol & Cellulai, F-67404 Illkirch Graffenstaden, France.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU Roche Research Foundation; FEES; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); Canton of Basel
FX We thank K. Beier and I. Ginez for assistance with histological
   analysis; T. Harach for assistance with the glucose tolerance test: A.
   Hein and P. Demougin for help with qPCR; J. Zoll, A.L. Lang, and B. Geny
   for valuable discussions and technical assistance with Clark electrode
   measurements; A. Loschmann for technical assistance with genotyping and
   histology; and T. Sorg, X. Warot, and M.F. Champy for contributions to
   generation and phenotyping of knockout mice. We thank K. Thomas and
   members of the Hall, Ruegg, and Auwerx groups for helpful discussions.
   We acknowledge support from the Roche Research Foundation (P.P.), FEES
   (J.N.F.), and the Swiss National Science Foundation and the Canton of
   Basel (M.A.R. and M.N.H.). We declare that no competing interests exist.
CR Aguilar V, 2007, CELL METAB, V5, P476, DOI 10.1016/j.cmet.2007.05.006
   Bell A, 2000, OBES RES, V8, P249, DOI 10.1038/oby.2000.29
   Bentzinger CF, 2008, CELL METAB, V8, P411, DOI 10.1016/j.cmet.2008.10.002
   Beretta L, 1996, EMBO J, V15, P658, DOI 10.1002/j.1460-2075.1996.tb00398.x
   Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188
   Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009
   Brand MD, 2005, CELL METAB, V2, P85, DOI 10.1016/j.cmet.2005.06.002
   Brunn GJ, 1997, SCIENCE, V277, P99, DOI 10.1126/science.277.5322.99
   Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432
   Cederberg A, 2001, CELL, V106, P563, DOI 10.1016/S0092-8674(01)00474-3
   Cho HJ, 2004, BIOCHEM BIOPH RES CO, V321, P942, DOI 10.1016/j.bbrc.2004.07.050
   Christian M, 2005, MOL CELL BIOL, V25, P9383, DOI 10.1128/MCB.25.21.9383-9391.2005
   Considine RV, 1996, NEW ENGL J MED, V334, P292, DOI 10.1056/NEJM199602013340503
   Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dowling RJO, 2007, CANCER RES, V67, P10804, DOI 10.1158/0008-5472.CAN-07-2310
   El-Chaar D, 2004, INT J OBESITY, V28, P191, DOI 10.1038/sj.ijo.0802554
   Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001
   Gagnon A, 2001, J CELL PHYSIOL, V189, P14, DOI 10.1002/jcp.1132
   Gimeno RE, 2005, CURR OPIN PHARMACOL, V5, P122, DOI 10.1016/j.coph.2005.01.006
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Gwinn DM, 2008, MOL CELL, V30, P214, DOI 10.1016/j.molcel.2008.03.003
   Hansen JB, 2004, P NATL ACAD SCI USA, V101, P4112, DOI 10.1073/pnas.0301964101
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704
   He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033
   Kaeberlein M, 2005, SCIENCE, V310, P1193, DOI 10.1126/science.1115535
   Kaeberlein M, 2007, AGEING RES REV, V6, P128, DOI 10.1016/j.arr.2007.04.001
   Kapahi P, 2004, CURR BIOL, V14, P885, DOI 10.1016/j.cub.2004.03.059
   Kershaw EE, 2004, J CLIN ENDOCR METAB, V89, P2548, DOI 10.1210/jc.2004-0395
   Kim DH, 2003, MOL CELL, V11, P895, DOI 10.1016/S1097-2765(03)00114-X
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kim JE, 2004, DIABETES, V53, P2748, DOI 10.2337/diabetes.53.11.2748
   Kiskinis E, 2007, EMBO J, V26, P4831, DOI 10.1038/sj.emboj.7601908
   Krebs M, 2007, DIABETES, V56, P1600, DOI 10.2337/db06-1016
   Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5
   Le Bacquer O, 2007, J CLIN INVEST, V117, P387, DOI 10.1172/JCI29528
   LEMONNIER D, 1972, J CLIN INVEST, V51, P2907, DOI 10.1172/JCI107115
   Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Nicholls DG, 2001, BIOCHEM SOC T, V29, P751, DOI 10.1042/bst0290751
   Pende M, 2000, NATURE, V408, P994
   Powers RW, 2006, GENE DEV, V20, P174, DOI 10.1101/gad.1381406
   Puigserver P, 1998, CELL, V92, P829, DOI 10.1016/S0092-8674(00)81410-5
   Rovira J, 2008, TRANSPL INT, V21, P992, DOI 10.1111/j.1432-2277.2008.00710.x
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Scime A, 2005, CELL METAB, V2, P283, DOI 10.1016/j.cmet.2005.10.002
   Seale P, 2007, CELL METAB, V6, P38, DOI 10.1016/j.cmet.2007.06.001
   Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026
   Shaw RJ, 2005, SCIENCE, V310, P1642, DOI 10.1126/science.1120781
   Shaw RJ, 2004, CANCER CELL, V6, P91, DOI 10.1016/j.ccr.2004.06.007
   Shi YG, 2004, NAT REV DRUG DISCOV, V3, P695, DOI 10.1038/nrd1469
   TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X
   Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006
   Ueno M, 2005, DIABETOLOGIA, V48, P506, DOI 10.1007/s00125-004-1662-6
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547
   Vellai T, 2003, NATURE, V426, P620, DOI 10.1038/426620a
   Weisberg SP, 2006, J CLIN INVEST, V116, P115, DOI 10.1172/JCI24335
   Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451
   Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206
   YEH WC, 1995, P NATL ACAD SCI USA, V92, P11086, DOI 10.1073/pnas.92.24.11086
NR 70
TC 341
Z9 350
U1 1
U2 24
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1550-4131
J9 CELL METAB
JI Cell Metab.
PD NOV 5
PY 2008
VL 8
IS 5
BP 399
EP 410
DI 10.1016/j.cmet.2008.09.003
PG 12
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 369DU
UT WOS:000260675300007
PM 19046571
DA 2021-01-25
ER

PT J
AU Bentzinger, CF
   Romanino, K
   Cloetta, D
   Lin, S
   Mascarenhas, JB
   Oliveri, F
   Xia, JY
   Casanova, E
   Costa, CF
   Brink, M
   Zorzato, F
   Hall, MN
   Ruegg, MA
AF Bentzinger, C. Florian
   Romanino, Klaas
   Cloetta, Dimitri
   Lin, Shuo
   Mascarenhas, Joseph B.
   Oliveri, Filippo
   Xia, Jinyu
   Casanova, Emilio
   Costa, Celine F.
   Brink, Marijke
   Zorzato, Francesco
   Hall, Michael N.
   Rueegg, Markus A.
TI Skeletal Muscle-Specific Ablation of raptor, but Not of rictor, Causes
   Metabolic Changes and Results in Muscle Dystrophy
SO CELL METABOLISM
LA English
DT Article
ID TRANSCRIPTIONAL COACTIVATOR PGC-1-ALPHA; FIBER-TYPE; SIGNALING PATHWAYS;
   MAMMALIAN TARGET; PROTEIN-KINASE; RAPAMYCIN MTOR; CELL-CYCLE; MDX MICE;
   ATROPHY; GROWTH
AB Mammalian target of rapamycin (mTOR) is a central controller of cell growth. mTOR assembles into two distinct multiprotein complexes called mTOR complex 1 (mTORC1) and mTORC2. Here we show that the mTORC1 component raptor is critical for muscle function and prolonged survival. In contrast, muscles lacking the mTORC2 component rictor are indistinguishable from wild-type controls. Raptor-deficient muscles become progressively dystrophic, are impaired in their oxidative capacity, and contain increased glycogen stores, but they express structural components indicative of oxidative muscle fibers. Biochemical analysis indicates that these changes are probably due to loss of activation of direct downstream targets of mTORC1, downregulation of genes involved in mitochondrial biogenesis, including PGC1 alpha, and hyperactivation of PKB/Akt. Finally, we show that activation of PKB/Akt does not require mTORC2. Together, these results demonstrate that muscle mTORC1 has an unexpected role in the regulation of the metabolic properties and that its function is essential for life.
C1 [Bentzinger, C. Florian; Romanino, Klaas; Cloetta, Dimitri; Lin, Shuo; Mascarenhas, Joseph B.; Oliveri, Filippo; Costa, Celine F.; Hall, Michael N.; Rueegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Xia, Jinyu; Zorzato, Francesco] Univ Basel Hosp, Dept Anesthesia, CH-4031 Basel, Switzerland.
   [Xia, Jinyu; Zorzato, Francesco] Univ Basel Hosp, Dept Biomed, CH-4031 Basel, Switzerland.
   [Casanova, Emilio; Brink, Marijke] Univ Basel, Inst Physiol, Dept Biomed, CH-4056 Basel, Switzerland.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Bentzinger, C. Florian/A-1151-2015; Ruegg, Markus/X-7256-2019; Casanova,
   Emilio/Y-6553-2019
OI Ruegg, Markus/0000-0002-4974-9384; Casanova, Emilio/0000-0001-7992-5361;
   Bentzinger, C. Florian/0000-0003-0422-9622; Brink,
   Marijke/0000-0002-1790-0190; Mascarenhas, Joseph B/0000-0002-4735-3140
FU Swiss National Science FoundationAssociation Francaise contres les
   MyopathiesSwiss National Science Foundation (SNSF); Swiss Foundation for
   Research on Muscle Disease; The Roche Research Foundation
FX We thank people of the Transgenic Mouse Core Facility of the University
   of Basel, in particular D. Klewe Nebenius, for their help in generating
   the floxed mice. We are indebted to Drs. A. Felley and T. Pedrazzini at
   the Rodent Cardiovascular Assessment Facility of the University of
   Lausanne for echocardiography measurements and U. Sauder from the
   Microscopy Center of the University of Basel for assistance with
   electron microscopy. We thank Drs. D. Glass, T. Meier, and M. Sandri for
   reading the manuscript. This work was supported by the Cantons of
   Basel-Stadt and Baselland, grants from the Swiss National Science
   Foundation (M.N.H. and M.A.R.), the Association Francaise contres les
   Myopathies (F.Z.), and the Swiss Foundation for Research on Muscle
   Disease (M.A.R.). C.F.B. is a recipient of a fellowship from The Roche
   Research Foundation.
CR Alessi DR, 1997, CURR BIOL, V7, P261, DOI 10.1016/S0960-9822(06)00122-9
   AUSTYN JM, 1981, EUR J IMMUNOL, V11, P805, DOI 10.1002/eji.1830111013
   Bassel-Duby R, 2006, ANNU REV BIOCHEM, V75, P19, DOI 10.1146/annurev.biochem.75.103004.142622
   Bayascas JR, 2005, MOL CELL, V18, P143, DOI 10.1016/j.molcel.2005.03.020
   Beals CR, 1997, SCIENCE, V275, P1930, DOI 10.1126/science.275.5308.1930
   Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014
   Bozulic L, 2008, MOL CELL, V30, P203, DOI 10.1016/j.molcel.2008.02.024
   Cunningham JT, 2007, NATURE, V450, P736, DOI 10.1038/nature06322
   Dunant P, 2003, MOL THER, V8, P80, DOI 10.1016/S1525-0016(03)00129-1
   Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018
   GOLLNICK PD, 1991, ACTA PHYSIOL SCAND, V142, P135, DOI 10.1111/j.1748-1716.1991.tb09139.x
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Handschin C, 2007, J BIOL CHEM, V282, P30014, DOI 10.1074/jbc.M704817200
   Harrington LS, 2004, J CELL BIOL, V166, P213, DOI 10.1083/jcb.200403069
   HEITMAN J, 1991, SCIENCE, V253, P905, DOI 10.1126/science.1715094
   Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Kumar A, 2008, MOL CELL BIOL, V28, P61, DOI 10.1128/MCB.01405-07
   Laws N, 2004, J APPL PHYSIOL, V97, P1970, DOI 10.1152/japplphysiol.01357.2003
   Leone TC, 2005, PLOS BIOL, V3, P672, DOI 10.1371/journal.pbio.0030101
   Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904
   Manning BD, 2004, J CELL BIOL, V167, P399, DOI 10.1083/jcb.200408161
   Ohanna M, 2005, NAT CELL BIOL, V7, P286, DOI 10.1038/ncb1231
   Pallafacchina G, 2002, P NATL ACAD SCI USA, V99, P9213, DOI 10.1073/pnas.142166599
   Polak P, 2008, CELL METAB, V8, P399, DOI 10.1016/j.cmet.2008.09.003
   Popovic ZB, 2005, J PHYSIOL-LONDON, V568, P255, DOI 10.1113/jphysiol.2005.090779
   Potthoff MJ, 2007, J CLIN INVEST, V117, P2459, DOI 10.1172/JCI31960
   Ringelmann B, 1999, EXP CELL RES, V246, P165, DOI 10.1006/excr.1998.4244
   Rodriguez CI, 2000, NAT GENET, V25, P139, DOI 10.1038/75973
   Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009
   Sakamoto K, 2002, J APPL PHYSIOL, V93, P369, DOI 10.1152/japplphysiol.00167.2002
   Sandri M, 2004, CELL, V117, P399, DOI 10.1016/S0092-8674(04)00400-3
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schieke SM, 2006, J BIOL CHEM, V281, P27643, DOI 10.1074/jbc.M603536200
   Schwander M, 2003, DEV CELL, V4, P673, DOI 10.1016/S1534-5807(03)00118-7
   Sewry CA, 2002, NEUROMUSCULAR DISORD, V12, P930, DOI 10.1016/S0960-8966(02)00135-9
   Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013
   Song XM, 1999, AM J PHYSIOL-REG I, V277, pR1690
   Sorokin LM, 1997, DEV BIOL, V189, P285, DOI 10.1006/dbio.1997.8668
   Stitt TN, 2004, MOL CELL, V14, P395, DOI 10.1016/S1097-2765(04)00211-4
   Treves S, 2008, CURR OPIN PHARMACOL, V8, P319, DOI 10.1016/j.coph.2008.01.005
   Tsang CK, 2007, DRUG DISCOV TODAY, V12, P112, DOI 10.1016/j.drudis.2006.12.008
   Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866
   Wende AR, 2007, J BIOL CHEM, V282, P36642, DOI 10.1074/jbc.M707006200
   Wiedmann M, 2005, J NEUROSCI RES, V81, P226, DOI 10.1002/jnr.20556
   Winkel LPF, 2005, J NEUROL, V252, P875, DOI 10.1007/s00415-005-0922-9
   Wu H, 2000, EMBO J, V19, P1963, DOI 10.1093/emboj/19.9.1963
   Wu H, 2007, TRENDS CELL BIOL, V17, P251, DOI 10.1016/j.tcb.2007.04.006
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 50
TC 417
Z9 425
U1 0
U2 20
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1550-4131
J9 CELL METAB
JI Cell Metab.
PD NOV 5
PY 2008
VL 8
IS 5
BP 411
EP 424
DI 10.1016/j.cmet.2008.10.002
PG 14
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 369DU
UT WOS:000260675300008
PM 19046572
DA 2021-01-25
ER

PT J
AU Padavattan, S
   Schmidt, M
   Hoffman, DR
   Markovic-Housley, Z
AF Padavattan, Sivaraman
   Schmidt, Margit
   Hoffman, Donald R.
   Markovic-Housley, Zora
TI Crystal Structure of the Major Allergen from Fire Ant Venom, Sol i 3
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE major fire ant allergen; Sol i 3; crystal structure; cross-reactivity
ID HYMENOPTERA VENOM; CROSS-REACTIVITY; PROTEIN; BEE; COMPLEX;
   IDENTIFICATION; HYALURONIDASE; TRANSITION; EFFICACY; ANTIBODY
AB Fire ant venom is an extremely potent allergy-inducing agent containing four major allergens, Sol i 1 to Sol i 4, which are the most frequent cause of hypersensitivity reactions to hymenoptera in the Southern USA. The crystal structure of recombinant (Baculovirus) major fire ant allergen Sol i 3 has been determined to a resolution of 3.1 angstrom by the method of molecular replacement. The secondary-structure elements of Sol i 3 are arranged in an sandwich fold consisting of a central antiparallel beta-sheet surrounded on both sides by alpha helices. The overall structure is very similar to that of the homologous wasp venom allergen Ves v 5 with major differences occurring in the solvent-exposed loop regions that contain amino acid insertions. Consequently, the limited conservation of surface chemical properties and topology between Sol i 3 and Ves v 5 may explain the observed lack of relevant cross-reactivity. It is concluded that Sol i 3 recognizes immunoglobulin E antibodies with a distinct set of its own epitopes, which are different from those of Ves v 5. Indeed, the molecular area in Sol i 3 covered by non-conserved residues is large enough to accommodate four unique Sol i 3 epitopes. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Padavattan, Sivaraman; Markovic-Housley, Zora] Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
   [Schmidt, Margit] E Carolina Univ, Dept Biol, Greenville, NC 27858 USA.
   [Hoffman, Donald R.] E Carolina Univ, Dept Pathol & Lab Med, Brody Sch Med, Greenville, NC 27834 USA.
RP Markovic-Housley, Z (corresponding author), Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
EM zora.housley@unibas.ch
OI Padavattan, Sivaraman/0000-0002-1732-5421
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [31-116804]; North Carolina Biotechnology Center
FX We thank Rhonda Sakell for technical assistance and the staff at
   synchrotron beam line PX at the Swiss Light Source in Villigen,
   Switzerland. This study was supported by the Swiss National Science
   Foundation grant 31-116804 (to Z.M.-H.) and in part by the North
   Carolina Biotechnology Center (to D.R.H.).
CR Asero R, 2001, INT ARCH ALLERGY IMM, V124, P67, DOI 10.1159/000053671
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   DAVIES DR, 1990, ANNU REV BIOCHEM, V59, P439, DOI 10.1146/annurev.biochem.59.1.439
   DESHAZO RD, 1984, J ALLERGY CLIN IMMUN, V74, P841, DOI 10.1016/0091-6749(84)90188-X
   Fujita C, 2001, INT ARCH ALLERGY IMM, V125, P44, DOI 10.1159/000053795
   Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hawdon JM, 1996, J BIOL CHEM, V271, P6672, DOI 10.1074/jbc.271.12.6672
   Henriksen A, 2001, PROTEINS, V45, P438, DOI 10.1002/prot.1160
   Hoffman DR, 2005, J ALLERGY CLIN IMMUN, V115, P611, DOI 10.1016/j.jaci.2004.11.020
   HOFFMAN DR, 1995, ALLERGY, V50, P535, DOI 10.1111/j.1398-9995.1995.tb01196.x
   HOFFMAN DR, 1988, J ALLERGY CLIN IMMUN, V82, P828, DOI 10.1016/0091-6749(88)90085-1
   Hoffman DR, 2006, CLIN REV ALLERG IMMU, V30, P109, DOI 10.1385/CRIAI:30:2:109
   HOFFMAN DR, 1988, J ALLERGY CLIN IMMUN, V82, P818, DOI 10.1016/0091-6749(88)90084-X
   HOFFMAN DR, 1991, ANN ALLERGY, V66, P29
   HOFFMAN DR, 1985, J ALLERGY CLIN IMMUN, V75, P599, DOI 10.1016/0091-6749(85)90036-3
   HOFFMAN DR, 1993, J ALLERGY CLIN IMMUN, V91, P71, DOI 10.1016/0091-6749(93)90298-T
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   Kulkarni-Kale U, 2005, NUCLEIC ACIDS RES, V33, pW168, DOI 10.1093/nar/gki460
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   LESLIE AGW, 1992, JOINT CCP4 ESF EACBM, V26
   MACCONNELL JG, 1974, ANN ENTOMOL SOC AM, V67, P134, DOI 10.1093/aesa/67.1.134
   Markovic-Housley Z, 2000, STRUCTURE, V8, P1025, DOI 10.1016/S0969-2126(00)00511-6
   Mirza O, 2000, J IMMUNOL, V165, P331, DOI 10.4049/jimmunol.165.1.331
   Muller UR, 2002, ALLERGY, V57, P570, DOI 10.1034/j.1398-9995.2002.02157.x
   Padavattan S, 2007, J MOL BIOL, V368, P742, DOI 10.1016/j.jmb.2007.02.036
   Schmidt M, 2003, ALLERGY, V58, P342, DOI 10.1034/j.1398-9995.2003.00085.x
   SCHMIDT M, 1993, FEBS LETT, V319, P138, DOI 10.1016/0014-5793(93)80053-W
   Schmidt M, 1996, J ALLERGY CLIN IMMUN, V98, P82, DOI 10.1016/S0091-6749(96)70229-4
   SCOTT DL, 1990, SCIENCE, V250, P1563, DOI 10.1126/science.2274788
   STAFFORD CT, 1992, J ALLERGY CLIN IMMUN, V90, P653, DOI 10.1016/0091-6749(92)90139-S
   Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956
   Tankersley MS, 2002, J ALLERGY CLIN IMMUN, V109, P556, DOI 10.1067/mai.2002.121956
   TERWILLIGER TC, 1982, J BIOL CHEM, V257, P6016
   Valenta R, 2007, J ALLERGY CLIN IMMUN, V119, P826, DOI 10.1016/j.jaci.2007.01.025
NR 35
TC 30
Z9 31
U1 0
U2 0
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD OCT 31
PY 2008
VL 383
IS 1
BP 178
EP 185
DI 10.1016/j.jmb.2008.08.023
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 362IN
UT WOS:000260191500015
PM 18761353
DA 2021-01-25
ER

PT J
AU Stepien, AE
   Arber, S
AF Stepien, Anna E.
   Arber, Silvia
TI Probing the Locomotor Conundrum: Descending the 'V' Interneuron Ladder
SO NEURON
LA English
DT Editorial Material
ID MOUSE SPINAL-CORD; V2-DERIVED INTERNEURONS; CIRCUITS; WALKING; EPHA4;
   FATE
AB The assembly of neuronal circuits involved in locomotor control in the mammalian spinal cord is influenced by genetic programs specifying four ventral M interneuron populations (V0-V3). In this issue of Neuron, Crone et al. and Zhang et al. make use of genetic tools to map connectivity patterns and to abolish the function of V2a and V3 interneurons. The absence of V2a interneurons reveals defects in left-right alternation during locomotion, whereas ablation of either V2a or V3 interneurons leads to disturbances in the precision and reliability of the motor output.
C1 [Stepien, Anna E.; Arber, Silvia] Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   [Stepien, Anna E.; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Arber, S (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.
EM silvia.arber@unibas.ch
OI Arber, Silvia/0000-0002-6261-250X
CR Al-Mosawie A, 2007, EUR J NEUROSCI, V26, P3003, DOI 10.1111/j.1460-9568.2007.05907.x
   Barbeau H, 1999, BRAIN RES REV, V30, P27, DOI 10.1016/S0165-0173(99)00008-9
   Briscoe J, 2000, CELL, V101, P435, DOI 10.1016/S0092-8674(00)80853-3
   Crone SA, 2008, NEURON, V60, P70, DOI 10.1016/j.neuron.2008.08.009
   Gosgnach S, 2006, NATURE, V440, P215, DOI 10.1038/nature04545
   Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017
   Grillner S, 2003, NAT REV NEUROSCI, V4, P573, DOI 10.1038/nrn1137
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   KUDO N, 1987, NEUROSCI LETT, V75, P43, DOI 10.1016/0304-3940(87)90072-3
   Kullander K, 2003, SCIENCE, V299, P1889, DOI 10.1126/science.1079641
   Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1
   Lundfald L, 2007, EUR J NEUROSCI, V26, P2989, DOI 10.1111/j.1460-9568.2007.05906.x
   Marder E, 2007, ANNU REV PHYSIOL, V69, P291, DOI 10.1146/annurev.physiol.69.031905.161516
   Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4
   Zhang Y, 2008, NEURON, V60, P84, DOI 10.1016/j.neuron.2008.09.027
NR 15
TC 32
Z9 32
U1 0
U2 4
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0896-6273
J9 NEURON
JI Neuron
PD OCT 9
PY 2008
VL 60
IS 1
BP 1
EP 4
DI 10.1016/j.neuron.2008.09.030
PG 4
WC Neurosciences
SC Neurosciences & Neurology
GA 363AC
UT WOS:000260237300001
PM 18940581
DA 2021-01-25
ER

PT J
AU Mrosek, M
   Meier, S
   Ucurum-Fotiadis, Z
   von Castelmur, E
   Hedbom, E
   Lustig, A
   Grzesiek, S
   Labeit, D
   Labeit, S
   Mayans, O
AF Mrosek, Michael
   Meier, Sebastian
   Ucurum-Fotiadis, Zoehre
   von Castelmur, Eleonore
   Hedbom, Erik
   Lustig, Ariel
   Grzesiek, Stephan
   Labeit, Dietmar
   Labeit, Siegfried
   Mayans, Olga
TI Structural analysis of B-box 2 from MuRF1: Identification of a novel
   self-association pattern in a RING-like fold
SO BIOCHEMISTRY
LA English
DT Article
ID E3 UBIQUITIN LIGASES; ZINC-BINDING DOMAIN; CRYSTAL-STRUCTURE; U-BOX;
   M-LINE; B-BOX; PROTEIN; FINGER; REVEALS; COMPLEX
AB The B-box motif is the defining feature of the TRIM family of proteins, characterized by a RING finger-B-box-coiled coil tripartite fold. We have elucidated the crystal structure of B-box 2 (132) from MuRF1, a TRIM protein that supports a wide variety of protein interactions in the sarcomere and regulates the trophic state of striated muscle tissue. MuRF1 B2 coordinates two zinc ions through a cross-brace alpha/beta-topology typical of members of the RING finger superfamily. However, it self-associates into dimers with high affinity. The dimerization pattern is mediated by the helical component of this fold and is unique among RING-like folds. This 132 reveals a long shallow groove that encircles the C-terminal metal binding site ZnII and appears as the defining protein-protein interaction feature of this domain. A cluster of conserved hydrophobic residues in this groove and, in particular, a highly conserved aromatic residue (Y133 in MuRF1 B2) is likely to be central to this role. We expect these findings to aid the future exploration of the cellular function and therapeutic potential of MuRF1.
C1 [Mrosek, Michael; Meier, Sebastian; Ucurum-Fotiadis, Zoehre; von Castelmur, Eleonore; Hedbom, Erik; Lustig, Ariel; Grzesiek, Stephan; Mayans, Olga] Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Labeit, Dietmar; Labeit, Siegfried] Univ Klinikum Mannheim, Inst Anasthesiol & Operat Intensivmed, D-68167 Mannheim, Germany.
   [Mayans, Olga] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England.
RP Mayans, O (corresponding author), Univ Basel, Div Struct Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Olga.Mayans@liverpool.ac.uk
RI Meier, Sebastian/A-4279-2015
OI Meier, Sebastian/0000-0003-3761-3217; von Castelmur,
   Eleonore/0000-0001-7061-4890; Mayans, Olga/0000-0001-6876-8532;
   Grzesiek, Stephan/0000-0003-1998-4225
FU Royal SocietyRoyal Society of London; DFGGerman Research Foundation
   (DFG) [La668/11-1]; SNF [3100A0-100852]
FX This work was supported by grants from The Royal Society to O.M. and DFG
   (La668/11-1) to S.L. M.M. and Z.U.-F. were supported by SNF
   (3100A0-100852).
CR Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   BARLOW PN, 1994, J MOL BIOL, V237, P201, DOI 10.1006/jmbi.1994.1222
   Bellon SF, 1997, NAT STRUCT BIOL, V4, P586, DOI 10.1038/nsb0797-586
   Bodine SC, 2001, SCIENCE, V294, P1704, DOI 10.1126/science.1065874
   BORDEN KLB, 1995, EMBO J, V14, P5947, DOI 10.1002/j.1460-2075.1995.tb00283.x
   Brzovic PS, 2001, NAT STRUCT BIOL, V8, P833, DOI 10.1038/nsb1001-833
   Capili AD, 2001, EMBO J, V20, P165, DOI 10.1093/emboj/20.1.165
   Centner T, 2001, J MOL BIOL, V306, P717, DOI 10.1006/jmbi.2001.4448
   Cornilescu G, 1998, J AM CHEM SOC, V120, P6836, DOI 10.1021/ja9812610
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Dumas JJ, 2001, MOL CELL, V8, P947, DOI 10.1016/S1097-2765(01)00385-9
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   Kostic M, 2006, J MOL BIOL, V363, P433, DOI 10.1016/j.jmb.2006.08.027
   Koyama S, 2008, J MOL BIOL, V376, P1224, DOI 10.1016/j.jmb.2007.11.049
   Legge GB, 2004, J MOL BIOL, V343, P1081, DOI 10.1016/j.jmb.2004.08.087
   Machaidze Gia, 2006, Journal of Biological Physics and Chemistry, V6, P91
   Massiah MA, 2006, J MOL BIOL, V358, P532, DOI 10.1016/j.jmb.2006.02.009
   Massiah MA, 2007, J MOL BIOL, V369, P1, DOI 10.1016/j.jmb.2007.03.017
   McElhinny AS, 2002, J CELL BIOL, V157, P125, DOI 10.1083/jcb.200108089
   Meroni G, 2005, BIOESSAYS, V27, P1147, DOI 10.1002/bies.20304
   Misra S, 1999, CELL, V97, P657, DOI 10.1016/S0092-8674(00)80776-X
   Mrosek M, 2007, FASEB J, V21, P1383, DOI 10.1096/fj.06-7644com
   Ohi MD, 2003, NAT STRUCT BIOL, V10, P250, DOI 10.1038/nsb906
   Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200
   Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263
   Reymond A, 2001, EMBO J, V20, P2140, DOI 10.1093/emboj/20.9.2140
   Shoham N, 2003, INTERVIROLOGY, V46, P239, DOI 10.1159/000072434
   Short KM, 2006, J BIOL CHEM, V281, P8970, DOI 10.1074/jbc.M512755200
   Short KM, 2002, BMC CELL BIOL, V3, DOI 10.1186/1471-2121-3-1
   Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956
   Tao H, 2008, BIOCHEMISTRY-US, V47, P2450, DOI 10.1021/bi7018496
   Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839
   Terwilliger TC, 2003, ACTA CRYSTALLOGR D, V59, P38, DOI 10.1107/S0907444902018036
   Torok M, 2001, DIFFERENTIATION, V67, P63, DOI 10.1046/j.1432-0436.2001.067003063.x
   Vander Kooi CW, 2006, BIOCHEMISTRY-US, V45, P121, DOI 10.1021/bi051787e
   Witt CC, 2008, EMBO J, V27, P350, DOI 10.1038/sj.emboj.7601952
   Xu Z, 2006, BIOCHEMISTRY-US, V45, P4749, DOI 10.1021/bi0601508
   Zheng N, 2000, CELL, V102, P533, DOI 10.1016/S0092-8674(00)00057-X
NR 43
TC 29
Z9 30
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD OCT 7
PY 2008
VL 47
IS 40
BP 10722
EP 10730
DI 10.1021/bi800733z
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 353XW
UT WOS:000259603600021
PM 18795805
DA 2021-01-25
ER

PT J
AU Mally, M
   Cornelis, GR
AF Mally, Manuela
   Cornelis, Guy R.
TI Genetic tools for studying Capnocytophaga canimorsus
SO APPLIED AND ENVIRONMENTAL MICROBIOLOGY
LA English
DT Article
ID GLIDING-MOTILITY; PORPHYROMONAS-GINGIVALIS; BACTEROIDES-FRAGILIS;
   TRANSPOSABLE ELEMENT; CYTOPHAGA JOHNSONAE; CLONING VECTORS;
   FLAVOBACTERIUM; RESISTANCE; MUTAGENESIS; PLASMID
AB Capnocytophaga canimorsus, a commensal bacterium from canine oral flora, has been isolated throughout the world from severe human infections caused by dog bites. Due to the low level of evolutionary relationship to Proteobacteria, genetic methods suitable for the genus Capnocytophaga needed to be established. Here, we show that Tn4351, derived from Bacteroides fragilis, could be introduced by conjugation into C. canimorsus and conferred resistance to erythromycin. By mapping and sequencing a naturally occurring plasmid isolated from a clinical isolate of C. canimorsus, we identified a repA gene that allowed us to construct Escherichia coli-Capnocytophaga shuttle vectors. Most commonly used antibiotic markers were not functional in C. canimorsus, but cefoxitin (cfxA), tetracycline (tetQ), and erythromycin (ermF) resistances could be used as markers for plasmid maintenance in C. canimorsus and even in some other Capnocytophaga spp. Shuttle vectors were introduced into C. canimorsus either by conjugation using the origin of transfer (oriT) of RP4 or by electrotransformation. Taking advantage of the promoter of ermF, an expression vector was constructed. Finally, a method that allows site-directed mutagenesis is described. All these genetic tools pave the way, not only for molecular studies of the pathogenesis of C. canimorsus, but also for studies of other oral Capnocytophaga species.
C1 [Mally, Manuela; Cornelis, Guy R.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [32-65393.01]
FX We thank Mark J. McBride for generously providing plasmids and for
   invaluable advice, Georges Wauters and Michel Delmee for providing
   Capnocytophaga strains, and Hwain Shin for critical reading of the
   manuscript. We are also grateful to Nadia B. Shoemaker and Abigail A.
   Salyers for helpful suggestions. This work was supported by the Swiss
   National Science Foundation (grant 32-65393.01).
CR Agarwal S, 1997, P NATL ACAD SCI USA, V94, P12139, DOI 10.1073/pnas.94.22.12139
   Alvarez B, 2004, APPL ENVIRON MICROB, V70, P581, DOI 10.1128/AEM.70.1.581-587.2004
   Bayley DP, 2000, FEMS MICROBIOL LETT, V193, P149, DOI 10.1016/S0378-1097(00)00472-9
   BOBO RA, 1976, AM J CLIN PATHOL, V65, P564
   Braun TF, 2005, J BACTERIOL, V187, P6943, DOI 10.1128/JB.187.20.6943-6952.2005
   BRENNER DJ, 1989, J CLIN MICROBIOL, V27, P231, DOI 10.1128/JCM.27.2.231-235.1989
   Cooper AJ, 1997, J BACTERIOL, V179, P6221, DOI 10.1128/jb.179.20.6221-6227.1997
   DYER DW, 1992, BIOCHEM BIOPH RES CO, V186, P1012, DOI 10.1016/0006-291X(92)90847-E
   GENCO CA, 1995, INFECT IMMUN, V63, P393
   HOOVER CI, 1992, PLASMID, V27, P246, DOI 10.1016/0147-619X(92)90028-9
   Hunnicutt DW, 2000, J BACTERIOL, V182, P911, DOI 10.1128/JB.182.4.911-918.2000
   Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x
   KADO CI, 1981, J BACTERIOL, V145, P1365, DOI 10.1128/JB.145.3.1365-1373.1981
   Kempf MJ, 2000, J BACTERIOL, V182, P1671, DOI 10.1128/JB.182.6.1671-1679.2000
   KOVACH ME, 1995, GENE, V166, P175, DOI 10.1016/0378-1119(95)00584-1
   LI LY, 1995, J BACTERIOL, V177, P4992, DOI 10.1128/jb.177.17.4992-4999.1995
   Lion C, 1996, EUR J EPIDEMIOL, V12, P521, DOI 10.1007/BF00144007
   MALLY M, PLOS PATHOG IN PRESS
   McBride MJ, 1996, J BACTERIOL, V178, P583, DOI 10.1128/jb.178.3.583-590.1996
   McBride MJ, 1996, APPL ENVIRON MICROB, V62, P3017, DOI 10.1128/AEM.62.8.3017-3022.1996
   Metcalf WW, 1996, PLASMID, V35, P1, DOI 10.1006/plas.1996.0001
   MEYER S, IMMUNOBIOLO IN PRESS
   PRIDMORE RD, 1987, GENE, V56, P309, DOI 10.1016/0378-1119(87)90149-1
   RASMUSSEN JL, 1986, J BACTERIOL, V168, P523, DOI 10.1128/jb.168.2.523-533.1986
   Reeves AR, 1996, J BACTERIOL, V178, P823, DOI 10.1128/jb.178.3.823-830.1996
   Salyers AA, 2000, METHODS, V20, P35, DOI 10.1006/meth.1999.0903
   Sambrook J., 2001, MOL CLONING LAB MANU
   Shin H, 2007, J INFECT DIS, V195, P375, DOI 10.1086/510243
   SHOEMAKER NB, 1985, J BACTERIOL, V162, P626, DOI 10.1128/JB.162.2.626-632.1985
   SHOEMAKER NB, 1986, J BACTERIOL, V165, P929, DOI 10.1128/jb.165.3.929-936.1986
   SIMON R, 1983, BIO-TECHNOL, V1, P784, DOI 10.1038/nbt1183-784
   SMITH CJ, 1993, J BACTERIOL, V175, P2682, DOI 10.1128/JB.175.9.2682-2691.1993
   Tierney DM, 2006, J CLIN MICROBIOL, V44, P649, DOI 10.1128/JCM.44.2.649-651.2006
   Vandamme P, 1996, INT J SYST BACTERIOL, V46, P782, DOI 10.1099/00207713-46-3-782
   YANISCHPERRON C, 1985, GENE, V33, P103, DOI 10.1016/0378-1119(85)90120-9
   Youderian P, 2003, MOL MICROBIOL, V49, P555, DOI 10.1046/j.1365-2958.2003.03582.x
NR 36
TC 21
Z9 21
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0099-2240
J9 APPL ENVIRON MICROB
JI Appl. Environ. Microbiol.
PD OCT
PY 2008
VL 74
IS 20
BP 6369
EP 6377
DI 10.1128/AEM.01218-08
PG 9
WC Biotechnology & Applied Microbiology; Microbiology
SC Biotechnology & Applied Microbiology; Microbiology
GA 359KJ
UT WOS:000259985300025
PM 18723653
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Sigmund, JC
   Vogler, C
   Huynh, KD
   de Quervain, DJF
   Papassotiropoulos, A
AF Sigmund, Jessica C.
   Vogler, Christian
   Huynh, Kim-Dung
   de Quervain, Dominique J. -F.
   Papassotiropoulos, Andreas
TI Fine-mapping at the HTR2A locus reveals multiple episodic memory-related
   variants
SO BIOLOGICAL PSYCHOLOGY
LA English
DT Article
DE Serotonin; Polymorphism; Hippocampus; Imputation
ID POLYMORPHISM; PERFORMANCE; IDENTIFICATION; GENOME; BRAIN
AB A functional polymorphism (His452Tyr) in the gene encoding the serotonin 2A receptor (HTR2A) has been previously associated with human episodic memory performance and with differences in brain volume in memory-related brain regions. Here we present data obtained through imputation and fine-mapping showing that multiple loci within HTR2A are significantly associated with human memory performance independently of the His452Tyr polymorphism. Our data support the existence of multiple memory-related loci within HTR2A. (C) 2008 Elsevier B.V. All rights reserved
C1 [Sigmund, Jessica C.; Vogler, Christian; Huynh, Kim-Dung; Papassotiropoulos, Andreas] Univ Basel, Div Mol Psychol, CH-4055 Basel, Switzerland.
   [de Quervain, Dominique J. -F.] Univ Zurich, Div Psychiat Res, CH-8029 Zurich, Switzerland.
   [Sigmund, Jessica C.; Vogler, Christian; Huynh, Kim-Dung; Papassotiropoulos, Andreas] Univ Basel, Biozentrum, Life Sci Training Facil, CH-4056 Basel, Switzerland.
RP Sigmund, JC (corresponding author), Univ Basel, Div Mol Psychol, Missionsstr 62A, CH-4055 Basel, Switzerland.
EM jessica.sigmund@unibas.ch
OI Papassotiropoulos, Andreas/0000-0002-2210-9651; de Quervain,
   Dominique/0000-0001-7131-2464
FU Swiss National Science Foundation (SNSF)Swiss National Science
   Foundation (SNSF) [PP00B-114813]; Freie Akademische Gesellschaft
FX Supported in part by the Swiss National Science Foundation (SNSF) grant
   PP00B-114813 (to AP). This work is also part of the National Centre of
   Competence in Research (NCCR) Swiss Etiological Study of Adjustment and
   Mental Health (sesam), The Swiss National Science Foundation (SNF)
   (project no. 51A240-104890), the University of Basel, the F. Hoffmann-La
   Roche Corp. and the Freie Akademische Gesellschaft provided core support
   for the NCCR sesam.
CR Barrett JC, 2005, BIOINFORMATICS, V21, P263, DOI 10.1093/bioinformatics/bth457
   Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874
   BOUCHARD TJ, 1981, SCIENCE, V212, P1055, DOI 10.1126/science.7195071
   Buhot M C, 1999, IDrugs, V2, P426
   CASSEL JC, 1995, NEUROSCIENCE, V69, P1, DOI 10.1016/0306-4522(95)00241-A
   De La Vega Francisco M, 2006, Pac Symp Biocomput, P487, DOI 10.1142/9789812701626_0045
   de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103
   de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Filippini N, 2006, EUR J HUM GENET, V14, P443, DOI 10.1038/sj.ejhg.5201573
   Hager W., 1994, HDB DEUTSCHSPRACHIGE
   Harvey PJ, 2006, J NEUROPHYSIOL, V96, P1158, DOI 10.1152/jn.01088.2005
   HIRANO H, 1995, J NEUROCHEM, V65, P1139
   Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI DOI 10.1080/10618600.1996.10474713
   Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020
   Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088
   McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560
   Ozaki N, 1997, J NEUROCHEM, V68, P2186
   Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837
   Reynolds CA, 2006, NEUROBIOL AGING, V27, P150, DOI 10.1016/j.neurobiolaging.2004.12.009
   SQUIRE LR, 1995, CURR OPIN NEUROBIOL, V5, P169, DOI 10.1016/0959-4388(95)80023-9
   Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130
   Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114
   Wingen M, 2007, J PSYCHOPHARMACOL, V21, P477, DOI 10.1177/0269881106072506
NR 24
TC 16
Z9 17
U1 0
U2 6
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0301-0511
EI 1873-6246
J9 BIOL PSYCHOL
JI Biol. Psychol.
PD OCT
PY 2008
VL 79
IS 2
BP 239
EP 242
DI 10.1016/j.biopsycho.2008.06.002
PG 4
WC Psychology, Biological; Behavioral Sciences; Psychology; Psychology,
   Experimental
SC Psychology; Behavioral Sciences
GA 363RC
UT WOS:000260283400014
PM 18602445
DA 2021-01-25
ER

PT J
AU Muller, DJ
   Engel, A
AF Muller, Daniel J.
   Engel, Andreas
TI Strategies to prepare and characterize native membrane proteins and
   protein membranes by AFM
SO CURRENT OPINION IN COLLOID & INTERFACE SCIENCE
LA English
DT Review
DE atomic force microscopy; compartments; native protein membranes;
   single-molecule force spectroscopy; tethered membranes; polymer
   supported membranes; protein assembly; structure and function
   relationship; molecular interactions
ID ATOMIC-FORCE MICROSCOPY; SCANNING PROBE MICROSCOPY; BILAYER-LIPID
   MEMBRANES; SINGLE-MOLECULE; SUPPORTED MEMBRANES; CONFORMATIONAL-CHANGES;
   ATP SYNTHASE; CELL-MEMBRANES; GOLD SURFACES; IMMOBILIZATION
AB Progress in characterizing native membrane proteins and protein membranes by atomic force microscopy (AFM) opens exciting possibilities. While the structure, oligomeric state and supramolecular assembly of membrane proteins arc assessed directly by AFM, single-molecule force spectroscopy (SMFS) identifies interactions that stabilize the fold, and characterize the switching between functional states of membrane proteins. But what is next? I-low can we approach cell biological, pharmaceutical and medical questions associated with native cellular membranes? Flow can we probe the functional state of cell membranes and study the dynamic formation of compartments? Such questions have been addressed by immobilizing membranes on solid Supports, which ensures the integrity of the native state of membrane proteins but does not necessarily provide a native-like environment. Direct attachment of membranes to solid supports involves non-specific interactions that may change the physical state of supported lipids and proteins possibly hindering the assembly of membrane proteins into native functional compartments. Thus, to observe the dynamic assembly and working of proteins in native membranes by AFM. Supports arc required that mimic the native environment of the cell membrane as closely as possible. This review reports on recent progress in characterizing native membrane proteins by AFM, and surveys conventional and new approaches of supporting surfaces, which will allow the function, dynamics, and assembly of membrane proteins to be studied by AFM in native cell membranes. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Muller, Daniel J.] Tech Univ Dresden, Ctr Biotechnol, D-01307 Dresden, Germany.
   [Engel, Andreas] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Muller, DJ (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Tatzberg 47-51, D-01307 Dresden, Germany.
EM mueller@biotec.tu-dresden.de
RI Muller, Daniel J/A-5967-2010
OI Muller, Daniel J/0000-0003-3075-0665
FU Deutsche ForschngsgemeinschaftGerman Research Foundation (DFG);
   VolkswagenstiftungVolkswagen; European UnionEuropean Union (EU)
   [NEST2004, PathSYS29084]; Free State of Saxony; Swiss National Research
   FoundationSwiss National Science Foundation (SNSF); M. E. Muller
   Foundation; Swiss National Center of Competence in Research (NCCR)Swiss
   National Science Foundation (SNSF)
FX The authors acknowledge support by the Deutsche Forschngsgemeinschaft,
   Volkswagenstiftung, European Union (EFRE and NANOMOT project, NEST2004,
   PathSYS29084), the Free State of Saxony, the Swiss National Research
   Foundation, the M. E. Muller Foundation, the Swiss National Center of
   Competence in Research (NCCR) 'Structural Biology' and the NCCR
   'Nanoscale Science'. We thank Ch. Bippes and T. Sapra for critical
   reading of the manuscript.
CR Andersen C, 2002, J BIOL CHEM, V277, P41318, DOI 10.1074/jbc.M206804200
   Buzhynskyy N, 2007, EMBO REP, V8, P51, DOI 10.1038/sj.embor.7400858
   Cisneros DA, 2006, ANGEW CHEM INT EDIT, V45, P3252, DOI 10.1002/anie.200504506
   Czajkowsky DM, 2004, EMBO J, V23, P3206, DOI 10.1038/sj.emboj.7600350
   Danelon C, 2006, LANGMUIR, V22, P22, DOI 10.1021/la052387v
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394
   Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013
   Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Fotiadis D, 2004, J BIOL CHEM, V279, P2063, DOI 10.1074/jbc.M310382200
   Friedel M, 2006, P NATL ACAD SCI USA, V103, P8396, DOI 10.1073/pnas.0601210103
   Giess F, 2004, BIOPHYS J, V87, P3213, DOI 10.1529/biophysj.104.046169
   Goennenwein S, 2003, BIOPHYS J, V85, P646, DOI 10.1016/S0006-3495(03)74508-1
   Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063
   Goncalves RP, 2006, NAT METHODS, V3, P1007, DOI 10.1038/nmeth965
   Guthold M, 1999, BIOPHYS J, V77, P2284, DOI 10.1016/S0006-3495(99)77067-0
   He LH, 2005, LANGMUIR, V21, P11666, DOI 10.1021/la051771p
   Hemmersam AG, 2005, COLLOID SURFACE B, V43, P208, DOI 10.1016/j.colsurfb.2005.04.007
   Hinterdorfer P, 2006, NAT METHODS, V3, P347, DOI 10.1038/NMETH871
   Hogan J, 2006, NATURE, V440, P14, DOI 10.1038/440014a
   Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073
   Kedrov A, 2005, EMBO REP, V6, P668, DOI 10.1038/sj.embor.7400455
   Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640
   Kufer SK, 2005, EUR BIOPHYS J BIOPHY, V35, P72, DOI 10.1007/s00249-005-0010-1
   Milhiet PE, 2006, BIOPHYS J, V91, P3268, DOI 10.1529/biophysj.106.087791
   Muller DJ, 2006, CURR OPIN STRUC BIOL, V16, P489, DOI 10.1016/j.sbi.2006.06.001
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 2003, J MOL BIOL, V327, P925, DOI 10.1016/S0022-2836(03)00206-7
   Muller DJ, 2002, EMBO J, V21, P3598, DOI 10.1093/emboj/cdf365
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875
   Muller DJ, 2000, BBA-BIOENERGETICS, V1460, P27, DOI 10.1016/S0005-2728(00)00127-4
   Park PSH, 2007, J BIOL CHEM, V282, P11377, DOI 10.1074/jbc.M610341200
   Picco LM, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/4/044030
   Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517
   Pogoryelov D, 2007, J BACTERIOL, V189, P5895, DOI 10.1128/JB.00581-07
   Purrucker O, 2004, CHEMPHYSCHEM, V5, P327, DOI 10.1002/cphc.200300863
   Radler U, 2000, BIOPHYS J, V79, P3144
   Remigy HW, 2003, FEBS LETT, V555, P160, DOI 10.1016/S0014-5793(03)01105-0
   Rigaud JL, 2002, BRAZ J MED BIOL RES, V35, P753, DOI 10.1590/S0100-879X2002000700001
   Rigler P, 2004, LANGMUIR, V20, P7901, DOI 10.1021/la049002d
   Sackmann E, 2002, CHEMPHYSCHEM, V3, P262, DOI 10.1002/1439-7641(20020315)3:3<262::AID-CPHC262>3.0.CO;2-U
   Sako Y, 2003, NAT CELL BIOL, pSS1, DOI 10.1038/nrm1193
   Scheuring S, 2005, BBA-BIOMEMBRANES, V1712, P109, DOI 10.1016/j.bbamem.2005.04.005
   Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879
   Scheuring S, 2002, EUR BIOPHYS J BIOPHY, V31, P172, DOI 10.1007/s00249-001-0197-8
   Scheuring S, 2006, CURR OPIN CHEM BIOL, V10, P387, DOI 10.1016/j.cbpa.2006.08.007
   Schiller SM, 2003, ANGEW CHEM INT EDIT, V42, P208, DOI 10.1002/anie.200390080
   Seelert H, 2000, NATURE, V405, P418
   Seelert H, 2003, J MOL BIOL, V333, P337, DOI 10.1016/j.jmb.2003.08.046
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   Sinner EK, 2004, ANAL BIOCHEM, V333, P216, DOI 10.1016/j.ab.2004.05.022
   Sinner EK, 2001, CURR OPIN CHEM BIOL, V5, P705, DOI 10.1016/S1367-5931(01)00269-1
   Sleytr UB, 2007, FEBS J, V274, P323, DOI 10.1111/j.1742-4658.2006.05606.x
   STAHLBERG H, 2001, EMBO REP, V21, P1
   Stock D, 1999, SCIENCE, V286, P1700, DOI 10.1126/science.286.5445.1700
   Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941
   Tanaka M, 2005, NATURE, V437, P656, DOI 10.1038/nature04164
   Terrettaz S, 2002, PROTEIN SCI, V11, P1917, DOI 10.1110/ps.0206102
   Tinazli A, 2005, CHEM-EUR J, V11, P5249, DOI 10.1002/chem.200500154
   Wagner ML, 2000, BIOPHYS J, V79, P1400, DOI 10.1016/S0006-3495(00)76392-2
   Wagner P, 1998, FEBS LETT, V430, P112, DOI 10.1016/S0014-5793(98)00614-0
   Yildiz O, 2006, EMBO J, V25, P3702, DOI 10.1038/sj.emboj.7601237
   Yokokawa M, 2006, EMBO J, V25, P4567, DOI 10.1038/sj.emboj.7601326
   Yu JS, 2007, J BIOL CHEM, V282, P8895, DOI 10.1074/jbc.M609317200
NR 66
TC 37
Z9 43
U1 2
U2 64
PU ELSEVIER SCIENCE LONDON
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1359-0294
J9 CURR OPIN COLLOID IN
JI Curr. Opin. Colloid Interface Sci.
PD OCT
PY 2008
VL 13
IS 5
BP 338
EP 350
DI 10.1016/j.cocis.2007.09.002
PG 13
WC Chemistry, Physical
SC Chemistry
GA 356AC
UT WOS:000259750100004
DA 2021-01-25
ER

PT J
AU Bumann, D
AF Bumann, Dirk
TI Has nature already identified all useful antibacterial targets?
SO CURRENT OPINION IN MICROBIOLOGY
LA English
DT Review
ID DISCOVERY; GENES; DRUGS; ANTIMICROBIALS; ANTIBIOTICS; METABOLISM;
   CHALLENGES; INHIBITOR; BACILLUS; GENOME
AB Novel antimicrobial targets are urgently needed to overcome rising antibiotic resistance of important human pathogens. However, evidence from previous antimicrobial screenings, in silico analysis, and experimental target evaluation suggests that the number of novel bacterial broad-spectrum targets might be severely limited. This is because of the poor conservation of genes among diverse bacterial pathogens, partial functional redundancy and nutrient-rich host environments. Remaining opportunities under these circumstances include the development of narrow-spectrum antibiotics against specific pathogens and the exploration of target combinations.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Bumann, D (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM dirk.bumann@unibas.ch
FU Society for Biomolecular Screening; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB621-A9];
   Deutsches Bundesministerium fur Bildung und Forschung [Go-Bio 0315077]
FX I would like to thank Society for Biomolecular Screening (Small
   endowment grant 2006), Deutsche Forschungsgemeinschaft (SFB621-A9), and
   Deutsches Bundesministerium fur Bildung und Forschung (Go-Bio 0315077)
   for their financial support.
CR Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050
   BALTZ RH, 2008, CURR OPIN PHARMACOL, V3, P3
   Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   Becker SA, 2007, NAT PROTOC, V2, P727, DOI 10.1038/nprot.2007.99
   Black MT, 2005, ADV DRUG DELIVER REV, V57, P1528, DOI 10.1016/j.addr.2005.04.006
   Buynak JD, 2006, BIOCHEM PHARMACOL, V71, P930, DOI 10.1016/j.bcp.2005.11.012
   Cegelski L, 2008, NAT REV MICROBIOL, V6, P17, DOI 10.1038/nrmicro1818
   Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006
   Frantz S, 2005, NATURE, V437, P942, DOI 10.1038/437942a
   Glass JI, 2006, P NATL ACAD SCI USA, V103, P425, DOI 10.1073/pnas.0510013103
   Hillenmeyer ME, 2008, SCIENCE, V320, P362, DOI 10.1126/science.1150021
   Kobayashi K, 2003, P NATL ACAD SCI USA, V100, P4678, DOI 10.1073/pnas.0730515100
   Lange RP, 2007, CURR PHARM DESIGN, V13, P3140, DOI 10.2174/138161207782110408
   Loferer H, 2000, MOL MED TODAY, V6, P470, DOI 10.1016/S1357-4310(00)01815-3
   Mazurkiewicz P, 2006, NAT REV GENET, V7, P929, DOI 10.1038/nrg1984
   Moy TI, 2006, P NATL ACAD SCI USA, V103, P10414, DOI 10.1073/pnas.0604055103
   Muschiol S, 2006, P NATL ACAD SCI USA, V103, P14566, DOI 10.1073/pnas.0606412103
   Muzzi A, 2007, DRUG DISCOV TODAY, V12, P429, DOI 10.1016/j.drudis.2007.04.008
   Norrby SR, 2005, LANCET INFECT DIS, V5, P115, DOI 10.1016/S1473-3099(05)01283-1
   Payne DJ, 2007, NAT REV DRUG DISCOV, V6, P29, DOI 10.1038/nrd2201
   Poehlsgaard J, 2005, NAT REV MICROBIOL, V3, P870, DOI 10.1038/nrmicro1265
   Projan SJ, 2007, CURR OPIN MICROBIOL, V10, P441, DOI 10.1016/j.mib.2007.08.007
   Schmid MB, 2006, NAT BIOTECHNOL, V24, P419, DOI 10.1038/nbt0406-419
   Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103
   Spellberg B, 2004, CLIN INFECT DIS, V38, P1279, DOI 10.1086/420937
   Thomson CJ, 2004, CURR OPIN MICROBIOL, V7, P445, DOI 10.1016/j.mib.2004.08.009
   Wyss PC, 2003, J MED CHEM, V46, P2304, DOI 10.1021/jm020495y
NR 27
TC 33
Z9 33
U1 0
U2 5
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 1369-5274
J9 CURR OPIN MICROBIOL
JI Curr. Opin. Microbiol.
PD OCT
PY 2008
VL 11
IS 5
BP 387
EP 392
DI 10.1016/j.mib.2008.08.002
PG 6
WC Microbiology
SC Microbiology
GA 377JG
UT WOS:000261246900002
PM 18804175
DA 2021-01-25
ER

PT J
AU Caroni, P
   Scheiffelle, P
AF Caroni, Pico
   Scheiffelle, Peter
TI Neuronal and glial cell biology
SO CURRENT OPINION IN NEUROBIOLOGY
LA English
DT Editorial Material
C1 [Caroni, Pico] Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
   [Scheiffelle, Peter] Biozentrum Univ Basel, CH-4056 Basel, Switzerland.
RP Caroni, P (corresponding author), Friedrich Miescher Inst, Maulbeerstr 66, CH-4058 Basel, Switzerland.
EM caroni@fmi.ch; peter.scheiffele@unibas.ch
NR 0
TC 0
Z9 0
U1 0
U2 1
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-4388
J9 CURR OPIN NEUROBIOL
JI Curr. Opin. Neurobiol.
PD OCT
PY 2008
VL 18
IS 5
BP 469
EP 471
DI 10.1016/j.conb.2008.10.004
PG 3
WC Neurosciences
SC Neurosciences & Neurology
GA 384OV
UT WOS:000261755000001
PM 18977302
DA 2021-01-25
ER

PT J
AU Sturgill, TW
   Cohen, A
   Diefenbacher, M
   Trautwein, M
   Martin, DE
   Hall, MN
AF Sturgill, Thomas W.
   Cohen, Adiel
   Diefenbacher, Melanie
   Trautwein, Mark
   Martin, Dietmar E.
   Hall, Michael N.
TI TOR1 and TOR2 Have Distinct Locations in Live Cells
SO EUKARYOTIC CELL
LA English
DT Article
ID SACCHAROMYCES-CEREVISIAE; MAMMALIAN TARGET; ENDOPLASMIC-RETICULUM;
   NUCLEAR-LOCALIZATION; ACTIN CYTOSKELETON; SIGNALING PATHWAY; PROTEIN
   COMPLEXES; GROWTH CONTROL; BUDDING YEAST; RAPAMYCIN
AB TOR is a structurally and functionally conserved Ser/Thr kinase found in two multiprotein complexes that regulate many cellular processes to control cell growth. Although extensively studied, the localization of TOR is still ambiguous, possibly because endogenous TOR in live cells has not been examined. Here, we examined the localization of green fluorescent protein (GFP) tagged, endogenous TOR1 and TOR2 in live S. cerevisiae cells. A DNA cassette encoding three copies of green fluorescent protein (3XGFP) was inserted in the TOR1 gene (at codon D330) or the TOR2 gene (at codon N321). The TORs were tagged internally because TOR1 or TOR2 tagged at the N or C terminus was not functional. The TOR1(D330-3XGFP) strain was not hypersensitive to rapamycin, was not cold sensitive, and was not resistant to manganese toxicity caused by the loss of Pmr1, all indications that TOR1-3XGFP was expressed and functional. TOR2-3XGFP was functional, as TOR2 is an essential gene and TOR2(N321-3XGFP) haploid cells were viable. Thus, TOR1 and TOR2 retain function after the insertion of 748 amino acids in a variable region of their noncatalytic domain. The localization patterns of TOR1-3XGFP and TOR2-3XGFP were documented by imaging of live cells. TOR1-3XGFP was diffusely cytoplasmic and concentrated near the vacuolar membrane. The TOR2-3XGFP signal was cytoplasmic but predominately in dots at the plasma membrane. Thus, TOR1 and TOR2 have distinct localization patterns, consistent with the regulation of cellular processes as part of two different complexes.
C1 [Sturgill, Thomas W.] Univ Virginia, Dept Pharmacol, Hlth Sci Ctr, Charlottesville, VA 22908 USA.
   [Cohen, Adiel; Diefenbacher, Melanie; Trautwein, Mark; Martin, Dietmar E.; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Sturgill, TW (corresponding author), Univ Virginia, Dept Pharmacol, Hlth Sci Ctr, Box 800735,Room 5045,Jordan Hall, Charlottesville, VA 22908 USA.
EM Thomas_Sturgill@virginia.edu
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); National Institutes of HealthUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USA [DK052753];
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [R01DK052753, R01DK052753, R01DK052753,
   R01DK052753, R01DK052753, R01DK052753, R01DK052753, R01DK052753,
   R01DK052753, R01DK052753, R01DK052753, R01DK052753, R01DK052753,
   R01DK052753, R01DK052753] Funding Source: NIH RePORTER
FX This research was supported by the Swiss National Science Foundation and
   the Canton of Basel (M.N.H.) and by the National Institutes of Health
   (DK052753) (T.W.S.).
CR Adami A, 2007, MOL CELL, V27, P509, DOI 10.1016/j.molcel.2007.05.040
   Araki T, 2005, GENES GENET SYST, V80, P325, DOI 10.1266/ggs.80.325
   Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015
   Aronova S, 2007, MOL BIOL CELL, V18, P2779, DOI 10.1091/mbc.E07-03-0274
   CARDENAS ME, 1995, EMBO J, V14, P5892, DOI 10.1002/j.1460-2075.1995.tb00277.x
   Cohen A, 1999, J BIOL CHEM, V274, P26885, DOI 10.1074/jbc.274.38.26885
   Combet C, 2000, TRENDS BIOCHEM SCI, V25, P147, DOI 10.1016/S0968-0004(99)01540-6
   De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884
   Deitz SB, 2000, TRAFFIC, V1, P172, DOI 10.1034/j.1600-0854.2000.010209.x
   Devasahayam G, 2007, GENETICS, V177, P231, DOI 10.1534/genetics.107.073577
   Devasahayam G, 2006, P NATL ACAD SCI USA, V103, P17840, DOI 10.1073/pnas.0604303103
   Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020
   Durr G, 1998, MOL BIOL CELL, V9, P1149, DOI 10.1091/mbc.9.5.1149
   Fadri M, 2005, MOL BIOL CELL, V16, P1883, DOI 10.1091/mbc.E04-07-0564
   Gauss R, 2005, YEAST, V22, P1, DOI 10.1002/yea.1187
   Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519
   Kamada Y, 2005, MOL CELL BIOL, V25, P7239, DOI 10.1128/MCB.25.16.7239-7248.2005
   Katzmann DJ, 2004, MOL BIOL CELL, V15, P468, DOI 10.1091/mbc.E03-07-0473
   Khalfan WA, 2002, CURR OPIN CELL BIOL, V14, P468, DOI 10.1016/S0955-0674(02)00343-5
   Kim JE, 2000, P NATL ACAD SCI USA, V97, P14340, DOI 10.1073/pnas.011511898
   Kunz J, 2000, J BIOL CHEM, V275, P37011, DOI 10.1074/jbc.M007296200
   Lee WL, 2003, J CELL BIOL, V160, P355, DOI 10.1083/jcb.200209022
   Lemmon MA, 2003, TRAFFIC, V4, P201, DOI 10.1034/j.1600-0854.2004.00071.x
   Li H, 2006, NATURE, V442, P1058, DOI 10.1038/nature05020
   Liu K, 2005, BIOCHEM SOC T, V33, P1170, DOI 10.1042/BST0331170
   Liu XY, 2007, MOL BIOL CELL, V18, P1073, DOI 10.1091/mbc.E06-05-0406
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Losev E, 2006, NATURE, V441, P1002, DOI 10.1038/nature04717
   Luo GZ, 2008, J BIOL CHEM, V283, P10433, DOI 10.1074/jbc.M709972200
   Mavrakis M, 2007, AUTOPHAGY, V3, P151, DOI 10.4161/auto.3632
   Proszynski TJ, 2005, P NATL ACAD SCI USA, V102, P17981, DOI 10.1073/pnas.0509107102
   Reinke A, 2004, J BIOL CHEM, V279, P14752, DOI 10.1074/jbc.M313062200
   Reinke A, 2006, J BIOL CHEM, V281, P31616, DOI 10.1074/jbc.M603107200
   Saito K, 2005, J BIOCHEM, V137, P423, DOI 10.1093/jb/mvi046
   Schmelzle T, 2004, MOL CELL BIOL, V24, P338, DOI 10.1128/MCB.24.1.338-351.2004
   Swaminathan S, 2006, NAT CELL BIOL, V8, P310, DOI 10.1038/ncb0406-310
   Urban J, 2007, MOL CELL, V26, P663, DOI 10.1016/j.molcel.2007.04.020
   VIDA TA, 1995, J CELL BIOL, V128, P779, DOI 10.1083/jcb.128.5.779
   Walther TC, 2006, NATURE, V439, P998, DOI 10.1038/nature04472
   Wedaman KP, 2003, MOL BIOL CELL, V14, P1204, DOI 10.1091/mbc.E02-09-0609
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Zhang XW, 2002, J BIOL CHEM, V277, P28127, DOI 10.1074/jbc.M202625200
   Zurita-Martinez SA, 2007, GENETICS, V176, P2139, DOI 10.1534/genetics.107.072835
NR 43
TC 100
Z9 102
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 1535-9778
J9 EUKARYOT CELL
JI Eukaryot. Cell
PD OCT
PY 2008
VL 7
IS 10
BP 1819
EP 1830
DI 10.1128/EC.00088-08
PG 12
WC Microbiology; Mycology
SC Microbiology; Mycology
GA 358CA
UT WOS:000259892900018
PM 18723607
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Wong, LE
   Masse, JE
   Jaravine, V
   Orekhov, V
   Pervushin, K
AF Wong, Leo E.
   Masse, James E.
   Jaravine, Victor
   Orekhov, Vladislav
   Pervushin, Konstantin
TI Automatic assignment of protein backbone resonances by direct spectrum
   inspection in targeted acquisition of NMR data
SO JOURNAL OF BIOMOLECULAR NMR
LA English
DT Article
DE MDD; automatic resonance assignment; nonlinear data sampling; targeted
   NMR data acquisition
ID FILTER DIAGONALIZATION METHOD; MULTIDIMENSIONAL NMR; FOURIER-TRANSFORM;
   COVARIANCE NMR; NOESY SPECTRA; GFT NMR; RESOLUTION; SPECTROSCOPY;
   IDENTIFICATION; ALGORITHM
AB The necessity to acquire large multidimensional datasets, a basis for assignment of NMR resonances, results in long data acquisition times during which substantial degradation of a protein sample might occur. Here we propose a method applicable for such a protein for automatic assignment of backbone resonances by direct inspection of multidimensional NMR spectra. In order to establish an optimal balance between completeness of resonance assignment and losses of cross-peaks due to dynamic processes/degradation of protein, assignment of backbone resonances is set as a stirring criterion for dynamically controlled targeted nonlinear NMR data acquisition. The result is demonstrated with the 12 kDa C-13,(15) N-labeled apo-form of heme chaperone protein CcmE, where hydrolytic cleavage of 29 C-terminal amino acids is detected. For this protein, 90 and 98% of manually assignable resonances are automatically assigned within 10 and 40 h of nonlinear sampling of five 3D NMR spectra, respectively, instead of 600 h needed to complete the full time domain grid. In addition, resonances stemming from degradation products are identified. This study indicates that automatic resonance assignment might serve as a guiding criterion for optimal run-time allocation of NMR resources in applications to proteins prone to degradation.
C1 [Wong, Leo E.; Pervushin, Konstantin] Nanyang Technol Univ, Sch Biol Sci, Singapore 637551, Singapore.
   [Masse, James E.] ETH Honggerberg, Phys Chem Lab, CH-8093 Zurich, Switzerland.
   [Jaravine, Victor; Orekhov, Vladislav] Gothenburg Univ, Swedish NMR Ctr, S-40530 Gothenburg, Sweden.
   [Pervushin, Konstantin] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pervushin, K (corresponding author), Nanyang Technol Univ, Sch Biol Sci, 60 Nanyang Dr, Singapore 637551, Singapore.
EM konstantin.pervushin@unibas.ch; konstantin.pervushin@unibas.ch
RI Pervushin, Konstantin/AAJ-6580-2020; , Vladislav/AAD-8464-2019
OI Pervushin, Konstantin/0000-0002-6393-4340; ,
   Vladislav/0000-0002-7892-6896
FU Ministry of Education of SingaporeMinistry of Education, Singapore;
   Bruker BioSpin Group AG, Germany
FX This work was funded by the Academic Research Fund Tier-2 grant of
   Ministry of Education of Singapore to Konstantin Pervushin and Bruker
   BioSpin Group AG, Germany, grant to James E. Masse.
CR Armstrong GS, 2005, J MAGN RESON, V173, P160, DOI 10.1016/j.jmr.2004.11.027
   Atreya HS, 2007, J AM CHEM SOC, V129, P680, DOI 10.1021/ja066586s
   Atreya HS, 2000, J BIOMOL NMR, V17, P125, DOI 10.1023/A:1008315111278
   Atreya HS, 2002, CURR SCI INDIA, V83, P1372
   BARTELS C, 1995, J BIOMOL NMR, V6, P1, DOI 10.1007/BF00417486
   Bohm M, 2005, LECT NOTES COMPUT SC, V3523, P75
   Coggins BE, 2003, J BIOMOL NMR, V26, P93, DOI 10.1023/A:1023589029301
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Eghbalnia HR, 2005, J AM CHEM SOC, V127, P12528, DOI 10.1021/ja052120I
   Eghbalnia HR, 2005, J BIOMOL NMR, V32, P219, DOI 10.1007/s10858-005-7944-6
   Enggist E, 2002, STRUCTURE, V10, P1551, DOI 10.1016/S0969-2126(02)00885-7
   Fiorito F, 2006, J BIOMOL NMR, V35, P27, DOI 10.1007/s10858-006-0030-x
   Frueh DP, 2006, J AM CHEM SOC, V128, P5757, DOI 10.1021/ja0584222
   Frydman L, 2003, J AM CHEM SOC, V125, P9204, DOI 10.1021/ja030055b
   Gal M, 2007, J AM CHEM SOC, V129, P1372, DOI 10.1021/ja066915g
   Grishaev A, 2005, PROTEINS, V61, P36, DOI 10.1002/prot.20457
   Grishaev A, 2004, J BIOMOL NMR, V28, P1, DOI 10.1023/B:JNMR.0000012846.56763.f7
   Herrmann T, 2002, J MOL BIOL, V319, P209, DOI 10.1016/S0022-2836(02)00241-3
   Herrmann T, 2002, J BIOMOL NMR, V24, P171, DOI 10.1023/A:1021614115432
   Hiller S, 2005, P NATL ACAD SCI USA, V102, P10876, DOI 10.1073/pnas.0504818102
   Hiller S, 2007, J AM CHEM SOC, V129, P10823, DOI 10.1021/ja072564+
   Hitchens TK, 2003, J BIOMOL NMR, V25, P1, DOI 10.1023/A:1021975923026
   Jaravine V, 2006, NAT METHODS, V3, P605, DOI 10.1038/NMETH900
   Jaravine VA, 2008, J AM CHEM SOC, V130, P3927, DOI 10.1021/ja077282o
   Jaravine VA, 2006, J AM CHEM SOC, V128, P13421, DOI 10.1021/ja062146p
   Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad
   Kazimierczuk K, 2006, J MAGN RESON, V179, P323, DOI 10.1016/j.jmr.2006.02.001
   Kazimierczuk K, 2006, J BIOMOL NMR, V36, P157, DOI 10.1007/s10858-006-9077-y
   Kim S, 2003, J AM CHEM SOC, V125, P1385, DOI 10.1021/ja028197d
   Kupce E, 2004, J AM CHEM SOC, V126, P6429, DOI 10.1021/ja049432q
   Kupce E, 2007, MAGN RESON CHEM, V45, P2, DOI 10.1002/mrc.1931
   Langmead CJ, 2004, J BIOMOL NMR, V29, P111, DOI 10.1023/B:JNMR.0000019247.89110.e6
   Lin HN, 2005, NUCLEIC ACIDS RES, V33, P4593, DOI 10.1093/nar/gki768
   Luan T, 2005, J BIOMOL NMR, V33, P1, DOI 10.1007/s10858-005-1363-6
   Mandelshtam VA, 2000, J MAGN RESON, V144, P343, DOI 10.1006/jmre.2000.2023
   Mandelshtam VA, 1998, J MAGN RESON, V133, P304, DOI 10.1006/jmre.1998.1476
   Marion D, 2005, J BIOMOL NMR, V32, P141, DOI 10.1007/s10858-005-5977-5
   Masse JE, 2006, J MAGN RESON, V181, P45, DOI 10.1016/j.jmr.2006.03.012
   Masse JE, 2005, J MAGN RESON, V174, P133, DOI 10.1016/j.jmr.2005.01.017
   Mishkovsky M, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2748768
   Nilges M, 1997, J MOL BIOL, V269, P408, DOI 10.1006/jmbi.1997.1044
   Orekhov VY, 2001, J BIOMOL NMR, V20, P49, DOI 10.1023/A:1011234126930
   Pervushin K, 2002, J AM CHEM SOC, V124, P12898, DOI 10.1021/ja027149q
   Pristovsek P, 2002, J COMPUT CHEM, V23, P335, DOI 10.1002/jcc.10011
   Rovnyak D, 2004, J MAGN RESON, V170, P15, DOI 10.1016/j.jmr.2004.05.016
   Schanda P, 2005, J BIOMOL NMR, V33, P199, DOI 10.1007/s10858-005-4425-x
   Snyder DA, 2007, J AM CHEM SOC, V129, P14126, DOI 10.1021/ja075533n
   Snyder DA, 2007, J BIOMOL NMR, V39, P165, DOI 10.1007/s10858-007-9187-1
   Takeda M, 2007, NAT PROTOC, V2, P2896, DOI 10.1038/nprot.2007.423
   Tian F, 2001, J AM CHEM SOC, V123, P11791, DOI 10.1021/ja011806h
   Tugarinov V, 2005, J AM CHEM SOC, V127, P2767, DOI 10.1021/ja044032o
   Wu KP, 2005, LECT NOTES COMPUT SC, V3500, P103
   Zhang FL, 2004, J AM CHEM SOC, V126, P13180, DOI 10.1021/ja047241h
NR 53
TC 6
Z9 6
U1 0
U2 5
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 0925-2738
EI 1573-5001
J9 J BIOMOL NMR
JI J. Biomol. NMR
PD OCT
PY 2008
VL 42
IS 2
BP 77
EP 86
DI 10.1007/s10858-008-9269-8
PG 10
WC Biochemistry & Molecular Biology; Spectroscopy
SC Biochemistry & Molecular Biology; Spectroscopy
GA 357AL
UT WOS:000259818600001
PM 18784977
OA Green Published
DA 2021-01-25
ER

PT J
AU Arber, W
AF Arber, Werner
TI Roots, promotion and impact of technological innovation
SO JOURNAL OF BIOTECHNOLOGY
LA English
DT Meeting Abstract
C1 [Arber, Werner] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0168-1656
EI 1873-4863
J9 J BIOTECHNOL
JI J. Biotechnol.
PD OCT
PY 2008
VL 136
SU S
MA PL-10
BP S5
EP S5
DI 10.1016/j.jbiotec.2008.07.1854
PG 1
WC Biotechnology & Applied Microbiology
SC Biotechnology & Applied Microbiology
GA V32VT
UT WOS:000208979400007
DA 2021-01-25
ER

PT J
AU Meier, T
   Erb, M
   Meinen, S
   Barzaghi, P
   Ruegg, M
AF Meier, T.
   Erb, M.
   Meinen, S.
   Barzaghi, P.
   Rueegg, M.
TI Omigapil/SNT-317 prevents apoptosis and ameliorates the pathology of
   laminin-alpha2 deficient muscle dystrophy
SO NEUROMUSCULAR DISORDERS
LA English
DT Meeting Abstract
CT 13th International Congress of the World-Muscle-Society
CY SEP 29-OCT 02, 2008
CL Newcastle upon Tyne, ENGLAND
SP World Muscle Soc
C1 [Meier, T.; Erb, M.; Barzaghi, P.] Santhera Pharmaceut, Liestal, Switzerland.
   [Meinen, S.; Rueegg, M.] Univ Basel, Biozentrum, Basel, Switzerland.
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 0
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0960-8966
J9 NEUROMUSCULAR DISORD
JI Neuromusc. Disord.
PD OCT
PY 2008
VL 18
IS 9-10
BP 832
EP 832
DI 10.1016/j.nmd.2008.06.377
PG 1
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 356JQ
UT WOS:000259774900359
DA 2021-01-25
ER

PT J
AU Linden, MH
   Hartmann, RK
   Klostermeier, D
AF Linden, Martin H.
   Hartmann, Roland K.
   Klostermeier, Dagmar
TI The putative RNase P motif in the DEAD box helicase Hera is dispensable
   for efficient interaction with RNA and helicase activity
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID C-TERMINAL DOMAIN; S RIBOSOMAL-RNA; ESCHERICHIA-COLI; RIBONUCLEASE-P;
   BACILLUS-SUBTILIS; THERMUS-THERMOPHILUS; CRYSTAL-STRUCTURE; GROUP-I;
   BIOCHEMICAL-CHARACTERIZATION; PROTEIN INTERACTIONS
AB DEAD box helicases use the energy of ATP hydrolysis to remodel RNA structures or RNA/protein complexes. They share a common helicase core with conserved signature motifs, and additional domains may confer substrate specificity. Identification of a specific substrate is crucial towards understanding the physiological role of a helicase. RNA binding and ATPase stimulation are necessary, but not sufficient criteria for a bona fide helicase substrate. Here, we report single molecule FRET experiments that identify fragments of the 23S rRNA comprising hairpin 92 and RNase P RNA as substrates for the Thermus thermophilus DEAD box helicase Hera. Both substrates induce a switch to the closed conformation of the helicase core and stimulate the intrinsic ATPase activity of Hera. Binding of these RNAs is mediated by the Hera C-terminal domain, but does not require a previously proposed putative RNase P motif within this domain. ATP-dependent unwinding of a short helix adjacent to hairpin 92 in the ribosomal RNA suggests a specific role for Hera in ribosome assembly, analogously to the Escherichia coli and Bacillus subtilis helicases DbpA and YxiN. In addition, the specificity of Hera for RNase P RNA may be required for RNase P RNA folding or RNase P assembly.
C1 [Linden, Martin H.; Klostermeier, Dagmar] Univ Basel, Dept Biophys Chem, Biozentrum, CH-4056 Basel, Switzerland.
   [Hartmann, Roland K.] Univ Marburg, Inst Pharmaceut Chem, D-35037 Marburg, Germany.
RP Klostermeier, D (corresponding author), Univ Basel, Dept Biophys Chem, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@unibas.ch
FU VolkswagenStiftungVolkswagen; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG); Oxford
   University Press
FX VolkswagenStiftung (to D. K.); the Swiss National Science Foundation (to
   D. K.); and the Deutsche Forschungsgemeinschaft (to R. K. H). The Open
   Access publication charge for this article has been waived by Oxford
   University Press. NAR Editorial Board members are entitled to one free
   paper per year in recognition of their work on behalf of the journal.
CR Adam H., 1962, METHODEN ENZYMATISCH, P573
   Andersen CBF, 2006, SCIENCE, V313, P1968, DOI 10.1126/science.1131981
   Biswas R, 2000, J MOL BIOL, V296, P19, DOI 10.1006/jmbi.1999.3443
   Bono F, 2006, CELL, V126, P713, DOI 10.1016/j.cell.2006.08.006
   BROWN JW, 1992, NUCLEIC ACIDS RES, V20, P1451, DOI 10.1093/nar/20.7.1451
   Buck AH, 2005, NAT STRUCT MOL BIOL, V12, P958, DOI 10.1038/nsmb1004
   Busch S, 2000, J MOL BIOL, V299, P941, DOI 10.1006/jmbi.2000.3789
   Cordin O, 2006, GENE, V367, P17, DOI 10.1016/j.gene.2005.10.019
   Cuzic S, 2007, BIOL CHEM, V388, P717, DOI 10.1515/BC.2007.095
   Day-Storms JJ, 2004, RNA, V10, P1595, DOI 10.1261/rna.7550104
   Feltens R, 2003, P NATL ACAD SCI USA, V100, P5724, DOI 10.1073/pnas.0931462100
   FORSTER T, 1959, DISCUSS FARADAY SOC, P7
   Gossringer M, 2007, MOL MICROBIOL, V66, P801, DOI 10.1111/j.1365-2958.2007.05962.x
   GORBALENYA AE, 1993, CURR OPIN STRUC BIOL, V3, P419, DOI 10.1016/S0959-440X(05)80116-2
   Grohman JK, 2007, BIOCHEMISTRY-US, V46, P3013, DOI 10.1021/bi0619472
   GUERRIERTAKADA C, 1983, CELL, V35, P849, DOI 10.1016/0092-8674(83)90117-4
   Halls C, 2007, J MOL BIOL, V365, P835, DOI 10.1016/j.jmb.2006.09.083
   Hartmann E, 2003, TRENDS GENET, V19, P561, DOI 10.1016/j.tig.2003.08.007
   HARTMANN RK, 1991, NUCLEIC ACIDS RES, V19, P5957, DOI 10.1093/nar/19.21.5957
   Heide C, 1999, RNA, V5, P102, DOI 10.1017/S1355838299981499
   Huang HR, 2005, P NATL ACAD SCI USA, V102, P163, DOI 10.1073/pnas.0407896101
   Jovanovic M, 2002, NUCLEIC ACIDS RES, V30, P5065, DOI 10.1093/nar/gkf670
   Karginov FV, 2005, J BIOL CHEM, V280, P35499, DOI 10.1074/jbc.M506815200
   Karow AR, 2007, FEBS J, V274, P463, DOI 10.1111/j.1742-4658.2006.05593.x
   Kossen K, 2002, J MOL BIOL, V324, P625, DOI 10.1016/S0022-2836(02)01140-3
   Kossen K, 1999, NUCLEIC ACIDS RES, V27, P3811, DOI 10.1093/nar/27.19.3811
   Magde D, 2002, PHOTOCHEM PHOTOBIOL, V75, P327, DOI 10.1562/0031-8655(2002)075<0327:FQYATR>2.0.CO;2
   Marszalkowski M, 2008, RNA, V14, P127, DOI 10.1261/rna.762508
   Mohr G, 2008, J MOL BIOL, V375, P1344, DOI 10.1016/j.jmb.2007.11.041
   Mohr S, 2006, P NATL ACAD SCI USA, V103, P3569, DOI 10.1073/pnas.0600332103
   Mohr S, 2002, CELL, V109, P769, DOI 10.1016/S0092-8674(02)00771-7
   Morlang S, 1999, J MOL BIOL, V294, P795, DOI 10.1006/jmbi.1999.3282
   Niranjanakumari S, 2007, RNA, V13, P521, DOI 10.1261/rna.308707
   PARKER CA, 1960, ANALYST, V85, P587, DOI 10.1039/an9608500587
   Pugh GE, 1999, J MOL BIOL, V292, P771, DOI 10.1006/jmbi.1999.3112
   Rox C, 2002, J MOL BIOL, V315, P551, DOI 10.1006/jmbi.2001.5261
   Rudolph MG, 2006, J MOL BIOL, V361, P731, DOI 10.1016/j.jmb.2006.06.065
   Sengoku T, 2006, CELL, V125, P287, DOI 10.1016/j.cell.2006.01.054
   Story RM, 2001, P NATL ACAD SCI USA, V98, P1465, DOI 10.1073/pnas.98.4.1465
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   TALBOT SJ, 1994, BIOCHEMISTRY-US, V33, P1406, DOI 10.1021/bi00172a017
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   Tijerina P, 2006, P NATL ACAD SCI USA, V103, P16698, DOI 10.1073/pnas.0603127103
   Torres-Larios A, 2006, CURR OPIN STRUC BIOL, V16, P327, DOI 10.1016/j.sbi.2006.04.002
   Tsai HY, 2003, J MOL BIOL, V325, P661, DOI 10.1016/S0022-2836(02)01267-6
   WANG S, 2006, RNA
   WAUGH DS, 1990, J BACTERIOL, V172, P6316, DOI 10.1128/jb.172.11.6316-6322.1990
   Wegscheid B, 2006, RNA, V12, P2135, DOI 10.1261/rna.188306
   Wong TN, 2007, P NATL ACAD SCI USA, V104, P17995, DOI 10.1073/pnas.0705038104
NR 49
TC 31
Z9 31
U1 0
U2 5
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD OCT
PY 2008
VL 36
IS 18
BP 5800
EP 5811
DI 10.1093/nar/gkn581
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 361UP
UT WOS:000260152900007
PM 18782831
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Duany, YD
   Jungblut, SP
   Schmidt, AS
   Klostermeier, D
AF Duany, Yoandris del Toro
   Jungblut, Stefan P.
   Schmidt, Andreas S.
   Klostermeier, Dagmar
TI The reverse gyrase helicase-like domain is a nucleotide-dependent switch
   that is attenuated by the topoisomerase domain
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID BOX PROTEIN EIF4A; ATP-GAMMA-S; COOPERATIVE BINDING; TERMINAL DOMAIN;
   RNA HELICASE; DNA; HYPERTHERMOPHILE; SPECIFICITY; HYDROLYSIS; MODULATION
AB Reverse gyrase is a topoisomerase that introduces positive supercoils into DNA in an ATP-dependent manner. It is unique to hyperthermophilic archaea and eubacteria, and has been proposed to protect their DNA from damage at high temperatures. Cooperation between its N-terminal helicase-like and the C-terminal topoisomerase domain is required for positive supercoiling, but the precise role of the helicase-like domain is currently unknown. Here, the characterization of the isolated helicase-like domain from Thermotoga maritima reverse gyrase is presented. We show that the helicase-like domain contains all determinants for nucleotide binding and ATP hydrolysis. Its intrinsic ATP hydrolysis is significantly stimulated by ssDNA, dsDNA and plasmid DNA. During the nucleotide cycle, the helicase-like domain switches between high- and low-affinity states for dsDNA, while its affinity for ssDNA in the ATP and ADP states is similar. In the context of reverse gyrase, the differences in DNA affinities of the nucleotide states are smaller, and the DNA-stimulated ATPase activity is strongly reduced. This inhibitory effect of the topoisomerase domain decelerates the progression of reverse gyrase through the nucleotide cycle, possibly providing optimal coordination of ATP hydrolysis with the complex reaction of DNA supercoiling.
C1 [Duany, Yoandris del Toro; Jungblut, Stefan P.; Schmidt, Andreas S.; Klostermeier, Dagmar] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Klostermeier, D (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM dagmar.klostermeier@unibas.ch
FU VolkswagenStiftungVolkswagen; Swiss National Science FoundationSwiss
   National Science Foundation (SNSF)
FX VolkswagenStiftung; Swiss National Science Foundation. Funding for open
   access charge: Swiss National Science Foundation.
CR Atomi H, 2004, J BACTERIOL, V186, P4829, DOI 10.1128/JB.186.14.4829-4833.2004
   CONFALONIERI F, 1993, P NATL ACAD SCI USA, V90, P4753, DOI 10.1073/pnas.90.10.4753
   Declais AC, 2000, J BIOL CHEM, V275, P19498, DOI 10.1074/jbc.M910091199
   Forterre P, 2002, TRENDS GENET, V18, P236, DOI 10.1016/S0168-9525(02)02650-1
   Gee P, 2008, J BIOL CHEM, V283, P9488, DOI 10.1074/jbc.M706777200
   HIRATSUKA T, 1983, BIOCHIM BIOPHYS ACTA, V742, P496, DOI 10.1016/0167-4838(83)90267-4
   Hsieh TS, 2006, J BIOL CHEM, V281, P5640, DOI 10.1074/jbc.M513252200
   Jaxel C, 1999, EUR J BIOCHEM, V260, P103, DOI 10.1046/j.1432-1327.1999.00128.x
   Jungblut SP, 2007, J MOL BIOL, V371, P197, DOI 10.1016/j.jmb.2007.05.031
   Kampmann M, 2004, NUCLEIC ACIDS RES, V32, P3537, DOI 10.1093/nar/gkh683
   KIKUCHI A, 1984, NATURE, V309, P677, DOI 10.1038/309677a0
   KIRKEGAARD K, 1985, J MOL BIOL, V185, P625, DOI 10.1016/0022-2836(85)90075-0
   Kossen K, 2002, J MOL BIOL, V324, P625, DOI 10.1016/S0022-2836(02)01140-3
   KOVALSKY OI, 1990, NUCLEIC ACIDS RES, V18, P2801, DOI 10.1093/nar/18.9.2801
   Krah R, 1997, J BIOL CHEM, V272, P13986, DOI 10.1074/jbc.272.21.13986
   Krah R, 1996, P NATL ACAD SCI USA, V93, P106, DOI 10.1073/pnas.93.1.106
   Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2180, DOI 10.1021/bi972430g
   Lorsch JR, 1998, BIOCHEMISTRY-US, V37, P2194, DOI 10.1021/bi9724319
   Ma E, 2008, J MOL BIOL, V380, P237, DOI 10.1016/j.jmb.2008.05.005
   Morlang S, 1999, J MOL BIOL, V294, P795, DOI 10.1006/jmbi.1999.3282
   Peck ML, 2003, RNA, V9, P1180, DOI 10.1261/rna.2103703
   Polach KJ, 2002, BIOCHEMISTRY-US, V41, P3693, DOI 10.1021/bi012062n
   Pyle AM, 2008, ANNU REV BIOPHYS, V37, P317, DOI 10.1146/annurev.biophys.37.032807.125908
   Rodriguez AC, 2003, BIOCHEMISTRY-US, V42, P5993, DOI 10.1021/bi034188l
   Rodriguez AC, 2002, J BIOL CHEM, V277, P29865, DOI 10.1074/jbc.M202853200
   Rodriguez AC, 2002, EMBO J, V21, P418, DOI 10.1093/emboj/21.3.418
   Rogers GW, 1999, J BIOL CHEM, V274, P12236, DOI 10.1074/jbc.274.18.12236
   Rogers GW, 2001, J BIOL CHEM, V276, P30914, DOI 10.1074/jbc.M100157200
   SHIBATA T, 1987, J BIOL CHEM, V262, P10419
   Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016
   Theissen B, 2008, P NATL ACAD SCI USA, V105, P548, DOI 10.1073/pnas.0705488105
   Yang QS, 2005, BIOCHEMISTRY-US, V44, P13591, DOI 10.1021/bi0508946
   Yang QS, 2006, NAT STRUCT MOL BIOL, V13, P981, DOI 10.1038/nsmb1165
NR 33
TC 22
Z9 22
U1 0
U2 2
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD OCT
PY 2008
VL 36
IS 18
BP 5882
EP 5895
DI 10.1093/nar/gkn587
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 361UP
UT WOS:000260152900015
PM 18796525
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Tripodi, M
   Evers, JF
   Mauss, A
   Bate, M
   Landgraf, M
AF Tripodi, Marco
   Evers, Jan Felix
   Mauss, Alex
   Bate, Michael
   Landgraf, Matthias
TI Structural Homeostasis: Compensatory Adjustments of Dendritic Arbor
   Geometry in Response to Variations of Synaptic Input
SO PLOS BIOLOGY
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; INTRINSIC ELECTROPHYSIOLOGICAL CHARACTERISTICS;
   PLATE TANGENTIAL CELLS; CONFOCAL IMAGE STACKS; STEM AUDITORY NUCLEI;
   TOXIN LIGHT-CHAIN; DROSOPHILA CNS; IN-VIVO; RECEPTORS SPECIFY;
   CALCIUM-RELEASE
AB As the nervous system develops, there is an inherent variability in the connections formed between differentiating neurons. Despite this variability, neural circuits form that are functional and remarkably robust. One way in which neurons deal with variability in their inputs is through compensatory, homeostatic changes in their electrical properties. Here, we show that neurons also make compensatory adjustments to their structure. We analysed the development of dendrites on an identified central neuron (aCC) in the late Drosophila embryo at the stage when it receives its first connections and first becomes electrically active. At the same time, we charted the distribution of presynaptic sites on the developing postsynaptic arbor. Genetic manipulations of the presynaptic partners demonstrate that the postsynaptic dendritic arbor adjusts its growth to compensate for changes in the activity and density of synaptic sites. Blocking the synthesis or evoked release of presynaptic neurotransmitter results in greater dendritic extension. Conversely, an increase in the density of presynaptic release sites induces a reduction in the extent of the dendritic arbor. These growth adjustments occur locally in the arbor and are the result of the promotion or inhibition of growth of neurites in the proximity of presynaptic sites. We provide evidence that suggest a role for the postsynaptic activity state of protein kinase A in mediating this structural adjustment, which modifies dendritic growth in response to synaptic activity. These findings suggest that the dendritic arbor, at least during early stages of connectivity, behaves as a homeostatic device that adjusts its size and geometry to the level and the distribution of input received. The growing arbor thus counterbalances naturally occurring variations in synaptic density and activity so as to ensure that an appropriate level of input is achieved.
C1 [Tripodi, Marco; Evers, Jan Felix; Mauss, Alex; Bate, Michael; Landgraf, Matthias] Univ Cambridge, Dept Zool, Cambridge, England.
RP Tripodi, M (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
EM marco.tripodi@unibas.ch; ml10006@cam.ac.uk
RI Evers, Jan Felix/E-4753-2014; Evers, Jan Felix/P-7021-2019
OI Evers, Jan Felix/0000-0001-6377-4570; Tripodi,
   Marco/0000-0002-6827-6690; Mauss, Alex/0000-0002-8061-8024
FU Wellcome TrusWellcome Trust; Medical Research Council (MRC)Medical
   Research Council UK (MRC); Gates Cambridge Scholarship; Royal
   SocietyRoyal Society of London; Medical Research CouncilMedical Research
   Council UK (MRC) [MC_UP_1201/2] Funding Source: Researchfish
FX This work was supported by the Wellcome Trust by a studentship under the
   auspices of the 4-Year PhD Programme in Developmental Biology to MT and
   a Programme Grant to MB and ML (Ref.: 075934). AM is funded by a Medical
   Research Council (MRC) studentship and a Gates Cambridge Scholarship.
   The work was also supported by the Royal Society: MB is a Royal Society
   Research Professor and ML a Royal Society Research Fellow.
CR Agmon-Snir H, 1998, NATURE, V393, P268
   Baines RA, 2002, J NEUROSCI, V22, P6587
   Baines RA, 2001, J NEUROSCI, V21, P1523
   Baines RA, 1999, CURR BIOL, V9, P1267, DOI 10.1016/S0960-9822(99)80510-7
   Baines RA, 1998, J NEUROSCI, V18, P4673
   Baines RA, 2003, J NEUROSCI, V23, P8664
   Barth M, 1997, J NEUROSCI, V17, P1493
   Bashaw GJ, 1999, CELL, V97, P917, DOI 10.1016/S0092-8674(00)80803-X
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Burrone J, 2003, CURR OPIN NEUROBIOL, V13, P560, DOI 10.1016/j.conb.2003.09.007
   Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3
   Davis GW, 1998, NEURON, V20, P305, DOI 10.1016/S0896-6273(00)80458-4
   DiAntonio A, 2001, NATURE, V412, P449, DOI 10.1038/35086595
   Evers JF, 2006, DEV BIOL, V297, P214, DOI 10.1016/j.ydbio.2006.05.012
   Evers JF, 2005, J NEUROPHYSIOL, V93, P2331, DOI 10.1152/jn.00761.2004
   Finch EA, 1998, NATURE, V396, P753, DOI 10.1038/25541
   Furrer MP, 2007, DEVELOPMENT, V134, P3795, DOI 10.1242/dev.02882
   GOODMAN LA, 1990, J NEUROBIOL, V21, P283, DOI 10.1002/neu.480210204
   GREENSPAN RJ, 1980, J COMP NEUROL, V189, P741, DOI 10.1002/cne.901890409
   Haag J, 1997, J COMPUT NEUROSCI, V4, P349, DOI 10.1023/A:1008804117334
   Haag J, 1999, J COMPUT NEUROSCI, V7, P213, DOI 10.1023/A:1008950515719
   Jan YN, 2003, NEURON, V40, P229, DOI 10.1016/S0896-6273(03)00631-7
   Lohmann C, 2005, NAT NEUROSCI, V8, P305, DOI 10.1038/nn1406
   London M, 2005, ANNU REV NEUROSCI, V28, P503, DOI 10.1146/annurev.neuro.28.061604.135703
   MacLean JN, 2003, NEURON, V37, P109, DOI 10.1016/S0896-6273(02)01104-2
   MacNeil MA, 1998, NEURON, V20, P971, DOI 10.1016/S0896-6273(00)80478-X
   Malpel S, 2002, DEVELOPMENT, V129, P1443
   Marder E, 2003, NEURON, V37, P2, DOI 10.1016/S0896-6273(02)01173-X
   Marder E, 2002, BIOESSAYS, V24, P1145, DOI 10.1002/bies.10185
   MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X
   McAllister AK, 1996, NEURON, V17, P1057, DOI 10.1016/S0896-6273(00)80239-1
   Murray MJ, 1998, J NEUROBIOL, V37, P607, DOI 10.1002/(SICI)1097-4695(199812)37:4<607::AID-NEU9>3.3.CO;2-H
   Niell CM, 2004, NAT NEUROSCI, V7, P254, DOI 10.1038/nn1191
   Olofsson B, 2005, DEV BIOL, V279, P233, DOI 10.1016/j.ydbio.2004.12.020
   PARKS TN, 1975, J COMP NEUROL, V164, P435, DOI 10.1002/cne.901640404
   Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907
   Polsky A, 2004, NAT NEUROSCI, V7, P621, DOI 10.1038/nn1253
   Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5
   Rajan I, 1998, J NEUROSCI, V18, P7836
   Redmond L, 2002, NEURON, V34, P999, DOI 10.1016/S0896-6273(02)00737-7
   ROCHA M, 1995, P NATL ACAD SCI USA, V92, P8026, DOI 10.1073/pnas.92.17.8026
   Rose CR, 2001, NEURON, V31, P519, DOI 10.1016/S0896-6273(01)00402-0
   Salvaterra Paul M., 2001, Gene Expression Patterns, V1, P73, DOI 10.1016/S1567-133X(01)00011-4
   Schmitt S, 2004, NEUROIMAGE, V23, P1283, DOI 10.1016/j.neuroimage.2004.06.047
   SCHULZE KL, 1995, CELL, V80, P311, DOI 10.1016/0092-8674(95)90414-X
   Scott EK, 2003, BMC NEUROSCI, V4, DOI 10.1186/1471-2202-4-14
   Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3
   Single S, 1998, SCIENCE, V281, P1848, DOI 10.1126/science.281.5384.1848
   SMITH ZDJ, 1983, J COMP NEUROL, V220, P199, DOI 10.1002/cne.902200207
   Svoboda K, 1999, NEURON, V22, P427, DOI 10.1016/S0896-6273(00)80698-4
   SWEENEY ST, 1995, NEURON, V14, P341, DOI 10.1016/0896-6273(95)90290-2
   Takechi H, 1998, NATURE, V396, P757, DOI 10.1038/25547
   THOMAS JB, 1984, NATURE, V310, P203, DOI 10.1038/310203a0
   TURRIGIANO G, 1994, SCIENCE, V264, P974, DOI 10.1126/science.8178157
   Turrigiano GG, 1999, TRENDS NEUROSCI, V22, P221, DOI 10.1016/S0166-2236(98)01341-1
   Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103
   VAUGHN JE, 1989, SYNAPSE, V3, P255, DOI 10.1002/syn.890030312
   Wong ROL, 2002, NAT REV NEUROSCI, V3, P803, DOI 10.1038/nrn941
   Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222
   Yamagata M, 2008, NATURE, V451, P465, DOI 10.1038/nature06469
   Zars T, 2000, LEARN MEMORY, V7, P18, DOI 10.1101/lm.7.1.18
   Zhang YQ, 2002, GENESIS, V34, P142, DOI 10.1002/gene.10144
   Zlatic M, 2003, NEURON, V37, P41, DOI 10.1016/S0896-6273(02)01131-5
NR 63
TC 72
Z9 73
U1 0
U2 4
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1545-7885
J9 PLOS BIOL
JI PLoS. Biol.
PD OCT
PY 2008
VL 6
IS 10
BP 2172
EP 2187
AR e260
DI 10.1371/journal.pbio.0060260
PG 16
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 365QW
UT WOS:000260423900013
PM 18959482
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Nisius, L
   Rogowski, M
   Vangelista, L
   Grzesiek, S
AF Nisius, Lydia
   Rogowski, Marco
   Vangelista, Luca
   Grzesiek, Stephan
TI Large-scale expression and purification of the major HIV-1 coreceptor
   CCR5 and characterization of its interaction with RANTES
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
DE CCR5; HIV-1; GPCR; membrane protein; RANTES; secondary structure; NMR;
   ITC; CD; baculovirus; Sf9 cells
ID PROTEIN-COUPLED-RECEPTOR; CRYSTAL-STRUCTURE; HETEROLOGOUS EXPRESSION;
   CHEMOKINE RECEPTORS; INSECT CELLS; MIP-1 ALPHA; BINDING; IDENTIFICATION;
   DIMERIZATION; AGGREGATION
AB The G protein-coupled receptor CCR5 is a human chemokine receptor involved in the activation and migration of leukocytes. CCR5 is also the major HIV-1 coreceptor that, together with human CD4 and the viral glycoprotein gp120, promotes virus entry into host cells. Thus inhibition of the CCR5-gp120 interaction presents a promising route to prevent HIV infections. Atomic structural details of the interaction between CCR5 and its cognate chemokines or gp120 are presently unknown due to the general difficulties of membrane protein structure determination. Here, we report the high-yield expression of human CCR5 in baculovirus-infected Sf9 insect cells. Highly purified (> 90%) CCR5 is obtained in detergent-solubilized form at yields of about 1 mg/l cell culture. The conformational integrity of recombinant CCR5 after purification is shown by immunoprecipitation with the conformation-dependent monoclonal antibody 2D7, CD and NMR spectroscopy. The detergent micelles contain CCR5 in monomeric and dimeric forms, which can be separated by size exclusion chromatography and characterized individually. Further functional characterization by isothermal titration calorimetry indicates that the recombinant receptor interacts with its cognate chemokine RANTES. This interaction is strongly suppressed when sulfation of CCR5 is inhibited in the insect cells. (c) 2008 Elsevier Inc. All rights reserved.
C1 [Nisius, Lydia; Rogowski, Marco; Grzesiek, Stephan] Univ Basel, Biozentrum, Div Struct Biol, CH-4056 Basel, Switzerland.
   [Vangelista, Luca] Ist Sci San Raffaele, Unit Human Virol, DIBIT, I-20132 Milan, Italy.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, Div Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Stephan.Grzesiek@unibas.ch
OI Vangelista, Luca/0000-0003-0764-5031; Grzesiek,
   Stephan/0000-0003-1998-4225
FU 6th Framework European Microbicides Program (EMPRO)European Union (EU);
   SNF Grant [31-109712]
FX We thank Prof. P. Lusso for providing the CCR5 cDNA and many stimulating
   discussions, I. Cima for help during initial expression tests, Drs. P.
   Werten and A. Strauss for helpful hints concerning the baculovirus
   expression, Prof. I. Jones for providing a further CCR5 baculovirus
   construct, Prof A. Engel and Dr. Petr Broz for electron microscopic,
   Profs. M. Karas and A. Sinz for mass spectroscopic characterization of
   CCR5HS as well as Prof. A. Seelig and Dr. S. Perspicace for help with
   ITC assays. This work was supported by the 6th Framework European
   Microbicides Program (EMPRO) and SNF Grant 31-109712 (S.G.) as Well as
   by a stipend of the Boehringer Ingelheim Fonds (L.N.).
CR Akermoun M, 2005, PROTEIN EXPRES PURIF, V44, P65, DOI 10.1016/j.pep.2005.04.016
   Alkhatib G, 1996, SCIENCE, V272, P1955, DOI 10.1126/science.272.5270.1955
   Appay V, 1999, J BIOL CHEM, V274, P27505, DOI 10.1074/jbc.274.39.27505
   Bannert N, 2001, J EXP MED, V194, P1661, DOI 10.1084/jem.194.11.1661
   Benkirane M, 1997, J BIOL CHEM, V272, P30603, DOI 10.1074/jbc.272.49.30603
   Blanpain C, 2001, J BIOL CHEM, V276, P23795, DOI 10.1074/jbc.M100583200
   Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577
   COCCHI F, 1995, SCIENCE, V270, P1811, DOI 10.1126/science.270.5243.1811
   Czaplewski LG, 1999, J BIOL CHEM, V274, P16077, DOI 10.1074/jbc.274.23.16077
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   DINGLEY AJ, 1995, J BIOMOL NMR, V6, P321
   Dukkipati A, 2006, PROTEIN EXPRES PURIF, V50, P203, DOI 10.1016/j.pep.2006.07.016
   Duma L, 2007, J MOL BIOL, V365, P1063, DOI 10.1016/j.jmb.2006.10.040
   Farzan M, 1999, CELL, V96, P667, DOI 10.1016/S0092-8674(00)80577-2
   Hartley O, 2004, P NATL ACAD SCI USA, V101, P16460, DOI 10.1073/pnas.0404802101
   Huang CC, 2007, SCIENCE, V317, P1930, DOI 10.1126/science.1145373
   Jin HJ, 2007, J BIOL CHEM, V282, P27976, DOI 10.1074/jbc.M702654200
   Littman DR, 1998, CELL, V93, P677, DOI 10.1016/S0092-8674(00)81429-4
   Mirzabekov T, 2000, NAT BIOTECHNOL, V18, P649, DOI 10.1038/76501
   Mirzabekov T, 1999, J BIOL CHEM, V274, P28745, DOI 10.1074/jbc.274.40.28745
   Nardese V, 2001, NAT STRUCT BIOL, V8, P611, DOI 10.1038/89653
   Palczewski K, 2000, SCIENCE, V289, P739, DOI 10.1126/science.289.5480.739
   Paterlini MG, 2002, BIOPHYS J, V83, P3012, DOI 10.1016/S0006-3495(02)75307-1
   Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908
   Polo S, 2000, EUR J IMMUNOL, V30, P3190, DOI 10.1002/1521-4141(200011)30:11<3190::AID-IMMU3190>3.0.CO;2-E
   Raport CJ, 1996, J BIOL CHEM, V271, P17161, DOI 10.1074/jbc.271.29.17161
   Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325
   Sarramegna V, 2003, CELL MOL LIFE SCI, V60, P1529, DOI 10.1007/s00018-003-3168-7
   Scarlatti G, 1997, NAT MED, V3, P1259, DOI 10.1038/nm1197-1259
   Skerra A, 1999, BIOMOL ENG, V16, P79, DOI 10.1016/S1050-3862(99)00033-9
   SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1
   Sodhi A, 2004, NAT REV MOL CELL BIO, V5, P998, DOI 10.1038/nrm1529
   Springael JY, 2006, MOL PHARMACOL, V69, P1652, DOI 10.1124/mol.105.019414
   Springael JY, 2005, CYTOKINE GROWTH F R, V16, P611, DOI 10.1016/j.cytogfr.2005.05.005
   Tate CG, 1996, TRENDS BIOTECHNOL, V14, P426, DOI 10.1016/0167-7799(96)10059-7
   Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052
   Wise A, 2002, DRUG DISCOV TODAY, V7, P235, DOI 10.1016/S1359-6446(01)02131-6
   Wu LJ, 1997, J EXP MED, V186, P1373, DOI 10.1084/jem.186.8.1373
   ZHAO Y, 1993, ARCH BIOCHEM BIOPHYS, V304, P434, DOI 10.1006/abbi.1993.1372
NR 39
TC 24
Z9 25
U1 1
U2 14
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD OCT
PY 2008
VL 61
IS 2
BP 155
EP 162
DI 10.1016/j.pep.2008.06.001
PG 8
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 347WM
UT WOS:000259172100009
PM 18588983
DA 2021-01-25
ER

PT J
AU Guilvout, I
   Chami, M
   Berrier, C
   Ghazi, A
   Engel, A
   Pugsley, AP
   Bayan, N
AF Guilvout, Ingrid
   Chami, Mohamed
   Berrier, Catherine
   Ghazi, Alexandre
   Engel, Andreas
   Pugsley, Anthony P.
   Bayan, Nicolas
TI In vitro multimerization and membrane insertion of bacterial outer
   membrane secretin PulD
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE type II secretion; protein multimerization; in vitro synthesis; membrane
   protein insertion
ID CELL-FREE SYNTHESIS; CHAPERONE-LIKE PROTEIN; ESCHERICHIA-COLI;
   NEISSERIA-MENINGITIDIS; KLEBSIELLA-PNEUMONIAE; PULLULANASE SECRETION;
   STRUCTURAL INSIGHTS; ELECTRON-MICROSCOPY; FREE EXPRESSION; PILQ SECRETIN
AB Synthesis of the Klebsiella oxytoca outer membrane secretin PulD, or its membrane-associated core domain, in a liposome-supplemented Escherichia coli in vitro transcription-translation system resulted in the formation of multimers that appeared as typical dodecameric secretin rings when examined by negative-stain electron microscopy. Cryo-electron microscopy of unstained liposomes and differential extraction by urea indicated that the secretin particles were inserted into the liposome membranes. When made in the presence of the detergent Brij-35, PulD and the core domain were synthesized as monomers. Both proteins caused almost immediate growth cessation when synthesized in E. coli without a signal peptide. The small amounts of PulD synthesized before cell death appeared as multimers with characteristics similar to those of the normal outer membrane secretin dodecamers. It was concluded that multimerization and membrane insertion are intrinsic properties of secretin PulD that are independent of a specific membrane environment or membrane-associated factors. The closely related Erwinia chrysanthemi secretin OutD behaved similarly to PulD in all assays,but the more distantly related Neisseria meningitidis secretin PilQ did not form multimers either when made in vitro in the presence of liposomes or when made in E. coli without its signal peptide. This is the first report of the apparently spontaneous in vitro assembly and membrane insertion of a large outer membrane protein complex. Spontaneous multimerization and insertion appear to be restricted to outer membrane proteins closely related to PulD. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Guilvout, Ingrid; Pugsley, Anthony P.; Bayan, Nicolas] Inst Pasteur, Mol Genet Unit, F-75724 Paris, France.
   [Guilvout, Ingrid; Pugsley, Anthony P.; Bayan, Nicolas] Inst Pasteur, CNRS, URA2172, F-75724 Paris, France.
   [Chami, Mohamed; Engel, Andreas] Univ Basel, ME Muller Inst, Biozentrum, CH-4056 Basel, Switzerland.
   [Berrier, Catherine; Ghazi, Alexandre; Bayan, Nicolas] CNRS, UMR8619, F-91405 Orsay, France.
   [Berrier, Catherine; Ghazi, Alexandre] Univ Paris 11, Canaux Ion Grp, F-91405 Orsay, France.
   [Bayan, Nicolas] Univ Paris 11, Microbiol Mol & Cellulaire Grp, F-91405 Orsay, France.
RP Pugsley, AP (corresponding author), Inst Pasteur, Mol Genet Unit, 25 Rue Dr Roux, F-75724 Paris, France.
EM max@pasteur.fr
RI Bayan, Nicolas/AAI-5034-2020
OI Bayan, Nicolas/0000-0001-7760-0811
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100A-10899]; M. E. Muller Foundation of Switzerland
FX We are grateful to members of the Molecular Genetics Unit for
   stimulating discussions and help with the manuscript. We thank
   Jean-Michel Betton for pDIA17, Nathalie Nadeau for technical assistance,
   Guillaume Vignon for help with PulD antibody preparation and testing,
   Etienne Carbonelle for N. meningitidis cell extracts, and Muhamed
   Kier-Taha and Dario Giorgini for N. meningitidis DNA. The work was
   supported, in part, by grants from the Agence National de Recherche (to
   A.P.P and A.G.), by Swiss National Science Foundation grant 3100A-10899
   (to A.E.), and by the M. E. Muller Foundation of Switzerland.
CR Bayan N, 2006, MOL MICROBIOL, V60, P1, DOI 10.1111/j.1365-2958.2006.05084.x
   Berrier C, 2004, BIOCHEMISTRY-US, V43, P12585, DOI 10.1021/bi049049y
   Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   Carbonnelle E, 2005, MOL MICROBIOL, V55, P54, DOI 10.1111/j.1365-2958.2004.04364.x
   Chami M, 2005, J BIOL CHEM, V280, P37732, DOI 10.1074/jbc.M504463200
   Collin S, 2007, MOL MICROBIOL, V64, P1350, DOI 10.1111/j.1365-2958.2007.05743.x
   Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200
   Collins RF, 2003, J BACTERIOL, V185, P2611, DOI 10.1128/JB.185.8.2611-2617.2003
   Daefler S, 1997, MOL MICROBIOL, V24, P465, DOI 10.1046/j.1365-2958.1997.3531727.x
   deCock H, 1996, J BIOL CHEM, V271, P12885, DOI 10.1074/jbc.271.22.12885
   DeLisa MP, 2003, P NATL ACAD SCI USA, V100, P6115, DOI 10.1073/pnas.0937838100
   DENFERT C, 1989, J BIOL CHEM, V264, P17462
   DENFERT C, 1987, EMBO J, V6, P3531, DOI 10.1002/j.1460-2075.1987.tb02679.x
   DENFERT C, 1989, J BACTERIOL, V171, P3673, DOI 10.1128/jb.171.7.3673-3679.1989
   Elbaz Y, 2004, P NATL ACAD SCI USA, V101, P1519, DOI 10.1073/pnas.0306533101
   Guilvout I, 1999, J BACTERIOL, V181, P7212, DOI 10.1128/JB.181.23.7212-7220.1999
   Guilvout I, 2006, EMBO J, V25, P5241, DOI 10.1038/sj.emboj.7601402
   Hardie KR, 1996, MOL MICROBIOL, V22, P967, DOI 10.1046/j.1365-2958.1996.01539.x
   Hardie KR, 1996, EMBO J, V15, P978, DOI 10.1002/j.1460-2075.1996.tb00434.x
   Helm RA, 2007, J BACTERIOL, V189, P3198, DOI 10.1128/JB.01833-06
   Kalmbach R, 2007, J MOL BIOL, V371, P639, DOI 10.1016/j.jmb.2007.05.087
   Klammt C, 2005, FEBS J, V272, P6024, DOI 10.1111/j.1742-4658.2005.05002.x
   Klammt C, 2006, FEBS J, V273, P4141, DOI 10.1111/j.1742-4658.2006.05432.x
   Koch AL, 1998, CRIT REV MICROBIOL, V24, P23, DOI 10.1080/10408419891294172
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   MICHAELIS S, 1985, J BACTERIOL, V164, P633, DOI 10.1128/JB.164.2.633-638.1985
   Miller J.H., 1992, SHORT COURSE BACTERI
   Mouratou B, 2007, P NATL ACAD SCI USA, V104, P17983, DOI 10.1073/pnas.0702963104
   MUNIER H, 1991, EUR J BIOCHEM, V196, P469, DOI 10.1111/j.1432-1033.1991.tb15838.x
   Nouwen N, 2000, EMBO J, V19, P2229, DOI 10.1093/emboj/19.10.2229
   Nouwen N, 1999, P NATL ACAD SCI USA, V96, P8173, DOI 10.1073/pnas.96.14.8173
   Opalka N, 2003, J MOL BIOL, V325, P461, DOI 10.1016/S0022-2836(02)01246-9
   Park KH, 2007, BIOCHEM J, V403, P183, DOI 10.1042/BJ20061473
   Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377
   Robichon C, 2005, J BIOL CHEM, V280, P974, DOI 10.1074/jbc.M411059200
   Schwarz D, 2007, NAT PROTOC, V2, P2945, DOI 10.1038/nprot.2007.426
   SEN K, 1991, J BIOL CHEM, V266, P11295
   Shevchik VE, 1998, MICROBIOL-UK, V144, P3219, DOI 10.1099/00221287-144-11-3219
   Tokuda H, 2004, BIOCHIM BIOPHYS ACTA, V1694, pIN1
   van Dalen A, 2002, FEBS LETT, V511, P51, DOI 10.1016/S0014-5793(01)03278-1
   Voulhoux R, 2004, RES MICROBIOL, V155, P129, DOI 10.1016/j.resmic.2003.11.007
   Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973
   Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015
   Zhao SQ, 2005, MOL MICROBIOL, V57, P1238, DOI 10.1111/j.1365-2958.2005.04752.x
NR 45
TC 52
Z9 52
U1 1
U2 11
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD SEP 26
PY 2008
VL 382
IS 1
BP 13
EP 23
DI 10.1016/j.jmb.2008.06.055
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 353SM
UT WOS:000259588500002
PM 18616949
DA 2021-01-25
ER

PT J
AU Bosshart, PD
   Casagrande, F
   Frederix, PLTM
   Ratera, M
   Bippes, CA
   Muller, DJ
   Palacin, M
   Engel, A
   Fotiadis, D
AF Bosshart, Patrick D.
   Casagrande, Fabio
   Frederix, Patrick L. T. M.
   Ratera, Merce
   Bippes, Christian A.
   Mueller, Daniel J.
   Palacin, Manuel
   Engel, Andreas
   Fotiadis, Dimitrios
TI High-throughput single-molecule force spectroscopy for membrane proteins
SO NANOTECHNOLOGY
LA English
DT Article
ID DYNAMIC ENERGY LANDSCAPE; UNFOLDING PATHWAYS; RECOGNITION SITE;
   TRANSPORTER; ANTIPORTER; IDENTIFICATION; TOPOLOGY; MECHANISM; BINDING;
   SURFACE
AB Atomic force microscopy-based single-molecule force spectroscopy (SMFS) is a powerful tool for studying the mechanical properties, intermolecular and intramolecular interactions, unfolding pathways, and energy landscapes of membrane proteins. One limiting factor for the large-scale applicability of SMFS on membrane proteins is its low efficiency in data acquisition. We have developed a semi-automated high-throughput SMFS (HT-SMFS) procedure for efficient data acquisition. In addition, we present a coarse filter to efficiently extract protein unfolding events from large data sets. The HT-SMFS procedure and the coarse filter were validated using the proton pump bacteriorhodopsin ( BR) from Halobacterium salinarum and the L-arginine/agmatine antiporter AdiC from the bacterium Escherichia coli. To screen for molecular interactions between AdiC and its substrates, we recorded data sets in the absence and in the presence of L-arginine, D-arginine, and agmatine. Altogether similar to 400000 force-distance curves were recorded. Application of coarse filtering to this wealth of data yielded six data sets with similar to 200 ( AdiC) and similar to 400 ( BR) force-distance spectra in each. Importantly, the raw data for most of these data sets were acquired in one to two days, opening new perspectives for HT-SMFS applications.
C1 [Bosshart, Patrick D.; Casagrande, Fabio; Frederix, Patrick L. T. M.; Engel, Andreas; Fotiadis, Dimitrios] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Ratera, Merce; Palacin, Manuel] Univ Barcelona, Inst Res Biomed, Dept Biochem & Mol Biol, Fac Biol, E-08028 Barcelona, Spain.
   [Ratera, Merce; Palacin, Manuel] Ctr Invest Biomed Red Enfermedades Raras, E-08028 Barcelona, Spain.
   [Bippes, Christian A.; Mueller, Daniel J.] Tech Univ, Ctr BioTechnol, D-01307 Dresden, Germany.
   [Fotiadis, Dimitrios] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland.
RP Bosshart, PD (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch; dimitrios.fotiadis@mci.unibe.ch
RI Muller, Daniel J/A-5967-2010
OI Muller, Daniel J/0000-0003-3075-0665
CR Abramson J, 2003, SCIENCE, V301, P610, DOI 10.1126/science.1088196
   BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175
   BUTT HJ, 1992, BIOPHYS J, V63, P578, DOI 10.1016/S0006-3495(92)81601-6
   BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001
   Cisneros DA, 2005, STRUCTURE, V13, P235, DOI 10.1016/j.str.2004.12.005
   CLOSS EI, 1993, J BIOL CHEM, V268, P20796
   Dietz H, 2007, JPN J APPL PHYS 1, V46, P5540, DOI 10.1143/JJAP.46.5540
   Engel A, 2008, ANNU REV BIOCHEM, V77, P127, DOI 10.1146/annurev.biochem.77.062706.154450
   Engelman DM, 2003, FEBS LETT, V555, P122, DOI 10.1016/S0014-5793(03)01106-2
   Essen LO, 1998, P NATL ACAD SCI USA, V95, P11673, DOI 10.1073/pnas.95.20.11673
   Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200
   Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021
   Fotiadis D, 2002, MICRON, V33, P385, DOI 10.1016/S0968-4328(01)00026-9
   Gasol E, 2004, J BIOL CHEM, V279, P31228, DOI 10.1074/jbc.M402428200
   Hu LA, 1998, BIOCHEM J, V336, P69, DOI 10.1042/bj3360069
   Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797
   Janovjak H, 2004, STRUCTURE, V12, P871, DOI 10.1016/S0969-2126(04)00098-X
   Janovjak H, 2003, EMBO J, V22, P5220, DOI 10.1093/emboj/cdg509
   Janovjak H, 2008, CHEMPHYSCHEM, V9, P954, DOI 10.1002/cphc.200700662
   Jimenez-Vidal M, 2004, J BIOL CHEM, V279, P11214, DOI 10.1074/jbc.M309866200
   Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200
   Kedrov A, 2004, J MOL BIOL, V340, P1143, DOI 10.1016/j.jmb.2004.05.026
   Kedrov A, 2008, J MOL BIOL, V375, P1258, DOI 10.1016/j.jmb.2007.11.032
   Kedrov A, 2007, J STRUCT BIOL, V159, P290, DOI 10.1016/j.jsb.2007.02.010
   Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640
   Kessler M, 2006, STRUCTURE, V14, P521, DOI 10.1016/j.str.2005.11.023
   Kimura Y, 1997, NATURE, V389, P206, DOI 10.1038/38323
   King SC, 2003, BIOCHEM J, V376, P645, DOI 10.1042/BJ20030595
   Klyszejko AL, 2008, J MOL BIOL, V376, P35, DOI 10.1016/j.jmb.2007.11.030
   Krogh A, 2001, J MOL BIOL, V305, P567, DOI 10.1006/jmbi.2000.4315
   Kuhn M, 2005, J MICROSC-OXFORD, V218, P125, DOI 10.1111/j.1365-2818.2005.01478.x
   Marsico A, 2007, BIOINFORMATICS, V23, pE231, DOI 10.1093/bioinformatics/btl293
   Minchin RF, 2004, INT J BIOCHEM CELL B, V36, P271, DOI 10.1016/S1357-2725(03)00245-0
   Moller C, 2003, J STRUCT BIOL, V142, P369, DOI 10.1016/S1047-8477(03)00066-2
   Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309
   Muller DJ, 2006, CURR OPIN STRUC BIOL, V16, P489, DOI 10.1016/j.sbi.2006.06.001
   Muller DJ, 2002, BIOPHYS J, V83, P3578, DOI 10.1016/S0006-3495(02)75358-7
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   Reig N, 2007, J BIOL CHEM, V282, P13270, DOI 10.1074/jbc.M610695200
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Sapra KT, 2006, J MOL BIOL, V355, P640, DOI 10.1016/j.jmb.2005.10.080
   Soksawatmaekhin W, 2006, J BIOL CHEM, V281, P29213, DOI 10.1074/jbc.M600754200
   Xie H, 2004, MOL MEMBR BIOL, V21, P323, DOI 10.1080/09687860400003941
NR 43
TC 18
Z9 18
U1 0
U2 10
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD SEP 24
PY 2008
VL 19
IS 38
AR 384014
DI 10.1088/0957-4484/19/38/384014
PG 15
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 336SU
UT WOS:000258385700015
PM 21832573
DA 2021-01-25
ER

PT J
AU Frederix, PLTM
   Bosshart, PD
   Akiyama, T
   Chami, M
   Gullo, MR
   Blackstock, JJ
   Dooleweerdt, K
   de Rooij, NF
   Staufer, U
   Engel, A
AF Frederix, Patrick L. T. M.
   Bosshart, Patrick D.
   Akiyama, Terunobu
   Chami, Mohamed
   Gullo, Maurizio R.
   Blackstock, Jason J.
   Dooleweerdt, Karin
   de Rooij, Nico F.
   Staufer, Urs
   Engel, Andreas
TI Conductive supports for combined AFM-SECM on biological membranes
SO NANOTECHNOLOGY
LA English
DT Article
ID SCANNING ELECTROCHEMICAL MICROSCOPY; ATOMIC-FORCE MICROSCOPY;
   ELECTRON-TRANSFER KINETICS; ORDERED GRAPHITE; PROBES; MODE; TIP;
   ULTRAMICROELECTRODE; CANTILEVERS; FABRICATION
AB Four different conductive supports are analysed regarding their suitability for combined atomic force and scanning electrochemical microscopy ( AFM-SECM) on biological membranes. Highly oriented pyrolytic graphite ( HOPG), MoS2, template stripped gold, and template stripped platinum are compared as supports for high resolution imaging of reconstituted membrane proteins or native membranes, and as electrodes for transferring electrons from or to a redox molecule. We demonstrate that high resolution topographs of the bacterial outer membrane protein F can be recorded by contact mode AFM on all four supports. Electrochemical feedback experiments with conductive cantilevers that feature nanometre-scale electrodes showed fast re-oxidation of the redox couple Ru(NH3)(6)(3+)/2(+) with the two metal supports after prolonged immersion in electrolyte. In contrast, the re-oxidation rates decayed quickly to unpractical levels with HOPG or MoS2 under physiological conditions. On HOPG we observed heterogeneity in the re-oxidation rate of the redox molecules with higher feedback currents at step edges. The latter results demonstrate the capability of conductive cantilevers with small electrodes to measure minor variations in an SECM signal and to relate them to nanometre-scale features in a simultaneously recorded AFM topography. Rapid decay of re-oxidation rate and surface heterogeneity make HOPG or MoS2 less attractive for combined AFM-SECM experiments on biological membranes than template stripped gold or platinum supports.
C1 [Frederix, Patrick L. T. M.; Bosshart, Patrick D.; Dooleweerdt, Karin; Engel, Andreas] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Akiyama, Terunobu; Gullo, Maurizio R.; de Rooij, Nico F.; Staufer, Urs] Univ Neuchatel, Inst Microtechnol, CH-2002 Neuchatel, Switzerland.
   [Blackstock, Jason J.] Hewlett Packard Labs, Quantum Sci Res Grp, Palo Alto, CA USA.
RP Frederix, PLTM (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RI Staufer, Urs/J-6866-2016; Gullo, Maurizio/B-4383-2012
OI Staufer, Urs/0000-0002-3519-6467; 
CR Akiyama T, 2004, JPN J APPL PHYS 1, V43, P3865, DOI 10.1143/JJAP.43.3865
   Banks CE, 2005, CHEM COMMUN, P829, DOI 10.1039/b413177k
   BARD AJ, 1992, J PHYS CHEM-US, V96, P1861, DOI 10.1021/j100183a064
   BARD AJ, 1989, ANAL CHEM, V61, P132, DOI 10.1021/ac00177a011
   Bard AJ, 2001, ELECTROCHEMICAL METH
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Blackstock JJ, 2003, SURF SCI, V546, P87, DOI 10.1016/j.susc.2003.09.039
   Burt DP, 2005, NANO LETT, V5, P639, DOI 10.1021/nl050018d
   CLEMMER CR, 1992, SCANNING MICROSCOPY, V6, P319
   COWAN SW, 1992, NATURE, V358, P727, DOI 10.1038/358727a0
   Davoodi A, 2005, ELECTROCHEM SOLID ST, V8, pB21, DOI 10.1149/1.1911900
   Dobson PS, 2006, PHYS CHEM CHEM PHYS, V8, P3909, DOI 10.1039/b605828k
   Dobson PS, 2005, ANAL CHEM, V77, P424, DOI 10.1021/ac048930e
   Edwards MA, 2006, PHYSIOL MEAS, V27, pR63, DOI 10.1088/0967-3334/27/12/R01
   ENGEL A, 1992, J STRUCT BIOL, V109, P219, DOI 10.1016/1047-8477(92)90035-9
   Etienne M, 2004, ELECTROCHEM COMMUN, V6, P288, DOI 10.1016/j.elecom.2004.01.006
   Fasching RJ, 2005, SENSOR ACTUAT B-CHEM, V108, P964, DOI 10.1016/j.snb.2004.10.058
   Fermin DJ, 2006, CHIMIA, V60, pA789, DOI 10.2533/chimia.2006.789
   Frederix PLTM, 2005, NANOTECHNOLOGY, V16, P997, DOI 10.1088/0957-4484/16/8/001
   Frederix PLTM, 2003, CURR OPIN CHEM BIOL, V7, P641, DOI 10.1016/j.cbpa.2003.08.010
   Gardner CE, 2005, ELECTROCHEM COMMUN, V7, P612, DOI 10.1016/j.elecom.2005.04.005
   Gardner CE, 2002, ANAL CHEM, V74, p576A, DOI 10.1021/ac0221482
   GIERST L, 1965, J ELECTROANAL CHEM, V10, P397, DOI 10.1016/0022-0728(65)80042-0
   Gullo MR, 2006, ANAL CHEM, V78, P5436, DOI 10.1021/ac0521495
   HEGNER M, 1998, PROCEDURES SCANNING, P169
   Hirata Y, 2004, BIOELECTROCHEMISTRY, V63, P217, DOI 10.1016/j.bioelechem.2004.01.001
   KNETEN KR, 1992, ANAL CHEM, V64, P2518, DOI 10.1021/ac00045a011
   Kranz C, 2004, ULTRAMICROSCOPY, V100, P127, DOI 10.1016/j.ultramic.2003.10.004
   Kranz C, 2001, ANAL CHEM, V73, P2491, DOI 10.1021/ac001099v
   Kueng A, 2005, METH MOL B, V300, P403
   Kueng A, 2005, BIOSENS BIOELECTRON, V21, P346, DOI 10.1016/j.bios.2004.10.020
   Kueng A, 2005, ANGEW CHEM INT EDIT, V44, P3419, DOI 10.1002/anie.200461556
   Kueng A, 2003, ANGEW CHEM INT EDIT, V42, P3238, DOI 10.1002/anie.200351111
   KWAK J, 1989, ANAL CHEM, V61, P1794, DOI 10.1021/ac00192a003
   LEE CM, 1990, P NATL ACAD SCI USA, V87, P1740, DOI 10.1073/pnas.87.5.1740
   Li J, 1996, ELECTROANAL, V8, P107, DOI 10.1002/elan.1140080202
   Liebetrau JM, 2003, ANAL CHEM, V75, P563, DOI 10.1021/ac026166v
   LIU HY, 1986, J AM CHEM SOC, V108, P3838, DOI 10.1021/ja00273a054
   LUDWIG M, 1995, REV SCI INSTRUM, V66, P2857, DOI 10.1063/1.1145568
   Macpherson JV, 2000, ANAL CHEM, V72, P276, DOI 10.1021/ac990921w
   MCDERMOTT MT, 1992, J PHYS CHEM-US, V96, P3124, DOI 10.1021/j100186a063
   Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Niimi Y, 2006, PHYS REV B, V73, DOI 10.1103/PhysRevB.73.085421
   OSHEA SJ, 1995, REV SCI INSTRUM, V66, P2508, DOI 10.1063/1.1145649
   Shao YH, 1997, ANAL CHEM, V69, P1627, DOI 10.1021/ac960887a
   Shin H, 2007, ANAL CHEM, V79, P4769, DOI 10.1021/ac070598u
   Sklyar O, 2005, SURF SCI, V597, P181, DOI 10.1016/j.susc.2004.02.041
   STUPIAN GW, 1987, APPL PHYS LETT, V51, P1560, DOI 10.1063/1.98635
   Sun P, 2006, ANAL CHEM, V78, P6526, DOI 10.1021/ac060924q
   WIGHTMAN RM, 1989, ELECTROANAL CHEM, V15, P267
   Wittstock G, 2007, ANGEW CHEM INT EDIT, V46, P1584, DOI 10.1002/anie.200602750
   Yasukawa T, 1999, ANAL CHEM, V71, P4637, DOI 10.1021/ac9903104
   Zoski CG, 2004, ANAL CHEM, V76, P3646, DOI 10.1021/ac049938r
NR 54
TC 37
Z9 37
U1 1
U2 51
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
EI 1361-6528
J9 NANOTECHNOLOGY
JI Nanotechnology
PD SEP 24
PY 2008
VL 19
IS 38
AR 384004
DI 10.1088/0957-4484/19/38/384004
PG 10
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 336SU
UT WOS:000258385700005
PM 21832564
DA 2021-01-25
ER

PT J
AU Hoogenboom, BW
   Frederix, PLTM
   Fotiadis, D
   Hug, HJ
   Engel, A
AF Hoogenboom, B. W.
   Frederix, P. L. T. M.
   Fotiadis, D.
   Hug, H. J.
   Engel, A.
TI Potential of interferometric cantilever detection and its application
   for SFM/AFM in liquids
SO NANOTECHNOLOGY
LA English
DT Article
ID ATOMIC-FORCE MICROSCOPY; SPECTROSCOPY; SENSITIVITY; FRICTION
AB We have developed an optical cantilever deflection detector with a spot size < 3 mu m and fm Hz(-1/2) sensitivity over a > 10 MHz bandwidth. In this work, we demonstrate its potential for detecting small-amplitude oscillations of various flexural and torsional oscillation modes of cantilevers. The high deflection sensitivity of the interferometer is particularly useful for detecting cantilever oscillations in aqueous solutions, enabling us to reach the thermal noise limit in scanning or atomic force microscopy experiments with stiff cantilevers. This has resulted in atomic-resolution images of solid-liquid interfaces and submolecular-resolution images of native membranes.
C1 [Hoogenboom, B. W.] UCL, London Ctr Nanotechnol, London WC1H 0AH, England.
   [Hoogenboom, B. W.] UCL, Dept Phys & Astron, London WC1H 0AH, England.
   [Frederix, P. L. T. M.; Engel, A.] Univ Basel, Biozentrum, ME Muller Inst, CH-4056 Basel, Switzerland.
   [Hug, H. J.] Univ Bern, Inst Biochem & Mol Med, CH-3012 Bern, Switzerland.
   [Hug, H. J.] Univ Basel, Dept Phys, CH-4056 Basel, Switzerland.
RP Hoogenboom, BW (corresponding author), UCL, London Ctr Nanotechnol, 17-19 Gordon St, London WC1H 0AH, England.
EM b.hoogenboom@ucl.ac.uk
OI Hoogenboom, Bart/0000-0002-8882-4324
CR ALBRECHT TR, 1991, J APPL PHYS, V69, P668, DOI 10.1063/1.347347
   BUTT HJ, 1995, NANOTECHNOLOGY, V6, P1, DOI 10.1088/0957-4484/6/1/001
   DRAKE B, 1989, SCIENCE, V243, P1586, DOI 10.1126/science.2928794
   ERLANDSSON R, 1988, J CHEM PHYS, V89, P5190, DOI 10.1063/1.455608
   Fukuma T, 2005, REV SCI INSTRUM, V76, DOI 10.1063/1.1896938
   Fukuma T, 2007, PHYS REV LETT, V98, DOI 10.1103/PhysRevLett.98.106101
   Giessibl FJ, 2003, REV MOD PHYS, V75, P949, DOI 10.1103/RevModPhys.75.949
   Giessibl FJ, 2006, SURF INTERFACE ANAL, V38, P1696, DOI 10.1002/sia.2392
   Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073
   Hoogenboom BW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2202638
   Hoogenboom BW, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1866229
   HOOGENBOOM BW, 2005, GIT IMAGING MICROSC, V7, P36
   HUG HJ, 2008, UNPUB
   Katan A. J., 2007, THESIS LEIDEN U
   Metzger CH, 2004, NATURE, V432, P1002, DOI 10.1038/nature03118
   Oral A, 2003, REV SCI INSTRUM, V74, P3656, DOI 10.1063/1.1593786
   RUGAR D, 1989, APPL PHYS LETT, V55, P2588, DOI 10.1063/1.101987
   Sader JE, 2004, APPL PHYS LETT, V84, P1801, DOI 10.1063/1.1667267
   SARID D, 1991, SCANNING FORCE MICRO
   Socoliuc A, 2006, SCIENCE, V313, P207, DOI 10.1126/science.1125874
   Viani MB, 1999, J APPL PHYS, V86, P2258, DOI 10.1063/1.371039
   Yang JL, 2005, APPL PHYS LETT, V86, DOI 10.1063/1.1895482
NR 22
TC 21
Z9 21
U1 0
U2 9
PU IOP PUBLISHING LTD
PI BRISTOL
PA TEMPLE CIRCUS, TEMPLE WAY, BRISTOL BS1 6BE, ENGLAND
SN 0957-4484
J9 NANOTECHNOLOGY
JI Nanotechnology
PD SEP 24
PY 2008
VL 19
IS 38
AR 384019
DI 10.1088/0957-4484/19/38/384019
PG 6
WC Nanoscience & Nanotechnology; Materials Science, Multidisciplinary;
   Physics, Applied
SC Science & Technology - Other Topics; Materials Science; Physics
GA 336SU
UT WOS:000258385700020
PM 21832578
DA 2021-01-25
ER

PT J
AU Aanismaa, P
   Gatlik-Landwojtowicz, E
   Seelig, A
AF Aanismaa, Paivi
   Gatlik-Landwojtowicz, Ewa
   Seelig, Anna
TI P-glycoprotein senses its substrates and the lateral membrane packing
   density: Consequences for the catalytic cycle
SO BIOCHEMISTRY
LA English
DT Article
ID BRAIN-BARRIER PERMEATION; ATP HYDROLYSIS; LIPID-MEMBRANES; DRUG
   TRANSPORT; MULTIDRUG TRANSPORTER; ABC TRANSPORTER; PLASMA-MEMBRANE;
   STATE; BINDING; MODULATION
AB P-glycoprotein (ABCB1) prevents absorption (e.g., blood-brain barrier) or enhances excretion (e.g., kidney) by moving substrates from the cytosolic to the extracellular membrane leaflet at the expense of ATP hydrolysis. It translocates various drugs and functions in membranes exhibiting different lateral packing densities. To gain more functional insight, we measured the temperature dependence of the P-glycoprotein ATPase activity in NIH-MDRI-G185 cell membranes in the absence and presence of three drugs (promazine, verapamil, and PSC833), exhibiting significantly different transporter affinities. Activation enthalpies (Delta H(double dagger)) and entropies (T Delta S(double dagger)) were derived from Eyring plots. In the absence of drugs, the activation enthalpy and the free energy of activation for P-glycoprotein ATPase activity was determined as Delta H(double dagger) = 92.6 +/- 4.2 kJ/mol and Delta G(double dagger) =73.1 +/- 7.2 kJ/mol, respectively. Increasing the drug concentration reduced the activation enthalpy, whereby the drug with the highest transporter affinity had the strongest effect (Delta Delta H(double dagger) = -21 %). The free energy of activation decreased for activating (Delta Delta G(double dagger)=similar to-3.8%) and increased for inhibitory compounds (Delta Delta G(double dagger)=similar to+0.7%). The drug-specific changes of the free energy of activation are thus barely above thermal energy. A comparison with literature data revealed that a decrease of the lateral membrane packing density reduces the enthalpic and the entropic contribution to the free energy of activation. Although the P-glycoprotein ATPase activity increases only slightly with decreasing lateral membrane packing density, the mode of action changes from strongly entropy-driven at high, to essentially enthalpy-driven at low packing densities. This Suggests that the transporter and the membrane form a functional entity.
C1 [Aanismaa, Paivi; Gatlik-Landwojtowicz, Ewa; Seelig, Anna] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Seelig, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Anna.Seelig@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [3100AO-107793]
FX Funding provided by the Swiss National Science Foundation (Grant
   3100AO-107793).
CR Aanismaa P, 2007, BIOCHEMISTRY-US, V46, P3394, DOI 10.1021/bi0619526
   Al-Shawi MK, 2003, J BIOL CHEM, V278, P52629, DOI 10.1074/jbc.M308175200
   ALSHAWI MK, 1993, J BIOL CHEM, V268, P4197
   Ambudkar SV, 1997, J BIOL CHEM, V272, P21160, DOI 10.1074/jbc.272.34.21160
   ANDERSEN C, 1995, J GEN PHYSIOL, V105, P385, DOI 10.1085/jgp.105.3.385
   AUGER M, 1988, BIOCHEMISTRY-US, V27, P4660, DOI 10.1021/bi00413a012
   Buxbaum E, 1999, EUR J BIOCHEM, V265, P54, DOI 10.1046/j.1432-1327.1999.00643.x
   CANTOR CR, 1980, BIOPHYSICAL CHEM, V1, P283
   Chen M, 2003, J BIOL CHEM, V278, P29686, DOI 10.1074/jbc.M302757200
   Cornelius F, 2001, BIOCHEMISTRY-US, V40, P8842, DOI 10.1021/bi010541g
   DOIGE CA, 1993, BIOCHIM BIOPHYS ACTA, V1146, P65, DOI 10.1016/0005-2736(93)90339-2
   Exner O., 1973, PROG PHYS ORG CHEM, V10, P411
   Fischer H, 1998, J MEMBRANE BIOL, V165, P201, DOI 10.1007/s002329900434
   Gatlik-Landwojtowicz E, 2006, BIOCHEMISTRY-US, V45, P3020, DOI 10.1021/bi051380+
   Gatlik-Landwojtowicz E, 2004, BIOCHEMISTRY-US, V43, P14840, DOI 10.1021/bi048761s
   Glavinas Hristos, 2004, Current Drug Delivery, V1, P27, DOI 10.2174/1567201043480036
   Gorbulev S, 2001, P NATL ACAD SCI USA, V98, P3732, DOI 10.1073/pnas.061467898
   Gottesman Michael M, 2006, Discov Med, V6, P18
   Higgins CF, 2004, NAT STRUCT MOL BIOL, V11, P918, DOI 10.1038/nsmb836
   Kerr KM, 2001, J BIOL CHEM, V276, P8657, DOI 10.1074/jbc.M010044200
   LANDWOJTOWICZ E, 2002, BIOZENTRUM, P121
   LAUGER P, 1991, ELECTROGENIC ION PUM
   Litman T, 1997, BBA-MOL BASIS DIS, V1361, P159, DOI 10.1016/S0925-4439(97)00026-4
   Lu PH, 2001, EUR J BIOCHEM, V268, P1687, DOI 10.1046/j.1432-1327.2001.02041.x
   Meier M, 2006, BIOPHYS J, V91, P2943, DOI 10.1529/biophysj.106.089581
   Omote H, 2004, BIOCHEMISTRY-US, V43, P3917, DOI 10.1021/bi035365l
   Omote H, 2002, J BIOL CHEM, V277, P45688, DOI 10.1074/jbc.M206479200
   Pretz MG, 2006, BIOCHEMISTRY-US, V45, P15056, DOI 10.1021/bi061230e
   Qu Q, 2003, BIOCHEMISTRY-US, V42, P1345, DOI 10.1021/bi0267745
   Ramnanan CJ, 2006, J EXP BIOL, V209, P677, DOI 10.1242/jeb.02052
   RAVIV Y, 1990, J BIOL CHEM, V265, P3975
   Romsicki Y, 1998, EUR J BIOCHEM, V256, P170, DOI 10.1046/j.1432-1327.1998.2560170.x
   Rosenberg MF, 2005, J BIOL CHEM, V280, P2857, DOI 10.1074/jbc.M410296200
   Sauna ZE, 2001, J BIOL CHEM, V276, P21199, DOI 10.1074/jbc.M100886200
   Sauna ZE, 2001, J BIOL CHEM, V276, P11653, DOI 10.1074/jbc.M011294200
   Schote U, 2002, J PHARM SCI, V91, P856, DOI 10.1002/jps.10071
   Seelig A, 2005, MINI-REV MED CHEM, V5, P135, DOI 10.2174/1389557053402693
   SEELIG A, 1992, BIOCHEMISTRY-US, V31, P2897, DOI 10.1021/bi00126a008
   Seelig A, 2000, INT J CLIN PHARM TH, V38, P111
   Seelig A, 1998, EUR J BIOCHEM, V251, P252, DOI 10.1046/j.1432-1327.1998.2510252.x
   SEELIG A, 1987, BIOCHIM BIOPHYS ACTA, V899, P196, DOI 10.1016/0005-2736(87)90400-7
   SEELIG A, 1977, BIOCHEMISTRY-US, V16, P45, DOI 10.1021/bi00620a008
   Seelig A, 2007, J MOL NEUROSCI, V33, P32, DOI 10.1007/s12031-007-0055-y
   Seelig A, 2006, EXPERT OPIN DRUG MET, V2, P733, DOI 10.1517/17425255.2.5.733
   SEELIG J, 1991, BIOCHEMISTRY-US, V30, P9354, DOI 10.1021/bi00102a031
   Senior AE, 1995, FEBS LETT, V377, P285, DOI 10.1016/0014-5793(95)01345-8
   Shapiro AB, 1997, EUR J BIOCHEM, V250, P122, DOI 10.1111/j.1432-1033.1997.00122.x
   Sharom FJ, 1999, BBA-BIOMEMBRANES, V1461, P327, DOI 10.1016/S0005-2736(99)00166-2
   SQUIER TC, 1988, J BIOL CHEM, V263, P9178
   ZHU N, 1994, LIPIDS, V29, P869, DOI 10.1007/BF02536255
NR 50
TC 31
Z9 31
U1 0
U2 3
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD SEP 23
PY 2008
VL 47
IS 38
BP 10197
EP 10207
DI 10.1021/bi800209h
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 349GA
UT WOS:000259268100028
PM 18759452
DA 2021-01-25
ER

PT J
AU Grieder, NC
   Caussinus, E
   Parker, DS
   Cadigan, K
   Affolter, M
   Luschnig, S
AF Grieder, Nicole C.
   Caussinus, Emmanuel
   Parker, David S.
   Cadigan, Kenneth
   Affolter, Markus
   Luschnig, Stefan
TI gamma COP Is Required for Apical Protein Secretion and Epithelial
   Morphogenesis in Drosophila melanogaster
SO PLOS ONE
LA English
DT Article
ID GENETIC-CONTROL; TRACHEAL MORPHOGENESIS; TUBE MORPHOGENESIS; VESICLE
   TRANSPORT; SALIVARY-GLAND; GTPASE; CHITIN; TRAFFICKING; EXPRESSION;
   COMPONENTS
AB Background: There is increasing evidence that tissue-specific modifications of basic cellular functions play an important role in development and disease. To identify the functions of COPI coatomer-mediated membrane trafficking in Drosophila development, we were aiming to create loss-of-function mutations in the gamma COP gene, which encodes a subunit of the COPI coatomer complex.
   Principal Findings: We found that gamma COP is essential for the viability of the Drosophila embryo. In the absence of zygotic gamma COP activity, embryos die late in embryogenesis and display pronounced defects in morphogenesis of the embryonic epidermis and of tracheal tubes. The coordinated cell rearrangements and cell shape changes during tracheal tube morphogenesis critically depend on apical secretion of certain proteins. Investigation of tracheal morphogenesis in gamma COP loss-of-function mutants revealed that several key proteins required for tracheal morphogenesis are not properly secreted into the apical lumen. As a consequence, gamma COP mutants show defects in cell rearrangements during branch elongation, in tube dilation, as well as in tube fusion. We present genetic evidence that a specific subset of the tracheal defects in gamma COP mutants is due to the reduced secretion of the Zona Pellucida protein Piopio. Thus, we identified a critical target protein of COPI-dependent secretion in epithelial tube morphogenesis.
   Conclusions/Significance: These studies highlight the role of COPI coatomer-mediated vesicle trafficking in both general and tissue-specific secretion in a multicellular organism. Although COPI coatomer is generally required for protein secretion, we show that the phenotypic effect of gamma COP mutations is surprisingly specific. Importantly, we attribute a distinct aspect of the gamma COP phenotype to the effect on a specific key target protein.
C1 [Grieder, Nicole C.; Caussinus, Emmanuel; Affolter, Markus] Biozentrum Univ Basel, Abt Zellbiol, Basel, Switzerland.
   [Parker, David S.; Cadigan, Kenneth] Univ Michigan, Dept Mol, Cellular & Dev Biol, Ann Arbor, MI 48109 USA.
   [Luschnig, Stefan] Univ Zurich, Inst Zool, CH-8006 Zurich, Switzerland.
RP Grieder, NC (corresponding author), NICHD, NIH, Bethesda, MD USA.
EM nicole.grieder@unibas.ch
RI Luschnig, Stefan E/A-7253-2010
OI Luschnig, Stefan E/0000-0002-0634-3368; Affolter,
   Markus/0000-0002-5171-0016; Cadigan, Ken/0000-0003-2431-1703
FU Kantons Basel-Stadt; Basel-Land; German Research FoundationGerman
   Research Foundation (DFG); The Swiss National Science FoundationSwiss
   National Science Foundation (SNSF); EMBOEuropean Molecular Biology
   Organization (EMBO) [fellowship]; FEBS [fellowship]; Treubel-Fonds,
   Basel; NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA [RO1 GM082994]; NATIONAL INSTITUTE OF
   GENERAL MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01GM082994, R01GM082994,
   R01GM082994, R01GM082994] Funding Source: NIH RePORTER
FX This work was supported by grants from the Kantons Basel-Stadt and
   Basel-Land (MA), the German Research Foundation (SL), The Swiss National
   Science Foundation, an EMBO long term fellowship (EC), a FEBS fellowship
   (EC), the Treubel-Fonds, Basel (NCG) and the NIH grant RO1 GM082994
   (KC).
CR Abrams EW, 2005, DEVELOPMENT, V132, P2743, DOI 10.1242/dev.01863
   Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031
   Beitel GJ, 2000, DEVELOPMENT, V127, P3271
   Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615
   BENDER W, 1983, J MOL BIOL, V168, P17, DOI 10.1016/S0022-2836(83)80320-9
   Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7
   CADIGAN KM, 1994, GENE DEV, V8, P899, DOI 10.1101/gad.8.8.899
   CAMPBELL RE, 2002, MONOMETRIC RED FLUOR
   CAVENER DR, 1987, NUCLEIC ACIDS RES, V15, P1353, DOI 10.1093/nar/15.4.1353
   Coutinho P, 2004, DEV CELL, V7, P547, DOI 10.1016/j.devcel.2004.07.020
   Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102
   Duden R, 1998, EMBO J, V17, P985, DOI 10.1093/emboj/17.4.985
   Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905
   FARQUHAR MG, 1997, GOLGI APPARATUS, P65
   Gaynor EC, 1998, BBA-MOL CELL RES, V1404, P33, DOI 10.1016/S0167-4889(98)00045-7
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   GLOOR GB, 1993, GENETICS, V135, P81
   Grieder NC, 2005, GENE EXPR PATTERNS, V6, P11, DOI 10.1016/j.modgep.2005.06.001
   Hoffman GR, 2003, MOL CELL, V12, P615, DOI 10.1016/j.molcel.2003.08.002
   HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0
   Jayaram SA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001964
   Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049
   Jiang L, 2007, DEV BIOL, V311, P487, DOI 10.1016/j.ydbio.2007.08.049
   Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012
   Kerman BE, 2006, DIFFERENTIATION, V74, P326, DOI 10.1111/j.1432-0436.2006.00095.x
   Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7
   LaJeunesse DR, 2004, BIOTECHNIQUES, V36, P784, DOI 10.2144/04365ST01
   Lay D, 2006, BBA-MOL CELL RES, V1763, P1678, DOI 10.1016/j.bbamcr.2006.08.036
   Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307
   Lee S, 2002, DEVELOPMENT, V129, P1509
   Liegeois S, 2007, GENETICS, V175, P709, DOI 10.1534/genetics.106.066035
   Lippincott-Schwartz Jennifer, 2006, Trends Cell Biol, V16, pe1, DOI 10.1016/j.tcb.2006.08.008
   Liu J, 2003, DEV CELL, V5, P487, DOI 10.1016/S1534-5807(03)00262-4
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072
   Malhotra V, 2006, NATURE, V441, P939, DOI 10.1038/441939a
   Matsuura-Tokita K, 2006, NATURE, V441, P1007, DOI 10.1038/nature04737
   McMahon HT, 2004, CURR OPIN CELL BIOL, V16, P379, DOI 10.1016/j.ceb.2004.06.009
   Miyasaka H, 2002, J MOL EVOL, V55, P52, DOI 10.1007/s00239-001-0090-1
   Parker DS, 2002, DEVELOPMENT, V129, P2565
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Rorth P, 1998, MECH DEVELOP, V78, P113, DOI 10.1016/S0925-4773(98)00157-9
   Samakovlis C, 1996, DEVELOPMENT, V122, P3531
   Sato T, 2007, NATURE, V448, P366, DOI 10.1038/nature05929
   Schledzewski K, 1999, J MOL EVOL, V48, P770, DOI 10.1007/PL00006521
   SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435
   STRUHL G, 1993, CELL, V72, P527, DOI 10.1016/0092-8674(93)90072-X
   Swanson LE, 2006, CURR BIOL, V16, pR51, DOI 10.1016/j.cub.2006.01.008
   TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697
   Thummel CS, 1992, DROS INF SERV, V71, P150
   Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012
   Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Wang JB, 2006, APPL MATH COMPUT, V180, P185, DOI 10.1016/j.amc.2005.11.162
   Wegmann D, 2004, MOL CELL BIOL, V24, P1070, DOI 10.1128/MCB.24.3.1070-1080.2004
NR 55
TC 36
Z9 37
U1 0
U2 1
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 19
PY 2008
VL 3
IS 9
AR e3241
DI 10.1371/journal.pone.0003241
PG 12
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 422LF
UT WOS:000264428600001
PM 18802472
OA DOAJ Gold, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Plaza, S
   Prince, F
   Adachi, Y
   Punzo, C
   Cribbs, DL
   Gehring, WJ
AF Plaza, Serge
   Prince, Frederic
   Adachi, Yoshitsugu
   Punzo, Claudio
   Cribbs, David L.
   Gehring, Walter J.
TI Cross-regulatory protein-protein interactions between Hox and Pax
   transcription factors
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE Drosophila; antagonism; regulation
ID DNA-BINDING SPECIFICITY; DROSOPHILA HOMEOTIC GENES; PHENOTYPIC
   SUPPRESSION; EMPTY SPIRACLES; EYE DEVELOPMENT; HOMEOBOX GENES;
   EXTRADENTICLE; HOMEODOMAIN; SEGMENTATION; ULTRABITHORAX
AB Homeotic Hox selector genes encode highly conserved transcriptional regulators involved in the differentiation of multicellular organisms. Ectopic expression of the Antennapedia (ANTP) homeodomain protein in Drosophila imaginal discs induces distinct phenotypes, including an antenna-to-leg transformation and eye reduction. We have proposed that the eye loss phenotype is a consequence of a negative posttranslational control mechanism because of direct protein-protein interactions between ANTP and Eyeless(EY). In the present work, we analyzed the effect of various ANTP homeodomain mutations for their interaction with EY and for head development. Contrasting with the eye loss phenotype, we provide evidence that the antenna-to-leg transformation involves ANTP DNA-binding activity. In a complementary genetic screen performed in yeast, we isolated mutations located in the N terminus of the ANTP homeodomain that inhibit direct interactions with EY without abolishing DNA binding in vitro and in vivo. In a bimolecular fluorescence complementation assay, we detected the ANTP-EY interaction in vivo, these interactions occurring through the paired domain and/or the homeodomain of EY. These results demonstrate that the homeodomain supports multiple molecular regulatory functions in addition to protein-DNA and protein-RNA interactions; it is also involved in protein-protein interactions.
C1 [Prince, Frederic; Adachi, Yoshitsugu; Punzo, Claudio; Gehring, Walter J.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Plaza, Serge; Cribbs, David L.] CNRS, Ctr Dev Biol, F-31062 Toulouse, France.
RP Gehring, WJ (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM walter.gehring@unibas.ch
RI plaza, serge/F-5290-2015
OI Punzo, Claudio/0000-0001-5207-0041
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); European Network of Excellence "Cells into Organs"; Centre
   National de la Recherche ScientifiqueCentre National de la Recherche
   Scientifique (CNRS); EMBOEuropean Molecular Biology Organization (EMBO)
FX We are grateful to Yasushi Saka and Jim Smith (Gurdon Institute,
   University of Cambridge) for Venus BiFC plasmids. We also thank Tom
   Kerppola (University of Michigan, Ann Arbor, MI) for BiFC plasmids and
   information on his web site (http://sitemaker.umich.edu/kerppola.lab/
   kerppola_lab_bifc). This work was supported by the Kantons of
   Basel-Stadt and Basel-Land, a grant from the Swiss National Science
   Foundation, and the European Network of Excellence "Cells into Organs."
   S.P. was supported by the Centre National de la Recherche Scientifique
   and an EMBO fellowship.
CR Affolter M, 2001, SCIENCE, V292, P1080, DOI 10.1126/science.1060856
   Benassayag C, 2003, DEVELOPMENT, V130, P575, DOI 10.1242/dev.00226
   Biggin MD, 1997, DEVELOPMENT, V124, P4425
   Bondos SE, 2006, MOL CELL PROTEOMICS, V5, P824, DOI 10.1074/mcp.M500256-MCP200
   Burz DS, 2001, J MOL BIOL, V305, P219, DOI 10.1006/jmbi.2000.4287
   Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706
   CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8
   Emmons RB, 2007, DEV BIOL, V302, P412, DOI 10.1016/j.ydbio.2006.09.044
   Gong KQ, 2007, MOL CELL BIOL, V27, P7661, DOI 10.1128/MCB.00465-07
   GONZALEZREYES A, 1990, NATURE, V344, P78, DOI 10.1038/344078a0
   Haerry TE, 1996, P NATL ACAD SCI USA, V93, P13884, DOI 10.1073/pnas.93.24.13884
   Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3
   Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024
   LAWRENCE PA, 1994, CELL, V78, P181, DOI 10.1016/0092-8674(94)90289-5
   LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0
   Luo LF, 2004, NATURE, V427, P749, DOI 10.1038/nature02305
   Macias A, 1996, EMBO J, V15, P334, DOI 10.1002/j.1460-2075.1996.tb00363.x
   Mahaffey JW, 2005, CURR OPIN GENET DEV, V15, P422, DOI 10.1016/j.gde.2005.06.009
   Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3
   MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N
   MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2
   Morata G, 1999, DEVELOPMENT, V126, P2823
   MUHLRAD D, 1992, YEAST, V8, P79, DOI 10.1002/yea.320080202
   Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87
   OTTING G, 1990, EMBO J, V9, P3085, DOI 10.1002/j.1460-2075.1990.tb07505.x
   PEIFER M, 1990, GENE DEV, V4, P1209, DOI 10.1101/gad.4.7.1209
   Pinsonneault J, 1997, EMBO J, V16, P2032, DOI 10.1093/emboj/16.8.2032
   Plaza S, 2001, EMBO J, V20, P802, DOI 10.1093/emboj/20.4.802
   Prince F, 2008, DEVELOPMENT, V135, P1669, DOI 10.1242/dev.018028
   Punzo C, 2001, GENE DEV, V15, P1716, DOI 10.1101/gad.196401
   Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6
   Saka Y, 2007, DEVELOPMENT, V134, P4209, DOI 10.1242/dev.010645
   Schock F, 2000, NATURE, V405, P351
   SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115
   TREISMAN J, 1989, CELL, V59, P553
   VANDIJK MA, 1994, CELL, V78, P617, DOI 10.1016/0092-8674(94)90526-6
   Wang N, 2006, EMBO J, V25, P1469, DOI 10.1038/sj.emboj.7601037
NR 37
TC 38
Z9 39
U1 0
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD SEP 9
PY 2008
VL 105
IS 36
BP 13439
EP 13444
DI 10.1073/pnas.0806106105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 349AR
UT WOS:000259251700048
PM 18755899
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Galgano, A
   Forrer, M
   Jaskiewicz, L
   Kanitz, A
   Zavolan, M
   Gerber, AP
AF Galgano, Alessia
   Forrer, Michael
   Jaskiewicz, Lukasz
   Kanitz, Alexander
   Zavolan, Mihaela
   Gerber, Andre P.
TI Comparative Analysis of mRNA Targets for Human PUF Family Proteins
   Suggests Extensive Interaction with the miRNA Regulatory System
SO PLOS ONE
LA English
DT Article
AB Genome-wide identification of mRNAs regulated by RNA-binding proteins is crucial to uncover post-transcriptional gene regulatory systems. The conserved PUF family RNA-binding proteins repress gene expression post-transcriptionally by binding to sequence elements in 39-UTRs of mRNAs. Despite their well-studied implications for development and neurogenesis in metazoa, the mammalian PUF family members are only poorly characterized and mRNA targets are largely unknown. We have systematically identified the mRNAs associated with the two human PUF proteins, PUM1 and PUM2, by the recovery of endogenously formed ribonucleoprotein complexes and the analysis of associated RNAs with DNA microarrays. A largely overlapping set comprised of hundreds of mRNAs were reproducibly associated with the paralogous PUM proteins, many of them encoding functionally related proteins. A characteristic PUF-binding motif was highly enriched among PUM bound messages and validated with RNA pull-down experiments. Moreover, PUF motifs as well as surrounding sequences exhibit higher conservation in PUM bound messages as opposed to transcripts that were not found to be associated, suggesting that PUM function may be modulated by other factors that bind conserved elements. Strikingly, we found that PUF motifs are enriched around predicted miRNA binding sites and that high-confidence miRNA binding sites are significantly enriched in the 39-UTRs of experimentally determined PUM1 and PUM2 targets, strongly suggesting an interaction of human PUM proteins with the miRNA regulatory system. Our work suggests extensive connections between the RBP and miRNA post-transcriptional regulatory systems and provides a framework for deciphering the molecular mechanism by which PUF proteins regulate their target mRNAs.
C1 [Galgano, Alessia; Forrer, Michael; Kanitz, Alexander; Gerber, Andre P.] ETH, Inst Pharmaceut Sci, Zurich, Switzerland.
   [Jaskiewicz, Lukasz; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Galgano, A (corresponding author), ETH, Inst Pharmaceut Sci, Zurich, Switzerland.
EM andre.gerber@pharma.ethz.ch
RI Zavolan, Mihaela/S-3888-2016
OI Kanitz, Alexander/0000-0002-3468-0652; Zavolan,
   Mihaela/0000-0002-8832-2041
FU SNF [3100A0-114001]; Bonizzi-Theler Foundation; International Human
   Frontier Science Program Organization (HFSP)Human Frontier Science
   Program [CDA0048/2005]
FX L.J. was supported by SNF grant #3100A0-114001 to M.Z. A.K. was
   supported by a grant from the Bonizzi-Theler Foundation to A.P.G. A.P.G.
   is the recipient of a Career Development Award (CDA0048/2005) from the
   International Human Frontier Science Program Organization (HFSP).
CR Alibes A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-9
   Asaoka-Taguchi M, 1999, NAT CELL BIOL, V1, P431
   Bailey TL, 2006, NUCLEIC ACIDS RES, V34, pW369, DOI 10.1093/nar/gkl198
   Ball CA, 2005, NUCLEIC ACIDS RES, V33, pD580
   Baroni Timothy E., 2008, V419, P93, DOI 10.1007/978-1-59745-033-1_6
   Benson DA, 2008, NUCLEIC ACIDS RES, V36, pD25, DOI 10.1093/nar/gkm929
   Bernstein D, 2005, RNA, V11, P447, DOI 10.1261/rna.7255805
   Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031
   Birney E, 2004, GENOME RES, V14, P925, DOI 10.1101/gr.1860604
   Boyle EI, 2004, BIOINFORMATICS, V20, P3710, DOI 10.1093/bioinformatics/bth456
   Chen Gregory J, 2006, Recent Pat Cardiovasc Drug Discov, V1, P211, DOI 10.2174/157489006777442478
   Cheng N, 2002, CYTOKINE GROWTH F R, V13, P75, DOI 10.1016/S1359-6101(01)00031-4
   Colicelli John, 2004, Sci STKE, V2004, pRE13, DOI 10.1126/stke.2502004re13
   Coniglio SJ, 2008, MOL CELL BIOL, V28, P4162, DOI 10.1128/MCB.01532-07
   Dreyfuss G, 2002, NAT REV MOL CELL BIO, V3, P195, DOI 10.1038/nrm760
   Dubnau J, 2003, CURR BIOL, V13, P286, DOI 10.1016/S0960-9822(03)00064-2
   Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525
   Edwards TA, 2001, CELL, V105, P281, DOI 10.1016/S0092-8674(01)00318-X
   Filipowicz W, 2008, NAT REV GENET, V9, P102, DOI 10.1038/nrg2290
   Forbes A, 1998, DEVELOPMENT, V125, P679
   Fox M, 2005, GENOMICS, V85, P92, DOI 10.1016/j.ygeno.2004.10.003
   Furic L, 2008, RNA, V14, P324, DOI 10.1261/rna.720308
   Gaidatzis D, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-69
   Garcia-Rodriguez LJ, 2007, J CELL BIOL, V176, P197, DOI 10.1083/jcb.200606054
   Gebauer F, 2004, NAT REV MOL CELL BIO, V5, P827, DOI 10.1038/nrm1488
   George Ajish D, 2006, RNA Biol, V3, P57
   Gerber AP, 2004, PLOS BIOL, V2, P342, DOI 10.1371/journal.pbio.0020079
   Gerber AP, 2006, P NATL ACAD SCI USA, V103, P4487, DOI 10.1073/pnas.0509260103
   Goldstrohm AC, 2006, NAT STRUCT MOL BIOL, V13, P533, DOI 10.1038/nsmb1100
   Grillo G, 2003, NUCLEIC ACIDS RES, V31, P3608, DOI 10.1093/nar/gkg548
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Gupta YK, 2008, STRUCTURE, V16, P549, DOI 10.1016/j.str.2008.01.006
   Halbeisen RE, 2008, CELL MOL LIFE SCI, V65, P798, DOI 10.1007/s00018-007-7447-6
   Kadyrova LY, 2007, DEVELOPMENT, V134, P1519, DOI 10.1242/dev.002212
   Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034
   Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111
   Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47
   Keene JD, 2002, MOL CELL, V9, P1161, DOI 10.1016/S1097-2765(02)00559-2
   Kraemer A, 2007, AM J PHYSIOL-CELL PH, V292, pC1061, DOI 10.1152/ajpcell.00073.2006
   Lal A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001864
   Lee MH, 2007, PLOS GENET, V3, P2540, DOI 10.1371/journal.pgen.0030233
   Lin HF, 1997, DEVELOPMENT, V124, P2463
   Masckauchan TNH, 2006, MOL BIOL CELL, V17, P5163, DOI 10.1091/mbc.E06-04-0320
   Mckee AE, 2007, CELL RES, V17, P581, DOI 10.1038/cr.2007.54
   Menon KP, 2004, NEURON, V44, P663, DOI 10.1016/j.neuron.2004.10.028
   Mi HY, 2005, NUCLEIC ACIDS RES, V33, pD284, DOI 10.1093/nar/gki078
   Miller MT, 2008, NAT STRUCT MOL BIOL, V15, P397, DOI 10.1038/nsmb.1390
   Molina JR, 2006, J THORAC ONCOL, V1, P7, DOI 10.1097/01243894-200601000-00004
   Moore FL, 2003, P NATL ACAD SCI USA, V100, P538, DOI 10.1073/pnas.0234478100
   Moore MJ, 2005, SCIENCE, V309, P1514, DOI 10.1126/science.1111443
   Morris AR, 2008, MOL CELL BIOL, V28, P4093, DOI 10.1128/MCB.00155-08
   Muraro NI, 2008, J NEUROSCI, V28, P2099, DOI 10.1523/JNEUROSCI.5092-07.2008
   MURATA Y, 1995, CELL, V80, P747, DOI 10.1016/0092-8674(95)90353-4
   Nolde MJ, 2007, DEV BIOL, V305, P551, DOI 10.1016/j.ydbio.2007.02.040
   Olivas W, 2000, EMBO J, V19, P6602, DOI 10.1093/emboj/19.23.6602
   Parisi M, 2000, CURR BIOL, V10, pR81, DOI 10.1016/S0960-9822(00)00283-9
   Prinz S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000249
   Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732
   Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006
   Rossant J, 2002, ANNU REV CELL DEV BI, V18, P541, DOI 10.1146/annurev.cellbio.18.012502.105825
   Saint-Georges Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002293
   Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Spassov DS, 2003, IUBMB LIFE, V55, P359, DOI 10.1080/15216540310001603093
   St Johnston D, 2005, NAT REV MOL CELL BIO, V6, P363, DOI 10.1038/nrm1643
   Tadauchi T, 2001, EMBO J, V20, P552, DOI 10.1093/emboj/20.3.552
   Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498
   Urano J, 2005, MOL REPROD DEV, V71, P290, DOI 10.1002/mrd.20270
   van Nimwegen E, 2006, PLOS GENET, V2, P587, DOI 10.1371/journal.pgen.0020024
   Vessey JP, 2006, J NEUROSCI, V26, P6496, DOI 10.1523/JNEUROSCI.0649-06.2006
   Roretz C, 2008, J CELL BIOL, V181, P189, DOI 10.1083/jcb.200712054
   Wang XQ, 2002, CELL, V110, P501, DOI 10.1016/S0092-8674(02)00873-5
   Wasylyk B, 1998, TRENDS BIOCHEM SCI, V23, P213, DOI 10.1016/S0968-0004(98)01211-0
   Wickens M, 2002, TRENDS GENET, V18, P150, DOI 10.1016/S0168-9525(01)02616-6
   Wilusz CJ, 2004, TRENDS GENET, V20, P491, DOI 10.1016/j.tig.2004.07.011
   Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441
   Xu EY, 2007, MOL REPROD DEV, V74, P912, DOI 10.1002/mrd.20687
   Zerlin M, 2008, ANGIOGENESIS, V11, P63, DOI 10.1007/s10456-008-9095-3
   Zhang BL, 1997, NATURE, V390, P477, DOI 10.1038/37297
   Zhong J, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-17
NR 80
TC 184
Z9 186
U1 1
U2 10
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD SEP 8
PY 2008
VL 3
IS 9
AR e3164
DI 10.1371/journal.pone.0003164
PG 16
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 422JQ
UT WOS:000264424300008
PM 18776931
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Belak, K
   Koenen, F
   Vanderhallen, H
   Mittelholzer, C
   Feliziani, F
   De Mia, GM
   Belak, S
AF Belak, Katinka
   Koenen, Frank
   Vanderhallen, Hans
   Mittelholzer, Christian
   Feliziani, Francesco
   De Mia, Gian Mario
   Belak, Sandor
TI Comparative studies on the pathogenicity and tissue distribution of
   three virulence variants of classical swine fever virus, two field
   isolates and one vaccine strain, with special regard to
   immunohistochemical investigations
SO ACTA VETERINARIA SCANDINAVICA
LA English
DT Article
ID HOG-CHOLERA VIRUS; INFECTED-PIGS; PATHOGENESIS; DISEASE
AB Background: The aim of this study was to compare the tissue distribution and pathogenicity of three virulence variants of classical swine fever virus (CSFV) and to investigate the applicability of various conventional diagnostic procedures.
   Methods: 64 pigs were divided into three groups and infected with the highly virulent isolate ISS/60, the moderately virulent isolate Wingene'93 and the live attenuated vaccine strain Riems, respectively. Clinical signs, gross and histopathological changes were compared in relation to time elapsed post infection. Virus spread in various organs was followed by virus isolation, by immunohistochemistry, applying monoclonal antibodies in a two-step method and by in situ hybridisation using a digoxigenin-labelled riboprobe.
   Results: The tissue distribution data are discussed in details, analyzing the results of the various diagnostic approaches. The comparative studies revealed remarkable differences in the onset of clinical signs as well as in the development of the macro- and microscopical changes, and in the tissue distribution of CSFV in the three experimental groups.
   Conclusion: The present study demonstrates that in the case of highly and moderately virulent virus variants the virulence does not affect the pattern of the viral spread, however, it influences the outcome, the duration and the intensity of the disease. Immunohistochemistry has the advantage to allow the rapid detection and localisation of the virus, especially in cases of early infection, when clinical signs are still absent. Compared to virus isolation, the advantage of this method is that no cell culture facilities are required. Thus, immunohistochemistry provides simple and sensitive tools for the prompt detection of newly emerging variants of CSFV, including the viruses of very mild virulence.
C1 [Belak, Katinka; Koenen, Frank; Vanderhallen, Hans; Mittelholzer, Christian; Feliziani, Francesco; De Mia, Gian Mario; Belak, Sandor] Natl Vet Inst, Dept Virol, Joint Res & Dev Div, S-75189 Uppsala, Sweden.
   [Belak, Katinka] Natl Vet Inst, Dept Pathol & Wildlife Dis, S-75189 Uppsala, Sweden.
   [Koenen, Frank; Vanderhallen, Hans] CODA CERVA, Dept Virol, B-1180 Uccle, Belgium.
   [Feliziani, Francesco; De Mia, Gian Mario] Ist Zooprofilatt Sperimentale Umbria & Marche, I-06126 Perugia, Italy.
   [Mittelholzer, Christian] Univ Basel, Biozentrum, Inst Biol Struct, CH-4056 Basel, Switzerland.
   [Belak, Katinka; Koenen, Frank; Vanderhallen, Hans; Mittelholzer, Christian; Feliziani, Francesco; De Mia, Gian Mario; Belak, Sandor] Swedish Univ Agr Sci, S-75189 Uppsala, Sweden.
RP Belak, K (corresponding author), Natl Vet Inst, Dept Virol, Joint Res & Dev Div, S-75189 Uppsala, Sweden.
EM katinka@belak.se; frank.koenen@var.fgov.be;
   hans.vanderhallen@veilinghoogstraten.be;
   christian.mittelholzer@unibas.ch; f.feliziani@izsum.it;
   gm.demia@izsum.it; sandor.belak@bvf.slu.se
FU European CommissionEuropean CommissionEuropean Commission Joint Research
   Centre [FAIR PL 95-707, SSP1-501599]
FX This work was supported by the European Commission (Grants: FAIR PL
   95-707 and SSP1-501599). The authors thank the laboratory staff for the
   excellent technical assistance. Ms. Irja Johansson is specially
   acknowledged for her valuable support and performing of in situ
   hybridisation. Many thanks are due to Professor Carl Hard af Segerstad
   and Dr. Dolores Gavier-Widen for the critical reading and constructive
   suggestions.
CR Belak K, 1999, COMP IMMUNOL MICROB, V22, P207, DOI 10.1016/S0147-9571(99)00008-9
   Belak S, 2001, Expert Rev Mol Diagn, V1, P434
   Choi C, 2003, VET PATHOL, V40, P107, DOI 10.1354/vp.40-1-107
   DAHLE J, 1992, COMP IMMUNOL MICROB, V15, P203, DOI 10.1016/0147-9571(92)90093-7
   Elbers ARW, 1999, PREV VET MED, V42, P157, DOI 10.1016/S0167-5877(99)00074-4
   Gomez-Villamandos JC, 2006, VET PATHOL, V43, P530, DOI 10.1354/vp.43-4-530
   Greiser-Wilke I, 2006, DEUT TIERARZTL WOCH, V113, P134
   Greiser-Wilke I, 2000, VET MICROBIOL, V73, P131, DOI 10.1016/S0378-1135(00)00140-1
   KADEN V, 1987, ARCH EXP VET MED, V41, P841
   KAMOLSIRIPRICHAIPORN S, 1992, AUST VET J, V69, P240, DOI 10.1111/j.1751-0813.1992.tb09870.x
   Koenen F, 1997, J VET MED B, V44, P281, DOI 10.1111/j.1439-0450.1997.tb00974.x
   Koenen F, 1996, VET REC, V139, P367, DOI 10.1136/vr.139.15.367
   LieblerTenorio EM, 1997, ARCH VIROL, V142, P1613, DOI 10.1007/s007050050184
   MENGELING WL, 1969, AM J VET RES, V30, P409
   Narita M, 2000, VET PATHOL, V37, P402, DOI 10.1354/vp.37-5-402
   RESSANG AA, 1973, ZBL VET MED B, V20, P272
   RESSANG AA, 1973, ZBL VET MED B, V20, P256
   Sanchez-Cordon PJ, 2003, VET PATHOL, V40, P254, DOI 10.1354/vp.40-3-254
   Thur B, 1998, J VIROL METHODS, V74, P47, DOI 10.1016/S0166-0934(98)00069-X
   WENSVOORT G, 1985, TIJDSCHR DIERGENEESK, V110, P263
NR 20
TC 17
Z9 17
U1 0
U2 2
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0044-605X
EI 1751-0147
J9 ACTA VET SCAND
JI Acta Vet. Scand.
PD SEP 5
PY 2008
VL 50
AR 34
DI 10.1186/1751-0147-50-34
PG 13
WC Veterinary Sciences
SC Veterinary Sciences
GA 355JJ
UT WOS:000259704900001
PM 18775072
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Fischer, D
   Kley, RA
   Strach, K
   Meyer, C
   Sommer, T
   Eger, K
   Rolfs, A
   Meyer, W
   Pou, A
   Pradas, J
   Heyer, CM
   Grossmann, A
   Huebner, A
   Kress, W
   Reimann, J
   Schroder, R
   Eymard, B
   Fardeau, M
   Udd, B
   Goldfarb, L
   Vorgerd, M
   Olive, M
AF Fischer, D.
   Kley, R. A.
   Strach, K.
   Meyer, C.
   Sommer, T.
   Eger, K.
   Rolfs, A.
   Meyer, W.
   Pou, A.
   Pradas, J.
   Heyer, C. M.
   Grossmann, A.
   Huebner, A.
   Kress, W.
   Reimann, J.
   Schroeder, R.
   Eymard, B.
   Fardeau, M.
   Udd, B.
   Goldfarb, L.
   Vorgerd, M.
   Olive, M.
TI Distinct muscle imaging patterns in myofibrillar myopathies
SO NEUROLOGY
LA English
DT Article
ID DESMIN-RELATED MYOPATHIES; SKELETAL MYOPATHY; DISTAL MYOPATHY; MUTATION;
   GENE; PHENOTYPE; MYOTILINOPATHY; DESMINOPATHIES; POSITIVITY; SPECTRUM
AB Objective: To compare muscle imaging findings in different subtypes of myofibrillar myopathies (MFM) in order to identify characteristic patterns of muscle alterations that may be helpful to separate these genetic heterogeneous muscular disorders.
   Methods: Muscle imaging and clinical findings of 46 patients with MFM were evaluated (19 desminopathy, 12 myotilinopathy, 11 filaminopathy, 1 alpha B-crystallinopathy, and 3 ZASPopathy). The data were collected retrospectively in 43 patients and prospectively in 3 patients.
   Results: In patients with desminopathy, the semitendinosus was at least equally affected as the biceps femoris, and the peroneal muscles were never less involved than the tibialis anterior (sensitivity of these imaging criteria to detect desminopathy in our cohort 100%, specificity 95%). In most of the patients with myotilinopathy, the adductor magnus showed more alterations than the gracilis muscle, and the sartorius was at least equally affected as the semitendinosus (sensitivity 90%, specificity 93%). In filaminopathy, the biceps femoris and semitendinosus were at least equally affected as the sartorius muscle, and the medial gastrocnemius was more affected than the lateral gastrocnemius. The semimembranosus mostly showed more alterations than the adductor magnus (sensitivity 88%, specificity 96%). Early adult onset and cardiac involvement was most often associated with desminopathy. In patients with filaminopathy, muscle weakness typically beginning in the 5th decade of life was mostly pronounced proximally, while late adult onset (> 50 years) with distal weakness was more often present in myotilinopathy.
   Conclusions: Muscle imaging in combination with clinical data may be helpful for separation of distinct myofibrillar myopathy subtypes and in scheduling of genetic analysis.
C1 [Fischer, D.] Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland.
   [Fischer, D.] Univ Childrens Hosp Basel, Dept Neuropediat, Basel, Switzerland.
   [Kley, R. A.; Vorgerd, M.] Ruhr Univ Bochum, Neuromuscular Ctr Ruhrgebiet, Dept Neurol, Bochum, Germany.
   [Strach, K.; Meyer, C.; Sommer, T.] Univ Hosp Bonn, Dept Radiol, Bonn, Germany.
   [Fischer, D.; Reimann, J.] Univ Hosp Bonn, Dept Neurol, Bonn, Germany.
   [Eger, K.] Univ Hosp Halle, Dept Neurol, Halle, Germany.
   [Rolfs, A.; Meyer, W.] Univ Hosp Rostock, Dept Neurol, Rostock, Germany.
   [Grossmann, A.] Univ Hosp Rostock, Dept Radiol, Rostock, Germany.
   [Pou, A.] Hosp del Mar, Servei Neurol, Barcelona, Spain.
   [Pradas, J.] Hosp Santa Creu & Sant Pau, Sevei Neurol, Barcelona, Spain.
   [Heyer, C. M.] Univ Hosp Bergmannsheil, Dept Radiol, Bochum, Germany.
   [Huebner, A.] Tech Univ Dresden, Childrens Hosp, Dresden, Germany.
   [Kress, W.] Univ Wurzburg, Biozentrum, Inst Human Genet, D-97070 Wurzburg, Germany.
   [Udd, B.] Univ Helsinki, Tampere Med Sch, Dept Neurol, FIN-00014 Helsinki, Finland.
   [Udd, B.] Univ Helsinki, Univ Hosp, FIN-00014 Helsinki, Finland.
   [Udd, B.] Univ Helsinki, Vaasa Cent Hosp, FIN-00014 Helsinki, Finland.
   [Udd, B.] Univ Helsinki, Folkhalsan Inst Genet, FIN-00014 Helsinki, Finland.
   [Udd, B.] Univ Helsinki, Dept Med Genet, FIN-00014 Helsinki, Finland.
   [Schroeder, R.] Univ Hosp Erlangen, Inst Neuropathol, Erlangen, Germany.
   [Schroeder, R.] Univ Hosp Erlangen, Dept Neurol, Erlangen, Germany.
   [Eymard, B.; Fardeau, M.] Grp Hosp Pitie Salpetriere, Inst Myol, F-75634 Paris, France.
   [Goldfarb, L.] Natl Inst Neurol Disorders & Stroke, NIH, Bethesda, MD USA.
   [Olive, M.] Hosp Llobregat, Bellvitge Hosp, IDIBELL, Inst Neuropatol, Barcelona, Spain.
   [Meyer, W.] Queen Mary Univ London, St Bartholomews & Royal London Sch Med, London, England.
RP Fischer, D (corresponding author), Univ Basel Hosp, Dept Neurol, CH-4031 Basel, Switzerland.
EM fischerdi@uhbs.ch
RI Schroder, Rolf/B-2774-2011; Kley, Rudolf Andre/AAT-8094-2020
OI Olive, Montse/0000-0001-5727-0165
FU DFGGerman Research Foundation (DFG) [Fi 913/2-1]; BONFOR; German network
   on muscular dystrophies MD-NET [01GM0601]; German ministry of education
   and research (BMBF, Bonn, Germany)Federal Ministry of Education &
   Research (BMBF); Finnish AcademyAcademy of Finland; Juselius Foundation;
   Genetic Research Funds of Folkhalsan Foundation; Spanish Ministry of
   HealthInstituto de Salud Carlos IIISpanish Government; Instituto de
   Salud Carlos IIIInstituto de Salud Carlos III [PI05/1213]; NATIONAL
   INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Neurological Disorders & Stroke (NINDS)
   [ZIANS002973, ZIANS002973, ZIANS002973, ZIANS002973, ZIANS002973]
   Funding Source: NIH RePORTER
FX D.F. was supported by the DFG (Fi 913/2-1) and BONFOR. D.F., R.K., R.S.,
   W.K., and M.V. are members of the German network on muscular dystrophies
   (MD-NET, 01GM0601) funded by the German ministry of education and
   research (BMBF, Bonn, Germany). B. U. was supported by the Finnish
   Academy, the Juselius Foundation, and the Genetic Research Funds of
   Folkhalsan Foundation. M.O. was supported by the Spanish Ministry of
   Health, Instituto de Salud Carlos III (PI05/1213).
CR Bar H, 2005, HUM MOL GENET, V14, P1251, DOI 10.1093/hmg/ddi136
   Berciano J, 2008, J NEUROL NEUROSUR PS, V79, DOI 10.1136/jnnp.2007.125435
   BULCKE JA, 1979, NEURORADIOLOGY, V17, P127
   Carlsson L, 2001, ACTA PHYSIOL SCAND, V171, P341, DOI 10.1046/j.1365-201x.2001.00837.x
   Carlsson L, 2000, HISTOCHEM CELL BIOL, V114, P39
   Clemen CS, 2005, FEBS LETT, V579, P3777, DOI 10.1016/j.febslet.2005.05.051
   Dagvadorj A, 2004, J NEUROL, V251, P143, DOI 10.1007/s00415-004-0289-3
   DeBleecker JL, 1996, J NEUROPATH EXP NEUR, V55, P563, DOI 10.1097/00005072-199605000-00009
   Engel AG, 1999, ANN NEUROL, V46, P681, DOI 10.1002/1531-8249(199911)46:5<681::AID-ANA1>3.0.CO;2-B
   Fardeau M, 2000, REV NEUROL, V156, P497
   Fischer D, 2006, NEUROLOGY, V67, P2217, DOI 10.1212/01.wnl.0000249151.45200.71
   Fischer D, 2005, J NEUROL, V252, P538, DOI 10.1007/s00415-005-0684-4
   Fischer D, 2006, NEUROMUSCULAR DISORD, V16, P361, DOI 10.1016/j.nmd.2006.03.007
   Fischer D, 2006, BRAIN, V129, P1463, DOI 10.1093/brain/awl071
   Goebel HH, 1997, CURR OPIN NEUROL, V10, P426, DOI 10.1097/00019052-199710000-00012
   Goldfarb LG, 1998, NAT GENET, V19, P402, DOI 10.1038/1300
   Goldfarb LG, 2004, BRAIN, V127, P723, DOI 10.1093/brain/awh033
   Goudeau B, 2006, HUM MUTAT, V27, P906, DOI 10.1002/humu.20351
   Griggs R, 2007, BRAIN, V130, P1477, DOI 10.1093/brain/awm006
   Hauser MA, 2002, AM J HUM GENET, V71, P1428, DOI 10.1086/344532
   HAWLEY RJ, 1984, ARCH NEUROL-CHICAGO, V41, P383, DOI 10.1001/archneur.1984.04050160045014
   Jungbluth H, 2004, NEUROMUSCULAR DISORD, V14, P785, DOI 10.1016/j.nmd.2004.08.006
   Kaminska A, 2004, HUM GENET, V114, P306, DOI 10.1007/s00439-003-1057-7
   Kley RA, 2007, BRAIN, V130, P3250, DOI 10.1093/brain/awm271
   Nakano S, 1996, J NEUROPATH EXP NEUR, V55, P549, DOI 10.1097/00005072-199605000-00008
   Olive M, 2005, BRAIN, V128, P2315, DOI 10.1093/brain/awh576
   Olive M, 2007, NEUROMUSCULAR DISORD, V17, P443, DOI 10.1016/j.nmd.2007.02.009
   Schroder R, 2003, HUM MOL GENET, V12, P657, DOI 10.1093/hmg/ddg060
   Selcen D, 2005, ANN NEUROL, V57, P269, DOI 10.1002/ana.20376
   Selcen D, 2004, NEUROLOGY, V62, P1363, DOI 10.1212/01.WNL.0000123576.74801.75
   Vicart P, 1998, NAT GENET, V20, P92, DOI 10.1038/1765
   Vorgerd M, 2005, AM J HUM GENET, V77, P297, DOI 10.1086/431959
   Vrabie A, 2005, ACTA NEUROPATHOL, V109, P411, DOI 10.1007/s00401-005-0980-1
   Walter MC, 2007, BRAIN, V130, P1485, DOI 10.1093/brain/awm039
NR 34
TC 114
Z9 118
U1 0
U2 3
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0028-3878
J9 NEUROLOGY
JI Neurology
PD SEP 2
PY 2008
VL 71
IS 10
BP 758
EP 765
DI 10.1212/01.wnl.0000324927.28817.9b
PG 8
WC Clinical Neurology
SC Neurosciences & Neurology
GA 343WC
UT WOS:000258885100010
PM 18765652
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Connolly, E
   Melegari, M
   Landgraf, P
   Tchaikovskaya, T
   Tennant, BC
   Slagle, BL
   Rogler, LE
   Zavolan, M
   Tuschl, T
   Rogler, CE
AF Connolly, Erin
   Melegari, Margherita
   Landgraf, Pablo
   Tchaikovskaya, Tatyana
   Tennant, Bud C.
   Slagle, Betty L.
   Rogler, Leslie E.
   Zavolan, Mihaela
   Tuschl, Thomas
   Rogler, Charles E.
TI Elevated expression of the miR-17-92 polycistron and miR-21 in
   hepadnavirus-associated hepatocellular carcinoma contributes to the
   malignant phenotype
SO AMERICAN JOURNAL OF PATHOLOGY
LA English
DT Article
ID MICRORNA CLUSTER; INTEGRATION; BIOGENESIS; ACTIVATION; ONCOMIRS; MIRNAS;
   RISK; GENE; RNA; MYC
AB Alterations in microRNA (miRNA) expression in both human and animal models have been linked to many forms of cancer. Such miRNAs, which act directly as repressors of gene expression, have been found to frequently reside in fragile sites and genomic regions associated with cancer. This study describes a miRNA signature for human primary hepatitis B virus-positive human hepatocellular carcinoma. Moreover, two known oncomiRs miRNAs with known roles in cancer-the miR-17-92 polycistron and miR-21, exhibited increased expression in 100% of primary human and woodchuck hepatocellular carcinomas surveyed. To determine the importance of these miRNAs in tumorigenesis, an in vitro antisense oligonucleotide knockdown model was evaluated for its ability to reverse the malignant phenotype. Both in human and woodchuck HCC cell lines, separate treatments with antisense oligonucleotides specific for either the miR-17-92 polycistron (all six members) or miR-21 caused a 50% reduction in both hepatocyte proliferation and anchorage-independent growth. The combination of assays presented here supports a role for these miRNAs in the maintenance of the malignant transformation of hepatocytes.
C1 [Connolly, Erin; Melegari, Margherita; Tchaikovskaya, Tatyana; Rogler, Leslie E.; Rogler, Charles E.] Albert Einstein Coll Med, Dept Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA.
   [Landgraf, Pablo; Tuschl, Thomas] Rockefeller Univ, Lab RNA Biol, New York, NY 10021 USA.
   [Tennant, Bud C.] Cornell Univ, Coll Vet Med, Dept Anim Sci, Ithaca, NY 14853 USA.
   [Slagle, Betty L.] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA.
   [Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Zavolan, Mihaela] Swiss Inst Bioinformat, Lausanne, Switzerland.
RP Rogler, CE (corresponding author), Albert Einstein Coll Med, Dept Med, Marion Bessin Liver Res Ctr, Bronx, NY 10461 USA.
EM crogler@aecom.yu.edu
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute Funding
   Source: Medline; NCI NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [CA95388, P30 CA013330, R01 CA095388, R56 CA095388,
   CA37232, 5P30CA13330, R01 CA037232] Funding Source: Medline; NIDDK NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [DK061153, 5P30DK41296, R01
   DK061153, U24 DK058768, P30 DK041296, 5U24DK058768] Funding Source:
   Medline; PHS HHSUnited States Public Health Service [N01-A105399]
   Funding Source: Medline; NATIONAL CANCER INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, R01CA037232, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   R01CA037232, R01CA037232, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, R01CA037232, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, R01CA037232, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   R01CA037232, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, R01CA095388, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, R01CA037232,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   R01CA037232, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, R01CA037232, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, R01CA037232,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, R01CA037232,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   R01CA037232, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   R01CA037232, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   R01CA037232, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   R01CA037232, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, R01CA037232, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, R01CA095388,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, R01CA037232, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, R56CA095388, R01CA037232, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   R01CA037232, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   R01CA095388, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, R01CA037232,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, R01CA037232, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, R01CA095388, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, R01CA037232, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, R01CA037232, P30CA013330, P30CA013330,
   R01CA037232, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   R01CA037232, P30CA013330, R01CA037232, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, P30CA013330,
   P30CA013330, P30CA013330, P30CA013330, P30CA013330, R01CA095388] Funding
   Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND
   KIDNEY DISEASESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, U24DK058768, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, U24DK058768,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, R01DK061153, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   R01DK061153, P30DK041296, P30DK041296, U24DK058768, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   R01DK061153, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   R01DK061153, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, U24DK058768,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, R01DK061153, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296, P30DK041296, P30DK041296, P30DK041296, P30DK041296,
   P30DK041296] Funding Source: NIH RePORTER
CR Buendia M A, 1992, Semin Cancer Biol, V3, P309
   Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1
   Chuang JC, 2007, PEDIATR RES, V61, p24R, DOI 10.1203/pdr.0b013e3180457684
   Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036
   ESPINOSA CES, 2006, YALE J BIOL MED, V79, P131
   Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840
   ETIEMBLE J, 1994, ONCOGENE, V9, P727
   Fattovich G, 2004, GASTROENTEROLOGY, V127, pS35, DOI 10.1053/j.gastro.2004.09.014
   Flajolet M, 1998, J VIROL, V72, P6175, DOI 10.1128/JVI.72.7.6175-6180.1998
   Giannakakis A, 2007, EXPERT OPIN BIOL TH, V7, P1375, DOI 10.1517/14712598.7.9.1375
   Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017
   Gronbaek K, 2007, APMIS, V115, P1039, DOI 10.1111/j.1600-0463.2007.apm_636.xml.x
   Harris TM, 1998, ONCOGENE, V16, P203, DOI 10.1038/sj.onc.1201519
   Hayashita Y, 2005, CANCER RES, V65, P9628, DOI 10.1158/0008-5472.CAN-05-2352
   He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552
   Herath NI, 2006, J GASTROEN HEPATOL, V21, P15, DOI 10.1111/j.1440-1746.2005.04043.x
   Hessein M, 2005, TUMORI J, V91, P241
   Johnson DG, 2006, CURR MOL MED, V6, P731
   Kutay H, 2006, J CELL BIOCHEM, V99, P671, DOI 10.1002/jcb.20982
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Liu W, 2007, WORLD J GASTROENTERO, V13, P497, DOI 10.3748/wjg.v13.i4.497
   Loffler D, 2007, BLOOD, V110, P1330, DOI 10.1182/blood-2007-03-081133
   Lund E, 2006, COLD SPRING HARB SYM, V71, P59, DOI 10.1101/sqb.2006.71.050
   Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022
   Mishima T, 2007, BRAIN RES, V1131, P37, DOI 10.1016/j.brainres.2006.11.035
   Moran DM, 2008, J SURG RES, V147, P23, DOI 10.1016/j.jss.2007.04.022
   Murakami Y, 2005, GUT, V54, P1162, DOI 10.1136/gut.2004.054452
   Nam Soon Woo, 2007, Korean Journal of Internal Medicine, V22, P73
   Novotny GW, 2007, CELL DEATH DIFFER, V14, P879, DOI 10.1038/sj.cdd.4402090
   Perron MP, 2008, FRONT BIOSCI-LANDMRK, V13, P2537, DOI 10.2741/2865
   POPPER H, 1987, P NATL ACAD SCI USA, V84, P866, DOI 10.1073/pnas.84.3.866
   Rinaldi A, 2007, LEUKEMIA LYMPHOMA, V48, P410, DOI 10.1080/10428190601059738
   Si ML, 2007, ONCOGENE, V26, P2799, DOI 10.1038/sj.onc.1210083
   SLAGLE BL, 1991, CANCER RES, V51, P49
   Sylvestre Y, 2007, J BIOL CHEM, V282, P2135, DOI 10.1074/jbc.M608939200
   WEI Y, 1992, J VIROL, V66, P5265, DOI 10.1128/JVI.66.9.5265-5276.1992
   Yang DY, 1996, J VIROL, V70, P6260, DOI 10.1128/JVI.70.9.6260-6268.1996
   Yu MC, 2004, GASTROENTEROLOGY, V127, pS72, DOI 10.1016/j.gastro.2004.09.018
NR 38
TC 207
Z9 218
U1 0
U2 7
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA
SN 0002-9440
EI 1525-2191
J9 AM J PATHOL
JI Am. J. Pathol.
PD SEP
PY 2008
VL 173
IS 3
BP 856
EP 864
DI 10.2353/ajpath.2008.080096
PG 9
WC Pathology
SC Pathology
GA 344JD
UT WOS:000258921900024
PM 18688024
OA Green Published
DA 2021-01-25
ER

PT J
AU Spang, A
AF Spang, A.
TI The life cycle of a transport vesicle
SO CELLULAR AND MOLECULAR LIFE SCIENCES
LA English
DT Review
DE vesicle biogenesis; small GTPases; coat proteins; SNAREs; Arf1;
   coatomer; adaptor complex; clathrin; COPII; COPI; Sar1
ID NUCLEOTIDE-EXCHANGE FACTORS; CLATHRIN-MEDIATED ENDOCYTOSIS;
   ADP-RIBOSYLATION FACTOR; PLASMA-MEMBRANE ATPASE; ENDOPLASMIC-RETICULUM;
   SACCHAROMYCES-CEREVISIAE; COPII VESICLES; COATED VESICLES; RETROGRADE
   TRANSPORT; PROTEIN-TRANSPORT
AB Vesicular transport is the basic communication mechanism between different compartments in a cell and with the environment. In this review I discuss the principles of vesicle generation and consumption with particular emphasis on the different types of coat proteins and the timing of the shedding of the coat proteins from transport containers. In recent years it has become clear that there are more coat complexes than the classical COPI, COPII and clathrin coats. These additional coats may generate vesicles that transport cargo in a temporally and/or spatially controlled manner. Work over the last years suggests that GTP hydrolysis occurs early during vesicle biogenesis, destabilizing the coat perhaps before fission of the vesicle from the donor membrane occurs. Recent findings imply, however, that tethers at the receiving compartment specifically detect the coat on vesicle.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spang, A (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anne.spang@unibas.ch
RI Wunder, Stephanie L/B-5066-2012; Zdilla, Michael J/B-4145-2011; Spang,
   Anne/M-7223-2019; Spang, Anne/A-7029-2008
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203
CR Aguilera-Romero A, 2008, J CELL BIOL, V180, P713, DOI 10.1083/jcb.200710025
   Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200
   Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019
   Bannykh SI, 1998, TRENDS CELL BIOL, V8, P21, DOI 10.1016/S0962-8924(97)01184-7
   Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097
   Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06
   Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852
   Bi XP, 2007, DEV CELL, V13, P635, DOI 10.1016/j.devcel.2007.10.006
   Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040
   Bielli A, 2005, J CELL BIOL, V171, P919, DOI 10.1083/jcb.200509095
   Bigay J, 2005, EMBO J, V24, P2244, DOI 10.1038/sj.emboj.7600714
   Bigay J, 2003, NATURE, V426, P563, DOI 10.1038/nature02108
   Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876
   Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6
   Cai HQ, 2007, NATURE, V445, P941, DOI 10.1038/nature05527
   Campbell JL, 1997, P NATL ACAD SCI USA, V94, P837, DOI 10.1073/pnas.94.3.837
   Casanova JE, 2007, TRAFFIC, V8, P1476, DOI 10.1111/j.1600-0854.2007.00634.x
   Chadda R, 2007, TRAFFIC, V8, P702, DOI 10.1111/j.1600-0854.2007.00565.x
   Chantalat S, 2004, J CELL SCI, V117, P711, DOI 10.1242/jcs.00896
   Chantalat S, 2003, MOL BIOL CELL, V14, P2357, DOI 10.1091/mbc.E02-10-0693
   Cosson P, 1998, EMBO J, V17, P6863, DOI 10.1093/emboj/17.23.6863
   Daro E, 1997, J CELL BIOL, V139, P1747, DOI 10.1083/jcb.139.7.1747
   del Pozo MA, 2005, NAT CELL BIOL, V7, P901, DOI 10.1038/ncb1293
   Dierks S, 2001, WATER SCI TECHNOL, V44, P477
   Echarri A, 2007, SEMIN CELL DEV BIOL, V18, P627, DOI 10.1016/j.semcdb.2007.08.004
   Fath S, 2007, CELL, V129, P1325, DOI 10.1016/j.cell.2007.05.036
   Ficarro SB, 2002, NAT BIOTECHNOL, V20, P301, DOI 10.1038/nbt0302-301
   FRANZUSOFF A, 1991, J CELL BIOL, V112, P27, DOI 10.1083/jcb.112.1.27
   Frick M, 2007, CURR BIOL, V17, P462, DOI 10.1016/j.cub.2007.01.069
   Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005
   FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8
   Gaus K, 2006, J CELL BIOL, V174, P725, DOI 10.1083/jcb.200603034
   Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5
   Goldberg J, 1999, CELL, V96, P893, DOI 10.1016/S0092-8674(00)80598-X
   Gommel DU, 2001, EMBO J, V20, P6751, DOI 10.1093/emboj/20.23.6751
   Gu F, 1997, J CELL BIOL, V139, P1183, DOI 10.1083/jcb.139.5.1183
   Guigas G, 2007, FEBS LETT, V581, P5094, DOI 10.1016/j.febslet.2007.09.054
   Gurkan C, 2006, NAT REV MOL CELL BIO, V7, P727, DOI 10.1038/nrm2025
   HARSAY E, 1995, J CELL BIOL, V131, P297, DOI 10.1083/jcb.131.2.297
   Harsay E, 2002, J CELL BIOL, V156, P271, DOI 10.1083/jcb.200109077
   Harter C, 1998, P NATL ACAD SCI USA, V95, P11649, DOI 10.1073/pnas.95.20.11649
   Honda A, 2005, J CELL BIOL, V168, P1039, DOI 10.1083/jcb.200409138
   Huang MD, 2001, J CELL BIOL, V155, P937, DOI 10.1083/jcb.200106039
   Huizing M, 2000, TRAFFIC, V1, P823, DOI 10.1034/j.1600-0854.2000.011103.x
   Jackson CL, 2000, TRENDS CELL BIOL, V10, P60, DOI 10.1016/S0962-8924(99)01699-2
   Jenkins D, 2007, AM J HUM GENET, V80, P1162, DOI 10.1086/518047
   Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940
   Kamena F, 2004, SCIENCE, V304, P286, DOI 10.1126/science.1095049
   Kins S, 2006, NEURODEGENER DIS, V3, P218, DOI 10.1159/000095259
   Kurihara T, 2000, MOL BIOL CELL, V11, P983, DOI 10.1091/mbc.11.3.983
   Lanoix J, 1999, EMBO J, V18, P4935, DOI 10.1093/emboj/18.18.4935
   Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017
   Lederkremer GZ, 2001, P NATL ACAD SCI USA, V98, P10704, DOI 10.1073/pnas.191359398
   Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025
   Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307
   Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008
   Lewis SM, 2004, MOL BIOL CELL, V15, P4064, DOI 10.1091/mbc.E04-04-0316
   Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103
   Macara IG, 2006, CELL, V125, P419, DOI 10.1016/j.cell.2006.04.011
   Malsam J, 1999, FEBS LETT, V462, P267, DOI 10.1016/S0014-5793(99)01543-4
   Marzesco AM, 2002, MOL BIOL CELL, V13, P1819, DOI 10.1091/mbc.02-02-0029
   Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9
   Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216
   Mesmin B, 2007, BIOCHEMISTRY-US, V46, P1779, DOI 10.1021/bi062288w
   Meurer S, 2004, J BIOL CHEM, V279, P49346, DOI 10.1074/jbc.M410565200
   Michelsen K, 2007, J CELL BIOL, V179, P209, DOI 10.1083/jcb.200704142
   Mironov AA, 2003, DEV CELL, V5, P583, DOI 10.1016/S1534-5807(03)00294-6
   Nickel W, 1998, SEMIN CELL DEV BIOL, V9, P493, DOI 10.1006/scdb.1998.0256
   Peyroche A, 1996, NATURE, V384, P479, DOI 10.1038/384479a0
   Puthenveedu MA, 2006, CELL, V127, P113, DOI 10.1016/j.cell.2006.08.035
   Rao YJ, 2006, BIOCHEM BIOPH RES CO, V348, P908, DOI 10.1016/j.bbrc.2006.07.148
   Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092
   Richter S, 2007, NATURE, V448, P488, DOI 10.1038/nature05967
   Roberg KJ, 1999, J CELL BIOL, V145, P659, DOI 10.1083/jcb.145.4.659
   Robinson MS, 2004, TRENDS CELL BIOL, V14, P167, DOI 10.1016/j.tcb.2004.02.002
   Sanchatjate S, 2006, MOL BIOL CELL, V17, P4157, DOI 10.1091/mbc.E06-03-0210
   Sandmann T, 2003, MOL BIOL CELL, V14, P3097, DOI 10.1091/mbc.E02-11-0736
   Saraste J, 2007, MOL BIOL CELL, V18, P1430, DOI 10.1091/mbc.E06-10-0933
   Schindler C, 2007, MOL BIOL CELL, V18, P2852, DOI 10.1091/mbc.E06-08-0756
   Schonthaler HB, 2008, DEVELOPMENT, V135, P387, DOI 10.1242/dev.006098
   Shields D, 1999, CURR OPIN CELL BIOL, V11, P489, DOI 10.1016/S0955-0674(99)80070-2
   Shimoni Y, 2000, J CELL BIOL, V151, P973, DOI 10.1083/jcb.151.5.973
   Shimoni Y, 2002, METHOD ENZYMOL, V351, P258
   Smith R, 2007, J NEUROCHEM, V103, P115, DOI 10.1111/j.1471-4159.2007.04703.x
   Soderholm J, 2004, DEV CELL, V6, P649, DOI 10.1016/S1534-5807(04)00129-7
   Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239
   Spang A, 2002, CURR OPIN CELL BIOL, V14, P423, DOI 10.1016/S0955-0674(02)00346-0
   Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035
   Spang A, 1998, P NATL ACAD SCI USA, V95, P11199, DOI 10.1073/pnas.95.19.11199
   Springer S, 1998, SCIENCE, V281, P698, DOI 10.1126/science.281.5377.698
   Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9
   Stagg SM, 2007, CURR OPIN STRUC BIOL, V17, P221, DOI 10.1016/j.sbi.2007.03.010
   Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339
   Takei K, 1998, CELL, V94, P131, DOI 10.1016/S0092-8674(00)81228-3
   Tang BL, 1999, BIOCHEM BIOPH RES CO, V258, P679, DOI 10.1006/bbrc.1999.0574
   Terai T, 2006, MOL BIOL CELL, V17, P2465, DOI 10.1091/mbc.E05-09-0826
   Trautwein M, 2006, EMBO J, V25, P943, DOI 10.1038/sj.emboj.7601007
   VanRheenen SM, 2001, TRAFFIC, V2, P212, DOI 10.1034/j.1600-0854.2001.020307.x
   Wang CW, 2006, J CELL BIOL, V174, P973, DOI 10.1083/jcb.200605106
   WATERS M G, 1991, Current Opinion in Cell Biology, V3, P615, DOI 10.1016/0955-0674(91)90031-S
   Weiss M, 2003, TRAFFIC, V4, P65, DOI 10.1034/j.1600-0854.2003.40202.x
   Wells CD, 2006, CELL, V125, P535, DOI 10.1016/j.cell.2006.02.045
   Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893
   Yang JS, 2002, J CELL BIOL, V159, P69, DOI 10.1083/jcb.200206015
NR 104
TC 43
Z9 43
U1 0
U2 13
PU SPRINGER BASEL AG
PI BASEL
PA PICASSOPLATZ 4, BASEL, 4052, SWITZERLAND
SN 1420-682X
J9 CELL MOL LIFE SCI
JI Cell. Mol. Life Sci.
PD SEP
PY 2008
VL 65
IS 18
BP 2781
EP 2789
DI 10.1007/s00018-008-8349-y
PG 9
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 351WX
UT WOS:000259457700002
PM 18726180
DA 2021-01-25
ER

PT J
AU Blanco, J
   Gehring, WJ
AF Blanco, Jorge
   Gehring, Walter J.
TI Analysis of twin of eyeless regulation during early embryogenesis in
   Drosophila melanogaster
SO GENE EXPRESSION PATTERNS
LA English
DT Article
DE Drosophila blastoderm stage; Eye development; toy; bicoid; torso;
   dorsal; hunchback; knirps
ID BICOID PROTEIN; GENE; HEAD; EXPRESSION; PATTERN; TRANSCRIPTION;
   GRADIENT; REGION; AXIS
AB The Drosophila Pax6 homolog twin of eyeless (toy) is so far the first zygotically expressed gene involved in eye morphogenesis in Drosophila. The study of its expression during embryogenesis is therefore informative of the initial events of eye development in Drosophila. We have analyzed how the initial expression domain of toy at cellular blastoderm is regulated. We show that the three maternal patterning systems active in the cephalic region (the anterior, terminal and dorsal-ventral systems) cooperate with zygotically activated gap genes to shape the initial expression domain of toy. Whereas Bicoid, Dorsal and Torso signaling synergistically act as activators, Hunchback, Knirps and Decapentaplegic act as repressors. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Blanco, Jorge; Gehring, Walter J.] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Blanco, J (corresponding author), Univ Basel, Pharmazentrum, Dept Mol Zool, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM Jorge.Blanco@unibas.ch
FU Kantons of Basel-Stadt and Basel-Land; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); Spanish Ministerio
   de Educacion y CulturaGerman Research Foundation (DFG)
FX We acknowledge E.A. Wimmer, M. Affolter, J. Casanova and the Bloomington
   Drosophila stock center for kindly providing fly Strains. This work was
   Supported by the Kantons of Basel-Stadt and Basel-Land, the Swiss
   National Science Foundation and a Grant from the Spanish Ministerio de
   Educacion y Cultura (to J.B.).
CR BRONNER G, 1991, MECH DEVELOP, V35, P205, DOI 10.1016/0925-4773(91)90019-3
   COUREY AJ, 1995, BBA-GENE STRUCT EXPR, V1261, P1, DOI 10.1016/0167-4781(94)00234-T
   Czerny T, 1999, MOL CELL, V3, P297, DOI 10.1016/S1097-2765(00)80457-8
   DRIEVER W, 1988, CELL, V54, P83, DOI 10.1016/0092-8674(88)90182-1
   DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0
   DRIEVER W, 1988, CELL, V54, P95, DOI 10.1016/0092-8674(88)90183-3
   DUFFY JB, 1994, DEV BIOL, V166, P380, DOI 10.1006/dbio.1994.1324
   ELDON ED, 1991, DEVELOPMENT, V111, P367
   Gao Q, 1996, MECH DEVELOP, V56, P3, DOI 10.1016/0925-4773(96)00504-7
   Gehring WJ, 2004, INT J DEV BIOL, V48, P707, DOI 10.1387/ijdb.041900wg
   Gehring WJ, 1999, TRENDS GENET, V15, P371, DOI 10.1016/S0168-9525(99)01776-X
   GREEN P, 1993, CELL TISSUE RES, V273, P583, DOI 10.1007/BF00333712
   GROSSNIKLAUS U, 1994, DEVELOPMENT, V120, P3155
   Hauptmann G, 2001, METHODS, V23, P359, DOI 10.1006/meth.2000.1148
   Janody F, 2000, DEVELOPMENT, V127, P279
   Jimenez G, 2000, GENE DEV, V14, P224
   Kammermeier L, 2001, MECH DEVELOP, V103, P71, DOI 10.1016/S0925-4773(01)00328-8
   Kozmik Z, 2005, CURR OPIN GENET DEV, V15, P430, DOI 10.1016/j.gde.2005.05.001
   Kronhamn J, 2002, DEVELOPMENT, V129, P1015
   Lindsley D., 1992, GENOME DROSOPHILA ME
   Niessing D, 1997, J CELL PHYSIOL, V173, P162, DOI 10.1002/(SICI)1097-4652(199711)173:2<162::AID-JCP15>3.0.CO;2-I
   PIGNONI F, 1992, DEVELOPMENT, V115, P239
   Punzo C, 2004, DEVELOPMENT, V131, P3943, DOI 10.1242/dev.01278
   RAY RP, 1991, DEVELOPMENT, V113, P35
   RONCHI E, 1993, CELL, V74, P347, DOI 10.1016/0092-8674(93)90425-P
   ROTHE M, 1994, MECH DEVELOP, V46, P169, DOI 10.1016/0925-4773(94)90069-8
   Rusch J, 1997, DEVELOPMENT, V124, P303
   Schaeffer V, 2000, DEVELOPMENT, V127, P3993
   STRUHL G, 1992, CELL, V69, P237, DOI 10.1016/0092-8674(92)90405-2
   STRUHL G, 1989, CELL, V57, P1259, DOI 10.1016/0092-8674(89)90062-7
   WIMMER EA, 1995, MECH DEVELOP, V53, P235, DOI 10.1016/0925-4773(95)00439-8
   YOUNOSSIHARTENSTEIN A, 1993, ROUX ARCH DEV BIOL, V203, P60, DOI 10.1007/BF00539891
NR 32
TC 5
Z9 6
U1 0
U2 6
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1567-133X
EI 1872-7298
J9 GENE EXPR PATTERNS
JI Gene Expr. Patterns
PD SEP
PY 2008
VL 8
IS 7-8
BP 523
EP 527
DI 10.1016/j.gep.2008.06.002
PG 5
WC Developmental Biology; Genetics & Heredity
SC Developmental Biology; Genetics & Heredity
GA 358DE
UT WOS:000259896100008
PM 18586115
DA 2021-01-25
ER

PT J
AU Koberle, M
   Goppel, D
   Grandl, T
   Berchtold, S
   Luscher, B
   Labat, MLA
   Sorg, I
   Pallardy, M
   Barth, H
   Autenrieth, IB
   Bohn, E
AF Koeberle, M.
   Goeppel, D.
   Grandl, T.
   Berchtold, S.
   Luescher, B.
   Labat, M. L. Asselin
   Sorg, I.
   Pallardy, M.
   Barth, H.
   Autenrieth, I. B.
   Bohn, E.
TI The transcriptions factors USF-1 and USF-2 are essential for
   Y-enterocolitica YopT and C-difficile toxin B induced GILZ expression
SO INTERNATIONAL JOURNAL OF MEDICAL MICROBIOLOGY
LA English
DT Meeting Abstract
CT 60th Annual Meeting of the
   Deutschen-Gesellschaft-fur-Hygiene-und-Mikrobiologie
CY SEP 21-24, 2008
CL Dresden, GERMANY
SP Deutsch Gesell Hygiene & Mikrobiol
C1 [Koeberle, M.; Goeppel, D.; Grandl, T.; Berchtold, S.; Autenrieth, I. B.; Bohn, E.] Univ Klinikum Tubingen, Inst Med Mikrobiol & Hyg, Tubingen, Germany.
   [Luescher, B.] Univ Klinikum Aachan, Inst Biochem, Aachen, Germany.
   [Labat, M. L. Asselin; Pallardy, M.] Fac Pharm Paris XI, INSERM, UMR S 749, Chatenay Malabry, France.
   [Sorg, I.] Biozentrum Univ Basel, Dept Infect Biol, Basel, Switzerland.
   [Barth, H.] Univ Ulm, Inst Pharmacol & Toxicol, Med Ctr, Ulm, Germany.
RI Barth, Holger/E-7920-2013
NR 0
TC 0
Z9 0
U1 1
U2 2
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 1438-4221
J9 INT J MED MICROBIOL
JI Int. J. Med. Microbiol.
PD SEP
PY 2008
VL 298
SU 45
BP 63
EP 63
PG 1
WC Microbiology; Virology
SC Microbiology; Virology
GA 353SV
UT WOS:000259589400246
DA 2021-01-25
ER

PT J
AU Knechtle, B
   Duff, B
   Schulze, I
   Kohler, G
AF Knechtle, Beat
   Duff, Brida
   Schulze, Ingo
   Kohler, Gotz
TI A multi-stage ultra-endurance run over 1,200 km leads to a continuous
   accumulation of total body water
SO JOURNAL OF SPORTS SCIENCE AND MEDICINE
LA English
DT Article
DE body fat; body mass; dehydration; skeletal muscle mass
ID SKELETAL-MUSCLE MASS; BIOELECTRICAL-IMPEDANCE; RENAL-FUNCTION; HYDRATION
   CHANGES; RUNNING RACE; EXERCISE; RESPONSES; FLUID; TRIATHLON; BALANCE
AB We determined whether ultra-runners in a multi-stage ultra-endurance run lose body mass, fat mass, skeletal muscle mass or total body water in a descriptive field study at the 'Deutschlandlauf' 2007 a 1,200 km run within 17 consecutive days with 10 male non-professional Caucasian ultra-runners (mean +/- SD, 43.8 +/- 6.2 years, 73.8 +/- 6.0 kg body mass, 1.77 +/- 0.05 m body height, BMI 23.3 +/- 1.8 kg.m(-2)). Body mass, fat mass, skeletal muscle mass, lean body mass and percent total body water were determined using bioelectrical impedance analysis and the anthropometric method before the race and after each stage. In addition, urinary specific gravity was measured in order to quantify hydration status. Fat mass (bioelectrical impedance analysis) decreased by 3.9 kg (p < 0.05), skeletal muscle mass (anthropometric method) decreased by 2.0 kg (p < 0.05) whereas percent total body water increased by 6.1 % (p < 0.05) by the end of the race. Ultra-runners in a multi-stage ultra-endurance event over 1,200 km, with 17 consecutive stages, showed a cumulative increase in percent total body water, a decrease in skeletal muscle mass and a decrease in fat mass, depending upon the method used. We presume that the eccentric component of running leads to damage of skeletal muscle, leading to rhabdomyolysis, with impaired renal function.
C1 [Knechtle, Beat; Duff, Brida] Gesundheitszentrum, Facharzt FMH Allgemeinmed, CH-9001 St Gallen, Switzerland.
   [Knechtle, Beat] Univ Zurich, Dept Gen Practice, Zurich, Switzerland.
   [Schulze, Ingo] Deutschlandlauf, Horb Nordstetten, Germany.
   [Kohler, Gotz] Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
RP Knechtle, B (corresponding author), Gesundheitszentrum, Facharzt FMH Allgemeinmed, Vadianstr 26, CH-9001 St Gallen, Switzerland.
EM beat.knechtle@hispeed.ch; bridaduff@hotmail.com; ultralauf@ischulze.de;
   goetz.kohler@unibas.ch
CR Ball SD, 2004, EUR J CLIN NUTR, V58, P1525, DOI 10.1038/sj.ejcn.1602003
   Bircher S, 2006, J SPORT SCI MED, V5, P154
   DANCASTER C P, 1969, South African Medical Journal, V43, P758
   DEUSTER PA, 1992, MED SCI SPORT EXER, V24, P72, DOI 10.1249/00005768-199201000-00013
   FELLMANN N, 1992, SPORTS MED, V13, P37, DOI 10.2165/00007256-199213010-00004
   Fellmann N, 1999, EUR J APPL PHYSIOL, V80, P353, DOI 10.1007/s004210050603
   FELLMANN N, 1989, INT J SPORTS MED, V10, P406, DOI 10.1055/s-2007-1024934
   FREUND BJ, 1987, J APPL PHYSIOL, V63, P669
   FREUND BJ, 1991, J APPL PHYSIOL, V70, P900
   Gastmann U, 1998, J SPORT MED PHYS FIT, V38, P18
   GAULT MH, 1992, NEPHRON, V62, P249, DOI 10.1159/000187054
   IRVING RA, 1990, MED SCI SPORT EXER, V22, P756, DOI 10.1249/00005768-199012000-00004
   KAMINSKY LA, 1993, J SPORT MED PHYS FIT, V33, P172
   Kavouras SA, 2002, CURR OPIN CLIN NUTR, V5, P519, DOI 10.1097/00075197-200209000-00010
   Kim HJ, 2007, EUR J APPL PHYSIOL, V99, P443, DOI 10.1007/s00421-006-0362-y
   Knechtle B, 2008, INT J SPORTS MED, V29, P343, DOI 10.1055/s-2007-965354
   Knechtle B, 2005, INT J SPORTS MED, V26, P499, DOI 10.1055/s-2004-821136
   Knechtle B, 2008, Praxis (Bern 1994), V97, P243
   KNECHTLE B, 2006, SCHWEIZERISCHE Z SPO, V55, P102
   Knechtle B, 2007, J SPORT SCI MED, V6, P401
   Koller A, 1998, J SPORT MED PHYS FIT, V38, P10
   Lee RC, 2000, AM J CLIN NUTR, V72, P796
   LEHMANN M, 1995, INT J SPORTS MED, V16, P155, DOI 10.1055/s-2007-972984
   MACSEARRAIGH ETM, 1979, NEPHRON, V24, P236, DOI 10.1159/000181723
   Maughan R J, 1985, Br J Sports Med, V19, P138
   MELIN B, 1980, EUR J APPL PHYSIOL O, V44, P141, DOI 10.1007/BF00421092
   MILLEDGE JS, 1982, CLIN SCI, V62, P595, DOI 10.1042/cs0620595
   Mischler I, 2003, MED SCI SPORT EXER, V35, P75, DOI 10.1097/00005768-200301000-00013
   Montagnani M, 1998, APPL RADIAT ISOTOPES, V49, P499, DOI 10.1016/S0969-8043(97)00180-2
   Neumayr G, 2005, INT J SPORTS MED, V26, P2, DOI 10.1055/s-2004-815717
   NEVIACKAS JA, 1981, SOUTHERN MED J, V74, P1457
   Pialoux V, 2004, BRIT J NUTR, V91, P153, DOI 10.1079/BJN20031031
   POORTMANS JR, 1984, SPORTS MED, V1, P125, DOI 10.2165/00007256-198401020-00003
   RAMSAY DJ, 1989, BAILLIERE CLIN ENDOC, V3, P371, DOI 10.1016/S0950-351X(89)80008-4
   Raschka C, 1992, Schweiz Z Sportmed, V40, P13
   RASCHKA C, 1991, Z ERNAHRUNGSWISS, V30, P276, DOI 10.1007/BF01651957
   REHRER NJ, 1992, EUR J APPL PHYSIOL O, V64, P1, DOI 10.1007/BF00376431
   Saunders MJ, 1998, MED SCI SPORT EXER, V30, P885, DOI 10.1097/00005768-199806000-00017
   Skenderi KP, 2006, MED SCI SPORT EXER, V38, P1054, DOI 10.1249/01.mss.0000222831.35897.5f
   Uberoi H S, 1991, J Assoc Physicians India, V39, P677
   Wu HJ, 2004, WORLD J GASTROENTERO, V10, P2711, DOI 10.3748/wjg.v10.i18.2711
NR 41
TC 36
Z9 36
U1 0
U2 4
PU JOURNAL SPORTS SCIENCE & MEDICINE
PI BURSA
PA MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY
SN 1303-2968
J9 J SPORT SCI MED
JI J. Sport. Sci. Med.
PD SEP
PY 2008
VL 7
IS 3
BP 357
EP 364
PG 8
WC Sport Sciences
SC Sport Sciences
GA 343PJ
UT WOS:000258865700007
PM 24149903
OA DOAJ Gold
DA 2021-01-25
ER

PT J
AU Muller, SA
   Aebi, U
   Engel, A
AF Mueller, Shirley A.
   Aebi, Ueli
   Engel, Andreas
TI What transmission electron microscopes can visualize now and in the
   future
SO JOURNAL OF STRUCTURAL BIOLOGY
LA English
DT Review
DE transmission electron microscopy/microscope (TEM); electron
   crystallography; electron tomography; STEM mass determination; single
   cell proteomics; low-dose EM; automated TEM
ID NUCLEAR-PORE COMPLEX; CRYOELECTRON MICROSCOPY; 3-DIMENSIONAL
   RECONSTRUCTION; MOLECULAR ARCHITECTURE; ACETYLCHOLINE-RECEPTOR;
   FREEZE-SUBSTITUTION; VITREOUS SECTIONS; MEMBRANE-PROTEIN; WATER
   PERMEATION; CELL-CYCLE
AB Our review concentrates on the progress made in high-resolution transmission electron microscopy (TEM) in the past decade. This includes significant improvements in sample preparation by quick-freezing aimed at preserving the specimen in a close-to-native state in the high Vacuum of the microscope. Following advances in cold stage and TEM vacuum technology systems, the observation of native, frozen hydrated specimens has become a widely used approach. It fostered the development of computer guided, fully automated low-dose data acquisition systems allowing matched pairs of images and diffraction patterns to be recorded for electron crystallography, and the collection of entire tilt-series for electron tomography. To achieve optimal information transfer to atomic resolution, held emission electron guns combined with acceleration voltages of 200-300 kV are now routinely used. The outcome of these advances is illustrated by the atomic structure of mammalian aquaporin-O and by the pore-forming bacterial cytotoxin ClyA resolved to 12 A. Further, the Yersinia injectisome needle, a bacterial pseudopilus and the binding of phalloidin to muscle actin filaments were chosen to document the advantage of the high contrast offered by dedicated scanning transmission electron microscopy (STEM) and/or the STEM's ability to measure the mass of protein complexes and directly link this to their shape. Continued progress emerging from leading research laboratories and microscope manufacturers will eventually enable LIS to determine the proteome of a single cell by electron tomography, and to more routinely solve the atomic structure of membrane proteins by electron crystallography. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Mueller, Shirley A.; Aebi, Ueli; Engel, Andreas] Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Muller, SA (corresponding author), Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM shirley.mueller@unibas.ch
FU Swiss National Science Foundation (SNF)Swiss National Science Foundation
   (SNSF) [3100A0-108299]; national center of competence in research
   (NCCR)Swiss National Science Foundation (SNSF); European UnionEuropean
   Union (EU) [LSHG-CT-2004-502828, LSHG-CF-2005-018811]; University of
   Basel; Maurice E. Muller Foundation of Switzerland
FX The authors acknowledge financial support from the Swiss National
   Science Foundation (SNF Grant 3100A0-108299 to AE), and the national
   center of competence in research (NCCR) Of Structural biology, the
   European Union (EU project LSHG-CT-2004-502828, and EU project
   LSHG-CF-2005-018811), the University of Basel, and the Maurice E. Muller
   Foundation of Switzerland. The authors thank Bert de Groot for providing
   the coordinates of the single file of water molecules and Ansgar
   Philippsen for his help with Fig. 2B.
CR Abu-Arish A, 2004, J BIOL CHEM, V279, P25359, DOI 10.1074/jbc.M401804200
   Adrian M, 1998, MICRON, V29, P145, DOI 10.1016/S0968-4328(97)00068-1
   ADRIAN M, 1984, NATURE, V308, P32, DOI 10.1038/308032a0
   Al-Amoudi A, 2005, J STRUCT BIOL, V150, P109, DOI 10.1016/j.jsb.2005.01.003
   Al-Amoudi A, 2004, J STRUCT BIOL, V148, P131, DOI 10.1016/j.jsb.2004.03.010
   Al-Amoudi A, 2004, EMBO J, V23, P3583, DOI 10.1038/sj.emboj.7600366
   Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068
   BALCOME GE, 2005, SEM SAMPLE HOLDER AP
   Ballweber E, 2002, J MOL BIOL, V315, P613, DOI 10.1006/jmbi.2001.5281
   Baumeister W, 2005, PROTEIN SCI, V14, P257, DOI 10.1110/ps.041148605
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170
   Bouchet-Marquis C, 2007, BIOL CELL, V99, P45, DOI 10.1042/BC20060081
   BREMER A, 1992, ULTRAMICROSCOPY, V46, P85, DOI 10.1016/0304-3991(92)90008-8
   BREMER A, 1994, J MOL BIOL, V242, P683, DOI 10.1006/jmbi.1994.1617
   Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x
   Burghout P, 2004, J BACTERIOL, V186, P4645, DOI 10.1128/JB.186.14.4645-4654.2004
   Buser C, 2007, J VIROL, V81, P3042, DOI 10.1128/JVI.01564-06
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   Cyrklaff M, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000420
   de Groot BL, 2005, CURR OPIN STRUC BIOL, V15, P176, DOI 10.1016/j.sbi.2005.02.003
   Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329
   Di Carlo D, 2005, LAB CHIP, V5, P171, DOI 10.1039/b413139h
   Di Carlo D, 2006, LAB CHIP, V6, P1445, DOI 10.1039/b605937f
   DOWELL RD, 2001, BMC BIOINFORMATICS, V2, pE420
   Dube P, 2005, MOL CELL, V20, P867, DOI 10.1016/j.molcel.2005.11.008
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Egelman EH, 2007, CURR OPIN STRUC BIOL, V17, P556, DOI 10.1016/j.sbi.2007.07.006
   EGELMAN EH, 1995, CURR OPIN STRUC BIOL, V5, P172, DOI 10.1016/0959-440X(95)80072-7
   Eifler N, 2006, EMBO J, V25, P2652, DOI 10.1038/sj.emboj.7601130
   Endres NF, 2006, NATURE, V439, P875, DOI 10.1038/nature04320
   Fahrenkrog B, 2000, MOL BIOL CELL, V11, P3885, DOI 10.1091/mbc.11.11.3885
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   FELLMANN D, 2006, MICROSC TODAY, P24
   Ford RC, 2008, TRENDS BIOCHEM SCI, V33, P38, DOI 10.1016/j.tibs.2007.10.002
   Fotiadis D, 2002, J MOL BIOL, V318, P1381, DOI 10.1016/S0022-2836(02)00143-2
   Frangakis AS, 2002, P NATL ACAD SCI USA, V99, P14153, DOI 10.1073/pnas.172520299
   Freitag B, 2005, ULTRAMICROSCOPY, V102, P209, DOI 10.1016/j.ultramic.2004.09.013
   Fujiyoshi Y, 1998, ADV BIOPHYS, V35, P25, DOI 10.1016/S0065-227X(98)80003-8
   Gao HX, 2005, STRUCTURE, V13, P401, DOI 10.1016/j.str.2005.01.004
   Gao HX, 2003, CELL, V113, P789, DOI 10.1016/S0092-8674(03)00427-6
   Giddings TH, 2001, METHOD CELL BIOL, V67, P27
   Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029
   Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321
   Goodman J. W., 2005, INTRO FOURIER OPTICS
   Gregori L, 1997, J BIOL CHEM, V272, P58
   GUO Z, 2006, CLAMP CHEM STAINING
   Hahn E, 2002, J MOL BIOL, V323, P845, DOI 10.1016/S0022-2836(02)01005-7
   Hainfeld JF, 2000, J HISTOCHEM CYTOCHEM, V48, P471, DOI 10.1177/002215540004800404
   Harris A, 2006, J MOL BIOL, V355, P562, DOI 10.1016/j.jmb.2005.10.035
   He WZ, 2007, J STRUCT BIOL, V160, P103, DOI 10.1016/j.jsb.2007.07.004
   HENDERSON R, 1975, NATURE, V257, P28, DOI 10.1038/257028a0
   Hess MW, 2007, METHOD CELL BIOL, V79, P57, DOI 10.1016/S0091-679X(06)79003-3
   Hoenger A, 2008, METHOD CELL BIOL, V84, P425, DOI 10.1016/S0091-679X(07)84014-3
   Kikkawa M, 2004, J MOL BIOL, V343, P943, DOI 10.1016/j.jmb.2004.08.051
   King ME, 2001, AM J PATHOL, V158, P1481, DOI 10.1016/S0002-9440(10)64099-0
   Kohler R, 2004, MOL MICROBIOL, V54, P647, DOI 10.1111/j.1365-2958.2004.04307.x
   Koster AJ, 1997, J STRUCT BIOL, V120, P276, DOI 10.1006/jsbi.1997.3933
   Krzysiak TC, 2006, EMBO J, V25, P2263, DOI 10.1038/sj.emboj.7601108
   Lee KK, 2003, CURR OPIN STRUC BIOL, V13, P558, DOI 10.1016/j.sbi.2003.09.007
   Lenzi D, 1999, J NEUROSCI, V19, P119
   LORENTZ M, 1993, J MOL BIOL, V234, P926
   Maco Bohumil, 2006, V322, P273
   MARTIN J, 1994, BIOL CHEM H-S, V375, P635
   Masugi-Tokita M, 2007, CURR OPIN NEUROBIOL, V17, P387, DOI 10.1016/j.conb.2007.04.012
   McDonald K, 2007, METHOD CELL BIOL, V79, P23, DOI 10.1016/S0091-679X(06)79002-1
   Metlagel Z, 2007, J STRUCT BIOL, V157, P95, DOI 10.1016/j.jsb.2006.07.015
   Miyazawa A, 2003, NATURE, V423, P949, DOI 10.1038/nature01748
   MORGELIN M, 1995, BIOCHEM J, V307, P595
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Muller SA, 2006, CHIMIA, V60, pA749, DOI 10.2533/chimia.2006.749
   Muller-Karger CM, 2001, CMES-COMP MODEL ENG, V2, P1
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Nickell S, 2006, NAT REV MOL CELL BIO, V7, P225, DOI 10.1038/nrm1861
   Nickell S, 2005, J STRUCT BIOL, V149, P227, DOI 10.1016/j.jsb.2004.10.006
   Philippsen A, 2007, ULTRAMICROSCOPY, V107, P202, DOI 10.1016/j.ultramic.2006.07.010
   Philippsen A, 2007, J STRUCT BIOL, V157, P28, DOI 10.1016/j.jsb.2006.06.009
   Phillips DM, 1998, METHOD CELL BIOL, V57, P297
   Plancon L, 1997, J BIOL CHEM, V272, P16868, DOI 10.1074/jbc.272.27.16868
   Rath BK, 2004, J STRUCT BIOL, V145, P84, DOI 10.1016/j.jsb.2003.11.015
   REICHELT R, 1990, J CELL BIOL, V110, P883, DOI 10.1083/jcb.110.4.883
   Remigy HW, 2003, FEBS LETT, V555, P160, DOI 10.1016/S0014-5793(03)01105-0
   Rizzoli SO, 2005, NAT REV NEUROSCI, V6, P57, DOI 10.1038/nrn1583
   Robenek H, 2008, BIOL PROCED ONLINE, V10, P9, DOI 10.1251/bpo138
   Robertson CE, 2007, METHOD CELL BIOL, V79, P169, DOI 10.1016/S0091-679X(06)79007-0
   Roseman AM, 2000, ACTA CRYSTALLOGR D, V56, P1332, DOI 10.1107/S0907444900010908
   Sandblad L, 2006, CELL, V127, P1415, DOI 10.1016/j.cell.2006.11.025
   Segui-Simarro JM, 2006, PLANTA, V223, P223, DOI 10.1007/s00425-005-0082-2
   Severs NJ, 2007, NAT PROTOC, V2, P547, DOI 10.1038/nprot.2007.55
   Shaikh TR, 2005, P NATL ACAD SCI USA, V102, P1023, DOI 10.1073/pnas.0409020102
   Shakil SS, 2005, SYNAPSE, V58, P200, DOI 10.1002/syn.20198
   Sindelar CV, 2007, J CELL BIOL, V177, P377, DOI 10.1083/jcb.200612090
   Skiniotis G, 2003, EMBO J, V22, P1518, DOI 10.1093/emboj/cdg164
   Sousa AA, 2007, J STRUCT BIOL, V159, P507, DOI 10.1016/j.jsb.2007.06.006
   Stagg SM, 2006, J STRUCT BIOL, V155, P470, DOI 10.1016/j.jsb.2006.04.005
   Stagg SM, 2006, NATURE, V439, P234, DOI 10.1038/nature04339
   Steinmetz MO, 1998, J MOL BIOL, V276, P1, DOI 10.1006/jmbi.1997.1529
   Steinmetz MO, 1997, J STRUCT BIOL, V119, P295, DOI 10.1006/jsbi.1997.3873
   Steven AC, 2005, CURR OPIN STRUC BIOL, V15, P227, DOI 10.1016/j.sbi.2005.03.008
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Suloway C, 2005, J STRUCT BIOL, V151, P41, DOI 10.1016/j.jsb.2005.03.010
   Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030
   Traxler KW, 2001, J STRUCT BIOL, V135, P231, DOI 10.1006/jsbi.2001.4411
   Unwin N, 2005, J MOL BIOL, V346, P967, DOI 10.1016/j.jmb.2004.12.031
   von Bergen M, 2006, BIOCHEMISTRY-US, V45, P6446, DOI 10.1021/bi052530j
   Wang YA, 2006, J MOL BIOL, V361, P209, DOI 10.1016/j.jmb.2006.06.027
   Wang YA, 2006, STRUCTURE, V14, P1189, DOI 10.1016/j.str.2006.05.018
   Wickert U, 2005, EUR J CELL BIOL, V84, P379, DOI 10.1016/j.ejcb.2005.01.004
   Winey M, 1997, MOL BIOL CELL, V8, P2119, DOI 10.1091/mbc.8.11.2119
   Yakushevska AE, 2007, J STRUCT BIOL, V159, P381, DOI 10.1016/j.jsb.2007.04.006
   Yonekura K, 2003, NATURE, V424, P643, DOI 10.1038/nature01830
   Young RJ, 2005, INTRODUCTION TO FOCUSED ION BEAMS: INSTRUMENTATION, THEORY, TECHNIQUES AND PRACTICE, P247, DOI 10.1007/0-387-23313-X_12
NR 112
TC 35
Z9 36
U1 0
U2 90
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1047-8477
EI 1095-8657
J9 J STRUCT BIOL
JI J. Struct. Biol.
PD SEP
PY 2008
VL 163
IS 3
BP 235
EP 245
DI 10.1016/j.jsb.2008.05.008
PG 11
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 356CH
UT WOS:000259755800009
PM 18614377
DA 2021-01-25
ER

PT J
AU Hofbauer, KG
   Lecourt, AC
   Peter, JC
AF Hofbauer, Karl G.
   Lecourt, Anne-Catherine
   Peter, Jean-Christophe
TI Antibodies as pharmacologic tools for studies on the regulation of
   energy balance
SO NUTRITION
LA English
DT Article; Proceedings Paper
CT 9th Neuropeptide Y International Meeting 2008
CY MAR 16-19, 2008
CL Okinawa, JAPAN
DE immunization; melanocortin-4 receptor; food intake; anorexia;
   lipopolysaccharide; G-protein-coupled receptor; inverse agonist
ID CENTRAL MELANOCORTIN SYSTEM; BODY-TEMPERATURE; RECEPTOR; PROTEIN;
   HOMEOSTASIS; CACHEXIA; GENE; RATS
AB Objective: Active immunization in rats may serve several purposes: the production of a disease-like phenotype, the generation of pharmacologic tools, and the development of clinically useful therapies. We selected the melanocortin-4 receptor (MC4R) as a target because its blockade could provide a treatment for anorexia and cachexia.
   Methods: We used a sequence of the N-terminal (NT) domain of the MC4R as an antigen. Rats immunized against the NT peptide produced specific MC4R antibodies (Abs) that were purified and characterized in vitro and in vivo.
   Results: The Abs acted as inverse agonists and reduced under basal conditions the production of cyclic adenosine monophosphate in HEK-293 cells expressing the human MC4R. Rats immunized against the NT peptide developed a phenotype consistent with hypothalamic MC4R blockade, i.e., increased food intake and body weight, liver and fat-pad weights, hepatic steatosis, and increased plasma triacylglycerols. With a high-fat diet, plasma insulin levels were significantly increased. In separate experiments an increase in food intake was observed after injection of purified MC4R Abs into the third ventricle. When lipopolysaccharide was administered in NT-immunized rats the reduction of food intake was partly prevented in this model of cytokine-induced anorexia.
   Conclusion: Our results show that active immunization of rats against the MC4R resulted in the generation of specific Abs that stimulated food intake by acting as inverse agonists of the hypothalamic MC4R. Pharmacologically active monoclonal MC4R Abs could be the starting point for the development of novel treatments for patients with anorexia or cachexia. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Hofbauer, Karl G.; Lecourt, Anne-Catherine; Peter, Jean-Christophe] Univ Basel, Biozentrum, Basel, Switzerland.
RP Hofbauer, KG (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM karl.hofbauer@unibas.ch
CR Adan RAH, 2006, BRIT J PHARMACOL, V149, P815, DOI 10.1038/sj.bjp.0706929
   Banks WA, 2002, PEPTIDES, V23, P2223, DOI 10.1016/S0196-9781(02)00261-9
   Brekke OH, 2003, NAT REV DRUG DISCOV, V2, P52, DOI 10.1038/nrd984
   Chen M, 2006, REGUL PEPTIDES, V136, P40, DOI 10.1016/j.regpep.2006.04.010
   Cone RD, 2005, NAT NEUROSCI, V8, P571, DOI 10.1038/nn1455
   Cowley MA, 2003, EUR J PHARMACOL, V480, P3, DOI 10.1016/j.ejphar.2003.08.087
   DeBoer MD, 2006, TRENDS ENDOCRIN MET, V17, P199, DOI 10.1016/j.tem.2006.05.005
   Ellacott KLJ, 2004, RECENT PROG HORM RES, V59, P395, DOI 10.1210/rp.59.1.395
   Fan T, 2000, ENDOCRINOLOGY, V141, P3072
   Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050
   Felies M, 2004, J PHYSIOL-LONDON, V561, P245, DOI 10.1113/jphysiol.2004.073635
   GANTZ I, 1993, J BIOL CHEM, V268, P15174
   Huang QH, 1999, AM J PHYSIOL-REG I, V276, pR864, DOI 10.1152/ajpregu.1999.276.3.R864
   Hudson PJ, 2003, NAT MED, V9, P129, DOI 10.1038/nm0103-129
   Kamel R, 2005, BIOCHEM PHARMACOL, V70, P1009, DOI 10.1016/j.bcp.2005.07.005
   Marks DL, 2001, CANCER RES, V61, P1432
   Matsushita A, 2007, EXP ANIM TOKYO, V56, P339, DOI 10.1538/expanim.56.339
   Mirzadegan T, 2003, BIOCHEMISTRY-US, V42, P2759, DOI 10.1021/bi027224+
   NEIMARK J, 1993, PEPTIDE RES, V6, P219
   Nicholson JR, 2007, J NEUROENDOCRINOL, V19, P974, DOI 10.1111/j.1365-2826.2007.01610.x
   Nordheim U, 2006, PEPTIDES, V27, P438, DOI 10.1016/j.peptides.2005.01.026
   Obici S, 2001, J CLIN INVEST, V108, P1079, DOI 10.1172/JCI12954
   Peter JC, 2005, FASEB J, V19, P943, DOI 10.1096/fj.04-3042com
   PETER JC, 2008, INT J OBES IN PRESS, P4
   Peter JC, 2007, AM J PHYSIOL-REG I, V292, pR2151, DOI 10.1152/ajpregu.00878.2006
   Reichert JM, 2001, NAT BIOTECHNOL, V19, P819, DOI 10.1038/nbt0901-819
   Sebhat IK, 2002, J MED CHEM, V45, P4589, DOI 10.1021/jm025539h
   Small CJ, 2001, DIABETES, V50, P248, DOI 10.2337/diabetes.50.2.248
   Srinivasan S, 2004, J CLIN INVEST, V114, P1158, DOI 10.1172/JCI200421927
NR 29
TC 18
Z9 24
U1 0
U2 2
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0899-9007
EI 1873-1244
J9 NUTRITION
JI Nutrition
PD SEP
PY 2008
VL 24
IS 9
BP 791
EP 797
DI 10.1016/j.nut.2008.06.001
PG 7
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 347ZE
UT WOS:000259179600003
PM 18662861
DA 2021-01-25
ER

PT J
AU Mally, M
   Shin, H
   Paroz, C
   Landmann, R
   Cornelis, GR
AF Mally, Manuela
   Shin, Hwain
   Paroz, Cecile
   Landmann, Regine
   Cornelis, Guy R.
TI Capnocytophaga canimorsus: A human pathogen feeding at the surface of
   epithelial cells and phagocytes
SO PLOS PATHOGENS
LA English
DT Article
ID SIALIC-ACID; RIEMERELLA-ANATIPESTIFER; NEISSERIA-MENINGITIDIS; BACTERIAL
   DIVERSITY; DOG-BITE; SEPTICEMIA; INFECTION; METABOLISM; MODEL;
   PNEUMONIAE
AB Capnocytophaga canimorsus, a commensal bacterium of the canine oral flora, has been repeatedly isolated since 1976 from severe human infections transmitted by dog bites. Here, we show that C. canimorsus exhibits robust growth when it is in direct contact with mammalian cells, including phagocytes. This property was found to be dependent on a surface-exposed sialidase allowing C. canimorsus to utilize internal aminosugars of glycan chains from host cell glycoproteins. Although sialidase probably evolved to sustain commensalism, by releasing carbohydrates from mucosal surfaces, it also contributed to bacterial persistence in a murine infection model: the wild type, but not the sialidase-deficient mutant, grew and persisted, both when infected singly or in competition. This study reveals an example of pathogenic bacteria feeding on mammalian cells, including phagocytes by deglycosylation of host glycans, and it illustrates how the adaptation of a commensal to its ecological niche in the host, here the dog's oral cavity, contributes to being a potential pathogen.
C1 [Mally, Manuela; Shin, Hwain; Paroz, Cecile; Cornelis, Guy R.] Univ Basel, Biozentrum, Basel, Switzerland.
   [Landmann, Regine] Univ Basel Hosp, Dept Res, CH-4031 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Klingelberg Str, Basel, Switzerland.
EM guy.cornelis@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF) [32-65393.01]
FX This work was funded by Swiss National Science Foundation grant Nr
   32-65393.01.
CR BARRY GT, 1959, NATURE, V183, P117, DOI 10.1038/183117a0
   Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   BHATTACHARJEE AK, 1975, J BIOL CHEM, V250, P1926
   BOBO RA, 1976, AM J CLIN PATHOL, V65, P564
   BRENNER DJ, 1989, J CLIN MICROBIOL, V27, P231, DOI 10.1128/JCM.27.2.231-235.1989
   Bry L, 1996, SCIENCE, V273, P1380, DOI 10.1126/science.273.5280.1380
   BURNAUGH AM, 2007, J BACTERIOL
   Cooper AJ, 1997, J BACTERIOL, V179, P6221, DOI 10.1128/jb.179.20.6221-6227.1997
   CORFIELD T, 1992, GLYCOBIOLOGY, V2, P509, DOI 10.1093/glycob/2.6.509
   Coyne MJ, 2008, J BACTERIOL, V190, P736, DOI 10.1128/JB.01559-07
   Coyne MJ, 2005, SCIENCE, V307, P1778, DOI 10.1126/science.1106469
   Duchaud E, 2007, NAT BIOTECHNOL, V25, P763, DOI 10.1038/nbt1313
   Exley RM, 2005, J EXP MED, V201, P1637, DOI 10.1084/jem.20041548
   Goetz M, 2001, P NATL ACAD SCI USA, V98, P12221, DOI 10.1073/pnas.211106398
   HOYER LL, 1991, J BIOCHEM-TOKYO, V110, P462, DOI 10.1093/oxfordjournals.jbchem.a123603
   King SJ, 2006, MOL MICROBIOL, V59, P961, DOI 10.1111/j.1365-2958.2005.04984.x
   Koretke KK, 2006, J STRUCT BIOL, V155, P154, DOI 10.1016/j.jsb.2006.03.012
   Kristian SA, 2003, J INFECT DIS, V188, P414, DOI 10.1086/376533
   Kroes I, 1999, P NATL ACAD SCI USA, V96, P14547, DOI 10.1073/pnas.96.25.14547
   Le Moal GL, 2003, CLIN INFECT DIS, V36, pE42, DOI 10.1086/345477
   Lion C, 1996, EUR J EPIDEMIOL, V12, P521, DOI 10.1007/BF00144007
   MALLY M, 2008, APPL ENV MI IN PRESS
   MANDRELL RE, 1993, IMMUNOBIOLOGY, V187, P382, DOI 10.1016/S0171-2985(11)80352-9
   McBride MJ, 2004, J MOL MICROB BIOTECH, V7, P63, DOI 10.1159/000077870
   MEYER S, 2008, IMMUNOBIOLO IN PRESS
   Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001
   Pers C, 1996, CLIN INFECT DIS, V23, P71, DOI 10.1093/clinids/23.1.71
   PUGSLEY AP, 1990, MOL MICROBIOL, V4, P59, DOI 10.1111/j.1365-2958.1990.tb02015.x
   Quevillon E, 2005, NUCLEIC ACIDS RES, V33, pW116, DOI 10.1093/nar/gki442
   ROGGENTIN P, 1989, GLYCOCONJUGATE J, V6, P349, DOI 10.1007/BF01047853
   Schauer R, 2000, GLYCOCONJUGATE J, V17, P485, DOI 10.1023/A:1011062223612
   SCHREINER E, 1991, CARBOHYD RES, V216, P61
   Schuijffel DF, 2005, INFECT IMMUN, V73, P6812, DOI 10.1128/IAI.73.10.6812-6821.2005
   SEGERS P, 1993, INT J SYST BACTERIOL, V43, P768, DOI 10.1099/00207713-43-4-768
   Shin H, 2007, J INFECT DIS, V195, P375, DOI 10.1086/510243
   Soong G, 2006, J CLIN INVEST, V116, P2297, DOI 10.1172/JCI27920
   Subramaniam S, 2000, CLIN DIAGN LAB IMMUN, V7, P168, DOI 10.1128/CDLI.7.2.168-174.2000
   Tierney DM, 2006, J CLIN MICROBIOL, V44, P649, DOI 10.1128/JCM.44.2.649-651.2006
   Traving C, 1998, CELL MOL LIFE SCI, V54, P1330, DOI 10.1007/s000180050258
   Varki A, 2007, NATURE, V446, P1023, DOI 10.1038/nature05816
   Varki NM, 2007, LAB INVEST, V87, P851, DOI 10.1038/labinvest.3700656
   Vimr ER, 2004, MICROBIOL MOL BIOL R, V68, P132, DOI 10.1128/MMBR.68.1.132-153.2004
   von Itzstein M, 2007, NAT REV DRUG DISCOV, V6, P967, DOI 10.1038/nrd2400
   WESSELS MR, 1989, P NATL ACAD SCI USA, V86, P8983, DOI 10.1073/pnas.86.22.8983
NR 44
TC 40
Z9 40
U1 1
U2 6
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1553-7366
EI 1553-7374
J9 PLOS PATHOG
JI PLoS Pathog.
PD SEP
PY 2008
VL 4
IS 9
AR e1000164
DI 10.1371/journal.ppat.1000164
PG 11
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 356MW
UT WOS:000259783300021
PM 18818736
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Robertson, JWF
   Friedrich, MG
   Kibrom, A
   Knoll, W
   Naumann, RLC
   Walz, D
AF Robertson, Joseph W. F.
   Friedrich, Marcel G.
   Kibrom, Asmorom
   Knoll, Wolfgang
   Naumann, Renate L. C.
   Walz, Dieter
TI Modeling ion transport in tethered bilayer lipid membranes. 1. Passive
   ion permeation
SO JOURNAL OF PHYSICAL CHEMISTRY B
LA English
DT Article
ID PHOSPHOLIPID-BILAYERS; GRAMICIDIN CHANNELS; IMPEDANCE ANALYSIS;
   TRANSMEMBRANE; VALINOMYCIN; THIOLIPIDS
AB Ion transport across tethered bilayer lipid membranes (tBLMs) is modeled using a hybrid network description which combines potential-dependent rate equations with passive electrical elements. Passive permeation of ions is described by the integrated Nernst-Planck equation. Simulations based on this model are performed with the network simulation program SPICE (simulation program with integrated circuit emphasis). Electrochemical impedance spectra of tBLMs are simulated with this algorithm and challenged by spectra measured with tBLMs submersed in 0.1 M KCl solution and subjected to various potential differences. It is found that the simulated spectra can only satisfactorily represent the experimental data if the permeability coefficients of the ions are dependent on the membrane potential. It is concluded that the mechanism of passive ion transport across the tBLM seems to follow the transient pore model rather than the solubility-diffusion model. This algorithm can be easily extended to include ion transport processes due to channels, carriers, or pumps incorporated into the tBLM.
C1 [Robertson, Joseph W. F.; Friedrich, Marcel G.; Kibrom, Asmorom; Knoll, Wolfgang; Naumann, Renate L. C.] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
   [Walz, Dieter] Univ Basel, Biozentrum, Basel, Switzerland.
RP Naumann, RLC (corresponding author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.
EM naumannr@mpip-mainz.mpg.de
OI Robertson, Joseph/0000-0002-2087-3939
CR Becucci L, 2005, J AM CHEM SOC, V127, P13316, DOI 10.1021/ja052920t
   Becucci L, 2005, J ELECTROANAL CHEM, V576, P121, DOI 10.1016/j.jelechem.2004.09.032
   Becucci L, 2003, LANGMUIR, V19, P3386, DOI 10.1021/la0266177
   Chizmadzhev YA, 2004, BIOELECTROCHEM P & P, V6, P173
   Cornell BA, 1997, NATURE, V387, P580, DOI 10.1038/42432
   Freites JA, 2005, P NATL ACAD SCI USA, V102, P15059, DOI 10.1073/pnas.0507618102
   Giess F, 2004, BIOPHYS J, V87, P3213, DOI 10.1529/biophysj.104.046169
   GLASER RW, 1988, BIOCHIM BIOPHYS ACTA, V940, P275, DOI 10.1016/0005-2736(88)90202-7
   Glasstone S., 1941, THEORY RATE PROCESSE
   Glazier SA, 2000, LANGMUIR, V16, P10428, DOI 10.1021/la000690k
   Guidelli R, 2001, J ELECTROANAL CHEM, V504, P1, DOI 10.1016/S0022-0728(01)00382-5
   He LH, 2005, LANGMUIR, V21, P11666, DOI 10.1021/la051771p
   Knoll W, 2004, SPR S C S B, V2, P239
   Krishna G, 2003, LANGMUIR, V19, P2294, DOI 10.1021/la026238d
   Macdonald JR, 2005, IMPEDANCE SPECTROSCOPY: THEORY, EXPERIMENT, AND APPLICATIONS, 2ND EDITION, P1, DOI 10.1002/0471716243.ch1
   Naumann R, 2002, BIOSENS BIOELECTRON, V17, P25, DOI 10.1016/S0956-5663(01)00182-8
   Naumann R, 1999, BIOSENS BIOELECTRON, V14, P651, DOI 10.1016/S0956-5663(99)00036-6
   Naumann R, 2003, J ELECTROANAL CHEM, V550, P241, DOI 10.1016/S0022-0728(03)00013-5
   Naumann R, 2003, LANGMUIR, V19, P5435, DOI 10.1021/la0342060
   NEUMCKE B, 1969, BIOPHYS J, V9, P1160, DOI 10.1016/S0006-3495(69)86443-X
   Paula S, 1996, BIOPHYS J, V70, P339, DOI 10.1016/S0006-3495(96)79575-9
   Paula S, 1998, BIOPHYS J, V74, P319, DOI 10.1016/S0006-3495(98)77789-6
   Schiller SM, 2003, ANGEW CHEM INT EDIT, V42, P208, DOI 10.1002/anie.200390080
   Sinner EK, 2001, CURR OPIN CHEM BIOL, V5, P705, DOI 10.1016/S1367-5931(01)00269-1
   Steinem C, 1997, BIOELECTROCH BIOENER, V42, P213, DOI 10.1016/S0302-4598(96)05113-6
   STRYER L, 1981, BIOCHEMISTRY-US, P215
   Valincius G, 2006, J PHYS CHEM B, V110, P10213, DOI 10.1021/jp0616516
   Vallejo AE, 2002, BIOELECTROCHEMISTRY, V57, P1, DOI 10.1016/S1567-5394(01)00127-X
   Vladimirescu A., 1994, SPICE BOOK
   WALZ D, 1995, BIOELECTROCHEM PRINC, V1, P49
   WALZ D, 1995, BIOELECTROCHEMISTRY, V1, P1
NR 31
TC 19
Z9 19
U1 0
U2 15
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 1520-6106
EI 1520-5207
J9 J PHYS CHEM B
JI J. Phys. Chem. B
PD AUG 28
PY 2008
VL 112
IS 34
BP 10475
EP 10482
DI 10.1021/jp800162d
PG 8
WC Chemistry, Physical
SC Chemistry
GA 340GF
UT WOS:000258633400013
PM 18680332
DA 2021-01-25
ER

PT J
AU Beck, A
   Tsamaloukas, AD
   Jurcevic, P
   Heerklotz, H
AF Beck, Andreas
   Tsamaloukas, Alekos D.
   Jurcevic, Petar
   Heerklotz, Heiko
TI Additive action of two or more solutes on lipid membranes
SO LANGMUIR
LA English
DT Article
ID ISOTHERMAL TITRATION CALORIMETRY; SODIUM DODECYL-SULFATE;
   BETA-D-GLUCOPYRANOSIDE; PHOSPHATIDYLCHOLINE VESICLES; OCTYL GLUCOSIDE;
   FLIP-FLOP; PARTITION BEHAVIOR; MICELLE TRANSITION; CURVATURE STRAIN;
   WATER PHASES
AB A wide variety of biological processes, pharmaceutical applications, and technical procedures is based on the combined action of two or more soluble compounds to perturb, permeabilize, or lyse biological membranes. Here we present a general model describing the additive action of solutes on the properties of membranes or micelles. The onset and completion of membrane solubilization induced by two surfactants (lauryl maltoside, with nonyl maltoside, octyl glucoside, or CHAPS, respectively) are very well described by our model on the basis of their individual partition coefficients, cmc's, and critical mole ratios R(e)(sat) and R(e)(sol) as detected by isothermal titration calorimetry. This suggests that the thermodynamic phase transition is governed by a single parameter (e.g., spontaneous curvature) in spite of the complexity of structural changes. Such surfactant mixtures show unique features such as nonlinear solubilization boundaries and concentration-dependent effective partition coefficients. Other phenomena such as membrane leakage are predicted to obey additive action if the solutes act via the same mechanism (e.g., toroidal pore formation) but deviate from the model in the case of independent, synergistic, or antagonistic action.
C1 [Tsamaloukas, Alekos D.; Heerklotz, Heiko] Univ Toronto, Leslie Dan Fac Pharm, Toronto, ON M5S 3M2, Canada.
   Biozentrum Univ Basel, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Heerklotz, H (corresponding author), Univ Toronto, Leslie Dan Fac Pharm, 144 Coll St, Toronto, ON M5S 3M2, Canada.
EM heiko.heerklotz@utoronto.ca
RI Jurcevic, Petar/O-4268-2014
OI Jurcevic, Petar/0000-0003-1234-6386; Heerklotz,
   Heiko/0000-0003-4615-7022
CR Almgren M, 2000, BBA-BIOMEMBRANES, V1508, P146, DOI 10.1016/S0005-2736(00)00309-6
   *AN INC, 2004, AN CAT
   ANDELMAN D, 1994, EUROPHYS LETT, V25, P231, DOI 10.1209/0295-5075/25/3/013
   Apel-Paz M, 2005, LANGMUIR, V21, P9843, DOI 10.1021/la050568r
   Bechinger B, 2006, BBA-BIOMEMBRANES, V1758, P1529, DOI 10.1016/j.bbamem.2006.07.001
   Binder H, 2003, BIOPHYS J, V85, P982, DOI 10.1016/S0006-3495(03)74537-8
   Clint J.H., 1992, SURFACTANT AGGREGATI
   CLINT JH, 1975, J CHEM SOC FARAD T 1, V71, P1327, DOI 10.1039/f19757101327
   Davies SMA, 2001, BIOCHEMISTRY-US, V40, P10522, DOI 10.1021/bi010904c
   DELAMAZA A, 1994, BIOCHEM J, V303, P907, DOI 10.1042/bj3030907
   delaMaza A, 1997, BIOPHYS J, V72, P1668, DOI 10.1016/S0006-3495(97)78812-X
   DELAMAZA A, 1992, LANGMUIR, V8, P2422, DOI 10.1021/la00046a014
   delaMaza A, 1996, BBA-LIPID LIPID MET, V1300, P125, DOI 10.1016/0005-2760(96)00005-7
   Diab C, 2007, LANGMUIR, V23, P3025, DOI 10.1021/la062522j
   EPAND RM, 1994, BIOPHYS J, V66, P1450, DOI 10.1016/S0006-3495(94)80935-X
   EPAND RM, 1990, TRENDS PHARMACOL SCI, V11, P317, DOI 10.1016/0165-6147(90)90234-Y
   Fang Z, 1997, ANESTH ANALG, V84, P1042, DOI 10.1097/00000539-199705000-00017
   Francis G, 2002, BRIT J NUTR, V88, P587, DOI 10.1079/BJN2002725
   Grisshammer Reinhard, 2005, Journal of Structural and Functional Genomics, V6, P159, DOI 10.1007/s10969-005-1917-6
   Heerklotz H, 2004, J PHYS-CONDENS MAT, V16, pR441, DOI 10.1088/0953-8984/16/15/R01
   HEERKLOTZ H, 1994, BBA-BIOMEMBRANES, V1196, P114, DOI 10.1016/0005-2736(94)00222-3
   Heerklotz H, 1996, J PHYS CHEM-US, V100, P6764, DOI 10.1021/jp9523534
   Heerklotz H, 2000, BIOPHYS J, V78, P2435, DOI 10.1016/S0006-3495(00)76787-7
   Heerklotz H, 2003, J MOL BIOL, V329, P793, DOI 10.1016/S0022-2836(03)00504-7
   Heerklotz H, 2001, BIOPHYS J, V81, P184, DOI 10.1016/S0006-3495(01)75690-1
   Heerklotz H, 2001, BIOPHYS J, V80, P271, DOI 10.1016/S0006-3495(01)76012-2
   HEERKLOTZ H, 1995, CHEM PHYS LETT, V235, P517, DOI 10.1016/0009-2614(95)00139-U
   Heerklotz H, 2000, BBA-BIOMEMBRANES, V1508, P69, DOI 10.1016/S0304-4157(00)00009-5
   Heerklotz H, 2007, EUR BIOPHYS J BIOPHY, V36, P305, DOI 10.1007/s00249-006-0091-5
   Heerklotz HH, 1998, J PHYS CHEM B, V102, P5363, DOI 10.1021/jp980884x
   Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102
   HELFRICH W, 1973, Z NATURFORSCH C, VC 28, P693, DOI 10.1515/znc-1973-11-1209
   Hildebrand A, 2002, LANGMUIR, V18, P2836, DOI 10.1021/la011421c
   Israelachvili J. N., 1991, INTERMOLECULAR SURFA
   Kadi M, 2004, J PHYS CHEM B, V108, P7344, DOI 10.1021/jp049848q
   KAMAYA H, 1976, P NATL ACAD SCI USA, V73, P1868, DOI 10.1073/pnas.73.6.1868
   Keller M, 1997, BBA-BIOMEMBRANES, V1326, P178, DOI 10.1016/S0005-2736(97)00022-9
   Keller S, 2005, J AM CHEM SOC, V127, P11469, DOI 10.1021/ja052764q
   Keller S, 2006, BIOPHYS J, V90, P4509, DOI 10.1529/biophysj.105.077867
   Kozlovsky Y, 2002, BIOPHYS J, V83, P2634, DOI 10.1016/S0006-3495(02)75274-0
   Kragh-Hansen U, 1998, BIOPHYS J, V75, P2932, DOI 10.1016/S0006-3495(98)77735-5
   Krepkiy D, 2007, PROTEIN PEPTIDE LETT, V14, P1031, DOI 10.2174/092986607782541051
   LANGE H, 1953, KOLLOID Z Z POLYM, V131, P96, DOI 10.1007/BF01512931
   LANGE H, 1973, KOLLOID Z Z POLYM, V251, P424, DOI 10.1007/BF01498689
   LICHTENBERG D, 1985, BIOCHIM BIOPHYS ACTA, V821, P470, DOI 10.1016/0005-2736(85)90052-5
   Lichtenberg D, 2000, BBA-BIOMEMBRANES, V1508, P1, DOI 10.1016/S0304-4157(00)00004-6
   Matsuzaki K, 1996, BIOCHEMISTRY-US, V35, P11361, DOI 10.1021/bi960016v
   McGregor CL, 2003, NAT BIOTECHNOL, V21, P171, DOI 10.1038/nbt776
   McIntosh TJ, 1999, BIOPHYS J, V76, P2090, DOI 10.1016/S0006-3495(99)77365-0
   Opatowski E, 1997, BIOPHYS J, V73, P1448, DOI 10.1016/S0006-3495(97)78177-3
   OVERTON CE, 2001, STUDIEN UEBER NARKOS
   Pantaler E, 2000, BBA-BIOMEMBRANES, V1509, P397, DOI 10.1016/S0005-2736(00)00322-9
   Paternostre M, 1995, BIOPHYS J, V69, P2476, DOI 10.1016/S0006-3495(95)80118-9
   Pokorny A, 2004, BIOCHEMISTRY-US, V43, P8846, DOI 10.1021/bi0497087
   Schurholz T, 1996, BIOPHYS CHEM, V58, P87, DOI 10.1016/0301-4622(95)00088-7
   SEELIG J, 1991, BIOCHEMISTRY-US, V30, P9354, DOI 10.1021/bi00102a031
   STARK RE, 1984, J PHYS CHEM-US, V88, P6063, DOI 10.1021/j150668a066
   UENO M, 1989, BIOCHEMISTRY-US, V28, P5631, DOI 10.1021/bi00439a044
   Viriyaroj A, 2005, CHEM PHARM BULL, V53, P1140, DOI 10.1248/cpb.53.1140
   VOGEL SS, 1993, J BIOL CHEM, V268, P25764
   Walter A, 2000, BBA-BIOMEMBRANES, V1508, P20, DOI 10.1016/S0304-4157(00)00005-8
   WALTER A, 1991, BIOPHYS J, V60, P1315, DOI 10.1016/S0006-3495(91)82169-5
   Wenk MR, 1997, J PHYS CHEM B, V101, P5224, DOI 10.1021/jp9707955
   Williams AC, 2004, ADV DRUG DELIVER REV, V56, P603, DOI 10.1016/j.addr.2003.10.025
   Yeliseev AA, 2005, PROTEIN SCI, V14, P2638, DOI 10.1110/ps.051550305
NR 65
TC 16
Z9 16
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD AUG 19
PY 2008
VL 24
IS 16
BP 8833
EP 8840
DI 10.1021/la800682q
PG 8
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 336PU
UT WOS:000258377900066
PM 18646725
DA 2021-01-25
ER

PT J
AU Seelig, A
   Guethe, S
   Gerebtzoff, G
AF Seelig, Anna
   Guethe, Sarah
   Gerebtzoff, Gregori
TI MEDI 276-In silico prediction of blood-brain barrier permeation.
SO ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Meeting Abstract
CT 236th National Meeting of the American-Chemical-Society
CY AUG 17-21, 2008
CL Philadelphia, PA
SP Amer Chem Soc
C1 [Guethe, Sarah] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Gerebtzoff, Gregori] F Hoffmann La Roche Ltd, CH-4070 Basel, Switzerland.
EM Anna.Seelig@unibas.ch; sarah.guethe@unibas.ch;
   gregori.gerebtzoff@roche.com
NR 0
TC 0
Z9 0
U1 0
U2 0
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0065-7727
J9 ABSTR PAP AM CHEM S
JI Abstr. Pap. Am. Chem. Soc.
PD AUG 17
PY 2008
VL 236
MA 276-MEDI
PG 1
WC Chemistry, Multidisciplinary
SC Chemistry
GA 499WD
UT WOS:000270256305688
DA 2021-01-25
ER

PT J
AU Jiang, H
   Schiffer, E
   Song, ZF
   Wang, JW
   Zurbig, P
   Thedieck, K
   Moes, S
   Bantel, H
   Saal, N
   Jantos, J
   Brecht, M
   Jeno, P
   Hall, MN
   Hager, K
   Manns, MP
   Hecker, H
   Ganser, A
   Dohner, K
   Bartke, A
   Meissner, C
   Mischak, H
   Ju, ZY
   Rudolph, KL
AF Jiang, Hong
   Schiffer, Eric
   Song, Zhangfa
   Wang, Jianwei
   Zuerbig, Petra
   Thedieck, Kathrin
   Moes, Suzette
   Bantel, Heike
   Saal, Nadja
   Jantos, Justyna
   Brecht, Meiken
   Jenoe, Paul
   Hall, Michael N.
   Hager, Klaus
   Manns, Michael P.
   Hecker, Hartmut
   Ganser, Arnold
   Doehner, Konstanze
   Bartke, Andrzej
   Meissner, Christoph
   Mischak, Harald
   Ju, Zhenyu
   Rudolph, K. Lenhard
TI Proteins induced by telomere dysfunction and DNA damage represent
   biomarkers of human aging and disease
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE senescence; EF-1 alpha; personalized therapy; stem cells; CRAMP
ID STEM-CELL FUNCTION; MOUSE TELOMERASE; LIFE-SPAN; SENESCENCE; TISSUE;
   INTERLEUKIN-6; MUTATIONS; CANCER; ACCUMULATION; CYTOKINE
AB Telomere dysfunction limits the proliferative capacity of human cells by activation of DNA damage responses, inducing senescence or apoptosis. In humans, telomere shortening occurs in the vast majority of tissues during aging, and telomere shortening is accelerated in chronic diseases that increase the rate of cell turnover. Yet, the functional role of telomere dysfunction and DNA damage in human aging and diseases remains under debate. Here, we identified marker proteins (i.e., CRAMP, stathmin, EF-1 alpha, and chitinase) that are secreted from telomere-clysfunctional bone-marrow cells of late generation telomerase knockout mice (G4mTerc(-/-)). The expression levels of these proteins increase in blood and in various tissues of aging G4mTerc(-/-) mice but not in aging mice with long telomere reserves. Orthologs of these proteins are up-regulated in late-passage presenescent human fibroblasts and in early passage human cells in response to gamma-irradiation. The study shows that the expression level of these marker proteins increases in the blood plasma of aging humans and shows a further increase in geriatric patients with aging-associated diseases. Moreover, there was a significant increase in the expression of the biomarkers in the blood plasma of patients with chronic diseases that are associated with increased rates of cell turnover and telomere shortening, such as cirrhosis and myelodysplastic syndromes (MDS). Analysis of blinded test samples validated the effectiveness of the biomarkers to discriminate between young and old, and between disease groups (MDS, cirrhosis) and healthy controls. These results support the concept that telomere dysfunction and DNA damage are interconnected pathways that are activated during human aging and disease.
C1 [Jiang, Hong; Song, Zhangfa; Wang, Jianwei; Ju, Zhenyu; Rudolph, K. Lenhard] Univ Ulm, Dept Mol Med, D-89081 Ulm, Germany.
   [Jiang, Hong; Song, Zhangfa; Wang, Jianwei; Ju, Zhenyu; Rudolph, K. Lenhard] Univ Ulm, Max Planck Res Grp Stem Cell Aging, D-89081 Ulm, Germany.
   [Doehner, Konstanze] Univ Ulm, Dept Internal Med 3, D-89081 Ulm, Germany.
   [Schiffer, Eric; Zuerbig, Petra; Jantos, Justyna; Mischak, Harald] Mosaiques Diagnost & Therapeut AG, D-30625 Hannover, Germany.
   [Thedieck, Kathrin; Moes, Suzette; Jenoe, Paul; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Bantel, Heike; Saal, Nadja; Manns, Michael P.] Hannover Med Sch, Dept Gastroenterol Hepatol & Endocrinol, D-30625 Hannover, Germany.
   [Hecker, Hartmut] Hannover Med Sch, Dept Biostat, D-30625 Hannover, Germany.
   [Ganser, Arnold] Hannover Med Sch, Dept Hematol Hemostasis Oncol & Stem Cell Transpl, D-30625 Hannover, Germany.
   [Brecht, Meiken; Hager, Klaus] Henriettenstiftung, Dept Geriatr Med, D-30171 Hannover, Germany.
   [Bartke, Andrzej] So Illinois Univ, Sch Med, Springfield, IL 62794 USA.
   [Meissner, Christoph] Univ Hosp Schleswig Holstein, Dept Forens Med, D-23562 Lubeck, Germany.
   [Ju, Zhenyu] Chinese Acad Med Sci, Inst Lab Anim Sci, Beijing 100864, Peoples R China.
   [Ju, Zhenyu] Chinese Acad Med Sci, Max Planck Partner Grp Stem Cell Aging, Beijing 100864, Peoples R China.
RP Rudolph, KL (corresponding author), Univ Ulm, Dept Mol Med, Albert Einstein Allee 11, D-89081 Ulm, Germany.
EM lenhard.rudolph@uni-ulm.de
RI Hager, Klaus/G-6495-2015; Bartke, Andzej/D-6640-2017; Mischak,
   Harald/E-8685-2011
OI Hager, Klaus/0000-0003-4497-3878; Bartke, Andzej/0000-0002-2569-557X;
   Siwy, Justyna/0000-0003-1407-2534; Zurbig, Petra/0000-0003-3465-2173;
   Mischak, Harald/0000-0003-0323-0306; Song, Zhangfa/0000-0001-6301-1813;
   Thedieck, Kathrin/0000-0002-9069-2930; Rudolph, Karl
   Lenhard/0000-0002-4839-2862
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [RU745/10-1, RU745/7-1, SFB738, KFO167]; European UnionEuropean Union
   (EU) [LSHC-CT-2005-018704]
FX We thank Prof. R.L. Gallo for providing the anti-CRAMP antibody and
   purified CRAMP protein and Prof. S Kimura for providing the anti-Chi3L3
   antibody. K.L.R. was supported by funding from the Deutsche
   Forschungsgemeinschaft (RU745/10-1, RU745/7-1, SFB738, KFO167), the
   Wilhelm-Sander Foundation, the Fritz-Thyssen Foundation, the Deutsche
   Krebshilfe e.V., and the European Union projects GENINCA and TELOMARKER.
   This work was supported by the INCA consortium (www.inca-project.org)
   under the Sixth Research Framework: Program of the European Union
   (Integrated Project LSHC-CT-2005-018704) (to E.S., P.Z., J.J., and H.M).
CR Armanios MY, 2007, NEW ENGL J MED, V356, P1317, DOI 10.1056/NEJMoa066157
   Artandi SE, 2000, NATURE, V406, P641, DOI 10.1038/35020592
   Chang S, 2004, NAT GENET, V36, P877, DOI 10.1038/ng1389
   Chin L, 1999, CELL, V97, P527, DOI 10.1016/S0092-8674(00)80762-X
   Choudhury AR, 2007, NAT GENET, V39, P99, DOI 10.1038/ng1937
   DADDA DF, 2003, NATURE, V426, P194, DOI DOI 10.1038/NATURE02118
   DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363
   Dozin B, 2002, MATRIX BIOL, V21, P449, DOI 10.1016/S0945-053X(02)00028-8
   Ershler WB, 2000, ANNU REV MED, V51, P245, DOI 10.1146/annurev.med.51.1.245
   FAGIOLO U, 1993, EUR J IMMUNOL, V23, P2375, DOI 10.1002/eji.1830230950
   GIORDANO T, 1989, EXP GERONTOL, V24, P501, DOI 10.1016/0531-5565(89)90056-9
   Hao LY, 2005, CELL, V123, P1121, DOI 10.1016/j.cell.2005.11.020
   Harris TB, 1999, AM J MED, V106, P506, DOI 10.1016/S0002-9343(99)00066-2
   Herbig U, 2006, SCIENCE, V311, P1257, DOI 10.1126/science.1122446
   Herrera E, 1999, EMBO J, V18, P2950, DOI 10.1093/emboj/18.11.2950
   Jeyapalan JC, 2007, MECH AGEING DEV, V128, P36, DOI 10.1016/j.mad.2006.11.008
   Jiang H, 2007, Z GERONTOL GERIATR, V40, P314, DOI 10.1007/s00391-007-0480-0
   Ju ZY, 2007, NAT MED, V13, P742, DOI 10.1038/nm1578
   Lee HW, 1998, NATURE, V392, P569, DOI 10.1038/33345
   Licastro F, 2003, NEUROBIOL AGING, V24, P921, DOI 10.1016/S0197-4580(03)00013-7
   Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141
   Nizet V, 2001, NATURE, V414, P454, DOI 10.1038/35106587
   OHYASHIKI JH, 1994, CANCER RES, V54, P3557
   Parrinello S, 2005, J CELL SCI, V118, P485, DOI 10.1242/jcs.01635
   PROWSE KR, 1995, P NATL ACAD SCI USA, V92, P4818, DOI 10.1073/pnas.92.11.4818
   Reese TA, 2007, NATURE, V447, P92, DOI 10.1038/nature05746
   Rubin CI, 2004, J CELL BIOCHEM, V93, P242, DOI 10.1002/jcb.20187
   Rudolph KL, 1999, CELL, V96, P701, DOI 10.1016/S0092-8674(00)80580-2
   Satyanarayana A, 2004, MOL CELL BIOL, V24, P5459, DOI 10.1128/MCB.24.12.5459-5474.2004
   Schaetzlein S, 2007, CELL, V130, P863, DOI 10.1016/j.cell.2007.08.029
   Takai H, 2003, CURR BIOL, V13, P1549, DOI 10.1016/S0960-9822(03)00542-6
   Theodorescu D, 2005, ELECTROPHORESIS, V26, P2797, DOI 10.1002/elps.200400208
   Tsakiri KD, 2007, P NATL ACAD SCI USA, V104, P7552, DOI 10.1073/pnas.0701009104
   Vasto S, 2007, MECH AGEING DEV, V128, P83, DOI 10.1016/j.mad.2006.11.015
   Vulliamy T, 2002, LANCET, V359, P2168, DOI 10.1016/S0140-6736(02)09087-6
   WANG E, 1989, EXP GERONTOL, V24, P485, DOI 10.1016/0531-5565(89)90055-7
   Wiemann SU, 2002, FASEB J, V16, P935, DOI 10.1096/fj.01-0977com
   WRIGHT WE, 1992, EXP GERONTOL, V27, P383, DOI 10.1016/0531-5565(92)90069-C
   Xue W, 2007, NATURE, V445, P656, DOI 10.1038/nature05529
   Zhu Z, 2004, SCIENCE, V304, P1678, DOI 10.1126/science.1095336
   Zou Y, 2004, MOL BIOL CELL, V15, P3709, DOI 10.1091/mbc.E04-03-0207
   Zurbig P, 2006, ELECTROPHORESIS, V27, P2111, DOI 10.1002/elps.200500827
NR 42
TC 117
Z9 121
U1 0
U2 11
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 12
PY 2008
VL 105
IS 32
BP 11299
EP 11304
DI 10.1073/pnas.0801457105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 339EK
UT WOS:000258560700049
PM 18695223
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Lin, S
   Maj, M
   Bezakova, G
   Magyar, JP
   Brenner, HR
   Ruegg, MA
AF Lin, Shuo
   Maj, Marcin
   Bezakova, Gabriela
   Magyar, Josef P.
   Brenner, Hans Rudolf
   Ruegg, Markus A.
TI Muscle-wide secretion of a miniaturized form of neural agrin rescues
   focal neuromuscular innervation in agrin mutant mice
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE acetylcholine; MuSK; synapse formation
ID RECEPTOR TYROSINE KINASE; IN-VIVO; SKELETAL-MUSCLE; DEFICIENT MICE;
   POSTSYNAPTIC DIFFERENTIATION; CHOLINE-ACETYLTRANSFERASE;
   MUSCULAR-DYSTROPHY; JUNCTION FORMATION; NEURITE OUTGROWTH; SYNAPSE
   FORMATION
AB Agrin and its receptor MuSK are required for the formation of the postsynaptic apparatus at the neuromuscular junction (NMJ). In the current model the local deposition of agrin by the nerve and the resulting local activation of MUSK are responsible for creating and maintaining the postsynaptic apparatus including clusters of acetylcholine receptors (AChRs). Concomitantly, the release of acetylcholine (ACh) and the resulting depolarization disperses those postsynaptic structures that are not apposed by the nerve and thus not stabilized by agrin-MuSK signaling. Here we show that a miniaturized form of agrin, consisting of the laminin-binding and MuSK-activating domains, is sufficient to fully restore NMJs in agrin mutant mice when expressed by developing muscle. Although miniagrin is expressed uniformly throughout muscle fibers and induces ectopic AChR clusters, the size and the number of those AChR clusters contacted by the motor nerve increase during development. We provide experimental evidence that this is due to ACh, because the AChR agonist carbachol stabilizes AChR clusters in organotypic cultures of embryonic diaphragms. in summary, our results show that agrin function in NMJ development requires only two small domains, and that this function does not depend on the local deposition of agrin at synapses. Finally, they suggest a novel local function of ACh in stabilizing postsynaptic structures.
C1 [Lin, Shuo; Maj, Marcin; Bezakova, Gabriela; Ruegg, Markus A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Brenner, Hans Rudolf] Univ Basel, Inst Physiol, Dept Biomed, CH-4056 Basel, Switzerland.
   [Magyar, Josef P.] Santhera Pharmaceut, CH-4410 Liestal, Switzerland.
RP Ruegg, MA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus-a.ruegg@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); Swiss Foundation for Research on Muscle Diseases; Cantons of
   Basel-Stadt and Baselland
FX We thank F. Schnuriger and G. Bittcher for support in the initial stages
   of the project. We are grateful to J. L. Bixby for comments on the
   manuscript and to L. Landmann for help with confocal microscopy and
   quantification. The Transgenic Mouse Core Facility of the University of
   Basel is acknowledged for generating the transgenic mice, Dr. J. R.
   Sanes for providing the agrin knockout mice, and Dr. N. Raben for the
   MCK-tTA mice. This work was supported by grants from the Swiss National
   Science Foundation, the Swiss Foundation for Research on Muscle
   Diseases, and the Cantons of Basel-Stadt and Baselland.
CR Akaaboune M, 1999, SCIENCE, V286, P503, DOI 10.1126/science.286.5439.503
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   Brandon EP, 2003, J NEUROSCI, V23, P539
   CAMPOSANO R, 1995, DESIGN AUTOMATION EM, V1, P5
   Chang D, 1997, DEV BIOL, V181, P21, DOI 10.1006/dbio.1996.8435
   Cohen I, 1997, MOL CELL NEUROSCI, V9, P237, DOI 10.1006/mcne.1997.0623
   Dalva MB, 2007, NAT REV NEUROSCI, V8, P206, DOI 10.1038/nrn2075
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   Denzer AJ, 1997, J CELL BIOL, V137, P671, DOI 10.1083/jcb.137.3.671
   Dimitropoulou A, 2005, MOL CELL NEUROSCI, V28, P292, DOI 10.1016/j.mcn.2004.09.013
   Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2
   Fox MA, 2007, CELL, V129, P179, DOI 10.1016/j.cell.2007.02.035
   Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2
   GAUTAM M, 1995, NATURE, V377, P232, DOI 10.1038/377232a0
   GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   Harvey SJ, 2007, AM J PATHOL, V171, P139, DOI 10.2353/ajpath.2007.061116
   Jones G, 1997, P NATL ACAD SCI USA, V94, P2654, DOI 10.1073/pnas.94.6.2654
   Jones G, 1999, J NEUROSCI, V19, P3376
   Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026
   Koenen M, 2005, EMBO REP, V6, P570, DOI 10.1038/sj.embor.7400429
   Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007
   Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003
   Lin S, 2008, J NEUROSCI, V28, P3333, DOI 10.1523/JNEUROSCI.5590-07.2008
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002
   MCMAHAN UJ, 1990, COLD SH Q B, V55, P407
   Megeath LJ, 1998, J NEUROSCI, V18, P672
   Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x
   Meinen S, 2007, J CELL BIOL, V176, P979, DOI 10.1083/jcb.200611152
   Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6
   Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102
   Moll J, 2001, NATURE, V413, P302, DOI 10.1038/35095054
   Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142
   Pun S, 2002, NEURON, V34, P357, DOI 10.1016/S0896-6273(02)00670-0
   Sander A, 2001, J CELL BIOL, V155, P1287, DOI 10.1083/jcb.200105034
   Scotton P, 2006, J BIOL CHEM, V281, P36835, DOI 10.1074/jbc.M607887200
   STERNBERG EA, 1988, MOL CELL BIOL, V8, P2896, DOI 10.1128/MCB.8.7.2896
   Villarroel A, 1996, J PHYSIOL-LONDON, V496, P331, DOI 10.1113/jphysiol.1996.sp021688
   Vock VM, 2008, J NEUROSCI, V28, P3123, DOI 10.1523/JNEUROSCI.5080-07.2008
   Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696
   Yang X, 2000, SCIENCE, V287, P131, DOI 10.1126/science.287.5450.131
NR 42
TC 38
Z9 38
U1 0
U2 3
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD AUG 12
PY 2008
VL 105
IS 32
BP 11406
EP 11411
DI 10.1073/pnas.0801683105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 339EK
UT WOS:000258560700067
PM 18685098
OA Green Published, Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Farhan, H
   Weiss, M
   Tani, K
   Kaufman, RJ
   Hauri, HP
AF Farhan, Hesso
   Weiss, Matthias
   Tani, Katsuko
   Kaufman, Randal J.
   Hauri, Hans-Peter
TI Adaptation of endoplasmic reticulum exit sites to acute and chronic
   increases in cargo load
SO EMBO JOURNAL
LA English
DT Article
DE COPII; phosphatidylinositol-4 kinase III alpha; Sec16; secretory
   pathway; unfolded protein response
ID UNFOLDED PROTEIN RESPONSE; DE-NOVO FORMATION; COPII COAT; GOLGI
   PROTEINS; BREFELDIN-A; ER EXPORT; SIGNAL; XBP1; ORGANIZATION; BIOGENESIS
AB The biogenesis of endoplasmic reticulum (ER) exit sites (ERES) involves the formation of phosphatidylinositol-4 phosphate (PI4) and Sec16, but it is entirely unknown how ERES adapt to variations in cargo load. Here, we studied acute and chronic adaptive responses of ERES to an increase in cargo load for ER export. The acute response (within minutes) to increased cargo load stimulated ERES fusion events, leading to larger but less ERES. Silencing either PI4-kinase III alpha (PI4K-III alpha) or Sec16 inhibited the acute response. Overexpression of secretory cargo for 24 h induced the unfolded protein response (UPR), upregulated COPII, and the cells formed more ERES. This chronic response was insensitive to silencing PI4K-III alpha, but was abrogated by silencing Sec16. The UPR was required as the chronic response was absent in cells lacking inositol-requiring protein 1. Mathematical model simulations further support the notion that increasing ERES number together with COPII levels is an efficient way to enhance the secretory flux. These results indicate that chronic and acute increases in cargo load are handled differentially by ERES and are regulated by different factors.
C1 [Farhan, Hesso; Hauri, Hans-Peter] Univ Basel, Dept Pharmacol & Neurobiol, Biozentrum, CH-4056 Basel, Switzerland.
   [Weiss, Matthias] German Canc Res Ctr, D-6900 Heidelberg, Germany.
   [Tani, Katsuko] Tokyo Univ Pharm & Life Sci, Sch Life Sci, Tokyo, Japan.
   [Kaufman, Randal J.] Univ Michigan, Med Ctr, Dept Biol Chem & Internal Med, Ann Arbor, MI USA.
   [Kaufman, Randal J.] Univ Michigan, Med Ctr, Howard Hughes Med Inst, Ann Arbor, MI 48109 USA.
RP Hauri, HP (corresponding author), Univ Basel, Dept Pharmacol & Neurobiol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Hans-Peter.Hauri@unibas.ch
RI Matthias, Weiss/A-6094-2012; Farhan, Hesso/C-7997-2012
OI Farhan, Hesso/0000-0002-0889-8463
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [20570190] Funding Source: KAKEN; NATIONAL HEART, LUNG, AND BLOOD
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, R01HL052173, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   R01HL052173, P01HL057346, P01HL057346, P01HL057346, R01HL052173,
   R01HL052173, R01HL052173, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, R01HL052173, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   R01HL052173, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, R01HL052173,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, R01HL052173,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   R01HL052173, R01HL052173, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, R01HL052173, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, R01HL052173, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   R01HL052173, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   P01HL057346, P01HL057346, P01HL057346, P01HL057346, P01HL057346,
   R01HL052173, P01HL057346, P01HL057346, P01HL057346, R01HL052173,
   R01HL052173] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF
   DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of
   Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)
   [R01DK042394, R37DK042394, R37DK042394, R37DK042394, R37DK042394,
   R37DK042394, R37DK042394, R37DK042394, R37DK042394, R37DK042394,
   R37DK042394, R01DK042394, R01DK042394, R37DK042394, R37DK042394,
   R37DK042394, R01DK042394] Funding Source: NIH RePORTER; Howard Hughes
   Medical InstituteHoward Hughes Medical Institute Funding Source:
   Medline; NHLBI NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung
   & Blood Institute (NHLBI) [P01 HL057346, P01 HL057346-11A18575, R01
   HL052173-11, P01 HL057346-100006, R01 HL052173, R01 HL052173-12] Funding
   Source: Medline; NIDDK NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of Diabetes & Digestive & Kidney Diseases (NIDDK) [R37 DK042394-11, R01
   DK042394, R37 DK042394-10, R01 DK042394-09, R37 DK042394] Funding
   Source: Medline
CR Acosta-Alvear D, 2007, MOL CELL, V27, P53, DOI 10.1016/j.molcel.2007.06.011
   Bevis BJ, 2002, NAT CELL BIOL, V4, P750, DOI 10.1038/ncb852
   Bhattacharyya D, 2007, MOL BIOL CELL, V18, P839, DOI 10.1091/mbc.E06-08-0707
   Bi XP, 2002, NATURE, V419, P271, DOI 10.1038/nature01040
   Blumental-Perry A, 2006, DEV CELL, V11, P671, DOI 10.1016/j.devcel.2006.09.001
   Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045
   DOMS RW, 1989, J CELL BIOL, V109, P61, DOI 10.1083/jcb.109.1.61
   Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200
   Forster R, 2006, CURR BIOL, V16, P173, DOI 10.1016/j.cub.2005.11.076
   Gimeno RE, 1996, MOL BIOL CELL, V7, P1815
   Guo YS, 2006, J CELL BIOL, V174, P53, DOI 10.1083/jcb.200604058
   Hanton SL, 2007, PLANT PHYSIOL, V143, P1640, DOI 10.1104/pp.106.094110
   Heinzer S, 2008, J CELL SCI, V121, P55, DOI 10.1242/jcs.013383
   Iinuma T, 2007, J BIOL CHEM, V282, P17632, DOI 10.1074/jbc.M611237200
   Lee AH, 2005, EMBO J, V24, P4368, DOI 10.1038/sj.emboj.7600903
   Lee K, 2002, GENE DEV, V16, P452, DOI 10.1101/gad.964702
   Lee MCS, 2004, ANNU REV CELL DEV BI, V20, P87, DOI 10.1146/annurev.cellbio.20.010403.105307
   Lin JH, 2007, SCIENCE, V318, P944, DOI 10.1126/science.1146361
   LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5
   Mancias JD, 2007, MOL CELL, V26, P403, DOI 10.1016/j.molcel.2007.03.017
   Matsuoka K, 1998, CELL, V93, P263, DOI 10.1016/S0092-8674(00)81577-9
   Mezzacasa A, 2002, TRAFFIC, V3, P833, DOI 10.1034/j.1600-0854.2002.31108.x
   Nishimura N, 1999, J BIOL CHEM, V274, P15937, DOI 10.1074/jbc.274.22.15937
   Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199
   Sato M, 2002, BIOCHEM BIOPH RES CO, V296, P560, DOI 10.1016/S0006-291X(02)00922-1
   Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134
   Shaffer AL, 2004, IMMUNITY, V21, P81, DOI 10.1016/j.immuni.2004.06.010
   Shugrue CA, 1999, J CELL SCI, V112, P4547
   Sriburi R, 2007, J BIOL CHEM, V282, P7024, DOI 10.1074/jbc.M609490200
   Stephens DJ, 2003, EMBO REP, V4, P210, DOI 10.1038/sj.embor.embor736
   Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1
   Watson P, 2006, TRAFFIC, V7, P1678, DOI 10.1111/j.1600-0854.2006.00493.x
   Wendeler MW, 2007, EMBO REP, V8, P258, DOI 10.1038/sj.embor.7400893
   Wong K, 1997, J BIOL CHEM, V272, P13236, DOI 10.1074/jbc.272.20.13236
   Zhang KZ, 2005, J CLIN INVEST, V115, P268, DOI 10.1172/JCI200521848
NR 35
TC 89
Z9 90
U1 0
U2 2
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 0261-4189
J9 EMBO J
JI Embo J.
PD AUG 6
PY 2008
VL 27
IS 15
BP 2043
EP 2054
DI 10.1038/emboj.2008.136
PG 12
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 334JU
UT WOS:000258218900002
PM 18650939
OA Green Published
DA 2021-01-25
ER

PT J
AU Dehio, C
AF Dehio, Christoph
TI Infection-associated type IV secretion systems of Bartonella and their
   diverse roles in host cell interaction
SO CELLULAR MICROBIOLOGY
LA English
DT Review
ID ENDOTHELIAL-CELLS; PATHOGEN BARTONELLA; HENSELAE; VIRULENCE;
   PROLIFERATION; BACTEREMIA; GRAHAMII; INVASION; CLONING; NOV.
AB Type IV secretion systems (T4SSs) are transporters of Gram-negative bacteria that mediate interbacterial DNA transfer, and translocation of virulence factors into eukaryotic host cells. The alpha-proteobacterial genus Bartonella comprises arthropod-borne pathogens that colonize endothelial cells and erythrocytes of their mammalian reservoir hosts, thereby causing long-lasting intraerythrocytic infections. The deadly human pathogen Bartonella bacilliformis holds an isolated position in the Bartonella phylogeny as a sole representative of an ancestral lineage. All other species evolved in a separate 'modern' lineage by radial speciation and represent highly host-adapted pathogens of limited virulence potential. Unlike B. bacilliformis, the species of the modern lineage encode at least one of the closely related T4SSs, VirB/VirD4 or Vbh. These VirB-like T4SSs represent major host adaptability factors that contributed to the remarkable evolutionary success of the modern lineage. At the molecular level, the VirB/VirD4 T4SS was shown to translocate several effector proteins into endothelial cells that subvert cellular functions critical for establishing chronic infection. A third T4SS, Trw, is present in a sub-branch of the modern lineage. Trw does not translocate any known effectors, but produces multiple variant pilus subunits critically involved in the invasion of erythrocytes. The T4SSs laterally acquired by the bartonellae have thus adopted highly diverse functions during infection, highlighting their versatility as pathogenicity factors.
C1 Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
RP Dehio, C (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM christoph.dehio@unibas.ch
RI Dehio, Christoph/AAD-5572-2019; Dehio, Christoph/R-8277-2016
OI Dehio, Christoph/0000-0001-7288-1052; Dehio,
   Christoph/0000-0001-7288-1052
FU Howard Hughes Medical InstituteHoward Hughes Medical Institute
   [55005501] Funding Source: Medline
CR Backert S, 2005, TRENDS MICROBIOL, V13, P476, DOI 10.1016/j.tim.2005.08.002
   CABEZON E, 1994, J BACTERIOL, V176, P4455, DOI 10.1128/jb.176.14.4455-4458.1994
   Cascales E, 2004, SCIENCE, V304, P1170, DOI 10.1126/science.1095211
   Christie PJ, 2005, ANNU REV MICROBIOL, V59, P451, DOI 10.1146/annurev.micro.58.030603.123630
   de Paz HD, 2005, MICROBIOL-SGM, V151, P3505, DOI 10.1099/mic.0.28410-0
   Dehio C, 2005, NAT REV MICROBIOL, V3, P621, DOI 10.1038/nrmicro1209
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Dehio C, 1997, J CELL SCI, V110, P2141
   Dehio C, 2003, CURR OPIN MICROBIOL, V6, P61, DOI 10.1016/S1369-5274(03)00006-7
   Eremeeva ME, 2007, NEW ENGL J MED, V356, P2381, DOI 10.1056/NEJMoa065987
   Frank AC, 2005, MOL BIOL EVOL, V22, P1325, DOI 10.1093/molbev/msi124
   Heller R, 1998, INT J SYST BACTERIOL, V48, P1333, DOI 10.1099/00207713-48-4-1333
   Kempf VAJ, 2001, CELL MICROBIOL, V3, P623, DOI 10.1046/j.1462-5822.2001.00144.x
   Kirby JE, 2002, P NATL ACAD SCI USA, V99, P4656, DOI 10.1073/pnas.072292699
   Koesling J, 2001, J IMMUNOL, V167, P11, DOI 10.4049/jimmunol.167.1.11
   Kosoy M, 2008, J CLIN MICROBIOL, V46, P772, DOI 10.1128/JCM.02120-07
   Marlovits TC, 2004, SCIENCE, V306, P1040, DOI 10.1126/science.1102610
   Mavris M, 2005, ANN NY ACAD SCI, V1063, P312, DOI 10.1196/annals.1355.050
   Nystedt B, 2008, MOL BIOL EVOL, V25, P287, DOI 10.1093/molbev/msm252
   Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500
   Padmalayam I, 2000, DNA CELL BIOL, V19, P377, DOI 10.1089/10445490050043344
   Resto-Ruiz SI, 2002, INFECT IMMUN, V70, P4564, DOI 10.1128/IAI.70.8.4564-4570.2002
   Saenz HL, 2007, NAT GENET, V39, P1469, DOI 10.1038/ng.2007.38
   Schmid MC, 2004, MOL MICROBIOL, V52, P81, DOI 10.1111/j.1365-2958.2003.03964.x
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schmiederer M, 2000, DNA CELL BIOL, V19, P141, DOI 10.1089/104454900314528
   Schroder G, 2005, TRENDS MICROBIOL, V13, P336, DOI 10.1016/j.tim.2005.05.008
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Seubert A, 2003, PLASMID, V49, P44, DOI 10.1016/S0147-619X(02)00103-8
NR 32
TC 67
Z9 73
U1 0
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1462-5814
J9 CELL MICROBIOL
JI Cell Microbiol.
PD AUG
PY 2008
VL 10
IS 8
BP 1591
EP 1598
DI 10.1111/j.1462-5822.2008.01171.x
PG 8
WC Cell Biology; Microbiology
SC Cell Biology; Microbiology
GA 326GY
UT WOS:000257647800003
PM 18489724
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Zuber, B
   Chami, M
   Houssin, C
   Dubochet, J
   Griffiths, G
   Daffe, M
AF Zuber, Benoit
   Chami, Mohamed
   Houssin, Christine
   Dubochet, Jacques
   Griffiths, Gareth
   Daffe, Mamadou
TI Direct visualization of the outer membrane of mycobacteria and
   corynebacteria in their native state
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID MYCOLIC ACID BIOSYNTHESIS; CELL-WALL; CRYOELECTRON MICROSCOPY; VITREOUS
   SECTIONS; ELECTRON-MICROSCOPY; PERIPLASMIC SPACE; CULTIVABLE
   MYCOBACTERIA; FREEZE-SUBSTITUTION; BILAYER THICKNESS; DRUG-RESISTANCE
AB The cell envelope of mycobacteria, which include the causative agents of tuberculosis and leprosy, is crucial for their success as pathogens. Despite a continued strong emphasis on identifying the multiple chemical components of this envelope, it has proven difficult to combine its components into a comprehensive structural model, primarily because the available ultrastructural data rely on conventional electron microscopy embedding and sectioning, which are known to induce artifacts. The existence of an outer membrane billayer has long been postulated but has never been directly observed by electron microscopy of ultrathin sections. Here we have used cryo-electron microscopy of vitreous sections (CEMOVIS) to perform a detailed ultrastructural analysis of three species belonging to the Corynebacterineae suborder, namely, Mycobacterium bovis BCG, Mycobacterium smegmatis, and Corynebacterium glutamicum, in their native state. We provide new information that accurately describes the different layers of the mycobacterial cell envelope and challenges current models of the organization of its components. We show a direct visualization of an outer membrane, analogous to that found in gram-negative bacteria, in the three bacterial species examined. Furthermore, we demonstrate that mycolic acids, the hallmark of mycobacteria and related genera, are essential for the formation of this outer membrane. In addition, a granular layer and a low-density zone typifying the periplasmic space of gram-positive bacteria are apparent in CEMOVIS images of mycobacteria and corynebacteria. Based on our observations, a model of the organization of the lipids in the outer membrane is proposed. The architecture we describe should serve as a reference for future studies to relate the structure of the mycobacteriall cell envelope to its function.
C1 [Zuber, Benoit; Dubochet, Jacques] Univ Lausanne, Lab Ultrastruct Anal, CH-1015 Lausanne, Switzerland.
   [Chami, Mohamed] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Houssin, Christine] Univ Paris 11, Inst Genet & Microbiol, F-91405 Orsay, France.
   [Houssin, Christine] CNRS, F-91405 Orsay, France.
   [Griffiths, Gareth] EMBL, D-69117 Heidelberg, Germany.
   [Daffe, Mamadou] Univ Toulouse 3, IPBS, F-31077 Toulouse 4, France.
   [Daffe, Mamadou] CNRS, IPBS, Dept Mecanismes Mol Infect Mycobacteriennes, F-31077 Toulouse 4, France.
RP Zuber, B (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.
EM bzuber@mrc-lmb.cam.ac.uk; mamadou.daffe@ipbs.fr
RI Zuber, Benoit/U-1952-2019
OI Zuber, Benoit/0000-0001-7725-5579
CR Al-Amoudi A, 2005, J STRUCT BIOL, V150, P109, DOI 10.1016/j.jsb.2005.01.003
   Al-Amoudi A, 2004, EMBO J, V23, P3583, DOI 10.1038/sj.emboj.7600366
   Alderwick LJ, 2005, J BIOL CHEM, V280, P32362, DOI 10.1074/jbc.M506339200
   Bardou F, 1996, ANTIMICROB AGENTS CH, V40, P2459, DOI 10.1128/AAC.40.11.2459
   BARKSDALE L, 1977, BACTERIOL REV, V41, P217, DOI 10.1128/MMBR.41.1.217-372.1977
   BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333
   CHAMI M, 1995, BIOL CELL, V83, P219, DOI 10.1016/0248-4900(96)81311-6
   Daffe M, 1998, ADV MICROB PHYSIOL, V39, P131
   DAFFE M, 2005, HDB CORYNEBACTERIUM, P121
   DAFFE M, 1989, FEMS MICROBIOL LETT, V52, P89
   DRAPER P, 1971, J GEN MICROBIOL, V69, P313, DOI 10.1099/00221287-69-3-313
   Draper P, 1998, Front Biosci, V3, pD1253
   Dubochet J, 2001, MICRON, V32, P91, DOI 10.1016/S0968-4328(00)00026-3
   DUBOCHET J, 1988, Q REV BIOPHYS, V21, P129, DOI 10.1017/S0033583500004297
   Etienne G, 2005, MICROBIOL-SGM, V151, P2075, DOI 10.1099/mic.0.27869-0
   Etienne G, 2002, MICROBIOL-SGM, V148, P3089, DOI 10.1099/00221287-148-10-3089
   FREHEL C, 1988, FEMS MICROBIOL LETT, V56, P225, DOI 10.1016/0378-1097(88)90195-4
   Gande R, 2004, J BIOL CHEM, V279, P44847, DOI 10.1074/jbc.M408648200
   Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100
   Henderson GP, 2006, MOL MICROBIOL, V60, P376, DOI 10.1111/j.1365-2958.2006.05113.x
   Hoffmann C, 2008, P NATL ACAD SCI USA, V105, P3963, DOI 10.1073/pnas.0709530105
   Karakousis PC, 2004, CELL MICROBIOL, V6, P105, DOI 10.1046/j.1462-5822.2003.00351.x
   Lemassu A, 1996, MICROBIOL-UK, V142, P1513, DOI 10.1099/13500872-142-6-1513
   LEMASSU A, 1994, BIOCHEM J, V297, P351, DOI 10.1042/bj2970351
   LEWIS BA, 1983, J MOL BIOL, V166, P211, DOI 10.1016/S0022-2836(83)80007-2
   LIU J, 1995, P NATL ACAD SCI USA, V92, P11254, DOI 10.1073/pnas.92.24.11254
   Mahfoud M, 2006, J BIOL CHEM, V281, P5908, DOI 10.1074/jbc.M511642200
   Marienfeld S, 1997, ANTON LEEUW INT J G, V72, P291, DOI 10.1023/A:1000578811089
   Matias VRF, 2006, J BACTERIOL, V188, P1011, DOI 10.1128/JB.188.3.1011-1021.2006
   Matias VRF, 2005, MOL MICROBIOL, V56, P240, DOI 10.1111/j.1365-2958.2005.04535.x
   Matias VRF, 2003, J BACTERIOL, V185, P6112, DOI 10.1128/JB.185.20.6112-6118.2003
   MCNEIL MR, 1991, RES MICROBIOL, V142, P451, DOI 10.1016/0923-2508(91)90120-Y
   Minnikin D. E., 1982, BIOL MYCOBACTERIA, V1, P95
   Minnikin DE, 2002, CHEM BIOL, V9, P545, DOI 10.1016/S1074-5521(02)00142-4
   NGUYEN HT, 1979, J BACTERIOL, V138, P552, DOI 10.1128/JB.138.2.552-558.1979
   Niederweis M, 2003, MOL MICROBIOL, V49, P1167, DOI 10.1046/j.1365-2958.2003.03662.x
   OrtaloMagne A, 1996, MICROBIOL-UK, V142, P927, DOI 10.1099/00221287-142-4-927
   OrtaloMagne A, 1996, J BACTERIOL, V178, P456, DOI 10.1128/jb.178.2.456-461.1996
   PAUL TR, 1994, INFECT IMMUN, V62, P1542, DOI 10.1128/IAI.62.5.1542-1550.1994
   PAUL TR, 1992, J BACTERIOL, V174, P6508, DOI 10.1128/JB.174.20.6508-6517.1992
   Portevin D, 2005, J BIOL CHEM, V280, P8862, DOI 10.1074/jbc.M408578200
   Portevin D, 2004, P NATL ACAD SCI USA, V101, P314, DOI 10.1073/pnas.0305439101
   Puech V, 2001, MICROBIOL-SGM, V147, P1365, DOI 10.1099/00221287-147-5-1365
   RASTOGI N, 1991, RES MICROBIOL, V142, P464, DOI 10.1016/0923-2508(91)90121-P
   Sambrook J., 2001, MOL CLONING LAB MANU
   Seybert A, 2006, J STRUCT BIOL, V156, P342, DOI 10.1016/j.jsb.2006.04.010
   SILVA MT, 1984, J GEN MICROBIOL, V130, P369
   SILVA MT, 1983, BIOL CELL, V47, P383
   Sonden B, 2005, MOL MICROBIOL, V58, P426, DOI 10.1111/j.1365-2958.2005.04847.x
   STECK PA, 1978, J BIOL CHEM, V253, P5625
   Studer D, 2001, J MICROSC-OXFORD, V203, P285, DOI 10.1046/j.1365-2818.2001.00919.x
   TAHARA Y, 1994, MICRON, V25, P141, DOI 10.1016/0968-4328(94)90039-6
   Tropis M, 2005, J BIOL CHEM, V280, P26573, DOI 10.1074/jbc.M502104200
   Villeneuve M, 2005, BBA-BIOMEMBRANES, V1715, P71, DOI 10.1016/j.bbamem.2005.07.005
   Villeneuve M, 2007, BBA-BIOMEMBRANES, V1768, P1717, DOI 10.1016/j.bbamem.2007.04.003
   WHITE DL, 1976, BIOCHIM BIOPHYS ACTA, V436, P577, DOI 10.1016/0005-2736(76)90442-9
   WONG MYH, 1979, J BIOL CHEM, V254, P5734
   Zuber B, 2005, P NATL ACAD SCI USA, V102, P19192, DOI 10.1073/pnas.0509527102
   Zuber B, 2006, J BACTERIOL, V188, P6652, DOI 10.1128/JB.00391-06
NR 59
TC 274
Z9 278
U1 1
U2 85
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD AUG
PY 2008
VL 190
IS 16
BP 5672
EP 5680
DI 10.1128/JB.01919-07
PG 9
WC Microbiology
SC Microbiology
GA 335EU
UT WOS:000258274400015
PM 18567661
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Onelli, E
   Prescianotto-Baschong, C
   Caccianiga, M
   Moscatelli, A
AF Onelli, Elisabetta
   Prescianotto-Baschong, Cristina
   Caccianiga, Marco
   Moscatelli, Alessandra
TI Clathrin-dependent and independent endocytic pathways in tobacco
   protoplasts revealed by labelling with charged nanogold
SO JOURNAL OF EXPERIMENTAL BOTANY
LA English
DT Article
DE charged nanogold; endocytosis; membrane recycling; Nicotiana tabacum;
   protoplasts; vesicle trafficking
ID PARTIALLY-COATED RETICULUM; TRANS-GOLGI NETWORK; BREFELDIN-A;
   PLANT-CELLS; PLASMA-MEMBRANE; PREVACUOLAR COMPARTMENTS; POST-GOLGI;
   VESICLE TRAFFICKING; SOYBEAN PROTOPLASTS; DOWN-REGULATION
AB Positively charged nanogold was used as a probe to trace the internalization of plasma membrane (PM) domains carrying negatively charged residues at an ultrastructural level. The probe revealed distinct endocytic pathways within tobacco protoplasts and allowed the morphology of the organelles involved in endocytosis to be characterized in great detail. Putative early endosomes with a tubulo-vesicular structure, similar to that observed in animal cells, are described and a new compartment, characterized by interconnected vesicles, was identified as a late endosome using the Arabidopsis anti-syntaxin family Syp-21 antibody. Endocytosis dissection using Brefeldin A (BFA), pulse chase, temperature- and energy-dependent experiments combined with quantitative analysis of nanogold particles in different compartments, suggested that recycling to the PM predominated with respect to degradation. Further experiments using ikarugamycin (IKA), an inhibitor of clathrin-dependent endocytosis, and negatively charged nanogold confirmed that distinct endocytic pathways coexist in tobacco protoplasts.
C1 [Onelli, Elisabetta; Caccianiga, Marco; Moscatelli, Alessandra] Univ Milan, Dept Biol, Milan, Italy.
   [Prescianotto-Baschong, Cristina] Univ Basel, Dept Biochem, Biozentrum, Basel, Switzerland.
RP Moscatelli, A (corresponding author), Univ Milan, Dept Biol, Milan, Italy.
EM alessandra.moscatelli@unimi.it
RI Moscatelli, alessandra/B-1138-2017; ONELLI, ELISABETTA/B-1164-2017;
   CACCIANIGA, MARCO STEFANO/B-1025-2017
OI Moscatelli, alessandra/0000-0003-0912-5697; ONELLI,
   ELISABETTA/0000-0003-3724-4116; CACCIANIGA, MARCO
   STEFANO/0000-0001-9715-1830
CR Ang AL, 2004, J CELL BIOL, V167, P531, DOI 10.1083/jcb.200408165
   Baba T, 2001, TRAFFIC, V2, P501, DOI 10.1034/j.1600-0854.2001.20707.x
   Baluska F, 2002, PLANT PHYSIOL, V130, P422, DOI 10.1104/pp.007526
   Baluska F, 2004, J EXP BOT, V55, P463, DOI 10.1093/jxb/erh042
   Battey NH, 1999, PLANT CELL, V11, P643, DOI 10.1105/tpc.11.4.643
   Bolte S, 2004, J MICROSC-OXFORD, V214, P159, DOI 10.1111/j.0022-2720.2004.01348.x
   Borner GHH, 2005, PLANT PHYSIOL, V137, P104, DOI 10.1104/pp.104.053041
   Conceicao ADS, 1997, PLANT CELL, V9, P571, DOI 10.2307/3870508
   Dettmer J, 2006, PLANT CELL, V18, P715, DOI 10.1105/tpc.105.037978
   Dhonukshe P, 2007, CURR BIOL, V17, P520, DOI 10.1016/j.cub.2007.01.052
   Echeverria E, 2000, PLANT PHYSIOL, V123, P1217, DOI 10.1104/pp.123.4.1217
   Emans N, 2002, PLANT CELL, V14, P71, DOI 10.1105/tpc.010339
   Foresti O, 2006, PLANT CELL, V18, P2275, DOI 10.1105/tpc.105.040279
   Fowke L. C., 1991, Endocytosis, exocytosis and vesicle traffic in plants., P15
   Geldner N, 2003, CELL, V112, P219, DOI 10.1016/S0092-8674(03)00003-5
   Geldner N, 2006, CURR OPIN PLANT BIOL, V9, P589, DOI 10.1016/j.pbi.2006.09.011
   GODA Y, 1988, CELL, V55, P309, DOI 10.1016/0092-8674(88)90054-2
   Gruenberg J, 2001, NAT REV MOL CELL BIO, V2, P721, DOI 10.1038/35096054
   Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360
   Haas TJ, 2007, PLANT CELL, V19, P1295, DOI 10.1105/tpc.106.049346
   Hao MM, 2000, J BIOL CHEM, V275, P15279, DOI 10.1074/jbc.275.20.15279
   HASUMI K, 1992, EUR J BIOCHEM, V205, P841, DOI 10.1111/j.1432-1033.1992.tb16848.x
   Henkel AW, 1996, P NATL ACAD SCI USA, V93, P1918, DOI 10.1073/pnas.93.5.1918
   HESLOPHARRISON J, 1970, STAIN TECHNOL, V45, P115, DOI 10.3109/10520297009085351
   Holstein SEH, 2002, TRAFFIC, V3, P614, DOI 10.1034/j.1600-0854.2002.30903.x
   Jiang LW, 1998, J CELL BIOL, V143, P1183, DOI 10.1083/jcb.143.5.1183
   Jurgens G, 2004, ANNU REV CELL DEV BI, V20, P481, DOI 10.1146/annurev.cellbio.20.082503.103057
   Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973
   Kim DH, 2001, PLANT CELL, V13, P287, DOI 10.1105/tpc.13.2.287
   Kirkham M, 2005, J CELL BIOL, V168, P465, DOI 10.1083/jcb.200407078
   Kotzer AM, 2004, J CELL SCI, V117, P6377, DOI 10.1242/jcs.01564
   KUNZE I, 1995, J PLANT PHYSIOL, V146, P71, DOI 10.1016/S0176-1617(11)81970-X
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Lam SK, 2007, PLANT CELL, V19, P296, DOI 10.1105/tpc.106.045708
   Li YB, 2002, PLANT CELL PHYSIOL, V43, P726, DOI 10.1093/pcp/pcf085
   Luo TC, 2001, J VIROL, V75, P2488, DOI 10.1128/JVI.75.5.2488-2492.2001
   Luzio JP, 2000, J CELL SCI, V113, P1515
   Martin SW, 2005, TRENDS PLANT SCI, V10, P263, DOI 10.1016/j.tplants.2005.04.004
   Marty F, 1999, PLANT CELL, V11, P587, DOI 10.1105/tpc.11.4.587
   Maxfield FR, 2004, NAT REV MOL CELL BIO, V5, P121, DOI 10.1038/nrm1315
   Moscatelli A, 2007, J CELL SCI, V120, P3804, DOI 10.1242/jcs.012138
   Murphy AS, 2005, ANNU REV PLANT BIOL, V56, P221, DOI 10.1146/annurev.arplant.56.032604.144150
   Nebenfuhr A, 2002, PLANT PHYSIOL, V130, P1102, DOI 10.1104/pp.011569
   Nichols BJ, 2001, TRENDS CELL BIOL, V11, P406, DOI 10.1016/S0962-8924(01)02107-9
   Parton RM, 2001, J CELL SCI, V114, P2685
   Pelkmans L, 2003, CURR OPIN CELL BIOL, V15, P414, DOI 10.1016/S0955-0674(03)00081-4
   PESACRETA TC, 1985, PROTOPLASMA, V125, P173, DOI 10.1007/BF01281235
   Prescianotto-Baschong C, 1998, MOL BIOL CELL, V9, P173, DOI 10.1091/mbc.9.1.173
   Ritzenthaler C, 2002, PLANT CELL, V14, P237, DOI 10.1105/tpc.010237
   SAMUELS AL, 1990, J CELL SCI, V97, P157
   Sanderfoot AA, 1998, P NATL ACAD SCI USA, V95, P9920, DOI 10.1073/pnas.95.17.9920
   SatiatJeunemaitre B, 1996, J MICROSC-OXFORD, V181, P162, DOI 10.1046/j.1365-2818.1996.112393.x
   SCHINDLER T, 1994, PLANTA, V192, P404, DOI 10.1007/BF00198577
   Sheff DR, 1999, J CELL BIOL, V145, P123, DOI 10.1083/jcb.145.1.123
   Son O, 2003, PLANT SCI, V165, P1239, DOI 10.1016/S0168-9452(03)00331-5
   Surpin M, 2004, NAT REV MOL CELL BIO, V5, P100, DOI 10.1038/nrm1311
   TANCHAK MA, 1984, PLANTA, V162, P481, DOI 10.1007/BF00399912
   TANCHAK MA, 1988, PLANTA, V175, P433, DOI 10.1007/BF00393062
   THILO L, 1995, J CELL SCI, V108, P1791
   TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350
   Tse YC, 2004, PLANT CELL, V16, P672, DOI 10.1105/tpc.019703
   Tse YC, 2006, PLANT PHYSIOL, V142, P1442, DOI 10.1104/pp.106.090423
   Ueda T, 2004, PLANT J, V40, P783, DOI 10.1111/j.1365-313X.2004.02249.x
   Ueda T, 2001, EMBO J, V20, P4730, DOI 10.1093/emboj/20.17.4730
   Uemura T, 2004, CELL STRUCT FUNCT, V29, P49, DOI 10.1247/csf.29.49
   WILEMAN T, 1985, BIOCHEM J, V262, P19404
   Yamada K, 2005, PLANT J, V41, P888, DOI 10.1111/j.1365-313X.2005.02349.x
NR 67
TC 56
Z9 60
U1 1
U2 27
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0022-0957
EI 1460-2431
J9 J EXP BOT
JI J. Exp. Bot.
PD AUG
PY 2008
VL 59
IS 11
BP 3051
EP 3068
DI 10.1093/jxb/ern154
PG 18
WC Plant Sciences
SC Plant Sciences
GA 335XZ
UT WOS:000258330200013
PM 18603619
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Zinzalla, V
   Hall, MN
AF Zinzalla, Vittoria
   Hall, Michael N.
TI Signal transduction - Linking nutrients to growth
SO NATURE
LA English
DT Editorial Material
ID MAMMALIAN TARGET; AMINO-ACIDS; MTOR; TOR; RAPAMYCIN; YEAST
C1 [Zinzalla, Vittoria; Hall, Michael N.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Zinzalla, V (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM m.hall@unibas.ch
CR Bai XC, 2007, SCIENCE, V318, P977, DOI 10.1126/science.1147379
   Dubouloz F, 2005, MOL CELL, V19, P15, DOI 10.1016/j.molcel.2005.05.020
   Gao MG, 2006, NAT CELL BIOL, V8, P657, DOI 10.1038/ncb1419
   Gulati P, 2008, CELL METAB, V7, P456, DOI 10.1016/j.cmet.2008.03.002
   Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051
   KIM E, 2008, NATURE CELL BIOL
   Long XM, 2005, J BIOL CHEM, V280, P23433, DOI 10.1074/jbc.C500169200
   Patti ME, 2004, NAT MED, V10, P1049, DOI 10.1038/nm1004-1049
   Sancak Y, 2008, SCIENCE, V320, P1496, DOI 10.1126/science.1157535
   Smith EM, 2005, J BIOL CHEM, V280, P18717, DOI 10.1074/jbc.M414499200
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 11
TC 10
Z9 11
U1 0
U2 1
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 0028-0836
J9 NATURE
JI Nature
PD JUL 17
PY 2008
VL 454
IS 7202
BP 287
EP 288
DI 10.1038/454287a
PG 2
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 326ND
UT WOS:000257665300026
PM 18633406
DA 2021-01-25
ER

PT J
AU Owsianowski, E
   Walter, D
   Fahrenkrog, B
AF Owsianowski, Esther
   Walter, David
   Fahrenkrog, Birthe
TI Negative regulation of apoptosis in yeast
SO BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
LA English
DT Review
DE apoptosis; BIR; IAP; ROS; yeast
ID PROGRAMMED CELL-DEATH; MITOCHONDRIAL OUTER-MEMBRANE; DOMAIN-CONTAINING
   PROTEIN; DYNAMIN-RELATED GTPASE; CYTOCHROME-C RELEASE; BCL-2
   FAMILY-MEMBERS; SACCHAROMYCES-CEREVISIAE; SCHIZOSACCHAROMYCES-POMBE;
   FISSION YEAST; OXIDATIVE STRESS
AB In recent years, yeast has been proven to be a useful model organism for studying programmed cell death. It not only exhibits characteristic markets of apoptotic cell death when heterologous inducers of apoptosis are expressed or when treated with apoptosis inducing drugs such as hydrogen peroxide (H2O2) or acetic acid, but contains homologues of several components of the apoptotic machinery identified in mammals, flies and nematodes, such as caspases, apoptosis inducing factor (AIF), Omi/HtrA2 and inhibitor-of-apoptosis proteins (IAPs). In this review, we focus on the role of negative regulators of apoptosis in yeasts. Bir1p is the only IAP protein in Saccharomyces cerevisiae and has long been known to play a role in cell cycle progression by acting as kinetochore and chromosomal passenger protein. Recent data established Bir1p's protective function against programmed cell death induced by H2O2 treatment and in chronological ageing. Other factors that have a direct or indirect influence on intracellular levels of reactive oxygen species (ROS) and thus lead to apoptosis if they are misregulated or non-functional will be discussed. (C) 2008 Elsevier B.V. All rights reserved.
C1 [Owsianowski, Esther; Walter, David; Fahrenkrog, Birthe] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Fahrenkrog, B (corresponding author), Univ Basel, ME Muller Inst Struct Biol, Biozentrum, Klingelberstr 70, CH-4056 Basel, Switzerland.
EM birthe.fahrenkrog@Unibas.ch
RI Walter, David/A-8436-2008; Fahrenkrog, Birthe/D-5840-2011
OI Walter, David/0000-0003-4363-0339; Fahrenkrog,
   Birthe/0000-0003-4080-9413
CR Ahn SH, 2005, CELL, V120, P25, DOI 10.1016/j.cell.2004.11.016
   Ambrosini G, 1997, NAT MED, V3, P917, DOI 10.1038/nm0897-917
   Asai T, 2002, JPN J CANCER RES, V93, P296, DOI 10.1111/j.1349-7006.2002.tb02172.x
   Baek YU, 2004, FEBS LETT, V556, P47, DOI 10.1016/S0014-5793(03)01363-2
   Bartke T, 2004, MOL CELL, V14, P801, DOI 10.1016/j.molcel.2004.05.018
   Bleazard W, 1999, NAT CELL BIOL, V1, P298
   Bouck DC, 2005, P NATL ACAD SCI USA, V102, P5408, DOI 10.1073/pnas.0405925102
   Bounhar Y, 2001, J BIOL CHEM, V276, P39145, DOI 10.1074/jbc.C100443200
   Bounhar Y, 2006, FEMS YEAST RES, V6, P1204, DOI 10.1111/j.1567-1364.2006.00122.x
   Brace JL, 2005, YEAST, V22, P641, DOI 10.1002/yea.1235
   Braun RJ, 2006, J BIOL CHEM, V281, P25757, DOI 10.1074/jbc.M513699200
   Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021
   Cheeseman LM, 2002, CELL, V111, P163, DOI 10.1016/S0092-8674(02)00973-X
   Chen SR, 2003, FREE RADICAL BIO MED, V34, P1315, DOI 10.1016/S0891-5849(03)00146-1
   Cho NC, 2006, CAN J MICROBIOL, V52, P1261, DOI 10.1139/W06-081
   Cory S, 2002, NAT REV CANCER, V2, P647, DOI 10.1038/nrc883
   CROOK NE, 1993, J VIROL, V67, P2168, DOI 10.1128/JVI.67.4.2168-2174.1993
   Danial NN, 2004, CELL, V116, P205, DOI 10.1016/S0092-8674(04)00046-7
   Desagher S, 2000, TRENDS CELL BIOL, V10, P369, DOI 10.1016/S0962-8924(00)01803-1
   Deveraux QL, 1999, GENE DEV, V13, P239, DOI 10.1101/gad.13.3.239
   Drakulic T, 2005, FEMS YEAST RES, V5, P1215, DOI 10.1016/j.femsyr.2005.06.001
   Earnshaw WC, 1999, NATURE, V397, P387, DOI 10.1038/17015
   Fabrizio P, 2004, J CELL BIOL, V166, P1055, DOI 10.1083/jcb.200404002
   Fahrenkrog B, 2004, J CELL SCI, V117, P115, DOI 10.1242/jcs.00848
   Fannjiang Y, 2004, GENE DEV, V18, P2785, DOI 10.1101/gad.1247904
   Frank S, 2001, DEV CELL, V1, P515, DOI 10.1016/S1534-5807(01)00055-7
   Fraser AG, 1999, CURR BIOL, V9, P292, DOI 10.1016/S0960-9822(99)80137-7
   Frohlich KU, 2007, SEMIN CANCER BIOL, V17, P112, DOI 10.1016/j.semcancer.2006.11.006
   Gillis AN, 2005, J CELL BIOL, V171, P773, DOI 10.1083/jcb.200507017
   GONZALEZGARCIA M, 1994, DEVELOPMENT, V120, P3033
   Gourlay CW, 2005, NAT REV MOL CELL BIO, V6, P583, DOI 10.1038/nrm1682
   Gourlay CW, 2004, J CELL BIOL, V164, P803, DOI 10.1083/jcb.200310148
   Guaragnella N, 2008, FEBS LETT, V582, P210, DOI 10.1016/j.febslet.2007.12.007
   HANADA M, 1995, J BIOL CHEM, V270, P11962, DOI 10.1074/jbc.270.20.11962
   Hao YY, 2004, NAT CELL BIOL, V6, P849, DOI 10.1038/ncb1159
   Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025
   Herker E, 2004, J CELL BIOL, V164, P501, DOI 10.1083/jcb.200310014
   Hu SM, 2003, J BIOL CHEM, V278, P10055, DOI 10.1074/jbc.M207197200
   Jagasia R, 2005, NATURE, V433, P754, DOI 10.1038/nature03316
   Jarosch E, 2002, TRAFFIC, V3, P530, DOI 10.1034/j.1600-0854.2002.30803.x
   Jones G, 2000, J BIOL CHEM, V275, P22157, DOI 10.1074/jbc.M000369200
   Jurgensmeier JM, 1997, MOL BIOL CELL, V8, P325
   Kaufmann T, 2003, J CELL BIOL, V160, P53, DOI 10.1083/jcb.200210084
   Kim SJ, 2006, J MICROBIOL, V44, P689
   Kinnally KW, 2007, APOPTOSIS, V12, P857, DOI 10.1007/s10495-007-0722-z
   KISPAL G, 1988, J BIOL CHEM, V263, P11145
   Kissova I, 2006, J BIOL CHEM, V281, P36187, DOI 10.1074/jbc.M607444200
   LAWEN A, 2007, MOL MICROBIOL
   Lee YJ, 2007, MOL BIOL CELL, V18, P3556, DOI 10.1091/mbc.E07-02-0118
   Lens SMA, 2003, EMBO J, V22, P2934, DOI 10.1093/emboj/cdg307
   Li AM, 2005, J BIOL CHEM, V280, P17430, DOI 10.1074/jbc.C500058200
   Li FZ, 2000, J BIOL CHEM, V275, P6707, DOI 10.1074/jbc.275.10.6707
   Liang QL, 2007, MOL BIOL CELL, V18, P4741, DOI 10.1091/mbc.E07-05-0431
   Ligr M, 1998, FEBS LETT, V438, P61, DOI 10.1016/S0014-5793(98)01227-7
   LITHGOW T, 1994, CELL GROWTH DIFFER, V5, P411
   Longo VD, 1997, J CELL BIOL, V137, P1581, DOI 10.1083/jcb.137.7.1581
   Longo VD, 1996, J BIOL CHEM, V271, P12275, DOI 10.1074/jbc.271.21.12275
   Ludovico P, 2002, MOL BIOL CELL, V13, P2598, DOI 10.1091/mbc.E01-12-0161
   Ludovico P, 2001, MICROBIOL-SGM, V147, P2409, DOI 10.1099/00221287-147-9-2409
   Ly JD, 2003, APOPTOSIS, V8, P115, DOI 10.1023/A:1022945107762
   Madeo F, 2002, MOL CELL, V9, P911, DOI 10.1016/S1097-2765(02)00501-4
   Madeo F, 1997, J CELL BIOL, V139, P729, DOI 10.1083/jcb.139.3.729
   Madeo F, 1999, J CELL BIOL, V145, P757, DOI 10.1083/jcb.145.4.757
   Mancini M, 1997, J CELL BIOL, V138, P449, DOI 10.1083/jcb.138.2.449
   Manon S, 1998, J BIOENERG BIOMEMBR, V30, P419, DOI 10.1023/A:1020533928491
   Manon S, 1997, FEBS LETT, V415, P29, DOI 10.1016/S0014-5793(97)01087-9
   Maris AF, 2001, CURR GENET, V39, P137, DOI 10.1007/s002940100194
   MCDONNELL TJ, 1989, CELL, V57, P79, DOI 10.1016/0092-8674(89)90174-8
   Montpetit B, 2006, J CELL BIOL, V174, P653, DOI 10.1083/jcb.200605019
   Morishita J, 2001, GENES CELLS, V6, P743, DOI 10.1046/j.1365-2443.2001.00459.x
   Mozdy AD, 2000, J CELL BIOL, V151, P367, DOI 10.1083/jcb.151.2.367
   Narasimhan ML, 2001, MOL CELL, V8, P921, DOI 10.1016/S1097-2765(01)00365-3
   NGUYEN M, 1993, J BIOL CHEM, V268, P25265
   Okamoto K, 2005, ANNU REV GENET, V39, P503, DOI 10.1146/annurev.genet.38.072902.093019
   Otsuga D, 1998, J CELL BIOL, V143, P333, DOI 10.1083/jcb.143.2.333
   Pereira C, 2007, MOL MICROBIOL, V66, P571, DOI 10.1111/j.1365-2958.2007.05926.x
   Peter ME, 2003, CELL DEATH DIFFER, V10, P26, DOI 10.1038/sj.cdd.4401186
   Phillips AJ, 2003, P NATL ACAD SCI USA, V100, P14327, DOI 10.1073/pnas.2332326100
   Piper PW, 2006, YEAST, V23, P215, DOI 10.1002/yea.1354
   Poliakova D, 2002, MICROBIOL-SGM, V148, P2789, DOI 10.1099/00221287-148-9-2789
   Poon B, 1997, J VIROL, V71, P3961, DOI 10.1128/JVI.71.5.3961-3971.1997
   Rajagopalan S, 1999, FEBS LETT, V460, P187, DOI 10.1016/S0014-5793(99)01329-0
   Rajagopalan S, 2002, GENETICS, V160, P445
   Rajagopalan S, 2006, GENES CELLS, V11, P815, DOI 10.1111/j.1365-2443.2006.00980.x
   Rhoads RE, 1999, J BIOL CHEM, V274, P30337, DOI 10.1074/jbc.274.43.30337
   Riedl SJ, 2004, NAT REV MOL CELL BIO, V5, P897, DOI 10.1038/nrm1496
   Roucou X, 2005, CELL DEATH DIFFER, V12, P783, DOI 10.1038/sj.cdd.4401629
   Roucou X, 2003, J BIOL CHEM, V278, P40877, DOI 10.1074/jbc.M306177200
   Sandall S, 2006, CELL, V127, P1179, DOI 10.1016/j.cell.2006.09.049
   SATO T, 1994, P NATL ACAD SCI USA, V91, P9238, DOI 10.1073/pnas.91.20.9238
   Severin FF, 2002, CURR BIOL, V12, pR233, DOI 10.1016/S0960-9822(02)00776-5
   Shirogane T, 1999, IMMUNITY, V11, P709, DOI 10.1016/S1074-7613(00)80145-4
   Silke J, 2001, J CELL SCI, V114, P1821
   Skoufias DA, 2000, J CELL BIOL, V151, P1575, DOI 10.1083/jcb.151.7.1575
   Somasundaran M, 2002, P NATL ACAD SCI USA, V99, P9503, DOI 10.1073/pnas.142313699
   Suzuki Y, 2001, P NATL ACAD SCI USA, V98, P8662, DOI 10.1073/pnas.161506698
   Temme A, 2003, MOL BIOL CELL, V14, P78, DOI 10.1091/mbc.E02-04-0182
   Temple MD, 2005, TRENDS CELL BIOL, V15, P319, DOI 10.1016/j.tcb.2005.04.003
   Thomas S, 2007, MOL BIOL CELL, V18, P3820, DOI 10.1091/mbc.E07-03-0201
   TODA T, 1991, GENE DEV, V5, P60, DOI 10.1101/gad.5.1.60
   Toone WM, 1998, GENE DEV, V12, P1453, DOI 10.1101/gad.12.10.1453
   Trancikova A, 2004, FEMS YEAST RES, V5, P149, DOI 10.1016/j.femsyr.2004.06.014
   Tsujimoto Y, 2004, CLIN CANCER RES, V10, P3007, DOI 10.1158/1078-0432.CCR-03-0191
   Uren AG, 1998, TRENDS BIOCHEM SCI, V23, P159, DOI 10.1016/S0968-0004(98)01198-0
   Uren AG, 1999, P NATL ACAD SCI USA, V96, P10170, DOI 10.1073/pnas.96.18.10170
   Vander Heiden MG, 2002, J BIOL CHEM, V277, P44870, DOI 10.1074/jbc.M204888200
   VAUX DL, 1988, NATURE, V335, P440, DOI 10.1038/335440a0
   Vaux DL, 2005, NAT REV MOL CELL BIO, V6, P287, DOI 10.1038/nrm1621
   Velot C, 1999, BIOCHEMISTRY-US, V38, P16195, DOI 10.1021/bi991695n
   Verhagen AM, 2001, GENOME BIOL, V2
   Vernooy SY, 2002, CURR BIOL, V12, P1164, DOI 10.1016/S0960-9822(02)00935-1
   Walter D, 2006, J CELL SCI, V119, P1843, DOI 10.1242/jcs.02902
   Widlund PO, 2006, MOL BIOL CELL, V17, P1065, DOI 10.1091/mbc.E05-07-0640
   Wilson R, 2002, NAT CELL BIOL, V4, P445, DOI 10.1038/ncb799
   Wissing S, 2004, J CELL BIOL, V166, P969, DOI 10.1083/jcb.200404138
   Wohlschlegel JA, 2004, J BIOL CHEM, V279, P45662, DOI 10.1074/jbc.M409203200
   Xu QL, 1998, MOL CELL, V1, P337, DOI 10.1016/S1097-2765(00)80034-9
   Yamamoto S, 2005, ANN SURG ONCOL, V12, P925, DOI 10.1245/ASO.2005.07.002
   Yoon HJ, 1999, P NATL ACAD SCI USA, V96, P13208, DOI 10.1073/pnas.96.23.13208
   Zelivianski S, 2006, APOPTOSIS, V11, P377, DOI 10.1007/s10495-006-4030-9
   Zhang L, 2003, BIOCHEM BIOPH RES CO, V307, P308, DOI 10.1016/S0006-291X(03)01168-9
   Zhang Q, 2003, J BIOL CHEM, V278, P47145, DOI 10.1074/jbc.M306998200
   Zhao YQ, 1996, J VIROL, V70, P5821, DOI 10.1128/JVI.70.9.5821-5826.1996
   Zhao YQ, 1998, VIROLOGY, V246, P266, DOI 10.1006/viro.1998.9208
   Zhou WD, 2004, J BIOL CHEM, V279, P32262, DOI 10.1074/jbc.M404173200
   Zischka H, 2006, MOL CELL PROTEOMICS, V5, P2185, DOI 10.1074/mcp.T600018-MCP200
   Zoratti M, 2005, BBA-BIOENERGETICS, V1706, P40, DOI 10.1016/j.bbabio.2004.10.006
NR 127
TC 24
Z9 25
U1 0
U2 7
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 0167-4889
EI 1879-2596
J9 BBA-MOL CELL RES
JI Biochim. Biophys. Acta-Mol. Cell Res.
PD JUL
PY 2008
VL 1783
IS 7
BP 1303
EP 1310
DI 10.1016/j.bbamcr.2008.03.006
PG 8
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 324YM
UT WOS:000257555300005
PM 18406356
DA 2021-01-25
ER

PT J
AU Knechtlet, B
   Schwanke, M
   Knechtle, P
   Kohler, G
AF Knechtlet, B.
   Schwanke, M.
   Knechtle, P.
   Kohler, G.
TI Decrease in body fat during an ultra-endurance triathlon is associated
   with race intensity
SO BRITISH JOURNAL OF SPORTS MEDICINE
LA English
DT Article
ID SKELETAL-MUSCLE MASS; IRONMAN TRIATHLON; WEIGHT CHANGES;
   BIOCHEMICAL-CHANGES; EXERCISE INTENSITY; HYDRATION STATUS;
   ADIPOSE-TISSUE; OXIDATION; PERFORMANCE; METABOLISM
AB Objective: To investigate whether adipose subcutaneous tissue or skeletal muscle mass decreased during a nonstop ultra-endurance triathlon.
   Design: Descriptive field study.
   Setting: The Triple Iron Triathlon Germany 2006 in Lensahn: 11.6 km swimming, 540 km cycling and 126.6 km running.
   Subjects: 17 male Caucasian triathletes, mean (SD) age 39.2 (7.5) years, height 178 (5) cm, body mass 80.7 (8.9) kg and body mass index (BMI) 25.4 (2.4) kg/m(2).
   Interventions: None.
   Main outcome measurements: Determination of body mass, skin-fold thicknesses, limb circumference, skeletal muscle mass and percentage body fat in order to show changes after the race.
   Results: A significant decrease was shown for body mass (p < 0.001), BMI (p < 0.001) and calculated percentage body fat (p < 0.001) whereas skeletal muscle mass did not change significantly (p > 0.05). Circumferences of the thigh, upper arm and calf did not decrease significantly (p > 0.05), whereas all skin-fold thicknesses decreased significantly (p < 0.05), with the exception of those at the chest and thigh. A significant correlation was found between the loss of percentage body fat and the loss of body mass (p < 0.01, r(2) = 0.55) as well as change in percentage body fat with race performance (p < 0.05, r(2) = 0.24).
   Conclusions: Ultra-endurance triathletes at the Triple Iron Triathlon Germany 2006 showed a significant decrease in body mass and percentage body fat, where decrease in percentage body fat was associated with race intensity.
C1 [Knechtlet, B.; Knechtle, P.] Gesundheitszentrum St Gallen, CH-9001 St Gallen, Switzerland.
   [Schwanke, M.] Triple Iron Triathlon Germany, Lensahn, Germany.
   [Kohler, G.] Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
   [Knechtlet, B.] Univ Zurich Hosp, Dept Gen Practice, CH-8091 Zurich, Switzerland.
RP Knechtlet, B (corresponding author), Gesundheitszentrum St Gallen, Vadianstr 26, CH-9001 St Gallen, Switzerland.
EM beat.knechtle@hispeed.ch
CR Achten J, 2003, INT J SPORTS MED, V24, P603, DOI 10.1055/s-2003-43265
   Achten J, 2003, METABOLISM, V52, P747, DOI 10.1016/S0026-0495(03)00068-4
   Achten J, 2002, MED SCI SPORT EXER, V34, P92, DOI 10.1097/00005768-200201000-00015
   ASTRAND P, 1964, J APPL PHYSIOL, V19, P829
   Ball SD, 2004, EUR J CLIN NUTR, V58, P1525, DOI 10.1038/sj.ejcn.1602003
   Bircher S, 2006, J SPORT SCI MED, V5, P154
   Boschmann M, 2002, INT J SPORTS MED, V23, P537, DOI 10.1055/s-2002-35527
   Bulow J, 2006, CLIN PHYSIOL FUNCT I, V26, P205, DOI 10.1111/j.1475-097X.2006.00664.x
   Casey D, 1995, HUM GENOME NEWS, V7, P4
   DAVIDSON RJL, 1987, INT J SPORTS MED, V8, P19, DOI 10.1055/s-2008-1025634
   DAVIES CTM, 1986, J APPL PHYSIOL, V61, P611
   Frykman PN, 2003, WILD ENVIRON MED, V14, P240, DOI 10.1580/1080-6032(2003)14[240:EOAMEE]2.0.CO;2
   Helge JW, 2003, J EXP BIOL, V206, P1075, DOI 10.1242/jeb.00218
   Kavouras SA, 2002, CURR OPIN CLIN NUTR, V5, P519, DOI 10.1097/00075197-200209000-00010
   Knechtle B, 2005, INT J SPORTS MED, V26, P499, DOI 10.1055/s-2004-821136
   Knechtle B, 2004, INT J SPORTS MED, V25, P38, DOI 10.1055/s-2003-45232
   KNECHTLE B, 2008, BRIT J SPORT MED, V42, P21
   Knechtle B, 2007, J SPORT SCI MED, V6, P401
   Lange KHW, 2002, J AM GERIATR SOC, V50, P275, DOI 10.1046/j.1532-5415.2002.50059.x
   Laursen PB, 2006, BRIT J SPORT MED, V40, P320, DOI 10.1136/bjsm.2005.022426
   Lee RC, 2000, AM J CLIN NUTR, V72, P796
   LEHMANN M, 1995, INT J SPORTS MED, V16, P155, DOI 10.1055/s-2007-972984
   Lindemann R, 1978, Am Correct Ther J, V32, P107
   NAGEL D, 1989, EUR J APPL PHYSIOL O, V59, P16, DOI 10.1007/BF02396574
   R Development Core Team, 2005, R LANG ENV STAT COMP
   Raschka C, 1992, Schweiz Z Sportmed, V40, P13
   RASCHKA C, 1991, Z ERNAHRUNGSWISS, V30, P276, DOI 10.1007/BF01651957
   REFSUM HE, 1973, SCAND J CLIN LAB INV, V32, P117, DOI 10.3109/00365517309084338
   Reynolds RD, 1999, J NUTR, V129, P1307
   ROBERTSHAW M, 1993, J MED, V24, P311
   ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380
   Sharwood K, 2002, CLIN J SPORT MED, V12, P391, DOI 10.1097/00042752-200211000-00012
   Sharwood KA, 2004, BRIT J SPORT MED, V38, P718, DOI 10.1136/bjsm.2003.007187
   Speedy DB, 2001, CLIN J SPORT MED, V11, P44, DOI 10.1097/00042752-200101000-00008
   Speedy DB, 1997, CLIN J SPORT MED, V7, P100, DOI 10.1097/00042752-199704000-00005
   Volk O, 2001, DEUT Z SPORTMED, V52, P169
   VOLK O, 1998, SCHWEIZERISCHE Z SPO, V46, P67
   VOLK O, 2002, O J SPORTMED, V4, P18
   VOLK O, 2001, OSTERREICHISCHES J S, V3, P22
   WELLS CL, 1987, MED SCI SPORT EXER, V19, P137
   WHITING PH, 1984, EUR J APPL PHYSIOL O, V52, P183, DOI 10.1007/BF00433390
   Wu HJ, 2004, WORLD J GASTROENTERO, V10, P2711, DOI 10.3748/wjg.v10.i18.2711
NR 42
TC 26
Z9 26
U1 0
U2 2
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0306-3674
J9 BRIT J SPORT MED
JI Br. J. Sports Med.
PD JUL
PY 2008
VL 42
IS 7
BP 609
EP 613
DI 10.1136/bjsm.2007.040956
PG 5
WC Sport Sciences
SC Sport Sciences
GA 322ZE
UT WOS:000257413000012
PM 18048432
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Dyachok, O
   Idevall-Hagren, O
   Sagetorp, J
   Tian, G
   Wuttke, A
   Arrieumerlou, C
   Akusjarvi, G
   Gylfe, E
   Tengholm, A
AF Dyachok, Oleg
   Idevall-Hagren, Olof
   Sagetorp, Jenny
   Tian, Geng
   Wuttke, Anne
   Arrieumerlou, Cecile
   Akusjarvi, Goran
   Gylfe, Erik
   Tengholm, Anders
TI Glucose-induced cyclic AMP oscillations regulate pulsatile insulin
   secretion
SO CELL METABOLISM
LA English
DT Article
ID PANCREATIC BETA-CELLS; PROTEIN-KINASE-A; FREE CA2+; ADENYLATE-CYCLASE;
   CYTOPLASMIC CA2+; ELECTRICAL-ACTIVITY; OXYGEN-CONSUMPTION; MOUSE ISLETS;
   B-CELLS; RELEASE
AB Cyclic AMP (cAMP) and Ca2+ are key regulators of exocytosis in many cells, including insulin-secreting cells. Glucose-stimulated insulin secretion from cells is pulsatile and involves oscillations of the cytoplasmic Ca2+ concentration ([Ca2+](i)), but little is known about the detailed kinetics of cAMP signaling. Using evanescent-wave fluorescence imaging we found that glucose induces pronounced oscillations of cAMP in the submembrane space of single MINIS cells and primary mouse beta cells. These oscillations were preceded and enhanced by elevations of [Ca2+](i). However, conditions raising cytoplasmic ATP could trigger cAMP elevations without accompanying [Ca2+](i) rise, indicating that adenylyl cyclase activity may be controlled also by the substrate concentration. The cAMP oscillations correlated with pulsatile insulin release. Whereas elevation of cAMP enhanced secretion, inhibition of adenylyl cyclases suppressed both cAMP oscillations and pulsatile insulin release. We conclude that cell metabolism directly controls cAMP and that glucose-induced cAMP oscillations regulate the magnitude and kinetics of insulin exocytosis.
C1 [Dyachok, Oleg; Idevall-Hagren, Olof; Sagetorp, Jenny; Tian, Geng; Wuttke, Anne; Gylfe, Erik; Tengholm, Anders] Uppsala Univ, Biomed Ctr, Dept Med Cell Biol, SE-75123 Uppsala, Sweden.
   [Dyachok, Oleg] Kiev T Shevchenko Natl Univ, Dept Biophys, UA-01033 Kiev, Ukraine.
   [Arrieumerlou, Cecile] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Gylfe, Erik] Uppsala Univ, Biomed Ctr, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden.
RP Tengholm, A (corresponding author), Uppsala Univ, Biomed Ctr, Dept Med Cell Biol, Box 571, SE-75123 Uppsala, Sweden.
EM anders.tengholm@mcb.uu.se
RI Dyachok, Oleg/B-5935-2017
OI Gylfe, Erik/0000-0002-8414-2107; ARRIEUMERLOU,
   Cecile/0000-0002-6463-2897
CR AbdelHalim SM, 1996, DIABETES, V45, P934, DOI 10.2337/diabetes.45.7.934
   AMMALA C, 1993, NATURE, V363, P356, DOI 10.1038/363356a0
   Berenjian S, 2006, VIRUS RES, V115, P16, DOI 10.1016/j.virusres.2005.07.001
   BERGSTEN P, 1994, J BIOL CHEM, V269, P8749
   CHARLES MA, 1973, SCIENCE, V179, P569, DOI 10.1126/science.179.4073.569
   CHOW RH, 1995, J PHYSIOL-LONDON, V485, P607, DOI 10.1113/jphysiol.1995.sp020756
   Dachicourt N, 1996, AM J PHYSIOL-ENDOC M, V271, pE725
   DAVIS B, 1972, BIOCHEM J, V129, P373, DOI 10.1042/bj1290373
   Delmeire D, 2003, DIABETOLOGIA, V46, P1383, DOI 10.1007/s00125-003-1203-8
   DESA SS, 1983, Q J EXP PHYSIOL CMS, V68, P247, DOI 10.1113/expphysiol.1983.sp002716
   Dunn TA, 2006, J NEUROSCI, V26, P12807, DOI 10.1523/JNEUROSCI.3238-06.2006
   Dyachok O, 2004, J BIOL CHEM, V279, P45455, DOI 10.1074/jbc.M407673200
   Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410
   Edholm D, 2001, J VIROL, V75, P9579, DOI 10.1128/JVI.75.20.9579-9584.2001
   Eliasson L, 2003, J GEN PHYSIOL, V121, P181, DOI 10.1085/jgp.20028707
   GILON P, 1993, J BIOL CHEM, V268, P22265
   Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835
   GRAPENGIESSER E, 1993, ARCH BIOCHEM BIOPHYS, V300, P372, DOI 10.1006/abbi.1993.1050
   GRILL V, 1973, FEBS LETT, V33, P311, DOI 10.1016/0014-5793(73)80218-2
   GRYNKIEWICZ G, 1985, J BIOL CHEM, V260, P3440
   Haugh JM, 2000, J CELL BIOL, V151, P1269, DOI 10.1083/jcb.151.6.1269
   He TC, 1998, P NATL ACAD SCI USA, V95, P2509, DOI 10.1073/pnas.95.5.2509
   HELLMAN B, 1994, DIABETOLOGIA, V37, pS11, DOI 10.1007/BF00400821
   HELLMAN B, 1974, P NATL ACAD SCI USA, V71, P3405, DOI 10.1073/pnas.71.9.3405
   Henquin JC, 2000, DIABETES, V49, P1751, DOI 10.2337/diabetes.49.11.1751
   IDEVALLHAGREN O, 2006, J BIOL CHEM, V281, P39121
   Jung SK, 2000, J BIOL CHEM, V275, P6642, DOI 10.1074/jbc.275.9.6642
   Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200
   LANG DA, 1981, DIABETES, V30, P435, DOI 10.2337/diabetes.30.5.435
   Lembert N, 1998, DIABETES, V47, P339, DOI 10.2337/diabetes.47.3.339
   Liu YJ, 1998, J PHYSIOL-LONDON, V508, P471, DOI 10.1111/j.1469-7793.1998.471bq.x
   LONGO EA, 1991, J BIOL CHEM, V266, P9314
   Luciani DS, 2006, J PHYSIOL-LONDON, V572, P379, DOI 10.1113/jphysiol.2005.101766
   MIYAZAKI JI, 1990, ENDOCRINOLOGY, V127, P126, DOI 10.1210/endo-127-1-126
   Molin M, 1998, J VIROL, V72, P8358, DOI 10.1128/JVI.72.10.8358-8361.1998
   Molin M, 2000, J VIROL, V74, P9002, DOI 10.1128/JVI.74.19.9002-9009.2000
   Nilsson T, 1996, BIOCHEM J, V314, P91, DOI 10.1042/bj3140091
   PHILIPSON L, 1961, VIROLOGY, V15, P263, DOI 10.1016/0042-6822(61)90357-9
   PRENTKI M, 1987, PHYSIOL REV, V67, P1185
   Pyne NJ, 2003, DIABETOLOGIA, V46, P1179, DOI 10.1007/s00125-003-1176-7
   RABINOVITCH A, 1976, DIABETOLOGIA, V12, P581, DOI 10.1007/BF01220634
   REDDY R, 1995, J BIOL CHEM, V270, P14340, DOI 10.1074/jbc.270.24.14340
   Renstrom E, 1997, J PHYSIOL-LONDON, V502, P105, DOI 10.1111/j.1469-7793.1997.105bl.x
   SCHUIT FC, 1986, SCIENCE, V232, P875, DOI 10.1126/science.2871625
   SCHUIT FC, 1985, ENDOCRINOLOGY, V117, P834, DOI 10.1210/endo-117-3-834
   Schulze DU, 2007, DIABETOLOGIA, V50, P2126, DOI 10.1007/s00125-007-0742-9
   Seino S, 2005, PHYSIOL REV, V85, P1303, DOI 10.1152/physrev.00001.2005
   SHARP GWG, 1979, DIABETOLOGIA, V16, P287, DOI 10.1007/BF01223617
   Takahashi N, 1999, P NATL ACAD SCI USA, V96, P760, DOI 10.1073/pnas.96.2.760
   Tarasov AI, 2006, DIABETES, V55, P2446, DOI 10.2337/db06-0360
   Tengholm A, 1999, J BIOL CHEM, V274, P36883, DOI 10.1074/jbc.274.52.36883
   Tsuboi T, 2003, CURR BIOL, V13, P563, DOI 10.1016/S0960-9822(03)00176-3
   VALDEOLMILLOS M, 1989, FEBS LETT, V259, P19, DOI 10.1016/0014-5793(89)81484-X
   VALVERDE I, 1979, SCIENCE, V206, P225, DOI 10.1126/science.225798
   Westerlund J, 1997, J CLIN INVEST, V100, P2547, DOI 10.1172/JCI119797
   Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812
   WOLLHEIM CB, 1981, PHYSIOL REV, V61, P914
NR 57
TC 129
Z9 131
U1 0
U2 12
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1550-4131
J9 CELL METAB
JI Cell Metab.
PD JUL
PY 2008
VL 8
IS 1
BP 26
EP 37
DI 10.1016/j.cmet.2008.06.003
PG 12
WC Cell Biology; Endocrinology & Metabolism
SC Cell Biology; Endocrinology & Metabolism
GA 321XK
UT WOS:000257339600007
PM 18590690
DA 2021-01-25
ER

PT J
AU Affolter, M
   Pyrowolakis, G
   Weiss, A
   Basler, K
AF Affolter, Markus
   Pyrowolakis, George
   Weiss, Alexander
   Basler, Konrad
TI Signal-induced repression: The exception or the rule in developmental
   signaling?
SO DEVELOPMENTAL CELL
LA English
DT Review
ID TGF-BETA; MORPHOGEN GRADIENT; TRANSCRIPTIONAL REPRESSION; NUCLEAR
   RECEPTORS; DPP TARGETS; DNA-BINDING; C-MYC; DROSOPHILA; CATENIN; GENE
AB Cell-cell communication plays a key role in organ formation and patterning in multicellular animals and is carried out by a few evolutionarily conserved signaling pathways. The modes of action of these pathways share a number of general properties, or habits, that allow them to strongly activate target genes in a ligand-dependent manner in the proper cellular contexts. Recent studies have revealed that some developmental signaling pathways can also strongly repress genes in a ligand-dependent manner. These new findings raise the interesting possibility that this repressive mode of action is shared by many or most developmental signaling pathways.
C1 [Affolter, Markus; Weiss, Alexander] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Pyrowolakis, George] Univ Freiburg, Inst Biol 1, D-79104 Freiburg, Germany.
   [Basler, Konrad] Univ Zurich, Inst Mol Biol, CH-8057 Zurich, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch; basler@molbio.unizh.ch
OI Basler, Konrad/0000-0003-3534-1529; Affolter, Markus/0000-0002-5171-0016
CR Affolter M, 2007, NAT REV GENET, V8, P663, DOI 10.1038/nrg2166
   Alliston T, 2001, EMBO J, V20, P2254, DOI 10.1093/emboj/20.9.2254
   Aranda A, 2001, PHYSIOL REV, V81, P1269
   Arce L, 2006, ONCOGENE, V25, P7492, DOI 10.1038/sj.onc.1210056
   Barker N, 2001, EMBO J, V20, P4935, DOI 10.1093/emboj/20.17.4935
   Barolo S, 2002, GENE DEV, V16, P1167, DOI 10.1101/gad.976502
   Belenkaya TY, 2002, DEVELOPMENT, V129, P4089
   Blauwkamp TA, 2008, EMBO J, V27, P1436, DOI 10.1038/emboj.2008.80
   Brantjes H, 2002, BIOL CHEM, V383, P255, DOI 10.1515/BC.2002.027
   Bray SJ, 2006, NAT REV MOL CELL BIO, V7, P678, DOI 10.1038/nrm2009
   Brunner E, 1997, NATURE, V385, P829, DOI 10.1038/385829a0
   Campbell G, 1999, CELL, V96, P553, DOI 10.1016/S0092-8674(00)80659-5
   Cavallo RA, 1998, NATURE, V395, P604, DOI 10.1038/26982
   Chen CR, 2002, CELL, V110, P19, DOI 10.1016/S0092-8674(02)00801-2
   Cinnamon E, 2004, EMBO J, V23, P4571, DOI 10.1038/sj.emboj.7600457
   Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018
   Cordier F, 2006, J MOL BIOL, V361, P659, DOI 10.1016/j.jmb.2006.06.045
   de las Heras JM, 2006, MECH DEVELOP, V123, P481, DOI 10.1016/j.mod.2006.03.009
   Feng XH, 2005, ANNU REV CELL DEV BI, V21, P659, DOI 10.1146/annurev.cellbio.21.022404.142018
   Frederick JP, 2004, MOL CELL BIOL, V24, P2546, DOI 10.1128/MCB.24.6.2546-2559.2004
   Furriols M, 2003, EMBO J, V22, P1947, DOI 10.1093/emboj/cdg224
   Gabay L, 1996, DEVELOPMENT, V122, P3355
   Gao S, 2005, J BIOL CHEM, V280, P36158, DOI 10.1074/jbc.M506882200
   Gronemeyer H, 2004, NAT REV DRUG DISCOV, V3, P950, DOI 10.1038/nrd1551
   Halfon MS, 2000, CELL, V103, P63, DOI 10.1016/S0092-8674(00)00105-7
   Hasson P, 2001, EMBO J, V20, P5725, DOI 10.1093/emboj/20.20.5725
   Hecht A, 2000, EMBO J, V19, P1839, DOI 10.1093/emboj/19.8.1839
   Hecht A, 1999, J BIOL CHEM, V274, P18017, DOI 10.1074/jbc.274.25.18017
   Hoppler S, 2007, J CELL SCI, V120, P385, DOI 10.1242/jcs.03363
   Houston DW, 2002, DEVELOPMENT, V129, P4015
   Huangfu D, 2006, DEVELOPMENT, V133, P3, DOI 10.1242/dev.02169
   Hurlbut GD, 2007, CURR OPIN CELL BIOL, V19, P166, DOI 10.1016/j.ceb.2007.02.012
   Hurlstone A, 2002, EMBO J, V21, P2303, DOI 10.1093/emboj/21.10.2303
   Jamora C, 2003, NATURE, V422, P317, DOI 10.1038/nature01458
   Jazwinska A, 1999, CELL, V96, P563, DOI 10.1016/S0092-8674(00)80660-1
   Jimenez G, 2000, GENE DEV, V14, P224
   Kang JS, 2005, EMBO J, V24, P2543, DOI 10.1038/sj.emboj.7600729
   Kang YB, 2003, MOL CELL, V11, P915, DOI 10.1016/S1097-2765(03)00109-6
   Kim DW, 2003, MOL CELL BIOL, V23, P8704, DOI 10.1128/MCB.23.23.8704-8717.2003
   Kim S, 2006, J BIOL CHEM, V281, P14066, DOI 10.1074/jbc.M602696200
   Kioussi C, 2002, CELL, V111, P673, DOI 10.1016/S0092-8674(02)01084-X
   Kramps T, 2002, CELL, V109, P47, DOI 10.1016/S0092-8674(02)00679-7
   Lawrence N, 2000, INT J DEV BIOL, V44, P749
   Lazar MA, 2003, J CLIN INVEST, V112, P497, DOI 10.1172/JCI200319479
   Leung TH, 2004, CELL, V118, P453, DOI 10.1016/j.cell.2004.08.007
   Li J, 2008, NAT CELL BIOL, V10, P160, DOI 10.1038/ncb1684
   Liu D, 2004, EMBO J, V23, P1557, DOI 10.1038/sj.emboj.7600179
   Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126
   Luecke HF, 2005, GENE DEV, V19, P1116, DOI 10.1101/gad.1297105
   Massague J, 2005, GENE DEV, V19, P2783, DOI 10.1101/gad.1350705
   Massague J, 2006, FEBS LETT, V580, P2811, DOI 10.1016/j.febslet.2006.04.033
   Minami M, 1999, NATURE, V398, P242, DOI 10.1038/18451
   Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053
   Muller B, 2003, CELL, V113, P221, DOI 10.1016/S0092-8674(03)00241-1
   Nygard M, 2003, MOL ENDOCRINOL, V17, P79, DOI 10.1210/me.2002-0107
   Nygard M, 2006, J MOL ENDOCRINOL, V36, P517, DOI 10.1677/jme.1.01874
   Ogawa S, 2005, CELL, V122, P707, DOI 10.1016/j.cell.2005.06.029
   Olson LE, 2006, CELL, V125, P593, DOI 10.1016/j.cell.2006.02.046
   Parker AB, 1907, YALE LAW J, V17, P1, DOI 10.2307/785833
   Parker DS, 2008, MOL CELL BIOL, V28, P1815, DOI 10.1128/MCB.01230-07
   Parker DS, 2002, DEVELOPMENT, V129, P2565
   Parker L, 2004, PROG MOLEC, V34, P73
   Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680
   Piepenburg O, 2000, MOL CELL, V6, P203, DOI 10.1016/S1097-2765(00)00022-8
   Pyrowolakis G, 2004, DEV CELL, V7, P229, DOI 10.1016/j.devcel.2004.07.008
   PYROWOLAKIS G, 2007, TGF SS FAMILY, P493
   RAFTERY LA, 2006, PROTEINS CELL REGULA, V5, P55
   Roose J, 1999, SCIENCE, V285, P1923, DOI 10.1126/science.285.5435.1923
   Rosenfeld MG, 2006, GENE DEV, V20, P1405, DOI 10.1101/gad.1424806
   Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007
   SAATCIOGLU F, 1993, CELL, V75, P1095, DOI 10.1016/0092-8674(93)90319-L
   Schmierer B, 2007, NAT REV MOL CELL BIO, V8, P970, DOI 10.1038/nrm2297
   Schweizer L, 2003, P NATL ACAD SCI USA, V100, P5846, DOI 10.1073/pnas.1037533100
   Scully KM, 2000, SCIENCE, V290, P1127, DOI 10.1126/science.290.5494.1127
   Shi YG, 1998, CELL, V94, P585, DOI 10.1016/S0092-8674(00)81600-1
   Shitashige M, 2008, CANCER SCI, V99, P631, DOI 10.1111/j.1349-7006.2007.00716.x
   Sivasankaran R, 2000, EMBO J, V19, P6162, DOI 10.1093/emboj/19.22.6162
   Stadeli R, 2006, CURR BIOL, V16, pR378, DOI 10.1016/j.cub.2006.04.019
   Takemaru KI, 2000, J CELL BIOL, V149, P249, DOI 10.1083/jcb.149.2.249
   Theisen H, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000142
   Thompson B, 2002, NAT CELL BIOL, V4, P367, DOI 10.1038/ncb786
   Tootle TL, 2005, BIOESSAYS, V27, P285, DOI 10.1002/bies.20198
   Tran H, 2008, GENE DEV, V22, P528, DOI 10.1101/gad.463208
   Tseng ASK, 2007, CURR BIOL, V17, P728, DOI 10.1016/j.cub.2007.03.023
   vandeWetering M, 1997, CELL, V88, P789, DOI 10.1016/S0092-8674(00)81925-X
   Willert K, 2006, GENE DEV, V20, P1394, DOI 10.1101/gad.1424006
   Winter SE, 2004, DEVELOPMENT, V131, P6071, DOI 10.1242/dev.01538
   Yao LC, 2006, DEVELOPMENT, V133, P4025, DOI 10.1242/dev.02561
NR 88
TC 23
Z9 23
U1 0
U2 2
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1534-5807
EI 1878-1551
J9 DEV CELL
JI Dev. Cell
PD JUL
PY 2008
VL 15
IS 1
BP 11
EP 22
DI 10.1016/j.devcel.2008.06.006
PG 12
WC Cell Biology; Developmental Biology
SC Cell Biology; Developmental Biology
GA 325CU
UT WOS:000257566600006
PM 18606137
DA 2021-01-25
ER

PT J
AU Harder, D
   Stolz, J
   Casagrande, F
   Obrdlik, P
   Weitz, D
   Fotiadis, D
   Daniel, H
AF Harder, Daniel
   Stolz, Juergen
   Casagrande, Fabio
   Obrdlik, Petr
   Weitz, Dietmar
   Fotiadis, Dimitrios
   Daniel, Hannelore
TI DtpB (YhiP) and DtpA (TppB, YdgR) are prototypical proton-dependent
   peptide transporters of Escherichia coli
SO FEBS JOURNAL
LA English
DT Article
DE E. coli; peptide; PTR; TppB; transport
ID DIPEPTIDE-BINDING PROTEIN; SALMONELLA-TYPHIMURIUM; FUNCTIONAL
   RECONSTITUTION; CHARGE TRANSLOCATION; SUBSTRATE AFFINITY;
   LACTOCOCCUS-LACTIS; CYTOCHROME-C; MEMBRANE; SYMPORTER; PERMEASE
AB The genome of Escherichia coli contains four genes assigned to the peptide transporter (PTR) family. Of these, only tppB (ydgR) has been characterized, and named tripeptide permease, whereas protein functions encoded by the yhiP, ybgH and yjdL genes have remained unknown. Here we describe the overexpression of yhiP as a His-tagged fusion protein in E. coli and show saturable transport of glycyl-sarcosine (Gly-Sar) with an apparent affinity constant of 6.5 mm. Overexpression of the gene also increased the susceptibility of cells to the toxic dipeptide alafosfalin. Transport was strongly decreased in the presence of a protonophore but unaffected by sodium depletion, suggesting H(+)-dependence. This was confirmed by purification of YhiP and TppB by nickel affinity chromatography and reconstitution into liposomes. Both transporters showed Gly-Sar influx in the presence of an artificial proton gradient and generated transport currents on a chip-based sensor. Competition experiments established that YhiP transported dipeptides and tripeptides. Western blot analysis revealed an apparent mass of YhiP of 40 kDa. Taken together, these findings show that yhiP encodes a protein that mediates proton-dependent electrogenic transport of dipeptides and tripeptides with similarities to mammalian PEPT1. On the basis of our results, we propose to rename YhiP as DtpB (dipeptide and tripeptide permease B), by analogy with the nomenclature in other bacteria. We also propose to rename TppB as DtpA, to better describe its function as the first protein of the PTR family characterized in E. coli.
C1 [Harder, Daniel; Stolz, Juergen; Weitz, Dietmar; Daniel, Hannelore] Tech Univ Munich, Mol Nutr Unit, D-85350 Freising Weihenstephan, Germany.
   [Casagrande, Fabio; Fotiadis, Dimitrios] Univ Basel, ME Muller Inst Struct Biol, Biozentrum, CH-4003 Basel, Switzerland.
   [Obrdlik, Petr] IonGate Biosci GmbH, Frankfurt, Germany.
RP Daniel, H (corresponding author), Tech Univ Munich, Mol Nutr Unit, Forum 5, D-85350 Freising Weihenstephan, Germany.
EM daniel@wzw.tum.de
RI Daniel, Hannelore/B-8982-2009
OI Harder, Daniel/0000-0003-4226-9748
CR ABOUHAMAD WN, 1991, MOL MICROBIOL, V5, P1035, DOI 10.1111/j.1365-2958.1991.tb01876.x
   Biegel A, 2006, AMINO ACIDS, V31, P137, DOI 10.1007/s00726-006-0331-0
   Bretschneider B, 1999, PHARMACEUT RES, V16, P55, DOI 10.1023/A:1018814627484
   Daley DO, 2005, SCIENCE, V308, P1321, DOI 10.1126/science.1109730
   Daniel H, 2006, PHYSIOLOGY, V21, P93, DOI 10.1152/physiol.00054.2005
   DANIEL H, 1992, J BIOL CHEM, V267, P9565
   Detmers FJM, 2001, RES MICROBIOL, V152, P245, DOI 10.1016/S0923-2508(01)01196-2
   DRIESSEN AJM, 1985, P NATL ACAD SCI USA, V82, P7555, DOI 10.1073/pnas.82.22.7555
   GIBSON MM, 1984, J BACTERIOL, V160, P122, DOI 10.1128/JB.160.1.122-130.1984
   Goh EB, 2004, J BACTERIOL, V186, P4019, DOI 10.1128/JB.186.12.4019-4024.2004
   Hagting A, 1997, BIOCHEMISTRY-US, V36, P6777, DOI 10.1021/bi963068t
   Hagting A, 1997, EUR J BIOCHEM, V247, P581, DOI 10.1111/j.1432-1033.1997.00581.x
   HIGGINS CF, 1986, METHOD ENZYMOL, V125, P365
   Higgins CF, 2001, RES MICROBIOL, V152, P205, DOI 10.1016/S0923-2508(01)01193-7
   HILES ID, 1987, J MOL BIOL, V195, P125, DOI 10.1016/0022-2836(87)90332-9
   JAMIESON DJ, 1984, J BACTERIOL, V160, P131, DOI 10.1128/JB.160.1.131-136.1984
   JAMIESON DJ, 1986, J BACTERIOL, V168, P389, DOI 10.1128/jb.168.1.389-397.1986
   Kelety B, 2006, ASSAY DRUG DEV TECHN, V4, P575, DOI 10.1089/adt.2006.4.575
   Kottra G, 2002, J BIOL CHEM, V277, P32683, DOI 10.1074/jbc.M204192200
   Meyer-Lipp K, 2004, BIOCHEMISTRY-US, V43, P12606, DOI 10.1021/bi0489053
   PAYNE JW, 1994, ADV MICROB PHYSIOL, V36, P1, DOI 10.1016/S0065-2911(08)60176-9
   Payne JW, 2001, BBA-BIOMEMBRANES, V1514, P65, DOI 10.1016/S0005-2736(01)00364-9
   Payne JW, 2000, BIOCHEM BIOPH RES CO, V267, P283, DOI 10.1006/bbrc.1999.1967
   Payne JW, 2000, ARCH BIOCHEM BIOPHYS, V384, P9, DOI 10.1006/abbi.2000.2084
   PAYNE JW, 2001, MICROBIAL TRANSPORT, P139
   Smith MW, 1999, MICROBIOL-SGM, V145, P2891, DOI 10.1099/00221287-145-10-2891
   STEINER HY, 1995, MOL MICROBIOL, V16, P825, DOI 10.1111/j.1365-2958.1995.tb02310.x
   STOLZ J, 1994, PLANT J, V6, P225, DOI 10.1046/j.1365-313X.1994.6020225.x
   Terada T, 2000, PFLUG ARCH EUR J PHY, V440, P679, DOI 10.1007/s004240000339
   Weitz D, 2007, J BIOL CHEM, V282, P2832, DOI 10.1074/jbc.M604866200
   YU CA, 1975, J BIOL CHEM, V250, P1383
   Zuber D, 2005, BBA-BIOENERGETICS, V1709, P240, DOI 10.1016/j.bbabio.2005.07.009
NR 32
TC 30
Z9 32
U1 0
U2 7
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUL
PY 2008
VL 275
IS 13
BP 3290
EP 3298
DI 10.1111/j.1742-4658.2008.06477.x
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 311QF
UT WOS:000256614000003
PM 18485005
OA Bronze
DA 2021-01-25
ER

PT J
AU Nesper, J
   Brosig, A
   Ringler, P
   Patel, GJ
   Muller, SA
   Kleinschmidt, JH
   Boos, W
   Diederichs, K
   Welte, W
AF Nesper, Jutta
   Brosig, Alexander
   Ringler, Philippe
   Patel, Geetika J.
   Mueller, Shirley A.
   Kleinschmidt, Joerg H.
   Boos, Winfried
   Diederichs, Kay
   Welte, Wolfram
TI Omp85(Tt) from Thermus thermophilus HB27: an ancestral type of the omp85
   protein family
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID OUTER-MEMBRANE PROTEIN; BLUE NATIVE ELECTROPHORESIS; BETA-BARREL;
   BIOGENESIS; IDENTIFICATION; LAYER; FHAC; HB8; TRANSPORTERS; EXPRESSION
AB Proteins belonging to the Omp85 family are involved in the assembly of P-barrel outer membrane proteins or in the translocation of proteins across the outer membrane in bacteria, mitochondria, and chloroplasts. The cell envelope of the thermophilic bacterium Thermus thermophilus HB27 is multilayered, including an outer membrane that is not well characterized. Neither the precise lipid composition nor much about integral membrane proteins is known. The genome of HB27 encodes one Omp85-like protein, Omp85(Tt), representing an ancestral type of this family. We overexpressed Omp85(Tt) in T. thermophilus and purified it from the native outer membranes. In the presence of detergent, purified Omp85Tt existed mainly as a monomer, composed of two stable protease-resistant modules. Circular dichroism spectroscopy indicated predominantly R-sheet secondary structure. Electron microscopy of negatively stained lipid-embedded Omp85Tt revealed ring-like structures with a central cavity of similar to 1.5 nm in diameter. Single-channel conductance recordings indicated that Omp85(Tt) forms ion channels with two different conducting states, characterized by conductances of similar to 0.4 nS and similar to 0.65 nS, respectively.
C1 [Nesper, Jutta; Brosig, Alexander; Patel, Geetika J.; Kleinschmidt, Joerg H.; Boos, Winfried; Diederichs, Kay; Welte, Wolfram] Univ Konstanz, Dept Biol, D-78457 Constance, Germany.
   [Ringler, Philippe; Mueller, Shirley A.] Univ Basel, Biozentrum, Maurice E Muller Inst, CH-4056 Basel, Switzerland.
RP Nesper, J (corresponding author), Univ Konstanz, Dept Biol, D-78457 Constance, Germany.
EM Jutta.Nesper@uni-konstanz.de
RI Kleinschmidt, Jorg/B-9918-2011; Kleinschmidt, Jorg H/G-3395-2012
OI Kleinschmidt, Jorg H/0000-0003-0986-334X
CR Abramoff D., 2004, BIOPHOTONICS INT, V11, P36, DOI DOI 10.1117/1.3589100
   Bos MP, 2007, EMBO REP, V8, P1149, DOI 10.1038/sj.embor.7401092
   Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245
   Bredemeier R, 2007, J BIOL CHEM, V282, P1882, DOI 10.1074/jbc.M609598200
   Brouns SJJ, 2005, J BIOL CHEM, V280, P11422, DOI 10.1074/jbc.M413623200
   Bruggemann H, 2006, J BIOTECHNOL, V124, P654, DOI 10.1016/j.jbiotec.2006.03.043
   Castan P, 2001, J BACTERIOL, V183, P1491, DOI 10.1128/JB.183.4.1491-1494.2001
   CASTON JR, 1988, FEMS MICROBIOL LETT, V51, P225, DOI 10.1016/0378-1097(88)90404-1
   CASTON JR, 1993, MOL MICROBIOL, V9, P65, DOI 10.1111/j.1365-2958.1993.tb01669.x
   Cava F, 2004, MOL MICROBIOL, V52, P677, DOI 10.1111/j.1365-2958.2004.04011.x
   Clantin B, 2007, SCIENCE, V317, P957, DOI 10.1126/science.1143860
   COMPTON LA, 1986, ANAL BIOCHEM, V155, P155, DOI 10.1016/0003-2697(86)90241-1
   Ertel F, 2005, J BIOL CHEM, V280, P28281, DOI 10.1074/jbc.M503035200
   FERNANDEZHERRERO LA, 1995, J BACTERIOL, V177, P5460, DOI 10.1128/jb.177.19.5460-5466.1995
   Gentle IE, 2005, MOL MICROBIOL, V58, P1216, DOI 10.1111/j.1365-2958.2005.04906.x
   GRIMBERG J, 1989, NUCLEIC ACIDS RES, V17, P8893, DOI 10.1093/nar/17.21.8893
   Guedin S, 2000, J BIOL CHEM, V275, P30202, DOI 10.1074/jbc.M005515200
   Gupta RS, 2000, CRIT REV MICROBIOL, V26, P111, DOI 10.1080/10408410091154219
   Habib SJ, 2007, J CELL BIOL, V176, P77, DOI 10.1083/jcb.200602050
   Henne A, 2004, NAT BIOTECHNOL, V22, P547, DOI 10.1038/nbt956
   Heuberger EHML, 2002, J MOL BIOL, V317, P591, DOI 10.1006/jmbi.2002.5416
   Hinnah SC, 1997, EMBO J, V16, P7351, DOI 10.1093/emboj/16.24.7351
   Jacob-Dubuisson F, 2001, MOL MICROBIOL, V40, P306, DOI 10.1046/j.1365-2958.2001.02278.x
   Kim S, 2007, SCIENCE, V317, P961, DOI 10.1126/science.1143993
   Kozjak V, 2003, J BIOL CHEM, V278, P48520, DOI 10.1074/jbc.C300442200
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   Leone S, 2006, GLYCOBIOLOGY, V16, P766, DOI 10.1093/glycob/cwj120
   Li HL, 2007, J BACTERIOL, V189, P7497, DOI 10.1128/JB.00541-07
   LOWRY OH, 1951, J BIOL CHEM, V193, P265
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Maier E, 2001, J BACTERIOL, V183, P800, DOI 10.1128/JB.183.2.800-803.2001
   MATHER MW, 1992, APPL ENVIRON MICROB, V58, P421, DOI 10.1128/AEM.58.1.421-425.1992
   Meli AC, 2006, J BIOL CHEM, V281, P158, DOI 10.1074/jbc.M508524200
   Moreno R, 2005, APPL ENVIRON MICROB, V71, P591, DOI 10.1128/AEM.71.1.591-593.2005
   Moreno R, 2003, PLASMID, V49, P2, DOI 10.1016/S0147-619X(02)00146-4
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Paschen SA, 2003, NATURE, V426, P862, DOI 10.1038/nature02208
   Pocanschi CL, 2006, J MOL BIOL, V355, P548, DOI 10.1016/j.jmb.2005.10.060
   QUINTELA JC, 1995, J BACTERIOL, V177, P4947, DOI 10.1128/jb.177.17.4947-4962.1995
   Rigaud JL, 1997, J STRUCT BIOL, V118, P226, DOI 10.1006/jsbi.1997.3848
   Robert V, 2006, PLOS BIOL, V4, P1984, DOI 10.1371/journal.pbio.0040377
   Rumszauer J, 2006, FEBS J, V273, P3261, DOI 10.1111/j.1742-4658.2006.05335.x
   Sambrook J, 1989, MOL CLONING LAB MANU
   Sanchez-Pulido L, 2003, TRENDS BIOCHEM SCI, V28, P523, DOI 10.1016/j.tibs.2003.08.003
   SCHAGGER H, 1991, ANAL BIOCHEM, V199, P223, DOI 10.1016/0003-2697(91)90094-A
   Schleiff E, 2005, EMBO REP, V6, P1023, DOI 10.1038/sj.embor.7400563
   Schultz J, 1998, P NATL ACAD SCI USA, V95, P5857, DOI 10.1073/pnas.95.11.5857
   Shanmugavadivu B, 2007, J MOL BIOL, V368, P66, DOI 10.1016/j.jmb.2007.01.066
   SMITH PK, 1985, ANAL BIOCHEM, V150, P76, DOI 10.1016/0003-2697(85)90442-7
   Stothard P, 2005, NUCLEIC ACIDS RES, V33, pD317, DOI 10.1093/nar/gki075
   Voulhoux R, 2003, SCIENCE, V299, P262, DOI 10.1126/science.1078973
   Wittig I, 2006, NAT PROTOC, V1, P418, DOI 10.1038/nprot.2006.62
   Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015
NR 53
TC 23
Z9 23
U1 0
U2 1
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD JUL
PY 2008
VL 190
IS 13
BP 4568
EP 4575
DI 10.1128/JB.00369-08
PG 8
WC Microbiology
SC Microbiology
GA 319OW
UT WOS:000257174400022
PM 18456816
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Clements, J
   Lu, Z
   Gehring, WJ
   Meinertzhagen, IA
   Callaerts, P
AF Clements, Jason
   Lu, Zhiyuan
   Gehring, Walter J.
   Meinertzhagen, Ian A.
   Callaerts, Patrick
TI Central projections of photoreceptor axons originating from ectopic eyes
   in Drosophila
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
ID PERIPHERAL PIONEER NEURONS; DEVELOPING VISUAL-SYSTEM; RETINAL AXONS;
   TARGETED EXPRESSION; IMAGINAL DISKS; OPTIC NEUROPIL; PATHWAYS; GENE;
   DACHSHUND; GUIDANCE
AB Ectopic expression of the retinal determination gene eyeless (ey) induces the formation of supernumerary eyes on antennae, legs, wings, and halteres. These ectopic eyes form ommatidia that contain photoreceptors and accessory cells and respond to light. Here, we demonstrate that ectopic eyes on antennae and legs extend axonal projections to the central nervous system. Furthermore, electroretinograms and morphological evidence indicate that the photoreceptor axons of at least the antennal ectopic eyes can form completely constituted ectopic synapses with foreign postsynaptic elements and suggest that transmission at these sites may be functional. However, the ectopic axons do not connect to their correct optic lobe targets and do not project deeply into the neuropile, but rather form synapses at superficial positions in the neuropils. By means of confocal and electron microscopy we show that these ectopic synapses resemble normal synapses, albeit with some distinct morphological differences. Our data strongly suggest that the developmental programs controlling photoreceptor synaptogenesis and visual map formation depend to a considerable extent on presynaptic and thus photoreceptor-autonomous steps. Our data also suggest that photoreceptor axon projections and the establishment of the highly stereotypical neural circuitry in the optic lobe, the normal target neuropil, may depend on target-specific cues that appear to be absent from the antennal lobe and thoracic ganglion.
C1 [Gehring, Walter J.] Univ Basel, Dept Cell & Dev Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Clements, Jason; Callaerts, Patrick] Vlaams Inst Biotechnol, Lab Dev Genet, B-3000 Leuven, Belgium.
   [Clements, Jason; Callaerts, Patrick] Katholieke Univ Leuven, Ctr Human Genet, B-3000 Leuven, Belgium.
   [Lu, Zhiyuan; Meinertzhagen, Ian A.] Dalhousie Univ, Inst Neurosci, Halifax, NS B3H 4J1, Canada.
   [Lu, Zhiyuan; Meinertzhagen, Ian A.] Dalhousie Univ, Dept Psychol, Halifax, NS B3H 4J1, Canada.
RP Gehring, WJ (corresponding author), Univ Basel, Dept Cell & Dev Biol, Biozentrum, CH-4056 Basel, Switzerland.
EM walter.gehring@unibas.ch; patrick.callaerts@med.kuleuven.be
RI Callaerts, Patrick/I-8118-2013
OI Clements, Jason/0000-0002-8901-784X; Meinertzhagen,
   Ian/0000-0002-6578-4526
FU NEI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01
   EY003592, EY-03592] Funding Source: Medline; NATIONAL EYE
   INSTITUTEUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI)
   [R01EY003592, R01EY003592, R01EY003592, R01EY003592, R01EY003592,
   R01EY003592, R01EY003592, R01EY003592, R01EY003592, R01EY003592,
   R01EY003592, R01EY003592, R01EY003592, R01EY003592, R01EY003592,
   R01EY003592, R01EY003592, R01EY003592, R01EY003592, R01EY003592,
   R01EY003592, R01EY003592, R01EY003592, R01EY003592, R01EY003592,
   R01EY003592, R01EY003592, R01EY003592, R01EY003592] Funding Source: NIH
   RePORTER
CR BATE CM, 1976, NATURE, V260, P54, DOI 10.1038/260054a0
   BENTLEY D, 1982, SCIENCE, V218, P1082, DOI 10.1126/science.218.4577.1082
   BERLOT J, 1984, SCIENCE, V223, P493, DOI 10.1126/science.223.4635.493
   BLAIR SS, 1987, J NEUROSCI, V7, P4165
   Bonini NM, 1997, DEVELOPMENT, V124, P4819
   Callaerts P, 2006, ARTHROPOD STRUCT DEV, V35, P379, DOI 10.1016/j.asd.2006.09.002
   CAPDEVILA J, 1994, EMBO J, V13, P4459, DOI 10.1002/j.1460-2075.1994.tb06768.x
   Chen R, 1997, CELL, V91, P893, DOI 10.1016/S0092-8674(00)80481-X
   COOMBE PE, 1986, J COMP PHYSIOL A, V159, P655, DOI 10.1007/BF00612038
   Dearborn R, 2004, DEVELOPMENT, V131, P2291, DOI 10.1242/dev.01111
   EICHENBAUM DM, 1968, J EXP ZOOL, V169, P15, DOI 10.1002/jez.1401690104
   Frankfort BJ, 2002, DEVELOPMENT, V129, P1295
   FROHLICH A, 1985, J COMP NEUROL, V241, P311, DOI 10.1002/cne.902410306
   FROHLICH A, 1982, J NEUROCYTOL, V11, P159, DOI 10.1007/BF01258010
   FROHLICH A, 1983, J NEUROSCI, V3, P2336
   GRAHAM RC, 1966, J HISTOCHEM CYTOCHEM, V14, P291, DOI 10.1177/14.4.291
   HALDER G, 1995, SCIENCE, V267, P1788, DOI 10.1126/science.7892602
   HAY BA, 1994, DEVELOPMENT, V120, P2121
   HEISENBERG M, 1971, J EXP BIOL, V55, P85
   Hiesinger PR, 2006, CURR BIOL, V16, P1835, DOI 10.1016/j.cub.2006.07.047
   Huang Z, 1996, CELL, V86, P411, DOI 10.1016/S0092-8674(00)80114-2
   Huang Z, 1998, CELL, V95, P693, DOI 10.1016/S0092-8674(00)81639-6
   Huang Z, 1998, DEVELOPMENT, V125, P3753
   JAN YN, 1985, J NEUROSCI, V5, P2453
   KESHISHIAN H, 1983, DEV BIOL, V96, P116, DOI 10.1016/0012-1606(83)90316-0
   KUNES S, 1993, J NEUROSCI, V13, P752
   Larsen CW, 2003, DEVELOPMENT, V130, P5625, DOI 10.1242/dev.00867
   MARCEY DJ, 1985, DEV BIOL, V107, P180, DOI 10.1016/0012-1606(85)90386-0
   MARDON G, 1994, DEVELOPMENT, V120, P3473
   Mast JD, 2006, SEMIN CELL DEV BIOL, V17, P42, DOI 10.1016/j.semcdb.2005.11.004
   MEINERTZHAGEN IA, 1991, J COMP NEUROL, V305, P232, DOI 10.1002/cne.903050206
   Meinertzhagen Ian A., 1993, P1363
   MURRAY MA, 1984, DEV BIOL, V104, P259, DOI 10.1016/0012-1606(84)90082-4
   NARDI JB, 1983, DEV BIOL, V95, P163, DOI 10.1016/0012-1606(83)90015-5
   PAK WL, 1969, NATURE, V222, P351, DOI 10.1038/222351a0
   Pan D, 1998, P NATL ACAD SCI USA, V95, P15508, DOI 10.1073/pnas.95.26.15508
   Pappu K, 2002, RES PRO CEL, V37, P5
   Pignoni F, 1997, CELL, V91, P881, DOI 10.1016/S0092-8674(00)80480-8
   Poeck B, 2001, NEURON, V29, P99, DOI 10.1016/S0896-6273(01)00183-0
   Prokop A, 2006, SEMIN CELL DEV BIOL, V17, P20, DOI 10.1016/j.semcdb.2005.11.010
   SELLECK SB, 1992, NATURE, V355, P253, DOI 10.1038/355253a0
   Shen WP, 1997, DEVELOPMENT, V124, P45
   Shepherd D, 1996, DEVELOPMENT, V122, P2375
   Silver SJ, 2005, DEVELOPMENT, V132, P3, DOI 10.1242/dev.01539
   SIVASUBRAMANIAN P, 1980, EXPERIENTIA, V36, P993, DOI 10.1007/BF01953841
   STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585
   STARK WS, 1986, CELL TISSUE RES, V246, P481, DOI 10.1007/BF00215187
   TAKEMURA S, 2008, J COMP NEUR IN PRESS
   TIX S, 1989, DEVELOPMENT, V105, P739
   TIX S, 1989, DEVELOPMENT, V107, P855
   Treisman JE, 1998, CURR TOP DEV BIOL, V39, P119, DOI 10.1016/S0070-2153(08)60454-8
   TRUJILLOCENOZ O, 1975, NATURWISSENSCHAFTEN, V62, P42, DOI 10.1007/BF00594052
   VANVACTOR D, 1988, CELL, V52, P281, DOI 10.1016/0092-8674(88)90517-X
   Wagh DA, 2006, NEURON, V49, P833, DOI 10.1016/j.neuron.2006.02.008
   Wolff Tanya, 1993, P1277
NR 55
TC 13
Z9 14
U1 0
U2 2
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JUL 1
PY 2008
VL 105
IS 26
BP 8968
EP 8973
DI 10.1073/pnas.0803254105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 322DC
UT WOS:000257354400031
PM 18577588
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Affolter, M
   Slattery, M
   Mann, RS
AF Affolter, Markus
   Slattery, Matthew
   Mann, Richard S.
TI A lexicon for homeodomain-DNA recognition
SO CELL
LA English
DT Editorial Material
ID HOX; PROTEIN
AB Decoding the cis-regulatory logic of eukaryotic genomes requires knowledge of the DNA-binding specificities of all transcription factors. New work (Berger et al., 2008; Noyes et al., 2008) provides individual specificities for nearly all Drosophila and mouse homeodomains, key DNA-binding domains in many transcription factors. The data underscore the complexity of determining target specificities in vivo.
C1 [Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Slattery, Matthew; Mann, Richard S.] Columbia Univ, Dept Biochem & Mol Biophys, New York, NY 10032 USA.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM markus.affolter@unibas.ch; rsm10@columbia.edu
OI Affolter, Markus/0000-0002-5171-0016
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM054510,
   R01GM054510, R01GM054510, R01GM054510, R01GM054510, R01GM054510,
   R01GM054510, R01GM054510, R01GM054510, R01GM054510, R01GM054510,
   R01GM054510, R01GM054510, R01GM054510, R01GM054510, R01GM054510,
   R01GM054510, R01GM054510, R01GM054510, R01GM054510, R01GM054510] Funding
   Source: NIH RePORTER; NIGMS NIH HHSUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute of General Medical Sciences (NIGMS) [R01 GM054510] Funding
   Source: Medline
CR Berkes CA, 2004, MOL CELL, V14, P465, DOI 10.1016/S1097-2765(04)00260-6
   Galant R, 2002, DEVELOPMENT, V129, P3115
   GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5
   Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024
   Levine M, 2003, NATURE, V424, P147, DOI 10.1038/nature01763
   Mann RS, 1998, CURR OPIN GENET DEV, V8, P423, DOI 10.1016/S0959-437X(98)80113-5
   Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032
   Warren CL, 2006, P NATL ACAD SCI USA, V103, P867, DOI 10.1073/pnas.0509843102
NR 8
TC 21
Z9 21
U1 0
U2 1
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD JUN 27
PY 2008
VL 133
IS 7
BP 1133
EP 1135
DI 10.1016/j.cell.2008.06.008
PG 3
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 319DP
UT WOS:000257144600007
PM 18585344
DA 2021-01-25
ER

PT J
AU Vajpai, N
   Strauss, A
   Fendrich, G
   Cowan-Jacob, SW
   Manley, PW
   Grzesiek, S
   Jahnke, W
AF Vajpai, Navratna
   Strauss, Andre
   Fendrich, Gabriele
   Cowan-Jacob, Sandra W.
   Manley, Paul W.
   Grzesiek, Stephan
   Jahnke, Wolfgang
TI Solution conformations and dynamics of ABL kinase-inhibitor complexes
   determined by NMR substantiate the different binding modes of
   imatinib/nilotinib and dasatinib
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID CHRONIC MYELOGENOUS LEUKEMIA; RECEPTOR TYROSINE KINASES; CHRONIC
   MYELOID-LEUKEMIA; INFECTED INSECT CELLS; BCR-ABL; STRUCTURAL BASIS;
   SELECTIVE INHIBITOR; STI-571 INHIBITION; CRYSTAL-STRUCTURES; C-ABL
AB Current structural understanding of kinases is largely based on x-ray crystallographic studies, whereas very little data exist on the conformations and dynamics that kinases adopt in the solution state. ABL kinase is an important drug target in the treatment of chronic myelogenous leukemia. Here, we present the first characterization of ABL kinase in complex with three clinical inhibitors (imatinib, nilotinib, and dasatinib) by modern solution NMR techniques. Structural and dynamical results were derived from complete backbone resonance assignments, experimental residual dipolar couplings, and N-15 relaxation data. Residual dipolar coupling data on the imatinib and nilotinib complexes show that the activation loop adopts the inactive conformation, whereas the dasatinib complex preserves the active conformation, which does not support contrary predictions based upon molecular modeling. Nanosecond as well as microsecond dynamics can be detected for certain residues in the activation loop in the inactive and active conformation complexes.
C1 [Vajpai, Navratna; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Strauss, Andre; Fendrich, Gabriele; Cowan-Jacob, Sandra W.; Manley, Paul W.; Jahnke, Wolfgang] Novartis Inst Biomed Res, CH-4002 Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch; wolfgang.jahnke@novartis.com
OI Grzesiek, Stephan/0000-0003-1998-4225
CR Cowan-Jacob SW, 2007, ACTA CRYSTALLOGR D, V63, P80, DOI 10.1107/S0907444906047287
   Cowan-Jacob SW, 2004, MINI-REV MED CHEM, V4, P285, DOI 10.2174/1389557043487321
   Cowan-Jacob SW, 2005, STRUCTURE, V13, P861, DOI 10.1016/j.str.2005.03.012
   Das J, 2006, J MED CHEM, V49, P6819, DOI 10.1021/jm060727j
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dosset P, 2000, J BIOMOL NMR, V16, P23, DOI 10.1023/A:1008305808620
   Druker BJ, 2006, NEW ENGL J MED, V355, P2408, DOI 10.1056/NEJMoa062867
   Eisenmesser EZ, 2005, NATURE, V438, P117, DOI 10.1038/nature04105
   Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7
   GRZESIEK S, 1993, J BIOMOL NMR, V3, P185
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   HUBBARD SR, 1994, NATURE, V372, P746, DOI 10.1038/372746a0
   Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655
   Kraker AJ, 2000, BIOCHEM PHARMACOL, V60, P885, DOI 10.1016/S0006-2952(00)00405-6
   Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144
   LIPARI G, 1982, J AM CHEM SOC, V104, P4546, DOI 10.1021/ja00381a009
   Manley PW, 2002, EUR J CANCER, V38, pS19, DOI 10.1016/S0959-8049(02)80599-8
   Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147
   Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200
   Nagar B, 2002, CANCER RES, V62, P4236
   Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6
   Ottiger M, 1998, J MAGN RESON, V131, P373, DOI 10.1006/jmre.1998.1361
   Pargellis C, 2002, NAT STRUCT BIOL, V9, P268, DOI 10.1038/nsb770
   Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938
   Seeliger MA, 2007, STRUCTURE, V15, P299, DOI 10.1016/j.str.2007.01.015
   Strauss A, 2005, J BIOMOL NMR, V31, P343, DOI 10.1007/s10858-005-2451-3
   Strauss A, 2003, J BIOMOL NMR, V26, P367, DOI 10.1023/A:1024013111478
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187
   VAJPAI N, 2008, BIOMOL NMR ASSIGN
   Verkhivker GA, 2007, BIOPOLYMERS, V85, P333, DOI 10.1002/bip.20656
   Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770
   Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6
   Weisberg E, 2006, BRIT J CANCER, V94, P1765, DOI 10.1038/sj.bjc.6603170
   Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007
   Wiesner S, 2006, EMBO J, V25, P4686, DOI 10.1038/sj.emboj.7601315
   Wisniewski D, 2002, CANCER RES, V62, P4244
   Wissing J, 2004, MOL CELL PROTEOMICS, V3, P1181, DOI 10.1074/mcp.M400124-MCP200
   Young MA, 2006, CANCER RES, V66, P1007, DOI 10.1158/0008-5472.CAN-05-2788
NR 43
TC 146
Z9 146
U1 1
U2 29
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JUN 27
PY 2008
VL 283
IS 26
BP 18292
EP 18302
DI 10.1074/jbc.M801337200
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 316KU
UT WOS:000256949200057
PM 18434310
OA Bronze
DA 2021-01-25
ER

PT J
AU Affolter, M
   Caussinus, E
AF Affolter, Markus
   Caussinus, Emmanuel
TI Tracheal branching morphogenesis in Drosophila: new insights into cell
   behaviour and organ architecture
SO DEVELOPMENT
LA English
DT Review
ID EPITHELIAL TUBE MORPHOGENESIS; GENETIC-CONTROL; VASCULAR DEVELOPMENT;
   IN-VIVO; MOLECULAR-MECHANISMS; ZEBRAFISH EMBRYO; DUAL FUNCTION; MOUSE
   LUNG; FGF; SYSTEM
AB Our understanding of the molecular control of morphological processes has increased tremendously over recent years through the development and use of high resolution in vivo imaging approaches, which have enabled cell behaviour to be linked to molecular functions. Here we review how such approaches have furthered our understanding of tracheal branching morphogenesis in Drosophila, during which the control of cell invagination, migration, competition and rearrangement is accompanied by the sequential secretion and resorption of proteins into the apical luminal space, a vital step in the elaboration of the trachea's complex tubular network. We also discuss the similarities and differences between flies and vertebrates in branched organ formation that are becoming apparent from these studies.
C1 [Affolter, Markus; Caussinus, Emmanuel] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Affolter, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Markus.Affolter@unibas.ch
OI Affolter, Markus/0000-0002-5171-0016
CR Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0
   Affolter M, 2000, CURR OPIN CELL BIOL, V12, P731, DOI 10.1016/S0955-0674(00)00160-5
   Araujo SJ, 2005, DEV BIOL, V288, P179, DOI 10.1016/j.ydbio.2005.09.031
   Baer MM, 2007, GENETICS, V176, P2279, DOI 10.1534/genetics.107.074088
   Behr M, 2007, NAT CELL BIOL, V9, P847, DOI 10.1038/ncb1611
   Beitel GJ, 2000, DEVELOPMENT, V127, P3271
   Bellusci S, 1997, DEVELOPMENT, V124, P4867
   Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038
   Borghese L, 2006, DEV CELL, V10, P497, DOI 10.1016/j.devcel.2006.02.004
   Brodu V, 2006, GENE DEV, V20, P1817, DOI 10.1101/gad.375706
   Cabernard C, 2005, DEV CELL, V9, P831, DOI 10.1016/j.devcel.2005.10.008
   Cardoso WV, 2006, DEVELOPMENT, V133, P1611, DOI 10.1242/dev.02310
   Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653
   Casanova J, 2007, EMBO REP, V8, P335, DOI 10.1038/sj.embor.7400942
   Cela C, 2006, DEVELOPMENT, V133, P3115, DOI 10.1242/dev.02482
   Chanut-Delalande H, 2007, GENETICS, V176, P2177, DOI 10.1534/genetics.107.073890
   Chihara T, 2003, DEVELOPMENT, V130, P1419, DOI 10.1242/dev.00361
   Childs S, 2002, DEVELOPMENT, V129, P973
   Costantini F, 2006, DIFFERENTIATION, V74, P402, DOI 10.1111/j.1432-0436.2006.00106.x
   Dammai V, 2003, GENE DEV, V17, P2812, DOI 10.1101/gad.1096903
   De Moerlooze L, 2000, DEVELOPMENT, V127, P483
   Devine WP, 2005, P NATL ACAD SCI USA, V102, P17014, DOI 10.1073/pnas.0506676102
   Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669
   Gerhardt H, 2003, J CELL BIOL, V161, P1163, DOI 10.1083/jcb.200302047
   Ghabrial A, 2003, ANNU REV CELL DEV BI, V19, P623, DOI 10.1146/annurev.cellbio.19.031403.160043
   Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829
   Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184
   Guillemin K, 1996, DEVELOPMENT, V122, P1353
   Hacohen N, 1998, CELL, V92, P253, DOI 10.1016/S0092-8674(00)80919-8
   Hogan BLM, 2002, NAT REV GENET, V3, P513, DOI 10.1038/nrg840
   Ikeya T, 1999, DEVELOPMENT, V126, P4455
   Imam F, 1999, GENETICS, V152, P307
   Jarecki J, 1999, CELL, V99, P211, DOI 10.1016/S0092-8674(00)81652-9
   Jazwinska A, 2003, NAT CELL BIOL, V5, P895, DOI 10.1038/ncb1049
   Jiang L, 2007, DEV BIOL, V311, P487, DOI 10.1016/j.ydbio.2007.08.049
   Jovine L, 2005, ANNU REV BIOCHEM, V74, P83, DOI 10.1146/annurev.biochem.74.082803.133039
   Jung AC, 2006, CURR BIOL, V16, P1224, DOI 10.1016/j.cub.2006.04.048
   Kakihara K, 2008, MECH DEVELOP, V125, P325, DOI 10.1016/j.mod.2007.10.012
   Kamei M, 2004, METHOD CELL BIOL, V76, P51
   Kamei M, 2005, ZEBRAFISH, V2, P113, DOI 10.1089/zeb.2005.2.113
   Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923
   KLAMBT C, 1992, GENE DEV, V6, P1668, DOI 10.1101/gad.6.9.1668
   Kondo T, 2007, NAT CELL BIOL, V9, P660, DOI 10.1038/ncb1595
   Kuhnlein RP, 1996, DEVELOPMENT, V122, P2215
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Lee S, 2002, DEVELOPMENT, V129, P1509
   Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244
   Levi BP, 2006, DEVELOPMENT, V133, P2383, DOI 10.1242/dev.02404
   Llimargas M, 1999, DEVELOPMENT, V126, P2355
   Lu PF, 2006, J MAMMARY GLAND BIOL, V11, P213, DOI 10.1007/s10911-006-9027-z
   Lu XW, 2004, NATURE, V432, P179, DOI 10.1038/nature03080
   Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204
   Luschnig S, 2006, CURR BIOL, V16, P186, DOI 10.1016/j.cub.2005.11.072
   Matusek T, 2006, DEVELOPMENT, V133, P957, DOI 10.1242/dev.02266
   Moussian B, 2006, DEVELOPMENT, V133, P163, DOI 10.1242/dev.02177
   Neumann M, 2006, EMBO REP, V7, P36, DOI 10.1038/sj.embor.7400597
   Nishimura M, 2007, DEVELOPMENT, V134, P4273, DOI 10.1242/dev.010397
   Nogawa H, 1998, DEV DYNAM, V213, P228, DOI 10.1002/(SICI)1097-0177(199810)213:2<228::AID-AJA8>3.0.CO;2-I
   Park WY, 1998, DEV BIOL, V201, P125, DOI 10.1006/dbio.1998.8994
   Petit V, 2004, MOL CELL BIOL, V24, P3769, DOI 10.1128/MCB.24.9.3769-3781.2004
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Ribeiro C, 2002, DEV CELL, V2, P677, DOI 10.1016/S1534-5807(02)00171-5
   Roca C, 2007, GENE DEV, V21, P2511, DOI 10.1101/gad.1589207
   Samakovlis C, 1996, DEVELOPMENT, V122, P3531
   Samakovlis C, 1996, DEVELOPMENT, V122, P1395
   Sato M, 2002, DEV CELL, V3, P195, DOI 10.1016/S1534-5807(02)00202-2
   Sekine K, 1999, NAT GENET, V21, P138, DOI 10.1038/5096
   Shakya R, 2005, DEV CELL, V8, P65, DOI 10.1016/j.devcel.2004.11.008
   Shindo M, 2008, DEVELOPMENT, V135, P1355, DOI 10.1242/dev.015982
   Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577
   Steneberg P, 1999, MECH DEVELOP, V87, P153, DOI 10.1016/S0925-4773(99)00157-4
   Suchting S, 2006, EXP CELL RES, V312, P668, DOI 10.1016/j.yexcr.2005.11.009
   Sutherland D, 1996, CELL, V87, P1091, DOI 10.1016/S0092-8674(00)81803-6
   Swanson LE, 2006, CURR BIOL, V16, pR51, DOI 10.1016/j.cub.2006.01.008
   Tanaka H, 2004, DEV BIOL, V274, P413, DOI 10.1016/j.ydbio.2004.07.035
   TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697
   Tonning A, 2005, DEV CELL, V9, P423, DOI 10.1016/j.devcel.2005.07.012
   Tsarouhas V, 2007, DEV CELL, V13, P214, DOI 10.1016/j.devcel.2007.06.008
   Tucker AS, 2007, SEMIN CELL DEV BIOL, V18, P237, DOI 10.1016/j.semcdb.2007.01.006
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Vincent S, 1998, MOL CELL, V2, P515, DOI 10.1016/S1097-2765(00)80151-3
   Wang SQ, 2006, CURR BIOL, V16, P180, DOI 10.1016/j.cub.2005.11.074
   Warburton D, 2005, PEDIATR RES, V57, p26R, DOI 10.1203/01.PDR.0000159570.01327.ED
   Weinstein BM, 2002, SEMIN CELL DEV BIOL, V13, P515, DOI 10.1016/S1084952102001052
   Wilk R, 1996, GENE DEV, V10, P93, DOI 10.1101/gad.10.1.93
   Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6
   Wilson R, 2004, MOL CELL BIOL, V24, P2263, DOI 10.1128/MCB.24.6.2263-2276.2004
   Yan D, 2007, DEV BIOL, V312, P203, DOI 10.1016/j.ydbio.2007.09.015
   Zelzer E, 2000, BIOESSAYS, V22, P219, DOI 10.1002/(SICI)1521-1878(200003)22:3<219::AID-BIES3>3.0.CO;2-A
NR 90
TC 108
Z9 109
U1 0
U2 10
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0950-1991
J9 DEVELOPMENT
JI Development
PD JUN 15
PY 2008
VL 135
IS 12
BP 2055
EP 2064
DI 10.1242/dev.014498
PG 10
WC Developmental Biology
SC Developmental Biology
GA 305FM
UT WOS:000256163200001
PM 18480161
OA Bronze
DA 2021-01-25
ER

PT J
AU Vajpai, N
   Strauss, A
   Fendrich, G
   Cowan-Jacob, SW
   Manley, PW
   Jahnke, W
   Grzesiek, S
AF Vajpai, Navratna
   Strauss, Andre
   Fendrich, Gabriele
   Cowan-Jacob, Sandra W.
   Manley, Paul W.
   Jahnke, Wolfgang
   Grzesiek, Stephan
TI Backbone NMR resonance assignment of the Abelson kinase domain in
   complex with imatinib
SO BIOMOLECULAR NMR ASSIGNMENTS
LA English
DT Article
DE tyrosine kinases; Glivec; BCR-ABL; chronic myelogenous leukemia;
   selective labeling
ID CHRONIC MYELOGENOUS LEUKEMIA; INFECTED INSECT CELLS; ABL
AB Imatinib (Glivec or Gleevec) potently inhibits the tyrosine kinase activity of BCR-ABL, a constitutively activated kinase, which causes chronic myelogenous leukemia (CML). Here we report the first almost complete backbone assignment of c-ABL kinase domain in complex with imatinib.
C1 [Vajpai, Navratna; Grzesiek, Stephan] Univ Basel, Biozentrum, Basel, Switzerland.
   [Strauss, Andre; Fendrich, Gabriele; Cowan-Jacob, Sandra W.; Manley, Paul W.; Jahnke, Wolfgang] Novartis Inst Biomed Res, Basel, Switzerland.
RP Grzesiek, S (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, Basel, Switzerland.
EM wolfgang.jahnke@novartis.com; stephan.grzesiek@unibas.ch
OI Grzesiek, Stephan/0000-0003-1998-4225
FU SNF [31-109712]; Novartis Pharma AG
FX We would like to thank Drs. Sonja Alexandra Dames and Martin Allan for
   their help during the initial phase of the project. This work was
   supported by SNF grant 31-109712 (S.G.) and Novartis Pharma AG.
CR Cowan-Jacob SW, 2007, ACTA CRYSTALLOGR D, V63, P80, DOI 10.1107/S0907444906047287
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610
   GRZESIEK S, 1992, J MAGN RESON, V96, P432, DOI 10.1016/0022-2364(92)90099-S
   JOHNSON BA, 1994, J BIOMOL NMR, V4, P603, DOI 10.1007/BF00404272
   Nagar B, 2002, CANCER RES, V62, P4236
   Pervushin K, 1997, P NATL ACAD SCI USA, V94, P12366, DOI 10.1073/pnas.94.23.12366
   Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567
   Strauss A, 2005, J BIOMOL NMR, V31, P343, DOI 10.1007/s10858-005-2451-3
   Strauss A, 2003, J BIOMOL NMR, V26, P367, DOI 10.1023/A:1024013111478
NR 10
TC 21
Z9 21
U1 0
U2 4
PU SPRINGER
PI DORDRECHT
PA VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS
SN 1874-2718
J9 BIOMOL NMR ASSIGM
JI Biomol. NMR Assign.
PD JUN
PY 2008
VL 2
IS 1
BP 41
EP 42
DI 10.1007/s12104-008-9079-7
PG 2
WC Biophysics; Spectroscopy
SC Biophysics; Spectroscopy
GA 341OC
UT WOS:000258722800011
PM 19636920
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Pieters, J
AF Pieters, Jean
TI Mycobacterium tuberculosis and the macrophage: Maintaining a balance
SO CELL HOST & MICROBE
LA English
DT Review
ID PROTEIN-KINASE-G; PHAGOSOME MATURATION; PATHOGENIC MYCOBACTERIA;
   VIRULENCE FACTOR; IMMUNE CONTROL; NITRIC-OXIDE; IFN-GAMMA; PERSISTENCE;
   MEMBRANE; SURVIVAL
AB Mycobacterium tuberculosis is a highly efficient pathogen, killing millions of infected people annually. The capacity of M. tuberculosis to survive and cause disease is strongly correlated to their ability to escape immune defense mechanisms. In particular, M. tuberculosis has the remarkable capacity to survive within the hostile environment of the macrophage. Understanding M. tuberculosis virulence strategies will not only define novel targets for drug development but will also help to uncover previously unknown signaling pathways related to the host's response to M. tuberculosis infection.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
CR Abdallah AM, 2007, NAT REV MICROBIOL, V5, P883, DOI 10.1038/nrmicro1773
   ADAMS DO, 1984, ANNU REV IMMUNOL, V2, P283, DOI 10.1146/annurev.immunol.2.1.283
   Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   AMIGORENA S, 1994, NATURE, V369, P113, DOI 10.1038/369113a0
   ARMSTRONG JA, 1975, J EXP MED, V142, P1, DOI 10.1084/jem.142.1.1
   Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0
   Bach H, 2008, CELL HOST MICROBE, V3, P316, DOI 10.1016/j.chom.2008.03.008
   Bartlett JG, 2007, J INFECT DIS, V196, pS124, DOI 10.1086/518668
   Bentrup KHZ, 2001, TRENDS MICROBIOL, V9, P597, DOI 10.1016/S0966-842X(01)02238-7
   Birkeland HCG, 2004, CURR TOP MICROBIOL, V282, P89
   Blander JM, 2006, NAT IMMUNOL, V7, P1029, DOI 10.1038/ni1006-1029
   Bogdan C, 2006, TRENDS IMMUNOL, V27, P282, DOI 10.1016/j.it.2006.04.004
   BRENNAN PJ, 1995, ANNU REV BIOCHEM, V64, P29, DOI 10.1146/annurev.bi.64.070195.000333
   Cambi A, 2005, CELL MICROBIOL, V7, P481, DOI 10.1111/j.1462-5822.2005.00506.x
   Caron E, 1998, SCIENCE, V282, P1717, DOI 10.1126/science.282.5394.1717
   Champion PAD, 2007, CELL MICROBIOL, V9, P1376, DOI 10.1111/j.1462-5822.2007.00943.x
   Chan J, 2004, CLIN IMMUNOL, V110, P2, DOI 10.1016/S1521-6616(03)00210-9
   CHAN J, 1991, INFECT IMMUN, V59, P1755, DOI 10.1128/IAI.59.5.1755-1761.1991
   Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006
   Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159
   Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033
   Cousin MA, 2001, TRENDS NEUROSCI, V24, P659, DOI 10.1016/S0166-2236(00)01930-5
   Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x
   Dannenberg AM, 2003, TUBERCULOSIS, V83, P251, DOI 10.1016/S1472-9792(03)00048-9
   Darwin KH, 2003, SCIENCE, V302, P1963, DOI 10.1126/science.1091176
   de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7
   De Libero G, 2005, NAT REV IMMUNOL, V5, P485, DOI 10.1038/nri1631
   Dheda K, 2005, J INFECT DIS, V192, P1201, DOI 10.1086/444545
   Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677
   Ernst JD, 1998, INFECT IMMUN, V66, P1277, DOI 10.1128/IAI.66.4.1277-1281.1998
   Feng CG, 2004, J IMMUNOL, V172, P1163, DOI 10.4049/jimmunol.172.2.1163
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Flynn JL, 2003, CURR OPIN IMMUNOL, V15, P450, DOI 10.1016/S0952-7915(03)00075-X
   Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93
   Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100
   Fremond CM, 2004, J CLIN INVEST, V114, P1790, DOI 10.1172/JCI200421027
   Gao LY, 2004, MOL MICROBIOL, V53, P1677, DOI 10.1111/j.1365-2958.2004.04261.x
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   Glickman MS, 2000, MOL CELL, V5, P717, DOI 10.1016/S1097-2765(00)80250-6
   GORDON S, 1994, IMMUNOBIOLOGY, V191, P369, DOI 10.1016/S0171-2985(11)80442-0
   Greenberg S, 1999, ADV CELL MOL BIOL ME, V5, P149, DOI 10.1016/S1874-5172(99)80031-5
   Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645
   Gruenberg J, 2004, NAT REV MOL CELL BIO, V5, P317, DOI 10.1038/nrm1360
   Grundner C, 2005, STRUCTURE, V13, P1625, DOI 10.1016/j.str.2005.07.017
   Guinn KM, 2004, MOL MICROBIOL, V51, P359, DOI 10.1046/j.1365-2958.2003.03844.x
   Hasan Z, 1997, MOL MICROBIOL, V24, P545, DOI 10.1046/j.1365-2958.1997.3591731.x
   Haucke V, 2007, CURR OPIN CELL BIOL, V19, P426, DOI 10.1016/j.ceb.2007.06.003
   Hill AVS, 1998, ANNU REV IMMUNOL, V16, P593, DOI 10.1146/annurev.immunol.16.1.593
   Hisert KB, 2004, INFECT IMMUN, V72, P5315, DOI 10.1128/IAI.72.9.5315-5321.2004
   Hsu T, 2003, P NATL ACAD SCI USA, V100, P12420, DOI 10.1073/pnas.1635213100
   Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9
   Itoh T, 2002, CELL SIGNAL, V14, P733, DOI 10.1016/S0898-6568(02)00028-1
   Jayachandran R, 2008, MOL BIOL CELL, V19, P1241, DOI 10.1091/mbc.E07-07-0640
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Jordao L, 2008, CELL MICROBIOL, V10, P529, DOI 10.1111/j.1462-5822.2007.01067.x
   Jouanguy E, 1999, CURR OPIN IMMUNOL, V11, P346, DOI 10.1016/S0952-7915(99)80055-7
   Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646
   Kaufmann SHE, 2001, NAT REV IMMUNOL, V1, P20, DOI 10.1038/35095558
   KAUFMANN SHE, 1993, ANNU REV IMMUNOL, V11, P129, DOI 10.1146/annurev.iy.11.040193.001021
   Knutson KL, 1998, J BIOL CHEM, V273, P645, DOI 10.1074/jbc.273.1.645
   Li ZM, 1998, J INFECT DIS, V177, P1030, DOI 10.1086/515254
   Liu PT, 2007, J IMMUNOL, V179, P2060, DOI 10.4049/jimmunol.179.4.2060
   Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933
   MacMicking J, 1997, ANNU REV IMMUNOL, V15, P323, DOI 10.1146/annurev.immunol.15.1.323
   MacMicking JD, 2005, CURR OPIN MICROBIOL, V8, P74, DOI 10.1016/j.mib.2004.12.012
   MacMicking JD, 1997, P NATL ACAD SCI USA, V94, P5243, DOI 10.1073/pnas.94.10.5243
   MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063
   Majlessi L, 2007, J IMMUNOL, V179, P1825, DOI 10.4049/jimmunol.179.3.1825
   Makinoshima H, 2005, NATURE, V436, P406, DOI 10.1038/nature03713
   Martens S, 2006, ANNU REV CELL DEV BI, V22, P559, DOI 10.1146/annurev.cellbio.22.010305.104619
   MCDONOUGH KA, 1993, INFECT IMMUN, V61, P2763, DOI 10.1128/IAI.61.7.2763-2773.1993
   McLaughlin B, 2007, PLOS PATHOG, V3, P1051, DOI 10.1371/journal.ppat.0030105
   Mellman I, 1996, ANNU REV CELL DEV BI, V12, P575, DOI 10.1146/annurev.cellbio.12.1.575
   MERDZHITOV R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI DOI 10.1016/50952-7915(98)80024-1
   Morgan A, 2004, CURR BIOL, V14, pR968, DOI 10.1016/j.cub.2004.10.045
   Mueller P, 2008, NAT IMMUNOL, V9, P424, DOI 10.1038/ni1570
   Munoz-Elias EJ, 2005, NAT MED, V11, P638, DOI 10.1038/nm1252
   Mwandumba HC, 2004, J IMMUNOL, V172, P4592, DOI 10.4049/jimmunol.172.7.4592
   Nathan C, 2006, SCIENCE, V312, P1874
   Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005
   Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009
   Niebisch A, 2006, J BIOL CHEM, V281, P12300, DOI 10.1074/jbc.M512515200
   Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920
   Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105
   Pearce MJ, 2006, EMBO J, V25, P5423, DOI 10.1038/sj.emboj.7601405
   Peyron P, 2000, J IMMUNOL, V165, P5186, DOI 10.4049/jimmunol.165.9.5186
   Pieters J, 2003, SCIENCE, V302, P1900, DOI 10.1126/science.1092873
   Pieters J, 1997, CURR OPIN IMMUNOL, V9, P89, DOI 10.1016/S0952-7915(97)80164-1
   PIETERS J, 2008, CORONIN 1 INNATE IMM
   PIETERS J, 2008, HDB TUBERCULOSIS MOL
   Roth MG, 2004, PHYSIOL REV, V84, P699, DOI 10.1152/physrev.00033.2003
   Rothman JE, 1996, SCIENCE, V272, P227, DOI 10.1126/science.272.5259.227
   Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034
   Saleh MT, 2000, J BACTERIOL, V182, P6850, DOI 10.1128/JB.182.23.6850-6853.2000
   Saunders BM, 2007, IMMUNOL CELL BIOL, V85, P103, DOI 10.1038/sj.icb.7100027
   Schekman R W, 1994, Harvey Lect, V90, P41
   Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104
   Schmid SL, 1997, ANNU REV BIOCHEM, V66, P511, DOI 10.1146/annurev.biochem.66.1.511
   Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577
   Stenger S, 2005, ANN RHEUM DIS, V64, P24, DOI 10.1136/ard.2005.042531
   Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183
   Takeda K, 2003, ANNU REV IMMUNOL, V21, P335, DOI 10.1146/annurev.immunol.21.120601.141126
   TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0
   Turner KM, 1999, TRENDS NEUROSCI, V22, P459, DOI 10.1016/S0166-2236(99)01436-8
   Uetrecht AC, 2006, TRENDS CELL BIOL, V16, P421, DOI 10.1016/j.tcb.2006.06.002
   van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059
   Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102
   Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   Warner DF, 2006, CLIN MICROBIOL REV, V19, P558, DOI 10.1128/CMR.00060-05
   WEST MA, 1994, NATURE, V369, P147, DOI 10.1038/369147a0
   *WHO, 2007, 2007 TUB FACTS
   Winslow MM, 2003, CURR OPIN IMMUNOL, V15, P299, DOI 10.1016/S0952-7915(03)00050-5
   Wolf PR, 1995, ANNU REV CELL DEV BI, V11, P267, DOI 10.1146/annurev.cb.11.110195.001411
   Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129
   Yew WW, 2008, AM J RESP CRIT CARE, V177, P479, DOI 10.1164/rccm.200710-1561UP
   Young D, 2002, NAT IMMUNOL, V3, P1026, DOI 10.1038/ni1102-1026
   Zasloff M, 2006, NAT MED, V12, P388, DOI 10.1038/nm0406-388
NR 119
TC 273
Z9 288
U1 0
U2 62
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD JUN
PY 2008
VL 3
IS 6
BP 399
EP 407
DI 10.1016/j.chom.2008.05.006
PG 9
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 316GE
UT WOS:000256936600010
PM 18541216
DA 2021-01-25
ER

PT J
AU Lim, RYH
   Fahrenkrog, B
   Deng, J
   Kapinos, L
   Koeser, J
   Aebi, U
AF Lim, R. Y. H.
   Fahrenkrog, B.
   Deng, J.
   Kapinos, L.
   Koeser, J.
   Aebi, U.
TI Tinkering with a cellular nanomachine by a minimalist approach
SO FEBS JOURNAL
LA English
DT Meeting Abstract
CT Joint Conference of the 33rd FEBS Congress/11th IUBMB Conference
CY JUN 28-JUL 03, 2008
CL Athens, GREECE
C1 [Lim, R. Y. H.; Fahrenkrog, B.; Kapinos, L.; Koeser, J.; Aebi, U.] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Basel, Switzerland.
   [Deng, J.] Inst Mat Res & Engn, Singapore, Singapore.
CR LIM, 2006, CURR OPIN CELL BIOL, V18, P1
   LIM, 2007, SCIENCE, V318, P640
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
NR 3
TC 0
Z9 0
U1 0
U2 1
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1742-464X
J9 FEBS J
JI FEBS J.
PD JUN
PY 2008
VL 275
SU 1
BP 7
EP 7
PG 1
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 311XI
UT WOS:000256633300023
DA 2021-01-25
ER

PT J
AU Knechtle, P
   Kaufmann, A
   Cavicchioli, D
   Philippsen, P
AF Knechtle, Philipp
   Kaufmann, Andreas
   Cavicchioli, Daniele
   Philippsen, Peter
TI The Paxillin-like protein AgPxl1 is required for apical branching and
   maximal hyphal growth in A-gossypii
SO FUNGAL GENETICS AND BIOLOGY
LA English
DT Article
DE maturation; filamentous fungi; Paxillin; PAK; development
ID SACCHAROMYCES-CEREVISIAE; ASHBYA-GOSSYPII; GENE; MORPHOGENESIS;
   RESISTANCE; SEPTATION; SEQUENCE; POLARITY; LESSONS; GENOME
AB The development from young, slowly growing hyphae to fast growing hyphae in filamentous fungi is referred to as hyphal maturation. We have identified the Paxillin-like protein AgPxl1 in Ashbya gossypii as a developmental protein that is specifically required for hyphal maturation. The early development of A. gossypii strains lacking AgPxl1 is indistinguishable from wild-type. However, at later developmental stages the maximal hyphal extension rate is less than half compared to wild-type and apical branching is affected. Apical branching is characterised as the symmetric division of fast growing hyphal tips resulting in two sister hyphae. In Agpxl1 A strains two thirds of the apical branching events lead to asymmetric sister hyphae where growth of one branch is either completely aborted or slowed down while extension of the other branch is not affected. This suggests that AgPxl1 plays a role in the organisation of growth and efficient division of growth upon apical branching in mature mycelia. The conserved C-terminal LIM domains are necessary for AgPxl1 function and also contribute to tip localisation. AgCLA4, a PAK-like kinase, is epistatic to AgPXL1 and robust localisation of AgPxl1 depends on AgCla4. This suggests that AgCla4 acts upstream of AgPxl1. (c) 2008 Elsevier Inc. All rights reserved.
C1 [Knechtle, Philipp; Kaufmann, Andreas; Cavicchioli, Daniele; Philippsen, Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Philippsen, P (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM peter.philippsen@unibas.ch
OI Knechtle, Philipp/0000-0003-0377-9446
CR AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Ayad-Durieux Y, 2000, J CELL SCI, V113, P4563
   Bach I, 2000, MECH DEVELOP, V91, P5, DOI 10.1016/S0925-4773(99)00314-7
   Berman J, 2002, NAT REV GENET, V3, P918, DOI 10.1038/nrg948
   Bistis GN, 2003, FUNGAL GENET NEWSL, V50, P17, DOI DOI 10.4148/1941-4765.1154
   Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004
   Brown MC, 2004, PHYSIOL REV, V84, P1315, DOI 10.1152/physrev.00002.2004
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Ellis J, 2006, PLANT CELL, V18, P523, DOI 10.1105/tpc.105.040584
   ESSER K, 2006, MYCOTA
   FREYD G, 1990, NATURE, V344, P876, DOI 10.1038/344876a0
   Gancedo JM, 2001, FEMS MICROBIOL REV, V25, P107, DOI 10.1111/j.1574-6976.2001.tb00573.x
   Gao XD, 2004, MOL BIOL CELL, V15, P3977, DOI 10.1091/mbc.E04-01-0079
   Gattiker A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-9
   Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B
   GOW NAR, 1982, J GEN MICROBIOL, V128, P2187
   Heinrich M, 2007, EUKARYOT CELL, V6, P317, DOI 10.1128/EC.00102-06
   KATZ D, 1972, J BACTERIOL, V109, P1097, DOI 10.1128/JB.109.3.1097-1100.1972
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   Knechtle P, 2006, EUKARYOT CELL, V5, P1635, DOI 10.1128/EC.00210-06
   Lengeler KB, 2000, MICROBIOL MOL BIOL R, V64, P746, DOI 10.1128/MMBR.64.4.746-785.2000
   Mackin NA, 2004, MOL BIOL CELL, V15, P1904, DOI 10.1091/mbc.E04-01-0004
   Philippsen P, 2005, CURR OPIN MICROBIOL, V8, P370, DOI 10.1016/j.mib.2005.06.021
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Schmitz HP, 2006, MOL BIOL CELL, V17, P130
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tumbarello DA, 2002, FEBS LETT, V513, P114, DOI 10.1016/S0014-5793(01)03244-6
   Weiss EL, 2000, NAT CELL BIOL, V2, P677, DOI 10.1038/35036300
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Wendland J, 2005, NAT REV MICROBIOL, V3, P421, DOI 10.1038/nrmicro1148
   Wendland J, 2002, FUNGAL GENET BIOL, V37, P81, DOI 10.1016/S1087-1845(02)00034-8
   Wendland J, 2001, GENETICS, V157, P601
NR 32
TC 10
Z9 10
U1 0
U2 2
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1087-1845
EI 1096-0937
J9 FUNGAL GENET BIOL
JI Fungal Genet. Biol.
PD JUN
PY 2008
VL 45
IS 6
BP 829
EP 838
DI 10.1016/j.fgb.2008.03.010
PG 10
WC Genetics & Heredity; Mycology
SC Genetics & Heredity; Mycology
GA 307KL
UT WOS:000256317700005
PM 18448364
DA 2021-01-25
ER

PT J
AU Vaupotic, T
   Veranic, P
   Jenoe, P
   Plemenitas, A
AF Vaupotic, Tomaz
   Veranic, Peter
   Jenoe, Paul
   Plemenitas, Ana
TI Mitochondrial mediation of environmental osmolytes discrimination during
   osmoadaptation in the extremely halotolerant black yeast Hortaea
   werneckii
SO FUNGAL GENETICS AND BIOLOGY
LA English
DT Article
DE osmoadaptation; dothideales; ecology; extremophiles; metabolism;
   mitochondria; ATPase; proteome; 14-3-3
ID SACCHAROMYCES-CEREVISIAE; OXIDATIVE STRESS; OSMOTIC-STRESS; WHOLE
   GENOMES; PROTEIN; PATHWAY; SALINITY; GENES; IDENTIFICATION; BIOSYNTHESIS
AB We have investigated the mitochondrial responses to hyperosmotic environments of ionic (4.5 M NaCl) and non-ionic (3.0 M sorbitol) osmolytes in the most halo/osmo-tolerant black yeast, Hortaea werneckii. Adaptation to both types of osmolytes resulted in differential expression of mitochondria-related genes. Live-cell imaging has revealed a condensation of mitochondria in hyperosmotic media that depends on osmolyte type. In the hypersaline medium, this was accompanied by increased ATP synthesis and oxidative damage protection, whereas adaptation to the non-ionic osmolyte resulted in a decrease in ATP synthesis and lipid peroxidation level in mitochondria. A proteomic study of the mitochondria revealed preferential accumulation of energy metabolism enzymes in the hypersaline medium, and accumulation of protein chaperones in the non-ionic osmolyte. The HwBmh1/14-3-3 protein, localized to mitochondria in hypersaline conditions, and not at optimal salinity, suggesting its role in differential perception of ionic and non-ionic osmolytes in H. werneckii. (c) 2008 Elsevier Inc. All rights reserved.
C1 [Vaupotic, Tomaz; Plemenitas, Ana] Univ Ljubljana, Fac Med, Inst Biochem, SI-1000 Ljubljana, Slovenia.
   [Veranic, Peter] Univ Ljubljana, Fac Med, Inst Cell Biol, SI-1000 Ljubljana, Slovenia.
   [Jenoe, Paul] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Plemenitas, A (corresponding author), Univ Ljubljana, Fac Med, Inst Biochem, Vrazov Trg 2, SI-1000 Ljubljana, Slovenia.
EM ana.plemenitas@mf.uni-lj.si
CR Bagnat M, 2000, P NATL ACAD SCI USA, V97, P3254, DOI 10.1073/pnas.060034697
   Behm-Ansmant I, 2004, J BIOL CHEM, V279, P52998, DOI 10.1074/jbc.M409581200
   BOWMAN EJ, 1988, METHOD ENZYMOL, V157, P562
   Bunney TD, 2001, P NATL ACAD SCI USA, V98, P4249, DOI 10.1073/pnas.061437498
   Cleves AE, 1996, J CELL BIOL, V133, P1017, DOI 10.1083/jcb.133.5.1017
   Coelho PSR, 2002, GENE DEV, V16, P2755, DOI 10.1101/gad.1035002
   de Nadal E, 2002, EMBO REP, V3, P735, DOI 10.1093/embo-reports/kvf158
   Desmyter L, 2007, BIOGERONTOLOGY, V8, P527, DOI 10.1007/s10522-007-9095-5
   Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n
   Gorjan A, 2006, FEMS MICROBIOL LETT, V265, P41, DOI 10.1111/j.1574-6968.2006.00473.x
   Green DR, 2004, SCIENCE, V305, P626, DOI 10.1126/science.1099320
   Gunde-Cimerman N, 2000, FEMS MICROBIOL ECOL, V32, P235
   Hohmann S, 2002, MICROBIOL MOL BIOL R, V66, P300, DOI 10.1128/MMBR.66.2.300-372.2002
   Iborra FJ, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-9
   Ichimura T, 2004, BIOCHEMISTRY-US, V43, P6149, DOI 10.1021/bi035421i
   Jensen RE, 2005, CURR OPIN CELL BIOL, V17, P384, DOI 10.1016/j.ceb.2005.06.011
   KLEIMENOVA N N, 1976, Byulleten' Eksperimental'noi Biologii i Meditsiny, V81, P37
   Kogej T, 2005, APPL ENVIRON MICROB, V71, P6600, DOI 10.1128/AEM.71.11.6600-6605.2005
   Kogej T, 2006, MYCOL RES, V110, P713, DOI 10.1016/j.mycres.2006.01.014
   Lenassi Metka, 2007, Saline Syst, V3, P3, DOI 10.1186/1746-1448-3-3
   Li JX, 2003, MOL CELL PROTEOMICS, V2, P1198, DOI 10.1074/mcp.M300070-MCP200
   Liska AJ, 2004, PLANT PHYSIOL, V136, P2806, DOI 10.1104/pp.104.039438
   Liu ZC, 2006, ANNU REV GENET, V40, P159, DOI 10.1146/annurev.genet.40.110405.090613
   Mashkevich G, 1997, J BIOL CHEM, V272, P14356, DOI 10.1074/jbc.272.22.14356
   Mewes HW, 2006, NUCLEIC ACIDS RES, V34, pD169, DOI 10.1093/nar/gkj148
   Mewes HW, 2002, NUCLEIC ACIDS RES, V30, P31, DOI 10.1093/nar/30.1.31
   Moller IM, 2001, ANNU REV PLANT PHYS, V52, P561, DOI 10.1146/annurev.arplant.52.1.561
   Neupert W, 1997, ANNU REV BIOCHEM, V66, P863, DOI 10.1146/annurev.biochem.66.1.863
   Newmeyer DD, 2003, CELL, V112, P481, DOI 10.1016/S0092-8674(03)00116-8
   Norbeck J, 1997, J BIOL CHEM, V272, P5544, DOI 10.1074/jbc.272.9.5544
   OHKAWA H, 1979, ANAL BIOCHEM, V95, P351, DOI 10.1016/0003-2697(79)90738-3
   Ohlmeier S, 2004, J BIOL CHEM, V279, P3956, DOI 10.1074/jbc.M310160200
   Petrovic U, 2002, MOL MICROBIOL, V45, P665, DOI 10.1046/j.1365-2958.2002.03021.x
   Petrovic U, 1999, FEMS MICROBIOL LETT, V180, P325, DOI 10.1111/j.1574-6968.1999.tb08813.x
   Petrovic U, 2006, FEMS YEAST RES, V6, P816, DOI 10.1111/j.1567-1364.2006.00063.x
   Rebrikov DV, 2000, NUCLEIC ACIDS RES, V28, DOI 10.1093/nar/28.20.e90
   Reed SH, 1998, J BIOL CHEM, V273, P29481, DOI 10.1074/jbc.273.45.29481
   REINDERS J, 2007, MOL CELL PROTEOMICS
   Reinders J, 2006, J PROTEOME RES, V5, P1543, DOI 10.1021/pr050477f
   Rep M, 2000, J BIOL CHEM, V275, P8290, DOI 10.1074/jbc.275.12.8290
   Ruepp A, 2004, NUCLEIC ACIDS RES, V32, P5539, DOI 10.1093/nar/gkh894
   Ryan MT, 2007, ANNU REV BIOCHEM, V76, P701, DOI 10.1146/annurev.biochem.76.052305.091720
   Shaw JM, 2002, TRENDS CELL BIOL, V12, P178, DOI 10.1016/S0962-8924(01)02246-2
   Sickmann A, 2003, P NATL ACAD SCI USA, V100, P13207, DOI 10.1073/pnas.2135385100
   Turk M, 2004, EXTREMOPHILES, V8, P53, DOI 10.1007/s00792-003-0360-5
   Van Wuytswinkel O, 2000, MOL MICROBIOL, V37, P382, DOI 10.1046/j.1365-2958.2000.02002.x
   VAUPOTIC T, 2007, FUNGAL GENET BIOL
   Vaupotic T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-280
   Vaupotic T, 2007, FEBS LETT, V581, P3391, DOI 10.1016/j.febslet.2007.06.038
   Westermann B, 2002, EMBO REP, V3, P527, DOI 10.1093/embo-reports/kvf113
   Yale J, 2001, J BIOL CHEM, V276, P15996, DOI 10.1074/jbc.M008209200
   ZELENAYATROITSKAYA O, 1995, EMBO J, V14, P3268, DOI 10.1002/j.1460-2075.1995.tb07330.x
NR 52
TC 17
Z9 17
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1087-1845
EI 1096-0937
J9 FUNGAL GENET BIOL
JI Fungal Genet. Biol.
PD JUN
PY 2008
VL 45
IS 6
BP 994
EP 1007
DI 10.1016/j.fgb.2008.01.006
PG 14
WC Genetics & Heredity; Mycology
SC Genetics & Heredity; Mycology
GA 307KL
UT WOS:000256317700020
PM 18343697
DA 2021-01-25
ER

PT J
AU Mesecke, N
   Spang, A
   Deponte, M
   Herrmann, JM
AF Mesecke, Nikola
   Spang, Anne
   Deponte, Marcel
   Herrmann, Johannes M.
TI A novel group of glutaredoxins in the cis-Golgi critical for oxidative
   stress resistance
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID DISULFIDE-BOND FORMATION; SACCHAROMYCES-CEREVISIAE;
   ENDOPLASMIC-RETICULUM; MONOTHIOL GLUTAREDOXINS; QUALITY-CONTROL;
   PROTEIN; LOCALIZATION; THIOREDOXIN; GLUTATHIONE; EUKARYOTES
AB Glutaredoxins represent a ubiquitous family of proteins that catalyze the reduction of disulfide bonds in their substrate proteins by use of reduced glutathione. In an attempt to identify the full complement of glutaredoxins in baker's yeast, we found three so-far uncharacterized glutaredoxin-like proteins that we named Grx6, Grx7, and Grx8. Grx6 and Grx7 represent closely related monothiol glutaredoxins that are synthesized with N-terminal signal sequences. Both proteins are located in the cis-Golgi, thereby representing the first glutaredoxins found in a compartment of the secretory pathway. In contrast to formerly described monothiol glutaredoxins, Grx6 and Grx7, showed a high glutaredoxin activity in vitro. Grx6 and Grx7 overlap in their activity and deletion mutants lacking both proteins show growth defects and a strongly increased sensitivity toward oxidizing agents such as hydrogen peroxide or diamide. Our observations suggest that Grx6 and Grx7 do not play a general role in the oxidative folding of proteins in the early secretory pathway but rather counteract the oxidation of specific thiol groups in substrate proteins.
C1 [Mesecke, Nikola; Herrmann, Johannes M.] Univ Kaiserslautern, D-67663 Kaiserslautern, Germany.
   [Mesecke, Nikola; Deponte, Marcel] Univ Munich, Inst Physiol Chem, D-81377 Munich, Germany.
   [Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Herrmann, JM (corresponding author), Univ Kaiserslautern, D-67663 Kaiserslautern, Germany.
EM hannes.herrmann@biologi.uni-kl.de
RI Spang, Anne/M-7223-2019; Spang, Anne/A-7029-2008; Wagener,
   Nikola/L-3202-2017
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203;
   Deponte, Marcel/0000-0003-2141-917X
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG)
   [He2803/4-1]; Bayerische Eliteforderung; University of Basel
FX We are grateful to Soledad Funes and Karl Bihlmaier for help with some
   experiments and Walter Neupert for constant support. We thank Chris
   Kaiser and Carolyn Sevier (both of the Massachusetts Institute of
   Technology, Cambridge, MA) for antibodies against Ero1, and Jakob
   Winther (University of Copenhagen, Denmark) for Pdi1 serum. We thank
   Katja Becker (University of Giessen, Germany) for providing the pQE30
   plasmid encoding PfGrx. This work was supported by grants to J.M.H from
   the Deutsche Forschungsgemeinschaft (He2803/4-1) and the Stiftung fur
   Innovation in Rheinland-Pfalz,to N.M. by the Bayerische Eliteforderung
   and to A.S. by the University of Basel.
CR BANFIELD DK, 1994, J CELL BIOL, V127, P357, DOI 10.1083/jcb.127.2.357
   Barford D, 2004, CURR OPIN STRUC BIOL, V14, P679, DOI 10.1016/j.sbi.2004.09.012
   Bass R, 2004, J BIOL CHEM, V279, P5257, DOI 10.1074/jbc.M304951200
   Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200
   Chuang JS, 1996, J CELL BIOL, V135, P597, DOI 10.1083/jcb.135.3.597
   Deponte M, 2005, BIOL CHEM, V386, P33, DOI 10.1515/BC.2005.005
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Ellgaard L, 2004, BIOCHEM SOC T, V32, P663, DOI 10.1042/BST0320663
   Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052
   Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131
   Frickel EM, 2004, J BIOL CHEM, V279, P18277, DOI 10.1074/jbc.M314089200
   Grant CM, 2001, MOL MICROBIOL, V39, P533, DOI 10.1046/j.1365-2958.2001.02283.x
   Haugen AC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r95
   Herrero E, 2007, CELL MOL LIFE SCI, V64, P1518, DOI 10.1007/s00018-007-6554-8
   Herrmann J.M., 1994, CELL BIOL LABORATORY, V1, P538
   Holmgren A, 2005, BIOCHEM SOC T, V33, P1375, DOI 10.1042/BST0331375
   HOLMGREN A, 1995, METHOD ENZYMOL, V252, P283
   HWANG C, 1992, SCIENCE, V257, P1496, DOI 10.1126/science.1523409
   Janke C, 2004, YEAST, V21, P947, DOI 10.1002/yea.1142
   Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538
   Lillig CH, 2007, ANTIOXID REDOX SIGN, V9, P25, DOI 10.1089/ars.2007.9.25
   Lopreiato R, 2004, BIOCHEM J, V377, P395, DOI 10.1042/BJ20030638
   Luikenhuis S, 1998, MOL BIOL CELL, V9, P1081, DOI 10.1091/mbc.9.5.1081
   Marzioch M, 1999, MOL BIOL CELL, V10, P1923, DOI 10.1091/mbc.10.6.1923
   Mesecke N, 2005, CELL, V121, P1059, DOI 10.1016/j.cell.2005.04.011
   Mesecke N, 2008, BIOCHEMISTRY-US, V47, P1452, DOI 10.1021/bi7017865
   MYERS AM, 1985, EMBO J, V4, P2087, DOI 10.1002/j.1460-2075.1985.tb03896.x
   Norgaard P, 2003, YEAST, V20, P645, DOI 10.1002/yea.978
   Ojeda L, 2006, J BIOL CHEM, V281, P17661, DOI 10.1074/jbc.M602165200
   Ostergaard H, 2004, J CELL BIOL, V166, P337, DOI 10.1083/jcb.200402120
   Paget MSB, 2003, ANNU REV GENET, V37, P91, DOI 10.1146/annurev.genet.37.110801.142538
   Pedrajas JR, 2002, BIOCHEM J, V364, P617, DOI 10.1042/BJ20020570
   Pollard MG, 1998, MOL CELL, V1, P171, DOI 10.1016/S1097-2765(00)80018-0
   Porras P, 2006, J BIOL CHEM, V281, P16551, DOI 10.1074/jbc.M600790200
   Pujol-Carrion N, 2006, J CELL SCI, V119, P4554, DOI 10.1242/jcs.03229
   Rahlfs S, 2001, J BIOL CHEM, V276, P37133, DOI 10.1074/jbc.M105524200
   Rodriguez-Manzaneque MT, 2002, MOL BIOL CELL, V13, P1109, DOI 10.1091/mbc.01-10-0517
   Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039
   Sevier CS, 2002, NAT REV MOL CELL BIO, V3, P836, DOI 10.1038/nrm954
   Sevier CS, 2001, NAT CELL BIOL, V3, P874, DOI 10.1038/ncb1001-874
   Sherman F., 1986, METHODS YEAST GENETI
   SIKORSKI RS, 1989, GENETICS, V122, P19
   Sitia R, 2003, NATURE, V426, P891, DOI 10.1038/nature02262
   Tamarit J, 2003, J BIOL CHEM, V278, P25745, DOI 10.1074/jbc.M303477200
   Tu BP, 2004, J CELL BIOL, V164, P341, DOI 10.1083/jcb.200311055
   Tu BP, 2002, MOL CELL, V10, P983, DOI 10.1016/S1097-2765(02)00696-2
   Wilkinson B, 2004, BBA-PROTEINS PROTEOM, V1699, P35, DOI 10.1016/j.bbapap.2004.02.017
   Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711
   WUESTEHUBE LJ, 1992, METHOD ENZYMOL, V219, P124
NR 49
TC 57
Z9 59
U1 0
U2 4
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD JUN
PY 2008
VL 19
IS 6
BP 2673
EP 2680
DI 10.1091/mbc.E07-09-0896
PG 8
WC Cell Biology
SC Cell Biology
GA 347QD
UT WOS:000259155200031
PM 18400945
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Mueller, CA
   Broz, P
   Cornelis, GR
AF Mueller, C. A.
   Broz, P.
   Cornelis, G. R.
TI The type III secretion system tip complex and translocon
SO MOLECULAR MICROBIOLOGY
LA English
DT Article
ID ENTEROPATHOGENIC ESCHERICHIA-COLI; YERSINIA YOPE CYTOTOXIN; TARGET-CELL
   CONTACT; PLASMID ANTIGEN-D; DEPENDENT HEMOLYTIC-ACTIVITY; RECOMBINANT
   V-ANTIGEN; PSEUDOMONAS-AERUGINOSA; SHIGELLA-FLEXNERI;
   BURKHOLDERIA-PSEUDOMALLEI; PROTEIN TRANSLOCATION
AB The type III secretion machinery of Gram-negative bacteria, also known as the injectisome or needle complex, is composed of a basal body spanning both bacterial membranes and the periplasm, and an external needle protruding from the bacterial surface. A set of three proteins, two hydrophobic and one hydrophilic, are required to allow translocation of proteins from the bacterium to the host cell cytoplasm. These proteins are involved in the formation of a translocation pore, the translocon, in the host cell membrane. Exciting progress has recently been made on the interaction between the translocators and the injectisome needle and the assembly of the translocon in the host cell membrane. As expected, the two hydrophobic translocators insert into the target cell membrane. Unexpectedly, the third, hydrophilic translocator, forms a complex on the distal end of the injectisome needle, the tip complex, and serves as an assembly platform for the two hydrophobic translocators.
C1 [Mueller, C. A.; Broz, P.; Cornelis, G. R.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM guy.cornelis@unibas.ch
RI Broz, Petr/AAC-7940-2019
OI Broz, Petr/0000-0002-2334-7790
CR Black DS, 2000, MOL MICROBIOL, V37, P515, DOI 10.1046/j.1365-2958.2000.02021.x
   Blocker A, 1999, J CELL BIOL, V147, P683, DOI 10.1083/jcb.147.3.683
   Boland A, 1996, EMBO J, V15, P5191, DOI 10.1002/j.1460-2075.1996.tb00904.x
   Broms JE, 2003, J INFECT DIS, V188, P239, DOI 10.1086/376452
   Broz P, 2007, MOL MICROBIOL, V65, P1311, DOI 10.1111/j.1365-2958.2007.05871.x
   Burr SE, 2003, J BACTERIOL, V185, P6583, DOI 10.1128/JB.185.22.6583-6591.2003
   BURROWS TW, 1956, NATURE, V177, P426, DOI 10.1038/177426b0
   Chakravortty D, 2005, EMBO J, V24, P2043, DOI 10.1038/sj.emboj.7600676
   Cordes FS, 2005, J MOL BIOL, V354, P206, DOI 10.1016/j.jmb.2005.09.062
   Cordes FS, 2003, J BIOL CHEM, V278, P17103, DOI 10.1074/jbc.M300091200
   Cornelis GR, 2006, NAT REV MICROBIOL, V4, P811, DOI 10.1038/nrmicro1526
   Dacheux D, 2001, MOL MICROBIOL, V40, P76, DOI 10.1046/j.1365-2958.2001.02368.x
   Daniell SJ, 2001, CELL MICROBIOL, V3, P865, DOI 10.1046/j.1462-5822.2001.00168.x
   Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103
   DeBord KL, 2001, J BACTERIOL, V183, P4588, DOI 10.1128/JB.183.15.4588-4598.2001
   Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010
   Doring G, 2008, VACCINE, V26, P1011, DOI 10.1016/j.vaccine.2007.12.007
   Druar C, 2008, FEMS IMMUNOL MED MIC, V52, P78, DOI 10.1111/j.1574-695X.2007.00345.x
   Erskine PT, 2006, J MOL BIOL, V363, P125, DOI 10.1016/j.jmb.2006.07.069
   Espina M, 2007, PROTEIN SCI, V16, P704, DOI 10.1110/ps.062645007
   Espina M, 2006, BIOCHEMISTRY-US, V45, P9219, DOI 10.1021/bi060625v
   Espina M, 2006, INFECT IMMUN, V74, P4391, DOI 10.1128/IAI.00440-06
   Faudry E, 2006, BIOCHEMISTRY-US, V45, P8117, DOI 10.1021/bi060452+
   Fields KA, 1999, INFECT IMMUN, V67, P5395, DOI 10.1128/IAI.67.10.5395-5408.1999
   FORSBERG A, 1991, MOL MICROBIOL, V5, P977, DOI 10.1111/j.1365-2958.1991.tb00773.x
   Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x
   Frank DW, 2002, J INFECT DIS, V186, P64, DOI 10.1086/341069
   Frithz-Lindsten E, 1998, MOL MICROBIOL, V29, P1155, DOI 10.1046/j.1365-2958.1998.00994.x
   Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272
   Goure J, 2005, J INFECT DIS, V192, P218, DOI 10.1086/430932
   Goure J, 2004, INFECT IMMUN, V72, P4741, DOI 10.1128/IAI.72.8.4741-4750.2004
   HAKANSSON S, 1993, INFECT IMMUN, V61, P71
   Hakansson S, 1996, EMBO J, V15, P5812, DOI 10.1002/j.1460-2075.1996.tb00968.x
   Haque A, 2006, J INFECT DIS, V194, P1241, DOI 10.1086/508217
   Heath DG, 1998, VACCINE, V16, P1131, DOI 10.1016/S0264-410X(98)80110-2
   Hill J, 1997, INFECT IMMUN, V65, P4476, DOI 10.1128/IAI.65.11.4476-4482.1997
   Holmstrom A, 2001, MOL MICROBIOL, V39, P620, DOI 10.1046/j.1365-2958.2001.02259.x
   Ide T, 2001, CELL MICROBIOL, V3, P669, DOI 10.1046/j.1462-5822.2001.00146.x
   Iriarte M, 1998, EMBO J, V17, P1907, DOI 10.1093/emboj/17.7.1907
   Johnson S, 2007, J BIOL CHEM, V282, P4035, DOI 10.1074/jbc.M607945200
   Kenjale R, 2005, J BIOL CHEM, V280, P42929, DOI 10.1074/jbc.M508377200
   Knutton S, 1998, EMBO J, V17, P2166, DOI 10.1093/emboj/17.8.2166
   La Ragione RM, 2006, MICROBES INFECT, V8, P426, DOI 10.1016/j.micinf.2005.07.009
   LAWTON WD, 1963, J IMMUNOL, V91, P179
   Levine MM, 2007, NAT REV MICROBIOL, V5, P540, DOI 10.1038/nrmicro1662
   Li Z, 1999, INFECT IMMUN, V67, P5938, DOI 10.1128/IAI.67.11.5938-5945.1999
   Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2
   MARKHAM AP, 2008, IN PRESS PROTEINS
   Miki T, 2004, MICROB PATHOGENESIS, V37, P65, DOI 10.1016/j.micpath.2004.04.006
   Mota LJ, 2005, SCIENCE, V307, P1278, DOI 10.1126/science.1107679
   MOTIN VL, 1994, INFECT IMMUN, V62, P4192, DOI 10.1128/IAI.62.10.4192-4201.1994
   Mueller CA, 2005, SCIENCE, V310, P674, DOI 10.1126/science.1118476
   Neyt C, 1999, MOL MICROBIOL, V33, P971, DOI 10.1046/j.1365-2958.1999.01537.x
   Noguera-Obenza M, 2003, EMERG INFECT DIS, V9, P545, DOI 10.3201/eid0905.020441
   Oaks EV, 1996, CLIN DIAGN LAB IMMUN, V3, P242, DOI 10.1128/CDLI.3.2.242-245.1996
   Olive AJ, 2007, INFECT IMMUN, V75, P2626, DOI 10.1128/IAI.01599-06
   Olsson J, 2004, J BACTERIOL, V186, P4110, DOI 10.1128/JB.186.13.4110-4123.2004
   Pallen MJ, 2005, FEMS MICROBIOL REV, V29, P201, DOI 10.1016/j.femsre.2005.01.001
   PERSSON C, 1995, MOL MICROBIOL, V18, P135, DOI 10.1111/j.1365-2958.1995.mmi_18010135.x
   Pettersson J, 1999, MOL MICROBIOL, V32, P961, DOI 10.1046/j.1365-2958.1999.01408.x
   Pettersson J, 1996, SCIENCE, V273, P1231, DOI 10.1126/science.273.5279.1231
   Picking WL, 2005, INFECT IMMUN, V73, P1432, DOI 10.1128/IAI.73.3.1432-1440.2005
   Roggenkamp A, 1997, INFECT IMMUN, V65, P446, DOI 10.1128/IAI.65.2.446-451.1997
   ROSQVIST R, 1991, INFECT IMMUN, V59, P4562, DOI 10.1128/IAI.59.12.4562-4569.1991
   ROSQVIST R, 1994, EMBO J, V13, P964, DOI 10.1002/j.1460-2075.1994.tb06341.x
   Sani M, 2007, BBA-GEN SUBJECTS, V1770, P307, DOI 10.1016/j.bbagen.2006.10.007
   Sawa T, 1999, NAT MED, V5, P392
   Schoehn G, 2003, EMBO J, V22, P4957, DOI 10.1093/emboj/cdg499
   Sekiya K, 2001, P NATL ACAD SCI USA, V98, P11638, DOI 10.1073/pnas.191378598
   Shaw RK, 2001, CELL MICROBIOL, V3, P213, DOI 10.1046/j.1462-5822.2001.00105.x
   Shime N, 2001, J IMMUNOL, V167, P5880, DOI 10.4049/jimmunol.167.10.5880
   Shin H, 2007, CELL MICROBIOL, V9, P2893, DOI 10.1111/j.1462-5822.2007.01004.x
   SORY MP, 1994, MOL MICROBIOL, V14, P583, DOI 10.1111/j.1365-2958.1994.tb02191.x
   Stevens MP, 2004, MICROBIOL-SGM, V150, P2669, DOI 10.1099/mic.0.27146-0
   Tardy F, 1999, EMBO J, V18, P6793, DOI 10.1093/emboj/18.23.6793
   Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x
   Troisfontaines P, 2005, PHYSIOLOGY, V20, P326, DOI 10.1152/physiol.00011.2005
   UNE T, 1984, J IMMUNOL, V133, P2226
   Veenendaal AKJ, 2007, MOL MICROBIOL, V63, P1719, DOI 10.1111/j.1365-2958.2007.05620.x
   Viboud GI, 2001, EMBO J, V20, P5373, DOI 10.1093/emboj/20.19.5373
   von Pawel-Rammingen U, 2000, MOL MICROBIOL, V36, P737, DOI 10.1046/j.1365-2958.2000.01898.x
   Wachter C, 1999, MOL MICROBIOL, V31, P1695, DOI 10.1046/j.1365-2958.1999.01303.x
   Warawa J, 1999, INFECT IMMUN, V67, P5538, DOI 10.1128/IAI.67.10.5538-5540.1999
   Williams AW, 1998, J BACTERIOL, V180, P350, DOI 10.1128/JB.180.2.350-358.1998
   WILLIAMSON ED, 1995, FEMS IMMUNOL MED MIC, V12, P223, DOI 10.1111/j.1574-695X.1995.tb00196.x
   Williamson ED, 1997, VACCINE, V15, P1079, DOI 10.1016/S0264-410X(96)00303-9
   Yip CK, 2005, NAT STRUCT MOL BIOL, V12, P75, DOI 10.1038/nsmb879
   Zhang L, 2007, J BIOL CHEM, V282, P32144, DOI 10.1074/jbc.M703403200
NR 88
TC 170
Z9 172
U1 0
U2 20
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 0950-382X
J9 MOL MICROBIOL
JI Mol. Microbiol.
PD JUN
PY 2008
VL 68
IS 5
BP 1085
EP 1095
DI 10.1111/j.1365-2958.2008.06237.x
PG 11
WC Biochemistry & Molecular Biology; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 298WJ
UT WOS:000255717500004
PM 18430138
DA 2021-01-25
ER

PT J
AU Cueni, L
   Canepari, M
   Lujan, R
   Emmenegger, Y
   Watanabe, M
   Bond, CT
   Franken, P
   Adelman, JP
   Luthi, A
AF Cueni, Lucius
   Canepari, Marco
   Lujan, Rafael
   Emmenegger, Yann
   Watanabe, Masahiko
   Bond, Chris T.
   Franken, Paul
   Adelman, John P.
   Luthi, Anita
TI T-type Ca2+ channels, SK2 channels and SERCAs gate sleep-related
   oscillations in thalamic dendrites
SO NATURE NEUROSCIENCE
LA English
DT Article
ID CA2+-ACTIVATED K+ CHANNELS; SMALL-CONDUCTANCE; POTASSIUM CHANNELS;
   DIFFERENTIAL DISTRIBUTION; RETICULAR NUCLEUS; IN-VITRO; NEURONS;
   MODULATION; CURRENTS; DETERMINANTS
AB T-type Ca2+ channels (T channels) underlie rhythmic burst discharges during neuronal oscillations that are typical during sleep. However, the Ca2+-dependent effectors that are selectively regulated by T currents remain unknown. We found that, in dendrites of nucleus reticularis thalami (nRt), intracellular Ca2+ concentration increases were dominated by Ca2+ influx through T channels and shaped rhythmic bursting via competition between Ca2+-dependent small-conductance (SK)-type K1 channels and Ca2+ uptake pumps. Oscillatory bursting was initiated via selective activation of dendritically located SK2 channels, whereas Ca2+ sequestration by sarco/endoplasmic reticulum Ca2+-ATPases (SERCAs) and cumulative T channel inactivation dampened oscillations. Sk2(-/-) (also known as Kcnn2) mice lacked cellular oscillations, showed a greater than threefold reduction in low-frequency rhythms in the electroencephalogram of non-rapid-eye-movement sleep and had disrupted sleep. Thus, the interplay of T channels, SK2 channels and SERCAs in nRt dendrites comprises a specialized Ca2+ signaling triad to regulate oscillatory dynamics related to sleep.
C1 [Cueni, Lucius; Canepari, Marco; Luthi, Anita] Univ Basel, Div Pharmacol & Neurobiol Biozentrum, CH-4056 Basel, Switzerland.
   [Lujan, Rafael] Univ Castilla La Mancha, Crib Fac Med, Dept Ciencias Med, Albacete 02006, Spain.
   [Emmenegger, Yann; Franken, Paul] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland.
   [Watanabe, Masahiko] Hokkaido Univ, Sch Med, Dept Anat, Kita Ku, Sapporo, Hokkaido 0608638, Japan.
   [Bond, Chris T.; Adelman, John P.] Oregon Hlth & Sci Univ, Vollum Inst, Portland, OR 97201 USA.
   [Luthi, Anita] Univ Lausanne, Fac Biol & Med, Dept Cell Biol & Morphol, CH-1005 Lausanne, Switzerland.
RP Luthi, A (corresponding author), Univ Basel, Div Pharmacol & Neurobiol Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM anita.luthi@unil.ch
RI Canepari, Marco/H-6772-2012; Watanabe, Masahiko/S-3614-2019; WATANABE,
   Masahiko/A-4055-2012; Franken, Paul/A-9633-2018; Lujan,
   Rafael/G-2555-2015
OI Canepari, Marco/0000-0001-9759-2388; Watanabe,
   Masahiko/0000-0001-5037-7138; WATANABE, Masahiko/0000-0001-5037-7138;
   Franken, Paul/0000-0002-2500-2921; Lujan Miras,
   Rafael/0000-0003-2001-9545; Luthi, Anita/0000-0002-4954-4143
CR AMZICA F, 1992, NEUROSCIENCE, V51, P285, DOI 10.1016/0306-4522(92)90315-S
   AVANZINI G, 1989, J PHYSIOL-LONDON, V416, P111, DOI 10.1113/jphysiol.1989.sp017752
   BAL T, 1993, J PHYSIOL-LONDON, V468, P669, DOI 10.1113/jphysiol.1993.sp019794
   Bildl W, 2004, NEURON, V43, P847, DOI 10.1016/j.neuron.2004.08.033
   Blethyn KL, 2006, J NEUROSCI, V26, P2474, DOI 10.1523/JNEUROSCI.3607-05.2006
   Bond CT, 2005, CURR OPIN NEUROBIOL, V15, P305, DOI 10.1016/j.conb.2005.05.001
   Bond CT, 2004, J NEUROSCI, V24, P5301, DOI 10.1523/JNEUROSCI.0182-04.2004
   Buzsaki G, 2002, NEURON, V33, P325, DOI 10.1016/S0896-6273(02)00586-X
   Cai X, 2004, NEURON, V44, P351, DOI 10.1016/j.neuron.2004.09.026
   Canepari M, 2004, J NEUROSCI, V24, P3563, DOI 10.1523/JNEUROSCI.5374-03.2004
   Contreras D, 2006, CNS NEUROL DISORD-DR, V5, P571, DOI 10.2174/187152706779025526
   Crunelli V, 2006, CELL CALCIUM, V40, P175, DOI 10.1016/j.ceca.2006.04.022
   Cui GH, 2004, J NEUROSCI, V24, P11079, DOI 10.1523/JNEUROSCI.2713-04.2004
   Debarbieux F, 1998, J NEUROPHYSIOL, V79, P2911
   Destexhe A, 1996, J NEUROSCI, V16, P169
   Diana MA, 2007, J NEUROSCI, V27, P3823, DOI 10.1523/JNEUROSCI.4719-06.2007
   DOMICH L, 1986, J PHYSIOL-LONDON, V379, P429, DOI 10.1113/jphysiol.1986.sp016262
   Egger V, 2003, J NEUROSCI, V23, P7551
   Fierro L, 1998, J PHYSIOL-LONDON, V510, P499, DOI 10.1111/j.1469-7793.1998.499bk.x
   Franken P, 1999, SLEEP, V22, P155
   Franken P, 1998, AM J PHYSIOL-REG I, V275, pR1127
   Frazier CJ, 2001, J GEN PHYSIOL, V118, P457, DOI 10.1085/jgp.118.5.457
   Fuentealba P, 2005, PROG NEUROBIOL, V75, P125, DOI 10.1016/j.pneurobio.2005.01.002
   Gottesmann C, 1996, NEUROSCI BIOBEHAV R, V20, P367, DOI 10.1016/0149-7634(95)00055-0
   Huguenard JR, 2007, TRENDS NEUROSCI, V30, P350, DOI 10.1016/j.tins.2007.05.007
   Ivanov AI, 2000, J NEUROSCI, V20, P4930
   Joho RH, 2006, EUR J NEUROSCI, V23, P1567, DOI 10.1111/j.1460-9568.2006.04672.x
   Joksovic PM, 2005, J PHYSIOL-LONDON, V566, P125, DOI 10.1113/jphysiol.2005.086579
   Kohler M, 1996, SCIENCE, V273, P1709, DOI 10.1126/science.273.5282.1709
   Kramar EA, 2004, J NEUROSCI, V24, P5151, DOI 10.1523/JNEUROSCI.0800-04.2004
   Kuisle M, 2006, J PHYSIOL-LONDON, V575, P83, DOI 10.1113/jphysiol.2006.110486
   Liguori R, 2001, BRAIN, V124, P2417, DOI 10.1093/brain/124.12.2417
   Lujan R, 1996, EUR J NEUROSCI, V8, P1488, DOI 10.1111/j.1460-9568.1996.tb01611.x
   LYTTON J, 1992, J BIOL CHEM, V267, P14483
   Marrion NV, 1998, NATURE, V395, P900, DOI 10.1038/27674
   Misquitta CM, 1999, CELL CALCIUM, V25, P277, DOI 10.1054/ceca.1999.0032
   Munsch T, 1997, NEUROREPORT, V8, P2411, DOI 10.1097/00001756-199707280-00001
   Ngo-Anh TJ, 2005, NAT NEUROSCI, V8, P642, DOI 10.1038/nn1449
   OGDEN D, 1995, PFLUG ARCH EUR J PHY, V429, P587, DOI 10.1007/BF00704165
   Pape HC, 2004, PFLUG ARCH EUR J PHY, V448, P131, DOI 10.1007/s00424-003-1234-5
   Pedarzani P, 2001, J BIOL CHEM, V276, P9762, DOI 10.1074/jbc.M010001200
   Perez-Reyes E, 2003, PHYSIOL REV, V83, P117, DOI 10.1152/physrev.00018.2002
   Pinault D, 2004, BRAIN RES REV, V46, P1, DOI 10.1016/j.brainresrev.2004.04.008
   Richter TA, 2005, J NEUROSCI, V25, P8267, DOI 10.1523/JNEUROSCI.1942-05.2005
   Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029
   Stocker M, 2004, NAT REV NEUROSCI, V5, P758, DOI 10.1038/nrn1516
   Stocker M, 2000, MOL CELL NEUROSCI, V15, P476, DOI 10.1006/mcne.2000.0842
   Talley EM, 1999, J NEUROSCI, V19, P1895
   Uebachs M, 2006, J PHYSIOL-LONDON, V571, P519, DOI 10.1113/jphysiol.2005.103614
   Vyazovskiy VV, 2002, BRAIN RES, V947, P204, DOI 10.1016/S0006-8993(02)02925-6
NR 50
TC 134
Z9 135
U1 0
U2 9
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1097-6256
EI 1546-1726
J9 NAT NEUROSCI
JI Nat. Neurosci.
PD JUN
PY 2008
VL 11
IS 6
BP 683
EP 692
DI 10.1038/nn.2124
PG 10
WC Neurosciences
SC Neurosciences & Neurology
GA 304UD
UT WOS:000256133700015
PM 18488023
DA 2021-01-25
ER

PT J
AU Coseno, M
   Martin, G
   Berger, C
   Gilmartin, G
   Keller, W
   Doublie, S
AF Coseno, Molly
   Martin, Georges
   Berger, Christopher
   Gilmartin, Gregory
   Keller, Walter
   Doublie, Sylvie
TI Crystal structure of the 25 kDa subunit of human cleavage factor I-m
SO NUCLEIC ACIDS RESEARCH
LA English
DT Article
ID PRE-MESSENGER-RNA; MECHANISM; HYDROLASE; POLYADENYLATION;
   POLYPHOSPHATES; PROTEINS; INSIGHTS; REVEALS; COMPLEX; TOOLS
AB Cleavage factor I-m is an essential component of the pre-messenger RNA 3'-end processing machinery in higher eukaryotes, participating in both the polyadenylation and cleavage steps. Cleavage factor I-m is an oligomer composed of a small 25 kDa subunit (CF I(m)25) and a variable larger subunit of either 59, 68 or 72 kDa. The small subunit also interacts with RNA, poly(A) polymerase, and the nuclear poly(A)-binding protein. These proteinprotein interactions are thought to be facilitated by the Nudix domain of CF I(m)25, a hydrolase motif with a characteristic alpha/beta/alpha fold and a conserved catalytic sequence or Nudix box. We present here the crystal structures of human CF I(m)25 in its free and diadenosine tetraphosphate (Ap(4)A) bound forms at 1.85 and 1.80 angstrom, respectively. CF I(m)25 crystallizes as a dimer and presents the classical Nudix fold. Results from crystallographic and biochemical experiments suggest that CF I(m)25 makes use of its Nudix fold to bind but not hydrolyze ATP and Ap(4)A. The complex and apo protein structures provide insight into the active oligomeric state of CF I-m and suggest a possible role of nucleotide binding in either the polyadenylation and/or cleavage steps of pre-messenger RNA 3'-end processing.
C1 [Coseno, Molly; Gilmartin, Gregory; Doublie, Sylvie] Univ Vermont, Dept Microbiol, Burlington, VT 05405 USA.
   [Coseno, Molly; Gilmartin, Gregory; Doublie, Sylvie] Univ Vermont, Dept Mol Genet, Burlington, VT 05405 USA.
   [Martin, Georges; Keller, Walter] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Doublie, S (corresponding author), Univ Vermont, Dept Microbiol, Burlington, VT 05405 USA.
EM sdoublie@uvm.edu
OI Doublie, Sylvie/0000-0002-6294-5304
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM062239,
   R01GM062239, R01GM062239, R01GM062239, R01GM062239] Funding Source: NIH
   RePORTER; NCI NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [Y1-CO-1020] Funding Source: Medline; NIGMS NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM062239, GM62239, R01 GM062239-05,
   Y1-GM-1104] Funding Source: Medline
CR AMES BN, 1960, J BIOL CHEM, V235, P769
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   Bailey S, 2002, STRUCTURE, V10, P589, DOI 10.1016/S0969-2126(02)00746-3
   BAXI MD, 1995, J PHARMACOL TOX MET, V33, P121, DOI 10.1016/1056-8719(94)00127-P
   Bessman MJ, 1996, J BIOL CHEM, V271, P25059, DOI 10.1074/jbc.271.41.25059
   Blower MD, 2005, CELL, V121, P223, DOI 10.1016/j.cell.2005.02.016
   Brown KM, 2003, MOL CELL, V12, P1467, DOI 10.1016/S1097-2765(03)00453-2
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Champagne KS, 2005, J BIOL CHEM, V280, P34096, DOI 10.1074/jbc.M505041200
   de Vries H, 2000, EMBO J, V19, P5895, DOI 10.1093/emboj/19.21.5895
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   Dettwiler S, 2004, J BIOL CHEM, V279, P35788, DOI 10.1074/jbc.M403927200
   Doublie S., 2007, MACROMOLECULAR CRYST, V1, P91
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Gabelli SB, 2001, NAT STRUCT BIOL, V8, P467, DOI 10.1038/87647
   Holm L, 1997, NUCLEIC ACIDS RES, V25, P231, DOI 10.1093/nar/25.1.231
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Kisselev LL, 1998, FEBS LETT, V427, P157, DOI 10.1016/S0014-5793(98)00420-7
   LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944
   Logan DT, 1999, SCIENCE, V283, P1499, DOI 10.1126/science.283.5407.1499
   McLennan AG, 2006, CELL MOL LIFE SCI, V63, P123, DOI 10.1007/s00018-005-5386-7
   Mildvan AS, 2005, ARCH BIOCHEM BIOPHYS, V433, P129, DOI 10.1016/j.abb.2004.08.017
   Millevoi S, 2006, EMBO J, V25, P4854, DOI 10.1038/sj.emboj.7601331
   Minvielle-Sebastia L, 1999, CURR OPIN CELL BIOL, V11, P352, DOI 10.1016/S0955-0674(99)80049-0
   NICHOLLS A, 1991, PROTEINS, V11, P281, DOI 10.1002/prot.340110407
   Noble CG, 2007, NUCLEIC ACIDS RES, V35, P87, DOI 10.1093/nar/gkl1010
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444
   Ranatunga W, 2004, J MOL BIOL, V339, P103, DOI 10.1016/j.jmb.2004.01.065
   ROULD MA, 2006, METHOD MOL BIOL, V364, P159
   Ruegsegger U, 1996, J BIOL CHEM, V271, P6107
   Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046
   She MP, 2006, NAT STRUCT MOL BIOL, V13, P63, DOI 10.1038/nsmb1033
   Shimazu T, 2007, J BIOL CHEM, V282, P4470, DOI 10.1074/jbc.M609745200
   Sillero MAG, 2002, EUR J BIOCHEM, V269, P5323, DOI 10.1046/j.1432-1033.2002.03253.x
   Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839
   Terwilliger TC, 2000, ACTA CRYSTALLOGR D, V56, P965, DOI 10.1107/S0907444900005072
   TROPEA JE, 2007, MACROMOLECULAR CRYST, V1, P1
   Venkataraman K, 2005, GENE DEV, V19, P1315, DOI 10.1101/gad.1298605
   VONRHEIN C, 2007, MACROMOLECULAR CRYST, V1, P215
   Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1111/j.1574-6976.1999.tb00400.x
   Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777
   Yengo CM, 2000, J BIOL CHEM, V275, P25481, DOI 10.1074/jbc.M002910200
   Yoshiba S, 2004, J BIOL CHEM, V279, P37163, DOI 10.1074/jbc.M403817200
   Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999
NR 45
TC 31
Z9 33
U1 0
U2 0
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 0305-1048
EI 1362-4962
J9 NUCLEIC ACIDS RES
JI Nucleic Acids Res.
PD JUN
PY 2008
VL 36
IS 10
BP 3474
EP 3483
DI 10.1093/nar/gkn079
PG 10
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 319SC
UT WOS:000257183200030
PM 18445629
OA DOAJ Gold, Green Accepted, Green Published
DA 2021-01-25
ER

PT J
AU Vohradsky, J
   Branny, P
   Li, XM
   Thompson, CJ
AF Vohradsky, Jiri
   Branny, Pavel
   Li, Xin-Ming
   Thompson, Charles J.
TI Effect of protein degradation on spot M-r distribution in 2-D gels - a
   case study of proteolysis during development of Streptomyces coelicolor
   cultures
SO PROTEOMICS
LA English
DT Article
DE 2-DE; M-r distribution; proteolysis; Streptomyces
ID COLONY
AB Proteolysis, a regulated biological process, is reflected by protein spot molecular weight distribution in 2-D gel electrophoretograms. Here we report studies of Streptomyces cultures as they undergo two different developmental processes involving proteolysis. Systematic changes in protein molecular weight distribution between the control samples and those with high activity of proteases were demonstrated. The observations were supported by a numerical model of degradation and its influence on the M-r distribution. Simple statistics could be used to distinguish between normal and degradative 2-D gel electrophoretic patterns.
C1 [Vohradsky, Jiri; Branny, Pavel] Acad Sci Czech Republic, Inst Microbiol, Prague 14220, Czech Republic.
   [Li, Xin-Ming; Thompson, Charles J.] Univ Basel, Biozentrum, Div Mol Microbial, Basel, Switzerland.
RP Vohradsky, J (corresponding author), Acad Sci Czech Republic, Inst Microbiol, Videnska 1083, Prague 14220, Czech Republic.
EM vohr@biomed.cas.cz
RI Branny, Pavel/H-2490-2014
CR ALLAN EJ, 1983, J GEN MICROBIOL, V129, P2029
   Chater KF, 1998, MICROBIOL-UK, V144, P1465, DOI 10.1099/00221287-144-6-1465
   MENDEZ C, 1985, CAN J MICROBIOL, V31, P446, DOI 10.1139/m85-083
   Nicieza RG, 1999, J BIOL CHEM, V274, P20366, DOI 10.1074/jbc.274.29.20366
   PUGLIA AM, 1995, MOL MICROBIOL, V17, P737, DOI 10.1111/j.1365-2958.1995.mmi_17040737.x
   Schulenberg B, 2003, PROTEOMICS, V3, P1196, DOI 10.1002/pmic.200300440
   Vohradsky J, 1997, ELECTROPHORESIS, V18, P1418, DOI 10.1002/elps.1150180817
NR 7
TC 4
Z9 5
U1 0
U2 2
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD JUN
PY 2008
VL 8
IS 12
BP 2371
EP 2375
DI 10.1002/pmic.200701075
PG 5
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 323SH
UT WOS:000257468200002
PM 18563729
DA 2021-01-25
ER

PT J
AU Paul, R
   Jaeger, T
   Abel, S
   Wiederkehr, I
   Folcher, M
   Biondi, EG
   Laub, MT
   Jenal, U
AF Paul, Ralf
   Jaeger, Tina
   Abel, Soeren
   Wiederkehr, Irene
   Folcher, Marc
   Biondi, Emanuele G.
   Laub, Michael T.
   Jenal, Urs
TI Allosteric regulation of histidine kinases by their cognate response
   regulator determines cell fate
SO CELL
LA English
DT Article
ID 2-COMPONENT SIGNAL-TRANSDUCTION; CAULOBACTER-CRESCENTUS; DYNAMIC
   LOCALIZATION; CYCLE PROGRESSION; TYROSINE KINASE; PROTEIN-KINASE;
   DIFFERENTIATION; DIVISION; PHOSPHORYLATION; MORPHOGENESIS
AB The two-component phosphorylation network is of critical importance for bacterial growth and physiology. Here, we address plasticity and interconnection of distinct signal transduction pathways within this network. In Caulobacter crescentus antagonistic activities of the PleC phosphatase and DivJ kinase localized at opposite cell poles control the phosphorylation state and subcellular localization of the cell fate determinator protein DivK. We show that DivK functions as an allosteric regulator that switches PleC from a phosphatase into an autokinase state and thereby mediates a cyclic di-GMP-dependent morphogenetic program. Through allosteric activation of the DivJ autokinase, DivK also stimulates its own phosphorylation and polar localization. These data suggest that DivK is the central effector of an integrated circuit that operates via spatially organized feedback loops to control asymmetry and cell fate determination in C. crescentus. Thus, single domain response regulators can facilitate crosstalk, feedback control, and long-range communication among members of the two-component network.
C1 [Paul, Ralf; Jaeger, Tina; Abel, Soeren; Wiederkehr, Irene; Folcher, Marc; Jenal, Urs] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Biondi, Emanuele G.; Laub, Michael T.] MIT, Dept Biol, Cambridge, MA 02139 USA.
RP Jenal, U (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM urs.jenal@unibas.ch
OI Abel, Soren/0000-0002-4041-6989; Laub, Michael/0000-0002-8288-7607
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM082899,
   R01GM082899, R01GM082899, R01GM082899, R01GM082899, R01GM082899,
   R01GM082899, R01GM082899, R01GM082899, R01GM082899, R01GM082899,
   R01GM082899] Funding Source: NIH RePORTER; NIGMS NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS) [R01
   GM082899-01, R01 GM082899] Funding Source: Medline
CR Aldridge P, 1999, MOL MICROBIOL, V32, P379, DOI 10.1046/j.1365-2958.1999.01358.x
   Aldridge P, 2003, MOL MICROBIOL, V47, P1695, DOI 10.1046/j.1365-2958.2003.03401.x
   BETSCHINGER J, 2004, NATURE, V444, P899
   Crymes WB, 1999, J BACTERIOL, V181, P3967, DOI 10.1128/JB.181.13.3967-3973.1999
   Domian IJ, 1997, CELL, V90, P415, DOI 10.1016/S0092-8674(00)80502-4
   ELY B, 1991, METHOD ENZYMOL, V204, P372
   HECHT GB, 1995, EMBO J, V14, P3915, DOI 10.1002/j.1460-2075.1995.tb00063.x
   Hung DY, 2002, P NATL ACAD SCI USA, V99, P13160, DOI 10.1073/pnas.202495099
   Jacobs C, 2001, P NATL ACAD SCI USA, V98, P4095, DOI 10.1073/pnas.051609998
   Jenal U, 1996, EMBO J, V15, P2393, DOI 10.1002/j.1460-2075.1996.tb00597.x
   Lam H, 2003, DEV CELL, V5, P149, DOI 10.1016/S1534-5807(03)00191-6
   Levi A, 2006, J BACTERIOL, V188, P5315, DOI 10.1128/JB.01725-05
   Matroule JY, 2004, CELL, V118, P579, DOI 10.1016/j.cell.2004.08.019
   McAdams HH, 2003, SCIENCE, V301, P1874, DOI 10.1126/science.1087694
   Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003
   OHTA N, 1992, P NATL ACAD SCI USA, V89, P10297, DOI 10.1073/pnas.89.21.10297
   PARKINSON JS, 1992, ANNU REV GENET, V26, P71, DOI 10.1146/annurev.ge.26.120192.000443
   Paul R, 2004, GENE DEV, V18, P715, DOI 10.1101/gad.289504
   Paul R, 2007, J BIOL CHEM, V282, P29170, DOI 10.1074/jbc.M704702200
   Quon KC, 1998, P NATL ACAD SCI USA, V95, P120, DOI 10.1073/pnas.95.1.120
   Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2
   Radhakrishnan SK, 2008, GENE DEV, V22, P212, DOI 10.1101/gad.1601808
   Robinson VL, 2000, NAT STRUCT BIOL, V7, P626, DOI 10.1038/77915
   Sciochetti SA, 2005, MOL MICROBIOL, V56, P1467, DOI 10.1111/j.1365-2958.2005.04652.x
   Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334
   SOMMER JM, 1991, GENETICS, V129, P623
   Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183
   Viollier PH, 2002, P NATL ACAD SCI USA, V99, P13831, DOI 10.1073/pnas.182411999
   WANG SP, 1993, P NATL ACAD SCI USA, V90, P630, DOI 10.1073/pnas.90.2.630
   Wassmann P, 2007, STRUCTURE, V15, P915, DOI 10.1016/j.str.2007.06.016
   Wheeler RT, 1999, MOL CELL, V4, P683, DOI 10.1016/S1097-2765(00)80379-2
   Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068
   Wu JG, 1998, P NATL ACAD SCI USA, V95, P1443, DOI 10.1073/pnas.95.4.1443
   Yamamoto K, 2005, J BIOL CHEM, V280, P1448, DOI 10.1074/jbc.M410104200
   Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X
NR 35
TC 107
Z9 110
U1 1
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 0092-8674
EI 1097-4172
J9 CELL
JI Cell
PD MAY 2
PY 2008
VL 133
IS 3
BP 452
EP 461
DI 10.1016/j.cell.2008.02.045
PG 10
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 295WD
UT WOS:000255503900016
PM 18455986
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Moehren, U
   Denayer, S
   Podvinec, M
   Verrijd, G
   Claessens, F
AF Moehren, Udo
   Denayer, Sarah
   Podvinec, Michael
   Verrijd, Guy
   Claessens, Frank
TI Identification of androgen-selective androgen-response elements in the
   human aquaporin-5 and Rad9 genes
SO BIOCHEMICAL JOURNAL
LA English
DT Article
DE androgen receptor (AR); androgen-response element (ARE);
   androgen-selectivity; aquaporin-5 (AQP5); NUBIScan; radiation-sensitive
   9 (Rad9)
ID PROSTATIC BINDING-PROTEIN; DIFFERENTIAL DNA-BINDING;
   GLUCOCORTICOID-RECEPTORS; 1ST INTRON; TRANSCRIPTION FACTOR; CANCER
   CELLS; EXPRESSION; TRANSACTIVATION; SPECIFICITY; PROMOTER
AB The AR (androgen receptor) is known to influence the expression of its target genes by binding to different sets of AREs (androgen-response elements) in the DNA. One set consists of the classical steroid-response elements which are partial palindromic repeats of the 5'-TGTTCT-3' steroid-receptor monomer-binding element. The second set contains motifs that are AR-specific and that are proposed to be partial direct repeats of the same motif. On the basis of this assumption, we used an in silico approach to identify new androgen-selective AREs in the regulatory regions of known androgen-responsive genes. We have used an extension of the NUBIScan algorithm to screen a collection of 85 known human androgen-responsive genes compiled from literature and database searches. We report the evaluation of the most promising hits resulting from this computational search by in vitro DNA-binding assays using full-size ARs and GRs (glucocorticoid receptors) as well as their isolated DBDs (DNA-binding domains). We also describe the ability of some of these motifs to confer androgen-, but not glucocorticoid-, responsiveness to reporter-gene expression. The elements found in the aquaporin-5 and the Rad9 (radiation-sensitive 9) genes showed selective AR versus GR binding in band-shift assays and a strong activity and selectivity in functional assays, both as isolated elements and in their original contexts. Our data indicate the validity of the hypothesis that selective AREs are recognizable as direct 5'-TGTTCT-3' repeats, and extend the list of currently known selective elements.
C1 [Moehren, Udo; Denayer, Sarah; Verrijd, Guy; Claessens, Frank] Catholic Univ Louvain, Fac Med, Dept Mol Cell Biol, Mol Endocrinol Lab, B-3000 Louvain, Belgium.
   [Podvinec, Michael] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Claessens, F (corresponding author), Catholic Univ Louvain, Fac Med, Dept Mol Cell Biol, Mol Endocrinol Lab, Campus Gasthuisberg,Onderwijs & Navorsing 1,Box 9, B-3000 Louvain, Belgium.
EM frank.claessens@med.kuleuven.be
RI Claessens, Frank/M-8565-2016
OI Claessens, Frank/0000-0002-8676-7709
CR ADLER AJ, 1991, MOL ENDOCRINOL, V5, P1587, DOI 10.1210/mend-5-11-1587
   ADLER AJ, 1992, P NATL ACAD SCI USA, V89, P11660, DOI 10.1073/pnas.89.24.11660
   Barbulescu K, 2001, MOL ENDOCRINOL, V15, P1803, DOI 10.1210/me.15.10.1803
   Bolton EC, 2007, GENE DEV, V21, P2005, DOI 10.1101/gad.1564207
   CLAESSENS F, 1989, BIOCHEM BIOPH RES CO, V164, P833, DOI 10.1016/0006-291X(89)91534-9
   Claessens F, 2001, J STEROID BIOCHEM, V76, P23, DOI 10.1016/S0960-0760(00)00154-0
   Claessens F, 1996, J BIOL CHEM, V271, P19013, DOI 10.1074/jbc.271.32.19013
   CLAESSENS F, 1990, MOL CELL ENDOCRINOL, V74, P203, DOI 10.1016/0303-7207(90)90225-W
   Cleutjens KBJM, 1996, J BIOL CHEM, V271, P6379, DOI 10.1074/jbc.271.11.6379
   Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004
   Dame C H, 1997, MOL CELL ENDOCRINOL, V132, P13
   Delporte C, 2006, BBA-BIOMEMBRANES, V1758, P1061, DOI 10.1016/j.bbamem.2006.01.022
   DePrimo SE, 2002, GENOME BIOL, V3
   Diehn M, 2003, NUCLEIC ACIDS RES, V31, P219, DOI 10.1093/nar/gkg014
   Flodby P, 2007, BIOCHEM BIOPH RES CO, V356, P26, DOI 10.1016/j.bbrc.2007.02.076
   Germain P, 2006, PHARMACOL REV, V58, P685, DOI 10.1124/pr.58.4.2
   Haelens A, 2003, BIOCHEM J, V369, P141, DOI 10.1042/BJ20020912
   Haelens A, 2007, CANCER RES, V67, P4514, DOI 10.1158/0008-5472.CAN-06-1701
   HAM J, 1988, NUCLEIC ACIDS RES, V16, P5263, DOI 10.1093/nar/16.12.5263
   Kobayashi M, 2006, GENES CELLS, V11, P1133, DOI 10.1111/j.1365-2443.2006.01009.x
   Komatsu K, 2000, NAT CELL BIOL, V2, P1
   Konttinen YT, 2006, AUTOIMMUN REV, V6, P16, DOI 10.1016/j.autrev.2006.03.003
   Lieberman HB, 2006, J CELL BIOCHEM, V97, P690, DOI 10.1002/jcb.20759
   Lu S, 1999, MOL ENDOCRINOL, V13, P376, DOI 10.1210/me.13.3.376
   LUND SD, 1991, CELL BIOL, V11, P5426
   Ma TH, 1999, J BIOL CHEM, V274, P20071, DOI 10.1074/jbc.274.29.20071
   Massie CE, 2007, EMBO REP, V8, P871, DOI 10.1038/sj.embor.7401046
   MURTHA P, 1993, BIOCHEMISTRY-US, V32, P6459, DOI 10.1021/bi00076a020
   Nelson CC, 1999, MOL ENDOCRINOL, V13, P2090, DOI 10.1210/me.13.12.2090
   Nelson PS, 2002, NUCLEIC ACIDS RES, V30, P218, DOI 10.1093/nar/30.1.218
   Nomura J, 2006, BIOCHEM BIOPH RES CO, V351, P1048, DOI 10.1016/j.bbrc.2006.10.159
   Parrilla-Castellar ER, 2004, DNA REPAIR, V3, P1009, DOI 10.1016/j.dnarep.2004.03.032
   Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269
   RENNIE PS, 1993, MOL ENDOCRINOL, V7, P23, DOI 10.1210/me.7.1.23
   Schauwaers K, 2007, P NATL ACAD SCI USA, V104, P4961, DOI 10.1073/pnas.0610814104
   SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097
   Schoenmakers E, 1999, BIOCHEM J, V341, P515, DOI 10.1042/0264-6021:3410515
   Schoenmakers E, 2000, J BIOL CHEM, V275, P12290, DOI 10.1074/jbc.275.16.12290
   Segawa T, 2002, ONCOGENE, V21, P8749, DOI 10.1038/sj.onc.1205992
   Steketee K, 2004, J MOL ENDOCRINOL, V33, P477, DOI 10.1677/jme.1.01478
   Sui XM, 1999, J BIOL CHEM, V274, P9449, DOI 10.1074/jbc.274.14.9449
   Tomlins SA, 2005, SCIENCE, V310, P644, DOI 10.1126/science.1117679
   Verrijdt G, 2000, J BIOL CHEM, V275, P12298, DOI 10.1074/jbc.275.16.12298
   Verrijdt G, 1999, MOL ENDOCRINOL, V13, P1558, DOI 10.1210/me.13.9.1558
   Verrijdt G, 2003, MOL GENET METAB, V78, P175, DOI 10.1016/S1096-7192(03)00003-9
   Verrijdt G, 2002, J BIOL CHEM, V277, P35191, DOI 10.1074/jbc.M205928200
   Wang L, 2004, MOL CELL BIOL, V24, P2202, DOI 10.1128/MCB.24.5.2202-2213.2004
   Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041
   Yin YX, 2004, P NATL ACAD SCI USA, V101, P8864, DOI 10.1073/pnas.0403130101
NR 49
TC 24
Z9 24
U1 0
U2 1
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 0264-6021
J9 BIOCHEM J
JI Biochem. J.
PD MAY 1
PY 2008
VL 411
BP 679
EP 686
DI 10.1042/BJ20071352
PN 3
PG 8
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 298QK
UT WOS:000255702000022
PM 18215141
DA 2021-01-25
ER

PT J
AU Lizano, E
   Scheibe, M
   Rammelt, C
   Betat, H
   Morl, M
AF Lizano, Esther
   Scheibe, Marion
   Rammelt, Christiane
   Betat, Heike
   Moerl, Mario
TI A comparative analysis of CCA-adding enzymes from human and E. coli:
   Differences in CCA addition and tRNA 3 '-end repair
SO BIOCHIMIE
LA English
DT Article
DE back-up mechanism; CCA-adding enzyme; tRNA nucleotidyltransferase
ID HEPATITIS-DELTA VIRUS; ESCHERICHIA-COLI; NUCLEOTIDYLTRANSFERASE
   SUPERFAMILY; HD DOMAIN; IN-VITRO; POLYMERIZATION; SUBSTRATE;
   3'-TERMINUS; MATURATION; TEMPLATE
AB Representing one of the most fascinating RNA polymerases, the CCA-adding enzyme (tRNA nucleotidyltransferase) is responsible for synthesis and repair of the 3'-terminal CCA sequence in tRNA transcripts. As a consequence of this important function, this enzyme is found in all organisms analyzed so far.
   Here, it is shown that the closely related enzymes of Homo sapiens and Escherichia coli differ substantially in their substrate preferences for the incorporation of CTP and ATP. While both enzymes require helical structures (mimicking the upper part of tRNAs) for C addition, the data indicate that the E. coli enzyme-in contrast to the human version-is quite promiscuous concerning the incorporation of ATP, where any RNA ending with two C residues is accepted. This feature is consistent with the primary function of the E. coli protein as a repair enzyme.
   Furthermore, even if the amino acid motif that interacts with the incoming nucleotides in the NTP binding pocket of these enzymes is destroyed and does no longer discriminate between individual bases, both nucleotidyltransferases have a back-up mechanism that ensures CCA addition with considerable accuracy and efficiency in order to guarantee functional protein synthesis and, consequently, the survival of the cell. (C) 2008 Elsevier Masson SAS. All rights reserved.
C1 [Lizano, Esther; Scheibe, Marion; Betat, Heike; Moerl, Mario] Univ Leipzig, Inst Biochem, D-04103 Leipzig, Germany.
   [Rammelt, Christiane] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Morl, M (corresponding author), Univ Leipzig, Inst Biochem, Bruderstr 34, D-04103 Leipzig, Germany.
EM moerl@uni-leipzig.de
OI Morl, Mario/0000-0003-0972-9386; Lizano, Esther/0000-0003-3304-9807
CR Aravind L, 1998, TRENDS BIOCHEM SCI, V23, P469, DOI 10.1016/S0968-0004(98)01293-6
   Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609
   BEEN MD, 1994, TRENDS BIOCHEM SCI, V19, P251, DOI 10.1016/0968-0004(94)90151-1
   Betat H, 2004, MOL CELL, V15, P389, DOI 10.1016/j.molcel.2004.06.026
   Cho HDD, 2002, J BIOL CHEM, V277, P3447, DOI 10.1074/jbc.M109559200
   Cho HD, 2007, P NATL ACAD SCI USA, V104, P54, DOI 10.1073/pnas.0606961104
   CHOWRIRA BM, 1994, J BIOL CHEM, V269, P25856
   CUDNY H, 1986, J BIOL CHEM, V261, P6450
   DEUTSCHER MP, 1985, P NATL ACAD SCI USA, V82, P6427, DOI 10.1073/pnas.82.19.6427
   HEGG LA, 1990, J BIOL CHEM, V265, P17441
   Helm M, 2000, RNA, V6, P1356, DOI 10.1017/S1355838200001047
   Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7
   Li YF, 1999, J AM CHEM SOC, V121, P5364, DOI 10.1021/ja990592p
   Li ZJ, 1997, BIOCHEM J, V327, P847, DOI 10.1042/bj3270847
   Li ZL, 1996, BIOCHEM J, V314, P49, DOI 10.1042/bj3140049
   Lizano E, 2007, J MOL BIOL, V366, P1258, DOI 10.1016/j.jmb.2006.12.016
   MASIAKOWSKI P, 1977, FEBS LETT, V77, P261, DOI 10.1016/0014-5793(77)80247-0
   Morl M., 2005, HDB RNA BIOCH, P22
   Nagaike T, 2001, J BIOL CHEM, V276, P40041, DOI 10.1074/jbc.M106202200
   Nakano S, 2007, BIOCHEMISTRY-US, V46, P3001, DOI 10.1021/bi061732s
   Okabe M, 2003, EMBO J, V22, P5918, DOI 10.1093/emboj/cdg563
   PADMANABHA KP, 1991, J BACTERIOL, V173, P1376, DOI 10.1128/jb.173.4.1376-1381.1991
   Reichert AS, 2001, BIOL CHEM, V382, P1431, DOI 10.1515/BC.2001.176
   Schimmel P, 2004, NAT STRUCT MOL BIOL, V11, P807, DOI 10.1038/nsmb0904-807
   Schurer H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf055
   Schurer H, 2001, BIOL CHEM, V382, P1147, DOI 10.1515/BC.2001.144
   Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197
   Shi PY, 1998, RNA, V4, P276
   Soukup GA, 1999, RNA, V5, P1308, DOI 10.1017/S1355838299990891
   Sprinzl M, 1979, Prog Nucleic Acid Res Mol Biol, V22, P1, DOI 10.1016/S0079-6603(08)60798-9
   THOMPSON JE, 1994, BIOCHEMISTRY-US, V33, P7408, DOI 10.1021/bi00189a047
   Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712
   Tomita K, 2006, NATURE, V443, P956, DOI 10.1038/nature05204
   Weiner AM, 2004, CURR BIOL, V14, pR883, DOI 10.1016/j.cub.2004.09.069
   Williams MA, 2000, NUCLEIC ACIDS RES, V28, P4444, DOI 10.1093/nar/28.22.4444
   Xiong Y, 2006, CURR OPIN STRUC BIOL, V16, P12, DOI 10.1016/j.sbi.2005.12.001
   Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711
   Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4
   Yakunin AF, 2004, J BIOL CHEM, V279, P36819, DOI 10.1074/jbc.M405120200
   Yue DX, 1998, J BIOL CHEM, V273, P29693, DOI 10.1074/jbc.273.45.29693
   Yue DX, 1996, RNA, V2, P895
   ZHU LQ, 1987, EMBO J, V6, P2473, DOI 10.1002/j.1460-2075.1987.tb02528.x
   Zuo YH, 2002, J BIOL CHEM, V277, P29654, DOI 10.1074/jbc.M204252200
NR 43
TC 33
Z9 33
U1 0
U2 6
PU ELSEVIER FRANCE-EDITIONS SCIENTIFIQUES MEDICALES ELSEVIER
PI PARIS
PA 23 RUE LINOIS, 75724 PARIS, FRANCE
SN 0300-9084
J9 BIOCHIMIE
JI Biochimie
PD MAY
PY 2008
VL 90
IS 5
BP 762
EP 772
DI 10.1016/j.biochi.2007.12.007
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 306NV
UT WOS:000256256000009
PM 18226598
DA 2021-01-25
ER

PT J
AU Bissiere, S
   Plachta, N
   Hoyer, D
   McAllister, KH
   Olpe, HR
   Grace, AA
   Cryan, JF
AF Bissiere, Stephanie
   Plachta, Nicolas
   Hoyer, Daniel
   McAllister, Kevin H.
   Olpe, Hans-Rudolf
   Grace, Anthony A.
   Cryan, John F.
TI The rostral anterior cingulate cortex modulates the efficiency of
   amygdala-dependent fear learning
SO BIOLOGICAL PSYCHIATRY
LA English
DT Article
DE amygdala; anterior cingulate cortex; fear acquisition; fear
   conditioning; medial prefrontal modulation
ID POSTTRAUMATIC-STRESS-DISORDER; OBSESSIVE-COMPULSIVE DISORDER; MEDIAL
   PREFRONTAL CORTEX; ANXIETY-RELATED-BEHAVIOR; SYMPTOM PROVOCATION;
   FUNCTIONAL INACTIVATION; VISUAL-DISCRIMINATION; BASOLATERAL AMYGDALA;
   POSTERIOR CINGULATE; CONDITIONED FEAR
AB Background: The rostral anterior cingulate cortex (rACC) and the amygdala consistently emerge from neuroimaging studies as brain regions crucially involved in normal and abnormal fear processing. To date, however,the role of the rACC specifically during the acquisition of auditory fear conditioning still remains unknown. The aim of this study is to investigate a possible top-down control of a specific rACC sub-region over amygdala activation during pavlovian fear acquisition.
   Methods: We performed excitotoxic lesions, temporal inactivation, and activation of a specific sub-region of the rACC that we identified by tracing studies as supporting most of the connectivity with the basolateral amygdala (r(Amy)-ACC). The effects of these manipulations over amygdala function were investigated with a classical tone-shock associative fear conditioning paradigm in the rat.
   Results: Excitotoxic lesions and transient inactivation of the r(Amy)-ACC pre-training selectively produced deficits in the acquisition of the tone-shock associative learning (but not context). This effect was specific for the acquisition phase. However, the deficit was found to be transient and could be overcome by overtraining. Conversely, pre-training transient activation of the r(Amy)-ACC facilitated associative learning and increased fear expression.
   Conclusions: Our results suggest that a subregion of the rACC is key to gating the efficiency of amygdala-dependent auditory fear conditioning learning. Because r(Amy)-ACC inputs were confirmed to be glutamatergic, we propose that recruitment of this brain area might modulate overall basolateral amygdala excitatory tone during conditioned stimulus-unconditioned stimulus concomitant processing. In the light of clinical research, our results provide new insight on the effect of inappropriate rACC recruitment during emotional events.
C1 [Cryan, John F.] Natl Univ Ireland Univ Coll Cork, Dept Pharmacol & Therapeut, Sch Pharm, Cork, Ireland.
   [Bissiere, Stephanie; Hoyer, Daniel; McAllister, Kevin H.; Olpe, Hans-Rudolf; Cryan, John F.] Novartis Pharma AG, Novartis Inst BioMed Res, Basel, Switzerland.
   [Plachta, Nicolas] Univ Basel, Biozentrum, Dept Neurobiol, Basel, Switzerland.
   [Grace, Anthony A.] Univ Pittsburgh, Dept Neurosci Psychiat & Psychol, Pittsburgh, PA USA.
RP Cryan, JF (corresponding author), Natl Univ Ireland Univ Coll Cork, Dept Pharmacol & Therapeut, Sch Pharm, Cavanagh Pharm Bldg, Cork, Ireland.
EM j.cryan@ucc.ie
RI Cryan, John F./A-6950-2013; hoyer, daniel/L-3647-2019
OI Cryan, John F./0000-0001-5887-2723; hoyer, daniel/0000-0002-1405-7089;
   Grace, Anthony/0000-0003-1864-5504
FU NIDA NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Drug Abuse
   (NIDA) [R01 DA015408, R01 DA015408-07] Funding Source: Medline; NATIONAL
   INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   on Drug Abuse (NIDA) [R01DA015408, R01DA015408, R01DA015408,
   R01DA015408, R01DA015408, R01DA015408, R01DA015408, R01DA015408] Funding
   Source: NIH RePORTER
CR AGGLETON JP, 1980, BRAIN RES, V190, P347, DOI 10.1016/0006-8993(80)90279-6
   Aguado Luis, 2003, Span J Psychol, V6, P155
   Bissiere S, 2006, BEHAV BRAIN RES, V175, P195, DOI 10.1016/j.bbr.2006.08.022
   Blair HT, 2005, J NEUROSCI, V25, P4198, DOI 10.1523/JNEUROSCI.0674-05.2005
   Breiter HC, 1996, ARCH GEN PSYCHIAT, V53, P595
   Buchel C, 2000, CURR OPIN NEUROBIOL, V10, P219, DOI 10.1016/S0959-4388(00)00078-7
   Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2
   Bush G, 1999, BIOL PSYCHIAT, V45, P1542, DOI 10.1016/S0006-3223(99)00083-9
   Bussey TJ, 1996, BEHAV BRAIN RES, V82, P45, DOI 10.1016/S0166-4328(97)81107-2
   Bussey TJ, 1997, BEHAV NEUROSCI, V111, P920, DOI 10.1037/0735-7044.111.5.920
   Cannistraro Paul A, 2003, Psychopharmacol Bull, V37, P8
   CASSELL MD, 1986, BRAIN RES BULL, V17, P321, DOI 10.1016/0361-9230(86)90237-6
   COLEMANMESCHES K, 1995, BRAIN RES, V670, P75, DOI 10.1016/0006-8993(94)01272-J
   CONDE F, 1995, J COMP NEUROL, V352, P567, DOI 10.1002/cne.903520407
   Cryan JF, 2005, NAT REV DRUG DISCOV, V4, P775, DOI 10.1038/nrd1825
   Cryan JF, 2004, J PHARMACOL EXP THER, V310, P952, DOI 10.1124/jpet.104.066753
   Davis KD, 2000, NEUROL RES, V22, P313
   Davis M, 2001, MOL PSYCHIATR, V6, P13, DOI 10.1038/sj.mp.4000812
   Demaree Heath A, 2005, Behav Cogn Neurosci Rev, V4, P3, DOI 10.1177/1534582305276837
   DENENBERG VH, 1983, AM J PHYSIOL, V245, pR505
   DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279
   DICKINSONANSON H, 1993, BEHAV NEURAL BIOL, V60, P1, DOI 10.1016/0163-1047(93)90638-X
   Etkin A, 2006, NEURON, V51, P871, DOI 10.1016/j.neuron.2006.07.029
   Fendt M, 1999, NEUROSCI BIOBEHAV R, V23, P743, DOI 10.1016/S0149-7634(99)00016-0
   Frankland PW, 2006, LEARN MEMORY, V13, P451, DOI 10.1101/lm.183406
   Frankland PW, 2005, NAT REV NEUROSCI, V6, P119, DOI 10.1038/nrn1607
   Frankland PW, 2004, SCIENCE, V304, P881, DOI 10.1126/science.1094804
   GABRIEL M, 1990, PROG BRAIN RES, V85, P467
   GODEMENT P, 1987, DEVELOPMENT, V101, P697
   Han CJ, 2003, P NATL ACAD SCI USA, V100, P13087, DOI 10.1073/pnas.2132313100
   Hariri AR, 2003, BIOL PSYCHIAT, V53, P494, DOI 10.1016/S0006-3223(02)01786-9
   Imanaka A, 2006, BEHAV BRAIN RES, V173, P129, DOI 10.1016/j.bbr.2006.06.012
   Johansen JP, 2001, P NATL ACAD SCI USA, V98, P8077, DOI 10.1073/pnas.141218998
   Johansen JP, 2004, NAT NEUROSCI, V7, P398, DOI 10.1038/nn1207
   Jones BF, 2005, NEUROSCIENCE, V133, P193, DOI 10.1016/j.neuroscience.2005.01.063
   Kennerley SW, 2006, NAT NEUROSCI, V9, P940, DOI 10.1038/nn1724
   Killgore WDS, 2004, NEUROIMAGE, V21, P1215, DOI 10.1016/j.neuroimage.2003.12.033
   Knight DC, 2004, J NEUROSCI, V24, P218, DOI 10.1523/JNEUROSCI.0433-03.2004
   Knight DC, 1999, NEUROREPORT, V10, P3665, DOI 10.1097/00001756-199911260-00037
   Koyama T, 2005, P NATL ACAD SCI USA, V102, P12950, DOI 10.1073/pnas.0408576102
   Lebron K, 2004, LEARN MEMORY, V11, P544, DOI 10.1101/lm.78604
   LeDoux J, 2003, CELL MOL NEUROBIOL, V23, P727, DOI 10.1023/A:1025048802629
   LEVY J, 1979, TRENDS NEUROSCI, V2, P222, DOI 10.1016/0166-2236(79)90087-0
   Malin EL, 2007, NEUROBIOL LEARN MEM, V87, P295, DOI 10.1016/j.nlm.2006.09.004
   Maren S, 2001, ANNU REV NEUROSCI, V24, P897, DOI 10.1146/annurev.neuro.24.1.897
   MARTIN JH, 1991, NEUROSCI LETT, V127, P160, DOI 10.1016/0304-3940(91)90784-Q
   Milad MR, 2006, BIOL PSYCHOL, V73, P61, DOI 10.1016/j.biopsycho.2006.01.008
   Morris JS, 1998, NATURE, V393, P467, DOI 10.1038/30976
   Muigg P, 2007, BIOL PSYCHIAT, V61, P782, DOI 10.1016/j.biopsych.2006.08.035
   Muller J, 1997, BEHAV NEUROSCI, V111, P683, DOI 10.1037/0735-7044.111.4.683
   Muller JF, 2006, J COMP NEUROL, V494, P635, DOI 10.1002/cne.20832
   OTTERSEN OP, 1982, J COMP NEUROL, V205, P30, DOI 10.1002/cne.902050104
   Ozdinler PH, 2006, NAT NEUROSCI, V9, P1371, DOI 10.1038/nn1789
   Park JK, 2000, SPORT PSYCHOL, V14, P63, DOI 10.1123/tsp.14.1.63
   Phelps EA, 2001, NAT NEUROSCI, V4, P437, DOI 10.1038/86110
   Pitkanen A, 2000, Folia Morphol (Warsz), V59, P1
   Pitkanen A., 2000, AMYGDALA FUNCTIONAL, P31, DOI DOI 10.1080/713932668
   Quirk GJ, 2006, CURR OPIN NEUROBIOL, V16, P723, DOI 10.1016/j.conb.2006.07.004
   Quirk GJ, 2006, BIOL PSYCHIAT, V60, P337, DOI 10.1016/j.biopsych.2006.03.010
   RAUCH SL, 1995, ARCH GEN PSYCHIAT, V52, P20
   RAUCH SL, 1994, ARCH GEN PSYCHIAT, V51, P62
   Rosenkranz JA, 2003, J NEUROSCI, V23, P11054
   Salome N, 2004, BIOL PSYCHIAT, V55, P715, DOI 10.1016/j.biopsych.2003.10.021
   Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X
   Singewald N, 2003, BIOL PSYCHIAT, V53, P275, DOI 10.1016/S0006-3223(02)01574-3
   SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111
   VOGT BA, 1992, CEREB CORTEX, V2, P435, DOI 10.1093/cercor/2.6.435-a
   Wilensky AE, 1999, J NEUROSCI, V19
   Wiltgen BJ, 2006, J NEUROSCI, V26, P5484, DOI 10.1523/JNEUROSCI.2685-05.2006
   Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014
NR 70
TC 81
Z9 83
U1 0
U2 17
PU ELSEVIER SCIENCE INC
PI NEW YORK
PA 360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA
SN 0006-3223
EI 1873-2402
J9 BIOL PSYCHIAT
JI Biol. Psychiatry
PD MAY 1
PY 2008
VL 63
IS 9
BP 821
EP 831
DI 10.1016/j.biopsych.2007.10.022
PG 11
WC Neurosciences; Psychiatry
SC Neurosciences & Neurology; Psychiatry
GA 287VU
UT WOS:000254945400002
PM 18155183
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Friedrich, MG
   Robertson, JWF
   Walz, D
   Knoll, W
   Naumann, RLC
AF Friedrich, Marcel G.
   Robertson, Joseph W. F.
   Walz, Dieter
   Knoll, Wolfgang
   Naumann, Renate L. C.
TI Electronic wiring of a multi-redox site membrane protein in a biomimetic
   surface architecture
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID CYTOCHROME-C-OXIDASE; LIPID-MEMBRANE; RHODOBACTER-SPHAEROIDES; PROTON
   TRANSLOCATION; FILM VOLTAMMETRY; CATALYTIC CYCLE; BILAYER; REDUCTION;
   KINETICS; PURIFICATION
AB Bioelectronic coupling of multi-redox-site membrane proteins was accomplished with cytochrome c oxidase (CcO) as an example. A biomimetic membrane system was used for the oriented immobilization of the CcO oxidase on a metal electrode. When the protein is immobilized with the CcO binding side directed toward the electrode and reconstituted in situ into a lipid bilayer, it is addressable by direct electron transfer to the redox centers. Electron transfer to the enzyme via the spacer, referred to as electronic wiring, shows an exceptionally high rate constant. This allows a kinetic analysis of all four consecutive electron transfer steps within the enzyme to be carried out. Electron transfer followed by rapid scan cyclic voltametry in combination with surface-enhanced resonance Raman spectroscopy provides mechanistic and structural information about the heme centers. Probing the enzyme under turnover conditions showed mechanistic insights into proton translocation coupled to electron transfer. This bio-electronic approach opens a new field of activity to investigate complex processes in a wide variety of membrane proteins.
C1 [Friedrich, Marcel G.; Robertson, Joseph W. F.; Knoll, Wolfgang; Naumann, Renate L. C.] Max Planck Inst Polymer Res, D-55128 Mainz, Germany.
   [Walz, Dieter] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
RP Naumann, RLC (corresponding author), Max Planck Inst Polymer Res, Ackermannweg 10, D-55128 Mainz, Germany.
OI Robertson, Joseph/0000-0002-2087-3939
CR Armstrong FA, 2002, J CHEM SOC DALTON, P661, DOI 10.1039/b108359g
   Ataka K, 2004, J AM CHEM SOC, V126, P16199, DOI 10.1021/ja045951h
   Bard AJ, 2001, ELECTROCHEMICAL METH
   Blankespoor R, 2005, LANGMUIR, V21, P3362, DOI 10.1021/la047139y
   Budnikova YG, 1996, ZH OBSHCH KHIM+, V66, P1876
   CULLISON JK, 1994, LANGMUIR, V10, P877, DOI 10.1021/la00015a044
   Dopner S, 2000, BBA-PROTEIN STRUCT M, V1480, P57, DOI 10.1016/S0167-4838(00)00103-5
   Faxen K, 2005, NATURE, V437, P286, DOI 10.1038/nature03921
   Friedrich MG, 2004, CHEM COMMUN, P2376, DOI 10.1039/b410998h
   Giess F, 2004, BIOPHYS J, V87, P3213, DOI 10.1529/biophysj.104.046169
   Gorbikova EA, 2006, BIOCHEMISTRY-US, V45, P5641, DOI 10.1021/bi060257v
   HEIBEL GE, 1993, BIOCHEMISTRY-US, V32, P10866, DOI 10.1021/bi00091a042
   Hellwig P, 2002, BIOCHEMISTRY-US, V41, P9116, DOI 10.1021/bi012056r
   Hill T., 1977, FREE ENERGY TRANSDUC
   Hirst J, 1996, J AM CHEM SOC, V118, P5031, DOI 10.1021/ja9534361
   Hirst J, 1998, J AM CHEM SOC, V120, P7085, DOI 10.1021/ja980380c
   HOSLER JP, 1992, J BIOL CHEM, V267, P24264
   Jeuken LJC, 2006, J AM CHEM SOC, V128, P1711, DOI 10.1021/ja056972u
   Jeuken LJC, 2003, BBA-BIOENERGETICS, V1604, P67, DOI 10.1016/S0005-2728(03)00026-4
   Jeuken LJC, 2002, J PHYS CHEM B, V106, P2304, DOI 10.1021/jp0134291
   KOBAYASHI K, 1989, J BIOL CHEM, V264, P7976
   LAVIRON E, 1979, J ELECTROANAL CHEM, V101, P19, DOI 10.1016/S0022-0728(79)80075-3
   Leger C, 2003, BIOCHEMISTRY-US, V42, P8653, DOI 10.1021/bi034789c
   Michel H, 1999, BIOCHEMISTRY-US, V38, P15129, DOI 10.1021/bi9910934
   MITCHELL DM, 1995, FEBS LETT, V368, P148, DOI 10.1016/0014-5793(95)00626-K
   MOODY AJ, 1991, FEBS LETT, V293, P101, DOI 10.1016/0014-5793(91)81161-Z
   Naumann R, 2002, BIOSENS BIOELECTRON, V17, P25, DOI 10.1016/S0956-5663(01)00182-8
   Naumann R, 1999, BIOSENS BIOELECTRON, V14, P651, DOI 10.1016/S0956-5663(99)00036-6
   Naumann R, 2003, LANGMUIR, V19, P5435, DOI 10.1021/la0342060
   NILSSON T, 1992, P NATL ACAD SCI USA, V89, P6497, DOI 10.1073/pnas.89.14.6497
   Pfitzner U, 1998, J BIOENERG BIOMEMBR, V30, P89, DOI 10.1023/A:1020515713103
   Richter OMH, 2003, REV PHYSIOL BIOCH P, V147, P47, DOI 10.1007/s10254-003-0006-0
   Ruitenberg M, 2002, NATURE, V417, P99, DOI 10.1038/417099a
   SALAMON Z, 1993, P NATL ACAD SCI USA, V90, P6420, DOI 10.1073/pnas.90.14.6420
   Svensson-Ek M, 2002, J MOL BIOL, V321, P329, DOI 10.1016/S0022-2836(02)00619-8
   Szundi I, 2001, BIOCHEMISTRY-US, V40, P2186, DOI 10.1021/bi002341v
   TSUKIHARA T, 1995, SCIENCE, V269, P1069, DOI 10.1126/science.7652554
   VANDERKOOI JM, 1987, J BIOL CHEM, V262, P5476
   Verkhovsky MI, 1999, NATURE, V400, P480
   VERKHOVSKY MI, 1995, BIOCHEMISTRY-US, V34, P7483, DOI 10.1021/bi00022a023
   Verkhovsky MI, 2006, BBA-BIOENERGETICS, V1757, P401, DOI 10.1016/j.bbabio.2006.05.026
   WALZ D, 1995, BIOELECTROCHEMISTRY, V1
   Wikstrom M, 2004, BBA-BIOENERGETICS, V1655, P241, DOI 10.1016/j.bbabio.2003.07.013
   WINKLER JR, 1995, BIOPHYS CHEM, V54, P199, DOI 10.1016/0301-4622(94)00156-E
   Zaslavsky D, 2000, BBA-BIOENERGETICS, V1458, P164, DOI 10.1016/S0005-2728(00)00066-9
NR 45
TC 35
Z9 35
U1 0
U2 19
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD MAY 1
PY 2008
VL 94
IS 9
BP 3698
EP 3705
DI 10.1529/biophysj.107.117846
PG 8
WC Biophysics
SC Biophysics
GA 286EW
UT WOS:000254829700030
PM 18222995
OA Green Published
DA 2021-01-25
ER

PT J
AU Maillet, F
   Bischoff, V
   Vignal, C
   Hoffmann, J
   Royet, J
AF Maillet, Frederic
   Bischoff, Vincent
   Vignal, Cecile
   Hoffmann, Jules
   Royet, Julien
TI The Drosophila peptidoglycan recognition protein PGRP-LF blocks PGRP-LC
   and IMD/JNK pathway activation
SO CELL HOST & MICROBE
LA English
DT Article
ID NF-KAPPA-B; L-ALANINE AMIDASE; INNATE IMMUNE-RESPONSES; GRAM-POSITIVE
   BACTERIA; GENOME-WIDE ANALYSIS; PATTERN-RECOGNITION; ANTIBACTERIAL
   DEFENSE; DOWN-REGULATION; FACTOR RELISH; TOLL PATHWAY
AB Eukaryotic peptidoglycan recognition proteins (PGRPs) are related to bacterial amidases. In Drosophila, PGRPs bind peptidoglycan and function as central sensors and regulators of the innate immune response. PGRP-LC/PGRP-LE constitute the receptor complex in the immune deficiency (IMD) pathway, which is an innate immune cascade triggered upon Gram-negative bacterial infection. Here, we present the functional analysis of the nonamidase, membrane-associated PGRP-LF. We show that PGRP-LF acts as a specific negative regulator of the IMID pathway. Reduction of PGRP-LF levels, in the absence of infection, is sufficient to trigger IMID pathway activation. Furthermore, normal development is impaired in the absence of functional PGRP-LF, a phenotype mediated by the JNK pathway. Thus, PGRP-LF prevents constitutive activation of both the JNK and the IMID pathways. We propose a model in which PGRP-LF keeps the Drosophila IMID pathway silent by sequestering circulating peptidoglycan.
C1 [Maillet, Frederic; Royet, Julien] Univ Aix Marseille 2, Inst Biol Dev Marseille Luminy, CNRS, UMR 6216, F-13288 Marseille 9, France.
   [Bischoff, Vincent] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Vignal, Cecile] Ctr Hosp Reg & Univ Lille, Hop Swynghedauw, INSERM, U795, F-59037 Lille, France.
   [Hoffmann, Jules] CNRS, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France.
RP Royet, J (corresponding author), Univ Aix Marseille 2, Inst Biol Dev Marseille Luminy, CNRS, UMR 6216, Parc Sci Luminy Case 907, F-13288 Marseille 9, France.
EM j.royet@ibdm.univ-mrs.fr
RI Vignal, Cecile/K-9913-2018
OI Vignal, Cecile/0000-0002-4674-9565
CR Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112
   Bischoff V, 2004, NAT IMMUNOL, V5, P1175, DOI 10.1038/ni1123
   Bischoff Vincent, 2006, PLoS Pathog, V2, pe14
   Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002
   Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8
   Brennan CA, 2004, ANNU REV IMMUNOL, V22, P457, DOI 10.1146/annurev.immunol.22.012703.104626
   Chang CI, 2006, SCIENCE, V311, P1761, DOI 10.1126/science.1123056
   Chang CI, 2005, P NATL ACAD SCI USA, V102, P10279, DOI 10.1073/pnas.0504547102
   Choe KM, 2005, P NATL ACAD SCI USA, V102, P1122, DOI 10.1073/pnas.0404952102
   Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216
   De Gregorio E, 2001, P NATL ACAD SCI USA, V98, P12590, DOI 10.1073/pnas.221458698
   Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217
   Garver LS, 2006, P NATL ACAD SCI USA, V103, P660, DOI 10.1073/pnas.0506182103
   Gelius E, 2003, BIOCHEM BIOPH RES CO, V306, P988, DOI 10.1016/S0006-291X(03)01096-9
   Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4
   GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X
   Gobert V, 2003, SCIENCE, V302, P2126, DOI 10.1126/science.1085432
   Gordon MD, 2005, NATURE, V437, P746, DOI 10.1038/nature04073
   Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734
   Guan RJ, 2004, P NATL ACAD SCI USA, V101, P17168, DOI 10.1073/pnas.0407856101
   Irving P, 2001, P NATL ACAD SCI USA, V98, P15119, DOI 10.1073/pnas.261573998
   Kallio J, 2005, MICROBES INFECT, V7, P811, DOI 10.1016/j.micinf.2005.03.014
   Kaneko T, 2004, IMMUNITY, V20, P637, DOI 10.1016/S1074-7613(04)00104-9
   Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356
   Kang DW, 1998, P NATL ACAD SCI USA, V95, P10078, DOI 10.1073/pnas.95.17.10078
   Kim LK, 2007, PLOS BIOL, V5, P2064, DOI 10.1371/journal.pbio.0050238
   Kim MS, 2003, NAT IMMUNOL, V4, P787, DOI 10.1038/ni952
   Kim T, 2005, NAT IMMUNOL, V6, P211, DOI 10.1038/ni1159
   Kumar S, 2005, J BIOL CHEM, V280, P37005, DOI 10.1074/jbc.M506385200
   Lemaitre B, 2007, ANNU REV IMMUNOL, V25, P697, DOI 10.1146/annurev.immunol.25.022106.141615
   Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073
   Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922
   Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4
   Li X, 2007, IMMUNITY, V27, P518, DOI 10.1016/j.immuni.2007.07.020
   Liu C, 2001, J BIOL CHEM, V276, P34686, DOI 10.1074/jbc.M105566200
   Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901
   Mellroth P, 2005, P NATL ACAD SCI USA, V102, P6455, DOI 10.1073/pnas.0407559102
   Mellroth P, 2003, J BIOL CHEM, V278, P7059, DOI 10.1074/jbc.M208900200
   Mellroth P, 2006, BIOCHEM BIOPH RES CO, V350, P994, DOI 10.1016/j.bbrc.2006.09.139
   Merino D, 2006, MOL CELL BIOL, V26, P7046, DOI 10.1128/MCB.00520-06
   Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a
   Naitza S, 2002, IMMUNITY, V17, P575, DOI 10.1016/S1074-7613(02)00454-5
   Park JM, 2004, GENE DEV, V18, P584, DOI 10.1101/gad.1168104
   Peng J, 2005, CURR BIOL, V15, P1690, DOI 10.1016/j.cub.2005.08.048
   Persson C, 2007, INSECT BIOCHEM MOLEC, V37, P1309, DOI 10.1016/j.ibmb.2007.08.003
   Pili-Floury S, 2004, J BIOL CHEM, V279, P12848, DOI 10.1074/jbc.M313324200
   Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735
   Royet J, 2005, CURR OPIN IMMUNOL, V17, P11, DOI 10.1016/j.coi.2004.12.002
   Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801
   Rutschmann S, 2000, IMMUNITY, V12, P569, DOI 10.1016/S1074-7613(00)80208-3
   Silverman N, 2000, GENE DEV, V14, P2461, DOI 10.1101/gad.817800
   Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200
   Stenbak CR, 2004, J IMMUNOL, V173, P7339, DOI 10.4049/jimmunol.173.12.7339
   Stoven S, 2000, EMBO REP, V1, P347, DOI 10.1093/embo-reports/kvd072
   Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100
   Stronach B, 2002, GENE DEV, V16, P377, DOI 10.1101/gad.953002
   Swaminathan CP, 2006, P NATL ACAD SCI USA, V103, P684, DOI 10.1073/pnas.0507656103
   Takehana A, 2004, EMBO J, V23, P4690, DOI 10.1038/sj.emboj.7600466
   Takehana A, 2002, P NATL ACAD SCI USA, V99, P13705, DOI 10.1073/pnas.212301199
   Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301
   Wang ZM, 2003, J BIOL CHEM, V278, P49044, DOI 10.1074/jbc.M307758200
   Werner T, 2000, P NATL ACAD SCI USA, V97, P13772, DOI 10.1073/pnas.97.25.13772
   Yoshida H, 1996, J BIOL CHEM, V271, P13854, DOI 10.1074/jbc.271.23.13854
   Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012
NR 64
TC 110
Z9 118
U1 0
U2 17
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 1931-3128
EI 1934-6069
J9 CELL HOST MICROBE
JI Cell Host Microbe
PD MAY
PY 2008
VL 3
IS 5
BP 293
EP 303
DI 10.1016/j.chom.2008.04.002
PG 11
WC Microbiology; Parasitology; Virology
SC Microbiology; Parasitology; Virology
GA 302MO
UT WOS:000255972600006
PM 18474356
DA 2021-01-25
ER

PT J
AU Prince, F
   Katsuyama, T
   Oshima, Y
   Plaza, S
   Resendez-Perez, D
   Berry, M
   Kurata, S
   Gehring, WJ
AF Prince, Frederic
   Katsuyama, Tomonori
   Oshima, Yoshiteru
   Plaza, Serge
   Resendez-Perez, Diana
   Berry, Meera
   Kurata, Shoichiro
   Gehring, Walter J.
TI The YPWM motif links Antennapedia to the basal transcriptional machinery
SO DEVELOPMENT
LA English
DT Article
DE ANTP; HOX; bip2; dTAF3; Drosophila; eye-to-wing transformation; homeotic
   transformation
ID DROSOPHILA EYE DEVELOPMENT; DNA-SEQUENCE RECOGNITION; ADJACENT HOMOLOGY
   DOMAIN; HOX PROTEIN; FUNCTIONAL SPECIFICITY; PHD FINGER;
   GENE-EXPRESSION; HOMEOTIC GENES; ECTOPIC EXPRESSION; SEGMENTAL IDENTITY
AB HOX genes specify segment identity along the anteroposterior axis of the embryo. They code for transcription factors harbouring the highly conserved homeodomain and a YPWM motif, situated amino terminally to it. Despite their highly diverse functions in vivo, HOX proteins display similar biochemical properties in vitro, raising the question of how this specificity is achieved. In our study, we investigated the importance of the Antennapedia (Antp) YPWM motif for homeotic transformations in adult Drosophila. By ectopic overexpression, the head structures of the fly can be transformed into structures of the second thoracic segment, such as antenna into second leg, head capsule into thorax (notum) and eye into wing. We found that the YPWM motif is absolutely required for the eye-to-wing transformation. Using the yeast two-hybrid system, we were able to identify a novel ANTP-interacting protein, Bric-a-brac interacting protein 2 (BIP2), that specifically interacts with the YPWM motif of ANTP in vitro, as well as in vivo, transforming eye to wing tissue. BIP2 is a TATA-binding protein associated factor (also known as dTAFII3) that links ANTP to the basal transcriptional machinery.
C1 [Prince, Frederic; Gehring, Walter J.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Katsuyama, Tomonori; Oshima, Yoshiteru; Kurata, Shoichiro] Swiss Fed Inst Technol, Dept Biosyst, CH-4058 Basel, Switzerland.
   [Plaza, Serge] Ctr Dev Biol, CNS, F-31062 Toulouse, France.
   [Berry, Meera] Micromet AG, D-82152 Martinsried, Germany.
RP Gehring, WJ (corresponding author), Univ Basel, Biozentrum, Klingelberstr 70, CH-4056 Basel, Switzerland.
EM walter.gehring@unibas.ch
RI Resendez-Perez, Diana/AAE-3352-2019; plaza, serge/F-5290-2015
OI Resendez-Perez, Diana/0000-0002-4709-7677; 
CR AASLAND R, 1995, TRENDS BIOCHEM SCI, V20, P56, DOI 10.1016/S0968-0004(00)88957-4
   Akam M, 1998, CURR BIOL, V8, pR676, DOI 10.1016/S0960-9822(98)70433-6
   Albright SR, 2000, GENE, V242, P1, DOI 10.1016/S0378-1119(99)00495-3
   Aldaz S, 2003, DEVELOPMENT, V130, P4473, DOI 10.1242/dev.00643
   Baena-Lopez LA, 2003, DEVELOPMENT, V130, P197, DOI 10.1242/dev.00187
   BARTEL PL, 1995, METHOD ENZYMOL, V254, P241
   Bello B, 1998, DEVELOPMENT, V125, P2193
   Berry M, 2000, EMBO J, V19, P2946, DOI 10.1093/emboj/19.12.2946
   Biggin MD, 1997, DEVELOPMENT, V124, P4425
   BONINI NM, 1993, CELL, V72, P379, DOI 10.1016/0092-8674(93)90115-7
   BRAND AH, 1993, DEVELOPMENT, V118, P401
   Callebaut I, 1999, FEBS LETT, V446, P189, DOI 10.1016/S0014-5793(99)00132-5
   CARROLL SB, 1995, NATURE, V375, P58, DOI 10.1038/375058a0
   Casares F, 1998, NATURE, V392, P723, DOI 10.1038/33706
   Casares F, 1996, EMBO J, V15, P3934, DOI 10.1002/j.1460-2075.1996.tb00767.x
   CHAN SK, 1993, GENE DEV, V7, P796, DOI 10.1101/gad.7.5.796
   Chan SK, 1996, P NATL ACAD SCI USA, V93, P5223, DOI 10.1073/pnas.93.11.5223
   Chauvet S, 2000, P NATL ACAD SCI USA, V97, P4064, DOI 10.1073/pnas.070046997
   Connolly JB, 1996, SCIENCE, V274, P2104, DOI 10.1126/science.274.5295.2104
   COUSO JP, 1994, DEVELOPMENT, V120, P621
   EKKER SC, 1994, EMBO J, V13, P3551, DOI 10.1002/j.1460-2075.1994.tb06662.x
   EKKER SC, 1991, EMBO J, V10, P1179, DOI 10.1002/j.1460-2075.1991.tb08058.x
   FORTINI ME, 1993, NATURE, V365, P555, DOI 10.1038/365555a0
   Furriols M, 2001, CURR BIOL, V11, P60, DOI 10.1016/S0960-9822(00)00044-0
   FURUKUBOTOKUNAGA K, 1993, P NATL ACAD SCI USA, V90, P6360, DOI 10.1073/pnas.90.13.6360
   Galant R, 2002, DEVELOPMENT, V129, P3115
   Gangloff YG, 2001, MOL CELL BIOL, V21, P5109, DOI 10.1128/MCB.21.15.5109-5121.2001
   GARBER RL, 1983, EMBO J, V2, P2027, DOI 10.1002/j.1460-2075.1983.tb01696.x
   Gebelein B, 2002, DEV CELL, V3, P487, DOI 10.1016/S1534-5807(02)00257-5
   GEHRING WJ, 1994, CELL, V78, P211, DOI 10.1016/0092-8674(94)90292-5
   Georgieva S, 2000, MOL CELL BIOL, V20, P1639, DOI 10.1128/MCB.20.5.1639-1648.2000
   GONZALEZCRESPO S, 1995, DEVELOPMENT, V121, P2117
   Grant PA, 1998, CELL, V94, P45, DOI 10.1016/S0092-8674(00)81220-9
   Halder G, 1998, DEVELOPMENT, V125, P2181
   Hauck B, 1999, P NATL ACAD SCI USA, V96, P564, DOI 10.1073/pnas.96.2.564
   Hittinger CT, 2005, DEVELOPMENT, V132, P5261, DOI 10.1242/dev.02146
   IZPISUABELMONTE JC, 1991, NATURE, V350, P585, DOI 10.1038/350585a0
   Jang CC, 2003, DEVELOPMENT, V130, P2939, DOI 10.1242/dev.00522
   Jaw TJ, 2000, MECH DEVELOP, V91, P279, DOI 10.1016/S0925-4773(99)00316-0
   Joshi R, 2007, CELL, V131, P530, DOI 10.1016/j.cell.2007.09.024
   Katsuyama T, 2005, P NATL ACAD SCI USA, V102, P15918, DOI 10.1073/pnas.0507945102
   Kim J, 1996, NATURE, V382, P133, DOI 10.1038/382133a0
   KUHN DT, 1993, GENETICS, V133, P593
   Kurata S, 2000, P NATL ACAD SCI USA, V97, P2117, DOI 10.1073/pnas.040556497
   KUZIORA MA, 1993, MECH DEVELOP, V42, P125, DOI 10.1016/0925-4773(93)90002-F
   LEWIS EB, 1978, NATURE, V276, P565, DOI 10.1038/276565a0
   Li HT, 2006, NATURE, V442, P91, DOI 10.1038/nature04802
   Li XL, 1999, EMBO J, V18, P198, DOI 10.1093/emboj/18.1.198
   Li XL, 1999, P NATL ACAD SCI USA, V96, P6802, DOI 10.1073/pnas.96.12.6802
   LIN L, 1992, GENE DEV, V6, P1071, DOI 10.1101/gad.6.6.1071
   Lohr U, 2005, CURR BIOL, V15, P643, DOI 10.1016/j.cub.2005.02.048
   Mann RS, 2000, ANNU REV CELL DEV BI, V16, P243, DOI 10.1146/annurev.cellbio.16.1.243
   MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y
   Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3
   Martinez E, 1998, J BIOL CHEM, V273, P23781, DOI 10.1074/jbc.273.37.23781
   Maves L, 2003, CURR OPIN GENET DEV, V13, P472, DOI 10.1016/j.gde.2003.08.006
   MCGINNIS W, 1984, CELL, V37, P403, DOI 10.1016/0092-8674(84)90370-2
   Merabet S, 2003, DEV CELL, V4, P761, DOI 10.1016/S1534-5807(03)00126-6
   Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2
   Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833
   PEIFER M, 1990, GENE DEV, V4, P1209, DOI 10.1101/gad.4.7.1209
   Pena PV, 2006, NATURE, V442, P100, DOI 10.1038/nature04814
   Percival-Smith A, 1998, GENETICS, V150, P189
   PHILLIPS RG, 1993, DEVELOPMENT, V118, P427
   Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5
   Plaza S, 2001, EMBO J, V20, P802, DOI 10.1093/emboj/20.4.802
   Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013
   Sambrook J, 1989, MOL CLONING LAB MANU
   SCHNEUWLY S, 1987, NATURE, V325, P816, DOI 10.1038/325816a0
   SCOTT MP, 1984, P NATL ACAD SCI-BIOL, V81, P4115, DOI 10.1073/pnas.81.13.4115
   SCOTT MP, 1983, CELL, V35, P763, DOI 10.1016/0092-8674(83)90109-5
   Shi XB, 2006, NATURE, V442, P96, DOI 10.1038/nature04835
   SPRADLING AC, 1982, SCIENCE, V218, P341, DOI 10.1126/science.6289435
   STAEHLINGHAMPTON K, 1994, CELL GROWTH DIFFER, V5, P585
   Verrijzer CP, 1996, TRENDS BIOCHEM SCI, V21, P338, DOI 10.1016/0968-0004(96)10044-X
   WAKIMOTO BT, 1981, DEV BIOL, V81, P51, DOI 10.1016/0012-1606(81)90347-X
   Wieczorek E, 1998, NATURE, V393, P187, DOI 10.1038/30283
   WILLIAMS JA, 1991, GENE DEV, V5, P2481, DOI 10.1101/gad.5.12b.2481
   Wysocka J, 2006, NATURE, V442, P86, DOI 10.1038/nature04815
   Yao LC, 1999, DEV BIOL, V211, P268, DOI 10.1006/dbio.1999.9309
   ZENG WL, 1993, DEVELOPMENT, V118, P339
   Zhao JJG, 1996, EMBO J, V15, P1313, DOI 10.1002/j.1460-2075.1996.tb00473.x
NR 82
TC 40
Z9 40
U1 0
U2 10
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0950-1991
J9 DEVELOPMENT
JI Development
PD MAY 1
PY 2008
VL 135
IS 9
BP 1669
EP 1679
DI 10.1242/dev.018028
PG 11
WC Developmental Biology
SC Developmental Biology
GA 287LF
UT WOS:000254917900011
PM 18367556
OA Bronze
DA 2021-01-25
ER

PT J
AU Keiser, J
   Morson, G
AF Keiser, Jennifer
   Morson, Gianni
TI Fasciola hepatica: Surface tegumental responses to in vitro and in vivo
   treatment with the experimental fasciolicide OZ78
SO EXPERIMENTAL PARASITOLOGY
LA English
DT Article
DE Fasciola hepatica; food-borne trematodiasis; 1,2,4 trioxolanes;
   synthetic peroxides; OZ78; in vivo studies; in vitro studies; scanning
   electron microscopy
ID TRICLABENDAZOLE; ARTEMETHER; ARTESUNATE; RESISTANCE
AB The tegumental alterations in adult Fasciola hepatica induced by the experimental fasciolide OZ78 were investigated utilizing scanning electron microscopy (SEM). Twelve weeks post-infection with F hepatica, rats were treated with a single 100 mg/kg oral dose of OZ78 and flukes were recovered from the bile ducts after 24-72 h. In vitro F hepatica were incubated with OZ78 for 48 h at a concentration of 10 mu g/ml in the absence or presence of haemin. Twenty-four and 48 h post-treatment of rats disruption of the tegument of F hepatica as blebbing, swelling and furrowing was evident. The recovery of flukes 72 h post-treatment was low. Flukes examined at this time point showed an increasing severity of tegumental damage as sloughing and absence of spines, in particular in the tail region. SEM analysis of F. hepatica incubated in the presence of OZ78 without haemin showed only minor and localized damage of the tegument. In the presence of haemin extensive tegumental damage, including sloughing or blebbing, in particular in the anterior part, was observed. In conclusion, our experiments confirm the interesting fasciocidal properties of OZ78. The tegument of adult F. hepatica might play a role in the action of this drug. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Keiser, Jennifer] Swiss Trop Inst, CH-4002 Basel, Switzerland.
   [Morson, Gianni] Univ Basel, Ctr Microscopy, Biozentrum, CH-4056 Basel, Switzerland.
RP Keiser, J (corresponding author), Swiss Trop Inst, Socinstr 57, CH-4002 Basel, Switzerland.
EM jennifer.keiser@unibas.ch
CR Alvarez-Sanchez MA, 2006, VET REC, V159, P424, DOI 10.1136/vr.159.13.424
   Fairweather I, 2005, J HELMINTHOL, V79, P227, DOI 10.1079/JOH2005298
   Keiser J, 2005, EXPERT OPIN INV DRUG, V14, P1513, DOI 10.1517/13543784.14.12.1513
   Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614
   Keiser J, 2008, EXP PARASITOL, V118, P228, DOI 10.1016/j.exppara.2007.08.007
   Keiser J, 2007, T ROY SOC TROP MED H, V101, P1219, DOI 10.1016/j.trstmh.2007.07.012
   Keiser J, 2007, J PARASITOL, V93, P1208, DOI 10.1645/GE-1143R.1
   Keiser J, 2006, J ANTIMICROB CHEMOTH, V57, P1139, DOI 10.1093/jac/dkl125
   Keiser J, 2006, J ANTIMICROB CHEMOTH, V58, P1193, DOI 10.1093/jac/dkl408
   McManus DP, 2006, PARASITOLOGY, V133, pS43, DOI 10.1017/S0031182006001806
   Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7
   RICHTER J, 2002, CURRENT TREATMENT OP, V4, P313
   Schweizer G, 2005, VET REC, V157, P188, DOI 10.1136/vr.157.7.188
   Vennerstrom JL, 2004, NATURE, V430, P900, DOI 10.1038/nature02779
   *WHO, 1995, WHO TECH REP SER, V849
NR 15
TC 14
Z9 14
U1 0
U2 0
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4894
J9 EXP PARASITOL
JI Exp. Parasitol.
PD MAY
PY 2008
VL 119
IS 1
BP 87
EP 93
DI 10.1016/j.exppara.2007.12.015
PG 7
WC Parasitology
SC Parasitology
GA 299AS
UT WOS:000255728800013
PM 18261730
DA 2021-01-25
ER

PT J
AU Pulliainen, AT
   Hytonen, J
   Haataja, S
   Finne, J
AF Pulliainen, Arto Taplo
   Hytonen, Jukka
   Haataja, Sauli
   Finne, Jukka
TI Deficiency of the Rgg regulator promotes H2O2 resistance, AhpCF-mediated
   H2O2 decomposition, and virulence in Streptococcus pyogenes
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID ALKYL HYDROPEROXIDE REDUCTASE; GROUP-A STREPTOCOCCUS; BACILLUS-SUBTILIS;
   SALMONELLA-TYPHIMURIUM; PEROXIDE RESISTANCE; OXIDATIVE STRESS; IRON
   HOMEOSTASIS; FULL VIRULENCE; PERR REGULON; NADH OXIDASE
AB Streptococcus pyogenes (group A streptococcus [GAS]), a catalase-negative gram-positive bacterium, is aero-tolerant and survives H2O2 exposures that kill many catalase-positive bacteria. The molecular basis of the H2O2 resistance is poorly known. Here, we demonstrate that serotype M49 GAS lacking the Rgg regulator is more resistant to H2O2 and also decomposes more H2O2 than the parental strain. Subgenomic transcriptional profiling and genome-integrated green fluorescent protein reporters showed that a bicistronic operon, a homolog of the Streptococcus mutans ahpCF operon, is transcriptionally up-regulated in the absence of Rgg. Phenotypic assays with ahpCF operon knockouts demonstrated that the gene products decompose H2O2 and protect GAS against peroxide stress. In a murine intraperitoneal-infection model, Rgg deficiency increased the virulence of GAS, although in an ahpCF-independent manner. Rgg-mediated repression of H2O2 resistance is divergent from the previously characterized peroxide resistance repressor PerR. Moreover, Rgg-mediated repression of H2O2 resistance is inducible by cellular stresses of diverse natures-ethanol, organic hydroperoxide, and H2O2. Rgg is thus identified as a novel sensoregulator of streptococcal H2O2 resistance with potential implications for the virulence of the catalase-negative GAS.
C1 [Pulliainen, Arto Taplo; Haataja, Sauli; Finne, Jukka] Univ Turku, Dept Med Biochem & Mol Biol, FI-20520 Turku, Finland.
   [Hytonen, Jukka] Univ Turku, Dept Med Microbiol & Immunol, FI-20520 Turku, Finland.
RP Pulliainen, AT (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM arto.pulliainen@unibas.cli
RI Finne, Jukka/B-6881-2008; Haataja, Sauli/AAR-5103-2020
OI Finne, Jukka/0000-0002-8076-3344; Pulliainen, Arto
   Tapio/0000-0002-9361-8963; Hytonen, Jukka/0000-0002-0585-9338
CR Bartilson M, 2001, MOL MICROBIOL, V39, P126, DOI 10.1046/j.1365-2958.2001.02218.x
   Bates CS, 2005, INFECT IMMUN, V73, P5743, DOI 10.1128/IAI.73.9.5743-5753.2005
   Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103
   Brenot A, 2005, MOL MICROBIOL, V55, P221, DOI 10.1111/j.1365-2958.2004.04370.x
   Brenot A, 2004, INFECT IMMUN, V72, P408, DOI 10.1128/IAI.72.1.408-413.2004
   Brenot A, 2007, MOL MICROBIOL, V63, P1185, DOI 10.1111/j.1365-2958.2006.05577.x
   Bsat N, 1996, J BACTERIOL, V178, P6579, DOI 10.1128/jb.178.22.6579-6586.1996
   Bsat N, 1998, MOL MICROBIOL, V29, P189, DOI 10.1046/j.1365-2958.1998.00921.x
   Chaussee MA, 2004, J BACTERIOL, V186, P7091, DOI 10.1128/JB.186.21.7091-7099.2004
   Chaussee MS, 1999, INFECT IMMUN, V67, P1715
   Chaussee MS, 2003, J BACTERIOL, V185, P6016, DOI 10.1128/JB.185.20.6016-6024.2003
   Chaussee MS, 2002, INFECT IMMUN, V70, P762, DOI 10.1128/IAI.70.2.762-770.2002
   Chaussee MS, 2001, INFECT IMMUN, V69, P822, DOI 10.1128/IAI.69.2.822-831.2001
   CLEARY PP, 1979, J BACTERIOL, V140, P1090, DOI 10.1128/JB.140.3.1090-1097.1979
   Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0
   Dmitriev AV, 2006, J BACTERIOL, V188, P7230, DOI 10.1128/JB.00877-06
   Ellis HR, 1997, BIOCHEMISTRY-US, V36, P13349, DOI 10.1021/bi9713658
   Eriksson A, 2003, INFECT IMMUN, V71, P211, DOI 10.1128/IAI.71.1.211-217.2003
   Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999
   Ferretti JJ, 2001, P NATL ACAD SCI USA, V98, P4658, DOI 10.1073/pnas.071559398
   Fuangthong M, 2002, J BACTERIOL, V184, P3276, DOI 10.1128/JB.184.12.3276-3286.2002
   Gibson CM, 2000, J BACTERIOL, V182, P448, DOI 10.1128/JB.182.2.448-455.2000
   Helmann JD, 2003, J BACTERIOL, V185, P243, DOI 10.1128/JB.185.1.243-253.2003
   JACOBSON FS, 1989, J BIOL CHEM, V264, P1488
   Jones CH, 2001, INFECT IMMUN, V69, P5538, DOI 10.1128/IAI.69.9.5538-5545.2001
   King KY, 2000, J BACTERIOL, V182, P5290, DOI 10.1128/JB.182.19.5290-5299.2000
   Kwon HY, 2003, INFECT IMMUN, V71, P3757, DOI 10.1128/IAI.71.7.3757-3765.2003
   Lee JW, 2006, NATURE, V440, P363, DOI 10.1038/nature04537
   Lyon WR, 1998, EMBO J, V17, P6263, DOI 10.1093/emboj/17.21.6263
   MALKE H, 1974, J MED MICROBIOL, V7, P367, DOI 10.1099/00222615-7-3-367
   Poole LB, 1996, BIOCHEMISTRY-US, V35, P56, DOI 10.1021/bi951887s
   Poole LB, 2000, FREE RADICAL BIO MED, V28, P108, DOI 10.1016/S0891-5849(99)00218-X
   Poole LB, 2004, ANNU REV PHARMACOL, V44, P325, DOI 10.1146/annurev.pharmtox.44.101802.121735
   Pulliainen AT, 2005, MOL MICROBIOL, V57, P1086, DOI 10.1111/j.1365-2958.2005.04756.x
   Pulliainen AT, 2003, J BIOL CHEM, V278, P7996, DOI 10.1074/jbc.M210174200
   Ricci S, 2002, INFECT IMMUN, V70, P4968, DOI 10.1128/IAI.70.9.4968-4976.2002
   Saito M, 2001, MICROBIOL-SGM, V147, P2469, DOI 10.1099/00221287-147-9-2469
   TAO L, 1992, GENE, V120, P105, DOI 10.1016/0378-1119(92)90016-I
   VOELKER U, 1995, J BACTERIOL, V177, P3771, DOI 10.1128/jb.177.13.3771-3780.1995
   Wentworth P, 2001, SCIENCE, V293, P1806, DOI 10.1126/science.1062722
   Yamamoto Y, 2000, J BACTERIOL, V182, P3740, DOI 10.1128/JB.182.13.3740-3747.2000
NR 41
TC 22
Z9 25
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
J9 J BACTERIOL
JI J. Bacteriol.
PD MAY
PY 2008
VL 190
IS 9
BP 3225
EP 3235
DI 10.1128/JB.01843-07
PG 11
WC Microbiology
SC Microbiology
GA 291MS
UT WOS:000255202100016
PM 18310340
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Donahue, JE
   Stopa, EG
   Johanson, CE
   Chaudhry, H
   Miller, MC
   Fallon, JR
   Ruegg, M
   Rauch, SM
   Burgess, RW
AF Donahue, John Edward
   Stopa, Edward G.
   Johanson, Conrad E.
   Chaudhry, Hira
   Miller, Miles C.
   Fallon, Justin R.
   Ruegg, Markus
   Rauch, Steven M.
   Burgess, Robert W.
TI Altering agrin expression influences AP deposition in APP(Swe)/PS1(ex9)
   transgenic mice
SO JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY
LA English
DT Meeting Abstract
CT 84th Annual Meeting of the American-Association-of-Neuropathologists
CY APR 04-07, 2008
CL San Diego, CA
SP Amer Assoc Neuropathol
C1 [Donahue, John Edward; Stopa, Edward G.; Johanson, Conrad E.; Chaudhry, Hira; Miller, Miles C.] Rhode Isl Hosp, Providence, RI USA.
   [Fallon, Justin R.] Brown Univ, Providence, RI 02912 USA.
   [Ruegg, Markus] Univ Basel, Biozentrum, Basel, Switzerland.
   [Rauch, Steven M.; Burgess, Robert W.] Jackson Lab, Bar Harbor, ME 04609 USA.
RI Donahue, John E/A-3000-2008; Ruegg, Markus/X-7256-2019
OI Donahue, John E/0000-0001-7186-2562; Ruegg, Markus/0000-0002-4974-9384
NR 0
TC 0
Z9 0
U1 0
U2 0
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 0022-3069
J9 J NEUROPATH EXP NEUR
JI J. Neuropathol. Exp. Neurol.
PD MAY
PY 2008
VL 67
IS 5
BP 511
EP 511
PG 1
WC Clinical Neurology; Neurosciences; Pathology
SC Neurosciences & Neurology; Pathology
GA 294YN
UT WOS:000255442300124
DA 2021-01-25
ER

PT J
AU Zoller, FA
   Padeste, C
   Ekinci, Y
   Solak, HH
   Engel, A
AF Zoller, Frank A.
   Padeste, Celestino
   Ekinci, Yasin
   Solak, Harun H.
   Engel, Andreas
TI Nanostructured substrates for high density protein arrays
SO MICROELECTRONIC ENGINEERING
LA English
DT Article; Proceedings Paper
CT 33rd International Conference on Micro- and Nano-Engineering
CY SEP 23-26, 2007
CL Copenhagen, DENMARK
DE EUV interference lithography; glancing angle deposition; gold nanodot
   array; selective protein immobilization
ID LITHOGRAPHY; FABRICATION; GOLD; NANOLITHOGRAPHY; SURFACES
AB Nearly defect-free arrays of several 10(4) gold dots of 12 +/- 3 nm in diameter inside 10 nm deep cavities were fabricated for immobilization of proteins. Extreme ultraviolet interference lithography (EUV-IL) at the XIL-beamline of the Swiss Light Source was used to produce 140 nm period arrays of 50 nm holes in a 40 nm thick PMMA layer on oxidized silicon wafers. The size of the openings was reduced by glancing angle deposition (GLAD) of metals such as chromium and silver. Reactive ion etching of the underlying substrate, followed by deposition of a few nanometers of gold, lift-off and thermal annealing resulted in perfectly ordered arrays of small gold nanoparticles with well-defined size distribution. The combination of passivation of the silica surface with polyethylene glycol (PEG) derivatives and functionalization of gold with thiols enables the preparation of large area arrays of well separated functional protein molecules. (c) 2008 Elsevier B.V. All rights reserved.
C1 [Zoller, Frank A.; Padeste, Celestino; Ekinci, Yasin; Solak, Harun H.] Paul Scherrer Inst, Lab Micro & Nanotechnol, CH-5232 Villigen, PSI, Switzerland.
   [Zoller, Frank A.; Engel, Andreas] Univ Basel, Biozentrum, Maurice E Muller Inst, CH-4056 Basel, Switzerland.
   Swiss Fed Inst Technol, Lab Metal Phys & Technol, CH-8093 Zurich, Switzerland.
RP Padeste, C (corresponding author), Paul Scherrer Inst, Lab Micro & Nanotechnol, CH-5232 Villigen, PSI, Switzerland.
EM celestino.padeste@psi.ch
RI Ekinci, Yasin/B-3699-2014; Ekinci, Yasin/B-6232-2008
OI Ekinci, Yasin/0000-0002-0331-0501; Padeste,
   Celestino/0000-0001-7577-5781
CR Agheli H, 2006, NANO LETT, V6, P1165, DOI 10.1021/nl060403i
   Groll J, 2005, CHEMBIOCHEM, V6, P1782, DOI 10.1002/cbic.200500041
   Hanarp P, 2003, J PHYS CHEM B, V107, P5768, DOI 10.1021/jp027562k
   Hu WC, 2004, J VAC SCI TECHNOL B, V22, P1711, DOI 10.1116/1.1763897
   Huang NP, 2001, LANGMUIR, V17, P489, DOI 10.1021/la000736+
   KUMAR A, 1993, APPL PHYS LETT, V63, P2002, DOI 10.1063/1.110628
   Liu GY, 2002, P NATL ACAD SCI USA, V99, P5165, DOI 10.1073/pnas.072695699
   Lueking A, 2005, DRUG DISCOV TODAY, V10, P789, DOI 10.1016/S1359-6446(05)03449-5
   Piner RD, 1999, SCIENCE, V283, P661, DOI 10.1126/science.283.5402.661
   Robbie K, 1997, J VAC SCI TECHNOL A, V15, P1460, DOI 10.1116/1.580562
   Solak HH, 2007, J VAC SCI TECHNOL B, V25, P91, DOI 10.1116/1.2401612
   Solak HH, 2006, J PHYS D APPL PHYS, V39, pR171, DOI 10.1088/0022-3727/39/10/R01
   Tan BJY, 2005, J PHYS CHEM B, V109, P11100, DOI 10.1021/jp045172n
   Wadu-Mesthrige K, 2001, BIOPHYS J, V80, P1891, DOI 10.1016/S0006-3495(01)76158-9
   Xu S, 1997, LANGMUIR, V13, P127, DOI 10.1021/la962029f
NR 15
TC 21
Z9 21
U1 0
U2 11
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-9317
J9 MICROELECTRON ENG
JI Microelectron. Eng.
PD MAY-JUN
PY 2008
VL 85
IS 5-6
BP 1370
EP 1374
DI 10.1016/j.mee.2007.12.061
PG 5
WC Engineering, Electrical & Electronic; Nanoscience & Nanotechnology;
   Optics; Physics, Applied
SC Engineering; Science & Technology - Other Topics; Optics; Physics
GA 322ZI
UT WOS:000257413400159
DA 2021-01-25
ER

PT J
AU Mitrovic, S
   Ben-Tekaya, H
   Koegler, E
   Gruenberg, J
   Hauri, HP
AF Mitrovic, Sandra
   Ben-Tekaya, Houchaima
   Koegler, Eva
   Gruenberg, Jean
   Hauri, Hans-Peter
TI The cargo receptors Surf4, endoplasmic reticulum-Golgi intermediate
   compartment (ERGIC)-53, and p25 are required to maintain the
   architecture of ERGIC and Golgi
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID TRANSPORT VESICLES; MEMBRANE-PROTEIN; RETROGRADE TRANSPORT; SECRETORY
   PATHWAY; RECYCLING PATHWAY; FAMILY-MEMBERS; LIVING CELLS; TRANSMEMBRANE
   PROTEIN; LECTIN ERGIC-53; COATED VESICLES
AB Rapidly cycling proteins of the early secretory pathway can operate as cargo receptors. Known cargo receptors are abundant proteins, but it remains mysterious why their inactivation leads to rather limited secretion phenotypes. Studies of Surf4, the human orthologue of the yeast cargo receptor Erv29p, now reveal a novel function of cargo receptors. Surf4 was found to interact with endoplasmic reticulum-Golgi intermediate compartment (ERGIC)-53 and p24 proteins. Silencing Surf4 together with ERGIC-53 or silencing the p24 family member p25 induced an identical phenotype characterized by a reduced number of ERGIC clusters and fragmentation of the Golgi apparatus without effect on anterograde transport. Live imaging showed decreased stability of ERGIC clusters after knockdown of p25. Silencing of Surf4/ERGIC-53 or p25 resulted in partial redistribution of coat protein (COP) I but not Golgi matrix proteins to the cytosol and partial resistance of the cis-Golgi to brefeldin A. These findings imply that cargo receptors are essential for maintaining the architecture of ERGIC and Golgi by controlling COP I recruitment.
C1 [Mitrovic, Sandra; Ben-Tekaya, Houchaima; Koegler, Eva; Hauri, Hans-Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Gruenberg, Jean] Univ Geneva, Dept Biochem, CH-1211 Geneva 4, Switzerland.
RP Hauri, HP (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM hans-peter.hauri@unibas.ch
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); University of Basel
FX We thank Anne Spang for helpful suggestion; Kathy Bucher for technical
   assistance; Paul Jeno for mass spectrometry analysis; Ursula Sauder for
   electron microscopy analysis; Adam Linstedt for anti-giantin; David S.
   Nelson for anti-p115 and anti-GM130; Felix Wieland for antibodies to
   p23, p24, and p25; Fred Gorelick for anti-Sec31; and Vivek Malhotra for
   anti-GRASP65. This work was supported by the Swiss National Science
   Foundation and the University of Basel.
CR Andersson H, 1999, J BIOL CHEM, V274, P15080, DOI 10.1074/jbc.274.21.15080
   Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708
   Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019
   Aridor M, 1999, J BIOL CHEM, V274, P4389, DOI 10.1074/jbc.274.7.4389
   ARIDOR M, 1995, J CELL BIOL, V131, P875, DOI 10.1083/jcb.131.4.875
   Barr FA, 1998, EMBO J, V17, P3258, DOI 10.1093/emboj/17.12.3258
   Barr FA, 1997, CELL, V91, P253, DOI 10.1016/S0092-8674(00)80407-9
   Barr FA, 2001, J CELL BIOL, V155, P885, DOI 10.1083/jcb.200108102
   BARROSO M, 1995, P NATL ACAD SCI USA, V92, P527, DOI 10.1073/pnas.92.2.527
   Belden WJ, 2001, SCIENCE, V294, P1528, DOI 10.1126/science.1065224
   Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7
   Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06
   Blum R, 1999, J CELL SCI, V112, P537
   Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1
   Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6
   Breuza L, 2004, J BIOL CHEM, V279, P47242, DOI 10.1074/jbc.M406644200
   Caldwell SR, 2001, J BIOL CHEM, V276, P23296, DOI 10.1074/jbc.M102962200
   COSSON P, 1994, SCIENCE, V263, P1629, DOI 10.1126/science.8128252
   Denzel A, 2000, CURR BIOL, V10, P55, DOI 10.1016/S0960-9822(99)00266-3
   Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045
   Dominguez M, 1998, J CELL BIOL, V140, P751, DOI 10.1083/jcb.140.4.751
   Emery G, 2000, J CELL SCI, V113, P2507
   Emery G, 2003, J CELL SCI, V116, P4821, DOI 10.1242/jcs.00802
   Fiedler K, 1996, SCIENCE, V273, P1396, DOI 10.1126/science.273.5280.1396
   Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939
   Guo YS, 2006, J CELL BIOL, V174, P53, DOI 10.1083/jcb.200604058
   Harlow E., 1999, USING ANTIBODIES LAB
   Hauri HP, 2000, J CELL SCI, V113, P587
   Hunte C., 2003, MEMBRANE PROTEIN PUR
   ITIN C, 1995, J CELL BIOL, V131, P57, DOI 10.1083/jcb.131.1.57
   JACKSON MR, 1990, EMBO J, V9, P3153, DOI 10.1002/j.1460-2075.1990.tb07513.x
   Jenne N, 2002, J BIOL CHEM, V277, P46504, DOI 10.1074/jbc.M206989200
   Kaiser C, 2000, P NATL ACAD SCI USA, V97, P3783, DOI 10.1073/pnas.97.8.3783
   KLAUSNER RD, 1992, J CELL BIOL, V116, P1071, DOI 10.1083/jcb.116.5.1071
   Klumperman J, 1998, J CELL SCI, V111, P3411
   Lavoie C, 1999, J CELL BIOL, V146, P285, DOI 10.1083/jcb.146.2.285
   Lee TH, 1999, MOL BIOL CELL, V10, P1445, DOI 10.1091/mbc.10.5.1445
   LINSTEDT AD, 1993, MOL BIOL CELL, V4, P679
   LIPPINCOTTSCHWARTZ J, 1990, CELL, V60, P821, DOI 10.1016/0092-8674(90)90096-W
   Majoul I, 1998, J CELL BIOL, V143, P601, DOI 10.1083/jcb.143.3.601
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   Nakamura N, 1997, CELL, V89, P445, DOI 10.1016/S0092-8674(00)80225-1
   Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715
   Nelson DS, 1998, J CELL BIOL, V143, P319, DOI 10.1083/jcb.143.2.319
   Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0
   Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102
   Nyfeler B, 2006, TRAFFIC, V7, P1473, DOI 10.1111/j.1600-0854.2006.00483.x
   Otte S, 2004, NAT CELL BIOL, V6, P1189, DOI 10.1038/ncb1195
   Presley JF, 1997, NATURE, V389, P81, DOI 10.1038/38001
   Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366
   REEVES JE, 1995, MOL MEMBR BIOL, V12, P201, DOI 10.3109/09687689509027508
   Rojo M, 2000, J CELL SCI, V113, P1043
   ROTHMAN JE, 1994, NATURE, V372, P55, DOI 10.1038/372055a0
   Scales SJ, 1997, CELL, V90, P1137, DOI 10.1016/S0092-8674(00)80379-7
   SCHIMMOLLER F, 1995, EMBO J, V14, P1329, DOI 10.1002/j.1460-2075.1995.tb07119.x
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Shugrue CA, 1999, J CELL SCI, V112, P4547
   Simpson JC, 2006, MOL BIOL CELL, V17, P723, DOI 10.1091/mbc.E05-06-0580
   Sohda M, 2005, BIOCHEM BIOPH RES CO, V338, P1268, DOI 10.1016/j.bbrc.2005.10.084
   Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239
   STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011
   Stauber T, 2006, CURR BIOL, V16, P2245, DOI 10.1016/j.cub.2006.09.060
   Storrie B, 2005, INT REV CYTOL, V244, P69, DOI 10.1016/S0074-7696(05)44002-4
   Suga K, 2005, FEBS LETT, V579, P4226, DOI 10.1016/j.febslet.2005.06.053
   Sutterlin C, 2002, CELL, V109, P359, DOI 10.1016/S0092-8674(02)00720-1
   Taguchi T, 2003, TRAFFIC, V4, P344, DOI 10.1034/j.1600-0854.2003.00091.x
   Teasdale RD, 1996, ANNU REV CELL DEV BI, V12, P27, DOI 10.1146/annurev.cellbio.12.1.27
   Vetrivel KS, 2007, MOL NEURODEGENER, V2, DOI 10.1186/1750-1326-2-4
   Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377
   Zeuschner D, 2006, NAT CELL BIOL, V8, P377, DOI 10.1038/ncb1371
   Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153
NR 72
TC 62
Z9 67
U1 3
U2 11
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD MAY
PY 2008
VL 19
IS 5
BP 1976
EP 1990
DI 10.1091/mbc.E07-10-0989
PG 15
WC Cell Biology
SC Cell Biology
GA 344UE
UT WOS:000258952000016
PM 18287528
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Dames, SA
AF Dames, Sonja A.
TI A fast and simple method to prepare the FKBP-rapamycin binding domain of
   human target of rapamycin for NMR binding assays
SO PROTEIN EXPRESSION AND PURIFICATION
LA English
DT Article
DE target of rapamycin; TOR; FKBP; refolding; inclusion body; HPLC; NMR
ID CELL-GROWTH CONTROL; TERNARY COMPLEX; CANCER-THERAPY; MTOR; PROTEIN;
   STABILITY; DISEASE
AB Mammalian target of rapamycin (TOR) controls cell growth and metabolism in response to the availability of nutrients, growth factors, and the cellular energy status. Misregulation of TOR can result in a pathogenic increase or decrease in organ size and in cancer. TOR can be inhibited by binding of a complex of rapamycin and FKBP to the FKBP-rapamycin binding (FRB) domain. Rapamycin and derivatives of it have been used as immunosuppressive drugs. Because TOR is further an interesting drug target in cancer research, we established an expression, purification, and refolding protocol for the FRB domain of human TOR (hFRB). hFRB is extracted from inclusion bodies, purified by reversed phase HPLC, and refolded by drop-wise dilution of the denatured protein into a native buffer. The procedure is very simple and can easily be scaled up to prepare large amounts of functional protein for high-throughput cancer drug screening assays by NMR and other techniques. (C) 2008 Elsevier Inc. All rights reserved.
C1 Univ Basel, Biozentrum, Dept Biol Struct, CH-4056 Basel, Switzerland.
RP Dames, SA (corresponding author), Univ Basel, Biozentrum, Dept Biol Struct, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM sonja.dames@unibas.ch
OI Dames, Sonja/0000-0001-7495-6943
CR ANDRADE MA, 1995, NAT GENET, V11, P115, DOI 10.1038/ng1095-115
   Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y
   Bjornsti MA, 2004, NAT REV CANCER, V4, P335, DOI 10.1038/nrc1362
   Bosotti R, 2000, TRENDS BIOCHEM SCI, V25, P225, DOI 10.1016/S0968-0004(00)01563-2
   CHEN J, 1995, P NATL ACAD SCI USA, V92, P4947, DOI 10.1073/pnas.92.11.4947
   Choi JW, 1996, SCIENCE, V273, P239, DOI 10.1126/science.273.5272.239
   Choo AY, 2006, CANCER CELL, V9, P77, DOI 10.1016/j.ccr.2006.01.021
   Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885
   Dames SA, 2005, J BIOL CHEM, V280, P20558, DOI 10.1074/jbc.M501116200
   De Virgilio C, 2006, ONCOGENE, V25, P6392, DOI 10.1038/sj.onc.1209884
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Golovanov AP, 2004, J AM CHEM SOC, V126, P8933, DOI 10.1021/ja049297h
   Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007
   Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jacinto E, 2003, NAT REV MOL CELL BIO, V4, P117, DOI 10.1038/nrm1018
   Johnson Bruce A, 2004, Methods Mol Biol, V278, P313
   Leone M, 2006, BIOCHEMISTRY-US, V45, P10294, DOI 10.1021/bi060976+
   Liang J, 1999, ACTA CRYSTALLOGR D, V55, P736, DOI 10.1107/S0907444998014747
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Odagaki Y, 1997, J AM CHEM SOC, V119, P10253, DOI 10.1021/ja972098w
   Rudolph R, 1996, FASEB J, V10, P49
   Tee AR, 2005, SEMIN CELL DEV BIOL, V16, P29, DOI 10.1016/j.semcdb.2004.11.005
   VEVERKA V, 2007, ONCOGENE
   Veverka V, 2006, J BIOMOL NMR, V36, P3, DOI 10.1007/s10858-005-4324-1
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
NR 26
TC 3
Z9 3
U1 0
U2 12
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-5928
J9 PROTEIN EXPRES PURIF
JI Protein Expr. Purif.
PD MAY
PY 2008
VL 59
IS 1
BP 31
EP 37
DI 10.1016/j.pep.2008.01.014
PG 7
WC Biochemical Research Methods; Biochemistry & Molecular Biology;
   Biotechnology & Applied Microbiology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology
GA 293CL
UT WOS:000255312300005
PM 18313330
DA 2021-01-25
ER

PT J
AU Shumaker, DK
   Solimando, L
   Sengupta, K
   Shimi, T
   Adam, SA
   Grunwald, A
   Strelkov, SV
   Aebi, U
   Cardoso, MC
   Goldman, RD
AF Shumaker, Dale K.
   Solimando, Liliana
   Sengupta, Kaushik
   Shimi, Takeshi
   Adam, Stephen A.
   Grunwald, Antje
   Strelkov, Sergei V.
   Aebi, Ueli
   Cardoso, M. Cristina
   Goldman, Robert D.
TI The highly conserved nuclear lamin Ig-fold binds to PCNA: its role in
   DNA replication
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID A-TYPE LAMINS; DREIFUSS MUSCULAR-DYSTROPHY; B-TYPE LAMINS; EGG EXTRACTS;
   IN-VITRO; ESCHERICHIA-COLI; LIVING CELLS; REPAIR SITES; FACTOR-C;
   ANTIGEN
AB This study provides insights into the role of nuclear lamins in DNA replication. Our data demonstrate that the Ig-fold motif located in the lamin C terminus binds directly to proliferating cell nuclear antigen ( PCNA), the processivity factor necessary for the chain elongation phase of DNA replication. We find that the introduction of a mutation in the Ig-fold, which alters its structure and causes human muscular dystrophy, inhibits PCNA binding. Studies of nuclear assembly and DNA replication show that lamins, PCNA, and chromatin are closely associated in situ. Exposure of replicating nuclei to an excess of the lamin domain containing the Ig-fold inhibits DNA replication in a concentration-dependent fashion. This inhibitory effect is significantly diminished in nuclei exposed to the same domain bearing the Ig-fold mutation. Using the crystal structures of the lamin Ig-fold and PCNA, molecular docking simulations suggest probable interaction sites. These findings also provide insights into the mechanisms underlying the numerous disease-causing mutations located within the lamin Ig-fold.
C1 [Shumaker, Dale K.; Solimando, Liliana; Sengupta, Kaushik; Shimi, Takeshi; Adam, Stephen A.; Goldman, Robert D.] Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.
   [Grunwald, Antje; Cardoso, M. Cristina] Max Delbruck Ctr Mol Med, D-13125 Berlin, Germany.
   [Strelkov, Sergei V.] Catholic Univ Louvain, Dept Pharmaceut Sci, B-3000 Louvain, Belgium.
   [Aebi, Ueli] Univ Basel, Biozentrum, Maurice E Muller Inst, CH-4056 Basel, Switzerland.
RP Goldman, RD (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Cell & Mol Biol, Chicago, IL 60611 USA.
EM r-goldman@northwestern.edu
RI Strelkov, Sergei V/G-7425-2014; Cardoso, M. Cristina/F-5215-2011
OI Strelkov, Sergei V/0000-0001-7189-4652; Adam,
   Stephen/0000-0003-3444-7655; Shimi, Takeshi/0000-0002-9864-1820
FU NATIONAL CANCER INSTITUTEUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Cancer
   Institute (NCI) [R01CA031760, R01CA031760, R01CA031760, R01CA031760,
   R01CA031760, R01CA031760, R01CA031760, R01CA031760, R01CA031760,
   R01CA031760, R01CA031760, R01CA031760, R01CA031760, R01CA031760,
   R01CA031760, R01CA031760, R01CA031760, R01CA031760, R01CA031760,
   R01CA031760, R01CA031760, R01CA031760, R01CA031760, R01CA031760,
   R01CA031760, R01CA031760, R01CA031760, R01CA031760, R01CA031760,
   R01CA031760] Funding Source: NIH RePORTER; NCI NIH HHSUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Cancer Institute (NCI) [R01 CA31760, R01 CA031760]
   Funding Source: Medline
CR AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   BLOW JJ, 1986, CELL, V47, P577, DOI 10.1016/0092-8674(86)90622-7
   Bonne G, 1999, NAT GENET, V21, P285, DOI 10.1038/6799
   Bowman GD, 2004, NATURE, V429, P724, DOI 10.1038/nature02585
   BRAVO R, 1985, EMBO J, V4, P655, DOI 10.1002/j.1460-2075.1985.tb03679.x
   Comeau SR, 2004, BIOINFORMATICS, V20, P45, DOI 10.1093/bioinformatics/btg371
   Dechat T, 2000, J CELL SCI, V113, P3473
   DESSEV G, 1989, DEV BIOL, V131, P496, DOI 10.1016/S0012-1606(89)80020-X
   Dhe-Paganon S, 2002, J BIOL CHEM, V277, P17381, DOI 10.1074/jbc.C200038200
   GOLDBERG M, 1995, J CELL SCI, V108, P3451
   Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502
   Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505
   HEITLINGER E, 1991, J CELL BIOL, V113, P485, DOI 10.1083/jcb.113.3.485
   JENKINS H, 1993, J CELL SCI, V106, P275
   Johnson BR, 2004, P NATL ACAD SCI USA, V101, P9677, DOI 10.1073/pnas.0403250101
   Kazmirski SL, 2005, P NATL ACAD SCI USA, V102, P13801, DOI 10.1073/pnas.0506430102
   Kennedy BK, 2000, GENE DEV, V14, P2855, DOI 10.1101/gad.842600
   KONG XP, 1992, CELL, V69, P425, DOI 10.1016/0092-8674(92)90445-I
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LEE SH, 1990, P NATL ACAD SCI USA, V87, P5672, DOI 10.1073/pnas.87.15.5672
   Leonhardt H, 2000, J CELL BIOL, V149, P271, DOI 10.1083/jcb.149.2.271
   LI XY, 1995, J BIOL CHEM, V270, P22109, DOI 10.1074/jbc.270.38.22109
   Lopez-Soler RI, 2001, J CELL BIOL, V154, P61, DOI 10.1083/jcb.200101025
   Lourim D, 1996, J CELL SCI, V109, P1775
   Machado C, 2000, J CELL BIOL, V151, P639, DOI 10.1083/jcb.151.3.639
   Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653
   Mattock H, 2001, EXP CELL RES, V265, P242, DOI 10.1006/excr.2001.5181
   Millar D, 2004, BIOCHEMISTRY-US, V43, P12723, DOI 10.1021/bi048349c
   Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179
   MOIR RD, 1994, J CELL BIOL, V125, P1201, DOI 10.1083/jcb.125.6.1201
   Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155
   Mortusewicz O, 2005, P NATL ACAD SCI USA, V102, P8905, DOI 10.1073/pnas.0501034102
   Mortusewicz O, 2006, NUCLEIC ACIDS RES, V34, P3523, DOI 10.1093/nar/gkl492
   NEWMEYER DD, 1991, METHOD CELL BIOL, V36, P607
   NEWMEYER DD, 1986, J CELL BIOL, V103, P2091, DOI 10.1083/jcb.103.6.2091
   NEWPORT JW, 1990, J CELL BIOL, V111, P2247, DOI 10.1083/jcb.111.6.2247
   NIGG E A, 1992, Current Opinion in Cell Biology, V4, P105, DOI 10.1016/0955-0674(92)90066-L
   Rodriguez-Lopez AM, 2003, MECH AGEING DEV, V124, P167, DOI 10.1016/S0047-6374(02)00131-8
   Sasse B, 1997, EUR J BIOCHEM, V250, P30, DOI 10.1111/j.1432-1033.1997.t01-1-00030.x
   Shumaker DK, 2006, P NATL ACAD SCI USA, V103, P8703, DOI 10.1073/pnas.0602569103
   Shumaker DK, 2005, P NATL ACAD SCI USA, V102, P15494, DOI 10.1073/pnas.0507612102
   Shumaker DK, 2003, CURR OPIN CELL BIOL, V15, P358, DOI 10.1016/S0955-0674(03)00050-4
   Solovei I, 2004, CHROMOSOMA, V112, P410
   Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201
   Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047
   Sporbert A, 2002, MOL CELL, V10, P1355, DOI 10.1016/S1097-2765(02)00729-3
   STICK R, 1988, EMBO J, V7, P3189, DOI 10.1002/j.1460-2075.1988.tb03186.x
   TOSCHI L, 1988, J CELL BIOL, V107, P1623, DOI 10.1083/jcb.107.5.1623
   Tovchigrechko A, 2006, NUCLEIC ACIDS RES, V34, pW310, DOI 10.1093/nar/gkl206
   Tsai MY, 2006, SCIENCE, V311, P1887, DOI 10.1126/science.1122771
   Tsurimoto Toshiki, 1999, Frontiers in Bioscience, V4, pd849, DOI 10.2741/Tsurimoto
   WAGA S, 1994, NATURE, V369, P574, DOI 10.1038/369574a0
   Warbrick E, 1998, NUCLEIC ACIDS RES, V26, P3925, DOI 10.1093/nar/26.17.3925
   Yao N, 2003, J BIOL CHEM, V278, P50744, DOI 10.1074/jbc.M309206200
   Yao NY, 2006, J BIOL CHEM, V281, P17528, DOI 10.1074/jbc.M601273200
   Zastrow MS, 2006, J CELL SCI, V119, P239, DOI 10.1242/jcs.02728
   Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102
NR 59
TC 82
Z9 83
U1 0
U2 4
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD APR 21
PY 2008
VL 181
IS 2
BP 269
EP 280
DI 10.1083/jcb.200708155
PG 12
WC Cell Biology
SC Cell Biology
GA 294MO
UT WOS:000255410300011
PM 18426975
OA Green Published, Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Blum, Y
   Belting, HG
   Ellertsdottir, E
   Herwig, L
   Luders, F
   Affolter, M
AF Blum, Yannick
   Belting, Heinz-Georg
   Ellertsdottir, Elin
   Herwig, Lukas
   Lueders, Florian
   Affolter, Markus
TI Complex cell rearrangements during intersegmental vessel sprouting and
   vessel fusion in the zebrafish embryo
SO DEVELOPMENTAL BIOLOGY
LA English
DT Article
DE angiogenesis; ISV; vessel fusion; VE-cadherin; adherens junctions;
   transgenic; ZO-1; zebrafish
ID TRACHEAL MORPHOGENESIS; GENETIC-CONTROL; ANGIOGENESIS; CADHERIN; TUBE;
   EXPRESSION
AB The formation of intersegmental blood vessels (ISVs) in the zebrafish embryo serves as a paradigm to study angiogenesis in vivo. ISV formation is thought to occur in discrete steps. First, endothelial cells of the dorsal aorta migrate out and align along the dorsoventral axis. The dorsal-most cell, also called tip cell, then joins with its anterior and posterior neighbours, thus establishing a simple vascular network. The vascular lumen is then established via formation of vacuoles, which eventually fuse with those of adjacent endothelial cells to generate a seamless tube with an intracellular lumen. To investigate the cellular architecture and the development of ISVs in detail, we have analysed the arrangement of endothelial cell junctions and have performed single cell live imaging. In contrast to previous reports, we find that endothelial cells are not arranged in a linear head-to-tail configuration but overlap extensively and form a multicellular tube, which contains an extracellular lumen. Our studies demonstrate that a number of cellular behaviours, such as cell divisions, cell rearrangements and dynamic alterations in cell-cell contacts, have to be considered when studying the morphological and molecular processes involved in ISV and endothelial lumen formation in vivo. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Blum, Yannick; Belting, Heinz-Georg; Ellertsdottir, Elin; Herwig, Lukas; Lueders, Florian; Affolter, Markus] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Belting, HG (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM heinz-georg.belting@unibas.ch; markus.affolter@unibas.ch
OI Affolter, Markus/0000-0002-5171-0016; Belting,
   Heinz-Georg/0000-0002-1538-4364
CR Adams RH, 2007, NAT REV MOL CELL BIO, V8, P464, DOI 10.1038/nrm2183
   Affolter M, 2003, DEV CELL, V4, P11, DOI 10.1016/S1534-5807(02)00410-0
   Barolo S, 2000, BIOTECHNIQUES, V29, P726, DOI 10.2144/00294bm10
   Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970
   Beis D, 2006, TRENDS CELL BIOL, V16, P105, DOI 10.1016/j.tcb.2005.12.001
   Carmeliet P, 2005, NATURE, V438, P932, DOI 10.1038/nature04478
   Childs S, 2002, DEVELOPMENT, V129, P973
   Coultas L, 2005, NATURE, V438, P937, DOI 10.1038/nature04479
   Ghabrial AS, 2006, NATURE, V441, P746, DOI 10.1038/nature04829
   Isogai S, 2003, DEVELOPMENT, V130, P5281, DOI 10.1242/dev.00733
   Isogai S, 2001, DEV BIOL, V230, P278, DOI 10.1006/dbio.2000.9995
   Kamei M, 2006, NATURE, V442, P453, DOI 10.1038/nature04923
   KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302
   Larson JD, 2004, DEV DYNAM, V231, P204, DOI 10.1002/dvdy.20102
   Lawson ND, 2002, NAT REV GENET, V3, P674, DOI 10.1038/nrg888
   Lawson ND, 2002, DEV BIOL, V248, P307, DOI 10.1006/dbio.2002.0711
   Leslie JD, 2007, DEVELOPMENT, V134, P839, DOI 10.1242/dev.003244
   Lubarsky B, 2003, CELL, V112, P19, DOI 10.1016/S0092-8674(02)01283-7
   Neumann M, 2006, EMBO REP, V7, P36, DOI 10.1038/sj.embor.7400597
   Ny A, 2006, EXP CELL RES, V312, P684, DOI 10.1016/j.yexcr.2005.10.018
   Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056
   Samakovlis C, 1996, DEVELOPMENT, V122, P3531
   Siekmann AF, 2007, NATURE, V445, P781, DOI 10.1038/nature05577
   TanakaMatakatsu M, 1996, DEVELOPMENT, V122, P3697
   Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659
   Uv A, 2003, TRENDS CELL BIOL, V13, P301, DOI 10.1016/S0962-8924(03)00083-7
   Westerfield M., 2000, ZEBRAFISH BOOK GUIDE
NR 27
TC 199
Z9 203
U1 0
U2 18
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0012-1606
EI 1095-564X
J9 DEV BIOL
JI Dev. Biol.
PD APR 15
PY 2008
VL 316
IS 2
BP 312
EP 322
DI 10.1016/j.ydbio.2008.01.038
PG 11
WC Developmental Biology
SC Developmental Biology
GA 286UF
UT WOS:000254870800011
PM 18342303
DA 2021-01-25
ER

PT J
AU Kamena, F
   Diefenbacher, M
   Kilchert, C
   Schwarz, H
   Spang, A
AF Kamena, Faustin
   Diefenbacher, Melanie
   Kilchert, Cornelia
   Schwarz, Heinz
   Spang, Anne
TI Ypt1p is essential for retrograde Golgi-ER transport and for Golgi
   maintenance in S. cerevisiae
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE ER-Golgi shuttle; YPT1; Rab; retrograde transport; yeast
ID GDP DISSOCIATION INHIBITOR; GTP-BINDING PROTEIN; PURIFIED CYTOSOLIC
   PROTEINS; YEAST SECRETORY PATHWAY; ENDOPLASMIC-RETICULUM;
   SACCHAROMYCES-CEREVISIAE; VACUOLE INHERITANCE; MEMBRANE-FUSION; COPII
   VESICLES; SNARE PROTEINS
AB The small GTPase Ypt1p of the Rab family is required for docking of ER-derived transport vesicles with the Golgi prior to fusion. However, the identity of the Rab protein that mediates docking of Golgi-derived COPI vesicles with the ER in retrograde transport remains elusive. Here, we show that in yeast Ypt1p is essential for retrograde transport from the Golgi to the ER. Retrieval of gp alpha F-HDEL (glycolylated pro-alpha-factor with an HDEL tag at the C-terminus) was blocked in Delta ypt1/SLY1-20 membranes at the restrictive temperature in vitro. Moreover, Ypt1p and the ER-resident t-SNARE Ufe1p interact genetically and biochemically, indicating a role for Ypt1p in consumption of COPI vesicles at the ER. Ypt1p is also essential for the maintenance of the morphology and the protein composition of the Golgi. Interestingly, the concentrations of the Golgi enzymes Anp1p and Mnn1p, the cargo protein Emp47p and the v-SNARE Sec22p were all substantially reduced in Golgi from a Delta ypt1/SLY1-20 strain as compared with wild-type Golgi, while the concentration of Arf1p and of coatomer were mildly affected. Finally, COPI vesicles generated from Delta ypt1/SLY1-20 Golgi membranes in vitro were depleted of Emp47p and Sec22p. These data demonstrate that Ypt1p plays an essential role in retrograde transport from the Golgi to the ER.
C1 [Kamena, Faustin; Diefenbacher, Melanie; Spang, Anne] Max Planck Gesell, Friedrich Miescher Lab, D-72076 Tubingen, Germany.
   [Diefenbacher, Melanie; Kilchert, Cornelia; Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Schwarz, Heinz] Max Planck Inst Dev Biol, D-72076 Tubingen, Germany.
RP Spang, A (corresponding author), Max Planck Gesell, Friedrich Miescher Lab, Spemannstr 39, D-72076 Tubingen, Germany.
EM anne.spang@unibas.ch
RI Spang, Anne/A-7029-2008; Spang, Anne/M-7223-2019
OI Spang, Anne/0000-0002-2387-6203; Spang, Anne/0000-0002-2387-6203;
   Kilchert, Cornelia/0000-0001-6834-0704
CR ACHSTETTER T, 1988, J BIOL CHEM, V263, P11711
   Alvarez C, 2003, MOL BIOL CELL, V14, P2116, DOI 10.1091/mbc.E02-09-0625
   Andag U, 2001, J BIOL CHEM, V276, P39150, DOI 10.1074/jbc.M105833200
   ARAKI S, 1990, J BIOL CHEM, V265, P13007
   BACON RA, 1989, J CELL BIOL, V109, P1015, DOI 10.1083/jcb.109.3.1015
   BAKER D, 1990, P NATL ACAD SCI USA, V87, P355, DOI 10.1073/pnas.87.1.355
   BAKER D, 1988, CELL, V54, P335, DOI 10.1016/0092-8674(88)90196-1
   Ballew N, 2005, MOL BIOL CELL, V16, P1839, DOI 10.1091/mbc.E04-08-0725
   BARLOWE C, 1994, CELL, V77, P895, DOI 10.1016/0092-8674(94)90138-4
   Barlowe C, 1997, J CELL BIOL, V139, P1097, DOI 10.1083/jcb.139.5.1097
   Benli M, 1996, EMBO J, V15, P6460, DOI 10.1002/j.1460-2075.1996.tb01037.x
   Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1
   Bucci C, 2000, MOL BIOL CELL, V11, P467, DOI 10.1091/mbc.11.2.467
   Cao XC, 2000, J CELL BIOL, V149, P55, DOI 10.1083/jcb.149.1.55
   Cao XC, 1998, EMBO J, V17, P2156, DOI 10.1093/emboj/17.8.2156
   Cosson P, 1997, EUR J CELL BIOL, V73, P93
   DASCHER C, 1991, MOL CELL BIOL, V11, P872, DOI 10.1128/MCB.11.2.872
   DEAN N, 1990, J CELL BIOL, V111, P369, DOI 10.1083/jcb.111.2.369
   DIRACSVEJSTRUP AB, 1994, J BIOL CHEM, V269, P15427
   Frei SB, 2006, MOL CELL BIOL, V26, P7299, DOI 10.1128/MCB.02405-05
   GARRETT MD, 1994, EMBO J, V13, P1718, DOI 10.1002/j.1460-2075.1994.tb06436.x
   HAAS A, 1995, EMBO J, V14, P5258, DOI 10.1002/j.1460-2075.1995.tb00210.x
   HOSOBUCHI M, 1992, NATURE, V360, P603, DOI 10.1038/360603a0
   JEDD G, 1995, J CELL BIOL, V131, P583, DOI 10.1083/jcb.131.3.583
   Jedd G, 1997, J CELL BIOL, V137, P563, DOI 10.1083/jcb.137.3.563
   KAHN RA, 1995, J BIOL CHEM, V270, P143, DOI 10.1074/jbc.270.1.143
   Kamena F, 2004, SCIENCE, V304, P286, DOI 10.1126/science.1095049
   Kosodo Y, 2002, J CELL SCI, V115, P3683, DOI 10.1242/jcs.00027
   Li BJ, 1996, J BIOL CHEM, V271, P16813, DOI 10.1074/jbc.271.28.16813
   Lupashin VV, 1997, SCIENCE, V276, P1255, DOI 10.1126/science.276.5316.1255
   MERESSE S, 1995, J CELL SCI, V108, P3349
   Morsomme P, 2002, DEV CELL, V2, P307, DOI 10.1016/S1534-5807(02)00133-8
   OSSIG R, 1991, MOL CELL BIOL, V11, P2980, DOI 10.1128/MCB.11.6.2980
   Peng RW, 2002, J CELL BIOL, V157, P645, DOI 10.1083/jcb.200202006
   PETER F, 1994, J CELL BIOL, V126, P1393, DOI 10.1083/jcb.126.6.1393
   Peters C, 2001, NATURE, V409, P581, DOI 10.1038/35054500
   Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555
   Poteryaev D, 2007, EMBO J, V26, P301, DOI 10.1038/sj.emboj.7601498
   Ram RJ, 2002, MOL BIOL CELL, V13, P1484, DOI 10.1091/mbc.01-10-0495
   Reilly BA, 2001, MOL BIOL CELL, V12, P3783, DOI 10.1091/mbc.12.12.3783
   Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092
   REXACH MF, 1991, J CELL BIOL, V114, P219, DOI 10.1083/jcb.114.2.219
   Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043
   SALAMA NR, 1993, EMBO J, V12, P4073, DOI 10.1002/j.1460-2075.1993.tb06091.x
   Sandmann T, 2003, MOL BIOL CELL, V14, P3097, DOI 10.1091/mbc.E02-11-0736
   SASAKI T, 1990, J BIOL CHEM, V265, P2333
   SEGEV N, 1988, CELL, V52, P915, DOI 10.1016/0092-8674(88)90433-3
   Segev N, 2001, CURR OPIN CELL BIOL, V13, P500, DOI 10.1016/S0955-0674(00)00242-8
   SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589
   Spang A, 2001, MOL BIOL CELL, V12, P1035, DOI 10.1091/mbc.12.4.1035
   ULLRICH O, 1993, J BIOL CHEM, V268, P18143
   Vonderheit A, 2005, PLOS BIOL, V3, P1225, DOI 10.1371/journal.pbio.0030233
   Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X
   Xu ZY, 1997, J CELL BIOL, V136, P299, DOI 10.1083/jcb.136.2.299
NR 56
TC 23
Z9 26
U1 0
U2 1
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
EI 1477-9137
J9 J CELL SCI
JI J. Cell Sci.
PD APR 15
PY 2008
VL 121
IS 8
BP 1293
EP 1302
DI 10.1242/jcs.016998
PG 10
WC Cell Biology
SC Cell Biology
GA 283TX
UT WOS:000254660500017
PM 18388317
OA Green Accepted, Bronze
DA 2021-01-25
ER

PT J
AU Reiman, EM
   Chen, K
   Caselli, RJ
   Alexander, GE
   Bandy, D
   Adamson, JL
   Lee, W
   Cannon, A
   Stephan, EA
   Stephan, DA
   Papassotiropoulos, A
AF Reiman, Eric M.
   Chen, Kewei
   Caselli, Richard J.
   Alexander, Gene E.
   Bandy, Daniel
   Adamson, Jennifer L.
   Lee, Wendy
   Cannon, Ashley
   Stephan, Elizabeth A.
   Stephan, Dietrich A.
   Papassotiropoulos, Andreas
TI Cholesterol-related genetic risk scores are associated with
   hypometabolism in Alzheimer's-affected brain regions
SO NEUROIMAGE
LA English
DT Article; Proceedings Paper
CT 10th International Conference on Alzheimers Disease and Related
   Disorders
CY JUL 15-16, 2006-2007
CL Madrid, SPAIN
DE Alzheimer's disease; genetics; cholesterol; positron emission
   tomography; endophenotype
ID BETA-AMYLOID IMMUNOREACTIVITY; APOLIPOPROTEIN-E GENOTYPE; TRANSGENIC
   MOUSE MODEL; E EPSILON-4 ALLELE; LATE-LIFE; SET ASSOCIATION; IN-VITRO;
   DISEASE; DEMENTIA; PATHOLOGY
AB We recently implicated a cluster of nine single nucleotide polymorphisms from seven cholesterol-related genes in the risk of Alzheimer's disease (AD) in a European cohort, and we proposed calculating an aggregate cholesterol-related genetic score (CREGS) to characterize a person's risk. In a separate study, we found that apolipoprotein E (APOE) epsilon 4 gene dose, an established AD risk factor, was correlated with fluorodeoxyglucose (FDG) positron emission tomography (PET) measurements of hypometabolism in AD-affected brain regions in a cognitively normal American cohort, and we proposed using PET as a presymptomatic endophenotype to help assess putative modifiers of AD risk. Thus, the objective in the present study is to determine whether CREGS is related to PET measurements of hypometabolism in AD-affected brain regions. DNA and PET data from 141 cognitively normal late middle-aged APOE epsilon 4 homozygotes, heterozygotes and noncarriers were analyzed to evaluate the relationship between CREGS and regional PET measurements. Cholesterol-related genetic risk scores were associated with hypometabolism in AD-affected brain regions, even when controlling for the effects of APOE epsilon 4 gene dose. The results support the role of cholesterol-related genes in the predisposition to AD and support the value of neuroimaging in the presymptomatic assessment of putative modifiers of AD risk. (C) 2008 Elsevier Inc. All rights reserved.
C1 [Reiman, Eric M.; Chen, Kewei; Bandy, Daniel; Lee, Wendy] Banner Alzheimers Inst, Phoenix, AZ 85006 USA.
   [Reiman, Eric M.; Chen, Kewei; Bandy, Daniel; Lee, Wendy] Banner Good Samaritan PET Ctr, Phoenix, AZ 85006 USA.
   [Reiman, Eric M.] Univ Arizona, Dept Psychiat, Tucson, AZ 85724 USA.
   [Chen, Kewei] Univ Arizona, Dept Radiol, Tucson, AZ 85724 USA.
   [Chen, Kewei] Arizona State Univ, Dept Math, Tempe, AZ 85287 USA.
   [Alexander, Gene E.] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA.
   [Alexander, Gene E.] Univ Arizona, Evelyn F Mcknight Brain Inst, Tucson, AZ 85721 USA.
   [Caselli, Richard J.] Mayo Clin, Dept Neurol, Scottsdale, AZ 85259 USA.
   [Adamson, Jennifer L.; Cannon, Ashley] Mayo Clin, Dept Neurosci, Jacksonville, FL 32224 USA.
   [Reiman, Eric M.; Stephan, Elizabeth A.; Stephan, Dietrich A.; Papassotiropoulos, Andreas] Translat Genom Res Inst, Neurogenom Div, Phoenix, AZ 85004 USA.
   [Papassotiropoulos, Andreas] Univ Basel, Div Mol Psychol, Basel, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Life Sci Training Facil Biozentrum, Basel, Switzerland.
   [Reiman, Eric M.; Chen, Kewei; Caselli, Richard J.; Alexander, Gene E.; Bandy, Daniel; Stephan, Elizabeth A.; Stephan, Dietrich A.; Papassotiropoulos, Andreas] Arizona Alzheimers Consortium, Phoenix, AZ 85006 USA.
RP Reiman, EM (corresponding author), Banner Alzheimers Inst, 901 E Willetta St, Phoenix, AZ 85006 USA.
EM eric.reiman@bannerhealth.com; andreas.papas@unibas.ch
RI Kennedy, Kristen M/B-4699-2008; Chen, Kewei/P-6304-2015
OI Kennedy, Kristen M/0000-0001-5373-9026; Chen, Kewei/0000-0001-8497-3069;
   Papassotiropoulos, Andreas/0000-0002-2210-9651
FU NIA NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)
   [P30 AG019610-07, P30 AG019610, P30 AG19610] Funding Source: Medline;
   NIMH NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Mental Health
   (NIMH) [R01 MH057899-09, R01 MH057899-08, R01 MH57899, R01 MH057899]
   Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTHUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Mental Health (NIMH)
   [R01MH057899, R01MH057899, R01MH057899, R01MH057899, R01MH057899,
   R01MH057899, R01MH057899, R01MH057899, R01MH057899] Funding Source: NIH
   RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health
   & Human ServicesNational Institutes of Health (NIH) - USANIH National
   Institute on Aging (NIA) [P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610, P30AG019610, P30AG019610, P30AG019610, P30AG019610,
   P30AG019610] Funding Source: NIH RePORTER
CR Alexander GE, 2002, AM J PSYCHIAT, V159, P738, DOI 10.1176/appi.ajp.159.5.738
   CORDER EH, 1993, SCIENCE, V261, P921, DOI 10.1126/science.8346443
   CROOK R, 1994, J NEUROSCI METH, V53, P125, DOI 10.1016/0165-0270(94)90168-6
   Farrer LA, 1997, JAMA-J AM MED ASSOC, V278, P1349, DOI 10.1001/jama.278.16.1349
   Fassbender K, 2001, P NATL ACAD SCI USA, V98, P5856, DOI 10.1073/pnas.081620098
   Gatz M, 2006, ARCH GEN PSYCHIAT, V63, P168, DOI 10.1001/archpsyc.63.2.168
   Hoh J, 2001, GENOME RES, V11, P2115, DOI 10.1101/gr.204001
   Howland DS, 1998, J BIOL CHEM, V273, P16576, DOI 10.1074/jbc.273.26.16576
   Hutter-Paier B, 2004, NEURON, V44, P227, DOI 10.1016/j.neuron.2004.08.043
   Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X
   Kalmijn S, 2000, ARTERIOSCL THROM VAS, V20, P2255, DOI 10.1161/01.ATV.20.10.2255
   Kim S, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-S1-S9
   Kivipelto M, 2006, ACTA NEUROL SCAND, V114, P50, DOI 10.1111/j.1600-0404.2006.00685.x
   Kivipelto M, 2002, ANN INTERN MED, V137, P149, DOI 10.7326/0003-4819-137-3-200208060-00006
   Mahley RW, 2006, ACTA NEUROL SCAND, V114, P8, DOI 10.1111/j.1600-0404.2006.00679.x
   MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935
   Maitland-Van Der Zee AH, 2005, PHARMACOGENET GENOM, V15, P287, DOI 10.1097/01213011-200505000-00003
   Mielke MM, 2005, NEUROLOGY, V64, P1689, DOI 10.1212/01.WNL.0000161870.78572.A5
   Miyata M, 1996, NAT GENET, V14, P55, DOI 10.1038/ng0996-55
   Notkola IL, 1998, NEUROEPIDEMIOLOGY, V17, P14, DOI 10.1159/000026149
   Ott J, 2003, J COMPUT BIOL, V10, P569, DOI 10.1089/10665270360688192
   Papassotiropoulos A, 2005, J CLIN PSYCHIAT, V66, P940, DOI 10.4088/JCP.v66n0720
   Papassotiropoulos A, 2006, J CLIN PSYCHIAT, V67, P652, DOI 10.4088/JCP.v67n0418
   Pappolla MA, 2003, NEUROLOGY, V61, P199, DOI 10.1212/01.WNL.0000070182.02537.84
   Puglielli L, 2003, NAT NEUROSCI, V6, P345, DOI 10.1038/nn0403-345
   Refolo LM, 2001, NEUROBIOL DIS, V8, P890, DOI 10.1006/nbdi.2001.0422
   Refolo LM, 2000, NEUROBIOL DIS, V7, P321, DOI 10.1006/nbdi.2000.0304
   Reiman EM, 2005, P NATL ACAD SCI USA, V102, P8299, DOI 10.1073/pnas.0500579102
   Reiman EM, 1996, NEW ENGL J MED, V334, P752, DOI 10.1056/NEJM199603213341202
   Reiman EM, 2001, P NATL ACAD SCI USA, V98, P3334, DOI 10.1073/pnas.061509598
   Rockwood K, 2006, ACTA NEUROL SCAND, V114, P71, DOI 10.1111/j.1600-0404.2006.00688.x
   Shepherd J, 2002, LANCET, V360, P1623, DOI 10.1016/S0140-6736(02)11600-X
   Shobab LA, 2005, LANCET NEUROL, V4, P841, DOI 10.1016/S1474-4422(05)70248-9
   SPARKS DL, 1994, EXP NEUROL, V126, P88, DOI 10.1006/exnr.1994.1044
   Sparks DL, 1996, NEUROBIOL AGING, V17, P291, DOI 10.1016/0197-4580(95)02067-5
   Sparks DL, 2005, ARCH NEUROL-CHICAGO, V62, P753, DOI 10.1001/archneur.62.5.753
   STRITTMATTER WJ, 1994, EXP NEUROL, V125, P163, DOI 10.1006/exnr.1994.1019
   Talairach J., 1998, COPLANAR STEREOTAXIC
   Tan ZS, 2003, ARCH INTERN MED, V163, P1053, DOI 10.1001/archinte.163.9.1053
   Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2
   WISNIEWSKI T, 1994, AM J PATHOL, V145, P1030
   Wolozin B, 2004, NEURON, V41, P7, DOI 10.1016/S0896-6273(03)00840-7
   Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439
   Wolozin B, 2007, BMC MED, V5, DOI 10.1186/1741-7015-5-20
   Zandi PP, 2005, ARCH GEN PSYCHIAT, V62, P217, DOI 10.1001/archpsyc.62.2.217
NR 45
TC 23
Z9 23
U1 0
U2 6
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1053-8119
EI 1095-9572
J9 NEUROIMAGE
JI Neuroimage
PD APR 15
PY 2008
VL 40
IS 3
BP 1214
EP 1221
DI 10.1016/j.neuroimage.2007.12.066
PG 8
WC Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical
   Imaging
SC Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging
GA 284TH
UT WOS:000254728200020
PM 18280754
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Martin, G
   Doublie, S
   Keller, W
AF Martin, Georges
   Doublie, Sylvie
   Keller, Walter
TI Determinants of substrate specificity in RNA-dependent nucleotidyl
   transferases
SO BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS
LA English
DT Review
DE nucleotidyl transferase; terminal uridylyl transferase; CCA-adding
   enzyme; poly(A) polymerase; catalytic mechanism
ID CCA-ADDING ENZYME; TERMINAL URIDYLYL TRANSFERASE; CEREVISIAE POLY(A)
   POLYMERASE; MESSENGER-RNA; CRYSTAL-STRUCTURES; STRUCTURAL BASIS;
   QUALITY-CONTROL; BINDING; MECHANISM; DNA
AB Poly(A) polymerases were identified almost 50 years ago as enzymes that add multiple AMP residues to the 3' ends of primer RNAs without use of a template from ATP as cosubstrate and with release of pyrophosphate. Based on sequence homology of a signature motif in the catalytic domain, poly(A) polymerases were later found to belong to a superfamily of nucleotidyl transferases acting on a very diverse array of substrates. Enzymes belonging to the superfamily can add from single nucleotides of AMP, CMP or UMP to RNA, antibiotics and proteins but also homopolymers of many hundred residues to the 3' ends of RNA molecules.
   The recently reported structures of several nucleotidyl transferases facilitate the study of the catalytic mechanisms of these very diverse enzymes. Numerous structures of CCA-adding enzymes have now revealed all steps in the formation of a CCA tail at the 3' end of tRNAs. In addition, structures of poly(A) polymerases and uridylyl transferases are now available as binary and ternary complexes with incoming nucleotide and RNA primer. Some of these proteins undergo significant conformational changes after substrate binding. This is proposed to be an indication for an induced fit mechanism that drives substrate selection and leads to catalysis. Insights from recent structures of ternary complexes indicate an important role for the primer molecule in selecting the incoming nucleotide. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Martin, Georges; Keller, Walter] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [Doublie, Sylvie] Univ Vermont, Dept Microbiol & Mol Genet, Burlington, VT 05405 USA.
RP Keller, W (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM walter.keller@unibas.ch
OI Doublie, Sylvie/0000-0002-6294-5304
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [GM62239, R01 GM062239-05, R01 GM062239]
   Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM062239, R01GM062239, R01GM062239,
   R01GM062239, R01GM062239] Funding Source: NIH RePORTER
CR Aphasizhev R, 2002, CELL, V108, P637, DOI 10.1016/S0092-8674(02)00647-5
   Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609
   Augustin MA, 2003, J MOL BIOL, V328, P985, DOI 10.1016/S0022-2836(03)00381-4
   BAKER EN, 1984, PROG BIOPHYS MOL BIO, V44, P97, DOI 10.1016/0079-6107(84)90007-5
   Balbo PB, 2007, STRUCTURE, V15, P1117, DOI 10.1016/j.str.2007.07.010
   Balbo PB, 2007, J MOL BIOL, V366, P1401, DOI 10.1016/j.jmb.2006.12.030
   Balbo PB, 2005, BIOCHEMISTRY-US, V44, P7777, DOI 10.1021/bi050089r
   Bard J, 2000, SCIENCE, V289, P1346, DOI 10.1126/science.289.5483.1346
   Batra VK, 2006, STRUCTURE, V14, P757, DOI 10.1016/j.str.2006.01.011
   Betat H, 2004, MOL CELL, V15, P389, DOI 10.1016/j.molcel.2004.06.026
   Cho HD, 2005, J BIOL CHEM, V280, P9555, DOI 10.1074/jbc.M412594200
   Deng JP, 2005, EMBO J, V24, P4007, DOI 10.1038/sj.emboj.7600861
   Hall TMT, 2002, CURR OPIN STRUC BIOL, V12, P82, DOI 10.1016/S0959-440X(02)00293-2
   Helming S, 2001, MOL CELL BIOL, V21, P2026, DOI 10.1128/MCB.21.6.2026-2037.2001
   HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4
   Johnson L, 2004, J MOL BIOL, V337, P843, DOI 10.1016/j.jmb.2004.01.058
   Justesen J, 2000, CELL MOL LIFE SCI, V57, P1593, DOI 10.1007/PL00000644
   Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804
   Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070
   Kerwitz Y, 2003, EMBO J, V22, P3705, DOI 10.1093/emboj/cdg347
   Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008
   Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007
   LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029
   Lehmann C, 2005, PROTEINS, V60, P807, DOI 10.1002/prot.20586
   Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7
   LINGNER J, 1991, NATURE, V354, P496, DOI 10.1038/354496a0
   Liu QS, 2006, CELL, V127, P1223, DOI 10.1016/j.cell.2006.10.037
   Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223
   Martin G, 2004, J MOL BIOL, V341, P911, DOI 10.1016/j.jmb.2004.06.047
   Martin G, 2004, RNA, V10, P899, DOI 10.1261/rna.5242304
   Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x
   Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193
   Martin G, 2007, RNA, V13, P1834, DOI 10.1261/rna.652807
   McManus MT, 2000, MOL CELL BIOL, V20, P883, DOI 10.1128/MCB.20.3.883-891.2000
   MONTE CM, 2006, MOL CELL, V22, P339
   MOON AF, 2007, DNA REPAIR, P1
   RAABE T, 1991, NATURE, V353, P229, DOI 10.1038/353229a0
   Ramadan K, 2004, NAT REV MOL CELL BIO, V5, P1038, DOI 10.1038/nrm1530
   Reuther J, 2007, J MOL MICROB BIOTECH, V12, P139, DOI 10.1159/000096469
   Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06
   Ryan CM, 2005, RNA, V11, P763, DOI 10.1261/rna.7248605
   Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812
   Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521
   Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197
   Smith Clyde A., 2002, Current Drug Targets - Infectious Disorders, V2, P143, DOI 10.2174/1568005023342533
   Stagno J, 2007, P NATL ACAD SCI USA, V104, P14634, DOI 10.1073/pnas.0704259104
   Stagno J, 2007, J MOL BIOL, V366, P882, DOI 10.1016/j.jmb.2006.11.065
   Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542
   Stevenson AL, 2006, YEAST, V23, P991, DOI 10.1002/yea.1408
   Suh N, 2006, P NATL ACAD SCI USA, V103, P15108, DOI 10.1073/pnas.0607050103
   Thai TH, 2005, ADV IMMUNOL, V86, P113, DOI 10.1016/S0065-2776(04)86003-6
   Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712
   Trippe R, 2006, RNA, V12, P1494, DOI 10.1261/rna.87706
   Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189
   Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005
   WAHLE E, 1991, J BIOL CHEM, V266, P3131
   WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J
   Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1111/j.1574-6976.1999.tb00400.x
   Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039
   Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000
   Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030
   Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711
   Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4
   Yehudai-Resheff S, 2000, NUCLEIC ACIDS RES, V28, P1139, DOI 10.1093/nar/28.5.1139
   Yin YW, 2004, CELL, V116, P393, DOI 10.1016/S0092-8674(04)00120-5
   Yue DX, 1996, RNA, V2, P895
   ZABEL P, 1981, NUCLEIC ACIDS RES, V9, P2433, DOI 10.1093/nar/9.11.2433
   Zhelkovsky A, 1998, MOL CELL BIOL, V18, P5942, DOI 10.1128/MCB.18.10.5942
   ZHELKOVSKY AM, 1995, J BIOL CHEM, V270, P26715, DOI 10.1074/jbc.270.44.26715
NR 69
TC 16
Z9 17
U1 0
U2 2
PU ELSEVIER
PI AMSTERDAM
PA RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS
SN 1874-9399
EI 1876-4320
J9 BBA-GENE REGUL MECH
JI Biochim. Biophys. Acta-Gene Regul. Mech.
PD APR
PY 2008
VL 1779
IS 4
BP 206
EP 216
DI 10.1016/j.bbagrm.2007.12.003
PG 11
WC Biochemistry & Molecular Biology; Biophysics
SC Biochemistry & Molecular Biology; Biophysics
GA 298PU
UT WOS:000255700400002
PM 18177750
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Kreplak, L
   Herrmann, H
   Aebi, U
AF Kreplak, Laurent
   Herrmann, Harald
   Aebi, Ueli
TI Tensile properties of single desmin intermediate filaments
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID MECHANICAL-PROPERTIES; MUSCLE; FORCE; DISEASE; ARCHITECTURE; MUTATIONS;
   COMPOSITE; INSIGHTS; NETWORK; MATRIX
AB Within muscle fibers, desmin intermediate filaments (IFs) are major constituents of the extrasarcomeric cytoskeleton. However, their contribution to the mechanical properties of myocytes has remained elusive. We present an experimental approach to measure the extensibility and the tensile strength of in vitro reconstituted desmin IFs adsorbed to a solid support. The tip of an atomic force microscope (AFM) was used to push on single filaments perpendicular to the filament axis. The torque of the AFM cantilever was monitored during the pushing events to yield an estimate of the lateral force necessary to bend and stretch the filaments. Desmin IFs were stretched up to 3.4-fold with a maximum force of similar to 3.5 nN. Fully stretched filaments exhibited a much smaller diameter than did native IFs, i.e., similar to 3.5 nm compared to 12.6 nm, both by AFM and electron microscopy. Moreover, we combined the morphological and lateral force data to compute an average stress-strain curve for a single desmin filament. The main features were a pronounced strain-hardening regime above 50% extension and a tensile strength of at least 240 MPa. Because of these nonlinear tensile properties, desmin IFs may dissipate mechanical energy and serve as a physical link between successive sarcomeres during large deformation.
C1 [Kreplak, Laurent; Aebi, Ueli] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Herrmann, Harald] German Canc Res Ctr, Dept Mol Genet, D-69120 Heidelberg, Germany.
RP Kreplak, L (corresponding author), Dalhousie Univ, Dept Phys & Atmospher Sci, Halifax, NS B3H 3J5, Canada.
EM kreplak@fizz.phys.dal.ca
OI kreplak, laurent/0000-0001-9370-9809
CR Bar H, 2006, J MOL BIOL, V360, P1031, DOI 10.1016/j.jmb.2006.05.068
   Bar H, 2005, P NATL ACAD SCI USA, V102, P15099, DOI 10.1073/pnas.0504568102
   Capetanaki Y, 2007, EXP CELL RES, V313, P2063, DOI 10.1016/j.yexcr.2007.03.033
   Falvo MR, 1997, BIOPHYS J, V72, P1396, DOI 10.1016/S0006-3495(97)78786-1
   FRASER RDB, 1969, POLYMER, V10, P810, DOI 10.1016/0032-3861(69)90110-4
   Fudge DS, 2004, P ROY SOC B-BIOL SCI, V271, P291, DOI 10.1098/rspb.2003.2591
   Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3
   GRANGER BL, 1979, CELL, V18, P1053, DOI 10.1016/0092-8674(79)90218-6
   GRANZIER HL, 1995, BIOPHYS J, V68, P1027, DOI 10.1016/S0006-3495(95)80278-X
   Guzman C, 2006, J MOL BIOL, V360, P623, DOI 10.1016/j.jmb.2006.05.030
   Heidelberg A, 2006, NANO LETT, V6, P1101, DOI 10.1021/nl060028u
   HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   INAGAKI M, 1987, NATURE, V328, P649, DOI 10.1038/328649a0
   Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092
   Kreplak L, 2004, BIOPHYS J, V87, P640, DOI 10.1529/biophysj.103.036749
   Kreplak L, 2007, BIOESSAYS, V29, P26, DOI 10.1002/bies.20514
   Landau L. D., 1970, THEORY ELASTICITY
   LAZARIDES E, 1976, P NATL ACAD SCI USA, V73, P4344, DOI 10.1073/pnas.73.12.4344
   Li ZL, 1997, J CELL BIOL, V139, P129, DOI 10.1083/jcb.139.1.129
   Lieber RL, 1996, J APPL PHYSIOL, V80, P278
   Mucke N, 2005, J STRUCT BIOL, V150, P268, DOI 10.1016/j.jsb.2005.02.012
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   NONNENMACHER M, 1991, J VAC SCI TECHNOL B, V9, P1358, DOI 10.1116/1.585196
   Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319
   Perng MD, 2004, MOL BIOL CELL, V15, P2335, DOI 10.1091/mbc.E03-12-0893
   SADER JE, 1995, REV SCI INSTRUM, V66, P3789, DOI 10.1063/1.1145439
   Sam M, 2000, AM J PHYSIOL-CELL PH, V279, pC1116
   Shah SB, 2004, BIOPHYS J, V86, P2993, DOI 10.1016/S0006-3495(04)74349-0
   Strelkov SV, 2003, BIOESSAYS, V25, P243, DOI 10.1002/bies.10246
   Tsuda Y, 1996, P NATL ACAD SCI USA, V93, P12937, DOI 10.1073/pnas.93.23.12937
   WANG K, 1993, BIOPHYS J, V64, P1161, DOI 10.1016/S0006-3495(93)81482-6
   WANG K, 1983, J CELL BIOL, V96, P562, DOI 10.1083/jcb.96.2.562
NR 33
TC 92
Z9 93
U1 0
U2 17
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0006-3495
EI 1542-0086
J9 BIOPHYS J
JI Biophys. J.
PD APR 1
PY 2008
VL 94
IS 7
BP 2790
EP 2799
DI 10.1529/biophysj.107.119826
PG 10
WC Biophysics
SC Biophysics
GA 275MM
UT WOS:000254076300035
PM 18178641
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Landgraf, P
   Rusu, M
   Sheridan, R
   Sewer, A
   Borkhardt, A
   Zavolan, M
   Tuschl, T
AF Landgraf, P.
   Rusu, M.
   Sheridan, R.
   Sewer, A.
   Borkhardt, A.
   Zavolan, M.
   Tuschl, T.
TI miRNA profiling of the haematopoietic lineage and paediatric precursor
   B-ALL samples by small RNA cloning and sequencing
SO BRITISH JOURNAL OF HAEMATOLOGY
LA English
DT Meeting Abstract
CT 48th Annual Scientific Meeting of the British-Society-for-Haematology
CY APR 07-09, 2008
CL Glasgow, SCOTLAND
SP British Soc Haematol
C1 [Landgraf, P.; Tuschl, T.] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA.
   [Landgraf, P.; Borkhardt, A.] Univ Dusseldorf, Clin Pediat Oncol Haematol & Clin Immunol, D-4000 Dusseldorf, Germany.
   [Rusu, M.; Sewer, A.; Zavolan, M.] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Sheridan, R.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10021 USA.
RI Zavolan, Mihaela/S-3888-2016
NR 0
TC 1
Z9 1
U1 0
U2 2
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0007-1048
J9 BRIT J HAEMATOL
JI Br. J. Haematol.
PD APR
PY 2008
VL 141
SU 1
MA 172
BP 63
EP 64
PG 2
WC Hematology
SC Hematology
GA 289CL
UT WOS:000255032500173
DA 2021-01-25
ER

PT J
AU Knechtle, B
   Knechtle, P
   Schulze, I
   Kohler, G
AF Knechtle, B.
   Knechtle, P.
   Schulze, I.
   Kohler, G.
TI Upper arm circumference is associated with race performance in
   ultra-endurance runners
SO BRITISH JOURNAL OF SPORTS MEDICINE
LA English
DT Article
ID LONG-DISTANCE RUNNERS; BODY-COMPOSITION; SKINFOLD THICKNESSES; SWIMMING
   PERFORMANCE; RUNNING PERFORMANCE; AFRICAN RUNNERS; FAT OXIDATION;
   MARATHON; LEVEL; SWIMMERS
AB Objective: To investigate the association of anthropometric parameters to race performance in ultra-endurance runners in a multistage ultra-endurance run.
   Design: Descriptive field study.
   Setting: The Deutschlandlauf 2006 race in Germany, where athletes had to run 1200 km within 17 consecutive days. There were no interventions.
   Subjects: In total, there were 19 male Caucasian ultra-endurancerunners (mean (SD) 46.2 (9.6) years, 71.8 (5.2) kg, 179 (6) cm, BMI 22.5 (1.9) kg/m(2)).
   Main outcome measurements: Determination of body mass, body height, length of lower limbs, skin-fold thicknesses, circumference of limbs, body mass index (BMI), percentage skeletal muscle mass (%SM), and percentage body fat (%BF) in 19 successful finishers in order to correlate anthropometric parameters with running performance.
   Results: A significant association of upper arm circumference with the total running time was found (p < 0.05, r(2) = 0.26). No significant association was found with the directly measured anthropometric properties body height, body mass, average skin-fold thickness and the circumference of thigh and calf (p > 0.05). Furthermore, no significant association was observed between the running time and the calculated parameters BMI, % BF, and %SM (p > 0.05).
   Conclusions: In an ultra-endurance run over 1200 km within 17 consecutive days, circumference of the upper arm was the only factor associated with performance in well-experienced ultra-endurance runners. Body mass, BMI, body height, length of limbs, skin-fold thicknesses, circumference of limbs and the calculated percentage body composition of skeletal muscle mass and body fat showed no association with running performance.
C1 [Knechtle, B.; Knechtle, P.] Gesundheitszentrum St Gallen, St Gallen, Switzerland.
   [Kohler, G.] Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
RP Knechtle, B (corresponding author), Gesundheitszentrum St Gallen, St Gallen, Switzerland.
EM beat.knechtle@hispeed.ch
CR Achten J, 2003, METABOLISM, V52, P747, DOI 10.1016/S0026-0495(03)00068-4
   Arrese AL, 2006, INT J SPORTS MED, V27, P289, DOI 10.1055/s-2005-865628
   Arrese AL, 2005, J SPORT MED PHYS FIT, V45, P512
   Arrese AL, 2006, J SPORT SCI, V24, P69, DOI 10.1080/02640410500127751
   Bale P, 1986, Br J Sports Med, V20, P170
   Bale P, 1985, J SPORT SCI, V3, P115, DOI 10.1080/02640418508729741
   Ball SD, 2004, EUR J CLIN NUTR, V58, P1525, DOI 10.1038/sj.ejcn.1602003
   Berg K, 2003, SPORTS MED, V33, P59, DOI 10.2165/00007256-200333010-00005
   Billat VL, 2001, MED SCI SPORT EXER, V33, P2089, DOI 10.1097/00005768-200112000-00018
   BOSCH AN, 1990, EUR J APPL PHYSIOL O, V61, P68, DOI 10.1007/BF00236696
   Christensen C L, 1983, Br J Sports Med, V17, P166
   Esteve-Lanao J, 2005, MED SCI SPORT EXER, V37, P496, DOI 10.1249/01.MSS.0000155393.78744.86
   Geladas ND, 2005, INT J SPORTS MED, V26, P139, DOI 10.1055/s-2004-817862
   Hagan R D, 1987, Br J Sports Med, V21, P3
   Helge JW, 2003, J EXP BIOL, V206, P1075, DOI 10.1242/jeb.00218
   Hetland ML, 1998, SCAND J MED SCI SPOR, V8, P102
   Jagomagi Gennadi, 2005, Anthropologischer Anzeiger, V63, P213
   Keatinge WR, 2001, BRIT J SPORT MED, V35, P352, DOI 10.1136/bjsm.35.5.352
   Knechtle B, 2004, INT J SPORTS MED, V25, P38, DOI 10.1055/s-2003-45232
   Landers GJ, 2000, ANN HUM BIOL, V27, P387, DOI 10.1080/03014460050044865
   Larsen HB, 2003, COMP BIOCHEM PHYS A, V136, P161, DOI 10.1016/S1095-6433(03)00227-7
   LAURENSON NM, 1993, INT J SPORTS MED, V14, P455, DOI 10.1055/s-2007-1021210
   Lee RC, 2000, AM J CLIN NUTR, V72, P796
   LEEDY HE, 1965, RES QUART, V36, P158, DOI 10.1080/10671188.1965.10614674
   Legaz A, 2005, BRIT J SPORT MED, V39, P851, DOI 10.1136/bjsm.2005.018960
   Maldonado S, 2002, INT J SPORTS MED, V23, P268, DOI 10.1055/s-2002-29083
   Marino FE, 2004, J APPL PHYSIOL, V96, P124, DOI 10.1152/japplphysiol.00582.2003
   McLean BD, 1989, J SPORT SCI, V7, P247, DOI 10.1080/02640418908729845
   Noakes T, 1998, S AFR J SCI, V94, P531
   *R DEV COR TEAM, 2005, LANG ENV STAT COMP
   Rahmani A, 2004, EUR J APPL PHYSIOL, V91, P399, DOI 10.1007/s00421-003-0989-x
   RASCHKA C, 1991, Z ERNAHRUNGSWISS, V30, P276, DOI 10.1007/BF01651957
   RIEDENAU RP, 1968, RES QUART, V29, P200
   Saltin B., 1995, Scandinavian Journal of Medicine and Science in Sports, V5, P209
   Sharwood K, 2002, CLIN J SPORT MED, V12, P391, DOI 10.1097/00042752-200211000-00012
   SIDERS WA, 1993, J SPORT MED PHYS FIT, V33, P166
   SJODIN B, 1985, SPORTS MED, V2, P83
   TANAKA K, 1982, ANN HUM BIOL, V9, P473, DOI 10.1080/03014468200006001
   Tokudome S, 2004, J EPIDEMIOL, V14, P161, DOI 10.2188/jea.14.161
   Tuuri G, 2002, MED SCI SPORT EXER, V34, P2110, DOI 10.1097/00005768-200212000-00037
   Weston AR, 1999, J APPL PHYSIOL, V86, P915
   Weston AR, 2000, MED SCI SPORT EXER, V32, P1130, DOI 10.1097/00005768-200006000-00015
   Yeung SS, 2001, J SPORT MED PHYS FIT, V41, P170
NR 43
TC 41
Z9 43
U1 0
U2 13
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0306-3674
J9 BRIT J SPORT MED
JI Br. J. Sports Med.
PD APR
PY 2008
VL 42
IS 4
BP 295
EP 299
DI 10.1136/bjsm.2007.038570
PG 5
WC Sport Sciences
SC Sport Sciences
GA 283YR
UT WOS:000254672900013
PM 17599951
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Engel, A
   Fujiyoshi, Y
   Gonen, T
   Walz, T
AF Engel, Andreas
   Fujiyoshi, Yoshinori
   Gonen, Tamir
   Walz, Thomas
TI Junction-forming aquaporins
SO CURRENT OPINION IN STRUCTURAL BIOLOGY
LA English
DT Review
ID MAJOR INTRINSIC PROTEIN; MOLECULAR CHARACTERIZATION; WATER PERMEABILITY;
   GAP-JUNCTIONS; HUMAN LENS; RAT-BRAIN; CHANNEL; MEMBRANE; TRANSPORT;
   ARRAYS
AB Aquaporins (AQPs) are a family of ubiquitous membrane channels that conduct water and solutes across membranes. This review focuses on AQP0 and AQP4, which in addition to forming water channels also appear to play a role in cell adhesion. We discuss the recently determined structures of the membrane junctions mediated by these two AQPs, the mechanisms that regulate junction formation, and evidence that supports a role for AQP0 and AQP4 in cell adhesion.
C1 [Walz, Thomas] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.
   [Engel, Andreas] Univ Basel, Maurice E Mueller Inst, Biozentrum, CH-4056 Basel, Switzerland.
   [Fujiyoshi, Yoshinori] Kyoto Univ, Fac Sci, Dept Biophys, Sakyo Ku, Kyoto 6068502, Japan.
   [Gonen, Tamir] Univ Washington, Dept Biochem, Seattle, WA 98195 USA.
RP Walz, T (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, 240 Longwood Ave, Boston, MA 02115 USA.
EM twalz@hms.harvard.edu
RI Fujiyoshi, Yoshinori/E-5989-2012
OI Fujiyoshi, Yoshinori/0000-0002-8070-1493
FU NEI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01
   EY015107, R01 EY015107-05] Funding Source: Medline; NIGMS NIH HHSUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of General Medical Sciences
   (NIGMS) [R01 GM079233-02, P01 GM062580-06A16830, R01 GM079233, P01
   GM062580] Funding Source: Medline; NATIONAL EYE INSTITUTEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Eye Institute (NEI) [R01EY015107, R01EY015107,
   R01EY015107, R01EY015107, R01EY015107, R01EY015107, R01EY015107,
   R01EY015107] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL
   MEDICAL SCIENCESUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [P01GM062580, P01GM062580,
   P01GM062580, P01GM062580, P01GM062580, P01GM062580, P01GM062580,
   P01GM062580, R01GM079233, P01GM062580, P01GM062580, P01GM062580,
   P01GM062580, P01GM062580, P01GM062580, P01GM062580, P01GM062580,
   P01GM062580, P01GM062580, P01GM062580, R01GM079233, P01GM062580,
   P01GM062580, P01GM062580, P01GM062580, P01GM062580, P01GM062580,
   P01GM062580, P01GM062580, P01GM062580, P01GM062580, P01GM062580,
   P01GM062580, P01GM062580, P01GM062580, P01GM062580, P01GM062580,
   P01GM062580, P01GM062580, P01GM062580, P01GM062580, P01GM062580,
   P01GM062580, P01GM062580, P01GM062580, R01GM079233, R01GM079233,
   P01GM062580, P01GM062580, P01GM062580, P01GM062580, P01GM062580,
   P01GM062580, P01GM062580, R01GM079233, P01GM062580, R01GM079233,
   P01GM062580, P01GM062580, P01GM062580, P01GM062580, P01GM062580,
   P01GM062580, P01GM062580, R01GM079233, P01GM062580, P01GM062580,
   P01GM062580, P01GM062580] Funding Source: NIH RePORTER
CR Amiry-Moghaddam M, 2003, NAT REV NEUROSCI, V4, P991, DOI 10.1038/nrn1252
   Ball LE, 2003, INVEST OPHTH VIS SCI, V44, P4820, DOI 10.1167/iovs.02-1317
   BLOEMENDAL H, 1972, Cell Differentiation, V1, P91, DOI 10.1016/0045-6039(72)90032-2
   Buzhynskyy N, 2007, EMBO REP, V8, P51, DOI 10.1038/sj.embor.7400858
   Cooper GJ, 2002, J PHYSIOL-LONDON, V542, P17, DOI 10.1113/jphysiol.2002.023218
   COSTELLO MJ, 1989, INVEST OPHTH VIS SCI, V30, P975
   de Groot BL, 2005, CURR OPIN STRUC BIOL, V15, P176, DOI 10.1016/j.sbi.2005.02.003
   DUNIA I, 1987, J CELL BIOL, V105, P1679, DOI 10.1083/jcb.105.4.1679
   Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920
   Fu DX, 2000, SCIENCE, V290, P481, DOI 10.1126/science.290.5491.481
   Furman CS, 2003, P NATL ACAD SCI USA, V100, P13609, DOI 10.1073/pnas.2235843100
   Gonen T, 2004, J MOL BIOL, V342, P1337, DOI 10.1016/j.jmb.2004.07.076
   Gonen T, 2004, NATURE, V429, P193, DOI 10.1038/nature02503
   Gonen T, 2005, NATURE, V438, P633, DOI 10.1038/nature04321
   Gonen T, 2006, Q REV BIOPHYS, V39, P361, DOI 10.1017/S0033583506004458
   Harries WEC, 2004, P NATL ACAD SCI USA, V101, P14045, DOI 10.1073/pnas.0405274101
   HASEGAWA H, 1994, J BIOL CHEM, V269, P5497
   Hasler L, 1998, J MOL BIOL, V279, P855, DOI 10.1006/jmbi.1998.1796
   Hiroaki Y, 2006, J MOL BIOL, V355, P628, DOI 10.1016/j.jmb.2005.10.081
   Hite RK, 2007, CURR OPIN STRUC BIOL, V17, P389, DOI 10.1016/j.sbi.2007.06.006
   HITE RK, 2007, IN PRESS PFLUGERA AR
   JUNG JS, 1994, P NATL ACAD SCI USA, V91, P13052, DOI 10.1073/pnas.91.26.13052
   KISTLER J, 1980, FEBS LETT, V111, P73, DOI 10.1016/0014-5793(80)80764-2
   Kukulski W, 2005, J MOL BIOL, V350, P611, DOI 10.1016/j.jmb.2005.05.001
   Liu ZJ, 2002, P NATL ACAD SCI USA, V99, P6053, DOI 10.1073/pnas.092131899
   Lu MQ, 1996, P NATL ACAD SCI USA, V93, P10908, DOI 10.1073/pnas.93.20.10908
   Maurel C, 2007, FEBS LETT, V581, P2227, DOI 10.1016/j.febslet.2007.03.021
   MULDERS SM, 1995, J BIOL CHEM, V270, P9010, DOI 10.1074/jbc.270.15.9010
   Murata K, 2000, NATURE, V407, P599, DOI 10.1038/35036519
   Neely JD, 1999, BIOCHEMISTRY-US, V38, P11156, DOI 10.1021/bi990941s
   Nemeth-Cahalan KL, 2000, J BIOL CHEM, V275, P6777, DOI 10.1074/jbc.275.10.6777
   Nielsen S, 1997, J NEUROSCI, V17, P171
   Palanivelu DV, 2006, J MOL BIOL, V355, P605, DOI 10.1016/j.jmb.2005.10.032
   PIATIGORSKY J, 1989, CELL, V57, P197, DOI 10.1016/0092-8674(89)90956-2
   PRESTON GM, 1992, SCIENCE, V256, P385, DOI 10.1126/science.256.5055.385
   Rash JE, 1998, P NATL ACAD SCI USA, V95, P11981, DOI 10.1073/pnas.95.20.11981
   TAKEMOTO L, 1986, INVEST OPHTH VIS SCI, V27, P443
   Tsukaguchi H, 1998, J BIOL CHEM, V273, P24737, DOI 10.1074/jbc.273.38.24737
   Yasui M, 1999, NATURE, V402, P184
   ZAMPIGHI G, 1982, J CELL BIOL, V93, P175, DOI 10.1083/jcb.93.1.175
NR 40
TC 58
Z9 59
U1 1
U2 10
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-440X
J9 CURR OPIN STRUC BIOL
JI Curr. Opin. Struct. Biol.
PD APR
PY 2008
VL 18
IS 2
BP 229
EP 235
DI 10.1016/j.sbi.2007.11.003
PG 7
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA 300BV
UT WOS:000255800200014
PM 18194855
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Chern, TM
   Paul, N
   van Nimwegen, E
   Zavolan, M
AF Chern, Tzu-Ming
   Paul, Nicodeme
   van Nimwegen, Erik
   Zavolan, Mihaela
TI Computational analysis of full-length cDNAs reveals frequent coupling
   between transcriptional and splicing programs
SO DNA RESEARCH
LA English
DT Article
DE alternative splicing; transcription initiation
ID PROMOTER ARCHITECTURE; GENE-EXPRESSION; MOUSE; GENOME; INITIATION; EXONS
AB High-throughput sequencing studies revealed that the majority of human and mouse multi-exon genes have multiple splice forms. High-density ofigonucleotide array-based measurements have further established that many exons are expressed in a tissue-specific manner. The mechanisms underlying the tissue-dependent expression of most alternative exons remain, however, to be understood. In this study, we focus on one possible mechanism, namely the coupling of (tissue specific) transcription regulation with alternative splicing. We analyzed the FANTOM3 and H-Invitational datasets of full-length mouse and human cDNAs, respectively, and found that in transcription units with multiple start sites, the inclusion of at least 15% and possibly up to 30% of the 'cassette' exons correlates with the use of specific transcription start sites (TSS). The vast majority of TSS-associated exons are conserved between human and mouse, yet the conservation is weaker when compared with TSS-independent exons. Additionally, the currently available data only support a weak correlation between the probabilities of TSS association of orthologous exons. Our analysis thus suggests frequent coupling of transcriptional and splicing programs, and provides a large dataset of exons on which the molecular basis of this coupling can be further studied.
C1 [Chern, Tzu-Ming; Paul, Nicodeme; van Nimwegen, Erik; Zavolan, Mihaela] Univ Basel, Biozentrum, Div Bioinformat, CH-4056 Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Div Bioinformat, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Okuzaki, Daisuke/AAN-5641-2020; Zavolan, Mihaela/S-3888-2016
OI Okuzaki, Daisuke/0000-0002-4552-783X; Zavolan,
   Mihaela/0000-0002-8832-2041; van Nimwegen, Erik/0000-0001-6338-1312
CR Auboeuf D, 2002, SCIENCE, V298, P416, DOI 10.1126/science.1073734
   Baek D, 2005, P NATL ACAD SCI USA, V102, P12813, DOI 10.1073/pnas.0506139102
   Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030
   BERGET SM, 1995, J BIOL CHEM, V270, P2411, DOI 10.1074/jbc.270.6.2411
   Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014
   Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789
   Chern TM, 2006, PLOS GENET, V2, P606, DOI 10.1371/journal.pgen.0020045
   Imanishi T, 2004, PLOS BIOL, V2, P856, DOI 10.1371/journal.pbio.0020162
   Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211
   Kornblihtt AR, 2006, NAT STRUCT MOL BIOL, V13, P5, DOI 10.1038/nsmb0106-5
   Kornblihtt AR, 2005, CURR OPIN CELL BIOL, V17, P262, DOI 10.1016/j.ceb.2005.04.014
   KRUMM A, 1995, GENE DEV, V9, P559, DOI 10.1101/gad.9.5.559
   Lim LP, 1998, MOL CELL BIOL, V18, P3900, DOI 10.1128/MCB.18.7.3900
   Modrek B, 2003, NAT GENET, V34, P177, DOI 10.1038/ng1159
   Monsalve M, 2000, MOL CELL, V6, P307, DOI 10.1016/S1097-2765(00)00031-9
   Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200
   Pagani F, 2003, J BIOL CHEM, V278, P1511, DOI 10.1074/jbc.M209676200
   Plass M, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-50
   SHAPIRO MB, 1987, NUCLEIC ACIDS RES, V15, P7155, DOI 10.1093/nar/15.17.7155
   Sorek R, 2003, GENOME RES, V13, P1631, DOI 10.1101/gr.1208803
   Stamm S, 2000, DNA CELL BIOL, V19, P739, DOI 10.1089/104454900750058107
   Sugnet C W, 2004, Pac Symp Biocomput, P66
   VANNN, 2006, PLOS GENET, V2, pE24
   Wang JH, 2005, NUCLEIC ACIDS RES, V33, P5053, DOI 10.1093/nar/gki810
   Zavolan M, 2002, GENOME RES, V12, P1377, DOI 10.1101/gr.191702
   Zavolan M, 2003, GENOME RES, V13, P1290, DOI 10.1101/gr.1017303
NR 26
TC 2
Z9 2
U1 0
U2 1
PU OXFORD UNIV PRESS
PI OXFORD
PA GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND
SN 1340-2838
J9 DNA RES
JI DNA Res.
PD APR
PY 2008
VL 15
IS 2
BP 63
EP 72
DI 10.1093/dnares/dsm036
PG 10
WC Genetics & Heredity
SC Genetics & Heredity
GA 309WC
UT WOS:000256489900001
PM 18276623
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Hofbauer, KG
AF Hofbauer, Karl G.
TI Academic institutions and industry: bridging the gap
SO EXPERT OPINION ON DRUG DISCOVERY
LA English
DT Editorial Material
DE drug development; drug discovery; pharmaceutical industry; translational
   research; university
ID TRANSITION
AB Academic institutions and industry are separate entities but strongly depend on each other. As innovation is their common interest, the exchange of scientific information and of highly qualified scientists is essential for their success. However, there are serious obstacles for the mobility of scientists between academic institutions and industry. These institutions have different goals and objectives that determine the working conditions. In the present article, several terms describing the characteristics of work in either institution are presented and discussed. Whereas academic life seems to proceed in circles around a topic of interest, life in industry may be best described by vectors that can rapidly change size and direction. Scientists moving between academic institutions and industry need a high degree of flexibility to adapt to the different environments.
C1 Univ Basel, Biozentrum Pharmazentrum, CH-4056 Basel, Switzerland.
RP Hofbauer, KG (corresponding author), Univ Basel, Biozentrum Pharmazentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM karl.hofbauer@unibas.ch
CR Bonetta L, 2007, J NEUROSCI, V27, pII, DOI 10.1523/JNEUROSCI.0866-07.2007
   Brockway LM, 2006, FASEB J, V20, P2435, DOI 10.1096/fj.06-6723LSF
   Brunetti ND, 2007, EUR J INTERN MED, V18, P3, DOI 10.1016/j.ejim.2006.09.002
   *EUR COMM, 2006, 22573 EUR
   Fetzer J, 2003, ANAL BIOANAL CHEM, V377, P381, DOI 10.1007/s00216-003-2178-5
   Fluckiger SL, 2006, EXP BIOL MED, V231, P1257
   Horton B, 2000, NATURE, V404, P793
   Love TW, 2006, EXP BIOL MED, V231, P1682, DOI 10.1177/153537020623101103
   Vagelos P Roy, 2007, Cleve Clin J Med, V74 Suppl 2, pS12
   Wilan KH, 2007, CELL, V129, P847, DOI 10.1016/j.cell.2007.05.032
NR 10
TC 1
Z9 1
U1 0
U2 4
PU INFORMA HEALTHCARE
PI LONDON
PA TELEPHONE HOUSE, 69-77 PAUL STREET, LONDON EC2A 4LQ, ENGLAND
SN 1746-0441
J9 EXPERT OPIN DRUG DIS
JI Expert. Opin. Drug Discov.
PD APR
PY 2008
VL 3
IS 4
BP 369
EP 373
DI 10.1517/17460441.3.4.369
PG 5
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 362CI
UT WOS:000260175400001
PM 23489093
DA 2021-01-25
ER

PT J
AU Donahue, JE
   Stopa, EG
   Johanson, CE
   Chaudhry, H
   Miller, MC
   Fallon, JR
   Ruegg, M
   Rauch, SM
   Burgess, RW
AF Donahue, John Edward
   Stopa, Edward G.
   Johanson, Conrad E.
   Chaudhry, Hira
   Miller, Miles C.
   Fallon, Justin R.
   Ruegg, Markus
   Rauch, Steven M.
   Burgess, Robert W.
TI Altering Agrin Expression Influences A beta Deposition in
   APP(Swe)/PS1(ex9) Transgenic Mice
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 [Donahue, John Edward; Stopa, Edward G.; Johanson, Conrad E.; Chaudhry, Hira; Miller, Miles C.] Rhode Isl Hosp, Providence, RI USA.
   [Fallon, Justin R.] Brown Univ, Providence, RI 02912 USA.
   [Ruegg, Markus] Univ Basel, Biozentrum, Basel, Switzerland.
   [Rauch, Steven M.; Burgess, Robert W.] Jackson Lab, Bar Harbor, ME 04609 USA.
RI Ruegg, Markus/X-7256-2019; Donahue, John E/A-3000-2008
OI Ruegg, Markus/0000-0002-4974-9384; Donahue, John E/0000-0001-7186-2562
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2008
VL 22
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA V25GZ
UT WOS:000208467802467
DA 2021-01-25
ER

PT J
AU Hall, MN
AF Hall, Michael N.
TI TOR signalling and control of cell growth in yeast and mammals
SO FASEB JOURNAL
LA English
DT Meeting Abstract
C1 [Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU FEDERATION AMER SOC EXP BIOL
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0892-6638
J9 FASEB J
JI Faseb J.
PD APR
PY 2008
VL 22
PG 1
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA V25GZ
UT WOS:000208467802468
DA 2021-01-25
ER

PT J
AU Knechtle, B
   Knechtle, P
   Schuck, R
   Andonie, JL
   Kohler, G
AF Knechtle, B.
   Knechtle, P.
   Schueck, R.
   Andonie, J. L.
   Kohler, G.
TI Effects of a Deca Iron Triathlon on body composition - A case study
SO INTERNATIONAL JOURNAL OF SPORTS MEDICINE
LA English
DT Article
DE ultra-endurance; metabolism; water; energy expenditure
ID EXTREME ENDURANCE RUN; LONG-DISTANCE RUN; WEIGHT CHANGES; SUBSTRATE
   OXIDATION; ENERGY-EXPENDITURE; TROPICAL CLIMATE; ULTRA-TRIATHLON; MUSCLE
   MASS; HEART-RATE; PERFORMANCE
AB We investigated energy balance and change of body composition in one athlete in a multistage triathlon, the World Challenge Deca Iron Triathlon 2006, where athletes had to perform one Ironman triathlon of 3.8 km swimming, 180 km cycling and 42.195 km running per day for ten consecutive days. In one well-experienced male ultra-endurance triathlete, we measured body mass, skinfold thicknesses and perimeters of extremities, in order to calculate skeletal muscle mass, fat mass and percentage of body fat. Energy intake was measured by analysis of nutrition, and energy expenditure was calculated using a portable heart rate monitor. This was performed to quantify energy deficit. In addition, bio-impedance measurements were performed to determine fluid metabolism. The athlete finished the race in 128 hours, 22 minutes and 42 seconds in 3rd position. Body mass decreased by 1 kilogram, skeletal muscle mass decreased by 0.9 kilograms and calculated fat mass decreased by 0.8 kilograms. Total body water increased by 2.8 liters. Total energy expenditure for the Deca Iron was 89112 kilocalories and a total energy deficit of 11480 kilocalories resulted. We presume that energy deficit was covered by consumption of adipose subcutaneous tissue as well as skeletal muscle mass; the degradation of muscle mass seems to lead to hypoproteinemic edemas.
C1 [Knechtle, B.; Knechtle, P.] Gesundheitszentrum St Gallen, CH-9001 St Gallen, Switzerland.
   [Schueck, R.] Praxis Dornacherhof, Heerbrugg, St Gallen, Switzerland.
   [Andonie, J. L.] Multisport Andonie, Monterrey, Mexico.
   [Kohler, G.] Univ Basel, Div Biophys Chem, Biozentrum, Basel, Switzerland.
RP Knechtle, B (corresponding author), Gesundheitszentrum St Gallen, Vadianstr 26, CH-9001 St Gallen, Switzerland.
EM beat.knechtle@hispeed.ch
CR Arngrimsson SA, 2004, EUR J APPL PHYSIOL, V92, P524, DOI 10.1007/s00421-004-1053-1
   Atwater W.O., 1909, P AM PHYSL SOC, V30, P14
   Ball SD, 2004, EUR J CLIN NUTR, V58, P1525, DOI 10.1038/sj.ejcn.1602003
   Bircher S, 2006, J SPORT SCI MED, V5, P154
   Boschmann M, 2002, INT J SPORTS MED, V23, P537, DOI 10.1055/s-2002-35527
   Case S, 1995, Alaska Med, V37, P20
   Daniel John A., 2005, Biomedical Instrumentation & Technology, V39, P397, DOI 10.2345/0899-8205(2005)39[397:EOBCMF]2.0.CO;2
   Davidson L, 1997, BRIT J NUTR, V78, P695, DOI 10.1079/BJN19970188
   DRESSENDORFER RH, 1991, MED SCI SPORT EXER, V23, P954
   FRAYN KN, 1983, J APPL PHYSIOL, V55, P628
   Gastmann U, 1998, J SPORT MED PHYS FIT, V38, P18
   Helge JW, 2003, J EXP BIOL, V206, P1075, DOI 10.1242/jeb.00218
   Hiilloskorpi HK, 2003, INT J SPORTS MED, V24, P332
   HOCHLI D, 1995, INT J SPORTS MED, V16, P343, DOI 10.1055/s-2007-973017
   Kimber NE, 2002, INT J SPORT NUTR EXE, V12, P47, DOI 10.1123/ijsnem.12.1.47
   Knechtle B, 2005, Praxis (Bern 1994), V94, P371
   Knechtle B, 2005, INT J SPORTS MED, V26, P499, DOI 10.1055/s-2004-821136
   KUIPERS H, 1989, INT J SPORTS MED, V10, pS156, DOI 10.1055/s-2007-1024965
   Laursen PB, 2006, BRIT J SPORT MED, V40, P320, DOI 10.1136/bjsm.2005.022426
   Lee RC, 2000, AM J CLIN NUTR, V72, P796
   LEHMANN M, 1995, INT J SPORTS MED, V16, P155, DOI 10.1055/s-2007-972984
   Macfarlane DJ, 2007, ASIA PAC J CLIN NUTR, V16, P66
   McAnulty SR, 2005, INT J SPORTS MED, V26, P188, DOI 10.1055/s-2004-820990
   NAGEL D, 1989, EUR J APPL PHYSIOL O, V59, P16, DOI 10.1007/BF02396574
   Raschka C, 1992, Schweiz Z Sportmed, V40, P13
   RASCHKA C, 1991, Z ERNAHRUNGSWISS, V30, P276, DOI 10.1007/BF01651957
   Reynolds RD, 1999, J NUTR, V129, P1307
   ROBERTSHAW M, 1993, J MED, V24, P311
   ROMIJN JA, 1993, AM J PHYSIOL, V265, pE380
   Sharwood K, 2002, CLIN J SPORT MED, V12, P391, DOI 10.1097/00042752-200211000-00012
   Sharwood KA, 2004, BRIT J SPORT MED, V38, P718, DOI 10.1136/bjsm.2003.007187
   SJOSTROM M, 1988, ACTA PHYSIOL SCAND, V132, P537, DOI 10.1111/j.1748-1716.1988.tb08362.x
   SJOSTROM M, 1987, ACTA PHYSIOL SCAND, V130, P513, DOI 10.1111/j.1748-1716.1987.tb08170.x
   Speedy DB, 2000, CLIN J SPORT MED, V10, P136, DOI 10.1097/00042752-200004000-00009
   Speedy DB, 2001, CLIN J SPORT MED, V11, P44, DOI 10.1097/00042752-200101000-00008
   Speedy DB, 1997, CLIN J SPORT MED, V7, P100, DOI 10.1097/00042752-199704000-00005
   Vaananen II, 2005, J SPORT MED PHYS FIT, V45, P301
   Vasudev Sudha, 2004, J Assoc Physicians India, V52, P877
   VOLK N, 2000, J SPORTMED, V4, P18
   Voltaire B, 2003, J SPORT MED PHYS FIT, V43, P306
   Voltaire B, 2002, CAN J APPL PHYSIOL, V27, P551, DOI 10.1139/h02-031
   WALSH RM, 1994, INT J SPORTS MED, V15, P392, DOI 10.1055/s-2007-1021076
   YAMASHITA Y, 2005, EUR J SPORT SCI, V5, P153
   1991, KLEINE SOUCIFACHMANN
NR 44
TC 24
Z9 24
U1 0
U2 4
PU GEORG THIEME VERLAG KG
PI STUTTGART
PA RUDIGERSTR 14, D-70469 STUTTGART, GERMANY
SN 0172-4622
J9 INT J SPORTS MED
JI Int. J. Sports Med.
PD APR
PY 2008
VL 29
IS 4
BP 343
EP 351
DI 10.1055/s-2007-965354
PG 9
WC Sport Sciences
SC Sport Sciences
GA 290LP
UT WOS:000255124600013
PM 17879892
DA 2021-01-25
ER

PT J
AU Kohli, M
   Buck, S
   Schmitz, HP
AF Koehli, Michael
   Buck, Sabrina
   Schmitz, Hans-Peter
TI The function of two closely related Rho proteins is determined by an
   atypical switch I region
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE GTP-binding protein; switch I; gene duplication; filamentous fungus;
   Ashbya gossypii
ID GTP-BINDING PROTEIN; FUNGUS ASHBYA-GOSSYPII; YEAST
   SACCHAROMYCES-CEREVISIAE; NEUROSPORA-CRASSA; ESCHERICHIA-COLI; GENOME
   SEQUENCE; GTPASES; KINASE; FAMILY; TRANSFORMATION
AB We show here that the encoded proteins of the two duplicated RHO1 genes from the filamentous fungus Ashbya gossypii, AgRHO1a and AgRHO1b have functionally diverged by unusual mutation of the conserved switch I region. Interaction studies and in vitro assays suggest that a different regulation by the two GTPase activating proteins ( GAPs) AgLrg1 and AgSac7 contributes to the functional differences. GAP-specificity and protein function is determined to a large part by a single position in the switch I region of the two Rho1 proteins. In AgRho1b, this residue is a tyrosine that is conserved among the Rho-protein family, whereas AgRho1a carries an atypical histidine at the same position. Mutation of this histidine to a tyrosine changes GAP-specificity, protein function and localization of AgRho1a. Furthermore, it enables the mutated allele to complement the lethality of an AgRHO1b deletion. In summary, our findings show that a simple mutation in the switch I region of a GTP-binding protein can change its affinity towards its GAPs, which finally leads to a decoupling of very similar protein function without impairing effector interaction.
C1 [Buck, Sabrina; Schmitz, Hans-Peter] Univ Osnabruck, Dept Genet, D-49076 Osnabruck, Germany.
   [Koehli, Michael] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Schmitz, HP (corresponding author), Univ Osnabruck, Dept Genet, Barbarastr 11, D-49076 Osnabruck, Germany.
EM hans-peter.schmitz@biologie.uni-osnabrueck.de
OI Schmitz, Hans-Peter/0000-0001-5449-4593
CR Ahmadian MR, 1997, FEBS LETT, V408, P315, DOI 10.1016/S0014-5793(97)00422-5
   AltmannJohl R, 1996, MOL GEN GENET, V250, P69, DOI 10.1007/BF02191826
   Amberg D. C., 2005, METHODS YEAST GENETI
   ARVANITIDIS A, 1994, J BIOL CHEM, V269, P8911
   Borkovich KA, 2004, MICROBIOL MOL BIOL R, V68, P1, DOI 10.1128/MMBR.68.1.1-108.2004
   Boureux A, 2007, MOL BIOL EVOL, V24, P203, DOI 10.1093/molbev/msl145
   Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337
   Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781
   Drgonova J, 1996, SCIENCE, V272, P277, DOI 10.1126/science.272.5259.277
   Dvorsky R, 2004, J BIOL CHEM, V279, P7098, DOI 10.1074/jbc.M311911200
   Galagan JE, 2003, NATURE, V422, P859, DOI 10.1038/nature01554
   GIETZ RD, 1988, GENE, V74, P527, DOI 10.1016/0378-1119(88)90185-0
   Gladfelter AS, 2006, J CELL BIOL, V172, P347, DOI 10.1083/jcb.200507003
   Gladfelter AS, 2002, J CELL BIOL, V156, P315, DOI 10.1083/jcb.200109062
   Haeusler LC, 2003, FEBS LETT, V555, P556, DOI 10.1016/S0014-5793(03)01351-6
   HANAHAN D, 1983, J MOL BIOL, V166, P557, DOI 10.1016/S0022-2836(83)80284-8
   Heo WD, 2003, CELL, V113, P315
   Jaitner BK, 1997, J BIOL CHEM, V272, P29927, DOI 10.1074/jbc.272.47.29927
   James P, 1996, GENETICS, V144, P1425
   Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424
   KIPPERT F, 1995, FEMS MICROBIOL LETT, V132, P215
   Knechtle P, 2003, MOL BIOL CELL, V14, P4140, DOI 10.1091/mbc.E03-03-0167
   Kohno H, 1996, EMBO J, V15, P6060, DOI 10.1002/j.1460-2075.1996.tb00994.x
   Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005
   Longtine MS, 1998, YEAST, V14, P953, DOI 10.1002/(SICI)1097-0061(199807)14:10<953::AID-YEA293>3.0.CO;2-U
   Lorberg A, 2001, MOL GENET GENOMICS, V266, P514
   MADAULE P, 1987, P NATL ACAD SCI USA, V84, P779, DOI 10.1073/pnas.84.3.779
   Mazur P, 1996, J BIOL CHEM, V271, P14604, DOI 10.1074/jbc.271.24.14604
   MILBURN MV, 1990, SCIENCE, V247, P939, DOI 10.1126/science.2406906
   Nierman WC, 2005, NATURE, V438, P1151, DOI 10.1038/nature04332
   NONAKA H, 1995, EMBO J, V14, P5931, DOI 10.1002/j.1460-2075.1995.tb00281.x
   Ozaki K, 1996, EMBO J, V15, P2196, DOI 10.1002/j.1460-2075.1996.tb00573.x
   Philippsen P, 2005, CURR OPIN MICROBIOL, V8, P370, DOI 10.1016/j.mib.2005.06.021
   Qadota H, 1996, SCIENCE, V272, P279, DOI 10.1126/science.272.5259.279
   Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2
   Rodicio R, 2006, MICROBIOL-SGM, V152, P2635, DOI 10.1099/mic.0.29105-0
   Saka A, 2001, J BIOL CHEM, V276, P46165, DOI 10.1074/jbc.M103805200
   Sambrook J., 2001, MOL CLONING LAB MANU
   Schmidt A, 2002, MOL MICROBIOL, V45, P1433, DOI 10.1046/j.1365-2958.2002.03110.x
   Schmitz HP, 2001, J MOL BIOL, V311, P1, DOI 10.1006/jmbi.2001.4848
   Smith Susan J M, 2002, Methods Mol Biol, V189, P13
   Storici F, 2001, NAT BIOTECHNOL, V19, P773, DOI 10.1038/90837
   Takai Y, 2001, PHYSIOL REV, V81, P153
   TORRES L, 1991, MOL MICROBIOL, V5, P2845, DOI 10.1111/j.1365-2958.1991.tb01993.x
   Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009
   VIEIRA J, 1991, GENE, V100, P189, DOI 10.1016/0378-1119(91)90365-I
   Walther A, 2005, CURR GENET, V48, P247, DOI 10.1007/s00294-005-0017-2
   Watanabe D, 2001, YEAST, V18, P943, DOI 10.1002/yea.742
   Wendland J, 2000, GENE, V242, P381, DOI 10.1016/S0378-1119(99)00509-0
   Wendland J, 2001, GENETICS, V157, P601
   Wherlock M, 2002, J CELL SCI, V115, P239
   Wolfe KH, 2006, PHILOS T ROY SOC B, V361, P403, DOI 10.1098/rstb.2005.1799
   Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899
NR 53
TC 52
Z9 53
U1 0
U2 0
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD APR
PY 2008
VL 121
IS 7
BP 1065
EP 1075
DI 10.1242/jcs.015933
PG 11
WC Cell Biology
SC Cell Biology
GA 283TV
UT WOS:000254660300016
PM 18334559
OA Bronze
DA 2021-01-25
ER

PT J
AU Arber, W
AF Arber, Werner
TI Molecular mechanisms driving Darwinian evolution
SO MATHEMATICAL AND COMPUTER MODELLING
LA English
DT Article
DE molecular evolution; genetic variation; horizontal gene transfer;
   evolution genes; variation generator; modulation of mutation frequency
ID DEOXYRIBONUCLEIC-ACID; MICROBIAL EVOLUTION; ELEMENTS
AB According to the Neodarwinian theory, biological evolution depends (1) on the availability of genetic variants, (2) on natural selection exerted on all available forms of life and (3) on geographical and reproductive isolation. The now available methodology of molecular genetics enables us to explore the molecular nature of genetic variation. It has become clear that many different molecular mechanisms contribute to the overall production of alterations in DNA sequences. These mechanisms can be classified into three conceptually different natural strategies of genetic variation. These strategies differ in the quality of their contributions to biological evolution. Alterations in genomic DNA sequences can imply either (1) a small local sequence change or (2) the intragenomic rearrangement of DNA segments or (3) the acquisition of a DNA segment from another kind of organism by horizontal gene transfer. Combinations of these strategies can also be seen in single processes.
   In principle, genetic variation occurs more or less randomly rather than as a targeted response to an identified need. It is the natural selection together with the available forms of life that determine the directions that biological evolution takes. Interestingly, genetic variation nevertheless depends on products of so-called evolution genes. These products act as generators of genetic variations and/or as modulators of the frequency of genetic variation. The products of evolution genes exert their activities in close collaboration with various nongenetic factors such as structural flexibilities of biologically relevant molecules, chemical instability of nucleotides, random encounter, chemical and physical mutagens. In conclusion, natural reality cares actively for biological evolution, which should not any longer be seen as resulting from errors and accidents. Some philosophical, worldview implications will be discussed. (C) 2007 Elsevier Ltd. All rights reserved.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Arber, W (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM werner.arber@unibas.ch
CR Arber W, 2005, IUBMB LIFE, V57, P263, DOI 10.1080/15216540500092625
   Arber W, 2003, GENE, V317, P3, DOI 10.1016/S0378-1119(03)00654-1
   ARBER W, 1991, J MOL EVOL, V33, P4, DOI 10.1007/BF02100190
   Arber W, 2000, FEMS MICROBIOL REV, V24, P1, DOI 10.1111/j.1574-6976.2000.tb00529.x
   ARBER W, 1965, ANNU REV MICROBIOL, V19, P365, DOI 10.1146/annurev.mi.19.100165.002053
   ARBER W, 1990, J STRUCT BIOL, V194, P107
   ARBER W, 1999, SCIENCE, V870, P36
   ARBER W, 2004, ENCY MOL CELL BIOL M, V5, P331
   Avery OT, 1944, J EXP MED, V79, P137, DOI 10.1084/jem.79.2.137
   LEDERBERG J, 1947, GENETICS, V32, P505
   MAYR E, 1980, EVOLUTIONRY SYNTHESI
   Shapiro JA, 1983, MOBILE GENETIC ELEME
   WATSON JD, 1953, NATURE, V171, P964, DOI 10.1038/171964b0
   WATSON JD, 1953, NATURE, V171, P737, DOI 10.1038/171737a0
   Weber M, 1996, BIOL PHILOS, V11, P67, DOI 10.1007/BF00127472
   ZINDER ND, 1952, J BACTERIOL, V64, P679, DOI 10.1002/path.1700640402
NR 16
TC 5
Z9 5
U1 0
U2 6
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0895-7177
J9 MATH COMPUT MODEL
JI Math. Comput. Model.
PD APR
PY 2008
VL 47
IS 7-8
BP 666
EP 674
DI 10.1016/j.mcm.2007.06.003
PG 9
WC Computer Science, Interdisciplinary Applications; Computer Science,
   Software Engineering; Mathematics, Applied
SC Computer Science; Mathematics
GA 276YP
UT WOS:000254179900002
OA Bronze
DA 2021-01-25
ER

PT J
AU Hallstrom, T
   Muller, SA
   Morgelin, M
   Mollenkvist, A
   Forsgren, A
   Riesbeck, K
AF Hallstrom, Teresia
   Muller, Shirley A.
   Morgelin, Matthias
   Mollenkvist, Andrea
   Forsgren, Arne
   Riesbeck, Kristian
TI The Moraxella IgD-binding protein MID/Hag is an oligomeric
   autotransporter
SO MICROBES AND INFECTION
LA English
DT Article
DE adhesin; MID; Moraxella catarrhalis
ID TRANSMISSION ELECTRON-MICROSCOPY; CATARRHALIS; PATHOGEN; ADHESIN; YADA;
   HAG; MECHANISM; TRANSPORT; MODEL
AB The immunoglobulin D (IgD)-binding protein MID/Hag of the human respiratory pathogen Moraxella catarrhalis is an outer membrane protein of approximately 200 kDa belonging to the autotransporter family. MID also functions as an adhesin and hemagglutinin. In the present paper, the ultrastructure of MID was mapped. Using a series of Escherichia coli transformants, the last 210 aa of the C-terminal region were shown to translocate protein MID through the outer membrane suggesting that MID has beta-barrel structure comprising of 10 transmembrane P-sheets. Electron microscopy mapping with gold-labelled specific antibodies, and partial unravelling using guanidine hydrochloride showed that the rest of the MID protein forms an approximately 120 nm long, fibrillar structure in which the individual monomers fold back on themselves to expose a globular distal domain at their tips comprising both the IgD-binding (MID962-1200) and adhesive (MID764-913) regions. This positions their N-termini close to the C-terminal membrane spanning domains. Mass measurements by scanning transmission electron microscopy (STEM) verified that the MID molecule is an oligomer. (C) 2007 Elsevier Masson SAS. All rights reserved.
C1 [Hallstrom, Teresia; Mollenkvist, Andrea; Forsgren, Arne; Riesbeck, Kristian] Lund Univ, Dept Lab Med, Malmo Univ Hosp, SE-20502 Malmo, Sweden.
   [Morgelin, Matthias] Lund Univ, Sect Clin & Expt Infect Med, Dept Clin Sci, SE-22184 Lund, Sweden.
   [Muller, Shirley A.] Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
RP Riesbeck, K (corresponding author), Lund Univ, Dept Lab Med, Malmo Univ Hosp, SE-20502 Malmo, Sweden.
EM kristian.riesbeck@med.lu.se
OI Riesbeck, Kristian/0000-0001-6274-6965
CR Buchanan SK, 1999, NAT STRUCT BIOL, V6, P56
   Bullard B, 2005, INFECT IMMUN, V73, P5127, DOI 10.1128/IAI.73.8.5127-5136.2005
   Bullard B, 2007, BMC MICROBIOL, V7, DOI 10.1186/1471-2180-7-65
   Cotter SE, 2005, TRENDS MICROBIOL, V13, P199, DOI 10.1016/j.tim.2005.03.004
   Diederichs K, 1998, PROTEIN SCI, V7, P2413, DOI 10.1002/pro.5560071119
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   ENGEL J, 1987, METHOD ENZYMOL, V145, P3
   Forsgren A, 2004, J INFECT DIS, V190, P352, DOI 10.1086/422155
   Forsgren A, 2003, INFECT IMMUN, V71, P3302, DOI 10.1128/IAI.71.6.3302-3309.2003
   Forsgren A, 2001, J IMMUNOL, V167, P2112, DOI 10.4049/jimmunol.167.4.2112
   Henderson IR, 2004, MICROBIOL MOL BIOL R, V68, P692, DOI 10.1128/MMBR.68.4.692-744.2004
   Hoiczyk E, 2000, EMBO J, V19, P5989, DOI 10.1093/emboj/19.22.5989
   Karalus R, 2000, MICROBES INFECT, V2, P547, DOI 10.1016/S1286-4579(00)00314-2
   Linke D, 2006, TRENDS MICROBIOL, V14, P264, DOI 10.1016/j.tim.2006.04.005
   LUCOCQ JM, 1986, EUR J CELL BIOL, V42, P332
   LUPAS A, 1995, J MOL BIOL, V248, P180, DOI 10.1006/jmbi.1995.0210
   McMichael JC, 2000, VACCINE, V19, pS101, DOI 10.1016/S0264-410X(00)00287-5
   Mohan Katta A. V. S. K., 2004, In Silico Biology, V4, P549
   Mollenkvist A, 2003, J BACTERIOL, V185, P2285, DOI 10.1128/JB.185.7.2285-2295.2003
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   Nordstrom T, 2005, J IMMUNOL, V175, P3628, DOI 10.4049/jimmunol.175.6.3628
   Nordstrom T, 2004, J IMMUNOL, V173, P4598, DOI 10.4049/jimmunol.173.7.4598
   Nordstrom T, 2002, J BIOL CHEM, V277, P34692, DOI 10.1074/jbc.M203858200
   Pearson MM, 2002, INFECT IMMUN, V70, P4523, DOI 10.1128/IAI.70.8.4523-4533.2002
   Riesbeck K, 2006, CRIT REV IMMUNOL, V26, P353, DOI 10.1615/CritRevImmunol.v26.i4.40
   Roggenkamp A, 2003, J BACTERIOL, V185, P3735, DOI 10.1128/JB.185.13.3735-3744.2003
   Schulz GE, 2002, BBA-BIOMEMBRANES, V1565, P308, DOI 10.1016/S0005-2736(02)00577-1
   Surana NK, 2004, J BIOL CHEM, V279, P14679, DOI 10.1074/jbc.M311496200
   Suzuki T, 1995, J BIOL CHEM, V270, P30874, DOI 10.1074/jbc.270.52.30874
   Veiga E, 2002, EMBO J, V21, P2122, DOI 10.1093/emboj/21.9.2122
   Verduin CM, 2002, CLIN MICROBIOL REV, V15, P125, DOI 10.1128/CMR.15.1.125-144.2002
   Wollmann P, 2006, INT J BIOL MACROMOL, V39, P3, DOI 10.1016/j.ijbiomac.2005.11.009
NR 32
TC 10
Z9 11
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD APR
PY 2008
VL 10
IS 4
BP 374
EP 381
DI 10.1016/j.micinf.2007.12.015
PG 8
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 304KL
UT WOS:000256108300007
PM 18400547
DA 2021-01-25
ER

PT J
AU Roth, A
   Looser, R
   Kaufmann, M
   Blattler, SM
   Rencurel, F
   Huang, WD
   Moore, DD
   Meyer, UA
AF Roth, Adrian
   Looser, Renate
   Kaufmann, Michel
   Blaettler, Sharon M.
   Rencurel, Franck
   Huang, Wendong
   Moore, David D.
   Meyer, Urs A.
TI Regulatory cross-talk between drug metabolism and lipid homeostasis:
   Constitutive androstane receptor and pregnane X receptor increase
   Insig-1 expression
SO MOLECULAR PHARMACOLOGY
LA English
DT Article
ID ACTIVATED PROTEIN-KINASE; ELEMENT-BINDING PROTEINS; NUCLEAR RECEPTOR;
   LIPOGENIC PATHWAY; MOUSE-LIVER; INDUCTION; CHOLESTEROL; GENES;
   OVEREXPRESSION; MECHANISM
AB Activation of pregnane X receptor ( PXR) and constitutive androstane receptor ( CAR) by xenobiotic inducers of cytochromes P450 is part of a pleiotropic response that includes liver hypertrophy, tumor promotion, effects on lipid homeostasis, and energy metabolism. Here, we describe an acute response to CAR and PXR activators that is associated with induction of Insig-1, a protein with antilipogenic properties. We first observed that activation of CAR and PXR in mouse liver results in activation of Insig-1 along with reduced protein levels of the active form of sterol regulatory element binding protein 1 ( Srebp-1). Studies in mice deficient in CAR and PXR revealed that the effect on triglycerides involves these two nuclear receptors. Finally, we identified a functional binding site for CAR and PXR in the Insig-1 gene by in vivo, in vitro, and in silico genomic analysis. Our experiments suggest that activation of Insig-1 by drugs leads to reduced levels of active Srebp-1 and consequently to reduced target gene expression including the genes responsible for triglyceride synthesis. The reduction in nuclear Srebp-1 by drugs is not observed when Insig-1 expression is repressed by small interfering RNA. In addition, we observed that Insig-1 is also a target of AMP-activated kinase, the hepatic activity of which is increased by activators of CAR and PXR and is known to cause a reduction of triglycerides. The fact that drugs that serve as CAR or PXR ligands induce Insig-1 might have clinical consequences and explains alterations in lipid levels after drug therapy.
C1 [Roth, Adrian; Looser, Renate; Kaufmann, Michel; Blaettler, Sharon M.; Rencurel, Franck; Meyer, Urs A.] Univ Basel, Biozentrum, Div Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
   [Huang, Wendong] City Hope Natl Med Ctr, Beckman Res Inst, Dept Gene Regulat & Drug Discovery, Duarte, CA 91010 USA.
   [Moore, David D.] Baylor Coll Med, Dept Mol & Cellular Biol, Houston, TX 77030 USA.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Kingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM urs-a.meyer@unibas.ch
CR BJONDAHL K, 1978, ARZNEIMITTEL-FORSCH, V28-1, P817
   Blattler SM, 2007, P NATL ACAD SCI USA, V104, P1045, DOI 10.1073/pnas.0610216104
   El Hadri K, 2004, J BIOL CHEM, V279, P15130, DOI 10.1074/jbc.M312875200
   Engelking LJ, 2004, J CLIN INVEST, V113, P1168, DOI 10.1172/JCI200420978
   Foretz M, 2005, DIABETES, V54, P1331, DOI 10.2337/diabetes.54.5.1331
   HALL IH, 1990, ARCH PHARM, V323, P579, DOI 10.1002/ardp.19903230905
   Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2
   Handschin C, 2002, J BIOL CHEM, V277, P29561, DOI 10.1074/jbc.M202739200
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   Horton JD, 1998, J CLIN INVEST, V101, P2331, DOI 10.1172/JCI2961
   Hua XX, 1996, J BIOL CHEM, V271, P10379, DOI 10.1074/jbc.271.17.10379
   Huang WD, 2003, P NATL ACAD SCI USA, V100, P4156, DOI 10.1073/pnas.0630614100
   Kahn BB, 2005, CELL METAB, V1, P15, DOI 10.1016/j.cmet.2004.12.003
   Kiyosawa N, 2004, ARCH TOXICOL, V78, P435, DOI 10.1007/s00204-004-0565-0
   Locker J, 2003, HEPATOLOGY, V38, P314, DOI 10.1053/jhep.2003.50299
   Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638
   Nakagawa Y, 2006, NAT MED, V12, P107, DOI 10.1038/nm1334
   Nakamura K, 2007, J BIOL CHEM, V282, P9768, DOI 10.1074/jbc.M610072200
   Podvinec M, 2002, MOL ENDOCRINOL, V16, P1269, DOI 10.1210/me.16.6.1269
   Rencurel F, 2005, J BIOL CHEM, V280, P4367, DOI 10.1074/jbc.M412711200
   Rencurel F, 2006, MOL PHARMACOL, V70, P1925, DOI 10.1124/mol.106.029421
   Shimano H, 1999, J BIOL CHEM, V274, P35832, DOI 10.1074/jbc.274.50.35832
   Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8
   Staudinger JL, 2001, P NATL ACAD SCI USA, V98, P3369, DOI 10.1073/pnas.051551698
   Takaishi K, 2004, P NATL ACAD SCI USA, V101, P7106, DOI 10.1073/pnas.0401715101
   VENKATESAN N, 1994, METABOLISM, V43, P348, DOI 10.1016/0026-0495(94)90103-1
   Yabe D, 2002, P NATL ACAD SCI USA, V99, P12753, DOI 10.1073/pnas.162488899
   Yang T, 2002, CELL, V110, P489, DOI 10.1016/S0092-8674(02)00872-3
   Zhang J, 2004, J BIOL CHEM, V279, P49517, DOI 10.1074/jbc.M409041200
   Zhou GC, 2001, J CLIN INVEST, V108, P1167, DOI 10.1172/JCI200113505
   Zhou J, 2006, J BIOL CHEM, V281, P15013, DOI 10.1074/jbc.M511116200
NR 31
TC 102
Z9 106
U1 0
U2 4
PU AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA
SN 0026-895X
J9 MOL PHARMACOL
JI Mol. Pharmacol.
PD APR
PY 2008
VL 73
IS 4
BP 1282
EP 1289
DI 10.1124/mol.107.041012
PG 8
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 275IK
UT WOS:000254064900026
PM 18187584
DA 2021-01-25
ER

PT J
AU Mueller, P
   Massner, J
   Jayachandran, R
   Combaluzier, B
   Albrecht, I
   Gatfield, J
   Blum, C
   Ceredig, R
   Rodewald, HR
   Rolink, AG
   Pieters, J
AF Mueller, Philipp
   Massner, Jan
   Jayachandran, Rajesh
   Combaluzier, Benoit
   Albrecht, Imke
   Gatfield, John
   Blum, Carmen
   Ceredig, Rod
   Rodewald, Hans-Reimer
   Rolink, Antonius G.
   Pieters, Jean
TI Regulation of T cell survival through coronin-1-mediated generation of
   inositol-1,4,5-trisphosphate and calcium mobilization after T cell
   receptor triggering
SO NATURE IMMUNOLOGY
LA English
DT Article
ID CLASS-II MOLECULES; ACTIN POLYMERIZATION; PHOSPHOLIPASE-C; ACTIVATION;
   MEMORY; COMPLEX; PROTEIN; TCR; MYCOBACTERIA; CYTOSKELETON
AB T cell homeostasis is essential for the functioning of the vertebrate immune system, but the intracellular signals required for T cell homeostasis are largely unknown. We here report that the WD-repeat protein family member coronin-1, encoded by the gene Coro1a, is essential in the mouse for T cell survival through its promotion of Ca2+ mobilization from intracellular stores. Upon T cell receptor triggering, coronin-1 was essential for the generation of inositol-1,4,5-trisphosphate from phosphatidylinositol-4,5-bisphosphate. The absence of coronin-1, although it did not affect T cell development, resulted in a profound defect in Ca2+ mobilization, interleukin-2 production, T cell proliferation and T cell survival. We conclude that coronin-1, through activation of Ca2+ release from intracellular stores, is an essential regulator of peripheral lymphocyte survival.
C1 [Mueller, Philipp; Massner, Jan; Jayachandran, Rajesh; Combaluzier, Benoit; Albrecht, Imke; Gatfield, John; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Blum, Carmen; Rodewald, Hans-Reimer] Univ Ulm, Inst Immunol, D-89069 Ulm, Germany.
   [Ceredig, Rod; Rolink, Antonius G.] Univ Basel, Dept Clin Biol Sci, CH-4056 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
RI Ceredig, Rhodri/A-7077-2010
OI Pieters, Jean/0000-0002-5284-9757; Ceredig, Rhodri/0000-0002-4393-727X
CR Altman A, 2003, IMMUNOL REV, V192, P53, DOI 10.1034/j.1600-065X.2003.00027.x
   Bae YS, 2003, MOL PHARMACOL, V63, P1043, DOI 10.1124/mol.63.5.1043
   Barda-Saad M, 2005, NAT IMMUNOL, V6, P80, DOI 10.1038/ni1143
   Bunnell SC, 2001, IMMUNITY, V14, P315, DOI 10.1016/S1074-7613(01)00112-1
   Denys A, 2004, FEBS LETT, V564, P177, DOI 10.1016/S0014-5793(04)00361-8
   Ebinu JO, 2000, BLOOD, V95, P3199
   Farber DL, 1998, J IMMUNOL, V160, P535
   Farber DL, 1997, EUR J IMMUNOL, V27, P2094, DOI 10.1002/eji.1830270838
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563
   Gallo EM, 2006, NAT IMMUNOL, V7, P25, DOI 10.1038/ni1295
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   Goldrath AW, 1999, NATURE, V402, P255, DOI 10.1038/35005508
   Huang YP, 2004, J BIOL CHEM, V279, P28827, DOI 10.1074/jbc.R400012200
   Jameson SC, 2002, NAT REV IMMUNOL, V2, P547, DOI 10.1038/nri853
   JAYACHANDRAN J, MOL BIOL CELL
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Kirberg J, 1997, J EXP MED, V186, P1269, DOI 10.1084/jem.186.8.1269
   Labrecque N, 2001, IMMUNITY, V15, P71, DOI 10.1016/S1074-7613(01)00170-4
   Lee WT, 1996, J IMMUNOL, V157, P5300
   Lewis RS, 2001, ANNU REV IMMUNOL, V19, P497, DOI 10.1146/annurev.immunol.19.1.497
   Marrack P, 2004, ANNU REV IMMUNOL, V22, P765, DOI 10.1146/annurev.immunol.22.012703.104554
   Murali-Krishna K, 1999, SCIENCE, V286, P1377, DOI 10.1126/science.286.5443.1377
   NAKAYAMA T, 1990, SCIENCE, V249, P1558, DOI 10.1126/science.2120773
   Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022
   Nolz JC, 2006, CURR BIOL, V16, P24, DOI 10.1016/j.cub.2005.11.036
   Okumura M, 1998, DNA CELL BIOL, V17, P779, DOI 10.1089/dna.1998.17.779
   PIETERS J, 1991, J CELL BIOL, V115, P1213, DOI 10.1083/jcb.115.5.1213
   Pieters J, 2001, CURR OPIN IMMUNOL, V13, P37, DOI 10.1016/S0952-7915(00)00179-5
   Polic B, 2001, P NATL ACAD SCI USA, V98, P8744, DOI 10.1073/pnas.141218898
   ROEDERER M, 1995, CYTOMETRY, V21, P187, DOI 10.1002/cyto.990210211
   Saparov A, 1999, INT IMMUNOL, V11, P1253, DOI 10.1093/intimm/11.8.1253
   Singer WD, 1997, ANNU REV BIOCHEM, V66, P475, DOI 10.1146/annurev.biochem.66.1.475
   Sprent J, 2001, SCIENCE, V293, P245, DOI 10.1126/science.1062416
   Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107
   SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N
   Swain SL, 2000, PHILOS T ROY SOC B, V355, P407, DOI 10.1098/rstb.2000.0581
   Takeda S, 1996, IMMUNITY, V5, P217, DOI 10.1016/S1074-7613(00)80317-9
   Teixeiro E, 2004, IMMUNITY, V21, P515, DOI 10.1016/j.immuni.2004.08.014
   THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466
   TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0
   YANG LJ, 1994, J BIOL CHEM, V269, P7156
   Zhang WG, 1998, CELL, V92, P83, DOI 10.1016/S0092-8674(00)80901-0
   Zhang WW, 2005, AM J PHYSIOL-CELL PH, V288, pC1145, DOI 10.1152/ajpcell.00387.2004
NR 45
TC 116
Z9 118
U1 0
U2 6
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 1529-2908
J9 NAT IMMUNOL
JI Nat. Immunol.
PD APR
PY 2008
VL 9
IS 4
BP 424
EP 431
DI 10.1038/ni1570
PG 8
WC Immunology
SC Immunology
GA 276ED
UT WOS:000254123200018
PM 18345003
DA 2021-01-25
ER

PT J
AU Roth, A
   Looser, R
   Kaufmann, M
   Meyer, UA
AF Roth, Adrian
   Looser, Renate
   Kaufmann, Michel
   Meyer, Urs A.
TI Sterol regulatory element binding protein 1 interacts with pregnane X
   receptor and constitutive androstane receptor and represses their target
   genes
SO PHARMACOGENETICS AND GENOMICS
LA English
DT Article
DE constitutive androstane receptor; cytochrome P450; drug metabolism;
   lipid homeostasis; peroxisome-proliferator-activated receptor-gamma
   coactivator-1; pregnane X receptor; steroid receptor coactivator 1;
   sterol regulatory element binding protein 1
ID ORPHAN NUCLEAR RECEPTOR; OBESE ZUCKER RAT; DIETARY-CHOLESTEROL;
   FATTY-ACIDS; PHENOBARBITAL TREATMENT; XENOBIOTIC RECEPTOR; RESPONSIVE
   ENHANCER; MEDIATED INDUCTION; SREBP-1C PROMOTER; DRUG-METABOLISM
AB Objective Sterol regulatory element binding protein 1 (SREBP-1) is a lipogenic transcription factor of the basic helix-loop-helix family. SREBP-1 binds to sterol regulatory elements (SREs) in the promoter of lipogenic genes and induces fatty acid and triglyceride synthesis. Decreased drug clearance has been observed in obese and other dyslipidemic rodents as well as in diabetic, obese or overfed rodents. A hallmark of these conditions is increased expression of SREBP-1 in the liver. We therefore searched for a possible link between regulation of cytochromes P450 (CYPs) and SREBP-1.
   Methods We combined gene expression analysis, lipid analysis, effects of high levels of SREBP-1 in hepatocyte cultures to characterize the effects and protein interaction and chromatin immunoprecipitation assays to define the underlying mechanism. Finally, mice were fed a diet enriched in cholesterol to demonstrate the relevance of our data in vivo. By analyzing gene expression and lipids in cholesterol-fed mice or transfection of recombinant SREBP-1 in hepatocyte cultures the effect on CYPs was characterized. By use of protein interaction assays and chromatin immunoprecipitation the underlying mechanism was defined.
   Results We observed that SREBP-1 represses drug-mediated induction of hepatic CYPs, mainly members of the 2B and the 3A subfamilies. These drugs induce transcription of CYPs and other drug metabolizing enzymes via activation of the nuclear receptors pregnane X receptor (PXR) and constitutive androstane receptor (CAR). Here we report that the activation of SREBP-1 by insulin or cholesterol in mouse liver and primary human hepatocytes inhibits the transcriptional effects in PXR and CAR. Our results suggest that SREBP-1 functions as a non-DNA binding inhibitor and blocks the interaction of PXR and CAR with cofactors such as steroid receptor coactivator 1. Consequently, mRNA induction of CYPs by drugs and other xenochemicals is impaired.
   Conclusion We conclude that PXR and CAR respond to lipid accumulation by direct interaction with SREBP-1 and show that drug metabolism and lipid metabolism are interconnected within a complex network of transcriptional regulators. Pharmacogenetics and Genomics 18:325-337 (c) 2008 Wolters Kluwer Health vertical bar Lippincott Williams & Wilkins.
C1 [Roth, Adrian; Looser, Renate; Kaufmann, Michel; Meyer, Urs A.] Univ Basel, Div Pharmacol Neurobol, Biozentrum, CH-4056 Basel, Switzerland.
RP Meyer, UA (corresponding author), Univ Basel, Div Pharmacol Neurobol, Biozentrum, Kingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Urs-A.Meyer@unibas.ch
CR Arnold Katja A, 2004, Nucl Recept, V2, P1, DOI 10.1186/1478-1336-2-1
   BLOUIN RA, 1987, CLIN PHARMACY, V6, P706
   BROUWER KLR, 1984, J PHARMACOL EXP THER, V231, P654
   BROUWER KLR, 1984, J PHARMACOL EXP THER, V231, P649
   Burk O, 2005, MOL PHARMACOL, V67, P1954, DOI 10.1124/mol.104.009019
   Cagen LM, 2005, BIOCHEM J, V385, P207, DOI 10.1042/BJ20040162
   Chawla A, 2001, SCIENCE, V294, P1866, DOI 10.1126/science.294.5548.1866
   Chirieac DV, 2004, AM J PHYSIOL-ENDOC M, V287, pE42, DOI 10.1152/ajpendo.00297.2003
   Corcos L, 2001, PHARMACOL TOXICOL, V89, P113, DOI 10.1034/j.1600-0773.2001.d01-144.x
   Davis RA, 2002, J LIPID RES, V43, P533
   Dif N, 2006, BIOCHEM J, V400, P179, DOI 10.1042/BJ20060499
   DUELAND S, 1993, J LIPID RES, V34, P923
   Eberle D, 2004, DIABETES, V53, P2153, DOI 10.2337/diabetes.53.8.2153
   Fleischmann M, 2000, BIOCHEM J, V349, P13, DOI 10.1042/0264-6021:3490013
   Francis GA, 2003, ANNU REV PHYSIOL, V65, P261, DOI 10.1146/annurev.physiol.65.092101.142528
   Fraser DJ, 2003, J BIOL CHEM, V278, P39392, DOI 10.1074/jbc.M306148200
   FUNGWE TV, 1993, J LIPID RES, V34, P933
   Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2
   Handschin C, 2000, J BIOL CHEM, V275, P13362, DOI 10.1074/jbc.275.18.13362
   Handschin C, 2002, J BIOL CHEM, V277, P29561, DOI 10.1074/jbc.M202739200
   Handschin C, 2001, MOL PHARMACOL, V60, P681
   Handschin C, 2001, MOL ENDOCRINOL, V15, P1571, DOI 10.1210/me.15.9.1571
   Handschin C, 2000, P NATL ACAD SCI USA, V97, P10769, DOI 10.1073/pnas.97.20.10769
   Honkakoski P, 2003, ANN MED, V35, P172, DOI 10.1080/07853890310008224
   Honkakoski P, 1998, MOL CELL BIOL, V18, P5652, DOI 10.1128/MCB.18.10.5652
   Horton JD, 2003, J BIOL CHEM, V278, P36652, DOI 10.1074/jbc.M306540200
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   HUA XX, 1995, GENOMICS, V25, P667, DOI 10.1016/0888-7543(95)80009-B
   IRIZAR A, 1995, EUR J PHARM-ENVIRON, V293, P385, DOI 10.1016/S0014-2999(95)80097-2
   Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015
   Joannard F, 2000, CELL BIOL TOXICOL, V16, P325, DOI 10.1023/A:1026702615125
   Kakuma T, 2000, P NATL ACAD SCI USA, V97, P8536, DOI 10.1073/pnas.97.15.8536
   Kawamoto T, 1999, MOL CELL BIOL, V19, P6318
   Kim HJ, 2002, ANN NY ACAD SCI, V967, P34
   Kliewer SA, 1998, CELL, V92, P73, DOI 10.1016/S0092-8674(00)80900-9
   Kocarek TA, 2002, MOL PHARMACOL, V62, P1177, DOI 10.1124/mol.62.5.1177
   Koike C, 2007, MOL PHARMACOL, V71, P1217, DOI 10.1124/mol.107.034538
   Korn BS, 1998, J CLIN INVEST, V102, P2050, DOI 10.1172/JCI5341
   Kotlyar M, 1999, INT J CLIN PHARM TH, V37, P8
   Liao W, 1997, ENDOCRINOLOGY, V138, P3276, DOI 10.1210/en.138.8.3276
   MITRO N, 2007, FEBS LETT, V1721
   Muller-Wieland D, 2002, ANN NY ACAD SCI, V967, P19
   Nelson DR, 1996, PHARMACOGENETICS, V6, P1, DOI 10.1097/00008571-199602000-00002
   PIRTTIAHO HI, 1984, BRIT J CLIN PHARMACO, V18, P895, DOI 10.1111/j.1365-2125.1984.tb02561.x
   Plewka A, 1996, EXP TOXICOL PATHOL, V48, P249, DOI 10.1016/S0940-2993(96)80009-1
   PONUGOTI B, 2007, MOL ENDOCRINOLOGY
   QUATTROCHI LC, 1995, J BIOL CHEM, V270, P28917, DOI 10.1074/jbc.270.48.28917
   Saradhi M, 2005, BBA-MOL CELL RES, V1746, P85, DOI 10.1016/j.bbamcr.2005.10.004
   Sekiya M, 2003, HEPATOLOGY, V38, P1529, DOI 10.1016/j.hep.2003.09.028
   Shimano H, 2001, PROG LIPID RES, V40, P439, DOI 10.1016/S0163-7827(01)00010-8
   Shimomura I, 1999, J BIOL CHEM, V274, P30028, DOI 10.1074/jbc.274.42.30028
   Squires EJ, 2004, J BIOL CHEM, V279, P49307, DOI 10.1074/jbc.M407281200
   Su GM, 1999, J PHARMACOL EXP THER, V291, P953
   Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123
   Tabor DE, 1999, J BIOL CHEM, V274, P20603, DOI 10.1074/jbc.274.29.20603
   Toth JI, 2004, MOL CELL BIOL, V24, P8288, DOI 10.1128/MCB.24.18.8288-8300.2004
   Venkateswaran A, 2000, J BIOL CHEM, V275, P14700, DOI 10.1074/jbc.275.19.14700
   Watson AM, 1999, DRUG METAB DISPOS, V27, P695
   Xiong H, 2002, DRUG METAB DISPOS, V30, P918, DOI 10.1124/dmd.30.8.918
   Yamamoto T, 2004, J BIOL CHEM, V279, P12027, DOI 10.1074/jbc.M310333200
   YOKOYAMA C, 1993, CELL, V75, P187, DOI 10.1016/0092-8674(93)90690-R
   Yu LQ, 2002, J CLIN INVEST, V110, P671, DOI [10.1172/JCI200216001, 10.1172/JCI0216001]
   ZANNIKOS PN, 1993, DRUG METAB DISPOS, V21, P782
   ZANNIKOS PN, 1994, INT J OBESITY, V18, P369
   Zeng LF, 2004, J BIOL CHEM, V279, P48801, DOI 10.1074/jbc.M407817200
NR 65
TC 46
Z9 51
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA 530 WALNUT ST, PHILADELPHIA, PA 19106-3621 USA
SN 1744-6872
J9 PHARMACOGENET GENOM
JI Pharmacogenet. Genomics
PD APR
PY 2008
VL 18
IS 4
BP 325
EP 337
DI 10.1097/FPC.0b013e3282f706e0
PG 13
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology
   & Pharmacy
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology
   & Pharmacy
GA 281KR
UT WOS:000254496300006
PM 18334917
DA 2021-01-25
ER

PT J
AU Lin, S
   Landmann, L
   Ruegg, MA
   Brenner, HR
AF Lin, Shuo
   Landmann, Lukas
   Ruegg, Markus A.
   Brenner, Hans Rudolf
TI The role of nerve-versus muscle-derived factors in mammalian
   neuromuscular junction formation
SO JOURNAL OF NEUROSCIENCE
LA English
DT Article
DE agrin; MuSK; synapse formation; development; neuromuscular junction;
   muscle
ID SECONDARY MYOTUBES; POSTSYNAPTIC DIFFERENTIATION; SKELETAL-MUSCLES; RAT
   MUSCLE; AGRIN; MUSK; COLOCALIZATION; REQUIREMENT; EXPRESSION; RECEPTORS
AB Neuromuscular junctions (NMJs) normally form in the central region of developing muscle. In this process, agrin released from motor neurons has been considered to initiate the formation of synaptic acetylcholine receptor ( AChR) clusters (neurocentric model). However, in muscle developing in the absence of nerves and thus of agrin, AChR clusters still form in the muscle center. This raises the possibility that the region of NMJ formation is determined by muscle-derived cues that spatially restrict the nerve to form synapses from aneural AChR clusters, e. g., by patterned expression of the agrin receptor MuSK ( muscle-specific kinase) (myocentric model). Here we examine at initial stages of synaptogenesis whether the responsiveness of myotubes to agrin is spatially restricted, whether the regions of NMJ formation in wild-type muscle and of aneural AChR cluster formation in agrin-deficient animals correlate, and whether AChR cluster growth depends on the presence of agrin. We show that primary myotubes form AChR clusters in response to exogenous agrin in their central region only, a pattern that can spatially restrict NMJ formation. However, the nerve also makes synapses in regions in which aneural AChR clusters do not form, and agrin promotes synaptic cluster growth from the first stages of neuromuscular contact formation. These data indicate that aneural AChR clusters per se are not required for NMJ formation. A model is proposed that explains either the neurocentric or the myocentric mode of NMJ formation depending on a balance between the levels of MuSK expression and the availability of nerve-released agrin.
C1 [Brenner, Hans Rudolf] Univ Basel, Dept Biomed, Inst Physiol, CH-4056 Basel, Switzerland.
   [Landmann, Lukas] Univ Basel, Dept Biomed, Inst Anat, CH-4056 Basel, Switzerland.
   [Lin, Shuo; Ruegg, Markus A.] Univ Basel, Dept Biomed, Biozentrum, CH-4056 Basel, Switzerland.
RP Brenner, HR (corresponding author), Univ Basel, Dept Biomed, Inst Physiol, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM hans-rudolf.brenner@unibas.ch
RI Ruegg, Markus/X-7256-2019
OI Ruegg, Markus/0000-0002-4974-9384
CR ANDERSON MJ, 1977, J PHYSIOL-LONDON, V268, P757, DOI 10.1113/jphysiol.1977.sp011880
   Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X
   ASHBY PR, 1993, DEV BIOL, V156, P529, DOI 10.1006/dbio.1993.1099
   ASHBY PR, 1993, DEV BIOL, V156, P519, DOI 10.1006/dbio.1993.1098
   Babiuk RP, 2003, J COMP NEUROL, V455, P477, DOI 10.1002/cne.10503
   Bezakova G, 2003, NAT REV MOL CELL BIO, V4, P295, DOI 10.1038/nrm1074
   BRENNER HR, 1990, NATURE, V344, P544, DOI 10.1038/344544a0
   Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]
   DeChiara TM, 1996, CELL, V85, P501, DOI 10.1016/S0092-8674(00)81251-9
   DENNIS MJ, 1981, DEV BIOL, V81, P266, DOI 10.1016/0012-1606(81)90290-6
   Dimitropoulou A, 2005, MOL CELL NEUROSCI, V28, P292, DOI 10.1016/j.mcn.2004.09.013
   DUXSON MJ, 1989, DEVELOPMENT, V107, P743
   Flanagan-Steet H, 2005, DEVELOPMENT, V132, P4471, DOI 10.1242/dev.02044
   FRANK E, 1979, J CELL BIOL, V83, P143, DOI 10.1083/jcb.83.1.143
   FRANK E, 1975, ACTA PHYSIOL SCAND, V95, P66, DOI 10.1111/j.1748-1716.1975.tb10026.x
   Gautam M, 1996, CELL, V85, P525, DOI 10.1016/S0092-8674(00)81253-2
   GESEMANN M, 1995, J CELL BIOL, V128, P625, DOI 10.1083/jcb.128.4.625
   HARRIS AJ, 1981, PHILOS T ROY SOC B, V293, P257, DOI 10.1098/rstb.1981.0076
   HARRIS AJ, 1989, DEVELOPMENT, V107, P771
   HERCZEG A, 1995, NEUROSCI LETT, V193, P33, DOI 10.1016/0304-3940(95)11661-F
   Jones G, 1999, J NEUROSCI, V19, P3376
   Kim N, 2008, NAT NEUROSCI, V11, P19, DOI 10.1038/nn2026
   Ksiazek I, 2007, J NEUROSCI, V27, P7183, DOI 10.1523/JNEUROSCI.1609-07.2007
   KUES WA, 1995, EUR J NEUROSCI, V7, P1376, DOI 10.1111/j.1460-9568.1995.tb01129.x
   Kummer TT, 2006, CURR OPIN NEUROBIOL, V16, P74, DOI 10.1016/j.conb.2005.12.003
   Landmann L, 2004, MICROSC RES TECHNIQ, V64, P103, DOI 10.1002/jemt.20066
   Lefebvre JL, 2007, P NATL ACAD SCI USA, V104, P2483, DOI 10.1073/pnas.0610822104
   Lin WC, 2001, NATURE, V410, P1057, DOI 10.1038/35074025
   Lin WC, 2005, NEURON, V46, P569, DOI 10.1016/j.neuron.2005.04.002
   Lomo T, 2003, J NEUROCYTOL, V32, P835, DOI 10.1023/B:NEUR.0000020627.18156.b1
   MCMAHAN UJ, 1990, COLD SH Q B, V55, P407
   Meier T, 1998, EUR J NEUROSCI, V10, P3141, DOI 10.1046/j.1460-9568.1998.00320.x
   Misgeld T, 2005, P NATL ACAD SCI USA, V102, P11088, DOI 10.1073/pnas.0504806102
   Moore C, 2001, P NATL ACAD SCI USA, V98, P14655, DOI 10.1073/pnas.251291598
   Okada K, 2006, SCIENCE, V312, P1802, DOI 10.1126/science.1127142
   PRANZER JA, 2006, J NEUROSCI, V26, P934
   Takahashi M, 2002, EMBO REP, V3, P674, DOI 10.1093/embo-reports/kvf128
   Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1
   Wang CY, 2001, NEURON, V32, P99, DOI 10.1016/S0896-6273(01)00434-2
   Weatherbee SD, 2006, DEVELOPMENT, V133, P4993, DOI 10.1242/dev.02696
   YOUNG SH, 1983, NATURE, V305, P634, DOI 10.1038/305634a0
NR 41
TC 50
Z9 53
U1 0
U2 3
PU SOC NEUROSCIENCE
PI WASHINGTON
PA 11 DUPONT CIRCLE, NW, STE 500, WASHINGTON, DC 20036 USA
SN 0270-6474
EI 1529-2401
J9 J NEUROSCI
JI J. Neurosci.
PD MAR 26
PY 2008
VL 28
IS 13
BP 3333
EP 3340
DI 10.1523/JNEUROSCI.5590-07.2008
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA 279WT
UT WOS:000254386600009
PM 18367600
OA Bronze, Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Idrissi, FZ
   Grotsch, H
   Fernandez-Golbano, IM
   Presciatto-Baschong, C
   Riezman, H
   Geli, MI
AF Idrissi, Fatima-Zahra
   Groetsch, Helga
   Fernandez-Golbano, Isabel M.
   Presciatto-Baschong, Cristina
   Riezman, Howard
   Geli, Maria-Isabel
TI Distinct acto/myosin-I structures associate with endocytic profiles at
   the plasma membrane
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID BUDDING YEAST; SACCHAROMYCES-CEREVISIAE; MEDIATED ENDOCYTOSIS; MYOSIN-I;
   ACTIN POLYMERIZATION; ELECTRON-MICROSCOPY; SH3 DOMAIN; CLATHRIN;
   DYNAMIN; INTERNALIZATION
AB Endocytosis in yeast requires actin and clathrin. Live cell imaging has previously shown that massive actin polymerization occurs concomitant with a slow 200-nm inward movement of the endocytic coat (Kaksonen, M., Y. Sun, and D. G. Drubin. 2003. Cell. 115: 475-487). However, the nature of the primary endocytic pro. le in yeast and how clathrin and actin cooperate to generate an endocytic vesicle is unknown. In this study, we analyze the distribution of nine different proteins involved in endocytic uptake along plasma membrane invaginations using immunoelectron microscopy. We find that the primary endocytic profiles are tubular invaginations of up to 50 nm in diameter and 180 nm in length, which accumulate the endocytic coat components at the tip. Interestingly, significant actin labeling is only observed on invaginations longer than 50 nm, suggesting that initial membrane bending occurs before initiation of the slow inward movement. We also find that in the longest profiles, actin and the myosin-I Myo5p form two distinct structures that might be implicated in vesicle fission.
C1 [Idrissi, Fatima-Zahra; Groetsch, Helga; Fernandez-Golbano, Isabel M.; Geli, Maria-Isabel] CSIC, Inst Mol Biol Barcelona, E-08028 Barcelona, Spain.
   [Presciatto-Baschong, Cristina] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Riezman, Howard] Univ Geneva, CH-1211 Geneva, Switzerland.
RP Geli, MI (corresponding author), CSIC, Inst Mol Biol Barcelona, E-08028 Barcelona, Spain.
EM mgfbmc@ibmb.csic.es
RI Fernandez-Golbano, Isabel/J-7409-2017; Geli, Maria Isabel/L-3246-2014;
   Idrissi Azami, Fatima Zohra/P-5627-2015
OI Fernandez-Golbano, Isabel/0000-0002-8525-6376; Geli, Maria
   Isabel/0000-0002-3452-6700; Grotsch, Helga/0000-0003-1948-3922; Riezman,
   Howard/0000-0003-4680-9422; Idrissi Azami, Fatima
   Zohra/0000-0003-3672-7618
CR Anderson BL, 1998, J CELL BIOL, V141, P1357, DOI 10.1083/jcb.141.6.1357
   COCHRAN WG, 1954, BIOMETRICS, V10, P417, DOI 10.2307/3001616
   Drees BL, 2001, J CELL BIOL, V154, P549, DOI 10.1083/jcb.200104057
   Engqvist-Goldstein AEY, 2003, ANNU REV CELL DEV BI, V19, P287, DOI 10.1146/annurev.cellbio.19.111401.093127
   GAMMIE AE, 1995, J CELL BIOL, V130, P553, DOI 10.1083/jcb.130.3.553
   Geli MI, 2000, EMBO J, V19, P4281, DOI 10.1093/emboj/19.16.4281
   GUTHRIE C, 1991, METHOD ENZYMOL, V194, P933
   Hermann R, 1996, HISTOCHEM CELL BIOL, V106, P31
   Hinrichsen L, 2006, P NATL ACAD SCI USA, V103, P8715, DOI 10.1073/pnas.0600312103
   Huckaba TM, 2004, J CELL BIOL, V167, P519, DOI 10.1083/jcb.200404173
   Hurley JH, 2002, CELL, V111, P143, DOI 10.1016/S0092-8674(02)01044-9
   ITO H, 1983, J BACTERIOL, V153, P163, DOI 10.1128/JB.153.1.163-168.1983
   Jonsdottir GA, 2004, CURR BIOL, V14, P1604, DOI 10.1016/j.cub.2004.08.055
   Kaksonen M, 2003, CELL, V115, P475, DOI 10.1016/S0092-8674(03)00883-3
   Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024
   Kaksonen M, 2006, NAT REV MOL CELL BIO, V7, P404, DOI 10.1038/nrm1940
   Krendel M, 2007, FEBS LETT, V581, P644, DOI 10.1016/j.febslet.2007.01.021
   KRUSKAL WH, 1952, J AM STAT ASSOC, V47, P583, DOI 10.1080/01621459.1952.10483441
   Lechler T, 2000, J CELL BIOL, V148, P363, DOI 10.1083/jcb.148.2.363
   LEMMON SK, 1988, J CELL BIOCHEM, V36, P329, DOI 10.1002/jcb.240360403
   McCullagh P., 1989, GEN LINEAR MODELS
   Merrifield CJ, 2002, NAT CELL BIOL, V4, P691, DOI 10.1038/ncb837
   Mochida J, 2002, GENETICS, V160, P923
   MULHOLLAND J, 1994, J CELL BIOL, V125, P381, DOI 10.1083/jcb.125.2.381
   Mulholland J, 1999, MOL BIOL CELL, V10, P799, DOI 10.1091/mbc.10.3.799
   Newpher TM, 2005, DEV CELL, V9, P87, DOI 10.1016/j.devcel.2005.04.014
   POLLARD TD, 1991, ANNU REV PHYSIOL, V53, P653, DOI 10.1146/annurev.ph.53.030191.003253
   REYNOLDS ES, 1963, J CELL BIOL, V17, P208, DOI 10.1083/jcb.17.1.208
   Rodal AA, 2005, MOL BIOL CELL, V16, P372, DOI 10.1091/mbc.E04-08-0734
   Rodal AA, 2003, CURR BIOL, V13, P1000, DOI 10.1016/S0960-9822(03)00383-X
   Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718
   Song BD, 2003, BIOCHEMISTRY-US, V42, P1369, DOI 10.1021/bi027062h
   Sun YD, 2007, J CELL BIOL, V177, P355, DOI 10.1083/jcb.200611011
   Sun YD, 2006, DEV CELL, V11, P33, DOI 10.1016/j.devcel.2006.05.008
   Toshima JY, 2006, P NATL ACAD SCI USA, V103, P5793, DOI 10.1073/pnas.0601042103
   Wach A, 1997, YEAST, V13, P1065, DOI 10.1002/(SICI)1097-0061(19970915)13:11<1065::AID-YEA159>3.0.CO;2-K
   Yu XW, 2004, J CELL SCI, V117, P3839, DOI 10.1242/jcs.01239
NR 37
TC 102
Z9 103
U1 0
U2 9
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD MAR 24
PY 2008
VL 180
IS 6
BP 1219
EP 1232
DI 10.1083/jcb.200708060
PG 14
WC Cell Biology
SC Cell Biology
GA 278OE
UT WOS:000254295400015
PM 18347067
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Hartmann, C
   Chami, M
   Zachariae, U
   de Groot, BL
   Engel, A
   Grutter, MG
AF Hartmann, Claudia
   Chami, Mohamed
   Zachariae, Ulrich
   de Groot, Bert L.
   Engel, Andreas
   Gruetter, Markus G.
TI Vacuolar protein sorting: Two different functional states of the
   AAA-ATPase Vps4p
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE ESCRT; membrane traffic; HIV; AAA-ATPase; Vps
ID ESCRT-III; MEMBRANE ASSOCIATION; ELECTRON-MICROSCOPY; CRYSTAL-STRUCTURE;
   MIT DOMAIN; OLIGOMERIZATION; RESOLUTION; CHAPERONE; RECONSTRUCTION;
   COMPLEXES
AB The vacuolar protein sorting (Vps) pathway, in which Vps4 class I AAA-ATPases play a central role, regulates growth factor receptors, immune response, and developmental signaling, and participates in tumor suppression, apoptosis, and retrovirus budding. We present the first atonLic structure of the nucleotide-free yeast HiS(6)Delta NVps4p dimer and its AMPPNP (5'-adenylyl-beta,gamma-imidodiphosphate)-bound tetradecamer, derived from a cryo electron microscopy map. Vps4p dimers form two distinct heptameric rings and accommodate AAA cassettes in a head-to-head-not in a head-to-tail-fashion as in class 11 AAA-ATPases. Our model suggests a mechanism for disassembling ESCRT (endosomal sorting complex required for transport) complexes by movements of substrate-binding domains located at the periphery of the tetradecamer during ATP hydrolysis in one ring, followed by translocation through the central pore and ATP hydrolysis in the second ring. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Hartmann, Claudia; Chami, Mohamed; Engel, Andreas] Univ Basel, Biozentrum, ME Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Hartmann, Claudia; Gruetter, Markus G.] Univ Zurich, Inst Biochem, CH-8057 Zurich, Switzerland.
   [Zachariae, Ulrich; de Groot, Bert L.] Max Planck Inst Biophys Chem, D-37077 Gottingen, Germany.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, ME Inst Struct Biol, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch; gruetter@bioc.uzh.ch
OI Zachariae, Ulrich/0000-0003-3287-8494
CR Akoev V, 2004, PROTEIN SCI, V13, P567, DOI 10.1110/ps.03422604
   Azmi I, 2006, J CELL BIOL, V172, P705, DOI 10.1083/jcb.200508166
   Babst M, 1998, EMBO J, V17, P2982, DOI 10.1093/emboj/17.11.2982
   BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103
   Bochtler M, 2000, NATURE, V403, P800, DOI 10.1038/35001629
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   DARDEN T, 1993, J CHEM PHYS, V98, P10089, DOI 10.1063/1.464397
   DeLaBarre B, 2005, J MOL BIOL, V347, P437, DOI 10.1016/j.jmb.2005.01.060
   DeLaBarre B, 2003, NAT STRUCT BIOL, V10, P856, DOI 10.1038/nsb972
   Frank J, 1996, J STRUCT BIOL, V116, P190, DOI 10.1006/jsbi.1996.0030
   Guo FS, 2002, J BIOL CHEM, V277, P46743, DOI 10.1074/jbc.M207796200
   Hess B, 1997, J COMPUT CHEM, V18, P1463, DOI 10.1002/(SICI)1096-987X(199709)18:12<1463::AID-JCC4>3.3.CO;2-L
   Hurley JH, 2006, ANNU REV BIOPH BIOM, V35, P277, DOI 10.1146/annurev.biophys.35.040405.102126
   Huyton T, 2003, J STRUCT BIOL, V144, P337, DOI 10.1016/j.jsb.2003.10.007
   Jorgensen WL, 1996, J AM CHEM SOC, V118, P11225, DOI 10.1021/ja9621760
   JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869
   Katzmann DJ, 2002, NAT REV MOL CELL BIO, V3, P893, DOI 10.1038/nrm973
   Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163
   Lee S, 2003, CELL, V115, P229, DOI 10.1016/S0092-8674(03)00807-9
   Leschziner AE, 2007, ANNU REV BIOPH BIOM, V36, P43, DOI 10.1146/annurev.biophys.36.040306.132742
   LESLIE AGW, 1992, NEWSL PROTEIN, V26
   Lottridge JM, 2006, P NATL ACAD SCI USA, V103, P6202, DOI 10.1073/pnas.0601712103
   Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174
   Mahul-Mellier AL, 2006, J NEUROSCI, V26, P542, DOI 10.1523/JNEUROSCI.3069-05.2006
   Mindell JA, 2003, J STRUCT BIOL, V142, P334, DOI 10.1016/S1047-8477(03)00069-8
   Neuwald AF, 1999, GENOME RES, V9, P27
   Nickerson Daniel P, 2006, J Cell Biol, V175, P715, DOI 10.1083/jcb.200606113
   Obita T, 2007, NATURE, V449, P735, DOI 10.1038/nature06171
   PENCZEK P, 1992, ULTRAMICROSCOPY, V40, P33, DOI 10.1016/0304-3991(92)90233-A
   Pornillos O, 2003, J CELL BIOL, V162, P425, DOI 10.1083/jcb.200302138
   Rohrwild M, 1997, NAT STRUCT BIOL, V4, P133, DOI 10.1038/nsb0297-133
   Rouiller I, 2002, NAT STRUCT BIOL, V9, P950, DOI 10.1038/nsb872
   Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035
   Scheuring S, 2001, J MOL BIOL, V312, P469, DOI 10.1006/jmbi.2001.4917
   Scott A, 2005, P NATL ACAD SCI USA, V102, P13813, DOI 10.1073/pnas.0502165102
   Scott A, 2005, EMBO J, V24, P3658, DOI 10.1038/sj.emboj.7600818
   Shim S, 2007, TRAFFIC, V8, P1068, DOI 10.1111/j.1600-0854.2007.00584.x
   Sorzano COS, 2004, J STRUCT BIOL, V148, P194, DOI 10.1016/j.jsb.2004.06.006
   STUCHELLBRERETO.MD, 2007, ATPASES NATURE, V449, P740
   Takasu H, 2005, BIOCHEM BIOPH RES CO, V334, P460, DOI 10.1016/j.bbrc.2005.06.110
   Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020
   TURK D, 1992, THESIS TU MUNCHEN MU
   Vajjhala PR, 2007, FEBS J, V274, P1894, DOI 10.1111/j.1742-4658.2007.05736.x
   Vajjhala PR, 2006, FEBS J, V273, P2357, DOI 10.1111/j.1742-4658.2006.05238.x
   Van der Spoel D, 2005, J COMPUT CHEM, V26, P1701, DOI 10.1002/jcc.20291
   VRIEND G, 1990, J MOL GRAPHICS, V8, P52, DOI 10.1016/0263-7855(90)80070-V
   Wriggers W, 1999, J STRUCT BIOL, V125, P185, DOI 10.1006/jsbi.1998.4080
   Xiao JY, 2007, J MOL BIOL, V374, P655, DOI 10.1016/j.jmb.2007.09.067
   Yeo SCL, 2003, J CELL SCI, V116, P3957, DOI 10.1242/jcs.00751
   Zhang XJ, 2004, J STRUCT BIOL, V146, P155, DOI 10.1016/j.jsb.2003.10.020
NR 52
TC 40
Z9 40
U1 0
U2 6
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD MAR 21
PY 2008
VL 377
IS 2
BP 352
EP 363
DI 10.1016/j.jmb.2008.01.010
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 282RY
UT WOS:000254586100005
PM 18272179
OA Green Published
DA 2021-01-25
ER

PT J
AU Merkl, R
   Zwick, M
AF Merkl, Rainer
   Zwick, Matthias
TI H2r: Identification of evolutionary important residues by means of an
   entropy based analysis of multiple sequence alignments
SO BMC BIOINFORMATICS
LA English
DT Article
ID FUNCTIONALLY IMPORTANT RESIDUES; TRYPTOPHAN SYNTHASE; CORRELATED
   MUTATIONS; PROTEIN FAMILIES; ALLOSTERIC COMMUNICATION;
   SALMONELLA-TYPHIMURIUM; CATALYTIC MECHANISM; CRYSTAL-STRUCTURE; SH3
   DOMAIN; T-COFFEE
AB Background: A multiple sequence alignment (MSA) generated for a protein can be used to characterise residues by means of a statistical analysis of single columns. In addition to the examination of individual positions, the investigation of co-variation of amino acid frequencies offers insights into function and evolution of the protein and residues.
   Results: We introduce conn(k), a novel parameter for the characterisation of individual residues. For each residue k, conn( k) is the number of most extreme signals of co-evolution. These signals were deduced from a normalised mutual information (MI) value U(k, l) computed for all pairs of residues k, l. We demonstrate that conn(k) is a more robust indicator than an individual MI-value for the prediction of residues most plausibly important for the evolution of a protein. This proposition was inferred by means of statistical methods. It was further confirmed by the analysis of several proteins. A server, which computes conn(k)-values is available at http://www-bioinf.uniregensburg.de.
   Conclusion: The algorithms H2r, which analyses MSAs and computes conn(k)-values, characterises a specific class of residues. In contrast to strictly conserved ones, these residues possess some flexibility in the composition of side chains. However, their allocation is sensibly balanced with several other positions, as indicated by conn( k).
C1 [Merkl, Rainer; Zwick, Matthias] Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany.
   [Zwick, Matthias] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Merkl, R (corresponding author), Univ Regensburg, Inst Biophys & Phys Biochem, D-93040 Regensburg, Germany.
EM Rainer.Merkl@biologie.uni-regensburg.de;
   Matthias.Zwick@biologie.uni-regensburg.de
RI Merkl, Rainer/A-4534-2008
OI Merkl, Rainer/0000-0002-3521-2957
CR ALTSCHUH D, 1987, J MOL BIOL, V193, P693, DOI 10.1016/0022-2836(87)90352-4
   Atchley WR, 2000, MOL BIOL EVOL, V17, P164, DOI 10.1093/oxfordjournals.molbev.a026229
   Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272
   Caffrey DR, 2004, PROTEIN SCI, V13, P190, DOI 10.1110/ps.03323604
   Capra JA, 2007, BIOINFORMATICS, V23, P1875, DOI 10.1093/bioinformatics/btm270
   Dekker JP, 2004, BIOINFORMATICS, V20, P1565, DOI 10.1093/bioinformatics/bth128
   Dima RI, 2006, PROTEIN SCI, V15, P258, DOI 10.1110/ps.051767306
   Estabrook RA, 2005, P NATL ACAD SCI USA, V102, P994, DOI 10.1073/pnas.0409128102
   Eyal E, 2007, PROTEINS, V67, P142, DOI 10.1002/prot.21223
   Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149
   Fleishman SJ, 2004, J MOL BIOL, V340, P307, DOI 10.1016/j.jmb.2004.04.064
   Gloor GB, 2005, BIOCHEMISTRY-US, V44, P7156, DOI 10.1021/bi050293e
   GOBEL U, 1994, PROTEINS, V18, P309, DOI 10.1002/prot.340180402
   HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108
   HYDE CC, 1988, J BIOL CHEM, V263, P17857
   Kalinina OV, 2004, NUCLEIC ACIDS RES, V32, pW424, DOI 10.1093/nar/gkh391
   Kalinina OV, 2004, PROTEIN SCI, V13, P443, DOI 10.1110/ps.03191704
   Kass I, 2002, PROTEINS, V48, P611, DOI 10.1002/prot.10180
   Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198
   Kelley LA, 2000, J MOL BIOL, V299, P499, DOI 10.1006/jmbi.2000.3741
   Kulik V, 2005, J MOL BIOL, V352, P608, DOI 10.1016/j.jmb.2005.07.014
   Kulik V, 2002, J MOL BIOL, V324, P677, DOI 10.1016/S0022-2836(02)01109-9
   Landau M, 2005, NUCLEIC ACIDS RES, V33, pW299, DOI 10.1093/nar/gki370
   Larson SM, 2000, J MOL BIOL, V303, P433, DOI 10.1006/jmbi.2000.4146
   Laskowski RA, 2005, NUCLEIC ACIDS RES, V33, pD266, DOI 10.1093/nar/gki001
   Lassmann T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-S5-S9
   Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295
   Martin LC, 2005, BIOINFORMATICS, V21, P4116, DOI 10.1093/bioinformatics/bti671
   Merkl R, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-59
   Mesa AD, 2003, J MOL BIOL, V326, P1289, DOI 10.1016/S0022-2836(02)01451-1
   NEHER E, 1994, P NATL ACAD SCI USA, V91, P98, DOI 10.1073/pnas.91.1.98
   NOBLE MEM, 1993, EMBO J, V12, P2617, DOI 10.1002/j.1460-2075.1993.tb05922.x
   Noivirt O, 2005, PROTEIN ENG DES SEL, V18, P247, DOI 10.1093/protein/gzi029
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Olmea O, 1997, FOLD DES, V2, pS25, DOI 10.1016/S1359-0278(97)00060-6
   Ouzounis C, 1998, Pac Symp Biocomput, P401
   Pearl F, 2005, NUCLEIC ACIDS RES, V33, pD247, DOI 10.1093/nar/gki024
   Rost B, 1996, METHOD ENZYMOL, V266, P525
   SANDER C, 1991, PROTEINS, V9, P56, DOI 10.1002/prot.340090107
   Saraf MC, 2003, PROTEIN ENG, V16, P397, DOI 10.1093/protein/gzg053
   Sato T, 2005, BIOINFORMATICS, V21, P3482, DOI 10.1093/bioinformatics/bti564
   SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097
   SHANNON CE, 1948, BELL SYST TECH J, V27, P423
   Steegborn C, 1999, J MOL BIOL, V290, P983, DOI 10.1006/jmbi.1999.2935
   Suel GM, 2003, NAT STRUCT BIOL, V10, P59, DOI 10.1038/nsb881
   Teukolsky S A, 1992, NUMERICAL RECIPES C
   Tillier ERM, 2003, BIOINFORMATICS, V19, P750, DOI 10.1093/bioinformatics/btg072
   Tsai J, 1999, J MOL BIOL, V290, P253, DOI 10.1006/jmbi.1999.2829
   VILLAR HO, 1994, FEBS LETT, V349, P125, DOI 10.1016/0014-5793(94)00648-2
   Wallace IM, 2006, NUCLEIC ACIDS RES, V34, P1692, DOI 10.1093/nar/gkl091
   Weber-Ban E, 2001, BIOCHEMISTRY-US, V40, P3497, DOI 10.1021/bi002690p
   WNAG K, 2006, BMC BIOINFORMATICS, V7, P385
   ZUCKERKANDL E, 1965, J THEOR BIOL, V8, P357, DOI 10.1016/0022-5193(65)90083-4
NR 53
TC 15
Z9 15
U1 0
U2 2
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2105
J9 BMC BIOINFORMATICS
JI BMC Bioinformatics
PD MAR 18
PY 2008
VL 9
AR 151
DI 10.1186/1471-2105-9-151
PG 14
WC Biochemical Research Methods; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Mathematical & Computational Biology
GA 292RH
UT WOS:000255283300001
PM 18366663
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Ziegler, A
   Seelig, J
AF Ziegler, Andre
   Seelig, Joachim
TI Binding and clustering of glycosaminoglycans: A common property of mono-
   and multivalent cell-penetrating compounds
SO BIOPHYSICAL JOURNAL
LA English
DT Article
ID HEPARAN-SULFATE PROTEOGLYCANS; N-LINKED OLIGOSACCHARIDES; HIV-1 TAT;
   CATIONIC PEPTIDE; GENE DELIVERY; PROTEIN; KINASE; DNA; THERMODYNAMICS;
   AGGREGATION
AB Recent observations in cell culture provide evidence that negatively charged glycosaminoglycans (GAGs) at the surface of biological cells bind cationic cell-penetrating compounds (CPCs) and cluster during CPC binding, thereby contributing to their endocytotic uptake. The GAG binding and clustering occur in the low-micromolar concentration range and suggest a tight interaction between GAGs and CPCs, although the relation between binding affinity and specificity of this interaction remains to be investigated. We therefore measured the GAG binding and clustering of various mono- and multivalent CPCs such as DNA transfection vectors (polyethylenimine; 1,2-dioleoyl-3-trimethylammonium-propane), amino acid homopolymers (oligoarginine; oligolysine), and cell-penetrating peptides (Penetratin; HIV-1 Tat) by means of isothermal titration calorimetry and dynamic light scattering. We find that these structurally diverse CPCs share the property of GAG binding and clustering. The binding is very tight (microscopic dissociation constants between 0.34 and 1.34 mu M) and thus biologically relevant. The hydrodynamic radius of the resulting aggregates ranges from 78 nm to 586 nm, suggesting that they consist of numerous GAG chains cross-linked by CPCs. Likewise, the membrane-permeant monovalent cation acridine orange leads to GAG binding and clustering, in contrast to its membrane-impermeant structural analogs propidium iodide and ethidium bromide. Because the binding and clustering of GAGs were found to be a common denominator of all CPCs tested, these properties might be helpful to identify further CPCs.
C1 [Ziegler, Andre; Seelig, Joachim] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Ziegler, A (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM andre.ziegler@unibas.ch
CR Andrade SM, 2002, PHOTOCH PHOTOBIO SCI, V1, P500, DOI 10.1039/b201477g
   BANK HL, 1987, DIABETOLOGIA, V30, P812
   BEISKER W, 1989, J HISTOCHEM CYTOCHEM, V37, P1699, DOI 10.1177/37.11.2478614
   Belting M, 2003, TRENDS BIOCHEM SCI, V28, P145, DOI 10.1016/S0968-0004(03)00031-8
   BIENER Y, 1990, EUR J BIOCHEM, V194, P243, DOI 10.1111/j.1432-1033.1990.tb19449.x
   BRUGIDOU J, 1995, BIOCHEM BIOPH RES CO, V214, P685, DOI 10.1006/bbrc.1995.2340
   CHAUDHURI S, 1975, INT J RADIAT BIOL, V28, P345, DOI 10.1080/09553007514551131
   CONNOLLY ML, 1993, J MOL GRAPHICS, V11, P139, DOI 10.1016/0263-7855(93)87010-3
   Cramer F., 1995, PHARM ACTA HELV, V69, p[193, 195], DOI DOI 10.1016/0031-6865(95)00012-X
   DELLANTONE P, 1974, FEBS LETT, V39, P67, DOI 10.1016/0014-5793(74)80018-9
   Dull RO, 2003, AM J PHYSIOL-LUNG C, V285, pL986, DOI 10.1152/ajplung.00022.2003
   Fischer R, 2005, CHEMBIOCHEM, V6, P2126, DOI 10.1002/cbic.200500044
   FREEZE HH, 1986, BIOCHEM BIOPH RES CO, V140, P967, DOI 10.1016/0006-291X(86)90730-8
   Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607
   Gammon ST, 2003, BIOCONJUGATE CHEM, V14, P368, DOI 10.1021/bc0256291
   GIANCOTTI V, 1973, EUR J BIOCHEM, V35, P78, DOI 10.1111/j.1432-1033.1973.tb02812.x
   Goncalves E, 2006, BIOCHEMISTRY-US, V45, P3086, DOI 10.1021/bi052221t
   Goncalves E, 2005, BIOCHEMISTRY-US, V44, P2692, DOI 10.1021/bi048046i
   HARAN G, 1993, BIOCHIM BIOPHYS ACTA, V1151, P201, DOI 10.1016/0005-2736(93)90105-9
   Herz J, 2001, J CLIN INVEST, V108, P779, DOI 10.1172/JCI200113992
   Hileman RE, 1998, BIOCHEMISTRY-US, V37, P15231, DOI 10.1021/bi980212x
   JONSSON M, 2003, J PHYS CHEM B, V115, P3406
   KHAN NA, 1990, BIOCHEM INT, V20, P863
   Kopatz I, 2004, J GENE MED, V6, P769, DOI 10.1002/jgm.558
   KOPPEL DE, 1972, J CHEM PHYS, V57, P4814, DOI 10.1063/1.1678153
   Kreuger J, 2005, BIOCHEM J, V389, P145, DOI 10.1042/BJ20042129
   MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x
   Martinho RG, 1996, MOL BIOL CELL, V7, P1771
   MATTEONI R, 1987, J CELL BIOL, V105, P1253, DOI 10.1083/jcb.105.3.1253
   McMahon HT, 2005, NATURE, V438, P590, DOI 10.1038/nature04396
   MENTER JM, 1979, BIOPOLYMERS, V18, P493, DOI 10.1002/bip.1979.360180302
   MOHAMMADI M, 1993, BIOCHEMISTRY-US, V32, P8742, DOI 10.1021/bi00085a004
   Mulloy B, 2001, CURR OPIN STRUC BIOL, V11, P623, DOI 10.1016/S0959-440X(00)00257-8
   MYHR BC, 1971, BIOPOLYMERS, V10, P425, DOI 10.1002/bip.360100302
   Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824
   Patel MM, 2005, BIOPHYS J, V88, P2089, DOI 10.1529/biophysj.104.052100
   Rejman J, 2004, BBA-BIOMEMBRANES, V1660, P41, DOI 10.1016/j.bbamem.2003.10.011
   Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200
   ROUX L, 1988, J BIOL CHEM, V263, P8879
   Rouzina I, 1996, J PHYS CHEM-US, V100, P9977, DOI 10.1021/jp960458g
   Rusnati M, 1999, J BIOL CHEM, V274, P28198, DOI 10.1074/jbc.274.40.28198
   Sakai N, 2003, J AM CHEM SOC, V125, P14348, DOI 10.1021/ja037601l
   SCHAFER IA, 1968, J CLIN INVEST, V47, P321, DOI 10.1172/JCI105727
   SHEN WC, 1979, MOL PHARMACOL, V16, P614
   SMITS RG, 1993, J PHYS CHEM-US, V97, P5745, DOI 10.1021/j100123a047
   STURTEVANT JM, 1977, P NATL ACAD SCI USA, V74, P2236, DOI 10.1073/pnas.74.6.2236
   SUGAR J, 1958, Krebsarzt, V13, P119
   Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998
   TANFORD C, 1979, P NATL ACAD SCI USA, V76, P4175, DOI 10.1073/pnas.76.9.4175
   THOMPSON LD, 1994, BIOCHEMISTRY-US, V33, P3831, DOI 10.1021/bi00179a006
   Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200
   TURNBULL JE, 1991, BIOCHEM J, V277, P297, DOI 10.1042/bj2770297
   Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200
   VANHOLDE KE, 1998, PRINCIPLES PHYS BIOC, P604
   Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003
   Wiethoff CM, 2001, J BIOL CHEM, V276, P32806, DOI 10.1074/jbc.M007940200
   WIRTH MJ, 1991, ANAL CHEM, V63, P1311, DOI 10.1021/ac00013a025
   XU QY, 1991, BIOCHEMISTRY-US, V30, P11811, DOI 10.1021/bi00115a011
   Yao H, 2007, J COLLOID INTERF SCI, V307, P272, DOI 10.1016/j.jcis.2006.11.030
   Zhang W, 1996, P NATL ACAD SCI USA, V93, P2511, DOI 10.1073/pnas.93.6.2511
   Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604
   Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6
   Ziegler A, 2007, BIOCHEMISTRY-US, V46, P8138, DOI 10.1021/bi700416h
NR 63
TC 96
Z9 97
U1 1
U2 17
PU BIOPHYSICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD MAR 15
PY 2008
VL 94
IS 6
BP 2142
EP 2149
DI 10.1529/biophysj.107.113472
PG 8
WC Biophysics
SC Biophysics
GA 269UQ
UT WOS:000253676200018
PM 18065465
OA Green Published
DA 2021-01-25
ER

PT J
AU Farhan, H
   Reiterer, V
   Kriz, A
   Hauri, HP
   Pavelka, M
   Sitte, HH
   Freissmuth, M
AF Farhan, Hesso
   Reiterer, Veronika
   Kriz, Alexander
   Hauri, Hans-Peter
   Pavelka, Margit
   Sitte, Harald H.
   Freissmuth, Michael
TI Signal-dependent export of GABA transporter 1 from the ER-Golgi
   intermediate compartment is specified by a C-terminal motif
SO JOURNAL OF CELL SCIENCE
LA English
DT Article
DE GABA transporter-1; ER-to-Golgi trafficking; ERGIC
ID ENDOPLASMIC-RETICULUM; PROTEIN; RECRUITMENT; PATHWAY; BINDING;
   ORGANIZATION; CELLS
AB The C-terminus of GABA transporter 1 (GAT1, SLC6A1) is required for trafficking of the protein through the secretory pathway to reach its final destination, i.e. the rim of the synaptic specialization. We identified a motif of three hydrophobic residues ((VMI571)-V-569) that was required for export of GAT1 from the ER-Golgi intermediate compartment ( ERGIC). This conclusion was based on the following observations: (i) GAT1-SSS, the mutant in which (VMI571)-V-569 was replaced by serine residues, was exported from the ER in a COPII-dependent manner but accumulated in punctate structures and failed to reach the Golgi; (ii) under appropriate conditions ( imposing a block at 15 C, disruption of COPI), these structures also contained ERGIC53; (iii) the punctae were part of a dynamic compartment, because it was accessible to a second anterograde cargo [the temperature-sensitive variant of vesicular stomatitis virus G protein (VSV-G)] and because GAT1-SSS could be retrieved from the punctate structures by addition of a KKxx-based retrieval motif, which supported retrograde transport to the ER. To the best of our knowledge, the VMI-motif of GAT1 provides the first example of a cargo-based motif that specifies export from the ERGIC.
C1 [Farhan, Hesso; Reiterer, Veronika; Sitte, Harald H.; Freissmuth, Michael] Med Univ Vienna, Ctr Biomol Med & Pharmacol, Inst Pharmacol, A-1090 Vienna, Austria.
   [Kriz, Alexander; Hauri, Hans-Peter] Univ Basel, Biozentrum, Dept Pharmacol & Neurobiol, CH-4056 Basel, Switzerland.
   [Pavelka, Margit] Med Univ Vienna, Ctr Anat & Cell Biol, Dept Cell Biol & Ultrastruct Res, A-1090 Vienna, Austria.
RP Freissmuth, M (corresponding author), Med Univ Vienna, Ctr Biomol Med & Pharmacol, Inst Pharmacol, Waehringer Str 13A, A-1090 Vienna, Austria.
EM michael.freissmuth@meduniwien.ac.at
RI Sitte, Harald/O-7025-2019; Farhan, Hesso/C-7997-2012; Sitte,
   Harald/N-2681-2013
OI Sitte, Harald/0000-0002-1339-7444; Farhan, Hesso/0000-0002-0889-8463;
   Sitte, Harald/0000-0002-1339-7444; Freissmuth,
   Michael/0000-0001-9398-1765
FU Austrian Science Fund FWFAustrian Science Fund (FWF) [P 18706] Funding
   Source: Medline
CR Alvarez C, 2003, MOL BIOL CELL, V14, P2116, DOI 10.1091/mbc.E02-09-0625
   Appenzeller-Herzog C, 2006, J CELL SCI, V119, P2173, DOI 10.1242/jcs.03019
   Aridor M, 2000, J BIOL CHEM, V275, P35673, DOI 10.1074/jbc.C000449200
   Ben-Tekaya H, 2005, J CELL SCI, V118, P357, DOI 10.1242/jcs.01615
   Farhan H, 2004, J BIOL CHEM, V279, P28553, DOI 10.1074/jbc.M307325200
   Farhan H, 2007, J BIOL CHEM, V282, P7679, DOI 10.1074/jbc.M609720200
   Gomez M, 2000, J BIOL CHEM, V275, P29162, DOI 10.1074/jbc.M003630200
   Guo YS, 2006, J CELL BIOL, V174, P53, DOI 10.1083/jcb.200604058
   Hauri HP, 2000, J CELL SCI, V113, P587
   Horstmann H, 2002, J CELL SCI, V115, P4263, DOI 10.1242/jcs.00115
   KRIJNSELOCKER J, 1995, MOL BIOL CELL, V6, P1315
   LIPPINCOTTSCHWARTZ J, 1989, CELL, V56, P801, DOI 10.1016/0092-8674(89)90685-5
   Monetta P, 2007, MOL BIOL CELL, V18, P2400, DOI 10.1091/mbc.E06-11-1005
   Nakamura N, 1995, J CELL BIOL, V131, P1715, DOI 10.1083/jcb.131.6.1715
   O'Kelly I, 2002, CELL, V111, P577, DOI 10.1016/S0092-8674(02)01040-1
   PEPPERKOK R, 1993, CELL, V74, P71, DOI 10.1016/0092-8674(93)90295-2
   Sannerud R, 2006, MOL BIOL CELL, V17, P1514, DOI 10.1091/mbc.E05-08-0792
   SCHWANINGER R, 1992, METHOD ENZYMOL, V219, P110
   SCHWEIZER A, 1993, J CELL SCI, V104, P671
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Tobler AR, 1999, J NEUROSCI, V19, P2027
   Xu DL, 2004, J CELL BIOL, V167, P997, DOI 10.1083/jcb.200408135
   Yu S, 2006, J CELL BIOL, V174, P359, DOI 10.1083/jcb.200603044
   ZILBERSTEIN A, 1980, CELL, V21, P417, DOI 10.1016/0092-8674(80)90478-X
NR 24
TC 24
Z9 24
U1 0
U2 0
PU COMPANY OF BIOLOGISTS LTD
PI CAMBRIDGE
PA BIDDER BUILDING CAMBRIDGE COMMERCIAL PARK COWLEY RD, CAMBRIDGE CB4 4DL,
   CAMBS, ENGLAND
SN 0021-9533
J9 J CELL SCI
JI J. Cell Sci.
PD MAR 15
PY 2008
VL 121
IS 6
BP 753
EP 761
DI 10.1242/jcs.017681
PG 9
WC Cell Biology
SC Cell Biology
GA 283TU
UT WOS:000254660200004
PM 18285449
OA Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Ziegler, A
AF Ziegler, Andre
TI Thermodynamic studies and binding mechanisms of cell-penetrating
   peptides with lipids and glycosaminoglycans
SO ADVANCED DRUG DELIVERY REVIEWS
LA English
DT Review
DE carrier proteins; cell-penetrating peptides; genetic vectors; gene
   therapy; endocytosis; lipid bilayers; lipofectants; permeability;
   polyamines; proteoglycans; transfection
ID HEPARAN-SULFATE PROTEOGLYCANS; ARGININE-RICH PEPTIDES; HIV-1 TAT
   PROTEIN; SOLID-STATE NMR; AMPHIPATHIC CARRIER PEPTIDES; HUMAN
   IMMUNODEFICIENCY VIRUS; N-LINKED OLIGOSACCHARIDES; CULTURED
   MAMMALIAN-CELLS; MYELIN BASIC-PROTEIN; POLY-L-LYSINE
AB Cell-penetrating peptides (CPPs) traverse the membrane of biological cells at low micromolar concentrations and are able to take various cargo molecules along with. Despite large differences in their chemical structure, CPPs share the structural similarity of a high cationic charge density. This property confers to them the ability to bind electrostatically membrane constituents such as anionic lipids and glycosaminoglycans (GAGs). Controversies exist, however, about the biological response after the interaction of CPPs with such membrane constituents. Present review compares thermodynamic binding studies with conditions of the biological CPP uptake. It becomes evident that CPPs enter biological cells by different and probably competing mechanisms. For example, some amphipathic CPPs traverse pure lipid model membranes at low micromolar concentrations - at least in the absence of cargos. In contrast, no direct translocation at these conditions is observed for non-amphipathic CPPs. Finally, CPPs bind GAGs at low micromolar concentrations with potential consequences for endocytotic pathways. (C) 2007 Elsevier B.V. All rights reserved.
C1 Univ Basel, BioZentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Ziegler, A (corresponding author), Univ Basel, BioZentrum, Dept Biophys Chem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM andre.ziegler@unibas.ch
CR Afonin S, 2006, CHEMPHYSCHEM, V7, P2134, DOI 10.1002/cphc.200600306
   Akinc A, 2005, J GENE MED, V7, P657, DOI 10.1002/jgm.696
   Akinchina A, 2003, J PHYS CHEM B, V107, P8011, DOI 10.1021/jp022460f
   ANDERSEN MN, 1960, J THORAC CARDIOV SUR, V39, P613
   ANGHILERI LJ, 1976, NUKLEARMED, V15, P242
   ARNOLD LJ, 1979, P NATL ACAD SCI USA, V76, P3246, DOI 10.1073/pnas.76.7.3246
   Avrahami D, 2004, J BIOL CHEM, V279, P12277, DOI 10.1074/jbc.M312260200
   Avrahami D, 2003, BIOCHEMISTRY-US, V42, P14946, DOI 10.1021/bi035142v
   Barany-Wallje E, 2004, FEBS LETT, V567, P265, DOI 10.1016/j.febslet.2004.04.079
   Barany-Wallje E, 2005, BIOPHYS J, V89, P2513, DOI 10.1529/biophysj.105.067694
   Barany-Wallje E, 2007, FEBS LETT, V581, P2389, DOI 10.1016/j.febslet.2007.04.046
   BATSFORD SR, 1983, LAB INVEST, V49, P260
   BAYER MH, 1985, J BACTERIOL, V162, P50, DOI 10.1128/JB.162.1.50-54.1985
   Belting M, 2003, J BIOL CHEM, V278, P47181, DOI 10.1074/jbc.M308325200
   Berlose JP, 1996, EUR J BIOCHEM, V242, P372, DOI 10.1111/j.1432-1033.1996.0372r.x
   Binder H, 2003, PHYS CHEM CHEM PHYS, V5, P5108, DOI 10.1039/b309667j
   Binder H, 2003, BIOPHYS J, V85, P982, DOI 10.1016/S0006-3495(03)74537-8
   Bishop JR, 2007, NATURE, V446, P1030, DOI 10.1038/nature05817
   BLANQUET PR, 1976, HISTOCHEMISTRY, V47, P175, DOI 10.1007/BF00489961
   Blazyk J, 2001, J BIOL CHEM, V276, P27899, DOI 10.1074/jbc.M102865200
   BLIXT Y, 1990, IN VITRO CELL DEV B, V26, P691
   Blondeau P, 2007, CHEM SOC REV, V36, P198, DOI 10.1039/b603089k
   BONDESON J, 1990, BIOCHIM BIOPHYS ACTA, V1026, P186, DOI 10.1016/0005-2736(90)90063-T
   BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297
   BRETSCHER MS, 1972, NATURE-NEW BIOL, V236, P11
   Broder DH, 2006, CELL, V126, P917, DOI 10.1016/j.cell.2006.06.053
   BROWN MS, 1978, J SUPRAMOL STR CELL, V8, P223, DOI 10.1002/jss.400080302
   BROWN SS, 1979, J CELL BIOL, V80, P499, DOI 10.1083/jcb.80.2.499
   BRUGIDOU J, 1995, BIOCHEM BIOPH RES CO, V214, P685, DOI 10.1006/bbrc.1995.2340
   BURMEISTER DW, 1991, CELL MOTIL CYTOSKEL, V19, P255, DOI 10.1002/cm.970190404
   BUSER CA, 1994, BIOCHEMISTRY-US, V33, P13093, DOI 10.1021/bi00248a019
   Caesar CEB, 2006, BIOCHEMISTRY-US, V45, P7682, DOI 10.1021/bi052095t
   CARRIER D, 1986, BIOCHEMISTRY-US, V25, P4167, DOI 10.1021/bi00362a027
   Chaloin L, 1997, BIOCHEMISTRY-US, V36, P11179, DOI 10.1021/bi9708491
   Chang M, 2005, PLANT CELL PHYSIOL, V46, P482, DOI 10.1093/pcp/pci046
   Chang M, 2007, NEW PHYTOL, V174, P46, DOI 10.1111/j.1469-8137.2007.01977.x
   CHEMOMORDIK LV, 1995, CURR OPIN STRUC BIOL, V5, P541
   Choosakoonkriang S, 2003, J PHARM SCI-US, V92, P1710, DOI 10.1002/jps.10437
   Christiaens B, 2004, EUR J BIOCHEM, V271, P1187, DOI 10.1111/j.1432-1033.2004.04022.x
   Christiaens B, 2002, EUR J BIOCHEM, V269, P2918, DOI 10.1046/j.1432-1033.2002.02963.x
   CLEJAN S, 1986, J BACTERIOL, V168, P334, DOI 10.1128/jb.168.1.334-340.1986
   CONRAD HE, 1989, ANN NY ACAD SCI, V556, P18
   CRAIGHEAD JOHN E., 1967, J VIROL, V1, P988
   Curnow P, 2005, BIOCHEM SOC SYMP, V72, P199, DOI 10.1042/bss0720199
   Dathe M, 1996, BIOCHEMISTRY-US, V35, P12612, DOI 10.1021/bi960835f
   DEMBITZER HM, 1972, TRANSFUSION, V12, P94, DOI 10.1111/j.1537-2995.1972.tb05891.x
   DEROSSI D, 1994, J BIOL CHEM, V269, P10444
   Derossi D, 1996, J BIOL CHEM, V271, P18188, DOI 10.1074/jbc.271.30.18188
   Deshayes S, 2004, BIOCHEMISTRY-US, V43, P7698, DOI 10.1021/bi049298m
   Deshayes S, 2005, CELL MOL LIFE SCI, V62, P1839, DOI 10.1007/s00018-005-5109-0
   Deshayes S, 2005, CURR PHARM DESIGN, V11, P3629, DOI 10.2174/138161205774580741
   Deshayes S, 2004, BIOCHEMISTRY-US, V43, P1449, DOI 10.1021/bi035682s
   Deshayes S, 2004, BBA-BIOMEMBRANES, V1667, P141, DOI 10.1016/j.bbamem.2004.09.010
   Deshayes S, 2006, BBA-BIOMEMBRANES, V1758, P328, DOI 10.1016/j.bbamem.2005.10.004
   Deshayes S, 2006, BBA-BIOMEMBRANES, V1758, P1846, DOI 10.1016/j.bbamem.2006.08.010
   Deshayes S, 2006, J PEPT SCI, V12, P758, DOI 10.1002/psc.810
   DEVAUX PF, 1991, BIOCHEMISTRY-US, V30, P1163, DOI 10.1021/bi00219a001
   Donato JL, 1996, BRIT J PHARMACOL, V119, P1447, DOI 10.1111/j.1476-5381.1996.tb16057.x
   Drin G, 2003, J BIOL CHEM, V278, P31192, DOI 10.1074/jbc.M303938200
   Drin G, 2001, BIOCHEMISTRY-US, V40, P1824, DOI 10.1021/bi002019k
   Drin G, 2001, EUR J BIOCHEM, V268, P1304, DOI 10.1046/j.1432-1327.2001.01997.x
   Duchardt F, 2007, TRAFFIC, V8, P848, DOI 10.1111/j.1600-0854.2007.00572.x
   Dull RO, 2003, AM J PHYSIOL-LUNG C, V285, pL986, DOI 10.1152/ajplung.00022.2003
   DUZGUNES N, 1981, J MEMBRANE BIOL, V59, P115, DOI 10.1007/BF01875709
   EHRLICH M, 1976, BIOCHIM BIOPHYS ACTA, V454, P397, DOI 10.1016/0005-2787(76)90266-5
   EIKA C, 1972, SCAND J HAEMATOL, V9, P248
   ELFERINK JGR, 1985, INFLAMMATION, V9, P321, DOI 10.1007/BF00916280
   Elliott G, 1997, CELL, V88, P223, DOI 10.1016/S0092-8674(00)81843-7
   Epand RF, 2006, BBA-BIOMEMBRANES, V1758, P1343, DOI 10.1016/j.bbamem.2006.01.018
   EPAND RF, 1988, BIOCHIM BIOPHYS ACTA, V938, P131, DOI 10.1016/0005-2736(88)90152-6
   EPAND RM, 1988, BIOCHEMISTRY-US, V27, P8776, DOI 10.1021/bi00424a013
   FARGE E, 1992, BIOPHYS J, V61, P347, DOI 10.1016/S0006-3495(92)81841-6
   Fernandez-Carneado J, 2004, BIOPOLYMERS, V76, P196, DOI 10.1002/bip.10585
   Fischer A, 2000, BBA-BIOMEMBRANES, V1467, P177, DOI 10.1016/S0005-2736(00)00217-0
   Fisher L, 2004, GENE THER, V11, P1264, DOI 10.1038/sj.gt.3302291
   FRANKEL AD, 1988, CELL, V55, P1189, DOI 10.1016/0092-8674(88)90263-2
   Franzin CM, 2001, BIOPHYS J, V81, P3346, DOI 10.1016/S0006-3495(01)75968-1
   FRASER PE, 1989, BIOCHIM BIOPHYS ACTA, V983, P23, DOI 10.1016/0005-2736(89)90375-1
   FREEZE HH, 1986, BIOCHEM BIOPH RES CO, V140, P967, DOI 10.1016/0006-291X(86)90730-8
   Fretz MM, 2007, BIOCHEM J, V403, P335, DOI 10.1042/BJ20061808
   Fromm JR, 1997, ARCH BIOCHEM BIOPHYS, V343, P92, DOI 10.1006/abbi.1997.0147
   FROMM JR, 1995, ARCH BIOCHEM BIOPHYS, V323, P279, DOI 10.1006/abbi.1995.9963
   FROMME HG, 1978, CYTOBIOLOGIE, V18, P52
   Fuchs SM, 2004, BIOCHEMISTRY-US, V43, P2438, DOI 10.1021/bi035933x
   Fuki IV, 2000, BIOCHEM J, V351, P607, DOI 10.1042/0264-6021:3510607
   Futaki S, 2001, BIOCONJUGATE CHEM, V12, P1005, DOI 10.1021/bc015508l
   Futaki S, 2007, BIOCHEM SOC T, V35, P784, DOI 10.1042/BST0350784
   Futaki S, 2001, J BIOL CHEM, V276, P5836, DOI 10.1074/jbc.M007540200
   Gammon ST, 2003, BIOCONJUGATE CHEM, V14, P368, DOI 10.1021/bc0256291
   GAVINO VC, 1981, J LIPID RES, V22, P57
   GELMAN RA, 1974, BIOPOLYMERS, V13, P139, DOI 10.1002/bip.1974.360130109
   Gerbal-Chaloin S, 2007, BIOL CELL, V99, P223, DOI 10.1042/BC20060123
   Geueke B, 2005, CHEMBIOCHEM, V6, P982, DOI 10.1002/cbic.200400394
   Ghibaudi E, 2005, J PEPT SCI, V11, P401, DOI 10.1002/psc.633
   Glukhov E, 2005, J BIOL CHEM, V280, P33960, DOI 10.1074/jbc.M507042200
   GOLDFINE H, 1984, J LIPID RES, V25, P1501
   Golebiewska U, 2006, BIOPHYS J, V91, P588, DOI 10.1529/biophysj.106.081562
   Goncalves E, 2005, BIOCHEMISTRY-US, V44, P2692, DOI 10.1021/bi048046i
   GREEN M, 1988, CELL, V55, P1179, DOI 10.1016/0092-8674(88)90262-0
   GREENWALT TJ, 1973, BRIT J HAEMATOL, V25, P227, DOI 10.1111/j.1365-2141.1973.tb01734.x
   GRIFFIN CC, 1995, CARBOHYD RES, V276, P183, DOI 10.1016/0008-6215(95)00166-Q
   Gros E, 2006, BBA-BIOMEMBRANES, V1758, P384, DOI 10.1016/j.bbamem.2006.02.006
   GRUNER SM, 1985, P NATL ACAD SCI USA, V82, P3665, DOI 10.1073/pnas.82.11.3665
   GUTTLER F, 1969, BIOCHEM J, V115, P959
   Hafez IM, 2001, GENE THER, V8, P1188, DOI 10.1038/sj.gt.3301506
   Hakansson S, 2003, BIOCHEMISTRY-US, V42, P8999, DOI 10.1021/bi020715+
   Hallbrink M, 2004, BBA-BIOMEMBRANES, V1667, P222, DOI 10.1016/j.bbamem.2004.10.009
   Harishchandran A, 2005, BBA-BIOMEMBRANES, V1713, P73, DOI 10.1016/j.bbamem.2005.05.008
   Hariton-Gazal E, 2003, J CELL SCI, V116, P4577, DOI 10.1242/jcs.00757
   HASNAIN SE, 1980, INDIAN J EXP BIOL, V18, P1230
   Heerklotz H, 2001, BIOPHYS J, V81, P1547, DOI 10.1016/S0006-3495(01)75808-0
   Heerklotz H, 2001, BIOPHYS J, V81, P184, DOI 10.1016/S0006-3495(01)75690-1
   Henriques ST, 2007, MOL MEMBR BIOL, V24, P282, DOI 10.1080/09687860601142936
   Henriques ST, 2005, FEBS LETT, V579, P4498, DOI 10.1016/j.febslet.2005.06.085
   Henriques ST, 2005, BIOCHEMISTRY-US, V44, P10189, DOI 10.1021/bi0502644
   Henriques ST, 2005, BBA-BIOMEMBRANES, V1669, P75, DOI 10.1016/j.bbamem.2004.11.017
   Henriques ST, 2004, BIOCHEMISTRY-US, V43, P9716, DOI 10.1021/bi036325k
   Herbig ME, 2006, BIOCHEMISTRY-US, V45, P3598, DOI 10.1021/bi050923c
   Herbig ME, 2005, BIOPHYS J, V89, P4056, DOI 10.1529/biophysj.105.068692
   Herbig ME, 2005, BBA-BIOMEMBRANES, V1712, P197, DOI 10.1016/j.bbamem.2005.04.006
   HISCOCK DRR, 1994, J BIOL CHEM, V269, P4539
   Hitz T, 2006, BIOCHEMISTRY-US, V45, P5817, DOI 10.1021/bi060285d
   Ho A, 2001, CANCER RES, V61, P474
   Hoekstra D, 2007, BIOCHEM SOC T, V35, P68, DOI 10.1042/BST0350068
   Holm T, 2005, FEBS LETT, V579, P5217, DOI 10.1016/j.febslet.2005.07.099
   Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001
   Hurley JH, 2002, CELL, V111, P143, DOI 10.1016/S0092-8674(02)01044-9
   Ibanez M, 1996, BIOCHEM CELL BIOL, V74, P633, DOI 10.1139/o96-068
   ISENBERG G, 1976, CELL TISSUE RES, V173, P495
   JACQUES PJ, 1969, LYSOSOMES BIOLOGY PA, V2, P395
   Jones LS, 2004, MOL CELL PROTEOMICS, V3, P746, DOI 10.1074/mcp.R400008-MCP200
   Jones SW, 2005, BRIT J PHARMACOL, V145, P1093, DOI 10.1038/sj.bjp.0706279
   JONSSON M, 2003, J PHYS CHEM B, V115, P3406
   Kaplan IM, 2005, J CONTROL RELEASE, V102, P247, DOI 10.1016/j.jconrel.2004.10.018
   Keller S, 2007, CHEMBIOCHEM, V8, P546, DOI 10.1002/cbic.200600553
   Kichler A, 2006, BBA-BIOMEMBRANES, V1758, P301, DOI 10.1016/j.bbamem.2006.02.005
   KOOPMAN G, 1994, BLOOD, V84, P1415, DOI 10.1182/blood.V84.5.1415.1415
   Kopatz I, 2004, J GENE MED, V6, P769, DOI 10.1002/jgm.558
   Kramer SD, 2003, BBA-BIOMEMBRANES, V1609, P161, DOI 10.1016/S0005-2736(02)00683-1
   KUHN H, 1994, LOCK KEY PRINCIPLE, P247
   Kwoh DY, 1999, BBA-GENE STRUCT EXPR, V1444, P171, DOI 10.1016/S0167-4781(98)00274-7
   Lamaziere A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000201
   Lee H, 2002, J CONTROL RELEASE, V79, P283, DOI 10.1016/S0168-3659(02)00002-0
   Lee PHA, 2004, J BIOL CHEM, V279, P48640, DOI 10.1074/jbc.M407241200
   Lensink MF, 2005, BIOPHYS J, V88, P939, DOI 10.1529/biophysj.104.052787
   Letoha T, 2005, J PEPT SCI, V11, P805, DOI 10.1002/psc.678
   Lindahl U, 2000, GLYCOCONJUGATE J, V17, P597, DOI 10.1023/A:1011030711317
   Lindberg M, 2001, BIOCHEMISTRY-US, V40, P3141, DOI 10.1021/bi0008985
   Lindgren M, 2000, TRENDS PHARMACOL SCI, V21, P99, DOI 10.1016/S0165-6147(00)01447-4
   Lindgren ME, 2004, BIOCHEM J, V377, P69, DOI 10.1042/BJ20030760
   LIS LJ, 1982, BIOPHYS J, V37, P657
   Lu JX, 2006, BBA-BIOMEMBRANES, V1758, P1303, DOI 10.1016/j.bbamem.2006.02.002
   Lundberg M, 2002, BIOCHEM BIOPH RES CO, V291, P367, DOI 10.1006/bbrc.2002.6450
   Macdonald PM, 2000, SOLID STATE NUCL MAG, V16, P21, DOI 10.1016/S0926-2040(00)00051-5
   Maget-Dana R, 1999, BBA-BIOMEMBRANES, V1462, P109, DOI 10.1016/S0005-2736(99)00203-5
   Magzoub M, 2004, Q REV BIOPHYS, V37, P147, DOI 10.1017/S0033583505004014
   Magzoub M, 2001, BBA-BIOMEMBRANES, V1512, P77, DOI 10.1016/S0005-2736(01)00304-2
   Magzoub M, 2005, BIOCHEMISTRY-US, V44, P14890, DOI 10.1021/bi051356w
   Magzoub M, 2003, BIOPHYS CHEM, V103, P271, DOI 10.1016/S0301-4622(02)00321-6
   Maiolo JR, 2005, BBA-BIOMEMBRANES, V1712, P161, DOI 10.1016/j.bbamem.2005.04.010
   Malina A, 2005, BIOCHEM J, V390, P695, DOI 10.1042/BJ20050520
   Mangavel C, 1998, BBA-BIOMEMBRANES, V1371, P265, DOI 10.1016/S0005-2736(98)00026-1
   MANN DA, 1991, EMBO J, V10, P1733, DOI 10.1002/j.1460-2075.1991.tb07697.x
   Mano M, 2005, BIOCHEM J, V390, P603, DOI 10.1042/BJ20050577
   Mano M, 2007, J PEPT SCI, V13, P301, DOI 10.1002/psc.842
   Mano M, 2006, BBA-BIOMEMBRANES, V1758, P336, DOI 10.1016/j.bbamem.2006.01.014
   Marek J, 1971, Verh Dtsch Ges Pathol, V55, P706
   MARIKOVSKY Y, 1978, JNCI-J NATL CANCER I, V60, P741, DOI 10.1093/jnci/60.4.741
   MARTIN SJ, 1995, J EXP MED, V182, P1545, DOI 10.1084/jem.182.5.1545
   Martinho RG, 1996, MOL BIOL CELL, V7, P1771
   Mason AJ, 2007, MINI-REV MED CHEM, V7, P491, DOI 10.2174/138955707780619563
   Mason AJ, 2006, FASEB J, V20, P320, DOI 10.1096/fj.05-4293fje
   MAYHEW E, 1973, EXP CELL RES, V77, P409, DOI 10.1016/0014-4827(73)90595-8
   MAYHEW E, 1973, J MEMBRANE BIOL, V14, P213, DOI 10.1007/BF01868079
   Mislick KA, 1996, P NATL ACAD SCI USA, V93, P12349, DOI 10.1073/pnas.93.22.12349
   Mitchell DJ, 2000, J PEPT RES, V56, P318, DOI 10.1034/j.1399-3011.2000.00723.x
   MOHAMMAD SF, 1977, THROMB RES, V10, P193, DOI 10.1016/0049-3848(77)90001-9
   Moore VD, 2004, J BIOL CHEM, V279, P32541, DOI 10.1074/jbc.M405930200
   MORAD N, 1984, BIOCHIM BIOPHYS ACTA, V801, P117, DOI 10.1016/0304-4165(84)90219-8
   Morein S, 1996, J BIOL CHEM, V271, P6801, DOI 10.1074/jbc.271.12.6801
   MORGAN DML, 1988, J CELL SCI, V91, P231
   Morris MC, 2001, NAT BIOTECHNOL, V19, P1173, DOI 10.1038/nbt1201-1173
   Morris MC, 1997, NUCLEIC ACIDS RES, V25, P2730, DOI 10.1093/nar/25.14.2730
   Nakase I, 2007, BIOCHEMISTRY-US, V46, P492, DOI 10.1021/bi0612824
   Nascimento FD, 2007, J BIOL CHEM, V282, P21349, DOI 10.1074/jbc.M604876200
   Natsume H, 1999, INT J PHARM, V185, P1, DOI 10.1016/S0378-5173(99)00100-3
   Nekhotiaeva N, 2003, FASEB J, V17, P394, DOI 10.1096/fj.03-0449fje
   Nisole S, 1999, J BIOL CHEM, V274, P27875, DOI 10.1074/jbc.274.39.27875
   Oehlke J, 1997, FEBS LETT, V415, P196, DOI 10.1016/S0014-5793(97)01123-X
   Padari K, 2005, BIOCONJUGATE CHEM, V16, P1399, DOI 10.1021/bc050125z
   PAGANO JOSEPH S., 1967, J VIROL, V1, P891
   Palm C, 2006, PEPTIDES, V27, P1710, DOI 10.1016/j.peptides.2006.01.006
   Pankov R, 2006, CHEM-BIOL INTERACT, V164, P167, DOI 10.1016/j.cbi.2006.09.010
   PAPAHADJOPOULOS D, 1977, BIOCHIM BIOPHYS ACTA, V465, P579, DOI 10.1016/0005-2736(77)90275-9
   Parenteau J, 2005, FEBS LETT, V579, P4873, DOI 10.1016/j.febslet.2005.07.064
   PATTON JL, 1991, J BACTERIOL, V173, P3101, DOI 10.1128/JB.173.10.3101-3108.1991
   PERSIANI S, 1989, LIFE SCI, V45, P2605, DOI 10.1016/0024-3205(89)90245-2
   Persson D, 2003, BIOCHEMISTRY-US, V42, P421, DOI 10.1021/bi026453t
   Persson D, 2004, BBA-BIOMEMBRANES, V1665, P142, DOI 10.1016/j.bbamem.2004.07.008
   Persson D, 2004, BIOCHEMISTRY-US, V43, P11045, DOI 10.1021/bi036054d
   Persson D, 2001, FEBS LETT, V505, P307, DOI 10.1016/S0014-5793(01)02843-5
   Plank C, 1996, HUM GENE THER, V7, P1437, DOI 10.1089/hum.1996.7.12-1437
   Plenat T, 2005, BIOPHYS J, V89, P4300, DOI 10.1529/biophysj.105.061697
   Plenat T, 2004, LANGMUIR, V20, P9255, DOI 10.1021/la048622b
   Pooga M, 1998, FASEB J, V12, P67
   Poon GMK, 2007, BIOCHEM SOC T, V35, P788, DOI 10.1042/BST0350788
   PRINZ R, 1978, BIOCHEM J, V176, P671, DOI 10.1042/bj1760671
   Prochiantz A, 1996, CURR OPIN NEUROBIOL, V6, P629, DOI 10.1016/S0959-4388(96)80095-X
   Rabenstein DL, 2002, NAT PROD REP, V19, P312, DOI 10.1039/b100916h
   REYNAUD JA, 1993, BIOCHEMISTRY-US, V32, P4997, DOI 10.1021/bi00070a005
   Rhee M, 2006, J BIOL CHEM, V281, P1233, DOI 10.1074/jbc.M509813200
   Richard JP, 2003, J BIOL CHEM, V278, P585, DOI 10.1074/jbc.M209548200
   Roberts MR, 2005, PLANT METHODS, V1, DOI 10.1186/1746-4811-1-12
   Rosenbluh J, 2005, J MOL BIOL, V345, P387, DOI 10.1016/j.jmb.2004.10.046
   Rosenbluh J, 2004, BBA-BIOMEMBRANES, V1664, P230, DOI 10.1016/j.bbamem.2004.06.003
   Ross MF, 2004, BIOCHEM J, V383, P457, DOI 10.1042/BJ20041095
   Rothbard JB, 2005, ADV DRUG DELIVER REV, V57, P495, DOI 10.1016/j.addr.2004.10.003
   Rothbard JB, 2004, J AM CHEM SOC, V126, P9506, DOI 10.1021/ja0482536
   ROUX L, 1988, J BIOL CHEM, V263, P8879
   ROUX M, 1989, BIOCHEMISTRY-US, V28, P2313, DOI 10.1021/bi00431a050
   ROUX M, 1988, EUR BIOPHYS J BIOPHY, V16, P267
   Rusnati M, 1999, J BIOL CHEM, V274, P28198, DOI 10.1074/jbc.274.40.28198
   Rusnati M, 1997, J BIOL CHEM, V272, P11313, DOI 10.1074/jbc.272.17.11313
   RYSER HJP, 1965, SCIENCE, V150, P501, DOI 10.1126/science.150.3695.501
   RYSER HJP, 1982, J CELL PHYSIOL, V113, P167, DOI 10.1002/jcp.1041130126
   RYSER HJP, 1978, LIFE SCI, V22, P1253, DOI 10.1016/0024-3205(78)90094-2
   RYSER HJP, 1976, J CELL PHYSIOL, V87, P221, DOI 10.1002/jcp.1040870210
   Saalik P, 2004, BIOCONJUGATE CHEM, V15, P1246, DOI 10.1021/bc049938y
   Sakai N, 2005, CHEMBIOCHEM, V6, P114, DOI 10.1002/cbic.200400256
   Sakai N, 2003, J AM CHEM SOC, V125, P14348, DOI 10.1021/ja037601l
   Salamon Z, 2003, BIOPHYS J, V84, P1796, DOI 10.1016/S0006-3495(03)74987-X
   SANDERS EJ, 1970, J CELL SCI, V7, P739
   Sandgren S, 2002, J BIOL CHEM, V277, P38877, DOI 10.1074/jbc.M205395200
   SANDSTROM RP, 1989, PLANT PHYSIOL, V90, P1207, DOI 10.1104/pp.90.3.1207
   SCHROEDER F, 1991, BIOCHIM BIOPHYS ACTA, V1066, P183, DOI 10.1016/0005-2736(91)90185-B
   SEILER MW, 1977, LAB INVEST, V36, P48
   Sharonov A, 2007, BIOCHEMISTRY-US, V46, P7963, DOI 10.1021/bi700505h
   SHEN WC, 1981, P NATL ACAD SCI-BIOL, V78, P7589, DOI 10.1073/pnas.78.12.7589
   SHEN WC, 1978, P NATL ACAD SCI USA, V75, P1872, DOI 10.1073/pnas.75.4.1872
   SIEGEL DP, 1986, BIOPHYS J, V49, P1171, DOI 10.1016/S0006-3495(86)83745-6
   SIGAL CT, 1994, P NATL ACAD SCI USA, V91, P12253, DOI 10.1073/pnas.91.25.12253
   Silhol M, 2002, EUR J BIOCHEM, V269, P494, DOI 10.1046/j.0014-2956.2001.02671.x
   Simeoni F, 2003, NUCLEIC ACIDS RES, V31, P2717, DOI 10.1093/nar/gkg385
   STONE AL, 1977, BIOCHIM BIOPHYS ACTA, V497, P298, DOI 10.1016/0304-4165(77)90163-5
   Summerford C, 1998, J VIROL, V72, P1438, DOI 10.1128/JVI.72.2.1438-1445.1998
   Suzuki T, 2002, J BIOL CHEM, V277, P2437, DOI 10.1074/jbc.M110017200
   Takeshima K, 2003, J BIOL CHEM, V278, P1310, DOI 10.1074/jbc.M208762200
   TAKETOMI Y, 1975, THROMB DIATH HAEMOST, V34, P568
   Takeuchi T, 2006, ACS CHEM BIOL, V1, P299, DOI 10.1021/cb600127m
   TANFORD C, 1979, P NATL ACAD SCI USA, V76, P4175, DOI 10.1073/pnas.76.9.4175
   Terrone D, 2003, BIOCHEMISTRY-US, V42, P13787, DOI 10.1021/bi035293y
   Thoren PEG, 2000, FEBS LETT, V482, P265, DOI 10.1016/S0014-5793(00)02072-X
   Thoren PEG, 2005, BIOPHYS CHEM, V114, P169, DOI 10.1016/j.bpc.2004.11.016
   Thoren PEG, 2004, BIOCHEMISTRY-US, V43, P3471, DOI 10.1021/bi0360049
   Thoren PEG, 2003, BIOCHEM BIOPH RES CO, V307, P100, DOI 10.1016/S0006-291X(03)01135-5
   Tiriveedhi V, 2007, BIOCHEMISTRY-US, V46, P3888, DOI 10.1021/bi602527t
   Tkachenko E, 2002, J BIOL CHEM, V277, P19946, DOI 10.1074/jbc.M200841200
   Trehin R, 2004, PHARM RES-DORDR, V21, P1248, DOI 10.1023/B:PHAM.0000033013.45204.c3
   Tunnemann G, 2006, FASEB J, V20, P1775, DOI 10.1096/fj.05-5523com
   TVELD GI, 1993, FEMS MICROBIOL REV, V12, P293
   Tyagi M, 2001, J BIOL CHEM, V276, P3254, DOI 10.1074/jbc.M006701200
   Van Mau N, 1999, J MEMBRANE BIOL, V167, P241
   VANDERREST ME, 1995, MICROBIOL REV, V59, P304, DOI 10.1128/MMBR.59.2.304-322.1995
   VANHOLDE KE, 1998, PRINCIPLES PHYS BIOC, P604
   Vie V, 2000, BIOPHYS J, V78, P846, DOI 10.1016/S0006-3495(00)76642-2
   Violini S, 2002, BIOCHEMISTRY-US, V41, P12652, DOI 10.1021/bi026097e
   Vives E, 1997, J BIOL CHEM, V272, P16010, DOI 10.1074/jbc.272.25.16010
   Wadia JS, 2005, ADV DRUG DELIVER REV, V57, P579, DOI 10.1016/j.addr.2004.10.005
   Wagner K, 2004, BIOCHEMISTRY-US, V43, P12459, DOI 10.1021/bi049181y
   Wagner K, 2004, BIOPHYS J, V87, P386, DOI 10.1529/biophysj.103.036921
   Weller K, 2005, BIOCHEMISTRY-US, V44, P15799, DOI 10.1021/bi051535d
   Wender PA, 2000, P NATL ACAD SCI USA, V97, P13003, DOI 10.1073/pnas.97.24.13003
   WHITE SH, 1994, CURR OPIN STRUC BIOL, V4, P79, DOI 10.1016/S0959-440X(94)90063-9
   Wieprecht T, 2002, BIOPHYS CHEM, V96, P191, DOI 10.1016/S0301-4622(02)00025-X
   WROBEL I, 1995, BBA-BIOMEMBRANES, V1235, P296, DOI 10.1016/0005-2736(95)80017-A
   WUDUNN D, 1989, J VIROL, V63, P52, DOI 10.1128/JVI.63.1.52-58.1989
   Yandek LE, 2007, BIOPHYS J, V92, P2434, DOI 10.1529/biophysj.106.100198
   YOSHINO Y, 1990, JPN J PHARMACOL, V52, P387, DOI 10.1254/jjp.52.387
   ZACHOWSKI A, 1993, BIOCHEM J, V294, P1
   Zaro JL, 2005, EXP CELL RES, V307, P164, DOI 10.1016/j.yexcr.2005.02.024
   Zaro JL, 2003, BIOCHEM BIOPH RES CO, V307, P241, DOI 10.1016/S0006-291X(03)01167-7
   Zelphati O, 1996, PHARMACEUT RES, V13, P1367, DOI 10.1023/A:1016026101195
   Zhang W, 1996, P NATL ACAD SCI USA, V93, P2511, DOI 10.1073/pnas.93.6.2511
   Zhang WT, 1999, BIOPHYS J, V76, P1008, DOI 10.1016/S0006-3495(99)77265-6
   Zhang XP, 2004, MOL PHARMACEUT, V1, P145, DOI 10.1021/mp034014y
   Ziegler A, 2006, J CHROMATOGR B, V837, P76, DOI 10.1016/j.jchromb.2006.04.013
   Ziegler A, 2005, BIOCHEMISTRY-US, V44, P138, DOI 10.1021/bi0491604
   Ziegler A, 2004, BIOPHYS J, V86, P254, DOI 10.1016/S0006-3495(04)74101-6
   Ziegler A, 2003, BIOCHEMISTRY-US, V42, P9185, DOI 10.1021/bi0346805
   Ziegler A, 2007, BIOCHEMISTRY-US, V46, P8138, DOI 10.1021/bi700416h
   Zorko M, 2005, ADV DRUG DELIVER REV, V57, P529, DOI 10.1016/j.addr.2004.10.010
NR 291
TC 188
Z9 193
U1 0
U2 40
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0169-409X
EI 1872-8294
J9 ADV DRUG DELIVER REV
JI Adv. Drug Deliv. Rev.
PD MAR 1
PY 2008
VL 60
IS 4-5
BP 580
EP 597
DI 10.1016/j.addr.2007.10.005
PG 18
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 275JP
UT WOS:000254068000013
PM 18045730
DA 2021-01-25
ER

PT J
AU Knechtle, B
   Knechtle, P
   Kohler, G
AF Knechtle, Beat
   Knechtle, Patrizia
   Kohler, Goetz
TI No correlation, of anthropometry and race performance in ultra-endurance
   swimmers at a 12-hours-swim
SO ANTHROPOLOGISCHER ANZEIGER
LA English
DT Article
DE body mass index; BMI; skeletal muscle mass; fat mass; endurance
   performance
ID BODY-COMPOSITION; SKINFOLD THICKNESSES; SWIMMING PERFORMANCE; DISTANCE;
   RUNNERS; MASS
AB Background: In swimmers, the effects of the anthropometric factors, upper extremity length, hand length and body height, on performance over 100 in have been shown, but no data exist about the influence of anthropometric factors on performance in ultraendurance swimmers. Subjects and methods: Twelve male Caucasian ultra-swimmers participated in our study at the 9(th) edition in 2007 of the 12-hours-swim in Zurich, Switzerland. We determined body mass, length of arms and legs, body height, circumferences of extremities, skeletal muscle mass and fat mass in order to correlate with the covered distance and to find an effect on race performance. Results: The 12 swimmers achieved an average distance of 29.4 +/- 5.1 km, varying from 22.8 km to 39.1 km during these 12 hours. There was no correlation between body mass, length of arms and legs, body height, circumferences of extremities, skeletal muscle mass and fat mass to race performance. Conclusion: In these 12 male ultraendurance swimmers no effect of the anthropometric parameters body mass, body height, BMI, circumferences of extremities, length of arms and legs, skeletal muscle mass and fat mass, on performance in a 12-hours-swim has been found.
C1 [Knechtle, Beat; Knechtle, Patrizia] Gesundheitszentrum St Gallen, Facharzt FMH Allgemeinmed, CH-9001 St Gallen, Switzerland.
   [Kohler, Goetz] Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
RP Knechtle, B (corresponding author), Gesundheitszentrum St Gallen, Facharzt FMH Allgemeinmed, Vadianstr 26, CH-9001 St Gallen, Switzerland.
EM beat.knechtle@hispeed.ch
CR Arrese AL, 2006, J SPORT SCI, V24, P69, DOI 10.1080/02640410500127751
   Bale P, 1986, Br J Sports Med, V20, P170
   Ball SD, 2004, EUR J CLIN NUTR, V58, P1525, DOI 10.1038/sj.ejcn.1602003
   Bircher S, 2006, J SPORT SCI MED, V5, P154
   Geladas ND, 2005, INT J SPORTS MED, V26, P139, DOI 10.1055/s-2004-817862
   Hagan R D, 1987, Br J Sports Med, V21, P3
   HATFIELD HS, 1951, NATURE, V168, P918, DOI 10.1038/168918a0
   Helge JW, 2003, J EXP BIOL, V206, P1075, DOI 10.1242/jeb.00218
   Jagomagi Gennadi, 2005, Anthropologischer Anzeiger, V63, P213
   Keatinge WR, 2001, BRIT J SPORT MED, V35, P352, DOI 10.1136/bjsm.35.5.352
   Knechtle B, 2005, Praxis (Bern 1994), V94, P371
   Knechtle B, 2005, INT J SPORTS MED, V26, P499, DOI 10.1055/s-2004-821136
   Landers GJ, 2000, ANN HUM BIOL, V27, P387, DOI 10.1080/03014460050044865
   Lee RC, 2000, AM J CLIN NUTR, V72, P796
   Legaz A, 2005, BRIT J SPORT MED, V39, P851, DOI 10.1136/bjsm.2005.018960
   Maldonado S, 2002, INT J SPORTS MED, V23, P268, DOI 10.1055/s-2002-29083
   PUGH LGC, 1955, LANCET, V2, P761
   *R DEV COR TEAM, 2006, LANG ENV STAT COMP R
   Sharwood K, 2002, CLIN J SPORT MED, V12, P391, DOI 10.1097/00042752-200211000-00012
   SIDERS WA, 1993, J SPORT MED PHYS FIT, V33, P166
   TANAKA K, 1982, ANN HUM BIOL, V9, P473, DOI 10.1080/03014468200006001
   Tuuri G, 2002, MED SCI SPORT EXER, V34, P2110, DOI 10.1097/00005768-200212000-00037
NR 22
TC 10
Z9 10
U1 0
U2 1
PU E SCHWEIZERBARTSCHE VERLAGS
PI STUTTGART
PA NAEGELE U OBERMILLER, SCIENCE PUBLISHERS, JOHANNESSTRASSE 3A, D 70176
   STUTTGART, GERMANY
SN 0003-5548
J9 ANTHROPOL ANZ
JI Anthropol. Anz.
PD MAR
PY 2008
VL 66
IS 1
BP 73
EP 79
DI 10.1127/aa/66/2008/73
PG 7
WC Anthropology
SC Anthropology
GA 283SP
UT WOS:000254657100006
PM 18435207
DA 2021-01-25
ER

PT J
AU Rowat, AC
   Lammerding, J
   Herrmann, H
   Aebi, U
AF Rowat, Amy C.
   Lammerding, Jan
   Herrmann, Harald
   Aebi, Ueli
TI Towards an integrated understanding of the structure and mechanics of
   the cell nucleus
SO BIOESSAYS
LA English
DT Review
ID ACTIN-BINDING PROTEINS; LAMIN-A; DEVELOPMENTAL CONTROL;
   SPATIAL-ORGANIZATION; CYCLE PROGRESSION; MEMBRANE; ENVELOPE; CHROMATIN;
   SHAPE; CYTOSKELETAL
AB Changes in the shape and structural organization of the cell nucleus occur during many fundamental processes including development, differentiation and aging. In many of these processes, the cell responds to physical forces by altering gene expression within the nucleus. How the nucleus itself senses and responds to such mechanical cues is not well understood. In addition to these external forces, epigenetic modifications of chromatin structure inside the nucleus could also alter its physical properties. To achieve a better understanding, we need to elucidate the relationship between nuclear structure and material properties. Recently, new approaches have been developed to systematically investigate nuclear mechanical properties. These experiments provide important new insights into the disease mechanism of a growing class of tissue-specific disorders termed 'nuclear envelopathies'. Here we review our current understanding of what determines the shape and mechanical properties of the cell nucleus.
C1 [Rowat, Amy C.] Harvard Univ, Sch Engn & Appl Sci, Dept Phys, Engn & Sci Lab, Cambridge, MA 02138 USA.
   [Lammerding, Jan] Harvard Univ, Sch Med, Brigham & Womens Hosp, Boston, MA USA.
   [Herrmann, Harald] German Canc Res Ctr, Div Mol Genet, Heidelberg, Germany.
   [Aebi, Ueli] Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, Basel, Switzerland.
RP Rowat, AC (corresponding author), Harvard Univ, Sch Engn & Appl Sci, Dept Phys, Engn & Sci Lab, 40 Oxford St, Cambridge, MA 02138 USA.
EM rowat@seas.harvard.edu
RI Lammerding, Jan/A-9498-2016
OI Lammerding, Jan/0000-0003-4335-8611
FU NHLBI NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Heart Lung & Blood
   Institute (NHLBI) [HL082792, R01 HL082792] Funding Source: Medline;
   NINDS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [NS059348] Funding Source: Medline; NATIONAL
   HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health &
   Human ServicesNational Institutes of Health (NIH) - USANIH National
   Heart Lung & Blood Institute (NHLBI) [R01HL082792, R01HL082792,
   R01HL082792, R01HL082792, R01HL082792, R01HL082792, R01HL082792,
   R01HL082792, R01HL082792, R01HL082792] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS059348, R01NS059348, R01NS059348, R01NS059348, R01NS059348,
   R01NS059348] Funding Source: NIH RePORTER
CR AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   ANKENBAUER T, 1989, NATURE, V342, P822, DOI 10.1038/342822a0
   Bacher CP, 2004, BMC CELL BIOL, V5, DOI 10.1186/1471-2121-5-45
   BELMONT AS, 1993, J CELL BIOL, V123, P1671, DOI 10.1083/jcb.123.6.1671
   BENZEEV A, 1980, CELL, V21, P365, DOI 10.1016/0092-8674(80)90473-0
   BEREZNEY R, 1974, BIOCHEM BIOPH RES CO, V60, P1410, DOI 10.1016/0006-291X(74)90355-6
   Blessing CA, 2004, TRENDS CELL BIOL, V14, P435, DOI 10.1016/j.tcb.2004.07.009
   Bohnsack MT, 2006, NAT CELL BIOL, V8, P257, DOI 10.1038/ncb1357
   Brandt A, 2006, CURR BIOL, V16, P543, DOI 10.1016/j.cub.2006.01.051
   BRIDGER JM, 1993, J CELL SCI, V104, P297
   Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005
   Broers JLV, 2005, EXP CELL RES, V304, P582, DOI 10.1016/j.yexcr.2004.11.020
   Broers JLV, 2004, HUM MOL GENET, V13, P2567, DOI 10.1093/hmg/ddh295
   Burke B, 2006, ANNU REV GENOM HUM G, V7, P369, DOI 10.1146/annurev.genom.7.080505.115732
   Caille N, 1998, ANN BIOMED ENG, V26, P409, DOI 10.1114/1.132
   Caille N, 2002, J BIOMECH, V35, P177, DOI 10.1016/S0021-9290(01)00201-9
   Cao K, 2007, P NATL ACAD SCI USA, V104, P4949, DOI 10.1073/pnas.0611640104
   CAPCO DG, 1982, CELL, V29, P847, DOI 10.1016/0092-8674(82)90446-9
   Capell BC, 2006, NAT REV GENET, V7, P940, DOI 10.1038/nrg1906
   CARMOFONSECA M, 1988, EUR J CELL BIOL, V45, P282
   Cremer T, 2006, CURR OPIN CELL BIOL, V18, P307, DOI 10.1016/j.ceb.2006.04.007
   Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124
   CTEMER T, 2004, BIOL CELL, V96, P555
   Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554
   Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357
   Dahl KN, 2006, P NATL ACAD SCI USA, V103, P10271, DOI 10.1073/pnas.0601058103
   Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089
   de Vries AHB, 2007, NANO LETT, V7, P1424, DOI 10.1021/nl070603+
   Dechat T, 2007, P NATL ACAD SCI USA, V104, P4955, DOI 10.1073/pnas.0700854104
   DONG C, 1991, BIORHEOLOGY, V28, P557
   FEY EG, 1984, J CELL BIOL, V98, P1973, DOI 10.1083/jcb.98.6.1973
   Fidzianska A, 1998, J NEUROL SCI, V159, P88, DOI 10.1016/S0022-510X(98)00130-0
   FOLKMAN J, 1978, NATURE, V273, P345, DOI 10.1038/273345a0
   FRANKE WW, 1970, J CELL BIOL, V46, P379, DOI 10.1083/jcb.46.2.379
   Fricker M, 1997, J CELL BIOL, V136, P531, DOI 10.1083/jcb.136.3.531
   FURUKAWA K, 1993, EMBO J, V12, P97, DOI 10.1002/j.1460-2075.1993.tb05635.x
   GEORGATOS SD, 1987, P NATL ACAD SCI USA, V84, P6780, DOI 10.1073/pnas.84.19.6780
   GOLDMAN AE, 1992, J CELL BIOL, V119, P725, DOI 10.1083/jcb.119.4.725
   Goldman RD, 2004, P NATL ACAD SCI USA, V101, P8963, DOI 10.1073/pnas.0402943101
   Gorisch S, 2005, HISTOCHEM CELL BIOL, V123, P217, DOI 10.1007/s00418-005-0752-y
   Gotzmann J, 2006, HISTOCHEM CELL BIOL, V125, P33, DOI 10.1007/s00418-005-0050-8
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   Guilak F, 1995, J BIOMECH, V28, P1529, DOI 10.1016/0021-9290(95)00100-X
   Guilak F, 2000, BIOCHEM BIOPH RES CO, V269, P781, DOI 10.1006/bbrc.2000.2360
   Guillemin K, 2001, NAT CELL BIOL, V3, P848, DOI 10.1038/ncb0901-848
   Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI 10.1073/pnas.0506755102
   Hancock R, 2004, J STRUCT BIOL, V146, P281, DOI 10.1016/j.jsb.2003.12.008
   Handwerger KE, 2005, MOL BIOL CELL, V16, P202, DOI 10.1091/mbc.E04-08-0742
   Harborth J, 2001, J CELL SCI, V114, P4557
   HENNEKES H, 1994, J CELL SCI, V107, P1019
   Hoffmann K, 2007, CHROMOSOMA, V116, P227, DOI 10.1007/s00412-007-0094-8
   Holaska JM, 2004, PLOS BIOL, V2, P1354, DOI 10.1371/journal.pbio.0020231
   Houben F, 2007, BBA-MOL CELL RES, V1773, P675, DOI 10.1016/j.bbamcr.2006.09.018
   Huang HD, 2004, AM J PHYSIOL-CELL PH, V287, pC1, DOI 10.1152/ajpcell.00559.2003
   Ingber DE, 2003, ANN MED, V35, P564, DOI 10.1080/07853890310016333
   INOUE S, 1995, MOL BIOL CELL, V6, P1619
   Ji JY, 2007, J BIOL CHEM, V282, P20015, DOI 10.1074/jbc.M611094200
   Jiang GY, 2006, BIOPHYS J, V90, P1804, DOI 10.1529/biophysj.105.072462
   Kasza KE, 2007, CURR OPIN CELL BIOL, V19, P101, DOI 10.1016/j.ceb.2006.12.002
   KHANDWALA AS, 1971, J BIOL CHEM, V246, P6242
   KITTEN GT, 1991, J CELL BIOL, V113, P13, DOI 10.1083/jcb.113.1.13
   Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092
   Lammerding J, 2005, J CELL BIOL, V170, P781, DOI 10.1083/jcb.200502148
   LARNMERDING J, 2004, J CLIN INVEST, V113, P370
   Lee JSH, 2007, BIOPHYS J, V93, P2542, DOI 10.1529/biophysj.106.102426
   Libotte T, 2005, MOL BIOL CELL, V16, P3411, DOI 10.1091/mbc.E04-11-1009
   Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937
   LUTZ RJ, 1992, P NATL ACAD SCI USA, V89, P3000, DOI 10.1073/pnas.89.7.3000
   Mallampalli MP, 2005, P NATL ACAD SCI USA, V102, P14416, DOI 10.1073/pnas.0503712102
   Maniotis AJ, 1997, P NATL ACAD SCI USA, V94, P849, DOI 10.1073/pnas.94.3.849
   Markiewicz E, 2002, J STRUCT BIOL, V140, P241, DOI 10.1016/S1047-8477(02)00573-7
   Meshorer E, 2007, HISTOL HISTOPATHOL, V22, P311, DOI 10.14670/HH-22.311
   Mislow JMK, 2002, FEBS LETT, V525, P135, DOI 10.1016/S0014-5793(02)03105-8
   Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179
   Moir RD, 2000, J CELL BIOL, V151, P1155, DOI 10.1083/jcb.151.6.1155
   Nickerson JA, 2001, J CELL SCI, V114, P463
   PADDOCK SW, 1988, EXP CELL RES, V175, P409, DOI 10.1016/0014-4827(88)90205-4
   PADDY MR, 1990, CELL, V62, P89, DOI 10.1016/0092-8674(90)90243-8
   Pederson T, 2000, MOL BIOL CELL, V11, P799, DOI 10.1091/mbc.11.3.799
   Pederson T, 2005, MOL BIOL CELL, V16, P5055, DOI 10.1091/mbc.E05-07-0656
   Pederson T, 2004, CURR OPIN GENET DEV, V14, P203, DOI 10.1016/j.gde.2004.02.008
   Percipalle P, 2006, J CELL BIOL, V172, P967, DOI 10.1083/jcb.200512083
   Pilot F, 2006, DEVELOPMENT, V133, P711, DOI 10.1242/dev.02251
   Prufert K, 2004, J CELL SCI, V117, P6105, DOI 10.1242/jcs.01532
   Ralle T, 2004, J CELL SCI, V117, P6095, DOI 10.1242/jcs.01528
   Reinsch S, 1998, J CELL SCI, V111, P2283
   Richter K, 2007, J CELL SCI, V120, P1673, DOI 10.1242/jcs.03440
   Rowat AC, 2006, BIOPHYS J, V91, P4649, DOI 10.1529/biophysj.106.086454
   Rowat AC, 2005, J R SOC INTERFACE, V2, P63, DOI 10.1098/rsif.2004.0022
   Rowat AC, 2005, BBA-BIOMEMBRANES, V1713, P29, DOI 10.1016/j.bbamem.2005.04.014
   Sasseville AMJ, 1998, FEBS LETT, V425, P485, DOI 10.1016/S0014-5793(98)00294-4
   SCHEER U, 1984, CELL, V39, P111, DOI 10.1016/0092-8674(84)90196-X
   Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176
   SIMS JR, 1992, J CELL SCI, V103, P1215
   Starr DA, 2002, SCIENCE, V298, P406, DOI 10.1126/science.1075119
   Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913
   Thakar R, 2006, J CELL SCI, V119, P4165, DOI 10.1242/jcs.03183
   Toth JI, 2005, P NATL ACAD SCI USA, V102, P12873, DOI 10.1073/pnas.0505767102
   Tseng Y, 2004, J CELL SCI, V117, P2159, DOI 10.1242/jcs.01073
   Vigouroux C, 2001, J CELL SCI, V114, P4459
   WANG X, 1989, EUR J CELL BIOL, V50, P462
   WATSON PA, 1991, FASEB J, V5, P2013
   Worman HJ, 2006, TRENDS CELL BIOL, V16, P67, DOI 10.1016/j.tcb.2005.12.006
   Yeung T, 2005, CELL MOTIL CYTOSKEL, V60, P24, DOI 10.1002/cm.20041
   Zhang QP, 2005, J CELL SCI, V118, P673, DOI 10.1242/jcs.01642
   Zhang QP, 2002, GENOMICS, V80, P473, DOI 10.1006/geno.2002.6859
   Zhen YY, 2002, J CELL SCI, V115, P3207
   Zink D, 2004, NAT REV CANCER, V4, P677, DOI 10.1038/nrc1430
NR 108
TC 78
Z9 81
U1 1
U2 24
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 0265-9247
EI 1521-1878
J9 BIOESSAYS
JI Bioessays
PD MAR
PY 2008
VL 30
IS 3
BP 226
EP 236
DI 10.1002/bies.20720
PG 11
WC Biochemistry & Molecular Biology; Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics
GA 273VS
UT WOS:000253960600005
PM 18293361
DA 2021-01-25
ER

PT J
AU Jayachandran, R
   Gatfield, J
   Massner, J
   Albrecht, I
   Zanolari, B
   Pieters, J
AF Jayachandran, Rajesh
   Gatfield, John
   Massner, Jan
   Albrecht, Imke
   Zanolari, Bettina
   Pieters, Jean
TI RNA interference in J774 macrophages reveals a role for coronin 1 in
   mycobacterial trafficking but not in actin-dependent processes
SO MOLECULAR BIOLOGY OF THE CELL
LA English
DT Article
ID PROTEIN-KINASE-G; BINDING-PROTEIN; PHOSPHOINOSITIDE 3-KINASE;
   MICROTUBULE CYTOSKELETONS; INTRACELLULAR SURVIVAL; TRANSIENT
   ASSOCIATION; PHAGOSOME MATURATION; DENDRITIC CELLS; BOVIS BCG; WD REPEAT
AB Macrophages are crucial for innate immunity, apoptosis, and tissue remodeling, processes that rely on the capacity of macrophages to internalize and process cargo through phagocytosis. Coronin 1, a member of the WD repeat protein family of coronins specifically expressed in leukocytes, was originally identified as a molecule that is recruited to mycobacterial phagosomes and prevents the delivery of mycobacteria to lysosomes, allowing these to survive within phagosomes. However, a role for coronin 1 in mycobacterial pathogenesis has been disputed in favor for its role in mediating phagocytosis and cell motility. In this study, a role for coronin 1 in actin-mediated cellular processes was addressed using RNA interference in the murine macrophage cell line J774. It is shown that the absence of coronin 1 in J774 macrophages expressing small interfering RNA constructs specific for coronin 1 does not affect phagocytosis, macropinocytosis, cell locomotion, or regulation of NADPH oxidase activity. However, in coronin 1-negative J774 cells, internalized mycobacteria were rapidly transferred to lysosomes and killed. Therefore, these results show that in J774 cells coronin 1 has a specific role in modulating phagosome-lysosome transport upon mycobacterial infection and that it is dispensable for most F-actin-mediated cytoskeletal rearrangements.
C1 [Jayachandran, Rajesh; Gatfield, John; Massner, Jan; Albrecht, Imke; Zanolari, Bettina; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
FU Swiss National Science FoundationSwiss National Science Foundation
   (SNSF); World Health OrganizationWorld Health Organization; Swiss Life
   Jubilaeumsstiftung
FX We thank Anna Melone for the generation and analysis of macrophages
   expressing coronin 1-fluorescent protein fusions. This work was
   supported by grants from the Swiss National Science Foundation, the
   World Health Organization, and the Swiss Life Jubilaeumsstiftung (to J.
   P.).
CR Aderem A, 1999, ANNU REV IMMUNOL, V17, P593, DOI 10.1146/annurev.immunol.17.1.593
   Allen LAH, 1999, BLOOD, V93, P3521, DOI 10.1182/blood.V93.10.3521.410k21_3521_3530
   Amyere M, 2000, MOL BIOL CELL, V11, P3453, DOI 10.1091/mbc.11.10.3453
   Araki N, 1996, J CELL BIOL, V135, P1249, DOI 10.1083/jcb.135.5.1249
   Brummelkamp TR, 2002, SCIENCE, V296, P550, DOI 10.1126/science.1068999
   David V, 1998, J CELL SCI, V111, P2877
   de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7
   DEHOSTOS EL, 1991, EMBO J, V10, P4097, DOI 10.1002/j.1460-2075.1991.tb04986.x
   DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163
   Ferrari G, 1997, J CELL BIOL, V139, P1433, DOI 10.1083/jcb.139.6.1433
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563
   Gatfield J, 2000, SCIENCE, V288, P1647, DOI 10.1126/science.288.5471.1647
   Gatfield J, 2005, MOL BIOL CELL, V16, P2786, DOI 10.1091/mbc.E05-01-0042
   GERISCH G, 1993, SYM SOC EXP BIOL, V47, P297
   Goode BL, 1999, J CELL BIOL, V144, P83, DOI 10.1083/jcb.144.1.83
   Grogan A, 1997, J CELL SCI, V110, P3071
   Guerin I, 2000, INFECT IMMUN, V68, P2655, DOI 10.1128/IAI.68.5.2655-2662.2000
   Heil-Chapdelaine RA, 1998, CURR BIOL, V8, P1281, DOI 10.1016/S0960-9822(07)00539-8
   Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113
   Itoh S, 2002, BIOL PHARM BULL, V25, P837, DOI 10.1248/bpb.25.837
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Johannes L, 2002, TRAFFIC, V3, P443, DOI 10.1034/j.1600-0854.2002.30701.x
   MANIAK M, 1995, CELL, V83, P915, DOI 10.1016/0092-8674(95)90207-4
   Nal B, 2004, INT IMMUNOL, V16, P231, DOI 10.1093/intimm/dxh022
   Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005
   Okumura M, 1998, DNA CELL BIOL, V17, P779, DOI 10.1089/dna.1998.17.779
   Pantaloni D, 2001, SCIENCE, V292, P1502, DOI 10.1126/science.1059975
   Parente JA, 1999, J BIOL CHEM, V274, P3017, DOI 10.1074/jbc.274.5.3017
   Pieters J, 2001, CURR OPIN IMMUNOL, V13, P37, DOI 10.1016/S0952-7915(00)00179-5
   Rybakin V, 2005, BIOESSAYS, V27, P625, DOI 10.1002/bies.20235
   Scherr N, 2007, P NATL ACAD SCI USA, V104, P12151, DOI 10.1073/pnas.0702842104
   Schuller S, 2001, CELL MICROBIOL, V3, P785, DOI 10.1046/j.1462-5822.2001.00155.x
   Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5
   STEINMAN RM, 1995, J EXP MED, V182, P283, DOI 10.1084/jem.182.2.283
   SUZUKI K, 1995, FEBS LETT, V364, P283, DOI 10.1016/0014-5793(95)00393-N
   Tailleux L, 2003, J IMMUNOL, V170, P1939, DOI 10.4049/jimmunol.170.4.1939
   TULP A, 1994, NATURE, V369, P120, DOI 10.1038/369120a0
   Vieira OV, 2002, BIOCHEM J, V366, P689, DOI 10.1042/BJ20020691
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   Yan M, 2005, MOL BIOL CELL, V16, P3077, DOI 10.1091/mbc.E04-11-0989
   Zheng PY, 2003, CELL MICROBIOL, V5, P25, DOI 10.1046/j.1462-5822.2003.00250.x
NR 42
TC 46
Z9 47
U1 0
U2 4
PU AMER SOC CELL BIOLOGY
PI BETHESDA
PA 8120 WOODMONT AVE, STE 750, BETHESDA, MD 20814-2755 USA
SN 1059-1524
J9 MOL BIOL CELL
JI Mol. Biol. Cell
PD MAR
PY 2008
VL 19
IS 3
BP 1241
EP 1251
DI 10.1091/mbc.E07-07-0640
PG 11
WC Cell Biology
SC Cell Biology
GA 344TY
UT WOS:000258951400041
PM 18162581
OA Green Published, Green Accepted
DA 2021-01-25
ER

PT J
AU Sinkkonen, L
   Hugenschmidt, T
   Berninger, P
   Gaidatzis, D
   Mohn, F
   Artus-Revel, CG
   Zavolan, M
   Svoboda, P
   Filipowicz, W
AF Sinkkonen, Lasse
   Hugenschmidt, Tabea
   Berninger, Philipp
   Gaidatzis, Dimos
   Mohn, Fabio
   Artus-Revel, Caroline G.
   Zavolan, Mihaela
   Svoboda, Petr
   Filipowicz, Witold
TI MicroRNAs control de novo DNA methylation through regulation of
   transcriptional repressors in mouse embryonic stem cells
SO NATURE STRUCTURAL & MOLECULAR BIOLOGY
LA English
DT Article
ID EXPRESSION; DICER; DNMT3A; GENES; OCT4; BIOGENESIS; TRANSITION;
   MECHANISMS; TARGETS; MIRNAS
AB Loss of microRNA (miRNA) pathway components negatively affects differentiation of embryonic stem (ES) cells, but the underlying molecular mechanisms remain poorly defined. Here we characterize changes in mouse ES cells lacking Dicer (Dicer1). Transcriptome analysis of Dicer(-/-) cells indicates that the ES-specific miR-290 cluster has an important regulatory function in undifferentiated ES cells. Consistently, many of the defects in Dicer-deficient cells can be reversed by transfection with miR-290 family miRNAs. We demonstrate that Oct4 (also known as Pou5f1) silencing in differentiating Dicer(-/-) ES cells is accompanied by accumulation of repressive histone marks but not by DNA methylation, which prevents the stable repression of Oct4. The methylation defect correlates with downregulation of de novo DNA methyltransferases (Dnmts). The downregulation is mediated by Rbl2 and possibly other transcriptional repressors, potential direct targets of miR-290 cluster miRNAs. The defective DNA methylation can be rescued by ectopic expression of de novo Dnmts or by transfection of the miR-290 cluster miRNAs, indicating that de novo DNA methylation in ES cells is controlled by miRNAs.
C1 [Svoboda, Petr] Acad Sci Czech Republ, Inst Mol Genet, Prague, Czech Republic.
   [Sinkkonen, Lasse; Hugenschmidt, Tabea; Mohn, Fabio; Artus-Revel, Caroline G.; Filipowicz, Witold] Friedrich Miescher Inst Biomed Res, CH-4058 Basel, Switzerland.
   [Berninger, Philipp; Gaidatzis, Dimos; Zavolan, Mihaela] Univ Basel, Biozentrum, Div Bioinformat, CH-4056 Basel, Switzerland.
   [Berninger, Philipp; Gaidatzis, Dimos; Zavolan, Mihaela] Swiss Inst Bioinformat, Basel, Switzerland.
RP Svoboda, P (corresponding author), Acad Sci Czech Republ, Inst Mol Genet, Videnska 1083, Prague, Czech Republic.
EM svobodap@img.cas.cz; filipowi@fmi.ch
RI Svoboda, Petr/AAC-1501-2020; Svoboda, Petr/G-3890-2012; Zavolan,
   Mihaela/S-3888-2016
OI Svoboda, Petr/0000-0002-4370-3705; Zavolan, Mihaela/0000-0002-8832-2041;
   Mohn, Fabio/0000-0001-9889-5225
CR Aapola U, 2004, BIOCHEM J, V380, P705, DOI 10.1042/BJ20040067
   Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871
   Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020
   Brennecke J, 2005, PLOS BIOL, V3, P404, DOI 10.1371/journal.pbio.0030085
   Bushati N, 2007, ANNU REV CELL DEV BI, V23, P175, DOI 10.1146/annurev.cellbio.23.090506.123406
   Chen TP, 2003, MOL CELL BIOL, V23, P5594, DOI 10.1128/MCB.23.16.5594-5605.2003
   Chen TP, 2002, J BIOL CHEM, V277, P38746, DOI 10.1074/jbc.M205312200
   Choi WY, 2007, SCIENCE, V318, P271, DOI 10.1126/science.1147535
   Dotto GP, 2000, BBA-REV CANCER, V1471, pM43, DOI 10.1016/S0304-419X(00)00019-6
   Fabbri M, 2007, P NATL ACAD SCI USA, V104, P15805, DOI 10.1073/pnas.0707628104
   Feldman N, 2006, NAT CELL BIOL, V8, P188, DOI 10.1038/ncb1353
   Gartel AL, 2005, CANCER RES, V65, P3980, DOI 10.1158/0008-5472.CAN-04-3995
   Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689
   Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112
   Gu PL, 2006, MOL CELL BIOL, V26, P9471, DOI 10.1128/MCB.00898-06
   Harris TW, 2004, NUCLEIC ACIDS RES, V32, pD411, DOI 10.1093/nar/gkh066
   He L, 2005, NATURE, V435, P828, DOI 10.1038/nature03552
   He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379
   Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2
   Ishida C, 2003, GENE, V310, P151, DOI 10.1016/S0378-1119(03)00545-6
   Jinawath A, 2005, BIOCHEM J, V385, P557, DOI 10.1042/BJ20040684
   Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505
   Kim VN, 2005, NAT REV MOL CELL BIO, V6, P376, DOI 10.1038/nrm1644
   Kotaja N, 2006, P NATL ACAD SCI USA, V103, P2647, DOI 10.1073/pnas.0509333103
   Krutzfeldt J, 2005, NATURE, V438, P685, DOI 10.1038/nature04303
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035
   Li JY, 2007, MOL CELL BIOL, V27, P8748, DOI 10.1128/MCB.01380-07
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Litovchick L, 2007, MOL CELL, V26, P539, DOI 10.1016/j.molcel.2007.04.015
   Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760
   Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873
   Murakami M, 2004, MOL CELL BIOL, V24, P6710, DOI 10.1128/mcb.24.15.6710-6718.2004
   Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102
   Nimura K, 2006, GENES CELLS, V11, P1225, DOI 10.1111/j.1365-2443.2006.01012.x
   Nordhoff V, 2001, MAMM GENOME, V12, P309, DOI 10.1007/s003350010279
   Okabe M, 1997, FEBS LETT, V407, P313, DOI 10.1016/S0014-5793(97)00313-X
   Pillai RS, 2007, TRENDS CELL BIOL, V17, P118, DOI 10.1016/j.tcb.2006.12.007
   Rajewsky N, 2006, NAT GENET, V38, pS8, DOI 10.1038/ng1798
   Robertson KD, 2000, NUCLEIC ACIDS RES, V28, P2108, DOI 10.1093/nar/28.10.2108
   Schmitter D, 2006, NUCLEIC ACIDS RES, V34, P4801, DOI 10.1093/nar/gkl646
   Schultz RM, 2002, HUM REPROD UPDATE, V8, P323, DOI 10.1093/humupd/8.4.323
   Sinkkonen L, 2005, NUCLEIC ACIDS RES, V33, P2440, DOI 10.1093/nar/gki502
   Smith AG, 2001, ANNU REV CELL DEV BI, V17, P435, DOI 10.1146/annurev.cellbio.17.1.435
   Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199
   Suh MR, 2004, DEV BIOL, V270, P488, DOI 10.1016/j.ydbio.2004.02.019
   Svoboda P, 2004, NUCLEIC ACIDS RES, V32, P3601, DOI 10.1093/nar/gkh697
   Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707
   Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806
   Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969
   Zamore PD, 2005, SCIENCE, V309, P1519, DOI 10.1126/science.1111444
   Zeng FY, 2004, DEV BIOL, V272, P483, DOI 10.1016/j.ydbio.2004.05.018
   Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663
NR 54
TC 347
Z9 372
U1 4
U2 36
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1545-9993
EI 1545-9985
J9 NAT STRUCT MOL BIOL
JI Nat. Struct. Mol. Biol.
PD MAR
PY 2008
VL 15
IS 3
BP 259
EP 267
DI 10.1038/nsmb.1391
PG 9
WC Biochemistry & Molecular Biology; Biophysics; Cell Biology
SC Biochemistry & Molecular Biology; Biophysics; Cell Biology
GA 271UY
UT WOS:000253815400010
PM 18311153
DA 2021-01-25
ER

PT J
AU Adamczyk, P
   Meier, S
   Gross, T
   Hobmayer, B
   Grzesiek, S
   Bachinger, HP
   Holstein, TW
   Ozbek, S
AF Adamczyk, Patrizia
   Meier, Sebastien
   Gross, Thomas
   Hobmayer, Bert
   Grzesiek, Stephan
   Baechinger, Hans Peter
   Holstein, Thomas W.
   Oezbek, Suat
TI Minicoliagen-15, a novel minicollagen isolated from hydra, forms tubule
   structures in nematocysts
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE minicollagen; Hydra; nematocyst; evolution; cysteine-rich domain
ID DISULFIDE LINKAGE; CHEMICAL-SHIFT; NMR STRUCTURE; PROTEIN; DOMAIN; WALL;
   COLLAGENS; EVOLUTION; ALIGNMENT; PEPTIDES
AB Minicollagens constitute a family of unusually short collagen molecules isolated from cnidarians. They are restricted to the nematocyst, a cylindrical explosive organelle serving in defense and capture of prey. The nematocyst capsule contains a long tubule inside of its matrix, which is expelled and everted during an ultrafast discharge process. Here, we report the cloning and characterization of a novel minicollagen in Hydra, designated minicollagen-15 (NCol-15). NCol-15, like NCol-3 and NCol-4, shows deviations from the canonical cysteine pattern in its terminal cysteine-rich domains (CRDs). Minicollagens share common domain architectures with a central collagen sequence flanked by polyproline stretches and short N- and C-terminal CRDs. The CRDs are involved in the formation of a highly resistant cysteine network, which constitutes the basic structure of the nematocyst capsule. Unlike NCol-1, which is part of the capsule wall, NCol-15 is localized to tubules, arguing for a functional differentiation of minicollagens within the nematocyst architecture. NMR analysis of the altered C-terminal CRD of NCol-15 showed a novel disulfide-linked structure within the cysteine-containing region exhibiting similar folding kinetics and stability as the canonical CRDs. Our data provide evidence for evolutionary diversification among minicollagens, which probably facilitated alterations in the morphology of the nematocyst wall and tubule. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Adamczyk, Patrizia; Gross, Thomas; Holstein, Thomas W.; Oezbek, Suat] Inst Zool, Dept Mol Evolut & Genom, D-69130 Heidelberg, Germany.
   [Meier, Sebastien] Univ Copenhagen, Inst Mol Biol & Physiol, DK-2100 Copenhagen, Denmark.
   [Hobmayer, Bert] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria.
   [Hobmayer, Bert] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria.
   [Grzesiek, Stephan] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
   [Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Dept Biochem & Mol Biol, Portland, OR 97239 USA.
   [Baechinger, Hans Peter] Oregon Hlth & Sci Univ, Shriners Hosp Children, Portland, OR 97239 USA.
RP Holstein, TW (corresponding author), Inst Zool, Dept Mol Evolut & Genom, Neunheimer Feld 230, D-69130 Heidelberg, Germany.
EM holstein@uni-hd.de; soezbek@zoo.uni-heidelberg.de
RI Meier, Sebastian/A-4279-2015; Ozbek, Suat/D-3701-2014
OI Meier, Sebastian/0000-0003-3761-3217; Grzesiek,
   Stephan/0000-0003-1998-4225; Ozbek, Suat/0000-0003-2569-3942
CR Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740
   DAVID CN, 1974, J CELL SCI, V16, P359
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Engel U, 2001, EMBO J, V20, P3063, DOI 10.1093/emboj/20.12.3063
   ENGEL U, 2002, J CELL SCI, P115
   FASMAN GD, 1976, BIOPHYS J, V16, P1201, DOI 10.1016/S0006-3495(76)85768-2
   GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   HAWKINS HC, 1991, BIOCHEM J, V275, P341, DOI 10.1042/bj2750341
   Hellstern S, 2006, FEBS J, V273, P3230, DOI 10.1111/j.1742-4658.2006.05331.x
   HUTCHINSON EG, 1994, PROTEIN SCI, V3, P2207, DOI 10.1002/pro.5560031206
   Koch AW, 1998, J CELL SCI, V111, P1545
   KORADI R, 1996, J MOL GRAPHICS, V14, P29
   KURZ EM, 1991, J CELL BIOL, V115, P1159, DOI 10.1083/jcb.115.4.1159
   LOOMIS WF, 1953, SCIENCE, V117, P565, DOI 10.1126/science.117.3047.565
   Meier S, 2004, FEBS LETT, V569, P112, DOI 10.1016/j.febslet.2004.05.034
   Meier S, 2007, J MOL BIOL, V368, P718, DOI 10.1016/j.jmb.2007.02.026
   Meier S, 2007, CURR BIOL, V17, P173, DOI 10.1016/j.cub.2006.10.063
   Milbradt AG, 2005, J MOL BIOL, V354, P591, DOI 10.1016/j.jmb.2005.09.080
   Ozbek S, 2004, J BIOL CHEM, V279, P52016, DOI 10.1074/jbc.M407613200
   Ozbek S, 2002, J BIOL CHEM, V277, P49200, DOI 10.1074/jbc.M209401200
   Ozbek S, 2002, J STRUCT BIOL, V137, P11, DOI 10.1006/jsbi.2002.4436
   Pokidysheva E, 2004, J BIOL CHEM, V279, P30395, DOI 10.1074/jbc.M403734200
   Sass HJ, 2001, J BIOMOL NMR, V21, P275, DOI 10.1023/A:1012998006281
   Shi T, 2006, ANGEW CHEM INT EDIT, V45, P1780, DOI 10.1002/anie.200503470
   Technau U, 1996, DEV BIOL, V177, P599, DOI 10.1006/dbio.1996.0189
   WISHART DS, 1995, J BIOMOL NMR, V6, P135, DOI 10.1007/BF00211777
   ZHANG RM, 1989, J BIOL CHEM, V264, P18472
   Zhang XM, 2007, J BIOL CHEM, V282, P6792, DOI 10.1074/jbc.M607528200
NR 30
TC 25
Z9 26
U1 0
U2 10
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD FEB 29
PY 2008
VL 376
IS 4
BP 1008
EP 1020
DI 10.1016/j.jmb.2007.10.090
PG 13
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 273HI
UT WOS:000253920600010
PM 18206162
DA 2021-01-25
ER

PT J
AU Courjean, O
   Chevreux, G
   Perret, E
   Morel, A
   Sanglier, S
   Potier, N
   Engel, J
   Van Dorsselaer, A
   Feracci, H
AF Courjean, Olivier
   Chevreux, Guillaume
   Perret, Emilie
   Morel, Anne
   Sanglier, Sarah
   Potier, Noelle
   Engel, Juergen
   Van Dorsselaer, Alain
   Feracci, Helene
TI Modulation of E-cadherin monomer folding by cooperative binding of
   calcium ions
SO BIOCHEMISTRY
LA English
DT Article
ID IONIZATION MASS-SPECTROMETRY; NONCOVALENT PROTEIN COMPLEXES; AMINO-ACID
   SUBSTITUTIONS; CELL-CELL ADHESION; CONFORMATIONAL-CHANGES; STRUCTURAL
   BASIS; CA2+ BINDING; MECHANISM; HOMOASSOCIATION; SPECTROSCOPY
AB Classical cadherins are transmembrane glycoproteins involved in calcium-dependent cell-cell adhesion. Calcium ions are coordinated at the interface between successive modules of the cadherin ectodomain and are thought to regulate the adhesive interactions of cadherins when present at millimolar concentrations. It is widely accepted that calcium plays a critical role in cadherin-mediated cell-cell adhesion, but the nature of cadherin-calcium binding remains a matter of debate. We investigated the parameters of noncovalent cadherin-calcium binding, using the two N-terminal modules of E-cadherin (E/EC12) with a native N-terminal end and nondenaturing electrospray ionization mass spectrometry. By directly visualizing the molecular complexes, we demonstrated that E/EC12 binds three calcium ions, with an average K-D of 20 +/- 0.7 mu M. These calcium ions bound cooperatively to E/EC12 in its monomeric state, and these properties were not modified by an N-terminal extension consisting of a single methionine residue. This binding induced specific structural changes, as shown by assessments of protease sensitivity, circular dichroism, and mass spectrometry. Furthermore, the D103A mutation (a residue involved in E-cadherin adhesive function) modified calcium binding and led to a loss of cooperativity and the absence of structural changes, despite calcium binding. As the amino acids involved in calcium binding are found within the cadherin consensus motif, our findings may be relevant to other members of the cadherin family.
C1 [Courjean, Olivier; Perret, Emilie; Morel, Anne; Feracci, Helene] CNRS, Inst Curie, UMR 144, Morphogenese Cellulaire & Progress Tumorale, Paris, France.
   [Courjean, Olivier; Feracci, Helene] Univ Bordeaux 1, Ctr Rech Paul Pascal, CNRS, UPR 8641, F-33600 Pessac, France.
   [Chevreux, Guillaume; Sanglier, Sarah; Potier, Noelle; Van Dorsselaer, Alain] Univ Strasbourg, Inst Pluridisciplinaire Hubert Curien, Lab Spectrometr Masse Bioorgan, CNRS,UMR 7178, Strasbourg 2, France.
   [Engel, Juergen] Biozentrum Univ Basel, Dept Biophys Chem, Basel, Switzerland.
RP Feracci, H (corresponding author), CNRS, Inst Curie, UMR 144, Morphogenese Cellulaire & Progress Tumorale, Paris, France.
EM feracci@crpp-bordeaux.cnrs.fr
OI Cianferani, Sarah/0000-0003-4013-4129; CHEVREUX,
   Guillaume/0000-0003-3452-2125
CR Alattia JR, 1997, FEBS LETT, V417, P405, DOI 10.1016/S0014-5793(97)01333-1
   Bayas MV, 2006, BIOPHYS J, V90, P1385, DOI 10.1529/biophysj.105.069583
   Boggon TJ, 2002, SCIENCE, V296, P1308, DOI 10.1126/science.1071559
   Chan MWC, 2004, J BIOL CHEM, V279, P41047, DOI 10.1074/jbc.M406631200
   Chevreux G, 2005, J AM SOC MASS SPECTR, V16, P1367, DOI 10.1016/j.jasms.2005.03.023
   Chitaev NA, 1998, J CELL BIOL, V142, P837, DOI 10.1083/jcb.142.3.837
   CHOWDHURY SK, 1990, J AM CHEM SOC, V112, P9012, DOI 10.1021/ja00180a074
   CITI S, 1994, J CELL SCI, V107, P683
   Craig TA, 2006, J AM SOC MASS SPECTR, V17, P1158, DOI 10.1016/j.jasms.2006.04.029
   Doherty-Kirby Amanda L, 2002, Methods Mol Biol, V173, P161
   Duguay D, 2003, DEV BIOL, V253, P309, DOI 10.1016/S0012-1606(02)00016-7
   Felitsyn N, 2002, INT J MASS SPECTROM, V219, P39, DOI 10.1016/S1387-3806(02)00588-2
   GANEM B, 1991, J AM CHEM SOC, V113, P6294, DOI 10.1021/ja00016a069
   GRAIG TA, 1997, BIOCHEMISTRY-US, V36, P10482
   Gumbiner BM, 2005, NAT REV MOL CELL BIO, V6, P622, DOI 10.1038/nrm1699
   Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9
   Handschuh G, 1999, ONCOGENE, V18, P4301, DOI 10.1038/sj.onc.1202790
   Handschuh G, 2001, J MOL BIOL, V314, P445, DOI 10.1006/jmbi.2001.5143
   Hanley WD, 2004, J CELL SCI, V117, P2503, DOI 10.1242/jcs.01088
   Harrison OJ, 2005, J CELL SCI, V118, P711, DOI 10.1242/jcs.01665
   Haussinger D, 2004, EMBO J, V23, P1699, DOI 10.1038/sj.emboj.7600192
   Haussinger D, 2002, J MOL BIOL, V324, P823, DOI 10.1016/S0022-2836(02)01137-3
   Heck AJR, 2004, MASS SPECTROM REV, V23, P368, DOI 10.1002/mas.10081
   Hofer AM, 2005, J CELL SCI, V118, P855, DOI 10.1242/jcs.01705
   HU PF, 1994, ANAL CHEM, V66, P4190, DOI 10.1021/ac00095a013
   Huang J, 2004, J BIOL CHEM, V279, P44915, DOI 10.1074/jbc.M407039200
   HYAFIL F, 1981, CELL, V26, P447, DOI 10.1016/0092-8674(81)90214-2
   Kaltashov IA, 2006, ANAL BIOANAL CHEM, V386, P472, DOI 10.1007/s00216-006-0636-6
   Kemler R, 1992, Semin Cell Biol, V3, P149
   Klingelhofer J, 2002, MOL CELL BIOL, V22, P7449, DOI 10.1128/MCB.22.21.7449-7458.2002
   Koch AW, 1997, BIOCHEMISTRY-US, V36, P7697, DOI 10.1021/bi9705624
   Koch AW, 1999, CURR OPIN STRUC BIOL, V9, P275, DOI 10.1016/S0959-440X(99)80038-4
   Konermann L, 1998, J AM SOC MASS SPECTR, V9, P1248, DOI 10.1016/S1044-0305(98)00103-2
   Larue L, 1996, DEVELOPMENT, V122, P3185
   Loo JA, 1997, MASS SPECTROM REV, V16, P1
   Loo JA, 2000, INT J MASS SPECTROM, V200, P175, DOI 10.1016/S1387-3806(00)00298-0
   Nagafuchi A, 2001, CURR OPIN CELL BIOL, V13, P600, DOI 10.1016/S0955-0674(00)00257-X
   Nagar B, 1996, NATURE, V380, P360, DOI 10.1038/380360a0
   Nollet F, 2000, J MOL BIOL, V299, P551, DOI 10.1006/jmbi.2000.3777
   NOSE A, 1990, CELL, V61, P147, DOI 10.1016/0092-8674(90)90222-Z
   NOSE A, 1988, CELL, V54, P993, DOI 10.1016/0092-8674(88)90114-6
   OVERDUIN M, 1995, SCIENCE, V267, P386, DOI 10.1126/science.7824937
   OZAWA M, 1990, CELL, V63, P1033, DOI 10.1016/0092-8674(90)90506-A
   OZAWA M, 1990, J CELL BIOL, V111, P1645, DOI 10.1083/jcb.111.4.1645
   Patel SD, 2003, CURR OPIN STRUC BIOL, V13, P690, DOI 10.1016/j.sbi.2003.10.007
   Perret E, 2002, EMBO J, V21, P2537, DOI 10.1093/emboj/21.11.2537
   Perret E, 2004, P NATL ACAD SCI USA, V101, P16472, DOI 10.1073/pnas.0402085101
   Pertz O, 1999, EMBO J, V18, P1738, DOI 10.1093/emboj/18.7.1738
   Peschke M, 2004, J AM SOC MASS SPECTR, V15, P1424, DOI 10.1016/j.jasms.2004.05.005
   Pla P, 2001, J CELL PHYSIOL, V189, P121, DOI 10.1002/jcp.10008
   POKUTTA S, 1994, EUR J BIOCHEM, V223, P1019, DOI 10.1111/j.1432-1033.1994.tb19080.x
   Potier N, 2005, METHOD ENZYMOL, V402, P361, DOI 10.1016/S0076-6879(05)02011-2
   Prakasam A, 2006, BIOCHEMISTRY-US, V45, P6930, DOI 10.1021/bi060213m
   Prasad A, 2005, BIOCHEMISTRY-US, V44, P13692, DOI 10.1021/bi0510274
   RINGWALD M, 1987, EMBO J, V6, P3647, DOI 10.1002/j.1460-2075.1987.tb02697.x
   Rogniaux H, 2001, ANAL BIOCHEM, V291, P48, DOI 10.1006/abio.2000.4975
   Sanglier S, 2004, EUR J BIOCHEM, V271, P4958, DOI 10.1111/j.1432-1033.2004.04466.x
   SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0
   Sotomayor M, 2005, STRUCTURE, V13, P669, DOI 10.1016/j.str.2005.03.001
   Steinberg MS, 1999, CURR OPIN CELL BIOL, V11, P554, DOI 10.1016/S0955-0674(99)00027-7
   Takeda H, 1999, NAT STRUCT BIOL, V6, P310, DOI 10.1038/7542
   TAKEICHI M, 1995, CURR OPIN CELL BIOL, V7, P619, DOI 10.1016/0955-0674(95)80102-2
   Tamura K, 1998, NEURON, V20, P1153, DOI 10.1016/S0896-6273(00)80496-1
   Tang LX, 1998, NEURON, V20, P1165, DOI 10.1016/S0896-6273(00)80497-3
   Troyanovsky S, 2005, EUR J CELL BIOL, V84, P225, DOI 10.1016/j.ejcb.2004.12.009
   Veenstra TD, 1998, RAPID COMMUN MASS SP, V12, P613, DOI 10.1002/(SICI)1097-0231(19980529)12:10<613::AID-RCM202>3.0.CO;2-5
   Venters RA, 2003, ANAL BIOCHEM, V317, P59, DOI 10.1016/S0003-2697(03)00084-8
NR 67
TC 19
Z9 20
U1 0
U2 5
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0006-2960
J9 BIOCHEMISTRY-US
JI Biochemistry
PD FEB 26
PY 2008
VL 47
IS 8
BP 2339
EP 2349
DI 10.1021/bi701340d
PG 11
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 264JJ
UT WOS:000253283300010
PM 18232713
DA 2021-01-25
ER

PT J
AU Salzburger, W
   Renn, SCP
   Steinke, D
   Braasch, I
   Hofmann, HA
   Meyer, A
AF Salzburger, Walter
   Renn, Susan C. P.
   Steinke, Dirk
   Braasch, Ingo
   Hofmann, Hans A.
   Meyer, Axel
TI Annotation of expressed sequence tags for the East African cichlid fish
   Astatotilapia burtoni and evolutionary analyses of cichlid ORFs
SO BMC GENOMICS
LA English
DT Article
ID GENETIC-LINKAGE MAP; LAKE VICTORIA; HAPLOCHROMIS-BURTONI; BEHAVIORAL
   PLASTICITY; EXPLOSIVE SPECIATION; SYMPATRIC SPECIATION; CDNA MICROARRAY;
   SPECIES FLOCK; EST DATABASE; BAC LIBRARY
AB Background: The cichlid fishes in general, and the exceptionally diverse East African haplochromine cichlids in particular, are famous examples of adaptive radiation and explosive speciation. Here we report the collection and annotation of more than 12,000 expressed sequence tags (ESTs) generated from three different cDNA libraries obtained from the East African haplochromine cichlid species Astatotilapia burtoni and Metriaclima zebra.
   Results: We first annotated more than 12,000 newly generated cichlid ESTs using the Gene Ontology classification system. For evolutionary analyses, we combined these ESTs with all available sequence data for haplochromine cichlids, which resulted in a total of more than 45,000 ESTs. The ESTs represent a broad range of molecular functions and biological processes. We compared the haplochromine ESTs to sequence data from those available for other fish model systems such as pufferfish (Takifugu rubripes and Tetraodon nigroviridis), trout, and zebrafish. We characterized genes that show a faster or slower rate of base substitutions in haplochromine cichlids compared to other fish species, as this is indicative of a relaxed or reinforced selection regime. Four of these genes showed the signature of positive selection as revealed by calculating K-a/K-s ratios.
   Conclusion: About 22% of the surveyed ESTs were found to have cichlid specific rate differences suggesting that these genes might play a role in lineage specific characteristics of cichlids. We also conclude that the four genes with a K-a/K-s ratio greater than one appear as good candidate genes for further work on the genetic basis of evolutionary success of haplochromine cichlid fishes.
C1 [Salzburger, Walter; Steinke, Dirk; Braasch, Ingo; Meyer, Axel] Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolut Biol, D-78467 Constance, Germany.
   [Salzburger, Walter] Univ Basel, Inst Zool, CH-4051 Basel, Switzerland.
   [Renn, Susan C. P.] Reed Coll, Dept Biol, Portland, OR 97202 USA.
   [Steinke, Dirk] Univ Guelph, Guelph Ctr DNA Barcoding Biodivers, Inst Ontario, Guelph, ON N1G 2W1, Canada.
   [Braasch, Ingo] Univ Wurzburg, Biozentrum, D-97074 Wurzburg, Germany.
   [Hofmann, Hans A.] Univ Texas Austin, Sect Integrat Biol, Austin, TX 78712 USA.
RP Salzburger, W (corresponding author), Univ Konstanz, Dept Biol, Lehrstuhl Zool & Evolut Biol, D-78467 Constance, Germany.
EM walter.salzburger@unibas.ch; renns@reed.edu; dsteinke@uoguelph.ca;
   ingo.braasch@biozentrum.uni-wuerzburg.de; hans@mail.utexas.edu;
   axel.meyer@unikonstanz.de
RI Salzburger, Walter/G-1598-2011; Steinke, Dirk/D-4700-2009; Braasch,
   Ingo/A-6948-2010; Meyer, Axel/C-9826-2009; Hofmann, Hans A/E-4538-2016
OI Salzburger, Walter/0000-0002-9988-1674; Braasch,
   Ingo/0000-0003-4766-611X; Meyer, Axel/0000-0002-0888-8193; Hofmann, Hans
   A/0000-0002-3335-330X; Steinke, Dirk/0000-0002-8992-575X
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [P50 GM068763, GM068763] Funding Source:
   Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of General Medical Sciences (NIGMS)
   [P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763,
   P50GM068763, P50GM068763, P50GM068763, P50GM068763, P50GM068763] Funding
   Source: NIH RePORTER
CR Albertson RC, 2005, P NATL ACAD SCI USA, V102, P16287, DOI 10.1073/pnas.0506649102
   Albertson RC, 2005, EVOLUTION, V59, P686, DOI 10.1111/j.0014-3820.2005.tb01027.x
   Albertson RC, 2003, P NATL ACAD SCI USA, V100, P5252, DOI 10.1073/pnas.0930235100
   Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556
   Aubin-Horth N, 2007, MOL ECOL, V16, P1349, DOI 10.1111/j.1365-294X.2007.03249.x
   Bailey LC, 1998, GENOME RES, V8, P362, DOI 10.1101/gr.8.4.362
   Banfi S, 1996, NAT GENET, V13, P167, DOI 10.1038/ng0696-167
   Barluenga M, 2006, NATURE, V439, P719, DOI 10.1038/nature04325
   Carleton KL, 2001, MOL BIOL EVOL, V18, P1540, DOI 10.1093/oxfordjournals.molbev.a003940
   CONSORTIUM TGO, 2001, GENOME RES, V11, P1425
   Crapon de Caprona MD, 1980, Z TIERPSYCHOL, V52, P113
   DECAPRONA MD, 1984, NETH J ZOOL, V34, P503
   Ewing B, 2000, NAT GENET, V25, P232, DOI 10.1038/76115
   Fryer G., 1972, CICHLID FISHES GREAT
   Ge YC, 2003, TEST-SPAIN, V12, P1, DOI 10.1007/BF02595811
   Genner MJ, 2007, MOL BIOL EVOL, V24, P1269, DOI 10.1093/molbev/msm050
   Gerhold D, 1996, BIOESSAYS, V18, P973, DOI 10.1002/bies.950181207
   Gibson G., 2002, PRIMER GENOME SCI
   Grosenick L, 2007, NATURE, V445, P429, DOI 10.1038/nature05511
   Gupta S, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-72
   Habermann B, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r67
   Hagedorn M, 1998, DEV BRAIN RES, V108, P217, DOI 10.1016/S0165-3806(98)00051-0
   Hofmann H.A., 2001, J AQUARICULTURE AQUA, V9, P1
   Hofmann HA, 2003, J NEUROBIOL, V54, P272, DOI 10.1002/neu.10172
   Hofmann HA, 2006, CURR OPIN NEUROBIOL, V16, P343, DOI 10.1016/j.conb.2006.05.005
   JANSEN E, 1995, J BIOL CHEM, V270, P15391, DOI 10.1074/jbc.270.25.15391
   Katagiri T, 2001, ANIM GENET, V32, P200, DOI 10.1046/j.1365-2052.2001.00764.x
   Kijimoto T, 2005, MOL BIOL EVOL, V22, P1649, DOI 10.1093/molbev/msi159
   Kobayashi N, 2006, GENE, V373, P126, DOI 10.1016/j.gene.2006.01.016
   Kocher TD, 1998, GENETICS, V148, P1225
   KOCHER TD, 1993, MOL PHYLOGENET EVOL, V2, P158, DOI 10.1006/mpev.1993.1016
   Kocher TD, 2004, NAT REV GENET, V5, P288, DOI 10.1038/nrg1316
   Kornfield I, 2000, ANNU REV ECOL SYST, V31, P163, DOI 10.1146/annurev.ecolsys.31.1.163
   Kroger RHH, 2001, VISION RES, V41, P549, DOI 10.1016/S0042-6989(00)00283-2
   Lang M, 2006, J EXP ZOOL PART B, V306B, P35, DOI 10.1002/jez.b.21068
   Lee BY, 2005, GENETICS, V170, P237, DOI 10.1534/genetics.104.035022
   LIEM KF, 1973, SYST ZOOL, V22, P425, DOI 10.2307/2412950
   Lorenzen MD, 2005, GENETICS, V170, P741, DOI 10.1534/genetics.104.032227
   Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551
   MEYER A, 1993, TRENDS ECOL EVOL, V8, P279, DOI 10.1016/0169-5347(93)90255-N
   MEYER A, 1990, NATURE, V347, P550, DOI 10.1038/347550a0
   Morita K, 1999, P NATL ACAD SCI USA, V96, P511, DOI 10.1073/pnas.96.2.511
   Nilsson RH, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-87
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Philippe H, 2005, MOL BIOL EVOL, V22, P1246, DOI 10.1093/molbev/msi111
   Renn SCP, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-42
   Rise ML, 2004, GENOME RES, V14, P478, DOI 10.1101/gr.1687304
   Robison RR, 2001, ENDOCRINOLOGY, V142, P1737, DOI 10.1210/en.142.5.1737
   Salzburger W, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-17
   Salzburger W, 2004, NATURWISSENSCHAFTEN, V91, P277, DOI 10.1007/s00114-004-0528-6
   Salzburger W, 2002, SYST BIOL, V51, P113, DOI 10.1080/106351502753475907
   Scheetz TE, 2001, GENOME RES, V11, P497, DOI 10.1101/gr.GR-1516R
   SCHLIEWEN UK, 1994, NATURE, V368, P629, DOI 10.1038/368629a0
   Schmitt AO, 1999, NUCLEIC ACIDS RES, V27, P4251, DOI 10.1093/nar/27.21.4251
   SMITH JJ, 2005, GENETICS
   Steinke D, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-20
   STEINKE D, 2004, PHYLOINFORMATICS, V6, P1
   STEINKE D, 2006, IN PRESS J MOL EVOL
   Stiassny MLJ, 1999, SCI AM, V280, P64, DOI 10.1038/scientificamerican0299-64
   Streelman JT, 2003, MOL ECOL, V12, P2465, DOI 10.1046/j.1365-294X.2003.01920.x
   Sugie A, 2004, GENE, V343, P337, DOI 10.1016/j.gene.2004.09.019
   TAJIMA F, 1993, GENETICS, V135, P599
   Talukder AH, 2003, J BIOL CHEM, V278, P11676, DOI 10.1074/jbc.M209570200
   Terai Y, 2002, MOL BIOL EVOL, V19, P1628, DOI 10.1093/oxfordjournals.molbev.a004225
   Trainor BC, 2006, ENDOCRINOLOGY, V147, P5119, DOI 10.1210/en.2006-0511
   Verheyen E, 2003, SCIENCE, V300, P325, DOI 10.1126/science.1080699
   Wasmuth JD, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-187
   Watanabe M, 2004, GENE, V343, P263, DOI 10.1016/j.gene.2004.09.013
   Watanabe M, 2003, GENES GENET SYST, V78, P103
   Whitfield CW, 2002, GENOME RES, V12, P555, DOI 10.1101/gr.5302
   Wickler W., 1962, Zeitschrift fuer Tierpsychologie, V19, P129
   WICKLER W, 1962, NATURE, V194, P1092, DOI 10.1038/1941092a0
   WICKLER W, 1969, ENCY CINEMATOGRAPHIC
   Yang ZH, 1998, MOL BIOL EVOL, V15, P568, DOI 10.1093/oxfordjournals.molbev.a025957
   Zhang BH, 2005, CELL RES, V15, P336, DOI 10.1038/sj.cr.7290302
NR 75
TC 49
Z9 51
U1 0
U2 11
PU BIOMED CENTRAL LTD
PI LONDON
PA 236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD FEB 25
PY 2008
VL 9
AR 96
DI 10.1186/1471-2164-9-96
PG 14
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 282ZY
UT WOS:000254607500001
PM 18298844
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Aguilera-Romero, A
   Kaminska, J
   Spang, A
   Riezman, H
   Muniz, M
AF Aguilera-Romero, Auxiliadora
   Kaminska, Joanna
   Spang, Anne
   Riezman, Howard
   Muniz, Manuel
TI The yeast p24 complex is required for the formation of COPI retrograde
   transport vesicles from the Golgi apparatus
SO JOURNAL OF CELL BIOLOGY
LA English
DT Article
ID UNFOLDED PROTEIN RESPONSE; ENDOPLASMIC-RETICULUM;
   SACCHAROMYCES-CEREVISIAE; ARF-GAP; TRANSMEMBRANE PROTEIN; COATOMER
   SUBUNITS; SECRETORY PATHWAY; ER; MUTANTS; FAMILY
AB The p24 family members are transmembrane proteins assembled into heteromeric complexes that continuously cycle between the ER and the Golgi apparatus. These cargo proteins were assumed to play a structural role in COPI budding because of their major presence in mammalian COPI vesicles. However, this putative function has not been proved conclusively so far. Furthermore, deletion of all eight yeast p24 family members does not produce severe transport phenotypes, suggesting that the p24 complex is not essential for CON function. In this paper we provide direct evidence that the yeast p24 complex plays an active role in retrograde transport from Golgi to ER by facilitating the formation of COPI-coated vesicles. Therefore, our results demonstrate that p24 proteins are important for vesicle formation instead of simply being a passive traveler, supporting the model in which cargo together with a small GTPase of the ARF superfamily and coat subunits act as primer for vesicle formation.
C1 [Aguilera-Romero, Auxiliadora; Muniz, Manuel] Univ Seville, Dept Cell Biol, E-41012 Seville, Spain.
   [Kaminska, Joanna] Inst Biochem & Biophys PAS, PL-02106 Warsaw, Poland.
   [Spang, Anne] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Riezman, Howard] Univ Geneva, Dept Biochem, CH-1211 Geneva, Switzerland.
RP Muniz, M (corresponding author), Univ Seville, Dept Cell Biol, E-41012 Seville, Spain.
EM mmuniz@us.es
RI Spang, Anne/A-7029-2008; Kaminska, Joanna/D-1063-2011; IBIS,
   EUCARIONTES/H-7494-2016; muniz, manuel/Q-2890-2019; Spang,
   Anne/M-7223-2019; Kaminska, Joanna/AAS-5742-2020
OI Spang, Anne/0000-0002-2387-6203; Kaminska, Joanna/0000-0002-0168-7882;
   muniz, manuel/0000-0001-8011-6991; Spang, Anne/0000-0002-2387-6203;
   Kaminska, Joanna/0000-0002-0168-7882; Riezman,
   Howard/0000-0003-4680-9422
CR Belden WJ, 2001, MOL BIOL CELL, V12, P957, DOI 10.1091/mbc.12.4.957
   Belden WJ, 2001, J BIOL CHEM, V276, P43040, DOI 10.1074/jbc.M108113200
   Bethune J, 2006, MOL CELL BIOL, V26, P8011, DOI 10.1128/MCB.01055-06
   Bremser M, 1999, CELL, V96, P495, DOI 10.1016/S0092-8674(00)80654-6
   Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4
   Dogic D, 1999, EUR J CELL BIOL, V78, P305, DOI 10.1016/S0171-9335(99)80064-8
   DUDEN R, 1994, J BIOL CHEM, V269, P24486
   ElrodErickson MJ, 1996, MOL BIOL CELL, V7, P1043
   Emery G, 2003, J CELL SCI, V116, P4821, DOI 10.1242/jcs.00802
   ESMON PC, 1987, J BIOL CHEM, V262, P4387
   Eugster A, 2000, EMBO J, V19, P3905, DOI 10.1093/emboj/19.15.3905
   Fullekrug J, 1999, MOL BIOL CELL, V10, P1939, DOI 10.1091/mbc.10.6.1939
   Gaynor EC, 1997, J CELL BIOL, V136, P789, DOI 10.1083/jcb.136.4.789
   Goldberg J, 2000, CELL, V100, P671, DOI 10.1016/S0092-8674(00)80703-5
   Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.3.CO;2-B
   Gommel DU, 2001, EMBO J, V20, P6751, DOI 10.1093/emboj/20.23.6751
   KUBLER E, 1994, EMBO J, V13, P5539, DOI 10.1002/j.1460-2075.1994.tb06891.x
   Lanoix J, 2001, J CELL BIOL, V155, P1199, DOI 10.1083/jcb.200108017
   Lavoie C, 1999, J CELL BIOL, V146, P285, DOI 10.1083/jcb.146.2.285
   Lee SY, 2005, J CELL BIOL, V168, P281, DOI 10.1083/jcb.200404008
   Lewis SM, 2004, MOL BIOL CELL, V15, P4064, DOI 10.1091/mbc.E04-04-0316
   Marzioch M, 1999, MOL BIOL CELL, V10, P1923, DOI 10.1091/mbc.10.6.1923
   Muniz M, 2000, J CELL BIOL, V148, P925, DOI 10.1083/jcb.148.5.925
   Muniz M, 2001, CELL, V104, P313, DOI 10.1016/S0092-8674(01)00215-X
   Poon PP, 1999, EMBO J, V18, P555, DOI 10.1093/emboj/18.3.555
   Prinz WA, 2000, J CELL BIOL, V150, P461, DOI 10.1083/jcb.150.3.461
   Rein U, 2002, J CELL BIOL, V157, P395, DOI 10.1083/jcb.200112092
   Rojo M, 1997, J CELL BIOL, V139, P1119, DOI 10.1083/jcb.139.5.1119
   Rossanese OW, 2001, J CELL BIOL, V153, P47, DOI 10.1083/jcb.153.1.47
   Sandmann T, 2003, MOL BIOL CELL, V14, P3097, DOI 10.1091/mbc.E02-11-0736
   Sato K, 1997, P NATL ACAD SCI USA, V94, P9693, DOI 10.1073/pnas.94.18.9693
   SEMENZA JC, 1990, CELL, V61, P1349, DOI 10.1016/0092-8674(90)90698-E
   Sheff D, 1996, J BIOL CHEM, V271, P7230, DOI 10.1074/jbc.271.12.7230
   SHERMAN F, 1991, METHOD ENZYMOL, V194, P3
   Sohn K, 1996, J CELL BIOL, V135, P1239, DOI 10.1083/jcb.135.5.1239
   Spang A, 2002, CURR OPIN CELL BIOL, V14, P423, DOI 10.1016/S0955-0674(02)00346-0
   Spang A, 1998, J CELL BIOL, V143, P589, DOI 10.1083/jcb.143.3.589
   Springer S, 2000, P NATL ACAD SCI USA, V97, P4034, DOI 10.1073/pnas.070044097
   Springer S, 1999, CELL, V97, P145, DOI 10.1016/S0092-8674(00)80722-9
   STAMNES MA, 1995, P NATL ACAD SCI USA, V92, P8011, DOI 10.1073/pnas.92.17.8011
   STEVENS T, 1982, CELL, V30, P439, DOI 10.1016/0092-8674(82)90241-0
   Sutterlin C, 1998, BIOCHEM J, V332, P153
   Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810
   Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1
   Yahara N, 2006, J CELL SCI, V119, P2604, DOI 10.1242/jcs.02997
NR 45
TC 46
Z9 47
U1 0
U2 9
PU ROCKEFELLER UNIV PRESS
PI NEW YORK
PA 950 THIRD AVE, 2ND FLR, NEW YORK, NY 10022 USA
SN 0021-9525
EI 1540-8140
J9 J CELL BIOL
JI J. Cell Biol.
PD FEB 25
PY 2008
VL 180
IS 4
BP 713
EP 720
DI 10.1083/jcb.200710025
PG 8
WC Cell Biology
SC Cell Biology
GA 267FD
UT WOS:000253494000021
PM 18283113
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Steinmetz, MO
   Gattin, Z
   Verel, R
   Ciani, B
   Stromer, T
   Green, JM
   Tittmann, P
   Schulze-Bdese, C
   Gross, H
   van Gunsteren, WF
   Meier, BH
   Serpell, LC
   Muller, SA
   Kammerer, RA
AF Steinmetz, Michel O.
   Gattin, Zrinka
   Verel, Rene
   Ciani, Barbara
   Stromer, Thusnelda
   Green, Janelle M.
   Tittmann, Peter
   Schulze-Bdese, Clemens
   Gross, Heinz
   van Gunsteren, Wilfred F.
   Meier, Beat H.
   Serpell, Louise C.
   Mueller, Shirley A.
   Kammerer, Richard A.
TI Atomic models of de novo designed cc beta-met amyloid-like fibrils
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
ID HELICAL COILED COILS; MOLECULAR-DYNAMICS SIMULATIONS; NEURODEGENERATIVE
   DISEASES; COMBINATORIAL LIBRARIES; PROTEINS; FIBRILLOGENESIS;
   AGGREGATION; CONVERSION; EVOLUTION; RESONANCE
AB The common characteristics of amyloid and amyloid-like fibrils from disease- and non-disease-associated proteins offer the prospect that well-defined model systems can be used to systematically dissect the driving forces of amyloid formation. We recently reported the de novo designed cc peptide model system that forms a native-like coiled-coil structure at low temperatures and which can be switched to amyloid-like fibrils by increasing the temperature. Here, we report a detailed molecular description of the system in its fibrillar state by characterizing the cc beta-Met variant using several microscopic techniques, circular dichroism spectroscopy, X-ray fiber diffraction, solid-state nuclear magnetic resonance, and molecular dynamics calculations. We show that cc beta-Met forms amyloid-like fibrils of different morphologies on both the macroscopic and atomic levels, which can be controlled by variations of assembly conditions. Interestingly, heterogeneity is also observed along single fibrils. We propose atomic models of the cc beta-Met amyloid-like fibril, which are in good agreement with all experimental data. The models provide a rational, explanation why oxidation of methionine residues completely abolishes cc beta-Met amyloid fibril formation, indicating that a small number of site-specific hydrophobic interactions can play a major role in the packing of polypeptide-chain segments within amyloid fibrils. The detailed structural information available for the cc beta model system provides a strong molecular basis for understanding the influence and relative contribution of hydrophobic interactions on native-state stability, kinetics of fibril formation, fibril packing, and polymorphism. (C) 2007 Elsevier Ltd. All rights reserved.
C1 [Steinmetz, Michel O.] Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
   [Gattin, Zrinka; Verel, Rene; van Gunsteren, Wilfred F.; Meier, Beat H.] ETH, CH-8093 Zurich, Switzerland.
   [Ciani, Barbara; Kammerer, Richard A.] Univ Manchester, Fac Life Sci, Wellcome Trust Ctr Cell Matrix Res, Manchester M13 PT, Lancs, England.
   [Stromer, Thusnelda; Serpell, Louise C.] Univ Sussex, Sch Life Sci, Dept Biochem, Brighton BN1 9QG, E Sussex, England.
   [Green, Janelle M.; Mueller, Shirley A.] Univ Basel, Muller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
   [Tittmann, Peter; Gross, Heinz] ETH, CH-8093 Zurich, Switzerland.
   [Schulze-Bdese, Clemens] Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
RP Steinmetz, MO (corresponding author), Paul Scherrer Inst, CH-5232 Villigen, Switzerland.
EM michel.steinmetz@psi.ch; richard.kammerer@manchester.ac.uk
RI Verel, Rene/F-1539-2011; Meier, Beat H/K-4066-2016; Ciani,
   Barbara/A-1679-2012
OI Verel, Rene/0000-0003-1575-2232; Meier, Beat H/0000-0002-9107-4464;
   Ciani, Barbara/0000-0001-7223-4154; Serpell, Louise/0000-0001-9335-7751;
   Kammerer, Richard/0000-0003-4570-5197; Steinmetz,
   Michel/0000-0001-6157-3687
FU Biotechnology and Biological Sciences Research CouncilBiotechnology and
   Biological Sciences Research Council (BBSRC) [BB/A500061/1] Funding
   Source: Medline; Wellcome TrustWellcome Trust Funding Source: Medline
CR Aguzzi A, 2003, SCIENCE, V302, P814, DOI 10.1126/science.1087348
   BENNETT AE, 1995, J CHEM PHYS, V103, P6951, DOI 10.1063/1.470372
   Berendsen H.J., 1981, INTERMOLECULAR FORCE, P331, DOI DOI 10.1007/978-94-015-7658-1_21
   BERENDSEN HJC, 1984, J CHEM PHYS, V81, P3684, DOI 10.1063/1.448118
   Burkhard P, 2001, TRENDS CELL BIOL, V11, P82, DOI 10.1016/S0962-8924(00)01898-5
   Carulla N, 2005, NATURE, V436, P554, DOI 10.1038/nature03986
   Christen M, 2005, J COMPUT CHEM, V26, P1719, DOI 10.1002/jcc.20303
   COHEN C, 1990, PROTEINS, V7, P1, DOI 10.1002/prot.340070102
   Cohen FE, 1998, ANNU REV BIOCHEM, V67, P793, DOI 10.1146/annurev.biochem.67.1.793
   DADO PG, 1993, J AM CHEM SOC, P12609
   Ding F, 2005, J BIOL CHEM, V280, P40235, DOI 10.1074/jbc.M506372200
   Dobson CM, 2003, NATURE, V426, P884, DOI 10.1038/nature02261
   EDELHOCH H, 1967, BIOCHEMISTRY-US, V6, P1948, DOI 10.1021/bi00859a010
   GarciaEcheverria C, 1996, BIOORG MED CHEM LETT, V6, P229, DOI 10.1016/0960-894X(96)00009-1
   Goldsbury C, 2005, J MOL BIOL, V352, P282, DOI 10.1016/j.jmb.2005.07.029
   Green J, 2003, J MOL BIOL, V326, P1147, DOI 10.1016/S0022-2836(02)01377-3
   GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1
   Hecht MH, 2004, PROTEIN SCI, V13, P1711, DOI 10.1110/ps.04690804
   HEDIGER S, 1995, CHEM PHYS LETT, V240, P449, DOI 10.1016/0009-2614(95)00505-X
   Heinz TN, 2001, J CHEM PHYS, V115, P1125, DOI 10.1063/1.1379764
   Kammerer RA, 2004, P NATL ACAD SCI USA, V101, P4435, DOI 10.1073/pnas.0306786101
   Kammerer RA, 1997, MATRIX BIOL, V15, P555, DOI 10.1016/S0945-053X(97)90031-7
   Kammerer RA, 2006, J STRUCT BIOL, V155, P146, DOI 10.1016/j.jsb.2006.01.017
   Kelly JW, 2003, J CELL BIOL, V161, P461, DOI 10.1083/jcb.200304074
   Kohn WD, 1998, TRENDS BIOTECHNOL, V16, P379, DOI 10.1016/S0167-7799(98)01212-8
   Lansbury PT, 1999, P NATL ACAD SCI USA, V96, P3342, DOI 10.1073/pnas.96.7.3342
   Lupas AN, 2005, ADV PROTEIN CHEM, V70, P37, DOI 10.1016/S0065-3233(04)70003-0
   Makin OS, 2005, FEBS J, V272, P5950, DOI 10.1111/j.1742-4658.2005.05025.x
   MAKIN OS, 2007, APPL CRYST, V40, P966
   MULLER SA, 1992, ULTRAMICROSCOPY, V46, P317, DOI 10.1016/0304-3991(92)90022-C
   MUTTER M, 1990, ANGEW CHEM INT EDIT, V29, P185, DOI 10.1002/anie.199001851
   Nelson R, 2005, NATURE, V435, P773, DOI 10.1038/nature03680
   Oostenbrink C, 2004, J COMPUT CHEM, V25, P1656, DOI 10.1002/jcc.20090
   Perutz MF, 1999, TRENDS BIOCHEM SCI, V24, P58, DOI 10.1016/S0968-0004(98)01350-4
   Petkova AT, 2005, SCIENCE, V307, P262, DOI 10.1126/science.1105850
   Prusiner SB, 2001, NEW ENGL J MED, V344, P1516, DOI 10.1056/NEJM200105173442006
   Prusiner SB, 1998, CELL, V93, P337, DOI 10.1016/S0092-8674(00)81163-0
   Rochet JC, 2000, CURR OPIN STRUC BIOL, V10, P60, DOI 10.1016/S0959-440X(99)00049-4
   RYCKAERT JP, 1977, J COMPUT PHYS, V23, P327, DOI 10.1016/0021-9991(77)90098-5
   Sacchettini JC, 2002, NAT REV DRUG DISCOV, V1, P267, DOI 10.1038/nrd769
   Sawaya MR, 2007, NATURE, V447, P453, DOI 10.1038/nature05695
   Saxton WO, 1996, J STRUCT BIOL, V116, P230, DOI 10.1006/jsbi.1996.0035
   SMITH SA, 1994, J MAGN RESON SER A, V106, P75, DOI 10.1006/jmra.1994.1008
   Stefani M, 2003, J MOL MED, V81, P678, DOI 10.1007/s00109-003-0464-5
   Sunde M, 1997, J MOL BIOL, V273, P729, DOI 10.1006/jmbi.1997.1348
   Taylor JP, 2002, SCIENCE, V296, P1991, DOI 10.1126/science.1067122
   TIRONI IG, 1995, J CHEM PHYS, V102, P5451, DOI 10.1063/1.469273
   vanGunsteren WF, 1996, GROMOS96 MANUAL USER
   West MW, 1999, P NATL ACAD SCI USA, V96, P11211, DOI 10.1073/pnas.96.20.11211
   Woolfson DN, 2005, ADV PROTEIN CHEM, V70, P79, DOI 10.1016/S0065-3233(04)70004-2
   Yu H, 2006, PROTEINS, V65, P285, DOI 10.1002/prot.20991
   Zhang SG, 1997, P NATL ACAD SCI USA, V94, P23, DOI 10.1073/pnas.94.1.23
   Zhang SG, 2003, NAT BIOTECHNOL, V21, P1171, DOI 10.1038/nbt874
NR 53
TC 25
Z9 25
U1 0
U2 7
PU ACADEMIC PRESS LTD ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD FEB 22
PY 2008
VL 376
IS 3
BP 898
EP 912
DI 10.1016/j.jmb.2007.11.100
PG 15
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 265JM
UT WOS:000253354900024
PM 18178219
DA 2021-01-25
ER

PT J
AU Bello, BC
   Izergina, N
   Caussinus, E
   Reichert, H
AF Bello, Bruno C.
   Izergina, Natalya
   Caussinus, Emmanuel
   Reichert, Heinrich
TI Amplification of neural stem cell proliferation by intermediate
   progenitor cells in Drosophila brain development
SO NEURAL DEVELOPMENT
LA English
DT Article
ID CENTRAL-NERVOUS-SYSTEM; NEUROBLAST SELF-RENEWAL; ASYMMETRIC DIVISION;
   POSTEMBRYONIC NEUROBLASTS; FATE DETERMINANTS; MOSAIC ANALYSIS; NEURONS
   ARISE; MARKER MARCM; PROSPERO; NEUROGENESIS
AB Background: In the mammalian brain, neural stem cells divide asymmetrically and often amplify the number of progeny they generate via symmetrically dividing intermediate progenitors. Here we investigate whether specific neural stem cell-like neuroblasts in the brain of Drosophila might also amplify neuronal proliferation by generating symmetrically dividing intermediate progenitors.
   Results: Cell lineage-tracing and genetic marker analysis show that remarkably large neuroblast lineages exist in the dorsomedial larval brain of Drosophila. These lineages are generated by brain neuroblasts that divide asymmetrically to self renew but, unlike other brain neuroblasts, do not segregate the differentiating cell fate determinant Prospero to their smaller daughter cells. These daughter cells continue to express neuroblast-specific molecular markers and divide repeatedly to produce neural progeny, demonstrating that they are proliferating intermediate progenitors. The proliferative divisions of these intermediate progenitors have novel cellular and molecular features; they are morphologically symmetrical, but molecularly asymmetrical in that key differentiating cell fate determinants are segregated into only one of the two daughter cells.
   Conclusion: Our findings provide cellular and molecular evidence for a new mode of neurogenesis in the larval brain of Drosophila that involves the amplification of neuroblast proliferation through intermediate progenitors. This type of neurogenesis bears remarkable similarities to neurogenesis in the mammalian brain, where neural stem cells as primary progenitors amplify the number of progeny they generate through generation of secondary progenitors. This suggests that key aspects of neural stem cell biology might be conserved in brain development of insects and mammals.
C1 [Bello, Bruno C.; Izergina, Natalya; Caussinus, Emmanuel; Reichert, Heinrich] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Bello, BC (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM bruno.bello@unibas.ch; natalya.izergina@stud.unibas.ch;
   emmanuel.caussinus@unibas.ch; heinrich.reichert@unibas.ch
FU Swiss NSFSwiss National Science Foundation (SNSF)
FX This work was supported by a grant from the Swiss NSF to HR.
CR Akong K, 2002, DEV BIOL, V250, P71, DOI 10.1006/dbio.2002.0777
   Al-Hajj M, 2004, ONCOGENE, V23, P7274, DOI 10.1038/sj.onc.1207947
   Bardin AJ, 2004, CURR OPIN NEUROBIOL, V14, P6, DOI 10.1016/j.conb.2003.12.002
   Bello B, 2006, DEVELOPMENT, V133, P2639, DOI 10.1242/dev.02429
   Bello B, 2007, DEVELOPMENT, V134, P1091, DOI 10.1242/dev.02793
   Betschinger J, 2006, CELL, V124, P1241, DOI 10.1016/j.cell.2006.01.038
   Betschinger J, 2004, CURR BIOL, V14, pR674, DOI 10.1016/j.cub.2004.08.017
   Caussinus E, 2005, NAT GENET, V37, P1125, DOI 10.1038/ng1632
   Ceron J, 2001, DEV BIOL, V230, P125, DOI 10.1006/dbio.2000.0110
   Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015
   CHULAGRAFF Q, 1991, DEVELOPMENT, P79
   Egger B, 2008, PHILOS T R SOC B, V363, P39, DOI 10.1098/rstb.2006.2011
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100
   IkeshimaKataoka H, 1997, NATURE, V390, P625
   ITO K, 1992, DEV BIOL, V149, P134, DOI 10.1016/0012-1606(92)90270-Q
   Karcavich RE, 2005, DEV DYNAM, V232, P609, DOI 10.1002/dvdy.20273
   KNOBLICH JA, 1995, NATURE, V377, P624, DOI 10.1038/377624a0
   Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008
   Lee CY, 2006, DEV CELL, V10, P441, DOI 10.1016/j.devcel.2006.01.017
   Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299
   Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4
   Li L, 2000, GENE DEV, V14, P147
   MARTINEZ C, 2006, CEREB CORTEX S1, V16, pI152
   Maurange C, 2005, TRENDS NEUROSCI, V28, P30, DOI 10.1016/j.tins.2004.10.009
   Merkle FT, 2006, CURR OPIN CELL BIOL, V18, P704, DOI 10.1016/j.ceb.2006.09.008
   Miyata T, 2004, DEVELOPMENT, V131, P3133, DOI 10.1242/dev.01173
   Morrison SJ, 2006, NATURE, V441, P1068, DOI 10.1038/nature04956
   Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172
   Oliver TG, 2004, NEURON, V42, P885, DOI 10.1016/j.neuron.2004.06.011
   Pearson BJ, 2004, ANNU REV CELL DEV BI, V20, P619, DOI 10.1146/annurev.cellbio.19.111301.115142
   Pereanu W, 2006, J NEUROSCI, V26, P5534, DOI 10.1523/JNEUROSCI.4708-05.2006
   PROKOP A, 1991, DEVELOPMENT, V111, P79
   Rusan NM, 2007, J CELL BIOL, V177, P13, DOI 10.1083/jcb.200612140
   Schuldt AJ, 1998, GENE DEV, V12, P1847, DOI 10.1101/gad.12.12.1847
   Shen CP, 1997, CELL, V90, P449, DOI 10.1016/S0092-8674(00)80505-X
   Skeath JB, 2003, CURR OPIN NEUROBIOL, V13, P8, DOI 10.1016/S0959-4388(03)00007-2
   SPANA EP, 1995, DEVELOPMENT, V121, P3187
   Technau GM, 2006, DEV DYNAM, V235, P861, DOI 10.1002/dvdy.20566
   TRUMAN JW, 1988, DEV BIOL, V125, P145, DOI 10.1016/0012-1606(88)90067-X
   Truman JW, 2004, DEVELOPMENT, V131, P5167, DOI 10.1242/dev.01371
   Urbach R, 2003, DEVELOPMENT, V130, P3589, DOI 10.1242/dev.00528
   VAESSIN H, 1991, CELL, V67, P941, DOI 10.1016/0092-8674(91)90367-8
   Wang HY, 2005, BIOL CELL, V97, P63
   Wu JS, 2006, NAT PROTOC, V1, P2583, DOI 10.1038/nprot.2006.320
   YounossiHartenstein A, 1996, J COMP NEUROL, V370, P313, DOI 10.1002/(SICI)1096-9861(19960701)370:3<313::AID-CNE3>3.0.CO;2-7
   Yu FW, 2006, NEURON, V51, P13, DOI 10.1016/j.neuron.2006.06.016
   1976, ATLAS INSECT BRAIN
   PUBLIC DOMAIN JAVA I
NR 49
TC 227
Z9 231
U1 0
U2 14
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1749-8104
J9 NEURAL DEV
JI Neural Dev.
PD FEB 19
PY 2008
VL 3
AR 5
DI 10.1186/1749-8104-3-5
PG 17
WC Developmental Biology; Neurosciences
SC Developmental Biology; Neurosciences & Neurology
GA 345PZ
UT WOS:000259010000001
PM 18284664
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Mahdavi, A
   Ferreira, L
   Sundback, C
   Nichol, JW
   Chan, EP
   Carter, DJD
   Bettinger, CJ
   Patanavanich, S
   Chignozha, L
   Ben-Joseph, E
   Galakatos, A
   Pryor, H
   Pomerantseva, I
   Masiakos, PT
   Faquin, W
   Zumbuehl, A
   Hong, S
   Borenstein, J
   Vacanti, J
   Langer, R
   Karp, JM
AF Mahdavi, Alborz
   Ferreira, Lino
   Sundback, Cathryn
   Nichol, Jason W.
   Chan, Edwin P.
   Carter, David J. D.
   Bettinger, Chris J.
   Patanavanich, Siamrut
   Chignozha, Loice
   Ben-Joseph, Eli
   Galakatos, Alex
   Pryor, Howard
   Pomerantseva, Irina
   Masiakos, Peter T.
   Faquin, William
   Zumbuehl, Andreas
   Hong, Seungpyo
   Borenstein, Jeffrey
   Vacanti, Joseph
   Langer, Robert
   Karp, Jeffrey M.
TI A biodegradable and biocompatible gecko-inspired tissue adhesive
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE chemical cross-link; medical adhesive; nanotopography; surgical suture
ID FOOT-HAIR; HYDROGELS; FORCE; SETAE
AB There is a significant medical need for tough biodegradable polymer adhesives that can adapt to or recover from various mechanical deformations while remaining strongly attached to the underlying tissue. We approached this problem by using a polymer poly(glycerol-co-sebacate acrylate) and modifying the surface to mimic the nanotopography of gecko feet, which allows attachment to vertical surfaces. Translation of existing gecko-inspired adhesives for medical applications is complex, as multiple parameters must be optimized, including: biocompatibility, biodegradation, strong adhesive tissue bonding, as well as compliance and conformability to tissue surfaces. Ideally these adhesives would also have the ability to deliver drugs or growth factors to promote healing. As a first demonstration, we have created a gecko-inspired tissue adhesive from a biocompatible and biodegradable elastomer combined with a thin tissue-reactive biocompatible surface coating. Tissue adhesion was optimized by varying dimensions of the nanoscale pillars, including the ratio of tip diameter to pitch and the ratio of tip diameter to base diameter. Coating these nanomolded pillars of biodegradable elastomers with a thin layer of oxidized dextran significantly increased the interfacial adhesion strength on porcine intestine tissue in vitro and in the rat abdominal subfascial in vivo environment. This gecko-inspired medical adhesive may have potential applications for sealing wounds and for replacement or augmentation of sutures or staples.
C1 [Mahdavi, Alborz; Ferreira, Lino; Patanavanich, Siamrut; Chignozha, Loice; Ben-Joseph, Eli; Galakatos, Alex; Hong, Seungpyo; Langer, Robert] MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
   [Ferreira, Lino] Univ Coimbra, Ctr Neurosci & Cell Biol, P-3060197 Cantanhede, Portugal.
   [Ferreira, Lino] Biocant Biotechnol Innovat Ctr, P-3060197 Cantanhede, Portugal.
   [Sundback, Cathryn; Pryor, Howard; Pomerantseva, Irina; Vacanti, Joseph] Massachusetts Gen Hosp, Ctr Regenerat Med, Boston, MA 02114 USA.
   [Masiakos, Peter T.; Vacanti, Joseph] Massachusetts Gen Hosp, Dept Pediat Surg, Boston, MA 02114 USA.
   [Faquin, William] Massachusetts Gen Hosp, Dept Pathol, Boston, MA 02114 USA.
   [Sundback, Cathryn; Pryor, Howard; Pomerantseva, Irina; Masiakos, Peter T.; Faquin, William; Vacanti, Joseph] Harvard Univ, Sch Med, Boston, MA 02115 USA.
   [Nichol, Jason W.; Chan, Edwin P.; Bettinger, Chris J.; Langer, Robert; Karp, Jeffrey M.] Harvard Univ, MIT, Div Hlth Sci & Technol, Cambridge, MA 02139 USA.
   [Carter, David J. D.; Borenstein, Jeffrey] Charles Stark Draper Lab Inc, Cambridge, MA 02139 USA.
   [Zumbuehl, Andreas] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Karp, Jeffrey M.] Brigham & Womens Hosp, Ctr Biomed Engn, Boston, MA 02115 USA.
RP Langer, R (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.
EM rlanger@mit.edu; jkarp@rics.bwh.harvard.edu
RI Chan, Edwin/G-1904-2011; Borenstein, Jeffrey/K-5459-2019; Abrams,
   William R/A-5782-2008; Bettinger, Christopher/A-3895-2009; Zumbuehl,
   Andreas/C-5324-2008
OI Borenstein, Jeffrey/0000-0002-4482-3274; Bettinger,
   Christopher/0000-0002-6564-5681; Patanavanich,
   Siamrut/0000-0002-1632-1525; ferreira, lino/0000-0001-8985-9302;
   Zumbuehl, Andreas/0000-0002-8003-4432
FU NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Dental & Craniofacial Research (NIDCR)
   [R01DE013023, R01DE013023, R01DE013023, R01DE013023, R01DE013023,
   R01DE013023, R01DE013023, R01DE013023] Funding Source: NIH RePORTER;
   NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCHUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Dental & Craniofacial Research (NIDCR)
   [R01DE013023, R01DE013023, R01DE013023, R01DE013023, R01DE013023,
   R01DE013023, R01DE013023, R01DE013023, R01DE013023, R01DE013023,
   R01DE013023, R01DE013023] Funding Source: NIH RePORTER; NIDCR NIH
   HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Dental &
   Craniofacial Research (NIDCR) [DE013023, R01 DE013023] Funding Source:
   Medline
CR Autumn K, 2006, J EXP BIOL, V209, P3569, DOI 10.1242/jeb.02486
   Autumn K, 2002, P NATL ACAD SCI USA, V99, P12252, DOI 10.1073/pnas.192252799
   Autumn K, 2000, NATURE, V405, P681
   Autumn K, 2006, J COMP PHYSIOL A, V192, P1205, DOI 10.1007/s00359-006-0149-y
   Chan EP, 2007, MRS BULL, V32, P496, DOI 10.1557/mrs2007.84
   Crosby AJ, 2005, LANGMUIR, V21, P11738, DOI 10.1021/la051721k
   Ferreira L, 2002, BIOMATERIALS, V23, P3957, DOI 10.1016/S0142-9612(02)00132-1
   Geim AK, 2003, NAT MATER, V2, P461, DOI 10.1038/nmat917
   Hansen WR, 2005, P NATL ACAD SCI USA, V102, P385, DOI 10.1073/pnas.0408304102
   Huber G, 2005, P NATL ACAD SCI USA, V102, P16293, DOI 10.1073/pnas.0506328102
   Lee H, 2007, NATURE, V448, P338, DOI 10.1038/nature05968
   Maia J, 2005, POLYMER, V46, P9604, DOI 10.1016/j.polymer.2005.07.089
   Mo XM, 2000, J BIOMAT SCI-POLYM E, V11, P341, DOI 10.1163/156856200743742
   Nijst CLE, 2007, BIOMACROMOLECULES, V8, P3067, DOI 10.1021/bm070423u
   Pennisi E, 2000, SCIENCE, V288, P1717
   Santerre JP, 1997, J BIOMED MATER RES, V36, P223
   SOMANI BL, 1987, ANAL BIOCHEM, V167, P327, DOI 10.1016/0003-2697(87)90172-2
   Sun WX, 2005, BIOPHYS J, V89, pL14, DOI 10.1529/biophysj.105.065268
   Sundback CA, 2005, BIOMATERIALS, V26, P5454, DOI 10.1016/j.biomaterials.2005.02.004
   Wang DA, 2007, NAT MATER, V6, P385, DOI 10.1038/nmat1890
   Wang YD, 2002, NAT BIOTECHNOL, V20, P602, DOI 10.1038/nbt0602-602
NR 21
TC 337
Z9 343
U1 6
U2 216
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD FEB 19
PY 2008
VL 105
IS 7
BP 2307
EP 2312
DI 10.1073/pnas.0712117105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 266XB
UT WOS:000253469900013
PM 18287082
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Rezen, T
   Juvan, P
   Tacer, KF
   Kuzman, D
   Roth, A
   Pompon, D
   Aggerbeck, LP
   Meyer, UA
   Rozman, D
AF Rezen, Tadeja
   Juvan, Peter
   Tacer, Klementina Fon
   Kuzman, Drago
   Roth, Adrian
   Pompon, Denis
   Aggerbeck, Lawrence P.
   Meyer, Urs A.
   Rozman, Damjana
TI The Sterolgene v0 cDNA microarray: a systemic approach to studies of
   cholesterol homeostasis and drug metabolism
SO BMC GENOMICS
LA English
DT Article
ID GENE-EXPRESSION MEASUREMENTS; NUCLEAR RECEPTORS; CAR; REPRODUCIBILITY;
   NORMALIZATION; INDUCTION; LXR; INCONSISTENCIES; PLATFORMS; SIGNATURE
AB Background: Cholesterol homeostasis and xenobiotic metabolism are complex biological processes, which are difficult to study with traditional methods. Deciphering complex regulation and response of these two processes to different factors is crucial also for understanding of disease development. Systems biology tools as are microarrays can importantly contribute to this knowledge and can also discover novel interactions between the two processes.
   Results: We have developed a low density Sterolgene v0 cDNA microarray dedicated to studies of cholesterol homeostasis and drug metabolism in the mouse. To illustrate its performance, we have analyzed mouse liver samples from studies focused on regulation of cholesterol homeostasis and drug metabolism by diet, drugs and inflammation. We observed down- regulation of cholesterol biosynthesis during fasting and high- cholesterol diet and subsequent up- regulation by inflammation. Drug metabolism was down- regulated by fasting and inflammation, but up- regulated by phenobarbital treatment and high- cholesterol diet. Additionally, the performance of the Sterolgene v0 was compared to the two commercial high density microarray platforms: the Agilent cDNA ( G4104A) and the Affymetrix MOE430A GeneChip. We hybridized identical RNA samples to the commercial microarrays and showed that the performance of Sterolgene is comparable to commercial arrays in terms of detection of changes in cholesterol homeostasis and drug metabolism.
   Conclusion: Using the Sterolgene v0 microarray we were able to detect important changes in cholesterol homeostasis and drug metabolism caused by diet, drugs and inflammation. Together with its next generations the Sterolgene microarrays represent original and dedicated tools enabling focused and cost effective studies of cholesterol homeostasis and drug metabolism. These microarrays have the potential of being further developed into screening or diagnostic tools.
C1 [Rezen, Tadeja; Tacer, Klementina Fon; Rozman, Damjana] Univ Ljubljana, Fac Med, Inst Biochem, Ctr Funct Gen & Biochips, SI-1000 Ljubljana, Slovenia.
   [Kuzman, Drago] Lek Pharmaceut DD, SI-1000 Ljubljana, Slovenia.
   [Roth, Adrian; Meyer, Urs A.] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Pompon, Denis; Aggerbeck, Lawrence P.] CNRS, F-91198 Gif Sur Yvette, France.
RP Rozman, D (corresponding author), Univ Ljubljana, Fac Med, Inst Biochem, Ctr Funct Gen & Biochips, Zaloska 4, SI-1000 Ljubljana, Slovenia.
EM tadeja.rezen@mf.uni-lj.si; peter.juvan@fri.uni-lj.si;
   klementina.fon-tacer@mf.uni-lj.si; drago.kuzman@sandoz.com;
   adrian_b.roth@roche.com; Denis.Pompon@cgm.cnrs-gif.fr;
   aggerbeck@cgm.cnrs-gif.fr; Urs-A.Meyer@unibas.ch;
   damjana.rozman@mf.uni-lj.si
OI Rozman, Damjana/0000-0002-6501-2163; Juvan, Peter/0000-0003-2873-5247
CR Ach RA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-148
   Bammler T, 2005, NAT METHODS, V2, P351, DOI 10.1038/nmeth0605-477a
   Bauer M, 2004, PHYSIOL GENOMICS, V17, P230, DOI 10.1152/physiolgenomics.00203.2003
   Carter SL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-107
   CLEVELAND WS, 1988, J AM STAT ASSOC, V83, P596, DOI 10.2307/2289282
   de Longueville F, 2002, BIOCHEM PHARMACOL, V64, P137, DOI 10.1016/S0006-2952(02)01055-9
   DEMSAR J, 2004, ORANGE EXPT MACHINE, P15
   Glas AM, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-278
   Gupta S, 2002, BIOCHEM BIOPH RES CO, V293, P338, DOI 10.1016/S0006-291X(02)00229-2
   Gwinn MR, 2005, OMICS, V9, P334, DOI 10.1089/omi.2005.9.334
   Handschin C, 2005, ARCH BIOCHEM BIOPHYS, V433, P387, DOI 10.1016/j.abb.2004.08.030
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Inoue A, 2002, J MOL ENDOCRINOL, V29, P175, DOI 10.1677/jme.0.0290175
   Irizarry RA, 2005, NAT METHODS, V2, P345, DOI 10.1038/nmeth756
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Jarvinen AK, 2004, GENOMICS, V83, P1164, DOI 10.1016/j.ygeno.2004.01.004
   Jover R, 1996, BIOCHEM BIOPH RES CO, V226, P152, DOI 10.1006/bbrc.1996.1325
   Kothapalli R, 2002, BMC BIOINFORMATICS, V3, DOI 10.1186/1471-2105-3-22
   Larkin JE, 2005, NAT METHODS, V2, P337, DOI 10.1038/nmeth757
   Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262
   Maxwell KN, 2003, J LIPID RES, V44, P2109, DOI 10.1194/jlr.M300203-JLR200
   Mecham BH, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh071
   Newton SS, 2005, METHODS, V37, P238, DOI 10.1016/j.ymeth.2005.09.004
   Nielsen HB, 2002, BIOINFORMATICS, V18, P321, DOI 10.1093/bioinformatics/18.2.321
   Ohta H, 2005, ATHEROSCLEROSIS, V180, P11, DOI 10.1016/j.atherosclerosis.2004.11.016
   Oscarson M, 2006, CLIN PHARMACOL THER, V80, P440, DOI 10.1016/j.clpt.2006.08.013
   Patterson TA, 2006, NAT BIOTECHNOL, V24, P1140, DOI 10.1038/nbt1242
   Perez-Iratxeta C, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-183
   Repa JJ, 2000, ANNU REV CELL DEV BI, V16, P459, DOI 10.1146/annurev.cellbio.16.1.459
   Saal LH, 2002, GENOME BIOL, V3
   Shi LM, 2006, NAT BIOTECHNOL, V24, P1151, DOI 10.1038/nbt1239
   TACER KF, 2007, PHYSL GENOMICS
   Tan PK, 2003, NUCLEIC ACIDS RES, V31, P5676, DOI 10.1093/nar/gkg763
   Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1
   Van Ess PJ, 2002, J PHARMACOL EXP THER, V300, P824, DOI 10.1124/jpet.300.3.824
   Verdugo RA, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-58
   Wang HX, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-71
   Waxman DJ, 1999, ARCH BIOCHEM BIOPHYS, V369, P11, DOI 10.1006/abbi.1999.1351
   Wei P., 2002, Pharmacogenomics Journal, V2, P117, DOI 10.1038/sj.tpj.6500087
   Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15
   Yauk CL, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-266
NR 41
TC 19
Z9 20
U1 0
U2 0
PU BMC
PI LONDON
PA CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1471-2164
J9 BMC GENOMICS
JI BMC Genomics
PD FEB 11
PY 2008
VL 9
AR 76
DI 10.1186/1471-2164-9-76
PG 15
WC Biotechnology & Applied Microbiology; Genetics & Heredity
SC Biotechnology & Applied Microbiology; Genetics & Heredity
GA 274GB
UT WOS:000253988700001
PM 18261244
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Meier, S
   Blackledge, M
   Grzesiek, S
AF Meier, Sebastian
   Blackledge, Martin
   Grzesiek, Stephan
TI Conformational distributions of unfolded polypeptides from novel NMR
   techniques
SO JOURNAL OF CHEMICAL PHYSICS
LA English
DT Review
ID RESIDUAL DIPOLAR COUPLINGS; X-RAY-SCATTERING; 8 M UREA; PROTEIN
   SECONDARY STRUCTURE; LIQUID-CRYSTALLINE MEDIA; LONG-RANGE INTERACTIONS;
   RANDOM-COIL BEHAVIOR; DENATURED STATE; ALPHA-SYNUCLEIN; STAPHYLOCOCCAL
   NUCLEASE
AB How the information content of an unfolded polypeptide sequence directs a protein towards a well-formed three-dimensional structure during protein folding remains one of the fundamental questions in structural biology. Unfolded proteins have recently attracted further interest due to their surprising prevalence in the cellular milieu, where they fulfill not only central regulatory functions, but also are implicated in diseases involving protein aggregation. The understanding of both the protein folding transition and these often natively unfolded proteins hinges on a more detailed experimental characterization of the conformations and conformational transitions in the unfolded state. This description is intrinsically very difficult due to the very large size of the conformational space. In principle, solution NMR can monitor unfolded polypeptide conformations and their transitions at atomic resolution. However, traditional NMR parameters such as chemical shifts, J couplings, and nuclear Overhauser enhancements yield only rather limited and often qualitative descriptions. This situation has changed in recent years by the introduction of residual dipolar couplings and paramagnetic relaxation enhancements, which yield a high number of well-defined, quantitative parameters reporting on the averages of local conformations and long-range interactions even under strongly denaturing conditions. This information has been used to obtain plausible all-atom models of the unfolded state at increasing accuracy. Currently, the best working model is the coil model, which derives amino acid specific local conformations from the distribution of amino acid torsion angles in the nonsecondary structure conformations of the protein data bank. Deviations from the predictions of such models can often be interpreted as increased order resulting from long-range contacts within the unfolded ensemble. (c) 2008 American Institute of Physics.
C1 [Meier, Sebastian] Carlsberg Lab, DK-2500 Copenhagen, Denmark.
   [Blackledge, Martin] CNRS, CEA, Inst Biol Struct Jean Pierre Ebel, UJF UMR 5075, F-38027 Grenoble, France.
   [Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Meier, S (corresponding author), Carlsberg Lab, Gamle Carlsberg Vej 10, DK-2500 Copenhagen, Denmark.
EM martin.blackledge@ibs.fr; stephan.grzesiek@unibas.ch
RI Meier, Sebastian/A-4279-2015
OI Meier, Sebastian/0000-0003-3761-3217; Grzesiek,
   Stephan/0000-0003-1998-4225
CR Alexandrescu AT, 2003, PROTEIN SCI, V12, P2132, DOI 10.1110/ps.03164403
   ALEXANDRESCU AT, 1994, BIOCHEMISTRY-US, V33, P1063, DOI 10.1021/bi00171a004
   Almond A, 2002, J AM CHEM SOC, V124, P9986, DOI 10.1021/ja026876i
   Bernado P, 2004, J AM CHEM SOC, V126, P4907, DOI 10.1021/ja036977w
   Bernado P, 2005, J AM CHEM SOC, V127, P17968, DOI 10.1021/ja055538p
   Bernado P, 2005, P NATL ACAD SCI USA, V102, P17002, DOI 10.1073/pnas.0506202102
   Bernado P, 2007, J AM CHEM SOC, V129, P5656, DOI 10.1021/ja069124n
   Bertoncini CW, 2005, P NATL ACAD SCI USA, V102, P1430, DOI 10.1073/pnas.0407146102
   Bertoncini CW, 2005, J BIOL CHEM, V280, P30649, DOI 10.1074/jbc.C500288200
   Bieri O, 1999, P NATL ACAD SCI USA, V96, P9597, DOI 10.1073/pnas.96.17.9597
   BUNDI A, 1979, BIOPOLYMERS, V18, P285, DOI 10.1002/bip.1979.360180206
   CANTOR CR, 1980, BIOPHYSICAL CHEM, V2, P22902
   Chikenji G, 2006, P NATL ACAD SCI USA, V103, P3141, DOI 10.1073/pnas.0508195103
   Cho MK, 2007, J AM CHEM SOC, V129, P3032, DOI 10.1021/ja067482k
   Choy WY, 2003, J AM CHEM SOC, V125, P11988, DOI 10.1021/ja035705q
   Choy WY, 2002, J MOL BIOL, V316, P101, DOI 10.1006/jmbi.2001.5328
   Choy WY, 2003, J AM CHEM SOC, V125, P1748, DOI 10.1021/ja021179b
   Clore GM, 1998, J AM CHEM SOC, V120, P10571, DOI 10.1021/ja982592f
   Dames SA, 2006, J AM CHEM SOC, V128, P13508, DOI 10.1021/ja063606h
   Dedmon MM, 2005, J AM CHEM SOC, V127, P476, DOI 10.1021/ja044834j
   Ding KY, 2004, J MOL BIOL, V335, P1299, DOI 10.1016/j.jmb.2003.11.042
   Fieber W, 2004, J MOL BIOL, V339, P1191, DOI 10.1016/j.jmb.2004.04.037
   Fiebig KM, 1996, J PHYS CHEM-US, V100, P2661, DOI 10.1021/jp952747v
   Fitzkee NC, 2005, TRENDS BIOCHEM SCI, V30, P73, DOI 10.1016/j.tibs.2004.12.005
   Fitzkee NC, 2005, PROTEINS, V58, P852, DOI 10.1002/prot.20394
   Fitzkee NC, 2004, P NATL ACAD SCI USA, V101, P12497, DOI 10.1073/pnas.0404236101
   Francis CJ, 2006, PROTEINS, V65, P145, DOI 10.1002/prot.21077
   Gebel EB, 2006, J AM CHEM SOC, V128, P9310, DOI 10.1021/ja0627693
   Gillespie JR, 1997, J MOL BIOL, V268, P170, DOI 10.1006/jmbi.1997.0953
   Graf J, 2007, J AM CHEM SOC, V129, P1179, DOI 10.1021/ja0660406
   Hansen MR, 1998, NAT STRUCT BIOL, V5, P1065, DOI 10.1038/4176
   Havlin RH, 2005, P NATL ACAD SCI USA, V102, P3284, DOI 10.1073/pnas.0406130102
   Hoffmann A, 2007, P NATL ACAD SCI USA, V104, P105, DOI 10.1073/pnas.0604353104
   HOWARTH OW, 1978, PROG NUCL MAG RES SP, V12, P1, DOI 10.1016/0079-6565(78)80001-6
   Jha AK, 2005, P NATL ACAD SCI USA, V102, P13099, DOI 10.1073/pnas.0506078102
   Klein-Seetharaman J, 2002, SCIENCE, V295, P1719, DOI 10.1126/science.1067680
   Kohn JE, 2004, P NATL ACAD SCI USA, V101, P12491, DOI 10.1073/pnas.0403643101
   Korzhnev DM, 2004, NATURE, V430, P586, DOI 10.1038/nature02655
   Kristjansdottir S, 2005, J MOL BIOL, V347, P1053, DOI 10.1016/j.jmb.2005.01.009
   Laurence TA, 2005, P NATL ACAD SCI USA, V102, P17348, DOI 10.1073/pnas.0508584102
   LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044
   Lindorff-Larsen K, 2004, J AM CHEM SOC, V126, P3291, DOI 10.1021/ja039250g
   Lipfert J, 2007, ANNU REV BIOPH BIOM, V36, P307, DOI 10.1146/annurev.biophys.36.040306.132655
   Louhivuori M, 2003, J AM CHEM SOC, V125, P15647, DOI 10.1021/ja035427v
   Louhivuori M, 2004, J BIOMOL NMR, V29, P517, DOI 10.1023/B:JNMR.0000034347.01925.ad
   Louhivuori M, 2007, J BIOMOL NMR, V39, P141, DOI 10.1007/s10858-007-9182-6
   Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286
   Marsh JA, 2007, J MOL BIOL, V367, P1494, DOI 10.1016/j.jmb.2007.01.038
   Marsh JA, 2006, PROTEIN SCI, V15, P2795, DOI 10.1110/ps.062465306
   Massad T, 2007, J BIOMOL NMR, V38, P107, DOI 10.1007/s10858-007-9150-1
   Meier S, 2003, J AM CHEM SOC, V125, P44, DOI 10.1021/ja028740q
   Meier S, 2004, J MOL BIOL, V344, P1051, DOI 10.1016/j.jmb.2004.09.079
   Meier S, 2007, J AM CHEM SOC, V129, P9799, DOI 10.1021/ja0724339
   Meier S, 2007, J AM CHEM SOC, V129, P754, DOI 10.1021/ja067522k
   Meiler J, 2001, J AM CHEM SOC, V123, P6098, DOI 10.1021/ja010002z
   Millet IS, 2002, ADV PROTEIN CHEM, V62, P241
   MIRANKER A, 1991, NATURE, V349, P633, DOI 10.1038/349633a0
   Mittag T, 2007, CURR OPIN STRUC BIOL, V17, P3, DOI 10.1016/j.sbi.2007.01.009
   Mohana-Borges R, 2004, J MOL BIOL, V340, P1131, DOI 10.1016/j.jmb.2004.05.022
   Mukrasch MD, 2007, J AM CHEM SOC, V129, P5235, DOI 10.1021/ja0690159
   Mukrasch MD, 2007, J BIOL CHEM, V282, P12230, DOI 10.1074/jbc.M607159200
   Mukrasch MD, 2005, J BIOL CHEM, V280, P24978, DOI 10.1074/jbc.M501565200
   NERI D, 1992, SCIENCE, V257, P1559, DOI 10.1126/science.1523410
   Nettels D, 2007, P NATL ACAD SCI USA, V104, P2655, DOI 10.1073/pnas.0611093104
   Obolensky OI, 2007, J BIOMOL NMR, V39, P1, DOI 10.1007/s10858-007-9169-3
   Ohnishi S, 2003, PROTEINS, V50, P546, DOI 10.1002/prot.10327
   Ohnishi S, 2004, BIOCHEMISTRY-US, V43, P4064, DOI 10.1021/bi049879b
   Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i
   RODER H, 1985, BIOCHEMISTRY-US, V24, P7407, DOI 10.1021/bi00346a056
   Rose GD, 2006, P NATL ACAD SCI USA, V103, P16623, DOI 10.1073/pnas.0606843103
   Ruckert M, 2000, J AM CHEM SOC, V122, P7793, DOI 10.1021/ja001068h
   Salamat G, 1999, LANGMUIR, V15, P5414, DOI 10.1021/la980928t
   Sallum CO, 2005, BIOCHEMISTRY-US, V44, P6392, DOI 10.1021/bi0473410
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   Schwalbe H, 1997, BIOCHEMISTRY-US, V36, P8977, DOI 10.1021/bi970049q
   Schwarzinger S, 2002, BIOCHEMISTRY-US, V41, P12681, DOI 10.1021/bi020381o
   SERRANO L, 1995, J MOL BIOL, V254, P322, DOI 10.1006/jmbi.1995.0619
   Shakhnovich E, 2006, CHEM REV, V106, P1559, DOI 10.1021/cr040425u
   Shortle D, 1996, FASEB J, V10, P27
   Shortle D, 2002, PROTEIN SCI, V11, P18, DOI 10.1110/ps.ps.31002
   Shortle D, 2001, SCIENCE, V293, P487, DOI 10.1126/science.1060438
   Sibille N, 2006, BIOCHEMISTRY-US, V45, P12560, DOI 10.1021/bi060964o
   Simons KT, 1997, J MOL BIOL, V268, P209, DOI 10.1006/jmbi.1997.0959
   Skora L, 2006, ANGEW CHEM INT EDIT, V45, P7012, DOI 10.1002/anie.200602317
   Smith LJ, 1996, J MOL BIOL, V255, P494, DOI 10.1006/jmbi.1996.0041
   SPERA S, 1991, J AM CHEM SOC, V113, P5490, DOI 10.1021/ja00014a071
   SWINDELLS MB, 1995, NAT STRUCT BIOL, V2, P596, DOI 10.1038/nsb0795-596
   TANFORD C, 1966, J BIOL CHEM, V241, P1921
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   TOLMAN JR, 1995, P NATL ACAD SCI USA, V92, P9279, DOI 10.1073/pnas.92.20.9279
   Tolman JR, 1997, NAT STRUCT BIOL, V4, P292, DOI 10.1038/nsb0497-292
   Tran HT, 2006, BIOPHYS J, V91, P1868, DOI 10.1529/biophysj.106.086264
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   van Gunsteren WF, 2001, ANGEW CHEM INT EDIT, V40, P351, DOI 10.1002/1521-3773(20010119)40:2<351::AID-ANIE351>3.0.CO;2-6
   Wang YJ, 2002, PROTEIN SCI, V11, P852, DOI 10.1110/ps.3180102
   WISHART DS, 1995, J BIOMOL NMR, V5, P67, DOI 10.1007/BF00227471
   WISHART DS, 1992, BIOCHEMISTRY-US, V31, P1647, DOI 10.1021/bi00121a010
   Wu ZR, 2002, J AM CHEM SOC, V124, P9672, DOI 10.1021/ja026845n
   ZWANZIG R, 1992, P NATL ACAD SCI USA, V89, P20, DOI 10.1073/pnas.89.1.20
   Zweckstetter M, 2000, J AM CHEM SOC, V122, P3791, DOI 10.1021/ja0000908
   Zweckstetter M, 2001, J BIOMOL NMR, V20, P365, DOI 10.1023/A:1011263920003
NR 102
TC 76
Z9 76
U1 0
U2 19
PU AMER INST PHYSICS
PI MELVILLE
PA 1305 WALT WHITMAN RD, STE 300, MELVILLE, NY 11747-4501 USA
SN 0021-9606
EI 1089-7690
J9 J CHEM PHYS
JI J. Chem. Phys.
PD FEB 7
PY 2008
VL 128
IS 5
AR 052204
DI 10.1063/1.2838167
PG 14
WC Chemistry, Physical; Physics, Atomic, Molecular & Chemical
SC Chemistry; Physics
GA 262CD
UT WOS:000253125700006
PM 18266409
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Nyfeler, B
   Kamiya, Y
   Boehlen, F
   Yamamoto, K
   Kato, K
   de Moerloose, P
   Hauri, HP
   Neerman-Arbez, M
AF Nyfeler, Beat
   Kamiya, Yukiko
   Boehlen, Francoise
   Yamamoto, Kazuo
   Kato, Koichi
   de Moerloose, Philippe
   Hauri, Hans-Peter
   Neerman-Arbez, Marguerite
TI Deletion of 3 residues from the C-terminus of MCFD2 affects binding to
   ERGIC-53 and causes combined factor V and factor VIII deficiency
SO BLOOD
LA English
DT Article
ID MUTATIONS; GENE; FAMILIES; COMPARTMENT; COMPLEX; LMAN1; F5F8D
AB Combined factor V and factor VIII deficiency (F5F8D) is a rare, autosomal recessive coagulation disorder. F5F8D is genetically linked to mutations in the transmembrane lectin ERGIC-53 and its soluble interaction partner MCFD2. The ERGIC-53/MCFD2 protein complex functions as transport receptor of coagulation factors V and VIII by mediating their export from the endoplasmic reticulum (ER). Here, we studied a F5F8D patient who was found to be a compound heterozygote for 2 novel mutations in MCFD2: a large deletion of 8.4 kb eliminating the 5'UTR of the gene and a nonsense mutation resulting in the deletion of only 3 amino acids (Delta SLQ) from the C-terminus of MCFD2. Biochemical and structural analysis of the Delta SLQ mutant demonstrated impaired binding to ERGIC-53 due to modification of the 3-dimensional structure of MCFD2. Our results highlight the importance of the ERGIC-53/MCFD2 protein interaction for the efficient secretion of coagulation factors V and VIII.
C1 [Nyfeler, Beat; Hauri, Hans-Peter] Univ Basel, Biozentrum, CH-4003 Basel, Switzerland.
   [Kamiya, Yukiko; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Nagoya, Aichi, Japan.
   [Boehlen, Francoise; de Moerloose, Philippe; Neerman-Arbez, Marguerite] Univ Hosp Geneva, Div Angiol & Hemostas, Geneva, Switzerland.
   [Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Chiba, Japan.
   [Kato, Koichi] Natl Inst Nat Sci, Inst Mol Sci, Okazaki, Aichi, Japan.
   [Neerman-Arbez, Marguerite] Univ Med Sch Geneva, Dept Med Genet, Geneva, Switzerland.
RP Neerman-Arbez, M (corresponding author), Dept Med Genet & Dev, 1 Rue Michel Servet, CH-1211 Geneva, Switzerland.
EM Marguerite.Arbez@medecine.unige.ch
OI Kato, Koichi/0000-0001-7187-9612; Neerman-Arbez,
   Marguerite/0000-0002-9351-4195
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [18390016] Funding Source: KAKEN
CR Harlow E., 1999, USING ANTIBODIES LAB
   Jayandharan G, 2007, HAEMOPHILIA, V13, P413, DOI 10.1111/j.1365-2516.2007.01477.x
   Mohanty D, 2005, AM J HEMATOL, V79, P262, DOI 10.1002/ajh.20397
   Neerman-Arbez M, 1999, BLOOD, V93, P2253
   NeermanArbez M, 1997, AM J HUM GENET, V61, P143, DOI 10.1086/513897
   Nichols WC, 1997, J CLIN INVEST, V99, P596, DOI 10.1172/JCI119201
   Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0
   Nichols WC, 1999, BLOOD, V93, P2261
   Nyfeler B, 2006, TRAFFIC, V7, P1473, DOI 10.1111/j.1600-0854.2006.00483.x
   OERI J, 1954, Bibl Paediatr, V58, P575
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Sirachainan N, 2005, HAEMOPHILIA, V11, P280, DOI 10.1111/j.1365-2516.2005.01092.x
   Zhang B, 2006, BLOOD, V107, P1903, DOI 10.1182/blood-2005-09-3620
   Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200
   Zhang B, 2004, J THROMB HAEMOST, V2, P1564, DOI 10.1111/j.1538-7836.2004.00857.x
   Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153
NR 16
TC 15
Z9 15
U1 0
U2 1
PU AMER SOC HEMATOLOGY
PI WASHINGTON
PA 1900 M STREET. NW SUITE 200, WASHINGTON, DC 20036 USA
SN 0006-4971
J9 BLOOD
JI Blood
PD FEB 1
PY 2008
VL 111
IS 3
BP 1299
EP 1301
DI 10.1182/blood-2007-09-112854
PG 3
WC Hematology
SC Hematology
GA 257IR
UT WOS:000252792900055
PM 17971482
DA 2021-01-25
ER

PT J
AU Knechtle, B
   Fraire, OS
   Andonie, JL
   Kohler, G
AF Knechtle, B.
   Fraire, O. Salas
   Andonie, J. L.
   Kohler, G.
TI Effect of a multistage ultra-endurance triathlon on body composition:
   World Challenge Deca Iron Triathlon 2006
SO BRITISH JOURNAL OF SPORTS MEDICINE
LA English
DT Article
ID BIOELECTRICAL-IMPEDANCE; ENERGY-BALANCE; WEIGHT CHANGES; RACE; RUN;
   PERFORMANCE; METABOLISM; RESPONSES; FITNESS; FAT
AB Objective: To investigate the effect of a multistage ultra-endurance triathlon on body composition in ultra-triathletes.
   Design: Descriptive field study.
   Setting: The "World Challenge Deca Iron Triathlon 2006'' in Monterrey, Mexico, in which every day for 10 consecutive days athletes had to perform the distance of one Ironman triathlon.
   Subjects: Eight male ultra-endurance athletes (mean (SD) age 40.6 (10.7) years, weight 76.4 (8.4) kg, height 175 (4) cm and body mass index (BMI) 24.7 (2.2) kg/m(2)).
   Interventions: None.
   Main outcome measurements: Determination of body mass, protein mass, body fat, per cent body fat, mineral mass, total body water, intracellular water, extracellular water and lean body mass with a direct segmental multifrequency bioelectrical impedance method before the race and after each stage in order to show changes in body composition.
   Results: A statistically significant decrease of body mass (22.4 kg, p = 0.014), body fat (25 kg, p = 0.0078) and per cent body fat (26.4%, p = 0.0078) occurred at the end of the first day compared to values taken in the prerace period. In contrast, at the same time, a statistically significant increase of protein mass (+ 0.7 kg, p = 0.035), mineral mass (+ 0.2 kg, p = 0.04), total body water (+ 1.8 litres, p = 0.042), intracellular water (+ 1.6 litres, p = 0.034) and lean body mass (+ 2.6 kg, p = 0.023) was shown. After the first day until the end of the challenge, body fat (23 kg, p > 0.05) and per cent body fat (-3.9%, p > 0.05) showed a statistically significant decrease, whereas the other parameters showed no changes.
   Conclusions: Athletes taking part in a multistage ultra-endurance triathlon over 10 Ironman triathlon distances in 10 consecutive days lost 3 kg of body fat; skeletal muscle mass, mineral mass and body water were unchanged.
C1 [Knechtle, B.] Gesundheitszentrum St Gallen, St Gallen, Switzerland.
   [Fraire, O. Salas] Univ Autonoma Nuevo Leon, Nuevo, Leon, Mexico.
   [Andonie, J. L.] Multisport Andonie, Nuevo, Leon, Mexico.
   [Kohler, G.] Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
RP Knechtle, B (corresponding author), Vadianstr 26, St Gallen, Switzerland.
EM beat.knechtle@hispeed.ch
CR Bircher S, 2006, J SPORT SCI MED, V5, P154
   Broeder CE, 1997, MED SCI SPORT EXER, V29, P705, DOI 10.1097/00005768-199705000-00019
   Cox C, 2003, INT J SPORT NUTR EXE, V13, P286, DOI 10.1123/ijsnem.13.3.286
   Daniel John A., 2005, Biomedical Instrumentation & Technology, V39, P397, DOI 10.2345/0899-8205(2005)39[397:EOBCMF]2.0.CO;2
   DAVIES CTM, 1986, J APPL PHYSIOL, V61, P611
   DEWAART FG, 1993, BRIT J NUTR, V69, P657, DOI 10.1079/BJN19930067
   DRESSENDORFER RH, 1991, MED SCI SPORT EXER, V23, P954
   Fornetti WC, 1999, J APPL PHYSIOL, V87, P1114
   Frykman PN, 2003, WILD ENVIRON MED, V14, P240, DOI 10.1580/1080-6032(2003)14[240:EOAMEE]2.0.CO;2
   Gualdi-Russo Emanuela, 1997, Zeitschrift fuer Morphologie und Anthropologie, V81, P321
   Helge JW, 2003, J EXP BIOL, V206, P1075, DOI 10.1242/jeb.00218
   HOCHLI D, 1995, INT J SPORTS MED, V16, P343, DOI 10.1055/s-2007-973017
   Kimber NE, 2002, INT J SPORT NUTR EXE, V12, P47, DOI 10.1123/ijsnem.12.1.47
   Kitano T, 2001, J NUTR SCI VITAMINOL, V47, P122, DOI 10.3177/jnsv.47.122
   Knechtle B, 2005, Praxis (Bern 1994), V94, P371
   Knechtle B, 2005, INT J SPORTS MED, V26, P499, DOI 10.1055/s-2004-821136
   Laursen PB, 2006, BRIT J SPORT MED, V40, P320, DOI 10.1136/bjsm.2005.022426
   LEHMANN M, 1995, INT J SPORTS MED, V16, P155, DOI 10.1055/s-2007-972984
   Macfarlane DJ, 2007, ASIA PAC J CLIN NUTR, V16, P66
   NAGEL D, 1989, EUR J APPL PHYSIOL O, V59, P16, DOI 10.1007/BF02396574
   R Development Core Team, 2005, R LANG ENV STAT COMP
   Raschka C, 1992, Schweiz Z Sportmed, V40, P13
   RASCHKA C, 1991, Z ERNAHRUNGSWISS, V30, P276, DOI 10.1007/BF01651957
   Reynolds RD, 1999, J NUTR, V129, P1307
   Saunders MJ, 1998, MED SCI SPORT EXER, V30, P885, DOI 10.1097/00005768-199806000-00017
   Sharwood KA, 2004, BRIT J SPORT MED, V38, P718, DOI 10.1136/bjsm.2003.007187
   Speedy DB, 2001, CLIN J SPORT MED, V11, P44, DOI 10.1097/00042752-200101000-00008
   Speedy DB, 1997, CLIN J SPORT MED, V7, P100, DOI 10.1097/00042752-199704000-00005
   Vaananen II, 2005, J SPORT MED PHYS FIT, V45, P301
   Vasudev Sudha, 2004, J Assoc Physicians India, V52, P877
NR 30
TC 46
Z9 46
U1 0
U2 4
PU B M J PUBLISHING GROUP
PI LONDON
PA BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND
SN 0306-3674
J9 BRIT J SPORT MED
JI Br. J. Sports Med.
PD FEB
PY 2008
VL 42
IS 2
BP 121
EP 125
DI 10.1136/bjsm.2007.038034
PG 5
WC Sport Sciences
SC Sport Sciences
GA 259RU
UT WOS:000252957200008
PM 17601765
OA Green Accepted
DA 2021-01-25
ER

PT J
AU di Sanguinetto, SADT
   Dasen, JS
   Arber, S
AF di Sanguinetto, Simon A. Dalla Torre
   Dasen, Jeremy S.
   Arber, Silvia
TI Transcriptional mechanisms controlling motor neuron diversity and
   connectivity
SO CURRENT OPINION IN NEUROBIOLOGY
LA English
DT Review
ID SPINAL-CORD DEVELOPMENT; LIM HOMEOBOX GENES; CHICK HIND-LIMB; POOL
   IDENTITY; SENSORY AFFERENTS; EXPRESSION; MOTONEURONS; AXONS; PEA3;
   SPECIFICATION
AB The control of movement relies on the precision with which motor circuits are assembled during development. Spinal motor neurons (MNs) provide the trigger to signal the appropriate sequence of muscle contractions and initiate movement. This task is accommodated by the diversification of MNs into discrete subpopulations, each of which acquires precise axonal trajectories and central connectivity patterns. An upstream Hox factor-based regulatory network in MNs defines their competence to deploy downstream programs including the expression of Nkx and ETS transcription factors. These interactive transcriptional programs coordinate MN differentiation and connectivity, defining a sophisticated roadmap of motor circuit assembly in the spinal cord. Similar principles using modular interaction of transcriptional programs to control neuronal diversification and circuit connectivity are likely to act in other CNS circuits.
C1 [Dasen, Jeremy S.] NYU, Sch Med, Dept Physiol & Neurosci, Smilow Neurosci Program, New York, NY 10016 USA.
   [di Sanguinetto, Simon A. Dalla Torre; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   [di Sanguinetto, Simon A. Dalla Torre; Arber, Silvia] Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
RP Dasen, JS (corresponding author), NYU, Sch Med, Dept Physiol & Neurosci, Smilow Neurosci Program, 522 1st Ave,SML 504, New York, NY 10016 USA.
EM jeremy.dasen@med.nyu.edu; silvia.arber@unibas.ch
OI Arber, Silvia/0000-0002-6261-250X; Dalla Torre di Sanguinetto,
   Simon/0000-0002-0808-4638
CR Arber S, 1999, NEURON, V23, P659, DOI 10.1016/S0896-6273(01)80026-X
   Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   Carpenter EM, 2002, DEV NEUROSCI-BASEL, V24, P24, DOI 10.1159/000064943
   Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028
   Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036
   Choe A, 2006, GENE EXPR PATTERNS, V6, P730, DOI 10.1016/j.modgep.2005.12.004
   Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009
   Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051
   Garcia NVDM, 2008, NEURON, V57, P217, DOI 10.1016/j.neuron.2007.11.033
   Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4
   Hanson MG, 2008, BRAIN RES REV, V57, P77, DOI 10.1016/j.brainresrev.2007.06.021
   Helmbacher F, 2003, NEURON, V39, P767, DOI 10.1016/S0896-6273(03)00493-8
   Hippenmeyer S, 2005, PLOS BIOL, V3, P878, DOI 10.1371/journal.pbio.0030159
   HOLLYDAY M, 1990, J COMP NEUROL, V302, P575, DOI 10.1002/cne.903020313
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   Kania A, 2000, CELL, V102, P161, DOI 10.1016/S0092-8674(00)00022-2
   Kania A, 2003, NEURON, V38, P581, DOI 10.1016/S0896-6273(03)00292-7
   Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753
   Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008
   Ladle DR, 2007, NEURON, V56, P270, DOI 10.1016/j.neuron.2007.09.026
   Lance-Jones C, 2001, DEVELOPMENT, V128, P2255
   LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545
   LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546
   Landmesser LT, 2001, INT J DEV NEUROSCI, V19, P175, DOI 10.1016/S0736-5748(00)00090-3
   Lin AW, 2003, J NEUROBIOL, V56, P328, DOI 10.1002/neu.10239
   Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   MCGINNIS W, 1992, CELL, V68, P283, DOI 10.1016/0092-8674(92)90471-N
   Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032
   Muhr J, 2001, CELL, V104, P861, DOI 10.1016/S0092-8674(01)00283-5
   Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7
   ROMANES GJ, 1951, J COMP NEUROL, V94, P313, DOI 10.1002/cne.900940209
   Romanes GJ, 1942, J ANAT, V77, P1
   Rottkamp CA, 2008, DEV BIOL, V314, P23, DOI 10.1016/j.ydbio.2007.10.046
   Ryan JM, 1998, BRAIN BEHAV EVOLUT, V51, P90
   Shirasaki R, 2002, ANNU REV NEUROSCI, V25, P251, DOI 10.1146/annurev.neuro.25.112701.142916
   Shirasaki R, 2006, NEURON, V50, P841, DOI 10.1016/j.neuron.2006.04.030
   Soshnikova N, 2008, BIOESSAYS, V30, P199, DOI 10.1002/bies.20724
   Tarchini B, 2005, GENE DEV, V19, P2862, DOI 10.1101/gad.351105
   Thaler J, 1999, NEURON, V23, P675, DOI 10.1016/S0896-6273(01)80027-1
   Thaler JP, 2004, NEURON, V41, P337, DOI 10.1016/S0896-6273(04)00011-X
   Tiret L, 1998, DEVELOPMENT, V125, P279
   TSUCHIDA T, 1994, CELL, V79, P957, DOI 10.1016/0092-8674(94)90027-2
   Vermot J, 2005, DEVELOPMENT, V132, P1611, DOI 10.1242/dev.01718
   Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042
   Wang GY, 2007, DEV DYNAM, V236, P2109, DOI 10.1002/dvdy.21236
   Wu Y, 2008, DEVELOPMENT, V135, P171, DOI 10.1242/dev.009225
NR 47
TC 80
Z9 81
U1 0
U2 6
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-4388
EI 1873-6882
J9 CURR OPIN NEUROBIOL
JI Curr. Opin. Neurobiol.
PD FEB
PY 2008
VL 18
IS 1
BP 36
EP 43
DI 10.1016/j.conb.2008.04.002
PG 8
WC Neurosciences
SC Neurosciences & Neurology
GA 325XI
UT WOS:000257621700006
PM 18524570
DA 2021-01-25
ER

PT J
AU Huang, ZJ
   Scheiffele, P
AF Huang, Z. Josh
   Scheiffele, Peter
TI GABA and neuroligin signaling: linking synaptic activity and adhesion in
   inhibitory synapse development
SO CURRENT OPINION IN NEUROBIOLOGY
LA English
DT Review
ID GLUTAMIC-ACID DECARBOXYLASE; CENTRAL-NERVOUS-SYSTEM; PRIMARY
   VISUAL-CORTEX; ALPHA-NEUREXINS; GABAERGIC INNERVATION;
   CHOLINE-ACETYLTRANSFERASE; GLUTAMATERGIC SYNAPSES; RECEPTOR SUBTYPES;
   PYRAMIDAL NEURONS; CRITICAL PERIOD
AB GABA-mediated synaptic inhibition is crucial in neural circuit operations. In mammalian brains, the development of inhibitory synapses and innervation patterns is often a prolonged postnatal process, regulated by neural activity. Emerging evidence indicates that gamma-aminobutyric acid (GABA) acts beyond inhibitory transmission and regulates inhibitory synapse development. Indeed, GABA(A) receptors not only function as chloride channels that regulate membrane voltage and conductance but also play structural roles in synapse maturation and stabilization. The link from GABA(A) receptors to postsynaptic and presynaptic adhesion is probably mediated, partly by neuroligin-reurexin interactions, which are potent in promoting GABAergic synapse formation. Therefore, similar to glutamate signaling at excitatory synapse, GABA signaling may coordinate maturation of presynaptic and postsynaptic sites at inhibitory synapses. Defining the many steps from GABA signaling to receptor trafficking/stability and neuroligin function will provide further mechanistic insights into activity-dependent development and possibly plasticity of inhibitory synapses.
C1 [Huang, Z. Josh] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA.
   [Scheiffele, Peter] Univ Basel, Biozentrum, Dept Cell Biol, CH-4003 Basel, Switzerland.
RP Huang, ZJ (corresponding author), Cold Spring Harbor Lab, POB 100, Cold Spring Harbor, NY 11724 USA.
EM huangj@cshl.edu
OI Huang, Z. Josh/0000-0003-0592-028X
FU NINDS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Neurological
   Disorders & Stroke (NINDS) [R01 NS052784] Funding Source: Medline;
   NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States
   Department of Health & Human ServicesNational Institutes of Health (NIH)
   - USANIH National Institute of Neurological Disorders & Stroke (NINDS)
   [R01NS052784, R01NS052784, R01NS052784, R01NS052784] Funding Source: NIH
   RePORTER
CR Asada H, 1997, P NATL ACAD SCI USA, V94, P6496, DOI 10.1073/pnas.94.12.6496
   Ben-Ari Y, 2004, TRENDS NEUROSCI, V27, P422, DOI 10.1016/j.tins.2004.05.002
   Ben-Ari Y, 2007, PHYSIOL REV, V87, P1215, DOI 10.1152/physrev.00017.2006
   BENARI Y, 1989, J PHYSIOL-LONDON, V416, P303, DOI 10.1113/jphysiol.1989.sp017762
   Bonhoeffer T, 2002, NEURON, V35, P1019, DOI 10.1016/S0896-6273(02)00906-6
   Boucard AA, 2005, NEURON, V48, P229, DOI 10.1016/j.neuron.2005.08.026
   Brandon EP, 2003, J NEUROSCI, V23, P539
   Brose N, 1999, NATURWISSENSCHAFTEN, V86, P516, DOI 10.1007/s001140050666
   Carroll RC, 1999, NAT NEUROSCI, V2, P454
   Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004
   Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015
   Chih B, 2005, SCIENCE, V307, P1324, DOI 10.1126/science.1107470
   Chih B, 2006, NEURON, V51, P171, DOI 10.1016/j.neuron.2006.06.005
   Chubykin AA, 2007, NEURON, V54, P919, DOI 10.1016/j.neuron.2007.05.029
   Craig AM, 2007, CURR OPIN NEUROBIOL, V17, P43, DOI 10.1016/j.conb.2007.01.011
   Di Cristo G, 2004, NAT NEUROSCI, V7, P1184, DOI 10.1038/nn1334
   Di Cristo G, 2007, NAT NEUROSCI, V10, P1569, DOI 10.1038/nn2008
   Dong N, 2007, MOL CELL NEUROSCI, V35, P14, DOI 10.1016/j.mcn.2007.01.013
   Dudanova I, 2007, J COMP NEUROL, V502, P261, DOI 10.1002/cne.21305
   Ehlers MD, 2007, NEURON, V54, P447, DOI 10.1016/j.neuron.2007.04.010
   Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104
   Essrich C, 1998, NAT NEUROSCI, V1, P563, DOI 10.1038/2798
   Fang C, 2006, J NEUROSCI, V26, P12758, DOI 10.1523/JNEUROSCI.4214-06.2006
   Fritschy JM, 2006, CEREBELLUM, V5, P275, DOI 10.1080/14734220600962805
   Fritschy JM, 2006, J NEUROSCI, V26, P3245, DOI 10.1523/JNEUROSCI.5118-05.2006
   Futai K, 2007, NAT NEUROSCI, V10, P186, DOI 10.1038/nn1837
   Graf ER, 2006, J NEUROSCI, V26, P4256, DOI 10.1523/JNEUROSCI.1253-05.2006
   Hanus C, 2006, J NEUROSCI, V26, P4586, DOI 10.1523/JNEUROSCI.5123-05.2006
   Hennou S, 2002, EUR J NEUROSCI, V16, P197, DOI 10.1046/j.1460-9568.2002.02073.x
   Hua JY, 2005, NATURE, V434, P1022, DOI 10.1038/nature03409
   Hua JYY, 2004, NAT NEUROSCI, V7, P327, DOI 10.1038/nn1218
   Huang ZJ, 2007, NAT REV NEUROSCI, V8, P673, DOI 10.1038/nrn2188
   JACOB TC, 2008, NAT REV NEUROSCI
   Ji FY, 1999, NEUROSCI RES, V33, P187, DOI 10.1016/S0168-0102(99)00011-5
   Jiao YY, 2006, J NEUROSCI, V26, P8691, DOI 10.1523/JNEUROSCI.2478-06.2006
   Kang YH, 2008, J BIOL CHEM, V283, P2323, DOI 10.1074/jbc.M703957200
   Klostermann O, 1999, NEUROSCIENCE, V92, P1243, DOI 10.1016/S0306-4522(99)00009-3
   LEINEKUGEL X, 1995, J PHYSIOL-LONDON, V487, P319, DOI 10.1113/jphysiol.1995.sp020882
   Levinson JN, 2005, NEURON, V48, P171, DOI 10.1016/j.neuron.2005.09.017
   Li RW, 2005, J NEUROCHEM, V95, P756, DOI 10.1111/j.1471-4159.2005.03426.x
   Malinow R, 2002, ANNU REV NEUROSCI, V25, P103, DOI 10.1146/annurev.neuro.25.112701.142758
   Markram H, 2004, NAT REV NEUROSCI, V5, P793, DOI 10.1038/nrn1519
   Michels G, 2007, CRIT REV BIOCHEM MOL, V42, P3, DOI 10.1080/10409230601146219
   MILLER MW, 1986, DEV BRAIN RES, V25, P271, DOI 10.1016/0165-3806(86)90217-8
   Misgeld T, 2002, NEURON, V36, P635, DOI 10.1016/S0896-6273(02)01020-6
   Missler M, 2003, NATURE, V423, P939, DOI 10.1038/nature01755
   Morales B, 2002, J NEUROSCI, V22, P8084
   Owens DF, 2002, NAT REV NEUROSCI, V3, P715, DOI 10.1038/nrn919
   Represa A, 2005, TRENDS NEUROSCI, V28, P278, DOI 10.1016/j.tins.2005.03.010
   Rivera C, 1999, NATURE, V397, P251
   Ruthazer ES, 2003, SCIENCE, V301, P66, DOI 10.1126/science.1082545
   Saliba RS, 2007, J NEUROSCI, V27, P13341, DOI 10.1523/JNEUROSCI.3277-07.2007
   Schweizer C, 2003, MOL CELL NEUROSCI, V24, P442, DOI 10.1016/S1044-7431(03)00202-1
   Shi SH, 1999, SCIENCE, V284, P1811, DOI 10.1126/science.284.5421.1811
   Soghomonian JJ, 1998, TRENDS PHARMACOL SCI, V19, P500, DOI 10.1016/S0165-6147(98)01270-X
   Tashiro A, 2003, NEURON, V38, P773, DOI 10.1016/S0896-6273(03)00299-X
   Tretter V, 2008, J NEUROSCI, V28, P1356, DOI 10.1523/JNEUROSCI.5050-07.2008
   Tyzio R, 1999, J NEUROSCI, V19, P10372
   Varoqueaux F, 2002, P NATL ACAD SCI USA, V99, P9037, DOI 10.1073/pnas.122623799
   Varoqueaux F, 2006, NEURON, V51, P741, DOI 10.1016/j.neuron.2006.09.003
   Verhage M, 2000, SCIENCE, V287, P864, DOI 10.1126/science.287.5454.864
   Wong WT, 2001, NAT NEUROSCI, V4, P351, DOI 10.1038/85987
   Zhang LI, 2001, NAT NEUROSCI, V4, P1207, DOI 10.1038/nn753
   ZHENG JQ, 1994, NATURE, V368, P140, DOI 10.1038/368140a0
NR 64
TC 70
Z9 71
U1 0
U2 4
PU CURRENT BIOLOGY LTD
PI LONDON
PA 84 THEOBALDS RD, LONDON WC1X 8RR, ENGLAND
SN 0959-4388
EI 1873-6882
J9 CURR OPIN NEUROBIOL
JI Curr. Opin. Neurobiol.
PD FEB
PY 2008
VL 18
IS 1
BP 77
EP 83
DI 10.1016/j.conb.2008.05.008
PG 7
WC Neurosciences
SC Neurosciences & Neurology
GA 325XI
UT WOS:000257621700011
PM 18513949
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Keiser, J
   Morson, G
AF Keiser, Jennifer
   Morson, Gianni
TI Fasciola hepatica: Tegumental alterations in adult flukes following in
   vitro and in vivo administration of artesunate and artemether
SO EXPERIMENTAL PARASITOLOGY
LA English
DT Article
DE Fasciola hepatica; artesunate; artemether; food-borne trematodiasis; in
   vivo studies; in vitro studies; scanning electron microscopy
ID SCHISTOSOMA-JAPONICUM; ARTEMISININ; RESISTANCE; TRICLABENDAZOLE;
   DERIVATIVES; TREMATODES; OLD
AB The tegumental changes in adult Fasciola hepatica induced by artemether and artesunate were assessed utilizing scanning electron microscopy (SEM). F hepatica were incubated with artemether and artesunate for 48 h at a concentration of 10 mu g/ml in the absence or presence of haemin. For the latter experiment both, a triclabendazole-resistant and sensitive F hepatica isolate were used. For the in vivo studies rats were treated with single 200 mg/kg oral doses of artemether and artesunate and flukes recovered from the bile ducts after 24-96 h. SEM analysis of the flukes incubated in the presence of the drugs without haemin showed only minor and localized damage of the tegument. In the presence of haemin extensive tegumental damage, including sloughing, blebbing and eruptions, particularly in the ventral and dorsal mid-body and tail region, was evident. No difference in the extent of damage could be observed between artemether and artesunate and between the triclabendazole-resistant and non-resistant flukes. After 24 h in vivo disruption of the tegument was evident in the artemether-treated flukes, and the damage increased in severity 48-72 h post-treatment. Sloughing, swelling and extensive furrowing of the tegument was observed in several flukes, in particular in the tail region and the ventral apical cone region. In the artesunate treatment, tegumental damage was evident after 72 h, but seemed slightly less pronounced when compared to the artemether-treated specimens examined at the same time point. Concluding our experiments confirm that artemether and artesunate are potent fasciocidal drugs and the tegument of adult F hepatica appears to be a target for the action of these drugs. (C) 2007 Elsevier Inc. All rights reserved.
C1 [Keiser, Jennifer] Swiss Trop Inst, CH-4002 Basel, Switzerland.
   [Morson, Gianni] Univ Basel, Ctr Microscopy, Biozentrum, CH-4056 Basel, Switzerland.
RP Keiser, J (corresponding author), Swiss Trop Inst, PO Box, CH-4002 Basel, Switzerland.
EM jennifer.keiser@unibas.ch
CR Alvarez-Sanchez MA, 2006, VET REC, V159, P424, DOI 10.1136/vr.159.13.424
   FACINO RM, 1982, FARMACO-ED SCI, V37, P184
   Fairweather I, 1999, VET J, V158, P81, DOI 10.1053/tvjl.1999.0377
   Fairweather I, 1999, FASCIOLOSIS, P225
   Golenser J, 2006, INT J PARASITOL, V36, P1427, DOI 10.1016/j.ijpara.2006.07.011
   HALTON DW, 1967, PARASITOLOGY, V57, P639, DOI 10.1017/S003118200007311X
   Halton DW, 2004, MICRON, V35, P361, DOI 10.1016/j.micron.2003.12.001
   Haynes RK, 2006, CURR TOP MED CHEM, V6, P509, DOI 10.2174/156802606776743129
   Keiser J, 2005, EXPERT OPIN INV DRUG, V14, P1513, DOI 10.1517/13543784.14.12.1513
   Keiser J, 2005, EMERG INFECT DIS, V11, P1507, DOI 10.3201/eid1110.050614
   Keiser J, 2006, ANTIMICROB AGENTS CH, V50, P803, DOI 10.1128/AAC.50.2.803-805.2006
   KEISER J, IN PRESS T ROYAL SOC
   Keiser J, 2006, INT J ANTIMICROB AG, V28, P370, DOI 10.1016/j.ijantimicag.2006.08.004
   Keiser J, 2006, J ANTIMICROB CHEMOTH, V57, P1139, DOI 10.1093/jac/dkl125
   McManus DP, 2006, PARASITOLOGY, V133, pS43, DOI 10.1017/S0031182006001806
   Meaney M, 2003, PARASITOL RES, V91, P238, DOI 10.1007/s00436-003-0863-0
   Meshnick SR, 2002, INT J PARASITOL, V32, P1655, DOI 10.1016/S0020-7519(02)00194-7
   Schweizer G, 2005, VET REC, V157, P188, DOI 10.1136/vr.157.7.188
   Utzinger J, 2004, EXPERT OPIN PHARMACO, V5, P263, DOI 10.1517/14656566.5.2.263
   Utzinger J, 2007, CURR OPIN INVEST DR, V8, P105
   *WHO, 1995, 849 WHO
   Xiao SH, 2003, PARASITOL RES, V89, P459, DOI 10.1007/s00436-002-0786-1
   Xiao SH, 2001, T ROY SOC TROP MED H, V95, P67, DOI 10.1016/S0035-9203(01)90336-0
NR 23
TC 44
Z9 50
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0014-4894
J9 EXP PARASITOL
JI Exp. Parasitol.
PD FEB
PY 2008
VL 118
IS 2
BP 228
EP 237
DI 10.1016/j.exppara.2007.08.007
PG 10
WC Parasitology
SC Parasitology
GA 260AO
UT WOS:000252982400012
PM 17888906
DA 2021-01-25
ER

PT J
AU Burger, L
   van Nimwegen, E
AF Burger, Lukas
   van Nimwegen, Erik
TI Accurate prediction of protein-protein interactions from sequence
   alignments using a Bayesian method
SO MOLECULAR SYSTEMS BIOLOGY
LA English
DT Article
DE Bayesian network; polyketide synthases; protein-protein interaction;
   signaling network; two-component systems
ID 2-COMPONENT SIGNAL-TRANSDUCTION; CELL-CYCLE PROGRESSION; RECOGNITION;
   NETWORKS; PATHWAYS; SYSTEM
AB Accurate and large-scale prediction of protein-protein interactions directly from amino-acid sequences is one of the great challenges in computational biology. Here we present a new Bayesian network method that predicts interaction partners using only multiple alignments of amino-acid sequences of interacting protein domains, without tunable parameters, and without the need for any training examples. We first apply the method to bacterial two-component systems and comprehensively reconstruct two-component signaling networks across all sequenced bacteria. Comparisons of our predictions with known interactions show that our method infers interaction partners genome-wide with high accuracy. To demonstrate the general applicability of our method we show that it also accurately predicts interaction partners in a recent dataset of polyketide synthases. Analysis of the predicted genome-wide two-component signaling networks shows that cognates (interacting kinase/regulator pairs, which lie adjacent on the genome) and orphans (which lie isolated) form two relatively independent components of the signaling network in each genome. In addition, while most genes are predicted to have only a small number of interaction partners, we find that 10% of orphans form a separate class of 'hub' nodes that distribute and integrate signals to and from up to tens of different interaction partners.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM erik.vannimwegen@unibas.ch
OI van Nimwegen, Erik/0000-0001-6338-1312
CR Alm E, 2006, PLOS COMPUT BIOL, V2, P1329, DOI 10.1371/journal.pcbi.0020143
   Ausmees N, 2003, ANNU REV MICROBIOL, V57, P225, DOI 10.1146/annurev.micro.57.030502.091006
   Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI 10.1093/nar/gkh121
   Biondi EG, 2006, NATURE, V444, P899, DOI 10.1038/nature05321
   Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003
   CERQUIDES J, 2003, P 20 INT C MACH LEAR
   Fabret C, 1999, J BACTERIOL, V181, P1975, DOI 10.1128/JB.181.7.1975-1983.1999
   Grebe TW, 1999, ADV MICROB PHYSIOL, V41, P139, DOI 10.1016/S0065-2911(08)60167-8
   HIGGINS CF, 1992, ANNU REV CELL BIOL, V8, P67, DOI 10.1146/annurev.cb.08.110192.000435
   Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361
   Jaynes E. T., 2003, PROBABILITY THEORY L
   KACZMARSKI RS, 1991, BLOOD REV, V5, P193, DOI 10.1016/0268-960X(91)90036-C
   Koretke KK, 2000, MOL BIOL EVOL, V17, P1956, DOI 10.1093/oxfordjournals.molbev.a026297
   Lockless SW, 1999, SCIENCE, V286, P295, DOI 10.1126/science.286.5438.295
   Meila M, 2006, STAT COMPUT, V16, P77, DOI 10.1007/s11222-006-5535-3
   Ohta N, 2003, J BACTERIOL, V185, P4424, DOI 10.1128/JB.185.15.4424-4431.2003
   Pazos F, 2002, PROTEINS, V47, P219, DOI 10.1002/prot.10074
   Shoemaker BA, 2007, PLOS COMPUT BIOL, V3, P595, DOI 10.1371/journal.pcbi.0030043
   Skerker JM, 2004, NAT REV MICROBIOL, V2, P325, DOI 10.1038/nrmicro864
   Skerker JM, 2005, PLOS BIOL, V3, P1770, DOI 10.1371/journal.pbio.0030334
   Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183
   Thattai M, 2007, PLOS COMPUT BIOL, V3, P1827, DOI 10.1371/journal.pcbi.0030186
   Valencia A, 2002, CURR OPIN STRUC BIOL, V12, P368, DOI 10.1016/S0959-440X(02)00333-0
   van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8
   Weissman KJ, 2005, NAT REV MICROBIOL, V3, P925, DOI 10.1038/nrmicro1287
   Wu JG, 1999, P NATL ACAD SCI USA, V96, P13068, DOI 10.1073/pnas.96.23.13068
   Zapf J, 2000, STRUCTURE, V8, P851, DOI 10.1016/S0969-2126(00)00174-X
NR 27
TC 123
Z9 125
U1 0
U2 12
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1744-4292
J9 MOL SYST BIOL
JI Mol. Syst. Biol.
PD FEB
PY 2008
VL 4
AR 165
DI 10.1038/msb4100203
PG 14
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 271AM
UT WOS:000253761300004
PM 18277381
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Matsumoto, T
   Rauskolb, S
   Polack, M
   Klose, J
   Kolbeck, R
   Korte, M
   Barde, YA
AF Matsumoto, Tomoya
   Rauskolb, Stefanie
   Polack, Martin
   Klose, Johannes
   Kolbeck, Roland
   Korte, Martin
   Barde, Yves-Alain
TI Biosynthesis and processing of endogenous BDNF: CNS neurons store and
   secrete BDNF, not pro-BDNF
SO NATURE NEUROSCIENCE
LA English
DT Article
ID LONG-TERM DEPRESSION; NEUROTROPHIC FACTOR; BRAIN; P75(NTR); ACTIVATION;
   GENE; MICE
AB Pro- and mature BDNF activate very different receptors and intracellular pathways, potentially leading to either neuronal death or survival. Here we examined the biochemistry of endogenous BDNF in mouse neurons using sensitive reagents and found that pro-BDNF is rapidly converted intracellularly to mature BDNF, the latter being stored and released by excitatory input.
C1 [Matsumoto, Tomoya; Rauskolb, Stefanie; Barde, Yves-Alain] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Polack, Martin; Korte, Martin] Tech Univ Carolo Wilhelmina Braunschweig, D-38106 Braunschweig, Germany.
   [Klose, Johannes; Kolbeck, Roland; Barde, Yves-Alain] Max Planck Inst Neurobiol, D-82152 Martinsried, Germany.
   [Kolbeck, Roland] Medimmune Inc, Gaithersburg, MD 20878 USA.
RP Barde, YA (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM yves.barde@unibas.ch
RI Barde, Yves/F-6019-2011
OI Barde, Yves/0000-0002-7627-461X
CR BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x
   Chen ZY, 2006, SCIENCE, V314, P140, DOI 10.1126/science.1129663
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550
   Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835
   Harrington AW, 2004, P NATL ACAD SCI USA, V101, P6226, DOI 10.1073/pnas.0305755101
   Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x
   KORTE M, 1995, P NATL ACAD SCI USA, V92, P8856, DOI 10.1073/pnas.92.19.8856
   Lu B, 2005, NAT REV NEUROSCI, V6, P603, DOI 10.1038/nrn1726
   Mowla SJ, 2001, J BIOL CHEM, V276, P12660, DOI 10.1074/jbc.M008104200
   Poo MM, 2001, NAT REV NEUROSCI, V2, P24, DOI 10.1038/35049004
   Rosch H, 2005, P NATL ACAD SCI USA, V102, P7362, DOI 10.1073/pnas.0502460102
   Teng HK, 2005, J NEUROSCI, V25, P5455, DOI 10.1523/JNEUROSCI.5123-04.2005
   Woo NH, 2005, NAT NEUROSCI, V8, P1069, DOI 10.1038/nn1510
   Zagrebelsky M, 2005, J NEUROSCI, V25, P9989, DOI 10.1523/JNEUROSCI.2492-05.2005
NR 15
TC 248
Z9 256
U1 1
U2 23
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK STREET, 9TH FLOOR, NEW YORK, NY 10013-1917 USA
SN 1097-6256
J9 NAT NEUROSCI
JI Nat. Neurosci.
PD FEB
PY 2008
VL 11
IS 2
BP 131
EP 133
DI 10.1038/nn2038
PG 3
WC Neurosciences
SC Neurosciences & Neurology
GA 256FC
UT WOS:000252712100006
PM 18204444
DA 2021-01-25
ER

PT J
AU Chen, PY
   Weinmann, L
   Gaidatzis, D
   Pei, Y
   Zavolan, M
   Tuschl, T
   Meister, G
AF Chen, Po Yu
   Weinmann, Lasse
   Gaidatzis, Dimos
   Pei, Yi
   Zavolan, Mihaela
   Tuschl, Thomas
   Meister, Gunter
TI Strand-specific 5 '-O-methylation of siRNA duplexes controls guide
   strand selection and targeting specificity
SO RNA
LA English
DT Article
DE RNA interference; RNAi; off-target effects; gene silencing; siRNA; RISC
ID STEM-CELL MAINTENANCE; PIWI-INTERACTING RNAS; A-AEOLICUS ARGONAUTE;
   CRYSTAL-STRUCTURE; MICRORNA MATURATION; STRUCTURAL BASIS; RISC;
   RECOGNITION; IDENTIFICATION; EXPRESSION
AB Small interfering RNAs (siRNAs) and microRNAs (miRNAs) guide catalytic sequence-specific cleavage of fully or nearly fully complementary target mRNAs or control translation and/or stability of many mRNAs that share 6-8 nucleotides (nt) of complementarity to the siRNA and miRNA 5' end. siRNA- and miRNA-containing ribonucleoprotein silencing complexes are assembled from double-stranded 21- to 23-nt RNase III processing intermediates that carry 5' phosphates and 2-nt overhangs with free 3' hydroxyl groups. Despite the structural symmetry of a duplex siRNA, the nucleotide sequence asymmetry can generate a bias for preferred loading of one of the two duplex-forming strands into the RNA-induced silencing complex (RISC). Here we show that the 5'-phosphorylation status of the siRNA strands also acts as an important determinant for strand selection. 5'-O-methylated siRNA duplexes refractory to 5' phosphorylation were examined for their biases in siRNA strand selection. Asymmetric, single methylation of siRNA duplexes reduced the occupancy of the silencing complex by the methylated strand with concomitant elimination of its off-targeting signature and enhanced off-targeting signature of the phosphorylated strand. Methylation of both siRNA strands reduced but did not completely abolish RNA silencing, without affecting strand selection relative to that of the unmodified siRNA. We conclude that asymmetric 5' modification of siRNA duplexes can be useful for controlling targeting specificity.
C1 [Chen, Po Yu; Weinmann, Lasse; Meister, Gunter] Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, New York, NY 10021 USA.
   Max Planck Inst Biochem, Munich Ctr Integrated Prot Sci, D-82152 Martinsried, Germany.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Gaidatzis, Dimos; Zavolan, Mihaela] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Tuschl, T (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, Lab RNA Mol Biol, 1230 York Ave,Box 186, New York, NY 10021 USA.
EM ttuschl@rockefeller.edu; meister@biochem.mpg.de
RI Weinmann, Lasse/B-9839-2008; Zavolan, Mihaela/S-3888-2016; Pei,
   Yi/D-8998-2011
OI Pei, Yi/0000-0002-3466-760X; Zavolan, Mihaela/0000-0002-8832-2041
FU NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department
   of Health & Human ServicesNational Institutes of Health (NIH) - USANIH
   National Institute of General Medical Sciences (NIGMS) [R01GM068476,
   R01GM068476, R01GM068476, R01GM068476, R01GM068476] Funding Source: NIH
   RePORTER; NIGMS NIH HHSUnited States Department of Health & Human
   ServicesNational Institutes of Health (NIH) - USANIH National Institute
   of General Medical Sciences (NIGMS) [R01 GM068476-01, R01 GM068476]
   Funding Source: Medline
CR Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5
   Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854
   Carmell MA, 2002, GENE DEV, V16, P2733, DOI 10.1101/gad.1026102
   Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868
   Dorsett Y, 2004, NAT REV DRUG DISCOV, V3, P318, DOI 10.1038/nrd1345
   Ebhardt HA, 2005, P NATL ACAD SCI USA, V102, P13398, DOI 10.1073/pnas.0506597102
   Echeverri CJ, 2006, NAT REV GENET, V7, P373, DOI 10.1038/nrg1836
   Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301
   Elmen J, 2005, NUCLEIC ACIDS RES, V33, P439, DOI 10.1093/nar/gki193
   Filipowicz W, 2005, CELL, V122, P17, DOI 10.1016/j.cell.2005.06.023
   Filipowicz W, 2005, CURR OPIN STRUC BIOL, V15, P331, DOI 10.1016/j.sbi.2005.05.006
   Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236
   Fuchs Florian, 2006, Briefings in Functional Genomics & Proteomics, V5, P52, DOI 10.1093/bfgp/ell007
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022
   Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791
   Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509
   Hammond SM, 2001, SCIENCE, V293, P1146, DOI 10.1126/science.1064023
   Harborth J, 2003, ANTISENSE NUCLEIC A, V13, P83, DOI 10.1089/108729003321629638
   Horwich MD, 2007, CURR BIOL, V17, P1265, DOI 10.1016/j.cub.2007.06.030
   Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827
   Jackson AL, 2006, RNA, V12, P1197, DOI 10.1261/rna.30706
   Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706
   Jackson AL, 2003, NAT BIOTECHNOL, V21, P635, DOI 10.1038/nbt831
   Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005
   Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8
   Kirino Y, 2007, NAT STRUCT MOL BIOL, V14, P347, DOI 10.1038/nsmb1218
   Krausz E, 2007, MOL BIOSYST, V3, P232, DOI 10.1039/b616187c
   Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865
   Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062
   Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942
   Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637
   Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3
   Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315
   Lin XY, 2005, NUCLEIC ACIDS RES, V33, P4527, DOI 10.1093/nar/gki762
   Lingel A, 2004, NAT STRUCT MOL BIOL, V11, P576, DOI 10.1038/nsmb777
   Linsley PS, 2007, MOL CELL BIOL, V27, P2240, DOI 10.1128/MCB.02005-06
   Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513
   Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710
   Liu X, 2006, RNA, V12, P1514, DOI 10.1261/rna.101606
   Ma JB, 2005, NATURE, V434, P666, DOI 10.1038/nature03514
   Ma JB, 2004, NATURE, V429, P318, DOI 10.1038/nature02519
   Maniataki E, 2005, GENE DEV, V19, P2979, DOI 10.1101/gad.1384005
   Martinez J, 2002, CELL, V110, P563, DOI 10.1016/S0092-8674(02)00908-X
   Martinez LA, 2002, P NATL ACAD SCI USA, V99, P14849, DOI 10.1073/pnas.222406899
   Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044
   Meister G, 2005, CURR BIOL, V15, P2149, DOI 10.1016/j.cub.2005.10.048
   Meister G, 2004, MOL CELL, V15, P185, DOI 10.1016/j.molcel.2004.07.007
   Meister G, 2004, NATURE, V431, P343, DOI 10.1038/nature02873
   Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605
   Nykanen A, 2001, CELL, V107, P309, DOI 10.1016/S0092-8674(01)00547-5
   Ohara T, 2007, NAT STRUCT MOL BIOL, V14, P349, DOI 10.1038/nsmb1220
   Parker JS, 2005, NATURE, V434, P663, DOI 10.1038/nature03462
   Parker JS, 2004, EMBO J, V23, P4727, DOI 10.1038/sj.emboj.7600488
   Pei Y, 2006, NAT METHODS, V3, P670, DOI 10.1038/NMETH911
   Pelisson A, 2007, J VIROL, V81, P1951, DOI 10.1128/JVI.01980-06
   Peters L, 2007, MOL CELL, V26, P611, DOI 10.1016/j.molcel.2007.05.001
   Preall JB, 2005, CELL, V123, P543, DOI 10.1016/j.cell.2005.11.006
   Rajewsky N, 2004, DEV BIOL, V267, P529, DOI 10.1016/j.ydbio.2003.12.003
   Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020
   Rand TA, 2004, P NATL ACAD SCI USA, V101, P14385, DOI 10.1073/pnas.0405913101
   Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918
   Robb GB, 2007, MOL CELL, V26, P523, DOI 10.1016/j.molcel.2007.04.016
   Root DE, 2006, NAT METHODS, V3, P715, DOI 10.1038/NMETH924
   Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235
   Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1
   Song JJ, 2006, CURR OPIN STRUC BIOL, V16, P5, DOI 10.1016/j.sbi.2006.01.010
   Song JJ, 2004, SCIENCE, V305, P1434, DOI 10.1126/science.1102514
   Song JJ, 2003, NAT STRUCT BIOL, V10, P1026, DOI 10.1038/nsb1016
   Stark A, 2003, PLOS BIOL, V1, P397, DOI 10.1371/journal.pbio.0000060
   Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105
   Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755
   Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1
   Tuschl T, 1999, GENE DEV, V13, P3191, DOI 10.1101/gad.13.24.3191
   Vagin VV, 2006, SCIENCE, V313, P320, DOI 10.1126/science.1129333
   Weitzer S, 2007, NATURE, V447, P222, DOI 10.1038/nature05777
   Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683
   Yan KS, 2003, NATURE, V426, P469, DOI 10.1038/nature02129
   Yu B, 2005, SCIENCE, V307, P932, DOI 10.1126/science.1107130
   Yuan YR, 2005, MOL CELL, V19, P405, DOI 10.1016/j.molcel.2005.07.011
   Yuan YR, 2006, STRUCTURE, V14, P1557, DOI 10.1016/j.str.2006.08.009
NR 81
TC 133
Z9 141
U1 0
U2 20
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1355-8382
EI 1469-9001
J9 RNA
JI RNA
PD FEB
PY 2008
VL 14
IS 2
BP 263
EP 274
DI 10.1261/rna.789808
PG 12
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 259HC
UT WOS:000252929400009
PM 18094121
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Kamiya, Y
   Kamiya, D
   Yamamoto, K
   Nyfeler, B
   Hauri, HP
   Kato, K
AF Kamiya, Yukiko
   Kamiya, Daiki
   Yamamoto, Kazuo
   Nyfeler, Beat
   Hauri, Hans-Peter
   Kato, Koichi
TI Molecular basis of sugar recognition by the human L-type lectins
   ERGIC-53, VIPL, and VIP36
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID FRONTAL AFFINITY-CHROMATOGRAPHY; ENDOPLASMIC-RETICULUM; SECRETORY
   PATHWAY; TRANSPORT RECEPTOR; BINDING-PROPERTIES; PROTEIN; GLYCOPROTEINS;
   GLYCANS; GLUCOSYLATION; COMPARTMENT
AB ERGIC-53, VIPL, and VIP36 are related type 1 membrane proteins of the mammalian early secretory pathway. They are classified as L-type lectins because of their luminal carbohydrate recognition domain, which exhibits homology to leguminous lectins. These L-type lectins have different intracellular distributions and dynamics in the endoplasmic reticulum-Golgi system of the secretory pathway and interact with N-glycans of glycoproteins in a Ca2+ -dependent manner, suggesting a role in glycoprotein sorting and trafficking. To understand the function of these lectins, knowledge of their carbohydrate specificity is crucial but only available for VIP36 (Kamiya, Y., Yamaguchi, Y., Takahashi, N., Arata, Y., Kasai, K. I., Ihara, Y., Matsuo, I., Ito, Y., Yamamoto, K., and Kato, K. ( 2005) J. Biol. Chem. 280, 37178-37182). Here we provide a comprehensive and quantitative analysis of sugar recognition of the carbohydrate recognition domains of ERGIC-53 and VIPL in comparison with VIP36 using a pyridylaminated sugar library in conjunction with frontal affinity chromatography. Frontal affinity chromatography revealed selective interaction of VIPL and VIP36 with the deglucosylated trimannose in the D1 branch of high-mannose-type oligosaccharides but with different pH dependence. ERGIC-53 bound high-mannose-type oligosaccharides with low affinity and broad specificity, not discriminating between monoglucosylated and deglucosylated high-mannose-type oligosaccharides. Based on the sugar-binding properties in conjunction with known features of these proteins, we propose a model for the action of the three lectins in glycoprotein guidance and trafficking. Moreover, structure-based mutagenesis revealed that the sugar-binding properties of these L-type lectins can be switched by single amino acid substitutions.
C1 [Kamiya, Yukiko; Kamiya, Daiki; Kato, Koichi] Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, Nagoya, Aichi 4678603, Japan.
   [Yamamoto, Kazuo; Kato, Koichi] CREST, Japan Sci & Technol Corp, Kawaguchi, Saitama 3321102, Japan.
   [Yamamoto, Kazuo] Univ Tokyo, Grad Sch Frontier Sci, Chiba 2278562, Japan.
   [Nyfeler, Beat; Hauri, Hans-Peter] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Kato, Koichi] Nat Inst Nat Sci, Inst Mol Sci, Aichi 4448787, Japan.
   [Kato, Koichi] Ocahanomizu Univ, Glycosci Inst, Bunkyo Ku, Tokyo 1128610, Japan.
   [Kato, Koichi] GLYENCE Co Ltd, Nagoya, Aichi 4740858, Japan.
RP Kato, K (corresponding author), Nagoya City Univ, Grad Sch Pharmaceut Sci, Mizuho Ku, 3-1 Tanabe Dori, Nagoya, Aichi 4678603, Japan.
EM kkato@phar.nagoya-cu.ac.jp
OI /0000-0001-7582-3886; Kato, Koichi/0000-0001-7187-9612
FU Grants-in-Aid for Scientific ResearchMinistry of Education, Culture,
   Sports, Science and Technology, Japan (MEXT)Japan Society for the
   Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)
   [18390016, 06J07840] Funding Source: KAKEN
CR Anelli T, 2007, EMBO J, V26, P4177, DOI 10.1038/sj.emboj.7601844
   Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Appenzeller-Herzog C, 2004, J BIOL CHEM, V279, P12943, DOI 10.1074/jbc.M313245200
   Appenzeller-Herzog C, 2005, MOL BIOL CELL, V16, P1258, DOI 10.1091/mbc.E04-08-0708
   Arata Y, 2001, J BIOL CHEM, V276, P3068, DOI 10.1074/jbc.M008602200
   Fullekrug J, 1999, J CELL SCI, V112, P2813
   Hauri HP, 2000, J CELL SCI, V113, P587
   Hauri HP, 2000, FEBS LETT, V476, P32, DOI 10.1016/S0014-5793(00)01665-3
   Helenius A, 2004, ANNU REV BIOCHEM, V73, P1019, DOI 10.1146/annurev.biochem.73.011303.073752
   Hirabayashi J, 2003, METHOD ENZYMOL, V362, P353
   Kamiya Y, 2005, J BIOL CHEM, V280, P37178, DOI 10.1074/jbc.M505757200
   Kamiya Y, 2006, TRENDS GLYCOSCI GLYC, V18, P231, DOI 10.4052/tigg.18.231
   KASAI K, 1986, J CHROMATOGR, V376, P33, DOI 10.1016/S0378-4347(00)80822-1
   Kato K, 2007, GLYCOBIOLOGY, V17, P1031, DOI 10.1093/glycob/cwm046
   Molinari M, 2007, NAT CHEM BIOL, V3, P313, DOI 10.1038/nchembio880
   Neve EPA, 2003, EXP CELL RES, V288, P70, DOI 10.1016/S0014-4827(03)00161-7
   Nufer O, 2003, J BIOL CHEM, V278, P15886, DOI 10.1074/jbc.M211199200
   Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102
   Nyfeler B, 2006, TRAFFIC, V7, P1473, DOI 10.1111/j.1600-0854.2006.00483.x
   Parodi AJ, 2000, ANNU REV BIOCHEM, V69, P69, DOI 10.1146/annurev.biochem.69.1.69
   Satoh T, 2007, J BIOL CHEM, V282, P28246, DOI 10.1074/jbc.M703064200
   SCHWEIZER A, 1988, J CELL BIOL, V107, P1643, DOI 10.1083/jcb.107.5.1643
   Spiro RG, 2004, CELL MOL LIFE SCI, V61, P1025, DOI 10.1007/s00018-004-4037-8
   Totani K, 2006, J BIOL CHEM, V281, P31502, DOI 10.1074/jbc.M605457200
   Velloso LM, 2003, J MOL BIOL, V334, P845, DOI 10.1016/j.jmb.2003.10.031
   Williams DB, 2006, J CELL SCI, V119, P615, DOI 10.1242/jcs.02856
   Yamaguchi D, 2007, GLYCOBIOLOGY, V17, P1061, DOI 10.1093/glycob/cwm074
   Zhang B, 2005, J BIOL CHEM, V280, P25881, DOI 10.1074/jbc.M502160200
   Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153
NR 29
TC 91
Z9 92
U1 0
U2 10
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3996 USA
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD JAN 25
PY 2008
VL 283
IS 4
BP 1857
EP 1861
DI 10.1074/jbc.M709384200
PG 5
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 253EH
UT WOS:000252501000011
PM 18025080
OA Bronze
DA 2021-01-25
ER

PT J
AU Buttner, CR
   Sorg, I
   Cornelis, GR
   Heinz, DW
   Niemann, HH
AF Buttner, Carina R.
   Sorg, Isabel
   Cornelis, Guy R.
   Heinz, Dirk W.
   Niemann, Hartmut H.
TI Structure of the Yersinia enterocolitica type III secretion translocator
   chaperone SycD
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE alternative dimer assembly; chaperone; SycD; tetratricopeptide repeat;
   type III secretion
ID PROTEIN-PROTEIN INTERACTIONS; DIFFRACTION DATA; TETRATRICOPEPTIDE
   REPEATS; REDUCTIVE METHYLATION; AMPHIPATHIC DOMAIN; SUBSTRATE-BINDING;
   VIRULENCE FACTORS; CRYSTAL-STRUCTURE; YOPD; SYSTEM
AB Many Gram-negative bacteria use a type III secretion (T3S) system to directly inject effector molecules into eucaryotic cells in order to establish a symbiotic or pathogenic relationship with their host. The translocation of many T3S proteins requires specialized chaperones from the bacterial cytosol. SycD belongs to a class of T3S chaperones that assists the secretion of pore-forming translocators and, specifically chaperones the translocators YopB and YopD from enteropathogenic Yersinia enterocolitica. In addition, SycD is involved in the regulation of virulence factor biosynthesis and secretion. In this study,,we present two crystal structures of Y. enterocolitica SycD at 1.95 and 2.6 angstrom resolution, the first experimental structures of a T3S class 11 chaperone specific for translocators. The fold of SycD is entirely a-helical and reveals three tetratricopeptide repeat-like motifs that had been predicted from amino acid sequence. In both structures, SycD forms dimers utilizing residues from the first tetratricopeptide repeat motif. Using site-directed mutagenesis and size exclusion chromatography, we verified that SycD forms head-to-head homodimers in solution. Although in both structures, dimerization largely depends on the same residues, the two assemblies represent alternative dimers that exhibit different monomer orientations and overall shape. In these two distinct head-to-head dimers, both the concave and the convex surface of each monomer are accessible for interactions with the SycD binding partners YopB and YopD. A SycD variant carrying two point mutations in the dimerization interface is properly folded but defective in dimerization. Expression of this stable SycD monomer in Yersinia does not rescue the phenotype of a sycD null mutant, suggesting a physiological relevance of the dimerization interface. (c) 2007 Elsevier Ltd. All rights reserved.
C1 [Buttner, Carina R.; Heinz, Dirk W.; Niemann, Hartmut H.] Helmholtz Ctr Infect Res, Div Struct Biol, D-38124 Braunschweig, Germany.
   [Sorg, Isabel; Cornelis, Guy R.] Univ Basel, Biozentrum, Div Mol Microbiol, CH-4056 Basel, Switzerland.
RP Niemann, HH (corresponding author), Univ Bielefeld, Dept Chem, Univ Str 25, D-33615 Bielefeld, Germany.
EM Hartmut.Niemann@uni-bielefeld.de
RI Buttner, Carina/P-1679-2017; Niemann, Hartmut/F-7947-2011
OI Niemann, Hartmut/0000-0002-8582-0360
CR Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657
   Anderson DM, 2002, J BACTERIOL, V184, P1287, DOI 10.1128/JB.184.5.1287-1295.2002
   Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398
   Bogan AA, 1998, J MOL BIOL, V280, P1, DOI 10.1006/jmbi.1998.1843
   Broms JE, 2005, J BACTERIOL, V187, P7738, DOI 10.1128/JB.187.22.7738-7752.2005
   Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/s0907444998003254
   Buttner D, 2002, TRENDS MICROBIOL, V10, P186, DOI 10.1016/S0966-842X(02)02331-4
   Cambronne ED, 2004, J BACTERIOL, V186, P829, DOI 10.1128/JB.186.3.829-841.2004
   Cha HJ, 2002, J MOL BIOL, V320, P1065, DOI 10.1016/S0022-2836(02)00558-2
   CORNELIS G, 1987, MICROB PATHOGENESIS, V2, P367, DOI 10.1016/0882-4010(87)90078-7
   D'Andrea LD, 2003, TRENDS BIOCHEM SCI, V28, P655, DOI 10.1016/j.tibs.2003.10.007
   Darwin KH, 2001, EMBO J, V20, P1850, DOI 10.1093/emboj/20.8.1850
   Das AK, 1998, EMBO J, V17, P1192, DOI 10.1093/emboj/17.5.1192
   Day JB, 2000, J BACTERIOL, V182, P1834, DOI 10.1128/JB.182.7.1834-1843.2000
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   Deo RC, 2002, CELL, V108, P71, DOI 10.1016/S0092-8674(01)00632-8
   Diederichs K, 1997, NAT STRUCT BIOL, V4, P269, DOI 10.1038/nsb0497-269
   Edqvist PJ, 2007, MICROBES INFECT, V9, P224, DOI 10.1016/j.micinf.2006.11.010
   Edqvist PJ, 2006, MOL MICROBIOL, V59, P31, DOI 10.1111/j.1365-2958.2005.04923.x
   Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158
   Faudry E, 2007, FEBS J, V274, P3601, DOI 10.1111/j.1742-4658.2007.05893.x
   Feldman MF, 2003, FEMS MICROBIOL LETT, V219, P151, DOI 10.1016/S0378-1097(03)00042-9
   Flom G, 2007, BIOCHEM J, V404, P159, DOI 10.1042/BJ20070084
   Francis MS, 2000, MOL MICROBIOL, V38, P85, DOI 10.1046/j.1365-2958.2000.02112.x
   Francis MS, 2001, MOL MICROBIOL, V42, P1075, DOI 10.1046/j.1365-2958.2001.02702.x
   Galan JE, 2006, NATURE, V444, P567, DOI 10.1038/nature05272
   Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305
   Heinig M, 2004, NUCLEIC ACIDS RES, V32, pW500, DOI 10.1093/nar/gkh429
   HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489
   Hutchinson EG, 1996, PROTEIN SCI, V5, P212
   Iriarte M, 1999, J BACTERIOL, V181, P675, DOI 10.1128/JB.181.2.675-680.1999
   Jinek M, 2004, NAT STRUCT MOL BIOL, V11, P1001, DOI 10.1038/nsmb833
   Johnson S, 2005, CURR OPIN STRUC BIOL, V15, P700, DOI 10.1016/j.sbi.2005.10.007
   JONES S, 1995, PROG BIOPHYS MOL BIO, V63, P31, DOI 10.1016/0079-6107(94)00008-W
   KABSCH W, 1976, ACTA CRYSTALLOGR A, V32, P922, DOI 10.1107/S0567739476001873
   KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588
   Kim K, 2006, BIOCHEM BIOPH RES CO, V340, P1028, DOI 10.1016/j.bbrc.2005.12.108
   Krissinel E, 2005, LECT NOTES COMPUT SC, V3695, P163
   LASKOWSKI RA, 1995, J MOL GRAPHICS, V13, P323, DOI 10.1016/0263-7855(95)00073-9
   LAWRENCE MC, 1993, J MOL BIOL, V234, P946, DOI 10.1006/jmbi.1993.1648
   Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202
   Lilic M, 2006, MOL CELL, V21, P653, DOI 10.1016/j.molcel.2006.01.026
   Luo Y, 2001, NAT STRUCT BIOL, V8, P1031, DOI 10.1038/nsb717
   Main ERG, 2003, STRUCTURE, V11, P497, DOI 10.1016/S0969-2126(03)00076-5
   Marenne MN, 2003, MICROB PATHOGENESIS, V35, P243, DOI 10.1016/S0882-4010(03)00154-2
   MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2
   Mavris M, 2002, MOL MICROBIOL, V43, P1543, DOI 10.1046/j.1365-2958.2002.02836.x
   Mota LJ, 2005, ANN MED, V37, P234, DOI 10.1080/07853890510037329
   Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255
   Navarro L, 2005, CURR OPIN MICROBIOL, V8, P21, DOI 10.1016/j.mib.2004.12.014
   Neuvirth H, 2004, J MOL BIOL, V338, P181, DOI 10.1016/j.jmb.2004.02.040
   Neyt C, 1999, MOL MICROBIOL, V31, P143, DOI 10.1046/j.1365-2958.1999.01154.x
   Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X
   Pallen MJ, 2003, FEMS MICROBIOL LETT, V223, P53, DOI 10.1016/S0378-1097(03)00344-6
   Parsot C, 2003, CURR OPIN MICROBIOL, V6, P7, DOI 10.1016/S1369-5274(02)00002-4
   Pearson WR, 1997, GENOMICS, V46, P24, DOI 10.1006/geno.1997.4995
   Pekkala M, 2004, J BIOL CHEM, V279, P52255, DOI 10.1074/jbc.M410007200
   Quinaud M, 2007, P NATL ACAD SCI USA, V104, P7803, DOI 10.1073/pnas.0610098104
   Rychlewski L, 2000, PROTEIN SCI, V9, P232, DOI 10.1110/ps.9.2.232
   RYPNIEWSKI WR, 1993, BIOCHEMISTRY-US, V32, P9851, DOI 10.1021/bi00088a041
   Scheufler C, 2000, CELL, V101, P199, DOI 10.1016/S0092-8674(00)80830-2
   Schmid A, 2006, PROTEIN EXPRES PURIF, V49, P176, DOI 10.1016/j.pep.2006.04.012
   Schubot FD, 2004, ACTA CRYSTALLOGR D, V60, P1981, DOI [10.1107/S0907444904023005, 10.1107/S090744490402.1005]
   SIKORSKI RS, 1990, CELL, V60, P307, DOI 10.1016/0092-8674(90)90745-Z
   Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956
   Swietnicki W, 2004, J BIOL CHEM, V279, P38693, DOI 10.1074/jbc.M405217200
   Tengel T, 2002, EUR J BIOCHEM, V269, P3659, DOI 10.1046/j.1432-1033.2002.03051.x
   Thomas J, 2004, P NATL ACAD SCI USA, V101, P3945, DOI 10.1073/pnas.0307223101
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   WATTIAU P, 1994, P NATL ACAD SCI USA, V91, P10493, DOI 10.1073/pnas.91.22.10493
   Wilharm G, 2007, INT J MED MICROBIOL, V297, P27, DOI 10.1016/j.ijmm.2006.10.003
   Wu YK, 2006, NAT STRUCT MOL BIOL, V13, P589, DOI 10.1038/nsmb1106
   Wulff-Strobel CR, 2002, MOL MICROBIOL, V43, P411, DOI 10.1046/j.1365-2958.2002.02752.x
   Yip CK, 2005, NAT STRUCT MOL BIOL, V12, P75, DOI 10.1038/nsmb879
   Yu CM, 2006, J CHROMATOGR A, V1132, P99, DOI 10.1016/j.chroma.2006.07.017
NR 75
TC 46
Z9 46
U1 0
U2 12
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
J9 J MOL BIOL
JI J. Mol. Biol.
PD JAN 25
PY 2008
VL 375
IS 4
BP 997
EP 1012
DI 10.1016/j.jmb.2007.11.009
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 261RP
UT WOS:000253098000010
PM 18054956
DA 2021-01-25
ER

PT J
AU Meier, M
   Seelig, J
AF Meier, Matthias
   Seelig, Joachim
TI Length dependence of the coil reversible arrow beta-sheet transition in
   a membrane environment
SO JOURNAL OF THE AMERICAN CHEMICAL SOCIETY
LA English
DT Article
ID SOLID-STATE NMR; LIPID-MEMBRANES; SECONDARY STRUCTURE; AMYLOID FIBRILS;
   MOLECULAR-STRUCTURE; HAIRPIN FORMATION; HELIX FORMATION; PEPTIDE;
   STABILITY; PROTEINS
AB The most abundant structural element in protein aggregates is the beta-sheet. Designed peptides that fold into a beta-sheet structure upon binding to lipid membranes are useful models to elucidate the thermodynamic characteristics of the random coil reversible arrow beta-structure transition. Here, we examine the effect of strand length on the random coil reversible arrow beta-sheet transition of the (KIGAKI)(n) peptide with the total chain length varying between 7 and 30 amino acids. The beta-sheet content of the peptides in the presence and absence of membranes was measured with circular dichroism spectroscopy. The peptides were titrated with small unilamellar lipid vesicles, and the thermodynamic binding parameters were determined with isothermal titration calorimetry (ITC). Membrane binding includes at least two processes, namely (i) the transfer of the peptide from the aqueous phase to the lipid surface and (ii) the conformational change from a random coil conformation to a beta-sheet structure. CD spectroscopy and ITC analysis demonstrate that beta-sheet formation depends cooperatively on the peptide chain length with a distinct increase in beta-structure for n > 10-12. Binding to the lipid membrane is an entropy-driven process as the binding enthalpy is always endothermic. The contribution of the beta-sheet folding reaction to the overall process was determined with analogues of the KIGAKI repeat where two adjacent amino acids were replaced by their D-enantiomers. The folding reaction for peptides with n >= 12 is characterized by a negative free folding energy of Delta G degrees(beta) congruent to -0.15 kcal/ mol per amino acid residue. The folding step proper is exothermic with Delta H degrees(beta) congruent to -0.2 to -0.6 kcal/mol per residue and counteracted by a negative entropy term T Delta S degrees(beta) = -0.1 to -0.5 kcal/mol per residue, depending on the chain length (18 >= n >= 30). For a short chain with n = 12, beta-sheet formation is unfavorable with Delta G degrees(beta) similar to +0.08 kcal/mol per residue. Small changes of environmental parameters like pH or temperature can thus be anticipated to have profound effects on aggregation reactions, leading to amyloid fibril formation.
C1 [Meier, Matthias; Seelig, Joachim] Univ Basel, Biozentrum, Dept Biophys Chem, CH-4056 Basel, Switzerland.
RP Seelig, J (corresponding author), Univ Basel, Biozentrum, Dept Biophys Chem, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM joachim.seelig@unibas.ch
RI Meier, Matthias/C-6917-2013
CR AVEYARD R, 1973, CAMBRIDGE CHEM TEST
   BARLOW DJ, 1988, J MOL BIOL, V201, P601, DOI 10.1016/0022-2836(88)90641-9
   Blazyk J, 2001, J BIOL CHEM, V276, P27899, DOI 10.1074/jbc.M102865200
   Chan JCC, 2005, BIOCHEMISTRY-US, V44, P10669, DOI 10.1021/bi050724t
   CHOU KC, 1983, J MOL BIOL, V168, P389, DOI 10.1016/S0022-2836(83)80025-4
   deAlba E, 1997, J AM CHEM SOC, V119, P175, DOI 10.1021/ja962325e
   EISENBERG M, 1979, BIOCHEMISTRY-US, V18, P5213, DOI 10.1021/bi00590a028
   Espinosa JF, 2001, J MOL BIOL, V306, P397, DOI 10.1006/jmbi.2000.4349
   Gellman SH, 1998, CURR OPIN CHEM BIOL, V2, P717, DOI 10.1016/S1367-5931(98)80109-9
   Gorman PM, 2003, J MOL BIOL, V325, P743, DOI 10.1016/S0022-2836(02)01279-2
   Harper JD, 1997, ANNU REV BIOCHEM, V66, P385, DOI 10.1146/annurev.biochem.66.1.385
   Hortschansky P, 2005, PROTEIN SCI, V14, P2915, DOI 10.1110/ps.051585905
   Hortschansky P, 2005, PROTEIN SCI, V14, P1753, DOI 10.1110/ps.041266605
   Jaroniec CP, 2004, P NATL ACAD SCI USA, V101, P711, DOI 10.1073/pnas.0304849101
   KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211
   Kumar S, 1998, BIOPHYS J, V75, P1935, DOI 10.1016/S0006-3495(98)77634-9
   MCLAUGHLIN S, 1977, CURR TOP MEMBR TRANS, V9, P71
   Meier M, 2007, J MOL BIOL, V369, P277, DOI 10.1016/j.jmb.2007.02.082
   PANEL S, 2003, J PROTEIN ENG, V16, P957
   Petkova AT, 2002, P NATL ACAD SCI USA, V99, P16742, DOI 10.1073/pnas.262663499
   Ramirez-Alvarado M, 2001, PROTEIN SCI, V10, P1381, DOI 10.1110/ps.52901
   ROSEMAN MA, 1988, J MOL BIOL, V201, P621, DOI 10.1016/0022-2836(88)90642-0
   ROTHEMUND S, 1995, BIOCHEMISTRY-US, V34, P12954, DOI 10.1021/bi00040a005
   Russell SJ, 2003, J AM CHEM SOC, V125, P388, DOI 10.1021/ja028075l
   SCHOLTZ JM, 1991, BIOPOLYMERS, V31, P1463, DOI 10.1002/bip.360311304
   SEARLE MS, 1995, NAT STRUCT BIOL, V2, P999, DOI 10.1038/nsb1195-999
   SEELIG J, 1993, BIOCHEMISTRY-US, V32, P9714, DOI 10.1021/bi00088a025
   Seelig J, 1997, BBA-REV BIOMEMBRANES, V1331, P103, DOI 10.1016/S0304-4157(97)00002-6
   Sengupta P, 2003, BIOCHEMISTRY-US, V42, P10506, DOI 10.1021/bi0341410
   Sharman GJ, 1998, J AM CHEM SOC, V120, P5291, DOI 10.1021/ja9705405
   SMITH CK, 1994, BIOCHEMISTRY-US, V33, P5510, DOI 10.1021/bi00184a020
   Stanger HE, 2001, P NATL ACAD SCI USA, V98, P12015, DOI 10.1073/pnas.211536998
   Syud FA, 2003, J MOL BIOL, V326, P553, DOI 10.1016/S0022-2836(02)01304-9
   Terzi E, 1997, BIOCHEMISTRY-US, V36, P14845, DOI 10.1021/bi971843e
   TERZI E, 1995, J MOL BIOL, V252, P633, DOI 10.1006/jmbi.1995.0525
   Tycko R, 2006, Q REV BIOPHYS, V39, P1, DOI 10.1017/S0033583506004173
   Wenk MR, 1997, BIOPHYS J, V73, P2565, DOI 10.1016/S0006-3495(97)78285-7
   Wieprecht T, 1999, J MOL BIOL, V294, P785, DOI 10.1006/jmbi.1999.3268
   Wieprecht T, 1996, BIOCHEMISTRY-US, V35, P10844, DOI 10.1021/bi960362c
   Wieprecht T, 2000, BIOCHEMISTRY-US, V39, P15297, DOI 10.1021/bi001774v
   Williams AD, 2006, J MOL BIOL, V357, P1283, DOI 10.1016/j.jmb.2006.01.041
   Wimley WC, 1996, NAT STRUCT BIOL, V3, P842, DOI 10.1038/nsb1096-842
   ZIMM BH, 1959, P NATL ACAD SCI USA, V45, P1601, DOI 10.1073/pnas.45.11.1601
NR 43
TC 37
Z9 37
U1 0
U2 7
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0002-7863
J9 J AM CHEM SOC
JI J. Am. Chem. Soc.
PD JAN 23
PY 2008
VL 130
IS 3
BP 1017
EP 1024
DI 10.1021/ja077231r
PG 8
WC Chemistry, Multidisciplinary
SC Chemistry
GA 252DW
UT WOS:000252426300047
PM 18163629
DA 2021-01-25
ER

PT J
AU Engel, A
AF Engel, Andreas
TI Remarkable results in study by Riethmuller et al.
SO BIOPHYSICAL JOURNAL
LA English
DT News Item
C1 [Engel, Andreas] Univ Basel, ME Muller Inst Struct Biol Biozentrum, CH-4056 Basel, Switzerland.
RP Engel, A (corresponding author), Univ Basel, ME Muller Inst Struct Biol Biozentrum, CH-4056 Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BIOPHYSICAL SOC
PI BETHESDA
PA 9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA
SN 0006-3495
J9 BIOPHYS J
JI Biophys. J.
PD JAN 15
PY 2008
VL 94
IS 2
BP 333
EP 333
DI 10.1529/biophysj.107.117549
PG 1
WC Biophysics
SC Biophysics
GA 245GX
UT WOS:000251924200005
PM 17981898
OA Green Published
DA 2021-01-25
ER

PT J
AU Suga, H
   Schmid, V
   Gehring, WJ
AF Suga, Hiroshi
   Schmid, Volker
   Gehring, Walter J.
TI Evolution and functional diversity of jellyfish opsins
SO CURRENT BIOLOGY
LA English
DT Article
ID PHOTORECEPTORS; REGENERATION; MELANOPSIN
AB Cnidaria are the most basal animal phylum possessing complex eyes [1]. Their eyes predominantly use ciliary photoreceptor cells (c-PRCs) like vertebrates, whereas insect eyes use rhabdomeric photoreceptor cells (r-PRCs) [1-4]. These two cell types show not only different cytoarchitectures but distinct phototransduction cascades, which are triggered by the respective types of opsins (e.g., [5]), ciliary opsins (c-opsins) and rhabdomeric opsins (r-opsins) [6]. Recent reports suggested that the c- and r-PRCs and their respective opsins diverged at least before the deuterostome-protostome split [7-9]. To study the earlier evolution of animal PRCs and opsins, we investigated two hydrozoan jellyfishes. We report here the first-characterized cnidarian opsins. Molecular phylogeny revealed that the cloned 20 jellyfish opsins, together with all the opsins from a hydra and some from a sea anemone, are more closely related to the c-opsins than to any other major opsin subfamily, indicating that the divergence of c- and r-opsins antedates the Cnidaria-Bilateria split. Possible scenarios of animal PRC evolution are discussed. Furthermore, Cladonema opsins show several distinct tissue- and stage-specific expression patterns. The expression of specific opsins in the eyes suggests a role in vision, whereas that in the gonads suggests a role in light-controlled release of gametes.
C1 [Suga, Hiroshi; Schmid, Volker; Gehring, Walter J.] Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Gehring, WJ (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM walter.gehring@unibas.ch
CR Arendt D, 2004, SCIENCE, V306, P869, DOI 10.1126/science.1099955
   ARKETT SA, 1989, NATO ADV SCI I A-LIF, V188, P373
   BOUILLON J, 1974, Archives de Biologie, V85, P307
   Bouillon J., 1994, TRAITE ZOOLOGIE CNID, VIII
   EAKIN RM, 1962, P NATL ACAD SCI USA, V48, P826, DOI 10.1073/pnas.48.5.826
   Eakin RM, 1963, GENERAL PHYSIOLOGY C, P393
   Levy O, 2007, SCIENCE, V318, P467, DOI 10.1126/science.1145432
   Martin VJ, 2002, CAN J ZOOL, V80, P1703, DOI 10.1139/Z02-136
   Miyata T, 2001, BIOESSAYS, V23, P1018, DOI 10.1002/bies.1147
   Nilsson DE, 2004, CURR OPIN NEUROBIOL, V14, P407, DOI 10.1016/j.conb.2004.07.004
   Nordstrom K, 2003, P ROY SOC B-BIOL SCI, V270, P2349, DOI 10.1098/rspb.2003.2504
   Panda S, 2005, SCIENCE, V307, P600, DOI 10.1126/science.1105121
   Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158
   Qiu XD, 2005, NATURE, V433, P745, DOI 10.1038/nature03345
   Shimodaira H, 2001, BIOINFORMATICS, V17, P1246, DOI 10.1093/bioinformatics/17.12.1246
   SINGLA CL, 1974, CELL TISSUE RES, V149, P413
   Stierwald M, 2004, DEV BIOL, V274, P70, DOI 10.1016/j.ydbio.2004.06.018
   Terakita A, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-3-213
   WEBER C, 1981, J MORPHOL, V167, P313, DOI 10.1002/jmor.1051670306
NR 19
TC 92
Z9 92
U1 0
U2 43
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0960-9822
EI 1879-0445
J9 CURR BIOL
JI Curr. Biol.
PD JAN 8
PY 2008
VL 18
IS 1
BP 51
EP 55
DI 10.1016/j.cub.2007.11.059
PG 5
WC Biochemistry & Molecular Biology; Biology; Cell Biology
SC Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other
   Topics; Cell Biology
GA 250IE
UT WOS:000252292400028
PM 18160295
DA 2021-01-25
ER

PT J
AU Wiesel, N
   Mattout, A
   Melcer, S
   Melamed-Book, N
   Herrmann, H
   Medalia, O
   Aebi, U
   Gruenbaum, Y
AF Wiesel, Naama
   Mattout, Anna
   Melcer, Shai
   Melamed-Book, Naomi
   Herrmann, Harald
   Medalia, Ohad
   Aebi, Ueli
   Gruenbaum, Yosef
TI Laminopathic mutations interfere with the assembly, localization, and
   dynamics of nuclear lamins
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE filament assembly; laminopathic diseases; nuclear envelope
ID INTERMEDIATE-FILAMENTS; CELL-CYCLE; ENVELOPE; EXPRESSION; PROTEIN;
   BLOCKS; DOMAIN
AB Lamins are nuclear intermediate filament proteins and the major building blocks of the nuclear lamina. Besides providing nuclear shape and mechanical stability, lamins are required for chromatin organization, transcription regulation, DNA replication, nuclear assembly, nuclear positioning, and apoptosis. Mutations in human lamins cause many different heritable diseases, affecting various tissues and causing early aging. Although many of these mutations result in nuclear deformation, their effects on lamin filament assembly are unknown. Caenorhabditis elegans has a single evolutionarily conserved lamin protein, which can form stable 10-nm-thick filaments in vitro. To gain insight into the molecular basis of lamin filament assembly and the effects of laminopathic mutations on this process, we investigated mutations in conserved residues of the rod and tail domains that are known to cause various laminopathies in human. We show that 8 of 14 mutant lamins present WT-like assembly into filaments or paracrystals, whereas 6 mutants show assembly defects. Correspondingly, expressing these mutants in transgenic animals shows abnormal distribution of Ce-lamin, abnormal nuclear shape or change in lamin mobility. These findings help in understanding the role of individual residues and domains in laminopathy pathology and, eventually, promote the development of therapeutic interventions.
C1 [Wiesel, Naama; Mattout, Anna; Melcer, Shai; Melamed-Book, Naomi; Gruenbaum, Yosef] Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel.
   [Herrmann, Harald] German Canc Res Ctr, Div Mol Genet, D-69120 Heidelberg, Germany.
   [Medalia, Ohad] Ben Gurion Univ Negev, Dept Life Sci, IL-84120 Beer Sheva, Israel.
   [Medalia, Ohad] Ben Gurion Univ Negev, Natl Inst Biotechnol Negev, IL-84120 Beer Sheva, Israel.
   [Aebi, Ueli] Univ Basel, ME Mueller Inst Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Gruenbaum, Y (corresponding author), Hebrew Univ Jerusalem, Dept Genet, Inst Life Sci, IL-91904 Jerusalem, Israel.
EM gru@vms.huji.ac.il
OI Mattout, Anna/0000-0003-1736-9165; Medalia, Ohad/0000-0003-0994-2937
CR AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   Broers JLV, 2006, PHYSIOL REV, V86, P967, DOI 10.1152/physrev.00047.2005
   Foeger N, 2006, J STRUCT BIOL, V155, P340, DOI 10.1016/j.jsb.2006.03.026
   Fridkin A, 2004, P NATL ACAD SCI USA, V101, P6987, DOI 10.1073/pnas.0307880101
   GERACE L, 1980, CELL, V19, P277, DOI 10.1016/0092-8674(80)90409-2
   Goldman RD, 2002, GENE DEV, V16, P533, DOI 10.1101/gad.960502
   Gruenbaum Y, 2005, NAT REV MOL CELL BIO, V6, P21, DOI 10.1038/nrm1550
   Haithcock E, 2005, P NATL ACAD SCI USA, V102, P16690, DOI 10.1073/pnas.0506755102
   Hajdu-Cronin YM, 2004, GENETICS, V168, P1937, DOI 10.1534/genetics.104.028423
   HEITLINGER E, 1992, J STRUCT BIOL, V108, P74, DOI 10.1016/1047-8477(92)90009-Y
   Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823
   Herrmann H, 2003, CELL MOL LIFE SCI, V60, P1607, DOI 10.1007/s00018-003-3004-0
   Karabinos A, 2003, J MOL BIOL, V325, P241, DOI 10.1016/S0022-2836(02)01240-8
   Klapper M, 1997, J CELL SCI, V110, P2519
   Lee KK, 2000, MOL BIOL CELL, V11, P3089, DOI 10.1091/mbc.11.9.3089
   Liu J, 2000, MOL BIOL CELL, V11, P3937, DOI 10.1091/mbc.11.11.3937
   Margalit A, 2007, J CELL BIOL, V178, P661, DOI 10.1083/jcb.200704049
   Mattout A, 2007, J CELL SCI, V120, P77, DOI 10.1242/jcs.03325
   Mattout A, 2006, CURR OPIN CELL BIOL, V18, P335, DOI 10.1016/j.ceb.2006.03.007
   Melcer S, 2007, EXP CELL RES, V313, P2157, DOI 10.1016/j.yexcr.2007.03.004
   Moir RD, 2000, J STRUCT BIOL, V129, P324, DOI 10.1006/jsbi.2000.4251
   Praitis V, 2001, GENETICS, V157, P1217
   RABUT G, 2005, PHOTOBLEACHING TECHN
   Schirmer EC, 2003, SCIENCE, V301, P1380, DOI 10.1126/science.1088176
   STRINGHAM EG, 1992, MOL BIOL CELL, V3, P221, DOI 10.1091/mbc.3.2.221
   Stuurman N, 1998, J STRUCT BIOL, V122, P42, DOI 10.1006/jsbi.1998.3987
   Tzur YB, 2002, J STRUCT BIOL, V137, P146, DOI 10.1006/jsbi.2002.4452
   VICEK S, 2007, CURR OPIN CELL BIOL, V19, P298
   Worman HJ, 2005, INT REV CYTOL, V246, P231, DOI 10.1016/S0074-7696(05)46006-4
   Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028
NR 30
TC 69
Z9 73
U1 0
U2 6
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD JAN 8
PY 2008
VL 105
IS 1
BP 180
EP 185
DI 10.1073/pnas.0708974105
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 252GP
UT WOS:000252435300036
PM 18162544
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Berman, HM
   Adams, P
   Kouranov, A
   Nair, R
   Tao, W
   Schwede, T
   Shah, R
   Westbrook, J
AF Berman, Helen M.
   Adams, Paul
   Kouranov, Andrei
   Nair, Rajesh
   Tao, Wendy
   Schwede, Torsten
   Shah, Raship
   Westbrook, John
TI The PSI structural genomics knowledgebase
SO ACTA CRYSTALLOGRAPHICA A-FOUNDATION AND ADVANCES
LA English
DT Meeting Abstract
DE structural genomics; biosciences databases; structural biological
   function
C1 [Berman, Helen M.; Kouranov, Andrei; Nair, Rajesh; Tao, Wendy; Shah, Raship; Westbrook, John] Rutgers State Univ, Chem & Chem Biol, Piscataway, NJ 08854 USA.
   [Adams, Paul] Lawrence Berkeley Natl Lab, Berkeley Struct Genom Ctr, Berkeley, CA 94720 USA.
   [Schwede, Torsten] Univ Basel, Div Bioinformat, Biozentrum, CH-4056 Basel, Switzerland.
EM berman@rcsb.rutgers.edu
RI Adams, Paul D/A-1977-2013
OI Adams, Paul D/0000-0001-9333-8219
FU NIHUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USA
FX The PSI SG KB is funded by the NIH.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU INT UNION CRYSTALLOGRAPHY
PI CHESTER
PA 2 ABBEY SQ, CHESTER, CH1 2HU, ENGLAND
SN 2053-2733
J9 ACTA CRYSTALLOGR A
JI Acta Crystallogr. Sect. A
PY 2008
VL 64
SU S
MA P04.22.430
BP C364
EP C364
DI 10.1107/S0108767308088363
PG 1
WC Chemistry, Multidisciplinary; Crystallography
SC Chemistry; Crystallography
GA VI3WO
UT WOS:000480420703206
OA Bronze
DA 2021-01-25
ER

PT J
AU Wang, W
   Sass, HJ
   Zahringer, U
   Grzesiek, S
AF Wang, Wei
   Sass, Hans Juergen
   Zaehringer, Ulrich
   Grzesiek, Stephan
TI Structure and Dynamics of C-13,N-15-Labeled Lipopolysaccharides in a
   Membrane Mimetic
SO ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
LA English
DT Article
DE isotopic labeling; lipopolysaccharides; membrane mimetics; NMR
   spectroscopy; structure elucidation
ID BIOSYNTHETIC PRECURSOR; CRYSTAL-STRUCTURE; SEVERE SEPSIS; NMR;
   ALIGNMENT; BIOMOLECULES; COUPLINGS; RESPONSES; COMPLEX; COSTS
C1 [Zaehringer, Ulrich] Res Ctr Borstel, Div Immunochem, D-23845 Borstel, Germany.
   [Wang, Wei; Sass, Hans Juergen; Grzesiek, Stephan] Univ Basel, Div Struct Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Zahringer, U (corresponding author), Res Ctr Borstel, Div Immunochem, Pk Allee 4A, D-23845 Borstel, Germany.
EM uzaehr@fz-borstel.de; stephan.grzesiek@unibas.ch
OI Grzesiek, Stephan/0000-0003-1998-4225
FU Roche Research Foundation; Schweizerische NationalfondsSwiss National
   Science Foundation (SNSF) [31-109712]; Deutsche
   ForschungsgemeinschaftGerman Research Foundation (DFG) [SFB 470, B4]
FX This work was supported by a stipend from the Roche Research Foundation
   (to W.W.), the Schweizerische Nationalfonds (grant no. 31-109712 to
   S.G.), and by the Deutsche Forschungsgemeinschaft (SFB 470, Project B4;
   to U.Z.)
CR Angus DC, 2001, CRIT CARE MED, V29, P1303, DOI [10.1097/00003246-200107000-00002, 10.1097/00003246-200107001-00035]
   BROOKS BR, 1983, J COMPUT CHEM, V4, P187, DOI 10.1002/jcc.540040211
   Burchardi H, 2004, PHARMACOECONOMICS, V22, P793, DOI 10.2165/00019053-200422120-00003
   Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216
   Dixon DR, 2005, J DENT RES, V84, P584, DOI 10.1177/154405910508400702
   Ferguson AD, 1998, SCIENCE, V282, P2215, DOI 10.1126/science.282.5397.2215
   Fushman D, 2000, J AM CHEM SOC, V122, P10640, DOI 10.1021/ja001128j
   GRZESIEK S, 1995, J AM CHEM SOC, V117, P5312, DOI 10.1021/ja00124a014
   Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002
   LOPPNOW H, 1989, J IMMUNOL, V142, P3229
   Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111
   Oikawa M, 2004, ORG BIOMOL CHEM, V2, P3557, DOI 10.1039/b410544c
   Oikawa M, 2001, B CHEM SOC JPN, V74, P1455, DOI 10.1246/bcsj.74.1455
   Prestegard JH, 2000, Q REV BIOPHYS, V33, P371, DOI 10.1017/S0033583500003656
   Sass HJ, 2000, J BIOMOL NMR, V18, P303, DOI 10.1023/A:1026703605147
   Sass J, 1999, J AM CHEM SOC, V121, P2047, DOI 10.1021/ja983887w
   STRAIN SM, 1983, J BIOL CHEM, V258, P3466
   Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111
   Tycko R, 2000, J AM CHEM SOC, V122, P9340, DOI 10.1021/ja002133q
   WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311
   ZAHRINGER U, 1993, TETRAHEDRON, V49, P4193, DOI 10.1016/S0040-4020(01)85737-9
   Zahringer U, 1999, ENDOTOXIN IN HEALTH AND DISEASE, P93
NR 22
TC 16
Z9 16
U1 2
U2 11
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA POSTFACH 101161, 69451 WEINHEIM, GERMANY
SN 1433-7851
EI 1521-3773
J9 ANGEW CHEM INT EDIT
JI Angew. Chem.-Int. Edit.
PY 2008
VL 47
IS 51
BP 9870
EP 9874
DI 10.1002/anie.200803474
PG 5
WC Chemistry, Multidisciplinary
SC Chemistry
GA 387AF
UT WOS:000261923400007
PM 19034945
DA 2021-01-25
ER

PT S
AU Engel, A
   Gaub, HE
AF Engel, Andreas
   Gaub, Hermann E.
TI Structure and mechanics of membrane proteins
SO ANNUAL REVIEW OF BIOCHEMISTRY
SE Annual Review of Biochemistry
LA English
DT Review; Book Chapter
DE atomic force microscope; bacteriorhodopsin; folding potential; ligand
   binding; scanning electrochemical microscope; single-molecule force
   spectroscopy
ID ATOMIC-FORCE MICROSCOPY; RESOLUTION AFM TOPOGRAPHS; MITOCHONDRIAL OUTER
   MEMBRANES; TITIN IMMUNOGLOBULIN DOMAINS; PHOTOSYNTHETIC CORE COMPLEX;
   NATIVE DISC MEMBRANES; MOLECULAR-INTERACTIONS; COUPLED RECEPTORS;
   LIGAND-BINDING; SUPRAMOLECULAR ASSEMBLIES
AB Evolution has tuned membrane proteins to exist in a lipid bilayer, provide for cell-cell communication, transport solutes, and convert energies. These proteins exhibit a hydrophobic belt that interacts with the lipid bilayer. Detergents are therefore used to extract membrane proteins and keep them in solution for purification and subsequent analyses. However, most membrane proteins are unstable when solubilized and hence often not accessible to NMR or X-ray crystallography. The atomic force microscope (AFM) is a powerful tool for imaging and manipulating membrane proteins in their native state. Superb images of native membranes have been recorded, and a quantitative interpretation of the data acquired using the AFM tip has become possible. In addition, multifunctional probes to simultaneously acquire information on the topography and electrical properties of membrane proteins have been produced. This progress is discussed here and fosters expectations for future developments and applications of AFM and single-molecule force spectroscopy.
C1 [Engel, Andreas] Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Gaub, Hermann E.] Univ Munich, Ctr Neurosci, D-80799 Munich, Germany.
   [Gaub, Hermann E.] Univ Munich, Dept Phys, D-80799 Munich, Germany.
RP Engel, A (corresponding author), Univ Basel, Biozentrum, Maurice E Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
EM andreas.engel@unibas.ch; gaub@lmu.de
CR AKIYAMA T, 2003, 12 INT C SCANN TUNN
   Andersen C, 2002, J BIOL CHEM, V277, P41318, DOI 10.1074/jbc.M206804200
   Ando T, 2001, P NATL ACAD SCI USA, V98, P12468, DOI 10.1073/pnas.211400898
   Bahatyrova S, 2004, NATURE, V430, P1058, DOI 10.1038/nature02823
   Bayburt TH, 2007, J BIOL CHEM, V282, P14875, DOI 10.1074/jbc.M701433200
   BINNIG G, 1986, PHYS REV LETT, V56, P930, DOI 10.1103/PhysRevLett.56.930
   Blank K, 2006, CHEMBIOCHEM, V7, P1349, DOI 10.1002/cbic.200600198
   Bouvier M, 2001, NAT REV NEUROSCI, V2, P274, DOI 10.1038/35067575
   Buzhynskyy N, 2007, BIOPHYS J, V93, P2870, DOI 10.1529/biophysj.107.109728
   Buzhynskyy N, 2007, EMBO REP, V8, P51, DOI 10.1038/sj.embor.7400858
   Carrion-Vazquez M, 1999, P NATL ACAD SCI USA, V96, P3694, DOI 10.1073/pnas.96.7.3694
   Chon JWM, 2000, J APPL PHYS, V87, P3978, DOI 10.1063/1.372455
   Cisneros DA, 2005, STRUCTURE, V13, P235, DOI 10.1016/j.str.2004.12.005
   Clausen-Schaumann H, 2000, CURR OPIN CHEM BIOL, V4, P524, DOI 10.1016/S1367-5931(00)00126-5
   Czajkowsky DM, 1998, J MOL BIOL, V276, P325, DOI 10.1006/jmbi.1997.1535
   de Groot BL, 2001, SCIENCE, V294, P2353, DOI 10.1126/science.1062459
   Engel A, 2000, NAT STRUCT BIOL, V7, P715, DOI 10.1038/78929
   Engelman DM, 2005, NATURE, V438, P578, DOI 10.1038/nature04394
   EVANS E, 1999, J PHYS-CONDENS MAT, V11, P1
   Fotiadis D, 2006, CURR OPIN STRUC BIOL, V16, P252, DOI 10.1016/j.sbi.2006.03.013
   Fotiadis D, 2000, J MOL BIOL, V300, P779, DOI 10.1006/jmbi.2000.3920
   Fotiadis D, 2003, NATURE, V421, P127, DOI 10.1038/421127a
   Fotiadis D, 2004, J BIOL CHEM, V279, P2063, DOI 10.1074/jbc.M310382200
   Fotiadis D, 2002, J MOL BIOL, V318, P1381, DOI 10.1016/S0022-2836(02)00143-2
   Frederix PLTM, 2005, NANOTECHNOLOGY, V16, P997, DOI 10.1088/0957-4484/16/8/001
   Frederix PT, 2004, MRS BULL, V29, P449, DOI 10.1557/mrs2004.138
   Friedsam C, 2003, J PHYS-CONDENS MAT, V15, pS1709, DOI 10.1088/0953-8984/15/18/305
   Goncalves RP, 2005, J STRUCT BIOL, V152, P221, DOI 10.1016/j.jsb.2005.10.002
   Goncalves RP, 2007, J MOL BIOL, V369, P413, DOI 10.1016/j.jmb.2007.03.063
   Goncalves RP, 2006, NAT METHODS, V3, P1007, DOI 10.1038/nmeth965
   Grandbois M, 1999, SCIENCE, V283, P1727, DOI 10.1126/science.283.5408.1727
   Grater F, 2005, BIOPHYS J, V88, P790, DOI 10.1529/biophysj.104.052423
   Grubmuller H, 1996, SCIENCE, V271, P997, DOI 10.1126/science.271.5251.997
   Gullo MR, 2006, ANAL CHEM, V78, P5436, DOI 10.1021/ac0521495
   Gullo MR, 2005, MICROELECTRON ENG, V78-79, P571, DOI 10.1016/j.mee.2004.12.072
   Guo W, 2005, P NATL ACAD SCI USA, V102, P17495, DOI 10.1073/pnas.0508950102
   HANSMA PK, 1994, APPL PHYS LETT, V64, P1738, DOI 10.1063/1.111795
   Hoogenboom BW, 2007, J MOL BIOL, V370, P246, DOI 10.1016/j.jmb.2007.04.073
   Hoogenboom BW, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2202638
   Hugel T, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.048301
   Hugel T, 2001, MACROMOLECULES, V34, P1039, DOI 10.1021/ma0009404
   James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978
   Janovjak H, 2003, EMBO J, V22, P5220, DOI 10.1093/emboj/cdg509
   Janovjak H, 2007, J AM CHEM SOC, V129, P246, DOI 10.1021/ja065684a
   Jastrzebska B, 2006, J BIOL CHEM, V281, P11917, DOI 10.1074/jbc.M600422200
   Kedrov A, 2005, EMBO REP, V6, P668, DOI 10.1038/sj.embor.7400455
   Kedrov A, 2004, J MOL BIOL, V340, P1143, DOI 10.1016/j.jmb.2004.05.026
   Kedrov A, 2007, J STRUCT BIOL, V159, P290, DOI 10.1016/j.jsb.2007.02.010
   Kedrov A, 2007, ANNU REV BIOPH BIOM, V36, P233, DOI 10.1146/annurev.biophys.36.040306.132640
   Kellermayer MSZ, 1997, SCIENCE, V276, P1112, DOI 10.1126/science.276.5315.1112
   Kessler M, 2006, STRUCTURE, V14, P521, DOI 10.1016/j.str.2005.11.023
   Kessler M, 2006, J MOL BIOL, V357, P644, DOI 10.1016/j.jmb.2005.12.065
   Kreuzer HJ, 1999, NEW J PHYS, V1, DOI 10.1088/1367-2630/1/1/321
   Li H, 1999, APPL PHYS A-MATER, V68, P407, DOI 10.1007/s003390050914
   Li HB, 1999, CHEM PHYS LETT, V305, P197, DOI 10.1016/S0009-2614(99)00389-9
   Liang Y, 2003, J BIOL CHEM, V278, P21655, DOI 10.1074/jbc.M302536200
   Livadaru L, 2003, MACROMOLECULES, V36, P3732, DOI 10.1021/ma020751g
   Lu H, 1998, BIOPHYS J, V75, P662, DOI 10.1016/S0006-3495(98)77556-3
   MANNELLA CA, 1984, SCIENCE, V224, P165, DOI 10.1126/science.6322311
   Marszalek PE, 1999, NATURE, V402, P100
   Moller C, 2003, J STRUCT BIOL, V142, P369, DOI 10.1016/S1047-8477(03)00066-2
   Muller DJ, 2007, NAT PROTOC, V2, P2191, DOI 10.1038/nprot.2007.309
   MULLER D, CURR OPIN C IN PRESS
   Muller DJ, 1999, P NATL ACAD SCI USA, V96, P13170, DOI 10.1073/pnas.96.23.13170
   Muller DJ, 1999, BIOPHYS J, V76, P1101, DOI 10.1016/S0006-3495(99)77275-9
   Muller DJ, 2002, BIOPHYS J, V83, P3578, DOI 10.1016/S0006-3495(02)75358-7
   MULLER DJ, 1995, J MOL BIOL, V249, P239, DOI 10.1006/jmbi.1995.0292
   Muller DJ, 1999, J MOL BIOL, V285, P1347, DOI 10.1006/jmbi.1998.2359
   Muller DJ, 1997, J STRUCT BIOL, V119, P172, DOI 10.1006/jsbi.1997.3875
   Muller DJ, 2000, BBA-BIOENERGETICS, V1460, P27, DOI 10.1016/S0005-2728(00)00127-4
   Neuert G, 2006, MACROMOLECULES, V39, P789, DOI 10.1021/ma051622d
   Oesterhelt F, 2000, SCIENCE, V288, P143, DOI 10.1126/science.288.5463.143
   Park PSH, 2007, J BIOL CHEM, V282, P11377, DOI 10.1074/jbc.M610341200
   Picco LM, 2007, NANOTECHNOLOGY, V18, DOI 10.1088/0957-4484/18/4/044030
   Pogoryelov D, 2005, EMBO REP, V6, P1040, DOI 10.1038/sj.embor.7400517
   Preiner J, 2007, BIOPHYS J, V93, P930, DOI 10.1529/biophysj.106.096982
   Rief M, 1997, SCIENCE, V276, P1109, DOI 10.1126/science.276.5315.1109
   Rief M, 1997, SCIENCE, V275, P1295, DOI 10.1126/science.275.5304.1295
   Rief M, 2000, ADV EXP MED BIOL, V481, P129
   Rief M, 1999, J MOL BIOL, V286, P553, DOI 10.1006/jmbi.1998.2466
   SCHABERT FA, 1995, SCIENCE, V268, P92, DOI 10.1126/science.7701347
   Scheuring S, 2006, J MOL BIOL, V358, P83, DOI 10.1016/j.jmb.2006.01.085
   Scheuring S, 2005, SCIENCE, V309, P484, DOI 10.1126/science.1110879
   Scheuring S, 2004, EMBO J, V23, P4127, DOI 10.1038/sj.emboj.7600429
   Scheuring S, 2005, J BIOL CHEM, V280, P1426, DOI 10.1074/jbc.M411334200
   Scheuring S, 2003, P NATL ACAD SCI USA, V100, P1690, DOI 10.1073/pnas.0437992100
   Scheuring S, 2002, MOL MICROBIOL, V44, P675, DOI 10.1046/j.1365-2958.2002.02864.x
   Scheuring S, 2002, EUR BIOPHYS J BIOPHY, V31, P172, DOI 10.1007/s00249-001-0197-8
   Scheuring S, 1999, EMBO J, V18, P4981, DOI 10.1093/emboj/18.18.4981
   Scheuring S, 2001, EMBO J, V20, P3029, DOI 10.1093/emboj/20.12.3029
   Scheuring S, 2007, J STRUCT BIOL, V160, P385, DOI 10.1016/j.jsb.2007.07.009
   Scheuring S, 2007, J STRUCT BIOL, V159, P268, DOI 10.1016/j.jsb.2007.01.021
   Scheuring S, 2006, CURR OPIN CHEM BIOL, V10, P387, DOI 10.1016/j.cbpa.2006.08.007
   Schitter G, 2007, IEEE T CONTR SYST T, V15, P906, DOI 10.1109/TCST.2007.902953
   Seelert H, 2000, NATURE, V405, P418
   Seitz M, 2003, CHEMPHYSCHEM, V4, P986, DOI 10.1002/cphc.200300760
   Simons K, 1997, NATURE, V387, P569, DOI 10.1038/42408
   STAHLBERG H, 2001, EMBO REP, V21, P1
   Suda K, 2004, MOL MEMBR BIOL, V21, P435, DOI 10.1080/09687860400020291
   Terrillon S, 2004, EMBO REP, V5, P30, DOI 10.1038/sj.embor.7400052
   Urry DW, 2002, PHILOS T R SOC B, V357, P169, DOI 10.1098/rstb.2001.1023
   Yildiz O, 2006, EMBO J, V25, P3702, DOI 10.1038/sj.emboj.7601237
   Yokokawa M, 2006, EMBO J, V25, P4567, DOI 10.1038/sj.emboj.7601326
NR 103
TC 168
Z9 169
U1 4
U2 93
PU ANNUAL REVIEWS
PI PALO ALTO
PA 4139 EL CAMINO WAY, PO BOX 10139, PALO ALTO, CA 94303-0139 USA
SN 0066-4154
BN 978-0-8243-0877-3
J9 ANNU REV BIOCHEM
JI Annu. Rev. Biochem.
PY 2008
VL 77
BP 127
EP 148
DI 10.1146/annurev.biochem.77.062706.154450
PG 22
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 325NY
UT WOS:000257596800007
PM 18518819
DA 2021-01-25
ER

PT J
AU Knechtle, B
   Knechtle, P
   Schulze, I
   Kohler, G
AF Knechtle, Beat
   Knechtle, Patrizia
   Schulze, Ingo
   Kohler, Goetz
TI Vitamins, minerals and race performance in ultra-endurance runners -
   Deutschlandlauf 2006
SO ASIA PACIFIC JOURNAL OF CLINICAL NUTRITION
LA English
DT Article
DE ultra running; supplementation; nutrition; ergogenic aids; exercise
ID NUTRITIONAL SUPPLEMENTS; PHYSICAL PERFORMANCE; DIETARY-SUPPLEMENTS;
   PATTERNS
AB We investigated the effect of pre-race intake of vitamins and minerals, in the form of supplementation, before a multi-stage ultra-endurance run and their effect on race performance. At the Deutschlandlauf 2006 in Germany, where athletes had to run across Germany from the north (Kap Arkona - Rugen) to the south (Lorrach) over 1,200 km within 17 consecutive stages, twenty male ultra runners (46.2 +/- 9.6 years, 71.8 +/- 5.2 kg, 179 +/- 6 cm, BMI 22.5 +/- 1.9 kg/m(2)) completed a questionnaire about their intake of vitamin and mineral supplements in the four weeks before the race. Race performance of athletes with- and athletes without regular intake of these supplements were compared. In the four weeks before the run, nine runners (45%) ingested vitamin- and twelve athletes (60%) mineral supplements. Athletes with an intake of vitamins (152.8 +/- 14.1 h versus 160.6 +/- 14.6 h, p > 0.05) and minerals (151.6 +/- 14.5 h versus 165.3 +/- 10.8 h, p > 0.05) finished the race no faster than athletes without an intake of vitamins and minerals. We concluded that in the Deutschlandlauf 2006 of over 1,200 km within 17 consecutive stages, athletes with a regular intake of vitamin and mineral supplements in the four weeks before the race finished the competition no faster than athletes without an intake of vitamins and minerals.
C1 [Knechtle, Beat; Knechtle, Patrizia] Gesundheitszentrum, Facharzt FMH Allgemeinmed, CH-9001 St Gallen, Switzerland.
   [Knechtle, Beat] Univ Zurich, Dept Gen Practice, Zurich, Switzerland.
   [Schulze, Ingo] Deutschlandlauf, Horb Nordstetten, Germany.
   [Kohler, Goetz] Univ Basel, Biozentrum, Div Biophys Chem, Basel, Switzerland.
RP Knechtle, B (corresponding author), Gesundheitszentrum, Facharzt FMH Allgemeinmed, Vadian Str 26, CH-9001 St Gallen, Switzerland.
EM beat.knechtle@hispeed.ch
CR Ahrendt DM, 2001, AM FAM PHYSICIAN, V63, P913
   Applegate E A, 1991, Int J Sport Nutr, V1, P118
   CROWLEY JJ, 2004, ASIA PACIFIC J CLI S, V13, pS39
   ECONOMOS CD, 1993, SPORTS MED, V16, P381, DOI 10.2165/00007256-199316060-00004
   Fry Andrew C, 2006, Res Sports Med, V14, P53, DOI 10.1080/15438620500528323
   GRANDJEAN AC, 1994, CLIN SPORT MED, V13, P235
   GREANDJEAN AC, 1983, CLIN SPORTS MED, V2, P105
   Huang SH, 2006, CLIN J SPORT MED, V16, P27, DOI 10.1097/01.jsm.0000194766.35443.9c
   Kim SH, 1999, INT J SPORT NUTR, V9, P391, DOI 10.1123/ijsn.9.4.391
   Lukaski HC, 2004, NUTRITION, V20, P632, DOI 10.1016/j.nut.2004.04.001
   Maughan RJ, 2004, J SPORT SCI, V22, P95, DOI 10.1080/0264041031000140581
   NIEMAN DC, 1989, J AM DIET ASSOC, V89, P1615
   Nieper A, 2005, BRIT J SPORT MED, V39, P645, DOI 10.1136/bjsm.2004.015842
   Peters EM, 1997, INT J SPORT NUTR, V7, P80, DOI 10.1123/ijsn.7.2.80
   SINGH A, 1993, MED SCI SPORT EXER, V25, P328
   SINGH A, 1992, MED SCI SPORT EXER, V24, P726
   SOBAL J, 1994, INT J SPORT NUTR, V4, P320, DOI 10.1123/ijsn.4.4.320
   Striegel H, 2006, INT J SPORTS MED, V27, P236, DOI 10.1055/s-2005-865648
   Sundgot-Borgen J, 2003, SCAND J MED SCI SPOR, V13, P138, DOI 10.1034/j.1600-0838.2003.10288.x
   VANERPBAART AMJ, 1989, INT J SPORTS MED, V10, pS11, DOI 10.1055/s-2007-1024948
   WEIGHT LM, 1988, AM J CLIN NUTR, V47, P192
   WILLIAMS MH, 1992, MED SCI SPORT EXER, V24, pS344
   WORME JD, 1990, AM J CLIN NUTR, V51, P690
NR 23
TC 21
Z9 22
U1 0
U2 2
PU H E C PRESS, HEALTHY EATING CLUB PTY LTD
PI SOUTHBANK
PA EMERALD HILL CLINIC 157 CLARENDON ST, SOUTHBANK, VIC 3006, AUSTRALIA
SN 0964-7058
J9 ASIA PAC J CLIN NUTR
JI Asia Pac. J. Clin. Nutr.
PY 2008
VL 17
IS 2
BP 194
EP 198
PG 5
WC Nutrition & Dietetics
SC Nutrition & Dietetics
GA 328FS
UT WOS:000257784400002
PM 18586636
DA 2021-01-25
ER

PT S
AU Shaw, JR
   Pfrender, ME
   Eads, BD
   Klaper, R
   Callaghan, A
   Sibly, RM
   Colson, I
   Jansen, B
   Gilbert, D
   Colbourne, JK
AF Shaw, Joseph R.
   Pfrender, Michael E.
   Eads, Brian D.
   Klaper, Rebecca
   Callaghan, Amanda
   Sibly, Richard M.
   Colson, Isabelle
   Jansen, Bastiaan
   Gilbert, Donald
   Colbourne, John K.
BE Hogstrand, C
   Kille, P
TI Daphnia as an emerging model for toxicological genomics
SO COMPARATIVE TOXICOGENOMICS
SE Advances in Experimental Biology
LA English
DT Article; Book Chapter
DE BioMart; BLAST; cDNA; Ceriodaphnia dubia; Daphnia Genomic Consortium;
   Daphnia magna; Daphnia pulex; daphniid; ecology; environment; evolution;
   expressed sequence tag (EST); gene; gene expression; gene-expression
   profiling; gene inventory; Gene Ontology (GO); Generic Model Organism
   Database (GMOD); genetic map; genetics; genome; genomics; microarray;
   model system; physical map; quantitative trait loci (QTL) analysis;
   toxicity test; toxicogenomics; toxicology; toxicological genomics;
   wFleaBase
ID QUANTITATIVE TRAIT LOCI; GENE-EXPRESSION PROFILES; TAXONOMIC
   REEVALUATION; NATURAL-POPULATIONS; MICROSATELLITE MARKERS; PHENOTYPIC
   PLASTICITY; GENOTYPIC FREQUENCIES; ENZYME VARIABILITY; STRESS RESPONSES;
   SEQUENCE TAGS
AB Daphnia are already an established model species in toxicology. This freshwater crustacean is used commonly for environmental monitoring of pollutants around the globe and plays an important role in establishing regulatory criteria by government agencies (e.g., US EPA, Environment Canada organization for Economic Cooperation and Development, Environment Agency of Japan). Consequently, daphniids represent 8% of all experimental data for aquatic animals within the toxicological databases (Denslow et al., 2007). As such, their incorporation within the new field of toxicological genomics is limited only by the advancement of genomic resources. Because the development of these technologies requires the input and feedback of a large research community that extends far beyond the boundaries of any one discipline, the Daphnia Genomics Consortium (DGC) was formed in 2001 to: (i) provide the organizational framework to coordinate efforts at developing the Daphnia genomic toolbox; (ii) facilitate collaborative research and (iii) develop bioinformatics strategies for organizing the rapidly growing database. This chapter reviews the progress in establishing Daphnia as model species for genomic studies, with emphasis on toxicological applications. As the goals of the DGC are defined largely by extending the boundaries of current biological research in light of genomic information, this chapter first reviews Daphnia's unique biological attributes that make it ideal for such an expansion of research efforts. These attributes include a long tradition of ecological, evolutionary and toxicological study, culminating in the benefits provided by emerging genomic tools.
C1 [Shaw, Joseph R.] Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA.
   [Pfrender, Michael E.] Utah State Univ, Dept Biol, Logan, UT 84322 USA.
   [Eads, Brian D.; Gilbert, Donald] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.
   [Klaper, Rebecca] Univ Wisconsin, Great Lakes WATER Inst, Milwaukee, WI 53204 USA.
   [Callaghan, Amanda; Sibly, Richard M.] Univ Reading, Sch Biol Sci, Reading RG6 6AJ, Berks, England.
   [Colson, Isabelle] Univ Basel, Inst Zool, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
   [Jansen, Bastiaan] Katholieke Univ Leuven, Aquat Ecol Lab, B-3000 Louvain, Belgium.
   [Colbourne, John K.] Indiana Univ, Ctr Genom & Bioinformat, Bloomington, IN 47405 USA.
RP Shaw, JR (corresponding author), Indiana Univ, Sch Publ & Environm Affairs, Bloomington, IN 47405 USA.
EM joeshaw@indiana.edu
RI ; Colbourne, John/L-7748-2014
OI Sibly, Richard/0000-0001-6828-3543; Colbourne, John/0000-0002-6966-2972;
   Klaper, Rebecca/0000-0002-9239-6916
CR Adamowicz SJ, 2004, ZOOL J LINN SOC-LOND, V140, P171, DOI 10.1111/j.1096-3642.2003.00089.x
   ADAMS MD, 1991, SCIENCE, V252, P1651, DOI 10.1126/science.2047873
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Amin RP, 2002, TOXICOLOGY, V181, P555, DOI 10.1016/S0300-483X(02)00481-X
   Anderson B. G., 1944, SEWAGE WORKS JOUR, V16, P1156
   ANDERSON BG, 1945, SCIENCE, V102, P539, DOI 10.1126/science.102.2656.539
   Andrew AS, 2003, ENVIRON HEALTH PERSP, V111, P825, DOI 10.1289/ehp.111-1241504
   Audic S, 1997, GENOME RES, V7, P986, DOI 10.1101/gr.7.10.986
   AVEROF M, 1995, PHILOS T R SOC B, V347, P293, DOI 10.1098/rstb.1995.0028
   AVEROF M, 1995, NATURE, V376, P420, DOI 10.1038/376420a0
   Ball CA, 2006, OMICS, V10, P138, DOI 10.1089/omi.2006.10.138
   BANTA AM, 1939, STUDIES PHYSL GENETI
   Bartosiewicz MJ, 2001, J PHARMACOL EXP THER, V297, P895
   Bing N, 2005, GENETICS, V170, P533, DOI 10.1534/genetics.105.041103
   Blomberg SP, 2002, J EVOLUTION BIOL, V15, P899, DOI 10.1046/j.1420-9101.2002.00472.x
   Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577
   Bradshaw HD, 1998, GENETICS, V149, P367
   Brede N, 2006, MOL ECOL NOTES, V6, P536, DOI 10.1111/j.1471-8286.2005.01218.x
   Breukelman J, 1932, SCIENCE, V76, P302, DOI 10.1126/science.76.1970.302
   Caceres CE, 1998, ECOLOGY, V79, P1699, DOI 10.1890/0012-9658(1998)079[1699:IVITAP]2.0.CO;2
   Campbell AK, 2004, COMP BIOCHEM PHYS B, V139, P225, DOI 10.1016/j.cbpc.2004.07.004
   Carlborg O, 2005, BIOINFORMATICS, V21, P2383, DOI 10.1093/bioinformatics/bti241
   Carlborg O, 2004, NAT REV GENET, V5, P618, DOI 10.1038/nrg1407
   CARPENTER SR, 1987, ECOLOGY, V68, P1863, DOI 10.2307/1939878
   Cheung VG, 2002, NAT GENET, V32, P522, DOI 10.1038/ng1036
   Chiavelli DA, 2001, APPL ENVIRON MICROB, V67, P3220, DOI 10.1128/AEM.67.7.3220-3225.2001
   Colbourne JK, 2006, BIOL J LINN SOC, V89, P469, DOI 10.1111/j.1095-8312.2006.00687.x
   Colbourne JK, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-45
   Colbourne JK, 2004, MOL ECOL NOTES, V4, P485, DOI 10.1111/j.1471-8286.2004.00721.x
   Colbourne JK, 1996, PHILOS T ROY SOC B, V351, P349, DOI 10.1098/rstb.1996.0028
   Colbourne JK, 1998, BIOL J LINN SOC, V65, P347, DOI 10.1111/j.1095-8312.1998.tb01146.x
   Colbourne JK, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-217
   Colbourne John K., 1997, P163
   Connon R, 2008, ENVIRON SCI TECHNOL, V42, P2181, DOI 10.1021/es702469b
   Cook J., 2007, GENOMIC APPROACHES C
   Cooney J.D., 1995, FUNDAMENTALS AQUATIC, P71
   Coulibaly I, 2005, ANIM GENET, V36, P309, DOI 10.1111/j.1365-2052.2005.01305.x
   Cousyn C, 2001, P NATL ACAD SCI USA, V98, P6256, DOI 10.1073/pnas.111606798
   Cristescu MEA, 2006, GENOMICS, V88, P415, DOI 10.1016/j.ygeno.2006.03.007
   Davis J., 1977, P 3 AQ TOX WORKSH
   de Hoogh CJ, 2006, ENVIRON SCI TECHNOL, V40, P2678, DOI 10.1021/es052035a
   de Koning DJ, 2005, VET IMMUNOL IMMUNOP, V105, P343, DOI 10.1016/j.vetimm.2005.02.007
   DEMEESTER L, 1993, FRESHWATER BIOL, V30, P219
   DeMeester L, 1996, ECOSCIENCE, V3, P385, DOI 10.1080/11956860.1996.11682356
   Denslow N., 2007, GENOMIC APPROACHES C
   Diachenko LB, 1996, BIOCHEM BIOPH RES CO, V219, P824, DOI 10.1006/bbrc.1996.0317
   Dix DJ, 2006, NAT BIOTECHNOL, V24, P1108, DOI 10.1038/nbt0906-1108
   DODSON SI, 1995, ENVIRON HEALTH PERSP, V103, P7, DOI 10.2307/3432405
   Dong YJ, 2006, FIELD CROP RES, V95, P420, DOI 10.1016/j.fcr.2005.03.005
   DOUDOROFF P, 1950, SEWAGE IND WASTES, V22, P1432
   Drysdale RA, 2005, NUCLEIC ACIDS RES, V33, pD390, DOI 10.1093/nar/gki046
   Dudycha JL, 2003, OECOLOGIA, V135, P555, DOI 10.1007/s00442-003-1230-7
   Dudycha JL, 2001, ECOL LETT, V4, P102
   Durinck S, 2005, BIOINFORMATICS, V21, P3439, DOI 10.1093/bioinformatics/bti525
   Eads BD, 2008, HEREDITY, V100, P184, DOI 10.1038/sj.hdy.6800999
   Eads BD, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-464
   Eaton D., 1996, CASARETT DOULLS TOXI
   Ebert D, 2004, AM NAT, V164, pS19, DOI 10.1086/424606
   Edmondson W., 1987, DAPHNIA MEMORIE I IT, V45
   ELENDT BP, 1990, WATER RES, V24, P1157, DOI 10.1016/0043-1354(90)90180-E
   Ford AT, 2005, ENVIRON TOXICOL CHEM, V24, P1019, DOI 10.1897/04-363R.1
   Fox JA, 2004, MOL ECOL NOTES, V4, P544, DOI 10.1111/j.1471-8286.2004.00706.x
   FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0
   Gallagher K, 2006, HUM ECOL RISK ASSESS, V12, P572, DOI 10.1080/10807030600561717
   Gallo M., 1996, CASARETT DOULLS TOXI
   Glover CN, 2005, J EXP BIOL, V208, P951, DOI 10.1242/jeb.01426
   Gracey AY, 2001, P NATL ACAD SCI USA, V98, P1993, DOI 10.1073/pnas.98.4.1993
   Haag CR, 2002, EVOLUTION, V56, P518
   Haber F., 1924, FUNF VORTRAGE JAHREN, P76
   Hairston NG, 1999, NATURE, V401, P446, DOI 10.1038/46731
   HAIRSTON NG, 1995, ECOLOGY, V76, P1706, DOI 10.2307/1940704
   Hairston NG, 2001, EVOLUTION, V55, P2203
   Hall SR, 2006, ECOLOGY, V87, P1684, DOI 10.1890/0012-9658(2006)87[1684:WDNHTM]2.0.CO;2
   Hamadeh HK, 2002, TOXICOL SCI, V67, P232, DOI 10.1093/toxsci/67.2.232
   Hayes KR, 2005, CHEM RES TOXICOL, V18, P403, DOI 10.1021/tx0496690
   Hebert P., 1987, DAPHNIA MEMORIE I IT, V45
   Hebert PDN, 1996, CAN J ZOOL, V74, P632, DOI 10.1139/z96-073
   HEBERT PDN, 1974, GENETICS, V77, P323
   HEBERT PDN, 1974, GENETICS, V77, P335
   HEBERT PDN, 1993, CAN J ZOOL, V71, P908, DOI 10.1139/z93-119
   HEBERT PDN, 1972, GENETICS, V71, P639
   Hebert PDN, 1997, CAN J ZOOL, V75, P1254, DOI 10.1139/z97-148
   HEBERT PDN, 1974, HEREDITY, V33, P327, DOI 10.1038/hdy.1974.99
   Heckmann LH, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-175
   Hubner N, 2005, NAT GENET, V37, P243, DOI 10.1038/ng1522
   Hughes TR, 2000, CELL, V102, P109, DOI 10.1016/S0092-8674(00)00015-5
   Hunter K, 2004, ENVIRON TOXICOL CHEM, V23, P1311, DOI 10.1897/03-369
   Hutchinson G. E., 1932, Internationale Revue der Hydrobiologie Leipzig, V28, P90
   Jansen RC, 2001, TRENDS GENET, V17, P388, DOI 10.1016/S0168-9525(01)02310-1
   Jensen KH, 2006, PLOS BIOL, V4, P1265, DOI 10.1371/journal.pbio.0040197
   Kerfoot WC, 1999, LIMNOL OCEANOGR, V44, P1232, DOI 10.4319/lo.1999.44.5.1232
   Kilham SS, 1998, HYDROBIOLOGIA, V377, P147, DOI 10.1023/A:1003231628456
   Klaper R, 2004, BIOSCIENCE, V54, P403, DOI 10.1641/0006-3568(2004)054[0403:ATCOGA]2.0.CO;2
   Klaper R, 2006, ENVIRON HEALTH PERSP, V114, P1337, DOI 10.1289/ehp.8786
   KLUGH A. BROOKER, 1926, PROC TRANS ROY SOC CANADA, V20, P225
   KOIVISTO S, 1992, HYDROBIOLOGIA, V248, P125, DOI 10.1007/BF00006080
   KOIVISTO S, 1995, ENVIRON POLLUT, V90, P263, DOI 10.1016/0269-7491(95)00029-Q
   Korf I, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-59
   Korovchinsky NM, 1997, HYDROBIOLOGIA, V360, P1, DOI 10.1023/A:1003156802800
   Larkin P, 2002, MAR ENVIRON RES, V54, P395, DOI 10.1016/S0141-1136(02)00172-1
   Li HQ, 2005, HUM MOL GENET, V14, P1119, DOI 10.1093/hmg/ddi124
   Limburg PA, 2002, P ROY SOC B-BIOL SCI, V269, P281, DOI 10.1098/rspb.2001.1868
   LISITSYN N, 1993, SCIENCE, V259, P946, DOI 10.1126/science.8438152
   Little TJ, 2000, P ROY SOC B-BIOL SCI, V267, P2037, DOI 10.1098/rspb.2000.1246
   Little TJ, 2003, CURR BIOL, V13, P489, DOI 10.1016/S0960-9822(03)00163-5
   Lopes I, 2004, ARCH ENVIRON CON TOX, V46, P43, DOI 10.1007/s00244-003-2143-5
   Lubbock J, 1857, PHILOS T R SOC LOND, V8, P352
   LYNCH M, 1983, AM NAT, V122, P745, DOI 10.1086/284169
   LYNCH M, 1983, EVOLUTION, V37, P358, DOI 10.1111/j.1558-5646.1983.tb05545.x
   Lynch M., 1998, GENETICS ANAL QUANTI
   Lynch Michael, 1994, P109
   Mackay TFC, 2001, NAT REV GENET, V2, P11, DOI 10.1038/35047544
   Mattingly CJ, 2004, PHARMACOGENOMICS J, V4, P5, DOI 10.1038/sj.tpj.6500225
   MCCLEARN GE, 1993, J EXP ANIM SCI, V35, P251
   Merrick BA, 2004, CURR OPIN MOL THER, V6, P600
   Miller FJ, 2000, TOXICOLOGY, V149, P21, DOI 10.1016/S0300-483X(00)00229-8
   Miner BG, 2005, TRENDS ECOL EVOL, V20, P685, DOI 10.1016/j.tree.2005.08.002
   Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797
   MORT MA, 1991, TRENDS ECOL EVOL, V6, P41, DOI 10.1016/0169-5347(91)90120-M
   MUELLER OF, 1785, ENTOMOSTRACA SEU INS
   Nardi F, 2003, SCIENCE, V299, P1887, DOI 10.1126/science.1078607
   Nielsen R, 2006, SCIENCE, V311, P960, DOI 10.1126/science.1124663
   Oda S, 2005, CHEMOSPHERE, V61, P1168, DOI 10.1016/j.chemosphere.2005.02.075
   Olmstead AW, 2003, ENVIRON HEALTH PERSP, V111, P919, DOI 10.1289/ehp.5982
   Paland S, 2006, SCIENCE, V311, P990, DOI 10.1126/science.1118152
   Pedra JHF, 2004, P NATL ACAD SCI USA, V101, P7034, DOI 10.1073/pnas.0400580101
   Peters R. H., 1987, DAPHNIA MEMORIE I IT, V45
   Peters R. H., 1987, DAPHNIA MEMORIE I IT, V45
   Pfrender ME, 2000, MOL ECOL, V9, P1717, DOI 10.1046/j.1365-294x.2000.01062.x
   Pigliucci M, 2005, TRENDS ECOL EVOL, V20, P481, DOI 10.1016/j.tree.2005.06.001
   Pollard HG, 2003, AMBIO, V32, P214, DOI 10.1639/0044-7447(2003)032[0214:ROCDCI]2.0.CO;2
   Poynton HC, 2007, ENVIRON SCI TECHNOL, V41, P1044, DOI 10.1021/es0615573
   Regier JC, 2005, P ROY SOC B-BIOL SCI, V272, P395, DOI 10.1098/rspb.2004.2917
   Regier JC, 1997, MOL BIOL EVOL, V14, P902, DOI 10.1093/oxfordjournals.molbev.a025833
   Richard J., 1895, Annales des Sciences Naturelles, V(7), P279
   Richard J., 1896, ANN SCI NAT ZOOL PAL, V18, P279
   Rider CV, 2005, J EXP BIOL, V208, P15, DOI 10.1242/jeb.01343
   Robinson CD, 2006, J EXP ZOOL PART A, V305A, P62, DOI 10.1002/jez.a.250
   Schierwater B., 1994, Experientia Supplementum (Basel), V69, P495
   Schwenk K, 2000, P ROY SOC B-BIOL SCI, V267, P1833, DOI 10.1098/rspb.2000.1218
   Shaw JR, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-477
   Shaw JR, 2006, ENVIRON TOXICOL CHEM, V25, P182, DOI 10.1897/05-243R.1
   Shiga Y, 2006, EVOL DEV, V8, P407, DOI 10.1111/j.1525-142X.2006.00114.x
   Soetaert A, 2006, COMP BIOCHEM PHYS C, V142, P66, DOI 10.1016/j.cbpc.2005.10.009
   Soetaert A, 2007, AQUAT TOXICOL, V83, P212, DOI 10.1016/j.aquatox.2007.04.010
   Soetaert A, 2007, CHEMOSPHERE, V67, P60, DOI 10.1016/j.chemosphere.2006.09.076
   Stein LD, 2002, GENOME RES, V12, P1599, DOI 10.1101/gr.403602
   Swammerdam J., 1669, HIST INSECTORUM GEN
   Swammerdam John, 1758, BOOK NATURE HIST INS
   Tavazoie S, 1999, NAT GENET, V22, P281
   Tessier AJ, 2000, ECOLOGY, V81, P826, DOI 10.1890/0012-9658(2000)081[0826:AFTOIR]2.0.CO;2
   TOLLRIAN R, 1993, J PLANKTON RES, V15, P1309, DOI 10.1093/plankt/15.11.1309
   TOLLRIAN R, 1995, OECOLOGIA, V101, P151, DOI 10.1007/BF00317278
   United States Environmental Protection Agency, 2002, METH MEAS AC TOX EFF
   Vasemagi A, 2005, MOL BIOL EVOL, V22, P1067, DOI 10.1093/molbev/msi093
   Versteeg DJ, 1997, CHEMOSPHERE, V34, P869, DOI 10.1016/S0045-6535(97)00014-3
   Viehoever A., 1936, J AM PHARM ASSOC, V25, P112
   Viehoever A., 1931, AM J PHARM, V103, P252
   VIEHOEVER ARNO, 1937, AMER JOUR PHARM, V109, P360
   Waring JF, 2001, TOXICOL LETT, V120, P359, DOI 10.1016/S0378-4274(01)00267-3
   Waring JF, 2001, TOXICOL APPL PHARM, V175, P28, DOI 10.1006/taap.2001.9243
   Warren E, 1900, Q J MICROSC SCI, V43, P199
   Watanabe H, 2005, GENOME, V48, P606, DOI 10.1139/G05-038
   Watanabe H, 2007, ENVIRON TOXICOL CHEM, V26, P669, DOI 10.1897/06-075R.1
   West-Eberhard Mary Jane, 2003, pi
   Whitehead A, 2006, P NATL ACAD SCI USA, V103, P5425, DOI 10.1073/pnas.0507648103
   Yampolsky LY, 2005, ZH OBSHCH BIOL, V66, P416
NR 167
TC 64
Z9 66
U1 1
U2 32
PU ELSEVIER NORTH HOLLAND
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1872-2423
BN 978-0-08-056002-1; 978-0-44-453274-9
J9 ADV EXP BIOL
PY 2008
VL 2
BP 165
EP 219
DI 10.1016/S1872-2423(08)00005-7
PG 55
WC Biology; Toxicology
SC Life Sciences & Biomedicine - Other Topics; Toxicology
GA BCK51
UT WOS:000310455400006
DA 2021-01-25
ER

PT J
AU Meyer, UA
AF Meyer, Urs A.
TI FORECASTING OF HUMAN DRUG RESPONSE FROM ANIMAL AND IN VITRO DATA: A
   REALITY CHECK
SO DRUG METABOLISM REVIEWS
LA English
DT Meeting Abstract
CT 10th European Regional Meeting of the
   International-Society-for-the-Study-of-Xenobiotics
CY MAY 18-21, 2008
CL Vienna, AUSTRIA
SP Int Soc Study Xenobiot
ID GENES
C1 [Meyer, Urs A.] Univ Basel, Biozentrum, Dept Pharmacol Neurobiol, CH-4056 Basel, Switzerland.
CR Blattler SM, 2007, P NATL ACAD SCI USA, V104, P1045, DOI 10.1073/pnas.0610216104
   Meyer UA, 2007, DRUG METAB REV, V39, P639, DOI 10.1080/03602530701498737
   Oscarson M, 2006, CLIN PHARMACOL THER, V80, P440, DOI 10.1016/j.clpt.2006.08.013
   Podvinec M, 2006, EXPERT OPIN DRUG MET, V2, P367, DOI 10.1517/17425255.2.3.367
NR 4
TC 0
Z9 0
U1 0
U2 0
PU TAYLOR & FRANCIS INC
PI PHILADELPHIA
PA 325 CHESTNUT ST, SUITE 800, PHILADELPHIA, PA 19106 USA
SN 0360-2532
J9 DRUG METAB REV
JI Drug Metab. Rev.
PY 2008
VL 40
MA 18
BP 12
EP 13
PG 2
WC Pharmacology & Pharmacy
SC Pharmacology & Pharmacy
GA 434EG
UT WOS:000265257400016
DA 2021-01-25
ER

PT J
AU Reiterer, V
   Sauter, C
   Klosch, G
   Lalouschek, W
   Zeitlhofer, J
AF Reiterer, Veronika
   Sauter, Cornelia
   Kloesch, Gerhard
   Lalouschek, Wolfgang
   Zeitlhofer, Josef
TI Actigraphy - A Useful Tool for Motor Activity Monitoring in Stroke
   Patients
SO EUROPEAN NEUROLOGY
LA English
DT Article
DE Actigraphy; Stroke rehabilitation; Motor recovery
ID FUNCTIONAL REORGANIZATION; CEREBRAL INFARCTION; OUTCOME MEASURES;
   RECOVERY; PATTERNS; SCALES; SLEEP; DISABILITY; DISEASE; CORTEX
AB Aim: The aim of the present study was the evaluation of actigraphy as a tool to objectify the recovery process after motor paresis due to stroke. Methods: The motor activity of both arms of patients suffering from stroke was actigraphically recorded at four different time points during the course of rehabilitation: 24-36 h, 5-7 days, 3 months, and 6 months after stroke. Results: Motor activity monitored by wrist-worn actigraphs located at the impaired side revealed an increase in activity between the first two time points and the subsequent ones. Additionally, actigraphic recordings showed lower total motor activity at the impaired side as compared to the nonimpaired side. A significant positive correlation was found between the actigraphically recorded motor activity and the results of the Scandinavian Stroke scale, the Barthel Index, the Rankin Scale Score and with the Motoricity Index during the 1st week, which corresponds to the time when neurological deficits were most pronounced. Conclusion: Our results suggest that actigraphy is a useful tool in the objective evaluation of motor activity after stroke. Moreover, actigraphy covers additional aspects that are not reflected by the usual stroke scales in a clinical situation. Copyright (C) 2008 S. Karger AG, Basel
C1 [Sauter, Cornelia; Kloesch, Gerhard; Lalouschek, Wolfgang; Zeitlhofer, Josef] Med Univ Vienna, Dept Neurol, AT-1090 Vienna, Austria.
   [Reiterer, Veronika] Univ Basel, Biozentrum, Basel, Switzerland.
RP Zeitlhofer, J (corresponding author), Med Univ Vienna, Dept Neurol, Wahringer Gurtel 18-20, AT-1090 Vienna, Austria.
EM josef.zeitlhofer@meduniwien.ac.at
OI Kloesch, Gerhard/0000-0001-9280-7319
CR Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342
   Andrews AW, 2003, ARCH PHYS MED REHAB, V84, P125, DOI 10.1053/apmr.2003.50003
   ASPLUND K, 1985, STROKE, V16, P885
   BAMFORD J, 1991, LANCET, V337, P1521, DOI 10.1016/0140-6736(91)93206-O
   Bauldoff GS, 2007, WESTERN J NURS RES, V29, P789, DOI 10.1177/0193945906297371
   BRION JP, 1989, STROKE, V20, P1079, DOI 10.1161/01.STR.20.8.1079
   BROTT T, 1989, STROKE, V20, P864, DOI 10.1161/01.STR.20.7.864
   CHOLLET F, 1991, ANN NEUROL, V29, P63, DOI 10.1002/ana.410290112
   Corbetta M, 2002, P NATL ACAD SCI USA, V99, P17066, DOI 10.1073/pnas.262669099
   Cramer SC, 2008, CURR OPIN NEUROL, V21, P76, DOI 10.1097/WCO.0b013e3282f36cb6
   DEHAAN R, 1993, STROKE, V24, P1178, DOI 10.1161/01.STR.24.8.1178
   DEMEURISSE G, 1980, EUR NEUROL, V19, P382, DOI 10.1159/000115178
   Dickstein R, 2004, CLIN NEUROPHYSIOL, V115, P790, DOI 10.1016/j.clinph.2003.11.018
   Dromerick AW, 2003, J REHABIL RES DEV, V40, P1, DOI 10.1682/JRRD.2003.01.0001
   Fridman EA, 2004, BRAIN, V127, P747, DOI 10.1093/brain/awh082
   GRANGER CV, 1990, STROKE, V21, P46
   Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4
   Gresham GE, 1995, POSTSTROKE REHABILIT
   Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1
   KAZENWADEL J, 1995, SLEEP, V18, P689, DOI 10.1093/sleep/18.8.689
   KEITH RA, 1995, AM J PHYS MED REHAB, V74, P73, DOI 10.1097/00002060-199501000-00013
   Klosch G, 2001, WIEN KLIN WOCHENSCHR, V113, P288
   Kos D, 2007, CHRONOBIOL INT, V24, P345, DOI 10.1080/07420520701282364
   Lemke MR, 1998, FORTSCHR NEUROL PSYC, V66, P43, DOI 10.1055/s-2007-995238
   MAHONEY F I, 1965, Md State Med J, V14, P61
   Mochio S, 1997, Nihon Rinsho, V55, P158
   NAKAYAMA H, 1994, ARCH PHYS MED REHAB, V75, P394, DOI 10.1016/0003-9993(94)90161-9
   Nudo RJ, 1996, SCIENCE, V272, P1791, DOI 10.1126/science.272.5269.1791
   Page SJ, 2002, ARCH PHYS MED REHAB, V83, P286, DOI 10.1053/apmr.2002.28007
   RANKIN J, 1957, Scott Med J, V2, P200
   SADEH A, 1991, PEDIATRICS, V87, P494
   Seitz RJ, 2004, RESTOR NEUROL NEUROS, V22, P207
   Vallieres A, 2003, SLEEP, V26, P902, DOI 10.1093/sleep/26.7.902
   VANHILTEN JJ, 1991, J NEUROL NEUROSUR PS, V54, P976, DOI 10.1136/jnnp.54.11.976
   Wade D T, 1988, Int Disabil Stud, V10, P64
   WEILLER C, 1993, ANN NEUROL, V33, P181
   WOODDAUPHINEE SL, 1990, STROKE, V21, P731, DOI 10.1161/01.STR.21.5.731
NR 37
TC 24
Z9 24
U1 0
U2 4
PU KARGER
PI BASEL
PA ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND
SN 0014-3022
J9 EUR NEUROL
JI Eur. Neurol.
PY 2008
VL 60
IS 6
BP 285
EP 291
DI 10.1159/000157882
PG 7
WC Clinical Neurology; Neurosciences
SC Neurosciences & Neurology
GA 369IG
UT WOS:000260687300003
PM 18824856
DA 2021-01-25
ER

PT J
AU Molina, N
   van Nimwegen, E
AF Molina, Nacho
   van Nimwegen, Erik
TI Universal patterns of purifying selection at noncoding positions in
   bacteria
SO GENOME RESEARCH
LA English
DT Article
ID BINDING-SITES; PHYLOGENETIC ANALYSIS; INITIATION CODON; GENOME; DNA;
   TRANSCRIPTION; TRANSLATION; EVOLUTION; MODEL; BIAS
AB To investigate the dependence of the number of regulatory sites per intergenic region on genome size, we developed a new method for detecting purifying selection at noncoding positions in clades of related bacterial genomes. We comprehensively quantified evidence of purifying selection at noncoding positions across bacteria and found several striking universal patterns. Consistent with selection acting at transcriptional regulatory elements near the transcription start, we find a universal positional profile of selection with respect to gene starts and ends, showing most evidence of selection immediately upstream and least immediately downstream front genes. A further set of universal features indicates that selection for translation initiation efficiency is the major determinant of the sequence composition around translation start in all clades. In addition to a peak in selection at ribosomal binding sites, the region immediately around translation start shows a universal pattern of high adenine frequency, significant selection at silent positions, and avoidance of RNA secondary structure. Surprisingly, although the number of transcription factors (TF) increases quadratically with genome size, we present several lines of evidence that small and large genomes have the same average number of regulatory sites per intergenic region. By comparing the sequence diversity of the most and least conserved DNA words in intergenic regions across clades we provide evidence that the structure of transcription regulatory networks changes dramatically with genome size: Small genomes have a small number of TFs with a large number of target sites, whereas large genomes have a large number of TFs with a small number of target sites each.
C1 [Molina, Nacho; van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Molina, Nacho; van Nimwegen, Erik] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP van Nimwegen, E (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM erik.vannimwegen@unibas.ch
RI Molina, Nacho/F-2244-2010
OI Molina, Nacho/0000-0003-0233-3055; van Nimwegen,
   Erik/0000-0001-6338-1312
CR Bateman A, 2004, NUCLEIC ACIDS RES, V32, pD138, DOI 10.1093/nar/gkh121
   Beletskii A, 1996, P NATL ACAD SCI USA, V93, P13919, DOI 10.1073/pnas.93.24.13919
   Bentley SD, 2004, ANNU REV GENET, V38, P771, DOI 10.1146/annurev.genet.38.072902.094318
   BERG OG, 1987, J MOL BIOL, V193, P723, DOI 10.1016/0022-2836(87)90354-8
   Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007
   Brown CT, 2004, P NATL ACAD SCI USA, V101, P2404, DOI 10.1073/pnas.0308628100
   CAVALLISFORZA LL, 1967, AM J HUM GENET, V19, P233, DOI 10.2307/2406616
   Chen SL, 2004, P NATL ACAD SCI USA, V101, P3480, DOI 10.1073/pnas.0307827100
   Cherry JL, 2003, J THEOR BIOL, V221, P401, DOI 10.1006/jtbi.2003.3194
   Eyre-Walker A, 2006, TRENDS ECOL EVOL, V21, P569, DOI 10.1016/j.tree.2006.06.015
   EYREWALKER A, 1993, NUCLEIC ACIDS RES, V21, P4599, DOI 10.1093/nar/21.19.4599
   Felsenstein J, 1996, MOL BIOL EVOL, V13, P93, DOI 10.1093/oxfordjournals.molbev.a025575
   FELSENSTEIN J, 1981, J MOL EVOL, V17, P368, DOI 10.1007/BF01734359
   GOLDING B, 1990, J MOL EVOL, V31, P511, DOI 10.1007/BF02102078
   Halligan DL, 2006, GENOME RES, V16, P875, DOI 10.1101/gr.5022906
   Halligan DL, 2004, GENOME RES, V14, P273, DOI 10.1101/gr.1329204
   Halpern AL, 1998, MOL BIOL EVOL, V15, P910, DOI 10.1093/oxfordjournals.molbev.a025995
   HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694
   HOFACKER IL, 1994, MONATSH CHEM, V125, P167, DOI 10.1007/BF00818163
   KNIGHT RD, 2001, GENOME BIOL, V2, P1
   Kummerfeld SK, 2006, NUCLEIC ACIDS RES, V34, pD74, DOI 10.1093/nar/gkj131
   Mitchison G, 2005, TRENDS GENET, V21, P440, DOI 10.1016/j.tig.2005.06.002
   Moran NA, 2005, J BACTERIOL, V187, P4229, DOI 10.1128/JB.187.12.4229-4237.2005
   Moses AM, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-12-r98
   Mustonen V, 2005, P NATL ACAD SCI USA, V102, P15936, DOI 10.1073/pnas.0505537102
   Nielsen R, 2005, ANNU REV GENET, V39, P197, DOI 10.1146/annurev.genet.39.073003.112420
   Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042
   Ochman H, 2003, MOL BIOL EVOL, V20, P2091, DOI 10.1093/molbev/msg229
   Price MN, 2005, NUCLEIC ACIDS RES, V33, P880, DOI 10.1093/nar/gki232
   Rajewsky N, 2002, GENOME RES, V12, P298, DOI 10.1101/gr.207502. Article published online before print in January 2002
   Rocha EPC, 1999, NUCLEIC ACIDS RES, V27, P3567, DOI 10.1093/nar/27.17.3567
   Rocha EPC, 2002, TRENDS GENET, V18, P291, DOI 10.1016/S0168-9525(02)02690-2
   Rogozin IB, 2002, NUCLEIC ACIDS RES, V30, P4264, DOI 10.1093/nar/gkf549
   Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156
   Sandelin A, 2004, J MOL BIOL, V338, P207, DOI 10.1016/j.jmb.2004.02.048
   Sato T, 2001, J BIOCHEM, V129, P851, DOI 10.1093/oxfordjournals.jbchem.a002929
   Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502
   SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136
   SHARP PM, 1987, NUCLEIC ACIDS RES, V15, P1281, DOI 10.1093/nar/15.3.1281
   SHINE J, 1974, Proceedings of the National Academy of Sciences of the United States of America, V71, P1342, DOI 10.1073/pnas.71.4.1342
   Siddharthan R, 2005, PLOS COMPUT BIOL, V1, P534, DOI 10.1371/journal.pcbi.0010067
   Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005
   Sinha S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-170
   Sinha S, 2003, BIOINFORMATICS, V19, pi292, DOI 10.1093/bioinformatics/btg1040
   Stenstrom CM, 2001, GENE, V263, P273, DOI 10.1016/S0378-1119(00)00550-3
   Stover CK, 2000, NATURE, V406, P959
   van Nimwegen E, 2003, TRENDS GENET, V19, P479, DOI 10.1016/S0168-9525(03)00203-8
   VANNIMWEGEN E, 2004, POWER LAWS SCALE FRE, P236
   Voges D, 2004, BIOCHEM BIOPH RES CO, V318, P601, DOI 10.1016/j.bbrc.2004.04.064
   WAGNER R, 2000, TRANSCRIPTION REGULA
   Wall DP, 2003, BIOINFORMATICS, V19, P1710, DOI 10.1093/bioinformatics/btg213
   YANG ZH, 1995, GENETICS, V139, P993
   Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555
NR 53
TC 41
Z9 41
U1 0
U2 7
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1088-9051
EI 1549-5469
J9 GENOME RES
JI Genome Res.
PD JAN
PY 2008
VL 18
IS 1
BP 148
EP 160
DI 10.1101/gr.6759507
PG 13
WC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
SC Biochemistry & Molecular Biology; Biotechnology & Applied Microbiology;
   Genetics & Heredity
GA 245UW
UT WOS:000251965300015
PM 18032729
OA Bronze, Green Published
DA 2021-01-25
ER

PT J
AU Meyer, S
   Shin, H
   Cornelis, GR
AF Meyer, Salome
   Shin, Hwain
   Cornelis, Guy R.
TI Capnocytophaga canimorsus resists phagocytosis by macrophages and blocks
   the ability of macrophages to kill other bacteria
SO IMMUNOBIOLOGY
LA English
DT Article; Proceedings Paper
CT 21st Annual Conference of the
   European-Macrophage-and-Dendritic-Cell-Society
CY SEP 13-15, 2007
CL Innsbruck, AUSTRIA
SP European Macrophage & Dendrit Cell Soc, Abbott, AESCA, BD Biosci, Novartis, PEPROTECH, Pfizer, Profos, Wyeth
DE Capnocytophaga canimorsus; Macrophages; Phagocytosis
ID YERSINIA-ENTEROCOLITICA; DOG-BITE; SEPTICEMIA
AB Capnocytophaga canimorsus is a commensal bacterium from the canine oral flora, which can cause septicemia or meningitis in humans upon bite wound infections. C canimorsus 5 (Cc5), a strain isolated from a. patient with fatal septicemia, was used to investigate the interaction between C canimorsus and J774.1 mouse macrophages. J774.1 cells infected at high multiplicity with Cc5 did not phagocytose nor kill Cc5 within 120 min of infection, unless the bacteria were opsonized with specific antibodies. Opsonization with complement, however, did not increase phagocytosis. Moreover, infection of J774.1 cells with live Cc5 led to the release of a soluble factor, which interfered with the ability of macrophages to kill other phagocytosed bacteria. These results provide an example of how C canimorsus neutralizes the innate immune system. (C) 2008 Elsevier GmbH. All rights reserved.
C1 [Meyer, Salome; Shin, Hwain; Cornelis, Guy R.] Univ Basel, Biozentrum Basel, CH-4056 Basel, Switzerland.
RP Cornelis, GR (corresponding author), Univ Basel, Biozentrum Basel, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM guy.cornelis@unibas.ch
CR Blanche P, 1998, J INFECTION, V36, P134, DOI 10.1016/S0163-4453(98)93918-4
   BRENNER DJ, 1989, J CLIN MICROBIOL, V27, P231, DOI 10.1128/JCM.27.2.231-235.1989
   CORNELIS G, 1986, MICROB PATHOGENESIS, V1, P349, DOI 10.1016/0882-4010(86)90067-7
   Grosdent N, 2002, INFECT IMMUN, V70, P4165, DOI 10.1128/IAI.70.8.4165-4176.2002
   HANTSON P, 1991, ANN EMERG MED, V20, P93, DOI 10.1016/S0196-0644(05)81130-8
   Kelly D, 2004, NAT IMMUNOL, V5, P104, DOI 10.1038/ni1018
   Le Moal GL, 2003, CLIN INFECT DIS, V36, pE42, DOI 10.1086/345477
   Letzelter M, 2006, EMBO J, V25, P3223, DOI 10.1038/sj.emboj.7601202
   Lion C, 1996, EUR J EPIDEMIOL, V12, P521, DOI 10.1007/BF00144007
   Shin H, 2007, J INFECT DIS, V195, P375, DOI 10.1086/510243
   Tierney DM, 2006, J CLIN MICROBIOL, V44, P649, DOI 10.1128/JCM.44.2.649-651.2006
   Vandamme P, 1996, INT J SYST BACTERIOL, V46, P782, DOI 10.1099/00207713-46-3-782
   VANHONSEBROUCK AY, 1991, ACTA CLIN BELG, V46, P364, DOI 10.1080/17843286.1991.11718192
   WOESTYN S, 1994, J BACTERIOL, V176, P1561, DOI 10.1128/jb.176.6.1561-1569.1994
NR 14
TC 22
Z9 22
U1 0
U2 0
PU ELSEVIER GMBH, URBAN & FISCHER VERLAG
PI JENA
PA OFFICE JENA, P O BOX 100537, 07705 JENA, GERMANY
SN 0171-2985
J9 IMMUNOBIOLOGY
JI Immunobiology
PY 2008
VL 213
IS 9-10
SI SI
BP 805
EP 814
DI 10.1016/j.imbio.2008.07.019
PG 10
WC Immunology
SC Immunology
GA 365EI
UT WOS:000260388300012
PM 18926295
DA 2021-01-25
ER

PT S
AU Lim, RYH
   Ullman, KS
   Fahrenkrog, B
AF Lim, Roderick Y. H.
   Ullman, Katharine S.
   Fahrenkrog, Birthe
BE Jeon, KW
TI Biology and biophysics of the nuclear pore complex and its components
SO INTERNATIONAL REVIEW OF CELL AND MOLECULAR BIOLOGY, VOL 267
SE International Review of Cell and Molecular Biology
LA English
DT Review; Book Chapter
DE nuclear pore complex; nuclear envelope; nucleoporins; nucleocytoplasmic
   transport; transmembrane proteins
ID PHENYLALANINE-GLYCINE NUCLEOPORINS; CYCLE-DEPENDENT PHOSPHORYLATION;
   N-TERMINAL DOMAIN; FG-REPEAT DOMAINS; SPINDLE POLE BODY; RAN GTPASE
   CYCLE; IMPORTIN-BETA; MEMBRANE-PROTEIN; NUCLEOCYTOPLASMIC TRANSPORT;
   CELL-CYCLE
AB Nucleocytoplasmic exchange of proteins and ribonucleoprotein particles occurs via nuclear pore complexes (NPCs) that reside in the double membrane of the nuclear envelope (NE). Significant progress has been made during the past few years in obtaining better structural resolution of the three-dimensional architecture of NPC with the help of cryo-electron tomography and atomic structures of domains from nuclear pore proteins (nucleoporins). Biophysical and imaging approaches have helped elucidate how nucleoporins act as a selective barrier in nucleocytoplasmic transport. Nucleoporins act not only in trafficking of macromolecules but also in proper microtubule attachment to kinetochores, in the regulation of gene expression and signaling events associated with, for example, innate and adaptive immunity, development and neurodegenerative disorders. Recent research has also been focused on the dynamic processes of NPC assembly and disassembly that occur with each cell cycle. Here we review emerging results aimed at understanding the molecular arrangement of the NPC and how it is achieved, defining the roles of individual nucleoporins both at the NPC and at other sites within the cell, and finally deciphering how the NPC serves as both a barrier and a conduit of active transport.
C1 [Lim, Roderick Y. H.; Fahrenkrog, Birthe] Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   [Ullman, Katharine S.] Univ Utah, Dept Oncol Sci, Huntsman Canc Inst, Salt Lake City, UT 84112 USA.
RP Lim, RYH (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
RI Fahrenkrog, Birthe/D-5840-2011
OI Fahrenkrog, Birthe/0000-0003-4080-9413; Ullman,
   Katharine/0000-0003-3693-2830; Lim, Roderick/0000-0001-5015-6087
FU NIGMS NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01 GM061275-08, GM61275, R01 GM061275]
   Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL
   SCIENCESUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of General
   Medical Sciences (NIGMS) [R01GM061275, R01GM061275, R01GM061275,
   R01GM061275, R01GM061275, R01GM061275, R01GM061275, R01GM061275,
   R01GM061275, R01GM061275, R01GM061275, R01GM061275, R01GM061275,
   R01GM061275] Funding Source: NIH RePORTER
CR AKEY CW, 1993, J CELL BIOL, V122, P1, DOI 10.1083/jcb.122.1.1
   AKEY CW, 1990, BIOPHYS J, V58, P341, DOI 10.1016/S0006-3495(90)82381-X
   Antonin W, 2005, MOL CELL, V17, P83, DOI 10.1016/j.molcel.2004.12.010
   Antonin W, 2005, NAT CELL BIOL, V7, P10, DOI 10.1038/ncb0105-10
   Arnaoutov A, 2005, NAT CELL BIOL, V7, P626, DOI 10.1038/ncb1263
   Askjaer P, 2002, MOL BIOL CELL, V13, P4355, DOI 10.1091/mbc.E02-06-0346
   Aslanukov A, 2006, PLOS GENET, V2, P1653, DOI 10.1371/journal.pgen.0020177
   Bai XT, 2006, CANCER RES, V66, P4584, DOI 10.1158/0008-5472.CAN-05-3101
   Ball JR, 2005, CHROMOSOMA, V114, P319, DOI 10.1007/s00412-005-0019-3
   Baur T, 2007, J CELL SCI, V120, P2895, DOI 10.1242/jcs.010181
   Bayliss R, 2000, CELL, V102, P99, DOI 10.1016/S0092-8674(00)00014-3
   Bayliss R, 2002, J BIOL CHEM, V277, P50597, DOI 10.1074/jbc.M209037200
   Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Beck M, 2007, NATURE, V449, P611, DOI 10.1038/nature06170
   Bednenko J, 2003, J CELL BIOL, V162, P391, DOI 10.1083/jcb.200303085
   Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081
   Ben-Efraim I, 2001, J CELL BIOL, V152, P411, DOI 10.1083/jcb.152.2.411
   Berke IC, 2004, J CELL BIOL, V167, P591, DOI 10.1083/jcb.200408109
   Bernad R, 2004, MOL CELL BIOL, V24, P2373, DOI 10.1128/MCB.24.6.2373-2384.2004
   Bernad R, 2006, J BIOL CHEM, V281, P19378, DOI 10.1074/jbc.M512585200
   Bethune J, 2006, J MEMBRANE BIOL, V211, P65, DOI 10.1007/s00232-006-0859-7
   Bickel T, 2002, BIOPHYS J, V83, P3079, DOI 10.1016/S0006-3495(02)75312-5
   BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527
   Bodoor K, 1999, J CELL SCI, V112, P2253
   Boehmer T, 2003, P NATL ACAD SCI USA, V100, P981, DOI 10.1073/pnas.252749899
   Brown CR, 2007, CURR OPIN GENET DEV, V17, P100, DOI 10.1016/j.gde.2007.02.005
   BUSTAMANTE C, 1994, SCIENCE, V265, P1599, DOI 10.1126/science.8079175
   Cabal GG, 2006, NATURE, V441, P770, DOI 10.1038/nature04752
   Cai YF, 2001, J BIOL CHEM, V276, P41594, DOI 10.1074/jbc.M104514200
   Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205
   Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9
   CHAUDHARY N, 1993, J CELL BIOL, V122, P295, DOI 10.1083/jcb.122.2.295
   Chial HJ, 1998, J CELL BIOL, V143, P1789, DOI 10.1083/jcb.143.7.1789
   Cohen M, 2003, MOL BIOL CELL, V14, P4230, DOI 10.1091/mbc.E03-04-0260
   Collins R, 2000, SIGHT SOUND, V10, P8
   Cordes VC, 1997, J CELL BIOL, V136, P515, DOI 10.1083/jcb.136.3.515
   Cotter L, 2007, J MOL BIOL, V369, P683, DOI 10.1016/j.jmb.2007.03.051
   Cronshaw JA, 2002, J CELL BIOL, V158, P915, DOI 10.1083/jcb.200206106
   D'Angelo MA, 2006, SCIENCE, V312, P440, DOI 10.1126/science.1124196
   Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089
   Danker T, 1999, P NATL ACAD SCI USA, V96, P13530, DOI 10.1073/pnas.96.23.13530
   De Souza CPC, 2004, CURR BIOL, V14, P1973, DOI 10.1016/j.cub.2004.10.050
   Denning DP, 2007, MOL CELL PROTEOMICS, V6, P272, DOI 10.1074/mcp.M600309-MCP200
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Devos D, 2004, PLOS BIOL, V2, P2085, DOI 10.1371/journal.pbio.0020380
   Devos D, 2006, P NATL ACAD SCI USA, V103, P2172, DOI 10.1073/pnas.0506345103
   Dilworth DJ, 2005, J CELL BIOL, V171, P955, DOI 10.1083/jcb.200509061
   Drin G, 2007, NAT STRUCT MOL BIOL, V14, P138, DOI 10.1038/nsmb1194
   Drummond SP, 2006, CAN J PHYSIOL PHARM, V84, P423, DOI 10.1139/Y05-148
   Drummond SP, 2002, J CELL BIOL, V158, P53, DOI 10.1083/jcb.200108145
   Ellenberg J, 1997, J CELL BIOL, V138, P1193, DOI 10.1083/jcb.138.6.1193
   Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861
   Enninga J, 2003, MOL CELL BIOL, V23, P7271, DOI 10.1128/MCB.23.20.7271-7284.2003
   Enss K, 2003, J MEMBRANE BIOL, V196, P147, DOI 10.1007/s00232-003-0632-0
   Eriksson C, 2004, FEBS LETT, V572, P261, DOI 10.1016/j.febslet.2004.07.044
   Ewald A, 2001, EUR J CELL BIOL, V80, P678, DOI 10.1078/0171-9335-00207
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Fahrenkrog B, 1998, J CELL BIOL, V143, P577, DOI 10.1083/jcb.143.3.577
   Faria AMC, 2006, IMMUNITY, V24, P295, DOI 10.1016/j.immuni.2006.01.014
   Favreau C, 1996, BIOCHEMISTRY-US, V35, P8035, DOI 10.1021/bi9600660
   FELDHERR CM, 1991, J CELL BIOL, V115, P933, DOI 10.1083/jcb.115.4.933
   Feldherr CM, 1997, J CELL SCI, V110, P3065
   FELDHERR CM, 1990, J CELL BIOL, V111, P1, DOI 10.1083/jcb.111.1.1
   Fernandez AG, 2006, CURR BIOL, V16, P1757, DOI 10.1016/j.cub.2006.07.071
   Ferreira PA, 1996, NATURE, V383, P637, DOI 10.1038/383637a0
   Ferreira PA, 1997, P NATL ACAD SCI USA, V94, P1556, DOI 10.1073/pnas.94.4.1556
   Feuerbach F, 2002, NAT CELL BIOL, V4, P214, DOI 10.1038/ncb756
   Fontoura BMA, 2001, P NATL ACAD SCI USA, V98, P3208, DOI 10.1073/pnas.061014698
   Forler D, 2004, MOL CELL BIOL, V24, P1155, DOI 10.1128/MCB.24.3.1155-1167.2004
   Franz C, 2005, EMBO J, V24, P3519, DOI 10.1038/sj.emboj.7600825
   Franz C, 2007, EMBO REP, V8, P165, DOI 10.1038/sj.embor.7400889
   Frey S, 2007, CELL, V130, P512, DOI 10.1016/j.cell.2007.06.024
   Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516
   Frosst P, 2002, J CELL BIOL, V156, P617, DOI 10.1083/jcb.200106046
   Galy V, 2000, NATURE, V403, P108, DOI 10.1038/47528
   Galy V, 2006, CURR BIOL, V16, P1748, DOI 10.1016/j.cub.2006.06.067
   Ghannam G, 2004, J BIOL CHEM, V279, P866, DOI 10.1074/jbc.M307280200
   Gigliotti S, 1998, J CELL BIOL, V142, P1195, DOI 10.1083/jcb.142.5.1195
   Glavy JS, 2007, P NATL ACAD SCI USA, V104, P3811, DOI 10.1073/pnas.0700058104
   Goldberg MW, 2000, J MOL BIOL, V300, P519, DOI 10.1006/jmbi.2000.3891
   Goldberg MW, 1997, J CELL SCI, V110, P409
   Gorlich D, 2003, EMBO J, V22, P1088, DOI 10.1093/emboj/cdg113
   Gorlich D, 1996, EMBO J, V15, P1810, DOI 10.1002/j.1460-2075.1996.tb00530.x
   Gorlich D, 1999, ANNU REV CELL DEV BI, V15, P607, DOI 10.1146/annurev.cellbio.15.1.607
   Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.E03-10-0743
   Griffis ER, 2003, MOL BIOL CELL, V14, P600, DOI 10.1091/mbc.E02-09-0582
   Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538
   Grimaldi MR, 2007, GENETICS, V175, P1751, DOI 10.1534/genetics.106.062844
   HALPERIN A, 1992, ADV POLYM SCI, V100, P31
   Handa N, 2006, J MOL BIOL, V363, P114, DOI 10.1016/j.jmb.2006.07.089
   Haraguchi T, 2000, J CELL SCI, V113, P779
   Harel A, 2003, MOL BIOL CELL, V14, P4387, DOI 10.1091/mbc.E03-05-0275
   Harel A, 2003, MOL CELL, V11, P853, DOI 10.1016/S1097-2765(03)00116-3
   Hase ME, 2003, MOL BIOL CELL, V14, P1923, DOI 10.1091/mbc.E02-09-0620
   Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.E04-10-0857
   Higa MM, 2007, J BIOL CHEM, V282, P17090, DOI 10.1074/jbc.M702715200
   HINSHAW JE, 1992, CELL, V69, P1133, DOI 10.1016/0092-8674(92)90635-P
   Hodel AE, 2002, MOL CELL, V10, P347, DOI 10.1016/S1097-2765(02)00589-0
   Hogarth C, 2005, BIOESSAYS, V27, P1011, DOI 10.1002/bies.20289
   Hutten S, 2006, MOL CELL BIOL, V26, P6772, DOI 10.1128/MCB.00342-06
   Imreh G, 2003, EXP CELL RES, V284, P173, DOI 10.1016/S0014-4827(02)00034-4
   Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007
   Isgro TA, 2007, STRUCTURE, V15, P977, DOI 10.1016/j.str.2007.06.011
   Isgro TA, 2007, J MOL BIOL, V366, P330, DOI 10.1016/j.jmb.2006.11.048
   Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0
   Jaggi RD, 2003, BIOPHYS J, V85, P4093, DOI 10.1016/S0006-3495(03)74821-8
   Jaggi RD, 2003, BIOPHYS J, V84, P665
   Joseph J, 2004, CURR BIOL, V14, P611, DOI 10.1016/j.cub.2004.03.031
   Joseph J, 2002, J CELL BIOL, V156, P595, DOI 10.1083/jcb.200110109
   Kalab P, 2006, NATURE, V440, P697, DOI 10.1038/nature04589
   Kalab P, 2002, SCIENCE, V295, P2452, DOI 10.1126/science.1068798
   Kasper LH, 1999, MOL CELL BIOL, V19, P764
   Kiseleva E, 2004, J STRUCT BIOL, V145, P272, DOI 10.1016/j.jsb.2003.11.010
   Kiseleva E, 1996, J MOL BIOL, V260, P304, DOI 10.1006/jmbi.1996.0401
   Kiseleva E, 2001, J CELL SCI, V114, P3607
   Kiseleva E, 1998, J CELL SCI, V111, P223
   Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471
   Kopito RB, 2007, P NATL ACAD SCI USA, V104, P12743, DOI 10.1073/pnas.0702690104
   Krull S, 2004, MOL BIOL CELL, V15, P4261, DOI 10.1091/mbc.E04-03-0165
   Kubitscheck U, 2005, J CELL BIOL, V168, P233, DOI 10.1083/jcb.200411005
   Kustanovich T, 2004, BIOPHYS J, V86, P2008, DOI 10.1016/S0006-3495(04)74262-9
   Lau CK, 2004, EUKARYOT CELL, V3, P447, DOI 10.1128/EC.3.2.447-458.2004
   Lenart P, 2006, METHODS, V38, P17, DOI 10.1016/j.ymeth.2005.07.010
   Lenart P, 2003, J CELL BIOL, V160, P1055, DOI 10.1083/jcb.200211076
   Lewin JM, 2007, J UROLOGY, V177, P1526, DOI 10.1016/j.juro.2006.11.048
   Lewis A, 2007, J CELL BIOL, V178, P813, DOI 10.1083/jcb.200702154
   Li X, 2001, MOL PLANT MICROBE IN, V14, P1131, DOI 10.1094/MPMI.2001.14.10.1131
   Lim RYH, 2007, J STRUCT BIOL, V159, P277, DOI 10.1016/j.jsb.2007.01.018
   Lim RYH, 2006, CURR OPIN CELL BIOL, V18, P342, DOI 10.1016/j.ceb.2006.03.006
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
   Lim RYH, 2006, CHROMOSOMA, V115, P15, DOI 10.1007/s00412-005-0037-1
   Lim RYH, 2005, STRUCTURE, V13, P1741, DOI 10.1016/j.str.2005.11.002
   Liu J, 2003, DEV CELL, V5, P487, DOI 10.1016/S1534-5807(03)00262-4
   Liu Q, 2007, J CELL BIOL, V178, P785, DOI 10.1083/jcb.200704108
   Liu SM, 2005, J MOL BIOL, V349, P515, DOI 10.1016/j.jmb.2005.04.003
   Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878
   Lusk CP, 2007, TRAFFIC, V8, P647, DOI 10.1111/j.1600-0854.2007.00559.x
   Lusk CP, 2002, J CELL BIOL, V159, P267, DOI 10.1083/jcb.200203079
   Luthra R, 2007, J BIOL CHEM, V282, P3042, DOI 10.1074/jbc.M608741200
   Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001
   MACAULAY C, 1995, J BIOL CHEM, V270, P254, DOI 10.1074/jbc.270.1.254
   Macaulay C, 1996, J CELL BIOL, V132, P5, DOI 10.1083/jcb.132.1.5
   Madrid AS, 2006, J CELL BIOL, V173, P361, DOI 10.1083/jcb.200506199
   Maeshima K, 2006, J CELL SCI, V119, P4442, DOI 10.1242/jcs.03207
   Maison C, 1997, EMBO J, V16, P4839, DOI 10.1093/emboj/16.16.4839
   Makhnevych T, 2003, CELL, V115, P813, DOI 10.1016/S0092-8674(03)00986-3
   Makhnevych T, 2007, J CELL BIOL, V177, P39, DOI 10.1083/jcb.200608066
   Mans BJ, 2004, CELL CYCLE, V3, P1612
   Mansfeld J, 2006, MOL CELL, V22, P93, DOI 10.1016/j.molcel.2006.02.015
   Marelli M, 1998, J CELL BIOL, V143, P1813, DOI 10.1083/jcb.143.7.1813
   Marelli M, 2001, J CELL BIOL, V153, P709, DOI 10.1083/jcb.153.4.709
   Marko JF, 1995, MACROMOLECULES, V28, P8759, DOI 10.1021/ma00130a008
   Marshall ICB, 1997, CELL CALCIUM, V21, P151, DOI 10.1016/S0143-4160(97)90039-7
   Matunis MJ, 1998, J CELL BIOL, V140, P499, DOI 10.1083/jcb.140.3.499
   MAUL GG, 1980, CYTOGENET CELL GENET, V26, P175, DOI 10.1159/000131439
   Mazzanti M, 2001, PHYSIOL REV, V81, P1, DOI 10.1152/physrev.2001.81.1.1
   Melcak I, 2007, SCIENCE, V315, P1729, DOI 10.1126/science.1135730
   Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007
   Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102
   Miao M, 2006, GENETICS, V172, P1441, DOI 10.1534/genetics.105.052068
   MILNER ST, 1991, SCIENCE, V251, P905, DOI 10.1126/science.251.4996.905
   Mooren OL, 2004, PHYS BIOL, V1, P125, DOI 10.1088/1478-3967/1/2/008
   Muhlhausser P, 2007, J CELL BIOL, V178, P595, DOI 10.1083/jcb.200703002
   Nachury MV, 1999, P NATL ACAD SCI USA, V96, P9622, DOI 10.1073/pnas.96.17.9622
   Naim B, 2007, J BIOL CHEM, V282, P3881, DOI 10.1074/jbc.M608329200
   Nakielny S, 1999, EMBO J, V18, P1982, DOI 10.1093/emboj/18.7.1982
   Napetschnig J, 2007, P NATL ACAD SCI USA, V104, P1783, DOI 10.1073/pnas.0610828104
   Nemergut ME, 2001, SCIENCE, V292, P1540, DOI 10.1126/science.292.5521.1540
   Nielsen B, 2006, J BIOL PHYS, V32, P465, DOI 10.1007/s10867-006-9029-5
   Niepel M, 2005, J CELL BIOL, V170, P225, DOI 10.1083/jcb.200504140
   Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682
   Olsson M, 2004, EXP CELL RES, V292, P359, DOI 10.1016/j.yexcr.2003.09.014
   Onischenko EA, 2005, MOL BIOL CELL, V16, P5152, DOI 10.1091/mbc.E05-07-0642
   Onischenko EA, 2004, TRAFFIC, V5, P152, DOI 10.1111/j.1600-0854.2004.0166.x
   Onischenko EA, 2007, EXP CELL RES, V313, P2744, DOI 10.1016/j.yexcr.2007.05.011
   Orjalo AV, 2006, MOL BIOL CELL, V17, P3806, DOI 10.1091/mbc.E05-11-1061
   PAINE PL, 1975, NATURE, V254, P109, DOI 10.1038/254109a0
   Palancade B, 2007, MOL BIOL CELL, V18, P2912, DOI 10.1091/mbc.E07-02-0123
   Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308
   Paradise A, 2007, J MOL BIOL, V365, P50, DOI 10.1016/j.jmb.2006.09.089
   Parry G, 2006, PLANT CELL, V18, P1590, DOI 10.1105/tpc.106.041566
   Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044
   Paulillo SM, 2006, J MOL BIOL, V363, P39, DOI 10.1016/j.jmb.2006.08.021
   Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034
   Perez-Terzic C, 2003, CIRC RES, V92, P444, DOI 10.1161/01.RES.0000059415.25070.54
   Perez-Terzic Carmen, 2007, Nat Clin Pract Cardiovasc Med, V4 Suppl 1, pS68, DOI 10.1038/ncpcardio0763
   Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x
   Pichler A, 2002, CELL, V108, P109, DOI 10.1016/S0092-8674(01)00633-X
   Prunuske AJ, 2006, MOL BIOL CELL, V17, P760, DOI 10.1091/mbc.E05-06-0485
   Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184
   Rasala BA, 2006, P NATL ACAD SCI USA, V103, P17801, DOI 10.1073/pnas.0608484103
   Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664
   Robinson MA, 2005, J BIOL CHEM, V280, P35723, DOI 10.1074/jbc.M505068200
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Rout MP, 2003, TRENDS CELL BIOL, V13, P622, DOI 10.1016/j.tcb.2003.10.007
   Ryan KJ, 2007, MOL BIOL CELL, V18, P886, DOI 10.1091/mbc.E06-06-0525
   Ryan KJ, 2003, J CELL BIOL, V160, P1041, DOI 10.1083/jcb.200209116
   Sabri N, 2007, J CELL BIOL, V178, P557, DOI 10.1083/jcb.200612135
   Salina D, 2003, J CELL BIOL, V162, P991, DOI 10.1083/jcb.200304080
   Scarcelli JJ, 2007, J CELL BIOL, V178, P799, DOI 10.1083/jcb.200702120
   Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012
   Schwartz TU, 2005, CURR OPIN STRUC BIOL, V15, P221, DOI 10.1016/j.sbi.2005.03.003
   Schwarz-Herion K, 2007, J MOL BIOL, V370, P796, DOI 10.1016/j.jmb.2007.05.030
   Shahin V, 2005, J CELL PHYSIOL, V202, P591, DOI 10.1002/jcp.20152
   Shahin V, 2001, FASEB J, V15, P1895, DOI 10.1096/fj.00-0838com
   SHEEHAN MA, 1988, J CELL BIOL, V106, P1, DOI 10.1083/jcb.106.1.1
   Shibata S, 2002, GENES CELLS, V7, P421, DOI 10.1046/j.1365-2443.2002.00525.x
   Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003
   SOULLAM B, 1995, J CELL BIOL, V130, P15, DOI 10.1083/jcb.130.1.15
   Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001
   Stavru F, 2006, J CELL BIOL, V173, P477, DOI 10.1083/jcb.200601002
   Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114
   Stoffler D, 1999, J MOL BIOL, V287, P741, DOI 10.1006/jmbi.1999.2637
   Stoffler D, 2003, J MOL BIOL, V328, P119, DOI 10.1016/S0022-2836(03)00266-3
   Strambio-de-Castillia C, 1999, J CELL BIOL, V144, P839, DOI 10.1083/jcb.144.5.839
   Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097
   Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X
   Therizols P, 2006, J CELL BIOL, V172, P189, DOI 10.1083/jcb.200505159
   Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141
   Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027
   Um JW, 2006, J BIOL CHEM, V281, P3595, DOI 10.1074/jbc.M504994200
   vanDeursen J, 1996, EMBO J, V15, P5574, DOI 10.1002/j.1460-2075.1996.tb00942.x
   Walther TC, 2003, NATURE, V424, P689, DOI 10.1038/nature01898
   Walther TC, 2003, CELL, V113, P195, DOI 10.1016/S0092-8674(03)00235-6
   Walther TC, 2002, J CELL BIOL, V158, P63, DOI 10.1083/jcb.200202088
   Wang HW, 1999, BIOPHYS J, V77, P241, DOI 10.1016/S0006-3495(99)76885-2
   Weirich CS, 2004, MOL CELL, V16, P749, DOI 10.1016/j.molcel.2004.10.032
   Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5
   Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X
   Winey M, 1997, MOL BIOL CELL, V8, P2119, DOI 10.1091/mbc.8.11.2119
   Yang L, 1997, J CELL BIOL, V137, P1199, DOI 10.1083/jcb.137.6.1199
   Yang Q, 1998, MOL CELL, V1, P223, DOI 10.1016/S1097-2765(00)80023-4
   Yang WD, 2004, P NATL ACAD SCI USA, V101, P12887, DOI 10.1073/pnas.0403675101
   Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053
   YOKOYAMA N, 1995, NATURE, V376, P184, DOI 10.1038/376184a0
   Zeitler B, 2004, J CELL BIOL, V167, P583, DOI 10.1083/jcb.200407156
   Zhang CM, 2002, CURR BIOL, V12, P498, DOI 10.1016/S0960-9822(02)00714-5
   Zhang YL, 2005, PLANT CELL, V17, P1306, DOI 10.1105/tpc.104.029926
   Zhang YL, 2003, PLANT CELL, V15, P2636, DOI 10.1105/tpc.015842
   Zhao B, 2000, PROG POLYM SCI, V25, P677, DOI 10.1016/S0079-6700(00)00012-5
   Zhong HL, 2005, J BIOL CHEM, V280, P10675, DOI 10.1074/jbc.M412878200
   Zilman A, 2007, PLOS COMPUT BIOL, V3, P1281, DOI 10.1371/journal.pcbi.0030125
   Zimowska G, 1997, J CELL SCI, V110, P927
   Zuccolo M, 2007, EMBO J, V26, P1853, DOI 10.1038/sj.emboj.7601642
NR 245
TC 60
Z9 60
U1 1
U2 16
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1937-6448
BN 978-0-12-374374-9
J9 INT REV CEL MOL BIO
JI Int. Rev. Cell Mol. Biol.
PY 2008
VL 267
BP 299
EP +
DI 10.1016/S1937-6448(08)00632-1
PG 45
WC Biochemistry & Molecular Biology; Cell Biology
SC Biochemistry & Molecular Biology; Cell Biology
GA BHW40
UT WOS:000257039800007
PM 18544502
OA Green Accepted
DA 2021-01-25
ER

PT S
AU Kreplak, L
   Richter, K
   Aebi, U
   Herrmann, H
AF Kreplak, Laurent
   Richter, Karsten
   Aebi, Ueli
   Herrmann, Harald
BE Allen, TD
TI Electron microscopy of intermediate filaments: Teaming up with atomic
   force and confocal laser scanning microscopy
SO INTRODUCTION TO ELECTRON MICROSCOPY FOR BIOLOGISTS
SE Methods in Cell Biology
LA English
DT Review; Book Chapter
ID VERTEBRATE SMOOTH-MUSCLE; IN-VITRO; NUCLEAR-ENVELOPE;
   CAENORHABDITIS-ELEGANS; SIZED FILAMENTS; CROSS-BRIDGES; VIMENTIN; CELLS;
   PROTEINS; PLECTIN
AB Intermediate filaments (IFs) were originally discovered and defined by electron microscopy in myoblasts. In the following it was demonstrated and confirmed that they constitute, in addition to microtubules and microfilaments, a third independent, general filament system in the cytoplasm of most metazoan cells. In contrast to the other two systems, IFs are present in cells in two principally distinct cytoskeletal forms: (i) extended and free-running filament arrays in the cytoplasm that are integrated into the cytoskeleton by associated proteins of the plakin type; and (ii) a membrane- and chromatin-bound thin 'lamina' of a more or less regular network of interconnected filaments made from nuclear IF proteins, the lamins, which differ in several important structural aspects from cytoplasmic IF proteins. In man, more than 65 genes code for distinct IF proteins that are expressed during embryogenesis in various routes of differentiation in a tightly controlled manner. IF proteins exhibit rather limited sequence identity implying that the different types of IFs have distinct biochemical properties. Hence, to characterize the structural properties of the various IFs, in vitro assembly regimes have been developed in combination with different visualization methods such as transmission electron microscopy of fixed and negatively stained samples as well as methods that do not use staining such as scanning transmission electron microscopy (STEM) and cryoelectron microscopy as well as atomic force microscopy. Moreover, with the generation of both IF-type specific antibodies and chimeras of fluorescent proteins and IF proteins, it has become possible to investigate the subcellular organization of IFs by correlative fluorescence and electron microscopic methods. The combination of these powerful methods should help to further develop our understanding of nuclear architecture, in particular how nuclear subcompartments are organized and in which way lamins are involved.
C1 [Kreplak, Laurent; Aebi, Ueli] Univ Basel, ME Muller Inst Struct Biol Biozentrum, CH-4056 Basel, Switzerland.
   [Richter, Karsten] German Canc Res Ctr, Dept Mol Genet, D-69120 Heidelberg, Germany.
   [Herrmann, Harald] German Canc Res Ctr, Funct Architecture Cell, D-69120 Heidelberg, Germany.
RP Kreplak, L (corresponding author), Univ Basel, ME Muller Inst Struct Biol Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
OI kreplak, laurent/0000-0001-9370-9809
CR AEBI U, 1983, J CELL BIOL, V97, P1131, DOI 10.1083/jcb.97.4.1131
   AEBI U, 1986, NATURE, V323, P560, DOI 10.1038/323560a0
   BADER BL, 1991, J CELL BIOL, V115, P1293, DOI 10.1083/jcb.115.5.1293
   Bar H, 2007, HUM MUTAT, V28, P374, DOI 10.1002/humu.20459
   BARNIK E, 1986, J CELL BIOL, V102, P2033, DOI 10.1083/jcb.102.6.2033
   BLESSING M, 1993, J CELL BIOL, V120, P743, DOI 10.1083/jcb.120.3.743
   BOND M, 1982, J CELL BIOL, V95, P403, DOI 10.1083/jcb.95.2.403
   Bridger JM, 1998, J CELL SCI, V111, P1241
   BUCKELY IK, 1967, PROTOPLASMA, V64, P349, DOI 10.1007/BF01666538
   CAPCO DG, 1982, CELL, V29, P847, DOI 10.1016/0092-8674(82)90446-9
   CARMOFONSECA M, 1988, EUR J CELL BIOL, V45, P282
   Clubb BH, 2000, BIOCHEM BIOPH RES CO, V273, P183, DOI 10.1006/bbrc.2000.2916
   Cohen M, 2002, J STRUCT BIOL, V140, P232, DOI 10.1016/S1047-8477(02)00516-6
   DODEMONT H, 1994, EMBO J, V13, P2625, DOI 10.1002/j.1460-2075.1994.tb06553.x
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P355, DOI 10.1016/S0304-3991(78)80052-7
   ENGEL A, 1978, ULTRAMICROSCOPY, V3, P273, DOI 10.1016/S0304-3991(78)80037-0
   Erber A, 1999, J MOL EVOL, V49, P260, DOI 10.1007/PL00006548
   FOISNER R, 1988, J CELL BIOL, V106, P723, DOI 10.1083/jcb.106.3.723
   FOWLER WE, 1983, J ULTRA MOL STRUCT R, V83, P319, DOI 10.1016/S0022-5320(83)90139-9
   FRANKE WW, 1978, P NATL ACAD SCI USA, V75, P5034, DOI 10.1073/pnas.75.10.5034
   Goldie KN, 2007, J STRUCT BIOL, V158, P378, DOI 10.1016/j.jsb.2006.12.007
   GOLDMAN AE, 1992, J CELL BIOL, V119, P725, DOI 10.1083/jcb.119.4.725
   GOLDMAN RD, 1969, EXP CELL RES, V57, P263, DOI 10.1016/0014-4827(69)90150-5
   GOLDMAN RD, 1970, SCIENCE, V169, P286, DOI 10.1126/science.169.3942.286
   GRANGER BL, 1982, CELL, V30, P263, DOI 10.1016/0092-8674(82)90032-0
   HEINS S, 1993, J CELL BIOL, V123, P1517, DOI 10.1083/jcb.123.6.1517
   HENDERSON D, 1982, J MOL BIOL, V155, P173, DOI 10.1016/0022-2836(82)90444-2
   Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688
   Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528
   Herrmann H, 2004, METHOD CELL BIOL, V78, P3
   Herrmann H, 2003, INT REV CYTOL, V223, P83
   Herrmann H, 2002, J STRUCT BIOL, V137, P82, DOI 10.1006/jsbi.2002.4466
   HERRMANN H, 1983, J BIOL CHEM, V258, P4610
   HERRMANN H, 1993, J MOL BIOL, V234, P99, DOI 10.1006/jmbi.1993.1566
   Herrmann H, 1998, Subcell Biochem, V31, P319
   Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197
   HEUSER JE, 1980, J CELL BIOL, V86, P212, DOI 10.1083/jcb.86.1.212
   HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129
   HIROKAWA N, 1982, J CELL BIOL, V94, P425, DOI 10.1083/jcb.94.2.425
   HOZAK P, 1995, J CELL SCI, V108, P635
   ISHIKAWA H, 1968, J CELL BIOL, V38, P538, DOI 10.1083/jcb.38.3.538
   Kirmse R, 2007, J BIOL CHEM, V282, P18563, DOI 10.1074/jbc.M701063200
   Kreplak L, 2005, J MOL BIOL, V354, P569, DOI 10.1016/j.jmb.2005.09.092
   KRISHNAN N, 1979, J CELL BIOL, V82, P323, DOI 10.1083/jcb.82.2.323
   Leterrier JF, 1996, J BIOL CHEM, V271, P15687, DOI 10.1074/jbc.271.26.15687
   Mucke N, 2005, J STRUCT BIOL, V150, P268, DOI 10.1016/j.jsb.2005.02.012
   Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039
   Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038
   MUELLER H, 1983, J MOL BIOL, V163, P647, DOI 10.1016/0022-2836(83)90116-X
   OKAZAKI K, 1965, J HISTOCHEM CYTOCHEM, V13, P726, DOI 10.1177/13.8.726
   PADDY MR, 1990, CELL, V62, P89, DOI 10.1016/0092-8674(90)90243-8
   Reichenzeller M, 2000, J STRUCT BIOL, V129, P175, DOI 10.1006/jsbi.2000.4224
   Richter K, 2005, EXP CELL RES, V303, P128, DOI 10.1016/j.yexcr.2004.09.022
   SMALL JV, 1977, J CELL SCI, V23, P243
   STEINERT PM, 1985, ANNU REV CELL BIOL, V1, P41
   STEVEN AC, 1982, P NATL ACAD SCI-BIOL, V79, P3101, DOI 10.1073/pnas.79.10.3101
   Strelkov SV, 2004, METHOD CELL BIOL, V78, P25
   STROMER MH, 1987, BIOCHEM J, V246, P75, DOI 10.1042/bj2460075
   Svitkina TM, 1996, J CELL BIOL, V135, P991, DOI 10.1083/jcb.135.4.991
   Wickert U, 2005, EUR J CELL BIOL, V84, P379, DOI 10.1016/j.ejcb.2005.01.004
NR 60
TC 13
Z9 13
U1 0
U2 11
PU ELSEVIER ACADEMIC PRESS INC
PI SAN DIEGO
PA 525 B STREET, SUITE 1900, SAN DIEGO, CA 92101-4495 USA
SN 0091-679X
BN 978-0-12-374320-6
J9 METHOD CELL BIOL
JI Methods Cell Biol.
PY 2008
VL 88
BP 273
EP 297
DI 10.1016/S0091-679X(08)00415-9
PG 25
WC Cell Biology
SC Cell Biology
GA BHZ54
UT WOS:000257693100015
PM 18617039
DA 2021-01-25
ER

PT J
AU Bumann, D
   Buss, LW
AF Bumann, Dirk
   Buss, Leo W.
TI Nutritional physiology and colony form in Podocoryna carnea (Cnidaria:
   Hydrozoa)
SO INVERTEBRATE BIOLOGY
LA English
DT Article
DE hydroid; growth rate; morphology; gastrovascular; metabolism
ID EXPERIMENTAL HETEROCHRONY; HYDRACTINIA-SYMBIOLONGICARPUS; GASTROVASCULAR
   FLOW; PAGURUS-LONGICARPUS; HERMIT-CRAB; HYDROIDS; GROWTH; POLYPS
AB We compared growth rates and final morphological states of the athecate colonial hydroid Podocoryna carnea in two nutritional environments: one varying the quantity of food provided at a fixed interval and the second varying the time between feedings of a fixed quantity. In both environments, replicate colonies were either fed uniformly, or fed on only one side and starved on the other. In addition, we fed colonies fluorescence-labeled cultures of Artemia salina and documented the subsequent distribution of label. We found that both the growth rates and the final morphological state varied logarithmically with food supply. Heterogeneous feeding had a marked effect on colony morphology, with a sharp boundary in polyp number, stolon density, and polyp size forming at the fed-unfed interface. The distribution of fluorescence was correlated with sites of colony growth. These results confirm and extend early work on the priority of growth zones in colonial hydroids, and present new challenges for understanding the relationship among energy metabolism, gastrovascular circulation, and colony form.
C1 [Buss, Leo W.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA.
   [Buss, Leo W.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA.
   [Bumann, Dirk] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Buss, LW (corresponding author), Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA.
EM leo.buss@yale.edu
FU Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [Bu
   971/1-1,2]
FX We thank J. Rimas Vaisnys and Neil Blackstone for extensive discussions.
   D.B. was supported by the Deutsche Forschungsgemeinschaft (Bu
   971/1-1,2).
CR Bach CE, 2006, J EXP MAR BIOL ECOL, V333, P181, DOI 10.1016/j.jembe.2005.12.003
   Berking S, 2006, INT J DEV BIOL, V50, P123, DOI 10.1387/ijdb.052043sb
   BERRILL NJ, 1951, BIOL REV, V26, P456, DOI 10.1111/j.1469-185X.1951.tb01207.x
   BERRILL NJ, 1950, J MORPHOL, V87, P1, DOI 10.1002/jmor.1050870102
   Bishop J.W., 1973, P433
   BLACKSTONE NW, 1993, J EVOLUTION BIOL, V6, P307, DOI 10.1046/j.1420-9101.1993.6030307.x
   Blackstone NW, 1997, BIOL BULL, V193, P47, DOI 10.2307/1542735
   Blackstone NW, 1998, J EXP BIOL, V201, P2821
   Blackstone NW, 2005, INTEGR COMP BIOL, V45, P605, DOI 10.1093/icb/45.4.605
   Blackstone NW, 2005, J EXP BIOL, V208, P383, DOI 10.1242/jeb.01394
   Blackstone NW, 2004, INVERTEBR BIOL, V123, P43
   Blackstone NW, 2003, J EXP BIOL, V206, P651, DOI 10.1242/jeb.00138
   Blackstone NW, 2001, J EXP BIOL, V204, P1845
   BLACKSTONE NW, 1992, P NATL ACAD SCI USA, V89, P4057, DOI 10.1073/pnas.89.9.4057
   Blackstone NW, 1998, J EVOLUTION BIOL, V11, P421, DOI 10.1007/s000360050097
   Blackstone NW, 1996, BIOL BULL, V190, P56, DOI 10.2307/1542675
   Braverman M, 1966, CNIDARIA THEIR EVOLU, P169
   Braverman M, 1974, ANN REV OCEANOGRAPHY, V12, P129
   BRAVERMAN MH, 1963, J EMBRYOL EXP MORPH, V11, P239
   Buss LW, 2001, EVOLUTIONARY PATTERNS: GROWTH, FORM, AND TEMPO IN THE FOSSIL RECORD, P3
   BUSS LW, 1979, BIOL SYSTEMATICS COL, P459
   CHRISTENSEN HANS E., 1967, OPHELIA, V4, P245
   CROWELL S, 1957, J EXP ZOOL, V134, P63, DOI 10.1002/jez.1401340104
   CROWELL S, 1953, PHYSIOL ZOOL, V26, P319, DOI 10.1086/physzool.26.4.30152158
   Damiani CC, 2003, J EXP MAR BIOL ECOL, V288, P203, DOI 10.1016/S0022-0981(03)00005-4
   Dudgeon S, 1999, BIOL BULL, V196, P1, DOI 10.2307/1543161
   Gordon D.P., 1977, P335
   Jackso J. B. C., 1979, BIOL SYSTEMATICS COL, P499
   KOSSEVITCH IA, 2006, BRANCHING MORPHOGENE, P91
   KUHN A, 1913, HYDROIDEN ERG FORTSC, V4, P1
   LEVERSEE GJ, 1976, BIOL BULL, V151, P344, DOI 10.2307/1540667
   SCHIERWATER B, 1992, J EXP BIOL, V162, P1
   Sebens KP, 1996, MAR BIOL, V127, P303, DOI 10.1007/BF00942116
   SLAUTTERBACK DB, 1967, J CELL SCI, V2, P563
   VanWinkle DH, 1997, INVERTEBR BIOL, V116, P6
   Wagner A, 1998, NATURWISSENSCHAFTEN, V85, P117, DOI 10.1007/s001140050465
NR 36
TC 7
Z9 7
U1 0
U2 8
PU WILEY-BLACKWELL
PI MALDEN
PA COMMERCE PLACE, 350 MAIN ST, MALDEN 02148, MA USA
SN 1077-8306
J9 INVERTEBR BIOL
JI Invertebr. Biol.
PY 2008
VL 127
IS 4
BP 368
EP 380
DI 10.1111/j.1744-7410.2008.00135.x
PG 13
WC Marine & Freshwater Biology; Zoology
SC Marine & Freshwater Biology; Zoology
GA 381II
UT WOS:000261528900002
DA 2021-01-25
ER

PT J
AU Berninger, P
   Gaidatzis, D
   van Nimwegen, E
   Zavolan, M
AF Berninger, Philipp
   Gaidatzis, Dimos
   van Nimwegen, Erik
   Zavolan, Mihaela
TI Computational analysis of small RNA cloning data
SO METHODS
LA English
DT Article
DE deep sequencing; annotation; alignment; expression profiling
ID CAENORHABDITIS-ELEGANS; IDENTIFICATION; MICRORNAS; PROTEIN; MILI
AB Cloning and sequencing is the method of choice for small regulatory RNA identification. Using deep sequencing technologies one can now obtain up to a billion nucleotides - and tens of millions of small RNAs-from a single library. Careful computational analyses of such libraries enabled the discovery of miRNAs, rasiRNAs, piRNAs, and 21 U RNAs. Given the large number of sequences that can be obtained from each individual sample, deep sequencing may soon become an alternative to oligonucleotide microarray technology for mRNA expression profiling. In this report we present the methods that we developed for the annotation and expression profiling of small RNAs obtained through large-scale sequencing. These include a fast algorithm for finding nearly perfect matches of small RNAs in sequence databases, a web-accessible software system for the annotation of small RNA libraries, and a Bayesian method for comparing small RNA expression across samples. (c) 2007 Elsevier Inc. All rights reserved.
C1 [Berninger, Philipp; Gaidatzis, Dimos; van Nimwegen, Erik; Zavolan, Mihaela] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   [Berninger, Philipp; Gaidatzis, Dimos; van Nimwegen, Erik; Zavolan, Mihaela] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland.
RP Zavolan, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM mihaela.zavolan@unibas.ch
RI Zavolan, Mihaela/S-3888-2016
OI Zavolan, Mihaela/0000-0002-8832-2041; van Nimwegen,
   Erik/0000-0001-6338-1312
CR ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2
   Aravin A, 2006, NATURE, V442, P203, DOI 10.1038/nature04916
   Aravin AA, 2007, SCIENCE, V316, P744, DOI 10.1126/science.1142612
   Bennett S, 2004, PHARMACOGENOMICS, V5, P433, DOI 10.1517/14622416.5.4.433
   Berezikov E, 2006, GENOME RES, V16, P1289, DOI 10.1101/gr.5159906
   Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043
   Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014
   Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689
   Girard A, 2006, NATURE, V442, P199, DOI 10.1038/nature04917
   Houbaviy HB, 2003, DEV CELL, V5, P351, DOI 10.1016/S1534-5807(03)00227-2
   Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921
   Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040
   Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062
   Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329
   Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959
   Olsen PH, 1999, DEV BIOL, V216, P671, DOI 10.1006/dbio.1999.9523
   Pfeffer S, 2005, NAT METHODS, V2, P269, DOI 10.1038/NMETH746
   Pfeffer S, 2004, SCIENCE, V304, P734, DOI 10.1126/science.1096781
   Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607
   Reinhart BJ, 2002, SCIENCE, V297, P1831, DOI 10.1126/science.1077183
   Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040
   Sijen T, 2003, NATURE, V426, P310, DOI 10.1038/nature02107
   Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973
   Zamore PD, 2000, CELL, V101, P25, DOI 10.1016/S0092-8674(00)80620-0
   Zhang Z, 2000, J COMPUT BIOL, V7, P203, DOI 10.1089/10665270050081478
NR 25
TC 46
Z9 49
U1 0
U2 1
PU ACADEMIC PRESS INC ELSEVIER SCIENCE
PI SAN DIEGO
PA 525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA
SN 1046-2023
EI 1095-9130
J9 METHODS
JI Methods
PD JAN
PY 2008
VL 44
IS 1
BP 13
EP 21
DI 10.1016/j.ymeth.2007.10.002
PG 9
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 263AF
UT WOS:000253189300003
PM 18158128
DA 2021-01-25
ER

PT J
AU Cordier, F
   Nisius, L
   Dingley, AJ
   Grzesiek, S
AF Cordier, Florence
   Nisius, Lydia
   Dingley, Andrew J.
   Grzesiek, Stephan
TI Direct detection of N-H center dot center dot center dot O=C hydrogen
   bonds in biomolecules by NMR spectroscopy
SO NATURE PROTOCOLS
LA English
DT Article
ID ISOTOPE LABELING PROTOCOL; SCALAR COUPLINGS; C-13/N-15-LABELED PROTEINS;
   (3H)J(NC'); SUPPRESSION; RESONANCE; EFFICIENT; NETWORK
AB A nuclear magnetic resonance (NMR) experiment is described for the direct detection of N-H center dot center dot center dot O=C hydrogen bonds (H-bonds) in N-15 and C-13 isotope-labeled biomolecules. This quantitative 'long-range' HNCO-COSY (correlation spectroscopy) experiment detects and quantifies electron-mediated scalar couplings across the H-bond (H-bond scalar couplings), which connect the magnetically active N-15 and C-13 nuclei on both sides of the H-bond. Detectable H-bonds comprise the canonical backbone H-bonds in proteins as well as other H-bonds in proteins and nucleic acids with N-H donors and O=C (carbonylic or carboxylic) acceptors. Unlike other NMR observables, which provide only indirect evidence of the presence of H-bonds, the H-bond scalar couplings identify all partners of the H-bond, the donor, the donor proton and the acceptor, in a single experiment. The size of the scalar couplings can be related to H-bond geometries. The time required to detect the N-H center dot center dot center dot O=C H-bonds in small proteins (<= approximate to 10 kDa) is typically on the order of 1 d at millimolar concentrations, whereas H-bond detection for larger proteins (<= approximate to 30 kDa) may be possible within several days depending on concentration, isotope composition, magnetic field strength and molecular weight. The proteins ubiquitin (8.6 kDa), dimeric RANTES (2 x 3 8.5 kDa) and MAP30 (30 kDa) are used as examples to illustrate this procedure.
C1 [Nisius, Lydia; Grzesiek, Stephan] Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
   [Cordier, Florence] Inst Pasteur, Dept Struct Biol & Chem, F-75015 Paris, France.
   [Dingley, Andrew J.] Univ Auckland, Dept Chem, Auckland 1, New Zealand.
   [Dingley, Andrew J.] Univ Auckland, Sch Biol Sci, Auckland 1, New Zealand.
RP Grzesiek, S (corresponding author), Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch
RI Dingley, Andrew/G-6427-2013
OI Dingley, Andrew/0000-0002-6838-5803; Cordier,
   Florence/0000-0002-5963-7773; Grzesiek, Stephan/0000-0003-1998-4225
CR Assadi-Porter FM, 2003, J BIOL CHEM, V278, P31331, DOI 10.1074/jbc.M302663200
   Barfield M, 2002, J AM CHEM SOC, V124, P4158, DOI 10.1021/ja012674v
   BLAKE PR, 1992, J BIOMOL NMR, V2, P527, DOI 10.1007/BF02192814
   Bougault CM, 2003, BIOCHEMISTRY-US, V42, P4357, DOI 10.1021/bi027264d
   Cai ML, 1998, J BIOMOL NMR, V11, P97, DOI 10.1023/A:1008222131470
   Cordier F, 2000, J MOL BIOL, V304, P497, DOI 10.1006/jmbi.2000.4274
   Cordier F, 2002, J MOL BIOL, V317, P739, DOI 10.1006/jmbi.2002.5446
   Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d
   Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024
   Cornilescu G, 1999, J AM CHEM SOC, V121, P2949, DOI 10.1021/ja9902221
   Crabtree RH, 1996, ACCOUNTS CHEM RES, V29, P348, DOI 10.1021/ar950150s
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dingley AJ, 2000, J BIOMOL NMR, V16, P279, DOI 10.1023/A:1008307115641
   Dingley AJ, 2001, CONCEPT MAGNETIC RES, V13, P103
   Dingley AJ, 1998, J AM CHEM SOC, V120, P8293, DOI 10.1021/ja981513x
   DINGLEY AJ, NAT PROTOC, V3, P242
   Golubev NS, 1999, CHEM-EUR J, V5, P492, DOI 10.1002/(SICI)1521-3765(19990201)5:2<492::AID-CHEM492>3.0.CO;2-I
   Goto NK, 2000, CURR OPIN STRUC BIOL, V10, P585, DOI 10.1016/S0959-440X(00)00135-4
   Grzesiek S, 2004, PROG NUCL MAG RES SP, V45, P275, DOI 10.1016/j.pnmrs.2004.08.001
   GRZESIEK S, 1993, J AM CHEM SOC, V115, P4369, DOI 10.1021/ja00063a068
   Grzesiek S, 2001, METHOD ENZYMOL, V338, P111
   GRZESIEK S, 2003, BIOL MAGN RESON, V20, P255
   Jaravine VA, 2001, PROTEIN SCI, V10, P943, DOI 10.1110/ps.48501
   Jeffrey G.A., 1991, HYDROGEN BONDING BIO
   Li H, 2000, J BIOMOL NMR, V18, P207, DOI 10.1023/A:1026537609584
   Liu AZ, 2000, J BIOMOL NMR, V17, P305, DOI 10.1023/A:1008390813387
   Liu AZ, 2000, J BIOMOL NMR, V17, P79, DOI 10.1023/A:1008373501591
   Marley J, 2001, J BIOMOL NMR, V20, P71, DOI 10.1023/A:1011254402785
   MESSERLE BA, 1989, J MAGN RESON, V85, P608, DOI 10.1016/0022-2364(89)90252-7
   Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147
   REILLY D, 1994, J BIOMOL NMR, V4, P459
   Sass HJ, 2007, J AM CHEM SOC, V129, P5898, DOI 10.1021/ja068336h
   Shenderovich IG, 1998, BER BUNSEN PHYS CHEM, V102, P422, DOI 10.1002/bbpc.19981020322
   SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1
   VENTERS RA, 1995, J BIOMOL NMR, V5, P339
   Wang YX, 1999, J BIOMOL NMR, V14, P181, DOI 10.1023/A:1008346517302
NR 36
TC 23
Z9 24
U1 1
U2 24
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-2189
J9 NAT PROTOC
JI Nat. Protoc.
PY 2008
VL 3
IS 2
BP 235
EP 241
DI 10.1038/nprot.2007.498
PG 7
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 276JL
UT WOS:000254137000010
PM 18274525
DA 2021-01-25
ER

PT J
AU Dingley, AJ
   Nisius, L
   Cordier, F
   Grzesiek, S
AF Dingley, Andrew J.
   Nisius, Lydia
   Cordier, Florence
   Grzesiek, Stephan
TI Direct detection of N-H center dot center dot center dot N hydrogen
   bonds in biomolecules by NMR spectroscopy
SO NATURE PROTOCOLS
LA English
DT Article
ID SCALAR COUPLINGS; BASE-PAIRS; TEMPERATURE-DEPENDENCE; HIGH-RESOLUTION;
   DNA; (3H)J(NC'); RNA; CRYSTALLOGRAPHY; SUPPRESSION; RESONANCE
AB A nuclear magnetic resonance (NMR) experiment is described for the direct detection of N-H center dot center dot center dot N hydrogen bonds (H-bonds) in N-15 isotope-labeled biomolecules. This quantitative HNN-COSY (correlation spectroscopy) experiment detects and quantifies electron-mediated scalar couplings across the H-bond (H-bond scalar couplings), which connect magnetically active N-15 nuclei of the H-bond donor and acceptor. Detectable H-bonds comprise the imino H-bonds in canonical Watson-Crick base pairs, many H-bonds in unusual nucleic acid base pairs and H-bonds between protein backbone or side-chain N-H donor and N acceptor moieties. Unlike other NMR observables, which provide only indirect evidence of the presence of H-bonds, the H-bond scalar couplings identify all partners of the H-bond, the donor, the donor proton and the acceptor in a single experiment. The size of the scalar couplings can be related to H-bond geometries and as a time average to H-bond dynamics. The time required to detect the H-bonds is typically less than 1 d at millimolar concentrations for samples of molecular weight <= approximate to 25 kDa. A N-15/C-13-labeled potato spindle tuber viroid T1 RNA domain is used as an example to illustrate this procedure.
C1 [Nisius, Lydia; Grzesiek, Stephan] Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
   [Dingley, Andrew J.] Univ Auckland, Dept Chem, Auckland 1142, New Zealand.
   [Dingley, Andrew J.] Univ Auckland, Sch Biol Sci, Auckland 1142, New Zealand.
   [Cordier, Florence] Inst Pasteur, Dept Struct Biol & Chem, F-75015 Paris, France.
RP Grzesiek, S (corresponding author), Univ Basel, Dept Biol Struct, Biozentrum, CH-4056 Basel, Switzerland.
EM stephan.grzesiek@unibas.ch
RI Dingley, Andrew/G-6427-2013
OI Dingley, Andrew/0000-0002-6838-5803; Grzesiek,
   Stephan/0000-0003-1998-4225
CR Addlagatta A, 2001, ACTA CRYSTALLOGR D, V57, P649, DOI 10.1107/S0907444901003468
   Al-Hashimi HM, 2002, J MOL BIOL, V318, P637, DOI 10.1016/S0022-2836(02)00160-2
   Barfield M, 2002, J AM CHEM SOC, V124, P4158, DOI 10.1021/ja012674v
   Barfield M, 2001, J AM CHEM SOC, V123, P4014, DOI 10.1021/ja003781c
   Batey RT, 1995, METHOD ENZYMOL, V261, P300
   BATEY RT, 1992, NUCLEIC ACIDS RES, V20, P4515, DOI 10.1093/nar/20.17.4515
   BAX A, 1991, J MAGN RESON, V91, P174, DOI 10.1016/0022-2364(91)90422-P
   Becker E.D., 1996, ENCY NUCL MAGNETIC R, V4, P2409
   BLAKE PR, 1992, J BIOMOL NMR, V2, P527, DOI 10.1007/BF02192814
   Bytchenkoff D, 2002, MAGN RESON CHEM, V40, P377, DOI 10.1002/mrc.1018
   Cordier F, 1999, J AM CHEM SOC, V121, P1601, DOI 10.1021/ja983945d
   Cordier F, 2008, NAT PROTOC, V3, P235, DOI 10.1038/nprot.2007.498
   Cornilescu G, 1999, J AM CHEM SOC, V121, P6275, DOI 10.1021/ja9909024
   Cornilescu G, 1999, J AM CHEM SOC, V121, P2949, DOI 10.1021/ja9902221
   Crabtree RH, 1996, ACCOUNTS CHEM RES, V29, P348, DOI 10.1021/ar950150s
   DELAGLIO F, 1995, J BIOMOL NMR, V6, P277, DOI 10.1007/BF00197809
   Dingley AJ, 2005, J AM CHEM SOC, V127, P14466, DOI 10.1021/ja0540369
   Dingley AJ, 2000, J BIOMOL NMR, V16, P279, DOI 10.1023/A:1008307115641
   Dingley AJ, 2003, J MOL BIOL, V334, P751, DOI 10.1016/j.jmb.2003.10.015
   Dingley AJ, 2001, CONCEPT MAGNETIC RES, V13, P103
   Dingley AJ, 1999, J AM CHEM SOC, V121, P6019, DOI 10.1021/ja9908321
   Dingley AJ, 1998, J AM CHEM SOC, V120, P8293, DOI 10.1021/ja981513x
   Gerwert K, 1999, BIOL CHEM, V380, P931, DOI 10.1515/BC.1999.115
   Golubev NS, 1999, CHEM-EUR J, V5, P492, DOI 10.1002/(SICI)1521-3765(19990201)5:2<492::AID-CHEM492>3.0.CO;2-I
   Grzesiek S, 2004, PROG NUCL MAG RES SP, V45, P275, DOI 10.1016/j.pnmrs.2004.08.001
   Grzesiek S, 2001, METHOD ENZYMOL, V338, P111
   GRZESIEK S, 2003, BIOL MAGN RESON, V20, P255
   Hennig M, 2000, NUCLEIC ACIDS RES, V28, P1585, DOI 10.1093/nar/28.7.1585
   Hennig M, 1999, J AM CHEM SOC, V121, P5123, DOI 10.1021/ja990340o
   Hu JZ, 1998, J AM CHEM SOC, V120, P9863, DOI 10.1021/ja9816786
   Jeffrey G.A., 1991, HYDROGEN BONDING BIO
   Jelsch C, 2000, P NATL ACAD SCI USA, V97, P3171, DOI 10.1073/pnas.97.7.3171
   Kojima C, 2000, J BIOMOL NMR, V18, P269, DOI 10.1023/A:1026717101063
   Louis JM, 1998, J BIOL CHEM, V273, P2374, DOI 10.1074/jbc.273.4.2374
   Luy B, 2000, J AM CHEM SOC, V122, P8095, DOI 10.1021/ja0000910
   Majumdar A, 2002, ACCOUNTS CHEM RES, V35, P1, DOI 10.1021/ar010097+
   Majumdar A, 1999, J BIOMOL NMR, V14, P67, DOI 10.1023/A:1008335502416
   Majumdar A, 1999, J BIOMOL NMR, V15, P207, DOI 10.1023/A:1008357304708
   Majumdar A, 2001, J BIOMOL NMR, V19, P103, DOI 10.1023/A:1008311624772
   MESSERLE BA, 1989, J MAGN RESON, V85, P608, DOI 10.1016/0022-2364(89)90252-7
   NIKONOWICZ EP, 1992, NUCLEIC ACIDS RES, V20, P4507, DOI 10.1093/nar/20.17.4507
   Pervushin K, 1998, P NATL ACAD SCI USA, V95, P14147, DOI 10.1073/pnas.95.24.14147
   Rene Brigitte, 2006, J Biomol NMR, V36, P137, DOI 10.1007/s10858-006-9075-0
   SCHWALBE H, 1996, ENCY NUCL MAGNETIC R, V3, P1473
   Shenderovich IG, 1998, BER BUNSEN PHYS CHEM, V102, P422, DOI 10.1002/bbpc.19981020322
   Shu F, 2000, P NATL ACAD SCI USA, V97, P3872, DOI 10.1073/pnas.060024697
   SKLENAR V, 1987, J MAGN RESON, V74, P469, DOI 10.1016/0022-2364(87)90269-1
   ZHU G, 1993, J MAGN RESON SER A, V105, P219, DOI 10.1006/jmra.1993.1274
NR 48
TC 29
Z9 29
U1 0
U2 21
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1754-2189
EI 1750-2799
J9 NAT PROTOC
JI Nat. Protoc.
PY 2008
VL 3
IS 2
BP 242
EP 248
DI 10.1038/nprot.2007.497
PG 7
WC Biochemical Research Methods
SC Biochemistry & Molecular Biology
GA 276JL
UT WOS:000254137000011
PM 18274526
DA 2021-01-25
ER

PT J
AU Buchmann, A
   Mondadori, CRA
   Haenggi, J
   Aerni, A
   Vrticka, P
   Luechinger, R
   Boesiger, P
   Hock, C
   Nitsch, RM
   de Quervaina, DJF
   Papassotiropoulos, A
   Henke, K
AF Buchmann, Andreas
   Mondadori, Christian R. A.
   Haenggi, Juergen
   Aerni, Amanda
   Vrticka, Pascal
   Luechinger, Roger
   Boesiger, Peter
   Hock, Christoph
   Nitsch, Roger M.
   de Quervaina, Dominique J. -F.
   Papassotiropoulos, Andreas
   Henke, Katharina
TI Prion protein M129V polymorphism affects retrieval-related brain
   activity
SO NEUROPSYCHOLOGIA
LA English
DT Article
DE learning; episodic memory; gene; fMRI; consolidation; compensation
ID LONG-TERM POTENTIATION; CREUTZFELDT-JAKOB-DISEASE; MEDIAL TEMPORAL-LOBE;
   EVENT-RELATED FMRI; MEMORY PERFORMANCE; EPISODIC MEMORY;
   HIPPOCAMPAL-FORMATION; RECOGNITION MEMORY; ALZHEIMERS-DISEASE;
   PREFRONTAL CORTEX
AB The prion protein Met129Val polymorphism has recently been related to human long-term memory with carriers of either the 129(MM) or the 129(MV) genotype recalling 17% more words than 129(VV) carriers at 24 h following learning. Here, we sampled genotype differences in retrieval-related brain activity at 30 min and 24 h following learning. Furthermore, genotype groups were compared regarding grey matter concentrations and cognitive profiles. We used event-related functional magnetic resonance imaging (fMRI) during a word recognition task on 12 Met/Met carriers, 12 Val/Met carriers, and 12 Val/Val carriers. These groups were matched for retrieval performance, gender, age, education, and other memory-related genetic polymorphisms. Although retrieval performance was matched, Val carriers exhibited enhanced retrieval-related brain activity at 30 min and 24 h following learning. At both time lags, correlations between retrieval-related brain activity and retrieval success were negative for Val homozygotes (the more activity, the worse retrieval success), while correlations showed no significance or were positive for Met homozygotes and heterozygotes. These results suggest a less economic use of retrieval-related neural resources in Val relative to Met carriers. Furthermore, Val carriers exhibited higher neocortical grey matter concentrations compared to Met carriers. When controlling for grey matter concentration, genotype effects in retrieval-related brain activity remained significant. Val and Met carriers yielded comparable brain activations for correct rejections of non-studied words and for working memory, which speaks to the specificity of the genotype effect. Findings suggest that the prion protein Met129Val polymorphism affects neural plasticity following learning at a time-scale of minutes to hours. (C) 2008 Elsevier Ltd. All rights reserved.
C1 [Henke, Katharina] Univ Bern, Dept Psychol, CH-3000 Bern, Switzerland.
   [Papassotiropoulos, Andreas] Univ Basel, Div Mol Psychol & Biozentrum, CH-4055 Basel, Switzerland.
   [Luechinger, Roger; Boesiger, Peter] Univ & ETH Zurich, Inst Biomed Engn, CH-8092 Zurich, Switzerland.
   [Vrticka, Pascal] Univ Geneva, Dept Neurosci, CH-1205 Geneva, Switzerland.
   [Haenggi, Juergen] Univ Zurich, Dept Psychol, CH-8050 Zurich, Switzerland.
   [Buchmann, Andreas; Mondadori, Christian R. A.; Aerni, Amanda; Hock, Christoph; Nitsch, Roger M.; de Quervaina, Dominique J. -F.; Papassotiropoulos, Andreas] Univ Zurich, Div Psychiat Res, CH-8032 Zurich, Switzerland.
   [Buchmann, Andreas; Mondadori, Christian R. A.; Aerni, Amanda; Hock, Christoph; Nitsch, Roger M.; de Quervaina, Dominique J. -F.; Papassotiropoulos, Andreas] Univ Zurich, Hosp Psychogeriat Med Zurich, CH-8032 Zurich, Switzerland.
RP Henke, K (corresponding author), Univ Bern, Dept Psychol, Muesmattstrasse 45, CH-3000 Bern, Switzerland.
EM henke@psy.unibe.ch
RI Luechinger, Roger/AAD-5192-2019; Vrticka, Pascal/H-2209-2013; Vrticka,
   Pascal/U-9166-2018
OI Luechinger, Roger/0000-0002-7365-0421; Vrticka,
   Pascal/0000-0002-4806-9037; Vrticka, Pascal/0000-0002-8920-5509; de
   Quervain, Dominique/0000-0001-7131-2464; Hanggi,
   Jurgen/0000-0001-8124-6018; Papassotiropoulos,
   Andreas/0000-0002-2210-9651
CR Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582
   BENDHEIM PE, 1992, NEUROLOGY, V42, P149, DOI 10.1212/WNL.42.1.149
   Bertolino A, 2006, PSYCHIAT RES-NEUROIM, V147, P221, DOI 10.1016/j.pscychresns.2006.04.001
   Bondi MW, 2005, NEUROLOGY, V64, P501, DOI 10.1212/01.WNL.0000150885.00929.7E
   Bookheimer SY, 2000, NEW ENGL J MED, V343, P450, DOI 10.1056/NEJM200008173430701
   Cabeza R, 2000, J COGNITIVE NEUROSCI, V12, P1, DOI 10.1162/08989290051137585
   Casanova R, 2007, NEUROIMAGE, V34, P137, DOI 10.1016/j.neuroimage.2006.09.011
   Colling SB, 1997, BRAIN RES, V755, P28, DOI 10.1016/S0006-8993(97)00087-5
   COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0
   Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001
   Daselaar SM, 2006, CEREB CORTEX, V16, P1771, DOI 10.1093/cercor/bhj112
   Daselaar SM, 2006, J NEUROSCI, V26, P5835, DOI 10.1523/JNEUROSCI.0258-06.2006
   de Quervain DJF, 2003, NAT NEUROSCI, V6, P1141, DOI 10.1038/nn1146
   Egan MF, 2004, P NATL ACAD SCI USA, V101, P12604, DOI 10.1073/pnas.0405077101
   Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7
   FRISTON KJ, 1995, NEUROIMAGE, V2, P45, DOI 10.1006/nimg.1995.1007
   Friston KJ, 1995, HUM BRAIN MAPP, V3, P165, DOI 10.1002/hbm.460030303
   GARDINER JM, 1988, MEM COGNITION, V16, P309, DOI 10.3758/BF03197041
   Georgsson G, 2006, ACTA NEUROL SCAND, V113, P419, DOI 10.1111/j.1600-0404.2006.00632.x
   Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011
   Good CD, 2001, REV NEUROL-FRANCE, V157, P797
   Grady CL, 2005, NEUROPSYCHOLOGIA, V43, P1466, DOI 10.1016/j.neuropsychologia.2004.12.016
   Grunwald T, 2006, CLIN EEG NEUROSCI, V37, P309, DOI 10.1177/155005940603700408
   Hager W., 1994, HDB DEUTSCHSPRACHIGE
   Harting C, 2000, WECHSLER GEDAECHTNIS
   Helmstaedter C., 2001, VLMT VERBALER LERN M
   Herms JW, 1995, EUR J NEUROSCI, V7, P2508, DOI 10.1111/j.1460-9568.1995.tb01049.x
   Hessl D, 2007, BRAIN, V130, P404, DOI 10.1093/brain/awl338
   Heun R, 2004, EUR PSYCHIAT, V19, P42, DOI 10.1016/j.eurpsy.2003.09.005
   Huentelman MJ, 2007, HUM MOL GENET, V16, P1469, DOI 10.1093/hmg/ddm097
   Johnson JD, 2008, NEUROIMAGE, V39, P406, DOI 10.1016/j.neuroimage.2007.08.050
   Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020
   Keshet GI, 1999, J NEUROCHEM, V72, P1224, DOI 10.1046/j.1471-4159.1999.0721224.x
   Kim H, 2007, CEREB CORTEX, V17, P2143, DOI 10.1093/cercor/bhl122
   Lehrl S., 1999, MEHRFACHWAHL WORTSCH
   LIEDO PM, 1996, P NATL ACAD SCI USA, V93, P2403
   LUETHI A, 1994, NATURE, V372, P777
   MANSON JC, 1995, NEURODEGENERATION, V4, P113
   McClearn GE, 1997, SCIENCE, V276, P1560, DOI 10.1126/science.276.5318.1560
   McDermott KB, 2000, J COGNITIVE NEUROSCI, V12, P965, DOI 10.1162/08989290051137503
   Mead S, 2001, AM J HUM GENET, V69, P1225, DOI 10.1086/324710
   Meltzer JA, 2005, NEUROIMAGE, V24, P384, DOI 10.1016/j.neuroimage.2004.09.001
   MEYER JS, 1993, NEUROL RES, V15, P362
   Meyer-Lindenberg A, 2005, NAT NEUROSCI, V8, P594, DOI 10.1038/nn1438
   Miyamoto E, 2006, J PHARMACOL SCI, V100, P433, DOI 10.1254/jphs.CPJ06007X
   Mondadori CRA, 2007, CEREB CORTEX, V17, P1934, DOI 10.1093/cercor/bhl103
   Mondadori CRA, 2006, BRAIN, V129, P2908, DOI 10.1093/brain/awl266
   Moscovitch M, 2006, CURR OPIN NEUROBIOL, V16, P179, DOI 10.1016/j.conb.2006.03.013
   Moya KL, 2000, MICROSC RES TECHNIQ, V50, P58, DOI 10.1002/1097-0029(20000701)50:1<58::AID-JEMT9>3.0.CO;2-5
   Nakagami Y, 2000, J NEUROSCI, V20, P2003
   Nieznanski K, 2006, BIOCHEM BIOPH RES CO, V349, P391, DOI 10.1016/j.bbrc.2006.08.051
   Nurmi MH, 2003, ACTA NEUROL SCAND, V108, P374, DOI 10.1034/j.1600-0404.2003.00199.x
   Nyberg L, 2005, CURR OPIN NEUROL, V18, P424, DOI 10.1097/01.wco.0000168080.99730.1c
   PALMER MS, 1991, NATURE, V352, P340, DOI 10.1038/352340a0
   Papassotiropoulos A, 2005, HUM MOL GENET, V14, P2241, DOI 10.1093/hmg/ddi228
   Papassotiropoulos A, 2006, SCIENCE, V314, P475, DOI 10.1126/science.1129837
   Pastalkova E, 2006, SCIENCE, V313, P1141, DOI 10.1126/science.1128657
   Rao HY, 2007, BIOL PSYCHIAT, V62, P600, DOI 10.1016/j.biopsych.2006.11.028
   Rieger R, 1997, NAT MED, V3, P1383, DOI 10.1038/nm1297-1383
   Rugg MD, 2000, TRENDS COGN SCI, V4, P108, DOI 10.1016/S1364-6613(00)01445-5
   Rugg MD, 2002, PHILOS T R SOC B, V357, P1097, DOI 10.1098/rstb.2002.1102
   Rutishauser U, 2006, NEURON, V49, P805, DOI 10.1016/j.neuron.2006.02.015
   Sales N, 2002, EUR J NEUROSCI, V15, P1163, DOI 10.1046/j.1460-9568.2002.01953.x
   SCHATZL HM, 1995, J MOL BIOL, V245, P362, DOI 10.1006/jmbi.1994.0030
   Schmidt CF, 2005, NEUROIMAGE, V25, P625, DOI 10.1016/j.neuroimage.2004.12.002
   Schmitt-Ulms G, 2001, J MOL BIOL, V314, P1209, DOI 10.1006/jmbi.2000.5183
   Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1
   Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3
   Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651
   Tahiri-Alaoui A, 2004, J BIOL CHEM, V279, P31390, DOI 10.1074/jbc.M401754200
   TEWES U, 1991, HAWIE R HAMBURG WECH
   TULVING E, 1985, CAN PSYCHOL, V26, P1, DOI 10.1037/h0080017
   Tulving E, 1972, EPISODIC SEMANTIC ME
   Wheeler ME, 2004, NEUROIMAGE, V21, P1337, DOI 10.1016/j.neuroimage.2003.11.001
   Whitlock JR, 2006, SCIENCE, V313, P1093, DOI 10.1126/science.1128134
   WHITTINGTON MA, 1995, NAT GENET, V9, P197, DOI 10.1038/ng0295-197
   Wishart HA, 2006, AM J PSYCHIAT, V163, P1603, DOI 10.1176/appi.ajp.163.9.1603
NR 77
TC 8
Z9 8
U1 0
U2 7
PU PERGAMON-ELSEVIER SCIENCE LTD
PI OXFORD
PA THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND
SN 0028-3932
J9 NEUROPSYCHOLOGIA
JI Neuropsychologia
PY 2008
VL 46
IS 9
BP 2389
EP 2402
DI 10.1016/j.neuropsychologia.2008.03.002
PG 14
WC Behavioral Sciences; Neurosciences; Psychology, Experimental
SC Behavioral Sciences; Neurosciences & Neurology; Psychology
GA 326EP
UT WOS:000257641400013
PM 18423780
DA 2021-01-25
ER

PT J
AU Matsumoto, T
   Rauskolb, S
   Dieni, S
   Frotscher, M
   Barde, YA
AF Matsumoto, Tomoya
   Rauskolb, Stefanie
   Dieni, Sandra
   Frotscher, Michael
   Barde, Yves-Alain
TI Biosynthesis and localization of endogenous BDNF in CNS neurons
SO NEUROSCIENCE RESEARCH
LA English
DT Meeting Abstract
C1 [Matsumoto, Tomoya; Rauskolb, Stefanie; Barde, Yves-Alain] Univ Basel, Biozentrum, Dept Neurobiol, Basel, Switzerland.
   [Dieni, Sandra; Frotscher, Michael] Univ Freiburg, Inst Anat & Cell Biol, Freiburg, Germany.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU ELSEVIER IRELAND LTD
PI CLARE
PA ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000,
   IRELAND
SN 0168-0102
J9 NEUROSCI RES
JI Neurosci. Res.
PY 2008
VL 61
BP S15
EP S15
PG 1
WC Neurosciences
SC Neurosciences & Neurology
GA 381PJ
UT WOS:000261548100087
DA 2021-01-25
ER

PT J
AU Wyniger, D
   Burckhardt, D
   Muhlethaler, R
   Mathys, D
AF Wyniger, D.
   Burckhardt, D.
   Muehlethaler, R.
   Mathys, D.
TI Documentation of brochosomes within Hemiptera, with emphasis on
   Heteroptera (Insecta)
SO ZOOLOGISCHER ANZEIGER
LA English
DT Article
DE Brochosomes; Hemiptera; Heteroptera; Miridae
ID CICADELLIDAE; LEAFHOPPERS; BIOAEROSOLS; PROCONIINI; HOMOPTERA; CUTICLE
AB Brochosomes, small secretory particles often found in abundance of the integument of leafhoppers, are currently considered a unique feature of the family Cicadellidae. The present work documents, for the first time, brochosomes in two other groups of Hemiptera, i.e. Psylloidea and Heteroptera. In Heteroptera the occurrence of relatively large amounts of brochosomes on various body parts is documented in several species of different families. Morphological structures of the legs and the setation are illustrated in detail and compared to those of Cicadellidae. The results are based on scanning electron microscopy (SEM) examination of museum specimens. The possible function of brochosomes within Hemiptera is briefly discussed. (C) 2008 Elsevier GmbH. All rights reserved.
C1 [Wyniger, D.] Amer Museum Nat Hist, Div Invertebrate Zool, New York, NY 10024 USA.
   [Burckhardt, D.; Muehlethaler, R.] Nat Hist Museum Basel, Abt Biowissensch, CH-4001 Basel, Switzerland.
   [Mathys, D.] Univ Basel, Zentrum Mikroskopie, Biozentrum, Pharmazentrum, CH-4056 Basel, Switzerland.
RP Wyniger, D (corresponding author), Natur Museum, Kasernenpl 6, CH-6003 Luzern, Switzerland.
EM Denise.Wyniger@lu.ch
OI Muhlethaler, Roland/0000-0003-3858-4171
CR Arzone A., 1986, Atti della Accademia Nazionale Italiana di Entomologia Rendiconti, V34, P59
   Bigg EK, 2003, ATMOS RES, V66, P141, DOI 10.1016/S0169-8095(02)00156-4
   DAY MF, 1958, J ULTRA MOL STRUCT R, V2, P239, DOI 10.1016/S0022-5320(58)90021-2
   DAY MF, 1993, P 8 AUCH C DELPH GRE, P1011
   de Azevedo WS, 2005, NEOTROP ENTOMOL, V34, P387, DOI 10.1590/S1519-566X2005000300005
   GOURANTON J, 1967, J MICROSC-PARIS, V6, P53
   GOURANTON J, 1966, C R SOC BIOL, V8, P1725
   Grimaldi David, 2005, pi
   Gunthart H., 1977, Mitteilungen der Schweizerischen Entomologischen Gessellschaft, V50, P189
   Hix R. L., 2001, California Agriculture, V55, P19, DOI 10.3733/ca.v055n04p19
   Humphrey Elaine C., 2002, Denisia, V4, P433
   KULLENBERG B, 1944, ZOOL BIDR UPPSALA, V23
   Mayse M. A., 1981, Proceedings of the Arkansas Academy of Science, V35, P84
   Navone P., 1987, Annali della Facolta di Scienze Agrarie della Universita degli Studi di Torino, V14, P237
   NEVILLE AC, 1970, NATURE, V225, P199, DOI 10.1038/225199b0
   Rakitov R.A., 1998, RUSSIAN ENTOMOLOGICA, V6, P7
   RAKITOV RA, 1992, ZOOL ZH, V71, P49
   Rakitov RA, 2005, ANN ENTOMOL SOC AM, V98, P444, DOI 10.1603/0013-8746(2005)098[0444:NESHCP]2.0.CO;2
   Rakitov RA, 1996, EUR J ENTOMOL, V93, P167
   Rakitov RA, 2004, ZOOL J LINN SOC-LOND, V140, P353, DOI 10.1111/j.1096-3642.2003.00103.x
   RAKITOV RA, 1995, ZOOL ZH, V74, P19
   Rakitov RA, 1999, INT J INSECT MORPHOL, V28, P179, DOI 10.1016/S0020-7322(99)00023-9
   Rakitov RA, 2000, TISSUE CELL, V32, P28, DOI 10.1054/tice.1999.0084
   Rakitov RA, 2000, J NEW YORK ENTOMOL S, V108, P171, DOI 10.1664/0028-7199(2000)108[0171:NBAABO]2.0.CO;2
   Rakitov Roman, 2002, Denisia, V4, P411
   Schuh R. T., 2004, AM MUS NOVIT, V3436, P36
   Schuh R. T., 2004, AM MUS NOVIT, V3463, P58
   Schuh R.T., 1995, TRUE BUGS WORLD HEMI
   SCHUH RT, 2000, AM MUS NOVIT, P44
   SCHUH RT, 2005, AM MUS NOVIT, P55
   SCHUH RT, 2006, B AM MUS NAT HIST, V301, P115
   SCHWARTZ MD, 2005, AM MUS NOVIT, P23
   SCHWARTZ MD, 2004, AM MUS NOVIT, P55
   SMITH DS, 1960, J BIOPHYS BIOCHEM CY, V8, P103, DOI 10.1083/jcb.8.1.103
   STONEDAHL G, 1990, B AM MUS NAT HIST, V198, P88
   Swain R. B., 1936, Entomological News Philadelphia, V47, P264
   Tulloch G. S., 1953, Bulletin of the Brooklyn Entomological Society, V48, P57
   TULLOCH G. S., 1952, BULL BROOKLYN ENT SOC, V47, P41
   TULLOCH GS, 1954, SCIENCE, V120, P232, DOI 10.1126/science.120.3110.232
   Vidano C., 1984, MITT SCHWEIZ ENTOMOL, V57, P444
   WIFFEN RD, 1969, NATURE, V224, P715, DOI 10.1038/224715a0
   WILDE HA, 1956, P ENTOMOL SOC BRIT C, V53, P19
   Wittmaack K, 2005, ATMOS ENVIRON, V39, P1173, DOI 10.1016/j.atmosenv.2004.11.003
   Wittmaack K, 2005, SCI TOTAL ENVIRON, V346, P244, DOI 10.1016/j.scitotenv.2004.11.009
   WYGODZINSKY PW, 1991, B AM MUS NAT HIST, V200, P265
NR 45
TC 6
Z9 7
U1 1
U2 10
PU ELSEVIER GMBH
PI MUNICH
PA HACKERBRUCKE 6, 80335 MUNICH, GERMANY
SN 0044-5231
J9 ZOOL ANZ
JI Zool. Anz.
PY 2008
VL 247
IS 4
BP 329
EP 341
DI 10.1016/j.jcz.2008.07.001
PG 13
WC Zoology
SC Zoology
GA 365MG
UT WOS:000260410100006
DA 2021-01-25
ER

PT J
AU Stephens, C
   Christen, B
   Watanabe, K
   Fuchs, T
   Jenal, U
AF Stephens, Craig
   Christen, Beat
   Watanabe, Kelly
   Fuchs, Thomas
   Jenal, Urs
TI Regulation of D-xylose metabolism in Caulobacter crescentus by a
   LacI-type repressor
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID CELL-CYCLE PROGRESSION; PROTEASE COMPLEX; GENOME SEQUENCE; DNA;
   PROMOTER; PATHWAY; PROTEINS; BACILLUS; GLUCOSE; GROWTH
AB In the oligotrophic freshwater bacterium Caulobacter crescentus, D-xylose induces expression of over 50 genes, including the xyl operon, which encodes key enzymes for xylose metabolism. The promoter (P-xylX) controlling expression of the xyl operon is widely used as a tool for inducible heterologous gene expression in C. crescentus. We show here that P-xylX and at least one other promoter in the xylose regulon are controlled by the CC3065 (xylR) gene product, a LacI-type repressor. Electrophoretic gel mobility shift assays showed that operator binding by XylR is greatly reduced in the presence of D-xylose. The data support the hypothesis that there is a simple regulatory mechanism in which XylR obstructs xylose-inducible promoters in the absence of the sugar; the repressor is induced to release DNA upon binding D-xylose, thereby freeing the promoter for productive interaction with RNA polymerase. XylR also has an effect on glucose metabolism, as xylR mutants exhibit reduced expression of the Entner-Doudoroff operon and their ability to utilize glucose as a sole carbon and energy source is compromised.
C1 [Stephens, Craig; Watanabe, Kelly] Santa Clara Univ, Dept Biol, Santa Clara, CA 95053 USA.
   [Christen, Beat; Fuchs, Thomas; Jenal, Urs] Univ Basel, Biozentrum, CH-4054 Basel, Switzerland.
RP Stephens, C (corresponding author), Santa Clara Univ, Dept Biol, 500 El Camino Real, Santa Clara, CA 95053 USA.
EM CStephens@scu.edu
RI Christen, Beat/AAC-2974-2021
OI Christen, Beat/0000-0002-9528-3685
CR Biondi EG, 2006, MOL MICROBIOL, V59, P386, DOI 10.1111/j.1365-2958.2005.04970.x
   Brouns SJJ, 2006, J BIOL CHEM, V281, P27378, DOI 10.1074/jbc.M605549200
   DAHL MK, 1995, J BACTERIOL, V177, P5467, DOI 10.1128/jb.177.19.5467-5472.1995
   DAVIS EO, 1987, J BIOL CHEM, V262, P13928
   DELORENZO V, 1990, J BACTERIOL, V172, P6568, DOI 10.1128/jb.172.11.6568-6572.1990
   ELY B, 1991, METHOD ENZYMOL, V204, P372
   FRIEDMAN AM, 1995, SCIENCE, V268, P1721, DOI 10.1126/science.7792597
   GARTNER D, 1992, MOL GEN GENET, V232, P415
   Hottes AK, 2004, J BACTERIOL, V186, P1448, DOI 10.1128/JB.186.5.1448-1461.2004
   Iniesta AA, 2006, P NATL ACAD SCI USA, V103, P10935, DOI 10.1073/pnas.0604554103
   JACOB F, 1961, J MOL BIOL, V3, P318, DOI 10.1016/S0022-2836(61)80072-7
   Jenal U, 1998, EMBO J, V17, P5658, DOI 10.1093/emboj/17.19.5658
   Laikova ON, 2001, FEMS MICROBIOL LETT, V205, P315, DOI 10.1016/S0378-1097(01)00495-5
   Mannisto MK, 1999, ARCH MICROBIOL, V171, P189, DOI 10.1007/s002030050698
   McGrath PT, 2006, CELL, V124, P535, DOI 10.1016/j.cell.2005.12.033
   Meisenzahl AC, 1997, J BACTERIOL, V179, P592, DOI 10.1128/jb.179.3.592-600.1997
   MOSSING MC, 1986, SCIENCE, V233, P889, DOI 10.1126/science.3090685
   Nierman WC, 2001, P NATL ACAD SCI USA, V98, P4136, DOI 10.1073/pnas.061029298
   POINDEXTER JS, 1964, BACTERIOL REV, V28, P231, DOI 10.1128/MMBR.28.3.231-295.1964
   Quon KC, 1996, CELL, V84, P83, DOI 10.1016/S0092-8674(00)80995-2
   Sambrook J, 1989, MOL CLONING LABORATO
   Schmiedel D, 1996, MOL GEN GENET, V250, P259
   Song SG, 1997, J BACTERIOL, V179, P7025, DOI 10.1128/jb.179.22.7025-7032.1997
   Stephens C, 1996, P NATL ACAD SCI USA, V93, P1210, DOI 10.1073/pnas.93.3.1210
   Stephens C, 2007, J BACTERIOL, V189, P2181, DOI 10.1128/JB.01438-06
   Tsai JW, 2001, J BACTERIOL, V183, P5001, DOI 10.1128/JB.183.17.5001-5007.2001
   West L, 2002, J BACTERIOL, V184, P2155, DOI 10.1128/JB.184.8.2155-2166.2002
NR 27
TC 27
Z9 28
U1 0
U2 5
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD DEC
PY 2007
VL 189
IS 24
BP 8828
EP 8834
DI 10.1128/JB.01342-07
PG 7
WC Microbiology
SC Microbiology
GA 246FL
UT WOS:000251992800008
PM 17933895
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Thone, F
   Schwanhausser, B
   Becker, D
   Ballmaier, M
   Burnann, D
AF Thoene, Friedenike
   Schwanhaeusser, Bjoern
   Becker, Daniel
   Ballmaier, Matthias
   Burnann, Dirk
TI FACS-isolation of Salmonella-infected cells with defined bacterial load
   from mouse spleen
SO JOURNAL OF MICROBIOLOGICAL METHODS
LA English
DT Article
DE flow cytometry; Salmonella; green flourescent protein
ID GENE-EXPRESSION; TYPHIMURIUM; PATHOGEN; DYNAMICS; SUBSETS
AB Salmonella can cause a typhoid fever like disease in genetically susceptible mice. In contrast to in vitro cell culture models, most host cells in infected tissues contain only one or two Salmonella, but a small subpopulation of infected host cells contains many Salmonella. It has been proposed that these various subpopulations have differential relevance during infection but to test this, methods for isolating such Salmonella will be required. We developed a method to purify differentially infected host cells by flow cytometry using Salmonella expressing the green fluorescent protein (GFP). Critical parameters for this method were sufficient GFP expression to detect infected cells against strong host cell autofluorescence, and low variation in GFP content of individual Salmonella. We evaluated more than hundred different GFP-constructs but only one single-copy chromosomal P-sifB-gfp fusion met these criteria and enabled differentiation of weakly and highly infected cells based on total GFP fluorescence. Confocal microscopy of sorted cells confirmed the successful separation of these subpopulations. In addition to isolation of infected cells, our method also enabled enumeration of the subpopulations and phenotypic characterization by staining with antibodies to surface markers. surprisingly, a small subpopulation of highly infected host cells contained the majority of Salmonella but based on MHC II and ICAM I expression, this subpopulation was not more strongly activated than weakly infected cells. Our method will facilitate future characterization of the different subpopulations and the identification of bacterial and host factors that control Salmonella load and proliferation in vivo. (c) 2007 Elsevier B.V. All rights reserved.
C1 [Burnann, Dirk] Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
   [Thoene, Friedenike; Burnann, Dirk] Hannover Med Sch, Junior Res Grp Mucosal Infect, D-30625 Hannover, Germany.
   [Schwanhaeusser, Bjoern; Becker, Daniel; Burnann, Dirk] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany.
   [Ballmaier, Matthias] Hannover Med Sch, Core Fac Flow Cytometry, D-30652 Hannover, Germany.
RP Burnann, D (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Dirk.Bumann@unibas.ch
RI Ballmaier, Matthias/J-4175-2014
OI Ballmaier, Matthias/0000-0002-1352-5995
CR Becker D, 2006, NATURE, V440, P303, DOI 10.1038/nature04616
   Brown SP, 2006, PLOS BIOL, V4, P2091, DOI 10.1371/journal.pbio.0040349
   Bumann D, 2002, MOL MICROBIOL, V43, P1269, DOI 10.1046/j.1365-2958.2002.02821.x
   HOISETH SK, 1981, NATURE, V291, P238, DOI 10.1038/291238a0
   Kalupahana RS, 2005, IMMUNOLOGY, V115, P462, DOI 10.1111/j.1365-2567.2005.02180.x
   Rollenhagen C, 2006, INFECT IMMUN, V74, P1649, DOI 10.1128/IAI.74.3.1649-1660.2006
   Rollenhagen C, 2004, P NATL ACAD SCI USA, V101, P8739, DOI 10.1073/pnas.0401283101
   Ruiz-Albert J, 2002, MOL MICROBIOL, V44, P645, DOI 10.1046/j.1365-2958.2002.02912.x
   Salcedo SP, 2001, CELL MICROBIOL, V3, P587, DOI 10.1046/j.1462-5822.2001.00137.x
   Santos RL, 2001, MICROBES INFECT, V3, P1335, DOI 10.1016/S1286-4579(01)01495-2
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Sheppard M, 2003, CELL MICROBIOL, V5, P593, DOI 10.1046/j.1462-5822.2003.00296.x
   Wendland M, 2002, FEBS LETT, V521, P105, DOI 10.1016/S0014-5793(02)02834-X
   Yrlid U, 2002, J IMMUNOL, V169, P108, DOI 10.4049/jimmunol.169.1.108
NR 14
TC 14
Z9 14
U1 0
U2 5
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 0167-7012
J9 J MICROBIOL METH
JI J. Microbiol. Methods
PD DEC
PY 2007
VL 71
IS 3
BP 220
EP 224
DI 10.1016/j.mimet.2007.08.016
PG 5
WC Biochemical Research Methods; Microbiology
SC Biochemistry & Molecular Biology; Microbiology
GA 247LI
UT WOS:000252080300006
PM 17931727
DA 2021-01-25
ER

PT J
AU Nicholson, JR
   Peter, JC
   Lecourt, AC
   Barde, YA
   Hofbauer, KG
AF Nicholson, J. R.
   Peter, J. -C.
   Lecourt, A. -C.
   Barde, Y. -A.
   Hofbauer, K. G.
TI Melanocortin-4 receptor activation stimulates hypothalamic brain-derived
   neurotrophic factor release to regulate food intake, body temperature
   and cardiovascular function
SO JOURNAL OF NEUROENDOCRINOLOGY
LA English
DT Article
DE antibody; body weight; neurotrophin; blood pressure; heart rate
ID BROWN ADIPOSE-TISSUE; NERVOUS-SYSTEM; VENTROMEDIAL HYPOTHALAMUS; SEVERE
   OBESITY; FACTOR BDNF; RATS; AGONIST; GENE; CHOLECYSTOKININ; WEIGHT
AB In the present study, we aimed to investigate the neuromodulatory role played by hypothalamic brain-derived neurotrophic factor (BDNF) in the regulation of acute cardiovascular and feeding responses to melanocortin-4 receptor (MC4R) activation. In vitro, a selective MC4R agonist, MK1, stimulated BDNF release from isolated rat hypothalami and this effect was blocked by preincubation with the MC3/4R antagonist SHU-9119. In vivo, peripheral administration of MK1 decreased food intake in rats and this effect was blocked by pretreatment with an anti-BDNF antibody administered into the third ventricle. When anorexia was induced with the cannabinoid-1 receptor (CB1R) antagonist AM251, the anti-BDNF antibody did not prevent the reduction in food intake. Peripheral administration of MK1 also increased mean arterial pressure, heart rate and body temperature. These effects were prevented by pretreatment with the anti-BDNF antibody whereas the intracerebroventricular administration of BDNF caused changes similar to those of MK1. These findings demonstrate for the first time that activation of MC4R leads to an acute release of BDNF in the hypothalamus. This release is a prerequisite for MC4R-induced effects on appetite, body temperature and cardiovascular function. By contrast, CB1R antagonist-mediated anorexia is independent of the MC4R/BDNF pathway. Overall, these results show that BDNF is an important downstream mediator of the MC4R pathway.
C1 Univ Basel, Chair Appl Pharmacol, CH-4056 Basel, Switzerland.
   Univ Basel, Chair Focal Area Neurobiol, CH-4056 Basel, Switzerland.
   Univ Basel, Chair Biozentrum, CH-4056 Basel, Switzerland.
RP Hofbauer, KG (corresponding author), Univ Basel, Chair Appl Pharmacol, 50-70 Klingelbergstr, CH-4056 Basel, Switzerland.
EM karl.hofbauer@unibas.ch
RI Barde, Yves/F-6019-2011
OI Barde, Yves/0000-0002-7627-461X
CR Balkowiec A, 2002, J NEUROSCI, V22, P10399
   Bamshad M, 1999, AM J PHYSIOL-REG I, V276, pR1569
   Bard F, 2000, NAT MED, V6, P916, DOI 10.1038/78682
   Bariohay B, 2005, ENDOCRINOLOGY, V146, P5612, DOI 10.1210/en.2005-0419
   Cettour-Rose P, 2002, ENDOCRINOLOGY, V143, P2277, DOI 10.1210/en.143.6.2277
   Chambers AP, 2006, BRIT J PHARMACOL, V147, P109, DOI 10.1038/sj.bjp.0706439
   Fan W, 2004, NAT NEUROSCI, V7, P335, DOI 10.1038/nn1214
   Farooqi IS, 2003, NEW ENGL J MED, V348, P1085, DOI 10.1056/NEJMoa022050
   Gray J, 2006, DIABETES, V55, P3366, DOI 10.2337/db06-0550
   Hill C, 2002, PEPTIDES, V23, P1625, DOI 10.1016/S0196-9781(02)00103-1
   Huszar D, 1997, CELL, V88, P131, DOI 10.1016/S0092-8674(00)81865-6
   King BA, 2006, PHYSIOL BEHAV, V87, P221, DOI 10.1016/j.physbeh.2005.10.007
   Kolbeck R, 1999, J NEUROCHEM, V72, P1930, DOI 10.1046/j.1471-4159.1999.0721930.x
   Komori T, 2006, NEUROSCIENCE, V139, P1107, DOI 10.1016/j.neuroscience.2005.12.066
   Kramer K, 2003, PHYSIOL GENOMICS, V13, P197, DOI 10.1152/physiolgenomics.00164.2002
   Lebrun B, 2006, AUTON NEUROSCI-BASIC, V126, P30, DOI 10.1016/j.autneu.2006.02.027
   MOUNTJOY KG, 1994, MOL ENDOCRINOL, V8, P1298, DOI 10.1210/me.8.10.1298
   Murphy B, 2000, J APPL PHYSIOL, V89, P273
   Naert G, 2006, NEUROSCIENCE, V139, P779, DOI 10.1016/j.neuroscience.2005.12.028
   Ni XP, 2006, J HYPERTENS, V24, P2239, DOI 10.1097/01.hjh.0000249702.49854.fa
   Nordheim U, 2006, PEPTIDES, V27, P438, DOI 10.1016/j.peptides.2005.01.026
   Osei-Hyiaman D, 2006, INT J OBESITY, V30, pS33, DOI 10.1038/sj.ijo.0803276
   RAIBLE LH, 1993, PHARMACOL BIOCHEM BE, V44, P533, DOI 10.1016/0091-3057(93)90163-N
   Rios M, 2001, MOL ENDOCRINOL, V15, P1748, DOI 10.1210/me.15.10.1748
   Sebhat IK, 2002, J MED CHEM, V45, P4589, DOI 10.1021/jm025539h
   Shinyama H, 2003, ENDOCRINOLOGY, V144, P1301, DOI 10.1210/en.2002-220931
   SINNAYAH P, 2006, APPETITE, V46, P337
   Tsuchida A, 2001, INT J OBESITY, V25, P1286, DOI 10.1038/sj.ijo.0801678
   Verty ANA, 2004, NEUROPHARMACOLOGY, V47, P593, DOI 10.1016/j.neuropharm.2004.06.002
   WANG C, 2007, AM J PHYSL REGUL INT
   Wang H, 2002, NEUROSCIENCE, V112, P967, DOI 10.1016/S0306-4522(02)00085-4
   Xu BJ, 2003, NAT NEUROSCI, V6, P736, DOI 10.1038/nn1073
   Yang B, 2002, NAT NEUROSCI, V5, P539, DOI 10.1038/nn853
   Yeo GSH, 2004, NAT NEUROSCI, V7, P1187, DOI 10.1038/nn1336
   YOSHIMATSU H, 1993, BRAIN RES, V601, P121, DOI 10.1016/0006-8993(93)91702-T
   YOSHIMATSU H, 1992, BRAIN RES, V597, P298, DOI 10.1016/0006-8993(92)91486-X
NR 36
TC 56
Z9 56
U1 0
U2 2
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 0953-8194
J9 J NEUROENDOCRINOL
JI J. Neuroendocrinol.
PD DEC
PY 2007
VL 19
IS 12
BP 974
EP 982
DI 10.1111/j.1365-2826.2007.01610.x
PG 9
WC Endocrinology & Metabolism; Neurosciences
SC Endocrinology & Metabolism; Neurosciences & Neurology
GA 231JR
UT WOS:000250943500006
PM 18001327
DA 2021-01-25
ER

PT J
AU Knechtle, B
   Kohler, G
AF Knechtle, Beat
   Kohler, Goetz
TI Running 338 kilometres within five days has no effect on body mass and
   body fat but reduces skeletal muscle mass - the Isarrun 2006
SO JOURNAL OF SPORTS SCIENCE AND MEDICINE
LA English
DT Article
DE body composition; anthropometry; ultra-running; stage race; fat mass;
   ultra-endurance
ID SIMPLE ANTHROPOMETRIC MEASUREMENTS; EXTREME ENDURANCE RUN; IRONMAN
   TRIATHLON; WEIGHT CHANGES; HYDRATION STATUS; ULTRA-TRIATHLON;
   ADIPOSE-TISSUE; ENERGY-BALANCE; RACE; PERFORMANCE
AB We investigated the change of body composition in ultra-endurance runners during a multi-stage ultra-endurance run, the Isarrun 2006 in Bavaria, Germany, where athletes had to run 338 km within 5 days. Body mass, skin fold thicknesses and circumferences of extremities were measured in 21 well-experienced extreme endurance male runners (mean +/- SD, 41.5 +/- 6.9 years, 72.6 +/- 6.4 kg, 178 +/- 5 cm, BMI 23.0 +/- 2.0 kg . m(-2)), who finished mainly within the first half of the ranking, in order to calculate skeletal muscle mass and body fat mass to prove changes after the race. Body mass and calculated fat mass did not change significantly (p > 0.05), but, calculated skeletal muscle mass decreased significantly (p < 0.05) by 0.63 +/- 0.79 kg by the end of the race. The most apparent decline (p < 0.01) of the calculated skeletal muscle mass was during the first stage, and no changes were observed during the last 4 stages. We conclude, that a multi-stage ultra-endurance run over 338 km within 5 days leads to no changes of body mass or body fat mass, but a statistically significant decrease of skeletal muscle mass of 0.63 +/- 0.79 kg by the end of the race in well-trained and well-experienced ultra-endurance runners. The change of skeletal muscle mass has to be evaluated in further studies at ultra-endurance races with suitable methods to detect changes in hydration status and water metabolism.
C1 [Knechtle, Beat] Gesundheitszentrum St Gallen, Facharzt FMH Allgemeinmed, CH-9001 St Gallen, Switzerland.
   [Kohler, Goetz] Univ Basel, Biozentrum, Div Biophys Chem, CH-4003 Basel, Switzerland.
RP Knechtle, B (corresponding author), Gesundheitszentrum St Gallen, Facharzt FMH Allgemeinmed, Vadianstr 26, CH-9001 St Gallen, Switzerland.
EM beat.knechtle@hispeed.ch; goetz.kohler@unibas.ch
CR ASTRAND P, 1964, J APPL PHYSIOL, V19, P829
   Ball SD, 2004, EUR J CLIN NUTR, V58, P1525, DOI 10.1038/sj.ejcn.1602003
   Bircher S, 2006, J SPORT SCI MED, V5, P154
   Bonora E, 1995, METABOLISM, V44, P1617, DOI 10.1016/0026-0495(95)90084-5
   Boschmann M, 2002, INT J SPORTS MED, V23, P537, DOI 10.1055/s-2002-35527
   BRODIE DA, 1988, SPORTS MED, V5, P11, DOI 10.2165/00007256-198805010-00003
   Chan YL, 1998, J PAEDIATR CHILD H, V34, P22, DOI 10.1046/j.1440-1754.1998.00147.x
   Cox C, 2003, INT J SPORT NUTR EXE, V13, P286, DOI 10.1123/ijsnem.13.3.286
   DAVIDSON RJL, 1987, INT J SPORTS MED, V8, P19, DOI 10.1055/s-2008-1025634
   DRESSENDORFER RH, 1991, MED SCI SPORT EXER, V23, P954
   Eisenmann JC, 2002, ANN HUM BIOL, V29, P389, DOI 10.1080/03014460110092252
   Fournier PE, 1997, INT J SPORTS MED, V18, P252, DOI 10.1055/s-2007-972629
   Frykman PN, 2003, WILD ENVIRON MED, V14, P240, DOI 10.1580/1080-6032(2003)14[240:EOAMEE]2.0.CO;2
   Gastmann U, 1998, J SPORT MED PHYS FIT, V38, P18
   Helge JW, 2003, J EXP BIOL, V206, P1075, DOI 10.1242/jeb.00218
   HILDRETH HG, 1997, AM J CLIN NUTR, V66, P1435
   HOCHLI D, 1995, INT J SPORTS MED, V16, P343, DOI 10.1055/s-2007-973017
   HOUSH DJ, 1995, MED SCI SPORT EXER, V27, P784
   Housh TJ, 1996, MED SCI SPORT EXER, V28, P1331, DOI 10.1097/00005768-199610000-00019
   Kavouras SA, 2002, CURR OPIN CLIN NUTR, V5, P519, DOI 10.1097/00075197-200209000-00010
   Kimber NE, 2002, INT J SPORT NUTR EXE, V12, P47, DOI 10.1123/ijsnem.12.1.47
   Knechtle B, 2005, Praxis (Bern 1994), V94, P371
   Knechtle B, 2005, INT J SPORTS MED, V26, P499, DOI 10.1055/s-2004-821136
   Kuriyan R, 2004, INDIAN J MED RES, V119, P121
   Laursen PB, 2006, BRIT J SPORT MED, V40, P320, DOI 10.1136/bjsm.2005.022426
   Lean MEJ, 1996, AM J CLIN NUTR, V63, P4
   Lee RC, 2000, AM J CLIN NUTR, V72, P796
   LEHMANN M, 1995, INT J SPORTS MED, V16, P155, DOI 10.1055/s-2007-972984
   Lindemann R, 1978, Am Correct Ther J, V32, P107
   NAGEL D, 1989, EUR J APPL PHYSIOL O, V59, P16, DOI 10.1007/BF02396574
   PESTELL RG, 1989, CLIN EXPT PHARM PHYS, V15, P353
   R Development Core Team, 2005, R LANG ENV STAT COMP
   Raschka C, 1995, Sportverletz Sportschaden, V9, P123, DOI 10.1055/s-2007-993439
   Raschka C, 1992, Schweiz Z Sportmed, V40, P13
   RASCHKA C, 1991, Z ERNAHRUNGSWISS, V30, P276, DOI 10.1007/BF01651957
   REFSUM HE, 1973, SCAND J CLIN LAB INV, V32, P117, DOI 10.3109/00365517309084338
   Reynolds RD, 1999, J NUTR, V129, P1307
   SCAVO D, 1991, J SPORTS MED PHYS FI, V31, P201
   Sharwood K, 2002, CLIN J SPORT MED, V12, P391, DOI 10.1097/00042752-200211000-00012
   Sharwood KA, 2004, BRIT J SPORT MED, V38, P718, DOI 10.1136/bjsm.2003.007187
   Speedy DB, 2001, CLIN J SPORT MED, V11, P44, DOI 10.1097/00042752-200101000-00008
   Speedy DB, 1997, CLIN J SPORT MED, V7, P100, DOI 10.1097/00042752-199704000-00005
   Vaananen II, 2005, J SPORT MED PHYS FIT, V45, P301
   Volk O, 2001, DEUT Z SPORTMED, V52, P169
   VOLK O, 1998, SCHWEIZERISCHE Z SPO, V46, P67
   VOLK O, 2001, OSTERREICHISCHES J S, V3, P22
   WALSH RM, 1994, INT J SPORTS MED, V15, P392, DOI 10.1055/s-2007-1021076
   WELLS CL, 1987, MED SCI SPORT EXER, V19, P137
   WHITING PH, 1984, EUR J APPL PHYSIOL O, V52, P183, DOI 10.1007/BF00433390
   Wu HJ, 2004, WORLD J GASTROENTERO, V10, P2711, DOI 10.3748/wjg.v10.i18.2711
NR 50
TC 42
Z9 42
U1 0
U2 2
PU JOURNAL SPORTS SCIENCE & MEDICINE
PI BURSA
PA MEDICAL FACULTY ULUDAG UNIV, DEPT SPORTS MEDICINE, BURSA, 16059, TURKEY
SN 1303-2968
J9 J SPORT SCI MED
JI J. Sport. Sci. Med.
PD DEC
PY 2007
VL 6
IS 4
BP 401
EP 407
PG 7
WC Sport Sciences
SC Sport Sciences
GA 259EG
UT WOS:000252921300003
PM 24149470
OA DOAJ Gold
DA 2021-01-25
ER

PT J
AU Saenz, HL
   Engel, P
   Stoeckli, MC
   Lanz, C
   Raddatz, G
   Vayssier-Taussat, M
   Birtles, R
   Schuster, SC
   Dehio, C
AF Saenz, Henri L.
   Engel, Philipp
   Stoeckli, Michele C.
   Lanz, Christa
   Raddatz, Gunter
   Vayssier-Taussat, Muriel
   Birtles, Richard
   Schuster, Stephan C.
   Dehio, Christoph
TI Genomic analysis of Bartonella identifies type IV secretion systems as
   host adaptability factors
SO NATURE GENETICS
LA English
DT Article
ID PATHOGEN BARTONELLA; NEGATIVE SELECTION; SEQUENCE ALIGNMENT; GENUS
   BARTONELLA; BACILLIFORMIS; ERYTHROCYTES; TRANSPOSASE; STRATEGY;
   HENSELAE; HISTORY
AB The bacterial genus Bartonella comprises 21 pathogens causing characteristic intraerythrocytic infections. Bartonella bacilliformis is a severe pathogen representing an ancestral lineage, whereas the other species are benign pathogens that evolved by radial speciation. Here, we have used comparative and functional genomics to infer pathogenicity genes specific to the radiating lineage, and we suggest that these genes may have facilitated adaptation to the host environment. We determined the complete genome sequence of Bartonella tribocorum by shotgun sequencing and functionally identified 97 pathogenicity genes by signature-tagged mutagenesis. Eighty-one pathogenicity genes belong to the core genome ( 1,097 genes) of the radiating lineage inferred from genome comparison of B. tribocorum, Bartonella henselae and Bartonella quintana. Sixty-six pathogenicity genes are present in B. bacilliformis, and one has been lost by deletion. The 14 pathogenicity genes specific for the radiating lineage encode two laterally acquired type IV secretion systems, suggesting that these systems have a role in host adaptability.
C1 Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
   Max Planck Inst Dev Biol, D-72076 Tubingen, Germany.
   Ecol Natl Vet Alfort, INRA, Unite Biol Mol Immunol Parasitaire Fongique, F-94700 Maisons Alfort, France.
   Univ Liverpool, Fac Vet Sci, Dept Vet Pathol, Liverpool L69 7LB, Merseyside, England.
   Penn State Univ, Ctr Infect Dis Dynam, Ctr Comparat Genom & Bioinformat, University Pk, PA 16802 USA.
RP Schuster, SC (corresponding author), Univ Basel, Biozentrum, Focal Area Infect Biol, CH-4056 Basel, Switzerland.
EM scs@bx.psu.edu; christoph.dehio@unibas.ch
RI Engel, Philipp/N-1788-2015; Dehio, Christoph/AAD-5572-2019; Dehio,
   Christoph/R-8277-2016
OI Engel, Philipp/0000-0002-4678-6200; Dehio,
   Christoph/0000-0001-7288-1052; Dehio, Christoph/0000-0001-7288-1052;
   Birtles, Richard/0000-0002-4216-5044; Saenz, Henri/0000-0001-7536-7817
CR Alsmark CM, 2004, P NATL ACAD SCI USA, V101, P9716, DOI 10.1073/pnas.0305659101
   Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008
   Birtles RJ, 1996, INT J SYST BACTERIOL, V46, P891, DOI 10.1099/00207713-46-4-891
   Birtles RJ, 2002, J CLIN MICROBIOL, V40, P3606, DOI 10.1128/JCM.40.10.3606-3612.2002
   Carver TJ, 2005, BIOINFORMATICS, V21, P3422, DOI 10.1093/bioinformatics/bti553
   Cascales E, 2003, NAT REV MICROBIOL, V1, P137, DOI 10.1038/nrmicro753
   Dehio C, 2004, ANNU REV MICROBIOL, V58, P365, DOI 10.1146/annurev.micro.58.030603.123700
   Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P2369, DOI 10.1093/nar/27.11.2369
   Eppinger M, 2006, PLOS GENET, V2, P1097, DOI 10.1371/journal.pgen.0020120
   Ewing B, 1998, GENOME RES, V8, P186, DOI 10.1101/gr.8.3.186
   Ewing B, 1998, GENOME RES, V8, P175, DOI 10.1101/gr.8.3.175
   FLEISCHMANN RD, 1995, SCIENCE, V269, P496, DOI 10.1126/science.7542800
   Gordon D, 1998, GENOME RES, V8, P195, DOI 10.1101/gr.8.3.195
   Halling SM, 2005, J BACTERIOL, V187, P2715, DOI 10.1128/JB.187.8.2715-2726.2005
   Heller R, 1998, INT J SYST BACTERIOL, V48, P1333, DOI 10.1099/00207713-48-4-1333
   HENSEL M, 1995, SCIENCE, V269, P400, DOI 10.1126/science.7618105
   Horn M, 2004, SCIENCE, V304, P728, DOI 10.1126/science.1096330
   Houpikian P, 2001, FEMS MICROBIOL LETT, V200, P1, DOI 10.1111/j.1574-6968.2001.tb10684.x
   Ihler GM, 1996, FEMS MICROBIOL LETT, V144, P1, DOI [10.1016/0378-1097(96)00307-2, 10.1111/j.1574-6968.1996.tb08501.x]
   Jacomo V, 2002, CLIN DIAGN LAB IMMUN, V9, P8, DOI 10.1128/CDLI.9.1.8-18.2002
   Kaneko T, 2002, DNA RES, V9, P189, DOI 10.1093/dnares/9.6.189
   Kumar S, 2004, BRIEF BIOINFORM, V5, P150, DOI 10.1093/bib/5.2.150
   Lampe DJ, 1999, P NATL ACAD SCI USA, V96, P11428, DOI 10.1073/pnas.96.20.11428
   Lampe DJ, 1996, EMBO J, V15, P5470, DOI 10.1002/j.1460-2075.1996.tb00930.x
   Lindroos HL, 2005, J BACTERIOL, V187, P6155, DOI 10.1128/JB.187.17.6155-6165.2005
   Maiden MCJ, 2006, ANNU REV MICROBIOL, V60, P561, DOI 10.1146/annurev.micro.59.030804.121325
   Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140
   Marston EL, 1999, INT J SYST BACTERIOL, V49, P1015, DOI 10.1099/00207713-49-3-1015
   McClelland M, 2004, NAT GENET, V36, P1268, DOI 10.1038/ng1470
   Meyer F, 2003, NUCLEIC ACIDS RES, V31, P2187, DOI 10.1093/nar/gkg312
   Parkhill J, 2003, NAT GENET, V35, P32, DOI 10.1038/ng1227
   Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083
   Preston A, 2004, NAT REV MICROBIOL, V2, P379, DOI 10.1038/nrmicro886
   Saenz HL, 2005, CURR OPIN MICROBIOL, V8, P612, DOI 10.1016/j.mib.2005.08.013
   Schmid MC, 2006, PLOS PATHOG, V2, P1083, DOI 10.1371/journal.ppat.0020115
   Schulein R, 2005, P NATL ACAD SCI USA, V102, P856, DOI 10.1073/pnas.0406796102
   Schulein R, 2002, MOL MICROBIOL, V46, P1053, DOI 10.1046/j.1365-2958.2002.03208.x
   Schulein R, 2001, J EXP MED, V193, P1077, DOI 10.1084/jem.193.9.1077
   Seubert A, 2003, MOL MICROBIOL, V49, P1253, DOI 10.1046/j.1365-2958.2003.03650.x
   Seubert A, 2002, INT J MED MICROBIOL, V291, P555
   Sweger D, 2000, CLIN DIAGN LAB IMMUN, V7, P251, DOI 10.1128/CDLI.7.2.251-257.2000
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Wren BW, 2003, NAT REV MICROBIOL, V1, P55, DOI 10.1038/nrmicro730
NR 44
TC 98
Z9 363
U1 0
U2 15
PU NATURE PUBLISHING GROUP
PI NEW YORK
PA 75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA
SN 1061-4036
EI 1546-1718
J9 NAT GENET
JI Nature Genet.
PD DEC
PY 2007
VL 39
IS 12
BP 1469
EP 1476
DI 10.1038/ng.2007.38
PG 8
WC Genetics & Heredity
SC Genetics & Heredity
GA 235XK
UT WOS:000251267400014
PM 18037886
DA 2021-01-25
ER

PT J
AU Kreplak, L
   Wang, H
   Aebi, U
   Kong, XP
AF Kreplak, Laurent
   Wang, Huaibin
   Aebi, Ueli
   Kong, Xiang-Peng
TI Atomic force microscopy of mammalian urothelial surface
SO JOURNAL OF MOLECULAR BIOLOGY
LA English
DT Article
DE atomic force microscopy; urothelium; tissue; surface; cell junction
ID UROPATHOGENIC ESCHERICHIA-COLI; URINARY-BLADDER EPITHELIUM; PERMEABILITY
   BARRIER FUNCTION; LUMINAL PLASMA-MEMBRANE; TRACT-INFECTIONS; STRUCTURAL
   BASIS; UROPLAKIN-IA; TRANSITIONAL EPITHELIUM; 3-DIMENSIONAL STRUCTURE;
   MECHANICAL-PROPERTIES
AB The mammalian urothelium apical surface plays important roles in bladder physiology and diseases, and it provides a unique morphology for ultrastructural studies. Atomic force microscopy (AFM) is an emerging tool for studying the architecture and dynamic properties of biomolecular structures under near-physiological conditions. However, AFM imaging of soft tissues remains a challenge because of the lack of efficient methods for sample stabilization. Using a porous nitrocellulose membrane as the support, we were able to immobilize large pieces of soft mouse bladder tissue, thus enabling us to carry out the first AFM investigation of the mouse urothelial surface. The submicrometer-resolution AFM images revealed many details of the surface features, including the geometry of the urothelial plaques that cover the entire surface and the membrane interdigitation at the cell borders. This interdigitation creates a membrane zipper, likely contributing to the barrier function of the urothelium. In addition, we were able to image the intracellular bacterial communities of type 1-fimbriated bacteria grown between the intermediate filament bundles of the umbrella cells, shedding light on the bacterial colonization of the urothelium. (c) 2007 Elsevier Ltd. All rights reserved.
C1 NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.
   Univ Basel, ME Muller Inst Struct Biol Biozentrum, CH-4056 Basel, Switzerland.
RP Kong, XP (corresponding author), NYU, Sch Med, Dept Biochem, 550 First Ave, New York, NY 10016 USA.
EM xiangpeng.kong@med.nyu.edu
OI Kong, Xiang-Peng/0000-0001-5773-2681; kreplak,
   laurent/0000-0001-9370-9809
FU NIDDK NIH HHSUnited States Department of Health & Human ServicesNational
   Institutes of Health (NIH) - USANIH National Institute of Diabetes &
   Digestive & Kidney Diseases (NIDDK) [DK52206, P01 DK052206, P01
   DK052206-070003, P01 DK052206-06A10003] Funding Source: Medline;
   NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited
   States Department of Health & Human ServicesNational Institutes of
   Health (NIH) - USANIH National Institute of Diabetes & Digestive &
   Kidney Diseases (NIDDK) [P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206, P01DK052206, P01DK052206, P01DK052206,
   P01DK052206, P01DK052206] Funding Source: NIH RePORTER
CR Acharya P, 2004, AM J PHYSIOL-RENAL, V287, pF305, DOI 10.1152/ajprenal.00341.2003
   Anderson GG, 2003, SCIENCE, V301, P105, DOI 10.1126/science.1084550
   Anderson GG, 2004, TRENDS MICROBIOL, V12, P424, DOI 10.1016/j.tim.2004.07.005
   Apodaca G, 2004, TRAFFIC, V5, P117, DOI 10.1046/j.1600-0854.2003.00156.x
   Braga P.C., 2004, METHODS MOL BIOL, V242
   BRISSON A, 1983, J MOL BIOL, V166, P21, DOI 10.1016/S0022-2836(83)80048-5
   CLAUDE P, 1978, J MEMBRANE BIOL, V39, P219, DOI 10.1007/BF01870332
   CLAUDE P, 1973, J CELL BIOL, V58, P390, DOI 10.1083/jcb.58.2.390
   Eto DS, 2006, CELL MICROBIOL, V8, P704, DOI 10.1111/j.1462-5822.2006.00691.x
   Foxman B, 2003, INFECT DIS CLIN N AM, V17, P227, DOI 10.1016/S0891-5520(03)00005-9
   Frederix PLTM, 2003, CURR OPIN CHEM BIOL, V7, P641, DOI 10.1016/j.cbpa.2003.08.010
   Hicks R M, 1978, Int Rev Exp Pathol, V18, P199
   HICKS RM, 1969, NATURE, V224, P1304, DOI 10.1038/2241304a0
   HICKS RM, 1966, J CELL BIOL, V30, P623, DOI 10.1083/jcb.30.3.623
   HICKS RM, 1965, J CELL BIOL, V26, P25, DOI 10.1083/jcb.26.1.25
   HICKS RM, 1975, BIOL REV, V50, P215, DOI 10.1111/j.1469-185X.1975.tb01057.x
   HOH JH, 1994, J CELL SCI, V107, P1105
   Hu P, 2002, AM J PHYSIOL-RENAL, V283, pF1200, DOI 10.1152/ajprenal.00043.2002
   Huttner WB, 2001, CURR OPIN CELL BIOL, V13, P478, DOI 10.1016/S0955-0674(00)00239-8
   Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104
   Justice SS, 2004, P NATL ACAD SCI USA, V101, P1333, DOI 10.1073/pnas.0308125100
   Kachar B, 1999, J MOL BIOL, V285, P595, DOI 10.1006/jmbi.1998.2304
   KOSS LG, 1969, LAB INVEST, V21, P154
   Lavelle J, 2002, AM J PHYSIOL-RENAL, V283, pF242, DOI 10.1152/ajprenal.00307.2001
   LEWIS SA, 1976, J MEMBRANE BIOL, V28, P1, DOI 10.1007/BF01869689
   LEWIS SA, 1976, J MEMBRANE BIOL, V28, P41, DOI 10.1007/BF01869690
   Lewis SA, 2000, AM J PHYSIOL-RENAL, V278, pF867
   Liang FX, 2001, BIOCHEM J, V355, P13, DOI 10.1042/0264-6021:3550013
   Litwin MS, 2005, J UROLOGY, V173, P933, DOI 10.1097/01.ju.0000152365.43125.3b
   Martinez JJ, 2000, EMBO J, V19, P2803, DOI 10.1093/emboj/19.12.2803
   MERK FB, 1977, CANCER RES, V37, P2843
   Min GW, 2006, J CELL BIOL, V173, P975, DOI 10.1083/jcb.200602086
   Min GW, 2003, J CELL SCI, V116, P4087, DOI 10.1242/jcs.00811
   Min GW, 2002, J MOL BIOL, V317, P697, DOI 10.1006/jmbi.2002.5442
   MINSKY BD, 1978, J CELL BIOL, V77, P685, DOI 10.1083/jcb.77.3.685
   Miyazaki H, 1999, MED BIOL ENG COMPUT, V37, P530, DOI 10.1007/BF02513342
   Mulvey MA, 1998, SCIENCE, V282, P1494, DOI 10.1126/science.282.5393.1494
   Negrete HO, 1996, AM J PHYSIOL-RENAL, V271, pF886
   NEWMAN J, 1977, HISTOPATHOLOGY, V1, P125, DOI 10.1111/j.1365-2559.1977.tb01651.x
   Oostergetel GT, 2001, J MOL BIOL, V314, P245, DOI 10.1006/jmbi.2001.5128
   PETER S, 1978, CELL TISSUE RES, V187, P439
   PORTER KR, 1967, PROTOPLASMA, V63, P262, DOI 10.1007/BF01248042
   Ramesh N, 2004, MOL THER, V10, P697, DOI 10.1016/j.ymthe.2004.07.002
   Reichlin T, 2005, J STRUCT BIOL, V152, P52, DOI 10.1016/j.jsb.2005.07.009
   RIESCO JM, 1989, ANAT ANZEIGER, V168, P245
   Romih R, 2005, CELL TISSUE RES, V320, P259, DOI 10.1007/s00441-004-1005-4
   Romih R, 2002, APPL IMMUNOHISTO M M, V10, P339, DOI 10.1097/00022744-200212000-00009
   Romih R, 1999, HISTOCHEM CELL BIOL, V112, P375, DOI 10.1007/s004180050419
   SABATINI DD, 1963, J CELL BIOL, V17, P19, DOI 10.1083/jcb.17.1.19
   STAEHELIN LA, 1972, J CELL BIOL, V53, P73, DOI 10.1083/jcb.53.1.73
   Stolz M, 2004, BIOPHYS J, V86, P3269, DOI 10.1016/S0006-3495(04)74375-1
   STUBBS CD, 1979, BIOCHIM BIOPHYS ACTA, V558, P58, DOI 10.1016/0005-2736(79)90315-8
   Sun TT, 1999, ADV EXP MED BIOL, V462, P7
   TAYLOR KA, 1984, J ULTRA MOL STRUCT R, V87, P23, DOI 10.1016/S0022-5320(84)90113-8
   Truschel ST, 2002, MOL BIOL CELL, V13, P830, DOI 10.1091/mbc.01-09-0435
   Tsilimbaris MK, 2000, INVEST OPHTH VIS SCI, V41, P680
   Veranic P, 2002, CELL MOTIL CYTOSKEL, V53, P317, DOI 10.1002/cm.10077
   VERGARA J, 1969, J MOL BIOL, V46, P593, DOI 10.1016/0022-2836(69)90200-9
   VERGARA J, 1974, J CELL BIOL, V61, P83, DOI 10.1083/jcb.61.1.83
   WALZ T, 1995, J MOL BIOL, V248, P887, DOI 10.1006/jmbi.1995.0269
   Wu XR, 1996, P NATL ACAD SCI USA, V93, P9630, DOI 10.1073/pnas.93.18.9630
   WU XR, 1990, J BIOL CHEM, V265, P19170
   Xie B, 2006, J BIOL CHEM, V281, P14644, DOI 10.1074/jbc.M600877200
   Zhou G, 2001, J CELL SCI, V114, P4095
NR 64
TC 36
Z9 37
U1 1
U2 6
PU ACADEMIC PRESS LTD- ELSEVIER SCIENCE LTD
PI LONDON
PA 24-28 OVAL RD, LONDON NW1 7DX, ENGLAND
SN 0022-2836
EI 1089-8638
J9 J MOL BIOL
JI J. Mol. Biol.
PD NOV 23
PY 2007
VL 374
IS 2
BP 365
EP 373
DI 10.1016/j.jmb.2007.09.040
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 238PO
UT WOS:000251459900008
PM 17936789
OA Green Accepted
DA 2021-01-25
ER

PT J
AU Thedieck, K
   Polak, P
   Kim, ML
   Molle, KD
   Cohen, A
   Jeno, P
   Arrieumerlou, C
   Hall, MN
AF Thedieck, Kathrin
   Polak, Pazit
   Kim, Man Lyang
   Molle, Klaus D.
   Cohen, Adiel
   Jenoe, Paul
   Arrieumerlou, Cecile
   Hall, Michael N.
TI PRAS40 and PRR5-Like Protein Are New mTOR Interactors that Regulate
   Apoptosis
SO PLOS ONE
LA English
DT Article
AB TOR (Target of Rapamycin) is a highly conserved protein kinase and a central controller of cell growth. TOR is found in two functionally and structurally distinct multiprotein complexes termed TOR complex 1 (TORC1) and TOR complex 2 (TORC2). In the present study, we developed a two-dimensional liquid chromatography tandem mass spectrometry (2D LC-MS/MS) based proteomic strategy to identify new mammalian TOR ( mTOR) binding proteins. We report the identification of Proline-rich Akt substrate (PRAS40) and the hypothetical protein Q6MZQ0/FLJ14213/CAE45978 as new mTOR binding proteins. PRAS40 binds mTORC1 via Raptor, and is an mTOR phosphorylation substrate. PRAS40 inhibits mTORC1 autophosphorylation and mTORC1 kinase activity toward eIF-4E binding protein (4E-BP) and PRAS40 itself. HeLa cells in which PRAS40 was knocked down were protected against induction of apoptosis by TNF alpha and cycloheximide. Rapamycin failed to mimic the pro-apoptotic effect of PRAS40, suggesting that PRAS40 mediates apoptosis independently of its inhibitory effect on mTORC1. Q6MZQ0 is structurally similar to proline rich protein 5 (PRR5) and was therefore named PRR5-Like (PRR5L). PRR5L binds specifically to mTORC2, via Rictor and/or SIN1. Unlike other mTORC2 members, PRR5L is not required for mTORC2 integrity or kinase activity, but dissociates from mTORC2 upon knock down of tuberous sclerosis complex 1 (TSC1) and TSC2. Hyperactivation of mTOR by TSC1/2 knock down enhanced apoptosis whereas PRR5L knock down reduced apoptosis. PRR5L knock down reduced apoptosis also in mTORC2 deficient cells. The above suggests that mTORC2-dissociated PRR5L may promote apoptosis when mTOR is hyperactive. Thus, PRAS40 and PRR5L are novel mTOR-associated proteins that control the balance between cell growth and cell death.
C1 [Thedieck, Kathrin; Polak, Pazit; Kim, Man Lyang; Molle, Klaus D.; Cohen, Adiel; Jenoe, Paul; Arrieumerlou, Cecile; Hall, Michael N.] Univ Basel, Biozentrum, Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Basel, Biozentrum, Basel, Switzerland.
EM m.hall@unibas.ch
OI Thedieck, Kathrin/0000-0002-9069-2930; ARRIEUMERLOU,
   Cecile/0000-0002-6463-2897
FU Peter und Traudl Engelhorn Stiftung zur Forderung der Biotechnologie und
   Gentechnik; Roche Research Foundation; Swiss National Science
   FoundationSwiss National Science Foundation (SNSF); Canton of Basel
   (MNH)
FX We acknowledge support from the Peter und Traudl Engelhorn Stiftung zur
   Forderung der Biotechnologie und Gentechnik (KT), the Roche Research
   Foundation (PP), and the Swiss National Science Foundation and the
   Canton of Basel (MNH). The funders had no role in study design, data
   collection and analysis, decision to publish, or preparation of the
   manuscript.
CR Avellino R, 2005, BLOOD, V106, P1400, DOI 10.1182/blood-2005-03-0929
   Avruch J, 2006, ONCOGENE, V25, P6361, DOI 10.1038/sj.onc.1209882
   Beuvink I, 2005, CELL, V120, P747, DOI 10.1016/j.cell.2004.12.040
   BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0
   Brunn GJ, 1997, J BIOL CHEM, V272, P32547, DOI 10.1074/jbc.272.51.32547
   Burnett PE, 1998, P NATL ACAD SCI USA, V95, P1432, DOI 10.1073/pnas.95.4.1432
   CHIU MI, 1994, P NATL ACAD SCI USA, V91, P12574, DOI 10.1073/pnas.91.26.12574
   Chrestensen CA, 2004, J BIOL CHEM, V279, P10176, DOI 10.1074/jbc.M310486200
   Corradetti MN, 2006, ONCOGENE, V25, P6347, DOI 10.1038/sj.onc.1209885
   Crino PB, 2006, NEW ENGL J MED, V355, P1345, DOI 10.1056/NEJMra055323
   Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518
   Edinger AL, 2004, ONCOGENE, V23, P5654, DOI 10.1038/sj.onc.1207738
   Frias MA, 2006, CURR BIOL, V16, P1865, DOI 10.1016/j.cub.2006.08.001
   Gangloff YG, 2004, MOL CELL BIOL, V24, P9508, DOI 10.1128/MCB.24.21.9508-9516.2004
   Garami A, 2003, MOL CELL, V11, P1457, DOI 10.1016/S1097-2765(03)00220-X
   Gatlin CL, 2000, ANAL CHEM, V72, P757, DOI 10.1021/ac991025n
   Ghosh S, 2006, CANCER CELL, V10, P215, DOI 10.1016/j.ccr.2006.08.007
   Guertin DA, 2006, DEV CELL, V11, P859, DOI 10.1016/j.devcel.2006.10.007
   Hahn M, 2005, MOL CANCER THER, V4, P457
   Hara K, 2002, CELL, V110, P177, DOI 10.1016/S0092-8674(02)00833-4
   Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704
   Huang B, 2005, ACTA PHARMACOL SIN, V26, P1253, DOI 10.1111/j.1745-7254.2005.00184.x
   Inoki K, 2003, CELL, V115, P577, DOI 10.1016/S0092-8674(03)00929-2
   Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183
   Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033
   Johnstone CN, 2005, GENOMICS, V85, P338, DOI 10.1016/j.ygeno.2004.11.002
   Kettritz R, 2002, KIDNEY INT, V61, P502, DOI 10.1046/j.1523-1755.2002.00161.x
   Kim DH, 2002, CELL, V110, P163, DOI 10.1016/S0092-8674(02)00808-5
   Kovacina KS, 2003, J BIOL CHEM, V278, P10189, DOI 10.1074/jbc.M210837200
   KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F
   Kwiatkowski DJ, 2003, ANN HUM GENET, V67, P87, DOI 10.1046/j.1469-1809.2003.00012.x
   Liou J, 2005, CURR BIOL, V15, P1235, DOI 10.1016/j.cub.2005.05.055
   Loewith R, 2002, MOL CELL, V10, P457, DOI 10.1016/S1097-2765(02)00636-6
   Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6
   Menand B, 2002, P NATL ACAD SCI USA, V99, P6422, DOI 10.1073/pnas.092141899
   Nobukuni T, 2005, P NATL ACAD SCI USA, V102, P14238, DOI 10.1073/pnas.0506925102
   Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700
   SABATINI DM, 1994, CELL, V78, P35, DOI 10.1016/0092-8674(94)90570-3
   Saito A, 2004, J NEUROSCI, V24, P1584, DOI 10.1523/JNEUROSCI.5209-03.2004
   Sancak Y, 2007, MOL CELL, V25, P903, DOI 10.1016/j.molcel.2007.03.003
   Sarbassov DD, 2006, MOL CELL, V22, P159, DOI 10.1016/j.molcel.2006.03.029
   Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148
   Sarbassov DD, 2004, CURR BIOL, V14, P1296, DOI 10.1016/j.cub.2004.06.054
   Schmidt A, 1997, CELL, V88, P531, DOI 10.1016/S0092-8674(00)81893-0
   Shah OJ, 2004, CURR BIOL, V14, P1650, DOI 10.1016/j.cub.2004.08.026
   Shaw RJ, 2006, NATURE, V441, P424, DOI 10.1038/nature04869
   Shiota C, 2006, DEV CELL, V11, P583, DOI 10.1016/j.devcel.2006.08.013
   Teachey DT, 2006, BLOOD, V107, P1149, DOI 10.1182/blood-2005-05-1935
   Thimmaiah KN, 2003, CANCER RES, V63, P364
   Treeck O, 2006, GYNECOL ONCOL, V102, P292, DOI 10.1016/j.ygyno.2005.12.019
   Vander Haar E, 2007, NAT CELL BIOL, V9, P316, DOI 10.1038/ncb1547
   Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016
   Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103
   Yang Q, 2006, GENE DEV, V20, P2820, DOI 10.1101/gad.1461206
   Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000
   Zhang Y, 2003, NAT CELL BIOL, V5, P578, DOI 10.1038/ncb999
NR 56
TC 201
Z9 205
U1 0
U2 7
PU PUBLIC LIBRARY SCIENCE
PI SAN FRANCISCO
PA 1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA
SN 1932-6203
J9 PLOS ONE
JI PLoS One
PD NOV 21
PY 2007
VL 2
IS 11
AR e1217
DI 10.1371/journal.pone.0001217
PG 10
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA V10JB
UT WOS:000207459200027
PM 18030348
OA DOAJ Gold, Green Published
DA 2021-01-25
ER

PT J
AU Rakhmatullina, E
   Braun, T
   Chami, M
   Malinova, V
   Meier, W
AF Rakhmatullina, Ekaterina
   Braun, Thomas
   Chami, Mohamed
   Malinova, Violeta
   Meier, Wolfgang
TI Self-organization behavior of methacrylate-based Amphiphilic Di- and
   triblock copolymers
SO LANGMUIR
LA English
DT Article
ID TRANSFER RADICAL POLYMERIZATION; BLOCK-COPOLYMERS; AQUEOUS-SOLUTIONS;
   LIGHT-SCATTERING; MICELLES; VESICLES; NANOPARTICLES; SIZE;
   MICELLIZATION; ENCAPSULATION
AB Amphiphilic di- and triblock copolymers having different hydrophilic-to-hydrophobic block length ratio were synthesized using ATRP. The self-assembly behavior of these AB and ABA block copolymers consisting of poly(n-butyl methacrylate) (B) and poly(2,2-(dimethylaminoethyl methacrylate) (A) was investigated using a combination of dynamic light scattering, negative-stain transmission electron microscopy, cryoelectron microscopy, and atomic force microscopy. Two populations of self-organized structures in aqueous solution, micelles and compound micelles, were detected for diblock copolymers. Triblock copolymers assembled into vesicular structures of uniform sizes. Furthermore it was found that these vesicles tended to compensate the high curvature by additional organization of the polymer chains outside of the membrane. The chain hydrophilicity of the polymers appeared to have a critical impact on the self-assembly response toward temperature change. The self-reorganization of the polymers at different temperatures is discussed.
C1 Univ Basel, Dept Chem, CH-4056 Basel, Switzerland.
   Univ Basel, Dept Phys, CH-4056 Basel, Switzerland.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Meier, W (corresponding author), Univ Basel, Dept Chem, Klingelbergstr 80, CH-4056 Basel, Switzerland.
EM E.Rakhmatullina@unibas.ch; Thomas.Braun@unibas.ch;
   Mohamed.Chami@unibas.ch; V.Malinova@unibas.ch; wolfgang.meier@unibas.ch
CR Antonietti M, 1996, MACROMOLECULES, V29, P3800, DOI 10.1021/ma951446g
   Bednarek M, 2000, MACROMOL CHEM PHYSIC, V201, P58, DOI 10.1002/(SICI)1521-3935(20000101)201:1<58::AID-MACP58>3.0.CO;2-G
   Burchard W., 1994, PHYS TECHNIQUES STUD, P151, DOI DOI 10.1007/978-1-4615-2101-3_4
   Cai YL, 2004, MACROMOLECULES, V37, P9728, DOI 10.1021/ma0487756
   Cameron NS, 2002, BIOMACROMOLECULES, V3, P124, DOI 10.1021/bm015596c
   Colombani O, 2007, MACROMOLECULES, V40, P4351, DOI 10.1021/ma0609580
   Dai S, 2003, LANGMUIR, V19, P5175, DOI 10.1021/la0340652
   Dimitrov P, 2004, MACROMOLECULES, V37, P1000, DOI 10.1021/ma0354039
   Discher DE, 2002, SCIENCE, V297, P967, DOI 10.1126/science.1074972
   Dominguez-Gutierrez D, 2006, NANO LETT, V6, P145, DOI 10.1021/nl051944v
   Grumelard J, 2004, CHEM COMMUN, P1462, DOI 10.1039/b405671j
   Hamley IW, 2003, NANOTECHNOLOGY, V14, pR39, DOI 10.1088/0957-4484/14/10/201
   Huang WX, 2003, NANOTECHNOLOGY, V14, P1075, DOI 10.1088/0957-4484/14/10/304
   Hunter DG, 1998, BIOPHYS J, V74, P2996, DOI 10.1016/S0006-3495(98)78006-3
   Ivanova R, 2001, ADV COLLOID INTERFAC, V89, P351, DOI 10.1016/S0001-8686(00)00049-X
   JAKES J, 1988, CZECH J PHYS, V38, P1305, DOI 10.1007/BF01597611
   Katsampas I, 2005, MACROMOL RAPID COMM, V26, P1371, DOI 10.1002/marc.200500387
   Kjoniksen AL, 2005, MACROMOLECULES, V38, P948, DOI 10.1021/ma048581q
   Kwon GS, 1996, ADV DRUG DELIVER REV, V21, P107, DOI 10.1016/S0169-409X(96)00401-2
   KWON GS, 1995, ADV DRUG DELIVER REV, V16, P295, DOI 10.1016/0169-409X(95)00031-2
   Kwon GS, 1998, CRIT REV THER DRUG, V15, P481
   LASIC DD, 1993, LIPOSOMES PHYS APPL, P195
   Li CM, 2005, BIOMACROMOLECULES, V6, P994, DOI 10.1021/bm049331k
   Liu XM, 2004, BIOMATERIALS, V25, P2619, DOI 10.1016/j.biomaterials.2003.09.028
   Liu XM, 2003, J COLLOID INTERF SCI, V266, P295, DOI 10.1016/S0021-9797(03)00691-X
   Luo LB, 2001, J AM CHEM SOC, V123, P1012, DOI 10.1021/ja005824v
   Ma YH, 2003, MACROMOLECULES, V36, P3475, DOI 10.1021/ma021762c
   MORI S, 1990, J LIQ CHROMATOGR, V13, P1719, DOI 10.1080/01483919008048988
   Nardin C, 2000, LANGMUIR, V16, P1035, DOI 10.1021/la990951u
   Narrainen AP, 2002, J POLYM SCI POL CHEM, V40, P439, DOI 10.1002/pola.10122
   Nasseau M, 2001, BIOTECHNOL BIOENG, V75, P615, DOI 10.1002/bit.10074
   Neradovic D, 2004, BIOMATERIALS, V25, P2409, DOI 10.1016/j.biomaterials.2003.09.024
   Patrickios CS, 1997, J POLYM SCI POL CHEM, V35, P1181, DOI 10.1002/(SICI)1099-0518(199705)35:7<1181::AID-POLA4>3.0.CO;2-5
   PEFFERKORN E, 1975, J APPL POLYM SCI, V19, P2929, DOI 10.1002/app.1975.070191031
   Photos PJ, 2003, J CONTROL RELEASE, V90, P323, DOI 10.1016/S0168-3659(03)00201-3
   Radowski MR, 2007, ANGEW CHEM INT EDIT, V46, P1265, DOI 10.1002/anie.200603801
   Rakhmatullina E, 2007, MACROMOL CHEM PHYS, V208, P1283, DOI 10.1002/macp.200700119
   Rangelov S, 2005, J PHYS CHEM B, V109, P1162, DOI 10.1021/jp046118+
   Riegel IC, 2004, PURE APPL CHEM, V76, P123, DOI 10.1351/pac200476010123
   Seo SH, 2006, ANGEW CHEM INT EDIT, V45, P7526, DOI 10.1002/anie.200600688
   Soga O, 2004, LANGMUIR, V20, P9388, DOI 10.1021/la048354h
   Soo PL, 2004, J POLYM SCI POL PHYS, V42, P923, DOI 10.1002/polb.10739
   Sun QL, 2005, POLYMER, V46, P4958, DOI 10.1016/j.polymer.2005.03.091
   Szczubialka K, 2003, J MATER SCI-MATER M, V14, P699, DOI 10.1023/A:1024911716152
   TANFORD D, 1961, PHYS CHEM MACROMOLEC, P287
   Verbrugghe S, 2003, POLYMER, V44, P6807, DOI 10.1016/j.polymer.2003.07.003
   Von Klitzing R, 2004, CURR OPIN COLLOID IN, V9, P158, DOI 10.1016/j.cocis.2004.05.022
   Vriezema DM, 2005, CHEM REV, V105, P1445, DOI 10.1021/cr0300688
   Wang LY, 2004, CHEM COMMUN, P2840, DOI 10.1039/b411163j
   Wang Y, 2007, COLLOID SURFACE A, V292, P159, DOI 10.1016/j.colsurfa.2006.06.018
   Weaver JVM, 2004, MACROMOLECULES, V37, P2395, DOI 10.1021/ma0356358
   Wu C, 1996, PHYS REV LETT, V77, P3053, DOI 10.1103/PhysRevLett.77.3053
   Xie D, 2007, CHEM-EUR J, V13, P3346, DOI 10.1002/chem.200601361
   Yamamoto Y, 2002, J CONTROL RELEASE, V82, P359, DOI 10.1016/S0168-3659(02)00147-5
   Zhang LF, 1998, POLYM ADVAN TECHNOL, V9, P677
   Zhu JT, 2005, J PHYS CHEM B, V109, P8619, DOI 10.1021/jp044344d
NR 56
TC 35
Z9 35
U1 0
U2 27
PU AMER CHEMICAL SOC
PI WASHINGTON
PA 1155 16TH ST, NW, WASHINGTON, DC 20036 USA
SN 0743-7463
J9 LANGMUIR
JI Langmuir
PD NOV 20
PY 2007
VL 23
IS 24
BP 12371
EP 12379
DI 10.1021/la7023132
PG 9
WC Chemistry, Multidisciplinary; Chemistry, Physical; Materials Science,
   Multidisciplinary
SC Chemistry; Materials Science
GA 231VG
UT WOS:000250976700069
PM 17949024
DA 2021-01-25
ER

PT J
AU Junne, T
   Schwede, T
   Goder, V
   Spiess, M
AF Junne, Tina
   Schwede, Torsten
   Goder, Veit
   Spiess, Martin
TI Mutations in the Sec61p channel affecting signal sequence recognition
   and membrane protein topology
SO JOURNAL OF BIOLOGICAL CHEMISTRY
LA English
DT Article
ID TRANSLOCATION CHANNEL; TRANSMEMBRANE ORIENTATION; ENDOPLASMIC-RETICULUM;
   CHARGED RESIDUES; ANCHOR PROTEINS; PLUG DOMAIN; EXPORT; DETERMINANTS;
   CONTRIBUTES; TRANSPORT
AB The orientation of most single-spanning membrane proteins obeys the "positive-insiderule", i.e. the flanking region of the transmembrane segment that is more positively charged remains in the cytosol. These membrane proteins are integrated by the Sec61/SecY translocon, but how their orientation is achieved is unknown. We have screened for mutations in yeast Sec61p that alter the orientation of single-spanning membrane proteins. We identified a class of mutants that are less efficient in retaining the positively charged flanking region in the cytosol. Surprisingly, these mutations are located at many different sites in the Sec61/SecY molecule, and they do not only involve charged amino acid residues. All these mutants have a prl phenotype that so far have only been seen in bacteria; they allow proteins with defective signal sequences to be translocated, likely because the Sec61p channel opens more easily. A similar correlation between topology defects and prl phenotype was also seen with previously identified yeast Sec61 mutants. Our results suggest a model in which the regulated opening of the translocon is required for the faithful orientation of membrane proteins.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Spiess, M (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM Martin.Spiess@unibas.ch
RI Schwede, Torsten/A-4650-2008; Goder, Veit/F-8092-2016
OI Schwede, Torsten/0000-0003-2715-335X; Goder, Veit/0000-0003-0854-4873;
   Spiess, Martin/0000-0001-7139-0550
CR Alder NN, 2004, J BIOL CHEM, V279, P22787, DOI 10.1074/jbc.R400002200
   BELTZER JP, 1991, J BIOL CHEM, V266, P973
   COLLIER DN, 1988, CELL, V53, P273, DOI 10.1016/0092-8674(88)90389-3
   Denzer AJ, 1995, EMBO J, V14, P6311, DOI 10.1002/j.1460-2075.1995.tb00321.x
   DERMAN AI, 1993, EMBO J, V12, P879, DOI 10.1002/j.1460-2075.1993.tb05728.x
   EMR SD, 1981, CELL, V23, P79, DOI 10.1016/0092-8674(81)90272-5
   Finke K, 1996, EMBO J, V15, P1482, DOI 10.1002/j.1460-2075.1996.tb00492.x
   Goder V, 2004, MOL BIOL CELL, V15, P1470, DOI 10.1091/mbc.E03-08-0599
   Goder V, 2003, EMBO J, V22, P3645, DOI 10.1093/emboj/cdg361
   HARTMANN E, 1989, P NATL ACAD SCI USA, V86, P5786, DOI 10.1073/pnas.86.15.5786
   Johnson AE, 1999, ANNU REV CELL DEV BI, V15, P799, DOI 10.1146/annurev.cellbio.15.1.799
   Junne T, 2006, MOL BIOL CELL, V17, P4063, DOI 10.1091/mbc.E06-03-0200
   Li WK, 2007, MOL CELL, V26, P511, DOI 10.1016/j.molcel.2007.05.002
   Maillard AP, 2007, J BIOL CHEM, V282, P1281, DOI 10.1074/jbc.M610060200
   Mitra K, 2005, NATURE, V438, P318, DOI 10.1038/nature04133
   Ng DTW, 1996, J CELL BIOL, V134, P269, DOI 10.1083/jcb.134.2.269
   Osborne AR, 2007, CELL, V129, P97, DOI 10.1016/j.cell.2007.02.036
   Osborne AR, 2005, ANNU REV CELL DEV BI, V21, P529, DOI 10.1146/annurev.cellbio.21.012704.133214
   Pilon M, 1997, EMBO J, V16, P4540, DOI 10.1093/emboj/16.15.4540
   Plath K, 2000, J CELL BIOL, V151, P167, DOI 10.1083/jcb.151.1.167
   Prinz WA, 1998, J BIOL CHEM, V273, P8419, DOI 10.1074/jbc.273.14.8419
   RANDALL LL, 1990, SCIENCE, V248, P860, DOI 10.1126/science.2188362
   ROBZYK K, 1992, NUCLEIC ACIDS RES, V20, P3790, DOI 10.1093/nar/20.14.3790
   Rosch K, 2000, J BIOL CHEM, V275, P14916, DOI 10.1074/jbc.M000456200
   SAKAGUCHI M, 1992, P NATL ACAD SCI USA, V89, P16, DOI 10.1073/pnas.89.1.16
   Saparov SM, 2007, MOL CELL, V26, P501, DOI 10.1016/j.molcel.2007.03.022
   Shimohata N, 2007, J CELL BIOL, V176, P307, DOI 10.1083/jcb.200611121
   Smith MA, 2005, J BACTERIOL, V187, P6454, DOI 10.1128/JB.187.18.6454-6465.2005
   STIRLING CJ, 1992, MOL BIOL CELL, V3, P129
   Tam PCK, 2005, EMBO J, V24, P3380, DOI 10.1038/sj.emboj.7600804
   UHLAND K, 1994, J BACTERIOL, V176, P4565, DOI 10.1128/JB.176.15.4565-4571.1994
   van den Berg B, 2004, NATURE, V427, P36, DOI 10.1038/nature02218
   Veenendaal AKJ, 2004, BBA-MOL CELL RES, V1694, P81, DOI 10.1016/j.bbamcr.2004.02.009
   VONHEIJNE G, 1986, EMBO J, V5, P3021, DOI 10.1002/j.1460-2075.1986.tb04601.x
   VONHEIJNE G, 1990, J MEMBRANE BIOL, V115, P195, DOI 10.1007/BF01868635
   Wahlberg JM, 1997, J CELL BIOL, V137, P555, DOI 10.1083/jcb.137.3.555
NR 36
TC 52
Z9 52
U1 0
U2 5
PU AMER SOC BIOCHEMISTRY MOLECULAR BIOLOGY INC
PI ROCKVILLE
PA 11200 ROCKVILLE PIKE, SUITE 302, ROCKVILLE, MD, UNITED STATES
SN 0021-9258
EI 1083-351X
J9 J BIOL CHEM
JI J. Biol. Chem.
PD NOV 9
PY 2007
VL 282
IS 45
BP 33201
EP 33209
DI 10.1074/jbc.M707219200
PG 9
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 226YW
UT WOS:000250625400067
PM 17893139
OA Other Gold
DA 2021-01-25
ER

PT J
AU Meyer, UA
AF Meyer, U. A.
TI Hepatic porphyrias: pathogenesis and clinical outcomes
SO BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY
LA English
DT Meeting Abstract
C1 Univ Basel, Biozentrum, Div Pharmacol Neurobiol, Basel, Switzerland.
NR 0
TC 0
Z9 0
U1 0
U2 0
PU BLACKWELL PUBLISHING
PI OXFORD
PA 9600 GARSINGTON RD, OXFORD OX4 2DQ, OXON, ENGLAND
SN 1742-7835
J9 BASIC CLIN PHARMACOL
JI Basic Clin. Pharmacol. Toxicol.
PD NOV
PY 2007
VL 101
IS 5
MA PMS-2
BP 365
EP 365
PG 1
WC Pharmacology & Pharmacy; Toxicology
SC Pharmacology & Pharmacy; Toxicology
GA 217CB
UT WOS:000249924900037
DA 2021-01-25
ER

PT J
AU Nyfeler, B
   Hauri, HP
AF Nyfeler, B.
   Hauri, H. -P.
TI Visualization of protein interactions inside the secretory pathway
SO BIOCHEMICAL SOCIETY TRANSACTIONS
LA English
DT Article; Proceedings Paper
CT Focus Topic at Life Sciences 2007 Conference
CY JUL 09-12, 2007
CL Glasgow, SCOTLAND
DE cargo receptor; endoplasmic reticulum; endoplasmic reticulum-Golgi
   intermediate compartment protein of 53 kDa (ERGIC-53); fluorescence;
   protein fragment complementation assay (PCA); protein-protein
   interaction; yellow fluorescent protein (YFP)
ID BIMOLECULAR FLUORESCENCE COMPLEMENTATION; LIVING CELLS;
   ENDOPLASMIC-RETICULUM; TRANSPORT RECEPTOR; LECTIN ERGIC-53; GENETIC
   SYSTEM; IN-VIVO; LUCIFERASE; MECHANISM; COMPLEX
AB The ER (endoplasmic reticulum) is a major protein folding and modification organelle. in its lumen, the ER processes a third of all newly synthesized proteins. To accomplish this task, numerous resident proteins capture the nascent and newly synthesized proteins. The underlying luminal protein-protein interactions, however, are inherently difficult to analyse, mainly due to their transient nature and the rather specialized environment of the ER. To overcome these limitations, we developed a PCA (protein fragment complementation assay) based on the citrine variant of YFP (yellow fluorescent protein). YFP PCA was successfully applied to visualize the protein interactions of the cargo transport receptor ERGIC-53 (endoplasmic reticulum-Golgi intermediate compartment protein of 53 kDa) with its luminal interaction partner MCFD2 (multiple coagulation factor deficiency protein 2) and its cargo proteins cathepsin Z and cathepsin C in a specific manner. With the prospect of screening cDNA libraries for novel protein-protein interactions, YFP PCA is a promising emerging technique for mapping protein interactions inside the secretory pathway in a genome-wide setting.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Nyfeler, B (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
CR Aebersold R, 2003, NATURE, V422, P198, DOI 10.1038/nature01511
   Appenzeller C, 1999, NAT CELL BIOL, V1, P330
   Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052
   FIELDS S, 1989, NATURE, V340, P245, DOI 10.1038/340245a0
   Galarneau A, 2002, NAT BIOTECHNOL, V20, P619, DOI 10.1038/nbt0602-619
   Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w
   Griesbeck O, 2001, J BIOL CHEM, V276, P29188, DOI 10.1074/jbc.M102815200
   Hauri HP, 2000, J CELL SCI, V113, P587
   Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3
   Jach G, 2006, NAT METHODS, V3, P597, DOI 10.1038/NMETH901
   Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101
   Magliery TJ, 2005, J AM CHEM SOC, V127, P146, DOI 10.1021/ja046699g
   Michnick SW, 2000, METHOD ENZYMOL, V328, P208, DOI 10.1016/S0076-6879(00)28399-7
   Nichols WC, 1998, CELL, V93, P61, DOI 10.1016/S0092-8674(00)81146-0
   Nyfeler B, 2005, P NATL ACAD SCI USA, V102, P6350, DOI 10.1073/pnas.0501976102
   Nyfeler B, 2006, TRAFFIC, V7, P1473, DOI 10.1111/j.1600-0854.2006.00483.x
   Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c
   Remy I, 2004, NAT CELL BIOL, V6, P358, DOI 10.1038/ncb1113
   Remy I, 2004, METHODS, V32, P381, DOI 10.1016/j.ymeth.2003.10.011
   Remy I, 2004, MOL CELL BIOL, V24, P1493, DOI 10.1128/MCB.24.4.1493-1504.2004
   Remy I, 2001, P NATL ACAD SCI USA, V98, P7678, DOI 10.1073/pnas.131216098
   Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979
   Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187
   Vollenweider F, 1998, J CELL BIOL, V142, P377, DOI 10.1083/jcb.142.2.377
   Zhang B, 2003, NAT GENET, V34, P220, DOI 10.1038/ng1153
NR 25
TC 8
Z9 8
U1 0
U2 5
PU PORTLAND PRESS LTD
PI LONDON
PA THIRD FLOOR, EAGLE HOUSE, 16 PROCTER STREET, LONDON WC1V 6 NX, ENGLAND
SN 0300-5127
J9 BIOCHEM SOC T
JI Biochem. Soc. Trans.
PD NOV
PY 2007
VL 35
BP 970
EP 973
DI 10.1042/BST0350970
PN 5
PG 4
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 236CE
UT WOS:000251279800029
PM 17956257
DA 2021-01-25
ER

PT J
AU Nikoletopoulou, V
   Plachta, N
   Allen, ND
   Pinto, L
   Gotz, M
   Barde, YA
AF Nikoletopoulou, Vassiliki
   Plachta, Nicolas
   Allen, Nicolas D.
   Pinto, Luisa
   Goetz, Magdalena
   Barde, Yves-Alain
TI Neurotrophin receptor-mediated death of misspecified neurons generated
   from embryonic stem cells lacking pax6
SO CELL STEM CELL
LA English
DT Article
ID CEREBRAL-CORTEX; MAMMALIAN TELENCEPHALON; TRANSCRIPTION FACTOR; MUTANT
   MICE; MOUSE; DIFFERENTIATION; ROLES; MIGRATION; IDENTITY; GENES
AB Pax6-positive radial glial (RG) cells are the progenitors of most glutamatergic neurons in the cortex, a lineage that can be recapitulated in vitro using embryonic stem (ES) cells. We show here that ES cells lacking Pax6, a transcription factor long known to be essential for cortical development, generate Mash1-positive RG cells that differentiate in GABAergic neurons. These neurons express high levels of the neurotrophin receptor p75(NTR) causing their rapid death. Pax6 function was also investigated following transplantation of ES cells in the developing chick telencephalon and in mice lacking both Pax6 and p75(NTR). Taken together, our results indicate that reliable predictions can be made with cultured ES cells when used to explore the role of genes impacting early aspects of mammalian neurogenesis. They also provide a novel opportunity to compare the molecular constituents of glutamatergic with those of GABA-ergic neurons and to explore the mechanisms of their generation.
C1 Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
   Cardiff Univ, Sch Biosci, Cardiff CF10 3US, Wales.
   Natl Res Ctr Environm & Hlth, Inst Stem Cell Res, D-85764 Neuherberg, Germany.
   Univ Munich, Inst Physiol, D-80336 Munich, Germany.
RP Barde, YA (corresponding author), Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
EM yves.barde@unibas.ch
RI Pinto, Luisa/A-7414-2010; Barde, Yves/F-6019-2011; allen,
   nick/A-4336-2010
OI Pinto, Luisa/0000-0002-7724-0446; Nikoletopoulou,
   Vassiliki/0000-0003-3646-992X; Allen, Nicholas/0000-0003-4009-186X;
   Barde, Yves/0000-0002-7627-461X
CR ALLENDOERFER KL, 1990, P NATL ACAD SCI USA, V87, P187, DOI 10.1073/pnas.87.1.187
   Bibel M, 2004, NAT NEUROSCI, V7, P1003, DOI 10.1038/nn1301
   Bibel M, 2007, NAT PROTOC, V2, P1034, DOI 10.1038/nprot.2007.147
   Cobos I, 2001, DEV BIOL, V239, P30, DOI 10.1006/dbio.2001.0422
   DeFelipe J, 1997, J CHEM NEUROANAT, V14, P1, DOI 10.1016/S0891-0618(97)10013-8
   Fode C, 2000, GENE DEV, V14, P67
   Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739
   Gschwendtner A, 2003, MOL CELL NEUROSCI, V24, P307, DOI 10.1016/S1044-7431(03)00167-2
   Hack MA, 2004, MOL CELL NEUROSCI, V25, P664, DOI 10.1016/j.mcn.2003.12.012
   Heins N, 2002, NAT NEUROSCI, V5, P308, DOI 10.1038/nn828
   Huang EJ, 2003, ANNU REV BIOCHEM, V72, P609, DOI 10.1146/annurev.biochem.72.121801.161629
   Jimenez D, 2002, J NEUROCYTOL, V31, P719, DOI 10.1023/A:1025751914372
   Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605
   Kroll TT, 2005, P NATL ACAD SCI USA, V102, P7374, DOI 10.1073/pnas.0500819102
   KUBOTA Y, 1994, JPN J PHYSIOL, V44, pS145
   Majdan M, 1997, J NEUROSCI, V17, P6988
   Malatesta P, 2003, NEURON, V37, P751, DOI 10.1016/S0896-6273(03)00116-8
   Philips GT, 2005, DEV BIOL, V279, P308, DOI 10.1016/j.ydbio.2004.12.018
   Plachta N, 2004, DEVELOPMENT, V131, P5449, DOI 10.1242/dev.01420
   Plachta N, 2007, NAT NEUROSCI, V10, P712, DOI 10.1038/nn1897
   PORTEUS MH, 1994, J NEUROSCI, V14, P6370
   Quinn JC, 2007, DEV BIOL, V302, P50, DOI 10.1016/j.ydbio.2006.08.035
   Scardigli R, 2003, DEVELOPMENT, V130, P3269, DOI 10.1242/dev.00539
   SCHMAHL W, 1993, ACTA NEUROPATHOL, V86, P126, DOI 10.1007/BF00334879
   Schuurmans C, 2004, EMBO J, V23, P2892, DOI 10.1038/sj.emboj.7600278
   SilosSantiago I, 1997, EUR J NEUROSCI, V9, P2045, DOI 10.1111/j.1460-9568.1997.tb01372.x
   SIMEONE A, 1992, EMBO J, V11, P2541, DOI 10.1002/j.1460-2075.1992.tb05319.x
   Stoykova A, 2000, J NEUROSCI, V20, P8042
   Stoykova A, 2003, CEREB CORTEX, V13, P560, DOI 10.1093/cercor/13.6.560
   STOYKOVA A, 1994, J NEUROSCI, V14, P1395
   Talamillo A, 2003, DEV BIOL, V255, P151, DOI 10.1016/S0012-1606(02)00046-5
   Toresson H, 2000, DEVELOPMENT, V127, P4361
   von Schack D, 2001, NAT NEUROSCI, V4, P977, DOI 10.1038/nn730
   WALTHER C, 1991, DEVELOPMENT, V113, P1435
   Warren N, 1999, CEREB CORTEX, V9, P627, DOI 10.1093/cercor/9.6.627
   Yun K, 2001, DEVELOPMENT, V128, P193
NR 36
TC 39
Z9 39
U1 0
U2 6
PU CELL PRESS
PI CAMBRIDGE
PA 600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA
SN 1934-5909
J9 CELL STEM CELL
JI Cell Stem Cell
PD NOV
PY 2007
VL 1
IS 5
BP 529
EP 540
DI 10.1016/j.stem.2007.08.011
PG 12
WC Cell & Tissue Engineering; Cell Biology
SC Cell Biology
GA 236AX
UT WOS:000251276500011
PM 18371392
DA 2021-01-25
ER

PT J
AU Melchers, F
AF Melchers, Fritz
TI Starting at the end
SO EUROPEAN JOURNAL OF IMMUNOLOGY
LA English
DT Article
DE B cells; lymphocyte development; Novartis prize; pre-B cells
ID B-CELL DEVELOPMENT; MARROW-DERIVED LYMPHOCYTES; PRE-B; IN-VIVO; MOUSE
   LYMPHOCYTES; MITOGEN; MICE; MATURATION; SURFACE; GENE
AB From the time when I entered immunology - in January 1965 at the Salk Institute for Biological Studies in La Jolla, California in the laboratories of Edwin (Ed) Lennox and Melvin (Mel) Cohn - my love has always been B lymphocytes and antibodies. I began my studies at the end of the developmental pathway of these B cells, with plasma cells. After more than 40 years in immunology, I have moved "backwards" over mature B cells, immature B cells, precursor B cells and lymphocyte progenitors to pluripotent hematopoietic stem cells. Initially it was an intellectual exercise to trace the unknown progenitor of known B-lineage cells; now it has become an experimental approach - to de- and re -differentiate B-lineage cells to earlier differentiation stages and to other lineages of hematopoietic cells.
C1 Max Planck Inst Infect Biol, D-10117 Berlin, Germany.
   Univ Basel, Biozentrum, Dept Cell Biol, Basel, Switzerland.
RP Melchers, F (corresponding author), Max Planck Inst Infect Biol, Campus Charite Mitte, Chariteplatz 1, D-10117 Berlin, Germany.
EM melchers@mpiib-berlin.mpg.de
CR Andersson J, 1977, Cold Spring Harb Symp Quant Biol, V41 Pt 1, P227
   ANDERSSON J, 1974, EUR J IMMUNOL, V4, P170, DOI 10.1002/eji.1830040305
   ANDERSSON J, 1974, J EXP MED, V140, P742, DOI 10.1084/jem.140.3.742
   ANDERSSON J, 1977, J EXP MED, V145, P1511, DOI 10.1084/jem.145.6.1511
   ANDERSSON J, 1980, P NATL ACAD SCI-BIOL, V77, P1612, DOI 10.1073/pnas.77.3.1612
   ANDERSSON J, 1973, J EXP MED, V137, P943, DOI 10.1084/jem.137.4.943
   ANDERSSON J, 1977, J EXP MED, V145, P1520, DOI 10.1084/jem.145.6.1520
   ANDERSSON J, 1977, CELL, V10, P27, DOI 10.1016/0092-8674(77)90136-2
   BURNET FM, 1959, CLONAL SELECTION THE
   EICHMANN K, 1977, J EXP MED, V146, P1436, DOI 10.1084/jem.146.5.1436
   Ghia P, 1996, J EXP MED, V184, P2217, DOI 10.1084/jem.184.6.2217
   GRONOWICZ E, 1976, EUR J IMMUNOL, V6, P588, DOI 10.1002/eji.1830060812
   HARDY RR, 1984, J EXP MED, V159, P1169, DOI 10.1084/jem.159.4.1169
   HILSCHMANN N, 1965, P NATL ACAD SCI USA, V53, P1403, DOI 10.1073/pnas.53.6.1403
   HOMBACH J, 1988, EMBO J, V7, P3451, DOI 10.1002/j.1460-2075.1988.tb03219.x
   ISCOVE NN, 1978, J EXP MED, V147, P923, DOI 10.1084/jem.147.3.923
   JERNE N K, 1971, European Journal of Immunology, V1, P1, DOI 10.1002/eji.1830010102
   JERNE NK, 1980, COMMUNICATION
   JERNE NK, 1967, COLD SPRING HARB S Q
   KARASUYAMA H, 1988, J EXP MED, V167, P1377, DOI 10.1084/jem.167.4.1377
   KUDO A, 1987, EMBO J, V6, P2267, DOI 10.1002/j.1460-2075.1987.tb02500.x
   KUDO A, 1989, PROGR IMMUNOLOGY, V7, P339
   MAKI R, 1980, SCIENCE, V209, P1366, DOI 10.1126/science.6774416
   MELCHERS F, 1975, SCAND J IMMUNOL, V4, P853, DOI 10.1111/j.1365-3083.1975.tb02697.x
   Melchers F, 1977, Cold Spring Harb Symp Quant Biol, V41 Pt 1, P147
   MELCHERS F, 1980, EUR J IMMUNOL, V10, P679, DOI 10.1002/eji.1830100905
   MELCHERS F, 1974, EUR J IMMUNOL, V4, P181, DOI 10.1002/eji.1830040306
   MELCHERS F, 1986, ANNU REV IMMUNOL, V4, P13, DOI 10.1146/annurev.iy.04.040186.000305
   Melchers F, 2000, IMMUNOL REV, V175, P33, DOI 10.1034/j.1600-065X.2000.017510.x
   MELCHERS F, 1975, J EXP MED, V142, P473, DOI 10.1084/jem.142.2.473
   Melchers F, 1999, P NATL ACAD SCI USA, V96, P2571, DOI 10.1073/pnas.96.6.2571
   MELCHERS F, 1989, COLD SPRING HARB SYM, V54, P183
   MELCHERS F, 1973, BIOCHEMISTRY-US, V12, P1471, DOI 10.1021/bi00732a001
   MELCHERS F, IMMUNE SYSTEM FESTSC, V1, P124
   MELCHERS F, 1972, 23 MOSB C GERM SOC B, P409
   MELCHERS F, C HIGH TECHN SOC FDN, P35
   MELCHERS F, 2006, MAX DELBRUCK HUNDERS
   MELCHERS F, 1967, COLD SPRING HARB S Q
   MELCHERS F, 2007, MAX DELBRUCK COLOGNE, P108
   Nutt SL, 1999, NATURE, V401, P556
   POTTER M, 1986, SEMIN ONCOL, V13, P275
   ROLINK A, 1991, EMBO J, V10, P327, DOI 10.1002/j.1460-2075.1991.tb07953.x
   ROLINK A, 1994, INT IMMUNOL, V6, P1257, DOI 10.1093/intimm/6.8.1257
   ROLINK AG, 1987, J EXP MED, V165, P1675, DOI 10.1084/jem.165.6.1675
   Rolink AG, 2000, IMMUNOL REV, V175, P104, DOI 10.1111/j.1600-065X.2000.imr017512.x
   Rolink AG, 1999, NATURE, V401, P603, DOI 10.1038/44164
   Rolink AG, 2002, EUR J IMMUNOL, V32, P2004, DOI 10.1002/1521-4141(200207)32:7<2004::AID-IMMU2004>3.0.CO;2-5
   Rolink AG, 1998, EUR J IMMUNOL, V28, P3738, DOI 10.1002/(SICI)1521-4141(199811)28:11<3738::AID-IMMU3738>3.0.CO;2-Q
   SAKAGUCHI N, 1988, EMBO J, V7, P3457, DOI 10.1002/j.1460-2075.1988.tb03220.x
   SAKAGUCHI N, 1986, NATURE, V324, P579, DOI 10.1038/324579a0
   Schaniel C, 2002, BLOOD, V99, P472, DOI 10.1182/blood.V99.2.472
   Schaniel C, 2002, BLOOD, V99, P2760, DOI 10.1182/blood.V99.8.2760
   SCHREIER MH, 1980, J EXP MED, V151, P194, DOI 10.1084/jem.151.1.194
   STRASSER A, 1989, J EXP MED, V170, P1973, DOI 10.1084/jem.170.6.1973
   TENBOEKEL E, 1995, INT IMMUNOL, V7, P1013
   TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0
   URBANEK P, 1994, CELL, V79, P901, DOI 10.1016/0092-8674(94)90079-5
   ZACHAU HG, 1966, COLD SPRING HARB SYM, V31, P417, DOI 10.1101/SQB.1966.031.01.054
NR 58
TC 0
Z9 0
U1 0
U2 0
PU WILEY-V C H VERLAG GMBH
PI WEINHEIM
PA PO BOX 10 11 61, D-69451 WEINHEIM, GERMANY
SN 0014-2980
J9 EUR J IMMUNOL
JI Eur. J. Immunol.
PD NOV
PY 2007
VL 37
SU 1
BP S125
EP S133
DI 10.1002/eji.200737773
PG 9
WC Immunology
SC Immunology
GA 235NB
UT WOS:000251239900014
PM 17972356
DA 2021-01-25
ER

PT J
AU Belle, MD
   Pattison, EF
   Cheunsuang, O
   Stewart, A
   Kramer, I
   Sigrist, M
   Arber, S
   Morris, R
AF Belle, Mino D.
   Pattison, Edward F.
   Cheunsuang, Ornsiri
   Stewart, Anika
   Kramer, Ina
   Sigrist, Markus
   Arber, Silvia
   Morris, Richard
TI Characterization of a thy1.2 GFP transgenic mouse reveals a
   tissue-specific organization of the spinal dorsal horn
SO GENESIS
LA English
DT Article
DE substantia gelatinosa; epidermal sensation; somatosensory; green
   fluorescent protein; epidermal primary afferents isolectin B4;
   nonpeptidergic primary afferents; somatosensory; Thy1.2 promoter
ID SUBSTANTIA-GELATINOSA NEURONS; PRIMARY AFFERENT NEURONS; ROOT GANGLION
   NEURONS; NEUROPATHIC PAIN; SENSORY NEURONS; NERVE INJURY; EXPRESSION;
   RECEPTOR; P2X(3); PARVALBUMIN
AB In this study, transgenic mice in which membrane-linked enhanced green fluorescent protein (mGFP) is expressed from the Thy1.2 promoter were used. In these mice, a subpopulation of small to medium sized DRG neurons double stained for 11134 but not for CGRP Most of the peripheral terminals traversed the dermis and ramify within the epidermis and form superficial terminals. Within the spinal cord, these afferents terminated exclusively within the substantia gelatinosa (SG). A second fibre type in the skin also expressed mGFP, and formed club-shaped endings towards the bases of hairs. Injury to the sciatic nerve resulted in mGFP loss from the SG ipsilateral to the nerve injury, but also in the corresponding region contralaterally. Together, these findings reveal the specificity of connectivity of a defined subpopulation of DRG sensory neurons innervating the epidermis and this will facilitate analysis of their physiological functions. genesis 45:679-688, 2007. (c) 2007 Wiley-Liss, Inc.
C1 [Belle, Mino D.; Pattison, Edward F.; Cheunsuang, Ornsiri; Stewart, Anika; Morris, Richard] Univ Liverpool, Dept Vet Preclin Sci, Liverpool L69 7ZJ, Merseyside, England.
   [Cheunsuang, Ornsiri] Chulalongkorn Univ, Dept Vet Anat, Bangkok, Thailand.
   [Kramer, Ina; Sigrist, Markus; Arber, Silvia] Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
RP Morris, R (corresponding author), Univ Liverpool, Dept Vet Preclin Sci, Liverpool L69 7ZJ, Merseyside, England.
EM richardm@liv.ac.uk
RI Belle, Mino/AAV-6093-2020
OI Belle, Mino/0000-0002-4917-957X; Arber, Silvia/0000-0002-6261-250X
CR Bautista DM, 2005, P NATL ACAD SCI USA, V102, P12248, DOI 10.1073/pnas.0505356102
   Bennett DLH, 1998, J NEUROSCI, V18, P3059
   BLEAZARD L, 1994, J NEUROSCI, V14, P7655
   Bradbury EJ, 1998, MOL CELL NEUROSCI, V12, P256, DOI 10.1006/mcne.1998.0719
   Caroni P, 1997, J NEUROSCI METH, V71, P3, DOI 10.1016/S0165-0270(96)00121-5
   De Paola V, 2003, NAT NEUROSCI, V6, P491, DOI 10.1038/nn1046
   DODD J, 1986, J EXP BIOL, V124, P225
   Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2
   Gerke MB, 2001, BRAIN RES, V911, P101, DOI 10.1016/S0006-8993(01)02750-0
   Guo A, 1999, EUR J NEUROSCI, V11, P946, DOI 10.1046/j.1460-9568.1999.00503.x
   Hamilton SG, 2000, BRAIN, V123, P1238, DOI 10.1093/brain/123.6.1238
   Hammond DL, 2004, J COMP NEUROL, V475, P575, DOI 10.1002/cne.20209
   Hantman AW, 2005, J COMP NEUROL, V492, P90, DOI 10.1002/cne.20709
   Hantman AW, 2004, J NEUROSCI, V24, P836, DOI 10.1523/JNEUROSCI.4221-03.2004
   Heinbecker P, 1933, ARCH NEURO PSYCHIATR, V29, P771, DOI 10.1001/archneurpsyc.1933.02240100090008
   HILLIGES M, 1995, J INVEST DERMATOL, V104, P134, DOI 10.1111/1523-1747.ep12613631
   Hilliges M, 2002, PAIN, V98, P59, DOI 10.1016/S0304-3959(01)00469-9
   Howard C. V., 1998, ROY MICRO S, P19
   HUNT SP, 1985, PHILOS T ROY SOC B, V308, P283, DOI 10.1098/rstb.1985.0028
   Ichikawa H, 1997, EXP NEUROL, V146, P414, DOI 10.1006/exnr.1997.6545
   Ichikawa H, 1997, BRAIN RES, V770, P294, DOI 10.1016/S0006-8993(97)00826-3
   Kashiba H, 1999, MOL BRAIN RES, V66, P24, DOI 10.1016/S0169-328X(98)00346-5
   KNYIHARCSILLIK E, 1981, PROG HISTOCHEM CYTOC, V14, P1
   Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794
   Koltzenburg M, 1999, TRENDS NEUROSCI, V22, P122, DOI 10.1016/S0166-2236(98)01302-2
   LAWSON SN, 1979, J NEUROCYTOL, V8, P275, DOI 10.1007/BF01236123
   Li L, 2001, J COMP NEUROL, V439, P259, DOI 10.1002/cne.1349
   Liu M, 2004, NEUROSCIENCE, V127, P659, DOI 10.1016/j.neuroscience.2004.05.041
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   MELZACK R, 1965, SCIENCE, V150, P971, DOI 10.1126/science.150.3699.971
   Morris R, 2004, BRAIN RES REV, V46, P173, DOI 10.1016/j.brainresrev.2004.07.002
   OBRIEN C, 1989, NEUROSCIENCE, V32, P493, DOI 10.1016/0306-4522(89)90096-1
   Olausson H, 2002, NAT NEUROSCI, V5, P900, DOI 10.1038/nn896
   Peier AM, 2002, SCIENCE, V296, P2046, DOI 10.1126/science.1073140
   REXED B, 1954, J COMP NEUROL, V100, P297, DOI 10.1002/cne.901000205
   Schmelz M, 2003, J NEUROPHYSIOL, V89, P2441, DOI 10.1152/jn.01139.2002
   SELTZER Z, 1990, PAIN, V43, P205, DOI 10.1016/0304-3959(90)91074-S
   Shields SD, 2003, J PAIN, V4, P465, DOI 10.1067/S1526-5900(03)00781-8
   SILVERMAN JD, 1988, SOMATOSENS MOT RES, V5, P259, DOI 10.3109/07367228809144630
   Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2
   Todd AJ, 2002, EXP PHYSIOL, V87, P245, DOI 10.1113/eph8702351
   Vulchanova L, 2001, NEUROSCIENCE, V108, P143, DOI 10.1016/S0306-4522(01)00377-3
   Vulchanova L, 1998, EUR J NEUROSCI, V10, P3470, DOI 10.1046/j.1460-9568.1998.00355.x
   Wang R, 2003, NEUROSCIENCE, V121, P815, DOI 10.1016/S0306-4522(03)00491-3
   Woodbury CJ, 2004, J NEUROSCI, V24, P6410, DOI 10.1523/JNEUROSCI.1421-04.2004
   YOSHIMURA M, 1993, NEUROSCIENCE, V53, P519, DOI 10.1016/0306-4522(93)90216-3
   Zylka MJ, 2005, NEURON, V45, P17, DOI 10.1016/j.neuron.2004.12.015
   Zylka MJ, 2003, P NATL ACAD SCI USA, V100, P10043, DOI 10.1073/pnas.1732949100
NR 48
TC 6
Z9 6
U1 0
U2 3
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1526-954X
EI 1526-968X
J9 GENESIS
JI Genesis
PD NOV
PY 2007
VL 45
IS 11
BP 679
EP 688
DI 10.1002/dvg.20331
PG 10
WC Developmental Biology; Genetics & Heredity
SC Developmental Biology; Genetics & Heredity
GA 241DE
UT WOS:000251636300003
PM 17987661
DA 2021-01-25
ER

PT J
AU Nguyen, L
   Scherr, N
   Gatfield, J
   Walburger, A
   Pieters, J
   Thompson, CJ
AF Nguyen, Liem
   Scherr, Nicole
   Gatfield, John
   Walburger, Anne
   Pieters, Jean
   Thompson, Charles J.
TI Antigen 84, an effector of pleiomorphism in Mycobactetium smegmatis
SO JOURNAL OF BACTERIOLOGY
LA English
DT Article
ID DIVISION PROTEIN DIVIVA; SCANNING-ELECTRON-MICROSCOPY; TUBERCULOSIS
   CELL-DIVISION; BACILLUS-SUBTILIS; ESCHERICHIA-COLI;
   STREPTOMYCES-COELICOLOR; CHROMOSOME SEGREGATION; BACTERIAL DIVISION;
   POLAR LOCALIZATION; FISSION YEAST
AB While in most rod-shaped bacteria, morphology is based on MreB-like proteins that form an actin-like cytoskeletal scaffold for cell wall biosynthesis, the factors that determine the more flexible rod-like shape in actinobacteria such as Mycobacterium species are unknown. Here we show that a Mycobacterium smegmatis protein homologous to eubacterial DivIVA-like proteins, including M. tuberculosis antigen 84 (Ag84), localized symmetrically to centers of peptidoglycan biosynthesis at the poles and septa. Controlled gene disruption experiments indicated that the gene encoding Ag84, wag31, was essential; when overexpressed, cells became longer and wider, with Ag84 asymmetrically distributed at one pole. Many became grossly enlarged, bowling-pin-shaped cells having up to 80-fold-increased volume. In these cells, Ag84 accumulated predominantly at a bulbous pole that was apparently generated by uncontrolled cell wall expansion. In some cells, Ag84 was associated with exceptional sites of cell wall expansion (buds) that evolved into branches. M. bovis BCG Ag84 was able to form oligomers in vitro, perhaps reflecting its superstructure in vivo. These data suggested a role for Ag84 in cell division and modulating cell shape in pleiomorphic actinobacteria.
C1 Univ Basel, Biozentrum, Dept Biochem, CH-4056 Basel, Switzerland.
   Case Western Reserve Univ, Sch Med, Dept Mol Biol & Microbiol, Cleveland, OH 44106 USA.
   Univ British Columbia, Life Sci Ctr, Vancouver, BC V6T 1Z3, Canada.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Dept Biochem, 50-70 Klingelbergstr, CH-4056 Basel, Switzerland.
EM Jean.Pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757; Nguyen, Liem/0000-0002-1523-1472
CR BALASUBRAMANIAN MK, 1992, NATURE, V360, P84, DOI 10.1038/360084a0
   Balasubramanian V, 1996, J BACTERIOL, V178, P273, DOI 10.1128/jb.178.1.273-279.1996
   Bardarov S, 2002, MICROBIOL-SGM, V148, P3007, DOI 10.1099/00221287-148-10-3007
   BARNETTE WN, 1981, ANAL BIOCHEM, V112, P195
   Bernhardt TG, 2005, MOL CELL, V18, P555, DOI 10.1016/j.molcel.2005.04.012
   Cabeen MT, 2005, NAT REV MICROBIOL, V3, P601, DOI 10.1038/nrmicro1205
   Carballido-Lopez R, 2003, DEV CELL, V4, P19, DOI 10.1016/S1534-5807(02)00403-3
   Carballido-Lopez R, 2006, MOL MICROBIOL, V60, P815, DOI 10.1111/j.1365-2958.2006.05161.x
   Carballido-Lopez R, 2006, MICROBIOL MOL BIOL R, V70, P888, DOI 10.1128/MMBR.00014-06
   Carriere C, 1997, J CLIN MICROBIOL, V35, P3232
   Cha JH, 1997, J BACTERIOL, V179, P1671, DOI 10.1128/jb.179.5.1671-1683.1997
   Chauhan A, 2006, J BACTERIOL, V188, P1856, DOI 10.1128/JB.188.5.1856-1865.2006
   Chauhan A, 2006, MOL MICROBIOL, V62, P132, DOI 10.1111/j.1365-2958.2006.05333.x
   Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159
   Dahl JL, 2005, CAN J MICROBIOL, V51, P277, DOI 10.1139/W05-001
   Dahl JL, 2004, FEMS MICROBIOL LETT, V240, P15, DOI 10.1016/j.femsle.2004.09.004
   Daniel RA, 2003, CELL, V113, P767, DOI 10.1016/S0092-8674(03)00421-5
   Dmitriev BA, 2000, INT J MED MICROBIOL, V290, P251
   Edwards DH, 2000, EMBO J, V19, P2719, DOI 10.1093/emboj/19.11.2719
   Edwards DH, 1997, MOL MICROBIOL, V24, P905, DOI 10.1046/j.1365-2958.1997.3811764.x
   Egelman EH, 2003, CURR OPIN STRUC BIOL, V13, P244, DOI 10.1016/S0959-440X(03)00027-7
   Flardh K, 2003, MOL MICROBIOL, V49, P1523, DOI 10.1046/j.1365-2958.2003.03660.x
   Flardh K, 2003, CURR OPIN MICROBIOL, V6, P564, DOI 10.1016/j.mib.2003.10.011
   Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038
   Gunning P, 1997, ANAT EMBRYOL, V195, P311, DOI 10.1007/s004290050050
   Harry EJ, 2003, MOL MICROBIOL, V47, P37, DOI 10.1046/j.1365-2958.2003.03253.x
   HERMANS PWM, 1995, INFECT IMMUN, V63, P954, DOI 10.1128/IAI.63.3.954-960.1995
   Holtje JV, 1998, MICROBIOL MOL BIOL R, V62, P181
   Howard M, 2005, J CELL BIOL, V168, P533, DOI 10.1083/jcb.200411122
   Jones LJF, 2001, CELL, V104, P913, DOI 10.1016/S0092-8674(01)00287-2
   Kang CM, 2005, GENE DEV, V19, P1692, DOI 10.1101/gad.1311105
   Kruse T, 2005, MOL MICROBIOL, V55, P78, DOI 10.1111/j.1365-2958.2004.04367.x
   LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0
   LLEO MM, 1990, J BACTERIOL, V172, P3758, DOI 10.1128/jb.172.7.3758-3771.1990
   Margolin W, 2006, CURR BIOL, V16, pR881, DOI 10.1016/j.cub.2006.09.025
   Marston AL, 1998, GENE DEV, V12, P3419, DOI 10.1101/gad.12.21.3419
   Marston AL, 1999, MOL MICROBIOL, V33, P84, DOI 10.1046/j.1365-2958.1999.01450.x
   Mazza P, 2006, MOL MICROBIOL, V60, P838, DOI 10.1111/j.1365-2958.2006.05134.x
   MINNIKIN DE, 1991, RES MICROBIOL, V142, P423, DOI 10.1016/0923-2508(91)90114-P
   Muchova K, 2002, MICROBIOL-SGM, V148, P807, DOI 10.1099/00221287-148-3-807
   MULDER E, 1989, J BACTERIOL, V171, P4303, DOI 10.1128/JB.171.8.4303-4314.1989
   MULLER T, 1991, J MICROSC-OXFORD, V161, P73
   NYKA W, 1974, INFECT IMMUN, V9, P843, DOI 10.1128/IAI.9.5.843-850.1974
   Ojha AK, 2000, INFECT IMMUN, V68, P4084, DOI 10.1128/IAI.68.7.4084-4091.2000
   Pante N, 1997, RNA, V3, P498
   Ramirez-Arcos S, 2005, MICROBIOL-SGM, V151, P1381, DOI 10.1099/mic.0.27718-0
   Ramos A, 2003, MICROBIOL-SGM, V149, P3531, DOI 10.1099/mic.0.26653-0
   Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971
   Rose A, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-66
   Rothfield L, 2005, NAT REV MICROBIOL, V3, P959, DOI 10.1038/nrmicro1290
   Sassetti CM, 2003, MOL MICROBIOL, V48, P77, DOI 10.1046/j.1365-2958.2003.03425.x
   Scheffers DJ, 2004, MOL MICROBIOL, V51, P749, DOI 10.1046/j.1365-2958.2003.03854.x
   Seiler P, 2003, J INFECT DIS, V188, P1326, DOI 10.1086/378563
   Shapiro L, 2002, SCIENCE, V298, P1942, DOI 10.1126/science.1072163
   Shapiro L, 1997, SCIENCE, V276, P712, DOI 10.1126/science.276.5313.712
   Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581
   SNAPPER SB, 1990, MOL MICROBIOL, V4, P1911, DOI 10.1111/j.1365-2958.1990.tb02040.x
   Stahlberg H, 2004, MOL MICROBIOL, V52, P1281, DOI 10.1111/j.1365-2958.2004.04074.x
   Stewart GC, 2005, MOL MICROBIOL, V57, P1177, DOI 10.1111/j.1365-2958.2005.04760.x
   STOVER CK, 1991, NATURE, V351, P456, DOI 10.1038/351456a0
   Thanky NR, 2007, TUBERCULOSIS, V87, P231, DOI 10.1016/j.tube.2006.10.004
   THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673
   Tiyanont K, 2006, P NATL ACAD SCI USA, V103, P11033, DOI 10.1073/pnas.0600829103
   Triccas JA, 1998, FEMS MICROBIOL LETT, V167, P151, DOI 10.1111/j.1574-6968.1998.tb13221.x
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   WOLDRINGH CL, 1990, RES MICROBIOL, V141, P39, DOI 10.1016/0923-2508(90)90096-9
   Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606
   Wu LJ, 2004, CELL, V117, P915, DOI 10.1016/j.cell.2004.06.002
   Young KD, 2003, MOL MICROBIOL, V49, P571, DOI 10.1046/j.1365-2958.2003.03607.x
NR 69
TC 70
Z9 71
U1 0
U2 4
PU AMER SOC MICROBIOLOGY
PI WASHINGTON
PA 1752 N ST NW, WASHINGTON, DC 20036-2904 USA
SN 0021-9193
EI 1098-5530
J9 J BACTERIOL
JI J. Bacteriol.
PD NOV
PY 2007
VL 189
IS 21
BP 7896
EP 7910
DI 10.1128/JB.00726-07
PG 15
WC Microbiology
SC Microbiology
GA 224AK
UT WOS:000250417200039
PM 17766411
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Sundaramurthy, V
   Pieters, J
AF Sundaramurthy, Varadharajan
   Pieters, Jean
TI Interactions of pathogenic mycobacteria with host macrophages
SO MICROBES AND INFECTION
LA English
DT Article
DE tuberculosis; macrophages; innate immunity
ID TOLL-LIKE RECEPTORS; PROTEIN-KINASE-G; PHAGOSOME MATURATION ARREST;
   TUBERCULOSIS PHAGOSOME; DEFENSE-MECHANISM; PHAGOLYSOSOME BIOGENESIS;
   INNATE IMMUNITY; CORONIN FAMILY; SURVIVAL; AUTOPHAGY
AB Tuberculosis, caused by the bacterium Mycobacterium tuberculosis, is one of the most deadly infectious diseases across the globe. The success of M. tuberculosis is related to its capacity to survive and replicate in macrophages, cells of the host innate immune system that are designed to detect and eliminate pathogens [1,2]. In this review, we will focus on the mechanisms used by the innate system of the host to detect and eliminate mycobacteria and the strategies used by M. tuberculosis to overcome host responses to establish a successful infection. (c) 2007 Elsevier Masson SAS. All rights reserved.
C1 [Sundaramurthy, Varadharajan; Pieters, Jean] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Pieters, J (corresponding author), Univ Basel, Biozentrum, Klingelbergstr 50, CH-4056 Basel, Switzerland.
EM jean.pieters@unibas.ch
OI Pieters, Jean/0000-0002-5284-9757
CR ADAMS DO, 1992, MACROPHAGE, P75
   Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015
   ARMSTRONG JA, 1971, J EXP MED, V134, P713, DOI 10.1084/jem.134.3.713
   Av-Gay Y, 2000, TRENDS MICROBIOL, V8, P238, DOI 10.1016/S0966-842X(00)01734-0
   Blander JM, 2004, SCIENCE, V304, P1014, DOI 10.1126/science.1096158
   Booth JW, 2001, SEMIN IMMUNOL, V13, P357, DOI 10.1006/smim.2001.0332
   Bulut Y, 2005, J BIOL CHEM, V280, P20961, DOI 10.1074/jbc.M411379200
   Butler D, 2000, NATURE, V406, P670, DOI 10.1038/35021291
   Chan J, 2004, CLIN IMMUNOL, V110, P2, DOI 10.1016/S1521-6616(03)00210-9
   Chua J, 2004, CURR OPIN MICROBIOL, V7, P71, DOI 10.1016/j.mib.2003.12.011
   Clemens DL, 1996, TRENDS MICROBIOL, V4, P113, DOI 10.1016/0966-842X(96)81528-9
   Cohen-Gonsaud M, 2005, NAT STRUCT MOL BIOL, V12, P270, DOI 10.1038/nsmb905
   Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006
   Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159
   Cosma CL, 2003, ANNU REV MICROBIOL, V57, P641, DOI 10.1146/annurev.micro.57.030502.091033
   Cowley S, 2004, MOL MICROBIOL, V52, P1691, DOI 10.1111/j.1365-2958.2004.04085.x
   de Hostos EL, 1999, TRENDS CELL BIOL, V9, P345, DOI 10.1016/S0962-8924(99)01620-7
   DEHOSTOS EL, 1993, J CELL BIOL, V120, P163, DOI 10.1083/jcb.120.1.163
   Deretic V, 2006, CELL MICROBIOL, V8, P719, DOI 10.1111/j.1462-5822.2006.00705.x
   Deretic V, 2006, CURR OPIN IMMUNOL, V18, P375, DOI 10.1016/j.coi.2006.05.019
   Doyle SE, 2004, J EXP MED, V199, P81, DOI 10.1084/jem.20031237
   Falkow S, 2006, CELL, V124, P699, DOI 10.1016/j.cell.2006.02.004
   Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004
   Ferrari G, 1999, CELL, V97, P435, DOI 10.1016/S0092-8674(00)80754-0
   Floto RA, 2006, SCIENCE, V314, P454, DOI 10.1126/science.1133515
   Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93
   Flynn JL, 2001, INFECT IMMUN, V69, P4195, DOI 10.1128/IAI.69.7.4195-4201.2001
   Foger N, 2006, SCIENCE, V313, P839, DOI 10.1126/science.1130563
   Fratti RA, 2001, J CELL BIOL, V154, P631, DOI 10.1083/jcb.200106049
   Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100
   Greenstein AE, 2005, J MOL MICROB BIOTECH, V9, P167, DOI 10.1159/000089645
   Grosset J, 2003, ANTIMICROB AGENTS CH, V47, P833, DOI 10.1128/AAC.47.3.833-836.2003
   Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038
   HART PD, 1991, J EXP MED, V174, P881, DOI 10.1084/jem.174.4.881
   Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9
   Houben ENG, 2006, CURR OPIN MICROBIOL, V9, P76, DOI 10.1016/j.mib.2005.12.014
   Humphries CL, 2002, J CELL BIOL, V159, P993, DOI 10.1083/jcb.200206113
   JANEWAY CA, 1989, COLD SH Q B, V54, P1
   Jayachandran R, 2007, CELL, V130, P37, DOI 10.1016/j.cell.2007.04.043
   Karakousis PC, 2004, J EXP MED, V200, P647, DOI 10.1084/jem.20040646
   Kaufmann SHE, 2006, IMMUNITY, V24, P351, DOI 10.1016/j.immuni.2006.04.003
   Kendall SL, 2004, TRENDS MICROBIOL, V12, P537, DOI 10.1016/j.tim.2004.10.005
   Krutzik SR, 2004, SEMIN IMMUNOL, V16, P35, DOI 10.1016/j.smim.2003.10.005
   Liu PT, 2006, SCIENCE, V311, P1770, DOI 10.1126/science.1123933
   Malik ZA, 2003, J IMMUNOL, V170, P2811, DOI 10.4049/jimmunol.170.6.2811
   Martens S, 2004, J IMMUNOL, V173, P2594, DOI 10.4049/jimmunol.173.4.2594
   Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131
   MERDZHITOV R, 1998, CURR OPIN IMMUNOL, V10, P12, DOI DOI 10.1016/50952-7915(98)80024-1
   Murry JP, 2005, TRENDS MICROBIOL, V13, P366, DOI 10.1016/j.tim.2005.06.003
   Nathan C, 2006, SCIENCE, V312, P1874
   Nathan C, 2002, AM J RESP CRIT CARE, V166, P130, DOI 10.1164/rccm.2205016
   Nguyen L, 2005, J BACTERIOL, V187, P5852, DOI 10.1128/JB.187.16.5852-5856.2005
   Nguyen L, 2005, TRENDS CELL BIOL, V15, P269, DOI 10.1016/j.tcb.2005.03.009
   Niebisch A, 2006, J BIOL CHEM, V281, P12300, DOI 10.1074/jbc.M512515200
   Orme IM, 2003, TUBERCULOSIS, V83, P112, DOI 10.1016/S1472-9792(02)00069-0
   PANCHOLI P, 1993, SCIENCE, V260, P984, DOI 10.1126/science.8098550
   Parente JA, 1999, J BIOL CHEM, V274, P3017, DOI 10.1074/jbc.274.5.3017
   Pethe K, 2004, P NATL ACAD SCI USA, V101, P13642, DOI 10.1073/pnas.0401657101
   Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006
   Pieters J, 2002, TRENDS MICROBIOL, V10, P142, DOI 10.1016/S0966-842X(02)02305-3
   Pieters J, 2001, CURR OPIN IMMUNOL, V13, P37, DOI 10.1016/S0952-7915(00)00179-5
   Quesniaux V, 2004, MICROBES INFECT, V6, P946, DOI 10.1016/j.micinf.2004.04.016
   Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043
   Russell DG, 2001, NAT REV MOL CELL BIO, V2, P569, DOI 10.1038/35085034
   Russell DG, 1996, J IMMUNOL, V156, P4764
   Rybakin V, 2004, FEBS LETT, V573, P161, DOI 10.1016/j.febslet.2004.07.066
   Ryffel B, 2005, TUBERCULOSIS, V85, P395, DOI 10.1016/j.tube.2005.08.021
   Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846
   Shintani T, 2004, SCIENCE, V306, P990, DOI 10.1126/science.1099993
   Shleeva MO, 2002, MICROBIOL-SGM, V148, P1581, DOI 10.1099/00221287-148-5-1581
   Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577
   Smith TF, 1999, TRENDS BIOCHEM SCI, V24, P181, DOI 10.1016/S0968-0004(99)01384-5
   Stewart GR, 2003, NAT REV MICROBIOL, V1, P97, DOI 10.1038/nrmicro749
   Stewart GR, 2005, PLOS PATHOG, V1, P269, DOI 10.1371/journal.ppat.0010033
   STURGILLKOSZYCKI S, 1994, SCIENCE, V263, P678, DOI 10.1126/science.8303277
   SturgillKoszycki S, 1996, EMBO J, V15, P6960, DOI 10.1002/j.1460-2075.1996.tb01088.x
   Ulrichs T, 2006, J PATHOL, V208, P261, DOI 10.1002/path.1906
   Vergne I, 2005, P NATL ACAD SCI USA, V102, P4033, DOI 10.1073/pnas.0409716102
   Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015
   Vergne I, 2003, J EXP MED, V198, P653, DOI 10.1084/jem.20030527
   Villarino A, 2005, J MOL BIOL, V350, P953, DOI 10.1016/j.jmb.2005.05.049
   Walburger A, 2004, SCIENCE, V304, P1800, DOI 10.1126/science.1099384
   Watts C, 2004, SCIENCE, V304, P976, DOI 10.1126/science.1098573
   Wurmser AE, 1999, J BIOL CHEM, V274, P9129, DOI 10.1074/jbc.274.14.9129
   *XDR TB, 2006, LANCET, V368, P964
   Yeo HJ, 2004, J BACTERIOL, V186, P1919, DOI 10.1128/JB.186.7.1919-1926.2004
   Zarember KA, 2002, J IMMUNOL, V168, P554, DOI 10.4049/jimmunol.168.2.554
NR 87
TC 44
Z9 49
U1 0
U2 2
PU ELSEVIER SCIENCE BV
PI AMSTERDAM
PA PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS
SN 1286-4579
EI 1769-714X
J9 MICROBES INFECT
JI Microbes Infect.
PD NOV-DEC
PY 2007
VL 9
IS 14-15
BP 1671
EP 1679
DI 10.1016/j.micinf.2007.09.007
PG 9
WC Immunology; Infectious Diseases; Microbiology
SC Immunology; Infectious Diseases; Microbiology
GA 250WX
UT WOS:000252333100021
PM 18023233
DA 2021-01-25
ER

PT J
AU Sturgill, TW
   Hall, MN
AF Sturgill, Thomas W.
   Hall, Michael N.
TI Holding back TOR advances mitosis
SO NATURE CELL BIOLOGY
LA English
DT Editorial Material
ID FISSION YEAST; NITROGEN STARVATION; CELL-GROWTH; KINASE; DOWNSTREAM;
   DIVISION; PATHWAY; PHASE; LINKS; SIZE
AB The control of cell size through the coordination of cell growth and division is a longstanding fundamental problem. a study in fission yeast shows that TOR controls entry into mitosis through the MaP kinase sty1 and so provides a molecular mechanism for the control of cell size.
C1 Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Hall, MN (corresponding author), Univ Virginia, Dept Pharmacol, Charlottesville, VA 22908 USA.
EM m.hall@unibas.ch
CR Alvarez B, 2006, J CELL SCI, V119, P4475, DOI 10.1242/jcs.03241
   FANTES P, 1977, EXP CELL RES, V107, P377, DOI 10.1016/0014-4827(77)90359-7
   Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802
   Helliwell SB, 1998, GENETICS, V148, P99
   Jorgensen P, 2004, CURR BIOL, V14, pR1014, DOI 10.1016/j.cub.2004.11.027
   Lopez-Aviles S, 2005, MOL CELL, V17, P49, DOI 10.1016/j.molcel.2004.11.043
   Manke IA, 2005, MOL CELL, V17, P37, DOI 10.1016/j.molcel.2004.11.021
   Matsuo T, 2007, MOL CELL BIOL, V27, P3154, DOI 10.1128/MCB.01039-06
   NURSE P, 1990, NATURE, V344, P503, DOI 10.1038/344503a0
   Petersen J, 2005, NATURE, V435, P507, DOI 10.1038/nature03590
   Petersen J, 2007, NAT CELL BIOL, V9, P1263, DOI 10.1038/ncb1646
   Uritani M, 2006, GENES CELLS, V11, P1367, DOI 10.1111/j.1365-2443.2006.01025.x
   Weisman R, 2001, J BIOL CHEM, V276, P7027, DOI 10.1074/jbc.M010446200
   Weisman R, 2007, GENETICS, V175, P1153, DOI 10.1534/genetics.106.064170
NR 14
TC 8
Z9 8
U1 0
U2 0
PU NATURE PUBLISHING GROUP
PI LONDON
PA MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND
SN 1465-7392
J9 NAT CELL BIOL
JI Nat. Cell Biol.
PD NOV
PY 2007
VL 9
IS 11
BP 1221
EP 1222
DI 10.1038/ncb1107-1221
PG 2
WC Cell Biology
SC Cell Biology
GA 227MA
UT WOS:000250659600004
PM 17975544
DA 2021-01-25
ER

PT J
AU Oscarson, M
   Burk, O
   Winter, S
   Schwab, M
   Wolbold, R
   Dippon, J
   Eichelbaum, M
   Meyer, UA
AF Oscarson, Mikael
   Burk, Oliver
   Winter, Stefan
   Schwab, Matthias
   Wolbold, Renzo
   Dippon, Juergen
   Eichelbaum, Michel
   Meyer, Urs A.
TI Effects of rifampicin on global gene expression in human small intestine
SO PHARMACOGENETICS AND GENOMICS
LA English
DT Article
DE ATP-binding cassette transporters; cholesterol; cytochrome P450; gene
   expression microarray analysis; glucuronosyltransferase; rifampicin;
   small intestine
ID PREGNANE-X-RECEPTOR; CONSTITUTIVE ANDROSTANE RECEPTOR; PRIMARY CULTURED
   RAT; RESPONSE ELEMENTS; UDP-GLUCURONOSYLTRANSFERASES; CYTOCHROME-P450
   EXPRESSION; GLUCOCORTICOID-RECEPTOR; MICROSOMAL-ENZYME;
   DRUG-INTERACTIONS; HUMAN HEPATOCYTES
AB Objectives: The small intestinal wall serves as an important barrier for the entry of foreign substances into the organism. Of particular importance are enzymes and transporters that can inactivate or prevent the uptake of many xenobiotics including drugs. Some of the genes encoding these proteins are transcriptionally activated by xenobiotics, a response well studied in liver but less so in the intestine. The effect of the inducer drug rifampicin on intestinal cells was therefore evaluated both in vivo and in vitro.
   Methods: Seven healthy volunteers were treated with rifampicin for 9 days and the global gene expression profile was analysed in RNA from duodenal biopsies taken before and after drug treatment. The gene expression profile was also assessed in LS1 74T cells derived from a human colon adenocarcinoma after exposure to 10 mu mol/l rifampicin for 24 h.
   Results: We identified 32 genes that were upregulated and two genes that were downregulated by rifampicin treatment in vivo. The list of rifampicin regulated transcripts expectedly included drug metabolizing enzymes and drug transporters, but also genes involved in lipid and amino acid metabolism as well as genes not previously recognized to be part of the adaptation of intestinal cells to xenobiotic exposure. Only a limited number of these rifampicin-regulated transcripts were however also regulated by rifampicin in LS1 74T cells.
   Conclusion: The similarities and differences of changes in gene expression after rifampicin treatment between duodenal biopsies and cell culture provide a new assessment of the extent and diversity of systems affected by drug exposure.
C1 Univ Basel, Biozentrum, Div Pharmacol Neurol, CH-4056 Basel, Switzerland.
   Univ Stuttgart, Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-7000 Stuttgart, Germany.
   Univ Stuttgart, Dept Math, D-7000 Stuttgart, Germany.
   Univ Tubingen, Div Clin Pharmacol, Tubingen, Germany.
RP Meyer, UA (corresponding author), Univ Basel, Biozentrum, Div Pharmacol Neurol, Kingelbergstr 50-70, CH-4056 Basel, Switzerland.
EM Urs-A.Meyer@unibas.ch
RI Schwab, Matthias/ABH-7449-2020
CR Araya Z, 1999, BBA-MOL CELL BIOL L, V1438, P47, DOI 10.1016/S1388-1981(99)00031-1
   Arnold Katja A, 2004, Nucl Recept, V2, P1, DOI 10.1186/1478-1336-2-1
   BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x
   Bertilsson G, 1998, P NATL ACAD SCI USA, V95, P12208, DOI 10.1073/pnas.95.21.12208
   Bertilsson G, 2001, BIOCHEM BIOPH RES CO, V280, P139, DOI 10.1006/bbrc.2000.4066
   Bihain BE, 1998, CURR OPIN LIPIDOL, V9, P221, DOI 10.1097/00041433-199806000-00006
   Charpentier AH, 2000, CANCER RES, V60, P5977
   Chen YP, 2003, MOL PHARMACOL, V64, P316, DOI 10.1124/mol.64.2.316
   Davis RA, 2002, J LIPID RES, V43, P533
   Dussault I, 2003, P NATL ACAD SCI USA, V100, P833, DOI 10.1073/pnas.0336235100
   Ferguson SS, 2002, MOL PHARMACOL, V62, P737, DOI 10.1124/mol.62.3.737
   Finch CK, 2002, ARCH INTERN MED, V162, P985, DOI 10.1001/archinte.162.9.985
   FRASER DJ, 2003, J BIOL CHEM
   Fromm MF, 2000, AM J PATHOL, V157, P1575, DOI 10.1016/S0002-9440(10)64794-3
   GED C, 1989, BRIT J CLIN PHARMACO, V28, P373, DOI 10.1111/j.1365-2125.1989.tb03516.x
   Geick A, 2001, J BIOL CHEM, V276, P14581, DOI 10.1074/jbc.M010173200
   Gellner K, 2001, PHARMACOGENETICS, V11, P111, DOI 10.1097/00008571-200103000-00002
   Gentleman R, 2005, BIOINFORMATICS COMPU, V746718470
   Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80
   Gerbal-Chaloin S, 2002, J BIOL CHEM, V277, P209, DOI 10.1074/jbc.M107228200
   Glaeser H, 2005, BRIT J CLIN PHARMACO, V59, P199, DOI 10.1111/j.1365-2125.2004.02265.x
   Goodwin B, 1999, MOL PHARMACOL, V56, P1329
   Goodwin B, 2003, P NATL ACAD SCI USA, V100, P223, DOI 10.1073/pnas.0237082100
   Goodwin B, 2002, ANNU REV PHARMACOL, V42, P1, DOI 10.1146/annurev.pharmtox.42.111901.111051
   Greiner B, 1999, J CLIN INVEST, V104, P147, DOI 10.1172/JCI6663
   Handschin C, 2003, PHARMACOL REV, V55, P649, DOI 10.1124/pr.55.4.2
   Hassett C, 1998, BIOCHEM PHARMACOL, V55, P1059, DOI 10.1016/S0006-2952(97)00679-5
   Horton JD, 2002, J CLIN INVEST, V109, P1125, DOI 10.1172/JCI200215593
   Huber Wolfgang, 2002, Bioinformatics, V18 Suppl 1, pS96
   Hugen PWH, 2000, ANN PHARMACOTHER, V34, P465
   Hustert E, 2001, DRUG METAB DISPOS, V29, P1454
   Ichikawa T, 2006, J BIOL CHEM, V281, P16927, DOI 10.1074/jbc.M600896200
   Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249
   Jakobsson PJ, 1997, J BIOL CHEM, V272, P22934, DOI 10.1074/jbc.272.36.22934
   Jigorel E, 2006, DRUG METAB DISPOS, V34, P1756, DOI 10.1124/dmd.106.010033
   Kawabe T, 1999, FEBS LETT, V456, P327, DOI 10.1016/S0014-5793(99)00979-5
   Keppler D, 2000, SEMIN LIVER DIS, V20, P265, DOI 10.1055/s-2000-9391
   Kocarek TA, 1998, MOL PHARMACOL, V54, P474
   KOLARS JC, 1992, J CLIN INVEST, V90, P1871, DOI 10.1172/JCI116064
   LeCluyse EL, 2001, EUR J PHARM SCI, V13, P343, DOI 10.1016/S0928-0987(01)00135-X
   Lehmann JM, 1998, J CLIN INVEST, V102, P1016, DOI 10.1172/JCI3703
   Lin JH, 2001, ANNU REV PHARMACOL, V41, P535, DOI 10.1146/annurev.pharmtox.41.1.535
   Maglich JM, 2002, MOL PHARMACOL, V62, P638, DOI 10.1124/mol.62.3.638
   Nishimura M, 2002, YAKUGAKU ZASSHI, V122, P339, DOI 10.1248/yakushi.122.339
   Numazawa Satoshi, 2004, J Toxicol Sci, V29, P81, DOI 10.2131/jts.29.81
   Ohta K, 2004, DEV CELL, V7, P347, DOI 10.1016/j.devcel.2004.08.014
   Ourlin JC, 2002, BIOCHEM BIOPH RES CO, V291, P378, DOI 10.1006/bbrc.2002.6464
   Ourlin JC, 2003, MOL ENDOCRINOL, V17, P1693, DOI 10.1210/me.2002-0383
   Pascussi JM, 1999, BIOCHEM BIOPH RES CO, V260, P377, DOI 10.1006/bbrc.1999.0745
   Rae JM, 2001, J PHARMACOL EXP THER, V299, P849
   Rosenfeld JM, 2003, MOL ENDOCRINOL, V17, P1268, DOI 10.1210/me.2002-0421
   Ruschitzka F, 2000, LANCET, V355, P548, DOI 10.1016/S0140-6736(99)05467-7
   Sabol SL, 2005, J LIPID RES, V46, P2151, DOI 10.1194/jlr.M500080-JLR200
   Schmitz G, 2001, J LIPID RES, V42, P1513
   Shang YF, 2002, SCIENCE, V295, P2465, DOI 10.1126/science.1068537
   Shelby MK, 2006, DRUG METAB DISPOS, V34, P1772, DOI 10.1124/dmd.106.010397
   Shenoy SD, 2004, DRUG METAB DISPOS, V32, P66, DOI 10.1124/dmd.32.1.66
   Smyth G.K., 2004, STAT APPL GENET MOL, V3, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]
   Sonoda J, 2002, P NATL ACAD SCI USA, V99, P13801, DOI 10.1073/pnas.212494599
   Sueyoshi T, 2001, ANNU REV PHARMACOL, V41, P123, DOI 10.1146/annurev.pharmtox.41.1.123
   TOM BH, 1976, IN VITRO CELL DEV B, V12, P180
   Tukey RH, 2000, ANNU REV PHARMACOL, V40, P581, DOI 10.1146/annurev.pharmtox.40.1.581
   TURLEY SD, 1981, J LIPID RES, V22, P551
   Ueda A, 2002, MOL PHARMACOL, V61, P1, DOI 10.1124/mol.61.1.1
   Wilbur K, 2000, CLIN PHARMACOKINET, V38, P355, DOI 10.2165/00003088-200038040-00004
   Xie W, 2001, P NATL ACAD SCI USA, V98, P3375, DOI 10.1073/pnas.051014398
   Yen FT, 1999, J BIOL CHEM, V274, P13390, DOI 10.1074/jbc.274.19.13390
NR 67
TC 20
Z9 20
U1 0
U2 2
PU LIPPINCOTT WILLIAMS & WILKINS
PI PHILADELPHIA
PA TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA
SN 1744-6872
EI 1744-6880
J9 PHARMACOGENET GENOM
JI Pharmacogenet. Genomics
PD NOV
PY 2007
VL 17
IS 11
BP 907
EP 918
DI 10.1097/FPC.0b013e3280143dfc
PG 12
WC Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology
   & Pharmacy
SC Biotechnology & Applied Microbiology; Genetics & Heredity; Pharmacology
   & Pharmacy
GA 224VW
UT WOS:000250476300002
PM 18075461
DA 2021-01-25
ER

PT J
AU Vohradsky, J
   Branny, P
   Thompson, CJ
AF Vohradsky, Jiri
   Branny, Pavel
   Thompson, Charles J.
TI Comparative analysis of gene expression on mRNA and protein level during
   development of Streptomyces cultures by using singular value
   decomposition
SO PROTEOMICS
LA English
DT Article
DE development; gene expression profiling; singular value decomposition;
   Streptomyces
ID COELICOLOR A3(2); SUBMERGED CULTURE; ESCHERICHIA-COLI; SPORULATION;
   GROWTH; DIFFERENTIATION; IDENTIFICATION; TRANSCRIPTION; PATTERNS
AB This paper describes a comparative systems level analysis of the developmental proteome and transcriptome in the model antibiotic-producing eubacterium Streptomyces coelicolor, cultured on different media. The analysis formulates expression as the superposition of effects of regulatory networks and biological processes which can be identified using singular value decomposition (SVD) of a data matrix formed by time series measurements of expression of individual genes throughout the cell cycle of the bacterium. SVD produces linearly orthogonal factors, each of which can represent an independent system behavior defined by a linear combination of the genes/proteins highly correlated with the corresponding factor. By using SVD of the developmental time series of gene expression, as measured by both protein and RNA levels, we show that on the highest level of control (representing the basic kinetic behavior of the population), the results are identical, regardless of the type of experiment or cultivation method. The results show that this approach is capable of identifying basic regulatory processes independent of the environment in which the organism lives. It also shows that these processes are manifested equally on protein and RNA levels. Biological interpretation of the correlation of the genes and proteins with significant eigenprofiles (representing the highest level kinetic behavior of protein and/or RNA synthesis) revealed their association with metabolic processes, stress responses, starvation, and secondary metabolite production.
C1 Acad Sci Czech Republic, Inst Microbiol, CR-14220 Prague, Czech Republic.
   Univ Basel, Biozentrum, Div Mol Microbiol, Basel, Switzerland.
RP Vohradsky, J (corresponding author), Acad Sci Czech Republic, Inst Microbiol, Videnska 1083, CR-14220 Prague, Czech Republic.
EM vohr@biomed.cas.cz
RI Branny, Pavel/H-2490-2014
CR Almaas E, 2004, NATURE, V427, P839, DOI 10.1038/nature02289
   Alter O, 2000, P NATL ACAD SCI USA, V97, P10101, DOI 10.1073/pnas.97.18.10101
   Alter O, 2003, P NATL ACAD SCI USA, V100, P3351, DOI 10.1073/pnas.0530258100
   Bendt AK, 2003, PROTEOMICS, V3, P1637, DOI 10.1002/pmic.200300494
   Berrar D., 2003, PRACTICAL APPROACH M, P91
   BLANCO G, 1994, MOL MICROBIOL, V12, P375, DOI 10.1111/j.1365-2958.1994.tb01027.x
   Chater KF, 1998, MICROBIOL-UK, V144, P1465, DOI 10.1099/00221287-144-6-1465
   DARY A, 1993, MOL MICROBIOL, V10, P759, DOI 10.1111/j.1365-2958.1993.tb00946.x
   DAVIS NK, 1992, MOL GEN GENET, V232, P351, DOI 10.1007/BF00266237
   DAZA A, 1989, J GEN MICROBIOL, V135, P2483
   Floriano B, 1996, MOL MICROBIOL, V21, P385, DOI 10.1046/j.1365-2958.1996.6491364.x
   GRANOZZI C, 1990, J GEN MICROBIOL, V136, P713, DOI 10.1099/00221287-136-4-713
   HOLT TG, 1992, MOL MICROBIOL, V6, P969, DOI 10.1111/j.1365-2958.1992.tb02163.x
   Holter NS, 2000, P NATL ACAD SCI USA, V97, P8409, DOI 10.1073/pnas.150242097
   Holter NS, 2001, P NATL ACAD SCI USA, V98, P1693, DOI 10.1073/pnas.98.4.1693
   Huang JQ, 2001, GENE DEV, V15, P3183, DOI 10.1101/gad.943401
   KENDRICK KE, 1983, J BACTERIOL, V155, P357, DOI 10.1128/JB.155.1.357-366.1983
   Levine A, 2006, PROTEOMICS, V6, P2157, DOI 10.1002/pmic.200500352
   NOVELLA IS, 1992, CAN J MICROBIOL, V38, P769, DOI 10.1139/m92-125
   Novotna J, 2003, MOL MICROBIOL, V48, P1289, DOI 10.1046/j.1365-2958.2003.03529.x
   Press WH, 1994, NUMERICAL RECIPES C, P59
   PUGLIA AM, 1995, MOL MICROBIOL, V17, P737, DOI 10.1111/j.1365-2958.1995.mmi_17040737.x
   SALAHBEY K, 1995, MOL MICROBIOL, V17, P1001, DOI 10.1111/j.1365-2958.1995.mmi_17051001.x
   SOLIVERI J, 1992, J BACTERIOL, V174, P6215, DOI 10.1128/JB.174.19.6215-6220.1992
   Susstrunk U, 1998, MOL MICROBIOL, V30, P33, DOI 10.1046/j.1365-2958.1998.01033.x
   Viollier PH, 2001, J BACTERIOL, V183, P3193, DOI 10.1128/JB.183.10.3193-3203.2001
   Vohradsky J, 1997, ELECTROPHORESIS, V18, P1418, DOI 10.1002/elps.1150180817
   Vohradsky J, 2001, FASEB J, V15, P2054, DOI 10.1096/fj.00-0889fje
   WRAY LV, 1991, J BACTERIOL, V173, P7351, DOI 10.1128/jb.173.22.7351-7360.1991
NR 29
TC 11
Z9 11
U1 0
U2 8
PU WILEY
PI HOBOKEN
PA 111 RIVER ST, HOBOKEN 07030-5774, NJ USA
SN 1615-9853
EI 1615-9861
J9 PROTEOMICS
JI Proteomics
PD NOV
PY 2007
VL 7
IS 21
BP 3853
EP 3866
DI 10.1002/pmic.200700005
PG 14
WC Biochemical Research Methods; Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 232KA
UT WOS:000251016800003
PM 17960737
DA 2021-01-25
ER

PT J
AU Martin, G
   Keller, W
AF Martin, Georges
   Keller, Walter
TI RNA-specific ribonucleotidyl transferases
SO RNA
LA English
DT Review
DE CCA-adding enzyme; poly(A) polymerase; RNA modification; terminal
   uridylyl transferase; 2'-5'-oligo(A) synthetase
ID CCA-ADDING ENZYME; DNA-POLYMERASE-BETA; MAMMALIAN POLY(A) POLYMERASE;
   INDUCED FIT MECHANISM; PRE-MESSENGER-RNA; S-M CHECKPOINT;
   ESCHERICHIA-COLI; SACCHAROMYCES-CEREVISIAE; CRYSTAL-STRUCTURES; FISSION
   YEAST
AB RNA-specific nucleotidyl transferases (rNTrs) are a diverse family of template-independent polymerases that add ribonucleotides to the 3'-ends of RNA molecules. All rNTrs share a related active-site architecture first described for DNA polymerase beta and a catalytic mechanism conserved among DNA and RNA polymerases. The best known examples are the nuclear poly( A) polymerases involved in the 3'-end processing of eukaryotic messenger RNA precursors and the ubiquitous CCA- adding enzymes that complete the 3'- ends of tRNA molecules. In recent years, a growing number of new enzymes have been added to the list that now includes the "noncanonical'' poly(A) polymerases involved in RNA quality control or in the readenylation of dormant messenger RNAs in the cytoplasm. Other members of the group are terminal uridylyl transferases adding single or multiple UMP residues in RNA-editing reactions or upon the maturation of small RNAs and poly(U) polymerases, the substrates of which are still not known. 2'-5'Oligo(A) synthetases differ from the other rNTrs by synthesizing oligonucleotides with 2'-5'phosphodiester bonds de novo.
C1 Univ Basel, Dept Cell Biol, Biozentrum, CH-4056 Basel, Switzerland.
RP Keller, W (corresponding author), Univ Basel, Dept Cell Biol, Biozentrum, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM walter.keller@unibas.ch
CR Aphasizhev R, 2005, CELL MOL LIFE SCI, V62, P2194, DOI 10.1007/s00018-005-5198-9
   Aphasizhev R, 2004, FEBS LETT, V572, P15, DOI 10.1016/j.febslet.2004.07.004
   Aravind L, 1999, NUCLEIC ACIDS RES, V27, P1609, DOI 10.1093/nar/27.7.1609
   AUGUST JT, 1962, J BIOL CHEM, V237, P3786
   Augustin MA, 2003, J MOL BIOL, V328, P985, DOI 10.1016/S0022-2836(03)00381-4
   BAKALARA N, 1989, J BIOL CHEM, V264, P18679
   Balbo PB, 2007, J MOL BIOL, V366, P1401, DOI 10.1016/j.jmb.2006.12.030
   Balbo PB, 2005, BIOCHEMISTRY-US, V44, P7777, DOI 10.1021/bi050089r
   Bard J, 2000, SCIENCE, V289, P1346, DOI 10.1126/science.289.5483.1346
   Barnard DC, 2004, CELL, V119, P641, DOI 10.1016/j.cell.2004.10.029
   BENECH P, 1987, MOL CELL BIOL, V7, P4498, DOI 10.1128/MCB.7.12.4498
   Betat H, 2004, MOL CELL, V15, P389, DOI 10.1016/j.molcel.2004.06.026
   BLUM B, 1990, CELL, V62, P391, DOI 10.1016/0092-8674(90)90375-O
   Carpousis AJ, 2007, ANNU REV MICROBIOL, V61, P71, DOI 10.1146/annurev.micro.61.080706.093440
   Castano IB, 1996, NUCLEIC ACIDS RES, V24, P2404, DOI 10.1093/nar/24.12.2404
   Castano IB, 1996, GENE DEV, V10, P2564, DOI 10.1101/gad.10.20.2564
   Cho HDD, 2006, J BIOL CHEM, V281, P9801, DOI 10.1074/jbc.M512603200
   Cho HD, 2007, P NATL ACAD SCI USA, V104, P54, DOI 10.1073/pnas.0606961104
   Colgan DF, 1996, NATURE, V384, P282, DOI 10.1038/384282a0
   Colgan DF, 1998, EMBO J, V17, P1053, DOI 10.1093/emboj/17.4.1053
   DeLano W. L., 2002, PYMOL MOL GRAPHICS S
   Delarue M, 2002, EMBO J, V21, P427, DOI 10.1093/emboj/21.3.427
   Deng JP, 2005, EMBO J, V24, P4007, DOI 10.1038/sj.emboj.7600861
   Deutscher MP, 2003, J BIOL CHEM, V278, P45041, DOI 10.1074/jbc.R300031200
   Edmonds M, 2002, PROG NUCLEIC ACID RE, V71, P285, DOI 10.1016/S0079-6603(02)71046-5
   EDMONDS M, 1960, J BIOL CHEM, V235, P1142
   Gunderson SI, 1998, MOL CELL, V1, P255, DOI 10.1016/S1097-2765(00)80026-X
   Gunderson SI, 1997, GENE DEV, V11, P761, DOI 10.1101/gad.11.6.761
   GUNDERSON SI, 1994, CELL, V76, P531, DOI 10.1016/0092-8674(94)90116-3
   HAJNSDORF E, 1995, P NATL ACAD SCI USA, V92, P3973, DOI 10.1073/pnas.92.9.3973
   Hartmann R, 2003, MOL CELL, V12, P1173, DOI 10.1016/S1097-2765(03)00433-7
   HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P345, DOI 10.1016/S0968-0004(00)89071-4
   HOLM L, 1993, J MOL BIOL, V233, P123, DOI 10.1006/jmbi.1993.1489
   Justesen J, 2000, CELL MOL LIFE SCI, V57, P1593, DOI 10.1007/PL00000644
   Kadaba S, 2004, GENE DEV, V18, P1227, DOI 10.1101/gad.1183804
   Kadyk LC, 1998, DEVELOPMENT, V125, P1803
   Kashiwabara S, 2000, DEV BIOL, V228, P106, DOI 10.1006/dbio.2000.9894
   Kaufmann I, 2004, EMBO J, V23, P616, DOI 10.1038/sj.emboj.7600070
   Kim JH, 2006, MOL CELL, V24, P173, DOI 10.1016/j.molcel.2006.08.016
   Kuhn U, 2004, BBA-GENE STRUCT EXPR, V1678, P67, DOI 10.1016/j.bbaexp.2004.03.008
   Kuhn U, 2003, J BIOL CHEM, V278, P16916, DOI 10.1074/jbc.M209886200
   Kushner SR, 2002, J BACTERIOL, V184, P4658, DOI 10.1128/JB.184.17.4658-4665.2002
   Kwak JE, 2007, RNA, V13, P860, DOI 10.1261/rna.514007
   Kwak JE, 2004, P NATL ACAD SCI USA, V101, P4407, DOI 10.1073/pnas.0400779101
   Kyriakopoulou CB, 2001, J BIOL CHEM, V276, P33504, DOI 10.1074/jbc.M104599200
   LaCava J, 2005, CELL, V121, P713, DOI 10.1016/j.cell.2005.04.029
   Lee YJ, 2001, MOL CELLS, V11, P379
   Lee YJ, 2000, FEBS LETT, V487, P287, DOI 10.1016/S0014-5793(00)02367-X
   Lehmann C, 2005, PROTEINS, V60, P807, DOI 10.1002/prot.20586
   Li F, 2002, CELL, V111, P815, DOI 10.1016/S0092-8674(02)01115-7
   LINGNER J, 1991, NATURE, V354, P496, DOI 10.1038/354496a0
   Martin G, 2004, J MOL BIOL, V341, P911, DOI 10.1016/j.jmb.2004.06.047
   Martin G, 2004, RNA, V10, P899, DOI 10.1261/rna.5242304
   Martin G, 1996, EMBO J, V15, P2593, DOI 10.1002/j.1460-2075.1996.tb00617.x
   Martin G, 2000, EMBO J, V19, P4193, DOI 10.1093/emboj/19.16.4193
   Matsuyama A, 2006, NAT BIOTECHNOL, V24, P841, DOI 10.1038/nbt1222
   McManus MT, 2000, MOL CELL BIOL, V20, P883, DOI 10.1128/MCB.20.3.883-891.2000
   Mendez R, 2001, NAT REV MOL CELL BIO, V2, P521, DOI 10.1038/35080081
   Minoda Y, 2006, BIOCHEM BIOPH RES CO, V344, P1023, DOI 10.1016/j.bbrc.2006.04.006
   Mohanty BK, 2006, NUCLEIC ACIDS RES, V34, P5695, DOI 10.1093/nar/gkl684
   Mohanty BK, 2000, P NATL ACAD SCI USA, V97, P11966, DOI 10.1073/pnas.220295997
   Mohanty BK, 1999, MOL MICROBIOL, V34, P1109, DOI 10.1046/j.1365-2958.1999.01674.x
   Moure CM, 2006, MOL CELL, V22, P339, DOI 10.1016/j.molcel.2006.03.015
   Nagaike T, 2005, J BIOL CHEM, V280, P19721, DOI 10.1074/jbc.M500804200
   Nakanishi T, 2006, DEV BIOL, V289, P115, DOI 10.1016/j.ydbio.2005.10.017
   OHARA EB, 1995, P NATL ACAD SCI USA, V92, P1807, DOI 10.1073/pnas.92.6.1807
   PEDERSEN LC, 1995, BIOCHEMISTRY-US, V34, P13305, DOI 10.1021/bi00041a005
   PELLETIER H, 1994, SCIENCE, V264, P1891, DOI 10.1126/science.7516580
   Perumal K, 2001, J BIOL CHEM, V276, P21791, DOI 10.1074/jbc.M101905200
   Pines J, 2006, TRENDS CELL BIOL, V16, P55, DOI 10.1016/j.tcb.2005.11.006
   RAABE T, 1991, NATURE, V353, P229, DOI 10.1038/353229a0
   Ramadan K, 2004, NAT REV MOL CELL BIO, V5, P1038, DOI 10.1038/nrm1530
   Read RL, 2002, P NATL ACAD SCI USA, V99, P12079, DOI 10.1073/pnas.192467799
   Rissland OS, 2007, MOL CELL BIOL, V27, P3612, DOI 10.1128/MCB.02209-06
   Rogozin IB, 2003, J MOL BIOL, V326, P1449, DOI 10.1016/S0022-2836(03)00055-X
   Rott R, 2003, J BIOL CHEM, V278, P15771, DOI 10.1074/jbc.M211571200
   SADOFF BU, 1995, GENETICS, V141, P465
   Saitoh S, 2002, CELL, V109, P563, DOI 10.1016/S0092-8674(02)00753-5
   Sawaya MR, 1997, BIOCHEMISTRY-US, V36, P11205, DOI 10.1021/bi9703812
   SAWAYA MR, 1994, SCIENCE, V264, P1930, DOI 10.1126/science.7516581
   Schneider C, 2007, MOL CELL, V27, P324, DOI 10.1016/j.molcel.2007.06.006
   SCHNIERLE BS, 1992, P NATL ACAD SCI USA, V89, P2897, DOI 10.1073/pnas.89.7.2897
   Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521
   Shi PY, 1998, EMBO J, V17, P3197, DOI 10.1093/emboj/17.11.3197
   Shi PY, 1998, RNA, V4, P276
   Simpson L, 2004, RNA, V10, P159, DOI 10.1261/rna.5170704
   Stagno J, 2007, J MOL BIOL, V366, P882, DOI 10.1016/j.jmb.2006.11.065
   Steitz TA, 1998, NATURE, V391, P231, DOI 10.1038/34542
   Stevenson AL, 2006, YEAST, V23, P991, DOI 10.1002/yea.1408
   Stuart KD, 2005, TRENDS BIOCHEM SCI, V30, P97, DOI 10.1016/j.tibs.2004.12.006
   Suh N, 2006, P NATL ACAD SCI USA, V103, P15108, DOI 10.1073/pnas.0607050103
   Thai TH, 2005, ADV IMMUNOL, V86, P113, DOI 10.1016/S0065-2776(04)86003-6
   Tomecki R, 2004, NUCLEIC ACIDS RES, V32, P6001, DOI 10.1093/nar/gkh923
   Tomita K, 2004, NATURE, V430, P700, DOI 10.1038/nature02712
   Tomita K, 2006, NATURE, V443, P956, DOI 10.1038/nature05204
   Topalian SL, 2001, MOL CELL BIOL, V21, P5614, DOI 10.1128/MCB.21.16.5614-5623.2001
   Trippe R, 2003, EUR J BIOCHEM, V270, P971, DOI 10.1046/j.1432-1033.2003.03466.x
   Trippe R, 2006, RNA, V12, P1494, DOI 10.1261/rna.87706
   Vagner S, 2000, GENE DEV, V14, P403
   Vanacova S, 2005, PLOS BIOL, V3, P986, DOI 10.1371/journal.pbio.0030189
   Vanacova S, 2007, EMBO REP, V8, P651, DOI 10.1038/sj.embor.7401005
   WAHLE E, 1991, EMBO J, V10, P4251, DOI 10.1002/j.1460-2075.1991.tb05003.x
   WAHLE E, 1991, CELL, V66, P759, DOI 10.1016/0092-8674(91)90119-J
   Wahle E, 1999, FEMS MICROBIOL REV, V23, P277, DOI 10.1111/j.1574-6976.1999.tb00400.x
   Walowsky C, 1999, J BIOL CHEM, V274, P7302, DOI 10.1074/jbc.274.11.7302
   Wang GL, 1999, MOL CELL BIOL, V19, P342
   Wang LT, 2002, NATURE, V419, P312, DOI 10.1038/nature01039
   Wang SW, 1999, J CELL SCI, V112, P927
   Wang SW, 2000, MOL CELL BIOL, V20, P3234, DOI 10.1128/MCB.20.9.3234-3244.2000
   Wang ZH, 2000, SCIENCE, V289, P774, DOI 10.1126/science.289.5480.774
   Win TZ, 2006, MOL CELL BIOL, V26, P1710, DOI 10.1128/MCB.26.5.1710-1721.2006
   Wyers F, 2005, CELL, V121, P725, DOI 10.1016/j.cell.2005.04.030
   Xiong Y, 2006, CURR OPIN STRUC BIOL, V16, P12, DOI 10.1016/j.sbi.2005.12.001
   Xiong Y, 2004, NATURE, V430, P640, DOI 10.1038/nature02711
   Xiong Y, 2003, MOL CELL, V12, P1165, DOI 10.1016/S1097-2765(03)00440-4
   Yehudai-Resheff S, 2000, NUCLEIC ACIDS RES, V28, P1139, DOI 10.1093/nar/28.5.1139
   Yue DX, 1996, RNA, V2, P895
   Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999
   Zhao WQ, 1996, MOL CELL BIOL, V16, P2378
   ZHELKOVSKY AM, 1995, J BIOL CHEM, V270, P26715, DOI 10.1074/jbc.270.44.26715
NR 120
TC 152
Z9 152
U1 0
U2 8
PU COLD SPRING HARBOR LAB PRESS, PUBLICATIONS DEPT
PI COLD SPRING HARBOR
PA 1 BUNGTOWN RD, COLD SPRING HARBOR, NY 11724 USA
SN 1355-8382
EI 1469-9001
J9 RNA
JI RNA
PD NOV
PY 2007
VL 13
IS 11
BP 1834
EP 1849
DI 10.1261/rna.652807
PG 16
WC Biochemistry & Molecular Biology
SC Biochemistry & Molecular Biology
GA 221KK
UT WOS:000250225900002
PM 17872511
OA Green Published, Bronze, Green Accepted
DA 2021-01-25
ER

PT J
AU Lim, RYH
   Fahrenkrog, B
   Koser, J
   Schwarz-Herion, K
   Deng, J
   Aebi, U
AF Lim, Roderick Y. H.
   Fahrenkrog, Birthe
   Koeser, Joachim
   Schwarz-Herion, Kyrill
   Deng, Jie
   Aebi, Ueli
TI Nanomechanical basis of selective gating by the nuclear pore complex
SO SCIENCE
LA English
DT Article
ID PHENYLALANINE-GLYCINE NUCLEOPORINS; NUCLEOCYTOPLASMIC TRANSPORT; PROTEIN
   IMPORT; BINDING-DYNAMICS; REPEAT REGIONS; MECHANISM; PERMEABILITY;
   SPECTROSCOPY; TOPOLOGY; CYCLE
AB The nuclear pore complex regulates cargo transport between the cytoplasm and the nucleus. We set out to correlate the governing biochemical interactions to the nanoscopic responses of the phenylalanine-glycine (FG)-rich nucleoporin domains, which are involved in attenuating or promoting cargo translocation. We found that binding interactions with the transport receptor karyopherin-beta 1 caused the FG domains of the human nucleoporin Nup153 to collapse into compact molecular conformations. This effect was reversed by the action of Ran guanosine triphosphate, which returned the FG domains into a polymer brush-like, entropic barrier conformation. Similar effects were observed in Xenopus oocyte nuclei in situ. Thus, the reversible collapse of the FG domains may play an important role in regulating nucleocytoplasmic transport.
C1 Univ Basel, Biozentrum, ME Muller Inst Struct Biol, CH-4056 Basel, Switzerland.
   Inst Mat Res & Engn, Singapore 117602, Singapore.
RP Lim, RYH (corresponding author), Univ Basel, Biozentrum, ME Muller Inst Struct Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM roderick.lim@unibas.ch; birthe.fahrenkrog@unibas.ch
RI Fahrenkrog, Birthe/D-5840-2011
OI Fahrenkrog, Birthe/0000-0003-4080-9413; Lim,
   Roderick/0000-0001-5015-6087
CR Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808
   Chattopadhyay K, 2005, P NATL ACAD SCI USA, V102, P2385, DOI 10.1073/pnas.0500127102
   Denning DP, 2003, P NATL ACAD SCI USA, V100, P2450, DOI 10.1073/pnas.0437902100
   Dunker AK, 2001, NAT BIOTECHNOL, V19, P805, DOI 10.1038/nbt0901-805
   Eijkel JCT, 2005, MICROFLUID NANOFLUID, V1, P249, DOI 10.1007/s10404-004-0012-9
   Fahrenkrog B, 2003, NAT REV MOL CELL BIO, V4, P757, DOI 10.1038/nrm1230
   Fahrenkrog B, 2002, J STRUCT BIOL, V140, P254, DOI 10.1016/S1047-8477(02)00524-5
   Frey S, 2006, SCIENCE, V314, P815, DOI 10.1126/science.1132516
   Gorlich D, 1996, EMBO J, V15, P5584, DOI 10.1002/j.1460-2075.1996.tb00943.x
   Isgro TA, 2005, STRUCTURE, V13, P1869, DOI 10.1016/j.str.2005.09.007
   Lim RYH, 2007, J STRUCT BIOL, V159, P277, DOI 10.1016/j.jsb.2007.01.018
   Lim RYH, 2006, P NATL ACAD SCI USA, V103, P9512, DOI 10.1073/pnas.0603521103
   Macara IG, 2001, MICROBIOL MOL BIOL R, V65, P570, DOI 10.1128/MMBR.65.4.570-594.2001
   Pante N, 2002, MOL BIOL CELL, V13, P425, DOI 10.1091/mbc.01-06-0308
   Paradise A, 2007, J MOL BIOL, V365, P50, DOI 10.1016/j.jmb.2006.09.089
   Patel SS, 2007, CELL, V129, P83, DOI 10.1016/j.cell.2007.01.044
   Paulillo SM, 2005, J MOL BIOL, V351, P784, DOI 10.1016/j.jmb.2005.06.034
   Peters R, 2005, TRAFFIC, V6, P421, DOI 10.1111/j.1600-0854.2005.00287.x
   REXACH M, 1995, CELL, V83, P683, DOI 10.1016/0092-8674(95)90181-7
   Ribbeck K, 2002, EMBO J, V21, P2664, DOI 10.1093/emboj/21.11.2664
   Rout MP, 2000, J CELL BIOL, V148, P635, DOI 10.1083/jcb.148.4.635
   Shoemaker BA, 2000, P NATL ACAD SCI USA, V97, P8868, DOI 10.1073/pnas.160259697
   Shulga N, 2003, MOL CELL BIOL, V23, P534, DOI 10.1128/MCB.23.2.534-542.2003
   Stewart M, 2007, NAT REV MOL CELL BIO, V8, P195, DOI 10.1038/nrm2114
   Strawn LA, 2004, NAT CELL BIOL, V6, P197, DOI 10.1038/ncb1097
   Suntharalingam M, 2003, DEV CELL, V4, P775, DOI 10.1016/S1534-5807(03)00162-X
   Timney BL, 2006, J CELL BIOL, V175, P579, DOI 10.1083/jcb.200608141
   Weis K, 2003, CELL, V112, P441, DOI 10.1016/S0092-8674(03)00082-5
   Yang WD, 2006, J CELL BIOL, V174, P951, DOI 10.1083/jcb.200605053
NR 29
TC 218
Z9 218
U1 1
U2 47
PU AMER ASSOC ADVANCEMENT SCIENCE
PI WASHINGTON
PA 1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA
SN 0036-8075
J9 SCIENCE
JI Science
PD OCT 26
PY 2007
VL 318
IS 5850
BP 640
EP 643
DI 10.1126/science.1145980
PG 4
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 223XL
UT WOS:000250409200045
PM 17916694
DA 2021-01-25
ER

PT J
AU Ladle, DR
   Pecho-Vrieseling, E
   Arber, S
AF Ladle, David R.
   Pecho-Vrieseling, Eline
   Arber, Silvia
TI Assembly of motor circuits in the spinal cord: Driven to function by
   genetic and experience-dependent mechanisms
SO NEURON
LA English
DT Review
ID NOCICEPTIVE WITHDRAWAL REFLEXES; POSTNATAL-DEVELOPMENT;
   LOCOMOTOR-ACTIVITY; ALPHA-MOTONEURONS; SENSORY AXONS; DORSAL-HORN;
   NEURON POOL; CELL BODY; INTERNEURONS; ORGANIZATION
AB Motor circuits in the spinal cord integrate information from various sensory and descending pathways to control appropriate motor behavior. Recent work has revealed that target-derived retrograde signaling mechanisms act to influence sequential assembly of motor circuits through combinatorial action of genetic and experience-driven programs. These parallel activities imprint somatotopic information at the level of the spinal cord in precisely interconnected circuits and equip animals with motor circuits capable of reacting to changing demands throughout life.
C1 Univ Basel, Biozentrum, Dept Cell Biol, CH-4056 Basel, Switzerland.
   Friedrich Miescher Inst, CH-4058 Basel, Switzerland.
RP Arber, S (corresponding author), Univ Basel, Biozentrum, Dept Cell Biol, Klingelbergstr 70, CH-4056 Basel, Switzerland.
EM silvia.arber@unibas.ch
RI Pecho-Vrieseling, Eline/AAP-7239-2020
OI Arber, Silvia/0000-0002-6261-250X
CR Alvarez FJ, 2005, J COMP NEUROL, V493, P177, DOI 10.1002/cne.20711
   ALVAREZ FJ, 2007, IN PRESS J PHYSL
   Arber S, 2000, CELL, V101, P485, DOI 10.1016/S0092-8674(00)80859-4
   Boldogkoi Z, 2004, PROG NEUROBIOL, V72, P417, DOI 10.1016/j.pneurobio.2004.03.010
   Branchereau P, 2000, BRAIN RES BULL, V53, P711, DOI 10.1016/S0361-9230(00)00403-2
   BROWN AG, 1981, J PHYSIOL-LONDON, V313, P121, DOI 10.1113/jphysiol.1981.sp013654
   BROWN AG, 1978, J PHYSIOL-LONDON, V274, P111, DOI 10.1113/jphysiol.1978.sp012137
   BROWN AG, 1982, Q J EXP PHYSIOL CMS, V67, P193
   Burke RE, 1996, J COMP NEUROL, V372, P465
   Carr PA, 1998, NEUROREPORT, V9, P2657, DOI 10.1097/00001756-199808030-00043
   Chang Q, 1999, J NEUROSCI, V19, P10813
   Chen AI, 2006, NEURON, V49, P395, DOI 10.1016/j.neuron.2005.12.028
   Chen CL, 2006, NEURON, V49, P365, DOI 10.1016/j.neuron.2005.10.036
   Chen HH, 2002, J NEUROSCI, V22, P3512
   Chen XY, 1997, J NEUROPHYSIOL, V78, P1730
   CONRADI S, 1979, J COMP NEUROL, V184, P741, DOI 10.1002/cne.901840407
   CULLHEIM S, 1985, DEV BRAIN RES, V17, P63, DOI 10.1016/0165-3806(85)90132-4
   Dasen JS, 2005, CELL, V123, P477, DOI 10.1016/j.cell.2005.09.009
   Dasen JS, 2003, NATURE, V425, P926, DOI 10.1038/nature02051
   DAVIS BM, 1989, J COMP NEUROL, V279, P556, DOI 10.1002/cne.902790405
   ECCLES JC, 1957, J PHYSIOL-LONDON, V137, P22, DOI 10.1113/jphysiol.1957.sp005794
   FLUMELLI H, 2007, CURR OPIN NEUROBIOL, V17, P81
   FRANK E, 1993, NEURON, V10, P779, DOI 10.1016/0896-6273(93)90194-V
   Fyffe REW, 2001, METH NE FRO NEUROSCI, P21
   FYFFE REW, 1991, J NEUROPHYSIOL, V65, P1134
   Gonzalez-Islas C, 2006, NEURON, V49, P563, DOI 10.1016/j.neuron.2006.01.017
   Goulding M, 2005, CURR OPIN NEUROBIOL, V15, P14, DOI 10.1016/j.conb.2005.01.017
   Grande G, 2005, J COMP NEUROL, V491, P339, DOI 10.1002/cne.20699
   Grillner S, 2006, NEURON, V52, P751, DOI 10.1016/j.neuron.2006.11.008
   Gross MK, 2002, NEURON, V34, P535, DOI 10.1016/S0896-6273(02)00690-6
   Haase G, 2002, NEURON, V35, P893, DOI 10.1016/S0896-6273(02)00864-4
   Hanson MG, 2003, J NEUROSCI, V23, P587
   Hellstrom J, 2003, J COMP NEUROL, V460, P476, DOI 10.1002/cne.10648
   Helms AW, 2003, CURR OPIN NEUROBIOL, V13, P42, DOI 10.1016/S0959-4388(03)00010-2
   Hinckley CA, 2005, J NEUROPHYSIOL, V93, P1439, DOI 10.1152/jn.00647.2004
   Hippenmeyer S, 2004, TRENDS NEUROSCI, V27, P482, DOI 10.1016/j.tins.2004.05.012
   Hodge LK, 2007, NEURON, V55, P572, DOI 10.1016/j.neuron.2007.07.010
   HOLLYDAY M, 1977, BRAIN RES, V132, P197, DOI 10.1016/0006-8993(77)90416-4
   Hollyday M., 1980, Current Topics in Developmental Biology, V15, P181
   Holmberg H, 1996, J PHYSIOL-LONDON, V493, P239, DOI 10.1113/jphysiol.1996.sp021379
   Huang ZJ, 2006, NAT NEUROSCI, V9, P163, DOI 10.1038/nn1638
   Hubner CA, 2001, NEURON, V30, P515, DOI 10.1016/S0896-6273(01)00297-5
   Hultborn H, 2006, PROG NEUROBIOL, V78, P215, DOI 10.1016/j.pneurobio.2006.04.001
   Inoue K, 2002, NAT NEUROSCI, V5, P946, DOI 10.1038/nn925
   JANKOWSKA E, 1992, PROG NEUROBIOL, V38, P335, DOI 10.1016/0301-0082(92)90024-9
   Jessell TM, 2000, NAT REV GENET, V1, P20, DOI 10.1038/35049541
   Katz PS, 1999, CURR OPIN NEUROBIOL, V9, P628, DOI 10.1016/S0959-4388(99)00012-4
   Kiehn O, 2002, TRENDS NEUROSCI, V25, P108, DOI 10.1016/S0166-2236(02)02038-6
   Kiehn O, 2006, ANNU REV NEUROSCI, V29, P279, DOI 10.1146/annurev.neuro.29.051605.112910
   Kramer I, 2006, NEURON, V49, P379, DOI 10.1016/j.neuron.2006.01.008
   Kudo N, 1998, ANN NY ACAD SCI, V860, P306, DOI 10.1111/j.1749-6632.1998.tb09058.x
   LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P371, DOI 10.1113/jphysiol.1978.sp012545
   LANDMESSER L, 1978, J PHYSIOL-LONDON, V284, P391, DOI 10.1113/jphysiol.1978.sp012546
   Lanuza GM, 2004, NEURON, V42, P375, DOI 10.1016/S0896-6273(04)00249-1
   Lemon RN, 2005, MUSCLE NERVE, V32, P261, DOI 10.1002/mus.20333
   Levanon D, 2002, EMBO J, V21, P3454, DOI 10.1093/emboj/cdf370
   Levinsson A, 2002, J NEUROSCI, V22, P8170
   Levinsson A, 1999, J NEUROSCI, V19, P10397
   Lin JH, 1998, CELL, V95, P393, DOI 10.1016/S0092-8674(00)81770-5
   Livet J, 2002, NEURON, V35, P877, DOI 10.1016/S0896-6273(02)00863-2
   Luo WQ, 2007, NEURON, V54, P739, DOI 10.1016/j.neuron.2007.04.027
   Mears SC, 1997, J NEUROSCI, V17, P3128
   Mendell LM, 2001, J PHYSIOL-LONDON, V533, P91, DOI 10.1111/j.1469-7793.2001.0091b.x
   Mendell LM, 1999, J PHYSIOLOGY-PARIS, V93, P297, DOI 10.1016/S0928-4257(00)80058-3
   Mentis GZ, 2006, J NEUROSCI, V26, P13297, DOI 10.1523/JNEUROSCI.2945-06.2006
   Mentis GZ, 2005, P NATL ACAD SCI USA, V102, P7344, DOI 10.1073/pnas.0502788102
   Miles GB, 2007, P NATL ACAD SCI USA, V104, P2448, DOI 10.1073/pnas.0611134104
   Milner LD, 1999, J NEUROSCI, V19, P3007
   Muller T, 2002, NEURON, V34, P551, DOI 10.1016/S0896-6273(02)00689-X
   Myers CP, 2005, NEURON, V46, P37, DOI 10.1016/j.neuron.2005.02.022
   Nishimaru H, 2005, P NATL ACAD SCI USA, V102, P5245, DOI 10.1073/pnas.0501331102
   NORNES HO, 1978, BRAIN RES, V159, P1, DOI 10.1016/0006-8993(78)90105-1
   O'Donovan MJ, 1999, CURR OPIN NEUROBIOL, V9, P94, DOI 10.1016/S0959-4388(99)80012-9
   OKADO N, 1990, ANAT EMBRYOL, V182, P113
   Ozaki S, 1997, J COMP NEUROL, V380, P215
   Patel TD, 2003, NEURON, V38, P403, DOI 10.1016/S0896-6273(03)00261-7
   Pearson KG, 2004, PROG BRAIN RES, V143, P123, DOI 10.1016/S0079-6123(03)43012-4
   Peng CY, 2007, NEURON, V53, P813, DOI 10.1016/j.neuron.2007.02.019
   Petersson P, 2003, NATURE, V424, P72, DOI 10.1038/nature01719
   Pierani A, 2001, NEURON, V29, P367, DOI 10.1016/S0896-6273(01)00212-4
   ROMANES GJ, 1951, J COMP NEUROL, V94, P313, DOI 10.1002/cne.900940209
   ROSE PK, 1995, J NEUROPHYSIOL, V73, P1319
   Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005
   Ryan JM, 1998, BRAIN BEHAV EVOLUT, V51, P90
   Schouenborg J, 2002, BRAIN RES REV, V40, P80, DOI 10.1016/S0165-0173(02)00191-1
   Schouenborg J, 2004, CURR OPIN NEUROBIOL, V14, P693, DOI 10.1016/j.conb.2004.10.009
   SCHOUENBORG J, 1990, EXP BRAIN RES, V83, P67
   SCHOUENBORG J, 1992, EXP BRAIN RES, V90, P469
   SCHOUENBORG J, 1995, EXP BRAIN RES, V106, P19
   STRAZNICKY C, 1983, ANAT EMBRYOL, V166, P209, DOI 10.1007/BF00305083
   Tourtellotte WG, 1998, NAT GENET, V20, P87
   Vrieseling E, 2006, CELL, V127, P1439, DOI 10.1016/j.cell.2006.10.042
   Waldenstrom A, 2003, J NEUROSCI, V23, P7719
   Wang Z, 2007, J NEUROSCI, V27, P3686, DOI 10.1523/JNEUROSCI.0197-07.2007
   Wenner P, 2000, J NEUROPHYSIOL, V84, P2651
   Whelan P, 2000, J NEUROPHYSIOL, V84, P2821
   Wickersham IR, 2007, NEURON, V53, P639, DOI 10.1016/j.neuron.2007.01.033
   Wilson JM, 2005, J NEUROSCI, V25, P5710, DOI 10.1523/JNEUROSCI.0274-05.2005
   Wilson JM, 2004, J COMP NEUROL, V474, P13, DOI 10.1002/cne.20089
   Windhorst U, 2007, BRAIN RES BULL, V73, P155, DOI 10.1016/j.brainresbull.2007.03.010
   WINDHORST U, 1990, PROG NEUROBIOL, V35, P135, DOI 10.1016/0301-0082(90)90020-H
   Wolpaw JR, 2001, ANNU REV NEUROSCI, V24, P807, DOI 10.1146/annurev.neuro.24.1.807
   Xu HY, 2007, J NEUROPHYSIOL, V97, P2769, DOI 10.1152/jn.01324.2006
   Yang HW, 2003, EXP BRAIN RES, V149, P458, DOI 10.1007/s00221-003-1393-9
NR 104
TC 70
Z9 70
U1 0
U2 9
PU CELL PRESS
PI CAMBRIDGE
PA 50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA
SN 0896-6273
EI 1097-4199
J9 NEURON
JI Neuron
PD OCT 25
PY 2007
VL 56
IS 2
BP 270
EP 283
DI 10.1016/j.neuron.2007.09.026
PG 14
WC Neurosciences
SC Neurosciences & Neurology
GA 228PA
UT WOS:000250740700006
PM 17964245
DA 2021-01-25
ER

PT J
AU Stefan, E
   Aquin, S
   Berger, N
   Landry, CR
   Nyfeler, B
   Bouvier, M
   Michnick, SW
AF Stefan, E.
   Aquin, S.
   Berger, N.
   Landry, C. R.
   Nyfeler, B.
   Bouvier, M.
   Michnick, S. W.
TI Quantification of dynamic protein complexes using Renilla luciferase
   fragment complementation applied to protein kinase A activities in vivo
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE G protein-coupled receptor; complementation assays; protein-protein
   interactions; protein fragment
ID COUPLED RECEPTORS; LIVING CELLS; CYCLIC-AMP; BETA(2)-ADRENERGIC
   RECEPTOR; MAMMALIAN-CELLS; BETA-ARRESTIN; CAMP; ACTIVATION; SENSORS;
   OLIGOMERIZATION
AB The G protein-coupled receptor (GPCR) superfamily represents the most important class of pharmaceutical targets. Therefore, the characterization of receptor cascades and their ligands is a prerequisite to discovering novel drugs. Quantification of agonist-induced second messengers and downstream-coupled kinase activities is central to characterization of GPCRs or other pathways that converge on GPCR-mediated signaling. Furthermore, there is a need for simple, cell-based assays that would report on direct or indirect actions on GPCR-mediated effectors of signaling. More generally, there is a demand for sensitive assays to quantify alterations of protein complexes in vivo. We describe the development of a Renilla luciferase (RIuc)-based protein fragment complementation assay (PCA) that was designed specifically to investigate dynamic protein complexes. We demonstrate these features for GPCR-induced disassembly of protein kinase A (PKA) regulatory and catalytic subunits, a key effector of GPCR signaling. Taken together, our observations show that the PCA allows for direct and accurate measurements of live changes of absolute values of protein complex assembly and disassembly as well as cellular imaging and dynamic localization of protein complexes. Moreover, the RIuc-PCA has a sufficiently high signal-to-background ratio to identify endogenously expressed Gas protein-coupled receptors. We provide pharmacological evidence that the phosphodiesterase-4 family selectively down-regulates constitutive beta-2 adrenergic- but not vasopressin-2 receptor-mediated PKA activities. Our results show that the sensitivity of the RIuc-PCA simplifies the recording of pharmacological profiles of GPCR-based candidate drugs and could be extended to high-throughput screens to identify novel direct modulators of PKA or upstream components of GPCR signaling cascades.
C1 Univ Montreal, Dept Biochim, Montreal, PQ H3C 3J7, Canada.
   Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ H3C 3J7, Canada.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Michnick, SW (corresponding author), Univ Montreal, Dept Biochim, CP 6128, Montreal, PQ H3C 3J7, Canada.
EM stephen.michnick@umontreal.ca
RI Landry, Christian/F-3890-2011; Bouvier, Michel/H-2758-2014
OI Bouvier, Michel/0000-0003-1128-0100; Stefan, Eduard/0000-0003-3650-4713
CR Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389
   Azzi M, 2003, P NATL ACAD SCI USA, V100, P11406, DOI 10.1073/pnas.1936664100
   Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911
   Breit A, 2004, J BIOL CHEM, V279, P28756, DOI 10.1074/jbc.M313310200
   Cohen P, 2002, NAT REV DRUG DISCOV, V1, P309, DOI 10.1038/nrd773
   Dodge-Kafka KL, 2005, NATURE, V437, P574, DOI 10.1038/nature03966
   Dorsam RT, 2007, NAT REV CANCER, V7, P79, DOI 10.1038/nrc2069
   Galarneau A, 2002, NAT BIOTECHNOL, V20, P619, DOI 10.1038/nbt0602-619
   Ghosh I, 2000, J AM CHEM SOC, V122, P5658, DOI 10.1021/ja994421w
   Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892
   Houslay MD, 2005, DRUG DISCOV TODAY, V10, P1503, DOI 10.1016/S1359-6446(05)03622-6
   Hu CD, 2003, NAT BIOTECHNOL, V21, P539, DOI 10.1038/nbt816
   Jacoby E, 2006, CHEMMEDCHEM, V1, P760, DOI 10.1002/cmdc.200600134
   JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340
   Kaihara A, 2003, ANAL CHEM, V75, P4176, DOI 10.1021/ac0300800
   Lavoie C, 2002, J BIOL CHEM, V277, P35402, DOI 10.1074/jbc.M204163200
   Luker KE, 2004, P NATL ACAD SCI USA, V101, P12288, DOI 10.1073/pnas.0404041101
   Lynch MJ, 2005, J BIOL CHEM, V280, P33178, DOI 10.1074/jbc.M414316200
   Marinissen MJ, 2001, TRENDS PHARMACOL SCI, V22, P368, DOI 10.1016/S0165-6147(00)01678-3
   Michnick SW, 2000, METHOD ENZYMOL, V328, P208, DOI 10.1016/S0076-6879(00)28399-7
   Morello JP, 2000, J CLIN INVEST, V105, P887, DOI 10.1172/JCI8688
   Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c
   Pelletier JN, 1999, NAT BIOTECHNOL, V17, P683
   Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141
   Perry SJ, 2002, SCIENCE, V298, P834, DOI 10.1126/science.1074683
   Pierce KL, 2002, NAT REV MOL CELL BIO, V3, P639, DOI 10.1038/nrm908
   Prinz A, 2006, CELL SIGNAL, V18, P1616, DOI 10.1016/j.cellsig.2006.01.013
   Remy I, 1999, P NATL ACAD SCI USA, V96, P5394, DOI 10.1073/pnas.96.10.5394
   Remy I, 1999, SCIENCE, V283, P990, DOI 10.1126/science.283.5404.990
   REMY I, 2005, PROTEIN PROTEIN INTE, P637
   Remy I, 2006, NAT METHODS, V3, P977, DOI 10.1038/nmeth979
   Rich TC, 2002, ANN BIOMED ENG, V30, P1088, DOI 10.1114/1.1511242
   SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626
   Seifert R, 2002, N-S ARCH PHARMACOL, V366, P381, DOI 10.1007/s00210-002-0588-0
   Shabb JB, 2001, CHEM REV, V101, P2381, DOI 10.1021/cr000236l
   Smith FD, 2006, TRENDS BIOCHEM SCI, V31, P316, DOI 10.1016/j.tibs.2006.04.009
   Spotts JM, 2002, P NATL ACAD SCI USA, V99, P15142, DOI 10.1073/pnas.232565699
   Taylor SS, 2004, BBA-PROTEINS PROTEOM, V1697, P259, DOI 10.1016/j.bbapap.2003.11.029
   Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050
   Vigil D, 2004, BIOCHEMISTRY-US, V43, P5629, DOI 10.1021/bi0499157
   Wehrman T, 2002, P NATL ACAD SCI USA, V99, P3469, DOI 10.1073/pnas.062043699
   Willoughby D, 2006, EMBO J, V25, P2051, DOI 10.1038/sj.emboj.7601113
   Wong W, 2004, NAT REV MOL CELL BIO, V5, P959, DOI 10.1038/nrm1527
   Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102
   Zaccolo M, 2000, NAT CELL BIOL, V2, P25
   Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140
   Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798
NR 47
TC 126
Z9 130
U1 0
U2 18
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 23
PY 2007
VL 104
IS 43
BP 16916
EP 16921
DI 10.1073/pnas.0704257104
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 224ZT
UT WOS:000250487600036
PM 17942691
OA Green Published, Bronze
DA 2021-01-25
ER

PT J
AU Merabet, S
   Saadaoui, M
   Sambrani, N
   Hudry, B
   Pradel, J
   Affolter, M
   Graba, Y
AF Merabet, Samir
   Saadaoui, Mehdi
   Sambrani, Nagraj
   Hudry, Bruno
   Pradel, Jacques
   Affolter, Markus
   Graba, Yacine
TI A unique Extradenticle recruitment mode in the Drosophila Hox protein
   Ultrabithorax
SO PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF
   AMERICA
LA English
DT Article
DE development; transcription; hexapeptide; UbdA
ID IN-VIVO; HOMEO DOMAIN; TARGET GENE; DNA-BINDING; HOMEODOMAIN;
   HEXAPEPTIDE; SPECIFICITY; REPRESSION; COMPLEX; MOTIF
AB Hox transcription factors are essential for shaping body morphology in development and evolution. The control of Hox protein activity in part arises from interaction with the PBC class of partners, pre-B cell transcription factor (Pbx) proteins in vertebrates and Extradenticle (Exd) in Drosophila. Characterized interactions occur through a single mode, involving a short hexapeptide motif in the Hox protein. This apparent uniqueness in Hox-PBC interaction provides little mechanistic insight in how the same cofactors endow Hox proteins with specific and diverse activities. Here, we identify in the Drosophila Ultrabithorax (Ubx) protein a short motif responsible for an alternative mode of Exd recruitment. Together with previous reports, this finding highlights that the Hox protein Ubx has multiple ways to interact with the Excl cofactor and suggests that flexibility in Hox-PBC contacts contributes to specify and diversify Hox protein function.
C1 Univ Aix Marseille 2, CNRS, Inst Biol Dev Marseille Luminy, F-13288 Marseille 09, France.
   Univ Basel, Biozentrum, CH-4056 Basel, Switzerland.
RP Merabet, S (corresponding author), Univ Aix Marseille 2, CNRS, Inst Biol Dev Marseille Luminy, Parc Sci Luminy,Case 907, F-13288 Marseille 09, France.
EM merabet@ibdm.univ-mrs.fr; graba@ibdm.univ-mrs.fr
RI HUDRY, Bruno/S-4330-2018; Sambrani, Nagraj/E-2655-2019; Graba,
   Yacine/AAC-9010-2019
OI HUDRY, Bruno/0000-0003-1299-843X; Sambrani, Nagraj/0000-0001-5956-5725;
   Affolter, Markus/0000-0002-5171-0016
CR Chan SK, 1996, EMBO J, V15, P2476, DOI 10.1002/j.1460-2075.1996.tb00605.x
   CHAN SK, 1993, GENE DEV, V7, P796, DOI 10.1101/gad.7.5.796
   Chan SK, 1997, DEVELOPMENT, V124, P2007
   CHAN SK, 1994, CELL, V78, P603, DOI 10.1016/0092-8674(94)90525-8
   Galant R, 2002, DEVELOPMENT, V129, P3115
   Galant R, 2002, NATURE, V415, P910, DOI 10.1038/nature717
   Gebelein B, 2004, NATURE, V431, P653, DOI 10.1038/nature02946
   Gebelein B, 2002, DEV CELL, V3, P487, DOI 10.1016/S1534-5807(02)00257-5
   GONZALEZREYES A, 1990, CELL, V61, P515, DOI 10.1016/0092-8674(90)90533-K
   JOHNSON FB, 1995, P NATL ACAD SCI USA, V92, P739, DOI 10.1073/pnas.92.3.739
   KNOEPFLER PS, 1995, MOL CELL BIOL, V15, P5811
   LaRonde-LeBlanc NA, 2003, GENE DEV, V17, P2060, DOI 10.1101/gad.1103303
   MANAK JR, 1994, DEVELOPMENT, V120, P3605
   MANN RS, 1990, CELL, V60, P597, DOI 10.1016/0092-8674(90)90663-Y
   Mann RS, 1996, TRENDS GENET, V12, P258, DOI 10.1016/0168-9525(96)10026-3
   MCCORMICK AM, 1995, DEVELOPMENT, V121, P2799
   Medina-Martinez O, 2003, DEV BIOL, V264, P77, DOI 10.1016/j.ydbio.2003.07.020
   Merabet S, 2003, DEV CELL, V4, P761, DOI 10.1016/S1534-5807(03)00126-6
   Moens CB, 2006, DEV BIOL, V291, P193, DOI 10.1016/j.ydbio.2005.10.032
   Passner JM, 1999, NATURE, V397, P714, DOI 10.1038/17833
   Pearson JC, 2005, NAT REV GENET, V6, P893, DOI 10.1038/nrg1726
   PEIFER M, 1990, GENE DEV, V4, P1209, DOI 10.1101/gad.4.7.1209
   Piper DE, 1999, CELL, V96, P587, DOI 10.1016/S0092-8674(00)80662-5
   POPPERL H, 1995, CELL, V81, P1031, DOI 10.1016/S0092-8674(05)80008-X
   RAUSKOLB C, 1994, EMBO J, V13, P3561, DOI 10.1002/j.1460-2075.1994.tb06663.x
   Remacle S, 2004, MOL CELL BIOL, V24, P8567, DOI 10.1128/MCB.24.19.8567-8575.2004
   Rieckhof GE, 1997, CELL, V91, P171, DOI 10.1016/S0092-8674(00)80400-6
   Ronshaugen M, 2002, NATURE, V415, P914, DOI 10.1038/nature716
   Ryoo HD, 1999, DEVELOPMENT, V126, P5137
   SUN B, 1995, EMBO J, V14, P520, DOI 10.1002/j.1460-2075.1995.tb07028.x
   Tour E, 2005, DEVELOPMENT, V132, P5271, DOI 10.1242/dev.02138
   VACHON G, 1992, CELL, V71, P437, DOI 10.1016/0092-8674(92)90513-C
   White RAH, 2000, MECH DEVELOP, V91, P217, DOI 10.1016/S0925-4773(99)00306-8
NR 33
TC 56
Z9 56
U1 0
U2 4
PU NATL ACAD SCIENCES
PI WASHINGTON
PA 2101 CONSTITUTION AVE NW, WASHINGTON, DC 20418 USA
SN 0027-8424
J9 P NATL ACAD SCI USA
JI Proc. Natl. Acad. Sci. U. S. A.
PD OCT 23
PY 2007
VL 104
IS 43
BP 16946
EP 16951
DI 10.1073/pnas.0705832104
PG 6
WC Multidisciplinary Sciences
SC Science & Technology - Other Topics
GA 224ZT
UT WOS:000250487600041
PM 17942685
OA Bronze, Green Published
DA 2021-01-25
ER

EF